ffects of Drugs|physiological effects of drugs|mesh-ancestor
138473947|NCT04736433|Valsartan|valsartan|mesh-list
138473948|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138473949|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138473950|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138473951|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138473952|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138421488|NCT03194893|Crizotinib|crizotinib|mesh-list
138473953|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473955|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473956|NCT04735523|Warfarin|warfarin|mesh-list
138390749|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473958|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
138473959|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
138473960|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138473961|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
138473962|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473963|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473964|NCT04734730|Prednisone|prednisone|mesh-list
138473965|NCT04734730|Cortisone|cortisone|mesh-list
138473966|NCT04734730|Leuprolide|leuprolide|mesh-list
138473967|NCT04734730|Goserelin|goserelin|mesh-list
138473968|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
138473969|NCT04734730|Bicalutamide|bicalutamide|mesh-list
138473970|NCT04734730|Talazoparib|talazoparib|mesh-list
138473971|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473972|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
138473974|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473975|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473976|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138473977|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473978|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138473979|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
138473980|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473981|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138473982|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473983|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473984|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473985|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138473986|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
138473987|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138473988|NCT04681820|Flumatinib|flumatinib|mesh-list
138473989|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473990|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473993|NCT04675788|Testosterone|testosterone|mesh-list
138473994|NCT04675788|Progesterone|progesterone|mesh-list
138473995|NCT04675788|Androgens|androgens|mesh-ancestor
138473997|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473998|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473999|NCT04675788|Progestins|progestins|mesh-ancestor
138474000|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138474001|NCT04667572|Riboflavin|riboflavin|mesh-list
138474002|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
138474003|NCT04667572|Vitamins|vitamins|mesh-ancestor
138474004|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
138474005|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474006|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138474007|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474008|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
138474009|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138474010|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138474011|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474012|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
138474013|NCT04651166|Coagulants|coagulants|mesh-ancestor
138474014|NCT04642547|Lenvatinib|lenvatinib|mesh-list
138474016|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474017|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474018|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474019|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474020|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
138474021|NCT04539314|Bupivacaine|bupivacaine|mesh-list
138474022|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474023|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
138474024|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474025|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474026|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
138474027|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474028|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138474029|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390851|NCT01502267|Bortezomib|bortezomib|mesh-list
138474031|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138474032|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138474033|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138474034|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
138390884|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474035|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474036|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474037|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
138474038|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474039|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474040|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474041|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474042|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
138474043|NCT04508894|Ketamine|ketamine|mesh-list
138474044|NCT04508894|Bupivacaine|bupivacaine|mesh-list
138474045|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474046|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
138474047|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474048|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474049|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
138474050|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474052|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474053|NCT04508894|Analgesics|analgesics|mesh-ancestor
138474054|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138474056|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138474057|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
138204423|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204424|NCT05776212|Fluorides|fluorides|mesh-list
138474058|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204425|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
138204426|NCT05776212|Protective Agents|protective agents|mesh-ancestor
138204427|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474059|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474060|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138474061|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138474062|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
138474063|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138474064|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138474065|NCT04506125|Chrysarobin|chrysarobin|mesh-list
138474066|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138474068|NCT04506125|Analgesics|analgesics|mesh-ancestor
138474069|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
138474070|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474071|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474072|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474073|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474074|NCT04487236|Capecitabine|capecitabine|mesh-list
138474075|NCT04487236|Trastuzumab|trastuzumab|mesh-list
138474076|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474077|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
138474078|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474079|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474080|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474081|NCT04429022|Acetaminophen|acetaminophen|mesh-list
138474082|NCT04429022|Celecoxib|celecoxib|mesh-list
138474083|NCT04429022|Ketorolac|ketorolac|mesh-list
138474084|NCT04429022|Oxycodone|oxycodone|mesh-list
138474085|NCT04429022|Gabapentin|gabapentin|mesh-list
138474086|NCT04429022|Hydromorphone|hydromorphone|mesh-list
138474087|NCT04429022|Ropivacaine|ropivacaine|mesh-list
138474088|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
138474089|NCT04429022|Anesthetics|anesthetics|mesh-list
138474090|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474091|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474092|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
138474093|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474094|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474095|NCT04429022|Analgesics|analgesics|mesh-ancestor
138474096|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
138474097|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138474098|NCT04429022|Narcotics|narcotics|mesh-ancestor
138474099|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138390936|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474100|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474101|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474103|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138474105|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474106|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
138474107|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138474108|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138474109|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474110|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138474111|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138474112|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474113|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
138474114|NCT04400838|Vaccines|vaccines|mesh-list
138474115|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
138474116|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474117|NCT04396990|Prednisolone|prednisolone|mesh-list
138474118|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474119|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
138474120|NCT04396990|Hormones|hormones|mesh-ancestor
138474121|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474122|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474123|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474124|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474125|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
138474126|NCT04394624|Ramucirumab|ramucirumab|mesh-list
138474127|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474128|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474129|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474130|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474131|NCT04364555|Clobetasol|clobetasol|mesh-list
138474132|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474133|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
138474134|NCT04364555|Hormones|hormones|mesh-ancestor
138474135|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474136|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474137|NCT04324606|Acetaminophen|acetaminophen|mesh-list
138474138|NCT04324606|Vaccines|vaccines|mesh-list
138474139|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
138390977|NCT01503359|Glycine|glycine|mesh-list
138474142|NCT04324606|Analgesics|analgesics|mesh-ancestor
138474143|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
138474144|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474145|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
138474146|NCT04321408|Ziconotide|ziconotide|mesh-list
138474147|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138474148|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474149|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474150|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138474151|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474152|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138474153|NCT04321408|Protective Agents|protective agents|mesh-ancestor
138474154|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474155|NCT04321408|Analgesics|analgesics|mesh-ancestor
138474156|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
138474157|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474158|NCT04298606|Vaccines|vaccines|mesh-list
138474159|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138474160|NCT04298606|Mitogens|mitogens|mesh-list
138188308|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474161|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
138474162|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474163|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474164|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474165|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138474167|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474168|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474170|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474171|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138474172|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
138474173|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474175|NCT04254081|Buprenorphine|buprenorphine|mesh-list
138474176|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474177|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
138474178|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474179|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474180|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
138474181|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474182|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138474183|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138474184|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138474185|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474186|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474187|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138391045|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474189|NCT04254081|Analgesics|analgesics|mesh-ancestor
138474192|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
138474193|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474194|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
138474195|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474196|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474197|NCT04243122|Aspirin|aspirin|mesh-list
138474198|NCT04243122|Apixaban|apixaban|mesh-list
138474199|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138474200|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474201|NCT04243122|Analgesics|analgesics|mesh-ancestor
138474202|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
138474203|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474204|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474205|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474206|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474207|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138474208|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138474209|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474210|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138474211|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138474212|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474213|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
138474214|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138474215|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
138474216|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138474217|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
138474218|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
138474220|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138474221|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391101|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474223|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474224|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474225|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
138474226|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
138474227|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474228|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138474229|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474230|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474231|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
138474232|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474235|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
138474237|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474238|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138474239|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138474240|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
138474242|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474243|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138474244|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138474245|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474246|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474247|NCT04122196|Pregabalin|pregabalin|mesh-list
138474248|NCT04122196|Analgesics|analgesics|mesh-ancestor
138474249|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
138474250|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474251|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474252|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
138474253|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138474254|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474255|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474256|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138474257|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138474258|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138474259|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474260|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474261|NCT04106115|Durvalumab|durvalumab|mesh-list
138474262|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138474263|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474264|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474265|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138474266|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
138474267|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474268|NCT04105231|Cannabidiol|cannabidiol|mesh-list
138474269|NCT04105231|Risperidone|risperidone|mesh-list
138474270|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138474271|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
138474272|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474273|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474274|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474275|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138474276|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138474277|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474278|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474279|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138474280|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
138474281|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
138474282|NCT04073615|Trifluridine|trifluridine|mesh-list
138474283|NCT04073615|Apatinib|apatinib|mesh-list
138474284|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474285|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474286|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474287|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474289|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
138474290|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474291|NCT04050085|Nivolumab|nivolumab|mesh-list
138474292|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474293|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474294|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474295|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474297|NCT04042558|Atezolizumab|atezolizumab|mesh-list
138474298|NCT04042558|Carboplatin|carboplatin|mesh-list
138474299|NCT04042558|Pemetrexed|pemetrexed|mesh-list
138474300|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138474302|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474303|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474304|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474305|NCT04042558|Growth Substances|growth substances|mesh-ancestor
138474306|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474307|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474308|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474309|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474310|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138474311|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138474312|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474313|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
138474315|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
138474316|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138474317|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
138474318|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474319|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474320|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138474321|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
138474323|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474325|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474326|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474327|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
138474328|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474329|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138474330|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138474331|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138474332|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474333|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474335|NCT04034238|LMB-100|lmb-100|mesh-list
138474336|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138474337|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474338|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391271|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474339|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474341|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
138474342|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474343|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
138474345|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
138474346|NCT03994172|Teriparatide|teriparatide|mesh-list
138474347|NCT03994172|Citric Acid|citric acid|mesh-list
138474348|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
138474349|NCT03994172|Calcium|calcium|mesh-list
138474350|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
138474352|NCT03994172|Hormones|hormones|mesh-list
138474353|NCT03994172|Vitamins|vitamins|mesh-ancestor
138474354|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
138474355|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474356|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138474357|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138474358|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
138474359|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138474360|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
138474361|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
138474362|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474363|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474364|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138474365|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138474366|NCT03978442|Bupropion|bupropion|mesh-list
138474367|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138474368|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
138474369|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474370|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138474371|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138474372|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474373|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474374|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
138474375|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474376|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474377|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138474378|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138474379|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474380|NCT03956966|Dexamethasone|dexamethasone|mesh-list
138474381|NCT03956966|Bupivacaine|bupivacaine|mesh-list
138474382|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474383|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
138474384|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
138391331|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474386|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474387|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474390|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474391|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474392|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474393|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474394|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
138474395|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474396|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
138474397|NCT03956056|Poly I-C|poly i-c|mesh-list
138474398|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138474399|NCT03956056|Poly ICLC|poly iclc|mesh-list
138474400|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
138474401|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
138474402|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474403|NCT03956056|Laxatives|laxatives|mesh-ancestor
138474404|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474405|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
138474406|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474407|NCT03954041|Glyburide|glyburide|mesh-list
138474408|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138474409|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474410|NCT03950154|Bevacizumab|bevacizumab|mesh-list
138474411|NCT03950154|Capecitabine|capecitabine|mesh-list
138474412|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
138474414|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474415|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474416|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474417|NCT03950154|Growth Substances|growth substances|mesh-ancestor
138474418|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474419|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474420|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474421|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
138204461|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
138204462|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
138474422|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474423|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
138474424|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474425|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
138474426|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474427|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474428|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138474429|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
138474430|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474431|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
138474432|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474433|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474434|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138474435|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
138474436|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474437|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474438|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138474439|NCT03936023|Saxagliptin|saxagliptin|mesh-list
138474440|NCT03936023|Incretins|incretins|mesh-ancestor
138474442|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474443|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474444|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138474446|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474447|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474448|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138474449|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
138474450|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474451|NCT03878199|Cytarabine|cytarabine|mesh-list
138474454|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474455|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
138474456|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474457|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204469|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204471|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138204472|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204473|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204474|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204475|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
138204476|NCT05775861|Ropivacaine|ropivacaine|mesh-list
138204477|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138204478|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204479|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204480|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204481|NCT05775861|Analgesics|analgesics|mesh-ancestor
138204482|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
138204483|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204484|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138204485|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138204486|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138204487|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
138204488|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474458|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
138474459|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474460|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474461|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
138474462|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474463|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138474464|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138474465|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138474466|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474467|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474468|NCT03859024|Acetaminophen|acetaminophen|mesh-list
138474469|NCT03859024|Dexamethasone|dexamethasone|mesh-list
138474470|NCT03859024|Ibuprofen|ibuprofen|mesh-list
138474471|NCT03859024|Celecoxib|celecoxib|mesh-list
138474472|NCT03859024|Oxycodone|oxycodone|mesh-list
138474473|NCT03859024|Gabapentin|gabapentin|mesh-list
138474474|NCT03859024|Bupivacaine|bupivacaine|mesh-list
138474475|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474476|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
138474477|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
138474478|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474479|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474480|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474481|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
138474483|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474484|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474485|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474486|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
138391442|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474487|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
138474488|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474489|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
138474490|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474491|NCT03859024|Analgesics|analgesics|mesh-ancestor
138474492|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
138474493|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138474494|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474495|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138474496|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474497|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474498|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138474499|NCT03859024|Narcotics|narcotics|mesh-ancestor
138474500|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138474501|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
138474502|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138474503|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138474504|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474505|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138474506|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138474507|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474508|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
138204503|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204504|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204505|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138204506|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
138204507|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474509|NCT03830866|Carboplatin|carboplatin|mesh-list
138474510|NCT03830866|Durvalumab|durvalumab|mesh-list
138474511|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474512|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204511|NCT05775536|Aspirin|aspirin|mesh-list
138474513|NCT03794388|Pregabalin|pregabalin|mesh-list
138474514|NCT03794388|Capsaicin|capsaicin|mesh-list
138474515|NCT03794388|Analgesics|analgesics|mesh-ancestor
138474516|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
138474517|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474518|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474519|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
138391484|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
138474521|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474522|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474523|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138474525|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138474526|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474527|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474528|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
138474529|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474530|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138474531|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
138474532|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
138474533|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474534|NCT03679949|Oxycodone|oxycodone|mesh-list
138474535|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138474536|NCT03679949|Narcotics|narcotics|mesh-ancestor
138474537|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474539|NCT03679949|Analgesics|analgesics|mesh-ancestor
138474540|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
138474541|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474543|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138474544|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474545|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474547|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138474548|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474549|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
138474550|NCT03607175|Hormones|hormones|mesh-ancestor
138474551|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474552|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474553|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474554|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
138391524|NCT01505504|Mirtazapine|mirtazapine|mesh-list
138474558|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
138474559|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474560|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474561|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474562|NCT03560960|Pramlintide|pramlintide|mesh-list
138474563|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138474564|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474565|NCT03534323|Venetoclax|venetoclax|mesh-list
138474566|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474567|NCT03520842|Methotrexate|methotrexate|mesh-list
138474568|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138474569|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
138474570|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138474571|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474572|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474573|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
138474574|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474575|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204517|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204518|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204519|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204520|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138204521|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138474576|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474577|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204522|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204523|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138474578|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138474579|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474580|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
138474581|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474582|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138474583|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
138474584|NCT03454529|Simvastatin|simvastatin|mesh-list
138474585|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138474586|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138474587|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
138474588|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474589|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138391568|NCT01505920|Lidocaine|lidocaine|mesh-list
138474590|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138474591|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474592|NCT03414658|Trastuzumab|trastuzumab|mesh-list
138474594|NCT03414658|Vinorelbine|vinorelbine|mesh-list
138474595|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474596|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474597|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138474598|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474599|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474600|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474601|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474602|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138474603|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
138474604|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474605|NCT03358875|Docetaxel|docetaxel|mesh-list
138474606|NCT03358875|Tislelizumab|tislelizumab|mesh-list
138474607|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474608|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474609|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474610|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474611|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474612|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474613|NCT03284502|Cetuximab|cetuximab|mesh-list
138474614|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474615|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474616|NCT03277482|Durvalumab|durvalumab|mesh-list
138474617|NCT03277482|Tremelimumab|tremelimumab|mesh-list
138391598|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138474620|NCT03249142|Durvalumab|durvalumab|mesh-list
138474621|NCT03249142|Tremelimumab|tremelimumab|mesh-list
138474622|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138474623|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474624|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474625|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
138474626|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474627|NCT03236428|Daratumumab|daratumumab|mesh-list
138474628|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474629|NCT03149770|Naloxone|naloxone|mesh-list
138474630|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138474631|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474632|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
138474633|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474634|NCT03095235|Riboflavin|riboflavin|mesh-list
138204598|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204599|NCT05463341|Analgesics|analgesics|mesh-ancestor
138474635|NCT03095235|Vitamins|vitamins|mesh-ancestor
138474636|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
138474637|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204600|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
138204601|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204602|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138474638|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
138474639|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138474640|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474641|NCT03016819|Dacarbazine|dacarbazine|mesh-list
138474642|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138474643|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
138474644|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474645|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474646|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
138474647|NCT03012971|Morphine|morphine|mesh-list
138474648|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138474649|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474650|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474651|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474652|NCT03012971|Analgesics|analgesics|mesh-ancestor
138474653|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
138474654|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474655|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138474656|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138474657|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138474658|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
138474659|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474660|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474662|NCT03012971|Narcotics|narcotics|mesh-ancestor
138474663|NCT02960659|Metformin|metformin|mesh-list
138474664|NCT02960659|Liraglutide|liraglutide|mesh-list
138474665|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138474666|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474667|NCT02960659|Incretins|incretins|mesh-ancestor
138474668|NCT02960659|Hormones|hormones|mesh-ancestor
138474669|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474670|NCT02936622|Paclitaxel|paclitaxel|mesh-list
138474671|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138474672|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138474673|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474674|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474675|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474676|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474677|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474679|NCT02916771|Lenalidomide|lenalidomide|mesh-list
138474680|NCT02916771|Ixazomib|ixazomib|mesh-list
138474682|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
138474683|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
138474684|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474685|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474686|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474687|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
138474689|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474690|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474691|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474692|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
138474693|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474694|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474695|NCT02916771|Growth Substances|growth substances|mesh-ancestor
138474696|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474697|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
138474698|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474699|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391674|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474700|NCT02913196|Prednisone|prednisone|mesh-list
138474701|NCT02913196|Docetaxel|docetaxel|mesh-list
138474702|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
138474703|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474704|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474705|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474706|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474707|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474708|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474709|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
138474710|NCT02913196|Hormones|hormones|mesh-ancestor
138474711|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474712|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474713|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474714|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138474715|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474716|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
138474717|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138474719|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138474720|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
138474721|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474722|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474723|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474725|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138474726|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138474727|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138474728|NCT02844933|Cannabidiol|cannabidiol|mesh-list
138474729|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
138474730|NCT02842749|Everolimus|everolimus|mesh-list
138474731|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138474732|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474733|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474735|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474736|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
138474737|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474738|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474739|NCT02797470|Cytarabine|cytarabine|mesh-list
138474740|NCT02797470|Etoposide|etoposide|mesh-list
138474741|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
138474742|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
138474743|NCT02797470|Melphalan|melphalan|mesh-list
138474744|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
138474745|NCT02797470|Carmustine|carmustine|mesh-list
138474746|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138474747|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138474748|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474749|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138474750|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138474751|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474752|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474753|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474754|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
138474755|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
138474756|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474757|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474758|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
138474759|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474760|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138474761|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
138391768|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
138474763|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
138474764|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138474765|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474766|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474767|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474768|NCT02744690|Mitomycins|mitomycins|mesh-list
138474769|NCT02744690|Mitomycin|mitomycin|mesh-list
138474770|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138474771|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474772|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
138474773|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474774|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138474775|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204618|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204619|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204620|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204621|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138204622|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138204623|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474776|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
138204625|NCT05376904|Ropivacaine|ropivacaine|mesh-list
138474777|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474778|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474779|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474780|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474781|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
138474782|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
138474783|NCT02582775|Busulfan|busulfan|mesh-list
138474784|NCT02582775|Fludarabine|fludarabine|mesh-list
138474785|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
138474786|NCT02582775|Tacrolimus|tacrolimus|mesh-list
138474787|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
138474788|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138391804|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474789|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138474791|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474792|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474793|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138474794|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
138474795|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474796|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474797|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138474798|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474799|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
138474800|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474801|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138474802|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474803|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138474804|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138474805|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
138474806|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138474808|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474809|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474810|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474811|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474812|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
138474813|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
138474814|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
138474815|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474816|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474817|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138474818|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474819|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
138474820|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474821|NCT02460497|Minoxidil|minoxidil|mesh-list
138391853|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
138391858|NCT01506804|Hormones|hormones|mesh-ancestor
138474824|NCT02460289|Minoxidil|minoxidil|mesh-list
138474825|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138474826|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
138474827|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
138474828|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474829|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
138204629|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204630|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
138474830|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204633|NCT05298670|Interferons|interferons|mesh-list
138474831|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474832|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138474834|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138474835|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
138474836|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138474837|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474838|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474839|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474840|NCT02261883|Treprostinil|treprostinil|mesh-list
138474841|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138474842|NCT02253316|Dexamethasone|dexamethasone|mesh-list
138474843|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
138474844|NCT02253316|Lenalidomide|lenalidomide|mesh-list
138474845|NCT02253316|Ixazomib|ixazomib|mesh-list
138474846|NCT02253316|BB 1101|bb 1101|mesh-list
138474847|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474849|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
138474850|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474851|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204652|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
138204653|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204654|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138204655|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
138204658|NCT05252598|Psilocybin|psilocybin|mesh-list
138474852|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474853|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
138474854|NCT02253316|Hormones|hormones|mesh-ancestor
138474855|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474856|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138474857|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474858|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
138474859|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474860|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474861|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
138474862|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474863|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474864|NCT02253316|Growth Substances|growth substances|mesh-ancestor
138474865|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474866|NCT02169089|Spironolactone|spironolactone|mesh-list
138474867|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138474868|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
138474869|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391897|NCT01507194|Ondansetron|ondansetron|mesh-list
138474871|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138474872|NCT02169089|Diuretics|diuretics|mesh-ancestor
138474873|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
138474874|NCT02130453|Regadenoson|regadenoson|mesh-list
138474875|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138474876|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138474877|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
138474878|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
138474879|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138474880|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474881|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474883|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474884|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474885|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391918|NCT01507311|Liraglutide|liraglutide|mesh-list
138474888|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474889|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474890|NCT01130519|Bevacizumab|bevacizumab|mesh-list
138474891|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138474892|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474893|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474894|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474895|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474896|NCT01130519|Growth Substances|growth substances|mesh-ancestor
138474897|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474898|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474899|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138474900|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474901|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474902|NCT00655967|Acamprosate|acamprosate|mesh-list
138474903|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138391977|NCT01507467|Nimorazole|nimorazole|mesh-list
138391982|NCT01507480|Bevacizumab|bevacizumab|mesh-list
138474906|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
138474907|NCT00601198|Amifostine|amifostine|mesh-list
138392035|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
138474908|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204706|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474909|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474910|NCT00601198|Antidotes|antidotes|mesh-ancestor
138204707|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204708|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138204709|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138204710|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138204711|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138474911|NCT00601198|Protective Agents|protective agents|mesh-ancestor
138474912|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
138474913|NCT00601198|Vitamins|vitamins|mesh-ancestor
138474914|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
138474915|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138474916|NCT02006498|Silymarin|silymarin|mesh-list
138474917|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
138474918|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474919|NCT02006498|Protective Agents|protective agents|mesh-ancestor
138474920|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474922|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
138474923|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138474924|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138474925|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138474926|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474927|NCT02006602|Candesartan|candesartan|mesh-list
138474928|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
138474929|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138474930|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138474931|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138474932|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474934|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
138474935|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474936|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
138474937|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474938|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138474939|NCT02006849|Hormones|hormones|mesh-ancestor
138474940|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474941|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474942|NCT02006914|Chromium|chromium|mesh-list
138474943|NCT02006914|Picolinic acid|picolinic acid|mesh-list
138474944|NCT02006914|Trace Elements|trace elements|mesh-ancestor
138474945|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
138474946|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474947|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138474948|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
138474949|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
138392080|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474950|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474952|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474953|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
138474954|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138474955|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474956|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
138474957|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474958|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138474959|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138474960|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138474961|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474962|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474963|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
138474964|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474965|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138474966|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138474967|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
138204713|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204714|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138204716|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
138204717|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138204718|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
138204719|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204720|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204721|NCT04779320|Vedolizumab|vedolizumab|mesh-list
138474968|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474970|NCT02007148|Capecitabine|capecitabine|mesh-list
138474971|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474972|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
138474973|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474974|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474976|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474977|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
138474978|NCT02007161|Diclofenac|diclofenac|mesh-list
138474979|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138474980|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138474981|NCT02007161|Analgesics|analgesics|mesh-ancestor
138474982|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
138474983|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474984|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474985|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138474986|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474987|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138474988|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474989|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474990|NCT02007174|Bevacizumab|bevacizumab|mesh-list
138474991|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474992|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474993|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138474994|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138474995|NCT02007174|Growth Substances|growth substances|mesh-ancestor
138474996|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474997|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
138474999|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
138392181|NCT01508468|Rituximab|rituximab|mesh-list
138475000|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
138475001|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475002|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475004|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475005|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138475006|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138475007|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138475008|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475009|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204728|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
138204729|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138204730|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138204731|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204732|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
138204733|NCT04733157|Coagulants|coagulants|mesh-ancestor
138204734|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
138204735|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138204736|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204737|NCT04633122|Sunitinib|sunitinib|mesh-list
138204738|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204739|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138204740|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138204741|NCT04633122|Growth Substances|growth substances|mesh-ancestor
138204743|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
138475010|NCT02007408|Lidocaine|lidocaine|mesh-list
138475011|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
138475012|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
138475013|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475014|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475015|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
138475016|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475017|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138475018|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138475019|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138475020|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475021|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475022|NCT02007447|Oxytocin|oxytocin|mesh-list
138475023|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
138475024|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475025|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475026|NCT02007603|Amoxicillin|amoxicillin|mesh-list
138475027|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
138475028|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
138475032|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138475033|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475034|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475035|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475036|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138475037|NCT02007629|Riociguat|riociguat|mesh-list
138475038|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
138475039|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475040|NCT02007746|Liver Extracts|liver extracts|mesh-list
138475041|NCT02007746|Hematinics|hematinics|mesh-ancestor
138475042|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
138475043|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138475044|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475045|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475046|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475047|NCT02007798|Analgesics|analgesics|mesh-ancestor
138475048|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
138475049|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475050|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138475051|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475052|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475053|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475054|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475055|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475056|NCT02007837|Aspirin|aspirin|mesh-list
138475057|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475058|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475059|NCT02007837|Analgesics|analgesics|mesh-ancestor
138475061|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475062|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475063|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475064|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475065|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138475066|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138475067|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475068|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138475069|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138475070|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204748|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204749|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
138204750|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475071|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
138475072|NCT02007850|Ropivacaine|ropivacaine|mesh-list
138475073|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
138475074|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
138475075|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475076|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475077|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
138392258|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475078|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475080|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138475081|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475083|NCT02007928|Risperidone|risperidone|mesh-list
138475084|NCT02007928|Aripiprazole|aripiprazole|mesh-list
138475085|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138475086|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
138475087|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475088|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475089|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475090|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138475091|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138475092|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475093|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138475094|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138475095|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
138475096|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
138475097|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
138475098|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475099|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475100|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138475101|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138475102|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475103|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
138475105|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138475106|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138475107|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138475108|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138475109|NCT02008006|Cytarabine|cytarabine|mesh-list
138392304|NCT01509131|Cathartics|cathartics|mesh-ancestor
138475112|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138475113|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475114|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475115|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138475116|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138475117|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475118|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475119|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475120|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
138475121|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
138475122|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475123|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475124|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
138475125|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475126|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475127|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
138475128|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475129|NCT02008019|Everolimus|everolimus|mesh-list
138475130|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138475131|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138204761|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204762|NCT04273165|Etravirine|etravirine|mesh-list
138475132|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475133|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475134|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475135|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
138475136|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475137|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475138|NCT02008123|Primidone|primidone|mesh-list
138475139|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
138475140|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
138475142|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475143|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475144|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475146|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138475147|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475148|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475149|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475150|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475151|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475152|NCT02008162|Bromides|bromides|mesh-list
138475153|NCT02008162|Albuterol|albuterol|mesh-list
138475154|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
138475155|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
138475156|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
138475157|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475158|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475159|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138475160|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
138475161|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
138475162|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138475163|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
138392391|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475164|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475165|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475166|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
138475167|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
138475168|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475169|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138475170|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138475171|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475172|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475174|NCT02008201|Vitamins|vitamins|mesh-ancestor
138475175|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
138475176|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475177|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138475179|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138204774|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204775|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204776|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204777|NCT04030962|Lifitegrast|lifitegrast|mesh-list
138204778|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138204779|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138204781|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138204782|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204783|NCT03951753|Incretins|incretins|mesh-ancestor
138204784|NCT03951753|Hormones|hormones|mesh-ancestor
138204785|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475180|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475181|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475182|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138475183|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138475184|NCT02008214|Protective Agents|protective agents|mesh-ancestor
138475185|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475186|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
138475187|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138475188|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
138475189|NCT02008383|Panitumumab|panitumumab|mesh-list
138475190|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475192|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
138475193|NCT02008422|Tegafur|tegafur|mesh-list
138475194|NCT02008422|Endostar protein|endostar protein|mesh-list
138475195|NCT02008422|Endostatins|endostatins|mesh-list
138392439|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475196|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475197|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475198|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
138475199|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475200|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138475201|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138475202|NCT02008422|Growth Substances|growth substances|mesh-ancestor
138475203|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475204|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
138475206|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138475207|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475208|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475209|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475210|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475211|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475212|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
138475213|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138475214|NCT02008578|Antibodies|antibodies|mesh-list
138475215|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
138475216|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475218|NCT02008721|Protective Agents|protective agents|mesh-ancestor
138475219|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475220|NCT02008734|Palbociclib|palbociclib|mesh-list
138475221|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475222|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138475223|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392482|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475224|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475225|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
138475227|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
138475228|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475229|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204786|NCT03947671|Acetaminophen|acetaminophen|mesh-list
138204787|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204788|NCT03947671|Analgesics|analgesics|mesh-ancestor
138204789|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
138475230|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
138475231|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475232|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138475233|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
138475234|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138475235|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475236|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475237|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138475239|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475240|NCT02008786|Ramipril|ramipril|mesh-list
138475241|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138475242|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138475243|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138475244|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
138475245|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475246|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138475247|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138475248|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475249|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138475250|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
138475251|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138475252|NCT02008968|Allopurinol|allopurinol|mesh-list
138475254|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475255|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475256|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
138475257|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475258|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138475260|NCT02008968|Protective Agents|protective agents|mesh-ancestor
138475261|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475262|NCT02008981|Aspirin|aspirin|mesh-list
138475263|NCT02008981|Turmeric extract|turmeric extract|mesh-list
138475264|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475265|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475266|NCT02008981|Analgesics|analgesics|mesh-ancestor
138475267|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
138475268|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475269|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475270|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475271|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475272|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138475273|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138475274|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392587|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
138475275|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138475276|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138475277|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475278|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
138475279|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
138475280|NCT02008981|Protective Agents|protective agents|mesh-ancestor
138475281|NCT02009007|Phenylephrine|phenylephrine|mesh-list
138475282|NCT02009007|Dopamine|dopamine|mesh-list
138475283|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
138475284|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138475285|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
138475286|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
138475287|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475288|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475289|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
138475290|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138475291|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
138475292|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
138475293|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138475294|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138204809|NCT03603184|Paclitaxel|paclitaxel|mesh-list
138204810|NCT03603184|Carboplatin|carboplatin|mesh-list
138204811|NCT03603184|Atezolizumab|atezolizumab|mesh-list
138204812|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204813|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204814|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475296|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475297|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475298|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475299|NCT02009007|Protective Agents|protective agents|mesh-ancestor
138475300|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
138475301|NCT02009098|Cefuroxime|cefuroxime|mesh-list
138475302|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
138475303|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138475304|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475305|NCT02009189|Taurolidine|taurolidine|mesh-list
138475306|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475307|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138475308|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392632|NCT01511198|Liraglutide|liraglutide|mesh-list
138475310|NCT02009202|Cathartics|cathartics|mesh-ancestor
138475311|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475312|NCT02009215|Piperaquine|piperaquine|mesh-list
138475313|NCT02009215|Artenimol|artenimol|mesh-list
138475314|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
138475315|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138475316|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138475317|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475318|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
138475319|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138475320|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138475321|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475322|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475323|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475324|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
138475325|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138475326|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475327|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475328|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475329|NCT05778305|Analgesics|analgesics|mesh-ancestor
138475330|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
138475331|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475332|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138475333|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475334|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475335|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475336|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475337|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475338|NCT05778097|Androgens|androgens|mesh-list
138475339|NCT05778097|Hormones|hormones|mesh-ancestor
138475340|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475341|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475342|NCT05778084|Empagliflozin|empagliflozin|mesh-list
138475343|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138475344|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475345|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138475346|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475347|NCT05777902|Ozanimod|ozanimod|mesh-list
138475348|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138475349|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475350|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475351|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
138392685|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
138475356|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475357|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475358|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475359|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475360|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475361|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475362|NCT05777694|Anesthetics|anesthetics|mesh-list
138475363|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204815|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204816|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475364|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475365|NCT05777369|Prednisone|prednisone|mesh-list
138475366|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
138475368|NCT05777369|Vincristine|vincristine|mesh-list
138475369|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
138475370|NCT05777369|Vindesine|vindesine|mesh-list
138475371|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475372|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
138475373|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475374|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475375|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475376|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
138475377|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475378|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475379|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475380|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475381|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475383|NCT05777369|Hormones|hormones|mesh-ancestor
138392706|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475385|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475386|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475387|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475388|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475389|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475390|NCT05777369|Analgesics|analgesics|mesh-ancestor
138475391|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
138475392|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475393|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138475394|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138475395|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475397|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
138475398|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
138475399|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475400|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475401|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
138475402|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475403|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138475404|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138475405|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138475406|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475407|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475408|NCT05616390|Bevacizumab|bevacizumab|mesh-list
138475409|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475410|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392750|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
138475413|NCT05616390|Growth Substances|growth substances|mesh-ancestor
138475414|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475415|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
138475416|NCT05548270|Scopolamine|scopolamine|mesh-list
138475417|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138475418|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
138475419|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
138475420|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475421|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475422|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475423|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
138475424|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138475425|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475426|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475427|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475428|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138475429|NCT05410158|Ketamine|ketamine|mesh-list
138475430|NCT05410158|Analgesics|analgesics|mesh-ancestor
138204822|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204823|NCT03493490|Diclofenac|diclofenac|mesh-list
138204826|NCT03493490|Analgesics|analgesics|mesh-ancestor
138475431|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
138475432|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475433|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475434|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138475435|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138475436|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
138475437|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
138475438|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204831|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204832|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138204833|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204834|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204836|NCT03377491|Gemcitabine|gemcitabine|mesh-list
138204837|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475439|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138475440|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138475441|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475442|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475444|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
138475445|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475446|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475447|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475448|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475449|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475450|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475451|NCT05121168|Bupivacaine|bupivacaine|mesh-list
138475452|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
138475453|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
138475454|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475455|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475456|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
138475457|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475458|NCT05091905|Ropivacaine|ropivacaine|mesh-list
138475459|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
138475460|NCT05091905|Anesthetics|anesthetics|mesh-list
138475461|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475462|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475463|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
138475464|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475465|NCT04983589|Pilocarpine|pilocarpine|mesh-list
138475466|NCT04983589|Miotics|miotics|mesh-ancestor
138475467|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
138475468|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475469|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475470|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138475471|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138475472|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475473|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475474|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475475|NCT04886154|Vaccines|vaccines|mesh-list
138475476|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
138475477|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475478|NCT04861922|Heparin|heparin|mesh-list
138475479|NCT04861922|Calcium heparin|calcium heparin|mesh-list
138475480|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
138475481|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138475482|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138475483|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475485|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475486|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475487|NCT04782830|Midodrine|midodrine|mesh-list
138475488|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138475489|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138475490|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138475491|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475492|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204893|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204894|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475493|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475494|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475495|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475496|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
138475497|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
138475498|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475499|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138475500|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138475501|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475502|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475503|NCT04771000|Ambrisentan|ambrisentan|mesh-list
138475504|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138475505|NCT04620382|Midodrine|midodrine|mesh-list
138475506|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
138475507|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
138475508|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475509|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475510|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138475511|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138475512|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138392876|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
138475513|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475514|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138475515|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475516|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475517|NCT04567420|Fulvestrant|fulvestrant|mesh-list
138475518|NCT04567420|Palbociclib|palbociclib|mesh-list
138475519|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138392917|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475520|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475521|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138475522|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138475523|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
138475524|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475525|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475526|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138475527|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475528|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475529|NCT04461587|Pirfenidone|pirfenidone|mesh-list
138475531|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
138475532|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392918|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475533|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475534|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475535|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475536|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475537|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475538|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475539|NCT04371107|Azithromycin|azithromycin|mesh-list
138475540|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138475541|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475542|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138475543|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138475544|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138475545|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
138475546|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475547|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
138475548|NCT04278833|Dexamethasone|dexamethasone|mesh-list
138204913|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
138204914|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
138204915|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475549|NCT04278833|Triamcinolone|triamcinolone|mesh-list
138475550|NCT04278833|Betamethasone|betamethasone|mesh-list
138475551|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475552|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
138475553|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
138475554|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475555|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475556|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475557|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
138475559|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475560|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475561|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475562|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138475563|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
138475564|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
138475565|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
138475566|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138475567|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475570|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475571|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
138475572|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
138475573|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475574|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475575|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475576|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
138475577|NCT04221087|Hormones|hormones|mesh-ancestor
138475578|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475579|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475580|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475581|NCT04062591|Piroxicam|piroxicam|mesh-list
138475582|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475583|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475584|NCT04062591|Analgesics|analgesics|mesh-ancestor
138475585|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
138475586|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475587|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475588|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475589|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475590|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138475591|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475592|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475593|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138475594|NCT04059770|Amphotericin B|amphotericin b|mesh-list
138475595|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
138393009|NCT01512862|Calcitriol|calcitriol|mesh-list
138475596|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475598|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138475599|NCT04059770|Amebicides|amebicides|mesh-ancestor
138475600|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138475602|NCT04050280|Cladribine|cladribine|mesh-list
138475603|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
138475604|NCT04050280|Lenograstim|lenograstim|mesh-list
138475605|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475606|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
138475607|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475608|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475609|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
138475610|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475611|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475612|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
138475613|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475614|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138475615|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204926|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204927|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
138204928|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
138475617|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
138475618|NCT03994731|Acetaminophen|acetaminophen|mesh-list
138475619|NCT03994731|Folic Acid|folic acid|mesh-list
138475620|NCT03994731|Fexofenadine|fexofenadine|mesh-list
138475621|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
138475622|NCT03994731|Methotrexate|methotrexate|mesh-list
138475623|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138475625|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475626|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475627|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475628|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
138475629|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475630|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475631|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
138475632|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475633|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138475634|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475635|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
138475636|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475637|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138475638|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475639|NCT03994731|Analgesics|analgesics|mesh-ancestor
138475640|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
138475641|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475643|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475644|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
138475645|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
138475646|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475647|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
138475648|NCT03994731|Hormones|hormones|mesh-ancestor
138475649|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475650|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138475651|NCT03994731|Protective Agents|protective agents|mesh-ancestor
138475652|NCT03994731|Hematinics|hematinics|mesh-ancestor
138475653|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
138475654|NCT03994731|Vitamins|vitamins|mesh-ancestor
138475655|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
138475656|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138475657|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138475659|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
138475660|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
138475661|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475662|NCT03984357|Gemcitabine|gemcitabine|mesh-list
138475664|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
138475665|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
138204934|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204935|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204936|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475666|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475667|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475668|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475670|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475672|NCT03824522|Coagulants|coagulants|mesh-ancestor
138475673|NCT03812991|Calcitonin|calcitonin|mesh-list
138475674|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
138475675|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138475676|NCT03812991|Katacalcin|katacalcin|mesh-list
138475677|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138475678|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475679|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138475680|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
138475681|NCT03737968|Durvalumab|durvalumab|mesh-list
138393151|NCT01513603|Analgesics|analgesics|mesh-ancestor
138475682|NCT03737968|Tremelimumab|tremelimumab|mesh-list
138393156|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475683|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138475684|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475685|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475686|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
138475687|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475689|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138475691|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475692|NCT03652753|Expectorants|expectorants|mesh-ancestor
138475693|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
138475694|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138475695|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
138475696|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475697|NCT03652753|Protective Agents|protective agents|mesh-ancestor
138475698|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475699|NCT03652753|Antidotes|antidotes|mesh-ancestor
138475700|NCT03556202|Mirikizumab|mirikizumab|mesh-list
138475701|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475702|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475703|NCT03556202|Analgesics|analgesics|mesh-ancestor
138475704|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
138475705|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475708|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475709|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138475710|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475711|NCT03480438|Blinatumomab|blinatumomab|mesh-list
138475712|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475713|NCT03463876|Apatinib|apatinib|mesh-list
138475714|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475715|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138475716|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475717|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475719|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
138475720|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393254|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393255|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
138475721|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475722|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
138475723|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475726|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138475727|NCT03396588|Narcotics|narcotics|mesh-ancestor
138475728|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204963|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138204964|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204965|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204967|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204968|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204969|NCT00199095|Cytarabine|cytarabine|mesh-list
138204970|NCT00199095|Dexamethasone|dexamethasone|mesh-list
138350229|NCT06083961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350230|NCT06083961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138350231|NCT06083935|Metformin|metformin|mesh-list
138350232|NCT06083935|Contraceptive Agents|contraceptive agents|mesh-list
138475729|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475730|NCT03396588|Analgesics|analgesics|mesh-ancestor
138475731|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
138475732|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188309|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475733|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138475734|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
138475735|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
138475736|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138475737|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138475738|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138475739|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
138393317|NCT01514487|Liraglutide|liraglutide|mesh-list
138475740|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475741|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475743|NCT03350451|Renal Agents|renal agents|mesh-ancestor
138475744|NCT03329508|Pramipexole|pramipexole|mesh-list
138475745|NCT03329508|Rasagiline|rasagiline|mesh-list
138475746|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
138475747|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475748|NCT03329508|Protective Agents|protective agents|mesh-ancestor
138475749|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475750|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138475751|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138475752|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
138475753|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
138475754|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475755|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138475756|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475757|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138393370|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138475759|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475760|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475761|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138475762|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138475763|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
138475764|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475765|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475766|NCT03281304|Tofacitinib|tofacitinib|mesh-list
138475767|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138475768|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138475769|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475770|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475771|NCT03153319|Adalimumab|adalimumab|mesh-list
138475773|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475774|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475775|NCT03145272|Oxycodone|oxycodone|mesh-list
138475776|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138475777|NCT03145272|Narcotics|narcotics|mesh-ancestor
138475778|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138475779|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475780|NCT03145272|Analgesics|analgesics|mesh-ancestor
138475781|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
138475782|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475784|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138475785|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475786|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475787|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475788|NCT03109093|Blinatumomab|blinatumomab|mesh-list
138204971|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
138475789|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204972|NCT00199095|Ifosfamide|ifosfamide|mesh-list
138204973|NCT00199095|Methotrexate|methotrexate|mesh-list
138204974|NCT00199095|Vincristine|vincristine|mesh-list
138475790|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
138475791|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
138475792|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475793|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475794|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138475795|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138475796|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
138475797|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475798|NCT02649998|Furosemide|furosemide|mesh-list
138475799|NCT02649998|Isosorbide|isosorbide|mesh-list
138475800|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138475801|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138475802|NCT02649998|Diuretics|diuretics|mesh-ancestor
138475803|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
138475804|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475805|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138475806|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475807|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475808|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138475809|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
138475810|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138475811|NCT02503358|Paclitaxel|paclitaxel|mesh-list
138475812|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138475813|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475814|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475815|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475816|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475817|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475818|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475819|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
138475820|NCT02432963|Vaccines|vaccines|mesh-list
138475822|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475823|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475824|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475825|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138475826|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475828|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
138475829|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475830|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475831|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475833|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
138475834|NCT02349906|Treosulfan|treosulfan|mesh-list
138475835|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475836|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
138475837|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475838|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475839|NCT02336087|Metformin|metformin|mesh-list
138475840|NCT02336087|Paclitaxel|paclitaxel|mesh-list
138204984|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475841|NCT02336087|Gemcitabine|gemcitabine|mesh-list
138204985|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204986|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475842|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138475843|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475844|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475845|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475846|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475847|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475848|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475849|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475850|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
138475852|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475855|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475856|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475857|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138475858|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475859|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475861|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138475862|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475863|NCT02048150|Antibodies|antibodies|mesh-list
138475864|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138475865|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
138475866|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475867|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138475868|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
138393652|NCT01516450|Belimumab|belimumab|mesh-list
138475869|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138475870|NCT02038452|Prednisolone|prednisolone|mesh-list
138475871|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
138475872|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138475873|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
138475874|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475875|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
138475876|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
138475877|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475878|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475879|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138475880|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
138475882|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475883|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138475884|NCT02038452|Protective Agents|protective agents|mesh-ancestor
138188310|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
138475885|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475886|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475887|NCT01748448|Vitamin D|vitamin d|mesh-list
138475888|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
138475889|NCT01748448|Vitamins|vitamins|mesh-ancestor
138475890|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
138475891|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475892|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138475893|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138475894|NCT01476839|Cytarabine|cytarabine|mesh-list
138475896|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
138475898|NCT01476839|Carmustine|carmustine|mesh-list
138475899|NCT01476839|Basiliximab|basiliximab|mesh-list
138475900|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475901|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475902|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205006|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205007|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205008|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205009|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138475903|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138475904|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475905|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393751|NCT01516814|Warfarin|warfarin|mesh-list
138475906|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475908|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
138475909|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475910|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475911|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
138475912|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475913|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475914|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
138475915|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475916|NCT01332097|Prednisone|prednisone|mesh-list
138475917|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475918|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
138475919|NCT01332097|Hormones|hormones|mesh-ancestor
138475920|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475921|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475922|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475923|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475924|NCT01163357|Sirolimus|sirolimus|mesh-list
138475925|NCT01163357|Fludarabine|fludarabine|mesh-list
138475926|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
138475928|NCT01163357|Melphalan|melphalan|mesh-list
138475929|NCT01163357|Tacrolimus|tacrolimus|mesh-list
138393811|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138475930|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475931|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475932|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
138475933|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475934|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475935|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
138475936|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475937|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138475938|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475939|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138475940|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475941|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138475942|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
138475943|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475944|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
138475945|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475946|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
138475947|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138475948|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
138475949|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475950|NCT00967005|Expectorants|expectorants|mesh-ancestor
138475951|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
138475952|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138475954|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475955|NCT00967005|Protective Agents|protective agents|mesh-ancestor
138475956|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475957|NCT00967005|Antidotes|antidotes|mesh-ancestor
138475959|NCT00863369|Gemcitabine|gemcitabine|mesh-list
138475960|NCT00863369|Bortezomib|bortezomib|mesh-list
138475961|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475962|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205023|NCT00199056|Daunorubicin|daunorubicin|mesh-list
138205024|NCT00199056|Asparaginase|asparaginase|mesh-list
138205025|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
138205026|NCT00199056|Idarubicin|idarubicin|mesh-list
138205027|NCT00199056|Thioguanine|thioguanine|mesh-list
138475963|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
138205029|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475964|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475965|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393866|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
138475966|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138475967|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
138475968|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475970|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
138475971|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475972|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
138475973|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475974|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138475975|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138475976|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
138475977|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475978|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475979|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138475980|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138475981|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138475982|NCT00538031|Analgesics|analgesics|mesh-ancestor
138475983|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
138475984|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475985|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475986|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138475987|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138475989|NCT00203996|Pioglitazone|pioglitazone|mesh-list
138475990|NCT00203996|Leuprolide|leuprolide|mesh-list
138475991|NCT00203996|Estrogens|estrogens|mesh-list
138475992|NCT00203996|Progestins|progestins|mesh-list
138475993|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138475994|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475995|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138475996|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
138475997|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475998|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475999|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476000|NCT00203996|Hormones|hormones|mesh-ancestor
138476001|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476002|NCT02009280|Anesthetics|anesthetics|mesh-list
138476003|NCT02009280|Propofol|propofol|mesh-list
138476004|NCT02009280|Sevoflurane|sevoflurane|mesh-list
138476005|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476006|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476007|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476008|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476009|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
138476010|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138393980|NCT01518062|Estrogens|estrogens|mesh-list
138476012|NCT02009306|Midazolam|midazolam|mesh-list
138476013|NCT02009306|Fentanyl|fentanyl|mesh-list
138476014|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138476015|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476016|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476017|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476018|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138476019|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476020|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476021|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476022|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
138476023|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
138205037|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205038|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205039|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
138205040|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
138205041|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205042|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476024|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
138476025|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
138476026|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476027|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476028|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138476029|NCT02009306|Narcotics|narcotics|mesh-ancestor
138476030|NCT02009306|Analgesics|analgesics|mesh-ancestor
138476031|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
138476032|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476033|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138394016|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394017|NCT01518166|Incretins|incretins|mesh-ancestor
138476034|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138476035|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138476036|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476037|NCT02009410|Pancrelipase|pancrelipase|mesh-list
138476038|NCT02009410|Pancreatin|pancreatin|mesh-list
138476039|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476040|NCT02009436|Azacitidine|azacitidine|mesh-list
138476041|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476042|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
138476043|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476044|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476045|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476046|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138476047|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476048|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138476049|NCT02009462|Protective Agents|protective agents|mesh-ancestor
138476050|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476052|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138476053|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476054|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138476055|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476057|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
138476058|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476059|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
138476060|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138476061|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138476062|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138476063|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476064|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476065|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
138476066|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476067|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476068|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138476069|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476070|NCT02009592|Rifaximin|rifaximin|mesh-list
138476071|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476072|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476073|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476074|NCT02009618|Rifaximin|rifaximin|mesh-list
138476075|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476076|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205048|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
138205049|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205050|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476077|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476078|NCT02009631|Veliparib|veliparib|mesh-list
138476079|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138476080|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476081|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476082|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476083|NCT02009709|Riboflavin|riboflavin|mesh-list
138476084|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138476085|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476086|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
138476087|NCT02009709|Vitamins|vitamins|mesh-ancestor
138476089|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476090|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138476091|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
138476092|NCT02009748|Vitamin D|vitamin d|mesh-list
138476093|NCT02009748|Vitamins|vitamins|mesh-ancestor
138476094|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
138476095|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476096|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138476097|NCT02009787|Vitamin D|vitamin d|mesh-list
138476098|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
138476099|NCT02009787|Vitamins|vitamins|mesh-ancestor
138476100|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
138476101|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476102|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138476103|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138476104|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138476105|NCT02009943|Hematinics|hematinics|mesh-ancestor
138476106|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
138476107|NCT02010164|Ubiquinone|ubiquinone|mesh-list
138476108|NCT02010164|Vitamins|vitamins|mesh-ancestor
138476109|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
138476110|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476111|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138476112|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138476113|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138394243|NCT01519336|Ritonavir|ritonavir|mesh-list
138476114|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
138476115|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476116|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476117|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
138476118|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138476119|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476120|NCT02010723|Polidocanol|polidocanol|mesh-list
138476121|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138476122|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476124|NCT02010762|Vitamins|vitamins|mesh-ancestor
138476125|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
138476126|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476127|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138476128|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
138394294|NCT01519687|Tofisopam|tofisopam|mesh-list
138476129|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138476130|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138476131|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138476132|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476133|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205066|NCT00199030|Cladribine|cladribine|mesh-list
138205067|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476134|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
138476135|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476136|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476137|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138476138|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476139|NCT02010827|Glucagon|glucagon|mesh-list
138476140|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476141|NCT02010827|Hormones|hormones|mesh-ancestor
138476142|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476143|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476144|NCT02010905|Losartan|losartan|mesh-list
138476145|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138476146|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476147|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138476148|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138476149|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476150|NCT02010944|Mirabegron|mirabegron|mesh-list
138476151|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
138476152|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138476153|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138394354|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476154|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138476155|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476156|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476157|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476158|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476159|NCT02010944|Urological Agents|urological agents|mesh-ancestor
138476160|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138476161|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138476162|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138476163|NCT02010957|Etomidate|etomidate|mesh-list
138476164|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476165|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476166|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476167|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476168|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
138476169|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
138476170|NCT02010970|Itraconazole|itraconazole|mesh-list
138476171|NCT02010970|Diltiazem|diltiazem|mesh-list
138476172|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
138476173|NCT02010970|Midazolam|midazolam|mesh-list
138476174|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138476175|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476176|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138476177|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476178|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476179|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138476180|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476181|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476182|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476183|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
138476184|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
138476185|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
138476186|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
138205087|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205088|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
138205089|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205090|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205091|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205092|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205093|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
138205094|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
138476187|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476188|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476189|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
138476190|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476191|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138476192|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138476193|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476194|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138476195|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
138476196|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476197|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138476198|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476199|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394451|NCT01520753|Insulin|insulin|mesh-list
138476202|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
138476203|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476204|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476205|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476207|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
138476208|NCT02011191|Vitamins|vitamins|mesh-ancestor
138476209|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
138476210|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476211|NCT02011347|Ketamine|ketamine|mesh-list
138476212|NCT02011347|Analgesics|analgesics|mesh-ancestor
138476213|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
138476214|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476215|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476216|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138476217|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476218|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
138476219|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
138476220|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476221|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138476222|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138476223|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394503|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476224|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476226|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476227|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476228|NCT02011620|Isosorbide|isosorbide|mesh-list
138476229|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138476230|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138476231|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138476232|NCT02011620|Diuretics|diuretics|mesh-ancestor
138476233|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
138476234|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476235|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476236|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138476237|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476238|NCT02011633|Metformin|metformin|mesh-list
138476239|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138476240|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138476241|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476242|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138476243|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138476244|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
138476245|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476246|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138476247|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138205095|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205096|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205098|NCT00198978|Hormones|hormones|mesh-ancestor
138205099|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205100|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205101|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476248|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476249|NCT02011659|Ramosetron|ramosetron|mesh-list
138476250|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
138476251|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
138476252|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476253|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476254|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476255|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138476256|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
138476257|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476258|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476259|NCT02011737|Naftopidil|naftopidil|mesh-list
138476260|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138476261|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138476262|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476263|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476264|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476265|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476266|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476267|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138476268|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476269|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138476270|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138476272|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
138476273|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476274|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476275|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
138476276|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476277|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476278|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
138476279|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476280|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476281|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476282|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
138476283|NCT02011828|Vitamin D|vitamin d|mesh-list
138476284|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138476285|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476286|NCT02011828|Vitamins|vitamins|mesh-ancestor
138476287|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
138476288|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138476289|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
138205104|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205105|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205106|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
138205107|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205108|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205109|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205110|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205111|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
138205122|NCT00109395|Lorazepam|lorazepam|mesh-list
138476290|NCT02011841|Rifaximin|rifaximin|mesh-list
138476291|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476292|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476293|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138476294|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138476295|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476296|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476297|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476298|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138476299|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138476300|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476301|NCT02011906|Vitamins|vitamins|mesh-list
138476302|NCT02011906|Vitamin E|vitamin e|mesh-list
138476303|NCT02011906|Tocopherols|tocopherols|mesh-list
138476304|NCT02011906|Tocotrienols|tocotrienols|mesh-list
138476305|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
138476306|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
138476307|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476308|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
138476309|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476311|NCT02011958|Amphotericin B|amphotericin b|mesh-list
138476312|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138476313|NCT02011958|Miltefosine|miltefosine|mesh-list
138476314|NCT02011958|Amebicides|amebicides|mesh-ancestor
138476315|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138476316|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138476317|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476318|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476319|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
138476320|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476321|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138476322|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138476323|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138476324|NCT02012049|Risperidone|risperidone|mesh-list
138476325|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138476326|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
138476327|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476328|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394633|NCT01521975|Adefovir|adefovir|mesh-list
138476329|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476330|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138476331|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476332|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476333|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476334|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138476335|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
138476336|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
138476337|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476338|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476340|NCT02012075|Carvedilol|carvedilol|mesh-list
138476341|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138476342|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476343|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
138476344|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
138476345|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476346|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205130|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138205131|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
138205132|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
138205133|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
138205134|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
138205135|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205136|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205137|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
138476347|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138476348|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138476349|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138476350|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476351|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476352|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476354|NCT02012075|Protective Agents|protective agents|mesh-ancestor
138476355|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138476356|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476357|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138476358|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
138394665|NCT01522105|Daptomycin|daptomycin|mesh-list
138476360|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138476362|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
138476363|NCT02012088|Rituximab|rituximab|mesh-list
138476364|NCT02012088|Doxorubicin|doxorubicin|mesh-list
138476365|NCT02012088|Vincristine|vincristine|mesh-list
138476366|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476367|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
138476369|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138476370|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138476371|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
138476372|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476373|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476374|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138476375|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476376|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138476377|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138476378|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138476379|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476380|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138476381|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
138476382|NCT02012088|Hormones|hormones|mesh-ancestor
138476383|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476384|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138476385|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138476386|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138476387|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138476388|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138476389|NCT02012140|Ticagrelor|ticagrelor|mesh-list
138476390|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138476391|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138476392|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138476393|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138476394|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
138476395|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476396|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476397|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476398|NCT02012166|Insulin|insulin|mesh-list
138476399|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138476400|NCT02012166|Octreotide|octreotide|mesh-list
138476401|NCT02012166|Glucagon|glucagon|mesh-list
138476402|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138205144|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
138205145|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205150|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205151|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205152|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205159|NCT00004144|Gemcitabine|gemcitabine|mesh-list
138476403|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476404|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476405|NCT02012166|Hormones|hormones|mesh-ancestor
138476406|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476407|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138476408|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476409|NCT02012244|Fentanyl|fentanyl|mesh-list
138476410|NCT02012244|Anesthetics|anesthetics|mesh-list
138476411|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
138476412|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138476413|NCT02012244|Narcotics|narcotics|mesh-ancestor
138476414|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476415|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476416|NCT02012244|Analgesics|analgesics|mesh-ancestor
138476417|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
138476418|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476420|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476421|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
138476422|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138476423|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
138394762|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
138476424|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476426|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
138476427|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
138476428|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476429|NCT02012322|Vitamins|vitamins|mesh-ancestor
138476430|NCT02012335|Ketamine|ketamine|mesh-list
138476431|NCT02012335|Analgesics|analgesics|mesh-ancestor
138476432|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
138476433|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476434|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476435|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138476436|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476437|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
138476439|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476440|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138476441|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138476442|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476443|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476444|NCT02012387|Omalizumab|omalizumab|mesh-list
138476445|NCT02012387|Vaccines|vaccines|mesh-list
138476446|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138476447|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
138476448|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476449|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138476450|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138394798|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476453|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
138476454|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138476455|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476456|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138476458|NCT02012517|Cephalexin|cephalexin|mesh-list
138476459|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138476460|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476461|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
138476462|NCT02012556|Tesamorelin|tesamorelin|mesh-list
138476463|NCT02012556|Growth Substances|growth substances|mesh-ancestor
138476464|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476465|NCT02012569|Hemostatics|hemostatics|mesh-list
138476466|NCT02012569|Coagulants|coagulants|mesh-ancestor
138476467|NCT02012595|Donepezil|donepezil|mesh-list
138476468|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138205243|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
138205244|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205245|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138205246|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138205247|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138205248|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476469|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476470|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476471|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
138476472|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476473|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476474|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
138476475|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
138476476|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476477|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
138476478|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476479|NCT02012777|Propranolol|propranolol|mesh-list
138476480|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138476481|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138476482|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476483|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476484|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476485|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394846|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476486|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138476487|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476488|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476490|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188466|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476491|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138476492|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476493|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476494|NCT02012933|Amifampridine|amifampridine|mesh-list
138476495|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138476496|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476497|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476498|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138476499|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476500|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476501|NCT02012946|Simendan|simendan|mesh-list
138476502|NCT02012946|Dobutamine|dobutamine|mesh-list
138476503|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138476504|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476505|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138394887|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
138476506|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138476507|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476508|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476509|NCT02012946|Protective Agents|protective agents|mesh-ancestor
138476510|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476511|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
138476512|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
138476513|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476514|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138476515|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138476516|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138476517|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476518|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476519|NCT02012998|Vaccines|vaccines|mesh-list
138476520|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
138476521|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476522|NCT02013102|Decitabine|decitabine|mesh-list
138476523|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476524|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
138476525|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476526|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205261|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138205262|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
138205263|NCT00004990|Dexamethasone|dexamethasone|mesh-list
138476527|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476528|NCT02013115|Budesonide|budesonide|mesh-list
138476529|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138476530|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138476531|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
138476532|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476533|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476534|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138476535|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476536|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
138476537|NCT02013115|Hormones|hormones|mesh-ancestor
138476538|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476539|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138476540|NCT02013219|Atezolizumab|atezolizumab|mesh-list
138476542|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476543|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476544|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476545|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138476546|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476547|NCT02013232|Aripiprazole|aripiprazole|mesh-list
138476548|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
138476549|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476550|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138476551|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476552|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476553|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476554|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
138476555|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
138476556|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476557|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476558|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138476559|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138476560|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
138476561|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138476562|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138476563|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138476564|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138476565|NCT02013258|Oxytocin|oxytocin|mesh-list
138476566|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
138476567|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138476568|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476569|NCT02013271|Paclitaxel|paclitaxel|mesh-list
138394981|NCT01523678|Paclitaxel|paclitaxel|mesh-list
138476570|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138476571|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476572|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138476573|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138476574|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138476575|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476576|NCT02013362|Folic Acid|folic acid|mesh-list
138476577|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
138476578|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
138476579|NCT02013362|Vitamins|vitamins|mesh-ancestor
138476580|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
138476581|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476582|NCT02013362|Hematinics|hematinics|mesh-ancestor
138476583|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
138476584|NCT02013453|Paclitaxel|paclitaxel|mesh-list
138205272|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205273|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205274|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205275|NCT01216735|Fluticasone|fluticasone|mesh-list
138205277|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138476585|NCT02013453|Carboplatin|carboplatin|mesh-list
138476586|NCT02013453|Fluorouracil|fluorouracil|mesh-list
138476587|NCT02013453|Pemetrexed|pemetrexed|mesh-list
138476588|NCT02013453|Omeprazole|omeprazole|mesh-list
138476589|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138476591|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
138476592|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
138476593|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
138476594|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476595|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
138476596|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476597|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476598|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
138476599|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476600|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476601|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138476602|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138476603|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138476604|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476605|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138476606|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
138476607|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476608|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476609|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476610|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138476611|NCT02013570|Analgesics|analgesics|mesh-ancestor
138476612|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
138476613|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476614|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138476615|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138395025|NCT01524081|Fluconazole|fluconazole|mesh-list
138395043|NCT01524094|Leucovorin|leucovorin|mesh-list
138476616|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138476617|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476618|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476619|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476620|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
138476621|NCT02013856|Procyanidin|procyanidin|mesh-list
138476622|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
138476623|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476624|NCT02013856|Protective Agents|protective agents|mesh-ancestor
138476625|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476626|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138476627|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138476628|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476629|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
138476630|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138476631|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476632|NCT02013960|Misoprostol|misoprostol|mesh-list
138476633|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138476634|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
138476635|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138476636|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476637|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138476638|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476639|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
138476641|NCT02013986|Propofol|propofol|mesh-list
138476642|NCT02013986|Etomidate|etomidate|mesh-list
138476643|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476644|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205285|NCT00004186|Carboplatin|carboplatin|mesh-list
138205287|NCT00004186|Topotecan|topotecan|mesh-list
138205288|NCT00004186|Ifosfamide|ifosfamide|mesh-list
138205289|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205290|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205291|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205292|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205293|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476645|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476646|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476647|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
138476649|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138476650|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138476652|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138476653|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
138476654|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
138476655|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476656|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476657|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138476658|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138476659|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138476660|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476661|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476662|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476663|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476664|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476665|NCT02013089|Everolimus|everolimus|mesh-list
138476666|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138476667|NCT02013089|Sorafenib|sorafenib|mesh-list
138476668|NCT02013089|Sunitinib|sunitinib|mesh-list
138476669|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
138476671|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138476672|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476673|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476674|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476675|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476676|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
138476677|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476678|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476679|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138476680|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138476681|NCT02013089|Growth Substances|growth substances|mesh-ancestor
138476682|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138476683|NCT02014103|Tacrolimus|tacrolimus|mesh-list
138476684|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476685|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
138476686|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476687|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138476688|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476689|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476690|NCT02014337|Mifepristone|mifepristone|mesh-list
138476691|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138476693|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138476694|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476695|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138476696|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138476697|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138476699|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138205294|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205295|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138476700|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138476701|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
138476702|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476703|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
138476704|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138476705|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138476706|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
138476707|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138476708|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
138476709|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476710|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
138476711|NCT02014428|Protective Agents|protective agents|mesh-ancestor
138476713|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138476714|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476715|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138476716|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138476717|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138476718|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476719|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476721|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138476722|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138476723|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476726|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138476727|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476728|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
138476729|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476730|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138476731|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138476732|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
138476733|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476734|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476735|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138476736|NCT02014532|Montelukast|montelukast|mesh-list
138476737|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138476738|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138476739|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476740|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
138476741|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476742|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476743|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138476744|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138476745|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476747|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
138476748|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138476749|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
138476750|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138476751|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476752|NCT02014558|Voriconazole|voriconazole|mesh-list
138476753|NCT02014558|Cephalexin|cephalexin|mesh-list
138476754|NCT02014558|Midazolam|midazolam|mesh-list
138476755|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138476756|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476757|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476758|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476759|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138476760|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138476761|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205316|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138205317|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205318|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138205319|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205320|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205321|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138205322|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
138476762|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476763|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
138476764|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
138476765|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
138476766|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
138476767|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476768|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476769|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
138476770|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476771|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138476772|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138476773|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476774|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138476775|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
138476776|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476777|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138476778|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476779|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
138395340|NCT06051786|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476780|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
138476781|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
138476782|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476783|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
138476784|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476785|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476786|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
138476787|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476788|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476789|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138476790|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476791|NCT02014714|Fentanyl|fentanyl|mesh-list
138476792|NCT02014714|Morphine|morphine|mesh-list
138476793|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138476795|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476796|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476797|NCT02014714|Analgesics|analgesics|mesh-ancestor
138476798|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
138476799|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476800|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138476801|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138476802|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
138476803|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
138476804|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138476805|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138476806|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
138476807|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476808|NCT02014727|Antacids|antacids|mesh-ancestor
138476809|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476810|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476811|NCT02014753|Cobalt|cobalt|mesh-list
138476812|NCT02014753|Chromium|chromium|mesh-list
138476813|NCT02014753|Everolimus|everolimus|mesh-list
138476814|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138476815|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476816|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205323|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205325|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205326|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
138205327|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205328|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205330|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138205331|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138476817|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476818|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476819|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
138476820|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476821|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395393|NCT06046248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476822|NCT02014753|Trace Elements|trace elements|mesh-ancestor
138476823|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
138476824|NCT02014831|Cetuximab|cetuximab|mesh-list
138476825|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476826|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476827|NCT02014922|Vitamin E|vitamin e|mesh-list
138476828|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
138476829|NCT02014922|Tocopherols|tocopherols|mesh-list
138476830|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138476831|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138476832|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
138476833|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138476834|NCT02014922|Laxatives|laxatives|mesh-ancestor
138476835|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138476836|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
138476837|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476838|NCT02014922|Protective Agents|protective agents|mesh-ancestor
138476839|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476840|NCT02014922|Vitamins|vitamins|mesh-ancestor
138476841|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
138476842|NCT02015156|Trastuzumab|trastuzumab|mesh-list
138476843|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476844|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476845|NCT02015169|Lapatinib|lapatinib|mesh-list
138476846|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476848|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476849|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476850|NCT02015182|Bupivacaine|bupivacaine|mesh-list
138476851|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
138476852|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
138476853|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138476854|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476855|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
138476856|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476857|NCT02015260|Citric Acid|citric acid|mesh-list
138476858|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
138476859|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138476860|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
138476861|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
138476862|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476864|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138476865|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138476866|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476867|NCT02015299|Incretins|incretins|mesh-ancestor
138476868|NCT02015299|Hormones|hormones|mesh-ancestor
138476869|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138476870|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
138476871|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476872|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476873|NCT02015312|Silicon|silicon|mesh-list
138476874|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138476875|NCT02015312|Mannitol|mannitol|mesh-list
138476876|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138476877|NCT02015312|Diuretics|diuretics|mesh-ancestor
138205335|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205336|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
138476878|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
138476879|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476880|NCT02015312|Trace Elements|trace elements|mesh-ancestor
138476881|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
138476882|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
138476883|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476884|NCT02015312|Protective Agents|protective agents|mesh-ancestor
138395494|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138395495|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395496|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
138395497|NCT05874570|Antacids|antacids|mesh-ancestor
138395499|NCT05874570|Diuretics|diuretics|mesh-ancestor
138476885|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138476886|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138476887|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476888|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138476889|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
138476890|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138476891|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
138476892|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476893|NCT02015403|Expectorants|expectorants|mesh-ancestor
138476894|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476895|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138476896|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
138476897|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476898|NCT02015403|Protective Agents|protective agents|mesh-ancestor
138476899|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476900|NCT02015403|Antidotes|antidotes|mesh-ancestor
138476902|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
138476903|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476904|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
138476905|NCT02015494|Coagulants|coagulants|mesh-ancestor
138476906|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
138476907|NCT02015507|Ivacaftor|ivacaftor|mesh-list
138476908|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476909|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476910|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138476911|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138476912|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476913|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476914|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476915|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138476916|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138476917|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138476918|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476919|NCT02015559|Protective Agents|protective agents|mesh-list
138476920|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476921|NCT02015598|Carbocysteine|carbocysteine|mesh-list
138476922|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138476923|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476924|NCT02015598|Expectorants|expectorants|mesh-ancestor
138476925|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476926|NCT02015650|Fluorouracil|fluorouracil|mesh-list
138476929|NCT02015650|Mitomycin|mitomycin|mesh-list
138476930|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
138476931|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476932|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138476933|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476934|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476935|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
138476936|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205346|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205347|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138205348|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
138205349|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138205350|NCT03009799|Laxatives|laxatives|mesh-ancestor
138205351|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205353|NCT00005026|Carboplatin|carboplatin|mesh-list
138476937|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476938|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138476939|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
138476940|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138476941|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476943|NCT02015728|Everolimus|everolimus|mesh-list
138476944|NCT02015728|Temozolomide|temozolomide|mesh-list
138476945|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138476946|NCT02015728|Sorafenib|sorafenib|mesh-list
138395590|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138476948|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138476949|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476950|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138476951|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138476952|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476953|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476954|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138476955|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138476956|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138476957|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
138476958|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476959|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138476960|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
138476961|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138476962|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476964|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476965|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476966|NCT02015949|Methylphenidate|methylphenidate|mesh-list
138476967|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138395620|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138395621|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138476968|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476969|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138476970|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138476971|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476972|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476973|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
138476974|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476975|NCT02015988|Simvastatin|simvastatin|mesh-list
138476976|NCT02015988|Fenofibrate|fenofibrate|mesh-list
138476977|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138476978|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138476979|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
138476980|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476981|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138476982|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138476983|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476985|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
138476986|NCT02016001|Protective Agents|protective agents|mesh-ancestor
138476987|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138476988|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
138476989|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476990|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476991|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205360|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205361|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138205362|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205363|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205364|NCT00016718|Emtricitabine|emtricitabine|mesh-list
138205365|NCT00016718|Efavirenz|efavirenz|mesh-list
138476992|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138476994|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476995|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476996|NCT02016196|Rifaximin|rifaximin|mesh-list
138476997|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476998|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138476999|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477001|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138477002|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138395741|NCT04888858|Fentanyl|fentanyl|mesh-list
138477003|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477004|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138477005|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138477006|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138477007|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477008|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
138477009|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138477010|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477011|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477012|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477013|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477014|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138477015|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138477016|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477017|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477018|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477020|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138477021|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
138477022|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138477023|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138477024|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477025|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138477026|NCT02016274|Paclitaxel|paclitaxel|mesh-list
138477027|NCT02016274|Cisplatin|cisplatin|mesh-list
138477028|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138477029|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477030|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138477031|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138477032|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395768|NCT04837716|Pemetrexed|pemetrexed|mesh-list
138477033|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477034|NCT02016287|Paclitaxel|paclitaxel|mesh-list
138477035|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138477036|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477037|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
138477038|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
138477039|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
138477040|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477041|NCT02016365|Doxycycline|doxycycline|mesh-list
138477042|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138477043|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138477044|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477045|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
138477046|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138477047|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138205373|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205374|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205375|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138205376|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138477048|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138477049|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477050|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
138477051|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138477052|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477056|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
138205387|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
138205388|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138205389|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205390|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205391|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138477057|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477058|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138205393|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205394|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477059|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138477060|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138477061|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
138477062|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477063|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477065|NCT02016417|Gemcitabine|gemcitabine|mesh-list
138477066|NCT02016417|Docetaxel|docetaxel|mesh-list
138477067|NCT02016417|Fluorouracil|fluorouracil|mesh-list
138477068|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477069|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477070|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
138477071|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477072|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138477073|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138477074|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138477075|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477076|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
138477077|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477079|NCT02016443|Analgesics|analgesics|mesh-ancestor
138477080|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
138477081|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477082|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477083|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
138477084|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138477087|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
138477088|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138477090|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138477091|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
138477092|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477093|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477095|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
138477096|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477097|NCT02016495|Protective Agents|protective agents|mesh-ancestor
138477098|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477099|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
138477101|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
138477102|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138477103|NCT02016547|Abciximab|abciximab|mesh-list
138477104|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138477105|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138477106|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477108|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138477109|NCT02016664|Ketamine|ketamine|mesh-list
138477110|NCT02016664|Analgesics|analgesics|mesh-ancestor
138477111|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
138477112|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477113|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477114|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138477115|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138477116|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
138477117|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
138477118|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477119|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138477120|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138477121|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477122|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477124|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
138477125|NCT02016729|Trametinib|trametinib|mesh-list
138477126|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477127|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138205450|NCT00005578|Etoposide|etoposide|mesh-list
138205451|NCT00005578|Vincristine|vincristine|mesh-list
138205452|NCT00005578|Bleomycin|bleomycin|mesh-list
138205453|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
138205454|NCT00005578|Razoxane|razoxane|mesh-list
138205455|NCT00005578|Lenograstim|lenograstim|mesh-list
138477128|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477129|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477130|NCT02016807|Sucralfate|sucralfate|mesh-list
138477131|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138477132|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477133|NCT02016846|Liraglutide|liraglutide|mesh-list
138477134|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138477135|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477136|NCT02016846|Incretins|incretins|mesh-ancestor
138477137|NCT02016846|Hormones|hormones|mesh-ancestor
138477138|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477139|NCT02016976|Midazolam|midazolam|mesh-list
138477140|NCT02016976|Meperidine|meperidine|mesh-list
138477141|NCT02016976|Analgesics|analgesics|mesh-list
138477142|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
138477143|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477144|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477145|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138477146|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138477147|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477148|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138477149|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477150|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477151|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138477152|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
138477153|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
138477154|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
138477155|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
138477156|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477157|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477158|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138477159|NCT02016976|Narcotics|narcotics|mesh-ancestor
138477160|NCT02017119|Lactulose|lactulose|mesh-list
138477161|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477162|NCT02017197|Warfarin|warfarin|mesh-list
138477163|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
138477164|NCT02017314|Morphine|morphine|mesh-list
138477165|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138477166|NCT02017314|Narcotics|narcotics|mesh-ancestor
138477167|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188468|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138477168|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477170|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
138477171|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477172|NCT02017340|Nilvadipine|nilvadipine|mesh-list
138205461|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
138205462|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205463|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205464|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205465|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205466|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205467|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205468|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205469|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205470|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
138205471|NCT00005578|Hormones|hormones|mesh-ancestor
138205472|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205473|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396077|NCT03630042|Rituximab|rituximab|mesh-list
138477174|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138477175|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477176|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477177|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477178|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477180|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
138477181|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
138477182|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477183|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477184|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
138477186|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138477187|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138477188|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138477189|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477190|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477191|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
138477192|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138477194|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
138477195|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477196|NCT02017457|Azacitidine|azacitidine|mesh-list
138477197|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477198|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
138477199|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477200|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477202|NCT02017561|Metformin|metformin|mesh-list
138477203|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138477204|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477205|NCT02017600|Fluorouracil|fluorouracil|mesh-list
138477206|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477207|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
138477208|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477209|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477210|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477211|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
138477212|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477213|NCT02017613|Tenalisib|tenalisib|mesh-list
138477214|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138477215|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477216|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477217|NCT02017639|Simvastatin|simvastatin|mesh-list
138477218|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138477219|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138477220|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
138477221|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477222|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396200|NCT02420860|Lenalidomide|lenalidomide|mesh-list
138477223|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138477225|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
138477226|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477227|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477228|NCT02018055|Aspirin|aspirin|mesh-list
138477229|NCT02018055|Clopidogrel|clopidogrel|mesh-list
138477230|NCT02018055|Ticagrelor|ticagrelor|mesh-list
138477231|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138477232|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138477233|NCT02018055|Analgesics|analgesics|mesh-ancestor
138477234|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
138477235|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205476|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205477|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205478|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205479|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138205481|NCT00022490|Cytarabine|cytarabine|mesh-list
138477236|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477237|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477238|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477240|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138477241|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477242|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138477243|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138477244|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477245|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
138477246|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138477247|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138477248|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138396249|NCT01415882|Hormones|hormones|mesh-ancestor
138477250|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477251|NCT02018081|Levofloxacin|levofloxacin|mesh-list
138477252|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138477253|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477254|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138477255|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138477256|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138477257|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477258|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477259|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477260|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138477261|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138477263|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
138477264|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
138477265|NCT02018094|Metronidazole|metronidazole|mesh-list
138477266|NCT02018094|Clindamycin|clindamycin|mesh-list
138477267|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138477268|NCT02018094|Teicoplanin|teicoplanin|mesh-list
138477269|NCT02018094|Povidone|povidone|mesh-list
138477270|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477271|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477273|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138477274|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138477275|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138477276|NCT02018094|Trace Elements|trace elements|mesh-ancestor
138477277|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
138396348|NCT00336024|Methotrexate|methotrexate|mesh-list
138477278|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477279|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138477280|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477281|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477282|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
138477283|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
138477284|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138477286|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
138477287|NCT02018133|Vitamins|vitamins|mesh-ancestor
138477288|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
138477289|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477290|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138477291|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477292|NCT02018159|Menotropins|menotropins|mesh-list
138477293|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138477294|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
138477295|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477296|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205488|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205489|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477297|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
138477298|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
138477299|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
138477300|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477301|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477302|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
138477303|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477304|NCT02018276|Lidocaine|lidocaine|mesh-list
138396407|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138477306|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
138477307|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477308|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477309|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
138477310|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477311|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138477312|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138477313|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138477314|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477315|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477316|NCT02018289|Triclosan|triclosan|mesh-list
138477317|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477318|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477319|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138477320|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138477321|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
138477322|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477323|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138477324|NCT02018328|Curcumin|curcumin|mesh-list
138477325|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138477326|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138477327|NCT02018328|Analgesics|analgesics|mesh-ancestor
138477328|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
138477329|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477330|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477331|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477332|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477333|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477334|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477335|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477336|NCT02018367|Proflavine|proflavine|mesh-list
138477337|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477338|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477339|NCT02018419|Vaccines|vaccines|mesh-list
138477341|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477342|NCT02018523|Lenalidomide|lenalidomide|mesh-list
138477343|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
138477344|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477345|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138477346|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138477347|NCT02018523|Growth Substances|growth substances|mesh-ancestor
138477348|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
138477349|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477350|NCT02018536|Simeprevir|simeprevir|mesh-list
138477351|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
138477352|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205502|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205503|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205504|NCT00097448|Prednisone|prednisone|mesh-list
138205505|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
138205506|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138205507|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138205508|NCT00097448|Prednisolone|prednisolone|mesh-list
138477353|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
138477354|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477355|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477356|NCT02018588|Tryptophan|tryptophan|mesh-list
138477357|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138477358|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
138477359|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477360|NCT02018601|Acetaminophen|acetaminophen|mesh-list
138477361|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138477362|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138477363|NCT02018601|Analgesics|analgesics|mesh-ancestor
138477364|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
138477365|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477366|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477367|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
138477368|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138477369|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477370|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477371|NCT02018731|Metformin|metformin|mesh-list
138477372|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138477373|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477375|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
138477376|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138477377|NCT02018757|Estrogens|estrogens|mesh-ancestor
138477378|NCT02018757|Hormones|hormones|mesh-ancestor
138477379|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477380|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477381|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477382|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477383|NCT02018783|Listerine|listerine|mesh-list
138477384|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
138477385|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
138477386|NCT02018783|Protective Agents|protective agents|mesh-ancestor
138396620|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
138477388|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477389|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477391|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477392|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
138477393|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477395|NCT02018965|Vitamins|vitamins|mesh-list
138477396|NCT02018965|Niacin|niacin|mesh-list
138477397|NCT02018965|Niacinamide|niacinamide|mesh-list
138477398|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
138477399|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
138477400|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
138477401|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477402|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138477403|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
138477404|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477405|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138477406|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138477407|NCT02018991|Everolimus|everolimus|mesh-list
138477408|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138477409|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138477410|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477411|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477412|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477413|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
138477414|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477415|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205516|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205517|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477416|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
138477417|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138477418|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138477419|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138477420|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477421|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477422|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
138477423|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477424|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477425|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138477426|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477429|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138477430|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
138205531|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205532|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
138205533|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477431|NCT02019056|Vitamins|vitamins|mesh-ancestor
138477432|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
138477433|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477434|NCT02019095|Dimercaprol|dimercaprol|mesh-list
138477435|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
138477436|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
138477437|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477438|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
138477441|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
138477442|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
138477443|NCT02019160|Protective Agents|protective agents|mesh-ancestor
138477444|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477445|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138477446|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477449|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
138477450|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477451|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
138477452|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477453|NCT02019186|Protective Agents|protective agents|mesh-ancestor
138477454|NCT02019290|Midazolam|midazolam|mesh-list
138477455|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138477456|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138477457|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477458|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477459|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138477460|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477461|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477462|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138477463|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
138477464|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
138477465|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
138396797|NCT01527279|Antazoline|antazoline|mesh-list
138477466|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
138477467|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477468|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477469|NCT02019329|Risperidone|risperidone|mesh-list
138477470|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138477471|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
138477472|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477473|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477474|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477475|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138477476|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477477|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477478|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477479|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138477480|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
138477481|NCT02019355|Fluorouracil|fluorouracil|mesh-list
138477482|NCT02019355|Calcipotriene|calcipotriene|mesh-list
138477483|NCT02019355|Petrolatum|petrolatum|mesh-list
138477484|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
138477485|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477486|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477487|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477488|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477489|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
138477490|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477491|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
138477492|NCT02019355|Emollients|emollients|mesh-ancestor
138477493|NCT02019381|Vitamin D|vitamin d|mesh-list
138477494|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
138205593|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205603|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
138477495|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
138477496|NCT02019381|Vitamins|vitamins|mesh-list
138477497|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
138396819|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
138477499|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477500|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138289132|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477501|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138477502|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138477503|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
138477504|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477505|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477506|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477507|NCT02019446|Terbinafine|terbinafine|mesh-list
138477508|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
138477509|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477510|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477511|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477512|NCT02019459|Nicotine|nicotine|mesh-list
138477513|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138477514|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
138396865|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477516|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477517|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138477518|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138477519|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
138477520|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477521|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477522|NCT02019485|Tapentadol|tapentadol|mesh-list
138477523|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138477524|NCT02019485|Narcotics|narcotics|mesh-ancestor
138477525|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477526|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477527|NCT02019485|Analgesics|analgesics|mesh-ancestor
138477528|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
138477529|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477530|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138396922|NCT01527864|Paclitaxel|paclitaxel|mesh-list
138477532|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477533|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477535|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477537|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
138477538|NCT02019524|Molgramostim|molgramostim|mesh-list
138477539|NCT02019524|Vaccines|vaccines|mesh-list
138477540|NCT02019524|Sargramostim|sargramostim|mesh-list
138477541|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
138477542|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477543|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477544|NCT02019524|Hematinics|hematinics|mesh-ancestor
138477545|NCT02019524|Vitamins|vitamins|mesh-ancestor
138477546|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
138477547|NCT02019784|Rifaximin|rifaximin|mesh-list
138477548|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138477549|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477550|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477551|NCT02019797|Desflurane|desflurane|mesh-list
138477552|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138477553|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
138477554|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
138205612|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
138205613|NCT00005596|Vitamins|vitamins|mesh-ancestor
138205614|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
138205615|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138477555|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205616|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138477556|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477557|NCT02019810|Dobutamine|dobutamine|mesh-list
138477558|NCT02019810|Norepinephrine|norepinephrine|mesh-list
138477559|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138477560|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138477561|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
138477562|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477563|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477564|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477565|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
138477566|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
138477567|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477568|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138477569|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138477570|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138477571|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138477572|NCT02019810|Protective Agents|protective agents|mesh-ancestor
138477574|NCT02019836|Vitamins|vitamins|mesh-ancestor
138477575|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
138477576|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477577|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138477578|NCT02020005|Nicotine|nicotine|mesh-list
138477579|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138477580|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
138477582|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477583|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138477584|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138477585|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
138477586|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477587|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477588|NCT02020122|Pregabalin|pregabalin|mesh-list
138477589|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138477590|NCT02020122|Analgesics|analgesics|mesh-ancestor
138477591|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
138477592|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477593|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477594|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
138477595|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138477596|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477597|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477598|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477600|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477602|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477603|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138477604|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138477605|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477606|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
138477607|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
138477608|NCT02020161|Methotrexate|methotrexate|mesh-list
138477609|NCT02020161|Idarubicin|idarubicin|mesh-list
138477610|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138477611|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
138477612|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477613|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477614|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477615|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
138205628|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205629|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205630|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
138205631|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205633|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477616|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477617|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477618|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
138477619|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477620|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138477621|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477622|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
138477623|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477624|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138477625|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138477626|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138477627|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138477628|NCT02020200|Methylphenidate|methylphenidate|mesh-list
138477629|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138477630|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477631|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138477632|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138477633|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477634|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477635|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
138477636|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477638|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
138477639|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477640|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138477641|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138477642|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138477643|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138477644|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138477645|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477646|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477647|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138477648|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
138477649|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477650|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477651|NCT02020330|Lumefantrine|lumefantrine|mesh-list
138477653|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138477654|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
138477655|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138477656|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138477657|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477658|NCT02020499|Lanreotide|lanreotide|mesh-list
138477659|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477660|NCT02020551|Lidocaine|lidocaine|mesh-list
138477661|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
138477662|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
138477663|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477664|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477665|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
138205640|NCT00005068|Protective Agents|protective agents|mesh-ancestor
138205641|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
138205642|NCT00005068|Vitamins|vitamins|mesh-ancestor
138205643|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
138205645|NCT00004264|Amifostine|amifostine|mesh-list
138205646|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205647|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205648|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205649|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205650|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205651|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138477666|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477667|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138477668|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138477669|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138477670|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477671|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477672|NCT02020603|Epinephrine|epinephrine|mesh-list
138477673|NCT02020603|Racepinephrine|racepinephrine|mesh-list
138477674|NCT02020603|Hemostatics|hemostatics|mesh-list
138477675|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
138477676|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138477677|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138477678|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
138477679|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477680|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477681|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477683|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138477684|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
138477685|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477686|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138477687|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
138477688|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
138477689|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
138477690|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138477693|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138477694|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477695|NCT02020681|Fluorides|fluorides|mesh-list
138477696|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
138477697|NCT02020681|Protective Agents|protective agents|mesh-ancestor
138477698|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477699|NCT02018796|Misoprostol|misoprostol|mesh-list
138477700|NCT02018796|Mifepristone|mifepristone|mesh-list
138477701|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138477702|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
138477703|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477704|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477705|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138477706|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477708|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138477709|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138477710|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138477711|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138477712|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
138477713|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138477714|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138477715|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
138477716|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477717|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
138477718|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138477719|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138477720|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138477721|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138477723|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138477724|NCT02021097|Estradiol|estradiol|mesh-list
138477725|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138477728|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477729|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205657|NCT00005074|Growth Substances|growth substances|mesh-ancestor
138205662|NCT00005602|Carboplatin|carboplatin|mesh-list
138477730|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138477731|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
138477732|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477733|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138477734|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138477735|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138477736|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138477737|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138477738|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138477739|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477740|NCT02021123|Anidulafungin|anidulafungin|mesh-list
138477741|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
138477742|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477743|NCT02021201|Risperidone|risperidone|mesh-list
138477745|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138477746|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
138477747|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397388|NCT01530152|Lidocaine|lidocaine|mesh-list
138477750|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138477751|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477752|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477753|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477754|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138477755|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
138477756|NCT02021214|Methylphenidate|methylphenidate|mesh-list
138477757|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138477758|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477759|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138477760|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138477761|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477762|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477763|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
138477764|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477765|NCT02021240|Dexamethasone|dexamethasone|mesh-list
138477767|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477768|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
138477769|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
138477770|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477771|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477772|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477773|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
138477774|NCT02021240|Hormones|hormones|mesh-ancestor
138477775|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477776|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477777|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477779|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
138477780|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138477781|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138477783|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
138477784|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477785|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138477786|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138477787|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477788|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477789|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
138477790|NCT02021409|Hematinics|hematinics|mesh-ancestor
138477791|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
138477792|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138477793|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138477794|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138477795|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477796|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477797|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
138477798|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477799|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477800|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138205673|NCT00004276|Growth Substances|growth substances|mesh-ancestor
138477801|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477803|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
138477804|NCT02021422|Irinotecan|irinotecan|mesh-list
138477805|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138477806|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
138477807|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477808|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397470|NCT01530503|Mitomycin|mitomycin|mesh-list
138477811|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
138477812|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477813|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138477814|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138477815|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477816|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477817|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138477818|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477819|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
138477820|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477821|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477823|NCT02021825|Analgesics|analgesics|mesh-ancestor
138477824|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
138477825|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477826|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477827|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477828|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138477829|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138477830|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477831|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477832|NCT02021851|Dexamethasone|dexamethasone|mesh-list
138477833|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
138477834|NCT02021851|Ondansetron|ondansetron|mesh-list
138477835|NCT02021851|Aprepitant|aprepitant|mesh-list
138477836|NCT02021851|BB 1101|bb 1101|mesh-list
138477837|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477838|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
138477839|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
138477840|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477841|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477842|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138477843|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
138477845|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138477846|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397523|NCT01530698|Vaccines|vaccines|mesh-list
138477850|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477851|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
138477852|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138477853|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138477854|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138477855|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
138477856|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477857|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138477858|NCT02021864|Vitamin D|vitamin d|mesh-list
138477859|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
138477860|NCT02021864|Vitamins|vitamins|mesh-ancestor
138477861|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
138477862|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477863|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138205681|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205682|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205683|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205686|NCT00005086|Gemcitabine|gemcitabine|mesh-list
138477864|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477866|NCT02022163|Vaccines|vaccines|mesh-list
138477867|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
138477868|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477869|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138477870|NCT02022163|Antacids|antacids|mesh-ancestor
138477871|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477873|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138477874|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138477875|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
138477876|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138477877|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
138477879|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477880|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138477881|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477882|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477883|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138477884|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
138477885|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138477886|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
138477887|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477888|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477889|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138477890|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477891|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477892|NCT02022254|Metformin|metformin|mesh-list
138477893|NCT02022254|Warfarin|warfarin|mesh-list
138477894|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138477895|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477896|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
138477897|NCT02022293|Atorvastatin|atorvastatin|mesh-list
138477898|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138477899|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138477900|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
138477901|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477902|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138477903|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138477904|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477905|NCT02022358|Leucovorin|leucovorin|mesh-list
138477906|NCT02022358|Folic Acid|folic acid|mesh-list
138477907|NCT02022358|Methotrexate|methotrexate|mesh-list
138477908|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
138477909|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138477910|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
138477911|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138477912|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477913|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138477914|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
138477915|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477916|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477917|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
138477918|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477919|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138477920|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138477921|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
138477922|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477923|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138477925|NCT02022358|Protective Agents|protective agents|mesh-ancestor
138477926|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
138477927|NCT02022358|Vitamins|vitamins|mesh-ancestor
138477928|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
138477929|NCT02022358|Hematinics|hematinics|mesh-ancestor
138477930|NCT02022475|Vitamin D|vitamin d|mesh-list
138477931|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
138477932|NCT02022475|Vitamins|vitamins|mesh-ancestor
138477933|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
138477935|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138477936|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138477937|NCT02022488|Midazolam|midazolam|mesh-list
138477938|NCT02022488|Ketamine|ketamine|mesh-list
138477939|NCT02022488|Alfentanil|alfentanil|mesh-list
138477940|NCT02022488|Analgesics|analgesics|mesh-ancestor
138477941|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
138477942|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477943|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477944|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138477945|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138477946|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
138477947|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
138477948|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477949|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138477950|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138477951|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138477952|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477954|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138477955|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138477956|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477957|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138477958|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
138477959|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
138477960|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138477961|NCT02022488|Narcotics|narcotics|mesh-ancestor
138477962|NCT02022527|Aspirin|aspirin|mesh-list
138477963|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
138477964|NCT02022527|Salicylates|salicylates|mesh-list
138477965|NCT02022527|Warfarin|warfarin|mesh-list
138477966|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138397695|NCT01531764|Vinorelbine|vinorelbine|mesh-list
138477968|NCT02022527|Analgesics|analgesics|mesh-ancestor
138477969|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
138477970|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477971|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477972|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477973|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138477974|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138477975|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138477976|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477977|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138477978|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138477979|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477981|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
138477982|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477983|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
138477984|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
138477985|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
138477986|NCT02022540|Ranibizumab|ranibizumab|mesh-list
138477987|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138477988|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138477989|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138477990|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138477991|NCT02022540|Growth Substances|growth substances|mesh-ancestor
138477992|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477993|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
138477994|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477995|NCT02022722|Triamcinolone|triamcinolone|mesh-list
138477996|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138477997|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138477999|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138205696|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138205697|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
138205698|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478000|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
138478001|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
138205699|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478002|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478003|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478004|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
138478005|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478006|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478007|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
138478008|NCT02022722|Hormones|hormones|mesh-ancestor
138478009|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478010|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478011|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
138478012|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478013|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478014|NCT02022761|Laninamivir|laninamivir|mesh-list
138478015|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
138478016|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478017|NCT02022852|Capecitabine|capecitabine|mesh-list
138478018|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478019|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
138478020|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478021|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478022|NCT02022917|Bevacizumab|bevacizumab|mesh-list
138478025|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138478026|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138478027|NCT02022917|Growth Substances|growth substances|mesh-ancestor
138478028|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478029|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
138478030|NCT02022930|Triamcinolone|triamcinolone|mesh-list
138478031|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138478032|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138478033|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138478034|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478035|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
138478036|NCT02022930|Hormones|hormones|mesh-ancestor
138289133|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478037|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478039|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478040|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
138478041|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478042|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478044|NCT02023021|Gemcitabine|gemcitabine|mesh-list
138478045|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138478046|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478047|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138478048|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138397841|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
138478050|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478051|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478052|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
138478053|NCT02023047|Nifedipine|nifedipine|mesh-list
138478054|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138478055|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478056|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478057|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478058|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478059|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478060|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
138478061|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478062|NCT02023086|Tropicamide|tropicamide|mesh-list
138478063|NCT02023086|Mydriatics|mydriatics|mesh-list
138478064|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
138478065|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478066|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478067|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138478068|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138478069|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
138478070|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478071|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478072|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
138478073|NCT02023164|Promethazine|promethazine|mesh-list
138478074|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138478075|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138478077|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478078|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
138478079|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
138478080|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
138478081|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478082|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
138478083|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
138478084|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478085|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138478086|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
138478087|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
138478088|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478089|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478090|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138478091|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
138478092|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
138478094|NCT02023359|Exemestane|exemestane|mesh-list
138478095|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138478096|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478097|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478098|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478099|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478100|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
138478101|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478102|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478103|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138478104|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138478105|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138478106|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478107|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478108|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
138478109|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
138478110|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138478111|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
138478112|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478114|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478115|NCT02023450|Ritonavir|ritonavir|mesh-list
138478116|NCT02023450|Saquinavir|saquinavir|mesh-list
138478117|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138478119|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138478120|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478121|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205725|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205726|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
138205727|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205728|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138205729|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138205730|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
138205732|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
138478122|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138478123|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138478124|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
138478125|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478126|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138478127|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138478128|NCT02023554|Azithromycin|azithromycin|mesh-list
138478129|NCT02023554|Theophylline|theophylline|mesh-list
138478130|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478131|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478132|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138478133|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
138478134|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478135|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478136|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138478137|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
138478138|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138478139|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478140|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478141|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478142|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138478143|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138478144|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
138478145|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478147|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138478148|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138478149|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
138478150|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478151|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478152|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478153|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138478154|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478155|NCT02023684|Lidocaine|lidocaine|mesh-list
138478156|NCT02023684|Ropivacaine|ropivacaine|mesh-list
138478157|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
138478158|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
138478159|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478160|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478161|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
138478162|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478163|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478164|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138478165|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138478166|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478167|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478168|NCT02023710|Paclitaxel|paclitaxel|mesh-list
138478169|NCT02023710|Bevacizumab|bevacizumab|mesh-list
138478171|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138478172|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478174|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138478175|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138478176|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478177|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478178|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138478179|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138478180|NCT02023710|Growth Substances|growth substances|mesh-ancestor
138478181|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478182|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138478183|NCT02023840|Metronidazole|metronidazole|mesh-list
138205746|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205747|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205748|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138478184|NCT02023840|Erythritol|erythritol|mesh-list
138478185|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478186|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478187|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138478188|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138205757|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138205758|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138478189|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478190|NCT02023853|Metronidazole|metronidazole|mesh-list
138205759|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205760|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478191|NCT02023853|Erythritol|erythritol|mesh-list
138478192|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478193|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478194|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138478195|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138478196|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478197|NCT02023892|Atorvastatin|atorvastatin|mesh-list
138478198|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138478199|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138478200|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
138289134|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
138478201|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478202|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138478203|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138478207|NCT02023931|Protective Agents|protective agents|mesh-ancestor
138478208|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478209|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478210|NCT02024009|Nelfinavir|nelfinavir|mesh-list
138478211|NCT02024009|Paclitaxel|paclitaxel|mesh-list
138478212|NCT02024009|Gemcitabine|gemcitabine|mesh-list
138478213|NCT02024009|Capecitabine|capecitabine|mesh-list
138478214|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138478215|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478216|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
138478217|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
138478218|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
138478219|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478220|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478221|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
138478222|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138478223|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138478224|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
138478225|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478226|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205821|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138205822|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
138205823|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
138205824|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205825|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205826|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138205827|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
138205828|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205829|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138205830|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138478227|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138478228|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
138478229|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478230|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
138478231|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
138478233|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478234|NCT02024152|Cetirizine|cetirizine|mesh-list
138478236|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138478237|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138478238|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
138478239|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
138478240|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478241|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478242|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478245|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478246|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478247|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
138478248|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478249|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
138478250|NCT02024256|Analgesics|analgesics|mesh-ancestor
138478251|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
138478252|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478253|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478254|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
138478255|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478256|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478257|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
138478258|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138478259|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478260|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478261|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478262|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
138478263|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478264|NCT02024295|Choline|choline|mesh-list
138478265|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138478266|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
138478267|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138478268|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
138478269|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478270|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478271|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138478272|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
138478273|NCT02024308|Cytarabine|cytarabine|mesh-list
138478274|NCT02024308|Fludarabine|fludarabine|mesh-list
138478275|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478276|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478277|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
138478278|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478279|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478280|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
138478281|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478282|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
138478283|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478284|NCT02024334|Leflunomide|leflunomide|mesh-list
138478285|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478286|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478287|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205854|NCT00004390|Narcotics|narcotics|mesh-ancestor
138205855|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205856|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205857|NCT00004390|Analgesics|analgesics|mesh-ancestor
138205858|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
138205859|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205860|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
138478288|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
138478289|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478291|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138478292|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138478293|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
138478294|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478296|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138478297|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478298|NCT02024425|Antioxidants|antioxidants|mesh-list
138478299|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478300|NCT02024425|Protective Agents|protective agents|mesh-ancestor
138478301|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478302|NCT02024555|Azithromycin|azithromycin|mesh-list
138478303|NCT02024555|Levofloxacin|levofloxacin|mesh-list
138478304|NCT02024555|Rifampin|rifampin|mesh-list
138478305|NCT02024555|Ethambutol|ethambutol|mesh-list
138478306|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478307|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478308|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138478309|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138478310|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138478311|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478312|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478313|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478314|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138478315|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138478316|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138478317|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
138478318|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
138478319|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138478320|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138478321|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138478322|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138478323|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138478324|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138478325|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138478326|NCT02024568|Pregabalin|pregabalin|mesh-list
138478327|NCT02024568|Analgesics|analgesics|mesh-ancestor
138478328|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
138478329|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478330|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478331|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
138478332|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138478333|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478334|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205864|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205865|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138205866|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138205867|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205868|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205870|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205871|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205872|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138478335|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478336|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138478337|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138478338|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478342|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
138478343|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
138478344|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478345|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478346|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138478348|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
138478349|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478350|NCT02024633|Gemcitabine|gemcitabine|mesh-list
138478351|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478352|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
138478353|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478354|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478356|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478357|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138478358|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
138478359|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478360|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478361|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138478362|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
138478363|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
138478364|NCT02024659|Hormones|hormones|mesh-ancestor
138478365|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478366|NCT02024841|Docetaxel|docetaxel|mesh-list
138478367|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478368|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
138478369|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
138478370|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
138478371|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478372|NCT02024906|Caseins|caseins|mesh-list
138478373|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
138478374|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
138478375|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478376|NCT02024919|Diltiazem|diltiazem|mesh-list
138478377|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138478378|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138478379|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478380|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478381|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478382|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478383|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478384|NCT02024945|Propiverine|propiverine|mesh-list
138398180|NCT01534754|Analgesics|analgesics|mesh-ancestor
138478385|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
138478386|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
138478387|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478388|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478389|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138478390|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138478391|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
138478392|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205884|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205885|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478393|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478394|NCT02024945|Urological Agents|urological agents|mesh-ancestor
138478396|NCT02024984|Enclomiphene|enclomiphene|mesh-list
138478397|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
138478398|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138478399|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478400|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478401|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478402|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138478403|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
138478404|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478405|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138478406|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138478407|NCT02025023|Triamcinolone|triamcinolone|mesh-list
138478408|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138478409|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138478410|NCT02025023|Fluorouracil|fluorouracil|mesh-list
138478411|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138478412|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
138478415|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478416|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478417|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
138478418|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478419|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478420|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
138478421|NCT02025023|Hormones|hormones|mesh-ancestor
138478422|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478423|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478424|NCT02025140|Anesthetics|anesthetics|mesh-list
138478426|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478427|NCT02025166|Acetaminophen|acetaminophen|mesh-list
138478429|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138478430|NCT02025166|Analgesics|analgesics|mesh-ancestor
138478431|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
138478432|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205901|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205902|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138205903|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205905|NCT00004426|Hormones|hormones|mesh-list
138205906|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205907|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205908|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138205909|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
138205910|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205913|NCT00004438|Leuprolide|leuprolide|mesh-list
138478433|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478434|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
138478435|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138478436|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478437|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478438|NCT02025192|Capecitabine|capecitabine|mesh-list
138478439|NCT02025192|Trastuzumab|trastuzumab|mesh-list
138478440|NCT02025192|Tucatinib|tucatinib|mesh-list
138478441|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478442|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
138478443|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478444|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478445|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478446|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478447|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478449|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478450|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478451|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478452|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478454|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478455|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138478456|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
138478457|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
138478458|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478459|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478460|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138478461|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138478462|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138478463|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
138478464|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478465|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478466|NCT02025361|Lidocaine|lidocaine|mesh-list
138478467|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
138478468|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
138478469|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478470|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478471|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
138478472|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478473|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478474|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138478475|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138478476|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478477|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478478|NCT02025374|Bupivacaine|bupivacaine|mesh-list
138478479|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
138478480|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
138478481|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
138478482|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478483|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478484|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
138205933|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205934|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138205936|NCT02197273|Analgesics|analgesics|mesh-ancestor
138205937|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138205938|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138205940|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138205941|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138205942|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
138205943|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478485|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478486|NCT02025465|Metoprolol|metoprolol|mesh-list
138478487|NCT02025465|Diltiazem|diltiazem|mesh-list
138478488|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478489|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138478490|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
138478491|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
138478492|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478493|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478494|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138478495|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138478498|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289135|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478499|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478500|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138478501|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478502|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478503|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478504|NCT02025491|Amphotericin B|amphotericin b|mesh-list
138478505|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138478506|NCT02025491|Amebicides|amebicides|mesh-ancestor
138478507|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138478508|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138478509|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478510|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478511|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
138478512|NCT02025608|Pramipexole|pramipexole|mesh-list
138478513|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
138478514|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478515|NCT02025608|Protective Agents|protective agents|mesh-ancestor
138478516|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478517|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138478518|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138205944|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205947|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
138478519|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
138478520|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
138478521|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478522|NCT02025712|Everolimus|everolimus|mesh-list
138478523|NCT02025712|Exemestane|exemestane|mesh-list
138478524|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138478525|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478526|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478527|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478528|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478529|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
138478530|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478531|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478532|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138478533|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138478534|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138478535|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478536|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478537|NCT02025803|Capecitabine|capecitabine|mesh-list
138478538|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478539|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
138478540|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478541|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478542|NCT02025855|Methadone|methadone|mesh-list
138478543|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138478544|NCT02025855|Narcotics|narcotics|mesh-ancestor
138478545|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478546|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478548|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
138478549|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478550|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
138478551|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
138478552|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
138478553|NCT02025868|Darunavir|darunavir|mesh-list
138478554|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138478555|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138478556|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
138478557|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478558|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138478559|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138478560|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478561|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478562|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138478563|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138478565|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
138478566|NCT02025881|Thiotepa|thiotepa|mesh-list
138478567|NCT02025881|Carboplatin|carboplatin|mesh-list
138478568|NCT02025881|Etoposide|etoposide|mesh-list
138478569|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478570|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
138478571|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478572|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478573|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138478574|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
138478575|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478577|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138478578|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138478579|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205994|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138205995|NCT01288807|Milnacipran|milnacipran|mesh-list
138205996|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138205997|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138205998|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478580|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138478581|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478585|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478586|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478587|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138478588|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
138478589|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138478590|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478591|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478592|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138478593|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478594|NCT02026050|Dexamethasone|dexamethasone|mesh-list
138478595|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
138478596|NCT02026050|BB 1101|bb 1101|mesh-list
138478597|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478598|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
138478599|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
138478600|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478601|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478602|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478603|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
138478605|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478606|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138478607|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478608|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
138478609|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478610|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478611|NCT02026219|Clopidogrel|clopidogrel|mesh-list
138478613|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138478614|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138398373|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
138478616|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138478617|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
138478618|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478619|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478620|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478621|NCT02026310|Metformin|metformin|mesh-list
138478622|NCT02026310|Glimepiride|glimepiride|mesh-list
138478623|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478624|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478625|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138478626|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478627|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
138478628|NCT02026479|Dexamethasone|dexamethasone|mesh-list
138478629|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
138478630|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138478631|NCT02026479|BB 1101|bb 1101|mesh-list
138478632|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478633|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
138478634|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
138478635|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478636|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478637|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478638|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
138478639|NCT02026479|Hormones|hormones|mesh-ancestor
138478640|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478641|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138478642|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478643|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
138478645|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478647|NCT02026492|Miotics|miotics|mesh-ancestor
138478648|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
138478649|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478650|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478651|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138206004|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
138478652|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138478653|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
138478654|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138478655|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138478656|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
138478657|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478658|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478660|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478661|NCT02026518|Vitamin D|vitamin d|mesh-list
138478662|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
138478663|NCT02026518|Vitamins|vitamins|mesh-ancestor
138478664|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
138478665|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478666|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138478667|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478669|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138478670|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138478671|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
138478672|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478673|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138478674|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138478675|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478677|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
138478678|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138478679|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138478680|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478681|NCT02026778|Betahistine|betahistine|mesh-list
138478682|NCT02026778|Ondansetron|ondansetron|mesh-list
138478683|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
138478684|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
138478685|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478686|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478687|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478688|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
138478689|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138478690|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138478691|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138478692|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
138478693|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478694|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478695|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478696|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
138478697|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
138478698|NCT02026817|Metformin|metformin|mesh-list
138478699|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138478700|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478701|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478702|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138478703|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138478705|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478706|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138478707|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138478709|NCT02026856|Selenious Acid|selenious acid|mesh-list
138478710|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
138478711|NCT02026856|Trace Elements|trace elements|mesh-ancestor
138478712|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
138478713|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478715|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478716|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206012|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206013|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206014|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
138478717|NCT02026921|Carboplatin|carboplatin|mesh-list
138478718|NCT02026921|Docetaxel|docetaxel|mesh-list
138478719|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478720|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138478721|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138478722|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138478723|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478724|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
138478725|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
138478726|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478727|NCT02026973|Fulvestrant|fulvestrant|mesh-list
138478728|NCT02026973|Anastrozole|anastrozole|mesh-list
138478729|NCT02026973|Somatostatin|somatostatin|mesh-list
138478730|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138478731|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478732|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138478733|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138478734|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478735|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478736|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478737|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138478738|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138478739|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478740|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478741|NCT02026973|Hormones|hormones|mesh-ancestor
138478742|NCT02027064|Interferons|interferons|mesh-list
138478743|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
138478744|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478745|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
138478746|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478747|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
138478748|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478749|NCT02027103|Metformin|metformin|mesh-list
138478750|NCT02027103|Pioglitazone|pioglitazone|mesh-list
138478751|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478752|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478753|NCT02027220|Dexamethasone|dexamethasone|mesh-list
138478754|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
138478755|NCT02027220|Bortezomib|bortezomib|mesh-list
138478756|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478757|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
138478758|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478759|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478760|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138478761|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
138478762|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478763|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478764|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138478765|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478766|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
138478767|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
138478770|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
138478771|NCT02027220|Hormones|hormones|mesh-ancestor
138478772|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478773|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138478774|NCT02027298|Abatacept|abatacept|mesh-list
138478775|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138478776|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478777|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478778|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478779|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478780|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
138478781|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478782|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478783|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
138478784|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
138478785|NCT02027324|Povidone|povidone|mesh-list
138478786|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138478787|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478788|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
138478789|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
138478790|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
138478791|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
138478792|NCT02027337|Drospirenone|drospirenone|mesh-list
138478793|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138478794|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138478795|NCT02027337|Cyproterone|cyproterone|mesh-list
138478796|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
138478797|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138478798|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138478799|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138478800|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
138478801|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478803|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138478804|NCT02027337|Estrogens|estrogens|mesh-ancestor
138478806|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478807|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138478808|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478809|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138478810|NCT02027337|Diuretics|diuretics|mesh-ancestor
138478811|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
138478812|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
138478813|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478814|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138478815|NCT02027363|Capecitabine|capecitabine|mesh-list
138478816|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478817|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
138478818|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478819|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478820|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
138478821|NCT02027454|Cabotegravir|cabotegravir|mesh-list
138478822|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478823|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478824|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138478825|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138206024|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138206025|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138478826|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206026|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
138206027|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206028|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206029|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
138206030|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138206031|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206032|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
138206033|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206034|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350497|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350498|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350499|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350501|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138350502|NCT05039801|Growth Substances|growth substances|mesh-ancestor
138350503|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350504|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
138350505|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
138350506|NCT05032183|Leucovorin|leucovorin|mesh-list
138350507|NCT05032183|Cytarabine|cytarabine|mesh-list
138350508|NCT05032183|Dexamethasone|dexamethasone|mesh-list
138350509|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
138350510|NCT05032183|Prednisone|prednisone|mesh-list
138478827|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478828|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478829|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138478830|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138478832|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138478833|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
138478835|NCT02027493|Ribavirin|ribavirin|mesh-list
138478836|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
138478837|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
138478838|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138478839|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478840|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
138478841|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478842|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
138478843|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478844|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
138478845|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478847|NCT02027532|Cefazolin|cefazolin|mesh-list
138478848|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478849|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478850|NCT02027675|Micronutrients|micronutrients|mesh-list
138478851|NCT02027675|Trace Elements|trace elements|mesh-list
138478852|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478853|NCT02027753|Metformin|metformin|mesh-list
138478854|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
138478855|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138478856|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478857|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478858|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
138478859|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478860|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478861|NCT02027792|Diclofenac|diclofenac|mesh-list
138478862|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138478863|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138478864|NCT02027792|Analgesics|analgesics|mesh-ancestor
138478865|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
138478866|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478867|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478868|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138478869|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138478870|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138478874|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138478875|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478876|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138478877|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478878|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
138478879|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478880|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
138478881|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478882|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138478883|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
138478884|NCT02027922|Protective Agents|protective agents|mesh-ancestor
138478885|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478886|NCT02027961|Durvalumab|durvalumab|mesh-list
138478887|NCT02027961|Trametinib|trametinib|mesh-list
138478888|NCT02027961|Dabrafenib|dabrafenib|mesh-list
138478889|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478890|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206035|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138206036|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
138206038|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478891|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478893|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478894|NCT02027987|Valproic Acid|valproic acid|mesh-list
138478895|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
138478896|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478897|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478898|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
138478899|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478902|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138478903|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138478904|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138478905|NCT02028026|Citalopram|citalopram|mesh-list
138478906|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138478907|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138478908|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138478909|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289136|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138478910|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478911|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478913|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478914|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138478915|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
138478916|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138478917|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138478918|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138478920|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138478921|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138478922|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478923|NCT02028234|Omeprazole|omeprazole|mesh-list
138478924|NCT02028234|Pantoprazole|pantoprazole|mesh-list
138478925|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138478926|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138478927|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138478928|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478929|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478930|NCT02028260|Modafinil|modafinil|mesh-list
138478931|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138478932|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478933|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138478934|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138478935|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138478936|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478937|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138478938|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138478939|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
138478940|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138478941|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138478942|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138478943|NCT02028403|BMS-936559|bms-936559|mesh-list
138478944|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138478945|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206048|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206049|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138206050|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206051|NCT00004486|Fluoxetine|fluoxetine|mesh-list
138206052|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138206053|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138206054|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138478946|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478947|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
138398732|NCT01538108|Paclitaxel|paclitaxel|mesh-list
138478949|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
138478950|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
138478951|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478952|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478953|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
138478954|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478955|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138478956|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138478957|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478958|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478959|NCT02028429|Urological Agents|urological agents|mesh-ancestor
138478960|NCT02028494|Capecitabine|capecitabine|mesh-list
138478961|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478962|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
138478963|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478964|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478965|NCT02028507|Capecitabine|capecitabine|mesh-list
138478966|NCT02028507|Fulvestrant|fulvestrant|mesh-list
138478967|NCT02028507|Palbociclib|palbociclib|mesh-list
138478969|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478970|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
138478971|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478972|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138478973|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138478974|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138478975|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138478976|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
138478977|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478978|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478979|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478980|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478981|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138478982|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138478984|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
138478985|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138478986|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478987|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
138478988|NCT02028598|Clomipramine|clomipramine|mesh-list
138478989|NCT02028598|Citric Acid|citric acid|mesh-list
138478990|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
138478991|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
138478992|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138478993|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
138478994|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
138478995|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478998|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138479000|NCT02028598|Urological Agents|urological agents|mesh-ancestor
138479001|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138479002|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
138479003|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479004|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138479005|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138479006|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479007|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479008|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
138479009|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206062|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138206064|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479010|NCT02028663|Esomeprazole|esomeprazole|mesh-list
138479011|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138479012|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479013|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138479014|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479015|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479016|NCT02028689|Metformin|metformin|mesh-list
138479017|NCT02028689|Lesinurad|lesinurad|mesh-list
138479018|NCT02028689|Furosemide|furosemide|mesh-list
138479019|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479020|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479021|NCT02028689|Diuretics|diuretics|mesh-ancestor
138479022|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
138479023|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138479024|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479025|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479026|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
138479027|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398788|NCT01538446|Clopidogrel|clopidogrel|mesh-list
138479031|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138479032|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138479033|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479034|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479035|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138479036|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138479037|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
138479039|NCT02028910|Ondansetron|ondansetron|mesh-list
138479040|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
138479041|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
138479042|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479043|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479044|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479045|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
138479046|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479047|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138479048|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138479049|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
138479050|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479051|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479052|NCT02028923|Morphine|morphine|mesh-list
138479053|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479054|NCT02028923|Narcotics|narcotics|mesh-ancestor
138479055|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479056|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479057|NCT02028923|Analgesics|analgesics|mesh-ancestor
138479058|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
138479059|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479060|NCT02028949|Idarubicin|idarubicin|mesh-list
138479061|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138479062|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479063|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138398824|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
138479064|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479065|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479066|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479067|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
138479068|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138479069|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
138479070|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479072|NCT02029105|Protective Agents|protective agents|mesh-ancestor
138479074|NCT02029118|Metoprolol|metoprolol|mesh-list
138479076|NCT02029118|Atorvastatin|atorvastatin|mesh-list
138206076|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138206077|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138206078|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138206079|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
138206081|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479077|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138479078|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138479079|NCT02029118|Analgesics|analgesics|mesh-ancestor
138479080|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
138479081|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479082|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479083|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138479084|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138479085|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138479086|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138479087|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479088|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479089|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138479090|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479091|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
138479092|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138479093|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479094|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
138479095|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138479096|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138479097|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138479098|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138479099|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
138479100|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
138479101|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138479102|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138479103|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138479104|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
138479105|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479106|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138398869|NCT01538693|Dexetimide|dexetimide|mesh-list
138479107|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
138479109|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138479110|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
138479111|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138479112|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
138479113|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479114|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479115|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138479116|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138479117|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479119|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138479120|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479121|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
138479122|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479123|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138479124|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138479125|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138479126|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479127|NCT02029482|Ponesimod|ponesimod|mesh-list
138479128|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138479129|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479130|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479131|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
138479132|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479133|NCT02029534|Atorvastatin|atorvastatin|mesh-list
138479134|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138479135|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479136|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
138398903|NCT01538797|Ranitidine|ranitidine|mesh-list
138479139|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138479140|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479141|NCT02029573|Temozolomide|temozolomide|mesh-list
138479143|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138479144|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479145|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
138479146|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479148|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138479149|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479150|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138479151|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
138479152|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479153|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
138479154|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479155|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138479156|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479157|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479158|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479159|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
138479160|NCT02029599|Acetaminophen|acetaminophen|mesh-list
138479161|NCT02029599|Methotrexate|methotrexate|mesh-list
138479162|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138479164|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138479165|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479166|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479167|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
138479168|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479169|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479170|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479171|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479174|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
138479175|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138479176|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479177|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138479179|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
138479180|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479181|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
138479183|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138479184|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
138479185|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479186|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479187|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138479188|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138479189|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
138479190|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479191|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479192|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138479193|NCT02029625|Ezetimibe|ezetimibe|mesh-list
138479194|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138479195|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479196|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
138479197|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479198|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138479199|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138479200|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479201|NCT02029794|Acetic Acid|acetic acid|mesh-list
138479202|NCT02029794|Retinol acetate|retinol acetate|mesh-list
138479203|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206085|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138206086|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
138206087|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206088|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206089|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138206090|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
138479204|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479205|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138479206|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
138479207|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479208|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138479209|NCT02029794|Protective Agents|protective agents|mesh-ancestor
138479210|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479211|NCT02029898|Remifentanil|remifentanil|mesh-list
138479212|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479213|NCT02029898|Narcotics|narcotics|mesh-ancestor
138479214|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479215|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479216|NCT02029898|Analgesics|analgesics|mesh-ancestor
138479217|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
138479218|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479219|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
138479220|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479221|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479223|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138479224|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479225|NCT02029950|Cytarabine|cytarabine|mesh-list
138479226|NCT02029950|Etoposide|etoposide|mesh-list
138479227|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
138479228|NCT02029950|Daunorubicin|daunorubicin|mesh-list
138479229|NCT02029950|Idarubicin|idarubicin|mesh-list
138479230|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
138479231|NCT02029950|Pomalidomide|pomalidomide|mesh-list
138479232|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138479233|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479234|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138479235|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479238|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479239|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
138479240|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
138479241|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479242|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479243|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
138479244|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479245|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138479246|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206099|NCT00005782|Lenograstim|lenograstim|mesh-list
138206100|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138206101|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
138206102|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206104|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138206105|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138206106|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
138206107|NCT00004552|Acamprosate|acamprosate|mesh-list
138479247|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138479248|NCT02029950|Growth Substances|growth substances|mesh-ancestor
138479249|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
138479250|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
138479251|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479253|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479254|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479255|NCT02030561|Trastuzumab|trastuzumab|mesh-list
138479256|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479257|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479258|NCT02031367|Triamcinolone|triamcinolone|mesh-list
138479259|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138479260|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138479261|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138479262|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138479263|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
138479264|NCT02031367|Hormones|hormones|mesh-ancestor
138399000|NCT01539174|Hormones|hormones|mesh-ancestor
138479265|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479266|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479267|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479269|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289137|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479270|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479271|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
138479273|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
138479274|NCT02031692|Calcium|calcium|mesh-list
138479275|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479276|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479277|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138479278|NCT02031692|Vitamins|vitamins|mesh-ancestor
138479279|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
138479280|NCT02031692|Antacids|antacids|mesh-ancestor
138479281|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479282|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479283|NCT02031991|Bevacizumab|bevacizumab|mesh-list
138479284|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479285|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479286|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138479287|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138479288|NCT02031991|Growth Substances|growth substances|mesh-ancestor
138479289|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479290|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
138479291|NCT02032043|Ivermectin|ivermectin|mesh-list
138479292|NCT02032043|Albendazole|albendazole|mesh-list
138479293|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138479294|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479295|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
138479296|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
138479297|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138479298|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138479300|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479301|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479302|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479303|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479305|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138479306|NCT02032134|Protective Agents|protective agents|mesh-ancestor
138479307|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479308|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138479309|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
138479310|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479311|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
138206131|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138206132|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138206133|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
138206134|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479312|NCT02032186|Cathartics|cathartics|mesh-ancestor
138479313|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479314|NCT02033356|Lidocaine|lidocaine|mesh-list
138479315|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
138479316|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
138479317|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479318|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479319|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
138479320|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479321|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138479322|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138479323|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138479324|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479325|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479326|NCT02033733|Cisatracurium|cisatracurium|mesh-list
138479327|NCT02033733|Atracurium|atracurium|mesh-list
138479328|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138479329|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138479330|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479331|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399078|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479332|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138479334|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138479336|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479337|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479338|NCT02034253|Risperidone|risperidone|mesh-list
138479339|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138479340|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
138479341|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479342|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479343|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479344|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138479345|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479346|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479347|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479348|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138479349|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
138479350|NCT02035020|Interferons|interferons|mesh-list
138479351|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
138479352|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479353|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
138479354|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479355|NCT02035709|Hydromorphone|hydromorphone|mesh-list
138479356|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479357|NCT02035709|Narcotics|narcotics|mesh-ancestor
138479358|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479359|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479360|NCT02035709|Analgesics|analgesics|mesh-ancestor
138479361|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
138479362|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479363|NCT02035891|Colchicine|colchicine|mesh-list
138479364|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
138479365|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138479366|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
138206139|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138206140|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138206141|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138206142|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
138479367|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479369|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206143|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206144|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206146|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206147|NCT00005806|Paclitaxel|paclitaxel|mesh-list
138206148|NCT00005806|Carboplatin|carboplatin|mesh-list
138479371|NCT02035956|Vaccines|vaccines|mesh-list
138479372|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
138479373|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479374|NCT02036151|Fluorides|fluorides|mesh-list
138479375|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
138479376|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
138479377|NCT02036151|Protective Agents|protective agents|mesh-ancestor
138479378|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479380|NCT02036255|Heparin|heparin|mesh-list
138479381|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
138479382|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138479383|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138479384|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479385|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479386|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138479387|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479388|NCT02038062|Sevoflurane|sevoflurane|mesh-list
138479389|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479390|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138479391|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
138479392|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
138479393|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479394|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479396|NCT02039453|Meperidine|meperidine|mesh-list
138479397|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479398|NCT02039453|Narcotics|narcotics|mesh-ancestor
138479399|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479400|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479401|NCT02039453|Analgesics|analgesics|mesh-ancestor
138479402|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
138479403|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479404|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138479405|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138479406|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
138479408|NCT02039492|Spironolactone|spironolactone|mesh-list
138479409|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138479410|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
138479411|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479414|NCT02039492|Diuretics|diuretics|mesh-ancestor
138479415|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
138479419|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138479420|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479421|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479422|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479424|NCT02040064|Tremelimumab|tremelimumab|mesh-list
138479425|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479426|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138479427|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479428|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479429|NCT02040142|Mitomycins|mitomycins|mesh-list
138479430|NCT02040142|Mitomycin|mitomycin|mesh-list
138479431|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206150|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138206151|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206152|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
138206153|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
138206154|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479432|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479433|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
138479434|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479435|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479436|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479437|NCT02040220|Aflibercept|aflibercept|mesh-list
138479438|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138479439|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138479440|NCT02040220|Growth Substances|growth substances|mesh-ancestor
138479441|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479442|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
138479443|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479444|NCT02040246|Metformin|metformin|mesh-list
138479445|NCT02040246|Repaglinide|repaglinide|mesh-list
138479446|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479447|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479448|NCT02040285|Metoclopramide|metoclopramide|mesh-list
138479449|NCT02040285|Bisacodyl|bisacodyl|mesh-list
138479451|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
138479452|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479453|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479454|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479455|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138479456|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138479457|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
138479458|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479459|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479460|NCT02040285|Cathartics|cathartics|mesh-ancestor
138479461|NCT02040285|Laxatives|laxatives|mesh-ancestor
138479462|NCT02040311|Topiramate|topiramate|mesh-list
138479463|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
138479464|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479465|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479466|NCT02040350|Pralidoxime|pralidoxime|mesh-list
138479467|NCT02040350|Antidotes|antidotes|mesh-ancestor
138479468|NCT02040350|Protective Agents|protective agents|mesh-ancestor
138479469|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479470|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
138479471|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
138479472|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479473|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
138479474|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479475|NCT02040402|Vaccines|vaccines|mesh-list
138479476|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
138479477|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479478|NCT02040415|Eperisone|eperisone|mesh-list
138479479|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
138479480|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138479481|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479482|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479483|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479484|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479485|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138479486|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138479487|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479488|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
138206169|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206170|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479489|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
138479491|NCT02040441|Spironolactone|spironolactone|mesh-list
138206171|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
138206172|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479492|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138479493|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
138479494|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479495|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479496|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138479497|NCT02040441|Diuretics|diuretics|mesh-ancestor
138479498|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
138479499|NCT02040454|Paclitaxel|paclitaxel|mesh-list
138479500|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138479501|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479502|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
138479503|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479504|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479505|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479506|NCT02040571|Insulin|insulin|mesh-list
138479507|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479508|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479509|NCT02040597|Beclomethasone|beclomethasone|mesh-list
138479510|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
138479511|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
138479512|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138479513|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
138479514|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479515|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479516|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138479517|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138479518|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138479519|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138479520|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138479521|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
138479522|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479523|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479524|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138479525|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138399259|NCT01540747|Inositol|inositol|mesh-list
138479526|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138479527|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
138479528|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138479529|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
138479530|NCT02040597|Hormones|hormones|mesh-ancestor
138479531|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479533|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
138479534|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479536|NCT02040649|Propofol|propofol|mesh-list
138479537|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138479538|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479539|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206182|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
138206183|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206185|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138479540|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138479541|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
138479542|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
138479543|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138479544|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138479545|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479546|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479547|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
138479548|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
138479549|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479550|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479551|NCT02040662|Morphine|morphine|mesh-list
138479552|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479553|NCT02040662|Narcotics|narcotics|mesh-ancestor
138479554|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479555|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479556|NCT02040662|Analgesics|analgesics|mesh-ancestor
138479557|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
138479558|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479559|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
138479560|NCT02040818|Tigecycline|tigecycline|mesh-list
138479561|NCT02040818|Heparin|heparin|mesh-list
138479562|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138479563|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
138479564|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138479565|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138479566|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479567|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
138206205|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206206|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479568|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206207|NCT00004696|Analgesics|analgesics|mesh-ancestor
138206208|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
138206209|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206210|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
138206211|NCT00004744|Antibodies|antibodies|mesh-list
138206212|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
138206213|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138206214|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138206215|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
138206216|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206218|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138206219|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206220|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206221|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138206222|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138206223|NCT01292005|Protective Agents|protective agents|mesh-ancestor
138479569|NCT02040818|Expectorants|expectorants|mesh-ancestor
138206224|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206225|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
138479570|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
138479571|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138479572|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
138479573|NCT02040818|Protective Agents|protective agents|mesh-ancestor
138479574|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479575|NCT02040818|Antidotes|antidotes|mesh-ancestor
138479576|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138479577|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138479578|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479579|NCT02040831|Vaccines|vaccines|mesh-list
138479580|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
138479581|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479582|NCT02040883|Olanzapine|olanzapine|mesh-list
138479583|NCT02040883|Risperidone|risperidone|mesh-list
138479584|NCT02040883|Aripiprazole|aripiprazole|mesh-list
138479585|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138479586|NCT02040883|Ziprasidone|ziprasidone|mesh-list
138479587|NCT02040883|Tandospirone|tandospirone|mesh-list
138479588|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138479589|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
138479590|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479591|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479592|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479593|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138479594|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479595|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479596|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479597|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138479598|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
138479599|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
138479601|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479602|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479603|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138479604|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138479605|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479606|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
138479607|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
138479608|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138479609|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138479610|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138479611|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138479612|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138479613|NCT02040909|Propofol|propofol|mesh-list
138479615|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479616|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479617|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138479618|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
138479619|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
138479620|NCT02040935|Trastuzumab|trastuzumab|mesh-list
138479621|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479622|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479623|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
138479624|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138479625|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479626|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138479627|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479628|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206232|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206233|NCT00004786|Iloprost|iloprost|mesh-list
138206234|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138206235|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
138479629|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479630|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479631|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138479632|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138479633|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479634|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
138479635|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479636|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138479637|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138479638|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479640|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
138479641|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
138479642|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479643|NCT02041273|Palbociclib|palbociclib|mesh-list
138479644|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479645|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138479646|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479647|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479648|NCT02041338|Paclitaxel|paclitaxel|mesh-list
138479649|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138479650|NCT02041338|Carboplatin|carboplatin|mesh-list
138479651|NCT02041338|Epirubicin|epirubicin|mesh-list
138479652|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138479653|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479654|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
138479655|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479656|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479657|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479658|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138479659|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138479660|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479661|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479662|NCT02041351|Docetaxel|docetaxel|mesh-list
138479663|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479664|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138479665|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479666|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479667|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479668|NCT02041455|Amitriptyline|amitriptyline|mesh-list
138479669|NCT02041455|Melatonin|melatonin|mesh-list
138479670|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
138479671|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479672|NCT02041455|Protective Agents|protective agents|mesh-ancestor
138479673|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479674|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479675|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138479676|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
138479677|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479678|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138479679|NCT02041455|Analgesics|analgesics|mesh-ancestor
138479680|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
138479681|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479682|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138206246|NCT00004804|Interferons|interferons|mesh-list
138206247|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
138206248|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479683|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138479684|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479685|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
138479686|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479687|NCT02041481|Leucovorin|leucovorin|mesh-list
138479688|NCT02041481|Fluorouracil|fluorouracil|mesh-list
138479689|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
138479690|NCT02041481|Calcium|calcium|mesh-list
138479692|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479693|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479694|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
138479695|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479696|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479697|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479698|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479699|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
138479700|NCT02041481|Antidotes|antidotes|mesh-ancestor
138479701|NCT02041481|Protective Agents|protective agents|mesh-ancestor
138479702|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
138479703|NCT02041481|Vitamins|vitamins|mesh-ancestor
138479704|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
138479705|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138479706|NCT02041546|Poractant alfa|poractant alfa|mesh-list
138479707|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138479708|NCT02041650|Ticagrelor|ticagrelor|mesh-list
138479709|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479710|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138479711|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138479712|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138479713|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
138479714|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479715|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479716|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479718|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138479719|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479720|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
138479721|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479722|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479723|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138479724|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
138479725|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479726|NCT02042170|Hormones|hormones|mesh-list
138399367|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138479727|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479728|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479730|NCT02042196|Estradiol|estradiol|mesh-list
138479731|NCT02042196|Estrogens|estrogens|mesh-ancestor
138479732|NCT02042196|Hormones|hormones|mesh-ancestor
138289138|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
138479733|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479734|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479735|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138479736|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138479737|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
138479738|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
138479739|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
138479740|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479741|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
138479742|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206266|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
138206267|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
138206268|NCT01341301|Tacrolimus|tacrolimus|mesh-list
138206269|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206270|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
138206271|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206272|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206273|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138479743|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479744|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479745|NCT02042482|Ubiquinone|ubiquinone|mesh-list
138479746|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
138479747|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
138479748|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479749|NCT02042482|Vitamins|vitamins|mesh-ancestor
138479750|NCT02042495|Metformin|metformin|mesh-list
138479751|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479752|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399407|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479754|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
138479755|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479756|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138479757|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138479758|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479759|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479760|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479761|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
138479762|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479763|NCT02042599|Sevoflurane|sevoflurane|mesh-list
138479764|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479765|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138479766|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
138479767|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
138479768|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479769|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479770|NCT02042612|Sevoflurane|sevoflurane|mesh-list
138479771|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479772|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138479773|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
138479774|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
138479775|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399454|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
138479777|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138479778|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138479779|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479780|NCT02042664|Metformin|metformin|mesh-list
138479781|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479782|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479783|NCT02042690|Dexamethasone|dexamethasone|mesh-list
138479784|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
138479785|NCT02042690|Methotrexate|methotrexate|mesh-list
138479786|NCT02042690|Epirubicin|epirubicin|mesh-list
138479787|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
138479788|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479789|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
138479790|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479791|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138479792|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138479793|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
138479794|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479795|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479796|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138479797|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138479799|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
138479800|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479801|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479802|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
138479803|NCT02042690|Hormones|hormones|mesh-ancestor
138479804|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479805|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138479806|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479807|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138479808|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
138479809|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138479810|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479811|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
138479812|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479813|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138479814|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479815|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138479816|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138479817|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479818|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138479820|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479822|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479823|NCT02042742|Protective Agents|protective agents|mesh-ancestor
138479824|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479825|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479826|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138479828|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138479829|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138479830|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479831|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138479832|NCT02043054|Liraglutide|liraglutide|mesh-list
138479833|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479834|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479835|NCT02043054|Incretins|incretins|mesh-ancestor
138479836|NCT02043054|Hormones|hormones|mesh-ancestor
138479837|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138479838|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138479840|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479841|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479842|NCT02043171|Vitamin D|vitamin d|mesh-list
138479843|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
138479844|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
138479845|NCT02043171|Vitamins|vitamins|mesh-list
138479846|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
138479849|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138479850|NCT02043223|Vitamins|vitamins|mesh-list
138479851|NCT02043223|Vitamin A|vitamin a|mesh-list
138479852|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
138479853|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
138479854|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479855|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
138479856|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479857|NCT02043223|Protective Agents|protective agents|mesh-ancestor
138479858|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138479859|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479860|NCT02043288|Gemcitabine|gemcitabine|mesh-list
138479861|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479862|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
138479863|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479864|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479865|NCT02043314|Isoniazid|isoniazid|mesh-list
138479866|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206291|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206292|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
138206293|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206294|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206295|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206296|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138350511|NCT05032183|Cortisone|cortisone|mesh-list
138479867|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138479868|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479869|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138479870|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138479871|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
138479872|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479873|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138479874|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
138479875|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479877|NCT02043717|Vitamins|vitamins|mesh-ancestor
138479878|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
138479879|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479880|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138479881|NCT02043730|Paclitaxel|paclitaxel|mesh-list
138479882|NCT02043730|Gemcitabine|gemcitabine|mesh-list
138479883|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138479884|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479885|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
138479886|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479887|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479888|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479889|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479892|NCT02043756|Analgesics|analgesics|mesh-ancestor
138479893|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
138479894|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479895|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479896|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479897|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138479898|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138479899|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479900|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479901|NCT02043821|Capecitabine|capecitabine|mesh-list
138479902|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479903|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
138479904|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479905|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479907|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138479908|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479909|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479910|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138289139|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138479911|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479914|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
138479915|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
138479916|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138479917|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479918|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479919|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138479920|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479921|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479922|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138479923|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138479924|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
138479925|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479926|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479927|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138479928|NCT02043977|Propofol|propofol|mesh-list
138479929|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138479930|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138479931|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479932|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138479933|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
138479934|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
138479935|NCT02044120|Irinotecan|irinotecan|mesh-list
138479936|NCT02044120|Temozolomide|temozolomide|mesh-list
138479937|NCT02044120|Niraparib|niraparib|mesh-list
138479938|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138479939|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138399678|NCT01543139|Valproic Acid|valproic acid|mesh-list
138479941|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350512|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
138350513|NCT05032183|Rituximab|rituximab|mesh-list
138479942|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350514|NCT05032183|Methotrexate|methotrexate|mesh-list
138479943|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138479944|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
138479945|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138479946|NCT02044133|Vitamin D|vitamin d|mesh-list
138479947|NCT02044133|Vitamins|vitamins|mesh-ancestor
138479948|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
138479949|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479950|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138479951|NCT02044146|Clopidogrel|clopidogrel|mesh-list
138479952|NCT02044146|Ticagrelor|ticagrelor|mesh-list
138479953|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138479954|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138479955|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138479956|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138479957|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138479958|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
138479959|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479960|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479961|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479962|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
138399709|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138508093|NCT06196554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508094|NCT06196554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508095|NCT06196554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508096|NCT06196554|Antimetabolites|antimetabolites|mesh-ancestor
138508097|NCT06196554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508098|NCT06196554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508099|NCT06196554|Immunologic Factors|immunologic factors|mesh-ancestor
138508100|NCT06196554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508101|NCT06196554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138508102|NCT06196554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138508103|NCT06196554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508104|NCT06196515|Calcium, Dietary|calcium, dietary|mesh-list
138508105|NCT06196515|Calcium|calcium|mesh-list
138508106|NCT06196515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138508107|NCT06196515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508108|NCT06196515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138508109|NCT06196203|Azacitidine|azacitidine|mesh-list
138508110|NCT06196203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508111|NCT06196203|Antimetabolites|antimetabolites|mesh-ancestor
138508112|NCT06196203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206302|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
138206303|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206304|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
138508113|NCT06196203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508114|NCT06196203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508115|NCT06196047|Cilostazol|cilostazol|mesh-list
138508116|NCT06196047|Ticagrelor|ticagrelor|mesh-list
138508117|NCT06196047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138508118|NCT06196047|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138508119|NCT06196047|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138508120|NCT06196047|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138508121|NCT06196047|Purinergic Agents|purinergic agents|mesh-ancestor
138508122|NCT06196047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508123|NCT06196047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508124|NCT06196047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508125|NCT06196047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138508126|NCT06196047|Autonomic Agents|autonomic agents|mesh-ancestor
138508127|NCT06196047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508128|NCT06196047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138508129|NCT06196047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138508130|NCT06196047|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138508131|NCT06196047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138508132|NCT06196047|Vasodilator Agents|vasodilator agents|mesh-ancestor
138508133|NCT06196047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138508134|NCT06196047|Protective Agents|protective agents|mesh-ancestor
138508135|NCT06196047|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138508136|NCT06196047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138508137|NCT06196047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508138|NCT06195241|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138508139|NCT06195241|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138508140|NCT06195241|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138508141|NCT06195241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508142|NCT06195241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508143|NCT06195241|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138508144|NCT06195241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508145|NCT06195241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508146|NCT06195241|Cholinergic Agents|cholinergic agents|mesh-ancestor
138508147|NCT06195241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508148|NCT06193200|Dexamethasone|dexamethasone|mesh-list
138508149|NCT06193200|Dexamethasone acetate|dexamethasone acetate|mesh-list
138508150|NCT06193200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138508151|NCT06193200|BB 1101|bb 1101|mesh-list
138508152|NCT06193200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508153|NCT06193200|Antiemetics|antiemetics|mesh-ancestor
138508154|NCT06193200|Autonomic Agents|autonomic agents|mesh-ancestor
138508155|NCT06193200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508156|NCT06193200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508157|NCT06193200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508158|NCT06193200|Glucocorticoids|glucocorticoids|mesh-ancestor
138508159|NCT06193200|Hormones|hormones|mesh-ancestor
138508160|NCT06193200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508161|NCT06193200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508162|NCT06193200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508163|NCT06193200|Protease Inhibitors|protease inhibitors|mesh-ancestor
138184587|NCT04372849|Insulin|insulin|mesh-list
138508164|NCT06193200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206332|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138206333|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138206334|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206335|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206336|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
138206337|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
138206338|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206339|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215223|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215224|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215225|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
138215226|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508165|NCT06193200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508166|NCT06193044|Amlodipine|amlodipine|mesh-list
138508167|NCT06193044|Valsartan|valsartan|mesh-list
138508168|NCT06193044|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138508169|NCT06193044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138508170|NCT06193044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138508171|NCT06193044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508172|NCT06193044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508173|NCT06193044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138508174|NCT06193044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508175|NCT06193044|Vasodilator Agents|vasodilator agents|mesh-ancestor
138455951|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
138508176|NCT06193044|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138508177|NCT06193044|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138508178|NCT06192784|Lenvatinib|lenvatinib|mesh-list
138508179|NCT06192784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508180|NCT06192784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508181|NCT06192784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508182|NCT06192784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508183|NCT06192238|Epinephrine|epinephrine|mesh-list
138508184|NCT06192238|Racepinephrine|racepinephrine|mesh-list
138508185|NCT06192238|Epinephryl borate|epinephryl borate|mesh-list
138508186|NCT06192238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138508187|NCT06192238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138508188|NCT06192238|Adrenergic Agents|adrenergic agents|mesh-ancestor
138508189|NCT06192238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399904|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138508190|NCT06192238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508191|NCT06192238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508192|NCT06192238|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138508193|NCT06192238|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138508194|NCT06192238|Autonomic Agents|autonomic agents|mesh-ancestor
138508195|NCT06192238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508196|NCT06192238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138508197|NCT06192238|Respiratory System Agents|respiratory system agents|mesh-ancestor
138508198|NCT06192238|Mydriatics|mydriatics|mesh-ancestor
138508199|NCT06192238|Sympathomimetics|sympathomimetics|mesh-ancestor
138508200|NCT06192238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138508201|NCT06191692|Rifampin|rifampin|mesh-list
138508202|NCT06191692|Rifapentine|rifapentine|mesh-list
138508203|NCT06191692|Isoniazid|isoniazid|mesh-list
138508204|NCT06191692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138508205|NCT06191692|Antitubercular Agents|antitubercular agents|mesh-ancestor
138508206|NCT06191692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138508207|NCT06191692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138508208|NCT06191692|Leprostatic Agents|leprostatic agents|mesh-ancestor
138508209|NCT06191692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138508210|NCT06191692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508211|NCT06191692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508212|NCT06191692|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138508213|NCT06191692|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138508214|NCT06191692|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138508215|NCT06191692|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138508216|NCT06191692|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138508217|NCT06191692|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138399955|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138508218|NCT06191692|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138508219|NCT06191692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138508220|NCT06191692|Antimetabolites|antimetabolites|mesh-ancestor
138508221|NCT06191692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206340|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138206341|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138206342|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
138206344|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138508222|NCT06189781|Lidocaine|lidocaine|mesh-list
138508223|NCT06189781|Bupivacaine|bupivacaine|mesh-list
138508224|NCT06189781|Ropivacaine|ropivacaine|mesh-list
138508225|NCT06189781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138508226|NCT06189781|Anesthetics|anesthetics|mesh-ancestor
138508227|NCT06189781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508228|NCT06189781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508229|NCT06189781|Sensory System Agents|sensory system agents|mesh-ancestor
138508230|NCT06189781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508231|NCT06189781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138508232|NCT06189781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138508233|NCT06189781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138508234|NCT06189781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508235|NCT06189781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184660|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138508237|NCT06183437|Cariostatic Agents|cariostatic agents|mesh-ancestor
138508238|NCT06183437|Protective Agents|protective agents|mesh-ancestor
138508239|NCT06183437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508240|NCT06170346|Antioxidants|antioxidants|mesh-list
138508241|NCT06170346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508242|NCT06170346|Protective Agents|protective agents|mesh-ancestor
138508243|NCT06170346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508244|NCT06169124|Leuprolide|leuprolide|mesh-list
138508245|NCT06169124|Exemestane|exemestane|mesh-list
138508246|NCT06169124|Androgen Antagonists|androgen antagonists|mesh-list
138508247|NCT06169124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138508248|NCT06169124|Fertility Agents|fertility agents|mesh-ancestor
138508249|NCT06169124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508250|NCT06169124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508251|NCT06169124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508252|NCT06169124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508253|NCT06169124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138508254|NCT06169124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138508255|NCT06169124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508256|NCT06169124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508257|NCT06169124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138508258|NCT06169124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138508259|NCT06169124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400001|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138508265|NCT06158698|Gout Suppressants|gout suppressants|mesh-ancestor
138508266|NCT06158698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508267|NCT06158698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138508268|NCT06158698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138508269|NCT06158698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138508270|NCT06158698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508271|NCT06158698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508276|NCT06144242|Metronidazole|metronidazole|mesh-list
138508277|NCT06144242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138508278|NCT06144242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138508279|NCT06144242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138508280|NCT06144242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138508281|NCT06138132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138508282|NCT06138132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508283|NCT06138132|Alkylating Agents|alkylating agents|mesh-ancestor
138206350|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206351|NCT00103376|Hormones|hormones|mesh-ancestor
138206352|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206353|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206354|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
138508284|NCT06138132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695435|NCT03556696|Narcotics|narcotics|mesh-ancestor
138508285|NCT06138132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508286|NCT06135389|Acetaminophen|acetaminophen|mesh-list
138508287|NCT06135389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508288|NCT06135389|Analgesics|analgesics|mesh-ancestor
138508289|NCT06135389|Sensory System Agents|sensory system agents|mesh-ancestor
138508290|NCT06135389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508291|NCT06135389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508292|NCT06135389|Antipyretics|antipyretics|mesh-ancestor
138508293|NCT06133114|Buprenorphine|buprenorphine|mesh-list
138508294|NCT06133114|Clonazepam|clonazepam|mesh-list
138508295|NCT06133114|Olanzapine|olanzapine|mesh-list
138508296|NCT06133114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138508297|NCT06133114|Narcotics|narcotics|mesh-ancestor
138508298|NCT06133114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508299|NCT06133114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508300|NCT06133114|Analgesics|analgesics|mesh-ancestor
138508301|NCT06133114|Sensory System Agents|sensory system agents|mesh-ancestor
138508302|NCT06133114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508303|NCT06133114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138508304|NCT06133114|Antiemetics|antiemetics|mesh-ancestor
138508305|NCT06133114|Autonomic Agents|autonomic agents|mesh-ancestor
138508306|NCT06133114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508307|NCT06133114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138508308|NCT06133114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138508309|NCT06133114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184752|NCT03409835|Ramosetron|ramosetron|mesh-list
138508310|NCT06133114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138508311|NCT06133114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138508312|NCT06133114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508313|NCT06133114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508314|NCT06133114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508315|NCT06133114|Serotonin Agents|serotonin agents|mesh-ancestor
138508316|NCT06133114|Anticonvulsants|anticonvulsants|mesh-ancestor
138508317|NCT06133114|GABA Modulators|gaba modulators|mesh-ancestor
138508318|NCT06133114|GABA Agents|gaba agents|mesh-ancestor
138508319|NCT06088862|Nicotine|nicotine|mesh-list
138508320|NCT06088862|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138508321|NCT06088862|Autonomic Agents|autonomic agents|mesh-ancestor
138508322|NCT06088862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508323|NCT06088862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508324|NCT06088862|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138508325|NCT06088862|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138508326|NCT06088862|Cholinergic Agents|cholinergic agents|mesh-ancestor
138508327|NCT06088862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330314|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508328|NCT06088862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508330|NCT06084364|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138508331|NCT06084364|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138508332|NCT06084364|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138508333|NCT06084364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508334|NCT06084364|Glucocorticoids|glucocorticoids|mesh-ancestor
138508335|NCT06084364|Hormones|hormones|mesh-ancestor
138508336|NCT06084364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206364|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206365|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138206366|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
138206367|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
138206368|NCT01296763|Irinotecan|irinotecan|mesh-list
138206369|NCT01296763|Olaparib|olaparib|mesh-list
138206370|NCT01296763|Mitomycins|mitomycins|mesh-list
138206371|NCT01296763|Mitomycin|mitomycin|mesh-list
138508337|NCT06084364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508338|NCT06084364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508339|NCT06084364|Immunologic Factors|immunologic factors|mesh-ancestor
138206372|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206373|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138508340|NCT06084364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508341|NCT06084364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508342|NCT06081907|Lenvatinib|lenvatinib|mesh-list
138508343|NCT06081907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508344|NCT06081907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138456008|NCT01909830|Pemetrexed|pemetrexed|mesh-list
138508345|NCT06081907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508346|NCT06081907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508347|NCT06077422|Bupivacaine|bupivacaine|mesh-list
138508348|NCT06077422|Anesthetics, Local|anesthetics, local|mesh-ancestor
138508349|NCT06077422|Anesthetics|anesthetics|mesh-ancestor
138508350|NCT06077422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508351|NCT06077422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695453|NCT00551733|Paclitaxel|paclitaxel|mesh-list
138508352|NCT06077422|Sensory System Agents|sensory system agents|mesh-ancestor
138508353|NCT06077422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508354|NCT06069375|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138508355|NCT06069375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508356|NCT06068543|Vitamins|vitamins|mesh-list
138508357|NCT06068543|Ascorbic Acid|ascorbic acid|mesh-list
138508358|NCT06068543|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138508359|NCT06068543|Micronutrients|micronutrients|mesh-ancestor
138508360|NCT06068543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508361|NCT06068543|Antioxidants|antioxidants|mesh-ancestor
138508362|NCT06068543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508363|NCT06068543|Protective Agents|protective agents|mesh-ancestor
138508364|NCT06068543|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138508365|NCT06068543|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138508366|NCT06068543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508367|NCT06068543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138508368|NCT06053658|Nivolumab|nivolumab|mesh-list
138508369|NCT06053658|Tivozanib|tivozanib|mesh-list
138508370|NCT06053658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138400114|NCT01545830|Vitamin D|vitamin d|mesh-list
138508371|NCT06053658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508372|NCT06053658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508373|NCT06053658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508374|NCT06053658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508375|NCT06053658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508376|NCT06053567|Nicotine|nicotine|mesh-list
138508377|NCT06053567|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138508378|NCT06053567|Autonomic Agents|autonomic agents|mesh-ancestor
138508379|NCT06053567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508380|NCT06053567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508381|NCT06053567|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138508382|NCT06053567|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138508383|NCT06053567|Cholinergic Agents|cholinergic agents|mesh-ancestor
138508384|NCT06053567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456023|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
138508385|NCT06053567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508387|NCT06045247|Cyclophosphamide|cyclophosphamide|mesh-list
138508388|NCT06045247|Rituximab|rituximab|mesh-list
138508389|NCT06045247|Vincristine|vincristine|mesh-list
138508390|NCT06045247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508391|NCT06045247|Immunologic Factors|immunologic factors|mesh-ancestor
138508392|NCT06045247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206376|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206377|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138206378|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138400144|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206379|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
138206380|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206381|NCT01349491|Ranolazine|ranolazine|mesh-list
138206382|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138206383|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508393|NCT06045247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508394|NCT06045247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508395|NCT06045247|Alkylating Agents|alkylating agents|mesh-ancestor
138508396|NCT06045247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508397|NCT06045247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508398|NCT06045247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138508399|NCT06045247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508400|NCT06045247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508401|NCT06045247|Glucocorticoids|glucocorticoids|mesh-ancestor
138508402|NCT06045247|Hormones|hormones|mesh-ancestor
138508403|NCT06045247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508404|NCT06045247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508405|NCT06045247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138508406|NCT06045247|Tubulin Modulators|tubulin modulators|mesh-ancestor
138508407|NCT06045247|Antimitotic Agents|antimitotic agents|mesh-ancestor
138508408|NCT06045247|Mitosis Modulators|mitosis modulators|mesh-ancestor
138508409|NCT06039358|Caffeine|caffeine|mesh-list
138508410|NCT06039358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138508411|NCT06039358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508412|NCT06039358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138508413|NCT06039358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508414|NCT06039358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508415|NCT06039358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138508416|NCT06039358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138508417|NCT06039358|Purinergic Agents|purinergic agents|mesh-ancestor
138508418|NCT06039358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508419|NCT06036472|Anesthetics|anesthetics|mesh-list
138508420|NCT06036472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206384|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206385|NCT01280695|Pioglitazone|pioglitazone|mesh-list
138206386|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206387|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508421|NCT06036472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508422|NCT06013020|Aspirin|aspirin|mesh-list
138508423|NCT06013020|Rivaroxaban|rivaroxaban|mesh-list
138508424|NCT06013020|Clopidogrel|clopidogrel|mesh-list
138508425|NCT06013020|Ticagrelor|ticagrelor|mesh-list
138508426|NCT06013020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138508427|NCT06013020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508428|NCT06013020|Analgesics|analgesics|mesh-ancestor
138508429|NCT06013020|Sensory System Agents|sensory system agents|mesh-ancestor
138508430|NCT06013020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508431|NCT06013020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508432|NCT06013020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508433|NCT06013020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508434|NCT06013020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138508435|NCT06013020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138508436|NCT06013020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508437|NCT06013020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138508438|NCT06013020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138508439|NCT06013020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508440|NCT06013020|Antipyretics|antipyretics|mesh-ancestor
138508441|NCT06013020|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138508442|NCT06013020|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138508443|NCT06013020|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138508444|NCT06013020|Purinergic Agents|purinergic agents|mesh-ancestor
138508445|NCT06013020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508446|NCT06013020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138508447|NCT06013020|Antithrombins|antithrombins|mesh-ancestor
138508448|NCT06013020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138508449|NCT06013020|Protease Inhibitors|protease inhibitors|mesh-ancestor
138508450|NCT06013020|Anticoagulants|anticoagulants|mesh-ancestor
138508451|NCT05998642|Rituximab|rituximab|mesh-list
138508452|NCT05998642|Methotrexate|methotrexate|mesh-list
138508453|NCT05998642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508454|NCT05998642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400237|NCT01547104|Incretins|incretins|mesh-ancestor
138508456|NCT05998642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508457|NCT05998642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508458|NCT05998642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138508459|NCT05998642|Abortifacient Agents|abortifacient agents|mesh-ancestor
138508460|NCT05998642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508461|NCT05998642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508462|NCT05998642|Antimetabolites|antimetabolites|mesh-ancestor
138508463|NCT05998642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508464|NCT05998642|Dermatologic Agents|dermatologic agents|mesh-ancestor
138508465|NCT05998642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508466|NCT05998642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138508467|NCT05998642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508468|NCT05998642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138508469|NCT05995704|Acetaminophen|acetaminophen|mesh-list
138508470|NCT05995704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508471|NCT05995704|Analgesics|analgesics|mesh-ancestor
138508472|NCT05995704|Sensory System Agents|sensory system agents|mesh-ancestor
138508473|NCT05995704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508474|NCT05995704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508475|NCT05995704|Antipyretics|antipyretics|mesh-ancestor
138508476|NCT05987332|Pembrolizumab|pembrolizumab|mesh-list
138508477|NCT05987332|Nivolumab|nivolumab|mesh-list
138508478|NCT05987332|Ipilimumab|ipilimumab|mesh-list
138508479|NCT05987332|Dacarbazine|dacarbazine|mesh-list
138508480|NCT05987332|Crizotinib|crizotinib|mesh-list
138206429|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
138206430|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138206431|NCT00104858|Cyclosporins|cyclosporins|mesh-list
138206432|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
138206433|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508481|NCT05987332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508482|NCT05987332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508483|NCT05987332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508484|NCT05987332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508485|NCT05987332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508486|NCT05987332|Alkylating Agents|alkylating agents|mesh-ancestor
138508487|NCT05987332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508488|NCT05987332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508489|NCT05983198|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138508490|NCT05983198|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138456073|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
138508491|NCT05983198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508492|NCT05981534|Vitamin D|vitamin d|mesh-list
138508493|NCT05981534|Vitamins|vitamins|mesh-ancestor
138508494|NCT05981534|Micronutrients|micronutrients|mesh-ancestor
138508495|NCT05981534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508496|NCT05981534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138508497|NCT05946551|Cetirizine|cetirizine|mesh-list
138508498|NCT05946551|Famotidine|famotidine|mesh-list
138508499|NCT05946551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138508500|NCT05946551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508501|NCT05946551|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138508502|NCT05946551|Histamine Antagonists|histamine antagonists|mesh-ancestor
138508503|NCT05946551|Histamine Agents|histamine agents|mesh-ancestor
138508504|NCT05946551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508505|NCT05946551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508506|NCT05946551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508507|NCT05946551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138508508|NCT05946551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138508509|NCT05946551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138508510|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138508511|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
138508512|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508513|NCT05892276|Cannabidiol|cannabidiol|mesh-list
138508515|NCT05870579|Fulvestrant|fulvestrant|mesh-list
138508516|NCT05870579|Goserelin|goserelin|mesh-list
138508517|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508518|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508519|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138508520|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138508521|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
138508522|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400332|NCT01547416|Narcotics|narcotics|mesh-ancestor
138508531|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508532|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508534|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138508535|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508536|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508537|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138508538|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
138508539|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508540|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508541|NCT05820763|Dexamethasone|dexamethasone|mesh-list
138508542|NCT05820763|Lenalidomide|lenalidomide|mesh-list
138508543|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508544|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
138508545|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
138508546|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508547|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508548|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508549|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
138508550|NCT05820763|Hormones|hormones|mesh-ancestor
138508551|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508552|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508553|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508554|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
138456099|NCT01910246|Metformin|metformin|mesh-list
138508555|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508556|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138508557|NCT05820763|Growth Substances|growth substances|mesh-ancestor
138508558|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138508559|NCT05813327|Ifosfamide|ifosfamide|mesh-list
138508560|NCT05813327|Mesna|mesna|mesh-list
138508561|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508562|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
138508563|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508564|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508565|NCT05813327|Protective Agents|protective agents|mesh-ancestor
138508566|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508567|NCT05789537|Protein C|protein c|mesh-list
138508568|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
138508569|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138508570|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138508571|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508572|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138508573|NCT05786612|Laxatives|laxatives|mesh-ancestor
138508574|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508575|NCT05784012|Niraparib|niraparib|mesh-list
138508576|NCT05784012|Dostarlimab|dostarlimab|mesh-list
138508577|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508578|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138508579|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695515|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508580|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508581|NCT05783609|Rituximab|rituximab|mesh-list
138508582|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508583|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508584|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
138508585|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508586|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508587|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
138508588|NCT05769530|Nalbuphine|nalbuphine|mesh-list
138508589|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138508590|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508591|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508592|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508593|NCT05769530|Analgesics|analgesics|mesh-ancestor
138508594|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
138508595|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508596|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138508597|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138508598|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138508599|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138508600|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508601|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508602|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138508603|NCT05769530|Narcotics|narcotics|mesh-ancestor
138508604|NCT05724589|Mitogens|mitogens|mesh-list
138508605|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138206452|NCT01304407|Calcium|calcium|mesh-list
138206453|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138206454|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206455|NCT00106106|Acamprosate|acamprosate|mesh-list
138206456|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138206457|NCT01304641|Atorvastatin|atorvastatin|mesh-list
138508606|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508607|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138456123|NCT01910259|Diuretics|diuretics|mesh-ancestor
138508608|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508609|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138508610|NCT05701059|Meloxicam|meloxicam|mesh-list
138508611|NCT05701059|Cimetidine|cimetidine|mesh-list
138508612|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138508613|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508614|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138508615|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
138508616|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
138508617|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508618|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508619|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508620|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138508621|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138508622|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400447|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138508623|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138508625|NCT05701059|Analgesics|analgesics|mesh-ancestor
138508626|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
138508627|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508628|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508629|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508630|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138508631|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138508632|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138508633|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
138508634|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
138508635|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508636|NCT05672667|Oxytocin|oxytocin|mesh-list
138508637|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
138508638|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508639|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508640|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
138400499|NCT01548521|Oxytocin|oxytocin|mesh-list
138508642|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
138508643|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508644|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508645|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
138508646|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508647|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138508648|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
138508649|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138508650|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508651|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508652|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138508653|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
138508654|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508655|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
138508656|NCT05664217|Antithrombins|antithrombins|mesh-list
138508657|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138508658|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
138508659|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508660|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508661|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
138206465|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508662|NCT05660850|Mannitol|mannitol|mesh-list
138206466|NCT04753112|Valsartan|valsartan|mesh-list
138206467|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138508663|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138508664|NCT05660850|Diuretics|diuretics|mesh-ancestor
138508665|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
138508666|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508667|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138508668|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138400540|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508669|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508670|NCT05657652|Cytarabine|cytarabine|mesh-list
138508671|NCT05657652|Venetoclax|venetoclax|mesh-list
138508672|NCT05657652|Cladribine|cladribine|mesh-list
138508673|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508676|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508677|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
138508678|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138508679|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508680|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
138508681|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508682|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
138508683|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138508684|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508685|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138508686|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138508688|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
138508689|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
138508690|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508691|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508692|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
138508693|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508694|NCT05642026|Analgesics|analgesics|mesh-ancestor
138508695|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508696|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508700|NCT05606315|Midazolam|midazolam|mesh-list
138508701|NCT05606315|Propofol|propofol|mesh-list
138508702|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138508703|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508704|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508705|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138508706|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
138508707|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
138508708|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138508709|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138508710|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138508711|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138508712|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
138508713|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
138508714|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508715|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508716|NCT05574036|Vitamin E|vitamin e|mesh-list
138508717|NCT05574036|Febuxostat|febuxostat|mesh-list
138508718|NCT05574036|Vitamins|vitamins|mesh-ancestor
138508719|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
138508720|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508721|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
138508722|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508723|NCT05574036|Protective Agents|protective agents|mesh-ancestor
138206480|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206481|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138206482|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508724|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
138206483|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138206484|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206485|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206486|NCT01410409|Acetaminophen|acetaminophen|mesh-list
138508725|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508726|NCT05573204|Vitamin E|vitamin e|mesh-list
138508727|NCT05573204|Vitamins|vitamins|mesh-ancestor
138508728|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
138508729|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508730|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
138479963|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138508731|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508732|NCT05573204|Protective Agents|protective agents|mesh-ancestor
138508733|NCT05533775|Rituximab|rituximab|mesh-list
138508734|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
138508735|NCT05533775|Carboplatin|carboplatin|mesh-list
138508736|NCT05533775|Etoposide|etoposide|mesh-list
138508737|NCT05533775|Ifosfamide|ifosfamide|mesh-list
138508738|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508739|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508740|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
138508741|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508742|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508743|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138508744|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138508745|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372458|NCT01418430|Daclizumab|daclizumab|mesh-list
138508746|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508747|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508748|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508749|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
138508750|NCT05526417|Coal Tar|coal tar|mesh-list
138508751|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
138508752|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
138508753|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138508754|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
138508755|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138508756|NCT05497804|Dexamethasone|dexamethasone|mesh-list
138508757|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
138508758|NCT05497804|Lenalidomide|lenalidomide|mesh-list
138508759|NCT05497804|Daratumumab|daratumumab|mesh-list
138508760|NCT05497804|Ichthammol|ichthammol|mesh-list
138508761|NCT05497804|BB 1101|bb 1101|mesh-list
138508762|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508763|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
138508764|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
138508765|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508766|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508767|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508768|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
138508769|NCT05497804|Hormones|hormones|mesh-ancestor
138508770|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508771|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138508772|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508773|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
138508774|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508775|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508776|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
138508777|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508778|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138508779|NCT05497804|Growth Substances|growth substances|mesh-ancestor
138508780|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138508781|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
138508782|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138508783|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138206493|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
138206494|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138206495|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138206496|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138206497|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206499|NCT01410565|Apaziquone|apaziquone|mesh-list
138508784|NCT05472779|Estradiol|estradiol|mesh-list
138206501|NCT01357135|Metformin|metformin|mesh-list
138508785|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138508786|NCT05472779|Estrogens|estrogens|mesh-ancestor
138508787|NCT05472779|Hormones|hormones|mesh-ancestor
138508788|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508789|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508790|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138508792|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508793|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138508794|NCT05467176|Relugolix|relugolix|mesh-list
138508795|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
138508796|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138508797|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138508798|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508799|NCT05465174|Nivolumab|nivolumab|mesh-list
138508800|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508802|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508803|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508804|NCT05455424|Niraparib|niraparib|mesh-list
138508805|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138508806|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508807|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508808|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508809|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138508810|NCT05432791|Temozolomide|temozolomide|mesh-list
138508811|NCT05432791|Trabectedin|trabectedin|mesh-list
138508812|NCT05432791|Olaparib|olaparib|mesh-list
138508813|NCT05432791|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138508814|NCT05432791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138508815|NCT05432791|Alkylating Agents|alkylating agents|mesh-ancestor
138508816|NCT05432791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508817|NCT05432791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508818|NCT05432791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508819|NCT05423379|Everolimus|everolimus|mesh-list
138508820|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138508821|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508822|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508823|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508824|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508825|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
138508826|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508827|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508828|NCT05420636|Paclitaxel|paclitaxel|mesh-list
138508829|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138508830|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508831|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138508832|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138508833|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138508834|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508835|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
138508836|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138508837|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138330326|NCT00612222|Interleukin-2|interleukin-2|mesh-list
138508838|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138206503|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138206504|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206505|NCT01357135|Incretins|incretins|mesh-ancestor
138206506|NCT01357135|Hormones|hormones|mesh-ancestor
138206508|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138508839|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138508840|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400826|NCT01550640|Analgesics|analgesics|mesh-ancestor
138508841|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138508842|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138508843|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508844|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508845|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508846|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138508847|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
138508848|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508849|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508850|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138508851|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138508852|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138508854|NCT05388006|Venetoclax|venetoclax|mesh-list
138508855|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
138508856|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
138508857|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138508858|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
138508859|NCT05388006|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138508860|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508861|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294753|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
138508862|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
138508863|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508864|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508865|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508866|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508867|NCT05381597|Fluorouracil|fluorouracil|mesh-list
138508868|NCT05381597|Calcipotriene|calcipotriene|mesh-list
138508869|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
138508870|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508871|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508872|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508873|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508874|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
138508875|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508876|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
138508878|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138508879|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508880|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508881|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508882|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
138508883|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138508884|NCT05279833|Sotalol|sotalol|mesh-list
138508886|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138508887|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138508888|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
138206519|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
138206520|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
138206521|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508889|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508890|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508891|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508892|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138508893|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
138508894|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
138508895|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508896|NCT05264974|Vaccines|vaccines|mesh-list
138508897|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
138508898|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508899|NCT05260008|Epinephrine|epinephrine|mesh-list
138508900|NCT05260008|Bupivacaine|bupivacaine|mesh-list
138508901|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
138508902|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
138508903|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508904|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508905|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
138508906|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508907|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138508908|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138508909|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
138508910|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508911|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508912|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138508913|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138508915|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138508916|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
138508917|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
138508918|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
138508919|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138508920|NCT05253131|Durvalumab|durvalumab|mesh-list
138508921|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508922|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508923|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138508924|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456173|NCT01910428|Asparaginase|asparaginase|mesh-list
138508925|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508926|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508927|NCT05211323|Bevacizumab|bevacizumab|mesh-list
138508928|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138508929|NCT05211323|Atezolizumab|atezolizumab|mesh-list
138508930|NCT05211323|Cisplatin|cisplatin|mesh-list
138508931|NCT05211323|Gemcitabine|gemcitabine|mesh-list
138508932|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
138508933|NCT05211323|Antibodies|antibodies|mesh-list
138508934|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
138508935|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138508936|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
138508937|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508938|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138695675|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138508939|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138508940|NCT05211323|Growth Substances|growth substances|mesh-ancestor
138508941|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508942|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
138206543|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138206544|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138206545|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206546|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206547|NCT01359007|Antidotes|antidotes|mesh-ancestor
138206548|NCT01359007|Protective Agents|protective agents|mesh-ancestor
138206549|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206550|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
138206551|NCT01359007|Vitamins|vitamins|mesh-ancestor
138508943|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
138508944|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508945|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
138508946|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508947|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508948|NCT05208047|Sunitinib|sunitinib|mesh-list
138508949|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508950|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508951|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138508952|NCT05208047|Growth Substances|growth substances|mesh-ancestor
138508953|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508954|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
138508955|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508956|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508957|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508958|NCT05168930|Venetoclax|venetoclax|mesh-list
138508959|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
138508960|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508961|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138508962|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508963|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508965|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508966|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508967|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138508968|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508969|NCT05115110|Risdiplam|risdiplam|mesh-list
138508970|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138508971|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508972|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508973|NCT05090280|Nafamostat|nafamostat|mesh-list
138508974|NCT05090280|Naltrexone|naltrexone|mesh-list
138508975|NCT05090280|Oxycodone|oxycodone|mesh-list
138508976|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138508977|NCT05090280|Narcotics|narcotics|mesh-ancestor
138508978|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508979|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508980|NCT05090280|Analgesics|analgesics|mesh-ancestor
138508981|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
138508982|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508983|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138508984|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138508985|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138508986|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138508987|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138508988|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508989|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
138508990|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
138508991|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508992|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508993|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138508994|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138508995|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138206556|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138508996|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508997|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
138508998|NCT05065736|Clofarabine|clofarabine|mesh-list
138206557|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508999|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401052|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509001|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509002|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509003|NCT05062356|Ketorolac|ketorolac|mesh-list
138509004|NCT05062356|Epinephrine|epinephrine|mesh-list
138509005|NCT05062356|Bupivacaine|bupivacaine|mesh-list
138509006|NCT05062356|Prilocaine|prilocaine|mesh-list
138509007|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138509008|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
138509009|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
138509010|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509011|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509012|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
138509013|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509014|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138509015|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138509016|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
138509017|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509018|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509019|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138509020|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138509021|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
138509022|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138509023|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
138509024|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
138509025|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
138509026|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138509027|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401084|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401085|NCT01552330|Artesunate|artesunate|mesh-list
138509029|NCT05062356|Analgesics|analgesics|mesh-ancestor
138509030|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509031|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509032|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138509033|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509034|NCT05056727|Valsartan|valsartan|mesh-list
138509035|NCT05056727|Lisinopril|lisinopril|mesh-list
138509036|NCT05056727|Irbesartan|irbesartan|mesh-list
138509037|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138509038|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138509039|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138509040|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509041|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138509042|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
138509043|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509044|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138509045|NCT05056727|Protective Agents|protective agents|mesh-ancestor
138509046|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509047|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138509048|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138509049|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206574|NCT01362127|Carboplatin|carboplatin|mesh-list
138206575|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
138206576|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509050|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206577|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
138206578|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138206579|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206582|NCT01362205|Analgesics|analgesics|mesh-ancestor
138509051|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
138509052|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138509053|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138509054|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138509055|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138509056|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509057|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
138509058|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509059|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509060|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138185496|NCT04364425|Hormones|hormones|mesh-ancestor
138509061|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509062|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
138509063|NCT05000216|Methotrexate|methotrexate|mesh-list
138509064|NCT05000216|Vaccines|vaccines|mesh-list
138509065|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138509066|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
138509067|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509068|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138509069|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
138509070|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138401139|NCT01552850|Narcotics|narcotics|mesh-ancestor
138509071|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509072|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
138509073|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509074|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509075|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509076|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509077|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138509078|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509079|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138509080|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509081|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138509082|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
138509083|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138509084|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509085|NCT04967196|Nivolumab|nivolumab|mesh-list
138509086|NCT04967196|Ipilimumab|ipilimumab|mesh-list
138509087|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509088|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509089|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509090|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509091|NCT04957095|Levodopa|levodopa|mesh-list
138509092|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138509093|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138509094|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
138509095|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509096|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509097|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509098|NCT04940546|Bevacizumab|bevacizumab|mesh-list
138509099|NCT04940546|Capecitabine|capecitabine|mesh-list
138509100|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
138509101|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509102|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509103|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206590|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509104|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509105|NCT04940546|Growth Substances|growth substances|mesh-ancestor
138509106|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509107|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509108|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509109|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
138509110|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509111|NCT04918186|Durvalumab|durvalumab|mesh-list
138509112|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509113|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509114|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138509115|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138509116|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138509117|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
138509118|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509119|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138509120|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138509121|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509122|NCT04883645|Imiquimod|imiquimod|mesh-list
138509123|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138509124|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
138509125|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509126|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509127|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
138509128|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
138456266|NCT01910987|Bortezomib|bortezomib|mesh-list
138509129|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138509130|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138509131|NCT04873583|Prednisolone|prednisolone|mesh-list
138509132|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
138509133|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138509134|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
138509135|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509136|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
138509137|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
138509138|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509139|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509140|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509141|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
138509142|NCT04873583|Hormones|hormones|mesh-ancestor
138509143|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509144|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138509145|NCT04873583|Protective Agents|protective agents|mesh-ancestor
138509146|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509147|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509148|NCT04869449|Ketoconazole|ketoconazole|mesh-list
138509149|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
138509150|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509151|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138509152|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138509153|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509154|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401250|NCT01553942|Afatinib|afatinib|mesh-list
138401251|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509155|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138509156|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
138509157|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509158|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509159|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138509161|NCT04852887|Letrozole|letrozole|mesh-list
138509162|NCT04852887|Exemestane|exemestane|mesh-list
138509163|NCT04852887|Anastrozole|anastrozole|mesh-list
138206608|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
138206609|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206610|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138206611|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138206612|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206613|NCT01363843|Leucovorin|leucovorin|mesh-list
138509164|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509165|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138509166|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138509167|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509168|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509169|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138509170|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
138509171|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509172|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509173|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509174|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138509175|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138509176|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138509177|NCT04851457|Tirofiban|tirofiban|mesh-list
138509178|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138509179|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138509180|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509181|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138509182|NCT04825275|Posaconazole|posaconazole|mesh-list
138509183|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
138509184|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509185|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138509186|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138509187|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138509188|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138509189|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138509190|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401315|NCT01554826|Vaccines|vaccines|mesh-list
138509191|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509192|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138509193|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
138509194|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509195|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509196|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
138509197|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509198|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509199|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509200|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509202|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
138509203|NCT04770272|Carboplatin|carboplatin|mesh-list
138509204|NCT04770272|Atezolizumab|atezolizumab|mesh-list
138509205|NCT04770272|Epirubicin|epirubicin|mesh-list
138509206|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509207|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509208|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509209|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509210|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509211|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509212|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509213|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509214|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
138509215|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509216|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509217|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138206618|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206619|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
138206620|NCT01363843|Vitamins|vitamins|mesh-ancestor
138509218|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
138509219|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509220|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509221|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509222|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509223|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138509224|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138509225|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509227|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
138509228|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509229|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
138509230|NCT04710628|Lenvatinib|lenvatinib|mesh-list
138509231|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509232|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509233|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509234|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509235|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138509236|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509237|NCT04704934|Paclitaxel|paclitaxel|mesh-list
138509238|NCT04704934|Trastuzumab|trastuzumab|mesh-list
138509239|NCT04704934|Ramucirumab|ramucirumab|mesh-list
138509240|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138509241|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509242|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509243|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509244|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509245|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509246|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509247|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509248|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
138509249|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
138509250|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509251|NCT04685135|Docetaxel|docetaxel|mesh-list
138509252|NCT04685135|Adagrasib|adagrasib|mesh-list
138509253|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509254|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509255|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509256|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509257|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509258|NCT04672330|Tislelizumab|tislelizumab|mesh-list
138509259|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509260|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509261|NCT04658147|Nivolumab|nivolumab|mesh-list
138509262|NCT04658147|Relatlimab|relatlimab|mesh-list
138509263|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509264|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509265|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509266|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509267|NCT04657289|Ranibizumab|ranibizumab|mesh-list
138509268|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138509269|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509270|NCT04657289|Growth Substances|growth substances|mesh-ancestor
138509271|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456347|NCT01911494|Methyldopa|methyldopa|mesh-list
138509272|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509273|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509275|NCT04650581|Ipatasertib|ipatasertib|mesh-list
138509276|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138206634|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206635|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
138206636|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206637|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138509277|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509278|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138401369|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
138509279|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138509280|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
138509281|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509282|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509283|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138509284|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509285|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509286|NCT04576156|Imetelstat|imetelstat|mesh-list
138509287|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
138509288|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509289|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509290|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138509291|NCT04576104|Metformin|metformin|mesh-list
138509292|NCT04576104|Megestrol|megestrol|mesh-list
138509293|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
138509294|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138509295|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509296|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138509297|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138509298|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138509299|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
138509300|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138509301|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138509302|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138509303|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509304|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509305|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
138509306|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138509308|NCT04557956|Dabrafenib|dabrafenib|mesh-list
138509309|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138509310|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509311|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138509312|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509313|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509314|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138509315|NCT04557956|Protective Agents|protective agents|mesh-ancestor
138509316|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509317|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138509318|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
138509319|NCT04533737|Brodalumab|brodalumab|mesh-list
138509320|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509321|NCT04530149|Acetaminophen|acetaminophen|mesh-list
138509322|NCT04530149|Bupivacaine|bupivacaine|mesh-list
138509323|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
138509324|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
138509325|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509326|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509327|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
138509328|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509329|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138509330|NCT04530149|Analgesics|analgesics|mesh-ancestor
138509331|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
138509332|NCT04524871|Bevacizumab|bevacizumab|mesh-list
138509333|NCT04524871|Atezolizumab|atezolizumab|mesh-list
138509334|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509335|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509336|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206647|NCT00153842|Bexarotene|bexarotene|mesh-list
138206648|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206649|NCT01314001|Nicotine|nicotine|mesh-list
138206650|NCT01314001|Varenicline|varenicline|mesh-list
138206651|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138509337|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509338|NCT04524871|Growth Substances|growth substances|mesh-ancestor
138509339|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509340|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509341|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509342|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509343|NCT04508400|Dexamethasone|dexamethasone|mesh-list
138509344|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
138509345|NCT04508400|Ondansetron|ondansetron|mesh-list
138509346|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
138509347|NCT04508400|Aprepitant|aprepitant|mesh-list
138509348|NCT04508400|BB 1101|bb 1101|mesh-list
138509349|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509350|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
138509351|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
138509352|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509353|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509354|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509355|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
138509356|NCT04508400|Hormones|hormones|mesh-ancestor
138509357|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509358|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509359|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695790|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
138509360|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138509361|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509362|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509363|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
138509364|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509365|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138509366|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138509367|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
138509368|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509369|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138509370|NCT04502550|Propofol|propofol|mesh-list
138509371|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138509372|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509373|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509374|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138509375|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
138509376|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
138509377|NCT04492319|Neostigmine|neostigmine|mesh-list
138509378|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138509379|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509380|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509381|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
138509382|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509383|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509384|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138509385|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
138509386|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509387|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
138509388|NCT04485013|Cetuximab|cetuximab|mesh-list
138509389|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509390|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509391|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509392|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509393|NCT04482244|Cannabidiol|cannabidiol|mesh-list
138509394|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
138509395|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
138509396|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206653|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509397|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509398|NCT04458922|Atezolizumab|atezolizumab|mesh-list
138509399|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509400|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509401|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456364|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
138509402|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138401476|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509404|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
138509405|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509406|NCT04334941|Atezolizumab|atezolizumab|mesh-list
138509407|NCT04334941|Talazoparib|talazoparib|mesh-list
138509408|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509409|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509410|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509411|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509412|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509413|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
138509414|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509415|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138509416|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509417|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138509418|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138509419|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138695797|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509420|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138509421|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509422|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509423|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509424|NCT04313335|Analgesics|analgesics|mesh-ancestor
138509425|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
138509426|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509427|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
138509428|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138509429|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
138509431|NCT04310007|Docetaxel|docetaxel|mesh-list
138509432|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138509433|NCT04310007|Gemcitabine|gemcitabine|mesh-list
138509434|NCT04310007|Nivolumab|nivolumab|mesh-list
138509435|NCT04310007|Ramucirumab|ramucirumab|mesh-list
138509436|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138509438|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
138509439|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509440|NCT04310007|Lexatumumab|lexatumumab|mesh-list
138509441|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509442|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509443|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509444|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509445|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509446|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509447|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
138509448|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509449|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509450|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
138509451|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509452|NCT04297618|Lifitegrast|lifitegrast|mesh-list
138509453|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138509454|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138509455|NCT04282109|Paclitaxel|paclitaxel|mesh-list
138206666|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206667|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138206668|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206669|NCT00257894|Baclofen|baclofen|mesh-list
138206670|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206671|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138206672|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138509456|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138509457|NCT04282109|Nivolumab|nivolumab|mesh-list
138509458|NCT04282109|Cetuximab|cetuximab|mesh-list
138509459|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509460|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509461|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509462|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509463|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509464|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509465|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509466|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509467|NCT04240054|Dexamethasone|dexamethasone|mesh-list
138509468|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
138509469|NCT04240054|Bortezomib|bortezomib|mesh-list
138509470|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509471|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
138509472|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509473|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509474|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509475|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
138509476|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509477|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509478|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509479|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509480|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
138695816|NCT05427500|Bupivacaine|bupivacaine|mesh-list
138509481|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
138509482|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509483|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509484|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
138509485|NCT04240054|Hormones|hormones|mesh-ancestor
138509486|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509487|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509488|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
138330344|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
138509489|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509490|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509491|NCT04222504|Tenofovir|tenofovir|mesh-list
138509492|NCT04222504|Emtricitabine|emtricitabine|mesh-list
138509493|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
138509494|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509495|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138509496|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138509497|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509498|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509499|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138509500|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138509501|NCT04218851|Posaconazole|posaconazole|mesh-list
138401587|NCT05847660|Cetrorelix|cetrorelix|mesh-list
138509503|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509504|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138509505|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138509506|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138509507|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138509508|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138509509|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185947|NCT03035617|Bupivacaine|bupivacaine|mesh-list
138509510|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509511|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138206673|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206674|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138206675|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
138206676|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
138206677|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206678|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206679|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138509512|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
138509513|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509514|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509515|NCT04198662|Epinephrine|epinephrine|mesh-list
138509516|NCT04198662|Ropivacaine|ropivacaine|mesh-list
138509517|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
138509518|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
138509519|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509520|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509521|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
138509522|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509523|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138509524|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138509525|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
138509526|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509527|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509528|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138509529|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138509530|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
138509531|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138509532|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
138509533|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
138509534|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
138509535|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138509536|NCT04197310|Nivolumab|nivolumab|mesh-list
138509537|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509538|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509539|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509540|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509541|NCT04175912|Paclitaxel|paclitaxel|mesh-list
138509542|NCT04175912|Carboplatin|carboplatin|mesh-list
138509543|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138509544|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138509545|NCT04175912|Pevonedistat|pevonedistat|mesh-list
138509546|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509547|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509548|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509549|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509550|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509551|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509553|NCT04169828|Folic Acid|folic acid|mesh-list
138509554|NCT04169828|Methotrexate|methotrexate|mesh-list
138509555|NCT04169828|Ondansetron|ondansetron|mesh-list
138509556|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
138509557|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138509558|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
138509559|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138509560|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509561|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509562|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
138509563|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509564|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509565|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509566|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509567|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138509568|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509569|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
138509570|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509571|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138509573|NCT04169828|Protective Agents|protective agents|mesh-ancestor
138509574|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
138509575|NCT04169828|Vitamins|vitamins|mesh-ancestor
138206680|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138206681|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138509576|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
138509577|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
138509578|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
138509579|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509580|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509581|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
138509582|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138509583|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138509585|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509586|NCT04169828|Hematinics|hematinics|mesh-ancestor
138509588|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509589|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509590|NCT04166396|Resveratrol|resveratrol|mesh-list
138509591|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
138509592|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509593|NCT04166396|Protective Agents|protective agents|mesh-ancestor
138509594|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509595|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509596|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138509597|NCT04092283|Paclitaxel|paclitaxel|mesh-list
138509598|NCT04092283|Etoposide|etoposide|mesh-list
138509599|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
138509600|NCT04092283|Cisplatin|cisplatin|mesh-list
138509601|NCT04092283|Carboplatin|carboplatin|mesh-list
138509602|NCT04092283|Pemetrexed|pemetrexed|mesh-list
138509603|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138509604|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
138509605|NCT04092283|Durvalumab|durvalumab|mesh-list
138509606|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
138509607|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509608|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
138509609|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509610|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509611|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509612|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509613|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509614|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509615|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138509616|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138509617|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509618|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138509619|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138509620|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509621|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
138509622|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509624|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509625|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
138206691|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
138206692|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138206695|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206696|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206697|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138206698|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509626|NCT04088890|Fludarabine|fludarabine|mesh-list
138509627|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509628|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
138509629|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509630|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509631|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509632|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
138509633|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509634|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509635|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509636|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
138509637|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
138509638|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138509639|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509640|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138509642|NCT03984448|Cortisone|cortisone|mesh-list
138509643|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
138509644|NCT03984448|Rituximab|rituximab|mesh-list
138509645|NCT03984448|Doxorubicin|doxorubicin|mesh-list
138509646|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138509647|NCT03984448|Etoposide|etoposide|mesh-list
138509648|NCT03984448|Vincristine|vincristine|mesh-list
138509649|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
138509651|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
138509652|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138509653|NCT03984448|Antibodies|antibodies|mesh-list
138509654|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
138509655|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138509656|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509657|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
138509658|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509659|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509660|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509661|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
138509662|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509663|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509664|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509665|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509666|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138509667|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138509668|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509669|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401747|NCT05840406|Narcotics|narcotics|mesh-ancestor
138509671|NCT03984448|Hormones|hormones|mesh-ancestor
138509672|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509673|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509674|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509675|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509676|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509677|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509678|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
138509679|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509680|NCT03941860|Lenalidomide|lenalidomide|mesh-list
138206714|NCT01316263|Olaratumab|olaratumab|mesh-list
138206715|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206716|NCT03015857|Phenylephrine|phenylephrine|mesh-list
138206717|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
138206718|NCT03015857|Norepinephrine|norepinephrine|mesh-list
138509681|NCT03941860|Ixazomib|ixazomib|mesh-list
138509682|NCT03941860|Glycine|glycine|mesh-list
138509683|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
138206720|NCT03015857|Bupivacaine|bupivacaine|mesh-list
138206721|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
138206722|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
138206724|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509684|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509685|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138509686|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509687|NCT03941860|Growth Substances|growth substances|mesh-ancestor
138509688|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509689|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509690|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509691|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
138509692|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509693|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
138509694|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509695|NCT03909412|Dexamethasone|dexamethasone|mesh-list
138509696|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
138509697|NCT03909412|Lenograstim|lenograstim|mesh-list
138509698|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509699|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
138509700|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509701|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509702|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509703|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
138509704|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509705|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509706|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509707|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509708|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
138509709|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
138509710|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509711|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509712|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
138509713|NCT03909412|Hormones|hormones|mesh-ancestor
138509714|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509715|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456437|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
138509722|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509723|NCT03870529|Vitamins|vitamins|mesh-list
138509724|NCT03870529|Vitamin A|vitamin a|mesh-list
138509725|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
138509726|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
138509727|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
138509728|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509729|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
138509730|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509731|NCT03870529|Protective Agents|protective agents|mesh-ancestor
138509732|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138509733|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509734|NCT03865212|Interferons|interferons|mesh-list
138509735|NCT03865212|Interferon-beta|interferon-beta|mesh-list
138509736|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509737|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
138509738|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186159|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
138509739|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
138509740|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509741|NCT03815344|Misoprostol|misoprostol|mesh-list
138509742|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138509743|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
138509744|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138509745|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509746|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138206731|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138206732|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
138206733|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138206734|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
138206735|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
138509747|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509748|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
138509755|NCT03773562|Erenumab|erenumab|mesh-list
138509756|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138509757|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509758|NCT03773562|Analgesics|analgesics|mesh-ancestor
138509759|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
138509760|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509761|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509762|NCT03769714|Bupivacaine|bupivacaine|mesh-list
138509763|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
138509764|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
138401809|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
138509765|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509766|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509767|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
138509768|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509769|NCT03709758|Cytarabine|cytarabine|mesh-list
138509770|NCT03709758|Daunorubicin|daunorubicin|mesh-list
138509771|NCT03709758|Venetoclax|venetoclax|mesh-list
138509772|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509773|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
138509774|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509775|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509776|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
138509777|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509778|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509779|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
138509780|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509781|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509782|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138509783|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138509784|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509785|NCT03698162|Bevacizumab|bevacizumab|mesh-list
138509786|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509787|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509788|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138509789|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509790|NCT03698162|Growth Substances|growth substances|mesh-ancestor
138509791|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509792|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509794|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138401837|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
138401842|NCT05839197|Apatinib|apatinib|mesh-list
138509795|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509797|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
138509798|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509799|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509800|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
138509801|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
138509802|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509803|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509804|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509805|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509806|NCT03651518|Rituximab|rituximab|mesh-list
138509807|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138509808|NCT03651518|Ustekinumab|ustekinumab|mesh-list
138509809|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206745|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509810|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206746|NCT03015857|Protective Agents|protective agents|mesh-ancestor
138206747|NCT03295487|Estrogens|estrogens|mesh-list
138509811|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
138509812|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509813|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509814|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509815|NCT03618641|Nivolumab|nivolumab|mesh-list
138509816|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509817|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509818|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509819|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509820|NCT03600831|Docetaxel|docetaxel|mesh-list
138509821|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509822|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
138509823|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
138509824|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
138509825|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509826|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
138509827|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
138509828|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509829|NCT03580928|Venetoclax|venetoclax|mesh-list
138509830|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
138509831|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
138509832|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509833|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509834|NCT03506360|Dexamethasone|dexamethasone|mesh-list
138509835|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
138509836|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
138509837|NCT03506360|Ixazomib|ixazomib|mesh-list
138509838|NCT03506360|Ichthammol|ichthammol|mesh-list
138509839|NCT03506360|BB 1101|bb 1101|mesh-list
138509840|NCT03506360|Glycine|glycine|mesh-list
138509841|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509842|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
138509843|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
138509844|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509845|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509846|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138509847|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
138509848|NCT03506360|Hormones|hormones|mesh-ancestor
138509849|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509850|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138509851|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509853|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509854|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509855|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509856|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509857|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509858|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
138509859|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138509860|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
138509861|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
138509862|NCT03477500|Cladribine|cladribine|mesh-list
138509863|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
138509864|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206759|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138206760|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206761|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138206762|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138509865|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
138509866|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206763|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138509867|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509868|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509869|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
138695915|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
138509870|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509871|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509872|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509873|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509875|NCT03420521|Ipilimumab|ipilimumab|mesh-list
138509876|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509877|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509878|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509879|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509880|NCT03411096|Ropivacaine|ropivacaine|mesh-list
138509881|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138509882|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
138401915|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
138509883|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509884|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509885|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
138509886|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509887|NCT03334305|Vaccines|vaccines|mesh-list
138509888|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
138509889|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186316|NCT03401957|Cetuximab|cetuximab|mesh-list
138509890|NCT03330821|Cytarabine|cytarabine|mesh-list
138509891|NCT03330821|Idarubicin|idarubicin|mesh-list
138509892|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138509893|NCT03330821|Pevonedistat|pevonedistat|mesh-list
138509894|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509895|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
138509896|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509897|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509898|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
138509899|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509900|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509901|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
138509902|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509903|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509904|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138509905|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138509906|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
138509907|NCT03297606|Nivolumab|nivolumab|mesh-list
138509908|NCT03297606|Trastuzumab|trastuzumab|mesh-list
138509909|NCT03297606|Ipilimumab|ipilimumab|mesh-list
138509910|NCT03297606|Pertuzumab|pertuzumab|mesh-list
138509911|NCT03297606|Sunitinib|sunitinib|mesh-list
138509912|NCT03297606|Dasatinib|dasatinib|mesh-list
138509913|NCT03297606|Olaparib|olaparib|mesh-list
138509914|NCT03297606|Palbociclib|palbociclib|mesh-list
138509915|NCT03297606|Temsirolimus|temsirolimus|mesh-list
138509916|NCT03297606|Axitinib|axitinib|mesh-list
138509917|NCT03297606|Vemurafenib|vemurafenib|mesh-list
138509918|NCT03297606|Crizotinib|crizotinib|mesh-list
138509919|NCT03297606|Tucatinib|tucatinib|mesh-list
138509920|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509921|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509922|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509923|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509924|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138509925|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509926|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138509927|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138509928|NCT03297606|Growth Substances|growth substances|mesh-ancestor
138509929|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509930|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
138509931|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138509932|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138509933|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509934|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
138401942|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
138509936|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138509937|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509938|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509939|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
138509940|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509941|NCT03258567|Nivolumab|nivolumab|mesh-list
138509942|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509943|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509944|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509945|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509946|NCT03257761|Durvalumab|durvalumab|mesh-list
138509947|NCT03257761|Guadecitabine|guadecitabine|mesh-list
138509948|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509949|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509950|NCT03250273|Nivolumab|nivolumab|mesh-list
138509951|NCT03250273|Entinostat|entinostat|mesh-list
138509952|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138509953|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509954|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138509955|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509956|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138509957|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509958|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
138509959|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
138509960|NCT03128359|Melphalan|melphalan|mesh-list
138509961|NCT03128359|Busulfan|busulfan|mesh-list
138509962|NCT03128359|Fludarabine|fludarabine|mesh-list
138509963|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
138509964|NCT03128359|Tacrolimus|tacrolimus|mesh-list
138509965|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138509966|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
138509967|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509968|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138509969|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138509970|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
138649753|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138509971|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509972|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509973|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509974|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509975|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
138509976|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138509977|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509978|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138509979|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138509980|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
138509981|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206798|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
138206799|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138206800|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206801|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
138206802|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138509982|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509983|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138509984|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138509985|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138509986|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138509988|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509989|NCT03040596|Fluticasone|fluticasone|mesh-list
138509990|NCT03040596|Xhance|xhance|mesh-list
138509991|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138509992|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138509993|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
138509994|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509995|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509996|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138509997|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
138509998|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
138509999|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138510000|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138510001|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510002|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510003|NCT02864953|Glyburide|glyburide|mesh-list
138510005|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510006|NCT02840240|Gabapentin|gabapentin|mesh-list
138510007|NCT02840240|Analgesics|analgesics|mesh-ancestor
138510008|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
138510009|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510010|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510011|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
138510012|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138510013|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138510014|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510015|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138510016|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138510017|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138510018|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510019|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510020|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
138510021|NCT02718820|Docetaxel|docetaxel|mesh-list
138510022|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
138401995|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
138510024|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510025|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510026|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510027|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510028|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510029|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138510030|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
138510031|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510032|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510033|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138510034|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510035|NCT02595905|Cisplatin|cisplatin|mesh-list
138510036|NCT02595905|Veliparib|veliparib|mesh-list
138510037|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510038|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138510039|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510040|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510041|NCT02567435|Sirolimus|sirolimus|mesh-list
138206805|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138206806|NCT01072643|Analgesics|analgesics|mesh-ancestor
138206807|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
138206808|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510042|NCT02567435|Dactinomycin|dactinomycin|mesh-list
138510043|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
138510044|NCT02567435|Irinotecan|irinotecan|mesh-list
138510045|NCT02567435|Vincristine|vincristine|mesh-list
138510046|NCT02567435|Temsirolimus|temsirolimus|mesh-list
138510048|NCT02567435|Camptothecin|camptothecin|mesh-list
138510049|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
138510050|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510051|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
138510052|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510053|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510054|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510055|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
138510056|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510057|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510058|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138510059|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510060|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510061|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510062|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510063|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510064|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510065|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510066|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510067|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510068|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510069|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
138510070|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510071|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138510072|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138510074|NCT02539537|Folic Acid|folic acid|mesh-list
138510075|NCT02539537|Gemcitabine|gemcitabine|mesh-list
138510076|NCT02539537|Fluorouracil|fluorouracil|mesh-list
138510077|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
138510078|NCT02539537|Irinotecan|irinotecan|mesh-list
138510079|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
138510080|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510081|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
138510082|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510083|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510084|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510085|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510086|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510087|NCT02539537|Antidotes|antidotes|mesh-ancestor
138510088|NCT02539537|Protective Agents|protective agents|mesh-ancestor
138510089|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510090|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
138510092|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
138510093|NCT02539537|Hematinics|hematinics|mesh-ancestor
138510094|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510095|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
138510096|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
138696028|NCT03911336|Ketoprofen|ketoprofen|mesh-list
138510097|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510098|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510099|NCT02479451|Theophylline|theophylline|mesh-list
138510100|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138510101|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
138510102|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510103|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510104|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138510106|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138510107|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510108|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206819|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138206820|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138206821|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510109|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
138510110|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138510111|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138510112|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
138510113|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510114|NCT02465268|Molgramostim|molgramostim|mesh-list
138510115|NCT02465268|Sargramostim|sargramostim|mesh-list
138510116|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
138510117|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510118|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510119|NCT02437110|Ritonavir|ritonavir|mesh-list
138510120|NCT02437110|Darunavir|darunavir|mesh-list
138510121|NCT02437110|Tenofovir|tenofovir|mesh-list
138510122|NCT02437110|Dolutegravir|dolutegravir|mesh-list
138186525|NCT03408119|Vitamin D|vitamin d|mesh-list
138510123|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138510124|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138510125|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
138510126|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510127|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510128|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138510129|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138510130|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
138510131|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510132|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138510133|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138510134|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138510135|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138510136|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138510137|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138510138|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138510140|NCT02245230|Phenylephrine|phenylephrine|mesh-list
138510141|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
138510142|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
138510143|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138510144|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
138510145|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
138510147|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510149|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138510150|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
138510151|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
138510152|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138510153|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138510154|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138510155|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
138510156|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510157|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510158|NCT02245230|Protective Agents|protective agents|mesh-ancestor
138510159|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138510160|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
138510161|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138510162|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138510163|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138510164|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138510165|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
138510166|NCT02224781|Nivolumab|nivolumab|mesh-list
138510167|NCT02224781|Ipilimumab|ipilimumab|mesh-list
138510168|NCT02224781|Trametinib|trametinib|mesh-list
138510169|NCT02224781|Dabrafenib|dabrafenib|mesh-list
138510170|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138510171|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510172|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510173|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138206828|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
138206829|NCT00117962|Carboplatin|carboplatin|mesh-list
138206830|NCT00117962|Pemetrexed|pemetrexed|mesh-list
138206831|NCT00117962|Cetuximab|cetuximab|mesh-list
138206832|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510174|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510175|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510176|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510177|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138510178|NCT02224781|Protective Agents|protective agents|mesh-ancestor
138510179|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510180|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138510181|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
138510182|NCT02196181|Trametinib|trametinib|mesh-list
138510183|NCT02196181|Dabrafenib|dabrafenib|mesh-list
138510184|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138510185|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510186|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510187|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510188|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402141|NCT04496596|Suramin|suramin|mesh-list
138510189|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138510190|NCT02196181|Protective Agents|protective agents|mesh-ancestor
138510191|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510192|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138510193|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
138510194|NCT02136134|Dexamethasone|dexamethasone|mesh-list
138510195|NCT02136134|Bortezomib|bortezomib|mesh-list
138510196|NCT02136134|Daratumumab|daratumumab|mesh-list
138510197|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510198|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
138510199|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
138510200|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510201|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510202|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138510203|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
138510204|NCT02136134|Hormones|hormones|mesh-ancestor
138510205|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510206|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510207|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510208|NCT01846663|Rifaximin|rifaximin|mesh-list
138510209|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510210|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510211|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138510212|NCT01712620|Spironolactone|spironolactone|mesh-list
138510213|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138510214|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
138510215|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696061|NCT05255367|Phenol|phenol|mesh-list
138510216|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510217|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138510218|NCT01712620|Diuretics|diuretics|mesh-ancestor
138510219|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
138510220|NCT01659151|Aldesleukin|aldesleukin|mesh-list
138510221|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
138510222|NCT01659151|Fludarabine|fludarabine|mesh-list
138510223|NCT01659151|Interleukin-2|interleukin-2|mesh-list
138510224|NCT01659151|Vemurafenib|vemurafenib|mesh-list
138206838|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
138206839|NCT00118274|Vaccines|vaccines|mesh-list
138206840|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
138206841|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
138510225|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138510226|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510228|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510229|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510230|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510231|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
138510232|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510233|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510234|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138510235|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510237|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
138510238|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510239|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138510240|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138510241|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
138510242|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510243|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510244|NCT01597388|Fulvestrant|fulvestrant|mesh-list
138510245|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510246|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510247|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138510248|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138510249|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138510250|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510251|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510252|NCT01394640|Vaccines|vaccines|mesh-list
138510253|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
138510254|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510255|NCT01352962|Carboplatin|carboplatin|mesh-list
138510256|NCT01352962|Gemcitabine|gemcitabine|mesh-list
138510257|NCT01352962|Lenalidomide|lenalidomide|mesh-list
138510258|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510259|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510260|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
138510261|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510262|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
138510263|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510264|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138510265|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138510266|NCT01352962|Growth Substances|growth substances|mesh-ancestor
138510267|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138510268|NCT01228331|Cytarabine|cytarabine|mesh-list
138510269|NCT01228331|Dexamethasone|dexamethasone|mesh-list
138510270|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
138510271|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
138510272|NCT01228331|Doxorubicin|doxorubicin|mesh-list
138510273|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138510275|NCT01228331|Etoposide|etoposide|mesh-list
138510276|NCT01228331|Vincristine|vincristine|mesh-list
138510277|NCT01228331|Daunorubicin|daunorubicin|mesh-list
138510279|NCT01228331|Clofarabine|clofarabine|mesh-list
138510280|NCT01228331|Pegaspargase|pegaspargase|mesh-list
138510281|NCT01228331|Thioguanine|thioguanine|mesh-list
138510282|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
138510283|NCT01228331|Amsacrine|amsacrine|mesh-list
138510284|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510285|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
138510286|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510287|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510288|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510289|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
138510290|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456549|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
138510291|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206872|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138206873|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138206874|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138206875|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
138206876|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138510292|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138510293|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510294|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
138510295|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
138510296|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510300|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510302|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510303|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138510304|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510305|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510306|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138510307|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
138510308|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138510309|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510310|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
138510311|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
138510312|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138510313|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138510314|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510316|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510317|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510318|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510319|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510320|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138510321|NCT01228331|Protective Agents|protective agents|mesh-ancestor
138510322|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
138510323|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510324|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510328|NCT00061438|Meropenem|meropenem|mesh-list
138510329|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510330|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510331|NCT00061477|Gemcitabine|gemcitabine|mesh-list
138510332|NCT00061477|Pemetrexed|pemetrexed|mesh-list
138510333|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510334|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
138510335|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510336|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510337|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510338|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138510339|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138510340|NCT02968342|Progesterone|progesterone|mesh-list
138510341|NCT02968342|Progestins|progestins|mesh-ancestor
138510342|NCT02968342|Hormones|hormones|mesh-ancestor
138510343|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510344|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510345|NCT02968303|Vemurafenib|vemurafenib|mesh-list
138510346|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510347|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510348|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510349|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510350|NCT00061516|Brinzolamide|brinzolamide|mesh-list
138510351|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138510352|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510353|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510354|NCT00061594|Ranibizumab|ranibizumab|mesh-list
138510355|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138510356|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138206888|NCT00118352|Fludarabine|fludarabine|mesh-list
138206889|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
138206890|NCT00118352|Antibodies|antibodies|mesh-list
138206891|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
138206892|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138206893|NCT00118352|Cyclosporins|cyclosporins|mesh-list
138206894|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
138206898|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
138510357|NCT00061594|Growth Substances|growth substances|mesh-ancestor
138510358|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510359|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138510360|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510361|NCT00061711|Hormones|hormones|mesh-list
138510362|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
138510363|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510364|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510365|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138510366|NCT00061711|Estrogens|estrogens|mesh-ancestor
138510367|NCT00061750|Deferasirox|deferasirox|mesh-list
138510368|NCT00061750|Deferoxamine|deferoxamine|mesh-list
138510369|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138510370|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
138402326|NCT03909152|Anastrozole|anastrozole|mesh-list
138510371|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
138510372|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510374|NCT00061789|Acetylcholine|acetylcholine|mesh-list
138510375|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
138510376|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138510377|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
138510378|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510379|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510380|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510381|NCT00061867|Doxorubicin|doxorubicin|mesh-list
138510382|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138510383|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330365|NCT04304274|Narcotics|narcotics|mesh-ancestor
138510384|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510385|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138510386|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510387|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510388|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510389|NCT00061906|Celecoxib|celecoxib|mesh-list
138510390|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138510391|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510392|NCT00061906|Analgesics|analgesics|mesh-ancestor
138510393|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
138510394|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510395|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510396|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510397|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510398|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138510399|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138510400|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402369|NCT03664180|Heparin|heparin|mesh-list
138696104|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510401|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510402|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
138510403|NCT00398554|Prednisone|prednisone|mesh-list
138510404|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
138510405|NCT00398554|Doxorubicin|doxorubicin|mesh-list
138510406|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138510407|NCT00398554|Etoposide|etoposide|mesh-list
138510408|NCT00398554|Vincristine|vincristine|mesh-list
138510409|NCT00398554|Vinblastine|vinblastine|mesh-list
138510410|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510411|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
138510412|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510413|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510414|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510415|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
138510416|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510417|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510418|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138510419|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510420|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138510421|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510422|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510423|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510424|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
138510425|NCT00398554|Hormones|hormones|mesh-ancestor
138510426|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186825|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
138510427|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510428|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510429|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510430|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510431|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510432|NCT04917900|Paclitaxel|paclitaxel|mesh-list
138510433|NCT04917900|Trastuzumab|trastuzumab|mesh-list
138510434|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138510435|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510436|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510437|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510438|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510439|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510440|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510441|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510442|NCT00061984|Doxorubicin|doxorubicin|mesh-list
138510443|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138510444|NCT00061984|Ifosfamide|ifosfamide|mesh-list
138510445|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510446|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510447|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138510448|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510449|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510450|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510451|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510452|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
138510454|NCT00062023|Sulindac|sulindac|mesh-list
138510455|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138510456|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138330444|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510457|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510459|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
138330746|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
138330968|NCT04778267|Dexamethasone|dexamethasone|mesh-list
138331045|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
138331193|NCT03282799|Etonogestrel|etonogestrel|mesh-list
138331267|NCT02540018|Paclitaxel|paclitaxel|mesh-list
138331358|NCT02099175|Antidotes|antidotes|mesh-ancestor
138331433|NCT01250496|Aminophylline|aminophylline|mesh-list
138510460|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331493|NCT04386876|Ritonavir|ritonavir|mesh-list
138510461|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510462|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510463|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510464|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138332175|NCT04342650|Amebicides|amebicides|mesh-ancestor
138332256|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138510465|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138332400|NCT04332276|Protective Agents|protective agents|mesh-ancestor
138332475|NCT01326000|Cetuximab|cetuximab|mesh-list
138332703|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
138332795|NCT03007446|Apatinib|apatinib|mesh-list
138510466|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510467|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138510468|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138510469|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206900|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206901|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206902|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
138206903|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206904|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206905|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206906|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138510470|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
138510471|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138510472|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138510473|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510476|NCT00062062|Gefitinib|gefitinib|mesh-list
138333670|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
138510477|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510478|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333889|NCT00670956|Hormones|hormones|mesh-ancestor
138402460|NCT03552575|Valsartan|valsartan|mesh-list
138510479|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510480|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510481|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
138334419|NCT00741468|Tolbutamide|tolbutamide|mesh-list
138334641|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138510482|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334790|NCT00788892|Daunorubicin|daunorubicin|mesh-list
138510483|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335042|NCT00806598|Hormones|hormones|mesh-ancestor
138335092|NCT00814788|Everolimus|everolimus|mesh-list
138510484|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510485|NCT00392340|Doxorubicin|doxorubicin|mesh-list
138510486|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138510487|NCT00392340|Vincristine|vincristine|mesh-list
138510488|NCT00392340|Topotecan|topotecan|mesh-list
138335841|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138510489|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510490|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335996|NCT00943098|Diclofenac|diclofenac|mesh-list
138336146|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
138510491|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138510493|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510494|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337036|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510495|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510497|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510498|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510499|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510500|NCT00062101|Celecoxib|celecoxib|mesh-list
138337413|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
138510501|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138510502|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510503|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510504|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510505|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337558|NCT03781817|Ketamine|ketamine|mesh-list
138337634|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
138337707|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
138337782|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
138510506|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138510507|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510508|NCT00062101|Analgesics|analgesics|mesh-ancestor
138338387|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
138510509|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
138338525|NCT01197612|Budesonide|budesonide|mesh-list
138510510|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338748|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
138338825|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138338899|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
138510511|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510512|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510513|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339194|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339270|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
138339416|NCT01335204|Bavituximab|bavituximab|mesh-list
138510514|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138510515|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138206919|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206920|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
138206921|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206923|NCT01859819|Rituximab|rituximab|mesh-list
138510516|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
138510517|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510518|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
138510519|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340090|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
138510520|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138340237|NCT01533948|Axitinib|axitinib|mesh-list
138510521|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510522|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
138340689|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340762|NCT05318469|Ivermectin|ivermectin|mesh-list
138510523|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510524|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340987|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510525|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341285|NCT03105843|Miotics|miotics|mesh-ancestor
138510527|NCT00062179|Paclitaxel|paclitaxel|mesh-list
138341435|NCT00653068|Folic Acid|folic acid|mesh-list
138510528|NCT00062179|Carboplatin|carboplatin|mesh-list
138341521|NCT00267683|Glyburide|glyburide|mesh-list
138510529|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341738|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138341807|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138510530|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510531|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510532|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
138510533|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
138189091|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138189168|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
138189264|NCT00633464|Cetuximab|cetuximab|mesh-list
138189493|NCT00637130|Travoprost|travoprost|mesh-list
138189544|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189616|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
138190804|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
138510539|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190888|NCT03593902|Rituximab|rituximab|mesh-list
138190958|NCT03031691|Trifluridine|trifluridine|mesh-list
138510540|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510541|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510542|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510543|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138510544|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191850|NCT01042795|Sunitinib|sunitinib|mesh-list
138510545|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192150|NCT03018665|Metformin|metformin|mesh-list
138192295|NCT01924819|Cisplatin|cisplatin|mesh-list
138510547|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138206928|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192379|NCT01170247|Ketamine|ketamine|mesh-list
138510548|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
138510549|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510550|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510551|NCT00062296|Rituximab|rituximab|mesh-list
138510552|NCT00062296|Epirubicin|epirubicin|mesh-list
138510553|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510554|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510555|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
138206929|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510556|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510557|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206930|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
138206931|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206932|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
138510558|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510559|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138193120|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
138193258|NCT03341156|Thrombin|thrombin|mesh-list
138206933|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206935|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
138510562|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193709|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138194012|NCT02564952|Cannabidiol|cannabidiol|mesh-list
138194243|NCT03780010|Paclitaxel|paclitaxel|mesh-list
138696178|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
138194833|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195056|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195653|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
138195816|NCT05478330|Flutamide|flutamide|mesh-list
138510577|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
138196027|NCT00843310|Dexamethasone|dexamethasone|mesh-list
138196102|NCT01606150|Lidocaine|lidocaine|mesh-list
138510578|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510579|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
138196325|NCT00623974|Vitamins|vitamins|mesh-ancestor
138196404|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138510580|NCT02967874|Protective Agents|protective agents|mesh-ancestor
138196708|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196778|NCT02338232|Telmisartan|telmisartan|mesh-list
138510582|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
138510583|NCT04733625|Vitamins|vitamins|mesh-ancestor
138510584|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
138197080|NCT00000226|Analgesics|analgesics|mesh-ancestor
138197231|NCT00000268|Bupropion|bupropion|mesh-list
138510585|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510586|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138197529|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
138197610|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
138197751|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197811|NCT00000376|Desipramine|desipramine|mesh-list
138197882|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
138197957|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510587|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138510589|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510590|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510592|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510593|NCT00062803|Heparin|heparin|mesh-list
138510594|NCT00062803|Warfarin|warfarin|mesh-list
138510595|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
138510596|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
138510597|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138510598|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138402542|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138510599|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510600|NCT00062842|Irinotecan|irinotecan|mesh-list
138510601|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510602|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510603|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510604|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510605|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510606|NCT00062881|Mafosfamide|mafosfamide|mesh-list
138510607|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138510608|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
138456687|NCT01913834|Teriparatide|teriparatide|mesh-list
138510609|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510610|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510612|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138510613|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510614|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
138510615|NCT00063076|Bexarotene|bexarotene|mesh-list
138510616|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510617|NCT00063193|Minocycline|minocycline|mesh-list
138510618|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206938|NCT02176031|Prednisolone|prednisolone|mesh-list
138206939|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
138206950|NCT02176031|Hormones|hormones|mesh-ancestor
138510619|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510620|NCT00063310|Leuprolide|leuprolide|mesh-list
138510621|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138510622|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
138510623|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138510624|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510625|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510626|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510627|NCT00063388|Cetuximab|cetuximab|mesh-list
138510628|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510629|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510630|NCT00063583|Pirfenidone|pirfenidone|mesh-list
138510631|NCT00063583|Analgesics|analgesics|mesh-ancestor
138510632|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
138510633|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206952|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138206953|NCT02176031|Protective Agents|protective agents|mesh-ancestor
138206954|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138206955|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206956|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
138206980|NCT03014297|Everolimus|everolimus|mesh-list
138510634|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510635|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138510636|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510637|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510638|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510639|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510640|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138510641|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510642|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510643|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510644|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510645|NCT00064012|Docetaxel|docetaxel|mesh-list
138510646|NCT00064012|Bortezomib|bortezomib|mesh-list
138510647|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510648|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138510649|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187054|NCT02245789|Remifentanil|remifentanil|mesh-list
138510650|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138510651|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510652|NCT00064051|Gemcitabine|gemcitabine|mesh-list
138510653|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510654|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
138510655|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510656|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510657|NCT00064090|Cytarabine|cytarabine|mesh-list
138510658|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510659|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
138510660|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510661|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510662|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
138510663|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510664|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510665|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
138510666|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510667|NCT00064129|Ipilimumab|ipilimumab|mesh-list
138402684|NCT02823574|Nivolumab|nivolumab|mesh-list
138456702|NCT01913964|Vitamins|vitamins|mesh-ancestor
138510668|NCT00064129|Sargramostim|sargramostim|mesh-list
138510669|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510670|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510671|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138510672|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510673|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
138510674|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510675|NCT00064207|Gemcitabine|gemcitabine|mesh-list
138510676|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510677|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
138510678|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510679|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510680|NCT00064246|Rituximab|rituximab|mesh-list
138696211|NCT02469155|Risperidone|risperidone|mesh-list
138510681|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138510682|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510683|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510684|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
138510685|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510686|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138510687|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
138510689|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510690|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138510691|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207006|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207007|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207008|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
138510692|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510693|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
138510694|NCT00064285|Growth Substances|growth substances|mesh-ancestor
138402734|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
138510695|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510697|NCT00392418|Trace Elements|trace elements|mesh-list
138510698|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510699|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138510700|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
138510701|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138510702|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138510703|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
138510704|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510705|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510706|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138510707|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
138510708|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138510709|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138510710|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138510711|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138510712|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510713|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510714|NCT00423748|Ambrisentan|ambrisentan|mesh-list
138510715|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138510716|NCT02967211|Insulin|insulin|mesh-list
138510717|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138510718|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
138510719|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
138510720|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
138510721|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
138510722|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
138510723|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138510724|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510726|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187138|NCT01008319|Clomiphene|clomiphene|mesh-list
138510727|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
138510728|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
138510729|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510730|NCT00065143|Clofarabine|clofarabine|mesh-list
138510731|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510732|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
138510733|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510734|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510735|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
138510736|NCT00398749|Hematinics|hematinics|mesh-ancestor
138510737|NCT00398788|Hydromorphone|hydromorphone|mesh-list
138510738|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138510739|NCT00398788|Narcotics|narcotics|mesh-ancestor
138510740|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510741|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510742|NCT00398788|Analgesics|analgesics|mesh-ancestor
138510743|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
138510744|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510745|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
138510746|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138510747|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207015|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138207016|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138207017|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138207018|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
138510748|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510749|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138207021|NCT00118742|Sirolimus|sirolimus|mesh-list
138510750|NCT00398827|Analgesics|analgesics|mesh-ancestor
138510751|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
138402828|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
138510752|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510753|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138510754|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138510755|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138510756|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
138510757|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510758|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510760|NCT00065455|Vitamins|vitamins|mesh-ancestor
138510761|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
138510762|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510763|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138510764|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138510765|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
138510766|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510767|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510768|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138510769|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138510770|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138510771|NCT00065884|Valproic Acid|valproic acid|mesh-list
138510772|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
138510773|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510774|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510775|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
138510776|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510777|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510778|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
138510780|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510781|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138510782|NCT00065923|Topiramate|topiramate|mesh-list
138510783|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
138510784|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138510785|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510786|NCT00065962|Secretin|secretin|mesh-list
138510787|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138510788|NCT00065962|Hormones|hormones|mesh-ancestor
138510789|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510790|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510791|NCT00066001|Metronidazole|metronidazole|mesh-list
138510792|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510793|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510794|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138510795|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138510796|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138510797|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138510798|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138510799|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
138510800|NCT00066157|Estradiol|estradiol|mesh-list
138187193|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
138510801|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138510802|NCT00066157|Estrogens|estrogens|mesh-list
138510803|NCT00066157|Progesterone|progesterone|mesh-list
138510804|NCT00066157|Hormones|hormones|mesh-ancestor
138207029|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207030|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207031|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
138207032|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207033|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207034|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207035|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138510805|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510806|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510807|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138510808|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
138510809|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138510810|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138510811|NCT00066157|Progestins|progestins|mesh-ancestor
138456768|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
138510812|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138510813|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138510814|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138510815|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138510816|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510817|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510819|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510821|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510822|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510824|NCT00066274|Fluorouracil|fluorouracil|mesh-list
138510825|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
138510826|NCT00066274|Irinotecan|irinotecan|mesh-list
138510827|NCT00066274|Calcium|calcium|mesh-list
138510828|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
138510829|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138510830|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510831|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
138479964|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402963|NCT01557335|Aspirin|aspirin|mesh-list
138510832|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510833|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138510834|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510835|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138510836|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
138510837|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510838|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510839|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510840|NCT00066274|Antidotes|antidotes|mesh-ancestor
138510841|NCT00066274|Protective Agents|protective agents|mesh-ancestor
138510842|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
138510843|NCT00066274|Vitamins|vitamins|mesh-ancestor
138510844|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
138510845|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
138510846|NCT04401150|Vitamins|vitamins|mesh-ancestor
138510847|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
138510848|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510849|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
138510850|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510851|NCT04401150|Protective Agents|protective agents|mesh-ancestor
138510852|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
138510853|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
138207042|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207043|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
138510854|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510855|NCT00066352|Bortezomib|bortezomib|mesh-list
138510856|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510857|NCT00066391|Irinotecan|irinotecan|mesh-list
138403019|NCT01557712|Ketamine|ketamine|mesh-list
138510858|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510859|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138510860|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138510861|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510862|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510863|NCT04388475|Temozolomide|temozolomide|mesh-list
138510864|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138510865|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
138510866|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510867|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510868|NCT00389987|Tazobactam|tazobactam|mesh-list
138510869|NCT00389987|Piperacillin|piperacillin|mesh-list
138510870|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510871|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138510872|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138510873|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138510874|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510875|NCT00066508|Bortezomib|bortezomib|mesh-list
138510876|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510877|NCT00066547|Antibodies|antibodies|mesh-list
138510878|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138510879|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
138510880|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510882|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510883|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138510884|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138510885|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510886|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510887|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138510888|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
138510889|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510890|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510892|NCT00066625|Bortezomib|bortezomib|mesh-list
138510893|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207067|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138207068|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207071|NCT01366885|Vitamins|vitamins|mesh-ancestor
138510894|NCT00066859|Sertraline|sertraline|mesh-list
138510895|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138510896|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138510897|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138510898|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138403120|NCT01558245|Kallikreins|kallikreins|mesh-list
138510899|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138510900|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510901|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510902|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
138510903|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510905|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
138510906|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510907|NCT04235673|Protective Agents|protective agents|mesh-ancestor
138510908|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510909|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510910|NCT00067015|Goserelin|goserelin|mesh-list
138510911|NCT00067015|Bicalutamide|bicalutamide|mesh-list
138510912|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138510913|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510914|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
138510915|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
138510916|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510917|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510918|NCT00067093|Vitamin K|vitamin k|mesh-list
138510919|NCT00067093|Heparin|heparin|mesh-list
138510920|NCT00067093|Calcium heparin|calcium heparin|mesh-list
138510921|NCT00067093|Idraparinux|idraparinux|mesh-list
138510922|NCT00067093|Vitamins|vitamins|mesh-ancestor
138510923|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
138510924|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510925|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
138510926|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138510927|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138696261|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138510928|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510929|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138510930|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
138510931|NCT00067093|Coagulants|coagulants|mesh-ancestor
138510932|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138510933|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
138510934|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138510935|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138510936|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510937|NCT00398905|Enoxaparin|enoxaparin|mesh-list
138510938|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
138510939|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138510940|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
138510941|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138510942|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
138510943|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510944|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207100|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207101|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207102|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207103|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207104|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
138207107|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207108|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207109|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138207110|NCT01035749|Vaccines|vaccines|mesh-list
138207111|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
138207112|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510945|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
138510946|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138510947|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138510948|NCT00067405|Micronutrients|micronutrients|mesh-list
138510949|NCT00067405|Trace Elements|trace elements|mesh-list
138510950|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510951|NCT00067444|Paroxetine|paroxetine|mesh-list
138510952|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138510953|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138510954|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138510955|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510956|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510958|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510959|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138510960|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
138510961|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138510962|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138510963|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138510964|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510965|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138510966|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138403271|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510967|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138696269|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
138510968|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138510969|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510970|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510971|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510972|NCT00399022|Analgesics|analgesics|mesh-ancestor
138510973|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
138510974|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510975|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
138510976|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138510977|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
138510979|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138510980|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510981|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510982|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138510983|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138510985|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138510986|NCT00067561|Alosetron|alosetron|mesh-list
138510987|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207116|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207117|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138207118|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
138207125|NCT01425853|Analgesics|analgesics|mesh-ancestor
138510988|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138510989|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
138510990|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510991|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403323|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138403325|NCT01559740|Bupivacaine|bupivacaine|mesh-list
138510992|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510993|NCT00067600|Calcium|calcium|mesh-list
138510994|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138510995|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510996|NCT05010707|Spironolactone|spironolactone|mesh-list
138510997|NCT05010707|Hormones|hormones|mesh-list
138510998|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510999|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511000|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138511001|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
138511002|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138511003|NCT05010707|Diuretics|diuretics|mesh-ancestor
138511004|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
138511005|NCT00067756|Butyric Acid|butyric acid|mesh-list
138511006|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
138511007|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
138511008|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511009|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511010|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511011|NCT04091880|Vaccines|vaccines|mesh-list
138403375|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138511012|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
138511013|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511014|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138511015|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138511016|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138511017|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138511018|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138511019|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511020|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511021|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511022|NCT00067912|Analgesics|analgesics|mesh-ancestor
138511023|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
138187413|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511024|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511025|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
138511027|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
138511028|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138511029|NCT00067951|Metformin|metformin|mesh-list
138511030|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
138511031|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138511032|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511033|NCT00392457|Ketoconazole|ketoconazole|mesh-list
138511034|NCT00392457|Hormones|hormones|mesh-list
138511035|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511036|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511037|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
138511038|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511039|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138207142|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138207143|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
138207144|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207145|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207146|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207147|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138350515|NCT05032183|Vincristine|vincristine|mesh-list
138350516|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
138350517|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138350518|NCT05032183|Antibodies|antibodies|mesh-list
138350519|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
138511040|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138511041|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511042|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511043|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138511044|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
138511045|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138511047|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511048|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138511049|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511050|NCT00068068|Talaporfin|talaporfin|mesh-list
138511051|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511052|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138511053|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511054|NCT00068302|Sirolimus|sirolimus|mesh-list
138511055|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138511056|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511057|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511058|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511059|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
138511060|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511061|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
138511062|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511063|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
138511064|NCT00068458|Calcium|calcium|mesh-list
138511065|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138511066|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511067|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138511068|NCT00068497|Gefitinib|gefitinib|mesh-list
138511069|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511070|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511071|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511072|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511074|NCT00068653|Gefitinib|gefitinib|mesh-list
138511075|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138511076|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511077|NCT00068653|Analgesics|analgesics|mesh-ancestor
138511078|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
138511079|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207148|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207149|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
138207150|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138207151|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138207152|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138207153|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207154|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207155|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
138207156|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207157|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207158|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138207159|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207160|NCT01427881|Cyclosporine|cyclosporine|mesh-list
138207161|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
138207163|NCT01427881|Fludarabine|fludarabine|mesh-list
138207165|NCT01427881|Cyclosporins|cyclosporins|mesh-list
138511080|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511081|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511082|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511083|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138511084|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138511085|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511086|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511087|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511088|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511089|NCT00068731|Lycopene|lycopene|mesh-list
138511090|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511091|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
138511092|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511093|NCT00068731|Protective Agents|protective agents|mesh-ancestor
138511094|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511095|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138511096|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138187488|NCT03111628|Omalizumab|omalizumab|mesh-list
138511097|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511098|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138511099|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
138511100|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456855|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
138511101|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
138511102|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
138511103|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138511104|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511105|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138511107|NCT00399061|Cyclosporins|cyclosporins|mesh-list
138511108|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511109|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511110|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511111|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
138511112|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511113|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
138511114|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511115|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403513|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
138511116|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511117|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138511118|NCT00069355|Propranolol|propranolol|mesh-list
138511119|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138511120|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138511121|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
138207170|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207171|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
138207172|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207173|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207174|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207175|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207182|NCT01319773|Cyclosporine|cyclosporine|mesh-list
138511122|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511123|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511124|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511125|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138511126|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138511127|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
138511128|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
138511129|NCT00069550|Donepezil|donepezil|mesh-list
138511130|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138511131|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511132|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511133|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
138511134|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511135|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511136|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
138511137|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
138511138|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138511139|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138511140|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138511141|NCT02966587|Durvalumab|durvalumab|mesh-list
138511142|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
138511143|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138511144|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
138511145|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511146|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511147|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
138511148|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511149|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
138511150|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
138511151|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511152|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138511153|NCT00069706|Latanoprost|latanoprost|mesh-list
138511154|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138511155|NCT00069901|Paclitaxel|paclitaxel|mesh-list
138511156|NCT00069901|Carboplatin|carboplatin|mesh-list
138511157|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138511158|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511159|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511160|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511161|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511162|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511163|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511164|NCT00069940|Sargramostim|sargramostim|mesh-list
138511165|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
138511166|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511167|NCT00390026|Bevacizumab|bevacizumab|mesh-list
138511168|NCT00390026|Verteporfin|verteporfin|mesh-list
138511169|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511170|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511171|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138511172|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138511173|NCT00390026|Growth Substances|growth substances|mesh-ancestor
138511174|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511175|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
138511176|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138511177|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511178|NCT00070057|Celecoxib|celecoxib|mesh-list
138207195|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207196|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
138207197|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207198|NCT04351867|Docetaxel|docetaxel|mesh-list
138207199|NCT04351867|Capecitabine|capecitabine|mesh-list
138207200|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
138207201|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207202|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511179|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138511180|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511181|NCT00070057|Analgesics|analgesics|mesh-ancestor
138511182|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
138511183|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511184|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511185|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511186|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511187|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138511188|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138511189|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511190|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511192|NCT00070174|Cyclosporine|cyclosporine|mesh-list
138511193|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
138511194|NCT00070174|Busulfan|busulfan|mesh-list
138511195|NCT00070174|Methotrexate|methotrexate|mesh-list
138511196|NCT00070174|Etoposide|etoposide|mesh-list
138511197|NCT00070174|Daunorubicin|daunorubicin|mesh-list
138511198|NCT00070174|Asparaginase|asparaginase|mesh-list
138511199|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
138511200|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
138511201|NCT00070174|Cyclosporins|cyclosporins|mesh-list
138511202|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511203|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
138511204|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511205|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511206|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511207|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
138511208|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511209|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511210|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511211|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138403623|NCT03676725|Lidocaine|lidocaine|mesh-list
138403624|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
138511212|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
138511213|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138511214|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138456895|NCT01915134|Cisplatin|cisplatin|mesh-list
138511215|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
138511216|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511217|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511218|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138511219|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138511220|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511221|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138511222|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138511223|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
138511224|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511225|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
138511226|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138511227|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511228|NCT00070174|Analgesics|analgesics|mesh-ancestor
138511229|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
138511230|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511231|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511232|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
138511233|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
138511234|NCT00070213|Leucovorin|leucovorin|mesh-list
138511235|NCT00070213|Capecitabine|capecitabine|mesh-list
138511236|NCT00070213|Fluorouracil|fluorouracil|mesh-list
138511237|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
138207207|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
138207208|NCT00262730|Temozolomide|temozolomide|mesh-list
138207209|NCT00262730|Poly ICLC|poly iclc|mesh-list
138207210|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207211|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
138511238|NCT00070213|Calcium|calcium|mesh-list
138511239|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
138511240|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138511241|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511242|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511243|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
138511244|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511245|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187637|NCT03023059|Levodopa|levodopa|mesh-list
138511246|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511247|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
138511248|NCT00070213|Antidotes|antidotes|mesh-ancestor
138696377|NCT02884206|Valsartan|valsartan|mesh-list
138511249|NCT00070213|Protective Agents|protective agents|mesh-ancestor
138511250|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
138511252|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
138511253|NCT00070252|Docetaxel|docetaxel|mesh-list
138511254|NCT00070252|Capecitabine|capecitabine|mesh-list
138511255|NCT00070252|Tipifarnib|tipifarnib|mesh-list
138511256|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511257|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511258|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511259|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511260|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511261|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511263|NCT00070447|Prednisone|prednisone|mesh-list
138511264|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
138511265|NCT00070447|Rituximab|rituximab|mesh-list
138511266|NCT00070447|Doxorubicin|doxorubicin|mesh-list
138511267|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138511268|NCT00070447|Vincristine|vincristine|mesh-list
138511269|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511270|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
138511271|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511272|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511273|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511274|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
138511275|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511276|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511277|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511278|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511279|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511280|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138511282|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511283|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511284|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
138511285|NCT00070447|Hormones|hormones|mesh-ancestor
138511286|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511287|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138511288|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511289|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511290|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511291|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511292|NCT03959865|Glucagon|glucagon|mesh-list
138207219|NCT04262934|Vitamins|vitamins|mesh-ancestor
138207220|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
138511293|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138511294|NCT03959865|Incretins|incretins|mesh-ancestor
138207221|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207222|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138207223|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138207225|NCT00262964|Fenofibrate|fenofibrate|mesh-list
138207226|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138207227|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
138511295|NCT03959865|Hormones|hormones|mesh-ancestor
138511296|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511297|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511298|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511300|NCT00070486|Zileuton|zileuton|mesh-list
138511301|NCT00070486|Carboplatin|carboplatin|mesh-list
138511302|NCT00070486|Gemcitabine|gemcitabine|mesh-list
138511303|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511304|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511305|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
138511306|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511307|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138511308|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511309|NCT00070486|Analgesics|analgesics|mesh-ancestor
138511310|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
138511311|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511312|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511313|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511314|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511315|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138696394|NCT02306291|Etoposide|etoposide|mesh-list
138511316|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138511317|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511318|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138511319|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138511320|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
138511321|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511322|NCT00070525|Tipifarnib|tipifarnib|mesh-list
138511323|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511324|NCT00070642|Dacarbazine|dacarbazine|mesh-list
138511325|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511326|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
138511327|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511328|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511329|NCT00070759|Daclizumab|daclizumab|mesh-list
138511330|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511331|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
138511332|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511333|NCT00070837|Antibodies|antibodies|mesh-list
138511334|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138511335|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
138456916|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511336|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511337|NCT00071188|Paclitaxel|paclitaxel|mesh-list
138511338|NCT00071188|Carboplatin|carboplatin|mesh-list
138511339|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138403875|NCT01567072|Ibuprofen|ibuprofen|mesh-list
138511340|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511341|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138207233|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
138207234|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207235|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138207236|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
138207237|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138207238|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
138207239|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207240|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207241|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138207242|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207243|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207244|NCT01899248|Sevoflurane|sevoflurane|mesh-list
138511342|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511343|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511344|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511345|NCT00071227|Triamcinolone|triamcinolone|mesh-list
138511346|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138511347|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138511348|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138511349|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511350|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
138511351|NCT00071227|Hormones|hormones|mesh-ancestor
138511352|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511353|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511354|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511355|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
138511356|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511357|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511359|NCT00071266|Lovastatin|lovastatin|mesh-list
138511360|NCT00071266|L 647318|l 647318|mesh-list
138511361|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
138511362|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138511363|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
138511364|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511365|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138511366|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
138511367|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138511368|NCT00071266|Vitamins|vitamins|mesh-ancestor
138511369|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
138511370|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403928|NCT01569685|Sertraline|sertraline|mesh-list
138511371|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138511372|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138511374|NCT02966743|Midazolam|midazolam|mesh-list
138511375|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
138511376|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138511377|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511378|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511379|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511380|NCT02966743|Analgesics|analgesics|mesh-ancestor
138511381|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
138511382|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511383|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138511384|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138511385|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138511386|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
138511387|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511388|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511389|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138511390|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138511391|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138511392|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138511393|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138511394|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
138511395|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
138207245|NCT01899248|Desflurane|desflurane|mesh-list
138207246|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138511396|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
138207247|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138511397|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
138511398|NCT00071539|Immunotoxins|immunotoxins|mesh-list
138511399|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
138511400|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
138511401|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511402|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138511403|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138511404|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138511405|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138511406|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138511407|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511408|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511411|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
138511412|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511413|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
138511414|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138511415|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
138511416|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138511417|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
138511418|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511420|NCT00071968|Temsirolimus|temsirolimus|mesh-list
138511421|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
138511422|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511423|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511424|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511425|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511426|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
138511427|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511428|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511429|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138511430|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511431|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511432|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
138511433|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
138511434|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138511435|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
138511436|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511437|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511438|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138511439|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
138511440|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138511441|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
138511442|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511443|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511444|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138511445|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
138511446|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
138511447|NCT00390065|Protective Agents|protective agents|mesh-ancestor
138511448|NCT00072007|Prednisone|prednisone|mesh-list
138207265|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138207266|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138207267|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207268|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207269|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138207271|NCT01322815|Growth Substances|growth substances|mesh-ancestor
138207272|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
138207273|NCT01322815|Antidotes|antidotes|mesh-ancestor
138511449|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
138511450|NCT00072007|Rituximab|rituximab|mesh-list
138511451|NCT00072007|Doxorubicin|doxorubicin|mesh-list
138511452|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138511453|NCT00072007|Vincristine|vincristine|mesh-list
138511454|NCT00072007|Cladribine|cladribine|mesh-list
138511455|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511456|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
138511457|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511458|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511459|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511460|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
138511461|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511462|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511463|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511464|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511465|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511466|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138511467|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138511468|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511469|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511470|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
138511471|NCT00072007|Hormones|hormones|mesh-ancestor
138511472|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511473|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138404117|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
138404118|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511474|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511475|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187861|NCT02982395|Docetaxel|docetaxel|mesh-list
138511477|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511478|NCT00072046|Interferons|interferons|mesh-list
138511479|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
138511480|NCT00072046|Bevacizumab|bevacizumab|mesh-list
138511481|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511482|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511483|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138511484|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138457000|NCT01915979|Hormones|hormones|mesh-ancestor
138511485|NCT00072046|Growth Substances|growth substances|mesh-ancestor
138511486|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511487|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
138511489|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511490|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
138511491|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
138511492|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138511493|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511494|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
138511496|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138511497|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511498|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404163|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138511499|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511501|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
138511502|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207274|NCT01322815|Protective Agents|protective agents|mesh-ancestor
138207275|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
138207276|NCT01322815|Vitamins|vitamins|mesh-ancestor
138207277|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
138207278|NCT00176228|Lamotrigine|lamotrigine|mesh-list
138207279|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
138511503|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138511504|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138511505|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138511506|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138511507|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511508|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511509|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138511510|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138511511|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
138511512|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
138511513|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138511514|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138511515|NCT00072085|Aldesleukin|aldesleukin|mesh-list
138511516|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
138511517|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511518|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138511519|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138511520|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
138511521|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511522|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138511523|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
138511524|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404215|NCT01571804|Pregabalin|pregabalin|mesh-list
138511525|NCT04730674|Tetracycline|tetracycline|mesh-list
138511526|NCT04730674|Lidocaine|lidocaine|mesh-list
138511527|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
138511528|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
138511529|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511530|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511531|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
138511532|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511533|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138511534|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138511535|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138511536|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138511537|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511538|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138511539|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511540|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138511541|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511542|NCT03959436|Carbetocin|carbetocin|mesh-list
138511543|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
138511544|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138511545|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511546|NCT00072124|Dacarbazine|dacarbazine|mesh-list
138511547|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511548|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511549|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
138187936|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
138511550|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511551|NCT00072163|Thalidomide|thalidomide|mesh-list
138511552|NCT00072163|Temozolomide|temozolomide|mesh-list
138511553|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511554|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
138404263|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207289|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138207290|NCT00176306|Levofloxacin|levofloxacin|mesh-list
138207291|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138207292|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511555|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511556|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511557|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511558|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
138511559|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511560|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
138511561|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138511562|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511563|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138511564|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138511565|NCT00072163|Growth Substances|growth substances|mesh-ancestor
138511566|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
138511568|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
138511569|NCT00072319|Epirubicin|epirubicin|mesh-list
138511570|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511571|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511572|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511573|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511574|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511575|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511576|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511577|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
138404307|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138511578|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511579|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511580|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373370|NCT01423864|Hormones|hormones|mesh-ancestor
138511581|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
138511582|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511583|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511584|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138511585|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138511586|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511587|NCT03959397|Paclitaxel|paclitaxel|mesh-list
138511588|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138511589|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511590|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511591|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511592|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511593|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511594|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511595|NCT00072436|Gemcitabine|gemcitabine|mesh-list
138511596|NCT00072436|Alvocidib|alvocidib|mesh-list
138511597|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511598|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
138207306|NCT00265616|Pentobarbital|pentobarbital|mesh-list
138207307|NCT00265616|Thiopental|thiopental|mesh-list
138207308|NCT00265616|Propofol|propofol|mesh-list
138207309|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138207310|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207311|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207312|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138207313|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
138207314|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
138207315|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
138207316|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
138207317|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
138207318|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511599|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511600|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511601|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
138511602|NCT00072436|Growth Substances|growth substances|mesh-ancestor
138511603|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511604|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511606|NCT00072553|Leucovorin|leucovorin|mesh-list
138511607|NCT00072553|Celecoxib|celecoxib|mesh-list
138511608|NCT00072553|Fluorouracil|fluorouracil|mesh-list
138511609|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
138511610|NCT00072553|Calcium|calcium|mesh-list
138511611|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
138511612|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138511613|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511614|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
138511615|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511616|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511617|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511618|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511619|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
138511620|NCT00072553|Antidotes|antidotes|mesh-ancestor
138511621|NCT00072553|Protective Agents|protective agents|mesh-ancestor
138511622|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
138511623|NCT00072553|Vitamins|vitamins|mesh-ancestor
138511624|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
138511625|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138511626|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138511627|NCT00072553|Analgesics|analgesics|mesh-ancestor
138511628|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
138511629|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511630|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511631|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511632|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138511633|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138511634|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511635|NCT00072592|Rituximab|rituximab|mesh-list
138404404|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511636|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511637|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511638|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
138511639|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511640|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511641|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138511642|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511643|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511644|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511645|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511646|NCT00072670|Trabectedin|trabectedin|mesh-list
138511647|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511648|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
138511649|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511650|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511651|NCT02966704|Caseins|caseins|mesh-list
138511652|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
138511653|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
138511654|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511655|NCT00072748|EKB 569|ekb 569|mesh-list
138511656|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511657|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138207328|NCT00176852|Lenograstim|lenograstim|mesh-list
138207329|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207330|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
138207331|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207332|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207333|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207334|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
138511658|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511659|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511660|NCT00072787|Cisplatin|cisplatin|mesh-list
138511661|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511662|NCT00072826|Acetylcholine|acetylcholine|mesh-list
138511663|NCT00072826|Oxypurinol|oxypurinol|mesh-list
138511664|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
138511665|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138511666|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
138511667|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511668|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511669|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511670|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511672|NCT00072865|Pemetrexed|pemetrexed|mesh-list
138511673|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511674|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511675|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511676|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138511677|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138511678|NCT00072904|Repaglinide|repaglinide|mesh-list
138511679|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138511680|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511681|NCT00072943|Interferons|interferons|mesh-list
138511682|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
138511684|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138511685|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
138511686|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511687|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511688|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
138511689|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511690|NCT00072982|Borage oil|borage oil|mesh-list
138511691|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511692|NCT03959124|Memantine|memantine|mesh-list
138511693|NCT03959124|Rivastigmine|rivastigmine|mesh-list
138511694|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138511695|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138511696|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
138511697|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511698|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511699|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511700|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138404487|NCT01572831|Protective Agents|protective agents|mesh-ancestor
138511701|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138511702|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138511704|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
138511705|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138511706|NCT03959124|Protective Agents|protective agents|mesh-ancestor
138511707|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
138511708|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138511709|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138511710|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511712|NCT02966236|Coagulants|coagulants|mesh-ancestor
138511713|NCT04711291|Tacrolimus|tacrolimus|mesh-list
138511714|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511715|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
138511716|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511717|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138511718|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511719|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207337|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207338|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207339|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
138207340|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
138207341|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207342|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138207343|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511720|NCT00073372|Abciximab|abciximab|mesh-list
138511721|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
138511722|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138511723|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138511724|NCT00073411|Escitalopram|escitalopram|mesh-list
138511725|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138511726|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138511727|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138511728|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511729|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511730|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
138511731|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511732|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511733|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
138511734|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138511735|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138511736|NCT00073411|Analgesics|analgesics|mesh-ancestor
138511737|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
138511738|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
138511739|NCT02966041|Ondansetron|ondansetron|mesh-list
138511740|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
138511741|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
138511742|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511743|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511744|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511745|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
138457047|NCT01916252|Melphalan|melphalan|mesh-list
138511746|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511747|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138511748|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138511749|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
138511750|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511751|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511752|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138511753|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511754|NCT00073840|Albuterol|albuterol|mesh-list
138511755|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138511756|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
138511757|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511758|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511759|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138511760|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138511761|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
138511762|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138511763|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138511764|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138511765|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138511766|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
138511767|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207345|NCT01323517|Ipilimumab|ipilimumab|mesh-list
138207346|NCT01323517|Melphalan|melphalan|mesh-list
138207347|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207348|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207349|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138207350|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207351|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207352|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
138207353|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138404582|NCT01573663|Ambroxol|ambroxol|mesh-list
138511768|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511769|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
138511770|NCT00073879|Fludarabine|fludarabine|mesh-list
138511771|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
138511772|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
138511773|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511774|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
138511775|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188159|NCT00361023|Losartan|losartan|mesh-list
138511776|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511777|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511778|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
138511779|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198113|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
138511780|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511781|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511782|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511783|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
138511784|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511785|NCT00074074|Infliximab|infliximab|mesh-list
138511786|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138511787|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511788|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511789|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511790|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511791|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138511792|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138511793|NCT00392652|Protective Agents|protective agents|mesh-ancestor
138511794|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511795|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511796|NCT00074191|Cytarabine|cytarabine|mesh-list
138511797|NCT00074191|Dexamethasone|dexamethasone|mesh-list
138511798|NCT00074191|Methotrexate|methotrexate|mesh-list
138511799|NCT00074191|Lomustine|lomustine|mesh-list
138511800|NCT00074191|Procarbazine|procarbazine|mesh-list
138511801|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138511802|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
138511803|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
138511804|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138511805|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511806|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511807|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
138207354|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207355|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
138207356|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207357|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207358|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207359|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138207360|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138207361|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207362|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138207364|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138207365|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138207366|NCT01323595|Analgesics|analgesics|mesh-ancestor
138207367|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
138207368|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207369|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511809|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511810|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138404612|NCT01573806|Exenatide|exenatide|mesh-list
138511812|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138511813|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
138511814|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138511815|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511816|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
138511817|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511818|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
138511819|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511820|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138511821|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511822|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
138511823|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511824|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138511826|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511827|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511828|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
138511829|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
138511830|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138511831|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
138511832|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511833|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511834|NCT00392691|Rituximab|rituximab|mesh-list
138511835|NCT00392691|Melphalan|melphalan|mesh-list
138511836|NCT00392691|Vinorelbine|vinorelbine|mesh-list
138511837|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138511838|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511839|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
138511840|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511841|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404651|NCT01574261|Inositol|inositol|mesh-list
138511842|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511843|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
138511844|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511845|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138511846|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511847|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138511848|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511849|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511850|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511851|NCT02966080|Heparin|heparin|mesh-list
138511852|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
138511853|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138511854|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138511855|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511857|NCT04767776|Charcoal|charcoal|mesh-list
138511858|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138511859|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
138511860|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138511861|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
138511862|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207372|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138207373|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138207374|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207375|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207376|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138207377|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138511863|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511864|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
138511865|NCT04767776|Antidotes|antidotes|mesh-ancestor
138511866|NCT04767776|Protective Agents|protective agents|mesh-ancestor
138511867|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511868|NCT04730245|Rifaximin|rifaximin|mesh-list
138511869|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138511870|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511871|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511872|NCT00074620|Hirudins|hirudins|mesh-list
138511873|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
138511874|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138511875|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
138511876|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511877|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511878|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
138511879|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138511880|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138511881|NCT02972333|Osimertinib|osimertinib|mesh-list
138511882|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511883|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511884|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696582|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
138511885|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511886|NCT00074737|Cytarabine|cytarabine|mesh-list
138511887|NCT00074737|Idarubicin|idarubicin|mesh-list
138511888|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511889|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
138511890|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511891|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511892|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
138511893|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138511894|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511895|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
138511896|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511897|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138511899|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138511900|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511902|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138511903|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511904|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138511905|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511906|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511907|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
138511908|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138511909|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138511910|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138511911|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138511912|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138511913|NCT00075010|Decitabine|decitabine|mesh-list
138511914|NCT00075010|Valproic Acid|valproic acid|mesh-list
138511915|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511916|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
138511917|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511918|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511919|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511920|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
138207378|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207379|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207380|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207382|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138207387|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511921|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
138511922|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511923|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511924|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
138511925|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138511926|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511927|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138511929|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
138511930|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511931|NCT04729595|Protective Agents|protective agents|mesh-ancestor
138511932|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404788|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
138511933|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138511934|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511935|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138511936|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138511937|NCT00075205|Rimonabant|rimonabant|mesh-list
138511938|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138511939|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138511940|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138511941|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511942|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511943|NCT00075205|Hormones|hormones|mesh-ancestor
138511944|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138511945|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511946|NCT00075439|Gefitinib|gefitinib|mesh-list
138511947|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511948|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138511949|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511950|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511951|NCT00075517|Gemcitabine|gemcitabine|mesh-list
138511952|NCT00075517|Docetaxel|docetaxel|mesh-list
138511953|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511954|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
138511955|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511956|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511957|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138511958|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138511959|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511960|NCT00075556|Capecitabine|capecitabine|mesh-list
138511961|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511962|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
138511963|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511964|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511965|NCT00075595|Leucovorin|leucovorin|mesh-list
138511966|NCT00075595|Fluorouracil|fluorouracil|mesh-list
138511967|NCT00075595|Irinotecan|irinotecan|mesh-list
138511968|NCT00075595|Calcium|calcium|mesh-list
138511969|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
138511970|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138511971|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511972|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
138511973|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207392|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207393|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138207394|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138207395|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207396|NCT01325311|Vitamin D|vitamin d|mesh-list
138207397|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
138207398|NCT01325311|Genistein|genistein|mesh-list
138207399|NCT01325311|Vitamins|vitamins|mesh-ancestor
138207400|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
138207401|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350520|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138350522|NCT05032183|BB 1101|bb 1101|mesh-list
138511974|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138511975|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138511976|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511977|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
138511978|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138511979|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138511980|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511981|NCT00075595|Antidotes|antidotes|mesh-ancestor
138511982|NCT00075595|Protective Agents|protective agents|mesh-ancestor
138511983|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
138511984|NCT00075595|Vitamins|vitamins|mesh-ancestor
138511985|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
138511986|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
138511987|NCT00075634|Doxorubicin|doxorubicin|mesh-list
138511988|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138511989|NCT00075634|Decitabine|decitabine|mesh-list
138511990|NCT00075634|Azacitidine|azacitidine|mesh-list
138511991|NCT00075634|Lenograstim|lenograstim|mesh-list
138511992|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138511993|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
138511994|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511995|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404877|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138511996|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138511997|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
138511998|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511999|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512000|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512001|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512002|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512003|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512004|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512005|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138512006|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512007|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
138512009|NCT00075673|Vinorelbine|vinorelbine|mesh-list
138512010|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138512011|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512012|NCT00075673|Analgesics|analgesics|mesh-ancestor
138512013|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
138512014|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512015|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512016|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512017|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512018|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138512019|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138512020|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512021|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512022|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138207402|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138207403|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138207404|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138207405|NCT01325311|Protective Agents|protective agents|mesh-ancestor
138207406|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207407|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138207408|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207409|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207410|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
138207413|NCT01325311|Hormones|hormones|mesh-ancestor
138207414|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512023|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512024|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512025|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512026|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512027|NCT00075712|Paclitaxel|paclitaxel|mesh-list
138512028|NCT00075712|Carboplatin|carboplatin|mesh-list
138512029|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138512030|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512031|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512032|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512033|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512034|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512035|NCT03958500|Methylene Blue|methylene blue|mesh-list
138512036|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512037|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512038|NCT00075751|Carboplatin|carboplatin|mesh-list
138512039|NCT00075751|Gemcitabine|gemcitabine|mesh-list
138512040|NCT00075751|Bortezomib|bortezomib|mesh-list
138512041|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512042|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512043|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
138512044|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512045|NCT00075868|Octreotide|octreotide|mesh-list
138512046|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138512047|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512048|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512049|NCT00075907|Ritonavir|ritonavir|mesh-list
138512050|NCT00075907|Lopinavir|lopinavir|mesh-list
138512051|NCT00075907|Efavirenz|efavirenz|mesh-list
138512052|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138512053|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138512054|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
138512055|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512056|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512057|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138512058|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138512059|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
138512060|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512061|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138512062|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138512063|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138512064|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138512065|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138512066|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138512067|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138512068|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138512069|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138512070|NCT03958383|Nivolumab|nivolumab|mesh-list
138512071|NCT03958383|Ipilimumab|ipilimumab|mesh-list
138512072|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138512073|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512074|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138512075|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207415|NCT01432015|Aprepitant|aprepitant|mesh-list
138207416|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
138207417|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
138207418|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
138207419|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207420|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188459|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
138512076|NCT00076414|Acetylcholine|acetylcholine|mesh-list
138512077|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512078|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138512081|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512082|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512083|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
138512084|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138512085|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
138512086|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512087|NCT00399256|Expectorants|expectorants|mesh-ancestor
138512088|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138512089|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138512090|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
138512091|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512092|NCT00399256|Protective Agents|protective agents|mesh-ancestor
138512093|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512094|NCT00399256|Antidotes|antidotes|mesh-ancestor
138512095|NCT00399295|Naltrexone|naltrexone|mesh-list
138512096|NCT00399295|Hydromorphone|hydromorphone|mesh-list
138512097|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
138512098|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138512099|NCT00399295|Narcotics|narcotics|mesh-ancestor
138512100|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512101|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512102|NCT00399295|Analgesics|analgesics|mesh-ancestor
138512103|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
138512104|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512105|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138512106|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
138512107|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138512108|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512109|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512110|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138512112|NCT00076492|Vitamins|vitamins|mesh-ancestor
138512113|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
138512114|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512115|NCT00076531|Leuprolide|leuprolide|mesh-list
138512116|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138512117|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
138512118|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138512119|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512120|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207431|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207432|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138207433|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138207434|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
138207435|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207436|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138207437|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138207438|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
138207439|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138207440|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138207441|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
138207442|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
138207443|NCT01378273|Hematinics|hematinics|mesh-ancestor
138207444|NCT01432405|Pioglitazone|pioglitazone|mesh-list
138512121|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512122|NCT00076609|Capecitabine|capecitabine|mesh-list
138512123|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512124|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
138512125|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512126|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512127|NCT00076726|Infliximab|infliximab|mesh-list
138512128|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138512129|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512130|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
138512131|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138512132|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512133|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138512134|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405034|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512135|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512136|NCT00077077|Capecitabine|capecitabine|mesh-list
138512137|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512138|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
138512139|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512140|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512141|NCT00077116|Cytarabine|cytarabine|mesh-list
138512142|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
138512143|NCT00077116|Busulfan|busulfan|mesh-list
138512144|NCT00077116|Idarubicin|idarubicin|mesh-list
138512145|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
138512146|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512147|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
138512148|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512149|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512150|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512151|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
138188534|NCT03168022|Analgesics|analgesics|mesh-ancestor
138512152|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512153|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512154|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512155|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512156|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
138512157|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
138512158|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512159|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512160|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512161|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512162|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512163|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138512164|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
138207445|NCT01432405|Exenatide|exenatide|mesh-list
138207446|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207447|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207448|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138207449|NCT01432405|Incretins|incretins|mesh-ancestor
138207450|NCT01432405|Hormones|hormones|mesh-ancestor
138207451|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207452|NCT01432561|Cysteamine|cysteamine|mesh-list
138207453|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138207454|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512165|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
138512166|NCT03951207|Amlodipine|amlodipine|mesh-list
138512167|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138512168|NCT03951207|Atorvastatin|atorvastatin|mesh-list
138512169|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138512170|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138512171|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
138512172|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512173|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138512174|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138512175|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512176|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512177|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138512178|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138512179|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138512180|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512181|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512182|NCT00077194|Romidepsin|romidepsin|mesh-list
138512183|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512184|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696655|NCT00556634|Efavirenz|efavirenz|mesh-list
138512185|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138512186|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512187|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512188|NCT00077233|Leucovorin|leucovorin|mesh-list
138512189|NCT00077233|Fluorouracil|fluorouracil|mesh-list
138512190|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
138512191|NCT00077233|Irinotecan|irinotecan|mesh-list
138512192|NCT00077233|Cetuximab|cetuximab|mesh-list
138512193|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512194|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
138512195|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512196|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512197|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512198|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512199|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
138512200|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138512201|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512202|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512203|NCT00077233|Antidotes|antidotes|mesh-ancestor
138512204|NCT00077233|Protective Agents|protective agents|mesh-ancestor
138512205|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138512206|NCT00077233|Vitamins|vitamins|mesh-ancestor
138512207|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
138512208|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138512209|NCT02958631|Losartan|losartan|mesh-list
138512210|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138512211|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512212|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138512213|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138207465|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207467|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
138207468|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207469|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207470|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207471|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
138207472|NCT01082939|Rituximab|rituximab|mesh-list
138207473|NCT01082939|Fludarabine|fludarabine|mesh-list
138207474|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
138207475|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
138512214|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512215|NCT00077311|Docetaxel|docetaxel|mesh-list
138512216|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
138512217|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
138512218|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512219|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512220|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512221|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512222|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512223|NCT00077311|Hematinics|hematinics|mesh-ancestor
138512224|NCT00077311|Protective Agents|protective agents|mesh-ancestor
138512225|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512226|NCT00077350|Gemcitabine|gemcitabine|mesh-list
138512227|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512229|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512230|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512231|NCT00077389|Carboplatin|carboplatin|mesh-list
138512232|NCT00077389|Doxorubicin|doxorubicin|mesh-list
138512233|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138512234|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512235|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512236|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512237|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512238|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512239|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512240|NCT00077428|Doxorubicin|doxorubicin|mesh-list
138512241|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138512242|NCT00077428|Bortezomib|bortezomib|mesh-list
138512243|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512244|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512245|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512246|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512247|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512248|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512249|NCT00077467|Bortezomib|bortezomib|mesh-list
138512250|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512251|NCT00077545|Cisplatin|cisplatin|mesh-list
138512252|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512253|NCT00077584|Bosentan|bosentan|mesh-list
138512254|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512255|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138512256|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512257|NCT00077779|Adalimumab|adalimumab|mesh-list
138512258|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138512259|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512260|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512261|NCT00077818|Enoxaparin|enoxaparin|mesh-list
138512262|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
138512263|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
138512264|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138512265|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138512266|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512267|NCT00078130|Buprenorphine|buprenorphine|mesh-list
138512268|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138512269|NCT00078130|Naloxone|naloxone|mesh-list
138207482|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207483|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207484|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207485|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207486|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207487|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
138207488|NCT01381471|Fluticasone|fluticasone|mesh-list
138207489|NCT01381471|Xhance|xhance|mesh-list
138207490|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138207491|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350523|NCT05032183|Mesna|mesna|mesh-list
138512270|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138512271|NCT00078130|Narcotics|narcotics|mesh-ancestor
138512272|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512273|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512274|NCT00078130|Analgesics|analgesics|mesh-ancestor
138512275|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
138512276|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512277|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138512278|NCT00399451|Polidocanol|polidocanol|mesh-list
138512279|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138512280|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138512281|NCT04711213|Dexamethasone|dexamethasone|mesh-list
138512282|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
138512283|NCT04711213|BB 1101|bb 1101|mesh-list
138512284|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512285|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
138405324|NCT01578889|Vaccines|vaccines|mesh-list
138512286|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
138512287|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512288|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512289|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138512290|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
138696681|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512292|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512293|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512294|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512295|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
138512296|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512297|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512298|NCT00078247|Lamivudine|lamivudine|mesh-list
138512299|NCT00078247|Zidovudine|zidovudine|mesh-list
138512300|NCT00078247|Abacavir|abacavir|mesh-list
138512301|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138512302|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138512303|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512304|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512305|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
138512306|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512307|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138512308|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138512309|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
138512310|NCT00078442|Interferons|interferons|mesh-list
138512311|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
138512312|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
138512313|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138512314|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512315|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
138512316|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512317|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
138512318|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207492|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138207493|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
138207494|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207495|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207496|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138207497|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
138512319|NCT00078481|Idebenone|idebenone|mesh-list
138512320|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
138512321|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512322|NCT00078481|Protective Agents|protective agents|mesh-ancestor
138512323|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512324|NCT00078598|Rituximab|rituximab|mesh-list
138512325|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
138512326|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138512327|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512328|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
138512329|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512330|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512331|NCT00078793|Etanercept|etanercept|mesh-list
138512332|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138512333|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512334|NCT00078793|Analgesics|analgesics|mesh-ancestor
138512335|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
138512336|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512337|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512338|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512339|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512340|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138512341|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512342|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
138512343|NCT00078832|Anastrozole|anastrozole|mesh-list
138512344|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512345|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512346|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138512347|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138512348|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512349|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512350|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138512351|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
138512352|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512353|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512354|NCT01350128|Bromides|bromides|mesh-list
138512355|NCT01350128|Ipratropium|ipratropium|mesh-list
138512356|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
138512357|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138512358|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
138512359|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512360|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512361|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138512362|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
138512363|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138512364|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
138512365|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512366|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512367|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
138512368|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512369|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138512370|NCT00078910|Protective Agents|protective agents|mesh-ancestor
138512371|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512372|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138512373|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512374|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207511|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207512|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
138207513|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138207514|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138207515|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207517|NCT05448456|Coagulants|coagulants|mesh-ancestor
138207518|NCT05448378|Inositol|inositol|mesh-list
138512375|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138512376|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512377|NCT00078910|Analgesics|analgesics|mesh-ancestor
138512378|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
138405463|NCT01579539|Protective Agents|protective agents|mesh-ancestor
138512379|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512380|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512381|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512382|NCT00078988|Carboplatin|carboplatin|mesh-list
138512384|NCT00078988|Thiotepa|thiotepa|mesh-list
138512385|NCT00078988|Isotretinoin|isotretinoin|mesh-list
138512386|NCT00078988|Lenograstim|lenograstim|mesh-list
138512387|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512388|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138512389|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512390|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512391|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512392|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512393|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138512394|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
138512395|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512396|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512397|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
138512398|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512399|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512400|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
138512401|NCT00079027|Doxorubicin|doxorubicin|mesh-list
138512402|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138512403|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512404|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512405|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512406|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512407|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512408|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512409|NCT00079105|Prednisolone|prednisolone|mesh-list
138512410|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
138512411|NCT00079105|Etoposide|etoposide|mesh-list
138512412|NCT00079105|Vincristine|vincristine|mesh-list
138512413|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
138512414|NCT00079105|Bleomycin|bleomycin|mesh-list
138512415|NCT00079105|Vinblastine|vinblastine|mesh-list
138512416|NCT00079105|Procarbazine|procarbazine|mesh-list
138512417|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
138512418|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512419|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
138512420|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512421|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512422|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207523|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
138207524|NCT01434121|Vitamins|vitamins|mesh-ancestor
138207525|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
138207526|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207527|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
138207528|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512423|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
138512424|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207529|NCT01434121|Protective Agents|protective agents|mesh-ancestor
138207530|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138207531|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
138207533|NCT01040819|Pioglitazone|pioglitazone|mesh-list
138512425|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512426|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512427|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138512428|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512429|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512430|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512431|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512432|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512433|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512434|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512436|NCT00079105|Hormones|hormones|mesh-ancestor
138512437|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512438|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512439|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512440|NCT00079105|Analgesics|analgesics|mesh-ancestor
138512441|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
138512442|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512443|NCT03647124|Lenalidomide|lenalidomide|mesh-list
138512444|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
138512445|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512446|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138512447|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138512448|NCT03647124|Growth Substances|growth substances|mesh-ancestor
138512449|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138512450|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512451|NCT00079144|Aldesleukin|aldesleukin|mesh-list
138512452|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
138512453|NCT00079144|Fludarabine|fludarabine|mesh-list
138512454|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
138512455|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
138512456|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512457|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
138512458|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512459|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512460|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512461|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
138512462|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512463|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512464|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512465|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512466|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
138512467|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138512468|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138512469|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138512470|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
138512471|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512472|NCT00079222|Itraconazole|itraconazole|mesh-list
138207541|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207542|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207543|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207544|NCT01084499|Letrozole|letrozole|mesh-list
138207545|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207546|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138207547|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138207548|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207549|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207550|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138512473|NCT00079222|Voriconazole|voriconazole|mesh-list
138512474|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
138512475|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512476|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138696738|NCT04665986|Vinorelbine|vinorelbine|mesh-list
138512477|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138512478|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512479|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512480|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138512481|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
138512482|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512483|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512484|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138512485|NCT00079261|Prednisone|prednisone|mesh-list
138512486|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
138512487|NCT00079261|Gemcitabine|gemcitabine|mesh-list
138512488|NCT00079261|Doxorubicin|doxorubicin|mesh-list
138512489|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138512490|NCT00079261|Vincristine|vincristine|mesh-list
138512491|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512492|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
138512493|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512494|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512495|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512496|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
138512497|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512498|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512499|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512500|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512501|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
138512502|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512503|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512504|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512505|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512506|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512507|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
138512509|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512510|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512511|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138512512|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512513|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512514|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512515|NCT00079300|Imiquimod|imiquimod|mesh-list
138512516|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138512517|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
138512518|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512519|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512520|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
138512521|NCT00079378|Decitabine|decitabine|mesh-list
138512522|NCT00079378|Azacitidine|azacitidine|mesh-list
138512523|NCT00079378|Valproic Acid|valproic acid|mesh-list
138512524|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512525|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
138198117|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512526|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512528|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512529|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
138512530|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
138512531|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512532|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512533|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
138512534|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138512535|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512536|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138512537|NCT00079456|Sirolimus|sirolimus|mesh-list
138512538|NCT00079456|Temsirolimus|temsirolimus|mesh-list
138512539|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
138696751|NCT04665830|Evolocumab|evolocumab|mesh-list
138512540|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138512541|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512542|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512543|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512544|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
138512545|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512546|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512547|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512548|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512549|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512550|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
138512551|NCT04467086|Propranolol|propranolol|mesh-list
138512552|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138512553|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138512554|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138512555|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512556|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512557|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512558|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138512559|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512560|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512561|NCT00079612|Sorafenib|sorafenib|mesh-list
138512562|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512563|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138512564|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512565|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512566|NCT03526107|Theobromine|theobromine|mesh-list
138512567|NCT03526107|Caffeine|caffeine|mesh-list
138512568|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138512569|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512570|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138512571|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512572|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512573|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138512574|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138512575|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
138512576|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512577|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138512578|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
138512579|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512580|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138512581|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
138512582|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512583|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
138512584|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138512585|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512586|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
138512587|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
138512588|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512589|NCT00079807|Protective Agents|protective agents|mesh-ancestor
138512590|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207551|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138207552|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207553|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207554|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
138207555|NCT01118273|Promethazine|promethazine|mesh-list
138207556|NCT01118273|Ibuprofen|ibuprofen|mesh-list
138207557|NCT01118273|Naproxen|naproxen|mesh-list
138207558|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207560|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512591|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
138512592|NCT00079807|Vitamins|vitamins|mesh-ancestor
138512593|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
138512594|NCT00079885|Tigecycline|tigecycline|mesh-list
138512595|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512596|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512597|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138512598|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512599|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512601|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138512602|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138512603|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512604|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138512605|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138512606|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
138512607|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512608|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138512609|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138512611|NCT00079963|Vitamin E|vitamin e|mesh-list
138512612|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
138512613|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512614|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
138512615|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512616|NCT00079963|Protective Agents|protective agents|mesh-ancestor
138512617|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
138512618|NCT00392886|Temozolomide|temozolomide|mesh-list
138512619|NCT00392886|Thiotepa|thiotepa|mesh-list
138512620|NCT00392886|Carboplatin|carboplatin|mesh-list
138512621|NCT00392886|Methotrexate|methotrexate|mesh-list
138512622|NCT00392886|Etoposide|etoposide|mesh-list
138512623|NCT00392886|Vincristine|vincristine|mesh-list
138512624|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512625|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
138512626|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512627|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512628|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512629|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
138405877|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405880|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138512630|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512631|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512632|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512633|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138512634|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
138512635|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138512636|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512637|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
138512638|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138512639|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512640|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138512641|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138512642|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138207566|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207567|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138207568|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207569|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
138207570|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138207571|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138207572|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207573|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
138207574|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
138207575|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
138512643|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512644|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512645|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512646|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512647|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512648|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
138512649|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512650|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138512651|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
138512652|NCT00080080|Docetaxel|docetaxel|mesh-list
138512653|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512654|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512655|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512656|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
138405926|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138512657|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512659|NCT00080158|Citalopram|citalopram|mesh-list
138512660|NCT00080158|Bupropion|bupropion|mesh-list
138512661|NCT00080158|Fluoxetine|fluoxetine|mesh-list
138512662|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138512663|NCT00080158|Sertraline|sertraline|mesh-list
138512664|NCT00080158|Escitalopram|escitalopram|mesh-list
138512665|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138457249|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
138512666|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138512667|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138512668|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512669|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512670|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
138512671|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512672|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138512673|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
138512674|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138512675|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138512676|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
138512677|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138512678|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138512679|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189050|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
138512680|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138512681|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512682|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138512683|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138512684|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
138512685|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
138512686|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138512687|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138512688|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138207576|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
138207577|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207578|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138512689|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138512690|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138512691|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138207579|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
138512692|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138512693|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138207580|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
138512694|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138512695|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512696|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138512697|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512698|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512700|NCT00080275|Simvastatin|simvastatin|mesh-list
138512701|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138512702|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138512703|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
138512704|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512705|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138512706|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138512707|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512708|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512709|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
138512710|NCT00080275|Vitamins|vitamins|mesh-ancestor
138512711|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
138512712|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512713|NCT00393003|Anesthetics|anesthetics|mesh-list
138512714|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512715|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512716|NCT00080314|Aripiprazole|aripiprazole|mesh-list
138512717|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
138512718|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138512719|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138512720|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138512721|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512722|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512723|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
138512724|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
138512725|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512726|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512727|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138512728|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138512729|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
138512730|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138512731|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138696788|NCT04665284|Empagliflozin|empagliflozin|mesh-list
138512732|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138512733|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138512734|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138512735|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138512736|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
138512737|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512739|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512740|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
138512741|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512742|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
138512743|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512744|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512745|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512746|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207595|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138207596|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207597|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207598|NCT01439815|Fluticasone|fluticasone|mesh-list
138512747|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512748|NCT03506373|Ixazomib|ixazomib|mesh-list
138512749|NCT03506373|Glycine|glycine|mesh-list
138512750|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512751|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189136|NCT03294850|Cholic Acids|cholic acids|mesh-list
138512752|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
138512753|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512754|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
138512755|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512756|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512757|NCT02972411|Acetazolamide|acetazolamide|mesh-list
138512758|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
138512759|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138512760|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406058|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
138512761|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512762|NCT02972411|Diuretics|diuretics|mesh-ancestor
138512763|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
138512764|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512766|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512767|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512768|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512769|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512770|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512771|NCT00080665|Docetaxel|docetaxel|mesh-list
138512772|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
138512773|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512775|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512776|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512777|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512778|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138512779|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512780|NCT00080743|Tamoxifen|tamoxifen|mesh-list
138512781|NCT00080743|Gefitinib|gefitinib|mesh-list
138512782|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512783|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138512784|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
138512785|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512786|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512787|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138512788|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512789|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138512790|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138512791|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138512792|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138512793|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512795|NCT00080782|Doxorubicin|doxorubicin|mesh-list
138512796|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138512797|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138512798|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512799|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512800|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512801|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512802|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207612|NCT01332253|Analgesics|analgesics|mesh-ancestor
138207613|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
138207614|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207615|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207616|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512803|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138512804|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512805|NCT00080782|Analgesics|analgesics|mesh-ancestor
138512806|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
138512807|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512808|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512809|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512810|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512811|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138512812|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138512813|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138512814|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138512815|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512817|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512819|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138512820|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
138512821|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512822|NCT00081055|Cyclosporine|cyclosporine|mesh-list
138457297|NCT01917331|Hormones|hormones|mesh-ancestor
138512824|NCT00081055|Busulfan|busulfan|mesh-list
138512825|NCT00081055|Methotrexate|methotrexate|mesh-list
138512826|NCT00081055|Cyclosporins|cyclosporins|mesh-list
138512827|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512828|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
138512829|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512830|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512831|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512832|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
138512833|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512834|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512835|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138512836|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138512837|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
138512838|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138512839|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512840|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
138512841|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
138512842|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512843|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138512844|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406196|NCT01593124|Imiquimod|imiquimod|mesh-list
138512846|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512847|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138512848|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138512849|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138512850|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512851|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
138512852|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
138512853|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512854|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138512855|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207627|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207628|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
138207629|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
138207630|NCT01384591|Losartan|losartan|mesh-list
138207631|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138207632|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138207633|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138350689|NCT04423211|Luteolytic Agents|luteolytic agents|mesh-ancestor
138350690|NCT04423211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138350691|NCT04423211|Contraceptive Agents|contraceptive agents|mesh-ancestor
138350692|NCT04423211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138350693|NCT04423211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138350694|NCT04423211|Antidepressive Agents|antidepressive agents|mesh-ancestor
138350695|NCT04423211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138350696|NCT04423211|Androgen Antagonists|androgen antagonists|mesh-ancestor
138350697|NCT04423211|Hormone Antagonists|hormone antagonists|mesh-ancestor
138350698|NCT04404088|Rituximab|rituximab|mesh-list
138512856|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512857|NCT00081172|Antibodies|antibodies|mesh-list
138512858|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138512859|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
138512860|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512861|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
138512862|NCT00081484|Hematinics|hematinics|mesh-ancestor
138512863|NCT00390260|Acetaminophen|acetaminophen|mesh-list
138512864|NCT00390260|Rofecoxib|rofecoxib|mesh-list
138512865|NCT00390260|Hydrocodone|hydrocodone|mesh-list
138512866|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138512867|NCT00390260|Analgesics|analgesics|mesh-ancestor
138512868|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
138512869|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512870|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512871|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
138512872|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512873|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
138406235|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406247|NCT01593293|Pemetrexed|pemetrexed|mesh-list
138512874|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138512875|NCT00390260|Narcotics|narcotics|mesh-ancestor
138512876|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138512877|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
138512878|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138512879|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138512880|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512881|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138512882|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138512883|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512884|NCT00081757|Thalidomide|thalidomide|mesh-list
138512885|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512886|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
138512887|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512888|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
138512889|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512890|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512891|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138512892|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138512893|NCT00081757|Growth Substances|growth substances|mesh-ancestor
138512895|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512896|NCT00081796|Capecitabine|capecitabine|mesh-list
138512897|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138512898|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
138406281|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138512899|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512901|NCT03152175|Propranolol|propranolol|mesh-list
138512902|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138512903|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138207634|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138207635|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138207636|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207637|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
138207640|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
138207641|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138207642|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
138207643|NCT01384591|Protective Agents|protective agents|mesh-ancestor
138207644|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207645|NCT01384591|Antidotes|antidotes|mesh-ancestor
138207647|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512904|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
138512905|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512906|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512907|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512908|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138512909|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512910|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
138512912|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
138512913|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138512914|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138512915|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138512916|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512917|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512918|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
138512919|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512920|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138512921|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138512922|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138512923|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138512924|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138512925|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138512926|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512927|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138512928|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138512929|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512930|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138512931|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
138512932|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138512933|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512934|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138512935|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138512936|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138512937|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
138512938|NCT00081835|Antibodies|antibodies|mesh-list
138512939|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
138512940|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138512941|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138512942|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
138512943|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512944|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138512945|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138512946|NCT03152097|Protective Agents|protective agents|mesh-ancestor
138512947|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512948|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512949|NCT00082186|Bosentan|bosentan|mesh-list
138512950|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138512951|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138512952|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207651|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207652|NCT00265850|Leucovorin|leucovorin|mesh-list
138207653|NCT00265850|Folic Acid|folic acid|mesh-list
138207654|NCT00265850|Bevacizumab|bevacizumab|mesh-list
138207655|NCT00265850|Cetuximab|cetuximab|mesh-list
138207656|NCT00265850|Fluorouracil|fluorouracil|mesh-list
138207657|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
138512953|NCT00082225|Antibodies|antibodies|mesh-list
138512954|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
138512955|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512956|NCT00082537|Caspofungin|caspofungin|mesh-list
138512957|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138512958|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
138406383|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
138512959|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512960|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512961|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512962|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138512963|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138512964|NCT00082576|Azithromycin|azithromycin|mesh-list
138512965|NCT00082576|Chloroquine|chloroquine|mesh-list
138512966|NCT00082576|Mefloquine|mefloquine|mesh-list
138512967|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512968|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512969|NCT00082576|Amebicides|amebicides|mesh-ancestor
138512970|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138512971|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138512972|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
138512973|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138512974|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
138512975|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138512976|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512977|NCT00082966|Bortezomib|bortezomib|mesh-list
138512978|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512979|NCT00083005|Thalidomide|thalidomide|mesh-list
138512980|NCT00083005|Docetaxel|docetaxel|mesh-list
138512981|NCT00083005|Estramustine|estramustine|mesh-list
138512982|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138512983|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138512984|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138512985|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138512986|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512987|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138512988|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
138512989|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512990|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
138512991|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138512992|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138512993|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138207671|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
138207672|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138207673|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138207674|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207675|NCT00265850|Antidotes|antidotes|mesh-ancestor
138207676|NCT00265850|Protective Agents|protective agents|mesh-ancestor
138207677|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
138207678|NCT00265850|Vitamins|vitamins|mesh-ancestor
138207679|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
138207680|NCT00265850|Hematinics|hematinics|mesh-ancestor
138207681|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138512994|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138512995|NCT00083005|Growth Substances|growth substances|mesh-ancestor
138512996|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
138512997|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138512998|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
138207682|NCT00125372|Bexarotene|bexarotene|mesh-list
138207683|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207687|NCT00125528|Cycloserine|cycloserine|mesh-list
138512999|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513000|NCT00083083|Paclitaxel|paclitaxel|mesh-list
138513001|NCT00083083|Etoposide|etoposide|mesh-list
138513002|NCT00083083|Vinorelbine|vinorelbine|mesh-list
138513003|NCT00083083|Vinblastine|vinblastine|mesh-list
138513004|NCT00083083|Docetaxel|docetaxel|mesh-list
138513005|NCT00083083|Carboplatin|carboplatin|mesh-list
138513006|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138513007|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513008|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513009|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513010|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513011|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513012|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513013|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138513014|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513015|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513016|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138513017|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
138513018|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
138513019|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138513020|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513021|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406465|NCT01594346|Vitamin E|vitamin e|mesh-list
138513022|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513023|NCT03151863|Analgesics|analgesics|mesh-ancestor
138513024|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
138513025|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513026|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138513027|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138513028|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138513029|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138513030|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513031|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513032|NCT03151863|Narcotics|narcotics|mesh-ancestor
138513033|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
138513034|NCT00083161|Etoposide|etoposide|mesh-list
138513035|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513036|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
138513037|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513038|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513039|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138513040|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
138513041|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513042|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513043|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207690|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138207691|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
138207692|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207693|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
138207694|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207696|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
138207697|NCT01390909|Lactitol|lactitol|mesh-list
138207698|NCT01390909|Cathartics|cathartics|mesh-ancestor
138207699|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207700|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513044|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513045|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138513046|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513047|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513048|NCT00083278|Ipilimumab|ipilimumab|mesh-list
138513049|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513050|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513051|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138513052|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513053|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
138513054|NCT00083434|Hematinics|hematinics|mesh-ancestor
138513055|NCT00083590|Huperzine A|huperzine a|mesh-list
138513056|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138513057|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513058|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513059|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
138513060|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513061|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513062|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138513063|NCT00083590|Protective Agents|protective agents|mesh-ancestor
138513064|NCT03151746|Gabapentin|gabapentin|mesh-list
138513065|NCT03151746|Analgesics|analgesics|mesh-ancestor
138513066|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
138513067|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513068|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513069|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
138513070|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138513071|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513072|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513073|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513074|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138513075|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138513076|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406559|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513077|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513078|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
138513079|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
138513080|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138513081|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513082|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138513083|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138513084|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513085|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696874|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513086|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513087|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513088|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138513089|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138513090|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
138513091|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513092|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513093|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138513094|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138513095|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
138207708|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207709|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
138207710|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
138207711|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513096|NCT00083707|Thalidomide|thalidomide|mesh-list
138513097|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207713|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513098|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
138513099|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513100|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
138513101|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513102|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513103|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138513104|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138513105|NCT00083707|Growth Substances|growth substances|mesh-ancestor
138513106|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138513107|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513108|NCT00083785|Talaporfin|talaporfin|mesh-list
138513109|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513110|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138513111|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138513112|NCT03151707|Niacinamide|niacinamide|mesh-list
138513113|NCT03151707|Niacin|niacin|mesh-list
138513114|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
138513115|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
138513116|NCT03151707|Vitamins|vitamins|mesh-ancestor
138513117|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
138513118|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513119|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138513120|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
138513121|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513122|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138513123|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
138513124|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
138513125|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138513126|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513127|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513128|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513129|NCT03151668|Analgesics|analgesics|mesh-ancestor
138513130|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
138513131|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406649|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138513133|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138513134|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138513135|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
138513136|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513137|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513138|NCT05568082|Itraconazole|itraconazole|mesh-list
138513139|NCT05568082|Sotorasib|sotorasib|mesh-list
138513140|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
138513141|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513142|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138513143|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138513144|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513145|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513146|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138513147|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
138513148|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513149|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513150|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138513152|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513153|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513154|NCT05567653|Sulfalene|sulfalene|mesh-list
138513155|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513156|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138207724|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207725|NCT01087931|Bupivacaine|bupivacaine|mesh-list
138207726|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
138207727|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
138207728|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207729|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406691|NCT01595815|Calcium|calcium|mesh-list
138406692|NCT01595815|Ionophores|ionophores|mesh-list
138513157|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
138513158|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138513159|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138513160|NCT04733508|Exenatide|exenatide|mesh-list
138513161|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138513162|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513163|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138513164|NCT04733508|Incretins|incretins|mesh-ancestor
138513165|NCT04733508|Hormones|hormones|mesh-ancestor
138513166|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513167|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138513168|NCT00135304|Vitamin D|vitamin d|mesh-list
138513169|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138513170|NCT00135304|Cinacalcet|cinacalcet|mesh-list
138513171|NCT00135304|Vitamins|vitamins|mesh-ancestor
138513172|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
138513173|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513174|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138513175|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138513176|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138513177|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
138513178|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513179|NCT00135499|Prednisone|prednisone|mesh-list
138513180|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
138513181|NCT00135499|Rituximab|rituximab|mesh-list
138513182|NCT00135499|Doxorubicin|doxorubicin|mesh-list
138513183|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138513184|NCT00135499|Vincristine|vincristine|mesh-list
138513185|NCT00135499|Bleomycin|bleomycin|mesh-list
138513186|NCT00135499|Vindesine|vindesine|mesh-list
138513187|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513188|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
138513189|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513190|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513191|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138513192|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
138457390|NCT01918098|Oxycodone|oxycodone|mesh-list
138198124|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
138406738|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138513193|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513195|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138513196|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513197|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138513198|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138513199|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513200|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513201|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189583|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
138513202|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
138207730|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
138207731|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207733|NCT03009409|Analgesics|analgesics|mesh-ancestor
138207734|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
138207735|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207736|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207737|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138207738|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138207739|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
138513204|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513205|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513206|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513207|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513208|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513209|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513212|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
138513213|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
138513214|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513215|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513216|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
138513217|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513218|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138513219|NCT03151434|Narcotics|narcotics|mesh-ancestor
138513221|NCT00135577|Alvimopan|alvimopan|mesh-list
138513222|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513223|NCT00135733|Alefacept|alefacept|mesh-list
138513224|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
138513225|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
138513226|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513227|NCT04061798|Heparin|heparin|mesh-list
138513228|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
138513229|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138513230|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138513231|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513232|NCT00135811|Cyclosporine|cyclosporine|mesh-list
138513233|NCT00135811|Dexamethasone|dexamethasone|mesh-list
138513234|NCT00135811|Cyclosporins|cyclosporins|mesh-list
138513235|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513236|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
138513237|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
138513238|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406835|NCT01596400|Granisetron|granisetron|mesh-list
138513239|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513240|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513241|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
138513242|NCT00135811|Hormones|hormones|mesh-ancestor
138513243|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513244|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513245|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513246|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457405|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138513247|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513248|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513249|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
138513250|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
138513251|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513252|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138513253|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513254|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138207740|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
138207741|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207742|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138207743|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138207744|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207745|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207746|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
138513255|NCT00135928|Lenograstim|lenograstim|mesh-list
138513256|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138207747|NCT00176930|Busulfan|busulfan|mesh-list
138207748|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207749|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
138513257|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
138207751|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513258|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513259|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
138513260|NCT00135967|Prednisone|prednisone|mesh-list
138513261|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
138513262|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138513263|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138513264|NCT00135967|Prednisolone|prednisolone|mesh-list
138513265|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
138513266|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138513267|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
138513268|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513270|NCT00135967|Hormones|hormones|mesh-ancestor
138513271|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513272|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513273|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513274|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513275|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138189661|NCT01920542|Analgesics|analgesics|mesh-ancestor
138513276|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138513277|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
138513278|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513279|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513281|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513282|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
138513283|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
138513284|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513285|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513286|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138513287|NCT00135967|Protective Agents|protective agents|mesh-ancestor
138513288|NCT00136045|Rotigotine|rotigotine|mesh-list
138513289|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
138513290|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
138513291|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513292|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513293|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513294|NCT00136201|Tigecycline|tigecycline|mesh-list
138513295|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513296|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513297|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138513298|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513299|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513300|NCT03151239|Niacinamide|niacinamide|mesh-list
138513301|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
138513302|NCT03151239|Vitamins|vitamins|mesh-ancestor
138513303|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
138513304|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513305|NCT00136396|Rituximab|rituximab|mesh-list
138513306|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513307|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513308|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
138513309|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513310|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207755|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207756|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207757|NCT01473745|Daminozide|daminozide|mesh-list
138207758|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138513311|NCT00136474|Amifostine|amifostine|mesh-list
138207759|NCT01473745|Growth Substances|growth substances|mesh-ancestor
138207760|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207761|NCT00178178|Bupivacaine|bupivacaine|mesh-list
138207762|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
138457435|NCT01918150|Chromium|chromium|mesh-list
138513312|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138513313|NCT00136474|Protective Agents|protective agents|mesh-ancestor
138513314|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513315|NCT00136552|Rituximab|rituximab|mesh-list
138513316|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513317|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513318|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
138513319|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513320|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513321|NCT00136591|Bortezomib|bortezomib|mesh-list
138513322|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513323|NCT03151161|Carboplatin|carboplatin|mesh-list
138513325|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513326|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513327|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513328|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138513329|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138513330|NCT00404053|Clopidogrel|clopidogrel|mesh-list
138513331|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138513332|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138513333|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138513334|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138513335|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
138513336|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513337|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513338|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513339|NCT03991130|Nivolumab|nivolumab|mesh-list
138513340|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513341|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513342|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138513343|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513345|NCT00136747|Bupropion|bupropion|mesh-list
138513346|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138513347|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
138513348|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513350|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138513351|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138513352|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513353|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
138513354|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406953|NCT01596764|Loperamide|loperamide|mesh-list
138513355|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513356|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138207771|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
138207772|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207773|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207774|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207775|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138207776|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207777|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138207778|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138207779|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513357|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138513358|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513359|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138513360|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138513361|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138513362|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138513364|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138513365|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138513366|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
138513367|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513368|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513369|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513370|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138513371|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138513372|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
138513373|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138513374|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
138513375|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513377|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
138513378|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138513379|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
138513380|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513381|NCT00136825|Protective Agents|protective agents|mesh-ancestor
138513382|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513383|NCT00136825|Antidotes|antidotes|mesh-ancestor
138513384|NCT00393198|Misoprostol|misoprostol|mesh-list
138513385|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
138513386|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138513387|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
138407001|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513388|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138513389|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513390|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138513391|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138513392|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138513393|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138513394|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
138513395|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138513396|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513397|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
138513398|NCT00136942|Atorvastatin|atorvastatin|mesh-list
138513399|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138513400|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138513401|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
138207790|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
138207791|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207792|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207793|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138207795|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
138207796|NCT01089569|Exenatide|exenatide|mesh-list
138207797|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207798|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207799|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138207800|NCT01089569|Incretins|incretins|mesh-ancestor
138207801|NCT01089569|Hormones|hormones|mesh-ancestor
138207802|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207803|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
138207804|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138513402|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513403|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138513404|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138513405|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513406|NCT00136981|Atorvastatin|atorvastatin|mesh-list
138513408|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138513409|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138513410|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
138513411|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513412|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138198127|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138513413|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138513415|NCT00137020|Ziprasidone|ziprasidone|mesh-list
138513416|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138513417|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
138513418|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513419|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513420|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513421|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138513422|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513423|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513424|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513425|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138513426|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
138513427|NCT00137059|Acetaminophen|acetaminophen|mesh-list
138513428|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513429|NCT00137059|Analgesics|analgesics|mesh-ancestor
138513430|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
138457452|NCT01918254|Paclitaxel|paclitaxel|mesh-list
138407044|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
138407045|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513431|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513432|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513433|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
138513434|NCT00137098|Caffeine|caffeine|mesh-list
138513435|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138513436|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513437|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138513438|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513439|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513440|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138513441|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138513442|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
138513443|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513444|NCT00137254|Insulin|insulin|mesh-list
138513445|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207808|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138207809|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
138207810|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207811|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
138207812|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
138207813|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207814|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207815|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207816|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
138207818|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207820|NCT00128180|Protective Agents|protective agents|mesh-ancestor
138207822|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513446|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513447|NCT03151044|Rituximab|rituximab|mesh-list
138513448|NCT03151044|Epirubicin|epirubicin|mesh-list
138513449|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513450|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513451|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
138513452|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513453|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513454|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138513455|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138513456|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513457|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513458|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513459|NCT00137410|Celecoxib|celecoxib|mesh-list
138513460|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138513461|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513462|NCT00137410|Analgesics|analgesics|mesh-ancestor
138513463|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
138513464|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513465|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513466|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513467|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513468|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138513469|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138513470|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513471|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513472|NCT00137527|Anesthetics|anesthetics|mesh-list
138513473|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513474|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513475|NCT00137566|Acetaminophen|acetaminophen|mesh-list
138513476|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513477|NCT00137566|Analgesics|analgesics|mesh-ancestor
138513478|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
138513479|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513480|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513481|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
138513482|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138513483|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
138513484|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513485|NCT00137761|Docetaxel|docetaxel|mesh-list
138513486|NCT00137761|Gefitinib|gefitinib|mesh-list
138513488|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513489|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513490|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513491|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513492|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138513493|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513494|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138513495|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513496|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138513498|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513499|NCT00137995|Cytarabine|cytarabine|mesh-list
138189888|NCT01925378|Nelfinavir|nelfinavir|mesh-list
138513500|NCT00137995|Dexamethasone|dexamethasone|mesh-list
138513501|NCT00137995|Rituximab|rituximab|mesh-list
138207826|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207827|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207828|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138207829|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138207830|NCT01121939|Growth Substances|growth substances|mesh-ancestor
138207831|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207832|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
138207833|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207834|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513502|NCT00137995|Etoposide|etoposide|mesh-list
138513503|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
138513504|NCT00137995|Melphalan|melphalan|mesh-list
138513505|NCT00137995|Ifosfamide|ifosfamide|mesh-list
138513506|NCT00137995|Carboplatin|carboplatin|mesh-list
138513507|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513508|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
138513509|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
138513510|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513511|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513512|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513513|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
138513514|NCT00137995|Hormones|hormones|mesh-ancestor
138513515|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513516|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513517|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513518|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513519|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
138513520|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513521|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513522|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138513523|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513524|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513525|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513526|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138513527|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
138513528|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
138513529|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513530|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513531|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138513532|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
138513533|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138513534|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
138513535|NCT00138112|Vancomycin|vancomycin|mesh-list
138513536|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513537|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513538|NCT00138229|Aldesleukin|aldesleukin|mesh-list
138513539|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
138513540|NCT00138229|Fludarabine|fludarabine|mesh-list
138513541|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
138513542|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138407159|NCT01597661|Bupropion|bupropion|mesh-list
138513543|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
138513544|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513545|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513546|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138513547|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
138513548|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513549|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513550|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138513551|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138513552|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
138513553|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138513554|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138513555|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
138513556|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513557|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138513558|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138513560|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207835|NCT03013751|Udenafil|udenafil|mesh-list
138207836|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138207837|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138207838|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207839|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207840|NCT01897844|Somatostatin|somatostatin|mesh-list
138207841|NCT01897844|Hormones|hormones|mesh-ancestor
138513561|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513562|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138513563|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
138513564|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513565|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513566|NCT00138580|Vildagliptin|vildagliptin|mesh-list
138513567|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138513568|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513569|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138513570|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
138513571|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457499|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
138513572|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513573|NCT03150771|Aripiprazole|aripiprazole|mesh-list
138513574|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
138513575|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513576|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138513577|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513578|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513579|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513580|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
138513581|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
138513582|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513583|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513584|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138513585|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138513586|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
138513587|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138513588|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138513589|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138513590|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138513591|NCT00138619|Vildagliptin|vildagliptin|mesh-list
138513592|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138513593|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513594|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138696976|NCT06087289|Carboplatin|carboplatin|mesh-list
138513595|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
138513596|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513597|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513599|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138513600|NCT03150732|Narcotics|narcotics|mesh-ancestor
138513601|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513602|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513603|NCT03150732|Analgesics|analgesics|mesh-ancestor
138513604|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
138513605|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513606|NCT03893825|Risperidone|risperidone|mesh-list
138513607|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138513608|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
138513609|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513610|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513611|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513612|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138513613|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513614|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513615|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138207845|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207846|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207847|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
138207848|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138207849|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
138513616|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138513617|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
138513618|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
138513619|NCT00138970|Cyclosporine|cyclosporine|mesh-list
138513620|NCT00138970|Prednisolone|prednisolone|mesh-list
138513621|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138513622|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
138513623|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138513624|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
138513625|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138513628|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513629|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
138513630|NCT00138970|Hormones|hormones|mesh-ancestor
138513631|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513632|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513633|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138513634|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513635|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
138513636|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
138513637|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513638|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513639|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138513640|NCT00138970|Protective Agents|protective agents|mesh-ancestor
138513641|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138513642|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138513643|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
138207856|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207857|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
138207858|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207859|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207860|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207861|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207863|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
138207864|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207865|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207867|NCT01445821|Hormones|hormones|mesh-ancestor
138513644|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513645|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513646|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513647|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513648|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
138513649|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138513650|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513651|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
138513652|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513653|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138513654|NCT00139009|Cyclosporine|cyclosporine|mesh-list
138513655|NCT00139009|Cyclosporins|cyclosporins|mesh-list
138513656|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513657|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513658|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513659|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
138513660|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513661|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
138513662|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513663|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138513664|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513665|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138513666|NCT03890666|Albuterol|albuterol|mesh-list
138513667|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138513668|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
138513669|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513670|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513671|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138513672|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
138513673|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
138697029|NCT06086483|Ropivacaine|ropivacaine|mesh-list
138513674|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138513675|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138513676|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138513677|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138513678|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
138513679|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513680|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513681|NCT00139165|Budesonide|budesonide|mesh-list
138513682|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513683|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138513684|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
138513685|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513686|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513687|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138513688|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
138513689|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
138513690|NCT00139165|Hormones|hormones|mesh-ancestor
138513691|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513692|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
138513693|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138513694|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207894|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207895|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207896|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138207897|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
138207898|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138207900|NCT01093469|Petrolatum|petrolatum|mesh-list
138207901|NCT01093469|Emollients|emollients|mesh-ancestor
138207902|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207903|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
138207904|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207905|NCT02543658|Neostigmine|neostigmine|mesh-list
138513695|NCT00139243|Leucovorin|leucovorin|mesh-list
138513696|NCT00139243|Fluorouracil|fluorouracil|mesh-list
138513697|NCT00139243|Docetaxel|docetaxel|mesh-list
138513698|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513699|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
138513700|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513701|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138513702|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513703|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
138513704|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513705|NCT00139243|Antidotes|antidotes|mesh-ancestor
138513706|NCT00139243|Protective Agents|protective agents|mesh-ancestor
138513707|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
138513708|NCT00139243|Vitamins|vitamins|mesh-ancestor
138513709|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
138513710|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513711|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513712|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513713|NCT00139282|Squalamine|squalamine|mesh-list
138513714|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513715|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513716|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138513717|NCT00139282|Protective Agents|protective agents|mesh-ancestor
138513718|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513719|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513720|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138513721|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138513722|NCT00139282|Growth Substances|growth substances|mesh-ancestor
138513723|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
138513725|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190113|NCT03490942|Glucagon|glucagon|mesh-list
138513726|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513727|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138513728|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138513729|NCT00139360|Growth Substances|growth substances|mesh-ancestor
138513730|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513731|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
138513732|NCT00139516|Nicotine|nicotine|mesh-list
138513733|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138513734|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
138513735|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513736|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513737|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138513738|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138513739|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
138513740|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513741|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513742|NCT00139555|Amlodipine|amlodipine|mesh-list
138513743|NCT00139555|Benazepril|benazepril|mesh-list
138513744|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138513745|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138513746|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138513747|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513748|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138207906|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138207907|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207908|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207909|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
138207910|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207911|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513749|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513750|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407504|NCT05690321|Opium|opium|mesh-list
138513751|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138513752|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
138513753|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513754|NCT00139633|Carboplatin|carboplatin|mesh-list
138513755|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513756|NCT00139711|Docetaxel|docetaxel|mesh-list
138513757|NCT00139711|Irinotecan|irinotecan|mesh-list
138513758|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513759|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513760|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513761|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513762|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513763|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138513764|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513765|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513766|NCT03837977|Leucovorin|leucovorin|mesh-list
138513767|NCT03837977|Folic Acid|folic acid|mesh-list
138513768|NCT03837977|Docetaxel|docetaxel|mesh-list
138513769|NCT03837977|Fluorouracil|fluorouracil|mesh-list
138513770|NCT03837977|Irinotecan|irinotecan|mesh-list
138513771|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
138513772|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513773|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407512|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
138513774|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513775|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513776|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513777|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
138513778|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138513779|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513781|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513782|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138513783|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138513784|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513786|NCT03837977|Protective Agents|protective agents|mesh-ancestor
138513787|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
138513788|NCT03837977|Vitamins|vitamins|mesh-ancestor
138513789|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
138513790|NCT03837977|Hematinics|hematinics|mesh-ancestor
138513791|NCT00404326|Hydralazine|hydralazine|mesh-list
138513792|NCT00404326|Valproic Acid|valproic acid|mesh-list
138513793|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
138513794|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513795|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513796|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
138513797|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513798|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513799|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
138513800|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138513801|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138513802|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138513803|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138407567|NCT05689242|Analgesics|analgesics|mesh-ancestor
138207921|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
138207922|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138207923|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
138207924|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207925|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207926|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207928|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207929|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138207930|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207931|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513806|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138513807|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138457612|NCT01919203|Remifentanil|remifentanil|mesh-list
138513808|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
138513809|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513810|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513811|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513812|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138513813|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138513814|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
138513815|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513816|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138513817|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138513818|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
138513819|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
138513820|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513821|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513823|NCT03150459|Simvastatin|simvastatin|mesh-list
138513824|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138513825|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138513826|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
138697106|NCT06085417|Tocolytic Agents|tocolytic agents|mesh-ancestor
138513827|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513828|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138479965|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513829|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138513830|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513831|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513832|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513833|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138513834|NCT00140023|Azithromycin|azithromycin|mesh-list
138513835|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513836|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513837|NCT00140062|Latanoprost|latanoprost|mesh-list
138513838|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138513839|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138513841|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513842|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513843|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513844|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513845|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513846|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513847|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
138513848|NCT03150420|Antidotes|antidotes|mesh-ancestor
138513849|NCT03150420|Protective Agents|protective agents|mesh-ancestor
138513850|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513851|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
138513852|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513853|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
138198137|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
138513854|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513855|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513856|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
138513857|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
138513858|NCT00140218|Pramipexole|pramipexole|mesh-list
138513859|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
138513860|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513861|NCT00140218|Protective Agents|protective agents|mesh-ancestor
138513862|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513863|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138207934|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207935|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
138207936|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207937|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513864|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138513865|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
138513866|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
138513867|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513868|NCT00140257|Escitalopram|escitalopram|mesh-list
138513869|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138513870|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138407667|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513871|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138513872|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513873|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513875|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513876|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
138513877|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138513878|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513879|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
138513880|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
138513881|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513883|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513884|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
138513885|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513886|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
138513887|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513888|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513889|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138513890|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138513891|NCT00140452|Growth Substances|growth substances|mesh-ancestor
138513892|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
138513893|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513894|NCT00140530|Sirolimus|sirolimus|mesh-list
138513895|NCT00140530|Paclitaxel|paclitaxel|mesh-list
138513896|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138513897|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513898|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
138513899|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
138513900|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
138513901|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513902|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513903|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513904|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138513905|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
138513906|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513907|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
138513908|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407700|NCT04753216|Irinotecan|irinotecan|mesh-list
138513909|NCT00140569|Interferons|interferons|mesh-list
138513910|NCT00140569|Fludarabine|fludarabine|mesh-list
138513911|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513912|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
138513913|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513914|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
138513915|NCT00140647|Ramipril|ramipril|mesh-list
138513916|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138513917|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513918|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138207945|NCT00270296|Nevirapine|nevirapine|mesh-list
138207946|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138207947|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138207948|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138207949|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
138207950|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207951|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207952|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138513919|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
138513920|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513921|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513922|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138513923|NCT00140725|Interferons|interferons|mesh-list
138513924|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
138513925|NCT00140725|Lamivudine|lamivudine|mesh-list
138513926|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
138513927|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513928|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
138513929|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513931|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513932|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138697165|NCT06078228|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138513934|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513935|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513936|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138513937|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138513938|NCT00140764|Metronidazole|metronidazole|mesh-list
138513939|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138513940|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138513941|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138513942|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138513943|NCT00138736|Lectins|lectins|mesh-list
138513944|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
138513945|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
138513946|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513947|NCT00138736|Coagulants|coagulants|mesh-ancestor
138513948|NCT00140920|Diclofenac|diclofenac|mesh-list
138513949|NCT00140920|Rofecoxib|rofecoxib|mesh-list
138513950|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138513951|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513952|NCT00140920|Analgesics|analgesics|mesh-ancestor
138513953|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
138513954|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407738|NCT04563494|Dexamethasone|dexamethasone|mesh-list
138513955|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513956|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513957|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513958|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138513959|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513960|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513961|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138513962|NCT03136497|Rituximab|rituximab|mesh-list
138513963|NCT03136497|Venetoclax|venetoclax|mesh-list
138513964|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138513965|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513966|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
138513967|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207956|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138207957|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138207958|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138207963|NCT01047527|Nicotine|nicotine|mesh-list
138513968|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513969|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138513970|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138513971|NCT00140998|Estradiol|estradiol|mesh-list
138513972|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138513973|NCT00140998|Estrogens|estrogens|mesh-ancestor
138513974|NCT00140998|Hormones|hormones|mesh-ancestor
138513975|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138513976|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513977|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138513978|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
138513979|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138513980|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138513981|NCT00141154|Celecoxib|celecoxib|mesh-list
138513982|NCT00141154|Loxoprofen|loxoprofen|mesh-list
138513983|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138407765|NCT04456296|Testosterone|testosterone|mesh-list
138513984|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513985|NCT00141154|Analgesics|analgesics|mesh-ancestor
138513986|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
138513987|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138513988|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513989|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138513990|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513991|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138513992|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138513993|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697174|NCT06076668|Dexmedetomidine|dexmedetomidine|mesh-list
138513994|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513996|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138513997|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138513998|NCT00141193|Analgesics|analgesics|mesh-ancestor
138513999|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
138514000|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514001|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514002|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514003|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514004|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138514005|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138514006|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514007|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514008|NCT00141232|Atorvastatin|atorvastatin|mesh-list
138514009|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138407810|NCT03967197|Lidocaine|lidocaine|mesh-list
138514010|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138514011|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
138514012|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514013|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138514014|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138514015|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514016|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
138207978|NCT01048697|Ethambutol|ethambutol|mesh-list
138207979|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
138207980|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207982|NCT01049243|Fluocinonide|fluocinonide|mesh-list
138207983|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207984|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
138207985|NCT01049243|Hormones|hormones|mesh-ancestor
138207988|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138514017|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514018|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
138514019|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138514020|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138514021|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514022|NCT00141310|Urological Agents|urological agents|mesh-ancestor
138514023|NCT00141388|Pregabalin|pregabalin|mesh-list
138514024|NCT00141388|Analgesics|analgesics|mesh-ancestor
138514025|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
138514026|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514027|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514028|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
138514029|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138514030|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514031|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514032|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138514033|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138514034|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138514035|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514036|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514037|NCT00404404|Paclitaxel|paclitaxel|mesh-list
138514038|NCT00404404|Bevacizumab|bevacizumab|mesh-list
138514039|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138514040|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138514041|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514042|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514043|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
138514044|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
138514045|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514046|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514047|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138697189|NCT06076668|Antioxidants|antioxidants|mesh-ancestor
138514049|NCT00404404|Growth Substances|growth substances|mesh-ancestor
138514050|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514051|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
138514052|NCT00404482|Cyclosporine|cyclosporine|mesh-list
138514053|NCT00404482|Cyclosporins|cyclosporins|mesh-list
138514054|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514055|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514056|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514057|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
138514058|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514059|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
138514060|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514061|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
138514062|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514063|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138514064|NCT00141427|Pregabalin|pregabalin|mesh-list
138514065|NCT00141427|Analgesics|analgesics|mesh-ancestor
138514066|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
138514067|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514068|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514069|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
138514070|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138514071|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207996|NCT03013205|Hormones|hormones|mesh-ancestor
138207997|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207998|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207999|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138208000|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
138208001|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208002|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208003|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
138208004|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
138514072|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514073|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138514074|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138514075|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138514076|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514077|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514078|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
138514080|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
138514081|NCT00141544|Estrone|estrone|mesh-list
138514082|NCT00141544|Testosterone|testosterone|mesh-list
138514083|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
138514084|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
138514085|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138514086|NCT00141544|Hormones|hormones|mesh-ancestor
138514087|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514088|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514089|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514090|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514091|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
138514092|NCT00141544|Androgens|androgens|mesh-ancestor
138514093|NCT00141583|Candesartan|candesartan|mesh-list
138514094|NCT00141583|Candesartan cilexetil|candesartan cilexetil|mesh-list
138514095|NCT00141583|Enalapril|enalapril|mesh-list
138514096|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138514097|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138407890|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514098|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138514099|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514100|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138514101|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
138514102|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514103|NCT00141700|Rituximab|rituximab|mesh-list
138514104|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514106|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
138457688|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
138514107|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514108|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514109|NCT00141895|Misoprostol|misoprostol|mesh-list
138697206|NCT06049693|Ferrous gluconate|ferrous gluconate|mesh-list
138514110|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138514111|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
138514112|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138514113|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514114|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138514115|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514116|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
138514117|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
138208005|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208006|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
138208007|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208008|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138208009|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138208010|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138208011|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208012|NCT01094717|Tazarotene|tazarotene|mesh-list
138208013|NCT01094717|Acitretin|acitretin|mesh-list
138208014|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138514118|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138514119|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
138514120|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514121|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514122|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138514123|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138514124|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138514125|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
138514126|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514127|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514128|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138514129|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
138514130|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
138514131|NCT00142051|Protective Agents|protective agents|mesh-ancestor
138514133|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514134|NCT02825979|Sotalol|sotalol|mesh-list
138514135|NCT02825979|Flecainide|flecainide|mesh-list
138514136|NCT02825979|Dronedarone|dronedarone|mesh-list
138514137|NCT02825979|Propafenone|propafenone|mesh-list
138514138|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138514139|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138514140|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138514141|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138514142|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514143|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514144|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514145|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
138514146|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
138514147|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514148|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138514149|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138514150|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514152|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
138514153|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138514154|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
138514155|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138514156|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138514157|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514158|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138514159|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514160|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514161|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138208022|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138208023|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514162|NCT00142246|Amodiaquine|amodiaquine|mesh-list
138514163|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
138514164|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138208056|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208057|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138208058|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138514165|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138514166|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514167|NCT00142324|Donepezil|donepezil|mesh-list
138514168|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138514169|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514170|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514171|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
138514172|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514173|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514174|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
138514175|NCT00142402|Modafinil|modafinil|mesh-list
138208060|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208061|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
138208063|NCT03012347|Protective Agents|protective agents|mesh-ancestor
138514176|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138514177|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514178|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138514179|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138514180|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138514181|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514182|NCT00142480|Bevacizumab|bevacizumab|mesh-list
138514183|NCT00142480|Capecitabine|capecitabine|mesh-list
138514184|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
138514185|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514186|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514187|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138514188|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138514189|NCT00142480|Growth Substances|growth substances|mesh-ancestor
138514190|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514191|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
138514192|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514193|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
138514194|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514195|NCT02806050|Letrozole|letrozole|mesh-list
138514196|NCT02806050|Palbociclib|palbociclib|mesh-list
138514197|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514198|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138514199|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138208112|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208113|NCT05272397|Methylphenidate|methylphenidate|mesh-list
138208114|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138208115|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514200|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514201|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514202|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138208159|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138208160|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138208161|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208162|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208163|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
138208169|NCT00136760|Bupropion|bupropion|mesh-list
138514203|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138514204|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514205|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514206|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138514207|NCT00142870|Bupropion|bupropion|mesh-list
138514208|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138208214|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514209|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
138514210|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514211|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138514212|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138514213|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514214|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514215|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
138514216|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514217|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208215|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
138208216|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208218|NCT01107665|Paclitaxel|paclitaxel|mesh-list
138514218|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138514219|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138514220|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514222|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138514223|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138514224|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514225|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
138514226|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208277|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138208278|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138514227|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
138514228|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138514229|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514230|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514231|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138514232|NCT02780427|Analgesics|analgesics|mesh-ancestor
138514233|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
138514234|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514235|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138514236|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138514237|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138514238|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
138514239|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514240|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514241|NCT00142987|Tegaserod|tegaserod|mesh-list
138514242|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138514243|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
138208344|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208345|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208346|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138208347|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208348|NCT02099084|Teduglutide|teduglutide|mesh-list
138208353|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
138514244|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514245|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514246|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514247|NCT00143026|Levodopa|levodopa|mesh-list
138514248|NCT00143026|Carbidopa|carbidopa|mesh-list
138514249|NCT00143026|Entacapone|entacapone|mesh-list
138514250|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138514251|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138208397|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208403|NCT00206336|Topiramate|topiramate|mesh-list
138514252|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
138514253|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514254|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408016|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514255|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514256|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138514257|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514258|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138208466|NCT05215067|Docetaxel|docetaxel|mesh-list
138208467|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208468|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514259|NCT00404599|Simvastatin|simvastatin|mesh-list
138514260|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138514261|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138514262|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
138514263|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514264|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138514265|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138514266|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514267|NCT00143065|Rituximab|rituximab|mesh-list
138514268|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
138514269|NCT00143065|Fludarabine|fludarabine|mesh-list
138514270|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514271|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514272|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
138514273|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514274|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208533|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208534|NCT00218426|Naltrexone|naltrexone|mesh-list
138514275|NCT00143104|Insulin|insulin|mesh-list
138514276|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138514277|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514278|NCT00143143|Pregabalin|pregabalin|mesh-list
138514279|NCT00143143|Analgesics|analgesics|mesh-ancestor
138514280|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
138514281|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514282|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514283|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
138208590|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208591|NCT04042142|Hormones|hormones|mesh-ancestor
138208592|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514284|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138208654|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208655|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514285|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514286|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514287|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138514288|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138514289|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138514290|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208657|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138408056|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208658|NCT01141049|Gabapentin|gabapentin|mesh-list
138208659|NCT01141049|Analgesics|analgesics|mesh-ancestor
138208660|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
138208661|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208662|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514291|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514293|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
138514294|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138514295|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138514296|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514297|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514298|NCT00143221|Urological Agents|urological agents|mesh-ancestor
138514299|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
138416710|NCT01666691|CKD732|ckd732|mesh-list
138514300|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514302|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138514303|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138514304|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514305|NCT00143260|Urological Agents|urological agents|mesh-ancestor
138514306|NCT00143299|Varenicline|varenicline|mesh-list
138514307|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138514308|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138514309|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
138514310|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514311|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514312|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514313|NCT00143338|Insulin|insulin|mesh-list
138514314|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138514315|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514316|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138514317|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138208713|NCT00298610|Quinidine|quinidine|mesh-list
138208714|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138208715|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
138208720|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
138514318|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138514319|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138208759|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208760|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208761|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208763|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138208764|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138208765|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138514320|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514321|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514322|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514323|NCT00143377|Urological Agents|urological agents|mesh-ancestor
138514324|NCT02972216|Docetaxel|docetaxel|mesh-list
138190716|NCT02245529|Tamsulosin|tamsulosin|mesh-list
138514325|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514326|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514327|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208766|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138514328|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
138514329|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208815|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138514330|NCT04726345|Fexofenadine|fexofenadine|mesh-list
138514331|NCT04726345|Terfenadine|terfenadine|mesh-list
138514332|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138514333|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138514334|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138514335|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
138514336|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
138208816|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208817|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208818|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208819|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138514337|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514338|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514339|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514340|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
138514341|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
138514342|NCT00143533|Irinotecan|irinotecan|mesh-list
138514343|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138514344|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138514345|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208876|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138208877|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208878|NCT01179113|Esmolol|esmolol|mesh-list
138208879|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138514346|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514347|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514348|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514349|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514350|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
138514351|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514352|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
138514353|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514354|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514355|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138514356|NCT00393315|Paclitaxel|paclitaxel|mesh-list
138514357|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138514358|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514359|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514360|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138514361|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138514362|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514363|NCT00143689|Ritonavir|ritonavir|mesh-list
138514364|NCT00143689|Lopinavir|lopinavir|mesh-list
138514365|NCT00143689|Lamivudine|lamivudine|mesh-list
138514366|NCT00143689|Zidovudine|zidovudine|mesh-list
138514367|NCT00143689|Nevirapine|nevirapine|mesh-list
138514368|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138514369|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138514370|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
138514371|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514372|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514373|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138514374|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138514375|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
138514376|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514377|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138514378|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138514379|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138208937|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208938|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208939|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138208941|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138208942|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
138208943|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208947|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
138514380|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138514381|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
138514382|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138514383|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138514384|NCT00143728|Lamivudine|lamivudine|mesh-list
138514385|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138514386|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138514387|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208972|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
138208973|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208987|NCT00300482|Calcium|calcium|mesh-list
138514388|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514389|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
138514390|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514392|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138514393|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138514394|NCT00140803|Verteporfin|verteporfin|mesh-list
138514395|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514396|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
138514397|NCT00140803|Hormones|hormones|mesh-ancestor
138514398|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514399|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209039|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
138209040|NCT01478581|Hormones|hormones|mesh-ancestor
138209041|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209042|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514402|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138514403|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
138514404|NCT00143806|Cyclosporine|cyclosporine|mesh-list
138514405|NCT00143806|Alefacept|alefacept|mesh-list
138514406|NCT00143806|Cyclosporins|cyclosporins|mesh-list
138514407|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514408|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514409|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514410|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
138514411|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514412|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
138514413|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514414|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
138514415|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514416|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138514417|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
138209099|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
138514418|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209100|NCT03917966|Docetaxel|docetaxel|mesh-list
138209101|NCT03917966|Apatinib|apatinib|mesh-list
138514419|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514420|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138514421|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138514422|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514423|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
138514424|NCT00144118|Sevoflurane|sevoflurane|mesh-list
138514425|NCT00144118|Isoflurane|isoflurane|mesh-list
138209157|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209158|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
138209159|NCT00248534|Hormones|hormones|mesh-ancestor
138514426|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138209160|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209161|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138209162|NCT00248534|Protective Agents|protective agents|mesh-ancestor
138514427|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138514428|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
138514429|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
138514430|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514431|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514432|NCT00144157|Zidovudine|zidovudine|mesh-list
138514433|NCT00144157|Nevirapine|nevirapine|mesh-list
138514434|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
138209220|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
138209221|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138209222|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138209223|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138209224|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
138514435|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457737|NCT01920984|Bevacizumab|bevacizumab|mesh-list
138514436|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138514437|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138514438|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514439|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
138514440|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514441|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138514442|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138514443|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138209283|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
138209284|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209285|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209286|NCT01480297|Analgesics|analgesics|mesh-ancestor
138209287|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
138209288|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209298|NCT01392703|Dasatinib|dasatinib|mesh-list
138514444|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138514446|NCT00144274|Expectorants|expectorants|mesh-ancestor
138408139|NCT03710564|Aflibercept|aflibercept|mesh-list
138514447|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
138514449|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
138514450|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138514451|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
138514452|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138514453|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138514454|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209343|NCT01481545|Leucovorin|leucovorin|mesh-list
138209344|NCT01481545|Bevacizumab|bevacizumab|mesh-list
138209345|NCT01481545|Fluorouracil|fluorouracil|mesh-list
138209346|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
138514455|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138514456|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514457|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514458|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138514459|NCT00144430|Pentostatin|pentostatin|mesh-list
138514460|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514461|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138209411|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209412|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
138209413|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209414|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
138209415|NCT05075330|Narcotics|narcotics|mesh-ancestor
138514462|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514463|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209477|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209478|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514464|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138514465|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
138514466|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514468|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138514469|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
138514470|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514471|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514472|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138514473|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
138514474|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138514475|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138514476|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514477|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138514478|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
138514479|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138514480|NCT00404716|Protective Agents|protective agents|mesh-ancestor
138514481|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138514482|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138514483|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514484|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
138514485|NCT00404794|Prednisolone|prednisolone|mesh-list
138514486|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138514487|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
138514488|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138514489|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
138514490|NCT00404794|Tacrolimus|tacrolimus|mesh-list
138209479|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209480|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138209482|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138514491|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138514492|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
138209483|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
138209484|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514493|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514494|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
138514495|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514496|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138514497|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514498|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514499|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138514500|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514501|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138514502|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
138514503|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514504|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209518|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209519|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138209520|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138209521|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209522|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209523|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
138209524|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
138209525|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138514505|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514506|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
138514508|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514509|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514510|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
138514511|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
138514512|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514513|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514514|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138514515|NCT00404794|Protective Agents|protective agents|mesh-ancestor
138514516|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
138514517|NCT00404833|Prednisolone|prednisolone|mesh-list
138514518|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138514519|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
138209570|NCT01184885|Sirolimus|sirolimus|mesh-list
138209571|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
138209572|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138209573|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514520|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138514521|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
138514522|NCT00404833|Chlorambucil|chlorambucil|mesh-list
138514523|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138514524|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
138514525|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138514526|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514527|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138514528|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
138514529|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514530|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514531|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514532|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209630|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209631|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209632|NCT04352465|Methotrexate|methotrexate|mesh-list
138209633|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138209634|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
138209635|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138209640|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514533|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514534|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
138514535|NCT00404833|Hormones|hormones|mesh-ancestor
138514536|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514537|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514538|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514539|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
138514540|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
138209689|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209690|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209691|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138209692|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138209693|NCT01194089|Nicotine|nicotine|mesh-list
138209753|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209754|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209756|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138209757|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
138209758|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209759|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138209760|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209761|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209762|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138209763|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
138209765|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514541|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514542|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514543|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138514544|NCT00404833|Protective Agents|protective agents|mesh-ancestor
138514545|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138514546|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
138514547|NCT05595109|Silymarin|silymarin|mesh-list
138514548|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
138209809|NCT00343460|Palonosetron|palonosetron|mesh-list
138190926|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
138209810|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209811|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
138209812|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
138209813|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209814|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209815|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209816|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
138209817|NCT00343460|Hormones|hormones|mesh-ancestor
138209819|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514549|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514550|NCT05595109|Protective Agents|protective agents|mesh-ancestor
138514551|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514552|NCT01807494|Cimetidine|cimetidine|mesh-list
138514553|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138514554|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514555|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138209868|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514556|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
138514557|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
138514558|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514559|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514560|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514561|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138514562|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138514563|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514564|NCT01807455|Lidocaine|lidocaine|mesh-list
138514565|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
138514566|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
138514567|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209936|NCT01792700|Tetracycline|tetracycline|mesh-list
138209937|NCT01792700|Esomeprazole|esomeprazole|mesh-list
138209938|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209967|NCT00316862|Irinotecan|irinotecan|mesh-list
138514568|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514569|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
138210000|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138210001|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138210002|NCT00365144|Growth Substances|growth substances|mesh-ancestor
138210003|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210004|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138210005|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210006|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210007|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210008|NCT00366626|Naltrexone|naltrexone|mesh-list
138697356|NCT05827081|Letrozole|letrozole|mesh-list
138514570|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514571|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138514572|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138514573|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138514574|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210009|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138210010|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138514575|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514576|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
138514578|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514579|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
138514580|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514581|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514582|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138514583|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
138514584|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514585|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514586|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138514587|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210057|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
138210058|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138210059|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138210060|NCT00369590|Growth Substances|growth substances|mesh-ancestor
138514588|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138514590|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138514591|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138514592|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514593|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514594|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138514595|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138514596|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514597|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138514598|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
138514599|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
138408377|NCT02702492|Niacin|niacin|mesh-list
138514601|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
138514602|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210112|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138210113|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210117|NCT05329428|Vitamin D|vitamin d|mesh-list
138210173|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210174|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514603|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514604|NCT03090737|Nivolumab|nivolumab|mesh-list
138514605|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514606|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514607|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138514608|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514609|NCT02972255|Meropenem|meropenem|mesh-list
138514610|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514611|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514612|NCT05468671|Remifentanil|remifentanil|mesh-list
138514613|NCT05468671|Oxycodone|oxycodone|mesh-list
138514614|NCT05468671|Propofol|propofol|mesh-list
138514615|NCT05468671|Rocuronium|rocuronium|mesh-list
138514616|NCT05468671|Flumazenil|flumazenil|mesh-list
138514617|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138514618|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514619|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514620|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138514621|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
138210175|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210176|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210177|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138210178|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514622|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
138514623|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138514624|NCT05468671|Narcotics|narcotics|mesh-ancestor
138514625|NCT05468671|Analgesics|analgesics|mesh-ancestor
138514626|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
138514627|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514628|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138514629|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138514630|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138514631|NCT05468671|Antidotes|antidotes|mesh-ancestor
138514632|NCT05468671|Protective Agents|protective agents|mesh-ancestor
138514633|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
138514634|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
138514635|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457763|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
138514636|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514639|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138514640|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
138514641|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138514642|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
138514643|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514644|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514645|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
138514647|NCT03079427|Gemcitabine|gemcitabine|mesh-list
138514648|NCT03079427|Capecitabine|capecitabine|mesh-list
138514649|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514650|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514651|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
138514652|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514653|NCT00390923|Selegiline|selegiline|mesh-list
138210224|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138210225|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210227|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138514654|NCT00390923|Nicotine|nicotine|mesh-list
138514655|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138514656|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
138514657|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514658|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514659|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138514660|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138514661|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
138514662|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210270|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138210271|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210272|NCT05901454|Vaccines|vaccines|mesh-list
138210273|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
138210274|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210275|NCT05901441|Sufentanil|sufentanil|mesh-list
138697377|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138210343|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210345|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210346|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408480|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514663|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514664|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
138514665|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514666|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138514667|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138514668|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138514669|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210347|NCT05897138|Lenvatinib|lenvatinib|mesh-list
138210349|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210350|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138514670|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138514671|NCT00390923|Protective Agents|protective agents|mesh-ancestor
138210401|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138210402|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514672|NCT00425425|Fluorouracil|fluorouracil|mesh-list
138514673|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
138514674|NCT00425425|Cetuximab|cetuximab|mesh-list
138514675|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
138514676|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514677|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514678|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210403|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210404|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
138210405|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138210406|NCT05833139|Itraconazole|itraconazole|mesh-list
138210407|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
138514679|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514680|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
138514681|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514682|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408544|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408547|NCT01599884|Antidotes|antidotes|mesh-ancestor
138514684|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
138514685|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
138514686|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210461|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138210462|NCT05661643|Temozolomide|temozolomide|mesh-list
138210463|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138210464|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
138210465|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210466|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210468|NCT05659056|Trastuzumab|trastuzumab|mesh-list
138210469|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138210470|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210471|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
138210472|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
138210473|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
138210474|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210475|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210476|NCT05654649|Dexamethasone|dexamethasone|mesh-list
138210477|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514687|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514688|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514689|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138514690|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
138514691|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514692|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514693|NCT02958163|Doxorubicin|doxorubicin|mesh-list
138514694|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138514695|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514696|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138457771|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
138514697|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138514698|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514699|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514700|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138514701|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138514702|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514704|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514705|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
138514706|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
138514707|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
138514708|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138514709|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514710|NCT01806792|Vitamins|vitamins|mesh-ancestor
138514711|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
138408596|NCT01602029|Simvastatin|simvastatin|mesh-list
138514712|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138210510|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138210511|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210512|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514713|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138514714|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514715|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514716|NCT05228431|Capecitabine|capecitabine|mesh-list
138514717|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514718|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
138514719|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210558|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138210559|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210560|NCT05123040|Prednisone|prednisone|mesh-list
138514720|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514721|NCT01806753|Midazolam|midazolam|mesh-list
138514722|NCT01806753|Propofol|propofol|mesh-list
138210561|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
138210562|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210563|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
138514723|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138514724|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210620|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138514725|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514726|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138514727|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
138514728|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
138514729|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138514730|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138514731|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138514732|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138514733|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
138514734|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
138514735|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210621|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
138210622|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210623|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210624|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138514736|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514737|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138514738|NCT01806675|Glycine|glycine|mesh-list
138514739|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138514740|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514741|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
138514743|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514744|NCT02762981|Paclitaxel|paclitaxel|mesh-list
138514745|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138514746|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138210680|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138210682|NCT04731103|Zidovudine|zidovudine|mesh-list
138210683|NCT04731103|Abacavir|abacavir|mesh-list
138210684|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
138210685|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138210686|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138210687|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210688|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210689|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
138210690|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210691|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138210692|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138210694|NCT04716712|Azithromycin|azithromycin|mesh-list
138514747|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514748|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514749|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
138514750|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
138514751|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514752|NCT04958044|Calcium|calcium|mesh-list
138514753|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210741|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
138210742|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138210743|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
138210744|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
138210745|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210746|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210747|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210748|NCT04572763|Venetoclax|venetoclax|mesh-list
138210749|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210750|NCT04556370|Norepinephrine|norepinephrine|mesh-list
138210751|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210752|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210753|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210754|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210755|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210756|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210757|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
138514754|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514755|NCT01806363|Telmisartan|telmisartan|mesh-list
138514756|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
138514757|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138514758|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138514759|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138514760|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514761|NCT01806363|Diuretics|diuretics|mesh-ancestor
138514762|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
138210806|NCT04423055|Etonogestrel|etonogestrel|mesh-list
138210807|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138210808|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210809|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138210810|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138210811|NCT04418401|Antibodies|antibodies|mesh-list
138408703|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
138514763|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514764|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138514765|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514766|NCT04846855|Anesthetics|anesthetics|mesh-list
138514767|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
138514768|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514769|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514770|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
138514771|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514772|NCT02964403|Indomethacin|indomethacin|mesh-list
138514773|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138514774|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138514776|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
138514777|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210866|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210867|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
138210868|NCT04088851|Metformin|metformin|mesh-list
138210869|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210870|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210871|NCT04074265|Ketorolac|ketorolac|mesh-list
138210872|NCT04074265|Epinephrine|epinephrine|mesh-list
138210873|NCT04074265|Ropivacaine|ropivacaine|mesh-list
138210874|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210875|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
138210876|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210877|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210878|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
138210879|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210880|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210881|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138514778|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514779|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514780|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514781|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
138514782|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
138514783|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138514784|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138514785|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514786|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514788|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
138514789|NCT00393393|Protective Agents|protective agents|mesh-ancestor
138408740|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514790|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514792|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138514793|NCT00405262|Bupivacaine|bupivacaine|mesh-list
138514794|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
138514795|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
138514796|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514797|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514798|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
138514799|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210911|NCT03759028|Acetaminophen|acetaminophen|mesh-list
138210912|NCT03759028|Ibuprofen|ibuprofen|mesh-list
138210913|NCT03759028|Oxycodone|oxycodone|mesh-list
138210914|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210915|NCT03759028|Analgesics|analgesics|mesh-ancestor
138210916|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
138210917|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210918|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210919|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
138210920|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138210921|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210956|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210957|NCT03574090|Amoxicillin|amoxicillin|mesh-list
138210958|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
138210959|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
138210960|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138514800|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138514801|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138514802|NCT00405262|Analgesics|analgesics|mesh-ancestor
138514803|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514804|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514805|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138514806|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514807|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211025|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211026|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514808|NCT00405301|Rifampin|rifampin|mesh-list
138514809|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
138514810|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138514811|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
138514812|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514813|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514814|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
138514815|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138211092|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138211093|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138211094|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
138211095|NCT00392834|Ifosfamide|ifosfamide|mesh-list
138211096|NCT00392834|Rituximab|rituximab|mesh-list
138211097|NCT00392834|Doxorubicin|doxorubicin|mesh-list
138211098|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138211099|NCT00392834|Methotrexate|methotrexate|mesh-list
138211100|NCT00392834|Etoposide|etoposide|mesh-list
138514816|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514817|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514818|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138514819|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138514820|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138514821|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138211154|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138211170|NCT02662634|Paclitaxel|paclitaxel|mesh-list
138514822|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138514823|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138514824|NCT00405340|Rituximab|rituximab|mesh-list
138514825|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457795|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
138211224|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408846|NCT01610999|Plerixafor|plerixafor|mesh-list
138514828|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514829|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514830|NCT04713319|Calcium|calcium|mesh-list
138514831|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138514832|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514833|NCT02647892|Lidocaine|lidocaine|mesh-list
138514834|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
138514835|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
138514836|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514837|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514838|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
138514839|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514840|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138514841|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138211225|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211226|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138211227|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514842|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138211228|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514843|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211229|NCT00397904|Irinotecan|irinotecan|mesh-list
138211230|NCT00397904|Cetuximab|cetuximab|mesh-list
138211231|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211232|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138211233|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211234|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211235|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211236|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211237|NCT00398918|Zonisamide|zonisamide|mesh-list
138211238|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
138211239|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138211240|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514844|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514845|NCT01806090|Clopidogrel|clopidogrel|mesh-list
138514846|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138191245|NCT03030287|Paclitaxel|paclitaxel|mesh-list
138514847|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138514848|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138514849|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138514850|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
138514851|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408900|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138514852|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514853|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514854|NCT02505893|Sirolimus|sirolimus|mesh-list
138514855|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514856|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211261|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211262|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211263|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211265|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
138211266|NCT01795430|Etoposide|etoposide|mesh-list
138211267|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
138211268|NCT01795430|Melphalan|melphalan|mesh-list
138211269|NCT01795430|Busulfan|busulfan|mesh-list
138211270|NCT01795430|Topotecan|topotecan|mesh-list
138514857|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138514858|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514859|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
138514860|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514861|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
138514862|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514863|NCT04341181|Trastuzumab|trastuzumab|mesh-list
138514864|NCT04341181|Atezolizumab|atezolizumab|mesh-list
138514865|NCT04341181|Pertuzumab|pertuzumab|mesh-list
138211315|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138211316|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138211317|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
138211318|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
138211319|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211320|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211321|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211322|NCT04749914|Dabigatran|dabigatran|mesh-list
138211323|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138211324|NCT04749914|Lasmiditan|lasmiditan|mesh-list
138514866|NCT04341181|Avelumab|avelumab|mesh-list
138514867|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138514868|NCT04341181|Niraparib|niraparib|mesh-list
138514869|NCT04341181|Axitinib|axitinib|mesh-list
138514870|NCT04341181|Vemurafenib|vemurafenib|mesh-list
138514871|NCT04341181|Maytansine|maytansine|mesh-list
138514872|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514873|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514874|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138514875|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514876|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514877|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138514878|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138514879|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138514880|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138514882|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138514883|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
138514884|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
138514886|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211373|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138211374|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
138211375|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138211376|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514887|NCT01806324|Losartan|losartan|mesh-list
138514888|NCT01806324|Atorvastatin|atorvastatin|mesh-list
138514889|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138514890|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138514891|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
138514892|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211426|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211427|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138514893|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138514894|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138211428|NCT05300802|Analgesics|analgesics|mesh-ancestor
138211429|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
138211430|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211431|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138514895|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211432|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138211433|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211434|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211435|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211436|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211437|NCT05299476|Bevacizumab|bevacizumab|mesh-list
138211438|NCT05299476|Tislelizumab|tislelizumab|mesh-list
138211439|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211440|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514896|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138514897|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138514898|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138514899|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138514900|NCT02423876|Hydromorphone|hydromorphone|mesh-list
138514901|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138514902|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514903|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
138514904|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514905|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138514906|NCT02423876|Narcotics|narcotics|mesh-ancestor
138514907|NCT02423876|Analgesics|analgesics|mesh-ancestor
138514908|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
138514909|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514910|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514911|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138514912|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514913|NCT01805895|Minocycline|minocycline|mesh-list
138514914|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138211475|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211477|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138211478|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
138211480|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138211481|NCT01793480|Narcotics|narcotics|mesh-ancestor
138211482|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211483|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211484|NCT01793480|Analgesics|analgesics|mesh-ancestor
138211485|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
138211486|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211488|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211500|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138211501|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211502|NCT05256264|Ketamine|ketamine|mesh-list
138211503|NCT05256264|Analgesics|analgesics|mesh-ancestor
138211504|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
138211505|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211506|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211507|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138211508|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138211509|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
138514915|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514916|NCT01805856|Cefazolin|cefazolin|mesh-list
138514917|NCT01805856|Piperacillin|piperacillin|mesh-list
138514918|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138514919|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514920|NCT01805817|Copper|copper|mesh-list
138514921|NCT01805817|Drospirenone|drospirenone|mesh-list
138514922|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
138514923|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138514924|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138514925|NCT01805817|Estradiol|estradiol|mesh-list
138514926|NCT01805817|Estrogens|estrogens|mesh-ancestor
138514927|NCT01805817|Hormones|hormones|mesh-ancestor
138514928|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514929|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514930|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138514931|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
138514932|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138514933|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138514934|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138514935|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138514936|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138211526|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211527|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
138211528|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211529|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211530|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211532|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138514937|NCT01805817|Trace Elements|trace elements|mesh-ancestor
138514938|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
138514939|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138514940|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
138514941|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138514942|NCT01805817|Diuretics|diuretics|mesh-ancestor
138514943|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
138514944|NCT04206046|Anesthetics|anesthetics|mesh-list
138514945|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211578|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
138211579|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211580|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211581|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211582|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
138211583|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211584|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138211585|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138211586|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211587|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211588|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211589|NCT00407966|Cytarabine|cytarabine|mesh-list
138211590|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
138211591|NCT00407966|Alvocidib|alvocidib|mesh-list
138211592|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138211593|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
138211594|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211595|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211597|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211598|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138514946|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457826|NCT01923974|Melatonin|melatonin|mesh-list
138514948|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138514949|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
138514950|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
138514952|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514953|NCT02157077|Aflibercept|aflibercept|mesh-list
138514954|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138514955|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138514956|NCT02157077|Growth Substances|growth substances|mesh-ancestor
138514957|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514958|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
138514959|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211627|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138211628|NCT05255406|Aflutinib|aflutinib|mesh-list
138211629|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211630|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211631|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211632|NCT05250050|Amoxicillin|amoxicillin|mesh-list
138211633|NCT05250050|Metronidazole|metronidazole|mesh-list
138211634|NCT05250050|Clarithromycin|clarithromycin|mesh-list
138211635|NCT05250050|Levofloxacin|levofloxacin|mesh-list
138514960|NCT01805700|Caffeine|caffeine|mesh-list
138514961|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138514962|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514963|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138514964|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514965|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514966|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138211684|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514967|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138514968|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
138514969|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138514970|NCT04033276|Rituximab|rituximab|mesh-list
138514971|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
138514972|NCT04033276|Antibodies|antibodies|mesh-list
138514973|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
138514974|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138514975|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138514976|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138514977|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514978|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
138211685|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138211686|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138211687|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
138211688|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211690|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138211691|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138211692|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211693|NCT05292066|Pregabalin|pregabalin|mesh-list
138211695|NCT05292066|Analgesics|analgesics|mesh-ancestor
138211696|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
138211697|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514979|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514980|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138514981|NCT00391157|Dexamethasone|dexamethasone|mesh-list
138514982|NCT00391157|Bortezomib|bortezomib|mesh-list
138514983|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514984|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
138514985|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
138514986|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514987|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514988|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514989|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
138514990|NCT00391157|Hormones|hormones|mesh-ancestor
138514991|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138514992|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514993|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514994|NCT03781063|Fulvestrant|fulvestrant|mesh-list
138514995|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138514996|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514997|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138514998|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138514999|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138515000|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515001|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515002|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
138211728|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211729|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
138211730|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211731|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211732|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138211733|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138211734|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211735|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
138211736|NCT05290662|Fludarabine|fludarabine|mesh-list
138211737|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211738|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
138211746|NCT05143502|Fluticasone|fluticasone|mesh-list
138515003|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138515004|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
138515005|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138515006|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
138515007|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515008|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515009|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
138515011|NCT01903421|Bupivacaine|bupivacaine|mesh-list
138515012|NCT01903421|Anesthetics|anesthetics|mesh-list
138515014|NCT01903421|Sevoflurane|sevoflurane|mesh-list
138515015|NCT01903421|Isoflurane|isoflurane|mesh-list
138515016|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
138515017|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515018|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515019|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
138515020|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515021|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138515022|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138515023|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
138515024|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138515025|NCT01903421|Narcotics|narcotics|mesh-ancestor
138515026|NCT01903421|Analgesics|analgesics|mesh-ancestor
138515027|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138515028|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409102|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515029|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138515030|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
138515031|NCT01723839|Rituximab|rituximab|mesh-list
138515032|NCT01723839|Fludarabine|fludarabine|mesh-list
138515033|NCT01723839|Lenalidomide|lenalidomide|mesh-list
138515034|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515035|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
138211767|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138211768|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211770|NCT05290116|Tislelizumab|tislelizumab|mesh-list
138211771|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211772|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211773|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211774|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211775|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211776|NCT00409292|Everolimus|everolimus|mesh-list
138211777|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138211778|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211779|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211780|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211781|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211782|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
138211783|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211784|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211785|NCT05246046|Bromides|bromides|mesh-list
138211786|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
138211787|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138211788|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
138515036|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515037|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515038|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515039|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
138515040|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515041|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515042|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515043|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515044|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138515045|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138515046|NCT01723839|Growth Substances|growth substances|mesh-ancestor
138515047|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515048|NCT03421483|Folic Acid|folic acid|mesh-list
138515049|NCT03421483|Hematinics|hematinics|mesh-ancestor
138515050|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
138211790|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211791|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138211792|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211793|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
138515051|NCT03421483|Vitamins|vitamins|mesh-ancestor
138211795|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
138211796|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211799|NCT00383942|Misoprostol|misoprostol|mesh-list
138515052|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
138515053|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515054|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138515055|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
138515056|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515057|NCT00405496|Difluprednate|difluprednate|mesh-list
138515058|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
138515059|NCT00405496|Hormones|hormones|mesh-ancestor
138515060|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515061|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515062|NCT00405535|Glycine|glycine|mesh-list
138515063|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
138515064|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211845|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138211846|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138211847|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211848|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211849|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211850|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211851|NCT00385268|Acamprosate|acamprosate|mesh-list
138211852|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138211853|NCT01657500|Gentamicins|gentamicins|mesh-list
138211855|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138211856|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138211857|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211858|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138211859|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211860|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211861|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
138211862|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
138211863|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
138211864|NCT00411086|Rituximab|rituximab|mesh-list
138211865|NCT00411086|Molgramostim|molgramostim|mesh-list
138211866|NCT00411086|Sargramostim|sargramostim|mesh-list
138211867|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211868|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211869|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
138211870|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211871|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211872|NCT01658904|Melphalan|melphalan|mesh-list
138211874|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211875|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211876|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
138515065|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515066|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515067|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138515068|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
138515069|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
138515070|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409149|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
138211879|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515071|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515072|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138515073|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138515074|NCT00405574|Growth Substances|growth substances|mesh-ancestor
138188471|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211949|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
138211950|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138211951|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
138515075|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515076|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515077|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515079|NCT02825641|Dinoprostone|dinoprostone|mesh-list
138515080|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
138515081|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138515082|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515083|NCT01646034|Paclitaxel|paclitaxel|mesh-list
138515084|NCT01646034|Docetaxel|docetaxel|mesh-list
138515085|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
138515086|NCT01646034|Carboplatin|carboplatin|mesh-list
138515087|NCT01646034|Gemcitabine|gemcitabine|mesh-list
138211952|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211954|NCT00456014|Escitalopram|escitalopram|mesh-list
138211955|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138211956|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211957|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211958|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211959|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211960|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
138211961|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211962|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
138211963|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211964|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138211965|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211966|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138211968|NCT05235516|Cisplatin|cisplatin|mesh-list
138211969|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211970|NCT00411398|Memantine|memantine|mesh-list
138211971|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138211972|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138211973|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
138211974|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211975|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211976|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211977|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138211980|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515088|NCT01646034|Doxorubicin|doxorubicin|mesh-list
138515089|NCT01646034|Thiotepa|thiotepa|mesh-list
138515090|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515091|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515092|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515093|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515094|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515095|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515096|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211981|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211982|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138211983|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138211984|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211985|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211986|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211987|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211988|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211989|NCT00457730|Analgesics|analgesics|mesh-ancestor
138515097|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
138515098|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515099|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515100|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515101|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
138515102|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515103|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212037|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138212038|NCT05177718|Natalizumab|natalizumab|mesh-list
138212039|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
138212040|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212042|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138212043|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138212044|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
138212045|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212046|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212047|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138212048|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138212049|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
138212050|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212052|NCT04241640|Nefopam|nefopam|mesh-list
138515104|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
138515105|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138515106|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515107|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138409175|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515108|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515110|NCT00391313|Amebicides|amebicides|mesh-ancestor
138515111|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138515112|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138515113|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515115|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515116|NCT01466517|Ibuprofen|ibuprofen|mesh-list
138515117|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138515118|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515119|NCT01466517|Analgesics|analgesics|mesh-ancestor
138515120|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
138515121|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515122|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515123|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515124|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212094|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212095|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138212096|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138212097|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138212098|NCT00462722|Ibuprofen|ibuprofen|mesh-list
138212099|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138212100|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212101|NCT00462722|Analgesics|analgesics|mesh-ancestor
138212102|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
138212103|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212104|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212105|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212106|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212107|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138212108|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212109|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212111|NCT00528398|Idarubicin|idarubicin|mesh-list
138212112|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212113|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
138515125|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138515126|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515127|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515128|NCT01466478|Calcitriol|calcitriol|mesh-list
138515129|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138515130|NCT01466478|Calcipotriene|calcipotriene|mesh-list
138515131|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138515132|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515133|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515134|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138515135|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515136|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515137|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138212133|NCT00414518|Emtricitabine|emtricitabine|mesh-list
138212150|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138212151|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212152|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138212153|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
138212154|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212155|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212156|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138515138|NCT01466478|Vitamins|vitamins|mesh-ancestor
138515139|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
138515140|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138515141|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515142|NCT00063830|Alicaforsen|alicaforsen|mesh-list
138515143|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515144|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515145|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
138515146|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212202|NCT00531518|Bupropion|bupropion|mesh-list
138212203|NCT00531518|Fluoxetine|fluoxetine|mesh-list
138212204|NCT00531518|Sertraline|sertraline|mesh-list
138212205|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138212207|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212208|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138212209|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138212210|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212211|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212212|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
138212213|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212214|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212215|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138212216|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138212217|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212218|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138515147|NCT00062816|Ribavirin|ribavirin|mesh-list
138515148|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
138515149|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515150|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
138515151|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515152|NCT00048113|Alicaforsen|alicaforsen|mesh-list
138515153|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515154|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212252|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138212253|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
138212254|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
138212255|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212256|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212257|NCT01658436|Dactolisib|dactolisib|mesh-list
138212258|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212260|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138212261|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212262|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212263|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212264|NCT05168280|Analgesics|analgesics|mesh-ancestor
138212265|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
138212266|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212267|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138212268|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138212269|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138212270|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212271|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212276|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
138515155|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
138515156|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409212|NCT01613469|Leucovorin|leucovorin|mesh-list
138515158|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138515159|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
138515160|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515161|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515162|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138515163|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138515164|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
138515165|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515166|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515167|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
138515168|NCT00001832|Fludarabine|fludarabine|mesh-list
138515169|NCT00001832|Interleukin-2|interleukin-2|mesh-list
138515170|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138515171|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515172|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
138515173|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515174|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515175|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138212306|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212307|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
138212308|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138212309|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138212310|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138212311|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138212312|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
138212313|NCT03463460|Sunitinib|sunitinib|mesh-list
138212314|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212325|NCT00535652|Ertapenem|ertapenem|mesh-list
138515176|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
138515177|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515178|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515179|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515180|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515181|NCT00001832|Analgesics|analgesics|mesh-ancestor
138515182|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
138515183|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515184|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138515186|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515187|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515188|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
138515189|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
138515190|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
138515191|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515192|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515193|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515194|NCT01466127|Oxytocin|oxytocin|mesh-list
138515195|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
138515196|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138515197|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515198|NCT00009191|Sertraline|sertraline|mesh-list
138515199|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212352|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138212353|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138212354|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138212355|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212356|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212357|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212359|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
138212360|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
138212361|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138212362|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138212363|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212364|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
138212366|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138515200|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515201|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138515202|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409284|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
138515203|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515204|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515205|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515206|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
138212392|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212393|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515207|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515208|NCT01466088|Donepezil|donepezil|mesh-list
138515209|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138212395|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138212396|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138212397|NCT00471380|Timolol|timolol|mesh-list
138212398|NCT00471380|Travoprost|travoprost|mesh-list
138212399|NCT00471380|Dorzolamide|dorzolamide|mesh-list
138212400|NCT00471380|Brinzolamide|brinzolamide|mesh-list
138212401|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138212402|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138212403|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212404|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212405|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212406|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212407|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138212408|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138212409|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138212410|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212412|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138212413|NCT00538850|Narcotics|narcotics|mesh-ancestor
138212414|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212415|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212416|NCT00538850|Analgesics|analgesics|mesh-ancestor
138212417|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
138212418|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515211|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515212|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
138212431|NCT00418574|Abagovomab|abagovomab|mesh-list
138212432|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515213|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515214|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515215|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
138515216|NCT00009230|Celecoxib|celecoxib|mesh-list
138212433|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212434|NCT00473642|Ranibizumab|ranibizumab|mesh-list
138515217|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138515218|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515219|NCT00009230|Analgesics|analgesics|mesh-ancestor
138212435|NCT00473642|Verteporfin|verteporfin|mesh-list
138212436|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138212437|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138212438|NCT00473642|Growth Substances|growth substances|mesh-ancestor
138212439|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212440|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
138212441|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212442|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138212443|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212445|NCT00539942|Fondaparinux|fondaparinux|mesh-list
138212446|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138212447|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
138212448|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138212449|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
138212450|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212451|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212452|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
138212453|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138212454|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138212455|NCT00419666|Calcitriol|calcitriol|mesh-list
138515220|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
138515221|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515222|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515223|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515224|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515225|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138515226|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138515227|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515228|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515229|NCT00009581|Acetylcholine|acetylcholine|mesh-list
138515230|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
138515231|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138515232|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
138212475|NCT00540722|Protective Agents|protective agents|mesh-ancestor
138212476|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212477|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138212478|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
138212479|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212480|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138212481|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138212482|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138212483|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138212484|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
138212485|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138212486|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
138212487|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515233|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515234|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515235|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515236|NCT00009620|Phenobarbital|phenobarbital|mesh-list
138515237|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
138515238|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138515239|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515240|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515241|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138515242|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138515243|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515244|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515245|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
138515246|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
138515247|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138515248|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138515249|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138515250|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
138515251|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138212526|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138212527|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
138212528|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212529|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212530|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212531|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212532|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212533|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212534|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212535|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138212536|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
138212537|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
138212538|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
138212539|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515252|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
138515253|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138515254|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515255|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138515256|NCT00009698|Aldesleukin|aldesleukin|mesh-list
138515257|NCT00009698|Interleukin-2|interleukin-2|mesh-list
138515258|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212566|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212567|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515259|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515260|NCT00009698|Analgesics|analgesics|mesh-ancestor
138515261|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
138409386|NCT01614301|Pioglitazone|pioglitazone|mesh-list
138515262|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515263|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515264|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138515265|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138515266|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
138515267|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515268|NCT01465893|Vitamin D|vitamin d|mesh-list
138212568|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
138515269|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
138212569|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212570|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212571|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138212572|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
138212573|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212574|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212575|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
138212576|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212577|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212578|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212579|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138212580|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212581|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138515270|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
138515271|NCT01465893|Vitamins|vitamins|mesh-list
138515272|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
138515273|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515274|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138515275|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515276|NCT00009776|Cyclosporine|cyclosporine|mesh-list
138515277|NCT00009776|Paclitaxel|paclitaxel|mesh-list
138515278|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138212607|NCT00544778|Razoxane|razoxane|mesh-list
138515279|NCT00009776|Antibodies|antibodies|mesh-list
138515280|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
138515281|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138515282|NCT00009776|Cyclosporins|cyclosporins|mesh-list
138515283|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515284|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697750|NCT04644029|Tenofovir|tenofovir|mesh-list
138515285|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515286|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515287|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
138212608|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138212609|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212610|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138212611|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138212612|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212613|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212614|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138212615|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212616|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138212617|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
138212618|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138212619|NCT00544778|Protective Agents|protective agents|mesh-ancestor
138212620|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138212621|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138212622|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
138212623|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212624|NCT00486824|Indomethacin|indomethacin|mesh-list
138212625|NCT00486824|Nifedipine|nifedipine|mesh-list
138212626|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138212627|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212628|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212629|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212630|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212631|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
138515288|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515289|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
138515290|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515291|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515292|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515293|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
138515294|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515295|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138515296|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515297|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138515298|NCT00009815|Leucovorin|leucovorin|mesh-list
138515299|NCT00009815|Etoposide|etoposide|mesh-list
138515300|NCT00009815|Tegafur|tegafur|mesh-list
138515301|NCT00009815|Calcium|calcium|mesh-list
138409454|NCT01614496|Insulin|insulin|mesh-list
138515302|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
138515303|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515304|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515305|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515306|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515307|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515308|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138515309|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515310|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515311|NCT00009815|Antidotes|antidotes|mesh-ancestor
138515312|NCT00009815|Protective Agents|protective agents|mesh-ancestor
138515313|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
138515314|NCT00009815|Vitamins|vitamins|mesh-ancestor
138515315|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
138515316|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515317|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
138515318|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138515319|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515320|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138515321|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515322|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212694|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212695|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212696|NCT00550394|Topiramate|topiramate|mesh-list
138212697|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138212698|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212699|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212700|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212701|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212702|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212703|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212704|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
138212705|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138212706|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138212707|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138212708|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212709|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
138212710|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138212711|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212712|NCT00492206|Cetuximab|cetuximab|mesh-list
138212713|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212714|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212715|NCT00431132|Estradiol|estradiol|mesh-list
138212720|NCT00493064|Niacin|niacin|mesh-list
138515323|NCT00009854|Ethanol|ethanol|mesh-list
138515324|NCT00009854|Carmustine|carmustine|mesh-list
138515325|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138515326|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515327|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515328|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515329|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515330|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
138515331|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515332|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515334|NCT00009893|Gemcitabine|gemcitabine|mesh-list
138515335|NCT00009893|Fluorouracil|fluorouracil|mesh-list
138515336|NCT00009893|Calcium|calcium|mesh-list
138515337|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
138212736|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515338|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515339|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
138515340|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515341|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212737|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
138212739|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212740|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515342|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212741|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138212742|NCT00493064|Protective Agents|protective agents|mesh-ancestor
138212743|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138212745|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212746|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138212747|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
138212748|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
138212749|NCT00493064|Vitamins|vitamins|mesh-ancestor
138212750|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
138212751|NCT00552422|Domperidone|domperidone|mesh-list
138212752|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
138212753|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
138212754|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212755|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212756|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212757|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138212761|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
138515343|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515344|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515345|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
138515346|NCT00009893|Antidotes|antidotes|mesh-ancestor
138515347|NCT00009893|Protective Agents|protective agents|mesh-ancestor
138515348|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
138515349|NCT00009893|Vitamins|vitamins|mesh-ancestor
138515350|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
138515351|NCT00009971|Fenretinide|fenretinide|mesh-list
138515352|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515353|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138515354|NCT00009971|Protective Agents|protective agents|mesh-ancestor
138515355|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515356|NCT00010010|Exemestane|exemestane|mesh-list
138515357|NCT00010010|Goserelin|goserelin|mesh-list
138515358|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515359|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138515360|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138515361|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515362|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515363|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138515364|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
138515365|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515366|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515367|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138409508|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
138409516|NCT01615107|Oxytocin|oxytocin|mesh-list
138515368|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
138515369|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515370|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138515371|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515372|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515373|NCT00010088|Leucovorin|leucovorin|mesh-list
138212777|NCT00433550|Irinotecan|irinotecan|mesh-list
138212778|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212779|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
138212780|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212781|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212782|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138212783|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138212784|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515374|NCT00010088|Gemcitabine|gemcitabine|mesh-list
138515375|NCT00010088|Fluorouracil|fluorouracil|mesh-list
138515376|NCT00010088|Calcium|calcium|mesh-list
138515377|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
138515378|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515379|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
138515380|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515381|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515382|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515383|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515384|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515385|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
138515386|NCT00010088|Antidotes|antidotes|mesh-ancestor
138515387|NCT00010088|Protective Agents|protective agents|mesh-ancestor
138515388|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
138515389|NCT00010088|Vitamins|vitamins|mesh-ancestor
138515390|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
138515391|NCT01465503|Heparin|heparin|mesh-list
138212812|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
138212813|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212814|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212815|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138212816|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138212818|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138212819|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
138212821|NCT03007927|Dexamethasone|dexamethasone|mesh-list
138212822|NCT03007927|Bupivacaine|bupivacaine|mesh-list
138212823|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212824|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
138212825|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
138212826|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212827|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515392|NCT01465503|Calcium heparin|calcium heparin|mesh-list
138515393|NCT01465503|Hirudins|hirudins|mesh-list
138515394|NCT01465503|Bivalirudin|bivalirudin|mesh-list
138212860|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138515395|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
138515396|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138515397|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138515398|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515399|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
138697791|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138212861|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138212862|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138212863|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138212864|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
138212865|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212866|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212867|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212868|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138212869|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138212870|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212871|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212873|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
138212874|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212875|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212877|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212878|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138515400|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138515401|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
138515402|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515403|NCT00010166|Gemcitabine|gemcitabine|mesh-list
138515404|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515405|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
138515406|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515407|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515408|NCT01465152|Metformin|metformin|mesh-list
138515409|NCT01465152|Repaglinide|repaglinide|mesh-list
138212909|NCT00555464|Protective Agents|protective agents|mesh-ancestor
138212910|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
138212911|NCT01795976|Fludarabine|fludarabine|mesh-list
138212912|NCT01795976|Interleukin-2|interleukin-2|mesh-list
138212913|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212914|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
138212915|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212916|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515410|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138515411|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515413|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
138515414|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
138515415|NCT01465113|Vitamins|vitamins|mesh-list
138515416|NCT01465113|Metformin|metformin|mesh-list
138515417|NCT01465113|Omeprazole|omeprazole|mesh-list
138515418|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
138515419|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212970|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138212971|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138515420|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138515421|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138515422|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515423|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138515424|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515425|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138515426|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515427|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515428|NCT01465074|Nicotine|nicotine|mesh-list
138515429|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138212972|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212973|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212974|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138212975|NCT00500240|Insulin|insulin|mesh-list
138212976|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138212977|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
138212978|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
138212979|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138212980|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212981|NCT01469767|Fluocinonide|fluocinonide|mesh-list
138212982|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212983|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
138212984|NCT01469767|Hormones|hormones|mesh-ancestor
138212985|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212986|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212987|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138212988|NCT03246620|Diazepam|diazepam|mesh-list
138515430|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
138515431|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515432|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515433|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138515434|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138515435|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138515436|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515437|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515438|NCT00010283|Beclomethasone|beclomethasone|mesh-list
138213008|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
138213009|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138213010|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138213011|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
138213012|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138213013|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138213014|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138213015|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138213016|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138213019|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
138213020|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
138515439|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515440|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
138515441|NCT00010283|Hormones|hormones|mesh-ancestor
138515442|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515443|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515444|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138515446|NCT00010322|Toremifene|toremifene|mesh-list
138515447|NCT00010322|Atamestane|atamestane|mesh-list
138213067|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213068|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138213069|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
138213070|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213071|NCT05079126|Protective Agents|protective agents|mesh-ancestor
138213072|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213073|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138213074|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213075|NCT05140278|Artesunate|artesunate|mesh-list
138515448|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138515449|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515450|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138515451|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138515452|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
138515453|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515454|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213130|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515455|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138515456|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515457|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515459|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
138515460|NCT00010361|Fludarabine|fludarabine|mesh-list
138515461|NCT00010361|Cyclosporins|cyclosporins|mesh-list
138515462|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515463|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515464|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515465|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
138515466|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213131|NCT01486615|Protective Agents|protective agents|mesh-ancestor
138213132|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213133|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213134|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138213135|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138213136|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138213137|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213138|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
138515467|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515468|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
138515469|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515470|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138515471|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515472|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138515473|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138515474|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138515475|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
138515476|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515477|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
138515478|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515479|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
138515480|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515481|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515482|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515483|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
138515484|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515485|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213176|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213177|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213178|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138213179|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138213180|NCT05021094|Estradiol|estradiol|mesh-list
138213181|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138213183|NCT05021094|Estrogens|estrogens|mesh-ancestor
138213184|NCT05021094|Hormones|hormones|mesh-ancestor
138213185|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213186|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213187|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138213188|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
138213189|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138213191|NCT05021094|Progestins|progestins|mesh-ancestor
138515486|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515488|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515489|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515490|NCT01464801|Resveratrol|resveratrol|mesh-list
138515491|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
138515492|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515493|NCT01464801|Protective Agents|protective agents|mesh-ancestor
138515494|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515496|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138213218|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
138213219|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138213220|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138213221|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138213222|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
138515497|NCT01464762|Bedaquiline|bedaquiline|mesh-list
138515498|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
138515499|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515500|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515501|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
138515502|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
138515503|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515504|NCT01464723|Ranibizumab|ranibizumab|mesh-list
138213279|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
138213280|NCT00509288|Fludarabine|fludarabine|mesh-list
138213282|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
138213283|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213284|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213285|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213286|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
138213287|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213288|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213289|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213290|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138213291|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138213292|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
138213293|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213294|NCT00442364|Polidocanol|polidocanol|mesh-list
138213295|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138213297|NCT00510224|Octreotide|octreotide|mesh-list
138515505|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138515506|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138515507|NCT01464723|Growth Substances|growth substances|mesh-ancestor
138515508|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213333|NCT00445484|Growth Substances|growth substances|mesh-ancestor
138515509|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515510|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515511|NCT01464606|Dactinomycin|dactinomycin|mesh-list
138515512|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
138515514|NCT01464606|Doxorubicin|doxorubicin|mesh-list
138515515|NCT01464606|Vincristine|vincristine|mesh-list
138515516|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515517|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
138515518|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515519|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515520|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515521|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
138515522|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515523|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515524|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515525|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138515526|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515527|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138457927|NCT01930318|Parecoxib|parecoxib|mesh-list
138515529|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515530|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515531|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515532|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515533|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515534|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213334|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
138213335|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213336|NCT01495585|Lonafarnib|lonafarnib|mesh-list
138213337|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213338|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213339|NCT00446264|Sirolimus|sirolimus|mesh-list
138213340|NCT00446264|Tacrolimus|tacrolimus|mesh-list
138213341|NCT00446264|Daclizumab|daclizumab|mesh-list
138213342|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213343|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
138213344|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213355|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
138515535|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138515536|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138515537|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
138515538|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138515539|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
138515540|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515541|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
138515542|NCT01464528|Protective Agents|protective agents|mesh-ancestor
138515543|NCT00393744|Amoxicillin|amoxicillin|mesh-list
138515544|NCT00393744|Pristinamycin|pristinamycin|mesh-list
138515545|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515546|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515547|NCT00011297|Gabapentin|gabapentin|mesh-list
138515548|NCT00011297|Lorazepam|lorazepam|mesh-list
138515549|NCT00011297|Analgesics|analgesics|mesh-ancestor
138515550|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
138515551|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213369|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213370|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
138213371|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515552|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515553|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
138213372|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213373|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213376|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213377|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213378|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213379|NCT00512876|Growth Substances|growth substances|mesh-ancestor
138213380|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213381|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
138213382|NCT05127876|Ephedrine|ephedrine|mesh-list
138213383|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
138213384|NCT05127876|Ondansetron|ondansetron|mesh-list
138213385|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
138213386|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
138213387|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409758|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138515555|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138515556|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515557|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515558|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138515559|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138515560|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515561|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213412|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
138213413|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213414|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213415|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213416|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213417|NCT02520726|Sertraline|sertraline|mesh-list
138213418|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
138213419|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213420|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138213421|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213422|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213427|NCT00450242|Lidocaine|lidocaine|mesh-list
138515562|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
138515563|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
138515564|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
138515565|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515566|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138515567|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
138515568|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
138515570|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515571|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515572|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138213464|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138213465|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213466|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213467|NCT05122884|Protective Agents|protective agents|mesh-ancestor
138213468|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213469|NCT00520286|Modafinil|modafinil|mesh-list
138213470|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138213482|NCT01395043|Bupivacaine|bupivacaine|mesh-list
138515573|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138515574|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515575|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515576|NCT00847938|Neostigmine|neostigmine|mesh-list
138515577|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138515578|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515579|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515580|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
138515581|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515582|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697854|NCT04346654|Hormones|hormones|mesh-ancestor
138515583|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138515584|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
138515585|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515586|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
138515587|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138515588|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515589|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515591|NCT00847860|Cilostazol|cilostazol|mesh-list
138515592|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138515593|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515595|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
138515596|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515597|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515598|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515599|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515600|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138515601|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138515602|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515603|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138515604|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138515605|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515607|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138515608|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
138515609|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138515610|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
138515611|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
138515612|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138515613|NCT00847860|Protective Agents|protective agents|mesh-ancestor
138515614|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138213522|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
138213523|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
138213524|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213525|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213526|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
138213527|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213528|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138515615|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138213547|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
138515616|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138515617|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
138515618|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138515619|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
138515620|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515621|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515622|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138515623|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138515624|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138515625|NCT00009932|Paclitaxel|paclitaxel|mesh-list
138515626|NCT00009932|Fenretinide|fenretinide|mesh-list
138515627|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515628|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515629|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515630|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515631|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515632|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515633|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138515634|NCT00009932|Protective Agents|protective agents|mesh-ancestor
138515635|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515636|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
138515637|NCT00847587|Etonogestrel|etonogestrel|mesh-list
138515638|NCT00847587|Desogestrel|desogestrel|mesh-list
138515639|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138515640|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515641|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138515642|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138515643|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138515644|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138515645|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138515646|NCT00847587|Progestins|progestins|mesh-ancestor
138515647|NCT00847587|Hormones|hormones|mesh-ancestor
138213548|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213549|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213550|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213551|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213552|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138213553|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213554|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213557|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213558|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213559|NCT00452426|Analgesics|analgesics|mesh-ancestor
138213560|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
138213561|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213562|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
138515648|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515649|NCT00011765|Fluoxetine|fluoxetine|mesh-list
138515650|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138515651|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138515652|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515653|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515654|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409819|NCT01617135|Levodopa|levodopa|mesh-list
138515655|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
138515656|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515657|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138213575|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213576|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213579|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138213580|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213581|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
138213582|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138213583|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138213584|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213585|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213586|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138213592|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
138515658|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515659|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515660|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138515661|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515662|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515664|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
138515665|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138515666|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515667|NCT00011921|Paclitaxel|paclitaxel|mesh-list
138213625|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138213626|NCT02124512|Rifaximin|rifaximin|mesh-list
138213627|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138213628|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213629|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213630|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
138213631|NCT01504711|Aprepitant|aprepitant|mesh-list
138213632|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
138213633|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
138213634|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213635|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213636|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213637|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138515668|NCT00011921|Etoposide|etoposide|mesh-list
138515669|NCT00011921|Carboplatin|carboplatin|mesh-list
138515670|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
138515671|NCT00011921|Epirubicin|epirubicin|mesh-list
138515672|NCT00011921|Ifosfamide|ifosfamide|mesh-list
138515673|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515674|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515675|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515676|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515677|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515678|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188472|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515679|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515680|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138515681|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515682|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138515683|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515684|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
138515686|NCT00011960|Cisplatin|cisplatin|mesh-list
138515687|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515688|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515689|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515690|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515691|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515692|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515693|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
138515694|NCT00847314|Testosterone|testosterone|mesh-list
138515695|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
138515696|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
138515697|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138515698|NCT00847314|Androgens|androgens|mesh-ancestor
138515699|NCT00847314|Hormones|hormones|mesh-ancestor
138515700|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515701|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515702|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138515703|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515704|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
138515705|NCT00011999|Paclitaxel|paclitaxel|mesh-list
138515706|NCT00011999|Cisplatin|cisplatin|mesh-list
138515707|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515708|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515709|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515710|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515711|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515712|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515713|NCT00012038|Irofulven|irofulven|mesh-list
138515714|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515715|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
138213680|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213681|NCT02125292|Analgesics|analgesics|mesh-ancestor
138213682|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
138213683|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213684|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213685|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213687|NCT01653912|Paclitaxel|paclitaxel|mesh-list
138515716|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515717|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515718|NCT00012116|Temozolomide|temozolomide|mesh-list
138515719|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515720|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
138515721|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515722|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515723|NCT00847119|Bevacizumab|bevacizumab|mesh-list
138515724|NCT00847119|Capecitabine|capecitabine|mesh-list
138515725|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515726|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515727|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138515728|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213702|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138213703|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213704|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213706|NCT02132468|Combretastatin|combretastatin|mesh-list
138213707|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138213708|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213710|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
138213711|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
138213712|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213713|NCT01508455|Midazolam|midazolam|mesh-list
138213714|NCT01508455|Fentanyl|fentanyl|mesh-list
138213715|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
138213716|NCT01508455|Morphine|morphine|mesh-list
138213717|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138213718|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213719|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213720|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213721|NCT01508455|Analgesics|analgesics|mesh-ancestor
138213722|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
138515729|NCT00847119|Growth Substances|growth substances|mesh-ancestor
138515730|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515731|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515732|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515733|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
138515734|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515735|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138515736|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138515737|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515738|NCT00847080|Incretins|incretins|mesh-ancestor
138515739|NCT00847080|Hormones|hormones|mesh-ancestor
138515740|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515741|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138515742|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
138515743|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515744|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515745|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138515746|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515747|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138515748|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515749|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515750|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
138515751|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
138192133|NCT03375385|Propofol|propofol|mesh-list
138515753|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
138515754|NCT00012311|Ifosfamide|ifosfamide|mesh-list
138515755|NCT00012311|Thiotepa|thiotepa|mesh-list
138515756|NCT00012311|Carboplatin|carboplatin|mesh-list
138515757|NCT00012311|Docetaxel|docetaxel|mesh-list
138515758|NCT00012311|Doxorubicin|doxorubicin|mesh-list
138515760|NCT00012311|Fluorouracil|fluorouracil|mesh-list
138515761|NCT00012311|Methotrexate|methotrexate|mesh-list
138515762|NCT00012311|Etoposide|etoposide|mesh-list
138213747|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515763|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515764|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
138213748|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213749|NCT02482428|Imiquimod|imiquimod|mesh-list
138213750|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138213751|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
138213752|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213753|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213755|NCT01510327|Aspirin|aspirin|mesh-list
138515765|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515766|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515767|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138515768|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
138515769|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515770|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515771|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515772|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515773|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138515774|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138515775|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198168|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213781|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138213782|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
138213783|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213784|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138213785|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138213786|NCT01401595|Dexetimide|dexetimide|mesh-list
138213787|NCT01401595|Citalopram|citalopram|mesh-list
138213788|NCT01401595|Escitalopram|escitalopram|mesh-list
138213789|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138213790|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213791|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213792|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213793|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213794|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
138515776|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515777|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138515778|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515779|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
138515780|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138515781|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138457977|NCT01930552|Antidotes|antidotes|mesh-ancestor
138515782|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
138515783|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138515784|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
138515786|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138515787|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138515788|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138515789|NCT00847002|Laxatives|laxatives|mesh-ancestor
138515790|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515792|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515793|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138515794|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138515795|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515796|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
138515797|NCT00012389|Irinotecan|irinotecan|mesh-list
138515798|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515799|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138515800|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138515801|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515802|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213828|NCT00115700|Prednisolone|prednisolone|mesh-list
138213829|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
138213830|NCT00115700|Rituximab|rituximab|mesh-list
138213831|NCT00115700|Vincristine|vincristine|mesh-list
138213832|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213833|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
138213834|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213835|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213836|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213837|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
138213838|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213839|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515803|NCT00846885|Sumatriptan|sumatriptan|mesh-list
138515804|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138515805|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138515806|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138515807|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
138515808|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515809|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515810|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515811|NCT00012467|Interferons|interferons|mesh-list
138515812|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
138515813|NCT00012467|Itraconazole|itraconazole|mesh-list
138515814|NCT00012467|Fluconazole|fluconazole|mesh-list
138515815|NCT00012467|Amphotericin B|amphotericin b|mesh-list
138515816|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138515817|NCT00012467|Flucytosine|flucytosine|mesh-list
138515818|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515819|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
138515820|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515821|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
138213869|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213870|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213871|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213872|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515822|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138213873|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
138213874|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213875|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138213876|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
138213877|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213878|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138213879|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138213880|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213881|NCT01556347|Rituximab|rituximab|mesh-list
138213882|NCT01556347|Bortezomib|bortezomib|mesh-list
138213883|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
138213884|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138213885|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138213886|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138213887|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213888|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
138213889|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515823|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515824|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515825|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515826|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138515827|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410022|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
138515828|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515829|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515830|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138515831|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138213890|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213891|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213892|NCT00561002|Vaccines|vaccines|mesh-list
138213893|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
138213894|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213895|NCT03236792|Dexamethasone|dexamethasone|mesh-list
138213896|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
138213897|NCT03236792|Ixazomib|ixazomib|mesh-list
138213898|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213899|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
138213900|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213901|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213908|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
138515832|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138213942|NCT00562328|Rituximab|rituximab|mesh-list
138213943|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
138213944|NCT00562328|Sargramostim|sargramostim|mesh-list
138213945|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515833|NCT00012467|Amebicides|amebicides|mesh-ancestor
138515834|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138515835|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138515836|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138515837|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
138515838|NCT00012506|Etanercept|etanercept|mesh-list
138697961|NCT03919955|Oxybutynin|oxybutynin|mesh-list
138515839|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138515840|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515841|NCT00012506|Analgesics|analgesics|mesh-ancestor
138515842|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
138515843|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515844|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515845|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138515846|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213946|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213947|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
138213948|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213949|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213950|NCT01514149|Metformin|metformin|mesh-list
138213951|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138213952|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213953|NCT05566093|Ethanol|ethanol|mesh-list
138213954|NCT05566093|Polidocanol|polidocanol|mesh-list
138213955|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138213956|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213957|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213958|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213959|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138213960|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138213963|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
138515847|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198169|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
138515848|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138515849|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
138515850|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
138515851|NCT00012584|Methylphenidate|methylphenidate|mesh-list
138515852|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138515853|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515854|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138515855|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138515856|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515857|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515858|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
138410058|NCT01618474|Docetaxel|docetaxel|mesh-list
138515859|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515860|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138515861|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138515862|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515863|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515864|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138515865|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
138515866|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138515867|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515868|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138515869|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515870|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515871|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138515873|NCT00846690|Phenylephrine|phenylephrine|mesh-list
138515874|NCT00846690|Benzocaine|benzocaine|mesh-list
138515875|NCT00846690|Tetracaine|tetracaine|mesh-list
138515876|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138515877|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
138213985|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
138213986|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213987|NCT01519063|Naltrexone|naltrexone|mesh-list
138213988|NCT01519063|Memantine|memantine|mesh-list
138213989|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138213990|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138213991|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213992|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
138213993|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213994|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138213995|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138213996|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
138213997|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213998|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214000|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138515878|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214014|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138214015|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
138515879|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515880|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
138515881|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515882|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138515883|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138515884|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138515885|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515886|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515887|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138214016|NCT00634166|Amebicides|amebicides|mesh-ancestor
138515888|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
138214017|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138214018|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138214019|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138214020|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138214021|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515889|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
138515891|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138214071|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214073|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
138515892|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
138515893|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
138515894|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138515895|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138410097|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138515896|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138515897|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
138515898|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515899|NCT00846690|Protective Agents|protective agents|mesh-ancestor
138515900|NCT00846651|Phenylephrine|phenylephrine|mesh-list
138515901|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
138515902|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138515903|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
138515904|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
138515905|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515906|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515907|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
138515908|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138515909|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
138515910|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
138515911|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138515912|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138214074|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515913|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138214075|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214076|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138214077|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138214078|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214081|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138214082|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138214083|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214084|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214085|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515914|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138214110|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
138515915|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515916|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515917|NCT00846651|Protective Agents|protective agents|mesh-ancestor
138515918|NCT00846612|Bevacizumab|bevacizumab|mesh-list
138515919|NCT00846612|Doxorubicin|doxorubicin|mesh-list
138515920|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138515921|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138515922|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214111|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214112|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214113|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214114|NCT00567008|Varenicline|varenicline|mesh-list
138214115|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138214116|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138214117|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214118|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214119|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214120|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214121|NCT00567320|Varenicline|varenicline|mesh-list
138214122|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138214123|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138214124|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214125|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214126|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214127|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214129|NCT01522417|Eptifibatide|eptifibatide|mesh-list
138214130|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138214131|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138214133|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138515923|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138515924|NCT00846612|Growth Substances|growth substances|mesh-ancestor
138515925|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515926|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515927|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138515928|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138515929|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138515930|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515931|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515932|NCT00012857|Acetaminophen|acetaminophen|mesh-list
138515933|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138515934|NCT00012857|Analgesics|analgesics|mesh-ancestor
138515935|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
138515936|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515937|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515938|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
138515940|NCT00394056|Vestipitant|vestipitant|mesh-list
138515941|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138214156|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
138214157|NCT05533580|Sufentanil|sufentanil|mesh-list
138214158|NCT05533580|Dsuvia|dsuvia|mesh-list
138214159|NCT05533580|Propofol|propofol|mesh-list
138214160|NCT05533580|Cisatracurium|cisatracurium|mesh-list
138214162|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138214163|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214164|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214165|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138214166|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
138214167|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
138515942|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138515943|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515944|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515945|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515946|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
138515947|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515948|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138515949|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515950|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515951|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138515952|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515953|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515954|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138214207|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214208|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
138214209|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
138214210|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
138515955|NCT00846339|Bupropion|bupropion|mesh-list
138214211|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138214212|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214213|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214214|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138214215|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138515956|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138515957|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515958|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515959|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138515960|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138515961|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138515962|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515963|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
138515964|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515965|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214262|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138214263|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214264|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214265|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138214266|NCT01528891|Analgesics|analgesics|mesh-ancestor
138214267|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
138214268|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214269|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138214270|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138214271|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138214272|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138214273|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214274|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214275|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
138214276|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138214277|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138515966|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138515967|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138515968|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410168|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138515970|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
138515971|NCT00846144|Trace Elements|trace elements|mesh-ancestor
138515972|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
138515973|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515974|NCT00846144|Antidotes|antidotes|mesh-ancestor
138515976|NCT00846144|Emetics|emetics|mesh-ancestor
138515977|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
138515978|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138515979|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138515980|NCT00845988|Aripiprazole|aripiprazole|mesh-list
138515981|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
138515982|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138515983|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138515984|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138515985|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138515986|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138515987|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
138515988|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
138515989|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515990|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515991|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138515992|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138515993|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
138515994|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138515995|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138515996|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138515997|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138515998|NCT00845910|Bevacizumab|bevacizumab|mesh-list
138515999|NCT00845910|Docetaxel|docetaxel|mesh-list
138516000|NCT00845910|Capecitabine|capecitabine|mesh-list
138516001|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138516002|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214308|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138214309|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138214310|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
138214311|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138214312|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214313|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214314|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
138214315|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138214316|NCT01571557|Dexamethasone|dexamethasone|mesh-list
138214317|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214318|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
138214319|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
138214324|NCT01571557|Hormones|hormones|mesh-ancestor
138516003|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516004|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516005|NCT00845910|Growth Substances|growth substances|mesh-ancestor
138516006|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516007|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516008|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516009|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516010|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516011|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516012|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516013|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
138516014|NCT00680628|Enoxaparin|enoxaparin|mesh-list
138516015|NCT00680628|Tenecteplase|tenecteplase|mesh-list
138516016|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
138516017|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
138516018|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138458030|NCT01930773|Clopidogrel|clopidogrel|mesh-list
138214335|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
138214336|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138214337|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214338|NCT00572468|Simvastatin|simvastatin|mesh-list
138214339|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138214340|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138214341|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
138214342|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214343|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138214344|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138214345|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214346|NCT02339246|Tacrolimus|tacrolimus|mesh-list
138214347|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214348|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
138214349|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516019|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138516020|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516022|NCT00013520|Zidovudine|zidovudine|mesh-list
138516023|NCT00013520|Efavirenz|efavirenz|mesh-list
138516024|NCT00013520|Nevirapine|nevirapine|mesh-list
138516025|NCT00013520|Abacavir|abacavir|mesh-list
138516026|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
138516027|NCT00013520|Didanosine|didanosine|mesh-list
138516028|NCT00013520|Stavudine|stavudine|mesh-list
138516029|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138516030|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138214378|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
138214379|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214380|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138214382|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214383|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214384|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138214385|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138214387|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138214388|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214389|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
138214390|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
138214391|NCT00576680|Temozolomide|temozolomide|mesh-list
138214393|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214394|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
138214395|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214396|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214397|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138214398|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214399|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214400|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214401|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
138214402|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214403|NCT04866602|Atovaquone|atovaquone|mesh-list
138214404|NCT04866602|Proguanil|proguanil|mesh-list
138214405|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138214406|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214407|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
138214408|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138214409|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138516031|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138516032|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138516033|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516034|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516035|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
138516036|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516037|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516038|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516039|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
138214417|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214418|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138214419|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
138214420|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214421|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138214422|NCT00578552|Gabapentin|gabapentin|mesh-list
138214423|NCT00578552|Analgesics|analgesics|mesh-ancestor
138214424|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
138214425|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214426|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214427|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
138214428|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138214429|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138214430|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214431|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214432|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138214433|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138214434|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214435|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214437|NCT01532089|Bevacizumab|bevacizumab|mesh-list
138214438|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138214439|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138214440|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
138214441|NCT01532089|Antibodies|antibodies|mesh-list
138214443|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138516040|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138516041|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138516042|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138516043|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138516044|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138516045|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138214459|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214460|NCT05246072|Ivermectin|ivermectin|mesh-list
138214461|NCT05246072|Colchicine|colchicine|mesh-list
138214462|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
138214463|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214464|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138214465|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214466|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214467|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214468|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214469|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138214470|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214471|NCT02135432|Ivacaftor|ivacaftor|mesh-list
138214472|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138214473|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214474|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214475|NCT05245994|Carboplatin|carboplatin|mesh-list
138214476|NCT05245994|Etoposide|etoposide|mesh-list
138214477|NCT05245994|Durvalumab|durvalumab|mesh-list
138214478|NCT05245994|Olaparib|olaparib|mesh-list
138214479|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516046|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138516047|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138214509|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138516048|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
138516049|NCT00013598|Pioglitazone|pioglitazone|mesh-list
138410240|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516050|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138516051|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516052|NCT00277017|Interferons|interferons|mesh-list
138516053|NCT00277017|Thalidomide|thalidomide|mesh-list
138214510|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214511|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214512|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138214513|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214514|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214515|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
138214516|NCT00581048|Vitamin E|vitamin e|mesh-list
138214517|NCT00581048|Tocopherols|tocopherols|mesh-list
138214518|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
138214519|NCT00581048|Vitamins|vitamins|mesh-ancestor
138214520|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
138214521|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214522|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
138214523|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214524|NCT00581048|Protective Agents|protective agents|mesh-ancestor
138214525|NCT01798472|Cimetidine|cimetidine|mesh-list
138516054|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516055|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
138516056|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516057|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516058|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
138516059|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516060|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
138516061|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138214560|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214561|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214562|NCT05121350|Epirubicin|epirubicin|mesh-list
138214563|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138214564|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214565|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138214566|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138214567|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214568|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214569|NCT00583622|Bevacizumab|bevacizumab|mesh-list
138214570|NCT00583622|Carboplatin|carboplatin|mesh-list
138214571|NCT00583622|Gemcitabine|gemcitabine|mesh-list
138214572|NCT00583622|Docetaxel|docetaxel|mesh-list
138214573|NCT00583622|Melphalan|melphalan|mesh-list
138214575|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214616|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214617|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214619|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214620|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214622|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138214623|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138214624|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138214625|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
138516062|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516063|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516064|NCT00277017|Growth Substances|growth substances|mesh-ancestor
138516065|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516066|NCT00276978|Aripiprazole|aripiprazole|mesh-list
138516067|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
138516068|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138516069|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138516070|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138516071|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516072|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516073|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
138516074|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
138214675|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138516075|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516076|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410276|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516077|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138516078|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138516079|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
138516080|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138516081|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138516082|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138214738|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138214739|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214740|NCT02138006|Insulin|insulin|mesh-list
138214741|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138214742|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138214743|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214744|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
138214745|NCT04545008|Famotidine|famotidine|mesh-list
138214746|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138516083|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138516085|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138214802|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138214803|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138214804|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
138516086|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138516087|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138516088|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138516089|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214805|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
138516090|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516091|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516092|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
138214806|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214807|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214808|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
138214809|NCT00668564|Busulfan|busulfan|mesh-list
138214810|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
138214811|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516093|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214859|NCT00670982|Vinorelbine|vinorelbine|mesh-list
138214860|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138516094|NCT00276861|Gemcitabine|gemcitabine|mesh-list
138516095|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
138516096|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516097|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
138516098|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516099|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516100|NCT00013871|Vaccines|vaccines|mesh-list
138214861|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516101|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138214862|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214863|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138214864|NCT00670982|Growth Substances|growth substances|mesh-ancestor
138214865|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214866|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214867|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214868|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
138214869|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214870|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214871|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214873|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138214874|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214875|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138214876|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138214877|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214878|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214879|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138214880|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
138214884|NCT00612716|Busulfan|busulfan|mesh-list
138516102|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
138516103|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516104|NCT00276783|Pemetrexed|pemetrexed|mesh-list
138516105|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516106|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516107|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516108|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138516109|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138410324|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516110|NCT00276705|Thalidomide|thalidomide|mesh-list
138214903|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214904|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214905|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138214906|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138214907|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214908|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214909|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214910|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
138214911|NCT01799798|Denosumab|denosumab|mesh-list
138214912|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138214913|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214914|NCT00614198|Caseins|caseins|mesh-list
138214915|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
138214916|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
138214917|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214918|NCT00616772|Choline|choline|mesh-list
138214919|NCT00616772|Atorvastatin|atorvastatin|mesh-list
138214920|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
138214921|NCT00616772|Fenofibrate|fenofibrate|mesh-list
138214922|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138516111|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
138516112|NCT00276705|Doxorubicin|doxorubicin|mesh-list
138516113|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138214949|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214950|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516114|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516115|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
138516116|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516117|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516118|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516119|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
138214951|NCT00673712|Analgesics|analgesics|mesh-ancestor
138214952|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
138214953|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214954|NCT04062032|Aspirin|aspirin|mesh-list
138214955|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138214957|NCT04062032|Analgesics|analgesics|mesh-ancestor
138214958|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
138214959|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214960|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214961|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214962|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214963|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138214968|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215001|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138215002|NCT03001609|Abivertinib|abivertinib|mesh-list
138215003|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215004|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215005|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215006|NCT03007381|Ketorolac|ketorolac|mesh-list
138215007|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138215010|NCT03007381|Analgesics|analgesics|mesh-ancestor
138516120|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516121|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516122|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138516123|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516124|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516125|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516126|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516127|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
138516128|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138516129|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516130|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215061|NCT01585441|Urological Agents|urological agents|mesh-ancestor
138215062|NCT00617942|Paclitaxel|paclitaxel|mesh-list
138215063|NCT00617942|Carboplatin|carboplatin|mesh-list
138215064|NCT00617942|Trastuzumab|trastuzumab|mesh-list
138215065|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138215066|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215067|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
138215068|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
138215069|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215070|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215071|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215072|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
138215073|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516131|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516132|NCT00276705|Growth Substances|growth substances|mesh-ancestor
138516133|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516135|NCT00276666|Lomustine|lomustine|mesh-list
138516136|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516137|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516138|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516139|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516140|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516141|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516142|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516144|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138516145|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
138516146|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138516147|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
138516148|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516149|NCT00014105|Carboplatin|carboplatin|mesh-list
138516150|NCT00014105|Temozolomide|temozolomide|mesh-list
138516151|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516152|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516153|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
138516154|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215114|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138215115|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215116|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215118|NCT00619970|Lactulose|lactulose|mesh-list
138215119|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215120|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138215121|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215123|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
138215124|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215125|NCT01592851|Fluorides|fluorides|mesh-list
138215126|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
138215127|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
138215128|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
138215131|NCT00675584|Budesonide|budesonide|mesh-list
138516155|NCT00014144|Gefitinib|gefitinib|mesh-list
138516156|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516157|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516158|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516159|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516160|NCT00276588|Paclitaxel|paclitaxel|mesh-list
138516161|NCT00276588|Carboplatin|carboplatin|mesh-list
138516162|NCT00276588|Gemcitabine|gemcitabine|mesh-list
138516163|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516164|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516166|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516167|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516168|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516169|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516170|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
138516171|NCT00276549|Gemcitabine|gemcitabine|mesh-list
138516172|NCT00276549|Docetaxel|docetaxel|mesh-list
138516173|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516174|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
138516175|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516176|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516177|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516178|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516179|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516180|NCT00014183|Gefitinib|gefitinib|mesh-list
138516181|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215157|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138215158|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138215159|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215160|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215161|NCT00676676|Testosterone|testosterone|mesh-list
138516182|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516183|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516184|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516185|NCT00014261|Interferons|interferons|mesh-list
138516186|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
138516187|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
138516188|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138516189|NCT00014261|Temozolomide|temozolomide|mesh-list
138516190|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516191|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
138516192|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215201|NCT00678470|Alefacept|alefacept|mesh-list
138215202|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215203|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
138215204|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215205|NCT00623012|Sirolimus|sirolimus|mesh-list
138215206|NCT00623012|Tacrolimus|tacrolimus|mesh-list
138215207|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516193|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516194|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
138516195|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516196|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
138215261|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215262|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
138215263|NCT00624416|Hormones|hormones|mesh-ancestor
138215264|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215265|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516197|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516198|NCT00014339|Prednisone|prednisone|mesh-list
138516199|NCT00014339|Melphalan|melphalan|mesh-list
138516200|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516201|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
138215266|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215267|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215268|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
138215269|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
138215270|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215271|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215272|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138215273|NCT00624416|Protective Agents|protective agents|mesh-ancestor
138215274|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138215275|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138215276|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215282|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138516203|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516204|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516205|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138516206|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516207|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516208|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
138516209|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516210|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138516211|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516212|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
138516213|NCT00014456|Gemcitabine|gemcitabine|mesh-list
138516214|NCT00014456|Docetaxel|docetaxel|mesh-list
138516215|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516216|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
138516217|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215312|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215313|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215314|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215315|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
138215316|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
138215317|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215318|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215319|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138215320|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138516220|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516221|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516222|NCT00276393|Insulin|insulin|mesh-list
138516223|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138516224|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516225|NCT00014534|Gemcitabine|gemcitabine|mesh-list
138516226|NCT00014534|Doxorubicin|doxorubicin|mesh-list
138516227|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138516228|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516229|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516230|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
138516231|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516232|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516233|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516234|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516235|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516236|NCT00014573|Aldesleukin|aldesleukin|mesh-list
138516237|NCT00014573|Paclitaxel|paclitaxel|mesh-list
138516238|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
138215362|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215363|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138215364|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215365|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215366|NCT03006445|Dotinurad|dotinurad|mesh-list
138215367|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
138215368|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
138215369|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516239|NCT00014573|Carmustine|carmustine|mesh-list
138516240|NCT00014573|Sargramostim|sargramostim|mesh-list
138516241|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516242|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516243|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516244|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516245|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410415|NCT01620450|Insulin|insulin|mesh-list
138516246|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516247|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138215415|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138215416|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215417|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215418|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138215419|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138215421|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
138215422|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215423|NCT02248207|Protective Agents|protective agents|mesh-ancestor
138215424|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215425|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138215426|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138215427|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
138215428|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
138215467|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138215468|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215469|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
138215470|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516248|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
138516249|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516250|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516251|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516252|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
138516253|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138516254|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516255|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516256|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
138215471|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215472|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215473|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215474|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138215475|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138215476|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138215479|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138516257|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516258|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
138516259|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138516260|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138458099|NCT01931137|Insulin|insulin|mesh-list
138516261|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138516262|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516263|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516264|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
138516265|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516266|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516267|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138516268|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516269|NCT00276276|Topotecan|topotecan|mesh-list
138516270|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138516271|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516272|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516273|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410461|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138516274|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516275|NCT00014651|Vapreotide|vapreotide|mesh-list
138215521|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138215522|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215523|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215571|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215572|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
138215573|NCT00631358|Hormones|hormones|mesh-ancestor
138215574|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215575|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215576|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215577|NCT02248753|Metoprolol|metoprolol|mesh-list
138215578|NCT02248753|Digoxin|digoxin|mesh-list
138516276|NCT00014651|Analgesics|analgesics|mesh-ancestor
138516277|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
138516278|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516279|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516280|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516281|NCT00014690|Topotecan|topotecan|mesh-list
138516282|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138516283|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516284|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516285|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516286|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516287|NCT00014729|Isotretinoin|isotretinoin|mesh-list
138516288|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
138516289|NCT00276198|Vitamin D|vitamin d|mesh-list
138516290|NCT00276198|Vitamin A|vitamin a|mesh-list
138516291|NCT00276198|Vitamins|vitamins|mesh-ancestor
138516292|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
138516293|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516294|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138516296|NCT00276081|Estrogens|estrogens|mesh-list
138516297|NCT00276081|Analgesics|analgesics|mesh-ancestor
138516298|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
138516299|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516300|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516301|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
138215623|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
138516302|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138516303|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215624|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215625|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138215626|NCT00687674|Growth Substances|growth substances|mesh-ancestor
138215627|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516304|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516305|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215628|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215630|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215631|NCT00687908|Adapalene|adapalene|mesh-list
138215632|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138215633|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215635|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215664|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138215665|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138215666|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138215667|NCT05568979|Vaccines|vaccines|mesh-list
138215668|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
138215669|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215670|NCT03005353|Clotrimazole|clotrimazole|mesh-list
138215671|NCT03005353|Miconazole|miconazole|mesh-list
138215672|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138215673|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215685|NCT00588536|Leucovorin|leucovorin|mesh-list
138516306|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138215730|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
138516307|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138516308|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516309|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516310|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
138516311|NCT00276081|Hormones|hormones|mesh-ancestor
138516312|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516313|NCT00276003|Gemcitabine|gemcitabine|mesh-list
138516314|NCT00276003|Irinotecan|irinotecan|mesh-list
138516315|NCT00276003|Allopurinol|allopurinol|mesh-list
138516316|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138215731|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215732|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215733|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138215734|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138215735|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
138215736|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215737|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138215738|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138215739|NCT00592124|Tenofovir|tenofovir|mesh-list
138215740|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
138215741|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215742|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138215743|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138215744|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215745|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215746|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138215747|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516317|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
138516318|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516319|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516320|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138516321|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516322|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516323|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
138516324|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516325|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138516326|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
138516327|NCT00276003|Protective Agents|protective agents|mesh-ancestor
138516328|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516329|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
138516331|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138516332|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138516333|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516334|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516335|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138516336|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138516337|NCT00015041|Buprenorphine|buprenorphine|mesh-list
138516338|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138516339|NCT00015041|Narcotics|narcotics|mesh-ancestor
138516340|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516341|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516342|NCT00015041|Analgesics|analgesics|mesh-ancestor
138215775|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138215776|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215777|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215778|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215780|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215781|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138215782|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215783|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215784|NCT00594308|Cyclosporine|cyclosporine|mesh-list
138215785|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
138215786|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
138215787|NCT00594308|Fludarabine|fludarabine|mesh-list
138215788|NCT00594308|Cyclosporins|cyclosporins|mesh-list
138215789|NCT00594308|Basiliximab|basiliximab|mesh-list
138215790|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138215791|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
138215792|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516343|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
138516344|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516345|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138516346|NCT00015080|Naltrexone|naltrexone|mesh-list
138516347|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138516348|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138516349|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516350|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
138516351|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516352|NCT00015236|Amantadine|amantadine|mesh-list
138516353|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138516354|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138516355|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
138516356|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516357|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
138516358|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516359|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516360|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516361|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138516362|NCT00015236|Analgesics|analgesics|mesh-ancestor
138215808|NCT02137538|Letrozole|letrozole|mesh-list
138215809|NCT02137538|Anastrozole|anastrozole|mesh-list
138215810|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215811|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138215812|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138215813|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215814|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215815|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138215816|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215817|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516363|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
138516364|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516365|NCT00015275|Cocaine|cocaine|mesh-list
138516366|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
138516367|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
138516368|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516369|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516370|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
138516371|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516372|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138516373|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138516374|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138516375|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516376|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516377|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
138215852|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215853|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215854|NCT00597896|Pramipexole|pramipexole|mesh-list
138215855|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
138215856|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215857|NCT00597896|Protective Agents|protective agents|mesh-ancestor
138215858|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215859|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138215860|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138215861|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
138215862|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
138215864|NCT01790282|Estradiol|estradiol|mesh-list
138215865|NCT01790282|Progesterone|progesterone|mesh-list
138215866|NCT01790282|Estrogens|estrogens|mesh-ancestor
138215867|NCT01790282|Hormones|hormones|mesh-ancestor
138215868|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516378|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516379|NCT00275730|Indomethacin|indomethacin|mesh-list
138516380|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138516381|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138516382|NCT00275730|Analgesics|analgesics|mesh-ancestor
138516383|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
138516384|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410578|NCT01621451|Aspirin|aspirin|mesh-list
138516385|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516386|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516387|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516388|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
138516389|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
138516390|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138516391|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138516392|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516393|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516394|NCT00275652|Lamivudine|lamivudine|mesh-list
138516395|NCT00275652|Telbivudine|telbivudine|mesh-list
138516396|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138516397|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138516398|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516399|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516400|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
138516401|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516402|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516403|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516404|NCT00275613|Rituximab|rituximab|mesh-list
138516405|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215900|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215901|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215902|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215903|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138516406|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215904|NCT00692978|Fluticasone|fluticasone|mesh-list
138215906|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215907|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215908|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
138215909|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215910|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215911|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138215912|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138516407|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
138516408|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516409|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516410|NCT00015548|Olanzapine|olanzapine|mesh-list
138516411|NCT00015548|Risperidone|risperidone|mesh-list
138516412|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138516414|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138516415|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
138516416|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516417|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516418|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516419|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138516420|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138516421|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516422|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138516423|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138516424|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
138516425|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
138516426|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
138516427|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516428|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138516429|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138516430|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138516431|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516432|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
138516433|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138516434|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
138516435|NCT00275535|Sirolimus|sirolimus|mesh-list
138516436|NCT00275535|Prednisone|prednisone|mesh-list
138516437|NCT00275535|Tacrolimus|tacrolimus|mesh-list
138516438|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
138516439|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138516440|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516441|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
138516442|NCT00275535|Hormones|hormones|mesh-ancestor
138516443|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516444|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516445|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138516446|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516447|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516448|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
138516449|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138516450|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215934|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
138215935|NCT00601796|Tretinoin|tretinoin|mesh-list
138215936|NCT00601796|Vaccines|vaccines|mesh-list
138215937|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
138215938|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215940|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215941|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516451|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516452|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516453|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138516454|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
138516455|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138516456|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516457|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
138516458|NCT00015626|Metformin|metformin|mesh-list
138516459|NCT00015626|Pioglitazone|pioglitazone|mesh-list
138516460|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
138516461|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138516462|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516463|NCT00015665|Voriconazole|voriconazole|mesh-list
138516464|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
138516465|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516466|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138516467|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138516468|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410717|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138215963|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215964|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138215965|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
138215967|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215968|NCT00603044|Fluticasone|fluticasone|mesh-list
138215970|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215971|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215972|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
138215973|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215974|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215975|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138215976|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
138215977|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215978|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138215979|NCT00646646|Midazolam|midazolam|mesh-list
138215980|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
138215981|NCT00646646|Propofol|propofol|mesh-list
138215982|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138516469|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516470|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138516471|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
138516472|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516473|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516474|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138516476|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
138516477|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516478|NCT00275457|Protective Agents|protective agents|mesh-ancestor
138516479|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216004|NCT02998424|Propofol|propofol|mesh-list
138216005|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138516480|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138516481|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138516482|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
138516483|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
138216006|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216007|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216008|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216009|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
138216010|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
138216011|NCT00696488|Fluorouracil|fluorouracil|mesh-list
138216012|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
138216013|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216014|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216016|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216017|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
138216018|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216019|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
138216026|NCT00650078|Hormones|hormones|mesh-ancestor
138516484|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516485|NCT00015704|Aldesleukin|aldesleukin|mesh-list
138516486|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516487|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516488|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516489|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
138516490|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516491|NCT00275418|Beta Carotene|beta carotene|mesh-list
138516492|NCT00275418|Carotenoids|carotenoids|mesh-list
138516493|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
138516494|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216050|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216051|NCT00651482|Bevacizumab|bevacizumab|mesh-list
138216052|NCT00651482|Everolimus|everolimus|mesh-list
138216053|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216054|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216055|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138216060|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138516495|NCT00275418|Protective Agents|protective agents|mesh-ancestor
138516496|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516497|NCT00275418|Provitamins|provitamins|mesh-ancestor
138516498|NCT00275418|Vitamins|vitamins|mesh-ancestor
138516499|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
138516500|NCT00015821|Thalidomide|thalidomide|mesh-list
138516501|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516502|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
138516503|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516505|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138516506|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516507|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516508|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516510|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516511|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516513|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
138698201|NCT02780804|Entinostat|entinostat|mesh-list
138516514|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
138516515|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516516|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516517|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138516518|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138516519|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138216135|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138216136|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
138516520|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
138216137|NCT02997332|Docetaxel|docetaxel|mesh-list
138516521|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516522|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216138|NCT02997332|Fluorouracil|fluorouracil|mesh-list
138516523|NCT00015860|Prednisone|prednisone|mesh-list
138516524|NCT00015860|Vincristine|vincristine|mesh-list
138516525|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
138516526|NCT00015860|Daunorubicin|daunorubicin|mesh-list
138516527|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516528|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
138516529|NCT00015860|Hormones|hormones|mesh-ancestor
138516530|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516531|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516532|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138516533|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516534|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516535|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516536|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516537|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516538|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516539|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516540|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516541|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516542|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516543|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516545|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516546|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516547|NCT00275106|Leucovorin|leucovorin|mesh-list
138516548|NCT00275106|Cytarabine|cytarabine|mesh-list
138216200|NCT01230593|Dexamethasone|dexamethasone|mesh-list
138516549|NCT00275106|Dexamethasone|dexamethasone|mesh-list
138516550|NCT00275106|Prednisolone|prednisolone|mesh-list
138516552|NCT00275106|Doxorubicin|doxorubicin|mesh-list
138516553|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138516554|NCT00275106|Methotrexate|methotrexate|mesh-list
138516555|NCT00275106|Vincristine|vincristine|mesh-list
138516556|NCT00275106|Daunorubicin|daunorubicin|mesh-list
138516557|NCT00275106|Asparaginase|asparaginase|mesh-list
138516558|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
138516559|NCT00275106|Thioguanine|thioguanine|mesh-list
138516560|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
138516561|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516562|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
138216320|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138516563|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516564|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516565|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516566|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
138516567|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516568|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516569|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138516570|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516571|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
138516572|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
138516573|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516574|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138516575|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
138516576|NCT00275106|Hormones|hormones|mesh-ancestor
138516577|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516578|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192960|NCT02185339|Rocuronium|rocuronium|mesh-list
138516579|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516580|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516581|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516582|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516583|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138516584|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
138516585|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138516586|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516587|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
138516588|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138516589|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138516590|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138516592|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516593|NCT00275106|Antidotes|antidotes|mesh-ancestor
138516594|NCT00275106|Protective Agents|protective agents|mesh-ancestor
138516595|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
138516596|NCT00275106|Vitamins|vitamins|mesh-ancestor
138516597|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
138516598|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516599|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516600|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516601|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516602|NCT00015938|Docetaxel|docetaxel|mesh-list
138516603|NCT00015938|Vinorelbine|vinorelbine|mesh-list
138516604|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516605|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516606|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516607|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216455|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216456|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
138216457|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216458|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138216459|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138216460|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138216461|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
138216462|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216463|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216464|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138216465|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216466|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138216467|NCT00666848|Enalapril|enalapril|mesh-list
138216468|NCT00666848|Enalaprilat|enalaprilat|mesh-list
138216471|NCT00666848|Incretins|incretins|mesh-ancestor
138516608|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516609|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516610|NCT00275067|Temozolomide|temozolomide|mesh-list
138516611|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
138516612|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516613|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
138516614|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516615|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516616|NCT00274989|Rituximab|rituximab|mesh-list
138516617|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138516618|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410884|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516619|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516620|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
138516621|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516622|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516623|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516624|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
138516625|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516626|NCT00015977|Interleukin-12|interleukin-12|mesh-list
138516627|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138516628|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
138516629|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516630|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516631|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516632|NCT00015977|Growth Substances|growth substances|mesh-ancestor
138516633|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516634|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516635|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
138516636|NCT01678586|Gabapentin|gabapentin|mesh-list
138516637|NCT01678586|Analgesics|analgesics|mesh-ancestor
138516638|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
138516639|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516640|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516641|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
138516642|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138516643|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138516644|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516645|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138516646|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138516647|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138516648|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516649|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516651|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138516652|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138516653|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138516655|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
138516656|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
138516657|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138516658|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138516659|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
138516660|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
138516661|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138516662|NCT00274950|Carboplatin|carboplatin|mesh-list
138516663|NCT00274950|Etoposide|etoposide|mesh-list
138516664|NCT00274950|Ifosfamide|ifosfamide|mesh-list
138516665|NCT00274950|Bleomycin|bleomycin|mesh-list
138516666|NCT00274950|Vinblastine|vinblastine|mesh-list
138516667|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516668|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516669|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516670|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516671|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516672|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516673|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516674|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
138516675|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516676|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516677|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516679|NCT00016016|Cytarabine|cytarabine|mesh-list
138516680|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
138516681|NCT00016016|Alvocidib|alvocidib|mesh-list
138516682|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516683|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
138516684|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516685|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516686|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
138516687|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516688|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516689|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
138516690|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516691|NCT00016016|Analgesics|analgesics|mesh-ancestor
138516692|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
138516693|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516694|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516695|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516696|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516697|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516698|NCT00016016|Growth Substances|growth substances|mesh-ancestor
138516699|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516700|NCT00130455|Escitalopram|escitalopram|mesh-list
138516701|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138516702|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138458183|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
138516703|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516704|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516705|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516707|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516708|NCT00016055|Temozolomide|temozolomide|mesh-list
138516709|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516710|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
138516711|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516712|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411041|NCT01624441|Epirubicin|epirubicin|mesh-list
138516713|NCT00016094|Bevacizumab|bevacizumab|mesh-list
138516714|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138516715|NCT00016094|Antibodies|antibodies|mesh-list
138516716|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
138516717|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138516718|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516719|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516720|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516721|NCT00016094|Growth Substances|growth substances|mesh-ancestor
138516722|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516723|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516724|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
138516725|NCT00130338|Rivastigmine|rivastigmine|mesh-list
138516726|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138516727|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516728|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516729|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
138516730|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516731|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516732|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138516733|NCT00130338|Protective Agents|protective agents|mesh-ancestor
138516734|NCT00016133|Leucovorin|leucovorin|mesh-list
138516735|NCT00016133|Fluorouracil|fluorouracil|mesh-list
138516736|NCT00016133|Vaccines|vaccines|mesh-list
138516737|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
138516738|NCT00016133|Calcium|calcium|mesh-list
138516739|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
138516740|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
138516741|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516742|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138516743|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
138215227|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516744|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516745|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516746|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516747|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516749|NCT00016133|Protective Agents|protective agents|mesh-ancestor
138516750|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
138516751|NCT00016133|Vitamins|vitamins|mesh-ancestor
138516752|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
138516753|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138516754|NCT00016172|Doxorubicin|doxorubicin|mesh-list
138516755|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138516756|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516757|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516758|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516759|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516760|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516761|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516762|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138698318|NCT01622868|Lapatinib|lapatinib|mesh-list
138516763|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516764|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138350781|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516765|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458197|NCT01931657|Mifepristone|mifepristone|mesh-list
138516766|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516767|NCT00394368|Fluticasone|fluticasone|mesh-list
138516768|NCT00394368|Xhance|xhance|mesh-list
138516769|NCT00394368|Beclomethasone|beclomethasone|mesh-list
138516770|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
138516771|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138516772|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138516773|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138350782|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516774|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
138350783|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
138350784|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138350785|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350786|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138350787|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138350788|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350789|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350791|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138350792|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350793|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
138350794|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350795|NCT04128501|Azacitidine|azacitidine|mesh-list
138350796|NCT04128501|Venetoclax|venetoclax|mesh-list
138350797|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350799|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350800|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350801|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350802|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
138350803|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138350804|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350805|NCT04075747|Venetoclax|venetoclax|mesh-list
138350806|NCT04075747|Midostaurin|midostaurin|mesh-list
138350807|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350808|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138350809|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350810|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350812|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138350813|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138350815|NCT04013542|Ipilimumab|ipilimumab|mesh-list
138350816|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350817|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350818|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350819|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350820|NCT03992456|Trifluridine|trifluridine|mesh-list
138350821|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138350822|NCT03992456|Panitumumab|panitumumab|mesh-list
138350823|NCT03992456|Antibodies|antibodies|mesh-list
138350824|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
138350825|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138350826|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
138350827|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350828|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350829|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
138350830|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350831|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
138350832|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350833|NCT03945812|Lenograstim|lenograstim|mesh-list
138350834|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138350835|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
138350836|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350837|NCT03799445|Nivolumab|nivolumab|mesh-list
138350838|NCT03799445|Ipilimumab|ipilimumab|mesh-list
138350839|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350840|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350841|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350842|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350843|NCT03784326|Fluorouracil|fluorouracil|mesh-list
138350844|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
138350845|NCT03784326|Atezolizumab|atezolizumab|mesh-list
138516775|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516776|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516777|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138516778|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
138516779|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138516780|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138516781|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138516782|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138516783|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138516784|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
138516785|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516786|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516787|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
138516788|NCT00394368|Hormones|hormones|mesh-ancestor
138516789|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516790|NCT01441349|Simvastatin|simvastatin|mesh-list
138516791|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138516792|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138516793|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
138516794|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516795|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138516796|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138516797|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516798|NCT00394407|Insulin|insulin|mesh-list
138516799|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138516800|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138516801|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516802|NCT00130143|Amifostine|amifostine|mesh-list
138516803|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138516804|NCT00130143|Protective Agents|protective agents|mesh-ancestor
138516805|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516806|NCT00016289|Interleukin-12|interleukin-12|mesh-list
138516807|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138516808|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
138516809|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516810|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516811|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138516812|NCT00016289|Growth Substances|growth substances|mesh-ancestor
138516813|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
138516814|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516815|NCT00130065|Folic Acid|folic acid|mesh-list
138516816|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
138516817|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
138516818|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138516819|NCT00130065|Hematinics|hematinics|mesh-ancestor
138516820|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
138516822|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
138516823|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516824|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
138516825|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138698337|NCT00317720|Trastuzumab|trastuzumab|mesh-list
138516826|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138516827|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516828|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138516829|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516830|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516831|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138516832|NCT00016328|Sirolimus|sirolimus|mesh-list
138516833|NCT00016328|Temsirolimus|temsirolimus|mesh-list
138516834|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
138516835|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516836|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516837|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516838|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516839|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
138516840|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516841|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516842|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138516843|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516844|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516845|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
138516846|NCT00130026|Caffeine|caffeine|mesh-list
138516847|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138516848|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516849|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138516850|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516851|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516852|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138516853|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138516854|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
138516855|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516856|NCT00016367|Cisplatin|cisplatin|mesh-list
138516857|NCT00016367|Gemcitabine|gemcitabine|mesh-list
138516858|NCT00016367|Trastuzumab|trastuzumab|mesh-list
138516859|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516860|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516861|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
138516862|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516863|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138516865|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516866|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516867|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516868|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
138516869|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516870|NCT00016406|Paclitaxel|paclitaxel|mesh-list
138516871|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
138516872|NCT00016406|Doxorubicin|doxorubicin|mesh-list
138516873|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516874|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516875|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516876|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516877|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516878|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516879|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516880|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
138516881|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516882|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138516883|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138516884|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
138516885|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138516886|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138516887|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138516888|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516889|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516891|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516892|NCT00016445|Hormones|hormones|mesh-list
138516893|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138516894|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516895|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
138516896|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138516897|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516898|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
138516899|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138516900|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
138516901|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516902|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516903|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138516904|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138516905|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138516906|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
138516907|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516908|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516909|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138516910|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
138516911|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
138516912|NCT00016523|Protective Agents|protective agents|mesh-ancestor
138516914|NCT00129597|Analgesics|analgesics|mesh-ancestor
138516915|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
138516916|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516917|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516918|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138516919|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138516920|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
138516921|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
138516922|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138516923|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138516924|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138516925|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516926|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516927|NCT00016601|Ritonavir|ritonavir|mesh-list
138516928|NCT00016601|Nelfinavir|nelfinavir|mesh-list
138516929|NCT00016601|Indinavir|indinavir|mesh-list
138516930|NCT00016601|Nevirapine|nevirapine|mesh-list
138516931|NCT00016601|Efavirenz|efavirenz|mesh-list
138516932|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138516933|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
138516934|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138516935|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138516936|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
138516937|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516938|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516939|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138516940|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138516941|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
138516942|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516943|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138698374|NCT04319341|Autoantibodies|autoantibodies|mesh-list
138516944|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138516945|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138516946|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138516947|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138516948|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138516949|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138516950|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138516951|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138516952|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138516953|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138516954|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138516955|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
138516956|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138516957|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193337|NCT00974051|Insulin|insulin|mesh-list
138516958|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138516959|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138516960|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138516961|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138516962|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516964|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138516965|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
138516966|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516967|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516968|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
138516969|NCT00016835|Metronidazole|metronidazole|mesh-list
138516970|NCT00016835|Doxycycline|doxycycline|mesh-list
138516971|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516972|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138516973|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138516974|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138516975|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
138516976|NCT00016874|Paclitaxel|paclitaxel|mesh-list
138516977|NCT00016874|Cisplatin|cisplatin|mesh-list
138516978|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138516979|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516980|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
138516981|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
138516982|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516983|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516984|NCT00016952|Leucovorin|leucovorin|mesh-list
138516985|NCT00016952|Fluorouracil|fluorouracil|mesh-list
138516986|NCT00016952|Irinotecan|irinotecan|mesh-list
138516987|NCT00016952|Calcium|calcium|mesh-list
138516988|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
138516989|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138516990|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516991|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
138516992|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138516993|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516994|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516995|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138516996|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
138516997|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138516998|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138516999|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517000|NCT00016952|Antidotes|antidotes|mesh-ancestor
138517001|NCT00016952|Protective Agents|protective agents|mesh-ancestor
138517002|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
138517004|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
138517005|NCT00129363|Carvedilol|carvedilol|mesh-list
138517006|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138517007|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138517008|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138517009|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517010|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517011|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517012|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138517013|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
138517014|NCT00129363|Protective Agents|protective agents|mesh-ancestor
138411318|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517015|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138517016|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517017|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138517018|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
138517019|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138517020|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138517021|NCT00016991|Gefitinib|gefitinib|mesh-list
138517022|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517023|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138517024|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517025|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517026|NCT00017030|Trabectedin|trabectedin|mesh-list
138517027|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517028|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
138517029|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517030|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517031|NCT00017069|Dexamethasone|dexamethasone|mesh-list
138517032|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
138517033|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517035|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
138517036|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517037|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517038|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138517039|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
138517040|NCT00017069|Hormones|hormones|mesh-ancestor
138517041|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517042|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138517043|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517044|NCT00129285|Modafinil|modafinil|mesh-list
138517045|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138517046|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517047|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138517048|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138517049|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138517050|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517051|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
138517053|NCT00017108|Fludarabine|fludarabine|mesh-list
138517054|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
138517055|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517056|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
138517057|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517058|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517059|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517060|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
138517061|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517062|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517063|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517064|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517065|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
138517066|NCT00129246|Naltrexone|naltrexone|mesh-list
138517067|NCT00129246|Bupropion|bupropion|mesh-list
138517068|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138517069|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138517070|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517071|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
138517072|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517073|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138517074|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
138517075|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517076|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138517077|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138517078|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517079|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517080|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
138517081|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517082|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138517083|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138517084|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517085|NCT00017147|Carmustine|carmustine|mesh-list
138517086|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138517087|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517088|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
138517089|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517090|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517091|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517093|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517094|NCT00129168|Cytarabine|cytarabine|mesh-list
138517095|NCT00129168|Daunorubicin|daunorubicin|mesh-list
138517096|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517097|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
138517098|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517099|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517100|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
138517101|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517102|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517103|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
138517104|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517105|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517106|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517107|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517108|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517109|NCT00017186|Gemcitabine|gemcitabine|mesh-list
138517110|NCT00017186|Epirubicin|epirubicin|mesh-list
138517111|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517112|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
138517113|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517114|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517115|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517116|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517117|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517118|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517119|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
138517120|NCT00017225|Melphalan|melphalan|mesh-list
138517121|NCT00017225|Ifosfamide|ifosfamide|mesh-list
138517122|NCT00017225|Dacarbazine|dacarbazine|mesh-list
138517124|NCT00017225|Doxorubicin|doxorubicin|mesh-list
138517125|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138517126|NCT00017225|Etoposide|etoposide|mesh-list
138517127|NCT00017225|Vincristine|vincristine|mesh-list
138517128|NCT00017225|Tretinoin|tretinoin|mesh-list
138517129|NCT00017225|Vindesine|vindesine|mesh-list
138517130|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517131|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
138517132|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517133|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411416|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
138517134|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517135|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
138517136|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517137|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517138|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517139|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517140|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517141|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517142|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517143|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517144|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517145|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517146|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517147|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
138517148|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
138517150|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138517151|NCT00128934|Estradiol|estradiol|mesh-list
138517152|NCT00128934|Estrogens|estrogens|mesh-ancestor
138517153|NCT00128934|Hormones|hormones|mesh-ancestor
138215228|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138517154|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517155|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517156|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138517157|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
138517158|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138517159|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138517160|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138517161|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138517162|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138517163|NCT00017264|Atrasentan|atrasentan|mesh-list
138517164|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517165|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138411451|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517166|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138517167|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517169|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
138517170|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517171|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517172|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517173|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517174|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
138517175|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517176|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517177|NCT00017303|Paclitaxel|paclitaxel|mesh-list
138517178|NCT00017303|Carboplatin|carboplatin|mesh-list
138698425|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
138517179|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517181|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517182|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517183|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517184|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517185|NCT00017342|Cytarabine|cytarabine|mesh-list
138517186|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
138517187|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517188|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
138517189|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517190|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517191|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
138517192|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517193|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517194|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
138517195|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517196|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517197|NCT00128739|Budesonide|budesonide|mesh-list
138517198|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517199|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138517200|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
138517201|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517202|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517203|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138411502|NCT01627678|Antacids|antacids|mesh-ancestor
138517204|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
138517205|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
138517206|NCT00128739|Hormones|hormones|mesh-ancestor
138517207|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517208|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
138517209|NCT00017381|Rituximab|rituximab|mesh-list
138517210|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138517211|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517212|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
138517213|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517214|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517215|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517216|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
138517217|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517219|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517220|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138517221|NCT00128700|Temozolomide|temozolomide|mesh-list
138517222|NCT00128700|Vatalanib|vatalanib|mesh-list
138517223|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517224|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
138517225|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517226|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517227|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138517228|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517230|NCT00017459|Tirapazamine|tirapazamine|mesh-list
138517231|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517232|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517233|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517234|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517235|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517236|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517237|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
138350846|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138350847|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
138350848|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350849|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350850|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350851|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350852|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
138517238|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517239|NCT00017498|Gemcitabine|gemcitabine|mesh-list
138517240|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517241|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
138517242|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517243|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517244|NCT00128544|Telbivudine|telbivudine|mesh-list
138517245|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
138517246|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517247|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138517248|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350853|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350854|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350855|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350856|NCT03776487|Fluorouracil|fluorouracil|mesh-list
138350857|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
138350858|NCT03776487|Nivolumab|nivolumab|mesh-list
138350859|NCT03776487|Ipilimumab|ipilimumab|mesh-list
138350860|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
138350861|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350862|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350863|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350864|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350865|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
138350876|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350877|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350879|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138350880|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
138350881|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350882|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350884|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138350885|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138350886|NCT03629327|Analgesics|analgesics|mesh-ancestor
138350887|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
138350888|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350889|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350890|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350891|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350892|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138350893|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138350895|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138350896|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138350897|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350898|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
138350899|NCT03575793|Nivolumab|nivolumab|mesh-list
138350900|NCT03575793|Ipilimumab|ipilimumab|mesh-list
138350901|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350902|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350904|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350905|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
138350906|NCT03488225|Leucovorin|leucovorin|mesh-list
138350907|NCT03488225|Folic Acid|folic acid|mesh-list
138350908|NCT03488225|Cytarabine|cytarabine|mesh-list
138350909|NCT03488225|Dexamethasone|dexamethasone|mesh-list
138350910|NCT03488225|Prednisone|prednisone|mesh-list
138350911|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
138350912|NCT03488225|Cortisone|cortisone|mesh-list
138350913|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
138350914|NCT03488225|Rituximab|rituximab|mesh-list
138350915|NCT03488225|Doxorubicin|doxorubicin|mesh-list
138350916|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138350917|NCT03488225|Methotrexate|methotrexate|mesh-list
138350918|NCT03488225|Vincristine|vincristine|mesh-list
138350919|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
138350920|NCT03488225|Ofatumumab|ofatumumab|mesh-list
138350921|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138350922|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138350923|NCT03488225|Antibodies|antibodies|mesh-list
138350924|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
138517249|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517250|NCT00128505|Mifepristone|mifepristone|mesh-list
138517251|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138517252|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
138517253|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138517254|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517255|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138517256|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138517257|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138517258|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
138517259|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138517260|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138517261|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138517262|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517263|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
138517264|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138517265|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138517268|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517269|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138517270|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517271|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138517272|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517273|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517274|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138517275|NCT00017576|Vitamins|vitamins|mesh-ancestor
138517276|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
138458367|NCT01932554|Ibuprofen|ibuprofen|mesh-list
138517277|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138517278|NCT00017654|Cyclosporine|cyclosporine|mesh-list
138517279|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
138517280|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
138517281|NCT00017654|Cyclosporins|cyclosporins|mesh-list
138517282|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138517283|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517284|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
138517285|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517286|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698552|NCT00540891|Alfuzosin|alfuzosin|mesh-list
138517287|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517288|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
138517289|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517290|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517291|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517292|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517293|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
138517294|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517295|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
138517296|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138517297|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517298|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
138517299|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
138517300|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517301|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138517302|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
138517303|NCT00017654|Hormones|hormones|mesh-ancestor
138517304|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517305|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138517306|NCT00017654|Protective Agents|protective agents|mesh-ancestor
138517307|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
138517308|NCT00394485|Procaterol|procaterol|mesh-list
138517309|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138517310|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
138517311|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517312|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517313|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138411617|NCT01628666|Vancomycin|vancomycin|mesh-list
138517314|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
138517316|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138517317|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
138517318|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517319|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517320|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
138517321|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138517322|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138517323|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138517324|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
138517325|NCT00017693|Interleukin-4|interleukin-4|mesh-list
138517326|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517327|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
138517328|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517329|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517330|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517331|NCT00128466|Gentamicins|gentamicins|mesh-list
138517332|NCT00128466|Streptomycin|streptomycin|mesh-list
138517334|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517335|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138517336|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517337|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517338|NCT00128427|Colchicine|colchicine|mesh-list
138517339|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
138517340|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517341|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517342|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517344|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517345|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517346|NCT00018603|Guanfacine|guanfacine|mesh-list
138517347|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138517348|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138517349|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138517350|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138517351|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
138517352|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517353|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517354|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517355|NCT00018642|Haloperidol|haloperidol|mesh-list
138517356|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138517357|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
138517358|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
138517359|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517360|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138517361|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138517362|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517363|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517364|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
138517365|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
138517366|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517367|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138517368|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138517369|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
138517370|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517371|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517372|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138517373|NCT00018083|Efavirenz|efavirenz|mesh-list
138517374|NCT00018083|Isoniazid|isoniazid|mesh-list
138517375|NCT00018083|Rifabutin|rifabutin|mesh-list
138350925|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138517376|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138517377|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138517378|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517379|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517380|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
138517381|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517382|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138517383|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138517384|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138350926|NCT03488225|BB 1101|bb 1101|mesh-list
138350927|NCT03488225|Calcium|calcium|mesh-list
138350928|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
138350929|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350930|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
138350931|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350932|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350934|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
138350935|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350936|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350937|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138350938|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350939|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
138350940|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
138350941|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350942|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350945|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350946|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138350947|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350948|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138350949|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138350950|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350951|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138350952|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138350953|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138350954|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
138350955|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350957|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
138350959|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138350960|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138350961|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
138350962|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350963|NCT03488225|Antidotes|antidotes|mesh-ancestor
138350964|NCT03488225|Protective Agents|protective agents|mesh-ancestor
138350965|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
138350966|NCT03488225|Vitamins|vitamins|mesh-ancestor
138350967|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
138350968|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138350969|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350970|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350971|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350972|NCT03488225|Hematinics|hematinics|mesh-ancestor
138350973|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
138350974|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
138350975|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
138350976|NCT03450122|Aldesleukin|aldesleukin|mesh-list
138350977|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
138350978|NCT03450122|Interleukin-2|interleukin-2|mesh-list
138350979|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350980|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
138350981|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350982|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350983|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138350984|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
138350985|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350986|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350987|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138350988|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138350990|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
138350991|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350992|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138517385|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138517386|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138517387|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138517388|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
138517389|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138517390|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138517391|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138517392|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
138517393|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138517394|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138517395|NCT00018200|Benztropine|benztropine|mesh-list
138517396|NCT00018200|Fluoxetine|fluoxetine|mesh-list
138517397|NCT00018200|Desipramine|desipramine|mesh-list
138517398|NCT00018200|Clomipramine|clomipramine|mesh-list
138517399|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138517400|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138517401|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517402|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517403|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517404|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
138517405|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517406|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138517407|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
138517408|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517409|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138517410|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138517411|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517412|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138517413|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138517414|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
138517415|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138517416|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138517417|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
138517418|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
138517419|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517420|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138517421|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138517422|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
138517423|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138517424|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
138517426|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138517427|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138517428|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517429|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517430|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517431|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
138517432|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517433|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138517434|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
138517435|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517436|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138517437|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138411708|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517438|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517440|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138517441|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138517442|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138517443|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138517444|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138517445|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
138517446|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517447|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517448|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517449|NCT00018954|Cytarabine|cytarabine|mesh-list
138517450|NCT00018954|Prednisone|prednisone|mesh-list
138517451|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
138517452|NCT00018954|Ifosfamide|ifosfamide|mesh-list
138517453|NCT00018954|Doxorubicin|doxorubicin|mesh-list
138517454|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138517456|NCT00018954|Etoposide|etoposide|mesh-list
138517457|NCT00018954|Vincristine|vincristine|mesh-list
138517458|NCT00018954|Daunorubicin|daunorubicin|mesh-list
138517459|NCT00018954|Asparaginase|asparaginase|mesh-list
138517460|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
138517461|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517462|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
138517463|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517464|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138517465|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517466|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
138517467|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698637|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
138517468|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517469|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517470|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517471|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517472|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517473|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517474|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517475|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
138517476|NCT00018954|Hormones|hormones|mesh-ancestor
138517477|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517478|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193864|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138517479|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138517480|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
138517481|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138517482|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517483|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
138517484|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138517485|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138517486|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138517487|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517488|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
138517489|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517490|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517491|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517492|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517494|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138517495|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517496|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517497|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
138517498|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517499|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517500|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
138517501|NCT00019032|Antibodies|antibodies|mesh-list
138517502|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138517503|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
138517504|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517505|NCT00019071|Cladribine|cladribine|mesh-list
138517506|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517507|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517508|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
138517509|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517510|NCT04734119|Anesthetics|anesthetics|mesh-list
138517511|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517512|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517513|NCT00018356|Testosterone|testosterone|mesh-list
138517514|NCT00018356|Androgens|androgens|mesh-ancestor
138517515|NCT00018356|Hormones|hormones|mesh-ancestor
138517516|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517517|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517518|NCT00019188|Interleukin-12|interleukin-12|mesh-list
138517519|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517520|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
138517521|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517522|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138517523|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138517524|NCT00019188|Growth Substances|growth substances|mesh-ancestor
138517525|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138517526|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517528|NCT00019227|Daclizumab|daclizumab|mesh-list
138517529|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
138517530|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138517531|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517532|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517533|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
138517534|NCT00019227|Antidotes|antidotes|mesh-ancestor
138517535|NCT00019227|Protective Agents|protective agents|mesh-ancestor
138517536|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
138517537|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
138517538|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517539|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138517540|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138517541|NCT00019344|Alvocidib|alvocidib|mesh-list
138517542|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517543|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138517544|NCT00019344|Growth Substances|growth substances|mesh-ancestor
138517545|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517546|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138517547|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517548|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517549|NCT00019383|Aldesleukin|aldesleukin|mesh-list
138517550|NCT00019383|Sargramostim|sargramostim|mesh-list
138517551|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
138517552|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
138517553|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517554|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517556|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138517557|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
138517558|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517559|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517560|NCT00019422|Carboplatin|carboplatin|mesh-list
138517561|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517562|NCT00018551|Folic Acid|folic acid|mesh-list
138517563|NCT00018551|Hematinics|hematinics|mesh-ancestor
138517564|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
138517565|NCT00018551|Vitamins|vitamins|mesh-ancestor
138517566|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
138517567|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517569|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517570|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138517571|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517572|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517573|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138517574|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517575|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138517576|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138517577|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351072|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138351073|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138351074|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138351075|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138351076|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
138517578|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517579|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517580|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138517581|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138517582|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138517583|NCT00019539|Thalidomide|thalidomide|mesh-list
138517584|NCT00019539|Bevacizumab|bevacizumab|mesh-list
138517585|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351077|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351078|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351080|NCT03283761|Paclitaxel|paclitaxel|mesh-list
138351081|NCT03283761|Fluorouracil|fluorouracil|mesh-list
138351082|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
138351083|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138351084|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351085|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138351086|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138351087|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138351088|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351089|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
138351090|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138351091|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351092|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
138351093|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351094|NCT03283761|Antidotes|antidotes|mesh-ancestor
138351095|NCT03283761|Protective Agents|protective agents|mesh-ancestor
138351096|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
138351098|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
138351099|NCT03191461|Adenosine|adenosine|mesh-list
138351100|NCT03191461|Analgesics|analgesics|mesh-ancestor
138351102|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351103|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351104|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138351105|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
138351106|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138351107|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
138351108|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
138351109|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351110|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351111|NCT03166644|Sufentanil|sufentanil|mesh-list
138351112|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138351113|NCT03166644|Narcotics|narcotics|mesh-ancestor
138351114|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351115|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351116|NCT03166644|Analgesics|analgesics|mesh-ancestor
138351117|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
138351118|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351119|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138351120|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138351122|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
138351124|NCT02998528|Vinorelbine|vinorelbine|mesh-list
138351125|NCT02998528|Docetaxel|docetaxel|mesh-list
138351126|NCT02998528|Carboplatin|carboplatin|mesh-list
138351127|NCT02998528|Gemcitabine|gemcitabine|mesh-list
138351128|NCT02998528|Nivolumab|nivolumab|mesh-list
138351129|NCT02998528|Pemetrexed|pemetrexed|mesh-list
138351130|NCT02998528|Ipilimumab|ipilimumab|mesh-list
138351131|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138351132|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351133|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
138351134|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
138351135|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
138351136|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351137|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138351138|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
138351139|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351140|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351141|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517586|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411863|NCT01630343|Acetaminophen|acetaminophen|mesh-list
138517587|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138517588|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138517589|NCT00019539|Growth Substances|growth substances|mesh-ancestor
138517590|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517591|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
138517592|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517593|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
138517594|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
138517595|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138517596|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517597|NCT00019695|Alendronate|alendronate|mesh-list
138517598|NCT00019695|Ketoconazole|ketoconazole|mesh-list
138517599|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
138517600|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517601|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138517602|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138517603|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517604|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517605|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138517606|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
138517607|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517608|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517609|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138517610|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138517611|NCT00019734|Aldesleukin|aldesleukin|mesh-list
138517612|NCT00019734|Vaccines|vaccines|mesh-list
138517613|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
138517614|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517615|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517616|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138517617|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138411884|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
138517618|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
138517619|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517621|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
138517622|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517623|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
138517624|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517625|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517626|NCT00019812|Paclitaxel|paclitaxel|mesh-list
138517627|NCT00019812|Trastuzumab|trastuzumab|mesh-list
138517628|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517629|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517630|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517631|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517632|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517633|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517634|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138517635|NCT00019890|Sargramostim|sargramostim|mesh-list
138517636|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
138517637|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517638|NCT00020007|Paclitaxel|paclitaxel|mesh-list
138517639|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517641|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517642|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517643|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517644|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517645|NCT00142454|Imiquimod|imiquimod|mesh-list
138517646|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517647|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
138517648|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517649|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517650|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
138517651|NCT00020124|Doxorubicin|doxorubicin|mesh-list
138517652|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138517653|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517654|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458443|NCT01933152|Ranibizumab|ranibizumab|mesh-list
138517655|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517656|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517657|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517658|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517660|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517661|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517662|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138517663|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517664|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517665|NCT05576675|Sufentanil|sufentanil|mesh-list
138517666|NCT05576675|Dsuvia|dsuvia|mesh-list
138517668|NCT05576675|Nalbuphine|nalbuphine|mesh-list
138517669|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138517670|NCT05576675|Narcotics|narcotics|mesh-ancestor
138517671|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517672|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517673|NCT05576675|Analgesics|analgesics|mesh-ancestor
138517674|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
138517675|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517676|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138517677|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138517678|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
138517679|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
138517680|NCT00020358|Aldesleukin|aldesleukin|mesh-list
138517681|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
138517682|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517683|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138517684|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138517685|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
138517686|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517687|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517688|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
138517689|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517690|NCT00020397|Aldesleukin|aldesleukin|mesh-list
138517691|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517692|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138517693|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138517694|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
138517695|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517696|NCT00020475|Interleukin-2|interleukin-2|mesh-list
138517697|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138517698|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517699|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138517700|NCT00020475|Analgesics|analgesics|mesh-ancestor
138517701|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
138517702|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517703|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517704|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138517705|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
138517706|NCT05576480|Capecitabine|capecitabine|mesh-list
138517707|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
138517708|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517709|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
138517710|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517711|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517712|NCT00020631|Pirfenidone|pirfenidone|mesh-list
138517713|NCT00020631|Analgesics|analgesics|mesh-ancestor
138517714|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
138517715|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517716|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517717|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138517718|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138517719|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517720|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698725|NCT04655807|Adalimumab|adalimumab|mesh-list
138517721|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517722|NCT05576324|Ivacaftor|ivacaftor|mesh-list
138517723|NCT05576324|Elexacaftor|elexacaftor|mesh-list
138517724|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138517725|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517726|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517727|NCT00020709|Docetaxel|docetaxel|mesh-list
138517728|NCT00020709|Etoposide|etoposide|mesh-list
138517729|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
138517730|NCT00020709|Gefitinib|gefitinib|mesh-list
138517731|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517732|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517733|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517734|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479966|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138517735|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517736|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517738|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517739|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517740|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138517741|NCT00020748|Irinotecan|irinotecan|mesh-list
138517742|NCT00020748|Epirubicin|epirubicin|mesh-list
138517743|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138517744|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517745|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517746|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517747|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517748|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517749|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517750|NCT00020787|Cisplatin|cisplatin|mesh-list
138517751|NCT00020787|Fluorouracil|fluorouracil|mesh-list
138517752|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517753|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
138517754|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517755|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517756|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517757|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
138517758|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517759|NCT00020865|Levofloxacin|levofloxacin|mesh-list
138517760|NCT00020865|Cefepime|cefepime|mesh-list
138517761|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138517762|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517763|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138517764|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517765|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517766|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517767|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517768|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517769|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138517770|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138517771|NCT00020943|Leucovorin|leucovorin|mesh-list
138517772|NCT00020943|Cytarabine|cytarabine|mesh-list
138517773|NCT00020943|Prednisone|prednisone|mesh-list
138517774|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
138517775|NCT00020943|Carmustine|carmustine|mesh-list
138517776|NCT00020943|Rituximab|rituximab|mesh-list
138517777|NCT00020943|Doxorubicin|doxorubicin|mesh-list
138517778|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138517779|NCT00020943|Methotrexate|methotrexate|mesh-list
138517780|NCT00020943|Etoposide|etoposide|mesh-list
138517781|NCT00020943|Vincristine|vincristine|mesh-list
138517782|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
138517783|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517784|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
138517785|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517787|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517788|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
138517789|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517790|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517791|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138517792|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138517793|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517794|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138517795|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138517796|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517797|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517798|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
138517799|NCT00020943|Hormones|hormones|mesh-ancestor
138517800|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517801|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138517802|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138517803|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
138517804|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138517805|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138517806|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
138517807|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
138517808|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138517809|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138517810|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517811|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
138517812|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517813|NCT00020943|Antidotes|antidotes|mesh-ancestor
138517814|NCT00020943|Protective Agents|protective agents|mesh-ancestor
138517815|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
138517816|NCT00020943|Vitamins|vitamins|mesh-ancestor
138517817|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
138517818|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517819|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517820|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517821|NCT00021060|Paclitaxel|paclitaxel|mesh-list
138517822|NCT00021060|Bevacizumab|bevacizumab|mesh-list
138517823|NCT00021060|Carboplatin|carboplatin|mesh-list
138517824|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138517825|NCT00021060|Antibodies|antibodies|mesh-list
138517826|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
138517827|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138479967|NCT02044224|Analgesics|analgesics|mesh-ancestor
138517828|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517829|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517830|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517831|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517832|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517833|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517834|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138517835|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138517836|NCT00021060|Growth Substances|growth substances|mesh-ancestor
138517837|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517838|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
138517839|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
138517840|NCT00021099|Epothilones|epothilones|mesh-list
138517841|NCT00021099|Epothilone B|epothilone b|mesh-list
138517842|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517843|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517844|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517845|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517846|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517847|NCT05574257|Propofol|propofol|mesh-list
138517848|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138517849|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517850|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517851|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138517852|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
138517853|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
138517855|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
138517856|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517857|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517858|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517859|NCT00021138|Nicotine|nicotine|mesh-list
138517861|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
138517862|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517863|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517864|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138517865|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138517866|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
138517867|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517868|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517869|NCT00020670|Vaccines|vaccines|mesh-list
138517870|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
138517871|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517872|NCT05574179|Midazolam|midazolam|mesh-list
138517873|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
138517874|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138517875|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517876|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517877|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138517878|NCT05574179|Analgesics|analgesics|mesh-ancestor
138517879|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
138517880|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517881|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138517882|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138517883|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138517884|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
138517885|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517886|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517887|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138517888|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138517889|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138517890|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517891|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138517892|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
138517893|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
138517894|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
138517895|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
138517896|NCT00021216|Bortezomib|bortezomib|mesh-list
138517897|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517898|NCT00021294|Eflornithine|eflornithine|mesh-list
138517899|NCT00021294|Triamcinolone|triamcinolone|mesh-list
138412201|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517900|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517901|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
138517902|NCT00021294|Hormones|hormones|mesh-ancestor
138517903|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517904|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517905|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517906|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517907|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517908|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138517909|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138517910|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138517911|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517912|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138517913|NCT00021333|Paclitaxel|paclitaxel|mesh-list
138517914|NCT00021333|Cisplatin|cisplatin|mesh-list
138517915|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517916|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517917|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517918|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517919|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517920|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517921|NCT00021372|Paclitaxel|paclitaxel|mesh-list
138517922|NCT00021372|Estramustine|estramustine|mesh-list
138517923|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138517924|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412243|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
138517925|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138517926|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138517927|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138517928|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517929|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138517930|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
138517931|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138517932|NCT00392093|Estrogens|estrogens|mesh-list
138517933|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138517934|NCT00392093|Hormones|hormones|mesh-ancestor
138517935|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458600|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138517936|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517938|NCT00018161|Nicotine|nicotine|mesh-list
138517939|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138517940|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
138517941|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517942|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517943|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138517944|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138517945|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138517946|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517947|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517948|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138517949|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138517950|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138517951|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138517952|NCT00021450|Goserelin|goserelin|mesh-list
138517953|NCT00021450|Bicalutamide|bicalutamide|mesh-list
138517954|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138517955|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517956|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
138517957|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
138517958|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517959|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517960|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
138517961|NCT00021489|Abacavir|abacavir|mesh-list
138517962|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138517963|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517964|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138517965|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
138517966|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138517967|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517968|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412294|NCT01633658|Vitamin D|vitamin d|mesh-list
138517969|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517970|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138517971|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138517972|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
138517973|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138517974|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138517975|NCT00021528|Mirtazapine|mirtazapine|mesh-list
138517977|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
138517978|NCT00021528|Sertraline|sertraline|mesh-list
138517979|NCT00021528|Citalopram|citalopram|mesh-list
138517980|NCT00021528|Nortriptyline|nortriptyline|mesh-list
138517981|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
138517982|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138517983|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138517984|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138517985|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138517986|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517987|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517988|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
138517989|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517990|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517991|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138517992|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517993|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138517994|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138517995|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
138517996|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
138517997|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138517998|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138517999|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138518000|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138518001|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
138518002|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138518003|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138518004|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138518005|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138518006|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138518007|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138518008|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138518009|NCT00021567|Interferons|interferons|mesh-list
138518010|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
138518011|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518012|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
138518013|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518014|NCT00021645|Vitamin E|vitamin e|mesh-list
138518015|NCT00021645|Vitamins|vitamins|mesh-ancestor
138518016|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
138518017|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518018|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
138518019|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518020|NCT00021645|Protective Agents|protective agents|mesh-ancestor
138518021|NCT00021996|Valdecoxib|valdecoxib|mesh-list
138518022|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138518023|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138518024|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518025|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518026|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138518027|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138518028|NCT00021996|Analgesics|analgesics|mesh-ancestor
138518029|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
138518030|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518031|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518032|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518033|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518034|NCT00022074|Gabapentin|gabapentin|mesh-list
138518035|NCT00022074|Analgesics|analgesics|mesh-ancestor
138412358|NCT01634061|Dactolisib|dactolisib|mesh-list
138518037|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518038|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518039|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
138518040|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138518041|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138518042|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138518043|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138518044|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138518045|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138518046|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518047|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518048|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
138518050|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518051|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518052|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518053|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518054|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518055|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518056|NCT00022191|Paclitaxel|paclitaxel|mesh-list
138518057|NCT00022191|Gemcitabine|gemcitabine|mesh-list
138518058|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518059|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518060|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518061|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518062|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518063|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518064|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518065|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
138518067|NCT00022230|Paclitaxel|paclitaxel|mesh-list
138518068|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
138518069|NCT00022230|Doxorubicin|doxorubicin|mesh-list
138518070|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138518071|NCT00022230|Sargramostim|sargramostim|mesh-list
138518072|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518073|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518074|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518075|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518076|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518077|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518078|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518079|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
138518080|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518081|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518082|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518083|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
138518084|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518086|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518087|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518088|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518089|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138518090|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138518091|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
138518092|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518093|NCT00022308|Irinotecan|irinotecan|mesh-list
138518094|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518095|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518096|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518097|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518098|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458689|NCT01935115|Ketamine|ketamine|mesh-list
138518100|NCT00022386|Hematinics|hematinics|mesh-ancestor
138518101|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
138518102|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518103|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518104|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518105|NCT00022464|Sirolimus|sirolimus|mesh-list
138518106|NCT00022464|Temsirolimus|temsirolimus|mesh-list
138518107|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
138518108|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518109|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518110|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518111|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518112|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
138518113|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518114|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518115|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518116|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518117|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518118|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
138518119|NCT00022542|Epothilones|epothilones|mesh-list
138518120|NCT00022542|Epothilone B|epothilone b|mesh-list
138698849|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
138518121|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138412427|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138518122|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518123|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518124|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518125|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518126|NCT00022581|Thalidomide|thalidomide|mesh-list
138518127|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518128|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
138518129|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518130|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
138518131|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518132|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518133|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518134|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138518135|NCT00022581|Growth Substances|growth substances|mesh-ancestor
138518136|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138518137|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518138|NCT05551871|Simvastatin|simvastatin|mesh-list
138518139|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138518140|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138518141|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
138518142|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518143|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138518144|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138518145|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518146|NCT00022620|Paclitaxel|paclitaxel|mesh-list
138518147|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518148|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518149|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518150|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518151|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518152|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518153|NCT00022737|Leucovorin|leucovorin|mesh-list
138518154|NCT00022737|Cytarabine|cytarabine|mesh-list
138518155|NCT00022737|Cyclosporine|cyclosporine|mesh-list
138518156|NCT00022737|Dexamethasone|dexamethasone|mesh-list
138518157|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
138518158|NCT00022737|Ifosfamide|ifosfamide|mesh-list
138518159|NCT00022737|Methotrexate|methotrexate|mesh-list
138518160|NCT00022737|Etoposide|etoposide|mesh-list
138518161|NCT00022737|Vincristine|vincristine|mesh-list
138518162|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
138518164|NCT00022737|Daunorubicin|daunorubicin|mesh-list
138518165|NCT00022737|Asparaginase|asparaginase|mesh-list
138518166|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
138518168|NCT00022737|Cyclosporins|cyclosporins|mesh-list
138518169|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
138458696|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
138518170|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518172|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518173|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518174|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518175|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
138518176|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518177|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518178|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518179|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518180|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
138518181|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
138518182|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518183|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138518184|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
138518185|NCT00022737|Hormones|hormones|mesh-ancestor
138518186|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518187|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518188|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138518189|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
138518190|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138518191|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518192|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
138518193|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518194|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518195|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138518196|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138518197|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518198|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518199|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518200|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
138518201|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518202|NCT00022737|Antidotes|antidotes|mesh-ancestor
138518203|NCT00022737|Protective Agents|protective agents|mesh-ancestor
138518204|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
138518205|NCT00022737|Vitamins|vitamins|mesh-ancestor
138518206|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
138518207|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518208|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518209|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518210|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
138518211|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138518212|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518213|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518214|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
138518215|NCT00022893|Antibodies|antibodies|mesh-list
138518216|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
138518217|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518218|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518219|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138518220|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
138518221|NCT00022932|Antibodies|antibodies|mesh-list
138518222|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
138518223|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518224|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518225|NCT00022971|Rituximab|rituximab|mesh-list
138518226|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138518227|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518228|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
138518229|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518230|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518231|NCT05512754|Ibuprofen|ibuprofen|mesh-list
138698882|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
138518232|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138518233|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138518235|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
138518236|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518237|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518238|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518239|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518240|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138412528|NCT01634932|Trace Elements|trace elements|mesh-ancestor
138518241|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518242|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518243|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
138518244|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
138518245|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
138518246|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138518247|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
138518248|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518249|NCT02971878|Protective Agents|protective agents|mesh-ancestor
138518250|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518251|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
138518253|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
138518254|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
138518255|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
138518256|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518257|NCT02971878|Expectorants|expectorants|mesh-ancestor
138518258|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
138518259|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138518260|NCT02971878|Antidotes|antidotes|mesh-ancestor
138518261|NCT00023166|Paclitaxel|paclitaxel|mesh-list
138518262|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518263|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518264|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518265|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518266|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518267|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518268|NCT00394992|Bevacizumab|bevacizumab|mesh-list
138518269|NCT00394992|Capecitabine|capecitabine|mesh-list
138518270|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
138518271|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375817|NCT01435902|Xhance|xhance|mesh-list
138518272|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518273|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518274|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138518275|NCT00394992|Growth Substances|growth substances|mesh-ancestor
138518276|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518277|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138518278|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518279|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
138518280|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518281|NCT00395031|Ziprasidone|ziprasidone|mesh-list
138518282|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138518283|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
138518284|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518285|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518286|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518287|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138518288|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138518289|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138518290|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138518291|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138518292|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
138518293|NCT00395070|Temozolomide|temozolomide|mesh-list
138518294|NCT00395070|Dacarbazine|dacarbazine|mesh-list
138518295|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518296|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
138518297|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518298|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518299|NCT00023244|Cyclosporine|cyclosporine|mesh-list
138518302|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
138518303|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138518304|NCT00023244|Prednisone|prednisone|mesh-list
138518305|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
138518306|NCT00023244|Tacrolimus|tacrolimus|mesh-list
138518307|NCT00023244|Cyclosporins|cyclosporins|mesh-list
138518308|NCT00023244|Basiliximab|basiliximab|mesh-list
138518309|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518310|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
138518311|NCT00023244|Hormones|hormones|mesh-ancestor
138518312|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518313|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518314|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518315|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518316|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518317|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
138518318|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138518319|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518320|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518321|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
138518322|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518323|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518324|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518325|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518326|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518327|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
138518328|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
138518329|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412610|NCT01635751|Pregabalin|pregabalin|mesh-list
138518330|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138518331|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138518332|NCT00023244|Protective Agents|protective agents|mesh-ancestor
138518333|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138518334|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
138518335|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138518336|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138518337|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138518338|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138518339|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138518340|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138518342|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138518343|NCT00023283|Narcotics|narcotics|mesh-ancestor
138518344|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138518345|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518346|NCT00023283|Analgesics|analgesics|mesh-ancestor
138518347|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
138518348|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518349|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138518351|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518352|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458727|NCT01935310|Imiquimod|imiquimod|mesh-list
138518353|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138518354|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
138518355|NCT00023400|Nelfinavir|nelfinavir|mesh-list
138518356|NCT00023400|Rifabutin|rifabutin|mesh-list
138518357|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138518358|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138518359|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138518360|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518361|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518362|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138518363|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138518364|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
138518365|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518366|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518367|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138412639|NCT01635803|Bevacizumab|bevacizumab|mesh-list
138518369|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
138518370|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138518371|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138518372|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518373|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
138518374|NCT05359172|Coagulants|coagulants|mesh-ancestor
138518375|NCT00023634|Sargramostim|sargramostim|mesh-list
138518376|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
138518377|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518378|NCT00023751|Leucovorin|leucovorin|mesh-list
138518379|NCT00023751|Fluorouracil|fluorouracil|mesh-list
138518380|NCT00023751|Calcium|calcium|mesh-list
138518381|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
138518382|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138518383|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518384|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
138518385|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518386|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518387|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518388|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518389|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
138518390|NCT00023751|Antidotes|antidotes|mesh-ancestor
138518391|NCT00023751|Protective Agents|protective agents|mesh-ancestor
138518392|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
138518393|NCT00023751|Vitamins|vitamins|mesh-ancestor
138518394|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
138518395|NCT00023790|Silicon|silicon|mesh-list
138518396|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
138518397|NCT00023790|Trace Elements|trace elements|mesh-ancestor
138518398|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
138518399|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518400|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
138518401|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138518402|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138518403|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518404|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
138518405|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138518406|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518407|NCT02971982|Dexamethasone|dexamethasone|mesh-list
138518408|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
138518409|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
138518410|NCT02971982|Rituximab|rituximab|mesh-list
138518411|NCT02971982|Bortezomib|bortezomib|mesh-list
138518412|NCT02971982|BB 1101|bb 1101|mesh-list
138518413|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518414|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
138518415|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518416|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518417|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138458757|NCT01935505|Bupropion|bupropion|mesh-list
138518418|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
138518419|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518420|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518421|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518422|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518423|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
138518424|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
138518425|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518426|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138518427|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
138518428|NCT02971982|Hormones|hormones|mesh-ancestor
138518429|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518430|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518431|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
138412706|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518432|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412713|NCT01636128|Sulindac|sulindac|mesh-list
138518433|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138518434|NCT00023829|Bicalutamide|bicalutamide|mesh-list
138518435|NCT00023829|Flutamide|flutamide|mesh-list
138518436|NCT00023829|Hormones|hormones|mesh-list
138518437|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518438|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518439|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
138518440|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138518441|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518442|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518443|NCT00023868|Leucovorin|leucovorin|mesh-list
138518444|NCT00023868|Doxorubicin|doxorubicin|mesh-list
138518445|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138518446|NCT00023868|Fluorouracil|fluorouracil|mesh-list
138518447|NCT00023868|Irinotecan|irinotecan|mesh-list
138518448|NCT00023868|Mitomycins|mitomycins|mesh-list
138518449|NCT00023868|Mitomycin|mitomycin|mesh-list
138518450|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
138518451|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518452|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518453|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518454|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518455|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518456|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518457|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518458|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
138518459|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518460|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518461|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
138518462|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518463|NCT00023868|Antidotes|antidotes|mesh-ancestor
138518464|NCT00023868|Protective Agents|protective agents|mesh-ancestor
138518465|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
138518466|NCT00023868|Vitamins|vitamins|mesh-ancestor
138518467|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
138194908|NCT01459406|Levan|levan|mesh-list
138412747|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518468|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
138518469|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138518471|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518472|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518473|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518474|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518475|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518476|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518478|NCT00023946|Epothilone B|epothilone b|mesh-list
138518479|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518480|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518481|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518482|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518483|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518485|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
138518486|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518487|NCT00024063|Orantinib|orantinib|mesh-list
138518488|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518489|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518490|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518491|NCT00024141|Fluorouracil|fluorouracil|mesh-list
138518492|NCT00024141|Irinotecan|irinotecan|mesh-list
138518493|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
138518494|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518495|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518496|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518497|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518498|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
138518499|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458779|NCT01935518|Fasudil|fasudil|mesh-list
138518500|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518501|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518502|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518503|NCT05239286|Anesthetics|anesthetics|mesh-list
138518504|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138518505|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518506|NCT00024180|Romidepsin|romidepsin|mesh-list
138518507|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518508|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518509|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138518510|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518511|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518512|NCT00024297|Warfarin|warfarin|mesh-list
138518513|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
138518514|NCT00024336|Tamoxifen|tamoxifen|mesh-list
138518515|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138518516|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
138518517|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518518|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518519|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518520|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518521|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138518522|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138518523|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138518524|NCT00024375|Paclitaxel|paclitaxel|mesh-list
138518525|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518526|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518527|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518528|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518529|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215229|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
138518530|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518531|NCT00024414|Paclitaxel|paclitaxel|mesh-list
138518532|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518533|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518534|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518535|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518536|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518537|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518538|NCT00024453|Teicoplanin|teicoplanin|mesh-list
138518539|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518540|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518541|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
138518542|NCT00024492|Analgesics|analgesics|mesh-ancestor
138518543|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
138518544|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518545|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518546|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518547|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518548|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518549|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518550|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518551|NCT00024531|Atorvastatin|atorvastatin|mesh-list
138518553|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138518554|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518555|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138518556|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138518557|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
138518558|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699002|NCT04651049|Propranolol|propranolol|mesh-list
138518559|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138518560|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138518561|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518562|NCT00024570|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138518563|NCT00024570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518564|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
138518565|NCT05080049|Hematinics|hematinics|mesh-ancestor
138518566|NCT00024687|Immunotoxins|immunotoxins|mesh-list
138518567|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
138518568|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
138518569|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518570|NCT05072444|QPX7728|qpx7728|mesh-list
138518571|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138518572|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518573|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518574|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518575|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518576|NCT00025038|Cytarabine|cytarabine|mesh-list
138518577|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
138518578|NCT00025038|Fludarabine|fludarabine|mesh-list
138518579|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
138518580|NCT00025038|Tipifarnib|tipifarnib|mesh-list
138518581|NCT00025038|Isotretinoin|isotretinoin|mesh-list
138518582|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
138518583|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138518584|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
138518585|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518586|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
138518587|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518588|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518589|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518590|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
138518591|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518592|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518593|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518594|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518595|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
138518596|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
138518597|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518598|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518599|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
138518600|NCT00025077|Thiotepa|thiotepa|mesh-list
138518601|NCT00025077|Carboplatin|carboplatin|mesh-list
138518602|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518603|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
138518604|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518605|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518606|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518607|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
138518608|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518609|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518610|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518611|NCT05051891|Prednisone|prednisone|mesh-list
138518612|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
138518613|NCT05051891|Vincristine|vincristine|mesh-list
138518614|NCT05051891|Rituximab|rituximab|mesh-list
138518615|NCT05051891|Doxorubicin|doxorubicin|mesh-list
138699042|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
138518616|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518617|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
138518618|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518619|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518620|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518621|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
138518622|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518623|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518624|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518625|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518626|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
138518627|NCT05051891|Hormones|hormones|mesh-ancestor
138458837|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
138518628|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138518629|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518630|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518631|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518632|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518633|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518634|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138518635|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518636|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518637|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518638|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518639|NCT00025194|Estramustine|estramustine|mesh-list
138518640|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518641|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
138215230|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518642|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518643|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518644|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518646|NCT00025272|Etoposide|etoposide|mesh-list
138518647|NCT00025272|Topotecan|topotecan|mesh-list
138518648|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518649|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518650|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518651|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518652|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518653|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518654|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518655|NCT00025311|Topotecan|topotecan|mesh-list
138518656|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518657|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518658|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518659|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518660|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518661|NCT00025116|Gefitinib|gefitinib|mesh-list
138518662|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518663|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518664|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518665|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518666|NCT00025350|Gefitinib|gefitinib|mesh-list
138518667|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518668|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518669|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699058|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
138518670|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518671|NCT00025389|Paclitaxel|paclitaxel|mesh-list
138518672|NCT00025389|Bevacizumab|bevacizumab|mesh-list
138518673|NCT00025389|Carboplatin|carboplatin|mesh-list
138518674|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518675|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518676|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518677|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518678|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518679|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518680|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138518681|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518682|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138518683|NCT00025389|Growth Substances|growth substances|mesh-ancestor
138518684|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518685|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
138518686|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
138518687|NCT00025428|Carboplatin|carboplatin|mesh-list
138518688|NCT00025428|Doxorubicin|doxorubicin|mesh-list
138518689|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138518690|NCT00025428|Etoposide|etoposide|mesh-list
138518691|NCT00025428|Vincristine|vincristine|mesh-list
138518692|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518693|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
138518694|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518695|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518696|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518697|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
138518698|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518699|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518700|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518701|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518702|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518703|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518704|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518705|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518706|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518707|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518708|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518710|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699076|NCT00558077|Metformin|metformin|mesh-list
138518711|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
138518712|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518713|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
138518714|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518715|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518716|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518717|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138413032|NCT01637454|Terlipressin|terlipressin|mesh-list
138518718|NCT00025467|Growth Substances|growth substances|mesh-ancestor
138518719|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
138518720|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518721|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
138518722|NCT00025545|Methotrexate|methotrexate|mesh-list
138518723|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518724|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
138518725|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518726|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518727|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518728|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
138518729|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518730|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518731|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518732|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138518733|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
138518734|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138518735|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518736|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
138518737|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518738|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518739|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138518740|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138518742|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518743|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
138518744|NCT00025623|Carboplatin|carboplatin|mesh-list
138518745|NCT00025623|Doxorubicin|doxorubicin|mesh-list
138518746|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138518747|NCT00025623|Etoposide|etoposide|mesh-list
138518748|NCT00025623|Vincristine|vincristine|mesh-list
138518749|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518750|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
138413063|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518751|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518753|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518754|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
138458858|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
138518755|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518756|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518757|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518758|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138518759|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518760|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518761|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518762|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518763|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518764|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518765|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
138518767|NCT00025740|Paroxetine|paroxetine|mesh-list
138518768|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138518769|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138518770|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138518771|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195146|NCT01350232|Fludarabine|fludarabine|mesh-list
138518772|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518773|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
138518774|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518775|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138518776|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
138518777|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138518778|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138699108|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138518779|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138518780|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518782|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
138518783|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
138518784|NCT00025779|Guanfacine|guanfacine|mesh-list
138518785|NCT00025779|Methylphenidate|methylphenidate|mesh-list
138518786|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138413119|NCT01637675|Tanshinone|tanshinone|mesh-list
138518787|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518788|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138518789|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138518790|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138518791|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518792|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
138518793|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518794|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138518795|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138518796|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138518797|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138518798|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138518799|NCT00026052|Riluzole|riluzole|mesh-list
138518800|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
138518801|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138518802|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138518803|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518804|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518805|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518806|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138518807|NCT00026052|Protective Agents|protective agents|mesh-ancestor
138518808|NCT00026091|Fenretinide|fenretinide|mesh-list
138518809|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413139|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518810|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138518811|NCT00026091|Protective Agents|protective agents|mesh-ancestor
138518812|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518813|NCT00026130|Gemcitabine|gemcitabine|mesh-list
138518814|NCT00026130|Fluorouracil|fluorouracil|mesh-list
138518815|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518816|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
138458872|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138518817|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518818|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518819|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518820|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
138518821|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518822|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
138518823|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518824|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518825|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518826|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518827|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138518828|NCT04808414|Polymyxins|polymyxins|mesh-list
138518829|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518830|NCT00026364|Leucovorin|leucovorin|mesh-list
138518831|NCT00026364|Fluorouracil|fluorouracil|mesh-list
138518832|NCT00026364|Irinotecan|irinotecan|mesh-list
138518833|NCT00026364|Gefitinib|gefitinib|mesh-list
138518834|NCT00026364|Calcium|calcium|mesh-list
138518835|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
138518836|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138518837|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518838|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
138518839|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518840|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518841|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518842|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518843|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
138518844|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518845|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138195224|NCT01269034|Hormones|hormones|mesh-ancestor
138518846|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413188|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138518849|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
138518850|NCT00026364|Vitamins|vitamins|mesh-ancestor
138518851|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
138518852|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138518853|NCT00026403|Gemcitabine|gemcitabine|mesh-list
138518854|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518855|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518856|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
138518857|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518858|NCT00026442|Capecitabine|capecitabine|mesh-list
138518859|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518860|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
138518861|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518862|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518863|NCT00026520|Interferons|interferons|mesh-list
138518864|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
138518865|NCT00026520|Thalidomide|thalidomide|mesh-list
138518866|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518867|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
138518868|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518869|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
138518870|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518871|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518872|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
138518873|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518874|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518875|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138518876|NCT00026520|Growth Substances|growth substances|mesh-ancestor
138518877|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
138518878|NCT00026637|Sertraline|sertraline|mesh-list
138518879|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
138518880|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138518881|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138518882|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138518883|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138518884|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518885|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138518886|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
138518887|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518889|NCT04610684|Etoposide|etoposide|mesh-list
138518890|NCT04610684|Atezolizumab|atezolizumab|mesh-list
138518891|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518892|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138518893|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518894|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518895|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215231|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138518896|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518897|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138518898|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138518899|NCT00027066|Aspirin|aspirin|mesh-list
138518900|NCT00027066|Warfarin|warfarin|mesh-list
138518901|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138518902|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138518903|NCT00027066|Analgesics|analgesics|mesh-ancestor
138518904|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
138518905|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518906|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518907|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518908|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518909|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138518910|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138518911|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518912|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138518913|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138518914|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518915|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
138518916|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
138518917|NCT04473950|Naloxone|naloxone|mesh-list
138518918|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138518919|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518920|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
138518921|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518922|NCT00027300|Natalizumab|natalizumab|mesh-list
138518923|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
138518924|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518925|NCT00395382|Alendronate|alendronate|mesh-list
138518926|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138518927|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518929|NCT00027339|Lopinavir|lopinavir|mesh-list
138518930|NCT00027339|Indinavir|indinavir|mesh-list
138518931|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
138518932|NCT00027339|Tenofovir|tenofovir|mesh-list
138518933|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138518934|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138518935|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
138518936|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413260|NCT01638325|Insulin|insulin|mesh-list
138518937|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518939|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138518940|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
138518941|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518942|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138518943|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138518944|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138518945|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138518946|NCT04206488|Digoxin|digoxin|mesh-list
138518947|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138518948|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138518949|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518950|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518951|NCT04206488|Protective Agents|protective agents|mesh-ancestor
138518952|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518953|NCT00027495|Curcumin|curcumin|mesh-list
138518954|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138518955|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138518956|NCT00027495|Analgesics|analgesics|mesh-ancestor
138518957|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
138518958|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518959|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518960|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138518961|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518962|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518963|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518964|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518965|NCT00027534|Metronidazole|metronidazole|mesh-list
138518966|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138518967|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138518968|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138518969|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138518970|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
138518971|NCT00027573|Methotrexate|methotrexate|mesh-list
138518972|NCT00027573|Fludarabine|fludarabine|mesh-list
138518973|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
138518975|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138518976|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
138518977|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518978|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138518979|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138518980|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
138518981|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518982|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518983|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138518984|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138518985|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
138518986|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138518987|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138518988|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
138518989|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
138518990|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518991|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138518992|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138518993|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138518994|NCT00027612|Irinotecan|irinotecan|mesh-list
138518995|NCT00027612|Carmustine|carmustine|mesh-list
138518996|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518997|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518998|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138518999|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519000|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519001|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519002|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
138519003|NCT00027690|Gefitinib|gefitinib|mesh-list
138519004|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519005|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138519006|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519007|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519008|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
138519009|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519010|NCT00027807|Aldesleukin|aldesleukin|mesh-list
138519011|NCT00027807|Molgramostim|molgramostim|mesh-list
138519012|NCT00027807|Sargramostim|sargramostim|mesh-list
138519013|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
138519014|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519015|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413326|NCT01638715|Infliximab|infliximab|mesh-list
138519017|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138519018|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
138519019|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519020|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
138519021|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138519022|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
138519023|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
138519024|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519025|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519026|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519027|NCT00392522|Analgesics|analgesics|mesh-ancestor
138519028|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
138519029|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519030|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
138519031|NCT00027885|Bevacizumab|bevacizumab|mesh-list
138519032|NCT00027885|Docetaxel|docetaxel|mesh-list
138519033|NCT00027885|Doxorubicin|doxorubicin|mesh-list
138519034|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138519035|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519036|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
138519037|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519038|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519039|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519040|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
138519041|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519042|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519043|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138519044|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519045|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138519046|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138519047|NCT00027885|Growth Substances|growth substances|mesh-ancestor
138519048|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
138519049|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519050|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519051|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519052|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138519053|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138519054|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519055|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519056|NCT00027924|Cyclosporine|cyclosporine|mesh-list
138519057|NCT00027924|Methotrexate|methotrexate|mesh-list
138519058|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
138519059|NCT00027924|Fludarabine|fludarabine|mesh-list
138519060|NCT00027924|Busulfan|busulfan|mesh-list
138519061|NCT00027924|Cyclosporins|cyclosporins|mesh-list
138519062|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138519063|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
138519064|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138519065|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413355|NCT01638858|Ranibizumab|ranibizumab|mesh-list
138519066|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519067|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
138519068|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519069|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519070|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138519071|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195448|NCT02518750|Analgesics|analgesics|mesh-ancestor
138519072|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138519073|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519074|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
138519075|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519076|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519077|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
138519078|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519079|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138519080|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
138519081|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519082|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138519083|NCT04022876|Carboplatin|carboplatin|mesh-list
138519084|NCT04022876|Pemetrexed|pemetrexed|mesh-list
138519085|NCT04022876|Topotecan|topotecan|mesh-list
138519086|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519087|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519088|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519089|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138519090|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519091|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138519092|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519093|NCT00027963|Gabapentin|gabapentin|mesh-list
138519094|NCT00027963|Analgesics|analgesics|mesh-ancestor
138519095|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
138351690|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138351691|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351692|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351693|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138351694|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138351695|NCT02912364|Analgesics|analgesics|mesh-ancestor
138351696|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
138351697|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351698|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138351699|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138351700|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351701|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138351702|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138519096|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519097|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519098|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
138519099|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138413400|NCT01638988|Metformin|metformin|mesh-list
138519100|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138519101|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519102|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519103|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138519104|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138519105|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519106|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519107|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
138519108|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138519109|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
138519110|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519111|NCT00395499|Risperidone|risperidone|mesh-list
138519112|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138519113|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
138519114|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519115|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519116|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519117|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138519118|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138519119|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519120|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519121|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138519122|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
138519123|NCT03960125|Imipramine|imipramine|mesh-list
138519124|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138519125|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
138519126|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519127|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138519128|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138519129|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519130|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519131|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138519132|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519133|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519134|NCT00395655|Hydralazine|hydralazine|mesh-list
138519135|NCT00395655|Valproic Acid|valproic acid|mesh-list
138519136|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
138519137|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519138|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519139|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
138519140|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519141|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519142|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
138519143|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138519144|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519145|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519146|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138519147|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
138519150|NCT00392561|Vitamins|vitamins|mesh-ancestor
138519151|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
138519152|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519153|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
138519154|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519155|NCT00392561|Protective Agents|protective agents|mesh-ancestor
138519156|NCT00392561|Trace Elements|trace elements|mesh-ancestor
138519157|NCT00028275|Interferons|interferons|mesh-list
138519158|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
138519159|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519160|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
138519161|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519162|NCT03959969|Ibuprofen|ibuprofen|mesh-list
138519163|NCT03959969|Oxycodone|oxycodone|mesh-list
138519164|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138519165|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519166|NCT03959969|Analgesics|analgesics|mesh-ancestor
138519167|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
138519168|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519169|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519170|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519171|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519172|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138519173|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519174|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519175|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138519176|NCT03959969|Narcotics|narcotics|mesh-ancestor
138519177|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519179|NCT00028314|Lopinavir|lopinavir|mesh-list
138519180|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138519181|NCT00028314|Nevirapine|nevirapine|mesh-list
138519182|NCT00028314|Abacavir|abacavir|mesh-list
138519183|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138519184|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138519185|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
138519186|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519187|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519188|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138519189|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138519190|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
138519191|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519192|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138519193|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138519195|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519196|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138519197|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138519198|NCT00028353|Toremifene|toremifene|mesh-list
138519199|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519200|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519201|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138519202|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138519203|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
138519204|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519205|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519206|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138519207|NCT03959852|Fentanyl|fentanyl|mesh-list
138519208|NCT03959852|Ketamine|ketamine|mesh-list
138519209|NCT03959852|Analgesics|analgesics|mesh-ancestor
138519210|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
138519211|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519212|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519213|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138519214|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138519215|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
138519216|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
138519217|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519218|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138519219|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138519220|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519221|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519222|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138519223|NCT03959852|Narcotics|narcotics|mesh-ancestor
138519225|NCT00028431|Ipilimumab|ipilimumab|mesh-list
138519226|NCT00028431|Antibodies|antibodies|mesh-list
138519227|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
138519228|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519229|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519230|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519231|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138519232|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519234|NCT00028587|Carboplatin|carboplatin|mesh-list
138519235|NCT00028587|Bortezomib|bortezomib|mesh-list
138519236|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519237|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519238|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519239|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519240|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519241|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519242|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
138519243|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138519244|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138519245|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138519246|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519247|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
138519248|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138519249|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
138519250|NCT00028665|Carmustine|carmustine|mesh-list
138519251|NCT00028665|Rituximab|rituximab|mesh-list
138519252|NCT00028665|Etoposide|etoposide|mesh-list
138519253|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519254|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
138519255|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519256|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519257|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519258|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
138519259|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519260|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519261|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138519262|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519263|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519264|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138519265|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519266|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519268|NCT03959540|Opicapone|opicapone|mesh-list
138519269|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138519270|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138519271|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
138519272|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519273|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519274|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519275|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138519276|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519277|NCT00028743|Paclitaxel|paclitaxel|mesh-list
138519278|NCT00028743|Carboplatin|carboplatin|mesh-list
138519279|NCT00028743|Topotecan|topotecan|mesh-list
138519280|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519281|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519282|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519283|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519284|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519285|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519286|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138519287|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519288|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519290|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138519291|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138519292|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519293|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138519294|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519295|NCT03959501|Incretins|incretins|mesh-ancestor
138519297|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195668|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
138519298|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138519299|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
138519300|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519302|NCT00028782|Imidazole|imidazole|mesh-list
138519303|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519304|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519305|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519306|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138519307|NCT00028821|Estradiol|estradiol|mesh-list
138519308|NCT00028821|Estrogens|estrogens|mesh-ancestor
138519309|NCT00028821|Hormones|hormones|mesh-ancestor
138519310|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519311|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519312|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519313|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519314|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519315|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519316|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413610|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519317|NCT03959384|Poractant alfa|poractant alfa|mesh-list
138519318|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138519319|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138519320|NCT00028860|Paclitaxel|paclitaxel|mesh-list
138519321|NCT00028860|Carboplatin|carboplatin|mesh-list
138519322|NCT00028860|Gemcitabine|gemcitabine|mesh-list
138519323|NCT00028860|Ifosfamide|ifosfamide|mesh-list
138519324|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519325|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519326|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519327|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519328|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519329|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519330|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519331|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
138519332|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519333|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
138519334|NCT00028899|Cytarabine|cytarabine|mesh-list
138519335|NCT00028899|Asparaginase|asparaginase|mesh-list
138519336|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
138519337|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
138519338|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519339|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
138519340|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519341|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519342|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
138519343|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519344|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519345|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
138519346|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519347|NCT00028899|Analgesics|analgesics|mesh-ancestor
138519348|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
138519349|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519350|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138519351|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519352|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519353|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519354|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
138519355|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
138519356|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138519357|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519358|NCT00028938|Paclitaxel|paclitaxel|mesh-list
138519359|NCT00028938|Carboplatin|carboplatin|mesh-list
138519360|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
138519361|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519362|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519364|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519365|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519366|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519367|NCT00028938|Hematinics|hematinics|mesh-ancestor
138519368|NCT00029250|Allicin|allicin|mesh-list
138519369|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519370|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138519371|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
138519372|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519373|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138519374|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
138519376|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519378|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138519379|NCT03959150|Capecitabine|capecitabine|mesh-list
138519380|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519381|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
138519382|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519383|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519384|NCT00029328|Etanercept|etanercept|mesh-list
138519385|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138519386|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519387|NCT00029328|Analgesics|analgesics|mesh-ancestor
138519388|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
138519389|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519390|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519391|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519392|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519393|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138519394|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519395|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
138519396|NCT00029523|Cytarabine|cytarabine|mesh-list
138519397|NCT00029523|Methotrexate|methotrexate|mesh-list
138519398|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138519399|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
138519400|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138519401|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519402|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519403|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
138519404|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519405|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519406|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138519407|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519408|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138519409|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519410|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
138519411|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519412|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519414|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519415|NCT00392717|Atorvastatin|atorvastatin|mesh-list
138519416|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138519417|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138519418|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
138519419|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519420|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138519421|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138519422|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519423|NCT00029679|Borage oil|borage oil|mesh-list
138519424|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519425|NCT03958799|Vaccines|vaccines|mesh-list
138519426|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
138519427|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519428|NCT00029757|Estrogens|estrogens|mesh-list
138519429|NCT00029757|Hormones|hormones|mesh-ancestor
138519430|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519431|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519432|NCT00029835|Rimonabant|rimonabant|mesh-list
138519433|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138519434|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138519435|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138519436|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519437|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519438|NCT00029835|Hormones|hormones|mesh-ancestor
138519439|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519440|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519441|NCT00395772|Vitamin K|vitamin k|mesh-list
138519442|NCT00395772|Heparin|heparin|mesh-list
138519443|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
138519444|NCT00395772|Vitamins|vitamins|mesh-ancestor
138519445|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
138519446|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519447|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
138519448|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138195826|NCT04331626|Gemcitabine|gemcitabine|mesh-list
138519450|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519451|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138519452|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
138519453|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138519454|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138519455|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519456|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138519457|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
138519458|NCT00395772|Coagulants|coagulants|mesh-ancestor
138519459|NCT00029874|Minocycline|minocycline|mesh-list
138519460|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138519461|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519462|NCT00030030|Silymarin|silymarin|mesh-list
138519463|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
138519464|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519465|NCT00030030|Protective Agents|protective agents|mesh-ancestor
138519466|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519467|NCT00030069|Calcitriol|calcitriol|mesh-list
138519468|NCT00030069|Dexamethasone|dexamethasone|mesh-list
138699321|NCT06022419|Calpastatin|calpastatin|mesh-list
138519469|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519470|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
138519471|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
138519472|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519473|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519474|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138519475|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
138519476|NCT00030069|Hormones|hormones|mesh-ancestor
138519477|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519478|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519479|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519480|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138519481|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138519482|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413747|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
138519483|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519485|NCT00030069|Vitamins|vitamins|mesh-ancestor
138519486|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
138519487|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138519488|NCT03958097|Antibodies|antibodies|mesh-list
138519489|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
138519490|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519491|NCT00030342|Interferons|interferons|mesh-list
138519492|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
138519493|NCT00030342|Fluorouracil|fluorouracil|mesh-list
138519494|NCT00030342|Sargramostim|sargramostim|mesh-list
138519495|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
138519496|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519497|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519498|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519499|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519500|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
138519501|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519502|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
138519503|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519504|NCT00030381|Esorubicin|esorubicin|mesh-list
138519505|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138519506|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519507|NCT00030420|Celecoxib|celecoxib|mesh-list
138519508|NCT00030420|Docetaxel|docetaxel|mesh-list
138519509|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519510|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519511|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519512|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519513|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519514|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138519515|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519516|NCT00030420|Analgesics|analgesics|mesh-ancestor
138519517|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
138519518|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519519|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519520|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413788|NCT01650181|Vitamins|vitamins|mesh-ancestor
138519521|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519522|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138519523|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138195891|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138519524|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519525|NCT00030459|Vinorelbine|vinorelbine|mesh-list
138519527|NCT00030459|Mitomycin|mitomycin|mesh-list
138519528|NCT00030459|Vinblastine|vinblastine|mesh-list
138519529|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519530|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519531|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519532|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519533|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519534|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519535|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138519536|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
138519537|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519538|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519539|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138519540|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519541|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138519542|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519543|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519544|NCT03873857|Venetoclax|venetoclax|mesh-list
138519545|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519546|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138519547|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519548|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138519549|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519550|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519551|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138519552|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519553|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138519554|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519555|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519556|NCT00030615|Decitabine|decitabine|mesh-list
138519557|NCT00030615|Azacitidine|azacitidine|mesh-list
138519558|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519559|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
138519560|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519561|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519562|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519563|NCT03857087|Edetic Acid|edetic acid|mesh-list
138519564|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138459029|NCT06071481|Vitamins|vitamins|mesh-list
138519565|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
138519566|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
138519567|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519568|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
138519569|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138519570|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138519571|NCT00030654|Ketoconazole|ketoconazole|mesh-list
138519572|NCT00030654|Vinblastine|vinblastine|mesh-list
138519573|NCT00030654|Docetaxel|docetaxel|mesh-list
138519574|NCT00030654|Doxorubicin|doxorubicin|mesh-list
138519575|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138519576|NCT00030654|Bicalutamide|bicalutamide|mesh-list
138519577|NCT00030654|Flutamide|flutamide|mesh-list
138519578|NCT00030654|Estramustine|estramustine|mesh-list
138519579|NCT00030654|Hormones|hormones|mesh-list
138519580|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519581|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519583|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519584|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
138699346|NCT06021951|Antimetabolites|antimetabolites|mesh-ancestor
138519585|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519586|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138519587|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138519588|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138519589|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519590|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519591|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519592|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
138519593|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519594|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138519595|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138519596|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138519597|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138519599|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
138519600|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519601|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519602|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
138519603|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
138519604|NCT03852407|Melphalan|melphalan|mesh-list
138519605|NCT03852407|Fludarabine|fludarabine|mesh-list
138519606|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
138519607|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519608|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
138519609|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519610|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519611|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519612|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
138413909|NCT01650740|Analgesics|analgesics|mesh-ancestor
138519613|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519614|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519615|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138519616|NCT00030693|Metronidazole|metronidazole|mesh-list
138519617|NCT00030693|Vaccines|vaccines|mesh-list
138519618|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
138519619|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519620|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519621|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138519622|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138519623|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138519624|NCT03823274|Aspirin|aspirin|mesh-list
138519625|NCT03823274|Clopidogrel|clopidogrel|mesh-list
138519626|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138519627|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519628|NCT03823274|Analgesics|analgesics|mesh-ancestor
138519629|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
138519630|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459052|NCT06070948|Venetoclax|venetoclax|mesh-list
138519631|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519632|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519633|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519634|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138519635|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138519636|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519637|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138519638|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138519639|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519640|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
138413952|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
138519641|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138519642|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138519644|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
138519645|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519646|NCT00030732|Gemcitabine|gemcitabine|mesh-list
138519647|NCT00030732|Capecitabine|capecitabine|mesh-list
138519648|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519649|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
138519650|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519651|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519652|NCT00030810|Docetaxel|docetaxel|mesh-list
138519653|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519654|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519655|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519656|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519657|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519658|NCT00030849|Interferons|interferons|mesh-list
138519659|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
138519660|NCT00030849|Bexarotene|bexarotene|mesh-list
138519661|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519662|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
138519663|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519664|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
138519665|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519666|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138519667|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519668|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138519669|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519670|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519671|NCT00030966|Natalizumab|natalizumab|mesh-list
138519672|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
138519674|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
138519675|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519676|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519677|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138519678|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519680|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138519681|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138519682|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519683|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138519684|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138519685|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
138519686|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519687|NCT03698006|Ropivacaine|ropivacaine|mesh-list
138519688|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138519689|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
138519690|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
138459053|NCT06070948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519691|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699393|NCT06021587|Simendan|simendan|mesh-list
138519692|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519693|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
138519694|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519695|NCT00031083|Interferons|interferons|mesh-list
138519696|NCT00031083|Interferon-beta|interferon-beta|mesh-list
138519697|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519698|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
138519699|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519700|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
138519701|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519702|NCT03559985|Acetaminophen|acetaminophen|mesh-list
138519703|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519704|NCT03559985|Analgesics|analgesics|mesh-ancestor
138519705|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
138519706|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519707|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519708|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
138519709|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
138519710|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138519711|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138519712|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519713|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519714|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519715|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138519716|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138519717|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519718|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519719|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519720|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
138519721|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138414030|NCT01651481|Montelukast|montelukast|mesh-list
138519722|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
138519723|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138519724|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138519725|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519726|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138519727|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
138519728|NCT00392912|Testosterone|testosterone|mesh-list
138519729|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
138519730|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
138519731|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138519732|NCT00392912|Androgens|androgens|mesh-ancestor
138519733|NCT00392912|Hormones|hormones|mesh-ancestor
138519734|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519735|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519736|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519737|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519738|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
138519739|NCT04712058|Tenofovir|tenofovir|mesh-list
138519740|NCT04712058|Emtricitabine|emtricitabine|mesh-list
138519741|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138519742|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
138519743|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519744|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138519745|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519746|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519747|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519748|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138519749|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138519750|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
138519752|NCT00393107|Fludarabine|fludarabine|mesh-list
138519753|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519754|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
138459068|NCT06070753|Cerebrolysin|cerebrolysin|mesh-list
138519755|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519756|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519757|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138519758|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
138519759|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519760|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519761|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138519762|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519764|NCT04711668|Ketamine|ketamine|mesh-list
138519765|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
138519766|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
138519767|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519768|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519769|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
138519770|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519771|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138519772|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138519773|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138519774|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519775|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519776|NCT04711668|Analgesics|analgesics|mesh-ancestor
138519777|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138519778|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138519779|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
138519780|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138519781|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138519782|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519783|NCT00031161|Nitisinone|nitisinone|mesh-list
138519784|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519785|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519786|NCT00031278|Trastuzumab|trastuzumab|mesh-list
138519787|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519788|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519789|NCT00031317|Clozapine|clozapine|mesh-list
138519790|NCT00031317|Paroxetine|paroxetine|mesh-list
138519791|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138519792|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138519793|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519794|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519795|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519796|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
138519797|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519798|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138519799|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
138519800|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138519801|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138519802|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138519803|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519804|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138519805|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138519806|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138519807|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138519808|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
138519809|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
138519810|NCT00396045|Lenalidomide|lenalidomide|mesh-list
138519811|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
138519812|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519813|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138519814|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138519815|NCT00396045|Growth Substances|growth substances|mesh-ancestor
138519816|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
138519817|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519818|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138519819|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138519820|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138519821|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
138519822|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188473|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519823|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138519824|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138519825|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519827|NCT00031395|Methylphenidate|methylphenidate|mesh-list
138351796|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
138351797|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138351798|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351800|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
138351801|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351804|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
138351806|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351807|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138351808|NCT02956122|Protective Agents|protective agents|mesh-ancestor
138351809|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351810|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351812|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351813|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138351814|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138351815|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
138351816|NCT02956746|Antibodies|antibodies|mesh-list
138351817|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
138351818|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138351820|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
138351821|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351822|NCT02967354|Tryptophan|tryptophan|mesh-list
138351824|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138351825|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
138519828|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138519829|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519830|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138519831|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138519832|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519833|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519834|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
138519835|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519836|NCT00031395|Analgesics|analgesics|mesh-ancestor
138519837|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
138519838|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519839|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138519840|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
138519841|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
138519842|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138519843|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138519844|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138519845|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
138519846|NCT00031434|Valganciclovir|valganciclovir|mesh-list
138519847|NCT00031434|Ganciclovir|ganciclovir|mesh-list
138519848|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138519849|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
138519850|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519851|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138519852|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519853|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519854|NCT03152123|Phentermine|phentermine|mesh-list
138519855|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138519856|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519857|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
138519858|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138519859|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
138519860|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
138519861|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519862|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138519863|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519864|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519865|NCT00031473|Ribavirin|ribavirin|mesh-list
138519866|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
138519867|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519868|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
138519869|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519870|NCT00031629|Gemcitabine|gemcitabine|mesh-list
138519871|NCT00031629|Docetaxel|docetaxel|mesh-list
138519872|NCT00031629|Lenograstim|lenograstim|mesh-list
138519873|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138519874|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
138519875|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519876|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519877|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519878|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519879|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519880|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138459091|NCT06070636|Lenvatinib|lenvatinib|mesh-list
138519882|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519883|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
138519884|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138479968|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
138519885|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519886|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138519887|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519888|NCT00031707|Megestrol|megestrol|mesh-list
138519889|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
138519890|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138519891|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138519892|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138519893|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
138519894|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138519895|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196271|NCT02598778|Listerine|listerine|mesh-list
138519896|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138519897|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138519898|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519899|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519900|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
138519901|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138519903|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
138519904|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
138519905|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519906|NCT00031785|Megestrol|megestrol|mesh-list
138519907|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
138519908|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138519909|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138519910|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138519911|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
138519912|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138519913|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519914|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138519915|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138519916|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519917|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519918|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
138519919|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138519920|NCT03151772|Metformin|metformin|mesh-list
138519921|NCT03151772|Disulfiram|disulfiram|mesh-list
138519922|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138519923|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519924|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138519925|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138519926|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519927|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519929|NCT02971644|Trace Elements|trace elements|mesh-ancestor
138519930|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
138519931|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519932|NCT00031824|Cyclosporine|cyclosporine|mesh-list
138519933|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
138519934|NCT00031824|Prednisone|prednisone|mesh-list
138519935|NCT00031824|Tacrolimus|tacrolimus|mesh-list
138519936|NCT00031824|Cyclosporins|cyclosporins|mesh-list
138519937|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519938|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
138519939|NCT00031824|Hormones|hormones|mesh-ancestor
138519940|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519941|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519942|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519943|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519944|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138519945|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
138519946|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138519947|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459105|NCT06069856|Iron|iron|mesh-list
138519948|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519949|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
138519950|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138519951|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
138519952|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519953|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
138519954|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138519955|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138519956|NCT00031863|Rofecoxib|rofecoxib|mesh-list
138519957|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138519958|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138519959|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519960|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519961|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138519962|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138519963|NCT00031863|Analgesics|analgesics|mesh-ancestor
138519964|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
138519965|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519966|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519967|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519968|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519969|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138196348|NCT00500890|Carboplatin|carboplatin|mesh-list
138519970|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
138519971|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138519972|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519973|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519974|NCT00031902|Prednisolone|prednisolone|mesh-list
138519975|NCT00031902|Rituximab|rituximab|mesh-list
138519976|NCT00031902|Vincristine|vincristine|mesh-list
138519977|NCT00031902|Bleomycin|bleomycin|mesh-list
138519978|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519979|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138519980|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
138519981|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519982|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519983|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138519984|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
138519985|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
138519986|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
138519987|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519988|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138519989|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
138519990|NCT00031902|Hormones|hormones|mesh-ancestor
138519991|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138519992|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519993|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138519994|NCT00031941|Lenalidomide|lenalidomide|mesh-list
138519995|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
138519996|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138519997|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138519998|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138519999|NCT00031941|Growth Substances|growth substances|mesh-ancestor
138520000|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
138520001|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520002|NCT00031980|Cyclosporine|cyclosporine|mesh-list
138520003|NCT00031980|Cyclosporins|cyclosporins|mesh-list
138459107|NCT06069856|Folic Acid|folic acid|mesh-list
138459108|NCT06069856|Micronutrients|micronutrients|mesh-list
138414266|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
138520004|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520005|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520006|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520007|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
138520008|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520009|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
138520010|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520011|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520012|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520013|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138520015|NCT03151499|BI 409306|bi 409306|mesh-list
138520016|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138520017|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
138520018|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138520019|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520020|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
138520021|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520022|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520023|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520024|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138520025|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138520026|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138520027|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138520028|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138520029|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138520030|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138520031|NCT00032019|Prednisone|prednisone|mesh-list
138520032|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
138520033|NCT00032019|Rituximab|rituximab|mesh-list
138520034|NCT00032019|Doxorubicin|doxorubicin|mesh-list
138520035|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138414291|NCT01652586|Remifentanil|remifentanil|mesh-list
138520037|NCT00032019|Vincristine|vincristine|mesh-list
138520038|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520039|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
138520040|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520041|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520042|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138520043|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
138699541|NCT05963347|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520044|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520046|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138520047|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138520048|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138520049|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138520050|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138520051|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520052|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520053|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
138520054|NCT00032019|Hormones|hormones|mesh-ancestor
138520055|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520056|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138520057|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138520058|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520059|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520060|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520061|NCT03151460|Dopamine|dopamine|mesh-list
138520062|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
138520063|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138520064|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
138520065|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
138520066|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520067|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520068|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520069|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520070|NCT03151460|Protective Agents|protective agents|mesh-ancestor
138520071|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
138520072|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520073|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138520074|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520075|NCT03151382|Tandospirone|tandospirone|mesh-list
138520076|NCT03151382|Donepezil|donepezil|mesh-list
138520077|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520078|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138520079|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520080|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
138520081|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520082|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520083|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
138520084|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138520085|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520086|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520087|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520088|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138520089|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
138520090|NCT00032136|Tamoxifen|tamoxifen|mesh-list
138520091|NCT00032136|Exemestane|exemestane|mesh-list
138520092|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520093|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138520094|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520095|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520096|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520097|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138520098|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520099|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138520100|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138520101|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138520102|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138520103|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138520104|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520105|NCT03151343|Empagliflozin|empagliflozin|mesh-list
138520106|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138520107|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520108|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138520109|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520110|NCT00032175|Gemcitabine|gemcitabine|mesh-list
138520111|NCT00032175|Capecitabine|capecitabine|mesh-list
138520112|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520113|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
138520114|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520115|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520116|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
138520118|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
138520119|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138520120|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138520121|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520122|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520123|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520124|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520125|NCT00032292|Visilizumab|visilizumab|mesh-list
138520126|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
138520127|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520128|NCT00032799|Natalizumab|natalizumab|mesh-list
138520129|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
138520130|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520131|NCT03150836|Durvalumab|durvalumab|mesh-list
138520132|NCT03150836|Tremelimumab|tremelimumab|mesh-list
138520133|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138520134|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520135|NCT00032838|Yohimbine|yohimbine|mesh-list
138520136|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
138520137|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
138520138|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520139|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520140|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138520141|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138520142|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138520143|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520144|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520145|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520146|NCT00032838|Urological Agents|urological agents|mesh-ancestor
138520147|NCT03150680|Clopidogrel|clopidogrel|mesh-list
138520148|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138520149|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138520150|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138520151|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138520152|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
138520153|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520154|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520155|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520156|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
138520157|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138520158|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
138520159|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520160|NCT00396396|Expectorants|expectorants|mesh-ancestor
138520161|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
138520162|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138520163|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
138520164|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520165|NCT00396396|Protective Agents|protective agents|mesh-ancestor
138520166|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520167|NCT00396396|Antidotes|antidotes|mesh-ancestor
138520168|NCT00032955|Buprenorphine|buprenorphine|mesh-list
138520169|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138520170|NCT00032955|Naloxone|naloxone|mesh-list
138520171|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138520172|NCT00032955|Narcotics|narcotics|mesh-ancestor
138520173|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520174|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520175|NCT00032955|Analgesics|analgesics|mesh-ancestor
138520176|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
138520177|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520178|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138520179|NCT03150524|Verapamil|verapamil|mesh-list
138520180|NCT03150524|Nimodipine|nimodipine|mesh-list
138520181|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138520182|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138520183|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414454|NCT01653457|Memantine|memantine|mesh-list
138520184|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351826|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138351827|NCT02968134|Posaconazole|posaconazole|mesh-list
138351828|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
138351829|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351830|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138351831|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138351832|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138351833|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138351834|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351835|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351836|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351837|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138351838|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
138352203|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520185|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520186|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520187|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138520188|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138520190|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138520191|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520192|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520193|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520194|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520195|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520196|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138520197|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138520198|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520199|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520200|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520201|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520202|NCT03150368|Docetaxel|docetaxel|mesh-list
138520203|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520204|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520205|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520206|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520207|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520208|NCT00033072|Selegiline|selegiline|mesh-list
138520209|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520210|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520211|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138520212|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138520213|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138520214|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520215|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520216|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138520217|NCT00033072|Protective Agents|protective agents|mesh-ancestor
138520218|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520219|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138520220|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138520221|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520222|NCT00033111|Cabergoline|cabergoline|mesh-list
138520223|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138520224|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138520225|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
138520226|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
138520227|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520228|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520229|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520230|NCT00033189|Ubiquinone|ubiquinone|mesh-list
138520231|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
138520232|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
138520233|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520234|NCT00033189|Vitamins|vitamins|mesh-ancestor
138520235|NCT00033267|Sirolimus|sirolimus|mesh-list
138520236|NCT00033267|Temsirolimus|temsirolimus|mesh-list
138520237|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
138520238|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138520239|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459172|NCT06065592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138520240|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520241|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520242|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
138520243|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520244|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520245|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138520246|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520247|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138520248|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
138520250|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138520251|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138520252|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520253|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520254|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520256|NCT02984384|Heparin|heparin|mesh-list
138520257|NCT02984384|Enoxaparin|enoxaparin|mesh-list
138520258|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138520259|NCT02984384|Tinzaparin|tinzaparin|mesh-list
138520260|NCT02984384|Dalteparin|dalteparin|mesh-list
138520261|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138520262|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520263|NCT02984384|Analgesics|analgesics|mesh-ancestor
138520264|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
138414525|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520265|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520266|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520267|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520268|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520269|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138520270|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138520271|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520272|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138520273|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138520276|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
138520277|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
138520278|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138520279|NCT00033345|Protective Agents|protective agents|mesh-ancestor
138520280|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520281|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520282|NCT00033423|Rituximab|rituximab|mesh-list
138520283|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138520284|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520285|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
138520286|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520287|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520288|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138520289|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520290|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138520291|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520292|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520293|NCT00393263|Clobetasol|clobetasol|mesh-list
138520294|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
138520295|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520296|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
138520297|NCT00393263|Hormones|hormones|mesh-ancestor
138520298|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520299|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520300|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138520301|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520302|NCT00393263|Analgesics|analgesics|mesh-ancestor
138520303|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
138520304|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520306|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520307|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520308|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
138520309|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138520310|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414550|NCT01654146|Carboplatin|carboplatin|mesh-list
138520311|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520312|NCT00033618|Epothilones|epothilones|mesh-list
138520313|NCT00033618|Epothilone B|epothilone b|mesh-list
138520314|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520315|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520316|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520317|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520318|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520319|NCT00033696|Paclitaxel|paclitaxel|mesh-list
138520320|NCT00033696|Etoposide|etoposide|mesh-list
138520321|NCT00033696|Carboplatin|carboplatin|mesh-list
138520322|NCT00033696|Topotecan|topotecan|mesh-list
138520323|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138520324|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520325|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520326|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520327|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520328|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520329|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138520330|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138520331|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520332|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138520333|NCT00033735|Fluorouracil|fluorouracil|mesh-list
138520334|NCT00033735|Irofulven|irofulven|mesh-list
138520335|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
138520336|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520337|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520338|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520339|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520340|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
138520341|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520342|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138520343|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
138520344|NCT00033813|Oxatomide|oxatomide|mesh-list
138520345|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138520346|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
138520347|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
138520348|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520349|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520350|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520351|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138520352|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138520353|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
138520354|NCT00033891|Infliximab|infliximab|mesh-list
138520355|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138520356|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520357|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520358|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520359|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520360|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
138520361|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
138520362|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
138520363|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138520364|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138520365|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520366|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414581|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138520367|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520368|NCT02149823|Oxytocin|oxytocin|mesh-list
138520369|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
138520370|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520371|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520372|NCT02971410|Simvastatin|simvastatin|mesh-list
138520373|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138520374|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138520375|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
138520376|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520377|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138520378|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138520379|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520380|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
138520381|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138520382|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138520383|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138520384|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520385|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520386|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
138520387|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520388|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520389|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138520390|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520391|NCT00034047|Nafarelin|nafarelin|mesh-list
138520392|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138520393|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
138520394|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520395|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520396|NCT00034086|Ritonavir|ritonavir|mesh-list
138520397|NCT00034086|Lopinavir|lopinavir|mesh-list
138520398|NCT00034086|Tenofovir|tenofovir|mesh-list
138520399|NCT00034086|Lamivudine|lamivudine|mesh-list
138520400|NCT00034086|Zidovudine|zidovudine|mesh-list
138520401|NCT00034086|Didanosine|didanosine|mesh-list
138520402|NCT00034086|Stavudine|stavudine|mesh-list
138520403|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138520404|NCT00034086|Vaccines|vaccines|mesh-list
138520405|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138520406|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
138520407|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520408|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138520409|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138520410|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
138520411|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520412|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520413|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138520414|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138520415|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
138520416|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520417|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138520418|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138352189|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352190|NCT02856126|Sorafenib|sorafenib|mesh-list
138352191|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352192|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138352193|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352196|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138352197|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138352198|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138352199|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352200|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352201|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352202|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520419|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138520420|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520421|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
138520423|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138520424|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520425|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520426|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520427|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138520428|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520429|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138520430|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138520431|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138520432|NCT00034164|Paclitaxel|paclitaxel|mesh-list
138520433|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138520434|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520435|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520436|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520437|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520438|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520439|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
138520440|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138520441|NCT00034242|Antibodies|antibodies|mesh-list
138520442|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
138520443|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138520444|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
138520445|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520446|NCT01807325|Pancrelipase|pancrelipase|mesh-list
138520447|NCT01807325|Pancreatin|pancreatin|mesh-list
138520448|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520449|NCT01807286|Dexamethasone|dexamethasone|mesh-list
138520450|NCT01807286|Melphalan|melphalan|mesh-list
138520451|NCT01807286|Pomalidomide|pomalidomide|mesh-list
138520452|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520453|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
138520454|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
138520455|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520456|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520457|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520458|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
138520459|NCT01807286|Hormones|hormones|mesh-ancestor
138699652|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138520460|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520461|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138520462|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520463|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138520464|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
138520465|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520466|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138520467|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520468|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
138520469|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138520470|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138520471|NCT01807286|Growth Substances|growth substances|mesh-ancestor
138520472|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
138520474|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138414660|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520475|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520476|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520477|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520478|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
138520479|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520480|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138520481|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138520482|NCT00034593|Gemcitabine|gemcitabine|mesh-list
138520483|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520484|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
138520485|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520486|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520487|NCT00034632|Posaconazole|posaconazole|mesh-list
138520488|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
138520489|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520490|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138520491|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138520492|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138520493|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138520494|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138520495|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520496|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520497|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138520498|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520499|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520500|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520501|NCT00034671|Posaconazole|posaconazole|mesh-list
138520502|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
138520503|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520504|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138520505|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138520506|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138520507|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138520508|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138520509|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520510|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520511|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138520512|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520513|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520514|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520516|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
138414710|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
138520517|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
138520518|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
138520519|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138520520|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138520521|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520522|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520523|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520524|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138520525|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138520526|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520527|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138520528|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
138520529|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138520530|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138520531|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520532|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520533|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138520534|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138520535|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
138520536|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138520537|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138520538|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520539|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138520540|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138520541|NCT00034710|Capsaicin|capsaicin|mesh-list
138520542|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
138520543|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520544|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
138520545|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459252|NCT06001762|Tamoxifen|tamoxifen|mesh-list
138520546|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520547|NCT00034749|Risperidone|risperidone|mesh-list
138520548|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138520549|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
138520550|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520551|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520552|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520553|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520554|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520555|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520556|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520557|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138520558|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
138520559|NCT00034788|Becaplermin|becaplermin|mesh-list
138520560|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
138520561|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138520562|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138520563|NCT00034788|Growth Substances|growth substances|mesh-ancestor
138520564|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520565|NCT00034866|Tipranavir|tipranavir|mesh-list
138520566|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138520567|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
138520568|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138520569|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138520570|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
138520571|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520572|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520573|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520574|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138520575|NCT00034905|Risperidone|risperidone|mesh-list
138520576|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138520577|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138520578|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
138520579|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520580|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520581|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520582|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520583|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520584|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414781|NCT01655316|Verapamil|verapamil|mesh-list
138520585|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520586|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138520587|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
138520588|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520589|NCT01806311|Amlodipine|amlodipine|mesh-list
138520590|NCT01806311|Candesartan|candesartan|mesh-list
138520591|NCT01806311|Candesartan cilexetil|candesartan cilexetil|mesh-list
138520592|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138520593|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138520594|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520595|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520596|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520597|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520598|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138520599|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138520600|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138520601|NCT00034944|Aprepitant|aprepitant|mesh-list
138520602|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
138520603|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
138520604|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520605|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520606|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520607|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138520608|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520609|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520610|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
138520611|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
138520612|NCT01806272|Vitamins|vitamins|mesh-ancestor
138520613|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
138520614|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520615|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
138520616|NCT01806272|Hematinics|hematinics|mesh-ancestor
138520617|NCT00034983|Aprepitant|aprepitant|mesh-list
138520618|NCT00034983|Paroxetine|paroxetine|mesh-list
138414816|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
138520619|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138520620|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138520621|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520622|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520623|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520624|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
138520625|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520626|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138520627|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520628|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520629|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138520630|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138520632|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
138520633|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
138520634|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520635|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520636|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138520637|NCT00035061|Pemetrexed|pemetrexed|mesh-list
138520638|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520639|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520640|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197032|NCT00001930|Amantadine|amantadine|mesh-list
138520641|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138520642|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520644|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138520645|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520646|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138520647|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138520648|NCT00393497|Growth Substances|growth substances|mesh-ancestor
138520649|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520650|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
138520651|NCT00035100|Epothilones|epothilones|mesh-list
138520652|NCT00035100|Epothilone B|epothilone b|mesh-list
138520653|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
138520654|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
138520655|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520656|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520657|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520658|NCT00035139|Methylphenidate|methylphenidate|mesh-list
138520659|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138520660|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520661|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138520662|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138520663|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459277|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
138520664|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520666|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520667|NCT00035178|Argatroban|argatroban|mesh-list
138520668|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
138520669|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138520670|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
138520671|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520672|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520673|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
138520674|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138520675|NCT00393614|Levetiracetam|levetiracetam|mesh-list
138520676|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
138520677|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
138520678|NCT00035256|Teriparatide|teriparatide|mesh-list
138520679|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138520680|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520681|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520682|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138520683|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138520684|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520685|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520686|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138520687|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138520689|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
138520690|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
138520691|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520692|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414888|NCT01655888|Tremelimumab|tremelimumab|mesh-list
138520694|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138520695|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520696|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520697|NCT01806116|Decitabine|decitabine|mesh-list
138520698|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520699|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
138520700|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520701|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520702|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520703|NCT00035451|Sotalol|sotalol|mesh-list
138520704|NCT00035451|Azimilide|azimilide|mesh-list
138520705|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138520706|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138520707|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520708|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520709|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520710|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520711|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138520712|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
138459312|NCT05866315|Desflurane|desflurane|mesh-list
138520713|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
138520714|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520716|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520717|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520718|NCT01805999|Psyllium|psyllium|mesh-list
138520719|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
138520720|NCT01805999|Cathartics|cathartics|mesh-ancestor
138520721|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520722|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
138520723|NCT00035490|Azimilide|azimilide|mesh-list
138520724|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138520725|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138520726|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520727|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520728|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520729|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520730|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
138520731|NCT00035607|Hematinics|hematinics|mesh-ancestor
138520732|NCT02971254|Sevoflurane|sevoflurane|mesh-list
138520733|NCT02971254|Desflurane|desflurane|mesh-list
138520734|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138520735|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138520736|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
138520737|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
138520738|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520739|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520741|NCT01805882|Ledipasvir|ledipasvir|mesh-list
138520742|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
138520743|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520744|NCT00035802|Topiramate|topiramate|mesh-list
138520745|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
138520746|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138520747|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520748|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
138520749|NCT04732377|Bupivacaine|bupivacaine|mesh-list
138520750|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
138520751|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
138520752|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520753|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520754|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
138520755|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520756|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138520757|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520758|NCT04732377|Analgesics|analgesics|mesh-ancestor
138520759|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138520760|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138520761|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138520762|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520763|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520764|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520765|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
138520767|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138520768|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520769|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520770|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520771|NCT01805726|Analgesics|analgesics|mesh-ancestor
138520772|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
138520773|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520774|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138520775|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138520776|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138520777|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
138520778|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520779|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520780|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138520781|NCT01805726|Narcotics|narcotics|mesh-ancestor
138520782|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138520783|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
138520784|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
138520785|NCT00035958|Prednisone|prednisone|mesh-list
138520786|NCT00035958|Etanercept|etanercept|mesh-list
138520787|NCT00035958|Methotrexate|methotrexate|mesh-list
138520788|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520789|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
138520790|NCT00035958|Hormones|hormones|mesh-ancestor
138520791|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520792|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520793|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138520794|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520795|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138520797|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520798|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520799|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
138520800|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520801|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520802|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520803|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138520804|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520805|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
138520806|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520807|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520808|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138520809|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520810|NCT00035958|Analgesics|analgesics|mesh-ancestor
138520811|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
138520812|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520813|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520814|NCT01805687|Zileuton|zileuton|mesh-list
138520815|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138520816|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138520817|NCT01805687|Analgesics|analgesics|mesh-ancestor
138699746|NCT05338619|Lazertinib|lazertinib|mesh-list
138520818|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
138520819|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520820|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520821|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520822|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520823|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138520824|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520825|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520826|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138520827|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138520828|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520829|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
138520830|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138520831|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520832|NCT01805570|Ticagrelor|ticagrelor|mesh-list
138520833|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138520834|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138520835|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138459357|NCT05741502|Olanzapine|olanzapine|mesh-list
138520836|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138520837|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138520838|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
138520839|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520840|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520841|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520843|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138520844|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
138520845|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138520846|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
138520847|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520848|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520849|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
138520850|NCT00036114|Aripiprazole|aripiprazole|mesh-list
138520851|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520852|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520853|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520854|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520855|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520856|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520857|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
138520858|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
138520859|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520860|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520861|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138520862|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138520863|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
138520864|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138520865|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138520866|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138520867|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138520868|NCT01805453|Losartan|losartan|mesh-list
138520869|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138520870|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138520871|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138520872|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138415079|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
138520873|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520874|NCT00036153|Methotrexate|methotrexate|mesh-list
138520875|NCT00036153|Tacrolimus|tacrolimus|mesh-list
138520876|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138520877|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
138520878|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520879|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520880|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138520881|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
138699755|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
138520882|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520883|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520884|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520885|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520886|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138520887|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520888|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
138520889|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138520890|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138520891|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138520892|NCT00036231|Secretin|secretin|mesh-list
138520893|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520894|NCT00036231|Hormones|hormones|mesh-ancestor
138520895|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520896|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459358|NCT05741502|Risperidone|risperidone|mesh-list
138520897|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138520898|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138520899|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138520900|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138520901|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520902|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520903|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520905|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
138520906|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520907|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520908|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520909|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
138520911|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520912|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520913|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520914|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520915|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520916|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520917|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
138520918|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
138520919|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520920|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520921|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138520922|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138520923|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
138520924|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138520925|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138520926|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138520927|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138520929|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138520930|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138520931|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
138520932|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520933|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415160|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138520934|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
138520935|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
138520936|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520937|NCT01466543|Udenafil|udenafil|mesh-list
138520938|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138520939|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138520940|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520941|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520942|NCT01466465|Vitamin D|vitamin d|mesh-list
138520943|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
138520944|NCT01466465|Vitamins|vitamins|mesh-ancestor
138520945|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
138520946|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520947|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138520948|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138520949|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
138520950|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138520951|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520952|NCT00036543|Atrasentan|atrasentan|mesh-list
138520953|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520954|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138520955|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138520956|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520957|NCT01466231|Everolimus|everolimus|mesh-list
138520958|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138520960|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459371|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520961|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520962|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138520963|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
138520964|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520965|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520966|NCT00036582|Clozapine|clozapine|mesh-list
138520967|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138520968|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
138520969|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138520970|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520971|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520972|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138520973|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138520974|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138520975|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138520976|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
138520977|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
138520978|NCT01466114|Norethindrone|norethindrone|mesh-list
138520979|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
138520980|NCT01466114|Progestins|progestins|mesh-list
138520981|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138520983|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138520984|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
138520985|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520986|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520987|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138520988|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138520989|NCT01466114|Hormones|hormones|mesh-ancestor
138520990|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520991|NCT00036777|Carboplatin|carboplatin|mesh-list
138520992|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138520993|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520994|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138520995|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520996|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138520997|NCT01465919|Mirtazapine|mirtazapine|mesh-list
138520998|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138520999|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521000|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138521001|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
138521002|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
138521003|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521004|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521005|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521006|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138521007|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138521008|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138521009|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138521010|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138521011|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138521012|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521013|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138521014|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138521015|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
138521016|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138521018|NCT00396513|Simvastatin|simvastatin|mesh-list
138521019|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521020|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521021|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138521022|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138521023|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
138459379|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521024|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521025|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138521026|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138521027|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521028|NCT00036855|Rituximab|rituximab|mesh-list
138521029|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138521030|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521031|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521032|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
138521033|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521034|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521035|NCT00036894|Lenalidomide|lenalidomide|mesh-list
138521036|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
138521037|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521038|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138521039|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138521040|NCT00036894|Growth Substances|growth substances|mesh-ancestor
138521041|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138521042|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521043|NCT01465685|Methylphenidate|methylphenidate|mesh-list
138521044|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138521045|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138521046|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521047|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138521048|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521049|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521050|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521051|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
138521052|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521053|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
138521054|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521055|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
138521056|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138521057|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521058|NCT00037011|Antibodies|antibodies|mesh-list
138521059|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138521060|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
138521061|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521062|NCT00037050|Vancomycin|vancomycin|mesh-list
138521063|NCT00037050|Linezolid|linezolid|mesh-list
138521064|NCT00037050|Oxacillin|oxacillin|mesh-list
138521065|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
138521066|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521067|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521068|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138521069|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479969|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521070|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521071|NCT00037089|Tegafur|tegafur|mesh-list
138521072|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521073|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
138521074|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521075|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521076|NCT01465568|Denosumab|denosumab|mesh-list
138521077|NCT01465568|Diphosphonates|diphosphonates|mesh-list
138521078|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138521079|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521080|NCT00037206|Anidulafungin|anidulafungin|mesh-list
138521081|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
138521082|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521083|NCT01465412|Adenosine|adenosine|mesh-list
138521084|NCT01465412|Analgesics|analgesics|mesh-ancestor
138521085|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
138521086|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521087|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521088|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138521089|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
138521090|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138521091|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
138521092|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
138521093|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521094|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521095|NCT01465373|Progesterone|progesterone|mesh-list
138521096|NCT01465373|Progestins|progestins|mesh-ancestor
138521097|NCT01465373|Hormones|hormones|mesh-ancestor
138521098|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521099|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521100|NCT01465256|Aspirin|aspirin|mesh-list
138521101|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521102|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521103|NCT01465256|Analgesics|analgesics|mesh-ancestor
138521104|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
138521105|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521106|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521107|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521108|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521109|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521110|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521111|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521112|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138521113|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138521114|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521115|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
138521116|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
138521117|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521118|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521119|NCT01464983|Aspirin|aspirin|mesh-list
138521120|NCT01464983|Ibuprofen|ibuprofen|mesh-list
138521121|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521122|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521123|NCT01464983|Analgesics|analgesics|mesh-ancestor
138521124|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
138521125|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521126|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521127|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198217|NCT00002092|Cimetidine|cimetidine|mesh-list
138521128|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521129|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521130|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521131|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521132|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138521133|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138521134|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521135|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
138521136|NCT00037518|Cinacalcet|cinacalcet|mesh-list
138459415|NCT05679388|Ritonavir|ritonavir|mesh-list
138521137|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521138|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521139|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138521140|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
138521141|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521142|NCT01464944|Aspirin|aspirin|mesh-list
138521143|NCT01464944|Acetaminophen|acetaminophen|mesh-list
138521144|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521145|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521146|NCT01464944|Analgesics|analgesics|mesh-ancestor
138521147|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
138521148|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521149|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521150|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521151|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521152|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521153|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521154|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521155|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138521156|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138521157|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521158|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
138521160|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
138521161|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521162|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
138521163|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521164|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521165|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
138521166|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521167|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521168|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
138521169|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521170|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521171|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
138521172|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
138521173|NCT00037635|Cinacalcet|cinacalcet|mesh-list
138521174|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521175|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521176|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138521177|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
138521178|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521179|NCT00037674|Topiramate|topiramate|mesh-list
138521180|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
138521181|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521182|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521183|NCT00037752|Sibutramine|sibutramine|mesh-list
138521184|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521185|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521186|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
138521187|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138521188|NCT01464671|Heparin|heparin|mesh-list
138521189|NCT01464671|Bivalirudin|bivalirudin|mesh-list
138521190|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
138521191|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521192|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138479970|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138521193|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459429|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
138521195|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138521196|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
138521197|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521198|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138521199|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521200|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521201|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521204|NCT00393731|Oxytocin|oxytocin|mesh-list
138521205|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
138521206|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138521207|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521208|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138521209|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
138521210|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138521211|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521212|NCT00038025|Pentostatin|pentostatin|mesh-list
138521213|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521214|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138521215|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521216|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521217|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
138521218|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
138521219|NCT00393770|Vitamins|vitamins|mesh-ancestor
138521220|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
138521221|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521222|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
138521223|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
138521224|NCT00038064|Hematinics|hematinics|mesh-ancestor
138521225|NCT00038181|Thalidomide|thalidomide|mesh-list
138521226|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521227|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
138521228|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521229|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
138521230|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521231|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521232|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138521233|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138521234|NCT00038181|Growth Substances|growth substances|mesh-ancestor
138521235|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
138521236|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521237|NCT00038220|Ritonavir|ritonavir|mesh-list
138521238|NCT00038220|Lopinavir|lopinavir|mesh-list
138521239|NCT00038220|Tenofovir|tenofovir|mesh-list
138521240|NCT00038220|Lamivudine|lamivudine|mesh-list
138521241|NCT00038220|Efavirenz|efavirenz|mesh-list
138521242|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138521243|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138521244|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
138521245|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521246|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521247|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138521248|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138521249|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
138415669|NCT01659684|Antibodies|antibodies|mesh-list
138521250|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521251|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138521252|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138521253|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138521254|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138521255|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138521256|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138521257|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138521258|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138521259|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138521260|NCT00038259|Aldesleukin|aldesleukin|mesh-list
138521261|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521262|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138521263|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138521264|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
138521265|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521267|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521268|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521269|NCT05433597|Cisplatin|cisplatin|mesh-list
138521270|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521271|NCT00847262|Amlodipine|amlodipine|mesh-list
138521272|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138521273|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138521274|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415716|NCT01659931|Montelukast|montelukast|mesh-list
138699874|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138521275|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521276|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521277|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521278|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
138521280|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521282|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138521283|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521284|NCT00847106|Daclizumab|daclizumab|mesh-list
138521285|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521286|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
138521287|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521288|NCT00396669|Bupropion|bupropion|mesh-list
138521289|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138521290|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521291|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521292|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138521293|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521294|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521295|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521296|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
138521297|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521298|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521299|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138521300|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138521301|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521303|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138521304|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138521305|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
138521306|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138521307|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138521308|NCT00396747|Prednisolone|prednisolone|mesh-list
138521309|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
138521310|NCT00396747|Infliximab|infliximab|mesh-list
138521311|NCT00396747|Methotrexate|methotrexate|mesh-list
138521312|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138521313|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
138521314|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138521315|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
138521316|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138521317|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521318|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521319|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
138521320|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521321|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521322|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
138521323|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521324|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138521325|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521326|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
138521327|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521328|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138521329|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521330|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
138521331|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
138521332|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699893|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
138521333|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521334|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
138521335|NCT00396747|Hormones|hormones|mesh-ancestor
138521336|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521337|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138521339|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138521340|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138521341|NCT00846950|Lorazepam|lorazepam|mesh-list
138521342|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138521343|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
138521344|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
138521345|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
138521346|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521347|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521348|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521349|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138521350|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138521351|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138521352|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138521354|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
138521355|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
138521356|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521357|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521358|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138521359|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
138521360|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
138521361|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
138521362|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138521363|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521364|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521365|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138521366|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521367|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521368|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521369|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521370|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138521371|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
138521372|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138521373|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521374|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138521375|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138521376|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138521377|NCT00846872|Mannitol|mannitol|mesh-list
138521378|NCT00846872|Hormones|hormones|mesh-list
138521379|NCT00846872|Secretagogues|secretagogues|mesh-list
138521380|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521381|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521382|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138521383|NCT00846872|Diuretics|diuretics|mesh-ancestor
138521384|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
138521385|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
138188474|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
138521386|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
138521387|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521388|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
138521389|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
138521390|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521391|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521392|NCT00846716|Pioglitazone|pioglitazone|mesh-list
138521393|NCT00846716|Biguanides|biguanides|mesh-list
138521394|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521395|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521396|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138521397|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138521398|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521399|NCT00846677|Vitamin D|vitamin d|mesh-list
138521400|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
138521401|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
138521402|NCT00846677|Vitamins|vitamins|mesh-list
138521403|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
138521404|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521405|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138521406|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521407|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
138521408|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521409|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
138521410|NCT05428683|Triamcinolone|triamcinolone|mesh-list
138521411|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521412|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521413|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138521414|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521415|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521416|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521417|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521418|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521419|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521420|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
138521421|NCT05428683|Hormones|hormones|mesh-ancestor
138521422|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521423|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138521424|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138521425|NCT00846443|Cisplatin|cisplatin|mesh-list
138521426|NCT00846443|Pemetrexed|pemetrexed|mesh-list
138521427|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521428|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521429|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521430|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138521431|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138521432|NCT00846326|Fluticasone|fluticasone|mesh-list
138521433|NCT00846326|Xhance|xhance|mesh-list
138521434|NCT00846326|Phenylephrine|phenylephrine|mesh-list
138521435|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
138521436|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521437|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138521438|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
138521439|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521440|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521441|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138521442|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
138521443|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
138521444|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138521445|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138521446|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138521447|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521448|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521449|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521450|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
138521451|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
138521452|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138521453|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138521454|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
138521455|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138521456|NCT00846326|Protective Agents|protective agents|mesh-ancestor
138521457|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
138521458|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138197846|NCT00002038|Fluconazole|fluconazole|mesh-list
138521459|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521460|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521461|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521462|NCT00846248|Chromium|chromium|mesh-list
138521463|NCT00846248|Trace Elements|trace elements|mesh-ancestor
138521464|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
138521465|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521466|NCT00846131|Sorafenib|sorafenib|mesh-list
138521467|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521468|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521469|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521470|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521471|NCT05116059|Amphotericin B|amphotericin b|mesh-list
138521472|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138521473|NCT05116059|Amebicides|amebicides|mesh-ancestor
138521474|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138521475|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138521476|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521477|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521478|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
138521479|NCT00845936|Metformin|metformin|mesh-list
138521480|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521481|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521482|NCT00277082|Camptothecin|camptothecin|mesh-list
138521483|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138521484|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521485|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138521486|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521487|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521488|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521490|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521491|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521492|NCT04888377|Analgesics|analgesics|mesh-ancestor
138521493|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
138521494|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521495|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521496|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521497|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521498|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521499|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521500|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521501|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138459493|NCT05576350|Ethanol|ethanol|mesh-list
138521502|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138521503|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521504|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
138521505|NCT00277043|Paclitaxel|paclitaxel|mesh-list
138521506|NCT00277043|Docetaxel|docetaxel|mesh-list
138521507|NCT00277043|Taxane|taxane|mesh-list
138521508|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138521509|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521510|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
138521511|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
138521512|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
138521513|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521514|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
138521515|NCT00276965|Sertraline|sertraline|mesh-list
138521516|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521517|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521518|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138521519|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521520|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521521|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521522|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521523|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
138521524|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521525|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521526|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
138521527|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138521528|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138521529|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
138521530|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521531|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521532|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521533|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521534|NCT00396786|Enoxaparin|enoxaparin|mesh-list
138521535|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
138521536|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138521538|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138521539|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
138521540|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521541|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521542|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
138521543|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521544|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521546|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
138521547|NCT00276848|Fludarabine|fludarabine|mesh-list
138521548|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
138521549|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521550|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
138521551|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521552|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521553|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138521554|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
138521555|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521556|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521557|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138521558|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521559|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
138521560|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
138459516|NCT05534750|Linezolid|linezolid|mesh-list
138521561|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521562|NCT00276809|Cytarabine|cytarabine|mesh-list
138521563|NCT00276809|Dexamethasone|dexamethasone|mesh-list
138521564|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
138521565|NCT00276809|Melphalan|melphalan|mesh-list
138521566|NCT00276809|Carmustine|carmustine|mesh-list
138521567|NCT00276809|Fludarabine|fludarabine|mesh-list
138521568|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
138521569|NCT00276809|Etoposide|etoposide|mesh-list
138521570|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
138521571|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521572|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
138521573|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521574|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521575|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138699999|NCT04324307|Irinotecan|irinotecan|mesh-list
138521576|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
138521577|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521578|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521579|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138521580|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521581|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
138521582|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
138521583|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416172|NCT01662869|Vitamins|vitamins|mesh-ancestor
138521584|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521586|NCT00276809|Hormones|hormones|mesh-ancestor
138521587|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521588|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138521589|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521590|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
138521591|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138521592|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138521593|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521594|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521595|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
138521596|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521597|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521598|NCT00276770|Fluorides|fluorides|mesh-list
138521599|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
138521600|NCT00276770|Protective Agents|protective agents|mesh-ancestor
138521601|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521602|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
138521603|NCT00276731|Carboplatin|carboplatin|mesh-list
138521604|NCT00276731|Etoposide|etoposide|mesh-list
138521605|NCT00276731|Vincristine|vincristine|mesh-list
138521606|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521607|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
138521608|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521609|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521610|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138521611|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
138521612|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521613|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521614|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138521615|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138521616|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138521617|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521618|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521619|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
138521620|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
138521621|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
138521622|NCT00276692|Irinotecan|irinotecan|mesh-list
138521623|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138521624|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521625|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521626|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521627|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521628|NCT00276575|Bevacizumab|bevacizumab|mesh-list
138521629|NCT00276575|Everolimus|everolimus|mesh-list
138521630|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138521631|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521632|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521634|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138521635|NCT00276575|Growth Substances|growth substances|mesh-ancestor
138521636|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521637|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138521638|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138521639|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521640|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521641|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521642|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521643|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
138521644|NCT00276536|Interferons|interferons|mesh-list
138521645|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
138521646|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138521647|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521648|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
138521649|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521650|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
138521651|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521653|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521654|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521655|NCT04430790|Doxapram|doxapram|mesh-list
138521656|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138521657|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521658|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138521659|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
138521660|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521661|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521662|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521663|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521664|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
138521665|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138521666|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521667|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521668|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138521669|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521670|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521671|NCT00276146|Dipyridamole|dipyridamole|mesh-list
138521672|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138521673|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521674|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521675|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138521676|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
138521677|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138521678|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
138521679|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521680|NCT04201665|Oxytocin|oxytocin|mesh-list
138521681|NCT04201665|Carbetocin|carbetocin|mesh-list
138521682|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
138521683|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138521684|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521685|NCT00276068|Lidocaine|lidocaine|mesh-list
138521686|NCT00276068|Desipramine|desipramine|mesh-list
138521687|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
138521688|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
138521689|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138521690|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521691|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
138459607|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521692|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521693|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138521694|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138521695|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138521696|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521697|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521698|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138521699|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521700|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521701|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521702|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138521703|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521704|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521705|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521706|NCT00276029|Etanercept|etanercept|mesh-list
138521707|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521708|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521709|NCT00276029|Analgesics|analgesics|mesh-ancestor
138521710|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
138521711|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521712|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521713|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521714|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521715|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521716|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521717|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
138521718|NCT00397059|Escitalopram|escitalopram|mesh-list
138416260|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
138521719|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138521720|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521721|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521722|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521724|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
138521725|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521727|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521728|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521729|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
138521730|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
138521731|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138521732|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138521733|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521734|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521735|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138521736|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138521737|NCT00397098|Amibegron|amibegron|mesh-list
138521738|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138521739|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138521740|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138521741|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521742|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521743|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521744|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521745|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138521746|NCT00275834|Zonisamide|zonisamide|mesh-list
138521747|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
138521748|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138521749|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521750|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521751|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521752|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521753|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138521754|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138521755|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138521756|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521757|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521758|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521759|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521760|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
138521761|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138521763|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138521764|NCT00275756|Dorzolamide|dorzolamide|mesh-list
138521765|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138521766|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138521767|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521768|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521769|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521770|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521771|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138521772|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138521773|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138521774|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138521775|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138521776|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138521777|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521778|NCT00275639|Losartan|losartan|mesh-list
138521779|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138521780|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138521781|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138521782|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138521783|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521785|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138521786|NCT03957057|Trace Elements|trace elements|mesh-ancestor
138521787|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
138521788|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521789|NCT03957057|Hematinics|hematinics|mesh-ancestor
138521790|NCT00275600|Vitamin E|vitamin e|mesh-list
138521791|NCT00275600|Vitamins|vitamins|mesh-ancestor
138521792|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
138521794|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
138521795|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521796|NCT00275600|Protective Agents|protective agents|mesh-ancestor
138521797|NCT00275522|Sirolimus|sirolimus|mesh-list
138521798|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521799|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521800|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138521801|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521802|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
138521803|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521804|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
138521805|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521806|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
138521807|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
138521808|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521809|NCT00275405|Protective Agents|protective agents|mesh-ancestor
138521810|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521811|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138521812|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521813|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138521814|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521815|NCT00275249|Levorphanol|levorphanol|mesh-list
138521816|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138521817|NCT00275249|Narcotics|narcotics|mesh-ancestor
138521818|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700091|NCT03889795|Metformin|metformin|mesh-list
138521819|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521820|NCT00275249|Analgesics|analgesics|mesh-ancestor
138521821|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
138521822|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521823|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
138521824|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521825|NCT00041535|Miglustat|miglustat|mesh-list
138521826|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521827|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521828|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138521829|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138521830|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
138521831|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521832|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138521833|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521834|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521835|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
138521836|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138521837|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
138521838|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521839|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521840|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138521841|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
138521842|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138521843|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
138521844|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521845|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521846|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138521847|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
138521848|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
138521849|NCT00041574|Protective Agents|protective agents|mesh-ancestor
138521850|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138521851|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459684|NCT05109364|Terazosin|terazosin|mesh-list
138521852|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521853|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521854|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521856|NCT00275093|Temsirolimus|temsirolimus|mesh-list
138521857|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
138521858|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138521859|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521860|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521861|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521862|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
138521863|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521864|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521865|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521866|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521867|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138521868|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
138521869|NCT00041652|Labetuzumab|labetuzumab|mesh-list
138521870|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521871|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521872|NCT03430596|Pramipexole|pramipexole|mesh-list
138521873|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
138521874|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
138521875|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521876|NCT03430596|Protective Agents|protective agents|mesh-ancestor
138521877|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416409|NCT01665209|Morphine|morphine|mesh-list
138521878|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138521879|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138521880|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
138521881|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
138521882|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521883|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138521884|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138521885|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
138521888|NCT00275054|Fludarabine|fludarabine|mesh-list
138521889|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521890|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
138521891|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521892|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521893|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138521894|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
138521895|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521896|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521897|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138521898|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521899|NCT03208179|Azithromycin|azithromycin|mesh-list
138521900|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
138521901|NCT03208179|Piperaquine|piperaquine|mesh-list
138521902|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
138521903|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138521904|NCT03208179|Artenimol|artenimol|mesh-list
138521905|NCT03208179|Artemisinins|artemisinins|mesh-list
138521906|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138521907|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521908|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
138521909|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138521910|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138521911|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138521912|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521913|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521914|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138521915|NCT00275015|Cytarabine|cytarabine|mesh-list
138521916|NCT00275015|Dexamethasone|dexamethasone|mesh-list
138521917|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
138521918|NCT00275015|Melphalan|melphalan|mesh-list
138521919|NCT00275015|Carmustine|carmustine|mesh-list
138521920|NCT00275015|Fludarabine|fludarabine|mesh-list
138521921|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
138521922|NCT00275015|Etoposide|etoposide|mesh-list
138521923|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521924|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
138521925|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521926|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521927|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138521928|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
138521929|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521930|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521931|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138521932|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521933|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
138521934|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
138521935|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521936|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138521937|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
138521938|NCT00275015|Hormones|hormones|mesh-ancestor
138521939|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138521940|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138521941|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138521942|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
138521943|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138521945|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138521946|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521947|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
138521948|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138521949|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
138521950|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138521951|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138521952|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
138521953|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138521954|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138521955|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521956|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138521957|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521958|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138521959|NCT03062826|Aspirin|aspirin|mesh-list
138521960|NCT03062826|Clopidogrel|clopidogrel|mesh-list
138521961|NCT03062826|Ticagrelor|ticagrelor|mesh-list
138521962|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521963|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521964|NCT03062826|Analgesics|analgesics|mesh-ancestor
138521965|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
138521966|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521967|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521968|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521969|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521970|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138521971|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138521972|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521973|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138521974|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138521975|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521976|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
138521977|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138521978|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138521979|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138521980|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
138521981|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521982|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
138521983|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138521984|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138521986|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
138521987|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521988|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521989|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138521990|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138521991|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
138521992|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138521993|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
138521994|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138521995|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138521996|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138521997|NCT00130325|Isoniazid|isoniazid|mesh-list
138521998|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
138521999|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522000|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522001|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138522002|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138522003|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
138522004|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522005|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138522006|NCT00041691|Labetuzumab|labetuzumab|mesh-list
138522007|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522008|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522009|NCT00394394|Enalapril|enalapril|mesh-list
138522010|NCT00394394|Amiloride|amiloride|mesh-list
138522011|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138522012|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522013|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522014|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522015|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522016|NCT00394394|Diuretics|diuretics|mesh-ancestor
138522017|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
138522018|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522019|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138522020|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138522021|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138522022|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138522023|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138522024|NCT00130091|Clonidine|clonidine|mesh-list
138522025|NCT00130091|Analgesics|analgesics|mesh-ancestor
138522026|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
138522027|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522028|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522029|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522030|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
138522031|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
138522032|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138522033|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138522034|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138522035|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
138522036|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522037|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522038|NCT00130013|Amoxicillin|amoxicillin|mesh-list
138522039|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522040|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522042|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138522043|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
138522044|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
138522045|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522046|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522047|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522048|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138522049|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138522050|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522051|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522052|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138522053|NCT00129857|Protective Agents|protective agents|mesh-ancestor
138522054|NCT00129818|Famciclovir|famciclovir|mesh-list
138522055|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
138522056|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522057|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138522058|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522059|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522060|NCT00129506|Methotrexate|methotrexate|mesh-list
138522061|NCT00129506|Misoprostol|misoprostol|mesh-list
138522062|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138522064|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138522065|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522066|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522067|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
138522068|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416557|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
138522069|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522070|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522071|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522072|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138522073|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522074|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
138522075|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522076|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138522077|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138522078|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522079|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
138522080|NCT00129233|Amlodipine|amlodipine|mesh-list
138522081|NCT00129233|Valsartan|valsartan|mesh-list
138522082|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138700199|NCT03620019|Denosumab|denosumab|mesh-list
138522084|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138522085|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522086|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138522087|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522088|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
138522089|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138522090|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138522092|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522093|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
138522094|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522095|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522096|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
138522097|NCT00712881|Docetaxel|docetaxel|mesh-list
138522098|NCT00712881|Doxorubicin|doxorubicin|mesh-list
138522099|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138522100|NCT00712881|Trastuzumab|trastuzumab|mesh-list
138522101|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522102|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
138522103|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522104|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522105|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522106|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
138416616|NCT01666262|Vaccines|vaccines|mesh-list
138522107|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522108|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522109|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138522110|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522111|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522112|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522113|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138522114|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138522115|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138522116|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522117|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522118|NCT00042003|Decitabine|decitabine|mesh-list
138522119|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522120|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
138522121|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522122|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522123|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522124|NCT00129038|Aspirin|aspirin|mesh-list
138522125|NCT00129038|Dipyridamole|dipyridamole|mesh-list
138522126|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138522127|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522128|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522129|NCT00129038|Analgesics|analgesics|mesh-ancestor
138522130|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
138522131|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522132|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522133|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522134|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522135|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138522136|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138522137|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522138|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138522139|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138522140|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522141|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
138522142|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138522143|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
138522144|NCT00103389|Docetaxel|docetaxel|mesh-list
138416655|NCT01666587|Ibuprofen|ibuprofen|mesh-list
138522145|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522146|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522147|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522148|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522149|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522150|NCT00128921|Bortezomib|bortezomib|mesh-list
138522151|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522152|NCT00128804|Beta Carotene|beta carotene|mesh-list
138522153|NCT00128804|Carotenoids|carotenoids|mesh-list
138522154|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
138522155|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522156|NCT00128804|Protective Agents|protective agents|mesh-ancestor
138522157|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522158|NCT00128804|Provitamins|provitamins|mesh-ancestor
138522159|NCT00128804|Vitamins|vitamins|mesh-ancestor
138522160|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
138522161|NCT00097851|Docetaxel|docetaxel|mesh-list
138522162|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522163|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522164|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522165|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522166|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522168|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
138522169|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
138522170|NCT00038376|Isotretinoin|isotretinoin|mesh-list
138522171|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522172|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
138522173|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522174|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
138522175|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522176|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522177|NCT00128531|Leuprolide|leuprolide|mesh-list
138522178|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138522179|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
138522180|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138522181|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522182|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522183|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416689|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522184|NCT00038454|Chrysarobin|chrysarobin|mesh-list
138522185|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522186|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522187|NCT00038454|Analgesics|analgesics|mesh-ancestor
138459789|NCT04825678|Erenumab|erenumab|mesh-list
138522188|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
138522189|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522190|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522191|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522192|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522193|NCT00128453|Colchicine|colchicine|mesh-list
138522194|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
138522195|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522196|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522197|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522198|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522199|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522200|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522201|NCT00128414|Colchicine|colchicine|mesh-list
138522202|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
138522203|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522204|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522205|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522206|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198591|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
138522207|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522208|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522209|NCT00038493|Temozolomide|temozolomide|mesh-list
138522210|NCT00038493|Lonafarnib|lonafarnib|mesh-list
138522211|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522212|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
138522213|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522214|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522215|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522216|NCT00038532|Ritonavir|ritonavir|mesh-list
138522217|NCT00038532|Saquinavir|saquinavir|mesh-list
138522218|NCT00038532|Amprenavir|amprenavir|mesh-list
138522219|NCT00038532|Efavirenz|efavirenz|mesh-list
138522220|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138522221|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138522222|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522223|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522224|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522225|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138522226|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138522227|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
138522228|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522229|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138522230|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138522231|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138522232|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138522233|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138522234|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138522235|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138522236|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138522237|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138522238|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138522239|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
138522240|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522241|NCT00038571|Bortezomib|bortezomib|mesh-list
138522242|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522243|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
138522244|NCT05770687|Empagliflozin|empagliflozin|mesh-list
138522245|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138522246|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
138522247|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
138522248|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522249|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138522250|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522252|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
138522253|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522254|NCT05770323|Protective Agents|protective agents|mesh-ancestor
138522255|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522256|NCT05769738|Furosemide|furosemide|mesh-list
138522257|NCT05769738|Diuretics|diuretics|mesh-list
138522258|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
138522259|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522260|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138522261|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138522262|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522263|NCT05769725|Docetaxel|docetaxel|mesh-list
138522264|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522265|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522266|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522267|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522268|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522269|NCT05769660|Temozolomide|temozolomide|mesh-list
138522270|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522271|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
138522272|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522273|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522274|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138522275|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
138522276|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522277|NCT05769049|Vaccines|vaccines|mesh-list
138522278|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
138522279|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522280|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
138522281|NCT05768997|Hematinics|hematinics|mesh-ancestor
138522282|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138198669|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138522283|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522284|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522285|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522286|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138522287|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522289|NCT05765305|Letrozole|letrozole|mesh-list
138522290|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522291|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138522292|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138522293|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522294|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522295|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138522296|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
138522297|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522298|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459816|NCT04788654|Hormones|hormones|mesh-ancestor
138522299|NCT05765305|Trace Elements|trace elements|mesh-ancestor
138522300|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
138522301|NCT05760612|Trastuzumab|trastuzumab|mesh-list
138522302|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522303|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522304|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138522305|NCT05760144|Etonogestrel|etonogestrel|mesh-list
138522306|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138522307|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
138522308|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138522309|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522310|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138522311|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138522312|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522313|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522314|NCT05744674|Ropivacaine|ropivacaine|mesh-list
138522316|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
138522317|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522318|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416880|NCT01668121|Budesonide|budesonide|mesh-list
138522319|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
138522320|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522321|NCT05736978|Azacitidine|azacitidine|mesh-list
138522322|NCT05736978|Venetoclax|venetoclax|mesh-list
138522323|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522324|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
138522325|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522326|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522327|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522328|NCT05736965|Azacitidine|azacitidine|mesh-list
138522329|NCT05736965|Venetoclax|venetoclax|mesh-list
138522330|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522331|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
138522332|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522333|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522334|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522335|NCT05657860|Guanfacine|guanfacine|mesh-list
138522336|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522337|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138700301|NCT02201108|Analgesics|analgesics|mesh-ancestor
138522338|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138522339|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138522340|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
138522341|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522342|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522343|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522344|NCT05595603|Gentamicins|gentamicins|mesh-list
138522345|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138522346|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522347|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416892|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522348|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138522349|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522350|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522351|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
138522352|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138522353|NCT05595603|Protective Agents|protective agents|mesh-ancestor
138522354|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522356|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
138522357|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
138522358|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522359|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522360|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522361|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522362|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522363|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138522364|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
138522365|NCT05568940|Hormones|hormones|mesh-ancestor
138522366|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
138522367|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522368|NCT05543785|Ketorolac|ketorolac|mesh-list
138522369|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522370|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522371|NCT05543785|Analgesics|analgesics|mesh-ancestor
138416937|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522372|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
138522373|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522374|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522375|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522376|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522377|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138522378|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522379|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522380|NCT05457465|Cannabidiol|cannabidiol|mesh-list
138522381|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
138522383|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138522384|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522385|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522386|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138522387|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
138522388|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
138522389|NCT05427786|Nicorandil|nicorandil|mesh-list
138522390|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138522391|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522392|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
138522393|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
138522394|NCT05427786|Vitamins|vitamins|mesh-ancestor
138522395|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
138522396|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522397|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138522398|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
138522399|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
138522400|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522401|NCT05402553|Ondansetron|ondansetron|mesh-list
138522402|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
138522403|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
138522404|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522405|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522406|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522407|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
138522408|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522409|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138522410|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138522411|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
138522412|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522413|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522414|NCT05379322|Adalimumab|adalimumab|mesh-list
138522415|NCT05379322|Golimumab|golimumab|mesh-list
138522416|NCT05379322|Etanercept|etanercept|mesh-list
138522417|NCT05379322|Upadacitinib|upadacitinib|mesh-list
138522418|NCT05379322|Tofacitinib|tofacitinib|mesh-list
138522419|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138522420|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138522421|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522422|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522423|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522424|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522426|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
138522427|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522428|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522429|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522430|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522431|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
138522432|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138522433|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522434|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522435|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138522436|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138522437|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522438|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
138522439|NCT05298696|Cilostazol|cilostazol|mesh-list
138417027|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522441|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
138522442|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522443|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522444|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138522445|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
138522446|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138522447|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138522448|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522449|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138522450|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
138522451|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138522452|NCT05298696|Protective Agents|protective agents|mesh-ancestor
138522453|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138522454|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138522455|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522456|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
138522457|NCT05287425|Gentamicins|gentamicins|mesh-list
138522458|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138522459|NCT05287425|Povidone|povidone|mesh-list
138522460|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522461|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522462|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138522463|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138522464|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700479|NCT02908191|Tenofovir|tenofovir|mesh-list
138522465|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522466|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522467|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138522468|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138522469|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138522470|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
138522471|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
138522472|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138522474|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
138522475|NCT05258721|Protective Agents|protective agents|mesh-ancestor
138522476|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522477|NCT05192850|Metformin|metformin|mesh-list
138522478|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138522479|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522480|NCT05111717|Desflurane|desflurane|mesh-list
138522481|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138522482|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
138522483|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
138522484|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522485|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522486|NCT05049603|Atorvastatin|atorvastatin|mesh-list
138522487|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138522489|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
138522490|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522491|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138522492|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138522493|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522494|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
138522495|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138522496|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138522497|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522498|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
138522499|NCT05037162|Coagulants|coagulants|mesh-ancestor
138522500|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
138522501|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522502|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522503|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138417113|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522504|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522506|NCT05020444|Fludarabine|fludarabine|mesh-list
138188475|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522507|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522508|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
138522509|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522510|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522511|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522512|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
138522513|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522514|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522515|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138522516|NCT05012189|Oseltamivir|oseltamivir|mesh-list
138522517|NCT05012189|Baloxavir|baloxavir|mesh-list
138522518|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
138522519|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522520|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522521|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522522|NCT04985721|Tislelizumab|tislelizumab|mesh-list
138522523|NCT04985721|Pamiparib|pamiparib|mesh-list
138522524|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522525|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522526|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138522527|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522528|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522529|NCT04864366|Tenofovir|tenofovir|mesh-list
138522530|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
138522531|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522532|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138522533|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138522534|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522535|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522536|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138522537|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138522538|NCT04859296|Dronabinol|dronabinol|mesh-list
138522539|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
138522540|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522542|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522543|NCT04859296|Analgesics|analgesics|mesh-ancestor
138522544|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
138522546|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138522547|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138522548|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522549|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522550|NCT04859296|Hormones|hormones|mesh-ancestor
138522551|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522552|NCT04857684|Bevacizumab|bevacizumab|mesh-list
138522553|NCT04857684|Atezolizumab|atezolizumab|mesh-list
138522554|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522555|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522556|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138522557|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138522558|NCT04857684|Growth Substances|growth substances|mesh-ancestor
138522559|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522560|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138522561|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138522562|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522563|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
138522564|NCT04846348|Promethazine|promethazine|mesh-list
138522565|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
138522566|NCT04846348|Salicylates|salicylates|mesh-list
138522567|NCT04846348|Emollients|emollients|mesh-list
138522568|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138417210|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138522569|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138522570|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522571|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522572|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
138522573|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
138522574|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
138522575|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522576|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
138522577|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
138522578|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522579|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138522580|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
138522581|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
138522582|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522583|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522584|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138522585|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
138522586|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522587|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522588|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522589|NCT04846348|Analgesics|analgesics|mesh-ancestor
138522590|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522591|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522592|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138522593|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522594|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138522595|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
138522596|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138522597|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
138522600|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
138522601|NCT04771520|DMP 777|dmp 777|mesh-list
138522602|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
138522603|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
138522604|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138522605|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522606|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522607|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522608|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522609|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522610|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522611|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522612|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
138522613|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138522614|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
138522615|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522616|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
138522617|NCT04769453|Protective Agents|protective agents|mesh-ancestor
138522619|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138522620|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215232|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138522621|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522622|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138522623|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138522624|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522625|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522626|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
138522628|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138522629|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522630|NCT04629534|Vitamins|vitamins|mesh-ancestor
138522631|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
138522632|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138522633|NCT04602065|Antibodies|antibodies|mesh-list
138522634|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138522635|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
138522636|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522637|NCT04598815|Sirolimus|sirolimus|mesh-list
138522638|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522639|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522640|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138522641|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522642|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
138522643|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522644|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
138522645|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522646|NCT04584112|Paclitaxel|paclitaxel|mesh-list
138522647|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138522648|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
138522649|NCT04584112|Carboplatin|carboplatin|mesh-list
138522650|NCT04584112|Doxorubicin|doxorubicin|mesh-list
138522651|NCT04584112|Atezolizumab|atezolizumab|mesh-list
138522652|NCT04584112|Molgramostim|molgramostim|mesh-list
138522653|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138522654|NCT04584112|Lenograstim|lenograstim|mesh-list
138522655|NCT04584112|Sargramostim|sargramostim|mesh-list
138522656|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138522657|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522658|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522659|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522660|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215233|NCT02174822|Paroxetine|paroxetine|mesh-list
138522661|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522662|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522663|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
138522664|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522665|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522666|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522667|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
138522668|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138522669|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138522670|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138522671|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138522672|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522673|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138522674|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522675|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138522676|NCT04573777|Evolocumab|evolocumab|mesh-list
138522677|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138522678|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138522679|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138522680|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
138522681|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522682|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138522683|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522684|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522685|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138522686|NCT04507711|Palonosetron|palonosetron|mesh-list
138522687|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
138522688|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
138522689|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522690|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522691|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522692|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138522693|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138522694|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
138522695|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522696|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522697|NCT04499274|Ondansetron|ondansetron|mesh-list
138522698|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
138522699|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
138522700|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522701|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522702|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522703|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
138522704|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
138522705|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138522706|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138522707|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
138522708|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522709|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522710|NCT04488159|Leucovorin|leucovorin|mesh-list
138522711|NCT04488159|Capecitabine|capecitabine|mesh-list
138522712|NCT04488159|Fluorouracil|fluorouracil|mesh-list
138522713|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
138522714|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522715|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
138522716|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522717|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522718|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522719|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
138522720|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522721|NCT04488159|Antidotes|antidotes|mesh-ancestor
138522722|NCT04488159|Protective Agents|protective agents|mesh-ancestor
138522723|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
138522724|NCT04488159|Vitamins|vitamins|mesh-ancestor
138522725|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
138522726|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138522727|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
138522728|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522729|NCT04300127|Pioglitazone|pioglitazone|mesh-list
138522730|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138522731|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522732|NCT04266236|Ropivacaine|ropivacaine|mesh-list
138522733|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
138700668|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
138522734|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522735|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522736|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138522737|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
138522738|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522739|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
138522740|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522741|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138522742|NCT04256343|Protective Agents|protective agents|mesh-ancestor
138522743|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522744|NCT04243629|Pramlintide|pramlintide|mesh-list
138417409|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138522745|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
138522746|NCT04243629|Pancrelipase|pancrelipase|mesh-list
138522747|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138522748|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522749|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522750|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
138522751|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
138522752|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138522753|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522754|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
138522755|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522756|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522757|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522758|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
138522759|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522760|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522761|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138522763|NCT04199026|Doxorubicin|doxorubicin|mesh-list
138522764|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138522765|NCT04199026|Daunorubicin|daunorubicin|mesh-list
138522766|NCT04199026|Irinotecan|irinotecan|mesh-list
138522767|NCT04199026|Vincristine|vincristine|mesh-list
138522768|NCT04199026|Everolimus|everolimus|mesh-list
138522769|NCT04199026|Temozolomide|temozolomide|mesh-list
138522770|NCT04199026|Temsirolimus|temsirolimus|mesh-list
138522771|NCT04199026|Ifosfamide|ifosfamide|mesh-list
138522772|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
138522773|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
138522774|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138522775|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138522776|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522777|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138522778|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138522779|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522780|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522781|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138522782|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138522783|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138522784|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138522785|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138522786|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138522787|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522788|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
138522789|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352204|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138352205|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352206|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
138352207|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138352209|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138352210|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
138352211|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352212|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352213|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352214|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522790|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522791|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
138522792|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522793|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522794|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
138522795|NCT04182997|Dexamethasone|dexamethasone|mesh-list
138522796|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522797|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
138522798|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
138522799|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522800|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522801|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522802|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
138522803|NCT04182997|Hormones|hormones|mesh-ancestor
138522804|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417451|NCT05596669|Ketamine|ketamine|mesh-list
138522805|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522806|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522807|NCT04134936|Lenalidomide|lenalidomide|mesh-list
138522808|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
138522809|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522810|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138522811|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138522812|NCT04134936|Growth Substances|growth substances|mesh-ancestor
138199214|NCT03009877|Midazolam|midazolam|mesh-list
138522813|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138522814|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522815|NCT04115111|Durvalumab|durvalumab|mesh-list
138522816|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522817|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522818|NCT04113109|Icatibant|icatibant|mesh-list
138522819|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138522820|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138522821|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522822|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522823|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522824|NCT04113109|Analgesics|analgesics|mesh-ancestor
138522825|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
138522826|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522827|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522828|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522829|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522830|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138522831|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138522832|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138522833|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138522834|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
138522835|NCT04107038|Anesthetics|anesthetics|mesh-list
138522836|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417466|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138522837|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522838|NCT04042233|Vancomycin|vancomycin|mesh-list
138522839|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522840|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522841|NCT03982693|Edetic Acid|edetic acid|mesh-list
138522842|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
138522843|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
138522844|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138522845|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
138522846|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
138352215|NCT04426500|Bupivacaine|bupivacaine|mesh-list
138352216|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352217|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
138352218|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352219|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352220|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
138352221|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352222|NCT04131192|Gemcitabine|gemcitabine|mesh-list
138352223|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138352224|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
138352227|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
138352228|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352229|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352230|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
138352232|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138522847|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522848|NCT03982693|Antidotes|antidotes|mesh-ancestor
138522849|NCT03982693|Protective Agents|protective agents|mesh-ancestor
138522850|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522851|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138522852|NCT03965195|Vaccines|vaccines|mesh-list
138522853|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
138522854|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522855|NCT03878082|Acetaminophen|acetaminophen|mesh-list
138522856|NCT03878082|Propacetamol|propacetamol|mesh-list
138522857|NCT03878082|Analgesics|analgesics|mesh-ancestor
138522858|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
138522859|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522860|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522861|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138522862|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522863|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522864|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522865|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
138522866|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
138700751|NCT04645745|Folic Acid|folic acid|mesh-list
138417533|NCT05596071|Dsuvia|dsuvia|mesh-list
138522867|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522868|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522869|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138522870|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522871|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522872|NCT03814941|Anesthetics|anesthetics|mesh-list
138522873|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522874|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522875|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
138522877|NCT03759938|Edoxaban|edoxaban|mesh-list
138522878|NCT03759938|Dabigatran|dabigatran|mesh-list
138522879|NCT03759938|Anticoagulants|anticoagulants|mesh-list
138522880|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138522881|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
138522882|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138522883|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522884|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522885|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522886|NCT03596164|Teduglutide|teduglutide|mesh-list
138522887|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199274|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
138522889|NCT03596164|Protective Agents|protective agents|mesh-ancestor
138522890|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522891|NCT03525873|Methylphenidate|methylphenidate|mesh-list
138522892|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138522893|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522894|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138352420|NCT03334734|Macozinone|macozinone|mesh-list
138352421|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
138352422|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352423|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352424|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138352425|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138352426|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
138352427|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352428|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138352429|NCT03336450|Midazolam|midazolam|mesh-list
138352430|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138352431|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138352432|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352433|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352434|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138352435|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138352436|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138352437|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138352438|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
138352439|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
138352440|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
138352441|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
138352442|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352443|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352444|NCT03340350|Minocycline|minocycline|mesh-list
138352445|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352446|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522895|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138522896|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138479971|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138522897|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522898|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
138522899|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138522901|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
138522902|NCT03492125|Venetoclax|venetoclax|mesh-list
138522903|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
138522904|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138522905|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522906|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
138522907|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522908|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522909|NCT03427463|Morphine|morphine|mesh-list
138522910|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138522911|NCT03427463|Narcotics|narcotics|mesh-ancestor
138522912|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138522913|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522914|NCT03427463|Analgesics|analgesics|mesh-ancestor
138522915|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
138522916|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522917|NCT03356873|Vitamin D|vitamin d|mesh-list
138522918|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
138522919|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
138522920|NCT03356873|Vitamins|vitamins|mesh-list
138522921|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
138700781|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
138522922|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522923|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138522924|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138522925|NCT03305341|Molgramostim|molgramostim|mesh-list
138522926|NCT03305341|Sargramostim|sargramostim|mesh-list
138522927|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
138522928|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522929|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522930|NCT03255473|Dexamethasone|dexamethasone|mesh-list
138522931|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
138522932|NCT03255473|Prednisone|prednisone|mesh-list
138522933|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138522934|NCT03255473|BB 1101|bb 1101|mesh-list
138522935|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522936|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
138522937|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
138522938|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522939|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522940|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522941|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
138522942|NCT03255473|Hormones|hormones|mesh-ancestor
138522943|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522944|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522945|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522946|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138522947|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522948|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522950|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522951|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
138522952|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138522953|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138522954|NCT03098225|Prednisolone|prednisolone|mesh-list
138522955|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
138522956|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138522957|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
138522958|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138522959|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
138522960|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
138522961|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522962|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199355|NCT01924052|Calcitonin|calcitonin|mesh-list
138522963|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138522964|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
138522965|NCT03098225|Hormones|hormones|mesh-ancestor
138522966|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138522967|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138522968|NCT03098225|Protective Agents|protective agents|mesh-ancestor
138522969|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138522970|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522971|NCT03017131|Aldesleukin|aldesleukin|mesh-list
138522972|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
138522973|NCT03017131|Decitabine|decitabine|mesh-list
138522974|NCT03017131|Interleukin-2|interleukin-2|mesh-list
138522975|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700809|NCT02905305|Hormones|hormones|mesh-ancestor
138522976|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
138522977|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522978|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138522979|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138522980|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
138522981|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522982|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522983|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138479972|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138522984|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138522985|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
138522986|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522987|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138522988|NCT03017131|Analgesics|analgesics|mesh-ancestor
138522989|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
138522990|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138522991|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138522992|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138522993|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
138522994|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522995|NCT02990468|Cisplatin|cisplatin|mesh-list
138522996|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138522997|NCT02882100|Vaccines|vaccines|mesh-list
138522998|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
138522999|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523000|NCT02855944|Paclitaxel|paclitaxel|mesh-list
138523001|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138523002|NCT02855944|Cisplatin|cisplatin|mesh-list
138523003|NCT02855944|Carboplatin|carboplatin|mesh-list
138523004|NCT02855944|Gemcitabine|gemcitabine|mesh-list
138523005|NCT02855944|Rucaparib|rucaparib|mesh-list
138523006|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138523007|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523008|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523009|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523010|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138523011|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523012|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523013|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
138523014|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138523015|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523016|NCT02603848|Ibuprofen|ibuprofen|mesh-list
138523017|NCT02603848|Morphine|morphine|mesh-list
138523018|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523019|NCT02603848|Narcotics|narcotics|mesh-ancestor
138523020|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523021|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523022|NCT02603848|Analgesics|analgesics|mesh-ancestor
138523023|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
138523024|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523025|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138523026|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138523027|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523028|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523029|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138523030|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523031|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523032|NCT02512887|Anesthetics|anesthetics|mesh-list
138523033|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523034|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523035|NCT02484261|Bortezomib|bortezomib|mesh-list
138523036|NCT02484261|Pravastatin|pravastatin|mesh-list
138523037|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523038|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138523039|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138523040|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
138523041|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523042|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138523043|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138523044|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523046|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
138523047|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
138523048|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138523049|NCT02471430|Panobinostat|panobinostat|mesh-list
138523050|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523051|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
138523052|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523053|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
138523054|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523055|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138523056|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523057|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523058|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
138523059|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289396|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289397|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138289398|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138289399|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138289400|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289401|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289403|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
138289404|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
138289405|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289407|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289408|NCT03714919|Acetaminophen|acetaminophen|mesh-list
138289409|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
138289410|NCT03714919|Ketamine|ketamine|mesh-list
138289411|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
138289412|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138289413|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289414|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289415|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289419|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138289420|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138289421|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138289422|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138523060|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523061|NCT02409342|Carboplatin|carboplatin|mesh-list
138523062|NCT02409342|Gemcitabine|gemcitabine|mesh-list
138523063|NCT02409342|Pemetrexed|pemetrexed|mesh-list
138523064|NCT02409342|Atezolizumab|atezolizumab|mesh-list
138523065|NCT02409342|Antibodies|antibodies|mesh-list
138523066|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138523067|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
138523068|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523069|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523070|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523071|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
138523072|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523073|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523074|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138523075|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138523076|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138523077|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523078|NCT02255409|Vaccines|vaccines|mesh-list
138523079|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
138523080|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523081|NCT02213757|Estrogens|estrogens|mesh-list
138523082|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138523083|NCT02213757|Hormones|hormones|mesh-ancestor
138523084|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523085|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523086|NCT02102243|Insulin|insulin|mesh-list
138523087|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138523088|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138523089|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523091|NCT01969227|Analgesics|analgesics|mesh-ancestor
138523092|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
138523093|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523094|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523095|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138523096|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138523097|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
138523098|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
138523099|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523100|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138523101|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138523102|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523103|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523104|NCT01885949|Tivozanib|tivozanib|mesh-list
138523105|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138523106|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523107|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523108|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
138523109|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523110|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523111|NCT01604135|Riboflavin|riboflavin|mesh-list
138523112|NCT01604135|Dextrans|dextrans|mesh-list
138523113|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
138523114|NCT01604135|Vitamins|vitamins|mesh-ancestor
138523115|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
138523116|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523117|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138523118|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523119|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
138523120|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
138523121|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
138523122|NCT00644189|Clofarabine|clofarabine|mesh-list
138523123|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523124|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
138523125|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523127|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
138523128|NCT00630032|Docetaxel|docetaxel|mesh-list
138523129|NCT00630032|Fluorouracil|fluorouracil|mesh-list
138523130|NCT00630032|Epirubicin|epirubicin|mesh-list
138523131|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523132|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
138523133|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523134|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523135|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138523136|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
138523137|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523138|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523139|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138523140|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523141|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523142|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138523143|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
138523144|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523145|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138523146|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138523147|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138523148|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523149|NCT00465517|Ganaxolone|ganaxolone|mesh-list
138523150|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
138523151|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523152|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523153|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523154|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
138523155|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
138523156|NCT00289952|Valproic Acid|valproic acid|mesh-list
138523157|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
138523158|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523159|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523160|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
138523161|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523162|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523163|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
138523164|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523165|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523166|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523167|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
138523168|NCT05772832|Remifentanil|remifentanil|mesh-list
138523169|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138523170|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523171|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523172|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138523173|NCT05772832|Analgesics|analgesics|mesh-ancestor
138523174|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
138523175|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523176|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138523177|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138523178|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138523179|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
138523180|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523181|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523182|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523183|NCT05772832|Narcotics|narcotics|mesh-ancestor
138523184|NCT05772728|Azacitidine|azacitidine|mesh-list
138523185|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
138523186|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700907|NCT04642001|Listerine|listerine|mesh-list
138523187|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
138523188|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523189|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523190|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523191|NCT05772728|Analgesics|analgesics|mesh-ancestor
138523192|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
138523193|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523194|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523195|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138523196|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138523198|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
138523199|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
138523200|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523201|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523202|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523203|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138523204|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523205|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523206|NCT05772624|Nivolumab|nivolumab|mesh-list
138417993|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523207|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523208|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523209|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138523210|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523212|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523213|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523214|NCT05772377|Carboplatin|carboplatin|mesh-list
138523215|NCT05772377|Cisplatin|cisplatin|mesh-list
138523216|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523217|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
138523218|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523219|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523220|NCT05772039|Listerine|listerine|mesh-list
138523221|NCT05772039|Fluorides|fluorides|mesh-list
138523222|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
138523223|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
138523224|NCT05772039|Protective Agents|protective agents|mesh-ancestor
138523225|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523226|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138523227|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523228|NCT05772013|Azithromycin|azithromycin|mesh-list
138523229|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138523230|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523231|NCT05771675|Simvastatin|simvastatin|mesh-list
138523232|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138523233|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138523234|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
138523235|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523236|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138523237|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138523238|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523239|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
138523240|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138523241|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138523242|NCT05771181|Vitamin E|vitamin e|mesh-list
138523243|NCT05771181|Tislelizumab|tislelizumab|mesh-list
138523244|NCT05771181|Vitamins|vitamins|mesh-ancestor
138523245|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
138523246|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523247|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523248|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523249|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
138523250|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523251|NCT05771181|Protective Agents|protective agents|mesh-ancestor
138523252|NCT05771038|Alendronate|alendronate|mesh-list
138523253|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138523254|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523255|NCT05771012|Cyclosporine|cyclosporine|mesh-list
138523256|NCT05771012|Cyclosporins|cyclosporins|mesh-list
138523257|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523258|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523259|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523260|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
138523261|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523262|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
138523263|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523264|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523265|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188476|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
138523266|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138523268|NCT05770960|Naloxegol|naloxegol|mesh-list
138523269|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523270|NCT05770960|Narcotics|narcotics|mesh-ancestor
138523271|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418086|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523272|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523273|NCT05770960|Analgesics|analgesics|mesh-ancestor
138523274|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
138523275|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523276|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
138523277|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
138523278|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138523279|NCT05769946|Hemay005|hemay005|mesh-list
138523280|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523281|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138523282|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138523283|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523284|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523285|NCT05768282|Prednisolone|prednisolone|mesh-list
138523286|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523287|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
138523289|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523290|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523291|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138523292|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523293|NCT05766800|Paclitaxel|paclitaxel|mesh-list
138523294|NCT05766800|Carboplatin|carboplatin|mesh-list
138523295|NCT05766800|Pemetrexed|pemetrexed|mesh-list
138523296|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138523297|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523298|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523299|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523300|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418135|NCT05814744|Analgesics|analgesics|mesh-ancestor
138523301|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523302|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523303|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138523304|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138523305|NCT05766410|Letrozole|letrozole|mesh-list
138523306|NCT05766410|Palbociclib|palbociclib|mesh-list
138523307|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523308|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138523309|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138523310|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523311|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523312|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138523313|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
138523314|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523315|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523316|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138523317|NCT05757011|Bupivacaine|bupivacaine|mesh-list
138523318|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
138523319|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
138523320|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523321|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523322|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
138523323|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523324|NCT05750875|Loratadine|loratadine|mesh-list
138523325|NCT05750875|Gabapentin|gabapentin|mesh-list
138523326|NCT05750875|Analgesics|analgesics|mesh-ancestor
138523327|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
138523328|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523329|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523330|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
138523331|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138523332|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523333|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523334|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523335|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138523336|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138523337|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523338|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523339|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
138523340|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
138523341|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523342|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138523343|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138523344|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138523345|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
138523346|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
138523347|NCT05680584|Melatonin|melatonin|mesh-list
138523348|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
138523349|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
138523350|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523351|NCT05680584|Protective Agents|protective agents|mesh-ancestor
138523352|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523353|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523354|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
138523355|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523356|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138523357|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
138523358|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
138523359|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523360|NCT05646992|Azathioprine|azathioprine|mesh-list
138523361|NCT05646992|Tacrolimus|tacrolimus|mesh-list
138523362|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523363|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
138523364|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523365|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138523366|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523367|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523368|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
138523369|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523370|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523371|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523372|NCT05549206|Vaccines|vaccines|mesh-list
138523373|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
138523374|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523375|NCT05533684|Gabapentin|gabapentin|mesh-list
138523376|NCT05533684|Analgesics|analgesics|mesh-ancestor
138418221|NCT05324761|Pregabalin|pregabalin|mesh-list
138523377|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
138523378|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523379|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523380|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
138523381|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138523382|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523383|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523384|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523385|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138523386|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138523387|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523388|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523389|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
138523390|NCT05458479|Fluoxetine|fluoxetine|mesh-list
138523391|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138523392|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138523393|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138523394|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523395|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523396|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
138523397|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523398|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138523399|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
138523400|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523401|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138523402|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138523403|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523405|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138523406|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523407|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523408|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
138523409|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523410|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
138523411|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138523412|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
138523413|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523414|NCT05408247|Expectorants|expectorants|mesh-ancestor
138523415|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
138523416|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138523417|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
138523418|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523419|NCT05408247|Protective Agents|protective agents|mesh-ancestor
138523420|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523421|NCT05408247|Antidotes|antidotes|mesh-ancestor
138523422|NCT05375942|Infliximab|infliximab|mesh-list
138523423|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138523424|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523425|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523426|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523427|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523428|NCT05209308|Rituximab|rituximab|mesh-list
138523429|NCT05209308|Venetoclax|venetoclax|mesh-list
138523430|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523431|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523432|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
138523433|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523434|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523435|NCT05153317|Ivacaftor|ivacaftor|mesh-list
138523436|NCT05153317|Elexacaftor|elexacaftor|mesh-list
138523437|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138523438|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138523439|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523440|NCT05112848|Vaccines|vaccines|mesh-list
138523441|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
138523442|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523443|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138523444|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
138523445|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138523446|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
138523447|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138523448|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523449|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138460174|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
138523450|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138523451|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523452|NCT04916418|Ropivacaine|ropivacaine|mesh-list
138523453|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
138523454|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
138523455|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523456|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523457|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
138523458|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523459|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138523460|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138523461|NCT04892511|Nitroprusside|nitroprusside|mesh-list
138523462|NCT04892511|Labetalol|labetalol|mesh-list
138523463|NCT04892511|Urapidil|urapidil|mesh-list
138523464|NCT04892511|Phenylephrine|phenylephrine|mesh-list
138523465|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138523466|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
138523467|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
138523468|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523469|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523470|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
138523471|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138523472|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
138523473|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
138523474|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138523475|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138523476|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138523477|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138523478|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523479|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523480|NCT04892511|Protective Agents|protective agents|mesh-ancestor
138523481|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138523482|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
138460201|NCT04176419|Analgesics|analgesics|mesh-ancestor
138523483|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138523484|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138523485|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138523486|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138523487|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138523488|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138523489|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
138523490|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138523491|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523492|NCT04855695|Venetoclax|venetoclax|mesh-list
138523493|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
138523494|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
138523495|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523496|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523497|NCT04785118|Scopolamine|scopolamine|mesh-list
138523498|NCT04785118|Ondansetron|ondansetron|mesh-list
138523499|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138523500|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
138523501|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
138523503|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523504|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523505|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
138523506|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523507|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138523508|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138523509|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
138523510|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523511|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523512|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138523514|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138523515|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
138523516|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138523517|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
138523518|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
138523519|NCT04702256|Prednisone|prednisone|mesh-list
138523520|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
138523521|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138523522|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138523523|NCT04702256|Prednisolone|prednisolone|mesh-list
138523524|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
138523525|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
138523526|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138523527|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
138523528|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138523529|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523530|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
138523531|NCT04702256|Hormones|hormones|mesh-ancestor
138523532|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523533|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523534|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138523535|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418356|NCT04335058|Iron|iron|mesh-list
138523536|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138523537|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138523539|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138523540|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523541|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523542|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523543|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
138523544|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
138523545|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523546|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523547|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138523548|NCT04702256|Protective Agents|protective agents|mesh-ancestor
138460244|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
138523549|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523550|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138523551|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
138523552|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
138523553|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523554|NCT04671966|Cetrorelix|cetrorelix|mesh-list
138523555|NCT04671966|Estradiol|estradiol|mesh-list
138523556|NCT04671966|Estrogens|estrogens|mesh-ancestor
138523557|NCT04671966|Hormones|hormones|mesh-ancestor
138523558|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523559|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523560|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138523561|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138523562|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
138523563|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
138523564|NCT04641702|Atropine|atropine|mesh-list
138523565|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138523566|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138523567|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138523568|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
138523569|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523570|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523571|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138523572|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
138523574|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
138523575|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138523576|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138523577|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
138523578|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523579|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523580|NCT04622553|Mexiletine|mexiletine|mesh-list
138523581|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138523582|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138523583|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138523584|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138523585|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523586|NCT04616807|Mexiletine|mexiletine|mesh-list
138523587|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138523588|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138523589|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138523590|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138523591|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523592|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
138523593|NCT04608630|Denosumab|denosumab|mesh-list
138523594|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138523595|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523596|NCT04580134|Risperidone|risperidone|mesh-list
138523597|NCT04580134|Clozapine|clozapine|mesh-list
138523598|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138523599|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
138523600|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523601|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523602|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523603|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138523604|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523605|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523606|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523607|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138523608|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
138523609|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
138523610|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
138523611|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
138523612|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523613|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523614|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460249|NCT04149171|Coagulants|coagulants|mesh-ancestor
138523615|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523616|NCT04529954|Valproic Acid|valproic acid|mesh-list
138523617|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
138523618|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523619|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523620|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
138523621|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418480|NCT02881242|Trametinib|trametinib|mesh-list
138418481|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523622|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523623|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
138523624|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523625|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523626|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523627|NCT04525755|Nicotine|nicotine|mesh-list
138523628|NCT04525755|Varenicline|varenicline|mesh-list
138523629|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138523630|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
138523631|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523632|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523633|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138523634|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138523635|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
138523636|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523637|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523638|NCT04512079|Enoxaparin|enoxaparin|mesh-list
138523639|NCT04512079|Apixaban|apixaban|mesh-list
138523640|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
138523641|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138523642|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138200048|NCT00002542|Tamoxifen|tamoxifen|mesh-list
138523643|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418533|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138523651|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523652|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
138523653|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523654|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523655|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138523656|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
138523657|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523658|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523659|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138523661|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
138523662|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
138523663|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523664|NCT04278092|Paclitaxel|paclitaxel|mesh-list
138523665|NCT04278092|Cetuximab|cetuximab|mesh-list
138523666|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138523667|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523668|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523669|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523670|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138523671|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523672|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523694|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523695|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523696|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
138523697|NCT04189107|Hormones|hormones|mesh-ancestor
138523698|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523699|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138523700|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523701|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
138523702|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523703|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523704|NCT04124991|Durvalumab|durvalumab|mesh-list
138523705|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523706|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523707|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
138523708|NCT04004221|Tislelizumab|tislelizumab|mesh-list
138523709|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523710|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523711|NCT03844997|Palbociclib|palbociclib|mesh-list
138523712|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523713|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138523714|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523715|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188477|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523716|NCT03589729|Cytarabine|cytarabine|mesh-list
138523717|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138523718|NCT03589729|Idarubicin|idarubicin|mesh-list
138523719|NCT03589729|Cladribine|cladribine|mesh-list
138523720|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
138523721|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
138523722|NCT03589729|Razoxane|razoxane|mesh-list
138523723|NCT03589729|Calicheamicins|calicheamicins|mesh-list
138523724|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523725|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
138479974|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523726|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523727|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523729|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523730|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523731|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
138460276|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
138523732|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523733|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138523734|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138523735|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138523736|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523737|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523738|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
138523739|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
138523740|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138523741|NCT03589729|Protective Agents|protective agents|mesh-ancestor
138523742|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523743|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
138523744|NCT03585686|Cytarabine|cytarabine|mesh-list
138523745|NCT03585686|Vemurafenib|vemurafenib|mesh-list
138523746|NCT03585686|Cladribine|cladribine|mesh-list
138523747|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523748|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
138523749|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523750|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523751|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
138523752|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523753|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523754|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
138523755|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523756|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138523757|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523758|NCT03479307|Ketotifen|ketotifen|mesh-list
138523759|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138418697|NCT06224790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418698|NCT06224790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138418699|NCT06224790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138418700|NCT06224790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418701|NCT06224790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523761|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
138523762|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523763|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138523764|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
138523765|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
138523766|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523767|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523768|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523769|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138523770|NCT03390933|Fluoxetine|fluoxetine|mesh-list
138523771|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138523772|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138523773|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138523774|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523775|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523776|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
138523777|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523778|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138523779|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
138523780|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523781|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138523782|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138523783|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523784|NCT03387787|Insulin|insulin|mesh-list
138523785|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138523786|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523787|NCT03364036|Cladribine|cladribine|mesh-list
138188478|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523788|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418751|NCT06224049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523789|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523791|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523792|NCT03338790|Prednisone|prednisone|mesh-list
138523793|NCT03338790|Docetaxel|docetaxel|mesh-list
138523794|NCT03338790|Nivolumab|nivolumab|mesh-list
138523795|NCT03338790|Rucaparib|rucaparib|mesh-list
138523796|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523797|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523798|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523799|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
138523800|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523801|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523803|NCT03338790|Hormones|hormones|mesh-ancestor
138523804|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138523805|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523806|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138523807|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523808|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138523809|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138523810|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523811|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
138523812|NCT03315897|Hematinics|hematinics|mesh-ancestor
138523813|NCT03299660|Capecitabine|capecitabine|mesh-list
138523814|NCT03299660|Fluorouracil|fluorouracil|mesh-list
138523815|NCT03299660|Avelumab|avelumab|mesh-list
138523816|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523817|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
138523818|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523819|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523820|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523821|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
138523822|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523823|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523824|NCT03140358|Atropine|atropine|mesh-list
138523825|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138523826|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138523827|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138523828|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
138523829|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523830|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523831|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138523832|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
138523833|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
138523834|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
138523835|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138523836|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138523837|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
138523838|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523839|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523840|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
138523841|NCT02954536|Capecitabine|capecitabine|mesh-list
138523842|NCT02954536|Fluorouracil|fluorouracil|mesh-list
138523843|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
138523844|NCT02954536|Trastuzumab|trastuzumab|mesh-list
138523846|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138523847|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138523848|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460304|NCT04060862|Ipatasertib|ipatasertib|mesh-list
138523849|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523850|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
138523851|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523852|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
138523853|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523854|NCT02899611|Valproic Acid|valproic acid|mesh-list
138523855|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
138523856|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523857|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523858|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
138523859|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523860|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523861|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
138523862|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138523863|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523864|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138523865|NCT02750202|Vaccines|vaccines|mesh-list
138523866|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
138523867|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200256|NCT04868708|Paclitaxel|paclitaxel|mesh-list
138523868|NCT02645266|Aflibercept|aflibercept|mesh-list
138523869|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138523870|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138523871|NCT02645266|Growth Substances|growth substances|mesh-ancestor
138523872|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523874|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523875|NCT02634294|Interferons|interferons|mesh-list
138523876|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
138523877|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
138523878|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138523879|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523880|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
138523881|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138523882|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
138523883|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523885|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523886|NCT02575677|Narcotics|narcotics|mesh-ancestor
138523887|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523888|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523889|NCT02575677|Analgesics|analgesics|mesh-ancestor
138523890|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
138523891|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523892|NCT02573831|Oxycodone|oxycodone|mesh-list
138523893|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523894|NCT02573831|Narcotics|narcotics|mesh-ancestor
138523895|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523896|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523897|NCT02573831|Analgesics|analgesics|mesh-ancestor
138523898|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
138523899|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523900|NCT02571881|Oxycodone|oxycodone|mesh-list
138523902|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523903|NCT02571881|Narcotics|narcotics|mesh-ancestor
138523904|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523905|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523906|NCT02571881|Analgesics|analgesics|mesh-ancestor
138523907|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
138418956|NCT06217120|Gout Suppressants|gout suppressants|mesh-ancestor
138523908|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523910|NCT02571179|Fentanyl|fentanyl|mesh-list
138523911|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523912|NCT02571179|Narcotics|narcotics|mesh-ancestor
138523913|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138523914|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523915|NCT02571179|Analgesics|analgesics|mesh-ancestor
138523916|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
138523917|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523918|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138523919|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138523920|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
138523921|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
138523922|NCT02511418|Simvastatin|simvastatin|mesh-list
138523923|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138523924|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138523925|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
138523926|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523927|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138523928|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138523929|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523930|NCT02278250|Carboplatin|carboplatin|mesh-list
138523931|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523932|NCT02250326|Paclitaxel|paclitaxel|mesh-list
138523933|NCT02250326|Azacitidine|azacitidine|mesh-list
138523935|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138523936|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523937|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138523938|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138523939|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138352447|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
138352448|NCT03341910|Tazarotene|tazarotene|mesh-list
138352449|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352450|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
138352451|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
138352452|NCT03341910|Vitamins|vitamins|mesh-ancestor
138352453|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
138352454|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352455|NCT03343080|Lidocaine|lidocaine|mesh-list
138352456|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352457|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
138352458|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352459|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352460|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
138523940|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523941|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138523942|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
138523943|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523944|NCT02225600|Oxytocin|oxytocin|mesh-list
138523945|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
138523946|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138523947|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523948|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
138523949|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138523950|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523951|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138523952|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523953|NCT02081404|Esomeprazole|esomeprazole|mesh-list
138523954|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138523955|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523956|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138419004|NCT06192160|Rifampin|rifampin|mesh-list
138523958|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523959|NCT01526603|Carboplatin|carboplatin|mesh-list
138523960|NCT01526603|Etoposide|etoposide|mesh-list
138523961|NCT01526603|Melphalan|melphalan|mesh-list
138523962|NCT01526603|Tretinoin|tretinoin|mesh-list
138523963|NCT01526603|Isotretinoin|isotretinoin|mesh-list
138523964|NCT01526603|Lenograstim|lenograstim|mesh-list
138523965|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523966|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138523967|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138523968|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138523969|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523970|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523971|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138523972|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
138523973|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138523974|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523975|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
138523976|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523977|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138523978|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
138523979|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138523981|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138523982|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138523983|NCT00038766|Analgesics|analgesics|mesh-ancestor
138523984|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
138523985|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419026|NCT06192160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138523986|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523987|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523988|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523989|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138523990|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
138523991|NCT00070070|Sargramostim|sargramostim|mesh-list
138523992|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
138523993|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
138701198|NCT00553683|Poly ICLC|poly iclc|mesh-list
138523994|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523995|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138523996|NCT02573909|Oxycodone|oxycodone|mesh-list
138523997|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138523998|NCT02573909|Narcotics|narcotics|mesh-ancestor
138523999|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524000|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524001|NCT02573909|Analgesics|analgesics|mesh-ancestor
138524002|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
138524003|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524004|NCT00042315|Vinorelbine|vinorelbine|mesh-list
138524005|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138352554|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
138352555|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352556|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352557|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138524006|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524007|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524008|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524009|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138352558|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
138524010|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524011|NCT00018668|Olanzapine|olanzapine|mesh-list
138524012|NCT00018668|Risperidone|risperidone|mesh-list
138524013|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138524014|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138524015|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
138524016|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524017|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524018|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524020|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138524021|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524022|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138524023|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138524024|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
138524025|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
138524026|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
138524027|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524028|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524029|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138524030|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138524031|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138524032|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
138524033|NCT00042354|Clofarabine|clofarabine|mesh-list
138524034|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524035|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
138524036|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460360|NCT03727100|Analgesics|analgesics|mesh-ancestor
138524037|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524039|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138524040|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
138524041|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524042|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138524043|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138524044|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524045|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524046|NCT00042471|Pramlintide|pramlintide|mesh-list
138524047|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138524048|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138524049|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524050|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
138524051|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138524052|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138419230|NCT06044935|Vasodilator Agents|vasodilator agents|mesh-ancestor
138524053|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524054|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138524055|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138524056|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524057|NCT00042588|Antibodies|antibodies|mesh-list
138524058|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138524059|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
138524060|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524061|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
138524062|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524063|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524064|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
138524065|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
138524066|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
138524067|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524068|NCT00018824|Naltrexone|naltrexone|mesh-list
138524069|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138524070|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138524071|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524072|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
138524073|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524074|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
138524075|NCT00038844|Rituximab|rituximab|mesh-list
138524076|NCT00038844|Fludarabine|fludarabine|mesh-list
138524077|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
138524078|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
138524079|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524080|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
138524081|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524082|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524083|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524084|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
138524085|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524086|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419339|NCT05995535|Autonomic Agents|autonomic agents|mesh-ancestor
138419343|NCT05994287|Aspirin|aspirin|mesh-list
138419344|NCT05994287|Celecoxib|celecoxib|mesh-list
138419345|NCT05994287|Ketorolac|ketorolac|mesh-list
138419348|NCT05994287|Analgesics|analgesics|mesh-ancestor
138524087|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524088|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524089|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524091|NCT00018863|Methylphenidate|methylphenidate|mesh-list
138524092|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138524093|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524094|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138524095|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138524096|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200478|NCT00199082|Hormones|hormones|mesh-ancestor
138524097|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524098|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
138524099|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524101|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524102|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524103|NCT00018902|Fluoxetine|fluoxetine|mesh-list
138524104|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138524105|NCT00018902|Citalopram|citalopram|mesh-list
138524106|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138524107|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138524108|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138524109|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524110|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524112|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524113|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138524114|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
138419379|NCT05992428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138419380|NCT05992428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138419381|NCT05992428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138419382|NCT05992428|Urological Agents|urological agents|mesh-ancestor
138419383|NCT05992428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138419384|NCT05992428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138419385|NCT05992428|Cholinergic Agents|cholinergic agents|mesh-ancestor
138419386|NCT05991401|Clarithromycin|clarithromycin|mesh-list
138419388|NCT05991401|DA-8010|da-8010|mesh-list
138419389|NCT05991401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138419421|NCT05972720|Cyclophosphamide|cyclophosphamide|mesh-list
138524115|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138524116|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138524117|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138524118|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524119|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138524120|NCT00038922|Oprelvekin|oprelvekin|mesh-list
138524121|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524122|NCT00018941|Aldesleukin|aldesleukin|mesh-list
138524123|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524124|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524125|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524126|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
138524127|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524128|NCT00038961|PENTA|penta|mesh-list
138524129|NCT00038961|Fondaparinux|fondaparinux|mesh-list
138524130|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138524131|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
138524132|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138524133|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138524134|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524135|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524136|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
138524137|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138701298|NCT02895672|Hormones|hormones|mesh-ancestor
138524138|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138524139|NCT00019019|Paclitaxel|paclitaxel|mesh-list
138524140|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138524141|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524142|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524143|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524144|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524145|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524146|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524147|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138524148|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138524149|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524150|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524151|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
138524152|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
138524153|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524154|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
138524155|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524156|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701318|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138524157|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138524158|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138524159|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138524160|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138524161|NCT00019058|Protective Agents|protective agents|mesh-ancestor
138524162|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524163|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
138524164|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138524165|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
138524166|NCT00039039|Paclitaxel|paclitaxel|mesh-list
138524167|NCT00039039|Carboplatin|carboplatin|mesh-list
138524168|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524169|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524170|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524171|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524172|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524173|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524174|NCT00019097|Melphalan|melphalan|mesh-list
138524175|NCT00019097|Sargramostim|sargramostim|mesh-list
138524176|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138524177|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524178|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
138524179|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524180|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524181|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198238|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524182|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524183|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
138524184|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524185|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524187|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524188|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524189|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138419533|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419534|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419535|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
138419536|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138419537|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
138524190|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
138460413|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524191|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524192|NCT00039117|Cytarabine|cytarabine|mesh-list
138524193|NCT00039117|Daunorubicin|daunorubicin|mesh-list
138524194|NCT00039117|Oblimersen|oblimersen|mesh-list
138524195|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524196|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
138524197|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524198|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524199|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
138524200|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524201|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524202|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
138524203|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524204|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524205|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138524206|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524207|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524208|NCT00019175|Aldesleukin|aldesleukin|mesh-list
138524209|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524210|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524211|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524212|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
138524213|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524214|NCT00039156|IDN 5109|idn 5109|mesh-list
138524215|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524216|NCT00019214|Aldesleukin|aldesleukin|mesh-list
138524217|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524218|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524219|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524220|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
138524221|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524222|NCT00039234|Aldesleukin|aldesleukin|mesh-list
138524223|NCT00039234|Histamine|histamine|mesh-list
138524224|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
138524225|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524226|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524227|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524228|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
138524229|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524230|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
138524231|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
138524232|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524233|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419713|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419714|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419715|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
138419716|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419717|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419718|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419719|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138419720|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419721|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138419722|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
138419723|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138524236|NCT00019331|Sargramostim|sargramostim|mesh-list
138524237|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
138524238|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524239|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524240|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524241|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524242|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
138524243|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200629|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
138524244|NCT00039273|Panitumumab|panitumumab|mesh-list
138524245|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524246|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524248|NCT00019409|Prednisone|prednisone|mesh-list
138524249|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
138524250|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138524251|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138524252|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138524254|NCT00019409|Methotrexate|methotrexate|mesh-list
138524255|NCT00019409|Vincristine|vincristine|mesh-list
138524256|NCT00019409|Daunorubicin|daunorubicin|mesh-list
138524257|NCT00019409|Asparaginase|asparaginase|mesh-list
138524258|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
138524259|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524260|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
138524261|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524262|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524263|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524264|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
138524265|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524266|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524267|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524268|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524269|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
138524270|NCT00019409|Hormones|hormones|mesh-ancestor
138524271|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524272|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524273|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138524274|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
138524276|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524277|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
138524278|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138524279|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524280|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138524281|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138524282|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
138524283|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524284|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524285|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524286|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524287|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524288|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524289|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138524290|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524291|NCT00019448|Interleukin-2|interleukin-2|mesh-list
138524292|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524293|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138524294|NCT00019448|Analgesics|analgesics|mesh-ancestor
138524295|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
138524296|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524297|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524299|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
138524300|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524301|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524302|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524303|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
138524304|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524305|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524306|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
138524307|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524308|NCT00039351|Prednisone|prednisone|mesh-list
138524309|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
138524310|NCT00039351|Vincristine|vincristine|mesh-list
138524311|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524312|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
138524313|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524314|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524315|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524316|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
138524317|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524318|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524319|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524320|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524321|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
138524322|NCT00039351|Hormones|hormones|mesh-ancestor
138419801|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
138419802|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419803|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419804|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419805|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419807|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
138419808|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138419809|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138524323|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524324|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524325|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524326|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524327|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524328|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524329|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138524330|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138524331|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524333|NCT00039390|Gefitinib|gefitinib|mesh-list
138524334|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524335|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
138524336|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524337|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524338|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524339|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524340|NCT00019721|Aldesleukin|aldesleukin|mesh-list
138524341|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
138524342|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524343|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524344|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524345|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
138524346|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524347|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524348|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
138524349|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524350|NCT00039468|Thalidomide|thalidomide|mesh-list
138524351|NCT00039468|Irinotecan|irinotecan|mesh-list
138524352|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138524353|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524354|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524355|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524356|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524357|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524358|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
138524359|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524360|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
138524361|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138524362|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524363|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138524364|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138524365|NCT00039468|Growth Substances|growth substances|mesh-ancestor
138524366|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
138524367|NCT00019838|Fludarabine|fludarabine|mesh-list
138524368|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
138524369|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138524370|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524371|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524372|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
138524373|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524374|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524375|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
138524376|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524377|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524378|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524379|NCT00019916|Aldesleukin|aldesleukin|mesh-list
138524380|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524381|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524382|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524383|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
138524384|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524385|NCT00039546|Paclitaxel|paclitaxel|mesh-list
138524386|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
138524387|NCT00039546|Gemcitabine|gemcitabine|mesh-list
138524388|NCT00039546|Epirubicin|epirubicin|mesh-list
138524389|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524390|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524391|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524392|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524393|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
138701496|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524394|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524395|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524396|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
138524397|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524398|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198244|NCT01196377|Albuterol|albuterol|mesh-list
138524399|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524400|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
138524401|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524402|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524403|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
138419879|NCT05633667|Paclitaxel|paclitaxel|mesh-list
138524404|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524405|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138524406|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524407|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524408|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
138524409|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524410|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524411|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524412|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524413|NCT00019994|Aldesleukin|aldesleukin|mesh-list
138524414|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
138524415|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524416|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524417|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524418|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
138524419|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524420|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524421|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
138524422|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524423|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
138524424|NCT00039663|Pravastatin|pravastatin|mesh-list
138524425|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
138524426|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138524427|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524428|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138524429|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138524430|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
138524431|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524432|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138524433|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138524434|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524435|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138524436|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138524437|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
138524438|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524439|NCT00020150|Temozolomide|temozolomide|mesh-list
138524440|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138524441|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524442|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
138524443|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524444|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524445|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524446|NCT00039858|Argatroban|argatroban|mesh-list
138524447|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
138524448|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138524449|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
138524450|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524451|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524452|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
138524453|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138524454|NCT00020189|Aspirin|aspirin|mesh-list
138524455|NCT00020189|Alvocidib|alvocidib|mesh-list
138524456|NCT00020189|Clopidogrel|clopidogrel|mesh-list
138524457|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138524458|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138524459|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138524460|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138524461|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
138524462|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524463|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524464|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524465|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138524466|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138524467|NCT00020189|Analgesics|analgesics|mesh-ancestor
138524468|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
138524469|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524470|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524471|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524472|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138524473|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138524474|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138524475|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524477|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524478|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138524479|NCT00020189|Growth Substances|growth substances|mesh-ancestor
138524480|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524481|NCT00039975|Ritonavir|ritonavir|mesh-list
138524482|NCT00039975|Indinavir|indinavir|mesh-list
138524483|NCT00039975|Amlodipine|amlodipine|mesh-list
138524484|NCT00039975|Diltiazem|diltiazem|mesh-list
138524485|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138524486|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138524487|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
138524488|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701551|NCT05427747|Cefotaxime|cefotaxime|mesh-list
138524489|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524490|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524491|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524492|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
138524493|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524494|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138524495|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138524496|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138524497|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138524498|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138524499|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524500|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524501|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
138524502|NCT00020267|Interleukin-2|interleukin-2|mesh-list
138524503|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138524504|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524505|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138524506|NCT00020267|Analgesics|analgesics|mesh-ancestor
138524507|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
138524508|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524509|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524510|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524511|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
138524513|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524514|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138524515|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138524516|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524517|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524518|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138524519|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
138524520|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524521|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524522|NCT00040053|Ondansetron|ondansetron|mesh-list
138524523|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
138524524|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
138524525|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524526|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524527|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524528|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
138524529|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
138524530|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138524531|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138524532|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
138524533|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524534|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524535|NCT00020462|Aldesleukin|aldesleukin|mesh-list
138524536|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524537|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524538|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524539|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
138524540|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524541|NCT00020501|Leucovorin|leucovorin|mesh-list
138524542|NCT00020501|Fluorouracil|fluorouracil|mesh-list
138524543|NCT00020501|Floxuridine|floxuridine|mesh-list
138198337|NCT00002116|Cidofovir|cidofovir|mesh-list
138198562|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
138198635|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524544|NCT00020501|Irinotecan|irinotecan|mesh-list
138524545|NCT00020501|Melphalan|melphalan|mesh-list
138524547|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
138199252|NCT00002398|Adefovir|adefovir|mesh-list
138199409|NCT00002260|Alovudine|alovudine|mesh-list
138199470|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138199551|NCT00002284|Zidovudine|zidovudine|mesh-list
138199777|NCT01245595|Aminophylline|aminophylline|mesh-list
138199840|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199917|NCT00002524|Pentamidine|pentamidine|mesh-list
138200071|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
138524548|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200144|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
138200365|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
138200444|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
138200744|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201205|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
138201285|NCT01057277|Everolimus|everolimus|mesh-list
138201354|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138201504|NCT04104178|Clindamycin|clindamycin|mesh-list
138201659|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
138201873|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202103|NCT00754364|Carboplatin|carboplatin|mesh-list
138202395|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202468|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202543|NCT00003124|Flutamide|flutamide|mesh-list
138203074|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524551|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524552|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524553|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203299|NCT00003934|Cytarabine|cytarabine|mesh-list
138524554|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524555|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
138524556|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203507|NCT00003274|Sargramostim|sargramostim|mesh-list
138203652|NCT00003742|Paclitaxel|paclitaxel|mesh-list
138203726|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203802|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524558|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204197|NCT00003862|Leucovorin|leucovorin|mesh-list
138204328|NCT00004906|Thiotepa|thiotepa|mesh-list
138524559|NCT00020501|Antidotes|antidotes|mesh-ancestor
138204632|NCT05298670|Metformin|metformin|mesh-list
138524560|NCT00020501|Protective Agents|protective agents|mesh-ancestor
138524561|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
138524562|NCT00020501|Vitamins|vitamins|mesh-ancestor
138524563|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
138524564|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524565|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
138205576|NCT00005596|Daunorubicin|daunorubicin|mesh-list
138205785|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138205935|NCT02197273|Narcotics|narcotics|mesh-ancestor
138524566|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524567|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
138524568|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524569|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
138524570|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206217|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
138524571|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138524572|NCT00020540|Protective Agents|protective agents|mesh-ancestor
138206440|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524574|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524575|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138524576|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460543|NCT02975882|Sirolimus|sirolimus|mesh-list
138524577|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524578|NCT00040209|Levodopa|levodopa|mesh-list
138524579|NCT00040209|Apomorphine|apomorphine|mesh-list
138524580|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138524581|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138524582|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
138524583|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524584|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524585|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524586|NCT00040209|Emetics|emetics|mesh-ancestor
138524587|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
138524588|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524589|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524590|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
138524591|NCT00040248|Daclizumab|daclizumab|mesh-list
138524592|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420098|NCT05473520|Doxycycline|doxycycline|mesh-list
138524593|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
138524594|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524595|NCT00020618|Morphine|morphine|mesh-list
138524596|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138524597|NCT00020618|Narcotics|narcotics|mesh-ancestor
138524598|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524599|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524600|NCT00020618|Analgesics|analgesics|mesh-ancestor
138524601|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
138524602|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524604|NCT00020657|Granisetron|granisetron|mesh-list
138524605|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
138524606|NCT00020657|Dolasetron|dolasetron|mesh-list
138524607|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
138524608|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
138524609|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524610|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206811|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138524611|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524612|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
138524613|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
138524614|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138524615|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138524617|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208321|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
138208475|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
138208695|NCT04312139|Calcium|calcium|mesh-list
138208770|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208840|NCT01173029|Diuretics|diuretics|mesh-list
138208986|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138209213|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
138209441|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209514|NCT01184417|Phenobarbital|phenobarbital|mesh-list
138209664|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
138210040|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210262|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138210410|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138210556|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210637|NCT04930315|Apatinib|apatinib|mesh-list
138210709|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138211030|NCT02042378|Rucaparib|rucaparib|mesh-list
138524618|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524619|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138211551|NCT05256108|Analgesics|analgesics|mesh-ancestor
138211747|NCT05143502|Xhance|xhance|mesh-list
138524620|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138211923|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
138211996|NCT00458822|Bortezomib|bortezomib|mesh-list
138212365|NCT00469508|Modafinil|modafinil|mesh-list
138212444|NCT00539942|PENTA|penta|mesh-list
138212512|NCT00420992|Morphine|morphine|mesh-list
138212665|NCT00546104|Dasatinib|dasatinib|mesh-list
138212744|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
138212817|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524621|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524622|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138524623|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138524625|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
138213556|NCT00452426|Narcotics|narcotics|mesh-ancestor
138524627|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201007|NCT00002590|Etoposide|etoposide|mesh-list
138524628|NCT02970630|Everolimus|everolimus|mesh-list
138214230|NCT02184416|Sorafenib|sorafenib|mesh-list
138524630|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524631|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
138524632|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214599|NCT00583700|Protective Agents|protective agents|mesh-ancestor
138214749|NCT04545008|Expectorants|expectorants|mesh-ancestor
138214822|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
138214901|NCT00613028|Growth Substances|growth substances|mesh-ancestor
138524633|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138524634|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215643|NCT00689078|Prednisolone|prednisolone|mesh-list
138215716|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138215863|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216015|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216097|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
138216318|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138216387|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138216607|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216682|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138216829|NCT02993588|Protective Agents|protective agents|mesh-ancestor
138217215|NCT01273454|Hydromorphone|hydromorphone|mesh-list
138217429|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
138217504|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138217590|NCT00756236|Metoprolol|metoprolol|mesh-list
138217655|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217729|NCT01301183|Estradiol|estradiol|mesh-list
138217802|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138217949|NCT03808844|Propofol|propofol|mesh-list
138218100|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138218172|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524635|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524636|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138524637|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524638|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218631|NCT00801398|Oxymorphone|oxymorphone|mesh-list
138218751|NCT06214468|Niacin|niacin|mesh-list
138219065|NCT06212583|Hormone Antagonists|hormone antagonists|mesh-ancestor
138524640|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524641|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524642|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138524643|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138524644|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
138524645|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524646|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524647|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138524649|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420241|NCT05358886|BPN14770|bpn14770|mesh-list
138524650|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
138219210|NCT06120972|Olaparib|olaparib|mesh-list
138219269|NCT06074588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219270|NCT06074588|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138219271|NCT06074588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138219272|NCT06068673|Clindamycin|clindamycin|mesh-list
138219273|NCT06068673|Clindamycin palmitate|clindamycin palmitate|mesh-list
138219274|NCT06068673|Clindamycin phosphate|clindamycin phosphate|mesh-list
138219275|NCT06068673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138219276|NCT06068673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219277|NCT06068673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138219278|NCT06068673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219279|NCT06068673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219280|NCT06065280|Dapagliflozin|dapagliflozin|mesh-list
138219281|NCT06065280|Empagliflozin|empagliflozin|mesh-list
138219282|NCT06065280|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138219283|NCT06065280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219284|NCT06065280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219285|NCT06065280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219286|NCT06055920|Anticoagulants|anticoagulants|mesh-list
138219351|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138219352|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219353|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
138219354|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219356|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138420279|NCT05317416|Growth Substances|growth substances|mesh-ancestor
138219425|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219427|NCT05776524|Gemcitabine|gemcitabine|mesh-list
138701794|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138219428|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219429|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219430|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219431|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219432|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219433|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219434|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219435|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
138219449|NCT05761171|Cytarabine|cytarabine|mesh-list
138219450|NCT05761171|Prednisone|prednisone|mesh-list
138219451|NCT05761171|Prednisolone|prednisolone|mesh-list
138219502|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524651|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524652|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524653|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524654|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
138524655|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524656|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524657|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524658|NCT00020774|Gemcitabine|gemcitabine|mesh-list
138524660|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524661|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
138524662|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524663|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524664|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524665|NCT00040521|Oprelvekin|oprelvekin|mesh-list
138524666|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524667|NCT00040599|Labetuzumab|labetuzumab|mesh-list
138524668|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524669|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524670|NCT00020930|Cetuximab|cetuximab|mesh-list
138524671|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524672|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524673|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
138524674|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524675|NCT00040794|Paclitaxel|paclitaxel|mesh-list
138524676|NCT00040794|Carboplatin|carboplatin|mesh-list
138524677|NCT00040794|Gefitinib|gefitinib|mesh-list
138524678|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524679|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524680|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524681|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524682|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524683|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524684|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524685|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524686|NCT00021047|Carboplatin|carboplatin|mesh-list
138524687|NCT00021047|Capecitabine|capecitabine|mesh-list
138524688|NCT00021047|Epirubicin|epirubicin|mesh-list
138524689|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420330|NCT05284552|Dalteparin|dalteparin|mesh-list
138524690|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219810|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138219811|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219812|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219813|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219814|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138219815|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
138219816|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138219817|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219818|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138219819|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138460597|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
138219825|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138219827|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
138219906|NCT05309616|Ixekizumab|ixekizumab|mesh-list
138219907|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
138219908|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138219909|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138219910|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138219911|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219912|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219913|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138219914|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138219915|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219916|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
138219917|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219918|NCT05306340|Tamoxifen|tamoxifen|mesh-list
138219919|NCT05306340|Dexamethasone|dexamethasone|mesh-list
138219920|NCT05306340|Fulvestrant|fulvestrant|mesh-list
138219921|NCT05306340|Everolimus|everolimus|mesh-list
138219922|NCT05306340|Exemestane|exemestane|mesh-list
138219923|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219941|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
138219942|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138219943|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138219944|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138219996|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219998|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
138219999|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220005|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220006|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220008|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220009|NCT05249556|Ganaxolone|ganaxolone|mesh-list
138220010|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
138220011|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220088|NCT05103358|Sirolimus|sirolimus|mesh-list
138220089|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138220090|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220091|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138220097|NCT05079230|Azacitidine|azacitidine|mesh-list
138524692|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220419|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
138220420|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
138220421|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
138220422|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220423|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138220424|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220425|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220426|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220427|NCT04432584|Eculizumab|eculizumab|mesh-list
138220428|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138352559|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352560|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138352561|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
138352563|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
138352564|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352565|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
138352566|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352567|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352569|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352570|NCT03485976|Ixekizumab|ixekizumab|mesh-list
138352571|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352574|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
138352575|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138352576|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
138352577|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352578|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352579|NCT03503292|Ondansetron|ondansetron|mesh-list
138352580|NCT03503292|Granisetron|granisetron|mesh-list
138352583|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352584|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352585|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352586|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
138352587|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352588|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138352589|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138220429|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220432|NCT04432376|Miconazole|miconazole|mesh-list
138220493|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
138220650|NCT03971669|Vaccines|vaccines|mesh-list
138524693|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524694|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138220895|NCT03395197|Talazoparib|talazoparib|mesh-list
138524697|NCT00021164|Aldesleukin|aldesleukin|mesh-list
138221649|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
138221985|NCT01370369|Hormones|hormones|mesh-ancestor
138524698|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
138222165|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138524699|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222474|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
138222834|NCT01395329|BQ 788|bq 788|mesh-list
138524700|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138223556|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223624|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524701|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138223849|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524703|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524704|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138524705|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
138224367|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420383|NCT05270213|Pembrolizumab|pembrolizumab|mesh-list
138224443|NCT01532141|Protective Agents|protective agents|mesh-ancestor
138524706|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524708|NCT00040872|Thiotepa|thiotepa|mesh-list
138225146|NCT01721798|Copper|copper|mesh-list
138524709|NCT00040872|Carboplatin|carboplatin|mesh-list
138225865|NCT01041638|Vitamin A|vitamin a|mesh-list
138226089|NCT03002675|Exenatide|exenatide|mesh-list
138524710|NCT00040872|Doxorubicin|doxorubicin|mesh-list
138524711|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138226555|NCT04369586|Meplazumab|meplazumab|mesh-list
138226857|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
138524713|NCT00040872|Vincristine|vincristine|mesh-list
138524714|NCT00040872|Topotecan|topotecan|mesh-list
138227001|NCT04356872|Ifosfamide|ifosfamide|mesh-list
138524715|NCT00040872|Isotretinoin|isotretinoin|mesh-list
138524717|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138524718|NCT00040872|Sargramostim|sargramostim|mesh-list
138524719|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524720|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
138524721|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524722|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524723|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524724|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
138227217|NCT00942578|Lenalidomide|lenalidomide|mesh-list
138227294|NCT01651793|Caffeine|caffeine|mesh-list
138227440|NCT02158520|Bevacizumab|bevacizumab|mesh-list
138227675|NCT01662791|Rifaximin|rifaximin|mesh-list
138227743|NCT03034382|Lidocaine|lidocaine|mesh-list
138227821|NCT04353362|Amoxicillin|amoxicillin|mesh-list
138227889|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
138228042|NCT01680653|Glucagon|glucagon|mesh-list
138228110|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228189|NCT02991209|Hormones|hormones|mesh-ancestor
138228265|NCT02485158|Hormones|hormones|mesh-ancestor
138229018|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229092|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
138229317|NCT01110434|Topiramate|topiramate|mesh-list
138229389|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524725|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524727|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138524728|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524729|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138524730|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524731|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524732|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524733|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524734|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524735|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524736|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138524737|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138524738|NCT00021242|Docetaxel|docetaxel|mesh-list
138524739|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524740|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524741|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524742|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524743|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524744|NCT00040950|Rituximab|rituximab|mesh-list
138524745|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524746|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524747|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
138524748|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524749|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138524750|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138524751|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524752|NCT00021281|Leucovorin|leucovorin|mesh-list
138524753|NCT00021281|Fluorouracil|fluorouracil|mesh-list
138524754|NCT00021281|Irinotecan|irinotecan|mesh-list
138524755|NCT00021281|Calcium|calcium|mesh-list
138524756|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
138524757|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524758|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524759|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
138524760|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524761|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524762|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524763|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420464|NCT05067283|Leucovorin|leucovorin|mesh-list
138524764|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
138524765|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138524766|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524767|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524768|NCT00021281|Antidotes|antidotes|mesh-ancestor
138524769|NCT00021281|Protective Agents|protective agents|mesh-ancestor
138524770|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
138524771|NCT00021281|Vitamins|vitamins|mesh-ancestor
138524772|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
138524773|NCT00041106|Gemcitabine|gemcitabine|mesh-list
138524774|NCT00041106|Gefitinib|gefitinib|mesh-list
138524775|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524776|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524777|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
138524778|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524779|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524780|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524781|NCT00021320|Paclitaxel|paclitaxel|mesh-list
138524782|NCT00021320|Fluorouracil|fluorouracil|mesh-list
138524783|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524784|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524785|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524786|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524787|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524788|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524789|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
138524790|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420501|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
138524791|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524792|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
138524793|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524794|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
138524796|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
138524797|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524798|NCT00041223|Protective Agents|protective agents|mesh-ancestor
138524799|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524800|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138524802|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524803|NCT00021359|Dexamethasone|dexamethasone|mesh-list
138524804|NCT00021359|Isotretinoin|isotretinoin|mesh-list
138524805|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524806|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
138524807|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
138524808|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524809|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524810|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524811|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
138524812|NCT00021359|Hormones|hormones|mesh-ancestor
138524813|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524814|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524815|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524816|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138524817|NCT00041262|Fluorouracil|fluorouracil|mesh-list
138524818|NCT00041262|Epirubicin|epirubicin|mesh-list
138524819|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524820|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
138524821|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524822|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524823|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524824|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
138524825|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524826|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138524827|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138524828|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524829|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524830|NCT00021398|Leucovorin|leucovorin|mesh-list
138524831|NCT00021398|Fluorouracil|fluorouracil|mesh-list
138524833|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
138524834|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524835|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524836|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
138524837|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524838|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524839|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524840|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524841|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
138524842|NCT00021398|Antidotes|antidotes|mesh-ancestor
138524843|NCT00021398|Protective Agents|protective agents|mesh-ancestor
138524844|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
138524845|NCT00021398|Vitamins|vitamins|mesh-ancestor
138524846|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
138524847|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138524848|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
138524849|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524850|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
138524851|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138524852|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138524853|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524854|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524855|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524856|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
138524857|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524858|NCT00049023|Octreotide|octreotide|mesh-list
138524859|NCT00049023|Edotreotide|edotreotide|mesh-list
138201239|NCT03014843|Bromides|bromides|mesh-list
138524860|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524861|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524862|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524863|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138524864|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524866|NCT00021671|Nevirapine|nevirapine|mesh-list
138524868|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
138524869|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138524870|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
138524871|NCT00021671|Ampicillin|ampicillin|mesh-list
138524872|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524873|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138524874|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138524875|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138524876|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138524877|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138524878|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229610|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524880|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
138524881|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138524882|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524883|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138524884|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138524885|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524886|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138524887|NCT00049062|Gefitinib|gefitinib|mesh-list
138524888|NCT00049062|Anastrozole|anastrozole|mesh-list
138524889|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524890|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524891|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524892|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524893|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524894|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138524895|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138524896|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138524897|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
138524898|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524899|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524900|NCT00049101|Leucovorin|leucovorin|mesh-list
138524901|NCT00049101|Fluorouracil|fluorouracil|mesh-list
138524902|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
138524903|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138420658|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420659|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352590|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
138352592|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352594|NCT03506724|Nifedipine|nifedipine|mesh-list
138352595|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138352596|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352597|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352598|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138352599|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352600|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
138352603|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138352604|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138352605|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352606|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352607|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138352608|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
138352609|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
138352610|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352611|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138352613|NCT03509766|Histamine|histamine|mesh-list
138352614|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
138352615|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
138352616|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352617|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352618|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352619|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
138352620|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138352621|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352622|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
138352623|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352624|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
138352625|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
138352626|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
138352627|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352628|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138352629|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138352633|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138352634|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138352635|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
138352636|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352637|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352638|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352639|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138352640|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352641|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
138352642|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352643|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352646|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138352647|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352648|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138352649|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352650|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138352651|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352653|NCT03574818|Necitumumab|necitumumab|mesh-list
138352654|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352655|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138352656|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
138352657|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352658|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420660|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138420661|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138420662|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
138420664|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420665|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138420666|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138420667|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420668|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420669|NCT04761393|Xenon|xenon|mesh-list
138420670|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138420671|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
138420672|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
138420673|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420674|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524904|NCT00049101|Calcium|calcium|mesh-list
138524905|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
138524906|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524907|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524908|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
138524909|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524910|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524911|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524912|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524913|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
138524914|NCT00049101|Antidotes|antidotes|mesh-ancestor
138524915|NCT00049101|Protective Agents|protective agents|mesh-ancestor
138524916|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
138524917|NCT00049101|Vitamins|vitamins|mesh-ancestor
138524918|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
138524919|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138524920|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524921|NCT00394628|Temozolomide|temozolomide|mesh-list
138524922|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138524923|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
138524924|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524925|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524926|NCT00049179|Cytarabine|cytarabine|mesh-list
138524927|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
138524928|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524929|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
138524930|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524931|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524932|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
138524933|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524934|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524935|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
138524936|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524937|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524938|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
138420731|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
138420732|NCT04747795|Vitamins|vitamins|mesh-ancestor
138420733|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
138420734|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420735|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
138420736|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420737|NCT04747795|Protective Agents|protective agents|mesh-ancestor
138420738|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
138420739|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138524939|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
138524941|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138524942|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138524943|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138524944|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524945|NCT00049218|Carboplatin|carboplatin|mesh-list
138524946|NCT00049218|Etoposide|etoposide|mesh-list
138524947|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524948|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524949|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138352747|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
138352749|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352750|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138352751|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138352752|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
138352753|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138352754|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352755|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352756|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524950|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138524951|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524952|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524953|NCT00049296|Thalidomide|thalidomide|mesh-list
138524954|NCT00049296|Docetaxel|docetaxel|mesh-list
138524955|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524956|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
138524957|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524958|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524959|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138524960|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524961|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
138524962|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524963|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
138524964|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138524965|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138524966|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138524967|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138524968|NCT00049296|Growth Substances|growth substances|mesh-ancestor
138524969|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
138524970|NCT00021827|Hormones|hormones|mesh-list
138524971|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
138524972|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138524973|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524974|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524975|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524976|NCT00049335|Capecitabine|capecitabine|mesh-list
138524977|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524978|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
138524979|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420740|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420744|NCT04736706|Lenvatinib|lenvatinib|mesh-list
138524980|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524981|NCT00049374|Thalidomide|thalidomide|mesh-list
138524982|NCT00049374|Dexamethasone|dexamethasone|mesh-list
138524983|NCT00049374|Oblimersen|oblimersen|mesh-list
138524984|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524985|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
138524986|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
138524987|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524988|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524989|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138524990|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
138524992|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524993|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524994|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524995|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138524996|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
138524997|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
138524998|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138524999|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525000|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138525001|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138525002|NCT00049374|Growth Substances|growth substances|mesh-ancestor
138525003|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525004|NCT00021983|Immunotoxins|immunotoxins|mesh-list
138525005|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
138525006|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
138525007|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525008|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
138525009|NCT00049413|Rituximab|rituximab|mesh-list
138525010|NCT00049413|Pentostatin|pentostatin|mesh-list
138525011|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525012|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
138525013|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525014|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525015|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525016|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
138525017|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525018|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525019|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525020|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525021|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138525022|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525023|NCT00022022|Docetaxel|docetaxel|mesh-list
138525024|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525026|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525027|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289423|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289424|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289425|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138289426|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138289427|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
138289429|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138289430|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138289431|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
138289432|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
138289433|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
138289434|NCT00000872|Lamivudine|lamivudine|mesh-list
138289435|NCT00000872|Zidovudine|zidovudine|mesh-list
138289436|NCT00000872|Nevirapine|nevirapine|mesh-list
138289437|NCT00000872|Abacavir|abacavir|mesh-list
138289438|NCT00000872|Stavudine|stavudine|mesh-list
138289439|NCT00000872|Nelfinavir|nelfinavir|mesh-list
138289440|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289441|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289442|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289443|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289444|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
138289445|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289446|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289447|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289448|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
138289449|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289450|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289451|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289452|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289453|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289456|NCT00000878|Stavudine|stavudine|mesh-list
138289457|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289458|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289459|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289460|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289461|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
138289462|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289463|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289464|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289465|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
138289466|NCT04204057|Tenalisib|tenalisib|mesh-list
138289467|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138289468|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289469|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289470|NCT00001736|Cysteamine|cysteamine|mesh-list
138289471|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138289472|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289473|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
138289474|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138289475|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
138289476|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289477|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138289479|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
138289480|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289481|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
138289482|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138289483|NCT00000884|Protective Agents|protective agents|mesh-ancestor
138289484|NCT00000896|Lamivudine|lamivudine|mesh-list
138289485|NCT00000896|Zidovudine|zidovudine|mesh-list
138289486|NCT00000896|Nevirapine|nevirapine|mesh-list
138289487|NCT00000896|Stavudine|stavudine|mesh-list
138289488|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138289489|NCT00000896|Indinavir|indinavir|mesh-list
138289490|NCT00000896|Interleukin-12|interleukin-12|mesh-list
138289491|NCT00000896|Sargramostim|sargramostim|mesh-list
138289493|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289494|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352760|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
138525028|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525030|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138525031|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525032|NCT00022139|Paclitaxel|paclitaxel|mesh-list
138525033|NCT00022139|Carboplatin|carboplatin|mesh-list
138525034|NCT00022139|Fluorouracil|fluorouracil|mesh-list
138525035|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525036|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525037|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525038|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525039|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525040|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525041|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
138525042|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525043|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525044|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
138525045|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525046|NCT00049569|Leucovorin|leucovorin|mesh-list
138525047|NCT00049569|Cytarabine|cytarabine|mesh-list
138525048|NCT00049569|Prednisone|prednisone|mesh-list
138525049|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
138525050|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138525051|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138525052|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138525053|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
138525054|NCT00049569|Doxorubicin|doxorubicin|mesh-list
138525055|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525056|NCT00049569|Methotrexate|methotrexate|mesh-list
138525057|NCT00049569|Etoposide|etoposide|mesh-list
138525058|NCT00049569|Vincristine|vincristine|mesh-list
138525059|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
138525060|NCT00049569|Asparaginase|asparaginase|mesh-list
138525061|NCT00049569|Pegaspargase|pegaspargase|mesh-list
138525062|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
138525063|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525064|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
138525065|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525066|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525067|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525068|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
138525069|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525070|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525071|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525072|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525073|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525074|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525075|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525076|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525077|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
138525078|NCT00049569|Hormones|hormones|mesh-ancestor
138525079|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138525080|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138525081|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138525082|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
138525083|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138525084|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525085|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
138201469|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
138525086|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
138525087|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138525088|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525089|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525090|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
138525091|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525092|NCT00049569|Antidotes|antidotes|mesh-ancestor
138525093|NCT00049569|Protective Agents|protective agents|mesh-ancestor
138525094|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
138525095|NCT00049569|Vitamins|vitamins|mesh-ancestor
138525096|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
138525097|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525098|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525099|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525100|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525101|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
138525102|NCT00022178|Doxorubicin|doxorubicin|mesh-list
138525103|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525104|NCT00022178|Fluorouracil|fluorouracil|mesh-list
138525105|NCT00022178|Vincristine|vincristine|mesh-list
138525106|NCT00022178|Epirubicin|epirubicin|mesh-list
138525107|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525108|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
138525109|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525110|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525111|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525112|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
138420839|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138525113|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525114|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525115|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525116|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525117|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525118|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525119|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525120|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
138525121|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353118|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138353119|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353123|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138353124|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138353126|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138353127|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353128|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353129|NCT02280252|Paclitaxel|paclitaxel|mesh-list
138525122|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525123|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525124|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525125|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525126|NCT00049608|Gemcitabine|gemcitabine|mesh-list
138525127|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525128|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
138525129|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525130|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525131|NCT00022217|Paclitaxel|paclitaxel|mesh-list
138525132|NCT00022217|Carboplatin|carboplatin|mesh-list
138525133|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525134|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525135|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525136|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525137|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525138|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525139|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
138525140|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525141|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138525142|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138525143|NCT00049725|Daclizumab|daclizumab|mesh-list
138525144|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525145|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
138525146|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525147|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138525148|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525149|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
138525150|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138525151|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138525152|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
138525153|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
138525154|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138525155|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525156|NCT00397761|Paclitaxel|paclitaxel|mesh-list
138525157|NCT00397761|Capecitabine|capecitabine|mesh-list
138525158|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138353555|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353556|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138353557|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138353558|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353559|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138353560|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138353561|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353562|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138353565|NCT00656916|Fluticasone|fluticasone|mesh-list
138353567|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138353568|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138353569|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
138353570|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353571|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353573|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353574|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
138353575|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138353576|NCT00619242|Sorafenib|sorafenib|mesh-list
138353577|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353579|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353580|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353581|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138353582|NCT00601848|Trioxsalen|trioxsalen|mesh-list
138353583|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353584|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
138353586|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
138353587|NCT00586716|Antibodies|antibodies|mesh-list
138353588|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
138353589|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138353590|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138353591|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
138353592|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353593|NCT00571194|Pravastatin|pravastatin|mesh-list
138353594|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138353595|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138353597|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353599|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138353600|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353601|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138353602|NCT00570258|Fulvestrant|fulvestrant|mesh-list
138353605|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353606|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353607|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138353608|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138353610|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
138353611|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353612|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353613|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
138353614|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353615|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
138353616|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353617|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353618|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138353620|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353621|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
138353622|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353623|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
138353624|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353627|NCT05599230|Ivacaftor|ivacaftor|mesh-list
138353628|NCT05599230|Elexacaftor|elexacaftor|mesh-list
138353629|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138525159|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525160|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201540|NCT03955198|Durvalumab|durvalumab|mesh-list
138525161|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525162|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525163|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525164|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525165|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525166|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
138525167|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138525168|NCT00022412|Vitamins|vitamins|mesh-ancestor
138525169|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
138525170|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525171|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138525173|NCT00397800|Rituximab|rituximab|mesh-list
138525174|NCT00397800|Fludarabine|fludarabine|mesh-list
138525175|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
138525176|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525177|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
138353854|NCT00000132|Betaxolol|betaxolol|mesh-list
138353855|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353856|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
138353857|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
138353858|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353859|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353860|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138353861|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138353862|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138353863|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353874|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138353875|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
138353876|NCT00000138|Hormones|hormones|mesh-ancestor
138353877|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353878|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353879|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138353884|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138353885|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138353886|NCT00000138|Protective Agents|protective agents|mesh-ancestor
138353888|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353889|NCT00000174|Rivastigmine|rivastigmine|mesh-list
138353890|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138353891|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353892|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353894|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353895|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353896|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138353897|NCT00000174|Protective Agents|protective agents|mesh-ancestor
138353898|NCT00000192|Lamotrigine|lamotrigine|mesh-list
138353899|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
138353900|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138353901|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353902|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353903|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353904|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353905|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138353906|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138353907|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353908|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353909|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138353910|NCT00000198|Piracetam|piracetam|mesh-list
138353911|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138353912|NCT00000198|Protective Agents|protective agents|mesh-ancestor
138353913|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353914|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
138353915|NCT00000204|Buprenorphine|buprenorphine|mesh-list
138353916|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353917|NCT00000204|Narcotics|narcotics|mesh-ancestor
138353918|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353919|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353920|NCT00000204|Analgesics|analgesics|mesh-ancestor
138353921|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
138353925|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353926|NCT00000210|Narcotics|narcotics|mesh-ancestor
138525178|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525179|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525180|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525181|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
138525182|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525183|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525184|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525185|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525186|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525187|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
138525188|NCT00022451|Tipifarnib|tipifarnib|mesh-list
138525189|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525190|NCT00022529|Trastuzumab|trastuzumab|mesh-list
138525191|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525192|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525193|NCT00022607|Thalidomide|thalidomide|mesh-list
138525194|NCT00022607|Bevacizumab|bevacizumab|mesh-list
138525195|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525196|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525197|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138525198|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138525199|NCT00022607|Growth Substances|growth substances|mesh-ancestor
138525200|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525201|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525202|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525203|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
138525204|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
138525205|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525206|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525207|NCT00049998|Topotecan|topotecan|mesh-list
138420891|NCT04533750|Antiviral Agents|antiviral agents|mesh-ancestor
138354017|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354019|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138354020|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354021|NCT00000294|Carvedilol|carvedilol|mesh-list
138354022|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138354023|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138354024|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138354025|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354026|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354027|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354028|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138354030|NCT00000294|Protective Agents|protective agents|mesh-ancestor
138354031|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138354033|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138354034|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
138354035|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138354036|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138354037|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
138354038|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138354039|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354040|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138354041|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138354042|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354044|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
138354045|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354047|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138354048|NCT00000318|Narcotics|narcotics|mesh-ancestor
138354049|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138354050|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354053|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354054|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138354056|NCT00000330|Narcotics|narcotics|mesh-ancestor
138354057|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138354060|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
138354061|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354062|NCT00000336|Selegiline|selegiline|mesh-list
138354063|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
138354064|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138354065|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138354066|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138479988|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479990|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138479991|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479993|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138479994|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138479995|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138479996|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
138479997|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138479998|NCT02044354|Docetaxel|docetaxel|mesh-list
138479999|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480000|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480001|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480002|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480003|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480004|NCT02044549|Oxytocin|oxytocin|mesh-list
138480005|NCT02044549|Carbetocin|carbetocin|mesh-list
138480006|NCT02044549|Methylergonovine|methylergonovine|mesh-list
138480007|NCT02044549|Syntometrine|syntometrine|mesh-list
138480008|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
138480009|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480010|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480011|NCT02044601|Paclitaxel|paclitaxel|mesh-list
138480012|NCT02044601|Carboplatin|carboplatin|mesh-list
138480013|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138480014|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480015|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480016|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480017|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480018|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480019|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480020|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138480021|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480022|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138480023|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138480024|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
138480025|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480026|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138480027|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297385|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
138354256|NCT00000714|Trimetrexate|trimetrexate|mesh-list
138354259|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138354261|NCT00000714|Antidotes|antidotes|mesh-ancestor
138354262|NCT00000714|Protective Agents|protective agents|mesh-ancestor
138354263|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
138354264|NCT00000714|Vitamins|vitamins|mesh-ancestor
138354265|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
138354266|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
138354267|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354268|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138354269|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
138354270|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354271|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354272|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138354273|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354274|NCT00000732|Zidovudine|zidovudine|mesh-list
138354275|NCT00000732|Trimethoprim|trimethoprim|mesh-list
138354276|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
138354277|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138354279|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354280|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354281|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354282|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354283|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
138354284|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354285|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354286|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354287|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138354288|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
138354289|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138354290|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138354291|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138354292|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138354293|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138354297|NCT00000738|Nimodipine|nimodipine|mesh-list
138354299|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354300|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354301|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354302|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354303|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
138354306|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354307|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138354308|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138354309|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354310|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138354311|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354314|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
138354315|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354316|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354317|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354318|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354319|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
138354320|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354321|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354322|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354323|NCT00000804|Indinavir|indinavir|mesh-list
138354324|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354325|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138480029|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480031|NCT02044653|Hematinics|hematinics|mesh-ancestor
138480032|NCT02044809|Cannabidiol|cannabidiol|mesh-list
138480033|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
138480036|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480037|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480038|NCT02044952|Analgesics|analgesics|mesh-ancestor
138480039|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
138480040|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480041|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480042|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480043|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480044|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480045|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138480046|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138480047|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
138480048|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480049|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480050|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
138480051|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480052|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
138480053|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480054|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138480055|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138354326|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
138480056|NCT02044965|Trimethoprim|trimethoprim|mesh-list
138480057|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
138480058|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480059|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138297416|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480062|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138480063|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138480064|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480065|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480066|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138354327|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354328|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354329|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354330|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354331|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
138354332|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354333|NCT00000810|Zidovudine|zidovudine|mesh-list
138354334|NCT00000810|Didanosine|didanosine|mesh-list
138354335|NCT00000810|Delavirdine|delavirdine|mesh-list
138354336|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
138354338|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354339|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354340|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354341|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
138354342|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354343|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354345|NCT00000834|Lamivudine|lamivudine|mesh-list
138354346|NCT00000834|Zidovudine|zidovudine|mesh-list
138354347|NCT00000834|Methotrexate|methotrexate|mesh-list
138354348|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138354349|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
138354350|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138354351|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354352|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138354354|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354355|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354357|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354358|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138354359|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354360|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
138354361|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138354362|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354363|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354364|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
138354365|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354366|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354369|NCT00000864|Abacavir|abacavir|mesh-list
138354370|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
138354371|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354372|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354373|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354374|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354375|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
138354376|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354377|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354378|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354381|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354382|NCT00000894|Ganciclovir|ganciclovir|mesh-list
138354383|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138354384|NCT00000894|Cidofovir|cidofovir|mesh-list
138354385|NCT00000894|Probenecid|probenecid|mesh-list
138354386|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
138354387|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354389|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354390|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354391|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
138354392|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
138354393|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138354394|NCT00000912|Efavirenz|efavirenz|mesh-list
138354395|NCT00000912|Abacavir|abacavir|mesh-list
138354396|NCT00000912|Adefovir|adefovir|mesh-list
138354397|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138480067|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138480068|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138480070|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138480071|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480072|NCT02045017|Dexamethasone|dexamethasone|mesh-list
138480073|NCT02045017|Pomalidomide|pomalidomide|mesh-list
138480074|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480075|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
138480076|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
138480077|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480078|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480079|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480080|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
138480081|NCT02045017|Hormones|hormones|mesh-ancestor
138480082|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480083|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480084|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480085|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
138480086|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480087|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138480088|NCT02045017|Growth Substances|growth substances|mesh-ancestor
138480089|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
138480090|NCT02045030|Aflibercept|aflibercept|mesh-list
138480091|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480092|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138480093|NCT02045030|Growth Substances|growth substances|mesh-ancestor
138480094|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480095|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
138480096|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480097|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
138480098|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138297462|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
138297469|NCT00003596|Mitomycins|mitomycins|mesh-list
138480101|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138480102|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138480103|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138480104|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480105|NCT02045069|Ivermectin|ivermectin|mesh-list
138480106|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138480107|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480108|NCT02045290|Metformin|metformin|mesh-list
138480109|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138480111|NCT02045368|Methotrexate|methotrexate|mesh-list
138480112|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138480113|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
138480114|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138354398|NCT00000912|Nelfinavir|nelfinavir|mesh-list
138354399|NCT00000912|Indinavir|indinavir|mesh-list
138354400|NCT00000912|Saquinavir|saquinavir|mesh-list
138354401|NCT00000912|Amprenavir|amprenavir|mesh-list
138354402|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354403|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354404|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354405|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354406|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
138354408|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354409|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354410|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354411|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138354412|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354413|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354414|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354415|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354416|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354419|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138354420|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138354421|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
138354422|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354426|NCT00000918|Amprenavir|amprenavir|mesh-list
138354427|NCT00000918|Lamivudine|lamivudine|mesh-list
138354428|NCT00000918|Zidovudine|zidovudine|mesh-list
138354429|NCT00000918|Didanosine|didanosine|mesh-list
138354430|NCT00000918|Stavudine|stavudine|mesh-list
138354431|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138354432|NCT00000918|Efavirenz|efavirenz|mesh-list
138354433|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354434|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138354435|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138354437|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354438|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354439|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354440|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
138354441|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354442|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138354443|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354444|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354445|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354446|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
138354448|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354449|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138354450|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354451|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354452|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138354453|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
138354455|NCT00000924|Ritonavir|ritonavir|mesh-list
138354456|NCT00000924|Nelfinavir|nelfinavir|mesh-list
138354457|NCT00000924|Nevirapine|nevirapine|mesh-list
138354458|NCT00000924|Didanosine|didanosine|mesh-list
138354459|NCT00000924|Stavudine|stavudine|mesh-list
138354460|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354461|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138354462|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
138354465|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354466|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354467|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
138354468|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354469|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138354470|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354471|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354472|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480115|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480116|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480117|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
138480118|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480119|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480120|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138480121|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480122|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138480123|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480124|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
138480126|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480127|NCT02045589|Gemcitabine|gemcitabine|mesh-list
138480128|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138480129|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480130|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
138480131|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480132|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480133|NCT02045602|Gemcitabine|gemcitabine|mesh-list
138480134|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138480135|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480136|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
138480137|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480139|NCT02045667|Mexiletine|mexiletine|mesh-list
138480140|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138297496|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
138480142|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138480143|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289694|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138289695|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
138289697|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
138289698|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289699|NCT00000218|Carbamazepine|carbamazepine|mesh-list
138289700|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
138289701|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
138289702|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138289703|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138480144|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480146|NCT02045693|Methadone|methadone|mesh-list
138480147|NCT02045693|Naloxone|naloxone|mesh-list
138480148|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138480149|NCT02045693|Narcotics|narcotics|mesh-ancestor
138480150|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138480151|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480152|NCT02045693|Analgesics|analgesics|mesh-ancestor
138480153|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
138480154|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480155|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138480156|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
138480157|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
138480158|NCT02045797|Gepotidacin|gepotidacin|mesh-list
138480159|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480160|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480161|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480162|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480163|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
138480164|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
138480166|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138480167|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480168|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
138480169|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480170|NCT02045849|Itraconazole|itraconazole|mesh-list
138480171|NCT02045849|Gepotidacin|gepotidacin|mesh-list
138480172|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
138480173|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480174|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138480175|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138480176|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414689|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138480177|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480178|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138480180|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480181|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480182|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138480183|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480184|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480185|NCT02045914|Calcium|calcium|mesh-list
138480186|NCT02045914|Ionophores|ionophores|mesh-list
138480187|NCT02045914|Ionomycin|ionomycin|mesh-list
138480188|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
138480189|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138480190|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480191|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480192|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480193|NCT02045940|GSK2881078|gsk2881078|mesh-list
138480194|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
138480195|NCT02045940|Hormones|hormones|mesh-ancestor
138480196|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480197|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480198|NCT02045953|Albuterol|albuterol|mesh-list
138480199|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138480200|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
138480201|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480202|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480203|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138297566|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
138480204|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138480206|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480207|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138480208|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138480209|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138480210|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
138480211|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289704|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289705|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289706|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289707|NCT00000218|Analgesics|analgesics|mesh-ancestor
138289708|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
138289709|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289710|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138289712|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289713|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289714|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289715|NCT00000224|Buprenorphine|buprenorphine|mesh-list
138289716|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289717|NCT00000224|Narcotics|narcotics|mesh-ancestor
138289718|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289719|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289720|NCT00000224|Analgesics|analgesics|mesh-ancestor
138289721|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
138289722|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289723|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138289724|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
138289725|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
138289726|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289727|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289728|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289729|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289730|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289731|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289732|NCT00000230|Buprenorphine|buprenorphine|mesh-list
138289733|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289734|NCT00000230|Narcotics|narcotics|mesh-ancestor
138289735|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289736|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289737|NCT00000230|Analgesics|analgesics|mesh-ancestor
138289738|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
138289739|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289740|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138289741|NCT00000236|Buprenorphine|buprenorphine|mesh-list
138289742|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138289746|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289747|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289748|NCT00000236|Analgesics|analgesics|mesh-ancestor
138289749|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
138289750|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289751|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138480212|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480214|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138480215|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480216|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138480217|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480218|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480219|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138480220|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138480221|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
138480222|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480224|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138480225|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138480226|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480227|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480228|NCT02046044|Protective Agents|protective agents|mesh-ancestor
138480229|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480230|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
138480231|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138480232|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480233|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
138480234|NCT02046187|Temozolomide|temozolomide|mesh-list
138480235|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480236|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
138297611|NCT00003632|Cytarabine|cytarabine|mesh-list
138480238|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480239|NCT02046304|Gemcitabine|gemcitabine|mesh-list
138480240|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480241|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
138480242|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480243|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480244|NCT02046421|Carboplatin|carboplatin|mesh-list
138480245|NCT02046421|Gemcitabine|gemcitabine|mesh-list
138480246|NCT02046421|Mifepristone|mifepristone|mesh-list
138480247|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480248|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480249|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
138480250|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480251|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138480252|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
138480253|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480254|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480255|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138480256|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138480257|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138480258|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
138480259|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138480260|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138480261|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
138480262|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480263|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
138480264|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138480265|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138480266|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
138480268|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138480269|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138480270|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138480271|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
138480272|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480273|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480274|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480276|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138480277|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138480278|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138480279|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138480280|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
138480281|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480282|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480283|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480284|NCT02046499|Oxytocin|oxytocin|mesh-list
138480285|NCT02046499|Ergonovine|ergonovine|mesh-list
138480286|NCT02046499|Syntometrine|syntometrine|mesh-list
138480287|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
138480288|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480289|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480290|NCT02046538|Leucovorin|leucovorin|mesh-list
138480291|NCT02046538|Fluorouracil|fluorouracil|mesh-list
138480292|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
138480293|NCT02046538|Irinotecan|irinotecan|mesh-list
138480294|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
138480295|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414690|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
138297692|NCT00003650|Cytarabine|cytarabine|mesh-list
138480296|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480297|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480298|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480299|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
138480300|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480301|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138480302|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480303|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480304|NCT02046538|Antidotes|antidotes|mesh-ancestor
138480305|NCT02046538|Protective Agents|protective agents|mesh-ancestor
138480306|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
138480308|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
138480309|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138480310|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138480311|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138480312|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480313|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480316|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480318|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
138480319|NCT02046577|Vitamins|vitamins|mesh-ancestor
138480320|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
138480321|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480322|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138480323|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138480324|NCT02046629|Teriflunomide|teriflunomide|mesh-list
138480325|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
138480326|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480327|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480328|NCT02046629|Analgesics|analgesics|mesh-ancestor
138480329|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
138480330|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480331|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480332|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480333|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480334|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480337|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138480338|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
138480339|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289752|NCT00000974|Pentamidine|pentamidine|mesh-list
138289753|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
138289754|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289755|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289756|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289757|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138289759|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
138289760|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
138289761|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138289762|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289763|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289764|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289765|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289766|NCT00000242|Analgesics|analgesics|mesh-ancestor
138289767|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
138289768|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289769|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138289770|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289771|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289772|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289773|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289775|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289776|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289777|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
138289778|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289779|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289780|NCT00000992|Itraconazole|itraconazole|mesh-list
138289781|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
138289782|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289783|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138289784|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289785|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289786|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289787|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138289788|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289789|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289790|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289791|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289792|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
138289793|NCT00000254|Isoflurane|isoflurane|mesh-list
138289794|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138289795|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
138289796|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
138289797|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289799|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289800|NCT00000254|Analgesics|analgesics|mesh-ancestor
138289801|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
138289802|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289803|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
138289805|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
138289807|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289809|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289810|NCT00000260|Analgesics|analgesics|mesh-ancestor
138289811|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
138289812|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289813|NCT00000266|Flupenthixol|flupenthixol|mesh-list
138289814|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138354558|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
138354559|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354561|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354562|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138354563|NCT00001062|Ganciclovir|ganciclovir|mesh-list
138354564|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138354565|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
138354566|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354567|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354568|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354569|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480340|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138480341|NCT02046668|Spironolactone|spironolactone|mesh-list
138480342|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138480343|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
138480344|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480345|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480346|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138480347|NCT02046668|Diuretics|diuretics|mesh-ancestor
138480348|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
138480349|NCT02046720|Propofol|propofol|mesh-list
138480350|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138480351|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138480352|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480353|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138480354|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
138480355|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
138480356|NCT02046733|Nivolumab|nivolumab|mesh-list
138480357|NCT02046733|Ipilimumab|ipilimumab|mesh-list
138480358|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138480359|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480360|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138480361|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480362|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138480363|NCT02046850|Rifampin|rifampin|mesh-list
138480364|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138480365|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
138480367|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480368|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
138354744|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
138354745|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
138354747|NCT00001812|Nystatin|nystatin|mesh-list
138480369|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480370|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354748|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354749|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354750|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
138354751|NCT00001812|Ionophores|ionophores|mesh-ancestor
138354752|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354753|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354754|NCT00001842|Dexamethasone|dexamethasone|mesh-list
138354755|NCT00001842|Lenograstim|lenograstim|mesh-list
138354756|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138354757|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
138354758|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
138354759|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354760|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354761|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138354762|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
138354763|NCT00001842|Hormones|hormones|mesh-ancestor
138354764|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354765|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138354767|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138354768|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
138354769|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138354770|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138354771|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
138354772|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354773|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354774|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138354775|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138354776|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138354778|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
138354779|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354781|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354782|NCT00001860|Octreotide|octreotide|mesh-list
138354783|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138354786|NCT00001890|Estrogens|estrogens|mesh-list
138354787|NCT00001890|Hormones|hormones|mesh-ancestor
138354788|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354789|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354791|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138354792|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354793|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138354794|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138354795|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138354798|NCT00001968|Amprenavir|amprenavir|mesh-list
138354799|NCT00001968|Lamivudine|lamivudine|mesh-list
138354800|NCT00001968|Abacavir|abacavir|mesh-list
138354801|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354802|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138354803|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
138354804|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354805|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354806|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354807|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354808|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
138354809|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354810|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138354811|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354812|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138297776|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480372|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138480373|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138480374|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138480375|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138480376|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138480377|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138480378|NCT02046915|Dexamethasone|dexamethasone|mesh-list
138480379|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
138480380|NCT02046915|Pomalidomide|pomalidomide|mesh-list
138480381|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480382|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
138480383|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480384|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480385|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480386|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
138480387|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480388|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297814|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297820|NCT00003662|Melphalan|melphalan|mesh-list
138480390|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480391|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
138480392|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
138480393|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480394|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480395|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
138480396|NCT02046915|Hormones|hormones|mesh-ancestor
138480397|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480398|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480399|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480400|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138480401|NCT02046915|Growth Substances|growth substances|mesh-ancestor
138480402|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
138480403|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
138480404|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138480405|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
138480406|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138480407|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
138480408|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480409|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480410|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
138480411|NCT02047019|Candesartan|candesartan|mesh-list
138480412|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
138480413|NCT02047019|Nifedipine|nifedipine|mesh-list
138480414|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138480415|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138480416|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138480417|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480418|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138414691|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480421|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480422|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
138480423|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
138480424|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480426|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
138480427|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
138354896|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
138354897|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
138354898|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354900|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138354901|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354902|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354903|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
138354904|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138354906|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138354907|NCT00002070|Ganciclovir|ganciclovir|mesh-list
138354910|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
138354911|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354912|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
138354913|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354914|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354915|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354916|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354917|NCT00002076|Fluconazole|fluconazole|mesh-list
138354918|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
138354919|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354920|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138354921|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354923|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354924|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138354925|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
138354926|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354927|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354928|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354929|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354930|NCT00002082|Azithromycin|azithromycin|mesh-list
138354931|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354932|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354934|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354935|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354936|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354937|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354939|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354940|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
138354941|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
138354942|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138354943|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138354944|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354947|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138354948|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138354949|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138354950|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138354951|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
138354952|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
138354953|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354954|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354955|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354956|NCT00002112|Fluconazole|fluconazole|mesh-list
138354957|NCT00002112|Nystatin|nystatin|mesh-list
138354958|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
138354959|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354960|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138354961|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354962|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354963|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354964|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138354966|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354967|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480428|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480429|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480430|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480431|NCT02047149|Zileuton|zileuton|mesh-list
138480432|NCT02047149|Dasatinib|dasatinib|mesh-list
138480433|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
138480434|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480435|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138480436|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480437|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480438|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480439|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480440|NCT02047149|Analgesics|analgesics|mesh-ancestor
138480441|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
138480442|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480443|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480445|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480446|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138480447|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138480448|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
138480449|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480450|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
138480451|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480452|NCT02047162|Bismuth|bismuth|mesh-list
138480453|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138480454|NCT02047162|Antacids|antacids|mesh-ancestor
138480455|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480456|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480457|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
138480460|NCT02047175|Telmisartan|telmisartan|mesh-list
138480461|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138480462|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138480463|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138480464|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480465|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297912|NCT00002779|Octreotide|octreotide|mesh-list
138355510|NCT00002442|Nelfinavir|nelfinavir|mesh-list
138355511|NCT00002442|Indinavir|indinavir|mesh-list
138355512|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355513|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355515|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355516|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
138355517|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355518|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355519|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355520|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355521|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355522|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355523|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
138355524|NCT00002448|Ritonavir|ritonavir|mesh-list
138355525|NCT00002448|Saquinavir|saquinavir|mesh-list
138355526|NCT00002448|Efavirenz|efavirenz|mesh-list
138355527|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355528|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355529|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355530|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355531|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355533|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355535|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355536|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355537|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355538|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355539|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355540|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138355541|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138355543|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138355544|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138355547|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138355548|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
138355549|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355550|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355552|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355553|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138355554|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138355555|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138355556|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
138355558|NCT00002466|Doxorubicin|doxorubicin|mesh-list
138355559|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138355560|NCT00002466|Etoposide|etoposide|mesh-list
138355562|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355563|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
138355564|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355565|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355566|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355567|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
138355568|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355569|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355570|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355571|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355573|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355574|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355575|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355576|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355577|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355578|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355581|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297913|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480468|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
138480469|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138480470|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138480471|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
138480472|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138480473|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138480474|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480475|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138480476|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138480477|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
138480479|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
138480480|NCT02047201|Docetaxel|docetaxel|mesh-list
138480481|NCT02047201|Fluorouracil|fluorouracil|mesh-list
138480482|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480483|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480484|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480485|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480486|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480487|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
138480488|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480489|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480490|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
138480491|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480492|NCT02047292|Tacrine|tacrine|mesh-list
138480493|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138480494|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480495|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480496|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138480497|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480498|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480499|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138480500|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
138480501|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480502|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
138480503|NCT00005823|Cytarabine|cytarabine|mesh-list
138480504|NCT00005823|Etoposide|etoposide|mesh-list
138480505|NCT00005823|Daunorubicin|daunorubicin|mesh-list
138480506|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
138480507|NCT00005823|Idarubicin|idarubicin|mesh-list
138480508|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
138480509|NCT00005823|Tretinoin|tretinoin|mesh-list
138480510|NCT00005823|Thioguanine|thioguanine|mesh-list
138480511|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480512|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480513|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138480514|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480515|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480516|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480517|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480518|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
138480519|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
138480520|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480521|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480522|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
138480523|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480524|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138480528|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
138480529|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480530|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
138480531|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
138480533|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480534|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138480535|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480536|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480537|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480538|NCT00005829|Gemcitabine|gemcitabine|mesh-list
138480539|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480540|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
138480541|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480542|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480544|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480545|NCT00005838|Paclitaxel|paclitaxel|mesh-list
138480546|NCT00005838|Vinorelbine|vinorelbine|mesh-list
138480547|NCT00005838|Carboplatin|carboplatin|mesh-list
138480548|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480549|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480550|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480551|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480552|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480553|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480554|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
138480555|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138480556|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
138480557|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480558|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
138480559|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480561|NCT00005850|Fluoxetine|fluoxetine|mesh-list
138480562|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480563|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480564|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
138480565|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480566|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138480567|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138480568|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480569|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480570|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
138480571|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480574|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138480575|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138480576|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138480577|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480578|NCT00005853|Etanercept|etanercept|mesh-list
138480579|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138480580|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480581|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480583|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
138480584|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480585|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480586|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480587|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480588|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480589|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480590|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
138480591|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
138480592|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480593|NCT00005859|Tipifarnib|tipifarnib|mesh-list
138355665|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
138355666|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138355667|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355668|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138355669|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
138355670|NCT00002532|Hormones|hormones|mesh-ancestor
138355671|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355672|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138355673|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355674|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138355675|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
138480594|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480595|NCT00005862|Semaxinib|semaxinib|mesh-list
138480596|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480597|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138480598|NCT00005862|Growth Substances|growth substances|mesh-ancestor
138480599|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480600|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
138480601|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480602|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138480603|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480604|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480605|NCT00005865|Vinorelbine|vinorelbine|mesh-list
138480606|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480607|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480608|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480609|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480610|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480611|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480613|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480614|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480615|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355841|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
138480616|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480617|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480618|NCT00005871|Fluorouracil|fluorouracil|mesh-list
138480619|NCT00005871|Rubitecan|rubitecan|mesh-list
138480620|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
138480621|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480622|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480623|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480625|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
138480628|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480629|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480630|NCT00005874|Rubitecan|rubitecan|mesh-list
138480631|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480632|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138480633|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480634|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480635|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480637|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480638|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138480639|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480640|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355844|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
138355845|NCT00002598|Sargramostim|sargramostim|mesh-list
138355846|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355847|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
138355848|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355849|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355850|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355851|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
138355852|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355854|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355855|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138355856|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
138355857|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138355858|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355859|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
138355871|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138355872|NCT00002604|Carmustine|carmustine|mesh-list
138355873|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138355874|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355875|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
138355876|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355877|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355880|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
138355881|NCT00002610|Carboplatin|carboplatin|mesh-list
138355882|NCT00002610|Doxorubicin|doxorubicin|mesh-list
138355883|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138355885|NCT00002610|Vincristine|vincristine|mesh-list
138355886|NCT00002610|Lenograstim|lenograstim|mesh-list
138355887|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355888|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
138355889|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355890|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355891|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355892|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
138355893|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355894|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355895|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355896|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355897|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355898|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355899|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355902|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355903|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355904|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355905|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138355906|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355908|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355909|NCT00002616|Aldesleukin|aldesleukin|mesh-list
138355910|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
138355912|NCT00002616|Carboplatin|carboplatin|mesh-list
138355913|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355914|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
138480641|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480642|NCT00005880|Budesonide|budesonide|mesh-list
138480643|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480644|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138480645|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
138480646|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480647|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480648|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138480649|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
138480650|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
138480652|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480653|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
138480654|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480655|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480656|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138480658|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480659|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480660|NCT00005886|Tamoxifen|tamoxifen|mesh-list
138480661|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138480662|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
138480663|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480664|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480665|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480666|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480667|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138480668|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138480669|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138480670|NCT00005889|Glucagon|glucagon|mesh-list
138480671|NCT00005889|Glycerol|glycerol|mesh-list
138480673|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480674|NCT00005889|Hormones|hormones|mesh-ancestor
138480675|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480676|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138480677|NCT00005889|Protective Agents|protective agents|mesh-ancestor
138480678|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
138480679|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480680|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
138480681|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480685|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480686|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480687|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480690|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
138480691|NCT00005898|Fludarabine|fludarabine|mesh-list
138480692|NCT00005898|Cyclosporins|cyclosporins|mesh-list
138480693|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138480694|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480695|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
138480696|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480697|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480698|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480699|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
138480700|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480701|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480702|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480703|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480704|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
138480705|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480706|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
138480707|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138480708|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480709|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
138480710|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
138480711|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480712|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480713|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
138480714|NCT00005898|Hormones|hormones|mesh-ancestor
138480715|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480716|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138480717|NCT00005898|Protective Agents|protective agents|mesh-ancestor
138480718|NCT00386412|Valganciclovir|valganciclovir|mesh-list
138480719|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
138480720|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480721|NCT00386529|Aspirin|aspirin|mesh-list
138480722|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480723|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480724|NCT00386529|Analgesics|analgesics|mesh-ancestor
138480725|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
138480726|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480727|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480728|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480729|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480730|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138480731|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138480732|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480733|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138480734|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138480735|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480736|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
138480737|NCT00005922|Triamcinolone|triamcinolone|mesh-list
138480738|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138480739|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138480740|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138480741|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480743|NCT00005922|Hormones|hormones|mesh-ancestor
138480744|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480745|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480746|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480747|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
138480748|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480749|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480751|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138480753|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
138480754|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480755|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480756|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480757|NCT00005928|Ramipril|ramipril|mesh-list
138480758|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138480760|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480761|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480762|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138480764|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480765|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138480766|NCT00005931|Growth Substances|growth substances|mesh-ancestor
138480767|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480768|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138480769|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480770|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138480771|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480772|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480773|NCT00005934|Azacitidine|azacitidine|mesh-list
138480774|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480775|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
138480776|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480777|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480778|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480779|NCT00005940|Iodine|iodine|mesh-list
138480780|NCT00005940|Cyclosporine|cyclosporine|mesh-list
138480781|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
138480782|NCT00005940|Busulfan|busulfan|mesh-list
138480783|NCT00005940|Methotrexate|methotrexate|mesh-list
138480784|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138480785|NCT00005940|Cyclosporins|cyclosporins|mesh-list
138480786|NCT00005940|Antibodies|antibodies|mesh-list
138480787|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
138480788|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138480789|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480790|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
138480791|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480792|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480793|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480794|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
138480795|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480796|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480799|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
138480800|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138480801|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480802|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
138480803|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
138480804|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480805|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356194|NCT00002730|Melphalan|melphalan|mesh-list
138356195|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
138480806|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138480807|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
138480808|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480809|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138480810|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138480811|NCT00005940|Trace Elements|trace elements|mesh-ancestor
138480812|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
138480813|NCT00005943|Aldesleukin|aldesleukin|mesh-list
138480814|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356196|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480815|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138356197|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
138356198|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356199|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356200|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356203|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356204|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
138356205|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356206|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356207|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138356208|NCT00002730|Protective Agents|protective agents|mesh-ancestor
138356209|NCT00002742|Amphotericin B|amphotericin b|mesh-list
138356210|NCT00002742|Nystatin|nystatin|mesh-list
138356211|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138356212|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138356213|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
138356214|NCT00002742|Amebicides|amebicides|mesh-ancestor
138356215|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138356216|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138356217|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356218|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356219|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
138356220|NCT00002742|Ionophores|ionophores|mesh-ancestor
138356221|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138356222|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356225|NCT00002748|Interleukin-2|interleukin-2|mesh-list
138356227|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356228|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138356229|NCT00002748|Analgesics|analgesics|mesh-ancestor
138356230|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
138356231|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356232|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356235|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138356236|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
138356237|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356238|NCT00002760|Ketoconazole|ketoconazole|mesh-list
138356239|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
138356240|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138356241|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138356245|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
138356246|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356247|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138356248|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138356249|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356250|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356251|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138356252|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
138356253|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356254|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356255|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138356257|NCT00002772|Paclitaxel|paclitaxel|mesh-list
138356258|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
138356259|NCT00002772|Carboplatin|carboplatin|mesh-list
138356260|NCT00002772|Doxorubicin|doxorubicin|mesh-list
138356261|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138356262|NCT00002772|Thiotepa|thiotepa|mesh-list
138356263|NCT00002772|Carmustine|carmustine|mesh-list
138356267|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356268|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356269|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356270|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480816|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138480817|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
138480818|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480819|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
138480821|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480822|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
138480823|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480824|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480825|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480826|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
138480827|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480828|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480829|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480830|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480831|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138480832|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480833|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480835|NCT00005949|Interleukin-2|interleukin-2|mesh-list
138480836|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480837|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138480838|NCT00005949|Analgesics|analgesics|mesh-ancestor
138480839|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
138480840|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480841|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480842|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138480843|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138480844|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
138480845|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480846|NCT00005952|Temozolomide|temozolomide|mesh-list
138480847|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480848|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
138356271|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
138356272|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356273|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356274|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356275|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
138356276|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356280|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356281|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138356282|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138356283|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356284|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356285|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138356286|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138356299|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
138356301|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356302|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356303|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
138356304|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356305|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356306|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356307|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356310|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356311|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
138356312|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356313|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356314|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356315|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356316|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356317|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356318|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356319|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138356320|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
138356321|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356322|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356328|NCT00002790|Methotrexate|methotrexate|mesh-list
138356329|NCT00002790|Cyclosporins|cyclosporins|mesh-list
138356330|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356331|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356332|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356333|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356336|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356337|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356338|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356339|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356340|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356341|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356342|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
138356343|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356344|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356345|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
138356346|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356351|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138356352|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
138356353|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356354|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356355|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138356356|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138356357|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138356360|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480849|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480850|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480851|NCT00005955|Temozolomide|temozolomide|mesh-list
138480852|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480853|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
138480854|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480855|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480856|NCT00005958|Gemcitabine|gemcitabine|mesh-list
138480858|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480859|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
138480860|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480861|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480862|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480867|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480868|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
138480869|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480870|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480871|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480873|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
138480874|NCT00005964|Doxorubicin|doxorubicin|mesh-list
138480875|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138480876|NCT00005964|Etoposide|etoposide|mesh-list
138480877|NCT00005964|Vincristine|vincristine|mesh-list
138480878|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480879|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
138480880|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480881|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480882|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480883|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
138480884|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480885|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480886|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480887|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138480888|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138480889|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480890|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480891|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480892|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
138480893|NCT00005964|Hormones|hormones|mesh-ancestor
138480894|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480895|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480896|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480897|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480898|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480899|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480901|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480902|NCT00005970|Tamoxifen|tamoxifen|mesh-list
138480903|NCT00005970|Paclitaxel|paclitaxel|mesh-list
138480904|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
138480905|NCT00005970|Doxorubicin|doxorubicin|mesh-list
138480906|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138480907|NCT00005970|Trastuzumab|trastuzumab|mesh-list
138480908|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138480909|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138480910|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138480911|NCT00005970|Antibodies|antibodies|mesh-list
138480912|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
138480913|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138480914|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138480915|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298058|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138480918|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480919|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480920|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480921|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480922|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
138480923|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480924|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480925|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480927|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480928|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138480929|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138480930|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480931|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480932|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138480933|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
138480934|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480935|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480936|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138480937|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138480938|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138480939|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138480940|NCT00005976|Carboplatin|carboplatin|mesh-list
138480942|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480943|NCT00005979|Leucovorin|leucovorin|mesh-list
138480944|NCT00005979|Fluorouracil|fluorouracil|mesh-list
138480945|NCT00005979|Irinotecan|irinotecan|mesh-list
138480946|NCT00005979|Calcium|calcium|mesh-list
138480947|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
138480948|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138480949|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480950|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
138480951|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480952|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480953|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480954|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480955|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
138480956|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138480957|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480958|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480959|NCT00005979|Antidotes|antidotes|mesh-ancestor
138480960|NCT00005979|Protective Agents|protective agents|mesh-ancestor
138480961|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
138480962|NCT00005979|Vitamins|vitamins|mesh-ancestor
138480963|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
138480964|NCT00005985|Cytarabine|cytarabine|mesh-list
138480966|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
138480967|NCT00005985|Carmustine|carmustine|mesh-list
138480968|NCT00005985|Etoposide|etoposide|mesh-list
138480969|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
138480970|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480971|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
138480976|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480977|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480978|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480979|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480981|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
138480982|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480983|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138480984|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
138480985|NCT00005985|Hormones|hormones|mesh-ancestor
138480986|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138480987|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138480988|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138480989|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138480990|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138480991|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480992|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138480993|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
138480994|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
138480995|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480997|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
138480999|NCT00005988|Cyclosporine|cyclosporine|mesh-list
138481000|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
138481001|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
138481002|NCT00005988|Methotrexate|methotrexate|mesh-list
138481003|NCT00005988|Cyclosporins|cyclosporins|mesh-list
138481004|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
138481005|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481006|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
138481007|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481008|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481009|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481010|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
138481011|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481012|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481013|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481014|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138481015|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
138481016|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481017|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481018|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
138481019|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481020|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481021|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138481022|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481023|NCT00005988|Antidotes|antidotes|mesh-ancestor
138481024|NCT00005988|Protective Agents|protective agents|mesh-ancestor
138481025|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
138481026|NCT00005988|Vitamins|vitamins|mesh-ancestor
138481027|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
138481028|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
138481029|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481030|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138481031|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481032|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
138481034|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481035|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481036|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
138481038|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481039|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138481040|NCT00005991|Gemcitabine|gemcitabine|mesh-list
138481041|NCT00005991|Doxorubicin|doxorubicin|mesh-list
138481042|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138481043|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481044|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
138159506|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481045|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481046|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481047|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138481048|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481049|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481050|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481051|NCT00005994|Ondansetron|ondansetron|mesh-list
138481052|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
138481053|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
138481054|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481055|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481056|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481057|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
138481058|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481059|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138481060|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138481061|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
138481062|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481063|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481065|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481066|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138481067|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481068|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481069|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481070|NCT00006003|Semaxinib|semaxinib|mesh-list
138481071|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138159552|NCT04697576|Nivolumab|nivolumab|mesh-list
138481072|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138481073|NCT00006003|Growth Substances|growth substances|mesh-ancestor
138481074|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481075|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
138481076|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481077|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138481078|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481079|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481080|NCT00006006|Interferons|interferons|mesh-list
138481081|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
138481082|NCT00006006|Thalidomide|thalidomide|mesh-list
138481083|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481084|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
138481087|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481088|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481089|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
138481090|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481091|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138481092|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138481093|NCT00006006|Growth Substances|growth substances|mesh-ancestor
138481094|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
138481096|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
138481097|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481099|NCT00006012|Etoposide|etoposide|mesh-list
138481101|NCT00006012|Amifostine|amifostine|mesh-list
138481102|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481103|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481104|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481105|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481106|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481107|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481108|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481109|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481110|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481111|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481112|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138481113|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138481114|NCT00006012|Protective Agents|protective agents|mesh-ancestor
138481115|NCT00006015|Leucovorin|leucovorin|mesh-list
138481116|NCT00006015|Fluorouracil|fluorouracil|mesh-list
138481117|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
138481118|NCT00006015|Trastuzumab|trastuzumab|mesh-list
138481119|NCT00006015|Calcium|calcium|mesh-list
138481120|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
138481121|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138481122|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481124|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481125|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481126|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481127|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481128|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
138481129|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481130|NCT00006015|Antidotes|antidotes|mesh-ancestor
138481131|NCT00006015|Protective Agents|protective agents|mesh-ancestor
138481132|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
138481133|NCT00006015|Vitamins|vitamins|mesh-ancestor
138481134|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
138481135|NCT00006018|Paclitaxel|paclitaxel|mesh-list
138159642|NCT04096638|Atezolizumab|atezolizumab|mesh-list
138481136|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481137|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481138|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481139|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481140|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481141|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481142|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
138481143|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
138481144|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
138481145|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481146|NCT00006021|Protective Agents|protective agents|mesh-ancestor
138481147|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481148|NCT00006021|Vitamins|vitamins|mesh-ancestor
138481150|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289817|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289818|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481152|NCT00006024|Lomustine|lomustine|mesh-list
138481153|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481154|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
138289819|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289820|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138289821|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
138289822|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289823|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289825|NCT00001016|Trimetrexate|trimetrexate|mesh-list
138289826|NCT00001016|Calcium|calcium|mesh-list
138289827|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
138289828|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138289829|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289830|NCT00001016|Antidotes|antidotes|mesh-ancestor
138289831|NCT00001016|Protective Agents|protective agents|mesh-ancestor
138289832|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
138289833|NCT00001016|Vitamins|vitamins|mesh-ancestor
138289834|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
138289835|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
138289836|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289837|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138289838|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
138289839|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289840|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289841|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138289842|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289843|NCT03811951|Insulin|insulin|mesh-list
138289844|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138289845|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289846|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
138289847|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289848|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138289849|NCT04332289|Protective Agents|protective agents|mesh-ancestor
138289850|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289851|NCT00001022|Zidovudine|zidovudine|mesh-list
138289852|NCT00001022|Didanosine|didanosine|mesh-list
138289853|NCT00001022|Zalcitabine|zalcitabine|mesh-list
138289854|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
138289855|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289856|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289857|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289858|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289859|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
138289860|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289861|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289862|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289863|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
138289864|NCT05218148|Trastuzumab|trastuzumab|mesh-list
138289865|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289866|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138289867|NCT00001934|Daclizumab|daclizumab|mesh-list
138289868|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289869|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
138289870|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289871|NCT00000278|Disulfiram|disulfiram|mesh-list
138289872|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138289873|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138289874|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289875|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289877|NCT00001028|Pentamidine|pentamidine|mesh-list
138289878|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289879|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
138289880|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289881|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289882|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138289883|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481155|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481156|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481157|NCT00006027|Paclitaxel|paclitaxel|mesh-list
138481158|NCT00006027|Cisplatin|cisplatin|mesh-list
138481159|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481160|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481161|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481162|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481163|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481164|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481166|NCT00386646|Laxatives|laxatives|mesh-ancestor
138159682|NCT03856047|Liraglutide|liraglutide|mesh-list
138289979|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481167|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481169|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481170|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481171|NCT00006030|Tamoxifen|tamoxifen|mesh-list
138481172|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138481173|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
138481174|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481175|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481176|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138481177|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289980|NCT00000302|Analgesics|analgesics|mesh-ancestor
138289981|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
138289982|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289983|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138289984|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138289985|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138289992|NCT00001058|Indinavir|indinavir|mesh-list
138289993|NCT00001058|Clarithromycin|clarithromycin|mesh-list
138289994|NCT00001058|Ethambutol|ethambutol|mesh-list
138289995|NCT00001058|Rifabutin|rifabutin|mesh-list
138289996|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289997|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289998|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289999|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290000|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290001|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290002|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290004|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290005|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138290006|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290007|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290008|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138290009|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
138290012|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
138290014|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290015|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
138290016|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
138290017|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290018|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
138290019|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290020|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290021|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290022|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138290023|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290024|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290025|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138290026|NCT00001994|Atovaquone|atovaquone|mesh-list
138290027|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290028|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
138290029|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138290030|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138290031|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290032|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290033|NCT00000320|Buprenorphine|buprenorphine|mesh-list
138290034|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138290035|NCT00000320|Narcotics|narcotics|mesh-ancestor
138290036|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290037|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290038|NCT00000320|Analgesics|analgesics|mesh-ancestor
138290039|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
138290040|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290041|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138290043|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138290044|NCT00000326|Narcotics|narcotics|mesh-ancestor
138290045|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290046|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290047|NCT00000326|Analgesics|analgesics|mesh-ancestor
138290049|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290050|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
138290051|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138290052|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138290053|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
138481178|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138481179|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138481180|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138481181|NCT00006033|Methotrexate|methotrexate|mesh-list
138481182|NCT00006033|Interleukin-2|interleukin-2|mesh-list
138481183|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138481184|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
138481185|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481186|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481187|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481188|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
138481189|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481190|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481191|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481192|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481193|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138481194|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481195|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
138481196|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481197|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481198|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138481199|NCT00006033|Analgesics|analgesics|mesh-ancestor
138481200|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
138481201|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481202|NCT00006036|Lurtotecan|lurtotecan|mesh-list
138481203|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481204|NCT00006039|Interferons|interferons|mesh-list
138159727|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481205|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
138298137|NCT05495035|Hormones|hormones|mesh-ancestor
138481207|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
138481208|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481209|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
138481210|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481211|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
138481212|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
138481213|NCT00006042|Fludarabine|fludarabine|mesh-list
138481214|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
138481215|NCT00006042|Tacrolimus|tacrolimus|mesh-list
138481216|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481217|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
138481218|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481219|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481220|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481221|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
138481222|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481223|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481224|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481225|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481227|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138481228|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481229|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138481230|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138481231|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
138481232|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481233|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481234|NCT05680974|Antibodies|antibodies|mesh-list
138481235|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
138481236|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481237|NCT00386763|Lumefantrine|lumefantrine|mesh-list
138481238|NCT00386763|Artemether|artemether|mesh-list
138481239|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138481240|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
138481241|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138481242|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138481243|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481244|NCT05680662|Metformin|metformin|mesh-list
138481245|NCT05680662|Quercetin|quercetin|mesh-list
138159762|NCT03440437|Paclitaxel|paclitaxel|mesh-list
138481246|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138481247|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481248|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
138481249|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481250|NCT05680662|Protective Agents|protective agents|mesh-ancestor
138481251|NCT05680389|Minocycline|minocycline|mesh-list
138481252|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481253|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481254|NCT05680194|Diphosphonates|diphosphonates|mesh-list
138481255|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138481256|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481257|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
138481258|NCT00386802|Clotrimazole|clotrimazole|mesh-list
138298153|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
138481260|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481261|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138481262|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138481263|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138481264|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481265|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481266|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138481267|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
138481268|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481269|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481270|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138481271|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138481272|NCT00386841|Escitalopram|escitalopram|mesh-list
138481273|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138481274|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138481275|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138481276|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159817|NCT03112603|Sirolimus|sirolimus|mesh-list
138481277|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481278|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
138481279|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481280|NCT05679453|Etodolac|etodolac|mesh-list
138481281|NCT05679453|Lornoxicam|lornoxicam|mesh-list
138481282|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138481283|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138481285|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
138481286|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481287|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481288|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481289|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481290|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138481291|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138481292|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481293|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481294|NCT05679375|Ketamine|ketamine|mesh-list
138481295|NCT05679375|Analgesics|analgesics|mesh-ancestor
138481296|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
138481297|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481298|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481299|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138481300|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138481301|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
138481302|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
138481303|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481304|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138481305|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138481306|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481307|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481308|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
138481310|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481311|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
138298181|NCT00003710|Irinotecan|irinotecan|mesh-list
138159838|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138159852|NCT03073317|Mitogens|mitogens|mesh-list
138481312|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481313|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481314|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481315|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
138481316|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481317|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481318|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481319|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481321|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138481322|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481323|NCT05626725|Insulin|insulin|mesh-list
138481324|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138481325|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481326|NCT05597163|Atropine|atropine|mesh-list
138481327|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138481328|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138481329|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138481330|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
138481331|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481332|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481333|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138481334|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
138481335|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
138481336|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
138481337|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138481338|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138481339|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
138481340|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481341|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481342|NCT05550129|Metformin|metformin|mesh-list
138481343|NCT05550129|Sotorasib|sotorasib|mesh-list
138481344|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138481345|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481346|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138481347|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481348|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481349|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481350|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
138481351|NCT00386958|Povidone|povidone|mesh-list
138481352|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
138481353|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
138481355|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481356|NCT00386997|Amphotericin B|amphotericin b|mesh-list
138481357|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138481358|NCT00386997|Amebicides|amebicides|mesh-ancestor
138481359|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138481360|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138481361|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481362|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481363|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
138481365|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481366|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481367|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
138481368|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138481369|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481370|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
138481371|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481372|NCT04921722|Sirolimus|sirolimus|mesh-list
138481373|NCT04921722|Temsirolimus|temsirolimus|mesh-list
138481375|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481377|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138481378|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481379|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
138481380|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481381|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
138481382|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481383|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138481384|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481385|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481386|NCT04833387|Antibodies|antibodies|mesh-list
138481387|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
138481388|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481389|NCT04793685|Prazosin|prazosin|mesh-list
138481390|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138481391|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138481392|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138481393|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138481394|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
138481395|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481396|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481397|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481398|NCT04552080|Amoxicillin|amoxicillin|mesh-list
138481399|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481400|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481402|NCT03834909|Emtricitabine|emtricitabine|mesh-list
138159911|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138481403|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138481405|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481406|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138481407|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481408|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481409|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481410|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138481411|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138481412|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
138481414|NCT04360473|Anesthetics|anesthetics|mesh-list
138481415|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481416|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481417|NCT04360473|Analgesics|analgesics|mesh-ancestor
138481418|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
138481419|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481420|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138159937|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481421|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138481423|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138481424|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138481425|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481426|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481427|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138481428|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
138481429|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138481430|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138481431|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138481432|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
138481433|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481434|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
138481435|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138481436|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298206|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481437|NCT03913221|Caffeine|caffeine|mesh-list
138481438|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
138481439|NCT03913221|Citric Acid|citric acid|mesh-list
138481440|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
138481441|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
138481442|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138481443|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
138481444|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
138481445|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481446|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138481447|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481448|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138481449|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481450|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138481451|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138481452|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
138481453|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481455|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138481456|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
138481457|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
138481458|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481459|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481460|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138481461|NCT03869736|Analgesics|analgesics|mesh-ancestor
138481462|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
138481463|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481464|NCT03741933|Apremilast|apremilast|mesh-list
138357402|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357403|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357405|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357406|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357407|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
138357408|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357409|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357410|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357411|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
138357413|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138357414|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
138357415|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
138357416|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357417|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138357418|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
138357419|NCT00003402|Hormones|hormones|mesh-ancestor
138357420|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138357421|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357422|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357423|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357424|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357425|NCT00003408|Interferons|interferons|mesh-list
138357426|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
138357427|NCT00003408|Aldesleukin|aldesleukin|mesh-list
138357431|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357432|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
138357433|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357434|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138357435|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138357436|NCT00003414|Interferons|interferons|mesh-list
138357437|NCT00003414|Aldesleukin|aldesleukin|mesh-list
138357438|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
138357439|NCT00003414|Cyclosporine|cyclosporine|mesh-list
138357440|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
138357441|NCT00003414|Busulfan|busulfan|mesh-list
138357442|NCT00003414|Cyclosporins|cyclosporins|mesh-list
138357443|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357444|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
138357445|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357446|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357447|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357452|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
138357453|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357454|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357455|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
138357456|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357457|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138357458|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138357459|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138357460|NCT00003426|Gemcitabine|gemcitabine|mesh-list
138357461|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357463|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357464|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357465|NCT00003462|Busulfan|busulfan|mesh-list
138357466|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
138357467|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357468|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357469|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
138357474|NCT00003528|Raltitrexed|raltitrexed|mesh-list
138357475|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357476|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
138357477|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357478|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357479|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138357490|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357492|NCT00003552|Fludarabine|fludarabine|mesh-list
138481465|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138481466|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138481467|NCT03741933|Analgesics|analgesics|mesh-ancestor
138481468|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
138481469|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481470|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481471|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481472|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481473|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138481474|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138481475|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298217|NCT00004232|Protective Agents|protective agents|mesh-ancestor
138481476|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481478|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481479|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
138481480|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
138481481|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481482|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481483|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481484|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
138481486|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481487|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138481488|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481489|NCT00387504|Fenretinide|fenretinide|mesh-list
138481490|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481491|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138481492|NCT00387504|Protective Agents|protective agents|mesh-ancestor
138481493|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481494|NCT02936505|Cyclosporine|cyclosporine|mesh-list
138481495|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
138481497|NCT02936505|Cyclosporins|cyclosporins|mesh-list
138481498|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
138481499|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138481500|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481501|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
138481502|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481503|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138481504|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481505|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481507|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481508|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481509|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481510|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138481511|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481512|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138481513|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
138481514|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481515|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
138481516|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
138481517|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138481518|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481519|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481520|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
138481521|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138481522|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481523|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481524|NCT02593110|Telmisartan|telmisartan|mesh-list
138481525|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138481526|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138481527|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138160076|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481528|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481529|NCT02373813|Folic Acid|folic acid|mesh-list
138481530|NCT02373813|Etanercept|etanercept|mesh-list
138481531|NCT02373813|Methotrexate|methotrexate|mesh-list
138481532|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138481533|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
138481534|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481535|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481536|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481537|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
138298256|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481539|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481540|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481541|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481542|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138481543|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481544|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
138481545|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481547|NCT02373813|Hematinics|hematinics|mesh-ancestor
138481548|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
138481549|NCT02373813|Vitamins|vitamins|mesh-ancestor
138481550|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
138481551|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138160115|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
138160116|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
138481552|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138481554|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
138481555|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481556|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481557|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481558|NCT01959204|Oxycodone|oxycodone|mesh-list
138481559|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138481560|NCT01959204|Narcotics|narcotics|mesh-ancestor
138481561|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481562|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481564|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
138481565|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481566|NCT00006045|Cytarabine|cytarabine|mesh-list
138481567|NCT00006045|Etoposide|etoposide|mesh-list
138481568|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
138481569|NCT00006045|Lintuzumab|lintuzumab|mesh-list
138481570|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481571|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481572|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481573|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481574|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481575|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481576|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481577|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
138481578|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
138481579|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481580|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481581|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
138481582|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481584|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
138481585|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481586|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481587|NCT00006048|Gemcitabine|gemcitabine|mesh-list
138481588|NCT00006048|Gefitinib|gefitinib|mesh-list
138481589|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481590|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481591|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
138481592|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481593|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138481594|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298266|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138481596|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481597|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
138481598|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481599|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481600|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481602|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481603|NCT00006054|Cyclosporine|cyclosporine|mesh-list
138481605|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
138481606|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
138481608|NCT00006054|Methotrexate|methotrexate|mesh-list
138481609|NCT00006054|Etoposide|etoposide|mesh-list
138481610|NCT00006054|Cyclosporins|cyclosporins|mesh-list
138481611|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138481612|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481613|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
138481614|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481615|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481616|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481617|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
138481618|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481619|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481620|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138160267|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
138481623|NCT00006054|Hormones|hormones|mesh-ancestor
138481624|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481625|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138481626|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138481627|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
138481628|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481629|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481630|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
138481631|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481632|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481633|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138481634|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481635|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481636|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481637|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481638|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
138481639|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481640|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138481642|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
138481643|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481644|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481645|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138481646|NCT00006054|Protective Agents|protective agents|mesh-ancestor
138481647|NCT00006063|Pancrelipase|pancrelipase|mesh-list
138481648|NCT00006063|Pancreatin|pancreatin|mesh-list
138481649|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481650|NCT00006066|Aldesleukin|aldesleukin|mesh-list
138481651|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481652|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138481653|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138481654|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
138481655|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481656|NCT00006072|Rituximab|rituximab|mesh-list
138481657|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481658|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481660|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481661|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481662|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
138481663|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138481664|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138481665|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481666|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
138481667|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481669|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138481670|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
138481671|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481672|NCT00006078|Protective Agents|protective agents|mesh-ancestor
138481673|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481674|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138481675|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138481676|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481678|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
138481679|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481680|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481681|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481682|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481683|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481684|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160360|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
138481685|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138481686|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
138481687|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481688|NCT00006084|Lintuzumab|lintuzumab|mesh-list
138481689|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481691|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
138481692|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481694|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481696|NCT00006105|Amifostine|amifostine|mesh-list
138481697|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481698|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481699|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
138481700|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481701|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138481703|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481704|NCT00006108|Paclitaxel|paclitaxel|mesh-list
138481705|NCT00006108|Capecitabine|capecitabine|mesh-list
138481706|NCT00006108|Trastuzumab|trastuzumab|mesh-list
138481707|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481708|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481709|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481710|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481711|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481712|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481713|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481714|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
138481715|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481716|NCT00006111|Fluorouracil|fluorouracil|mesh-list
138481717|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481718|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
138481719|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481720|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481723|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481725|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
138481726|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481727|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481728|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481729|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481730|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481731|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481732|NCT00006114|Analgesics|analgesics|mesh-ancestor
138481733|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
138481735|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481736|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138160466|NCT05737329|Estradiol|estradiol|mesh-list
138481737|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481739|NCT00006117|Gemcitabine|gemcitabine|mesh-list
138481740|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
138481741|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481742|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
138481743|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481744|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481745|NCT00006120|Paclitaxel|paclitaxel|mesh-list
138481746|NCT00006120|Docetaxel|docetaxel|mesh-list
138481747|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481748|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481749|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138481750|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138481751|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138481752|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481753|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
138481754|NCT00006123|Thiotepa|thiotepa|mesh-list
138481755|NCT00006123|Carmustine|carmustine|mesh-list
138481756|NCT00006123|Carboplatin|carboplatin|mesh-list
138481757|NCT00006123|Trastuzumab|trastuzumab|mesh-list
138481758|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481759|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
138481760|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481761|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481762|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481763|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
138481764|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481765|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481766|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481767|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481768|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
138481769|NCT00006126|Busulfan|busulfan|mesh-list
138160517|NCT04129619|Ether|ether|mesh-list
138298311|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
138298313|NCT00003728|Antidotes|antidotes|mesh-ancestor
138481771|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
138481772|NCT00006126|Etoposide|etoposide|mesh-list
138481773|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481774|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
138290054|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481775|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481776|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138290055|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290057|NCT00002000|Valacyclovir|valacyclovir|mesh-list
138481777|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481778|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
138290058|NCT00002000|Acyclovir|acyclovir|mesh-list
138290059|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
138290060|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290061|NCT03979807|Bromides|bromides|mesh-list
138290062|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
138290063|NCT03979807|Olodaterol|olodaterol|mesh-list
138290064|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138290065|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
138290066|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290067|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290068|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138290069|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
138290070|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
138481779|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481780|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481781|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481782|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481783|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
138481784|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138481785|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481786|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481787|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481788|NCT00006129|Testosterone|testosterone|mesh-list
138481789|NCT00006129|Androgens|androgens|mesh-ancestor
138481790|NCT00006129|Hormones|hormones|mesh-ancestor
138481791|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481793|NCT00006132|Acyclovir|acyclovir|mesh-list
138481794|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
138481795|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481796|NCT00006135|Acyclovir|acyclovir|mesh-list
138481797|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
138481798|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481799|NCT00006144|Ritonavir|ritonavir|mesh-list
138481800|NCT00006144|Lopinavir|lopinavir|mesh-list
138481801|NCT00006144|Emtricitabine|emtricitabine|mesh-list
138481802|NCT00006144|Stavudine|stavudine|mesh-list
138481803|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138481804|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138481805|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
138481806|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481807|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481808|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138481809|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138481810|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
138481811|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481812|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138481813|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138160609|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138481814|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138481815|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481816|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
138481817|NCT00006168|Methotrexate|methotrexate|mesh-list
138481818|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138481819|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
138481820|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481821|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298348|NCT05477875|Dronabinol|dronabinol|mesh-list
138481823|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
138481824|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481825|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481826|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138481827|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481828|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138481829|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481830|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
138481831|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481832|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481834|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481835|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138481836|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138481837|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481838|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481839|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138481840|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
138481841|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481842|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481843|NCT00006180|Alendronate|alendronate|mesh-list
138481844|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138481845|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481846|NCT00006195|Olanzapine|olanzapine|mesh-list
138481847|NCT00006195|Risperidone|risperidone|mesh-list
138481848|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138481849|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
138481850|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481851|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481852|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481853|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138481854|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160660|NCT00550953|Amlodipine|amlodipine|mesh-list
138481855|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481857|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138481858|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
138481859|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
138481860|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
138481861|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481862|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481863|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138298355|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
138481865|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138357493|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138481866|NCT00006198|Thalidomide|thalidomide|mesh-list
138481867|NCT00006198|Doxorubicin|doxorubicin|mesh-list
138481868|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138481869|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481870|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138481871|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481872|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481873|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481874|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481875|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
138357494|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357495|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
138357496|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357497|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357498|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357499|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
138357500|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357501|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357502|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357503|NCT00003558|Leucovorin|leucovorin|mesh-list
138357504|NCT00003558|Paclitaxel|paclitaxel|mesh-list
138357507|NCT00003558|Fluorouracil|fluorouracil|mesh-list
138357508|NCT00003558|Calcium|calcium|mesh-list
138357509|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
138357510|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357511|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357512|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357513|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357514|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357515|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357516|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138357517|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357519|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357520|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357522|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357523|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357524|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357526|NCT00003558|Protective Agents|protective agents|mesh-ancestor
138357527|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138357528|NCT00003558|Vitamins|vitamins|mesh-ancestor
138357529|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
138357530|NCT00003564|Procarbazine|procarbazine|mesh-list
138357531|NCT00003564|Isotretinoin|isotretinoin|mesh-list
138357532|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357533|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357534|NCT00003576|Fluorouracil|fluorouracil|mesh-list
138357535|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357536|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
138357537|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357539|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357540|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
138357541|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357542|NCT00003582|Paclitaxel|paclitaxel|mesh-list
138357543|NCT00003582|Fluorouracil|fluorouracil|mesh-list
138357544|NCT00003582|Amifostine|amifostine|mesh-list
138357545|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357546|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357547|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357548|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357549|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357550|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357552|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357553|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357554|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
138357555|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357556|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138357557|NCT00003582|Protective Agents|protective agents|mesh-ancestor
138357558|NCT00003594|Leucovorin|leucovorin|mesh-list
138357559|NCT00003594|Fluorouracil|fluorouracil|mesh-list
138357560|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
138357561|NCT00003594|Irinotecan|irinotecan|mesh-list
138357562|NCT00003594|Calcium|calcium|mesh-list
138357563|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
138358387|NCT00004242|Fluorouracil|fluorouracil|mesh-list
138358388|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
138358389|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358390|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
138358391|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358392|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358393|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358394|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
138358395|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358396|NCT00004248|Aldesleukin|aldesleukin|mesh-list
138358398|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138358399|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358400|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358401|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358402|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358403|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359163|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481876|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481877|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
138481878|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481879|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481880|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138481881|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138481882|NCT00006198|Growth Substances|growth substances|mesh-ancestor
138160689|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481883|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
138481884|NCT00006204|Naltrexone|naltrexone|mesh-list
138481885|NCT00006204|Fluoxetine|fluoxetine|mesh-list
138481886|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138481887|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138481888|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481889|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
138481890|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481891|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138481892|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138481894|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481895|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481896|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
138298384|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
138298385|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
138481897|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138481898|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
138481900|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138160734|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138481901|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138481902|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481904|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138481906|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481907|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138481908|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481909|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481910|NCT00006219|Clarithromycin|clarithromycin|mesh-list
138481911|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138481912|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138481913|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481914|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138481915|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481916|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481917|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138481918|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138481919|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138481920|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
138481921|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481922|NCT00387582|Ranibizumab|ranibizumab|mesh-list
138481923|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138481924|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138481925|NCT00387582|Growth Substances|growth substances|mesh-ancestor
138481926|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481927|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
138481928|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481929|NCT00006228|Aldesleukin|aldesleukin|mesh-list
138481930|NCT00006228|Trastuzumab|trastuzumab|mesh-list
138481931|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481932|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481933|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138481934|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138481935|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
138481936|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481937|NCT00006240|Dexamethasone|dexamethasone|mesh-list
138481938|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138481939|NCT00006240|Sargramostim|sargramostim|mesh-list
138159522|NCT04963712|Thymalfasin|thymalfasin|mesh-list
138481940|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160789|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138160798|NCT01794091|Diuretics|diuretics|mesh-ancestor
138481941|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
138481942|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
138481943|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481944|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481945|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481946|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
138481948|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138481950|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481951|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
138481952|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
138481953|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138481954|NCT02972463|Antibodies|antibodies|mesh-list
138481955|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
138481956|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481957|NCT00006243|Sargramostim|sargramostim|mesh-list
138481958|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
138481959|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
138481960|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481961|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138481962|NCT00006246|Busulfan|busulfan|mesh-list
138481963|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
138290071|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138290072|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
138290073|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290074|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290077|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138290078|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
138290079|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290080|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290081|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290082|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290083|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290085|NCT00002006|Sargramostim|sargramostim|mesh-list
138290086|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
138290087|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290088|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290089|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290090|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290091|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
138290092|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290093|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290094|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290095|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
138290096|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290097|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
138290098|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138290099|NCT04169113|Narcotics|narcotics|mesh-ancestor
138481964|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481965|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481966|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
138481967|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481968|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481969|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481970|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481971|NCT00006249|Interferons|interferons|mesh-list
138481972|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
138481973|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160841|NCT00550173|Pemetrexed|pemetrexed|mesh-list
138481974|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
138481975|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481976|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
138481977|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481978|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
138481979|NCT00006252|Fludarabine|fludarabine|mesh-list
138481980|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
138481981|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481982|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
138481983|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481984|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481985|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481986|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
138481987|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481989|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138481990|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481992|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
138481993|NCT00006258|Methotrexate|methotrexate|mesh-list
138481995|NCT00006258|Vincristine|vincristine|mesh-list
138481996|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138481997|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
138481998|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298441|NCT00003752|Bexarotene|bexarotene|mesh-list
138481999|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482000|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482001|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
138482002|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482003|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482004|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482005|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138482007|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482008|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482010|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482011|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482012|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138482013|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482014|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482015|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482016|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482017|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482018|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
138160869|NCT01429298|Hydromorphone|hydromorphone|mesh-list
138482019|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482020|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
138482021|NCT00006261|Docetaxel|docetaxel|mesh-list
138482022|NCT00006261|Doxorubicin|doxorubicin|mesh-list
138482023|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482024|NCT00006261|Fludarabine|fludarabine|mesh-list
138482026|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482027|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
138482028|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482029|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482030|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482031|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
138482032|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482033|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482034|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482035|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482036|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482037|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482038|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482040|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482041|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482042|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482043|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
138482044|NCT00006264|Zidovudine|zidovudine|mesh-list
138482045|NCT00006264|Aldesleukin|aldesleukin|mesh-list
138482046|NCT00006264|Ganciclovir|ganciclovir|mesh-list
138482047|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138482048|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
138482049|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482050|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138482051|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138160901|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482052|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482053|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
138482054|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482055|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482056|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482057|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482058|NCT00006267|Rubitecan|rubitecan|mesh-list
138482059|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482060|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482061|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482062|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482063|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482064|NCT00006270|Cosyntropin|cosyntropin|mesh-list
138482065|NCT00006270|Metyrapone|metyrapone|mesh-list
138482066|NCT00006270|Hormones|hormones|mesh-ancestor
138482067|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482068|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482069|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
138482070|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482071|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482072|NCT00006276|Paclitaxel|paclitaxel|mesh-list
138482073|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482074|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482075|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482076|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482077|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482078|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482079|NCT00006279|Nevirapine|nevirapine|mesh-list
138482080|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138482081|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482082|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160954|NCT00398983|Decitabine|decitabine|mesh-list
138482083|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482084|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
138482085|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482086|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482087|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482088|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138482089|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138298492|NCT00004328|Enalapril|enalapril|mesh-list
138298493|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
138482090|NCT00006291|Aldesleukin|aldesleukin|mesh-list
138482091|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482092|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482093|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482094|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
138482095|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482096|NCT00006294|Amlodipine|amlodipine|mesh-list
138482097|NCT00006294|Lisinopril|lisinopril|mesh-list
138482098|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
138482099|NCT00006294|Doxazosin|doxazosin|mesh-list
138482100|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138482101|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138482102|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138482103|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482104|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138482105|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482106|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
138482107|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138482108|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
138482109|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482110|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138482111|NCT00006294|Protective Agents|protective agents|mesh-ancestor
138482112|NCT00006294|Diuretics|diuretics|mesh-ancestor
138482113|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
138482114|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138482115|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138482116|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138482117|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138160993|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
138482118|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138482119|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482121|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482122|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482123|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482124|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482125|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160019|NCT01790555|Diazepam|diazepam|mesh-list
138482126|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138482127|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
138482128|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138482129|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
138482130|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138482131|NCT00006324|Estradiol|estradiol|mesh-list
138482132|NCT00006324|Estrogens|estrogens|mesh-ancestor
138482133|NCT00006324|Hormones|hormones|mesh-ancestor
138482134|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482135|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482136|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138482137|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
138482138|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482139|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138482140|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138482141|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138482142|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138482143|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138482144|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138482145|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482146|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138482147|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
138482148|NCT00005824|Busulfan|busulfan|mesh-list
138482149|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482150|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
138482151|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482152|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482153|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482154|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
138482155|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482156|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482157|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482159|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138482160|NCT00005827|Protective Agents|protective agents|mesh-ancestor
138482161|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482162|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482163|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482164|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482165|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482166|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
138482167|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138482168|NCT00005827|Estrogens|estrogens|mesh-ancestor
138482170|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482171|NCT00005830|Doxorubicin|doxorubicin|mesh-list
138482172|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482173|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482174|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160120|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
138482175|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298558|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482176|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482178|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482179|NCT00005833|Tipifarnib|tipifarnib|mesh-list
138482180|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482181|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
138482182|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482183|NCT00006330|Digoxin|digoxin|mesh-list
138482184|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138482185|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138482186|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161073|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
138482187|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482188|NCT00006330|Protective Agents|protective agents|mesh-ancestor
138482189|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482191|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
138482192|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482194|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482195|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482196|NCT00005842|Trastuzumab|trastuzumab|mesh-list
138482197|NCT00005842|Tipifarnib|tipifarnib|mesh-list
138482198|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482199|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482200|NCT00005845|Tipifarnib|tipifarnib|mesh-list
138482201|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482202|NCT00005848|Tipifarnib|tipifarnib|mesh-list
138482203|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482204|NCT00005851|Cyclosporine|cyclosporine|mesh-list
138482205|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
138482206|NCT00005851|Fludarabine|fludarabine|mesh-list
138482207|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
138482208|NCT00005851|Cyclosporins|cyclosporins|mesh-list
138482209|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482210|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482211|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
138482212|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161117|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
138482213|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482214|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
138482215|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482216|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482217|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
138482218|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482219|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482220|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482221|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138482222|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482223|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138482224|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
138482225|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138482226|NCT00005854|Cyclosporine|cyclosporine|mesh-list
138482227|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
138482228|NCT00005854|Methotrexate|methotrexate|mesh-list
138482229|NCT00005854|Cyclosporins|cyclosporins|mesh-list
138482230|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482231|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
138482232|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482233|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482234|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482235|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
138298587|NCT00384800|Tegafur|tegafur|mesh-list
138298602|NCT00384878|Leucovorin|leucovorin|mesh-list
138161173|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138482236|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482237|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482238|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482239|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138482240|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
138482241|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482242|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482243|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
138482244|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482245|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482246|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138482247|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482248|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
138482249|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482250|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138482251|NCT00005857|Docetaxel|docetaxel|mesh-list
138482252|NCT00005857|Trastuzumab|trastuzumab|mesh-list
138482253|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482254|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482255|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482256|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298603|NCT00384878|Fluorouracil|fluorouracil|mesh-list
138482257|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482259|NCT00005860|Leucovorin|leucovorin|mesh-list
138161225|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482260|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
138482261|NCT00005860|Floxuridine|floxuridine|mesh-list
138482263|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
138482264|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138482265|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482266|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482267|NCT00005860|Antidotes|antidotes|mesh-ancestor
138482268|NCT00005860|Protective Agents|protective agents|mesh-ancestor
138482269|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
138482270|NCT00005860|Vitamins|vitamins|mesh-ancestor
138482271|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
138482272|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482273|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
138482274|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482275|NCT00005863|Cytarabine|cytarabine|mesh-list
138482276|NCT00005863|Fludarabine|fludarabine|mesh-list
138482277|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
138482278|NCT00005863|Etoposide|etoposide|mesh-list
138482279|NCT00005863|Daunorubicin|daunorubicin|mesh-list
138482280|NCT00005863|Tretinoin|tretinoin|mesh-list
138482281|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482282|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482283|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
138482284|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482285|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482286|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
138482288|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482289|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482290|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138161275|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482291|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482292|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
138482293|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482294|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482295|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
138482297|NCT00005866|Cyclosporine|cyclosporine|mesh-list
138482298|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
138482299|NCT00005866|Busulfan|busulfan|mesh-list
138482300|NCT00005866|Methotrexate|methotrexate|mesh-list
138482301|NCT00005866|Cyclosporins|cyclosporins|mesh-list
138482303|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
138482305|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482306|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482307|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
138482308|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482309|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482310|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482311|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138482312|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
138482313|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482314|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482315|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
138482316|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482317|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482318|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138482319|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482320|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
138482321|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482322|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138482323|NCT00005869|Gemcitabine|gemcitabine|mesh-list
138482324|NCT00005869|Rubitecan|rubitecan|mesh-list
138482325|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482326|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
138160488|NCT00332579|Naltrexone|naltrexone|mesh-list
138482327|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482328|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161318|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482329|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482330|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482331|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482333|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482334|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482335|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482336|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482337|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482338|NCT00005875|Rubitecan|rubitecan|mesh-list
138482339|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482340|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482341|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482342|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482343|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482344|NCT00005878|Celecoxib|celecoxib|mesh-list
138482345|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138482346|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138482347|NCT00005878|Analgesics|analgesics|mesh-ancestor
138482348|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
138298675|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482349|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482350|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482351|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482352|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160596|NCT01432262|Vaccines|vaccines|mesh-list
138482353|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138482354|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138482356|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482357|NCT00005884|Eflornithine|eflornithine|mesh-list
138482358|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482360|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138482361|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138482362|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482363|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138482364|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482365|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482367|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
138482368|NCT00006339|Ritonavir|ritonavir|mesh-list
138482369|NCT00006339|Indinavir|indinavir|mesh-list
138482370|NCT00006339|Didanosine|didanosine|mesh-list
138482371|NCT00006339|Stavudine|stavudine|mesh-list
138482372|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
138482373|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138482374|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138482375|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
138482376|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482377|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482378|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482379|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482380|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
138482381|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482382|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138482383|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138482384|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482385|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
138298700|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482386|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482387|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
138482388|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138482389|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138482390|NCT00005890|Hormones|hormones|mesh-ancestor
138482391|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482392|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482393|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
138482394|NCT00005893|Busulfan|busulfan|mesh-list
138482395|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138482396|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482397|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
138482398|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482399|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482400|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161400|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482401|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
138482402|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482403|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482404|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482405|NCT00005896|Lenograstim|lenograstim|mesh-list
138482406|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138482407|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
138482408|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482409|NCT00386503|Artesunate|artesunate|mesh-list
138482410|NCT00386503|Amodiaquine|amodiaquine|mesh-list
138160792|NCT01794091|Eplerenone|eplerenone|mesh-list
138482411|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
138482412|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138482413|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138482414|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482415|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482416|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
138482417|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
138482418|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138482419|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
138482420|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138482421|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138482422|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138482423|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138482424|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482425|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138482426|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482427|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482428|NCT00006345|Dexamethasone|dexamethasone|mesh-list
138482429|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
138482430|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482431|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
138482432|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
138482433|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482434|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482435|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138482437|NCT00006345|Hormones|hormones|mesh-ancestor
138482438|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482439|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138482440|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482441|NCT00005920|Caspofungin|caspofungin|mesh-list
138482442|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
138482443|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482444|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161439|NCT00409825|Progestins|progestins|mesh-ancestor
138482445|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160908|NCT01427738|Nystatin|nystatin|mesh-list
138482448|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482450|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482451|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482452|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482453|NCT00005935|Cyclosporine|cyclosporine|mesh-list
138482454|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
138482455|NCT00005935|Cyclosporins|cyclosporins|mesh-list
138482456|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160987|NCT00338039|Cetuximab|cetuximab|mesh-list
138482457|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482458|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482459|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
138482460|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482461|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
138482462|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482463|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482464|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482465|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138161470|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482466|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482467|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482468|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138482469|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
138482470|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138482472|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
138482473|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
138482474|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482475|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482476|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138482477|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
138482478|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161091|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
138482479|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138482480|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138482481|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
138298764|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
138482482|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482483|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482485|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482486|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482487|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482488|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482489|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482490|NCT00005941|Cyclosporine|cyclosporine|mesh-list
138482491|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
138482492|NCT00005941|Fludarabine|fludarabine|mesh-list
138482493|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
138482494|NCT00005941|Cyclosporins|cyclosporins|mesh-list
138482495|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482496|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482497|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
138482498|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482499|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482500|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
138482501|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482502|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482503|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
138482504|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482505|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482506|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482507|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138482508|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482509|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138482510|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
138482511|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138482512|NCT00005944|Leucovorin|leucovorin|mesh-list
138482513|NCT00005944|Fluorouracil|fluorouracil|mesh-list
138482514|NCT00005944|Mitomycins|mitomycins|mesh-list
138482515|NCT00005944|Mitomycin|mitomycin|mesh-list
138482516|NCT00005944|Calcium|calcium|mesh-list
138482517|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
138482518|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138482519|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482520|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
138482521|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482522|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482523|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482524|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482525|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
138482526|NCT00005944|Antidotes|antidotes|mesh-ancestor
138482527|NCT00005944|Protective Agents|protective agents|mesh-ancestor
138482528|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
138482529|NCT00005944|Vitamins|vitamins|mesh-ancestor
138482530|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
138482531|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482532|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
138482533|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482534|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482535|NCT00387699|Bevacizumab|bevacizumab|mesh-list
138482537|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482538|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482539|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138482540|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138482541|NCT00387699|Growth Substances|growth substances|mesh-ancestor
138482542|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482543|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482544|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482545|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482546|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482547|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482548|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482549|NCT00005959|Prednisone|prednisone|mesh-list
138482550|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
138482551|NCT00005959|Rituximab|rituximab|mesh-list
138482552|NCT00005959|Doxorubicin|doxorubicin|mesh-list
138482553|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482554|NCT00005959|Vincristine|vincristine|mesh-list
138482555|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482556|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
138482557|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482558|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482559|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482560|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
138482561|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482562|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482563|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482564|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482565|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482566|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482567|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482568|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482569|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482570|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
138482571|NCT00005959|Hormones|hormones|mesh-ancestor
138482572|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482573|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358561|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
138358562|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358563|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
138358564|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358565|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358566|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358567|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
138358568|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358569|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358570|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358572|NCT00004482|Prednisone|prednisone|mesh-list
138358573|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
138358574|NCT00004482|Cyclosporins|cyclosporins|mesh-list
138358579|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358580|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358581|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358583|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482574|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298811|NCT00005036|Leucovorin|leucovorin|mesh-list
138482575|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482576|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482577|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482578|NCT00387738|Histamine|histamine|mesh-list
138161295|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482579|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
138482580|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
138482581|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482582|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482583|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482584|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
138482585|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482586|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138482588|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482589|NCT00005968|Irofulven|irofulven|mesh-list
138482590|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482591|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
138482592|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482593|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482594|NCT00387777|Buprenorphine|buprenorphine|mesh-list
138482595|NCT00387777|Analgesics|analgesics|mesh-list
138482596|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138482597|NCT00387777|Narcotics|narcotics|mesh-ancestor
138482598|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138482599|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482600|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
138482601|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482602|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138482604|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482605|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482606|NCT00005971|Growth Substances|growth substances|mesh-ancestor
138482607|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482608|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482609|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161360|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
138482610|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482611|NCT00005974|Alvocidib|alvocidib|mesh-list
138482612|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482613|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482614|NCT00005974|Growth Substances|growth substances|mesh-ancestor
138482615|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482616|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482617|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482618|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482619|NCT00005977|Leucovorin|leucovorin|mesh-list
138482620|NCT00005977|Cytarabine|cytarabine|mesh-list
138482621|NCT00005977|Dexamethasone|dexamethasone|mesh-list
138482622|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
138482623|NCT00005977|Ifosfamide|ifosfamide|mesh-list
138482624|NCT00005977|Doxorubicin|doxorubicin|mesh-list
138482625|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482626|NCT00005977|Methotrexate|methotrexate|mesh-list
138482628|NCT00005977|Vincristine|vincristine|mesh-list
138482629|NCT00005977|Lenograstim|lenograstim|mesh-list
138482630|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
138161673|NCT00360971|Cisplatin|cisplatin|mesh-list
138482631|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482632|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
138482633|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482634|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482635|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482636|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
138482637|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482638|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482639|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482640|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482641|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
138482642|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
138482643|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482644|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138482645|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
138161461|NCT03239015|Trastuzumab|trastuzumab|mesh-list
138482647|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482648|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138482649|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482650|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482651|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482652|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482653|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138482654|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
138482655|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138482657|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
138482658|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
138482659|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138482660|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482661|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482662|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
138482663|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482664|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138482665|NCT00005977|Antidotes|antidotes|mesh-ancestor
138482666|NCT00005977|Protective Agents|protective agents|mesh-ancestor
138482667|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
138482668|NCT00005977|Vitamins|vitamins|mesh-ancestor
138482669|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
138298855|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138298856|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138482670|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482671|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482672|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482673|NCT00005980|Doxorubicin|doxorubicin|mesh-list
138482674|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138161789|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482675|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482676|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482677|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482678|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482679|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161581|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138482681|NCT00005986|Interferons|interferons|mesh-list
138482682|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
138482683|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
138482684|NCT00005986|Busulfan|busulfan|mesh-list
138482685|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482686|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
138482687|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482688|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482689|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482690|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
138482691|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482692|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482693|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482694|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
138161849|NCT00375973|Analgesics|analgesics|mesh-ancestor
138482695|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482696|NCT00005989|Tipifarnib|tipifarnib|mesh-list
138482697|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482698|NCT00005998|Cytarabine|cytarabine|mesh-list
138482699|NCT00005998|Dexamethasone|dexamethasone|mesh-list
138482700|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
138482701|NCT00005998|Carmustine|carmustine|mesh-list
138482702|NCT00005998|Etoposide|etoposide|mesh-list
138482703|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
138482704|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161714|NCT03438487|Vaccines|vaccines|mesh-list
138482705|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
138482706|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482707|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482708|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482710|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161902|NCT01405508|Brivaracetam|brivaracetam|mesh-list
138482711|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482712|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482713|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482715|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
138482716|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482717|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138482718|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
138482719|NCT00005998|Hormones|hormones|mesh-ancestor
138482720|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138482721|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138482722|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482723|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138161959|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
138482725|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482726|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482728|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
138482729|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482731|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
138482732|NCT00006351|Gemcitabine|gemcitabine|mesh-list
138482733|NCT00006351|Lonafarnib|lonafarnib|mesh-list
138482734|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482735|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
138482736|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482737|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482738|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482739|NCT00006001|Semaxinib|semaxinib|mesh-list
138482740|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138482741|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138482742|NCT00006001|Growth Substances|growth substances|mesh-ancestor
138482743|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482744|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482745|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482746|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482747|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482748|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482749|NCT00006007|Gemcitabine|gemcitabine|mesh-list
138482750|NCT00006007|Pemetrexed|pemetrexed|mesh-list
138482751|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482752|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
138482753|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482754|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482755|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482756|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138482757|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482758|NCT00006010|Gemcitabine|gemcitabine|mesh-list
138482759|NCT00006010|Docetaxel|docetaxel|mesh-list
138482760|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162092|NCT02078726|Glucagon|glucagon|mesh-list
138482762|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482763|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482764|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482765|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482766|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298909|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482767|NCT00006013|Semaxinib|semaxinib|mesh-list
138482768|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138482769|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138482770|NCT00006013|Growth Substances|growth substances|mesh-ancestor
138161878|NCT01794767|Heparin|heparin|mesh-list
138482771|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482772|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482773|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162143|NCT01795235|Atenolol|atenolol|mesh-list
138482774|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482775|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482776|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482777|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
138482778|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482779|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482780|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482781|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482782|NCT00006016|Thalidomide|thalidomide|mesh-list
138482783|NCT00006016|Doxorubicin|doxorubicin|mesh-list
138482784|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482785|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482786|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482787|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482788|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138162199|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138482789|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482790|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482791|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482792|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
138482793|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482794|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
138161915|NCT00322439|Etanercept|etanercept|mesh-list
138482795|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138482796|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162261|NCT00394277|Ribavirin|ribavirin|mesh-list
138482797|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138482798|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138482799|NCT00006016|Growth Substances|growth substances|mesh-ancestor
138482800|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482801|NCT00006019|Azacitidine|azacitidine|mesh-list
138482802|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138482803|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482804|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
138482805|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482806|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482807|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482808|NCT00006022|Aldesleukin|aldesleukin|mesh-list
138482809|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
138482810|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298925|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482811|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482812|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482813|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
138482814|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482815|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138482816|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
138482817|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482818|NCT00006025|Irinotecan|irinotecan|mesh-list
138482819|NCT00006025|Temozolomide|temozolomide|mesh-list
138482820|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138161977|NCT00427297|Ritonavir|ritonavir|mesh-list
138482821|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482822|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482823|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482824|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482825|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482826|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
138482828|NCT00386659|Lopinavir|lopinavir|mesh-list
138482829|NCT00386659|Tenofovir|tenofovir|mesh-list
138482830|NCT00386659|Abacavir|abacavir|mesh-list
138482831|NCT00386659|Efavirenz|efavirenz|mesh-list
138482832|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
138482833|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138482834|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138482835|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
138482836|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482837|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482839|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482840|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
138482841|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482842|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138482843|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138482844|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138482845|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482846|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138482847|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138482848|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138482849|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138482850|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138482851|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
138482853|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482854|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482855|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
138482856|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482857|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
138482858|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
138482859|NCT00387933|Vatalanib|vatalanib|mesh-list
138482860|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482861|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162358|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482862|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482863|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482864|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
138482865|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138482866|NCT00006034|Doxorubicin|doxorubicin|mesh-list
138482867|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482868|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138359151|NCT00005802|Aldesleukin|aldesleukin|mesh-list
138359152|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
138359153|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138359154|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138359155|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138359156|NCT00005802|Methotrexate|methotrexate|mesh-list
138359157|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
138359158|NCT00005802|Fludarabine|fludarabine|mesh-list
138359159|NCT00005802|Etoposide|etoposide|mesh-list
138359160|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
138359161|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138359162|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
138482869|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482870|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482871|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482872|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482873|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482874|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482875|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138482876|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
138482877|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482880|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
138162405|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162406|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
138482881|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482882|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482883|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482884|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482885|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
138482886|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482887|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482888|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482889|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482890|NCT00006040|Etoposide|etoposide|mesh-list
138482891|NCT00006040|Antibodies|antibodies|mesh-list
138482892|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138482893|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
138482894|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482895|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162109|NCT00390611|Paclitaxel|paclitaxel|mesh-list
138482897|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482898|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482899|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162463|NCT05287607|Bilirubin|bilirubin|mesh-list
138482900|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482902|NCT00006363|Aldesleukin|aldesleukin|mesh-list
138482903|NCT00006363|Etoposide|etoposide|mesh-list
138482904|NCT00006363|Daunorubicin|daunorubicin|mesh-list
138162164|NCT00387829|Estradiol|estradiol|mesh-list
138482905|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
138482907|NCT00006363|Interleukin-2|interleukin-2|mesh-list
138482908|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482909|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482910|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482911|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482912|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482913|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482914|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482916|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
138482917|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482918|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482919|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
138298972|NCT00382837|Epratuzumab|epratuzumab|mesh-list
138482920|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482921|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
138482922|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138482923|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138482924|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482925|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138482927|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
138482928|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482929|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138482930|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138482932|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138482933|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138482934|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138482935|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482936|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482937|NCT00006366|Fluorouracil|fluorouracil|mesh-list
138162516|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482938|NCT00006366|Irinotecan|irinotecan|mesh-list
138482939|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
138482940|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482941|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482942|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482943|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138482944|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
138482945|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482946|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138482947|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482949|NCT00006372|Gemcitabine|gemcitabine|mesh-list
138482950|NCT00006372|Doxorubicin|doxorubicin|mesh-list
138482951|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138482952|NCT00006372|Vinorelbine|vinorelbine|mesh-list
138482953|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138482954|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
138482955|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482956|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482957|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138482958|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138482959|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138482960|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482961|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482962|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482963|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138162415|NCT00400205|Docetaxel|docetaxel|mesh-list
138482965|NCT00006378|Paclitaxel|paclitaxel|mesh-list
138482966|NCT00006378|Carboplatin|carboplatin|mesh-list
138482967|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138482968|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482969|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138482970|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482971|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482972|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482973|NCT00006381|Celecoxib|celecoxib|mesh-list
138482974|NCT00006381|Trastuzumab|trastuzumab|mesh-list
138482975|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138482976|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482977|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138482978|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138482979|NCT00006381|Analgesics|analgesics|mesh-ancestor
138482980|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
138482981|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138482982|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482983|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138482984|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138482985|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138482986|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138482987|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482988|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482989|NCT00006384|Interferons|interferons|mesh-list
138482990|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
138482991|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482992|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
138482993|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138482994|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
138482995|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482996|NCT00386815|Pemetrexed|pemetrexed|mesh-list
138482997|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482998|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482999|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483000|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138299013|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138299014|NCT00003920|Antibodies|antibodies|mesh-list
138483001|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483002|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138483003|NCT05678296|Analgesics|analgesics|mesh-list
138483004|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483005|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
138162594|NCT01421342|Aripiprazole|aripiprazole|mesh-list
138483006|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483007|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483009|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483010|NCT00006396|Zidovudine|zidovudine|mesh-list
138483011|NCT00006396|Nevirapine|nevirapine|mesh-list
138483012|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
138483013|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483014|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483015|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483016|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162638|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483017|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
138483018|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483020|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483021|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138483022|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138483025|NCT03996148|Propofol|propofol|mesh-list
138483026|NCT03996148|Desflurane|desflurane|mesh-list
138483027|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138483028|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138483029|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483031|NCT03996148|Analgesics|analgesics|mesh-ancestor
138483032|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
138483033|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483034|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138483035|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138483036|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138483037|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138483038|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483039|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483040|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138483041|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
138483042|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
138483043|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138483044|NCT03996148|Narcotics|narcotics|mesh-ancestor
138483045|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138483046|NCT00006399|Donepezil|donepezil|mesh-list
138483047|NCT00006399|Progesterone|progesterone|mesh-list
138483048|NCT00006399|Estrogens|estrogens|mesh-list
138483049|NCT00006399|Progestins|progestins|mesh-ancestor
138483050|NCT00006399|Hormones|hormones|mesh-ancestor
138483051|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483052|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483053|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138483054|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483055|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483056|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
138483057|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483058|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
138483060|NCT05660200|Trace Elements|trace elements|mesh-ancestor
138483061|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
138483062|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483063|NCT05552404|Aminophylline|aminophylline|mesh-list
138483064|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138483065|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
138483066|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483067|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483068|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138483069|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
138162674|NCT00452335|Lubiprostone|lubiprostone|mesh-list
138483070|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138483071|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138483072|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483073|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483074|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138483075|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138483076|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
138483077|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483078|NCT05552404|Protective Agents|protective agents|mesh-ancestor
138483079|NCT05546320|Aspirin|aspirin|mesh-list
138483080|NCT05546320|Metoprolol|metoprolol|mesh-list
138483081|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
138483082|NCT05546320|Clopidogrel|clopidogrel|mesh-list
138162738|NCT05966064|Denosumab|denosumab|mesh-list
138162742|NCT05966012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138483083|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138483085|NCT05546320|Analgesics|analgesics|mesh-ancestor
138483086|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
138483087|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483088|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483089|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483090|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483091|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138483092|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138483093|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483094|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138483095|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138483096|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483097|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
138483098|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138483099|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138483100|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138483102|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483103|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138483104|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
138483105|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138483107|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
138483108|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138483109|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138483110|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
138483111|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
138162788|NCT05965076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483112|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138483113|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138483114|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138483115|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138483116|NCT05535595|Perindopril|perindopril|mesh-list
138483117|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138483118|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483119|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483120|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483121|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138483122|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
138483123|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138483124|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138483125|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483126|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
138483127|NCT05470816|Coagulants|coagulants|mesh-ancestor
138483128|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138483129|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138483130|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138483131|NCT05431543|Aceclidine|aceclidine|mesh-list
138483132|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138162840|NCT05741372|Metformin|metformin|mesh-list
138483133|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138483134|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138483135|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138299107|NCT00004646|Hormones|hormones|mesh-ancestor
138483136|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
138483137|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483138|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483139|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483140|NCT05431543|Miotics|miotics|mesh-ancestor
138483141|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
138483142|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483143|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138483144|NCT05401786|Ipilimumab|ipilimumab|mesh-list
138483145|NCT05401786|Cemiplimab|cemiplimab|mesh-list
138483146|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483147|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483148|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138483149|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483150|NCT05285683|Levodopa|levodopa|mesh-list
138483152|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138483153|NCT05285683|Methylphenidate|methylphenidate|mesh-list
138483154|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138483155|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483156|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138483157|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138162889|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138483158|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162893|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
138483159|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483161|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483162|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138483163|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138483164|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138483165|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483166|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138483167|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
138483168|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
138483169|NCT05247970|Midazolam|midazolam|mesh-list
138483170|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138483171|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138483172|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138483173|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483174|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138483175|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138483176|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138483177|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138483178|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
138483179|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
138483180|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
138483181|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
138483182|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483183|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483184|NCT00006441|Lamivudine|lamivudine|mesh-list
138483185|NCT00006441|Zidovudine|zidovudine|mesh-list
138483186|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138483188|NCT00006441|Nelfinavir|nelfinavir|mesh-list
138360357|NCT00383370|Aflibercept|aflibercept|mesh-list
138483189|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483190|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483191|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483192|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483193|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
138483194|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483195|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483196|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483197|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
138483198|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299193|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138483200|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138483201|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483202|NCT05147233|Dexamethasone|dexamethasone|mesh-list
138483203|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483204|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
138483205|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
138483206|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483207|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483208|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138483209|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
138483210|NCT05147233|Hormones|hormones|mesh-ancestor
138163151|NCT04715646|Brivaracetam|brivaracetam|mesh-list
138483222|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483223|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
138163000|NCT05375630|Vitamin K|vitamin k|mesh-list
138483224|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483226|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138483227|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483228|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483229|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483230|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138483231|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483232|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483233|NCT00006459|Paclitaxel|paclitaxel|mesh-list
138163257|NCT04329728|Hormones|hormones|mesh-ancestor
138483235|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483236|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483237|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138483238|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138483239|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138163037|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483240|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483241|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483244|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483245|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483246|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299237|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299255|NCT00004754|Tezosentan|tezosentan|mesh-list
138483247|NCT00388011|Morphine|morphine|mesh-list
138483248|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138483249|NCT00388011|Narcotics|narcotics|mesh-ancestor
138483250|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138483251|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483252|NCT00388011|Analgesics|analgesics|mesh-ancestor
138483253|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
138483254|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483255|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138483256|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
138483257|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483258|NCT00388089|Bortezomib|bortezomib|mesh-list
138483259|NCT00388089|Topotecan|topotecan|mesh-list
138483260|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483261|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483262|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483263|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483264|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483265|NCT00388128|Caffeine|caffeine|mesh-list
138483266|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138483267|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483268|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138483269|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483270|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483271|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138163096|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138483272|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138483273|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
138483274|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483275|NCT00006462|Gemcitabine|gemcitabine|mesh-list
138163409|NCT03321630|Lenvatinib|lenvatinib|mesh-list
138483276|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483277|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
138483278|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299277|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
138483279|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483280|NCT00006465|Capecitabine|capecitabine|mesh-list
138483281|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
138483283|NCT00006465|Camptothecin|camptothecin|mesh-list
138483284|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483285|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
138483286|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483287|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483288|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483289|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483290|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483291|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483292|NCT00006468|Leucovorin|leucovorin|mesh-list
138483293|NCT00006468|Fluorouracil|fluorouracil|mesh-list
138483294|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
138483295|NCT00006468|Calcium|calcium|mesh-list
138483296|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
138483297|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138483298|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483299|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
138483300|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483301|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483302|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483303|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483304|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
138483305|NCT00006468|Antidotes|antidotes|mesh-ancestor
138483306|NCT00006468|Protective Agents|protective agents|mesh-ancestor
138483307|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
138483308|NCT00006468|Vitamins|vitamins|mesh-ancestor
138483309|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
138483310|NCT00006471|Fenretinide|fenretinide|mesh-list
138483311|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483312|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138483313|NCT00006471|Protective Agents|protective agents|mesh-ancestor
138483314|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483315|NCT00006474|Temozolomide|temozolomide|mesh-list
138483316|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138299315|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
138299326|NCT00004808|Fluconazole|fluconazole|mesh-list
138483317|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483318|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
138483319|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483320|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483321|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483323|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138483325|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483326|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483327|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483328|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138483329|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138163521|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163178|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138483331|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138483332|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138483333|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
138483334|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
138483335|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138483336|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138483337|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483338|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
138483339|NCT04192435|Coagulants|coagulants|mesh-ancestor
138483340|NCT00423397|Interferons|interferons|mesh-list
138483341|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
138483342|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
138483343|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138483344|NCT00423397|Gefitinib|gefitinib|mesh-list
138483345|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483346|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
138299356|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
138483347|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483348|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
138483349|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483350|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483351|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483352|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483353|NCT03265405|Prednisolone|prednisolone|mesh-list
138483354|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138483355|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
138483356|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138163229|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163230|NCT04495881|Incretins|incretins|mesh-ancestor
138163231|NCT04495881|Hormones|hormones|mesh-ancestor
138163232|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163233|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138163234|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163235|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163237|NCT04486625|Aztreonam|aztreonam|mesh-list
138483357|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
138483358|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138483359|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
138483360|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483361|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
138483363|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483364|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483365|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138483366|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483367|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
138483368|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
138483369|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163269|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138163271|NCT04241601|Interleukin-2|interleukin-2|mesh-list
138163272|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483370|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299400|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483372|NCT03265405|Protective Agents|protective agents|mesh-ancestor
138483373|NCT03808480|Nivolumab|nivolumab|mesh-list
138483374|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483375|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483376|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138483377|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483379|NCT02966548|Relatlimab|relatlimab|mesh-list
138483380|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483381|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483382|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138483383|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483384|NCT02890069|Everolimus|everolimus|mesh-list
138483385|NCT02890069|Panobinostat|panobinostat|mesh-list
138483386|NCT02890069|Spartalizumab|spartalizumab|mesh-list
138483387|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138483388|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483389|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483390|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483391|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483392|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
138483393|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483394|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483395|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138483396|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138299437|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138483397|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483398|NCT02425501|Aflibercept|aflibercept|mesh-list
138483399|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138483400|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138483401|NCT02425501|Growth Substances|growth substances|mesh-ancestor
138483402|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483403|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
138483404|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483405|NCT02409238|Metformin|metformin|mesh-list
138483406|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138483407|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483408|NCT00006480|Aldesleukin|aldesleukin|mesh-list
138163331|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163332|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483409|NCT00006480|Ganciclovir|ganciclovir|mesh-list
138483410|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138483411|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483412|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483413|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483414|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
138483415|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483416|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483417|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483418|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483419|NCT00006483|Sargramostim|sargramostim|mesh-list
138163808|NCT01381562|Meropenem|meropenem|mesh-list
138483420|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
138483421|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483422|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138483423|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483424|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138483425|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138483426|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299483|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138299492|NCT00385658|Simvastatin|simvastatin|mesh-list
138483427|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138483428|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483430|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483431|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483432|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483433|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483434|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
138483435|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483436|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483437|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483438|NCT00006591|Ritonavir|ritonavir|mesh-list
138483439|NCT00006591|Amprenavir|amprenavir|mesh-list
138483440|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138483441|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138483442|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483443|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483444|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483445|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483446|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483447|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
138483448|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483449|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138483450|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138483451|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138483452|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
138483453|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138483454|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
138483455|NCT00006630|Antibodies|antibodies|mesh-list
138483456|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
138483457|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138483458|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138483459|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
138483460|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483461|NCT00006669|Prednisone|prednisone|mesh-list
138483462|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
138483463|NCT00006669|Rituximab|rituximab|mesh-list
138483464|NCT00006669|Doxorubicin|doxorubicin|mesh-list
138483465|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138483467|NCT00006669|Vincristine|vincristine|mesh-list
138483468|NCT00006669|Sargramostim|sargramostim|mesh-list
138483469|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163403|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483470|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
138483471|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483472|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483473|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483474|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
138164072|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483475|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483476|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483477|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138483478|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483479|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138483480|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483481|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483482|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483483|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483484|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
138483485|NCT00006669|Hormones|hormones|mesh-ancestor
138483486|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483487|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299559|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299567|NCT00005810|Docetaxel|docetaxel|mesh-list
138483488|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483490|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138483491|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138483493|NCT00006708|Carboplatin|carboplatin|mesh-list
138483494|NCT00006708|Etoposide|etoposide|mesh-list
138483495|NCT00006708|Ifosfamide|ifosfamide|mesh-list
138164204|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483496|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483497|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483498|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
138483499|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483500|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483501|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483502|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483503|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483504|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483505|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483506|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483507|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
138483508|NCT00006747|Cytarabine|cytarabine|mesh-list
138483509|NCT00006747|Methotrexate|methotrexate|mesh-list
138483511|NCT00006747|Melphalan|melphalan|mesh-list
138483512|NCT00006747|Carmustine|carmustine|mesh-list
138483513|NCT00006747|Tacrolimus|tacrolimus|mesh-list
138483514|NCT00006747|Sargramostim|sargramostim|mesh-list
138483515|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138483516|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
138483517|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138483518|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483519|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483520|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
138483521|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483522|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483523|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
138483524|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483525|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138483526|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483527|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
138483528|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483529|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138163505|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
138483530|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360520|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
138360521|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360522|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360523|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138360524|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360525|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
138483531|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483532|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483533|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
138483534|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483535|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138483536|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483537|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
138483538|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138483540|NCT00006786|Bevacizumab|bevacizumab|mesh-list
138483541|NCT00006786|Fluorouracil|fluorouracil|mesh-list
138483542|NCT00006786|Irinotecan|irinotecan|mesh-list
138483543|NCT00006786|Calcium|calcium|mesh-list
138483544|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
138483545|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483546|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483547|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138483548|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138483549|NCT00006786|Growth Substances|growth substances|mesh-ancestor
138483550|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483551|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138483552|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138483553|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
138483554|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483555|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483556|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483557|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
138483558|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483559|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483560|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483561|NCT00006786|Antidotes|antidotes|mesh-ancestor
138483562|NCT00006786|Protective Agents|protective agents|mesh-ancestor
138483563|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
138483564|NCT00006786|Vitamins|vitamins|mesh-ancestor
138483565|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
138483566|NCT00006825|Doxorubicin|doxorubicin|mesh-list
138483567|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138483568|NCT00006825|Trastuzumab|trastuzumab|mesh-list
138483569|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138483570|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483571|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483572|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483573|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483574|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483575|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138483576|NCT00006864|Aldesleukin|aldesleukin|mesh-list
138483577|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483578|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483579|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483580|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
138483581|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483582|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
138483583|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483584|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138483585|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
138483586|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483587|NCT00006981|Immunotoxins|immunotoxins|mesh-list
138483588|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
138483589|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
138483590|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483591|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
138483592|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138483593|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483594|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138483595|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
138483596|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138483597|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483598|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483599|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483600|NCT00387556|Ondansetron|ondansetron|mesh-list
138483601|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
138483602|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
138483603|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483604|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483605|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138483606|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
138483607|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164626|NCT00492973|Cefuroxime|cefuroxime|mesh-list
138483608|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138483609|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138483610|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
138483611|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483612|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483613|NCT03780790|Bupivacaine|bupivacaine|mesh-list
138483614|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
138483615|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
138483616|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138483617|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164688|NCT00539695|Aldesleukin|aldesleukin|mesh-list
138483618|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
138483619|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483621|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
138483622|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483623|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483624|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483625|NCT00006043|Temozolomide|temozolomide|mesh-list
138483626|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483628|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483629|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483631|NCT00006049|Carboplatin|carboplatin|mesh-list
138483632|NCT00006049|Gefitinib|gefitinib|mesh-list
138483633|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483634|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483635|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138483636|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138483637|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138483638|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483639|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483640|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483641|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
138483642|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483643|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138483644|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483645|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483646|NCT00006055|Cyclosporine|cyclosporine|mesh-list
138483647|NCT00006055|Prednisone|prednisone|mesh-list
138483648|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
138483649|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
138483650|NCT00006055|Cyclosporins|cyclosporins|mesh-list
138483651|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138483652|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483653|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
138483654|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483655|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483656|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138483657|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
138163670|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
138483658|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164799|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
138299766|NCT04929847|Emollients|emollients|mesh-list
138483659|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483660|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138483661|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483662|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
138483663|NCT00006055|Hormones|hormones|mesh-ancestor
138483664|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483665|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138483666|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483667|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
138483668|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483669|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
138483670|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138483671|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
138483672|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
138483673|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483674|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138483675|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138483676|NCT00006055|Protective Agents|protective agents|mesh-ancestor
138483677|NCT00006070|Etanercept|etanercept|mesh-list
138483678|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138483679|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138483680|NCT00006070|Analgesics|analgesics|mesh-ancestor
138483681|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
138483682|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483683|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483684|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483685|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483686|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138483687|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483688|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
138483689|NCT00006079|Eflornithine|eflornithine|mesh-list
138483690|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483691|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138483692|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138483693|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138483694|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483695|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138483696|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299795|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483697|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483699|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483700|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483701|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483702|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483703|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483704|NCT00006088|Vinorelbine|vinorelbine|mesh-list
138483705|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483706|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483707|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138483708|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138483709|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138483710|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483711|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
138483712|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483713|NCT00006094|Fluorouracil|fluorouracil|mesh-list
138483714|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
138483715|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
138483716|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483717|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483718|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483719|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163756|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483720|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
138483721|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483722|NCT00006100|Aldesleukin|aldesleukin|mesh-list
138483723|NCT00006100|Fludarabine|fludarabine|mesh-list
138483724|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
138483725|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483726|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483727|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
138483728|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483729|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483730|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
138483731|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483732|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483733|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483734|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
138483735|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483737|NCT00006103|Fluorouracil|fluorouracil|mesh-list
138483738|NCT00006103|Irinotecan|irinotecan|mesh-list
138483739|NCT00006103|Calcium|calcium|mesh-list
138483740|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
138483742|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165099|NCT01797913|Gemcitabine|gemcitabine|mesh-list
138483743|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
138483744|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483745|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483746|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483747|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483748|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
138483749|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483750|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483751|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483752|NCT00006103|Antidotes|antidotes|mesh-ancestor
138483753|NCT00006103|Protective Agents|protective agents|mesh-ancestor
138483754|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
138483756|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
138483757|NCT00006106|Fluorouracil|fluorouracil|mesh-list
138483758|NCT00006106|Dl1520|dl1520|mesh-list
138483759|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483760|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
138483761|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483762|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483763|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483764|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
138483765|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483766|NCT00006112|Leucovorin|leucovorin|mesh-list
138483767|NCT00006112|Fluorouracil|fluorouracil|mesh-list
138483768|NCT00006112|Mitomycins|mitomycins|mesh-list
138483769|NCT00006112|Mitomycin|mitomycin|mesh-list
138483770|NCT00006112|Calcium|calcium|mesh-list
138483771|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
138483772|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138483773|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483774|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
138483775|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483776|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483777|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160285|NCT05266651|Tadalafil|tadalafil|mesh-list
138483778|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483779|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
138483780|NCT00006112|Antidotes|antidotes|mesh-ancestor
138483781|NCT00006112|Protective Agents|protective agents|mesh-ancestor
138483782|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
138483783|NCT00006112|Vitamins|vitamins|mesh-ancestor
138483784|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
138483785|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138483786|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
138483787|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483788|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483789|NCT00006115|Leucovorin|leucovorin|mesh-list
138483790|NCT00006115|Fluorouracil|fluorouracil|mesh-list
138483791|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
138483792|NCT00006115|Irinotecan|irinotecan|mesh-list
138483793|NCT00006115|Calcium|calcium|mesh-list
138483794|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
138483795|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138483796|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483797|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
138483798|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483799|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483800|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483801|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138483802|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
138483803|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483804|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483805|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483806|NCT00006115|Antidotes|antidotes|mesh-ancestor
138483807|NCT00006115|Protective Agents|protective agents|mesh-ancestor
138483808|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
138483809|NCT00006115|Vitamins|vitamins|mesh-ancestor
138163892|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138483810|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
138483811|NCT00006118|Paclitaxel|paclitaxel|mesh-list
138483812|NCT00006118|Gemcitabine|gemcitabine|mesh-list
138483813|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483814|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483815|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138483816|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138483817|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289140|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483818|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299903|NCT00002905|Zidovudine|zidovudine|mesh-list
138483819|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138483820|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
138483821|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
138483822|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483823|NCT00006124|Celecoxib|celecoxib|mesh-list
138483824|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138483825|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138483826|NCT00006124|Analgesics|analgesics|mesh-ancestor
138483827|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
138483828|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483829|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483830|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483831|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483832|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138483833|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138483834|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483835|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483836|NCT00006127|Amifostine|amifostine|mesh-list
138483837|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138483838|NCT00006127|Protective Agents|protective agents|mesh-ancestor
138483839|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483840|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138483841|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138483842|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138483843|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138483844|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
138483845|NCT00006133|Norethindrone|norethindrone|mesh-list
138483846|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
138483847|NCT00006133|Estradiol|estradiol|mesh-list
138483848|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138483850|NCT00006133|Hormones|hormones|mesh-ancestor
138483851|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483852|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483853|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138483854|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
138483855|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138483856|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138483857|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138483858|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138483859|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138483860|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138483861|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138483862|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483863|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
138483864|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
138299932|NCT00002905|Analgesics|analgesics|mesh-ancestor
138483865|NCT00006136|Hematinics|hematinics|mesh-ancestor
138483866|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483869|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483870|NCT00006154|Ritonavir|ritonavir|mesh-list
138483871|NCT00006154|Indinavir|indinavir|mesh-list
138483872|NCT00006154|Aldesleukin|aldesleukin|mesh-list
138483873|NCT00006154|Abacavir|abacavir|mesh-list
138483874|NCT00006154|Didanosine|didanosine|mesh-list
138483875|NCT00006154|Stavudine|stavudine|mesh-list
138483876|NCT00006154|Efavirenz|efavirenz|mesh-list
138483877|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138483878|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138483879|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483885|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165551|NCT05923970|Vaccines|vaccines|mesh-list
138483886|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138483887|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138163979|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
138163980|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163981|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163982|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138163983|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
138163984|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163985|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138163986|NCT00483223|Carboplatin|carboplatin|mesh-list
138483888|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483889|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483890|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483891|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138483892|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138483893|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138165612|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
138483894|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138483895|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138483896|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
138483897|NCT00006157|Desipramine|desipramine|mesh-list
138483898|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138483899|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
138483900|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138483901|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483902|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483903|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138483905|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138483906|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
138483907|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483908|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299961|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299962|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138483909|NCT00006190|Lamivudine|lamivudine|mesh-list
138483910|NCT00006190|Efavirenz|efavirenz|mesh-list
138483911|NCT00006190|Stavudine|stavudine|mesh-list
138483912|NCT00006190|Nelfinavir|nelfinavir|mesh-list
138483913|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138163994|NCT00420017|Amiodarone|amiodarone|mesh-list
138483914|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483915|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483916|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483917|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
138483919|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483920|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483921|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138483922|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138483923|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138483924|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138483925|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138483926|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138483927|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138483928|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138483929|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483930|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
138483931|NCT00006196|Vitamin D|vitamin d|mesh-list
138483932|NCT00006196|Vitamins|vitamins|mesh-ancestor
138483933|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
138483934|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483935|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138483936|NCT00006199|Topotecan|topotecan|mesh-list
138483937|NCT00006199|Tipifarnib|tipifarnib|mesh-list
138483938|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138483939|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138483940|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164034|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
138483941|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483942|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483943|NCT00006205|Topiramate|topiramate|mesh-list
138483944|NCT00006205|Ondansetron|ondansetron|mesh-list
138483945|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
138483946|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
138483947|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483948|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483949|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138483950|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
138483951|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
138483952|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138483953|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138483954|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
138483955|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483956|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483957|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
138483958|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138483959|NCT00006208|Emtricitabine|emtricitabine|mesh-list
138483961|NCT00006208|Didanosine|didanosine|mesh-list
138483962|NCT00006208|Stavudine|stavudine|mesh-list
138483963|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
138483964|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483965|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483966|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483967|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483968|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483969|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483970|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483971|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138483972|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138483973|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138483974|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138483975|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138164080|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138164083|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
138483976|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138483978|NCT00006211|Nelfinavir|nelfinavir|mesh-list
138483979|NCT00006211|Capravirine|capravirine|mesh-list
138483980|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138483981|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138483982|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483983|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290100|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290101|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290102|NCT04169113|Analgesics|analgesics|mesh-ancestor
138483984|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483985|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483986|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483987|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
138483988|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138483989|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138483990|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138483991|NCT00006214|Flutamide|flutamide|mesh-list
138483992|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
138483993|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
138483994|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483995|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483996|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138483997|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483999|NCT00006220|Tretinoin|tretinoin|mesh-list
138484000|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484002|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484003|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
138164127|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
138484006|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484007|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138484009|NCT03761953|Oritavancin|oritavancin|mesh-list
138484010|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484011|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484012|NCT00006226|Thalidomide|thalidomide|mesh-list
138484013|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484014|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
138484015|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484016|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
138484017|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484018|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484019|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138484020|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138484021|NCT00006226|Growth Substances|growth substances|mesh-ancestor
138484022|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
138484023|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484024|NCT00006232|Dexamethasone|dexamethasone|mesh-list
138484025|NCT00006232|Doxorubicin|doxorubicin|mesh-list
138484026|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138484027|NCT00006232|Vincristine|vincristine|mesh-list
138484029|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484030|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
138484031|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
138484032|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484033|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484034|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484035|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
138484036|NCT00006232|Hormones|hormones|mesh-ancestor
138484037|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484038|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138484039|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484040|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484041|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484042|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484043|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484044|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164166|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138164168|NCT00424619|Vitamin D|vitamin d|mesh-list
138360842|NCT01270932|Lenalidomide|lenalidomide|mesh-list
138360843|NCT01270932|BB 1101|bb 1101|mesh-list
138360844|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360845|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
138360846|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
138360847|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360848|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360849|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360850|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
138360851|NCT01270932|Hormones|hormones|mesh-ancestor
138360852|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360853|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360854|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360855|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
138360856|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360857|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360858|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
138484045|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484046|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484047|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484048|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484050|NCT00006235|Doxorubicin|doxorubicin|mesh-list
138484051|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138484052|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484053|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484054|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484055|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484056|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484057|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484058|NCT00006241|Lenograstim|lenograstim|mesh-list
138484059|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484060|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
138484061|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484062|NCT00006247|Semaxinib|semaxinib|mesh-list
138484063|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138484064|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138484065|NCT00006247|Growth Substances|growth substances|mesh-ancestor
138484066|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484067|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
138484068|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484069|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138484070|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484071|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484072|NCT00006250|Dexamethasone|dexamethasone|mesh-list
138484073|NCT00006250|Fludarabine|fludarabine|mesh-list
138300078|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484074|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
138484075|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
138484076|NCT00006250|Chlorambucil|chlorambucil|mesh-list
138484077|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484078|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
138484079|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
138484080|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484082|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484083|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
138484085|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484086|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138484088|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484089|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
138484090|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484091|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484092|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
138484093|NCT00006250|Analgesics|analgesics|mesh-ancestor
138484094|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
138484095|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484096|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484097|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484098|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484099|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
138484101|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
138484102|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484103|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
138484104|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484105|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484106|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
138484107|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484108|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484109|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
138484110|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484111|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138484112|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
138300112|NCT00003415|Protective Agents|protective agents|mesh-ancestor
138484113|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
138484114|NCT00007527|Buprenorphine|buprenorphine|mesh-list
138484115|NCT00007527|Naloxone|naloxone|mesh-list
138484116|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138484117|NCT00007527|Narcotics|narcotics|mesh-ancestor
138484118|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484119|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484120|NCT00007527|Analgesics|analgesics|mesh-ancestor
138484121|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
138484122|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484123|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138484124|NCT00006280|Tobramycin|tobramycin|mesh-list
138484125|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484126|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484127|NCT00006286|Fluoxetine|fluoxetine|mesh-list
138484128|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138484129|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138484130|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484131|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484132|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484134|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484135|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138484136|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
138484137|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138484138|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138484139|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138484140|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484142|NCT00007605|Sotalol|sotalol|mesh-list
138484143|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138484144|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
138300149|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484145|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138484146|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484147|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484148|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138484149|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138484150|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138484151|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484152|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138484153|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138484154|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138484155|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138484156|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138484157|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138484158|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484160|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
138484161|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
138484162|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484163|NCT00006292|Infliximab|infliximab|mesh-list
138484164|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138484165|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484166|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484167|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484168|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484169|NCT03709888|Pregabalin|pregabalin|mesh-list
138484170|NCT03709888|Memantine|memantine|mesh-list
138484171|NCT03709888|Analgesics|analgesics|mesh-ancestor
138484172|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
138484173|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484174|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484175|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
138484176|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138484177|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484178|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484179|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138484180|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138484181|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138484182|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484184|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138484185|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138484186|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
138484187|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484188|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138484189|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138484190|NCT00007683|Aspirin|aspirin|mesh-list
138484191|NCT00007683|Warfarin|warfarin|mesh-list
138484192|NCT00007683|Clopidogrel|clopidogrel|mesh-list
138484193|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138484194|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138484196|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
138484197|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484198|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484199|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484200|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484201|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138484202|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138484203|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484204|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138484205|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138484206|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484207|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
138484208|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138484209|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138484210|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138484211|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
138484212|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484214|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138484215|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
138484216|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484217|NCT00006337|Levodopa|levodopa|mesh-list
138484218|NCT00006337|Istradefylline|istradefylline|mesh-list
138484219|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138484220|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138300226|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300237|NCT00003007|Hormones|hormones|mesh-ancestor
138484221|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
138484222|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484223|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484224|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484225|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138484226|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138484228|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
138484229|NCT00006340|Ganciclovir|ganciclovir|mesh-list
138484230|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138484231|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
138484232|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
138484233|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484234|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138484235|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484236|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484237|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484238|NCT00006229|Paclitaxel|paclitaxel|mesh-list
138484239|NCT00006229|Carboplatin|carboplatin|mesh-list
138484240|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484241|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484242|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484243|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484244|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484245|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484246|NCT00006343|Interferons|interferons|mesh-list
138484247|NCT00006343|Cytarabine|cytarabine|mesh-list
138484249|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
138484250|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484251|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
138484252|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484253|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484254|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
138484255|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484256|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484257|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
138484258|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300270|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300289|NCT00003445|Docetaxel|docetaxel|mesh-list
138484259|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138484260|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484262|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484263|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484264|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484265|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484266|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484267|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484268|NCT03616717|Modafinil|modafinil|mesh-list
138484269|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138484270|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484271|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138484272|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138484273|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138484274|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484275|NCT00006349|Vitamin E|vitamin e|mesh-list
138484276|NCT00006349|Donepezil|donepezil|mesh-list
138484277|NCT00006349|Vitamins|vitamins|mesh-ancestor
138484278|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
138484279|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484280|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138484281|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484282|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484283|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
138484284|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484285|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
138484286|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
138484287|NCT00006349|Protective Agents|protective agents|mesh-ancestor
138484288|NCT00006352|Antibodies|antibodies|mesh-list
138484289|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138484290|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
138484291|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
138484292|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484293|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484295|NCT00007878|Fluorouracil|fluorouracil|mesh-list
138484296|NCT00007878|Bortezomib|bortezomib|mesh-list
138484297|NCT00007878|Calcium|calcium|mesh-list
138484298|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
138484299|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138484300|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300306|NCT00003451|Growth Substances|growth substances|mesh-ancestor
138484301|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
138484302|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484303|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484304|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484305|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484306|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
138484307|NCT00007878|Antidotes|antidotes|mesh-ancestor
138164301|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138484308|NCT00007878|Protective Agents|protective agents|mesh-ancestor
138484309|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
138484311|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
138484312|NCT00006355|NSC 366140|nsc 366140|mesh-list
138484313|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484314|NCT00006358|Thalidomide|thalidomide|mesh-list
138484315|NCT00006358|Temozolomide|temozolomide|mesh-list
138484316|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484317|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
138484318|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484319|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484320|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484321|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
138484323|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
138484324|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484325|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484326|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138484327|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138484328|NCT00006358|Growth Substances|growth substances|mesh-ancestor
138484329|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
138484330|NCT00006361|Semaxinib|semaxinib|mesh-list
138484331|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138484332|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138484333|NCT00006361|Growth Substances|growth substances|mesh-ancestor
138484334|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164319|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
138484335|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
138484336|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484337|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138484338|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484339|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300341|NCT00003493|Vincristine|vincristine|mesh-list
138484340|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
138484343|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138484344|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484345|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484346|NCT00007917|Gemcitabine|gemcitabine|mesh-list
138484347|NCT00007917|Alvocidib|alvocidib|mesh-list
138484348|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484349|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
138484350|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484351|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484353|NCT00007917|Growth Substances|growth substances|mesh-ancestor
138484354|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484355|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138484356|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484358|NCT00006367|Busulfan|busulfan|mesh-list
138484359|NCT00006367|Idarubicin|idarubicin|mesh-list
138484360|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484361|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
138484362|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484363|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484364|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
138484365|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484366|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484367|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
138484368|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484369|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
138484370|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484371|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484372|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484373|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484374|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484375|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484376|NCT00006370|Edotreotide|edotreotide|mesh-list
138164358|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
138484378|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484379|NCT00007956|Antibodies|antibodies|mesh-list
138484380|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138484381|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
138484382|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484383|NCT00006373|Etoposide|etoposide|mesh-list
138484384|NCT00006373|Topotecan|topotecan|mesh-list
138484385|NCT00006373|Ifosfamide|ifosfamide|mesh-list
138484386|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484387|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484388|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484389|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484390|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484391|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484392|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138484393|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484394|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
138484396|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484397|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
138484398|NCT00006379|Fludarabine|fludarabine|mesh-list
138484399|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
138484400|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138484401|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484402|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
138484403|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484404|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484405|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484406|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
138484407|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484408|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484409|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484410|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484411|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
138484412|NCT00006385|Interferons|interferons|mesh-list
138484413|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
138164399|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138164400|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484415|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
138484416|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484417|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
138484418|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484419|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
138484420|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484421|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484422|NCT00007995|Interferons|interferons|mesh-list
138484424|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
138484425|NCT00007995|Melphalan|melphalan|mesh-list
138484426|NCT00007995|Busulfan|busulfan|mesh-list
138484427|NCT00007995|Sargramostim|sargramostim|mesh-list
138484428|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484429|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
138484430|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484431|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289141|NCT00000776|Fluconazole|fluconazole|mesh-list
138484432|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484433|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
138484434|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484435|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484436|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484437|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
138484438|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484439|NCT00006388|Tamoxifen|tamoxifen|mesh-list
138484440|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138484441|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138484442|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484443|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484444|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300459|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484446|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138484447|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138484448|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138484449|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
138484450|NCT00008034|Capecitabine|capecitabine|mesh-list
138484452|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484453|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
138484454|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484455|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484456|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484457|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
138484458|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484459|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484460|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484461|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484462|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
138484463|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484464|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484465|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484466|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484467|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
138484468|NCT00006391|Topotecan|topotecan|mesh-list
138484469|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484470|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138484471|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484472|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484473|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484475|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484476|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484477|NCT00008073|Doxorubicin|doxorubicin|mesh-list
138484478|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138484479|NCT00008073|Octreotide|octreotide|mesh-list
138484480|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484481|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484482|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484483|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484484|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164473|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138484485|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484486|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484487|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138484488|NCT00006397|Ritonavir|ritonavir|mesh-list
138484489|NCT00006397|Indinavir|indinavir|mesh-list
138484490|NCT00006397|Didanosine|didanosine|mesh-list
138484491|NCT00006397|Stavudine|stavudine|mesh-list
138484492|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138484493|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138484494|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138484495|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484496|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484497|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138484498|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138484499|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
138484500|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484501|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138484502|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138484503|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
138484504|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138484505|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138484506|NCT00006412|Fenofibrate|fenofibrate|mesh-list
138484507|NCT00006412|Pravastatin|pravastatin|mesh-list
138484508|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138484510|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484511|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138484512|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138289142|NCT00000776|Amphotericin B|amphotericin b|mesh-list
138484513|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138484514|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484515|NCT00008112|Cisplatin|cisplatin|mesh-list
138484517|NCT00006427|Amitriptyline|amitriptyline|mesh-list
138484518|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138484519|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
138484520|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138484521|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138484522|NCT00006427|Analgesics|analgesics|mesh-ancestor
138484523|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
138484524|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484525|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484526|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138484527|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138484528|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484529|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484530|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
138484531|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484532|NCT00008151|Cyclosporine|cyclosporine|mesh-list
138484533|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
138484534|NCT00008151|Methotrexate|methotrexate|mesh-list
138484535|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
138484536|NCT00008151|Fludarabine|fludarabine|mesh-list
138484537|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
138484538|NCT00008151|Cyclosporins|cyclosporins|mesh-list
138484540|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
138484541|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300598|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138484542|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484543|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484544|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
138484545|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484546|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484547|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484549|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138484550|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484551|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
138484552|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484553|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138484554|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
138484555|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484556|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138484557|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484558|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138484559|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
138484560|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484561|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138484563|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
138484564|NCT00006448|Methadone|methadone|mesh-list
138164562|NCT00217022|Hormones|hormones|mesh-ancestor
138484565|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138484566|NCT00006448|Narcotics|narcotics|mesh-ancestor
138484567|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484568|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484569|NCT00006448|Analgesics|analgesics|mesh-ancestor
138484570|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
138484571|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484572|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
138484573|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
138484575|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
138484576|NCT00008190|Melphalan|melphalan|mesh-list
138484577|NCT00008190|Busulfan|busulfan|mesh-list
138484578|NCT00008190|Etoposide|etoposide|mesh-list
138484579|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484580|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
138484581|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484582|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484583|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300632|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
138484584|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
138484585|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484586|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484587|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484588|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484589|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484590|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484591|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484592|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138484593|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138484594|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
138484595|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484596|NCT00006451|Cyclosporine|cyclosporine|mesh-list
138484597|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
138484598|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
138484599|NCT00006451|Methotrexate|methotrexate|mesh-list
138484600|NCT00006451|Cyclosporins|cyclosporins|mesh-list
138484601|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138484602|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484603|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
138484604|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164592|NCT00490009|Trace Elements|trace elements|mesh-ancestor
138161113|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484605|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161114|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161115|NCT00352001|Lenalidomide|lenalidomide|mesh-list
138161116|NCT00352001|Azacitidine|azacitidine|mesh-list
138161125|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
138484606|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484607|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
138484608|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484609|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484610|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484611|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138484612|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
138484613|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138484614|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484615|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
138484616|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484617|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484618|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138484619|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138484620|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
138484621|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484622|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138484623|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300666|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484625|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
138484626|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484627|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484628|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
138484629|NCT00006451|Hormones|hormones|mesh-ancestor
138484630|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484631|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138484632|NCT00006451|Protective Agents|protective agents|mesh-ancestor
138484633|NCT00006454|Paclitaxel|paclitaxel|mesh-list
138484634|NCT00006454|Carboplatin|carboplatin|mesh-list
138484635|NCT00006454|Topotecan|topotecan|mesh-list
138164630|NCT00492973|Prednisolone|prednisolone|mesh-list
138484636|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484637|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484639|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484640|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484641|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484642|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138484643|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484644|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484645|NCT00008229|Melphalan|melphalan|mesh-list
138484646|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
138484647|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484648|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484649|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
138484650|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484651|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484652|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484653|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484654|NCT00006457|Oltipraz|oltipraz|mesh-list
138484655|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
138484656|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484657|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
138484658|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138484659|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
138484660|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138484661|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138484662|NCT00006457|Protective Agents|protective agents|mesh-ancestor
138484663|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484664|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484665|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138484666|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138484667|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484668|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484669|NCT00008268|Melphalan|melphalan|mesh-list
138164675|NCT05630534|Minocycline|minocycline|mesh-list
138484671|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484672|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484673|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
138484674|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484675|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484676|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484677|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484678|NCT00006463|Trabectedin|trabectedin|mesh-list
138484679|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484680|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
138484681|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484682|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484685|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
138484687|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
138484688|NCT00008307|Melphalan|melphalan|mesh-list
138484689|NCT00008307|Cyclosporins|cyclosporins|mesh-list
138484690|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138484691|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484692|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484693|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
138484694|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484695|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484696|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
138484697|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484698|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484699|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
138484700|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484701|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484702|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484703|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138484704|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484705|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138484706|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
138300713|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300714|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484707|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138484708|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484710|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
138484711|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484712|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484713|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
138484714|NCT00008307|Hormones|hormones|mesh-ancestor
138484715|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484716|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138484717|NCT00008307|Protective Agents|protective agents|mesh-ancestor
138484718|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484719|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
138484720|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484721|NCT00006469|Paclitaxel|paclitaxel|mesh-list
138484722|NCT00006469|Carboplatin|carboplatin|mesh-list
138484723|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484724|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164708|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
138484725|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484726|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484727|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484728|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484729|NCT00006472|Paclitaxel|paclitaxel|mesh-list
138484730|NCT00006472|Carboplatin|carboplatin|mesh-list
138484731|NCT00006472|Fluorouracil|fluorouracil|mesh-list
138484732|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484733|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484734|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484735|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484736|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484737|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484738|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
138484739|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484740|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300752|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300757|NCT00002875|Lomustine|lomustine|mesh-list
138484741|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
138484742|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484743|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
138484744|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484745|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138484746|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484747|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484748|NCT00008424|Irinotecan|irinotecan|mesh-list
138484749|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138484750|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484751|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484752|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484753|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484755|NCT00006484|Carboplatin|carboplatin|mesh-list
138484756|NCT00006484|Tirapazamine|tirapazamine|mesh-list
138484757|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484758|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164729|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138164730|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
138484759|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484760|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484761|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484762|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484763|NCT00006487|Etoposide|etoposide|mesh-list
138484764|NCT00006487|Tirapazamine|tirapazamine|mesh-list
138484765|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484766|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484767|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484768|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484769|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484770|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484771|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
138484772|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138484773|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484774|NCT00008463|Interferons|interferons|mesh-list
138484775|NCT00008463|Ribavirin|ribavirin|mesh-list
138484776|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
138484777|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
138484778|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138484779|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300804|NCT00003091|Interferons|interferons|mesh-list
138484780|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
138484781|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484782|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
138484783|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484784|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
138484785|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484787|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138484788|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484789|NCT00006682|Docetaxel|docetaxel|mesh-list
138484790|NCT00006682|Vinorelbine|vinorelbine|mesh-list
138484791|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484792|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484793|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484794|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164770|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
138484795|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484796|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484798|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484799|NCT00006760|Vinorelbine|vinorelbine|mesh-list
138484800|NCT00006760|Ifosfamide|ifosfamide|mesh-list
138484801|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484802|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484803|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484804|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484805|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484806|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484807|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484808|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
138484809|NCT00008736|Metoclopramide|metoclopramide|mesh-list
138484810|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
138484811|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
138484812|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484813|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484814|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484815|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138484816|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138484817|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
138484818|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484819|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484820|NCT00006799|Megestrol|megestrol|mesh-list
138484821|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
138300822|NCT00003619|Vitamins|vitamins|mesh-ancestor
138300823|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
138484822|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138484823|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138484824|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138484825|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
138484826|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138484827|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484828|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138484829|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138484830|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138161339|NCT00355199|Rituximab|rituximab|mesh-list
138484831|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484833|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138484834|NCT00006877|Temozolomide|temozolomide|mesh-list
138484835|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484836|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
138484837|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484839|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
138484840|NCT00007033|Analgesics|analgesics|mesh-ancestor
138484841|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
138484842|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484843|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484844|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
138484845|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484846|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138484847|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
138484848|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138484849|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484850|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300849|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484851|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138484852|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
138484853|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138484854|NCT00388401|Alvimopan|alvimopan|mesh-list
138484855|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484856|NCT00007189|Celecoxib|celecoxib|mesh-list
138484857|NCT00007189|Naproxen|naproxen|mesh-list
138484858|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138484859|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138484860|NCT00007189|Analgesics|analgesics|mesh-ancestor
138484861|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
138484862|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484863|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484864|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138484865|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484866|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138484867|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138484868|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484869|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484870|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
138484871|NCT00388219|Buprenorphine|buprenorphine|mesh-list
138484872|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138484873|NCT00388219|Narcotics|narcotics|mesh-ancestor
138484874|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484875|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484876|NCT00388219|Analgesics|analgesics|mesh-ancestor
138484877|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
138484878|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484879|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138484880|NCT00388258|Alvimopan|alvimopan|mesh-list
138484881|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484883|NCT00388336|Hematinics|hematinics|mesh-ancestor
138484884|NCT00007306|Hormones|hormones|mesh-list
138484885|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
138484886|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484887|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484888|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138484889|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
138484890|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484891|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
138484892|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484893|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138484894|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484895|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
138484896|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484897|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
138484898|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138484899|NCT00007423|Protective Agents|protective agents|mesh-ancestor
138484900|NCT00007774|Haloperidol|haloperidol|mesh-list
138484901|NCT00007774|Olanzapine|olanzapine|mesh-list
138484902|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
138484903|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
138484904|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
138484905|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484906|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484907|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138484908|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138484909|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138484910|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138484911|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138484912|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138484913|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138484914|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484915|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484916|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484917|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
138484918|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138484919|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
138484920|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138484921|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
138484922|NCT00007813|Carboplatin|carboplatin|mesh-list
138484923|NCT00007813|Etoposide|etoposide|mesh-list
138484924|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484925|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
138484926|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484927|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484928|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484929|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
138484930|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484931|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484932|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484933|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484934|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164871|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484935|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484936|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484937|NCT00007852|Cytarabine|cytarabine|mesh-list
138484938|NCT00007852|Rituximab|rituximab|mesh-list
138484940|NCT00007852|Melphalan|melphalan|mesh-list
138484941|NCT00007852|Carmustine|carmustine|mesh-list
138484942|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138484943|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484944|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
138484945|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484946|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484947|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484948|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138484949|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138484950|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484951|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484952|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484953|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
138484954|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
138484955|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138484956|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484957|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484958|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
138484959|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484960|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138484962|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
138484963|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138484964|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
138484965|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484966|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484968|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
138484969|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138484970|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
138484971|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484972|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
138484973|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484974|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
138484975|NCT00008008|Thiotepa|thiotepa|mesh-list
138484976|NCT00008008|Sargramostim|sargramostim|mesh-list
138484977|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484978|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
138484979|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484980|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138484981|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138484982|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
138484983|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484984|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484985|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138484986|NCT00008047|Paclitaxel|paclitaxel|mesh-list
138484987|NCT00008047|Fluorouracil|fluorouracil|mesh-list
138484988|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
138484989|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300956|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300958|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484990|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484991|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
138484992|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
138484993|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484994|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484995|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
138484996|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484997|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138484998|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
138484999|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485000|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
138485001|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485002|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485003|NCT00008086|Calcitriol|calcitriol|mesh-list
138485004|NCT00008086|Carboplatin|carboplatin|mesh-list
138485005|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485006|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485007|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485008|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138485009|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164935|NCT00542971|Cytarabine|cytarabine|mesh-list
138485010|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485011|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138485012|NCT00008086|Vitamins|vitamins|mesh-ancestor
138485013|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
138485014|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138485015|NCT00008125|Carboplatin|carboplatin|mesh-list
138485016|NCT00008125|Gemcitabine|gemcitabine|mesh-list
138485017|NCT00008125|Docetaxel|docetaxel|mesh-list
138485018|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485019|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138485020|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
138300975|NCT00003109|Irinotecan|irinotecan|mesh-list
138300985|NCT00003643|Paclitaxel|paclitaxel|mesh-list
138485021|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485022|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
138485023|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
138485024|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
138485025|NCT00008203|Interferons|interferons|mesh-list
138485026|NCT00008203|Aldesleukin|aldesleukin|mesh-list
138485027|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
138485028|NCT00008203|Cyclosporine|cyclosporine|mesh-list
138485029|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
138485030|NCT00008203|Thiotepa|thiotepa|mesh-list
138485031|NCT00008203|Carboplatin|carboplatin|mesh-list
138485032|NCT00008203|Cyclosporins|cyclosporins|mesh-list
138485033|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138485034|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
138485035|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485036|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138485037|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138485038|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
138485039|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485040|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485041|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138485042|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
138485043|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485044|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485045|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
138485046|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
138485047|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138485048|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485049|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485050|NCT00008242|Thalidomide|thalidomide|mesh-list
138485051|NCT00008242|Dexamethasone|dexamethasone|mesh-list
138485052|NCT00008242|Doxorubicin|doxorubicin|mesh-list
138485053|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138485054|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485055|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
138485056|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
138485057|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485058|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161564|NCT00412243|Clofarabine|clofarabine|mesh-list
138485059|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138485060|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
138485061|NCT00008242|Hormones|hormones|mesh-ancestor
138485062|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301017|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485063|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485064|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485065|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138485066|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138485067|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138485068|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485069|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485070|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138485071|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
138485072|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
138485073|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485074|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485075|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138485076|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138485077|NCT00008242|Growth Substances|growth substances|mesh-ancestor
138485078|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138485080|NCT00008281|Fluorouracil|fluorouracil|mesh-list
138485081|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
138485083|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
138485084|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485085|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485086|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
138485087|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485088|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138485089|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485090|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138485091|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
138485092|NCT00008281|Antidotes|antidotes|mesh-ancestor
138485093|NCT00008281|Protective Agents|protective agents|mesh-ancestor
138485094|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
138485095|NCT00008281|Vitamins|vitamins|mesh-ancestor
138485096|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
138485097|NCT00008359|Amphotericin B|amphotericin b|mesh-list
138485098|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138485099|NCT00008359|Caspofungin|caspofungin|mesh-list
138485100|NCT00008359|Amebicides|amebicides|mesh-ancestor
138485102|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485103|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485104|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485105|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
138485106|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485107|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485108|NCT00008398|Sargramostim|sargramostim|mesh-list
138485109|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
138485110|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485111|NCT00008476|Capsaicin|capsaicin|mesh-list
138485112|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
138485113|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
138485114|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
138485115|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485116|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485117|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138485118|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485120|NCT00008515|Hormones|hormones|mesh-ancestor
138485121|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485122|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485123|NCT00008554|Lamivudine|lamivudine|mesh-list
138485124|NCT00008554|Abacavir|abacavir|mesh-list
138485125|NCT00008554|Nelfinavir|nelfinavir|mesh-list
138485126|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
138485127|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485128|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485129|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485130|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485131|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
138485132|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485133|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485134|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485135|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138485136|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138485137|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
138485138|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
138485140|NCT05636566|Sevoflurane|sevoflurane|mesh-list
138485141|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138485142|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485143|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485144|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485145|NCT05636566|Analgesics|analgesics|mesh-ancestor
138485146|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
138485147|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485148|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138485149|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138485150|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138485151|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485152|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485153|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485154|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138485155|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
138485156|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
138485157|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138485158|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138485159|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138485160|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138485161|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485163|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138485164|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
138485165|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165028|NCT00506857|Fludarabine|fludarabine|mesh-list
138485166|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485167|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138485168|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138485169|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138485170|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138485171|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
138485172|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485173|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485174|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485176|NCT05637268|Cisplatin|cisplatin|mesh-list
138485177|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138485178|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485179|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
138485180|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
138485181|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
138485182|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485183|NCT05638984|Decitabine|decitabine|mesh-list
138485184|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138485185|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
138485186|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485187|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485188|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485189|NCT05639257|Mexiletine|mexiletine|mesh-list
138485190|NCT05639257|Lamotrigine|lamotrigine|mesh-list
138485191|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
138485192|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138485193|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485194|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485195|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485196|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485197|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138485198|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138485199|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485200|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485201|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138485202|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138301117|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485203|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138485204|NCT00000115|Acetazolamide|acetazolamide|mesh-list
138485205|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
138485206|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138485207|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485208|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485209|NCT00000115|Diuretics|diuretics|mesh-ancestor
138165049|NCT03597308|Acetaminophen|acetaminophen|mesh-list
138485210|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485211|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485212|NCT00000136|Ganciclovir|ganciclovir|mesh-list
138485213|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138485215|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
138485216|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485217|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485218|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485219|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485220|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485221|NCT00000139|Acyclovir|acyclovir|mesh-list
138485222|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
138485223|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485224|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138485225|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138485226|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485227|NCT00000142|Cidofovir|cidofovir|mesh-list
138485228|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
138485229|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485230|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485231|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485232|NCT00000145|Zinc|zinc|mesh-list
138301136|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
138301139|NCT00384631|Bevacizumab|bevacizumab|mesh-list
138485233|NCT00000145|Antioxidants|antioxidants|mesh-list
138485235|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
138485236|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485237|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485238|NCT00000145|Protective Agents|protective agents|mesh-ancestor
138485239|NCT00000151|Aspirin|aspirin|mesh-list
138485240|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138485241|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485242|NCT00000151|Analgesics|analgesics|mesh-ancestor
138485243|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
138485244|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485245|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485246|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485247|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138485248|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138485249|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138485250|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485251|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138485252|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138485253|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485254|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
138485255|NCT00000157|Aspirin|aspirin|mesh-list
138485256|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138485257|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485258|NCT00000157|Analgesics|analgesics|mesh-ancestor
138485259|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
138485260|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485261|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485262|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485263|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138485264|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138485265|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138485266|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485267|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138485268|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138485270|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
138485271|NCT00000172|Galantamine|galantamine|mesh-list
138485272|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138485273|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485274|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485275|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
138485276|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485277|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485278|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138301178|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
138485279|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
138485280|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485281|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
138485283|NCT00000175|Estrogens|estrogens|mesh-list
138485284|NCT00000175|Androgens|androgens|mesh-ancestor
138485285|NCT00000175|Hormones|hormones|mesh-ancestor
138485286|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485287|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485288|NCT00000187|Ritanserin|ritanserin|mesh-list
138485289|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138485290|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
138485291|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485292|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485293|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485295|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138485296|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485297|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485298|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138485299|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138485300|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485301|NCT00000205|Buprenorphine|buprenorphine|mesh-list
138485302|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138485303|NCT00000205|Narcotics|narcotics|mesh-ancestor
138485304|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485305|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485306|NCT00000205|Analgesics|analgesics|mesh-ancestor
138485307|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
138485308|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485309|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138485310|NCT00000214|Buprenorphine|buprenorphine|mesh-list
138485311|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138485312|NCT00000214|Narcotics|narcotics|mesh-ancestor
138165101|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
138485314|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485316|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
138485317|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485318|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138485319|NCT00000220|Buprenorphine|buprenorphine|mesh-list
138485320|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138485321|NCT00000220|Narcotics|narcotics|mesh-ancestor
138485322|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485323|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485324|NCT00000220|Analgesics|analgesics|mesh-ancestor
138485325|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
138485326|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485327|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138485328|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
138485329|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138485330|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
138485331|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
138485332|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485333|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485334|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485335|NCT00000256|Analgesics|analgesics|mesh-ancestor
138485336|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
138485337|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485338|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
138485339|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138485340|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
138485341|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485342|NCT00000421|Prednisone|prednisone|mesh-list
138485343|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485344|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
138485345|NCT00000421|Hormones|hormones|mesh-ancestor
138485346|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485347|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485348|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485349|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485350|NCT00000427|Alendronate|alendronate|mesh-list
138485351|NCT00000427|Hormones|hormones|mesh-list
138485352|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
138485353|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485354|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485355|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138485356|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485358|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138485359|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485360|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485361|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138485362|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138301249|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138485363|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485364|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485366|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485367|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485368|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138485369|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485370|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485372|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138485373|NCT00000463|Warfarin|warfarin|mesh-list
138485374|NCT00000463|Lovastatin|lovastatin|mesh-list
138485375|NCT00000463|L 647318|l 647318|mesh-list
138485376|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
138485377|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
138485378|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
138485379|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138485380|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138485381|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
138485382|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485383|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138485384|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138485385|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485386|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138485387|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
138485388|NCT00000466|Progesterone|progesterone|mesh-list
138485389|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138485390|NCT00000466|Estrogens|estrogens|mesh-list
138485391|NCT00000466|Progestins|progestins|mesh-ancestor
138485392|NCT00000466|Hormones|hormones|mesh-ancestor
138485393|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485394|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485395|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138485396|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138485397|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138485398|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
138485400|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138485401|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138485403|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485404|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485406|NCT00000472|Plasminogen|plasminogen|mesh-list
138301276|NCT00003151|Clarithromycin|clarithromycin|mesh-list
138301279|NCT00003151|Omeprazole|omeprazole|mesh-list
138485407|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138485408|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
138485409|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138485410|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138485411|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485412|NCT00000478|Atenolol|atenolol|mesh-list
138485413|NCT00000478|Diltiazem|diltiazem|mesh-list
138485414|NCT00000478|Nifedipine|nifedipine|mesh-list
138485415|NCT00000478|Isosorbide|isosorbide|mesh-list
138485416|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138485417|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138485418|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138485419|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485420|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485421|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485422|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485423|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485424|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
138485425|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138485426|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485427|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138485428|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
138485429|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
138485430|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485431|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138485432|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138485433|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138485434|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138161934|NCT00426517|Busulfan|busulfan|mesh-list
138485435|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485437|NCT00000478|Diuretics|diuretics|mesh-ancestor
138485438|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485439|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138485440|NCT00388999|Lectins|lectins|mesh-list
138485441|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
138485442|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
138485443|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485444|NCT00388999|Coagulants|coagulants|mesh-ancestor
138485445|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
138485447|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485448|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485449|NCT00000493|Propranolol|propranolol|mesh-list
138485450|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138165185|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138485451|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138485452|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485453|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485454|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485455|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485456|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485457|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138485458|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485459|NCT00000499|Metoprolol|metoprolol|mesh-list
138485460|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
138485461|NCT00000499|Hydralazine|hydralazine|mesh-list
138485462|NCT00000499|Reserpine|reserpine|mesh-list
138485463|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485464|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138485465|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
138485466|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
138485467|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485468|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485469|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138485470|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138485471|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138485472|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485473|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485474|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485476|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485477|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138485478|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485479|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485480|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138485481|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138485482|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485483|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485484|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138485485|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138485486|NCT00000514|Atenolol|atenolol|mesh-list
138485487|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
138485488|NCT00000514|Reserpine|reserpine|mesh-list
138485489|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485490|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138485491|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
138485492|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
138301348|NCT00003157|Gemcitabine|gemcitabine|mesh-list
138485493|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485494|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165212|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
138485495|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138485497|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138485498|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485499|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485500|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485502|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485503|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138485504|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485505|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138485506|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138162010|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
138485507|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485508|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485509|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138485510|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138485511|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138485512|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485513|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138485514|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485515|NCT00000517|Warfarin|warfarin|mesh-list
138485516|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
138485517|NCT00000520|Aspirin|aspirin|mesh-list
138485518|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
138485519|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138485520|NCT00000520|Antibodies|antibodies|mesh-list
138485521|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
138485522|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138485523|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138485524|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485525|NCT00000520|Analgesics|analgesics|mesh-ancestor
138485526|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
138485527|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485528|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485529|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485530|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138485531|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138485532|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138485533|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485534|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138485535|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138485537|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
138485538|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
138485539|NCT00000526|Flecainide|flecainide|mesh-list
138485540|NCT00000526|Moricizine|moricizine|mesh-list
138485541|NCT00000526|Encainide|encainide|mesh-list
138485542|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485543|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138165242|NCT00513799|Mupirocin|mupirocin|mesh-list
138485544|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138485545|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485546|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485548|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138485549|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
138485550|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485551|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485552|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485553|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485554|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138485555|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138485556|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138485558|NCT00000553|Simvastatin|simvastatin|mesh-list
138485559|NCT00000553|Antioxidants|antioxidants|mesh-list
138485560|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138485561|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138485562|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
138485563|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485564|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138485565|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138485566|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485567|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485568|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
138485569|NCT00000553|Vitamins|vitamins|mesh-ancestor
138485570|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
138485571|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485572|NCT00000553|Protective Agents|protective agents|mesh-ancestor
138485573|NCT00000556|Quinidine|quinidine|mesh-list
138485574|NCT00000556|Digoxin|digoxin|mesh-list
138485575|NCT00000556|Amiodarone|amiodarone|mesh-list
138485576|NCT00000556|Verapamil|verapamil|mesh-list
138485577|NCT00000556|Sotalol|sotalol|mesh-list
138485578|NCT00000556|Flecainide|flecainide|mesh-list
138485579|NCT00000556|Propafenone|propafenone|mesh-list
138485580|NCT00000556|Procainamide|procainamide|mesh-list
138485581|NCT00000556|Moricizine|moricizine|mesh-list
138485582|NCT00000556|Disopyramide|disopyramide|mesh-list
138485583|NCT00000556|Diltiazem|diltiazem|mesh-list
138485584|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138485585|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
138485586|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138485587|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138485588|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485589|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485590|NCT00000556|Protective Agents|protective agents|mesh-ancestor
138485591|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165286|NCT00216086|Irinotecan|irinotecan|mesh-list
138485593|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138485594|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485595|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138485596|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138485597|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485598|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138485599|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138485600|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138485601|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138485602|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138485603|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138485604|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138485605|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485607|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
138485608|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485609|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138485610|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138485611|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
138485612|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138485614|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485615|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138485616|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138485617|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
138301447|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
138485618|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138485619|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
138485620|NCT00000559|Hormones|hormones|mesh-list
138485621|NCT00000559|Estradiol|estradiol|mesh-list
138485622|NCT00000559|Estrogens|estrogens|mesh-list
138485623|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361174|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361175|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485624|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485625|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138485626|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
138485627|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138485628|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138485629|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138485630|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138361176|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138361177|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138361178|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138361180|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138361181|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138361182|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
138361183|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138361184|NCT00249288|Folic Acid|folic acid|mesh-list
138361186|NCT00249288|Hematinics|hematinics|mesh-ancestor
138361187|NCT00249288|Vitamins|vitamins|mesh-ancestor
138361188|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
138361189|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361191|NCT00247962|Etanercept|etanercept|mesh-list
138361192|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138361193|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361194|NCT00247962|Analgesics|analgesics|mesh-ancestor
138361195|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
138361196|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361197|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361198|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361199|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361200|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361201|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361203|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361204|NCT00247416|Dexamethasone|dexamethasone|mesh-list
138361205|NCT00247416|Carboplatin|carboplatin|mesh-list
138361206|NCT00247416|Gemcitabine|gemcitabine|mesh-list
138361207|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361208|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
138361209|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
138361210|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361211|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361212|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361213|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
138361215|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361216|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138361217|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361218|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361219|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
138361220|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361221|NCT00246012|Dacarbazine|dacarbazine|mesh-list
138361222|NCT00246012|Intetumumab|intetumumab|mesh-list
138361223|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138361224|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
138361225|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361226|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361227|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361228|NCT00245856|Dalteparin|dalteparin|mesh-list
138361229|NCT00245856|Tinzaparin|tinzaparin|mesh-list
138361230|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138361231|NCT00245856|Warfarin|warfarin|mesh-list
138361232|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
138361233|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138361234|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138361235|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361236|NCT00242580|Triamcinolone|triamcinolone|mesh-list
138361237|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138361238|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138485631|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138485632|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138485634|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485636|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138485637|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
138485638|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485639|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485640|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138485641|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
138485642|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138485643|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
138485644|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485645|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485646|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
138485647|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485648|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
138485649|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485650|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485651|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485652|NCT00000595|Deferoxamine|deferoxamine|mesh-list
138485653|NCT00000595|Siderophores|siderophores|mesh-ancestor
138301482|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301490|NCT00003187|Cytarabine|cytarabine|mesh-list
138485655|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
138485656|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
138485657|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485658|NCT00000601|Hormones|hormones|mesh-list
138485659|NCT00000601|Progesterone|progesterone|mesh-list
138485660|NCT00000601|Estrogens|estrogens|mesh-list
138485661|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485662|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485663|NCT00000601|Progestins|progestins|mesh-ancestor
138485664|NCT00000625|Zidovudine|zidovudine|mesh-list
138485665|NCT00000625|Didanosine|didanosine|mesh-list
138485666|NCT00000625|Zalcitabine|zalcitabine|mesh-list
138485667|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
138485668|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485669|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485670|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485671|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485672|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
138485673|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485674|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485675|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485676|NCT00000637|Zidovudine|zidovudine|mesh-list
138485677|NCT00000637|Didanosine|didanosine|mesh-list
138485678|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
138485679|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485680|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138165326|NCT04198844|Warfarin|warfarin|mesh-list
138485681|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485682|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485683|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
138485684|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485685|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485686|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485687|NCT00000640|Clindamycin|clindamycin|mesh-list
138485688|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
138485689|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
138485690|NCT00000640|Dapsone|dapsone|mesh-list
138485691|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138485692|NCT00000640|Primaquine|primaquine|mesh-list
138485693|NCT00000640|Trimethoprim|trimethoprim|mesh-list
138485694|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
138485695|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485696|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485697|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138485698|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485699|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485700|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
138485701|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138485702|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485703|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138485704|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138485705|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138485706|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138301520|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
138301524|NCT00003187|Hormones|hormones|mesh-ancestor
138485709|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
138485710|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138485711|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485712|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485713|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138485714|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138485715|NCT00000646|Protective Agents|protective agents|mesh-ancestor
138485716|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485717|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485718|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138485719|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
138485721|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138485722|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485723|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485724|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485725|NCT00389038|Analgesics|analgesics|mesh-ancestor
138485726|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
138485727|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485728|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165352|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138165378|NCT06069219|Dsuvia|dsuvia|mesh-list
138485730|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138485731|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485732|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485733|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485734|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485735|NCT00000652|Zidovudine|zidovudine|mesh-list
138485737|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
138485738|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485739|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485740|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485741|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485742|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
138485743|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485744|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485745|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485746|NCT00000676|Fluconazole|fluconazole|mesh-list
138485747|NCT00000676|Clotrimazole|clotrimazole|mesh-list
138485748|NCT00000676|Miconazole|miconazole|mesh-list
138485749|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
138485750|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301546|NCT00003781|Docetaxel|docetaxel|mesh-list
138485751|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138485752|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485753|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485754|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485755|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138485756|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
138485757|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138485758|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485759|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138485760|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138485761|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138485762|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138485763|NCT00000679|Zidovudine|zidovudine|mesh-list
138485764|NCT00000679|Zalcitabine|zalcitabine|mesh-list
138485765|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
138485766|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485767|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289154|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289155|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138289156|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289157|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
138289158|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289159|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138289160|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289161|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485768|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485769|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485770|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
138289221|NCT03679975|Protective Agents|protective agents|mesh-ancestor
138289222|NCT03887299|Disinfectants|disinfectants|mesh-list
138485772|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485773|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485774|NCT00000682|Zidovudine|zidovudine|mesh-list
138485775|NCT00000682|Zalcitabine|zalcitabine|mesh-list
138485776|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
138485777|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485778|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485779|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485780|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485781|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
138485782|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485783|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485785|NCT00000688|Ganciclovir|ganciclovir|mesh-list
138485786|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138485787|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
138485788|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485789|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485790|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485791|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485792|NCT00000712|Zidovudine|zidovudine|mesh-list
138485793|NCT00000712|Acyclovir|acyclovir|mesh-list
138485794|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
138485795|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485796|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485797|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485798|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485799|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
138485800|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485801|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485802|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485803|NCT00000715|Trimethoprim|trimethoprim|mesh-list
138289271|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289272|NCT02921906|Analgesics|analgesics|mesh-ancestor
138289273|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
138289276|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
138485804|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138485805|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
138485806|NCT00000715|Pentamidine|pentamidine|mesh-list
138485807|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138485808|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485809|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
138485810|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138485811|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485812|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138485813|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485814|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485815|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138485816|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138289416|NCT03714919|Analgesics|analgesics|mesh-ancestor
138289417|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
138289418|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485817|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485818|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
138485819|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138485820|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138301591|NCT00003799|Fluorouracil|fluorouracil|mesh-list
138485823|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
138485824|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485825|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485826|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485827|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289478|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485828|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
138485829|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485830|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485831|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485832|NCT00000739|Dapsone|dapsone|mesh-list
138485833|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485834|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
138485835|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138485836|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485837|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138485838|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289549|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138485839|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485840|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
138485841|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485842|NCT00000742|Zidovudine|zidovudine|mesh-list
138485843|NCT00000742|Didanosine|didanosine|mesh-list
138485844|NCT00000742|Atevirdine|atevirdine|mesh-list
138485845|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
138485846|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485847|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485848|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485849|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485850|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
138485852|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485853|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485854|NCT00000745|Vaccines|vaccines|mesh-list
138485855|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
138485856|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485857|NCT00000748|Trimethoprim|trimethoprim|mesh-list
138485858|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138289616|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485859|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
138485860|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138485861|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485862|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
138485863|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138485864|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138485865|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138485866|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165447|NCT06068439|Aspirin|aspirin|mesh-list
138289675|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
138289676|NCT00000950|Ethambutol|ethambutol|mesh-list
138485868|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138485869|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138485870|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485871|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485872|NCT00000751|Zidovudine|zidovudine|mesh-list
138485873|NCT00000751|Immune Sera|immune sera|mesh-list
138485874|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
138485875|NCT00000751|Antibodies|antibodies|mesh-list
138485876|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
138289744|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289745|NCT00000236|Narcotics|narcotics|mesh-ancestor
138289815|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138289816|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138289824|NCT00001016|Leucovorin|leucovorin|mesh-list
138485877|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289892|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138485878|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485879|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485880|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485881|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
138485882|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485883|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138301636|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485884|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485885|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
138485886|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485887|NCT00000754|Interferons|interferons|mesh-list
138485888|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
138485889|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
138485890|NCT00000754|Zidovudine|zidovudine|mesh-list
138485891|NCT00000754|Zalcitabine|zalcitabine|mesh-list
138485892|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485893|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
138485894|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485896|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485897|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
138485898|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485899|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485900|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289893|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138485901|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485902|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289894|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485903|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485905|NCT00000760|Didanosine|didanosine|mesh-list
138485906|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
138485907|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485908|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138485909|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485911|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
138485912|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485913|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485914|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138485915|NCT00000790|Thalidomide|thalidomide|mesh-list
138485916|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138485917|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
138289936|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289937|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
138289938|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485918|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485919|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
138485920|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485921|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485922|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138485923|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138485924|NCT00000790|Growth Substances|growth substances|mesh-ancestor
138290003|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
138290011|NCT00000308|Amphetamine|amphetamine|mesh-list
138485925|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138485926|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485927|NCT00000793|Mexiletine|mexiletine|mesh-list
138485928|NCT00000793|Amitriptyline|amitriptyline|mesh-list
138485929|NCT00000793|Benztropine|benztropine|mesh-list
138485930|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138485931|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485932|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485933|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485935|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
138485936|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485937|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290075|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
138290076|NCT00001082|Adefovir|adefovir|mesh-list
138290084|NCT00002006|Zidovudine|zidovudine|mesh-list
138290136|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
138290214|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290216|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485938|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138485939|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138485940|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485941|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485942|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485943|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485944|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138290294|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138290295|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290298|NCT00002042|Hematinics|hematinics|mesh-ancestor
138485945|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138290364|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485946|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138485947|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138485948|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138485949|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
138485950|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
138485951|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138485952|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138485953|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
138485954|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138485955|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
138485957|NCT00000799|Probenecid|probenecid|mesh-list
138485958|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
138485959|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
138485960|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138485962|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485963|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485964|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485965|NCT00000817|Amitriptyline|amitriptyline|mesh-list
138485966|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138485967|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485968|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485969|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138485970|NCT00000817|Analgesics|analgesics|mesh-ancestor
138485971|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
138485972|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485973|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485974|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138485975|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138485976|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485977|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485978|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
138485979|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138485980|NCT00000820|Aldesleukin|aldesleukin|mesh-list
138485981|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485982|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138485983|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290428|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290429|NCT03782233|Bromides|bromides|mesh-list
138290430|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138485984|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
138485985|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485986|NCT00000826|Clarithromycin|clarithromycin|mesh-list
138485988|NCT00000826|Rifabutin|rifabutin|mesh-list
138301683|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
138485989|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138485991|NCT00000826|Trimethoprim|trimethoprim|mesh-list
138290479|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
138290480|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485992|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
138290484|NCT00381134|Losartan|losartan|mesh-list
138485993|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485994|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138485995|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138485996|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485997|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485998|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138485999|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486000|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
138290547|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486001|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138165545|NCT05940545|Ribavirin|ribavirin|mesh-list
138486002|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138486003|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
138486004|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486005|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486006|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138486007|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138486008|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138290614|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
138290615|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486009|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
138486010|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138486011|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138486012|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138486013|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138486014|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138486015|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
138486016|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138290678|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486017|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486018|NCT00000859|Ritonavir|ritonavir|mesh-list
138486019|NCT00000859|Nelfinavir|nelfinavir|mesh-list
138486020|NCT00000859|Indinavir|indinavir|mesh-list
138486021|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486022|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486023|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486024|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486025|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486026|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486027|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486028|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
138486029|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486030|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486031|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486032|NCT00000877|Indinavir|indinavir|mesh-list
138486033|NCT00000877|Rifabutin|rifabutin|mesh-list
138486034|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138290750|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138486035|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486037|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486038|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486039|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486040|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486041|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
138486043|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486044|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138486045|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486046|NCT00000883|Azithromycin|azithromycin|mesh-list
138486047|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290893|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290894|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290895|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486048|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486049|NCT00000892|Ritonavir|ritonavir|mesh-list
138486050|NCT00000892|Nelfinavir|nelfinavir|mesh-list
138486051|NCT00000892|Saquinavir|saquinavir|mesh-list
138486052|NCT00000892|Delavirdine|delavirdine|mesh-list
138486053|NCT00000892|Adefovir|adefovir|mesh-list
138486054|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138486055|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486056|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486057|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486058|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290958|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291024|NCT00002300|Megestrol|megestrol|mesh-list
138290103|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
138290104|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290105|NCT00002012|Interferons|interferons|mesh-list
138291117|NCT04714177|Edaravone|edaravone|mesh-list
138291174|NCT03740659|Levofloxacin|levofloxacin|mesh-list
138291175|NCT03740659|Ofloxacin|ofloxacin|mesh-list
138291176|NCT03740659|Dexamethasone|dexamethasone|mesh-list
138291178|NCT03740659|BB 1101|bb 1101|mesh-list
138486059|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486060|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486061|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486062|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
138486063|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486064|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486065|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486066|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486067|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291249|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486068|NCT00000895|Azithromycin|azithromycin|mesh-list
138486069|NCT00000895|Nevirapine|nevirapine|mesh-list
138486070|NCT00000895|Nelfinavir|nelfinavir|mesh-list
138486071|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486072|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486073|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486074|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486076|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486077|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
138291383|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
138486078|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486079|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486080|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486081|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486082|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486083|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486084|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486085|NCT00000898|Ritonavir|ritonavir|mesh-list
138301725|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301726|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138486086|NCT00000898|Nelfinavir|nelfinavir|mesh-list
138486088|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486089|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486090|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291464|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291529|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486091|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486092|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486093|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486094|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486095|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
138486096|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486097|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486098|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291530|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291531|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291532|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
138291615|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486099|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
138486100|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138291695|NCT00002456|Cyclosporins|cyclosporins|mesh-list
138486101|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
138486102|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486103|NCT00389233|Protective Agents|protective agents|mesh-ancestor
138486104|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486106|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
138486107|NCT00389233|Laxatives|laxatives|mesh-ancestor
138486108|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138486109|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
138486110|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138486111|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
138486112|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486113|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138486114|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486115|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
138486116|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486117|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
138486118|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138486119|NCT00000904|Protective Agents|protective agents|mesh-ancestor
138486120|NCT00000919|Ritonavir|ritonavir|mesh-list
138486121|NCT00000919|Nelfinavir|nelfinavir|mesh-list
138291702|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291703|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291705|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291706|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138291707|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291708|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
138486122|NCT00000919|Indinavir|indinavir|mesh-list
138486123|NCT00000919|Amprenavir|amprenavir|mesh-list
138291709|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486124|NCT00000919|Lamivudine|lamivudine|mesh-list
138486125|NCT00000919|Zidovudine|zidovudine|mesh-list
138486126|NCT00000919|Abacavir|abacavir|mesh-list
138486127|NCT00000919|Didanosine|didanosine|mesh-list
138486128|NCT00000919|Stavudine|stavudine|mesh-list
138486129|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138486130|NCT00000919|Efavirenz|efavirenz|mesh-list
138486131|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
138486132|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486133|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486134|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486135|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301750|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138291753|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138486136|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486137|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486138|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291830|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486139|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
138486140|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486141|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486143|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486144|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486146|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138290106|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
138486147|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138486148|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138486149|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486150|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486152|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
138486153|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138486154|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486155|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486156|NCT00000922|Lamivudine|lamivudine|mesh-list
138486159|NCT00000922|Abacavir|abacavir|mesh-list
138486160|NCT00000922|Didanosine|didanosine|mesh-list
138291899|NCT02341495|Vitamin D|vitamin d|mesh-list
138291900|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
138291901|NCT02341495|Azacitidine|azacitidine|mesh-list
138291902|NCT02341495|Deferasirox|deferasirox|mesh-list
138291903|NCT02341495|Vitamins|vitamins|mesh-ancestor
138291904|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
138486161|NCT00000922|Stavudine|stavudine|mesh-list
138291912|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138291916|NCT00002534|Cytarabine|cytarabine|mesh-list
138291974|NCT00002552|Cytarabine|cytarabine|mesh-list
138486162|NCT00000922|Nelfinavir|nelfinavir|mesh-list
138486163|NCT00000922|Indinavir|indinavir|mesh-list
138486164|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486165|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486166|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486167|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486168|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
138486169|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486170|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138292158|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138292250|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486171|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486172|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138486173|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486174|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138486175|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138486176|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486177|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486178|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486179|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486180|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486181|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
138486183|NCT00000940|Amprenavir|amprenavir|mesh-list
138486184|NCT00000940|Lamivudine|lamivudine|mesh-list
138292256|NCT00002630|Trace Elements|trace elements|mesh-ancestor
138486185|NCT00000940|Abacavir|abacavir|mesh-list
138486186|NCT00000940|Stavudine|stavudine|mesh-list
138486187|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486188|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486189|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486190|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486191|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486192|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486193|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486194|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
138486195|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486196|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486198|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486199|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486201|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138486202|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486203|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486204|NCT00000943|Vaccines|vaccines|mesh-list
138486205|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
138486206|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486207|NCT00000952|Ritonavir|ritonavir|mesh-list
138486208|NCT00000952|Lamivudine|lamivudine|mesh-list
138486209|NCT00000952|Zidovudine|zidovudine|mesh-list
138486210|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486211|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486212|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
138301775|NCT00003835|Fluorouracil|fluorouracil|mesh-list
138486214|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486215|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486216|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486217|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
138486218|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486219|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486220|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486221|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486222|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486223|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
138486225|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
138486226|NCT00000643|Calcium|calcium|mesh-list
138486227|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
138486228|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138486229|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486230|NCT00000643|Antidotes|antidotes|mesh-ancestor
138486231|NCT00000643|Protective Agents|protective agents|mesh-ancestor
138486232|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
138486233|NCT00000643|Vitamins|vitamins|mesh-ancestor
138486234|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
138486235|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
138486236|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138486237|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138486238|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292399|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292402|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138486239|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138165691|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138486240|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486241|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486243|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138486244|NCT00000970|Foscarnet|foscarnet|mesh-list
138486245|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138486246|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
138486247|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292432|NCT01303003|Dexamethasone|dexamethasone|mesh-list
138486248|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486249|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486251|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486252|NCT00000973|Leucovorin|leucovorin|mesh-list
138486253|NCT00000973|Zidovudine|zidovudine|mesh-list
138486254|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
138486255|NCT00000973|Calcium|calcium|mesh-list
138486256|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
138486257|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138486258|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486259|NCT00000973|Antidotes|antidotes|mesh-ancestor
138486260|NCT00000973|Protective Agents|protective agents|mesh-ancestor
138486261|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
138486262|NCT00000973|Vitamins|vitamins|mesh-ancestor
138292503|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138486263|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
138301784|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486264|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
138486265|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486266|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486267|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486268|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486269|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
138486270|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486271|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486272|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486273|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
138486276|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138486278|NCT00000985|Foscarnet|foscarnet|mesh-list
138486279|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138486280|NCT00000985|Vidarabine|vidarabine|mesh-list
138486281|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
138486282|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486283|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138292572|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292573|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292574|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292575|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138486284|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486285|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486286|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486287|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
138486288|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138486290|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486292|NCT00001003|Pentamidine|pentamidine|mesh-list
138486293|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
138486294|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486295|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486296|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486297|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486298|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
138486299|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486300|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486301|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486302|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
138486303|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138486304|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138486305|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138486306|NCT00001030|Clarithromycin|clarithromycin|mesh-list
138486307|NCT00001030|Rifabutin|rifabutin|mesh-list
138486308|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138292735|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292736|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
138486309|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292737|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486310|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138486311|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486312|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486313|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486314|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486315|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138486316|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486317|NCT05639127|Prednisolone|prednisolone|mesh-list
138486318|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486319|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
138486320|NCT05639127|Hormones|hormones|mesh-ancestor
138486322|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486323|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486324|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486325|NCT00001033|Pyridoxine|pyridoxine|mesh-list
138486326|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
138486327|NCT00001033|Levofloxacin|levofloxacin|mesh-list
138486328|NCT00001033|Rifampin|rifampin|mesh-list
138292795|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
138292799|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
138486329|NCT00001033|Isoniazid|isoniazid|mesh-list
138292952|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
138486330|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
138486331|NCT00001033|Ethambutol|ethambutol|mesh-list
138486332|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138486333|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486334|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486335|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138486336|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292958|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
138486337|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292959|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292960|NCT04403516|Dexamethasone|dexamethasone|mesh-list
138292961|NCT04403516|Prednisolone|prednisolone|mesh-list
138292962|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138293031|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138486338|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293114|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
138486339|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486340|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138486341|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486342|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138486343|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
138486344|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
138293115|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293116|NCT00382538|Mifepristone|mifepristone|mesh-list
138486345|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486346|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138703941|NCT06225466|Rocuronium|rocuronium|mesh-list
138486347|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486348|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138486349|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138486350|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138486351|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486352|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138486354|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
138486355|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138486356|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
138486357|NCT00001033|Vitamins|vitamins|mesh-ancestor
138486358|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
138486359|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486360|NCT00001036|Zidovudine|zidovudine|mesh-list
138486361|NCT00001036|Interleukin-2|interleukin-2|mesh-list
138486362|NCT00001036|Thymalfasin|thymalfasin|mesh-list
138486363|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486364|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486366|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
138486367|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486368|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293190|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293191|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486370|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486371|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486372|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486373|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486374|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
138486375|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486376|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486377|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486378|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138486379|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
138486380|NCT00001045|Zidovudine|zidovudine|mesh-list
138486381|NCT00001045|Nevirapine|nevirapine|mesh-list
138486382|NCT00001045|Didanosine|didanosine|mesh-list
138486383|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
138486384|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486385|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486386|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293252|NCT00476827|Growth Substances|growth substances|mesh-ancestor
138486387|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293330|NCT00279409|Aripiprazole|aripiprazole|mesh-list
138486388|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
138486389|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486390|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486391|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486392|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486393|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486394|NCT00001048|Cytarabine|cytarabine|mesh-list
138486395|NCT00001048|Zidovudine|zidovudine|mesh-list
138486396|NCT00001048|Didanosine|didanosine|mesh-list
138486397|NCT00001048|Zalcitabine|zalcitabine|mesh-list
138486398|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486399|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
138486400|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486401|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486402|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
138486403|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486404|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486405|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
138486406|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486407|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486408|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138301867|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486410|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486411|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486412|NCT00001066|Lamivudine|lamivudine|mesh-list
138486413|NCT00001066|Zidovudine|zidovudine|mesh-list
138486414|NCT00001066|Didanosine|didanosine|mesh-list
138486415|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486416|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486417|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486418|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486419|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
138486420|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486421|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486422|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138162905|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
138486423|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
138486425|NCT00001075|Lamivudine|lamivudine|mesh-list
138486426|NCT00001075|Zidovudine|zidovudine|mesh-list
138486427|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486428|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486430|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486431|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486432|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486433|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486434|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
138486435|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486436|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486437|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486438|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138301892|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486439|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486440|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
138486442|NCT00001084|Zidovudine|zidovudine|mesh-list
138486443|NCT00001084|Stavudine|stavudine|mesh-list
138486444|NCT00001084|Indinavir|indinavir|mesh-list
138486445|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486446|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486447|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486448|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293398|NCT00019747|Growth Substances|growth substances|mesh-ancestor
138293399|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293400|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293401|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
138486449|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
138486450|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486451|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486452|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486453|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
138486454|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486455|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486456|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486457|NCT00001087|Ritonavir|ritonavir|mesh-list
138486458|NCT00001087|Nelfinavir|nelfinavir|mesh-list
138486459|NCT00001087|Saquinavir|saquinavir|mesh-list
138486460|NCT00001087|Lamivudine|lamivudine|mesh-list
138486461|NCT00001087|Zidovudine|zidovudine|mesh-list
138486462|NCT00001087|Didanosine|didanosine|mesh-list
138486463|NCT00001087|Stavudine|stavudine|mesh-list
138486464|NCT00001087|Zalcitabine|zalcitabine|mesh-list
138486465|NCT00001087|Efavirenz|efavirenz|mesh-list
138486466|NCT00001087|Adefovir|adefovir|mesh-list
138486467|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138486468|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138486469|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138486470|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486471|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486472|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486473|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138293490|NCT00728845|Paclitaxel|paclitaxel|mesh-list
138293571|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
138486474|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486475|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
138486476|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486477|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486478|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486479|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486480|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486481|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
138293572|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293574|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138486482|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138486483|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138486484|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138486485|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486486|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486488|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138486489|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
138486490|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486491|NCT00001111|Zidovudine|zidovudine|mesh-list
138486492|NCT00001111|Nevirapine|nevirapine|mesh-list
138486493|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
138486494|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486495|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486496|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486497|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486498|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
138486499|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486500|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486502|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138486503|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138486504|NCT00001114|Interferons|interferons|mesh-list
138486505|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
138293801|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
138293802|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293804|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138293805|NCT00000301|Amantadine|amantadine|mesh-list
138293806|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138293807|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138293808|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
138293809|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293810|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
138486506|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
138486508|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486509|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
138486510|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486511|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
138486512|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486513|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
138486514|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486515|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486516|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486517|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486518|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486519|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486520|NCT00001165|Doxorubicin|doxorubicin|mesh-list
138486521|NCT00001165|Streptozocin|streptozocin|mesh-list
138486522|NCT00001165|Fluorouracil|fluorouracil|mesh-list
138486523|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138486524|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486525|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138293854|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138293855|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293856|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
138293857|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138293860|NCT03521102|Acetaminophen|acetaminophen|mesh-list
138293908|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138293909|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293910|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293911|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138293912|NCT00000337|Protective Agents|protective agents|mesh-ancestor
138293913|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293914|NCT00000781|Zidovudine|zidovudine|mesh-list
138293915|NCT00000781|Nevirapine|nevirapine|mesh-list
138293978|NCT00000811|Azithromycin|azithromycin|mesh-list
138293979|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138293980|NCT00000811|Trimethoprim|trimethoprim|mesh-list
138293981|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
138293982|NCT00000811|Atovaquone|atovaquone|mesh-list
138293983|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138293984|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293985|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138486526|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138486527|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486528|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486529|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
138486530|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486531|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486532|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
138486533|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486534|NCT00001180|Hormones|hormones|mesh-list
138486535|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138486536|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138294122|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294123|NCT00002912|Analgesics|analgesics|mesh-ancestor
138294124|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
138486537|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486538|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486539|NCT00389272|Acetaminophen|acetaminophen|mesh-list
138294125|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294126|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294127|NCT04183790|Ivacaftor|ivacaftor|mesh-list
138294128|NCT04183790|Elexacaftor|elexacaftor|mesh-list
138294129|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138294130|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294131|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294133|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138294134|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138294135|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294180|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138294181|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294182|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138294183|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138294185|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
138294254|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138486540|NCT00389272|Ibuprofen|ibuprofen|mesh-list
138486541|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486542|NCT00389272|Analgesics|analgesics|mesh-ancestor
138486543|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
138486544|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486545|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486546|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
138486547|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138294257|NCT00000577|Colchicine|colchicine|mesh-list
138486548|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486549|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486550|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138486551|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486552|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486553|NCT00389311|Nonoxynol|nonoxynol|mesh-list
138486554|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138486555|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138486556|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486557|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138294322|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294323|NCT00000949|Aldesleukin|aldesleukin|mesh-list
138294324|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294325|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294326|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294327|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
138294328|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294329|NCT00002936|Etoposide|etoposide|mesh-list
138294330|NCT00002936|Altretamine|altretamine|mesh-list
138294331|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294332|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301951|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138486558|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
138486559|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138486560|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138486566|NCT00000114|Vitamin A|vitamin a|mesh-list
138486567|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
138486568|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486569|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
138486570|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486571|NCT00000114|Protective Agents|protective agents|mesh-ancestor
138486572|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
138486573|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138486574|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138294379|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486575|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
138294380|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138294381|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138294382|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294383|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294385|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138294386|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138294387|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294388|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486576|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486577|NCT00001267|Zidovudine|zidovudine|mesh-list
138486578|NCT00001267|Didanosine|didanosine|mesh-list
138486579|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
138486580|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486581|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486582|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486583|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486584|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
138486585|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486586|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486590|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
138294435|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294436|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
138294437|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294438|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486591|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486592|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486594|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
138486595|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138486596|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
138294498|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294500|NCT00002984|Fluorouracil|fluorouracil|mesh-list
138294502|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486597|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486598|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486599|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138486601|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
138486603|NCT00000120|Erythromycin|erythromycin|mesh-list
138486604|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
138486605|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138486606|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
138486607|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
138486608|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138486609|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486610|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138486611|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138486612|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486613|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486614|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138486616|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138486617|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138486618|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486619|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486621|NCT00001378|Fenretinide|fenretinide|mesh-list
138486622|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294566|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486623|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138294567|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138294568|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138294569|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138294570|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138294572|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138294573|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
138294574|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138486624|NCT00001378|Protective Agents|protective agents|mesh-ancestor
138486625|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486626|NCT00001387|Paclitaxel|paclitaxel|mesh-list
138486627|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138486628|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486629|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
138486630|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
138486631|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294618|NCT00000727|Zidovudine|zidovudine|mesh-list
138486632|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486633|NCT00388557|Ketoconazole|ketoconazole|mesh-list
138486634|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
138486635|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486636|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138486637|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486638|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294687|NCT00001063|Zidovudine|zidovudine|mesh-list
138294688|NCT00001063|Didanosine|didanosine|mesh-list
138294689|NCT00001063|Stavudine|stavudine|mesh-list
138294690|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
138294691|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294692|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294694|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294750|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294751|NCT00002323|Zidovudine|zidovudine|mesh-list
138294752|NCT00002323|Nevirapine|nevirapine|mesh-list
138294754|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294755|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294756|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294825|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138486639|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486641|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138486642|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486643|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486644|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138486645|NCT00388635|Prednisone|prednisone|mesh-list
138486646|NCT00388635|Melphalan|melphalan|mesh-list
138486647|NCT00388635|Bortezomib|bortezomib|mesh-list
138486648|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486649|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
138486651|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486652|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486653|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486654|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486655|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138486656|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
138294826|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294827|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294828|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294829|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138486657|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486658|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138486659|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486660|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
138486662|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486663|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486664|NCT00001474|Analgesics|analgesics|mesh-ancestor
138486665|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
138486666|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294877|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294879|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138294880|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
138294881|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138294882|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
138486667|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486668|NCT00001483|Sertraline|sertraline|mesh-list
138486669|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138486670|NCT00001483|Bupropion|bupropion|mesh-list
138294883|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294884|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294885|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138294886|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
138294887|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
138294930|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138294931|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294932|NCT00001999|Ganciclovir|ganciclovir|mesh-list
138294935|NCT00001999|Antibodies|antibodies|mesh-list
138486671|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
138486672|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138486673|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138486674|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138301983|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
138301984|NCT00003913|Hormones|hormones|mesh-ancestor
138301986|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138486675|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138295005|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138295006|NCT00002035|Zidovudine|zidovudine|mesh-list
138295007|NCT00002035|Didanosine|didanosine|mesh-list
138295008|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
138295009|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295010|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486676|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486677|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486679|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486680|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138486681|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138486682|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138486683|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
138486684|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138486685|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295072|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
138295073|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295074|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295075|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486686|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486688|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138486689|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138486690|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486691|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486692|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486693|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138486694|NCT00001507|Antibodies|antibodies|mesh-list
138295136|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295137|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295138|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295139|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295140|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295141|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295142|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295143|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
138295144|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486695|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
138486696|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138486697|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
138486698|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486699|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486700|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
138486701|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486702|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
138486703|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486705|NCT00001576|Melphalan|melphalan|mesh-list
138486707|NCT00001576|Antidotes|antidotes|mesh-ancestor
138486708|NCT00001576|Protective Agents|protective agents|mesh-ancestor
138486709|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486710|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
138486711|NCT00001576|Vitamins|vitamins|mesh-ancestor
138486712|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
138486713|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138486714|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
138486715|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486716|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486717|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138486718|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486719|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
138486720|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486721|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
138163207|NCT04561180|Dexamethasone|dexamethasone|mesh-list
138486723|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
138486724|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138486725|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138486727|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
138486730|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486731|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
138486732|NCT00000147|Hormones|hormones|mesh-ancestor
138302010|NCT00003925|Antidotes|antidotes|mesh-ancestor
138302013|NCT00003925|Vitamins|vitamins|mesh-ancestor
138295193|NCT00002107|Aldesleukin|aldesleukin|mesh-list
138486733|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486734|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295194|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295195|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295196|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295198|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295199|NCT00002113|Fluconazole|fluconazole|mesh-list
138486735|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486736|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486737|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
138486738|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
138486739|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486740|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138486741|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138486742|NCT00000147|Protective Agents|protective agents|mesh-ancestor
138486743|NCT00001624|Insulin|insulin|mesh-list
138486744|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138486745|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486746|NCT00001666|Methamphetamine|methamphetamine|mesh-list
138486747|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138295228|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295229|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295230|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
138295231|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295232|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295233|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295234|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295235|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295236|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295237|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
138295238|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138295239|NCT00001561|Antibodies|antibodies|mesh-list
138295240|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138295241|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
138295242|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295244|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295245|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138486748|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486749|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
138486751|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486752|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
138486753|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486754|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486755|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
138486756|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138295278|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295279|NCT00002131|Vesnarinone|vesnarinone|mesh-list
138295280|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138295281|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
138295282|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295283|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295293|NCT00380887|Hormones|hormones|mesh-ancestor
138486757|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138486758|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486759|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138486761|NCT00001669|Growth Substances|growth substances|mesh-ancestor
138486762|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486763|NCT00001693|Celecoxib|celecoxib|mesh-list
138486764|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138486765|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486766|NCT00001693|Analgesics|analgesics|mesh-ancestor
138486767|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
138486768|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486769|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486770|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486771|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486772|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138302033|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486774|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295411|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
138295412|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138486778|NCT00001696|Protective Agents|protective agents|mesh-ancestor
138295413|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295414|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138295415|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138295417|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295419|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138295420|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
138295421|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295422|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138486779|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486780|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486781|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138486782|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486783|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486784|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
138486785|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138486786|NCT00001696|Estrogens|estrogens|mesh-ancestor
138486787|NCT00001696|Hormones|hormones|mesh-ancestor
138295472|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138295536|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295537|NCT00383396|Cyclosporine|cyclosporine|mesh-list
138295540|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295541|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295542|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
138295543|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295544|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
138295607|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295608|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295609|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295610|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295611|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
138295612|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295614|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295616|NCT01568918|Tamsulosin|tamsulosin|mesh-list
138295617|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138486788|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486789|NCT00389428|Cytarabine|cytarabine|mesh-list
138486790|NCT00389428|Daunorubicin|daunorubicin|mesh-list
138486791|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486792|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
138486793|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486794|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486795|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
138486796|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486797|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486798|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
138486799|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295673|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295674|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
138295675|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295676|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
138295677|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
138295678|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138295679|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138295680|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138295681|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138295682|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
138295683|NCT00002509|Carboplatin|carboplatin|mesh-list
138295684|NCT00002509|Etoposide|etoposide|mesh-list
138295724|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295725|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295726|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295728|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295729|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295730|NCT00002215|Nelfinavir|nelfinavir|mesh-list
138295731|NCT00002215|Emivirine|emivirine|mesh-list
138295737|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295797|NCT00002527|Aspirin|aspirin|mesh-list
138295798|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138295799|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138295800|NCT00002527|Analgesics|analgesics|mesh-ancestor
138295801|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
138295802|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295803|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295804|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138295805|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295806|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138295807|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138486800|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295864|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138486801|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138486802|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138486803|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486804|NCT00001720|Alendronate|alendronate|mesh-list
138486805|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138486806|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486808|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486809|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486810|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138486811|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138295865|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295866|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138295867|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138295868|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138295869|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138295876|NCT00383474|Tipifarnib|tipifarnib|mesh-list
138486813|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
138486814|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486815|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
138486816|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486817|NCT00001741|Losartan|losartan|mesh-list
138486818|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138486819|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138486820|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138486821|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138295921|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138295922|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138295923|NCT05751733|Sunitinib|sunitinib|mesh-list
138295924|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
138302070|NCT00004855|Ritonavir|ritonavir|mesh-list
138486822|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486823|NCT00001777|Sertraline|sertraline|mesh-list
138486824|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
138486825|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138486826|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138486827|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138486828|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486829|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486833|NCT00000171|Melatonin|melatonin|mesh-list
138486834|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
138486835|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486836|NCT00000171|Protective Agents|protective agents|mesh-ancestor
138486837|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486838|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486839|NCT05641636|Hormones|hormones|mesh-list
138486840|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295986|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295987|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295988|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138295989|NCT00002798|Analgesics|analgesics|mesh-ancestor
138295990|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
138295993|NCT00002251|Ganciclovir|ganciclovir|mesh-list
138486841|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486843|NCT00000177|Hormones|hormones|mesh-ancestor
138486844|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486845|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486846|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
138486847|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138486848|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486849|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138486850|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486851|NCT00000216|Buprenorphine|buprenorphine|mesh-list
138486852|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138486853|NCT00000216|Narcotics|narcotics|mesh-ancestor
138296108|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486854|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486855|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486856|NCT00000216|Analgesics|analgesics|mesh-ancestor
138486857|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
138486858|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486859|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138486860|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
138486861|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138486862|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
138486865|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486866|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486867|NCT00000252|Analgesics|analgesics|mesh-ancestor
138296109|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296110|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296111|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296112|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
138486868|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
138486869|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486870|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
138486871|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138486872|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486873|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296173|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
138486874|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138486875|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138486876|NCT05640817|Protective Agents|protective agents|mesh-ancestor
138486877|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486878|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
138486879|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138486880|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
138486881|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
138486882|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138486883|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
138486884|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
138486885|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486886|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486887|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486888|NCT00000255|Analgesics|analgesics|mesh-ancestor
138486889|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
138302099|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302100|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
138486890|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486892|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138486893|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
138486894|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
138296311|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296312|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
138486897|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138486898|NCT00000258|Analgesics|analgesics|mesh-ancestor
138486899|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
138486900|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486901|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
138486902|NCT00389506|Fludarabine|fludarabine|mesh-list
138486903|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
138486904|NCT00389506|Immunotoxins|immunotoxins|mesh-list
138486905|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486906|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
138486907|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486908|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486909|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138486910|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
138296380|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
138296381|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
138296382|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296383|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296384|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138296385|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
138486911|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486912|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486913|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138486914|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486915|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
138486916|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
138486917|NCT00389584|Irinotecan|irinotecan|mesh-list
138486918|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138486919|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296437|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296438|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138296439|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138296440|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
138296443|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296444|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138296445|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138296446|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138296447|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138296448|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138296449|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138296450|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
138296451|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296452|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296453|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
138296488|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296489|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296490|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
138296491|NCT00002858|Doxorubicin|doxorubicin|mesh-list
138296492|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296493|NCT00002858|Etoposide|etoposide|mesh-list
138486920|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486921|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486922|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486923|NCT00000324|Tryptophan|tryptophan|mesh-list
138486924|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138486925|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
138302108|NCT04074343|Irinotecan|irinotecan|mesh-list
138486927|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
138296558|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296559|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138296560|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296561|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138296562|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
138296563|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296564|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296565|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138296566|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138296569|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296571|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
138486928|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138486929|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486930|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486932|NCT05640427|Analgesics|analgesics|mesh-ancestor
138486933|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
138486934|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486935|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138486937|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138486938|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
138486939|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486940|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486941|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
138486942|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138486943|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
138486944|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703942|NCT06225466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138486945|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486946|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486947|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
138486948|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
138486949|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138486950|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486951|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486952|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
138296615|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
138296616|NCT00003194|Thiotepa|thiotepa|mesh-list
138296617|NCT00003194|Carboplatin|carboplatin|mesh-list
138296618|NCT00003194|Etoposide|etoposide|mesh-list
138296619|NCT00003194|Topotecan|topotecan|mesh-list
138296620|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296663|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296664|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296665|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296666|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296667|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296668|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
138296669|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296670|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296671|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
138296737|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296738|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296739|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
138296740|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296741|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296742|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296743|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486954|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486955|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486956|NCT00000375|Nortriptyline|nortriptyline|mesh-list
138486957|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138486958|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138486959|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486961|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138486962|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138302151|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
138486964|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486965|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
138486966|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486967|NCT03295747|Peppermint oil|peppermint oil|mesh-list
138486968|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
138486969|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
138486970|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486971|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486972|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138486973|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
138486974|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
138486975|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138486976|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
138486977|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138486978|NCT03575208|Interferons|interferons|mesh-list
138486979|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
138486980|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
138486981|NCT03575208|Antibodies|antibodies|mesh-list
138296883|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296884|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138486982|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
138296885|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296886|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
138296887|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296888|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296889|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296890|NCT00002635|Lenograstim|lenograstim|mesh-list
138296891|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296892|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
138296894|NCT00003242|Paclitaxel|paclitaxel|mesh-list
138486983|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138486984|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138486985|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486986|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
138486987|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486988|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
138486989|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486990|NCT03295552|Carboplatin|carboplatin|mesh-list
138486992|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486993|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138486994|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
138486995|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486996|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486997|NCT05629468|Azithromycin|azithromycin|mesh-list
138486998|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138486999|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487000|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487001|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
138487003|NCT00000378|Nortriptyline|nortriptyline|mesh-list
138487004|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
138487005|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487006|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138487007|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138487008|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487009|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296924|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
138296926|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296927|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
138296928|NCT00003248|Rituximab|rituximab|mesh-list
138296929|NCT00003248|Fludarabine|fludarabine|mesh-list
138296930|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
138296931|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138296932|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296933|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
138296934|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296935|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296937|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
138296964|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
138296965|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296966|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296967|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296968|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
138296969|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296970|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296971|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296972|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296973|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296974|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138296986|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
138487010|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487011|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
138487012|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487013|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138487014|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138487015|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487017|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138487018|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138302188|NCT00003331|Antidotes|antidotes|mesh-ancestor
138487019|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487020|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487022|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
138487023|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487026|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487027|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138487028|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487029|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487031|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138487032|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138487033|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487034|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138297097|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297102|NCT00002665|Antidotes|antidotes|mesh-ancestor
138487035|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
138487036|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
138487037|NCT00389701|Dexamethasone|dexamethasone|mesh-list
138487038|NCT00389701|Bortezomib|bortezomib|mesh-list
138487039|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487040|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
138487041|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
138487042|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487043|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487044|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138487045|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
138487046|NCT00389701|Hormones|hormones|mesh-ancestor
138487047|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487048|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138487051|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138487053|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138487054|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
138487055|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138487056|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487057|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138487058|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138487059|NCT00000426|Calcium|calcium|mesh-list
138487060|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138487061|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297304|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297305|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
138297306|NCT00003296|Doxorubicin|doxorubicin|mesh-list
138297307|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297308|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297309|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297310|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297368|NCT00003584|Estramustine|estramustine|mesh-list
138487062|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138487063|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487064|NCT00000456|Naltrexone|naltrexone|mesh-list
138487065|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138487066|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138487067|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487068|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
138487069|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487070|NCT05519683|Escitalopram|escitalopram|mesh-list
138487071|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138487072|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138487073|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487074|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487075|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487078|NCT05442268|Acetaminophen|acetaminophen|mesh-list
138487079|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138487080|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138487081|NCT05442268|Analgesics|analgesics|mesh-ancestor
138487082|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
138297369|NCT00003584|Vinorelbine|vinorelbine|mesh-list
138297370|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297371|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
138297372|NCT00003584|Hormones|hormones|mesh-ancestor
138297373|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297374|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297375|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297376|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297377|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297378|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297379|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297380|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138361239|NCT00242580|Verteporfin|verteporfin|mesh-list
138361240|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138361241|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361242|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
138361244|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361245|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361246|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361247|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
138361248|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361255|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138361256|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138361257|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138361258|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361259|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361260|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
138361261|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361262|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361263|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138361264|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361265|NCT03804840|Dronabinol|dronabinol|mesh-list
138361266|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
138361267|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361268|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361269|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361270|NCT03804840|Analgesics|analgesics|mesh-ancestor
138361271|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
138361272|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361273|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138487083|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487084|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487085|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
138487086|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138487087|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138487088|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487089|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487090|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487091|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
138487092|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487093|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
138487094|NCT05448820|Doxorubicin|doxorubicin|mesh-list
138487095|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138487096|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487097|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138487099|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487100|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487101|NCT00000468|Plasminogen|plasminogen|mesh-list
138487102|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138487103|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138487104|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138487105|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487106|NCT02972476|Fluticasone|fluticasone|mesh-list
138487108|NCT02972476|Budesonide|budesonide|mesh-list
138487109|NCT02972476|Bromides|bromides|mesh-list
138487112|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138487113|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487114|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138487115|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
138487116|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487117|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487118|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138487119|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487120|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
138487121|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138487122|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
138487124|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302241|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487125|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138487126|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138487127|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138487128|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487129|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487130|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487131|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
138487132|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
138487133|NCT02972320|Temozolomide|temozolomide|mesh-list
138487134|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138487135|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
138487136|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487137|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487138|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138487140|NCT05349838|Rilpivirine|rilpivirine|mesh-list
138487141|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
138487142|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138487143|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138487144|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487145|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487147|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487148|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
138487149|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487150|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487151|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487152|NCT05305456|Vitamins|vitamins|mesh-list
138487153|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
138487154|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
138487155|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487156|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
138487157|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487158|NCT05305456|Protective Agents|protective agents|mesh-ancestor
138487159|NCT00388986|Glyburide|glyburide|mesh-list
138487160|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138487161|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487162|NCT05233696|Paclitaxel|paclitaxel|mesh-list
138487163|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138487164|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
138487165|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138487166|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487167|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188469|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138487168|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138487169|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138487171|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138487172|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138487174|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138487175|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138487176|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487177|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487178|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487179|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487180|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487181|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138487182|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
138487183|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
138487184|NCT00000504|Flecainide|flecainide|mesh-list
138487185|NCT00000504|Moricizine|moricizine|mesh-list
138487186|NCT00000504|Encainide|encainide|mesh-list
138487187|NCT00000504|Imipramine|imipramine|mesh-list
138487188|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487189|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138487190|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138487191|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487192|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487193|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138487194|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
138487195|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487196|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138487197|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138487198|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487199|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487200|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487201|NCT00389935|Thalidomide|thalidomide|mesh-list
138487202|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138487203|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
138487204|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487205|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
138487206|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487207|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487208|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138487209|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138487210|NCT00389935|Growth Substances|growth substances|mesh-ancestor
138487211|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
138487212|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487213|NCT05116930|Atropine|atropine|mesh-list
138487214|NCT05116930|Neostigmine|neostigmine|mesh-list
138487215|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138487216|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487217|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138487218|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
138487219|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302281|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138487220|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487221|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138487222|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487223|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
138487224|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
138487225|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138487226|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138487227|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
138487228|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487229|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487230|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138487231|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487232|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138487233|NCT00423475|Goserelin|goserelin|mesh-list
138487234|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138487235|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487236|NCT00000516|Enalapril|enalapril|mesh-list
138487237|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138487238|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487239|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487240|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487241|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138487242|NCT00000522|Acebutolol|acebutolol|mesh-list
138487243|NCT00000522|Amlodipine|amlodipine|mesh-list
138487244|NCT00000522|Enalapril|enalapril|mesh-list
138487245|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
138487246|NCT00000522|Doxazosin|doxazosin|mesh-list
138487247|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138487248|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138487250|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487252|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487253|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
138487254|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138487255|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487256|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487258|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
138487259|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138487260|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138487261|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138487262|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138487263|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487264|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487265|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487266|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
138487267|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
138302306|NCT00004921|Melphalan|melphalan|mesh-list
138302308|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487268|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487269|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138487270|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138487271|NCT03126799|Bevacizumab|bevacizumab|mesh-list
138487272|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138487273|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138487274|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487275|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138487276|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138487277|NCT03126799|Growth Substances|growth substances|mesh-ancestor
138487278|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487279|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
138487280|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138487281|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487282|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487283|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138487284|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
138487285|NCT00000525|Triamterene|triamterene|mesh-list
138487286|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138487287|NCT00000525|Diuretics|diuretics|mesh-ancestor
138487288|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
138487289|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487290|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138487291|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487292|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487293|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138487294|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138487295|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138487296|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138487297|NCT05020483|Coagulants|coagulants|mesh-ancestor
138487299|NCT00000531|Sotalol|sotalol|mesh-list
138487300|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487301|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
138487302|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138487303|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487304|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302334|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487306|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138487307|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487308|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487309|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487310|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138487311|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138487312|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138487313|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138487314|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487315|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487316|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487318|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
138487319|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487320|NCT00000534|Calcium|calcium|mesh-list
138487321|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138487322|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487323|NCT04935814|Vasopressins|vasopressins|mesh-list
138487324|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
138487325|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
138487326|NCT04935814|Coagulants|coagulants|mesh-ancestor
138487327|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138487328|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138487329|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
138487330|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487331|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138487332|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138487333|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487334|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
138487335|NCT00000555|Vitamin E|vitamin e|mesh-list
138487336|NCT00000555|Hormones|hormones|mesh-list
138487337|NCT00000555|Progesterone|progesterone|mesh-list
138487338|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138487339|NCT00000555|Estrogens|estrogens|mesh-list
138487340|NCT00000555|Vitamins|vitamins|mesh-ancestor
138487341|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
138487342|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487346|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487347|NCT00000555|Protective Agents|protective agents|mesh-ancestor
138487348|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138487349|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138487350|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487352|NCT00000576|Beclomethasone|beclomethasone|mesh-list
138487353|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487354|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
138487355|NCT00000576|Hormones|hormones|mesh-ancestor
138487356|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487357|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487358|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138487359|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487361|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
138487362|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138487363|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138487364|NCT00000579|Prednisolone|prednisolone|mesh-list
138487365|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
138487366|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138487367|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
138487368|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487369|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
138487370|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
138487371|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487372|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487374|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
138487376|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487377|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138487378|NCT00000579|Protective Agents|protective agents|mesh-ancestor
138487379|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138487380|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487381|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
138487382|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487383|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138487384|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487385|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487386|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487387|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138487388|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
138487389|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138487391|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
138487392|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
138362344|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
138487393|NCT00000588|Vitamins|vitamins|mesh-ancestor
138487394|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
138487395|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487397|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
138487398|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487399|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138487400|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
138487401|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138487402|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138487403|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
138362346|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
138362347|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362348|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138362349|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138362350|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138362351|NCT03401502|Ranolazine|ranolazine|mesh-list
138362352|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138362353|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362354|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362356|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138362357|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
138362359|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362360|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362365|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362366|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
138362367|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138362368|NCT03401268|Antibodies|antibodies|mesh-list
138362369|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
138362370|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362371|NCT03400722|Clomiphene|clomiphene|mesh-list
138362372|NCT03400722|Hormones|hormones|mesh-list
138362375|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138362376|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138362377|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138362378|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
138362379|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362380|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138362381|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138362383|NCT03400254|Gedatolisib|gedatolisib|mesh-list
138362384|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
138362385|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138362386|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138362387|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362388|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362389|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362391|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362392|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
138362393|NCT03400020|Vitamins|vitamins|mesh-ancestor
138362394|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
138362397|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362399|NCT00012012|Amifostine|amifostine|mesh-list
138362400|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138362401|NCT00012012|Protective Agents|protective agents|mesh-ancestor
138362402|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362404|NCT02240160|Analgesics|analgesics|mesh-ancestor
138362405|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
138362406|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362407|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362408|NCT02240238|Gemcitabine|gemcitabine|mesh-list
138362410|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
138362411|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362412|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362413|NCT02241096|Lidocaine|lidocaine|mesh-list
138362414|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138362415|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
138362416|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362417|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362418|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
138362420|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138362422|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138487404|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487405|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138487406|NCT00390091|Abetimus|abetimus|mesh-list
138487407|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138487408|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
138487409|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487410|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138487411|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
138487412|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487413|NCT04650880|Vitamin D|vitamin d|mesh-list
138487414|NCT04650880|Vitamins|vitamins|mesh-ancestor
138487415|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
138487416|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487417|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138487418|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
138487419|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138487420|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
138487421|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487422|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487423|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138487424|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487426|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
138487427|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487428|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487429|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138487430|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
138487431|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
138487432|NCT04601077|Protective Agents|protective agents|mesh-ancestor
138487434|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487435|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
138487436|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138487437|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487438|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487439|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138487440|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138487441|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487442|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487443|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487444|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138487445|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138487446|NCT04547530|Vitamin D|vitamin d|mesh-list
138487447|NCT04547530|Vitamins|vitamins|mesh-ancestor
138487448|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
138487449|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487450|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138487452|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138487453|NCT00000612|Hormones|hormones|mesh-ancestor
138362827|NCT00558636|Carboplatin|carboplatin|mesh-list
138362828|NCT00558636|Sorafenib|sorafenib|mesh-list
138362829|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138362830|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362831|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138362832|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138362838|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362839|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
138362840|NCT00558558|Hormones|hormones|mesh-ancestor
138362841|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362842|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362843|NCT00557622|Paroxetine|paroxetine|mesh-list
138362844|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138362845|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138362846|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363093|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487454|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487455|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487456|NCT00000639|Itraconazole|itraconazole|mesh-list
138487457|NCT00000639|Fluconazole|fluconazole|mesh-list
138487458|NCT00000639|Amphotericin B|amphotericin b|mesh-list
138487459|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138487460|NCT00000639|Flucytosine|flucytosine|mesh-list
138487461|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
138487462|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487463|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138487464|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487466|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487467|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138487468|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
138487469|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487470|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487471|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138487472|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487473|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138487475|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138487476|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487477|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487478|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
138487479|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138487480|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
138487481|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487482|NCT00000645|Hypericin|hypericin|mesh-list
138487483|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138487484|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487485|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487486|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
138487487|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487488|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487489|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487493|NCT04495504|Ropivacaine|ropivacaine|mesh-list
138487494|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
138487495|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
138487496|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138487497|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487498|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
138487499|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487500|NCT00390208|Dexamethasone|dexamethasone|mesh-list
138487501|NCT00390208|Ranibizumab|ranibizumab|mesh-list
138487502|NCT00390208|Verteporfin|verteporfin|mesh-list
138487503|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487504|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
138487505|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
138487506|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487507|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487508|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138487509|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
138487510|NCT00390208|Hormones|hormones|mesh-ancestor
138487511|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487512|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138487513|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487514|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138487515|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138487516|NCT00390208|Growth Substances|growth substances|mesh-ancestor
138487517|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
138487518|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138487519|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
138302448|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487520|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138487521|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138487522|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138487523|NCT00389025|Analgesics|analgesics|mesh-ancestor
138487524|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
138487525|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487526|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487527|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487528|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138487529|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138487530|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138487532|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
138487533|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
138487534|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487535|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487536|NCT00390247|Thalidomide|thalidomide|mesh-list
138487537|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138487538|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
138487539|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487540|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
138487541|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487542|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487543|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138487544|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138487545|NCT00390247|Growth Substances|growth substances|mesh-ancestor
138487547|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487548|NCT00000651|Zidovudine|zidovudine|mesh-list
138487549|NCT00000651|Zalcitabine|zalcitabine|mesh-list
138487550|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
138487551|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487552|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487553|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487554|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487555|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
138487556|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487557|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487558|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487559|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
138487560|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
138487561|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138487562|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487563|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487564|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138487566|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487568|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
138487569|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487570|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487571|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487572|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362949|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138487573|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
138487574|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487575|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487576|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487577|NCT04321954|Lenvatinib|lenvatinib|mesh-list
138487578|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487579|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138487580|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487581|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487582|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138487583|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
138487584|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487585|NCT00000678|Zidovudine|zidovudine|mesh-list
138487586|NCT00000678|Zalcitabine|zalcitabine|mesh-list
138487587|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
138487588|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487589|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138362950|NCT00552708|Protective Agents|protective agents|mesh-ancestor
138362951|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362952|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138362960|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
138362967|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363006|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363008|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
138363011|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363012|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
138363013|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363014|NCT03839550|Apatinib|apatinib|mesh-list
138363015|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363016|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138363017|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363018|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363020|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138363021|NCT03839160|Narcotics|narcotics|mesh-ancestor
138363022|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363023|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363025|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
138363026|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363027|NCT03838926|Trichostatin A|trichostatin a|mesh-list
138363028|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
138363029|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363030|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138363035|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363041|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363047|NCT03830034|Iron|iron|mesh-list
138363048|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
138363049|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
138363050|NCT03830034|Trace Elements|trace elements|mesh-ancestor
138363051|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
138363056|NCT03838068|Anesthetics|anesthetics|mesh-list
138363057|NCT03838068|Procaine|procaine|mesh-list
138363058|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
138363059|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363060|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363061|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
138363062|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363063|NCT05440734|Melatonin|melatonin|mesh-list
138363064|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
138363065|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363066|NCT05440734|Protective Agents|protective agents|mesh-ancestor
138363067|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363068|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363069|NCT05447208|Hormones|hormones|mesh-list
138363070|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363071|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363072|NCT05444556|Repaglinide|repaglinide|mesh-list
138363073|NCT05444556|Quinidine|quinidine|mesh-list
138363074|NCT05444556|Digoxin|digoxin|mesh-list
138363075|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
138363076|NCT05444556|Omeprazole|omeprazole|mesh-list
138363077|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138363078|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138363079|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138487590|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487591|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487592|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
138487593|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487594|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487597|NCT00390403|Temozolomide|temozolomide|mesh-list
138487598|NCT00390403|Retinol acetate|retinol acetate|mesh-list
138487599|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
138487600|NCT00390403|Gossypol|gossypol|mesh-list
138487601|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138487602|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
138487603|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487604|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487605|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487606|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487607|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138487608|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
138487609|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487610|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138487611|NCT00390403|Protective Agents|protective agents|mesh-ancestor
138487612|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138487613|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
138487614|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138487615|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138487616|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138487617|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138487618|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138487619|NCT00000681|Zidovudine|zidovudine|mesh-list
138487620|NCT00000681|Doxorubicin|doxorubicin|mesh-list
138487621|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138487622|NCT00000681|Bleomycin|bleomycin|mesh-list
138487623|NCT00000681|Vincristine|vincristine|mesh-list
138487624|NCT00000681|Sargramostim|sargramostim|mesh-list
138487625|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138487626|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487627|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138487628|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138487629|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487630|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487631|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138487632|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
138487633|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
138487634|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
138487636|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487637|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487639|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302477|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
138487640|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487641|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487642|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
138487643|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487644|NCT00000684|Dextrans|dextrans|mesh-list
138487645|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
138487646|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
138487647|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
138487648|NCT00000687|Interferons|interferons|mesh-list
138487649|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
138487650|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
138487651|NCT00000687|Zidovudine|zidovudine|mesh-list
138487652|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487653|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
138487654|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487655|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
138487656|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487657|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
138487658|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487659|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487660|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487661|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487662|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487663|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487664|NCT00000690|Dextrans|dextrans|mesh-list
138487665|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
138487666|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
138487667|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
138487668|NCT00000696|Interferons|interferons|mesh-list
138487669|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
138487670|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
138487671|NCT00000696|Zidovudine|zidovudine|mesh-list
138487672|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487675|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
138487676|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487677|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
138487678|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487679|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487680|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487681|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487682|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487683|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487685|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
138487686|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487687|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487688|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487689|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487690|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
138487691|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487692|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487693|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487694|NCT00000708|Fluconazole|fluconazole|mesh-list
138487695|NCT00000708|Amphotericin B|amphotericin b|mesh-list
138487696|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138487697|NCT00000708|Flucytosine|flucytosine|mesh-list
138487698|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
138487700|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138487701|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487702|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487703|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487704|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138487705|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
138487706|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487707|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487708|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487709|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138487710|NCT00000708|Amebicides|amebicides|mesh-ancestor
138487711|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138487712|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487713|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487714|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
138487715|NCT00000711|Zidovudine|zidovudine|mesh-list
138487716|NCT00000711|Sargramostim|sargramostim|mesh-list
138487717|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
138487718|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487719|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487720|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487721|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487722|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
138363080|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
138363081|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363082|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363083|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138363084|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363085|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138363086|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138363087|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138363088|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138363089|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138363090|NCT05444556|Protective Agents|protective agents|mesh-ancestor
138363091|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363092|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
138487723|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363578|NCT04612920|Oxycodone|oxycodone|mesh-list
138487724|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487725|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487726|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
138487727|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487729|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
138487730|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
138487731|NCT00000717|Primaquine|primaquine|mesh-list
138487732|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487733|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487734|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138487735|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487736|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487737|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
138487738|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138487741|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
138487742|NCT00000720|Antibodies|antibodies|mesh-list
138487743|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
138363579|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363580|NCT04612920|Analgesics|analgesics|mesh-ancestor
138363581|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
138363582|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363583|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363584|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
138363585|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363586|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363587|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363588|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138363590|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363591|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138363592|NCT04612920|Narcotics|narcotics|mesh-ancestor
138363593|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363594|NCT04570293|Lidocaine|lidocaine|mesh-list
138363595|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
138363596|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
138363597|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363598|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363599|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
138363600|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363601|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138363602|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138363603|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138363604|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363605|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363606|NCT04531462|Empagliflozin|empagliflozin|mesh-list
138363607|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138363608|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363609|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363610|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363611|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
138363612|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138363613|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
138363614|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363615|NCT04520139|Expectorants|expectorants|mesh-ancestor
138363616|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363618|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
138363619|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363620|NCT04520139|Protective Agents|protective agents|mesh-ancestor
138363621|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363622|NCT04520139|Antidotes|antidotes|mesh-ancestor
138363623|NCT04512105|Venetoclax|venetoclax|mesh-list
138363624|NCT04512105|Pitavastatin|pitavastatin|mesh-list
138363625|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363626|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138363627|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138363629|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
138363630|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363631|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363632|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363633|NCT04501120|Azacitidine|azacitidine|mesh-list
138363634|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138487744|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487745|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487746|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487747|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487749|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487750|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487751|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487752|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
138487753|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487754|NCT04142983|Vaccines|vaccines|mesh-list
138487755|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
138487756|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487757|NCT00000726|Foscarnet|foscarnet|mesh-list
138487761|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487762|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487763|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487765|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
138487766|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138487767|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138487768|NCT00000741|Prednisolone|prednisolone|mesh-list
138487769|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
138302514|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487770|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138487772|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487773|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
138487774|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
138487775|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487776|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487777|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138487778|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
138487779|NCT00000741|Hormones|hormones|mesh-ancestor
138487780|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487781|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138487782|NCT00000741|Protective Agents|protective agents|mesh-ancestor
138487783|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138487784|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487786|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
138487787|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487788|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138487789|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487790|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363635|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
138363636|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363637|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363638|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363639|NCT04477317|Epinephrine|epinephrine|mesh-list
138363640|NCT04477317|Racepinephrine|racepinephrine|mesh-list
138363641|NCT04477317|Nordefrin|nordefrin|mesh-list
138363642|NCT04477317|Carticaine|carticaine|mesh-list
138363643|NCT04477317|Mepivacaine|mepivacaine|mesh-list
138363644|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
138363645|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138363646|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363647|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363648|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363649|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363650|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363651|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138363652|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138363653|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
138363654|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363655|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138363656|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363657|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
138363658|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
138363659|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138363660|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
138363661|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
138363662|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363663|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
138363666|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138363667|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138363668|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138363669|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
138363670|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363671|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363672|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363673|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138363674|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363675|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138363676|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
138363677|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
138363678|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
138363679|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363680|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363681|NCT04344262|Atracurium|atracurium|mesh-list
138363682|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138363683|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138363684|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138363685|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363686|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363687|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138363688|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138363689|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363690|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363691|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363693|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138363694|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363695|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363696|NCT04291521|Ketamine|ketamine|mesh-list
138487791|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487792|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138487793|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138487794|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487795|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487796|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487797|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138487799|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138487800|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
138487801|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
138487802|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487803|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302531|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
138487804|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138487806|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138487807|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487808|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487809|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487810|NCT04020172|Protective Agents|protective agents|mesh-ancestor
138487812|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138363697|NCT04291521|Propofol|propofol|mesh-list
138363698|NCT04291521|Etomidate|etomidate|mesh-list
138363699|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138363700|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363701|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363702|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138363703|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
138363704|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
138363705|NCT04291521|Analgesics|analgesics|mesh-ancestor
138363706|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
138363707|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363708|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138363709|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138363710|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138363711|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363712|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363713|NCT04288427|Finasteride|finasteride|mesh-list
138363714|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138363715|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138363716|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363717|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363718|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
138363719|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363720|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363721|NCT04288427|Urological Agents|urological agents|mesh-ancestor
138363723|NCT04280601|Vitamins|vitamins|mesh-ancestor
138363724|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
138363725|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363726|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138363727|NCT04263064|Clonidine|clonidine|mesh-list
138363728|NCT04263064|Analgesics|analgesics|mesh-ancestor
138363729|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
138363730|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363731|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363733|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
138363734|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
138363735|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138363736|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138363737|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363738|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363739|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363740|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363742|NCT04131309|Bortezomib|bortezomib|mesh-list
138363743|NCT04131309|Daratumumab|daratumumab|mesh-list
138363744|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363745|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
138363746|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
138363747|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363748|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363749|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138363750|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
138363751|NCT04131309|Hormones|hormones|mesh-ancestor
138363752|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363754|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363755|NCT04040959|Niacinamide|niacinamide|mesh-list
138363757|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
138363758|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
138363759|NCT04040959|Vitamins|vitamins|mesh-ancestor
138363760|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
138363761|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487813|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487814|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487815|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487817|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487818|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487819|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487820|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138363762|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138363763|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
138363764|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363765|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363766|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
138363767|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
138363768|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138363769|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363770|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363771|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363772|NCT03959423|Insulin|insulin|mesh-list
138363773|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363774|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363775|NCT03835065|Calpastatin|calpastatin|mesh-list
138363776|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138363777|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
138363778|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363779|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363780|NCT03786783|Vitamin A|vitamin a|mesh-list
138363781|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
138363782|NCT03786783|Melphalan|melphalan|mesh-list
138363783|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
138363784|NCT03786783|Thiotepa|thiotepa|mesh-list
138363785|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138363786|NCT03786783|Cisplatin|cisplatin|mesh-list
138363787|NCT03786783|Carboplatin|carboplatin|mesh-list
138363788|NCT03786783|Doxorubicin|doxorubicin|mesh-list
138363789|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138363791|NCT03786783|Vincristine|vincristine|mesh-list
138363792|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
138363793|NCT03786783|Daunorubicin|daunorubicin|mesh-list
138363794|NCT03786783|Topotecan|topotecan|mesh-list
138363795|NCT03786783|Tretinoin|tretinoin|mesh-list
138363796|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
138363797|NCT03786783|Dinutuximab|dinutuximab|mesh-list
138363798|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
138363800|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
138363801|NCT03786783|Isotretinoin|isotretinoin|mesh-list
138363802|NCT03786783|Sargramostim|sargramostim|mesh-list
138363803|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138363804|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
138363805|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363806|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363807|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138363808|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
138363809|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363810|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363811|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138363812|NCT03786783|Vitamins|vitamins|mesh-ancestor
138363813|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
138363814|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138363815|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138363816|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138363817|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363818|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138363819|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
138363820|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
138363821|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
138363822|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138363823|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
138363824|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
138363825|NCT03786783|Protective Agents|protective agents|mesh-ancestor
138363826|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138363828|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
138363829|NCT03670056|Nivolumab|nivolumab|mesh-list
138363830|NCT03670056|Ipilimumab|ipilimumab|mesh-list
138363831|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363832|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487821|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138487822|NCT00000753|Zidovudine|zidovudine|mesh-list
138487823|NCT00000753|Didanosine|didanosine|mesh-list
138487824|NCT00000753|Zalcitabine|zalcitabine|mesh-list
138487825|NCT00000753|Atevirdine|atevirdine|mesh-list
138487826|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
138487827|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487828|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487829|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487830|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487831|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
138487832|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487833|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487834|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487835|NCT03991741|Interleukin-2|interleukin-2|mesh-list
138487836|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487837|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138487838|NCT03991741|Analgesics|analgesics|mesh-ancestor
138487839|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
138487840|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487841|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487842|NCT00000768|Ganciclovir|ganciclovir|mesh-list
138487843|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138487846|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487847|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487848|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487850|NCT00000789|Stavudine|stavudine|mesh-list
138487851|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
138487852|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487853|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487854|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487855|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487856|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
138487857|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487858|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487859|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487860|NCT00000792|Hypericin|hypericin|mesh-list
138487861|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
138487862|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487863|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487864|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
138487865|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487866|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487867|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487868|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138487869|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
138487870|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487871|NCT03937609|Infliximab|infliximab|mesh-list
138487872|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138487873|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138487874|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
138487875|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138487878|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138487879|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487880|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138487881|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487882|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487883|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487884|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
138487885|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138487886|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
138302608|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
138487887|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487888|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138487889|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487890|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
138487891|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487892|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
138487893|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138487894|NCT00000813|Protective Agents|protective agents|mesh-ancestor
138487896|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138487897|NCT00390598|Laxatives|laxatives|mesh-ancestor
138487898|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138487899|NCT00000816|Trimethoprim|trimethoprim|mesh-list
138487900|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138487901|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
138487902|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138487903|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487904|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
138487905|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138487906|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487907|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138487908|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487910|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138487912|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487913|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138487915|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
138487916|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
138487917|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138487918|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487919|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
138487920|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487921|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487922|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138487923|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138487924|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487925|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487927|NCT00000822|Didanosine|didanosine|mesh-list
138487928|NCT00000822|Stavudine|stavudine|mesh-list
138487929|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138487930|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138487931|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138487932|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487933|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487934|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487935|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487937|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487938|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138487939|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138487940|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
138487941|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487942|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487943|NCT03797560|Pregabalin|pregabalin|mesh-list
138487944|NCT03797560|Analgesics|analgesics|mesh-ancestor
138487945|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
138487946|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487947|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487948|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
138487952|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138487954|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138487955|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138487956|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487957|NCT03574402|Carboplatin|carboplatin|mesh-list
138487958|NCT03574402|Gemcitabine|gemcitabine|mesh-list
138487959|NCT03574402|Pemetrexed|pemetrexed|mesh-list
138487960|NCT03574402|Afatinib|afatinib|mesh-list
138487961|NCT03574402|Crizotinib|crizotinib|mesh-list
138487962|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
138487963|NCT03574402|Ensartinib|ensartinib|mesh-list
138487964|NCT03574402|Maleic acid|maleic acid|mesh-list
138487965|NCT03574402|Abivertinib|abivertinib|mesh-list
138487966|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487967|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138487968|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
138487969|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487970|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487971|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138363916|NCT02817360|Losartan|losartan|mesh-list
138363917|NCT02817360|Valsartan|valsartan|mesh-list
138363918|NCT02817360|Carvedilol|carvedilol|mesh-list
138363919|NCT02817360|Candesartan|candesartan|mesh-list
138363920|NCT02817360|Ramipril|ramipril|mesh-list
138363921|NCT02817360|Enalapril|enalapril|mesh-list
138363923|NCT02817360|Irbesartan|irbesartan|mesh-list
138363924|NCT02817360|Nebivolol|nebivolol|mesh-list
138363925|NCT02817360|Bisoprolol|bisoprolol|mesh-list
138363926|NCT02817360|Perindopril|perindopril|mesh-list
138363927|NCT02817360|Captopril|captopril|mesh-list
138363928|NCT02817360|Quinapril|quinapril|mesh-list
138363929|NCT02817360|Trandolapril|trandolapril|mesh-list
138363930|NCT02817360|Fosinopril|fosinopril|mesh-list
138363931|NCT02817360|Eprosartan|eprosartan|mesh-list
138363932|NCT02817360|Zofenopril|zofenopril|mesh-list
138363933|NCT02817360|Spirapril|spirapril|mesh-list
138363934|NCT02817360|Cilazapril|cilazapril|mesh-list
138363935|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138363936|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138363937|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138363938|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138363939|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363940|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138363941|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138363942|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363943|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363944|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363946|NCT02817360|Protective Agents|protective agents|mesh-ancestor
138363947|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138363948|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363949|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138363950|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
138363951|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138363952|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138363953|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138363954|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
138363955|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363956|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138363957|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138363958|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138363959|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363960|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
138363961|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
138363962|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363963|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138363966|NCT02689778|Analgesics|analgesics|mesh-ancestor
138363967|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
138363968|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363969|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363970|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363971|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363972|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363973|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363974|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363975|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138363976|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138363977|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138363978|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363979|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363980|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138363981|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363982|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363983|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138487972|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487973|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138487974|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138487975|NCT00000831|Lamivudine|lamivudine|mesh-list
138487976|NCT00000831|Zidovudine|zidovudine|mesh-list
138487977|NCT00000831|Didanosine|didanosine|mesh-list
138487978|NCT00000831|Stavudine|stavudine|mesh-list
138487979|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138487980|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138487981|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487982|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487983|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
138487984|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487985|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487986|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487988|NCT00000849|Aldesleukin|aldesleukin|mesh-list
138487989|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487990|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138487991|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487992|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
138487993|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487994|NCT03357952|Daratumumab|daratumumab|mesh-list
138487995|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487996|NCT00000855|Zidovudine|zidovudine|mesh-list
138364070|NCT01850303|Gemcitabine|gemcitabine|mesh-list
138364072|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364073|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
138364074|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364075|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364076|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364077|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138364078|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138364081|NCT01763671|Bevacizumab|bevacizumab|mesh-list
138364082|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138364083|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364084|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138364085|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138364086|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364087|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364088|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364089|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138364090|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138364091|NCT01763671|Growth Substances|growth substances|mesh-ancestor
138364092|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364093|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
138364094|NCT01696435|Vitamin D|vitamin d|mesh-list
138364095|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
138364096|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
138364097|NCT01696435|Vitamins|vitamins|mesh-list
138364098|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
138364099|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364100|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138364101|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138364102|NCT01681264|Guanfacine|guanfacine|mesh-list
138364103|NCT01681264|Morphine|morphine|mesh-list
138364104|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138364105|NCT01681264|Narcotics|narcotics|mesh-ancestor
138364106|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364107|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364108|NCT01681264|Analgesics|analgesics|mesh-ancestor
138364109|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
138364110|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364111|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364112|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138364113|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138364114|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138364115|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364116|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364117|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364118|NCT01654276|Febuxostat|febuxostat|mesh-list
138364119|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
138364120|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364121|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138487998|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487999|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488000|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488001|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488002|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
138488003|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488004|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488005|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488007|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138488008|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138488009|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
138488010|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488011|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488012|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488013|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138488014|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138488015|NCT00390676|Carboplatin|carboplatin|mesh-list
138488016|NCT00390676|Docetaxel|docetaxel|mesh-list
138488017|NCT00390676|Capecitabine|capecitabine|mesh-list
138488018|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488019|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488022|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488023|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488024|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
138488027|NCT00000870|Didanosine|didanosine|mesh-list
138488028|NCT00000870|Stavudine|stavudine|mesh-list
138488029|NCT00000870|Aldesleukin|aldesleukin|mesh-list
138488030|NCT00000870|Indinavir|indinavir|mesh-list
138488031|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302711|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
138488032|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488034|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488035|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
138488036|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488037|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488038|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488039|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
138488040|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488041|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488042|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488043|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488045|NCT00390832|Hematinics|hematinics|mesh-ancestor
138488047|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
138488048|NCT00390871|Propofol|propofol|mesh-list
138488049|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138488050|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488051|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488052|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138488053|NCT00390871|Analgesics|analgesics|mesh-ancestor
138488054|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
138488055|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488056|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138488057|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138488058|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138488059|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
138488060|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488062|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138488063|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
138488064|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
138488065|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138488066|NCT00390871|Narcotics|narcotics|mesh-ancestor
138488067|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138488069|NCT00000882|Zidovudine|zidovudine|mesh-list
138488070|NCT00000882|Stavudine|stavudine|mesh-list
138488071|NCT00000882|Delavirdine|delavirdine|mesh-list
138488072|NCT00000882|Indinavir|indinavir|mesh-list
138365167|NCT01390480|Vitamin D|vitamin d|mesh-list
138365168|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365169|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365170|NCT01390480|Vitamins|vitamins|mesh-ancestor
138365171|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
138365172|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138365173|NCT01390506|Selenious Acid|selenious acid|mesh-list
138365177|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365179|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138365180|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138365181|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365182|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365183|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365184|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
138365185|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365186|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365187|NCT01390571|Temozolomide|temozolomide|mesh-list
138365188|NCT01390571|Olaparib|olaparib|mesh-list
138365189|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138365190|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
138365191|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365192|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365193|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138365194|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365195|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
138365196|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138365197|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365199|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
138365200|NCT01390662|Vitamins|vitamins|mesh-ancestor
138365201|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
138365203|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138365204|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365205|NCT01390766|Azathioprine|azathioprine|mesh-list
138365206|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
138365207|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365208|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138365209|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365210|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365211|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
138365213|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365214|NCT01390792|Zanamivir|zanamivir|mesh-list
138365215|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
138365216|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365217|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365218|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365219|NCT01390805|Valacyclovir|valacyclovir|mesh-list
138365220|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
138365221|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365223|NCT01390883|Fondaparinux|fondaparinux|mesh-list
138365225|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
138365226|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138365227|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365228|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365229|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488073|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488074|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488075|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488076|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488077|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
138488078|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488079|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488080|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488081|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
138488082|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488083|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488084|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488086|NCT00000888|Lamivudine|lamivudine|mesh-list
138488087|NCT00000888|Zidovudine|zidovudine|mesh-list
138488088|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488089|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488090|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488091|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488092|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488093|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488094|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488097|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488098|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488099|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488100|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488101|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
138488103|NCT00000891|Saquinavir|saquinavir|mesh-list
138302782|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302783|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138488104|NCT00000891|Lamivudine|lamivudine|mesh-list
138488105|NCT00000891|Zidovudine|zidovudine|mesh-list
138488106|NCT00000891|Didanosine|didanosine|mesh-list
138488107|NCT00000891|Stavudine|stavudine|mesh-list
138488108|NCT00000891|Delavirdine|delavirdine|mesh-list
138488109|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488110|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488111|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488112|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488113|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488114|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488115|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488116|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
138488117|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488118|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488119|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488120|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488121|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488122|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
138488123|NCT00000903|Lamivudine|lamivudine|mesh-list
138488124|NCT00000903|Zidovudine|zidovudine|mesh-list
138488125|NCT00000903|Efavirenz|efavirenz|mesh-list
138488126|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138302825|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
138488127|NCT00000903|Nelfinavir|nelfinavir|mesh-list
138488128|NCT00000903|Indinavir|indinavir|mesh-list
138488129|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488130|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488131|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488133|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
138488134|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488135|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488136|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488137|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
138488138|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138488139|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488140|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138488141|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138488142|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138488143|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138488144|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488145|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488146|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488147|NCT02939365|Abatacept|abatacept|mesh-list
138488148|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138488149|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164585|NCT00490009|Analgesics|analgesics|mesh-ancestor
138488150|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488151|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488152|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302875|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302876|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302877|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
138302880|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
138488153|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
138488154|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488155|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488157|NCT00000906|Saquinavir|saquinavir|mesh-list
138488158|NCT00000906|Methadone|methadone|mesh-list
138488159|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488160|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138342040|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342041|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342042|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342045|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138342046|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138342047|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342048|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342049|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
138342050|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342051|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342052|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138342054|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138342079|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
138488161|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488163|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488165|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488166|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
138488167|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488168|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488169|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488170|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138488171|NCT00000906|Narcotics|narcotics|mesh-ancestor
138488172|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488173|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488174|NCT00000906|Analgesics|analgesics|mesh-ancestor
138488175|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
138302949|NCT00005791|Irinotecan|irinotecan|mesh-list
138488176|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488177|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
138488178|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
138488179|NCT02681302|Nivolumab|nivolumab|mesh-list
138488180|NCT02681302|Ipilimumab|ipilimumab|mesh-list
138342083|NCT01614210|Tamoxifen|tamoxifen|mesh-list
138488181|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488182|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488183|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138342136|NCT01621230|Narcotics|narcotics|mesh-ancestor
138488184|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488185|NCT00000951|Fluconazole|fluconazole|mesh-list
138488186|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
138488187|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488188|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138342137|NCT01621230|Analgesics|analgesics|mesh-ancestor
138342138|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138488189|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488190|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488191|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488192|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138488193|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
138488194|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342200|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138342201|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
138488195|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488196|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138488197|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138488199|NCT00000966|Azithromycin|azithromycin|mesh-list
138488200|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
138488201|NCT00000966|Calcium|calcium|mesh-list
138488202|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
138488203|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138488204|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488205|NCT00000966|Antidotes|antidotes|mesh-ancestor
138488206|NCT00000966|Protective Agents|protective agents|mesh-ancestor
138488207|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
138488208|NCT00000966|Vitamins|vitamins|mesh-ancestor
138488209|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
138488210|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342271|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
138342304|NCT01652976|Leucovorin|leucovorin|mesh-list
138488211|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488212|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
138488213|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138488214|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138488215|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138488216|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488217|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488218|NCT00000969|Didanosine|didanosine|mesh-list
138488220|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
138342334|NCT01661946|Bevacizumab|bevacizumab|mesh-list
138342335|NCT01661946|Ranibizumab|ranibizumab|mesh-list
138488221|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488222|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488223|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138164667|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
138488224|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488225|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
138488226|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488227|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488228|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488229|NCT00000975|Itraconazole|itraconazole|mesh-list
138488230|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
138488231|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488232|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138488233|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488234|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488235|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488236|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138488237|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
138488238|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488239|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488240|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488243|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
138342478|NCT01707420|Analgesics|analgesics|mesh-ancestor
138342479|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
138342480|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342534|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290107|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290108|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
138488244|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488245|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138342694|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
138342766|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342774|NCT01736358|Ketorolac|ketorolac|mesh-list
138488246|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488247|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488248|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
138488249|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488250|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488252|NCT00000999|Zidovudine|zidovudine|mesh-list
138488253|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
138488254|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488255|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488256|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488257|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488258|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
138488259|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488260|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488261|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488262|NCT00001002|Zidovudine|zidovudine|mesh-list
138488263|NCT00001002|Foscarnet|foscarnet|mesh-list
138488264|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138488265|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
138488266|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342908|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138342909|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
138488267|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138342974|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
138488270|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
138488271|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488272|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488273|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488275|NCT00005819|Fenretinide|fenretinide|mesh-list
138488276|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488277|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488278|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488279|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488280|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488281|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488282|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138488283|NCT00005819|Protective Agents|protective agents|mesh-ancestor
138488284|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488285|NCT00001005|Zidovudine|zidovudine|mesh-list
138488286|NCT00001005|Aldesleukin|aldesleukin|mesh-list
138488287|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
138488288|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488289|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488290|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488291|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488292|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
138488293|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488294|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488295|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488296|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488297|NCT00391105|Remifentanil|remifentanil|mesh-list
138488298|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138488299|NCT00391105|Narcotics|narcotics|mesh-ancestor
138488301|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488302|NCT00391105|Analgesics|analgesics|mesh-ancestor
138488303|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
138488304|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488305|NCT00391144|Triamcinolone|triamcinolone|mesh-list
138488306|NCT00391144|Bevacizumab|bevacizumab|mesh-list
138488307|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488308|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488309|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138488310|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138488311|NCT00391144|Growth Substances|growth substances|mesh-ancestor
138488312|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488313|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138488314|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488315|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
138488316|NCT00391144|Hormones|hormones|mesh-ancestor
138488317|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488318|NCT00005822|Tamoxifen|tamoxifen|mesh-list
138488319|NCT00005822|Doxorubicin|doxorubicin|mesh-list
138488320|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138488321|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488322|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488323|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138488324|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488325|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488326|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488327|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138488328|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
138488329|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488330|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488331|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138343052|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
138343053|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343054|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138343055|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138343056|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343057|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488332|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138488334|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138488336|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138488337|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488338|NCT00001008|Zidovudine|zidovudine|mesh-list
138488339|NCT00001008|Methadone|methadone|mesh-list
138488340|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
138488341|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488342|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488343|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488344|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488345|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
138488346|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488347|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488348|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488349|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138488350|NCT00001008|Narcotics|narcotics|mesh-ancestor
138488351|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488352|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488353|NCT00001008|Analgesics|analgesics|mesh-ancestor
138488354|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
138488355|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488356|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
138343060|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
138343061|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138343062|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343063|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138488357|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343086|NCT01794702|Idarubicin|idarubicin|mesh-list
138488358|NCT00005825|Vinorelbine|vinorelbine|mesh-list
138488359|NCT00005825|Mitomycins|mitomycins|mesh-list
138488360|NCT00005825|Mitomycin|mitomycin|mesh-list
138488361|NCT00005825|Tretinoin|tretinoin|mesh-list
138488362|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488363|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488364|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488365|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488366|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488367|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488368|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488369|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
138488370|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488371|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488372|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
138488373|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
138488375|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
138488376|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343110|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343111|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343168|NCT06020352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343169|NCT06020313|Resveratrol|resveratrol|mesh-list
138488377|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138343246|NCT06019130|Immunologic Factors|immunologic factors|mesh-ancestor
138488378|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488379|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488380|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
138488381|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488382|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488383|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488384|NCT00001014|Leucovorin|leucovorin|mesh-list
138488385|NCT00001014|Trimethoprim|trimethoprim|mesh-list
138488386|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138488387|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
138343547|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
138488388|NCT00001014|Trimetrexate|trimetrexate|mesh-list
138488389|NCT00001014|Calcium|calcium|mesh-list
138488390|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
138488391|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138488392|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488393|NCT00001014|Antidotes|antidotes|mesh-ancestor
138488394|NCT00001014|Protective Agents|protective agents|mesh-ancestor
138488395|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
138488396|NCT00001014|Vitamins|vitamins|mesh-ancestor
138488397|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
138488398|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138488399|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488400|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
138488401|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138488402|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138488403|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138488404|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488405|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488407|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138488408|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488409|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488410|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
138488411|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488412|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
138488413|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488415|NCT00005831|Carboplatin|carboplatin|mesh-list
138488416|NCT00005831|Gemcitabine|gemcitabine|mesh-list
138488417|NCT00005831|Trastuzumab|trastuzumab|mesh-list
138343548|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
138488418|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488419|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488420|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488421|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488422|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488423|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488424|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488425|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
138488426|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488428|NCT00005834|Dexamethasone|dexamethasone|mesh-list
138488429|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
138488430|NCT00005834|Etoposide|etoposide|mesh-list
138343672|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138343674|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138343738|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138488431|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488432|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
138488433|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488434|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488435|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488436|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
138488437|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488438|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488439|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488440|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488441|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
138343815|NCT04845035|Cytarabine|cytarabine|mesh-list
138343816|NCT04845035|Methotrexate|methotrexate|mesh-list
138343817|NCT04845035|Dasatinib|dasatinib|mesh-list
138488442|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
138488443|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488444|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138488445|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
138488447|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488448|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188470|NCT00989989|Growth Substances|growth substances|mesh-ancestor
138488449|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488450|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138488451|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488452|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488453|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
138488454|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488455|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488456|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138488457|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138488458|NCT00005834|Growth Substances|growth substances|mesh-ancestor
138488459|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
138488461|NCT00001029|Didanosine|didanosine|mesh-list
138488462|NCT00001029|Zalcitabine|zalcitabine|mesh-list
138488463|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
138488464|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488465|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488466|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488467|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488468|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
138488469|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488470|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488471|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488472|NCT00001032|Zidovudine|zidovudine|mesh-list
138488473|NCT00001032|Zalcitabine|zalcitabine|mesh-list
138488474|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
138488475|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488476|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488477|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488478|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488479|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
138488480|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488481|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488482|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488483|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
138488488|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488489|NCT00005840|Paclitaxel|paclitaxel|mesh-list
138488490|NCT00005840|Cisplatin|cisplatin|mesh-list
138488491|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488492|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488493|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488494|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488495|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488496|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488498|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488499|NCT00005849|Paclitaxel|paclitaxel|mesh-list
138488500|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
138488501|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488502|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488503|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
138343880|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343881|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138343882|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488504|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488505|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488506|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488507|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138488508|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
138488509|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488510|NCT00001047|Clarithromycin|clarithromycin|mesh-list
138488511|NCT00001047|Ethambutol|ethambutol|mesh-list
138488512|NCT00001047|Rifabutin|rifabutin|mesh-list
138343962|NCT04555577|Peposertib|peposertib|mesh-list
138343963|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343964|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
138344035|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
138488513|NCT00001047|Clofazimine|clofazimine|mesh-list
138488514|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488515|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488516|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138488517|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488518|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488519|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138344114|NCT04190056|Tamoxifen|tamoxifen|mesh-list
138488520|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138344192|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488522|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138488523|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488524|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
138488525|NCT00005852|Cyclosporine|cyclosporine|mesh-list
138488526|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
138488527|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
138488528|NCT00005852|Cyclosporins|cyclosporins|mesh-list
138488529|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138488530|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
138488531|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488532|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
138488533|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488552|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488553|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138488554|NCT00005852|Protective Agents|protective agents|mesh-ancestor
138488556|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138488557|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
138488558|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488559|NCT00005855|Carmustine|carmustine|mesh-list
138344395|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344396|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488560|NCT00005855|Efaproxiral|efaproxiral|mesh-list
138488561|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488562|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
138488563|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488564|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488565|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
138488566|NCT00001074|Didanosine|didanosine|mesh-list
138488567|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
138488568|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488569|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
138488570|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488571|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488572|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488573|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
138488574|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488575|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
138303297|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488578|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488581|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
138488582|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488583|NCT00005861|Doxorubicin|doxorubicin|mesh-list
138488584|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138488585|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488586|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488587|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138488588|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488589|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488590|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488591|NCT00001083|Ritonavir|ritonavir|mesh-list
138344452|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
138488592|NCT00001083|Indinavir|indinavir|mesh-list
138488593|NCT00001083|Lamivudine|lamivudine|mesh-list
138488594|NCT00001083|Zidovudine|zidovudine|mesh-list
138488597|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488598|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488599|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488600|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488601|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488602|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488603|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488604|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
138488605|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344515|NCT02343042|Ixazomib|ixazomib|mesh-list
138344516|NCT02343042|Elotuzumab|elotuzumab|mesh-list
138488606|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488607|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488608|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488609|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488610|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
138488611|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138488612|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138488613|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
138488614|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344580|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138344646|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
138488615|NCT00001086|Efavirenz|efavirenz|mesh-list
138488616|NCT00001086|Abacavir|abacavir|mesh-list
138488618|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488619|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488621|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488622|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
138488623|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303337|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
138303338|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303351|NCT02092116|Romidepsin|romidepsin|mesh-list
138488624|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138344647|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344648|NCT01705977|Belimumab|belimumab|mesh-list
138344649|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344650|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
138344651|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344652|NCT01686711|Pioglitazone|pioglitazone|mesh-list
138344653|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344654|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344655|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
138344656|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138344657|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344658|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
138344659|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
138488625|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488626|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138488627|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138488628|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138488629|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138488632|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488633|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488634|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488635|NCT00700258|Sirolimus|sirolimus|mesh-list
138488636|NCT00700258|Sunitinib|sunitinib|mesh-list
138488637|NCT00700258|Temsirolimus|temsirolimus|mesh-list
138488638|NCT00700258|Axitinib|axitinib|mesh-list
138488639|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
138488640|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488641|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138488642|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138488643|NCT00700258|Growth Substances|growth substances|mesh-ancestor
138488644|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488645|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344660|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488646|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138488647|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488648|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488649|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488650|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
138488651|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488652|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488653|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488656|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
138488657|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
138488659|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488660|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
138488661|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488662|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
138488663|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488664|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
138488665|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488666|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138303367|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344788|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138344801|NCT01822548|Metformin|metformin|mesh-list
138488667|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488668|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488669|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488670|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488672|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
138488673|NCT00005867|Doxorubicin|doxorubicin|mesh-list
138488674|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138488676|NCT00005867|Vincristine|vincristine|mesh-list
138488677|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
138488678|NCT00005867|Bleomycin|bleomycin|mesh-list
138488679|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488681|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488682|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488683|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488684|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
138488685|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488686|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488687|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488688|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488689|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138488690|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488691|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488694|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488695|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488696|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488699|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488700|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138488701|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488702|NCT00005867|Analgesics|analgesics|mesh-ancestor
138488703|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
138488704|NCT00005870|Gemcitabine|gemcitabine|mesh-list
138488705|NCT00005870|Fluorouracil|fluorouracil|mesh-list
138303401|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488706|NCT00005870|Mitomycins|mitomycins|mesh-list
138488707|NCT00005870|Mitomycin|mitomycin|mesh-list
138488708|NCT00005870|Rubitecan|rubitecan|mesh-list
138488709|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488710|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
138488711|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488712|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488713|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488714|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
138488715|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488716|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488717|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
138488718|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488719|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488720|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138488721|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488722|NCT00017407|Paclitaxel|paclitaxel|mesh-list
138488723|NCT00017407|Carboplatin|carboplatin|mesh-list
138488724|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488725|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488726|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488727|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488728|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488729|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488730|NCT00008866|Didanosine|didanosine|mesh-list
138488731|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
138488732|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488733|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
138488734|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344849|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344850|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344851|NCT01834404|Topiramate|topiramate|mesh-list
138488735|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488736|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488738|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488740|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488741|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488742|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488743|NCT00001119|Ritonavir|ritonavir|mesh-list
138488744|NCT00001119|Indinavir|indinavir|mesh-list
138488745|NCT00001119|Amprenavir|amprenavir|mesh-list
138303439|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138488746|NCT00001119|Lamivudine|lamivudine|mesh-list
138488748|NCT00001119|Abacavir|abacavir|mesh-list
138488749|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138344859|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
138344860|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
138344865|NCT01835262|Ketamine|ketamine|mesh-list
138488750|NCT00001119|Efavirenz|efavirenz|mesh-list
138488751|NCT00001119|Vaccines|vaccines|mesh-list
138488752|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
138488753|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488754|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488755|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488756|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488757|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488758|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488759|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488760|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488762|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488763|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488764|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488765|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488766|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488767|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
138488768|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138488769|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138488770|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138488771|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138488772|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138488773|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138488774|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
138488775|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488776|NCT00009061|Ritonavir|ritonavir|mesh-list
138488777|NCT00009061|Nelfinavir|nelfinavir|mesh-list
138488778|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
138488779|NCT00009061|Lamivudine|lamivudine|mesh-list
138488780|NCT00009061|Abacavir|abacavir|mesh-list
138488781|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138488782|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138488783|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
138488784|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488785|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488786|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488787|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138488788|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
138488789|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488790|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138488791|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488792|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138488793|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488794|NCT00005873|Rubitecan|rubitecan|mesh-list
138488795|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488796|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138488797|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488798|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488799|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488800|NCT00009178|Fluoxetine|fluoxetine|mesh-list
138488801|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138488802|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138488803|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488804|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488805|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488806|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
138488807|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488808|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138488809|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
138488810|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138344923|NCT01809054|Analgesics|analgesics|mesh-ancestor
138488811|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138344924|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
138344925|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344926|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488812|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138488813|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488814|NCT00009217|Haloperidol|haloperidol|mesh-list
138344946|NCT01842594|Sirolimus|sirolimus|mesh-list
138488815|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
138488816|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
138488817|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
138488818|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345005|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345006|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345007|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488819|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488820|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138488821|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138488822|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138488823|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488825|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138488827|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345008|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488828|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488829|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138488830|NCT00005876|Rubitecan|rubitecan|mesh-list
138488831|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488832|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138488833|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488834|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488835|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488836|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138488837|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138488838|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138488839|NCT00009646|Indomethacin|indomethacin|mesh-list
138488840|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138488841|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138488842|NCT00009646|Analgesics|analgesics|mesh-ancestor
138488843|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
138488844|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488845|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488846|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138488847|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488848|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
138488849|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
138488850|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138488851|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138488853|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488854|NCT00009763|Cyclosporine|cyclosporine|mesh-list
138488855|NCT00009763|Paclitaxel|paclitaxel|mesh-list
138488856|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138488857|NCT00009763|Antibodies|antibodies|mesh-list
138488858|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
138488859|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138488860|NCT00009763|Cyclosporins|cyclosporins|mesh-list
138488861|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488862|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488863|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488864|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488865|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488866|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488867|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
138488868|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488869|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488870|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488871|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
138488872|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488873|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
138488874|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488875|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138488876|NCT00009802|Calcitriol|calcitriol|mesh-list
138488877|NCT00009802|Paclitaxel|paclitaxel|mesh-list
138488878|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488879|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488880|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488881|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488882|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488883|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488885|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488886|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138488887|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488888|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138488889|NCT00009802|Vitamins|vitamins|mesh-ancestor
138488890|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
138488891|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138488892|NCT00009841|Mitogens|mitogens|mesh-list
138345219|NCT00954876|Cetuximab|cetuximab|mesh-list
138345220|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345221|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
138345222|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345223|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345224|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345225|NCT05746728|Tislelizumab|tislelizumab|mesh-list
138345226|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488893|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488894|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488895|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
138488896|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488897|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
138488898|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488899|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488900|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488901|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
138488902|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488903|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303565|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488904|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488906|NCT00009880|Fluorouracil|fluorouracil|mesh-list
138488907|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488908|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488909|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488910|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488911|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488912|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488913|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
138488914|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345390|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488915|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488916|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
138488918|NCT00009919|Semaxinib|semaxinib|mesh-list
138488919|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138488920|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138488921|NCT00009919|Growth Substances|growth substances|mesh-ancestor
138488922|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488923|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
138488924|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488925|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138488926|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488927|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488929|NCT00009958|Vaccines|vaccines|mesh-list
138488930|NCT00009958|Sargramostim|sargramostim|mesh-list
138488932|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488933|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488934|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138488935|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138488936|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138488937|NCT00009997|Tamoxifen|tamoxifen|mesh-list
138488938|NCT00009997|Paclitaxel|paclitaxel|mesh-list
138488939|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
138488940|NCT00009997|Doxorubicin|doxorubicin|mesh-list
138488941|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138488942|NCT00009997|Trastuzumab|trastuzumab|mesh-list
138488943|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488944|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488945|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138488946|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488947|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345444|NCT01907334|Fluticasone|fluticasone|mesh-list
138345445|NCT01907334|Xhance|xhance|mesh-list
138345446|NCT01907334|Albuterol|albuterol|mesh-list
138345447|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138488948|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488949|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345527|NCT01920282|Nebivolol|nebivolol|mesh-list
138488950|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
138488951|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345585|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138488952|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138488954|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
138488955|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488956|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138488957|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138488959|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488960|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138488961|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138345587|NCT01937598|Incretins|incretins|mesh-ancestor
138488962|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
138488963|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138488964|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138488965|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138488966|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138488967|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138488968|NCT00010036|Carboplatin|carboplatin|mesh-list
138345648|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345649|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345650|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345652|NCT01955382|Amodiaquine|amodiaquine|mesh-list
138345653|NCT01955382|Charcoal|charcoal|mesh-list
138488970|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488971|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138488972|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138488973|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488974|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488976|NCT00010075|Fluorouracil|fluorouracil|mesh-list
138488977|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
138488978|NCT00010075|Calcium|calcium|mesh-list
138488979|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
138488980|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138488981|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488982|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
138488983|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488984|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488985|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488986|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488987|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
138488988|NCT00010075|Antidotes|antidotes|mesh-ancestor
138488989|NCT00010075|Protective Agents|protective agents|mesh-ancestor
138345782|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138488990|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
138488991|NCT00010075|Vitamins|vitamins|mesh-ancestor
138488992|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
138488993|NCT00010075|Analgesics|analgesics|mesh-ancestor
138488994|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
138488995|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488996|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138345998|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138346027|NCT01965366|Hormones|hormones|mesh-ancestor
138488998|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488999|NCT00010153|Fulvestrant|fulvestrant|mesh-list
138489000|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489001|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346075|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138489002|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138489003|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138489004|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
138489005|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489006|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489007|NCT00010192|Aldesleukin|aldesleukin|mesh-list
138489008|NCT00010192|Rituximab|rituximab|mesh-list
138489009|NCT00010192|Interleukin-2|interleukin-2|mesh-list
138303641|NCT02079636|Ramucirumab|ramucirumab|mesh-list
138489010|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138489011|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489012|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
138489013|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489014|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489015|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138489016|NCT00010192|Analgesics|analgesics|mesh-ancestor
138489017|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
138489018|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489019|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489020|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489021|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
138489022|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489023|NCT00005912|Voriconazole|voriconazole|mesh-list
138489024|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
138489025|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489026|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138489027|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138489028|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489029|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489030|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138346130|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138346131|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
138346132|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138489031|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
138489032|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489033|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489034|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138489036|NCT00010231|Dexamethasone|dexamethasone|mesh-list
138489037|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489038|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
138489039|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
138489040|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489041|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489042|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489043|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
138489044|NCT00010231|Hormones|hormones|mesh-ancestor
138489045|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489046|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489047|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489048|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138489049|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138489050|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303659|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489051|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489052|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138489054|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
138489055|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138489057|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
138489058|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
138489059|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489062|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
138489063|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489064|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489065|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489066|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
138489067|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489068|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489069|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489071|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138289143|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138489072|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489073|NCT00386516|Fluorouracil|fluorouracil|mesh-list
138489074|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
138489075|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489076|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489077|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489078|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489079|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
138489080|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489082|NCT00010699|Vitamins|vitamins|mesh-ancestor
138489083|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
138489084|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489085|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
138489086|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489088|NCT00386555|Docetaxel|docetaxel|mesh-list
138489089|NCT00386555|Axitinib|axitinib|mesh-list
138489090|NCT00386555|Crenolanib|crenolanib|mesh-list
138489091|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489092|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489093|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489094|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489095|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489096|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489097|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346187|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346188|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
138346189|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346191|NCT02058420|Vitamin E|vitamin e|mesh-list
138489098|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138489099|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138489100|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489102|NCT00001191|Pantoprazole|pantoprazole|mesh-list
138489103|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138489104|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489105|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138489106|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489108|NCT00011089|Tenofovir|tenofovir|mesh-list
138489109|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
138346195|NCT02058420|Protective Agents|protective agents|mesh-ancestor
138489110|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346196|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489111|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138489112|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138489113|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489114|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489115|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489116|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489117|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138489118|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
138489119|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489120|NCT00005921|Caspofungin|caspofungin|mesh-list
138489121|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
138303726|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
138489122|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346260|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138489123|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489124|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489125|NCT00011362|Dexamethasone|dexamethasone|mesh-list
138489126|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
138489128|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489129|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
138489130|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
138489131|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489132|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489133|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346334|NCT02054754|HU 211|hu 211|mesh-list
138489134|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
138489135|NCT00011362|Hormones|hormones|mesh-ancestor
138489136|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489137|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489138|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489142|NCT00001212|Cyclosporine|cyclosporine|mesh-list
138489144|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
138489145|NCT00001212|Cyclosporins|cyclosporins|mesh-list
138489146|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489147|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
138489148|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489149|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489150|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489151|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
138489152|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489153|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489154|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489155|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489156|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
138489157|NCT00001212|Hormones|hormones|mesh-ancestor
138489158|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489159|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489160|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489161|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
138489162|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489163|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
138489164|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138489165|NCT00011479|Abacavir|abacavir|mesh-list
138489166|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138489167|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138489168|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489169|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489170|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
138489172|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489173|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489174|NCT00011635|Silymarin|silymarin|mesh-list
138489175|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
138489176|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489177|NCT00011635|Protective Agents|protective agents|mesh-ancestor
138489178|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489179|NCT00001221|Hormones|hormones|mesh-list
138489180|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489181|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489182|NCT00391417|Estradiol|estradiol|mesh-list
138489183|NCT00391417|Estrogens|estrogens|mesh-ancestor
138489184|NCT00391417|Hormones|hormones|mesh-ancestor
138489185|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489186|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489187|NCT00011908|Epratuzumab|epratuzumab|mesh-list
138489188|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138489189|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489190|NCT00012025|Fulvestrant|fulvestrant|mesh-list
138489191|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489192|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489193|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138489194|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138489195|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
138489196|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489199|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489200|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489201|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489202|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489203|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138318006|NCT01439568|Etoposide|etoposide|mesh-list
138318007|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346453|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346454|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346455|NCT02069184|Acetaminophen|acetaminophen|mesh-list
138346456|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346457|NCT02069184|Analgesics|analgesics|mesh-ancestor
138346458|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
138318008|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318009|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138346461|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
138318010|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138318011|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346464|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138318012|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318013|NCT01469052|Axitinib|axitinib|mesh-list
138318014|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318015|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318017|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318019|NCT01468818|Fludarabine|fludarabine|mesh-list
138318048|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318049|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318050|NCT01441596|Vinorelbine|vinorelbine|mesh-list
138318052|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318053|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346465|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
138346469|NCT02135016|Lidocaine|lidocaine|mesh-list
138318055|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138318056|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138318057|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318059|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318060|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138318061|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138318062|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138318063|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318065|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318066|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318067|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138346523|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
138346526|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318068|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
138318069|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318071|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
138318072|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138318073|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
138318074|NCT03026478|Clobetasol|clobetasol|mesh-list
138318075|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138318076|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318077|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
138318078|NCT03026478|Hormones|hormones|mesh-ancestor
138303856|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318079|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318080|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318081|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318082|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138318083|NCT04066764|Nadroparin|nadroparin|mesh-list
138318084|NCT04066764|Warfarin|warfarin|mesh-list
138318085|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
138318086|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
138318087|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138318088|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
138318105|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138318106|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138318107|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318123|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
138303874|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318124|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318126|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318128|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
138318129|NCT01466790|Simeprevir|simeprevir|mesh-list
138318130|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
138318131|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318132|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
138318133|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318134|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318135|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318148|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138318150|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138318151|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138318152|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138318153|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138318155|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
138318156|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318158|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318159|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318160|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318162|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318163|NCT01465230|Lenalidomide|lenalidomide|mesh-list
138318164|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
138318165|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318166|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138318167|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138318168|NCT01465230|Growth Substances|growth substances|mesh-ancestor
138318170|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318171|NCT01435122|Axitinib|axitinib|mesh-list
138318191|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138318192|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318193|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346587|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346588|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346589|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346590|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346591|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346592|NCT02170662|Bimatoprost|bimatoprost|mesh-list
138346593|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138318196|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
138318197|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318198|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
138318209|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318210|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318211|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318212|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138318213|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318214|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
138318215|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318216|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318218|NCT01392378|Ibuprofen|ibuprofen|mesh-list
138318219|NCT01392378|Vaccines|vaccines|mesh-list
138346669|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138289144|NCT00000776|Flucytosine|flucytosine|mesh-list
138346670|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346671|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
138318220|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138318221|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
138318222|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318223|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138318224|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138318225|NCT01392378|Analgesics|analgesics|mesh-ancestor
138318226|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
138318227|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318228|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318229|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318231|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318242|NCT01432938|Warfarin|warfarin|mesh-list
138318243|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
138318244|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138318245|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318246|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138318247|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138318248|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318249|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318250|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138346731|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
138346735|NCT02218320|Dolutegravir|dolutegravir|mesh-list
138318251|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318252|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318253|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
138318254|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318255|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138318256|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318257|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318258|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318259|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138318260|NCT01391130|Sunitinib|sunitinib|mesh-list
138318261|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318262|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138318263|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138318264|NCT01391130|Growth Substances|growth substances|mesh-ancestor
138318289|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138318290|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138318291|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138318292|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138318293|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138318294|NCT04044222|Carboplatin|carboplatin|mesh-list
138318296|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
138318315|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
138318316|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318319|NCT01405950|Analgesics|analgesics|mesh-ancestor
138318320|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
138318321|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318322|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318323|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
138318324|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138318325|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138318326|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
138318327|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
138318328|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138303943|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138318329|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138318330|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138318331|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138318332|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318333|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318334|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138318343|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346787|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346788|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
138346789|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346790|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346791|NCT02239380|Lorazepam|lorazepam|mesh-list
138346792|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
138346793|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
138346794|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
138346795|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346796|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318344|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318345|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318346|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138318347|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
138318348|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
138318349|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138318350|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138318351|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138303969|NCT02036502|Dexamethasone|dexamethasone|mesh-list
138303979|NCT02036502|Hormones|hormones|mesh-ancestor
138318355|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318356|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318357|NCT01428258|Coal Tar|coal tar|mesh-list
138318358|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
138318359|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318360|NCT01442688|Amoxicillin|amoxicillin|mesh-list
138318362|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318363|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318364|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138318365|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138318366|NCT01442688|Analgesics|analgesics|mesh-ancestor
138318367|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
138318368|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318369|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318371|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318372|NCT03814200|Rifampin|rifampin|mesh-list
138318373|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138318375|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318376|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318377|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
138318378|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318379|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318385|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138318386|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138318387|NCT01426854|Nepafenac|nepafenac|mesh-list
138318388|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138318390|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138318391|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346797|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346798|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346799|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346800|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138346801|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138346802|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318392|NCT01426854|Analgesics|analgesics|mesh-ancestor
138318393|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
138318394|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318395|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318396|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318397|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318398|NCT01403610|Bevacizumab|bevacizumab|mesh-list
138318399|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
138304024|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304026|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318413|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138318415|NCT01389102|Estradiol|estradiol|mesh-list
138318416|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138318417|NCT01389102|Estrogens|estrogens|mesh-ancestor
138318418|NCT01389102|Hormones|hormones|mesh-ancestor
138318448|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346891|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
138318450|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318451|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138318452|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138318453|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
138318454|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
138318455|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318457|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138318458|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318459|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138318460|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138304138|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138649762|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
138649763|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649764|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
138649765|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649766|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649767|NCT00297323|Topiramate|topiramate|mesh-list
138649768|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
138649769|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138649770|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346957|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138346958|NCT02282514|Protective Agents|protective agents|mesh-ancestor
138649772|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649773|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
138649774|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
138649775|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
138649776|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649778|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138649779|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649780|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649781|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649782|NCT00327327|Gemcitabine|gemcitabine|mesh-list
138649783|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138347017|NCT02285634|Phenylephrine|phenylephrine|mesh-list
138347018|NCT02285634|Epinephrine|epinephrine|mesh-list
138347019|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
138649784|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
138649785|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347078|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347079|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347080|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
138649786|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649787|NCT00297362|Galantamine|galantamine|mesh-list
138649788|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138649789|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649790|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649791|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
138649792|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649793|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649794|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138649795|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
138649796|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649797|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
138649798|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
138649799|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649800|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
138649801|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649802|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649803|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649804|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138347083|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138347126|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347127|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
138347128|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
138649805|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138649807|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649808|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649809|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138649810|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
138649811|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
138649812|NCT04231773|Protective Agents|protective agents|mesh-ancestor
138649815|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649816|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138649817|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347199|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347262|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138347263|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347335|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138649818|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649819|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138649820|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138649821|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138649822|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138649823|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649824|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138649825|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649826|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649827|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138649828|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649829|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304373|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304374|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649830|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649832|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
138649833|NCT04718714|Propofol|propofol|mesh-list
138649834|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138649835|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649836|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649837|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138649838|NCT04718714|Analgesics|analgesics|mesh-ancestor
138649839|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
138649840|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649841|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138649842|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138649843|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138649844|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649845|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649846|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649847|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138649849|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
138649850|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138649851|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138649852|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649853|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649854|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
138649855|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
138649856|NCT00298025|Cetrorelix|cetrorelix|mesh-list
138649857|NCT00298025|Menotropins|menotropins|mesh-list
138649858|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138649859|NCT00298025|Hormones|hormones|mesh-list
138649860|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138649861|NCT00298025|Ganirelix|ganirelix|mesh-list
138649862|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649863|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649864|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649866|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
138649867|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138649868|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
138649869|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138649870|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
138649871|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649872|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649873|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649874|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
138649875|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649876|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
138649877|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138347336|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138347337|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138347338|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347339|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347340|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649878|NCT00298181|Protective Agents|protective agents|mesh-ancestor
138649879|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138649880|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138649881|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649882|NCT03754140|Polidocanol|polidocanol|mesh-list
138649883|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138649884|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138649885|NCT00298415|Paclitaxel|paclitaxel|mesh-list
138649886|NCT00298415|Vinorelbine|vinorelbine|mesh-list
138649888|NCT00298415|Gemcitabine|gemcitabine|mesh-list
138649889|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138649890|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138649891|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649893|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138649894|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138649895|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649896|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649897|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
138649898|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138649899|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649900|NCT00298454|Furosemide|furosemide|mesh-list
138347343|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
138649901|NCT00298454|Diuretics|diuretics|mesh-ancestor
138304462|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138649902|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
138649903|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649904|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138649905|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649906|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649908|NCT00298571|Bupivacaine|bupivacaine|mesh-list
138649909|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
138649910|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
138649911|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649912|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649913|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
138649914|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347399|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347400|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347402|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649915|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138649916|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138649917|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649918|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649919|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347462|NCT05105256|Hormones|hormones|mesh-ancestor
138649920|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138649921|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649922|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
138649923|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649924|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
138649926|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
138649927|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138649928|NCT00298688|Gefitinib|gefitinib|mesh-list
138649929|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649930|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138649931|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649932|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649933|NCT05457894|Vaccines|vaccines|mesh-list
138649934|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
138347533|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
138304513|NCT01984164|Candesartan|candesartan|mesh-list
138649935|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649937|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649938|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649939|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138649940|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
138649941|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649942|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649943|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649944|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649945|NCT00298922|Azithromycin|azithromycin|mesh-list
138649946|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649947|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649948|NCT00299039|Acetaminophen|acetaminophen|mesh-list
138649949|NCT00299039|Ibuprofen|ibuprofen|mesh-list
138649950|NCT00299039|Codeine|codeine|mesh-list
138649951|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347596|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347598|NCT05722548|Indomethacin|indomethacin|mesh-list
138649952|NCT00299039|Analgesics|analgesics|mesh-ancestor
138649953|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
138649954|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649955|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649956|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
138649957|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138649958|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649961|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649962|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347654|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138347655|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138347656|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138649964|NCT00299039|Narcotics|narcotics|mesh-ancestor
138649965|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649966|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
138649967|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138649968|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138304541|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649969|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138649970|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649971|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649972|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649973|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649974|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649975|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649977|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138347718|NCT05549466|Apatinib|apatinib|mesh-list
138347719|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649978|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649979|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138649980|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649981|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649982|NCT00299390|Sagopilone|sagopilone|mesh-list
138649983|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649984|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
138649985|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
138649988|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
138649989|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649990|NCT00299858|Theophylline|theophylline|mesh-list
138649991|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649992|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
138649993|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649994|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649995|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649996|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
138649997|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138649998|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649999|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650000|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
138650001|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138650002|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138650003|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
138650004|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650006|NCT05455944|Analgesics|analgesics|mesh-ancestor
138650007|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
138347777|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347778|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138347779|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347780|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
138650008|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650009|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650010|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
138650011|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138650012|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650013|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650014|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650016|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650017|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650018|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347822|NCT04876638|Minocycline|minocycline|mesh-list
138650019|NCT00299936|Ribavirin|ribavirin|mesh-list
138650020|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138650021|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
138650022|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650023|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
138650024|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650025|NCT00300014|Triamcinolone|triamcinolone|mesh-list
138650026|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650027|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
138650028|NCT00300014|Hormones|hormones|mesh-ancestor
138650029|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650030|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650031|NCT00300131|Everolimus|everolimus|mesh-list
138650032|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138650033|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138650034|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650035|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650036|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138347887|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
138347888|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347889|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
138347890|NCT04320342|Hormones|hormones|mesh-ancestor
138650037|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
138650038|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347943|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
138650040|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
138650041|NCT01785459|Bupivacaine|bupivacaine|mesh-list
138650042|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138650043|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
138650044|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347944|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347946|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138347947|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138650045|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650046|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
138650047|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650048|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
138650049|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
138650051|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138650052|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650053|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650054|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138650055|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
138650056|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348006|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348007|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138348071|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650057|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650058|NCT04716894|Itraconazole|itraconazole|mesh-list
138650059|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
138650060|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650061|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138650062|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138650063|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255524|NCT05066607|Growth Substances|growth substances|mesh-ancestor
138650064|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650065|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138650067|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650068|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650069|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138650070|NCT00300287|Vildagliptin|vildagliptin|mesh-list
138650071|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138650072|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650073|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138650075|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650076|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650077|NCT00300404|Leucovorin|leucovorin|mesh-list
138650078|NCT00300404|Folic Acid|folic acid|mesh-list
138650079|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
138650080|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
138650081|NCT00300404|Antidotes|antidotes|mesh-ancestor
138650082|NCT00300404|Protective Agents|protective agents|mesh-ancestor
138650083|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650084|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
138650085|NCT00300404|Vitamins|vitamins|mesh-ancestor
138650086|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
138650087|NCT00300404|Hematinics|hematinics|mesh-ancestor
138650088|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
138650089|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138650090|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138650091|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650092|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138650093|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650094|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650096|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650097|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650098|NCT01539447|Analgesics|analgesics|mesh-ancestor
138650099|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
138650100|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650101|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650102|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650103|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650104|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
138650105|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138650107|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650108|NCT00300443|Bimatoprost|bimatoprost|mesh-list
138650109|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650110|NCT00300560|Colistin|colistin|mesh-list
138650111|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650112|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650113|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138650114|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
138650115|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650116|NCT00300716|Memantine|memantine|mesh-list
138348072|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348073|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138348074|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
138348075|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348076|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650117|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138650118|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138650119|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
138650120|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650121|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650122|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650123|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138650124|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138650125|NCT00300794|Ketamine|ketamine|mesh-list
138650126|NCT00300794|Analgesics|analgesics|mesh-ancestor
138348080|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
138348093|NCT00281658|Paclitaxel|paclitaxel|mesh-list
138650127|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
138650128|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650129|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650130|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138650131|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138650132|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
138650133|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
138650134|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650135|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138650136|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138650137|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650138|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650139|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
138650140|NCT05373303|Hematinics|hematinics|mesh-ancestor
138304737|NCT01932996|Nicotine|nicotine|mesh-list
138650141|NCT00300833|Tirofiban|tirofiban|mesh-list
138650142|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138650143|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138348144|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
138348145|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138348146|NCT02430090|Narcotics|narcotics|mesh-ancestor
138650144|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650145|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138650146|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
138650147|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138650148|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650149|NCT00327678|Rituximab|rituximab|mesh-list
138650150|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
138650151|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650152|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650153|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
138650154|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650155|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650156|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138650157|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650158|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650159|NCT00300950|Gemcitabine|gemcitabine|mesh-list
138348201|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650160|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650161|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
138650162|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650163|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650164|NCT00327756|Ubiquinone|ubiquinone|mesh-list
138650165|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
138650166|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
138650167|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650168|NCT00327756|Vitamins|vitamins|mesh-ancestor
138650169|NCT00301106|Interleukin-12|interleukin-12|mesh-list
138650170|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138348260|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650171|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
138348261|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348262|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138650172|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650173|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138650174|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138650175|NCT00301106|Growth Substances|growth substances|mesh-ancestor
138650176|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
138650178|NCT00301145|Varenicline|varenicline|mesh-list
138650179|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138650180|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138650181|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
138650182|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650183|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650184|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650185|NCT00301223|Pregabalin|pregabalin|mesh-list
138650186|NCT00301223|Analgesics|analgesics|mesh-ancestor
138650187|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
138650188|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650189|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348322|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
138348323|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650190|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
138650191|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138650192|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650193|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650194|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650195|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138650196|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650197|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650198|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650199|NCT00301301|Rituximab|rituximab|mesh-list
138650200|NCT00301301|Gemcitabine|gemcitabine|mesh-list
138650201|NCT00301301|Cisplatin|cisplatin|mesh-list
138304788|NCT01976364|Methotrexate|methotrexate|mesh-list
138650202|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348378|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
138348379|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650203|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650204|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
138650205|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650206|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650207|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650209|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650210|NCT00301535|Chrysarobin|chrysarobin|mesh-list
138650211|NCT00301535|HBOC 201|hboc 201|mesh-list
138650212|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650213|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650214|NCT00301535|Analgesics|analgesics|mesh-ancestor
138650215|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
138650216|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650217|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650218|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650219|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650220|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
138348437|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138348438|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348439|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
138650221|NCT00301574|Galantamine|galantamine|mesh-list
138650222|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138650223|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650224|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650225|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
138650226|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650227|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650228|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138650229|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
138650230|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650231|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
138650232|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138650233|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138650234|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650235|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304801|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138348494|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
138348495|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138348498|NCT02529072|Vaccines|vaccines|mesh-list
138348505|NCT02530476|Sorafenib|sorafenib|mesh-list
138304807|NCT01929876|Itraconazole|itraconazole|mesh-list
138650237|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650238|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650239|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650240|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
138650241|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138650242|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650243|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138650245|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650246|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650247|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650248|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650249|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
138255794|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
138650250|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138650251|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650252|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138650253|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
138650254|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650255|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704085|NCT06170788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138326948|NCT00100698|Hormones|hormones|mesh-list
138650257|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650258|NCT00301730|Aldesleukin|aldesleukin|mesh-list
138650259|NCT00301730|Paclitaxel|paclitaxel|mesh-list
138650260|NCT00301730|Trastuzumab|trastuzumab|mesh-list
138650261|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138650262|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650263|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
138650264|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
138650265|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
138650266|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650267|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650268|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138650269|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138650270|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
138650271|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650272|NCT00301847|Sorafenib|sorafenib|mesh-list
138348552|NCT02541864|Tetracycline|tetracycline|mesh-list
138348553|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138348554|NCT02541864|Pantoprazole|pantoprazole|mesh-list
138348556|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138348557|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348558|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138348559|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138650273|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650274|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348561|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650275|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650276|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650277|NCT00327990|Alendronate|alendronate|mesh-list
138650278|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
138650280|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650281|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
138650282|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
138650283|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138650284|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650285|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
138650286|NCT00301925|Capecitabine|capecitabine|mesh-list
138304884|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
138650287|NCT00301925|Fluorouracil|fluorouracil|mesh-list
138650288|NCT00301925|Methotrexate|methotrexate|mesh-list
138650290|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650291|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
138650292|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650293|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650294|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138650295|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
138650296|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348581|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138650297|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348582|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
138650298|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138348583|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
138650299|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650300|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
138650301|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138650302|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
138650303|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138650304|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
138650305|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650306|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138650307|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138650308|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138650309|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138650310|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138650312|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
138650313|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650314|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650315|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
138650316|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304938|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138304940|NCT02826551|Bupivacaine|bupivacaine|mesh-list
138650317|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138650318|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650319|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138650320|NCT00302354|Methylphenidate|methylphenidate|mesh-list
138650321|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138650322|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650323|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138650324|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650325|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650326|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650327|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
138650328|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650329|NCT00302393|Methylphenidate|methylphenidate|mesh-list
138650330|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138650331|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650332|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138650333|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650334|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304981|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650335|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650337|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650340|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
138650341|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650343|NCT00302432|Menthol|menthol|mesh-list
138650344|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
138650345|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
138650346|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138650347|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138650348|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
138650349|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650350|NCT00302549|Tacrolimus|tacrolimus|mesh-list
138650351|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650352|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
138650353|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650354|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138650355|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650356|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650357|NCT00419991|Tigecycline|tigecycline|mesh-list
138650358|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650359|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650360|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138650361|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650362|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650363|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
138650364|NCT00302627|Vitamin D|vitamin d|mesh-list
138650365|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
138650366|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
138650367|NCT00302627|Pamidronate|pamidronate|mesh-list
138650368|NCT00302627|Vitamins|vitamins|mesh-list
138650369|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
138650370|NCT00302627|Calcium|calcium|mesh-list
138650371|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
138348632|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
138650372|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650373|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650374|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138650375|NCT00302627|Antacids|antacids|mesh-ancestor
138650376|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650377|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138650378|NCT00302666|Dienogest|dienogest|mesh-list
138650379|NCT00302666|Nandrolone|nandrolone|mesh-list
138650380|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138650381|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
138650382|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348633|NCT02561130|Metformin|metformin|mesh-list
138348634|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
138650383|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650384|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138650385|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138650386|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138650387|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138650388|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
138255954|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
138650389|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650390|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138650392|NCT00302666|Androgens|androgens|mesh-ancestor
138650393|NCT00302666|Hormones|hormones|mesh-ancestor
138348692|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348693|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138650394|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
138650396|NCT00328302|Candesartan cilexetil|candesartan cilexetil|mesh-list
138650397|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650398|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138650399|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138650400|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650402|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650403|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650404|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138650405|NCT00418496|Aldesleukin|aldesleukin|mesh-list
138650406|NCT00418496|Sorafenib|sorafenib|mesh-list
138650407|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650408|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348756|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138348757|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
138348759|NCT05247684|Carboplatin|carboplatin|mesh-list
138348760|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138650409|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650410|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650411|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138650412|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305055|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138650414|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650416|NCT00302705|Enalapril|enalapril|mesh-list
138650417|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650418|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138348818|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348819|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138348820|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650419|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138650420|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650421|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138650422|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650423|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650424|NCT00302822|Tenofovir|tenofovir|mesh-list
138650425|NCT00302822|Emtricitabine|emtricitabine|mesh-list
138650426|NCT00302822|Efavirenz|efavirenz|mesh-list
138650427|NCT00302822|Lopinavir|lopinavir|mesh-list
138650428|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
138650429|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
138650430|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650431|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138650432|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138650433|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650434|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650435|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138650436|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138650437|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138650438|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138650439|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138650440|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138650441|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138650442|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138650443|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138650444|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138650445|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650446|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138650447|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138650448|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138650449|NCT00328458|Epothilones|epothilones|mesh-list
138650450|NCT00328458|Epothilone B|epothilone b|mesh-list
138650451|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
138650452|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
138650453|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
138650454|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650455|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650456|NCT00303017|Naproxen|naproxen|mesh-list
138650457|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650458|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650459|NCT00303017|Analgesics|analgesics|mesh-ancestor
138650460|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
138650461|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650462|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650463|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650464|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650465|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
138650466|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138650467|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650468|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650470|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650471|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650472|NCT00303056|Analgesics|analgesics|mesh-ancestor
138650473|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
138650474|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650475|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650476|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305113|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
138650478|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138650479|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138650480|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348884|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348885|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348886|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348893|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138650481|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138650482|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650483|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
138650484|NCT00328497|Bevacizumab|bevacizumab|mesh-list
138650485|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138650486|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650487|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256073|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
138650488|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138650489|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138650490|NCT00328497|Growth Substances|growth substances|mesh-ancestor
138650491|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650492|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
138650493|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
138650494|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
138650495|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
138650496|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650497|NCT00303290|Interferons|interferons|mesh-list
138650498|NCT00303290|Cytarabine|cytarabine|mesh-list
138650499|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
138650500|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
138650501|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138650502|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650503|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
138650504|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650505|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650506|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
138305120|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650507|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650508|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650510|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650512|NCT00328692|Diuretics|diuretics|mesh-ancestor
138650513|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
138650514|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650516|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138650517|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138650518|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650519|NCT00303407|Nadroparin|nadroparin|mesh-list
138650520|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
138650521|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138650522|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138650523|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650524|NCT00303524|Goserelin|goserelin|mesh-list
138650525|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138650526|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650527|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
138650528|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138650529|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138650530|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650531|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650532|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650533|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650534|NCT00419796|Analgesics|analgesics|mesh-ancestor
138650535|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
138650536|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305165|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650537|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348894|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138348897|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650538|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650539|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650541|NCT00419835|Enalapril|enalapril|mesh-list
138650542|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138650543|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650544|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138650546|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650547|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138650548|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650549|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650550|NCT00328809|Spironolactone|spironolactone|mesh-list
138650551|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138650552|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
138348908|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
138348909|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138348910|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138650553|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650554|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650555|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138650556|NCT00328809|Diuretics|diuretics|mesh-ancestor
138650557|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
138650558|NCT00420030|Abciximab|abciximab|mesh-list
138305209|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138650560|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138650561|NCT00303758|Leucovorin|leucovorin|mesh-list
138256187|NCT04342247|Hormones|hormones|mesh-ancestor
138650563|NCT00303758|Fluorouracil|fluorouracil|mesh-list
138650564|NCT00303758|Calcium|calcium|mesh-list
138650565|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
138650566|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650567|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650568|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
138650569|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650570|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650572|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650573|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
138650574|NCT00303758|Antidotes|antidotes|mesh-ancestor
138650575|NCT00303758|Protective Agents|protective agents|mesh-ancestor
138349111|NCT02631954|Voriconazole|voriconazole|mesh-list
138349112|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
138349113|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349114|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138349176|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650576|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
138650577|NCT00303758|Vitamins|vitamins|mesh-ancestor
138650578|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
138650579|NCT00303797|Bortezomib|bortezomib|mesh-list
138650580|NCT00303797|Sorafenib|sorafenib|mesh-list
138650581|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650582|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138650583|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650584|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650585|NCT00303836|Aldesleukin|aldesleukin|mesh-list
138650586|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
138650587|NCT00303836|Fludarabine|fludarabine|mesh-list
138650588|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
138650589|NCT00303836|Interleukin-2|interleukin-2|mesh-list
138650590|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
138650591|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650592|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
138650593|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650594|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305265|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138650595|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138650596|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
138650597|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650598|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650599|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138650600|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650601|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
138650603|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650605|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
138650606|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650607|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138650608|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138650609|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
138650610|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650611|NCT00303992|Trastuzumab|trastuzumab|mesh-list
138650612|NCT00303992|Irinotecan|irinotecan|mesh-list
138650613|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650614|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650615|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138650616|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138650617|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305303|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305304|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
138650618|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650621|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650622|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138650623|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650624|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650625|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650626|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650627|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
138650628|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138650629|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138650630|NCT00332319|Casopitant|casopitant|mesh-list
138650631|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
138650632|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
138650633|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650634|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650635|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138650636|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138650637|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349177|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138349178|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138349179|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650638|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650639|NCT00304382|Vaccines|vaccines|mesh-list
138650640|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138650641|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
138349184|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305358|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138650643|NCT00304421|Rabeprazole|rabeprazole|mesh-list
138650644|NCT00304421|Pantoprazole|pantoprazole|mesh-list
138650645|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138650646|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138650647|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138650648|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349185|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
138349186|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
138349187|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138201701|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349188|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138349189|NCT05281770|Erenumab|erenumab|mesh-list
138349190|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138349191|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349192|NCT05281770|Analgesics|analgesics|mesh-ancestor
138349193|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
138349194|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349195|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349196|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
138349197|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349198|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349199|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349200|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138349201|NCT05225610|Analgesics|analgesics|mesh-ancestor
138349202|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
138349205|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138650649|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650652|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
138650653|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650654|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650656|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650657|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
138650658|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650659|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
138650660|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650661|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138650662|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349244|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
138349245|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138349246|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138349247|NCT02652390|Prednisolone|prednisolone|mesh-list
138650663|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650664|NCT00304460|Aldesleukin|aldesleukin|mesh-list
138349309|NCT02655354|Paroxetine|paroxetine|mesh-list
138650665|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650666|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138650667|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138650668|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
138650669|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650671|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
138650672|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
138650673|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650674|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650675|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138650676|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138650677|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
138650678|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650679|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650682|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349310|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138349365|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650683|NCT00304538|Hormones|hormones|mesh-ancestor
138650684|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650685|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650686|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138650687|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138650688|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650689|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650690|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650691|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650692|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650693|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650694|NCT00328965|Lacidipine|lacidipine|mesh-list
138650695|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650696|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138650697|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650698|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650699|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138650700|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650702|NCT00304616|Risperidone|risperidone|mesh-list
138650703|NCT00304616|Aripiprazole|aripiprazole|mesh-list
138650706|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
138650707|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650708|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650709|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650710|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138650711|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650712|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650713|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650714|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138650715|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
138650716|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
138650717|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
138650718|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650719|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138650720|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138650721|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138305445|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305447|NCT01997567|Ropivacaine|ropivacaine|mesh-list
138650722|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650724|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
138650726|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138650727|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138650728|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138650729|NCT00332436|Timolol|timolol|mesh-list
138650730|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138650731|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138650732|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138650733|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650734|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650735|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650736|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650737|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138650738|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650739|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138650740|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138650741|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138650743|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
138650744|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349366|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349367|NCT02658240|Epinephrine|epinephrine|mesh-list
138349368|NCT02658240|Ropivacaine|ropivacaine|mesh-list
138349370|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
138650746|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650747|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650748|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650749|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
138650752|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650753|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138650754|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138650755|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
138650756|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138650757|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138650758|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138650759|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138650760|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138349374|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349375|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138650761|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138650762|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138650763|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138650764|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
138650765|NCT00332553|Estradiol|estradiol|mesh-list
138650766|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138650767|NCT00332553|Estrogens|estrogens|mesh-list
138650768|NCT00332553|Hormones|hormones|mesh-ancestor
138650769|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650771|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138650772|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
138650773|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138349436|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138349444|NCT02695446|Minocycline|minocycline|mesh-list
138650774|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138650775|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138650776|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138650777|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138650778|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138650779|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138650781|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138650782|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
138256522|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
138650783|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138349499|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
138349510|NCT02716818|Dexamethasone|dexamethasone|mesh-list
138650784|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138650785|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138349562|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
138650786|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
138650787|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138650788|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
138650789|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650790|NCT00332631|Expectorants|expectorants|mesh-ancestor
138650791|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
138650792|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138650793|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
138650794|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650795|NCT00332631|Protective Agents|protective agents|mesh-ancestor
138650796|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650797|NCT00332631|Antidotes|antidotes|mesh-ancestor
138650798|NCT00304772|Fluconazole|fluconazole|mesh-list
138650799|NCT00304772|Micafungin|micafungin|mesh-list
138650800|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
138650801|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650802|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138650803|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138201702|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650805|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650806|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138650807|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138650808|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650810|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138650811|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138650813|NCT00304811|Rifampin|rifampin|mesh-list
138650814|NCT00304811|Gentamicins|gentamicins|mesh-list
138650815|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650816|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650817|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138650818|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
138650819|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
138650820|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138650821|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650822|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650823|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138650824|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138650825|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138650826|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138349694|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
138650827|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138650828|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138650831|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138650832|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650833|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650834|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305537|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
138305538|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305542|NCT00755261|Bevacizumab|bevacizumab|mesh-list
138650835|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650836|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
138650837|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650838|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138650839|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
138650840|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650841|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138650842|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138650843|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650845|NCT00304850|Analgesics|analgesics|mesh-ancestor
138650846|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
138650847|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650848|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650849|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138650850|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138650851|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
138650853|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650854|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138650855|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138349743|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138349744|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349745|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138349746|NCT04415892|Protective Agents|protective agents|mesh-ancestor
138349748|NCT04176354|Palbociclib|palbociclib|mesh-list
138349749|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138349750|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349752|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650856|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650857|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650859|NCT00329316|Progestins|progestins|mesh-ancestor
138650860|NCT00329316|Hormones|hormones|mesh-ancestor
138650861|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650862|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650863|NCT00332826|Insulin|insulin|mesh-list
138305582|NCT03426137|Ketorolac|ketorolac|mesh-list
138305583|NCT03426137|Oxycodone|oxycodone|mesh-list
138650865|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650867|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138650868|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138650869|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
138650870|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650872|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138650873|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650874|NCT00329355|Naproxen|naproxen|mesh-list
138650875|NCT00329355|Sumatriptan|sumatriptan|mesh-list
138650876|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138650877|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650878|NCT00329355|Analgesics|analgesics|mesh-ancestor
138256645|NCT01715233|Fluorouracil|fluorouracil|mesh-list
138650879|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
138650880|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650881|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349782|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
138349834|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650882|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138650883|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138650884|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
138650885|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138650886|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650887|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650888|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138650889|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138650894|NCT00332904|Spironolactone|spironolactone|mesh-list
138650895|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138650896|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138650897|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650898|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650899|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650900|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650901|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138650902|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650903|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
138650904|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138650905|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138650906|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138650907|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138650909|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
138650911|NCT00329394|Analgesics|analgesics|mesh-ancestor
138650912|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
138305687|NCT00608465|Ramipril|ramipril|mesh-list
138650915|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138650916|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138650917|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
138650918|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
138650919|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650920|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138650921|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138650922|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650923|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650924|NCT00305396|Sirolimus|sirolimus|mesh-list
138650925|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650926|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650927|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138650928|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650929|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
138650930|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650931|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
138650933|NCT00329472|Gemcitabine|gemcitabine|mesh-list
138650934|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650935|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650936|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
138650937|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650938|NCT00305474|Risperidone|risperidone|mesh-list
138650939|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138305743|NCT01629329|Aspirin|aspirin|mesh-list
138650941|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650942|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650943|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650944|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138650945|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138650946|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138650947|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650948|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138650949|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
138650950|NCT00329511|Clonidine|clonidine|mesh-list
138349835|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349836|NCT04095624|Analgesics|analgesics|mesh-ancestor
138349837|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
138349839|NCT03745716|Azacitidine|azacitidine|mesh-list
138650951|NCT00329511|Methyldopa|methyldopa|mesh-list
138650952|NCT00329511|Analgesics|analgesics|mesh-ancestor
138650953|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
138650955|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650956|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138650958|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
138650959|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256787|NCT02730962|Vancomycin|vancomycin|mesh-list
138650960|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138650961|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138650962|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650963|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650964|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650966|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138650967|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650968|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138650969|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650970|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650971|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138650972|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138650973|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
138650974|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650977|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138650978|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
138650979|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138650980|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650981|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650982|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650984|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138650985|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138650986|NCT00305552|Thalidomide|thalidomide|mesh-list
138650987|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650988|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
138650989|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650990|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
138650991|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650992|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138650993|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138650994|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138650995|NCT00305552|Growth Substances|growth substances|mesh-ancestor
138650996|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
138650997|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650999|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651000|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
138651001|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138651002|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138651003|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651004|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651005|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651006|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138651007|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138651009|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138651010|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138651011|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138651012|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651013|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
138651015|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651016|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305817|NCT00379691|Protective Agents|protective agents|mesh-ancestor
138651017|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651018|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
138651019|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651020|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651021|NCT00329628|Enoxaparin|enoxaparin|mesh-list
138651022|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
138651023|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138651024|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
138651025|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138651026|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
138651027|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651028|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651029|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
138651030|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138651031|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138651032|NCT00305669|Sargramostim|sargramostim|mesh-list
138651033|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
138651034|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651035|NCT00305708|Fludarabine|fludarabine|mesh-list
138651036|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
138651038|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138651039|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651040|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651041|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
138651042|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651043|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651044|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
138651047|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138651048|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138651050|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138651051|NCT00305747|Protective Agents|protective agents|mesh-ancestor
138305860|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651053|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651054|NCT00333255|Nepafenac|nepafenac|mesh-list
138651055|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651056|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651057|NCT00333255|Analgesics|analgesics|mesh-ancestor
138651058|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
138651059|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651060|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651061|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651062|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651063|NCT00305786|Gemcitabine|gemcitabine|mesh-list
138651064|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
138651065|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138256924|NCT02975141|Paclitaxel|paclitaxel|mesh-list
138651066|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
138651067|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651068|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651069|NCT00305825|Bevacizumab|bevacizumab|mesh-list
138651070|NCT00305825|Letrozole|letrozole|mesh-list
138651071|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651073|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138651074|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138651075|NCT00305825|Growth Substances|growth substances|mesh-ancestor
138651076|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651077|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
138651078|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138651079|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138651080|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651081|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651082|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138651083|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
138651084|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651087|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651088|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138651089|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651090|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
138651091|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
138349842|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349843|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349844|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349845|NCT03341676|Dexamethasone|dexamethasone|mesh-list
138349846|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651092|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651093|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651094|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651095|NCT00305903|Memantine|memantine|mesh-list
138651096|NCT00305903|Rivastigmine|rivastigmine|mesh-list
138651097|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138651098|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138651099|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
138651100|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651101|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651102|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651103|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138651105|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138651106|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305946|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651109|NCT00305903|Protective Agents|protective agents|mesh-ancestor
138651111|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651112|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651113|NCT00329823|Analgesics|analgesics|mesh-ancestor
138651114|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
138651115|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651116|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651117|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651118|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651119|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651120|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651121|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
138651122|NCT00306020|Morphine|morphine|mesh-list
138651124|NCT00306020|Narcotics|narcotics|mesh-ancestor
138651125|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651126|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651127|NCT00306020|Analgesics|analgesics|mesh-ancestor
138651128|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
138651129|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651131|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
138651132|NCT00306137|Coagulants|coagulants|mesh-ancestor
138651133|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138651134|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138349852|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
138349854|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349855|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138349856|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349858|NCT03121716|Cisplatin|cisplatin|mesh-list
138651135|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
138651136|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306004|NCT00281879|Etoposide|etoposide|mesh-list
138651137|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651138|NCT00329940|Letrozole|letrozole|mesh-list
138651139|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651140|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138651141|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138651142|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651143|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651144|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138327847|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651145|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
138651146|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651147|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651148|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
138651149|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651150|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651152|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138651153|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651154|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651155|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
138651156|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651157|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651158|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651159|NCT00330018|Acyclovir|acyclovir|mesh-list
138651160|NCT00330018|Valganciclovir|valganciclovir|mesh-list
138651161|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
138651162|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306049|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
138306050|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306051|NCT00000809|Antacids|antacids|mesh-ancestor
138306052|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306053|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306059|NCT00240227|Prazosin|prazosin|mesh-list
138651163|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138651164|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
138651165|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651166|NCT00306254|Enoxaparin|enoxaparin|mesh-list
138651167|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
138651168|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
138651171|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651172|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138651173|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
138651174|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138651175|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
138651176|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651177|NCT00333489|Valsartan|valsartan|mesh-list
138651178|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138651179|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138651180|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138651181|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651182|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
138651183|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138651184|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
138651185|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651186|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
138651187|NCT00330135|Protective Agents|protective agents|mesh-ancestor
138651189|NCT03275558|Axitinib|axitinib|mesh-list
138651190|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651191|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138306095|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651192|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138651193|NCT03275558|Growth Substances|growth substances|mesh-ancestor
138651194|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651195|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
138651196|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651197|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651198|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651199|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138651200|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138651201|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651202|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138651203|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
138651204|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138651206|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651207|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651208|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651209|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651211|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
138159639|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651212|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651213|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651214|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651215|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651216|NCT00330252|Rituximab|rituximab|mesh-list
138651217|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
138651218|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651219|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651220|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
138651221|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651222|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651223|NCT00333645|Caspofungin|caspofungin|mesh-list
138651224|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
138651225|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651226|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651227|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651228|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
138651229|NCT00451100|Neostigmine|neostigmine|mesh-list
138651230|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138651231|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651232|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306142|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138651233|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138651234|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651235|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651236|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138651237|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
138257111|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651238|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651239|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138651240|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138651241|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138651242|NCT00420537|Cyclosporine|cyclosporine|mesh-list
138651243|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
138651244|NCT00420537|Everolimus|everolimus|mesh-list
138651245|NCT00420537|Cyclosporins|cyclosporins|mesh-list
138651246|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453590|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138651247|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651248|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651249|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
138349884|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138349885|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349886|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138349887|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138349888|NCT02714634|Analgesics|analgesics|mesh-ancestor
138349889|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
138349891|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651250|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651251|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
138651252|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651253|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
138651254|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306175|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
138651255|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138651256|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138651257|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651258|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651259|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138651260|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138651261|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
138651262|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651263|NCT00451139|Lumefantrine|lumefantrine|mesh-list
138651264|NCT00451139|Artemether|artemether|mesh-list
138651265|NCT00451139|Quinine|quinine|mesh-list
138651266|NCT00451139|Atovaquone|atovaquone|mesh-list
138651267|NCT00451139|Proguanil|proguanil|mesh-list
138651268|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138651269|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138651270|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
138651271|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138651272|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138651273|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651274|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138651275|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651276|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138651277|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651278|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651279|NCT00451139|Analgesics|analgesics|mesh-ancestor
138306230|NCT00000161|Beta Carotene|beta carotene|mesh-list
138651280|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
138651281|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651282|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651283|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
138651284|NCT00330486|Acamprosate|acamprosate|mesh-list
138651285|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138651287|NCT00451373|Daptomycin|daptomycin|mesh-list
138651288|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651289|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651290|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
138257192|NCT00002967|Tamoxifen|tamoxifen|mesh-list
138651291|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651292|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651295|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138327993|NCT00354978|Leucovorin|leucovorin|mesh-list
138651296|NCT00451412|Tinzaparin|tinzaparin|mesh-list
138651297|NCT00451412|Dalteparin|dalteparin|mesh-list
138651298|NCT00451412|Certoparin|certoparin|mesh-list
138651299|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
138651300|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138651301|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138651302|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651303|NCT00451490|Agomelatine|agomelatine|mesh-list
138651304|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138453591|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138651305|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651306|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651308|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
138651309|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349898|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138349899|NCT00553800|Growth Substances|growth substances|mesh-ancestor
138349900|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349901|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138349902|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349905|NCT02747628|Melatonin|melatonin|mesh-list
138651310|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
138651311|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138651312|NCT00333918|Bromfenac|bromfenac|mesh-list
138651313|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138651314|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138306281|NCT00000203|Narcotics|narcotics|mesh-ancestor
138651315|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651316|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651317|NCT00333918|Analgesics|analgesics|mesh-ancestor
138651318|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
138160056|NCT01393730|Dutasteride|dutasteride|mesh-list
138651319|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651320|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651321|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651322|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651324|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651325|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651326|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138651327|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138651328|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138651329|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138651330|NCT00451724|Ketamine|ketamine|mesh-list
138651331|NCT00451724|Analgesics|analgesics|mesh-ancestor
138651332|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
138651333|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651336|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138651337|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
138651338|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
138651339|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651340|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138651341|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138651342|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651343|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651344|NCT00451763|Bevacizumab|bevacizumab|mesh-list
138651345|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651346|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651347|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138651348|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138651349|NCT00451763|Growth Substances|growth substances|mesh-ancestor
138651350|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651352|NCT00330798|Ketorolac|ketorolac|mesh-list
138651353|NCT00330798|Nepafenac|nepafenac|mesh-list
138651354|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651355|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651356|NCT00330798|Analgesics|analgesics|mesh-ancestor
138651357|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
138651358|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651359|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257289|NCT00003021|Bizelesin|bizelesin|mesh-list
138651360|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651361|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651362|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138651363|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651364|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651365|NCT00451880|Famotidine|famotidine|mesh-list
138651366|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138651367|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306380|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
138201708|NCT00002896|Vitamins|vitamins|mesh-ancestor
138349907|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138349908|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
138349909|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349910|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349911|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138349912|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138349913|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
138349914|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651371|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651372|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328083|NCT01552590|Tolvaptan|tolvaptan|mesh-list
138651373|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651374|NCT00451997|Cytarabine|cytarabine|mesh-list
138651375|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
138651376|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651377|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
138257312|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
138651378|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651379|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651380|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
138651381|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651382|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651383|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
138651384|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651385|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651386|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651389|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138651390|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
138651391|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138651392|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651393|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138651394|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651395|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
138160275|NCT02988999|Erythritol|erythritol|mesh-list
138651396|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138651397|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138651398|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138651399|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138651400|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
138651401|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138651404|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651405|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
138651406|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138651407|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138651408|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138651409|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651410|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651411|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651412|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651413|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
138651415|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
138651416|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138651417|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651418|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138651419|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138651420|NCT00333996|Dexamethasone|dexamethasone|mesh-list
138306466|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651421|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651422|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
138651423|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
138651424|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651425|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651426|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651427|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
138651428|NCT00333996|Hormones|hormones|mesh-ancestor
138349915|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349916|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
138349917|NCT02747628|Protective Agents|protective agents|mesh-ancestor
138349918|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349919|NCT02754570|Pilocarpine|pilocarpine|mesh-list
138349920|NCT02754570|Miotics|miotics|mesh-ancestor
138349921|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
138651429|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651430|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138651433|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138651434|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138651435|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138651436|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651437|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138651438|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
138651439|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651440|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138651441|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138651442|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651443|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651445|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
138651446|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
138651447|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651448|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651449|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651450|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138651451|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306529|NCT00000293|Nefazodone|nefazodone|mesh-list
138651452|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651454|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651455|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651456|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138651457|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651458|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
138651459|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651460|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
138651461|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651462|NCT00334308|Caseins|caseins|mesh-list
138651463|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
138651464|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
138651465|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651467|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
138651468|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651469|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651470|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
138651471|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651472|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651473|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
138651474|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138651475|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651476|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651477|NCT00334386|Torsemide|torsemide|mesh-list
138651478|NCT00334386|Diuretics|diuretics|mesh-list
138651479|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138651480|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
138651481|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651482|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138651483|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651484|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138651485|NCT00452231|Cycloserine|cycloserine|mesh-list
138651486|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138651487|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651488|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138349923|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349924|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138349925|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138349926|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
138349927|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349928|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349930|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
138349931|NCT02765256|Vancomycin|vancomycin|mesh-list
138349932|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
138651489|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
138651490|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651491|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
138651492|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651493|NCT00334425|Menotropins|menotropins|mesh-list
138651494|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138651495|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
138651496|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160635|NCT01431950|Xhance|xhance|mesh-list
138651497|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651498|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
138651499|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138651500|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651501|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651502|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651503|NCT03275207|Analgesics|analgesics|mesh-ancestor
138651504|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
138651505|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651506|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138651507|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138651509|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
138651510|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651511|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651512|NCT00334464|Warfarin|warfarin|mesh-list
138651513|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
138651514|NCT03275012|Morphine|morphine|mesh-list
138651515|NCT03275012|Gabapentin|gabapentin|mesh-list
138651516|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138651517|NCT03275012|Narcotics|narcotics|mesh-ancestor
138257486|NCT03962725|Analgesics|analgesics|mesh-ancestor
138651518|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328217|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138651519|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651520|NCT03275012|Analgesics|analgesics|mesh-ancestor
138651521|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
138651522|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651523|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
138651524|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138306605|NCT00001115|Acyclovir|acyclovir|mesh-list
138651525|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138651526|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651527|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138651528|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138349934|NCT02765256|Fluconazole|fluconazole|mesh-list
138349935|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138349936|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138349937|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651529|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453592|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
138651530|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651531|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
138651532|NCT00334503|Miglitol|miglitol|mesh-list
138651533|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651534|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651535|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651536|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651537|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138651539|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138651540|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138651541|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138651542|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651543|NCT00452270|Xylometazoline|xylometazoline|mesh-list
138651544|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
138651545|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138651546|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
138651547|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
138651548|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
138651549|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138651550|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138651551|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651552|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651553|NCT00452582|Urological Agents|urological agents|mesh-ancestor
138651554|NCT00334698|Cetirizine|cetirizine|mesh-list
138651555|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
138651556|NCT00334698|Ephedrine|ephedrine|mesh-list
138651557|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138160794|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
138651558|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138651559|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138651560|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
138651561|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
138651562|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651563|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651564|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651565|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138651566|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
138651567|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651568|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138306636|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651571|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138651572|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138651573|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
138651574|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138651575|NCT00452660|Deferasirox|deferasirox|mesh-list
138651576|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138651577|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
138651578|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
138651579|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651580|NCT00334854|Doxorubicin|doxorubicin|mesh-list
138651581|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138651582|NCT00334854|Ifosfamide|ifosfamide|mesh-list
138651583|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138651584|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651585|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138651586|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138651588|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651590|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
138651591|NCT00334932|Doxorubicin|doxorubicin|mesh-list
138651592|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138651593|NCT00334932|Bortezomib|bortezomib|mesh-list
138651594|NCT00334932|Melphalan|melphalan|mesh-list
138651595|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138651596|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651597|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138651598|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138651600|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651601|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138651602|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
138651603|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138651604|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651605|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
138651606|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651608|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
138651610|NCT00452855|Sevoflurane|sevoflurane|mesh-list
138651611|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
138651612|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306663|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138651613|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651614|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138651615|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138651616|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
138651617|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138651618|NCT00452855|Narcotics|narcotics|mesh-ancestor
138651619|NCT00452855|Analgesics|analgesics|mesh-ancestor
138651620|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
138651621|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651623|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
138651624|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
138651625|NCT00335088|Povidone|povidone|mesh-list
138651626|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651628|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138651629|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138651630|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651631|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651632|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651633|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651634|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138651636|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
138651637|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
138651638|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
138651639|NCT00452894|Varenicline|varenicline|mesh-list
138651640|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138651642|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
138651643|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161161|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
138651644|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651645|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651647|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
138651648|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651649|NCT00335166|Protective Agents|protective agents|mesh-ancestor
138651650|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651651|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138651652|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138651653|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
138349961|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349962|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349963|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
138349964|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
138349965|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
138349966|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349967|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
138349968|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
138349969|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651654|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
138651655|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651656|NCT00452972|Anesthetics|anesthetics|mesh-list
138651657|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651658|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651659|NCT00335205|Ropinirole|ropinirole|mesh-list
138651661|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138651662|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
138651663|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
138651664|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651665|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651666|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651668|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138651669|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
138651670|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651671|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306744|NCT00001889|Dobutamine|dobutamine|mesh-list
138651672|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
138651673|NCT00335400|Anesthetics|anesthetics|mesh-list
138651674|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651675|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651676|NCT00420615|Epothilone B|epothilone b|mesh-list
138651677|NCT00420615|Epothilones|epothilones|mesh-list
138651678|NCT00420615|Omeprazole|omeprazole|mesh-list
138651679|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138651680|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651681|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138651682|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651683|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651685|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651686|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
138651687|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138651688|NCT00453167|Paclitaxel|paclitaxel|mesh-list
138651689|NCT00453167|Gemcitabine|gemcitabine|mesh-list
138651690|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138651691|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651692|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651693|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
138651694|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
138306790|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138306792|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138651695|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651697|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
138651698|NCT00420654|Hormones|hormones|mesh-list
138651699|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651700|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651701|NCT00420693|Sevoflurane|sevoflurane|mesh-list
138651702|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138651703|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138651704|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
138651705|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
138651706|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651708|NCT00453323|Paclitaxel|paclitaxel|mesh-list
138651709|NCT00453323|Capecitabine|capecitabine|mesh-list
138651710|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138651711|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651712|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651713|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138651714|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138651715|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257708|NCT01760785|Valproic Acid|valproic acid|mesh-list
138651716|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651718|NCT00335439|Ketorolac|ketorolac|mesh-list
138651719|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138651720|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651721|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651722|NCT00335439|Analgesics|analgesics|mesh-ancestor
138651723|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
138201709|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
138651725|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651726|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651727|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651728|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138651729|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651730|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651731|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
138651732|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
138651733|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161448|NCT04749069|Narcotics|narcotics|mesh-ancestor
138651734|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651738|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138651739|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651740|NCT00453635|Carboplatin|carboplatin|mesh-list
138651741|NCT00453635|Docetaxel|docetaxel|mesh-list
138651742|NCT00453635|Trastuzumab|trastuzumab|mesh-list
138651743|NCT00453635|Vinorelbine|vinorelbine|mesh-list
138651744|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651745|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
138306901|NCT00001991|Atovaquone|atovaquone|mesh-list
138651746|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
138651747|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
138453593|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651748|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651751|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138651752|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
138651753|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138651754|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
138651755|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138651756|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
138651757|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651759|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651760|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138651761|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651762|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651764|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138651765|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651766|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138651767|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651768|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651769|NCT00453908|Alfuzosin|alfuzosin|mesh-list
138651770|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138651771|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138651772|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138651774|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306943|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
138306953|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
138651775|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651776|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651778|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138651779|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138651780|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138651781|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
138651782|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651783|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138651784|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138651785|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651786|NCT00336375|Lumefantrine|lumefantrine|mesh-list
138651788|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138651789|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
138651790|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138651791|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138651792|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651794|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
138651795|NCT00336414|Azathioprine|azathioprine|mesh-list
138651796|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651797|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
138651798|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651799|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651800|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138651801|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
138651802|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651803|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306990|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
138306993|NCT00000659|Zidovudine|zidovudine|mesh-list
138651804|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138651805|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651808|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651809|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138651810|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
138651811|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651812|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
138651813|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
138651814|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
138651815|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651816|NCT00336453|Coagulants|coagulants|mesh-ancestor
138651819|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651820|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138651821|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138651822|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651823|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651824|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138651825|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
138257832|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138651826|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138651827|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651828|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138651829|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
138651830|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138651832|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651833|NCT00322062|Protective Agents|protective agents|mesh-ancestor
138651834|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651836|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
138651838|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651839|NCT00336648|Bevacizumab|bevacizumab|mesh-list
138651840|NCT00336648|Gemcitabine|gemcitabine|mesh-list
138651841|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651844|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138651845|NCT00336648|Growth Substances|growth substances|mesh-ancestor
138651846|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651847|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
138651848|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651849|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
138651850|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257937|NCT02652169|Amikacin|amikacin|mesh-list
138651851|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138651852|NCT03274817|Escitalopram|escitalopram|mesh-list
138651853|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138651854|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138651855|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138651856|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651857|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258002|NCT02260531|Trastuzumab|trastuzumab|mesh-list
138651858|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
138651859|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651860|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138651861|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
138651862|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138651863|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138651864|NCT00230204|Antibodies|antibodies|mesh-list
138651865|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
138651866|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651867|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
138651868|NCT00230321|Hematinics|hematinics|mesh-ancestor
138307079|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
138307083|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651869|NCT00230399|Celecoxib|celecoxib|mesh-list
138651870|NCT00230399|Capecitabine|capecitabine|mesh-list
138651871|NCT00230399|Irinotecan|irinotecan|mesh-list
138651872|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651873|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
138651874|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651875|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651876|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138651877|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138651878|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651879|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651880|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651881|NCT00230399|Analgesics|analgesics|mesh-ancestor
138161976|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
138651882|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
138651883|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651884|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651885|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651886|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651887|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138651888|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138651890|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651891|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651892|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651893|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651895|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138651896|NCT00230477|Adefovir|adefovir|mesh-list
138651897|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138651898|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138651899|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651900|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651901|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
138307128|NCT00001499|Cisplatin|cisplatin|mesh-list
138651902|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651904|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138651905|NCT00230516|Lansoprazole|lansoprazole|mesh-list
138651906|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138651907|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138651908|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138162087|NCT00429949|Dasatinib|dasatinib|mesh-list
138349970|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138349971|NCT02765256|Laxatives|laxatives|mesh-ancestor
138349972|NCT02767128|Citric Acid|citric acid|mesh-list
138651909|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651910|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651911|NCT00336882|Midazolam|midazolam|mesh-list
138651912|NCT00336882|Propofol|propofol|mesh-list
138651913|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138651914|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138651915|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651916|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138651917|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
138651918|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
138651919|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138651920|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138651921|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138307171|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
138651923|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
138651924|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
138651925|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258157|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138651926|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651927|NCT00336921|Alfuzosin|alfuzosin|mesh-list
138651928|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138651929|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138651930|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138651932|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651933|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651934|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651935|NCT00336921|Urological Agents|urological agents|mesh-ancestor
138651937|NCT00336960|Fluorouracil|fluorouracil|mesh-list
138651938|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
138651939|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651940|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138651941|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651942|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651943|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
138651944|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651945|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651946|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138651947|NCT00336960|Analgesics|analgesics|mesh-ancestor
138307224|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138651948|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
138651949|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651950|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651951|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138651952|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138651953|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138651954|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651955|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
138651957|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138651958|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651959|NCT00306410|Vitamins|vitamins|mesh-ancestor
138651960|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
138651961|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138651962|NCT00340080|Abacavir|abacavir|mesh-list
138651963|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307274|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307275|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307276|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
138651964|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138651965|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651966|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651967|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
138328674|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
138651968|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651969|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138651970|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138651971|NCT00418535|Cisplatin|cisplatin|mesh-list
138651972|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651973|NCT02960711|Metformin|metformin|mesh-list
138651974|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651975|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651976|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138651977|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
138651978|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138651979|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651980|NCT00306683|Diazoxide|diazoxide|mesh-list
138651981|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138651982|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138651984|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138651985|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138307330|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138651987|NCT00337389|Leucovorin|leucovorin|mesh-list
138651988|NCT00337389|Bevacizumab|bevacizumab|mesh-list
138651989|NCT00337389|Fluorouracil|fluorouracil|mesh-list
138651990|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651991|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651992|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138651993|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138651994|NCT00337389|Growth Substances|growth substances|mesh-ancestor
138651995|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651996|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
138651997|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
138651998|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651999|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652000|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652001|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
138652002|NCT00337389|Antidotes|antidotes|mesh-ancestor
138652003|NCT00337389|Protective Agents|protective agents|mesh-ancestor
138652004|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
138652005|NCT00337389|Vitamins|vitamins|mesh-ancestor
138652006|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
138652007|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138329360|NCT04750122|Trastuzumab|trastuzumab|mesh-list
138652008|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138307400|NCT00002135|Ganciclovir|ganciclovir|mesh-list
138652009|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138652010|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138652011|NCT00306878|Abatacept|abatacept|mesh-list
138652012|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138652013|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652014|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138652015|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652016|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652017|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
138652018|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652019|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652021|NCT00337506|Bortezomib|bortezomib|mesh-list
138652022|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652023|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
138652024|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
138652025|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652026|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652027|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652028|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
138652029|NCT00337506|Hormones|hormones|mesh-ancestor
138652030|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652031|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652032|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652034|NCT00307307|Simvastatin|simvastatin|mesh-list
138652035|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138652036|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138652037|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
138652038|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652039|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138652040|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138652041|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652042|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
138652043|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
138652044|NCT00307307|Vitamins|vitamins|mesh-ancestor
138652045|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
138307436|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652046|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652048|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652049|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
138652051|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652052|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652053|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652054|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652055|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
138652056|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138652057|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138652058|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652059|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138652060|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138652061|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
138652062|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652063|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
138652064|NCT00337740|Propranolol|propranolol|mesh-list
138329530|NCT00548418|Growth Substances|growth substances|mesh-ancestor
138652065|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138652066|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138258650|NCT02537951|Lidocaine|lidocaine|mesh-list
138652067|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652068|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652069|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652070|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652071|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138652072|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138307472|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138652073|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
138652074|NCT00307502|Ritonavir|ritonavir|mesh-list
138652075|NCT00307502|Lopinavir|lopinavir|mesh-list
138258690|NCT02487563|Decitabine|decitabine|mesh-list
138652076|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138652077|NCT00307502|Darunavir|darunavir|mesh-list
138652078|NCT00307502|Nelfinavir|nelfinavir|mesh-list
138652079|NCT00307502|Indinavir|indinavir|mesh-list
138652080|NCT00307502|Saquinavir|saquinavir|mesh-list
138652081|NCT00307502|Amprenavir|amprenavir|mesh-list
138652082|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
138652083|NCT00307502|Nevirapine|nevirapine|mesh-list
138652084|NCT00307502|Tipranavir|tipranavir|mesh-list
138652085|NCT00307502|Efavirenz|efavirenz|mesh-list
138652086|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138652087|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138652088|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138329587|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652089|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652090|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652091|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138652092|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138652093|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
138652094|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652095|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138652096|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138652097|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138652098|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138652099|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138652100|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138652101|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138652102|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138652103|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138652104|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138652105|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
138652106|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652107|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138652108|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138652109|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138652110|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652111|NCT00307619|Topiramate|topiramate|mesh-list
138652112|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
138652113|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138652114|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652115|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
138652116|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138652117|NCT00307658|Antibodies|antibodies|mesh-list
138329648|NCT00553410|Letrozole|letrozole|mesh-list
138652118|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
138652119|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
138652120|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138652121|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
138652122|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652124|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138652125|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138652127|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652128|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258846|NCT01827475|Analgesics|analgesics|mesh-ancestor
138652129|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
138652130|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652131|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652132|NCT00307775|Estradiol|estradiol|mesh-list
138652133|NCT00307775|Estrogens|estrogens|mesh-ancestor
138652134|NCT00307775|Hormones|hormones|mesh-ancestor
138652135|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652136|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652137|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
138652138|NCT00307814|Hematinics|hematinics|mesh-ancestor
138652139|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
138652140|NCT00341055|Hematinics|hematinics|mesh-ancestor
138652141|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138652142|NCT00338052|Norethindrone|norethindrone|mesh-list
138652143|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
138652144|NCT00338052|Estradiol|estradiol|mesh-list
138652145|NCT00338052|Estrogens|estrogens|mesh-ancestor
138652146|NCT00338052|Hormones|hormones|mesh-ancestor
138307560|NCT02973581|Acetaminophen|acetaminophen|mesh-list
138652147|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652148|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652149|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138652150|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
138652151|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138652152|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138652153|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138652154|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138652155|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138652157|NCT00338091|Benazepril|benazepril|mesh-list
138652158|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138652159|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652160|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138652161|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138652162|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652163|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138652164|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652165|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652166|NCT00308048|Interferons|interferons|mesh-list
138652167|NCT00308048|Ribavirin|ribavirin|mesh-list
138652168|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
138652169|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
138652170|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138329734|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
138652171|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652172|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
138652173|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652174|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
138652175|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652176|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
138652177|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307613|NCT00002453|Tenofovir|tenofovir|mesh-list
138652178|NCT00338130|Temozolomide|temozolomide|mesh-list
138652179|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138652180|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
138652181|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652182|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652183|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138652184|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
138652185|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
138652187|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138349998|NCT02774226|Vitamin E|vitamin e|mesh-list
138652188|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652189|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652190|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652191|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652192|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138652194|NCT00338247|Lapatinib|lapatinib|mesh-list
138652195|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328901|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
138652197|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652198|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652199|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138652200|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652201|NCT00308321|Prednisolone|prednisolone|mesh-list
138307638|NCT00002471|Dexamethasone|dexamethasone|mesh-list
138652202|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138652203|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
138652204|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138652205|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
138652206|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138652208|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652209|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
138652210|NCT00308321|Hormones|hormones|mesh-ancestor
138652211|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652212|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652213|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652214|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652215|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
138652216|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
138652217|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652218|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652219|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138652220|NCT00308321|Protective Agents|protective agents|mesh-ancestor
138652221|NCT00308360|Valproic Acid|valproic acid|mesh-list
138652223|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138652224|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
138652225|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652226|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652227|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652228|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138652229|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138652230|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652231|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652232|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138652233|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
138652234|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
138652235|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652236|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
138652237|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
138652238|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138652239|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138652240|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
138652241|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652242|NCT00341250|Antacids|antacids|mesh-ancestor
138652243|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652244|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652246|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652247|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138162958|NCT05541276|Melatonin|melatonin|mesh-list
138652248|NCT00308438|Protective Agents|protective agents|mesh-ancestor
138652249|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652250|NCT00308477|Dexamethasone|dexamethasone|mesh-list
138652251|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652252|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
138652253|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
138652254|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652255|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652256|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652257|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
138652258|NCT00308477|Hormones|hormones|mesh-ancestor
138652259|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652260|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652261|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652262|NCT00308594|Dexamethasone|dexamethasone|mesh-list
138652263|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652264|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
138652265|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
138329864|NCT02128230|Doxorubicin|doxorubicin|mesh-list
138652266|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652267|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652268|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652269|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
138652270|NCT00308594|Hormones|hormones|mesh-ancestor
138652271|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328977|NCT04270656|Insulin|insulin|mesh-list
138652272|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652273|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652274|NCT00308945|Travoprost|travoprost|mesh-list
138652275|NCT00308945|Latanoprost|latanoprost|mesh-list
138259165|NCT02576249|Ropivacaine|ropivacaine|mesh-list
138652277|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138652278|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652279|NCT00338481|Morphine|morphine|mesh-list
138652280|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138652281|NCT00338481|Narcotics|narcotics|mesh-ancestor
138652282|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652283|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652284|NCT00338481|Analgesics|analgesics|mesh-ancestor
138652285|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
138652286|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652287|NCT00309101|Tacrolimus|tacrolimus|mesh-list
138652288|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652289|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
138652290|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652291|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138652292|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652293|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652294|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
138652295|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138652296|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138652297|NCT00309218|Prednisolone|prednisolone|mesh-list
138652298|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
138652299|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138652300|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
138652301|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652303|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
138652304|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652305|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652306|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652307|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
138652308|NCT00309218|Hormones|hormones|mesh-ancestor
138652309|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652310|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138652311|NCT00309218|Protective Agents|protective agents|mesh-ancestor
138163075|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
138652312|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652313|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652314|NCT00309335|Phentolamine|phentolamine|mesh-list
138652315|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138652316|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138652317|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652318|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652319|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652320|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329981|NCT05363202|Xhance|xhance|mesh-list
138652321|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652322|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138652324|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138652325|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138652326|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
138652327|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163099|NCT04912505|Aspirin|aspirin|mesh-list
138652328|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138652329|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138652330|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652331|NCT00309413|Cannabidiol|cannabidiol|mesh-list
138652332|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
138652333|NCT00309491|Tamoxifen|tamoxifen|mesh-list
138652334|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
138652335|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138652336|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
138307874|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
138307875|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652337|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330006|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
138652338|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652339|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652340|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652341|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138652342|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138652343|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138652344|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138652345|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138652346|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652347|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652349|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652350|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
138652351|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
138652352|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
138652355|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
138652356|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652357|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652358|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652359|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652360|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
138652361|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652362|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
138652363|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330068|NCT05198232|TEMPO|tempo|mesh-list
138652364|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
138652365|NCT00309569|Fluorouracil|fluorouracil|mesh-list
138652366|NCT00309569|Methotrexate|methotrexate|mesh-list
138652367|NCT00309569|Epirubicin|epirubicin|mesh-list
138307926|NCT00002219|Nelfinavir|nelfinavir|mesh-list
138652368|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652369|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
138652370|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652371|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652372|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138652374|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652375|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652376|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138652378|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652379|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138652380|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
138652381|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138652382|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
138652383|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652384|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138652385|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259356|NCT02989519|Hormones|hormones|mesh-ancestor
138652386|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652387|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307967|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307975|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
138652389|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138652390|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138652391|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138652392|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652393|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652394|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652395|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138652396|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138652397|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
138652399|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652400|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138652402|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
138652403|NCT00309725|Galantamine|galantamine|mesh-list
138652404|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138652405|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652406|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652407|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
138652408|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652409|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652410|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138652411|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
138652412|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652413|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
138652414|NCT00338754|Adalimumab|adalimumab|mesh-list
138652415|NCT00338754|Antibodies|antibodies|mesh-list
138652416|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138163459|NCT02959164|Decitabine|decitabine|mesh-list
138652417|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
138308027|NCT00002285|Zidovudine|zidovudine|mesh-list
138652418|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652419|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138329170|NCT00431184|Lorazepam|lorazepam|mesh-list
138652421|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652422|NCT00338793|Prednisolone|prednisolone|mesh-list
138652423|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652424|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
138652425|NCT00338793|Hormones|hormones|mesh-ancestor
138652426|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652427|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652428|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330151|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652429|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652430|NCT00418847|Miglustat|miglustat|mesh-list
138652431|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259538|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
138308068|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652432|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652433|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138652434|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138652435|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
138652436|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652437|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138652438|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138652439|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652441|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
138652442|NCT00309881|Rituximab|rituximab|mesh-list
138652443|NCT00309881|Doxorubicin|doxorubicin|mesh-list
138652444|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138652446|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652447|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
138652448|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652449|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163557|NCT00453895|Growth Substances|growth substances|mesh-ancestor
138652450|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138652451|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
138652452|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308126|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138652453|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652454|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138652455|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138652456|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652457|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138652458|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652459|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652460|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652461|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
138652463|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652464|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652465|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138652466|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652467|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652468|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652469|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
138652471|NCT00309920|Doxorubicin|doxorubicin|mesh-list
138652472|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138652473|NCT00309920|Fluorouracil|fluorouracil|mesh-list
138652474|NCT00309920|Epirubicin|epirubicin|mesh-list
138652475|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
138652476|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652477|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
138652478|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652479|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652480|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138652481|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
138652482|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308181|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652483|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652484|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138652485|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652486|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652487|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652488|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652489|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138652490|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652491|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652492|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
138652493|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652494|NCT00309920|Hematinics|hematinics|mesh-ancestor
138652495|NCT00309998|Bevacizumab|bevacizumab|mesh-list
138652496|NCT00309998|Vinorelbine|vinorelbine|mesh-list
138329203|NCT01795794|Omeprazole|omeprazole|mesh-list
138652497|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138652498|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652499|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138652500|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138652501|NCT00309998|Growth Substances|growth substances|mesh-ancestor
138652502|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652503|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138652504|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308223|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652505|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652506|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652507|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652508|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652510|NCT00310154|Gefitinib|gefitinib|mesh-list
138652511|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652512|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652513|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652514|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652515|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652516|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138652517|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652518|NCT00338910|Metronidazole|metronidazole|mesh-list
138652519|NCT00338910|Budesonide|budesonide|mesh-list
138652520|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652521|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138652522|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
138652523|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652524|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652525|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138652526|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
138652527|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
138652528|NCT00338910|Hormones|hormones|mesh-ancestor
138652529|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652530|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652531|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138308275|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652533|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138652534|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
138652535|NCT00310232|Hematinics|hematinics|mesh-ancestor
138652536|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138652537|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652538|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652539|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652540|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138652541|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
138652542|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652544|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138652545|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138652546|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
138652547|NCT00310505|Amebicides|amebicides|mesh-ancestor
138652548|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138652549|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138652550|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308324|NCT05673785|Doxorubicin|doxorubicin|mesh-list
138308341|NCT05673785|Hormones|hormones|mesh-ancestor
138652551|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652552|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
138259792|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652553|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138652554|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652555|NCT00339066|Sertraline|sertraline|mesh-list
138652556|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
138652557|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652558|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138652559|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138652560|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652561|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652562|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308380|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138652563|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
138652564|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652566|NCT00310583|Analgesics|analgesics|mesh-ancestor
138259849|NCT01852669|Furosemide|furosemide|mesh-list
138652567|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
138652568|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652569|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330550|NCT01115569|Hydrocodone|hydrocodone|mesh-list
138652570|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
138652571|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138652572|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652573|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652575|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138652576|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138652577|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652578|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652579|NCT00421044|Epothilone B|epothilone b|mesh-list
138652580|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652581|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652582|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652583|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308440|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308441|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652584|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652585|NCT00425217|Rituximab|rituximab|mesh-list
138652586|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164073|NCT04017962|Letermovir|letermovir|mesh-list
138652588|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
138652589|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652590|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652591|NCT00310778|Atenolol|atenolol|mesh-list
138652592|NCT00310778|Valsartan|valsartan|mesh-list
138652593|NCT00310778|Candesartan|candesartan|mesh-list
138652594|NCT00310778|Candesartan cilexetil|candesartan cilexetil|mesh-list
138652595|NCT00310778|Ramipril|ramipril|mesh-list
138652596|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652597|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138652598|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138652599|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652600|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138652601|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652602|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652603|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138652604|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
138652605|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
138652606|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652607|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652608|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138652609|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138652610|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138652611|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652612|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652614|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
138652615|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138652616|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138652617|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652618|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652619|NCT00421083|Urological Agents|urological agents|mesh-ancestor
138652620|NCT00310895|Imetelstat|imetelstat|mesh-list
138652621|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
138652622|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652623|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652624|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138330694|NCT05765110|Protective Agents|protective agents|mesh-ancestor
138652625|NCT00310934|Buprenorphine|buprenorphine|mesh-list
138652626|NCT00310934|Methadone|methadone|mesh-list
138652627|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260090|NCT01874119|Aprepitant|aprepitant|mesh-list
138652629|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652630|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652631|NCT00310934|Analgesics|analgesics|mesh-ancestor
138652632|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
138308553|NCT00002783|Leucovorin|leucovorin|mesh-list
138652633|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652634|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138652635|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
138652636|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
138652637|NCT00421122|Budesonide|budesonide|mesh-list
138652638|NCT00421122|Terbutaline|terbutaline|mesh-list
138652639|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
138652640|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138652641|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652642|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138652644|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652645|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652646|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138652647|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
138350058|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
138350059|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138652648|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
138652649|NCT00421122|Hormones|hormones|mesh-ancestor
138652650|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652651|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138308594|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
138308598|NCT00381953|Ribavirin|ribavirin|mesh-list
138652652|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138652653|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138652654|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330764|NCT05731726|Analgesics|analgesics|mesh-ancestor
138652655|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652656|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652657|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
138652658|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
138652659|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138652661|NCT00311051|Montelukast|montelukast|mesh-list
138652662|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138652663|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138652664|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138652665|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
138652666|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652667|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652668|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138652669|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138652670|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652671|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138652672|NCT00311129|Rituximab|rituximab|mesh-list
138652673|NCT00311129|Fludarabine|fludarabine|mesh-list
138652674|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
138652675|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260268|NCT05588297|Nivolumab|nivolumab|mesh-list
138652676|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652677|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
138652678|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308650|NCT02972957|Azithromycin|azithromycin|mesh-list
138308651|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652680|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652681|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
138652682|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652683|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652685|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652686|NCT00342381|Amifampridine|amifampridine|mesh-list
138652687|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138652688|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652689|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652690|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138652691|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652692|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652693|NCT00311558|Interferons|interferons|mesh-list
138164272|NCT00462605|Entinostat|entinostat|mesh-list
138652694|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
138652695|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
138652696|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138652697|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652698|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
138652699|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652700|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
138652702|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138652703|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138652704|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
138652705|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138652706|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
138652707|NCT00418925|Dronabinol|dronabinol|mesh-list
138652708|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
138308696|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138652709|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652710|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652711|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138652712|NCT00418925|Analgesics|analgesics|mesh-ancestor
138652713|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
138652714|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652715|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138652716|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138652717|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652718|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652719|NCT00418925|Hormones|hormones|mesh-ancestor
138704086|NCT06170788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652720|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652721|NCT00339417|Ivermectin|ivermectin|mesh-list
138652722|NCT00339417|Albendazole|albendazole|mesh-list
138652723|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138652724|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652725|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
138652726|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
138308739|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
138652727|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138652728|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138652729|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652730|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652731|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652732|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652733|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652735|NCT00311636|Docetaxel|docetaxel|mesh-list
138652736|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
138652737|NCT00311636|Doxorubicin|doxorubicin|mesh-list
138652738|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138652739|NCT00311636|Fluorouracil|fluorouracil|mesh-list
138652740|NCT00311636|Methotrexate|methotrexate|mesh-list
138652741|NCT00311636|Epirubicin|epirubicin|mesh-list
138652742|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138652743|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138652744|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652745|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652746|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652747|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652748|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164489|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
138652749|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652750|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
138652751|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652752|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652753|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330883|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652755|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138652756|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652757|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138652758|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652759|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652760|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
138652761|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652762|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138652763|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
138652764|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138652765|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138652766|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138652767|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138652768|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
138652769|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138652770|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
138652771|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138652772|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652773|NCT00311753|Heparin|heparin|mesh-list
138652774|NCT00311753|Certoparin|certoparin|mesh-list
138652775|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
138652776|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138652777|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138652778|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652780|NCT00311870|Nisoldipine|nisoldipine|mesh-list
138652781|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138308847|NCT03575195|Rifaximin|rifaximin|mesh-list
138260608|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
138652782|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652783|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652784|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652785|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652786|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138652787|NCT00311870|Protective Agents|protective agents|mesh-ancestor
138652788|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652789|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138652790|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652791|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138330934|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138652792|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138308891|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138652793|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
138704087|NCT06170788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138453613|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138652795|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652796|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652798|NCT00342849|Antidotes|antidotes|mesh-ancestor
138652799|NCT00342849|Protective Agents|protective agents|mesh-ancestor
138652800|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652801|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
138652802|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
138260727|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652803|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652804|NCT00312104|Insulin|insulin|mesh-list
138652805|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138652806|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
138652807|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
138652808|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
138652809|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138652810|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652811|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
138308953|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308954|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308976|NCT03058289|Ipilimumab|ipilimumab|mesh-list
138652812|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652813|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652814|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138652815|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
138652816|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652817|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652818|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453614|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
138652819|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652821|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138652822|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
138652823|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652824|NCT00343005|Antacids|antacids|mesh-ancestor
138652825|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652826|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652827|NCT00312182|Nelfinavir|nelfinavir|mesh-list
138652828|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138652829|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138652830|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
138652831|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260925|NCT05446493|Tadalafil|tadalafil|mesh-list
138652832|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309021|NCT00002987|Hormones|hormones|mesh-ancestor
138652834|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138652835|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
138652836|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652838|NCT00312260|Amitriptyline|amitriptyline|mesh-list
138652839|NCT00312260|Analgesics|analgesics|mesh-ancestor
138652840|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
138652841|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652842|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652843|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
138652844|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138652845|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138652846|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652847|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138652848|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138652849|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138652850|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652851|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652852|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
138652853|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138652854|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
138331016|NCT04656301|Psilocybin|psilocybin|mesh-list
138652856|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138652857|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138309057|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
138652858|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652859|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652860|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138652861|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
138652862|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138652863|NCT00312299|Protective Agents|protective agents|mesh-ancestor
138652864|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652865|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138652866|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652867|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138652868|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138329579|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652869|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138652870|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652871|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309108|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309109|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
138309111|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331061|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
138652872|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652873|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652876|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652877|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652878|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138652879|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652880|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138652881|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261125|NCT00369863|Hormones|hormones|mesh-ancestor
138652882|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652883|NCT00343161|Esomeprazole|esomeprazole|mesh-list
138652884|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138350077|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652885|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
138652886|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138652887|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652888|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138652889|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652890|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652892|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
138309161|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309165|NCT00383357|Zolpidem|zolpidem|mesh-list
138652893|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652894|NCT00343161|Antacids|antacids|mesh-ancestor
138652896|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
138652897|NCT00312533|Protective Agents|protective agents|mesh-ancestor
138652898|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652899|NCT00312650|Gemcitabine|gemcitabine|mesh-list
138652901|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138652902|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652903|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
138652904|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652905|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652906|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652907|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138652908|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138652909|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652910|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
138261217|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138652911|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652912|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
138309211|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
138309213|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
138652913|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138652914|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138652915|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652916|NCT00343200|Urological Agents|urological agents|mesh-ancestor
138652917|NCT00312806|Pantoprazole|pantoprazole|mesh-list
138652918|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138652919|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138652920|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138652921|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453615|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138652922|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652924|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138652925|NCT00347685|Narcotics|narcotics|mesh-ancestor
138652926|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652927|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652928|NCT00347685|Analgesics|analgesics|mesh-ancestor
138652929|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
138652930|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652931|NCT00343239|Docetaxel|docetaxel|mesh-list
138652933|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652934|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652935|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652936|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331227|NCT02894398|Letrozole|letrozole|mesh-list
138652937|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652938|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
138652939|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138652940|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138652941|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
138652942|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652943|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
138652945|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
138652946|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138652947|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652948|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138652950|NCT00313001|Hormones|hormones|mesh-ancestor
138652951|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138652952|NCT00343278|Valacyclovir|valacyclovir|mesh-list
138652953|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
138652954|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652955|NCT00343317|Cefoxitin|cefoxitin|mesh-list
138652956|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138652957|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652958|NCT00313079|Vincristine|vincristine|mesh-list
138652959|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138652960|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652961|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138652962|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138652963|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138453616|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
138652964|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652966|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138652968|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138652969|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652970|NCT00347724|Analgesics|analgesics|mesh-ancestor
138652971|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
138652972|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652973|NCT00313157|Metoprolol|metoprolol|mesh-list
138652975|NCT00313157|Carvedilol|carvedilol|mesh-list
138652976|NCT00313157|Diltiazem|diltiazem|mesh-list
138652977|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138652978|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138652979|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
138652980|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
138652981|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138652982|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652983|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138652984|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138261673|NCT01916941|Prazosin|prazosin|mesh-list
138652985|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138652986|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652987|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309363|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309366|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309367|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652988|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652990|NCT00313157|Protective Agents|protective agents|mesh-ancestor
138652991|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138652992|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138652993|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138652994|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
138652995|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138652996|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138652998|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652999|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653000|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
138653001|NCT00313235|Vaccines|vaccines|mesh-list
138331322|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653002|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
138653003|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653004|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653005|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653006|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653007|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
138653008|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201710|NCT00002896|Trace Elements|trace elements|mesh-ancestor
138653009|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261794|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
138653010|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309416|NCT00003437|Dexamethasone|dexamethasone|mesh-list
138309417|NCT00003437|Prednisolone|prednisolone|mesh-list
138653011|NCT00347802|Bimatoprost|bimatoprost|mesh-list
138653012|NCT00347802|Travoprost|travoprost|mesh-list
138653013|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653014|NCT00313274|Clevudine|clevudine|mesh-list
138653015|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
138653016|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653017|NCT00419042|Gemcitabine|gemcitabine|mesh-list
138653018|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138653019|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653020|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
138653021|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653022|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653023|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653024|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653025|NCT00347841|Bimatoprost|bimatoprost|mesh-list
138653027|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138653028|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138653029|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653030|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
138653031|NCT00425126|Hematinics|hematinics|mesh-ancestor
138653032|NCT00343629|Sulindac|sulindac|mesh-list
138653033|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138653034|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653035|NCT00343629|Analgesics|analgesics|mesh-ancestor
138309466|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
138653036|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
138653037|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653038|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653039|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653040|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653041|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653042|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138653043|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165633|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138165634|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165641|NCT05679908|Oxytocin|oxytocin|mesh-list
138165642|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
138165643|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165645|NCT05672927|Vaccines|vaccines|mesh-list
138653044|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653046|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138653047|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138653048|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653049|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653050|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653052|NCT00343707|Vestipitant|vestipitant|mesh-list
138653053|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138653054|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138653055|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138653056|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165700|NCT05514405|Propofol|propofol|mesh-list
138653058|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
138653059|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653060|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138653061|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
138653062|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138653063|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138653064|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138653065|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653066|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138653067|NCT00313391|Risperidone|risperidone|mesh-list
138653068|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138653069|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
138653070|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653071|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653072|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309506|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653073|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138653074|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138653075|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653076|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138653077|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138653078|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
138653080|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138653081|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653082|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653083|NCT00313508|Vidarabine|vidarabine|mesh-list
138653084|NCT00313508|Fludarabine|fludarabine|mesh-list
138653085|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
138653086|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653087|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331461|NCT00651456|Cisplatin|cisplatin|mesh-list
138653088|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
138653089|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653090|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653091|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
138653092|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653094|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653095|NCT00313547|Amlodipine|amlodipine|mesh-list
138653096|NCT00313547|Quinapril|quinapril|mesh-list
138653097|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653098|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138309540|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309541|NCT00002831|Cyclosporine|cyclosporine|mesh-list
138653099|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138653100|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653101|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138653102|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350113|NCT04763226|Diuretics|diuretics|mesh-ancestor
138350142|NCT06084819|Cytarabine|cytarabine|mesh-list
138653103|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
138653104|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138653105|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138653106|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653108|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138653109|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653110|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653111|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
138653112|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653113|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653114|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
138653116|NCT00313625|Melphalan|melphalan|mesh-list
138653117|NCT00313625|Busulfan|busulfan|mesh-list
138653118|NCT00313625|Tacrolimus|tacrolimus|mesh-list
138653119|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138653120|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
138653121|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331503|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653122|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653123|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309589|NCT00002837|Doxorubicin|doxorubicin|mesh-list
138653124|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
138653125|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653126|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653127|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
138653128|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653129|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138653130|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653131|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
138653132|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653133|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138653134|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138653135|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653137|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138653140|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
138653141|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138309630|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653142|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653143|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653144|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138653145|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653146|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
138653147|NCT00313859|Simvastatin|simvastatin|mesh-list
138653148|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138653149|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138653150|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
138262330|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
138653151|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653153|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138653154|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653155|NCT00348231|Insulin|insulin|mesh-list
138653156|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653157|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653158|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
138653159|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
138653160|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138653161|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138653162|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653163|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350160|NCT06084780|Alemtuzumab|alemtuzumab|mesh-list
138350161|NCT06084780|Tacrolimus|tacrolimus|mesh-list
138653164|NCT00313898|Urological Agents|urological agents|mesh-ancestor
138653165|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
138653166|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653167|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653168|NCT00313976|Interferons|interferons|mesh-list
138653169|NCT00313976|Interferon-beta|interferon-beta|mesh-list
138653170|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
138653171|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653172|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
138653173|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653174|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
138653175|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653176|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138653177|NCT00348387|Vaccines|vaccines|mesh-list
138653178|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
138653179|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653180|NCT00314171|Timolol|timolol|mesh-list
138653181|NCT00314171|Dorzolamide|dorzolamide|mesh-list
138653182|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138653183|NCT00314171|Brinzolamide|brinzolamide|mesh-list
138653184|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138653185|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138653186|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138653187|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653188|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653189|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653190|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653191|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138653192|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653193|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138653194|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653195|NCT00348426|Antitoxins|antitoxins|mesh-list
138653196|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
138653197|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
138653198|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653199|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138653200|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
138653201|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138653202|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138653204|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653205|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653206|NCT00344253|Interferons|interferons|mesh-list
138653207|NCT00344253|Interferon-beta|interferon-beta|mesh-list
138653208|NCT00344253|Methotrexate|methotrexate|mesh-list
138653209|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138653210|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
138653211|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138653212|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653213|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653214|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
138653215|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653216|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653217|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138653218|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653219|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138653220|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653221|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
138653222|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653223|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309778|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
138653224|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
138653225|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653226|NCT00314405|Methylene Blue|methylene blue|mesh-list
138653227|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653228|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653229|NCT04715295|Azithromycin|azithromycin|mesh-list
138653230|NCT04715295|Doxycycline|doxycycline|mesh-list
138653231|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
138653232|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
138653233|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138653234|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653237|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138653239|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653240|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653241|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
138653242|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
138653243|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138653244|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138653245|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653246|NCT00348504|Simendan|simendan|mesh-list
138653247|NCT00348504|Dobutamine|dobutamine|mesh-list
138653248|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138653249|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
138653250|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138653251|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138309825|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138453617|NCT01886209|Hormones|hormones|mesh-ancestor
138653253|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653254|NCT00348504|Protective Agents|protective agents|mesh-ancestor
138653255|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653256|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
138653257|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
138653258|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653259|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138653261|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138653262|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653263|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653264|NCT00314561|Pioglitazone|pioglitazone|mesh-list
138653265|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
138653266|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653267|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653268|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
138653270|NCT00348582|Ketorolac|ketorolac|mesh-list
138653271|NCT00348582|Nepafenac|nepafenac|mesh-list
138653272|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138653273|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653274|NCT00348582|Analgesics|analgesics|mesh-ancestor
138653275|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
138653276|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653277|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653278|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653279|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653280|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138653281|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653282|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653284|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138653285|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653286|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138653287|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138653288|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138653289|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653290|NCT00314678|Paclitaxel|paclitaxel|mesh-list
138653291|NCT00314678|Topotecan|topotecan|mesh-list
138653292|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138653293|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653294|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
138653295|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
138653296|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
138653297|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653298|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138653299|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138653300|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653301|NCT00344526|Dexamethasone|dexamethasone|mesh-list
138653302|NCT00344526|Melphalan|melphalan|mesh-list
138331706|NCT04368546|Sunitinib|sunitinib|mesh-list
138653304|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
138653305|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
138653306|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262933|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
138309935|NCT00003215|Vitamins|vitamins|mesh-ancestor
138653307|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653308|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350177|NCT06084624|Betamethasone|betamethasone|mesh-list
138350178|NCT06084624|Betamethasone Valerate|betamethasone valerate|mesh-list
138653310|NCT00344526|Hormones|hormones|mesh-ancestor
138653311|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653312|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138653313|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653314|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653315|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
138653316|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263005|NCT01965002|Aspirin|aspirin|mesh-list
138653317|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138653318|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653319|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
138653320|NCT00344565|Modafinil|modafinil|mesh-list
138653321|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138653322|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653323|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138263055|NCT02308501|Alcaftadine|alcaftadine|mesh-list
138309976|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
138309977|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653324|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138653325|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138653326|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653328|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653329|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653330|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653331|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653332|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
138653333|NCT00348738|Hematinics|hematinics|mesh-ancestor
138653334|NCT00314912|Tramiprosate|tramiprosate|mesh-list
138653335|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
138653336|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
138653337|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
138653338|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331742|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
138653339|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653340|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653341|NCT00314990|Folic Acid|folic acid|mesh-list
138653343|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
138263133|NCT02012192|Paclitaxel|paclitaxel|mesh-list
138653345|NCT00314990|Hematinics|hematinics|mesh-ancestor
138653346|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
138653347|NCT00314990|Vitamins|vitamins|mesh-ancestor
138653348|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
138653349|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653351|NCT02960126|Clopidogrel|clopidogrel|mesh-list
138653352|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138653353|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653354|NCT02960126|Analgesics|analgesics|mesh-ancestor
138653355|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
138653356|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653357|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653358|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653359|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653360|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138653361|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138653362|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653363|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138653364|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138653365|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201711|NCT01249027|Everolimus|everolimus|mesh-list
138653368|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138653369|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138653370|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
138263308|NCT02023411|Hormones|hormones|mesh-list
138653371|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653373|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653374|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653376|NCT00344760|Lamivudine|lamivudine|mesh-list
138653377|NCT00344760|Efavirenz|efavirenz|mesh-list
138653378|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
138653379|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
138653380|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653381|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138653382|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138653383|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653384|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653385|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138653386|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138653387|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138653388|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138653389|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138653390|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138310082|NCT00004043|Vitamins|vitamins|mesh-ancestor
138653391|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138653392|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138653393|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138653394|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138653396|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
138331828|NCT04361370|Growth Substances|growth substances|mesh-ancestor
138653397|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138653398|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138653399|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138653400|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138653401|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653402|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653403|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653404|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653406|NCT00315536|Remifentanil|remifentanil|mesh-list
138653407|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138653408|NCT00315536|Narcotics|narcotics|mesh-ancestor
138653409|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653410|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653411|NCT00315536|Analgesics|analgesics|mesh-ancestor
138653412|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
138653413|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653414|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138653415|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138653416|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138653417|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
138653418|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653419|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653420|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
138653421|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653422|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310113|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
138653424|NCT00349089|Vinorelbine|vinorelbine|mesh-list
138653425|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653426|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653427|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653428|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138653429|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138653430|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138653431|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138653432|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138653433|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138653434|NCT00349128|Metformin|metformin|mesh-list
138653435|NCT00349128|Fenofibrate|fenofibrate|mesh-list
138653436|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653437|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331873|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138653438|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138653439|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
138653440|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653441|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138653444|NCT00315848|Narcotics|narcotics|mesh-ancestor
138653445|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653446|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653447|NCT00315848|Analgesics|analgesics|mesh-ancestor
138310158|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653448|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
138653449|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653450|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138653451|NCT00349206|Sirolimus|sirolimus|mesh-list
138653452|NCT00349206|Sorafenib|sorafenib|mesh-list
138653453|NCT00349206|Temsirolimus|temsirolimus|mesh-list
138653454|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
138653455|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653456|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653457|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263595|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653458|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653459|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653460|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
138653461|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653462|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138310207|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310208|NCT00004127|Leucovorin|leucovorin|mesh-list
138653463|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653464|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138653465|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
138653466|NCT00315887|Buprenorphine|buprenorphine|mesh-list
138653467|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138653468|NCT00315887|Narcotics|narcotics|mesh-ancestor
138653469|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653470|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653471|NCT00315887|Analgesics|analgesics|mesh-ancestor
138653472|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
138653473|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330176|NCT01798914|Insulin|insulin|mesh-list
138653475|NCT00421395|Epratuzumab|epratuzumab|mesh-list
138653476|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653477|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653478|NCT00315926|Melatonin|melatonin|mesh-list
138653479|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
138263656|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138653480|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653481|NCT00315926|Protective Agents|protective agents|mesh-ancestor
138653482|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653483|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653484|NCT00421434|Ribavirin|ribavirin|mesh-list
138653485|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138653486|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
138653487|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
138653488|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
138653489|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653490|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
138653491|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653492|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
138201712|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138653493|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653494|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138653495|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
138653496|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
138653497|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138653498|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
138653499|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653500|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653501|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138653502|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
138331960|NCT04355052|Azithromycin|azithromycin|mesh-list
138653503|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138653504|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
138653505|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653506|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653507|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138653508|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138653509|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
138653510|NCT00315965|Protective Agents|protective agents|mesh-ancestor
138653511|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
138653512|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
138653513|NCT00349245|Remifentanil|remifentanil|mesh-list
138653514|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138653515|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653517|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653518|NCT00349245|Analgesics|analgesics|mesh-ancestor
138653519|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
138653520|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653521|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138653522|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138653523|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138653524|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653525|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653526|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653527|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138653529|NCT06165679|Bupivacaine|bupivacaine|mesh-list
138653530|NCT06165679|Prilocaine|prilocaine|mesh-list
138653531|NCT06165679|Anesthetics, Local|anesthetics, local|mesh-ancestor
138653532|NCT06165679|Anesthetics|anesthetics|mesh-ancestor
138653533|NCT06165679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653534|NCT06165679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653535|NCT06165679|Sensory System Agents|sensory system agents|mesh-ancestor
138653536|NCT06165679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653537|NCT06165432|Benzocaine|benzocaine|mesh-list
138653538|NCT06165432|Anesthetics, Local|anesthetics, local|mesh-ancestor
138653539|NCT06165432|Anesthetics|anesthetics|mesh-ancestor
138653540|NCT06165432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653541|NCT06165432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263836|NCT02354534|Artesunate|artesunate|mesh-list
138653542|NCT06165432|Sensory System Agents|sensory system agents|mesh-ancestor
138653543|NCT06165432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653544|NCT06165276|Vaccines|vaccines|mesh-list
138653545|NCT06165276|Immunologic Factors|immunologic factors|mesh-ancestor
138653546|NCT06165276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653547|NCT06165146|Repaglinide|repaglinide|mesh-list
138653548|NCT06165146|Pirtobrutinib|pirtobrutinib|mesh-list
138653549|NCT06165146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653550|NCT06165146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653551|NCT06165146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653552|NCT06165146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653553|NCT06165146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653554|NCT06165042|Methamphetamine|methamphetamine|mesh-list
138653555|NCT06165042|Fluorides|fluorides|mesh-list
138653556|NCT06165042|Fluorides, Topical|fluorides, topical|mesh-list
138653557|NCT06165042|Cariostatic Agents|cariostatic agents|mesh-ancestor
138653558|NCT06165042|Protective Agents|protective agents|mesh-ancestor
138653559|NCT06165042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653560|NCT06165042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138653561|NCT06165042|Sympathomimetics|sympathomimetics|mesh-ancestor
138653562|NCT06165042|Autonomic Agents|autonomic agents|mesh-ancestor
138653563|NCT06165042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653564|NCT06165042|Dopamine Agents|dopamine agents|mesh-ancestor
138653565|NCT06165042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653566|NCT06165042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653567|NCT06165042|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653568|NCT06165042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138653569|NCT06165042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138653570|NCT06165042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138653571|NCT06165042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138653573|NCT06164834|Clopidogrel|clopidogrel|mesh-list
138653574|NCT06164834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138310352|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310353|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
138653575|NCT06164834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138653576|NCT06164834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138653577|NCT06164834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138653578|NCT06164834|Purinergic Agents|purinergic agents|mesh-ancestor
138653579|NCT06164834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653580|NCT06164834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653581|NCT06164834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653583|NCT06164834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138653584|NCT06164834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138653585|NCT06164834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653586|NCT06164665|Pioglitazone|pioglitazone|mesh-list
138653587|NCT06164665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138332087|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
138653589|NCT06164535|Metformin|metformin|mesh-list
138653590|NCT06164535|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138653591|NCT06164535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653592|NCT06164535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653593|NCT06164535|Protease Inhibitors|protease inhibitors|mesh-ancestor
138653594|NCT06164535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653595|NCT06164535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653596|NCT06164379|Spironolactone|spironolactone|mesh-list
138653597|NCT06164379|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138653598|NCT06164379|Hormone Antagonists|hormone antagonists|mesh-ancestor
138653599|NCT06164379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653600|NCT06164379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653602|NCT06164379|Diuretics|diuretics|mesh-ancestor
138653603|NCT06164379|Natriuretic Agents|natriuretic agents|mesh-ancestor
138653604|NCT06164327|Rituximab|rituximab|mesh-list
138653605|NCT06164327|Carboplatin|carboplatin|mesh-list
138653606|NCT06164327|Gemcitabine|gemcitabine|mesh-list
138310379|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653608|NCT06164327|Etoposide|etoposide|mesh-list
138653609|NCT06164327|Ifosfamide|ifosfamide|mesh-list
138653610|NCT06164327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653611|NCT06164327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653612|NCT06164327|Immunologic Factors|immunologic factors|mesh-ancestor
138653613|NCT06164327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653614|NCT06164327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653615|NCT06164327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653616|NCT06164327|Antimetabolites|antimetabolites|mesh-ancestor
138653617|NCT06164327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653618|NCT06164327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138653619|NCT06164327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138653620|NCT06164327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138653621|NCT06164327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332143|NCT04344756|Heparin|heparin|mesh-list
138653622|NCT06164327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653623|NCT06164327|Alkylating Agents|alkylating agents|mesh-ancestor
138653625|NCT06164275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138653627|NCT06164275|Pembrolizumab|pembrolizumab|mesh-list
138653628|NCT06164275|Dacarbazine|dacarbazine|mesh-list
138653629|NCT06164275|Vinblastine|vinblastine|mesh-list
138653630|NCT06164275|Imidazole|imidazole|mesh-list
138653631|NCT06164275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138653632|NCT06164275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653633|NCT06164275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138653634|NCT06164275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138653635|NCT06164275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653636|NCT06164275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653637|NCT06164275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653638|NCT06164275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138653639|NCT06164275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653640|NCT06164275|Alkylating Agents|alkylating agents|mesh-ancestor
138653641|NCT06164275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138653642|NCT06164275|Tubulin Modulators|tubulin modulators|mesh-ancestor
138653643|NCT06164275|Antimitotic Agents|antimitotic agents|mesh-ancestor
138653644|NCT06164275|Mitosis Modulators|mitosis modulators|mesh-ancestor
138653645|NCT06164080|Betamethasone|betamethasone|mesh-list
138653646|NCT06164080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653647|NCT06164080|Glucocorticoids|glucocorticoids|mesh-ancestor
138653648|NCT06164080|Hormones|hormones|mesh-ancestor
138653649|NCT06164080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653650|NCT06164080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653651|NCT06164080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138653652|NCT06164080|Respiratory System Agents|respiratory system agents|mesh-ancestor
138264159|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
138653654|NCT06164067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138653655|NCT06164067|Abortifacient Agents|abortifacient agents|mesh-ancestor
138653656|NCT06164067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138653657|NCT06164067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653658|NCT06164067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138653659|NCT06164067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138653660|NCT06164067|Oxytocics|oxytocics|mesh-ancestor
138653661|NCT06163989|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138653662|NCT06163989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138653663|NCT06163898|Dexamethasone|dexamethasone|mesh-list
138653664|NCT06163898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653665|NCT06163898|Antiemetics|antiemetics|mesh-ancestor
138653666|NCT06163898|Autonomic Agents|autonomic agents|mesh-ancestor
138653667|NCT06163898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653668|NCT06163898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653669|NCT06163898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138653670|NCT06163898|Glucocorticoids|glucocorticoids|mesh-ancestor
138653671|NCT06163898|Hormones|hormones|mesh-ancestor
138653672|NCT06163898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653673|NCT06163898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138653674|NCT06163898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653675|NCT06163807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
138653676|NCT06163807|Respiratory System Agents|respiratory system agents|mesh-ancestor
138653677|NCT06163768|Insulin|insulin|mesh-list
138653678|NCT06163768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653679|NCT06163768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653680|NCT06163755|Methylprednisolone|methylprednisolone|mesh-list
138653681|NCT06163755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138653682|NCT06163755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138653683|NCT06163755|Prednisolone|prednisolone|mesh-list
138653684|NCT06163755|Prednisolone acetate|prednisolone acetate|mesh-list
138653685|NCT06163755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138653686|NCT06163755|Prednisolone phosphate|prednisolone phosphate|mesh-list
138653687|NCT06163755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350253|NCT06083688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653689|NCT06163755|Autonomic Agents|autonomic agents|mesh-ancestor
138653690|NCT06163755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653691|NCT06163755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653692|NCT06163755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138653693|NCT06163755|Glucocorticoids|glucocorticoids|mesh-ancestor
138653695|NCT06163755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653696|NCT06163755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138653697|NCT06163755|Protective Agents|protective agents|mesh-ancestor
138653698|NCT06163755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330409|NCT04142502|Propofol|propofol|mesh-list
138653710|NCT06163729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653712|NCT06158412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653713|NCT06158412|Keratolytic Agents|keratolytic agents|mesh-ancestor
138653714|NCT06158412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138653715|NCT06158399|Azacitidine|azacitidine|mesh-list
138653716|NCT06158399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653717|NCT06158399|Antimetabolites|antimetabolites|mesh-ancestor
138653718|NCT06158399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653719|NCT06158399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653720|NCT06158399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653721|NCT06156514|Gemcitabine|gemcitabine|mesh-list
138653722|NCT06156514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653723|NCT06156514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653724|NCT06156514|Antimetabolites|antimetabolites|mesh-ancestor
138653725|NCT06156514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653738|NCT06153394|Enoxaparin|enoxaparin|mesh-list
138653739|NCT06153394|Dalteparin|dalteparin|mesh-list
138653741|NCT06153394|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138653742|NCT06153394|Enoxaparin sodium|enoxaparin sodium|mesh-list
138653743|NCT06153394|Anticoagulants|anticoagulants|mesh-ancestor
138653744|NCT06153394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138653745|NCT06153394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138653746|NCT06153394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653747|NCT06152809|Aldesleukin|aldesleukin|mesh-list
138653748|NCT06152809|Venetoclax|venetoclax|mesh-list
138653749|NCT06152809|Interleukin-2|interleukin-2|mesh-list
138653750|NCT06152809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653751|NCT06152809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653752|NCT06152809|Analgesics|analgesics|mesh-ancestor
138264580|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
138653753|NCT06152809|Sensory System Agents|sensory system agents|mesh-ancestor
138653754|NCT06152809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653755|NCT06152809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653756|NCT06152809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138653757|NCT06152809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138653758|NCT06152809|Antiviral Agents|antiviral agents|mesh-ancestor
138332311|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
138653759|NCT06152809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653760|NCT06151080|Lenalidomide|lenalidomide|mesh-list
138653761|NCT06151080|Immunologic Factors|immunologic factors|mesh-ancestor
138653762|NCT06151080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653763|NCT06151080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138653764|NCT06151080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138653765|NCT06151080|Growth Substances|growth substances|mesh-ancestor
138653766|NCT06151080|Growth Inhibitors|growth inhibitors|mesh-ancestor
138653767|NCT06151080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653768|NCT06149793|Empagliflozin|empagliflozin|mesh-list
138653769|NCT06149793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138653770|NCT06149793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653771|NCT06149793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138653772|NCT06149793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653773|NCT06124677|Faricimab|faricimab|mesh-list
138330482|NCT00570960|Dextrans|dextrans|mesh-list
138653774|NCT06124677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138653775|NCT06124677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138653776|NCT06124677|Growth Substances|growth substances|mesh-ancestor
138653777|NCT06124677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653778|NCT06124677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138653779|NCT06124677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653780|NCT06105684|Capecitabine|capecitabine|mesh-list
138653781|NCT06105684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653782|NCT06105684|Antimetabolites|antimetabolites|mesh-ancestor
138653783|NCT06105684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653784|NCT06105684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653785|NCT06080399|Apomorphine|apomorphine|mesh-list
138653786|NCT06080399|Emetics|emetics|mesh-ancestor
138653787|NCT06080399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653788|NCT06080399|Autonomic Agents|autonomic agents|mesh-ancestor
138653789|NCT06080399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653790|NCT06080399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310513|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
138653791|NCT06080399|Dopamine Agonists|dopamine agonists|mesh-ancestor
138653792|NCT06080399|Dopamine Agents|dopamine agents|mesh-ancestor
138653793|NCT06080399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653794|NCT06080399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653796|NCT06050252|Gemcitabine|gemcitabine|mesh-list
138653797|NCT06050252|Durvalumab|durvalumab|mesh-list
138653798|NCT06050252|Immunoglobulins|immunoglobulins|mesh-list
138653799|NCT06050252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138653800|NCT06050252|Immunoglobulin G|immunoglobulin g|mesh-list
138653801|NCT06050252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264702|NCT02065687|Paclitaxel|paclitaxel|mesh-list
138653802|NCT06050252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653804|NCT06050252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653805|NCT06050252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653806|NCT06050252|Immunologic Factors|immunologic factors|mesh-ancestor
138653807|NCT06050252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653808|NCT06047366|Lidocaine|lidocaine|mesh-list
138653809|NCT06047366|Epinephrine|epinephrine|mesh-list
138653810|NCT06047366|Racepinephrine|racepinephrine|mesh-list
138653811|NCT06047366|Carticaine|carticaine|mesh-list
138653812|NCT06047366|Mepivacaine|mepivacaine|mesh-list
138653813|NCT06047366|Epinephryl borate|epinephryl borate|mesh-list
138653814|NCT06047366|Anesthetics, Local|anesthetics, local|mesh-ancestor
138653815|NCT06047366|Anesthetics|anesthetics|mesh-ancestor
138653816|NCT06047366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653817|NCT06047366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653818|NCT06047366|Sensory System Agents|sensory system agents|mesh-ancestor
138332416|NCT04330872|Aspirin|aspirin|mesh-list
138653819|NCT06047366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653820|NCT06047366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138653821|NCT06047366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138653822|NCT06047366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138653823|NCT06047366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138653824|NCT06047366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653825|NCT06047366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138653826|NCT06047366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138653827|NCT06047366|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653828|NCT06047366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653829|NCT06047366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138653830|NCT06047366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138264867|NCT03101033|Hormones|hormones|mesh-ancestor
138653831|NCT06047366|Autonomic Agents|autonomic agents|mesh-ancestor
138653832|NCT06047366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138653833|NCT06047366|Respiratory System Agents|respiratory system agents|mesh-ancestor
138653834|NCT06047366|Mydriatics|mydriatics|mesh-ancestor
138653835|NCT06047366|Sympathomimetics|sympathomimetics|mesh-ancestor
138653836|NCT06047366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138653837|NCT06041646|Dexmedetomidine|dexmedetomidine|mesh-list
138653838|NCT06041646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138653839|NCT06041646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653840|NCT06041646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653841|NCT06041646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653842|NCT06041646|Analgesics|analgesics|mesh-ancestor
138310535|NCT00004265|Paclitaxel|paclitaxel|mesh-list
138310542|NCT00003365|Curcumin|curcumin|mesh-list
138653843|NCT06041646|Sensory System Agents|sensory system agents|mesh-ancestor
138653844|NCT06041646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264939|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
138653845|NCT06041646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138653846|NCT06041646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138653848|NCT06041646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138653849|NCT06041646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350264|NCT06082817|Androgens|androgens|mesh-ancestor
138653850|NCT06041646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330562|NCT01107886|Hormones|hormones|mesh-ancestor
138653852|NCT06024174|Adagrasib|adagrasib|mesh-list
138653853|NCT06024174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653854|NCT06024174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653855|NCT06004830|Spironolactone|spironolactone|mesh-list
138653856|NCT06004830|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138653857|NCT06004830|Hormone Antagonists|hormone antagonists|mesh-ancestor
138653858|NCT06004830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653859|NCT06004830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653860|NCT06004830|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138653861|NCT06004830|Diuretics|diuretics|mesh-ancestor
138653862|NCT06004830|Natriuretic Agents|natriuretic agents|mesh-ancestor
138653863|NCT05980806|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
138653864|NCT05980806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332495|NCT03035058|Vedolizumab|vedolizumab|mesh-list
138653866|NCT05980806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653867|NCT05972772|Azithromycin|azithromycin|mesh-list
138653869|NCT05972772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138653870|NCT05972772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653871|NCT05972772|Antimalarials|antimalarials|mesh-ancestor
138653872|NCT05972772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138653873|NCT05972772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138653874|NCT05965570|Clarithromycin|clarithromycin|mesh-list
138653875|NCT05965570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138653876|NCT05965570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653877|NCT05965570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138653878|NCT05965570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653879|NCT05965570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653880|NCT05965570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138653881|NCT05965570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138653882|NCT05936229|Interferons|interferons|mesh-list
138653883|NCT05936229|Interferon-beta|interferon-beta|mesh-list
138653884|NCT05936229|Interferon beta-1a|interferon beta-1a|mesh-list
138653885|NCT05936229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653886|NCT05936229|Antiviral Agents|antiviral agents|mesh-ancestor
138653887|NCT05936229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653888|NCT05936229|Immunologic Factors|immunologic factors|mesh-ancestor
138653889|NCT05936229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653890|NCT05936229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138653892|NCT05935748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332544|NCT03030300|Pioglitazone|pioglitazone|mesh-list
138653893|NCT05935748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653894|NCT05935748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653895|NCT05935748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653896|NCT05930613|Certolizumab Pegol|certolizumab pegol|mesh-list
138653897|NCT05930613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138653898|NCT05930613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138653899|NCT05930613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653900|NCT05930613|Immunologic Factors|immunologic factors|mesh-ancestor
138653901|NCT05930613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310556|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
138653904|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138653905|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653907|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138653908|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653909|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653910|NCT05849779|Sevoflurane|sevoflurane|mesh-list
138653911|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138653912|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138653913|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
138653914|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
138653915|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265312|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
138350276|NCT06082232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653916|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653917|NCT05809414|Amantadine|amantadine|mesh-list
138332593|NCT03018756|Fentanyl|fentanyl|mesh-list
138653918|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138653919|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138653920|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
138653921|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653922|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
138653923|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653924|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653925|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653926|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138653927|NCT05809414|Analgesics|analgesics|mesh-ancestor
138653928|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
138653929|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653930|NCT05801029|Osimertinib|osimertinib|mesh-list
138653931|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138653932|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653933|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653934|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653935|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653936|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653937|NCT05795517|Ezetimibe|ezetimibe|mesh-list
138653938|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138653939|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138653940|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
138653941|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653942|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138653943|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138653944|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653945|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653946|NCT05739942|Temozolomide|temozolomide|mesh-list
138653947|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653948|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
138653949|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653950|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653951|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
138653952|NCT05723510|Apixaban|apixaban|mesh-list
138653953|NCT05723510|Edoxaban|edoxaban|mesh-list
138653954|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138653955|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
138653956|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138653957|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
138653958|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653959|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653961|NCT05717400|Ribavirin|ribavirin|mesh-list
138653962|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
138653963|NCT05717400|Velpatasvir|velpatasvir|mesh-list
138653964|NCT05717400|Bevacizumab|bevacizumab|mesh-list
138653965|NCT05717400|Atezolizumab|atezolizumab|mesh-list
138653966|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653967|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653968|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138653969|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138653970|NCT05717400|Growth Substances|growth substances|mesh-ancestor
138653971|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653972|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
138653973|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
138653974|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653975|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
138332774|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
138653976|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653977|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138653979|NCT05704647|Relatlimab|relatlimab|mesh-list
138265652|NCT05985798|Hormones|hormones|mesh-ancestor
138653980|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138653981|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653982|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138653983|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653984|NCT05696977|Cyclosporine|cyclosporine|mesh-list
138653985|NCT05696977|Cyclosporins|cyclosporins|mesh-list
138653986|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653987|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653988|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138653989|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
138653990|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653991|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
138653992|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138653993|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
138653994|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653995|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138653996|NCT05686408|Tianeptine|tianeptine|mesh-list
138265691|NCT05983952|Antibodies|antibodies|mesh-list
138653997|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138653998|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
138653999|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138654001|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
138654002|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
138265746|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654003|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654005|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654006|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138654007|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138654008|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332879|NCT03005184|Icatibant|icatibant|mesh-list
138310582|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
138654010|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138654011|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138654012|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138265816|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
138654013|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654014|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654016|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
138654017|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138654018|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654019|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654020|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654021|NCT05665088|Analgesics|analgesics|mesh-ancestor
138654022|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
138654023|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654024|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138654025|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138654026|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138654027|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654028|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654029|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654030|NCT05661669|Ketamine|ketamine|mesh-list
138654031|NCT05661669|Analgesics|analgesics|mesh-ancestor
138654032|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
138654033|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654034|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654035|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138654036|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138654037|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
138654038|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
138654039|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654040|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138654041|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138654042|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654043|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654044|NCT05625776|Capsaicin|capsaicin|mesh-list
138654045|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
138332985|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
138333006|NCT02987556|Insulin|insulin|mesh-list
138654046|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654047|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
138654048|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654049|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654050|NCT05621616|Mirabegron|mirabegron|mesh-list
138654051|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138654052|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138654054|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654055|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654056|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654058|NCT05621616|Urological Agents|urological agents|mesh-ancestor
138654059|NCT05590260|Iron|iron|mesh-list
138654060|NCT05590260|Trace Elements|trace elements|mesh-ancestor
138654061|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
138654062|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654063|NCT05567315|Anesthetics|anesthetics|mesh-list
138654064|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
138654065|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654066|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654067|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
138266061|NCT05526690|Metformin|metformin|mesh-list
138654068|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654070|NCT05563220|Palbociclib|palbociclib|mesh-list
138654071|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138654072|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654073|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654074|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654075|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654076|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
138654077|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654078|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654079|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
138266114|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
138654081|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654082|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138654083|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654084|NCT05511428|Daratumumab|daratumumab|mesh-list
138654085|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138654086|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654087|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
138654088|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654089|NCT05483491|Aldesleukin|aldesleukin|mesh-list
138654090|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654091|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138654092|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138654093|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
138654094|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654095|NCT05479123|Timolol|timolol|mesh-list
138654096|NCT05479123|Propranolol|propranolol|mesh-list
138654097|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138654098|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138654099|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654100|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654101|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654103|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138310633|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
138654105|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
138654106|NCT05461820|Methimazole|methimazole|mesh-list
138654107|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
138654108|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654109|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654110|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654111|NCT05445778|Bevacizumab|bevacizumab|mesh-list
138654112|NCT05445778|Maytansine|maytansine|mesh-list
138654113|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
138654114|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333206|NCT02641782|Analgesics|analgesics|mesh-ancestor
138654115|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654116|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138654117|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138350296|NCT06082232|GABA Agents|gaba agents|mesh-ancestor
138654118|NCT05445778|Growth Substances|growth substances|mesh-ancestor
138654119|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654120|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
138654121|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654122|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654123|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654124|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654125|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654126|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
138654127|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
138654128|NCT05425862|Talazoparib|talazoparib|mesh-list
138654129|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138654130|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654131|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654133|NCT05413551|Isoniazid|isoniazid|mesh-list
138654134|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
138654135|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654136|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654137|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138654138|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138654139|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
138654140|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654141|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138654142|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138654143|NCT05403476|Hormones|hormones|mesh-ancestor
138654144|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654145|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654146|NCT05401071|Rifapentine|rifapentine|mesh-list
138654147|NCT05401071|Rifampin|rifampin|mesh-list
138654148|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138654149|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
138654150|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654151|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654152|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
138654153|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138654154|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266294|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138310656|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138654155|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654156|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138654157|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138654158|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138654159|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138654160|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138654161|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138654162|NCT05394337|Atezolizumab|atezolizumab|mesh-list
138654163|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654164|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333371|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138333378|NCT05139966|Fluorides|fluorides|mesh-list
138654165|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654166|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654167|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
138654168|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138654169|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
138654170|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138654171|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138654172|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654173|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138654174|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654175|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138654177|NCT05371964|Imetelstat|imetelstat|mesh-list
138654178|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
138350311|NCT06058572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654179|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654180|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654181|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654182|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
138654183|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138654184|NCT05317936|Venetoclax|venetoclax|mesh-list
138654185|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
138654186|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654187|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654188|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654189|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654190|NCT05285813|Acetaminophen|acetaminophen|mesh-list
138654191|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
138654192|NCT05285813|Promethazine|promethazine|mesh-list
138266378|NCT05156788|Lenvatinib|lenvatinib|mesh-list
138654194|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654195|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
138654196|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
138310677|NCT00004433|Pergolide|pergolide|mesh-list
138654197|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654198|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654199|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654200|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
138654201|NCT05285813|Hormones|hormones|mesh-ancestor
138654202|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654203|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654204|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654205|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654207|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
138654208|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
138654209|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138654210|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138654211|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654212|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
138654213|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
138654214|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138654215|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
138654216|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
138654217|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654218|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654219|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138654220|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
138654221|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654222|NCT05283226|Paclitaxel|paclitaxel|mesh-list
138654223|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654224|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654225|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654226|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654227|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654228|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333546|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654229|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
138654230|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138654231|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654232|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654233|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654234|NCT05271552|Analgesics|analgesics|mesh-ancestor
138654235|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
138654236|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654237|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138654238|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138654239|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138654240|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654241|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654242|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654243|NCT05264506|Estradiol|estradiol|mesh-list
138654244|NCT05264506|Estrogens|estrogens|mesh-ancestor
138654245|NCT05264506|Hormones|hormones|mesh-ancestor
138654246|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654247|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654249|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654250|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654251|NCT05211336|Prednisone|prednisone|mesh-list
138654252|NCT05211336|Lenalidomide|lenalidomide|mesh-list
138654254|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
138654255|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654256|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
138654257|NCT05211336|Hormones|hormones|mesh-ancestor
138654258|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654259|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654260|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654261|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654262|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
138654263|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138654264|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138266604|NCT05011266|Naloxone|naloxone|mesh-list
138654265|NCT05211336|Growth Substances|growth substances|mesh-ancestor
138654266|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138654267|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654268|NCT05201183|Fludarabine|fludarabine|mesh-list
138654269|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654270|NCT05183841|Fenoterol|fenoterol|mesh-list
138654271|NCT05183841|Ipratropium|ipratropium|mesh-list
138654272|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
138654273|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
138654274|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654277|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
138654278|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138654279|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
138654280|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654281|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654282|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
138654283|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
138654284|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138654285|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138654286|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138654287|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138654288|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654290|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
138654291|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654292|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654293|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654294|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266707|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
138654298|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138654299|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
138654300|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310726|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
138654301|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654302|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138654303|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138654304|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
138654305|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654306|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654307|NCT05139316|Prednisolone|prednisolone|mesh-list
138654308|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654309|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
138654310|NCT05139316|Hormones|hormones|mesh-ancestor
138654311|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654312|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350334|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350348|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138654313|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654314|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654315|NCT05132075|Docetaxel|docetaxel|mesh-list
138654316|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654317|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654318|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654319|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654320|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654322|NCT05071053|Maytansine|maytansine|mesh-list
138654323|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654324|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654326|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654327|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654328|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654329|NCT05050942|Octreotide|octreotide|mesh-list
138654330|NCT05050942|Lanreotide|lanreotide|mesh-list
138654331|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654332|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654333|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654335|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
138654336|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
138654337|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654338|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654339|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138654340|NCT04916951|Amoxicillin|amoxicillin|mesh-list
138654341|NCT04916951|Cephalexin|cephalexin|mesh-list
138654342|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654343|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654344|NCT04897269|Progesterone|progesterone|mesh-list
138654345|NCT04897269|Progestins|progestins|mesh-ancestor
138654346|NCT04897269|Hormones|hormones|mesh-ancestor
138654347|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654348|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654349|NCT04891419|Lidocaine|lidocaine|mesh-list
138654350|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
138654352|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654353|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654354|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
138654355|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654356|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138654357|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138654358|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138654359|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138654360|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654362|NCT04865289|Carboplatin|carboplatin|mesh-list
138654363|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
138654365|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654366|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654367|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654368|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654369|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654370|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331084|NCT04163432|Carboplatin|carboplatin|mesh-list
138267018|NCT04414475|Growth Substances|growth substances|mesh-ancestor
138654371|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654373|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654374|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654375|NCT04832399|Natalizumab|natalizumab|mesh-list
138654376|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
138654377|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654378|NCT04832087|Teduglutide|teduglutide|mesh-list
138654379|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654380|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138654381|NCT04832087|Protective Agents|protective agents|mesh-ancestor
138654382|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333837|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
138654383|NCT04780568|Osimertinib|osimertinib|mesh-list
138654384|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654385|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654386|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654387|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654388|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
138654389|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
138654390|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138654391|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654392|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654393|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
138654394|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138654395|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654396|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654397|NCT04771156|Ketorolac|ketorolac|mesh-list
138654398|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138654399|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654400|NCT04771156|Analgesics|analgesics|mesh-ancestor
138654401|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
138654402|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654403|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267126|NCT04233229|Insulin|insulin|mesh-list
138654404|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654405|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333885|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654406|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138654407|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654408|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654409|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138654410|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138654411|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654413|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138654414|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138654415|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138654416|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654417|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654418|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654419|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654420|NCT04666636|Urological Agents|urological agents|mesh-ancestor
138654422|NCT04659603|Maytansine|maytansine|mesh-list
138654423|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654424|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
138654425|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654426|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310766|NCT00004997|Leucovorin|leucovorin|mesh-list
138654427|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654428|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654429|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
138333935|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138654430|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654431|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
138654432|NCT04618913|Apixaban|apixaban|mesh-list
138654433|NCT04618913|Edoxaban|edoxaban|mesh-list
138654434|NCT04618913|Dabigatran|dabigatran|mesh-list
138654435|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138654436|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
138654437|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138654438|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
138654439|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654440|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654441|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
138654442|NCT04588792|Furosemide|furosemide|mesh-list
138654443|NCT04588792|Diuretics|diuretics|mesh-ancestor
138654444|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
138654445|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654446|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138654447|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138654448|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654449|NCT04568603|Islatravir|islatravir|mesh-list
138654450|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
138350353|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138654451|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654452|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333985|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
138310782|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138654453|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654454|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138654455|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138654458|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
138654459|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654460|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654461|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654462|NCT04497870|Peppermint oil|peppermint oil|mesh-list
138654463|NCT04497870|Menthol|menthol|mesh-list
138654464|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
138654465|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654466|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
138654468|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654469|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654470|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654471|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
138654472|NCT04455815|Gabexate|gabexate|mesh-list
138334038|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654473|NCT04455815|Camostat|camostat|mesh-list
138654474|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
138654475|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654476|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654477|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138654478|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138654479|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
138654480|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138654481|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
138654482|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
138654483|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654484|NCT04420975|Nivolumab|nivolumab|mesh-list
138654485|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654486|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654487|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654488|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654489|NCT04402073|Vincristine|vincristine|mesh-list
138654491|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654492|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654493|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654494|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654495|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654496|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654497|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138654498|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
138654499|NCT04209543|Progesterone|progesterone|mesh-list
138654500|NCT04209543|Progestins|progestins|mesh-ancestor
138654501|NCT04209543|Hormones|hormones|mesh-ancestor
138654502|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654503|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654504|NCT04158739|Cytarabine|cytarabine|mesh-list
138654505|NCT04158739|Antibodies|antibodies|mesh-list
138654506|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
138654507|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138654508|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
138654509|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654510|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654511|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
138654512|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654513|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654514|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
138654515|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654516|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654517|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138654518|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
138654519|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654520|NCT04082767|Midazolam|midazolam|mesh-list
138654521|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
138654522|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138654523|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654524|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654525|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654526|NCT04082767|Analgesics|analgesics|mesh-ancestor
138654527|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
138654528|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654529|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138654530|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138654531|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138654532|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654533|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654534|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654535|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138654536|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138654537|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138654538|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138654539|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138654540|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
138654541|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
138654542|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
138654543|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
138654544|NCT04068831|Avelumab|avelumab|mesh-list
138654545|NCT04068831|Talazoparib|talazoparib|mesh-list
138654546|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654547|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654548|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138654549|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267637|NCT03421288|Leucovorin|leucovorin|mesh-list
138654550|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654551|NCT04012138|Insulin|insulin|mesh-list
138654552|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138654553|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
138654554|NCT04012138|Albuterol|albuterol|mesh-list
138654555|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138654556|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654557|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138654558|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
138654559|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654560|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138654561|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
138654562|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
138654563|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138654564|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138334183|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
138350390|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
138350393|NCT05612984|Vitamins|vitamins|mesh-ancestor
138654565|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138654566|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138334185|NCT00715884|Sirolimus|sirolimus|mesh-list
138654567|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
138654568|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654569|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654570|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
138654571|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
138654572|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138654573|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138654574|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654575|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654576|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654577|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654578|NCT03964051|Omalizumab|omalizumab|mesh-list
138654579|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138654580|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138654581|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138654582|NCT03910452|Sirolimus|sirolimus|mesh-list
138654583|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
138654584|NCT03910452|Busulfan|busulfan|mesh-list
138654585|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
138654586|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310889|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654587|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
138654588|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654589|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654590|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138654591|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
138654592|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654593|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654594|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138654595|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654596|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654597|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138654598|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
138654599|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654600|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138654601|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138654602|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334229|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654603|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
138654604|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
138654605|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
138654606|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654608|NCT03793478|Fludarabine|fludarabine|mesh-list
138654609|NCT03793478|Etoposide|etoposide|mesh-list
138654610|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654611|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654612|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
138654613|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654614|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654615|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
138654616|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654617|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654618|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138654619|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267915|NCT02522715|Hormones|hormones|mesh-ancestor
138654620|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654621|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
138654622|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654624|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
138654625|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654627|NCT03706365|Hormones|hormones|mesh-ancestor
138654628|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654629|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654630|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654631|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654632|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138654633|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654634|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654635|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654636|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138654638|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
138654639|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
138654640|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138654641|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
138654642|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138654643|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
138654644|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654645|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654647|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
138654648|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138654649|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654650|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138654651|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654652|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
138654653|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654654|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
138654655|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654656|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654658|NCT03579446|Morphine|morphine|mesh-list
138654659|NCT03579446|Oxycodone|oxycodone|mesh-list
138654660|NCT03579446|Hydromorphone|hydromorphone|mesh-list
138654661|NCT03579446|Hydrocodone|hydrocodone|mesh-list
138654662|NCT03579446|Levorphanol|levorphanol|mesh-list
138654663|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138654664|NCT03579446|Narcotics|narcotics|mesh-ancestor
138334322|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654665|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138654666|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654668|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
138331384|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138654669|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654670|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
138654671|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138654673|NCT03574571|Docetaxel|docetaxel|mesh-list
138654674|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654675|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654676|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654677|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268159|NCT01758081|Vitamin D|vitamin d|mesh-list
138654678|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654679|NCT03537508|Vaccines|vaccines|mesh-list
138654680|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
138654681|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654682|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
138654683|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
138654684|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654685|NCT03405155|Nivolumab|nivolumab|mesh-list
138654686|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654687|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654688|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654689|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654690|NCT03383692|Ritonavir|ritonavir|mesh-list
138654691|NCT03383692|Itraconazole|itraconazole|mesh-list
138654693|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138654694|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138654695|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
138654696|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654697|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654699|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138654700|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
138654701|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654702|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138654703|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138654704|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
138654705|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138654706|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138654707|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654708|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654709|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654710|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
138654711|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
138654712|NCT03342196|Fludarabine|fludarabine|mesh-list
138654713|NCT03342196|Melphalan|melphalan|mesh-list
138654714|NCT03342196|Thiotepa|thiotepa|mesh-list
138654715|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334407|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138654716|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654717|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654718|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
138654719|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654720|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138654721|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
138654722|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138654725|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
138654726|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654727|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
138654728|NCT03330132|Coagulants|coagulants|mesh-ancestor
138654729|NCT03309007|Metformin|metformin|mesh-list
138654730|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
138654731|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138654732|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310951|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138654734|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654735|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654736|NCT03206671|Cytarabine|cytarabine|mesh-list
138654737|NCT03206671|Dexamethasone|dexamethasone|mesh-list
138654739|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
138654740|NCT03206671|Ifosfamide|ifosfamide|mesh-list
138654741|NCT03206671|Rituximab|rituximab|mesh-list
138654742|NCT03206671|Doxorubicin|doxorubicin|mesh-list
138654743|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138654744|NCT03206671|Methotrexate|methotrexate|mesh-list
138654745|NCT03206671|Etoposide|etoposide|mesh-list
138654746|NCT03206671|Vincristine|vincristine|mesh-list
138654747|NCT03206671|Vindesine|vindesine|mesh-list
138654748|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654749|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
138654750|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654751|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654752|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138654753|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
138654754|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654755|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654756|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138654757|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654759|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
138654760|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654761|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654762|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
138654764|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654765|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654766|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654767|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138654768|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138654769|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138654770|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654771|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138654773|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334507|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
138334516|NCT00753636|Isradipine|isradipine|mesh-list
138654774|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654776|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654778|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138654779|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654780|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
138654781|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654782|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654783|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654784|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654785|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
138654786|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654787|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654788|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654789|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654790|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
138654791|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654792|NCT03048019|Tirofiban|tirofiban|mesh-list
138654793|NCT03048019|Cangrelor|cangrelor|mesh-list
138654794|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138654795|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138654796|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654797|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138654798|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138654799|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138654800|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138654801|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
138654802|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654803|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654806|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
138654807|NCT03006705|Nivolumab|nivolumab|mesh-list
138654808|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654809|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
138654810|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654811|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654812|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654813|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654814|NCT02998645|Cyclosporine|cyclosporine|mesh-list
138654815|NCT02998645|Cyclosporins|cyclosporins|mesh-list
138654816|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654817|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654818|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654819|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
138654820|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654821|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
138654822|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654823|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654824|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654825|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138654826|NCT02752035|Azacitidine|azacitidine|mesh-list
138654827|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654829|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654830|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268624|NCT01349192|Mupirocin|mupirocin|mesh-list
138654831|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654832|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
138654833|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
138654834|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654835|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138654836|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138654837|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138654838|NCT02710734|Doxorubicin|doxorubicin|mesh-list
138654839|NCT02710734|Methotrexate|methotrexate|mesh-list
138654840|NCT02710734|Mitomycins|mitomycins|mesh-list
138654841|NCT02710734|Mitomycin|mitomycin|mesh-list
138654842|NCT02710734|Vinblastine|vinblastine|mesh-list
138654843|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654844|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138654845|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138268684|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
138654846|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311012|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138311013|NCT00005117|Pravastatin|pravastatin|mesh-list
138311021|NCT00385385|KRM 1648|krm 1648|mesh-list
138334654|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
138654849|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138654850|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
138654851|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138654852|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654853|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654855|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
138654856|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138654857|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654858|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
138654859|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654860|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138654861|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
138654862|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654863|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654864|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654865|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138654867|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
138654868|NCT02580994|Etoposide|etoposide|mesh-list
138654869|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654870|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654871|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654872|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654873|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654874|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138654875|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138268853|NCT03224351|VX-659|vx-659|mesh-list
138654876|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654879|NCT02546661|Adavosertib|adavosertib|mesh-list
138654880|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654881|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654882|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138654883|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654884|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654885|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138654886|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
138654887|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654889|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138654890|NCT02530489|Atezolizumab|atezolizumab|mesh-list
138654891|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138654892|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654893|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654894|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654895|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654896|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311035|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138654897|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654898|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654899|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654900|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
138268922|NCT03226457|Furosemide|furosemide|mesh-list
138654903|NCT02223377|Hydromorphone|hydromorphone|mesh-list
138654904|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138654905|NCT02223377|Narcotics|narcotics|mesh-ancestor
138654906|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334746|NCT00787332|Desirudin|desirudin|mesh-list
138334747|NCT00787332|Argatroban|argatroban|mesh-list
138654908|NCT02223377|Analgesics|analgesics|mesh-ancestor
138654909|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
138654910|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654911|NCT02094261|Osimertinib|osimertinib|mesh-list
138654912|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654913|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654914|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654915|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654916|NCT01697527|Aldesleukin|aldesleukin|mesh-list
138654917|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
138654918|NCT01697527|Fludarabine|fludarabine|mesh-list
138654919|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
138654920|NCT01697527|Interleukin-2|interleukin-2|mesh-list
138654922|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138654923|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654924|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
138654925|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654926|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654927|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138654928|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
138654929|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654930|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654931|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138654932|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654933|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
138654934|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138654935|NCT01697527|Analgesics|analgesics|mesh-ancestor
138654936|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
138654937|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654938|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138654939|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138654940|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
138654941|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654942|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138654944|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
138654945|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
138654946|NCT01653678|Vitamins|vitamins|mesh-list
138654947|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
138654948|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654949|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138654950|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334856|NCT00793650|Bortezomib|bortezomib|mesh-list
138654953|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654954|NCT01632007|Incretins|incretins|mesh-ancestor
138654955|NCT01632007|Hormones|hormones|mesh-ancestor
138654956|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654957|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138654958|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
138654959|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654960|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654963|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138654964|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654965|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654967|NCT01402271|Carboplatin|carboplatin|mesh-list
138334905|NCT00798018|Lidocaine|lidocaine|mesh-list
138654968|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138654970|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138654971|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654972|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331684|NCT04371978|Incretins|incretins|mesh-ancestor
138654973|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654974|NCT01387295|Capecitabine|capecitabine|mesh-list
138654975|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
138654976|NCT01387295|Trastuzumab|trastuzumab|mesh-list
138654977|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138654978|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
138654979|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654980|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654981|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654982|NCT01288378|Caspofungin|caspofungin|mesh-list
138654983|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
138654984|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654985|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654986|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654987|NCT01280682|Rituximab|rituximab|mesh-list
138654988|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138654989|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654990|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
138654991|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654992|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654993|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138654994|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138654995|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138654996|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138654997|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654998|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654999|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655000|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
138655002|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
138655004|NCT00679029|Gemcitabine|gemcitabine|mesh-list
138655005|NCT00679029|Doxorubicin|doxorubicin|mesh-list
138655006|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138655007|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138655008|NCT00679029|Antibodies|antibodies|mesh-list
138655009|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
138655010|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138655011|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655012|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655013|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655014|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
138655015|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655016|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655017|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138655018|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
138655019|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655020|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655021|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655022|NCT00679029|Growth Substances|growth substances|mesh-ancestor
138655023|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655024|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655026|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655027|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138655028|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138335006|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655029|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655031|NCT00519116|Tacrolimus|tacrolimus|mesh-list
138655032|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655033|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
138655034|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655035|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655036|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655037|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655038|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655039|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655040|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655041|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655042|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
138655043|NCT00518375|Cyclosporine|cyclosporine|mesh-list
138655044|NCT00518375|Sirolimus|sirolimus|mesh-list
138655045|NCT00518375|Cyclosporins|cyclosporins|mesh-list
138269310|NCT00358358|Xhance|xhance|mesh-list
138655046|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655047|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655048|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655049|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
138655050|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335053|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655051|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
138655052|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655054|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655055|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655056|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655057|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655058|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655059|NCT00195429|Sirolimus|sirolimus|mesh-list
138655060|NCT00195429|Prednisone|prednisone|mesh-list
138655061|NCT00195429|Tacrolimus|tacrolimus|mesh-list
138655062|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655063|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
138655064|NCT00195429|Hormones|hormones|mesh-ancestor
138655065|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655066|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655067|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138655068|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655069|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350486|NCT05039801|Bevacizumab|bevacizumab|mesh-list
138655072|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655073|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655074|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655075|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655076|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655077|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
138655078|NCT00349284|Ezetimibe|ezetimibe|mesh-list
138655079|NCT00349284|Fenofibrate|fenofibrate|mesh-list
138655080|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138655081|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655082|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
138655083|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655084|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655085|NCT00316160|Bupropion|bupropion|mesh-list
138655086|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138655087|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138655088|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
138655089|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655090|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138655091|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138655092|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655093|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655094|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
138655095|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655096|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655097|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138655098|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138655099|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655100|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138655102|NCT00349362|Androgens|androgens|mesh-ancestor
138655103|NCT00349362|Hormones|hormones|mesh-ancestor
138655104|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655105|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655106|NCT00316238|Olanzapine|olanzapine|mesh-list
138655107|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
138655108|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
138655109|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655110|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655112|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138655113|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138655114|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655115|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655116|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138655117|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138655118|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655119|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655120|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655121|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
138335153|NCT03936270|Palbociclib|palbociclib|mesh-list
138331835|NCT04359966|Amoxicillin|amoxicillin|mesh-list
138655123|NCT00349401|Morphine|morphine|mesh-list
138655124|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138655125|NCT00349401|Narcotics|narcotics|mesh-ancestor
138655126|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655127|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655128|NCT00349401|Analgesics|analgesics|mesh-ancestor
138350521|NCT05032183|Lenograstim|lenograstim|mesh-list
138655129|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
138655130|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655131|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138655132|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138655133|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655134|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655135|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138655136|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655137|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655138|NCT00349440|Cyclosporine|cyclosporine|mesh-list
138655139|NCT00349440|Cyclosporins|cyclosporins|mesh-list
138655140|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655141|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655142|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655143|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
138655144|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655145|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
138655146|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655147|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655148|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655149|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655150|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
138655151|NCT00316433|Irinotecan|irinotecan|mesh-list
138655153|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138655154|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655155|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655156|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655157|NCT00349518|Dasatinib|dasatinib|mesh-list
138655158|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655159|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655160|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655161|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655162|NCT00316472|Niacinamide|niacinamide|mesh-list
138655164|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
138655165|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655166|NCT00316472|Vitamins|vitamins|mesh-ancestor
138655167|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
138655168|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655169|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655170|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
138655171|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655172|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655173|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
138655174|NCT00349557|Bevacizumab|bevacizumab|mesh-list
138655175|NCT00349557|Goserelin|goserelin|mesh-list
138655177|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138655178|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655179|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655180|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655182|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655183|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655184|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138655185|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
138655186|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138655187|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655188|NCT00349596|Decitabine|decitabine|mesh-list
138655189|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655190|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
138655191|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655192|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655193|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350542|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
138655194|NCT00349635|Metformin|metformin|mesh-list
138655195|NCT00349635|Fenofibrate|fenofibrate|mesh-list
138655196|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655197|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655198|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655200|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655201|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655202|NCT00316745|Leucovorin|leucovorin|mesh-list
138655203|NCT00316745|Fluorouracil|fluorouracil|mesh-list
138655204|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
138655206|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
138655207|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655208|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655209|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655210|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655211|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
138655212|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655213|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138335286|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138655214|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269897|NCT05925790|Antibodies|antibodies|mesh-list
138655215|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655216|NCT00316745|Antidotes|antidotes|mesh-ancestor
138655217|NCT00316745|Protective Agents|protective agents|mesh-ancestor
138655218|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655219|NCT00316745|Vitamins|vitamins|mesh-ancestor
138655220|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
138655221|NCT00349674|Methotrexate|methotrexate|mesh-list
138655222|NCT00349674|Azathioprine|azathioprine|mesh-list
138655223|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138655224|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
138655225|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655226|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655227|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655228|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
138655229|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655230|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655231|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655232|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655233|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138655234|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269948|NCT05923879|Rituximab|rituximab|mesh-list
138655236|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655237|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138655238|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138655239|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655240|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655241|NCT00344955|Atorvastatin|atorvastatin|mesh-list
138655242|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138655243|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138270012|NCT05922384|Etoposide|etoposide|mesh-list
138655245|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655246|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655247|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138655248|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655249|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138655250|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138655251|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655252|NCT00316940|Bortezomib|bortezomib|mesh-list
138655253|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138655254|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655255|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138655256|NCT00316940|Analgesics|analgesics|mesh-ancestor
138655257|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
138655258|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655259|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655260|NCT00344994|Pramipexole|pramipexole|mesh-list
138655261|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
138335372|NCT00837252|Finasteride|finasteride|mesh-list
138655262|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655263|NCT00344994|Protective Agents|protective agents|mesh-ancestor
138655264|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655265|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138655266|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138655267|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
138655268|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
138655269|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655270|NCT00349791|Testosterone|testosterone|mesh-list
138655271|NCT00349791|Androgens|androgens|mesh-ancestor
138655272|NCT00349791|Hormones|hormones|mesh-ancestor
138655273|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655274|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655276|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138655277|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655278|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
138655279|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655280|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655281|NCT00317135|Vaccines|vaccines|mesh-list
138655282|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
138655283|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655285|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655286|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655287|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138655288|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655289|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270252|NCT05832398|Irinotecan|irinotecan|mesh-list
138655290|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138655291|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
138655292|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311181|NCT00005615|Interferons|interferons|mesh-list
138655293|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655296|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
138655297|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138655298|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
138655299|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655300|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655301|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
138655302|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138655303|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655304|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655305|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138655306|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138655307|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138655308|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138655309|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138655310|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138655311|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138655312|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655313|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
138655314|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655316|NCT00317408|Cytarabine|cytarabine|mesh-list
138655317|NCT00317408|Cyclosporine|cyclosporine|mesh-list
138655318|NCT00317408|Dexamethasone|dexamethasone|mesh-list
138655319|NCT00317408|Prednisolone|prednisolone|mesh-list
138655320|NCT00317408|Carboplatin|carboplatin|mesh-list
138655321|NCT00317408|Methotrexate|methotrexate|mesh-list
138655322|NCT00317408|Etoposide|etoposide|mesh-list
138655323|NCT00317408|Melphalan|melphalan|mesh-list
138655324|NCT00317408|Busulfan|busulfan|mesh-list
138655325|NCT00317408|Ifosfamide|ifosfamide|mesh-list
138655326|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
138655327|NCT00317408|Idarubicin|idarubicin|mesh-list
138655328|NCT00317408|Thiotepa|thiotepa|mesh-list
138655329|NCT00317408|Carmustine|carmustine|mesh-list
138655330|NCT00317408|Vinblastine|vinblastine|mesh-list
138655331|NCT00317408|Lomustine|lomustine|mesh-list
138655332|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
138655333|NCT00317408|Vindesine|vindesine|mesh-list
138270380|NCT05613426|Evolocumab|evolocumab|mesh-list
138655334|NCT00317408|Cyclosporins|cyclosporins|mesh-list
138335469|NCT00868452|Valproic Acid|valproic acid|mesh-list
138655336|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
138655337|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655338|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
138350558|NCT05032183|Vitamins|vitamins|mesh-ancestor
138655339|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
138655340|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655341|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655342|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655343|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
138655344|NCT00317408|Hormones|hormones|mesh-ancestor
138655345|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655347|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655348|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138655349|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
138332064|NCT04350684|Lopinavir|lopinavir|mesh-list
138655350|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655351|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138335505|NCT00871260|Regadenoson|regadenoson|mesh-list
138311217|NCT00005765|Nicotine|nicotine|mesh-list
138655353|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655354|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655355|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655356|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138655357|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655358|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
138655359|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655360|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138655361|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138655362|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138655363|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655364|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
138655365|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655367|NCT00317408|Protective Agents|protective agents|mesh-ancestor
138655368|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655369|NCT00317408|Vitamins|vitamins|mesh-ancestor
138655370|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
138655371|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
138655372|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655373|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138655374|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
138655375|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655377|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
138655378|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655379|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655380|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
138655381|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
138655382|NCT00317447|Prednisone|prednisone|mesh-list
138655383|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655384|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
138335567|NCT00879060|Diuretics|diuretics|mesh-ancestor
138655386|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655387|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655388|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138655389|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655390|NCT02959554|Nivolumab|nivolumab|mesh-list
138655391|NCT02959554|Sunitinib|sunitinib|mesh-list
138655392|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138655393|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655394|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138655395|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655396|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655397|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655398|NCT02959554|Growth Substances|growth substances|mesh-ancestor
138655399|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655400|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655401|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655402|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655403|NCT00345306|Progesterone|progesterone|mesh-list
138655404|NCT00345306|Progestins|progestins|mesh-ancestor
138655405|NCT00345306|Hormones|hormones|mesh-ancestor
138655406|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655407|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655408|NCT00317681|Tacrolimus|tacrolimus|mesh-list
138655409|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655410|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
138655411|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655412|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655413|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655414|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655415|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
138655417|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
138655418|NCT00350181|Busulfan|busulfan|mesh-list
138655419|NCT00350181|Carmustine|carmustine|mesh-list
138655420|NCT00350181|Etoposide|etoposide|mesh-list
138655421|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655422|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
138311227|NCT00005777|Dexamethasone|dexamethasone|mesh-list
138655423|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655424|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655425|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138655426|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
138655427|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655428|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655429|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655430|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138655431|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138655432|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655434|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655435|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138655436|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
138655437|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655438|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655441|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
138655442|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655443|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655444|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
138655445|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655446|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655447|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
138655448|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655449|NCT00317798|Sirolimus|sirolimus|mesh-list
138655450|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138655451|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655452|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655453|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655454|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655455|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
138655456|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335641|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
138655457|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
138655458|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655459|NCT00345501|Iloprost|iloprost|mesh-list
138655460|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138655461|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138655462|NCT00345657|Niacin|niacin|mesh-list
138655463|NCT00345657|Lovastatin|lovastatin|mesh-list
138655465|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
138655466|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655467|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
138655468|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655469|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138655470|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
138655471|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655472|NCT00345657|Vitamins|vitamins|mesh-ancestor
138655473|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
138655474|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655475|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138655476|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138655477|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201713|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335687|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138655478|NCT00317876|Cyclosporine|cyclosporine|mesh-list
138655479|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
138655480|NCT00317876|Methotrexate|methotrexate|mesh-list
138655481|NCT00317876|Cyclosporins|cyclosporins|mesh-list
138655482|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655483|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
138311233|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655484|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655485|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655486|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138655487|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
138655488|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655489|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655490|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655491|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138655492|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
138335745|NCT00905580|Analgesics|analgesics|mesh-ancestor
138655493|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655494|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655495|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
138655496|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655497|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655498|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138270949|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
138655499|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138655500|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
138655501|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655502|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138332223|NCT04340778|Lidocaine|lidocaine|mesh-list
138655504|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138655505|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138655506|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138655507|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655508|NCT00317954|Spironolactone|spironolactone|mesh-list
138655509|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138655510|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
138655511|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655512|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655513|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138655514|NCT00317954|Diuretics|diuretics|mesh-ancestor
138655515|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
138655516|NCT00317993|Simvastatin|simvastatin|mesh-list
138655517|NCT00317993|Ezetimibe|ezetimibe|mesh-list
138655518|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138655519|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138655520|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
138655521|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655522|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138271012|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655523|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138655524|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655525|NCT00350415|Mesalamine|mesalamine|mesh-list
138655526|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138655527|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138655528|NCT00350415|Analgesics|analgesics|mesh-ancestor
138655530|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655531|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655532|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655533|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350586|NCT04992260|Vaccines|vaccines|mesh-list
138655534|NCT00345696|Bevacizumab|bevacizumab|mesh-list
138655535|NCT00345696|Capecitabine|capecitabine|mesh-list
138655536|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
138655537|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138655538|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655539|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655540|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655541|NCT00345696|Growth Substances|growth substances|mesh-ancestor
138655542|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655544|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655545|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
138655546|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655547|NCT00350454|Sirolimus|sirolimus|mesh-list
138655548|NCT00350454|Temsirolimus|temsirolimus|mesh-list
138655549|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
138655550|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655551|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655552|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655553|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655554|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
138655555|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655556|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
138655557|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655558|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655559|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655560|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655562|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138655563|NCT00345735|Narcotics|narcotics|mesh-ancestor
138655564|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655565|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655566|NCT00345735|Analgesics|analgesics|mesh-ancestor
138655567|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
138655568|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655569|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138655570|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138655571|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
138655576|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332303|NCT04337268|Glucagon|glucagon|mesh-list
138655577|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655578|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655579|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655581|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655582|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655583|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655584|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
138655585|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
138655586|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655587|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655588|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655589|NCT00318383|Vaccines|vaccines|mesh-list
138655590|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
138655591|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655592|NCT00318422|Liraglutide|liraglutide|mesh-list
138655593|NCT00318422|Glimepiride|glimepiride|mesh-list
138655594|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
138655595|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655596|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655597|NCT00318422|Incretins|incretins|mesh-ancestor
138655598|NCT00318422|Hormones|hormones|mesh-ancestor
138655599|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655600|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138655601|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335871|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655603|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138655604|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
138655605|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655606|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138655607|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138655608|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655609|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655610|NCT00346047|Buprenorphine|buprenorphine|mesh-list
138655611|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138655612|NCT00346047|Narcotics|narcotics|mesh-ancestor
138655613|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655614|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655615|NCT00346047|Analgesics|analgesics|mesh-ancestor
138655616|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
138655617|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655618|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138655619|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138655620|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138655621|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
138655622|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
138655624|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
138655625|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655626|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138655627|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138655628|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655629|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311290|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655631|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
138655632|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655633|NCT00318890|Docetaxel|docetaxel|mesh-list
138655634|NCT00318890|Amifostine|amifostine|mesh-list
138655635|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655636|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655637|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138655638|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138655639|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655640|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138655641|NCT00318890|Protective Agents|protective agents|mesh-ancestor
138655642|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655643|NCT00318968|Esomeprazole|esomeprazole|mesh-list
138655644|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138655645|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655646|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138655647|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655648|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655650|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138655651|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138655652|NCT00319007|Analgesics|analgesics|mesh-ancestor
138655653|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
138655654|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655655|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655656|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655657|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655658|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655659|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138655660|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655661|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655663|NCT00350961|Capecitabine|capecitabine|mesh-list
138655664|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
138655665|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655666|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
138655667|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655668|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655669|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
138655670|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138311324|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
138655671|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655673|NCT00421473|Proguanil|proguanil|mesh-list
138655674|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138655675|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655677|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138655678|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138655679|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655680|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350595|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655682|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
138655683|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138350597|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
138655684|NCT00319163|Estradiol|estradiol|mesh-list
138655685|NCT00319163|Estrogens|estrogens|mesh-ancestor
138655686|NCT00319163|Hormones|hormones|mesh-ancestor
138271508|NCT02640534|Metformin|metformin|mesh-list
138655687|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655688|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655689|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138655690|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
138655691|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655692|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138655693|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138655694|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138655695|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138655697|NCT00319202|Candesartan cilexetil|candesartan cilexetil|mesh-list
138655698|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138655699|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138655700|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138655701|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655702|NCT00421512|Bevacizumab|bevacizumab|mesh-list
138655703|NCT00421512|Sunitinib|sunitinib|mesh-list
138655704|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138655705|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655706|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655707|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655708|NCT00421512|Growth Substances|growth substances|mesh-ancestor
138271638|NCT01968200|Enalapril|enalapril|mesh-list
138655709|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655710|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655711|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655712|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655713|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655714|NCT00319319|Mecamylamine|mecamylamine|mesh-list
138655715|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138655716|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138655717|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
138655718|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350605|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655719|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655720|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138655721|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138655722|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
138655723|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655724|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655725|NCT00346359|Methotrexate|methotrexate|mesh-list
138311356|NCT05893810|Mupirocin|mupirocin|mesh-list
138188446|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138655726|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
138655727|NCT00346359|Fludarabine|fludarabine|mesh-list
138655729|NCT00346359|Tacrolimus|tacrolimus|mesh-list
138655730|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138655731|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138655732|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
138655733|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655734|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655735|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655736|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
138655737|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655738|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655739|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655740|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655741|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138655742|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655743|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
138655744|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655745|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138655746|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655747|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
138655748|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138655749|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655750|NCT00319358|Antioxidants|antioxidants|mesh-list
138655751|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655752|NCT00319358|Protective Agents|protective agents|mesh-ancestor
138655753|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655754|NCT00319514|Docetaxel|docetaxel|mesh-list
138655755|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655756|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655757|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
138655758|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
138655759|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655760|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138655761|NCT00319670|Laxatives|laxatives|mesh-ancestor
138655762|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655763|NCT00351195|Capecitabine|capecitabine|mesh-list
138655764|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
138655765|NCT00351195|Etoposide|etoposide|mesh-list
138655766|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138655767|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
138655768|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655769|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271944|NCT00309478|Tamoxifen|tamoxifen|mesh-list
138655770|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138655771|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138655772|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655774|NCT00319709|Amibegron|amibegron|mesh-list
138655775|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138655776|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138655777|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138655778|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
138655779|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655780|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655781|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655782|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138655783|NCT00319787|Gefitinib|gefitinib|mesh-list
138655784|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336069|NCT00950352|Choline|choline|mesh-list
138655786|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655787|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655788|NCT00319865|Thalidomide|thalidomide|mesh-list
138655789|NCT00319865|Dexamethasone|dexamethasone|mesh-list
138655790|NCT00319865|Doxorubicin|doxorubicin|mesh-list
138655791|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138655792|NCT00319865|Bortezomib|bortezomib|mesh-list
138655793|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655794|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
138655795|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
138655796|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655797|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655798|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655799|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
138655800|NCT00319865|Hormones|hormones|mesh-ancestor
138272004|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655801|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655802|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138655803|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655804|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655805|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138655806|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655807|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655808|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655809|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655810|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
138655811|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
138655812|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655813|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655814|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655815|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655816|NCT00319865|Growth Substances|growth substances|mesh-ancestor
138655817|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655818|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
138655819|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655822|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655823|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
138655824|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
138655825|NCT00320060|Vitamins|vitamins|mesh-ancestor
138655826|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
138272048|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
138655828|NCT00320099|Insulin|insulin|mesh-list
138655829|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138655830|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
138655831|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138655832|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138655833|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138655834|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
138655835|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655836|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655837|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311401|NCT05885230|Lidocaine|lidocaine|mesh-list
138655838|NCT00320294|Irinotecan|irinotecan|mesh-list
138272103|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655839|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655840|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138655841|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138655842|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655843|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655844|NCT00346749|Fluticasone|fluticasone|mesh-list
138655845|NCT00346749|Xhance|xhance|mesh-list
138655846|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138272180|NCT00033657|Paclitaxel|paclitaxel|mesh-list
138655847|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138655848|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138655849|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
138655850|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655851|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655852|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138655853|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
138655854|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138655855|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138655856|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138655857|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138655858|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138655859|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
138655860|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655861|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655862|NCT00351507|Vildagliptin|vildagliptin|mesh-list
138655863|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655864|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655865|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138655866|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
138655867|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655868|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655869|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138655870|NCT00320567|Norgestimate|norgestimate|mesh-list
138655871|NCT00320567|Estradiol|estradiol|mesh-list
138655872|NCT00320567|Estrogens|estrogens|mesh-ancestor
138655873|NCT00320567|Hormones|hormones|mesh-ancestor
138655874|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272296|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
138655875|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655876|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138655877|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
138655878|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138655879|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138655880|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138655881|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138655882|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138655883|NCT00346827|Apomorphine|apomorphine|mesh-list
138655885|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655886|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
138655887|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655888|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138655889|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
138655890|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
138655892|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655893|NCT00346866|Anecortave|anecortave|mesh-list
138655894|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138655895|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655896|NCT00346866|Growth Substances|growth substances|mesh-ancestor
138655897|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655898|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
138655899|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655900|NCT00320723|Bupropion|bupropion|mesh-list
138655901|NCT00320723|Nicotine|nicotine|mesh-list
138655902|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138655903|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
138655904|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655905|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655906|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138655907|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138655908|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
138655909|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655910|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655911|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138655912|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
138655913|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655914|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138272353|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
138655915|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138655916|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655917|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
138655918|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138655919|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138655920|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655921|NCT00351546|Vildagliptin|vildagliptin|mesh-list
138655922|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655923|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655924|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138655925|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
138655926|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272388|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138655927|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655928|NCT00351585|Vildagliptin|vildagliptin|mesh-list
138655929|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655930|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655931|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138655932|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
138655933|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655934|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655935|NCT00320879|Irbesartan|irbesartan|mesh-list
138272456|NCT04960202|Ritonavir|ritonavir|mesh-list
138655936|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138655937|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138655938|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138655939|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655941|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
138655942|NCT00347100|Glyburide|glyburide|mesh-list
138655943|NCT00347100|Glipizide|glipizide|mesh-list
138655944|NCT00347100|Gliclazide|gliclazide|mesh-list
138311428|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
138311429|NCT05779943|Protective Agents|protective agents|mesh-ancestor
138655945|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138655946|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655947|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138655948|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138655949|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
138655950|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655951|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655952|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138655953|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
138655954|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138655955|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138655956|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138655957|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
138655958|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655959|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655961|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655963|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655964|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655965|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655966|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655967|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
138655968|NCT00321113|Tacrolimus|tacrolimus|mesh-list
138655969|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138655970|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
138655971|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336258|NCT00989586|Veltuzumab|veltuzumab|mesh-list
138655972|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138655973|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655974|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655975|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655976|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655977|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138655978|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
138655979|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138655980|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138655981|NCT00347256|Cisplatin|cisplatin|mesh-list
138655982|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350660|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138350661|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138655983|NCT00347295|Estazolam|estazolam|mesh-list
138655984|NCT00347295|Brotizolam|brotizolam|mesh-list
138655985|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
138655986|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138655987|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138655988|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655989|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655990|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138655991|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
138655992|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
138655993|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655994|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655995|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138655996|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
138655997|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138655998|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
138655999|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
138656000|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656001|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656002|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138311462|NCT05590468|Niacin|niacin|mesh-list
138656003|NCT00321191|Analgesics|analgesics|mesh-ancestor
138656004|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
138656005|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656006|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
138656007|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138656008|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
138656009|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656010|NCT00321230|Protective Agents|protective agents|mesh-ancestor
138656011|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656012|NCT00321230|Vitamins|vitamins|mesh-ancestor
138656013|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
138656014|NCT00321230|Laxatives|laxatives|mesh-ancestor
138656015|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336294|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656016|NCT00351663|Enoxaparin|enoxaparin|mesh-list
138656017|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
138656018|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138272752|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656019|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138656020|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656022|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
138656023|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
138656024|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656025|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656026|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
138656027|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656028|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138656029|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138656030|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138656031|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656032|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656033|NCT00351702|Isoniazid|isoniazid|mesh-list
138656034|NCT00351702|Ethambutol|ethambutol|mesh-list
138656035|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
138656036|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656037|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656038|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138656039|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656040|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
138656041|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656042|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138656043|NCT00351975|Azacitidine|azacitidine|mesh-list
138656044|NCT00351975|Belinostat|belinostat|mesh-list
138656045|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656046|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
138311467|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311468|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656047|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656049|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656050|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138656051|NCT00321581|Cediranib|cediranib|mesh-list
138656052|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656053|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336333|NCT01000818|Omeprazole|omeprazole|mesh-list
138656054|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201714|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656055|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656056|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
138656057|NCT00352092|Sirolimus|sirolimus|mesh-list
138656058|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138656059|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138656060|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656061|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138656062|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
138656063|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656064|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656065|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656066|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656067|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
138656068|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656069|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
138656070|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656072|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138656073|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138656074|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
138656075|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656076|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
138656077|NCT00352170|Vitamin D|vitamin d|mesh-list
138656078|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
138656079|NCT00352170|Calcium|calcium|mesh-list
138656080|NCT00352170|Vitamins|vitamins|mesh-ancestor
138272994|NCT00376883|Pamidronate|pamidronate|mesh-list
138656081|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
138656082|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656083|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656084|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138656086|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656087|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656088|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
138656089|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138656090|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656091|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656092|NCT00352287|Pioglitazone|pioglitazone|mesh-list
138656093|NCT00352287|Hormones|hormones|mesh-list
138656094|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656095|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656096|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138656097|NCT00352443|Everolimus|everolimus|mesh-list
138656098|NCT00352443|Lapatinib|lapatinib|mesh-list
138656099|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138656100|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656101|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656102|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656103|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656105|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656106|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656107|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
138656108|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656109|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138656110|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138656111|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656112|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656113|NCT00352482|Urological Agents|urological agents|mesh-ancestor
138656115|NCT00322400|Docetaxel|docetaxel|mesh-list
138656116|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
138656117|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138656118|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656119|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
138656120|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
138656121|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
138656122|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656123|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656124|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656125|NCT00352521|Bevacizumab|bevacizumab|mesh-list
138656126|NCT00352521|Irinotecan|irinotecan|mesh-list
138656127|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656128|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656129|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656130|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138656131|NCT00352521|Growth Substances|growth substances|mesh-ancestor
138656132|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656133|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
138656134|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138656135|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138656136|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656137|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656138|NCT00352599|Lovastatin|lovastatin|mesh-list
138656139|NCT00352599|L 647318|l 647318|mesh-list
138656140|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
138656141|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138656142|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138336393|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138656143|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
138656144|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656145|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138656146|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138656147|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656148|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138656149|NCT00322595|Paroxetine|paroxetine|mesh-list
138656150|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656151|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656152|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138656153|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138656154|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656155|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656156|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138656157|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656158|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656159|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656160|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656161|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
138656162|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138656163|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138311503|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656164|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138656165|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656166|NCT00352677|Bafetinib|bafetinib|mesh-list
138656167|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656168|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656169|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656170|NCT00331149|Ropinirole|ropinirole|mesh-list
138656171|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138656172|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138656173|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
138656175|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656176|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656177|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656179|NCT00331188|Analgesics|analgesics|mesh-ancestor
138656180|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
138656181|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656182|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273344|NCT04184297|Olodaterol|olodaterol|mesh-list
138656183|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656184|NCT00352833|Catumaxomab|catumaxomab|mesh-list
138656185|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656186|NCT00331305|Sertraline|sertraline|mesh-list
138656187|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656188|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656189|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138656190|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656191|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656192|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336479|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
138656193|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656194|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
138656195|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656197|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138656198|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138656199|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656200|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656201|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656202|NCT00352950|Panitumumab|panitumumab|mesh-list
138656203|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656204|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656205|NCT00322907|Mefloquine|mefloquine|mesh-list
138656206|NCT00322907|Quinine|quinine|mesh-list
138656207|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
138656208|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656209|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138656210|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656211|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138656212|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656213|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138656214|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656215|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656217|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
138656218|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138656219|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138656220|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138656221|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138656222|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656223|NCT00331500|Analgesics|analgesics|mesh-ancestor
138656224|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
138311527|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
138656225|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336522|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138656226|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656227|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656228|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656229|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138656230|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138656231|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138656232|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
138656233|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
138656234|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656235|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656237|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
138656238|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656239|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656240|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138656241|NCT00322985|Growth Substances|growth substances|mesh-ancestor
138656242|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
138656243|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656244|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
138656245|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656246|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656247|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138656248|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138656249|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656250|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656251|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656252|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138656253|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656254|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656255|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656256|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
138656257|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138656258|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656259|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138350683|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656260|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138656261|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138656262|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
138656263|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138656264|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656265|NCT00353067|Analgesics|analgesics|mesh-ancestor
138656266|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
138656267|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336568|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
138656268|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656269|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656270|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656272|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656273|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656274|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
138656275|NCT00323219|Cefazolin|cefazolin|mesh-list
138656276|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656277|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656278|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138656279|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138656280|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656281|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656282|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656283|NCT00323375|Chloroquine|chloroquine|mesh-list
138656284|NCT00323375|Amebicides|amebicides|mesh-ancestor
138656285|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656286|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138656287|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656288|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
138656289|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656290|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138656291|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138656292|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138656293|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
138656294|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656295|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656296|NCT00331695|Progestins|progestins|mesh-ancestor
138656297|NCT00331695|Hormones|hormones|mesh-ancestor
138656298|NCT00353145|Gemcitabine|gemcitabine|mesh-list
138656299|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
138656300|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656301|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
138656302|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656303|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656304|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138656305|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656306|NCT00353184|Montelukast|montelukast|mesh-list
138656307|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138656308|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656309|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138656310|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
138656311|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656312|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656313|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138656314|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138273736|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
138656315|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656316|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138656317|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138656318|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138656319|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656320|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333051|NCT02981784|Ponatinib|ponatinib|mesh-list
138656321|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
138656322|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656323|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138656324|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138656326|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138656327|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
138336637|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336640|NCT05402826|Vitamins|vitamins|mesh-ancestor
138656329|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
138656330|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656332|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138656333|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
138656334|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656335|NCT00353340|Expectorants|expectorants|mesh-ancestor
138273791|NCT02959255|Esomeprazole|esomeprazole|mesh-list
138656336|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656337|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138656338|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
138656339|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656340|NCT00353340|Protective Agents|protective agents|mesh-ancestor
138656341|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656342|NCT00353340|Antidotes|antidotes|mesh-ancestor
138656343|NCT00323843|Isoproterenol|isoproterenol|mesh-list
138656344|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138656345|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138656346|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
138336684|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656347|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656348|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656349|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656350|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138656352|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656353|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138656354|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656355|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138656356|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
138656357|NCT00323843|Protective Agents|protective agents|mesh-ancestor
138656358|NCT00331851|Metformin|metformin|mesh-list
138656359|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
138656360|NCT00331851|Liraglutide|liraglutide|mesh-list
138656361|NCT00331851|Glimepiride|glimepiride|mesh-list
138656362|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138656363|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656364|NCT00331851|Incretins|incretins|mesh-ancestor
138656365|NCT00331851|Hormones|hormones|mesh-ancestor
138656366|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656367|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138656368|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656369|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
138350704|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138656370|NCT00331890|Choline|choline|mesh-list
138656371|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138656372|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
138656373|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656374|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
138273900|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311579|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138656375|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656376|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656377|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138656378|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
138656380|NCT01059773|Ustekinumab|ustekinumab|mesh-list
138656381|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138656382|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
138656383|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138656384|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656385|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273950|NCT04450836|Trifluridine|trifluridine|mesh-list
138656386|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
138656387|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656388|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656389|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656390|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656391|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138656392|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656393|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
138656394|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274012|NCT00359359|Sagopilone|sagopilone|mesh-list
138656395|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138656396|NCT00353379|Guanfacine|guanfacine|mesh-list
138656397|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138656398|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138656399|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138656400|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138656401|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138656402|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656403|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656404|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656405|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
138656406|NCT00324077|Dasatinib|dasatinib|mesh-list
138656407|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656408|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656409|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656410|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656411|NCT00324194|Mocetinostat|mocetinostat|mesh-list
138656412|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138656413|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656414|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656415|NCT00324389|Interferons|interferons|mesh-list
138656416|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
138656417|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656418|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
138656419|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656420|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
138656421|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656422|NCT00353691|Metformin|metformin|mesh-list
138656423|NCT00353691|Glimepiride|glimepiride|mesh-list
138656424|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138656425|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656426|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138656427|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656428|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
138656429|NCT00332046|Casopitant|casopitant|mesh-list
138656430|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
138336770|NCT01053000|Tazarotene|tazarotene|mesh-list
138656431|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
138656432|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311606|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656433|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656434|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656435|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138656436|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656437|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656438|NCT00324467|Acetaminophen|acetaminophen|mesh-list
138656439|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
138656440|NCT00324467|Promethazine|promethazine|mesh-list
138656441|NCT00324467|Dexamethasone|dexamethasone|mesh-list
138656442|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
138656443|NCT00324467|Prednisone|prednisone|mesh-list
138656444|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
138656445|NCT00324467|Ifosfamide|ifosfamide|mesh-list
138656446|NCT00324467|Rituximab|rituximab|mesh-list
138656447|NCT00324467|Carboplatin|carboplatin|mesh-list
138656449|NCT00324467|Etoposide|etoposide|mesh-list
138656450|NCT00324467|Vincristine|vincristine|mesh-list
138656451|NCT00324467|Ondansetron|ondansetron|mesh-list
138656452|NCT00324467|BB 1101|bb 1101|mesh-list
138656454|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656455|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
138656456|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656457|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656458|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138656459|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
138656460|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656461|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656462|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138656463|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656464|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
138656465|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
138656466|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656467|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656468|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
138656469|NCT00324467|Hormones|hormones|mesh-ancestor
138656470|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274261|NCT00360607|Amikacin|amikacin|mesh-list
138656471|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138336800|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138656472|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
138656473|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656474|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656475|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138656476|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138656477|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138656478|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138656479|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
138656480|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
138656481|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
138656482|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656483|NCT00324467|Analgesics|analgesics|mesh-ancestor
138656484|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
138656485|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
138656486|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
138656487|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656488|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138656489|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138656490|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
138656491|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656492|NCT00324467|Protective Agents|protective agents|mesh-ancestor
138656493|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138656494|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138656495|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656497|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
138656498|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138336836|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656500|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
138656501|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138656502|NCT00332085|Chromium|chromium|mesh-list
138350728|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350730|NCT04306315|Brodalumab|brodalumab|mesh-list
138656503|NCT00332085|Picolinic acid|picolinic acid|mesh-list
138656504|NCT00332085|Trace Elements|trace elements|mesh-ancestor
138656505|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
138656506|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656507|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138656508|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
138656509|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
138656510|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656511|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
138656512|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138656513|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656514|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138656515|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
138656516|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656517|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656518|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656519|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656520|NCT00332124|Choline|choline|mesh-list
138274490|NCT02389218|Flecainide|flecainide|mesh-list
138656524|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656525|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656526|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138656528|NCT04714554|Erythromycin|erythromycin|mesh-list
138656529|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
138656530|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138656531|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
138656532|NCT04714554|Relugolix|relugolix|mesh-list
138656533|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656534|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656535|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656536|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138656537|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656538|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656539|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
138656540|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
138656541|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656542|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656543|NCT00419471|Escitalopram|escitalopram|mesh-list
138656544|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138656545|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656546|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656547|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656548|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656549|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
138656550|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311642|NCT05065957|Capecitabine|capecitabine|mesh-list
138656552|NCT00426348|Probucol|probucol|mesh-list
138656553|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138656554|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138656555|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138656556|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656557|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138656558|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656559|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
138656560|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138656561|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
138656562|NCT00426348|Protective Agents|protective agents|mesh-ancestor
138656563|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656564|NCT00353808|Reboxetine|reboxetine|mesh-list
138656565|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656566|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656567|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138274767|NCT00002805|Cobalt|cobalt|mesh-list
138656568|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656569|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656570|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656571|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
138656572|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656573|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656574|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
138656575|NCT00324623|Fludarabine|fludarabine|mesh-list
138656576|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
138656577|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656578|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
138656579|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656580|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656581|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138656582|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
138656583|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656584|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656585|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138656586|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656587|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
138656589|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656590|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656591|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
138656592|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656595|NCT00324818|Metronidazole|metronidazole|mesh-list
138656596|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656597|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656598|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656599|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138656601|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
138656602|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138656603|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656604|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138656605|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656606|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656607|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
138656608|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138656609|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138656610|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
138656611|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656612|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656613|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138656614|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656615|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
138274941|NCT03596905|Plecanatide|plecanatide|mesh-list
138350777|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656617|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
138656618|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656619|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656620|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
138656621|NCT00325169|Hormones|hormones|mesh-ancestor
138656622|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656623|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
138656624|NCT00426543|Rituximab|rituximab|mesh-list
138333355|NCT05313828|Hormones|hormones|mesh-ancestor
138656625|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656626|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656627|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
138656628|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656629|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656630|NCT00325286|Carbamazepine|carbamazepine|mesh-list
138656631|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275059|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
138656632|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656633|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
138656634|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138656635|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656636|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656637|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
138656638|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656639|NCT00325286|Analgesics|analgesics|mesh-ancestor
138656640|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
138656641|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656642|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138656643|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656644|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138656645|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138656648|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656649|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
138656650|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656651|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138656652|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656653|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275309|NCT00003957|Analgesics|analgesics|mesh-ancestor
138656654|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138656655|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656656|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656657|NCT00354081|Vitamins|vitamins|mesh-list
138656658|NCT00354081|Folic Acid|folic acid|mesh-list
138656659|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
138656660|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
138656661|NCT00354081|Pyridoxine|pyridoxine|mesh-list
138656662|NCT00354081|Pyridoxal|pyridoxal|mesh-list
138656663|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
138656664|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
138656665|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
138656666|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656667|NCT00354081|Hematinics|hematinics|mesh-ancestor
138656668|NCT00325637|Losartan|losartan|mesh-list
138656669|NCT00325637|Cilnidipine|cilnidipine|mesh-list
138656670|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138656671|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311671|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
138656672|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138656673|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138656674|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656675|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138656676|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656677|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656678|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656680|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656681|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
138656682|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656683|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656684|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138656685|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
138656686|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656687|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337249|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656688|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138656689|NCT00426582|Epothilone B|epothilone b|mesh-list
138656690|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656691|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138656692|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138656693|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138656694|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656695|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138656696|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
138656697|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138656698|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656699|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656700|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138656701|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138656702|NCT00354198|Protective Agents|protective agents|mesh-ancestor
138656703|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275543|NCT00004887|Paclitaxel|paclitaxel|mesh-list
138656704|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656705|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138656706|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
138656707|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656708|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
138656710|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656711|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138656712|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138656713|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337364|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656714|NCT00325676|Pantoprazole|pantoprazole|mesh-list
138656715|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138656717|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138656718|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656719|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656720|NCT00325715|Esomeprazole|esomeprazole|mesh-list
138656721|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138656722|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656723|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138656724|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656725|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656726|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138656727|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311687|NCT04850495|Vincristine|vincristine|mesh-list
138656730|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138656731|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656732|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656733|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656734|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656735|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656737|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138656738|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656740|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
138656741|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656742|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656743|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656744|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656745|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138656746|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656747|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656748|NCT04714242|Ranibizumab|ranibizumab|mesh-list
138656749|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656750|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138656751|NCT04714242|Growth Substances|growth substances|mesh-ancestor
138656752|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656753|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138656754|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656756|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656757|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
138656758|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656759|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656760|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
138656761|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656762|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656763|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
138656764|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656765|NCT00325910|Metformin|metformin|mesh-list
138656766|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138656767|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656768|NCT00325949|Acetaminophen|acetaminophen|mesh-list
138656769|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138656770|NCT00325949|Hydrocodone|hydrocodone|mesh-list
138656771|NCT00325949|Oxycodone|oxycodone|mesh-list
138656772|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656773|NCT00325949|Analgesics|analgesics|mesh-ancestor
138656774|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
138656775|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656776|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656778|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138656779|NCT00325949|Narcotics|narcotics|mesh-ancestor
138656780|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656781|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
138656782|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337467|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138337468|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138656783|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138656784|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656785|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656787|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138311701|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138656788|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656789|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138656790|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656791|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656792|NCT01059318|Everolimus|everolimus|mesh-list
138656793|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138656794|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656795|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656796|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656797|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656798|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
138656799|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656800|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656801|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
138656802|NCT04714515|Ivermectin|ivermectin|mesh-list
138656803|NCT04714515|Montelukast|montelukast|mesh-list
138656804|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
138656805|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656806|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138656807|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656808|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656809|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656810|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656811|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138656812|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656813|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138656814|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
138276165|NCT00003735|Topotecan|topotecan|mesh-list
138337502|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656815|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656816|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350798|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
138656817|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138656818|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138656819|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138656820|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656821|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656822|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138276206|NCT00004317|Leucovorin|leucovorin|mesh-list
138656824|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656825|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656826|NCT00354354|Ipratropium|ipratropium|mesh-list
138656828|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
138656829|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656830|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656831|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138656832|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656833|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656834|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276273|NCT00003753|Floxuridine|floxuridine|mesh-list
138656835|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138656836|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
138656837|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138656838|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
138656839|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656840|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138656841|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138656842|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656843|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656844|NCT01058655|Everolimus|everolimus|mesh-list
138656845|NCT01058655|Tivozanib|tivozanib|mesh-list
138656846|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138333586|NCT00592488|Vitamins|vitamins|mesh-ancestor
138656847|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656848|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656849|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656850|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138656851|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
138656852|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656853|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337612|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
138656854|NCT00326300|Methylphenidate|methylphenidate|mesh-list
138656855|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138656856|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656857|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138656858|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656859|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656860|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656861|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
138656862|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656863|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
138656864|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
138656865|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138337658|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138656866|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656867|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656868|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656869|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656870|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138350811|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
138656872|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138656873|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138656874|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656875|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276453|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138656876|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138656877|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138656879|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
138656880|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656881|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656882|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656883|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656884|NCT00326378|Docetaxel|docetaxel|mesh-list
138337720|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138656886|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138656887|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276521|NCT02678312|Enalapril|enalapril|mesh-list
138656888|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138656889|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656890|NCT00326768|Telmisartan|telmisartan|mesh-list
138656891|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138656892|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138656893|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138656894|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138656895|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656897|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
138656898|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656899|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138656900|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656901|NCT00326807|Naltrexone|naltrexone|mesh-list
138656902|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138656903|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138656904|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656905|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
138656906|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656907|NCT00354549|Bevacizumab|bevacizumab|mesh-list
138656909|NCT00354549|Gemcitabine|gemcitabine|mesh-list
138656910|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138656911|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656913|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656914|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138656915|NCT00354549|Growth Substances|growth substances|mesh-ancestor
138656916|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656917|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
138656918|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656920|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656921|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656922|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656924|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138656925|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656926|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138656927|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138656928|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138656929|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
138656930|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656931|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337831|NCT01094574|Narcotics|narcotics|mesh-ancestor
138656932|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656934|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656936|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
138656937|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656938|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
138656939|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138656940|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656941|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656942|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656943|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138656944|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138656945|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138656946|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138656947|NCT00425646|Bevacizumab|bevacizumab|mesh-list
138656948|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
138276755|NCT00005571|Eculizumab|eculizumab|mesh-list
138656949|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656950|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656951|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656952|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138656953|NCT00425646|Growth Substances|growth substances|mesh-ancestor
138656954|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656955|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
138656956|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138656957|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656958|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656959|NCT00327080|Acetylcholine|acetylcholine|mesh-list
138656960|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
138656961|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138656962|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
138656963|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656964|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656965|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656966|NCT00327119|Panitumumab|panitumumab|mesh-list
138656967|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138656968|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656970|NCT00426933|Daptomycin|daptomycin|mesh-list
138656971|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138656972|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656973|NCT00327197|Prednisolone|prednisolone|mesh-list
138656974|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656976|NCT00327197|Hormones|hormones|mesh-ancestor
138656977|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656978|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656979|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138656980|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138656981|NCT00425724|Cyclosporine|cyclosporine|mesh-list
138656982|NCT00425724|Prednisone|prednisone|mesh-list
138656983|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
138656984|NCT00425724|Cyclosporins|cyclosporins|mesh-list
138656985|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138656986|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
138656987|NCT00425724|Hormones|hormones|mesh-ancestor
138277010|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
138277011|NCT01689987|Ichthammol|ichthammol|mesh-list
138656988|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656989|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656990|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138656991|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337910|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
138656993|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656995|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
138656996|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
138656997|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277099|NCT02483000|Vitamins|vitamins|mesh-ancestor
138656998|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656999|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657000|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138657001|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
138657002|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
138657003|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657004|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657005|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138657006|NCT00425724|Protective Agents|protective agents|mesh-ancestor
138657007|NCT00426972|Estradiol|estradiol|mesh-list
138657010|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657011|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657012|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
138657013|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138657014|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138657015|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
138657016|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657017|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657018|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138657019|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657020|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138657021|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138657022|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138657023|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657024|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657025|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657026|NCT00425841|Gemcitabine|gemcitabine|mesh-list
138657028|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138657029|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
138657030|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657031|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311755|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
138657032|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
138657033|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138657034|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
138338096|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
138657036|NCT00427089|Protective Agents|protective agents|mesh-ancestor
138657037|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657038|NCT00427089|Vitamins|vitamins|mesh-ancestor
138657039|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
138657040|NCT00427089|Laxatives|laxatives|mesh-ancestor
138657041|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657042|NCT00427128|Fluoxetine|fluoxetine|mesh-list
138657043|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138657044|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657045|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657046|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657047|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657048|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
138657049|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657050|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138657051|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
138277339|NCT02424799|GSK2646264|gsk2646264|mesh-list
138657053|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138657054|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657055|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657056|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138657057|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138657058|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
138657059|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657060|NCT00427167|Antacids|antacids|mesh-ancestor
138657061|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657062|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657063|NCT00427206|Acetaminophen|acetaminophen|mesh-list
138657064|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657065|NCT00427206|Analgesics|analgesics|mesh-ancestor
138657066|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
138657067|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657068|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657069|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
138657070|NCT00425997|Amlodipine|amlodipine|mesh-list
138657071|NCT00425997|Valsartan|valsartan|mesh-list
138657072|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138657073|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138657074|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138657075|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657076|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657077|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138311770|NCT04649060|Dexamethasone|dexamethasone|mesh-list
138657078|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657079|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657080|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138657081|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138657083|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
138657084|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138657085|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
138657086|NCT00427245|Goserelin|goserelin|mesh-list
138657087|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657088|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
138657089|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657090|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657091|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138657092|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
138657093|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657094|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657095|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138657096|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138657098|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138657099|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138657100|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138657101|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277560|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138657102|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657103|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138657104|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138657105|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
138657106|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657107|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138657108|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657109|NCT00427362|Adalimumab|adalimumab|mesh-list
138657110|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138657111|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657112|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657114|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138657115|NCT00426192|Diuretics|diuretics|mesh-ancestor
138657116|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
138338181|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338183|NCT01128972|Listerine|listerine|mesh-list
138657118|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138657119|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
138657120|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657121|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138277694|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657122|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138657123|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657124|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657126|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138657127|NCT00432393|Levodopa|levodopa|mesh-list
138657128|NCT00432393|Carbidopa|carbidopa|mesh-list
138657129|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138657130|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138657131|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138657132|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
138657133|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657134|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657135|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657136|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138657137|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657138|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138657139|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
138657140|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
138657141|NCT05453045|Albendazole|albendazole|mesh-list
138657142|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
138657143|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138657144|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657145|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
138657146|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138657147|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138657148|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
138657149|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
138657150|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
138657151|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657152|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657154|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138657155|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657156|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
138657157|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657158|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657160|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138657161|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
138657162|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657163|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657164|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
138657165|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138657166|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657167|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657168|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138657169|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138657170|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138277952|NCT02514044|Adderall|adderall|mesh-list
138657171|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138657172|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138657173|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138657175|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138657176|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138657177|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138657178|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657179|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657180|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657181|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657182|NCT00432510|Complement C1s|complement c1s|mesh-list
138657183|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138657184|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138657185|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
138657186|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657187|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138657188|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657189|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
138657190|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
138657191|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138657192|NCT05354258|Amodiaquine|amodiaquine|mesh-list
138657193|NCT05354258|Albendazole|albendazole|mesh-list
138657194|NCT05354258|Praziquantel|praziquantel|mesh-list
138657195|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
138657196|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138657197|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138657198|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657199|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138657200|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657201|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657202|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138657203|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
138657204|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
138657205|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138657206|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
138657207|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
138657208|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
138657209|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657210|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
138350866|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350867|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350868|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350869|NCT03751436|Venetoclax|venetoclax|mesh-list
138350870|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350871|NCT03735875|Venetoclax|venetoclax|mesh-list
138350872|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350873|NCT03634839|Nicotine|nicotine|mesh-list
138350874|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138350875|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
138350878|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138657211|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138657212|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657213|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138657214|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657215|NCT02273466|Desipramine|desipramine|mesh-list
138657216|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138657217|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657218|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657219|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278273|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657220|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657221|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138657222|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657223|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657224|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657225|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657226|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657227|NCT00427713|Capecitabine|capecitabine|mesh-list
138657228|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
138657229|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138657230|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
138278338|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657231|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657232|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657233|NCT02273505|Aspirin|aspirin|mesh-list
138657234|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
138657235|NCT02273505|Salicylates|salicylates|mesh-list
138657236|NCT02273505|Dipyridamole|dipyridamole|mesh-list
138657237|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138657238|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657239|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
138657240|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
138657241|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
138657242|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138657243|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657244|NCT02273505|Analgesics|analgesics|mesh-ancestor
138657245|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
138657246|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657247|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657248|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657249|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657250|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138657251|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311823|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
138657252|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657253|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138657254|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138657255|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138657257|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138657258|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657259|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
138657260|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
138657261|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657263|NCT00432549|Almotriptan|almotriptan|mesh-list
138657264|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
138657265|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138657266|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657267|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138657268|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
138657269|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657270|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657271|NCT00427947|Ropivacaine|ropivacaine|mesh-list
138657272|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
138657273|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
138350894|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657274|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657275|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657276|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
138657277|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657278|NCT00432588|Misoprostol|misoprostol|mesh-list
138657279|NCT00432588|Dinoprostone|dinoprostone|mesh-list
138657280|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138657281|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
138657282|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138657283|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657284|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138657285|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657286|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
138657287|NCT00428025|Diclofenac|diclofenac|mesh-list
138657288|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138657289|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657290|NCT00428025|Analgesics|analgesics|mesh-ancestor
138657291|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
138657292|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657293|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657294|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657295|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657296|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138657297|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657298|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657299|NCT00428064|Cyclosporine|cyclosporine|mesh-list
138657300|NCT00428064|Sirolimus|sirolimus|mesh-list
138657301|NCT00428064|Cyclosporins|cyclosporins|mesh-list
138657302|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657303|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657304|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657305|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
138657306|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657307|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
138311847|NCT04484259|Ticagrelor|ticagrelor|mesh-list
138657308|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657309|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138657310|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657311|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138657312|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657313|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138657314|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657316|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138657317|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
138657318|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
138657319|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657320|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
138657321|NCT00419783|Ketoconazole|ketoconazole|mesh-list
138657322|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138350903|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138657323|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657324|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138657325|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278555|NCT04289792|Paclitaxel|paclitaxel|mesh-list
138657326|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657327|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657328|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657329|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657330|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
138657331|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138278603|NCT02544607|Ketamine|ketamine|mesh-list
138657332|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657333|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138657334|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657335|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657336|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138657337|NCT00428181|Ethanol|ethanol|mesh-list
138657338|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138657339|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657340|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657341|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657342|NCT00432861|Pancrelipase|pancrelipase|mesh-list
138657343|NCT00432861|Pancreatin|pancreatin|mesh-list
138657344|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657345|NCT04575233|Ropivacaine|ropivacaine|mesh-list
138657348|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657349|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657350|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
138657351|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657352|NCT00428454|Sirolimus|sirolimus|mesh-list
138657355|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138657356|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657357|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
138657358|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657359|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
138657360|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657361|NCT00432978|Bosentan|bosentan|mesh-list
138657362|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138657363|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138657364|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334101|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
138657366|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138657367|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138657368|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657369|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278794|NCT00367718|Bortezomib|bortezomib|mesh-list
138657371|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
138657372|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657373|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657374|NCT01056510|Rituximab|rituximab|mesh-list
138657375|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138657376|NCT01056510|Chlorambucil|chlorambucil|mesh-list
138657377|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138657378|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657379|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
138657380|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657381|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657382|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138657383|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
138657384|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657386|NCT01056276|Bortezomib|bortezomib|mesh-list
138657387|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138657388|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657389|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
138657390|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
138657391|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657392|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657393|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657394|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
138657395|NCT01056276|Hormones|hormones|mesh-ancestor
138657396|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657397|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138657398|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278856|NCT05588336|Morphine|morphine|mesh-list
138657399|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138657400|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
138657401|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657402|NCT01055886|Nicotine|nicotine|mesh-list
138657403|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138657405|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657406|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657407|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138657408|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138657409|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138657410|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657411|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657412|NCT00433095|Trastuzumab|trastuzumab|mesh-list
138657413|NCT00433095|Vinorelbine|vinorelbine|mesh-list
138657414|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278910|NCT03926624|Analgesics|analgesics|mesh-ancestor
138657415|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657416|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138657418|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138657419|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138657420|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657421|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138657422|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138657423|NCT00428649|Selenium|selenium|mesh-list
138657424|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
138657425|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657426|NCT00428649|Protective Agents|protective agents|mesh-ancestor
138657427|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657428|NCT00428649|Trace Elements|trace elements|mesh-ancestor
138657429|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
138657430|NCT00433173|Anastrozole|anastrozole|mesh-list
138657431|NCT00433173|Goserelin|goserelin|mesh-list
138657433|NCT00433173|Androgens|androgens|mesh-ancestor
138657434|NCT00433173|Hormones|hormones|mesh-ancestor
138657435|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657436|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279023|NCT04341727|Analgesics|analgesics|mesh-ancestor
138657437|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138657438|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334178|NCT00711828|Hormones|hormones|mesh-ancestor
138657439|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138657440|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138657441|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657442|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657443|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138657444|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657447|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138657448|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657449|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138657450|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138657451|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138279158|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657452|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657453|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138657454|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138657455|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138657456|NCT01055028|Growth Substances|growth substances|mesh-ancestor
138657457|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657458|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138657459|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
138657460|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138657461|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
138657462|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657463|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657464|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138657465|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657466|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138657467|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
138657468|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657469|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657470|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138657471|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657472|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
138657474|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
138657475|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138657476|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138657477|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657478|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657479|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657481|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657482|NCT04716569|Ivermectin|ivermectin|mesh-list
138657483|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138657484|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657485|NCT04703127|Lidocaine|lidocaine|mesh-list
138657486|NCT04703127|Tadalafil|tadalafil|mesh-list
138657487|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
138657488|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
138657489|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657490|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657491|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
138657492|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657493|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279433|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657494|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138657495|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138657496|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657497|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657498|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657499|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138657500|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138657501|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657502|NCT04703127|Urological Agents|urological agents|mesh-ancestor
138657504|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138657505|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
138279489|NCT02597101|Metformin|metformin|mesh-list
138657506|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657507|NCT00428883|Expectorants|expectorants|mesh-ancestor
138338457|NCT01177956|Cetuximab|cetuximab|mesh-list
138657508|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
138338459|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
138657509|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138657510|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
138657511|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334248|NCT00720330|Ropivacaine|ropivacaine|mesh-list
138657513|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657514|NCT00428883|Antidotes|antidotes|mesh-ancestor
138657515|NCT04702971|Flunarizine|flunarizine|mesh-list
138657516|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
138279556|NCT02608177|Incretins|incretins|mesh-ancestor
138657517|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138657518|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657519|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657520|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138657521|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657522|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138657523|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
138657524|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
138657525|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657526|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657527|NCT00433407|Trastuzumab|trastuzumab|mesh-list
138657528|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138657529|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657530|NCT00433485|Sirolimus|sirolimus|mesh-list
138657531|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657532|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657533|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138657534|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657535|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
138350933|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138657536|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657537|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
138657538|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657539|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
138657540|NCT02676791|Povidone|povidone|mesh-list
138657541|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
138657542|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
138657543|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138657544|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657545|NCT01600079|Vaccines|vaccines|mesh-list
138657546|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
138657547|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657548|NCT01370486|Melatonin|melatonin|mesh-list
138657549|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
138657550|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657551|NCT01370486|Protective Agents|protective agents|mesh-ancestor
138657552|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657553|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657554|NCT00327587|Amlodipine|amlodipine|mesh-list
138657555|NCT00327587|Valsartan|valsartan|mesh-list
138657558|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138657559|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657560|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657561|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138657562|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657563|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657564|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138657565|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138657566|NCT00327587|Diuretics|diuretics|mesh-ancestor
138657567|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
138657568|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138657570|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138657571|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
138657572|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657573|NCT00433641|Sibutramine|sibutramine|mesh-list
138657574|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657575|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657576|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
138657577|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138657578|NCT00429234|Gemcitabine|gemcitabine|mesh-list
138657581|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
138657582|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657583|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657584|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138657585|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657586|NCT00433719|Efavirenz|efavirenz|mesh-list
138657587|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138657588|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138657589|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138657590|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657591|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657592|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
138657593|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311921|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
138311923|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
138657594|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138657595|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657596|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138657597|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138657598|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138657599|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138657600|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138657601|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138657602|NCT04704297|Acetaminophen|acetaminophen|mesh-list
138657603|NCT04704297|Ibuprofen|ibuprofen|mesh-list
138657604|NCT04704297|Ketorolac|ketorolac|mesh-list
138657605|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138657606|NCT04704297|Amitriptyline|amitriptyline|mesh-list
138657607|NCT04704297|Bupivacaine|bupivacaine|mesh-list
138657608|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
138657609|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
138657610|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
138657611|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657612|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657613|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
138657614|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657615|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657616|NCT04704297|Analgesics|analgesics|mesh-ancestor
138657617|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
138657618|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138657619|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657620|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657621|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138657622|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657623|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657624|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138657625|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657626|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657627|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138657628|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138279931|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
138657629|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138657630|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138657631|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657632|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657633|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657634|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657635|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
138657636|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657637|NCT00328367|Aripiprazole|aripiprazole|mesh-list
138657638|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657639|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657640|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138657641|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138657643|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657644|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
138657645|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
138657646|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279961|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657647|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657648|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138657649|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138657650|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
138657651|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138657652|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138657653|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138657654|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138657655|NCT04703088|Ondansetron|ondansetron|mesh-list
138657656|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
138657657|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
138657658|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280017|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
138657659|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334400|NCT00736632|Vitamin D|vitamin d|mesh-list
138657660|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138657661|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
138657662|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
138657663|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138657664|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138657665|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
138657666|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657667|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657668|NCT00328718|Fluticasone|fluticasone|mesh-list
138657670|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138657671|NCT00328718|Montelukast|montelukast|mesh-list
138657672|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657673|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138657674|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
138657675|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657676|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657677|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138657678|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657679|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138657680|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138657681|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138657682|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138657683|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138657684|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657685|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657686|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657687|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138657688|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657689|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657690|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138657691|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138657693|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
138657694|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
138657695|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657696|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657697|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
138657698|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657699|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138657700|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138657701|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138657702|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280206|NCT00367562|Valsartan|valsartan|mesh-list
138657703|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657704|NCT00429468|Acetaminophen|acetaminophen|mesh-list
138657705|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138657706|NCT00429468|Hydrocodone|hydrocodone|mesh-list
138657707|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657708|NCT00429468|Analgesics|analgesics|mesh-ancestor
138657709|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
138657710|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657711|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657712|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
138657713|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138657714|NCT00429468|Narcotics|narcotics|mesh-ancestor
138657715|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657716|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
138657717|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657718|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138657719|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657720|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657721|NCT04702698|Peposertib|peposertib|mesh-list
138657722|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138657723|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657724|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657725|NCT00328874|Ubiquinone|ubiquinone|mesh-list
138657726|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
138657727|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
138657728|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657729|NCT00328874|Vitamins|vitamins|mesh-ancestor
138657730|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138657731|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138657732|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
138334472|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
138657733|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657734|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
138657735|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138657736|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657737|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138657738|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
138657739|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657740|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657741|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657742|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657744|NCT02957643|Trace Elements|trace elements|mesh-ancestor
138657745|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
138350943|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
138350944|NCT03488225|Hormones|hormones|mesh-ancestor
138657746|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657748|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138657749|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138657750|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138657751|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
138657752|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657753|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138657754|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
138657755|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657756|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138657757|NCT00329069|Atorvastatin|atorvastatin|mesh-list
138657758|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138657759|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138657760|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
138657761|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657762|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138657763|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138657764|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657765|NCT00429624|Acetaminophen|acetaminophen|mesh-list
138657766|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657768|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
138657769|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657770|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657772|NCT00329147|Paroxetine|paroxetine|mesh-list
138657773|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138657774|NCT00329147|Desipramine|desipramine|mesh-list
138657775|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138657776|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657777|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657778|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657779|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657780|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
138657781|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657782|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138657783|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657784|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657785|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138657786|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657787|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657788|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138657789|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138657790|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138657791|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
138657792|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138657793|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138280347|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
138657794|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138657795|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657797|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657798|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657799|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657800|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138657801|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657802|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657803|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
138657804|NCT00434031|Docetaxel|docetaxel|mesh-list
138657805|NCT00434031|Doxorubicin|doxorubicin|mesh-list
138657806|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138657808|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657810|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657811|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657812|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138657813|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
138657814|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657815|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657816|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138657817|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
138657818|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
138657819|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
138657820|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138657821|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138657822|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138657823|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657824|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138657825|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
138657826|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138657827|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657829|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138657830|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657831|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657832|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
138657833|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657834|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657835|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138657836|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
138657837|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657838|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138657839|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657840|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657841|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138657842|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138657843|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657844|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657845|NCT00329381|Omalizumab|omalizumab|mesh-list
138657846|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138657847|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138657848|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138657849|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
138338730|NCT01231230|Xhance|xhance|mesh-list
138657850|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
138657851|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657852|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
138657853|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138657854|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
138657855|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657857|NCT00329459|Sumatriptan|sumatriptan|mesh-list
138657858|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138657859|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138657860|NCT00329459|Analgesics|analgesics|mesh-ancestor
138657861|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
138657862|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657863|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657864|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280425|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
138657865|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138657866|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
138657867|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138350956|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138657868|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657869|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657870|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138657871|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138657872|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138657873|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
138657874|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657876|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
138312007|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657877|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657878|NCT00329498|Protective Agents|protective agents|mesh-ancestor
138657879|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657881|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
138657882|NCT00329537|Sargramostim|sargramostim|mesh-list
138657883|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
138657884|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657886|NCT00429897|Amiloride|amiloride|mesh-list
138657887|NCT00429897|Spironolactone|spironolactone|mesh-list
138657888|NCT00429897|Furosemide|furosemide|mesh-list
138657889|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138657890|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657891|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657892|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657893|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138657894|NCT00429897|Diuretics|diuretics|mesh-ancestor
138657895|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
138657896|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138657897|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138657898|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657899|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657900|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138657901|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138657902|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138657903|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138657904|NCT00429936|Fenretinide|fenretinide|mesh-list
138657905|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657906|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138657907|NCT00429936|Protective Agents|protective agents|mesh-ancestor
138657908|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657909|NCT00429975|Levofloxacin|levofloxacin|mesh-list
138280471|NCT02667704|Nintedanib|nintedanib|mesh-list
138657910|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
138657911|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138657912|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657913|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657914|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138657915|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138657916|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657917|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657918|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657919|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138657920|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657921|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
138657922|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
138657923|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
138657924|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138657925|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657926|NCT01056393|Ibalizumab|ibalizumab|mesh-list
138657927|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138657928|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138657929|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138657930|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
138657931|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338792|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657932|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
138657933|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657935|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138657936|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138657937|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138657938|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138657939|NCT00329693|Quinagolide|quinagolide|mesh-list
138657940|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
138657941|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
138657942|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657943|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657944|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657945|NCT00329810|Aripiprazole|aripiprazole|mesh-list
138657946|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657947|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657948|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138657949|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138657950|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138657951|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657952|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
138657954|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334695|NCT00770874|Cisplatin|cisplatin|mesh-list
138657955|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657956|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138657957|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138657958|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
138657959|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138657960|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138657961|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138657962|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138657963|NCT00430170|Dipyridamole|dipyridamole|mesh-list
138657964|NCT00430170|Caffeine|caffeine|mesh-list
138657965|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138657966|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657967|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138657968|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657969|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338818|NCT01250184|Lidocaine|lidocaine|mesh-list
138657970|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138657972|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
138657973|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657974|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138657975|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
138657976|NCT00330044|Carboplatin|carboplatin|mesh-list
138657977|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657978|NCT00430365|Lenalidomide|lenalidomide|mesh-list
138657979|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
138657980|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657981|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138657982|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138657983|NCT00430365|Growth Substances|growth substances|mesh-ancestor
138657984|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
138657985|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657986|NCT00330239|Paroxetine|paroxetine|mesh-list
138657987|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138312043|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657988|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138657989|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657990|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657991|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657992|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
138657993|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657994|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138657995|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
138657996|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138657997|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138657998|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138657999|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658000|NCT01051557|Sirolimus|sirolimus|mesh-list
138658001|NCT01051557|Temsirolimus|temsirolimus|mesh-list
138658002|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
138658003|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138658004|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658005|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138658006|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658007|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
138658008|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658009|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
138658010|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658011|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138658012|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658013|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658014|NCT00330278|Cefazolin|cefazolin|mesh-list
138658015|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138658016|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658017|NCT00330317|Letrozole|letrozole|mesh-list
138658018|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658019|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138658020|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138658021|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658022|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658023|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138658024|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
138658025|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658026|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658027|NCT00430443|Annamycin|annamycin|mesh-list
138658028|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138658029|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658030|NCT00330395|Caspofungin|caspofungin|mesh-list
138658031|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
138658032|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658033|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658034|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658035|NCT00434382|Fentanyl|fentanyl|mesh-list
138658036|NCT00434382|Sufentanil|sufentanil|mesh-list
138658037|NCT00434382|Remifentanil|remifentanil|mesh-list
138658038|NCT00434382|Alfentanil|alfentanil|mesh-list
138658039|NCT00434382|Propofol|propofol|mesh-list
138658040|NCT00434382|Sevoflurane|sevoflurane|mesh-list
138658041|NCT00434382|Desflurane|desflurane|mesh-list
138658042|NCT00434382|Isoflurane|isoflurane|mesh-list
138658043|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138658044|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658045|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658046|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138658047|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
138658048|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
138658049|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138658051|NCT00434382|Analgesics|analgesics|mesh-ancestor
138658052|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
138658053|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658054|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138312063|NCT03557008|Metronidazole|metronidazole|mesh-list
138658055|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138658056|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138658057|NCT00330707|Interferons|interferons|mesh-list
138658058|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
138658059|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
138658060|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658061|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
138658062|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658063|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
138338938|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138658064|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658065|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138658066|NCT00330746|Gemcitabine|gemcitabine|mesh-list
138658067|NCT00330746|Cetuximab|cetuximab|mesh-list
138658068|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658069|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
138658070|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658071|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658072|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138658074|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138658075|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138658076|NCT00330785|Amlodipine|amlodipine|mesh-list
138658077|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138658078|NCT00330785|Atorvastatin|atorvastatin|mesh-list
138658079|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138658080|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138658081|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
138658082|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338982|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
138350989|NCT03450122|Analgesics|analgesics|mesh-ancestor
138658085|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658086|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658087|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138658088|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138658089|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138658090|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658091|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658092|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138658093|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
138658094|NCT00330824|Dexamethasone|dexamethasone|mesh-list
138658095|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
138658096|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138658097|NCT00330824|BB 1101|bb 1101|mesh-list
138658098|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658099|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
138658100|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
138658101|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658102|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658103|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658104|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
138658105|NCT00330824|Hormones|hormones|mesh-ancestor
138658106|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658107|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658108|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658109|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138312073|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
138658111|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658112|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658113|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138658114|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138658115|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138658116|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
138658117|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138658118|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138658119|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138658120|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138658122|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
138658123|NCT00330902|Primaquine|primaquine|mesh-list
138658124|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
138658125|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138658126|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
138658127|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138658128|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138658129|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658130|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658132|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
138658133|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138658134|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
138658135|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138658136|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658137|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658138|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138658139|NCT00430794|Spironolactone|spironolactone|mesh-list
138658140|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138658141|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
138658142|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658143|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658144|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138658145|NCT00430794|Diuretics|diuretics|mesh-ancestor
138658146|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
138658147|NCT00330980|Simvastatin|simvastatin|mesh-list
138658148|NCT00330980|Pravastatin|pravastatin|mesh-list
138658149|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138658150|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138658151|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
138658152|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658153|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138658154|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138658155|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658156|NCT00430833|Candesartan|candesartan|mesh-list
138658157|NCT00430833|Candesartan cilexetil|candesartan cilexetil|mesh-list
138658158|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658159|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138658160|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138658161|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339070|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138658163|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658164|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
138658165|NCT00331058|Hormones|hormones|mesh-ancestor
138658166|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658167|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658168|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658169|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658170|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
138658171|NCT00331097|Docetaxel|docetaxel|mesh-list
138658172|NCT00331097|Fluorouracil|fluorouracil|mesh-list
138658173|NCT00331097|Methotrexate|methotrexate|mesh-list
138658174|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658175|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
138658176|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658177|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658178|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658179|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
138658180|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658181|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658182|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138658183|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658184|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658185|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658186|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
138658187|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658188|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138658189|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
138658190|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138658191|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
138658192|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658193|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138658194|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138658195|NCT00331214|Testosterone|testosterone|mesh-list
138658196|NCT00331214|Androgens|androgens|mesh-ancestor
138658198|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658199|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658200|NCT00434772|Glucagon|glucagon|mesh-list
138658201|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658202|NCT00434772|Hormones|hormones|mesh-ancestor
138658203|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658204|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339102|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658205|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
138280821|NCT02670343|Hormones|hormones|mesh-ancestor
138658206|NCT00431028|Triamcinolone|triamcinolone|mesh-list
138658207|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658208|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
138658209|NCT00431028|Hormones|hormones|mesh-ancestor
138658210|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658211|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658212|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658213|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658214|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138658215|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658216|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138658217|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138658218|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658219|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138658220|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138658221|NCT00431106|Gemcitabine|gemcitabine|mesh-list
138658222|NCT00431106|Capecitabine|capecitabine|mesh-list
138658223|NCT00431106|Vinorelbine|vinorelbine|mesh-list
138658224|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658225|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
138658226|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658227|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658228|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138658230|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658231|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658232|NCT00431145|Niacin|niacin|mesh-list
138658233|NCT00431145|Niacinamide|niacinamide|mesh-list
138658234|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
138658235|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138658236|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
138312096|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
138658237|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658238|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138658239|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658240|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
138658243|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658244|NCT00331487|Pioglitazone|pioglitazone|mesh-list
138658245|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
138658246|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138658247|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658248|NCT00331526|Aldesleukin|aldesleukin|mesh-list
138658249|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658250|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138658251|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138658252|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
138658253|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335001|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
138658254|NCT00431262|Disulfiram|disulfiram|mesh-list
138658255|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138658256|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138658257|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658258|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658259|NCT00331604|Insulin|insulin|mesh-list
138658260|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138658261|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
138658262|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
138658263|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138658264|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
138658265|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138658266|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658267|NCT00331643|Epothilones|epothilones|mesh-list
138658268|NCT00331643|Epothilone B|epothilone b|mesh-list
138658269|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658270|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658271|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658272|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658273|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339172|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
138339174|NCT01312038|Emollients|emollients|mesh-ancestor
138658276|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138658277|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658278|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658280|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138658281|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138658282|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658284|NCT00331838|Semuloparin|semuloparin|mesh-list
138658285|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138658286|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
138658287|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
138658288|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138658289|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138658290|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658291|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
138658292|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658293|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138658294|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138658295|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658296|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658297|NCT00431418|Urological Agents|urological agents|mesh-ancestor
138658298|NCT00331955|Doxorubicin|doxorubicin|mesh-list
138658299|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138658300|NCT00331955|Vorinostat|vorinostat|mesh-list
138658301|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138658302|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658303|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138658304|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138658305|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658306|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658307|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138658309|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658310|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138658311|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138658312|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138658313|NCT00332033|Pirfenidone|pirfenidone|mesh-list
138658314|NCT00332033|Analgesics|analgesics|mesh-ancestor
138658315|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
138658316|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658317|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658318|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138658319|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138658320|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658321|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658322|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658323|NCT00435279|Eszopiclone|eszopiclone|mesh-list
138658324|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138658325|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138658326|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138658327|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335073|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658328|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658329|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658330|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658331|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138658332|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
138658333|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658334|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138658335|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658336|NCT00332072|Timolol|timolol|mesh-list
138658337|NCT00332072|Bimatoprost|bimatoprost|mesh-list
138658338|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138658339|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138658340|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658341|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339259|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
138658342|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658343|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658344|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138658345|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658346|NCT00431613|Carboplatin|carboplatin|mesh-list
138658347|NCT00431613|Gemcitabine|gemcitabine|mesh-list
138658348|NCT00431613|Docetaxel|docetaxel|mesh-list
138658349|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658350|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658351|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
138658352|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658353|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658354|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658355|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658356|NCT00332228|Naltrexone|naltrexone|mesh-list
138658357|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138658358|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138658359|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658360|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
138658361|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658362|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
138658363|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658364|NCT00332306|Lamivudine|lamivudine|mesh-list
138658365|NCT00332306|Efavirenz|efavirenz|mesh-list
138658366|NCT00332306|Nevirapine|nevirapine|mesh-list
138658367|NCT00332306|Didanosine|didanosine|mesh-list
138658368|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138280981|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
138658369|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138658371|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658372|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
138658373|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658374|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138658375|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138658376|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138658377|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138658378|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138658379|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138658380|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138658381|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138658382|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
138658383|NCT00332345|Timolol|timolol|mesh-list
138658384|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138658385|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138658386|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138658387|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658388|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658389|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658390|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658391|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138658392|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658393|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138658394|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138658395|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138658396|NCT00332384|Timolol|timolol|mesh-list
138658397|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138658398|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138658399|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138658400|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658401|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335152|NCT03936270|Letrozole|letrozole|mesh-list
138658402|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658403|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658404|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138658405|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658406|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138658407|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138658408|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138658409|NCT00435435|Disulfiram|disulfiram|mesh-list
138312140|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658411|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138658412|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138280998|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138658414|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658416|NCT00332540|Bimatoprost|bimatoprost|mesh-list
138658417|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138658418|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138658419|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658420|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658421|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658422|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658423|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138658424|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658425|NCT00332618|Glycerol|glycerol|mesh-list
138658426|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138658427|NCT00332618|Protective Agents|protective agents|mesh-ancestor
138658428|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658429|NCT00332735|Bupivacaine|bupivacaine|mesh-list
138658430|NCT00332735|Carticaine|carticaine|mesh-list
138658431|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
138658432|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
138658433|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658434|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658435|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
138658436|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658437|NCT00332774|Ketorolac|ketorolac|mesh-list
138658438|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138658439|NCT00332774|Nepafenac|nepafenac|mesh-list
138658440|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138658441|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138658442|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138658443|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138658444|NCT00332774|Analgesics|analgesics|mesh-ancestor
138339375|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138658445|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
138281033|NCT04003987|Bupivacaine|bupivacaine|mesh-list
138658446|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658447|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658448|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658449|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658450|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138658451|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658452|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658453|NCT00431769|Bortezomib|bortezomib|mesh-list
138658454|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658455|NCT00332852|Letrozole|letrozole|mesh-list
138658456|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658457|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138658458|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138658459|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658460|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658461|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138658462|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
138658463|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658464|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658465|NCT00332891|Amibegron|amibegron|mesh-list
138658466|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138312158|NCT00003653|Leuprolide|leuprolide|mesh-list
138312159|NCT00003653|Goserelin|goserelin|mesh-list
138658468|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138658469|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658470|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658471|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658472|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658473|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138335223|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658475|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
138658476|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658477|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
138658479|NCT00332969|Octreotide|octreotide|mesh-list
138658480|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658481|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658482|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658483|NCT00333008|Prednisone|prednisone|mesh-list
138658484|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
138658485|NCT00333008|Rituximab|rituximab|mesh-list
138658486|NCT00333008|Vincristine|vincristine|mesh-list
138658487|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658488|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
138658489|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658490|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658491|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138351020|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658492|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
138658493|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658494|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658495|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138658496|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138658497|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658498|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
138658499|NCT00333008|Hormones|hormones|mesh-ancestor
138658500|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658501|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658502|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138658503|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658504|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658505|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658506|NCT00435747|Parecoxib|parecoxib|mesh-list
138658507|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138658508|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138658509|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658510|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658511|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138658512|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138658513|NCT00435747|Analgesics|analgesics|mesh-ancestor
138658514|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
138658515|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658516|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312174|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312175|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138312176|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
138312177|NCT00003671|Leucovorin|leucovorin|mesh-list
138312178|NCT00003671|Cytarabine|cytarabine|mesh-list
138658517|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658518|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658519|NCT00333047|Letrozole|letrozole|mesh-list
138658520|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658521|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138658522|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138658524|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658525|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138658526|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
138281103|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138658527|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658528|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658529|NCT00333086|Letrozole|letrozole|mesh-list
138658530|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658531|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138658532|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138658533|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658534|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658535|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138658536|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138339508|NCT01353144|Aspirin|aspirin|mesh-list
138658537|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658538|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658539|NCT00333125|Timolol|timolol|mesh-list
138658540|NCT00333125|Travoprost|travoprost|mesh-list
138658541|NCT00333125|Dorzolamide|dorzolamide|mesh-list
138658542|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138658543|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138658544|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138658545|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138658546|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658547|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201717|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
138351037|NCT03348670|Prednisone|prednisone|mesh-list
138351038|NCT03348670|Abiraterone Acetate|abiraterone acetate|mesh-list
138658548|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658549|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658550|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138658551|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138658552|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138658553|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658555|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138658556|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
138658557|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658558|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658559|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138658560|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
138658561|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138658563|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658564|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138658565|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658566|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138658567|NCT00333164|Protective Agents|protective agents|mesh-ancestor
138658568|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138658569|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138658570|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658571|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
138658572|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658574|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658575|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658576|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
138658577|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
138658578|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
138658579|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138658580|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138658582|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658583|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658584|NCT00333281|Tadalafil|tadalafil|mesh-list
138658585|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658586|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138658587|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138658588|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658589|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658590|NCT00333281|Urological Agents|urological agents|mesh-ancestor
138658591|NCT00333398|Vaccines|vaccines|mesh-list
138658592|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
138658593|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658594|NCT00333476|Squalamine|squalamine|mesh-list
138658595|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138281162|NCT00368498|Teicoplanin|teicoplanin|mesh-list
138658596|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658597|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138658598|NCT00333476|Protective Agents|protective agents|mesh-ancestor
138658599|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658600|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658601|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138658602|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138658603|NCT00333476|Growth Substances|growth substances|mesh-ancestor
138658604|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
138658606|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138658607|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
138658608|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658609|NCT00435981|Antacids|antacids|mesh-ancestor
138658610|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658611|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658612|NCT00432081|Indomethacin|indomethacin|mesh-list
138658613|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138658614|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138658615|NCT00432081|Analgesics|analgesics|mesh-ancestor
138658616|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
138658617|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658619|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658620|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188447|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138281222|NCT04338919|Aspirin|aspirin|mesh-list
138658621|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
138658623|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138658624|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138658625|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658626|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658627|NCT00333632|Midazolam|midazolam|mesh-list
138658628|NCT00333632|Fentanyl|fentanyl|mesh-list
138658629|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
138658630|NCT00333632|Propofol|propofol|mesh-list
138658631|NCT00333632|Isoflurane|isoflurane|mesh-list
138658632|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138658633|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312206|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138658634|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312207|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
138312208|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138312223|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658635|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138658637|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
138658638|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658639|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138658640|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138658641|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138658642|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658643|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658644|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658645|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138658646|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
138658647|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
138658648|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138658649|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138658650|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138658651|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658652|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
138658653|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
138658654|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138658655|NCT00333632|Narcotics|narcotics|mesh-ancestor
138658656|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138658657|NCT00436059|Bortezomib|bortezomib|mesh-list
138658658|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658659|NCT00420524|Epothilone B|epothilone b|mesh-list
138658660|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658661|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658662|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658663|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658664|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339613|NCT01377636|Isoproterenol|isoproterenol|mesh-list
138339628|NCT01378416|Decitabine|decitabine|mesh-list
138658666|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138658667|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138658668|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138658669|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138658670|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
138658671|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658672|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658673|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658675|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138658676|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138658677|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658678|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658679|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138658680|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
138658681|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
138658682|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658683|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658684|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
138658685|NCT00420563|Megestrol|megestrol|mesh-list
138658686|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658687|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
138658688|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658689|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658690|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658691|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
138658692|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658693|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658694|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138658695|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138658696|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138658697|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138658698|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
138658699|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138658700|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138658701|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138658702|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658704|NCT00432315|Cisplatin|cisplatin|mesh-list
138658705|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658706|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658707|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658708|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658709|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658710|NCT00333671|Glycerol|glycerol|mesh-list
138658711|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138658712|NCT00333671|Protective Agents|protective agents|mesh-ancestor
138339665|NCT01390818|Elafin|elafin|mesh-list
138658713|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658715|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138658716|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138658717|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
138658718|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658719|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138658720|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138658721|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658722|NCT00333944|Pralidoxime|pralidoxime|mesh-list
138658723|NCT00333944|Antidotes|antidotes|mesh-ancestor
138658724|NCT00333944|Protective Agents|protective agents|mesh-ancestor
138658725|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658726|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
138658727|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
138658728|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658729|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138658730|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658731|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
138658732|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138658733|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138658734|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658735|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138658736|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138658737|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
138658738|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658739|NCT04701528|Tacrolimus|tacrolimus|mesh-list
138658740|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658741|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
138658742|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312238|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312239|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658743|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138658744|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658745|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658746|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
138658747|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138658748|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658749|NCT03279978|Midazolam|midazolam|mesh-list
138658750|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138658751|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138658752|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658753|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658754|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138658755|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138658756|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658757|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138658758|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
138658759|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
138658760|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
138658761|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
138658762|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658763|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658764|NCT00438048|Pilocarpine|pilocarpine|mesh-list
138658765|NCT00438048|Miotics|miotics|mesh-ancestor
138658766|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
138658767|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658768|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658769|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138658770|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138339716|NCT01399008|Protective Agents|protective agents|mesh-ancestor
138335518|NCT00875550|Midazolam|midazolam|mesh-list
138658771|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
138658772|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658773|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658775|NCT00334256|Emtricitabine|emtricitabine|mesh-list
138658776|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
138658777|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658778|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138658779|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138658781|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658782|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138658783|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138658784|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
138658785|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138658786|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138658787|NCT00438087|Prednisolone|prednisolone|mesh-list
138658788|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
138658789|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138658790|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
138658791|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658792|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
138658793|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
138658794|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658795|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658796|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658797|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
138658798|NCT00438087|Hormones|hormones|mesh-ancestor
138658799|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658800|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138658801|NCT00438087|Protective Agents|protective agents|mesh-ancestor
138658802|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658803|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658805|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138658806|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
138312262|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312263|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658807|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658808|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658809|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339772|NCT01410084|Vitamin D|vitamin d|mesh-list
138658811|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138658812|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
138658813|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658814|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138658815|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138658816|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658817|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658818|NCT00334490|Urological Agents|urological agents|mesh-ancestor
138658819|NCT00334529|Oseltamivir|oseltamivir|mesh-list
138658820|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
138658821|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658822|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658823|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351055|NCT03308942|Dostarlimab|dostarlimab|mesh-list
138658824|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
138658825|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138658826|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658827|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138658828|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138658829|NCT00436293|Docetaxel|docetaxel|mesh-list
138658830|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658831|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658832|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658833|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658834|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658835|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
138658836|NCT00334646|Casopitant|casopitant|mesh-list
138658837|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658838|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
138658839|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658840|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658841|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658842|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
138658843|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335595|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138658844|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658845|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138658846|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
138658847|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
138658848|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658849|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658850|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138658851|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658852|NCT04701606|Artesunate|artesunate|mesh-list
138658853|NCT04701606|Pyronaridine|pyronaridine|mesh-list
138658854|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138658855|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
138658856|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138658857|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138658858|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312272|NCT00003731|Temozolomide|temozolomide|mesh-list
138312273|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658859|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658861|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
138281436|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
138658862|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138658863|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
138658864|NCT00334685|Pregabalin|pregabalin|mesh-list
138658865|NCT00334685|Reboxetine|reboxetine|mesh-list
138658866|NCT00334685|Analgesics|analgesics|mesh-ancestor
138658867|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
138658868|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658869|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658870|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
138658871|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138658872|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138658873|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658874|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138658875|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138658876|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138658877|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658878|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658879|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138658880|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138658881|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138658882|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
138658883|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339833|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
138658884|NCT00436371|Amisulpride|amisulpride|mesh-list
138658885|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138658886|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138658887|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138658888|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658889|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658890|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138658891|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
138658892|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658893|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658894|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138658895|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
138658897|NCT00334763|Bevacizumab|bevacizumab|mesh-list
138658898|NCT00334763|Carboplatin|carboplatin|mesh-list
138658899|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138281487|NCT04417920|Mitomycin|mitomycin|mesh-list
138658900|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658901|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
138658902|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658903|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658904|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658905|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138658906|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138658907|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138658908|NCT00334763|Growth Substances|growth substances|mesh-ancestor
138658909|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658910|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138658911|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
138658912|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138658913|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
138658914|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335672|NCT00895752|Riluzole|riluzole|mesh-list
138312292|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312293|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312294|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138658915|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658916|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138658917|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138658918|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658919|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138658920|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138658921|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138658922|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658924|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658925|NCT00436761|Cyclosporine|cyclosporine|mesh-list
138658926|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
138658928|NCT00436761|Busulfan|busulfan|mesh-list
138658929|NCT00436761|Cyclosporins|cyclosporins|mesh-list
138658930|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138658931|NCT00436761|Sargramostim|sargramostim|mesh-list
138658932|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658933|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658934|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138658935|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
138658936|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658937|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
138658938|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658939|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
138658940|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658941|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138658942|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339982|NCT01468584|Ribavirin|ribavirin|mesh-list
138658943|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
138658944|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
138658945|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658946|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138658948|NCT00436761|Hormones|hormones|mesh-ancestor
138658949|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658950|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138658951|NCT00436761|Protective Agents|protective agents|mesh-ancestor
138658952|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658953|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658954|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
138658955|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138658956|NCT00436800|Gemcitabine|gemcitabine|mesh-list
138658957|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
138658958|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658959|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
138658960|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658961|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658962|NCT00436839|Prednisone|prednisone|mesh-list
138658963|NCT00436839|Docetaxel|docetaxel|mesh-list
138658964|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
138658965|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658966|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138340043|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
138658967|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138658968|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658969|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658970|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138658971|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
138312304|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312305|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658973|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658974|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658975|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138658976|NCT00436839|Analgesics|analgesics|mesh-ancestor
138658977|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
138658978|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138658979|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138658980|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138658981|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138658982|NCT00335075|Temozolomide|temozolomide|mesh-list
138658983|NCT00335075|Semustine|semustine|mesh-list
138658984|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138658985|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
138658986|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658987|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658988|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
138658989|NCT00436995|Hematinics|hematinics|mesh-ancestor
138658990|NCT04716179|Hormones|hormones|mesh-list
138658991|NCT04716179|Testosterone|testosterone|mesh-list
138658992|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335743|NCT00905580|Pregabalin|pregabalin|mesh-list
138658993|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658994|NCT04716179|Androgens|androgens|mesh-ancestor
138658995|NCT00437229|Dexamethasone|dexamethasone|mesh-list
138658996|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
138658997|NCT00437229|Ondansetron|ondansetron|mesh-list
138658999|NCT00437229|BB 1101|bb 1101|mesh-list
138659000|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138659001|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
138659002|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
138659003|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659004|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659005|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138659006|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
138659007|NCT00437229|Hormones|hormones|mesh-ancestor
138659008|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659009|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659010|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659011|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659012|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659013|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659014|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
138659015|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659016|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138659017|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138659018|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
138659019|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281564|NCT00370591|Fluticasone|fluticasone|mesh-list
138659020|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138659021|NCT00335192|Tenofovir|tenofovir|mesh-list
138659023|NCT00335192|Abacavir|abacavir|mesh-list
138659024|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
138659025|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659026|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138659027|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659028|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312323|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
138312324|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659029|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659030|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138659031|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659032|NCT00437307|Topotecan|topotecan|mesh-list
138659033|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138659034|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138659035|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659036|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659037|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659038|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
138659039|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659040|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659041|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138659042|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138659043|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138659044|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138659045|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659046|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659047|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659048|NCT00335270|Ritonavir|ritonavir|mesh-list
138659049|NCT00335270|Amprenavir|amprenavir|mesh-list
138340192|NCT01520688|Hormones|hormones|mesh-ancestor
138659050|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
138659052|NCT00335270|Abacavir|abacavir|mesh-list
138659053|NCT00335270|Calcium|calcium|mesh-list
138659054|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659055|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659056|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138659057|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138659058|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659059|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659060|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659061|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138659062|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659063|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
138659064|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659065|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138659066|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138659067|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138659068|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659069|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138659070|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
138659071|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659072|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
138659073|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
138659074|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659075|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659076|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659077|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
138659078|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138659079|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659080|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659081|NCT00335309|Amoxicillin|amoxicillin|mesh-list
138659082|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
138659083|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
138659084|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312337|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
138312340|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312341|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
138659086|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138659087|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659088|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659089|NCT00335348|Dexamethasone|dexamethasone|mesh-list
138659091|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138659092|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
138659093|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
138659094|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659095|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659096|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138659097|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
138659098|NCT00335348|Hormones|hormones|mesh-ancestor
138659099|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659100|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659101|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659102|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138659103|NCT00437463|Ramipril|ramipril|mesh-list
138659104|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138659105|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659106|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659107|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659108|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659109|NCT00437502|Vaccines|vaccines|mesh-list
138659110|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
138659111|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659112|NCT00420797|Phenylephrine|phenylephrine|mesh-list
138659113|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
138659114|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138659115|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
138659116|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
138659117|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659118|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659119|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
138659120|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138340332|NCT06114953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138340333|NCT06114953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138659121|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
138659122|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
138659123|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138659124|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138659125|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138659126|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138659127|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659128|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659129|NCT00420797|Protective Agents|protective agents|mesh-ancestor
138659130|NCT00437619|Calcipotriene|calcipotriene|mesh-list
138659131|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659132|NCT00420836|Tobramycin|tobramycin|mesh-list
138659133|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659134|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312358|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659136|NCT00437697|Tinzaparin|tinzaparin|mesh-list
138659137|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138659138|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
138659139|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138659140|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138659141|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659142|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
138659143|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659144|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335898|NCT00928200|Razoxane|razoxane|mesh-list
138659145|NCT00335543|Gemcitabine|gemcitabine|mesh-list
138659146|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659147|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659148|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
138281670|NCT05453552|Busulfan|busulfan|mesh-list
138659149|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659151|NCT00437814|Analgesics|analgesics|mesh-ancestor
138659152|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
138659153|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659154|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659155|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138659156|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138659157|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
138659158|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
138659159|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659160|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138659161|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138659162|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659163|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659164|NCT00335582|Clonidine|clonidine|mesh-list
138659165|NCT00335582|Analgesics|analgesics|mesh-ancestor
138340435|NCT06114030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659166|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
138659167|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659168|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659169|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659170|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
138659171|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
138659172|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138659173|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138659174|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138659175|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
138659176|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659177|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659179|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659180|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659181|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138659182|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138659183|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659184|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340487|NCT06087419|Venetoclax|venetoclax|mesh-list
138659186|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
138201718|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659187|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659188|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659189|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
138659190|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138659191|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
138659192|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312384|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
138659193|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659194|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138659195|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138659196|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
138659197|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138659198|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
138659199|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659200|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659201|NCT00437892|Atorvastatin|atorvastatin|mesh-list
138659202|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659203|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659204|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
138659205|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659206|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659207|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659208|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659209|NCT00437970|Metformin|metformin|mesh-list
138659210|NCT00437970|Pioglitazone|pioglitazone|mesh-list
138659211|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659212|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659214|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659215|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659216|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
138659217|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659219|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659220|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659221|NCT00335933|Gabapentin|gabapentin|mesh-list
138659222|NCT00335933|Analgesics|analgesics|mesh-ancestor
138281750|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
138659223|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
138659224|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659225|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659227|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138659228|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138659229|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659230|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659231|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138659232|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138659233|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659234|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659235|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
138659236|NCT00336167|Bezafibrate|bezafibrate|mesh-list
138659237|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659238|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
138659239|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659240|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659241|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
138659242|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138659243|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659245|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
138659246|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659247|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659248|NCT00336245|Trace Elements|trace elements|mesh-ancestor
138659249|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
138659250|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
138659251|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659252|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
138659253|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659254|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659255|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659256|NCT00336401|Propofol|propofol|mesh-list
138659257|NCT00336401|Sevoflurane|sevoflurane|mesh-list
138659258|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659260|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659263|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
138659264|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138659265|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138659266|NCT00336518|Ribavirin|ribavirin|mesh-list
138659267|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138659268|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
138659269|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659270|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
138281787|NCT04766762|Flunarizine|flunarizine|mesh-list
138659271|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659273|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
138659274|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659275|NCT00347490|Enoxaparin|enoxaparin|mesh-list
138659276|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
138659277|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138659278|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138659279|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659280|NCT00336674|Insulin|insulin|mesh-list
138659281|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340626|NCT05800275|Capecitabine|capecitabine|mesh-list
138659282|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659284|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659285|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659286|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659287|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138659288|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138659289|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659290|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
138336044|NCT00945750|Famotidine|famotidine|mesh-list
138659291|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
138659292|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659293|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659294|NCT00336791|Paclitaxel|paclitaxel|mesh-list
138659295|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
138659296|NCT00336791|Doxorubicin|doxorubicin|mesh-list
138659297|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138659298|NCT00336791|Fluorouracil|fluorouracil|mesh-list
138659299|NCT00336791|Epirubicin|epirubicin|mesh-list
138659300|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138281804|NCT02737891|Metoprolol|metoprolol|mesh-list
138659301|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659302|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
138659303|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
138659304|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659305|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659306|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659307|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
138659308|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659309|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138659310|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138659311|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
138659312|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138659313|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138659314|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138659315|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138659316|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659318|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659320|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659321|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659322|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138351079|NCT03283761|Leucovorin|leucovorin|mesh-list
138312407|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659323|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
138659324|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138659325|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
138659326|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659327|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659328|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138659329|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659330|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659332|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659333|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
138659334|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659335|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659337|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659338|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659339|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659340|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
138659341|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659342|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659343|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659344|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
138659345|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138659346|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138659347|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659348|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
138659349|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340777|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138659350|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138659352|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659353|NCT00337259|Gemcitabine|gemcitabine|mesh-list
138659354|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659355|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
138659356|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659357|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659358|NCT04699734|Lidocaine|lidocaine|mesh-list
138659359|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
138659360|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
138659361|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659362|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659363|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
138659364|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659365|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138659366|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138659367|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138659368|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659369|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659370|NCT00337298|Amlodipine|amlodipine|mesh-list
138340831|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138659371|NCT00337298|Lisinopril|lisinopril|mesh-list
138659372|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659373|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138659374|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659375|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659376|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659377|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659378|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
138312415|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
138659379|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138659381|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659382|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138659383|NCT00337298|Protective Agents|protective agents|mesh-ancestor
138659384|NCT00337376|Sirolimus|sirolimus|mesh-list
138659385|NCT00337376|Paclitaxel|paclitaxel|mesh-list
138659386|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138659387|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138659388|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659389|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
138659391|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659392|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659393|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659394|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659395|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138659396|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
138659397|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659398|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
138659399|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659400|NCT00337493|Cyclosporine|cyclosporine|mesh-list
138659402|NCT00337493|Tacrolimus|tacrolimus|mesh-list
138659403|NCT00337493|Cyclosporins|cyclosporins|mesh-list
138340885|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
138659404|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659405|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
138659406|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659407|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138659408|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659409|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659410|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
138659411|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659412|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659413|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138659414|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138659415|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281969|NCT05057689|Analgesics|analgesics|mesh-ancestor
138659416|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138659417|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
138659418|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659419|NCT00444756|Lidocaine|lidocaine|mesh-list
138659420|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
138659421|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
138659422|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659423|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659424|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
138659425|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659426|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138659427|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138659428|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138659429|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659430|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659431|NCT00444834|Carvedilol|carvedilol|mesh-list
138659432|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138659433|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138659434|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138659435|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659436|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659437|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312434|NCT00003917|Topotecan|topotecan|mesh-list
138659438|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659439|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
138659440|NCT00444834|Protective Agents|protective agents|mesh-ancestor
138659442|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659443|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659444|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
138659445|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138659446|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138659447|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138659449|NCT00337766|Coagulants|coagulants|mesh-ancestor
138659450|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138659451|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
138659452|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659454|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659455|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138659456|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
138659457|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
138659458|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138659459|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659460|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138659461|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659462|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659463|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138659464|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138659465|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659466|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659468|NCT00451113|Hormones|hormones|mesh-ancestor
138659469|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659470|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659471|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282073|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
138659472|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659473|NCT00337922|Lamivudine|lamivudine|mesh-list
138659474|NCT00337922|Abacavir|abacavir|mesh-list
138659475|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138659476|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138341094|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
138659477|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659478|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659479|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
138659480|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659481|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138659482|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659483|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
138659484|NCT00451230|Cocaine|cocaine|mesh-list
138659485|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138659486|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138659487|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
138659488|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659489|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659490|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
138659491|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659492|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138659493|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138659494|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138659495|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659496|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659497|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
138659498|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659499|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
138659500|NCT00338000|Hematinics|hematinics|mesh-ancestor
138659501|NCT00338117|Galantamine|galantamine|mesh-list
138659502|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138659503|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312449|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659504|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659505|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
138659506|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659507|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659508|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138659509|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
138659510|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659511|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
138659512|NCT00338195|Caffeine|caffeine|mesh-list
138659513|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138659514|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659515|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138659516|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659517|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659518|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138659519|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138659520|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
138659521|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659522|NCT00338273|Aripiprazole|aripiprazole|mesh-list
138659523|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
138659524|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659525|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138659526|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138659527|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659528|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282174|NCT02194062|Hormones|hormones|mesh-ancestor
138659529|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
138659530|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
138659531|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659532|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659533|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138659534|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138659535|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
138659536|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138659537|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138659538|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138659539|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138659540|NCT00338312|Testosterone|testosterone|mesh-list
138659541|NCT00338312|Androgens|androgens|mesh-ancestor
138659542|NCT00338312|Hormones|hormones|mesh-ancestor
138659543|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659544|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659545|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
138659546|NCT00451386|Ertapenem|ertapenem|mesh-list
138659547|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659548|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659549|NCT00338390|Lamivudine|lamivudine|mesh-list
138659550|NCT00338390|Abacavir|abacavir|mesh-list
138312458|NCT04568837|Prednisone|prednisone|mesh-list
138659551|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
138312459|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138312460|NCT04568837|BB 1101|bb 1101|mesh-list
138659552|NCT00338390|Didanosine|didanosine|mesh-list
138312461|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312462|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
138659553|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138659554|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659555|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659556|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659558|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659559|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138659560|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659561|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
138659562|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
138659563|NCT00338468|Hematinics|hematinics|mesh-ancestor
138659564|NCT00338507|Erdosteine|erdosteine|mesh-list
138659565|NCT00338507|Expectorants|expectorants|mesh-ancestor
138659566|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
138659567|NCT00445185|Vaccines|vaccines|mesh-list
138659568|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
138659569|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659570|NCT00338546|Cocaine|cocaine|mesh-list
138659571|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
138659572|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659573|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659574|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659575|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138659576|NCT00338546|Analgesics|analgesics|mesh-ancestor
138659577|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
138659578|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659579|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138659580|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138659581|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138659582|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138659583|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659584|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659585|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
138659586|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
138659587|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138659588|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138659589|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138659590|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659591|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
138659592|NCT00338624|Oxybutynin|oxybutynin|mesh-list
138659593|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
138659594|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
138659595|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659596|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659597|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138659598|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138659599|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
138659600|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659601|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659602|NCT00338624|Urological Agents|urological agents|mesh-ancestor
138659604|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138659605|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659606|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312481|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312482|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
138312483|NCT04564469|Furosemide|furosemide|mesh-list
138659607|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659608|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
138659609|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659610|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138659611|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659612|NCT00451620|Glyburide|glyburide|mesh-list
138659613|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659614|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659615|NCT00445497|Amoxicillin|amoxicillin|mesh-list
138659616|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
138659617|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
138659618|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
138659619|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138659620|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659621|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659622|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138659623|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138659624|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659625|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659626|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659627|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138659628|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138659629|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138659630|NCT00451776|Propofol|propofol|mesh-list
138659632|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659633|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659634|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659635|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138659636|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
138659637|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
138659638|NCT00338936|Valsartan|valsartan|mesh-list
138659639|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138659640|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659641|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138659642|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138341449|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
138341475|NCT00653068|Vitamins|vitamins|mesh-ancestor
138659643|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659644|NCT00338936|Diuretics|diuretics|mesh-ancestor
138659645|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
138659646|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659647|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138659648|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659649|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
138312499|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138312500|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
138659650|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
138659651|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138659652|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659653|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659654|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659655|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659656|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138659657|NCT00339014|Zonisamide|zonisamide|mesh-list
138659658|NCT00339014|Bupropion|bupropion|mesh-list
138659659|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138659660|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
138659662|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138659663|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138341591|NCT01542684|Azacitidine|azacitidine|mesh-list
138659664|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659665|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351097|NCT03283761|Vitamins|vitamins|mesh-ancestor
138659666|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
138659667|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659668|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659669|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138659670|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138659671|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659672|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
138659673|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138659674|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659675|NCT00420953|Amiodarone|amiodarone|mesh-list
138659676|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138659677|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
138659678|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138659679|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341648|NCT01558128|Amiodarone|amiodarone|mesh-list
138659680|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659681|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138659682|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138659683|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138659684|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659685|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138659686|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138659687|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138659688|NCT00425204|Panitumumab|panitumumab|mesh-list
138659689|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138659690|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659691|NCT00425243|Zolpidem|zolpidem|mesh-list
138659692|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138659693|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659694|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659695|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659696|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138659697|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
138659698|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
138659699|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659700|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659701|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138659702|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659703|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659704|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659705|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138312528|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312529|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312530|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138312531|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659707|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659708|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659709|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659710|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
138659711|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659713|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659714|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659715|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
138659716|NCT00446004|Omeprazole|omeprazole|mesh-list
138659717|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138659718|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659719|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138659720|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659721|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659722|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138659723|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138659724|NCT00446082|Pasireotide|pasireotide|mesh-list
138351101|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
138659725|NCT00446082|Hormones|hormones|mesh-ancestor
138659726|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659727|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659728|NCT03275376|Atorvastatin|atorvastatin|mesh-list
138659729|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659730|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659731|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
138659732|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659733|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659734|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659735|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659736|NCT00340184|Paclitaxel|paclitaxel|mesh-list
138341748|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659737|NCT00340184|Carboplatin|carboplatin|mesh-list
138659738|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138659739|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659740|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138659741|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138659742|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659743|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659744|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
138659745|NCT00446316|Antacids|antacids|mesh-list
138659746|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659747|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138659748|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659749|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659750|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138659751|NCT00446433|Lenalidomide|lenalidomide|mesh-list
138659752|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
138659753|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659754|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138659755|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138659756|NCT00446433|Growth Substances|growth substances|mesh-ancestor
138659757|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
138659758|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659759|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138659760|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138659761|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
138659762|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659764|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659765|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138659766|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
138659767|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138312539|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659768|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659769|NCT00340691|Doxycycline|doxycycline|mesh-list
138659770|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138659771|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659772|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
138659773|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138341846|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138659775|NCT00452244|Gefitinib|gefitinib|mesh-list
138659777|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659778|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659779|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
138659780|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659781|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659782|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659783|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659784|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659785|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138659786|NCT00446472|Becaplermin|becaplermin|mesh-list
138659787|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
138659788|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138659789|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138659790|NCT00446472|Growth Substances|growth substances|mesh-ancestor
138659791|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659792|NCT00446589|Teriparatide|teriparatide|mesh-list
138659793|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
138659794|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138659795|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659796|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138659797|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
138659798|NCT00452322|Testosterone|testosterone|mesh-list
138659799|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
138659800|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
138659801|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138659802|NCT00452322|Androgens|androgens|mesh-ancestor
138659803|NCT00452322|Hormones|hormones|mesh-ancestor
138659804|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659805|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659806|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659807|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659808|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
138659809|NCT00452556|Docetaxel|docetaxel|mesh-list
138336573|NCT02406222|Hormones|hormones|mesh-ancestor
138659810|NCT00452556|Leuprolide|leuprolide|mesh-list
138659811|NCT00452556|Androgens|androgens|mesh-list
138659812|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659813|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138659814|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138659815|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659816|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659817|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138659818|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
138659819|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659820|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659821|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138659822|NCT00452556|Hormones|hormones|mesh-ancestor
138659823|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341960|NCT04868760|Ipilimumab|ipilimumab|mesh-list
138659824|NCT00446667|Mannitol|mannitol|mesh-list
138659825|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138312551|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138659826|NCT00446667|Diuretics|diuretics|mesh-ancestor
138659827|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
138659828|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312552|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312554|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138659829|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
138659830|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
138659831|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659832|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138659833|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138659834|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138659835|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659836|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282619|NCT04762381|Hormones|hormones|mesh-ancestor
138659837|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659838|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659839|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
138659840|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138659841|NCT00341432|Nicotine|nicotine|mesh-list
138659842|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138659843|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
138659844|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659845|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659846|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138659847|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138659848|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
138659849|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659850|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659851|NCT00452634|Irinotecan|irinotecan|mesh-list
138659852|NCT00452634|Simvastatin|simvastatin|mesh-list
138342012|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
138659853|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659854|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138659855|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138659856|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659857|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659858|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659859|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659860|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
138659861|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659862|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659863|NCT03277599|Tramadol|tramadol|mesh-list
138659864|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138659865|NCT03277599|Narcotics|narcotics|mesh-ancestor
138659866|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138659867|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659868|NCT03277599|Analgesics|analgesics|mesh-ancestor
138659869|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
138659870|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659871|NCT00452829|Folic Acid|folic acid|mesh-list
138659872|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
138659873|NCT00452829|Inositol|inositol|mesh-list
138188518|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
138659876|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
138659877|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659878|NCT00452907|Artesunate|artesunate|mesh-list
138659879|NCT00452907|Lumefantrine|lumefantrine|mesh-list
138659880|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
138659881|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
138659882|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138659883|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
138659884|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138659885|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138659886|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659887|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659888|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
138659889|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
138659890|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138659891|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
138659892|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138659893|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659894|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312564|NCT01925274|Irinotecan|irinotecan|mesh-list
138659895|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138659897|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138659898|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
138659899|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659900|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659901|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659902|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
138188572|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188573|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188574|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138659903|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659904|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659905|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659906|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659907|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138659908|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659909|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
138659910|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138659911|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659912|NCT00452985|Carboplatin|carboplatin|mesh-list
138659913|NCT00452985|Docetaxel|docetaxel|mesh-list
138659914|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659915|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138659916|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138659917|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659918|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659921|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659922|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
138659923|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659924|NCT00453141|Betamethasone|betamethasone|mesh-list
138659925|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138659926|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
138659927|NCT00453141|Hormones|hormones|mesh-ancestor
138659928|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138659929|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659930|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138659931|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
138659932|NCT00421109|Levocetirizine|levocetirizine|mesh-list
138659933|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138659934|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138659935|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
138659936|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
138659937|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138659938|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659939|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659940|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
138659941|NCT02273583|Methotrexate|methotrexate|mesh-list
138659942|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138659943|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
138659944|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659945|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138659946|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138188676|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188679|NCT04342065|Celecoxib|celecoxib|mesh-list
138659947|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
138659948|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659949|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312574|NCT01948830|Ranibizumab|ranibizumab|mesh-list
138659950|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138659951|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138659953|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659954|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138659955|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
138659956|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
138659957|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659958|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138659959|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138659961|NCT00446862|Enalapril|enalapril|mesh-list
138659962|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138282782|NCT02062489|Tamoxifen|tamoxifen|mesh-list
138659963|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138659966|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138659967|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138659968|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659969|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659970|NCT00446901|Selenium|selenium|mesh-list
138659971|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
138188732|NCT00421863|Analgesics|analgesics|mesh-ancestor
138659973|NCT00446901|Protective Agents|protective agents|mesh-ancestor
138659974|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659976|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
138659977|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
138659978|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
138659979|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282826|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
138659980|NCT00453375|Protective Agents|protective agents|mesh-ancestor
138659981|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659982|NCT00446940|Atorvastatin|atorvastatin|mesh-list
138659983|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138659984|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138659985|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138659986|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
138659987|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659988|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138659989|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138659990|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659991|NCT00453414|Iloprost|iloprost|mesh-list
138659992|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138659993|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
138659995|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138659996|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
138659997|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138659998|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138659999|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
138660000|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660001|NCT00447018|Mannitol|mannitol|mesh-list
138660002|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138660004|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
138660005|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660006|NCT00343070|Escitalopram|escitalopram|mesh-list
138660007|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138660008|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188773|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660009|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660010|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660011|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660012|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
138312587|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138660013|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660014|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
138660015|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660016|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660017|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660018|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660019|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660020|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138660022|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660023|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
138660024|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138660025|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138660026|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138660027|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660028|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660029|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
138660030|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660031|NCT00343226|Basiliximab|basiliximab|mesh-list
138660032|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660033|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
138660034|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660035|NCT00343265|Progesterone|progesterone|mesh-list
138660036|NCT00343265|Progestins|progestins|mesh-ancestor
138660038|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660039|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660041|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138660042|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138660043|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660044|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
138660045|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660046|NCT00447213|Insulin|insulin|mesh-list
138660047|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138660048|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
138660049|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138660050|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660051|NCT00453648|Vitamin A|vitamin a|mesh-list
138660052|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
138660053|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
138660054|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660055|NCT00453648|Protective Agents|protective agents|mesh-ancestor
138660056|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660057|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138660058|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660059|NCT00453648|Vitamins|vitamins|mesh-ancestor
138660061|NCT00343421|Vaccines|vaccines|mesh-list
138660062|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138660063|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
138660064|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660065|NCT00343499|Valsartan|valsartan|mesh-list
138660066|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138351121|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
138660067|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138660068|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138660069|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660071|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
138660072|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660073|NCT00447369|Pregabalin|pregabalin|mesh-list
138660074|NCT00447369|Valproic Acid|valproic acid|mesh-list
138660075|NCT00447369|Analgesics|analgesics|mesh-ancestor
138660076|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
138660077|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660078|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660079|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
138660080|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660081|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660082|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660083|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660084|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138660085|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660086|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660087|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138660088|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660089|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
138660090|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660091|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
138660092|NCT00343655|Atorvastatin|atorvastatin|mesh-list
138660093|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138660094|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138660095|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
138660096|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660097|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138660098|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138660099|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660100|NCT00453765|Montelukast|montelukast|mesh-list
138660101|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138660102|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138660103|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138660104|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
138660105|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660106|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660107|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138188969|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
138660108|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138660109|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660110|NCT00343733|Fentanyl|fentanyl|mesh-list
138336867|NCT05821062|Clopidogrel|clopidogrel|mesh-list
138660111|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138660113|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660114|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660115|NCT00343733|Analgesics|analgesics|mesh-ancestor
138283080|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
138660116|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
138660117|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660118|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138660119|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138660120|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
138660121|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
138660122|NCT00343811|Modafinil|modafinil|mesh-list
138660123|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138660124|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660125|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138660126|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138189018|NCT03034005|Hormones|hormones|mesh-ancestor
138660128|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660130|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138660131|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138312618|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138660132|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660133|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
138660134|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660136|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138660137|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660138|NCT00343850|Analgesics|analgesics|mesh-ancestor
138660139|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
138660140|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660141|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660142|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660143|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660145|NCT00344006|Lumefantrine|lumefantrine|mesh-list
138660146|NCT00344006|Artemether|artemether|mesh-list
138660147|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138660148|NCT00344006|Dapsone|dapsone|mesh-list
138660149|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
138660151|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
138660152|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138660153|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138660154|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660155|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660156|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
138660157|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
138660158|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138660159|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
138660160|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138660161|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660162|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660163|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
138660164|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660165|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
138660166|NCT02273661|Amphotericin B|amphotericin b|mesh-list
138660167|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138660168|NCT02273661|Amebicides|amebicides|mesh-ancestor
138660169|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138660170|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138660171|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660172|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660173|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
138660174|NCT00344123|Ritonavir|ritonavir|mesh-list
138660175|NCT00344123|Tipranavir|tipranavir|mesh-list
138660176|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138660177|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138660178|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138660179|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660180|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189119|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660181|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660182|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138660184|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
138660185|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660186|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138660187|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138660188|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138660189|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138660190|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
138660191|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312636|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312639|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138660192|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138660193|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138660196|NCT00453960|Norethindrone|norethindrone|mesh-list
138660197|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
138660198|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138660199|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138660200|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138660201|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
138660202|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138660203|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189166|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
138660204|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138660205|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138660206|NCT00447681|Fezakinumab|fezakinumab|mesh-list
138660207|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660208|NCT00447759|Ibuprofen|ibuprofen|mesh-list
138660209|NCT00447759|Celecoxib|celecoxib|mesh-list
138660210|NCT00447759|Diclofenac|diclofenac|mesh-list
138660211|NCT00447759|Naproxen|naproxen|mesh-list
138660212|NCT00447759|Meloxicam|meloxicam|mesh-list
138660213|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138660214|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660215|NCT00447759|Analgesics|analgesics|mesh-ancestor
138660216|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
138660217|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660218|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660219|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660220|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660221|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138660222|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660223|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660224|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138283205|NCT03026803|Capecitabine|capecitabine|mesh-list
138660225|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
138660226|NCT00344513|Carvedilol|carvedilol|mesh-list
138660227|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138189223|NCT01000285|Prednisone|prednisone|mesh-list
138660228|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138660229|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138660230|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
138660231|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660232|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660233|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660234|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660235|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
138660236|NCT00344513|Protective Agents|protective agents|mesh-ancestor
138660237|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660238|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660239|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660240|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660241|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138660242|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138312652|NCT01918332|Valsartan|valsartan|mesh-list
138312653|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138660243|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660244|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189274|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138660246|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138660247|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660249|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
138660250|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
138660251|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660252|NCT00447915|Vitamin D|vitamin d|mesh-list
138660253|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
138660254|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
138660255|NCT00447915|Calcium|calcium|mesh-list
138660256|NCT00447915|Vitamins|vitamins|mesh-ancestor
138660257|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
138660258|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660259|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660260|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138660261|NCT00344669|Albendazole|albendazole|mesh-list
138660262|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
138337015|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
138660263|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138189330|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
138660264|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660265|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
138660266|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138660267|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138660268|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138660269|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138660270|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138660271|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351143|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138351144|NCT02933255|Nivolumab|nivolumab|mesh-list
138351146|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660272|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660273|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
138660274|NCT04715165|Bupivacaine|bupivacaine|mesh-list
138660275|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
138660277|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660278|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660279|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
138660280|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660281|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138660282|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660283|NCT04715165|Analgesics|analgesics|mesh-ancestor
138660284|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138660285|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138660286|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138660287|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138660288|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660289|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660290|NCT00454233|Metformin|metformin|mesh-list
138660291|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138660292|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660293|NCT00454272|Vancomycin|vancomycin|mesh-list
138660294|NCT00454272|Teicoplanin|teicoplanin|mesh-list
138660295|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660296|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312673|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
138660297|NCT00344825|Fludarabine|fludarabine|mesh-list
138660298|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
138660299|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
138660300|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189453|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138189456|NCT02169115|Omalizumab|omalizumab|mesh-list
138660301|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138660302|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
138660303|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660304|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660305|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
138660306|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660307|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660308|NCT00448110|Diclofenac|diclofenac|mesh-list
138660309|NCT00448110|Ketorolac|ketorolac|mesh-list
138660310|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138189511|NCT00637052|Filanesib|filanesib|mesh-list
138660311|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660312|NCT00448110|Analgesics|analgesics|mesh-ancestor
138660313|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
138660314|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660315|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660316|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660317|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660318|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138660319|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660320|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660322|NCT00448149|Sorafenib|sorafenib|mesh-list
138660323|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138660324|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138660325|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660326|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660327|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660328|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
138189567|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189570|NCT02169427|Opicapone|opicapone|mesh-list
138660330|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660331|NCT00344942|Triamcinolone|triamcinolone|mesh-list
138660332|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138660333|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138660334|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138660335|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660336|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
138660337|NCT00344942|Hormones|hormones|mesh-ancestor
138660338|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660339|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660340|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660342|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660343|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660344|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138660345|NCT00454350|Vitamins|vitamins|mesh-ancestor
138660346|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
138660347|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660348|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138660349|NCT00454389|Ranibizumab|ranibizumab|mesh-list
138660350|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660351|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138312694|NCT01916226|Cetirizine|cetirizine|mesh-list
138312695|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138312697|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138312710|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138660352|NCT00454389|Growth Substances|growth substances|mesh-ancestor
138189625|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
138660353|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660354|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660355|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660357|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
138660358|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
138660359|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660360|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138660361|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138660362|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660363|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660364|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138660365|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660366|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660367|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
138189679|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
138660368|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
138660369|NCT00448266|Thiotepa|thiotepa|mesh-list
138660370|NCT00448266|Carboplatin|carboplatin|mesh-list
138660371|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660372|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
138660373|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660374|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660375|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138660376|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
138283430|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
138660377|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660378|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660379|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138660380|NCT00454545|Atorvastatin|atorvastatin|mesh-list
138660381|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138660382|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138660383|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
138660384|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660385|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138660386|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138660387|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660388|NCT00345059|Gemcitabine|gemcitabine|mesh-list
138660389|NCT00345059|Capecitabine|capecitabine|mesh-list
138660391|NCT00345059|Vinorelbine|vinorelbine|mesh-list
138660392|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138660393|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
138660394|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660395|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660396|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138660397|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138660398|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138660399|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138660400|NCT00345098|Amibegron|amibegron|mesh-list
138660401|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138660402|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138660403|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138660404|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138660405|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312711|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138660406|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660407|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660408|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138660409|NCT00448305|Paclitaxel|paclitaxel|mesh-list
138660410|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138660411|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138660412|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337177|NCT05450484|Durvalumab|durvalumab|mesh-list
138660413|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
138660414|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312726|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660415|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
138660416|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660417|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138660418|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660419|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660420|NCT00448383|Adalimumab|adalimumab|mesh-list
138660421|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138660422|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660424|NCT00448461|Heparin|heparin|mesh-list
138660425|NCT00448461|Bivalirudin|bivalirudin|mesh-list
138660426|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
138660427|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138660428|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138660429|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660430|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
138660431|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138660432|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660433|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660434|NCT00454662|Amlodipine|amlodipine|mesh-list
138660435|NCT00454662|Olmesartan|olmesartan|mesh-list
138660436|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138660437|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660438|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660439|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660440|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189835|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
138660441|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660442|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660443|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660444|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138660445|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138660446|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
138660447|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
138660448|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660449|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660450|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660451|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138660452|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660453|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138660454|NCT00454701|Alefacept|alefacept|mesh-list
138660455|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660456|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
138660457|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660458|NCT00345761|Bevacizumab|bevacizumab|mesh-list
138660459|NCT00345761|Capecitabine|capecitabine|mesh-list
138660460|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
138660461|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660462|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189890|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138189909|NCT02226159|BB 1101|bb 1101|mesh-list
138660464|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138660465|NCT00345761|Growth Substances|growth substances|mesh-ancestor
138660466|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660467|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660468|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138660470|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660471|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
138660472|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138660473|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138660474|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
138660475|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
138660476|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660477|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660478|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
138660479|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138660480|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138660481|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
138660482|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660483|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660484|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660485|NCT00454740|Urological Agents|urological agents|mesh-ancestor
138660486|NCT03276858|Midazolam|midazolam|mesh-list
138660487|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138189943|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660488|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138660489|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138660490|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660491|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660493|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660494|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138660495|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138660496|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
138660497|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
138660498|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
138660499|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
138660500|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660501|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660502|NCT00421187|Amphotericin B|amphotericin b|mesh-list
138660503|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138660504|NCT00421187|Amebicides|amebicides|mesh-ancestor
138660505|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138660506|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138660507|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660508|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660509|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
138660510|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
138660511|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138660512|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138342033|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
138660513|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
138660514|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660515|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312741|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
138312742|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138660516|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660517|NCT00454896|Urological Agents|urological agents|mesh-ancestor
138660518|NCT00346190|Alendronate|alendronate|mesh-list
138660519|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138660520|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660521|NCT00346229|Doxorubicin|doxorubicin|mesh-list
138660522|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138660523|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138660524|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660525|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138190051|NCT05136157|Insulin|insulin|mesh-list
138660526|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138660527|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660528|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660529|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
138660530|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660531|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660532|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
138660533|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
138190102|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138190103|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
138660534|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
138660535|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660536|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138660537|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138660538|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
138660539|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138660540|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138660541|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660542|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660543|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660544|NCT00346463|Allopurinol|allopurinol|mesh-list
138660545|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
138201719|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660546|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660548|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
138660549|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660550|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138660551|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
138660552|NCT00346463|Protective Agents|protective agents|mesh-ancestor
138660553|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660554|NCT00455091|Lamivudine|lamivudine|mesh-list
138660555|NCT00455091|Adefovir|adefovir|mesh-list
138660556|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138660557|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138660558|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138660559|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660560|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660561|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
138190230|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
138190231|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190232|NCT01075399|Imidazole|imidazole|mesh-list
138312763|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190233|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312771|NCT01912872|Hormones|hormones|mesh-ancestor
138190234|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190235|NCT03358576|Amoxicillin|amoxicillin|mesh-list
138190236|NCT03358576|Metronidazole|metronidazole|mesh-list
138660564|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660565|NCT00346580|Nelfinavir|nelfinavir|mesh-list
138660566|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138660567|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138660568|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660569|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660570|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660571|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138660572|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660573|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
138660574|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660575|NCT00346619|Nelfinavir|nelfinavir|mesh-list
138283599|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
138660576|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138660577|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138660578|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660579|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660580|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660581|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138660582|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660583|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
138660584|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660585|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
138660586|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138660587|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
138660588|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138660589|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660590|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660591|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660592|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
138660593|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138660594|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660595|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660596|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
138660597|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660599|NCT04698213|Axitinib|axitinib|mesh-list
138283642|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
138660600|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660601|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660602|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138190335|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138660603|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190336|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
138660604|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660605|NCT02273817|Ciclesonide|ciclesonide|mesh-list
138660606|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
138660607|NCT02273817|Hormones|hormones|mesh-ancestor
138660608|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660609|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660610|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138660611|NCT00346853|Fomepizole|fomepizole|mesh-list
138660612|NCT00346853|Antidotes|antidotes|mesh-ancestor
138660614|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312789|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660615|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660616|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660617|NCT00346970|Niacin|niacin|mesh-list
138660618|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138660619|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
138660620|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660621|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138660622|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660623|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
138660624|NCT00346970|Vitamins|vitamins|mesh-ancestor
138660625|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
138660626|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660627|NCT00455130|Mannitol|mannitol|mesh-list
138660628|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138660629|NCT00455130|Diuretics|diuretics|mesh-ancestor
138660630|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
138660631|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660632|NCT00347048|Tacrolimus|tacrolimus|mesh-list
138660633|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190460|NCT03520348|Vitamins|vitamins|mesh-ancestor
138337392|NCT04761159|Ketamine|ketamine|mesh-list
138660635|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660636|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138660637|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660638|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660640|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660641|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138660642|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138660643|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660644|NCT00347165|Bevacizumab|bevacizumab|mesh-list
138660645|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660646|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660647|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660648|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138660649|NCT00347165|Growth Substances|growth substances|mesh-ancestor
138660650|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190518|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138660651|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660653|NCT00347204|Nepafenac|nepafenac|mesh-list
138660654|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138660655|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660656|NCT00347204|Analgesics|analgesics|mesh-ancestor
138660657|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
138660658|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660659|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660660|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660661|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660662|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138660663|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660664|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660665|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
138283749|NCT05593939|Niacin|niacin|mesh-list
138660666|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138660667|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138660668|NCT00455286|Prednisolone|prednisolone|mesh-list
138660669|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
138312801|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312802|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660670|NCT00455286|Methotrexate|methotrexate|mesh-list
138660671|NCT00455286|Temozolomide|temozolomide|mesh-list
138660672|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138660673|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
138660674|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138660675|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
138190631|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660676|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138660677|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660678|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138660679|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
138660680|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660681|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660682|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660683|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660684|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138660685|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660686|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
138660687|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660688|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138660689|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138660690|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
138660691|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660693|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
138660694|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660695|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190695|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660698|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660699|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138660700|NCT00455286|Protective Agents|protective agents|mesh-ancestor
138660701|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138660702|NCT00455364|Voriconazole|voriconazole|mesh-list
138660704|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660705|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138660706|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138660707|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660708|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660709|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138190771|NCT03032315|Amlodipine|amlodipine|mesh-list
138660710|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138660711|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660712|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660713|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138660714|NCT00347399|Bevacizumab|bevacizumab|mesh-list
138660715|NCT00347399|Verteporfin|verteporfin|mesh-list
138312822|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312833|NCT01907100|Cisplatin|cisplatin|mesh-list
138660716|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660717|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660718|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660719|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138660720|NCT00347399|Growth Substances|growth substances|mesh-ancestor
138660721|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660722|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660723|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138660724|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660725|NCT00455442|Mifepristone|mifepristone|mesh-list
138660726|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138660727|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
138660728|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138660729|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660730|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138660731|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138660732|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138660733|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
138660734|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138190810|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660735|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138660737|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660738|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
138660739|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138660740|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138660741|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
138660742|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138660743|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
138660744|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660746|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660747|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138660748|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
138190863|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
138660749|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138660750|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138660751|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138660752|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660753|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660754|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
138660755|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660756|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660757|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138660758|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660759|NCT00347750|Lopinavir|lopinavir|mesh-list
138660760|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138660761|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138190940|NCT03944681|Droperidol|droperidol|mesh-list
138660762|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660763|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660764|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660765|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138660766|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660767|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
138660768|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660769|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138660770|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138660771|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
138660772|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
138312846|NCT01887288|Capecitabine|capecitabine|mesh-list
138660773|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138660774|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138660775|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312847|NCT01887288|Digoxin|digoxin|mesh-list
138312849|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
138660776|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660777|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138660778|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138660779|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660780|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660781|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660782|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
138337544|NCT04014283|Selenium|selenium|mesh-list
138660783|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660784|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138190983|NCT01093651|Hormones|hormones|mesh-ancestor
138190985|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138660785|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138660786|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660787|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660790|NCT00449202|Estrone|estrone|mesh-list
138660791|NCT00449202|Estrogens|estrogens|mesh-ancestor
138660792|NCT00449202|Hormones|hormones|mesh-ancestor
138660793|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660794|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660795|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138660796|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
138191033|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660797|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660798|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138660799|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138660800|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660801|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660802|NCT00455715|Urological Agents|urological agents|mesh-ancestor
138660803|NCT00455754|Esomeprazole|esomeprazole|mesh-list
138660804|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138660805|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138660806|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138660807|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660808|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660809|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138283907|NCT05096845|Vaccines|vaccines|mesh-list
138660810|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
138191096|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191103|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
138660811|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138660814|NCT00348023|Travoprost|travoprost|mesh-list
138660815|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138660816|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138660817|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138660818|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660819|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312856|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660820|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660821|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138660822|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660824|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660825|NCT00348101|Enoximone|enoximone|mesh-list
138660826|NCT00348101|Esmolol|esmolol|mesh-list
138660827|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138660828|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138660829|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138660830|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
138660831|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138660832|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191159|NCT02245451|Analgesics|analgesics|mesh-ancestor
138660834|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138660835|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660836|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138660837|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138660838|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660839|NCT00348101|Protective Agents|protective agents|mesh-ancestor
138660840|NCT00455832|Ribavirin|ribavirin|mesh-list
138660841|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
138660842|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660843|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
138660844|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660845|NCT00455871|Ranibizumab|ranibizumab|mesh-list
138660846|NCT00455871|Verteporfin|verteporfin|mesh-list
138660847|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660848|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138660849|NCT00455871|Growth Substances|growth substances|mesh-ancestor
138660850|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660851|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660852|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660853|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138660854|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660855|NCT00449280|Sirolimus|sirolimus|mesh-list
138660856|NCT00449280|Sorafenib|sorafenib|mesh-list
138660857|NCT00449280|Temsirolimus|temsirolimus|mesh-list
138660858|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
138337615|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191210|NCT03013075|Bupivacaine|bupivacaine|mesh-list
138660860|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138660861|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660862|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660863|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138660864|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660865|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138660866|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
138660867|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660868|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
138660869|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660870|NCT00455910|Thalidomide|thalidomide|mesh-list
138660871|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660872|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
138660873|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660874|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
138660875|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191258|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
138660876|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660877|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660878|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138660879|NCT00455910|Growth Substances|growth substances|mesh-ancestor
138660880|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
138660881|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660882|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
138660883|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138660884|NCT00348296|Antibodies|antibodies|mesh-list
138660885|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
138660886|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138660887|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
138191317|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660889|NCT00449319|Daunorubicin|daunorubicin|mesh-list
138660890|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138660891|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660892|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138660893|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138660894|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660895|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660896|NCT00348335|Cyclosporine|cyclosporine|mesh-list
138660897|NCT00348335|Cyclosporins|cyclosporins|mesh-list
138660898|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660899|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660900|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660901|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
138660902|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660903|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
138660904|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660905|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660906|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660907|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138660908|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
138660909|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138191388|NCT04353713|Laxatives|laxatives|mesh-ancestor
138660912|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
138660913|NCT00348413|Methotrexate|methotrexate|mesh-list
138660914|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138660915|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
138660916|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138660917|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
138660918|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138660919|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660920|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138660922|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660923|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660924|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660925|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660926|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138660927|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138660928|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
138660929|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660930|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312904|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138312905|NCT01880736|Insulin|insulin|mesh-list
138312910|NCT01880424|Linaclotide|linaclotide|mesh-list
138660931|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660932|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
138660933|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
138660934|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660935|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138660936|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
138660937|NCT00348413|Hormones|hormones|mesh-ancestor
138660938|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138660939|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138660940|NCT00348413|Protective Agents|protective agents|mesh-ancestor
138660941|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138660943|NCT00348452|Tramadol|tramadol|mesh-list
138660944|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138660945|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660946|NCT00348452|Analgesics|analgesics|mesh-ancestor
138660947|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
138660948|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660949|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191435|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660950|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660951|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660952|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138660953|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138660954|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660955|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660956|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138660958|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660959|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138660960|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
138660961|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284049|NCT04670978|Bevacizumab|bevacizumab|mesh-list
138660962|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138660963|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660964|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138660965|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660966|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
138660967|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138660968|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138660969|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660970|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660971|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191473|NCT02982161|Narcotics|narcotics|mesh-ancestor
138660972|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138660974|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
138660975|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138660976|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660977|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138660978|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138660979|NCT03274323|Travoprost|travoprost|mesh-list
138660980|NCT03274323|Latanoprost|latanoprost|mesh-list
138660981|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138660982|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138660983|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138660984|NCT00348530|Verapamil|verapamil|mesh-list
138312927|NCT01903356|Incretins|incretins|mesh-ancestor
138660985|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138660986|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660987|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660988|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660989|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138284072|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138660990|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660992|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138660993|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138660994|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
138660995|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138660996|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660997|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660998|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
138660999|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661000|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138661001|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138661002|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138661003|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138661004|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138661005|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
138661006|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661007|NCT00456027|Antacids|antacids|mesh-ancestor
138661008|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661009|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191519|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661011|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661012|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138661013|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138661014|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138661015|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661016|NCT00348725|Metformin|metformin|mesh-list
138661017|NCT00348725|Fenofibrate|fenofibrate|mesh-list
138661018|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661019|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661020|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138661021|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
138312946|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661022|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661023|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138661024|NCT00348764|Polidocanol|polidocanol|mesh-list
138661025|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138661026|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138661027|NCT03276156|Apatinib|apatinib|mesh-list
138661028|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661029|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661030|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661031|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661032|NCT00456144|Hormones|hormones|mesh-list
138201720|NCT00002902|Irinotecan|irinotecan|mesh-list
138661033|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661034|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661035|NCT00348920|Bupivacaine|bupivacaine|mesh-list
138661036|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
138661037|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
138661038|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661039|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191555|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661040|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
138661041|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661042|NCT00449514|Tamoxifen|tamoxifen|mesh-list
138661043|NCT00449514|Clomiphene|clomiphene|mesh-list
138661044|NCT00449514|Enclomiphene|enclomiphene|mesh-list
138661045|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
138661046|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138661047|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
138661048|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661049|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661050|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661051|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661052|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138661053|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138661054|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138661055|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138661057|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138661058|NCT00348998|Bevacizumab|bevacizumab|mesh-list
138661059|NCT00348998|Goserelin|goserelin|mesh-list
138661060|NCT00348998|Bicalutamide|bicalutamide|mesh-list
138661061|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138661062|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661063|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138661064|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138661065|NCT00348998|Growth Substances|growth substances|mesh-ancestor
138312982|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661066|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191602|NCT00955877|Analgesics|analgesics|mesh-ancestor
138661067|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138661068|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661069|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
138661070|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
138661071|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661073|NCT00449553|Pioglitazone|pioglitazone|mesh-list
138661074|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661075|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661076|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
138661077|NCT00349076|Fluorouracil|fluorouracil|mesh-list
138661078|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661079|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
138661080|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661081|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661082|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661083|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
138661084|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661085|NCT00349115|Thalidomide|thalidomide|mesh-list
138661086|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661087|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
138661088|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661089|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
138661090|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661091|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661092|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138661093|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138661094|NCT00349115|Growth Substances|growth substances|mesh-ancestor
138661095|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
138661096|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661097|NCT00456339|Amoxicillin|amoxicillin|mesh-list
138661098|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
138661099|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
138661100|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138661103|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661104|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661105|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
138661106|NCT00456339|Hormones|hormones|mesh-ancestor
138661107|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661108|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661109|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661110|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313011|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313012|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
138661111|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138661112|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661113|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661114|NCT00421421|Dutasteride|dutasteride|mesh-list
138661115|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138661116|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138661117|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661118|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661119|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
138661120|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661121|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661122|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
138661123|NCT00421460|Testosterone|testosterone|mesh-list
138661124|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
138661125|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
138661126|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138661127|NCT00421460|Androgens|androgens|mesh-ancestor
138661129|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661130|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191689|NCT01008059|Narcotics|narcotics|mesh-ancestor
138661131|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661134|NCT03274167|Gabapentin|gabapentin|mesh-list
138661135|NCT03274167|Analgesics|analgesics|mesh-ancestor
138661136|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
138661137|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661138|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661139|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
138661140|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138661141|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661142|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661143|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138661144|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138661145|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138661146|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661147|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661148|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
138661149|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
138661150|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661151|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661152|NCT00349583|Cyclosporine|cyclosporine|mesh-list
138661153|NCT00349583|Cyclosporins|cyclosporins|mesh-list
138661154|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313041|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661155|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313042|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661156|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661157|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
138661158|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661159|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
138661160|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661161|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
138661162|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661163|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138661164|NCT00349739|Anecortave|anecortave|mesh-list
138191785|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661165|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138661166|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138661167|NCT00349739|Growth Substances|growth substances|mesh-ancestor
138661168|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661169|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
138661170|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661171|NCT00456729|Metronidazole|metronidazole|mesh-list
138661172|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661173|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661174|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138661175|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138661176|NCT00450099|Bupivacaine|bupivacaine|mesh-list
138661177|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138661178|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
138661179|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661180|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661181|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
138661182|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661183|NCT00450138|Cisplatin|cisplatin|mesh-list
138661184|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661185|NCT00350051|Prednisone|prednisone|mesh-list
138661187|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661188|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
138661189|NCT00350051|Hormones|hormones|mesh-ancestor
138661190|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661191|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661192|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661193|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313067|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313103|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661194|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
138661195|NCT00350090|Hematinics|hematinics|mesh-ancestor
138661197|NCT04699110|Epinephrine|epinephrine|mesh-list
138661198|NCT04699110|Racepinephrine|racepinephrine|mesh-list
138661199|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
138661200|NCT04699110|Analgesics|analgesics|mesh-ancestor
138661201|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
138661202|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661203|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661204|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138661205|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
138191901|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
138661206|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138661207|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
138661208|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
138661209|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661210|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661211|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138661212|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138661213|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
138661214|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138661215|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138661217|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138661218|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661219|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
138661220|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
138661221|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138661222|NCT00350168|Amlodipine|amlodipine|mesh-list
138661223|NCT00350168|Valsartan|valsartan|mesh-list
138661224|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661225|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138661226|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138661227|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661228|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661229|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661230|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661231|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138284367|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
138661232|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138661233|NCT00105534|Azithromycin|azithromycin|mesh-list
138661234|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661235|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661236|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
138191957|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
138661237|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661238|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661239|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138661241|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661242|NCT00350441|Urological Agents|urological agents|mesh-ancestor
138661243|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138661244|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
138661245|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138661246|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138661247|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
138661248|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138661249|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661250|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138661251|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138661252|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661253|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661254|NCT00456963|Losartan|losartan|mesh-list
138661255|NCT00456963|Enalapril|enalapril|mesh-list
138661256|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138661257|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661258|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138661259|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138661260|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661261|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138661262|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
138661263|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661264|NCT00350597|Molgramostim|molgramostim|mesh-list
138661265|NCT00350597|Sargramostim|sargramostim|mesh-list
138661266|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
138661267|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661268|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661269|NCT00350753|Bevacizumab|bevacizumab|mesh-list
138661270|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138661271|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138192043|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
138661272|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661273|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138661274|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138661275|NCT00350753|Growth Substances|growth substances|mesh-ancestor
138661276|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661277|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138661278|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661279|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661280|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661282|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138661283|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661284|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661285|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661286|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661287|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
138661288|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661289|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661290|NCT00350948|Doxorubicin|doxorubicin|mesh-list
138192184|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138661292|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138661293|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661294|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138661295|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138661296|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661297|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661298|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138192321|NCT01168687|Levetiracetam|levetiracetam|mesh-list
138661300|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661302|NCT00421538|Calcium|calcium|mesh-list
138661303|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661304|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661305|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
138313113|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313116|NCT01894776|Maraviroc|maraviroc|mesh-list
138661306|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138661308|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661310|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138661311|NCT00351026|Narcotics|narcotics|mesh-ancestor
138661312|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661313|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661314|NCT00351026|Analgesics|analgesics|mesh-ancestor
138192389|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138661315|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
138661316|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661317|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
138661318|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661319|NCT00351104|Ketoprofen|ketoprofen|mesh-list
138661320|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138284434|NCT02817763|Dipyrone|dipyrone|mesh-list
138661321|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138661322|NCT00351104|Analgesics|analgesics|mesh-ancestor
138661323|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
138661324|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661325|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661326|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661327|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661328|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138661329|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661330|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661331|NCT00351143|Fluticasone|fluticasone|mesh-list
138661333|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138661334|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661335|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138661336|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
138661337|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661338|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661339|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138661340|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661341|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138661342|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138661343|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138661344|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138661345|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138661346|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
138661347|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661348|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661350|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138661351|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661352|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661353|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661354|NCT00457509|Vaccines|vaccines|mesh-list
138661355|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
138661356|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661357|NCT00450645|Heparin|heparin|mesh-list
138313136|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138192509|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
138192552|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313137|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313139|NCT01894152|Everolimus|everolimus|mesh-list
138661358|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138661359|NCT00450645|Tinzaparin|tinzaparin|mesh-list
138661360|NCT00450645|Dalteparin|dalteparin|mesh-list
138661361|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
138661362|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138661363|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138661364|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661365|NCT00351182|Doxycycline|doxycycline|mesh-list
138661366|NCT00351182|Telithromycin|telithromycin|mesh-list
138661367|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661369|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
138661370|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138661371|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138661372|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
138661373|NCT00457860|Immunotoxins|immunotoxins|mesh-list
138661374|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
138661375|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
138661376|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661377|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661378|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138661379|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
138661380|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138661381|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138661382|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661383|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661384|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661386|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661387|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661388|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138661389|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
138661390|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661391|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661392|NCT00458055|Niacin|niacin|mesh-list
138661393|NCT00458055|Atorvastatin|atorvastatin|mesh-list
138661394|NCT00458055|Fenofibrate|fenofibrate|mesh-list
138661395|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138661396|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138661397|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
138661398|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661399|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138661400|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138661401|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661402|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661403|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
138661404|NCT00458055|Vitamins|vitamins|mesh-ancestor
138661405|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
138661406|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661407|NCT00450762|Carboplatin|carboplatin|mesh-list
138661408|NCT00450762|Gemcitabine|gemcitabine|mesh-list
138661409|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661410|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661411|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
138661412|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313180|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138661413|NCT00450840|Simvastatin|simvastatin|mesh-list
138661414|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138661415|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138661416|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
138661417|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661418|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138661419|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138661420|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661421|NCT00352196|Risperidone|risperidone|mesh-list
138661422|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138661423|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
138661424|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661425|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661426|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661427|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138661428|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661429|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661430|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138661431|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138661432|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
138661433|NCT00352235|KRN 7000|krn 7000|mesh-list
138661434|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138661435|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
138661436|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661437|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661438|NCT00352313|Carboplatin|carboplatin|mesh-list
138661439|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661440|NCT00450957|Lycopene|lycopene|mesh-list
138661441|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
138661442|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661443|NCT00450957|Protective Agents|protective agents|mesh-ancestor
138661444|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661445|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661446|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138661447|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138661448|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661449|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
138661450|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138284529|NCT03065179|Nivolumab|nivolumab|mesh-list
138661451|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
138661452|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661453|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661454|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138661455|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661456|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138661457|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
138661458|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661459|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661460|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138661461|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661462|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
138661463|NCT00352430|Protective Agents|protective agents|mesh-ancestor
138661464|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138661465|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
138661466|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138661467|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138661468|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661469|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661470|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661471|NCT00451074|Gentamicins|gentamicins|mesh-list
138201721|NCT00002902|Raltitrexed|raltitrexed|mesh-list
138313181|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313183|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661472|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661473|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661474|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138661475|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661476|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661477|NCT00465621|Latanoprost|latanoprost|mesh-list
138661478|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138661479|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138661480|NCT00352625|Ketoprofen|ketoprofen|mesh-list
138661481|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138661482|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138661483|NCT00352625|Analgesics|analgesics|mesh-ancestor
138661484|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
138661485|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661486|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661487|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661488|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661489|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138661490|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661491|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661493|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138661494|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661495|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
138661496|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
138661497|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661498|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661499|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138661500|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138661501|NCT00352742|Growth Substances|growth substances|mesh-ancestor
138661502|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661503|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
138661504|NCT00352859|Interferons|interferons|mesh-list
138661505|NCT00352859|Gemcitabine|gemcitabine|mesh-list
138661506|NCT00352859|Sorafenib|sorafenib|mesh-list
138661507|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661508|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
138661509|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661510|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661511|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
138661512|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661513|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661514|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661515|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
138661516|NCT00105183|Antibodies|antibodies|mesh-list
138661517|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
138661518|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138661519|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138661520|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
138192718|NCT03011905|Dexamethasone|dexamethasone|mesh-list
138661521|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138192720|NCT03011905|Oxycodone|oxycodone|mesh-list
138661523|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661524|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313193|NCT01852812|Montelukast|montelukast|mesh-list
138661525|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138661526|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661527|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661528|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284591|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138661529|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661531|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138661532|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138661533|NCT00466128|Analgesics|analgesics|mesh-ancestor
138661534|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
138661535|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661536|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661537|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661538|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661539|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
138661540|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
138661541|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138661542|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138661543|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661544|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661545|NCT00353015|Cisplatin|cisplatin|mesh-list
138661546|NCT00353015|Irinotecan|irinotecan|mesh-list
138192766|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661548|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138661549|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138661550|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661551|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661552|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138661553|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661554|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661555|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661556|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661557|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
138661558|NCT00353054|Antacids|antacids|mesh-ancestor
138661559|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661560|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138661561|NCT00466401|Simvastatin|simvastatin|mesh-list
138661562|NCT00466401|Ezetimibe|ezetimibe|mesh-list
138661563|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138661564|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138661565|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
138661566|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661567|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138661568|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138661569|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661570|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138661571|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192814|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
138661572|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138313213|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313214|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661573|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138661575|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138661576|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661577|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661578|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661579|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138661580|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661581|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661584|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661585|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138661586|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138661587|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661588|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661589|NCT00353561|Fluconazole|fluconazole|mesh-list
138192865|NCT01138969|Esomeprazole|esomeprazole|mesh-list
138661591|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661592|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138661593|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138661594|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661595|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661596|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138661597|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
138661598|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661599|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661600|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138661601|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138661602|NCT00466596|Vitamins|vitamins|mesh-list
138661603|NCT00466596|Vitamin E|vitamin e|mesh-list
138661604|NCT00466596|Tocopherols|tocopherols|mesh-list
138661605|NCT00466596|Tocotrienols|tocotrienols|mesh-list
138661607|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
138661608|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
138661609|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661610|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
138661611|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284722|NCT03108482|Analgesics|analgesics|mesh-ancestor
138661612|NCT00466596|Protective Agents|protective agents|mesh-ancestor
138661613|NCT00353678|Darexaban|darexaban|mesh-list
138661614|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138661615|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
138661616|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138661617|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
138661618|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661619|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661620|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
138661621|NCT00458250|Cyclosporine|cyclosporine|mesh-list
138661622|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
138661624|NCT00458250|Methotrexate|methotrexate|mesh-list
138661625|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
138313237|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
138313238|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138313239|NCT01851330|Ledipasvir|ledipasvir|mesh-list
138661627|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661628|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
138661629|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661630|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661631|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138661632|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
138661633|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661634|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661635|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138661636|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138661637|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
138661638|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138661639|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661640|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
138661641|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138661642|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661643|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138661644|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138661645|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
138661646|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661647|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138661648|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138661650|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138661651|NCT00353717|Cetuximab|cetuximab|mesh-list
138661652|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138661653|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661654|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138661655|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138661656|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138661657|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661658|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138661659|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
138661660|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661661|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661662|NCT00466791|Methylphenidate|methylphenidate|mesh-list
138661663|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138661664|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661665|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138661666|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138661667|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138661668|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661669|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
138661671|NCT00353912|Amlodipine|amlodipine|mesh-list
138661672|NCT00353912|Valsartan|valsartan|mesh-list
138661673|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661674|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138661675|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193083|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661676|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661677|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661678|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661679|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661680|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138661681|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138661683|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313260|NCT01867710|Dexamethasone|dexamethasone|mesh-list
138661684|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661686|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138661687|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661688|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661689|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
138661690|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661691|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661692|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138661693|NCT00354068|Temozolomide|temozolomide|mesh-list
138661694|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
138661695|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138661696|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
138661697|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661698|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661699|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661700|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661701|NCT00466869|Betahistine|betahistine|mesh-list
138661702|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661703|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
138661704|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
138661705|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661706|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661707|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661709|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661710|NCT00458367|Risperidone|risperidone|mesh-list
138661711|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138661712|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
138661713|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661714|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661715|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661716|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138661717|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661718|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138661719|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138661720|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138661721|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
138661723|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661724|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138661725|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661726|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661727|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138661728|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661729|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
138661730|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
138661731|NCT00354302|Alendronate|alendronate|mesh-list
138661732|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
138661733|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
138661734|NCT00354302|Calcium|calcium|mesh-list
138661735|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138661736|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661737|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138313277|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
138313278|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138661738|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661739|NCT00354302|Vitamins|vitamins|mesh-ancestor
138661740|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
138661741|NCT00354302|Antacids|antacids|mesh-ancestor
138661742|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138661743|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138661744|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138661745|NCT04714229|Vaccines|vaccines|mesh-list
138661746|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
138661747|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661748|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
138661749|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138661750|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661751|NCT00354380|Artesunate|artesunate|mesh-list
138661752|NCT00354380|Amodiaquine|amodiaquine|mesh-list
138661753|NCT00354380|Methylene Blue|methylene blue|mesh-list
138661754|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
138193226|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
138661755|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138661756|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138661757|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661758|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661760|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
138661761|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138661762|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
138661763|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661764|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661765|NCT00354419|Cyclosporine|cyclosporine|mesh-list
138661766|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
138661767|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
138661768|NCT00354419|Cyclosporins|cyclosporins|mesh-list
138661769|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
138661770|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138661771|NCT00354419|Lenograstim|lenograstim|mesh-list
138661772|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
138661773|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661774|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
138661775|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661776|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661777|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138661778|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
138661779|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661780|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661781|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138661782|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138661783|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313297|NCT01832532|Hormones|hormones|mesh-ancestor
138313298|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313299|NCT04414956|Vitamin K|vitamin k|mesh-list
138313300|NCT04414956|Agglutinins|agglutinins|mesh-list
138661784|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
138661785|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661786|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313301|NCT04414956|Vitamins|vitamins|mesh-ancestor
138661787|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138661788|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138661789|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138661790|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
138661791|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661793|NCT00354458|Diuretics|diuretics|mesh-ancestor
138661794|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
138661795|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661796|NCT00458718|Rimonabant|rimonabant|mesh-list
138661797|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138661798|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138661799|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138661800|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661801|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661802|NCT00458718|Hormones|hormones|mesh-ancestor
138661803|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661804|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661805|NCT00467181|Fenoldopam|fenoldopam|mesh-list
138661806|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661807|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
138193408|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
138661808|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
138661809|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
138661810|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661811|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661812|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661813|NCT00425711|Acamprosate|acamprosate|mesh-list
138661814|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138661815|NCT03274011|Apatinib|apatinib|mesh-list
138661816|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661817|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661818|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661819|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661820|NCT00425906|Nicotine|nicotine|mesh-list
138661821|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138661822|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
138661823|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661824|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313323|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313324|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313325|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138313326|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313327|NCT01848210|Troxerutin|troxerutin|mesh-list
138313328|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
138313329|NCT01830816|Ixazomib|ixazomib|mesh-list
138313330|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313331|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
138313332|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313333|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313334|NCT01846416|Atezolizumab|atezolizumab|mesh-list
138313335|NCT01846416|Antibodies|antibodies|mesh-list
138313336|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
138313341|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661825|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138661826|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138661827|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
138661828|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661829|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661830|NCT00467376|Insulin|insulin|mesh-list
138661831|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138661832|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
138661833|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
138661834|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138661835|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661836|NCT00426023|Ketotifen|ketotifen|mesh-list
138661837|NCT00426023|Cyclosporine|cyclosporine|mesh-list
138661838|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138661839|NCT00426023|Cyclosporins|cyclosporins|mesh-list
138661840|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661841|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661842|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661843|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
138193463|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661844|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661845|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
138661846|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661847|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
138661848|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661849|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138661850|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138661851|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
138661852|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138661853|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
138661854|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
138661855|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661856|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138661857|NCT00467454|Naltrexone|naltrexone|mesh-list
138661858|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138661859|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138661860|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661862|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661864|NCT00426101|Dexamethasone|dexamethasone|mesh-list
138661865|NCT00426101|Etoposide|etoposide|mesh-list
138661866|NCT00426101|Cyclosporins|cyclosporins|mesh-list
138661867|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661868|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
138661869|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
138661870|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661871|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661872|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138661873|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
138661874|NCT00426101|Hormones|hormones|mesh-ancestor
138661875|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193561|NCT04127396|Lenvatinib|lenvatinib|mesh-list
138661876|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661877|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661878|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138661879|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138313344|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313345|NCT01803282|Leucovorin|leucovorin|mesh-list
138313346|NCT01803282|Paclitaxel|paclitaxel|mesh-list
138661880|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138661881|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661882|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661883|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138661884|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
138661885|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
138661886|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661887|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
138661888|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138661889|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138661890|NCT00426140|Epothilone B|epothilone b|mesh-list
138661891|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661892|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138661893|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138661894|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138661895|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661896|NCT00467493|Anastrozole|anastrozole|mesh-list
138661897|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138661898|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661899|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138661900|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138661901|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661902|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661903|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138661904|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338667|NCT01218984|Analgesics|analgesics|mesh-ancestor
138284890|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138661905|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138661906|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661907|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
138661908|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661909|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661910|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661911|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661912|NCT00458913|Bortezomib|bortezomib|mesh-list
138661913|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661914|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
138661915|NCT00458991|Caffeine|caffeine|mesh-list
138661916|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138661917|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661918|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138661919|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661920|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661921|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138661922|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138661923|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
138661924|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661925|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
138661926|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661927|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138661928|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138661929|NCT01059617|Vaccines|vaccines|mesh-list
138661930|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
138193667|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138661931|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661932|NCT04705337|Simendan|simendan|mesh-list
138313366|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313367|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
138313383|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
138661933|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138661934|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
138661935|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138661936|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138661938|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661939|NCT04705337|Protective Agents|protective agents|mesh-ancestor
138661940|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661941|NCT00467571|Amoxicillin|amoxicillin|mesh-list
138661942|NCT00467571|Clarithromycin|clarithromycin|mesh-list
138661943|NCT00467571|Lansoprazole|lansoprazole|mesh-list
138661944|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
138661945|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138661946|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661947|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138661948|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661949|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661950|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138661951|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138661952|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138661953|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138661954|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138661955|NCT00426296|Ritonavir|ritonavir|mesh-list
138661956|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138661957|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138661958|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138661959|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
138193715|NCT01222273|Vitamin D|vitamin d|mesh-list
138661960|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661961|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661962|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138661963|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138661964|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
138661965|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661966|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138661967|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138661968|NCT03271905|Bromides|bromides|mesh-list
138661969|NCT03271905|Albuterol|albuterol|mesh-list
138313385|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313386|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313388|NCT01611090|Rituximab|rituximab|mesh-list
138661970|NCT03271905|Ipratropium|ipratropium|mesh-list
138661971|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
138661972|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138661973|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
138661974|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661975|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661976|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138661977|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
138661978|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
138661979|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138661980|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138338749|NCT01231230|Hormones|hormones|mesh-ancestor
138661981|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138661982|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138661983|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193770|NCT02983214|Cilostazol|cilostazol|mesh-list
138661984|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661985|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661986|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138661987|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138661988|NCT00426413|Pioglitazone|pioglitazone|mesh-list
138661990|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661991|NCT00459264|Folic Acid|folic acid|mesh-list
138661992|NCT00459264|Hematinics|hematinics|mesh-ancestor
138661993|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
138661994|NCT00459264|Vitamins|vitamins|mesh-ancestor
138661995|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
138661996|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661997|NCT00426452|Vatalanib|vatalanib|mesh-list
138661998|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138661999|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662000|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662001|NCT00426491|Misoprostol|misoprostol|mesh-list
138193815|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193834|NCT04393220|Nivolumab|nivolumab|mesh-list
138662002|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138662003|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
138662004|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138662005|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662006|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138662007|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662008|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
138662009|NCT00426530|Everolimus|everolimus|mesh-list
138662010|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138662011|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138662012|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662013|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662014|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662015|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
138662016|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662017|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662018|NCT00459420|Caffeine|caffeine|mesh-list
138662019|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138662020|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662021|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138313416|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138313417|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138662022|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193872|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138662023|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662025|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138662026|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
138662027|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662028|NCT00467766|Donepezil|donepezil|mesh-list
138662029|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138662030|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662031|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662032|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
138662033|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662034|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662035|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
138662036|NCT00467883|Amphotericin B|amphotericin b|mesh-list
138662037|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138662038|NCT00467883|Amebicides|amebicides|mesh-ancestor
138662039|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138662040|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138662041|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193925|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662042|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662043|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
138662044|NCT00426608|Alprazolam|alprazolam|mesh-list
138662045|NCT00426608|Metyrapone|metyrapone|mesh-list
138662046|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662047|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662048|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662049|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138662050|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138662051|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662052|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
138338817|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
138662053|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
138662054|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662055|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662056|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
138662057|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662059|NCT00426647|Tramadol|tramadol|mesh-list
138662060|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662061|NCT00426647|Narcotics|narcotics|mesh-ancestor
138662062|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662063|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193980|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662064|NCT00426647|Analgesics|analgesics|mesh-ancestor
138662065|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
138662066|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662067|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138662068|NCT00459615|Artesunate|artesunate|mesh-list
138662069|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
138662070|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138662071|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138662072|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662073|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662074|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
138662075|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
138313437|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662076|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138662077|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
138662078|NCT00468351|Triamcinolone|triamcinolone|mesh-list
138662079|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138662080|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138662082|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138662083|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662084|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662085|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662086|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662088|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662089|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138194038|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662091|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
138662092|NCT00468351|Hormones|hormones|mesh-ancestor
138662093|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662094|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662095|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
138662096|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662097|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662098|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138662099|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662100|NCT00468429|Bevacizumab|bevacizumab|mesh-list
138662101|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662102|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662103|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662104|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662105|NCT00468429|Growth Substances|growth substances|mesh-ancestor
138662106|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662107|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
138662108|NCT00459771|Candesartan|candesartan|mesh-list
138662109|NCT00459771|Candesartan cilexetil|candesartan cilexetil|mesh-list
138662110|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138662111|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138662112|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138662113|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662114|NCT01058369|Deferasirox|deferasirox|mesh-list
138662115|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138662116|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
138662117|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
138662118|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662119|NCT01057433|Ritonavir|ritonavir|mesh-list
138662120|NCT01057433|Lopinavir|lopinavir|mesh-list
138662121|NCT01057433|Pitavastatin|pitavastatin|mesh-list
138662122|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138662123|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138662124|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
138662125|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662126|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662127|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138662128|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138313453|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138662129|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
138662130|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662131|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138313454|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
138338887|NCT01262118|Tofacitinib|tofacitinib|mesh-list
138662132|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138662133|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138662134|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138662135|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138662137|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138662139|NCT01058642|Analgesics|analgesics|mesh-ancestor
138662140|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
138662141|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662142|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662143|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
138662144|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138662145|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662146|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662147|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138662148|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138662149|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138662150|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662151|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662153|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138662154|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662155|NCT00426998|Bevacizumab|bevacizumab|mesh-list
138662156|NCT00426998|Verteporfin|verteporfin|mesh-list
138662157|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662158|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662159|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662160|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662161|NCT00426998|Growth Substances|growth substances|mesh-ancestor
138194185|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662162|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662163|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138662164|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138662165|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
138662167|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138662168|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662169|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662170|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138662171|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
138313475|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138313476|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313477|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313478|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138313479|NCT01840410|Ranibizumab|ranibizumab|mesh-list
138313480|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138313481|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138313482|NCT01840410|Growth Substances|growth substances|mesh-ancestor
138313483|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313484|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
138313485|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313486|NCT01797432|Triamcinolone|triamcinolone|mesh-list
138313487|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138313488|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138313489|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138313490|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662172|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138662173|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138662175|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138662176|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138662177|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662178|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138662180|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138662181|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662182|NCT00427271|Analgesics|analgesics|mesh-ancestor
138662183|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
138662184|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662185|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194236|NCT05436522|Propofol|propofol|mesh-list
138662186|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662188|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138662189|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138662190|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662191|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138662192|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138662193|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662194|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
138662195|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
138662196|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138662197|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662198|NCT00460083|Analgesics|analgesics|mesh-ancestor
138662199|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
138662200|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662201|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662202|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662203|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662204|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138662205|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662207|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138662208|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662209|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662210|NCT00427310|Fluorouracil|fluorouracil|mesh-list
138662211|NCT00427310|Heparin|heparin|mesh-list
138662212|NCT00427310|Calcium heparin|calcium heparin|mesh-list
138662213|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
138662214|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662215|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138662216|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662217|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662218|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
138662219|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662220|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
138313493|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313494|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313496|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
138662221|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138194287|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
138662222|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138662223|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
138662224|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138662225|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138662226|NCT00427388|Prednisolone|prednisolone|mesh-list
138662227|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
138662228|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138662229|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
138662230|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662231|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
138662232|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
138662233|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662234|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662235|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662236|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
138662237|NCT00427388|Hormones|hormones|mesh-ancestor
138201722|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138662238|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662239|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138662240|NCT00427388|Protective Agents|protective agents|mesh-ancestor
138285102|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
138194326|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
138662241|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662242|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662243|NCT00427427|Trastuzumab|trastuzumab|mesh-list
138662244|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662245|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662246|NCT04704947|Alendronate|alendronate|mesh-list
138662247|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138662248|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
138662249|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138662250|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662251|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138662252|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
138662253|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194381|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
138194387|NCT04391660|Eusol|eusol|mesh-list
138662254|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662255|NCT00427466|Pemetrexed|pemetrexed|mesh-list
138662256|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662257|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662258|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662259|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138662260|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138662261|NCT00427505|Deferasirox|deferasirox|mesh-list
138662262|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138662263|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
138662264|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
138662265|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662266|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
138662267|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662268|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138662269|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662270|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313517|NCT01796964|Growth Substances|growth substances|mesh-ancestor
138662271|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
138313518|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662272|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138662273|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662274|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138351181|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351182|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351183|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138351184|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138351185|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138351186|NCT02416128|Prednisolone|prednisolone|mesh-list
138351187|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138351188|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
138351189|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138351190|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
138351191|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138351192|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
138351193|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351194|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
138351195|NCT02416128|Hormones|hormones|mesh-ancestor
138194449|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
138662275|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
138285117|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
138662276|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662277|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662278|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662279|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662280|NCT00469053|Buprenorphine|buprenorphine|mesh-list
138662281|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662282|NCT00469053|Narcotics|narcotics|mesh-ancestor
138662283|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662284|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662285|NCT00469053|Analgesics|analgesics|mesh-ancestor
138662286|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
138662287|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662288|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138662289|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
138662291|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662292|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
138662293|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662294|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138662295|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662296|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662297|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138662298|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194501|NCT01457690|Vitamins|vitamins|mesh-ancestor
138662299|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138662300|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
138662301|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662302|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662303|NCT00428129|Plasminogen|plasminogen|mesh-list
138662304|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138662305|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138313535|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138313536|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
138662306|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662307|NCT00428168|Betahistine|betahistine|mesh-list
138662308|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
138662309|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
138662310|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
138662311|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662312|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662313|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662314|NCT00428480|Methamphetamine|methamphetamine|mesh-list
138662315|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138662316|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662317|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
138662318|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
138662319|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662320|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
138662321|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662322|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662323|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
138662324|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138662325|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138662326|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662327|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138662328|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
138662329|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662330|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662331|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662332|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662333|NCT00460473|Analgesics|analgesics|mesh-ancestor
138662334|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
138662335|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662336|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138662337|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138662338|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138662339|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138662340|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662341|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662342|NCT00428519|Aprepitant|aprepitant|mesh-list
138662343|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
138662344|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
138662345|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
138662346|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662347|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662348|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662349|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138313572|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138662350|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194669|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138662351|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662353|NCT00428558|Daunorubicin|daunorubicin|mesh-list
138662354|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138662355|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
138662356|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662357|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662358|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
138662359|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662360|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662361|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
138662362|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662363|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138285204|NCT02878057|Apatinib|apatinib|mesh-list
138662364|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138662365|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138194717|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662366|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662367|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138662368|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138662369|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138662370|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662371|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662372|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662373|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138662374|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138662375|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
138194775|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662376|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662377|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662378|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138662379|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138662381|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
138662382|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138662383|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662384|NCT01055834|Eszopiclone|eszopiclone|mesh-list
138662385|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662386|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662387|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662388|NCT00469326|Atorvastatin|atorvastatin|mesh-list
138662389|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138662390|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138662391|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
138662392|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662393|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138662394|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138662395|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662397|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
138662398|NCT00460707|Ketoconazole|ketoconazole|mesh-list
138351197|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351199|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662400|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
138662401|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662402|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138662403|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138662404|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662405|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662406|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138662407|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
138662408|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662409|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662410|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138313601|NCT01818258|Ritonavir|ritonavir|mesh-list
138313602|NCT01818258|Lopinavir|lopinavir|mesh-list
138313603|NCT01818258|Lamivudine|lamivudine|mesh-list
138662412|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
138662413|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662414|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662415|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138662416|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662417|NCT00469404|Buprenorphine|buprenorphine|mesh-list
138662418|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662419|NCT00469404|Narcotics|narcotics|mesh-ancestor
138662420|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662421|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662422|NCT00469404|Analgesics|analgesics|mesh-ancestor
138194910|NCT05489952|Iron|iron|mesh-list
138662423|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
138662424|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662425|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138662426|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
138662427|NCT00460785|Narcotics|narcotics|mesh-ancestor
138662428|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662429|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662430|NCT00460785|Analgesics|analgesics|mesh-ancestor
138662431|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
138662432|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662433|NCT01054976|Galantamine|galantamine|mesh-list
138662434|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138662435|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662436|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662437|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
138662438|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662439|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194945|NCT03984838|Dolutegravir|dolutegravir|mesh-list
138194946|NCT03984838|Rilpivirine|rilpivirine|mesh-list
138662440|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138662441|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
138662442|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662443|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
138662445|NCT00469443|Bevacizumab|bevacizumab|mesh-list
138662446|NCT00469443|Capecitabine|capecitabine|mesh-list
138662447|NCT00469443|Fluorouracil|fluorouracil|mesh-list
138662448|NCT00469443|Irinotecan|irinotecan|mesh-list
138662449|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662450|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662451|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662452|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662453|NCT00469443|Growth Substances|growth substances|mesh-ancestor
138662454|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662455|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138662456|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138662457|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
138662458|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313612|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
138662459|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662460|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
138662461|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138662462|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138662463|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662464|NCT00469443|Antidotes|antidotes|mesh-ancestor
138662465|NCT00469443|Protective Agents|protective agents|mesh-ancestor
138662466|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
138662468|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
138662469|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
138662470|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138662471|NCT00428909|Acetaminophen|acetaminophen|mesh-list
138662472|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
138662473|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662474|NCT00428909|Analgesics|analgesics|mesh-ancestor
138662475|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
138662476|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662477|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662478|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
138662479|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662480|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138662481|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662482|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662484|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662485|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662487|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662488|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662489|NCT06189742|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138662490|NCT06189742|Immunologic Factors|immunologic factors|mesh-ancestor
138662491|NCT06189742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662492|NCT06189638|Anti-Infective Agents|anti-infective agents|mesh-list
138662493|NCT06189638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138662494|NCT06189586|Glucocorticoids|glucocorticoids|mesh-list
138662495|NCT06189586|Hormones|hormones|mesh-ancestor
138662496|NCT06189586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662497|NCT06189586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662498|NCT06189521|Dexamethasone|dexamethasone|mesh-list
138662499|NCT06189521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662501|NCT06189521|Autonomic Agents|autonomic agents|mesh-ancestor
138662502|NCT06189521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662503|NCT06189521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662504|NCT06189521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662505|NCT06189521|Glucocorticoids|glucocorticoids|mesh-ancestor
138662506|NCT06189521|Hormones|hormones|mesh-ancestor
138662507|NCT06189521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662508|NCT06189521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662509|NCT06189521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662510|NCT06189404|Theophylline|theophylline|mesh-list
138285283|NCT03115801|Nivolumab|nivolumab|mesh-list
138662511|NCT06189404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138662513|NCT06189404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662514|NCT06189404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662515|NCT06189404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138313637|NCT01792830|Metformin|metformin|mesh-list
138662516|NCT06189404|Respiratory System Agents|respiratory system agents|mesh-ancestor
138662517|NCT06189404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138662518|NCT06189404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662519|NCT06189404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662520|NCT06189404|Vasodilator Agents|vasodilator agents|mesh-ancestor
138662521|NCT06189404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138662522|NCT06189404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138662523|NCT06189404|Purinergic Agents|purinergic agents|mesh-ancestor
138195096|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662524|NCT06189404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662526|NCT06189209|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138662527|NCT06189209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662528|NCT06189209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662530|NCT06189144|Dermatologic Agents|dermatologic agents|mesh-ancestor
138662531|NCT06189092|Bleomycin|bleomycin|mesh-list
138662532|NCT06189092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138662533|NCT06189092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662534|NCT06189001|Oxytocin|oxytocin|mesh-list
138662535|NCT06189001|Oxytocics|oxytocics|mesh-ancestor
138662536|NCT06189001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138195148|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662537|NCT06189001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662538|NCT06188832|Psyllium|psyllium|mesh-list
138662539|NCT06188832|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138662540|NCT06188832|Cathartics|cathartics|mesh-ancestor
138313660|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313661|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313662|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
138313664|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
138662541|NCT06188832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662542|NCT06188767|Methyltestosterone|methyltestosterone|mesh-list
138662543|NCT06188767|Testosterone|testosterone|mesh-list
138662544|NCT06188767|Testosterone undecanoate|testosterone undecanoate|mesh-list
138662545|NCT06188767|Testosterone enanthate|testosterone enanthate|mesh-list
138662546|NCT06188767|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138662547|NCT06188767|Androgens|androgens|mesh-ancestor
138662548|NCT06188767|Hormones|hormones|mesh-ancestor
138662549|NCT06188767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662550|NCT06188767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662551|NCT06188767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662552|NCT06188767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662554|NCT06188676|Prednisolone|prednisolone|mesh-list
138662555|NCT06188676|Cyclophosphamide|cyclophosphamide|mesh-list
138195209|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
138662556|NCT06188676|Rituximab|rituximab|mesh-list
138662558|NCT06188676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138662559|NCT06188676|Nivolumab|nivolumab|mesh-list
138195210|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662560|NCT06188676|Etoposide|etoposide|mesh-list
138662561|NCT06188676|Vincristine|vincristine|mesh-list
138662562|NCT06188676|Etoposide phosphate|etoposide phosphate|mesh-list
138662563|NCT06188676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195267|NCT01890200|Ribavirin|ribavirin|mesh-list
138662564|NCT06188676|Immunologic Factors|immunologic factors|mesh-ancestor
138662565|NCT06188676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662566|NCT06188676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662567|NCT06188676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138662568|NCT06188676|Alkylating Agents|alkylating agents|mesh-ancestor
138662569|NCT06188676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662570|NCT06188676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313709|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
138662571|NCT06188676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138662572|NCT06188676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662573|NCT06188676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138662574|NCT06188676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138662575|NCT06188676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138662576|NCT06188676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662577|NCT06188676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138662578|NCT06188676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138662579|NCT06188676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138662580|NCT06188676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138662581|NCT06188676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138662582|NCT06188676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662583|NCT06188676|Glucocorticoids|glucocorticoids|mesh-ancestor
138662584|NCT06188676|Hormones|hormones|mesh-ancestor
138195337|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
138662585|NCT06188676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662586|NCT06188676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662588|NCT06188637|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138662589|NCT06188637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662590|NCT06188637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662591|NCT06188637|Immunologic Factors|immunologic factors|mesh-ancestor
138662592|NCT06188637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662593|NCT06188546|Propofol|propofol|mesh-list
138662594|NCT06188546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662595|NCT06188546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662596|NCT06188546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662597|NCT06188546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138662598|NCT06188546|Anesthetics, General|anesthetics, general|mesh-ancestor
138662599|NCT06188546|Anesthetics|anesthetics|mesh-ancestor
138662600|NCT06188468|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138662601|NCT06188468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138662602|NCT06188468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662603|NCT06188455|Apatinib|apatinib|mesh-list
138662604|NCT06188455|Fluzoparib|fluzoparib|mesh-list
138662605|NCT06188455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662606|NCT06188455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138662607|NCT06188455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662608|NCT06188455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662609|NCT06188455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138662610|NCT06188442|Doxycycline|doxycycline|mesh-list
138662611|NCT06188442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662612|NCT06188442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662613|NCT06188442|Antimalarials|antimalarials|mesh-ancestor
138662614|NCT06188442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138662615|NCT06188442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138662616|NCT06188390|Hyaluronic Acid|hyaluronic acid|mesh-list
138662617|NCT06188390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138313754|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
138662618|NCT06188390|Immunologic Factors|immunologic factors|mesh-ancestor
138662619|NCT06188390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662620|NCT06188390|Viscosupplements|viscosupplements|mesh-ancestor
138662621|NCT06188390|Protective Agents|protective agents|mesh-ancestor
138662622|NCT06188325|Eliglustat|eliglustat|mesh-list
138662623|NCT06188325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662624|NCT06188325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662625|NCT06188221|Lidocaine|lidocaine|mesh-list
138195443|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
138195444|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662626|NCT06188221|Anesthetics, Local|anesthetics, local|mesh-ancestor
138662627|NCT06188221|Anesthetics|anesthetics|mesh-ancestor
138662628|NCT06188221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662629|NCT06188221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662630|NCT06188221|Sensory System Agents|sensory system agents|mesh-ancestor
138662631|NCT06188221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662632|NCT06188221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138662633|NCT06188221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138662634|NCT06188221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138662635|NCT06188221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662636|NCT06188221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662637|NCT06188208|Pembrolizumab|pembrolizumab|mesh-list
138662638|NCT06188208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195569|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138662640|NCT06188208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138662641|NCT06188208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662642|NCT06188195|Dexamethasone|dexamethasone|mesh-list
138662643|NCT06188195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662644|NCT06188195|Antiemetics|antiemetics|mesh-ancestor
138662645|NCT06188195|Autonomic Agents|autonomic agents|mesh-ancestor
138662646|NCT06188195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662647|NCT06188195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662648|NCT06188195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662649|NCT06188195|Glucocorticoids|glucocorticoids|mesh-ancestor
138662650|NCT06188195|Hormones|hormones|mesh-ancestor
138662651|NCT06188195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195632|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662652|NCT06188195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662653|NCT06188195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662657|NCT06188143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662658|NCT06188143|Analgesics|analgesics|mesh-ancestor
138662659|NCT06188143|Sensory System Agents|sensory system agents|mesh-ancestor
138662660|NCT06188143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662661|NCT06188143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662663|NCT06188143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313779|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313780|NCT01814748|Metformin|metformin|mesh-list
138313781|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138662664|NCT06188143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138662665|NCT06188143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662666|NCT06188143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662667|NCT06188143|Antipyretics|antipyretics|mesh-ancestor
138662668|NCT06188104|Acetic Acid|acetic acid|mesh-list
138662669|NCT06188104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138662670|NCT06188104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662671|NCT06188052|Tranexamic Acid|tranexamic acid|mesh-list
138662672|NCT06188052|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138662673|NCT06188052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138662674|NCT06188052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662675|NCT06188052|Hemostatics|hemostatics|mesh-ancestor
138662676|NCT06188052|Coagulants|coagulants|mesh-ancestor
138662677|NCT06187987|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138662678|NCT06187987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138662679|NCT06187987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138662680|NCT06187987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662681|NCT06187961|Lenvatinib|lenvatinib|mesh-list
138662682|NCT06187961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662683|NCT06187961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138662684|NCT06187961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662685|NCT06187961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662686|NCT06187922|Pregabalin|pregabalin|mesh-list
138662687|NCT06187922|Analgesics|analgesics|mesh-ancestor
138662688|NCT06187922|Sensory System Agents|sensory system agents|mesh-ancestor
138662689|NCT06187922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662690|NCT06187922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662691|NCT06187922|Anticonvulsants|anticonvulsants|mesh-ancestor
138662692|NCT06187922|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138662693|NCT06187922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662694|NCT06187922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662695|NCT06187922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138662696|NCT06187922|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138662697|NCT06187922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138662698|NCT06187922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662699|NCT06187922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662700|NCT06187896|Propofol|propofol|mesh-list
138662701|NCT06187896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662702|NCT06187896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662703|NCT06187896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662704|NCT06187896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138662705|NCT06187896|Anesthetics, General|anesthetics, general|mesh-ancestor
138662706|NCT06187896|Anesthetics|anesthetics|mesh-ancestor
138662707|NCT06187584|Acetaminophen|acetaminophen|mesh-list
138662708|NCT06187584|Ibuprofen|ibuprofen|mesh-list
138662709|NCT06187584|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138662710|NCT06187584|Hydrocodone|hydrocodone|mesh-list
138662711|NCT06187584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313806|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138313807|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313833|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
138662712|NCT06187584|Analgesics|analgesics|mesh-ancestor
138662713|NCT06187584|Sensory System Agents|sensory system agents|mesh-ancestor
138662714|NCT06187584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662715|NCT06187584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662716|NCT06187584|Antipyretics|antipyretics|mesh-ancestor
138662717|NCT06187584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138662718|NCT06187584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662719|NCT06187584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662720|NCT06187584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138662721|NCT06187584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662722|NCT06187584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662723|NCT06187584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662725|NCT06187584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662727|NCT06187584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138662728|NCT06187519|Uric Acid|uric acid|mesh-list
138662729|NCT06187519|Antioxidants|antioxidants|mesh-ancestor
138662730|NCT06187519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662731|NCT06187519|Protective Agents|protective agents|mesh-ancestor
138662732|NCT06187519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662733|NCT06187506|BCG Vaccine|bcg vaccine|mesh-list
138662734|NCT06187506|Disitamab vedotin|disitamab vedotin|mesh-list
138662735|NCT06187506|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138195857|NCT00981370|Deferasirox|deferasirox|mesh-list
138662736|NCT06187506|Immunologic Factors|immunologic factors|mesh-ancestor
138662737|NCT06187506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662738|NCT06187506|Immunoconjugates|immunoconjugates|mesh-ancestor
138662739|NCT06187493|Dapagliflozin|dapagliflozin|mesh-list
138662740|NCT06187493|Empagliflozin|empagliflozin|mesh-list
138351214|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662741|NCT06187493|Enalapril|enalapril|mesh-list
138662742|NCT06187493|Lisinopril|lisinopril|mesh-list
138662743|NCT06187493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138662744|NCT06187493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662745|NCT06187493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138662746|NCT06187493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662747|NCT06187493|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138662748|NCT06187493|Protease Inhibitors|protease inhibitors|mesh-ancestor
138662749|NCT06187493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662750|NCT06187493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138662751|NCT06187493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138662752|NCT06187493|Protective Agents|protective agents|mesh-ancestor
138662753|NCT06187441|Dexamethasone|dexamethasone|mesh-list
138662754|NCT06187441|Lenalidomide|lenalidomide|mesh-list
138662764|NCT06187441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662765|NCT06187441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662766|NCT06187441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662767|NCT06187441|Immunologic Factors|immunologic factors|mesh-ancestor
138662768|NCT06187441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138662769|NCT06187441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662770|NCT06187441|Growth Substances|growth substances|mesh-ancestor
138662788|NCT06187090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662789|NCT06187090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138662791|NCT06187090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662792|NCT06187090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662793|NCT06187090|Antiviral Agents|antiviral agents|mesh-ancestor
138662794|NCT06187090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662795|NCT06187090|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138662796|NCT06187090|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138662797|NCT06187090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662798|NCT06187090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662800|NCT06187090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662801|NCT06186986|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138196114|NCT01602016|Leucovorin|leucovorin|mesh-list
138662802|NCT06186986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662803|NCT06186986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662804|NCT06186986|Immunotoxins|immunotoxins|mesh-ancestor
138662805|NCT06186986|Immunoconjugates|immunoconjugates|mesh-ancestor
138662806|NCT06186986|Immunologic Factors|immunologic factors|mesh-ancestor
138662807|NCT06186986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662809|NCT06186921|Diclofenac|diclofenac|mesh-list
138662810|NCT06186921|Bupivacaine|bupivacaine|mesh-list
138662811|NCT06186921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662812|NCT06186921|Antiemetics|antiemetics|mesh-ancestor
138662813|NCT06186921|Autonomic Agents|autonomic agents|mesh-ancestor
138662814|NCT06186921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662815|NCT06186921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662816|NCT06186921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662817|NCT06186921|Glucocorticoids|glucocorticoids|mesh-ancestor
138662818|NCT06186921|Hormones|hormones|mesh-ancestor
138662819|NCT06186921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662820|NCT06186921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662821|NCT06186921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662822|NCT06186921|Anesthetics, Local|anesthetics, local|mesh-ancestor
138662823|NCT06186921|Anesthetics|anesthetics|mesh-ancestor
138196226|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138662824|NCT06186921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662825|NCT06186921|Sensory System Agents|sensory system agents|mesh-ancestor
138662826|NCT06186921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138662827|NCT06186921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138662829|NCT06186921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662830|NCT06186921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138662831|NCT06186921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662832|NCT06186921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662833|NCT06186895|Fentanyl|fentanyl|mesh-list
138662834|NCT06186895|Dexmedetomidine|dexmedetomidine|mesh-list
138662835|NCT06186895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138662836|NCT06186895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662837|NCT06186895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662838|NCT06186895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313849|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138313850|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138662839|NCT06186895|Analgesics|analgesics|mesh-ancestor
138662840|NCT06186895|Sensory System Agents|sensory system agents|mesh-ancestor
138662841|NCT06186895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313851|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662842|NCT06186895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138662843|NCT06186895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138662844|NCT06186895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138662845|NCT06186895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138662847|NCT06186895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662848|NCT06186895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138662850|NCT06186895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138662851|NCT06186895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138662852|NCT06186895|Anesthetics, General|anesthetics, general|mesh-ancestor
138662853|NCT06186895|Anesthetics|anesthetics|mesh-ancestor
138662854|NCT06186700|Cyclophosphamide|cyclophosphamide|mesh-list
138662855|NCT06186700|Doxorubicin|doxorubicin|mesh-list
138662856|NCT06186700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138662857|NCT06186700|Pentoxifylline|pentoxifylline|mesh-list
138662858|NCT06186700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138662859|NCT06186700|Immunologic Factors|immunologic factors|mesh-ancestor
138662860|NCT06186700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662861|NCT06186700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138285508|NCT00375440|Coagulants|coagulants|mesh-ancestor
138662862|NCT06186700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138662863|NCT06186700|Alkylating Agents|alkylating agents|mesh-ancestor
138662864|NCT06186700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662865|NCT06186700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662866|NCT06186700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138662867|NCT06186700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138662868|NCT06186700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138662869|NCT06186700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138662870|NCT06186700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662871|NCT06186700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138662872|NCT06186700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138662873|NCT06186700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138339632|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662874|NCT06186700|Protective Agents|protective agents|mesh-ancestor
138196343|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138662875|NCT06186700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138662876|NCT06186700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138662877|NCT06186700|Antioxidants|antioxidants|mesh-ancestor
138662878|NCT06186648|Obinutuzumab|obinutuzumab|mesh-list
138662879|NCT06186648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662880|NCT06186648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662881|NCT06186609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138662882|NCT06186609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662883|NCT06186609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662884|NCT06186609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662885|NCT06186596|Triamcinolone|triamcinolone|mesh-list
138196396|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
138662889|NCT06186596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662890|NCT06186596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662891|NCT06186440|Temozolomide|temozolomide|mesh-list
138662892|NCT06186440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662893|NCT06186440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138313874|NCT01769508|Fluorouracil|fluorouracil|mesh-list
138662894|NCT06186440|Alkylating Agents|alkylating agents|mesh-ancestor
138662895|NCT06186440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662896|NCT06186388|TEMPO|tempo|mesh-list
138662897|NCT06186388|Antioxidants|antioxidants|mesh-ancestor
138662898|NCT06186388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662899|NCT06186388|Protective Agents|protective agents|mesh-ancestor
138662900|NCT06186388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662901|NCT06186219|Rituximab|rituximab|mesh-list
138662902|NCT06186219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662903|NCT06186219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662904|NCT06186219|Immunologic Factors|immunologic factors|mesh-ancestor
138662905|NCT06186219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662906|NCT06186219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662907|NCT06185933|Lidocaine|lidocaine|mesh-list
138662908|NCT06185933|Anesthetics, Local|anesthetics, local|mesh-ancestor
138662909|NCT06185933|Anesthetics|anesthetics|mesh-ancestor
138662910|NCT06185933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662911|NCT06185933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662912|NCT06185933|Sensory System Agents|sensory system agents|mesh-ancestor
138662913|NCT06185933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662914|NCT06185933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138662915|NCT06185933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138662916|NCT06185933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138662917|NCT06185933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662918|NCT06185933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662919|NCT06185179|Metformin|metformin|mesh-list
138662920|NCT06185179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138662921|NCT06185179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662922|NCT06184282|Lidocaine|lidocaine|mesh-list
138662923|NCT06184282|Anesthetics, Local|anesthetics, local|mesh-ancestor
138662924|NCT06184282|Anesthetics|anesthetics|mesh-ancestor
138662925|NCT06184282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138662926|NCT06184282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662927|NCT06184282|Sensory System Agents|sensory system agents|mesh-ancestor
138662928|NCT06184282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662929|NCT06184282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138662930|NCT06184282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138662931|NCT06184282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138662932|NCT06184282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138662933|NCT06184282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662934|NCT06184204|Rivaroxaban|rivaroxaban|mesh-list
138662935|NCT06184204|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138662936|NCT06184204|Antithrombins|antithrombins|mesh-ancestor
138662937|NCT06184204|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138662938|NCT06184204|Protease Inhibitors|protease inhibitors|mesh-ancestor
138662939|NCT06184204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662940|NCT06184204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662941|NCT06184204|Anticoagulants|anticoagulants|mesh-ancestor
138196638|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
138662943|NCT06182267|Fluorides|fluorides|mesh-list
138662944|NCT06182267|Sodium Fluoride|sodium fluoride|mesh-list
138313896|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313897|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
138662945|NCT06182267|Cariostatic Agents|cariostatic agents|mesh-ancestor
138662946|NCT06182267|Protective Agents|protective agents|mesh-ancestor
138662947|NCT06182267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662948|NCT06182267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138662949|NCT06182267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662950|NCT06179030|Dexamethasone|dexamethasone|mesh-list
138662951|NCT06179030|Ranibizumab|ranibizumab|mesh-list
138662952|NCT06179030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662953|NCT06179030|Antiemetics|antiemetics|mesh-ancestor
138662954|NCT06179030|Autonomic Agents|autonomic agents|mesh-ancestor
138662955|NCT06179030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662956|NCT06179030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662957|NCT06179030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662958|NCT06179030|Glucocorticoids|glucocorticoids|mesh-ancestor
138662960|NCT06179030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662961|NCT06179030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662962|NCT06179030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662963|NCT06179030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351238|NCT02017717|Ipilimumab|ipilimumab|mesh-list
138351239|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351240|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662964|NCT06179030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138662965|NCT06179030|Growth Substances|growth substances|mesh-ancestor
138662966|NCT06179030|Growth Inhibitors|growth inhibitors|mesh-ancestor
138662967|NCT06178367|Hyaluronic Acid|hyaluronic acid|mesh-list
138662968|NCT06178367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138662969|NCT06178367|Immunologic Factors|immunologic factors|mesh-ancestor
138662970|NCT06178367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662971|NCT06178367|Viscosupplements|viscosupplements|mesh-ancestor
138662972|NCT06178367|Protective Agents|protective agents|mesh-ancestor
138662973|NCT06174402|Fenofibrate|fenofibrate|mesh-list
138662974|NCT06174402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138662975|NCT06174402|Antimetabolites|antimetabolites|mesh-ancestor
138662976|NCT06174402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662977|NCT06174402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138662978|NCT06165900|Paclitaxel|paclitaxel|mesh-list
138662979|NCT06165900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138662980|NCT06165900|Carboplatin|carboplatin|mesh-list
138662981|NCT06165900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138662982|NCT06165900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662983|NCT06165900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138662984|NCT06165900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138662985|NCT06165900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138662986|NCT06165900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662987|NCT06161805|Esketamine|esketamine|mesh-list
138662988|NCT06161805|Antidepressive Agents|antidepressive agents|mesh-ancestor
138662989|NCT06161805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662990|NCT06157177|Oxazolidinones|oxazolidinones|mesh-list
138662991|NCT06157177|Metaxalone|metaxalone|mesh-list
138662992|NCT06157177|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138662993|NCT06157177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662994|NCT06157177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662995|NCT06157177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662996|NCT06157177|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138662997|NCT06157177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662998|NCT06157177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662999|NCT06153537|Insulin|insulin|mesh-list
138663000|NCT06153537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138663001|NCT06153537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663002|NCT06150144|Fluorouracil|fluorouracil|mesh-list
138663003|NCT06150144|Antimetabolites|antimetabolites|mesh-ancestor
138196813|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138663013|NCT06144099|Thrombin|thrombin|mesh-list
138663014|NCT06144099|Hemostatics|hemostatics|mesh-ancestor
138663015|NCT06144099|Coagulants|coagulants|mesh-ancestor
138663022|NCT06140966|Dexamethasone|dexamethasone|mesh-list
138663023|NCT06140966|Cyclophosphamide|cyclophosphamide|mesh-list
138663024|NCT06140966|Melphalan|melphalan|mesh-list
138663026|NCT06140966|Lenalidomide|lenalidomide|mesh-list
138663027|NCT06140966|Bortezomib|bortezomib|mesh-list
138663028|NCT06140966|Epirubicin|epirubicin|mesh-list
138663029|NCT06140966|Daratumumab|daratumumab|mesh-list
138663030|NCT06140966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663031|NCT06140966|Immunologic Factors|immunologic factors|mesh-ancestor
138663032|NCT06140966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663033|NCT06140966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663034|NCT06140966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138663035|NCT06140966|Alkylating Agents|alkylating agents|mesh-ancestor
138663036|NCT06140966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663037|NCT06140966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663038|NCT06140966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138663039|NCT06140966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663040|NCT06140966|Antiemetics|antiemetics|mesh-ancestor
138663041|NCT06140966|Autonomic Agents|autonomic agents|mesh-ancestor
138663042|NCT06140966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663043|NCT06140966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663044|NCT06140966|Glucocorticoids|glucocorticoids|mesh-ancestor
138663045|NCT06140966|Hormones|hormones|mesh-ancestor
138282883|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138663046|NCT06140966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663047|NCT06140966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663048|NCT06140966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138663049|NCT06140966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138663050|NCT06140966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138663051|NCT06140966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663052|NCT06140966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196900|NCT02749526|Tegafur|tegafur|mesh-list
138663053|NCT06140966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663055|NCT06140966|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663056|NCT06140966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138663057|NCT06139107|Letrozole|letrozole|mesh-list
138663058|NCT06139107|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138663059|NCT06139107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663060|NCT06139107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138663061|NCT06139107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663062|NCT06139107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663063|NCT06139107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138663064|NCT06139107|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663065|NCT06139107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663066|NCT06139107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663067|NCT06136832|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138663068|NCT06136832|Immunologic Factors|immunologic factors|mesh-ancestor
138663069|NCT06136832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663070|NCT06136455|Ethanol|ethanol|mesh-list
138663071|NCT06136455|Listerine|listerine|mesh-list
138663072|NCT06136455|Sodium Fluoride|sodium fluoride|mesh-list
138663073|NCT06136455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138663074|NCT06136455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196964|NCT05480280|Vitamins|vitamins|mesh-ancestor
138663075|NCT06136455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663076|NCT06136455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663077|NCT06136455|Cariostatic Agents|cariostatic agents|mesh-ancestor
138663078|NCT06136455|Protective Agents|protective agents|mesh-ancestor
138663079|NCT06133699|Methylene Blue|methylene blue|mesh-list
138663080|NCT06133699|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138663081|NCT06133699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663082|NCT06133699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663083|NCT06132126|Insulin|insulin|mesh-list
138663084|NCT06132126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313927|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138313928|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663085|NCT06132126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663086|NCT06118411|Upadacitinib|upadacitinib|mesh-list
138663087|NCT06118411|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138663088|NCT06118411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663090|NCT06118411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663091|NCT06118411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663092|NCT06117969|Tibolone|tibolone|mesh-list
138663093|NCT06117969|Androgen Antagonists|androgen antagonists|mesh-ancestor
138663094|NCT06117969|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663095|NCT06117969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663096|NCT06117969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663097|NCT06117969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138663098|NCT06117969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663099|NCT06117969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663100|NCT06117969|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138663101|NCT06117969|Anabolic Agents|anabolic agents|mesh-ancestor
138663102|NCT06117969|Hormones|hormones|mesh-ancestor
138663103|NCT06113341|Xultophy|xultophy|mesh-list
138663104|NCT06113341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138663105|NCT06113341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663106|NCT06113341|Incretins|incretins|mesh-ancestor
138663107|NCT06113341|Hormones|hormones|mesh-ancestor
138351247|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663108|NCT06113341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663109|NCT06110793|Lenvatinib|lenvatinib|mesh-list
138663110|NCT06110793|Fulvestrant|fulvestrant|mesh-list
138663111|NCT06110793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663112|NCT06110793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663113|NCT06110793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663114|NCT06110793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663115|NCT06110793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663116|NCT06110793|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138663117|NCT06110793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138663118|NCT06110793|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663119|NCT06110793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663120|NCT06110793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663122|NCT06101173|Immunologic Factors|immunologic factors|mesh-ancestor
138663124|NCT06097676|Gabapentin|gabapentin|mesh-list
138663125|NCT06097676|Alprazolam|alprazolam|mesh-list
138663126|NCT06097676|Analgesics|analgesics|mesh-ancestor
138663127|NCT06097676|Sensory System Agents|sensory system agents|mesh-ancestor
138663128|NCT06097676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663129|NCT06097676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663130|NCT06097676|Anticonvulsants|anticonvulsants|mesh-ancestor
138663131|NCT06097676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138663132|NCT06097676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138663133|NCT06097676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663134|NCT06097676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663135|NCT06097676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138663136|NCT06097676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138663137|NCT06097676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663138|NCT06097676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663140|NCT06097676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138663141|NCT06097676|GABA Modulators|gaba modulators|mesh-ancestor
138663142|NCT06097676|GABA Agents|gaba agents|mesh-ancestor
138313941|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313942|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663144|NCT06088030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663145|NCT06064097|Cisplatin|cisplatin|mesh-list
138663146|NCT06064097|Gemcitabine|gemcitabine|mesh-list
138663147|NCT06064097|Nivolumab|nivolumab|mesh-list
138663148|NCT06064097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663149|NCT06064097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663150|NCT06064097|Antimetabolites|antimetabolites|mesh-ancestor
138282884|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138663151|NCT06064097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663152|NCT06064097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663153|NCT06064097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663155|NCT06057038|Pembrolizumab|pembrolizumab|mesh-list
138663156|NCT06057038|Fluorouracil|fluorouracil|mesh-list
138663157|NCT06057038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663158|NCT06057038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663159|NCT06057038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663160|NCT06057038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663161|NCT06057038|Antimetabolites|antimetabolites|mesh-ancestor
138663162|NCT06057038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663163|NCT06057038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663165|NCT06057038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663166|NCT06056245|Methadone|methadone|mesh-list
138663167|NCT06056245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138663168|NCT06056245|Narcotics|narcotics|mesh-ancestor
138663169|NCT06056245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339937|NCT01460940|Panobinostat|panobinostat|mesh-list
138663170|NCT06056245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663171|NCT06056245|Analgesics|analgesics|mesh-ancestor
138663172|NCT06056245|Sensory System Agents|sensory system agents|mesh-ancestor
138663173|NCT06056245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663174|NCT06056245|Antitussive Agents|antitussive agents|mesh-ancestor
138663175|NCT06056245|Respiratory System Agents|respiratory system agents|mesh-ancestor
138663176|NCT06053281|Vitamin D|vitamin d|mesh-list
138663177|NCT06053281|Cholecalciferol|cholecalciferol|mesh-list
138663178|NCT06053281|Vitamins|vitamins|mesh-ancestor
138663179|NCT06053281|Micronutrients|micronutrients|mesh-ancestor
138663180|NCT06053281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663181|NCT06053281|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138663182|NCT06053281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138663183|NCT06048133|Gemcitabine|gemcitabine|mesh-list
138663184|NCT06048133|Quemliclustat|quemliclustat|mesh-list
138663185|NCT06048133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663186|NCT06048133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663187|NCT06048133|Antimetabolites|antimetabolites|mesh-ancestor
138663188|NCT06048133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663189|NCT06048133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663190|NCT06048133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663191|NCT06046274|Pembrolizumab|pembrolizumab|mesh-list
138663192|NCT06046274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663193|NCT06046274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663194|NCT06046274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138197234|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663196|NCT06041204|Letrozole|letrozole|mesh-list
138663197|NCT06041204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663198|NCT06041204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138663199|NCT06041204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138663200|NCT06041204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663201|NCT06041204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663202|NCT06041204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138313960|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138663203|NCT06041204|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663204|NCT06041204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663205|NCT06041204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663206|NCT06041048|Modafinil|modafinil|mesh-list
138663207|NCT06041048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138663208|NCT06041048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663209|NCT06041048|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138663210|NCT06041048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138663211|NCT06041048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138663212|NCT06041048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663213|NCT06028438|Certolizumab Pegol|certolizumab pegol|mesh-list
138663214|NCT06028438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138663215|NCT06028438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663216|NCT06028438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663217|NCT06028438|Immunologic Factors|immunologic factors|mesh-ancestor
138663218|NCT06028438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663219|NCT06028438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663220|NCT06010628|Tenecteplase|tenecteplase|mesh-list
138663221|NCT06010628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138663222|NCT06010628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663223|NCT06010628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663224|NCT06005480|Prilocaine|prilocaine|mesh-list
138663225|NCT06005480|Mepivacaine|mepivacaine|mesh-list
138663226|NCT06005480|Anesthetics, Local|anesthetics, local|mesh-ancestor
138663227|NCT06005480|Anesthetics|anesthetics|mesh-ancestor
138663228|NCT06005480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663229|NCT06005480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663230|NCT06005480|Sensory System Agents|sensory system agents|mesh-ancestor
138663231|NCT06005480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663232|NCT06003218|Dexmedetomidine|dexmedetomidine|mesh-list
138663233|NCT06003218|Remifentanil|remifentanil|mesh-list
138663234|NCT06003218|Oxycodone|oxycodone|mesh-list
138663235|NCT06003218|Esketamine|esketamine|mesh-list
138663236|NCT06003218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138663237|NCT06003218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663238|NCT06003218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663239|NCT06003218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663240|NCT06003218|Analgesics|analgesics|mesh-ancestor
138663241|NCT06003218|Sensory System Agents|sensory system agents|mesh-ancestor
138663242|NCT06003218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663243|NCT06003218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138663244|NCT06003218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138663245|NCT06003218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138663246|NCT06003218|Adrenergic Agents|adrenergic agents|mesh-ancestor
138340011|NCT01478256|Erythromycin|erythromycin|mesh-list
138663247|NCT06003218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663248|NCT06003218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663250|NCT06003218|Narcotics|narcotics|mesh-ancestor
138663251|NCT06003218|Antidepressive Agents|antidepressive agents|mesh-ancestor
138663252|NCT06003218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663253|NCT06002607|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138313975|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663258|NCT05981118|Betamethasone Valerate|betamethasone valerate|mesh-list
138663259|NCT05981118|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138663260|NCT05981118|Betamethasone benzoate|betamethasone benzoate|mesh-list
138663261|NCT05981118|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138663262|NCT05981118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663263|NCT05981118|Glucocorticoids|glucocorticoids|mesh-ancestor
138663265|NCT05981118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663266|NCT05981118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663267|NCT05981118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138663268|NCT05981118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138663269|NCT05956769|Tranexamic Acid|tranexamic acid|mesh-list
138663270|NCT05956769|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138663271|NCT05956769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663272|NCT05956769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663273|NCT05956769|Hemostatics|hemostatics|mesh-ancestor
138663274|NCT05956769|Coagulants|coagulants|mesh-ancestor
138663280|NCT05931601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138663281|NCT05931601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138663282|NCT05931601|Adrenergic Agents|adrenergic agents|mesh-ancestor
138663283|NCT05931601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663284|NCT05931601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663285|NCT05931601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663286|NCT05931601|Sympathomimetics|sympathomimetics|mesh-ancestor
138663287|NCT05931601|Autonomic Agents|autonomic agents|mesh-ancestor
138663288|NCT05931601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663289|NCT05931601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138663290|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
138663291|NCT05918029|Diuretics|diuretics|mesh-ancestor
138663292|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
138663293|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663294|NCT05918029|Expectorants|expectorants|mesh-ancestor
138663295|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
138663296|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138663297|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663298|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663300|NCT05896839|Prednisone|prednisone|mesh-list
138663301|NCT05896839|Cortisone|cortisone|mesh-list
138663302|NCT05896839|Nivolumab|nivolumab|mesh-list
138663303|NCT05896839|Ipilimumab|ipilimumab|mesh-list
138663304|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663305|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
138663306|NCT05896839|Hormones|hormones|mesh-ancestor
138663307|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663308|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663309|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663310|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313999|NCT01766778|Vildagliptin|vildagliptin|mesh-list
138663311|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663312|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663313|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663314|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138663315|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663316|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138663317|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
138663318|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663319|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
138663320|NCT05891093|Tamoxifen|tamoxifen|mesh-list
138663321|NCT05891093|Toremifene|toremifene|mesh-list
138663322|NCT05891093|Letrozole|letrozole|mesh-list
138663323|NCT05891093|Anastrozole|anastrozole|mesh-list
138663325|NCT05891093|Fluzoparib|fluzoparib|mesh-list
138663326|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663327|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138663328|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138663329|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663330|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663331|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138663332|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663333|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663334|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663335|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663336|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138663337|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138663338|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138663339|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138663340|NCT05889793|Emetine|emetine|mesh-list
138663341|NCT05889793|Amebicides|amebicides|mesh-ancestor
138663342|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138663343|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138663344|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663345|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
138663346|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
138663347|NCT05889793|Cathartics|cathartics|mesh-ancestor
138663348|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663349|NCT05889793|Emetics|emetics|mesh-ancestor
138663350|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663351|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
138663352|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663353|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138663354|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663355|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663356|NCT05884398|Androgens|androgens|mesh-list
138663357|NCT05884398|Hormones|hormones|mesh-ancestor
138663358|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197511|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197512|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663359|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663360|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138663361|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138663362|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663363|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663364|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138663365|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663366|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663367|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663369|NCT05878691|Atezolizumab|atezolizumab|mesh-list
138314029|NCT01766310|Vitamins|vitamins|mesh-ancestor
138663370|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663371|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663372|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663373|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663374|NCT05868122|Acetaminophen|acetaminophen|mesh-list
138663375|NCT05868122|Naproxen|naproxen|mesh-list
138663376|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663377|NCT05868122|Analgesics|analgesics|mesh-ancestor
138663378|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
138663379|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663380|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663381|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
138663384|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663385|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
138663386|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138663387|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663388|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663389|NCT05859477|Capecitabine|capecitabine|mesh-list
138663390|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
138663391|NCT05859477|Nivolumab|nivolumab|mesh-list
138663392|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663393|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
138663394|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663395|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663396|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663397|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663399|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663400|NCT05851924|Capecitabine|capecitabine|mesh-list
138663401|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663402|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
138197617|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663403|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663404|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663407|NCT05850546|Rituximab|rituximab|mesh-list
138663408|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663409|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663410|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
138663411|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663412|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663413|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663414|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
138663415|NCT05850546|Hormones|hormones|mesh-ancestor
138663416|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663417|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663418|NCT05845008|Acetaminophen|acetaminophen|mesh-list
138314035|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663419|NCT05845008|Naproxen|naproxen|mesh-list
138663420|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663421|NCT05845008|Analgesics|analgesics|mesh-ancestor
138663422|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
138663424|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663425|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
138663426|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663427|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663428|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663429|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
138663430|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138663431|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663432|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663433|NCT05844995|Acetaminophen|acetaminophen|mesh-list
138663434|NCT05844995|Naproxen|naproxen|mesh-list
138663435|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663436|NCT05844995|Analgesics|analgesics|mesh-ancestor
138663437|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
138663438|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663439|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663440|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
138286057|NCT03219866|Budesonide|budesonide|mesh-list
138663441|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663442|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663443|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663444|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
138663445|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138197724|NCT00002014|Didanosine|didanosine|mesh-list
138197725|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
138197726|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197727|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197728|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197729|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197730|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
138197731|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197732|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138663446|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663447|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663448|NCT05841290|Anesthetics|anesthetics|mesh-list
138663449|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663450|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663451|NCT05825963|Psyllium|psyllium|mesh-list
138663452|NCT05825963|Cathartics|cathartics|mesh-ancestor
138663453|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663454|NCT05823480|Azacitidine|azacitidine|mesh-list
138663455|NCT05823480|Magrolimab|magrolimab|mesh-list
138663456|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663457|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
138663458|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663459|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663460|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663461|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663462|NCT05811351|Prednisone|prednisone|mesh-list
138663463|NCT05811351|Triamcinolone|triamcinolone|mesh-list
138663464|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663465|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
138663466|NCT05811351|Hormones|hormones|mesh-ancestor
138197766|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197767|NCT00002032|Rifabutin|rifabutin|mesh-list
138197768|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138197769|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197770|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138197771|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
138197772|NCT01229527|Meperidine|meperidine|mesh-list
138197799|NCT00000358|Lofexidine|lofexidine|mesh-list
138663467|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663468|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663469|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663470|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340235|NCT01532700|Ofatumumab|ofatumumab|mesh-list
138663471|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
138663472|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138663473|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663474|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663477|NCT05784246|Mirikizumab|mirikizumab|mesh-list
138663478|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663479|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663480|NCT05784246|Analgesics|analgesics|mesh-ancestor
138663481|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
138663482|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663483|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663484|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663485|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138197814|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138197823|NCT02143388|Cisplatin|cisplatin|mesh-list
138663486|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138663487|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663488|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
138663489|NCT05782361|Tepotinib|tepotinib|mesh-list
138663490|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663491|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663492|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663493|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663494|NCT05768711|Venetoclax|venetoclax|mesh-list
138663495|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663496|NCT05765851|Trastuzumab|trastuzumab|mesh-list
138663497|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138663498|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663499|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663500|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
138663502|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663503|NCT05761574|Acetaminophen|acetaminophen|mesh-list
138663504|NCT05761574|Naproxen|naproxen|mesh-list
138663505|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663506|NCT05761574|Analgesics|analgesics|mesh-ancestor
138663507|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
138663508|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663509|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314089|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314090|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
138663510|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
138314091|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314092|NCT01762800|Fluticasone|fluticasone|mesh-list
138663511|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663512|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663513|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663514|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
138663515|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138663516|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663517|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663518|NCT05757869|Apixaban|apixaban|mesh-list
138663519|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138663520|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
138663521|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138663522|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
138663523|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663524|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663525|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
138663526|NCT05756621|Topiramate|topiramate|mesh-list
138663527|NCT05756621|Lacosamide|lacosamide|mesh-list
138663528|NCT05756621|Phenytoin|phenytoin|mesh-list
138663529|NCT05756621|Midazolam|midazolam|mesh-list
138663530|NCT05756621|Ketamine|ketamine|mesh-list
138663531|NCT05756621|Levetiracetam|levetiracetam|mesh-list
138663532|NCT05756621|Thiopental|thiopental|mesh-list
138663533|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
138663534|NCT05756621|Propofol|propofol|mesh-list
138663535|NCT05756621|Anesthetics|anesthetics|mesh-list
138663536|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138663537|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663538|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663539|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138663540|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
138663541|NCT05756621|Analgesics|analgesics|mesh-ancestor
138663542|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
138663543|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663544|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138663545|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138663546|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138663547|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663548|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663550|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138663551|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138663552|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663554|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
138663555|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138663556|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
138663557|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138663558|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138663559|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138663560|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138663561|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138663562|NCT05731492|Macitentan|macitentan|mesh-list
138663563|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138663564|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138663565|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663566|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138314109|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
138663567|NCT05730712|Trastuzumab|trastuzumab|mesh-list
138663569|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314110|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314113|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138663570|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663571|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138663572|NCT05728333|Tirofiban|tirofiban|mesh-list
138663573|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138663574|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663575|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663576|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138663577|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
138663578|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663579|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138663580|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138663581|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
138663582|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663583|NCT05723562|Dostarlimab|dostarlimab|mesh-list
138663584|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663585|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138663586|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138663587|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663588|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
138663589|NCT05698407|Sufentanil|sufentanil|mesh-list
138663590|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
138663591|NCT05698407|Dsuvia|dsuvia|mesh-list
138663592|NCT05698407|Ropivacaine|ropivacaine|mesh-list
138663593|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138663594|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663595|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663596|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663597|NCT05698407|Analgesics|analgesics|mesh-ancestor
138663599|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663600|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138663601|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138663602|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138663603|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138663604|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663605|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663606|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
138663608|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138663609|NCT05698407|Narcotics|narcotics|mesh-ancestor
138663610|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138663611|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138663612|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
138663613|NCT05694013|Atezolizumab|atezolizumab|mesh-list
138663614|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663615|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663616|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351261|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663617|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286242|NCT04332536|Codeine|codeine|mesh-list
138663619|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
138663620|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
138663621|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663622|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314126|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138314127|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138314140|NCT01777854|Omeprazole|omeprazole|mesh-list
138663623|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
138663624|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663625|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138663626|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138663627|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138663628|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138663629|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663632|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663633|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663634|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663635|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663636|NCT05676112|Analgesics|analgesics|mesh-ancestor
138663637|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
138663638|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663639|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663640|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663641|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663642|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663643|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663645|NCT05672342|Cannabidiol|cannabidiol|mesh-list
138663646|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
138663647|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
138663648|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663649|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663650|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663651|NCT05672342|Analgesics|analgesics|mesh-ancestor
138663653|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663654|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138663655|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138663656|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663657|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663658|NCT05672342|Hormones|hormones|mesh-ancestor
138663659|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663660|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
138663661|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663662|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663663|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663664|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663665|NCT05663866|Dexamethasone|dexamethasone|mesh-list
138663666|NCT05663866|Methotrexate|methotrexate|mesh-list
138663667|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138663668|NCT05663866|Montelukast|montelukast|mesh-list
138663669|NCT05663866|Lazertinib|lazertinib|mesh-list
138198208|NCT01151761|Capecitabine|capecitabine|mesh-list
138663671|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
138314148|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138314149|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138314157|NCT01777542|Insulin|insulin|mesh-list
138663672|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
138663673|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663674|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663675|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663676|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
138663678|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663679|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663680|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663681|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138663682|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
138663683|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138663684|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663685|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
138663686|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663687|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
138663689|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138663690|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663691|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
138663692|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663693|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138663694|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138663695|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138663696|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138663697|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
138663698|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138663699|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138663700|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663701|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663703|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
138198292|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198298|NCT00000574|Ibuprofen|ibuprofen|mesh-list
138663704|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663705|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663706|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663707|NCT05660967|Growth Substances|growth substances|mesh-ancestor
138663708|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663709|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663711|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138663712|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314176|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
138314178|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663724|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663725|NCT05641246|Diclofenac|diclofenac|mesh-list
138663726|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663727|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663728|NCT05641246|Analgesics|analgesics|mesh-ancestor
138663729|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
138198360|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198378|NCT00001504|Tretinoin|tretinoin|mesh-list
138663731|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663732|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663733|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663734|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138663735|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663736|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663737|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138663738|NCT05638295|Panitumumab|panitumumab|mesh-list
138663739|NCT05638295|Sotorasib|sotorasib|mesh-list
138663740|NCT05638295|Antibodies|antibodies|mesh-list
138663741|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
138663742|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138663743|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
138663744|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663745|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663746|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663747|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663748|NCT05609565|Bupivacaine|bupivacaine|mesh-list
138663749|NCT05609565|Prilocaine|prilocaine|mesh-list
138663750|NCT05609565|Anesthetics|anesthetics|mesh-list
138663751|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
138663752|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663753|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663754|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
138663755|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663756|NCT05601492|Thalidomide|thalidomide|mesh-list
138663757|NCT05601492|Apremilast|apremilast|mesh-list
138663758|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663759|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663760|NCT05601492|Analgesics|analgesics|mesh-ancestor
138314209|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314210|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314211|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
138314219|NCT01732770|Denosumab|denosumab|mesh-list
138663761|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
138663762|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663763|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663764|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663765|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663766|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138663767|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138663768|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663769|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198415|NCT00002122|Azithromycin|azithromycin|mesh-list
138663770|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663771|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
138663772|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
138663773|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138663774|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663775|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663776|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663777|NCT05601492|Growth Substances|growth substances|mesh-ancestor
138663778|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663779|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663781|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138663782|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663783|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138663784|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
138663785|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138663786|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
138663787|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138663788|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663789|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138663790|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663791|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663792|NCT05582434|Clindamycin|clindamycin|mesh-list
138663793|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
138663794|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
138663796|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138663798|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663799|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138663800|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663801|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663802|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
138663803|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663804|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663805|NCT05582434|Analgesics|analgesics|mesh-ancestor
138663806|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
138314232|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663807|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314233|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314234|NCT01755702|Analgesics|analgesics|mesh-ancestor
138314235|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
138314236|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663808|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663809|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663810|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663811|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
138663812|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138663813|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
138663814|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663816|NCT05575063|Protective Agents|protective agents|mesh-ancestor
138663817|NCT05572515|Dexamethasone|dexamethasone|mesh-list
138198489|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663819|NCT05572515|Pomalidomide|pomalidomide|mesh-list
138663820|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663821|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
138663822|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
138663824|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663825|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663826|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
138663827|NCT05572515|Hormones|hormones|mesh-ancestor
138663828|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663829|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663830|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663831|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
138663832|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663833|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663834|NCT05572515|Growth Substances|growth substances|mesh-ancestor
138663835|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663836|NCT05571644|Leucovorin|leucovorin|mesh-list
138663837|NCT05571644|Fluorouracil|fluorouracil|mesh-list
138663838|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
138663839|NCT05571644|Irinotecan|irinotecan|mesh-list
138663840|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
138663841|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
138663842|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663843|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663844|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663845|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663846|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
138663847|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663848|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138663849|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138663850|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663851|NCT05571644|Antidotes|antidotes|mesh-ancestor
138663852|NCT05571644|Protective Agents|protective agents|mesh-ancestor
138663853|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
138663854|NCT05571644|Vitamins|vitamins|mesh-ancestor
138663855|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
138663856|NCT05564052|Rituximab|rituximab|mesh-list
138663857|NCT05564052|Lenalidomide|lenalidomide|mesh-list
138663858|NCT05564052|Bortezomib|bortezomib|mesh-list
138663859|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663860|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663861|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
138663862|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314256|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663863|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138663864|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663865|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663866|NCT05564052|Growth Substances|growth substances|mesh-ancestor
138663867|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663868|NCT05563961|Acetaminophen|acetaminophen|mesh-list
138663869|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138663870|NCT05563961|Analgesics|analgesics|mesh-ancestor
138663871|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
138663873|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663874|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
138663875|NCT05552222|Dexamethasone|dexamethasone|mesh-list
138663876|NCT05552222|Lenalidomide|lenalidomide|mesh-list
138663877|NCT05552222|Daratumumab|daratumumab|mesh-list
138663878|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663879|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
138663880|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
138663881|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663882|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663883|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663884|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
138663885|NCT05552222|Hormones|hormones|mesh-ancestor
138663886|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663887|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138663888|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663889|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
138663890|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663891|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663892|NCT05552222|Growth Substances|growth substances|mesh-ancestor
138663893|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663895|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138663896|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663897|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
138663898|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663899|NCT05545137|Fosfomycin|fosfomycin|mesh-list
138663900|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
138663901|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138663902|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663903|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138663904|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138663905|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
138663906|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138663907|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138663908|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663909|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663910|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663911|NCT05538910|Nicotine|nicotine|mesh-list
138663912|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138663913|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
138663914|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663915|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663916|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138314280|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314281|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663917|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138663918|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
138663919|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138663920|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663921|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138663922|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
138663923|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663925|NCT05521087|Dexamethasone|dexamethasone|mesh-list
138663927|NCT05521087|Vincristine|vincristine|mesh-list
138663928|NCT05521087|Pegaspargase|pegaspargase|mesh-list
138663929|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663930|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
138663931|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
138663932|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663933|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663934|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138663935|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
138663936|NCT05521087|Hormones|hormones|mesh-ancestor
138663937|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138663938|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286557|NCT03383588|Fentanyl|fentanyl|mesh-list
138663939|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663940|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663941|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
138663942|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663943|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663944|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
138663946|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663947|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138663948|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138663949|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138663950|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138663952|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138663953|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663954|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
138663955|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663956|NCT05511246|Ethanol|ethanol|mesh-list
138663957|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138663958|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663959|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138663960|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663961|NCT05498428|Carboplatin|carboplatin|mesh-list
138663962|NCT05498428|Pemetrexed|pemetrexed|mesh-list
138663963|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138663964|NCT05498428|Heparin|heparin|mesh-list
138663965|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138663967|NCT05498428|Dalteparin|dalteparin|mesh-list
138663968|NCT05498428|Anticoagulants|anticoagulants|mesh-list
138663969|NCT05498428|Lazertinib|lazertinib|mesh-list
138314301|NCT01755234|Sevoflurane|sevoflurane|mesh-list
138314302|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138663970|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663971|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663972|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663973|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138663974|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138663975|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138663976|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663977|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663978|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663980|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663981|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663982|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138663983|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663984|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138663985|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663986|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663987|NCT05476926|Ranibizumab|ranibizumab|mesh-list
138663988|NCT05476926|Faricimab|faricimab|mesh-list
138663989|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663990|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138663991|NCT05476926|Growth Substances|growth substances|mesh-ancestor
138663992|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663993|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
138663994|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663995|NCT05468242|Bevacizumab|bevacizumab|mesh-list
138663996|NCT05468242|Tislelizumab|tislelizumab|mesh-list
138663997|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138663998|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663999|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664000|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138340758|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138664001|NCT05468242|Growth Substances|growth substances|mesh-ancestor
138286617|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
138664002|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664003|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664004|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138664005|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
138664006|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138664007|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
138664008|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138664009|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664010|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138314329|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664011|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664012|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664014|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138664015|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664016|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
138664017|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664018|NCT05455320|Dexamethasone|dexamethasone|mesh-list
138664019|NCT05455320|Daratumumab|daratumumab|mesh-list
138664020|NCT05455320|Pomalidomide|pomalidomide|mesh-list
138664021|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664022|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
138664023|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
138664024|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664025|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664026|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664027|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
138664028|NCT05455320|Hormones|hormones|mesh-ancestor
138664029|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664030|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664031|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664032|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
138664033|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664034|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664035|NCT05455320|Growth Substances|growth substances|mesh-ancestor
138664036|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664037|NCT05454709|Glucagon|glucagon|mesh-list
138664038|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664039|NCT05454709|Hormones|hormones|mesh-ancestor
138664040|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664041|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664042|NCT05453903|Cytarabine|cytarabine|mesh-list
138664043|NCT05453903|Azacitidine|azacitidine|mesh-list
138664044|NCT05453903|Daunorubicin|daunorubicin|mesh-list
138664045|NCT05453903|Venetoclax|venetoclax|mesh-list
138664046|NCT05453903|Idarubicin|idarubicin|mesh-list
138664048|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
138286659|NCT03398330|Oxycodone|oxycodone|mesh-list
138664049|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664050|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664051|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
138664052|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664053|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664054|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
138314359|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138664055|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314360|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138664056|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664057|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138664058|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664059|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138198929|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
138198930|NCT00002194|Nevirapine|nevirapine|mesh-list
138664061|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664062|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664063|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664064|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664065|NCT05438043|Dexamethasone|dexamethasone|mesh-list
138664066|NCT05438043|Lenalidomide|lenalidomide|mesh-list
138664067|NCT05438043|Daratumumab|daratumumab|mesh-list
138664068|NCT05438043|Pomalidomide|pomalidomide|mesh-list
138664069|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664070|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
138664071|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
138198991|NCT02403986|Lidocaine|lidocaine|mesh-list
138664072|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664073|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664074|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664075|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
138664076|NCT05438043|Hormones|hormones|mesh-ancestor
138704088|NCT06170788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664077|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664078|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664079|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664080|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
138664081|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664082|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664083|NCT05438043|Growth Substances|growth substances|mesh-ancestor
138664084|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664085|NCT05427162|Epoprostenol|epoprostenol|mesh-list
138664086|NCT05427162|Tezosentan|tezosentan|mesh-list
138199050|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
138664088|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138664089|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
138664090|NCT05417165|Vaccines|vaccines|mesh-list
138664091|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138664093|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664094|NCT05416333|Azelaic acid|azelaic acid|mesh-list
138664095|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664096|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664097|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
138664098|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664099|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
138664100|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664101|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664102|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138664103|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
138664104|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664105|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664106|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138664107|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138664109|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138664110|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664111|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314388|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
138314389|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138314390|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
138314391|NCT01706250|Salicylates|salicylates|mesh-list
138314392|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664112|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664113|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664114|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664115|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
138664116|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664117|NCT05388058|Cannabidiol|cannabidiol|mesh-list
138664118|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
138664119|NCT05379595|Leucovorin|leucovorin|mesh-list
138664120|NCT05379595|Fluorouracil|fluorouracil|mesh-list
138664121|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
138664122|NCT05379595|Irinotecan|irinotecan|mesh-list
138664123|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138664124|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
138664125|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664126|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664127|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664128|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664129|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
138664130|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664131|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138664132|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664133|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199165|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138664134|NCT05379595|Antidotes|antidotes|mesh-ancestor
138664135|NCT05379595|Protective Agents|protective agents|mesh-ancestor
138664136|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
138664137|NCT05379595|Vitamins|vitamins|mesh-ancestor
138664138|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
138664139|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664140|NCT05370911|Psilocybin|psilocybin|mesh-list
138664141|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
138664142|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664143|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138664144|NCT05351385|Dimercaprol|dimercaprol|mesh-list
138664145|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
138664146|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
138664147|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664148|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138664149|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664150|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664151|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664152|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
138664153|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
138664154|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138664155|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138664156|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
138664157|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664158|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664159|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664160|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
138664161|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
138664162|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664163|NCT05253053|Paclitaxel|paclitaxel|mesh-list
138664164|NCT05253053|Atezolizumab|atezolizumab|mesh-list
138314405|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314406|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314408|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138314409|NCT01729728|Narcotics|narcotics|mesh-ancestor
138664165|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664166|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664167|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138664168|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664169|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282885|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138664170|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664172|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664174|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664175|NCT05250973|Dexamethasone|dexamethasone|mesh-list
138664176|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
138664177|NCT05250973|Bortezomib|bortezomib|mesh-list
138664178|NCT05250973|Daratumumab|daratumumab|mesh-list
138664179|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664180|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
138664181|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664182|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664183|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138664184|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
138664185|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664186|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664187|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138664188|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664189|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
138664190|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
138664191|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664192|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664193|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
138664194|NCT05250973|Hormones|hormones|mesh-ancestor
138664195|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664196|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664197|NCT05242484|Golimumab|golimumab|mesh-list
138664198|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138664199|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664200|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664201|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
138664202|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664203|NCT05242471|Golimumab|golimumab|mesh-list
138664204|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138199256|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199257|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664206|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664207|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
138664208|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664209|NCT05236673|Empagliflozin|empagliflozin|mesh-list
138664210|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138664211|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664212|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138664213|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664214|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138664215|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
138664216|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664219|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664220|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
138664221|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664222|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
138664223|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664224|NCT05185089|Maleic acid|maleic acid|mesh-list
138664225|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314424|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
138314425|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314426|NCT01728246|Acetaminophen|acetaminophen|mesh-list
138340985|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
138664226|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664227|NCT05181735|Luspatercept|luspatercept|mesh-list
138664228|NCT05181735|Hematinics|hematinics|mesh-ancestor
138664229|NCT05180474|Antibodies|antibodies|mesh-list
138664230|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138664231|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
138664232|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664233|NCT05179876|Selexipag|selexipag|mesh-list
138664234|NCT05179876|Tadalafil|tadalafil|mesh-list
138664235|NCT05179876|Macitentan|macitentan|mesh-list
138664236|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
138664237|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138664239|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664240|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664241|NCT05179876|Urological Agents|urological agents|mesh-ancestor
138664242|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138664243|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138664244|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138664245|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138664246|NCT05175131|Mebeverine|mebeverine|mesh-list
138664247|NCT05175131|Simethicone|simethicone|mesh-list
138664248|NCT05175131|Alverine|alverine|mesh-list
138664249|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
138664250|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664251|NCT05175131|Emollients|emollients|mesh-ancestor
138664252|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664253|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
138664254|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
138664255|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
138664256|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664257|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664258|NCT05167825|Macitentan|macitentan|mesh-list
138664259|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138664260|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138351278|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351279|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138351280|NCT00942331|Growth Substances|growth substances|mesh-ancestor
138664261|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664262|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138664263|NCT05162976|Nivolumab|nivolumab|mesh-list
138664264|NCT05162976|Azacitidine|azacitidine|mesh-list
138199419|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138664265|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664266|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664267|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138314438|NCT04414020|Progestins|progestins|mesh-ancestor
138314439|NCT04414020|Hormones|hormones|mesh-ancestor
138314440|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314441|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664268|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314442|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138314443|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138664269|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664270|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
138664271|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664272|NCT05151640|Nintedanib|nintedanib|mesh-list
138664273|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664274|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664275|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286865|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
138664276|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664277|NCT05139875|Triamcinolone|triamcinolone|mesh-list
138664278|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138664279|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138664280|NCT05139875|Betamethasone|betamethasone|mesh-list
138664281|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
138664282|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138664283|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
138664284|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
138664285|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138664286|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138664287|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664288|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
138664289|NCT05139875|Hormones|hormones|mesh-ancestor
138664290|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664291|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664292|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664293|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
138664294|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664295|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664296|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138664297|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
138314462|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314463|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138314464|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
138314465|NCT01703286|Incretins|incretins|mesh-ancestor
138314466|NCT01703286|Hormones|hormones|mesh-ancestor
138314467|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314468|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138314469|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
138314470|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314472|NCT01727700|Aripiprazole|aripiprazole|mesh-list
138664298|NCT05124210|Sotrovimab|sotrovimab|mesh-list
138664299|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
138664300|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341065|NCT04065399|Cobicistat|cobicistat|mesh-list
138664302|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
138664303|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664304|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138664305|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664306|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664307|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664308|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138664309|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138664310|NCT05112939|Cabotegravir|cabotegravir|mesh-list
138664311|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138664312|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138199539|NCT01421810|Dexamethasone|dexamethasone|mesh-list
138664313|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664314|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664315|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138664316|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138664317|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
138664318|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664320|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138664321|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664322|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664323|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664324|NCT05092269|Ustekinumab|ustekinumab|mesh-list
138664325|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664326|NCT05089604|Tacrolimus|tacrolimus|mesh-list
138664327|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199567|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
138664328|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
138664329|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664330|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138664331|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664332|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664333|NCT05083182|Ustekinumab|ustekinumab|mesh-list
138664334|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664335|NCT05083169|Dexamethasone|dexamethasone|mesh-list
138664336|NCT05083169|Bortezomib|bortezomib|mesh-list
138664337|NCT05083169|Daratumumab|daratumumab|mesh-list
138664338|NCT05083169|Pomalidomide|pomalidomide|mesh-list
138664339|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664340|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
138664341|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
138664342|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664343|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664344|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664345|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
138314494|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138314495|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314496|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314498|NCT01725126|Liraglutide|liraglutide|mesh-list
138314499|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138664346|NCT05083169|Hormones|hormones|mesh-ancestor
138664347|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664348|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199627|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138664349|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664350|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
138664351|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664352|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664353|NCT05083169|Growth Substances|growth substances|mesh-ancestor
138664354|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664355|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
138664356|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664357|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664358|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664359|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664360|NCT05071664|Golimumab|golimumab|mesh-list
138664361|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138664362|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664363|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664364|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
138664365|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664367|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138664368|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
138664369|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138664370|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199683|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199684|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
138199685|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138199686|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
138199687|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199688|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199689|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199690|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138664373|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
138664374|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138664375|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314519|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
138664376|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
138664377|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664378|NCT05056402|Vaccines|vaccines|mesh-list
138664379|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
138664380|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314520|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314521|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138314522|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138664381|NCT05054140|Calcium|calcium|mesh-list
138664382|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138664383|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664384|NCT05050097|Lenalidomide|lenalidomide|mesh-list
138664385|NCT05050097|Pomalidomide|pomalidomide|mesh-list
138664386|NCT05050097|Daratumumab|daratumumab|mesh-list
138664387|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
138664388|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664389|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664390|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664391|NCT05050097|Growth Substances|growth substances|mesh-ancestor
138664392|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664393|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664394|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
138664395|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664396|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664397|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664398|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664399|NCT05041062|Nivolumab|nivolumab|mesh-list
138664400|NCT05041062|Ipilimumab|ipilimumab|mesh-list
138664401|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664402|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664403|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664404|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664406|NCT05040126|Bedaquiline|bedaquiline|mesh-list
138664407|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286989|NCT00422773|Cetuximab|cetuximab|mesh-list
138664408|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664409|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138664411|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664412|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
138664413|NCT05029921|Ustekinumab|ustekinumab|mesh-list
138664414|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664415|NCT05013229|Insulin|insulin|mesh-list
138664416|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138664417|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
138664418|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
138664419|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138664420|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664421|NCT04992312|Glucagon|glucagon|mesh-list
138664422|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664423|NCT04992312|Hormones|hormones|mesh-ancestor
138664424|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664425|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664426|NCT04989218|Cisplatin|cisplatin|mesh-list
138664427|NCT04989218|Gemcitabine|gemcitabine|mesh-list
138664428|NCT04989218|Durvalumab|durvalumab|mesh-list
138664429|NCT04989218|Tremelimumab|tremelimumab|mesh-list
138664430|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664431|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664432|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
138664433|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664434|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664435|NCT04988295|Carboplatin|carboplatin|mesh-list
138664436|NCT04988295|Pemetrexed|pemetrexed|mesh-list
138664437|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138664438|NCT04988295|Lazertinib|lazertinib|mesh-list
138664439|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314548|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138199774|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664440|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314549|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
138314550|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314554|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
138664492|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
138664494|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
138314562|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664495|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138664496|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138664497|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138664498|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138664499|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
138664500|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664501|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664503|NCT04967417|Carboplatin|carboplatin|mesh-list
138664504|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
138664505|NCT04967417|Pemetrexed|pemetrexed|mesh-list
138664506|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664507|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664508|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138664509|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664510|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138664511|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664512|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664513|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664514|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664515|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138664516|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664517|NCT04963725|Ustekinumab|ustekinumab|mesh-list
138664518|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664519|NCT04940039|Risperidone|risperidone|mesh-list
138664520|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138664521|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138664522|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
138664523|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664524|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664525|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664526|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138664527|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138664528|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138664529|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138664530|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138664531|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
138664532|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138664533|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138664534|NCT04939662|Bevacizumab|bevacizumab|mesh-list
138664535|NCT04939662|Olaparib|olaparib|mesh-list
138664536|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664537|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664538|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664539|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664540|NCT04939662|Growth Substances|growth substances|mesh-ancestor
138664541|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664542|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664543|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138664544|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664545|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314581|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664546|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138314599|NCT01700946|Cytarabine|cytarabine|mesh-list
138664547|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138664548|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138664549|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664551|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664552|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664554|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
138664555|NCT04923893|Fludarabine|fludarabine|mesh-list
138664556|NCT04923893|Lenalidomide|lenalidomide|mesh-list
138664557|NCT04923893|Bortezomib|bortezomib|mesh-list
138664558|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664559|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
138664560|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664561|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664562|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138199952|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
138664563|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
138664564|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664565|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664566|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138664567|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664568|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
138664569|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
138664570|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664571|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664572|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
138664573|NCT04923893|Hormones|hormones|mesh-ancestor
138664574|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664575|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664576|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664577|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664578|NCT04923893|Growth Substances|growth substances|mesh-ancestor
138664579|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664580|NCT04892264|Dexamethasone|dexamethasone|mesh-list
138664581|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
138664582|NCT04892264|Lenalidomide|lenalidomide|mesh-list
138664583|NCT04892264|Daratumumab|daratumumab|mesh-list
138664584|NCT04892264|Ichthammol|ichthammol|mesh-list
138664585|NCT04892264|BB 1101|bb 1101|mesh-list
138664586|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664587|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
138664588|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
138664589|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664590|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664591|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664593|NCT04892264|Hormones|hormones|mesh-ancestor
138664594|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664595|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664596|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664597|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
138664598|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664599|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664600|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
138664601|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664602|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664603|NCT04892264|Growth Substances|growth substances|mesh-ancestor
138664604|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664605|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664607|NCT04886531|Letrozole|letrozole|mesh-list
138664608|NCT04886531|Anastrozole|anastrozole|mesh-list
138664609|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314603|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138314605|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138664610|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664611|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138664612|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138664613|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664614|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664615|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138664616|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
138664617|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664618|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664619|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664620|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
138664621|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664622|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664623|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664624|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664625|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
138664626|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138664627|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
138664628|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664629|NCT04829318|Esketamine|esketamine|mesh-list
138664630|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
138664631|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138664632|NCT04821622|Talazoparib|talazoparib|mesh-list
138664633|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138664634|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664635|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200028|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
138664636|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664637|NCT04802161|Cytarabine|cytarabine|mesh-list
138664638|NCT04802161|Thalidomide|thalidomide|mesh-list
138664639|NCT04802161|Daunorubicin|daunorubicin|mesh-list
138664640|NCT04802161|Pomalidomide|pomalidomide|mesh-list
138664641|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664642|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
138664643|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664644|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664645|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
138664646|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664647|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664648|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
138664649|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664650|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138664651|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664652|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664653|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664654|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664655|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664656|NCT04802161|Growth Substances|growth substances|mesh-ancestor
138664657|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664658|NCT04802161|Leprostatic Agents|leprostatic agents|mesh-ancestor
138664659|NCT04802161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138664660|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
138664661|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664662|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200074|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138314619|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200075|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664664|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314620|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
138664665|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138664666|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138664667|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664668|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664669|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664670|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
138664671|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287169|NCT03463915|Hormones|hormones|mesh-ancestor
138664673|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138664674|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138341434|NCT00653068|Leucovorin|leucovorin|mesh-list
138664675|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138664676|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
138664677|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664678|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664679|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664680|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138664681|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138664682|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138664683|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664684|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
138664685|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664686|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200121|NCT05749666|Hormones|hormones|mesh-ancestor
138664689|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664690|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
138664691|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664692|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
138664693|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664695|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138664696|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138664697|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138664698|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138664699|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
138664700|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664701|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664702|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664703|NCT04722146|Lenalidomide|lenalidomide|mesh-list
138664704|NCT04722146|Pomalidomide|pomalidomide|mesh-list
138664705|NCT04722146|Bortezomib|bortezomib|mesh-list
138664706|NCT04722146|Daratumumab|daratumumab|mesh-list
138664707|NCT04722146|Nirogacestat|nirogacestat|mesh-list
138664708|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
138664709|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664710|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138314633|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
138664711|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664712|NCT04722146|Growth Substances|growth substances|mesh-ancestor
138664713|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
138287187|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664714|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664715|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138664716|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664717|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664719|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664720|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664721|NCT04704999|Chloroquine|chloroquine|mesh-list
138664722|NCT04704999|Lumefantrine|lumefantrine|mesh-list
138664723|NCT04704999|Artemether|artemether|mesh-list
138664724|NCT04704999|Tafenoquine|tafenoquine|mesh-list
138200169|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138664725|NCT04704999|Amebicides|amebicides|mesh-ancestor
138664726|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138664727|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138664728|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664729|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
138664730|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664731|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138664732|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
138664733|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664734|NCT04673357|Ustekinumab|ustekinumab|mesh-list
138664735|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664736|NCT04669288|Azithromycin|azithromycin|mesh-list
138664737|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138664738|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664739|NCT04666987|Liraglutide|liraglutide|mesh-list
138664740|NCT04666987|Xultophy|xultophy|mesh-list
138664741|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138664742|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664743|NCT04666987|Incretins|incretins|mesh-ancestor
138664744|NCT04666987|Hormones|hormones|mesh-ancestor
138664745|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664746|NCT04666454|Adenosine|adenosine|mesh-list
138664747|NCT04666454|Dipyridamole|dipyridamole|mesh-list
138664748|NCT04666454|Apixaban|apixaban|mesh-list
138664749|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138664750|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
138664751|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138664752|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
138664753|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664754|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664755|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
138664756|NCT04666454|Analgesics|analgesics|mesh-ancestor
138664757|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
138664758|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664759|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314660|NCT01748994|Pioglitazone|pioglitazone|mesh-list
138664760|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138664761|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
138314661|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314662|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314663|NCT01721070|Ketoconazole|ketoconazole|mesh-list
138200203|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
138200206|NCT05232461|Celecoxib|celecoxib|mesh-list
138664762|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138314665|NCT01721070|Dsuvia|dsuvia|mesh-list
138664777|NCT04663347|Prednisone|prednisone|mesh-list
138664778|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
138664779|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138664780|NCT04663347|Ifosfamide|ifosfamide|mesh-list
138664781|NCT04663347|Rituximab|rituximab|mesh-list
138664782|NCT04663347|Carboplatin|carboplatin|mesh-list
138664783|NCT04663347|Gemcitabine|gemcitabine|mesh-list
138664784|NCT04663347|Doxorubicin|doxorubicin|mesh-list
138664785|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138664786|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
138664787|NCT04663347|Etoposide|etoposide|mesh-list
138664788|NCT04663347|Vincristine|vincristine|mesh-list
138664789|NCT04663347|Lenalidomide|lenalidomide|mesh-list
138664790|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
138664791|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664792|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
138664793|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664794|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138664795|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200248|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
138664796|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
138664797|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664798|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664799|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138664800|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664801|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
138664802|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
138664803|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664804|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664805|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
138664806|NCT04663347|Hormones|hormones|mesh-ancestor
138664807|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664808|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664809|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314681|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314682|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664810|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664811|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
138664812|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138314683|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138314684|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
138664813|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664814|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664815|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664816|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664817|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
138664818|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664820|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664821|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
138664822|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664823|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138341635|NCT01553058|Adalimumab|adalimumab|mesh-list
138664824|NCT04663347|Growth Substances|growth substances|mesh-ancestor
138664825|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664826|NCT04658862|Gemcitabine|gemcitabine|mesh-list
138664827|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664828|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664830|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664831|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
138664832|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664833|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664834|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138664835|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664836|NCT04640623|Gemcitabine|gemcitabine|mesh-list
138664837|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664838|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
138664839|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664840|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664841|NCT04630145|Clarithromycin|clarithromycin|mesh-list
138664842|NCT04630145|Rifampin|rifampin|mesh-list
138664843|NCT04630145|Ethambutol|ethambutol|mesh-list
138664844|NCT04630145|Rifabutin|rifabutin|mesh-list
138664846|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138664847|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664848|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138664849|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664850|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664851|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138664852|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138664853|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138664854|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
138664855|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
138664856|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664857|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138664858|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138664859|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138664860|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138664861|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138664862|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138664864|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138664866|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
138664867|NCT04623541|Rituximab|rituximab|mesh-list
138664868|NCT04623541|Doxorubicin|doxorubicin|mesh-list
138664869|NCT04623541|Vincristine|vincristine|mesh-list
138664870|NCT04623541|Lenalidomide|lenalidomide|mesh-list
138664872|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138664873|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
138664874|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664875|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200391|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664876|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314704|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138664877|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
138314705|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
138664878|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664879|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664880|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138664881|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664882|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138664883|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664884|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664885|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664886|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664887|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
138664888|NCT04623541|Hormones|hormones|mesh-ancestor
138664889|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664890|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664891|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664892|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138664893|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664894|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138664895|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664896|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664897|NCT04623541|Growth Substances|growth substances|mesh-ancestor
138287303|NCT03248947|Buprenorphine|buprenorphine|mesh-list
138664899|NCT04616534|Gemcitabine|gemcitabine|mesh-list
138664900|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138664901|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
138200439|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341705|NCT01565538|Pemetrexed|pemetrexed|mesh-list
138664902|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664903|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664904|NCT04606381|Lazertinib|lazertinib|mesh-list
138664905|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664906|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664907|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664908|NCT04599855|Esketamine|esketamine|mesh-list
138664909|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
138664910|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138664911|NCT04589754|Doxorubicin|doxorubicin|mesh-list
138664912|NCT04589754|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138664913|NCT04589754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138664914|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664915|NCT04589754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664916|NCT04589754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664917|NCT04589754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664918|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664919|NCT04586426|Daratumumab|daratumumab|mesh-list
138664920|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664922|NCT04585789|Entecavir|entecavir|mesh-list
138664923|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
138664924|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138664925|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
138664926|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664927|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138664928|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664929|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664930|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664931|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314715|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138314716|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
138314717|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664932|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138664933|NCT04581473|Paclitaxel|paclitaxel|mesh-list
138664934|NCT04581473|Irinotecan|irinotecan|mesh-list
138664935|NCT04581473|Apatinib|apatinib|mesh-list
138664937|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664938|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664939|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138664940|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138664941|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138664942|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664943|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
138664944|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664945|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138664946|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664947|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664948|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664949|NCT04577833|Prednisone|prednisone|mesh-list
138664950|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
138664951|NCT04577833|Niraparib|niraparib|mesh-list
138664952|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138664953|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
138664954|NCT04577833|Hormones|hormones|mesh-ancestor
138664955|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664956|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664957|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138664958|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664959|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138664960|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664961|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664962|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
138664963|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138664964|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138664965|NCT04567303|Ranibizumab|ranibizumab|mesh-list
138664966|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138664967|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138664968|NCT04567303|Growth Substances|growth substances|mesh-ancestor
138664969|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664970|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
138664971|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664972|NCT04565990|Selexipag|selexipag|mesh-list
138664973|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138664974|NCT04563871|Osimertinib|osimertinib|mesh-list
138664975|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314730|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138665013|NCT04542824|Lenalidomide|lenalidomide|mesh-list
138665014|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665015|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
138665016|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665017|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665018|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665019|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
138665020|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314762|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138665021|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665022|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138314763|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665024|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665025|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
138665026|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665028|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665029|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665030|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665032|NCT04542824|Hormones|hormones|mesh-ancestor
138665033|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665034|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665035|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665036|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665037|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665038|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665039|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665040|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665041|NCT04542824|Growth Substances|growth substances|mesh-ancestor
138665042|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665044|NCT04540692|Docetaxel|docetaxel|mesh-list
138665045|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
138665046|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665047|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665048|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665049|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665050|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665051|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665052|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665053|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
138665054|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665055|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200587|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200590|NCT00054314|IDN 5109|idn 5109|mesh-list
138665056|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665057|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
138665058|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138665060|NCT04538664|Pemetrexed|pemetrexed|mesh-list
138665061|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138665062|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665063|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665064|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665065|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665066|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665067|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665068|NCT04535544|Tenofovir|tenofovir|mesh-list
138665069|NCT04535544|Entecavir|entecavir|mesh-list
138665070|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
138665071|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665072|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138665073|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665074|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287432|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138665075|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665076|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314788|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
138665077|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138665078|NCT04532372|Leflunomide|leflunomide|mesh-list
138665079|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665080|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665081|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665082|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
138665083|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665084|NCT04514497|Irinotecan|irinotecan|mesh-list
138665085|NCT04514497|Topotecan|topotecan|mesh-list
138665086|NCT04514497|Camptothecin|camptothecin|mesh-list
138665087|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138665088|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665089|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665090|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665091|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665092|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665093|NCT04497844|Prednisone|prednisone|mesh-list
138665094|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
138665095|NCT04497844|Niraparib|niraparib|mesh-list
138665096|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665097|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
138665098|NCT04497844|Hormones|hormones|mesh-ancestor
138665099|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665100|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665101|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665102|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665103|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138665104|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665105|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665106|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665107|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138665108|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138665109|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138200699|NCT05073718|Aspirin|aspirin|mesh-list
138665113|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665114|NCT04494412|Zanamivir|zanamivir|mesh-list
138665115|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
138665116|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665117|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665118|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665119|NCT04487080|Osimertinib|osimertinib|mesh-list
138665120|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138665121|NCT04487080|Lazertinib|lazertinib|mesh-list
138665122|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665123|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138665124|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665125|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665126|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665128|NCT04461639|Coagulants|coagulants|mesh-ancestor
138665129|NCT04439539|Tenofovir|tenofovir|mesh-list
138665130|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
138665131|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138665132|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
138314812|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665140|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
138665141|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665142|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665143|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665144|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665146|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
138665147|NCT04418154|Epirubicin|epirubicin|mesh-list
138665148|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138665149|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665150|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665151|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665152|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665153|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665154|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665155|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665156|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
138665157|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665158|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665159|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665160|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
138665161|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138665162|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665163|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138665164|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665165|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665166|NCT04389294|Antibodies|antibodies|mesh-list
138665167|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
138665168|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200774|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
138200775|NCT00002704|Thiotepa|thiotepa|mesh-list
138665171|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665172|NCT04361825|Durvalumab|durvalumab|mesh-list
138665173|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665174|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665175|NCT04345913|Halichondrin B|halichondrin b|mesh-list
138665176|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665177|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665178|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665179|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665180|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665181|NCT04317807|Levetiracetam|levetiracetam|mesh-list
138665182|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
138665183|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
138665184|NCT04317105|Nivolumab|nivolumab|mesh-list
138665185|NCT04317105|Ipilimumab|ipilimumab|mesh-list
138665186|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665188|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665189|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314833|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138665223|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665225|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138665226|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138665227|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665228|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138665229|NCT04271475|Macitentan|macitentan|mesh-list
138665230|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138665231|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138665232|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665233|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138665234|NCT04263922|Valsartan|valsartan|mesh-list
138665235|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138665236|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138665238|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665240|NCT04224740|Carboplatin|carboplatin|mesh-list
138665241|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
138665242|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665243|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665244|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665245|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665246|NCT04224493|Rituximab|rituximab|mesh-list
138665247|NCT04224493|Lenalidomide|lenalidomide|mesh-list
138665248|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314842|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138314843|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138314844|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138665250|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
138665251|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665252|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665253|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665254|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665255|NCT04224493|Growth Substances|growth substances|mesh-ancestor
138665256|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665258|NCT04209595|Ondansetron|ondansetron|mesh-list
138665259|NCT04209595|Antiemetics|antiemetics|mesh-ancestor
138665260|NCT04209595|Autonomic Agents|autonomic agents|mesh-ancestor
138665261|NCT04209595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665262|NCT04209595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200906|NCT00002740|Vincristine|vincristine|mesh-list
138200907|NCT00002740|Lenograstim|lenograstim|mesh-list
138665263|NCT04209595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665264|NCT04209595|Antipruritics|antipruritics|mesh-ancestor
138665265|NCT04209595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665266|NCT04209595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138665267|NCT04209595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138665268|NCT04209595|Serotonin Agents|serotonin agents|mesh-ancestor
138665269|NCT04209595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665270|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665271|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138665272|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342032|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665273|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665274|NCT04204941|Doxorubicin|doxorubicin|mesh-list
138665275|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138665276|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665277|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665278|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138665279|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665280|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665281|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665282|NCT04200443|Temozolomide|temozolomide|mesh-list
138665283|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665285|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665286|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665288|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665289|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
138665290|NCT04182672|Hormones|hormones|mesh-ancestor
138665291|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665292|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665293|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665294|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
138665295|NCT04181827|Dexamethasone|dexamethasone|mesh-list
138665296|NCT04181827|Bortezomib|bortezomib|mesh-list
138665297|NCT04181827|Daratumumab|daratumumab|mesh-list
138665298|NCT04181827|Pomalidomide|pomalidomide|mesh-list
138665299|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665300|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
138665301|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
138314865|NCT01739400|Macitentan|macitentan|mesh-list
138665302|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665303|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665304|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665305|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
138665306|NCT04181827|Hormones|hormones|mesh-ancestor
138665307|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665308|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665309|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665310|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
138665311|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665312|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665313|NCT04181827|Growth Substances|growth substances|mesh-ancestor
138665314|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665315|NCT04179864|Prednisone|prednisone|mesh-list
138665316|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665317|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
138665318|NCT04179864|Hormones|hormones|mesh-ancestor
138665319|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665320|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665321|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665322|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665323|NCT04175600|Selexipag|selexipag|mesh-list
138665324|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138665325|NCT04175431|Prednisone|prednisone|mesh-list
138665326|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
138665328|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
138665329|NCT04175431|Hormones|hormones|mesh-ancestor
138665330|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665331|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665332|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201069|NCT00002788|Hormones|hormones|mesh-ancestor
138665333|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665334|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138665335|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665336|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665337|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665338|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138665339|NCT04172675|Gemcitabine|gemcitabine|mesh-list
138665340|NCT04172675|Mitomycins|mitomycins|mesh-list
138665341|NCT04172675|Mitomycin|mitomycin|mesh-list
138665342|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665343|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
138665344|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665345|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665346|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665347|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
138665348|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665349|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665350|NCT04133636|Dexamethasone|dexamethasone|mesh-list
138342104|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
138665351|NCT04133636|Lenalidomide|lenalidomide|mesh-list
138665352|NCT04133636|Bortezomib|bortezomib|mesh-list
138665353|NCT04133636|Daratumumab|daratumumab|mesh-list
138665354|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665355|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
138665356|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
138665357|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665358|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665359|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665361|NCT04133636|Hormones|hormones|mesh-ancestor
138665362|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665363|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665364|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665365|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
138314883|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665366|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665367|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665368|NCT04133636|Growth Substances|growth substances|mesh-ancestor
138665369|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665370|NCT04115163|Paclitaxel|paclitaxel|mesh-list
138665371|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138665372|NCT04115163|Gemcitabine|gemcitabine|mesh-list
138665373|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665374|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665375|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665376|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665377|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665378|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665379|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665381|NCT04108208|Androgens|androgens|mesh-list
138665382|NCT04108208|Hormones|hormones|mesh-ancestor
138665383|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665384|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665385|NCT04108195|Daratumumab|daratumumab|mesh-list
138665386|NCT04108195|Pomalidomide|pomalidomide|mesh-list
138201163|NCT04782128|Growth Substances|growth substances|mesh-ancestor
138665387|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665388|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
138665389|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665390|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665391|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665392|NCT04108195|Growth Substances|growth substances|mesh-ancestor
138665393|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665394|NCT04087317|Acetaminophen|acetaminophen|mesh-list
138665396|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138665397|NCT04087317|Analgesics|analgesics|mesh-ancestor
138665398|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
138665399|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665400|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665402|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138665403|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665404|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665405|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138665406|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665407|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665408|NCT04083599|Paclitaxel|paclitaxel|mesh-list
138665409|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138665410|NCT04083599|Carboplatin|carboplatin|mesh-list
138665411|NCT04083599|Gemcitabine|gemcitabine|mesh-list
138665412|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
138201212|NCT04748848|Azacitidine|azacitidine|mesh-list
138665413|NCT04083599|Pemetrexed|pemetrexed|mesh-list
138665414|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665415|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665416|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665417|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665418|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665419|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665420|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665421|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
138665422|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665423|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665424|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314897|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314898|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
138314899|NCT01691508|Hormones|hormones|mesh-ancestor
138314900|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665425|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665426|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665427|NCT04083235|Leucovorin|leucovorin|mesh-list
138665428|NCT04083235|Paclitaxel|paclitaxel|mesh-list
138314911|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665429|NCT04083235|Gemcitabine|gemcitabine|mesh-list
138665430|NCT04083235|Fluorouracil|fluorouracil|mesh-list
138665431|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
138665432|NCT04083235|Irinotecan|irinotecan|mesh-list
138665433|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665434|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665435|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665436|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665437|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665438|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665439|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665440|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
138665441|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665442|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
138665443|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665444|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138665445|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665446|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665447|NCT04083235|Antidotes|antidotes|mesh-ancestor
138665448|NCT04083235|Protective Agents|protective agents|mesh-ancestor
138665449|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
138665450|NCT04083235|Vitamins|vitamins|mesh-ancestor
138665451|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
138665452|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
138665453|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665454|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665455|NCT04077463|Carboplatin|carboplatin|mesh-list
138665456|NCT04077463|Pemetrexed|pemetrexed|mesh-list
138665457|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138665458|NCT04077463|Lazertinib|lazertinib|mesh-list
138665459|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665460|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665461|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665462|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665463|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665464|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138665465|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665466|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
138665467|NCT04068103|Leucovorin|leucovorin|mesh-list
138665468|NCT04068103|Folic Acid|folic acid|mesh-list
138665469|NCT04068103|Capecitabine|capecitabine|mesh-list
138665470|NCT04068103|Fluorouracil|fluorouracil|mesh-list
138665471|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
138665472|NCT04068103|Calcium|calcium|mesh-list
138665473|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
138314912|NCT01688466|Pomalidomide|pomalidomide|mesh-list
138665474|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138665475|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665476|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138665477|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665478|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
138665479|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314913|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
138314914|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314915|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138314916|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665480|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665481|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665483|NCT04068103|Antidotes|antidotes|mesh-ancestor
138665484|NCT04068103|Protective Agents|protective agents|mesh-ancestor
138665485|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
138665486|NCT04068103|Vitamins|vitamins|mesh-ancestor
138665487|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
138665488|NCT04068103|Hematinics|hematinics|mesh-ancestor
138665489|NCT04038515|Menthol|menthol|mesh-list
138665490|NCT04038515|Nicotine|nicotine|mesh-list
138665491|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138665492|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
138665493|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665494|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665495|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138665496|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138665497|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
138665498|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665499|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665500|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
138665502|NCT04035278|Vaccines|vaccines|mesh-list
138665503|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
138342260|NCT01644396|Adalimumab|adalimumab|mesh-list
138665504|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665505|NCT04034927|Olaparib|olaparib|mesh-list
138665506|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138665509|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665510|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665511|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665512|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665513|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
138665514|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665515|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665516|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665517|NCT04034095|Prednisolone|prednisolone|mesh-list
138665518|NCT04034095|Docetaxel|docetaxel|mesh-list
138665519|NCT04034095|Bicalutamide|bicalutamide|mesh-list
138665520|NCT04034095|Androgens|androgens|mesh-list
138665521|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665522|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665523|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665524|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665525|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665526|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665527|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
138665528|NCT04034095|Hormones|hormones|mesh-ancestor
138665529|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665530|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665531|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665532|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
138665533|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665534|NCT04020913|Hormones|hormones|mesh-list
138665535|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665536|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665537|NCT03993327|Iodine|iodine|mesh-list
138665538|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138665539|NCT03993327|Antibodies|antibodies|mesh-list
138665540|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
138665541|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665542|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
138665543|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665544|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665545|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138665546|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314926|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
138314927|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665548|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
138665549|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
138665550|NCT03969446|Decitabine|decitabine|mesh-list
138665551|NCT03969446|Venetoclax|venetoclax|mesh-list
138665552|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665553|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665554|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665555|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665556|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665557|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
138665558|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665559|NCT03944304|Paclitaxel|paclitaxel|mesh-list
138665560|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665561|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665562|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665563|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665564|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665565|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665566|NCT03934684|Dexamethasone|dexamethasone|mesh-list
138665567|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
138665568|NCT03934684|Lenalidomide|lenalidomide|mesh-list
138665569|NCT03934684|BB 1101|bb 1101|mesh-list
138665570|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665571|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
138665572|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
138665573|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665574|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665575|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665576|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
138665577|NCT03934684|Hormones|hormones|mesh-ancestor
138665578|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665579|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665580|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665581|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138201441|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665582|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665583|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665584|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
138665585|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665586|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665587|NCT03934684|Growth Substances|growth substances|mesh-ancestor
138665588|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665589|NCT03932201|Factor VIII|factor viii|mesh-list
138665590|NCT03932201|Coagulants|coagulants|mesh-ancestor
138665591|NCT03901963|Lenalidomide|lenalidomide|mesh-list
138665592|NCT03901963|Daratumumab|daratumumab|mesh-list
138665593|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
138665594|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665595|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665596|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665597|NCT03901963|Growth Substances|growth substances|mesh-ancestor
138665598|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665599|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665601|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138665602|NCT03899467|Hormones|hormones|mesh-ancestor
138665603|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665604|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665605|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
138665606|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665607|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
138665608|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138665609|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665610|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138665611|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314938|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665612|NCT03880019|Temozolomide|temozolomide|mesh-list
138665613|NCT03880019|Olaparib|olaparib|mesh-list
138314946|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665614|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138665615|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665616|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
138665617|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665618|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665619|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665620|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
138665621|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665623|NCT03864419|Prednisone|prednisone|mesh-list
138665624|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
138665625|NCT03864419|Rituximab|rituximab|mesh-list
138665626|NCT03864419|Doxorubicin|doxorubicin|mesh-list
138665627|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138665628|NCT03864419|Methotrexate|methotrexate|mesh-list
138665629|NCT03864419|Etoposide|etoposide|mesh-list
138665630|NCT03864419|Vincristine|vincristine|mesh-list
138665631|NCT03864419|Daunorubicin|daunorubicin|mesh-list
138665632|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
138665633|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138665634|NCT03864419|Antibodies|antibodies|mesh-list
138665635|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
138665636|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665638|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
138665639|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665640|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665641|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138665642|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
138665643|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665644|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665645|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138665646|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665647|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138665648|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665649|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665650|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665651|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
138665652|NCT03864419|Hormones|hormones|mesh-ancestor
138665653|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665654|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665655|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138665656|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
138665657|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138665658|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665660|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665661|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665662|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665663|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665664|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665665|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665666|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665667|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
138665668|NCT03829111|Nivolumab|nivolumab|mesh-list
138665669|NCT03829111|Ipilimumab|ipilimumab|mesh-list
138665670|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665671|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665672|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665673|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665674|NCT03828227|Bevacizumab|bevacizumab|mesh-list
138665675|NCT03828227|Capecitabine|capecitabine|mesh-list
138665676|NCT03828227|Fluorouracil|fluorouracil|mesh-list
138665677|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
138665678|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665679|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665680|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665681|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665682|NCT03828227|Growth Substances|growth substances|mesh-ancestor
138665684|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665685|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665686|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
138665687|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665688|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665689|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
138665690|NCT03822897|Cisplatin|cisplatin|mesh-list
138665691|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665692|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138665693|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
138665694|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665696|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138665697|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
138665698|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665699|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138665700|NCT03767244|Androgens|androgens|mesh-list
138665701|NCT03767244|Hormones|hormones|mesh-ancestor
138665702|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665703|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665704|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
138665705|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138665706|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
138665707|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138665708|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
138665709|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665710|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665711|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
138665713|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
138665714|NCT03748641|Niraparib|niraparib|mesh-list
138665715|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665716|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
138665717|NCT03748641|Hormones|hormones|mesh-ancestor
138201607|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138665718|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138665719|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665720|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138665721|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665722|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138665723|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665724|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665725|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665726|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138665727|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138665728|NCT03744104|Vaccines|vaccines|mesh-list
138665729|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
138665730|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314960|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
138665731|NCT03737994|Cisplatin|cisplatin|mesh-list
138314961|NCT01687296|Fluticasone|fluticasone|mesh-list
138665732|NCT03737994|Carboplatin|carboplatin|mesh-list
138665733|NCT03737994|Pemetrexed|pemetrexed|mesh-list
138665734|NCT03737994|Crizotinib|crizotinib|mesh-list
138665736|NCT03737994|Ensartinib|ensartinib|mesh-list
138665737|NCT03737994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138665738|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665739|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665740|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665741|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665742|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665743|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138287828|NCT02734940|Morphine|morphine|mesh-list
138665745|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665746|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665747|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665748|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665749|NCT03674112|Trastuzumab|trastuzumab|mesh-list
138665750|NCT03674112|Pertuzumab|pertuzumab|mesh-list
138665751|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665752|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665753|NCT03673501|Sunitinib|sunitinib|mesh-list
138665754|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665755|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665756|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138665757|NCT03673501|Growth Substances|growth substances|mesh-ancestor
138665758|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665759|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665760|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138665761|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665762|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665763|NCT03668340|Adavosertib|adavosertib|mesh-list
138665764|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665765|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665766|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
138665767|NCT03650764|Ramucirumab|ramucirumab|mesh-list
138665768|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665769|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665770|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665771|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665772|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
138665774|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665775|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
138665776|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665777|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138665778|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665779|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665780|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665781|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665782|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138665783|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
138314981|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138314982|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138314983|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138314984|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138665784|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138665785|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665786|NCT03625986|Nicotine|nicotine|mesh-list
138665787|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138665788|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
138665789|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665790|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665791|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138665792|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138665793|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
138665794|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665795|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665796|NCT03598270|Paclitaxel|paclitaxel|mesh-list
138665797|NCT03598270|Carboplatin|carboplatin|mesh-list
138665798|NCT03598270|Gemcitabine|gemcitabine|mesh-list
138665799|NCT03598270|Doxorubicin|doxorubicin|mesh-list
138665800|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138665801|NCT03598270|Atezolizumab|atezolizumab|mesh-list
138665802|NCT03598270|Niraparib|niraparib|mesh-list
138287856|NCT00378092|Risperidone|risperidone|mesh-list
138665803|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665804|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665805|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665806|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
138342566|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
138665807|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665808|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665809|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665810|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665811|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
138665812|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665813|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138665814|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138665815|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665816|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665817|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665818|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
138665819|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201731|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665820|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138665822|NCT03596645|Golimumab|golimumab|mesh-list
138665823|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138665824|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665825|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665826|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665827|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665828|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665829|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
138665830|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665831|NCT03593317|Spironolactone|spironolactone|mesh-list
138665832|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138665833|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
138665834|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315001|NCT01568112|Analgesics|analgesics|mesh-ancestor
138315017|NCT01568034|Levodopa|levodopa|mesh-list
138665835|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665836|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138665837|NCT03593317|Diuretics|diuretics|mesh-ancestor
138665838|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
138665839|NCT03582176|Ketotifen|ketotifen|mesh-list
138665840|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
138665841|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665842|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138201772|NCT01250977|Donepezil|donepezil|mesh-list
138665844|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
138287867|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
138665845|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138665846|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665847|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665848|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138665849|NCT03578367|Niacinamide|niacinamide|mesh-list
138665850|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
138665851|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665852|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138665853|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665854|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665855|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
138665856|NCT03578367|Vitamins|vitamins|mesh-ancestor
138665857|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
138665858|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665859|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
138665860|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665861|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665862|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
138665863|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665864|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665865|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665866|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665867|NCT03556839|Paclitaxel|paclitaxel|mesh-list
138665868|NCT03556839|Bevacizumab|bevacizumab|mesh-list
138665869|NCT03556839|Carboplatin|carboplatin|mesh-list
138665870|NCT03556839|Atezolizumab|atezolizumab|mesh-list
138665871|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665872|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665873|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138201824|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
138201825|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201826|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201827|NCT02189317|Bupivacaine|bupivacaine|mesh-list
138201828|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
138201829|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
138201830|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201831|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665876|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665877|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665878|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138665879|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315023|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315025|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665880|NCT03556839|Growth Substances|growth substances|mesh-ancestor
138665881|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665882|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665883|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665886|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665887|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665888|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665889|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665890|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665891|NCT03517722|Ustekinumab|ustekinumab|mesh-list
138665892|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665893|NCT03507491|Paclitaxel|paclitaxel|mesh-list
138665894|NCT03507491|Gemcitabine|gemcitabine|mesh-list
138665895|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138665896|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665897|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665898|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665899|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665900|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665901|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665902|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
138665903|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
138665904|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138665905|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201857|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138201858|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138665906|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
138665908|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665909|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665910|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
138665911|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665912|NCT03451851|Etanercept|etanercept|mesh-list
138665913|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138665914|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138665915|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138665916|NCT03451851|Analgesics|analgesics|mesh-ancestor
138665917|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
138665918|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665919|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665920|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665921|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665922|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138665923|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665924|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
138665925|NCT03441282|Fentanyl|fentanyl|mesh-list
138665926|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138665927|NCT03441282|Narcotics|narcotics|mesh-ancestor
138315045|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
138315046|NCT01686828|Acyline|acyline|mesh-list
138665928|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138665929|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665930|NCT03441282|Analgesics|analgesics|mesh-ancestor
138665931|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
138665932|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665933|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138665934|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138665935|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
138665936|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
138665937|NCT03439462|Sirolimus|sirolimus|mesh-list
138665938|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665939|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665940|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138665941|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665942|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138665943|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
138665944|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665945|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
138665946|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
138665947|NCT03414502|Minocycline|minocycline|mesh-list
138665948|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
138665949|NCT03414502|Adalimumab|adalimumab|mesh-list
138665950|NCT03414502|Infliximab|infliximab|mesh-list
138665951|NCT03414502|Golimumab|golimumab|mesh-list
138201897|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201898|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201899|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
138201902|NCT01281007|Acyclovir|acyclovir|mesh-list
138665952|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
138665953|NCT03414502|Etanercept|etanercept|mesh-list
138665954|NCT03414502|Rituximab|rituximab|mesh-list
138665955|NCT03414502|Abatacept|abatacept|mesh-list
138665956|NCT03414502|Methotrexate|methotrexate|mesh-list
138665957|NCT03414502|Azathioprine|azathioprine|mesh-list
138665958|NCT03414502|Leflunomide|leflunomide|mesh-list
138665959|NCT03414502|Tofacitinib|tofacitinib|mesh-list
138665960|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665961|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665962|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
138665964|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138665965|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138665966|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
138665967|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138665968|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138665969|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
138665970|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665971|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
138665972|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665973|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138665974|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138665975|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665976|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138665977|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138665978|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
138665979|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138665980|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138665981|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665982|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138315074|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665983|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138665984|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138665986|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
138665987|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665988|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138665989|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138665990|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138665991|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138665992|NCT03410615|Durvalumab|durvalumab|mesh-list
138665993|NCT03410615|Tremelimumab|tremelimumab|mesh-list
138665994|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665995|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138665996|NCT03390504|Docetaxel|docetaxel|mesh-list
138665997|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
138665998|NCT03390504|Mitogens|mitogens|mesh-list
138665999|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666000|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
138666001|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666002|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
138666003|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666004|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666005|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666006|NCT03384914|Vaccines|vaccines|mesh-list
138666007|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
138666008|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
138666009|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666010|NCT03384641|Bedaquiline|bedaquiline|mesh-list
138666011|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
138666012|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138666013|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666014|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
138666015|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138666016|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138666017|NCT03371498|Prednisolone|prednisolone|mesh-list
138666018|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
138666019|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138666020|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
138666021|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666022|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
138666023|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
138666024|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666025|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666026|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666027|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
138666028|NCT03371498|Hormones|hormones|mesh-ancestor
138666029|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666030|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138666031|NCT03371498|Protective Agents|protective agents|mesh-ancestor
138666032|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666033|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666034|NCT03368729|Trastuzumab|trastuzumab|mesh-list
138666035|NCT03368729|Niraparib|niraparib|mesh-list
138201958|NCT01555268|Cytarabine|cytarabine|mesh-list
138666036|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666037|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666038|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138666039|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666040|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666042|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666043|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666044|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666045|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666046|NCT03301220|Daratumumab|daratumumab|mesh-list
138666047|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666048|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
138666049|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138666050|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
138666051|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666052|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666053|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138666054|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
138666055|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138666056|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
138666057|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666058|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666059|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138666060|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
138666061|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
138666062|NCT03260569|Protective Agents|protective agents|mesh-ancestor
138202034|NCT04778072|Iron|iron|mesh-list
138666063|NCT03258593|Acetaminophen|acetaminophen|mesh-list
138666064|NCT03258593|Diphenhydramine|diphenhydramine|mesh-list
138666066|NCT03258593|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138666067|NCT03258593|Histamine Antagonists|histamine antagonists|mesh-list
138666068|NCT03258593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138666069|NCT03258593|Analgesics|analgesics|mesh-ancestor
138666070|NCT03258593|Sensory System Agents|sensory system agents|mesh-ancestor
138666071|NCT03258593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666072|NCT03258593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666073|NCT03258593|Antipyretics|antipyretics|mesh-ancestor
138666074|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666075|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666076|NCT03258593|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138666077|NCT03258593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138666078|NCT03258593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666079|NCT03258593|Anesthetics, Local|anesthetics, local|mesh-ancestor
138666080|NCT03258593|Anesthetics|anesthetics|mesh-ancestor
138666081|NCT03258593|Antiemetics|antiemetics|mesh-ancestor
138666082|NCT03258593|Autonomic Agents|autonomic agents|mesh-ancestor
138666083|NCT03258593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666084|NCT03258593|Histamine Agents|histamine agents|mesh-ancestor
138666085|NCT03258593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666086|NCT03258593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666087|NCT03258593|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138666088|NCT03234972|Dexamethasone|dexamethasone|mesh-list
138666090|NCT03234972|Daratumumab|daratumumab|mesh-list
138666091|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666092|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
138666093|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
138666094|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666095|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666096|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666097|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
138666098|NCT03234972|Hormones|hormones|mesh-ancestor
138666099|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666100|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666101|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666102|NCT03218488|Ustekinumab|ustekinumab|mesh-list
138666103|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315114|NCT01592292|Analgesics|analgesics|mesh-ancestor
138666104|NCT03217812|Prednisone|prednisone|mesh-list
138666105|NCT03217812|Bortezomib|bortezomib|mesh-list
138666106|NCT03217812|Melphalan|melphalan|mesh-list
138666107|NCT03217812|Daratumumab|daratumumab|mesh-list
138666108|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666109|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
138666111|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666112|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666113|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666114|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666115|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666116|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
138666117|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666118|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202080|NCT04780412|Alprostadil|alprostadil|mesh-list
138666119|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666120|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
138666121|NCT03212742|Temozolomide|temozolomide|mesh-list
138666122|NCT03212742|Olaparib|olaparib|mesh-list
138666123|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666124|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
138666125|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666126|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666127|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138666128|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666129|NCT03201458|Atezolizumab|atezolizumab|mesh-list
138666130|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138666131|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666132|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666133|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666134|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666135|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
138666136|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666137|NCT03193814|Apatinib|apatinib|mesh-list
138666138|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666139|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666140|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666141|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666142|NCT03178149|Trimethoprim|trimethoprim|mesh-list
138666143|NCT03178149|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138666144|NCT03178149|Sulfamethoxazole|sulfamethoxazole|mesh-list
138666145|NCT03178149|Acyclovir|acyclovir|mesh-list
138666146|NCT03178149|Nystatin|nystatin|mesh-list
138666147|NCT03178149|Tacrolimus|tacrolimus|mesh-list
138666148|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666149|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
138666150|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666151|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138666152|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666153|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666154|NCT03178149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138666155|NCT03178149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666156|NCT03178149|Antimalarials|antimalarials|mesh-ancestor
138666157|NCT03178149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138666158|NCT03178149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138666159|NCT03178149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138666160|NCT03178149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138315127|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138315128|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
138666163|NCT03178149|Antiviral Agents|antiviral agents|mesh-ancestor
138666164|NCT03178149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138666165|NCT03178149|Antifungal Agents|antifungal agents|mesh-ancestor
138666167|NCT03178149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138666168|NCT03125928|Paclitaxel|paclitaxel|mesh-list
138666169|NCT03125928|Trastuzumab|trastuzumab|mesh-list
138666170|NCT03125928|Atezolizumab|atezolizumab|mesh-list
138666171|NCT03125928|Pertuzumab|pertuzumab|mesh-list
138666172|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138666173|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666174|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
138666175|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666176|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
138666177|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666178|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138202245|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666179|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666180|NCT03114319|Nazartinib|nazartinib|mesh-list
138666181|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666182|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
138666183|NCT03113487|Vaccines|vaccines|mesh-list
138666184|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
138666185|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666186|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666187|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342939|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138666188|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666189|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666190|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
138666191|NCT03103971|Fludarabine|fludarabine|mesh-list
138666192|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666193|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
138666194|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666195|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666196|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666197|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
138666198|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666199|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666200|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138666201|NCT03090165|Bicalutamide|bicalutamide|mesh-list
138666202|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
138666203|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666204|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666205|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666206|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202310|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
138666210|NCT03033225|Verteporfin|verteporfin|mesh-list
138666211|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138666212|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315142|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315143|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666215|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138666216|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138666217|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666218|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666219|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666220|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666221|NCT03011567|Acetaminophen|acetaminophen|mesh-list
138666223|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138666224|NCT03011567|Analgesics|analgesics|mesh-ancestor
138666225|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
138666226|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666227|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666228|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
138666229|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138666230|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666231|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666232|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138666233|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666234|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666235|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
138666236|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
138666237|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
138666238|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666239|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666240|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666241|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666242|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
138666243|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666244|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666245|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202348|NCT00003046|Growth Substances|growth substances|mesh-ancestor
138666246|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666247|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666248|NCT03000439|Tofacitinib|tofacitinib|mesh-list
138666249|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138666250|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666251|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666252|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666255|NCT02891824|Bevacizumab|bevacizumab|mesh-list
138666256|NCT02891824|Atezolizumab|atezolizumab|mesh-list
138666257|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666258|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666259|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666260|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315161|NCT01564758|Linezolid|linezolid|mesh-list
138666261|NCT02891824|Growth Substances|growth substances|mesh-ancestor
138343023|NCT01785186|Vitamins|vitamins|mesh-ancestor
138666262|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666263|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
138666264|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666265|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666266|NCT02737046|Interferons|interferons|mesh-list
138666267|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
138351293|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138666268|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
138666269|NCT02737046|Zidovudine|zidovudine|mesh-list
138666270|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138666271|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138666272|NCT02737046|Belinostat|belinostat|mesh-list
138666273|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666274|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
138666275|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666276|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
138666277|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666278|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
138666279|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666280|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138666281|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138666282|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666283|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138666284|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138666285|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138666286|NCT02724878|Bevacizumab|bevacizumab|mesh-list
138666287|NCT02724878|Atezolizumab|atezolizumab|mesh-list
138666288|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666289|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666290|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666291|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138666292|NCT02724878|Growth Substances|growth substances|mesh-ancestor
138666293|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666294|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
138666295|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666296|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666297|NCT02713607|Doxycycline|doxycycline|mesh-list
138202438|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
138666299|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666300|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
138666301|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138666302|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138666303|NCT02698254|Bevacizumab|bevacizumab|mesh-list
138666304|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138666305|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
138666306|NCT02698254|Antibodies|antibodies|mesh-list
138666307|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
138666308|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138666309|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
138666310|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666311|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666312|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138666313|NCT02698254|Growth Substances|growth substances|mesh-ancestor
138666314|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666315|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
138666316|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
138666317|NCT02669173|Bevacizumab|bevacizumab|mesh-list
138666318|NCT02669173|Capecitabine|capecitabine|mesh-list
138315186|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138315187|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666319|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666321|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666322|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138666323|NCT02669173|Growth Substances|growth substances|mesh-ancestor
138666324|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666325|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
138666326|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138666327|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
138666328|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666329|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138202487|NCT00003082|Antibodies|antibodies|mesh-list
138666330|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
138666331|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351313|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
138666332|NCT02650401|Entrectinib|entrectinib|mesh-list
138666333|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666334|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666335|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666336|NCT02647203|Fluorides|fluorides|mesh-list
138666337|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
138666338|NCT02647203|Protective Agents|protective agents|mesh-ancestor
138666339|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666340|NCT02609776|Carboplatin|carboplatin|mesh-list
138666341|NCT02609776|Pemetrexed|pemetrexed|mesh-list
138666342|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138666343|NCT02609776|Lazertinib|lazertinib|mesh-list
138666344|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138666345|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666346|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666347|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666348|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138666349|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138666350|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666351|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666352|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
138666353|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666354|NCT02592317|Pioglitazone|pioglitazone|mesh-list
138666355|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138666356|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138666357|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138666358|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
138666359|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666360|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138315201|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
138666361|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138666362|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315203|NCT01538472|Cytarabine|cytarabine|mesh-list
138315204|NCT01538472|Rituximab|rituximab|mesh-list
138666363|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138666364|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666365|NCT02568267|Entrectinib|entrectinib|mesh-list
138666366|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666367|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666368|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666369|NCT02531516|Bicalutamide|bicalutamide|mesh-list
138666370|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
138666371|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666372|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666373|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666374|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666376|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
138666377|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666378|NCT02494986|Rilpivirine|rilpivirine|mesh-list
138666379|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138666380|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138666381|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666382|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666383|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
138666384|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666385|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138666386|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138666387|NCT02478099|Atezolizumab|atezolizumab|mesh-list
138666388|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666389|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666390|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666391|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666392|NCT02455687|Budesonide|budesonide|mesh-list
138666393|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
138666394|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666395|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138666396|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
138666397|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666398|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666399|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138666400|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138666401|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
138666402|NCT02455687|Hormones|hormones|mesh-ancestor
138202563|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138201723|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138666403|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666404|NCT02455687|Analgesics|analgesics|mesh-ancestor
138666405|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
138666406|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
138666407|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666408|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138666409|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
138343176|NCT06020300|Pyridoxine|pyridoxine|mesh-list
138666410|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138666411|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288221|NCT02147834|Ranolazine|ranolazine|mesh-list
138666412|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666413|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138666414|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
138315229|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666415|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138666416|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
138666417|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
138666418|NCT02446964|Fludarabine|fludarabine|mesh-list
138666419|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
138666420|NCT02446964|Tacrolimus|tacrolimus|mesh-list
138666421|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666422|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
138666423|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666424|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666425|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666426|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
138666427|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666428|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666429|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138666430|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138666432|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138666433|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666434|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138666435|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138666436|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
138666437|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138666438|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666439|NCT02446600|Paclitaxel|paclitaxel|mesh-list
138666440|NCT02446600|Carboplatin|carboplatin|mesh-list
138666441|NCT02446600|Gemcitabine|gemcitabine|mesh-list
138666442|NCT02446600|Doxorubicin|doxorubicin|mesh-list
138666443|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138666444|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138666445|NCT02446600|Olaparib|olaparib|mesh-list
138666446|NCT02446600|Cediranib|cediranib|mesh-list
138666447|NCT02446600|Maleic acid|maleic acid|mesh-list
138666448|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138666449|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666450|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
138666451|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666452|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
138315246|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315247|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315248|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202650|NCT00064844|Nicotine|nicotine|mesh-list
138666453|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315249|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
138315250|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138315251|NCT01585428|Aldesleukin|aldesleukin|mesh-list
138315252|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
138315253|NCT01585428|Fludarabine|fludarabine|mesh-list
138315254|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315255|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
138666454|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315256|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666455|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
138666456|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138666457|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138666458|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138666459|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666460|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138666461|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666463|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
138666464|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
138666465|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138315270|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666466|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666468|NCT02351063|Diuretics|diuretics|mesh-list
138666469|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138666470|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138666471|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138666472|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
138666473|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666474|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666475|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
138666476|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666477|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138666478|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666479|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666480|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138666481|NCT02316106|Daratumumab|daratumumab|mesh-list
138666482|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138666483|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666484|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
138666485|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666486|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
138666487|NCT02298959|Aflibercept|aflibercept|mesh-list
138666488|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
138666489|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666490|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666491|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138666492|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666493|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666494|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138666495|NCT02298959|Growth Substances|growth substances|mesh-ancestor
138666496|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666497|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
138666499|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138666500|NCT02270814|Cisplatin|cisplatin|mesh-list
138666501|NCT02270814|Carboplatin|carboplatin|mesh-list
138666502|NCT02270814|Cetuximab|cetuximab|mesh-list
138315271|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
138666503|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138315272|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666504|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666505|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
138666506|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666507|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
138666508|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666509|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138666510|NCT02228681|Tamoxifen|tamoxifen|mesh-list
138666511|NCT02228681|Everolimus|everolimus|mesh-list
138666512|NCT02228681|Letrozole|letrozole|mesh-list
138666513|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138666514|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
138666515|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138666516|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666517|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666518|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666519|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202739|NCT00003610|Capsaicin|capsaicin|mesh-list
138666520|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
138288255|NCT01974284|Ethanol|ethanol|mesh-list
138666521|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666522|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666523|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138666524|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666525|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138666526|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666527|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666528|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666529|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138666530|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138666531|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138666532|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138666533|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138666534|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138666535|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
138666536|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138666537|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138666538|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138666539|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138666540|NCT02213107|Finasteride|finasteride|mesh-list
138666541|NCT02213107|Dutasteride|dutasteride|mesh-list
138666542|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138666543|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666544|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666545|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666546|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666547|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666548|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666549|NCT02213107|Urological Agents|urological agents|mesh-ancestor
138315294|NCT01559844|Ribavirin|ribavirin|mesh-list
138666550|NCT02143414|Prednisone|prednisone|mesh-list
138666551|NCT02143414|Cortisone|cortisone|mesh-list
138666552|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138666553|NCT02143414|Methotrexate|methotrexate|mesh-list
138666554|NCT02143414|Vincristine|vincristine|mesh-list
138666555|NCT02143414|Dasatinib|dasatinib|mesh-list
138666556|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
138666557|NCT02143414|Blinatumomab|blinatumomab|mesh-list
138666558|NCT02143414|Antibodies|antibodies|mesh-list
138202795|NCT00384046|Hormones|hormones|mesh-ancestor
138666559|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
138666560|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138666561|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
138666562|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138666563|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
138666564|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666565|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666566|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666567|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
138666568|NCT02143414|Hormones|hormones|mesh-ancestor
138666569|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666570|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666571|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138666572|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
138666573|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138666574|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138666575|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
138666576|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666577|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
138666578|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666579|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138666580|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666581|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666582|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138666583|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138666584|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138666585|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666586|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138666587|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666588|NCT02123758|Prednisone|prednisone|mesh-list
138666589|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
138666590|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666591|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
138666592|NCT02123758|Hormones|hormones|mesh-ancestor
138666593|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666594|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666595|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666596|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666597|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666599|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666600|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
138202823|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
138666601|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315320|NCT01583166|Epinephrine|epinephrine|mesh-list
138315321|NCT01583166|Bupivacaine|bupivacaine|mesh-list
138666602|NCT02115282|Exemestane|exemestane|mesh-list
138666603|NCT02115282|Goserelin|goserelin|mesh-list
138666604|NCT02115282|Entinostat|entinostat|mesh-list
138666605|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138666606|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666607|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138666608|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666609|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666610|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666611|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138666612|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666613|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666614|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666615|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666616|NCT02111941|Vaccines|vaccines|mesh-list
138666617|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
138666618|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666619|NCT01998971|Acetaminophen|acetaminophen|mesh-list
138666620|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
138666621|NCT01998971|Promethazine|promethazine|mesh-list
138666622|NCT01998971|Thalidomide|thalidomide|mesh-list
138666623|NCT01998971|Dexamethasone|dexamethasone|mesh-list
138666624|NCT01998971|Prednisone|prednisone|mesh-list
138666625|NCT01998971|Lenalidomide|lenalidomide|mesh-list
138666626|NCT01998971|Melphalan|melphalan|mesh-list
138666627|NCT01998971|Bortezomib|bortezomib|mesh-list
138666628|NCT01998971|Daratumumab|daratumumab|mesh-list
138666629|NCT01998971|Pomalidomide|pomalidomide|mesh-list
138666630|NCT01998971|Montelukast|montelukast|mesh-list
138666631|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666632|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
138666633|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
138666634|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666635|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666636|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666638|NCT01998971|Hormones|hormones|mesh-ancestor
138666639|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666640|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666641|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315343|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666642|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
138666643|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138666644|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315344|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138315345|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666645|NCT01998971|Growth Substances|growth substances|mesh-ancestor
138666646|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202856|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666648|NCT01998971|Analgesics|analgesics|mesh-ancestor
138666649|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
138666650|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
138666651|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666652|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
138666653|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666654|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138666655|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666656|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
138666657|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138666658|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666659|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138666660|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
138666661|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138666662|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666663|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138666664|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138666665|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138666666|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138666667|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666668|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
138666669|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
138666670|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138666671|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
138666672|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
138666673|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666674|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138666675|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
138666676|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
138666677|NCT01991977|Temozolomide|temozolomide|mesh-list
138666678|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138666680|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666681|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666682|NCT01989585|Trametinib|trametinib|mesh-list
138666683|NCT01989585|Dabrafenib|dabrafenib|mesh-list
138666684|NCT01989585|Navitoclax|navitoclax|mesh-list
138666685|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666686|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666687|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666688|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666689|NCT01938261|Acetaminophen|acetaminophen|mesh-list
138666690|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138666691|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138666692|NCT01938261|Analgesics|analgesics|mesh-ancestor
138666693|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
138666694|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666695|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666696|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
138666697|NCT01934582|Treprostinil|treprostinil|mesh-list
138666698|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666700|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315375|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666701|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315396|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666702|NCT01792687|Prednisone|prednisone|mesh-list
138666703|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
138666704|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666705|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
138666706|NCT01792687|Hormones|hormones|mesh-ancestor
138666707|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666708|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666709|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666710|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666712|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666713|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666714|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288348|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138666715|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138666716|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
138666717|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666718|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666719|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666720|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666721|NCT01508897|Liraglutide|liraglutide|mesh-list
138666722|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138666723|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666724|NCT01508897|Incretins|incretins|mesh-ancestor
138666725|NCT01508897|Hormones|hormones|mesh-ancestor
138666726|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666727|NCT01394263|Goserelin|goserelin|mesh-list
138666728|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666729|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666730|NCT01263769|Axitinib|axitinib|mesh-list
138666731|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666732|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666733|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666734|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666735|NCT01154764|Ketoconazole|ketoconazole|mesh-list
138666736|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
138666737|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666738|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138666739|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138666740|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666741|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666742|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666743|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666744|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666745|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666746|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138666747|NCT01035983|Frovatriptan|frovatriptan|mesh-list
138666748|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138666749|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
138666750|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666751|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666752|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315398|NCT01557504|Incretins|incretins|mesh-ancestor
138666753|NCT01004978|Cisplatin|cisplatin|mesh-list
138666754|NCT01004978|Doxorubicin|doxorubicin|mesh-list
138666755|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138666756|NCT01004978|Sorafenib|sorafenib|mesh-list
138666757|NCT01004978|Mitomycins|mitomycins|mesh-list
138666758|NCT01004978|Mitomycin|mitomycin|mesh-list
138666759|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666760|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138666761|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138666762|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138666763|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666764|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666765|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138666766|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
138666767|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138666770|NCT00947531|Protective Agents|protective agents|mesh-ancestor
138666771|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666772|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
138666773|NCT00904540|Lidocaine|lidocaine|mesh-list
138666774|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
138666775|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
138666776|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666777|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666778|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
138666779|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666780|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138666781|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138666782|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138343560|NCT05622318|Tacrolimus|tacrolimus|mesh-list
138666783|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138666784|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666785|NCT00904202|Lidocaine|lidocaine|mesh-list
138666786|NCT00904202|Gabapentin|gabapentin|mesh-list
138666787|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
138666788|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
138666789|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666790|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666791|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
138666792|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666793|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138666794|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138666795|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138666796|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138203068|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203069|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
138666797|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666799|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
138666800|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138666801|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138666802|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138666803|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138666804|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138666805|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666806|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
138666807|NCT00904020|Lidocaine|lidocaine|mesh-list
138666808|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
138666809|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
138666810|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666811|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666812|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
138666813|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666814|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138666815|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138666816|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138666817|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138666818|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666819|NCT00903110|Mecasermin|mecasermin|mesh-list
138666820|NCT00903110|Growth Substances|growth substances|mesh-ancestor
138666821|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666822|NCT00719966|Letrozole|letrozole|mesh-list
138666823|NCT00719966|Anastrozole|anastrozole|mesh-list
138666824|NCT00719966|Exemestane|exemestane|mesh-list
138666825|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666826|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138666827|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666828|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666829|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666830|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138666831|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666832|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666833|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666834|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666835|NCT00671008|Insulin|insulin|mesh-list
138666836|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138666837|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
138666838|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
138666839|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
138666840|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138203116|NCT00003664|Interferons|interferons|mesh-list
138666842|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666843|NCT00644033|Frovatriptan|frovatriptan|mesh-list
138666844|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138666845|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
138666846|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666847|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666848|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666849|NCT00643604|Treprostinil|treprostinil|mesh-list
138666850|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666851|NCT00606346|Infliximab|infliximab|mesh-list
138666852|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138666853|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138666854|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
138666855|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666856|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138666857|NCT00585559|Acetaminophen|acetaminophen|mesh-list
138666858|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
138666859|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138666860|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138666861|NCT00585559|Analgesics|analgesics|mesh-ancestor
138666862|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
138666863|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666864|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666865|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
138666866|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
138666867|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138666868|NCT00585559|Expectorants|expectorants|mesh-ancestor
138666869|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
138666870|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138666871|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
138666872|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666873|NCT00585559|Protective Agents|protective agents|mesh-ancestor
138666874|NCT00585559|Antidotes|antidotes|mesh-ancestor
138666875|NCT00486356|Carboplatin|carboplatin|mesh-list
138666876|NCT00486356|Capecitabine|capecitabine|mesh-list
138666877|NCT00486356|Epirubicin|epirubicin|mesh-list
138666878|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666879|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138666880|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
138666881|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666882|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138666883|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138666884|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138666885|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666886|NCT00475514|Frovatriptan|frovatriptan|mesh-list
138666887|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138666888|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
138666889|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203150|NCT00003202|Gemcitabine|gemcitabine|mesh-list
138666891|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666892|NCT00447382|Insulin|insulin|mesh-list
138666894|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
138666895|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
138315479|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666896|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138666897|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666898|NCT00439946|Treprostinil|treprostinil|mesh-list
138666899|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666900|NCT00383877|Insulin|insulin|mesh-list
138666901|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138666902|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
138666903|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
138666904|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
138666905|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
138666906|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138666907|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666909|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666910|NCT00226421|Oxymorphone|oxymorphone|mesh-list
138666911|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138666912|NCT00226421|Narcotics|narcotics|mesh-ancestor
138666913|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666914|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666915|NCT00226421|Analgesics|analgesics|mesh-ancestor
138666916|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
138666917|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666918|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138666919|NCT00226395|Oxymorphone|oxymorphone|mesh-list
138666920|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138666921|NCT00226395|Narcotics|narcotics|mesh-ancestor
138666922|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666923|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666924|NCT00226395|Analgesics|analgesics|mesh-ancestor
138666925|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
138666926|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666927|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138666928|NCT00225797|Oxymorphone|oxymorphone|mesh-list
138666929|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138666930|NCT00225797|Narcotics|narcotics|mesh-ancestor
138666931|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666932|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666933|NCT00225797|Analgesics|analgesics|mesh-ancestor
138666934|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
138666935|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138666937|NCT00147199|Treprostinil|treprostinil|mesh-list
138666938|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666939|NCT00135668|Nitroprusside|nitroprusside|mesh-list
138666940|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138666941|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
138666942|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138666943|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666944|NCT00066703|Tamoxifen|tamoxifen|mesh-list
138666945|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138666946|NCT00066703|Exemestane|exemestane|mesh-list
138315500|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138666947|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138666948|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666949|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315501|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
138315505|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666951|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666952|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666953|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138666954|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138666955|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138666956|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138666957|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666958|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666959|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666960|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
138666961|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138666962|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
138666963|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138666964|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138666965|NCT00066690|Tamoxifen|tamoxifen|mesh-list
138666966|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138666967|NCT00066690|Exemestane|exemestane|mesh-list
138666968|NCT00066690|Tryptophan|tryptophan|mesh-list
138666969|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666970|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138666971|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666972|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138666973|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138666974|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138666975|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138666976|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138666977|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138666978|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138666979|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138666980|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138666981|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666982|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
138666983|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138666984|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
138666985|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138666986|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138666987|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138666988|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
138666989|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138666990|NCT00469560|Deferasirox|deferasirox|mesh-list
138666991|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138315523|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315524|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138666994|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138666995|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
138666996|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138666997|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138666998|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666999|NCT00469599|Vitamins|vitamins|mesh-ancestor
138667000|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
138667001|NCT00429377|Tacrolimus|tacrolimus|mesh-list
138667002|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667003|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
138667004|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667005|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138667006|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667007|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343772|NCT04978298|Phenelzine|phenelzine|mesh-list
138667008|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138667009|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
138667010|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
138667012|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667013|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
138667014|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138667015|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138667016|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138667017|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667018|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667019|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
138667020|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138667021|NCT04704245|Petrolatum|petrolatum|mesh-list
138667022|NCT04704245|Mitogens|mitogens|mesh-list
138667023|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667024|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667025|NCT04704245|Emollients|emollients|mesh-ancestor
138667026|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
138667027|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138667028|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138667029|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
138667030|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667031|NCT00429962|Ranibizumab|ranibizumab|mesh-list
138667032|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138667033|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138667034|NCT00429962|Growth Substances|growth substances|mesh-ancestor
138667035|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315553|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315555|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667036|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138667037|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667038|NCT00430001|Docetaxel|docetaxel|mesh-list
138667039|NCT00430001|Trastuzumab|trastuzumab|mesh-list
138667040|NCT00430001|Vinorelbine|vinorelbine|mesh-list
138667041|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667042|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667043|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
138667044|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667045|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667046|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138667047|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138667049|NCT00430079|Imidazole|imidazole|mesh-list
138667051|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667052|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667053|NCT00430118|Cytarabine|cytarabine|mesh-list
138667054|NCT00430118|Dexamethasone|dexamethasone|mesh-list
138667055|NCT00430118|Prednisone|prednisone|mesh-list
138667056|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
138667057|NCT00430118|Ifosfamide|ifosfamide|mesh-list
138667058|NCT00430118|Doxorubicin|doxorubicin|mesh-list
138667059|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138667060|NCT00430118|Methotrexate|methotrexate|mesh-list
138667062|NCT00430118|Vincristine|vincristine|mesh-list
138667063|NCT00430118|Daunorubicin|daunorubicin|mesh-list
138667064|NCT00430118|Asparaginase|asparaginase|mesh-list
138667065|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
138667066|NCT00430118|Thioguanine|thioguanine|mesh-list
138667067|NCT00430118|Vindesine|vindesine|mesh-list
138667068|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667069|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
138667070|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667071|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667072|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138667073|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
138667074|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667075|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667076|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138667077|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667078|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
138667079|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
138667080|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667081|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667082|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
138343861|NCT04774094|Ceftazidime|ceftazidime|mesh-list
138667083|NCT00430118|Hormones|hormones|mesh-ancestor
138667084|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667085|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667087|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138667088|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138315598|NCT01525602|Paclitaxel|paclitaxel|mesh-list
138667089|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667090|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138667091|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
138667092|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667093|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667094|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
138667095|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138667096|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138667097|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138667098|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138667099|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
138667100|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667101|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667102|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138667103|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667104|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
138667105|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138667106|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138667107|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203268|NCT00003682|Doxorubicin|doxorubicin|mesh-list
138203269|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203270|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138203271|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
138203272|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203273|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203274|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203275|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203276|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203277|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203278|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315611|NCT01549002|Analgesics|analgesics|mesh-ancestor
138315612|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
138315613|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203280|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
138667108|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667109|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
138667110|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138667111|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138667112|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138667113|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138667114|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667115|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667116|NCT00461565|Urological Agents|urological agents|mesh-ancestor
138667117|NCT00430196|Tizanidine|tizanidine|mesh-list
138667118|NCT00430196|Analgesics|analgesics|mesh-ancestor
138667119|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
138667120|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667121|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667122|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
138667123|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138667124|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138667125|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
138667126|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
138667127|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138667128|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138667129|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138667130|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
138667131|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667132|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667133|NCT00430235|Sorafenib|sorafenib|mesh-list
138667134|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203326|NCT00003694|Cytarabine|cytarabine|mesh-list
138667135|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138667136|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667137|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667138|NCT00470340|Gemcitabine|gemcitabine|mesh-list
138667139|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
138667140|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
138667141|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667142|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667143|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
138667144|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667145|NCT00430469|Lactoferrin|lactoferrin|mesh-list
138667146|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667147|NCT00461643|Metformin|metformin|mesh-list
138667148|NCT00461643|Citric Acid|citric acid|mesh-list
138667149|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
138667150|NCT00461643|Clomiphene|clomiphene|mesh-list
138667151|NCT00461643|Enclomiphene|enclomiphene|mesh-list
138667152|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
138667153|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138667154|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667155|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
138667156|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138667157|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
138343921|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
138667158|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
138667159|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667161|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
138667162|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667163|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138667164|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
138667165|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667166|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138667167|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138667169|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
138667170|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
138667171|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201724|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667172|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667173|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138667174|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138667175|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
138667176|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138667177|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138667178|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667179|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667180|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138667181|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667182|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667183|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
138203368|NCT00003262|Vinblastine|vinblastine|mesh-list
138667186|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138667187|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
138315687|NCT01546038|Decitabine|decitabine|mesh-list
138667188|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315688|NCT01546038|Daunorubicin|daunorubicin|mesh-list
138315689|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315690|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
138667189|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667190|NCT00461799|Orlistat|orlistat|mesh-list
138667191|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667192|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667193|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138667194|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138667195|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
138667196|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138667197|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667198|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138667199|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138667200|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138667201|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667202|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667203|NCT00430742|Hormones|hormones|mesh-ancestor
138667204|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667205|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667206|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
138667207|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
138667208|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667209|NCT03271164|Vitamin E|vitamin e|mesh-list
138667210|NCT03271164|Vitamins|vitamins|mesh-ancestor
138667211|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
138667212|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667213|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
138667214|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667215|NCT03271164|Protective Agents|protective agents|mesh-ancestor
138667216|NCT00430898|Basiliximab|basiliximab|mesh-list
138667217|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667218|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
138667219|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667222|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
138667223|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138667224|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
138667225|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667226|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667227|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138667228|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667229|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315719|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138315720|NCT01522950|Atenolol|atenolol|mesh-list
138315721|NCT01522950|Nebivolol|nebivolol|mesh-list
138315722|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138315724|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
138315725|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
138315726|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315727|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315728|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138667230|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138667232|NCT02957409|Valsartan|valsartan|mesh-list
138667233|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138667234|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138667235|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138667236|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138667237|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667238|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
138667239|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138667240|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667241|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138203429|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138667242|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
138667243|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138667244|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667245|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667246|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667247|NCT00431054|Docetaxel|docetaxel|mesh-list
138667248|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667249|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667250|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
138667251|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667252|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667253|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
138667254|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
138667255|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667256|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667257|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667258|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
138667259|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667260|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667261|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667262|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
138667263|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
138667264|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667265|NCT00431249|Cilostazol|cilostazol|mesh-list
138667266|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138667267|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
138667268|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667269|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667270|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138667271|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
138667272|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138315743|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315744|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667274|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667275|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667276|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
138667277|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138667278|NCT00431249|Protective Agents|protective agents|mesh-ancestor
138667279|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138667280|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138667281|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667283|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138667284|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138667285|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138667286|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667287|NCT00431522|Valproic Acid|valproic acid|mesh-list
138667288|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
138667289|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667290|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667291|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
138667292|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203481|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667293|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667295|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667296|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667297|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667298|NCT00462111|Indomethacin|indomethacin|mesh-list
138667299|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138667300|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138667301|NCT00462111|Analgesics|analgesics|mesh-ancestor
138667302|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
138667303|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667304|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667305|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315773|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667306|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667307|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
138667308|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
138667309|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667310|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138667311|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667312|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667314|NCT00431561|Lomustine|lomustine|mesh-list
138667315|NCT00431561|Trabedersen|trabedersen|mesh-list
138667316|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138667317|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
138667318|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667319|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667320|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
138667321|NCT00462189|Immunotoxins|immunotoxins|mesh-list
138667322|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
138667323|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
138667324|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667325|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667326|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
138667327|NCT00431678|Levofloxacin|levofloxacin|mesh-list
138667328|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
138667329|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138667330|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138667331|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667332|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138667333|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138667334|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667335|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667336|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667337|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138667338|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
138667339|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667340|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667341|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138667342|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138667343|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138667344|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138667345|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138667346|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138667347|NCT00471003|Telmisartan|telmisartan|mesh-list
138667348|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138667349|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138667350|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138667351|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667352|NCT00471042|Buprenorphine|buprenorphine|mesh-list
138667353|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138667354|NCT00471042|Narcotics|narcotics|mesh-ancestor
138667355|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667356|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667357|NCT00471042|Analgesics|analgesics|mesh-ancestor
138667358|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
138667359|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667360|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138667362|NCT00462540|Albuterol|albuterol|mesh-list
138667363|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
138667364|NCT00462540|Ipratropium|ipratropium|mesh-list
138667365|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138667366|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
138315812|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667367|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667368|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667369|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138667370|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138667371|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138667372|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138667373|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138667374|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344139|NCT04149964|Oxycodone|oxycodone|mesh-list
138667375|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667376|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667377|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
138667378|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
138667379|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667380|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138667381|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
138667383|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
138667384|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667385|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138667386|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138667387|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203533|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203535|NCT00085436|Interferons|interferons|mesh-list
138667388|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667390|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138667391|NCT00471159|Docetaxel|docetaxel|mesh-list
138667392|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667393|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667394|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
138667395|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667396|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667397|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138315826|NCT01514448|Everolimus|everolimus|mesh-list
138315827|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138315828|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315829|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667398|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
138667399|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667400|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138667401|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667402|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667403|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667404|NCT00431795|Doxorubicin|doxorubicin|mesh-list
138667405|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138667406|NCT00431795|Epirubicin|epirubicin|mesh-list
138667407|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138667408|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667409|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138667410|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138667411|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667412|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667413|NCT00462657|Dimercaprol|dimercaprol|mesh-list
138667414|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
138667415|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
138667416|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667419|NCT00431990|Romidepsin|romidepsin|mesh-list
138667420|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667421|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
138667422|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
138667423|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667424|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667425|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667426|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
138667427|NCT00431990|Hormones|hormones|mesh-ancestor
138667428|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667429|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667430|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667431|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138667432|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138667433|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315866|NCT01519674|Incretins|incretins|mesh-ancestor
138315867|NCT01519674|Hormones|hormones|mesh-ancestor
138315873|NCT01519518|Heparin|heparin|mesh-list
138667434|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667436|NCT00462696|Epirubicin|epirubicin|mesh-list
138667437|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667438|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667440|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667441|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667442|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138667443|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138667444|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138667445|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667446|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138667447|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138667448|NCT00462813|Protective Agents|protective agents|mesh-ancestor
138667449|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667450|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667451|NCT01052012|Bupivacaine|bupivacaine|mesh-list
138667452|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
138667453|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
138667454|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667455|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667456|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
138667457|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667458|NCT00462852|Gemcitabine|gemcitabine|mesh-list
138667459|NCT00462852|Dalteparin|dalteparin|mesh-list
138667460|NCT00462852|Tinzaparin|tinzaparin|mesh-list
138667461|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138667462|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667463|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
138667464|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667465|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667466|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
138667467|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138203600|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667468|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138667469|NCT00471393|Diclofenac|diclofenac|mesh-list
138667470|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138667471|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138667472|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138667473|NCT00471393|Analgesics|analgesics|mesh-ancestor
138667474|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
138667475|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315905|NCT01512108|Liraglutide|liraglutide|mesh-list
138315906|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138667476|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667477|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667478|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667479|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138667480|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667481|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667482|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138667484|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138667485|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
138667486|NCT00432068|Octreotide|octreotide|mesh-list
138667487|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667488|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667489|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667490|NCT03273231|Ketamine|ketamine|mesh-list
138667491|NCT03273231|Analgesics|analgesics|mesh-ancestor
138667492|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
138288908|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
138667493|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203635|NCT00003994|Carboplatin|carboplatin|mesh-list
138667494|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667495|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138667496|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138667497|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
138667498|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
138667499|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667500|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138667501|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138667502|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667503|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667504|NCT00432146|Lugol's solution|lugol's solution|mesh-list
138667505|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
138667506|NCT00432146|Coagulants|coagulants|mesh-ancestor
138667507|NCT00432302|Sagopilone|sagopilone|mesh-list
138667508|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667509|NCT00463008|Methotrexate|methotrexate|mesh-list
138667510|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138667511|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
138667512|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138667513|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667514|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667515|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
138667516|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667517|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667518|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
138667519|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667520|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138667521|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667522|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
138315938|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667523|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667524|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138315940|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
138667526|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
138667527|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138667528|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667529|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138667530|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138667531|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
138667532|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667533|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138667535|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138667536|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
138667537|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667538|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667539|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138667541|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
138667542|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138667543|NCT00471471|Sargramostim|sargramostim|mesh-list
138667544|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
138667545|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203675|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
138203676|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667546|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138667547|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667548|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138667549|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
138667550|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667551|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667552|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138667553|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667555|NCT00463203|Irinotecan|irinotecan|mesh-list
138667556|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138667557|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667558|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138667559|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138667560|NCT00463203|Growth Substances|growth substances|mesh-ancestor
138667561|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667562|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
138315962|NCT01462344|Hormones|hormones|mesh-ancestor
138315963|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315964|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
138667564|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138667565|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667566|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667568|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138667569|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138667570|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
138667571|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667572|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138667573|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138667574|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315995|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138667575|NCT00432575|Surinabant|surinabant|mesh-list
138667576|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138667577|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138667578|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667579|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667580|NCT00432575|Hormones|hormones|mesh-ancestor
138215499|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667581|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667582|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667583|NCT00432614|Escitalopram|escitalopram|mesh-list
138667584|NCT00432614|Amibegron|amibegron|mesh-list
138667585|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138667586|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138667587|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138667588|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667589|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667590|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667591|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
138667592|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667593|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138667594|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138667595|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138667596|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138667598|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138667599|NCT00432653|Rituximab|rituximab|mesh-list
138667600|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138667601|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667602|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
138667603|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667604|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667605|NCT00471588|Pramipexole|pramipexole|mesh-list
138315996|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138667606|NCT00471588|Amisulpride|amisulpride|mesh-list
138667607|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
138667608|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667609|NCT00471588|Protective Agents|protective agents|mesh-ancestor
138667610|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667611|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138667612|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138667613|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
138667614|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
138667615|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667616|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138667617|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667618|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667619|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667620|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138667621|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138667622|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
138667623|NCT00463359|Imiquimod|imiquimod|mesh-list
138667624|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138667625|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
138667626|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667627|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667628|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
138667629|NCT00471627|Pancrelipase|pancrelipase|mesh-list
138667630|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667631|NCT00432887|Caffeine|caffeine|mesh-list
138667632|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138667633|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667634|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138667635|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667636|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667637|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138667638|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138667639|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
138667640|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667641|NCT00471744|Levetiracetam|levetiracetam|mesh-list
138667642|NCT00471744|Sulthiame|sulthiame|mesh-list
138667643|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
138667644|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
138667645|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
138667646|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138316025|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
138667647|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667648|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
138667649|NCT00463515|Carboplatin|carboplatin|mesh-list
138667653|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
138667654|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667655|NCT00433043|Metoprolol|metoprolol|mesh-list
138667656|NCT00433043|Carvedilol|carvedilol|mesh-list
138667657|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138667658|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138667659|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138667660|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
138667661|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
138667662|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667663|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667664|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138667665|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138667666|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138667667|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667668|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667669|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
138667670|NCT00433043|Protective Agents|protective agents|mesh-ancestor
138667672|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667673|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138667674|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
138667675|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138316056|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667676|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138667678|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138667679|NCT03273075|Cangrelor|cangrelor|mesh-list
138667680|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667681|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138667682|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138667683|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138667684|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
138667685|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667686|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667687|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667688|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138667689|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138667690|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
138667691|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667692|NCT01051661|Vaccines|vaccines|mesh-list
138667693|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
138667694|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667695|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138667696|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138667697|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138667698|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667699|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316103|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
138316109|NCT03026946|Cyclosporine|cyclosporine|mesh-list
138203949|NCT00004048|Doxorubicin|doxorubicin|mesh-list
138667701|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667702|NCT01051466|Analgesics|analgesics|mesh-ancestor
138667703|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
138667704|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667705|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
138667706|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667707|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
138667708|NCT04446793|Bevacizumab|bevacizumab|mesh-list
138667709|NCT04446793|Onvansertib|onvansertib|mesh-list
138667710|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138667711|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667712|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138667713|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138667714|NCT04446793|Growth Substances|growth substances|mesh-ancestor
138667715|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667716|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
138667717|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138667718|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667719|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667721|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667722|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
138667723|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667724|NCT00433121|Olanzapine|olanzapine|mesh-list
138667725|NCT00433121|Risperidone|risperidone|mesh-list
138667726|NCT00433121|Citalopram|citalopram|mesh-list
138667727|NCT00433121|Escitalopram|escitalopram|mesh-list
138667728|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138667730|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667731|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667732|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667733|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138667734|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667735|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667736|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667737|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138667738|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
138667739|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138667740|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138667741|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667742|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
138667743|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667744|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138667745|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
138667746|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
138667747|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667748|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
138667749|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138667750|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
138667751|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667752|NCT00463671|Expectorants|expectorants|mesh-ancestor
138667753|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
138667754|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138667755|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
138667756|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667757|NCT00463671|Protective Agents|protective agents|mesh-ancestor
138667758|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316152|NCT06175377|Clopidogrel|clopidogrel|mesh-list
138667761|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667762|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
138667763|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667764|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667765|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
138667766|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667767|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667768|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
138204040|NCT00004840|Hormones|hormones|mesh-list
138667769|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667771|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138667772|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
138667773|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667774|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667775|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
138667776|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667777|NCT00433277|Cyclosporine|cyclosporine|mesh-list
138667778|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138667779|NCT00433277|Cyclosporins|cyclosporins|mesh-list
138667780|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667781|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667782|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667783|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
138667784|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667785|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
138667786|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667787|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
138667788|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667789|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138667790|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138667792|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138316167|NCT06175377|Antipyretics|antipyretics|mesh-ancestor
138316168|NCT06175377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138316169|NCT06175377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138316170|NCT06175377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138316171|NCT06175377|Purinergic Agents|purinergic agents|mesh-ancestor
138316172|NCT06175377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316174|NCT06175338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316175|NCT06175338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316176|NCT06175338|Immunologic Factors|immunologic factors|mesh-ancestor
138316177|NCT06175338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316178|NCT06175338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316179|NCT06175273|Cyproheptadine|cyproheptadine|mesh-list
138316180|NCT06175273|Dronabinol|dronabinol|mesh-list
138316181|NCT06175273|Hallucinogens|hallucinogens|mesh-ancestor
138316182|NCT06175273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667793|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138667794|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
138667795|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667796|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138667797|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138667798|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667799|NCT00433316|Ropivacaine|ropivacaine|mesh-list
138667800|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
138667801|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
138667802|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667803|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667804|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
138204073|NCT00004858|Estrogens|estrogens|mesh-ancestor
138667805|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667806|NCT00472134|Bupivacaine|bupivacaine|mesh-list
138667808|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
138667809|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667810|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667811|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
138667812|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667813|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138667814|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138667815|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667817|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138667818|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667819|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667820|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
138667821|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138667822|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138667823|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
138667824|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667826|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138667827|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667828|NCT00472329|Fludarabine|fludarabine|mesh-list
138667829|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667830|NCT00464217|Idarubicin|idarubicin|mesh-list
138667831|NCT00464217|Molgramostim|molgramostim|mesh-list
138667832|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138667833|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667834|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204118|NCT00003850|Thalidomide|thalidomide|mesh-list
138667836|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667837|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667838|NCT00433784|Clopidogrel|clopidogrel|mesh-list
138667839|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138667840|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138667841|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138667842|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138667843|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
138667844|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667845|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667846|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667848|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138667849|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138667850|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138667851|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453738|NCT01887184|Analgesics|analgesics|mesh-ancestor
138667852|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667854|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667855|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667856|NCT00433823|Atorvastatin|atorvastatin|mesh-list
138667857|NCT00433823|Ezetimibe|ezetimibe|mesh-list
138667858|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138667859|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138667860|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
138667861|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667862|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138667863|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138667864|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667866|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667867|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
138667868|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667869|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667870|NCT03273036|Triamcinolone|triamcinolone|mesh-list
138667871|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667873|NCT03273036|Hormones|hormones|mesh-ancestor
138667874|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667875|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667876|NCT03270735|Thrombin|thrombin|mesh-list
138667877|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
138667878|NCT03270735|Coagulants|coagulants|mesh-ancestor
138667879|NCT04702685|Ropivacaine|ropivacaine|mesh-list
138667880|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
138667881|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
138667882|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667883|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667884|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
138667885|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667886|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
138667887|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138667888|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138667889|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138667890|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138667891|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667892|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138316231|NCT06174935|Cholinergic Agents|cholinergic agents|mesh-ancestor
138667893|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316232|NCT06174935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316234|NCT06174935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138667894|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667896|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667897|NCT00472368|Panobinostat|panobinostat|mesh-list
138667898|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667899|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138667900|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667901|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204205|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204206|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204207|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667902|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
138667903|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138667904|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453771|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138204242|NCT00003874|Antibodies|antibodies|mesh-list
138204256|NCT00004102|Calcium|calcium|mesh-list
138667905|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667906|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138667907|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667908|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138667909|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
138667910|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
138667911|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138667912|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667913|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215500|NCT04387604|Ranibizumab|ranibizumab|mesh-list
138351321|NCT00577122|Progestins|progestins|mesh-ancestor
138667914|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138667915|NCT00464451|Analgesics|analgesics|mesh-ancestor
138667916|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
138667917|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667918|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138667919|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138667920|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138667921|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
138667922|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667923|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667925|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667926|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
138667927|NCT00433940|Hormones|hormones|mesh-ancestor
138316243|NCT06174922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667928|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667929|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667930|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138667931|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667932|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138667934|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667935|NCT01050764|Vidarabine|vidarabine|mesh-list
138667936|NCT01050764|Fludarabine|fludarabine|mesh-list
138667937|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
138667938|NCT01050764|Melphalan|melphalan|mesh-list
138667939|NCT01050764|Thiotepa|thiotepa|mesh-list
138667940|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
138667941|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138667942|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667943|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138667944|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
138667945|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667946|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138667947|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
138667948|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667949|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
138667950|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138667951|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138667952|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
138667953|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138667954|NCT00434096|Rimonabant|rimonabant|mesh-list
138667955|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138667956|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138667957|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138667958|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667959|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667960|NCT00434096|Hormones|hormones|mesh-ancestor
138667961|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667962|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667963|NCT01050569|Nicotine|nicotine|mesh-list
138667964|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138667965|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
138667966|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344752|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667967|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667968|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138667969|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138667970|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
138667971|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667972|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667973|NCT04702490|Empagliflozin|empagliflozin|mesh-list
138667974|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138667975|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351334|NCT00419770|Deferasirox|deferasirox|mesh-list
138351335|NCT00419770|Amebicides|amebicides|mesh-ancestor
138667976|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138667977|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667979|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138667980|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138667981|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667982|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138667983|NCT00464763|Analgesics|analgesics|mesh-ancestor
138667984|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
138667985|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667986|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138667987|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138316276|NCT06174285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316277|NCT06174285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667988|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138667989|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
138667990|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667991|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667992|NCT00434135|Paclitaxel|paclitaxel|mesh-list
138667993|NCT00434135|Gemcitabine|gemcitabine|mesh-list
138667994|NCT00434135|Pemetrexed|pemetrexed|mesh-list
138667995|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138667996|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667997|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667998|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
138667999|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
138668000|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668001|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668002|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
138668003|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668004|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138204395|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
138204396|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204397|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204398|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138204399|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
138668005|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138668007|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138668008|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668009|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668010|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668011|NCT01050257|Oseltamivir|oseltamivir|mesh-list
138668012|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
138316290|NCT06173986|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316291|NCT06173986|Antimitotic Agents|antimitotic agents|mesh-ancestor
138668013|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668014|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668015|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668016|NCT03272802|Riluzole|riluzole|mesh-list
138668017|NCT03272802|Edaravone|edaravone|mesh-list
138668018|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138668019|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
138668020|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204434|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204435|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
138204436|NCT05776043|Empagliflozin|empagliflozin|mesh-list
138668021|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138668022|NCT03272802|Protective Agents|protective agents|mesh-ancestor
138668023|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668024|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
138668025|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138668026|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138668027|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668028|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138668029|NCT01050062|Telmisartan|telmisartan|mesh-list
138668030|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138668031|NCT01050062|Diuretics|diuretics|mesh-ancestor
138668032|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668033|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668034|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138668035|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668036|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668037|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138668038|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138668039|NCT00464919|Sorafenib|sorafenib|mesh-list
138668041|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668042|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138668043|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668044|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668045|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668046|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
138668047|NCT00434174|Pemetrexed|pemetrexed|mesh-list
138668048|NCT00434174|Everolimus|everolimus|mesh-list
138204490|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204491|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
138204492|NCT05775770|Insulin|insulin|mesh-list
138204493|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138204494|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204495|NCT05775705|Antibodies|antibodies|mesh-list
138204496|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
138204497|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204498|NCT05775692|Fluconazole|fluconazole|mesh-list
138204499|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
138204500|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204501|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138668049|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668050|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668051|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668052|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138316334|NCT06155331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138668053|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138668054|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138668055|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138204527|NCT00004126|Paclitaxel|paclitaxel|mesh-list
138668057|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
138668058|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668059|NCT00464958|Tizanidine|tizanidine|mesh-list
138668060|NCT00464958|Analgesics|analgesics|mesh-ancestor
138668061|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
138668062|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668063|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668064|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
138668065|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138668066|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138668067|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
138668068|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
138668069|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138668070|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138668071|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668073|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668074|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668075|NCT00472758|Sifalimumab|sifalimumab|mesh-list
138668076|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
138668077|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668078|NCT01055444|Lidocaine|lidocaine|mesh-list
138668079|NCT01055444|Tetracaine|tetracaine|mesh-list
138668080|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
138668081|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
138668082|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668083|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351345|NCT00076310|Cisplatin|cisplatin|mesh-list
138351347|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138351355|NCT04340856|Bisacodyl|bisacodyl|mesh-list
138668084|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
138668085|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668086|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138668087|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138668088|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138668089|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668090|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668091|NCT01055015|Morphine|morphine|mesh-list
138668092|NCT01055015|Oxycodone|oxycodone|mesh-list
138668093|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138668094|NCT01055015|Narcotics|narcotics|mesh-ancestor
138668095|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204722|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138204723|NCT04762199|Osimertinib|osimertinib|mesh-list
138204724|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204725|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138668096|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668097|NCT01055015|Analgesics|analgesics|mesh-ancestor
138668098|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
138668099|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668100|NCT00472875|Glyburide|glyburide|mesh-list
138316358|NCT06131905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316374|NCT06087328|Nicotine|nicotine|mesh-list
138668102|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668103|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
138668104|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668105|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668106|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
138668107|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138668108|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668109|NCT00472953|Insulin|insulin|mesh-list
138668110|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138668111|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
138668112|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138204780|NCT03951753|Tirzepatide|tirzepatide|mesh-list
138668113|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668114|NCT02957630|Drospirenone|drospirenone|mesh-list
138344898|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668115|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
138668116|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138668117|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138668118|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
138668119|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138668120|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668121|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138668122|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138668123|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138668124|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138668125|NCT02957630|Estrogens|estrogens|mesh-ancestor
138668127|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668128|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138668129|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
138668130|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138668131|NCT02957630|Diuretics|diuretics|mesh-ancestor
138668132|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668133|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138668134|NCT00465036|Cathartics|cathartics|mesh-ancestor
138668135|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668136|NCT04702061|Anesthetics|anesthetics|mesh-list
138668137|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668138|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668139|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
138668140|NCT00465075|Estrogens|estrogens|mesh-list
138668141|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138668142|NCT00465075|Hormones|hormones|mesh-ancestor
138668143|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668144|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668145|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138668146|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138668147|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
138668148|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138668149|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138668150|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138668151|NCT00465192|Estradiol|estradiol|mesh-list
138668152|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138668153|NCT00465192|Estrogens|estrogens|mesh-ancestor
138316393|NCT06076018|Morphine|morphine|mesh-list
138668154|NCT00465192|Hormones|hormones|mesh-ancestor
138316394|NCT06076018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138316395|NCT06076018|Narcotics|narcotics|mesh-ancestor
138316398|NCT06076018|Analgesics|analgesics|mesh-ancestor
138668155|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668156|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204892|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668157|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138668158|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
138668159|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138668160|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138668161|NCT00434681|Acetaminophen|acetaminophen|mesh-list
138668162|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668163|NCT00434681|Analgesics|analgesics|mesh-ancestor
138668164|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
138668165|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668166|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668167|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
138668168|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138668169|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668170|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668171|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668172|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
138668173|NCT00473070|Hormones|hormones|mesh-ancestor
138668174|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668175|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668176|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138668177|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138204945|NCT00723697|Analgesics|analgesics|mesh-ancestor
138668178|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138668179|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
138668180|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668181|NCT04702334|Lidocaine|lidocaine|mesh-list
138668182|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
138668183|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
138668184|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
138668185|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668186|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668187|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
138668188|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668189|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138668190|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138668191|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138668192|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668193|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668194|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138668195|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
138668196|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
138668197|NCT04702334|Protective Agents|protective agents|mesh-ancestor
138668198|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
138668199|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138668200|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668201|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668202|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138316424|NCT06061809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138668203|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668204|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668205|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668206|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668207|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138668208|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
138668209|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138668210|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668211|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138668212|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138668213|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138668214|NCT00435305|Vancomycin|vancomycin|mesh-list
138668215|NCT00435305|Meropenem|meropenem|mesh-list
138668216|NCT00435305|Tazobactam|tazobactam|mesh-list
138668218|NCT00435305|Piperacillin|piperacillin|mesh-list
138668219|NCT00435305|Ceftazidime|ceftazidime|mesh-list
138668220|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138668221|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668222|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668223|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138668224|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668225|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668226|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138668227|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
138668228|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138668229|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668230|NCT00465543|Analgesics|analgesics|mesh-ancestor
138668231|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
138668232|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668233|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668234|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668235|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138668236|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
138668237|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668238|NCT00465543|Protective Agents|protective agents|mesh-ancestor
138668239|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138668240|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138668241|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668242|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668243|NCT00435500|Fluorides|fluorides|mesh-list
138668244|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
138668245|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
138668246|NCT00435500|Protective Agents|protective agents|mesh-ancestor
138668247|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668248|NCT03272412|Progesterone|progesterone|mesh-list
138668249|NCT03272412|Progestins|progestins|mesh-ancestor
138668250|NCT03272412|Hormones|hormones|mesh-ancestor
138668251|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668252|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668253|NCT00473616|Irinotecan|irinotecan|mesh-list
138668254|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138668255|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668256|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668257|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668258|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316446|NCT06034314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316447|NCT06002217|Levobupivacaine|levobupivacaine|mesh-list
138668259|NCT00435851|Hormones|hormones|mesh-list
138668260|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668261|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668262|NCT00436124|Oseltamivir|oseltamivir|mesh-list
138668263|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
138316464|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316465|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668264|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668265|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668266|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668267|NCT02957474|Omeprazole|omeprazole|mesh-list
138668268|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138668269|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668270|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138668271|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668272|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668273|NCT00465231|Fentanyl|fentanyl|mesh-list
138668274|NCT00465231|Bupivacaine|bupivacaine|mesh-list
138668275|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
138668276|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
138668277|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668278|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668279|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
138668280|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668281|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138668282|NCT00465231|Narcotics|narcotics|mesh-ancestor
138668283|NCT00465231|Analgesics|analgesics|mesh-ancestor
138668284|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138668285|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138668286|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
138668287|NCT00436241|Capecitabine|capecitabine|mesh-list
138668288|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
138668289|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668290|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
138668291|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668292|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668293|NCT00481455|Temozolomide|temozolomide|mesh-list
138668294|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138668295|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138668296|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
138668297|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668298|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668299|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
138668300|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
138668301|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
138668302|NCT00481533|Oxytocin|oxytocin|mesh-list
138668303|NCT00481533|Ergonovine|ergonovine|mesh-list
138668304|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
138668305|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138316466|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138668306|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668308|NCT00481572|Vasopressins|vasopressins|mesh-list
138668309|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
138668310|NCT00481572|Norepinephrine|norepinephrine|mesh-list
138668311|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138668312|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668313|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
138205146|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
138205147|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205148|NCT00004924|Paclitaxel|paclitaxel|mesh-list
138668314|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668315|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668316|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668317|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
138668318|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
138668319|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668320|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138668321|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
138668322|NCT00481572|Coagulants|coagulants|mesh-ancestor
138668323|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138668324|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668325|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138668326|NCT00474006|Daunorubicin|daunorubicin|mesh-list
138668327|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138668328|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668329|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138668330|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668331|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668332|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668333|NCT04697745|Dexamethasone|dexamethasone|mesh-list
138668334|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
138668335|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668336|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
138668337|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
138668338|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668339|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668340|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668341|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
138316492|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316493|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
138316494|NCT05837104|Pyridoxal|pyridoxal|mesh-list
138316495|NCT05837104|Pyridoxine|pyridoxine|mesh-list
138316496|NCT05837104|Vitamins|vitamins|mesh-ancestor
138668343|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668345|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668346|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138668347|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668348|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668349|NCT04697745|Analgesics|analgesics|mesh-ancestor
138668350|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
138668351|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138668352|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138668353|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668354|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668355|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668356|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205168|NCT00004150|Leucovorin|leucovorin|mesh-list
138205169|NCT00004150|Fluorouracil|fluorouracil|mesh-list
138205170|NCT00004150|Calcium|calcium|mesh-list
138205171|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
138205172|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205173|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205174|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
138205175|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668357|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
138668358|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668359|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668360|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138668361|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668362|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668363|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668364|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316529|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
138316530|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316531|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138316532|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138668365|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138668366|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668368|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
138668369|NCT00436709|Bevacizumab|bevacizumab|mesh-list
138668370|NCT00436709|Doxorubicin|doxorubicin|mesh-list
138668371|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138668372|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138668373|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138668374|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668375|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138668376|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138454054|NCT01888562|Ponatinib|ponatinib|mesh-list
138668377|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138668378|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668379|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138668380|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
138668381|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668382|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205192|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205193|NCT00003928|Gemcitabine|gemcitabine|mesh-list
138205194|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205196|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
138668383|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138668384|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
138668385|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138668386|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138668387|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138668388|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138668389|NCT00436709|Growth Substances|growth substances|mesh-ancestor
138668390|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
138668391|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138668392|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138668393|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668394|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668396|NCT00436787|Fondaparinux|fondaparinux|mesh-list
138668397|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138668398|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
138668399|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138668400|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668401|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668402|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668403|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
138668404|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138668405|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138668406|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138668407|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138316571|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138668408|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138668409|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
138668410|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316572|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
138316573|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
138316574|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316575|NCT05731895|BI 425809|bi 425809|mesh-list
138668411|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668413|NCT00481728|Urological Agents|urological agents|mesh-ancestor
138345200|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
138205237|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205238|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205239|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
138668414|NCT00436943|Bupropion|bupropion|mesh-list
138668415|NCT00436943|Nicotine|nicotine|mesh-list
138668416|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138668417|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
138668418|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668419|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668420|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138668421|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138668422|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
138668423|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668424|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668425|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138668426|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
138668427|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668428|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138668429|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138668430|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668431|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
138668432|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138668433|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668434|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668435|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138668436|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
138668437|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
138668439|NCT00481884|Emollients|emollients|mesh-ancestor
138668440|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138668441|NCT00481923|Rimonabant|rimonabant|mesh-list
138668442|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138668443|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138668444|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138668445|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205276|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205278|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
138668446|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668447|NCT00481923|Hormones|hormones|mesh-ancestor
138316593|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668449|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668450|NCT00481962|Tigecycline|tigecycline|mesh-list
138668451|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668452|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668453|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138668454|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668455|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668456|NCT00437177|Apomorphine|apomorphine|mesh-list
138668457|NCT00437177|Emetics|emetics|mesh-ancestor
138668458|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668459|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
138668460|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668461|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668462|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
138668463|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
138668464|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668465|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668466|NCT00437333|Metformin|metformin|mesh-list
138668467|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138668468|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668469|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138668470|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138668471|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668472|NCT00482079|Incretins|incretins|mesh-ancestor
138668473|NCT00482079|Hormones|hormones|mesh-ancestor
138668474|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454091|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138668475|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138668477|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668478|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668479|NCT00437372|Sunitinib|sunitinib|mesh-list
138668480|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668481|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138668482|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138668483|NCT00437372|Growth Substances|growth substances|mesh-ancestor
138668484|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668485|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316629|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138316634|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138316635|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138316636|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316637|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668486|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138668487|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668488|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668490|NCT00437450|Hematinics|hematinics|mesh-ancestor
138668491|NCT04701710|Ivermectin|ivermectin|mesh-list
138668492|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138668493|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668494|NCT00437606|Ethanol|ethanol|mesh-list
138668495|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138668496|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668497|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668498|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668499|NCT00482313|Methylphenidate|methylphenidate|mesh-list
138668500|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138668501|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668502|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138668503|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138668504|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668505|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668506|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
138668507|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668508|NCT00437684|Ribavirin|ribavirin|mesh-list
138668509|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138668510|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
138668511|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668512|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
138668513|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668514|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
138668515|NCT00437723|Hematinics|hematinics|mesh-ancestor
138668516|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
138668517|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138668518|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138668519|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138668520|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668521|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668522|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
138668523|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668524|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668525|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138668526|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668527|NCT00482508|Omalizumab|omalizumab|mesh-list
138668528|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138668530|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
138668531|NCT00437918|Acarbose|acarbose|mesh-list
138668532|NCT00437918|Nateglinide|nateglinide|mesh-list
138668533|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138668534|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668535|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668536|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138205352|NCT00005026|Paclitaxel|paclitaxel|mesh-list
138668537|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668538|NCT00437957|Temozolomide|temozolomide|mesh-list
138668539|NCT00437957|Valproic Acid|valproic acid|mesh-list
138668540|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138668541|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
138668542|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668543|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668544|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
138668545|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668546|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
138668547|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668550|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138668551|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668552|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668553|NCT03270176|Avelumab|avelumab|mesh-list
138668554|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138668555|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668556|NCT00474279|Hormones|hormones|mesh-list
138668557|NCT00474279|Secretagogues|secretagogues|mesh-list
138668558|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668559|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668560|NCT03270696|Propofol|propofol|mesh-list
138668561|NCT03270696|Rocuronium|rocuronium|mesh-list
138668562|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138668563|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668564|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668565|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138668566|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
138668567|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
138668568|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138668569|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138668570|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138668571|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668572|NCT00437996|Clonidine|clonidine|mesh-list
138668573|NCT00437996|Sufentanil|sufentanil|mesh-list
138668574|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
138668575|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138668576|NCT00437996|Narcotics|narcotics|mesh-ancestor
138668577|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668578|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668579|NCT00437996|Analgesics|analgesics|mesh-ancestor
138668580|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
138668581|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668582|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138668583|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138668584|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
138668585|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
138668586|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138668587|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
138668588|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
138668589|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138668590|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138668591|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668592|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668593|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668594|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668595|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
138668597|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138668598|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138668599|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
138668600|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668601|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138668602|NCT00474435|Tenofovir|tenofovir|mesh-list
138668603|NCT00474435|Emtricitabine|emtricitabine|mesh-list
138668604|NCT00474435|Efavirenz|efavirenz|mesh-list
138668605|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
138668606|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668607|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138668608|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138668609|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668610|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668611|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138668612|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316683|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668613|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138668614|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668615|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138668616|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138668617|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138668618|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138668620|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138668621|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668622|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
138454165|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
138668623|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
138668624|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668625|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
138668626|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668627|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668628|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668629|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138668630|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138668631|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668632|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138668634|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138668636|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138668637|NCT00438113|Diuretics|diuretics|mesh-ancestor
138668638|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668639|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668640|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138668641|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668642|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668643|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138668645|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
138668646|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205392|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668647|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138668648|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138668649|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138668650|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668651|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668652|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138668653|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138668654|NCT00438113|Urological Agents|urological agents|mesh-ancestor
138668655|NCT00438152|Ritonavir|ritonavir|mesh-list
138668656|NCT00438152|Lopinavir|lopinavir|mesh-list
138668657|NCT00438152|Saquinavir|saquinavir|mesh-list
138668658|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138668659|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138668660|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668661|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668662|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668663|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138668664|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138668665|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
138668666|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668667|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138668668|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668669|NCT00438230|Warfarin|warfarin|mesh-list
138668670|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
138668671|NCT00438269|Metronidazole|metronidazole|mesh-list
138668672|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
138668674|NCT00438269|Cefazolin|cefazolin|mesh-list
138668675|NCT00438269|Tazobactam|tazobactam|mesh-list
138668676|NCT00438269|Piperacillin|piperacillin|mesh-list
138668677|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138316693|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316700|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668678|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668679|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668680|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138668681|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138668682|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138668683|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668684|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668685|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668686|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668687|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138668688|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668689|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138668690|NCT00474591|PENTA|penta|mesh-list
138668691|NCT00474591|Fondaparinux|fondaparinux|mesh-list
138668692|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138668693|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
138668694|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138668695|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668696|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668697|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668698|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
138668699|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138668700|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138668701|NCT03279809|Aspirin|aspirin|mesh-list
138668702|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138668703|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668704|NCT03279809|Analgesics|analgesics|mesh-ancestor
138668705|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
138668706|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668707|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668708|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668709|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138668710|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138668711|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138668712|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668713|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138668714|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138668715|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668716|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
138668717|NCT00438386|Aripiprazole|aripiprazole|mesh-list
138668718|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
138668719|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668720|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138668721|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138668722|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668723|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668724|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
138668725|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
138668726|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454216|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
138316702|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
138668727|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668728|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138668729|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138668731|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138668732|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138668733|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138668734|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138668736|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138668737|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668738|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138668739|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
138668740|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
138668741|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668742|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668743|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668744|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138668745|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668746|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668747|NCT00475098|Tinzaparin|tinzaparin|mesh-list
138668748|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138668749|NCT00475098|Dalteparin|dalteparin|mesh-list
138668750|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
138668751|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138668752|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138668753|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668754|NCT00475137|Lamotrigine|lamotrigine|mesh-list
138668755|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
138668756|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138668757|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668758|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668759|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138668760|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668761|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138668762|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138668763|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668764|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668765|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138316729|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316730|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668766|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138668767|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
138351369|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
138668768|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668769|NCT00475293|Panitumumab|panitumumab|mesh-list
138668770|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454251|NCT01889407|Idarubicin|idarubicin|mesh-list
138668772|NCT00438737|Leucovorin|leucovorin|mesh-list
138668773|NCT00438737|Bevacizumab|bevacizumab|mesh-list
138668774|NCT00438737|Cetuximab|cetuximab|mesh-list
138668775|NCT00438737|Fluorouracil|fluorouracil|mesh-list
138668777|NCT00438737|Calcium|calcium|mesh-list
138668778|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
138668779|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138668780|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668781|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138668782|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138668783|NCT00438737|Growth Substances|growth substances|mesh-ancestor
138668784|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668785|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
138668786|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138668787|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
138668788|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668789|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668791|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
138668792|NCT00438737|Antidotes|antidotes|mesh-ancestor
138668793|NCT00438737|Protective Agents|protective agents|mesh-ancestor
138668794|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
138668795|NCT00438737|Vitamins|vitamins|mesh-ancestor
138668796|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
138668797|NCT00438776|Olanzapine|olanzapine|mesh-list
138668798|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
138668799|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
138668800|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668801|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205518|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668803|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138668804|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138668805|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668806|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668807|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138668808|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138668809|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668810|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668811|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668812|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
138668813|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138668814|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
138668815|NCT00475410|Coagulants|coagulants|mesh-ancestor
138668816|NCT00475527|Amoxicillin|amoxicillin|mesh-list
138668817|NCT00475527|Metronidazole|metronidazole|mesh-list
138668818|NCT00475527|Clarithromycin|clarithromycin|mesh-list
138668819|NCT00475527|Omeprazole|omeprazole|mesh-list
138668820|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668821|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668822|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138668823|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138316765|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
138668824|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138668825|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668826|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138668827|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668828|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668829|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138668830|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138668831|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138668832|NCT00475566|Everolimus|everolimus|mesh-list
138668833|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138668834|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138668835|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668836|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668837|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138668838|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
138668839|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668840|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668842|NCT00439166|Rifampin|rifampin|mesh-list
138668843|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668844|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668845|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
138668846|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138668847|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138668848|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138668849|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
138668850|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
138668851|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138668852|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668853|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668854|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138668855|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138668856|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138668857|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138668858|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138668859|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138668860|NCT00439283|Infliximab|infliximab|mesh-list
138668861|NCT00439283|Methotrexate|methotrexate|mesh-list
138345651|NCT01955382|Artesunate|artesunate|mesh-list
138668862|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138668863|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
138668864|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138668865|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668866|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668868|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668869|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668870|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138668871|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668872|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138668873|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138668874|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
138668875|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316789|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316791|NCT05060315|Treprostinil|treprostinil|mesh-list
138668877|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138668878|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668879|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668880|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
138668881|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138668882|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138668883|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668884|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668885|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138668886|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668887|NCT00475800|Analgesics|analgesics|mesh-ancestor
138668888|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
138668889|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668890|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668891|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668892|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138668893|NCT00439361|Carboplatin|carboplatin|mesh-list
138668894|NCT00439361|Etoposide|etoposide|mesh-list
138668895|NCT00439361|Bortezomib|bortezomib|mesh-list
138668896|NCT00439361|Ifosfamide|ifosfamide|mesh-list
138668897|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668898|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138668899|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138668900|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138668901|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668902|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668903|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138668904|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
138668905|NCT00475917|Gemcitabine|gemcitabine|mesh-list
138668906|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138668907|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
138205595|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
138668908|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668909|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668910|NCT00474669|Docetaxel|docetaxel|mesh-list
138668911|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668912|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138668913|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138668914|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138668915|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668916|NCT00439400|Doxycycline|doxycycline|mesh-list
138316810|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138316811|NCT04965519|Trastuzumab|trastuzumab|mesh-list
138668917|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668918|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668919|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
138668920|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138668921|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138668922|NCT00475956|Cediranib|cediranib|mesh-list
138668923|NCT00475956|Saracatinib|saracatinib|mesh-list
138668924|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668925|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138668926|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668927|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668928|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
138668929|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138668930|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138668931|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668932|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668933|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138668934|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138668935|NCT00476034|Analgesics|analgesics|mesh-ancestor
138668936|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
138668937|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668938|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668939|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668940|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138668941|NCT00476073|Fluticasone|fluticasone|mesh-list
138668942|NCT00476073|Xhance|xhance|mesh-list
138668943|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
138668944|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668945|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138668946|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
138668947|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668948|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668949|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138668950|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
138668951|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138668952|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138668953|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138668954|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138205596|NCT00005596|Hormones|hormones|mesh-ancestor
138205597|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205598|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205599|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138668955|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668956|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668957|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668958|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668959|NCT00476268|Beclomethasone|beclomethasone|mesh-list
138316841|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138668960|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
138316849|NCT04827576|Docetaxel|docetaxel|mesh-list
138668961|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138668962|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
138668963|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668964|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668965|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138668966|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
138668967|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138668968|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138668969|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138668970|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
138668971|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668972|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668973|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138668974|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
138668975|NCT00476268|Hormones|hormones|mesh-ancestor
138668976|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138668977|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138668978|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138668979|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138668980|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138668981|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138668982|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668983|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668984|NCT00105989|Analgesics|analgesics|mesh-ancestor
138668985|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
138668986|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138668987|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
138668988|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138668989|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
138668990|NCT00476346|Vitamin D|vitamin d|mesh-list
138668991|NCT00476346|Calcium|calcium|mesh-list
138668992|NCT00476346|Vitamins|vitamins|mesh-ancestor
138668993|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
138668994|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668995|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138668996|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138668997|NCT00476424|Efavirenz|efavirenz|mesh-list
138668998|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138668999|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669000|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669001|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669002|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
138669003|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205619|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138669004|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138669005|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138669006|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138669007|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138345798|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
138669008|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138669009|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138669011|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138669012|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138669013|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
138669014|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
138316878|NCT04756401|Ichthammol|ichthammol|mesh-list
138669015|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669016|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669017|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669018|NCT00476463|Emtricitabine|emtricitabine|mesh-list
138669019|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
138669020|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669021|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138669022|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669023|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669024|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669025|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669026|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669027|NCT00439751|Goserelin|goserelin|mesh-list
138669028|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138669029|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669030|NCT00438243|Bromfenac|bromfenac|mesh-list
138669031|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669032|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669033|NCT00438243|Analgesics|analgesics|mesh-ancestor
138669034|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
138669035|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669036|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669037|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669038|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669039|NCT00439829|Cetrorelix|cetrorelix|mesh-list
138669040|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138669041|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
138669042|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138669043|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669044|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453594|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669045|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669046|NCT03277248|Teriflunomide|teriflunomide|mesh-list
138669047|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669048|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669049|NCT03277248|Analgesics|analgesics|mesh-ancestor
138669050|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
138205644|NCT00004264|Docetaxel|docetaxel|mesh-list
138669051|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669052|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669053|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669054|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669055|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669056|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
138669058|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316884|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669059|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
138669060|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
138669061|NCT00440063|Hematinics|hematinics|mesh-ancestor
138669062|NCT00440102|Ketamine|ketamine|mesh-list
138669063|NCT00440102|Etomidate|etomidate|mesh-list
138669064|NCT00440102|Analgesics|analgesics|mesh-ancestor
138669065|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
138669066|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669067|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669068|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138669069|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138669070|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
138669071|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
138669072|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669073|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138669074|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138669075|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669076|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669077|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138669078|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
138669079|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669080|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669081|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
138669082|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
138669083|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
138669084|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669085|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138205679|NCT00004288|Analgesics|analgesics|mesh-ancestor
138669086|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138669087|NCT00440141|Latanoprost|latanoprost|mesh-list
138669088|NCT00440141|Brinzolamide|brinzolamide|mesh-list
138669089|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138669090|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453595|NCT01886196|Ibuprofen|ibuprofen|mesh-list
138669091|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138669092|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138669093|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138669094|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669095|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669096|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669097|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669098|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138669099|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669100|NCT00438321|Anastrozole|anastrozole|mesh-list
138669101|NCT00438321|Goserelin|goserelin|mesh-list
138669102|NCT00438321|Testosterone|testosterone|mesh-list
138669103|NCT00438321|Androgens|androgens|mesh-ancestor
138669104|NCT00438321|Hormones|hormones|mesh-ancestor
138669105|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669106|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316913|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669107|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138669108|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669109|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138669110|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138669111|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669112|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669113|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138669114|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138669115|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
138669116|NCT00476619|Hematinics|hematinics|mesh-ancestor
138669117|NCT03279536|Lactoferrin|lactoferrin|mesh-list
138669118|NCT03279536|Dextrans|dextrans|mesh-list
138669119|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
138669120|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669121|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
138669122|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
138669123|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
138669124|NCT03279536|Hematinics|hematinics|mesh-ancestor
138669125|NCT00440219|Prednisone|prednisone|mesh-list
138669126|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669127|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
138669128|NCT00440219|Hormones|hormones|mesh-ancestor
138669129|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669130|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669131|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138669132|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205711|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669133|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138669134|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138669135|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669136|NCT00440258|Cabergoline|cabergoline|mesh-list
138669137|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138669138|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138669139|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
138669140|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
138669141|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669142|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669143|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669144|NCT00440336|Latanoprost|latanoprost|mesh-list
138669145|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138669146|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138669147|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
138669148|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138669149|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669150|NCT00440414|Pemetrexed|pemetrexed|mesh-list
138669151|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138669152|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669153|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316948|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669154|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669155|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138669156|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669157|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345972|NCT01086540|Acetaminophen|acetaminophen|mesh-list
138669158|NCT03270462|Tacrolimus|tacrolimus|mesh-list
138669159|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669160|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
138669161|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669162|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138669163|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669164|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669165|NCT00440609|Ranibizumab|ranibizumab|mesh-list
138669166|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669167|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669168|NCT00440609|Growth Substances|growth substances|mesh-ancestor
138669169|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669170|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669171|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669172|NCT00440648|Sevelamer|sevelamer|mesh-list
138669173|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
138205737|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205741|NCT00005092|Thiotepa|thiotepa|mesh-list
138669174|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
138669175|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669176|NCT00440687|Fluticasone|fluticasone|mesh-list
138669177|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669178|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138669179|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
138669180|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669181|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669182|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138669183|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138669184|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
138669185|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138669186|NCT03271047|Nivolumab|nivolumab|mesh-list
138316982|NCT04498117|Paclitaxel|paclitaxel|mesh-list
138669187|NCT03271047|Ipilimumab|ipilimumab|mesh-list
138669188|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669189|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669190|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138669191|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669192|NCT00440765|Bortezomib|bortezomib|mesh-list
138669193|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669194|NCT00440804|Ibuprofen|ibuprofen|mesh-list
138669195|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669196|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669197|NCT00440804|Analgesics|analgesics|mesh-ancestor
138669198|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
138669199|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669200|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669201|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669202|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669203|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669204|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669205|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669206|NCT00440843|Olanzapine|olanzapine|mesh-list
138669207|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
138669208|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
138454472|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669209|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669210|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669211|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669212|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138669213|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138669214|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669215|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669216|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138669217|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138669218|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205775|NCT00005110|Albuterol|albuterol|mesh-list
138669219|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669220|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669221|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
138669222|NCT00438789|Eculizumab|eculizumab|mesh-list
138669223|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138669224|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669225|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
138669226|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669227|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138669228|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
138669229|NCT00440921|Coagulants|coagulants|mesh-ancestor
138669230|NCT00440960|Lidocaine|lidocaine|mesh-list
138669231|NCT00440960|Midazolam|midazolam|mesh-list
138669232|NCT00440960|Alfentanil|alfentanil|mesh-list
138669233|NCT00440960|Propofol|propofol|mesh-list
138669234|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
138669235|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
138669236|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669237|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669238|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
138669239|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669240|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138669241|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138669242|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138317021|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317022|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317024|NCT04258488|Vitamin K|vitamin k|mesh-list
138669243|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669244|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669245|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138669246|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138669247|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
138669248|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138669249|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138669250|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138669251|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669252|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
138669253|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
138669254|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669255|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138669256|NCT00440960|Narcotics|narcotics|mesh-ancestor
138669257|NCT00440960|Analgesics|analgesics|mesh-ancestor
138669258|NCT00438828|Dexamethasone|dexamethasone|mesh-list
138669259|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669260|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
138669261|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
138669262|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669263|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669264|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669265|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
138669266|NCT00438828|Hormones|hormones|mesh-ancestor
138669267|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669268|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138669269|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669270|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
138669271|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669272|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669273|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669274|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669275|NCT00106002|Pemetrexed|pemetrexed|mesh-list
138669276|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669277|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669278|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669279|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138669280|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669281|NCT00476853|Nevirapine|nevirapine|mesh-list
138669282|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454532|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669283|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669284|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412531|NCT01634945|Amodiaquine|amodiaquine|mesh-list
138669285|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669286|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
138669287|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669288|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669289|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669290|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138669291|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138669292|NCT00438906|Secretin|secretin|mesh-list
138669293|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669294|NCT00438906|Hormones|hormones|mesh-ancestor
138669295|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317036|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669296|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669297|NCT00438945|Eprosartan|eprosartan|mesh-list
138669298|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138669299|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138669300|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138669301|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669302|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
138669303|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138669304|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138346102|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
138669305|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
138669306|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669307|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669308|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669309|NCT00441428|Urological Agents|urological agents|mesh-ancestor
138669311|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
138669312|NCT00438984|Interleukin-2|interleukin-2|mesh-list
138669313|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669314|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
138669315|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669316|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669317|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138669318|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
138669319|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669320|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669321|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138669322|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669323|NCT00438984|Analgesics|analgesics|mesh-ancestor
138669324|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
138669325|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669326|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669327|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669328|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
138669329|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669330|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138669331|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669332|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669334|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669335|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
138669337|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669338|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669339|NCT00439062|Roxithromycin|roxithromycin|mesh-list
138669340|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138669341|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669342|NCT02957162|Atorvastatin|atorvastatin|mesh-list
138669343|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138669344|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138669345|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
138669346|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669347|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138317055|NCT04197687|Antibodies|antibodies|mesh-list
138669348|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138669350|NCT00441740|Gemcitabine|gemcitabine|mesh-list
138669351|NCT00441740|Docetaxel|docetaxel|mesh-list
138669352|NCT00441740|Vinorelbine|vinorelbine|mesh-list
138669353|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138669354|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
138669355|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669356|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669357|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138669358|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138669359|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138669360|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138669361|NCT02274012|Paclitaxel|paclitaxel|mesh-list
138669362|NCT02274012|Afatinib|afatinib|mesh-list
138669363|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138669364|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669365|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138669366|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138669367|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138669368|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669369|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669370|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669371|NCT00477048|Saquinavir|saquinavir|mesh-list
138669372|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138669373|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138669374|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
138669375|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669376|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669377|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669378|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669379|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
138669380|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346174|NCT02004990|Povidone|povidone|mesh-list
138669381|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138669382|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138669383|NCT00477126|Ritonavir|ritonavir|mesh-list
138669384|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138669385|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138669386|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
138669387|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669388|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669389|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669390|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669391|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
138669392|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669393|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138669394|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138669395|NCT03279341|Prucalopride|prucalopride|mesh-list
138669396|NCT03279341|Bisacodyl|bisacodyl|mesh-list
138669397|NCT03279341|Laxatives|laxatives|mesh-ancestor
138669398|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669399|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138669400|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138669401|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
138669402|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669403|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317081|NCT04185883|Atezolizumab|atezolizumab|mesh-list
138317082|NCT04185883|Palbociclib|palbociclib|mesh-list
138669404|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669405|NCT03279341|Cathartics|cathartics|mesh-ancestor
138669407|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
138669408|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669409|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138669410|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138669411|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669412|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669413|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669414|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669416|NCT00442052|Omeprazole|omeprazole|mesh-list
138669417|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669418|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669419|NCT00442052|Analgesics|analgesics|mesh-ancestor
138669420|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
138669421|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205878|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669422|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669423|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669424|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669425|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138669426|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138669427|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669428|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138669429|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669430|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669431|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
138669432|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138669433|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669434|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138669435|NCT00477282|Topotecan|topotecan|mesh-list
138669436|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138669437|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138669438|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669439|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669440|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669441|NCT00439530|Oseltamivir|oseltamivir|mesh-list
138669442|NCT00439530|Probenecid|probenecid|mesh-list
138669443|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
138669444|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669445|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669446|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669447|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
138669448|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
138669449|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669450|NCT00442325|Atorvastatin|atorvastatin|mesh-list
138669451|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138317100|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138317101|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138317107|NCT04117945|Cetuximab|cetuximab|mesh-list
138669453|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
138669454|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669455|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138669456|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138669457|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669458|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
138669459|NCT00477516|Calcium|calcium|mesh-list
138669460|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138669461|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669462|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138669463|NCT00477711|Capecitabine|capecitabine|mesh-list
138669464|NCT00477711|Cetuximab|cetuximab|mesh-list
138669465|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669466|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138669467|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
138669468|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669469|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669470|NCT00442403|Chloroquine|chloroquine|mesh-list
138454666|NCT01900587|Tapentadol|tapentadol|mesh-list
138669471|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138669472|NCT00442403|Amebicides|amebicides|mesh-ancestor
138669473|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138669474|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138669475|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669476|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
138669477|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205904|NCT00004426|Leuprolide|leuprolide|mesh-list
138669478|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669479|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138669480|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
138669481|NCT00477789|Allopurinol|allopurinol|mesh-list
138669482|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
138669483|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669484|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669485|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
138669486|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669487|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138669488|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
138669489|NCT00477789|Protective Agents|protective agents|mesh-ancestor
138669490|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669491|NCT00442481|Escitalopram|escitalopram|mesh-list
138669492|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138669493|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138669494|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669495|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669496|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669497|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
138669498|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669499|NCT00442637|Bevacizumab|bevacizumab|mesh-list
138669500|NCT00442637|Capecitabine|capecitabine|mesh-list
138669501|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669502|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317129|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
138669503|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669504|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669505|NCT00442637|Growth Substances|growth substances|mesh-ancestor
138669506|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669507|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669508|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138669509|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
138669510|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669511|NCT00442676|Celecoxib|celecoxib|mesh-list
138669512|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669513|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669514|NCT00442676|Analgesics|analgesics|mesh-ancestor
138669515|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
138669516|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669517|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669518|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669519|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669520|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138669521|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669522|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669523|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669524|NCT00477945|Clofarabine|clofarabine|mesh-list
138351390|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
138669525|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138669526|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
138669527|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669528|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669529|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
138669530|NCT00442793|Hematinics|hematinics|mesh-ancestor
138669531|NCT00442832|Vancomycin|vancomycin|mesh-list
138669532|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138669533|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669534|NCT00477984|Ethanol|ethanol|mesh-list
138669535|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138669536|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669537|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669538|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669539|NCT00478101|Fentanyl|fentanyl|mesh-list
138669540|NCT00478101|Oxycodone|oxycodone|mesh-list
138669541|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138669542|NCT00478101|Narcotics|narcotics|mesh-ancestor
138669543|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669544|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669545|NCT00478101|Analgesics|analgesics|mesh-ancestor
138669546|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
138317151|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317152|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317154|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138317155|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317158|NCT04043520|Estradiol|estradiol|mesh-list
138669547|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669548|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138669549|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138669550|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
138669552|NCT00440076|Bortezomib|bortezomib|mesh-list
138669553|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669554|NCT00443105|Tacrolimus|tacrolimus|mesh-list
138669555|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669556|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
138669557|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669558|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138669559|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669560|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669561|NCT00443144|Hormones|hormones|mesh-list
138669562|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669563|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669564|NCT00440154|Ezetimibe|ezetimibe|mesh-list
138669565|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138669566|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138669567|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
138669568|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669569|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138669570|NCT00478374|Doxorubicin|doxorubicin|mesh-list
138669571|NCT00478374|Sorafenib|sorafenib|mesh-list
138669572|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138669573|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669574|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138669575|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138669576|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669577|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669578|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669580|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138669581|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
138669582|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669583|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669584|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138669585|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
138669586|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669587|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669588|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138669589|NCT03279549|Mitogens|mitogens|mesh-list
138669590|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317179|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317180|NCT03863288|Oxytocin|oxytocin|mesh-list
138669591|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669593|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669594|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138669595|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138669596|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138669597|NCT00443222|Infliximab|infliximab|mesh-list
138669598|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138669599|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669600|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138669601|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669602|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669604|NCT00440349|Prednisone|prednisone|mesh-list
138669605|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669606|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
138669607|NCT00440349|Hormones|hormones|mesh-ancestor
138669608|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669609|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669610|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138669611|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669612|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138669613|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
138669614|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138669615|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138669616|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138669617|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
138669618|NCT00443339|Hematinics|hematinics|mesh-ancestor
138669619|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
138669620|NCT04700228|Bupivacaine|bupivacaine|mesh-list
138669621|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138669622|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
138669623|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205958|NCT02197273|Protective Agents|protective agents|mesh-ancestor
138205959|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205960|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205961|NCT00004444|Paromomycin|paromomycin|mesh-list
138205962|NCT00004444|Streptomycin|streptomycin|mesh-list
138205963|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138205965|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138205966|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138205968|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669624|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669625|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
138669626|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669627|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138669628|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669629|NCT04700228|Analgesics|analgesics|mesh-ancestor
138669630|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138669631|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138669632|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138669633|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669634|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669635|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669636|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138669637|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138669638|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138669639|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669640|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669641|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669642|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669643|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
138669644|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669646|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
138669647|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
138669648|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669649|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669650|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351400|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
138351401|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669651|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138669652|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
138669653|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669654|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669655|NCT00440622|Gemcitabine|gemcitabine|mesh-list
138669656|NCT00440622|Capecitabine|capecitabine|mesh-list
138669657|NCT00440622|Trastuzumab|trastuzumab|mesh-list
138669658|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138669659|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
138669660|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669661|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669662|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669663|NCT00440661|Diacerein|diacerein|mesh-list
138669664|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669665|NCT03278444|Trimetazidine|trimetazidine|mesh-list
138669666|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
138669667|NCT00440739|Etoricoxib|etoricoxib|mesh-list
138669668|NCT00440739|Flavoxate|flavoxate|mesh-list
138669669|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669670|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669672|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
138669673|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669674|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669675|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669676|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669677|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138669678|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669679|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669680|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669681|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
138669682|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
138669683|NCT00440739|Urological Agents|urological agents|mesh-ancestor
138669684|NCT00443573|Protein C|protein c|mesh-list
138669685|NCT00443573|Anticoagulants|anticoagulants|mesh-list
138669686|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138669687|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138669688|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669690|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669691|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
138669692|NCT00478764|Hormones|hormones|mesh-ancestor
138669693|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669694|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669695|NCT00440778|Abciximab|abciximab|mesh-list
138669696|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
138669697|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138669698|NCT03278405|Avelumab|avelumab|mesh-list
138669699|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669700|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669701|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138669702|NCT00443612|Irbesartan|irbesartan|mesh-list
138669703|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138669704|NCT00443612|Diuretics|diuretics|mesh-ancestor
138669705|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
138669706|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669707|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138317223|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
138317224|NCT03725059|Epirubicin|epirubicin|mesh-list
138669708|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669709|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669710|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138351407|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351408|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138669711|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138669712|NCT00443690|Rolofylline|rolofylline|mesh-list
138669713|NCT00443690|Diuretics|diuretics|mesh-ancestor
138669714|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
138669715|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669716|NCT00440895|Abciximab|abciximab|mesh-list
138669717|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
138669718|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138669719|NCT00440973|Bevacizumab|bevacizumab|mesh-list
138669720|NCT00440973|Interleukin-2|interleukin-2|mesh-list
138669721|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669722|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669723|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669724|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669725|NCT00440973|Growth Substances|growth substances|mesh-ancestor
138669726|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669727|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669728|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669729|NCT00440973|Analgesics|analgesics|mesh-ancestor
138669730|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
138669731|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669732|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138669733|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138669734|NCT00441051|Diclofenac|diclofenac|mesh-list
138669735|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138669736|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669737|NCT00441051|Analgesics|analgesics|mesh-ancestor
138669738|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
138669739|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669740|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669741|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669742|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669744|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317246|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
138317247|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138317256|NCT03607656|Docetaxel|docetaxel|mesh-list
138669745|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669746|NCT00443963|Esomeprazole|esomeprazole|mesh-list
138669747|NCT00443963|Ranitidine|ranitidine|mesh-list
138669748|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138669749|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669750|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138669751|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669752|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669753|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138669754|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
138346546|NCT02159976|Amoxicillin|amoxicillin|mesh-list
138669755|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
138669756|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669757|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669758|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
138669759|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
138669760|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669761|NCT00441207|Protective Agents|protective agents|mesh-ancestor
138669762|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669763|NCT00441207|Vitamins|vitamins|mesh-ancestor
138669764|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
138669765|NCT00444041|Bevacizumab|bevacizumab|mesh-list
138669766|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669767|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669768|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669769|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669770|NCT00444041|Growth Substances|growth substances|mesh-ancestor
138669771|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669772|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669773|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
138669774|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
138669775|NCT00441246|Ephedrine|ephedrine|mesh-list
138669776|NCT00441246|Guaifenesin|guaifenesin|mesh-list
138669777|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138669778|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138669779|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
138669780|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669781|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669782|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138669783|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
138669784|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
138669785|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138317285|NCT03584373|Oxycodone|oxycodone|mesh-list
138317286|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669786|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138669788|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669789|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669790|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669792|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138669793|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138669794|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
138669795|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138669796|NCT00478959|Lenalidomide|lenalidomide|mesh-list
138669797|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
138669798|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669799|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669800|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669801|NCT00478959|Growth Substances|growth substances|mesh-ancestor
138669802|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669803|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669804|NCT00444236|Esomeprazole|esomeprazole|mesh-list
138669805|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138669806|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669807|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138669808|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669809|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669810|NCT00478998|Tamsulosin|tamsulosin|mesh-list
138669811|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138669812|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138669813|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138669814|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669815|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669816|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669817|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669818|NCT00478998|Urological Agents|urological agents|mesh-ancestor
138669819|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138669820|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669821|NCT00479076|Aflibercept|aflibercept|mesh-list
138669822|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669823|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669824|NCT00479076|Growth Substances|growth substances|mesh-ancestor
138669825|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669826|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669827|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669828|NCT00441519|Aspirin|aspirin|mesh-list
138669829|NCT00441519|Omeprazole|omeprazole|mesh-list
138669831|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669832|NCT00441519|Analgesics|analgesics|mesh-ancestor
138669833|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
138317332|NCT03409718|Cimetidine|cimetidine|mesh-list
138669834|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669835|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669836|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669837|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138669838|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138669839|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138454811|NCT01901276|Omeprazole|omeprazole|mesh-list
138669840|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669841|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138669842|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669843|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669844|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
138669845|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138669846|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669847|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138669848|NCT00441597|Atorvastatin|atorvastatin|mesh-list
138669849|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138669850|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138669851|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
138669852|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669853|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138669854|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138669855|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138669856|NCT00479193|Bacitracin|bacitracin|mesh-list
138669857|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138669858|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669859|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138669860|NCT03278015|Paclitaxel|paclitaxel|mesh-list
138669861|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138669862|NCT03278015|Gemcitabine|gemcitabine|mesh-list
138669863|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138669864|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669865|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138669866|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138669867|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138669868|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669869|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138206080|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669870|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
138669872|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669873|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138669874|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138669875|NCT00444314|Growth Substances|growth substances|mesh-ancestor
138317359|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317360|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669876|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669877|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
138669878|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669880|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669882|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138669883|NCT02274051|Growth Substances|growth substances|mesh-ancestor
138669884|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669885|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
138669886|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138669887|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138669888|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669889|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
138669890|NCT00444470|Coagulants|coagulants|mesh-ancestor
138669891|NCT00444548|Reboxetine|reboxetine|mesh-list
138454832|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
138669892|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
138669893|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669894|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138669895|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138669896|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669897|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669898|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669899|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669900|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669901|NCT00444665|Travoprost|travoprost|mesh-list
138669902|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138669903|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
138669904|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669905|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669906|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138669907|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669908|NCT02274090|Metformin|metformin|mesh-list
138669909|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138669910|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669911|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
138669912|NCT00479661|Propofol|propofol|mesh-list
138669913|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138669914|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669915|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669916|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138669917|NCT00479661|Analgesics|analgesics|mesh-ancestor
138669918|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
138669919|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669920|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138669921|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138669922|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138669923|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138669924|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206111|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138669925|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669926|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138317395|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
138669929|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
138669930|NCT04700670|Coagulants|coagulants|mesh-ancestor
138669931|NCT00441870|Folic Acid|folic acid|mesh-list
138669932|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
138669933|NCT00441870|Hematinics|hematinics|mesh-ancestor
138669934|NCT00441870|Vitamins|vitamins|mesh-ancestor
138669935|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
138669936|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669937|NCT04700592|Ketamine|ketamine|mesh-list
138669938|NCT04700592|Gabapentin|gabapentin|mesh-list
138669939|NCT04700592|Analgesics|analgesics|mesh-ancestor
138669940|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
138669941|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669942|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669943|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138669944|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138669945|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
138669946|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
138669947|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669948|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138669949|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138669950|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669951|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669952|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
138669953|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138669954|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138669955|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669956|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
138669958|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138669959|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
138669960|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138669961|NCT00445016|Anesthetics|anesthetics|mesh-list
138669962|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669963|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669964|NCT00445055|Droperidol|droperidol|mesh-list
138669965|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138669966|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
138669968|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669969|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669970|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138669971|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138669972|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138669973|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669974|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138669975|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138669976|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138669977|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
138669978|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346770|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
138669979|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317411|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138669980|NCT00479739|Fluticasone|fluticasone|mesh-list
138669983|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
138317412|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317413|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
138669985|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669986|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138669987|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
138669988|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669989|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138669990|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138669991|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
138669992|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
138669993|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138669994|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
138669996|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669997|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138669998|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138669999|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138670000|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138670001|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670002|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670003|NCT00445094|Vancomycin|vancomycin|mesh-list
138670004|NCT00445094|Imipenem|imipenem|mesh-list
138670005|NCT00445094|Amikacin|amikacin|mesh-list
138670006|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138670007|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138670008|NCT00445094|Cilastatin|cilastatin|mesh-list
138670009|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670010|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670011|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670012|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138670013|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670014|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138670015|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
138670016|NCT00479778|Estrogens|estrogens|mesh-list
138670017|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138670018|NCT00479778|Hormones|hormones|mesh-ancestor
138670019|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670020|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670021|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138317429|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317430|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138670022|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138670023|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
138670024|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138670025|NCT00442026|Gemcitabine|gemcitabine|mesh-list
138670026|NCT00442026|Docetaxel|docetaxel|mesh-list
138670027|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670028|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
138670029|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670030|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670031|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138670032|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138670033|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138670034|NCT00479895|Chrysarobin|chrysarobin|mesh-list
138670035|NCT00479895|HBOC 201|hboc 201|mesh-list
138670036|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138670037|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138670038|NCT00479895|Analgesics|analgesics|mesh-ancestor
138351421|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351422|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670039|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
138670040|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670041|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670042|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670043|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670044|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
138670045|NCT00445250|Calcipotriene|calcipotriene|mesh-list
138670046|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138670047|NCT03279120|Tenofovir|tenofovir|mesh-list
138670048|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
138670049|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
138670050|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670051|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138670052|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138670053|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670054|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670055|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138670056|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138670057|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138670058|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
138670059|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138670060|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670061|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138670062|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138670063|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138670064|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
138670065|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317467|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138670066|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317468|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670068|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670069|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138670070|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138670071|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670072|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670073|NCT03274700|Tamsulosin|tamsulosin|mesh-list
138670074|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138670075|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138670076|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138670077|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454930|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138670078|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670079|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670080|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670081|NCT03274700|Urological Agents|urological agents|mesh-ancestor
138670083|NCT00442221|Sumatriptan|sumatriptan|mesh-list
138670084|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138670085|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138670086|NCT00442221|Analgesics|analgesics|mesh-ancestor
138670087|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
138670088|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670089|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670090|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670092|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
138670093|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138670094|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670095|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670096|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138670097|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138670098|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138670099|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
138670100|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351441|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670101|NCT00454259|Fentanyl|fentanyl|mesh-list
138670102|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138670103|NCT00454259|Narcotics|narcotics|mesh-ancestor
138670104|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670105|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670106|NCT00454259|Analgesics|analgesics|mesh-ancestor
138670107|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
138670108|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670109|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138670110|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138670111|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
138670112|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
138670113|NCT03278808|Azithromycin|azithromycin|mesh-list
138670114|NCT03278808|Chloroquine|chloroquine|mesh-list
138670115|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138670116|NCT03278808|Atovaquone|atovaquone|mesh-list
138670117|NCT03278808|Proguanil|proguanil|mesh-list
138670118|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138670119|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670120|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670121|NCT03278808|Amebicides|amebicides|mesh-ancestor
138670122|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138670123|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138670124|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
138454959|NCT01902225|Doxorubicin|doxorubicin|mesh-list
138670125|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670126|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138670127|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138670128|NCT03278808|Analgesics|analgesics|mesh-ancestor
138670129|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
138670130|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670131|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670132|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670133|NCT03278808|Filaricides|filaricides|mesh-ancestor
138670134|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
138670135|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
138670136|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670137|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670138|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
138670140|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670141|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
138670142|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670143|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670144|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
138670145|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670146|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670147|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
138670148|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670149|NCT00454883|Ziprasidone|ziprasidone|mesh-list
138670150|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138670151|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
138670152|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670153|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670154|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670155|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138670156|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670157|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670158|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138670159|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138670160|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
138670161|NCT03278652|Analgesics|analgesics|mesh-list
138670162|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
138670163|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670164|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670165|NCT00454961|Lumefantrine|lumefantrine|mesh-list
138670166|NCT00454961|Artemether|artemether|mesh-list
138670167|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138670168|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
138317510|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
138317511|NCT01585805|Cisplatin|cisplatin|mesh-list
138317512|NCT01585805|Gemcitabine|gemcitabine|mesh-list
138670169|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138670170|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138670171|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670172|NCT00480207|Folic Acid|folic acid|mesh-list
138670173|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
138670174|NCT00480207|Hematinics|hematinics|mesh-ancestor
138670176|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
138670177|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454985|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
138670178|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138670179|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670180|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670181|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670182|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670183|NCT02956655|Insulin|insulin|mesh-list
138670184|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138670185|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138670186|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670187|NCT00480246|Perphenazine|perphenazine|mesh-list
138670188|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138670189|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670190|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670191|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670192|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138670193|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138670194|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
138670195|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670196|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670197|NCT00455117|Parecoxib|parecoxib|mesh-list
138670198|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138670199|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138670200|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670201|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670202|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138670203|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138670205|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
138670206|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670207|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670208|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670209|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670210|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
138670211|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670212|NCT03274427|Trimetazidine|trimetazidine|mesh-list
138670213|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
138670214|NCT00455234|Promethazine|promethazine|mesh-list
138670215|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
138670216|NCT00455234|Haloperidol|haloperidol|mesh-list
138670217|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
138670218|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
138670219|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
138670220|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670221|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670222|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138670223|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138670224|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670225|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670226|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138670227|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138670228|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
138670229|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670230|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455011|NCT01902511|Hematinics|hematinics|mesh-ancestor
138670231|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138317544|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138317545|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670232|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
138317546|NCT01208662|Growth Substances|growth substances|mesh-ancestor
138317548|NCT00929045|Hormones|hormones|mesh-list
138670234|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138670235|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
138670236|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
138670237|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138670238|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138670239|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138670240|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
138670242|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
138670243|NCT00480363|Dexamethasone|dexamethasone|mesh-list
138670244|NCT00480363|Lenalidomide|lenalidomide|mesh-list
138670245|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670246|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
138670247|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
138670248|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670249|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670250|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138670251|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
138670252|NCT00480363|Hormones|hormones|mesh-ancestor
138670253|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670254|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138670255|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670256|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
138670257|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670258|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670259|NCT00480363|Growth Substances|growth substances|mesh-ancestor
138670260|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670261|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
138670263|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138670264|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670265|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
138670266|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670267|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138670268|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138670269|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670270|NCT00455507|Istradefylline|istradefylline|mesh-list
138670271|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138670272|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138670273|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138670274|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
138670275|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455032|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670276|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670277|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670278|NCT00480402|Progesterone|progesterone|mesh-list
138670279|NCT00480402|Progestins|progestins|mesh-ancestor
138670281|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670282|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670283|NCT00455585|Lamivudine|lamivudine|mesh-list
138670284|NCT00455585|Nevirapine|nevirapine|mesh-list
138670285|NCT00455585|Stavudine|stavudine|mesh-list
138670286|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138670287|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138670288|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670289|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670290|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
138670291|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670292|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138670293|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138670294|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138670295|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138670296|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
138670297|NCT00455624|Androgens|androgens|mesh-list
138670298|NCT00455624|Hormones|hormones|mesh-ancestor
138317553|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
138317554|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317559|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670299|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670300|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670301|NCT00455897|Rituximab|rituximab|mesh-list
138670302|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351450|NCT02796144|Metformin|metformin|mesh-list
138351451|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138670303|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670304|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
138670305|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670306|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670307|NCT00455936|Gefitinib|gefitinib|mesh-list
138670308|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670309|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670310|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670311|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670313|NCT00443235|Prednisone|prednisone|mesh-list
138670314|NCT00443235|Melphalan|melphalan|mesh-list
138670315|NCT00443235|Bortezomib|bortezomib|mesh-list
138670316|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670317|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
138670318|NCT00443235|Hormones|hormones|mesh-ancestor
138670319|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670320|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670321|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138670322|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670323|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138670324|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
138670325|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670326|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138670327|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670328|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
138670329|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
138670330|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670331|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670332|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670333|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670334|NCT00443235|Growth Substances|growth substances|mesh-ancestor
138670335|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670336|NCT04700943|Anesthetics|anesthetics|mesh-list
138670337|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670338|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670339|NCT00456248|Ribavirin|ribavirin|mesh-list
138670340|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
138317564|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
138670341|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
138670342|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670343|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
138670344|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670346|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
138670347|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670348|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
138670349|NCT04700709|Sirolimus|sirolimus|mesh-list
138670350|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138670351|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670352|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138670353|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
138670354|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670355|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670356|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670357|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670358|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
138670359|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670360|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
138670361|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670362|NCT04698317|Mitogens|mitogens|mesh-list
138670363|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
138670364|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670366|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
138670367|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
138670368|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138670369|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
138455083|NCT01902875|Paclitaxel|paclitaxel|mesh-list
138670370|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
138670371|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670372|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138670373|NCT04700436|Ezetimibe|ezetimibe|mesh-list
138670374|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138670375|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670376|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
138670377|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670378|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138317600|NCT01454076|Ixazomib|ixazomib|mesh-list
138317601|NCT01454076|Glycine|glycine|mesh-list
138670379|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138670380|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670381|NCT00480597|Gemcitabine|gemcitabine|mesh-list
138670382|NCT00480597|Capecitabine|capecitabine|mesh-list
138670383|NCT00480597|Vinorelbine|vinorelbine|mesh-list
138670384|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670385|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670386|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
138670387|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670388|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138670389|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
138670390|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
138670391|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
138670392|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138670393|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138670394|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
138670396|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670397|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670398|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138670399|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
138670400|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138670401|NCT00480675|Prednisolone|prednisolone|mesh-list
138670402|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
138670403|NCT00480675|Bupivacaine|bupivacaine|mesh-list
138670404|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138670405|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
138670406|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
138670407|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
138670408|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670409|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670410|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
138317635|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317637|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670412|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138317678|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670414|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
138670415|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138670416|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
138670417|NCT00480675|Hormones|hormones|mesh-ancestor
138670418|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670419|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138670420|NCT00480675|Protective Agents|protective agents|mesh-ancestor
138670421|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138670422|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670423|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
138670424|NCT00456560|Paroxetine|paroxetine|mesh-list
138670425|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138455118|NCT01903083|Gemcitabine|gemcitabine|mesh-list
138670426|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138670427|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670428|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670429|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347210|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
138670431|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206326|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670432|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138670434|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138670435|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138670436|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351463|NCT02813070|Flutemetamol|flutemetamol|mesh-list
138351464|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138351466|NCT02815644|Empagliflozin|empagliflozin|mesh-list
138670437|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670438|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138670439|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670440|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670441|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138670442|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138670443|NCT00456677|Minocycline|minocycline|mesh-list
138670444|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670445|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670446|NCT00456716|Sorafenib|sorafenib|mesh-list
138206375|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670447|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670448|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670449|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670450|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670451|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
138670452|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
138670453|NCT00456794|Istradefylline|istradefylline|mesh-list
138670454|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138670455|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138670456|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138670457|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
138670458|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670459|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670460|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670461|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138670462|NCT00456833|Everolimus|everolimus|mesh-list
138670463|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670464|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670465|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670466|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670467|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138206437|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
138670468|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670469|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
138670470|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670471|NCT00456872|Lidocaine|lidocaine|mesh-list
138670472|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
138670473|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
138670474|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670475|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455131|NCT01903109|Cevimeline|cevimeline|mesh-list
138670476|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
138670477|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670478|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138670479|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138670480|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138670481|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670482|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670483|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
138670484|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
138670485|NCT00457067|Ranibizumab|ranibizumab|mesh-list
138317700|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
138317701|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
138317702|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670486|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670487|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670488|NCT00457067|Growth Substances|growth substances|mesh-ancestor
138670489|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670490|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670491|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670492|NCT00480870|Donepezil|donepezil|mesh-list
138670493|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138670494|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670495|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351473|NCT02815644|Hormones|hormones|mesh-ancestor
138351475|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138670496|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
138670497|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670498|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670499|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
138670500|NCT00457106|Risperidone|risperidone|mesh-list
138670502|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138670503|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
138670504|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670505|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670506|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670507|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138670508|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670509|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670511|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138670512|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
138670513|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138670514|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138670515|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670516|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138670517|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
138670518|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138670519|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138670520|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670521|NCT00457145|Ranibizumab|ranibizumab|mesh-list
138670522|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670523|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670524|NCT00457145|Growth Substances|growth substances|mesh-ancestor
138670525|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670526|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670527|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670529|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
138670530|NCT00457223|Coagulants|coagulants|mesh-ancestor
138670531|NCT00443508|Everolimus|everolimus|mesh-list
138670532|NCT00443508|Tacrolimus|tacrolimus|mesh-list
138670533|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670534|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
138670535|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670536|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138670537|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670538|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670539|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138670540|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670541|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670542|NCT00457340|Atorvastatin|atorvastatin|mesh-list
138670543|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138670544|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670545|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
138670546|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670547|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138670548|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138670549|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670550|NCT03278379|Avelumab|avelumab|mesh-list
138670551|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138670552|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670553|NCT02956538|Thalidomide|thalidomide|mesh-list
138670554|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670555|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
138670556|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670557|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
138670558|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670559|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670560|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670561|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670562|NCT02956538|Growth Substances|growth substances|mesh-ancestor
138670563|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670564|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670565|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138670566|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138670567|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670568|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
138206652|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
138670569|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670570|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138670571|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138670572|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670573|NCT00457769|Donepezil|donepezil|mesh-list
138317790|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
138670574|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138670575|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670576|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670577|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
138670578|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670579|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670580|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
138670581|NCT00457808|Sirolimus|sirolimus|mesh-list
138670582|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670583|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670584|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138670585|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670586|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
138670587|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670588|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
138670589|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670590|NCT00481143|Deferasirox|deferasirox|mesh-list
138670591|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138670592|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
138670593|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
138670594|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670595|NCT00457964|Everolimus|everolimus|mesh-list
138670596|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138670597|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670598|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670599|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670600|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670601|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
138670602|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317819|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138670605|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138670606|NCT00458081|Rimonabant|rimonabant|mesh-list
138670607|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138670608|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138670609|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138670610|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670611|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670612|NCT00458081|Hormones|hormones|mesh-ancestor
138670613|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670614|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670615|NCT00481182|Ritonavir|ritonavir|mesh-list
138670616|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
138670617|NCT00481182|Methadone|methadone|mesh-list
138670618|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138670619|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138206693|NCT01364623|Androgens|androgens|mesh-ancestor
138670620|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
138670621|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351482|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670622|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351483|NCT02820324|Analgesics|analgesics|mesh-ancestor
138670624|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138351499|NCT02835846|Hormones|hormones|mesh-ancestor
138670625|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
138670626|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670627|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138670628|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138670629|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138670630|NCT00481182|Narcotics|narcotics|mesh-ancestor
138670631|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670632|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670633|NCT00481182|Analgesics|analgesics|mesh-ancestor
138670634|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
138670635|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670636|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
138670637|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
138670638|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
138670639|NCT00443937|Everolimus|everolimus|mesh-list
138670640|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138670641|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138670642|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670643|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670644|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670645|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
138670646|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670647|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670648|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138317867|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138317885|NCT01490190|NuvaRing|nuvaring|mesh-list
138670649|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138670650|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
138670651|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670652|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670653|NCT00458315|Paclitaxel|paclitaxel|mesh-list
138670654|NCT00458315|Bevacizumab|bevacizumab|mesh-list
138347435|NCT05602272|Anesthetics|anesthetics|mesh-list
138670655|NCT00458315|Gemcitabine|gemcitabine|mesh-list
138670656|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138670657|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670658|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138670659|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138670660|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138670661|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670662|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138455233|NCT01904110|Vitamin D|vitamin d|mesh-list
138670663|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138670664|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670665|NCT00458315|Growth Substances|growth substances|mesh-ancestor
138670666|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670667|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
138670668|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670669|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
138670670|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138670672|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670673|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138206719|NCT03015857|Fentanyl|fentanyl|mesh-list
138670674|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670675|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670676|NCT00458510|Fentanyl|fentanyl|mesh-list
138670677|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138670678|NCT00458510|Narcotics|narcotics|mesh-ancestor
138670679|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670680|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670681|NCT00458510|Analgesics|analgesics|mesh-ancestor
138670682|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
138670683|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670684|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138670685|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138670686|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
138670687|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
138670688|NCT00444132|Clopidogrel|clopidogrel|mesh-list
138670689|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138670690|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138670691|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138670692|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138670693|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
138670694|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670695|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670696|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670697|NCT00444171|Insulin|insulin|mesh-list
138670698|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138670699|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138670700|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670701|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
138670702|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670703|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670704|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138670705|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138670706|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670707|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455266|NCT01904357|Cefazolin|cefazolin|mesh-list
138670708|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670709|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138670710|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138670711|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138670712|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670713|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670715|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670716|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670717|NCT00459173|Rimonabant|rimonabant|mesh-list
138670718|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138670719|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138670720|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138670721|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670722|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670723|NCT00459173|Hormones|hormones|mesh-ancestor
138670724|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670725|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670726|NCT00444249|Dipivefrin|dipivefrin|mesh-list
138347528|NCT04143204|Insulin|insulin|mesh-list
138670727|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138670728|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
138206738|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
138670729|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670730|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670731|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670732|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138670734|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670735|NCT00459407|Protective Agents|protective agents|mesh-ancestor
138670736|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670737|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138670738|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138670739|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670740|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138670741|NCT03278262|Aflibercept|aflibercept|mesh-list
138670742|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138317911|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138317912|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317913|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138317914|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138317918|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
138670743|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138670744|NCT03278262|Growth Substances|growth substances|mesh-ancestor
138670745|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670746|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455293|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
138670747|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670748|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
138670749|NCT00459485|Astringents|astringents|mesh-ancestor
138670750|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670751|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
138670753|NCT00459563|Calcitriol|calcitriol|mesh-list
138670754|NCT00459563|Vitamins|vitamins|mesh-ancestor
138670755|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
138670756|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670757|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138670758|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138670759|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138670760|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670761|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670762|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138670763|NCT01242384|Silicon|silicon|mesh-list
138670764|NCT01242384|Trace Elements|trace elements|mesh-ancestor
138670765|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
138670766|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670767|NCT00488436|Cyclosporine|cyclosporine|mesh-list
138670768|NCT00488436|Cyclosporins|cyclosporins|mesh-list
138670769|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138670770|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670771|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670772|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670773|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
138670774|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670775|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
138670776|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670777|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
138670778|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670779|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138670780|NCT00459719|Tacrolimus|tacrolimus|mesh-list
138670781|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670782|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
138670783|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670784|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138670785|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670786|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670787|NCT00495183|Biperiden|biperiden|mesh-list
138670788|NCT00495183|Caffeine|caffeine|mesh-list
138317949|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138317951|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
138317953|NCT01470144|Epoprostenol|epoprostenol|mesh-list
138670789|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138670790|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670791|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138670793|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670794|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138670795|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138670796|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
138670797|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670798|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138670799|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138670800|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
138670801|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
138670802|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670803|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138455325|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317982|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670804|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138670805|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
138670807|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138670808|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138670809|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670810|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670811|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670812|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
138670813|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670814|NCT00459836|Gemcitabine|gemcitabine|mesh-list
138670815|NCT00459836|Docetaxel|docetaxel|mesh-list
138670816|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670817|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
138670818|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670819|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670820|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
138670821|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
138670822|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
138670823|NCT00488709|Cytarabine|cytarabine|mesh-list
138670824|NCT00488709|Fludarabine|fludarabine|mesh-list
138670825|NCT00488709|Topotecan|topotecan|mesh-list
138670826|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670827|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138670828|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
138670829|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670830|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670831|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
138670832|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670833|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
138670834|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670835|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138670836|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138670837|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670838|NCT00459992|Betahistine|betahistine|mesh-list
138670840|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
138670841|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
138670842|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670843|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670844|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670845|NCT00495339|Levofloxacin|levofloxacin|mesh-list
138670846|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138670847|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670848|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670849|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138670850|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138670851|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455349|NCT01904747|Palbociclib|palbociclib|mesh-list
138670852|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670853|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670854|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138670855|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138670856|NCT00460148|Ropinirole|ropinirole|mesh-list
138670857|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138670858|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138670859|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
138670860|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
138670861|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670862|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670863|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670864|NCT00460226|Lamotrigine|lamotrigine|mesh-list
138670865|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
138670866|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138670867|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670868|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206815|NCT01076231|Etoposide|etoposide|mesh-list
138670869|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138670870|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670871|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138670872|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138670873|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670874|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138670875|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138670876|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
138670877|NCT00495378|Hematinics|hematinics|mesh-ancestor
138670878|NCT00460304|Pramlintide|pramlintide|mesh-list
138670879|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138670880|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670882|NCT00460382|Darunavir|darunavir|mesh-list
138670883|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
138670884|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
138670885|NCT00460382|Etravirine|etravirine|mesh-list
138670886|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138670887|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138670888|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
138670889|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670890|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670891|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138670894|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670895|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138351500|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351501|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670896|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138670897|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138670898|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138670899|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138670900|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138670901|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138670902|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138670903|NCT01242579|Maraviroc|maraviroc|mesh-list
138670904|NCT01242579|Dapivirine|dapivirine|mesh-list
138670905|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138670906|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138670907|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670908|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138670909|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138670910|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
138670911|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670912|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138670913|NCT00460499|Insulin|insulin|mesh-list
138670914|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138670915|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670916|NCT00495573|Acyclovir|acyclovir|mesh-list
138670917|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
138670918|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670919|NCT00488787|Ketamine|ketamine|mesh-list
138670920|NCT00488787|Analgesics|analgesics|mesh-ancestor
138670921|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
138670922|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670923|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670924|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138670925|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138670926|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
138670927|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
138670928|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670929|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138670930|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138670931|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670932|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670933|NCT00460616|Cabergoline|cabergoline|mesh-list
138670934|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138670935|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138670936|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
138670937|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
138670938|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670939|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670940|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670941|NCT00495651|Isoniazid|isoniazid|mesh-list
138670942|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138670943|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
138670944|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670945|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670946|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138670947|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670948|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
138670949|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670950|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138347749|NCT05352282|Fentanyl|fentanyl|mesh-list
138670952|NCT00460733|Vitamin D|vitamin d|mesh-list
138670953|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
138670954|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
138670956|NCT00460733|Vitamins|vitamins|mesh-ancestor
138670957|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
138670960|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138670961|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138670962|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138670963|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670964|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138670965|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
138670966|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670968|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138670969|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138670970|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
138670971|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670972|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138670973|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138670974|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670975|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
138670977|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
138670978|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138670979|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138670980|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
138670981|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670982|NCT00461084|Clarithromycin|clarithromycin|mesh-list
138670983|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138670984|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138670985|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138670986|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670987|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670988|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138670989|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138670990|NCT00495846|Octreotide|octreotide|mesh-list
138670991|NCT00495846|Lanreotide|lanreotide|mesh-list
138670992|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138670993|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138670994|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670995|NCT00105482|Naltrexone|naltrexone|mesh-list
138670996|NCT00105482|Nicotine|nicotine|mesh-list
138670997|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138670998|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
138670999|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671000|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671001|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138671002|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138671003|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671004|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671005|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671006|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138671007|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138671012|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671013|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138671014|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138671015|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671016|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671017|NCT00489099|Vaccines|vaccines|mesh-list
138671018|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
138671019|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671020|NCT00496158|Adefovir|adefovir|mesh-list
138671021|NCT00496158|Clevudine|clevudine|mesh-list
138671022|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
138671023|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671024|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138671025|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138671026|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671027|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671028|NCT00489138|Ertapenem|ertapenem|mesh-list
138671029|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671030|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671031|NCT00461396|Interferons|interferons|mesh-list
138671032|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
138671033|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671034|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
138671035|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671036|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138671037|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
138671038|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671039|NCT01327651|Tenofovir|tenofovir|mesh-list
138671040|NCT01327651|Emtricitabine|emtricitabine|mesh-list
138671041|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
138671042|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671043|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138671044|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138671045|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671046|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671047|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138671048|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138671049|NCT00496275|Cisplatin|cisplatin|mesh-list
138671050|NCT00496275|Gemcitabine|gemcitabine|mesh-list
138671051|NCT00496275|Vinorelbine|vinorelbine|mesh-list
138671052|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671053|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671054|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
138671055|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671056|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138206897|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671058|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
138671059|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
138671060|NCT00591604|Vitamin D|vitamin d|mesh-list
138671061|NCT00591604|Vitamins|vitamins|mesh-ancestor
138671062|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
138671063|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671064|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138671065|NCT00591643|Epinephrine|epinephrine|mesh-list
138671066|NCT00591643|Racepinephrine|racepinephrine|mesh-list
138671067|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
138671068|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138671069|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138671070|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
138671071|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671072|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671073|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671074|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138671075|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138671076|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
138671077|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671078|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138671079|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
138671080|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
138671081|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
138671082|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138671083|NCT00461747|Thalidomide|thalidomide|mesh-list
138671084|NCT00461747|Dexamethasone|dexamethasone|mesh-list
138671085|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
138671086|NCT00461747|Bortezomib|bortezomib|mesh-list
138671087|NCT00461747|BB 1101|bb 1101|mesh-list
138671088|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671089|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
138671090|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
138671091|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671092|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671093|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138671094|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
138671095|NCT00461747|Hormones|hormones|mesh-ancestor
138282886|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671096|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671097|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671098|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671099|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
138347885|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671100|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671101|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671102|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671103|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
138671104|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
138671105|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671106|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671107|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206922|NCT01859819|Cytarabine|cytarabine|mesh-list
138671108|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671109|NCT00461747|Growth Substances|growth substances|mesh-ancestor
138671110|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671112|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
138671113|NCT00461825|Azathioprine|azathioprine|mesh-list
138671114|NCT00461825|Cyclosporins|cyclosporins|mesh-list
138671115|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671116|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671117|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671118|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
138671119|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671120|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
138351508|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351509|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671121|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671122|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
138671123|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671124|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138671125|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138671126|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671127|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138671128|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
138671129|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671130|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
138671131|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671132|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138671133|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
138671134|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671135|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
138671136|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138671137|NCT00489372|Protective Agents|protective agents|mesh-ancestor
138671138|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671139|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671140|NCT00461903|Perindopril|perindopril|mesh-list
138671141|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138671142|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138671143|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671144|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671145|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138671146|NCT00496392|Fentanyl|fentanyl|mesh-list
138671147|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138671149|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671150|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671153|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671154|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138671155|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138671156|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
138671157|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
138671158|NCT02893618|Diazoxide|diazoxide|mesh-list
138671159|NCT02893618|Choline|choline|mesh-list
138671160|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
138671161|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138671162|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
138671163|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671164|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138671165|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138671166|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
138671167|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138671168|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
138671169|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
138671170|NCT00496665|Methotrexate|methotrexate|mesh-list
138671171|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671172|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
138671173|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671174|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671175|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347960|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
138671176|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
138671177|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671178|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671179|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138671180|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138671181|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
138671182|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671183|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671184|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
138671185|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
138671186|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671187|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138671192|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671193|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
138671194|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671195|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671196|NCT00591916|Thrombin|thrombin|mesh-list
138671197|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
138671198|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
138671199|NCT00591916|Coagulants|coagulants|mesh-ancestor
138671200|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138671201|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
138671202|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671203|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
138671204|NCT00591916|Protective Agents|protective agents|mesh-ancestor
138671205|NCT00462215|Vaccines|vaccines|mesh-list
138671206|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
138671207|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671208|NCT00462371|Insulin|insulin|mesh-list
138671209|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671210|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671211|NCT00497016|Atorvastatin|atorvastatin|mesh-list
138671212|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138671213|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138671214|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
138671215|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671216|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138671217|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138671218|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671220|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
138671221|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138671222|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671223|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671224|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138671225|NCT00497172|Sirolimus|sirolimus|mesh-list
138671226|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671227|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671228|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138671229|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671230|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
138671231|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671232|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
138671233|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671234|NCT03273296|Amoxicillin|amoxicillin|mesh-list
138671238|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671239|NCT00497250|Gefitinib|gefitinib|mesh-list
138671240|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671241|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671242|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671243|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671244|NCT00462878|Vancomycin|vancomycin|mesh-list
138671245|NCT00462878|Meropenem|meropenem|mesh-list
138671246|NCT00462878|Teicoplanin|teicoplanin|mesh-list
138671247|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671248|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671249|NCT00462956|Lapatinib|lapatinib|mesh-list
138671250|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671251|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671252|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671253|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671254|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138671255|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671256|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671257|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671258|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671259|NCT00489528|Hormones|hormones|mesh-list
138671260|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671261|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671262|NCT00463073|Bevacizumab|bevacizumab|mesh-list
138671263|NCT00463073|Cetuximab|cetuximab|mesh-list
138671264|NCT00463073|Irinotecan|irinotecan|mesh-list
138671265|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138671266|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671267|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671268|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671269|NCT00463073|Growth Substances|growth substances|mesh-ancestor
138671270|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671271|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671272|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138671273|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138671274|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671275|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671276|NCT00463112|Sibutramine|sibutramine|mesh-list
138671283|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671284|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138671285|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671286|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
138671287|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671288|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
138671289|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671290|NCT00489645|Pramlintide|pramlintide|mesh-list
138671291|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138671292|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671293|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671294|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
138671295|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138671296|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138671297|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671298|NCT00463268|Vitamin D|vitamin d|mesh-list
138671299|NCT00463268|Alendronate|alendronate|mesh-list
138671300|NCT00463268|Calcium|calcium|mesh-list
138671301|NCT00463268|Vitamins|vitamins|mesh-ancestor
138455582|NCT01906762|Morphine|morphine|mesh-list
138671302|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
138671303|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671304|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138671305|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138671307|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138671308|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138671309|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138671310|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138671311|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671312|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671313|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671314|NCT00489723|Urological Agents|urological agents|mesh-ancestor
138671315|NCT00105443|Sorafenib|sorafenib|mesh-list
138671316|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671317|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671319|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671322|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671323|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671324|NCT00489840|Growth Substances|growth substances|mesh-ancestor
138671325|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671326|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671327|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671328|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671329|NCT00463502|Metformin|metformin|mesh-list
138348112|NCT02418312|Famotidine|famotidine|mesh-list
138671330|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671331|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671332|NCT00489996|Gemcitabine|gemcitabine|mesh-list
138671333|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671334|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671335|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
138671336|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671337|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
138671338|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138671339|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138671340|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671341|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671342|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671343|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671344|NCT00463541|Urological Agents|urological agents|mesh-ancestor
138671345|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
138671346|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
138671347|NCT00490113|Vitamins|vitamins|mesh-ancestor
138671348|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
138671349|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671350|NCT01243203|Varenicline|varenicline|mesh-list
138671351|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138671352|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138671353|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671354|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671355|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455600|NCT01906801|Diacerein|diacerein|mesh-list
138671356|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671357|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
138671358|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138671359|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
138207122|NCT01425853|Celecoxib|celecoxib|mesh-list
138671360|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671361|NCT00497328|Expectorants|expectorants|mesh-ancestor
138671362|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
138671363|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138671364|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
138671365|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671366|NCT00497328|Protective Agents|protective agents|mesh-ancestor
138671367|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671368|NCT00497328|Antidotes|antidotes|mesh-ancestor
138671369|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
138671370|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
138671371|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138671372|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
138671373|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671374|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671375|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671377|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138671378|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138671379|NCT00466154|Analgesics|analgesics|mesh-ancestor
138671380|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
138671381|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671382|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671383|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671384|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671385|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138671386|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138671387|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671388|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138671389|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138671390|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671391|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
138671392|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138671393|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138671394|NCT00490308|Estradiol|estradiol|mesh-list
138671395|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138671396|NCT00490308|Estrogens|estrogens|mesh-ancestor
138671397|NCT00490308|Hormones|hormones|mesh-ancestor
138671398|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671399|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671400|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138671401|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
138671402|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671403|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138671404|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
138671405|NCT00463736|Analgesics|analgesics|mesh-ancestor
138671406|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
138671407|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671408|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671410|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671411|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138671412|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
138671413|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138671414|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671415|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671416|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138671417|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
138671418|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671419|NCT00490464|Nicardipine|nicardipine|mesh-list
138671420|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138671422|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671423|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671424|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138671425|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671426|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
138671427|NCT00497523|Beclomethasone|beclomethasone|mesh-list
138671428|NCT00497523|Albuterol|albuterol|mesh-list
138671429|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138671430|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
138671431|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671432|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671433|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138671434|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138671435|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
138671436|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671437|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138671438|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138671439|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138671440|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
138671441|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671442|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671443|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671444|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
138671445|NCT00497523|Hormones|hormones|mesh-ancestor
138671446|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671447|NCT00463775|Topiramate|topiramate|mesh-list
138671448|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
138671449|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671450|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671451|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
138671452|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671453|NCT00466232|Sorafenib|sorafenib|mesh-list
138671454|NCT00466232|Topotecan|topotecan|mesh-list
138671455|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671456|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671457|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671458|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671459|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138671460|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138671461|NCT00490659|Gemcitabine|gemcitabine|mesh-list
138671462|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207162|NCT01427881|Busulfan|busulfan|mesh-list
138671463|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671465|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671467|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671468|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671469|NCT00497562|Tramadol|tramadol|mesh-list
138671470|NCT00497562|Amitriptyline|amitriptyline|mesh-list
138671471|NCT00497562|Fluoxetine|fluoxetine|mesh-list
138671472|NCT00497562|Hormones|hormones|mesh-list
138671473|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671474|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671475|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138671476|NCT00497562|Narcotics|narcotics|mesh-ancestor
138671477|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671478|NCT00497562|Analgesics|analgesics|mesh-ancestor
138671479|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
138671480|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671481|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138671482|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138671483|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671484|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671485|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671486|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
138671487|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138671488|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
138671489|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138671490|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138671491|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138671492|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671493|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138671494|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138671495|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138671496|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
138671497|NCT00497601|Amphotericin B|amphotericin b|mesh-list
138671498|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138671499|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138671500|NCT00497601|Amebicides|amebicides|mesh-ancestor
138671501|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138671502|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138671503|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671504|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671505|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
138671506|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138671507|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138671509|NCT00466388|Cevimeline|cevimeline|mesh-list
138671510|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138671511|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
138671512|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671513|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671514|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138671515|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138671516|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671517|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671518|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671519|NCT00466466|Everolimus|everolimus|mesh-list
138671520|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138671521|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671523|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671524|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671525|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
138671526|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671527|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671528|NCT00490854|Insulin|insulin|mesh-list
138671529|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138671530|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
138671531|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
138671532|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
138671533|NCT00490854|Protamines|protamines|mesh-list
138671534|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671535|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671536|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
138671537|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671538|NCT00490854|Coagulants|coagulants|mesh-ancestor
138671539|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
138671540|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671541|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671542|NCT03272126|Vitamin D|vitamin d|mesh-list
138671543|NCT03272126|Vitamins|vitamins|mesh-ancestor
138671544|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
138671545|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671546|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138671547|NCT00491049|Levofloxacin|levofloxacin|mesh-list
138671548|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138671549|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138671550|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138671551|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671552|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671553|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138671554|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138671555|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671556|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455707|NCT01907529|Epirubicin|epirubicin|mesh-list
138671557|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351510|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671561|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138671562|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138671563|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138671564|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351511|NCT02845752|Bromides|bromides|mesh-list
138671565|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671567|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671568|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671569|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
138671570|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138671571|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138671572|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138671573|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671574|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671575|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671576|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671577|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671578|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138671579|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671580|NCT03272321|Oxytocin|oxytocin|mesh-list
138671581|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
138671582|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671583|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671584|NCT00491127|Dexamethasone|dexamethasone|mesh-list
138671585|NCT00491127|Gemcitabine|gemcitabine|mesh-list
138671586|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671587|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
138671588|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
138671589|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671590|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671591|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138671592|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
138671593|NCT00491127|Hormones|hormones|mesh-ancestor
138671594|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671595|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671596|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671597|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671598|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
138671599|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671600|NCT00491166|Bromfenac|bromfenac|mesh-list
138671601|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138671603|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138671605|NCT00491166|Analgesics|analgesics|mesh-ancestor
138671606|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
138671607|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671608|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671609|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671610|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671611|NCT03273062|Tolcapone|tolcapone|mesh-list
138455730|NCT01907594|Nicotine|nicotine|mesh-list
138671612|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138671613|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138671614|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138671615|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671616|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671617|NCT00498108|Rotigotine|rotigotine|mesh-list
138671618|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
138671619|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
138671620|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671621|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671622|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671623|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138671624|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
138671625|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671626|NCT00498225|Gemcitabine|gemcitabine|mesh-list
138671627|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671628|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
138671629|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671630|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671631|NCT00466622|Metformin|metformin|mesh-list
138671632|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671633|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671634|NCT01327612|Leucovorin|leucovorin|mesh-list
138671635|NCT01327612|Bevacizumab|bevacizumab|mesh-list
138671636|NCT01327612|Conatumumab|conatumumab|mesh-list
138671637|NCT01327612|Fluorouracil|fluorouracil|mesh-list
138671638|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
138671639|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138671640|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671641|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671642|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671643|NCT01327612|Growth Substances|growth substances|mesh-ancestor
138671644|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671645|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671648|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671649|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671650|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
138671651|NCT01327612|Antidotes|antidotes|mesh-ancestor
138671652|NCT01327612|Protective Agents|protective agents|mesh-ancestor
138671653|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
138671654|NCT01327612|Vitamins|vitamins|mesh-ancestor
138671655|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
138671656|NCT01243281|Entecavir|entecavir|mesh-list
138671657|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
138671658|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671659|NCT00464399|Everolimus|everolimus|mesh-list
138671660|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138671661|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138671662|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207270|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671663|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671664|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671665|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
138671666|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671667|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671668|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
138671669|NCT04132882|Antidotes|antidotes|mesh-ancestor
138671670|NCT04132882|Protective Agents|protective agents|mesh-ancestor
138671671|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671672|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
138671673|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671674|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
138671675|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671676|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671677|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
138671678|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
138671679|NCT01243359|Bevacizumab|bevacizumab|mesh-list
138671680|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138671681|NCT01243359|Sunitinib|sunitinib|mesh-list
138671682|NCT01243359|Antibodies|antibodies|mesh-list
138671683|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
138671684|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138671685|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671686|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671687|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671688|NCT01243359|Growth Substances|growth substances|mesh-ancestor
138671689|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671690|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671691|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
138671694|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671695|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
138671696|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138671697|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
138671698|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671699|NCT00498342|Expectorants|expectorants|mesh-ancestor
138671700|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
138671701|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138351520|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
138671702|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
138348480|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138351521|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138351522|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671703|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351523|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671704|NCT00498342|Protective Agents|protective agents|mesh-ancestor
138671705|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671706|NCT00498342|Antidotes|antidotes|mesh-ancestor
138671707|NCT00466856|Octreotide|octreotide|mesh-list
138671708|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138671709|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671710|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671711|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
138671712|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671713|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671714|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138671715|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138671716|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671717|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671718|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207296|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671719|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138671720|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138671723|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138671724|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
138671725|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
138671726|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671727|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671728|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671729|NCT00464594|Metformin|metformin|mesh-list
138671730|NCT00464594|Acarbose|acarbose|mesh-list
138671731|NCT00464594|Gliclazide|gliclazide|mesh-list
138671732|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671733|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671734|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138671738|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138671739|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138671740|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138671741|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138671742|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671743|NCT00466895|Lenalidomide|lenalidomide|mesh-list
138671744|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
138671745|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671746|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671747|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671748|NCT00466895|Growth Substances|growth substances|mesh-ancestor
138671749|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671750|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671751|NCT02893540|Capecitabine|capecitabine|mesh-list
138671752|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138671753|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
138671754|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671755|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671756|NCT01327573|Eculizumab|eculizumab|mesh-list
138671757|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138671758|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671759|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
138671760|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671761|NCT02893384|Anesthetics|anesthetics|mesh-list
138671762|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
138671763|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671764|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671765|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
138671766|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671767|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
138455791|NCT01907984|Midazolam|midazolam|mesh-list
138671769|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
138671770|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671771|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671772|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
138671773|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671774|NCT00498537|Spironolactone|spironolactone|mesh-list
138671775|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138671776|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
138671777|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671778|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671779|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138671780|NCT00498537|Diuretics|diuretics|mesh-ancestor
138671781|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
138671783|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
138671785|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138671786|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138671787|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671788|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671789|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671790|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
138671791|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671792|NCT00491517|Sirolimus|sirolimus|mesh-list
138671793|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671794|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671795|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138671796|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671797|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
138671798|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671799|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
138671800|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671801|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
138671802|NCT00464789|Estrogens|estrogens|mesh-list
138671803|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138671804|NCT00464789|Hormones|hormones|mesh-ancestor
138671805|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671806|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671807|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138671808|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138671809|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
138671810|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138671811|NCT00467012|Paclitaxel|paclitaxel|mesh-list
138671812|NCT00467012|Bevacizumab|bevacizumab|mesh-list
138671813|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138671814|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671815|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138671816|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138671817|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138671818|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671819|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138671820|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671821|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138671823|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671824|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671825|NCT03272867|Mannitol|mannitol|mesh-list
138671826|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138671827|NCT03272867|Diuretics|diuretics|mesh-ancestor
138671828|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
138671829|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671830|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
138671831|NCT01327495|Testosterone|testosterone|mesh-list
138671832|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
138671833|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
138671834|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138671835|NCT01327495|Acyline|acyline|mesh-list
138671836|NCT01327495|Androgens|androgens|mesh-ancestor
138671837|NCT01327495|Hormones|hormones|mesh-ancestor
138207321|NCT00176852|Vidarabine|vidarabine|mesh-list
138671838|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671839|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671840|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671841|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671842|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
138671843|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
138671844|NCT00491634|Treosulfan|treosulfan|mesh-list
138671845|NCT00491634|Busulfan|busulfan|mesh-list
138671846|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138671847|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
138671848|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671849|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671850|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671851|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
138671852|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671853|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138671855|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138671856|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138671857|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
138671858|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
138671859|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671860|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671861|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671862|NCT01327300|Mesalamine|mesalamine|mesh-list
138671863|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138671864|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138671865|NCT01327300|Analgesics|analgesics|mesh-ancestor
138671866|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
138671875|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455829|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
138671876|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671877|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671878|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671879|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671880|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138671881|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671882|NCT00592111|Prednisone|prednisone|mesh-list
138671883|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
138671884|NCT00592111|Etoposide|etoposide|mesh-list
138671885|NCT00592111|Vincristine|vincristine|mesh-list
138671886|NCT00592111|Doxorubicin|doxorubicin|mesh-list
138671887|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138671889|NCT00592111|Vinblastine|vinblastine|mesh-list
138671890|NCT00592111|Procarbazine|procarbazine|mesh-list
138671891|NCT00592111|Mitogens|mitogens|mesh-list
138671892|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671893|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
138671894|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671895|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671896|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138671897|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
138671898|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671899|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671900|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138671901|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671902|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
138671903|NCT00592111|Hormones|hormones|mesh-ancestor
138671904|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671905|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138671906|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138671907|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138671908|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138671909|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671910|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
138671911|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
138671912|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
138671913|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138671914|NCT00592150|Fenoldopam|fenoldopam|mesh-list
138671915|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138671917|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
138671918|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
138671919|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671920|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207381|NCT01431391|Leuprolide|leuprolide|mesh-list
138671921|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671922|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
138671923|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138671924|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
138671925|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671926|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138671927|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
138671928|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138671929|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671930|NCT04377295|Ranibizumab|ranibizumab|mesh-list
138671931|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138671932|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138455848|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
138671933|NCT04377295|Growth Substances|growth substances|mesh-ancestor
138671934|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671935|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671936|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671937|NCT00491712|Triamcinolone|triamcinolone|mesh-list
138671938|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671939|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
138671940|NCT00491712|Hormones|hormones|mesh-ancestor
138671941|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671942|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671943|NCT02893111|Bortezomib|bortezomib|mesh-list
138671944|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671945|NCT04328272|Azithromycin|azithromycin|mesh-list
138671946|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
138671947|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138671948|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671949|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
138671950|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138671951|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138671952|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671953|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671954|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671955|NCT04328194|Thrombin|thrombin|mesh-list
138671956|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
138671957|NCT04328194|Coagulants|coagulants|mesh-ancestor
138671958|NCT00491790|Montelukast|montelukast|mesh-list
138671959|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138671960|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138671961|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138671962|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
138671963|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138671964|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671965|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138671966|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138671967|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671968|NCT03272009|Interferons|interferons|mesh-list
138671969|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
138671970|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
138671971|NCT03272009|Entecavir|entecavir|mesh-list
138671972|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138671973|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671974|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
138671975|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138671976|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
138671977|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671978|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138671979|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138671980|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138671981|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
138671982|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671983|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671984|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671985|NCT00498888|Urological Agents|urological agents|mesh-ancestor
138671986|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
138671987|NCT00491868|Hematinics|hematinics|mesh-ancestor
138671990|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
138671991|NCT00491907|Vitamins|vitamins|mesh-ancestor
138671992|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
138671993|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671994|NCT00499005|Carbetocin|carbetocin|mesh-list
138671995|NCT00499005|Oxytocin|oxytocin|mesh-list
138671996|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
138671997|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138671998|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671999|NCT00491946|Dactinomycin|dactinomycin|mesh-list
138672000|NCT00491946|Vincristine|vincristine|mesh-list
138672001|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138672002|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672003|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672004|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672005|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672006|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672007|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672008|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672009|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138672010|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138672011|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672012|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138672013|NCT00491985|Vaccines|vaccines|mesh-list
138672014|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
138672015|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672016|NCT02892916|Ketamine|ketamine|mesh-list
138672017|NCT02892916|Analgesics|analgesics|mesh-ancestor
138672018|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
138672019|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672020|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672021|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138672022|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138672023|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
138672024|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
138672025|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672026|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138672027|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138672028|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672029|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672030|NCT00492102|Montelukast|montelukast|mesh-list
138672031|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672032|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672033|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138672035|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672036|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672037|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138672038|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138672039|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672041|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672042|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672043|NCT00492141|Temozolomide|temozolomide|mesh-list
138672044|NCT00492141|Camptothecin|camptothecin|mesh-list
138672045|NCT00492141|Rubitecan|rubitecan|mesh-list
138672046|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138672047|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
138672048|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672049|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672050|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138672051|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138672052|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138672053|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672054|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
138672055|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138672056|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672057|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672058|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672059|NCT04327726|Analgesics|analgesics|mesh-ancestor
138672060|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
138672061|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672062|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138351549|NCT02864706|Cyclosporine|cyclosporine|mesh-list
138351550|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
138351551|NCT02864706|Everolimus|everolimus|mesh-list
138351552|NCT02864706|Cyclosporins|cyclosporins|mesh-list
138672063|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138672064|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138672065|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672066|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672067|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672069|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138672070|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672071|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138672072|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
138672074|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672075|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672076|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672078|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138672079|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672080|NCT00465257|Artesunate|artesunate|mesh-list
138672081|NCT00465257|Amodiaquine|amodiaquine|mesh-list
138672082|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
138672083|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138672084|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138672085|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672086|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672087|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
138672088|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
138672089|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138672090|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
138672091|NCT04130776|Kallikreins|kallikreins|mesh-list
138672092|NCT04130776|Coagulants|coagulants|mesh-ancestor
138672093|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138672094|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
138672095|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138672096|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672097|NCT00492258|Sorafenib|sorafenib|mesh-list
138672098|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672099|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672100|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672101|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672102|NCT02955810|Dexamethasone|dexamethasone|mesh-list
138672103|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
138672104|NCT02955810|Bortezomib|bortezomib|mesh-list
138672105|NCT02955810|Daratumumab|daratumumab|mesh-list
138672106|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672107|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
138672108|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672110|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138672111|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
138672116|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
138672117|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
138672118|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672119|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672120|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
138672121|NCT02955810|Hormones|hormones|mesh-ancestor
138672122|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672123|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138672124|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
138672125|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672126|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672127|NCT00492414|Paroxetine|paroxetine|mesh-list
138672128|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138672129|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138672130|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672131|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672132|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672133|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
138672134|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672135|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138672136|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
138672137|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672138|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138672139|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138672140|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672141|NCT01243632|Gemcitabine|gemcitabine|mesh-list
138672142|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138672143|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
138672144|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672145|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672146|NCT00467909|Micronutrients|micronutrients|mesh-list
138672147|NCT00467909|Trace Elements|trace elements|mesh-list
138672148|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672149|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138672150|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138672151|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672152|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
138672153|NCT00467948|Cefazolin|cefazolin|mesh-list
138672154|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672156|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138672158|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672159|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672160|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672161|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672162|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
138672163|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138672164|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
138672165|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672166|NCT00592618|Expectorants|expectorants|mesh-ancestor
138672167|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672168|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138672169|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
138672173|NCT00592618|Antidotes|antidotes|mesh-ancestor
138672174|NCT01243710|Taurolidine|taurolidine|mesh-list
138672176|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
138672177|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138672178|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138672179|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672180|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672181|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138672182|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672183|NCT00622843|Vaccines|vaccines|mesh-list
138672184|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138672185|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
138672186|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672187|NCT01245543|Docetaxel|docetaxel|mesh-list
138672188|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672189|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672190|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672191|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672192|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672193|NCT00592930|Olanzapine|olanzapine|mesh-list
138672194|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
138672195|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
138672196|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672197|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672198|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672199|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138672200|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138672201|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672202|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672203|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138672204|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138672205|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455950|NCT01909063|Vitamin D|vitamin d|mesh-list
138351559|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672206|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672207|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672208|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
138672209|NCT00592969|Metformin|metformin|mesh-list
138672210|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
138672211|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
138672212|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672213|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672214|NCT01245582|Capecitabine|capecitabine|mesh-list
138672215|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
138672216|NCT01245582|Sorafenib|sorafenib|mesh-list
138672217|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138672218|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
138672219|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672220|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672221|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672222|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672223|NCT00593008|Sirolimus|sirolimus|mesh-list
138672224|NCT00593008|Gemcitabine|gemcitabine|mesh-list
138672226|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
138672227|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138672228|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
138672229|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672230|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672231|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672232|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672233|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672234|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
138672235|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672236|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672237|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672238|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138672239|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
138672240|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138672241|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138672242|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672243|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672244|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
138672245|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672246|NCT00593125|Levetiracetam|levetiracetam|mesh-list
138672247|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
138672248|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
138672249|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
138672250|NCT00593164|Analgesics|analgesics|mesh-ancestor
138672251|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
138672252|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672253|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672254|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
138672255|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672256|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138672257|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
138672258|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138672259|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672260|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672261|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138672262|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
138672263|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138672264|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
138672265|NCT01316107|Nateglinide|nateglinide|mesh-list
138672266|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138672267|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672268|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672272|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138672273|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
138672274|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672275|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672276|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672277|NCT05653453|Paclitaxel|paclitaxel|mesh-list
138672278|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138672279|NCT05653453|Gemcitabine|gemcitabine|mesh-list
138672280|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138672281|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672282|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672283|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672284|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672285|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672286|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138672287|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
138672288|NCT00468182|Interferons|interferons|mesh-list
138672289|NCT00468182|Interferon-beta|interferon-beta|mesh-list
138672290|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
138672291|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672293|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672294|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
138672295|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672296|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138672297|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
138672298|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
138672299|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
138672300|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672302|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
138349086|NCT02618772|Midazolam|midazolam|mesh-list
138672303|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138672304|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
138456007|NCT01909830|Gemcitabine|gemcitabine|mesh-list
138672305|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
138672306|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672307|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672308|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
138672309|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672310|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672311|NCT00465452|Protective Agents|protective agents|mesh-ancestor
138672313|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138672314|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672315|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672316|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672317|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672318|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
138672321|NCT00468260|Epothilone B|epothilone b|mesh-list
138672322|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672323|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
138351597|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351598|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138672324|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672325|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672326|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672327|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
138672328|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138672329|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138672330|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
138672331|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672332|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672333|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672334|NCT01371994|Urological Agents|urological agents|mesh-ancestor
138672335|NCT00465608|Propranolol|propranolol|mesh-list
138672336|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138672337|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138672338|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672339|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672340|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672341|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672342|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138672343|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672344|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
138672345|NCT01371877|Vitamin D|vitamin d|mesh-list
138672346|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
138672347|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
138672348|NCT01371877|Vitamins|vitamins|mesh-list
138672349|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
138672350|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672351|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138672352|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138672353|NCT01245816|Eflornithine|eflornithine|mesh-list
138672354|NCT01245816|Sulindac|sulindac|mesh-list
138672355|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672356|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138672357|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138672358|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138672359|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672360|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138672361|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282887|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672362|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672363|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138672364|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672365|NCT01245816|Analgesics|analgesics|mesh-ancestor
138672369|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672370|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672371|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138672372|NCT00492687|Tamoxifen|tamoxifen|mesh-list
138672373|NCT00492687|Carboplatin|carboplatin|mesh-list
138672374|NCT00492687|Temozolomide|temozolomide|mesh-list
138672375|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672376|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672377|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138672378|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
138672379|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138672380|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138672381|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672382|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672383|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138672384|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138207585|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138672385|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138672386|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138672387|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
138672388|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138672389|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138351610|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672390|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672391|NCT01245855|Alprostadil|alprostadil|mesh-list
138672392|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138672393|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
138672394|NCT01245855|Urological Agents|urological agents|mesh-ancestor
138672395|NCT00473603|Heparin|heparin|mesh-list
138672396|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
138672397|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138672398|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138672399|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672400|NCT00492765|Interferons|interferons|mesh-list
138672401|NCT00492765|Interferon-beta|interferon-beta|mesh-list
138672402|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
138672403|NCT00492765|Simvastatin|simvastatin|mesh-list
138672404|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672405|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
138672407|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138672408|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138672409|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
138672410|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672411|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138672412|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138672413|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672414|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
138672415|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672416|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138672417|NCT00468533|Aripiprazole|aripiprazole|mesh-list
138672418|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
138672419|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672420|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138672421|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138672422|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672423|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672424|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
138672425|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
138207617|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672426|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672427|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672428|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138672429|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138672430|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
138672431|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138672432|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138672433|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138672434|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138672435|NCT00473720|Paclitaxel|paclitaxel|mesh-list
138672436|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138672437|NCT00473720|Satraplatin|satraplatin|mesh-list
138672438|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138672439|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672440|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672441|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672442|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672443|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672444|NCT00499668|Ondansetron|ondansetron|mesh-list
138672445|NCT00499668|Aprepitant|aprepitant|mesh-list
138672446|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
138672447|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
138672448|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672449|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672450|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672451|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
138672452|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672453|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138672454|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138672456|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672457|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672458|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138672460|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
138672461|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672463|NCT01366534|Vaccines|vaccines|mesh-list
138672464|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
138672465|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672466|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
138672467|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138672468|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672469|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
138672470|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
138672471|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672472|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672473|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138672474|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
138672475|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
138672476|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672477|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672478|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672479|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138672480|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
138672482|NCT01365910|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138672483|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672484|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672485|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672486|NCT01605526|Doxorubicin|doxorubicin|mesh-list
138672487|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138672488|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672489|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138672490|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138672491|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672492|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672493|NCT00468689|Ketoconazole|ketoconazole|mesh-list
138672494|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
138672495|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672496|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138672497|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138672498|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672499|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672500|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138672501|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
138672502|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672503|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672508|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138672510|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672511|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672512|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672513|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672514|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672515|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138672516|NCT00493077|Interferons|interferons|mesh-list
138672517|NCT00493077|Interferon-beta|interferon-beta|mesh-list
138672518|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
138672519|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672520|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
138672521|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672522|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
138672523|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672524|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138672525|NCT00474071|Remifentanil|remifentanil|mesh-list
138672526|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138672527|NCT00474071|Narcotics|narcotics|mesh-ancestor
138672528|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672529|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672530|NCT00474071|Analgesics|analgesics|mesh-ancestor
138672531|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
138672532|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672533|NCT00474110|Ketamine|ketamine|mesh-list
138672534|NCT00474110|Hydromorphone|hydromorphone|mesh-list
138672535|NCT00474110|Analgesics|analgesics|mesh-ancestor
138672536|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
138672537|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672538|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672539|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138672540|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138672541|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
138672542|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
138672543|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672544|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138672545|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138672546|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672547|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672548|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138672549|NCT00474110|Narcotics|narcotics|mesh-ancestor
138672551|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138672552|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456136|NCT01910285|Analgesics|analgesics|mesh-ancestor
138672554|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672555|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672556|NCT00468923|Candesartan|candesartan|mesh-list
138672557|NCT00468923|Candesartan cilexetil|candesartan cilexetil|mesh-list
138672558|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138672559|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138672560|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138672561|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
138672562|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672563|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138672564|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138672565|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672566|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672567|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138672568|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138672569|NCT01365481|Amlodipine|amlodipine|mesh-list
138672570|NCT01365481|Valsartan|valsartan|mesh-list
138672571|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138672572|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672573|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138672574|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207695|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
138672575|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672576|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138672577|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672578|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
138672579|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138672580|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138672581|NCT01365481|Diuretics|diuretics|mesh-ancestor
138672582|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
138672583|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138672584|NCT00493116|Interferons|interferons|mesh-list
138672585|NCT00493116|Interferon-beta|interferon-beta|mesh-list
138672586|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
138672587|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
138672588|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672589|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
138672590|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672591|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672592|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
138672593|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
138672594|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672595|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672596|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672597|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
138672598|NCT00493116|Hormones|hormones|mesh-ancestor
138672599|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672600|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138672601|NCT00493116|Protective Agents|protective agents|mesh-ancestor
138672602|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
138672603|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138672604|NCT00493194|Cyclosporine|cyclosporine|mesh-list
138672605|NCT00493194|Sirolimus|sirolimus|mesh-list
138672606|NCT00493194|Cyclosporins|cyclosporins|mesh-list
138351623|NCT02889510|Hormones|hormones|mesh-ancestor
138351625|NCT02902770|Ketorolac|ketorolac|mesh-list
138672607|NCT00493194|Daclizumab|daclizumab|mesh-list
138672608|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672609|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672610|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672616|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672617|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138672618|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672619|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138672620|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672622|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138672623|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138672624|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672625|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672626|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672627|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
138672628|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672629|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672630|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
138672631|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
138672632|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672633|NCT01350271|Mebendazole|mebendazole|mesh-list
138672634|NCT01350271|Piperazine|piperazine|mesh-list
138672635|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
138672636|NCT01350271|DMP 777|dmp 777|mesh-list
138672637|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
138672638|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
138672639|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138672640|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672641|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138672642|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672643|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138672644|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672648|NCT00493233|Risperidone|risperidone|mesh-list
138672649|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138672650|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
138672651|NCT00493233|Clozapine|clozapine|mesh-list
138672652|NCT00493233|Perphenazine|perphenazine|mesh-list
138672653|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138672654|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
138672655|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672656|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672657|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672659|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672660|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672661|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138672662|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
138672663|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
138672664|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
138672665|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672666|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672667|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138672668|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138672669|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672670|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
138672671|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
138672672|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
138672673|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
138672674|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
138672675|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138672676|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
138672677|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672678|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672679|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672680|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672681|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138672682|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
138672683|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672684|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672685|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138672688|NCT00500253|Protective Agents|protective agents|mesh-ancestor
138672689|NCT00500253|Miotics|miotics|mesh-ancestor
138672690|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138672691|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138672692|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138672693|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138672694|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
138672695|NCT01243788|Fluticasone|fluticasone|mesh-list
138672696|NCT01243788|Xhance|xhance|mesh-list
138672697|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138672698|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672699|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138672700|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
138672701|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672702|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672703|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672704|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672705|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672706|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138672707|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138672708|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138672709|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138207817|NCT00128180|Hormones|hormones|mesh-ancestor
138672710|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672711|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282888|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
138672712|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672714|NCT01243827|Bisoprolol|bisoprolol|mesh-list
138672715|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138672716|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138672717|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672718|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672719|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672720|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672721|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672722|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
138672725|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672726|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138672727|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
138672728|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138672729|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138672730|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
138672731|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
138672732|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672733|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138672735|NCT00500409|Vitamins|vitamins|mesh-ancestor
138672736|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
138672737|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672738|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138672739|NCT00469352|Ranibizumab|ranibizumab|mesh-list
138672740|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138672741|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138672742|NCT00469352|Growth Substances|growth substances|mesh-ancestor
138672743|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672744|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
138672745|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672746|NCT00469430|Metronidazole|metronidazole|mesh-list
138672747|NCT00469430|Cefotaxime|cefotaxime|mesh-list
138672748|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672749|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672750|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138672751|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138672752|NCT00469469|Bevacizumab|bevacizumab|mesh-list
138672753|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138672754|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672755|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138672756|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138672757|NCT00469469|Growth Substances|growth substances|mesh-ancestor
138672758|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672764|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672765|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
138672766|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672767|NCT00469547|Ethanol|ethanol|mesh-list
138672768|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
138672769|NCT00469547|Emollients|emollients|mesh-list
138672770|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138672771|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672772|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672773|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
138672774|NCT00500604|Valsartan|valsartan|mesh-list
138672775|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138672776|NCT00500604|Irbesartan|irbesartan|mesh-list
138672777|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672778|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138672779|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138672780|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672781|NCT00500604|Diuretics|diuretics|mesh-ancestor
138672782|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
138672783|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672784|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138672787|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138672788|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672789|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672791|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672792|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672793|NCT00500721|Desipramine|desipramine|mesh-list
138672794|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138672795|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
138672796|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672797|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672798|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672799|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138672800|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138672801|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672802|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672803|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672804|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672805|NCT00469586|Insulin|insulin|mesh-list
138672806|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138672807|NCT00469586|Metformin|metformin|mesh-list
138672808|NCT00469586|Glimepiride|glimepiride|mesh-list
138672809|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672810|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672811|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138672812|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672813|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
138672814|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
138672815|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138672816|NCT01606111|Protective Agents|protective agents|mesh-ancestor
138672817|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672818|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
138672819|NCT00493428|Baclofen|baclofen|mesh-list
138672820|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138672821|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672823|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672824|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138672825|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
138672826|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
138672827|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672828|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672829|NCT01342510|Lidocaine|lidocaine|mesh-list
138672830|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
138672831|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
138672834|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672835|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
138672836|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672837|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138672838|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138672839|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138672840|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672841|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672842|NCT01342510|Analgesics|analgesics|mesh-ancestor
138672843|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
138672844|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138672845|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138672846|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
138672847|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138672848|NCT01606345|Valrubicin|valrubicin|mesh-list
138672849|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672850|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138672851|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138672852|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672853|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672854|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138672855|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138672856|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138672857|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
138672858|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672859|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138672860|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138672861|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672862|NCT00469664|Guanfacine|guanfacine|mesh-list
138672863|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672864|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138672865|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456275|NCT01910987|Hormones|hormones|mesh-ancestor
138672867|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672868|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672869|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672870|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672871|NCT00469703|Thalidomide|thalidomide|mesh-list
138672872|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138672873|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
138672874|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672875|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
138672876|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207862|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
138672877|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672878|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138672879|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138672881|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
138672882|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672883|NCT01244100|Aspirin|aspirin|mesh-list
138672884|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138672889|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672890|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672891|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672892|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138672893|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138672894|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672895|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138672896|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138672897|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672898|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
138672899|NCT01340872|Ferric maltol|ferric maltol|mesh-list
138672900|NCT01340872|Hematinics|hematinics|mesh-ancestor
138672901|NCT00469781|Bromfenac|bromfenac|mesh-list
138672902|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
138672903|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138672904|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
138672905|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138672906|NCT00469781|Prednisolone|prednisolone|mesh-list
138672907|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138672908|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
138672909|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138672910|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672911|NCT00469781|Analgesics|analgesics|mesh-ancestor
138672912|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
138351641|NCT02902770|Analgesics|analgesics|mesh-ancestor
138672913|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672914|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672915|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672916|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672917|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
138672918|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
138672919|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672920|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
138672921|NCT00469781|Hormones|hormones|mesh-ancestor
138672922|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138672925|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138672926|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672927|NCT00474695|Ranibizumab|ranibizumab|mesh-list
138672928|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138672929|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138672930|NCT00474695|Growth Substances|growth substances|mesh-ancestor
138672931|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672932|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
138672933|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207876|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
138672935|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138672936|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672937|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
138672938|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138672939|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672940|NCT00474773|Celecoxib|celecoxib|mesh-list
138672941|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138672942|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672943|NCT00474773|Analgesics|analgesics|mesh-ancestor
138672944|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
138672945|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672946|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672947|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672948|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672949|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138672950|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138672951|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672952|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672953|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
138672954|NCT00474890|Ephedrine|ephedrine|mesh-list
138672955|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138672956|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
138672957|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672958|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672959|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672960|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672961|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
138672962|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138672963|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138672964|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
138672965|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138672966|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672967|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672968|NCT00501111|Donepezil|donepezil|mesh-list
138672969|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138672970|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672971|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672972|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
138672973|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672979|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138672980|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349759|NCT04128540|Fentanyl|fentanyl|mesh-list
138351654|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351655|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351662|NCT02908620|Anesthetics|anesthetics|mesh-list
138672981|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672982|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138672983|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
138207899|NCT01093469|Decanoic acid|decanoic acid|mesh-list
138672984|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138672985|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
138672986|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672987|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672988|NCT01246089|Ranibizumab|ranibizumab|mesh-list
138672989|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138672990|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138672991|NCT01246089|Growth Substances|growth substances|mesh-ancestor
138672992|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672993|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138672994|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672995|NCT00598897|Clarithromycin|clarithromycin|mesh-list
138672996|NCT00598897|Rifabutin|rifabutin|mesh-list
138672997|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672998|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672999|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138673000|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673001|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673002|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138673003|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673004|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138673005|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
138673006|NCT04697732|Anesthetics|anesthetics|mesh-list
138673007|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673008|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673009|NCT00501267|Oxybutynin|oxybutynin|mesh-list
138673010|NCT00501267|Solabegron|solabegron|mesh-list
138673011|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
138673012|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
138673013|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673014|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673015|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138673016|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138673017|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
138673018|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673019|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673020|NCT00501267|Urological Agents|urological agents|mesh-ancestor
138673021|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138673022|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138673023|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138207927|NCT00132002|Vorinostat|vorinostat|mesh-list
138673024|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
138673025|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
138673026|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673027|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673028|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673030|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
138673031|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138673032|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673033|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673034|NCT00599287|Haloperidol|haloperidol|mesh-list
138673035|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
138673036|NCT00599287|Methylphenidate|methylphenidate|mesh-list
138673037|NCT00599287|Rivastigmine|rivastigmine|mesh-list
138673038|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138673039|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673040|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138673041|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673042|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673043|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673044|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
138673045|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673046|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
138673047|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
138351670|NCT02911818|Liraglutide|liraglutide|mesh-list
138673048|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673049|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673050|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138673051|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138673052|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673053|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673054|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138673055|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138673056|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138673057|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673058|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
138673059|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138673060|NCT00599287|Protective Agents|protective agents|mesh-ancestor
138673061|NCT04326166|Metformin|metformin|mesh-list
138673062|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138673063|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673064|NCT00501384|Satavaptan|satavaptan|mesh-list
138673065|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138673066|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673067|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
138673068|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673069|NCT00599560|Vasopressins|vasopressins|mesh-list
138673070|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
138673072|NCT00599560|Coagulants|coagulants|mesh-ancestor
138673073|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138673074|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138673075|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
138673076|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673077|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
138673078|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138673079|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
138673080|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673081|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
138673082|NCT00599716|Protective Agents|protective agents|mesh-ancestor
138673083|NCT01246284|Triamcinolone|triamcinolone|mesh-list
138673084|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138673085|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138673086|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138673087|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673089|NCT01246284|Hormones|hormones|mesh-ancestor
138673090|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673091|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673092|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673093|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
138673094|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207981|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673095|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673096|NCT00599833|Cetuximab|cetuximab|mesh-list
138673097|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673098|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673099|NCT00469976|Bevacizumab|bevacizumab|mesh-list
138673100|NCT00469976|Carboplatin|carboplatin|mesh-list
138673101|NCT00469976|Gemcitabine|gemcitabine|mesh-list
138673102|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673103|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673104|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673105|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673106|NCT00469976|Growth Substances|growth substances|mesh-ancestor
138351673|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673107|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351674|NCT02911818|Incretins|incretins|mesh-ancestor
138351675|NCT02911818|Hormones|hormones|mesh-ancestor
138673108|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673109|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673110|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
138673111|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673112|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138673113|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138673114|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673115|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673116|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673117|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673118|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673119|NCT00599911|Analgesics|analgesics|mesh-ancestor
138673120|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
138673121|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673122|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673123|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673124|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
138673126|NCT00599950|Mitomycin|mitomycin|mesh-list
138673127|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138673128|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673129|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
138673130|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673131|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138673132|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673133|NCT00600145|Mirtazapine|mirtazapine|mesh-list
138673134|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673135|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673136|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138673137|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
138673138|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
138673139|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673140|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673141|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673142|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138673143|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208032|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208034|NCT05307341|Sufentanil|sufentanil|mesh-list
138673146|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138673147|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138673148|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
138673149|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138673150|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138673151|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
138673152|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138673153|NCT00470015|Aldesleukin|aldesleukin|mesh-list
138673154|NCT00470015|Interleukin-2|interleukin-2|mesh-list
138673155|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673156|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138673157|NCT00470015|Analgesics|analgesics|mesh-ancestor
138673158|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
138673159|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673160|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673161|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138673162|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138673163|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
138673164|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673165|NCT00600262|Bevacizumab|bevacizumab|mesh-list
138673166|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673167|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673168|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673169|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673170|NCT00600262|Growth Substances|growth substances|mesh-ancestor
138673171|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673172|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673174|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138673175|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138673176|NCT00600301|Bevacizumab|bevacizumab|mesh-list
138673177|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138673178|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673179|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673180|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673181|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673182|NCT00600301|Growth Substances|growth substances|mesh-ancestor
138673183|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673184|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673185|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673186|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
138673187|NCT00600301|Hormones|hormones|mesh-ancestor
138673188|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673189|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673190|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
138673191|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208059|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673192|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673193|NCT00501579|Prednisolone|prednisolone|mesh-list
138673194|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138673196|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138673197|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
138673198|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138673199|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
138673203|NCT00501579|Hormones|hormones|mesh-ancestor
138349980|NCT02769702|Hormones|hormones|mesh-ancestor
138673204|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673205|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673206|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138673207|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673208|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
138673209|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
138673210|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673211|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673212|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138673213|NCT00501579|Protective Agents|protective agents|mesh-ancestor
138673214|NCT00501618|Clozapine|clozapine|mesh-list
138673215|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138673216|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
138673217|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673218|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673219|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673220|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138673221|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138673222|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673223|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673224|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
138673225|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
138456441|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
138673226|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
138673227|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
138673228|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673229|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138673230|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673231|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673232|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673233|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673234|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673235|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673237|NCT00600691|Finasteride|finasteride|mesh-list
138673238|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138673239|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138673240|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673241|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673242|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673243|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673244|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673246|NCT00623077|Etoposide|etoposide|mesh-list
138673247|NCT00623077|Melphalan|melphalan|mesh-list
138673248|NCT00623077|Busulfan|busulfan|mesh-list
138673249|NCT00623077|Ifosfamide|ifosfamide|mesh-list
138673250|NCT00623077|Thiotepa|thiotepa|mesh-list
138673251|NCT00623077|Sargramostim|sargramostim|mesh-list
138673252|NCT00623077|Mesna|mesna|mesh-list
138673253|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138673254|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673255|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138673256|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138673257|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673258|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673259|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
138673260|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673261|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138673262|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
138673263|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138673264|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673265|NCT00623077|Protective Agents|protective agents|mesh-ancestor
138673266|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138673267|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138673268|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673269|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673270|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673271|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673272|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673273|NCT00475358|Analgesics|analgesics|mesh-ancestor
138673274|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
138673275|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673276|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673277|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673278|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
138673279|NCT00623116|Testosterone|testosterone|mesh-list
138673280|NCT00623116|Estrogens|estrogens|mesh-list
138673281|NCT00623116|Androgens|androgens|mesh-ancestor
138673282|NCT00623116|Hormones|hormones|mesh-ancestor
138208122|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
138673283|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673284|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673287|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138673288|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
138673289|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138673290|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138673291|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673292|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138673293|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673294|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673295|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138673296|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138673297|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673298|NCT00600769|Clarithromycin|clarithromycin|mesh-list
138673299|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138673300|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673301|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138673302|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673303|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673304|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138673305|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673306|NCT00470210|Ribavirin|ribavirin|mesh-list
138673307|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138673308|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
138351686|NCT02912364|Carbamazepine|carbamazepine|mesh-list
138351687|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138673309|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673310|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
138673311|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673312|NCT00600847|Loratadine|loratadine|mesh-list
138673313|NCT00600847|Desloratadine|desloratadine|mesh-list
138673314|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138673315|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
138673316|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673317|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673318|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673319|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138673320|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138673321|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
138673322|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
138673323|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
138673324|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138673325|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138673326|NCT04325932|Kallikreins|kallikreins|mesh-list
138673327|NCT04325932|Coagulants|coagulants|mesh-ancestor
138673328|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138673329|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
138673330|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138673331|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673332|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138673333|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138673334|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673336|NCT00501657|Hormones|hormones|mesh-ancestor
138673337|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673338|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138673339|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
138673340|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673341|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673342|NCT00600964|Obatoclax|obatoclax|mesh-list
138456470|NCT01912118|Remifentanil|remifentanil|mesh-list
138673343|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673344|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673345|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138673346|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138673347|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673348|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673349|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350138|NCT06085079|Ixekizumab|ixekizumab|mesh-list
138673350|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673351|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673352|NCT00475397|Analgesics|analgesics|mesh-ancestor
138673353|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
138673354|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673355|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673356|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673357|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
138673358|NCT00601042|Lobeline|lobeline|mesh-list
138673359|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138673360|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
138673361|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673362|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673363|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138673364|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138673365|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
138673366|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673367|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673368|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
138673369|NCT00501696|Naltrexone|naltrexone|mesh-list
138673370|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138673371|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138673372|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673373|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
138673374|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673375|NCT00601276|Leuprolide|leuprolide|mesh-list
138673376|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
138673377|NCT00601276|Cyproterone|cyproterone|mesh-list
138673378|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138673379|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
138673380|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138673381|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673382|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138673383|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673384|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
138673385|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673389|NCT00601315|Clarithromycin|clarithromycin|mesh-list
138673390|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138673391|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673392|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138673393|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673394|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673395|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138673396|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673397|NCT00470249|Carboplatin|carboplatin|mesh-list
138673398|NCT00470249|Gemcitabine|gemcitabine|mesh-list
138673399|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673400|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673401|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
138673402|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673403|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
138673404|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
138673405|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138673406|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138673407|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673408|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673409|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673410|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673411|NCT00601432|Levofloxacin|levofloxacin|mesh-list
138673412|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138673413|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673414|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138673415|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138673416|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138673417|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673418|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673419|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673420|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138673425|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673426|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
138673427|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673428|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673429|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673430|NCT00601588|Sertraline|sertraline|mesh-list
138673431|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673432|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673433|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138673434|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673435|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673436|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673437|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673438|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
138673439|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673441|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138673442|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138673443|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673444|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673445|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138673446|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
138673447|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
138673448|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673449|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673450|NCT01246362|Etoricoxib|etoricoxib|mesh-list
138673451|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138673452|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138673453|NCT01246362|Analgesics|analgesics|mesh-ancestor
138673454|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
138673455|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673456|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673457|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673458|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673459|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138673460|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138673465|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673466|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673467|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673468|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138673469|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138673470|NCT00601978|Levodopa|levodopa|mesh-list
138673471|NCT00601978|Carbidopa|carbidopa|mesh-list
138673472|NCT00601978|Entacapone|entacapone|mesh-list
138673473|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138673474|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138673475|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138673476|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
138673477|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673478|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673479|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673480|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138673481|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673482|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138673483|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138673484|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
138673485|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
138208293|NCT01474915|Aprepitant|aprepitant|mesh-list
138673486|NCT00601159|Gemcitabine|gemcitabine|mesh-list
138673487|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456533|NCT01912677|Labetalol|labetalol|mesh-list
138673488|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673490|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673491|NCT00602017|Amlodipine|amlodipine|mesh-list
138673492|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138673493|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138673494|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673495|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673496|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138673497|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673498|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673501|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673502|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673503|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673504|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673505|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
138673506|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673507|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138673508|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
138673509|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138673510|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138673511|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673512|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673513|NCT00602095|Misoprostol|misoprostol|mesh-list
138673514|NCT00602095|Dinoprostone|dinoprostone|mesh-list
138208294|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673515|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138673516|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
138673517|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351707|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
138351708|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351710|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673518|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673519|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138673520|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673521|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
138673522|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138673523|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138673524|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138673525|NCT00475553|Etonogestrel|etonogestrel|mesh-list
138673526|NCT00475553|Desogestrel|desogestrel|mesh-list
138673527|NCT00475553|NuvaRing|nuvaring|mesh-list
138673528|NCT00475553|Estradiol|estradiol|mesh-list
138673529|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138673530|NCT00475553|Estrogens|estrogens|mesh-ancestor
138673531|NCT00475553|Hormones|hormones|mesh-ancestor
138673532|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673534|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138673535|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
138673536|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138673537|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138673538|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138673539|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138673540|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138673541|NCT00475553|Progestins|progestins|mesh-ancestor
138673542|NCT01326481|Capecitabine|capecitabine|mesh-list
138673543|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673544|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
138456560|NCT01912755|Racepinephrine|racepinephrine|mesh-list
138673545|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673546|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673548|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673549|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673550|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673551|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673552|NCT00470522|Folic Acid|folic acid|mesh-list
138673553|NCT00470522|Methotrexate|methotrexate|mesh-list
138673554|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138673555|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
138673556|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138673557|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673558|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673559|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
138673560|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673561|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673562|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
138673563|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673564|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138673565|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673566|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
138673567|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673568|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138673569|NCT00470522|Hematinics|hematinics|mesh-ancestor
138673570|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
138673571|NCT00470522|Vitamins|vitamins|mesh-ancestor
138673572|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
138673573|NCT01244178|Insulin|insulin|mesh-list
138673574|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138673575|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138673580|NCT00470561|Analgesics|analgesics|mesh-ancestor
138673581|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
138673582|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673583|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673584|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673585|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673586|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138673587|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138673588|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673589|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138673590|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138673591|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673592|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
138673593|NCT00475826|Ezetimibe|ezetimibe|mesh-list
138673594|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138673595|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138673596|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
138673597|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673598|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138673599|NCT00502437|Granisetron|granisetron|mesh-list
138673600|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
138673601|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
138673602|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673603|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673604|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673605|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138673607|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
138673608|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673609|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673610|NCT00470678|Ranibizumab|ranibizumab|mesh-list
138673611|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673612|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673613|NCT00470678|Growth Substances|growth substances|mesh-ancestor
138673614|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673619|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673620|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
138673621|NCT00493545|Poly ICLC|poly iclc|mesh-list
138673622|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
138673623|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
138673624|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673625|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138673626|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673627|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138673628|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138673629|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673630|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208482|NCT01131065|Antibodies|antibodies|mesh-list
138673631|NCT00470873|Urological Agents|urological agents|mesh-ancestor
138673632|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
138456603|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
138673633|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138673634|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673636|NCT00476099|Beclomethasone|beclomethasone|mesh-list
138673637|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
138673638|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673639|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138673640|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
138673641|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673642|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673643|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138673648|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138673649|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138673650|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138673651|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138673652|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673653|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673654|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
138673655|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138673656|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
138673657|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673658|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
138673659|NCT00493662|Protective Agents|protective agents|mesh-ancestor
138673660|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
138673661|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138208523|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138673662|NCT00470912|Protective Agents|protective agents|mesh-ancestor
138673663|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673664|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138673665|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138673666|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
138673667|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673668|NCT00476138|Protective Agents|protective agents|mesh-ancestor
138673669|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673670|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138673671|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138673672|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673673|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138673674|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138673675|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138673677|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673678|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673680|NCT01246440|Catumaxomab|catumaxomab|mesh-list
138673681|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673682|NCT00471029|Esomeprazole|esomeprazole|mesh-list
138673683|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138673684|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673685|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138673686|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673687|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673688|NCT00476216|Fondaparinux|fondaparinux|mesh-list
138673689|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138673690|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
138673691|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138673692|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
138673693|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673694|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673695|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
138673696|NCT00471185|Acyline|acyline|mesh-list
138673697|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673698|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673699|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673700|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
138673701|NCT00493857|Antibodies|antibodies|mesh-list
138673702|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138673703|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
138673704|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673705|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673706|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673707|NCT00502788|Ribavirin|ribavirin|mesh-list
138673709|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
138673710|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673711|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
138673712|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673713|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
138673714|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
138673715|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673716|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673717|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673718|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673719|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
138673720|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673721|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138673722|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673723|NCT00494208|Testosterone|testosterone|mesh-list
138673724|NCT00494208|Androgens|androgens|mesh-ancestor
138673725|NCT00494208|Hormones|hormones|mesh-ancestor
138673726|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673727|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673728|NCT00471341|Celecoxib|celecoxib|mesh-list
138673729|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138673730|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138673731|NCT00471341|Analgesics|analgesics|mesh-ancestor
138673733|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673734|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673735|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673736|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673737|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138673738|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138673739|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673740|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673741|NCT01325428|Vinorelbine|vinorelbine|mesh-list
138673742|NCT01325428|Afatinib|afatinib|mesh-list
138673743|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138673744|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673745|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138673746|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138673747|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138673748|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673749|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673750|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673751|NCT00494247|Antibodies|antibodies|mesh-list
138673752|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
138673753|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673754|NCT00471419|Rimexolone|rimexolone|mesh-list
138673755|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
138673756|NCT00471419|Hormones|hormones|mesh-ancestor
138673757|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673758|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673760|NCT01325350|Minoxidil|minoxidil|mesh-list
138673761|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138673765|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673766|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138673767|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138673768|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673769|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673770|NCT01324999|Urological Agents|urological agents|mesh-ancestor
138673772|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138673773|NCT01324570|Narcotics|narcotics|mesh-ancestor
138673774|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673775|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673776|NCT01324570|Analgesics|analgesics|mesh-ancestor
138673777|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
138673778|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673779|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138673780|NCT04325698|Paclitaxel|paclitaxel|mesh-list
138673781|NCT04325698|Bevacizumab|bevacizumab|mesh-list
138673782|NCT04325698|Carboplatin|carboplatin|mesh-list
138673783|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208648|NCT01898624|Urological Agents|urological agents|mesh-ancestor
138673785|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138673786|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138673787|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138673788|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673789|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673790|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673791|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673792|NCT04325698|Growth Substances|growth substances|mesh-ancestor
138673793|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673794|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673795|NCT01324141|Fluorouracil|fluorouracil|mesh-list
138673796|NCT01324141|Mitomycins|mitomycins|mesh-list
138673797|NCT01324141|Mitomycin|mitomycin|mesh-list
138673798|NCT01324141|Tempol|tempol|mesh-list
138673799|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
138673800|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673801|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673802|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673803|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673804|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
138673805|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673809|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673811|NCT01324141|Protective Agents|protective agents|mesh-ancestor
138673812|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138673814|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138673815|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138673816|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138673817|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673818|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138673819|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138673820|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673821|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673822|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
138673823|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673824|NCT01244217|Fexofenadine|fexofenadine|mesh-list
138673825|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138673826|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138673827|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138673828|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
138673829|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
138673830|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673831|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673832|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673833|NCT00471653|Temozolomide|temozolomide|mesh-list
138673834|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138673835|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
138673836|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673837|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673838|NCT00494559|Pioglitazone|pioglitazone|mesh-list
138673839|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138673840|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673841|NCT00494598|Sufentanil|sufentanil|mesh-list
138673842|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138673843|NCT00494598|Narcotics|narcotics|mesh-ancestor
138673846|NCT00494598|Analgesics|analgesics|mesh-ancestor
138673847|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
138673848|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673849|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138673850|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138673851|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
138457046|NCT01916252|Bortezomib|bortezomib|mesh-list
138673853|NCT00503412|Cediranib|cediranib|mesh-list
138673854|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673855|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673856|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673857|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673858|NCT00503451|Panobinostat|panobinostat|mesh-list
138673859|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673860|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138673861|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673862|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673863|NCT00471809|Azithromycin|azithromycin|mesh-list
138673864|NCT00471809|Budesonide|budesonide|mesh-list
138673865|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138673866|NCT00471809|Montelukast|montelukast|mesh-list
138673867|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673868|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138673869|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
138673870|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673871|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673872|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138673873|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
138673874|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
138673875|NCT00471809|Hormones|hormones|mesh-ancestor
138673876|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673877|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138673878|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673879|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138673880|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138673881|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138673882|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
138673883|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673887|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138673888|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138673889|NCT00503490|Levofloxacin|levofloxacin|mesh-list
138673890|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138673891|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138673892|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138673893|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138673894|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138673895|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673896|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673897|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673898|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138673899|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673901|NCT00471965|Doxorubicin|doxorubicin|mesh-list
138673902|NCT00471965|Fluorouracil|fluorouracil|mesh-list
138673903|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
138673904|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138673905|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673906|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138673907|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138673908|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673909|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673910|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
138673911|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138673912|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673913|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
138673914|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673915|NCT00471965|Antidotes|antidotes|mesh-ancestor
138208741|NCT01144949|Silodosin|silodosin|mesh-list
138673916|NCT00471965|Protective Agents|protective agents|mesh-ancestor
138673917|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
138673919|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
138673920|NCT00472004|Tibolone|tibolone|mesh-list
138673921|NCT00472004|Estradiol|estradiol|mesh-list
138673925|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673926|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
138673927|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673928|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138673929|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138673930|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673931|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138673933|NCT00494715|Valsartan|valsartan|mesh-list
138673934|NCT00494715|Benazepril|benazepril|mesh-list
138673935|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138673936|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138673937|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138673938|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673939|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138673940|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
138673941|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673942|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138673943|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138673944|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138673945|NCT03271073|Apatinib|apatinib|mesh-list
138457314|NCT01917578|Fluorouracil|fluorouracil|mesh-list
138673946|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673947|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673948|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673949|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673951|NCT01246557|Lenalidomide|lenalidomide|mesh-list
138673952|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673953|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
138673954|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
138673955|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673956|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673957|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138673958|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
138673959|NCT01246557|Hormones|hormones|mesh-ancestor
138673960|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673961|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138673962|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673964|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138673965|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138673966|NCT01246557|Growth Substances|growth substances|mesh-ancestor
138673967|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673968|NCT00476918|Triamcinolone|triamcinolone|mesh-list
138673969|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138208762|NCT01145183|Doxazosin|doxazosin|mesh-list
138673970|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138673974|NCT00476918|Hormones|hormones|mesh-ancestor
138673975|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673976|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673977|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673978|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
138673979|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138673980|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673981|NCT01323790|Naloxegol|naloxegol|mesh-list
138673982|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138673983|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673984|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
138673985|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138673986|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
138673987|NCT00477035|Melphalan|melphalan|mesh-list
138673988|NCT00477035|Carmustine|carmustine|mesh-list
138673989|NCT00477035|Gemcitabine|gemcitabine|mesh-list
138673990|NCT00477035|Etoposide|etoposide|mesh-list
138673991|NCT00477035|Vinorelbine|vinorelbine|mesh-list
138673992|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138673993|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
138673994|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673995|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138673996|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138673997|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
138673998|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673999|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674000|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138674001|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674002|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
138674003|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138674004|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138674005|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138674006|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674007|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674008|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138674011|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674012|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674013|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674014|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674015|NCT00494832|Analgesics|analgesics|mesh-ancestor
138674016|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
138674017|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674018|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138674019|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138674020|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674021|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674022|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674023|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674024|NCT00477074|Dimercaprol|dimercaprol|mesh-list
138674025|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
138674026|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
138674027|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674028|NCT01323673|Clobetasol|clobetasol|mesh-list
138674029|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674030|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
138674031|NCT01323673|Hormones|hormones|mesh-ancestor
138674032|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674033|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674034|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138674035|NCT01246752|Cytarabine|cytarabine|mesh-list
138674036|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674037|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
138674038|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674039|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674040|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
138674041|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674042|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674043|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
138674044|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674045|NCT01323634|Fluticasone|fluticasone|mesh-list
138674046|NCT01323634|Xhance|xhance|mesh-list
138674047|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138674048|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674049|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138674050|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
138674055|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
138674056|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138674057|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138674058|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138674059|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674060|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674061|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674062|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674064|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
138674065|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
138674066|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674067|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674068|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
138674069|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674070|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138674071|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138674072|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138674073|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674074|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674075|NCT00494988|Insulin|insulin|mesh-list
138674076|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138674077|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
138674078|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
138674079|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
138674080|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
138674081|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138674082|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674083|NCT01323478|Vortioxetine|vortioxetine|mesh-list
138674084|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
138674085|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138674086|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138674087|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138674088|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674089|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674090|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138674091|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138674092|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674093|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674094|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674095|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
138674096|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138674097|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138674098|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138674099|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138674101|NCT00472355|Emetics|emetics|mesh-ancestor
138458061|NCT01930864|Metformin|metformin|mesh-list
138674109|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674110|NCT04325581|Liraglutide|liraglutide|mesh-list
138674111|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138674112|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674113|NCT04325581|Incretins|incretins|mesh-ancestor
138674115|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674116|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
138674117|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138674118|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674119|NCT01322386|Vancomycin|vancomycin|mesh-list
138674120|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674121|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674122|NCT00495066|Ipilimumab|ipilimumab|mesh-list
138674127|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
138674128|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674129|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674130|NCT00472472|Paclitaxel|paclitaxel|mesh-list
138674131|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138674132|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674133|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674134|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138674135|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138674136|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674137|NCT00503568|Vaccines|vaccines|mesh-list
138674138|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
138674139|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674140|NCT00472550|Esomeprazole|esomeprazole|mesh-list
138674141|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138674142|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674143|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138674144|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674145|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674146|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138674147|NCT00503607|Laxatives|laxatives|mesh-ancestor
138674148|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674149|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
138674150|NCT00477503|Gallium citrate|gallium citrate|mesh-list
138674151|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
138674153|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674154|NCT00477503|Antidotes|antidotes|mesh-ancestor
138674155|NCT00477503|Protective Agents|protective agents|mesh-ancestor
138674156|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674157|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138674158|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138674159|NCT01244334|Prednisolone|prednisolone|mesh-list
138674160|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138674161|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
138674162|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138674163|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
138674164|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138674168|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
138674169|NCT01244334|Hormones|hormones|mesh-ancestor
138674170|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674171|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674172|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138674173|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674174|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
138674175|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
138674176|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674177|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674178|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138674179|NCT01244334|Protective Agents|protective agents|mesh-ancestor
138674180|NCT00477542|Clofarabine|clofarabine|mesh-list
138674181|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674182|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
138674183|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674184|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674185|NCT00503763|Simvastatin|simvastatin|mesh-list
138674186|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138674187|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138674188|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
138674189|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674190|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138674191|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138674192|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674193|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138674194|NCT00477581|Exenatide|exenatide|mesh-list
138674195|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138674196|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674197|NCT00477581|Incretins|incretins|mesh-ancestor
138674198|NCT00477581|Hormones|hormones|mesh-ancestor
138674199|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458631|NCT01934777|Choline|choline|mesh-list
138674200|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138674201|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138674202|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674203|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674206|NCT00477737|Sevoflurane|sevoflurane|mesh-list
138674207|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674208|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674209|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674210|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674211|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
138674212|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
138674213|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138674214|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138674215|NCT00477776|Metoclopramide|metoclopramide|mesh-list
138674216|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
138674217|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
138674218|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458722|NCT01935206|Naloxone|naloxone|mesh-list
138674219|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674220|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674221|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138674222|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138674223|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
138674224|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674225|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674226|NCT00477815|Rituximab|rituximab|mesh-list
138674227|NCT00477815|Melphalan|melphalan|mesh-list
138674228|NCT00477815|Sargramostim|sargramostim|mesh-list
138674229|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138674230|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674231|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674232|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
138674233|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674234|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674235|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138674236|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
138674237|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674238|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138674239|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674241|NCT00477854|Picolinic acid|picolinic acid|mesh-list
138674242|NCT00477854|Trace Elements|trace elements|mesh-ancestor
138674243|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
138674244|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674245|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138674246|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
138674247|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
138674248|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674249|NCT00477893|Adalimumab|adalimumab|mesh-list
138674250|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138674253|NCT01247337|Gemcitabine|gemcitabine|mesh-list
138674254|NCT01247337|Capecitabine|capecitabine|mesh-list
138674255|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
138674256|NCT01247337|Cetuximab|cetuximab|mesh-list
138674257|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674258|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
138674259|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674260|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674261|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674262|NCT00478049|Docetaxel|docetaxel|mesh-list
138674263|NCT00478049|Gefitinib|gefitinib|mesh-list
138674264|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674265|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674266|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138674267|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138674268|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674270|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674271|NCT01248975|Montelukast|montelukast|mesh-list
138674272|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674273|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
138458944|NCT01936090|Bortezomib|bortezomib|mesh-list
138674274|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138674275|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
138674276|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674277|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674278|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138674279|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138674280|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674281|NCT02955927|Atropine|atropine|mesh-list
138674282|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138674283|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138674284|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138674286|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138674294|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138674295|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138674296|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674297|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674298|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674299|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
138674300|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138674302|NCT01247493|Fludarabine|fludarabine|mesh-list
138674303|NCT01247493|Idarubicin|idarubicin|mesh-list
138674304|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674305|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674306|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
138674307|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459129|NCT06067594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138674308|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674309|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
138674310|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674311|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
138674312|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674313|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138674314|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138674315|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138674316|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674317|NCT04325425|Carboplatin|carboplatin|mesh-list
138674318|NCT04325425|Etoposide|etoposide|mesh-list
138674319|NCT04325425|Folfirinox|folfirinox|mesh-list
138351123|NCT02998528|Paclitaxel|paclitaxel|mesh-list
138459192|NCT06062602|Paclitaxel|paclitaxel|mesh-list
138674320|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674321|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138674322|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138674323|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138674324|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674325|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674326|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
138674327|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674328|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674330|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674332|NCT00478517|Hematinics|hematinics|mesh-ancestor
138674333|NCT01321879|Telavancin|telavancin|mesh-list
138674334|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674335|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674336|NCT01321723|Teriparatide|teriparatide|mesh-list
138674337|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138674338|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674339|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138674340|NCT00478634|Irinotecan|irinotecan|mesh-list
138674341|NCT00478634|Cetuximab|cetuximab|mesh-list
138674342|NCT00478634|Everolimus|everolimus|mesh-list
138674343|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138674344|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138674345|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674346|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674347|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674348|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674349|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138674350|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674351|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674352|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
138674353|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674355|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
138674356|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674357|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674358|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674359|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
138674360|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674361|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674362|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138674363|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
138674365|NCT00478907|Ketamine|ketamine|mesh-list
138674366|NCT00478907|Thiopental|thiopental|mesh-list
138674367|NCT00478907|Propofol|propofol|mesh-list
138674368|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138459541|NCT05517122|Niacin|niacin|mesh-list
138674369|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674370|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674371|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674372|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
138674373|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
138674374|NCT00478907|Analgesics|analgesics|mesh-ancestor
138674375|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
138674376|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674377|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138674378|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138674379|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138674380|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674381|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674382|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
138674383|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
138674384|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
138674385|NCT00478946|Leucovorin|leucovorin|mesh-list
138674386|NCT00478946|Antidotes|antidotes|mesh-ancestor
138674387|NCT00478946|Protective Agents|protective agents|mesh-ancestor
138674388|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674389|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
138674390|NCT00478946|Vitamins|vitamins|mesh-ancestor
138674391|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
138674392|NCT01247961|Dexamethasone|dexamethasone|mesh-list
138674393|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
138674394|NCT01247961|BB 1101|bb 1101|mesh-list
138674395|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674396|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
138674398|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674399|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674400|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674401|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
138674402|NCT01247961|Hormones|hormones|mesh-ancestor
138674403|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674404|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138674405|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674406|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138674407|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459795|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674408|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674409|NCT01248078|Cephalexin|cephalexin|mesh-list
138674410|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674416|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
138674417|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674418|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138674419|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138674420|NCT02275416|Ipilimumab|ipilimumab|mesh-list
138674421|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674422|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674423|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138674424|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674425|NCT00472901|Afamelanotide|afamelanotide|mesh-list
138674426|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138674427|NCT02482233|Nicotine|nicotine|mesh-list
138674428|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138674429|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
138674430|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674431|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674432|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138674433|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138674434|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
138459922|NCT04604509|Bupropion|bupropion|mesh-list
138674435|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674437|NCT01248117|Ranibizumab|ranibizumab|mesh-list
138674438|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138674439|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138674440|NCT01248117|Growth Substances|growth substances|mesh-ancestor
138674441|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674442|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
138674443|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674444|NCT01248234|Propofol|propofol|mesh-list
138674445|NCT01248234|Etomidate|etomidate|mesh-list
138674446|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674447|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674448|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674449|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674450|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
138674451|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
138674452|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138674453|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
138674454|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674456|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138674457|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
138674458|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674459|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674460|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138674462|NCT00473213|Interferon-beta|interferon-beta|mesh-list
138674463|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674464|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
138674465|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674466|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
138674467|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674468|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
138674469|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138674470|NCT01319383|Vorinostat|vorinostat|mesh-list
138674471|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674472|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138674473|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674474|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674475|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
138674476|NCT05645029|Methamphetamine|methamphetamine|mesh-list
138674477|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
138674481|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
138209211|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138674482|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138674483|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674484|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
138674485|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
138674486|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674487|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
138674488|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674489|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674490|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674491|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138674492|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138674493|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674494|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138674495|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
138674496|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138674497|NCT05645029|Protective Agents|protective agents|mesh-ancestor
138674498|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138674499|NCT00479609|Testosterone|testosterone|mesh-list
138674500|NCT00479609|Androgens|androgens|mesh-ancestor
138674501|NCT00479609|Hormones|hormones|mesh-ancestor
138674502|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674503|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674504|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
138674505|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138674506|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
138674507|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674508|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460171|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
138674509|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
138674510|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674511|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
138674512|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138674513|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674514|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138674515|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674517|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674518|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674519|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
138460209|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
138674520|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674521|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674522|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674523|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674524|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
138674525|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674526|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674527|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674529|NCT02955732|Analgesics|analgesics|mesh-ancestor
138674530|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
138209290|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674531|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674532|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138674533|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138674534|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674535|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674536|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674537|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674538|NCT01315678|Tobramycin|tobramycin|mesh-list
138674539|NCT01315678|Amikacin|amikacin|mesh-list
138674540|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674541|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674542|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138674543|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138674544|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674545|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
138351346|NCT00076310|Docetaxel|docetaxel|mesh-list
138460335|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
138674546|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674547|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138674548|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138674549|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138674550|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674551|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674552|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674553|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674554|NCT00479726|Analgesics|analgesics|mesh-ancestor
138674555|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
138674556|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674557|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
138674558|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138674559|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
138674560|NCT01315249|Fluticasone|fluticasone|mesh-list
138674562|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
138674563|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138674564|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138674565|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674566|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138674567|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
138674568|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674569|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674570|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674571|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
138674572|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
138674573|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138674574|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138674576|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674577|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674578|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674579|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460587|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674580|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138674581|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138674582|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138674583|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674585|NCT01315249|Hormones|hormones|mesh-ancestor
138674586|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351736|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351737|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138674587|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
138674588|NCT04207411|Lidocaine|lidocaine|mesh-list
138674589|NCT04207411|Bupivacaine|bupivacaine|mesh-list
138674590|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
138674591|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
138674592|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674593|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674594|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
138674595|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460656|NCT01993810|Cisplatin|cisplatin|mesh-list
138674596|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138674597|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138674598|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138674599|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674600|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674601|NCT00473486|Carboplatin|carboplatin|mesh-list
138674602|NCT00473486|Pemetrexed|pemetrexed|mesh-list
138674603|NCT00473486|Sorafenib|sorafenib|mesh-list
138674604|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674605|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674606|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674607|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138460716|NCT01731236|Aspirin|aspirin|mesh-list
138674608|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138674609|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674610|NCT05644483|Propofol|propofol|mesh-list
138674611|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674612|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674613|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674614|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674615|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
138674616|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
138674617|NCT01248819|Ropivacaine|ropivacaine|mesh-list
138674618|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
138674619|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
138674621|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674622|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
138674623|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674624|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
138674625|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138674626|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138674627|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138674628|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674629|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674630|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674631|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674632|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674633|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138674634|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674636|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674637|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674638|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282889|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674639|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674641|NCT01313728|Tretinoin|tretinoin|mesh-list
138674642|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674643|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
138674644|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
138674645|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674646|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
138674647|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138674648|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138674649|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138674650|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674651|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674652|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
138674653|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674654|NCT00481364|Atorvastatin|atorvastatin|mesh-list
138674655|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138674656|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138460978|NCT01936961|Antibodies|antibodies|mesh-list
138674657|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
138674658|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674659|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138674660|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138674661|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674662|NCT00481442|Phenylephrine|phenylephrine|mesh-list
138674663|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
138674664|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138674665|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
138674666|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
138674667|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674668|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674671|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
138674672|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138674673|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138674674|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138674675|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674676|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138674677|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282890|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
138674678|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674679|NCT00481442|Protective Agents|protective agents|mesh-ancestor
138674680|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
138674682|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
138674683|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674684|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674685|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138674686|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674687|NCT04697537|Analgesics|analgesics|mesh-ancestor
138674688|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
138674689|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674690|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138674691|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138674692|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138674693|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
138351498|NCT02835846|Estrogens|estrogens|mesh-list
138674694|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674695|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674696|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
138674697|NCT00481481|Tacrolimus|tacrolimus|mesh-list
138674698|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674699|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
138674700|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674701|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138674702|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674703|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674704|NCT04516317|Artesunate|artesunate|mesh-list
138674705|NCT04516317|Quinine|quinine|mesh-list
138674706|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
138674707|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138674708|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138674709|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674710|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674711|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
138674712|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
138674713|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138674714|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
138674715|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138674716|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674717|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138674718|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674719|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674720|NCT04516317|Analgesics|analgesics|mesh-ancestor
138674721|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
138674722|NCT02891083|Paclitaxel|paclitaxel|mesh-list
138674723|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138674724|NCT02891083|Cisplatin|cisplatin|mesh-list
138674725|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138674726|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674727|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674728|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138674729|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138674730|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674731|NCT02891005|Paclitaxel|paclitaxel|mesh-list
138674732|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138674733|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674734|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674735|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138674736|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138674737|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674738|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138674739|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138674740|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138674741|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138674742|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
138674743|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138674744|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674745|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138674746|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138674747|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138674748|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138674749|NCT00480116|Vaccines|vaccines|mesh-list
138674750|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
138674751|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674752|NCT00504855|Calpastatin|calpastatin|mesh-list
138674753|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138674754|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138674758|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138674759|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138674760|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138674761|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
138674762|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
138674763|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674764|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674765|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674766|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
138674767|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138674769|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138674770|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138674771|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674772|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674773|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674774|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674775|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138674776|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674778|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138674779|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674780|NCT01313221|Analgesics|analgesics|mesh-ancestor
138674781|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
138674782|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674783|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674784|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674785|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674786|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674787|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674788|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
138674789|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
138674790|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138674793|NCT01313182|Calcium|calcium|mesh-list
138674794|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138674795|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674796|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
138674797|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
138674798|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674799|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674800|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138674801|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674802|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674803|NCT00480194|Xylometazoline|xylometazoline|mesh-list
138674804|NCT00480194|Bromides|bromides|mesh-list
138674805|NCT00480194|Ipratropium|ipratropium|mesh-list
138674806|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
138461741|NCT01941225|Iloprost|iloprost|mesh-list
138674807|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138674808|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
138674809|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674810|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674811|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674812|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
138674813|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138674814|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674815|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674816|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674817|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
138461863|NCT01941979|Antidotes|antidotes|mesh-ancestor
138674818|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138674819|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138674820|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
138674821|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674822|NCT00505167|Memantine|memantine|mesh-list
138674823|NCT00505167|Donepezil|donepezil|mesh-list
138674824|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138674825|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461930|NCT01942291|Niacin|niacin|mesh-list
138674826|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674827|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674828|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674829|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674830|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
138674831|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138674832|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138674833|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
138674834|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138674835|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138674836|NCT00480272|Prednisone|prednisone|mesh-list
138674839|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
138674840|NCT00480272|Hormones|hormones|mesh-ancestor
138674841|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674842|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674843|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138674844|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674845|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138674846|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674847|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
138674848|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138674849|NCT00480389|Sorafenib|sorafenib|mesh-list
138674850|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674851|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674852|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674853|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674854|NCT04519710|Rituximab|rituximab|mesh-list
138674855|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
138674856|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674857|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674858|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
138674859|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674860|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674861|NCT00482027|Vaccines|vaccines|mesh-list
138674862|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
138674863|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674864|NCT00482066|Abatacept|abatacept|mesh-list
138674866|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674867|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674868|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674869|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674870|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
138674874|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138674875|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674876|NCT01312909|Varenicline|varenicline|mesh-list
138674877|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138674878|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138674879|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
138674880|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138674881|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674882|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674883|NCT00482222|Leucovorin|leucovorin|mesh-list
138674884|NCT00482222|Capecitabine|capecitabine|mesh-list
138674885|NCT00482222|Fluorouracil|fluorouracil|mesh-list
138674886|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
138674887|NCT00482222|Cetuximab|cetuximab|mesh-list
138674888|NCT00482222|Calcium|calcium|mesh-list
138674889|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
138674890|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138674891|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674892|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674893|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
138674894|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674896|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674897|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
138674898|NCT00482222|Antidotes|antidotes|mesh-ancestor
138674899|NCT00482222|Protective Agents|protective agents|mesh-ancestor
138674900|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
138674901|NCT00482222|Vitamins|vitamins|mesh-ancestor
138674902|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
138674903|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674904|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
138674905|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674906|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138674907|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674908|NCT01312129|Analgesics|analgesics|mesh-ancestor
138674910|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674911|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674912|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674913|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674914|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674915|NCT04518852|Sorafenib|sorafenib|mesh-list
138674916|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674917|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674918|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674919|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674920|NCT01311661|Olodaterol|olodaterol|mesh-list
138674921|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138674922|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
138674923|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674924|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674925|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674926|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
138674928|NCT00482261|Aspirin|aspirin|mesh-list
138674929|NCT00482261|Dexamethasone|dexamethasone|mesh-list
138674930|NCT00482261|Lenalidomide|lenalidomide|mesh-list
138674931|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674932|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
138674933|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
138674934|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674935|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674936|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138674937|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
138674938|NCT00482261|Hormones|hormones|mesh-ancestor
138674939|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674940|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138674941|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674942|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138674943|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674944|NCT00482261|Analgesics|analgesics|mesh-ancestor
138674945|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
138674946|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674947|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138674948|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138674949|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674950|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138674951|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138674952|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674954|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
138674955|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138674960|NCT04518618|Naloxone|naloxone|mesh-list
138674961|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138674962|NCT04518618|Narcotics|narcotics|mesh-ancestor
138674963|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138674964|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674965|NCT04518618|Analgesics|analgesics|mesh-ancestor
138674966|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
138674967|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674968|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138674969|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674970|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
138674971|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
138674972|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138674973|NCT00480584|Gemcitabine|gemcitabine|mesh-list
138674974|NCT00480584|Capecitabine|capecitabine|mesh-list
138462317|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
138674975|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138674976|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138674977|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
138674978|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674979|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674980|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138674981|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674983|NCT01311505|Isoniazid|isoniazid|mesh-list
138674984|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138674987|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674989|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138674990|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674991|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462429|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138674992|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138674993|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138674994|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138674995|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138674996|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138674997|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138674998|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138674999|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675001|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675002|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
138675003|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675004|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
138675005|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675006|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675007|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138675008|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
138675009|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675010|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675011|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138675013|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675014|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138675015|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675016|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675017|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675018|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
138675019|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
138675020|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675021|NCT04518540|Protective Agents|protective agents|mesh-ancestor
138675022|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675023|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
138675024|NCT04518540|Vitamins|vitamins|mesh-ancestor
138675025|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
138675026|NCT00480623|Satraplatin|satraplatin|mesh-list
138675027|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675028|NCT01240655|Paclitaxel|paclitaxel|mesh-list
138675029|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138675030|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675031|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
138675032|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
138675033|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
138351764|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351765|NCT02953860|Fulvestrant|fulvestrant|mesh-list
138351766|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351767|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675034|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675035|NCT04518189|Lidocaine|lidocaine|mesh-list
138675036|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
138675037|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
138675038|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675039|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675040|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
138675041|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675042|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675043|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138675044|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138462644|NCT03333005|Miconazole|miconazole|mesh-list
138675046|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675049|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138675050|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675051|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
138675052|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138675053|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
138675054|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
138675055|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675056|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675057|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675058|NCT00482456|Analgesics|analgesics|mesh-ancestor
138675059|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
138675060|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675061|NCT00480896|Tacrolimus|tacrolimus|mesh-list
138675062|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675063|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
138675064|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675065|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138675066|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675067|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351872|NCT02988882|Hormones|hormones|mesh-ancestor
138675068|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138675069|NCT01309828|Olmesartan|olmesartan|mesh-list
138675070|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138675071|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
138675072|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138675073|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138675074|NCT01309828|Diuretics|diuretics|mesh-ancestor
138675075|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
138462723|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
138675076|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675077|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138675078|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675080|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138675083|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675084|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675085|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138675086|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138675087|NCT00482495|Growth Substances|growth substances|mesh-ancestor
138675088|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675089|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675091|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351771|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675092|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351773|NCT02956044|Metformin|metformin|mesh-list
138675093|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138675094|NCT00480935|Growth Substances|growth substances|mesh-ancestor
138675095|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675096|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675097|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138675098|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675099|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675100|NCT00482573|Epinephrine|epinephrine|mesh-list
138675101|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138675102|NCT00482573|Anesthetics|anesthetics|mesh-list
138675103|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675104|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675105|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138675106|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138675107|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
138675108|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675109|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675110|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138675111|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138675112|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
138675113|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675114|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138675115|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675117|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
138675118|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
138675120|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675122|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
138675123|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675124|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675125|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
138675126|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675127|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675128|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
138675129|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138675130|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675131|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138675132|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138675133|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
138675134|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138675135|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138675136|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675137|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675138|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
138675139|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675140|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138675141|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138675143|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138675144|NCT01240109|Narcotics|narcotics|mesh-ancestor
138675145|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675146|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675147|NCT01240109|Analgesics|analgesics|mesh-ancestor
138675148|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
138675149|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675150|NCT04517526|Bevacizumab|bevacizumab|mesh-list
138675151|NCT04517526|Durvalumab|durvalumab|mesh-list
138675152|NCT04517526|Carboplatin|carboplatin|mesh-list
138675153|NCT04517526|Pemetrexed|pemetrexed|mesh-list
138675154|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675155|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675156|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138675157|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138675158|NCT04517526|Growth Substances|growth substances|mesh-ancestor
138165992|NCT04578938|Ketamine|ketamine|mesh-list
138675159|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675160|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675161|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675162|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675163|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138675164|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138166049|NCT04393454|Sirolimus|sirolimus|mesh-list
138675165|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138675166|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138675167|NCT01309204|Brinzolamide|brinzolamide|mesh-list
138675168|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138675169|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138675170|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138675171|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138675172|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138675173|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
138675174|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675175|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675176|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675177|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138675178|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675180|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
138675181|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
138675182|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675183|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675184|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
138675185|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675186|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675187|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138675188|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138675189|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675190|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675191|NCT04325191|Melatonin|melatonin|mesh-list
138675192|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
138675193|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675194|NCT04325191|Protective Agents|protective agents|mesh-ancestor
138675195|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675196|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675197|NCT04517292|Cisplatin|cisplatin|mesh-list
138675198|NCT04517292|Gemcitabine|gemcitabine|mesh-list
138675199|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675200|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138675201|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
138675202|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675203|NCT00482846|Melphalan|melphalan|mesh-list
138675204|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138675205|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
138675206|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675207|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675208|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138675209|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675210|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
138675211|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675212|NCT01308736|Varenicline|varenicline|mesh-list
138675213|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138675214|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138675216|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675217|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166440|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675218|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675219|NCT04517214|Gemcitabine|gemcitabine|mesh-list
138675220|NCT04517214|Capecitabine|capecitabine|mesh-list
138675221|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675222|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138675223|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
138675224|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675225|NCT00483054|Efavirenz|efavirenz|mesh-list
138675226|NCT00483054|Nevirapine|nevirapine|mesh-list
138675227|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138675228|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138675232|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675233|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138675234|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138675235|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138675236|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138675237|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138675238|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138675240|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138675241|NCT01240226|Ketoconazole|ketoconazole|mesh-list
138675242|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
138166639|NCT04028024|Urinastatin|urinastatin|mesh-list
138675243|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675244|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138675245|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138675246|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675247|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675248|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138675249|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675250|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675251|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675252|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138675253|NCT01240824|Aminophylline|aminophylline|mesh-list
138675254|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138675255|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
138675256|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675257|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675258|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138166704|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
138675259|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675260|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138675261|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138675262|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675265|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138675266|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
138675267|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675268|NCT01240824|Protective Agents|protective agents|mesh-ancestor
138675269|NCT01240941|Exemestane|exemestane|mesh-list
138675270|NCT01240941|Goserelin|goserelin|mesh-list
138675271|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675272|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138675273|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138675274|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209987|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675275|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675276|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138675277|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675278|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675279|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675280|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138675281|NCT00482963|Efavirenz|efavirenz|mesh-list
138675282|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
138675283|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138675284|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138675285|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675286|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166904|NCT04026464|Ibuprofen|ibuprofen|mesh-list
138675287|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
138675288|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675289|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138675292|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138675293|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138675294|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138675295|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138675296|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
138675297|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138675298|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675299|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138675300|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138675301|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138675302|NCT01241019|Topiramate|topiramate|mesh-list
138675303|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
138675304|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675305|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675306|NCT01240928|Exemestane|exemestane|mesh-list
138675307|NCT01240928|Goserelin|goserelin|mesh-list
138675308|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675309|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138675310|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138675311|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675312|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675313|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138675314|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675315|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675316|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675317|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138675318|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
138675319|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138675320|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138675321|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675322|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675323|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675327|NCT00483132|Interferons|interferons|mesh-list
138675328|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
138675329|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
138675330|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675331|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
138675332|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675333|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
138675334|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675335|NCT00483210|Fenofibrate|fenofibrate|mesh-list
138675336|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675337|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
138675338|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675339|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675340|NCT00487994|Atorvastatin|atorvastatin|mesh-list
138675341|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138675342|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675343|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
138675344|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675345|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675346|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138675347|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675348|NCT00483158|Finafloxacin|finafloxacin|mesh-list
138675349|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138675350|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675351|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675352|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138675353|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675354|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675355|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675356|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675358|NCT01308580|Prednisolone|prednisolone|mesh-list
138675359|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675360|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
138675361|NCT01308580|Hormones|hormones|mesh-ancestor
138675362|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675363|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675364|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138675365|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675366|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
138675367|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138675368|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138675369|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675370|NCT00483275|Vitamins|vitamins|mesh-ancestor
138675371|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
138675372|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
138675373|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138675374|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
138675375|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675376|NCT00483314|Expectorants|expectorants|mesh-ancestor
138675377|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675378|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138675379|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
138675380|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675381|NCT00483314|Protective Agents|protective agents|mesh-ancestor
138675382|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675383|NCT00483314|Antidotes|antidotes|mesh-ancestor
138675384|NCT00483392|Metformin|metformin|mesh-list
138675385|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
138675386|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675387|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675388|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
138675389|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
138167329|NCT04961359|Vaccines|vaccines|mesh-list
138675390|NCT00483431|Coagulants|coagulants|mesh-ancestor
138675391|NCT00483600|PENTA|penta|mesh-list
138675392|NCT00483600|Fondaparinux|fondaparinux|mesh-list
138675393|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138675394|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
138675395|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138675396|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
138675398|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675399|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
138675400|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138675401|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138675402|NCT00488189|Tazobactam|tazobactam|mesh-list
138675403|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138675404|NCT00488189|Piperacillin|piperacillin|mesh-list
138675405|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675406|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675407|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138675408|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675409|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675410|NCT02956421|Vaccines|vaccines|mesh-list
138675411|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
138675412|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675414|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
138675415|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675416|NCT00488306|Tigecycline|tigecycline|mesh-list
138675417|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675418|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675419|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138675420|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675421|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675422|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
138675423|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
138675425|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138675426|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675427|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675428|NCT00483626|Urological Agents|urological agents|mesh-ancestor
138675430|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
138675431|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
138352247|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
138675432|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138675433|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
138675434|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
138675435|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675437|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
138675438|NCT05644210|Prednisone|prednisone|mesh-list
138675439|NCT05644210|Rituximab|rituximab|mesh-list
138675440|NCT05644210|Warfarin|warfarin|mesh-list
138675441|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675442|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675443|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
138675444|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675445|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675446|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675447|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
138675448|NCT05644210|Hormones|hormones|mesh-ancestor
138675449|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675450|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138675451|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675452|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675453|NCT05644210|Analgesics|analgesics|mesh-ancestor
138675454|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
138675455|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675456|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138675457|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138675458|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167567|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675460|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138675461|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675462|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
138675463|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
138675464|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
138675465|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138675466|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138675467|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675468|NCT00488384|Acitretin|acitretin|mesh-list
138675469|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
138675470|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
138675471|NCT00483834|Bevacizumab|bevacizumab|mesh-list
138675472|NCT00483834|Capecitabine|capecitabine|mesh-list
138675473|NCT00483834|Irinotecan|irinotecan|mesh-list
138675474|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675475|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675476|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138167644|NCT00493181|Oprelvekin|oprelvekin|mesh-list
138675477|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138675478|NCT00483834|Growth Substances|growth substances|mesh-ancestor
138675479|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675480|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675481|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138675482|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
138675483|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675484|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138675485|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675486|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675487|NCT01307449|Vaccines|vaccines|mesh-list
138675488|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138675491|NCT01307020|Ibuprofen|ibuprofen|mesh-list
138675492|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138675493|NCT01307020|Ketoprofen|ketoprofen|mesh-list
138675495|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675496|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675497|NCT01307020|Analgesics|analgesics|mesh-ancestor
138675498|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
138675499|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675500|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675501|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675502|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675503|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138675504|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675505|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675506|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138675507|NCT01307020|Narcotics|narcotics|mesh-ancestor
138675508|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675509|NCT00483743|Budesonide|budesonide|mesh-list
138675510|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675511|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138675512|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
138675513|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675514|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675515|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138675516|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675517|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
138675518|NCT00483743|Hormones|hormones|mesh-ancestor
138675519|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675520|NCT00483782|Paclitaxel|paclitaxel|mesh-list
138675521|NCT00483782|Bevacizumab|bevacizumab|mesh-list
138675522|NCT00483782|Carboplatin|carboplatin|mesh-list
138675523|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138675524|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675525|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
138675526|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
138675527|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
138675528|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675529|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675531|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138675532|NCT00483782|Growth Substances|growth substances|mesh-ancestor
138675533|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675534|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
138675536|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
138675537|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675538|NCT02890771|Protective Agents|protective agents|mesh-ancestor
138675539|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675540|NCT01306162|Dronedarone|dronedarone|mesh-list
138675541|NCT01306162|Dabigatran|dabigatran|mesh-list
138675542|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
138675543|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138675544|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
138675545|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675546|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675547|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
138675548|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675549|NCT04515732|Apremilast|apremilast|mesh-list
138675550|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675551|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675552|NCT04515732|Analgesics|analgesics|mesh-ancestor
138675553|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
138675554|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675555|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675556|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675557|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675558|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138675559|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138675560|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675561|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675562|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
138675563|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138675564|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138675565|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138675567|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
138675570|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
138675571|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675572|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138675573|NCT01304329|Empagliflozin|empagliflozin|mesh-list
138675574|NCT01304329|Simvastatin|simvastatin|mesh-list
138675575|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138675576|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675577|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
138675578|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675579|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675580|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138675581|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675582|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138675583|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675584|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675585|NCT04515420|Norepinephrine|norepinephrine|mesh-list
138675586|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138675587|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138675588|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
138675590|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675591|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675592|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
138675593|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
138675594|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675595|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138675596|NCT00488540|Acetaminophen|acetaminophen|mesh-list
138675597|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675599|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
138675600|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675601|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675604|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138675605|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
138675606|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351790|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138351791|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138351792|NCT02956122|Prednisolone|prednisolone|mesh-list
138351799|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
138675607|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675608|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138675609|NCT00483860|Topotecan|topotecan|mesh-list
138675610|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138675611|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675612|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282891|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675613|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675614|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675616|NCT01241097|Ezetimibe|ezetimibe|mesh-list
138675617|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138675618|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675619|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
138675620|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675621|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675622|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138675623|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675624|NCT01303861|Bupropion|bupropion|mesh-list
138675625|NCT01303861|Nicotine|nicotine|mesh-list
138675626|NCT01303861|Varenicline|varenicline|mesh-list
138675627|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138675628|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
138675629|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675630|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675631|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138675632|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138675634|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675635|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675636|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138675637|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
138675639|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138675640|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138675641|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675643|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138675644|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138675645|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675646|NCT01303627|Remifentanil|remifentanil|mesh-list
138675647|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138675648|NCT01303627|Narcotics|narcotics|mesh-ancestor
138675649|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675650|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675651|NCT01303627|Analgesics|analgesics|mesh-ancestor
138675652|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
138675653|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675654|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
138675655|NCT01241175|Analgesics|analgesics|mesh-ancestor
138675656|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
138675657|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675658|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675659|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
138675660|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675661|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675662|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
138675663|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138675664|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675665|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675666|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138675667|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
138675668|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138675669|NCT00484107|Estrogens|estrogens|mesh-list
138168201|NCT03585374|Analgesics|analgesics|mesh-ancestor
138675670|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138675671|NCT00484107|Hormones|hormones|mesh-ancestor
138675672|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675673|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675674|NCT01302964|Mirtazapine|mirtazapine|mesh-list
138675675|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
138675676|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138675677|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138675678|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
138675679|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
138675683|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138675684|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138675685|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675686|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138168312|NCT03589898|Gabapentin|gabapentin|mesh-list
138675687|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138675688|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138675689|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
138675690|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138675691|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138675692|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
138675693|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138675695|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675696|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675697|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138675698|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675699|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675700|NCT01302691|Losartan|losartan|mesh-list
138675701|NCT01302691|Amlodipine|amlodipine|mesh-list
138675702|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138675703|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138675704|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138675705|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675706|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675707|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138675709|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
138675710|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675711|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138675712|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138675713|NCT01302691|Diuretics|diuretics|mesh-ancestor
138675714|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
138675715|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138675716|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138675717|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675718|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138675719|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675720|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138675721|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675722|NCT05643820|Ivermectin|ivermectin|mesh-list
138675723|NCT05643820|Permethrin|permethrin|mesh-list
138675724|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138675725|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675726|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675727|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675728|NCT01242449|Trastuzumab|trastuzumab|mesh-list
138675729|NCT01242449|Vinorelbine|vinorelbine|mesh-list
138675730|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138675731|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675732|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138675733|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
138675734|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
138675735|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
138675736|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675737|NCT01241162|Decitabine|decitabine|mesh-list
138675738|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138675739|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
138675740|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168393|NCT03589430|Protein S|protein s|mesh-list
138675741|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675742|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675743|NCT00484133|Dobutamine|dobutamine|mesh-list
138675744|NCT00484133|Dopamine|dopamine|mesh-list
138351802|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351803|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351805|NCT02956122|Hormones|hormones|mesh-ancestor
138675745|NCT00484133|Enoximone|enoximone|mesh-list
138675746|NCT00484133|Norepinephrine|norepinephrine|mesh-list
138675747|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
138675748|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
138675749|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138675753|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675754|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138675755|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138675756|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138675757|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
138675758|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675759|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675760|NCT00484133|Protective Agents|protective agents|mesh-ancestor
138675761|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
138675762|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138675763|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138675764|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138675765|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138675767|NCT00484341|Doxorubicin|doxorubicin|mesh-list
138675768|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138675769|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675770|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138675771|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675772|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675773|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675774|NCT01242566|Temozolomide|temozolomide|mesh-list
138675775|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138675776|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
138675777|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675778|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675779|NCT04514835|Capecitabine|capecitabine|mesh-list
138675780|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675781|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138675782|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
138675783|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675784|NCT00488813|Cephalosporins|cephalosporins|mesh-list
138675785|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675786|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675787|NCT00484250|Metronidazole|metronidazole|mesh-list
138675788|NCT00484250|Doxycycline|doxycycline|mesh-list
138675789|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675790|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675791|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138675792|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138675793|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
138675794|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138675795|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
138675796|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138675797|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675798|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675799|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138675800|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138675801|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138675802|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
138675803|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675804|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675805|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138675806|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138675807|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
138675809|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
138675810|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675814|NCT00484575|Sevoflurane|sevoflurane|mesh-list
138675815|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138675816|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675817|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675818|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138675819|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
138675820|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
138210276|NCT05901441|Hydromorphone|hydromorphone|mesh-list
138675821|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138675822|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138351811|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675824|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138675825|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675826|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675827|NCT00488969|Morphine|morphine|mesh-list
138675828|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138675829|NCT00488969|Narcotics|narcotics|mesh-ancestor
138675830|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675831|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675832|NCT00488969|Analgesics|analgesics|mesh-ancestor
138675833|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
138675834|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675836|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138675837|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
138675838|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138675839|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138675840|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138675841|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675842|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675843|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
138675844|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675846|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138675847|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138675848|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675850|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
138675851|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
138675852|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675853|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675854|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
138675855|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675856|NCT00484484|Ketamine|ketamine|mesh-list
138675857|NCT00484484|Analgesics|analgesics|mesh-ancestor
138675858|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
138675859|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675860|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675861|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138675862|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138675863|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
138675865|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675866|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138675867|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138675868|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675869|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675872|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138675873|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675874|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138675875|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675876|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675877|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675878|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138675879|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
138675880|NCT00484640|Warfarin|warfarin|mesh-list
138675881|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
138675882|NCT00489164|Sirolimus|sirolimus|mesh-list
138675883|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675884|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675885|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138675886|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675887|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
138675888|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675889|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
138675890|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675891|NCT00484809|Etanercept|etanercept|mesh-list
138675892|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675893|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675894|NCT00484809|Analgesics|analgesics|mesh-ancestor
138675895|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
138675896|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675897|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675898|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675899|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675900|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138675901|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675902|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
138675903|NCT04514094|Fluorides|fluorides|mesh-list
138675904|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
138675905|NCT04514094|Protective Agents|protective agents|mesh-ancestor
138675909|NCT00484926|Clopidogrel|clopidogrel|mesh-list
138675910|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675911|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675912|NCT00484926|Analgesics|analgesics|mesh-ancestor
138675913|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
138675914|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675915|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675916|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138675917|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138675918|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138675919|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138675920|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675921|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138675922|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138675923|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675924|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
138675925|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138675926|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138675927|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138675928|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
138675929|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675931|NCT02275806|Camptothecin|camptothecin|mesh-list
138675932|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675933|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138675934|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138675935|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168858|NCT01855451|Cetuximab|cetuximab|mesh-list
138675936|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675937|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138675938|NCT01241409|Rabeprazole|rabeprazole|mesh-list
138675939|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138675940|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138675941|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138675942|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675943|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675944|NCT02275845|Metformin|metformin|mesh-list
138675945|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675946|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675947|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138675951|NCT00489398|Analgesics|analgesics|mesh-ancestor
138675952|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
138675953|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138675954|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675957|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138675958|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138675959|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138675960|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
138675961|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
138675962|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675963|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675964|NCT00485004|Sirolimus|sirolimus|mesh-list
138675965|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138675966|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675967|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138168980|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
138675968|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675969|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
138675970|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675971|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
138675972|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675974|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138675977|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675978|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138675979|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169041|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
138675980|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
138675982|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138675983|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138675984|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
138675985|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675986|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138675988|NCT00489437|Antibodies|antibodies|mesh-list
138675989|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
138675990|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675991|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
138675992|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138675993|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138675994|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675995|NCT00485160|Ibuprofen|ibuprofen|mesh-list
138675996|NCT00485160|Indomethacin|indomethacin|mesh-list
138675997|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675998|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138675999|NCT00485160|Analgesics|analgesics|mesh-ancestor
138676000|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
138676001|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676002|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676003|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676004|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676005|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138676006|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676007|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676008|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
138676009|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
138676010|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138676011|NCT00485030|Sirolimus|sirolimus|mesh-list
138676012|NCT00485030|Everolimus|everolimus|mesh-list
138676013|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138676014|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138676018|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
138676019|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676020|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676021|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676022|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676023|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138676024|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
138676025|NCT04513821|Minocycline|minocycline|mesh-list
138676026|NCT04513821|Ethanol|ethanol|mesh-list
138676027|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676028|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676029|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138676030|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676031|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676033|NCT00485108|Ketorolac|ketorolac|mesh-list
138676034|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
138352847|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138676037|NCT00485108|Hormones|hormones|mesh-ancestor
138676038|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676039|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676040|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138676041|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676042|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676043|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138676044|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138676046|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
138676047|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676048|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138676049|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676050|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676051|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138676052|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138676053|NCT00485238|Acetazolamide|acetazolamide|mesh-list
138676054|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
138676055|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138676056|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676057|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676058|NCT00485238|Diuretics|diuretics|mesh-ancestor
138676064|NCT04513509|Propranolol|propranolol|mesh-list
138676065|NCT04513509|Metoprolol|metoprolol|mesh-list
138676066|NCT04513509|Digoxin|digoxin|mesh-list
138676067|NCT04513509|Atenolol|atenolol|mesh-list
138676068|NCT04513509|Verapamil|verapamil|mesh-list
138676069|NCT04513509|Nebivolol|nebivolol|mesh-list
138676070|NCT04513509|Bisoprolol|bisoprolol|mesh-list
138676071|NCT04513509|Diltiazem|diltiazem|mesh-list
138676072|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138676073|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138676074|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676075|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676076|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169468|NCT00517595|Bevacizumab|bevacizumab|mesh-list
138676078|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138676079|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138676080|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
138676081|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
138676082|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
138676083|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676084|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138676085|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138676086|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676087|NCT04513509|Protective Agents|protective agents|mesh-ancestor
138676088|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138676090|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138676091|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138676092|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676093|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676094|NCT00485342|Interferons|interferons|mesh-list
138676095|NCT00485342|Ribavirin|ribavirin|mesh-list
138676096|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
138676097|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
138676098|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138676099|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676100|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
138676101|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676104|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
138676105|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676107|NCT00489593|Fluoxetine|fluoxetine|mesh-list
138676108|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
138352921|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
138676109|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
138676110|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676111|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676112|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676113|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676114|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676115|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676116|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676117|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676118|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676119|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676120|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676121|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676122|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
138676123|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138676124|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676125|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138676126|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138676127|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676128|NCT01241487|Amlodipine|amlodipine|mesh-list
138676129|NCT01241487|Valsartan|valsartan|mesh-list
138676130|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138676131|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138676132|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210416|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676133|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676134|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676135|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676136|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138676137|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138676140|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
138351819|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138676141|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676142|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676143|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676144|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676145|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676146|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676147|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676148|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676149|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676151|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138676152|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138676153|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676154|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676155|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138676156|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676157|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676158|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138676159|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
138676160|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
138676161|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
138676162|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
138676163|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676164|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676166|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676167|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
138676168|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676169|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676170|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138676171|NCT00485498|Olanzapine|olanzapine|mesh-list
138676172|NCT00485498|Risperidone|risperidone|mesh-list
138676173|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138676174|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
138676175|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676176|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676177|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676178|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676179|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138210432|NCT05736861|Ivermectin|ivermectin|mesh-list
138676180|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676184|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
138676185|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
138676186|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676187|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676188|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676189|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676190|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676191|NCT01302067|Fesoterodine|fesoterodine|mesh-list
138676192|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138676193|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138676194|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
138676195|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676196|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676197|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676198|NCT01302067|Urological Agents|urological agents|mesh-ancestor
138676199|NCT00485550|Methylphenidate|methylphenidate|mesh-list
138676200|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676201|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138676202|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351823|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138676203|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138676204|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676205|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676206|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676207|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
138676208|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676209|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676210|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676211|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676212|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676213|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676214|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676215|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676217|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676218|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676220|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138676221|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676222|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
138676223|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676224|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
138676225|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676226|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676227|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138170009|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138676228|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138676229|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676230|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676231|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676232|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
138676233|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138676234|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676236|NCT00489944|Sunitinib|sunitinib|mesh-list
138676237|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676238|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676242|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676243|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
138676244|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138676245|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676246|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138676247|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
138676248|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676249|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138676250|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138676251|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138676252|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138676253|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
138676254|NCT00485706|Calcium|calcium|mesh-list
138676255|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676256|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676257|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138676258|NCT00505947|Infliximab|infliximab|mesh-list
138676259|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138676260|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676261|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138676263|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676265|NCT00489983|Pemetrexed|pemetrexed|mesh-list
138676266|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138676267|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
138676268|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676269|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676270|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676271|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138676272|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138676273|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
138676274|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676275|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
138676276|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676277|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676278|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138676279|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
138676280|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676281|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676282|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138676287|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138676288|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
138676289|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676290|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138676291|NCT00485771|Lamotrigine|lamotrigine|mesh-list
138676292|NCT00485771|Olanzapine|olanzapine|mesh-list
138676293|NCT00485771|Fluoxetine|fluoxetine|mesh-list
138676294|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
138676295|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
138676296|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210526|NCT05340673|Petrolatum|petrolatum|mesh-list
138676297|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676298|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676299|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676300|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676301|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170300|NCT01677104|Exenatide|exenatide|mesh-list
138676302|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676303|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676304|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676305|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676306|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676307|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676308|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
138676309|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138676310|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676315|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138170363|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138676316|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676317|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138676318|NCT00485810|Olanzapine|olanzapine|mesh-list
138676319|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
138676320|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
138676321|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676322|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676323|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676324|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138353144|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138676325|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138170421|NCT00663793|Testosterone|testosterone|mesh-list
138676326|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676327|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676328|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676329|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676330|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676331|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676332|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676333|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
138676334|NCT00490373|Pemetrexed|pemetrexed|mesh-list
138676335|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676336|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676337|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676338|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138676339|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138676342|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
138676343|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676344|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676345|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676346|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676347|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676348|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676349|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676350|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676351|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676356|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138170543|NCT00393211|Analgesics|analgesics|mesh-ancestor
138676357|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676358|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676359|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676360|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676361|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676362|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676363|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676364|NCT00485888|Escitalopram|escitalopram|mesh-list
138676365|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676366|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676367|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170676|NCT00006170|Bupropion|bupropion|mesh-list
138676368|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676369|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676370|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
138676371|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676372|NCT00485862|Sertraline|sertraline|mesh-list
138676373|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676374|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676375|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676376|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676377|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676378|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676379|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676380|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676381|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
138676382|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676383|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676384|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676385|NCT00485901|Haloperidol|haloperidol|mesh-list
138676386|NCT00485901|Olanzapine|olanzapine|mesh-list
138676387|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
138676388|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
138676391|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676392|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676393|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676394|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676395|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676396|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676397|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138353250|NCT01717482|Metformin|metformin|mesh-list
138676398|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676399|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676400|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676401|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676402|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
138676403|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138676404|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
138676405|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138676406|NCT00490412|Vitamin D|vitamin d|mesh-list
138676407|NCT00490412|Vitamins|vitamins|mesh-ancestor
138676408|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
138676409|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676410|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138676412|NCT00485940|Laxatives|laxatives|mesh-ancestor
138676413|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676414|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138676415|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138676416|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
138351853|NCT02970552|Progesterone|progesterone|mesh-list
138676420|NCT00486005|Olanzapine|olanzapine|mesh-list
138676422|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
138676423|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
138676424|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676425|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676426|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676427|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676428|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676429|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676430|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676431|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138676432|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676433|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676434|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676435|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676436|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
138676437|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138676438|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138676439|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
138676440|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
138676443|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676444|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138676445|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138676446|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170982|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
138676447|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676448|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138676449|NCT00486083|Methylphenidate|methylphenidate|mesh-list
138676450|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676451|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138676452|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676453|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138171048|NCT03482102|Durvalumab|durvalumab|mesh-list
138676456|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676457|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
138676458|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676459|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676460|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676461|NCT00490685|Sorafenib|sorafenib|mesh-list
138676462|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676463|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138676464|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676465|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676466|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138676467|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138676468|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676469|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676470|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676472|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676473|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676475|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138676476|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676477|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138676478|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138676479|NCT04511715|Growth Substances|growth substances|mesh-ancestor
138676480|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676481|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
138676482|NCT00486317|Calcitonin|calcitonin|mesh-list
138676483|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
138676484|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138676485|NCT00486317|Katacalcin|katacalcin|mesh-list
138676486|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676487|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676488|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138676489|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
138676490|NCT00490880|Gemcitabine|gemcitabine|mesh-list
138676491|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676492|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138676493|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
138676494|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676495|NCT00486174|Methylene Blue|methylene blue|mesh-list
138676496|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676497|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676498|NCT00490958|Telmisartan|telmisartan|mesh-list
138676499|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138676500|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138676501|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138676502|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676503|NCT00486213|Pyridoxine|pyridoxine|mesh-list
138676504|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
138676505|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
138676506|NCT00486213|Vitamins|vitamins|mesh-ancestor
138676507|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
138676512|NCT00486369|Katacalcin|katacalcin|mesh-list
138676513|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138676514|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676515|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138676516|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
138676517|NCT00490997|Ketamine|ketamine|mesh-list
138676518|NCT00490997|Propofol|propofol|mesh-list
138676519|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138676520|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171216|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138676521|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676522|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138676523|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
138676524|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
138676525|NCT00490997|Analgesics|analgesics|mesh-ancestor
138676526|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
138676527|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676528|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138676529|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138676530|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138676531|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676532|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676533|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
138676534|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138676535|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
138676536|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138676537|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138676538|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676539|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676540|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
138676541|NCT00486486|Timolol|timolol|mesh-list
138676542|NCT00486486|Bimatoprost|bimatoprost|mesh-list
138676543|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138676544|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138676545|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676546|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676557|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138676558|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138676559|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138676560|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676561|NCT00486668|Paclitaxel|paclitaxel|mesh-list
138676562|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
138676563|NCT00486668|Doxorubicin|doxorubicin|mesh-list
138676564|NCT00486668|Trastuzumab|trastuzumab|mesh-list
138676565|NCT00486668|Lapatinib|lapatinib|mesh-list
138676566|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138676567|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676568|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138676569|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138676570|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138676571|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676572|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676573|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
138676574|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676575|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676576|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138676577|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
138210693|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
138676578|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138676579|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138676580|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138676583|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138676584|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138676585|NCT04510935|Anesthetics|anesthetics|mesh-list
138676586|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676587|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676588|NCT00491192|Diclofenac|diclofenac|mesh-list
138676589|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138171512|NCT04401878|Lidocaine|lidocaine|mesh-list
138676590|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138676591|NCT00491192|Analgesics|analgesics|mesh-ancestor
138676592|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
138676593|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676594|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676595|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676596|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676597|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138676598|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676599|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676600|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138676601|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676602|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676603|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138676604|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138676605|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171576|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138676606|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676608|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
138676609|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138676610|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676611|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676612|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676613|NCT00486785|Alfuzosin|alfuzosin|mesh-list
138676614|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138676615|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138676616|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138353439|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138676617|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676618|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676619|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676620|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676621|NCT00486785|Urological Agents|urological agents|mesh-ancestor
138676622|NCT04324411|Sirolimus|sirolimus|mesh-list
138676623|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676624|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676625|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138676626|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676627|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
138676628|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676629|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
138676630|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676631|NCT00486876|Tofisopam|tofisopam|mesh-list
138676632|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676633|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676634|NCT05643586|Ticagrelor|ticagrelor|mesh-list
138676635|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138676636|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138676640|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
138676641|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676642|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676643|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676644|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
138676645|NCT01242072|Ifosfamide|ifosfamide|mesh-list
138676646|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138676647|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
138676648|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676649|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676650|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138676651|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138171761|NCT02130635|Nemiralisib|nemiralisib|mesh-list
138676652|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138676653|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676654|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676655|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676656|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676657|NCT00491348|Analgesics|analgesics|mesh-ancestor
138676658|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
138676659|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676660|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138676664|NCT01242098|Beclomethasone|beclomethasone|mesh-list
138676665|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
138676666|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138676667|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676668|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138676669|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
138676670|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676671|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676672|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138676673|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
138676674|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
138676675|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138676676|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138676677|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138676680|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676681|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676684|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676685|NCT01301092|Dulaglutide|dulaglutide|mesh-list
138676686|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138676687|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676688|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138676689|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
138676690|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676691|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676692|NCT04510818|Capecitabine|capecitabine|mesh-list
138676693|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138676694|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
138676695|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676698|NCT05642689|Trace Elements|trace elements|mesh-ancestor
138676699|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
138676700|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676701|NCT01300819|Rotigotine|rotigotine|mesh-list
138676702|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
138676703|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
138676704|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676705|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676706|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676708|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
138676709|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210787|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138676710|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676711|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676712|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
138676713|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
138676714|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676715|NCT02275962|Rifampin|rifampin|mesh-list
138676716|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138676717|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
138676718|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676719|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676720|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
138676721|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138676722|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676725|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138676726|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138676727|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138676728|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138676729|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138676730|NCT00487032|Fluticasone|fluticasone|mesh-list
138676732|NCT00487032|Prazosin|prazosin|mesh-list
138676733|NCT00487032|Phenylephrine|phenylephrine|mesh-list
138676734|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
138676735|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676736|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138351858|NCT02978508|Permethrin|permethrin|mesh-list
138676737|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
138676738|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676739|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676740|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138676741|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
138676742|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
138676743|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138676744|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138676745|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138676746|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
138676747|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676748|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676749|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
138676750|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
138676751|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138676752|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138676753|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
138676754|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138676755|NCT00487032|Protective Agents|protective agents|mesh-ancestor
138676756|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138676757|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138676758|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138676759|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138676760|NCT00491426|Metronidazole|metronidazole|mesh-list
138676761|NCT00491426|Tazobactam|tazobactam|mesh-list
138676762|NCT00491426|Piperacillin|piperacillin|mesh-list
138676763|NCT00491426|Amphotericin B|amphotericin b|mesh-list
138676764|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138676768|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138676769|NCT00491426|Anidulafungin|anidulafungin|mesh-list
138676770|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676771|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138676772|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138676773|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138676774|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138676775|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676776|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676777|NCT00491426|Amebicides|amebicides|mesh-ancestor
138676778|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
138676779|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
138676781|NCT01300546|Sumatriptan|sumatriptan|mesh-list
138676782|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138676783|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138676784|NCT01300546|Analgesics|analgesics|mesh-ancestor
138676785|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
138676786|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676787|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676788|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676789|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676790|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
138676791|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138676792|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676793|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676794|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138676795|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138676796|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138676797|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
138676798|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676804|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676805|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676806|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
138210853|NCT04126031|Avibactam|avibactam|mesh-list
138676807|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
138676808|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
138676809|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676810|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138676811|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138676812|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
138676813|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676814|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676815|NCT00487136|Warfarin|warfarin|mesh-list
138676816|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138351861|NCT02881008|Entecavir|entecavir|mesh-list
138676817|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
138676818|NCT00487136|Fenofibrate|fenofibrate|mesh-list
138676819|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138676820|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138676821|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
138676822|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676823|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138676824|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138676825|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676826|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
138676827|NCT02276001|Cyclosporine|cyclosporine|mesh-list
138676828|NCT02276001|Cyclosporins|cyclosporins|mesh-list
138676829|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676830|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676831|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676832|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
138676833|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676834|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
138676835|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676836|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138676837|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676838|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138676839|NCT00491582|Hormones|hormones|mesh-list
138676840|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676841|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676842|NCT00487175|Tramadol|tramadol|mesh-list
138676843|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138676844|NCT00487175|Narcotics|narcotics|mesh-ancestor
138676845|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676846|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676847|NCT00487175|Analgesics|analgesics|mesh-ancestor
138676848|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
138676849|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676850|NCT00487227|Caffeine|caffeine|mesh-list
138676851|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138676852|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676853|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138676854|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676855|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676856|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138676857|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138676859|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676860|NCT01300351|Fulvestrant|fulvestrant|mesh-list
138676861|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138676862|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676863|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138676864|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138676865|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
138676866|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676867|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676868|NCT00487253|Miltefosine|miltefosine|mesh-list
138676869|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138676870|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
138676871|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676872|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676873|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138351865|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351866|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
138351880|NCT03009162|Lasmiditan|lasmiditan|mesh-list
138676874|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138676875|NCT04510233|Ivermectin|ivermectin|mesh-list
138676876|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138676877|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676878|NCT05641909|Fentanyl|fentanyl|mesh-list
138676879|NCT05641909|Remifentanil|remifentanil|mesh-list
138676880|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138676881|NCT05641909|Narcotics|narcotics|mesh-ancestor
138676882|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676883|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676884|NCT05641909|Analgesics|analgesics|mesh-ancestor
138676885|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
138676886|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676890|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
138676891|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
138676892|NCT02276196|Lixisenatide|lixisenatide|mesh-list
138676893|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138676894|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676895|NCT00487422|Prucalopride|prucalopride|mesh-list
138676896|NCT00487422|Laxatives|laxatives|mesh-ancestor
138676897|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676898|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138676899|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138676900|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
138676901|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676902|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676903|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676904|NCT04697355|Beta Carotene|beta carotene|mesh-list
138676905|NCT04697355|Naringenin|naringenin|mesh-list
138676906|NCT04697355|Carotenoids|carotenoids|mesh-list
138676907|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
138676908|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676909|NCT04697355|Protective Agents|protective agents|mesh-ancestor
138676910|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676911|NCT04697355|Provitamins|provitamins|mesh-ancestor
138676913|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
138676915|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676916|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138676917|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
138676918|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353737|NCT00538980|Dasatinib|dasatinib|mesh-list
138676919|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138676920|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676923|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676924|NCT00491855|Paclitaxel|paclitaxel|mesh-list
138676925|NCT00491855|Bevacizumab|bevacizumab|mesh-list
138676926|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
138676927|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138676928|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676929|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
138676930|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
138676931|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
138676932|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676933|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138676934|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138676935|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138676936|NCT00491855|Growth Substances|growth substances|mesh-ancestor
138676937|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676938|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
138676939|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138676940|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676941|NCT00487448|Cytarabine|cytarabine|mesh-list
138676942|NCT00487448|Fludarabine|fludarabine|mesh-list
138676943|NCT00487448|Idarubicin|idarubicin|mesh-list
138676944|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676945|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138676946|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
138676947|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676948|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676949|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
138676950|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676951|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
138676952|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676953|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138676954|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138676955|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138676956|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676957|NCT00506259|Melatonin|melatonin|mesh-list
138676958|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
138676959|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676960|NCT00506259|Protective Agents|protective agents|mesh-ancestor
138676961|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676962|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138676963|NCT00506298|Diflunisal|diflunisal|mesh-list
138676964|NCT00506298|Bezafibrate|bezafibrate|mesh-list
138676965|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138676966|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
138676967|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676968|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138676969|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138676970|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138676972|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
138676973|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676974|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676975|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138676976|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676977|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138676978|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676979|NCT01242215|Glimepiride|glimepiride|mesh-list
138676980|NCT01242215|Gliclazide|gliclazide|mesh-list
138676981|NCT01242215|Glyburide|glyburide|mesh-list
138676982|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
138676983|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138676984|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138676985|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676986|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676987|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
138676988|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138676989|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676990|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138676991|NCT01242228|Vildagliptin|vildagliptin|mesh-list
138676992|NCT01242228|Saxagliptin|saxagliptin|mesh-list
138676993|NCT01242228|Alogliptin|alogliptin|mesh-list
138676994|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
138676995|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138676999|NCT01242228|Hormones|hormones|mesh-ancestor
138677000|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677001|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138677002|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677003|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677004|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138677005|NCT01242306|Acetylcholine|acetylcholine|mesh-list
138677006|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677007|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138677008|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
138677009|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210945|NCT03675893|Metformin|metformin|mesh-list
138677010|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677012|NCT00492128|Losartan|losartan|mesh-list
138351882|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
138351886|NCT03009396|Clarithromycin|clarithromycin|mesh-list
138677013|NCT00492128|Amlodipine|amlodipine|mesh-list
138677014|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138677015|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138677016|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138677017|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677018|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677019|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138172186|NCT00753337|Cobalt|cobalt|mesh-list
138677020|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677021|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677022|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138677023|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138677028|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
138677029|NCT00487734|Testosterone|testosterone|mesh-list
138677030|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
138677031|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
138677032|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138677033|NCT00487734|Androgens|androgens|mesh-ancestor
138677034|NCT00487734|Hormones|hormones|mesh-ancestor
138677035|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677036|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677037|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138677038|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677039|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
138677040|NCT01300234|Tenofovir|tenofovir|mesh-list
138677041|NCT01300234|Adefovir|adefovir|mesh-list
138677042|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138677043|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
138677044|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677045|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138677046|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138677047|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677048|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677049|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138677050|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138677051|NCT01242332|Pregabalin|pregabalin|mesh-list
138677052|NCT01242332|Analgesics|analgesics|mesh-ancestor
138677053|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
138677054|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677055|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677056|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
138677057|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138677058|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677059|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677060|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677061|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138677062|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138677063|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677064|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138677065|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
138677067|NCT00487773|Albuterol|albuterol|mesh-list
138677068|NCT00487773|Montelukast|montelukast|mesh-list
138677069|NCT00487773|Vitamins|vitamins|mesh-ancestor
138677070|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
138677071|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677073|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677074|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
138677075|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677076|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138677077|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677078|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
138677080|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677081|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138677082|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138677083|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138677084|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138677085|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677087|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677088|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138677089|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138677090|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138677091|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677092|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677093|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677094|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677095|NCT01299961|Abatacept|abatacept|mesh-list
138677096|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138677097|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677098|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677099|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677100|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677101|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
138677102|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677103|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677104|NCT00492245|Mitomycins|mitomycins|mesh-list
138677105|NCT00492245|Mitomycin|mitomycin|mesh-list
138677106|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138677107|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677108|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
138677109|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677110|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138677111|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677112|NCT00487812|Dobutamine|dobutamine|mesh-list
138677113|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138677114|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
138677115|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
138677117|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677118|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138677119|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138677120|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138677121|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677122|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677123|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677124|NCT00487812|Protective Agents|protective agents|mesh-ancestor
138677126|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
138677127|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138677128|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138677129|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138677130|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677131|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677132|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138677133|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138677134|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677135|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677136|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677137|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
138677138|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138677139|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138677140|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138353965|NCT00000240|Analgesics|analgesics|mesh-ancestor
138677141|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138677142|NCT00487682|Valacyclovir|valacyclovir|mesh-list
138677143|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
138677144|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677145|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
138677146|NCT04512261|Trastuzumab|trastuzumab|mesh-list
138677147|NCT04512261|Tucatinib|tucatinib|mesh-list
138677148|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677149|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677150|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138677151|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677152|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138677153|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677154|NCT00487799|Ularitide|ularitide|mesh-list
138677158|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677159|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138677160|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677161|NCT00487799|Diuretics|diuretics|mesh-ancestor
138677162|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
138677163|NCT05149170|Antibodies|antibodies|mesh-list
138677164|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138677165|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
138677166|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677167|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
138677168|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677169|NCT00495287|Cytarabine|cytarabine|mesh-list
138677170|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677171|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
138677172|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677173|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677174|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
138677175|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677176|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677177|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
138677178|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677179|NCT00495326|Efavirenz|efavirenz|mesh-list
138677180|NCT00495326|Nevirapine|nevirapine|mesh-list
138677181|NCT00495326|Rifampin|rifampin|mesh-list
138677182|NCT00495326|Isoniazid|isoniazid|mesh-list
138677183|NCT00495326|Ethambutol|ethambutol|mesh-list
138677184|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138677185|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138677186|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677187|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677188|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
138677190|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138677191|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138677192|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138677195|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138677196|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138677197|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
138677198|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138677199|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
138677200|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138677201|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138677202|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138677203|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138677204|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138677205|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
138677206|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138677207|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138677208|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138677210|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138677211|NCT00492479|Growth Substances|growth substances|mesh-ancestor
138677212|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677214|NCT00495365|Hematinics|hematinics|mesh-ancestor
138677215|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
138677216|NCT00492518|Theophylline|theophylline|mesh-list
138677217|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138677218|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
138677219|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677220|NCT00492518|Expectorants|expectorants|mesh-ancestor
138677221|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677222|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138677223|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
138282892|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138677224|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677225|NCT00492518|Protective Agents|protective agents|mesh-ancestor
138677226|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677227|NCT00492518|Antidotes|antidotes|mesh-ancestor
138677228|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677229|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
138677230|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677231|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138677232|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138677233|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677234|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677235|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138677236|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138677237|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
138677238|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677239|NCT04513860|Cenobamate|cenobamate|mesh-list
138677240|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
138677241|NCT00495560|Misoprostol|misoprostol|mesh-list
138677242|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138677243|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
138677244|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677247|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138677248|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
138677249|NCT00506844|Capecitabine|capecitabine|mesh-list
138677250|NCT00506844|Irinotecan|irinotecan|mesh-list
138677251|NCT00506844|Cetuximab|cetuximab|mesh-list
138677252|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677253|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
138677254|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677255|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677256|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138677257|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677258|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677259|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677260|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138677261|NCT00506961|Simvastatin|simvastatin|mesh-list
138677262|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138677263|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138677264|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
138677265|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677266|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138677267|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138677268|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677269|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138677270|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677271|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138677272|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138677273|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677274|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677275|NCT00492635|Urological Agents|urological agents|mesh-ancestor
138677277|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
138677278|NCT00507000|Vitamins|vitamins|mesh-ancestor
138677279|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
138677280|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172291|NCT00578903|Tacrolimus|tacrolimus|mesh-list
138677281|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677282|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677283|NCT00495872|Lenalidomide|lenalidomide|mesh-list
138677284|NCT00495872|Sunitinib|sunitinib|mesh-list
138677285|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138677286|NCT00495872|Sorafenib|sorafenib|mesh-list
138677287|NCT00495872|Dasatinib|dasatinib|mesh-list
138677288|NCT00495872|Lapatinib|lapatinib|mesh-list
138677289|NCT00495872|Valproic Acid|valproic acid|mesh-list
138677290|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
138677291|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677292|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138677293|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138677294|NCT00495872|Growth Substances|growth substances|mesh-ancestor
138677295|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
138677296|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677297|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138677298|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677299|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677300|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
138677301|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
138677302|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677303|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
138677304|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138677305|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677306|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138677307|NCT00507117|Eszopiclone|eszopiclone|mesh-list
138677308|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138677309|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677310|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677312|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138677313|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
138677314|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677315|NCT01299571|Dutasteride|dutasteride|mesh-list
138677316|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138677317|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138677318|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215501|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351913|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138677319|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677320|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
138677321|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677322|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677323|NCT01243736|Metoclopramide|metoclopramide|mesh-list
138677324|NCT01243736|Simethicone|simethicone|mesh-list
138677325|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
138677326|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
138677327|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677328|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677329|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138677330|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138677331|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138677332|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
138677333|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677334|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677335|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
138677336|NCT01243736|Emollients|emollients|mesh-ancestor
138677337|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138677338|NCT00492986|Sorafenib|sorafenib|mesh-list
138677339|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677340|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138677341|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677342|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677343|NCT01243970|Phenylephrine|phenylephrine|mesh-list
138677344|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
138677345|NCT01243970|Ephedrine|ephedrine|mesh-list
138677346|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138677347|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
138677348|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
138677349|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677350|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677351|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
138677352|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138677353|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
138677354|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677355|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138677356|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138677357|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138677362|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138677364|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138677365|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677366|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138677367|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138677368|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677369|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677370|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138677371|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
138677372|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677373|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677374|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
138677375|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677376|NCT01244009|Niraparib|niraparib|mesh-list
138677377|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138677378|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677379|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172318|NCT00579137|Fludarabine|fludarabine|mesh-list
138677380|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677381|NCT04511832|Diclofenac|diclofenac|mesh-list
138677382|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138677383|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138677384|NCT04511832|Analgesics|analgesics|mesh-ancestor
138677385|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
138677386|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677387|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677388|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677389|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677390|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138677391|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677395|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
138677396|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677397|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677398|NCT00496028|Paclitaxel|paclitaxel|mesh-list
138677399|NCT00496028|Carboplatin|carboplatin|mesh-list
138677400|NCT00496028|Saracatinib|saracatinib|mesh-list
138677401|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138677402|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211160|NCT05361642|Analgesics|analgesics|mesh-ancestor
138677403|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138677404|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138677405|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138677406|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677408|NCT04516278|Bevacizumab|bevacizumab|mesh-list
138677409|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677410|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677411|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138677412|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138677413|NCT04516278|Growth Substances|growth substances|mesh-ancestor
138677414|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677415|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
138677416|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
138677417|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677418|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677419|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138677420|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138677421|NCT01297465|Hormones|hormones|mesh-ancestor
138677422|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677423|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677424|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677425|NCT04518462|Bupivacaine|bupivacaine|mesh-list
138677426|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
138677427|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
138677428|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677429|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677430|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
138677431|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677432|NCT00496184|Nifedipine|nifedipine|mesh-list
138677433|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138677434|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677435|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677436|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677437|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677438|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677439|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
138677440|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677441|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
138677442|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138677443|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
138677444|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677446|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677447|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138677448|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
138677449|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677450|NCT00493610|Protective Agents|protective agents|mesh-ancestor
138677451|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677452|NCT00493610|Antidotes|antidotes|mesh-ancestor
138677453|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
138677454|NCT02274506|Fludarabine|fludarabine|mesh-list
138677456|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677457|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
138677458|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677459|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677460|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138677461|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
138677462|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677463|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677464|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138677465|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677466|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
138677468|NCT00496223|Dacarbazine|dacarbazine|mesh-list
138677469|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677470|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138677471|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138677472|NCT00496223|Growth Substances|growth substances|mesh-ancestor
138677473|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677474|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
138677475|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138677476|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677477|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677478|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138677479|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
138677480|NCT00496301|Gemcitabine|gemcitabine|mesh-list
138677481|NCT00496301|Capecitabine|capecitabine|mesh-list
138677482|NCT00496301|Sorafenib|sorafenib|mesh-list
138677483|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677484|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
138677485|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677486|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677487|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138677488|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677489|NCT05141838|Vitamin D|vitamin d|mesh-list
138677490|NCT05141838|Vitamins|vitamins|mesh-ancestor
138677491|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
138677493|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677495|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138677496|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
138677497|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677498|NCT00493727|Expectorants|expectorants|mesh-ancestor
138677499|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677500|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138677501|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
138677502|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677503|NCT00493727|Protective Agents|protective agents|mesh-ancestor
138677504|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677505|NCT00493727|Antidotes|antidotes|mesh-ancestor
138677506|NCT00493766|Panobinostat|panobinostat|mesh-list
138677507|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677508|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138677509|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677510|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677511|NCT05146479|Fluorides|fluorides|mesh-list
138677512|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
138677513|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
138677514|NCT05146479|Protective Agents|protective agents|mesh-ancestor
138677515|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677516|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138677517|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138677518|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677519|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677520|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
138677521|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677522|NCT01296568|Gemcitabine|gemcitabine|mesh-list
138677523|NCT01296568|Pemetrexed|pemetrexed|mesh-list
138677524|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677525|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
138677526|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677527|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677528|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677529|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138677530|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138677531|NCT02598999|Lactoferrin|lactoferrin|mesh-list
138677532|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
138677533|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677534|NCT01296412|Metformin|metformin|mesh-list
138677535|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138677539|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677540|NCT01296412|Incretins|incretins|mesh-ancestor
138677541|NCT01296412|Hormones|hormones|mesh-ancestor
138677542|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677543|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138677544|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
138677545|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677546|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677547|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138677548|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677549|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
138677550|NCT00496652|Zalutumumab|zalutumumab|mesh-list
138677551|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677552|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677553|NCT02597634|Ibuprofen|ibuprofen|mesh-list
138677554|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138677555|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138677556|NCT02597634|Analgesics|analgesics|mesh-ancestor
138677557|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
138677558|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677559|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677560|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677561|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677562|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138677563|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677564|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677565|NCT02591199|Lidocaine|lidocaine|mesh-list
138677566|NCT02591199|Heparin|heparin|mesh-list
138677567|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
138677568|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
138677569|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677570|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677571|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
138677572|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677573|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138677574|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138677575|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138677577|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677579|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138677580|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138677581|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
138677582|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
138677583|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138677584|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138677585|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677586|NCT02596035|Nivolumab|nivolumab|mesh-list
138677587|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677588|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677589|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138677590|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677591|NCT00494156|Aspirin|aspirin|mesh-list
138677592|NCT00494156|Heparin|heparin|mesh-list
138677593|NCT00494156|Clopidogrel|clopidogrel|mesh-list
138677594|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138677595|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138677597|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
138677598|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677599|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677600|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677601|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677602|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138677603|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138677604|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677605|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138677606|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138677607|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677628|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
138677629|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677630|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677631|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138677632|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138677633|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138677634|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677635|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677636|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677637|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
138677638|NCT00497003|Protective Agents|protective agents|mesh-ancestor
138677639|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138677640|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677641|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677644|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138677645|NCT00494312|Pioglitazone|pioglitazone|mesh-list
138677646|NCT00494312|Glyburide|glyburide|mesh-list
138677647|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138677648|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677649|NCT02595372|Omeprazole|omeprazole|mesh-list
138677650|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138677651|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138677652|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138677653|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677654|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677655|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
138677656|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138677657|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677658|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
138677659|NCT02596503|Cefixime|cefixime|mesh-list
138677660|NCT02596503|Irinotecan|irinotecan|mesh-list
138677661|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138677662|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677663|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677664|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677665|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677666|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138677667|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677668|NCT00494429|Morphine|morphine|mesh-list
138677669|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138677670|NCT00494429|Narcotics|narcotics|mesh-ancestor
138677671|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677672|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677673|NCT00494429|Analgesics|analgesics|mesh-ancestor
138677674|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
138677675|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677676|NCT00497120|Acetazolamide|acetazolamide|mesh-list
138677677|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
138677678|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138677679|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677680|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677681|NCT00497120|Diuretics|diuretics|mesh-ancestor
138677682|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
138677683|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677684|NCT00494468|Zolpidem|zolpidem|mesh-list
138677685|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138677686|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138211325|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138677687|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677688|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677689|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138677690|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
138677691|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
138677692|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677693|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677694|NCT00497237|Fluticasone|fluticasone|mesh-list
138677695|NCT00497237|Beclomethasone|beclomethasone|mesh-list
138677696|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
138677697|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138677698|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677699|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677700|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
138677701|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677702|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677703|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138677704|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677705|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
138677706|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138677707|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138677708|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138677712|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677713|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
138677714|NCT00497237|Hormones|hormones|mesh-ancestor
138677715|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677716|NCT00497315|Pemetrexed|pemetrexed|mesh-list
138677717|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677718|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677719|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677720|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138677721|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138677722|NCT05142072|Vitamin D|vitamin d|mesh-list
138677723|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
138677724|NCT05142072|Vitamins|vitamins|mesh-ancestor
138677725|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
138677726|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677727|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677728|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677729|NCT00497354|Anesthetics|anesthetics|mesh-list
138677730|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
138677731|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677732|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677733|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
138677734|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677735|NCT00494624|Prednisolone|prednisolone|mesh-list
138677736|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677737|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
138677738|NCT00494624|Hormones|hormones|mesh-ancestor
138677739|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677740|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677741|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138677742|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677743|NCT00494663|Ketoconazole|ketoconazole|mesh-list
138677744|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
138677745|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211348|NCT05305404|BB 1101|bb 1101|mesh-list
138677747|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138677748|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677749|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677750|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138677751|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
138677752|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677753|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677754|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138677756|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
138677757|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138677760|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677762|NCT00507195|Midazolam|midazolam|mesh-list
138677763|NCT00507195|Propofol|propofol|mesh-list
138677764|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138677765|NCT00507195|Sevoflurane|sevoflurane|mesh-list
138677766|NCT00507195|Desflurane|desflurane|mesh-list
138677767|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138677768|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677769|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138677770|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
138677771|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
138677772|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138677773|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138677774|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138677775|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138677776|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
138677777|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
138677778|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677779|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677780|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138677781|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138677782|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
138677783|NCT00497471|Dapsone|dapsone|mesh-list
138677784|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
138677785|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138677786|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138677787|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677788|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138677789|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677790|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172535|NCT03084380|Fludarabine|fludarabine|mesh-list
138677792|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138677793|NCT05146635|Epirubicin|epirubicin|mesh-list
138677794|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138677795|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677796|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138677797|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677798|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677799|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677800|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
138677801|NCT00494741|Azathioprine|azathioprine|mesh-list
138677802|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138677803|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677804|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138677805|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
138677806|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138677807|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677808|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677809|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677810|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
138677811|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677812|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677813|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
138677814|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677815|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677816|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
138677817|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677818|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
138677819|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677820|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677822|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677823|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138677824|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138677825|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138677826|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677827|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677828|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677830|NCT05148546|Ipilimumab|ipilimumab|mesh-list
138677831|NCT05148546|Relatlimab|relatlimab|mesh-list
138677832|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138677833|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677834|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138677835|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677836|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138677837|NCT00506532|Calfactant|calfactant|mesh-list
138677838|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677839|NCT05149560|Ticagrelor|ticagrelor|mesh-list
138677840|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138677841|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138677842|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138677843|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138677844|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
138677845|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677846|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677847|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677848|NCT00494897|Cytarabine|cytarabine|mesh-list
138677849|NCT00494897|Prednisone|prednisone|mesh-list
138677850|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
138677851|NCT00494897|Methotrexate|methotrexate|mesh-list
138677852|NCT00494897|Vincristine|vincristine|mesh-list
138677853|NCT00494897|Daunorubicin|daunorubicin|mesh-list
138677854|NCT00494897|Asparaginase|asparaginase|mesh-list
138677855|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
138677857|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
138677858|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677859|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677860|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138677861|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
138677862|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677863|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677864|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138677865|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677866|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
138677867|NCT00494897|Hormones|hormones|mesh-ancestor
138677868|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138677869|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138677870|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138677871|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
138677872|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677873|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677874|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
138677875|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
138677879|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
138677880|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677881|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138677882|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
138677883|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
138677884|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
138677885|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138677886|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138677887|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677888|NCT00497744|Cefepime|cefepime|mesh-list
138677889|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138677890|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677891|NCT00495092|Biperiden|biperiden|mesh-list
138677892|NCT00495092|Caffeine|caffeine|mesh-list
138677893|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138677894|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677895|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138677896|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677897|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677898|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138677899|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138677900|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
138677901|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677902|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138677903|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138677904|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
138677905|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
138677906|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677907|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138677908|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138677909|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
138677910|NCT01244360|Resveratrol|resveratrol|mesh-list
138677911|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
138677912|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677913|NCT01244360|Protective Agents|protective agents|mesh-ancestor
138677914|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677915|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677916|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138677917|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
138677918|NCT00506571|Irinotecan|irinotecan|mesh-list
138677919|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677920|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138351948|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351949|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677921|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677922|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677923|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677924|NCT00497900|Vitamin D|vitamin d|mesh-list
138677925|NCT00497900|Vitamins|vitamins|mesh-ancestor
138677926|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
138677927|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677931|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
138677932|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677933|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677934|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677935|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
138677936|NCT00497939|Urological Agents|urological agents|mesh-ancestor
138677937|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138677938|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138677939|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677940|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677941|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138677942|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138677944|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
138677945|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677946|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677947|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677948|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138677949|NCT00498251|Albuterol|albuterol|mesh-list
138677950|NCT00498251|Ipratropium|ipratropium|mesh-list
138677951|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677952|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
138677953|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677954|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677955|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138677956|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
138677957|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
138677958|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677959|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138677960|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138677961|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138677962|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677963|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677965|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138677966|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
138354790|NCT00001944|Vinorelbine|vinorelbine|mesh-list
138677967|NCT00502658|Vitamins|vitamins|mesh-list
138677968|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
138677969|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677970|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
138677971|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677972|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677973|NCT05146089|Bosentan|bosentan|mesh-list
138677974|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138677975|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138677976|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677977|NCT02954913|Liver Extracts|liver extracts|mesh-list
138677978|NCT02954913|Hematinics|hematinics|mesh-ancestor
138677979|NCT00502892|Carboplatin|carboplatin|mesh-list
138677980|NCT00502892|Topotecan|topotecan|mesh-list
138677981|NCT00502892|Ifosfamide|ifosfamide|mesh-list
138677982|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677983|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138677984|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138677985|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677986|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677987|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138677988|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
138677989|NCT00502970|Interferons|interferons|mesh-list
138677990|NCT00502970|Ribavirin|ribavirin|mesh-list
138677991|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
138677992|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138677993|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
138677994|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138677995|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
138677996|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677997|NCT00502970|Hematinics|hematinics|mesh-ancestor
138677998|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
138677999|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138678000|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
138678001|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138678002|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138678003|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678004|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678005|NCT00498680|Urological Agents|urological agents|mesh-ancestor
138678006|NCT00498953|Carboplatin|carboplatin|mesh-list
138678007|NCT00498953|Docetaxel|docetaxel|mesh-list
138678008|NCT00498953|Fluorouracil|fluorouracil|mesh-list
138678009|NCT00498953|Lapatinib|lapatinib|mesh-list
138678010|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138678011|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678012|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138678013|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138211446|NCT00405938|Bevacizumab|bevacizumab|mesh-list
138678014|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678015|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678016|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
138678017|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678018|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678019|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
138678020|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678021|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678022|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678023|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138678024|NCT00503126|Bivalirudin|bivalirudin|mesh-list
138678025|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
138678026|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138678027|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
138678028|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678036|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
138678037|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678038|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678039|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138678040|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
138678041|NCT05145543|Hormones|hormones|mesh-ancestor
138678042|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678043|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678044|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678045|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138678046|NCT05145543|Narcotics|narcotics|mesh-ancestor
138678047|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678048|NCT05145543|Analgesics|analgesics|mesh-ancestor
138678049|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
138678050|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138678051|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138678052|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
138678053|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
138678054|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
138678056|NCT00503204|Lomustine|lomustine|mesh-list
138678057|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678058|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678059|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678060|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678061|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678062|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
138678063|NCT00503243|Mesalamine|mesalamine|mesh-list
138678064|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138678065|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678066|NCT00503243|Analgesics|analgesics|mesh-ancestor
138678067|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
138678068|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678072|NCT00498992|Vitamin E|vitamin e|mesh-list
138678073|NCT00498992|Lidocaine|lidocaine|mesh-list
138678074|NCT00498992|Vitamins|vitamins|mesh-ancestor
138678075|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
138678076|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678077|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
138678078|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
138678079|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678080|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
138678081|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678082|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138678083|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138678084|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138678085|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678086|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678087|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
138678088|NCT00498992|Protective Agents|protective agents|mesh-ancestor
138678089|NCT02276391|Telmisartan|telmisartan|mesh-list
138678090|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138678091|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138678092|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138678093|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678095|NCT05145270|Dexetimide|dexetimide|mesh-list
138678096|NCT05145270|Citalopram|citalopram|mesh-list
138678097|NCT05145270|Escitalopram|escitalopram|mesh-list
138678098|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138678099|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138678100|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678101|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678102|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678103|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
138678104|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678105|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138678108|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
138678109|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678110|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138678111|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138678112|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678113|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138678114|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
138678115|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138678116|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138678117|NCT05145270|Protective Agents|protective agents|mesh-ancestor
138678118|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354938|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
138678119|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
138678121|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678122|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
138678123|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678124|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678125|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138678126|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
138678127|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678128|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138678129|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
138678130|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678131|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
138678132|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138678133|NCT00503321|Protective Agents|protective agents|mesh-ancestor
138678134|NCT00503477|Cediranib|cediranib|mesh-list
138678135|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678136|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678137|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678138|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678139|NCT05144295|Lactulose|lactulose|mesh-list
138678140|NCT05144295|Bisacodyl|bisacodyl|mesh-list
138678141|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
138678142|NCT05144295|Lubiprostone|lubiprostone|mesh-list
138678143|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138678144|NCT05144295|Cathartics|cathartics|mesh-ancestor
138678145|NCT05144295|Laxatives|laxatives|mesh-ancestor
138678146|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138172719|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
138678147|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678148|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678150|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138678151|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
138678152|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138678153|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678154|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678155|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
138678156|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678157|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678158|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
138678159|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678160|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138678161|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678164|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138678166|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
138678167|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138678168|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138678169|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138678170|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
138678171|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138678172|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678173|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138678174|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138678175|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678176|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678178|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138678179|NCT05148195|Leucovorin|leucovorin|mesh-list
138678180|NCT05148195|Docetaxel|docetaxel|mesh-list
138678181|NCT05148195|Irinotecan|irinotecan|mesh-list
138678182|NCT05148195|Calcium|calcium|mesh-list
138678183|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
138172745|NCT00249769|Vaccines|vaccines|mesh-list
138678184|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678185|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
138678186|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
138678189|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138678190|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678191|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138678192|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138678193|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678194|NCT05148195|Antidotes|antidotes|mesh-ancestor
138678195|NCT05148195|Protective Agents|protective agents|mesh-ancestor
138678197|NCT05148195|Vitamins|vitamins|mesh-ancestor
138678198|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
138678199|NCT00499265|Gemcitabine|gemcitabine|mesh-list
138678200|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
138678201|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
138678202|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678203|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
138678204|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678205|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678206|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678207|NCT01246622|Cytarabine|cytarabine|mesh-list
138678208|NCT01246622|Lenalidomide|lenalidomide|mesh-list
138678209|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678210|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
138678211|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678212|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678213|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
138678214|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678215|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678216|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
138678217|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678218|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138678219|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138678221|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
138678222|NCT01245530|Donepezil|donepezil|mesh-list
138211540|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
138678223|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138678224|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678225|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172771|NCT03837873|Rituximab|rituximab|mesh-list
138678226|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678227|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678228|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678229|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
138678230|NCT05148312|Budesonide|budesonide|mesh-list
138678231|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678232|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138678233|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
138678234|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678235|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678236|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138678237|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678238|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
138678239|NCT05148312|Hormones|hormones|mesh-ancestor
138678240|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678241|NCT01246817|Sirolimus|sirolimus|mesh-list
138678242|NCT01246817|Temsirolimus|temsirolimus|mesh-list
138678243|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
138678244|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678245|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678246|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678247|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678248|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
138678249|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678250|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678251|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138678252|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678254|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
138678255|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138678256|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138678257|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138678258|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
138678259|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678260|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138678261|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138678262|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678263|NCT05148975|Dimercaprol|dimercaprol|mesh-list
138678264|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
138678265|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
138678266|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678267|NCT00499577|Vaccines|vaccines|mesh-list
138678268|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138678269|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
138355099|NCT00002190|Lamivudine|lamivudine|mesh-list
138678270|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678271|NCT02274740|Metformin|metformin|mesh-list
138678272|NCT02274740|Lixisenatide|lixisenatide|mesh-list
138678273|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678274|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678275|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
138678276|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172812|NCT03082742|Furosemide|furosemide|mesh-list
138678277|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
138211562|NCT05484492|Calcium|calcium|mesh-list
138678278|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678279|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678280|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678281|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
138678282|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678284|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138678285|NCT06155812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138678286|NCT06155760|Prednisolone|prednisolone|mesh-list
138678287|NCT06155760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678288|NCT06155760|Glucocorticoids|glucocorticoids|mesh-ancestor
138678289|NCT06155760|Hormones|hormones|mesh-ancestor
138678290|NCT06155760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678291|NCT06155760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678292|NCT06155760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678293|NCT06155760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678294|NCT06155604|Dapagliflozin|dapagliflozin|mesh-list
138678295|NCT06155604|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138678296|NCT06155604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678297|NCT06155604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678298|NCT06155604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678299|NCT06155578|Sodium metabisulfite|sodium metabisulfite|mesh-list
138678300|NCT06155578|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138678301|NCT06155578|Autonomic Agents|autonomic agents|mesh-ancestor
138678302|NCT06155578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678303|NCT06155578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678304|NCT06155578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678305|NCT06155279|Carboplatin|carboplatin|mesh-list
138678306|NCT06155279|Pembrolizumab|pembrolizumab|mesh-list
138678308|NCT06155279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678309|NCT06155279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678310|NCT06155279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678311|NCT06155279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678312|NCT06155279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678313|NCT06155279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138678314|NCT06155279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138678315|NCT06154967|Tislelizumab|tislelizumab|mesh-list
138678316|NCT06154967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678317|NCT06154967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678318|NCT06154902|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
138678319|NCT06154902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678320|NCT06154902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678321|NCT06154642|Mitogens|mitogens|mesh-list
138678322|NCT06154642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678323|NCT06154642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678324|NCT06154590|Tamoxifen|tamoxifen|mesh-list
138678325|NCT06154590|Fluorouracil|fluorouracil|mesh-list
138678326|NCT06154590|Melphalan|melphalan|mesh-list
138678327|NCT06154590|Antimetabolites|antimetabolites|mesh-ancestor
138678328|NCT06154590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678329|NCT06154590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678330|NCT06154590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678331|NCT06154590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678333|NCT06154590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678334|NCT06154590|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138678335|NCT06154590|Hormone Antagonists|hormone antagonists|mesh-ancestor
138678336|NCT06154590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678337|NCT06154590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678340|NCT06154590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138678341|NCT06154590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678342|NCT06154590|Alkylating Agents|alkylating agents|mesh-ancestor
138678343|NCT06154590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138678345|NCT06154304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138678346|NCT06154304|Autonomic Agents|autonomic agents|mesh-ancestor
138678347|NCT06154304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678348|NCT06154304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678349|NCT06154304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138678350|NCT06154304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678351|NCT06154304|Tocolytic Agents|tocolytic agents|mesh-ancestor
138678352|NCT06154304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138678353|NCT06154304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138678354|NCT06154304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138172860|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
138678355|NCT06154304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138678356|NCT06154304|Adrenergic Agents|adrenergic agents|mesh-ancestor
138678357|NCT06154304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678358|NCT06154304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678359|NCT06154200|Testosterone|testosterone|mesh-list
138678367|NCT06145360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678368|NCT06145360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678369|NCT06145360|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138211596|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
138211610|NCT00408200|Sotalol|sotalol|mesh-list
138678371|NCT06145360|Protease Inhibitors|protease inhibitors|mesh-ancestor
138678372|NCT06145360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678374|NCT06126419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678375|NCT06126419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678383|NCT06066359|Cyclophosphamide|cyclophosphamide|mesh-list
138678384|NCT06066359|Fludarabine|fludarabine|mesh-list
138678385|NCT06066359|Fludarabine phosphate|fludarabine phosphate|mesh-list
138678386|NCT06066359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678387|NCT06066359|Immunologic Factors|immunologic factors|mesh-ancestor
138678388|NCT06066359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678389|NCT06066359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678390|NCT06066359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678391|NCT06066359|Alkylating Agents|alkylating agents|mesh-ancestor
138678392|NCT06066359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678393|NCT06066359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678394|NCT06066359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138678395|NCT06066359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678396|NCT06066359|Antimetabolites|antimetabolites|mesh-ancestor
138678399|NCT06039566|Acetylcysteine|acetylcysteine|mesh-list
138678400|NCT06039566|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138678401|NCT06039566|Antiviral Agents|antiviral agents|mesh-ancestor
138678405|NCT06039566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138678406|NCT06039566|Antioxidants|antioxidants|mesh-ancestor
138678407|NCT06039566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678408|NCT06039566|Protective Agents|protective agents|mesh-ancestor
138678409|NCT06039566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678410|NCT06039566|Antidotes|antidotes|mesh-ancestor
138678411|NCT06030622|Metformin|metformin|mesh-list
138678412|NCT06030622|Digoxin|digoxin|mesh-list
138678413|NCT06030622|Simvastatin|simvastatin|mesh-list
138678414|NCT06030622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678415|NCT06030622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678416|NCT06030622|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138678418|NCT06030622|Antimetabolites|antimetabolites|mesh-ancestor
138678419|NCT06030622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678420|NCT06030622|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138678421|NCT06030622|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138678422|NCT06030622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678423|NCT06030622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138678424|NCT06030622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138678425|NCT06030622|Protective Agents|protective agents|mesh-ancestor
138678427|NCT06018727|Yohimbine|yohimbine|mesh-list
138678428|NCT06018727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678429|NCT06018727|Mydriatics|mydriatics|mesh-ancestor
138678430|NCT06018727|Autonomic Agents|autonomic agents|mesh-ancestor
138678431|NCT06018727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678432|NCT06018727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678440|NCT06015724|Nivolumab|nivolumab|mesh-list
138678441|NCT06015724|Daratumumab|daratumumab|mesh-list
138678442|NCT06015724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678443|NCT06015724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678444|NCT06015724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678445|NCT06015724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678446|NCT05929664|Cemiplimab|cemiplimab|mesh-list
138678447|NCT05929664|Immunoglobulins|immunoglobulins|mesh-list
138678448|NCT05929664|Immunoglobulin G|immunoglobulin g|mesh-list
138678449|NCT05929664|Immunologic Factors|immunologic factors|mesh-ancestor
138678451|NCT05929664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678452|NCT05929664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678453|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
138678454|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138678455|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138678456|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
138678457|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678458|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138678459|NCT05915104|Budesonide|budesonide|mesh-list
138678460|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678461|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138678462|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
138678463|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678464|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678465|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138678466|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678467|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
138678468|NCT05915104|Hormones|hormones|mesh-ancestor
138678469|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678470|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138678471|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138678472|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
138678473|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138678474|NCT05893225|Metformin|metformin|mesh-list
138678475|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678476|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678477|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138678478|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
138678479|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138678480|NCT05851508|Prednisolone|prednisolone|mesh-list
138678482|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138678483|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
138678484|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678485|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
138678486|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
138678487|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678492|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678493|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138678494|NCT05851508|Protective Agents|protective agents|mesh-ancestor
138678495|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678496|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678498|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
138678499|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678500|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678501|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678502|NCT05809011|Dexamethasone|dexamethasone|mesh-list
138678503|NCT05809011|Prednisone|prednisone|mesh-list
138678504|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678505|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
138678506|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
138678507|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678508|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678509|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138678510|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
138678511|NCT05809011|Hormones|hormones|mesh-ancestor
138678512|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678513|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678514|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678515|NCT05801419|Nicotine|nicotine|mesh-list
138172919|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
138678516|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138678517|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
138678518|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678519|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678520|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138678521|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138678522|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678523|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678524|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678525|NCT05789069|Tislelizumab|tislelizumab|mesh-list
138678526|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678527|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678528|NCT05763693|Azithromycin|azithromycin|mesh-list
138678529|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138678530|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678531|NCT05750264|Ibuprofen|ibuprofen|mesh-list
138678532|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138678533|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678534|NCT05750264|Analgesics|analgesics|mesh-ancestor
138678538|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678539|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678540|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138211657|NCT05250050|Antacids|antacids|mesh-ancestor
138678541|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678542|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678543|NCT05715281|Atezolizumab|atezolizumab|mesh-list
138678544|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138678545|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678546|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678547|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678548|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678549|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
138678550|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678551|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
138678552|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138678553|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138678554|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678558|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
138678559|NCT05638633|Vitamins|vitamins|mesh-list
138678560|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
138678561|NCT05638633|Prednisolone|prednisolone|mesh-list
138678562|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138678563|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
138678564|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138678565|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
138678566|NCT05638633|Corticosterone|corticosterone|mesh-list
138678567|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138678568|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
138678569|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
138678570|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678571|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678572|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
138678573|NCT05638633|Hormones|hormones|mesh-ancestor
138678574|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678575|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678576|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678577|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
138678578|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
138678579|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678580|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138678581|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138678582|NCT05638633|Protective Agents|protective agents|mesh-ancestor
138678583|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
138678584|NCT05635604|Growth Substances|growth substances|mesh-ancestor
138678585|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678586|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
138678587|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678588|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678592|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678593|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678594|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678595|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678596|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678597|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138678598|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138678599|NCT05514132|Durvalumab|durvalumab|mesh-list
138678600|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138678601|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678602|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678603|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
138678604|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678605|NCT05480111|Anesthetics|anesthetics|mesh-list
138678606|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678607|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678608|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
138351993|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678609|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138678610|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678611|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678612|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678613|NCT05439005|Analgesics|analgesics|mesh-ancestor
138678614|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
138678615|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678616|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138678617|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138678618|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138678619|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
138678620|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678621|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678622|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
138678623|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138678624|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138678625|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678626|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
138678627|NCT05429580|Coagulants|coagulants|mesh-ancestor
138678628|NCT05401565|Balovaptan|balovaptan|mesh-list
138678629|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138678632|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678633|NCT05362318|Nicotine|nicotine|mesh-list
138678634|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138678635|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
138678636|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678637|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678638|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138678639|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138678640|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678641|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678642|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678643|NCT05229042|Ricolinostat|ricolinostat|mesh-list
138678644|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678645|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138678646|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678647|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678648|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
138678649|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138678650|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138678651|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138678652|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678653|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678654|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678655|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678656|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678657|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138678658|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678659|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
138678660|NCT05187182|Nivolumab|nivolumab|mesh-list
138678661|NCT05187182|Trastuzumab|trastuzumab|mesh-list
138678662|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678663|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678664|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678665|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678666|NCT05146739|Leucovorin|leucovorin|mesh-list
138678667|NCT05146739|Cytarabine|cytarabine|mesh-list
138678669|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678670|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678672|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678673|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678674|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
138678675|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678676|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
138678677|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678678|NCT05146739|Antidotes|antidotes|mesh-ancestor
138678679|NCT05146739|Protective Agents|protective agents|mesh-ancestor
138678680|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
138678681|NCT05146739|Vitamins|vitamins|mesh-ancestor
138678682|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
138678683|NCT05135715|Trastuzumab|trastuzumab|mesh-list
138678684|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678685|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678686|NCT05111002|Doxycycline|doxycycline|mesh-list
138678687|NCT05111002|Lefamulin|lefamulin|mesh-list
138678688|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138678689|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678690|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
138678691|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138678692|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138678693|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
138678694|NCT05091346|Lenvatinib|lenvatinib|mesh-list
138678695|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678696|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678697|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678698|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678699|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678700|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678701|NCT05037812|Ketorolac|ketorolac|mesh-list
138678702|NCT05037812|Clonidine|clonidine|mesh-list
138678703|NCT05037812|Epinephrine|epinephrine|mesh-list
138678705|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138678706|NCT05037812|Narcotics|narcotics|mesh-ancestor
138678707|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678708|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678709|NCT05037812|Analgesics|analgesics|mesh-ancestor
138678710|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
138678711|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678712|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138678713|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138678714|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138678715|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678716|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678717|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138355545|NCT00002460|Tamoxifen|tamoxifen|mesh-list
138678718|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138678719|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
138678720|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138678721|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678722|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
138678723|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
138678724|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138678725|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138678726|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678727|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678728|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678729|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138678730|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678731|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138678732|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
138678733|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138678739|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
138678740|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
138678741|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
138678742|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678743|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172987|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
138678744|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
138678745|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678746|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138678747|NCT05019638|Narcotics|narcotics|mesh-ancestor
138678748|NCT05019638|Analgesics|analgesics|mesh-ancestor
138678749|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138678750|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138678751|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
138678752|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678753|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678754|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138678755|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138678756|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
138678757|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138678758|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
138678759|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
138678760|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
138678761|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138678762|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138678763|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678764|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678765|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678766|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138678767|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678768|NCT05019430|Cocaine|cocaine|mesh-list
138678769|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
138678770|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
138678771|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
138678772|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678773|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678774|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
138678775|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678776|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138678777|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138678778|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138678779|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678780|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678782|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678783|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138678784|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138678785|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
138678786|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138678787|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138678788|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138678789|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678790|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678791|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138678792|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678793|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355632|NCT00002508|Carboplatin|carboplatin|mesh-list
138678794|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
138678795|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678797|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138678798|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678799|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
138678800|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678801|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678802|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678805|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678806|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
138211806|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
138678807|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138678809|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678810|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
138678811|NCT04893174|Protective Agents|protective agents|mesh-ancestor
138678812|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138678814|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
138678815|NCT04790903|Rituximab|rituximab|mesh-list
138678816|NCT04790903|Doxorubicin|doxorubicin|mesh-list
138678817|NCT04790903|Venetoclax|venetoclax|mesh-list
138678818|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138678819|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678820|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
138678821|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678822|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678823|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678824|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
138678825|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678826|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678827|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138678828|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138352007|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678829|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138678830|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138678831|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138678832|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678833|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678834|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
138678835|NCT04790903|Hormones|hormones|mesh-ancestor
138678836|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678837|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678838|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
138678839|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
138678840|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678841|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678842|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678843|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678845|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
138678846|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678847|NCT04729543|Azacitidine|azacitidine|mesh-list
138678848|NCT04729543|Interleukin-2|interleukin-2|mesh-list
138678849|NCT04729543|Valproic Acid|valproic acid|mesh-list
138678851|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
138678852|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678853|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678854|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678855|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678857|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
138678858|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678859|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678860|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
138678861|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
138678863|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
138678864|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138678865|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678866|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138678868|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138678869|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138678870|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678871|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678872|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138678873|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
138678874|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
138678875|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678876|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678877|NCT04690855|Atezolizumab|atezolizumab|mesh-list
138678878|NCT04690855|Talazoparib|talazoparib|mesh-list
138678879|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678880|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678881|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678882|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678883|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138678884|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678885|NCT04634539|Paclitaxel|paclitaxel|mesh-list
138678886|NCT04634539|Gemcitabine|gemcitabine|mesh-list
138678887|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138678888|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678889|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
138678890|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
138678891|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678892|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678893|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678894|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
138678895|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
138678896|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678897|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678898|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678899|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678900|NCT04557878|Mitogens|mitogens|mesh-list
138678901|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678902|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678904|NCT04538742|Trastuzumab|trastuzumab|mesh-list
138678906|NCT04538742|Pertuzumab|pertuzumab|mesh-list
138678907|NCT04538742|Tucatinib|tucatinib|mesh-list
138678908|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138678909|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138678910|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678911|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138678912|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138678913|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678914|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678915|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678916|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
138678917|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
138678918|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678919|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138678920|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678921|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138678922|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
138678923|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138678924|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138678925|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138678926|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138678927|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678928|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138678929|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678930|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678931|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678932|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138678933|NCT04484337|Cabotegravir|cabotegravir|mesh-list
138678934|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138678935|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138678936|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138678941|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138678942|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
138678943|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678944|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678945|NCT04484337|Analgesics|analgesics|mesh-ancestor
138678946|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
138678947|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678948|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678949|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678950|NCT04473053|Nafamostat|nafamostat|mesh-list
138678951|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138678952|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138678953|NCT04473053|Analgesics|analgesics|mesh-ancestor
138678954|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
138678955|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678956|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678957|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678958|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138678959|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
138678960|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
138678961|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678962|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678963|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138678964|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138678965|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138678966|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138678969|NCT04455750|Goserelin|goserelin|mesh-list
138678970|NCT04455750|Rucaparib|rucaparib|mesh-list
138678971|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138678973|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138678974|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678975|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678976|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678977|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138678978|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352025|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678979|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678980|NCT04396860|Nivolumab|nivolumab|mesh-list
138678981|NCT04396860|Ipilimumab|ipilimumab|mesh-list
138678982|NCT04396860|Temozolomide|temozolomide|mesh-list
138678983|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138678984|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678985|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138678986|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678987|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138678988|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
138678989|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
138678990|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
138678991|NCT04387201|Dulaglutide|dulaglutide|mesh-list
138678992|NCT04387201|Vitamins|vitamins|mesh-ancestor
138678993|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
138678994|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678995|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
138678996|NCT04387201|Hematinics|hematinics|mesh-ancestor
138678997|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678998|NCT04331288|Ethanol|ethanol|mesh-list
138678999|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138679000|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679001|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138679002|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679003|NCT04230759|Fluorouracil|fluorouracil|mesh-list
138679004|NCT04230759|Durvalumab|durvalumab|mesh-list
138679005|NCT04230759|Mitomycins|mitomycins|mesh-list
138679006|NCT04230759|Mitomycin|mitomycin|mesh-list
138679007|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138679008|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
138679009|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679010|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679011|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679012|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679013|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
138679014|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679017|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
138679018|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679019|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679020|NCT04177095|Sirolimus|sirolimus|mesh-list
138679021|NCT04177095|Prednisone|prednisone|mesh-list
138679022|NCT04177095|Everolimus|everolimus|mesh-list
138679023|NCT04177095|Abatacept|abatacept|mesh-list
138679024|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679025|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
138679026|NCT04177095|Hormones|hormones|mesh-ancestor
138211967|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679027|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679028|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173137|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
138679029|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679030|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679031|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138679032|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679034|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679035|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679036|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
138679037|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679038|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138679039|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679040|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
138679041|NCT04177095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679042|NCT04177095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679043|NCT04177095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679044|NCT04170153|Niraparib|niraparib|mesh-list
138679045|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138679046|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679047|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679048|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679049|NCT04168203|Apixaban|apixaban|mesh-list
138679050|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138679051|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
138679052|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138679053|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
138679054|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679055|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679056|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
138679059|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
138679060|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679061|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138679062|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138679063|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138679064|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138679065|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138679066|NCT04150731|Estradiol|estradiol|mesh-list
138679067|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138679069|NCT04150731|Hormones|hormones|mesh-ancestor
138679070|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679071|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679072|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138679073|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
138679074|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679075|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138679076|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
138679077|NCT04083183|Sirolimus|sirolimus|mesh-list
138679078|NCT04083183|Vidarabine|vidarabine|mesh-list
138679079|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
138679080|NCT04083183|Fludarabine|fludarabine|mesh-list
138679081|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
138679082|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138679083|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
138679084|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138679085|NCT04083183|Antibodies|antibodies|mesh-list
138679086|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
138679087|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138679088|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
138679089|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138679090|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138679091|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679092|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
138679094|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679095|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679096|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
138355926|NCT00002634|Cobalt|cobalt|mesh-list
138679097|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679098|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679099|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138679100|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679101|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
138679102|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679103|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138679104|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
138679105|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138679106|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679108|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
138679109|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
138679111|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
138679112|NCT04069273|Ramucirumab|ramucirumab|mesh-list
138679113|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679114|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679115|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679116|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679117|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679118|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212041|NCT00414206|Mecamylamine|mecamylamine|mesh-list
138679119|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679120|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679121|NCT04060849|Ethanol|ethanol|mesh-list
138679122|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138679123|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138679124|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679125|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138679126|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679127|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
138679128|NCT04052334|Fludarabine|fludarabine|mesh-list
138679129|NCT04052334|Interleukin-2|interleukin-2|mesh-list
138679130|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679131|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
138679132|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679133|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679134|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679135|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
138679137|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679138|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138679139|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138679140|NCT04052334|Analgesics|analgesics|mesh-ancestor
138679141|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
138679142|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679143|NCT04004416|Lorazepam|lorazepam|mesh-list
138679144|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
138679145|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
138679146|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
138679147|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679148|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679149|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138679150|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138679151|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138679152|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138679153|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138679154|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138679155|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
138679156|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
138679157|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679158|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679159|NCT03964090|Cytarabine|cytarabine|mesh-list
138679160|NCT03964090|Isavuconazole|isavuconazole|mesh-list
138679161|NCT03964090|Methotrexate|methotrexate|mesh-list
138679162|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138679165|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679166|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679167|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
138679168|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679169|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679170|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679171|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679172|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138679173|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679174|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
138679175|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679176|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679177|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
138679178|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679179|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
138679181|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679182|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679183|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
138679184|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679185|NCT03871361|Abatacept|abatacept|mesh-list
138679186|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679187|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679188|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679189|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679190|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679191|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
138679192|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679193|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679194|NCT03795701|Liraglutide|liraglutide|mesh-list
138679195|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138679196|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679197|NCT03795701|Incretins|incretins|mesh-ancestor
138679201|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679202|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679203|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679204|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679205|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679206|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
138679207|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679208|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679209|NCT03664895|Goserelin|goserelin|mesh-list
138679210|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679211|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679212|NCT03559413|Imiquimod|imiquimod|mesh-list
138679213|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138679214|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
138679215|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679216|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679217|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
138679218|NCT03467867|Rituximab|rituximab|mesh-list
138679219|NCT03467867|Venetoclax|venetoclax|mesh-list
138679220|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679221|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679222|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
138679223|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679224|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679225|NCT03352765|Rituximab|rituximab|mesh-list
138679226|NCT03352765|Melphalan|melphalan|mesh-list
138679227|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138679228|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679229|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679230|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
138679231|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679232|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679233|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679234|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
138679235|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679236|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138679237|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679238|NCT03271372|Avelumab|avelumab|mesh-list
138679239|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138679240|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679241|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679242|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
138679243|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679244|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
138679245|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138679246|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138679247|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
138679252|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
138679253|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679254|NCT03241732|Protective Agents|protective agents|mesh-ancestor
138679255|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679256|NCT03241732|Antidotes|antidotes|mesh-ancestor
138679257|NCT03220035|Vemurafenib|vemurafenib|mesh-list
138679258|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679259|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679260|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679261|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679262|NCT03215706|Paclitaxel|paclitaxel|mesh-list
138679263|NCT03215706|Carboplatin|carboplatin|mesh-list
138679264|NCT03215706|Nivolumab|nivolumab|mesh-list
138679265|NCT03215706|Pemetrexed|pemetrexed|mesh-list
138679266|NCT03215706|Ipilimumab|ipilimumab|mesh-list
138679267|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679268|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679269|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679270|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679271|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679272|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679273|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679274|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679275|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679276|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138679277|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679278|NCT03214354|Sirolimus|sirolimus|mesh-list
138679279|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
138679281|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679282|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679283|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679284|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
138679285|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679286|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
138679287|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679288|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679290|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679291|NCT03151005|Metformin|metformin|mesh-list
138679292|NCT03151005|Liraglutide|liraglutide|mesh-list
138679293|NCT03151005|Exenatide|exenatide|mesh-list
138679297|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679298|NCT03151005|Incretins|incretins|mesh-ancestor
138679299|NCT03151005|Hormones|hormones|mesh-ancestor
138679300|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679301|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138679302|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679303|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138679304|NCT03143153|Fluorouracil|fluorouracil|mesh-list
138679305|NCT03143153|Nivolumab|nivolumab|mesh-list
138679306|NCT03143153|Ipilimumab|ipilimumab|mesh-list
138679307|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679308|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
138679309|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679310|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679311|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679312|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
138679313|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679314|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679315|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679316|NCT02927392|Leuprolide|leuprolide|mesh-list
138679317|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138679318|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
138679319|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679320|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679321|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679322|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679323|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
138679324|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138679325|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138679326|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679327|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
138679328|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
138679329|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679330|NCT02872116|Leucovorin|leucovorin|mesh-list
138679331|NCT02872116|Capecitabine|capecitabine|mesh-list
138679332|NCT02872116|Fluorouracil|fluorouracil|mesh-list
138679333|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
138679334|NCT02872116|Nivolumab|nivolumab|mesh-list
138679335|NCT02872116|Ipilimumab|ipilimumab|mesh-list
138679336|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679337|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
138679340|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679342|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679343|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679344|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679345|NCT02872116|Antidotes|antidotes|mesh-ancestor
138679346|NCT02872116|Protective Agents|protective agents|mesh-ancestor
138679347|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679348|NCT02872116|Vitamins|vitamins|mesh-ancestor
138679349|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
138679350|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
138679351|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679352|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679353|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
138679354|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138679355|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
138679356|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679357|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679358|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138679359|NCT02852486|Pioglitazone|pioglitazone|mesh-list
138679360|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
138679361|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138679362|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679363|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679364|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679365|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679366|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679367|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
138679368|NCT02828358|Leucovorin|leucovorin|mesh-list
138679369|NCT02828358|Folic Acid|folic acid|mesh-list
138679370|NCT02828358|Cytarabine|cytarabine|mesh-list
138679371|NCT02828358|Dexamethasone|dexamethasone|mesh-list
138679372|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
138679373|NCT02828358|Prednisolone|prednisolone|mesh-list
138679374|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138679375|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
138679376|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138679377|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
138679378|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
138679379|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138679380|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138679381|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138679382|NCT02828358|Cortisone|cortisone|mesh-list
138679383|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
138679384|NCT02828358|Methotrexate|methotrexate|mesh-list
138679385|NCT02828358|Vincristine|vincristine|mesh-list
138679386|NCT02828358|Azacitidine|azacitidine|mesh-list
138679387|NCT02828358|Daunorubicin|daunorubicin|mesh-list
138679388|NCT02828358|Asparaginase|asparaginase|mesh-list
138679389|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
138679390|NCT02828358|Pegaspargase|pegaspargase|mesh-list
138679391|NCT02828358|Thioguanine|thioguanine|mesh-list
138679392|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138679393|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
138679394|NCT02828358|BB 1101|bb 1101|mesh-list
138679395|NCT02828358|Calcium|calcium|mesh-list
138679396|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
138679397|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
138679398|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679399|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
138173465|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
138679400|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679401|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679402|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679403|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
138679404|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679405|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679406|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138679407|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679408|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
138679409|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
138679410|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679411|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138679412|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
138679414|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679415|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679416|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
138679418|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679419|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138679420|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138679421|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
138679422|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679423|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679424|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
138679425|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679426|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138679427|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679428|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
138679429|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679430|NCT02828358|Antidotes|antidotes|mesh-ancestor
138679431|NCT02828358|Protective Agents|protective agents|mesh-ancestor
138679432|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679433|NCT02828358|Vitamins|vitamins|mesh-ancestor
138679434|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
138679435|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679436|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679437|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679438|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679439|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138679440|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679441|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138679442|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138679443|NCT02828358|Hematinics|hematinics|mesh-ancestor
138679444|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
138679445|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679446|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679447|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679448|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679449|NCT02414399|Azithromycin|azithromycin|mesh-list
138679450|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138679451|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679453|NCT02363374|Folic Acid|folic acid|mesh-list
138679454|NCT02363374|Fluorouracil|fluorouracil|mesh-list
138679455|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
138679456|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
138679457|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
138679458|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679459|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679460|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679461|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679462|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
138679463|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679464|NCT02363374|Antidotes|antidotes|mesh-ancestor
138679465|NCT02363374|Protective Agents|protective agents|mesh-ancestor
138679466|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679470|NCT02314481|Trastuzumab|trastuzumab|mesh-list
138679471|NCT02314481|Atezolizumab|atezolizumab|mesh-list
138679472|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138679473|NCT02314481|Vemurafenib|vemurafenib|mesh-list
138679474|NCT02314481|Maytansine|maytansine|mesh-list
138679475|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679476|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679477|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138679478|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679479|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679480|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679481|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679482|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679483|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679484|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679485|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
138679486|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
138679487|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
138679488|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679489|NCT02286726|Cytarabine|cytarabine|mesh-list
138679490|NCT02286726|Daunorubicin|daunorubicin|mesh-list
138679491|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679492|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
138679494|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679495|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
138679496|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679497|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679498|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
138679499|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679500|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679501|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138679502|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138679503|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679504|NCT02205034|Oxytocin|oxytocin|mesh-list
138679505|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
138679506|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212199|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
138679507|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679509|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
138679510|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
138679511|NCT02174666|Vitamins|vitamins|mesh-list
138679512|NCT02174666|Genistein|genistein|mesh-list
138679513|NCT02174666|Biochanin A|biochanin a|mesh-list
138679514|NCT02174666|Daidzein|daidzein|mesh-list
138679515|NCT02174666|Formononetin|formononetin|mesh-list
138679516|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
138679517|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679518|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679519|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138679520|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138679521|NCT02174666|Protective Agents|protective agents|mesh-ancestor
138679522|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679523|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679524|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679525|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679526|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
138679527|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138679528|NCT02174666|Estrogens|estrogens|mesh-ancestor
138679529|NCT02174666|Hormones|hormones|mesh-ancestor
138679530|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679531|NCT02074631|Vitamin D|vitamin d|mesh-list
138679532|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
138679533|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
138679534|NCT02074631|Pamidronate|pamidronate|mesh-list
138679535|NCT02074631|Calcium|calcium|mesh-list
138679536|NCT02074631|Vitamins|vitamins|mesh-ancestor
138679537|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
138679538|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679539|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679540|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138679541|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
138679542|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679543|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679544|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679545|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679547|NCT01859858|Irinotecan|irinotecan|mesh-list
138679548|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138679549|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138679550|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212206|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
138679551|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679552|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679553|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138679554|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138679555|NCT01859858|Analgesics|analgesics|mesh-ancestor
138679556|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
138679557|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679558|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679559|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679560|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679561|NCT01613118|Irbesartan|irbesartan|mesh-list
138679562|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138679563|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138679564|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138679565|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679566|NCT01300962|Capecitabine|capecitabine|mesh-list
138679567|NCT01300962|Trastuzumab|trastuzumab|mesh-list
138679568|NCT01300962|Lapatinib|lapatinib|mesh-list
138679569|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679570|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
138352061|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679571|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352062|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
138679572|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679573|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679574|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679575|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679576|NCT00752479|Cyclosporine|cyclosporine|mesh-list
138679577|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
138679578|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
138679579|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138679580|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138679581|NCT00752479|Prednisolone|prednisolone|mesh-list
138679582|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
138679583|NCT00752479|Cyclosporins|cyclosporins|mesh-list
138679584|NCT00752479|Basiliximab|basiliximab|mesh-list
138679585|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
138679586|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138679587|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
138679588|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679589|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679590|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679591|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
138679592|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679593|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
138679594|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679595|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679596|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679597|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138679598|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138679599|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679600|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138679601|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
138679602|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138679605|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
138679606|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212244|NCT00534794|Analgesics|analgesics|mesh-ancestor
138679607|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138679608|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
138679609|NCT00752479|Hormones|hormones|mesh-ancestor
138679610|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679611|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138679612|NCT00752479|Protective Agents|protective agents|mesh-ancestor
138679613|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679615|NCT00732212|Coagulants|coagulants|mesh-ancestor
138679616|NCT00592280|Pancrelipase|pancrelipase|mesh-list
138679617|NCT00592280|Pancreatin|pancreatin|mesh-list
138679618|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138679619|NCT00589875|Valacyclovir|valacyclovir|mesh-list
138679620|NCT00589875|Temozolomide|temozolomide|mesh-list
138679621|NCT00589875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679622|NCT00589875|Alkylating Agents|alkylating agents|mesh-ancestor
138679623|NCT00589875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679624|NCT00589875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679625|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
138679626|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679627|NCT00503594|Cytarabine|cytarabine|mesh-list
138679628|NCT00503594|Methotrexate|methotrexate|mesh-list
138679629|NCT00503594|Vincristine|vincristine|mesh-list
138679630|NCT00503594|Temozolomide|temozolomide|mesh-list
138679631|NCT00503594|Procarbazine|procarbazine|mesh-list
138679632|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138679633|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
138679634|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679635|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356458|NCT05048940|Vaccines|vaccines|mesh-list
138679636|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679637|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
138679638|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679639|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679640|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679641|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679642|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138679643|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679644|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
138679645|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679646|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679647|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
138679648|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679649|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679650|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679651|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679652|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679653|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138679654|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
138679655|NCT00499811|Vorinostat|vorinostat|mesh-list
138679656|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679657|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138679658|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679659|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679660|NCT00499850|Leucovorin|leucovorin|mesh-list
138679661|NCT00499850|Fluorouracil|fluorouracil|mesh-list
138679662|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
138679665|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679666|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679667|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679668|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
138679669|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679670|NCT00499850|Antidotes|antidotes|mesh-ancestor
138679671|NCT00499850|Protective Agents|protective agents|mesh-ancestor
138679672|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679673|NCT00499850|Vitamins|vitamins|mesh-ancestor
138679674|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
138679675|NCT05146713|Propolis|propolis|mesh-list
138679676|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138679678|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679679|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
138679680|NCT00503828|Naproxen|naproxen|mesh-list
138679681|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138679682|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138679683|NCT00503828|Analgesics|analgesics|mesh-ancestor
138679684|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
138679685|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679686|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679687|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679688|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679689|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
138679690|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138679691|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679692|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679693|NCT00500006|Dasatinib|dasatinib|mesh-list
138679694|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679695|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138679696|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679697|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679698|NCT00506727|Amphetamine|amphetamine|mesh-list
138679700|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138679701|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138679702|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138679703|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138679704|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212287|NCT00465530|Gentamicins|gentamicins|mesh-list
138679705|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679706|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679711|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679712|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
138679713|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138679714|NCT04696536|Listerine|listerine|mesh-list
138679715|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138679716|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679717|NCT00500279|Celecoxib|celecoxib|mesh-list
138679718|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138679719|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138679720|NCT00500279|Analgesics|analgesics|mesh-ancestor
138679721|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
138352072|NCT03080142|Ropivacaine|ropivacaine|mesh-list
138352073|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352074|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
138679722|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679723|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679724|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679725|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679726|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138679727|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138679728|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679729|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679730|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
138679731|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138679732|NCT01245881|Protective Agents|protective agents|mesh-ancestor
138679733|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679734|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679735|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
138679736|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679737|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138679738|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679739|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679740|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
138679741|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679742|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679743|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138679744|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
138679745|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679746|NCT01247558|Vitamins|vitamins|mesh-ancestor
138679747|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
138679748|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679749|NCT00500552|Perhexiline|perhexiline|mesh-list
138679750|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138679752|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679753|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679754|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679755|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138679756|NCT00508209|Bortezomib|bortezomib|mesh-list
138679757|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679758|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
138679759|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138679760|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679761|NCT00507585|Leucovorin|leucovorin|mesh-list
138679762|NCT00507585|Bevacizumab|bevacizumab|mesh-list
138679763|NCT00507585|Fluorouracil|fluorouracil|mesh-list
138679764|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
138679765|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679766|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679767|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138679768|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138679769|NCT00507585|Growth Substances|growth substances|mesh-ancestor
138679770|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679771|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
138679772|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
138679773|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679774|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138679775|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679776|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
138679778|NCT00507585|Protective Agents|protective agents|mesh-ancestor
138679779|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679780|NCT00507585|Vitamins|vitamins|mesh-ancestor
138679781|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
138679782|NCT01247714|Phentermine|phentermine|mesh-list
138679783|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138679784|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679786|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138679787|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
138352081|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352082|NCT03088800|Analgesics|analgesics|mesh-ancestor
138352083|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
138352086|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679788|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
138679789|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679790|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679791|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679792|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679793|NCT00507663|Atenolol|atenolol|mesh-list
138679794|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138679795|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138679796|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
138679797|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
138679798|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679799|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679800|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138679801|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138679802|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138679803|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679804|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679805|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679806|NCT00508287|Exenatide|exenatide|mesh-list
138679807|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138679808|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679809|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138679810|NCT00508287|Incretins|incretins|mesh-ancestor
138679811|NCT00508287|Hormones|hormones|mesh-ancestor
138679812|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679813|NCT00508326|Paclitaxel|paclitaxel|mesh-list
138679814|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138679815|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679816|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138679817|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138679818|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679819|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679820|NCT00507858|Dexamethasone|dexamethasone|mesh-list
138679821|NCT00507858|Pemetrexed|pemetrexed|mesh-list
138679822|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679823|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
138679824|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
138679825|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679826|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679828|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
138679830|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679831|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138679832|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679833|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679834|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679835|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138679836|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138679837|NCT00508365|Carvedilol|carvedilol|mesh-list
138679838|NCT00508365|Lisinopril|lisinopril|mesh-list
138679839|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138679840|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138679841|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679842|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679843|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679844|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679845|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138679846|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
138679847|NCT00508365|Protective Agents|protective agents|mesh-ancestor
138679848|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138679849|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138679850|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679851|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
138679852|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138352090|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352091|NCT03096444|Lidocaine|lidocaine|mesh-list
138679853|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138679854|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138679855|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
138679856|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679857|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138679858|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
138679859|NCT00500864|Analgesics|analgesics|mesh-ancestor
138679860|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
138679861|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679862|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679863|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
138679864|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138679865|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138679869|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679870|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679872|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138679873|NCT00507975|Nicotine|nicotine|mesh-list
138679874|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138679875|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
138679876|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679882|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679883|NCT01247909|Gentamicins|gentamicins|mesh-list
138679884|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
138679886|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138679887|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679888|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138679889|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679890|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679892|NCT01245998|Tinzaparin|tinzaparin|mesh-list
138679893|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138679894|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
138679895|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138679896|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138679897|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679898|NCT02954484|Acetaminophen|acetaminophen|mesh-list
138679899|NCT02954484|Etoricoxib|etoricoxib|mesh-list
138679900|NCT02954484|Pregabalin|pregabalin|mesh-list
138679901|NCT02954484|Morphine|morphine|mesh-list
138679902|NCT02954484|Ropivacaine|ropivacaine|mesh-list
138679903|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138679904|NCT02954484|Narcotics|narcotics|mesh-ancestor
138679905|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138679908|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
138679909|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679910|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
138679911|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
138679912|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138679913|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
138679914|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
138679915|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138679916|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138679917|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679918|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679920|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138679921|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138679922|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138679923|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679924|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679925|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138679926|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138679927|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679928|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
138679929|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138679930|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679931|NCT00501098|Caspofungin|caspofungin|mesh-list
138679932|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
138679933|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679934|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679935|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679936|NCT00501137|Vaccines|vaccines|mesh-list
138679937|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
138679938|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679941|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
138679942|NCT01248260|Vitamins|vitamins|mesh-ancestor
138679943|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
138679944|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679945|NCT01246037|Bisoprolol|bisoprolol|mesh-list
138679946|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138679947|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
138679948|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
138679949|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679950|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679951|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138679952|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138679953|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138679954|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
138679955|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679956|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679957|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
138679958|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138679959|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679960|NCT00509184|Rituximab|rituximab|mesh-list
138679961|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679962|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679963|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
138679964|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679965|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679966|NCT00501254|Aspirin|aspirin|mesh-list
138679967|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
138679968|NCT00501254|Salicylates|salicylates|mesh-list
138679969|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679970|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
138679975|NCT00501254|Analgesics|analgesics|mesh-ancestor
138679976|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
138679977|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679978|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679979|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679980|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679981|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138679983|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679984|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138679985|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138679986|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138679987|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
138679988|NCT01248338|Metoprolol|metoprolol|mesh-list
138679989|NCT01248338|Nebivolol|nebivolol|mesh-list
138679990|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138679991|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138679992|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
138679993|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
138679994|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679995|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679996|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138679997|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138679998|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138679999|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
138680000|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680001|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680002|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
138680003|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138680004|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138680005|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138680006|NCT02953743|Lenvatinib|lenvatinib|mesh-list
138680007|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352106|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138680008|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680009|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680010|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680011|NCT00509379|Rituximab|rituximab|mesh-list
138680012|NCT00509379|Bortezomib|bortezomib|mesh-list
138680013|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138680016|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680019|NCT02274974|Epinephrine|epinephrine|mesh-list
138680020|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
138680021|NCT02274974|Anesthetics|anesthetics|mesh-list
138680022|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680023|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680024|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
138680025|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680026|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138680027|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138680028|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138680029|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680030|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680031|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138680032|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138680033|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
138680034|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680035|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138680036|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138680037|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
138680038|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138680039|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680041|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
138680042|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138680043|NCT02274545|Vaccines|vaccines|mesh-list
138680044|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
138680045|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680046|NCT02275013|Simendan|simendan|mesh-list
138680047|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138173812|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
138680049|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138680050|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138680051|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680052|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680053|NCT02275013|Protective Agents|protective agents|mesh-ancestor
138680054|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680055|NCT02274623|Calcifediol|calcifediol|mesh-list
138680056|NCT02274623|Vitamins|vitamins|mesh-ancestor
138680057|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
138680058|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680059|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138680060|NCT00509613|Sirolimus|sirolimus|mesh-list
138680061|NCT00509613|Sorafenib|sorafenib|mesh-list
138680062|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680064|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680065|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680066|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138680067|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680068|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138680069|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
138680070|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680071|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
138680072|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680073|NCT00501410|Leucovorin|leucovorin|mesh-list
138680074|NCT00501410|Fluorouracil|fluorouracil|mesh-list
138352115|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352116|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138352117|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138352120|NCT03107754|Anesthetics|anesthetics|mesh-list
138680075|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
138680076|NCT00501410|Cetuximab|cetuximab|mesh-list
138680077|NCT00501410|Dasatinib|dasatinib|mesh-list
138680078|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
138680079|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680080|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680081|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680082|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680083|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
138680084|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680085|NCT00501410|Antidotes|antidotes|mesh-ancestor
138680086|NCT00501410|Protective Agents|protective agents|mesh-ancestor
138680087|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
138680088|NCT00501410|Vitamins|vitamins|mesh-ancestor
138680089|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
138680090|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138356912|NCT00002994|Interleukin-2|interleukin-2|mesh-list
138680091|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680092|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680093|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
138680094|NCT02953275|Vedolizumab|vedolizumab|mesh-list
138680097|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680098|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138680099|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138680100|NCT02953275|Protective Agents|protective agents|mesh-ancestor
138680101|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680102|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
138680103|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138680104|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
138680105|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680106|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
138680107|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173831|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680108|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680109|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
138680110|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
138680111|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680112|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680113|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138680115|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138680116|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
138680117|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680118|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138680119|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138680120|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680121|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680122|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680123|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
138680124|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680125|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138680126|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138680127|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
138680128|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
138680129|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680131|NCT02955524|Tetracaine|tetracaine|mesh-list
138352125|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680132|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
138680133|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
138680134|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680135|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680136|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
138680137|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680138|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138680139|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138680140|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138680141|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680142|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680143|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
138680144|NCT02953041|Bromides|bromides|mesh-list
138680145|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
138680149|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
138680150|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680151|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680152|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680153|NCT00501566|Satavaptan|satavaptan|mesh-list
138680154|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138212560|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138680155|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680156|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
138680157|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680158|NCT00501605|Cediranib|cediranib|mesh-list
138680159|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680160|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680161|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680162|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356994|NCT00003066|Docetaxel|docetaxel|mesh-list
138680163|NCT00509847|Lactoferrin|lactoferrin|mesh-list
138680164|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680166|NCT01248494|Dactolisib|dactolisib|mesh-list
138680167|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680168|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138680169|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138680170|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680171|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680172|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138680173|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
138680174|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680175|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680176|NCT02952573|Dexamethasone|dexamethasone|mesh-list
138680177|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
138680178|NCT02952573|BB 1101|bb 1101|mesh-list
138680179|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680180|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
138680181|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
138680182|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680183|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680184|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680185|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
138680186|NCT02952573|Hormones|hormones|mesh-ancestor
138680188|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138680189|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680190|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
138680191|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680192|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680193|NCT00501722|Satavaptan|satavaptan|mesh-list
138680194|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138680195|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352144|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
138352146|NCT03148236|Protective Agents|protective agents|mesh-ancestor
138680197|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680198|NCT01248611|Fentanyl|fentanyl|mesh-list
138680199|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680200|NCT01248611|Narcotics|narcotics|mesh-ancestor
138680201|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173861|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138680202|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680203|NCT01248611|Analgesics|analgesics|mesh-ancestor
138680204|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
138680205|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680206|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138680207|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138680208|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
138680209|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
138680210|NCT00509964|Irinotecan|irinotecan|mesh-list
138680211|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138680212|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138680213|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680214|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680215|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680216|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
138680217|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138680218|NCT00510471|Antibodies|antibodies|mesh-list
138680219|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138680220|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
138680221|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680222|NCT00501839|Clomiphene|clomiphene|mesh-list
138680223|NCT00501839|Enclomiphene|enclomiphene|mesh-list
138680224|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
138680225|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138680226|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
138680227|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680228|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680229|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138680230|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
138680231|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680232|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138680233|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138680234|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
138680235|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138680237|NCT00510003|Analgesics|analgesics|mesh-ancestor
138680238|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
138680239|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680240|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680241|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680242|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138680243|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680244|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680245|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
138680246|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138680247|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680248|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680249|NCT00501878|Phenylephrine|phenylephrine|mesh-list
138680250|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
138680251|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138680252|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
138173896|NCT03793439|Hormones|hormones|mesh-ancestor
138680253|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
138680254|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352155|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680255|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680256|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
138680257|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138680258|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
138680259|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680260|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138680261|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138680262|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138680263|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
138680264|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680265|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680266|NCT00501878|Protective Agents|protective agents|mesh-ancestor
138680267|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
138680268|NCT00501917|Hematinics|hematinics|mesh-ancestor
138680270|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680271|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680272|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
138680273|NCT00510627|Irinotecan|irinotecan|mesh-list
138680274|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680275|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138680276|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138212678|NCT00547586|Bromides|bromides|mesh-list
138680278|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680281|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
138680282|NCT00502034|Interleukin-2|interleukin-2|mesh-list
138680283|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680284|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
138680285|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680286|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
138680287|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680288|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138680289|NCT00502034|Analgesics|analgesics|mesh-ancestor
138680290|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
138680291|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680292|NCT00510666|Tramadol|tramadol|mesh-list
138680293|NCT00510666|Butorphanol|butorphanol|mesh-list
138680294|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680295|NCT00510666|Narcotics|narcotics|mesh-ancestor
138680296|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680297|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680298|NCT00510666|Analgesics|analgesics|mesh-ancestor
138680299|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
138680300|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680301|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
138680302|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680303|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138680304|NCT00508092|Anesthetics|anesthetics|mesh-list
138680305|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
138680306|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680307|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680311|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680312|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680313|NCT00502073|Cyclosporine|cyclosporine|mesh-list
138680314|NCT00502073|Cyclosporins|cyclosporins|mesh-list
138680315|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680316|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680317|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680318|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
138680319|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680320|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
138680321|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680322|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680323|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138680324|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138680325|NCT01248923|Dexamethasone|dexamethasone|mesh-list
138680326|NCT01248923|Bortezomib|bortezomib|mesh-list
138680327|NCT01248923|Filanesib|filanesib|mesh-list
138680328|NCT01248923|Lenograstim|lenograstim|mesh-list
138680329|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138680330|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680331|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
138680332|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
138680333|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680334|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680335|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680336|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
138680338|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680339|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138680340|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680341|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138680342|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
138680343|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
138680344|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680345|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680346|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
138680347|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
138680348|NCT01249001|Aprepitant|aprepitant|mesh-list
138680349|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
138680350|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
138680351|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
138680352|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680353|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680354|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680355|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138680356|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680357|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680358|NCT00502112|Lenalidomide|lenalidomide|mesh-list
138680359|NCT00502112|Lintuzumab|lintuzumab|mesh-list
138680360|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
138680361|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680362|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138680363|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138680364|NCT00502112|Growth Substances|growth substances|mesh-ancestor
138680365|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
138680366|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680371|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680372|NCT00502229|Metformin|metformin|mesh-list
138680373|NCT00502229|Clomiphene|clomiphene|mesh-list
138680374|NCT00502229|Enclomiphene|enclomiphene|mesh-list
138680375|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
138680376|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680377|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680378|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138680379|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
138680380|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680381|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138680382|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
138680383|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680384|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138680385|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138680386|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138680387|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
138212738|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
138680388|NCT00502268|Vitamins|vitamins|mesh-ancestor
138680389|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
138680390|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680391|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138357219|NCT00003210|Interleukin-12|interleukin-12|mesh-list
138680392|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138680394|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138680395|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680396|NCT00502385|Cediranib|cediranib|mesh-list
138680397|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680398|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680399|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680400|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680401|NCT00510159|Artesunate|artesunate|mesh-list
138680402|NCT00510159|Sulfalene|sulfalene|mesh-list
138680403|NCT00510159|Praziquantel|praziquantel|mesh-list
138680404|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
138680405|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138680406|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138680410|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
138680411|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138680412|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
138680413|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138680414|NCT00502463|Immunomodulating Agents|immunomodulating agents|mesh-list
138680415|NCT00502463|Immunologic Factors|immunologic factors|mesh-ancestor
138680416|NCT00502463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680417|NCT02952807|Misoprostol|misoprostol|mesh-list
138680418|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138680419|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
138680420|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680421|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680422|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138680423|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680424|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
138680425|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
138680426|NCT02275130|Calcium|calcium|mesh-list
138680427|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138680428|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680429|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138680430|NCT03459417|Morphine|morphine|mesh-list
138680431|NCT03459417|Sulpiride|sulpiride|mesh-list
138680432|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680433|NCT03459417|Narcotics|narcotics|mesh-ancestor
138212762|NCT00432458|Thalidomide|thalidomide|mesh-list
138680434|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680435|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680436|NCT03459417|Analgesics|analgesics|mesh-ancestor
138680437|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
138680438|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680439|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138680440|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680441|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680442|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138680443|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
138680444|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680445|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680446|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138680447|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
138680448|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138680449|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680450|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
138680452|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680453|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680454|NCT01249430|Cytarabine|cytarabine|mesh-list
138680459|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138680460|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680461|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138680462|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138680464|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680465|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680466|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
138680467|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
138680468|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352194|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352195|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
138680469|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680470|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
138680471|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680472|NCT01249430|Analgesics|analgesics|mesh-ancestor
138680473|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
138680474|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680475|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138680476|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138680477|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138680478|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138680479|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
138680480|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680481|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138680482|NCT02952963|Cathartics|cathartics|mesh-ancestor
138680483|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680486|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680487|NCT00504062|Fluticasone|fluticasone|mesh-list
138680488|NCT00504062|Budesonide|budesonide|mesh-list
138680489|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680490|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138680491|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
138680492|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680493|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680494|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138680495|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680496|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680497|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138680498|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
138680500|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680501|NCT00504101|Bortezomib|bortezomib|mesh-list
138680502|NCT00504101|Melphalan|melphalan|mesh-list
138680503|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
138680504|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680505|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138680506|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
138680507|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680508|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138680509|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680510|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
138680511|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680512|NCT00504140|Interferons|interferons|mesh-list
138680513|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
138680514|NCT00504140|Etoposide|etoposide|mesh-list
138680515|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138680516|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680517|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138680518|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138680519|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680520|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680522|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680523|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
138680524|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680525|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138680527|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
138680528|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680529|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138680530|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
138680531|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138680532|NCT00511212|Antibodies|antibodies|mesh-list
138680533|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
138680534|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138680535|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
138680536|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680537|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
138680538|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680539|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680540|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680541|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680542|NCT01241006|Dexamethasone|dexamethasone|mesh-list
138680543|NCT01241006|Prednisone|prednisone|mesh-list
138680544|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
138680545|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680548|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680549|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680550|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138680551|NCT01241006|Hormones|hormones|mesh-ancestor
138680552|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680553|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138680554|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680555|NCT00510393|Everolimus|everolimus|mesh-list
138680556|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138680557|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680559|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680560|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680561|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
138680562|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680563|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680564|NCT01249547|Axitinib|axitinib|mesh-list
138680565|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680566|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680567|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680568|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680569|NCT00511719|Insulin|insulin|mesh-list
138680570|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138680571|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680572|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680573|NCT01246232|Amisulpride|amisulpride|mesh-list
138680574|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138680575|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680576|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680577|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680578|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680579|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138680580|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
138680581|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680582|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680583|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138680584|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
138680585|NCT01248962|Carboplatin|carboplatin|mesh-list
138680586|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680587|NCT00511446|Docetaxel|docetaxel|mesh-list
138680588|NCT00511446|Capecitabine|capecitabine|mesh-list
138680591|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
138680592|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
138680593|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
138680594|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680595|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680596|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
138680597|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138680598|NCT02955446|Nirogacestat|nirogacestat|mesh-list
138680599|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680600|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680601|NCT00511602|Insulin|insulin|mesh-list
138680602|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680603|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680604|NCT00511953|Gabapentin|gabapentin|mesh-list
138680605|NCT00511953|Analgesics|analgesics|mesh-ancestor
138680606|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
138680607|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680608|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680610|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138680611|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680612|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680613|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680614|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138680615|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138680616|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680617|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680618|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
138680619|NCT01249820|Anidulafungin|anidulafungin|mesh-list
138352208|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680620|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
138680621|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680622|NCT01247090|Vasopressins|vasopressins|mesh-list
138680623|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
138680624|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
138680625|NCT01247090|Coagulants|coagulants|mesh-ancestor
138680626|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138680627|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138680628|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
138680629|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680630|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
138680631|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680632|NCT02951754|Methylphenidate|methylphenidate|mesh-list
138680633|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138680634|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212872|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138680635|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138680636|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138680637|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680638|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174106|NCT03231722|Antidotes|antidotes|mesh-ancestor
138680639|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
138680641|NCT00504413|Digoxin|digoxin|mesh-list
138680642|NCT00504413|Midazolam|midazolam|mesh-list
138680643|NCT00504413|Methadone|methadone|mesh-list
138680644|NCT00504413|Bupropion|bupropion|mesh-list
138680645|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138680646|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138680647|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680648|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680649|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138680650|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680651|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680652|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138680653|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
138680654|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
138680655|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
138680656|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
138680657|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680658|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174136|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680659|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138680660|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
138680661|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138680662|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138680663|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680664|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
138680665|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138680666|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138680667|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680668|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680670|NCT00504413|Analgesics|analgesics|mesh-ancestor
138680671|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
138680672|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680673|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
138680674|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680675|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138680676|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138680677|NCT00504413|Protective Agents|protective agents|mesh-ancestor
138680678|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
138680679|NCT01243658|Oxytocin|oxytocin|mesh-list
138680680|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
138680681|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212894|NCT00555464|Hormones|hormones|mesh-ancestor
138680682|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680683|NCT01249664|Aflibercept|aflibercept|mesh-list
138680684|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138680685|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138680686|NCT01249664|Growth Substances|growth substances|mesh-ancestor
138680687|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174191|NCT00695435|Tobramycin|tobramycin|mesh-list
138680688|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
138680689|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680691|NCT00513162|Valproic Acid|valproic acid|mesh-list
138680692|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138680693|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680696|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680697|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680698|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
138680699|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
138680700|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680701|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680702|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
138680703|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680704|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680705|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138680706|NCT00513201|Insulin|insulin|mesh-list
138680707|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138680708|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680709|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680710|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
138680711|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138680714|NCT00512265|Expectorants|expectorants|mesh-ancestor
138680715|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680716|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138680717|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
138680718|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680719|NCT00512265|Protective Agents|protective agents|mesh-ancestor
138680720|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680721|NCT00512265|Antidotes|antidotes|mesh-ancestor
138680723|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
138680724|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138680725|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680726|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138680727|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138680728|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
138212917|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138680729|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680730|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138680732|NCT01249274|Progestins|progestins|mesh-ancestor
138680733|NCT01249274|Hormones|hormones|mesh-ancestor
138680734|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680735|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680736|NCT00513513|Ritonavir|ritonavir|mesh-list
138680737|NCT00513513|Darunavir|darunavir|mesh-list
138680738|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138680739|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138680740|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
138680741|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680742|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680743|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138352231|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
138352233|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
138680744|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138680745|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
138680746|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680747|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138680748|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138680749|NCT00504959|Ranibizumab|ranibizumab|mesh-list
138680750|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138680751|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138680753|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680754|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
138680755|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680756|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
138680757|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138680760|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
138680761|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
138680762|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680763|NCT00513552|Clarithromycin|clarithromycin|mesh-list
138680764|NCT00513552|Rifabutin|rifabutin|mesh-list
138680765|NCT00513552|Clofazimine|clofazimine|mesh-list
138680766|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138680767|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680768|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138680769|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680770|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680771|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138680772|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138680773|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138680774|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
138680775|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680776|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
138680777|NCT00513630|Metformin|metformin|mesh-list
138680778|NCT00513630|Glipizide|glipizide|mesh-list
138212943|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680779|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138680780|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680782|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
138680783|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
138680784|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680785|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680786|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
138680787|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680788|NCT04515719|Belimumab|belimumab|mesh-list
138680789|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680790|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
138680791|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680792|NCT00513786|Paclitaxel|paclitaxel|mesh-list
138680793|NCT00513786|Bevacizumab|bevacizumab|mesh-list
138680794|NCT00513786|Carboplatin|carboplatin|mesh-list
138680795|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138680796|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680797|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
138680798|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
138680799|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
138352242|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
138352243|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680800|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680801|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138680802|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138680803|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138680804|NCT00513786|Growth Substances|growth substances|mesh-ancestor
138680808|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
138680809|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138680810|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680811|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
138680812|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680814|NCT00512811|Furosemide|furosemide|mesh-list
138680815|NCT00512811|Diuretics|diuretics|mesh-ancestor
138680816|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
138680817|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680818|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138680819|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680820|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680821|NCT00513864|Morphine|morphine|mesh-list
138680822|NCT00513864|Codeine|codeine|mesh-list
138680823|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
138680824|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680825|NCT00513864|Narcotics|narcotics|mesh-ancestor
138680826|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680827|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680828|NCT00513864|Analgesics|analgesics|mesh-ancestor
138680829|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
138680830|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680831|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
138680832|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680833|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138174352|NCT01961271|Buprenorphine|buprenorphine|mesh-list
138680834|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138680835|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138680836|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680837|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138680838|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
138680839|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680840|NCT00512850|Folic Acid|folic acid|mesh-list
138680841|NCT00512850|Hematinics|hematinics|mesh-ancestor
138680842|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
138680843|NCT00512850|Vitamins|vitamins|mesh-ancestor
138680846|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
138680848|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
138680849|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
138680850|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138680851|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138680852|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680853|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
138680854|NCT00512928|Coagulants|coagulants|mesh-ancestor
138680855|NCT00512928|Vitamins|vitamins|mesh-ancestor
138680856|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
138680857|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680858|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
138680859|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138680860|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138680861|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138680862|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
138680863|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680864|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138680865|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138680866|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680867|NCT01246973|Curcumin|curcumin|mesh-list
138680868|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138680869|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138680870|NCT01246973|Analgesics|analgesics|mesh-ancestor
138680871|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
138680872|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680873|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680874|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680875|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138680876|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680877|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680878|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680880|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
138680882|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680883|NCT00513981|Leucovorin|leucovorin|mesh-list
138680884|NCT00513981|Methotrexate|methotrexate|mesh-list
138680885|NCT00513981|Calcium|calcium|mesh-list
138680886|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
138680887|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138680888|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680889|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138680890|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
138680891|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680892|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680893|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
138680894|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680895|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680896|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680897|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680898|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138680899|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138680900|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
138680901|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138680902|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138680903|NCT00513981|Antidotes|antidotes|mesh-ancestor
138680908|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138680909|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
138680910|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680911|NCT00514761|Capecitabine|capecitabine|mesh-list
138680912|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680913|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
138680914|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680915|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680916|NCT01245140|Alitretinoin|alitretinoin|mesh-list
138680917|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680918|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680919|NCT02951637|Carboplatin|carboplatin|mesh-list
138680920|NCT02951637|Pemetrexed|pemetrexed|mesh-list
138680921|NCT02951637|Gefitinib|gefitinib|mesh-list
138680922|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680923|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680924|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680925|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138680926|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138680927|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680928|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
138680929|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138680931|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
138680932|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680933|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138680934|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138680935|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680936|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680937|NCT01245062|Trametinib|trametinib|mesh-list
138680938|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680939|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680940|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680941|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680942|NCT01244984|Fluticasone|fluticasone|mesh-list
138680943|NCT01244984|Xhance|xhance|mesh-list
138680948|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213081|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
138352273|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
138680949|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138680950|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680951|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680952|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138680953|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138680955|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680957|NCT01244126|Fentanyl|fentanyl|mesh-list
138680958|NCT01244126|Morphine|morphine|mesh-list
138680959|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138680960|NCT01244126|Narcotics|narcotics|mesh-ancestor
138680961|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138680962|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680963|NCT01244126|Analgesics|analgesics|mesh-ancestor
138680964|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
138680965|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680966|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138680967|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138680968|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
138680969|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
138680970|NCT01243775|Docetaxel|docetaxel|mesh-list
138680971|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
138680972|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680973|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
138680974|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
138680975|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
138680978|NCT00514293|Docetaxel|docetaxel|mesh-list
138680979|NCT00514293|Capecitabine|capecitabine|mesh-list
138680980|NCT00514293|Tretinoin|tretinoin|mesh-list
138680981|NCT00514293|Bexarotene|bexarotene|mesh-list
138680982|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680983|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
138680984|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
138680985|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
138680986|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680987|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138680988|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
138680989|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
138680990|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
138680991|NCT02955641|Dexamethasone|dexamethasone|mesh-list
138680992|NCT02955641|Nepafenac|nepafenac|mesh-list
138680993|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138680994|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680995|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
138680996|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
138357853|NCT00003870|Antibodies|antibodies|mesh-list
138680997|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680998|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680999|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138681000|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
138681002|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681003|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138681004|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681005|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138681006|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138681007|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681008|NCT02955641|Analgesics|analgesics|mesh-ancestor
138681009|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
138681010|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681011|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138681013|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138681014|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138681015|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681017|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138681018|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138352281|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352282|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
138681019|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
138352291|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681020|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
138681021|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681022|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681024|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138681025|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681027|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681028|NCT00515151|Ethanol|ethanol|mesh-list
138681029|NCT00515151|Octenidine|octenidine|mesh-list
138681030|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138681031|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681032|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681033|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681034|NCT01241786|Lenalidomide|lenalidomide|mesh-list
138681035|NCT01241786|Azacitidine|azacitidine|mesh-list
138681036|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
138681037|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681038|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138681039|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681040|NCT01241786|Growth Substances|growth substances|mesh-ancestor
138681041|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138681042|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681043|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681045|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681046|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681047|NCT00514410|Folic Acid|folic acid|mesh-list
138681048|NCT00514410|Hematinics|hematinics|mesh-ancestor
138681049|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
138681050|NCT00514410|Vitamins|vitamins|mesh-ancestor
138681051|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
138681052|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681053|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
138681054|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138681055|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138681056|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681057|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
138681058|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681059|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
138681064|NCT00514527|Oritavancin|oritavancin|mesh-list
138681065|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138681066|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681068|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138681069|NCT01241240|Bimatoprost|bimatoprost|mesh-list
138681070|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138681071|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138681072|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138681073|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138213182|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
138681075|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681076|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681077|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681078|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681079|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681080|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138681081|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138681082|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174578|NCT00659165|Insulin|insulin|mesh-list
138681084|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
138681085|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138681086|NCT02950623|Protective Agents|protective agents|mesh-ancestor
138681087|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681088|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681089|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138681090|NCT00516009|Dexamethasone|dexamethasone|mesh-list
138681091|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681092|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
138681113|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352292|NCT03202134|Narcotics|narcotics|mesh-ancestor
138681114|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681115|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138681116|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138681117|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138681119|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
138681120|NCT03459144|Ranibizumab|ranibizumab|mesh-list
138681121|NCT03459144|Verteporfin|verteporfin|mesh-list
138681122|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138681123|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681124|NCT03459144|Growth Substances|growth substances|mesh-ancestor
138681125|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681126|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138681144|NCT01240382|Protective Agents|protective agents|mesh-ancestor
138681145|NCT01244828|Asenapine|asenapine|mesh-list
138681146|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138681147|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138681148|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681149|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357973|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138681150|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138681151|NCT00504192|Gemcitabine|gemcitabine|mesh-list
138681152|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
138681153|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681154|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
138681155|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681156|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681157|NCT01243346|Crenolanib|crenolanib|mesh-list
138681158|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681159|NCT01249443|Paclitaxel|paclitaxel|mesh-list
138681160|NCT01249443|Carboplatin|carboplatin|mesh-list
138681174|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681175|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138681176|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
138681177|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681178|NCT00516243|Protective Agents|protective agents|mesh-ancestor
138681179|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681180|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138681181|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138681182|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681183|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138681184|NCT01240889|Fluticasone|fluticasone|mesh-list
138681185|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681186|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138681187|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
138681188|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681189|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681190|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138681191|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
138681192|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681193|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138681194|NCT00516282|Temozolomide|temozolomide|mesh-list
138681203|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138681204|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681205|NCT01249521|Growth Substances|growth substances|mesh-ancestor
138681206|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681207|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
138681208|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
138681209|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138681210|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681211|NCT04511975|Azacitidine|azacitidine|mesh-list
138681212|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681213|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
138681214|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681215|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681216|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352299|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138681218|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
138681220|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
138681221|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
138681222|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681223|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681225|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681226|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681227|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138681228|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138681229|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681230|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681231|NCT04696848|Durvalumab|durvalumab|mesh-list
138681232|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681233|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681234|NCT01244256|Gentamicins|gentamicins|mesh-list
138681235|NCT01244256|Clotrimazole|clotrimazole|mesh-list
138681236|NCT01244256|Miconazole|miconazole|mesh-list
138681237|NCT01244256|Beclomethasone|beclomethasone|mesh-list
138681238|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138681239|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681240|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138681241|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681242|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681243|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681244|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
138681245|NCT01244256|Hormones|hormones|mesh-ancestor
138681246|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681247|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681248|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138681249|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138681252|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138174764|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681253|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138681254|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138681255|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
138681256|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138681257|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138681259|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
138681260|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681261|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681262|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681263|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
138681264|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138681265|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138681266|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681267|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681268|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681269|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
138681271|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138681272|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138681273|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213281|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681274|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681275|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138681276|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681277|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681278|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138681279|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681280|NCT04511000|Atorvastatin|atorvastatin|mesh-list
138352309|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352310|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138352311|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138352312|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352313|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352314|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138352315|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138681281|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138681282|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138681283|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
138681284|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174796|NCT00661895|Analgesics|analgesics|mesh-ancestor
138681285|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138681286|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138681287|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681288|NCT04519385|Dexamethasone|dexamethasone|mesh-list
138681289|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681290|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
138681291|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
138681292|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681293|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681294|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138681295|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
138681297|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681298|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138681299|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681301|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681302|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681303|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681304|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138681305|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681306|NCT00504465|Dinoprostone|dinoprostone|mesh-list
138681308|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681309|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681310|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
138681311|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138681312|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681313|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
138681314|NCT04510649|Rifampin|rifampin|mesh-list
138681315|NCT04510649|Rabeprazole|rabeprazole|mesh-list
138681316|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138681317|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138681318|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138681319|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681320|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681321|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138681322|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
138681323|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138681324|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174841|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
138681325|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
138681326|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681327|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138681328|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138681329|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138681330|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138681331|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138681332|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138681334|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138681338|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138681339|NCT01249092|Protective Agents|protective agents|mesh-ancestor
138681340|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681341|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
138681342|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138681343|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
138681344|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
138681345|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138681346|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681347|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681348|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352316|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138352317|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138681349|NCT02275182|Analgesics|analgesics|mesh-ancestor
138681350|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
138681351|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681352|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138681353|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138681354|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138681355|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681356|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681357|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681358|NCT01248780|Golimumab|golimumab|mesh-list
138681359|NCT01248780|Methotrexate|methotrexate|mesh-list
138681360|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138681361|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
138681362|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681363|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681364|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681365|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
138681366|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681367|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681368|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681369|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681370|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138681371|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681372|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
138681373|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681374|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681375|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138681376|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681378|NCT01248468|Acetaminophen|acetaminophen|mesh-list
138681379|NCT01248468|Sumatriptan|sumatriptan|mesh-list
138681381|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138681382|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681383|NCT01248468|Analgesics|analgesics|mesh-ancestor
138681384|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
138681385|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681386|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681387|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681388|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681389|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138681390|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138681391|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681392|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138681393|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138681394|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681395|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
138681396|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138681397|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138681398|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138681399|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138681400|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
138681401|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681402|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138681403|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138681404|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138681405|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
138681407|NCT02275299|Leflunomide|leflunomide|mesh-list
138681408|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138681409|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
138681410|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681411|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681412|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681414|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681415|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352325|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138681416|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681418|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138681419|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681420|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
138681421|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681422|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681423|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138681424|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681425|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681426|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681427|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681429|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
138681430|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681431|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
138681432|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681433|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138681434|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681435|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681436|NCT04510610|Decitabine|decitabine|mesh-list
138681437|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681438|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
138681439|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681440|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681441|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681442|NCT01246011|Warfarin|warfarin|mesh-list
138681443|NCT01246011|Argatroban|argatroban|mesh-list
138681444|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
138681445|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
138681446|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138681447|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138681448|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681449|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174950|NCT04317404|Triamcinolone|triamcinolone|mesh-list
138681450|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138681451|NCT01244490|Guanfacine|guanfacine|mesh-list
138681452|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138681453|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138681454|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213406|NCT01496131|Goserelin|goserelin|mesh-list
138681455|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681456|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681457|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681458|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681459|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681460|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681461|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138681462|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138681463|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138681464|NCT01243944|Lenalidomide|lenalidomide|mesh-list
138681469|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
138681470|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681471|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138681472|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681473|NCT01243944|Growth Substances|growth substances|mesh-ancestor
138681474|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
138681475|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681476|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
138681477|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681478|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681479|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681480|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138352334|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
138681481|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138681482|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138174970|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138681484|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
138681485|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
138681486|NCT00516399|Natamycin|natamycin|mesh-list
138681487|NCT00516399|Povidone|povidone|mesh-list
138681488|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138681489|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138681490|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
138681491|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
138681492|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138681493|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681494|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138681495|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
138681496|NCT00516438|Topotecan|topotecan|mesh-list
138681497|NCT00516438|Olaparib|olaparib|mesh-list
138681498|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138681499|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138681500|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138681501|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681502|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681503|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681504|NCT02275988|Clarithromycin|clarithromycin|mesh-list
138681506|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681507|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138681508|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681509|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681510|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138681511|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138681512|NCT02950155|Rituximab|rituximab|mesh-list
138681513|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681514|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681515|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
138681516|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681517|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681518|NCT00516672|Lapatinib|lapatinib|mesh-list
138681519|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175014|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
138681520|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681521|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681522|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681523|NCT00516711|Sevoflurane|sevoflurane|mesh-list
138681524|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138681525|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138681526|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
138681527|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
138681528|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681529|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681530|NCT00516750|Doxorubicin|doxorubicin|mesh-list
138681531|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138681533|NCT00516750|Vinblastine|vinblastine|mesh-list
138681534|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681535|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138681536|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138681537|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138681538|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681539|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681540|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138681541|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
138681542|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681543|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681544|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681545|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
138681546|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352348|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681547|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138681548|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681549|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
138681550|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681554|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138681555|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138681556|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
138681557|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
138681558|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681559|NCT00505427|Protective Agents|protective agents|mesh-ancestor
138681560|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681561|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
138681563|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
138681564|NCT00506168|Capecitabine|capecitabine|mesh-list
138681566|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138681567|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
138681568|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681569|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681570|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138681571|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138681572|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681574|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681575|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681576|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138681577|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681578|NCT04510220|Ofatumumab|ofatumumab|mesh-list
138681579|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681580|NCT02949648|Nicotine|nicotine|mesh-list
138681581|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138681582|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
138681583|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681584|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681585|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138681589|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681590|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
138681591|NCT04510337|Rocuronium|rocuronium|mesh-list
138681592|NCT04510337|Analgesics|analgesics|mesh-ancestor
138681593|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
138681594|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358432|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138681595|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681597|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681598|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681599|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
138681600|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138681601|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681602|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681603|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138681604|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
138681605|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681606|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138681607|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138681608|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138681611|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
138352354|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
138352355|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681612|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681613|NCT04518176|Oxytocin|oxytocin|mesh-list
138681614|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
138681615|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681616|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681617|NCT00516945|Lamivudine|lamivudine|mesh-list
138681618|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138681619|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681620|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681621|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681623|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681624|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138681625|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138681626|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138681627|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681628|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681629|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
138681630|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
138681631|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
138681632|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681634|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681635|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681636|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138681637|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
138681638|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138681639|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138681640|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681641|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681642|NCT00517179|Urological Agents|urological agents|mesh-ancestor
138681643|NCT00517218|Oblimersen|oblimersen|mesh-list
138681644|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681645|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
138681647|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681648|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138681650|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681651|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681652|NCT00517257|Atorvastatin|atorvastatin|mesh-list
138681653|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138681654|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138681655|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
138681656|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681657|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138681658|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138681659|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681660|NCT00506246|Propofol|propofol|mesh-list
138681661|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138681662|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681663|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681664|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138681665|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
138681666|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
138681667|NCT01243242|Metadoxine|metadoxine|mesh-list
138681668|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138358512|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138681669|NCT00517491|Lanreotide|lanreotide|mesh-list
138681670|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681671|NCT04517201|Insulin|insulin|mesh-list
138681672|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138681673|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138681674|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681675|NCT01241292|Elotuzumab|elotuzumab|mesh-list
138681676|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681677|NCT00517725|Carvedilol|carvedilol|mesh-list
138681678|NCT00517725|Nebivolol|nebivolol|mesh-list
138681679|NCT00517725|Bisoprolol|bisoprolol|mesh-list
138352376|NCT03278886|Naltrexone|naltrexone|mesh-list
138681680|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138681681|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138681682|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681683|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681684|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681685|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681686|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681687|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
138681688|NCT00517725|Protective Agents|protective agents|mesh-ancestor
138681689|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138681690|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681691|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138681693|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138681694|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138681695|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138681696|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138681697|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138681698|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
138681699|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
138681700|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681701|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138681702|NCT01240863|Hydrocodone|hydrocodone|mesh-list
138681703|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138681704|NCT01240863|Narcotics|narcotics|mesh-ancestor
138681705|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681706|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681707|NCT01240863|Analgesics|analgesics|mesh-ancestor
138681708|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
138681709|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681710|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
138681711|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
138681712|NCT01240746|Vaccines|vaccines|mesh-list
138681713|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
138681714|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681715|NCT01240590|Cisplatin|cisplatin|mesh-list
138681716|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681717|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
138681718|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138681719|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681720|NCT00504543|Everolimus|everolimus|mesh-list
138681721|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681722|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681723|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681724|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
138681725|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681726|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138681727|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681731|NCT02949843|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138681732|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681733|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681734|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138681735|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681736|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681737|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681738|NCT00517764|Citalopram|citalopram|mesh-list
138681739|NCT00517764|Escitalopram|escitalopram|mesh-list
138681740|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138681741|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138681742|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681743|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358582|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352385|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
138352386|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
138352387|NCT03285984|Protective Agents|protective agents|mesh-ancestor
138352388|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352391|NCT03287310|Albuterol|albuterol|mesh-list
138681744|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681746|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681747|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138681748|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
138681749|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138681750|NCT00517803|Micronutrients|micronutrients|mesh-list
138681751|NCT00517803|Trace Elements|trace elements|mesh-list
138681752|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681753|NCT04516304|Equol|equol|mesh-list
138681754|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
138681755|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138681756|NCT04516304|Estrogens|estrogens|mesh-ancestor
138681757|NCT04516304|Hormones|hormones|mesh-ancestor
138681758|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681759|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681760|NCT01242930|Niacinamide|niacinamide|mesh-list
138681761|NCT01242930|Lenalidomide|lenalidomide|mesh-list
138681762|NCT01242930|Imetelstat|imetelstat|mesh-list
138681763|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
138681764|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
138681765|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681766|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138681767|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681768|NCT01242930|Growth Substances|growth substances|mesh-ancestor
138681769|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
138681770|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681771|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681772|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681775|NCT01242930|Vitamins|vitamins|mesh-ancestor
138681776|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
138681777|NCT01241214|Cetirizine|cetirizine|mesh-list
138681778|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138681779|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138681780|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138681781|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
138681782|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
138681783|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681784|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681785|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681786|NCT01240512|Vitamin D|vitamin d|mesh-list
138681787|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
138681788|NCT01240512|Vitamins|vitamins|mesh-ancestor
138681789|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
138681790|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681791|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138681792|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138681793|NCT01240629|Doxorubicin|doxorubicin|mesh-list
138681794|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138681795|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138681797|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138681798|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138681799|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213593|NCT00526292|Fludarabine|fludarabine|mesh-list
138681800|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681801|NCT00518232|Methylphenidate|methylphenidate|mesh-list
138681802|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138681803|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681805|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138681806|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681807|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681808|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
138681809|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681811|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138681812|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352393|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
138681813|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681815|NCT00518271|Tacrolimus|tacrolimus|mesh-list
138681816|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681817|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
138681818|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681819|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138681820|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681821|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681822|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138681823|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138681824|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138681825|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681826|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
138681828|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681829|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681830|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
138681831|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138681832|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681833|NCT00518466|Topiramate|topiramate|mesh-list
138681834|NCT00518466|Phentermine|phentermine|mesh-list
138681835|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
138681836|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138681837|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681838|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138681839|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
138681840|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138681842|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
138681843|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681844|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681845|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681846|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681847|NCT00518583|Paclitaxel|paclitaxel|mesh-list
138681848|NCT00518583|Doxorubicin|doxorubicin|mesh-list
138681849|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138681850|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138681851|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681852|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
138681853|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
138681854|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138681855|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681856|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138681862|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138681863|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138681864|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681865|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138681866|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138681867|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138681868|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681869|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681870|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681871|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681872|NCT00519870|Losartan|losartan|mesh-list
138681873|NCT00519870|Nifedipine|nifedipine|mesh-list
138681874|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681875|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681876|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138681877|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138681878|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681879|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138681880|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352402|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138681881|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138681882|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681883|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138681884|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
138681885|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138681886|NCT00519909|Calcium|calcium|mesh-list
138681887|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138681888|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681889|NCT02949492|Interleukin-2|interleukin-2|mesh-list
138681890|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681891|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681892|NCT02949492|Analgesics|analgesics|mesh-ancestor
138681893|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
138681894|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681895|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681896|NCT04514588|Caffeine|caffeine|mesh-list
138681897|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138681898|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681899|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138681900|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681901|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681902|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138681905|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681906|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
138681907|NCT02276300|Imiquimod|imiquimod|mesh-list
138681908|NCT02276300|Sargramostim|sargramostim|mesh-list
138681909|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681910|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
138681911|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681912|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681913|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138681914|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
138681915|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681916|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681917|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138681918|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138681919|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
138681920|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
138681921|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
138681922|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138681923|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681924|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681925|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
138681926|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138681927|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681928|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681930|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681931|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681932|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138175380|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
138681933|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681935|NCT00518895|Oblimersen|oblimersen|mesh-list
138681936|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138681938|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681939|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681941|NCT00520104|Analgesics|analgesics|mesh-ancestor
138681942|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
138681943|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681944|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681945|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138681946|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138681947|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
138681948|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
138352415|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352416|NCT03315780|Dulaglutide|dulaglutide|mesh-list
138681949|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681950|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138681951|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138681952|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681953|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681954|NCT00519012|Sertraline|sertraline|mesh-list
138681955|NCT00519012|Paroxetine|paroxetine|mesh-list
138681956|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
138681957|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138681958|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138681959|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138681960|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681961|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681962|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681963|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
138681964|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681965|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138681966|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138681967|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138681969|NCT00520260|Ketorolac|ketorolac|mesh-list
138681970|NCT00520260|Bromfenac|bromfenac|mesh-list
138681971|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138681972|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681973|NCT00520260|Analgesics|analgesics|mesh-ancestor
138681974|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
138681975|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681976|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681977|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681978|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138681979|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138681980|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681981|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681982|NCT00520338|Celecoxib|celecoxib|mesh-list
138681983|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138681988|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681989|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138681991|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138681992|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138681993|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681994|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681995|NCT00519051|Fluoxetine|fluoxetine|mesh-list
138681996|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
138681997|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138681998|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138681999|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682000|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682001|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682002|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
138682003|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682004|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138682005|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682006|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138682007|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138682008|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682009|NCT02275832|Minoxidil|minoxidil|mesh-list
138682010|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138682011|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
138682012|NCT00519207|Lidocaine|lidocaine|mesh-list
138682013|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
138682014|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
138682015|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682016|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682017|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
138682018|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682019|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138682020|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138682021|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138682022|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682025|NCT02590094|Aflibercept|aflibercept|mesh-list
138682026|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138682027|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682028|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213709|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682029|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138682030|NCT02590094|Growth Substances|growth substances|mesh-ancestor
138682031|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682032|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
138682033|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
138682034|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138682035|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
138682036|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682037|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682038|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138682039|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138682040|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138682041|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
138682044|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682045|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138682046|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138682047|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682048|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682049|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682050|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138682051|NCT04514081|Decitabine|decitabine|mesh-list
138175470|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682052|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682053|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
138682054|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682056|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682057|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138682058|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
138682059|NCT00519246|Narcotics|narcotics|mesh-ancestor
138682060|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682061|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682062|NCT00519246|Analgesics|analgesics|mesh-ancestor
138682063|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
138682064|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682065|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682066|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682067|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682069|NCT00519987|Analgesics|analgesics|mesh-ancestor
138682070|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
138682071|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682072|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682073|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138682074|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138682075|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
138682076|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
138682077|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682078|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138682079|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138682080|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682081|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682082|NCT00519324|Everolimus|everolimus|mesh-list
138682083|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138682084|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138682085|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682086|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682087|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682088|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
138682089|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682090|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682091|NCT00520650|Aripiprazole|aripiprazole|mesh-list
138682092|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
138682093|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682094|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138682095|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138682096|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682097|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682098|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
138352468|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138352469|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
138352470|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
138352471|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352472|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352473|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352474|NCT03375294|Analgesics|analgesics|mesh-ancestor
138352475|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
138352476|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352477|NCT03395808|Tramadol|tramadol|mesh-list
138682099|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
138682100|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682101|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682102|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138682103|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138682104|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
138682105|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138682115|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138682116|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682118|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682119|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682121|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682122|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138682123|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138682124|NCT02954939|Prednisone|prednisone|mesh-list
138682125|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682126|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
138682127|NCT02954939|Hormones|hormones|mesh-ancestor
138682128|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682129|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682130|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682131|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682132|NCT00519519|Omeprazole|omeprazole|mesh-list
138682133|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138682134|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682135|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138682136|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682137|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682138|NCT00520806|Methocarbamol|methocarbamol|mesh-list
138682139|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138682140|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682141|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138682142|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682143|NCT00505739|Mifepristone|mifepristone|mesh-list
138682144|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138682145|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
138682146|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682147|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682148|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138682149|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138682150|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138682151|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
138682152|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138682153|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138682155|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682157|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138682158|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138682159|NCT02948985|Cetuximab|cetuximab|mesh-list
138682160|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138682161|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682162|NCT04513457|Liver Extracts|liver extracts|mesh-list
138682163|NCT04513457|Hematinics|hematinics|mesh-ancestor
138682164|NCT00521040|Levocetirizine|levocetirizine|mesh-list
138682165|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138682166|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138682167|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
138352478|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138682168|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
138682169|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682170|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682171|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682172|NCT04513340|Levodopa|levodopa|mesh-list
138682173|NCT04513340|Carbidopa|carbidopa|mesh-list
138682174|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138682175|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138682176|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
138682177|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175647|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682178|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682179|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682180|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138682181|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682182|NCT04513379|Efavirenz|efavirenz|mesh-list
138682183|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138359032|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682184|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682185|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682186|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682187|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
138682190|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138682191|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138682192|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138682193|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138682194|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138682195|NCT00521157|Naltrexone|naltrexone|mesh-list
138682196|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138682197|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138682198|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682199|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
138682200|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682201|NCT00505817|Leuprolide|leuprolide|mesh-list
138682202|NCT00505817|Cetrorelix|cetrorelix|mesh-list
138682203|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138682204|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
138682205|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682206|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682207|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682208|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682209|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
138682210|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682211|NCT00521430|Cyclosporine|cyclosporine|mesh-list
138682212|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
138682213|NCT00521430|Methotrexate|methotrexate|mesh-list
138682214|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
138682215|NCT00521430|Fludarabine|fludarabine|mesh-list
138682216|NCT00521430|Busulfan|busulfan|mesh-list
138682217|NCT00521430|Cyclosporins|cyclosporins|mesh-list
138682218|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138682219|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138682220|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
138175689|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138682221|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682222|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682223|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682224|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
138682225|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682226|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682231|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
138682233|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682234|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
138682235|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682236|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138682237|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682238|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
138682239|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
138682240|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682241|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682242|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
138682243|NCT00521430|Hormones|hormones|mesh-ancestor
138682244|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682245|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138682246|NCT00521430|Protective Agents|protective agents|mesh-ancestor
138682247|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
138682248|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138682249|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138682250|NCT00521274|Docetaxel|docetaxel|mesh-list
138682251|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682252|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682253|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138682254|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682255|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682256|NCT05146778|Lidocaine|lidocaine|mesh-list
138682257|NCT05146778|Fentanyl|fentanyl|mesh-list
138359113|NCT00005634|Vorinostat|vorinostat|mesh-list
138682258|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
138682259|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
138682260|NCT05146778|Anesthetics|anesthetics|mesh-list
138682261|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
138682262|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682263|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682264|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
138682265|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682266|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138682267|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138682268|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138682269|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682270|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682271|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138682272|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682274|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138682275|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138682276|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138682277|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213847|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
138682278|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682279|NCT05146778|Narcotics|narcotics|mesh-ancestor
138682280|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138682281|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138682282|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
138682284|NCT00505700|Bortezomib|bortezomib|mesh-list
138682285|NCT00505700|Idarubicin|idarubicin|mesh-list
138682286|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682287|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
138682288|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682289|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682290|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
138682291|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682292|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682293|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
138682294|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682295|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138682296|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138682297|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682298|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682299|NCT02948283|Metformin|metformin|mesh-list
138352507|NCT03426228|Progestins|progestins|mesh-ancestor
138682300|NCT02948283|Ritonavir|ritonavir|mesh-list
138682301|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682302|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682303|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138682304|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138682305|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
138682306|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213866|NCT03243890|Coagulants|coagulants|mesh-ancestor
138682307|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682311|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682312|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138682313|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138682314|NCT04512872|Denosumab|denosumab|mesh-list
138682315|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138682316|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682317|NCT00523185|Diazepam|diazepam|mesh-list
138682318|NCT00523185|Lorazepam|lorazepam|mesh-list
138682319|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
138682320|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
138682321|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
138682322|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682323|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682324|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682325|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138682326|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682327|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138682328|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138682329|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682330|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
138682331|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
138682332|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682333|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359184|NCT00005802|Analgesics|analgesics|mesh-ancestor
138175793|NCT01272089|Analgesics|analgesics|mesh-ancestor
138682334|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138682335|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138682336|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138682337|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138682338|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
138682340|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138682341|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138682342|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138682343|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
138682344|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682345|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682346|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138682348|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682349|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682350|NCT00521703|Lidocaine|lidocaine|mesh-list
138682351|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
138682352|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
138682353|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682354|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682355|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
138682358|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138682359|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138682360|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682361|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682363|NCT00521742|Glyburide|glyburide|mesh-list
138682364|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682365|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682366|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138682367|NCT00521781|Leuprolide|leuprolide|mesh-list
138682368|NCT00521781|Bicalutamide|bicalutamide|mesh-list
138682369|NCT00521781|Androgens|androgens|mesh-list
138682370|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
138682371|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682372|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138682373|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
138682374|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682375|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682376|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682377|NCT00521781|Hormones|hormones|mesh-ancestor
138682378|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682379|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
138682380|NCT00521820|Pioglitazone|pioglitazone|mesh-list
138682381|NCT00521820|Glyburide|glyburide|mesh-list
138682382|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682383|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682384|NCT00523263|Heparin|heparin|mesh-list
138682385|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
138682386|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138682387|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138682388|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682389|NCT00521859|Fludarabine|fludarabine|mesh-list
138682390|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
138682391|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682392|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682393|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
138682394|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682405|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138175871|NCT00637832|Prednisolone|prednisolone|mesh-list
138682406|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682407|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682408|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138682409|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682410|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682411|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138682412|NCT00522015|Protective Agents|protective agents|mesh-ancestor
138682413|NCT00523380|Doxorubicin|doxorubicin|mesh-list
138682414|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138682415|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138682417|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138682418|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682419|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682420|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682423|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138682424|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682425|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682426|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682427|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
138682428|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682429|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138682430|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138682431|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138682433|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138682434|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138682435|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138682436|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138682437|NCT00507065|Amphetamine|amphetamine|mesh-list
138682438|NCT00507065|Adderall|adderall|mesh-list
138682439|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138682440|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682441|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
138682442|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
138682443|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682444|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
138682445|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682446|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682447|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
138682448|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138682449|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138682450|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682451|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138682453|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
138682454|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138682455|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138682456|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682457|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682458|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
138682459|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
138682460|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138682461|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
138682462|NCT00522210|Insulin|insulin|mesh-list
138682463|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
138682464|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682465|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682466|NCT00522249|Interferons|interferons|mesh-list
138682467|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138682468|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
138682469|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138682470|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138682471|NCT00522249|Sunitinib|sunitinib|mesh-list
138682478|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138682479|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138682480|NCT00522249|Growth Substances|growth substances|mesh-ancestor
138682481|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682482|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
138682484|NCT05148767|Irinotecan|irinotecan|mesh-list
138682486|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682487|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682488|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682489|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682491|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138682492|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
138682493|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138682494|NCT00523692|Prednisolone|prednisolone|mesh-list
138682495|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
138682496|NCT00523692|Methotrexate|methotrexate|mesh-list
138682497|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138682498|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
138682499|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138682500|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
138682501|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682502|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682503|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682504|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
138682505|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682525|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682527|NCT00523692|Protective Agents|protective agents|mesh-ancestor
138682528|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682532|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138682533|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138682534|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682535|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682536|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682537|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
138682538|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
138682539|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682540|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
138682541|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138682542|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
138682543|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138682544|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
138682545|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138682546|NCT05148689|Protective Agents|protective agents|mesh-ancestor
138352539|NCT03459612|Promethazine|promethazine|mesh-list
138682547|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
138682548|NCT00522444|Analgesics|analgesics|mesh-ancestor
138682549|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
138682550|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682551|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682552|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
138682553|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682554|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138682555|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
138682556|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138682557|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682558|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682559|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138682560|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
138682561|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682562|NCT05148143|Raltitrexed|raltitrexed|mesh-list
138682563|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682564|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
138682565|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682566|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682567|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138682568|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682570|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138682571|NCT00523887|Narcotics|narcotics|mesh-ancestor
138682572|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682576|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682577|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138682578|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138682580|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
138682581|NCT05145218|Paclitaxel|paclitaxel|mesh-list
138682582|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138682583|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682584|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682585|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
138682586|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682588|NCT00523926|Bedaquiline|bedaquiline|mesh-list
138682589|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
138682590|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138682591|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682592|NCT05146271|Anesthetics|anesthetics|mesh-list
138682593|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682594|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682595|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
138682596|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
138682597|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682598|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
138682599|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682600|NCT05142098|Dexamethasone|dexamethasone|mesh-list
138682601|NCT05142098|Etoricoxib|etoricoxib|mesh-list
138682602|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138682603|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
138682604|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682605|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
138682606|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
138682607|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682608|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682609|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682610|NCT05142098|Hormones|hormones|mesh-ancestor
138682611|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682612|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682613|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682614|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138682617|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
138214079|NCT01797926|Losartan|losartan|mesh-list
138682619|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138682620|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352545|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
138682621|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682622|NCT00523965|Amphotericin B|amphotericin b|mesh-list
138682624|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138682625|NCT00523965|Miltefosine|miltefosine|mesh-list
138682626|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138682627|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
138682628|NCT00523965|Amebicides|amebicides|mesh-ancestor
138682629|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138682630|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138682631|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682632|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138682633|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
138682634|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682635|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138682636|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682637|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138682638|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138682639|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682640|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682642|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682643|NCT05141240|Palbociclib|palbociclib|mesh-list
138682644|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682645|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138682646|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682647|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682648|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
138682649|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
138682650|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682651|NCT05148377|Heparin|heparin|mesh-list
138682652|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
138682653|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138682654|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138682655|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682656|NCT00524160|Fentanyl|fentanyl|mesh-list
138682657|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138682658|NCT00524160|Narcotics|narcotics|mesh-ancestor
138682662|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
138682663|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682665|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138682666|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
138682667|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
138682669|NCT00524199|Protective Agents|protective agents|mesh-ancestor
138682670|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682671|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138682672|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138682673|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138682674|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
138682675|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682676|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682677|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682678|NCT00523068|Urological Agents|urological agents|mesh-ancestor
138682679|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138682680|NCT02276378|Telmisartan|telmisartan|mesh-list
138682681|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138682682|NCT02276378|Diuretics|diuretics|mesh-ancestor
138682683|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
138682684|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682685|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138682686|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682687|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682688|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138682689|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138682690|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
138682691|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
138682692|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
138682693|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176228|NCT00708071|Aprotinin|aprotinin|mesh-list
138682695|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
138682696|NCT02947932|Indomethacin|indomethacin|mesh-list
138682697|NCT02947932|Resveratrol|resveratrol|mesh-list
138682698|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
138682699|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682700|NCT02947932|Protective Agents|protective agents|mesh-ancestor
138682701|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682702|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682703|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138359561|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
138682707|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
138682708|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682709|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682710|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682711|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
138682712|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
138682713|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138682714|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138682715|NCT05146154|Imipenem|imipenem|mesh-list
138682716|NCT05146154|Relebactam|relebactam|mesh-list
138682717|NCT05146154|Cilastatin|cilastatin|mesh-list
138682718|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138682719|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682721|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682722|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682723|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138682724|NCT00524667|Fludarabine|fludarabine|mesh-list
138682725|NCT00524667|Valproic Acid|valproic acid|mesh-list
138682726|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682727|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176266|NCT00723749|Naloxone|naloxone|mesh-list
138682728|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682729|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
138682730|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682731|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
138682732|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682733|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
138682734|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138682735|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682736|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682737|NCT00524706|Leucovorin|leucovorin|mesh-list
138682738|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
138682739|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682740|NCT00524706|Antidotes|antidotes|mesh-ancestor
138682741|NCT00524706|Protective Agents|protective agents|mesh-ancestor
138682750|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682751|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682752|NCT00525993|Etoricoxib|etoricoxib|mesh-list
138682753|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138682754|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682755|NCT00525993|Analgesics|analgesics|mesh-ancestor
138682756|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
138682757|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682758|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682759|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682760|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682761|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138176308|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682762|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138682763|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682764|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682765|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
138682767|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138682768|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
138682769|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
138682770|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352562|NCT03463512|Racecadotril|racecadotril|mesh-list
138352568|NCT03473184|Diacerein|diacerein|mesh-list
138682771|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138682772|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138682773|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
138682774|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138682775|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138682776|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138682777|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214152|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
138682778|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682779|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138682787|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138682788|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682789|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
138682790|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138682791|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138682792|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682793|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
138682794|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682795|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682796|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682797|NCT02947737|Gentamicins|gentamicins|mesh-list
138682798|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138682799|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682800|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138682801|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682802|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682804|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138682805|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
138682806|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682807|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682808|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
138682809|NCT05143073|Ethanol|ethanol|mesh-list
138682810|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138682811|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682812|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682813|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682814|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
138682815|NCT00524901|Hematinics|hematinics|mesh-ancestor
138682816|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
138682817|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
138682818|NCT02954588|Vitamins|vitamins|mesh-ancestor
138682819|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
138682823|NCT02954549|Vitamins|vitamins|mesh-ancestor
138176382|NCT02992925|Vaccines|vaccines|mesh-list
138682824|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
138682825|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682826|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138682827|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138682828|NCT05145608|Lamotrigine|lamotrigine|mesh-list
138682829|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
138682830|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138682831|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682832|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682833|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138682834|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682835|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138682836|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138682837|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682838|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682839|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138682840|NCT02946294|Epinephrine|epinephrine|mesh-list
138682841|NCT02946294|Racepinephrine|racepinephrine|mesh-list
138682842|NCT02946294|Bupivacaine|bupivacaine|mesh-list
138682843|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
138352572|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138352573|NCT03496974|Antibodies|antibodies|mesh-list
138682844|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
138682845|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
138682846|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682847|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682848|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
138682849|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682850|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138682851|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138214218|NCT05395910|Paclitaxel|paclitaxel|mesh-list
138682852|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138176432|NCT00741455|Cyclosporine|cyclosporine|mesh-list
138682853|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682854|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682855|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138682856|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138682858|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138682863|NCT05146232|Anesthetics|anesthetics|mesh-list
138682864|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682865|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682866|NCT00525096|Celecoxib|celecoxib|mesh-list
138682867|NCT00525096|Exemestane|exemestane|mesh-list
138682868|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138682869|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682870|NCT00525096|Analgesics|analgesics|mesh-ancestor
138682871|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
138682872|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682873|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682874|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682875|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682876|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138682877|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138682878|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682879|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682880|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682881|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138682882|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138682883|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138682884|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
138682885|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682887|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
138682888|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682889|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
138682890|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682891|NCT02276859|Insulin|insulin|mesh-list
138682892|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138682893|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
138682894|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
138682895|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
138682896|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682897|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682898|NCT05143970|Trastuzumab|trastuzumab|mesh-list
138682899|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138682900|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682901|NCT00525252|Baclofen|baclofen|mesh-list
138682902|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138682903|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682915|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138682916|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682917|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682918|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682919|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138682920|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682922|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682923|NCT02276690|Hepcidins|hepcidins|mesh-list
138682924|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352581|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
138352582|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
138352591|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682925|NCT02947269|Prucalopride|prucalopride|mesh-list
138682926|NCT02947269|Laxatives|laxatives|mesh-ancestor
138682927|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682928|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138682929|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138682930|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
138682931|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682932|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682933|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682934|NCT00526305|Cytarabine|cytarabine|mesh-list
138682936|NCT00526305|Prednisone|prednisone|mesh-list
138682937|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
138682938|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
138682939|NCT00526305|Vincristine|vincristine|mesh-list
138682940|NCT00526305|Daunorubicin|daunorubicin|mesh-list
138682941|NCT00526305|Asparaginase|asparaginase|mesh-list
138682942|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
138682943|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
138682944|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682945|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
138682946|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176555|NCT02991911|MEDI3726|medi3726|mesh-list
138682947|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682948|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138682949|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
138682950|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682951|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682952|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138682953|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682954|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
138682956|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682957|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682958|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
138682959|NCT00526305|Hormones|hormones|mesh-ancestor
138682960|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682961|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138682962|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138682963|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682964|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
138682965|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682966|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682967|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
138682968|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
138682969|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682970|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138682971|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138682972|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682973|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682974|NCT00526305|Analgesics|analgesics|mesh-ancestor
138682975|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
138682976|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682977|NCT02276768|Trimebutine|trimebutine|mesh-list
138682978|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682979|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
138682980|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
138682981|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682982|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682983|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
138682984|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
138682985|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682986|NCT05147753|Moxonidine|moxonidine|mesh-list
138682987|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138682988|NCT00525408|Docetaxel|docetaxel|mesh-list
138682989|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682990|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
138682991|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
138682992|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682993|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682994|NCT00525447|Dexamethasone|dexamethasone|mesh-list
138682997|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682998|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
138682999|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
138683000|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683001|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683002|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683003|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
138683004|NCT00525447|Hormones|hormones|mesh-ancestor
138683005|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683006|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138683007|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683008|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
138359861|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138683009|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138683010|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138683011|NCT00525447|Growth Substances|growth substances|mesh-ancestor
138683012|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
138683013|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683015|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138683016|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683017|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683018|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683019|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683020|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
138683021|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
138683022|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138683023|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138683024|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
138683025|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683027|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
138683028|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683032|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138683033|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
138683034|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683035|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683036|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138683037|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
138683038|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138683039|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138683040|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138683041|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
138683042|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683043|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683044|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
138683045|NCT00525642|Docetaxel|docetaxel|mesh-list
138683046|NCT00525642|Doxorubicin|doxorubicin|mesh-list
138683047|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138683048|NCT00525642|Epirubicin|epirubicin|mesh-list
138683049|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683050|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
138683051|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683052|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683053|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138683054|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
138683055|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683056|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683057|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138683058|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
138683059|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683060|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683061|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683062|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138683063|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683064|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683065|NCT00525681|Cyclosporine|cyclosporine|mesh-list
138683067|NCT00525681|Cyclosporins|cyclosporins|mesh-list
138683068|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683069|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
138683070|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683071|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138683072|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683073|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683074|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
138683075|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683076|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683077|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683078|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
138683079|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138683080|NCT02945982|Entecavir|entecavir|mesh-list
138683083|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683084|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138683085|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138359956|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
138683086|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
138683087|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683088|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683089|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683090|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138683091|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
138683092|NCT02945982|Protective Agents|protective agents|mesh-ancestor
138683093|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138683094|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683095|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683096|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
138683097|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138683098|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138683099|NCT02954393|Amoxicillin|amoxicillin|mesh-list
138683100|NCT02954393|Metronidazole|metronidazole|mesh-list
138683101|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138683102|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683103|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138683104|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138683105|NCT02954276|Sumatriptan|sumatriptan|mesh-list
138683106|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138683107|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138683108|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138683109|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
138683110|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683111|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683112|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683113|NCT00507494|Pioglitazone|pioglitazone|mesh-list
138683114|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683115|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683116|NCT00526617|Temozolomide|temozolomide|mesh-list
138683127|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
138683128|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683129|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683130|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138683131|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138683132|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138683133|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683134|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683135|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683136|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
138683138|NCT00507962|Doxorubicin|doxorubicin|mesh-list
138683139|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138352612|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138683140|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683141|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683142|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138683143|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683144|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683145|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683146|NCT00508040|Interferons|interferons|mesh-list
138683147|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
138683148|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
138683149|NCT00508040|Prednisone|prednisone|mesh-list
138683150|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683151|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
138683152|NCT00508040|Hormones|hormones|mesh-ancestor
138683153|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683154|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683155|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138683156|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683157|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
138683158|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176654|NCT01270841|Hormones|hormones|mesh-ancestor
138683159|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
138683161|NCT00508664|Fluorouracil|fluorouracil|mesh-list
138683162|NCT00508664|Cetuximab|cetuximab|mesh-list
138683163|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683165|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683166|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683167|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683168|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
138683169|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683170|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683171|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
138683172|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683173|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683175|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138683176|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683177|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138683178|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683179|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683180|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138683181|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
138683182|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683183|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683184|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
138683185|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683186|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683187|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138683189|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
138683190|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138683191|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683192|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
138683193|NCT02946801|Protective Agents|protective agents|mesh-ancestor
138683194|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683195|NCT02953847|Rifampin|rifampin|mesh-list
138683196|NCT02953847|Isoniazid|isoniazid|mesh-list
138683197|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138683198|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
138683199|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138214392|NCT00576680|Everolimus|everolimus|mesh-list
138683200|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683201|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
138683202|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683203|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683204|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683205|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138683206|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138683207|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138683208|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138176673|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
138683209|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138683210|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138683213|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
138683214|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138683215|NCT00526695|Sevoflurane|sevoflurane|mesh-list
138683216|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138683217|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138683218|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
138683219|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
138683220|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683221|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683222|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
138683223|NCT00526929|Hematinics|hematinics|mesh-ancestor
138683225|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
138683226|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683227|NCT00526734|Melphalan|melphalan|mesh-list
138683228|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
138683229|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683230|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138683231|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
138683232|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683233|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683234|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138683235|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683237|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138683238|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683239|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138683240|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138683241|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683242|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683243|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683244|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
138683245|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683246|NCT00508898|Calcitriol|calcitriol|mesh-list
138683247|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683248|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683249|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138683250|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683251|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683252|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138683253|NCT00508898|Vitamins|vitamins|mesh-ancestor
138683254|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
138683255|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138683256|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
138683257|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138683258|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
138683263|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138683264|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
138683265|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138683266|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
138683267|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683268|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683269|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
138683271|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138683272|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138683273|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138683275|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683276|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683277|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683278|NCT00510536|Acetaminophen|acetaminophen|mesh-list
138683279|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138683280|NCT00510536|Analgesics|analgesics|mesh-ancestor
138683281|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
138683282|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683283|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683284|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
138683285|NCT03458715|Empagliflozin|empagliflozin|mesh-list
138683286|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138683287|NCT03458715|Linagliptin|linagliptin|mesh-list
138683288|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138352630|NCT03541356|Carbidopa|carbidopa|mesh-list
138683289|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683290|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683291|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683292|NCT03458715|Incretins|incretins|mesh-ancestor
138683293|NCT03458715|Hormones|hormones|mesh-ancestor
138683294|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683295|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
138683296|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683297|NCT00510614|Tinidazole|tinidazole|mesh-list
138683298|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
138683299|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683300|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138683301|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683302|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138683303|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138683304|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138683306|NCT00508976|Bupivacaine|bupivacaine|mesh-list
138683307|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
138683308|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
138683309|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683310|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683311|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
138683312|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683313|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138683314|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138683315|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138683316|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683317|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683319|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
138683320|NCT00509015|Primaquine|primaquine|mesh-list
138683321|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
138683322|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138683323|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
138683324|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138683325|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138683326|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683327|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683328|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
138683329|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
138683330|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138683331|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
138683332|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138683333|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683334|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683335|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138683336|NCT00528060|Ritonavir|ritonavir|mesh-list
138683337|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138683338|NCT00528060|Tenofovir|tenofovir|mesh-list
138683339|NCT00528060|Emtricitabine|emtricitabine|mesh-list
138683340|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138683341|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138683342|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
138683343|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683344|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683345|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138683346|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138683347|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
138683348|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683349|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138683351|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138683352|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683354|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683355|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683356|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138352632|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138683357|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
138683358|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683360|NCT00509327|Cathartics|cathartics|mesh-ancestor
138683361|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683362|NCT00509327|Laxatives|laxatives|mesh-ancestor
138683363|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
138683364|NCT00509405|Diuretics|diuretics|mesh-ancestor
138683365|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
138683366|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683368|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
138683369|NCT00509561|Capecitabine|capecitabine|mesh-list
138683370|NCT00509561|Cetuximab|cetuximab|mesh-list
138683371|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683372|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683373|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
138683374|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683375|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683376|NCT00509639|Metronidazole|metronidazole|mesh-list
138683377|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683378|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138683379|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138683380|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138683381|NCT00528177|Morphine|morphine|mesh-list
138683382|NCT00528177|Oxycodone|oxycodone|mesh-list
138683383|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138683384|NCT00528177|Narcotics|narcotics|mesh-ancestor
138683385|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683386|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683391|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683392|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683393|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
138683394|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683395|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683396|NCT00528216|Capsaicin|capsaicin|mesh-list
138683397|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
138683398|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683399|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
138683400|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683401|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683402|NCT00528255|Misoprostol|misoprostol|mesh-list
138683403|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138683404|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
138683405|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138683406|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683407|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138683408|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683409|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
138683410|NCT02953106|Fluticasone|fluticasone|mesh-list
138683411|NCT02953106|Azelastine|azelastine|mesh-list
138683412|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683413|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138683414|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
138214456|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138683415|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683416|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683417|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138683418|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138683419|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683420|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138683421|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138683422|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683423|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683424|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138683425|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138683428|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683429|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
138683430|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683431|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683432|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138683433|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683434|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
138352644|NCT03572478|Nivolumab|nivolumab|mesh-list
138683435|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683436|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138683437|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683438|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683439|NCT00509834|Lactoferrin|lactoferrin|mesh-list
138683440|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683441|NCT03459404|Sufentanil|sufentanil|mesh-list
138683442|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138683443|NCT03459404|Narcotics|narcotics|mesh-ancestor
138214482|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683445|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683446|NCT03459404|Analgesics|analgesics|mesh-ancestor
138683447|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
138683448|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683449|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138683450|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138683451|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
138683452|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
138683453|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
138683454|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138683455|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138683456|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138683457|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683458|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683459|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360310|NCT00381342|Incretins|incretins|mesh-ancestor
138683460|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683461|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683462|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138683463|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683464|NCT00510965|Ranibizumab|ranibizumab|mesh-list
138683465|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138683466|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138683467|NCT00510965|Growth Substances|growth substances|mesh-ancestor
138683468|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683469|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138683470|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683471|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
138683472|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138683473|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138683474|NCT00509990|Analgesics|analgesics|mesh-ancestor
138683475|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
138683476|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683477|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683478|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683479|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683480|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683481|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683482|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
138683483|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138683484|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683485|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683487|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138683488|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138683489|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138683490|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138683491|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683492|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
138683493|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138683494|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
138683495|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683496|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
138683497|NCT03459833|Protective Agents|protective agents|mesh-ancestor
138683499|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
138683500|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683501|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138683502|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
138352645|NCT03572478|Rucaparib|rucaparib|mesh-list
138683503|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683504|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138683505|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683506|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683507|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
138683508|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683509|NCT04692051|Paclitaxel|paclitaxel|mesh-list
138683510|NCT04692051|Cisplatin|cisplatin|mesh-list
138683511|NCT04692051|Gemcitabine|gemcitabine|mesh-list
138683512|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138683513|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683515|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683516|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683517|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683518|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683519|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
138683520|NCT00528723|Albuterol|albuterol|mesh-list
138683521|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138683522|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
138683523|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683524|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683525|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138683526|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
138683527|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
138683528|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176808|NCT03804931|Prednisone|prednisone|mesh-list
138683529|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138683530|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138683531|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138683532|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138683533|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683534|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683535|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
138683536|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683537|NCT01580514|Exenatide|exenatide|mesh-list
138683538|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683539|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683547|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
138683548|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683549|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138683550|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
138683551|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683552|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138683553|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138683554|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683555|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683557|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
138683558|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
138683559|NCT02953184|Docetaxel|docetaxel|mesh-list
138683560|NCT02953184|Doxorubicin|doxorubicin|mesh-list
138683561|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138683562|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
138683563|NCT02953184|Razoxane|razoxane|mesh-list
138683564|NCT02953184|Pirarubicin|pirarubicin|mesh-list
138683565|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683566|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
138683567|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683568|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683569|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138683570|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
138683571|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683572|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683573|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138683574|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
138176826|NCT02991131|Linezolid|linezolid|mesh-list
138683576|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683577|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683578|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683579|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138683580|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683581|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683586|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
138683587|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683588|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138683589|NCT00515229|Analgesics|analgesics|mesh-ancestor
138683590|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
138683591|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683592|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683593|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138683594|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138683595|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683596|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683597|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
138683598|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683599|NCT00511316|Montelukast|montelukast|mesh-list
138683600|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138683601|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
138683602|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138683603|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
138683604|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683605|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683606|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138683607|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138683608|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683609|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
138683610|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683611|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683612|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138683613|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
138683614|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138683615|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683616|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683617|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214601|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282893|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138683618|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
138683620|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138683621|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683622|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683623|NCT01356966|Folic Acid|folic acid|mesh-list
138683624|NCT01356966|Hematinics|hematinics|mesh-ancestor
138683625|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
138683626|NCT01356966|Vitamins|vitamins|mesh-ancestor
138683632|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138683633|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138683634|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683635|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683636|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683637|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683638|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
138683639|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138683640|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138683641|NCT00510263|Valacyclovir|valacyclovir|mesh-list
138683642|NCT00510263|Prednisolone|prednisolone|mesh-list
138683643|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138683644|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
138683645|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138683646|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
138683647|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138683648|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
138683649|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683650|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
138214642|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138683652|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683653|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352659|NCT03593538|Metformin|metformin|mesh-list
138352660|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683654|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138683655|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683656|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
138683657|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
138683658|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683659|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683660|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138683661|NCT00510263|Protective Agents|protective agents|mesh-ancestor
138683662|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
138683663|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683665|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138683666|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
138683667|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683668|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683669|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683670|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138683671|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138683672|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683673|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683674|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138683675|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
138683676|NCT00529425|Ropivacaine|ropivacaine|mesh-list
138683678|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
138683679|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683680|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683681|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
138683682|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683683|NCT02950935|Progesterone|progesterone|mesh-list
138683684|NCT02950935|Progestins|progestins|mesh-ancestor
138683687|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683689|NCT00529620|Piperaquine|piperaquine|mesh-list
138683690|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
138683691|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138683692|NCT00529620|Amodiaquine|amodiaquine|mesh-list
138683694|NCT00529620|Sulfalene|sulfalene|mesh-list
138683695|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
138683696|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138683697|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138683698|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683699|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138683700|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683701|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683702|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138683703|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
138683704|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138683705|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683706|NCT00513032|Methylene Blue|methylene blue|mesh-list
138683707|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683708|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683709|NCT00513110|Caffeine|caffeine|mesh-list
138683710|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138683711|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683712|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138683713|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683714|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683715|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138683716|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138683717|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
138683718|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683719|NCT02951897|Pemetrexed|pemetrexed|mesh-list
138683720|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683721|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683722|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683723|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138683724|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683725|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
138683726|NCT00511823|Granisetron|granisetron|mesh-list
138352663|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138683727|NCT00511823|Casopitant|casopitant|mesh-list
138683728|NCT00511823|Dolasetron|dolasetron|mesh-list
138214731|NCT00587678|Simvastatin|simvastatin|mesh-list
138683729|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683730|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683732|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
138683733|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683734|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683735|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138683736|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138683737|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
138683738|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683739|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683740|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138683741|NCT00515736|Vitamins|vitamins|mesh-list
138683746|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
138683747|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683748|NCT00515736|Trace Elements|trace elements|mesh-ancestor
138683749|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
138683750|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683751|NCT00515736|Protective Agents|protective agents|mesh-ancestor
138683752|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
138683753|NCT00511940|Acamprosate|acamprosate|mesh-list
138683754|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138683755|NCT00513149|Clopidogrel|clopidogrel|mesh-list
138683756|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138683757|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138683758|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138683759|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138683760|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
138683761|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683762|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683763|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683765|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138683766|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138683767|NCT02944227|Growth Substances|growth substances|mesh-ancestor
138683768|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683769|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214757|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138214763|NCT04527770|Dexamethasone|dexamethasone|mesh-list
138683770|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683772|NCT00513188|Cytarabine|cytarabine|mesh-list
138683773|NCT00513188|Prednisone|prednisone|mesh-list
138683774|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
138683775|NCT00513188|Doxorubicin|doxorubicin|mesh-list
138683776|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138683777|NCT00513188|Methotrexate|methotrexate|mesh-list
138683778|NCT00513188|Vincristine|vincristine|mesh-list
138683779|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
138683781|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683784|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683785|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138683786|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
138683787|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683788|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683789|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138683790|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683791|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138683792|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683793|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683794|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138683795|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
138683796|NCT00513188|Hormones|hormones|mesh-ancestor
138683797|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352670|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683798|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138683799|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138683800|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
138683801|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138683802|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683803|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
138683804|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683805|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138683806|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683807|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
138683808|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683809|NCT00513188|Antidotes|antidotes|mesh-ancestor
138683810|NCT00513188|Protective Agents|protective agents|mesh-ancestor
138683811|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
138683812|NCT00513188|Vitamins|vitamins|mesh-ancestor
138683813|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
138683814|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138683815|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138683816|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683817|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683818|NCT00513266|Leucovorin|leucovorin|mesh-list
138683819|NCT00513266|Bevacizumab|bevacizumab|mesh-list
138683820|NCT00513266|Cetuximab|cetuximab|mesh-list
138683821|NCT00513266|Fluorouracil|fluorouracil|mesh-list
138683822|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
138683823|NCT00513266|Irinotecan|irinotecan|mesh-list
138683824|NCT00513266|Calcium|calcium|mesh-list
138683825|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
138683826|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683827|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683828|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138683829|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138683830|NCT00513266|Growth Substances|growth substances|mesh-ancestor
138683831|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683832|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
138683833|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138683834|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
138683835|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683836|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683837|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683838|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
138683839|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138683840|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138683841|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683842|NCT00513266|Antidotes|antidotes|mesh-ancestor
138683843|NCT00513266|Protective Agents|protective agents|mesh-ancestor
138683844|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138683845|NCT00513266|Vitamins|vitamins|mesh-ancestor
138683846|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
138683847|NCT00513383|Paclitaxel|paclitaxel|mesh-list
138683848|NCT00513383|Docetaxel|docetaxel|mesh-list
138683849|NCT00513383|Carboplatin|carboplatin|mesh-list
138683850|NCT00513383|Fluorouracil|fluorouracil|mesh-list
138683851|NCT00513383|Panitumumab|panitumumab|mesh-list
138683852|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138683853|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683854|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138683855|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138683856|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683857|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683858|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
138683859|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683861|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
138683862|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683863|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683865|NCT00515892|Antibodies|antibodies|mesh-list
138683866|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
138683867|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138683868|NCT00515892|Immunotoxins|immunotoxins|mesh-list
138683870|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683871|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
138683872|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683873|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138683874|NCT00513539|Trioxsalen|trioxsalen|mesh-list
138683875|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683876|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683877|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138683879|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138683880|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683881|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683883|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
138683884|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
138683885|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683886|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138683887|NCT00513656|Oxycodone|oxycodone|mesh-list
138683888|NCT00513656|Naloxone|naloxone|mesh-list
138683889|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138683890|NCT00513656|Narcotics|narcotics|mesh-ancestor
138683891|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683892|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683893|NCT00513656|Analgesics|analgesics|mesh-ancestor
138683894|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
138683895|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683896|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138683897|NCT00530127|Deferiprone|deferiprone|mesh-list
138683898|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138683899|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
138683900|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
138683901|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683902|NCT04691934|Anesthetics|anesthetics|mesh-list
138683903|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683904|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683905|NCT00512057|Allopurinol|allopurinol|mesh-list
138683906|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
138683907|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683908|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683909|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
138683910|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138683911|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138683912|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
138683913|NCT00512057|Protective Agents|protective agents|mesh-ancestor
138683914|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683915|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
138683916|NCT00513929|Astringents|astringents|mesh-ancestor
138683917|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683918|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
138683922|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138683923|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683924|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683925|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683926|NCT03459248|Anesthetics|anesthetics|mesh-list
138683927|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683928|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683929|NCT00512291|Olanzapine|olanzapine|mesh-list
138683931|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
138683932|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
138683933|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683934|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683935|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683936|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138683937|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138683938|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683939|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683940|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138683941|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138683942|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683943|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683944|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683945|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
138683946|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138683947|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
138683948|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138352683|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138683949|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138683950|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683951|NCT00514163|Gemcitabine|gemcitabine|mesh-list
138683952|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683953|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
138683954|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683955|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683957|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138683958|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683959|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138683960|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138683961|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138683962|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683963|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
138683964|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683965|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138683966|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
138683967|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683968|NCT00512408|Testosterone|testosterone|mesh-list
138683969|NCT00512408|Androgens|androgens|mesh-ancestor
138683971|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683972|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683973|NCT00530400|Cefuroxime|cefuroxime|mesh-list
138683974|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
138683975|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138683976|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683977|NCT00531336|Bevacizumab|bevacizumab|mesh-list
138683978|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138683979|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683980|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138683981|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138683983|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683984|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138683985|NCT00530478|Donepezil|donepezil|mesh-list
138683986|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138683987|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683988|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683989|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
138683990|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683991|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683992|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
138683993|NCT00530556|Zolpidem|zolpidem|mesh-list
138683994|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138683995|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138683996|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683997|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683998|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138684000|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
138684001|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684002|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684003|NCT00512486|Benralizumab|benralizumab|mesh-list
138684004|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138684006|NCT00530595|Losartan|losartan|mesh-list
138684007|NCT00530595|Valsartan|valsartan|mesh-list
138684008|NCT00530595|Candesartan|candesartan|mesh-list
138684009|NCT00530595|Candesartan cilexetil|candesartan cilexetil|mesh-list
138684010|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138684011|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138684012|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138684013|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684014|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138684015|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
138684016|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138684017|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138684018|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684019|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
138684020|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684021|NCT02944110|Glucagon|glucagon|mesh-list
138684022|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684023|NCT02944110|Hormones|hormones|mesh-ancestor
138684024|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684025|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684026|NCT02951975|Dexamethasone|dexamethasone|mesh-list
138684027|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684028|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
138684029|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
138684030|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684031|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684032|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684033|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
138684034|NCT02951975|Hormones|hormones|mesh-ancestor
138684035|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684036|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138684037|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684038|NCT00514397|Temozolomide|temozolomide|mesh-list
138684039|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
138684040|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138684041|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
138684042|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684043|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684045|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684047|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684048|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684049|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138684050|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684051|NCT00531687|Paclitaxel|paclitaxel|mesh-list
138684052|NCT00531687|Gemcitabine|gemcitabine|mesh-list
138684053|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138684054|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684055|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138684056|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138684057|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138684058|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684059|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684060|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
138684061|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138684062|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
138684063|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684064|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
138360912|NCT01272258|Leronlimab|leronlimab|mesh-list
138684066|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684067|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138684068|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684069|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282894|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684070|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684072|NCT00530868|Letrozole|letrozole|mesh-list
138684073|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684074|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684076|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684077|NCT00530868|Growth Substances|growth substances|mesh-ancestor
138684078|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684079|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684080|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138684081|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138684082|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684083|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684084|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138684085|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
138684086|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684088|NCT00530907|Valproic Acid|valproic acid|mesh-list
138684089|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684090|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684091|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684092|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684093|NCT00530907|Growth Substances|growth substances|mesh-ancestor
138352695|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
138684094|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684095|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684096|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
138684097|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684098|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684099|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
138684100|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684101|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
138684102|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138684103|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684104|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684105|NCT00531024|Bevacizumab|bevacizumab|mesh-list
138684106|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684107|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684108|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684111|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684112|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684113|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
138684114|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138684115|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
138684116|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138684117|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684118|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
138684119|NCT00531063|Everolimus|everolimus|mesh-list
138684120|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138684121|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138684122|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684123|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684124|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684125|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
138684126|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214947|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
138684127|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684129|NCT02943798|Etoposide|etoposide|mesh-list
138684130|NCT02943798|Carboplatin|carboplatin|mesh-list
138684131|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138684132|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684133|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
138684134|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
138684135|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
138684136|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684137|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138684138|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684139|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684140|NCT02943369|Ticagrelor|ticagrelor|mesh-list
138684141|NCT02943369|Cangrelor|cangrelor|mesh-list
138684142|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138684143|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138684144|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138684145|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138684146|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
138684147|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684148|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684149|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684150|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138684151|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684152|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684154|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
138684155|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684156|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684157|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684158|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684159|NCT00515957|Antibodies|antibodies|mesh-list
138684160|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
138684161|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684162|NCT02943642|Vorinostat|vorinostat|mesh-list
138684163|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684164|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138684165|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684166|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684167|NCT04695509|Propofol|propofol|mesh-list
138684168|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138684169|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684170|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684171|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138684172|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
138684173|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
138684174|NCT02943135|Lidocaine|lidocaine|mesh-list
138684175|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
138684176|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
138684177|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684178|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684179|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
138684180|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684181|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138684182|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138684183|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138684184|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138684185|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684186|NCT02951234|Aspirin|aspirin|mesh-list
138684187|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138684188|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
138684189|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138684190|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684191|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684193|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
138684194|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684195|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684196|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684197|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684198|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138684199|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138684200|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684201|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138684202|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138684203|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684205|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
138684206|NCT02943252|Apatinib|apatinib|mesh-list
138684207|NCT02943252|Tegafur|tegafur|mesh-list
138684208|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684209|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138684210|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684211|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684212|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684213|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
138684214|NCT00514982|Adalimumab|adalimumab|mesh-list
138684215|NCT00514982|Infliximab|infliximab|mesh-list
138684216|NCT00514982|Mesalamine|mesalamine|mesh-list
138684217|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
138684218|NCT00514982|Tacrolimus|tacrolimus|mesh-list
138684219|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684220|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
138684221|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684222|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138684223|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684224|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684225|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138684227|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684228|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684229|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684230|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
138684231|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684233|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138352709|NCT03704376|Clonidine|clonidine|mesh-list
138684234|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684235|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684236|NCT00514982|Analgesics|analgesics|mesh-ancestor
138684237|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
138684238|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684239|NCT00531999|Ritonavir|ritonavir|mesh-list
138684240|NCT00531999|Lopinavir|lopinavir|mesh-list
138684241|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
138684242|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138684243|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138684244|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684245|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684246|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684247|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138684248|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138684249|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
138684250|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684251|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138684252|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138684253|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138684254|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138684256|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138684257|NCT05319912|Choline|choline|mesh-list
138684258|NCT05319912|Omeprazole|omeprazole|mesh-list
138684259|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138684260|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684261|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138684262|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684263|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684264|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
138684265|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138684267|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138684268|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
138684269|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
138684270|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
138684271|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684272|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684273|NCT05319912|Growth Substances|growth substances|mesh-ancestor
138684274|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684275|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684278|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
138684279|NCT00515138|Rituximab|rituximab|mesh-list
138684280|NCT00515138|Carboplatin|carboplatin|mesh-list
138684281|NCT00515138|Etoposide|etoposide|mesh-list
138684282|NCT00515138|Bortezomib|bortezomib|mesh-list
138684283|NCT00515138|Ifosfamide|ifosfamide|mesh-list
138684284|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684285|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684286|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
138684287|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361139|NCT01274988|Analgesics|analgesics|mesh-ancestor
138684288|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684289|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138684290|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138684291|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684292|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684293|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684294|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138684295|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
138684296|NCT00515255|Minocycline|minocycline|mesh-list
138684297|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138684298|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352717|NCT03704376|Analgesics|analgesics|mesh-ancestor
138352718|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138684299|NCT00516113|Paroxetine|paroxetine|mesh-list
138684300|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138684301|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138352719|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
138684302|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138684303|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684304|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684305|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
138684306|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684307|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138684308|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
138684309|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684310|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138684311|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138684312|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684314|NCT04695197|Lumefantrine|lumefantrine|mesh-list
138684315|NCT04695197|Artemether|artemether|mesh-list
138684316|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138684317|NCT04695197|Pyronaridine|pyronaridine|mesh-list
138684318|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138684319|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
138684320|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138684321|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138684322|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684323|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684324|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
138684325|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
138684326|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138684327|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
138684329|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
138684330|NCT00516152|Fludarabine|fludarabine|mesh-list
138684331|NCT00516152|Busulfan|busulfan|mesh-list
138684332|NCT00516152|Tacrolimus|tacrolimus|mesh-list
138684333|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138684334|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
138684335|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138684336|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684337|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684338|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
138684339|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684340|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684341|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684342|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684343|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138684344|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684345|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
138684346|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684347|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138684348|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138684349|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
138684350|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138684351|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138684352|NCT00516191|Doxorubicin|doxorubicin|mesh-list
138684353|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138684354|NCT00516191|Bortezomib|bortezomib|mesh-list
138684355|NCT00516191|Melphalan|melphalan|mesh-list
138684356|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138684357|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684358|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138684359|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684360|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684361|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684362|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138684363|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
138684364|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138684365|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684366|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
138684367|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684368|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
138684369|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138684370|NCT00515450|Antibodies|antibodies|mesh-list
138684371|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
138684372|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138684373|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
138684374|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684376|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138684377|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
138684378|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684379|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684380|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684381|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138684382|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138684383|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684384|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684385|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138684387|NCT02941575|Methamphetamine|methamphetamine|mesh-list
138684388|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138684389|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684390|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
138684391|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
138684392|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684393|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
138684394|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684395|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684396|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
138684397|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138684398|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138684399|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138684400|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138684401|NCT02941731|Oseltamivir|oseltamivir|mesh-list
138684402|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
138684403|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684404|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684405|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684406|NCT02951039|Edoxaban|edoxaban|mesh-list
138684407|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138684408|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
138684409|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138684410|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684411|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684412|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684413|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
138684415|NCT02951117|Venetoclax|venetoclax|mesh-list
138215104|NCT01589263|Tamsulosin|tamsulosin|mesh-list
138684416|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684417|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
138684418|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
138684419|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684421|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684422|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
138684423|NCT02951117|Hormones|hormones|mesh-ancestor
138684424|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684425|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138684426|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684428|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684429|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684430|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138177191|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684431|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684433|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684434|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684435|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684436|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684437|NCT00515684|Growth Substances|growth substances|mesh-ancestor
138684438|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684439|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684440|NCT05317767|Vaccines|vaccines|mesh-list
138684441|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
138684442|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684444|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352731|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
138684445|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684446|NCT05317611|Ondansetron|ondansetron|mesh-list
138684447|NCT05317611|Bupivacaine|bupivacaine|mesh-list
138684448|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
138684449|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
138684450|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684451|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684452|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
138684453|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684454|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
138684455|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
138684456|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684457|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
138684458|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684459|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138684460|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138684461|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
138684462|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684463|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684464|NCT05317572|Morphine|morphine|mesh-list
138684470|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
138684471|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684472|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
138684473|NCT00516425|Doxorubicin|doxorubicin|mesh-list
138684474|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138684475|NCT00516425|Epirubicin|epirubicin|mesh-list
138684476|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684477|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
138684478|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684479|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684480|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138684481|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
138684482|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684483|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684484|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138684485|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138684486|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138684487|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684488|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684489|NCT02942706|Cetuximab|cetuximab|mesh-list
138684490|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684491|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684492|NCT00516464|Ranibizumab|ranibizumab|mesh-list
138684493|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684494|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684495|NCT00516464|Growth Substances|growth substances|mesh-ancestor
138684496|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684497|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684498|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684499|NCT00516542|Letrozole|letrozole|mesh-list
138684501|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138684502|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138684503|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684504|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684505|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138684506|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
138684507|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684508|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684510|NCT03458481|Yimitasvir|yimitasvir|mesh-list
138684511|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
138684512|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684513|NCT02949752|Aripiprazole|aripiprazole|mesh-list
138684514|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
138684515|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684516|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138684517|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138684518|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352740|NCT03889158|Protective Agents|protective agents|mesh-ancestor
138684519|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684520|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
138684521|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
138684522|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684523|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684524|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138684525|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138684526|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
138684527|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138684528|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138684529|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138684530|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138684531|NCT02942550|Bromides|bromides|mesh-list
138684532|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
138215190|NCT00621686|Growth Substances|growth substances|mesh-ancestor
138684534|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138684535|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684536|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
138684537|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684538|NCT04694612|Remdesivir|remdesivir|mesh-list
138684539|NCT04694612|Favipiravir|favipiravir|mesh-list
138684540|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
138684541|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684542|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
138684543|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684545|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138684546|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684547|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138684548|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684549|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
138684550|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684551|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
138684552|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684553|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
138684555|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138684556|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138684557|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684558|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684559|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138684560|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138684561|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684562|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
138684564|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684565|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684566|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
138684567|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
138684568|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684569|NCT02940990|Paclitaxel|paclitaxel|mesh-list
138684570|NCT02940990|Etoposide|etoposide|mesh-list
138684571|NCT02940990|Vinorelbine|vinorelbine|mesh-list
138684572|NCT02940990|Docetaxel|docetaxel|mesh-list
138684573|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138684574|NCT02940990|Carboplatin|carboplatin|mesh-list
138684575|NCT02940990|Gemcitabine|gemcitabine|mesh-list
138684576|NCT02940990|Pemetrexed|pemetrexed|mesh-list
138684577|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138684578|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684579|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
138684580|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
138684581|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
138684582|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684583|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684584|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
138352748|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684585|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138684586|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684589|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138684590|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
138684591|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138684592|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138684593|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138684594|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
138684595|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684596|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138684597|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138684598|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684599|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215284|NCT00626210|Modafinil|modafinil|mesh-list
138684600|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138684601|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138684602|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684603|NCT02942043|Bevacizumab|bevacizumab|mesh-list
138684604|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138684605|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684606|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138684607|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684608|NCT02942043|Growth Substances|growth substances|mesh-ancestor
138684609|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684610|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138684612|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138684613|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684614|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138684615|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684616|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684617|NCT00518570|Levetiracetam|levetiracetam|mesh-list
138684618|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
138684619|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
138684620|NCT03458208|Metformin|metformin|mesh-list
138684621|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138684622|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684623|NCT00517283|Exenatide|exenatide|mesh-list
138684624|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138684625|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684626|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138684627|NCT00517283|Incretins|incretins|mesh-ancestor
138684628|NCT00517283|Hormones|hormones|mesh-ancestor
138684629|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684630|NCT02940912|Apomorphine|apomorphine|mesh-list
138684631|NCT02940912|Emetics|emetics|mesh-ancestor
138684632|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684633|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
138684634|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684635|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684636|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
138684637|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
138684638|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684639|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684640|NCT00517322|Ramipril|ramipril|mesh-list
138684641|NCT00517322|Irbesartan|irbesartan|mesh-list
138684642|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138684643|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684644|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684645|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684646|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138684647|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138684648|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138684649|NCT02939430|Atropine|atropine|mesh-list
138684650|NCT02939430|Neostigmine|neostigmine|mesh-list
138684651|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138684652|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138684653|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138352757|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
138684654|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
138352758|NCT04323852|Vitamin D|vitamin d|mesh-list
138352759|NCT04323852|Vitamins|vitamins|mesh-ancestor
138684655|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684656|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684657|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138684658|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
138684659|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
138684660|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
138684661|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138684662|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138684663|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
138684664|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684665|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684666|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138361512|NCT03214536|Ropivacaine|ropivacaine|mesh-list
138684667|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684668|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138684669|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
138684670|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
138684671|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684672|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684673|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684675|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138684676|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684677|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684678|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
138684679|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
138684680|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
138684681|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684682|NCT00517517|Coagulants|coagulants|mesh-ancestor
138684683|NCT02940756|Artesunate|artesunate|mesh-list
138684684|NCT02940756|Lumefantrine|lumefantrine|mesh-list
138684685|NCT02940756|Artemether|artemether|mesh-list
138684686|NCT02940756|Piperaquine|piperaquine|mesh-list
138684687|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138684688|NCT02940756|Amodiaquine|amodiaquine|mesh-list
138684689|NCT02940756|Artenimol|artenimol|mesh-list
138684690|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
138684691|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138684692|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138684693|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684694|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684695|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
138684699|NCT02939547|Betadex|betadex|mesh-list
138684700|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
138684701|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684702|NCT02941068|Fluconazole|fluconazole|mesh-list
138684703|NCT02941068|Caspofungin|caspofungin|mesh-list
138684704|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
138684705|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684706|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138684707|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138684708|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684709|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684710|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138177354|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
138684711|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
138684712|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352766|NCT04420572|Hormones|hormones|mesh-ancestor
138352767|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684713|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684714|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138684715|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138684716|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
138684717|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684718|NCT02939274|Verteporfin|verteporfin|mesh-list
138684719|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138684720|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684721|NCT04694183|Paclitaxel|paclitaxel|mesh-list
138684722|NCT04694183|Antibodies|antibodies|mesh-list
138684723|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
138684724|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138684725|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684727|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138684728|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215384|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
138684729|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684730|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
138684731|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684732|NCT00517946|Cetirizine|cetirizine|mesh-list
138684733|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
138684734|NCT00517946|Ephedrine|ephedrine|mesh-list
138684735|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138684736|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138684737|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138684738|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
138684739|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
138684740|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361586|NCT03211104|Curcumin|curcumin|mesh-list
138684741|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684744|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
138684745|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684746|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138684747|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138684748|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
138684749|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138684750|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138684751|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
138684752|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215420|NCT02248207|Pramipexole|pramipexole|mesh-list
138684753|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138684754|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138684755|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138684756|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138684757|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684758|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684759|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684761|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
138684762|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684763|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
138684764|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684765|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
138684766|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138684767|NCT04690920|Remdesivir|remdesivir|mesh-list
138684768|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684769|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684770|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
138684771|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
138684772|NCT00518102|Becaplermin|becaplermin|mesh-list
138684773|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
138684774|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138352785|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
138352794|NCT04284930|Bupivacaine|bupivacaine|mesh-list
138684775|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684776|NCT00518102|Growth Substances|growth substances|mesh-ancestor
138684777|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684778|NCT02939235|Morphine|morphine|mesh-list
138684779|NCT02939235|Metoclopramide|metoclopramide|mesh-list
138684780|NCT02939235|Ticagrelor|ticagrelor|mesh-list
138684781|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138684782|NCT02939235|Narcotics|narcotics|mesh-ancestor
138684783|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684784|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684785|NCT02939235|Analgesics|analgesics|mesh-ancestor
138684786|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
138684787|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684788|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138684789|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138684790|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138684791|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138684794|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684796|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
138684797|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684798|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138684799|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138684800|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
138684801|NCT00518141|Aspirin|aspirin|mesh-list
138684802|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
138684803|NCT00518141|Salicylates|salicylates|mesh-list
138684804|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684805|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
138684806|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
138684807|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684808|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684809|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684810|NCT00518141|Analgesics|analgesics|mesh-ancestor
138684811|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
138684812|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684813|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684814|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684815|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684816|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138684817|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684818|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684819|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138361650|NCT01833312|Meperidine|meperidine|mesh-list
138684821|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138684822|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
138684823|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
138684824|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138684825|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138684826|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684827|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
138684828|NCT02938962|Coagulants|coagulants|mesh-ancestor
138684829|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
138684830|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684831|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
138684832|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684833|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684834|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138684837|NCT04691076|Esketamine|esketamine|mesh-list
138684838|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138684839|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684840|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684841|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138684842|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
138684843|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
138684844|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138684845|NCT04691076|Narcotics|narcotics|mesh-ancestor
138684846|NCT04691076|Analgesics|analgesics|mesh-ancestor
138684847|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
138684848|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684849|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138684851|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138684852|NCT02949206|Thrombin|thrombin|mesh-list
138684853|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
138684854|NCT02949206|Coagulants|coagulants|mesh-ancestor
138684855|NCT05108454|Micronutrients|micronutrients|mesh-list
138684856|NCT05108454|Trace Elements|trace elements|mesh-list
138684857|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684858|NCT02940561|Methotrexate|methotrexate|mesh-list
138684859|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138684860|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
138684861|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138684862|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684863|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684864|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
138684865|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684866|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684867|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
138684868|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684869|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138684870|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138684871|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
138684872|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684873|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138684874|NCT02940366|Atorvastatin|atorvastatin|mesh-list
138684875|NCT02940366|Pitavastatin|pitavastatin|mesh-list
138684876|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138684877|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138684878|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
138684879|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684880|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138684881|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138684882|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684884|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138684885|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684886|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684887|NCT02940405|Analgesics|analgesics|mesh-ancestor
138684888|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
138684889|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684890|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684891|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684892|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684893|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138684894|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361725|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
138684895|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684897|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
138684898|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138684899|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138684900|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684901|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
138684905|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138684906|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684907|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
138684908|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
138684909|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684910|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684911|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138684912|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
138684913|NCT04690647|Hormones|hormones|mesh-ancestor
138684914|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684915|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138684916|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684917|NCT04690647|Analgesics|analgesics|mesh-ancestor
138684918|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
138684919|NCT00519467|Artesunate|artesunate|mesh-list
138684920|NCT00519467|Dapsone|dapsone|mesh-list
138684921|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
138684922|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
138684923|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138684924|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138684925|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684926|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684927|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
138684928|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
138684929|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138684930|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
138684931|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138684932|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684933|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684934|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
138684935|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138684937|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684938|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
138684939|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684940|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684941|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684942|NCT04974684|Apixaban|apixaban|mesh-list
138684943|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138684944|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
138684945|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138684946|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684947|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684948|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684950|NCT00520091|Celecoxib|celecoxib|mesh-list
138684951|NCT00520091|Irinotecan|irinotecan|mesh-list
138684952|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684953|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138684954|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138684955|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684956|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684957|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138684958|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138684959|NCT00520091|Analgesics|analgesics|mesh-ancestor
138684960|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
138684961|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684962|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684963|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684964|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138684965|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138684966|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138684967|NCT00520169|Ketamine|ketamine|mesh-list
138684968|NCT00520169|Analgesics|analgesics|mesh-ancestor
138684969|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
138684970|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138684971|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684972|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138684973|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138684974|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
138684975|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
138684976|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684977|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138684978|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138684979|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138684980|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684982|NCT00520247|Enalapril|enalapril|mesh-list
138684983|NCT00520247|Hematinics|hematinics|mesh-ancestor
138684984|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
138684985|NCT00520247|Vitamins|vitamins|mesh-ancestor
138684986|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
138684987|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684988|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138684989|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
138684990|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684991|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684992|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138684993|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
138684994|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
138684995|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684996|NCT00520325|Lectins|lectins|mesh-list
138684999|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352811|NCT04204200|Protective Agents|protective agents|mesh-ancestor
138685001|NCT00520442|Ibuprofen|ibuprofen|mesh-list
138685002|NCT00520442|Codeine|codeine|mesh-list
138685003|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138685004|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138685005|NCT00520442|Analgesics|analgesics|mesh-ancestor
138685006|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
138685007|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685008|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685009|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685010|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685011|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138685012|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685013|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685014|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138685015|NCT00520442|Narcotics|narcotics|mesh-ancestor
138685016|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685017|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
138685018|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138685019|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
138685020|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138685021|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685022|NCT02939898|Letrozole|letrozole|mesh-list
138685023|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138685024|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685025|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138215820|NCT00595556|Zonisamide|zonisamide|mesh-list
138685026|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685027|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685028|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138685029|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
138685030|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685031|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685032|NCT00520754|Levocetirizine|levocetirizine|mesh-list
138685033|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138685034|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138685035|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
138685036|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
138685037|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685038|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685039|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685040|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
138685041|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685042|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138685043|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138361877|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138685044|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685045|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685059|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685060|NCT00520949|Antacids|antacids|mesh-ancestor
138685061|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138685062|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138685063|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138685064|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138685065|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138685066|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138685067|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138685068|NCT02938260|Metoprolol|metoprolol|mesh-list
138685069|NCT02938260|Diltiazem|diltiazem|mesh-list
138685070|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138685071|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138685072|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
138685074|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685075|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685076|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138685077|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138685078|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138685079|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
138685080|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685081|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685082|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138685083|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685084|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138685085|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685087|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138685088|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138685089|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138685090|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138685091|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
138685092|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685093|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685094|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685095|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
138685096|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
138685097|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685098|NCT00521612|Sevoflurane|sevoflurane|mesh-list
138685099|NCT00521612|Isoflurane|isoflurane|mesh-list
138215966|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215969|NCT00603044|Xhance|xhance|mesh-list
138685100|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138685101|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138685102|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
138685104|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685105|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685106|NCT00521261|Antibodies|antibodies|mesh-list
138685107|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138685108|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
138685109|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685110|NCT02931591|Metformin|metformin|mesh-list
138685111|NCT02931591|Hormones|hormones|mesh-list
138685112|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138685113|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685114|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685115|NCT00521300|Octreotide|octreotide|mesh-list
138685116|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685117|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138685118|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685119|NCT00523133|Naltrexone|naltrexone|mesh-list
138352836|NCT03976752|Elvitegravir|elvitegravir|mesh-list
138352837|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
138352838|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685120|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138685121|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138685122|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685123|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
138685124|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685125|NCT02937792|Bupivacaine|bupivacaine|mesh-list
138685126|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
138685127|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
138685128|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685131|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685133|NCT02931474|Growth Substances|growth substances|mesh-ancestor
138685134|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685135|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
138685136|NCT02931357|Lidocaine|lidocaine|mesh-list
138685137|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
138685138|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
138685139|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
138685140|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685141|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685142|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
138685143|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685144|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138685145|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138685146|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138685147|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685148|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685149|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138352854|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685150|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
138685151|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
138685152|NCT02931357|Protective Agents|protective agents|mesh-ancestor
138685153|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138685154|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685156|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685157|NCT00521963|Infliximab|infliximab|mesh-list
138685158|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138685159|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685161|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685162|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685163|NCT02937402|Dimercaprol|dimercaprol|mesh-list
138685164|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
138685165|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
138685166|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685167|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
138685168|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
138685169|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685170|NCT02937363|Protective Agents|protective agents|mesh-ancestor
138685171|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685172|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
138685173|NCT02937363|Vitamins|vitamins|mesh-ancestor
138685174|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
138685175|NCT02948348|Capecitabine|capecitabine|mesh-list
138685176|NCT02948348|Nivolumab|nivolumab|mesh-list
138685177|NCT02948348|Ipilimumab|ipilimumab|mesh-list
138685178|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685179|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
138685180|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685184|NCT04693910|Hormones|hormones|mesh-list
138685185|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685186|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685187|NCT00522158|Atorvastatin|atorvastatin|mesh-list
138685188|NCT00522158|Simvastatin|simvastatin|mesh-list
138685189|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138685190|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138685191|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
138685192|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685193|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138685194|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138685196|NCT02931123|Rifaximin|rifaximin|mesh-list
138685197|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685198|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685199|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685200|NCT02936934|Morphine|morphine|mesh-list
138685201|NCT02936934|Oxycodone|oxycodone|mesh-list
138685202|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138685203|NCT02936934|Narcotics|narcotics|mesh-ancestor
138685204|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685205|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685206|NCT02936934|Analgesics|analgesics|mesh-ancestor
138685207|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
138685208|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685210|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138685211|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685212|NCT00522509|Floxuridine|floxuridine|mesh-list
138685213|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685214|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
138685215|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685216|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685217|NCT00522587|Remifentanil|remifentanil|mesh-list
138685218|NCT00522587|Sevoflurane|sevoflurane|mesh-list
138685219|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138685220|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138685221|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
138685222|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
138685223|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685224|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685225|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138685227|NCT00522587|Analgesics|analgesics|mesh-ancestor
138352904|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138685228|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
138685229|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685230|NCT00522665|Irinotecan|irinotecan|mesh-list
138685231|NCT00522665|Cetuximab|cetuximab|mesh-list
138685232|NCT00522665|Everolimus|everolimus|mesh-list
138685233|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138685234|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685235|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685236|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685237|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685238|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138685239|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138685240|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138685241|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685245|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685246|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685247|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138685248|NCT02937012|Bezafibrate|bezafibrate|mesh-list
138685249|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138685250|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685251|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138685252|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
138685253|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685254|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138685255|NCT00522782|Budesonide|budesonide|mesh-list
138685256|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
138685257|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685258|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138685259|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
138685260|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685261|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685262|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138685263|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
138685264|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
138685265|NCT00522782|Hormones|hormones|mesh-ancestor
138685266|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685267|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138362099|NCT01729104|Lenalidomide|lenalidomide|mesh-list
138685268|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
138685269|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685270|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685271|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138685272|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685273|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
138685274|NCT00522782|Protective Agents|protective agents|mesh-ancestor
138685275|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138685276|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
138685277|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138685278|NCT00522821|Antibodies|antibodies|mesh-list
138685279|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
138685280|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138685281|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685282|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
138685283|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685284|NCT02936895|Vitamin D|vitamin d|mesh-list
138685285|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
138216198|NCT01230593|Tobramycin|tobramycin|mesh-list
138685288|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685289|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138685290|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138685291|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138685293|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685294|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138685295|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685296|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685297|NCT04694105|Dexamethasone|dexamethasone|mesh-list
138352909|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685298|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
138685299|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685300|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
138685301|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
138685302|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685303|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685304|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685305|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
138685306|NCT04694105|Hormones|hormones|mesh-ancestor
138685307|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685308|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138685309|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685310|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138685311|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685312|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138685313|NCT04694105|Analgesics|analgesics|mesh-ancestor
138685314|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
138216210|NCT01230593|Hormones|hormones|mesh-ancestor
138685315|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138685316|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138685317|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138685318|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
138685319|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685320|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685322|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
138685323|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
138685324|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685325|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685326|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
138685327|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685328|NCT00523055|Lidocaine|lidocaine|mesh-list
138685329|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
138685330|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
138685334|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685335|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138685336|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138685337|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138685338|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685339|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685341|NCT00523289|Ropivacaine|ropivacaine|mesh-list
138685342|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
138685343|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
138685344|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685345|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685346|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
138685347|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685348|NCT00524381|Etanercept|etanercept|mesh-list
138685349|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138685350|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138685351|NCT00524381|Analgesics|analgesics|mesh-ancestor
138685352|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
138685353|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685354|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685355|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685356|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685357|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685358|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685360|NCT04502667|Vitamin D|vitamin d|mesh-list
138685361|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
138685362|NCT04502667|Vitamins|vitamins|mesh-ancestor
138685363|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
138685364|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685365|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138685366|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138685367|NCT00524498|Cisplatin|cisplatin|mesh-list
138685368|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685369|NCT00523406|Triamcinolone|triamcinolone|mesh-list
138685370|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685371|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
138685372|NCT00523406|Hormones|hormones|mesh-ancestor
138685373|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352917|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685374|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685375|NCT00524615|Spironolactone|spironolactone|mesh-list
138685376|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138685377|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
138685378|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685379|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685380|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138685381|NCT00524615|Diuretics|diuretics|mesh-ancestor
138685382|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
138685383|NCT00523445|Varenicline|varenicline|mesh-list
138685384|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138685385|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138685386|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
138685387|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685388|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685389|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685390|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
138685391|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138685392|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138685393|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685394|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
138685395|NCT02936661|Coagulants|coagulants|mesh-ancestor
138685396|NCT02948075|Paclitaxel|paclitaxel|mesh-list
138685397|NCT02948075|Carboplatin|carboplatin|mesh-list
138685398|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138685399|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685400|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685401|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685402|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685403|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685404|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
138685405|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685406|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138685407|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138685408|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685409|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685410|NCT02930811|Urological Agents|urological agents|mesh-ancestor
138685413|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
138685414|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685416|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685417|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685419|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138685420|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
138685421|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685422|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685423|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138685424|NCT00523757|Diuretics|diuretics|mesh-ancestor
138685425|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
138685426|NCT00524693|Montelukast|montelukast|mesh-list
138685427|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138685428|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
138685430|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
138685431|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685432|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685433|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138685434|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138685435|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685436|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138685437|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138685438|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685439|NCT02936427|Dexamethasone|dexamethasone|mesh-list
138685440|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
138685441|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138685443|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685444|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
138685445|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
138685446|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352919|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138685447|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685448|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685451|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685452|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138685453|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685454|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
138685455|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685456|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685457|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
138685458|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138685459|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685460|NCT02947763|Metronidazole|metronidazole|mesh-list
138685461|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
138685462|NCT02947763|Minocycline|minocycline|mesh-list
138685463|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685464|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685465|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138685466|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138685467|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138685468|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685469|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685470|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685471|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685472|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138685473|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138685474|NCT00523952|Tacrolimus|tacrolimus|mesh-list
138216353|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
138685475|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685476|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
138685477|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685478|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138685479|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685480|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685481|NCT00524069|Bevacizumab|bevacizumab|mesh-list
138685482|NCT00524069|Gemcitabine|gemcitabine|mesh-list
138685483|NCT00524069|Capecitabine|capecitabine|mesh-list
138685484|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138685485|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685486|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138685487|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138685488|NCT00524069|Growth Substances|growth substances|mesh-ancestor
138685489|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685490|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
138685491|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685493|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685494|NCT00524810|Docetaxel|docetaxel|mesh-list
138685495|NCT00524810|Doxorubicin|doxorubicin|mesh-list
138685496|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138685497|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685498|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685499|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685500|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685501|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685502|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138685503|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138685504|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685505|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685507|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138685508|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685509|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
138685510|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138685511|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
138685512|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
138685513|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685514|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685515|NCT00524966|Hemostatics|hemostatics|mesh-list
138685516|NCT00524966|Coagulants|coagulants|mesh-ancestor
138685518|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138352925|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
138685519|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685520|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685521|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685522|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685523|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685524|NCT02935725|Ketamine|ketamine|mesh-list
138685530|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138685531|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
138685532|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
138685533|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685534|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138685535|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138177654|NCT03417921|Paclitaxel|paclitaxel|mesh-list
138685536|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685537|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685540|NCT02935764|Irinotecan|irinotecan|mesh-list
138685541|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
138685542|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685543|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685544|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685545|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685546|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
138685547|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685548|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138685549|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685550|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685551|NCT02935764|Antidotes|antidotes|mesh-ancestor
138685552|NCT02935764|Protective Agents|protective agents|mesh-ancestor
138685553|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
138685554|NCT02935764|Vitamins|vitamins|mesh-ancestor
138685555|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
138685556|NCT02935998|Ziprasidone|ziprasidone|mesh-list
138685557|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138685558|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
138685559|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685560|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685561|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685562|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138685563|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138685564|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685565|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138685566|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138685567|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
138685568|NCT02930109|Cytarabine|cytarabine|mesh-list
138685569|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685570|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
138685571|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685572|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685573|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
138685574|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685577|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685578|NCT00524186|Leucovorin|leucovorin|mesh-list
138685579|NCT00524186|Fluorouracil|fluorouracil|mesh-list
138685580|NCT00524186|Irinotecan|irinotecan|mesh-list
138685581|NCT00524186|Sunitinib|sunitinib|mesh-list
138352929|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138352930|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138352931|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352932|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
138352933|NCT03805386|Narcotics|narcotics|mesh-ancestor
138352934|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352935|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352936|NCT03805386|Analgesics|analgesics|mesh-ancestor
138685582|NCT00524186|Calcium|calcium|mesh-list
138685583|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
138685584|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138685585|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685586|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
138685587|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685588|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685589|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685590|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685591|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
138177691|NCT03367689|Olaparib|olaparib|mesh-list
138685592|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138685593|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685594|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685595|NCT00524186|Antidotes|antidotes|mesh-ancestor
138685596|NCT00524186|Protective Agents|protective agents|mesh-ancestor
138685597|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
138685599|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
138685600|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138685601|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138685602|NCT00524186|Growth Substances|growth substances|mesh-ancestor
138685603|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138685604|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138685606|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
138685607|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685608|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685609|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685610|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685611|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685612|NCT00525200|Docetaxel|docetaxel|mesh-list
138685613|NCT00525200|Cisplatin|cisplatin|mesh-list
138685614|NCT00525200|Fluorouracil|fluorouracil|mesh-list
138685615|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685616|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685617|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685618|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685619|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685621|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685622|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685624|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685625|NCT02930265|Liraglutide|liraglutide|mesh-list
138685626|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138685627|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685628|NCT02930265|Incretins|incretins|mesh-ancestor
138685629|NCT02930265|Hormones|hormones|mesh-ancestor
138685630|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685631|NCT02947178|Bupivacaine|bupivacaine|mesh-list
138685651|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685652|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138216472|NCT00666848|Hormones|hormones|mesh-ancestor
138420926|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420927|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420928|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
138420929|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420930|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420931|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
138420932|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420933|NCT04390763|Paclitaxel|paclitaxel|mesh-list
138420934|NCT04390763|Gemcitabine|gemcitabine|mesh-list
138420935|NCT04390763|Spartalizumab|spartalizumab|mesh-list
138420936|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138420937|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420938|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
138420939|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
138420940|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
138420941|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420942|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420943|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
138420982|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420983|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420984|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138421027|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
138421028|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421029|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
138421030|NCT04205786|Hematinics|hematinics|mesh-ancestor
138421031|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138421032|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421033|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421034|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138421035|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138421036|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421057|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421059|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421060|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421061|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421062|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421079|NCT04090567|Olaparib|olaparib|mesh-list
138421080|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138421081|NCT04090567|Cediranib|cediranib|mesh-list
138421082|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421083|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421084|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421085|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421086|NCT04017546|Venetoclax|venetoclax|mesh-list
138421087|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421088|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
138421089|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138421090|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
138421091|NCT03952585|Cisplatin|cisplatin|mesh-list
138421092|NCT03952585|Nivolumab|nivolumab|mesh-list
138421093|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138421094|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421095|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421096|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421097|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421098|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138421099|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
138421100|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
138421101|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421102|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
138421104|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
138421105|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138421123|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421124|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138421125|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421126|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421127|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421128|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421129|NCT03811015|Deoxyglucose|deoxyglucose|mesh-list
138421130|NCT03811015|Cisplatin|cisplatin|mesh-list
138421131|NCT03811015|Nivolumab|nivolumab|mesh-list
138421136|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421137|NCT03811015|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138421138|NCT03811015|Antimetabolites|antimetabolites|mesh-ancestor
138421139|NCT03811015|Antiviral Agents|antiviral agents|mesh-ancestor
138421140|NCT03811015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421157|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
138421158|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138421159|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138421160|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421161|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
138421162|NCT03780894|Coagulants|coagulants|mesh-ancestor
138421163|NCT03763162|Dexamethasone|dexamethasone|mesh-list
138421164|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
138421165|NCT03763162|Bortezomib|bortezomib|mesh-list
138421166|NCT03763162|Daratumumab|daratumumab|mesh-list
138421167|NCT03763162|Ixazomib|ixazomib|mesh-list
138421168|NCT03763162|Ichthammol|ichthammol|mesh-list
138421169|NCT03763162|BB 1101|bb 1101|mesh-list
138421170|NCT03763162|Glycine|glycine|mesh-list
138421171|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421172|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
138421173|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
138421174|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421175|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421176|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421177|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
138421178|NCT03763162|Hormones|hormones|mesh-ancestor
138421179|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421180|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421181|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421182|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
138421183|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421184|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421185|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138421186|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
138421187|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421188|NCT03761095|Dacarbazine|dacarbazine|mesh-list
138421189|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421190|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
138421191|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421192|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421194|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138421195|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421196|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421197|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421198|NCT03739554|Venetoclax|venetoclax|mesh-list
138421199|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421200|NCT03729271|Rifaximin|rifaximin|mesh-list
138421201|NCT03729271|Lactulose|lactulose|mesh-list
138421202|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421203|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421204|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421205|NCT03719768|Avelumab|avelumab|mesh-list
138421206|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421207|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421208|NCT03689972|Natalizumab|natalizumab|mesh-list
138421209|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
138421210|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421211|NCT03662100|Mirikizumab|mirikizumab|mesh-list
138421212|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138421213|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138421215|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
138421216|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421217|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421218|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421219|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421220|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138421221|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421222|NCT03648905|Dopamine|dopamine|mesh-list
138421223|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138421224|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
138421225|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
138421226|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421227|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421276|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
138421277|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421278|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
138421279|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421281|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421282|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
138352952|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138352953|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
138421283|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421284|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421285|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421286|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
138421287|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421288|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421289|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138421290|NCT03511118|Metformin|metformin|mesh-list
138421291|NCT03511118|Topiramate|topiramate|mesh-list
138421292|NCT03511118|Amoxicillin|amoxicillin|mesh-list
138421293|NCT03511118|Azithromycin|azithromycin|mesh-list
138421294|NCT03511118|Doxycycline|doxycycline|mesh-list
138421295|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
138421296|NCT03511118|Levofloxacin|levofloxacin|mesh-list
138421297|NCT03511118|Clindamycin|clindamycin|mesh-list
138421298|NCT03511118|Valganciclovir|valganciclovir|mesh-list
138421299|NCT03511118|Remdesivir|remdesivir|mesh-list
138421300|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
138421301|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138421302|NCT03511118|Verapamil|verapamil|mesh-list
138421303|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138421304|NCT03511118|Labetalol|labetalol|mesh-list
138421305|NCT03511118|Nifedipine|nifedipine|mesh-list
138421306|NCT03511118|Furosemide|furosemide|mesh-list
138421307|NCT03511118|Sumatriptan|sumatriptan|mesh-list
138421308|NCT03511118|Oxycodone|oxycodone|mesh-list
138421309|NCT03511118|Buprenorphine|buprenorphine|mesh-list
138421310|NCT03511118|Hydrocodone|hydrocodone|mesh-list
138421311|NCT03511118|Gabapentin|gabapentin|mesh-list
138421312|NCT03511118|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138421313|NCT03511118|Levetiracetam|levetiracetam|mesh-list
138421314|NCT03511118|Ondansetron|ondansetron|mesh-list
138421315|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
138421316|NCT03511118|Trazodone|trazodone|mesh-list
138421317|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
138421318|NCT03511118|Methylphenidate|methylphenidate|mesh-list
138421319|NCT03511118|Citalopram|citalopram|mesh-list
138421320|NCT03511118|Bupropion|bupropion|mesh-list
138421321|NCT03511118|Sertraline|sertraline|mesh-list
138421322|NCT03511118|Paroxetine|paroxetine|mesh-list
138421323|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138421324|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
138421325|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138421326|NCT03511118|Escitalopram|escitalopram|mesh-list
138421327|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138421328|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421329|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421330|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421331|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138421332|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138421333|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
138421334|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421335|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138421336|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138421337|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421338|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138421339|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138421340|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
138421342|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138421343|NCT03511118|Narcotics|narcotics|mesh-ancestor
138421344|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421345|NCT03511118|Analgesics|analgesics|mesh-ancestor
138421346|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
138421347|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421348|NCT03511118|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138421349|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
138421350|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138421351|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138421352|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138421353|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138421354|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138421355|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421356|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
138421357|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138421358|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138421359|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138421360|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
138421361|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
138421362|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138421363|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
138421364|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
138421365|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421366|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
138421367|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138421368|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138421369|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138421370|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138421371|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138421372|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
138421373|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138421375|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
138421376|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138421377|NCT03511118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138421378|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138421379|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
138421382|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138421383|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138421384|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138421385|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421386|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138421387|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138421388|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138421389|NCT03511118|Nootropic Agents|nootropic agents|mesh-ancestor
138421390|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138421391|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
138421392|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138421393|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138421394|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138421395|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
138421396|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
138421397|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138421398|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421399|NCT03511118|Antitussive Agents|antitussive agents|mesh-ancestor
138421400|NCT03511118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138421401|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138421402|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138421403|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138421404|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138421405|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
138421406|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138421407|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138421408|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138421409|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
138421418|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421420|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421421|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421422|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138421423|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
138421424|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421425|NCT03442556|Carboplatin|carboplatin|mesh-list
138421426|NCT03442556|Docetaxel|docetaxel|mesh-list
138421427|NCT03442556|Rucaparib|rucaparib|mesh-list
138421428|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421429|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421461|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421462|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
138421463|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421464|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421510|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
138421511|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421512|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138421513|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138421515|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
138421516|NCT03102125|Regadenoson|regadenoson|mesh-list
138421517|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138421518|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138421519|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
138421520|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
138421521|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215502|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138421522|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421523|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421524|NCT03075527|Durvalumab|durvalumab|mesh-list
138421525|NCT03075527|Tremelimumab|tremelimumab|mesh-list
138421526|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421527|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421528|NCT03068624|Aldesleukin|aldesleukin|mesh-list
138421529|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
138421530|NCT03068624|Ipilimumab|ipilimumab|mesh-list
138421531|NCT03068624|Interleukin-2|interleukin-2|mesh-list
138421532|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421533|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
138421534|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421536|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421537|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
138421538|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421539|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421540|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138421541|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421542|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421543|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138421544|NCT03068624|Analgesics|analgesics|mesh-ancestor
138421545|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
138421548|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138421549|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
138421550|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421552|NCT02997228|Bevacizumab|bevacizumab|mesh-list
138421553|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138421554|NCT02997228|Atezolizumab|atezolizumab|mesh-list
138421555|NCT02997228|Fluorouracil|fluorouracil|mesh-list
138421556|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
138421557|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
138421558|NCT02997228|Antibodies|antibodies|mesh-list
138421559|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
138421560|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138421561|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
138421562|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421563|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138421564|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138421565|NCT02997228|Growth Substances|growth substances|mesh-ancestor
138421566|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421567|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138421568|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
138421569|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
138421570|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421571|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138421572|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421573|NCT02997228|Antidotes|antidotes|mesh-ancestor
138421574|NCT02997228|Protective Agents|protective agents|mesh-ancestor
138421575|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
138421577|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
138421578|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421580|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
138421581|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421582|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
138421583|NCT02960022|Hormones|hormones|mesh-ancestor
138421584|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421585|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421586|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421587|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421588|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138421589|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421591|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
138421592|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138421593|NCT02931253|Metformin|metformin|mesh-list
138421594|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138421595|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421596|NCT02830724|Aldesleukin|aldesleukin|mesh-list
138421597|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
138421598|NCT02830724|Fludarabine|fludarabine|mesh-list
138421599|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421600|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
138421601|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421602|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421603|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421604|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
138421605|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421606|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421607|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138421608|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138421609|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138421610|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
138421611|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421612|NCT02812524|Ipilimumab|ipilimumab|mesh-list
138421613|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421614|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421615|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421616|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421617|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138421618|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138421619|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138421620|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
138421621|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421622|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421623|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138421624|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421625|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421626|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421628|NCT02734004|Durvalumab|durvalumab|mesh-list
138421629|NCT02734004|Olaparib|olaparib|mesh-list
138421630|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421631|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421632|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138421633|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138421634|NCT02734004|Growth Substances|growth substances|mesh-ancestor
138421635|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421636|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
138421637|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138421638|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421639|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421640|NCT02697448|Propofol|propofol|mesh-list
138421641|NCT02697448|Sevoflurane|sevoflurane|mesh-list
138421642|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138421643|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421644|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421645|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138421646|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
138421647|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
138421648|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138421649|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138421650|NCT02688712|Capecitabine|capecitabine|mesh-list
138421651|NCT02688712|Fluorouracil|fluorouracil|mesh-list
138421652|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138421653|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
138421654|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421655|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421656|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421657|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
138421658|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421659|NCT02677922|Azacitidine|azacitidine|mesh-list
138421660|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138421661|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
138421662|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421663|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421664|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421665|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
138421666|NCT02641847|Gemcitabine|gemcitabine|mesh-list
138421667|NCT02641847|Docetaxel|docetaxel|mesh-list
138421668|NCT02641847|Doxorubicin|doxorubicin|mesh-list
138421669|NCT02641847|Epirubicin|epirubicin|mesh-list
138421670|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421671|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
138421672|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421674|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421675|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
138421676|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421677|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421678|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138421679|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138421680|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
138421681|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421682|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421683|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421684|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138421685|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138421686|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138421687|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421699|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421702|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
138421703|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138421704|NCT02567799|Estrogens|estrogens|mesh-ancestor
138421705|NCT02567799|Hormones|hormones|mesh-ancestor
138421706|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421713|NCT02339571|Nivolumab|nivolumab|mesh-list
138421714|NCT02339571|Ipilimumab|ipilimumab|mesh-list
138421715|NCT02339571|Sargramostim|sargramostim|mesh-list
138421716|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421717|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421718|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421719|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421720|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
138421721|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421722|NCT02306954|Aldesleukin|aldesleukin|mesh-list
138421723|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421724|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138421725|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138421726|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
138421727|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421728|NCT02299141|Nintedanib|nintedanib|mesh-list
138421729|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421730|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421731|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421732|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421776|NCT02078427|Coagulants|coagulants|mesh-ancestor
138421777|NCT02073968|Paclitaxel|paclitaxel|mesh-list
138421778|NCT02073968|Carboplatin|carboplatin|mesh-list
138421779|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138421780|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138421781|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352991|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138352992|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
138421782|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421783|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421784|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421785|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421786|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138421787|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138421788|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138421789|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
138421790|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421791|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318536|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138318538|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138318539|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318540|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318541|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138318542|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318543|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318544|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138318545|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318546|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
138318548|NCT01386606|Clomiphene|clomiphene|mesh-list
138318549|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
138318550|NCT01386606|Testosterone|testosterone|mesh-list
138704141|NCT06136598|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138704142|NCT06136598|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138704143|NCT06136598|Fludrocortisone|fludrocortisone|mesh-list
138704144|NCT06136598|BB 1101|bb 1101|mesh-list
138704145|NCT06136598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138704146|NCT06136598|Antiemetics|antiemetics|mesh-ancestor
138704147|NCT06136598|Autonomic Agents|autonomic agents|mesh-ancestor
138704148|NCT06136598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704149|NCT06136598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704184|NCT06107413|Folic Acid|folic acid|mesh-list
138704185|NCT06107413|Bevacizumab|bevacizumab|mesh-list
138704186|NCT06107413|Fluorouracil|fluorouracil|mesh-list
138704187|NCT06107413|Irinotecan|irinotecan|mesh-list
138704199|NCT06107413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704200|NCT06107413|Immunologic Factors|immunologic factors|mesh-ancestor
138704201|NCT06107413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138704202|NCT06107413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138704203|NCT06107413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704205|NCT06107413|Protective Agents|protective agents|mesh-ancestor
138704206|NCT06107413|Vitamin B Complex|vitamin b complex|mesh-ancestor
138704207|NCT06107413|Vitamins|vitamins|mesh-ancestor
138704208|NCT06107413|Micronutrients|micronutrients|mesh-ancestor
138704209|NCT06107413|Hematinics|hematinics|mesh-ancestor
138704248|NCT06055608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704249|NCT06055608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138704250|NCT06055608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704251|NCT06055608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138704252|NCT06055608|Antitubercular Agents|antitubercular agents|mesh-ancestor
138704253|NCT06055608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138704254|NCT06055608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704255|NCT06055608|Antifungal Agents|antifungal agents|mesh-ancestor
138704256|NCT06055608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138318559|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318560|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
138318561|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138318562|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
138318563|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138318564|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
138318565|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318566|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138318567|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138318569|NCT01385748|Analgesics|analgesics|mesh-ancestor
138318570|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
138318571|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318572|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318573|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138318574|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
138318575|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
138318576|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138318577|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138318578|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138318579|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
138318580|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704257|NCT06055608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704258|NCT06055608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704260|NCT06048718|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138704261|NCT06048718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704273|NCT06045806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704274|NCT06045806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138704275|NCT06045806|Alkylating Agents|alkylating agents|mesh-ancestor
138704276|NCT06045806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704277|NCT06045806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704278|NCT06045806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138704279|NCT06045806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138704280|NCT06045806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138704281|NCT06045806|Growth Substances|growth substances|mesh-ancestor
138704282|NCT06045806|Growth Inhibitors|growth inhibitors|mesh-ancestor
138704283|NCT06045806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704285|NCT06044311|Vactosertib|vactosertib|mesh-list
138704291|NCT06042478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138704292|NCT06042478|Remibrutinib|remibrutinib|mesh-list
138704293|NCT06042478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138704294|NCT06042478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138704295|NCT06042478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138704296|NCT06042478|Immunologic Factors|immunologic factors|mesh-ancestor
138704297|NCT06042478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704298|NCT06042478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704299|NCT06042478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704300|NCT06042478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704306|NCT06039826|Drospirenone|drospirenone|mesh-list
138704307|NCT06039826|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138704315|NCT06039826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138704316|NCT06039826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138704317|NCT06039826|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138704318|NCT06039826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138704319|NCT06039826|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138704321|NCT06039826|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138704322|NCT06039826|Diuretics|diuretics|mesh-ancestor
138704323|NCT06039826|Natriuretic Agents|natriuretic agents|mesh-ancestor
138704324|NCT06036836|Pembrolizumab|pembrolizumab|mesh-list
138704326|NCT06036836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704327|NCT06036836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704328|NCT06036836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704329|NCT06036836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704330|NCT06036836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704331|NCT06036836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704351|NCT06029270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704352|NCT06029270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704353|NCT06029270|Antimetabolites|antimetabolites|mesh-ancestor
138704354|NCT06029270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704355|NCT06029270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704356|NCT06029270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704357|NCT06029270|Immunologic Factors|immunologic factors|mesh-ancestor
138704358|NCT06029270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704359|NCT06004037|Delpazolid|delpazolid|mesh-list
138704360|NCT06004037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138704361|NCT06004037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704362|NCT06004037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138704363|NCT06004037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704364|NCT06004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704365|NCT06001788|Cytarabine|cytarabine|mesh-list
138704366|NCT06001788|Fludarabine|fludarabine|mesh-list
138704367|NCT06001788|Idarubicin|idarubicin|mesh-list
138704368|NCT06001788|Lenograstim|lenograstim|mesh-list
138704369|NCT06001788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704370|NCT06001788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704371|NCT06001788|Antimetabolites|antimetabolites|mesh-ancestor
138704372|NCT06001788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704380|NCT06001788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138704381|NCT06001788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138704382|NCT06001788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704383|NCT05991817|Anesthetics|anesthetics|mesh-list
138704384|NCT05991817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704385|NCT05991817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704392|NCT05955170|Trastuzumab|trastuzumab|mesh-list
138704393|NCT05955170|Tucatinib|tucatinib|mesh-list
138704394|NCT05955170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704395|NCT05955170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704396|NCT05955170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704397|NCT05955170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704398|NCT05955170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704399|NCT05947071|Vaccines|vaccines|mesh-list
138704400|NCT05947071|Immunologic Factors|immunologic factors|mesh-ancestor
138704405|NCT05919472|Vaccines|vaccines|mesh-list
138704406|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
138704407|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704408|NCT05919472|Trace Elements|trace elements|mesh-ancestor
138704409|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
138704413|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704414|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704415|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704416|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
138704417|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704418|NCT05909904|Tislelizumab|tislelizumab|mesh-list
138704419|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704420|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704423|NCT05900245|Propofol|propofol|mesh-list
138704424|NCT05900245|Anesthetics|anesthetics|mesh-list
138704425|NCT05900245|Succinylcholine|succinylcholine|mesh-list
138704426|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138704427|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704428|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704429|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138704430|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
138704431|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138704455|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
138704461|NCT05891171|Pemetrexed|pemetrexed|mesh-list
138704462|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704463|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
138289145|NCT00000776|Dexamethasone|dexamethasone|mesh-list
138704464|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704465|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704466|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704467|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
138704468|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704469|NCT05891171|Antidotes|antidotes|mesh-ancestor
138704470|NCT05891171|Protective Agents|protective agents|mesh-ancestor
138704471|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
138704473|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
138704474|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704475|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138704476|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138704477|NCT05889182|Upadacitinib|upadacitinib|mesh-list
138704478|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138704479|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704480|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704481|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704532|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704533|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704534|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138704535|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704536|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138704537|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704538|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
138704539|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704540|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
138704541|NCT05836584|Antidotes|antidotes|mesh-ancestor
138704542|NCT05836584|Protective Agents|protective agents|mesh-ancestor
138704545|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
138704546|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704611|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704612|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704613|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138704614|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138704615|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138704616|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
138704617|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704618|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704620|NCT05763004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704621|NCT05763004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704622|NCT05763004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704623|NCT05763004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704624|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
138704625|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704626|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704627|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704628|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704656|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704657|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
138704658|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138704659|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
138704660|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704661|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704662|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138704663|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138704664|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138704665|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
138704666|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704667|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704668|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138704669|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
138704670|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
138704671|NCT05721144|Protective Agents|protective agents|mesh-ancestor
138704711|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704733|NCT05634057|Anisodamine|anisodamine|mesh-list
138704734|NCT05634057|Heparin|heparin|mesh-list
138704735|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
138704736|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138704737|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138704738|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704739|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138704740|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138704741|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
138704742|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704743|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704744|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138704745|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138704746|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138704747|NCT05634057|Analgesics|analgesics|mesh-ancestor
138704748|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
138704767|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
138704768|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704883|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138704884|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138704885|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704886|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704887|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138704888|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
138704889|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704890|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704891|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138704892|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138704893|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138704894|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138704895|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138704896|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138704897|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704899|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138704900|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704901|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289146|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138704902|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704903|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704905|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704906|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704907|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704911|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704912|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704913|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704914|NCT05470491|Maraviroc|maraviroc|mesh-list
138704915|NCT05470491|Plerixafor|plerixafor|mesh-list
138704916|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138704917|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138704920|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138704921|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
138704922|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704923|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138704927|NCT05446870|Paclitaxel|paclitaxel|mesh-list
138704928|NCT05446870|Docetaxel|docetaxel|mesh-list
138704929|NCT05446870|Bevacizumab|bevacizumab|mesh-list
138704930|NCT05446870|Carboplatin|carboplatin|mesh-list
138704931|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
138704932|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138704933|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704934|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
138704935|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
138704936|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704937|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704938|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704939|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138704940|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138704941|NCT05446870|Growth Substances|growth substances|mesh-ancestor
138704944|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704945|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
138704946|NCT05442515|Fludarabine|fludarabine|mesh-list
138704947|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704948|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
138704949|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704950|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704951|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138704952|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
138704953|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704954|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704955|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138704957|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138704958|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
138704959|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138704960|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704961|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138704962|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138704963|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704964|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704965|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704989|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704990|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704991|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138704992|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704993|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138704994|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138704995|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138704996|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704998|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
138704999|NCT05406401|Hormones|hormones|mesh-ancestor
138705000|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705001|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138705002|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138705003|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
138705004|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705005|NCT05384262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138705006|NCT05384262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138705007|NCT05384262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138705008|NCT05384262|Antimetabolites|antimetabolites|mesh-ancestor
138705009|NCT05384262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705010|NCT05384262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138705011|NCT05384262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138705012|NCT05384262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705013|NCT05382286|Paclitaxel|paclitaxel|mesh-list
138705014|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138705015|NCT05382286|Carboplatin|carboplatin|mesh-list
138705016|NCT05382286|Gemcitabine|gemcitabine|mesh-list
138705017|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
138705018|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138705019|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705020|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705021|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705022|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705023|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705024|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705025|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705026|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
138705027|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705028|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705030|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
138705038|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
138705040|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705041|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705042|NCT05364944|Octreotide|octreotide|mesh-list
138705043|NCT05364944|Lanreotide|lanreotide|mesh-list
138705044|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138705045|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138705046|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705047|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
138705048|NCT05352672|Cemiplimab|cemiplimab|mesh-list
138705049|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705050|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705051|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705052|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705054|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
138705055|NCT05342636|Irinotecan|irinotecan|mesh-list
138705056|NCT05342636|Lenvatinib|lenvatinib|mesh-list
138705057|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
138705058|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705059|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705060|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705061|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705062|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705063|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705064|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705065|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705066|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705067|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705068|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705069|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
138705070|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705071|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705072|NCT05327010|Talazoparib|talazoparib|mesh-list
138705073|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138705074|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705075|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705077|NCT05319730|Acetaminophen|acetaminophen|mesh-list
138705078|NCT05319730|Dexamethasone|dexamethasone|mesh-list
138705079|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
138705080|NCT05319730|Irinotecan|irinotecan|mesh-list
138705081|NCT05319730|Lenvatinib|lenvatinib|mesh-list
138705082|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
138705083|NCT05319730|Histamine Antagonists|histamine antagonists|mesh-list
138705084|NCT05319730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138705085|NCT05319730|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
138705086|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705087|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318594|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138318595|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318596|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318597|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318598|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138318599|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138318600|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
138318601|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318602|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138318603|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138318604|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138318605|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318607|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138318608|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138318609|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138705092|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705093|NCT05319730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138705094|NCT05319730|Glucocorticoids|glucocorticoids|mesh-ancestor
138705096|NCT05319730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705097|NCT05319730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318612|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318613|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138318614|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
138318615|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318616|NCT01383954|Diclofenac|diclofenac|mesh-list
138318617|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138705108|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705109|NCT05319730|Histamine Agents|histamine agents|mesh-ancestor
138705110|NCT05319730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705111|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138705112|NCT05308446|Nivolumab|nivolumab|mesh-list
138705113|NCT05308446|Cetuximab|cetuximab|mesh-list
138705114|NCT05308446|Antibodies|antibodies|mesh-list
138705116|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705117|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
138705118|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705119|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705120|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705121|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705143|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138705144|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705145|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
138705146|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705148|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138705149|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
138705150|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705151|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705152|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
138705153|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138705154|NCT05206500|Amoxicillin|amoxicillin|mesh-list
138705159|NCT05206500|Penicillins|penicillins|mesh-list
138705160|NCT05206500|Ampicillin|ampicillin|mesh-list
138705161|NCT05206500|Fosfomycin|fosfomycin|mesh-list
138705162|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
138705163|NCT05206500|Cephalosporins|cephalosporins|mesh-list
138705164|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
138705165|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705166|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138705167|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138705168|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138705169|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705170|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705171|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138705172|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138705173|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138705174|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
138705175|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705177|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138705178|NCT05139017|Rituximab|rituximab|mesh-list
138705179|NCT05139017|Gemcitabine|gemcitabine|mesh-list
138705180|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
138705181|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138705188|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
138705189|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705190|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705191|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
138705197|NCT05069974|Linezolid|linezolid|mesh-list
138705198|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705199|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705200|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138705201|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705202|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705204|NCT05065411|Fulvestrant|fulvestrant|mesh-list
138705205|NCT05065411|Exemestane|exemestane|mesh-list
138705206|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138705207|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705208|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705209|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705211|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
138705212|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705213|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705214|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138705218|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705220|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138705226|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705227|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705228|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705230|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705231|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
138705232|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705233|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705234|NCT04989816|Trastuzumab|trastuzumab|mesh-list
138705235|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138705236|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705237|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705240|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705241|NCT04989699|Aflibercept|aflibercept|mesh-list
138705242|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138705243|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138705244|NCT04989699|Growth Substances|growth substances|mesh-ancestor
138705245|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705246|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
138705247|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705248|NCT04965493|Rituximab|rituximab|mesh-list
138705249|NCT04965493|Venetoclax|venetoclax|mesh-list
138705250|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
138705251|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705252|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705253|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
138705254|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705255|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705256|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705257|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705258|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705259|NCT04948749|Sirolimus|sirolimus|mesh-list
138705260|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705261|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705262|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705263|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705264|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
138705265|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705266|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
138705267|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705310|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
138705311|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705313|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138705314|NCT04895358|Doxorubicin|doxorubicin|mesh-list
138705315|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138705316|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
138705317|NCT04895358|Capecitabine|capecitabine|mesh-list
138705319|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705320|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705321|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705322|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705323|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705325|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138705326|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705327|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705328|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353010|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138318620|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
138318621|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318622|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318623|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318624|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318625|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138318626|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318627|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318628|NCT05365464|Progesterone|progesterone|mesh-list
138318629|NCT05365464|Progestins|progestins|mesh-ancestor
138318630|NCT05365464|Hormones|hormones|mesh-ancestor
138318631|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318632|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318633|NCT01383486|Naproxen|naproxen|mesh-list
138318634|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138705329|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705330|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138318635|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138705331|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
138705332|NCT04892017|Trametinib|trametinib|mesh-list
138318639|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318640|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318641|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318642|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
138289147|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
138705337|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705338|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705355|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705356|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138705357|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
138705358|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705359|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705360|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
138705361|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705362|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705363|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705364|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705365|NCT04840823|Enoxacin|enoxacin|mesh-list
138705366|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705367|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705368|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138705369|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705370|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705371|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705372|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705373|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138705374|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138705375|NCT04840602|Rituximab|rituximab|mesh-list
138705376|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138705377|NCT04840602|Venetoclax|venetoclax|mesh-list
138705378|NCT04840602|Antibodies|antibodies|mesh-list
138705379|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
138705380|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705381|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
138705382|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705383|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705384|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705385|NCT04838743|Xultophy|xultophy|mesh-list
138705386|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138705387|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705388|NCT04838743|Incretins|incretins|mesh-ancestor
138353019|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705389|NCT04838743|Hormones|hormones|mesh-ancestor
138705390|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705392|NCT04827979|Abatacept|abatacept|mesh-list
138705393|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
138705394|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
138705395|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
138705396|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705397|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705398|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705399|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705400|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705401|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705402|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705403|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
138705405|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138705406|NCT04821375|Hormones|hormones|mesh-ancestor
138705407|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705408|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705409|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138705411|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
138705412|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138705413|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
138705414|NCT04821141|Estrogens|estrogens|mesh-list
138705415|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138705416|NCT04821141|Hormones|hormones|mesh-ancestor
138705417|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705418|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705419|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138705420|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138705422|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138705423|NCT04801368|Anesthetics|anesthetics|mesh-list
138705424|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
138705425|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138705426|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705427|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
138705428|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705429|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
138705430|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705431|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705432|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705433|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705435|NCT04700124|Gemcitabine|gemcitabine|mesh-list
138705436|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
138705437|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705438|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705439|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
138705440|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705441|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705442|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705443|NCT04697628|Gemcitabine|gemcitabine|mesh-list
138705444|NCT04697628|Irinotecan|irinotecan|mesh-list
138705445|NCT04697628|Pemetrexed|pemetrexed|mesh-list
138705446|NCT04697628|Topotecan|topotecan|mesh-list
138705447|NCT04697628|Vinorelbine|vinorelbine|mesh-list
138705448|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
138705449|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705450|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
138705451|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705452|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705453|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705457|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138705458|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138353030|NCT02966184|Albuterol|albuterol|mesh-list
138705459|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705460|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705461|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705462|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705463|NCT04681677|Bevacizumab|bevacizumab|mesh-list
138705464|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705465|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705466|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138705467|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138705468|NCT04681677|Growth Substances|growth substances|mesh-ancestor
138705469|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705471|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
138705472|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138705473|NCT04674813|Fludarabine|fludarabine|mesh-list
138705474|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705475|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
138705476|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705477|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705478|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705479|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
138705480|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705481|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705482|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138705484|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
138705485|NCT04662515|Dabigatran|dabigatran|mesh-list
138705486|NCT04662515|Apixaban|apixaban|mesh-list
138705487|NCT04662515|Edoxaban|edoxaban|mesh-list
138705488|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
138705489|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138705490|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
138705491|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138705492|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
138705493|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705494|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705495|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
138705496|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705497|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
138705506|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705507|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705508|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
138705509|NCT04626479|Lenvatinib|lenvatinib|mesh-list
138705510|NCT04626479|Belzutifan|belzutifan|mesh-list
138705511|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705512|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705513|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705514|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705515|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705516|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705517|NCT04624243|Risperidone|risperidone|mesh-list
138705518|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138705519|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
138289148|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
138705520|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705521|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705522|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705524|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138705525|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138705526|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138705527|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138705528|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
138705535|NCT04576117|Vinblastine|vinblastine|mesh-list
138705536|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705537|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705538|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705539|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705540|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705558|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
138705559|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705560|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705561|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705562|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705563|NCT04421963|Olaparib|olaparib|mesh-list
138705568|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
138705569|NCT04420884|Fluorouracil|fluorouracil|mesh-list
138705570|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705571|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705572|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705573|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705574|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
138705575|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705576|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705577|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
138705622|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705623|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705624|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705625|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
138705626|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
138705627|NCT04282018|Tislelizumab|tislelizumab|mesh-list
138705628|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
138705629|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705630|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705631|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705632|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705633|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705638|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
138705639|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
138705640|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705641|NCT04241185|Gemcitabine|gemcitabine|mesh-list
138705642|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
138705643|NCT04241185|Fluorouracil|fluorouracil|mesh-list
138705645|NCT04241185|Mitomycin|mitomycin|mesh-list
138705646|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705647|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705648|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
138705649|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705650|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705651|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705652|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705653|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
138705654|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705655|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705656|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
138705657|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138705658|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705659|NCT04239625|Vitamin A|vitamin a|mesh-list
138705660|NCT04239625|Retinol acetate|retinol acetate|mesh-list
138705661|NCT04239625|Vitamins|vitamins|mesh-ancestor
138705662|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
138705663|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705664|NCT04239625|Protective Agents|protective agents|mesh-ancestor
138705665|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138705666|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705667|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138705668|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
138705670|NCT04238819|Temozolomide|temozolomide|mesh-list
138705671|NCT04238819|Dinutuximab|dinutuximab|mesh-list
138705672|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705673|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705674|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705675|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705676|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705677|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705678|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
138705679|NCT04234360|Prednisone|prednisone|mesh-list
138705680|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138705681|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
138705682|NCT04234360|Hormones|hormones|mesh-ancestor
138705712|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705713|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138705714|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
138705715|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138705716|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
138705717|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705718|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705719|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138705721|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
138705722|NCT04210115|Leucovorin|leucovorin|mesh-list
138705723|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
138705724|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
138705725|NCT04210115|Calcium|calcium|mesh-list
138705726|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
138705727|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705729|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705730|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705731|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138705732|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705733|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138705735|NCT04210115|Protective Agents|protective agents|mesh-ancestor
138705736|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
138705737|NCT04210115|Vitamins|vitamins|mesh-ancestor
138705738|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
138705739|NCT04206787|Afatinib|afatinib|mesh-list
138705740|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705741|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705742|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705754|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138705776|NCT04075292|Rituximab|rituximab|mesh-list
138705777|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
138705778|NCT04075292|Chlorambucil|chlorambucil|mesh-list
138705779|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705780|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705781|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
138705782|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705783|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705784|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705785|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
138705786|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705787|NCT04068194|Avelumab|avelumab|mesh-list
138705788|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705789|NCT04068194|Peposertib|peposertib|mesh-list
138705790|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705791|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705792|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
138705793|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705794|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705795|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705796|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705797|NCT04047862|Paclitaxel|paclitaxel|mesh-list
138705798|NCT04047862|Etoposide|etoposide|mesh-list
138705799|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138705800|NCT04047862|Carboplatin|carboplatin|mesh-list
138705801|NCT04047862|Capecitabine|capecitabine|mesh-list
138705802|NCT04047862|Fluorouracil|fluorouracil|mesh-list
138705803|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
138705804|NCT04047862|Pemetrexed|pemetrexed|mesh-list
138705805|NCT04047862|Tislelizumab|tislelizumab|mesh-list
138705806|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705807|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705808|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705809|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705810|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705811|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705812|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705813|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
138705814|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705815|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
138705816|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705817|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138705818|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705819|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705820|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138705821|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138705822|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705827|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705828|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705830|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705831|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705832|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705834|NCT03944941|Cetuximab|cetuximab|mesh-list
138705835|NCT03944941|Avelumab|avelumab|mesh-list
138705836|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353043|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705838|NCT03936777|Fenfluramine|fenfluramine|mesh-list
138318644|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705839|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138705840|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138705841|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138705842|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318645|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318646|NCT04766736|Antibodies|antibodies|mesh-list
138318647|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
138318648|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318649|NCT01396278|Fluticasone|fluticasone|mesh-list
138318650|NCT01396278|Xhance|xhance|mesh-list
138318651|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318652|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318653|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
138705843|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705844|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
138705845|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705846|NCT03929666|Leucovorin|leucovorin|mesh-list
138705847|NCT03929666|Bevacizumab|bevacizumab|mesh-list
138705848|NCT03929666|Gemcitabine|gemcitabine|mesh-list
138705849|NCT03929666|Capecitabine|capecitabine|mesh-list
138705850|NCT03929666|Fluorouracil|fluorouracil|mesh-list
138705851|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
138705852|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705853|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705854|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138705855|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138705856|NCT03929666|Growth Substances|growth substances|mesh-ancestor
138705857|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705858|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
138705859|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705861|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705862|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705863|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
138705865|NCT03929666|Protective Agents|protective agents|mesh-ancestor
138705866|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
138705869|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
138705870|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705871|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705872|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705873|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705874|NCT03843008|Melatonin|melatonin|mesh-list
138705875|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
138705876|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705877|NCT03843008|Protective Agents|protective agents|mesh-ancestor
138705878|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705879|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138705880|NCT03836040|Erenumab|erenumab|mesh-list
138705881|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705882|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138705883|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705884|NCT03836040|Analgesics|analgesics|mesh-ancestor
138705885|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
138705886|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705892|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705894|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
138705895|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705896|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705897|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
138705898|NCT03811886|Natalizumab|natalizumab|mesh-list
138705899|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
138705900|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705901|NCT03805477|Nintedanib|nintedanib|mesh-list
138705902|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705903|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705904|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705905|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705917|NCT03793166|Ipilimumab|ipilimumab|mesh-list
138705918|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705919|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705920|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705921|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705922|NCT03744468|Tislelizumab|tislelizumab|mesh-list
138705923|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705924|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705925|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138705926|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138705927|NCT03739814|Blinatumomab|blinatumomab|mesh-list
138705928|NCT03739814|Antibodies|antibodies|mesh-list
138705929|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
138705930|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705933|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
138705934|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705935|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705936|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705937|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705938|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
138705939|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
138705940|NCT03725007|Upadacitinib|upadacitinib|mesh-list
138705941|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138705942|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705943|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705944|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705945|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705946|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
138705947|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705948|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705949|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705950|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705952|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705953|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705954|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705955|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705957|NCT03613532|Azacitidine|azacitidine|mesh-list
138705958|NCT03613532|Busulfan|busulfan|mesh-list
138705959|NCT03613532|Decitabine|decitabine|mesh-list
138705960|NCT03613532|Venetoclax|venetoclax|mesh-list
138705961|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705962|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138705963|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
138705966|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
138705967|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705968|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705969|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
138705970|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705971|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138705973|NCT03605927|Tacrolimus|tacrolimus|mesh-list
138705974|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705975|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
138705977|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138318659|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138705978|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705979|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705980|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705981|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705982|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705983|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705984|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
138705985|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
138705986|NCT03504241|Sirolimus|sirolimus|mesh-list
138705987|NCT03504241|Prednisone|prednisone|mesh-list
138705988|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
138705989|NCT03504241|Abatacept|abatacept|mesh-list
138705990|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138705991|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
138353044|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705993|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705994|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705995|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138705996|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705997|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705998|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138706000|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138706001|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706003|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706004|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
138706005|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706006|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
138706007|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706008|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138706009|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706010|NCT03454035|Palbociclib|palbociclib|mesh-list
138706011|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706012|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138706013|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706014|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706015|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
138706016|NCT03448393|Fludarabine|fludarabine|mesh-list
138706017|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706018|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
138706019|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706020|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706021|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706022|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
138706023|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706024|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706025|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706026|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
138706027|NCT03399773|Thiotepa|thiotepa|mesh-list
138706028|NCT03399773|Fludarabine|fludarabine|mesh-list
138706029|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706030|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
138706031|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706032|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706033|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706034|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
138706035|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706036|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706037|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706038|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
138706039|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138706040|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138706041|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706042|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
138706043|NCT03326596|Coagulants|coagulants|mesh-ancestor
138706044|NCT03224767|Vemurafenib|vemurafenib|mesh-list
138706045|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706046|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138706047|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706050|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
138706051|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
138706052|NCT03204786|Coagulants|coagulants|mesh-ancestor
138706053|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138706054|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138706055|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
138706056|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706058|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706059|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706060|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138706061|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706062|NCT03142893|Ketoconazole|ketoconazole|mesh-list
138706063|NCT03142893|Dexamethasone|dexamethasone|mesh-list
138706064|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
138706065|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
138706066|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138706067|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138706068|NCT03142893|Hormones|hormones|mesh-list
138706069|NCT03142893|Cosyntropin|cosyntropin|mesh-list
138706070|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138706071|NCT03142893|BB 1101|bb 1101|mesh-list
138706072|NCT03142893|Ganirelix|ganirelix|mesh-list
138706073|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138706074|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
138706075|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
138706076|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706077|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706078|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138706079|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
138706080|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706081|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706082|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706083|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
138706084|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289149|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706085|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706086|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
138706087|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706088|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138706089|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138706090|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138706091|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
138706092|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138706093|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138706094|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
138706095|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
138706096|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138706097|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706098|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706099|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
138706100|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138706101|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706102|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706103|NCT02927301|Atezolizumab|atezolizumab|mesh-list
138706104|NCT02927301|Antibodies|antibodies|mesh-list
138706105|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138706107|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706108|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138706109|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706110|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706111|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706112|NCT02892123|Paclitaxel|paclitaxel|mesh-list
138706113|NCT02892123|Vinorelbine|vinorelbine|mesh-list
138706114|NCT02892123|Capecitabine|capecitabine|mesh-list
138706115|NCT02892123|Tucatinib|tucatinib|mesh-list
138706116|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138706117|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706118|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706119|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
138706120|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
138706121|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706122|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706123|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
138706124|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138706125|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706126|NCT02659930|Doxorubicin|doxorubicin|mesh-list
138318661|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
138706127|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138706128|NCT02659930|Pomalidomide|pomalidomide|mesh-list
138706129|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138706130|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706131|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138706132|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138706133|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706134|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706135|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
138706136|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706137|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138706138|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138706139|NCT02659930|Growth Substances|growth substances|mesh-ancestor
138706140|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
138706141|NCT02611037|Gemcitabine|gemcitabine|mesh-list
138706142|NCT02611037|Methotrexate|methotrexate|mesh-list
138706143|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706144|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706145|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
138706146|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706147|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138706149|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138706150|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706151|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
138706152|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706153|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138706154|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706155|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
138706156|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706157|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706159|NCT02607202|Carboplatin|carboplatin|mesh-list
138706160|NCT02607202|Gemcitabine|gemcitabine|mesh-list
138706161|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138706162|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706163|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706164|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138706165|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138706166|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706167|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706168|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
138706169|NCT02446236|Rituximab|rituximab|mesh-list
138706170|NCT02446236|Lenalidomide|lenalidomide|mesh-list
138706171|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706172|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706173|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
138706174|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706190|NCT02208375|Olaparib|olaparib|mesh-list
138706191|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138706192|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706193|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706194|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706229|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706230|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706231|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706232|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706233|NCT02040376|Metformin|metformin|mesh-list
138706234|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706235|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706236|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138706237|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138706238|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706239|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706240|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706241|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138706248|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
138706250|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706253|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706254|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706255|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
138706256|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706258|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706259|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706260|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
138706261|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
138706262|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706263|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706264|NCT01652092|Protective Agents|protective agents|mesh-ancestor
138706311|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138706312|NCT01081951|Carboplatin|carboplatin|mesh-list
138706314|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138706315|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706316|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706317|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353057|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706318|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
138706319|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706320|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138706321|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706322|NCT00777582|Olaparib|olaparib|mesh-list
138706323|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138706324|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706325|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706326|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706327|NCT00736385|Metformin|metformin|mesh-list
138706328|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706329|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706330|NCT00392327|Vitamin A|vitamin a|mesh-list
138706331|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
138706332|NCT00392327|Cisplatin|cisplatin|mesh-list
138706333|NCT00392327|Carboplatin|carboplatin|mesh-list
138706334|NCT00392327|Vincristine|vincristine|mesh-list
138706335|NCT00392327|Tretinoin|tretinoin|mesh-list
138706336|NCT00392327|Isotretinoin|isotretinoin|mesh-list
138706337|NCT00392327|Lenograstim|lenograstim|mesh-list
138706338|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706339|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
138706340|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706341|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706342|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706343|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
138706344|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706345|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706346|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706347|NCT00392327|Vitamins|vitamins|mesh-ancestor
138706348|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
138706349|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138318662|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
138706354|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
138706355|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
138706356|NCT00357565|Cyclosporine|cyclosporine|mesh-list
138706358|NCT00357565|Fludarabine|fludarabine|mesh-list
138706359|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
138706360|NCT00357565|Melphalan|melphalan|mesh-list
138706361|NCT00357565|Busulfan|busulfan|mesh-list
138706362|NCT00357565|Cyclosporins|cyclosporins|mesh-list
138706363|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706364|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706365|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
138706366|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706367|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706368|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
138706369|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706370|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706371|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
138706372|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706373|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
138706374|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706375|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138706376|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138706377|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138706378|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
138706379|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138706380|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706381|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
138706382|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706384|NCT00352534|Cactinomycin|cactinomycin|mesh-list
138706385|NCT00352534|Doxorubicin|doxorubicin|mesh-list
138706386|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138353065|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353070|NCT02434146|Phenylephrine|phenylephrine|mesh-list
138706387|NCT00352534|Vincristine|vincristine|mesh-list
138706388|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138706389|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706390|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138706391|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138706392|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706393|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706394|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138706395|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706397|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
138706398|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318684|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138318685|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
138318686|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318709|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
138318710|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318711|NCT01381926|Exenatide|exenatide|mesh-list
138318712|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138318713|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318714|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138318715|NCT01381926|Incretins|incretins|mesh-ancestor
138318716|NCT01381926|Hormones|hormones|mesh-ancestor
138318773|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318774|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318776|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
138318777|NCT01394952|Dulaglutide|dulaglutide|mesh-list
138318778|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138318779|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318780|NCT01394718|Acetaminophen|acetaminophen|mesh-list
138318781|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138318782|NCT01394718|Analgesics|analgesics|mesh-ancestor
138318783|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
138318784|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318785|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318786|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
138318788|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
138318789|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
138318790|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318791|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318792|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
138318793|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318794|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138318795|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138318796|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138318797|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318798|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318799|NCT01380990|Busulfan|busulfan|mesh-list
138318800|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
138318801|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318802|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318803|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
138318804|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318805|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138318806|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318807|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138318808|NCT05361330|Fluoxetine|fluoxetine|mesh-list
138318809|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138318810|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138318811|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318812|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318813|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318814|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
138318815|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318816|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138318817|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
138318818|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318819|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138318822|NCT00214968|Modafinil|modafinil|mesh-list
138318823|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138318824|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353079|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
138318825|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138318826|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138318827|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138318828|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318829|NCT03592212|Albuterol|albuterol|mesh-list
138318830|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318831|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
138318832|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318833|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318834|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318835|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
138318836|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
138318837|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318838|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138318840|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138318841|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138318842|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318843|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318844|NCT03024450|Trastuzumab|trastuzumab|mesh-list
138318845|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318847|NCT04263090|Nivolumab|nivolumab|mesh-list
138318848|NCT04263090|ON 01910|on 01910|mesh-list
138318849|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318850|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318851|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138318852|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318853|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318854|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318855|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
138318856|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318857|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318858|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138318859|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138318860|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318861|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318862|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318863|NCT05632692|Menthol|menthol|mesh-list
138318865|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318866|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
138318867|NCT03594162|Fludarabine|fludarabine|mesh-list
138318868|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318869|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
138318870|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318871|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318872|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138318873|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
138318874|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318875|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318876|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138318877|NCT04407312|Aspirin|aspirin|mesh-list
138318882|NCT04407312|Analgesics|analgesics|mesh-ancestor
138318883|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
138318884|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318885|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318886|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318888|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138318889|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138318890|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318891|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138318892|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138318893|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318895|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138318896|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138318897|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138318898|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
138318899|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318900|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318901|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
138318902|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318903|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138318904|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
138318905|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138318906|NCT04407312|Protective Agents|protective agents|mesh-ancestor
138318907|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138318908|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138318909|NCT04326738|Midazolam|midazolam|mesh-list
138318910|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138318911|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138318912|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318913|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318914|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138318915|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138318916|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318917|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138318918|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
138318920|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
138318921|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
138318922|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318923|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318924|NCT04347486|Atropine|atropine|mesh-list
138318925|NCT04347486|Neostigmine|neostigmine|mesh-list
138318926|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138318927|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138318928|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318929|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
138318930|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318931|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318932|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318933|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
138318934|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
138318935|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
138318936|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138318937|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138318938|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
138318939|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318940|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318941|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138318942|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318943|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138318944|NCT05632224|Aprepitant|aprepitant|mesh-list
138318945|NCT05632224|Granisetron|granisetron|mesh-list
138318946|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
138318947|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
138318948|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318949|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318950|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318951|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138318952|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318953|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318954|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138318955|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138318956|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
138318958|NCT03024840|Sevoflurane|sevoflurane|mesh-list
138318959|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138318960|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318961|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318962|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138318963|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
138318964|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
138318965|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138318966|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138318967|NCT05631678|Itraconazole|itraconazole|mesh-list
138318969|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
138318972|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138318974|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318975|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138318976|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
138318977|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318978|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318979|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138318980|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138318981|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
138353083|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138318982|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318983|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
138318984|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318985|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138318986|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138318989|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138318990|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138318992|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318993|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318994|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318995|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318996|NCT04008264|Scopolamine|scopolamine|mesh-list
138318997|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138318998|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138318999|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
138319000|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
138319001|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319002|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319003|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319004|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
138319005|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138319006|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
138319007|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319012|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138319013|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
138319014|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319016|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138319017|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138319018|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
138319019|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319020|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319021|NCT03599466|Lisinopril|lisinopril|mesh-list
138319022|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138319023|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
138319024|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319025|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319026|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138319027|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138319028|NCT03599466|Protective Agents|protective agents|mesh-ancestor
138319029|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319030|NCT03986970|Tenofovir|tenofovir|mesh-list
138319031|NCT03986970|Emtricitabine|emtricitabine|mesh-list
138319032|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
138319033|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319034|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138319035|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138319036|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215503|NCT04387604|Growth Substances|growth substances|mesh-ancestor
138353085|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319037|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319038|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138319039|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138319040|NCT03594396|Durvalumab|durvalumab|mesh-list
138319041|NCT03594396|Olaparib|olaparib|mesh-list
138319042|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319044|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138319045|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319046|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319047|NCT03594240|Folic Acid|folic acid|mesh-list
138319048|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
138319049|NCT03594240|Vitamins|vitamins|mesh-ancestor
138319050|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
138319051|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319052|NCT03594240|Hematinics|hematinics|mesh-ancestor
138319053|NCT03976362|Paclitaxel|paclitaxel|mesh-list
138319054|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138319055|NCT03976362|Carboplatin|carboplatin|mesh-list
138319056|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
138319057|NCT03976362|Olaparib|olaparib|mesh-list
138319058|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319059|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319060|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319061|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319062|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319063|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319064|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319065|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319066|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138319067|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319069|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
138319070|NCT03598374|Inositol|inositol|mesh-list
138319071|NCT03598374|Hematinics|hematinics|mesh-ancestor
138319072|NCT03598374|Vitamins|vitamins|mesh-ancestor
138319073|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
138319074|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319075|NCT04407078|Neostigmine|neostigmine|mesh-list
138319076|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138319077|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319078|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319079|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
138319080|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319081|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319082|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138319083|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
138319084|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319085|NCT00217620|Sorafenib|sorafenib|mesh-list
138319086|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319087|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319088|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319089|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319090|NCT00217464|Fulvestrant|fulvestrant|mesh-list
138319091|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319094|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138319095|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
138319096|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319097|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319098|NCT03597282|Nivolumab|nivolumab|mesh-list
138319099|NCT03597282|Ipilimumab|ipilimumab|mesh-list
138319100|NCT03597282|Poly ICLC|poly iclc|mesh-list
138319101|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319102|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319103|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319104|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319105|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
138319106|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
138319107|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319108|NCT03593304|Vitamins|vitamins|mesh-list
138319109|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
138319110|NCT03593304|Pyridoxine|pyridoxine|mesh-list
138319111|NCT03593304|Pyridoxal|pyridoxal|mesh-list
138319112|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
138319113|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
138319114|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
138319115|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319116|NCT00211536|Insulin|insulin|mesh-list
138319117|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138319118|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319119|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319120|NCT03596970|Everolimus|everolimus|mesh-list
138319121|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138319122|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319123|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319124|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319125|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319126|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
138319127|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319128|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319129|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
138319130|NCT03596892|Busulfan|busulfan|mesh-list
138319131|NCT03596892|Decitabine|decitabine|mesh-list
138319132|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319133|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
138319135|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319136|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138319137|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
138319138|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319139|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319140|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138319141|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138319142|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
138319143|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319144|NCT03592836|Furosemide|furosemide|mesh-list
138319145|NCT03592836|Diuretics|diuretics|mesh-list
138319146|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138319147|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
138319148|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319149|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319150|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319152|NCT03596502|Anticoagulants|anticoagulants|mesh-list
138319153|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
138319154|NCT04197570|Analgesics|analgesics|mesh-list
138319155|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138319157|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319158|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319159|NCT04197570|Narcotics|narcotics|mesh-ancestor
138319160|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
138319161|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319162|NCT04197882|Molgramostim|molgramostim|mesh-list
138319163|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319164|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138319165|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138319166|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319167|NCT03024216|Atezolizumab|atezolizumab|mesh-list
138319168|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319169|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319170|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319171|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319172|NCT03981744|Ustekinumab|ustekinumab|mesh-list
138319173|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319174|NCT03591900|Insulin|insulin|mesh-list
138319175|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319176|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319177|NCT03591744|Dexamethasone|dexamethasone|mesh-list
138319178|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
138319179|NCT03591744|Doxorubicin|doxorubicin|mesh-list
138319183|NCT03591744|Daratumumab|daratumumab|mesh-list
138319184|NCT03591744|Ichthammol|ichthammol|mesh-list
138319185|NCT03591744|BB 1101|bb 1101|mesh-list
138319186|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319188|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
138319189|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319190|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319191|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319192|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
138353120|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319193|NCT03591744|Hormones|hormones|mesh-ancestor
138319194|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319195|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138353121|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319196|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319197|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138319198|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138319199|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138319200|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319201|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319202|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
138319203|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138319206|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
138319207|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
138319208|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319209|NCT04196946|Fentanyl|fentanyl|mesh-list
138319210|NCT04196946|Alfentanil|alfentanil|mesh-list
138319211|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138319212|NCT04196946|Narcotics|narcotics|mesh-ancestor
138319213|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319214|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319216|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
138319217|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319218|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138319219|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138319220|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
138319221|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
138319222|NCT03023904|Nivolumab|nivolumab|mesh-list
138319223|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319224|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319225|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319226|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319227|NCT04196400|Betamethasone|betamethasone|mesh-list
138319228|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319229|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
138319231|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319232|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319234|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
138319236|NCT03023436|Fluorouracil|fluorouracil|mesh-list
138319237|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319238|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138319239|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
138319240|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319241|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319242|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
138319243|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319245|NCT04195074|Entecavir|entecavir|mesh-list
138319246|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
138319247|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319248|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138319249|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138319250|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319251|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319252|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138319253|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138319254|NCT03590262|Metformin|metformin|mesh-list
138319255|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319256|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319257|NCT04029636|Xenon|xenon|mesh-list
138319258|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138319259|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
138319260|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
138319261|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319262|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319263|NCT04194684|Paclitaxel|paclitaxel|mesh-list
138319264|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319265|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319266|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319267|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319268|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319269|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319271|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319272|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
138319273|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319274|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319275|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
138319276|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319277|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138319278|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138319279|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138319280|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319281|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319283|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138319287|NCT04029090|Protective Agents|protective agents|mesh-ancestor
138319288|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319289|NCT04193982|Vitamin E|vitamin e|mesh-list
138319290|NCT04193982|Vitamins|vitamins|mesh-ancestor
138319291|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
138319292|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319293|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
138319294|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319295|NCT04193982|Protective Agents|protective agents|mesh-ancestor
138319296|NCT04028778|Gefitinib|gefitinib|mesh-list
138319297|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319298|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319300|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319302|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319303|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
138319304|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319305|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138319306|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138319307|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138319308|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138319309|NCT04193592|Pirfenidone|pirfenidone|mesh-list
138319310|NCT04193592|Analgesics|analgesics|mesh-ancestor
138319311|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
138319312|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319313|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319314|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138319315|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138319316|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319317|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319318|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319319|NCT04027764|Paclitaxel|paclitaxel|mesh-list
138319320|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319321|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319322|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319323|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319324|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319325|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319326|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
138319327|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138319328|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319329|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319330|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319332|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
138319333|NCT03023358|Doxorubicin|doxorubicin|mesh-list
138319334|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138319335|NCT03023358|Vincristine|vincristine|mesh-list
138319336|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319337|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
138319338|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319339|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138353122|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353125|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138319340|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138319341|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
138319342|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319343|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319344|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138319345|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138319346|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138319347|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138319348|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319349|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319350|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
138319351|NCT03023358|Hormones|hormones|mesh-ancestor
138319352|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319353|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319354|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319355|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319356|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319357|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319358|NCT04192812|Leuprolide|leuprolide|mesh-list
138319359|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138319360|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
138319361|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138319362|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319363|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319364|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319365|NCT04407000|Favipiravir|favipiravir|mesh-list
138319366|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
138319367|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319368|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
138319369|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138319370|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138319373|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138319374|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
138319376|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
138319377|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
138319378|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319379|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319380|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319381|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
138319382|NCT04192656|Hormones|hormones|mesh-ancestor
138319383|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319384|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138319385|NCT04192656|Protective Agents|protective agents|mesh-ancestor
138319386|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319387|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319389|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138319390|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
138319391|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138319392|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138319393|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319394|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319395|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138319396|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319397|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
138319398|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319400|NCT04192032|Nicotine|nicotine|mesh-list
138319401|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138319402|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
138319403|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319404|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319405|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138319406|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138319407|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
138319408|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319409|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319410|NCT03023982|Morphine|morphine|mesh-list
138319411|NCT03023982|Bupivacaine|bupivacaine|mesh-list
138319412|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319413|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
138319414|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319415|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319416|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
138319417|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319418|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138319419|NCT03023982|Narcotics|narcotics|mesh-ancestor
138319420|NCT03023982|Analgesics|analgesics|mesh-ancestor
138319421|NCT04192110|Diuretics|diuretics|mesh-list
138319422|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
138319423|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319424|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
138319425|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138319426|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138319427|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319431|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319432|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319434|NCT04190160|Hormones|hormones|mesh-ancestor
138319435|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319436|NCT04190004|Vasopressins|vasopressins|mesh-list
138319437|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
138319438|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
138319439|NCT04190004|Coagulants|coagulants|mesh-ancestor
138319440|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138319441|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138319442|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
138319443|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319445|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319446|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
138319447|NCT04406376|Hormones|hormones|mesh-ancestor
138319448|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319449|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319450|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319451|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319452|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
138319453|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319454|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319455|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319456|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319457|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
138319458|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
138319459|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319460|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
138319461|NCT04023630|Clopidogrel|clopidogrel|mesh-list
138319463|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138319464|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138319465|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138319466|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138319467|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
138319468|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319469|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319470|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319474|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
138319475|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319476|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
138319477|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138319478|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
138319479|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319480|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319481|NCT04020666|Kallikreins|kallikreins|mesh-list
138319482|NCT04020666|Coagulants|coagulants|mesh-ancestor
138319483|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138319484|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
138319485|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138319486|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319488|NCT04021992|Gemcitabine|gemcitabine|mesh-list
138319489|NCT04021992|Doxorubicin|doxorubicin|mesh-list
138319490|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138319491|NCT04021992|Vinorelbine|vinorelbine|mesh-list
138319492|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319493|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319494|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
138319495|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319496|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319497|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138319498|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
138319499|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319500|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138319501|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138319502|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138319503|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319504|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319505|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319506|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319507|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319509|NCT04020588|Celecoxib|celecoxib|mesh-list
138319510|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138319511|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138319513|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
138319514|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319515|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319517|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319518|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138319519|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138319520|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319521|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319522|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319523|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319524|NCT04145856|Simethicone|simethicone|mesh-list
138319525|NCT04145856|Alverine|alverine|mesh-list
138319526|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
138319527|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319528|NCT04145856|Emollients|emollients|mesh-ancestor
138319529|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319530|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
138319531|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
138319532|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319533|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319534|NCT04140786|Gentamicins|gentamicins|mesh-list
138319535|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319536|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319537|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138319539|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319540|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138319541|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138319543|NCT04022226|Methohexital|methohexital|mesh-list
138319544|NCT04022226|Analgesics|analgesics|mesh-ancestor
138319545|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
138319546|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319547|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319548|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138319549|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138319550|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
138319551|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
138319552|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319553|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138319554|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138319555|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319556|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319557|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
138319558|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138319559|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
138319560|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
138319561|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319562|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319563|NCT04025658|Oxytocin|oxytocin|mesh-list
138319564|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
138319567|NCT05586438|Colistin|colistin|mesh-list
138319568|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319569|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319570|NCT04145232|Nivolumab|nivolumab|mesh-list
138319571|NCT04145232|Ipilimumab|ipilimumab|mesh-list
138319572|NCT04145232|Atezolizumab|atezolizumab|mesh-list
138319573|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319574|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319575|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319576|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319577|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
138319578|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138319579|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138319581|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319582|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319583|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319584|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
138319585|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
138319586|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319587|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
138319588|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138319589|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
138319590|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138319592|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319593|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319595|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
138319597|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138319598|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319599|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319600|NCT05580822|Tenecteplase|tenecteplase|mesh-list
138319601|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138319602|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138319603|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319604|NCT05580354|Tislelizumab|tislelizumab|mesh-list
138319605|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319606|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319607|NCT04143906|Carboplatin|carboplatin|mesh-list
138319608|NCT04143906|Gemcitabine|gemcitabine|mesh-list
138319612|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
138319613|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319614|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319615|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319616|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319617|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319618|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
138319619|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138319620|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
138319621|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319622|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
138319623|NCT02708706|Protective Agents|protective agents|mesh-ancestor
138319625|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319626|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319627|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
138319628|NCT02703714|Sargramostim|sargramostim|mesh-list
138319629|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319630|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319631|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319632|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319633|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
138319634|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319635|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
138319636|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138319637|NCT03904446|Methylergonovine|methylergonovine|mesh-list
138319638|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
138319639|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138319642|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319643|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319649|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319650|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
138319651|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319652|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
138319653|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319654|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319655|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319656|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138319657|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138319659|NCT05581992|Omeprazole|omeprazole|mesh-list
138319660|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138319661|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319662|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138319663|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319664|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319665|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319667|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319668|NCT03020940|Cefuroxime|cefuroxime|mesh-list
138319669|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
138319670|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319671|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319672|NCT03645408|Exenatide|exenatide|mesh-list
138319673|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138319674|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319675|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138319676|NCT03645408|Incretins|incretins|mesh-ancestor
138319677|NCT03645408|Hormones|hormones|mesh-ancestor
138319678|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319679|NCT04141410|Simendan|simendan|mesh-list
138319680|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138319681|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
138319682|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138319683|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138319684|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319685|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319686|NCT04141410|Protective Agents|protective agents|mesh-ancestor
138319689|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
138319690|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319691|NCT04149444|Trifluridine|trifluridine|mesh-list
138319692|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
138319693|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319694|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
138319695|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319696|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
138319697|NCT03020706|Analgesics|analgesics|mesh-ancestor
138319698|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
138319699|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319700|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319702|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319703|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138319705|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138319706|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319707|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319708|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138319709|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
138319710|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138319711|NCT03900624|Dexamethasone|dexamethasone|mesh-list
138319713|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
138319714|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
138319715|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319716|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319717|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319718|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
138319719|NCT03900624|Hormones|hormones|mesh-ancestor
138319720|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319721|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319722|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319723|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
138319728|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138319729|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
138319730|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138319731|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
138319732|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319733|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319734|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138319735|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138319736|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
138319737|NCT04149132|Protective Agents|protective agents|mesh-ancestor
138319738|NCT03908892|Tetracycline|tetracycline|mesh-list
138319739|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319740|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319741|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138319742|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319743|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319745|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319746|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319747|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319748|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319749|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319750|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353143|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319752|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138319753|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319755|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319756|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319757|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319758|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319760|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319761|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319762|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138319763|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319764|NCT03022500|Durvalumab|durvalumab|mesh-list
138319765|NCT03022500|Tremelimumab|tremelimumab|mesh-list
138319769|NCT04148898|Osimertinib|osimertinib|mesh-list
138319770|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319771|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319772|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138319773|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138319774|NCT04148898|Growth Substances|growth substances|mesh-ancestor
138319775|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319776|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
138319777|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319778|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319779|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319781|NCT04148820|Perindopril|perindopril|mesh-list
138319782|NCT04148820|Atorvastatin|atorvastatin|mesh-list
138319783|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138319784|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138319785|NCT04148820|Analgesics|analgesics|mesh-ancestor
138319786|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
138319787|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319788|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319789|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319790|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319791|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138319792|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138319793|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319794|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138319795|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138319796|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319797|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
138319798|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138319799|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138319800|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
138319801|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138319802|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138319803|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138319804|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
138319805|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138319806|NCT03941496|Azacitidine|azacitidine|mesh-list
138319807|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138319808|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
138319809|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319810|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319811|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319812|NCT03580980|Acetaminophen|acetaminophen|mesh-list
138319813|NCT03580980|Ketamine|ketamine|mesh-list
138319815|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
138319816|NCT03580980|Analgesics|analgesics|mesh-ancestor
138319819|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319820|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138319821|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138319822|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
138319824|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319825|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138319826|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138319827|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319828|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319829|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138319830|NCT03580980|Narcotics|narcotics|mesh-ancestor
138319831|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353146|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319832|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
138319833|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319834|NCT03587220|Lidocaine|lidocaine|mesh-list
138319835|NCT03587220|Capsaicin|capsaicin|mesh-list
138319836|NCT03587220|Histamine|histamine|mesh-list
138319837|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319838|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
138319839|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319840|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319841|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
138319842|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319843|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138319844|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138319845|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138319846|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319847|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319848|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
138319849|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319851|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
138319852|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319853|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138319854|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138319855|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
138319856|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138319857|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
138319858|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319859|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319860|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138319861|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
138319862|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
138319863|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138319864|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
138319865|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319866|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319868|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
138319869|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138319870|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138319871|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319872|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
138319873|NCT03580590|Coagulants|coagulants|mesh-ancestor
138319874|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138319875|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138319876|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138319877|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138319878|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319879|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
138319881|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138319882|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319883|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319889|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319890|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138319891|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138319892|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319893|NCT03346668|Gabapentin|gabapentin|mesh-list
138319894|NCT03346668|Analgesics|analgesics|mesh-ancestor
138319895|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
138319896|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319897|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319898|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
138319899|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138353149|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319900|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138319901|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319902|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138319903|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138319904|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138319905|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319906|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319907|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
138319909|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
138319910|NCT03585738|Inositol|inositol|mesh-list
138319911|NCT03585738|Hematinics|hematinics|mesh-ancestor
138319912|NCT03585738|Vitamins|vitamins|mesh-ancestor
138319913|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
138319914|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319915|NCT03583164|Olorofim|olorofim|mesh-list
138319916|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
138319917|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319918|NCT03589326|Cytarabine|cytarabine|mesh-list
138319919|NCT03589326|Dexamethasone|dexamethasone|mesh-list
138319920|NCT03589326|Prednisone|prednisone|mesh-list
138319921|NCT03589326|Methotrexate|methotrexate|mesh-list
138319922|NCT03589326|Vincristine|vincristine|mesh-list
138319923|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
138319930|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138319931|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
138319932|NCT03589326|Hormones|hormones|mesh-ancestor
138319933|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319934|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138319935|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319936|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138319937|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
138319938|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138319939|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138319940|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
138319941|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319942|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
138319943|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319944|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138319945|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319946|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
138319947|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319948|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138319949|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
138319950|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319951|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138319952|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319953|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138319954|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319955|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138319956|NCT03583866|Candesartan|candesartan|mesh-list
138319957|NCT03583866|Candesartan cilexetil|candesartan cilexetil|mesh-list
138319958|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138319959|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138319960|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138319961|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319962|NCT03585426|Vancomycin|vancomycin|mesh-list
138319963|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138319964|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319965|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138319966|NCT03585036|Tramadol|tramadol|mesh-list
138319967|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138319968|NCT03585036|Narcotics|narcotics|mesh-ancestor
138319969|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319970|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319971|NCT03585036|Analgesics|analgesics|mesh-ancestor
138319972|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
138319973|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319977|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319978|NCT03155568|Bupivacaine|bupivacaine|mesh-list
138319979|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319980|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
138319981|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319982|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319983|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
138319984|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319986|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
138319987|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
138319988|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138319989|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319990|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319991|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138319992|NCT03155646|Analgesics|analgesics|mesh-ancestor
138319993|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
138319994|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319995|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138319996|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138319997|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138319998|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138319999|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320000|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320001|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138320003|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
138320004|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
138320005|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
138320006|NCT03584178|Budesonide|budesonide|mesh-list
138320007|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320010|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320011|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320012|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320013|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320014|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
138320015|NCT03584178|Hormones|hormones|mesh-ancestor
138320017|NCT04405206|Capecitabine|capecitabine|mesh-list
138320018|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
138320019|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320020|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
138320021|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320022|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320028|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320029|NCT03159936|Tofacitinib|tofacitinib|mesh-list
138320030|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320032|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138320033|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320034|NCT03156816|Colchicine|colchicine|mesh-list
138320035|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
138320036|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320037|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138320038|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320039|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320040|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320041|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320043|NCT03583476|Metronidazole|metronidazole|mesh-list
138320044|NCT03583476|Clarithromycin|clarithromycin|mesh-list
138320045|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138320046|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138320047|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320048|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138320049|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138320050|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138320051|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320052|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320053|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138320054|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138320055|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138320056|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138320057|NCT03583242|Growth Substances|growth substances|mesh-ancestor
138320058|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320059|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138320060|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320061|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
138320062|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320063|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320064|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
138320065|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320066|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
138320067|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320068|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320070|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138320071|NCT03582306|Protective Agents|protective agents|mesh-ancestor
138320076|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138320077|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138320078|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138320079|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320080|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320081|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320082|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138320083|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138320084|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
138320085|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320086|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320087|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320088|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
138320089|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
138320090|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138320091|NCT05701332|Gemcitabine|gemcitabine|mesh-list
138320092|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
138320093|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320094|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
138320095|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320096|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320097|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138320098|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
138320099|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320100|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
138320101|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138289150|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320102|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320104|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138320105|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138320106|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138320107|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
138320108|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320109|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320111|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320112|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
138320113|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
138320114|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138320115|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138320116|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
138320118|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320119|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
138320120|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138320121|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320122|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138320123|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138320124|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
138320125|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320126|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
138320128|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
138320129|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138320130|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320131|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138320132|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138320133|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138320134|NCT01671384|Valproic Acid|valproic acid|mesh-list
138320135|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
138320136|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320137|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320138|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
138320139|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320140|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320141|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
138320142|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138320143|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320144|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320145|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
138320146|NCT01671774|Interleukin-2|interleukin-2|mesh-list
138320147|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320148|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138320150|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
138320151|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320152|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320153|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138320155|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320156|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138320157|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138320158|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
138320159|NCT01672086|Antacids|antacids|mesh-ancestor
138320160|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320161|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320162|NCT05547750|Vitamin K|vitamin k|mesh-list
138320163|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
138320164|NCT05547750|Vitamins|vitamins|mesh-ancestor
138320165|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
138320166|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320167|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138320168|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138320169|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320170|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
138320171|NCT05547750|Coagulants|coagulants|mesh-ancestor
138320172|NCT01672476|Valsartan|valsartan|mesh-list
138320173|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138320176|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320178|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
138320179|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320180|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138320181|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138320182|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320183|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320184|NCT05033808|Epirubicin|epirubicin|mesh-list
138320185|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320186|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320187|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320188|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320189|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320190|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320191|NCT04026984|Rifamycins|rifamycins|mesh-list
138320193|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138320194|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320195|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320196|NCT03153072|Amiodarone|amiodarone|mesh-list
138320197|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138320198|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
138320199|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138320200|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138320201|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320202|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138320203|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138320204|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138320205|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320206|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138320207|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138320208|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138320210|NCT01673724|Bromocriptine|bromocriptine|mesh-list
138320211|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
138320212|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320214|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320216|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138320217|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
138320219|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320220|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138320221|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320222|NCT04765098|Tamoxifen|tamoxifen|mesh-list
138320223|NCT04765098|Etoposide|etoposide|mesh-list
138320224|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320225|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320226|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320228|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320229|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320230|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138320231|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
138353164|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138320232|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320233|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320234|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320235|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138320236|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138320237|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138320238|NCT01674036|Venglustat|venglustat|mesh-list
138320239|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320240|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320241|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
138320242|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
138320243|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320244|NCT03032328|Vitamin D|vitamin d|mesh-list
138320245|NCT03032328|Vitamins|vitamins|mesh-ancestor
138320246|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
138320247|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320251|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320252|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138320253|NCT01674192|Prucalopride|prucalopride|mesh-list
138320254|NCT01674192|Laxatives|laxatives|mesh-ancestor
138320255|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320256|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138320257|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138320258|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
138320259|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320260|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320261|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320262|NCT01674270|Bicalutamide|bicalutamide|mesh-list
138320263|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
138320264|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
138320265|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320266|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320267|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320268|NCT01674504|Montelukast|montelukast|mesh-list
138320269|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320270|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320271|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138320273|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320274|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320275|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138320276|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138320277|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320278|NCT05353062|Epinephrine|epinephrine|mesh-list
138320279|NCT05353062|Hemostatics|hemostatics|mesh-list
138320284|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320285|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320286|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138320287|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138320289|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320291|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320292|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
138320293|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
138320294|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138320295|NCT05353062|Coagulants|coagulants|mesh-ancestor
138320296|NCT03152370|Leucovorin|leucovorin|mesh-list
138320297|NCT03152370|Folic Acid|folic acid|mesh-list
138320298|NCT03152370|Capecitabine|capecitabine|mesh-list
138320299|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
138320300|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
138320301|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320302|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
138320303|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320304|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320305|NCT03152370|Antidotes|antidotes|mesh-ancestor
138320306|NCT03152370|Protective Agents|protective agents|mesh-ancestor
138320307|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320308|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
138320309|NCT03152370|Vitamins|vitamins|mesh-ancestor
138320310|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
138320311|NCT03152370|Hematinics|hematinics|mesh-ancestor
138320312|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
138353167|NCT01881984|Glycerol|glycerol|mesh-list
138320313|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138320314|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138320315|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320316|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
138320317|NCT02187120|Coagulants|coagulants|mesh-ancestor
138320318|NCT01674738|Bevacizumab|bevacizumab|mesh-list
138320319|NCT01674738|Pemetrexed|pemetrexed|mesh-list
138320320|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320321|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320322|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138320323|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138320324|NCT01674738|Growth Substances|growth substances|mesh-ancestor
138320325|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320326|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
138320327|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320328|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320329|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138320330|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138320331|NCT01675206|Vitamin K|vitamin k|mesh-list
138320332|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
138320335|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320336|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138320337|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138320338|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320339|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
138320340|NCT01675206|Coagulants|coagulants|mesh-ancestor
138320341|NCT03150576|Paclitaxel|paclitaxel|mesh-list
138320343|NCT03150576|Olaparib|olaparib|mesh-list
138320344|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320345|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320346|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138320347|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320348|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320349|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320350|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138320351|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320354|NCT04747080|BB 1101|bb 1101|mesh-list
138320355|NCT04747080|Tacrolimus|tacrolimus|mesh-list
138320357|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
138320358|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
138320359|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320360|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320361|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320362|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
138320363|NCT04747080|Hormones|hormones|mesh-ancestor
138320364|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320365|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320366|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320367|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
138320368|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320369|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320370|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320371|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
138320372|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138320374|NCT01675362|Losartan|losartan|mesh-list
138320375|NCT01675362|Verapamil|verapamil|mesh-list
138320376|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
138320377|NCT01675362|Calcium|calcium|mesh-list
138320378|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138320379|NCT01675362|Antioxidants|antioxidants|mesh-list
138320380|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138320381|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320382|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138320383|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138320384|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138320385|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320386|NCT01675362|Protective Agents|protective agents|mesh-ancestor
138320387|NCT01675362|Trace Elements|trace elements|mesh-ancestor
138320388|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
138320389|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138320390|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
138320391|NCT01675518|ASP7991|asp7991|mesh-list
138320392|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138320394|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320395|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320397|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
138320398|NCT01675986|Pregabalin|pregabalin|mesh-list
138320400|NCT01675986|Analgesics|analgesics|mesh-ancestor
138320401|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
138320402|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320403|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320404|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
138320405|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138320406|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138320409|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138320410|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138320411|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320412|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320413|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
138320414|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
138320415|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138320416|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
138320417|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
138320418|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320419|NCT03875664|Bupivacaine|bupivacaine|mesh-list
138320420|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
138320421|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
138320422|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320423|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320424|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
138320425|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320426|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
138320427|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
138320428|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138320429|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138320430|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320431|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320432|NCT01670136|Urological Agents|urological agents|mesh-ancestor
138320434|NCT03873480|Bupivacaine|bupivacaine|mesh-list
138320435|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138320436|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138320437|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
138320438|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320439|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320440|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320441|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138320442|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138320443|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
138320444|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320445|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320446|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320447|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
138320448|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
138320449|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138320450|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
138320451|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
138320452|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320453|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
138320454|NCT04764084|Niraparib|niraparib|mesh-list
138320455|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138320457|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320458|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320459|NCT03866538|Budesonide|budesonide|mesh-list
138320460|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320461|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138320463|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320464|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320465|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320466|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320467|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
138320468|NCT03866538|Hormones|hormones|mesh-ancestor
138320469|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320470|NCT01677390|Everolimus|everolimus|mesh-list
138320471|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138320472|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138320473|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320474|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320475|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320477|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320478|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320479|NCT03749070|Silymarin|silymarin|mesh-list
138320480|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
138320481|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320482|NCT03749070|Protective Agents|protective agents|mesh-ancestor
138320483|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320484|NCT01345656|Spironolactone|spironolactone|mesh-list
138320485|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138320486|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138320487|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320488|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320489|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138320490|NCT01345656|Diuretics|diuretics|mesh-ancestor
138320491|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
138320492|NCT04763616|Cemiplimab|cemiplimab|mesh-list
138320493|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320494|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320495|NCT03652974|Valproic Acid|valproic acid|mesh-list
138320496|NCT03652974|Clozapine|clozapine|mesh-list
138320498|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
138320499|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320500|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320502|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320505|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138320506|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320507|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320508|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138320509|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
138320510|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138320511|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
138320512|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138353187|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320513|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
138320514|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138320515|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
138320516|NCT03649152|Propagermanium|propagermanium|mesh-list
138320517|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320518|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
138320519|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
138320520|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320521|NCT03646188|Doxorubicin|doxorubicin|mesh-list
138320523|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320524|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320525|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320526|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320527|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320528|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320530|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138320531|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
138320532|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138320533|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320534|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138320535|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138320536|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138320537|NCT02082678|Ondansetron|ondansetron|mesh-list
138320538|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
138320539|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
138320540|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320541|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320542|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320543|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
138320544|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138320545|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138320546|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138320547|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
138320548|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320549|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320550|NCT01677468|Doxorubicin|doxorubicin|mesh-list
138320551|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138320552|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138320553|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320555|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320556|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320557|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320558|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320559|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
138320560|NCT01677468|Coagulants|coagulants|mesh-ancestor
138320561|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
138320562|NCT00003816|Melphalan|melphalan|mesh-list
138320563|NCT00003816|Busulfan|busulfan|mesh-list
138320564|NCT00003816|Thiotepa|thiotepa|mesh-list
138320566|NCT00003816|Fludarabine|fludarabine|mesh-list
138320567|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
138320568|NCT00003816|Etoposide|etoposide|mesh-list
138320569|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138320571|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
138320572|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320573|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320574|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138320576|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320577|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320578|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138320579|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320580|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
138320581|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320582|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320583|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320584|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320586|NCT03618654|Durvalumab|durvalumab|mesh-list
138320587|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
138320588|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138320589|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
138320590|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320591|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320592|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320593|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320594|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
138320595|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
138320596|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138320597|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320598|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320599|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320601|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320603|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138320604|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138320605|NCT03609060|Dexamethasone|dexamethasone|mesh-list
138320606|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320607|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
138320608|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
138320609|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320610|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320611|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320612|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
138320613|NCT03609060|Hormones|hormones|mesh-ancestor
138320614|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320615|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320616|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320617|NCT03704766|Defensins|defensins|mesh-list
138320618|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
138320619|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320621|NCT03826992|Daunorubicin|daunorubicin|mesh-list
138320622|NCT03826992|Venetoclax|venetoclax|mesh-list
138320623|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320624|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
138320625|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320626|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320628|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320630|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
138320631|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320632|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320633|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320634|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320635|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320636|NCT00004092|Paclitaxel|paclitaxel|mesh-list
138320637|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
138320638|NCT00004092|Carboplatin|carboplatin|mesh-list
138320639|NCT00004092|Doxorubicin|doxorubicin|mesh-list
138320642|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320643|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320644|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138320646|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320647|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320648|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320649|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
138320650|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320651|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320652|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138320653|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
138320654|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138320655|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320656|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320657|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320658|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320659|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138320660|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320661|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138320662|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138320663|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320664|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138320665|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320666|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138320667|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320670|NCT03825198|Sufentanil|sufentanil|mesh-list
138320671|NCT03825198|Morphine|morphine|mesh-list
138320672|NCT03825198|Bromides|bromides|mesh-list
138320673|NCT03825198|Propofol|propofol|mesh-list
138320674|NCT03825198|Sevoflurane|sevoflurane|mesh-list
138320675|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
138320676|NCT03825198|Rocuronium|rocuronium|mesh-list
138320677|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320678|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
138320679|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
138320680|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320681|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320683|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
138320684|NCT03825198|Hormones|hormones|mesh-ancestor
138320685|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320686|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320687|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320688|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138320689|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320690|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138320691|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
138320692|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
138320693|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138320694|NCT03825198|Narcotics|narcotics|mesh-ancestor
138320695|NCT03825198|Analgesics|analgesics|mesh-ancestor
138320696|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
138320697|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138320698|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138320699|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138320700|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138320701|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320702|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138320704|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320705|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
138320706|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138320707|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138320708|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138320709|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138320710|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138320711|NCT03817320|Leucovorin|leucovorin|mesh-list
138320712|NCT03817320|Cytarabine|cytarabine|mesh-list
138320713|NCT03817320|Dexamethasone|dexamethasone|mesh-list
138320714|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
138320715|NCT03817320|Doxorubicin|doxorubicin|mesh-list
138320716|NCT03817320|Methotrexate|methotrexate|mesh-list
138320718|NCT03817320|Asparaginase|asparaginase|mesh-list
138320719|NCT03817320|Ixazomib|ixazomib|mesh-list
138320720|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320721|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
138320722|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
138320723|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320724|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320725|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320726|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
138320727|NCT03817320|Hormones|hormones|mesh-ancestor
138320728|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320733|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320734|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320735|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320736|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138320737|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
138320738|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138320739|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320741|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138320742|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138320743|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320744|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
138320745|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320746|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138320747|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
138320748|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320749|NCT03817320|Antidotes|antidotes|mesh-ancestor
138320750|NCT03817320|Protective Agents|protective agents|mesh-ancestor
138320751|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
138320752|NCT03817320|Vitamins|vitamins|mesh-ancestor
138320753|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
138320754|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320755|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138320756|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320757|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320758|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138320759|NCT03580356|Omalizumab|omalizumab|mesh-list
138320760|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138320761|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320762|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320764|NCT06125873|Glucagon|glucagon|mesh-list
138320765|NCT06125873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320766|NCT06125873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320767|NCT06125873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320768|NCT06125873|Hormones|hormones|mesh-ancestor
138289151|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138320769|NCT06125873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320770|NCT06125834|Trastuzumab|trastuzumab|mesh-list
138320771|NCT06125834|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138320772|NCT06125834|Maytansine|maytansine|mesh-list
138320773|NCT06125834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320774|NCT06125834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320775|NCT06125834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320776|NCT06125834|Tubulin Modulators|tubulin modulators|mesh-ancestor
138320777|NCT06125834|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320778|NCT06125834|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320779|NCT06125834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320780|NCT06125834|Immunotoxins|immunotoxins|mesh-ancestor
138320781|NCT06125834|Immunoconjugates|immunoconjugates|mesh-ancestor
138320782|NCT06125834|Immunologic Factors|immunologic factors|mesh-ancestor
138320783|NCT06125834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320784|NCT06125691|Vaccines|vaccines|mesh-list
138320785|NCT06125691|Immunologic Factors|immunologic factors|mesh-ancestor
138320786|NCT06125691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320787|NCT06125587|Metformin|metformin|mesh-list
138320788|NCT06125587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320789|NCT06125587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320790|NCT06125483|Fludarabine|fludarabine|mesh-list
138320791|NCT06125483|Melphalan|melphalan|mesh-list
138320792|NCT06125483|Busulfan|busulfan|mesh-list
138320793|NCT06125483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320794|NCT06125483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320795|NCT06125483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320797|NCT06125483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320798|NCT06125483|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138320799|NCT06125483|Alkylating Agents|alkylating agents|mesh-ancestor
138320800|NCT06125483|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138320801|NCT06125392|Adenosine|adenosine|mesh-list
138320802|NCT06125392|Acetylcholine|acetylcholine|mesh-list
138320803|NCT06125392|Papaverine|papaverine|mesh-list
138320804|NCT06125392|Analgesics|analgesics|mesh-ancestor
138320805|NCT06125392|Sensory System Agents|sensory system agents|mesh-ancestor
138320806|NCT06125392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320807|NCT06125392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320808|NCT06125392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138320809|NCT06125392|Vasodilator Agents|vasodilator agents|mesh-ancestor
138320810|NCT06125392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138320811|NCT06125392|Purinergic Agonists|purinergic agonists|mesh-ancestor
138320812|NCT06125392|Purinergic Agents|purinergic agents|mesh-ancestor
138320813|NCT06125392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320814|NCT06125392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320815|NCT06125392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138320816|NCT06125392|Cholinergic Agents|cholinergic agents|mesh-ancestor
138320817|NCT06125392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138320818|NCT06125392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320819|NCT06125392|Urological Agents|urological agents|mesh-ancestor
138320821|NCT06125353|Antioxidants|antioxidants|mesh-ancestor
138320822|NCT06125353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320823|NCT06125353|Protective Agents|protective agents|mesh-ancestor
138320824|NCT06125353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320825|NCT06125353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320826|NCT06125197|Pembrolizumab|pembrolizumab|mesh-list
138320827|NCT06125197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320828|NCT06125197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320829|NCT06125197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138320830|NCT06125197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320832|NCT06125171|Apatinib|apatinib|mesh-list
138320833|NCT06125171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320834|NCT06125171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138320836|NCT06125171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320837|NCT06125106|Blinatumomab|blinatumomab|mesh-list
138320838|NCT06125106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320839|NCT06125080|Bevacizumab|bevacizumab|mesh-list
138320840|NCT06125080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320841|NCT06125080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320842|NCT06125080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138320843|NCT06125080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138320844|NCT06125080|Growth Substances|growth substances|mesh-ancestor
138320845|NCT06125080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320846|NCT06125080|Growth Inhibitors|growth inhibitors|mesh-ancestor
138320847|NCT06125041|Carboplatin|carboplatin|mesh-list
138320848|NCT06125041|Etoposide|etoposide|mesh-list
138320849|NCT06125041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320850|NCT06125041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138320851|NCT06125041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320852|NCT06125041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320853|NCT06125041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320854|NCT06125041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320855|NCT06125028|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138320856|NCT06125028|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138320857|NCT06125028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320858|NCT06124924|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138320859|NCT06124924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320860|NCT06124924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320861|NCT06124924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320864|NCT06124729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138320865|NCT06124729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138320866|NCT06124729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320867|NCT06124729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138320868|NCT06124729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138320869|NCT06124729|Growth Substances|growth substances|mesh-ancestor
138320870|NCT06124729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320871|NCT06124729|Growth Inhibitors|growth inhibitors|mesh-ancestor
138320872|NCT06124729|Immunologic Factors|immunologic factors|mesh-ancestor
138320874|NCT06124573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138320875|NCT06124573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320876|NCT06124573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320877|NCT06124573|Incretins|incretins|mesh-ancestor
138320878|NCT06124573|Hormones|hormones|mesh-ancestor
138320879|NCT06124573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320882|NCT06124573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320883|NCT06124573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320884|NCT06124560|Metformin|metformin|mesh-list
138320885|NCT06124560|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138320886|NCT06124560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320887|NCT06124560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320888|NCT06124560|Incretins|incretins|mesh-ancestor
138320889|NCT06124560|Hormones|hormones|mesh-ancestor
138320890|NCT06124560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320891|NCT06124560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138320892|NCT06124560|Protease Inhibitors|protease inhibitors|mesh-ancestor
138320893|NCT06124560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320894|NCT06124560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320895|NCT06124547|Metformin|metformin|mesh-list
138320896|NCT06124547|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138320897|NCT06124547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320898|NCT06124547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320899|NCT06124547|Incretins|incretins|mesh-ancestor
138320900|NCT06124547|Hormones|hormones|mesh-ancestor
138320901|NCT06124547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320902|NCT06124547|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138320903|NCT06124547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138320904|NCT06124547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320905|NCT06124547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320906|NCT06124495|Metformin|metformin|mesh-list
138320907|NCT06124495|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138320908|NCT06124495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320909|NCT06124495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320910|NCT06124495|Incretins|incretins|mesh-ancestor
138320911|NCT06124495|Hormones|hormones|mesh-ancestor
138201725|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320912|NCT06124495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320913|NCT06124495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138320916|NCT06124495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320918|NCT06124417|Antidepressive Agents|antidepressive agents|mesh-ancestor
138320920|NCT06124417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138320921|NCT06124417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138320922|NCT06124417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138320923|NCT06124417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320924|NCT06124417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320925|NCT06124417|Serotonin Agents|serotonin agents|mesh-ancestor
138320926|NCT06124417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320928|NCT06124300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320929|NCT06124300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320930|NCT06124209|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138320932|NCT06124209|Coagulants|coagulants|mesh-ancestor
138320933|NCT06124157|Leucovorin|leucovorin|mesh-list
138320934|NCT06124157|Cytarabine|cytarabine|mesh-list
138320935|NCT06124157|Prednisone|prednisone|mesh-list
138320936|NCT06124157|Prednisolone|prednisolone|mesh-list
138320937|NCT06124157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138320938|NCT06124157|Methylprednisolone|methylprednisolone|mesh-list
138320939|NCT06124157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138320940|NCT06124157|Prednisolone acetate|prednisolone acetate|mesh-list
138320941|NCT06124157|Hydrocortisone|hydrocortisone|mesh-list
138320942|NCT06124157|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138320943|NCT06124157|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138320944|NCT06124157|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138320945|NCT06124157|Cortisone|cortisone|mesh-list
138320946|NCT06124157|Cyclophosphamide|cyclophosphamide|mesh-list
138320947|NCT06124157|Doxorubicin|doxorubicin|mesh-list
138320948|NCT06124157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138320949|NCT06124157|Methotrexate|methotrexate|mesh-list
138320950|NCT06124157|Vincristine|vincristine|mesh-list
138320951|NCT06124157|Daunorubicin|daunorubicin|mesh-list
138320952|NCT06124157|Asparaginase|asparaginase|mesh-list
138320953|NCT06124157|Dasatinib|dasatinib|mesh-list
138320954|NCT06124157|Mercaptopurine|mercaptopurine|mesh-list
138320955|NCT06124157|Pegaspargase|pegaspargase|mesh-list
138320956|NCT06124157|Thioguanine|thioguanine|mesh-list
138320957|NCT06124157|Blinatumomab|blinatumomab|mesh-list
138320958|NCT06124157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138320959|NCT06124157|Muromonab-CD3|muromonab-cd3|mesh-list
138320960|NCT06124157|Antibodies|antibodies|mesh-list
138320961|NCT06124157|Immunoglobulins|immunoglobulins|mesh-list
138320962|NCT06124157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138320963|NCT06124157|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138320965|NCT06124157|Prednisolone phosphate|prednisolone phosphate|mesh-list
138320966|NCT06124157|2-Aminopurine|2-aminopurine|mesh-list
138320967|NCT06124157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320968|NCT06124157|Immunologic Factors|immunologic factors|mesh-ancestor
138320969|NCT06124157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320970|NCT06124157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320971|NCT06124157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138320972|NCT06124157|Alkylating Agents|alkylating agents|mesh-ancestor
138320973|NCT06124157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320974|NCT06124157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320975|NCT06124157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138320976|NCT06124157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320977|NCT06124157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320978|NCT06124157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320980|NCT06124157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138320981|NCT06124157|Glucocorticoids|glucocorticoids|mesh-ancestor
138320983|NCT06124157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320984|NCT06124157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320985|NCT06124157|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138320986|NCT06124157|Abortifacient Agents|abortifacient agents|mesh-ancestor
138320987|NCT06124157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138320988|NCT06124157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320989|NCT06124157|Antimetabolites|antimetabolites|mesh-ancestor
138320990|NCT06124157|Dermatologic Agents|dermatologic agents|mesh-ancestor
138320991|NCT06124157|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138320992|NCT06124157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138320993|NCT06124157|Antiviral Agents|antiviral agents|mesh-ancestor
138320994|NCT06124157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320995|NCT06124157|Antidotes|antidotes|mesh-ancestor
138320996|NCT06124157|Protective Agents|protective agents|mesh-ancestor
138320997|NCT06124157|Vitamin B Complex|vitamin b complex|mesh-ancestor
138320998|NCT06124157|Vitamins|vitamins|mesh-ancestor
138320999|NCT06124157|Micronutrients|micronutrients|mesh-ancestor
138321000|NCT06124157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321001|NCT06124157|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321002|NCT06124157|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321003|NCT06124157|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321005|NCT06124157|Autonomic Agents|autonomic agents|mesh-ancestor
138321006|NCT06124157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321007|NCT06124157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138321008|NCT06124157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138321009|NCT06124157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321010|NCT06123962|Dimercaprol|dimercaprol|mesh-list
138321013|NCT06123962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321015|NCT06123884|Bevacizumab|bevacizumab|mesh-list
138321016|NCT06123884|Carboplatin|carboplatin|mesh-list
138321017|NCT06123884|Antibodies|antibodies|mesh-list
138321018|NCT06123884|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138321019|NCT06123884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321020|NCT06123884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321021|NCT06123884|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321022|NCT06123884|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321023|NCT06123884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321024|NCT06123884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321025|NCT06123884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321026|NCT06123884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138321027|NCT06123884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138321028|NCT06123884|Growth Substances|growth substances|mesh-ancestor
138321029|NCT06123884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321030|NCT06123884|Growth Inhibitors|growth inhibitors|mesh-ancestor
138321031|NCT06123884|Immunologic Factors|immunologic factors|mesh-ancestor
138321034|NCT06123715|Micronutrients|micronutrients|mesh-ancestor
138321035|NCT06123715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321036|NCT06123715|Antioxidants|antioxidants|mesh-ancestor
138321037|NCT06123715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321038|NCT06123715|Protective Agents|protective agents|mesh-ancestor
138321039|NCT06123702|Cannabidiol|cannabidiol|mesh-list
138321040|NCT06123702|Anticonvulsants|anticonvulsants|mesh-ancestor
138321041|NCT06123637|Anesthetics|anesthetics|mesh-list
138321042|NCT06123637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321043|NCT06123637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321044|NCT06123624|Sevoflurane|sevoflurane|mesh-list
138321045|NCT06123624|Desflurane|desflurane|mesh-list
138321046|NCT06123624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138321048|NCT06123624|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138321049|NCT06123624|Anesthetics, General|anesthetics, general|mesh-ancestor
138321050|NCT06123624|Anesthetics|anesthetics|mesh-ancestor
138321051|NCT06123624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321052|NCT06123624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321053|NCT06123364|Mirabegron|mirabegron|mesh-list
138321054|NCT06123364|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138321055|NCT06123364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138321056|NCT06123364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138321057|NCT06123364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138321058|NCT06123364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321059|NCT06123364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321060|NCT06123364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321061|NCT06123364|Urological Agents|urological agents|mesh-ancestor
138321064|NCT06122948|Analgesics|analgesics|mesh-ancestor
138321065|NCT06122948|Sensory System Agents|sensory system agents|mesh-ancestor
138321066|NCT06122948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321067|NCT06122948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321068|NCT06122948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138321069|NCT06122948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138321070|NCT06122948|Anesthetics, General|anesthetics, general|mesh-ancestor
138321071|NCT06122948|Anesthetics|anesthetics|mesh-ancestor
138321072|NCT06122948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321073|NCT06122948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138353224|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
138321074|NCT06122948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138321075|NCT06122948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321076|NCT06122948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321078|NCT06122948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138321079|NCT06122948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138321080|NCT06122948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138321081|NCT06122948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321082|NCT06122948|GABA Modulators|gaba modulators|mesh-ancestor
138321083|NCT06122948|GABA Agents|gaba agents|mesh-ancestor
138321084|NCT06121466|Lidocaine|lidocaine|mesh-list
138321085|NCT06121466|Anesthetics, Local|anesthetics, local|mesh-ancestor
138321086|NCT06121466|Anesthetics|anesthetics|mesh-ancestor
138321087|NCT06121466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321088|NCT06121466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321089|NCT06121466|Sensory System Agents|sensory system agents|mesh-ancestor
138321090|NCT06121466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321091|NCT06121466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138321092|NCT06121466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138321093|NCT06121466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138321094|NCT06121466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321095|NCT06121466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321096|NCT06119893|Dexamethasone|dexamethasone|mesh-list
138321097|NCT06119893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321101|NCT06119893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321102|NCT06119893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138321103|NCT06119893|Glucocorticoids|glucocorticoids|mesh-ancestor
138321104|NCT06119893|Hormones|hormones|mesh-ancestor
138321105|NCT06119893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321106|NCT06119893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138321107|NCT06119893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321108|NCT06118619|Interferons|interferons|mesh-list
138321109|NCT06118619|Interferon-gamma|interferon-gamma|mesh-list
138321110|NCT06118619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321111|NCT06118619|Antiviral Agents|antiviral agents|mesh-ancestor
138321112|NCT06118619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321113|NCT06113640|Levodopa|levodopa|mesh-list
138321114|NCT06113640|Carbidopa|carbidopa|mesh-list
138321115|NCT06113640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138321116|NCT06113640|Montelukast|montelukast|mesh-list
138321117|NCT06113640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138321118|NCT06113640|Respiratory System Agents|respiratory system agents|mesh-ancestor
138321119|NCT06113640|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138321120|NCT06113640|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321121|NCT06113640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321122|NCT06113640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321123|NCT06113640|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138321124|NCT06113640|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138321125|NCT06113640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321126|NCT06113640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138321127|NCT06113640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138321129|NCT06113640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321130|NCT06113640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138321132|NCT06113640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138321133|NCT06113640|Immunologic Factors|immunologic factors|mesh-ancestor
138321134|NCT06113640|Dopamine Agonists|dopamine agonists|mesh-ancestor
138321137|NCT06104280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321138|NCT06104280|Protective Agents|protective agents|mesh-ancestor
138321139|NCT06104280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321140|NCT06104280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321142|NCT06086340|Palbociclib|palbociclib|mesh-list
138321143|NCT06086340|Anastrozole|anastrozole|mesh-list
138321144|NCT06086340|Exemestane|exemestane|mesh-list
138321146|NCT06086340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321147|NCT06086340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138321148|NCT06086340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321149|NCT06086340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321150|NCT06086340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138321151|NCT06086340|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321152|NCT06086340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321153|NCT06086340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321154|NCT06086340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321155|NCT06086340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138321156|NCT06083883|Cyclophosphamide|cyclophosphamide|mesh-list
138321158|NCT06083883|Fludarabine phosphate|fludarabine phosphate|mesh-list
138321159|NCT06083883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321160|NCT06083883|Immunologic Factors|immunologic factors|mesh-ancestor
138321161|NCT06083883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321162|NCT06083883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321163|NCT06083883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321164|NCT06083883|Alkylating Agents|alkylating agents|mesh-ancestor
138321165|NCT06083883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321166|NCT06083883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321167|NCT06083883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138321168|NCT06083883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321169|NCT06083883|Antimetabolites|antimetabolites|mesh-ancestor
138321170|NCT06067438|Amiodarone|amiodarone|mesh-list
138321171|NCT06067438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138321172|NCT06067438|Vasodilator Agents|vasodilator agents|mesh-ancestor
138321173|NCT06067438|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138321174|NCT06067438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321175|NCT06067438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321176|NCT06067438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138321177|NCT06067438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138321178|NCT06067438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138321179|NCT06067438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321180|NCT06067438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138321181|NCT06067438|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138321182|NCT06067438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138321183|NCT06050954|Pembrolizumab|pembrolizumab|mesh-list
138321184|NCT06050954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321185|NCT06050954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321186|NCT06050954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321187|NCT06050954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321189|NCT06027723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138321190|NCT06027723|Autonomic Agents|autonomic agents|mesh-ancestor
138321191|NCT06027723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321192|NCT06027723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321193|NCT06027723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138321194|NCT06027723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138321197|NCT06027723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321198|NCT06001112|Etoricoxib|etoricoxib|mesh-list
138321199|NCT06001112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138321200|NCT06001112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321201|NCT06001112|Analgesics|analgesics|mesh-ancestor
138321202|NCT06001112|Sensory System Agents|sensory system agents|mesh-ancestor
138321203|NCT06001112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321204|NCT06001112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321205|NCT06001112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321206|NCT06001112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321209|NCT06001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321210|NCT06001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321211|NCT05991427|Vaccines|vaccines|mesh-list
138321212|NCT05991427|Immunologic Factors|immunologic factors|mesh-ancestor
138321213|NCT05991427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321215|NCT05991232|Analgesics|analgesics|mesh-ancestor
138321216|NCT05991232|Sensory System Agents|sensory system agents|mesh-ancestor
138321217|NCT05991232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321218|NCT05991232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321219|NCT05991232|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138321220|NCT05991232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138321221|NCT05991232|Anesthetics, General|anesthetics, general|mesh-ancestor
138353231|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
138321222|NCT05991232|Anesthetics|anesthetics|mesh-ancestor
138321223|NCT05991232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321224|NCT05991232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138321225|NCT05991232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138321226|NCT05991232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321227|NCT05991232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321228|NCT05990192|Niraparib|niraparib|mesh-list
138321229|NCT05990192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138321230|NCT05990192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321231|NCT05990192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321232|NCT05990192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321233|NCT05972512|Biotin|biotin|mesh-list
138321234|NCT05972512|Vitamin B Complex|vitamin b complex|mesh-ancestor
138321235|NCT05972512|Vitamins|vitamins|mesh-ancestor
138321236|NCT05972512|Micronutrients|micronutrients|mesh-ancestor
138321237|NCT05972512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321238|NCT05917522|Abatacept|abatacept|mesh-list
138289153|NCT00000776|Hormones|hormones|mesh-ancestor
138321240|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321241|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321242|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321243|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321244|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
138321245|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321246|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321248|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138321249|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138321250|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321251|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321252|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138321253|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138321254|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321255|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138321256|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
138321258|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
138321259|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
138321260|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321261|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321262|NCT05876390|Acetaminophen|acetaminophen|mesh-list
138321263|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321264|NCT05876390|Analgesics|analgesics|mesh-ancestor
138321265|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
138321266|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321267|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321268|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
138321269|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138321270|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321271|NCT05786768|Rituximab|rituximab|mesh-list
138321272|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
138321273|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321274|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321275|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
138321276|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321277|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321278|NCT05765084|Pemetrexed|pemetrexed|mesh-list
138353241|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138321279|NCT05765084|Atezolizumab|atezolizumab|mesh-list
138321280|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321281|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353251|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138321282|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321283|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138321284|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138321285|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321286|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321287|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
138321289|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321290|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321291|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321292|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321293|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321294|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138321295|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138321297|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138321299|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321300|NCT05700448|Gemcitabine|gemcitabine|mesh-list
138321301|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
138321302|NCT05700448|Pegaspargase|pegaspargase|mesh-list
138321303|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321304|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
138321305|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321306|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321307|NCT05689151|Abrocitinib|abrocitinib|mesh-list
138321308|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321309|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321310|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321311|NCT05668585|Trametinib|trametinib|mesh-list
138321312|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321313|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321314|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321315|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321316|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138321317|NCT05662865|Ertugliflozin|ertugliflozin|mesh-list
138321318|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321319|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138321320|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321321|NCT05622071|Tislelizumab|tislelizumab|mesh-list
138321322|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321323|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321324|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138321325|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321327|NCT05566054|Venetoclax|venetoclax|mesh-list
138321328|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321329|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
138321330|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321331|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321335|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
138321336|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321337|NCT05540288|Nalmefene|nalmefene|mesh-list
138321338|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138321339|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321340|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
138321341|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321342|NCT05523440|Bevacizumab|bevacizumab|mesh-list
138321343|NCT05523440|Niraparib|niraparib|mesh-list
138321344|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321345|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321346|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138321347|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138321351|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138321352|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321353|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321354|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
138321356|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321357|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
138321358|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321359|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321360|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321361|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
138321362|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321364|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138321365|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321366|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
138321367|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138321368|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321370|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138321371|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321373|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321374|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
138321375|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321376|NCT05391828|Cimetidine|cimetidine|mesh-list
138321377|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138321378|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138321379|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138321380|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138321381|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
138321382|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321383|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321384|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321385|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138321386|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138321388|NCT05390736|Vitamin D|vitamin d|mesh-list
138321390|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
138321391|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321392|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138321393|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
138321394|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321395|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321396|NCT05369052|Linezolid|linezolid|mesh-list
138321397|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321398|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321399|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138321400|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321401|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321402|NCT05353283|Tenofovir|tenofovir|mesh-list
138321403|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
138321404|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321405|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138321406|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138321407|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321408|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321409|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138321410|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138321411|NCT05344209|Sargramostim|sargramostim|mesh-list
138321412|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
138321419|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321420|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321423|NCT05321420|Analgesics|analgesics|mesh-ancestor
138321424|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
138321425|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321426|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321427|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138321428|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321429|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321430|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321431|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321432|NCT05299931|Ustekinumab|ustekinumab|mesh-list
138321433|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
138321434|NCT05216432|Fulvestrant|fulvestrant|mesh-list
138321435|NCT05216432|Palbociclib|palbociclib|mesh-list
138321436|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138321437|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321438|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138321439|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138321440|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321441|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353262|NCT01608906|Heparin|heparin|mesh-list
138321442|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321443|NCT05216432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321444|NCT05216432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321445|NCT05216432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321450|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
138321451|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321452|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
138321453|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321455|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321456|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321457|NCT05173987|Paclitaxel|paclitaxel|mesh-list
138321458|NCT05173987|Docetaxel|docetaxel|mesh-list
138321459|NCT05173987|Carboplatin|carboplatin|mesh-list
138321460|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
138321461|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321463|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321464|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321465|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321466|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321467|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321468|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321471|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138321472|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
138321473|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321474|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321478|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138321479|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138321480|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321481|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321484|NCT05160922|Crizotinib|crizotinib|mesh-list
138321485|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321486|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321487|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321488|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321489|NCT05060549|Cariprazine|cariprazine|mesh-list
138321490|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138321492|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321493|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321494|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321495|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138321496|NCT05041127|Cetuximab|cetuximab|mesh-list
138321497|NCT05041127|Antibodies|antibodies|mesh-list
138321498|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
138321500|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
138321501|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321502|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321503|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138321504|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138321505|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138321506|NCT04951050|Sirolimus|sirolimus|mesh-list
138321507|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321508|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321509|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138321510|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321511|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
138321512|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321513|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
138321514|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321515|NCT04944836|Clomiphene|clomiphene|mesh-list
138321516|NCT04944836|Enclomiphene|enclomiphene|mesh-list
138321517|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
138321518|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138321519|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321524|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138321525|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138321526|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138321528|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
138321529|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321530|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138321531|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138321532|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321533|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321534|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138321535|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321536|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321537|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321538|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138321539|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
138321542|NCT04827966|Fluorides|fluorides|mesh-list
138321543|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
138321544|NCT04827966|Caseins|caseins|mesh-list
138321545|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138321546|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321547|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138321548|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
138321549|NCT04827966|Protective Agents|protective agents|mesh-ancestor
138321550|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138321551|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321553|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
138321554|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321555|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
138321556|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321557|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321558|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321559|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321561|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321562|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321563|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138321564|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321565|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
138321566|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321567|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
138321568|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321569|NCT04739865|Psilocybin|psilocybin|mesh-list
138321570|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
138321571|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321572|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321573|NCT04638465|Cisplatin|cisplatin|mesh-list
138321574|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321575|NCT04630522|Vitamin D|vitamin d|mesh-list
138321576|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
138321577|NCT04630522|Calcium|calcium|mesh-list
138321578|NCT04630522|Vitamins|vitamins|mesh-ancestor
138321579|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
138321580|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321581|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138321582|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138321583|NCT04615013|Leucovorin|leucovorin|mesh-list
138321584|NCT04615013|Paclitaxel|paclitaxel|mesh-list
138321585|NCT04615013|Docetaxel|docetaxel|mesh-list
138321586|NCT04615013|Carboplatin|carboplatin|mesh-list
138321587|NCT04615013|Capecitabine|capecitabine|mesh-list
138321588|NCT04615013|Fluorouracil|fluorouracil|mesh-list
138321589|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
138321590|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138321591|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321592|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321593|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321594|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321595|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321596|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321597|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321598|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
138321599|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321600|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
138321601|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321602|NCT04615013|Antidotes|antidotes|mesh-ancestor
138321603|NCT04615013|Protective Agents|protective agents|mesh-ancestor
138321604|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
138321605|NCT04615013|Vitamins|vitamins|mesh-ancestor
138321606|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
138321607|NCT04597190|Norepinephrine|norepinephrine|mesh-list
138321608|NCT04597190|Serotonin|serotonin|mesh-list
138321610|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138321612|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
138321614|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321615|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321616|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
138321617|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
138321618|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321619|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138321620|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138321621|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
138321622|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138321623|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321624|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
138321625|NCT04579523|Fludarabine|fludarabine|mesh-list
138321626|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
138321627|NCT04579523|Daratumumab|daratumumab|mesh-list
138321628|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138321630|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
138321631|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138321632|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321633|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
138321634|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321635|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321636|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321637|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
138321638|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321639|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321643|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
138321644|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321645|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321646|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321647|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321648|NCT04535271|Gemcitabine|gemcitabine|mesh-list
138321651|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321652|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
138321653|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321654|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321655|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321656|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
138321659|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
138321660|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321661|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138321662|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321663|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321664|NCT04511052|Carotenoids|carotenoids|mesh-list
138321665|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
138321666|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321667|NCT04511052|Protective Agents|protective agents|mesh-ancestor
138321668|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321670|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321671|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321672|NCT04494425|Paclitaxel|paclitaxel|mesh-list
138321673|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138321674|NCT04494425|Capecitabine|capecitabine|mesh-list
138321675|NCT04494425|Trastuzumab|trastuzumab|mesh-list
138321676|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138321677|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321678|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321679|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321680|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321681|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321682|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321683|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321684|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
138321685|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321686|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
138321687|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
138321688|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321690|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138321692|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321694|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321695|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138321696|NCT04439279|Protective Agents|protective agents|mesh-ancestor
138321697|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321698|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138321699|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
138321700|NCT04294966|Dronabinol|dronabinol|mesh-list
138321702|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321703|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321704|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321705|NCT04294966|Analgesics|analgesics|mesh-ancestor
138321706|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
138321707|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321708|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138321709|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138321710|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321711|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321712|NCT04294966|Hormones|hormones|mesh-ancestor
138321713|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321714|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
138321715|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321716|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321717|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321718|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321719|NCT04274361|Ketamine|ketamine|mesh-list
138321720|NCT04274361|Analgesics|analgesics|mesh-ancestor
138321721|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
138321722|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321723|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321724|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138321725|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138321726|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
138321727|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
138321728|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321729|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138321730|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138321731|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321732|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321733|NCT04245215|Ustekinumab|ustekinumab|mesh-list
138321734|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
138321735|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
138321736|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
138321737|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321738|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321739|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321740|NCT04214990|Aspirin|aspirin|mesh-list
138321741|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138321742|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321743|NCT04214990|Analgesics|analgesics|mesh-ancestor
138321747|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321748|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321749|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138321750|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138321751|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321752|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138321753|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138321754|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321755|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
138321756|NCT04198727|Capecitabine|capecitabine|mesh-list
138353280|NCT01527942|Acetaminophen|acetaminophen|mesh-list
138353281|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353282|NCT01527942|Analgesics|analgesics|mesh-ancestor
138353283|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
138321757|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321758|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
138321759|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321760|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321762|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321763|NCT04095364|Paclitaxel|paclitaxel|mesh-list
138321764|NCT04095364|Carboplatin|carboplatin|mesh-list
138321765|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138321766|NCT04095364|Letrozole|letrozole|mesh-list
138321767|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321768|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321769|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321771|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321772|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321773|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138321774|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138321775|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321776|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138321777|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321778|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321779|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321781|NCT04068597|Azacitidine|azacitidine|mesh-list
138321783|NCT04068597|Pomalidomide|pomalidomide|mesh-list
138321784|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321785|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
138321786|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
138321787|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321789|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138321791|NCT04068597|Hormones|hormones|mesh-ancestor
138321792|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321793|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138321794|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321795|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321796|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
138321797|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321798|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321799|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
138321800|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138321801|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138321802|NCT04068597|Growth Substances|growth substances|mesh-ancestor
138321803|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
138321804|NCT04004442|Avelumab|avelumab|mesh-list
138321805|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321807|NCT03983954|Durvalumab|durvalumab|mesh-list
138321808|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
138321809|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138321810|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
138321811|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
138321812|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321813|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321814|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
138321815|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321816|NCT03969420|Cytarabine|cytarabine|mesh-list
138321817|NCT03969420|Alvocidib|alvocidib|mesh-list
138321818|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321819|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
138321820|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321821|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321822|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
138321823|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321824|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321825|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
138321828|NCT03969420|Growth Substances|growth substances|mesh-ancestor
138321829|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321830|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321831|NCT03945305|Antihypertensive Agents|antihypertensive agents|mesh-list
138321832|NCT03921242|Metformin|metformin|mesh-list
138321833|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138321835|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138321836|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321844|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321845|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321846|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321847|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321848|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321849|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
138321850|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321851|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321852|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
138321853|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321854|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321855|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321856|NCT03875573|Durvalumab|durvalumab|mesh-list
138321857|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321858|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321859|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138321860|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
138321861|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321862|NCT03861767|Metformin|metformin|mesh-list
138321863|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138321865|NCT03842696|Cyclosporine|cyclosporine|mesh-list
138321866|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
138321867|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
138321868|NCT03842696|Methotrexate|methotrexate|mesh-list
138321869|NCT03842696|Vorinostat|vorinostat|mesh-list
138321870|NCT03842696|Tacrolimus|tacrolimus|mesh-list
138321871|NCT03842696|Cyclosporins|cyclosporins|mesh-list
138321872|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321873|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
138321874|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321875|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321876|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321877|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
138321878|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321879|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321880|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138321881|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138321882|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
138321883|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138321884|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321889|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138321890|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138321891|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
138321892|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138321893|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138321894|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138321895|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
138321896|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321897|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138321899|NCT03756298|Atezolizumab|atezolizumab|mesh-list
138321900|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321901|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
138321902|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321903|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321904|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321906|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
138321907|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138321908|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321909|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138321910|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321911|NCT03716349|Anesthetics|anesthetics|mesh-list
138321912|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
138321913|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321914|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321915|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
138321920|NCT03691935|Ropivacaine|ropivacaine|mesh-list
138321921|NCT03691935|Anesthetics|anesthetics|mesh-list
138321922|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
138321923|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138321924|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321925|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
138321926|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321927|NCT03686345|Midostaurin|midostaurin|mesh-list
138321928|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321929|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321930|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321931|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321933|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
138321934|NCT03677141|Doxorubicin|doxorubicin|mesh-list
138321935|NCT03677141|Vincristine|vincristine|mesh-list
138321936|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138321937|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138321938|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
138321941|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321942|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
138321943|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321944|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321945|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138321946|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138321947|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138321948|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138321949|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321950|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138321951|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
138321952|NCT03677141|Hormones|hormones|mesh-ancestor
138321953|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321954|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138321955|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321956|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321957|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321958|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321959|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
138321960|NCT03617679|Rucaparib|rucaparib|mesh-list
138321961|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138321962|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321963|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321964|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321965|NCT03593915|Azacitidine|azacitidine|mesh-list
138321966|NCT03593915|Decitabine|decitabine|mesh-list
138321967|NCT03593915|Alvocidib|alvocidib|mesh-list
138321968|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321969|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
138321970|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321971|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321972|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321973|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
138321974|NCT03593915|Growth Substances|growth substances|mesh-ancestor
138321975|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321976|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138321977|NCT03587038|Temozolomide|temozolomide|mesh-list
138321978|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138321980|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321981|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321982|NCT03563716|Atezolizumab|atezolizumab|mesh-list
138321983|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138321984|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321985|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138321986|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321987|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
138321988|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
138321989|NCT03541850|Hormones|hormones|mesh-list
138321990|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138321991|NCT03541850|Androgens|androgens|mesh-list
138321992|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
138321993|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321994|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321995|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
138321996|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321997|NCT03541850|Protective Agents|protective agents|mesh-ancestor
138321998|NCT03541850|Vitamins|vitamins|mesh-ancestor
138321999|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
138322000|NCT03541850|Estrogens|estrogens|mesh-ancestor
138322001|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138322002|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322003|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
138322004|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322005|NCT03535272|Bismuth|bismuth|mesh-list
138322006|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138322007|NCT03535272|Antacids|antacids|mesh-ancestor
138322008|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322009|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322011|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
138322012|NCT03517137|Dacarbazine|dacarbazine|mesh-list
138322013|NCT03517137|Etoposide|etoposide|mesh-list
138322014|NCT03517137|Doxorubicin|doxorubicin|mesh-list
138322015|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138322016|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138322017|NCT03517137|Vinblastine|vinblastine|mesh-list
138322018|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322019|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
138322020|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322021|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322022|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322023|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
138322024|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322025|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322026|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138322027|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322028|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322029|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322033|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
138322034|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
138322035|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322036|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322037|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322038|NCT03485677|Eliglustat|eliglustat|mesh-list
138322039|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322040|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322041|NCT03442309|Fluorides|fluorides|mesh-list
138322042|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
138322043|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
138322044|NCT03442309|Protective Agents|protective agents|mesh-ancestor
138322045|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322046|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
138322047|NCT03384836|Propranolol|propranolol|mesh-list
138322048|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322049|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322050|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322051|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322052|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138322053|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138322054|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
138322055|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322056|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322057|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138322058|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322059|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322060|NCT03336333|Rituximab|rituximab|mesh-list
138322061|NCT03336333|Venetoclax|venetoclax|mesh-list
138322062|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138322063|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
138322064|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322065|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322066|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
138322067|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322068|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322069|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322070|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
138322071|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322075|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322076|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
138322077|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
138322078|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322079|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322080|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322081|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
138322082|NCT03275285|Hormones|hormones|mesh-ancestor
138322083|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322084|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138322085|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322086|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138322087|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
138322088|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
138322089|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322090|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322091|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138322092|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138322094|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322095|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322096|NCT03229057|Metformin|metformin|mesh-list
138322097|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322098|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322099|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
138322100|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138322101|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138322106|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
138322107|NCT03070184|Metoprolol|metoprolol|mesh-list
138322108|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138322109|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322110|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
138322111|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
138322112|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322113|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322114|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138322115|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138322116|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138322117|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138322118|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322119|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322120|NCT03033342|Omeprazole|omeprazole|mesh-list
138322121|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138322122|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322123|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138322124|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322125|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322127|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
138322128|NCT02957968|Carboplatin|carboplatin|mesh-list
138322130|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
138322131|NCT02957968|Decitabine|decitabine|mesh-list
138322132|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322133|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322134|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322135|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322136|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322137|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322138|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322139|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
138322140|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322141|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322142|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322143|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
138322144|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138322145|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322146|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322147|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322148|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322149|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322150|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322152|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
138322154|NCT02819518|Paclitaxel|paclitaxel|mesh-list
138322155|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138322157|NCT02819518|Gemcitabine|gemcitabine|mesh-list
138322158|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
138322159|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322160|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322161|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322162|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322163|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322164|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322165|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138322166|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
138322167|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353300|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322168|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322169|NCT02718066|Nivolumab|nivolumab|mesh-list
138322170|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322171|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322172|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322173|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322174|NCT02599363|Paclitaxel|paclitaxel|mesh-list
138322175|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322176|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322177|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322178|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322179|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322180|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322182|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138322183|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
138322184|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322185|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322186|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
138322187|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322189|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322190|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
138322191|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
138322192|NCT02475681|Chlorambucil|chlorambucil|mesh-list
138322193|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322194|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322195|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322196|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
138322197|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322198|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
138322199|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322200|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322201|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322202|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322203|NCT02407119|Amoxicillin|amoxicillin|mesh-list
138322204|NCT02407119|Clarithromycin|clarithromycin|mesh-list
138322206|NCT02407119|Rabeprazole|rabeprazole|mesh-list
138322207|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138322208|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322209|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322210|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138322211|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322212|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322213|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322214|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138322215|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138322216|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138322217|NCT02369406|Lamivudine|lamivudine|mesh-list
138322218|NCT02369406|Zidovudine|zidovudine|mesh-list
138322219|NCT02369406|Nevirapine|nevirapine|mesh-list
138322220|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138322221|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138322222|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322223|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322227|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138322228|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
138322229|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138322230|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138322231|NCT02127073|Oxytocin|oxytocin|mesh-list
138322232|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
138322233|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138322234|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322235|NCT02112214|Bismuth|bismuth|mesh-list
138322236|NCT02112214|Antacids|antacids|mesh-ancestor
138322237|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322238|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322240|NCT02074267|Analgesics|analgesics|mesh-ancestor
138322241|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
138322242|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322243|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322244|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
138322245|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138322246|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138322247|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322248|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138322249|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138322250|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138322251|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322252|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322253|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
138322255|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322256|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322257|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138322258|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322259|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322260|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138322261|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138322262|NCT01121588|Crizotinib|crizotinib|mesh-list
138322263|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322264|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322265|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322266|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322267|NCT00739986|Semapimod|semapimod|mesh-list
138322268|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138322269|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138322270|NCT00739986|Analgesics|analgesics|mesh-ancestor
138322271|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
138322272|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322273|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322274|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322275|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322277|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
138322278|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
138322279|NCT00716976|Antidotes|antidotes|mesh-ancestor
138322280|NCT00716976|Protective Agents|protective agents|mesh-ancestor
138322281|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322282|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
138322283|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322284|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
138322285|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322286|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322287|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
138322288|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
138322289|NCT00634634|Sorafenib|sorafenib|mesh-list
138322290|NCT00634634|Letrozole|letrozole|mesh-list
138322291|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322292|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322293|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322294|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322296|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138322298|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322299|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322300|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322301|NCT00509353|Irinotecan|irinotecan|mesh-list
138322302|NCT00509353|Vincristine|vincristine|mesh-list
138322303|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138322304|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138322305|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322306|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322307|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322308|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322309|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322310|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322311|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322312|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322313|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138322314|NCT00049595|Prednisone|prednisone|mesh-list
138322315|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
138322316|NCT00049595|Dacarbazine|dacarbazine|mesh-list
138322317|NCT00049595|Doxorubicin|doxorubicin|mesh-list
138322318|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138322319|NCT00049595|Etoposide|etoposide|mesh-list
138322320|NCT00049595|Vincristine|vincristine|mesh-list
138322321|NCT00049595|Bleomycin|bleomycin|mesh-list
138322322|NCT00049595|Vinblastine|vinblastine|mesh-list
138322323|NCT00049595|Procarbazine|procarbazine|mesh-list
138322324|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322325|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
138322326|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322327|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322328|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322329|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
138322330|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322331|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322332|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138322333|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322334|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322335|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322336|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322337|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322338|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
138322339|NCT00049595|Hormones|hormones|mesh-ancestor
138322340|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322341|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138322342|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322343|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322344|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322345|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322348|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138322349|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138322350|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138322351|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322352|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322353|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138322354|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138322355|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138322357|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322358|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322359|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
138322360|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322361|NCT01677546|Insulin|insulin|mesh-list
138322362|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138322363|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322364|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322365|NCT04403724|Fentanyl|fentanyl|mesh-list
138322366|NCT04403724|Morphine|morphine|mesh-list
138322367|NCT04403724|Bupivacaine|bupivacaine|mesh-list
138322368|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
138322369|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
138322370|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322371|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322372|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
138322373|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322374|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138322375|NCT04403724|Narcotics|narcotics|mesh-ancestor
138322376|NCT04403724|Analgesics|analgesics|mesh-ancestor
138322377|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138322378|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138322379|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
138322380|NCT04403568|Ursolic acid|ursolic acid|mesh-list
138322382|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138322383|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138322384|NCT04403568|Analgesics|analgesics|mesh-ancestor
138322385|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
138322386|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322388|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322389|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322390|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322391|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322392|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322393|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322395|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138322398|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
138353309|NCT01385280|Estrogens|estrogens|mesh-ancestor
138322399|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322400|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
138322401|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322402|NCT03564756|Protective Agents|protective agents|mesh-ancestor
138322404|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322405|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322406|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322407|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
138322408|NCT03458598|Narcotics|narcotics|mesh-ancestor
138322409|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322410|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322411|NCT03458598|Analgesics|analgesics|mesh-ancestor
138322412|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
138322413|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322414|NCT03791736|Octreotide|octreotide|mesh-list
138322415|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322416|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138322417|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322418|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
138322420|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138322421|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
138322422|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322423|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138322424|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138322425|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322426|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322427|NCT03524898|Paclitaxel|paclitaxel|mesh-list
138322428|NCT03524898|Gemcitabine|gemcitabine|mesh-list
138322429|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322430|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322431|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322432|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322434|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322435|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138322438|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322439|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322441|NCT03524508|Irinotecan|irinotecan|mesh-list
138322442|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
138322443|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322444|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138322445|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322446|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322447|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
138322448|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322449|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138322450|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322451|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322452|NCT03457818|Denosumab|denosumab|mesh-list
138322453|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138322454|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322455|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138322457|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
138322458|NCT01676844|Protective Agents|protective agents|mesh-ancestor
138322459|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322460|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
138322461|NCT04403334|Levofloxacin|levofloxacin|mesh-list
138322462|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322463|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322464|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322465|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322467|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322468|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322469|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138322470|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138322471|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138322472|NCT03779646|Bisoprolol|bisoprolol|mesh-list
138322473|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322474|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
138322475|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
138322476|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322477|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353315|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138322478|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138322479|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138322482|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322483|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322484|NCT00089778|Aldesleukin|aldesleukin|mesh-list
138322485|NCT00089778|Interleukin-2|interleukin-2|mesh-list
138322486|NCT00089778|Mitogens|mitogens|mesh-list
138322487|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322488|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138322489|NCT00089778|Analgesics|analgesics|mesh-ancestor
138322491|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322492|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322493|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322494|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322495|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138322496|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138322497|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
138322498|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322499|NCT00089544|Thalidomide|thalidomide|mesh-list
138322500|NCT00089544|Doxorubicin|doxorubicin|mesh-list
138322501|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138322502|NCT00089544|Ifosfamide|ifosfamide|mesh-list
138322503|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
138322504|NCT00089544|Dacarbazine|dacarbazine|mesh-list
138322505|NCT00089544|Imidazole|imidazole|mesh-list
138322507|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322508|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322509|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322510|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322511|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322512|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322513|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138322514|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
138322515|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322516|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322517|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
138322518|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322519|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
138322520|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322521|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322522|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138322523|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138322524|NCT00089544|Growth Substances|growth substances|mesh-ancestor
138322525|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
138322526|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138322528|NCT00089076|Antibodies|antibodies|mesh-list
138322529|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
138322530|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138322532|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322533|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322534|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322535|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322536|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138322537|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138322538|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322540|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138322541|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
138322542|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322543|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
138322544|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322545|NCT03770286|Fluorides|fluorides|mesh-list
138322546|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
138322547|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
138322549|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322550|NCT00087516|Metformin|metformin|mesh-list
138322551|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138322552|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322553|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322554|NCT00087516|Incretins|incretins|mesh-ancestor
138322555|NCT00087516|Hormones|hormones|mesh-ancestor
138322556|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322557|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138322558|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
138322559|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322560|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322562|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322563|NCT00087126|Topotecan|topotecan|mesh-list
138322564|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138322565|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322566|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322567|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322568|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322569|NCT00086346|Cyclosporine|cyclosporine|mesh-list
138322570|NCT00086346|Sirolimus|sirolimus|mesh-list
138322571|NCT00086346|Tacrolimus|tacrolimus|mesh-list
138322572|NCT00086346|Cyclosporins|cyclosporins|mesh-list
138322573|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322574|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
138322575|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322576|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138322578|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322579|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
138322580|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322581|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
138322582|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322583|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322584|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322585|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322586|NCT00085566|Everolimus|everolimus|mesh-list
138322587|NCT00085566|Gefitinib|gefitinib|mesh-list
138322588|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138322589|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322590|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322591|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322592|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322593|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
138322594|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322595|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322596|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
138322597|NCT00085098|Cisplatin|cisplatin|mesh-list
138322598|NCT00085098|Carboplatin|carboplatin|mesh-list
138322599|NCT00085098|Etoposide|etoposide|mesh-list
138322600|NCT00085098|Lenograstim|lenograstim|mesh-list
138322601|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322602|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
138322603|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322604|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322605|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322606|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
138322607|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322608|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322609|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138322610|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322611|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322612|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322613|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322614|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138322616|NCT00084864|Dexamethasone|dexamethasone|mesh-list
138322617|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322618|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
138322619|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
138322621|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322622|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138322623|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
138322624|NCT00084864|Hormones|hormones|mesh-ancestor
138322625|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322628|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138322629|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138322630|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138322631|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322632|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138322633|NCT00084864|Vitamins|vitamins|mesh-ancestor
138322634|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
138322635|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138322636|NCT01677702|Lactoferrin|lactoferrin|mesh-list
138322637|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322638|NCT01473108|Eplerenone|eplerenone|mesh-list
138322639|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138322640|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322641|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322642|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322643|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138322644|NCT01473108|Diuretics|diuretics|mesh-ancestor
138322645|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
138322646|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322648|NCT00084318|Cetuximab|cetuximab|mesh-list
138322649|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322650|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322651|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322652|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322653|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322654|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322655|NCT00083616|Panitumumab|panitumumab|mesh-list
138322656|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322657|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322658|NCT00083226|Doxorubicin|doxorubicin|mesh-list
138322663|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138322664|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138322666|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322667|NCT00082758|Interleukin-2|interleukin-2|mesh-list
138322668|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
138322669|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322670|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138322671|NCT00082758|Analgesics|analgesics|mesh-ancestor
138322672|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
138322673|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322674|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322675|NCT03438318|Atezolizumab|atezolizumab|mesh-list
138322676|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322677|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322678|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322679|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322680|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
138322681|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138322682|NCT03087942|Growth Substances|growth substances|mesh-ancestor
138322683|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322685|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138322686|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138322687|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
138322688|NCT04402320|Midazolam|midazolam|mesh-list
138322689|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138322690|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138322691|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322692|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322693|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138322694|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138322695|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138322696|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138322701|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322702|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322703|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
138322704|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322705|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322706|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322707|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322708|NCT03088176|Trametinib|trametinib|mesh-list
138322709|NCT03088176|Dabrafenib|dabrafenib|mesh-list
138322710|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138322711|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322712|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322713|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322714|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322715|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322716|NCT01678404|Rituximab|rituximab|mesh-list
138322717|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322718|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322719|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
138322720|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322721|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322722|NCT03087864|Paclitaxel|paclitaxel|mesh-list
138322723|NCT03087864|Carboplatin|carboplatin|mesh-list
138322724|NCT03087864|Atezolizumab|atezolizumab|mesh-list
138322725|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322726|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322727|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322728|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322729|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322730|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322731|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322732|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322733|NCT01678716|Micronutrients|micronutrients|mesh-list
138322734|NCT01678716|Trace Elements|trace elements|mesh-list
138322739|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322740|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138322741|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138322742|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322743|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322744|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138322745|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322746|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322747|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322748|NCT00088452|Lamotrigine|lamotrigine|mesh-list
138322749|NCT00088452|Valproic Acid|valproic acid|mesh-list
138322750|NCT00088452|Ethosuximide|ethosuximide|mesh-list
138322751|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
138322752|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138322753|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138322754|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322755|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138322756|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322757|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138322758|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138322759|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322760|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138322761|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138322762|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322763|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
138322764|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322765|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
138322767|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138322768|NCT01679106|Narcotics|narcotics|mesh-ancestor
138322769|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322770|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322771|NCT01679106|Analgesics|analgesics|mesh-ancestor
138322773|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322774|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138322775|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138322776|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
138322780|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
138322781|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138322782|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138322783|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
138322784|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322785|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322786|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138322787|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138322788|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
138322789|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322790|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138322791|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138322792|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
138322793|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138322794|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138322795|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322796|NCT03086538|Pemetrexed|pemetrexed|mesh-list
138322797|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138322798|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322799|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322800|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322801|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138322802|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138322803|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322805|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322806|NCT03081858|Paclitaxel|paclitaxel|mesh-list
138322807|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322808|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322809|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
138322810|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
138322811|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322812|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322814|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322815|NCT01679574|Metformin|metformin|mesh-list
138322816|NCT01679574|Letrozole|letrozole|mesh-list
138322818|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322819|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322820|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322821|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138322822|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138322824|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322825|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138322826|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322827|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322828|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138322829|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
138322830|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138322831|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138322832|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138322834|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138322835|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322836|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138322837|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138322838|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138322839|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
138322840|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322841|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322842|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322844|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322845|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322846|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138322847|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322849|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322850|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322851|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
138322852|NCT03417492|Citric Acid|citric acid|mesh-list
138322853|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
138322854|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
138322855|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138322856|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
138322857|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
138322858|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322859|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322860|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138322861|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138322862|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353342|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322863|NCT03417492|Urological Agents|urological agents|mesh-ancestor
138322864|NCT03080766|Decitabine|decitabine|mesh-list
138322865|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138322868|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322869|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322870|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
138322871|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138322872|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322873|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
138322874|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138322875|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322876|NCT03088254|Amlodipine|amlodipine|mesh-list
138322877|NCT03088254|Telmisartan|telmisartan|mesh-list
138322878|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138322880|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138322881|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138322882|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322883|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138322884|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322885|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138322886|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138322887|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138322888|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
138322889|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138322890|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138322891|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322892|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138322893|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138322895|NCT05684484|Salicylates|salicylates|mesh-list
138322896|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322897|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
138322898|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
138322899|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138322900|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138322901|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138322906|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138322907|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322908|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138322909|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322910|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322912|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
138322913|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138322914|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138322915|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138322916|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322917|NCT03086226|Itraconazole|itraconazole|mesh-list
138322918|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
138322919|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322920|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138322921|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138322922|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322923|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322924|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138322925|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
138322926|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322927|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322928|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138322929|NCT03085992|Bevacizumab|bevacizumab|mesh-list
138322930|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322931|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322932|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138322933|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138322935|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322941|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322942|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322943|NCT05688306|Oprelvekin|oprelvekin|mesh-list
138353348|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322944|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322945|NCT03086148|Ketamine|ketamine|mesh-list
138322946|NCT03086148|Analgesics|analgesics|mesh-ancestor
138322947|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
138322948|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322949|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322950|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138322951|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138322952|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
138322953|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
138322954|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322955|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138322956|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138322957|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322958|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322959|NCT03359538|Sirolimus|sirolimus|mesh-list
138322960|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138322961|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322962|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322963|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322964|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
138322965|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322966|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
138322967|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322968|NCT05345808|Triamcinolone|triamcinolone|mesh-list
138322971|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138322973|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
138322974|NCT05345808|Hormones|hormones|mesh-ancestor
138322975|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138322976|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322977|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322978|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
138322979|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322980|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322981|NCT02336958|Ropivacaine|ropivacaine|mesh-list
138322982|NCT02336958|Prilocaine|prilocaine|mesh-list
138322983|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
138322984|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
138322985|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138322986|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322987|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
138322988|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322989|NCT03085368|Trastuzumab|trastuzumab|mesh-list
138322991|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138322992|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322993|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138322994|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322995|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322996|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138322997|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138322999|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138323000|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323001|NCT03084978|Anesthetics|anesthetics|mesh-list
138323002|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323003|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323004|NCT03084588|Methadone|methadone|mesh-list
138323005|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138323006|NCT03084588|Narcotics|narcotics|mesh-ancestor
138323007|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323008|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323009|NCT03084588|Analgesics|analgesics|mesh-ancestor
138323011|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323013|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
138323014|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
138323015|NCT05345574|Remifentanil|remifentanil|mesh-list
138323016|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138323017|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323018|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323019|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323021|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
138323022|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323023|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138323024|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138323026|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
138323027|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323028|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323029|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138323031|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
138323032|NCT05598606|Denosumab|denosumab|mesh-list
138323033|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138323034|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323035|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
138323036|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138323037|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138323038|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323039|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
138323040|NCT04400916|Coagulants|coagulants|mesh-ancestor
138323041|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
138323042|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138323043|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323044|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323045|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138323046|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138323047|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323048|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323049|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323050|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
138323051|NCT04279938|Rituximab|rituximab|mesh-list
138323052|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
138323053|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323054|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323055|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
138323056|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323057|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323061|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323062|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323064|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323065|NCT03338244|Azithromycin|azithromycin|mesh-list
138323066|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323067|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323068|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
138323069|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138323070|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138323072|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
138323073|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138323074|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
138323075|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323077|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
138323078|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323079|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323080|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323081|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
138323082|NCT03082092|Hormones|hormones|mesh-ancestor
138323083|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323084|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138323085|NCT03082092|Protective Agents|protective agents|mesh-ancestor
138323086|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323088|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
138323089|NCT04401852|Analgesics|analgesics|mesh-ancestor
138323090|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
138323091|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323092|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323093|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
138323094|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323095|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138323097|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138323098|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323099|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323100|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138323101|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
138323102|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323106|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323107|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323109|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138323110|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
138323111|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323112|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323114|NCT03308916|Hematinics|hematinics|mesh-ancestor
138323115|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
138323116|NCT03081702|Itraconazole|itraconazole|mesh-list
138323117|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
138323118|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138323119|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138323120|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323121|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323122|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323123|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323124|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
138323125|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138323126|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138323127|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138323128|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323129|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323130|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323131|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138323133|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323134|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323135|NCT04760574|Testosterone|testosterone|mesh-list
138323136|NCT04760574|Androgens|androgens|mesh-ancestor
138323137|NCT04760574|Hormones|hormones|mesh-ancestor
138323138|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323139|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323142|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
138323143|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323144|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323145|NCT04400136|Lansoprazole|lansoprazole|mesh-list
138323146|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
138323147|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138323148|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323149|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138323150|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323151|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323152|NCT04857840|Firibastat|firibastat|mesh-list
138323153|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138323154|NCT04582968|Capecitabine|capecitabine|mesh-list
138323155|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138323156|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
138323157|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323158|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323161|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138323162|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138323163|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323164|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323165|NCT03261570|Protective Agents|protective agents|mesh-ancestor
138323166|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323167|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138323168|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
138323169|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323170|NCT03227562|Risperidone|risperidone|mesh-list
138323171|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138323172|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
138323173|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323174|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323175|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323176|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138323177|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138323178|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323180|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138323182|NCT04278378|Folic Acid|folic acid|mesh-list
138323183|NCT04278378|Riboflavin|riboflavin|mesh-list
138323184|NCT04278378|Hematinics|hematinics|mesh-ancestor
138323185|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
138323186|NCT04278378|Vitamins|vitamins|mesh-ancestor
138323187|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
138323188|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323189|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138323190|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323191|NCT04785924|Imipenem|imipenem|mesh-list
138323192|NCT04785924|Relebactam|relebactam|mesh-list
138323193|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323194|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323195|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138323196|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323197|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323198|NCT04451772|Upadacitinib|upadacitinib|mesh-list
138323199|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138323200|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323201|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323202|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323203|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323204|NCT03831984|Bromfenac|bromfenac|mesh-list
138323205|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
138323206|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138323207|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
138323208|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323209|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
138323210|NCT03831984|Protective Agents|protective agents|mesh-ancestor
138323211|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138323212|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323213|NCT03831984|Analgesics|analgesics|mesh-ancestor
138323214|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
138323215|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323216|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323217|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323218|NCT02084706|Triamcinolone|triamcinolone|mesh-list
138323219|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138323220|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138323221|NCT02084706|Lidocaine|lidocaine|mesh-list
138323222|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138323223|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323224|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
138323225|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323227|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
138323228|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323229|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138323230|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138323231|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138323232|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323233|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323234|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323235|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
138323237|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323238|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323239|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
138323240|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323241|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
138323242|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138323243|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323244|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323245|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138323246|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138323247|NCT04433988|Protective Agents|protective agents|mesh-ancestor
138323248|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323249|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
138323250|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138323253|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
138323254|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323255|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
138323256|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323257|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323260|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
138323261|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323262|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
138323263|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138323264|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138323265|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353354|NCT01284504|Analgesics|analgesics|mesh-ancestor
138323266|NCT04344678|Urological Agents|urological agents|mesh-ancestor
138323267|NCT03249558|Morphine|morphine|mesh-list
138323268|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138323269|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138323272|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323273|NCT03249558|Analgesics|analgesics|mesh-ancestor
138323274|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
138323275|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323276|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138323277|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138323278|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323279|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323280|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323281|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
138323282|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323283|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
138323284|NCT03246828|Gliclazide|gliclazide|mesh-list
138323285|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323286|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323287|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
138323288|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
138323289|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323290|NCT03204396|Dulaglutide|dulaglutide|mesh-list
138323292|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323293|NCT03174132|Lidocaine|lidocaine|mesh-list
138323294|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
138323295|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323296|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
138323297|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323298|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323299|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
138323300|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323301|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138323302|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138323303|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138323304|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323305|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323306|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138323307|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
138323309|NCT03174132|Protective Agents|protective agents|mesh-ancestor
138323310|NCT01812252|Azacitidine|azacitidine|mesh-list
138323311|NCT01812252|Decitabine|decitabine|mesh-list
138323312|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138323313|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
138323314|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323315|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323316|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323317|NCT03818802|Niacinamide|niacinamide|mesh-list
138323319|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
138323320|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
138323321|NCT03818802|Vitamins|vitamins|mesh-ancestor
138323322|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
138323329|NCT04398108|Margetuximab|margetuximab|mesh-list
138323330|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323331|NCT01625286|Paclitaxel|paclitaxel|mesh-list
138323332|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138323333|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138323334|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323335|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
138323336|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
138323337|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
138323338|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323340|NCT05158062|Docetaxel|docetaxel|mesh-list
138323341|NCT05158062|Bevacizumab|bevacizumab|mesh-list
138323342|NCT05158062|Carboplatin|carboplatin|mesh-list
138323343|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
138323344|NCT05158062|Olaparib|olaparib|mesh-list
138323345|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138323346|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323350|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323351|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323353|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138323354|NCT05158062|Growth Substances|growth substances|mesh-ancestor
138323355|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323356|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
138323357|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138323358|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138323359|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323360|NCT01076868|Primaquine|primaquine|mesh-list
138323361|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
138323362|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138323363|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138323364|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323365|NCT03193866|Interferons|interferons|mesh-list
138323366|NCT03193866|Interferon-beta|interferon-beta|mesh-list
138323367|NCT03193866|Rituximab|rituximab|mesh-list
138323368|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
138323369|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
138323370|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138323371|NCT03193866|Natalizumab|natalizumab|mesh-list
138323372|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138323373|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
138323374|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323376|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
138323377|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323378|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323383|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323384|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323385|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138323387|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
138323388|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323389|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138323390|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138323392|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323393|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138323394|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138323395|NCT03708588|Ticagrelor|ticagrelor|mesh-list
138323396|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138323397|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138323398|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138323399|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138323400|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
138323401|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323402|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323403|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323404|NCT04130802|Dexamethasone|dexamethasone|mesh-list
138323405|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323406|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
138323407|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
138323408|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323409|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323411|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
138323412|NCT04130802|Hormones|hormones|mesh-ancestor
138323413|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323414|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323415|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323416|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
138323417|NCT03087162|Lansoprazole|lansoprazole|mesh-list
138323418|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138323419|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323420|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138323422|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323423|NCT03165942|Ethanol|ethanol|mesh-list
138323424|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138323425|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323426|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323427|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323428|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
138323429|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323430|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323431|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138323432|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323433|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
138323439|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323440|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323441|NCT03392376|Haloperidol|haloperidol|mesh-list
138323442|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
138323443|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
138323444|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
138323445|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323446|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323448|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138323449|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138323450|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323451|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323452|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138323453|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
138323454|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323455|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323456|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138323457|NCT05243628|Insulin|insulin|mesh-list
138323458|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138323459|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323460|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323461|NCT05249478|Fentanyl|fentanyl|mesh-list
138323462|NCT05249478|Bupivacaine|bupivacaine|mesh-list
138323463|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323464|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
138323465|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323466|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323467|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
138323468|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323469|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138323470|NCT05249478|Narcotics|narcotics|mesh-ancestor
138323471|NCT05249478|Analgesics|analgesics|mesh-ancestor
138323472|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138323473|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138323474|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
138323475|NCT05244252|Bupivacaine|bupivacaine|mesh-list
138323476|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323477|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
138323480|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
138323481|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323482|NCT03286842|Olaparib|olaparib|mesh-list
138323483|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138323484|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323485|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323487|NCT05240274|Metformin|metformin|mesh-list
138323488|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323489|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323490|NCT05244018|Vitamin D|vitamin d|mesh-list
138323491|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
138323492|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
138323493|NCT05244018|Vitamins|vitamins|mesh-list
138323494|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
138323495|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323496|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138323497|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138323498|NCT02398500|Ranibizumab|ranibizumab|mesh-list
138323499|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138323500|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138323501|NCT02398500|Growth Substances|growth substances|mesh-ancestor
138323502|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323503|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
138323504|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323505|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
138323506|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
138323507|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323508|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
138323509|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323511|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323512|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323513|NCT05248932|Norepinephrine|norepinephrine|mesh-list
138323514|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138323515|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138323519|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323522|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323523|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138323524|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138323525|NCT02395614|Gentamicins|gentamicins|mesh-list
138323526|NCT02395614|Cefazolin|cefazolin|mesh-list
138323527|NCT02395614|Bacitracin|bacitracin|mesh-list
138323528|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
138323529|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323530|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138323531|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
138323532|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138323533|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323534|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323535|NCT04396938|Lamotrigine|lamotrigine|mesh-list
138323536|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
138323537|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138323538|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323539|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323540|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138323541|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323542|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138323543|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138323544|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323545|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323546|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138323547|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138323548|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
138323549|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323550|NCT02914158|Tamoxifen|tamoxifen|mesh-list
138323551|NCT02914158|Leuprolide|leuprolide|mesh-list
138323552|NCT02914158|Goserelin|goserelin|mesh-list
138323553|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138323554|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138323555|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323556|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323557|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323558|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323559|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323560|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138323561|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138323562|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138323563|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138323566|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138323567|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323568|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323571|NCT05241132|Tislelizumab|tislelizumab|mesh-list
138323572|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138323573|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323575|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138323576|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138323577|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323578|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323579|NCT05241054|Acetaminophen|acetaminophen|mesh-list
138323580|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
138323582|NCT05241054|Bupivacaine|bupivacaine|mesh-list
138323583|NCT05241054|Propofol|propofol|mesh-list
138323584|NCT05241054|Sevoflurane|sevoflurane|mesh-list
138323585|NCT05241054|Atracurium|atracurium|mesh-list
138323586|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323587|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
138323588|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323589|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323590|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
138323591|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323592|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138323593|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138323594|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
138323595|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138323596|NCT05241054|Narcotics|narcotics|mesh-ancestor
138323597|NCT05241054|Analgesics|analgesics|mesh-ancestor
138323598|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138323599|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323600|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
138323601|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138323602|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138323603|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
138323604|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138323605|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138323607|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138323608|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138323609|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
138323610|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323611|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323612|NCT00638508|Ketorolac|ketorolac|mesh-list
138323613|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138323614|NCT00638508|Ropivacaine|ropivacaine|mesh-list
138323615|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323616|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
138323617|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323618|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323619|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
138323620|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323621|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138323622|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323623|NCT00638508|Analgesics|analgesics|mesh-ancestor
138323624|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323625|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323626|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138323627|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323628|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323629|NCT00637806|Megestrol|megestrol|mesh-list
138323630|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
138323631|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138323632|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138323633|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138323635|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323636|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323637|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138323638|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138323639|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323641|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
138323642|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138323643|NCT00637728|Megestrol|megestrol|mesh-list
138323644|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
138323645|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138323646|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138323647|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138323648|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
138323649|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323650|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323651|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138323652|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138323653|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323654|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323655|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
138323656|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138323657|NCT01922466|Loxoprofen|loxoprofen|mesh-list
138323658|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138323659|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323660|NCT01922466|Analgesics|analgesics|mesh-ancestor
138323661|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
138323662|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323663|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323664|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323665|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323667|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
138323668|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138323669|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138323670|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138323671|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
138323672|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323673|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323674|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138323675|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138323676|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323677|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323678|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
138323679|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138323680|NCT00637416|Lansoprazole|lansoprazole|mesh-list
138323682|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138323683|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323684|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138353358|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323685|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323686|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323687|NCT00636792|Rituximab|rituximab|mesh-list
138323688|NCT00636792|Bortezomib|bortezomib|mesh-list
138323689|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138323690|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323691|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323692|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
138323693|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323694|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323695|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138323696|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
138323697|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323699|NCT00636636|Analgesics|analgesics|mesh-ancestor
138323702|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323703|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
138323704|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138323705|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138323706|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323707|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323708|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138323709|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138323710|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323711|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323714|NCT05244954|Piperaquine|piperaquine|mesh-list
138323715|NCT05244954|Artenimol|artenimol|mesh-list
138323716|NCT05244954|Amebicides|amebicides|mesh-ancestor
138323717|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138323718|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138323719|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323720|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
138323721|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323722|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
138323723|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
138323724|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138323725|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323726|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323727|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323729|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
138323730|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323731|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138323732|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138323733|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138323734|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
138323735|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323736|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323737|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
138323738|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
138323739|NCT04275960|Selitrectinib|selitrectinib|mesh-list
138323743|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
138323744|NCT00634920|Prednisolone|prednisolone|mesh-list
138323745|NCT00634920|Everolimus|everolimus|mesh-list
138323746|NCT00634920|Cyclosporins|cyclosporins|mesh-list
138323747|NCT00634920|Basiliximab|basiliximab|mesh-list
138323748|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323749|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323750|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323751|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
138323752|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323753|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
138323754|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323755|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323756|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323757|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138323758|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138323759|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323760|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323761|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138323762|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138323763|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
138323764|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323765|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323766|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
138353360|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138323768|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323769|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138323770|NCT01923012|Vitamin K|vitamin k|mesh-list
138323771|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
138323772|NCT01923012|Vitamins|vitamins|mesh-ancestor
138323773|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
138323774|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323775|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138323776|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138323777|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323778|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
138323779|NCT01923012|Coagulants|coagulants|mesh-ancestor
138323780|NCT01923090|Finasteride|finasteride|mesh-list
138323782|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138323785|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323786|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323787|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323788|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323789|NCT01923090|Urological Agents|urological agents|mesh-ancestor
138323790|NCT01929330|Dutasteride|dutasteride|mesh-list
138323791|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138323792|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138323793|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323794|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323795|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323796|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323797|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323799|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138323800|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
138323801|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323802|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323803|NCT04396548|Midodrine|midodrine|mesh-list
138323804|NCT04396548|Anesthetics|anesthetics|mesh-list
138323805|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323806|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323807|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
138323808|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
138323809|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323810|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138323811|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138323812|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138323813|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138323814|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
138323817|NCT01929798|Pancrelipase|pancrelipase|mesh-list
138323818|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323819|NCT00633984|Cycloserine|cycloserine|mesh-list
138323820|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138323821|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323822|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138323823|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
138323824|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323825|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
138323826|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323827|NCT04395612|Niraparib|niraparib|mesh-list
138323828|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138323829|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323830|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323831|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323833|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138323834|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323835|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323836|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
138323837|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323838|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323839|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
138323840|NCT01921218|Cyclosporine|cyclosporine|mesh-list
138323841|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
138323843|NCT01921218|Abatacept|abatacept|mesh-list
138323844|NCT01921218|Tacrolimus|tacrolimus|mesh-list
138323845|NCT01921218|Cyclosporins|cyclosporins|mesh-list
138323846|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138323847|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323848|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
138323849|NCT01921218|Hormones|hormones|mesh-ancestor
138323853|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323854|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323855|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
138323856|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323857|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323858|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
138323859|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323860|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323861|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323862|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138323863|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138323864|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
138323865|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323866|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138323867|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323868|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138323869|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323870|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323871|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323872|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323873|NCT00633360|Drospirenone|drospirenone|mesh-list
138323874|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138323875|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138323876|NCT00633360|Estradiol|estradiol|mesh-list
138323877|NCT00633360|Estrogens|estrogens|mesh-ancestor
138323878|NCT00633360|Hormones|hormones|mesh-ancestor
138323880|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323881|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138323882|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
138323883|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323884|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138323885|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138323886|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138323887|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138323888|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323889|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138323891|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
138323892|NCT00988260|Ganirelix|ganirelix|mesh-list
138323893|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323894|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323895|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323896|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138323897|NCT00633126|Cephalosporins|cephalosporins|mesh-list
138323898|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323899|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323901|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323902|NCT01923870|Enclomiphene|enclomiphene|mesh-list
138323903|NCT01923870|Clomiphene|clomiphene|mesh-list
138323904|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
138323905|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138323906|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
138323907|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323908|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323909|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138323910|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
138323911|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323912|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138323913|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138323914|NCT00632736|Ropinirole|ropinirole|mesh-list
138323915|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138323917|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
138323919|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323920|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323921|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323922|NCT01923948|Pregabalin|pregabalin|mesh-list
138323923|NCT01923948|Analgesics|analgesics|mesh-ancestor
138323924|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
138323925|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353366|NCT01183416|Antibodies|antibodies|mesh-list
138323926|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323927|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
138323928|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138323929|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138323930|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323931|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138323932|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138323933|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138323934|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323935|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323936|NCT00989196|Factor VIII|factor viii|mesh-list
138323937|NCT00989196|Coagulants|coagulants|mesh-ancestor
138323939|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138323940|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138323941|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323942|NCT00631488|Incretins|incretins|mesh-ancestor
138323943|NCT00631488|Hormones|hormones|mesh-ancestor
138323944|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323945|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138323946|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
138323947|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323948|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323949|NCT01924104|Aspirin|aspirin|mesh-list
138323950|NCT01924104|Heparin|heparin|mesh-list
138323951|NCT01924104|Calcium heparin|calcium heparin|mesh-list
138323952|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138323953|NCT01924104|Tinzaparin|tinzaparin|mesh-list
138323954|NCT01924104|Dalteparin|dalteparin|mesh-list
138323955|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138323956|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323957|NCT01924104|Analgesics|analgesics|mesh-ancestor
138323961|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138323962|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323963|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138323964|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138323965|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323966|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138323967|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138323968|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323969|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
138323970|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
138323972|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138323973|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323974|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323975|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323976|NCT00630786|Panitumumab|panitumumab|mesh-list
138323977|NCT00630786|Conatumumab|conatumumab|mesh-list
138323978|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323979|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323980|NCT00630396|Minocycline|minocycline|mesh-list
138323981|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138323982|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323983|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
138323984|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138323985|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138323986|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323987|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
138323988|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323990|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323991|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323993|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138323994|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323999|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324001|NCT04275258|Narcotics|narcotics|mesh-ancestor
138324002|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324003|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324004|NCT04275258|Analgesics|analgesics|mesh-ancestor
138324005|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
138324006|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324007|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138324008|NCT01925820|Entecavir|entecavir|mesh-list
138324009|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
138324010|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353369|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324011|NCT01925898|Midazolam|midazolam|mesh-list
138324012|NCT01925898|Ketamine|ketamine|mesh-list
138324013|NCT01925898|Analgesics|analgesics|mesh-ancestor
138324014|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
138324015|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324016|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324017|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138324018|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138324019|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
138324020|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
138324021|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324022|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138324023|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138324024|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324025|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324026|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138324027|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324028|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138324029|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324030|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324031|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
138324032|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
138324033|NCT00983580|Aspirin|aspirin|mesh-list
138324034|NCT00983580|Eflornithine|eflornithine|mesh-list
138324035|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138324036|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138324037|NCT00983580|Analgesics|analgesics|mesh-ancestor
138324038|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
138324039|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324040|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324041|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324042|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324043|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138324044|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138324045|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324046|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138324051|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138324052|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324053|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324054|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324055|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138324056|NCT00982878|Maraviroc|maraviroc|mesh-list
138324057|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138324058|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138324059|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324060|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138324061|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138324062|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
138324063|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324064|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138324065|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
138324067|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324068|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138324069|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324070|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324071|NCT00982020|Olanzapine|olanzapine|mesh-list
138324072|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
138324073|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
138324074|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324075|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324076|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324077|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138324078|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324079|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324080|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324081|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138324082|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138324088|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
138324089|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353370|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324090|NCT01926132|Protective Agents|protective agents|mesh-ancestor
138324091|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324093|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
138324095|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324096|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138324097|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138324098|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324099|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324100|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138324101|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
138324102|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324103|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324104|NCT01926288|Entecavir|entecavir|mesh-list
138324105|NCT01926288|Maleic acid|maleic acid|mesh-list
138324107|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324108|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
138324109|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324111|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138324112|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324113|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138324114|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138324115|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138324116|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324117|NCT00980148|Azithromycin|azithromycin|mesh-list
138324118|NCT00980148|Doxycycline|doxycycline|mesh-list
138324119|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324120|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324121|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
138324122|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324123|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324124|NCT03064854|Paclitaxel|paclitaxel|mesh-list
138324125|NCT03064854|Carboplatin|carboplatin|mesh-list
138324126|NCT03064854|Gemcitabine|gemcitabine|mesh-list
138324127|NCT03064854|Pemetrexed|pemetrexed|mesh-list
138324128|NCT03064854|Spartalizumab|spartalizumab|mesh-list
138324129|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138324130|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324131|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138324137|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324138|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138324139|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324140|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138324141|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324142|NCT00983814|Carbidopa|carbidopa|mesh-list
138324143|NCT00983814|Droxidopa|droxidopa|mesh-list
138324144|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138324145|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138324146|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
138324147|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324148|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324149|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324150|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138324151|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324152|NCT01921920|Omeprazole|omeprazole|mesh-list
138324153|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138324154|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324155|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138324156|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324157|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324158|NCT04275414|Bevacizumab|bevacizumab|mesh-list
138324159|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324160|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324161|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324162|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324163|NCT04275414|Growth Substances|growth substances|mesh-ancestor
138324164|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324165|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324166|NCT04395768|Vitamin D|vitamin d|mesh-list
138324167|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
138324168|NCT04395768|Vitamins|vitamins|mesh-list
138324169|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
138324170|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
138324171|NCT04395768|Azithromycin|azithromycin|mesh-list
138324174|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324175|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138324176|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324177|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138324178|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324179|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324180|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
138324181|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324182|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324183|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324184|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324185|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
138324186|NCT04395768|Protective Agents|protective agents|mesh-ancestor
138324187|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
138324188|NCT01927224|Nifurtimox|nifurtimox|mesh-list
138324189|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138324190|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324191|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324192|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324193|NCT01922154|Ranibizumab|ranibizumab|mesh-list
138324194|NCT01922154|Mitomycin|mitomycin|mesh-list
138324195|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324196|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324197|NCT01922154|Growth Substances|growth substances|mesh-ancestor
138324198|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324199|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324200|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324201|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
138324202|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324203|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138324204|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324205|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324208|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
138324209|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
138324211|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
138324212|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324213|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138324214|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
138324215|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324216|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138324217|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
138324218|NCT01928160|Carboplatin|carboplatin|mesh-list
138324219|NCT01928160|Pemetrexed|pemetrexed|mesh-list
138324220|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138324221|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324222|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324223|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324225|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324226|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138324227|NCT01928316|Mizolastine|mizolastine|mesh-list
138324228|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138324229|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138324230|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
138324231|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
138324232|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324233|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324234|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324235|NCT04550520|Glucagon|glucagon|mesh-list
138324236|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324238|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324242|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138324243|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138324244|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138324245|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324246|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138324247|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324248|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138324249|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324251|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138324252|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
138353378|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324253|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324254|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138324255|NCT01929096|Protective Agents|protective agents|mesh-ancestor
138324256|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324259|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324260|NCT03059004|Protective Agents|protective agents|mesh-ancestor
138324261|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324262|NCT04554888|Doxepin|doxepin|mesh-list
138324263|NCT04554888|Histamine|histamine|mesh-list
138324264|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
138324265|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
138324266|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324267|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324268|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324269|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138324270|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324271|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324272|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138324273|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
138324274|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324275|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
138324276|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
138324277|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138324278|NCT05601960|Protective Agents|protective agents|mesh-ancestor
138324279|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324280|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
138324282|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138324289|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324291|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324292|NCT04124016|Protective Agents|protective agents|mesh-ancestor
138324293|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324294|NCT04124094|Fluticasone|fluticasone|mesh-list
138324297|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138324298|NCT04124094|Charcoal|charcoal|mesh-list
138324299|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324300|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138324301|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
138324302|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324303|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324304|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138324305|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138324306|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
138324307|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138324308|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138324309|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138324310|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138324311|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138324312|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324313|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324314|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
138324315|NCT04124094|Hormones|hormones|mesh-ancestor
138324316|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324317|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
138324318|NCT04124094|Antidotes|antidotes|mesh-ancestor
138324319|NCT04124094|Protective Agents|protective agents|mesh-ancestor
138324321|NCT03033576|Ipilimumab|ipilimumab|mesh-list
138324322|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324323|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324324|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138324325|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324326|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
138324327|NCT04123392|Busulfan|busulfan|mesh-list
138324328|NCT04123392|Decitabine|decitabine|mesh-list
138324329|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324330|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
138324331|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324332|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324333|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138324334|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
138324335|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324336|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324337|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138324338|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324339|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
138324340|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324342|NCT04760262|Propofol|propofol|mesh-list
138324343|NCT04760262|Sevoflurane|sevoflurane|mesh-list
138324344|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324345|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324346|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324347|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138324348|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
138324349|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
138324350|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138324351|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138324352|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138324353|NCT04760262|Narcotics|narcotics|mesh-ancestor
138324354|NCT04760262|Analgesics|analgesics|mesh-ancestor
138324355|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
138324356|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324357|NCT03047928|Nivolumab|nivolumab|mesh-list
138324358|NCT03047928|Vaccines|vaccines|mesh-list
138324359|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
138324360|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324361|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324362|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324364|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324366|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324367|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324368|NCT05607810|Growth Substances|growth substances|mesh-ancestor
138324369|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324370|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324371|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324372|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138324373|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324375|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
138324376|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324378|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
138324379|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324380|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138324381|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138324382|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324383|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324384|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138324385|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138324386|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324387|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324388|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138324390|NCT04129788|Cathartics|cathartics|mesh-ancestor
138324391|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324392|NCT04129788|Laxatives|laxatives|mesh-ancestor
138324393|NCT03831126|Betamethasone|betamethasone|mesh-list
138324394|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
138324395|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138324396|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
138289176|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289177|NCT00329732|Lidocaine|lidocaine|mesh-list
138324397|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138324398|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
138324399|NCT03831126|Hormones|hormones|mesh-ancestor
138324400|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324401|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324402|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324404|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
138324406|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324407|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
138324408|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324409|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324410|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138324411|NCT05606796|Latanoprost|latanoprost|mesh-list
138324412|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138324413|NCT04129710|Rituximab|rituximab|mesh-list
138324414|NCT04129710|Methotrexate|methotrexate|mesh-list
138324415|NCT04129710|Etoposide|etoposide|mesh-list
138324416|NCT04129710|Lenalidomide|lenalidomide|mesh-list
138324417|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324418|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324419|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
138324420|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324421|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324422|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138324423|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
138324424|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138324425|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324426|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
138324432|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324433|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138289216|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138324434|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138324435|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138324436|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324437|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324438|NCT04129710|Growth Substances|growth substances|mesh-ancestor
138324439|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324441|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324442|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324444|NCT04129008|Indobufen|indobufen|mesh-list
138324448|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
138324449|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324450|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324451|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324452|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324453|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138324455|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324456|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138324457|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138324458|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324460|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
138324461|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324462|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
138324463|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324464|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324465|NCT04120350|Rituximab|rituximab|mesh-list
138324466|NCT04120350|Methotrexate|methotrexate|mesh-list
138324467|NCT04120350|Lenalidomide|lenalidomide|mesh-list
138324468|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324469|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324470|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
138324471|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324472|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324473|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138324474|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
138324475|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138324476|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324477|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
138324478|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324482|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324483|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324484|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324485|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324486|NCT04120350|Growth Substances|growth substances|mesh-ancestor
138324487|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324488|NCT04394598|Capecitabine|capecitabine|mesh-list
138324490|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324491|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
138324492|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324493|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324494|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138324495|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138324496|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324497|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138324498|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324499|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138324500|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
138324501|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324502|NCT05602428|Anesthetics|anesthetics|mesh-list
138324503|NCT05602428|Esketamine|esketamine|mesh-list
138324504|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324505|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324507|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324508|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138324509|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
138324510|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324511|NCT04127058|Iloperidone|iloperidone|mesh-list
138324512|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138324513|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324514|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324515|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324516|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324517|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
138324518|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
138324519|NCT03012360|Linezolid|linezolid|mesh-list
138289356|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324520|NCT03012360|Imipenem|imipenem|mesh-list
138324521|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324522|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324523|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138324524|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138324525|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324526|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324527|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324532|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138324533|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324534|NCT04126668|Vorolanib|vorolanib|mesh-list
138324535|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138324536|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324537|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324538|NCT04758936|Clonidine|clonidine|mesh-list
138324539|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
138324540|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324541|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324542|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324544|NCT04758936|Analgesics|analgesics|mesh-ancestor
138324545|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
138324546|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324547|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138324548|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138324549|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138324550|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
138324551|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324552|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324553|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138324554|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
138324555|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
138324556|NCT04126044|Bevacizumab|bevacizumab|mesh-list
138289402|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
138324557|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324558|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324559|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324560|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324561|NCT04126044|Growth Substances|growth substances|mesh-ancestor
138324562|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324563|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324564|NCT04758858|Glucagon|glucagon|mesh-list
138324565|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324566|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324567|NCT04758858|Hormones|hormones|mesh-ancestor
138414692|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324568|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324571|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324572|NCT02975310|Anesthetics|anesthetics|mesh-list
138324573|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324574|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324575|NCT04394208|Silymarin|silymarin|mesh-list
138324577|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324578|NCT04394208|Protective Agents|protective agents|mesh-ancestor
138324579|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324581|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138324582|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138324583|NCT03829566|Prednisolone|prednisolone|mesh-list
138324584|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
138324585|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
138324586|NCT03829566|Rituximab|rituximab|mesh-list
138289454|NCT00000878|Lamivudine|lamivudine|mesh-list
138324587|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
138324588|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138324589|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138324590|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
138324591|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324593|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324594|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324595|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138324596|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
138324597|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324598|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324599|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138324600|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324601|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324606|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
138324607|NCT03829566|Hormones|hormones|mesh-ancestor
138324608|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324610|NCT03829566|Protective Agents|protective agents|mesh-ancestor
138324611|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138324612|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
138324613|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324614|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324615|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324616|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138324617|NCT03933306|Analgesics|analgesics|mesh-ancestor
138324618|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
138324620|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138324621|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138324622|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138324623|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138324624|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324625|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324626|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
138324627|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
138324628|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324629|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324630|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324631|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324632|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324633|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324634|NCT02972424|Teriparatide|teriparatide|mesh-list
138324635|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138324636|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324637|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138324638|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
138324639|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324640|NCT04393584|Leucovorin|leucovorin|mesh-list
138324641|NCT04393584|Docetaxel|docetaxel|mesh-list
138324642|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
138324643|NCT04393584|Irinotecan|irinotecan|mesh-list
138324644|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324645|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138324646|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138324647|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138324648|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324649|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138324653|NCT04393584|Protective Agents|protective agents|mesh-ancestor
138324654|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324655|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
138324656|NCT04393584|Vitamins|vitamins|mesh-ancestor
138324657|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
138324658|NCT03828474|Acetazolamide|acetazolamide|mesh-list
138324659|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
138324660|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138324661|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324662|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324663|NCT03828474|Diuretics|diuretics|mesh-ancestor
138324664|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
138324666|NCT03828084|Decitabine|decitabine|mesh-list
138324667|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
138324668|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324669|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
138324670|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324671|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324672|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324673|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138324674|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
138324675|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324676|NCT02983734|Cycloserine|cycloserine|mesh-list
138324677|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138324678|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324679|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138324680|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
138324681|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324682|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
138324683|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324685|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324686|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
138324687|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324688|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324689|NCT03820518|Calcitriol|calcitriol|mesh-list
138324690|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138324691|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324692|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138324693|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324694|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324697|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
138324698|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138324699|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
138324700|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138324701|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138324702|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324703|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
138324704|NCT03820206|Coagulants|coagulants|mesh-ancestor
138324705|NCT02955654|Aripiprazole|aripiprazole|mesh-list
138324706|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
138324707|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324708|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138324709|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324711|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324712|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
138324713|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
138324714|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353394|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138324715|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353395|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138324716|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138324717|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138324718|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
138324719|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138324720|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138324721|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138324722|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138324723|NCT04392648|Dexamethasone|dexamethasone|mesh-list
138324724|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
138324726|NCT04392648|Pomalidomide|pomalidomide|mesh-list
138324727|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324728|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
138324729|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324730|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324731|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138324732|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
138324733|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324734|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324735|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138324736|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324738|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
138324739|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324740|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324741|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
138324742|NCT04392648|Hormones|hormones|mesh-ancestor
138324743|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324744|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138324745|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324746|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324748|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324749|NCT03826602|Metformin|metformin|mesh-list
138324750|NCT03826602|Tucatinib|tucatinib|mesh-list
138324751|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138324752|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324753|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324754|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138324755|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324757|NCT01453920|Ranibizumab|ranibizumab|mesh-list
138324758|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324759|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138324760|NCT01453920|Growth Substances|growth substances|mesh-ancestor
138324761|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324762|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138324763|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324764|NCT03820908|Bisantrene|bisantrene|mesh-list
138324765|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138324766|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324767|NCT02953548|Cannabidiol|cannabidiol|mesh-list
138324768|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
138324769|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
138324770|NCT02952222|Propofol|propofol|mesh-list
138324771|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138324772|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324773|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324774|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138324776|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
138324777|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324778|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138324779|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138324781|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
138324782|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324783|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324784|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138324785|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
138324786|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
138324787|NCT03826368|Cannabidiol|cannabidiol|mesh-list
138324788|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
138324789|NCT04391478|Milrinone|milrinone|mesh-list
138324790|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
138324791|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
138324792|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138324793|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138324794|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324795|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324796|NCT04391478|Urological Agents|urological agents|mesh-ancestor
138324797|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138324798|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138324799|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138324800|NCT04391478|Protective Agents|protective agents|mesh-ancestor
138324801|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324802|NCT03828006|Red yeast rice|red yeast rice|mesh-list
138324803|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138324804|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138289758|NCT00000242|Carbamazepine|carbamazepine|mesh-list
138324805|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138324806|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
138324807|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324808|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324809|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138324810|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
138324811|NCT04391868|Citric Acid|citric acid|mesh-list
138324812|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
138324813|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
138324814|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138324815|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
138324819|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138324820|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138324821|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324822|NCT04391868|Urological Agents|urological agents|mesh-ancestor
138324823|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
138324824|NCT03829332|Lenvatinib|lenvatinib|mesh-list
138324825|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138324826|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324828|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324829|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138324830|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324831|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
138324832|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324833|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324834|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324835|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324836|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138324837|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
138324838|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138324839|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138324840|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138324841|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138324843|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
138324844|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324845|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324846|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138324847|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138324848|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138324849|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138324850|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138324852|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
138324853|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324854|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324856|NCT01454622|Canagliflozin|canagliflozin|mesh-list
138324857|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138324858|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324859|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138324860|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324861|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
138324867|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324868|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138324869|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
138324870|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324871|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138324872|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
138324873|NCT01450566|Lidocaine|lidocaine|mesh-list
138324874|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138324875|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
138324876|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324877|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324878|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
138324879|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324885|NCT03043014|Misoprostol|misoprostol|mesh-list
138324886|NCT03043014|Mifepristone|mifepristone|mesh-list
138324887|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138324888|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
138324889|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138324890|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324891|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138324892|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324893|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
138324896|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138324897|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138324898|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
138324899|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138324900|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138324901|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
138324902|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324903|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
138324904|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138324905|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138324906|NCT02983344|Fentanyl|fentanyl|mesh-list
138324908|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
138324909|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
138324910|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324911|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324912|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
138324913|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324914|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138324915|NCT02983344|Narcotics|narcotics|mesh-ancestor
138324916|NCT02983344|Analgesics|analgesics|mesh-ancestor
138324917|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138324918|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138324919|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
138324920|NCT03824340|Doxycycline|doxycycline|mesh-list
138324921|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324922|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324923|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
138324924|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138324925|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138324926|NCT01455246|Meropenem|meropenem|mesh-list
138324927|NCT01455246|Daptomycin|daptomycin|mesh-list
138324928|NCT01455246|Ceftazidime|ceftazidime|mesh-list
138324929|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324930|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324931|NCT03823950|Lenograstim|lenograstim|mesh-list
138324932|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138324933|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
138324934|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324936|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324937|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138324938|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324939|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324941|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138324942|NCT03823638|Diuretics|diuretics|mesh-ancestor
138324943|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
138324944|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324946|NCT02884908|Analgesics|analgesics|mesh-ancestor
138324947|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
138324948|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324949|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324950|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
138324951|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138324952|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324953|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324954|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138324955|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138324956|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138324957|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324958|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138324959|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138324960|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138324961|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324964|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138324965|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
138324966|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324967|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324968|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324969|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138324970|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138324971|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
138324972|NCT02851056|Lenograstim|lenograstim|mesh-list
138324973|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138324974|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
138324977|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
138324978|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
138324979|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324980|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324981|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138324983|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324984|NCT01452750|Lansoprazole|lansoprazole|mesh-list
138324985|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
138324986|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138324987|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138324988|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138324989|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324990|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324991|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
138324992|NCT01452828|Tedizolid|tedizolid|mesh-list
138324993|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
138324994|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138324995|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324996|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138324997|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324998|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324999|NCT01452906|Omeprazole|omeprazole|mesh-list
138325000|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138325001|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325002|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138325004|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325005|NCT03823248|Folic Acid|folic acid|mesh-list
138325006|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
138325007|NCT03823248|Hematinics|hematinics|mesh-ancestor
138325008|NCT03823248|Vitamins|vitamins|mesh-ancestor
138325009|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
138325010|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325011|NCT03822936|Fluorouracil|fluorouracil|mesh-list
138325012|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
138325013|NCT03822936|Irinotecan|irinotecan|mesh-list
138325014|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
138325015|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290010|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138325017|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325018|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325019|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
138325020|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325021|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138325022|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138325023|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325025|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138325026|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
138325027|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325028|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325029|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138325030|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138325031|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
138325032|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325033|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325034|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
138325035|NCT01453686|Clobetasol|clobetasol|mesh-list
138325036|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325037|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
138325038|NCT01453686|Hormones|hormones|mesh-ancestor
138325039|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325040|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290048|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
138325041|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138325042|NCT01455870|Exenatide|exenatide|mesh-list
138325043|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138325044|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325045|NCT01455870|Incretins|incretins|mesh-ancestor
138325047|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325048|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138325051|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325052|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138325053|NCT01456260|Lansoprazole|lansoprazole|mesh-list
138325054|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
138325055|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138325056|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325057|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138325058|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325059|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325060|NCT01890408|Ropivacaine|ropivacaine|mesh-list
138325061|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
138325062|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
138325063|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325064|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325065|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
138325066|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325067|NCT04849650|Amisulpride|amisulpride|mesh-list
138325068|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138325069|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138325070|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325071|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325072|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325073|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138325074|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
138325075|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325076|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325077|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138325078|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
138325079|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
138325080|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138325081|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
138325082|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325083|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325084|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138325085|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325086|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138325087|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
138325088|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325089|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325090|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138325091|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325094|NCT02862132|Vedolizumab|vedolizumab|mesh-list
138325095|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325096|NCT02859402|Fludarabine|fludarabine|mesh-list
138325097|NCT02859402|Busulfan|busulfan|mesh-list
138325098|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325099|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325100|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325101|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
138325102|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325103|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
138325104|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138353420|NCT01031550|Isoflurane|isoflurane|mesh-list
138325105|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138325107|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
138325108|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325109|NCT04842552|Hydralazine|hydralazine|mesh-list
138325110|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138325111|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325112|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
138325113|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138325114|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
138325115|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
138325116|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325117|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325118|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325119|NCT01891812|Analgesics|analgesics|mesh-ancestor
138325120|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
138325121|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325122|NCT04390464|Ravulizumab|ravulizumab|mesh-list
138325123|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138325124|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325125|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
138325126|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325127|NCT01892748|Vitamin D|vitamin d|mesh-list
138325128|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
138325129|NCT01892748|Vitamins|vitamins|mesh-ancestor
138325130|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
138325131|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325132|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138325136|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
138325137|NCT01893060|Povidone|povidone|mesh-list
138325138|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138325139|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325140|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
138325141|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
138325142|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
138325143|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
138325144|NCT01457820|Allopurinol|allopurinol|mesh-list
138325145|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
138325146|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325147|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325148|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
138325149|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325150|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138325152|NCT01457820|Protective Agents|protective agents|mesh-ancestor
138325153|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325154|NCT05020782|Belimumab|belimumab|mesh-list
138325155|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325156|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
138325157|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325158|NCT01893294|Gemcitabine|gemcitabine|mesh-list
138325159|NCT01893294|Fluorouracil|fluorouracil|mesh-list
138325160|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138325161|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
138325162|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325163|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325164|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325165|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
138325166|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325168|NCT01458054|Omeprazole|omeprazole|mesh-list
138325169|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138325170|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138325171|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
138325172|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325173|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325174|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138325175|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138325176|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
138325177|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325178|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138325179|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138325182|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138325183|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
138325184|NCT01893450|Bromocriptine|bromocriptine|mesh-list
138325185|NCT01893450|Methimazole|methimazole|mesh-list
138325186|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138325187|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325188|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325189|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138325190|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138325191|NCT01893450|Protective Agents|protective agents|mesh-ancestor
138325192|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325193|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325194|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138325195|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
138325196|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138325197|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138325198|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325199|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325201|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
138325202|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325203|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
138325205|NCT05027100|Tislelizumab|tislelizumab|mesh-list
138325206|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138325207|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138325208|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325211|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138325213|NCT01458600|Propranolol|propranolol|mesh-list
138325214|NCT01458600|Metoprolol|metoprolol|mesh-list
138325215|NCT01458600|Methimazole|methimazole|mesh-list
138325216|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138325217|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325220|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325221|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325222|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325223|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325224|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138325226|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325227|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138325228|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138325229|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
138325230|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325231|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138325232|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138325233|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325234|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
138325235|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
138325236|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138325237|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
138325238|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325239|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325240|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
138325241|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325242|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138325243|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138325245|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325246|NCT02832570|Urological Agents|urological agents|mesh-ancestor
138325247|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
138325248|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
138325249|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138325250|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
138325251|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325252|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
138325255|NCT01459146|Lumefantrine|lumefantrine|mesh-list
138325256|NCT01459146|Artemether|artemether|mesh-list
138325257|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138325258|NCT01459146|Albendazole|albendazole|mesh-list
138325259|NCT01459146|Praziquantel|praziquantel|mesh-list
138325260|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
138325261|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138325262|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138325263|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325264|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
138325265|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
138325266|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138325267|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138325268|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138325269|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
138325270|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325271|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325272|NCT05026398|Fenfluramine|fenfluramine|mesh-list
138325273|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138325275|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290426|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325276|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325277|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325279|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325280|NCT05586750|Atorvastatin|atorvastatin|mesh-list
138325281|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138325282|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138325283|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
138325284|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325285|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138325286|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138325287|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325290|NCT02716974|Bicalutamide|bicalutamide|mesh-list
138325291|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325292|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
138325293|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
138325295|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325296|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138325298|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138325302|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325303|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325305|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138325306|NCT01459380|Carboplatin|carboplatin|mesh-list
138325307|NCT01459380|Doxorubicin|doxorubicin|mesh-list
138325308|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138325309|NCT01459380|Veliparib|veliparib|mesh-list
138325310|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
138325311|NCT01459380|Antibodies|antibodies|mesh-list
138325312|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
138325313|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138325314|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
138325315|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325316|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138325317|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325318|NCT01459380|Growth Substances|growth substances|mesh-ancestor
138325319|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325320|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
138325321|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
138325322|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138325323|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138325324|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138325325|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325326|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325327|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138325328|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138325329|NCT04346004|Hematinics|hematinics|mesh-ancestor
138325330|NCT02680314|Methotrexate|methotrexate|mesh-list
138290533|NCT00380822|Miglitol|miglitol|mesh-list
138325331|NCT02680314|Misoprostol|misoprostol|mesh-list
138325332|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138325333|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
138325334|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138325335|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325336|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138325337|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
138325338|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325339|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325340|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138325345|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325346|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138325347|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138325348|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325349|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
138325350|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138325351|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
138325352|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325353|NCT02706678|Tacrolimus|tacrolimus|mesh-list
138325354|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325356|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325357|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138325358|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325359|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325360|NCT02703948|Lidocaine|lidocaine|mesh-list
138325361|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
138325362|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
138325363|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325364|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325365|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
138325366|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325367|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138325368|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138325369|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138325370|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325371|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325374|NCT02666742|Edoxaban|edoxaban|mesh-list
138325375|NCT02666742|Dabigatran|dabigatran|mesh-list
138325376|NCT02666742|Anticoagulants|anticoagulants|mesh-list
138325377|NCT02666742|Coagulants|coagulants|mesh-list
138325378|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138325379|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325380|NCT02666742|Analgesics|analgesics|mesh-ancestor
138325381|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
138325382|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325383|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325384|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325385|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325386|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138325387|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138325388|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414693|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
138325390|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138325391|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325392|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
138325393|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138325394|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
138325395|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138325396|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
138325397|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
138325398|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138325399|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138325400|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325401|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138325402|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325404|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
138325405|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
138325406|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325407|NCT04390854|Clotrimazole|clotrimazole|mesh-list
138325408|NCT04390854|Miconazole|miconazole|mesh-list
138325409|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138325410|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325411|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
138325412|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138325413|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138325414|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325415|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325416|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138325417|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325418|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325419|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325420|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138325421|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138325422|NCT02630316|Treprostinil|treprostinil|mesh-list
138325423|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353430|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138353431|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325425|NCT02359968|Fluorouracil|fluorouracil|mesh-list
138325426|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
138325427|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138325428|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325429|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138325430|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138325431|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138325432|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325433|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
138325434|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138325435|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325437|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325438|NCT02624544|Desonide|desonide|mesh-list
138325439|NCT02624544|Esomeprazole|esomeprazole|mesh-list
138325440|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138325441|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325442|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138325443|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325444|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325445|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325446|NCT02603328|Atorvastatin|atorvastatin|mesh-list
138325447|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138325448|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138325449|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
138325450|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325451|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138325458|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325459|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325460|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325461|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138325462|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138325463|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325464|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325465|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138325467|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138290768|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325468|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138325471|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138325472|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
138325473|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
138325474|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325475|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325477|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
138325478|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325479|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
138325480|NCT01453530|Neostigmine|neostigmine|mesh-list
138325481|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138325482|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325483|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325484|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
138325485|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290815|NCT00000656|Zidovudine|zidovudine|mesh-list
138325492|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138325495|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138325496|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
138325497|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325498|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325499|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138325500|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325501|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138325502|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138325503|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325504|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325505|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138325506|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138325507|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
138325508|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325509|NCT02983422|Protective Agents|protective agents|mesh-ancestor
138325510|NCT02983422|Diuretics|diuretics|mesh-ancestor
138325511|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
138290868|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325512|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138325514|NCT05585814|Bevacizumab|bevacizumab|mesh-list
138325515|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
138325516|NCT05585814|Capecitabine|capecitabine|mesh-list
138325517|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
138325518|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138325519|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325520|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138325521|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325522|NCT05585814|Growth Substances|growth substances|mesh-ancestor
138325523|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325524|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
138325525|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138325526|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325527|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138325528|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
138325529|NCT05585736|Mydriatics|mydriatics|mesh-list
138325530|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
138325531|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325532|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325533|NCT01989780|Paclitaxel|paclitaxel|mesh-list
138325534|NCT01989780|Bevacizumab|bevacizumab|mesh-list
138325535|NCT01989780|Letrozole|letrozole|mesh-list
138325536|NCT01989780|Fulvestrant|fulvestrant|mesh-list
138325537|NCT01989780|Anastrozole|anastrozole|mesh-list
138325538|NCT01989780|Exemestane|exemestane|mesh-list
138325539|NCT01989780|Goserelin|goserelin|mesh-list
138325540|NCT01989780|Leuprolide|leuprolide|mesh-list
138325541|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138325542|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325543|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
138325550|NCT01989780|Growth Substances|growth substances|mesh-ancestor
138325551|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325552|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
138325553|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138325554|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138325555|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325556|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138325557|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325558|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325559|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325560|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138325561|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138325562|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
138325563|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138325565|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138325566|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138325567|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
138325568|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325569|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325570|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138325571|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325572|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138325573|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138325574|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325575|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138325576|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
138325577|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138325578|NCT02549898|Protective Agents|protective agents|mesh-ancestor
138325579|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138325580|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138353440|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138325581|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325582|NCT02549898|Hematinics|hematinics|mesh-ancestor
138325583|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138325584|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138325585|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
138325587|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138325588|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325589|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
138325590|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138325591|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
138325592|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138325593|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138325596|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138325598|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325599|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
138325600|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
138325601|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325602|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325603|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325604|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
138325605|NCT02283996|Hormones|hormones|mesh-ancestor
138325606|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325607|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138325608|NCT02283996|Protective Agents|protective agents|mesh-ancestor
138325609|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325610|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325611|NCT02369484|Afatinib|afatinib|mesh-list
138325612|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325613|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138325614|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325615|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325617|NCT04390152|Lopinavir|lopinavir|mesh-list
138325618|NCT04390152|Azithromycin|azithromycin|mesh-list
138325619|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
138325620|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138325621|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138325622|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138325623|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325624|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325626|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138325627|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
138325628|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325629|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138325630|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138414694|NCT01655082|Nicotine|nicotine|mesh-list
138325631|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138325632|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
138325633|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138325634|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138325635|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325636|NCT02496780|Insulin|insulin|mesh-list
138325637|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138325638|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
138325639|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
138325641|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325642|NCT01953588|Fulvestrant|fulvestrant|mesh-list
138325643|NCT01953588|Anastrozole|anastrozole|mesh-list
138325644|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325645|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291109|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
138414696|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
138325649|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325650|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325651|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138325652|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138325654|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325655|NCT01953510|Vaccines|vaccines|mesh-list
138325658|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325659|NCT02456532|Zolpidem|zolpidem|mesh-list
138325660|NCT02456532|Eszopiclone|eszopiclone|mesh-list
138325661|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138325662|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138325663|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325666|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
138325668|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325669|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325671|NCT05578950|Terbinafine|terbinafine|mesh-list
138325672|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
138325673|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325674|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138325675|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138325676|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325677|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325678|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138325680|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325681|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325682|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138325683|NCT05586126|Sevoflurane|sevoflurane|mesh-list
138325684|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138325685|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138325686|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
138325687|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
138325688|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325689|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325691|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138325692|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325694|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
138325696|NCT02442180|Lenograstim|lenograstim|mesh-list
138325697|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138325699|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325700|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325702|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
138325703|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325705|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
138325706|NCT02442180|Hormones|hormones|mesh-ancestor
138325707|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325709|NCT02442180|Protective Agents|protective agents|mesh-ancestor
138325710|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325711|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325712|NCT01924260|Gemcitabine|gemcitabine|mesh-list
138325714|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
138325715|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325716|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325717|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
138325719|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
138325721|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
138325722|NCT02432742|Protective Agents|protective agents|mesh-ancestor
138325723|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
138325724|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138325725|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138325726|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325728|NCT02086500|Coagulants|coagulants|mesh-ancestor
138325729|NCT02104986|Cisplatin|cisplatin|mesh-list
138325730|NCT02104986|Ifosfamide|ifosfamide|mesh-list
138325731|NCT02104986|Bleomycin|bleomycin|mesh-list
138325732|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325733|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138325734|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
138325735|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325739|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
138325740|NCT04757532|Bupropion|bupropion|mesh-list
138325741|NCT04757532|Testosterone|testosterone|mesh-list
138325742|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
138325743|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
138325744|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138325745|NCT04757532|Danazol|danazol|mesh-list
138325746|NCT04757532|Androgens|androgens|mesh-ancestor
138291310|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
138325747|NCT04757532|Hormones|hormones|mesh-ancestor
138325748|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325749|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325750|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325751|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325753|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138325754|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
138325755|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325756|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138325759|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325760|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
138325761|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325762|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138325763|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138325764|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325765|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138291355|NCT00002288|Zidovudine|zidovudine|mesh-list
138325766|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138325768|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325769|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138325770|NCT04757532|Diuretics|diuretics|mesh-ancestor
138325771|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
138325772|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138325773|NCT02063022|Dactinomycin|dactinomycin|mesh-list
138325774|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
138325777|NCT02063022|Ifosfamide|ifosfamide|mesh-list
138325778|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
138325779|NCT02063022|Doxorubicin|doxorubicin|mesh-list
138325780|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138325782|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
138325783|NCT02063022|Vincristine|vincristine|mesh-list
138325784|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325785|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
138325786|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325788|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138325789|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
138325790|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325791|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325792|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138325793|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138325794|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138325795|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138325796|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291411|NCT00002378|Nelfinavir|nelfinavir|mesh-list
138325797|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138325799|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138325800|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138325801|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138325802|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325803|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138325804|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138325805|NCT01895010|Tropisetron|tropisetron|mesh-list
138325807|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
138325808|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325809|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325810|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325811|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138325812|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138325813|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
138325814|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325815|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325818|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138325819|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325821|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138325824|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325825|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325827|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138325828|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325830|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
138325831|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325832|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325833|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325834|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138325835|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138325836|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325837|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325839|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
138325841|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
138325842|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325843|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138325844|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138325845|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
138325846|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138325847|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
138325850|NCT01428024|Protective Agents|protective agents|mesh-ancestor
138325851|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
138325852|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138325854|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325855|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
138325856|NCT01412190|Protective Agents|protective agents|mesh-ancestor
138325858|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
138325859|NCT01331148|Vitamins|vitamins|mesh-ancestor
138325860|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
138325861|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325862|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138325863|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138325864|NCT00273624|Olanzapine|olanzapine|mesh-list
138325865|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
138325867|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325868|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325869|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325870|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138325871|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138325872|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325873|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325874|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138325875|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138325876|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325877|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325878|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325879|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
138325881|NCT01253070|Sorafenib|sorafenib|mesh-list
138325884|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
138325885|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325886|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325887|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
138325888|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325889|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325891|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325892|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138325893|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325894|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138325895|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138325898|NCT01212822|Bevacizumab|bevacizumab|mesh-list
138325899|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138325900|NCT01212822|Fluorouracil|fluorouracil|mesh-list
138325901|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
138325902|NCT01212822|Antibodies|antibodies|mesh-list
138325903|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
138291605|NCT05701436|Fluorouracil|fluorouracil|mesh-list
138325904|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138325905|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
138325906|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325907|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138325908|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325909|NCT01212822|Growth Substances|growth substances|mesh-ancestor
138325910|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325911|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
138325914|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325916|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325917|NCT01212822|Antidotes|antidotes|mesh-ancestor
138325918|NCT01212822|Protective Agents|protective agents|mesh-ancestor
138325919|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
138325920|NCT01212822|Vitamins|vitamins|mesh-ancestor
138325921|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
138325922|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
138325923|NCT00163566|Androgens|androgens|mesh-ancestor
138325924|NCT00163566|Hormones|hormones|mesh-ancestor
138325925|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325926|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325927|NCT04705662|Lactulose|lactulose|mesh-list
138325928|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325929|NCT04782960|Bupivacaine|bupivacaine|mesh-list
138325930|NCT04782960|Anesthetics|anesthetics|mesh-list
138325931|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
138325932|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325933|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325934|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
138325935|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325936|NCT01026012|Regadenoson|regadenoson|mesh-list
138325937|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138325938|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138325939|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
138325940|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
138325941|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325942|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291659|NCT02436265|Hormones|hormones|mesh-ancestor
138325943|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325944|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
138325945|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138325946|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
138325947|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325948|NCT02088216|Expectorants|expectorants|mesh-ancestor
138325949|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325950|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138325951|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
138325952|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325953|NCT02088216|Protective Agents|protective agents|mesh-ancestor
138325954|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325955|NCT02088216|Antidotes|antidotes|mesh-ancestor
138325956|NCT01014936|Tepotinib|tepotinib|mesh-list
138325957|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325958|NCT01896180|Latanoprost|latanoprost|mesh-list
138325959|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138325960|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138325961|NCT00981162|Everolimus|everolimus|mesh-list
138325962|NCT00981162|Sorafenib|sorafenib|mesh-list
138325963|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138325964|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138325965|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325966|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325967|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291694|NCT00002456|Methotrexate|methotrexate|mesh-list
138291714|NCT01525927|Cisplatin|cisplatin|mesh-list
138325969|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325970|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325971|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
138325977|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325978|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325979|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138325981|NCT05320692|Hormones|hormones|mesh-ancestor
138325982|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325983|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325984|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325985|NCT01763580|Prednisolone|prednisolone|mesh-list
138325986|NCT01763580|Tacrolimus|tacrolimus|mesh-list
138325987|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325988|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
138325989|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353475|NCT00811590|Everolimus|everolimus|mesh-list
138325990|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138325992|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325993|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138325994|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
138325995|NCT01763580|Hormones|hormones|mesh-ancestor
138325996|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325997|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325998|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325999|NCT01740492|Ketamine|ketamine|mesh-list
138326000|NCT01740492|Analgesics|analgesics|mesh-ancestor
138326001|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
138326002|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326003|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326004|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138326005|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138326007|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
138291790|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
138291794|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
138326008|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326009|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138326010|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138326011|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326012|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326013|NCT04780854|Metformin|metformin|mesh-list
138326014|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138326015|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326016|NCT04780152|Fluoxetine|fluoxetine|mesh-list
138326017|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
138326019|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326020|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326021|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326022|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326024|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326025|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138326026|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326027|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138326028|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138326029|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326030|NCT00644280|Ranibizumab|ranibizumab|mesh-list
138326031|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326032|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326033|NCT00644280|Growth Substances|growth substances|mesh-ancestor
138326034|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326035|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326036|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326037|NCT04779762|Ustekinumab|ustekinumab|mesh-list
138326038|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326039|NCT04777968|Fluorides|fluorides|mesh-list
138326040|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
138326041|NCT04777968|Protective Agents|protective agents|mesh-ancestor
138326042|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326043|NCT01722708|Metronidazole|metronidazole|mesh-list
138326044|NCT01722708|Clindamycin|clindamycin|mesh-list
138326045|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
138326046|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
138326048|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326049|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138326050|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138326051|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138326052|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326053|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326055|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326056|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326057|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326058|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326059|NCT04756206|Dutasteride|dutasteride|mesh-list
138326060|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138326061|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138326062|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326063|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326064|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
138326065|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326066|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326068|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326069|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
138326070|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
138326071|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326072|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326073|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326074|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
138326076|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326077|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326078|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326079|NCT04777110|Esketamine|esketamine|mesh-list
138326085|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326086|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326087|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138326088|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
138326089|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138326090|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138326091|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326092|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138326093|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
138326096|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138326097|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138326099|NCT05171946|Vaccines|vaccines|mesh-list
138326100|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
138326109|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
138326110|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326111|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326112|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326113|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326114|NCT05605158|Pioglitazone|pioglitazone|mesh-list
138326115|NCT05605158|Empagliflozin|empagliflozin|mesh-list
138326116|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138326117|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326118|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138326119|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326121|NCT04775238|Trace Elements|trace elements|mesh-ancestor
138292008|NCT00002552|Antidotes|antidotes|mesh-ancestor
138326123|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326124|NCT05580042|Tofacitinib|tofacitinib|mesh-list
138326125|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138326126|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326127|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326128|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326129|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
138353495|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353496|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138326130|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
138326131|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326132|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
138326133|NCT03012984|Morphine|morphine|mesh-list
138326134|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138326135|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326136|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326137|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138326138|NCT03012984|Analgesics|analgesics|mesh-ancestor
138326142|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138326143|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138326144|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
138326145|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326146|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326147|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138326149|NCT02744430|Mirabegron|mirabegron|mesh-list
138326150|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138326151|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138326152|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138326153|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138326154|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326155|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326156|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326157|NCT02744430|Urological Agents|urological agents|mesh-ancestor
138326158|NCT00054756|Hormones|hormones|mesh-list
138326159|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
138326160|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326161|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326162|NCT01896960|Fentanyl|fentanyl|mesh-list
138326163|NCT01896960|Bupivacaine|bupivacaine|mesh-list
138326164|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
138326166|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326167|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326168|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
138326169|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326170|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138326172|NCT01896960|Analgesics|analgesics|mesh-ancestor
138326173|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138326174|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138326175|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
138326176|NCT00055692|Bevacizumab|bevacizumab|mesh-list
138326177|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138326178|NCT00055692|Antibodies|antibodies|mesh-list
138326179|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
138326180|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138326181|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326182|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326183|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326184|NCT00055692|Growth Substances|growth substances|mesh-ancestor
138326185|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326186|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326187|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
138326188|NCT04772352|Febuxostat|febuxostat|mesh-list
138326189|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
138326190|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326191|NCT00056472|Olanzapine|olanzapine|mesh-list
138326192|NCT00056472|Sertraline|sertraline|mesh-list
138326193|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
138326194|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
138326196|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326197|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326198|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138326199|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138326200|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326201|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326202|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138326203|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326204|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326205|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326206|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326208|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
138326209|NCT00056550|Antithrombins|antithrombins|mesh-list
138326210|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
138326211|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138326212|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
138326213|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326214|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326215|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
138326216|NCT04771884|Vancomycin|vancomycin|mesh-list
138326217|NCT04771884|Meropenem|meropenem|mesh-list
138326218|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
138326219|NCT04771884|Linezolid|linezolid|mesh-list
138326220|NCT04771884|Ceftazidime|ceftazidime|mesh-list
138326221|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
138326222|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326223|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326224|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138326225|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326226|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326227|NCT02538744|Doxazosin|doxazosin|mesh-list
138326228|NCT02538744|Cocaine|cocaine|mesh-list
138326229|NCT02538744|Modafinil|modafinil|mesh-list
138326230|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138326231|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326232|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138326233|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138326235|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326236|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
138326237|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
138326238|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326239|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
138326240|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326241|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138326242|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138326243|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326244|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326245|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
138326246|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326247|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138326248|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138326249|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138326250|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138326251|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
138326254|NCT00060528|Sargramostim|sargramostim|mesh-list
138326255|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
138326256|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326257|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326258|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326259|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326260|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138326261|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138326262|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
138326263|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138326264|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138326265|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326266|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
138326267|NCT04696224|Coagulants|coagulants|mesh-ancestor
138326268|NCT04753008|Dopamine|dopamine|mesh-list
138326269|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138326270|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
138326271|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
138326272|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326273|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326275|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326276|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326277|NCT04753008|Protective Agents|protective agents|mesh-ancestor
138326278|NCT00063570|Gemcitabine|gemcitabine|mesh-list
138326279|NCT00063570|Pemetrexed|pemetrexed|mesh-list
138326280|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326281|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
138326282|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326283|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326284|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326285|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138326286|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292149|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
138326288|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326289|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326290|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326291|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326293|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138326294|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138326295|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326296|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
138326297|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326298|NCT00064038|Dexamethasone|dexamethasone|mesh-list
138326299|NCT00064038|Lenalidomide|lenalidomide|mesh-list
138326300|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326301|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
138326302|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
138326303|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326304|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326305|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326306|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
138326307|NCT00064038|Hormones|hormones|mesh-ancestor
138326308|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326309|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326310|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326311|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
138326313|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326314|NCT00064038|Growth Substances|growth substances|mesh-ancestor
138326315|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326316|NCT01960530|Dexamethasone|dexamethasone|mesh-list
138326317|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
138326319|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138326320|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138326321|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326322|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
138326325|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326326|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326327|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
138326328|NCT01960530|Hormones|hormones|mesh-ancestor
138326329|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326331|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326332|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
138326333|NCT01897428|Salicylates|salicylates|mesh-list
138326334|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138326335|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138326336|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138326337|NCT01897428|Analgesics|analgesics|mesh-ancestor
138326338|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
138326339|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326340|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326341|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326342|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326343|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138326344|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326345|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326346|NCT00024102|Doxorubicin|doxorubicin|mesh-list
138326347|NCT00024102|Capecitabine|capecitabine|mesh-list
138326348|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326349|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326350|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138326351|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326352|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326353|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326354|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326355|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
138326357|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138326358|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326359|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326360|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326361|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326363|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326364|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138326365|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
138326366|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138292294|NCT01401049|Lidocaine|lidocaine|mesh-list
138326367|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138326368|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138326369|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326370|NCT00030264|Methotrexate|methotrexate|mesh-list
138326371|NCT00030264|Vinblastine|vinblastine|mesh-list
138326372|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138326373|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
138326374|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138326375|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326376|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326377|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
138326378|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326380|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326381|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326382|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138326383|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326384|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
138326385|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326386|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138326387|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138326388|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326389|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326391|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
138326392|NCT01897116|Vemurafenib|vemurafenib|mesh-list
138326393|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
138326394|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138326395|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138326396|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326397|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326398|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326399|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326400|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326401|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326402|NCT00036738|Cyclosporine|cyclosporine|mesh-list
138326403|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
138326405|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
138326407|NCT00036738|Dasatinib|dasatinib|mesh-list
138326408|NCT00036738|Cyclosporins|cyclosporins|mesh-list
138326409|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326410|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326412|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326413|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326416|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326417|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
138326418|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326419|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326420|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326421|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326422|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326423|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138326424|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
138326425|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326426|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326427|NCT00038610|Cytarabine|cytarabine|mesh-list
138326428|NCT00038610|Dexamethasone|dexamethasone|mesh-list
138292420|NCT01315873|Bortezomib|bortezomib|mesh-list
138326429|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
138326430|NCT00038610|Doxorubicin|doxorubicin|mesh-list
138326431|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138326432|NCT00038610|Methotrexate|methotrexate|mesh-list
138326435|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326436|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
138326437|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326438|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326439|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326440|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
138326441|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326445|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
138326446|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
138326447|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326448|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326449|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
138326450|NCT00038610|Hormones|hormones|mesh-ancestor
138326451|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326452|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326453|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326454|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138326455|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326456|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292429|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326457|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138326458|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
138326459|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138326460|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326462|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326463|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138326464|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138326465|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
138326466|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326467|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138326468|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326469|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326470|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326471|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326472|NCT00156936|Naltrexone|naltrexone|mesh-list
138326473|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138326474|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138326475|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326476|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
138326477|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326478|NCT00046566|Caseins|caseins|mesh-list
138326479|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
138326480|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
138326481|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326482|NCT00079326|Trastuzumab|trastuzumab|mesh-list
138326483|NCT00079326|Epothilone B|epothilone b|mesh-list
138326484|NCT00079326|Epothilones|epothilones|mesh-list
138326485|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138326486|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326487|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292480|NCT01821859|Bevacizumab|bevacizumab|mesh-list
138326488|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326489|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414697|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326492|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326494|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
138326495|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326496|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326498|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
138326499|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326500|NCT00051168|Travoprost|travoprost|mesh-list
138326501|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138326502|NCT00083382|Pamidronate|pamidronate|mesh-list
138326503|NCT00083382|Thalidomide|thalidomide|mesh-list
138326504|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326505|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
138326506|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326507|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
138326508|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326509|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326510|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326511|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326512|NCT00083382|Growth Substances|growth substances|mesh-ancestor
138326513|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326514|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326515|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138326516|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
138326517|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326518|NCT00167934|Valproic Acid|valproic acid|mesh-list
138326519|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
138326520|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326521|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326522|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
138326523|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326525|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
138326526|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138326527|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326528|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326529|NCT00168324|Dexamethasone|dexamethasone|mesh-list
138326530|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
138326531|NCT00168324|BB 1101|bb 1101|mesh-list
138326532|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326533|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
138326534|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
138326535|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326536|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326537|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326539|NCT00168324|Hormones|hormones|mesh-ancestor
138326540|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326542|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326543|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
138326544|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326545|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326547|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
138326548|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326550|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138326551|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326552|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326553|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
138326554|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
138326555|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326556|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326557|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138326558|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138326559|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
138326560|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138326561|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138326562|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138326563|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138353552|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
138326564|NCT00085254|Temozolomide|temozolomide|mesh-list
138326565|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326566|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
138326567|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326568|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326570|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138326571|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138326572|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326574|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326575|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138326576|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326577|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326578|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326579|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326581|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138326582|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
138326584|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138326585|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
138326586|NCT00254592|Bevacizumab|bevacizumab|mesh-list
138326587|NCT00254592|Carboplatin|carboplatin|mesh-list
138326588|NCT00254592|Doxorubicin|doxorubicin|mesh-list
138326589|NCT00254592|Trastuzumab|trastuzumab|mesh-list
138326590|NCT00254592|Sargramostim|sargramostim|mesh-list
138326591|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138326592|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326593|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326594|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326595|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326596|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326597|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326598|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
138326599|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326600|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326601|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326602|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
138326603|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326604|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138326605|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326606|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326607|NCT00254592|Growth Substances|growth substances|mesh-ancestor
138326608|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326609|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326610|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138326611|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326612|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326614|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
138326615|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
138326616|NCT00255684|Fludarabine|fludarabine|mesh-list
138326617|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
138326618|NCT00255684|Cyclosporins|cyclosporins|mesh-list
138326619|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326620|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
138326621|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326622|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326623|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326624|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
138326625|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326626|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326627|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326628|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353563|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
138353564|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
138326629|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
138326630|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326631|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
138326632|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326633|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326634|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326635|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326636|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138326637|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
138326638|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326640|NCT00256776|Dexamethasone|dexamethasone|mesh-list
138326641|NCT00256776|Bortezomib|bortezomib|mesh-list
138326642|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326643|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
138326644|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
138326645|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326646|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326647|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326648|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
138326649|NCT00256776|Hormones|hormones|mesh-ancestor
138326650|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326651|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326652|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326653|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326656|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326657|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326658|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326659|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326660|NCT00256776|Growth Substances|growth substances|mesh-ancestor
138326661|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326662|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
138326663|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326664|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
138326665|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326666|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326667|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326668|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
138326669|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326670|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326671|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326672|NCT00176202|Valproic Acid|valproic acid|mesh-list
138326673|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
138326675|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
138326676|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138326677|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
138326678|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326679|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326680|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326682|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326683|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326684|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138326686|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326687|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
138326688|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
138326689|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
138326690|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
138326691|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
138326692|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138326693|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
138326694|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326695|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326696|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326697|NCT00176826|Busulfan|busulfan|mesh-list
138326699|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326700|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326701|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
138326702|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326703|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326704|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326705|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326706|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
138326707|NCT00176904|Busulfan|busulfan|mesh-list
138326708|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138326709|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326710|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
138326711|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326712|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326713|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326714|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
138326715|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326716|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326717|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326718|NCT00179478|Interferons|interferons|mesh-list
138326719|NCT00179478|Interferon-beta|interferon-beta|mesh-list
138326720|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
138326721|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326722|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
138326723|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326724|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
138326726|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138292778|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138292780|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
138326728|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326729|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326730|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326731|NCT00085410|Bortezomib|bortezomib|mesh-list
138326732|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326734|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138326735|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138326736|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
138326737|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326738|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326739|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326740|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138326741|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138326742|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
138326743|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138326744|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326745|NCT00087672|Lenalidomide|lenalidomide|mesh-list
138326746|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
138326747|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326748|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326749|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326750|NCT00087672|Growth Substances|growth substances|mesh-ancestor
138326751|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326752|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326753|NCT00088218|Cytarabine|cytarabine|mesh-list
138326754|NCT00088218|Clofarabine|clofarabine|mesh-list
138326755|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326756|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
138326757|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326758|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326759|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
138326760|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326761|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326762|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
138326763|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326765|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138326767|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
138326768|NCT00091260|Dexamethasone|dexamethasone|mesh-list
138326769|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
138326770|NCT00091260|Lenalidomide|lenalidomide|mesh-list
138326771|NCT00091260|BB 1101|bb 1101|mesh-list
138326772|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326773|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
138326774|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
138326775|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326777|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326779|NCT00091260|Hormones|hormones|mesh-ancestor
138326780|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326781|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326782|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326783|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
138326784|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326785|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326786|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
138326787|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326788|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326789|NCT00091260|Growth Substances|growth substances|mesh-ancestor
138326790|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326791|NCT00193128|Docetaxel|docetaxel|mesh-list
138326792|NCT00193128|Capecitabine|capecitabine|mesh-list
138326793|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
138326794|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326795|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326796|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326797|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326798|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326799|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326801|NCT00193596|Paclitaxel|paclitaxel|mesh-list
138326802|NCT00193596|Etoposide|etoposide|mesh-list
138326803|NCT00193596|Carboplatin|carboplatin|mesh-list
138326804|NCT00193596|Gemcitabine|gemcitabine|mesh-list
138326805|NCT00193596|Irinotecan|irinotecan|mesh-list
138326806|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138326807|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326808|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326809|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326810|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326811|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326812|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326813|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
138326814|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138326815|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326816|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326817|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138326819|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
138326820|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
138326821|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326822|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326823|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138326824|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326825|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326826|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326827|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326828|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138326829|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138326830|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
138326831|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138326832|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138326833|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138326834|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326835|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
138326836|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326837|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326838|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138326839|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326840|NCT00093756|Paclitaxel|paclitaxel|mesh-list
138326841|NCT00093756|Carboplatin|carboplatin|mesh-list
138326842|NCT00093756|Bortezomib|bortezomib|mesh-list
138326843|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138326844|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326845|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
138326846|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
138326847|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326848|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326849|NCT04118556|Sirolimus|sirolimus|mesh-list
138326850|NCT04118556|Infliximab|infliximab|mesh-list
138326851|NCT04118556|Etanercept|etanercept|mesh-list
138326852|NCT04118556|Everolimus|everolimus|mesh-list
138326853|NCT04118556|Vedolizumab|vedolizumab|mesh-list
138326855|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326856|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326857|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353578|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326858|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326859|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
138326860|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326862|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326863|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326864|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326865|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
138326866|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138326867|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326868|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326869|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138326870|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326871|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138326872|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138326873|NCT04118556|Analgesics|analgesics|mesh-ancestor
138326874|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
138326875|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326876|NCT00267696|Bevacizumab|bevacizumab|mesh-list
138326877|NCT00267696|Carboplatin|carboplatin|mesh-list
138326878|NCT00267696|Gemcitabine|gemcitabine|mesh-list
138326879|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138326880|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326881|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138326882|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138326883|NCT00267696|Growth Substances|growth substances|mesh-ancestor
138326884|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326885|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
138326886|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138326887|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
138326888|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326889|NCT00195624|Cyclosporine|cyclosporine|mesh-list
138326890|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
138326891|NCT00195624|Cyclosporins|cyclosporins|mesh-list
138326892|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326893|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326894|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326895|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
138292985|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
138326896|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326898|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326899|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326900|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326901|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326902|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138326903|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326904|NCT00195702|Adalimumab|adalimumab|mesh-list
138326905|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138326906|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326907|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326908|NCT00197184|Vaccines|vaccines|mesh-list
138326909|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
138326910|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326911|NCT00098670|Rituximab|rituximab|mesh-list
138326912|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138326913|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
138326914|NCT00098670|Fludarabine|fludarabine|mesh-list
138326915|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
138326916|NCT00098670|Antibodies|antibodies|mesh-list
138326917|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
138326918|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138326919|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
138326920|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326921|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326922|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326923|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353585|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138326924|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
138326925|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326926|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326927|NCT00201864|Fulvestrant|fulvestrant|mesh-list
138326928|NCT00201864|Exemestane|exemestane|mesh-list
138326929|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138326930|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326931|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138326932|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138326933|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
138326934|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326935|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326936|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138326937|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138326938|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326939|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326940|NCT00202722|Remifentanil|remifentanil|mesh-list
138326941|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138326954|NCT00205374|Cidofovir|cidofovir|mesh-list
138326955|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
138326956|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326957|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326958|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326959|NCT00103194|Lapatinib|lapatinib|mesh-list
138326960|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326961|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138326962|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326963|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326964|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
138326965|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138326966|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138326969|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326970|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326971|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326972|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326973|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
138326974|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326975|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
138326976|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326990|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326991|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
138326992|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326993|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
138326994|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326995|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
138326996|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326997|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138326998|NCT01899690|Clindamycin|clindamycin|mesh-list
138327000|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327001|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138327002|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327003|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327004|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138327005|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138327006|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138327007|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
138327008|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327009|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327010|NCT01899846|Progestins|progestins|mesh-ancestor
138327011|NCT01899846|Hormones|hormones|mesh-ancestor
138327012|NCT00214890|Tenofovir|tenofovir|mesh-list
138327013|NCT00214890|Abacavir|abacavir|mesh-list
138327014|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
138327015|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327017|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138327018|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327019|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327020|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138353596|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
138353598|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327021|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138327022|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
138327023|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138327025|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327026|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138327027|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327028|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138327030|NCT00282282|Fludarabine|fludarabine|mesh-list
138327031|NCT00282282|Busulfan|busulfan|mesh-list
138327032|NCT00282282|Tacrolimus|tacrolimus|mesh-list
138327033|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327034|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327035|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327036|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
138327037|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327038|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138327039|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327040|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327041|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327042|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138327043|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
138327044|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
138293196|NCT00379015|Epirubicin|epirubicin|mesh-list
138327062|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
138327063|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
138327064|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138293237|NCT00476827|Paclitaxel|paclitaxel|mesh-list
138327065|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138327066|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
138327067|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327068|NCT00223236|Choline|choline|mesh-list
138327069|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138327070|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
138327071|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327072|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
138327073|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327074|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327075|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327076|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
138327077|NCT00223704|Icatibant|icatibant|mesh-list
138327078|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
138327079|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138327080|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138327081|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327084|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138327085|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327087|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
138327088|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327089|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327090|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327091|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327092|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138327093|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138327094|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138327095|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327096|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
138327097|NCT00224952|Carbamazepine|carbamazepine|mesh-list
138327098|NCT00224952|Valproic Acid|valproic acid|mesh-list
138327099|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
138327100|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327101|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327102|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
138293270|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
138327104|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327105|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
138327106|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327107|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327108|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327109|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327110|NCT00224952|Analgesics|analgesics|mesh-ancestor
138327111|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
138327112|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327113|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138327114|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327115|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138327116|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138327117|NCT00225420|Docetaxel|docetaxel|mesh-list
138327118|NCT00225420|Leuprolide|leuprolide|mesh-list
138327119|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327120|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138327121|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138327122|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327123|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327124|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138327125|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
138327126|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138327127|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327128|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327133|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
138327134|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327135|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327136|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327137|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327138|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327139|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327140|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327141|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327142|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
138327143|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
138327144|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
138327145|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327146|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327147|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138327148|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138327149|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327150|NCT00225732|Ibuprofen|ibuprofen|mesh-list
138327151|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138327152|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327153|NCT00225732|Analgesics|analgesics|mesh-ancestor
138327154|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
138327155|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327156|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327157|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327158|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327159|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138327160|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327161|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327162|NCT02096718|Afatinib|afatinib|mesh-list
138327163|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327164|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327165|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293350|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327166|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327167|NCT02097732|Ipilimumab|ipilimumab|mesh-list
138327168|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327169|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327170|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138327171|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327172|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
138327173|NCT00286182|Hematinics|hematinics|mesh-ancestor
138327175|NCT00226590|Carboplatin|carboplatin|mesh-list
138327176|NCT00226590|Gemcitabine|gemcitabine|mesh-list
138353603|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353604|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327177|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138327178|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327179|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
138327180|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
138327181|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327182|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327183|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327184|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
138327186|NCT00114114|Testosterone|testosterone|mesh-list
138327187|NCT00114114|Androgens|androgens|mesh-ancestor
138327188|NCT00114114|Hormones|hormones|mesh-ancestor
138327189|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327190|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327191|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327192|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327194|NCT00227760|Maleic acid|maleic acid|mesh-list
138327195|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327196|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327197|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327198|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327200|NCT00227994|Galantamine|galantamine|mesh-list
138327201|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138327202|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327203|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327204|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
138327205|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327207|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
138327208|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138327209|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
138327210|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327211|NCT00114504|Simvastatin|simvastatin|mesh-list
138327212|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327213|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327214|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
138327215|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327216|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327217|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327218|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327220|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
138327221|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327222|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327223|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
138327224|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327225|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327226|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
138327227|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327228|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327229|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327231|NCT00288366|Ziprasidone|ziprasidone|mesh-list
138327232|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
138327233|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327234|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327235|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327236|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327237|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327238|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
138327239|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
138327240|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327241|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327242|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138327243|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138327245|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138327246|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138327247|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138353625|NCT00569868|Bortezomib|bortezomib|mesh-list
138327248|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327249|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138327250|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
138327251|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138327252|NCT00288600|Antibodies|antibodies|mesh-list
138327253|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
138327254|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138327255|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
138327256|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327257|NCT00290472|Sirolimus|sirolimus|mesh-list
138327258|NCT00290472|Temsirolimus|temsirolimus|mesh-list
138327259|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
138327260|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327261|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327262|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327263|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327264|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
138327265|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327266|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327267|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327268|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327269|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138327270|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
138327272|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327273|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
138327274|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
138327275|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327276|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327277|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327278|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
138327279|NCT04752852|Hormones|hormones|mesh-ancestor
138327280|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327281|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327282|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327286|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
138327287|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327288|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327289|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138327290|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138327291|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
138327292|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138327293|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138327294|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138327295|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138327296|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327297|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327298|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327299|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
138327300|NCT00234078|Rebamipide|rebamipide|mesh-list
138327301|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138327302|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327303|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
138327304|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327305|NCT00234078|Protective Agents|protective agents|mesh-ancestor
138327306|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327307|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327308|NCT00118404|Fluoxetine|fluoxetine|mesh-list
138327309|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138327310|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138327311|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327312|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327313|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327314|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
138327315|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327316|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138327317|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
138327318|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327319|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138327320|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138327321|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327323|NCT00121836|Capecitabine|capecitabine|mesh-list
138327324|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327325|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327326|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327327|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327332|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
138327333|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327334|NCT00237666|Ziprasidone|ziprasidone|mesh-list
138327335|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138327336|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
138327337|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327338|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327339|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327340|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327341|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327342|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327343|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327344|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327345|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
138327348|NCT00296322|Doxifluridine|doxifluridine|mesh-list
138327349|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327350|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138327351|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
138327352|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327353|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138327354|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327355|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327356|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
138327357|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327358|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
138327359|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327360|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
138327361|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138327362|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
138293534|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
138327364|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
138327365|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138327366|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138327367|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327368|NCT00123162|Urological Agents|urological agents|mesh-ancestor
138327375|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
138327376|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327377|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327378|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138327379|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138327380|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
138327381|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138327382|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138327383|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138327384|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138327385|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327386|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327387|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327388|NCT00240162|Vatalanib|vatalanib|mesh-list
138327389|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327390|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327391|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327392|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
138327393|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138327395|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
138327396|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138327397|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
138353626|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327398|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327399|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
138327400|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
138327401|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
138327402|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138327403|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138327404|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293573|NCT00655057|Citalopram|citalopram|mesh-list
138327405|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327406|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327407|NCT00300456|Simvastatin|simvastatin|mesh-list
138327408|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327409|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327410|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
138327411|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327413|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327414|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327415|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
138327416|NCT00125034|Cetuximab|cetuximab|mesh-list
138327417|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327418|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327419|NCT02100930|Molgramostim|molgramostim|mesh-list
138327420|NCT02100930|Isotretinoin|isotretinoin|mesh-list
138327421|NCT02100930|Antibodies|antibodies|mesh-list
138327422|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138327423|NCT02100930|Sargramostim|sargramostim|mesh-list
138327424|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
138327425|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327426|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
138327427|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327428|NCT00241176|Aripiprazole|aripiprazole|mesh-list
138327429|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
138327430|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327433|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327434|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327437|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327438|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327439|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138327440|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138327441|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
138327442|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138327443|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138327444|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138327445|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327446|NCT02102100|Menthol|menthol|mesh-list
138327447|NCT02102100|Nicotine|nicotine|mesh-list
138327448|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138327449|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
138327450|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327451|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327452|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138327453|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138327454|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138327455|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327456|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327458|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
138327459|NCT02094534|Insulin|insulin|mesh-list
138327460|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327461|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353639|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
138353640|NCT05001048|Synephrine|synephrine|mesh-list
138327462|NCT00242502|Bevacizumab|bevacizumab|mesh-list
138327463|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138327464|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327465|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327466|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327467|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327469|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327470|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327471|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327472|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327473|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327474|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
138327475|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138327476|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327477|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
138327478|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327479|NCT04389060|Protective Agents|protective agents|mesh-ancestor
138327480|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327481|NCT01899066|Carboplatin|carboplatin|mesh-list
138327482|NCT01899066|Etoposide|etoposide|mesh-list
138327483|NCT01899066|Vincristine|vincristine|mesh-list
138327485|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327486|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138327489|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327490|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327491|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138327492|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138327493|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327494|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327495|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327496|NCT01899066|Growth Substances|growth substances|mesh-ancestor
138327497|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327500|NCT00127218|Atorvastatin|atorvastatin|mesh-list
138327501|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138327502|NCT00127218|Simvastatin|simvastatin|mesh-list
138327503|NCT00127218|Pravastatin|pravastatin|mesh-list
138327504|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327505|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327506|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
138327507|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327508|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327509|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327510|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327511|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
138327512|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
138327513|NCT00127218|Vitamins|vitamins|mesh-ancestor
138327514|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
138327515|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327516|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
138327517|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138327518|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327519|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327520|NCT00250926|Dexamethasone|dexamethasone|mesh-list
138327521|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
138327522|NCT00250926|Rituximab|rituximab|mesh-list
138327523|NCT00250926|Bortezomib|bortezomib|mesh-list
138327524|NCT00250926|BB 1101|bb 1101|mesh-list
138327525|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138353654|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327528|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327531|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
138327532|NCT00250926|Hormones|hormones|mesh-ancestor
138353655|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327533|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327534|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327535|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327536|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
138327537|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327538|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327539|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327540|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
138327541|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327542|NCT00303966|Sorafenib|sorafenib|mesh-list
138327543|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327544|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138327545|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327546|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327547|NCT00304746|Testosterone|testosterone|mesh-list
138327548|NCT00304746|Androgens|androgens|mesh-ancestor
138327549|NCT00304746|Hormones|hormones|mesh-ancestor
138327550|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327551|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327552|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
138327553|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
138327554|NCT00134004|Fludarabine|fludarabine|mesh-list
138327555|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
138327557|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327558|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
138327559|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327560|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327561|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138327562|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
138327563|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327565|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138327566|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327567|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
138327568|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138327569|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327570|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138327571|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138327572|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
138327573|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327574|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327575|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138327576|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
138327577|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327578|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
138327579|NCT02103114|Antithrombins|antithrombins|mesh-list
138327583|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138327584|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
138327585|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327586|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327587|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
138327588|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
138327589|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138327590|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138353669|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327593|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138327594|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
138327595|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327596|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
138327598|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327599|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327600|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327601|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
138327602|NCT01790022|Hormones|hormones|mesh-ancestor
138327603|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327604|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138327605|NCT01790022|Protective Agents|protective agents|mesh-ancestor
138327606|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327607|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327608|NCT00140556|Bevacizumab|bevacizumab|mesh-list
138327609|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138327610|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327611|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327612|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327613|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327614|NCT00140556|Growth Substances|growth substances|mesh-ancestor
138327615|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327616|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327618|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327619|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327620|NCT00142116|Thalidomide|thalidomide|mesh-list
138327621|NCT00142116|Rituximab|rituximab|mesh-list
138327622|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327623|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327624|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
138327625|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327626|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327627|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327628|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
138327630|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327631|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327632|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327633|NCT00142116|Growth Substances|growth substances|mesh-ancestor
138327634|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327635|NCT05201430|Capecitabine|capecitabine|mesh-list
138327636|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
138327637|NCT05201430|Irinotecan|irinotecan|mesh-list
138327638|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327639|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
138327640|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327641|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327642|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138327643|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138327644|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327645|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
138327646|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327647|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
138327648|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138327649|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138327650|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327651|NCT00142506|Urological Agents|urological agents|mesh-ancestor
138327652|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
138327653|NCT05266794|Selenium|selenium|mesh-list
138327654|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
138327655|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327656|NCT05266794|Protective Agents|protective agents|mesh-ancestor
138327657|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327658|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
138327659|NCT05266794|Vitamins|vitamins|mesh-ancestor
138327660|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
138327662|NCT00142818|Naltrexone|naltrexone|mesh-list
138327663|NCT00142818|Modafinil|modafinil|mesh-list
138327664|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138327665|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138327666|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327667|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
138327668|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327669|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138327670|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138327671|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138327672|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138327673|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327674|NCT05266716|Methamphetamine|methamphetamine|mesh-list
138327675|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138327676|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327677|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
138327678|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
138327680|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
138327681|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327682|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327683|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327684|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138327685|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138327686|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327687|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138327688|NCT05266560|Propofol|propofol|mesh-list
138327689|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138327690|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327691|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327692|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138327693|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
138327694|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
138327695|NCT00147966|Rituximab|rituximab|mesh-list
138327696|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327697|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327698|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
138327699|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327700|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327701|NCT04528212|Glimepiride|glimepiride|mesh-list
138327702|NCT04528212|Curcumin|curcumin|mesh-list
138327703|NCT04528212|Fenofibrate|fenofibrate|mesh-list
138327704|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138327705|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327706|NCT04528212|Analgesics|analgesics|mesh-ancestor
138327707|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
138327708|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327709|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327710|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327711|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327712|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327713|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327714|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327715|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138327716|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327717|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327718|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
138327719|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327720|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
138327721|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327722|NCT00148668|Carboplatin|carboplatin|mesh-list
138327724|NCT00148668|Trastuzumab|trastuzumab|mesh-list
138327725|NCT00148668|Vinorelbine|vinorelbine|mesh-list
138327726|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327727|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138327728|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138327729|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327730|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327731|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327735|NCT00324870|Bevacizumab|bevacizumab|mesh-list
138327736|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138327738|NCT00324870|Antibodies|antibodies|mesh-list
138327739|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
138327740|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138327741|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327742|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327743|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327744|NCT00324870|Growth Substances|growth substances|mesh-ancestor
138327745|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327746|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327747|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
138327748|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138327749|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327750|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327752|NCT00151320|Bortezomib|bortezomib|mesh-list
138327753|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327754|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327755|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
138327756|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327757|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327758|NCT00328770|Sirolimus|sirolimus|mesh-list
138327759|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327760|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327761|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138327762|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327763|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
138327764|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327765|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
138327766|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327767|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138327768|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138327769|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327770|NCT00330876|Pitavastatin|pitavastatin|mesh-list
138294010|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327771|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327772|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327773|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327774|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
138327775|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327776|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327777|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327778|NCT00334074|Cytarabine|cytarabine|mesh-list
138327779|NCT00334074|Clofarabine|clofarabine|mesh-list
138327780|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327781|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
138327782|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327783|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327784|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
138327785|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327786|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327787|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
138327788|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327789|NCT00335478|Daptomycin|daptomycin|mesh-list
138327790|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327791|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327792|NCT04345926|Propofol|propofol|mesh-list
138327793|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138327794|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327795|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327796|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138327800|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327801|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327802|NCT00338598|Glycine|glycine|mesh-list
138327803|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
138327804|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294056|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294057|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327805|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327806|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327807|NCT00338988|Capecitabine|capecitabine|mesh-list
138327808|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
138327809|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327810|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
138327811|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327812|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327813|NCT00343044|Bevacizumab|bevacizumab|mesh-list
138327814|NCT00343044|Topotecan|topotecan|mesh-list
138327815|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327816|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327817|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327818|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327819|NCT00343044|Growth Substances|growth substances|mesh-ancestor
138327820|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327821|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327822|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138327823|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138327824|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327825|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327826|NCT00344370|Atorvastatin|atorvastatin|mesh-list
138327827|NCT00344370|Pitavastatin|pitavastatin|mesh-list
138327828|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327829|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327830|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
138327831|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327832|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327833|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327834|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327835|NCT00344682|Memantine|memantine|mesh-list
138327836|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138327837|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138327838|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
138327839|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327840|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294099|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
138327841|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327842|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138327843|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138327844|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
138327845|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138327846|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327848|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327850|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
138327851|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327852|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138327853|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138327857|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327858|NCT01791114|Propranolol|propranolol|mesh-list
138327859|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138327860|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138327861|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327862|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327863|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327864|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327865|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138327866|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138327867|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
138327868|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138327869|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138327870|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327871|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138327872|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
138327873|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327874|NCT00350142|Gemcitabine|gemcitabine|mesh-list
138327875|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327876|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
138327877|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327879|NCT00350532|Clonidine|clonidine|mesh-list
138327880|NCT00350532|Analgesics|analgesics|mesh-ancestor
138327881|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
138327882|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327883|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327884|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138327885|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
138327886|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
138327887|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138327888|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138327889|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138327890|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327891|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327892|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327893|NCT00351000|Ziprasidone|ziprasidone|mesh-list
138327894|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138327895|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
138327896|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327897|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327898|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327899|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327900|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327901|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327902|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327903|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327905|NCT00351936|Aripiprazole|aripiprazole|mesh-list
138327906|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
138327907|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327908|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327909|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327910|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138327911|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327912|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
138327916|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138327917|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138327918|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
138327919|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138327920|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138327921|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138327922|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138327923|NCT00352794|Prednisone|prednisone|mesh-list
138327924|NCT00352794|Lenalidomide|lenalidomide|mesh-list
138327925|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138327926|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
138327927|NCT00352794|Hormones|hormones|mesh-ancestor
138327928|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327929|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327930|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327931|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327933|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327934|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138327935|NCT00352794|Growth Substances|growth substances|mesh-ancestor
138327936|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
138327937|NCT00353418|Ribavirin|ribavirin|mesh-list
138327938|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138327939|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
138327940|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327941|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
138327942|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327943|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
138327945|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138327946|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
138327949|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138327951|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
138327952|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138327953|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138327954|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327955|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327957|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138327958|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327959|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327960|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138327961|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138327962|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
138327963|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327964|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138327965|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138327966|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327968|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138327969|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327970|NCT01794078|Ambrisentan|ambrisentan|mesh-list
138327971|NCT01794078|Aminophylline|aminophylline|mesh-list
138327972|NCT01794078|Theophylline|theophylline|mesh-list
138327973|NCT01794078|Ethylene|ethylene|mesh-list
138327974|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138327975|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
138327976|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138327977|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327979|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
138327980|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138327981|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327982|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327983|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138327984|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138327985|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138327986|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
138327987|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327988|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138327989|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138327990|NCT01794078|Protective Agents|protective agents|mesh-ancestor
138327991|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138327992|NCT01794078|Growth Substances|growth substances|mesh-ancestor
138327994|NCT00354978|Bevacizumab|bevacizumab|mesh-list
138327995|NCT00354978|Fluorouracil|fluorouracil|mesh-list
138327997|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138327998|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138327999|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328000|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328001|NCT00354978|Growth Substances|growth substances|mesh-ancestor
138328002|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328003|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328004|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
138328005|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328006|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328007|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328008|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
138328009|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138328010|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328011|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328012|NCT00354978|Antidotes|antidotes|mesh-ancestor
138328013|NCT00354978|Protective Agents|protective agents|mesh-ancestor
138328014|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
138328016|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
138328017|NCT00357162|Belinostat|belinostat|mesh-list
138328019|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138328020|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328021|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328023|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
138328024|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138328025|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328026|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328027|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138328028|NCT03984240|Analgesics|analgesics|mesh-ancestor
138328029|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
138328030|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328031|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138328032|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138328033|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138328034|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138328035|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328036|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328037|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138328038|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138328039|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328040|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328041|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138328042|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
138328043|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
138328044|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
138328045|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
138328047|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138328048|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138328049|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138328050|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328051|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328052|NCT00359736|Urological Agents|urological agents|mesh-ancestor
138294429|NCT00000979|Zidovudine|zidovudine|mesh-list
138328053|NCT00360126|Lamotrigine|lamotrigine|mesh-list
138328054|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
138328055|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138328056|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328057|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328058|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138328059|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328060|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138328061|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328062|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328063|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328064|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138328065|NCT00360360|Paclitaxel|paclitaxel|mesh-list
138328066|NCT00360360|Bevacizumab|bevacizumab|mesh-list
138328067|NCT00360360|Carboplatin|carboplatin|mesh-list
138328068|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138328069|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138328070|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328071|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
138328072|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
138328073|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328074|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328075|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328076|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328077|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328078|NCT00360360|Growth Substances|growth substances|mesh-ancestor
138328079|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328080|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328081|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328082|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328084|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138328085|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328087|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328088|NCT00549978|Cilostazol|cilostazol|mesh-list
138328089|NCT00549978|Probucol|probucol|mesh-list
138328090|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138328091|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
138328092|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294451|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
138328093|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328098|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328099|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138328100|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
138328101|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138328102|NCT00549978|Protective Agents|protective agents|mesh-ancestor
138328103|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138328104|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138328105|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328106|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138328107|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138328108|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
138328109|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138328110|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
138328111|NCT03983226|Carboplatin|carboplatin|mesh-list
138328112|NCT03983226|Gemcitabine|gemcitabine|mesh-list
138328113|NCT03983226|Doxorubicin|doxorubicin|mesh-list
138328114|NCT03983226|Niraparib|niraparib|mesh-list
138328115|NCT03983226|Taxane|taxane|mesh-list
138328116|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328117|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328118|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
138328119|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328120|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328121|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328122|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328123|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328124|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138328126|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
138328127|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328128|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328132|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328133|NCT00360828|Irinotecan|irinotecan|mesh-list
138328134|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138328135|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328136|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328137|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328138|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328139|NCT00361140|Fludarabine|fludarabine|mesh-list
138328140|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
138328141|NCT00361140|Busulfan|busulfan|mesh-list
138328142|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328143|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328144|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
138328145|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328146|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328147|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
138328148|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328149|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
138328150|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328151|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328152|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
138328153|NCT00362466|Dasatinib|dasatinib|mesh-list
138328154|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328159|NCT00305682|Sirolimus|sirolimus|mesh-list
138328160|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
138328161|NCT00305682|Fludarabine|fludarabine|mesh-list
138328162|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138328163|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328164|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
138328165|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328166|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328167|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328168|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
138328169|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328170|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328171|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328172|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328173|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138328174|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
138328175|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138328176|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328178|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
138328179|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
138328180|NCT00305760|Cetuximab|cetuximab|mesh-list
138328181|NCT00305760|Vaccines|vaccines|mesh-list
138328182|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
138328183|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328184|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328185|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328186|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328187|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
138328188|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328189|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328190|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328191|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328192|NCT00309738|Simvastatin|simvastatin|mesh-list
138328193|NCT00309738|Pitavastatin|pitavastatin|mesh-list
138328194|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138328195|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138328196|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
138328197|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328198|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138328199|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138328200|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294582|NCT00000703|Antidotes|antidotes|mesh-ancestor
138328202|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328203|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328204|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328205|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138328206|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328207|NCT00363168|Ranibizumab|ranibizumab|mesh-list
138328208|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328209|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328216|NCT00365274|Doxorubicin|doxorubicin|mesh-list
138328218|NCT00365274|Vincristine|vincristine|mesh-list
138328219|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138328220|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328221|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
138328222|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328223|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328224|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328225|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
138328226|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328227|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328228|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328229|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328230|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328231|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328232|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328233|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328234|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
138328235|NCT00365274|Hormones|hormones|mesh-ancestor
138328236|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328237|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138328238|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138328239|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138328240|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138328241|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328242|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328243|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
138328244|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
138328245|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
138328246|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138328247|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138328248|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138328249|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328250|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328251|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
138328252|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328253|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328254|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138328255|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328256|NCT02104830|Lenograstim|lenograstim|mesh-list
138328257|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138328258|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
138294655|NCT00001057|Zidovudine|zidovudine|mesh-list
138328259|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328260|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138328261|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328262|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328263|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328264|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328267|NCT00314106|Fludarabine|fludarabine|mesh-list
138328268|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328269|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
138328270|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328271|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328272|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328273|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
138328274|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328275|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328276|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328277|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138328278|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138328279|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
138328280|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328281|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138328282|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
138328283|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328284|NCT00318708|Fluticasone|fluticasone|mesh-list
138328286|NCT00318708|Clarithromycin|clarithromycin|mesh-list
138328287|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328288|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138328292|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138353690|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138353691|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353692|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353693|NCT02411526|Risperidone|risperidone|mesh-list
138328293|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
138328294|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328295|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138328296|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138328297|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328298|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138328299|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328300|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328301|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138328302|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138328303|NCT00319644|Dimercaprol|dimercaprol|mesh-list
138328304|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
138328305|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
138328306|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328307|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138328308|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138328309|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138328311|NCT02405676|Prednisone|prednisone|mesh-list
138328312|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
138328313|NCT02405676|Ifosfamide|ifosfamide|mesh-list
138328314|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
138328315|NCT02405676|Rituximab|rituximab|mesh-list
138328316|NCT02405676|Methotrexate|methotrexate|mesh-list
138328317|NCT02405676|Etoposide|etoposide|mesh-list
138328318|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
138328319|NCT02405676|Vincristine|vincristine|mesh-list
138328320|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328321|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
138328322|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328323|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328324|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328325|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
138328326|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328327|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328328|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328329|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328330|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328331|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
138328332|NCT02405676|Hormones|hormones|mesh-ancestor
138328334|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138328335|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138328336|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
138328337|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138328338|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328339|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
138328340|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328341|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328342|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138328343|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328344|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138328345|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328346|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328347|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
138328348|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328349|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138328350|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138328351|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328353|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328354|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138328356|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328358|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138328359|NCT04751136|Protective Agents|protective agents|mesh-ancestor
138328360|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353696|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328361|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
138328362|NCT00390234|Aflibercept|aflibercept|mesh-list
138328365|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328367|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328368|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328369|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328371|NCT00391716|Analgesics|analgesics|mesh-ancestor
138328372|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
138328373|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328374|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328375|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
138328376|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138328377|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328378|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328379|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328380|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138328381|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138328382|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328383|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328384|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
138328386|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328387|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328388|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328389|NCT00392496|Growth Substances|growth substances|mesh-ancestor
138328390|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328391|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328392|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328393|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294817|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328394|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328395|NCT01958190|Sirolimus|sirolimus|mesh-list
138328396|NCT01958190|Tacrolimus|tacrolimus|mesh-list
138328397|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328398|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
138328401|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328402|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328403|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138328404|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328405|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328406|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328407|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
138328409|NCT00638898|Busulfan|busulfan|mesh-list
138328410|NCT00638898|Topotecan|topotecan|mesh-list
138328411|NCT00638898|Lenograstim|lenograstim|mesh-list
138328412|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138328413|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
138328414|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328415|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328416|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
138328417|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328418|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328419|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328420|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328421|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138328422|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328423|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328424|NCT00393978|Topiramate|topiramate|mesh-list
138328425|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138328426|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
138328427|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328428|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138353707|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353710|NCT00558870|Morphine|morphine|mesh-list
138328429|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138353711|NCT00558870|Methadone|methadone|mesh-list
138328430|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328431|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328432|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
138328433|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138328434|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
138328435|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138328436|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328437|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328440|NCT00397020|Valproic Acid|valproic acid|mesh-list
138328441|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138328442|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
138328443|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328444|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138328445|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328446|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328447|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328449|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328450|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328452|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328453|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
138328454|NCT00397878|Saracatinib|saracatinib|mesh-list
138328455|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328456|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328457|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328458|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
138328459|NCT00400686|Hematinics|hematinics|mesh-ancestor
138328461|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328462|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328463|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
138328464|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138328465|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
138328466|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328467|NCT00374088|Expectorants|expectorants|mesh-ancestor
138328468|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138328469|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138328470|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
138328471|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328472|NCT00374088|Protective Agents|protective agents|mesh-ancestor
138328473|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328474|NCT00374088|Antidotes|antidotes|mesh-ancestor
138328476|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138328477|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328478|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328479|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328480|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328481|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138328482|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
138328483|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328484|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328485|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138328486|NCT00377832|Acetaminophen|acetaminophen|mesh-list
138328489|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
138328490|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328491|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328493|NCT00401778|Everolimus|everolimus|mesh-list
138328494|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138328495|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328496|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328497|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328498|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328499|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
138328500|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328501|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328502|NCT00402714|Pentostatin|pentostatin|mesh-list
138328503|NCT00402714|Methoxsalen|methoxsalen|mesh-list
138328504|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328505|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138328506|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328507|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328508|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138328509|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328510|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
138328512|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138328513|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138328515|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328516|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138328517|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
138328518|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328519|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328520|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
138328521|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328524|NCT00381810|Promethazine|promethazine|mesh-list
138328525|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
138328527|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328529|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
138328530|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328531|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328532|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138328533|NCT00381810|Analgesics|analgesics|mesh-ancestor
138328534|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
138328535|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328536|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
138328537|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328538|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
138328539|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
138328540|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138328541|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
138328542|NCT00381810|Hormones|hormones|mesh-ancestor
138328543|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328544|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138328545|NCT00381810|Protective Agents|protective agents|mesh-ancestor
138328546|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138328547|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138328548|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328550|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
138328551|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138328552|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
138328553|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
138328554|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328555|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328556|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138328557|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
138328558|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295047|NCT00002065|Disulfiram|disulfiram|mesh-list
138328559|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138328560|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328561|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328562|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328563|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138328565|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
138328566|NCT00459732|Trace Elements|trace elements|mesh-ancestor
138328567|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
138328568|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328569|NCT00459732|Astringents|astringents|mesh-ancestor
138328570|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328572|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138328573|NCT00459810|Estradiol|estradiol|mesh-list
138328576|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138328577|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138328578|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138353719|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
138328579|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328580|NCT00459810|Estrogens|estrogens|mesh-ancestor
138353720|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353721|NCT00548886|Epinephrine|epinephrine|mesh-list
138353722|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138328581|NCT00459810|Hormones|hormones|mesh-ancestor
138328582|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328583|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328584|NCT00405522|Remifentanil|remifentanil|mesh-list
138328585|NCT00405522|Propofol|propofol|mesh-list
138328586|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138328587|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138295071|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138328588|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328590|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
138328591|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
138328592|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138328593|NCT00405522|Narcotics|narcotics|mesh-ancestor
138328594|NCT00405522|Analgesics|analgesics|mesh-ancestor
138328595|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
138328596|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328597|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
138328598|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138328599|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138328600|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138328601|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328602|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328603|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138328604|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328605|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328610|NCT00382590|Valproic Acid|valproic acid|mesh-list
138328611|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328612|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
138328613|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328614|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328615|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
138328616|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328617|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328618|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
138328619|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295119|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138328620|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328622|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
138328623|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328624|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
138328625|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138328626|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328627|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138328629|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
138328630|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
138328631|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328633|NCT00462072|Infliximab|infliximab|mesh-list
138328634|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138328635|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328636|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328637|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138328638|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328639|NCT00462228|Memantine|memantine|mesh-list
138328640|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138328641|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138328642|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
138328643|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328644|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328645|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328646|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138328647|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138328648|NCT00408564|Gemcitabine|gemcitabine|mesh-list
138328649|NCT00408564|Capecitabine|capecitabine|mesh-list
138353727|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353728|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138353729|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138353730|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
138328650|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
138328651|NCT00408564|Cetuximab|cetuximab|mesh-list
138328652|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328653|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
138328654|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328659|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
138328660|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
138328661|NCT00383448|Clofarabine|clofarabine|mesh-list
138328662|NCT00383448|Cyclosporins|cyclosporins|mesh-list
138328663|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328664|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328665|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328666|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
138328667|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328668|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
138328669|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328670|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328671|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328672|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138328673|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328675|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328676|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328677|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328678|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
138328679|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328680|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328681|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
138328682|NCT00384774|Lasmiditan|lasmiditan|mesh-list
138328683|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138328684|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
138328685|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328686|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328687|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328688|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138328690|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328691|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328692|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328693|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
138328694|NCT00464646|Bevacizumab|bevacizumab|mesh-list
138328695|NCT00464646|Docetaxel|docetaxel|mesh-list
138328696|NCT00464646|Trastuzumab|trastuzumab|mesh-list
138328697|NCT00464646|Epirubicin|epirubicin|mesh-list
138328698|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328699|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
138328700|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328701|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328702|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328703|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
138328704|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328705|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328706|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328707|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328708|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328709|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138295254|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328710|NCT00464646|Growth Substances|growth substances|mesh-ancestor
138328711|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328712|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
138328713|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353742|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
138328714|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328717|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328718|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328720|NCT00385008|Sumatriptan|sumatriptan|mesh-list
138328721|NCT00385008|Eletriptan|eletriptan|mesh-list
138328722|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138328723|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138328724|NCT00385008|Analgesics|analgesics|mesh-ancestor
138328725|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
138328726|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328727|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328728|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328729|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328730|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
138328731|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138328732|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328733|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328734|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138328735|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138328736|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138328737|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
138328738|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328739|NCT00410904|Pemetrexed|pemetrexed|mesh-list
138328740|NCT00410904|Cediranib|cediranib|mesh-list
138328741|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328742|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328743|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328744|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138328745|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328746|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328749|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
138328750|NCT00385788|Fludarabine|fludarabine|mesh-list
138328751|NCT00385788|Melphalan|melphalan|mesh-list
138328752|NCT00385788|Tacrolimus|tacrolimus|mesh-list
138328753|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
138328754|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138328755|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328756|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
138328757|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328758|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328759|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138328760|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
138328761|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138328764|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328765|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138328766|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328767|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
138328768|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328769|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138328770|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138328771|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328772|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
138328773|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328774|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
138328775|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138328776|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
138328777|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138328778|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328779|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138328780|NCT00412074|Vitamin D|vitamin d|mesh-list
138328781|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
138328782|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
138328783|NCT00412074|Vitamins|vitamins|mesh-list
138328784|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
138328785|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328786|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138295339|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328787|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138328788|NCT00412464|PENTA|penta|mesh-list
138328789|NCT00412464|Fondaparinux|fondaparinux|mesh-list
138328790|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138328791|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
138328792|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138328793|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
138328794|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328800|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328801|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328802|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328803|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328804|NCT02115750|Etanercept|etanercept|mesh-list
138328805|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138328806|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138328807|NCT02115750|Analgesics|analgesics|mesh-ancestor
138328808|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
138328809|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328810|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328811|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328812|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328813|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138295373|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138328815|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
138328816|NCT00413166|Idarubicin|idarubicin|mesh-list
138328817|NCT00413166|Tretinoin|tretinoin|mesh-list
138328818|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
138328819|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
138328820|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328821|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328822|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328823|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328824|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328825|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328826|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
138328827|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328828|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328829|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
138328830|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
138328831|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
138328832|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328833|NCT00413400|Etanercept|etanercept|mesh-list
138328834|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138328835|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138328836|NCT00413400|Analgesics|analgesics|mesh-ancestor
138328837|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
138328838|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328839|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328840|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328841|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328842|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138328843|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295418|NCT00002161|Adefovir|adefovir|mesh-list
138353774|NCT00108342|Nicotine|nicotine|mesh-list
138328844|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
138328845|NCT00413478|Azacitidine|azacitidine|mesh-list
138353776|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
138328846|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328847|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
138328848|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328849|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328850|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328853|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138328854|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328855|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138328857|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328858|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138328859|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
138328860|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328861|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328862|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138328863|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
138328864|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328865|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138328866|NCT00387660|Carboplatin|carboplatin|mesh-list
138328867|NCT00387660|Irinotecan|irinotecan|mesh-list
138328868|NCT00387660|Camptothecin|camptothecin|mesh-list
138328869|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328870|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138328871|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328872|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328873|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328874|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138328876|NCT00472056|Rituximab|rituximab|mesh-list
138328877|NCT00472056|Etoposide|etoposide|mesh-list
138328878|NCT00472056|Melphalan|melphalan|mesh-list
138328879|NCT00472056|Carmustine|carmustine|mesh-list
138328880|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328881|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328882|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
138328883|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328884|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328890|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138328892|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
138328893|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328894|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328895|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328896|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
138328897|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138328898|NCT00415506|Rituximab|rituximab|mesh-list
138328899|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328900|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328902|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328903|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328904|NCT00389532|Vaccines|vaccines|mesh-list
138328905|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
138328906|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328907|NCT00475878|Escitalopram|escitalopram|mesh-list
138328908|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138328909|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138328910|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328911|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328913|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
138328914|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328915|NCT01795170|Pyridoxine|pyridoxine|mesh-list
138328916|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
138328917|NCT01795170|Vitamins|vitamins|mesh-ancestor
138328918|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
138328919|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328921|NCT00477204|Ezetimibe|ezetimibe|mesh-list
138328922|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138328923|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138328924|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138328925|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
138328926|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328927|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138328928|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138328929|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328930|NCT00528450|Idarubicin|idarubicin|mesh-list
138328931|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
138328932|NCT00528450|Tretinoin|tretinoin|mesh-list
138328933|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328934|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328935|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328936|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328937|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328938|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328944|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328945|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
138328946|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328947|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328948|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328949|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
138328950|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328951|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328952|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295538|NCT00383396|Cyclosporins|cyclosporins|mesh-list
138295539|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328954|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
138328955|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
138328956|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328957|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138328958|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
138328960|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328961|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138328962|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328963|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138328964|NCT00478218|Growth Substances|growth substances|mesh-ancestor
138328965|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
138328966|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
138328967|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138328968|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138328969|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138328970|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328973|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328974|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328975|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138328976|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328978|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138328979|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328980|NCT00424554|Temozolomide|temozolomide|mesh-list
138328981|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328982|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
138353793|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353794|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353795|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
138353797|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138353798|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138353799|NCT00090870|Growth Substances|growth substances|mesh-ancestor
138353800|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138353801|NCT00074724|Dobutamine|dobutamine|mesh-list
138353802|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138353803|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
138328983|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328984|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328986|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
138328987|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
138328988|NCT00425802|Rituximab|rituximab|mesh-list
138328989|NCT00425802|Fludarabine|fludarabine|mesh-list
138328990|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
138328991|NCT00425802|Cyclosporins|cyclosporins|mesh-list
138328992|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138328993|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138328994|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
138328995|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328996|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138328997|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138328998|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
138328999|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329000|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329001|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329002|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329003|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329004|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
138329005|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329006|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
138329007|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329008|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329009|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138329010|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329011|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138329016|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329017|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
138329018|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329019|NCT00531882|Pioglitazone|pioglitazone|mesh-list
138329020|NCT00531882|Ibuprofen|ibuprofen|mesh-list
138329021|NCT00531882|Simvastatin|simvastatin|mesh-list
138295613|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138329022|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138329023|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138329024|NCT00531882|Analgesics|analgesics|mesh-ancestor
138329025|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
138329026|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329027|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329028|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329029|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329030|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138329031|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329032|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329033|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138329034|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138329035|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
138329036|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138329037|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138329038|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138329040|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
138329041|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329042|NCT00486018|Ranibizumab|ranibizumab|mesh-list
138329043|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329044|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329045|NCT00486018|Growth Substances|growth substances|mesh-ancestor
138329046|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329047|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
138353808|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138353809|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138353810|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353811|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353812|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353813|NCT00074724|Protective Agents|protective agents|mesh-ancestor
138353814|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
138329048|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329049|NCT00486642|Bicalutamide|bicalutamide|mesh-list
138329050|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
138329051|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295658|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329052|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329053|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329054|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329055|NCT00428922|Bevacizumab|bevacizumab|mesh-list
138329056|NCT00428922|Trastuzumab|trastuzumab|mesh-list
138329057|NCT00428922|Docetaxel|docetaxel|mesh-list
138329062|NCT00428922|Growth Substances|growth substances|mesh-ancestor
138329063|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329064|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329065|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329066|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329067|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329068|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329069|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
138329071|NCT00533442|Tacrolimus|tacrolimus|mesh-list
138329072|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329073|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
138329074|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329075|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138329076|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329077|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329078|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329079|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329080|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138329081|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
138353818|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353819|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353820|NCT00058188|Vitamins|vitamins|mesh-ancestor
138353821|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
138353822|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138353823|NCT00003726|Lepirudin|lepirudin|mesh-list
138353824|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
138353825|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138353826|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
138353827|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353828|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353830|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138353831|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138353832|NCT02595996|Propranolol|propranolol|mesh-list
138353833|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138329082|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329083|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329084|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
138329086|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329087|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329088|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329089|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
138329090|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138329091|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138329092|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138329093|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329094|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329095|NCT01954524|Urological Agents|urological agents|mesh-ancestor
138329097|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
138329098|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
138329099|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329100|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329101|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138329102|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138329103|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138329104|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
138329105|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329106|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329107|NCT00535002|Urological Agents|urological agents|mesh-ancestor
138329108|NCT02117934|Vaccines|vaccines|mesh-list
138329109|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
138329110|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329113|NCT00429702|Dexamethasone|dexamethasone|mesh-list
138329115|NCT00429702|Ondansetron|ondansetron|mesh-list
138329116|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329117|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
138329118|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
138329119|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329120|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329121|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329122|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
138353834|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138353835|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353836|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353837|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353838|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353839|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138353840|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353841|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
138329123|NCT00429702|Hormones|hormones|mesh-ancestor
138329124|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295739|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
138329125|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138329126|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329127|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329129|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329130|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138329131|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138329132|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
138329133|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329134|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138329135|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138329136|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329137|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
138329139|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
138329140|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138329141|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
138329142|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
138329143|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138329144|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
138329145|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138329146|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138329147|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329148|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
138329149|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
138329150|NCT00535392|Levetiracetam|levetiracetam|mesh-list
138329151|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
138329152|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
138329153|NCT00535782|Methotrexate|methotrexate|mesh-list
138329154|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138329155|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
138329156|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138329157|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329158|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329159|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
138329160|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295778|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
138329161|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329162|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329163|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329164|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138329165|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329166|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
138329167|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329168|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138329169|NCT00431184|Pentazocine|pentazocine|mesh-list
138329172|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
138329173|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
138329174|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329175|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353864|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353865|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353867|NCT00000138|Prednisolone|prednisolone|mesh-list
138353868|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138353869|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
138353870|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138353871|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
138353872|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138353873|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
138329176|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329177|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138329178|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329179|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138329180|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138329181|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329182|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
138329183|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
138329184|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329185|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329186|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138329187|NCT00431184|Narcotics|narcotics|mesh-ancestor
138329188|NCT00431184|Analgesics|analgesics|mesh-ancestor
138329189|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
138329190|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138329191|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138329192|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
138329193|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138329194|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138329195|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138329196|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138295815|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295816|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138329197|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329198|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
138329199|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329200|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329201|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138329202|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329204|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138329205|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329206|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138329207|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329210|NCT01796028|Docetaxel|docetaxel|mesh-list
138329211|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138329212|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329213|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329214|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329215|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329216|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329217|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329218|NCT00491244|Interferons|interferons|mesh-list
138329219|NCT00491244|Ribavirin|ribavirin|mesh-list
138329220|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
138329221|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
138329222|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138329223|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329224|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
138329225|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329226|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
138329227|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329228|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
138329229|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329231|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138295875|NCT00383474|Bortezomib|bortezomib|mesh-list
138329232|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329233|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329234|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138329235|NCT00492336|Protective Agents|protective agents|mesh-ancestor
138329236|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329238|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138353880|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353881|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
138353882|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
138353883|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329239|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329242|NCT00538824|Lenalidomide|lenalidomide|mesh-list
138329243|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329244|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
138329245|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
138329246|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329247|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329248|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329249|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
138329250|NCT00538824|Hormones|hormones|mesh-ancestor
138282897|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282898|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138282899|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138282900|NCT00373646|Thalidomide|thalidomide|mesh-list
138282901|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282903|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282904|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
138282905|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138282906|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282907|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138282908|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138282909|NCT00373646|Growth Substances|growth substances|mesh-ancestor
138282910|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
138282911|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282912|NCT03001453|Epinephrine|epinephrine|mesh-list
138282913|NCT03001453|Bupivacaine|bupivacaine|mesh-list
138282914|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
138282915|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
138282916|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282917|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282918|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
138282919|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282920|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138282921|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138282922|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282923|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282924|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282925|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138282926|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282927|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
138282928|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282929|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282930|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
138353893|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
138282931|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
138282932|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138282938|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282939|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138282940|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138282941|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
138282942|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
138282943|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282944|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138282945|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138282946|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282947|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282948|NCT02785159|Tazarotene|tazarotene|mesh-list
138282949|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282950|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
138282951|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
138282952|NCT02786719|Doxorubicin|doxorubicin|mesh-list
138282953|NCT02786719|Etoposide|etoposide|mesh-list
138282954|NCT02786719|Vincristine|vincristine|mesh-list
138282955|NCT02786719|Topotecan|topotecan|mesh-list
138282957|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282958|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
138282959|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282960|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282961|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138282962|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
138282963|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282964|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282965|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138282966|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138282969|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282970|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282971|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
138282972|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
138282973|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282974|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138282976|NCT03003949|Progesterone|progesterone|mesh-list
138282977|NCT03003949|Estrogens|estrogens|mesh-ancestor
138282979|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282980|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282981|NCT03003949|Progestins|progestins|mesh-ancestor
138282982|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
138282983|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138282984|NCT03007225|Estrogens|estrogens|mesh-ancestor
138282985|NCT03007225|Hormones|hormones|mesh-ancestor
138282986|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282987|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282988|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282989|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282990|NCT02800148|Azelaic acid|azelaic acid|mesh-list
138282991|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282992|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282993|NCT02902081|Cannabidiol|cannabidiol|mesh-list
138282994|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
138282995|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
138282996|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138282997|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
138282998|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282999|NCT02791945|Expectorants|expectorants|mesh-ancestor
138353922|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353923|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353924|NCT00000210|Buprenorphine|buprenorphine|mesh-list
138296052|NCT00003140|Letrozole|letrozole|mesh-list
138283000|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
138283001|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138283002|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
138283003|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283004|NCT02791945|Protective Agents|protective agents|mesh-ancestor
138283005|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283006|NCT02791945|Antidotes|antidotes|mesh-ancestor
138283007|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138283008|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138283009|NCT00374192|Eszopiclone|eszopiclone|mesh-list
138283010|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283011|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283012|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283013|NCT02806544|Tamoxifen|tamoxifen|mesh-list
138283014|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138283015|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
138283016|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283017|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283018|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283021|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138283023|NCT00374348|Aripiprazole|aripiprazole|mesh-list
138283024|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138283025|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283026|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138283027|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283028|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283029|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283030|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
138283031|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
138283032|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138296074|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283033|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283034|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138283035|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138283036|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
138283037|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138283038|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138283039|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138283042|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138283043|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138283044|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283045|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283046|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283047|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283049|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
138283050|NCT02902237|Coagulants|coagulants|mesh-ancestor
138283051|NCT02903407|Midazolam|midazolam|mesh-list
138283052|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
138283053|NCT02903407|Propofol|propofol|mesh-list
138283054|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283055|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283056|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283057|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283058|NCT02903407|Analgesics|analgesics|mesh-ancestor
138283059|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
138283060|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283061|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283062|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283063|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283064|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283065|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353938|NCT00000222|Analgesics|analgesics|mesh-ancestor
138353939|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
138283066|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283067|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283068|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
138283069|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
138283070|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283071|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138283072|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283073|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283074|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
138283075|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
138283076|NCT02905981|Citric Acid|citric acid|mesh-list
138283077|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
138283078|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
138283079|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138283083|NCT00374023|Vitamin A|vitamin a|mesh-list
138283084|NCT00374023|Vitamins|vitamins|mesh-ancestor
138283085|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
138283086|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283087|NCT02812238|Niacinamide|niacinamide|mesh-list
138283088|NCT02812238|Niacin|niacin|mesh-list
138283089|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
138283090|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
138283091|NCT02812238|Vitamins|vitamins|mesh-ancestor
138283092|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
138283093|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283094|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138283095|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
138283096|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283097|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138283099|NCT03015961|Bupivacaine|bupivacaine|mesh-list
138283100|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
138283101|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
138283102|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283103|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283105|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283106|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
138283107|NCT03018223|Sirolimus|sirolimus|mesh-list
138283108|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
138283109|NCT03018223|Busulfan|busulfan|mesh-list
138283110|NCT03018223|Fludarabine|fludarabine|mesh-list
138283111|NCT03018223|Lenograstim|lenograstim|mesh-list
138283112|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138283113|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
138283114|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283115|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283116|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138283117|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
138283118|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283119|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283120|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138283121|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138283122|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138283123|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
138283124|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138283125|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283126|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283127|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
138283128|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138283130|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138283131|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283132|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138283133|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
138283135|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138283136|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138283137|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138283139|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283140|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283141|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138283142|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138283143|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
138283144|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283145|NCT03019939|Isavuconazole|isavuconazole|mesh-list
138283146|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
138283147|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283148|NCT03020095|Ritonavir|ritonavir|mesh-list
138283149|NCT03020095|Ribavirin|ribavirin|mesh-list
138283150|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138283151|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138283152|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283153|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283154|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283155|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138283156|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138283157|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
138283158|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283159|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138283160|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138283161|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
138283162|NCT02934698|Ivacaftor|ivacaftor|mesh-list
138283163|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138283164|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283165|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283167|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
138283168|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283169|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
138283170|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
138283171|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414698|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283174|NCT03025945|Nepafenac|nepafenac|mesh-list
138283175|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138283176|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283177|NCT03025945|Analgesics|analgesics|mesh-ancestor
138283178|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
138283179|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283180|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283181|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283182|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283183|NCT02937506|Midazolam|midazolam|mesh-list
138283184|NCT02937506|Fentanyl|fentanyl|mesh-list
138283185|NCT02937506|Propofol|propofol|mesh-list
138283186|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283187|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283188|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283189|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283190|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
138283192|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283193|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138283194|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283195|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283196|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
138283197|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
138283198|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283199|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283200|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138283201|NCT02937506|Narcotics|narcotics|mesh-ancestor
138283202|NCT02937506|Analgesics|analgesics|mesh-ancestor
138283203|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
138283204|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283206|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
138283207|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283208|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
138283209|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283210|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283211|NCT03027661|Bupivacaine|bupivacaine|mesh-list
138296228|NCT00003152|Hormones|hormones|mesh-ancestor
138283212|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
138283213|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
138353949|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283214|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353950|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353951|NCT00000234|Buprenorphine|buprenorphine|mesh-list
138283215|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283216|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
138283217|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283219|NCT03022526|Bupivacaine|bupivacaine|mesh-list
138283220|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
138283221|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
138283222|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283223|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283224|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
138283225|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283226|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138283227|NCT03022526|Narcotics|narcotics|mesh-ancestor
138283228|NCT03022526|Analgesics|analgesics|mesh-ancestor
138283229|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283230|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283231|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
138283232|NCT02794441|Dexamethasone|dexamethasone|mesh-list
138283234|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
138283235|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
138283236|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283237|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283238|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283239|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
138283240|NCT02794441|Hormones|hormones|mesh-ancestor
138283241|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283242|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283243|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283244|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138283245|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138283246|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
138283247|NCT02941640|Hormones|hormones|mesh-ancestor
138283248|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283249|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283250|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283251|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283252|NCT02823080|Cetrorelix|cetrorelix|mesh-list
138283253|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138283254|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
138283255|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138283257|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138283258|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283259|NCT03022916|Efinaconazole|efinaconazole|mesh-list
138283260|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138283261|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
138283262|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283263|NCT03031795|Ketorolac|ketorolac|mesh-list
138283264|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138283265|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283266|NCT03031795|Analgesics|analgesics|mesh-ancestor
138283267|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
138283268|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283269|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283270|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283271|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283272|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138283273|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283274|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296291|NCT00002287|Zidovudine|zidovudine|mesh-list
138283276|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138283277|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283278|NCT02909959|Sulforaphane|sulforaphane|mesh-list
138283279|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138283280|NCT02909959|Protective Agents|protective agents|mesh-ancestor
138283281|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283282|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283283|NCT00373802|Phenylephrine|phenylephrine|mesh-list
138283284|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
138283285|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138283286|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
138283287|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
138283288|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283289|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283290|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
138283291|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138283292|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
138283293|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
138283294|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138283295|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283296|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283297|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283298|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283300|NCT00373802|Protective Agents|protective agents|mesh-ancestor
138283301|NCT02945150|Grazoprevir|grazoprevir|mesh-list
138283302|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
138283303|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283305|NCT03032965|Isoproterenol|isoproterenol|mesh-list
138283306|NCT03032965|Analgesics|analgesics|mesh-ancestor
138283307|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
138283308|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283309|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283310|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138283311|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138283312|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138283313|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
138283314|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
138283315|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283316|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283317|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138283318|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283319|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283320|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138283321|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
138283322|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138283323|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
138283324|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138283325|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
138283326|NCT03032965|Protective Agents|protective agents|mesh-ancestor
138283327|NCT03030638|Olodaterol|olodaterol|mesh-list
138283328|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138283329|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
138283330|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283331|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283332|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138283333|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
138283334|NCT02949674|Bupivacaine|bupivacaine|mesh-list
138283335|NCT02949674|Ropivacaine|ropivacaine|mesh-list
138283337|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
138283338|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283339|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283340|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
138283341|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283342|NCT03033511|Dexamethasone|dexamethasone|mesh-list
138283343|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
138283344|NCT03033511|BB 1101|bb 1101|mesh-list
138283345|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
138283346|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
138296392|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
138353961|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138283347|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283348|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
138353962|NCT00000240|Narcotics|narcotics|mesh-ancestor
138353963|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353966|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
138283349|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
138283350|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283351|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283352|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283353|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
138283354|NCT03033511|Hormones|hormones|mesh-ancestor
138283355|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283356|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283357|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283358|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283359|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283360|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283361|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
138283362|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
138283363|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138283364|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283365|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138283366|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138283367|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283368|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283369|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283373|NCT03035929|BB 1101|bb 1101|mesh-list
138283374|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283375|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
138283376|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
138283377|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283378|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283379|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283380|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
138283382|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283383|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283384|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283385|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283386|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283387|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283388|NCT02951702|Vancomycin|vancomycin|mesh-list
138283389|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138283390|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283391|NCT02831816|Ethanol|ethanol|mesh-list
138283392|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
138283393|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138283394|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138283395|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283396|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283397|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283398|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
138283399|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283401|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
138283402|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138283403|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283406|NCT02953886|Protective Agents|protective agents|mesh-ancestor
138283407|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283409|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138283410|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138283411|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283412|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283413|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283414|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283415|NCT00374426|Sertraline|sertraline|mesh-list
138283416|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
138283417|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283418|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138283419|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138283420|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283421|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283422|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283423|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
138283424|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283425|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138283426|NCT02916745|Trioxsalen|trioxsalen|mesh-list
138283427|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283428|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283432|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
138283433|NCT02954198|Everolimus|everolimus|mesh-list
138283434|NCT02954198|Tacrolimus|tacrolimus|mesh-list
138283435|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283436|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
138283437|NCT02954198|Hormones|hormones|mesh-ancestor
138283438|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283439|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283440|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283441|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283442|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138283443|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
138283444|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138283445|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283446|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283447|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138283448|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138283449|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138283451|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
138283452|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138283453|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283455|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
138283457|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283458|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138283459|NCT02954198|Protective Agents|protective agents|mesh-ancestor
138283460|NCT02956070|Dexamethasone|dexamethasone|mesh-list
138283461|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
138283462|NCT02956070|BB 1101|bb 1101|mesh-list
138283463|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283464|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
138283465|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
138283466|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283467|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283468|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283469|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
138283470|NCT02956070|Hormones|hormones|mesh-ancestor
138283471|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283472|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138283473|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283474|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283475|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283476|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283477|NCT02956616|Ketorolac|ketorolac|mesh-list
138283478|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138283479|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283480|NCT02956616|Analgesics|analgesics|mesh-ancestor
138283481|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
138283482|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283483|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414699|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138283486|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138283487|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283488|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283490|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138283491|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283492|NCT05829551|Ritonavir|ritonavir|mesh-list
138283493|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138283494|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138283495|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283496|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353981|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283497|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283498|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138283499|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138283500|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
138283501|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283502|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138283503|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138283504|NCT05829148|Pregabalin|pregabalin|mesh-list
138283505|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
138283506|NCT05829148|Melatonin|melatonin|mesh-list
138283507|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283508|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283509|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283510|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283512|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
138283513|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283514|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283515|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283516|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283517|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283518|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283519|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283520|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
138283521|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138283522|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283523|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138283524|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138283525|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283526|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283527|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
138283528|NCT05829148|Protective Agents|protective agents|mesh-ancestor
138283529|NCT05829057|Interleukin-2|interleukin-2|mesh-list
138283530|NCT05829057|Antibodies|antibodies|mesh-list
138283531|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138283533|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283534|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283535|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283536|NCT05829057|Analgesics|analgesics|mesh-ancestor
138283537|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
138283538|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283539|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138283540|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283541|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138283542|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283543|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
138283544|NCT05828199|Ketamine|ketamine|mesh-list
138283545|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283546|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283547|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283548|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283549|NCT05828199|Analgesics|analgesics|mesh-ancestor
138283550|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
138283551|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283552|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283553|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283554|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283555|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283556|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283557|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283558|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138283559|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283560|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
138283561|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
138283562|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138296676|NCT00002599|Prednisone|prednisone|mesh-list
138283563|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138283564|NCT05827991|Minoxidil|minoxidil|mesh-list
138283565|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138283566|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
138283567|NCT05827796|Paclitaxel|paclitaxel|mesh-list
138283568|NCT05827796|Gemcitabine|gemcitabine|mesh-list
138283569|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138283570|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138283571|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283572|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138283573|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138283574|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138283575|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283576|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283577|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
138283578|NCT05827770|Temozolomide|temozolomide|mesh-list
138283579|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138283580|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
138283581|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283582|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283584|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138283587|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283588|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283589|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
138283590|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283591|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283592|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283593|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283594|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138283595|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138283596|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
138283597|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283598|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138283600|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283601|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
138283602|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
138283603|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283604|NCT05825443|Paclitaxel|paclitaxel|mesh-list
138283605|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138283606|NCT05825443|Cisplatin|cisplatin|mesh-list
138283607|NCT05825443|Carboplatin|carboplatin|mesh-list
138283608|NCT05825443|Pemetrexed|pemetrexed|mesh-list
138283609|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138283610|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283611|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138283612|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138283613|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138283614|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283615|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283616|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138283617|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138283618|NCT05822934|Carboplatin|carboplatin|mesh-list
138283619|NCT05822934|Gemcitabine|gemcitabine|mesh-list
138283620|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283621|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283622|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
138283623|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283624|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
138283625|NCT05821972|Ketamine|ketamine|mesh-list
138283626|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283627|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283628|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283629|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283630|NCT05821972|Analgesics|analgesics|mesh-ancestor
138283631|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
138283632|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283633|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283634|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283635|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283636|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283637|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283638|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283639|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138353996|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353997|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138353998|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138283640|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283641|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
138414700|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138283644|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138283645|NCT05774236|Dinoprostone|dinoprostone|mesh-list
138283646|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
138283647|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138283648|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283650|NCT05748587|Deferoxamine|deferoxamine|mesh-list
138283651|NCT05748587|Trace Elements|trace elements|mesh-ancestor
138283652|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
138283653|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283654|NCT05748587|Siderophores|siderophores|mesh-ancestor
138283655|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138283656|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
138283657|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
138283658|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283659|NCT05728814|Dostarlimab|dostarlimab|mesh-list
138283660|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283661|NCT05707468|Hormones|hormones|mesh-list
138283662|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283663|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283664|NCT05698381|Acetic Acid|acetic acid|mesh-list
138283665|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138283666|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283667|NCT05683535|Atropine|atropine|mesh-list
138283668|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283669|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138283670|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138283671|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
138283672|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283673|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283675|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
138283676|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
138283677|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
138283678|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138283679|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138283680|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283681|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283682|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283683|NCT05678244|Acetaminophen|acetaminophen|mesh-list
138283684|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283685|NCT05678244|Analgesics|analgesics|mesh-ancestor
138283686|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
138283687|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283688|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283689|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
138283690|NCT05675800|Psilocybin|psilocybin|mesh-list
138283691|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
138283692|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283693|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283694|NCT05675319|Dexamethasone|dexamethasone|mesh-list
138283695|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
138283696|NCT05675319|Lenalidomide|lenalidomide|mesh-list
138283697|NCT05675319|Bortezomib|bortezomib|mesh-list
138283698|NCT05675319|Daratumumab|daratumumab|mesh-list
138283699|NCT05675319|Pomalidomide|pomalidomide|mesh-list
138283700|NCT05675319|Ixazomib|ixazomib|mesh-list
138283701|NCT05675319|Elotuzumab|elotuzumab|mesh-list
138283702|NCT05675319|BB 1101|bb 1101|mesh-list
138283703|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138283704|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283705|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
138283706|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
138283707|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283708|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283709|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283710|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
138283711|NCT05675319|Hormones|hormones|mesh-ancestor
138283712|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283716|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283717|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283718|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
138283719|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138283720|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138283721|NCT05675319|Growth Substances|growth substances|mesh-ancestor
138283722|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
138283723|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
138283724|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138283725|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283726|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283727|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138283728|NCT05641376|Analgesics|analgesics|mesh-ancestor
138283729|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
138283730|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283731|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283732|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138283733|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138283734|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283735|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283736|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283737|NCT05615311|Vitamin D|vitamin d|mesh-list
138283738|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
138283739|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
138283740|NCT05615311|Vitamins|vitamins|mesh-list
138283741|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
138283743|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138283744|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138283746|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
138283747|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283748|NCT05593939|Niacinamide|niacinamide|mesh-list
138283750|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
138283751|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
138283752|NCT05593939|Vitamins|vitamins|mesh-ancestor
138283753|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
138283754|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283755|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138283756|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
138283757|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283758|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138283759|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
138283761|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
138283762|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
138283763|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283764|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283765|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283766|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138283767|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
138283768|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283769|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283770|NCT05527912|Rituximab|rituximab|mesh-list
138283771|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
138283772|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138283773|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283774|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
138283775|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283776|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283777|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138283778|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283780|NCT05491187|Fentanyl|fentanyl|mesh-list
138283781|NCT05491187|Bupivacaine|bupivacaine|mesh-list
138283782|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
138283783|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
138283784|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283785|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283786|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
138283787|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354002|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
138354004|NCT00000276|Bupropion|bupropion|mesh-list
138283788|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138283789|NCT05491187|Narcotics|narcotics|mesh-ancestor
138283790|NCT05491187|Analgesics|analgesics|mesh-ancestor
138283791|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138283792|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138283793|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
138283794|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
138283795|NCT05480878|Escitalopram|escitalopram|mesh-list
138283796|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138283797|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138283798|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283799|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283800|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283801|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
138283802|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283803|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138283804|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283806|NCT05462236|Irinotecan|irinotecan|mesh-list
138283807|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138283808|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283809|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138283810|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283811|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138283812|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138283813|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283814|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138283815|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138283816|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283817|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283818|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283819|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283820|NCT05398367|Galactogogues|galactogogues|mesh-list
138283821|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283822|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
138283823|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138283824|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283825|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138283826|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283827|NCT05378945|Varenicline|varenicline|mesh-list
138283828|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138283829|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138283830|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283831|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283832|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283833|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283834|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
138283837|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
138283838|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283839|NCT05330377|Cytarabine|cytarabine|mesh-list
138283840|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
138283841|NCT05330377|Cladribine|cladribine|mesh-list
138283842|NCT05330377|Lenograstim|lenograstim|mesh-list
138283843|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283844|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
138283845|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283846|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283847|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
138283848|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138283849|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354018|NCT00000282|Pemoline|pemoline|mesh-list
138283850|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
138283851|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283852|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138283853|NCT05330377|Analgesics|analgesics|mesh-ancestor
138283854|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
138283855|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283856|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138283857|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138283858|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283860|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138283861|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
138283862|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138283863|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283865|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283866|NCT05323435|Vaccines|vaccines|mesh-list
138283867|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
138283868|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283869|NCT05322252|Misoprostol|misoprostol|mesh-list
138283870|NCT05322252|Mifepristone|mifepristone|mesh-list
138283871|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138283872|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
138283873|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138283874|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283875|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138283876|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283877|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
138283878|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138283879|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138283880|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138283881|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138283882|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
138283883|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138283884|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138283886|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283887|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
138283888|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138283889|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138283890|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138283891|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
138283892|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283893|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
138283894|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138283895|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138283896|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283897|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
138283898|NCT05246943|Coagulants|coagulants|mesh-ancestor
138283899|NCT05212454|Capecitabine|capecitabine|mesh-list
138283900|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283901|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
138283902|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283903|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283905|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138283906|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138283908|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
138283909|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283910|NCT05091866|Progesterone|progesterone|mesh-list
138283911|NCT05091866|Progestins|progestins|mesh-list
138283912|NCT05091866|Hormones|hormones|mesh-ancestor
138283913|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138283914|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354032|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283915|NCT05084989|Vaccines|vaccines|mesh-list
138283916|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
138283917|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283918|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138283919|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138297173|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138283920|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283921|NCT05042700|Melatonin|melatonin|mesh-list
138283922|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
138283923|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283924|NCT05042700|Protective Agents|protective agents|mesh-ancestor
138283925|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283926|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283927|NCT05010954|Lansoprazole|lansoprazole|mesh-list
138283928|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
138283929|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138283930|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138283931|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138283932|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283933|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283935|NCT05001724|Lenvatinib|lenvatinib|mesh-list
138283936|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283937|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138283938|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138283939|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414701|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283940|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283942|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283943|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
138283944|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138283945|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138283946|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283947|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
138283948|NCT04996368|Coagulants|coagulants|mesh-ancestor
138283949|NCT04994444|Nicotine|nicotine|mesh-list
138283950|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138283951|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
138283952|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283953|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283954|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138283955|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138283956|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283957|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283958|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283960|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138283961|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138283962|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138283963|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138283964|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138297261|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283965|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283966|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283970|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283971|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283972|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138283974|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
138283975|NCT04966663|Carboplatin|carboplatin|mesh-list
138283976|NCT04966663|Gemcitabine|gemcitabine|mesh-list
138283977|NCT04966663|Nivolumab|nivolumab|mesh-list
138283978|NCT04966663|Pemetrexed|pemetrexed|mesh-list
138283979|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283980|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283982|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283983|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138354043|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283984|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138354046|NCT00000318|Buprenorphine|buprenorphine|mesh-list
138283985|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283986|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138283987|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138283988|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138283989|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138283990|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283991|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283992|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283993|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138283994|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138283995|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138283996|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
138283997|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283998|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283999|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138284000|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138284001|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
138284002|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
138284003|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138284005|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284007|NCT04902950|Coagulants|coagulants|mesh-ancestor
138284008|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
138284009|NCT04889118|Lenvatinib|lenvatinib|mesh-list
138284010|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284011|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284012|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284013|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284014|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284015|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284016|NCT04819971|Docetaxel|docetaxel|mesh-list
138284017|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
138284018|NCT04819971|Trastuzumab|trastuzumab|mesh-list
138284019|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284020|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138284021|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138284022|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284023|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284024|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284025|NCT04724148|Fentanyl|fentanyl|mesh-list
138284026|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284027|NCT04724148|Narcotics|narcotics|mesh-ancestor
138284028|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284029|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284030|NCT04724148|Analgesics|analgesics|mesh-ancestor
138284032|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284033|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138284034|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284035|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
138284037|NCT04703803|Lidocaine|lidocaine|mesh-list
138284038|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284039|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
138284040|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284041|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297419|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297433|NCT00004082|Docetaxel|docetaxel|mesh-list
138284042|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
138284043|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284044|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138284045|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138284046|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138284047|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284048|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284050|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284051|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284052|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138354051|NCT00000318|Analgesics|analgesics|mesh-ancestor
138354052|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
138354055|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
138284053|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138284054|NCT04670978|Growth Substances|growth substances|mesh-ancestor
138284059|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284060|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284061|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284062|NCT04531943|Progesterone|progesterone|mesh-list
138284064|NCT04531943|Progestins|progestins|mesh-ancestor
138284065|NCT04531943|Hormones|hormones|mesh-ancestor
138284066|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284067|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284068|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
138284069|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284070|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284071|NCT04503460|Fluticasone|fluticasone|mesh-list
138284073|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138284074|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284075|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138284076|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
138284077|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284078|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284079|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138284080|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
138284081|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284082|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138284083|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138284084|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138284085|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138284086|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284088|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284089|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
138284091|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284092|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
138284094|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
138284095|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138284096|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
138284097|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138284098|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284099|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
138284100|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284101|NCT04414748|Progestins|progestins|mesh-ancestor
138284102|NCT04414748|Hormones|hormones|mesh-ancestor
138284103|NCT04395196|Choline|choline|mesh-list
138284104|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
138284105|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138284106|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
138284107|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284108|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284109|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138284110|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
138284111|NCT04233515|Anticoagulants|anticoagulants|mesh-list
138284112|NCT04169373|Upadacitinib|upadacitinib|mesh-list
138284113|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138284114|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284115|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284116|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284118|NCT04150042|Vitamins|vitamins|mesh-list
138284119|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
138284120|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
138284121|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
138354058|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354059|NCT00000330|Analgesics|analgesics|mesh-ancestor
138297499|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
138284123|NCT04150042|Melphalan|melphalan|mesh-list
138284124|NCT04150042|Carmustine|carmustine|mesh-list
138284125|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
138284126|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284127|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138284128|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
138284129|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284130|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284131|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138284132|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284133|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
138284134|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
138284135|NCT04150042|Protective Agents|protective agents|mesh-ancestor
138284136|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
138284137|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138284138|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284139|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284140|NCT04150042|Hematinics|hematinics|mesh-ancestor
138284142|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138284143|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284144|NCT04093024|Nintedanib|nintedanib|mesh-list
138284145|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284146|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284147|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284148|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284149|NCT04091503|Temozolomide|temozolomide|mesh-list
138284150|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138284151|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
138414702|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284154|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
138284155|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138284156|NCT04014790|KRN 7000|krn 7000|mesh-list
138284157|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138284159|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284160|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284161|NCT03965234|Cisplatin|cisplatin|mesh-list
138284162|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284163|NCT03921060|Denosumab|denosumab|mesh-list
138284164|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138284165|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284166|NCT03827070|Afatinib|afatinib|mesh-list
138284167|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284168|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284169|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284170|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284171|NCT03748303|Pregnanolone|pregnanolone|mesh-list
138284172|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
138284173|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284174|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284175|NCT03680053|Cetrorelix|cetrorelix|mesh-list
138284176|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
138284177|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138284178|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
138284179|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138284180|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284181|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
138284182|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284183|NCT03680053|Progestins|progestins|mesh-ancestor
138284184|NCT03680053|Hormones|hormones|mesh-ancestor
138284185|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
138284186|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138284189|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138284190|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
138284191|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138354073|NCT00000342|Risperidone|risperidone|mesh-list
138284192|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284193|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138284194|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138284195|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138284196|NCT03632369|Xenon|xenon|mesh-list
138284197|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138284198|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
138284199|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
138284200|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284201|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284202|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
138284203|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138284204|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284205|NCT03469284|Methylene Blue|methylene blue|mesh-list
138284206|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284207|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284208|NCT03425331|Nivolumab|nivolumab|mesh-list
138284209|NCT03425331|Ipilimumab|ipilimumab|mesh-list
138284210|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284211|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284212|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284213|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284214|NCT03149211|UB-421|ub-421|mesh-list
138284215|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138284216|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
138284217|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284218|NCT03141671|Prednisone|prednisone|mesh-list
138284219|NCT03141671|Bicalutamide|bicalutamide|mesh-list
138284220|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284223|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284225|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284226|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284227|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
138284228|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
138284229|NCT03043430|Midazolam|midazolam|mesh-list
138284230|NCT03043430|Ketamine|ketamine|mesh-list
138284231|NCT03043430|Analgesics|analgesics|mesh-ancestor
138284232|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
138284233|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284234|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284235|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138284236|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284237|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
138284238|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
138284239|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284240|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138284241|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138284242|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284243|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284244|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138284245|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138284246|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138284247|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138284248|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284249|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
138284250|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
138284251|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
138284252|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
138284253|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284254|NCT03004261|Ganciclovir|ganciclovir|mesh-list
138284259|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138284260|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354082|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284261|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284262|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138284264|NCT02856425|Nintedanib|nintedanib|mesh-list
138284265|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284266|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284267|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284268|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284269|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284270|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284271|NCT02785952|Nivolumab|nivolumab|mesh-list
138284272|NCT02785952|Ipilimumab|ipilimumab|mesh-list
138284273|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284274|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284275|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284276|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284277|NCT02443727|Oxytocin|oxytocin|mesh-list
138284278|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
138284279|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138284280|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284281|NCT02429700|Paclitaxel|paclitaxel|mesh-list
138284282|NCT02429700|Etoposide|etoposide|mesh-list
138284283|NCT02429700|Carboplatin|carboplatin|mesh-list
138284284|NCT02429700|Bleomycin|bleomycin|mesh-list
138284285|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284286|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284287|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138284288|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138284289|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284290|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284291|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138284292|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138284293|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284294|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138284297|NCT02429687|Carboplatin|carboplatin|mesh-list
138284298|NCT02429687|Bleomycin|bleomycin|mesh-list
138284299|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284300|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284301|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138284302|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138284303|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284304|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284305|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138284306|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138284307|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284308|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138284310|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138284312|NCT02194829|Adavosertib|adavosertib|mesh-list
138284313|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284314|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284315|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138284316|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138284317|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284318|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284319|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138284320|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
138284321|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284322|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
138284323|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138284324|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138354095|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
138284325|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284326|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
138284327|NCT01370460|Coagulants|coagulants|mesh-ancestor
138284328|NCT00621192|Meropenem|meropenem|mesh-list
138284329|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138284330|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284331|NCT00255346|Dasatinib|dasatinib|mesh-list
138284332|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284333|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284334|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284335|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284336|NCT02834624|Poractant alfa|poractant alfa|mesh-list
138284339|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138284340|NCT02837744|Hemostatics|hemostatics|mesh-list
138284341|NCT02837744|Coagulants|coagulants|mesh-ancestor
138284342|NCT02918617|Fluorides|fluorides|mesh-list
138284343|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
138284344|NCT02918617|Protective Agents|protective agents|mesh-ancestor
138284345|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284346|NCT02839772|Glycerol|glycerol|mesh-list
138284347|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138284348|NCT02839772|Protective Agents|protective agents|mesh-ancestor
138284349|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284350|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138284351|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284352|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284353|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284354|NCT03043105|Thalidomide|thalidomide|mesh-list
138284355|NCT03043105|Prednisone|prednisone|mesh-list
138284356|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
138284357|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284358|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
138284359|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284360|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138284361|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138284362|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
138284363|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284364|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297790|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284365|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138284366|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284369|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284370|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284371|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
138284372|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138284373|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284374|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138284375|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138284376|NCT03043105|Growth Substances|growth substances|mesh-ancestor
138284377|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
138284378|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
138284379|NCT00374647|Sirolimus|sirolimus|mesh-list
138284380|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138284381|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284384|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138284385|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284386|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297831|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284387|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284388|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
138284389|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284390|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
138354110|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138284391|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284392|NCT02964416|Tramadol|tramadol|mesh-list
138284393|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284394|NCT02964416|Narcotics|narcotics|mesh-ancestor
138284395|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284396|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284397|NCT02964416|Analgesics|analgesics|mesh-ancestor
138284398|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
138284399|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284400|NCT02812771|Efinaconazole|efinaconazole|mesh-list
138284404|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
138284405|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284406|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138284407|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138284408|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284409|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284410|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138284411|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138284412|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284413|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284416|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138284417|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138284418|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138297884|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284419|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138284421|NCT02970032|Calcium heparin|calcium heparin|mesh-list
138284422|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
138284423|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138284424|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138284425|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284426|NCT02813551|Torsemide|torsemide|mesh-list
138284427|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138284428|NCT02813551|Diuretics|diuretics|mesh-ancestor
138284429|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
138284430|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284431|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138284432|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284433|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284435|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138284436|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284437|NCT02817763|Analgesics|analgesics|mesh-ancestor
138354121|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
138354122|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
138354123|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
138284438|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
138284439|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284440|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284441|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284445|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284446|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284447|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284448|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284449|NCT03053401|Anesthetics|anesthetics|mesh-list
138284450|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
138284451|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284452|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284453|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
138284454|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284455|NCT03054103|Midazolam|midazolam|mesh-list
138284456|NCT03054103|Ketamine|ketamine|mesh-list
138284457|NCT03054103|Analgesics|analgesics|mesh-ancestor
138284458|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
138284459|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284460|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284461|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138284462|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284463|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
138284464|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
138284465|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284466|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138284467|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138297988|NCT00002785|Hormones|hormones|mesh-ancestor
138284468|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284469|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284470|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138284478|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138284479|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138284480|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138284481|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138284482|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
138284483|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284484|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284485|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284486|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
138284487|NCT03054805|Antacids|antacids|mesh-ancestor
138284488|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284489|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284490|NCT00374101|Omeprazole|omeprazole|mesh-list
138284491|NCT00374101|Pantoprazole|pantoprazole|mesh-list
138284492|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138284493|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284494|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138284495|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284496|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284498|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138284499|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138284500|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138284501|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284502|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284503|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
138284504|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354151|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354152|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
138354153|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284505|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284506|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138284507|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284508|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
138284509|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138284510|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284511|NCT03050294|Desoximetasone|desoximetasone|mesh-list
138284512|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284513|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
138284514|NCT03050294|Hormones|hormones|mesh-ancestor
138284515|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284516|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284517|NCT02831569|Loxoprofen|loxoprofen|mesh-list
138284518|NCT02831569|Methocarbamol|methocarbamol|mesh-list
138298082|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284519|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138284520|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284521|NCT02831569|Analgesics|analgesics|mesh-ancestor
138284522|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
138284527|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138284528|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138284531|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284532|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284533|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284534|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284535|NCT02988050|Lidocaine|lidocaine|mesh-list
138284536|NCT02988050|Epinephrine|epinephrine|mesh-list
138284537|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
138284538|NCT02988050|Remifentanil|remifentanil|mesh-list
138284539|NCT02988050|Bupivacaine|bupivacaine|mesh-list
138284540|NCT02988050|Propofol|propofol|mesh-list
138284541|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284542|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
138284543|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284544|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284545|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
138284546|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284547|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138284548|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138284549|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138284550|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284551|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284552|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138284553|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284554|NCT02988050|Analgesics|analgesics|mesh-ancestor
138284555|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138284556|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138284557|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138298131|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
138284559|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284560|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284561|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
138284562|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138284563|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138284564|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
138284565|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138284566|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138284567|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
138284568|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
138284569|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138284570|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284571|NCT02988050|Narcotics|narcotics|mesh-ancestor
138284572|NCT02988986|Tamoxifen|tamoxifen|mesh-list
138284573|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138284574|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
138284575|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354164|NCT00000450|Naltrexone|naltrexone|mesh-list
138354170|NCT00000510|Aspirin|aspirin|mesh-list
138284576|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284577|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284578|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284579|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138284580|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138284581|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138284582|NCT02832115|Lidocaine|lidocaine|mesh-list
138284583|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
138284584|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
138284585|NCT02832115|Anesthetics|anesthetics|mesh-list
138284586|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284587|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284588|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
138284589|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284590|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138284592|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138284593|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284594|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284596|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138284597|NCT03054506|Laxatives|laxatives|mesh-ancestor
138284598|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284599|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
138284600|NCT02935699|Promethazine|promethazine|mesh-list
138284601|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138284602|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138284603|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284604|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284605|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284606|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
138284607|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
138284608|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284609|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
138284610|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
138284611|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284612|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138284615|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284616|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284617|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138284618|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
138284619|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284620|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138284621|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138284622|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138284623|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284624|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
138284625|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284626|NCT02841241|Esmolol|esmolol|mesh-list
138284627|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138284628|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138284629|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138284630|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284631|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284632|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284633|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284634|NCT00374881|Phenylephrine|phenylephrine|mesh-list
138284635|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
138284636|NCT00374881|Morphine|morphine|mesh-list
138354172|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138354173|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284637|NCT00374881|Sorbitol|sorbitol|mesh-list
138354174|NCT00000510|Analgesics|analgesics|mesh-ancestor
138354175|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
138354176|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354177|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354179|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138284638|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284639|NCT00374881|Narcotics|narcotics|mesh-ancestor
138284640|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284641|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284642|NCT00374881|Analgesics|analgesics|mesh-ancestor
138284643|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
138284644|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284645|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138284646|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
138284647|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
138284648|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
138284649|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138284650|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
138284651|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
138284652|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138284653|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138284654|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138284655|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284658|NCT00374881|Protective Agents|protective agents|mesh-ancestor
138284659|NCT00374881|Cathartics|cathartics|mesh-ancestor
138284660|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284661|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
138284662|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138284663|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284664|NCT02846233|Metformin|metformin|mesh-list
138284665|NCT02846233|Empagliflozin|empagliflozin|mesh-list
138298248|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138284667|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138284669|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138284670|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284671|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284672|NCT02846233|Incretins|incretins|mesh-ancestor
138284673|NCT02846233|Hormones|hormones|mesh-ancestor
138284674|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284675|NCT02865590|Cimetidine|cimetidine|mesh-list
138284676|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138284677|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284678|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138284679|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
138284681|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284682|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284683|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284684|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138284687|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
138284689|NCT02868242|Ledipasvir|ledipasvir|mesh-list
138284690|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
138284691|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284692|NCT03075553|Nivolumab|nivolumab|mesh-list
138284693|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284694|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284695|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138284696|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354182|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354183|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138354184|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138354185|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354186|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
138354187|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138354188|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
138354189|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138354190|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
138354191|NCT00000600|Vitamins|vitamins|mesh-list
138354193|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
138284697|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
138284698|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284699|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
138284700|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284701|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284702|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
138284703|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284704|NCT02997722|Ketamine|ketamine|mesh-list
138284705|NCT02997722|Analgesics|analgesics|mesh-ancestor
138284706|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
138284707|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284708|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284709|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138284710|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284711|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
138284712|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
138284713|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284714|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138284715|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138284716|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284717|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284718|NCT03108482|Celecoxib|celecoxib|mesh-list
138284719|NCT03108482|Tramadol|tramadol|mesh-list
138284720|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138284721|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284723|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
138284724|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284726|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284727|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138284728|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138284729|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138284730|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284731|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284732|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284734|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284735|NCT02850601|Dexamethasone|dexamethasone|mesh-list
138284736|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284737|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
138284738|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
138284739|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284740|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284741|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284742|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
138284743|NCT02850601|Hormones|hormones|mesh-ancestor
138284744|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284745|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284746|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284747|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
138284748|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138284751|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284752|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
138284753|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284754|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284755|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
138284756|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284757|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138284758|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138284759|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138284760|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284761|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284762|NCT02874092|Ticagrelor|ticagrelor|mesh-list
138284763|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138284764|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138354194|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354195|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
138284765|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138284766|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138284767|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
138284768|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284769|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284771|NCT02876900|Asenapine|asenapine|mesh-list
138284772|NCT02876900|Maleic acid|maleic acid|mesh-list
138284773|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284774|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284775|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138284776|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138284777|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284778|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284779|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284780|NCT02878382|Calcipotriene|calcipotriene|mesh-list
138284781|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284782|NCT03117140|Dexamethasone|dexamethasone|mesh-list
138284783|NCT03117140|Clonidine|clonidine|mesh-list
138284784|NCT03117140|Buprenorphine|buprenorphine|mesh-list
138284785|NCT03117140|Ropivacaine|ropivacaine|mesh-list
138284786|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284787|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
138284788|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
138284789|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284790|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284791|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284792|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
138284793|NCT03117140|Hormones|hormones|mesh-ancestor
138159512|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
138159513|NCT05016947|Hormones|hormones|mesh-ancestor
138284794|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284795|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284796|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284797|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284799|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284800|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
138284801|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284802|NCT03117140|Narcotics|narcotics|mesh-ancestor
138284803|NCT03117140|Analgesics|analgesics|mesh-ancestor
138284804|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138284805|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138284806|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
138284807|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138284808|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138284809|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138284810|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284812|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284813|NCT03118466|Cytarabine|cytarabine|mesh-list
138284814|NCT03118466|Etoposide|etoposide|mesh-list
138284815|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
138284816|NCT03118466|Lenalidomide|lenalidomide|mesh-list
138284817|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284818|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284819|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138284820|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138284821|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284822|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284823|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138284825|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
138284826|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284827|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138284828|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
138284829|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284830|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138284831|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138284832|NCT03118466|Growth Substances|growth substances|mesh-ancestor
138284833|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
138284835|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
138284836|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284837|NCT03068312|Ivacaftor|ivacaftor|mesh-list
138284838|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138284839|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284840|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284841|NCT03119168|Simethicone|simethicone|mesh-list
138284842|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
138284843|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284844|NCT03119168|Emollients|emollients|mesh-ancestor
138284845|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284846|NCT03070730|Atenolol|atenolol|mesh-list
138284847|NCT03070730|Droxidopa|droxidopa|mesh-list
138284848|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138284849|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138284850|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
138284851|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
138284852|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284853|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284854|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138284855|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138284856|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138284857|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284858|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284859|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284860|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138284861|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138284862|NCT03121820|Memantine|memantine|mesh-list
138284863|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138284864|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138284865|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
138284866|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284867|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284868|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284869|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138284870|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138284871|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138284872|NCT03123614|Prednisolone|prednisolone|mesh-list
138284873|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138284874|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
138284875|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138284876|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
138284877|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138284878|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
138284879|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138159582|NCT04618016|Tocotrienols|tocotrienols|mesh-list
138159583|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
138284881|NCT03123614|Hormones|hormones|mesh-ancestor
138284882|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284883|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284884|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138284885|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284886|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
138284887|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
138284888|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284889|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138284891|NCT03123614|Protective Agents|protective agents|mesh-ancestor
138284892|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138284893|NCT03123848|Darunavir|darunavir|mesh-list
138284894|NCT03123848|Cobicistat|cobicistat|mesh-list
138284895|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138284896|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138284897|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138284898|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
138284899|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284900|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284901|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138284902|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138284903|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
138284904|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138284905|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138284906|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138284908|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284909|NCT02946073|Narcotics|narcotics|mesh-ancestor
138284910|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284911|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284912|NCT02946073|Analgesics|analgesics|mesh-ancestor
138284913|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
138284914|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284915|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138159629|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138284916|NCT03071744|Fentanyl|fentanyl|mesh-list
138284917|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138284918|NCT03071744|Narcotics|narcotics|mesh-ancestor
138284919|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284920|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284922|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
138284923|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284924|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138284925|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138284926|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
138284927|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
138284928|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
138284929|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138284930|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138284931|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138284932|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
138284933|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284934|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138284935|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138284936|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284937|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138284938|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138284939|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284940|NCT05404334|Androgens|androgens|mesh-list
138284941|NCT05404334|Hormones|hormones|mesh-ancestor
138284942|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159666|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159669|NCT03930212|Hormones|hormones|mesh-ancestor
138284944|NCT00374894|Succimer|succimer|mesh-list
138284945|NCT00374894|Antidotes|antidotes|mesh-ancestor
138284946|NCT00374894|Protective Agents|protective agents|mesh-ancestor
138284947|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284948|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
138284949|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
138284950|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284951|NCT03088267|Amphetamine|amphetamine|mesh-list
138284952|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138284953|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284954|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
138284955|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
138284956|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138284957|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
138284958|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284959|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284960|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
138284961|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138284962|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138284963|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284964|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138284965|NCT03088345|Vasopressins|vasopressins|mesh-list
138284966|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
138284967|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
138284968|NCT03088345|Coagulants|coagulants|mesh-ancestor
138284969|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138354213|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138354214|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138284970|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138284972|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284973|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138284974|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284976|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
138284977|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138284978|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
138284979|NCT02858713|Calcipotriene|calcipotriene|mesh-list
138284980|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138284981|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284982|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
138284983|NCT02858713|Hormones|hormones|mesh-ancestor
138284984|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284985|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284986|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138284987|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
138284988|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284991|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138284992|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138284993|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138159764|NCT03440437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284994|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284996|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138284998|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
138284999|NCT02860507|Neostigmine|neostigmine|mesh-list
138285000|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138285001|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285002|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285003|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285004|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285005|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285006|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138285007|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
138285008|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285009|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138285010|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138285011|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138285012|NCT03082196|Fluorides|fluorides|mesh-list
138285013|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
138285014|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
138285015|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
138285016|NCT03082196|Protective Agents|protective agents|mesh-ancestor
138285017|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285018|NCT02861131|Neostigmine|neostigmine|mesh-list
138285019|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138285020|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285021|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285022|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285023|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285024|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285025|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138285026|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
138285027|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285028|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138285029|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285030|NCT02953561|Azacitidine|azacitidine|mesh-list
138285031|NCT02953561|Avelumab|avelumab|mesh-list
138285032|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138285033|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138285035|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285036|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285037|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285038|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285039|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
138285040|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285042|NCT03090620|Physostigmine|physostigmine|mesh-list
138285043|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
138285044|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
138285045|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
138285046|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285047|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285048|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285049|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138285050|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285051|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138285052|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138285053|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285054|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
138285055|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
138159812|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285057|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285058|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138285059|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285060|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285062|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
138285063|NCT02953873|Prednisone|prednisone|mesh-list
138285064|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
138285065|NCT02953873|Tacrolimus|tacrolimus|mesh-list
138285066|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285067|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
138285068|NCT02953873|Hormones|hormones|mesh-ancestor
138285069|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285070|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285071|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285072|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285073|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138285074|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
138285075|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138285076|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159829|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138159833|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
138285078|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138285079|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138285080|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
138285081|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138285082|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285083|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
138285084|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
138285085|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285086|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285087|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138298648|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285088|NCT02953873|Protective Agents|protective agents|mesh-ancestor
138285090|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285091|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285092|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138285093|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285094|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
138285095|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138285096|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
138285097|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285098|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
138285099|NCT02867605|Protective Agents|protective agents|mesh-ancestor
138285100|NCT00375596|Ketotifen|ketotifen|mesh-list
138285101|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138285103|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
138285104|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138159881|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138285105|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
138285106|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
138285107|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285108|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285109|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285110|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138285111|NCT03093272|Prednisone|prednisone|mesh-list
138354224|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354225|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
138354226|NCT00000648|Penicillins|penicillins|mesh-list
138285112|NCT03093272|Docetaxel|docetaxel|mesh-list
138285113|NCT03093272|Leuprolide|leuprolide|mesh-list
138285114|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285115|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
138285116|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
138285118|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285119|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285120|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
138285121|NCT03093272|Hormones|hormones|mesh-ancestor
138285122|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285123|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285124|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285125|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138285126|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
138285127|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138285128|NCT03100123|Aspirin|aspirin|mesh-list
138285129|NCT03100123|Heparin|heparin|mesh-list
138285130|NCT03100123|Enoxaparin|enoxaparin|mesh-list
138285131|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138285132|NCT03100123|Tinzaparin|tinzaparin|mesh-list
138285134|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138285135|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138285136|NCT03100123|Analgesics|analgesics|mesh-ancestor
138285137|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
138285138|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285139|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285140|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285141|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138285142|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138285143|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138285144|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285145|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138285146|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138285147|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285148|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
138285149|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
138285150|NCT02957305|Misoprostol|misoprostol|mesh-list
138285151|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138285152|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
138285153|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138285154|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285155|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138285156|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285157|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
138285158|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
138285159|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138285160|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
138285161|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285162|NCT03104725|Expectorants|expectorants|mesh-ancestor
138285163|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
138285164|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138285165|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
138285166|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159980|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159981|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285168|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285170|NCT03154658|Ropivacaine|ropivacaine|mesh-list
138285171|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
138285172|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
138285173|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285174|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285175|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
138285176|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285177|NCT03098420|Dexamethasone|dexamethasone|mesh-list
138285178|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
138285180|NCT03098420|Bupivacaine|bupivacaine|mesh-list
138285181|NCT03098420|Ropivacaine|ropivacaine|mesh-list
138285182|NCT03098420|BB 1101|bb 1101|mesh-list
138354238|NCT00000660|Etoposide|etoposide|mesh-list
138285183|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285184|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
138285185|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
138285186|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285187|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285188|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285189|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
138285190|NCT03098420|Hormones|hormones|mesh-ancestor
138285191|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285192|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285193|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285194|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
138285195|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285196|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285197|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
138285198|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
138285199|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285200|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
138285201|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138285202|NCT03098420|Narcotics|narcotics|mesh-ancestor
138285203|NCT03098420|Analgesics|analgesics|mesh-ancestor
138285205|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285206|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138285207|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285208|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285209|NCT00422617|Alefacept|alefacept|mesh-list
138285210|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
138285211|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
138285212|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285213|NCT03104738|Insulin|insulin|mesh-list
138285214|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138285215|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285216|NCT03163472|Anesthetics|anesthetics|mesh-list
138285217|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
138285218|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285219|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160018|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
138285221|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285222|NCT04468568|Terbutaline|terbutaline|mesh-list
138285223|NCT04468568|Atosiban|atosiban|mesh-list
138285224|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138285225|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
138285226|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285227|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285228|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138285229|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
138285230|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
138285231|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
138285232|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138285233|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138285234|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138285235|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138285236|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
138285237|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285238|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285239|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
138285240|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285241|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
138285242|NCT03168308|Neostigmine|neostigmine|mesh-list
138160043|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138285243|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138285244|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285246|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
138354245|NCT00000702|Zidovudine|zidovudine|mesh-list
138285247|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285248|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285249|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138285250|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
138285251|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285252|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138285253|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138285254|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138285256|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285257|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138285258|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138285259|NCT03109015|Growth Substances|growth substances|mesh-ancestor
138285260|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285261|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
138285262|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138285263|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285264|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285265|NCT03115177|Doxycycline|doxycycline|mesh-list
138285266|NCT03115177|Cefazolin|cefazolin|mesh-list
138285267|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138285268|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285269|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
138285270|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138285271|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138285272|NCT03174158|Nicotine|nicotine|mesh-list
138285273|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138285274|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
138285275|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285276|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285277|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138285278|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138285279|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285280|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285281|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285282|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
138285284|NCT03115801|Atezolizumab|atezolizumab|mesh-list
138160091|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285285|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
138285286|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
138285287|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285288|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160096|NCT00337987|Hormones|hormones|mesh-ancestor
138285290|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285291|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285292|NCT00422708|Anesthetics|anesthetics|mesh-list
138285293|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285294|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285295|NCT03117517|Metformin|metformin|mesh-list
138285296|NCT03117517|Pioglitazone|pioglitazone|mesh-list
138285297|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138354257|NCT00000714|Calcium|calcium|mesh-list
138285298|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285299|NCT00375284|Pramipexole|pramipexole|mesh-list
138285300|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
138354258|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
138354260|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285301|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285302|NCT00375284|Protective Agents|protective agents|mesh-ancestor
138285303|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285304|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138285305|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138285306|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
138285307|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
138285308|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285309|NCT02966275|Glucagon|glucagon|mesh-list
138285310|NCT02966275|Pancrelipase|pancrelipase|mesh-list
138285311|NCT02966275|Pancreatin|pancreatin|mesh-list
138285312|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138285313|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285314|NCT02966275|Hormones|hormones|mesh-ancestor
138160124|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285315|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285317|NCT02966275|Incretins|incretins|mesh-ancestor
138285318|NCT03795350|Beclomethasone|beclomethasone|mesh-list
138285319|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
138285320|NCT03795350|Bromides|bromides|mesh-list
138285321|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
138285322|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138285323|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
138285324|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285325|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285326|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138285327|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
138285328|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138285329|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138285330|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138285331|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
138285332|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285333|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285334|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
138285335|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138285336|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138285337|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138285339|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285340|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
138285341|NCT03795350|Hormones|hormones|mesh-ancestor
138285342|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285343|NCT03118843|Velpatasvir|velpatasvir|mesh-list
138285344|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
138285345|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285346|NCT02222922|Fluconazole|fluconazole|mesh-list
138285347|NCT02222922|Avelumab|avelumab|mesh-list
138285348|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
138285349|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285350|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285351|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
138160172|NCT01873989|Hormones|hormones|mesh-ancestor
138160175|NCT01875159|Caffeine|caffeine|mesh-list
138285352|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285353|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138285354|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285355|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285356|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285357|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138285358|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
138285359|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285360|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285361|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138285362|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138285363|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
138285364|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
138285366|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138285367|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285368|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
138285369|NCT03122587|Vitamins|vitamins|mesh-ancestor
138285370|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
138285371|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285372|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138285373|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138285374|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138285375|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138285376|NCT02161146|Analgesics|analgesics|mesh-ancestor
138285377|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
138285378|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285380|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285381|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138285382|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138285383|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138285384|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138285385|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
138285386|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
138285387|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285388|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285389|NCT03447782|Naltrexone|naltrexone|mesh-list
138285390|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138285391|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138285392|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285393|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
138285394|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285395|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
138285396|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285397|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285398|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138299020|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285399|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285400|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
138285401|NCT02969317|Olodaterol|olodaterol|mesh-list
138160255|NCT00330161|Vorinostat|vorinostat|mesh-list
138160256|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285403|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
138285404|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285405|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285406|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138285407|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
138285408|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
138285409|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138285410|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285411|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285412|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285413|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
138285414|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
138285415|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
138285416|NCT05347082|Vitamin D|vitamin d|mesh-list
138285417|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138285418|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285419|NCT05347082|Vitamins|vitamins|mesh-ancestor
138285420|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
138285421|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138285422|NCT03087578|Mirabegron|mirabegron|mesh-list
138285423|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138160304|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
138285424|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138285426|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138285427|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285428|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285429|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285430|NCT03087578|Urological Agents|urological agents|mesh-ancestor
138285431|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138285432|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
138285433|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138354278|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
138285434|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138285436|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138285437|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
138285438|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285439|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285440|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285441|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138285442|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138285444|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299104|NCT00004646|Prednisone|prednisone|mesh-list
138285445|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138285446|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
138285447|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285448|NCT03132571|Naltrexone|naltrexone|mesh-list
138285449|NCT03132571|Bupropion|bupropion|mesh-list
138285450|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138285451|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138285452|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285453|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
138285454|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285455|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138285457|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285458|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138285459|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138285460|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138285461|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285462|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
138285463|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285464|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138285465|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285466|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285467|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
138285468|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285469|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285470|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
138285471|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138285473|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138285474|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
138285475|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285476|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
138285477|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285478|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285479|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
138285480|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
138285481|NCT01306994|Adenosine|adenosine|mesh-list
138285482|NCT01306994|Analgesics|analgesics|mesh-ancestor
138285483|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
138285484|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285485|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285486|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138160404|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160423|NCT00330863|Olanzapine|olanzapine|mesh-list
138285487|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
138285488|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138285489|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
138285490|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
138285491|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285492|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285494|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138285495|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
138285496|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354294|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354295|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354296|NCT00000738|Zidovudine|zidovudine|mesh-list
138285497|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285498|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285499|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285500|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138285501|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138285502|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138285503|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
138285504|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138285505|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138285506|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285509|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
138285510|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
138285511|NCT05113004|Leflunomide|leflunomide|mesh-list
138285512|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160453|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
138285513|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285514|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138285515|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
138285516|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138285517|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285518|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285519|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285520|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
138285521|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138285522|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138285523|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138285524|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138285525|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
138285526|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285527|NCT02983981|Desoximetasone|desoximetasone|mesh-list
138285528|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285529|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
138285531|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285532|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285533|NCT00375583|Albendazole|albendazole|mesh-list
138285534|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
138285535|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138285536|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285537|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
138285538|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138285539|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138285540|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
138160520|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
138285541|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
138285542|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138285543|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285544|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285545|NCT03143569|Heparin|heparin|mesh-list
138285546|NCT03143569|Calcium heparin|calcium heparin|mesh-list
138285547|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
138285548|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138285549|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138285550|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285551|NCT03149887|Bupivacaine|bupivacaine|mesh-list
138285552|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
138354304|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285553|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
138285554|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138354305|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354312|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
138285555|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285556|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
138285557|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285559|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
138285560|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
138285561|NCT02988349|Protective Agents|protective agents|mesh-ancestor
138285562|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285563|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138285564|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285565|NCT02159352|Ritonavir|ritonavir|mesh-list
138285566|NCT02159352|Lopinavir|lopinavir|mesh-list
138285567|NCT02159352|Darunavir|darunavir|mesh-list
138285568|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138285569|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138285570|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
138285571|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285572|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285573|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138285574|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138285575|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
138285576|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285577|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138285578|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285579|NCT02187744|Carboplatin|carboplatin|mesh-list
138285580|NCT02187744|Docetaxel|docetaxel|mesh-list
138285581|NCT02187744|Trastuzumab|trastuzumab|mesh-list
138285582|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285583|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
138160603|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138285585|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
138285586|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285587|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285589|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138285590|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
138285591|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138285592|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138285594|NCT02995915|Nicotine|nicotine|mesh-list
138285595|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138285596|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
138285597|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285598|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285599|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138285600|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138285601|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285602|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285603|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285604|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138285605|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
138285606|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285607|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138285608|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138285609|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138285610|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
138285611|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138160653|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160654|NCT00551031|Vaccines|vaccines|mesh-list
138285612|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285614|NCT03163303|Nicotine|nicotine|mesh-list
138285615|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138285616|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
138285617|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285618|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285619|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138285620|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138285621|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285622|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285623|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285624|NCT03000283|Conivaptan|conivaptan|mesh-list
138285625|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138285626|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285627|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
138285628|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285629|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
138285630|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138285631|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285632|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138285633|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285634|NCT03168841|Efinaconazole|efinaconazole|mesh-list
138285635|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
138285636|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285639|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138285640|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285641|NCT03185546|Nicotine|nicotine|mesh-list
138285642|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138285643|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
138285644|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285645|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285646|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138285647|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138285648|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285649|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285650|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285651|NCT02186652|Pantoprazole|pantoprazole|mesh-list
138285652|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138285653|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285654|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138285655|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285656|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285658|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138285659|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
138160749|NCT00392041|Eszopiclone|eszopiclone|mesh-list
138285661|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285662|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
138285663|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285664|NCT05363917|Folic Acid|folic acid|mesh-list
138285665|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
138285666|NCT05363917|Hematinics|hematinics|mesh-ancestor
138285667|NCT05363917|Vitamins|vitamins|mesh-ancestor
138285668|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
138285669|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285670|NCT03187730|Nicotine|nicotine|mesh-list
138285671|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138285672|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
138285673|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285674|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285675|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138285676|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138285677|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
138285678|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285679|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285680|NCT03261193|Bupivacaine|bupivacaine|mesh-list
138285681|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
138285682|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
138285683|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285684|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285685|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
138285686|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285687|NCT00375661|Interferons|interferons|mesh-list
138285688|NCT00375661|Ribavirin|ribavirin|mesh-list
138285689|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
138285690|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
138285692|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
138285693|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285694|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
138285695|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285696|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
138285697|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285698|NCT04736186|Loperamide|loperamide|mesh-list
138285699|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
138285700|NCT04736186|Bentonite|bentonite|mesh-list
138285701|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285702|NCT04736186|Antidotes|antidotes|mesh-ancestor
138285703|NCT04736186|Protective Agents|protective agents|mesh-ancestor
138285704|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285705|NCT04941170|Bupivacaine|bupivacaine|mesh-list
138285706|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
138285707|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
138285708|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285709|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285710|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
138285711|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285712|NCT05357911|Digoxin|digoxin|mesh-list
138285713|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138285714|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138285715|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285716|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285717|NCT05357911|Protective Agents|protective agents|mesh-ancestor
138285718|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285719|NCT03374839|Nivolumab|nivolumab|mesh-list
138285720|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285721|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285722|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138160849|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
138160850|NCT04163107|Dexamethasone|dexamethasone|mesh-list
138160858|NCT04163107|Hormones|hormones|mesh-ancestor
138285723|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285725|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138285726|NCT02221674|Narcotics|narcotics|mesh-ancestor
138285727|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285728|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285729|NCT02221674|Analgesics|analgesics|mesh-ancestor
138285730|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
138285731|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285732|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138285733|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138285734|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138285735|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285736|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
138285737|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285738|NCT04736719|Warfarin|warfarin|mesh-list
138285739|NCT04736719|Apixaban|apixaban|mesh-list
138285740|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
138285741|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138285742|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
138285744|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
138285745|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285746|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285747|NCT02221284|Alogliptin|alogliptin|mesh-list
138285748|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138285749|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285750|NCT02221284|Incretins|incretins|mesh-ancestor
138285751|NCT02221284|Hormones|hormones|mesh-ancestor
138285752|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285753|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138285754|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
138285755|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285756|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354337|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285758|NCT04736108|Goserelin|goserelin|mesh-list
138285759|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
138285760|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160949|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138285763|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138285764|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285765|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285766|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285767|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138285768|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285769|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285770|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
138285771|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285772|NCT02971033|Ezetimibe|ezetimibe|mesh-list
138285774|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138285775|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
138285776|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285777|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138285778|NCT05406674|Cisplatin|cisplatin|mesh-list
138285779|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285780|NCT05341375|Anesthetics|anesthetics|mesh-list
138285781|NCT05341375|Esketamine|esketamine|mesh-list
138285782|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285783|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299600|NCT05006677|Vitamin K|vitamin k|mesh-list
138285784|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138285785|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285786|NCT03200587|Avelumab|avelumab|mesh-list
138285787|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285788|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285789|NCT03198884|Dolutegravir|dolutegravir|mesh-list
138285790|NCT03198884|Darunavir|darunavir|mesh-list
138285791|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138285792|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138285793|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285794|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285795|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138285796|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138285797|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
138285798|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285799|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138285800|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138285801|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
138285802|NCT01801189|Pregabalin|pregabalin|mesh-list
138285803|NCT01801189|Analgesics|analgesics|mesh-ancestor
138285804|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
138285805|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285806|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285807|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
138285808|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138285809|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138299647|NCT04568876|Analgesics|analgesics|mesh-ancestor
138285810|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285811|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138285812|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138285813|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138285814|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285815|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285816|NCT04275362|Cimetidine|cimetidine|mesh-list
138285817|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138161009|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
138161010|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138285818|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285819|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138285820|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
138285821|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
138285822|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285823|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285824|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354344|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138285825|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138285826|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138285827|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285828|NCT05178043|Nivolumab|nivolumab|mesh-list
138285829|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285830|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285831|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138285832|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285833|NCT00716755|Olanzapine|olanzapine|mesh-list
138285834|NCT00716755|Risperidone|risperidone|mesh-list
138285835|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138285836|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
138285837|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285838|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285839|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285840|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138285841|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138285842|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285843|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285844|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138285845|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
138285846|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
138285847|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
138161025|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138285848|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285849|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285850|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138285853|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
138285854|NCT05406050|Vitamin D|vitamin d|mesh-list
138285855|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138285856|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285857|NCT05406050|Vitamins|vitamins|mesh-ancestor
138285858|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
138285859|NCT03202550|Oxycodone|oxycodone|mesh-list
138285860|NCT03202550|Lorazepam|lorazepam|mesh-list
138285861|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138285862|NCT03202550|Narcotics|narcotics|mesh-ancestor
138285863|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285864|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285865|NCT03202550|Analgesics|analgesics|mesh-ancestor
138285866|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
138285867|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285868|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
138285869|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
138285870|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
138285871|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285872|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138299754|NCT02211482|Lamivudine|lamivudine|mesh-list
138285873|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138285874|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138285875|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285876|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
138285877|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
138285878|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285879|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285881|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138285882|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138285883|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285884|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285885|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354353|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
138285886|NCT00392821|Everolimus|everolimus|mesh-list
138354356|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138285887|NCT00392821|Sorafenib|sorafenib|mesh-list
138285888|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138161065|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138285890|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285891|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285892|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138285893|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
138285894|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285895|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285896|NCT04708171|Anesthetics|anesthetics|mesh-list
138285897|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285898|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285899|NCT03290378|Tramadol|tramadol|mesh-list
138285900|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138285901|NCT03290378|Narcotics|narcotics|mesh-ancestor
138285902|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285903|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285904|NCT03290378|Analgesics|analgesics|mesh-ancestor
138285905|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
138285906|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285907|NCT02076217|Copper|copper|mesh-list
138285908|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138285909|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
138285910|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
138285911|NCT02076217|Etonogestrel|etonogestrel|mesh-list
138285912|NCT02076217|Desogestrel|desogestrel|mesh-list
138285913|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138285914|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285915|NCT02076217|Trace Elements|trace elements|mesh-ancestor
138285916|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
138285917|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138285918|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138285919|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138285920|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138285921|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138285922|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138285923|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285924|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285925|NCT02076217|Progestins|progestins|mesh-ancestor
138285926|NCT02076217|Hormones|hormones|mesh-ancestor
138285928|NCT03291080|Tretinoin|tretinoin|mesh-list
138285929|NCT03291080|Isotretinoin|isotretinoin|mesh-list
138161106|NCT00351299|Analgesics|analgesics|mesh-ancestor
138285931|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
138285932|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
138285933|NCT04874545|Propofol|propofol|mesh-list
138285934|NCT04874545|Sevoflurane|sevoflurane|mesh-list
138285935|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138285936|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285937|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285938|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138285939|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
138285940|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
138285941|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138285942|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138285943|NCT03181009|Omalizumab|omalizumab|mesh-list
138285944|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138285945|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138285946|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
138285948|NCT03296072|Fluorides|fluorides|mesh-list
138285949|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
138285950|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
138285951|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
138354367|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138285952|NCT03296072|Protective Agents|protective agents|mesh-ancestor
138285953|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285954|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138285955|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285956|NCT03185065|Amantadine|amantadine|mesh-list
138285957|NCT03185065|Methylphenidate|methylphenidate|mesh-list
138285958|NCT03185065|Modafinil|modafinil|mesh-list
138285959|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138285960|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299872|NCT04330027|Mitogens|mitogens|mesh-list
138161148|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161152|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
138285963|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138285964|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285965|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
138285966|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285967|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138285968|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138285969|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138285970|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138285971|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138285972|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
138285973|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285974|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138285975|NCT03185065|Analgesics|analgesics|mesh-ancestor
138285976|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
138285977|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285978|NCT02159040|Azacitidine|azacitidine|mesh-list
138285979|NCT02159040|Deferasirox|deferasirox|mesh-list
138285980|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138285981|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
138285982|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285983|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285984|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285985|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138285986|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
138285987|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
138285988|NCT03189589|Nemiralisib|nemiralisib|mesh-list
138285989|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138285990|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285991|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285992|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138285993|NCT03216902|Latanoprost|latanoprost|mesh-list
138285994|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138285995|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
138285996|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138285997|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285998|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138285999|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286000|NCT01632150|Thalidomide|thalidomide|mesh-list
138286001|NCT01632150|Dexamethasone|dexamethasone|mesh-list
138286002|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
138286003|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
138286004|NCT01632150|Elotuzumab|elotuzumab|mesh-list
138286005|NCT01632150|BB 1101|bb 1101|mesh-list
138286006|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138286008|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286009|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286010|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161197|NCT00558519|Daunorubicin|daunorubicin|mesh-list
138161198|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
138286011|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
138286012|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286013|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286014|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138286015|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286016|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
138286017|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
138354379|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138354380|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
138286018|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286019|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286020|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
138286021|NCT01632150|Hormones|hormones|mesh-ancestor
138286022|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286023|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286024|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138286025|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286026|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
138286027|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286028|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286029|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161218|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286030|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138286031|NCT01632150|Growth Substances|growth substances|mesh-ancestor
138286033|NCT02185014|Adalimumab|adalimumab|mesh-list
138286034|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138286035|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286036|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286038|NCT03297944|Alprazolam|alprazolam|mesh-list
138286039|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138286040|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138286041|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286042|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286043|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138286044|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
138286045|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
138286046|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286047|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286048|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138286049|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138286050|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286051|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
138286052|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
138286053|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138286054|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286055|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138286056|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286058|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
138286059|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138286060|NCT03219866|Ipratropium|ipratropium|mesh-list
138286061|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286062|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138286063|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
138286064|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286066|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138286067|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286068|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
138286069|NCT03219866|Hormones|hormones|mesh-ancestor
138300091|NCT00003397|Hormones|hormones|mesh-ancestor
138286070|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286071|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
138286072|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138286073|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286074|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286075|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286076|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
138286077|NCT03300674|Lidocaine|lidocaine|mesh-list
138354388|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138286078|NCT03300674|Hydromorphone|hydromorphone|mesh-list
138286079|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286081|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286082|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286083|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
138286084|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286085|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138286086|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138286087|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138286088|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286089|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286090|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138286091|NCT03300674|Narcotics|narcotics|mesh-ancestor
138286092|NCT03300674|Analgesics|analgesics|mesh-ancestor
138161322|NCT04528563|Ketorolac|ketorolac|mesh-list
138286093|NCT02158806|Aspirin|aspirin|mesh-list
138286094|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138286095|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138286096|NCT02158806|Analgesics|analgesics|mesh-ancestor
138286097|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
138286098|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286099|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286100|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286101|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286102|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138286103|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138286104|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286105|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138286106|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138286107|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286108|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
138286109|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
138286110|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138286112|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138286113|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286114|NCT03198871|Acetaminophen|acetaminophen|mesh-list
138286115|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138286116|NCT03198871|Analgesics|analgesics|mesh-ancestor
138286117|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
138286118|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286119|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286120|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
138286121|NCT02157948|Denosumab|denosumab|mesh-list
138286122|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138286123|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286124|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
138286125|NCT03220958|Promethazine|promethazine|mesh-list
138286126|NCT03220958|Metoclopramide|metoclopramide|mesh-list
138286127|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138286128|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138286129|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286130|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286131|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286132|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
138286133|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
138286134|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286135|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
138286136|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
138286137|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286138|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138286139|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
138286140|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
138286141|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354407|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286142|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286143|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138286144|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
138286145|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286146|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138286147|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138286148|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
138286149|NCT02182830|Empagliflozin|empagliflozin|mesh-list
138286150|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138286151|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161421|NCT00365209|Curcumin|curcumin|mesh-list
138286152|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138286153|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286155|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138286156|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286157|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138286158|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138286159|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138286160|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286161|NCT03303794|Bupivacaine|bupivacaine|mesh-list
138286162|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286163|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
138286164|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286165|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286166|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
138286167|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286168|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
138286169|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138286170|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286171|NCT03435614|Analgesics|analgesics|mesh-list
138286172|NCT03435614|Narcotics|narcotics|mesh-list
138286173|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286174|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286175|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
138286176|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286178|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
138286179|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286180|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138286181|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138286182|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161457|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138161462|NCT03239015|Everolimus|everolimus|mesh-list
138286184|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138286186|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286187|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286188|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286189|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
138286190|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138286191|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138286192|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138286193|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138286194|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
138286195|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138286196|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
138286197|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286198|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
138286199|NCT03438266|Protective Agents|protective agents|mesh-ancestor
138286200|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
138286201|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138286202|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
138286203|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138286204|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
138286205|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286206|NCT03228914|Phenylephrine|phenylephrine|mesh-list
138354417|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138354418|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
138354423|NCT00000918|Ritonavir|ritonavir|mesh-list
138286207|NCT03228914|Epinephrine|epinephrine|mesh-list
138286208|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
138286209|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138286210|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138286212|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286213|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286214|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161503|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138286215|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286216|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138161504|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138286218|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286219|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138286220|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286221|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
138286222|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
138286223|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138286224|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
138286225|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138286226|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138286227|NCT03228914|Protective Agents|protective agents|mesh-ancestor
138286228|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
138286229|NCT03316976|Lansoprazole|lansoprazole|mesh-list
138286230|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138286231|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286232|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138286233|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286234|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286235|NCT03234374|Bupivacaine|bupivacaine|mesh-list
138286236|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286237|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
138286238|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286239|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286240|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
138286241|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286243|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138286245|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286246|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286247|NCT04332536|Analgesics|analgesics|mesh-ancestor
138286248|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
138286249|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286250|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
138161539|NCT00411619|Everolimus|everolimus|mesh-list
138286251|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286253|NCT03236168|Permethrin|permethrin|mesh-list
138286254|NCT03236168|Malathion|malathion|mesh-list
138286255|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138286256|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286257|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286258|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286259|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138286260|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286261|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286262|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286263|NCT03306589|Molgramostim|molgramostim|mesh-list
138286264|NCT03306589|Sargramostim|sargramostim|mesh-list
138286265|NCT03306589|Cantharidin|cantharidin|mesh-list
138286266|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
138286267|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286268|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286269|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286270|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286271|NCT03312517|Suvorexant|suvorexant|mesh-list
138354424|NCT00000918|Indinavir|indinavir|mesh-list
138286272|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138286273|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138354425|NCT00000918|Saquinavir|saquinavir|mesh-list
138286274|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286275|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286276|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138286277|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286278|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286280|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138286281|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286282|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286283|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138286284|NCT03239522|Glycine|glycine|mesh-list
138286285|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
138286286|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138300374|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
138286287|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286288|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286289|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138286290|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
138286291|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138286292|NCT03242408|Testosterone|testosterone|mesh-list
138286293|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
138286294|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
138286295|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286296|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286297|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
138286298|NCT03242408|Hormones|hormones|mesh-ancestor
138286299|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286300|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286301|NCT03242408|Androgens|androgens|mesh-ancestor
138286302|NCT03459794|Ivermectin|ivermectin|mesh-list
138286303|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138286304|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161633|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286308|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
138286309|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286310|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138286311|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138286312|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138286313|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286314|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138286315|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138286316|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138286317|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286318|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138300421|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138286319|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138286321|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138286322|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
138286323|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286324|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138286325|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
138286326|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138286327|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286328|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
138286329|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138286330|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286331|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286332|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286333|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286334|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286335|NCT03245762|Oxytocin|oxytocin|mesh-list
138354436|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286336|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
138286337|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138161679|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286338|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286339|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
138286340|NCT03322657|Neostigmine|neostigmine|mesh-list
138286341|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138286342|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286343|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286344|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286345|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286346|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286347|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138286348|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
138286349|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286350|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138286351|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138286352|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138286354|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138286355|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286356|NCT03247790|Lasmiditan|lasmiditan|mesh-list
138286357|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138286358|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
138286359|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286360|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286361|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286362|NCT03249272|Adenosine|adenosine|mesh-list
138286363|NCT03249272|Regadenoson|regadenoson|mesh-list
138286364|NCT03249272|Analgesics|analgesics|mesh-ancestor
138286365|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
138286366|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286367|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286368|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138286369|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
138286370|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138286371|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
138286372|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
138161713|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286373|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161715|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
138286375|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138286376|NCT03468920|Acetaminophen|acetaminophen|mesh-list
138286377|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138286378|NCT03468920|Analgesics|analgesics|mesh-ancestor
138286379|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
138286380|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286381|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286383|NCT02181816|Amlodipine|amlodipine|mesh-list
138286384|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138286385|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138286386|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138286387|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286388|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286389|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138286390|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286391|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
138286392|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138286393|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138286394|NCT03256136|Carboplatin|carboplatin|mesh-list
138286395|NCT03256136|Nivolumab|nivolumab|mesh-list
138286396|NCT03256136|Pemetrexed|pemetrexed|mesh-list
138286397|NCT03256136|Ipilimumab|ipilimumab|mesh-list
138286398|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286399|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138286400|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138201726|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354447|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138286401|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286402|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286403|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138286404|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138286405|NCT03344510|Anesthetics|anesthetics|mesh-list
138286406|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286407|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161754|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286408|NCT03478982|Alprazolam|alprazolam|mesh-list
138286409|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138286410|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286411|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286412|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138286413|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138286414|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286415|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
138286416|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
138286417|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286418|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286419|NCT03270332|Albuterol|albuterol|mesh-list
138286420|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138286421|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
138286422|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286423|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286424|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138286425|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286426|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
138286427|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138286428|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138286429|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286430|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138286431|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
138286432|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286433|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286435|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
138286436|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286437|NCT03357614|Amoxicillin|amoxicillin|mesh-list
138286438|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
138286439|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
138286440|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
138286441|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138161794|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
138286442|NCT03357614|Ertapenem|ertapenem|mesh-list
138286443|NCT03357614|Lactams|lactams|mesh-list
138161800|NCT03284723|Letrozole|letrozole|mesh-list
138300596|NCT00002833|Hormones|hormones|mesh-ancestor
138286444|NCT03357614|Probenecid|probenecid|mesh-list
138286445|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286446|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286447|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138286448|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138286449|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286450|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286451|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286452|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138286453|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138286454|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138286455|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
138286456|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
138286457|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286458|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
138286459|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
138286460|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138286461|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138286462|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286463|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286464|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354454|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286465|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286466|NCT02216214|Mirabegron|mirabegron|mesh-list
138286467|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138286468|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286469|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138286470|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
138286471|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286472|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286473|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286474|NCT02216214|Urological Agents|urological agents|mesh-ancestor
138286475|NCT00376376|Levofloxacin|levofloxacin|mesh-list
138300641|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286476|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138286477|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286478|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286479|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138286480|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138286481|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286482|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286483|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286484|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138286485|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138286486|NCT02181504|Ranibizumab|ranibizumab|mesh-list
138286487|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138286488|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138286489|NCT02181504|Growth Substances|growth substances|mesh-ancestor
138286490|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286491|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138286492|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286493|NCT02213094|Vitamins|vitamins|mesh-list
138286494|NCT02213094|Niacinamide|niacinamide|mesh-list
138286496|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
138286497|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
138286498|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
138286499|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300689|NCT00003595|Prednisone|prednisone|mesh-list
138286500|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138286501|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
138286502|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286503|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138286504|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
138286505|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138286506|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
138286507|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286508|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138286509|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138286510|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286511|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286512|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286513|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
138286514|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286515|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138286516|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138286518|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138286520|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
138286521|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138286522|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
138286523|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286524|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286525|NCT03283436|Bupivacaine|bupivacaine|mesh-list
138286526|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286527|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
138286528|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286529|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354463|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354464|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286530|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
138286531|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286532|NCT00376064|Octreotide|octreotide|mesh-list
138286533|NCT00376064|Cabergoline|cabergoline|mesh-list
138286534|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286535|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286536|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286537|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138286538|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138286539|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
138286540|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
138286541|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286542|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286543|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286544|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
138286545|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138286546|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
138286547|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286548|NCT03581084|Expectorants|expectorants|mesh-ancestor
138286549|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286550|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138286551|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
138286552|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286553|NCT03581084|Protective Agents|protective agents|mesh-ancestor
138286554|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286556|NCT03383588|Epinephrine|epinephrine|mesh-list
138286558|NCT03383588|Morphine|morphine|mesh-list
138286559|NCT03383588|Bupivacaine|bupivacaine|mesh-list
138286560|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286561|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
138286562|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286563|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286564|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
138161965|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161966|NCT00365417|Growth Substances|growth substances|mesh-ancestor
138286565|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286566|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138286568|NCT03383588|Analgesics|analgesics|mesh-ancestor
138286569|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138286570|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138286571|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
138286572|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138286573|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138300773|NCT00003613|Carmustine|carmustine|mesh-list
138286574|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
138286575|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286576|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286577|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286578|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138286579|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
138286580|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138286581|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286582|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
138286583|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
138286584|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138286586|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286587|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286589|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138286590|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286591|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138286592|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138286593|NCT03393494|Analgesics|analgesics|mesh-ancestor
138286594|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
138286595|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286596|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286597|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286598|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162016|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286601|NCT03588806|Narcotics|narcotics|mesh-ancestor
138286602|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286603|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286604|NCT03588806|Analgesics|analgesics|mesh-ancestor
138286605|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
138286606|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286607|NCT02176356|Bimatoprost|bimatoprost|mesh-list
138286608|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138286609|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
138286610|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138286611|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138286612|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
138286613|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138286614|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138286615|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138300810|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
138286616|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286618|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286619|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286620|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138286621|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286622|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138286623|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138286624|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
138286625|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
138286626|NCT02176356|Protective Agents|protective agents|mesh-ancestor
138286627|NCT03591068|Fluticasone|fluticasone|mesh-list
138286629|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286630|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138286631|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
138286632|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286633|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286634|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138162057|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286635|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286636|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286637|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138286638|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
138286639|NCT03395990|Procaine|procaine|mesh-list
138286640|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286641|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
138286642|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286643|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286644|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
138286645|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286646|NCT02175966|Ribavirin|ribavirin|mesh-list
138286647|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
138286648|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
138286649|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286650|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
138286651|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286652|NCT02136576|Listerine|listerine|mesh-list
138286653|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
138286654|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
138286655|NCT02136576|Protective Agents|protective agents|mesh-ancestor
138286656|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286657|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138286658|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286660|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138162096|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286662|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286663|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286665|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
138286666|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286667|NCT00376766|Levetiracetam|levetiracetam|mesh-list
138286668|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
138354480|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138286669|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
138286670|NCT03403712|Dexamethasone|dexamethasone|mesh-list
138286671|NCT03403712|Palonosetron|palonosetron|mesh-list
138286672|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286673|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
138286674|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
138286675|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286676|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286677|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286678|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
138286679|NCT03403712|Hormones|hormones|mesh-ancestor
138286680|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286681|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286682|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286683|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138286684|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138286685|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
138286686|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286687|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286688|NCT03404648|Choline|choline|mesh-list
138286689|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
138286690|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138286691|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
138286692|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162150|NCT01795235|Incretins|incretins|mesh-ancestor
138286693|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286694|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138286696|NCT03383198|Bupivacaine|bupivacaine|mesh-list
138286697|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138286698|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
138286699|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286700|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286701|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
138286702|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286703|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
138286704|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138286705|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
138286706|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138286707|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
138286708|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286709|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286710|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
138286711|NCT03523988|Acetaminophen|acetaminophen|mesh-list
138286712|NCT03523988|Ibuprofen|ibuprofen|mesh-list
138286713|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138286715|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
138286716|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286717|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162190|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162192|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286719|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138286721|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286722|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138286723|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286724|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286725|NCT03525548|Ivacaftor|ivacaftor|mesh-list
138286726|NCT03525548|Elexacaftor|elexacaftor|mesh-list
138286727|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138286728|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138286729|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286730|NCT03528512|Midazolam|midazolam|mesh-list
138286731|NCT03528512|Fentanyl|fentanyl|mesh-list
138286732|NCT03528512|Ketamine|ketamine|mesh-list
138354486|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138354487|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138286733|NCT03528512|Analgesics|analgesics|mesh-ancestor
138300923|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
138354488|NCT00000942|Nevirapine|nevirapine|mesh-list
138286735|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286736|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286737|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138286738|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138286739|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
138286740|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
138286741|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286742|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138286743|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138286744|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286745|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286746|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138286747|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138286749|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138286750|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286751|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
138286752|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
138286753|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138286754|NCT03528512|Narcotics|narcotics|mesh-ancestor
138286755|NCT02133924|Prednisone|prednisone|mesh-list
138286756|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
138286757|NCT02133924|Natalizumab|natalizumab|mesh-list
138286758|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286759|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
138286760|NCT02133924|Hormones|hormones|mesh-ancestor
138286761|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162254|NCT00455689|Leuprolide|leuprolide|mesh-list
138286762|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286763|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286765|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
138286766|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
138286767|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286768|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286769|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138286770|NCT02133924|Protective Agents|protective agents|mesh-ancestor
138286771|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
138286772|NCT03537404|Ritonavir|ritonavir|mesh-list
138286773|NCT03537404|Tenofovir|tenofovir|mesh-list
138286774|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
138286775|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138286776|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138286777|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
138286778|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286779|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286780|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138286781|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138286782|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
138286783|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286784|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138286785|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138286786|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138286787|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138286788|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138286789|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138286790|NCT03626714|Tacrolimus|tacrolimus|mesh-list
138286791|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162273|NCT00395057|Growth Substances|growth substances|mesh-ancestor
138286794|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138286795|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286796|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286797|NCT03538808|Varenicline|varenicline|mesh-list
138286798|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138354495|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138286799|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138286800|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286801|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286802|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286803|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286804|NCT00377000|Clindamycin|clindamycin|mesh-list
138286805|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
138286806|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
138286807|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138286808|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138286809|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286810|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138286811|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286812|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286813|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286814|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138286815|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286816|NCT04501640|Mirabegron|mirabegron|mesh-list
138286817|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138286818|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138286819|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138286820|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162320|NCT01423604|Capecitabine|capecitabine|mesh-list
138286821|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286822|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286823|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286824|NCT04501640|Urological Agents|urological agents|mesh-ancestor
138286826|NCT03633344|Trace Elements|trace elements|mesh-ancestor
138286827|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
138286828|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286829|NCT02171130|Glucagon|glucagon|mesh-list
138286830|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138286831|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286832|NCT02171130|Hormones|hormones|mesh-ancestor
138286833|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286834|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286835|NCT02171130|Incretins|incretins|mesh-ancestor
138286836|NCT04749810|Eculizumab|eculizumab|mesh-list
138286837|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138286838|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138286839|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
138286840|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286842|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286843|NCT04495712|Spironolactone|spironolactone|mesh-list
138286844|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138286845|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
138286846|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286847|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286848|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138286851|NCT03553940|Vaccines|vaccines|mesh-list
138286852|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
138286853|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286855|NCT04456634|Artemether|artemether|mesh-list
138286856|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138286857|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
138286858|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138286859|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138286860|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286861|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
138286862|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138286863|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
138286864|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286866|NCT00377624|Protective Agents|protective agents|mesh-ancestor
138286867|NCT03562988|Vitamins|vitamins|mesh-list
138286868|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
138286869|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
138286871|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
138201729|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138286872|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286873|NCT03562988|Protective Agents|protective agents|mesh-ancestor
138286874|NCT03644108|Guaifenesin|guaifenesin|mesh-list
138286875|NCT03644108|Expectorants|expectorants|mesh-ancestor
138286876|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286877|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
138286879|NCT04713956|Fludarabine|fludarabine|mesh-list
138286880|NCT04713956|Decitabine|decitabine|mesh-list
138286881|NCT04713956|Lenograstim|lenograstim|mesh-list
138286882|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138286883|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
138286884|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286885|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138286886|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138286887|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
138286888|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286889|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286890|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138286891|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138286892|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
138286893|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286894|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138286895|NCT04425746|Afamelanotide|afamelanotide|mesh-list
138286896|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286897|NCT04392362|Adenosine|adenosine|mesh-list
138286898|NCT04392362|Analgesics|analgesics|mesh-ancestor
138286899|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
138286900|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286901|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286904|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138286905|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
138286906|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
138286907|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286908|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286909|NCT04734782|Antibodies|antibodies|mesh-list
138286910|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
138286911|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286912|NCT04390022|Ivermectin|ivermectin|mesh-list
138286913|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138286914|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286915|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
138286916|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
138286917|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
138162410|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138286918|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286920|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138286921|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286922|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286923|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286924|NCT03571724|Menthol|menthol|mesh-list
138286925|NCT03571724|Nicotine|nicotine|mesh-list
138354518|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
138286926|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138286927|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
138286928|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286929|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286930|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138286931|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138286932|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286933|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286934|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286935|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
138286936|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138286937|NCT03572972|Warfarin|warfarin|mesh-list
138286938|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
138286939|NCT03572972|Dabigatran|dabigatran|mesh-list
138286940|NCT03572972|Apixaban|apixaban|mesh-list
138286941|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
138286942|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138286943|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
138286944|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138286945|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
138301163|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
138286946|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138286947|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286949|NCT04352660|Mitomycin|mitomycin|mesh-list
138286950|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138286951|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162422|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
138286953|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286954|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162428|NCT01386554|Hormones|hormones|mesh-ancestor
138286957|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138286958|NCT04342130|Narcotics|narcotics|mesh-ancestor
138286959|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286960|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286961|NCT04342130|Analgesics|analgesics|mesh-ancestor
138286962|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
138286963|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286964|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
138286965|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138286966|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138286967|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286968|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
138286969|NCT04338074|Coagulants|coagulants|mesh-ancestor
138286970|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
138286971|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138286972|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
138286973|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286974|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286975|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138286976|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
138286977|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
138286978|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138286979|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286980|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286981|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286982|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
138286983|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162460|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
138286986|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
138286987|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
138286988|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286990|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138286991|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354544|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
138286992|NCT03329209|Vedolizumab|vedolizumab|mesh-list
138286993|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138286994|NCT03661346|Labetalol|labetalol|mesh-list
138286995|NCT03661346|Esmolol|esmolol|mesh-list
138286996|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138286997|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138286998|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138286999|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287000|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287001|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287002|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287003|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138287004|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
138287005|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
138287006|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287007|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138287008|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138287010|NCT03329911|Carboplatin|carboplatin|mesh-list
138287011|NCT03329911|Bevacizumab|bevacizumab|mesh-list
138287012|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138287013|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287014|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138287015|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138287016|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138287017|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287018|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138287019|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138287020|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138287021|NCT03329911|Growth Substances|growth substances|mesh-ancestor
138287022|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287023|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138287024|NCT04322396|Azithromycin|azithromycin|mesh-list
138287025|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
138287026|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287027|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287028|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
138287029|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138162506|NCT00448357|Methotrexate|methotrexate|mesh-list
138162507|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
138162508|NCT00448357|Fludarabine|fludarabine|mesh-list
138162509|NCT00448357|Busulfan|busulfan|mesh-list
138162510|NCT00448357|Tacrolimus|tacrolimus|mesh-list
138162511|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138162512|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
138162513|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138162514|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
138162515|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162517|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287030|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138287031|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287032|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287033|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138287034|NCT03961100|Entrectinib|entrectinib|mesh-list
138301300|NCT00003715|Interferons|interferons|mesh-list
138287035|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138287036|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287037|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287039|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
138287040|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
138287041|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287042|NCT03225313|Bupivacaine|bupivacaine|mesh-list
138287043|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138162518|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
138162519|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162520|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162521|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
138162522|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162523|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138162524|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162525|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
138162526|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162527|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162528|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138162532|NCT00450073|Vitamin D|vitamin d|mesh-list
138287044|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287045|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
138287046|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287047|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287048|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
138287049|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287050|NCT03949244|Latanoprost|latanoprost|mesh-list
138287051|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138287052|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138287053|NCT03948386|Bupivacaine|bupivacaine|mesh-list
138287054|NCT03948386|Mepivacaine|mepivacaine|mesh-list
138287055|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287056|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
138287057|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287058|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287059|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
138287060|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287061|NCT03445195|Imipenem|imipenem|mesh-list
138287062|NCT03445195|Sulbactam|sulbactam|mesh-list
138287063|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138287064|NCT03445195|Durlobactam|durlobactam|mesh-list
138287065|NCT03445195|Cilastatin|cilastatin|mesh-list
138287066|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287067|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287068|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
138287069|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287070|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287071|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138287072|NCT04277936|Levetiracetam|levetiracetam|mesh-list
138287073|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
138287077|NCT03670160|Analgesics|analgesics|mesh-ancestor
138287078|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
138287079|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287080|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287081|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138287082|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
138287083|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
138287084|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138287085|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287086|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287087|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287088|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287089|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287090|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
138287091|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287092|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287093|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287094|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287095|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
138287096|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
138287097|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138287098|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138287099|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138287100|NCT00375895|Cyclosporine|cyclosporine|mesh-list
138287101|NCT00375895|Cyclosporins|cyclosporins|mesh-list
138287102|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287103|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287104|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138287105|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
138301389|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138287106|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287107|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
138287108|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287109|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
138287110|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138287111|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138287112|NCT03338803|Linagliptin|linagliptin|mesh-list
138287113|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138287114|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287115|NCT03338803|Incretins|incretins|mesh-ancestor
138287116|NCT03338803|Hormones|hormones|mesh-ancestor
138287117|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287118|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138287119|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
138287120|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287121|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287122|NCT00377936|Gemcitabine|gemcitabine|mesh-list
138287123|NCT00377936|Paclitaxel|paclitaxel|mesh-list
138287124|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287125|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
138287126|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287127|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162609|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138162610|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287128|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138287129|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162612|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
138287130|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
138287131|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
138287132|NCT03696758|Metoprolol|metoprolol|mesh-list
138287133|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
138287134|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138287135|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138287136|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138287137|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287138|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287139|NCT03696758|Urological Agents|urological agents|mesh-ancestor
138287140|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138287141|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138287142|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
138287143|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
138287144|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287145|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287146|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138287147|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138287148|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138287150|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287151|NCT03233737|Anesthetics|anesthetics|mesh-list
138287152|NCT03233737|Tetracaine|tetracaine|mesh-list
138287153|NCT03233737|Benzocaine|benzocaine|mesh-list
138287154|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287155|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287156|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
138162622|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287158|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287159|NCT03711578|Tenalisib|tenalisib|mesh-list
138287160|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138287161|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287162|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287163|NCT03463915|Triamcinolone|triamcinolone|mesh-list
138287164|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138287165|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138287166|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138287167|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138287168|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
138287170|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287171|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287172|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354570|NCT00001068|Lamivudine|lamivudine|mesh-list
138287173|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
138287174|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287175|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287177|NCT03473665|Diclofenac|diclofenac|mesh-list
138287178|NCT03473665|Indomethacin|indomethacin|mesh-list
138287180|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138287181|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287182|NCT03473665|Analgesics|analgesics|mesh-ancestor
138287183|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
138287184|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287185|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287186|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301461|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
138287188|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138287189|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138287190|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287191|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287192|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
138287193|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
138287194|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287195|NCT03717506|Clindamycin|clindamycin|mesh-list
138287196|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
138287197|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
138287198|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287199|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287200|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138287201|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287202|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287203|NCT03861338|Buprenorphine|buprenorphine|mesh-list
138287204|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138287205|NCT03861338|Narcotics|narcotics|mesh-ancestor
138287206|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287207|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287208|NCT03861338|Analgesics|analgesics|mesh-ancestor
138287209|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
138287210|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287211|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138287212|NCT00377780|Docetaxel|docetaxel|mesh-list
138287213|NCT00377780|Doxorubicin|doxorubicin|mesh-list
138287215|NCT00377780|Trastuzumab|trastuzumab|mesh-list
138162717|NCT05966454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138287218|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
138287219|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138287220|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287221|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138287222|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138287223|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138287224|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287225|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138287226|NCT00376519|Cyclosporine|cyclosporine|mesh-list
138287227|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
138287228|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
138287229|NCT00376519|Fludarabine|fludarabine|mesh-list
138287230|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
138287231|NCT00376519|Cyclosporins|cyclosporins|mesh-list
138287232|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162765|NCT05965154|Bevacizumab|bevacizumab|mesh-list
138287234|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287236|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138287238|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287239|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287240|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138287241|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138354581|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138287242|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
138287243|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287244|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
138287245|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287246|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
138287247|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138287248|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138287249|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138287250|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138287251|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287252|NCT00422864|Leucovorin|leucovorin|mesh-list
138287253|NCT00422864|Fluorouracil|fluorouracil|mesh-list
138287255|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
138287256|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287257|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287258|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287259|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138287260|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
138287261|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287262|NCT00422864|Antidotes|antidotes|mesh-ancestor
138287263|NCT00422864|Protective Agents|protective agents|mesh-ancestor
138287264|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
138287265|NCT00422864|Vitamins|vitamins|mesh-ancestor
138287266|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
138287267|NCT03373591|Bupivacaine|bupivacaine|mesh-list
138287268|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287269|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
138301532|NCT00003775|Leflunomide|leflunomide|mesh-list
138287270|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287271|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287272|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
138287273|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287274|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
138287275|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287276|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287277|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287278|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287279|NCT03378973|Analgesics|analgesics|mesh-ancestor
138287280|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
138287281|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287282|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138162878|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138162879|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287283|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287284|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287285|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287286|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287287|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287288|NCT04121078|Rifampin|rifampin|mesh-list
138287289|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138287290|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
138287291|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287292|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287293|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
138287294|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138287295|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287296|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287297|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138287298|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138287299|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138287300|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138287301|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138287302|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138287304|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138287305|NCT03248947|Naloxone|naloxone|mesh-list
138287306|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138287307|NCT03248947|Narcotics|narcotics|mesh-ancestor
138354589|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287308|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287309|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287310|NCT03248947|Analgesics|analgesics|mesh-ancestor
138287311|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
138287312|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162924|NCT05626621|Azelastine|azelastine|mesh-list
138162925|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138287315|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287316|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
138287317|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287318|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287319|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
138287320|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287321|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138287322|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287324|NCT00376831|Fentanyl|fentanyl|mesh-list
138287325|NCT00376831|Ketamine|ketamine|mesh-list
138287326|NCT00376831|Analgesics|analgesics|mesh-ancestor
138287327|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
138287328|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287329|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287330|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138287331|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287332|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
138287333|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
138287334|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287335|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287336|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287337|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287338|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287339|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138287340|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287341|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138287342|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287343|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287344|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
138287345|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
138287346|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138287347|NCT00376831|Narcotics|narcotics|mesh-ancestor
138287348|NCT03857750|Rocuronium|rocuronium|mesh-list
138287349|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138287350|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138287351|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138287352|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287353|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287354|NCT03828422|Calcium|calcium|mesh-list
138287355|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138287356|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287357|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
138287358|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138287359|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287360|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
138287361|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287362|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
138287363|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138287364|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
138287365|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287366|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
138287367|NCT04081610|Protective Agents|protective agents|mesh-ancestor
138287368|NCT03840278|Pancrelipase|pancrelipase|mesh-list
138162968|NCT05493761|Alendronate|alendronate|mesh-list
138162971|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
138354598|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
138287369|NCT03840278|Pancreatin|pancreatin|mesh-list
138287371|NCT03838874|Bupivacaine|bupivacaine|mesh-list
138287372|NCT03838874|Mepivacaine|mepivacaine|mesh-list
138287373|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287374|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
138287375|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287376|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287377|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
138287378|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287379|NCT04045964|Nicotine|nicotine|mesh-list
138287380|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138287381|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
138287382|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287383|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287384|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138287385|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138287386|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287387|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287388|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287389|NCT04039412|Levofloxacin|levofloxacin|mesh-list
138287390|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138287391|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287392|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287393|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138287394|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138287395|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287396|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287397|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287398|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138287399|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138287400|NCT03831854|Lamotrigine|lamotrigine|mesh-list
138287401|NCT03831854|Ketamine|ketamine|mesh-list
138287402|NCT03831854|Analgesics|analgesics|mesh-ancestor
138162986|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162992|NCT05405257|Oxytocin|oxytocin|mesh-list
138287403|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
138287404|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287405|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287406|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138287407|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287409|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
138287410|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287411|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287412|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287413|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287414|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287415|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
138287416|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138287417|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138287418|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138287419|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138287420|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287421|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287422|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138287424|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
138354613|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354614|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
138287425|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138287426|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287427|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287428|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287429|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138287430|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287431|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287433|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
138287434|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
138287435|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
138287436|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
138287437|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163029|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163030|NCT05291338|Doxorubicin|doxorubicin|mesh-list
138163042|NCT05268237|Hormones|hormones|mesh-ancestor
138287438|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287440|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
138287441|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138287442|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
138287443|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
138287444|NCT03497845|Vaccines|vaccines|mesh-list
138287445|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
138287446|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287447|NCT04036292|Varenicline|varenicline|mesh-list
138287448|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138287449|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138287450|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287451|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287452|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287453|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287454|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138287455|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138287456|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138287457|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287458|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287459|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287460|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287461|NCT00377390|Omalizumab|omalizumab|mesh-list
138287462|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138287463|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138163071|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138163076|NCT05106127|Lenvatinib|lenvatinib|mesh-list
138287466|NCT03820388|Etomidate|etomidate|mesh-list
138287467|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287468|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287469|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287470|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287471|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
138287472|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
138287473|NCT03264157|Vaccines|vaccines|mesh-list
138287474|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
138287475|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287476|NCT04029584|Rifampin|rifampin|mesh-list
138287477|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138287478|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
138287479|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287480|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287481|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
138287482|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138287483|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354632|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287484|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287485|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138354645|NCT00001296|Melphalan|melphalan|mesh-list
138287486|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138287487|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138287488|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138287489|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138287490|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138287491|NCT04028960|Insulin|insulin|mesh-list
138287492|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138287493|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138287494|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287495|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
138287496|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138287497|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
138287498|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
138287499|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287500|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287501|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287502|NCT03502915|Analgesics|analgesics|mesh-ancestor
138287503|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
138163119|NCT04882813|Incretins|incretins|mesh-ancestor
138163120|NCT04882813|Hormones|hormones|mesh-ancestor
138163121|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163122|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138163123|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
138287504|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287505|NCT03506347|Vancomycin|vancomycin|mesh-list
138287506|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287507|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287508|NCT03266419|Rocuronium|rocuronium|mesh-list
138287509|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138287510|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138287511|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138287512|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287513|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287514|NCT00377468|Dronabinol|dronabinol|mesh-list
138287515|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
138287516|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287517|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287518|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287519|NCT00377468|Analgesics|analgesics|mesh-ancestor
138163147|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138163148|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163152|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
138287520|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
138287521|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287522|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138287523|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138287524|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287525|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287526|NCT00377468|Hormones|hormones|mesh-ancestor
138287527|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287528|NCT03799484|Lidocaine|lidocaine|mesh-list
138287529|NCT03799484|Prilocaine|prilocaine|mesh-list
138287530|NCT03799484|Petrolatum|petrolatum|mesh-list
138287531|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
138287532|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138287533|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138301793|NCT00003835|Vitamins|vitamins|mesh-ancestor
138287534|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287535|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
138287536|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287537|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287538|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
138287539|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287540|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138287541|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138287542|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138287543|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354646|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287544|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163204|NCT04566380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163205|NCT04566380|Alkylating Agents|alkylating agents|mesh-ancestor
138287545|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138287546|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287547|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287548|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138287550|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138287553|NCT00377546|Bromfenac|bromfenac|mesh-list
138287554|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138287555|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287556|NCT00377546|Analgesics|analgesics|mesh-ancestor
138287557|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
138287558|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287559|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287560|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138287561|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138287562|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138287563|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287564|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287565|NCT04290494|Plasminogen|plasminogen|mesh-list
138287566|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138287567|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138287568|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287569|NCT04005404|Ropivacaine|ropivacaine|mesh-list
138287570|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287571|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
138287572|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287573|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287574|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
138287575|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287576|NCT03232892|Trametinib|trametinib|mesh-list
138287577|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287578|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138287579|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287580|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287581|NCT03510481|Lumefantrine|lumefantrine|mesh-list
138287582|NCT03510481|Artemether|artemether|mesh-list
138287583|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
138287584|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138287585|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138287586|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287587|NCT03109418|Ketamine|ketamine|mesh-list
138287588|NCT03109418|Analgesics|analgesics|mesh-ancestor
138163259|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138287589|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
138287591|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287592|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138287593|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287594|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
138287595|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
138287596|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287597|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287598|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287599|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287600|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287601|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
138287602|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138287603|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138287604|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354653|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354654|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
138354656|NCT00001422|Fludarabine|fludarabine|mesh-list
138287605|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287606|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287607|NCT03771560|Leucovorin|leucovorin|mesh-list
138287608|NCT03771560|Folic Acid|folic acid|mesh-list
138287609|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
138287610|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287611|NCT03771560|Antidotes|antidotes|mesh-ancestor
138287612|NCT03771560|Protective Agents|protective agents|mesh-ancestor
138287613|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
138287614|NCT03771560|Vitamins|vitamins|mesh-ancestor
138287615|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
138287616|NCT03771560|Hematinics|hematinics|mesh-ancestor
138287617|NCT03767738|Aflibercept|aflibercept|mesh-list
138287618|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138287619|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138287620|NCT03767738|Growth Substances|growth substances|mesh-ancestor
138287621|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287622|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163293|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163294|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287623|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163296|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
138287625|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138163333|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287626|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
138287627|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138287628|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138287629|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287630|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287631|NCT02973620|Protective Agents|protective agents|mesh-ancestor
138287632|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287633|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
138287634|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287635|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287636|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287637|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287638|NCT05313386|Analgesics|analgesics|mesh-ancestor
138287639|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
138287640|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287641|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138287642|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287643|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287644|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287645|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287646|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287647|NCT04018664|Nalbuphine|nalbuphine|mesh-list
138287648|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138287649|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138287650|NCT04018664|Narcotics|narcotics|mesh-ancestor
138287651|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287652|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287653|NCT04018664|Analgesics|analgesics|mesh-ancestor
138287654|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
138287655|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287656|NCT03031340|Pregabalin|pregabalin|mesh-list
138287657|NCT03031340|Analgesics|analgesics|mesh-ancestor
138287658|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
138287659|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287661|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
138287662|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138287663|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138287664|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287665|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138354666|NCT00001440|Interleukin-2|interleukin-2|mesh-list
138287666|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138301893|NCT00003877|Paclitaxel|paclitaxel|mesh-list
138287667|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287668|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287669|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287670|NCT03405259|Fluorides|fluorides|mesh-list
138287671|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
138287672|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
138287673|NCT03405259|Protective Agents|protective agents|mesh-ancestor
138287674|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287675|NCT03513757|Lidocaine|lidocaine|mesh-list
138287676|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
138287677|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
138287678|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
138287679|NCT03513757|Propofol|propofol|mesh-list
138287680|NCT03513757|Sevoflurane|sevoflurane|mesh-list
138163345|NCT04136353|Hormones|hormones|mesh-list
138287681|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287682|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
138287683|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287684|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287685|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
138287686|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287687|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138287688|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138287689|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138287690|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138287691|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287692|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287693|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287694|NCT03513757|Analgesics|analgesics|mesh-ancestor
138287695|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138287696|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287697|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287698|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138163351|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138287699|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287700|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287701|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
138287702|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138287703|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138287704|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138287705|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138287706|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138287707|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287708|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
138287709|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138287710|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287711|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138287712|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287713|NCT03756038|Lorazepam|lorazepam|mesh-list
138287714|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
138287715|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
138287716|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
138287717|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287718|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287719|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138287720|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287721|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287722|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138287723|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287724|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287725|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
138287726|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
138287727|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287728|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287729|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
138287730|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138287731|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
138287732|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287733|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287734|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138287735|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138287736|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138287737|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
138287738|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138287739|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
138301956|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
138287740|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287741|NCT01495988|Bevacizumab|bevacizumab|mesh-list
138287742|NCT01495988|Vemurafenib|vemurafenib|mesh-list
138287743|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138287744|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287745|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138287746|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138287747|NCT01495988|Growth Substances|growth substances|mesh-ancestor
138287748|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163455|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163456|NCT03029143|Vedolizumab|vedolizumab|mesh-list
138287750|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138287751|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287752|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287753|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
138287754|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
138287755|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287756|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287757|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287758|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
138287759|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
138287760|NCT03415243|Acetaminophen|acetaminophen|mesh-list
138287761|NCT03415243|Phenylephrine|phenylephrine|mesh-list
138287762|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
138287763|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
138287764|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287765|NCT03415243|Analgesics|analgesics|mesh-ancestor
138287766|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
138287767|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287768|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287769|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
138287770|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138287771|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
138287772|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
138287773|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
138287774|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138287775|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
138287776|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
138287777|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138287778|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287779|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287780|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287781|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163504|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138354677|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
138354678|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287782|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287783|NCT03415243|Protective Agents|protective agents|mesh-ancestor
138287784|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
138163507|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287786|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287788|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
138287789|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138287790|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
138287791|NCT02892500|Bupivacaine|bupivacaine|mesh-list
138287792|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138287793|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287794|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
138287795|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287796|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287797|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
138287798|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287799|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138287800|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
138287801|NCT02892500|Hormones|hormones|mesh-ancestor
138287802|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287803|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138287804|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138287805|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
138287806|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138287807|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138287808|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287809|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
138287810|NCT00378872|Coagulants|coagulants|mesh-ancestor
138287811|NCT00378404|Docetaxel|docetaxel|mesh-list
138287812|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287813|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302030|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287814|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
138287815|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
138287816|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287817|NCT03742154|Varenicline|varenicline|mesh-list
138287818|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138287819|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138287820|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
138287821|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287822|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287823|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287824|NCT02734940|Lidocaine|lidocaine|mesh-list
138287825|NCT02734940|Fentanyl|fentanyl|mesh-list
138287826|NCT02734940|Ketamine|ketamine|mesh-list
138287827|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
138287829|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287830|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
138287831|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287832|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287833|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
138287834|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287835|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138287836|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138287837|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138287838|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163543|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163544|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
138287839|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287840|NCT02734940|Analgesics|analgesics|mesh-ancestor
138287841|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138163546|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138287843|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
138354706|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138287844|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287845|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138287846|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287847|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138287848|NCT02734940|Narcotics|narcotics|mesh-ancestor
138287849|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138287850|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287851|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287852|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138287853|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138287854|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287855|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
138287857|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138287858|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
138287859|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287860|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287861|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287862|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138287863|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138287864|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287865|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138163558|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287866|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138287868|NCT01347632|Metronidazole|metronidazole|mesh-list
138287869|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287871|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138287872|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138163575|NCT00409565|Cetuximab|cetuximab|mesh-list
138287873|NCT02679560|Bupivacaine|bupivacaine|mesh-list
138287874|NCT02679560|Ropivacaine|ropivacaine|mesh-list
138287875|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
138287876|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
138287877|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287878|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287879|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
138287880|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287882|NCT03723980|Calcium|calcium|mesh-list
138287883|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138287884|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287885|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287886|NCT01240304|Gemcitabine|gemcitabine|mesh-list
138287887|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287888|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
138287889|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287890|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354717|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
138287891|NCT02614586|Ondansetron|ondansetron|mesh-list
138287892|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
138354718|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163602|NCT00529555|Minocycline|minocycline|mesh-list
138287893|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
138287894|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287895|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287896|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138287897|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
138287898|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
138287899|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138287900|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138287901|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
138287902|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287903|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287904|NCT01211756|Oxytocin|oxytocin|mesh-list
138302101|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287905|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
138287906|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287907|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287908|NCT03591458|Amitriptyline|amitriptyline|mesh-list
138287909|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138287910|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
138287911|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287912|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138287913|NCT03591458|Analgesics|analgesics|mesh-ancestor
138287914|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
138287915|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138287916|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287917|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138287918|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138287919|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138287920|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287922|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287923|NCT03565328|Niacinamide|niacinamide|mesh-list
138287926|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
138287927|NCT03565328|Vitamins|vitamins|mesh-ancestor
138287928|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
138287929|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287930|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138287931|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
138163603|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138287933|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138287934|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
138287935|NCT01206296|Gemcitabine|gemcitabine|mesh-list
138287936|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287937|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
138287938|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287939|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287940|NCT02593682|Suvorexant|suvorexant|mesh-list
138287941|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138287942|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287943|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138287944|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354746|NCT00001716|Protective Agents|protective agents|mesh-ancestor
138287945|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138287947|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287948|NCT01200602|Megestrol|megestrol|mesh-list
138287949|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
138287950|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138287951|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138287952|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138287953|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
138287954|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287955|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163618|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138163622|NCT00477451|Alprazolam|alprazolam|mesh-list
138287956|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138287957|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138287958|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138287959|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287960|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
138287961|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138287963|NCT01194908|Decitabine|decitabine|mesh-list
138287964|NCT01194908|Panobinostat|panobinostat|mesh-list
138287965|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138287966|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
138287967|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287968|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287969|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287970|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138287971|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
138287972|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287973|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287974|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138287975|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138287976|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138287977|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138287979|NCT01163084|Leuprolide|leuprolide|mesh-list
138287980|NCT01163084|Goserelin|goserelin|mesh-list
138287981|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138287982|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
138287983|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287984|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163668|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138163669|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163672|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
138287985|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138287986|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287988|NCT01155518|Testosterone|testosterone|mesh-list
138287989|NCT01155518|Androgens|androgens|mesh-ancestor
138287990|NCT01155518|Hormones|hormones|mesh-ancestor
138287991|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138287992|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287993|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138287994|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
138287995|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138287996|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
138287997|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138287998|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138287999|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138288001|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
138288002|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138288003|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288004|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288005|NCT03490916|Diuretics|diuretics|mesh-ancestor
138288006|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
138288007|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354777|NCT00001854|Ribavirin|ribavirin|mesh-list
138163712|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138288008|NCT03333746|Nivolumab|nivolumab|mesh-list
138288009|NCT03333746|Lenalidomide|lenalidomide|mesh-list
138288010|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288011|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288012|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138288013|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288014|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
138288015|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288016|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138288017|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138288018|NCT03333746|Growth Substances|growth substances|mesh-ancestor
138288019|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
138288020|NCT01139996|Clonidine|clonidine|mesh-list
138288021|NCT01139996|Analgesics|analgesics|mesh-ancestor
138288022|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
138288023|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288024|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288025|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138288026|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
138288027|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
138288028|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138163764|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163773|NCT00387959|Rituximab|rituximab|mesh-list
138288030|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138288031|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288032|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288033|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288034|NCT02417870|Aldesleukin|aldesleukin|mesh-list
138288035|NCT02417870|Interleukin-2|interleukin-2|mesh-list
138288036|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288037|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138288038|NCT02417870|Analgesics|analgesics|mesh-ancestor
138288039|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
138288040|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288041|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288042|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138288043|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138288044|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
138288045|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288046|NCT01131884|Alendronate|alendronate|mesh-list
138288047|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138288048|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288049|NCT02389712|Lamotrigine|lamotrigine|mesh-list
138288050|NCT02389712|Fluoxetine|fluoxetine|mesh-list
138288051|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138288052|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288053|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288054|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288055|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288056|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
138288057|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288058|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138288059|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288060|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288061|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138288062|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138288063|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288064|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
138288065|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138354780|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
138288066|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138288067|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138288068|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138163819|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138288069|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288070|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138288072|NCT02369744|Silodosin|silodosin|mesh-list
138288073|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138288074|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138288075|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138288076|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288077|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288078|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302226|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288079|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288080|NCT02369744|Urological Agents|urological agents|mesh-ancestor
138288082|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
138288083|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288085|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138288086|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138288087|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288088|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288089|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138288090|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138288091|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288092|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138288093|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
138288094|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
138288095|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
138288096|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
138288097|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288098|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288099|NCT01078844|Memantine|memantine|mesh-list
138288100|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138288101|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138288102|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
138288103|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288104|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163849|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
138163857|NCT00414167|Bupropion|bupropion|mesh-list
138288105|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288106|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138288107|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138288109|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138288110|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288111|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288112|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288113|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288114|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
138288115|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288116|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138288117|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288118|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288119|NCT01072526|Cyclosporine|cyclosporine|mesh-list
138288120|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
138288121|NCT01072526|Cyclosporins|cyclosporins|mesh-list
138288122|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288123|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288124|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288125|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
138288126|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288127|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
138354796|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354797|NCT00001968|Ritonavir|ritonavir|mesh-list
138288128|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288129|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288130|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288131|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138288132|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138288133|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138288134|NCT05312840|Carboplatin|carboplatin|mesh-list
138288135|NCT05312840|Gemcitabine|gemcitabine|mesh-list
138288136|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288137|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163886|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163887|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138163890|NCT00481351|Simvastatin|simvastatin|mesh-list
138288138|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
138288139|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288141|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288142|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
138288143|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288145|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138288146|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138288147|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
138288148|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288149|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138288150|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
138288151|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
138288152|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
138288153|NCT01035944|Coagulants|coagulants|mesh-ancestor
138288154|NCT00378638|Bevacizumab|bevacizumab|mesh-list
138288155|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288156|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288157|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138288158|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138288159|NCT00378638|Growth Substances|growth substances|mesh-ancestor
138288160|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288161|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138288162|NCT03582553|Naringenin|naringenin|mesh-list
138288163|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138288164|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288165|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138288166|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288167|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288168|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288169|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
138288170|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138288171|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138288172|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
138288173|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288174|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138288175|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
138288176|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
138163925|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138288177|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138163927|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
138288180|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288181|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288182|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288183|NCT01023620|Pioglitazone|pioglitazone|mesh-list
138288184|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138288185|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288186|NCT03595579|Bupropion|bupropion|mesh-list
138288187|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138288188|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288189|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288190|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138288191|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288192|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288193|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288194|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
138288195|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302343|NCT00004993|Hormones|hormones|mesh-list
138288196|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288197|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138288198|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138288199|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288200|NCT02200328|Metronidazole|metronidazole|mesh-list
138288201|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288202|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138288204|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288206|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
138288207|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
138288208|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
138288209|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288210|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288211|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288212|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138288213|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138288214|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288215|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288218|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288219|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288220|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138288222|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138288223|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288224|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288225|NCT00979550|Imiquimod|imiquimod|mesh-list
138288226|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138288227|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
138288228|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288229|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288230|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
138288231|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
138288232|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138288233|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288234|NCT00379730|Prednisolone|prednisolone|mesh-list
138302367|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
138288235|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288236|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
138288237|NCT00379730|Hormones|hormones|mesh-ancestor
138288238|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288239|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288240|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138288241|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288242|NCT02074904|Topiramate|topiramate|mesh-list
138288243|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
138288244|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138288245|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288246|NCT02043860|Melphalan|melphalan|mesh-list
138288247|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
138288248|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288249|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138288250|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
138288251|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288252|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288253|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138354817|NCT00001998|Nystatin|nystatin|mesh-list
138288254|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288256|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138288257|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288258|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288259|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288260|NCT00869414|Insulin|insulin|mesh-list
138288261|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138288262|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
138288263|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138164002|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138164007|NCT00484393|Tetracaine|tetracaine|mesh-list
138288264|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288266|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138164026|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288267|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288268|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
138288269|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288270|NCT03608839|Dexamethasone|dexamethasone|mesh-list
138288271|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
138302406|NCT00004393|Risperidone|risperidone|mesh-list
138288272|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138288273|NCT03608839|BB 1101|bb 1101|mesh-list
138288274|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288275|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
138288276|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
138288277|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288278|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288279|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288281|NCT03608839|Hormones|hormones|mesh-ancestor
138288282|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288283|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138288284|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288285|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138288286|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288287|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288288|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138288289|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
138164027|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288290|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
138288291|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288292|NCT03610399|Primaquine|primaquine|mesh-list
138288293|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
138288294|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138288295|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288296|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288297|NCT03610633|Oxytocin|oxytocin|mesh-list
138288298|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
138288299|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288300|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288301|NCT00832520|Mirtazapine|mirtazapine|mesh-list
138288302|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288303|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288304|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138288305|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
138288306|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
138288307|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288308|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288309|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288310|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138302444|NCT00005017|Stavudine|stavudine|mesh-list
138288311|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138354830|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354831|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138288312|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288313|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138288314|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138288315|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138288316|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288317|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138288318|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138288319|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
138288320|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138288322|NCT03545893|Oxycodone|oxycodone|mesh-list
138288323|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138288324|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138288325|NCT03545893|Analgesics|analgesics|mesh-ancestor
138288326|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
138288327|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288328|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288329|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288330|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288331|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138288332|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288333|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288334|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138288335|NCT03545893|Narcotics|narcotics|mesh-ancestor
138288336|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288337|NCT01877564|Metformin|metformin|mesh-list
138288338|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138288339|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288340|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
138288341|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288342|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
138288343|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138288344|NCT00376987|Protective Agents|protective agents|mesh-ancestor
138288345|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288346|NCT01889420|Everolimus|everolimus|mesh-list
138288347|NCT01889420|Pomalidomide|pomalidomide|mesh-list
138288349|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138288350|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288351|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288352|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288353|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
138288354|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288357|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138288358|NCT01889420|Growth Substances|growth substances|mesh-ancestor
138302546|NCT00386269|Narcotics|narcotics|mesh-ancestor
138288359|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138288360|NCT00379028|Fluticasone|fluticasone|mesh-list
138288361|NCT00379028|Budesonide|budesonide|mesh-list
138288362|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
138288363|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138288364|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288365|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138288366|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
138288367|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288368|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288369|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138288370|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288371|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164081|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288372|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138288373|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
138288374|NCT00379028|Hormones|hormones|mesh-ancestor
138288375|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288376|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138288377|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138288378|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138288379|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
138354845|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
138288380|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288381|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288382|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138288383|NCT05286554|Hormones|hormones|mesh-list
138288384|NCT05286554|Progesterone|progesterone|mesh-list
138288385|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288386|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288388|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
138288389|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138288390|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
138288391|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288392|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138288393|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164082|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288395|NCT00379262|Capecitabine|capecitabine|mesh-list
138288396|NCT00379262|Fluorouracil|fluorouracil|mesh-list
138288397|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138288398|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
138288399|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288400|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288401|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288402|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
138288403|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288404|NCT00793520|Milnacipran|milnacipran|mesh-list
138288405|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
138288406|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138288407|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288408|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288409|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288410|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288411|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288412|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138288413|NCT00793520|Analgesics|analgesics|mesh-ancestor
138288414|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
138288415|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288416|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288417|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288418|NCT03621085|Ketamine|ketamine|mesh-list
138288419|NCT03621085|Analgesics|analgesics|mesh-ancestor
138288420|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
138288421|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288422|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288423|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138288424|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138288425|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
138288427|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288428|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138288429|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138164113|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
138302628|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288431|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288433|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
138288434|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354850|NCT00002034|Ganciclovir|ganciclovir|mesh-list
138288435|NCT00795236|Protective Agents|protective agents|mesh-ancestor
138288436|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288437|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288438|NCT00790478|Melatonin|melatonin|mesh-list
138288439|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
138288440|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288441|NCT00790478|Protective Agents|protective agents|mesh-ancestor
138288442|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288443|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288444|NCT04490239|Heparin|heparin|mesh-list
138288445|NCT04490239|Calcium heparin|calcium heparin|mesh-list
138288446|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
138288447|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138288448|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138288449|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288451|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138288452|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138288453|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138288454|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288455|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302664|NCT00005113|Cyclosporine|cyclosporine|mesh-list
138288456|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138288457|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138288458|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
138288459|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288460|NCT00771602|Rituximab|rituximab|mesh-list
138288461|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
138288462|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288463|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288464|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
138288465|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288466|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288467|NCT01804166|Infliximab|infliximab|mesh-list
138288468|NCT01804166|Golimumab|golimumab|mesh-list
138288469|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138288470|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288471|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288472|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288473|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288474|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288475|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
138288476|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288477|NCT04459585|Dabigatran|dabigatran|mesh-list
138288478|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
138288479|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138288480|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
138288481|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288482|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288483|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
138288485|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288487|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138288488|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288489|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288490|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288491|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288492|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
138288493|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288494|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
138302709|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288495|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138288496|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138288497|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138288498|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288499|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288500|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
138288501|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288502|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354869|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288503|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138164176|NCT00425477|Bexarotene|bexarotene|mesh-list
138288505|NCT00726830|Morphine|morphine|mesh-list
138288506|NCT00726830|Oxycodone|oxycodone|mesh-list
138288507|NCT00726830|Methadone|methadone|mesh-list
138288508|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138288509|NCT00726830|Narcotics|narcotics|mesh-ancestor
138288510|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288511|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288512|NCT00726830|Analgesics|analgesics|mesh-ancestor
138288513|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
138288514|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288515|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
138288516|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288517|NCT00691652|Rituximab|rituximab|mesh-list
138288518|NCT00691652|Clofarabine|clofarabine|mesh-list
138288519|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288520|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288521|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
138288522|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288523|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288524|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138288525|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
138288526|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288528|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
138288529|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288530|NCT00691574|Protective Agents|protective agents|mesh-ancestor
138288531|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288532|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288534|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
138288535|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288536|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
138288537|NCT00685880|Hormones|hormones|mesh-ancestor
138288538|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288539|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288540|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138288541|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288542|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138288543|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
138288544|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288545|NCT00681044|Melphalan|melphalan|mesh-list
138164228|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
138288547|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288548|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138288550|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288551|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288552|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138288553|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288554|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
138288555|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138288556|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
138288557|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288558|NCT03633487|Guaifenesin|guaifenesin|mesh-list
138288559|NCT03633487|Expectorants|expectorants|mesh-ancestor
138288560|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288561|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
138288562|NCT00423020|Hematinics|hematinics|mesh-ancestor
138288563|NCT01756586|Dexamethasone|dexamethasone|mesh-list
138288564|NCT01756586|Bupivacaine|bupivacaine|mesh-list
138288565|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288566|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
138288567|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
138288568|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288569|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288570|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288571|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
138288572|NCT01756586|Hormones|hormones|mesh-ancestor
138288573|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288574|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138288575|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288576|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138288577|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
138288578|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288579|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
138288580|NCT03636061|Varenicline|varenicline|mesh-list
138288581|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138288582|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138288583|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
138164261|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138164262|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
138288584|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288585|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288586|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288587|NCT00661466|Bupivacaine|bupivacaine|mesh-list
138288588|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
138288589|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
138288590|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288591|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288592|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
138288593|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288594|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
138288595|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138288596|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288597|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138288598|NCT01718444|Clomiphene|clomiphene|mesh-list
138288599|NCT01718444|Enclomiphene|enclomiphene|mesh-list
138288600|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
138288601|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
138288602|NCT01718444|Progestins|progestins|mesh-list
138288603|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138288604|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288605|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288606|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288607|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138288609|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288610|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138288611|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138288612|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138288613|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138288614|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138288615|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
138288616|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138288617|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138288618|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138288619|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138288620|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288621|NCT01718444|Hormones|hormones|mesh-ancestor
138288622|NCT00638222|Carvedilol|carvedilol|mesh-list
138288623|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138164296|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288624|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138288625|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288626|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288627|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288628|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288629|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138288631|NCT00638222|Protective Agents|protective agents|mesh-ancestor
138288632|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138288633|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288634|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138288635|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
138288636|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138288637|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138288639|NCT00634322|Antidotes|antidotes|mesh-ancestor
138288640|NCT00634322|Protective Agents|protective agents|mesh-ancestor
138288641|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288642|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
138288643|NCT00634322|Vitamins|vitamins|mesh-ancestor
138288644|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
138288645|NCT00379886|Thiopental|thiopental|mesh-list
138288646|NCT00379886|Propofol|propofol|mesh-list
138288647|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138288648|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288649|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288650|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138288651|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
138288652|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
138288653|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
138288654|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
138288655|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
138288656|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288657|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288658|NCT01705106|Celecoxib|celecoxib|mesh-list
138164333|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288660|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138288661|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
138288662|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288663|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288664|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138288665|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138288666|NCT01705106|Analgesics|analgesics|mesh-ancestor
138288667|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
138288668|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288669|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288670|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288671|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288672|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138288673|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138288674|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288675|NCT00624650|Phenylephrine|phenylephrine|mesh-list
138288678|NCT00624650|Vasopressins|vasopressins|mesh-list
138288679|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
138288680|NCT00624650|Epinephrine|epinephrine|mesh-list
138288681|NCT00624650|Racepinephrine|racepinephrine|mesh-list
138288682|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
138288683|NCT00624650|Norepinephrine|norepinephrine|mesh-list
138288684|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138288685|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
138288686|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138164373|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138164375|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138288687|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138288689|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288690|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288691|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288692|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138288693|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138288694|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
138288695|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288696|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138288697|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288698|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
138288699|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
138288700|NCT00624650|Diuretics|diuretics|mesh-ancestor
138288701|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
138288702|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138354899|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288703|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288704|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138288705|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
138288706|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138288707|NCT00624650|Protective Agents|protective agents|mesh-ancestor
138288708|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
138288709|NCT00624650|Coagulants|coagulants|mesh-ancestor
138288710|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138288711|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138288712|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
138288713|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138164423|NCT00535925|Hematinics|hematinics|mesh-ancestor
138288714|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138288716|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288717|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138164440|NCT01796093|Digoxin|digoxin|mesh-list
138288718|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138288719|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288720|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288721|NCT00377143|Warfarin|warfarin|mesh-list
138288722|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
138288723|NCT00610532|Probenecid|probenecid|mesh-list
138288724|NCT00610532|Phenytoin|phenytoin|mesh-list
138288725|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
138288726|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138288727|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138288728|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288729|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302995|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288730|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138288731|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138288732|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
138288733|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
138288734|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288736|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
138288737|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
138288738|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288739|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288740|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
138288741|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288742|NCT00379418|Abciximab|abciximab|mesh-list
138288743|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
138288744|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138288745|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
138288746|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288747|NCT00378716|Leucovorin|leucovorin|mesh-list
138288748|NCT00378716|Fluorouracil|fluorouracil|mesh-list
138288751|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
138288752|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138288753|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288754|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
138288755|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288756|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138288757|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288758|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288759|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
138354908|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138288760|NCT00378716|Antidotes|antidotes|mesh-ancestor
138288762|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
138354909|NCT00002070|Sargramostim|sargramostim|mesh-list
138288763|NCT00378716|Vitamins|vitamins|mesh-ancestor
138288764|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
138288765|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
138288766|NCT03644095|Guaifenesin|guaifenesin|mesh-list
138288767|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138288768|NCT03644095|Expectorants|expectorants|mesh-ancestor
138288769|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288770|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138288771|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138288772|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288773|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303040|NCT02105688|Grazoprevir|grazoprevir|mesh-list
138288775|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288776|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
138288777|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138288778|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
138288779|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
138288780|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288781|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
138288782|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138288783|NCT01633814|Estradiol|estradiol|mesh-list
138288784|NCT01633814|Estrogens|estrogens|mesh-ancestor
138288785|NCT01633814|Hormones|hormones|mesh-ancestor
138288786|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288787|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288788|NCT04714099|Cyclosporine|cyclosporine|mesh-list
138288789|NCT04714099|Cyclosporins|cyclosporins|mesh-list
138288790|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288791|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288792|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288793|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
138288794|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288795|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
138288796|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288797|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288798|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288799|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138288800|NCT04566770|Vaccines|vaccines|mesh-list
138288801|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
138288802|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288803|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
138288804|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138288805|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138288806|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288807|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288808|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288809|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138288810|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138288811|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288812|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288813|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288814|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
138288815|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138288816|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
138288817|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138288818|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138288819|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288820|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138288821|NCT00589550|Interferons|interferons|mesh-list
138288822|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
138288823|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
138288824|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138288825|NCT00589550|Sorafenib|sorafenib|mesh-list
138288826|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288827|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
138288828|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288829|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138288830|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288831|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288832|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
138164564|NCT03594968|Progesterone|progesterone|mesh-list
138164565|NCT03594968|Progestins|progestins|mesh-ancestor
138288834|NCT01636466|Everolimus|everolimus|mesh-list
138288835|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138288836|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138288837|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288838|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288839|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288840|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
138288841|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288842|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288843|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
138288844|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288845|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
138288846|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288847|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288848|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138288849|NCT03949621|Vedolizumab|vedolizumab|mesh-list
138288850|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288851|NCT04429880|Oxytocin|oxytocin|mesh-list
138288852|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
138288853|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288854|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288856|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138288857|NCT01692158|Tinzaparin|tinzaparin|mesh-list
138288858|NCT01692158|Dalteparin|dalteparin|mesh-list
138164576|NCT00490009|Acetaminophen|acetaminophen|mesh-list
138164577|NCT00490009|Iodine|iodine|mesh-list
138164578|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
138288861|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138288862|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288864|NCT01570634|Loperamide|loperamide|mesh-list
138288865|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
138288866|NCT01570634|Calcium|calcium|mesh-list
138288867|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138288868|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288869|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288870|NCT03928327|Itraconazole|itraconazole|mesh-list
138288872|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
138288873|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303165|NCT02098746|Glimepiride|glimepiride|mesh-list
138288874|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138288875|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138288876|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288877|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288878|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138288879|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288880|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138288882|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138288883|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138288884|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
138288885|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138288886|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
138288887|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138288888|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138288889|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138288890|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138288891|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138288892|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138288893|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138288894|NCT01055756|Loratadine|loratadine|mesh-list
138288895|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
138288896|NCT01055756|Ephedrine|ephedrine|mesh-list
138288897|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
138288898|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288899|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138164629|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138164631|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
138164632|NCT00492973|Clonidine|clonidine|mesh-list
138164633|NCT00492973|Epinephrine|epinephrine|mesh-list
138164634|NCT00492973|Morphine|morphine|mesh-list
138288901|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138288902|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
138288903|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
138288904|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288905|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288906|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288907|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138288909|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288910|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138288911|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
138288912|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
138288913|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138288914|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138288915|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
138288916|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288917|NCT00652574|Dasatinib|dasatinib|mesh-list
138288918|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288919|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138288920|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288921|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288922|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
138288923|NCT01550510|Irinotecan|irinotecan|mesh-list
138288924|NCT01550510|Camptothecin|camptothecin|mesh-list
138288925|NCT01550510|Vitamins|vitamins|mesh-ancestor
138288926|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
138288927|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288928|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138288929|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138288930|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288931|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288932|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288933|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
138288934|NCT01550510|Protective Agents|protective agents|mesh-ancestor
138164661|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164668|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
138288936|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
138288937|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
138288938|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138288939|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288940|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288941|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288942|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288943|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288944|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
138303241|NCT01627860|Topiramate|topiramate|mesh-list
138288945|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
138288946|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138288947|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138288948|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354945|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
138354946|NCT00002106|Ranitidine|ranitidine|mesh-list
138288949|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138288950|NCT00521924|Cyclosporine|cyclosporine|mesh-list
138288952|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
138288953|NCT00521924|Infliximab|infliximab|mesh-list
138288954|NCT00521924|Methotrexate|methotrexate|mesh-list
138288955|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
138288956|NCT00521924|Cyclosporins|cyclosporins|mesh-list
138164701|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138288957|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138288958|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
138164702|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138288960|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288961|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138288962|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
138288963|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288964|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288965|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288966|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288967|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138288968|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138288969|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
138288970|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138288971|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
138288972|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288973|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138288974|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138288975|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138288976|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138288978|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138288979|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288980|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
138288981|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138288982|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138288983|NCT00521924|Analgesics|analgesics|mesh-ancestor
138288984|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
138288985|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288986|NCT03927781|Pregabalin|pregabalin|mesh-list
138288987|NCT03927781|Analgesics|analgesics|mesh-ancestor
138288988|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
138288989|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164757|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138288992|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138288993|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288994|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288995|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138288996|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138288997|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138288998|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138288999|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289000|NCT00379964|Caspofungin|caspofungin|mesh-list
138289001|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
138289002|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289003|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289004|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289005|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138289006|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
138303317|NCT02118714|Atrasentan|atrasentan|mesh-list
138289007|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289008|NCT01526408|Famciclovir|famciclovir|mesh-list
138289009|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
138289010|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289011|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289012|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289013|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289015|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138289016|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289017|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164797|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138164798|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
138289018|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138289019|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
138289020|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
138289021|NCT00000734|Zidovudine|zidovudine|mesh-list
138289022|NCT00000734|Trimethoprim|trimethoprim|mesh-list
138289023|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
138289024|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138289025|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
138289026|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289027|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289028|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289029|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289030|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
138289031|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289032|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289033|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289034|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138289035|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
138289036|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289037|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289038|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138289039|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138289040|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138289041|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289042|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138164841|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
138289045|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
138289046|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289047|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289048|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
138289049|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289051|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
138289052|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
138289054|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289055|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
138289056|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289057|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
138289058|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289059|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
138289061|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138289062|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289063|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289064|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289066|NCT00484718|Oxycodone|oxycodone|mesh-list
138289067|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289068|NCT00484718|Narcotics|narcotics|mesh-ancestor
138289069|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289070|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289071|NCT00484718|Analgesics|analgesics|mesh-ancestor
138289072|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
138164892|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138289073|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289074|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138289075|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138354979|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
138289076|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138289077|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289078|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138289079|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138289080|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289081|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289082|NCT03665155|Daratumumab|daratumumab|mesh-list
138289083|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289084|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138289085|NCT00448682|Leucovorin|leucovorin|mesh-list
138289086|NCT00448682|Docetaxel|docetaxel|mesh-list
138289087|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
138289088|NCT00448682|Floxuridine|floxuridine|mesh-list
138289089|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
138289090|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289091|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138289092|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303443|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289093|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289094|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289095|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289097|NCT00448682|Protective Agents|protective agents|mesh-ancestor
138289098|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
138164940|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164952|NCT00504751|Dexamethasone|dexamethasone|mesh-list
138289100|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
138289101|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138289102|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
138289103|NCT04713488|Vaccines|vaccines|mesh-list
138289104|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
138289105|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289107|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138289108|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289109|NCT00380120|Warfarin|warfarin|mesh-list
138289110|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
138289111|NCT00000770|Zidovudine|zidovudine|mesh-list
138289112|NCT00000770|Nevirapine|nevirapine|mesh-list
138289113|NCT00000770|Didanosine|didanosine|mesh-list
138289114|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
138453618|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453619|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453620|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138453622|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
138453623|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
138303497|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
138453624|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453625|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453626|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138453628|NCT01886248|Antithrombins|antithrombins|mesh-list
138453629|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
138453630|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138453631|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453632|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453633|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453634|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
138453635|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
138453636|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
138453637|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
138453638|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453639|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453640|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
138453641|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453642|NCT01886365|Insulin|insulin|mesh-list
138453643|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138453644|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453647|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
138453650|NCT01886443|Tezosentan|tezosentan|mesh-list
138453651|NCT01886443|Melatonin|melatonin|mesh-list
138453652|NCT01886443|Antithrombins|antithrombins|mesh-list
138453653|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
138453654|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
138453655|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138453656|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
138453657|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453658|NCT01886443|Protective Agents|protective agents|mesh-ancestor
138453659|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453660|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453661|NCT01886443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138453662|NCT01886443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453663|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453664|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453665|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453666|NCT01886443|Hematinics|hematinics|mesh-ancestor
138453667|NCT01886443|Vitamins|vitamins|mesh-ancestor
138453668|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
138453669|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138453670|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453671|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453672|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
138453673|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453674|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138453675|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
138453676|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138453677|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453678|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
138453679|NCT01886534|Diuretics|diuretics|mesh-list
138453680|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453681|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453682|NCT01886560|Doxycycline|doxycycline|mesh-list
138453683|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453684|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453685|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
138453686|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138453687|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138453688|NCT01886573|Azacitidine|azacitidine|mesh-list
138453689|NCT01886573|Entinostat|entinostat|mesh-list
138453690|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138453691|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138453692|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
138453693|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453694|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453695|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453696|NCT01886599|Asunaprevir|asunaprevir|mesh-list
138453697|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453698|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453699|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165024|NCT03590444|Growth Substances|growth substances|mesh-ancestor
138453701|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138453702|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165026|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138453703|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453704|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453706|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453707|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138453708|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138453709|NCT01886664|Sevoflurane|sevoflurane|mesh-list
138453710|NCT01886664|Desflurane|desflurane|mesh-list
138453711|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138453712|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138453713|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
138453714|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
138453715|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453716|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355007|NCT00002142|Cidofovir|cidofovir|mesh-list
138453717|NCT01886768|Anesthetics|anesthetics|mesh-list
138453718|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453719|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453720|NCT01887119|Eplerenone|eplerenone|mesh-list
138453721|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138453722|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453723|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453724|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453725|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138453726|NCT01887119|Diuretics|diuretics|mesh-ancestor
138453727|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453728|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453729|NCT01887158|Bisacodyl|bisacodyl|mesh-list
138453730|NCT01887158|Cathartics|cathartics|mesh-ancestor
138165041|NCT04005170|Paclitaxel|paclitaxel|mesh-list
138165042|NCT04005170|Cisplatin|cisplatin|mesh-list
138165043|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165044|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453732|NCT01887158|Laxatives|laxatives|mesh-ancestor
138453733|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
138453734|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138453735|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453736|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453737|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453739|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
138453740|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453741|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138453742|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138453743|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138453744|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453745|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412680|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453746|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453747|NCT01887197|Mannitol|mannitol|mesh-list
138165088|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
138453748|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138453750|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453751|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453752|NCT01887223|Timolol|timolol|mesh-list
138453753|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138453754|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453755|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138453756|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138453757|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138453758|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165089|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165090|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453760|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453761|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453762|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138453763|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138453764|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453765|NCT01887249|Metronidazole|metronidazole|mesh-list
138453766|NCT01887249|Clarithromycin|clarithromycin|mesh-list
138453767|NCT01887249|Esomeprazole|esomeprazole|mesh-list
138453768|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453769|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453770|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138453772|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138453773|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453774|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138453775|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453776|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453777|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138453778|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138453779|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138453780|NCT01887275|Interferons|interferons|mesh-list
138453781|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453782|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
138453783|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453784|NCT01887340|Carboplatin|carboplatin|mesh-list
138453785|NCT01887340|Etoposide|etoposide|mesh-list
138453786|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453787|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165131|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138453789|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138453790|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453791|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453792|NCT01887379|Furosemide|furosemide|mesh-list
138453794|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453795|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453796|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138453797|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453798|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453799|NCT01887405|Epinephrine|epinephrine|mesh-list
138453800|NCT01887405|Racepinephrine|racepinephrine|mesh-list
138453801|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
138453802|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138453803|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138453804|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453805|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453806|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453807|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453808|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138453809|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138453810|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
138453811|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453812|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138453813|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
138453814|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
138453815|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
138453816|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138453817|NCT01887457|Voriconazole|voriconazole|mesh-list
138453818|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
138453819|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453820|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138303767|NCT02060370|Sunitinib|sunitinib|mesh-list
138453821|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138453822|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453823|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453824|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138453825|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453826|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453827|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453828|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138453830|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453831|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138453832|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453833|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453834|NCT01887613|Gabapentin|gabapentin|mesh-list
138453835|NCT01887613|Analgesics|analgesics|mesh-ancestor
138453836|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
138453837|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453838|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165174|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
138165175|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138165176|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165178|NCT03596060|Fentanyl|fentanyl|mesh-list
138453839|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
138453840|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138453841|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138453842|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453843|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138453844|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138453845|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138453846|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453847|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453848|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
138453850|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138453851|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138453852|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138453853|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138453854|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
138453855|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453856|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453857|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453858|NCT01887691|Eszopiclone|eszopiclone|mesh-list
138453859|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138453860|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453861|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453862|NCT01887704|Aspirin|aspirin|mesh-list
138453863|NCT01887704|Sirolimus|sirolimus|mesh-list
138453864|NCT01887704|Paclitaxel|paclitaxel|mesh-list
138453865|NCT01887704|Everolimus|everolimus|mesh-list
138453866|NCT01887704|Clopidogrel|clopidogrel|mesh-list
138453867|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138453868|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453869|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
138453870|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138453871|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138453872|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453873|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138453874|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453875|NCT01887704|Analgesics|analgesics|mesh-ancestor
138453876|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
138453877|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453878|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453879|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453880|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453881|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138453882|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138453883|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138165195|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138165196|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138165197|NCT00473837|Chloroquine|chloroquine|mesh-list
138453884|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138453885|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453886|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
138453887|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138453888|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138453889|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453890|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
138453891|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138453892|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138355035|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
138453894|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
138412830|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
138453895|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453896|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453897|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453898|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138453899|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
138453900|NCT01887743|Pantoprazole|pantoprazole|mesh-list
138453901|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138453902|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453903|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138453904|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453905|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453906|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138453907|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453908|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138453909|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453910|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165223|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
138453911|NCT01887821|Chloroquine|chloroquine|mesh-list
138453912|NCT01887821|Piperaquine|piperaquine|mesh-list
138453913|NCT01887821|Artenimol|artenimol|mesh-list
138453914|NCT01887821|Amebicides|amebicides|mesh-ancestor
138453916|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138453917|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453918|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
138453919|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453920|NCT01887847|Nicotine|nicotine|mesh-list
138453921|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138453922|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
138453923|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453924|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453925|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138453926|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138453927|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
138453928|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453929|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453930|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
138453931|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138453932|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
138453933|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453934|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
138453935|NCT01887873|Protective Agents|protective agents|mesh-ancestor
138453936|NCT01887951|Tramadol|tramadol|mesh-list
138453937|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138453938|NCT01887951|Narcotics|narcotics|mesh-ancestor
138453939|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453940|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453941|NCT01887951|Analgesics|analgesics|mesh-ancestor
138165268|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138453942|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
138453943|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453945|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138453946|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138453947|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453948|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453949|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453950|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
138453951|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453952|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453953|NCT01888107|Risperidone|risperidone|mesh-list
138453954|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138453955|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
138453956|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453957|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453958|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453959|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138453960|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138355048|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
138453961|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453962|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138453963|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138453964|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
138453966|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138453967|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453968|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453969|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453970|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453971|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138453972|NCT01888120|Protective Agents|protective agents|mesh-ancestor
138453973|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453975|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
138453976|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453977|NCT01888224|Isotretinoin|isotretinoin|mesh-list
138453978|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453979|NCT01888250|Lamotrigine|lamotrigine|mesh-list
138453980|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
138453981|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138453982|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453983|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453984|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453985|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453986|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138453987|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138453988|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453989|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138453990|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138453991|NCT01888263|Lamotrigine|lamotrigine|mesh-list
138453992|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
138453993|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138453994|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453995|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453996|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453997|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453998|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138453999|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454000|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454001|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165314|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454003|NCT01888289|Isotretinoin|isotretinoin|mesh-list
138454004|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454006|NCT01888302|Cisplatin|cisplatin|mesh-list
138454007|NCT01888302|Gemcitabine|gemcitabine|mesh-list
138355056|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355057|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355058|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355059|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138355060|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138355061|NCT00002178|Ritonavir|ritonavir|mesh-list
138355063|NCT00002178|Saquinavir|saquinavir|mesh-list
138355064|NCT00002178|Delavirdine|delavirdine|mesh-list
138454008|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454009|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454010|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
138454011|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454012|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454013|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454014|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138454015|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
138454016|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454017|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
138454018|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454019|NCT01888328|Isotretinoin|isotretinoin|mesh-list
138454020|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454021|NCT01888341|Isotretinoin|isotretinoin|mesh-list
138454022|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454023|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138454024|NCT01888354|Hormones|hormones|mesh-ancestor
138454025|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454026|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454027|NCT01888393|Ivacaftor|ivacaftor|mesh-list
138454028|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138454029|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454030|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454031|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
138165327|NCT04198844|Apixaban|apixaban|mesh-list
138165328|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
138454033|NCT01888458|Micafungin|micafungin|mesh-list
138454034|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
138454035|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454037|NCT01888536|Alprostadil|alprostadil|mesh-list
138454038|NCT01888536|Analgesics|analgesics|mesh-ancestor
138454039|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
138454040|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454041|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454042|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
138454043|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138454044|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454045|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454046|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454048|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454049|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454050|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454051|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138454052|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
138454053|NCT01888536|Urological Agents|urological agents|mesh-ancestor
138454055|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454056|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138454057|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454058|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454059|NCT01888575|Aspirin|aspirin|mesh-list
138355066|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355067|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355068|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355069|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355070|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355071|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355072|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
138355073|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454060|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138454061|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454062|NCT01888575|Analgesics|analgesics|mesh-ancestor
138454063|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
138454064|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454065|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454066|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138454067|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454069|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138454070|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454071|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138454072|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138454073|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454075|NCT01888718|Fexofenadine|fexofenadine|mesh-list
138454076|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138454077|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138454078|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138454079|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
138454080|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
138454081|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454082|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454083|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454084|NCT01888731|Lamotrigine|lamotrigine|mesh-list
138454085|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
138454086|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138454087|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454088|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454089|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454090|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454092|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454093|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454094|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454095|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138454096|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138454097|NCT01888744|Cetrorelix|cetrorelix|mesh-list
138454099|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138454100|NCT01888744|Ganirelix|ganirelix|mesh-list
138165415|NCT06068686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165416|NCT06068686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165417|NCT06068621|Cytarabine|cytarabine|mesh-list
138165418|NCT06068621|Azacitidine|azacitidine|mesh-list
138454101|NCT01888744|Progestins|progestins|mesh-ancestor
138454102|NCT01888744|Hormones|hormones|mesh-ancestor
138454103|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454104|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454105|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138454106|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138454107|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
138454110|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
138454111|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138454112|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454113|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454114|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454115|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454116|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138454117|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138413070|NCT01637558|Ritonavir|ritonavir|mesh-list
138454118|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454119|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454120|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138454121|NCT01888796|Linagliptin|linagliptin|mesh-list
138355074|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355075|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355078|NCT00002184|Lamivudine|lamivudine|mesh-list
138454122|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454123|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454124|NCT01888796|Incretins|incretins|mesh-ancestor
138454125|NCT01888796|Hormones|hormones|mesh-ancestor
138454126|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454127|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138454128|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454129|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454130|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454131|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
138454132|NCT01888822|Ampicillin|ampicillin|mesh-list
138454133|NCT01888822|Sulbactam|sulbactam|mesh-list
138454134|NCT01888822|Sultamicillin|sultamicillin|mesh-list
138454135|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165456|NCT06068439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138454138|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138454139|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454140|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454141|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454142|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138454143|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454144|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138454146|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
138454147|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454148|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138454149|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
138454151|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454152|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454153|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454154|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138454155|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454156|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454157|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138454158|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138454159|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138454160|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454161|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138454162|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138454163|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
138454164|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138454166|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
138165497|NCT06068023|Vitamins|vitamins|mesh-ancestor
138165498|NCT06068023|Micronutrients|micronutrients|mesh-ancestor
138454168|NCT01888861|Protective Agents|protective agents|mesh-ancestor
138454169|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454170|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
138454171|NCT01888861|Vitamins|vitamins|mesh-ancestor
138454172|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
138454173|NCT01888978|Leucovorin|leucovorin|mesh-list
138454174|NCT01888978|Gemcitabine|gemcitabine|mesh-list
138454175|NCT01888978|Fluorouracil|fluorouracil|mesh-list
138454177|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
138454178|NCT01888978|Irinotecan|irinotecan|mesh-list
138454179|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
138454180|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454181|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
138454182|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454183|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454184|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
138454185|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
138454186|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
138454187|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454188|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
138454189|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355084|NCT00002184|Saquinavir|saquinavir|mesh-list
138454190|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138454191|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138454192|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355085|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454193|NCT01888978|Antidotes|antidotes|mesh-ancestor
138454194|NCT01888978|Protective Agents|protective agents|mesh-ancestor
138454195|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
138454196|NCT01888978|Vitamins|vitamins|mesh-ancestor
138454197|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
138454198|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
138454199|NCT01889004|Propofol|propofol|mesh-list
138454200|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138454201|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454202|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454203|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454204|NCT01889004|Analgesics|analgesics|mesh-ancestor
138165539|NCT06055491|Cholecalciferol|cholecalciferol|mesh-list
138454205|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
138454206|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165540|NCT06055491|Vitamins|vitamins|mesh-ancestor
138454209|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138454210|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454211|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454212|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454213|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138454214|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
138454215|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
138454217|NCT01889056|Hematinics|hematinics|mesh-ancestor
138454218|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138454219|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454220|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454221|NCT01889134|Alendronate|alendronate|mesh-list
138454222|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138454223|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454224|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
138454225|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138454226|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
138454227|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454228|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138454229|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454230|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138454231|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454232|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454233|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454234|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138454235|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454236|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138454237|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454238|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454239|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
138165577|NCT05890352|Growth Substances|growth substances|mesh-ancestor
138454241|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454242|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
138454243|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454244|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
138454245|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138454246|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454247|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
138454248|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454249|NCT01889368|Protective Agents|protective agents|mesh-ancestor
138454250|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454252|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355100|NCT00002190|Zidovudine|zidovudine|mesh-list
138454253|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454254|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138454255|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138304209|NCT02047734|Interferons|interferons|mesh-list
138454256|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454257|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454258|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138454259|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
138454260|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454261|NCT01889446|Calcium|calcium|mesh-list
138454262|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454263|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454264|NCT01889498|Acetazolamide|acetazolamide|mesh-list
138454265|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
138413212|NCT01638182|Coagulants|coagulants|mesh-ancestor
138454266|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138454267|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454268|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454269|NCT01889498|Diuretics|diuretics|mesh-ancestor
138454270|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
138454271|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454272|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
138454273|NCT01889576|Antacids|antacids|mesh-ancestor
138454274|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454275|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454276|NCT01889680|Leucovorin|leucovorin|mesh-list
138454277|NCT01889680|Fluorouracil|fluorouracil|mesh-list
138454278|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
138454279|NCT01889680|Aflibercept|aflibercept|mesh-list
138454280|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
138454281|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
138165617|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454282|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454283|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454285|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454287|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454289|NCT01889680|Protective Agents|protective agents|mesh-ancestor
138454290|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
138304257|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138454293|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138454294|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138454295|NCT01889680|Growth Substances|growth substances|mesh-ancestor
138454296|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
138454297|NCT01889758|Tacrolimus|tacrolimus|mesh-list
138165656|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138165657|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138165658|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138165659|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165660|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165661|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165662|NCT05659459|Pioglitazone|pioglitazone|mesh-list
138165663|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454298|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454299|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
138454300|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454301|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138454302|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454303|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454305|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138454307|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454308|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454309|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138454310|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138454311|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
138454312|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138355107|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355108|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138454314|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138355109|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138454315|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138304292|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138454316|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
138454317|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454318|NCT01889914|Insulin|insulin|mesh-list
138454319|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138454320|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454321|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454322|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
138454323|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
138454324|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138454325|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138454326|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454327|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454328|NCT01889966|Urological Agents|urological agents|mesh-ancestor
138454330|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138454331|NCT01889979|Narcotics|narcotics|mesh-ancestor
138304338|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454332|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454333|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454334|NCT01889979|Analgesics|analgesics|mesh-ancestor
138454335|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
138454336|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454337|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
138454338|NCT01890538|Piracetam|piracetam|mesh-list
138454339|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
138413289|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
138454340|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
138454341|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454342|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454343|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454344|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138454345|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
138454346|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
138304432|NCT01963728|Insulin|insulin|mesh-list
138454347|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454348|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454349|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138454350|NCT01890538|Protective Agents|protective agents|mesh-ancestor
138454351|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
138454353|NCT01891292|Enalapril|enalapril|mesh-list
138454354|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138454355|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
138454356|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454358|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
138454359|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138454361|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454362|NCT01891292|Protective Agents|protective agents|mesh-ancestor
138454363|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454364|NCT01891292|Antidotes|antidotes|mesh-ancestor
138454365|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138454366|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454367|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454368|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454369|NCT01891487|Bimatoprost|bimatoprost|mesh-list
138454370|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454371|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
138454372|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138454373|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454375|NCT01893229|Valproic Acid|valproic acid|mesh-list
138454376|NCT01893229|Olanzapine|olanzapine|mesh-list
138454377|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138454378|NCT01893229|Ziprasidone|ziprasidone|mesh-list
138454379|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
138454380|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
138454381|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
138454382|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454383|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454384|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138355117|NCT00002202|Amprenavir|amprenavir|mesh-list
138454385|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138454386|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454387|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454388|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454390|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138454391|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454392|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454393|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454395|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
138454396|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454397|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
138454399|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
138454400|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138454401|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138454402|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
138454403|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138454404|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138454405|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138454406|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138454408|NCT01894269|Entecavir|entecavir|mesh-list
138454409|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454410|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138454411|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454412|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454413|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
138454414|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454415|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138454416|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138454417|NCT01894789|Clopidogrel|clopidogrel|mesh-list
138454418|NCT01894789|Ticagrelor|ticagrelor|mesh-list
138454419|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138454420|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138355125|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
138355126|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454421|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138454423|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
138454424|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454425|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454426|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454427|NCT01894815|Dexetimide|dexetimide|mesh-list
138454428|NCT01894815|Citalopram|citalopram|mesh-list
138454429|NCT01894815|Escitalopram|escitalopram|mesh-list
138454430|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138454431|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138454433|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454434|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454436|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454437|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138454438|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138454439|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
138454440|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
138454441|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454442|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138454443|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138454444|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138454445|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138454446|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
138454447|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454448|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
138454449|NCT01895049|Prednisone|prednisone|mesh-list
138454450|NCT01895049|Everolimus|everolimus|mesh-list
138454451|NCT01895049|Tacrolimus|tacrolimus|mesh-list
138454452|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
138454453|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138454454|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138454455|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
138454456|NCT01895049|Hormones|hormones|mesh-ancestor
138454457|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454459|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138454460|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454461|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454462|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
138454463|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138454464|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454465|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454466|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138454467|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138454468|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138454469|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138454470|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
138454471|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454474|NCT01896622|Cobicistat|cobicistat|mesh-list
138454479|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454481|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138454489|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138454490|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454492|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304715|NCT01934556|Ranibizumab|ranibizumab|mesh-list
138454493|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454494|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138454495|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454496|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
138454497|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454498|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454499|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454500|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
138355168|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138454501|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
138454502|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138454503|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138454504|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454505|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454506|NCT01897740|Urological Agents|urological agents|mesh-ancestor
138454508|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454509|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454511|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454512|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138454513|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138454514|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454515|NCT01898221|Ethanol|ethanol|mesh-list
138454516|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138454517|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454518|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454519|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454520|NCT01898338|Daptomycin|daptomycin|mesh-list
138454521|NCT01898338|Fosfomycin|fosfomycin|mesh-list
138454522|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454523|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454525|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138454526|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454527|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454529|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
138454530|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454531|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138454533|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454534|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
138454535|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454536|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138454537|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454538|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138454539|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138454540|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138304805|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138454541|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138454542|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138454545|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138454546|NCT01900028|Itraconazole|itraconazole|mesh-list
138454547|NCT01900028|Olaparib|olaparib|mesh-list
138454548|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138454549|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454550|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454551|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355180|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454552|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
138454553|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454554|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138454555|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454556|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138454557|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
138454558|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454559|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454560|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138454561|NCT01900041|Minoxidil|minoxidil|mesh-list
138454562|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454563|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
138304862|NCT03888755|Analgesics|analgesics|mesh-ancestor
138454564|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138454565|NCT01900093|Hormones|hormones|mesh-ancestor
138454566|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454567|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454568|NCT01900106|Ritonavir|ritonavir|mesh-list
138454570|NCT01900106|Lamivudine|lamivudine|mesh-list
138454571|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
138454572|NCT01900106|Abacavir|abacavir|mesh-list
138454573|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
138454575|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138454576|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454577|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454578|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454579|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138454580|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138454581|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
138454582|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454583|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138454584|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454585|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454586|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138454587|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138454588|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138454589|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
138454590|NCT01900158|Cisplatin|cisplatin|mesh-list
138454591|NCT01900158|Gemcitabine|gemcitabine|mesh-list
138454592|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454593|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454594|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
138454595|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454596|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138454597|NCT01900197|Hematinics|hematinics|mesh-ancestor
138454598|NCT01900301|Scopolamine|scopolamine|mesh-list
138454599|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138454600|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138454601|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
138454603|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454604|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454605|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454607|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138454608|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
138454609|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454610|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454611|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138454612|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
138454615|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
138454616|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454617|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454618|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
138454619|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138454620|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454621|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454622|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454623|NCT01900405|Analgesics|analgesics|mesh-ancestor
138454624|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
138454625|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454626|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138454627|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138454628|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138454629|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454630|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454631|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454634|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138454635|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454636|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
138454637|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454638|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454639|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
138454640|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
138454641|NCT01900509|Dexamethasone|dexamethasone|mesh-list
138454642|NCT01900509|Etoposide|etoposide|mesh-list
138454643|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
138454644|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138454645|NCT01900509|Clofarabine|clofarabine|mesh-list
138454646|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138454647|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
138454648|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
138454649|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454650|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454651|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305005|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454652|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
138454654|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454655|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138454656|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454657|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138454658|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138454659|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138454660|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454661|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454662|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138454663|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
138454665|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
138454667|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138454668|NCT01900587|Narcotics|narcotics|mesh-ancestor
138454669|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454670|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454671|NCT01900587|Analgesics|analgesics|mesh-ancestor
138454672|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
138454673|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454674|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138454675|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138454676|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454677|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454679|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454680|NCT01900639|Aspirin|aspirin|mesh-list
138454681|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138355218|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454682|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454683|NCT01900639|Analgesics|analgesics|mesh-ancestor
138454684|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
138454685|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454686|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454689|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138454690|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138454691|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454692|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138454693|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138454694|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454695|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
138454697|NCT01900717|Bevacizumab|bevacizumab|mesh-list
138454698|NCT01900717|Fluorouracil|fluorouracil|mesh-list
138454699|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
138454700|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138454701|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454702|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138454703|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138454704|NCT01900717|Growth Substances|growth substances|mesh-ancestor
138454705|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454706|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
138454707|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
138305087|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454708|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454709|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454710|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454711|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
138454712|NCT01900717|Antidotes|antidotes|mesh-ancestor
138454713|NCT01900717|Protective Agents|protective agents|mesh-ancestor
138454714|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
138454716|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
138454717|NCT01900795|Ibuprofen|ibuprofen|mesh-list
138454718|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138454719|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454720|NCT01900795|Analgesics|analgesics|mesh-ancestor
138454721|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
138454722|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454723|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454724|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138454725|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454726|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138454728|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454730|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
138454731|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
138454732|NCT01900860|Vitamins|vitamins|mesh-list
138454733|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
138454734|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355232|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
138355233|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454735|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138454736|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454739|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
138454740|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454741|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
138454742|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454743|NCT01900938|Midazolam|midazolam|mesh-list
138454744|NCT01900938|Propofol|propofol|mesh-list
138454745|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138454746|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454747|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454748|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138454749|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
138454750|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
138454753|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454754|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454756|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
138454757|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454758|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454759|NCT01900951|Temozolomide|temozolomide|mesh-list
138454760|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138454761|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
138454762|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454763|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454764|NCT01901003|Lorazepam|lorazepam|mesh-list
138454765|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
138454766|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
138454767|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
138454768|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454769|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454770|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454771|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138454772|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454773|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138454775|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138454776|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
138454778|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454779|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454780|NCT01901120|Mirabegron|mirabegron|mesh-list
138454781|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138454782|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138454783|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138454784|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454786|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454787|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454789|NCT01901172|Posaconazole|posaconazole|mesh-list
138454790|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
138454791|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454792|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138454793|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138454794|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138454795|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138454796|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454798|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454799|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138454800|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138305219|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138454802|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454803|NCT01901198|Interferons|interferons|mesh-list
138454804|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
138454805|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
138454806|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454807|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
138454808|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454809|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
138355258|NCT00002304|Ketoconazole|ketoconazole|mesh-list
138355259|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
138355263|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454810|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454812|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138454813|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138454814|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138454815|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454816|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454817|NCT01901380|Caseins|caseins|mesh-list
138454818|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
138454819|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
138454820|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454821|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138454822|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138454825|NCT01901471|Cyclosporine|cyclosporine|mesh-list
138454826|NCT01901471|Cyclosporins|cyclosporins|mesh-list
138454827|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454828|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454829|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454830|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
138454831|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454833|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454834|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454835|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454836|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138454837|NCT01901484|Praziquantel|praziquantel|mesh-list
138454838|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
138454839|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138454840|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454842|NCT01901549|Lisinopril|lisinopril|mesh-list
138454843|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138454844|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454845|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
138454846|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
138454847|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454848|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454849|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138454850|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138454852|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454853|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454854|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454855|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138454857|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454859|NCT01901549|Protective Agents|protective agents|mesh-ancestor
138454860|NCT01901601|Anesthetics|anesthetics|mesh-list
138454861|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454862|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454863|NCT01901640|Udenafil|udenafil|mesh-list
138289213|NCT03679975|Riluzole|riluzole|mesh-list
138454864|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138454865|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138454866|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454867|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413824|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
138454869|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454870|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454872|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454874|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454875|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454876|NCT01902017|Ketotifen|ketotifen|mesh-list
138454877|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
138454878|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
138355266|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
138454879|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138454880|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
138454881|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
138454882|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454883|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454884|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454885|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138454886|NCT01902108|Clonidine|clonidine|mesh-list
138454887|NCT01902108|Bupivacaine|bupivacaine|mesh-list
138454888|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
138454889|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
138454890|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454891|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289406|NCT00001676|Fludarabine|fludarabine|mesh-list
138454892|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
138305357|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138454893|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454894|NCT01902108|Analgesics|analgesics|mesh-ancestor
138454895|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138454896|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
138454897|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
138454898|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138454899|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138454900|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138454901|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
138454902|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454903|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454905|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138454906|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454907|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454911|NCT01902160|Temsirolimus|temsirolimus|mesh-list
138454912|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
138454913|NCT01902160|Antibodies|antibodies|mesh-list
138289535|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454918|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454919|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454920|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454921|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454922|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138454923|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
138454924|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454925|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138454926|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454927|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454928|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
138454929|NCT01902186|Ritonavir|ritonavir|mesh-list
138454931|NCT01902186|Tenofovir|tenofovir|mesh-list
138454932|NCT01902186|Emtricitabine|emtricitabine|mesh-list
138454933|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
138454934|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138454935|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138454936|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454937|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454938|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454940|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138188490|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138454942|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454943|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138454944|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454945|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138454946|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138454947|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138454948|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138355280|NCT00002322|Zidovudine|zidovudine|mesh-list
138454949|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138454950|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138454951|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454952|NCT01901861|Incretins|incretins|mesh-ancestor
138454953|NCT01901861|Hormones|hormones|mesh-ancestor
138454954|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454955|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138454956|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454957|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454958|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454960|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138454961|NCT01902225|Romidepsin|romidepsin|mesh-list
138454962|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138454963|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454964|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138454965|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138454966|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454967|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454968|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138454969|NCT01902238|Ethanol|ethanol|mesh-list
138454970|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
138454972|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454973|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454974|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454975|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454976|NCT01902342|Oseltamivir|oseltamivir|mesh-list
138454977|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
138289798|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454980|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454981|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
138454982|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138454983|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138454984|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454986|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454988|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138454990|NCT01902498|Aspirin|aspirin|mesh-list
138454991|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138454992|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138454993|NCT01902498|Analgesics|analgesics|mesh-ancestor
138454994|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
138454995|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454996|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454997|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138454998|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454999|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138455001|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455002|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138455003|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138455004|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455005|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
138305679|NCT01645709|Verapamil|verapamil|mesh-list
138455007|NCT01902511|Lenograstim|lenograstim|mesh-list
138455009|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
138455010|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455012|NCT01902524|Fentanyl|fentanyl|mesh-list
138455013|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138455014|NCT01902524|Narcotics|narcotics|mesh-ancestor
138455015|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455016|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455017|NCT01902524|Analgesics|analgesics|mesh-ancestor
138455018|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
138355287|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
138355288|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355289|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138455019|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455020|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138455021|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138455022|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
138455025|NCT01902537|Laxatives|laxatives|mesh-ancestor
138455026|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455027|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138455028|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138455030|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455031|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455034|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138455035|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138455036|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
138455037|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
138455038|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455039|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455040|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138455041|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138455042|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138455043|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138455044|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455045|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455047|NCT01902641|Succinylcholine|succinylcholine|mesh-list
138455048|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138455049|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138455050|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138455057|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455058|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138455059|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455060|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
138455062|NCT01902810|Metoprolol|metoprolol|mesh-list
138455063|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138455064|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138455065|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
138455066|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455067|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455068|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455069|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138455070|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138455071|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
138455072|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
138455073|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
138290191|NCT04085341|Growth Substances|growth substances|mesh-ancestor
138455074|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455075|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138455077|NCT01902862|Bortezomib|bortezomib|mesh-list
138455078|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138455079|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455080|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
138455081|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455082|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455084|NCT01902875|Cisplatin|cisplatin|mesh-list
138305884|NCT00500045|Niacin|niacin|mesh-list
138305886|NCT00500045|Niacinamide|niacinamide|mesh-list
138455085|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138455086|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455087|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455088|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455089|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455090|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455091|NCT01903018|Cisplatin|cisplatin|mesh-list
138455092|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455093|NCT01903057|Azithromycin|azithromycin|mesh-list
138455094|NCT01903057|Ivermectin|ivermectin|mesh-list
138355303|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355304|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138455095|NCT01903057|Albendazole|albendazole|mesh-list
138455096|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455098|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138455099|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
138455100|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
138455101|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138455102|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138455103|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455104|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455105|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455106|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455107|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455108|NCT01903070|Linagliptin|linagliptin|mesh-list
138455110|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455111|NCT01903070|Incretins|incretins|mesh-ancestor
138455112|NCT01903070|Hormones|hormones|mesh-ancestor
138455113|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138455115|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138455116|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455117|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455119|NCT01903083|Tadalafil|tadalafil|mesh-list
138455120|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455121|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
138455122|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455123|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455124|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290297|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
138455125|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138455126|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138455127|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455128|NCT01903083|Urological Agents|urological agents|mesh-ancestor
138455129|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
138455130|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138455132|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138455133|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
138455134|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455135|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455136|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138455137|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138455138|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455139|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455140|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455141|NCT01903122|Cevimeline|cevimeline|mesh-list
138455142|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138455143|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
138455144|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455146|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138455147|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138455148|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455149|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455150|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455151|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138455152|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
138455153|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138455154|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138455155|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138455156|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455157|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455158|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138355313|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455159|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
138455160|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455161|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138455162|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
138455163|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455164|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
138455165|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455167|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
138455168|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455169|NCT01903681|Protective Agents|protective agents|mesh-ancestor
138455170|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455171|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455172|NCT01903694|Sorafenib|sorafenib|mesh-list
138455173|NCT01903694|Pravastatin|pravastatin|mesh-list
138455176|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455177|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455178|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138455179|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138455180|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
138455181|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138290627|NCT00002144|Foscarnet|foscarnet|mesh-list
138455182|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138455184|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138455185|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
138455186|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455187|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455188|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138455189|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
138290681|NCT00000590|Antibodies|antibodies|mesh-list
138455191|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138455192|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138290743|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
138455193|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138455194|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138455195|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138455196|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455197|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455199|NCT01903824|Donepezil|donepezil|mesh-list
138455200|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138455201|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306157|NCT04941833|Progestins|progestins|mesh-ancestor
138455202|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455203|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455204|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455205|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455206|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
138455207|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138455208|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138455209|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138455210|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138455211|NCT01904045|Tacrolimus|tacrolimus|mesh-list
138455212|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455213|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
138455214|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455215|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138455216|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455217|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455219|NCT01904097|Analgesics|analgesics|mesh-ancestor
138455220|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
138455221|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455222|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455223|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
138455224|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138455225|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138355329|NCT00002352|Lobucavir|lobucavir|mesh-list
138455226|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455227|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455228|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138455229|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138455230|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455231|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138455232|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
138455234|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
138455235|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
138455236|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455237|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455238|NCT01904110|Vitamins|vitamins|mesh-ancestor
138455239|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
138290870|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455240|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138455241|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138455243|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455244|NCT01904162|Finafloxacin|finafloxacin|mesh-list
138455245|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138455246|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455247|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455248|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138455249|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455250|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455251|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455252|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455254|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138455255|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455256|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138290920|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138455257|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
138455258|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455259|NCT01904253|Topotecan|topotecan|mesh-list
138455260|NCT01904253|Amrubicin|amrubicin|mesh-list
138455264|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455265|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306249|NCT00000161|Protective Agents|protective agents|mesh-ancestor
138455267|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455268|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455269|NCT01904487|Tiagabine|tiagabine|mesh-list
138455270|NCT01904487|Flumazenil|flumazenil|mesh-list
138455271|NCT01904487|Antidotes|antidotes|mesh-ancestor
138455272|NCT01904487|Protective Agents|protective agents|mesh-ancestor
138455273|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455274|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
138455275|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
138455276|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455277|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455278|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
138455279|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138455280|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138455281|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455282|NCT01904500|Cefazolin|cefazolin|mesh-list
138455283|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455284|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455285|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138455287|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455288|NCT01904591|Vitamin E|vitamin e|mesh-list
138455289|NCT01904591|Selenium|selenium|mesh-list
138455290|NCT01904591|Vitamins|vitamins|mesh-ancestor
138455291|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
138455292|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215504|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355339|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355342|NCT00002364|Abacavir|abacavir|mesh-list
138455294|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455295|NCT01904591|Protective Agents|protective agents|mesh-ancestor
138455297|NCT01904643|Cytarabine|cytarabine|mesh-list
138455298|NCT01904643|Etoposide|etoposide|mesh-list
138455299|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
138455300|NCT01904643|Lenalidomide|lenalidomide|mesh-list
138455301|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
138455302|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138455303|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455304|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138455305|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455306|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455307|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455308|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455310|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
138455311|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455312|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455313|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
138455316|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138455317|NCT01904643|Growth Substances|growth substances|mesh-ancestor
138455318|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455320|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
138455321|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455322|NCT01904682|ON 01910|on 01910|mesh-list
138455323|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455324|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455326|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455327|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
138455328|NCT01904695|Diuretics|diuretics|mesh-list
138455329|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138455330|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138455331|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
138455332|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455333|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
138455334|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455335|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455336|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455338|NCT01904734|Enclomiphene|enclomiphene|mesh-list
138455339|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
138455340|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138455341|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
138455342|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138455343|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455344|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138455347|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138455348|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138455350|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455351|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455352|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455353|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455355|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
138455356|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455357|NCT01904786|Protective Agents|protective agents|mesh-ancestor
138455358|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455359|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455360|NCT01904981|Atenolol|atenolol|mesh-list
138455361|NCT01904981|Valsartan|valsartan|mesh-list
138455362|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138291259|NCT00002354|Stavudine|stavudine|mesh-list
138455363|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138455364|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138355349|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355350|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138455365|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138455367|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138455368|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
138455369|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455370|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455371|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138455374|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455375|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138455376|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138291393|NCT00002372|Indinavir|indinavir|mesh-list
138455377|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
138455378|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455382|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138455383|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
138455384|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138455385|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138455386|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455387|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455388|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
138455389|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455390|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138455391|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138455392|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138455393|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138414348|NCT01652820|Docetaxel|docetaxel|mesh-list
138455394|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138455395|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
138455396|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138455397|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138455398|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138455400|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455401|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455402|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455403|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291588|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138455404|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138455405|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455407|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
138455408|NCT01905150|Gemcitabine|gemcitabine|mesh-list
138455409|NCT01905150|Fluorouracil|fluorouracil|mesh-list
138455410|NCT01905150|Docetaxel|docetaxel|mesh-list
138455411|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
138455412|NCT01905150|Irinotecan|irinotecan|mesh-list
138455414|NCT01905150|Mitomycin|mitomycin|mesh-list
138455415|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
138455416|NCT01905150|Vitamins|vitamins|mesh-ancestor
138455417|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
138455418|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455419|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455420|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
138455421|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455422|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455423|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
138291723|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
138455424|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455425|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455426|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455427|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
138455428|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138455429|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455430|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455431|NCT01905150|Antidotes|antidotes|mesh-ancestor
138455432|NCT01905150|Protective Agents|protective agents|mesh-ancestor
138455433|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
138455434|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
138291788|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455435|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138455436|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
138455437|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138455438|NCT01905215|Vaccines|vaccines|mesh-list
138455439|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
138355363|NCT00002376|Lamivudine|lamivudine|mesh-list
138455440|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455441|NCT01905371|Amphetamine|amphetamine|mesh-list
138455442|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
138455443|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138455444|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455445|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
138455446|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
138455447|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455448|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
138455449|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455450|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455451|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138455452|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138455453|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138455454|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455455|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138455457|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455458|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455459|NCT01905566|Clopidogrel|clopidogrel|mesh-list
138455460|NCT01905566|Ticagrelor|ticagrelor|mesh-list
138455461|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138455462|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138455463|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138455465|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
138455466|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455467|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455468|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455469|NCT01905618|Nicotine|nicotine|mesh-list
138455470|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138455471|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
138455472|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455473|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455474|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138455475|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138455476|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455477|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455478|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455479|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
138291973|NCT00002552|Leucovorin|leucovorin|mesh-list
138455480|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138455481|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
138455482|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455483|NCT01905696|Expectorants|expectorants|mesh-ancestor
138455484|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
138455485|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138455486|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
138455487|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455488|NCT01905696|Protective Agents|protective agents|mesh-ancestor
138455489|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455492|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138455493|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
138455494|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
138455495|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455497|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138455498|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138455499|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
138455500|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
138455502|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455503|NCT01906073|Fentanyl|fentanyl|mesh-list
138455504|NCT01906073|Morphine|morphine|mesh-list
138455505|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138455506|NCT01906073|Narcotics|narcotics|mesh-ancestor
138355364|NCT00002376|Zidovudine|zidovudine|mesh-list
138355365|NCT00002376|Didanosine|didanosine|mesh-list
138455507|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455508|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455509|NCT01906073|Analgesics|analgesics|mesh-ancestor
138455510|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
138455512|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138455513|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138455514|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
138455515|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
138455516|NCT01906125|Palbociclib|palbociclib|mesh-list
138455517|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455518|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455519|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292152|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138455520|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455521|NCT01906216|Sorafenib|sorafenib|mesh-list
138455522|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455523|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455524|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455525|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455526|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
138455527|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138455528|NCT01906242|Eusol|eusol|mesh-list
138455529|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138455530|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455531|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
138455532|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138455533|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455534|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
138455535|NCT01906307|Giapreza|giapreza|mesh-list
138292227|NCT00002618|Vitamins|vitamins|mesh-ancestor
138455536|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138455537|NCT01906411|Dopamine|dopamine|mesh-list
138455538|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138455539|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
138455540|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
138455541|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455542|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455543|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
138455544|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414499|NCT01653639|Factor VIII|factor viii|mesh-list
138455546|NCT01906411|Protective Agents|protective agents|mesh-ancestor
138455548|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138292288|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138455549|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455551|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138455552|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138455553|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138455554|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455555|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455556|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138455557|NCT01906580|Entecavir|entecavir|mesh-list
138455558|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
138455559|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455560|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
138455561|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
138455562|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455563|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
138455564|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
138455565|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455566|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455567|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455568|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455569|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
138455570|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455571|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138455572|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455573|NCT01906749|Colchicine|colchicine|mesh-list
138455574|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
138455575|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455576|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455577|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455578|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455579|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455580|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455583|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138455584|NCT01906762|Narcotics|narcotics|mesh-ancestor
138455585|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455586|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455588|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
138455589|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455590|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138455592|NCT01906788|Lumefantrine|lumefantrine|mesh-list
138455593|NCT01906788|Artemether|artemether|mesh-list
138455594|NCT01906788|Primaquine|primaquine|mesh-list
138455595|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138455596|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
138455597|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138455598|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138455599|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455601|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455602|NCT01906879|Bismuth|bismuth|mesh-list
138455603|NCT01906879|Antacids|antacids|mesh-ancestor
138455604|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455605|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455606|NCT01906944|Triamcinolone|triamcinolone|mesh-list
138455607|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138455608|NCT01906944|Bupivacaine|bupivacaine|mesh-list
138455609|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
138455610|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
138455612|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455613|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
138455614|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455615|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455616|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
138455618|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138455619|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455620|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
138455621|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
138455622|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138455623|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
138455624|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138455625|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
138292583|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
138455626|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455627|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455628|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
138455629|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
138455630|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138455631|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
138455632|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455633|NCT01907061|Expectorants|expectorants|mesh-ancestor
138455634|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
138455637|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455639|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455640|NCT01907061|Antidotes|antidotes|mesh-ancestor
138355390|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355391|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138455644|NCT01907165|Temozolomide|temozolomide|mesh-list
138455645|NCT01907165|Disulfiram|disulfiram|mesh-list
138455646|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138455647|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
138455648|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455649|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455652|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455653|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138455654|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138455655|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455657|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138455658|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138455660|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
138455661|NCT01907204|Budesonide|budesonide|mesh-list
138455662|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138455663|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
138455664|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455665|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
138455666|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
138455667|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455668|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455669|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455670|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
138455673|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138455674|NCT01907204|Protective Agents|protective agents|mesh-ancestor
138455675|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138455676|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455677|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138455678|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138455679|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138455680|NCT01907230|Entecavir|entecavir|mesh-list
138455681|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
138455682|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455683|NCT01907308|Docetaxel|docetaxel|mesh-list
138455684|NCT01907308|Trebananib|trebananib|mesh-list
138455685|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355403|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355404|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355405|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355406|NCT00002400|Lamivudine|lamivudine|mesh-list
138355407|NCT00002400|Zidovudine|zidovudine|mesh-list
138355408|NCT00002400|Delavirdine|delavirdine|mesh-list
138355409|NCT00002400|Indinavir|indinavir|mesh-list
138355410|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355411|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355412|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455686|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455687|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455688|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455689|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455690|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138455691|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138455692|NCT01907308|Growth Substances|growth substances|mesh-ancestor
138455693|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455694|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455696|NCT01907373|Olmesartan|olmesartan|mesh-list
138455697|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138455698|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138455699|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138455700|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138455701|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455702|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
138292969|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
138455703|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
138455704|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455705|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
138455708|NCT01907529|Endostar protein|endostar protein|mesh-list
138455709|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455710|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
138455711|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455712|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455713|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138455714|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
138455715|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455716|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455717|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138455718|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455719|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455720|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455721|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138455722|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138455723|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455724|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455725|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138455726|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138455727|NCT01907529|Growth Substances|growth substances|mesh-ancestor
138455728|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455731|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138455733|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455734|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455735|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138455736|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138455737|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455738|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455739|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455740|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138455741|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306884|NCT00000623|Decitabine|decitabine|mesh-list
138455742|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138455743|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
138455744|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455745|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
138455746|NCT01907633|Domperidone|domperidone|mesh-list
138455748|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
138455749|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455750|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455751|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138355414|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
138455752|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138455753|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
138455754|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455755|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455757|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455758|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
138455759|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455760|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455761|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455762|NCT01907724|Simeprevir|simeprevir|mesh-list
138455763|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
138455764|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455765|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
138455766|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455767|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455768|NCT01907776|Arbekacin|arbekacin|mesh-list
138455769|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138455770|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455771|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455773|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455774|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455775|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455776|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455777|NCT01907867|Finafloxacin|finafloxacin|mesh-list
138455778|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138455779|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455780|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455781|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138455782|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455783|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455784|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455785|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455786|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
138455787|NCT01907880|Pamidronate|pamidronate|mesh-list
138455788|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138455789|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455790|NCT01907984|Diclofenac|diclofenac|mesh-list
138455792|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138455793|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138455794|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455795|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293357|NCT00801931|Melphalan|melphalan|mesh-list
138455796|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138455797|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138455798|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138455799|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138455800|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
138455801|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
138455802|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
138455803|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
138455805|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455806|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138455807|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138455808|NCT01907984|Analgesics|analgesics|mesh-ancestor
138455809|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
138455810|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455811|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455812|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455813|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138293383|NCT00780481|Kininogens|kininogens|mesh-list
138455814|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455815|NCT01907997|Lidocaine|lidocaine|mesh-list
138455816|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
138455817|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
138455818|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215505|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455819|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455820|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
138455821|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455822|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138307038|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455823|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138455824|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138455825|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455826|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455827|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138455828|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138455830|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455831|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455832|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138455833|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
138455835|NCT01908075|Hormones|hormones|mesh-ancestor
138455836|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138455837|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
138455839|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
138455842|NCT01908257|Ranitidine|ranitidine|mesh-list
138307081|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138455843|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138455844|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138455845|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455846|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138455847|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
138455849|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455850|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455851|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455852|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
138414806|NCT01655628|Cisplatin|cisplatin|mesh-list
138455854|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
138455855|NCT01908283|Vaccines|vaccines|mesh-list
138455856|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
138293565|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
138455857|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455858|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138455859|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
138455860|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
138455861|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138455862|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138455863|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138455864|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455865|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455866|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138455867|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138455868|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293623|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138455869|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455870|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455871|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455872|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
138455873|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138455874|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138455875|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138455876|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455877|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138455879|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455881|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455882|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455883|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138455884|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
138455885|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
138455886|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455887|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
138455888|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455890|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
138455891|NCT01908387|Azacitidine|azacitidine|mesh-list
138455892|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455893|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
138455894|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455895|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455896|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455897|NCT01908452|Pyridoxine|pyridoxine|mesh-list
138455898|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
138455899|NCT01908452|Vitamins|vitamins|mesh-ancestor
138455900|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
138455901|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455902|NCT01908478|Gemcitabine|gemcitabine|mesh-list
138455903|NCT01908478|Veliparib|veliparib|mesh-list
138455904|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455905|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
138455906|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455907|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307247|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455908|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138455909|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455910|NCT01908556|Letrozole|letrozole|mesh-list
138455911|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455912|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138455913|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138455914|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455915|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455916|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138455917|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
138455918|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138455919|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455920|NCT01908621|Cytarabine|cytarabine|mesh-list
138455921|NCT01908621|Lenograstim|lenograstim|mesh-list
138455922|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138455923|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
138455924|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455925|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138455926|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
138455927|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455928|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455930|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455931|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455932|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138455933|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
138455934|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455936|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138455937|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455939|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138293940|NCT00000805|Ganciclovir|ganciclovir|mesh-list
138455940|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138455942|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
138329251|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329252|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138329253|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329255|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329256|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329257|NCT00538824|Growth Substances|growth substances|mesh-ancestor
138355448|NCT00002418|Didanosine|didanosine|mesh-list
138329258|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
138355449|NCT00002418|Stavudine|stavudine|mesh-list
138329259|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329260|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
138329261|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329262|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329263|NCT00539526|Bimatoprost|bimatoprost|mesh-list
138329264|NCT00539526|Travoprost|travoprost|mesh-list
138329265|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138329266|NCT00539526|Latanoprost|latanoprost|mesh-list
138455943|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455944|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329269|NCT01796106|Fluorides|fluorides|mesh-list
138455945|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455946|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455947|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455948|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455949|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455952|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
138455953|NCT01909063|Vitamins|vitamins|mesh-list
138455954|NCT01909063|Vitamin E|vitamin e|mesh-list
138455955|NCT01909063|Vitamin A|vitamin a|mesh-list
138455956|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
138455957|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455958|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455959|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138455961|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455962|NCT01909063|Protective Agents|protective agents|mesh-ancestor
138455963|NCT01909115|Vitamin D|vitamin d|mesh-list
138455964|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
138455965|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
138455966|NCT01909115|Vitamins|vitamins|mesh-list
138294059|NCT00000829|Vaccines|vaccines|mesh-list
138455967|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
138455968|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455969|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138455970|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455971|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
138455972|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
138455973|NCT01909219|Cathartics|cathartics|mesh-ancestor
138455974|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455975|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
138294111|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
138455976|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
138455978|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
138307388|NCT00002129|Vesnarinone|vesnarinone|mesh-list
138455979|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455980|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
138455981|NCT01909622|Vitamin D|vitamin d|mesh-list
138455982|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
138329481|NCT00546156|Growth Substances|growth substances|mesh-ancestor
138329482|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
138455983|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
138455984|NCT01909622|Vitamins|vitamins|mesh-list
138329483|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329485|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455985|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
138455986|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455987|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138455988|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455990|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
138455991|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
138455992|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355463|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
138455993|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
138455994|NCT01909752|Imiquimod|imiquimod|mesh-list
138455995|NCT01909752|Vaccines|vaccines|mesh-list
138455996|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
138455997|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455998|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138455999|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456000|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138456001|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
138329669|NCT00524472|Insulin|insulin|mesh-list
138456003|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456004|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138456005|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138456006|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
138456009|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138456010|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
138456011|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456012|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456013|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456014|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138456015|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138456017|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
138456018|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456020|NCT01909856|Palonosetron|palonosetron|mesh-list
138456021|NCT01909856|Granisetron|granisetron|mesh-list
138456022|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456024|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
138456025|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456026|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456027|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456028|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
138456029|NCT01909856|Hormones|hormones|mesh-ancestor
138307636|NCT00002471|Leucovorin|leucovorin|mesh-list
138456030|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456031|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456032|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456033|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138456034|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138456035|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
138456036|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456037|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456038|NCT01910077|Tacrolimus|tacrolimus|mesh-list
138456039|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138456040|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
138456041|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456042|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138456043|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456044|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456045|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
138456046|NCT01910090|Famotidine|famotidine|mesh-list
138456047|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138456048|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456049|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138456050|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
138456051|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
138456052|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456053|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456054|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456055|NCT01910090|Analgesics|analgesics|mesh-ancestor
138456056|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
138456057|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456058|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138456059|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138456060|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456061|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456062|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138456063|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456064|NCT01910142|Vitamin K|vitamin k|mesh-list
138330300|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
138330301|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456065|NCT01910142|Calcium|calcium|mesh-list
138456066|NCT01910142|Vitamins|vitamins|mesh-ancestor
138456067|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
138456068|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456069|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456070|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138456071|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138456072|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456074|NCT01910142|Coagulants|coagulants|mesh-ancestor
138456075|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
138456076|NCT01910155|Dexamethasone|dexamethasone|mesh-list
138330438|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
138456079|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
138456080|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456081|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456082|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456083|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
138456084|NCT01910155|Hormones|hormones|mesh-ancestor
138456085|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456086|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456087|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330577|NCT05766605|Leucovorin|leucovorin|mesh-list
138456088|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138456089|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456090|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138456091|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456092|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456093|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456094|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138456095|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294396|NCT00000967|Zidovudine|zidovudine|mesh-list
138456096|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
138456097|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456098|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456100|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456101|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456102|NCT01910259|Amiloride|amiloride|mesh-list
138456103|NCT01910259|Riluzole|riluzole|mesh-list
138456104|NCT01910259|Fluoxetine|fluoxetine|mesh-list
138456105|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138456106|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138456107|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330652|NCT05765747|Celecoxib|celecoxib|mesh-list
138456108|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456109|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456110|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
138456111|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456112|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138456114|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138456115|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138456116|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456118|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
138456119|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138456120|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138456121|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138456122|NCT01910259|Protective Agents|protective agents|mesh-ancestor
138456124|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
138456125|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138456126|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138355486|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456127|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138456128|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138456129|NCT01910285|Sufentanil|sufentanil|mesh-list
138456130|NCT01910285|Dsuvia|dsuvia|mesh-list
138456131|NCT01910285|Remifentanil|remifentanil|mesh-list
138456132|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138456134|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456135|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456137|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
138456138|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456139|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138456140|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138456141|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
138456142|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
138456143|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
138456144|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138456145|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138456146|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138456147|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456148|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456149|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
138456150|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456151|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456152|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138331278|NCT02368886|Clobetasol|clobetasol|mesh-list
138456153|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456154|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
138456155|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138456157|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138456158|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456159|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138331361|NCT02099175|Vitamins|vitamins|mesh-ancestor
138456160|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456161|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456162|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456163|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456164|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138456165|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
138456166|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456167|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456168|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138456169|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138307963|NCT00002249|Levofloxacin|levofloxacin|mesh-list
138456170|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138456171|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138331479|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
138456172|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456175|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456176|NCT01910480|Ketoconazole|ketoconazole|mesh-list
138331565|NCT04379310|Calcium|calcium|mesh-list
138456177|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
138456178|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456179|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138456180|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456182|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456183|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138456184|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331697|NCT04370262|Famotidine|famotidine|mesh-list
138456185|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331763|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
138456187|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138456188|NCT01910506|Verinurad|verinurad|mesh-list
138456189|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
138456190|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456191|NCT01910532|Clevidipine|clevidipine|mesh-list
138456192|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138456193|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456195|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456196|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456198|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138456199|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456200|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456201|NCT01910610|Bevacizumab|bevacizumab|mesh-list
138456202|NCT01910610|Cetuximab|cetuximab|mesh-list
138456203|NCT01910610|Panitumumab|panitumumab|mesh-list
138456204|NCT01910610|Irinotecan|irinotecan|mesh-list
138456205|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138456206|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456207|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138456208|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138456209|NCT01910610|Growth Substances|growth substances|mesh-ancestor
138456210|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456211|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
138456212|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138456213|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456214|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456215|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456216|NCT01910766|Ubiquinone|ubiquinone|mesh-list
138456217|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
138456218|NCT01910766|Clomiphene|clomiphene|mesh-list
138456219|NCT01910766|Enclomiphene|enclomiphene|mesh-list
138456220|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
138456221|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138456222|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
138456223|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456224|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456225|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138456226|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
138456227|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456228|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138456229|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138456230|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
138308142|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456232|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
138456233|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138456234|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
138456235|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456236|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456237|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138456238|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
138456239|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456240|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456241|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138456242|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
138456243|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138456244|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
138456245|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456246|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456247|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138456248|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
138332470|NCT03063450|Nivolumab|nivolumab|mesh-list
138308183|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138456249|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456250|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456251|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138456252|NCT01910883|Finafloxacin|finafloxacin|mesh-list
138456253|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
138456254|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138456255|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138456256|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456257|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138456258|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138456259|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138332775|NCT03009006|Calcium|calcium|mesh-list
138456260|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456261|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456262|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456263|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138456264|NCT01910987|Dexamethasone|dexamethasone|mesh-list
138456265|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
138456267|NCT01910987|BB 1101|bb 1101|mesh-list
138456268|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456269|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
138456270|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
138456272|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456273|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456274|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
138332970|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456276|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456277|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456278|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456279|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
138456280|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333107|NCT02976012|Growth Substances|growth substances|mesh-ancestor
138456281|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456283|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138456284|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
138456285|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
138456286|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456287|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456289|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138456290|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
138456291|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456293|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456294|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456295|NCT01911299|Choline|choline|mesh-list
138456296|NCT01911299|Glycerol|glycerol|mesh-list
138456297|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
138456298|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138456299|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
138456300|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456301|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456302|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138456304|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138456305|NCT01911299|Protective Agents|protective agents|mesh-ancestor
138456306|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456307|NCT01911325|Docetaxel|docetaxel|mesh-list
138456308|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456309|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
138456310|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
138456311|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
138456312|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456313|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
138333531|NCT00588900|Irinotecan|irinotecan|mesh-list
138456314|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138456315|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
138456316|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456317|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456318|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138456319|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
138456321|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138456322|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
138456323|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456324|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355514|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456326|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138456327|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138456328|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138333736|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138456330|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456332|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456333|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456334|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138456335|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456336|NCT01911455|Acamprosate|acamprosate|mesh-list
138456337|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138456339|NCT01911468|Liraglutide|liraglutide|mesh-list
138456340|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138456342|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456343|NCT01911468|Incretins|incretins|mesh-ancestor
138456344|NCT01911468|Hormones|hormones|mesh-ancestor
138456345|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295127|NCT00381511|Heparin|heparin|mesh-list
138456346|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
138456348|NCT01911494|Analgesics|analgesics|mesh-ancestor
138456349|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
138456350|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456351|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456352|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
138456353|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456354|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138456355|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
138456356|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138456357|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456358|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456359|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456360|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
138456361|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456362|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138456363|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
138456365|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138334232|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
138456366|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456367|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138456368|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
138456369|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456370|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138456371|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456372|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334325|NCT00728910|Vitamins|vitamins|mesh-ancestor
138456373|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456374|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456375|NCT01911598|Paclitaxel|paclitaxel|mesh-list
138456376|NCT01911598|Carboplatin|carboplatin|mesh-list
138456377|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138456378|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456379|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
138334377|NCT00735306|Bevacizumab|bevacizumab|mesh-list
138456380|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
138456381|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
138456382|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456383|NCT01911624|Enoxaparin|enoxaparin|mesh-list
138456384|NCT01911624|Dabigatran|dabigatran|mesh-list
138456385|NCT01911624|Argatroban|argatroban|mesh-list
138456386|NCT01911624|Thrombin|thrombin|mesh-list
138456387|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
138355532|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138456388|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138334440|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456389|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138355534|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
138308503|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138456390|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456391|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
138456392|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138456393|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
138456394|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456395|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
138456397|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138456398|NCT01911728|Pioglitazone|pioglitazone|mesh-list
138456399|NCT01911728|Midazolam|midazolam|mesh-list
138456400|NCT01911728|Omeprazole|omeprazole|mesh-list
138456401|NCT01911728|Warfarin|warfarin|mesh-list
138456402|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138456403|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138456404|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456405|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456406|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138456407|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138456408|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138456409|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138456410|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
138456411|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
138456412|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
138456413|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
138456414|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456415|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456416|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456417|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
138456418|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138295510|NCT00002185|Nelfinavir|nelfinavir|mesh-list
138456419|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456420|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138456421|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456422|NCT01911949|Epinephrine|epinephrine|mesh-list
138456423|NCT01911949|Bupivacaine|bupivacaine|mesh-list
138456424|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
138456425|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
138456426|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456427|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456428|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
138456429|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456430|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456431|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138456432|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
138456433|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456434|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456435|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138334918|NCT00798720|Bortezomib|bortezomib|mesh-list
138456436|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138456438|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138456439|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
138456440|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
138456442|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138456443|NCT01911975|Lacosamide|lacosamide|mesh-list
138456444|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
138456445|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138456446|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138456447|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456448|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456449|NCT01912053|Gemcitabine|gemcitabine|mesh-list
138456450|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456451|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138188491|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
138456452|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
138456453|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456454|NCT01912066|Aceclofenac|aceclofenac|mesh-list
138456455|NCT01912066|Misoprostol|misoprostol|mesh-list
138456456|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138456457|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
138456458|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456459|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456460|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138335278|NCT00830388|Ketoconazole|ketoconazole|mesh-list
138308656|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138456461|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456462|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
138456463|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138335357|NCT00835224|Midodrine|midodrine|mesh-list
138456464|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138456465|NCT01912066|Analgesics|analgesics|mesh-ancestor
138456466|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
138456467|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456468|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456469|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456471|NCT01912118|Propofol|propofol|mesh-list
138456472|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138456473|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456474|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456475|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138456478|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138456480|NCT01912118|Analgesics|analgesics|mesh-ancestor
138456481|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
138456482|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456483|NCT01912261|Iron|iron|mesh-list
138456484|NCT01912261|Trace Elements|trace elements|mesh-ancestor
138456485|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
138456486|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456488|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
138456489|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456490|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456491|NCT01912391|Selegiline|selegiline|mesh-list
138456492|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
138456493|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138456494|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138456495|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138456496|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138456497|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456498|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456499|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138456500|NCT01912391|Protective Agents|protective agents|mesh-ancestor
138456501|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456502|NCT01912443|Bevacizumab|bevacizumab|mesh-list
138456503|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138456504|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456505|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138456506|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138456507|NCT01912443|Growth Substances|growth substances|mesh-ancestor
138456508|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456509|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138456511|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138456512|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138335835|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
138456513|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138456514|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456515|NCT01912573|Naloxone|naloxone|mesh-list
138456516|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138456517|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456518|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
138456519|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456520|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
138456521|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
138456522|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138456523|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138456524|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456525|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456526|NCT01912586|Urological Agents|urological agents|mesh-ancestor
138336121|NCT00973752|Cytarabine|cytarabine|mesh-list
138456527|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
138456528|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138456529|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
138296050|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138456530|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355542|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138456531|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
138456532|NCT01912638|Protective Agents|protective agents|mesh-ancestor
138456535|NCT01912677|Nifedipine|nifedipine|mesh-list
138456536|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138456537|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456538|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456539|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456540|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456541|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
138456542|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
138456543|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456544|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138456545|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138456546|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
138456547|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138296126|NCT00002263|Zidovudine|zidovudine|mesh-list
138456548|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138456550|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
138456551|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456552|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138456553|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138456554|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
138456555|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138456556|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456557|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138456558|NCT01912755|Lidocaine|lidocaine|mesh-list
138456559|NCT01912755|Epinephrine|epinephrine|mesh-list
138456561|NCT01912755|Carticaine|carticaine|mesh-list
138456562|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
138456563|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
138456564|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
138456565|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456566|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456567|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
138456568|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456569|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138456570|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138456572|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456573|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456574|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456575|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138456576|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
138456577|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456578|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138456579|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138296316|NCT00384020|Paroxetine|paroxetine|mesh-list
138456580|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
138456581|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138456583|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
138456584|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
138456585|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138456586|NCT01912820|Quercetin|quercetin|mesh-list
138456587|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
138456588|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336890|NCT05817162|Ropivacaine|ropivacaine|mesh-list
138456589|NCT01912820|Protective Agents|protective agents|mesh-ancestor
138456590|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456591|NCT01912898|Vitamin D|vitamin d|mesh-list
138456592|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
138456593|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
138456594|NCT01912898|Vitamins|vitamins|mesh-list
138456595|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
138308912|NCT00002939|Paclitaxel|paclitaxel|mesh-list
138456596|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456597|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138456598|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456599|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138355551|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456600|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138289115|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456602|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138456604|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138456605|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456606|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138456607|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456608|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456609|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456610|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456611|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456612|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138337242|NCT05124691|Ivermectin|ivermectin|mesh-list
138456613|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456614|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
138456615|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456616|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138337314|NCT04838379|Hormones|hormones|mesh-ancestor
138456617|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456618|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456619|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
138456620|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456621|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337449|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
138456622|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456624|NCT01913054|Propofol|propofol|mesh-list
138456625|NCT01913054|Etomidate|etomidate|mesh-list
138456626|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138456627|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456628|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456629|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337533|NCT04067518|Pegaspargase|pegaspargase|mesh-list
138456630|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
138456631|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
138456632|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138456633|NCT01913054|Narcotics|narcotics|mesh-ancestor
138456634|NCT01913054|Analgesics|analgesics|mesh-ancestor
138337670|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
138456635|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
138456636|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456637|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138456638|NCT01913106|Valacyclovir|valacyclovir|mesh-list
138456639|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
138456640|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456641|NCT01913119|Romidepsin|romidepsin|mesh-list
138456642|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138456643|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456644|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138456645|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456646|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456647|NCT01913379|Itraconazole|itraconazole|mesh-list
138456648|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
138456650|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456651|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138456652|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456653|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456654|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337890|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
138456655|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138456656|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
138201732|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355561|NCT00002466|Vincristine|vincristine|mesh-list
138456657|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456658|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456659|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138456661|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
138456662|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138456663|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138456664|NCT01913431|Entecavir|entecavir|mesh-list
138456665|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
138456666|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456667|NCT01913444|Antithrombins|antithrombins|mesh-list
138456668|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
138456669|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138456670|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
138456671|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309060|NCT00002999|Fluorouracil|fluorouracil|mesh-list
138456672|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338097|NCT05307042|Coagulants|coagulants|mesh-ancestor
138456673|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
138456674|NCT01913691|Ipilimumab|ipilimumab|mesh-list
138456675|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138456676|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456677|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138456678|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456681|NCT01913808|Trace Elements|trace elements|mesh-ancestor
138456682|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
138456683|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456684|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
138456685|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456686|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456688|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138456689|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456690|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138456692|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138456693|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138456694|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138456695|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456696|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456697|NCT01913847|Urological Agents|urological agents|mesh-ancestor
138456698|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138456699|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456700|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
138456701|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
138456703|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
138456704|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456705|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
138456706|NCT01913990|Dexamethasone|dexamethasone|mesh-list
138456707|NCT01913990|Ondansetron|ondansetron|mesh-list
138456708|NCT01913990|Aprepitant|aprepitant|mesh-list
138456709|NCT01913990|Antiemetics|antiemetics|mesh-list
138456710|NCT01913990|Emetics|emetics|mesh-list
138456711|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456712|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
138456713|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456714|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456715|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456716|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
138414703|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456718|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456719|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456720|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456721|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
138456722|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
138456723|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138456724|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138456725|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
138456726|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138355572|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138456727|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456728|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138456729|NCT01914042|Morphine|morphine|mesh-list
138456730|NCT01914042|Milnacipran|milnacipran|mesh-list
138456731|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
138456732|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138456733|NCT01914042|Narcotics|narcotics|mesh-ancestor
138456734|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456735|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456736|NCT01914042|Analgesics|analgesics|mesh-ancestor
138456737|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
138456738|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296697|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456739|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138456740|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138456741|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456742|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338849|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138456743|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456744|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138456745|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
138456746|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138456747|NCT01914081|Resveratrol|resveratrol|mesh-list
138456748|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
138456749|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456750|NCT01914081|Protective Agents|protective agents|mesh-ancestor
138338915|NCT01270542|Bevacizumab|bevacizumab|mesh-list
138456751|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456752|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456753|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138456754|NCT01914133|Acarbose|acarbose|mesh-list
138456755|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
138456756|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456757|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456758|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456759|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456760|NCT01914146|Insulin|insulin|mesh-list
138338971|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456761|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138456762|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456763|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456764|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
138456765|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138456766|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138296735|NCT00003446|Calcium|calcium|mesh-list
138456767|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456769|NCT01914211|Coagulants|coagulants|mesh-ancestor
138456770|NCT01914237|Castor Oil|castor oil|mesh-list
138456771|NCT01914237|Cathartics|cathartics|mesh-ancestor
138456772|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456773|NCT01914250|Analgesics|analgesics|mesh-list
138456774|NCT01914250|Tetracaine|tetracaine|mesh-list
138456775|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
138456776|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456777|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339099|NCT01304082|Lidocaine|lidocaine|mesh-list
138456778|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
138456779|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
138456780|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138355579|NCT00002472|Etoposide|etoposide|mesh-list
138355580|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456781|NCT01914380|Aflibercept|aflibercept|mesh-list
138456782|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138456783|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138456784|NCT01914380|Growth Substances|growth substances|mesh-ancestor
138456785|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456786|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
138456787|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456788|NCT01914419|Oxytocin|oxytocin|mesh-list
138456789|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
138456790|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456791|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456792|NCT01914432|Telmisartan|telmisartan|mesh-list
138456793|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138339217|NCT01315002|Nicotine|nicotine|mesh-list
138456794|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138456795|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138456796|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
138456797|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456798|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138296838|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
138456799|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138456800|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456801|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138456802|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138456803|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138456804|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138456805|NCT01914562|Cathartics|cathartics|mesh-ancestor
138456806|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456807|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
138456808|NCT01914627|Salicylates|salicylates|mesh-list
138456809|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456810|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
138456811|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
138456812|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
138456813|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138456814|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138456816|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
138456817|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456818|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456819|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456820|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456821|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138456822|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456823|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456824|NCT01914692|Somatostatin|somatostatin|mesh-list
138456825|NCT01914692|Hormones|hormones|mesh-ancestor
138414704|NCT01655095|Prucalopride|prucalopride|mesh-list
138456826|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456827|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456828|NCT01914718|Rituximab|rituximab|mesh-list
138456829|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138456831|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
138456832|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456833|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456835|NCT01914744|Entecavir|entecavir|mesh-list
138456836|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138456837|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138456838|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456839|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456840|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
138456841|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355593|NCT00002490|Mitomycins|mitomycins|mesh-list
138456842|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138456843|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138456844|NCT01914770|Belimumab|belimumab|mesh-list
138456846|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
138456847|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456848|NCT01914822|Methylphenidate|methylphenidate|mesh-list
138456849|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138456850|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456851|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138456852|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138456853|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138297013|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138456854|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456856|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456857|NCT01914939|Oxytocin|oxytocin|mesh-list
138456858|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
138456859|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456860|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456861|NCT01914965|Bupropion|bupropion|mesh-list
138456862|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138456863|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
138456864|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340025|NCT01479270|Epinephrine|epinephrine|mesh-list
138456865|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138456866|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138456867|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340092|NCT01504854|Protective Agents|protective agents|mesh-ancestor
138456868|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456869|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
138456870|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456871|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456872|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138456873|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456874|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456875|NCT01915069|Cilostazol|cilostazol|mesh-list
138456876|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138456877|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
138456878|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456879|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340228|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
138456880|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138456881|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
138456882|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138456883|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138456884|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456885|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138456886|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
138297139|NCT00004010|Vincristine|vincristine|mesh-list
138456887|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138456888|NCT01915069|Protective Agents|protective agents|mesh-ancestor
138355607|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456890|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138456891|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456892|NCT01915082|Azithromycin|azithromycin|mesh-list
138456893|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340370|NCT06114641|Enoxaparin|enoxaparin|mesh-list
138456894|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138456896|NCT01915134|Gemcitabine|gemcitabine|mesh-list
138456897|NCT01915134|Endostatins|endostatins|mesh-list
138456898|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456899|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138456900|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
138456901|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456902|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138456903|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138456905|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456906|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
138456907|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138456908|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138456909|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
138456910|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456911|NCT01915264|Metformin|metformin|mesh-list
138456912|NCT01915264|Acarbose|acarbose|mesh-list
138456913|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456914|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456915|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138456917|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456918|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
138456919|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138456920|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456921|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456922|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138456924|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
138456925|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456926|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138456927|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138456928|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138456929|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138456930|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138456931|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456932|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
138456933|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138456934|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138456935|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138456936|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456937|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456938|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
138456939|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340850|NCT04919369|Vitamin A|vitamin a|mesh-list
138456940|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456941|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138456942|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138456943|NCT01915472|Irinotecan|irinotecan|mesh-list
138456944|NCT01915472|Labetuzumab|labetuzumab|mesh-list
138456945|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
138341000|NCT04437485|Bupropion|bupropion|mesh-list
138456946|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
138456947|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456948|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138456949|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456950|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456951|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456952|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456953|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138456954|NCT01915537|Infliximab|infliximab|mesh-list
138201734|NCT01250899|Vitamins|vitamins|mesh-ancestor
138456955|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138456956|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456957|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
138456958|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456959|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138456960|NCT01915550|Insulin|insulin|mesh-list
138456961|NCT01915550|Metformin|metformin|mesh-list
138456962|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138456963|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
138456964|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456965|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456967|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456968|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138297384|NCT00002701|Cytarabine|cytarabine|mesh-list
138456969|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309364|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309365|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
138341414|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
138456970|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456972|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
138456973|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
138456974|NCT01915758|Tretinoin|tretinoin|mesh-list
138456975|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138456976|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188492|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
138456977|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138456978|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456979|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456980|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456981|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
138456982|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138456983|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138456985|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138456986|NCT01915901|Antacids|antacids|mesh-ancestor
138341565|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
138456987|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456988|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138456989|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138456990|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138456991|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
138456992|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456993|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
138456994|NCT01915979|Betamethasone|betamethasone|mesh-list
138456995|NCT01915979|Mitogens|mitogens|mesh-list
138456996|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297415|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
138201735|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
138355642|NCT00002526|Ifosfamide|ifosfamide|mesh-list
138456997|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138456998|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456999|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
138457001|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457002|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341697|NCT01564914|Bevacizumab|bevacizumab|mesh-list
138457003|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138457004|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138457005|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138457006|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138457007|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457008|NCT01916174|Insulin|insulin|mesh-list
138457009|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138457010|NCT01916174|Liraglutide|liraglutide|mesh-list
138297468|NCT00003596|Fluorouracil|fluorouracil|mesh-list
138341760|NCT01577706|Alprazolam|alprazolam|mesh-list
138457011|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
138457012|NCT01916174|Xultophy|xultophy|mesh-list
138457013|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138457014|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457015|NCT01916174|Incretins|incretins|mesh-ancestor
138457016|NCT01916174|Hormones|hormones|mesh-ancestor
138457017|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457018|NCT01916187|Imetelstat|imetelstat|mesh-list
138457019|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
138457020|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457021|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341822|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
138457023|NCT01916200|Paroxetine|paroxetine|mesh-list
138457024|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138457025|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138457026|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457027|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457028|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457029|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
138457030|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457031|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138457032|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
138457033|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138457034|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138457035|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138457036|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297653|NCT00003356|Rituximab|rituximab|mesh-list
138457037|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
138457038|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138457039|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
138457040|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457041|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
138457042|NCT01916213|Protective Agents|protective agents|mesh-ancestor
138457043|NCT01916252|Dexamethasone|dexamethasone|mesh-list
138457044|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
138457045|NCT01916252|Lenalidomide|lenalidomide|mesh-list
138457048|NCT01916252|Busulfan|busulfan|mesh-list
138457049|NCT01916252|BB 1101|bb 1101|mesh-list
138415983|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457052|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
138457053|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457054|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457055|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457057|NCT01916252|Hormones|hormones|mesh-ancestor
138309485|NCT00003449|Hormones|hormones|mesh-ancestor
138457058|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457059|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138457060|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457061|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
138457062|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457063|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138457064|NCT01916252|Growth Substances|growth substances|mesh-ancestor
138457065|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457066|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138457067|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
138457068|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188660|NCT00657241|Valsartan|valsartan|mesh-list
138457070|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457071|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
138457072|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457073|NCT01916265|Glucagon|glucagon|mesh-list
138457074|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457075|NCT01916265|Hormones|hormones|mesh-ancestor
138457076|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457077|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457078|NCT01916382|Nitisinone|nitisinone|mesh-list
138457079|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457080|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457081|NCT01916395|Sumatriptan|sumatriptan|mesh-list
138188923|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
138457082|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138457083|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138297877|NCT00004160|Paclitaxel|paclitaxel|mesh-list
138457084|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138457085|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
138457086|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457087|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457088|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457089|NCT01916408|Wobenzym|wobenzym|mesh-list
138457090|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138457091|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
138457092|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457093|NCT01916447|Bevacizumab|bevacizumab|mesh-list
138457094|NCT01916447|Irinotecan|irinotecan|mesh-list
138457095|NCT01916447|Camptothecin|camptothecin|mesh-list
138457096|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457097|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457098|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457099|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138457100|NCT01916447|Growth Substances|growth substances|mesh-ancestor
138457102|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457103|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138457104|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138457105|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457106|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457107|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138457109|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138457110|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138457111|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
138457112|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457113|NCT01916642|Lidocaine|lidocaine|mesh-list
138457114|NCT01916642|Etomidate|etomidate|mesh-list
138457115|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
138457116|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
138457117|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457118|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457119|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
138457120|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457121|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138457122|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138457123|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138457124|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457125|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309563|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138457126|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138457127|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138457128|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
138457130|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
138457131|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138297965|NCT00002785|Etoposide|etoposide|mesh-list
138189257|NCT01000987|Varenicline|varenicline|mesh-list
138457132|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138457133|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457134|NCT01916720|Darapladib|darapladib|mesh-list
138457135|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138457136|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457137|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457138|NCT01916733|Insulin|insulin|mesh-list
138457139|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138189355|NCT03105518|Fentanyl|fentanyl|mesh-list
138457140|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457141|NCT01916785|Dasatinib|dasatinib|mesh-list
138457142|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457143|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138457144|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414705|NCT01655095|Bisacodyl|bisacodyl|mesh-list
138189409|NCT01031953|Aprepitant|aprepitant|mesh-list
138457145|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457146|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138457147|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138457148|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138457149|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138414706|NCT01655095|Laxatives|laxatives|mesh-ancestor
138189463|NCT00376792|Docetaxel|docetaxel|mesh-list
138457150|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138355720|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309610|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
138457151|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138457152|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189535|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
138457154|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457155|NCT01916863|Canagliflozin|canagliflozin|mesh-list
138298076|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457156|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138457157|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138457158|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189602|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457159|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138457160|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457161|NCT01916902|Ticagrelor|ticagrelor|mesh-list
138457162|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138457163|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138457164|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138457165|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138457166|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
138457167|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414707|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457168|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457169|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457170|NCT01916915|Tramadol|tramadol|mesh-list
138457171|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
138457172|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457173|NCT01916915|Narcotics|narcotics|mesh-ancestor
138457174|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138298277|NCT00003728|Thioguanine|thioguanine|mesh-list
138457175|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457176|NCT01916915|Analgesics|analgesics|mesh-ancestor
138457177|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
138457178|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457179|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189885|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138457180|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
138457181|NCT01916954|Lumefantrine|lumefantrine|mesh-list
138457182|NCT01916954|Artemether|artemether|mesh-list
138457183|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138457184|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
138457185|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138457186|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138457188|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
138457189|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138457190|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414708|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138457191|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457192|NCT01917032|Folic Acid|folic acid|mesh-list
138457193|NCT01917032|Vitamin A|vitamin a|mesh-list
138457194|NCT01917032|Micronutrients|micronutrients|mesh-list
138457195|NCT01917032|Trace Elements|trace elements|mesh-list
138457196|NCT01917032|Tretinoin|tretinoin|mesh-list
138457197|NCT01917032|Vitamins|vitamins|mesh-ancestor
138457198|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457199|NCT01917032|Hematinics|hematinics|mesh-ancestor
138457200|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
138457201|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457203|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
138457204|NCT01917045|Sufentanil|sufentanil|mesh-list
138457205|NCT01917045|Morphine|morphine|mesh-list
138457206|NCT01917045|Dsuvia|dsuvia|mesh-list
138355739|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355740|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355742|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
138457207|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457208|NCT01917045|Narcotics|narcotics|mesh-ancestor
138457209|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457210|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457211|NCT01917045|Analgesics|analgesics|mesh-ancestor
138457212|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
138457213|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457214|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138457215|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138457216|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
138457217|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
138190166|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
138190167|NCT03354598|Probenecid|probenecid|mesh-list
138457218|NCT01917058|Abatacept|abatacept|mesh-list
138298475|NCT00004316|Capsaicin|capsaicin|mesh-list
138457219|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138414709|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138457220|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457221|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457222|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457223|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457224|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
138457225|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457226|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457227|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
138457228|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138457229|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457230|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298531|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
138457231|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457232|NCT01917097|Analgesics|analgesics|mesh-ancestor
138457233|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
138457234|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457235|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138457236|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138457237|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138457238|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
138457239|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457240|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457241|NCT01917149|Metoprolol|metoprolol|mesh-list
138457243|NCT01917149|Benazepril|benazepril|mesh-list
138457244|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138457245|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138309753|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138457246|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138457247|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457248|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138457250|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
138457251|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457252|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457253|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138298654|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
138457254|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138457255|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138457256|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
138457257|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457258|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138457260|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457261|NCT01917279|Docetaxel|docetaxel|mesh-list
138457262|NCT01917279|Capecitabine|capecitabine|mesh-list
138457263|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457264|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
138457265|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
138457266|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
138457267|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457268|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355750|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138457269|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
138457270|NCT01917318|Iloperidone|iloperidone|mesh-list
138457271|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138457272|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138457273|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457274|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457275|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138457276|NCT01917331|Beclomethasone|beclomethasone|mesh-list
138457277|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
138457278|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
138457279|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138457280|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
138457281|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190781|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
138457282|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457283|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138457284|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
138457285|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138457286|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138457287|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138457288|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
138457289|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190927|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
138190995|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
138457290|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457291|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138457292|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138457293|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138457295|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138457296|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
138457298|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457299|NCT01917448|Morphine|morphine|mesh-list
138457300|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457302|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457303|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457304|NCT01917448|Analgesics|analgesics|mesh-ancestor
138457305|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
138457306|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457307|NCT01917578|Paclitaxel|paclitaxel|mesh-list
138457308|NCT01917578|Docetaxel|docetaxel|mesh-list
138457309|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138457310|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
138457311|NCT01917578|Carboplatin|carboplatin|mesh-list
138457312|NCT01917578|Doxorubicin|doxorubicin|mesh-list
138457315|NCT01917578|Trastuzumab|trastuzumab|mesh-list
138457316|NCT01917578|Epirubicin|epirubicin|mesh-list
138457317|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138457318|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457319|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138457320|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298831|NCT00005036|Vitamins|vitamins|mesh-ancestor
138457321|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138191512|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
138457322|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457323|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457324|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
138457325|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457326|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191597|NCT00955877|Morphine|morphine|mesh-list
138457327|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138457328|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
138457329|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138457330|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138457331|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138457332|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355759|NCT00002568|Paclitaxel|paclitaxel|mesh-list
138457333|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457334|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
138191739|NCT00377104|Alvocidib|alvocidib|mesh-list
138457335|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138457336|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457337|NCT01917617|Cisplatin|cisplatin|mesh-list
138457338|NCT01917617|Gemcitabine|gemcitabine|mesh-list
138457339|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138457340|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457341|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138457342|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
138457343|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457344|NCT01917708|Abatacept|abatacept|mesh-list
138457345|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138191872|NCT01011413|Efavirenz|efavirenz|mesh-list
138457346|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457347|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457348|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416322|NCT01664650|Genistein|genistein|mesh-list
138457349|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457351|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457352|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457354|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138457355|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457356|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
138457357|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138457358|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138457359|NCT01917799|Aspirin|aspirin|mesh-list
138457360|NCT01917799|Heparin|heparin|mesh-list
138457361|NCT01917799|Enoxaparin|enoxaparin|mesh-list
138457362|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138457363|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457364|NCT01917799|Analgesics|analgesics|mesh-ancestor
138457365|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
138457366|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457367|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457368|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138457370|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138192223|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138457371|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138457372|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457373|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138457374|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138457375|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457377|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
138457378|NCT01917890|Curcumin|curcumin|mesh-list
138457379|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138457380|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457381|NCT01917890|Analgesics|analgesics|mesh-ancestor
138457382|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
138299129|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138457383|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457384|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457385|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138457386|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457387|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457388|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457389|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457392|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457393|NCT01918098|Narcotics|narcotics|mesh-ancestor
138457394|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457395|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457396|NCT01918098|Analgesics|analgesics|mesh-ancestor
138355770|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457397|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
138457398|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457399|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138355771|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
138457400|NCT01918111|Adenosine|adenosine|mesh-list
138457401|NCT01918111|Analgesics|analgesics|mesh-ancestor
138457402|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
138457403|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457404|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457406|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
138457407|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138457408|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
138457409|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
138457410|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457411|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457412|NCT01918124|Paclitaxel|paclitaxel|mesh-list
138457413|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
138457414|NCT01918124|Cisplatin|cisplatin|mesh-list
138457415|NCT01918124|Carboplatin|carboplatin|mesh-list
138457416|NCT01918124|Doxorubicin|doxorubicin|mesh-list
138457417|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138457418|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192869|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192870|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309955|NCT00003593|Cytarabine|cytarabine|mesh-list
138192871|NCT01139515|Eletriptan|eletriptan|mesh-list
138457419|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
138457420|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
138457421|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
138457422|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457423|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457424|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
138457425|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299254|NCT00004754|Epoprostenol|epoprostenol|mesh-list
138457426|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457427|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138193014|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
138457428|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
138457429|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138457430|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138457431|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138457432|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138457433|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457436|NCT01918150|Trace Elements|trace elements|mesh-ancestor
138457437|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
138457438|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457439|NCT01918176|Palbociclib|palbociclib|mesh-list
138457440|NCT01918176|Rabeprazole|rabeprazole|mesh-list
138457441|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457442|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138457443|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457444|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457445|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138457446|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457447|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138457448|NCT01918241|Lenograstim|lenograstim|mesh-list
138457449|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138457450|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
138457451|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457453|NCT01918254|Pertuzumab|pertuzumab|mesh-list
138193288|NCT05501340|Sargramostim|sargramostim|mesh-list
138457454|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138457455|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457456|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
138457457|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
138457458|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
138457459|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457460|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457462|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138457463|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138457464|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138457465|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
138457466|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193359|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457467|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138457468|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138457469|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457470|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138457471|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138457472|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138457473|NCT01918384|Arbekacin|arbekacin|mesh-list
138457475|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457476|NCT01918475|Carbetocin|carbetocin|mesh-list
138457477|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
138457478|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138457479|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457480|NCT01918488|Amiloride|amiloride|mesh-list
138457481|NCT01918488|Triamterene|triamterene|mesh-list
138457482|NCT01918488|Diuretics|diuretics|mesh-ancestor
138457483|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
138457484|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457485|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138457486|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138457487|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457488|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457489|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138457490|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138457491|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
138457492|NCT01918514|Analgesics|analgesics|mesh-ancestor
138457493|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
138457494|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457495|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457496|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
138457497|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457498|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138457500|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138457501|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457502|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457503|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138457504|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
138457505|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138457506|NCT01918631|Tenofovir|tenofovir|mesh-list
138457507|NCT01918631|Entecavir|entecavir|mesh-list
138457508|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
138457509|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457510|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138457511|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138457512|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457513|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457514|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138457515|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138457516|NCT01918709|Valsartan|valsartan|mesh-list
138193491|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
138457517|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138457518|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138457519|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138457520|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
138457521|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457522|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138457523|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138457524|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457525|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138457526|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138457527|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138457528|NCT01918813|Vancomycin|vancomycin|mesh-list
138457529|NCT01918813|Mupirocin|mupirocin|mesh-list
138457530|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138457531|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457532|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138457533|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457534|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457535|NCT01918852|Bevacizumab|bevacizumab|mesh-list
138457536|NCT01918852|Capecitabine|capecitabine|mesh-list
138457537|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457538|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457539|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457540|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138457541|NCT01918852|Growth Substances|growth substances|mesh-ancestor
138457542|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457543|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457544|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138457545|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
138457546|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457547|NCT01918865|Metformin|metformin|mesh-list
138457548|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138457549|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457550|NCT01918878|Aflibercept|aflibercept|mesh-list
138457551|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138299612|NCT00386126|Hematinics|hematinics|mesh-ancestor
138457552|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193523|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193524|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193525|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193528|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
138457553|NCT01918878|Growth Substances|growth substances|mesh-ancestor
138457554|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457555|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457556|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457557|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
138457558|NCT01918904|Antidotes|antidotes|mesh-ancestor
138457559|NCT01918904|Protective Agents|protective agents|mesh-ancestor
138457560|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457561|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
138457562|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457563|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
138457564|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138457565|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457566|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
138457567|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
138457568|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
138457569|NCT01918917|Morphine|morphine|mesh-list
138457570|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
138457571|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138457572|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457573|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457574|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457575|NCT01918917|Analgesics|analgesics|mesh-ancestor
138457576|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
138457577|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457578|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138457579|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138457580|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138457581|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
138457582|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457583|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457584|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457586|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
138457587|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
138457588|NCT01918995|Regadenoson|regadenoson|mesh-list
138457589|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138457590|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138457591|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
138457592|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
138355795|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138457593|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457594|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457595|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457596|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138457597|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
138457598|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138457599|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138457600|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138193556|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193557|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138193558|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138457601|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457602|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457604|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138457605|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138457606|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138457607|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
138457608|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457609|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457610|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457611|NCT01919047|Urological Agents|urological agents|mesh-ancestor
138310143|NCT00004085|Antibodies|antibodies|mesh-list
138457613|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457614|NCT01919203|Narcotics|narcotics|mesh-ancestor
138457615|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299797|NCT04561856|Dexamethasone|dexamethasone|mesh-list
138457616|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457617|NCT01919203|Analgesics|analgesics|mesh-ancestor
138457618|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
138457619|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457620|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
138457621|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
138457622|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
138457623|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
138457624|NCT01919255|Citric Acid|citric acid|mesh-list
138457625|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
138457626|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138457627|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
138457628|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
138457629|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457630|NCT01919255|Cathartics|cathartics|mesh-ancestor
138457631|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457632|NCT01919255|Antacids|antacids|mesh-ancestor
138457633|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
138457634|NCT01919294|Testosterone|testosterone|mesh-list
138457635|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
138457636|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
138457637|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138457638|NCT01919294|Androgens|androgens|mesh-ancestor
138457639|NCT01919294|Hormones|hormones|mesh-ancestor
138457640|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457641|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457642|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138457643|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457644|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
138457645|NCT01919346|Eculizumab|eculizumab|mesh-list
138457646|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138193583|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138457647|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457648|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
138457649|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193584|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
138457650|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
138457651|NCT01919424|Miotics|miotics|mesh-ancestor
138457652|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
138457653|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457654|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457655|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138457656|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138457657|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
138457658|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138299928|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
138457659|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138457660|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
138457661|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457662|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457664|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138457665|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
138457666|NCT01919593|Povidone|povidone|mesh-list
138299985|NCT00002935|Trioxsalen|trioxsalen|mesh-list
138457667|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138457668|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457669|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
138457670|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138457671|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
138457672|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
138457673|NCT01919788|Insulin|insulin|mesh-list
138457674|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138457675|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457676|NCT01919879|Cetuximab|cetuximab|mesh-list
138457677|NCT01919879|Afatinib|afatinib|mesh-list
138457678|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457679|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457680|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138457681|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457682|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193611|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457683|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
138457684|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
138193624|NCT03826316|Nalbuphine|nalbuphine|mesh-list
138457686|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457687|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457689|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138457690|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457691|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457692|NCT01919905|Vitamin D|vitamin d|mesh-list
138457693|NCT01919905|Vitamins|vitamins|mesh-ancestor
138457694|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
138457695|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457696|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138457697|NCT01919918|Adenosine|adenosine|mesh-list
138457698|NCT01919918|Analgesics|analgesics|mesh-ancestor
138355831|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457699|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
138457700|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457701|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457702|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138457703|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
138457704|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138457705|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
138457706|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
138457708|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457709|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
138457710|NCT01920022|Mifepristone|mifepristone|mesh-list
138457711|NCT01920022|Etonogestrel|etonogestrel|mesh-list
138457712|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138457713|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457714|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138457715|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
138457716|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138457717|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138457718|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138193650|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138193651|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
138457719|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138193652|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
138193653|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138457720|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138457721|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
138457722|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457723|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
138457724|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138457725|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138457727|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
138457728|NCT01920516|Melphalan|melphalan|mesh-list
138457729|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138457730|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
138457731|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457732|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457733|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138457734|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457735|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
138457736|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457738|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138457739|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457740|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457741|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138457742|NCT01920984|Growth Substances|growth substances|mesh-ancestor
138457743|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457744|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457745|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
138457746|NCT01921374|Interferons|interferons|mesh-list
138457747|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
138457748|NCT01921374|Interleukin-2|interleukin-2|mesh-list
138457749|NCT01921374|Interleukin-4|interleukin-4|mesh-list
138457750|NCT01921374|Dinoprostone|dinoprostone|mesh-list
138457751|NCT01921374|Hormones|hormones|mesh-list
138457752|NCT01921374|Estradiol|estradiol|mesh-list
138457753|NCT01921374|Testosterone|testosterone|mesh-list
138457754|NCT01921374|Progesterone|progesterone|mesh-list
138457755|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138457756|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138457757|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138457758|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
138457759|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138193686|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193687|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457760|NCT01921374|Antibodies|antibodies|mesh-list
138457761|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
138193688|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138355842|NCT00002598|Methotrexate|methotrexate|mesh-list
138355843|NCT00002598|Etoposide|etoposide|mesh-list
138457762|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
138457764|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
138457765|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
138457766|NCT01921374|Uric Acid|uric acid|mesh-list
138457767|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457768|NCT01921374|Vitamins|vitamins|mesh-ancestor
138457769|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
138457770|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457772|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457773|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457774|NCT01921374|Estrogens|estrogens|mesh-ancestor
138457775|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138457776|NCT01921374|Androgens|androgens|mesh-ancestor
138457777|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
138457778|NCT01921374|Progestins|progestins|mesh-ancestor
138457779|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457780|NCT01921374|Analgesics|analgesics|mesh-ancestor
138457781|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
138457782|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457783|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
138457784|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457785|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457786|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
138457787|NCT01921374|Protective Agents|protective agents|mesh-ancestor
138457788|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
138457789|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138457790|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457791|NCT01921972|Memantine|memantine|mesh-list
138457792|NCT01921972|Galantamine|galantamine|mesh-list
138457793|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138457794|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138457796|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457797|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457798|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457799|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138310270|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
138457800|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138457801|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138457802|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457803|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138193722|NCT03161912|Aflibercept|aflibercept|mesh-list
138457804|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138457805|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
138193723|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457806|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457808|NCT01923454|Acetazolamide|acetazolamide|mesh-list
138457809|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
138457810|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138457811|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457812|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457813|NCT01923454|Diuretics|diuretics|mesh-ancestor
138457814|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
138457815|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457816|NCT01923935|Melphalan|melphalan|mesh-list
138457817|NCT01923935|Busulfan|busulfan|mesh-list
138457818|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138457819|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
138457820|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457821|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457822|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138457823|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457824|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
138457825|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457827|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
138457828|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457829|NCT01923974|Protective Agents|protective agents|mesh-ancestor
138457830|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457831|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138355853|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457832|NCT01924013|Vitamin D|vitamin d|mesh-list
138457833|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
138457834|NCT01924013|Vitamins|vitamins|mesh-ancestor
138457835|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
138457836|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457837|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138457838|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138457839|NCT01924676|Oxycodone|oxycodone|mesh-list
138457840|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138457841|NCT01924676|Narcotics|narcotics|mesh-ancestor
138457842|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457843|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457845|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
138457846|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457847|NCT01925066|Vancomycin|vancomycin|mesh-list
138457848|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138457849|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457850|NCT01927640|Cocaine|cocaine|mesh-list
138193757|NCT02972294|Iron|iron|mesh-list
138193758|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
138457851|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
138457852|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138457853|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457854|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457855|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457856|NCT01927640|Analgesics|analgesics|mesh-ancestor
138457857|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
138457858|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457859|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138457860|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138457861|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138457862|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
138301102|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457863|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457864|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457865|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
138457866|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
138457867|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138457868|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138457869|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138457870|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457871|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
138457872|NCT01927679|Vitamin E|vitamin e|mesh-list
138457873|NCT01927679|Antioxidants|antioxidants|mesh-list
138457874|NCT01927679|Vitamins|vitamins|mesh-ancestor
138457875|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
138457876|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457877|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457878|NCT01927679|Protective Agents|protective agents|mesh-ancestor
138457879|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
138457880|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355860|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138355861|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355862|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138355863|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355864|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355865|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355866|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355867|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
138457881|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
138310358|NCT00003299|Paclitaxel|paclitaxel|mesh-list
138457882|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457883|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457884|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138457885|NCT01928407|Darunavir|darunavir|mesh-list
138457886|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138457887|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138457888|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
138457889|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457890|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193789|NCT02983214|Protective Agents|protective agents|mesh-ancestor
138193790|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138193791|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138193792|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193793|NCT03825068|Anesthetics|anesthetics|mesh-list
138457891|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138457892|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138457893|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
138457894|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457895|NCT01928875|Anesthetics|anesthetics|mesh-list
138457896|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457897|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457898|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
138457899|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457900|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138457901|NCT01929590|Laxatives|laxatives|mesh-ancestor
138457902|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138457904|NCT01930019|Etomidate|etomidate|mesh-list
138457905|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
138457906|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457907|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457908|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138457909|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138457910|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
138457911|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
138457912|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
138457913|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
138457914|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457915|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457916|NCT01930201|Anesthetics|anesthetics|mesh-list
138457917|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138457918|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457919|NCT01930292|Paclitaxel|paclitaxel|mesh-list
138457920|NCT01930292|Carboplatin|carboplatin|mesh-list
138457921|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138457922|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457923|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
138457924|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
138457925|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301488|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
138457926|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457928|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138457929|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138457930|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457931|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457932|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138457933|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138457934|NCT01930318|Analgesics|analgesics|mesh-ancestor
138457935|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
138457936|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457937|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301552|NCT00003193|Paclitaxel|paclitaxel|mesh-list
138193818|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138457939|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138457940|NCT01930331|Piperaquine|piperaquine|mesh-list
138457941|NCT01930331|Artenimol|artenimol|mesh-list
138355868|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355869|NCT00002598|Analgesics|analgesics|mesh-ancestor
138355870|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
138457942|NCT01930331|Artemisinins|artemisinins|mesh-list
138457943|NCT01930331|Artemisinin|artemisinin|mesh-list
138457944|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
138457945|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138457946|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138457947|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138457948|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138310478|NCT00004229|Endostatins|endostatins|mesh-list
138457949|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
138457950|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
138457951|NCT01930396|Heparin|heparin|mesh-list
138457952|NCT01930396|Calcium heparin|calcium heparin|mesh-list
138457953|NCT01930396|Tinzaparin|tinzaparin|mesh-list
138457954|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138457955|NCT01930396|Dalteparin|dalteparin|mesh-list
138457956|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
138457957|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138301679|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
138457958|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138457959|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457960|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
138457961|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
138457962|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457964|NCT01930552|Fluorouracil|fluorouracil|mesh-list
138457965|NCT01930552|Irinotecan|irinotecan|mesh-list
138457966|NCT01930552|Aflibercept|aflibercept|mesh-list
138457967|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
138457968|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457969|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138457970|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457971|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457972|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
138457973|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457974|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138457975|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138457976|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457978|NCT01930552|Protective Agents|protective agents|mesh-ancestor
138457979|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
138457980|NCT01930552|Vitamins|vitamins|mesh-ancestor
138193845|NCT01025453|Sorafenib|sorafenib|mesh-list
138457981|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
138457982|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138457983|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193846|NCT01025453|Temsirolimus|temsirolimus|mesh-list
138193847|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
138301808|NCT00004195|Eniluracil|eniluracil|mesh-list
138457986|NCT01930591|Clopidogrel|clopidogrel|mesh-list
138457987|NCT01930591|Ticagrelor|ticagrelor|mesh-list
138457988|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138457989|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138457990|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138457991|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138457992|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
138457993|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457994|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457995|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457996|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138457997|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138457998|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138457999|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138458000|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310527|NCT00004253|Paclitaxel|paclitaxel|mesh-list
138458001|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355878|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458002|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138458003|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138355879|NCT00002610|Dactinomycin|dactinomycin|mesh-list
138458004|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458005|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
138458006|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458007|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138458008|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138458009|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138458010|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138458011|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458013|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
138458014|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458015|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
138458016|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458017|NCT01930734|Dobutamine|dobutamine|mesh-list
138458018|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138193877|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
138458019|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
138193878|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
138193879|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458020|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
138458021|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458022|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458023|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138458024|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138458025|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138458026|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
138458027|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458028|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458029|NCT01930734|Protective Agents|protective agents|mesh-ancestor
138458031|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138458032|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138458033|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138458034|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138458035|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
138458036|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458037|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458038|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458039|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
138458040|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138458041|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138458042|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138458043|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138458044|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458045|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
138458046|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458047|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458048|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138458049|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458051|NCT01930812|Fluorides|fluorides|mesh-list
138458052|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
138458053|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138458054|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
138458055|NCT01930812|Protective Agents|protective agents|mesh-ancestor
138458056|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458057|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138458058|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458059|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138458060|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458062|NCT01930864|Irinotecan|irinotecan|mesh-list
138458063|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458064|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458065|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138458066|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138458067|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193910|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193911|NCT05509374|Dexamethasone|dexamethasone|mesh-list
138193912|NCT05509374|Pomalidomide|pomalidomide|mesh-list
138193913|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193914|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
138458068|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458069|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458070|NCT01930877|Lidocaine|lidocaine|mesh-list
138458071|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
138458072|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
138458073|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458074|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458075|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
138458076|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458077|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138458078|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138458079|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138458080|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138458081|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458082|NCT01930916|Anticoagulants|anticoagulants|mesh-list
138458083|NCT01930916|Antibodies|antibodies|mesh-list
138458084|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
138458085|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
138458086|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
138458087|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458088|NCT01931085|Triclabendazole|triclabendazole|mesh-list
138458089|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138458090|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
138458091|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138458092|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458093|NCT01931098|Topotecan|topotecan|mesh-list
138458094|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138458095|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138458096|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458097|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458098|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458100|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458101|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458102|NCT01931189|Infliximab|infliximab|mesh-list
138458103|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138458104|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417041|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
138458105|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138458106|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458107|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458109|NCT01931215|Morphine|morphine|mesh-list
138458110|NCT01931215|Ropivacaine|ropivacaine|mesh-list
138458111|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
138458112|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458113|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458114|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458115|NCT01931215|Narcotics|narcotics|mesh-ancestor
138458116|NCT01931215|Analgesics|analgesics|mesh-ancestor
138302352|NCT00004999|Nelfinavir|nelfinavir|mesh-list
138458117|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
138458118|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458119|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
138458120|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138458121|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
138458122|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
138458123|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138302421|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
138458124|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138458125|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138458126|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
138458127|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458128|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458129|NCT01931293|Folic Acid|folic acid|mesh-list
138458130|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
138458131|NCT01931293|Vitamins|vitamins|mesh-ancestor
138458132|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
138458133|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458134|NCT01931293|Hematinics|hematinics|mesh-ancestor
138458135|NCT01931306|Afatinib|afatinib|mesh-list
138458136|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458137|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458138|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302488|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
138458139|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458140|NCT01931319|Baclofen|baclofen|mesh-list
138458141|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138458142|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458143|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138458144|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458145|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138458146|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
138458147|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
138458148|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458149|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458150|NCT01931332|Heroin|heroin|mesh-list
138458151|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458152|NCT01931332|Narcotics|narcotics|mesh-ancestor
138458153|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458154|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458155|NCT01931332|Analgesics|analgesics|mesh-ancestor
138458156|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
138458157|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458158|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138458159|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138458160|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458162|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138458163|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
138458164|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138458165|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458166|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138458167|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458168|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
138458169|NCT01931501|Montelukast|montelukast|mesh-list
138458170|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138458171|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
138458172|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138458173|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
138458174|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458175|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458176|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138458177|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138458178|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458179|NCT01931514|Montelukast|montelukast|mesh-list
138417135|NCT01669967|Promethazine|promethazine|mesh-list
138458180|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138458181|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
138458182|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138458184|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458185|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458186|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138458187|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138458188|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458189|NCT01931592|Gentamicins|gentamicins|mesh-list
138458190|NCT01931592|Colistin|colistin|mesh-list
138458191|NCT01931592|Fosfomycin|fosfomycin|mesh-list
138310767|NCT00004997|Antidotes|antidotes|mesh-ancestor
138458192|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138458193|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458194|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138458195|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458196|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458198|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
138458199|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138458200|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
138458201|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138355900|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355901|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138458202|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458203|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138458204|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138458205|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138458206|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
138458207|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138302810|NCT00004699|Mitogens|mitogens|mesh-list
138458208|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138458209|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
138458210|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458211|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
138458212|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138458213|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138458214|NCT01931683|Remifentanil|remifentanil|mesh-list
138458215|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458216|NCT01931683|Narcotics|narcotics|mesh-ancestor
138458217|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458218|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458219|NCT01931683|Analgesics|analgesics|mesh-ancestor
138458220|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
138458221|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458222|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
138458223|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
138458224|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458225|NCT01931787|Protective Agents|protective agents|mesh-ancestor
138458226|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458227|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
138458228|NCT01931787|Vitamins|vitamins|mesh-ancestor
138458229|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
138458230|NCT01931982|Liraglutide|liraglutide|mesh-list
138458231|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138310806|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138458232|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458233|NCT01931982|Incretins|incretins|mesh-ancestor
138458234|NCT01931982|Hormones|hormones|mesh-ancestor
138458235|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458236|NCT01932151|Terlipressin|terlipressin|mesh-list
138458237|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138458238|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138458239|NCT01932177|Everolimus|everolimus|mesh-list
138458240|NCT01932177|Sorafenib|sorafenib|mesh-list
138458241|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138458242|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458243|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458244|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458245|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458246|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
138458247|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458248|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458249|NCT01932203|Aspirin|aspirin|mesh-list
138458250|NCT01932203|Cilostazol|cilostazol|mesh-list
138458251|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458252|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458253|NCT01932203|Analgesics|analgesics|mesh-ancestor
138458254|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
138458255|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458256|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458257|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458258|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458259|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138458260|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138458261|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355907|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138355911|NCT00002616|Thiotepa|thiotepa|mesh-list
138458262|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138458263|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458264|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458265|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
138458266|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138458267|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
138458268|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138458269|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193947|NCT05504694|Ofatumumab|ofatumumab|mesh-list
138458270|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138458271|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138458272|NCT01932203|Protective Agents|protective agents|mesh-ancestor
138458273|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138458274|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138458276|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458277|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458278|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458279|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458280|NCT01932268|Rifampin|rifampin|mesh-list
138458281|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138458282|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
138458283|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138458284|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458285|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
138458286|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138458287|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458288|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458289|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138458290|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138458291|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138458292|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138458293|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138458294|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138458295|NCT01932320|Ketoconazole|ketoconazole|mesh-list
138458296|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
138458297|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458298|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138458299|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138458300|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458301|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458302|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138458303|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
138458304|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458305|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458306|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138458308|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
138458309|NCT01932372|Tofacitinib|tofacitinib|mesh-list
138458310|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458311|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458312|NCT01932372|Analgesics|analgesics|mesh-ancestor
138458313|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
138458314|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458315|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458316|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458317|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138355917|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355918|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
138355919|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355920|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355921|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355922|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355923|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355924|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
138355925|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458318|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458319|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
138458320|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138458321|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458322|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458323|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458324|NCT01932385|Sorafenib|sorafenib|mesh-list
138458325|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458326|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458327|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458328|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458329|NCT01932424|Propofol|propofol|mesh-list
138458330|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138458331|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458332|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458333|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138458334|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
138458335|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
138458336|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
138458337|NCT01932502|Clobazam|clobazam|mesh-list
138458338|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
138458339|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138458340|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138458341|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458342|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458343|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458344|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138458345|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
138458346|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
138458347|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458348|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458349|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138458350|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138458351|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138458352|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303265|NCT02119416|Caffeine|caffeine|mesh-list
138458353|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458354|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458355|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138458356|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138458357|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138458358|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
138458359|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458360|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458361|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138458362|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138458363|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
138458364|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138458365|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138458366|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
138458368|NCT01932554|Fentanyl|fentanyl|mesh-list
138458369|NCT01932554|Morphine|morphine|mesh-list
138458370|NCT01932554|Hydromorphone|hydromorphone|mesh-list
138458371|NCT01932554|Narcotics|narcotics|mesh-list
138458372|NCT01932554|Abciximab|abciximab|mesh-list
138458373|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458374|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458375|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458376|NCT01932554|Analgesics|analgesics|mesh-ancestor
138458377|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
138458378|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458379|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138458380|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138458381|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
138458382|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
138458383|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458384|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458385|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458386|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458387|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458388|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458389|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458390|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
138458391|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138458393|NCT01932580|Fluorouracil|fluorouracil|mesh-list
138458394|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
138458395|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458396|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
138458397|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
138458398|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
138458399|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458400|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
138417347|NCT01678937|Cyclosporine|cyclosporine|mesh-list
138458401|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138458402|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458403|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
138458404|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458405|NCT01932918|Ketorolac|ketorolac|mesh-list
138458406|NCT01932918|Morphine|morphine|mesh-list
138458407|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458408|NCT01932918|Narcotics|narcotics|mesh-ancestor
138458409|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193957|NCT03519308|Nivolumab|nivolumab|mesh-list
138458410|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458411|NCT01932918|Analgesics|analgesics|mesh-ancestor
138458412|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
138310992|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
138458413|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458414|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458415|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458416|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458417|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458418|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458419|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458420|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458421|NCT01932931|Vitamin D|vitamin d|mesh-list
138458422|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
138458423|NCT01932931|Vitamins|vitamins|mesh-ancestor
138458424|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
138458425|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458426|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138458427|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138458428|NCT01933022|Leuprolide|leuprolide|mesh-list
138458429|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138458430|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
138458431|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138458432|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458433|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138458434|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458435|NCT01933061|Paclitaxel|paclitaxel|mesh-list
138458436|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138458437|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138458438|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458439|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
138458440|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
138458441|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
138458442|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355928|NCT00002634|Doxorubicin|doxorubicin|mesh-list
138458444|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138458445|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138458446|NCT01933152|Growth Substances|growth substances|mesh-ancestor
138458447|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311042|NCT00385463|Hormones|hormones|mesh-ancestor
138458448|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138458449|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458450|NCT01933347|Gefitinib|gefitinib|mesh-list
138303674|NCT04182984|Prednisone|prednisone|mesh-list
138458451|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458452|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458453|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458454|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458455|NCT01933360|Misoprostol|misoprostol|mesh-list
138458456|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138458457|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
138458458|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138458459|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458460|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138458461|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458462|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
138458463|NCT01933412|Vaccines|vaccines|mesh-list
138458464|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
138458465|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458466|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
138458467|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458468|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458469|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138458470|NCT01933503|Cathartics|cathartics|mesh-ancestor
138458471|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458472|NCT01933516|Rituximab|rituximab|mesh-list
138458473|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138458474|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458475|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
138458476|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458477|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458478|NCT01933542|Morphine|morphine|mesh-list
138458479|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
138458480|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458481|NCT01933542|Narcotics|narcotics|mesh-ancestor
138458482|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458483|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458484|NCT01933542|Analgesics|analgesics|mesh-ancestor
138458485|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
138458486|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458487|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138458488|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138458489|NCT01933568|Cisplatin|cisplatin|mesh-list
138458490|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458491|NCT01933698|Amoxicillin|amoxicillin|mesh-list
138458492|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138458493|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458494|NCT01933711|Rituximab|rituximab|mesh-list
138311083|NCT00005585|Hormones|hormones|mesh-ancestor
138458495|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138458496|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458497|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
138458498|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458499|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458500|NCT01933906|Interferons|interferons|mesh-list
138458501|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
138458502|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
138458503|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138458504|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458505|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
138458506|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458507|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
138458508|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458509|NCT01933945|Sorafenib|sorafenib|mesh-list
138458510|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458511|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458512|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458513|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458514|NCT01933971|Lenograstim|lenograstim|mesh-list
138458515|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138458516|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
138458517|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458518|NCT01933997|Pyridoxine|pyridoxine|mesh-list
138458519|NCT01933997|Metadoxine|metadoxine|mesh-list
138458520|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138458521|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
138458522|NCT01933997|Vitamins|vitamins|mesh-ancestor
138458523|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
138458524|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458525|NCT01934023|Varenicline|varenicline|mesh-list
138458526|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138458527|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138458528|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
138458529|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303749|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458530|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458531|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458532|NCT01934049|Anesthetics|anesthetics|mesh-list
138458533|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458534|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458535|NCT01934088|Midazolam|midazolam|mesh-list
138458536|NCT01934088|Fentanyl|fentanyl|mesh-list
138458537|NCT01934088|Propofol|propofol|mesh-list
138458538|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138458539|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458540|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458541|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138458542|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
138458543|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
138458544|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138458545|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138458546|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138458547|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458548|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
138458549|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
138458550|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193965|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
138458551|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458552|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138458553|NCT01934088|Narcotics|narcotics|mesh-ancestor
138417490|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458554|NCT01934088|Analgesics|analgesics|mesh-ancestor
138458555|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
138458556|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458557|NCT01934127|Vaccines|vaccines|mesh-list
138458558|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
138458559|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458560|NCT01934166|Nalmefene|nalmefene|mesh-list
138458561|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138458562|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458563|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
138458564|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458565|NCT01934205|Gepotidacin|gepotidacin|mesh-list
138458566|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138458567|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458568|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458569|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458570|NCT01934361|Carboplatin|carboplatin|mesh-list
138458571|NCT01934361|Lomustine|lomustine|mesh-list
138458572|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458573|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138458574|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
138458575|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458576|NCT01934569|Losartan|losartan|mesh-list
138458577|NCT01934569|Midazolam|midazolam|mesh-list
138458578|NCT01934569|Caffeine|caffeine|mesh-list
138458579|NCT01934569|Omeprazole|omeprazole|mesh-list
138458580|NCT01934569|Pravastatin|pravastatin|mesh-list
138458581|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138458582|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138458583|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458584|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458585|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138458586|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138458587|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458588|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138458589|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
138458590|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
138458591|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
138458592|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
138311210|NCT00385853|Vatalanib|vatalanib|mesh-list
138458593|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458594|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458595|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138458596|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138458597|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138458598|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138458599|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138458601|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458602|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138458603|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138458604|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
138458605|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138458606|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458607|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138458608|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138458609|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138458610|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
138458611|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138458612|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138458613|NCT01934634|Paclitaxel|paclitaxel|mesh-list
138458614|NCT01934634|Gemcitabine|gemcitabine|mesh-list
138458615|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138458616|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458617|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138458618|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138458619|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138458620|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458621|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138458622|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
138458623|NCT01934712|Insulin|insulin|mesh-list
138458624|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138458625|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
138458627|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138458628|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458629|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458630|NCT01934777|Vitamin E|vitamin e|mesh-list
138458632|NCT01934777|Vitamins|vitamins|mesh-ancestor
138458633|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
138458634|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458635|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
138458636|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458637|NCT01934777|Protective Agents|protective agents|mesh-ancestor
138458638|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
138458639|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138458640|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
138458641|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458642|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138458643|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
138458644|NCT01934816|Liraglutide|liraglutide|mesh-list
138458645|NCT01934816|Exenatide|exenatide|mesh-list
138458646|NCT01934816|Glucagon|glucagon|mesh-list
138458647|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138458648|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458649|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458650|NCT01934816|Incretins|incretins|mesh-ancestor
138458651|NCT01934816|Hormones|hormones|mesh-ancestor
138458652|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458653|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138458654|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458655|NCT01934829|Sorafenib|sorafenib|mesh-list
138458656|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458657|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458658|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458659|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458660|NCT01934933|Celecoxib|celecoxib|mesh-list
138458661|NCT01934933|Etanercept|etanercept|mesh-list
138458662|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458663|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458664|NCT01934933|Analgesics|analgesics|mesh-ancestor
138458665|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
138458666|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458667|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458668|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458669|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458670|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138458671|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458672|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458673|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458674|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458675|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458676|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
138458677|NCT01935063|Lidocaine|lidocaine|mesh-list
138458678|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
138458679|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
138458680|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458681|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458682|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
138458683|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458684|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138458685|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138458686|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138458687|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138458688|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458690|NCT01935115|Propofol|propofol|mesh-list
138458691|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138458692|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458693|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458694|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138458695|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
138458697|NCT01935115|Analgesics|analgesics|mesh-ancestor
138458698|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
138458699|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458700|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138458701|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138458702|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138458703|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458704|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458705|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
138458706|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138458708|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458709|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
138458710|NCT01935193|Analgesics|analgesics|mesh-ancestor
138458711|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
138304238|NCT01994226|Naproxen|naproxen|mesh-list
138458712|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458713|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458714|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138311305|NCT05895136|Enoxaparin|enoxaparin|mesh-list
138458716|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138355966|NCT00002652|Suramin|suramin|mesh-list
138458717|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458718|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138458719|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458720|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458721|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458723|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138458724|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458725|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
138458726|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458728|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138458729|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
138458730|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458731|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458732|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
138458733|NCT01935492|Paclitaxel|paclitaxel|mesh-list
138458734|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138458735|NCT01935492|Bevacizumab|bevacizumab|mesh-list
138458736|NCT01935492|Doxorubicin|doxorubicin|mesh-list
138458737|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138458738|NCT01935492|Capecitabine|capecitabine|mesh-list
138458739|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138458740|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458741|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138458742|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138458743|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138458744|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458745|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138458746|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138458747|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138458748|NCT01935492|Growth Substances|growth substances|mesh-ancestor
138458749|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304369|NCT01964352|Olodaterol|olodaterol|mesh-list
138458750|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
138458751|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138458752|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311337|NCT05894824|Ramucirumab|ramucirumab|mesh-list
138458753|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138458754|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458755|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138458756|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
138458759|NCT01935505|Varenicline|varenicline|mesh-list
138458760|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138458761|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
138458762|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304424|NCT01945242|Hormones|hormones|mesh-ancestor
138458763|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458764|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138458765|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138458766|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
138458767|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458768|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458769|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138458770|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
138458771|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458772|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138458773|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138458774|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138458775|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
138458776|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138458777|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138458778|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458780|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138458781|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138355969|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138458782|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458783|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138458784|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458785|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
138458786|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458787|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458788|NCT01935531|Diclofenac|diclofenac|mesh-list
138458789|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
138458790|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458791|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458792|NCT01935531|Analgesics|analgesics|mesh-ancestor
138458793|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
138458794|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458795|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458796|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458797|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458798|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458799|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458800|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458801|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138458802|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
138458803|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
138458804|NCT01935531|Protective Agents|protective agents|mesh-ancestor
138458805|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
138458806|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138355983|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355984|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
138458807|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138458808|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458809|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
138458810|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138458811|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458812|NCT01935557|Heparin|heparin|mesh-list
138458813|NCT01935557|Calcium heparin|calcium heparin|mesh-list
138458814|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
138458815|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138458816|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138458817|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458818|NCT01935596|Ropivacaine|ropivacaine|mesh-list
138458819|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
138458820|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
138458821|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
138458822|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458823|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458824|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
138458825|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458826|NCT01935648|Ropivacaine|ropivacaine|mesh-list
138458827|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
138458828|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
138458829|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304550|NCT01940484|Hematinics|hematinics|mesh-ancestor
138458830|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458831|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
138458832|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458834|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138458835|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138458836|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138458838|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458839|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458840|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138458841|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138458842|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
138458843|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458844|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138458845|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138458846|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138458847|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138458848|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
138458849|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138304621|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458850|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138458851|NCT01935804|Metformin|metformin|mesh-list
138458852|NCT01935804|Pioglitazone|pioglitazone|mesh-list
138458853|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458854|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458855|NCT01935817|Vitamin E|vitamin e|mesh-list
138458856|NCT01935817|Silybin|silybin|mesh-list
138458857|NCT01935817|Vitamins|vitamins|mesh-ancestor
138458859|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458860|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
138458861|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458862|NCT01935817|Protective Agents|protective agents|mesh-ancestor
138458863|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138458864|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458865|NCT01935830|Ritonavir|ritonavir|mesh-list
138458866|NCT01935830|Efavirenz|efavirenz|mesh-list
138458867|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138311446|NCT05656352|Chrysarobin|chrysarobin|mesh-list
138458868|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138458869|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
138458870|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458871|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458873|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138458874|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
138458875|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458876|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138458877|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138458878|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138458879|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138458880|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138458881|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138458882|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138458883|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138458884|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138458885|NCT01935869|Petrolatum|petrolatum|mesh-list
138458886|NCT01935869|Emollients|emollients|mesh-ancestor
138458887|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
138458888|NCT01935882|Lumefantrine|lumefantrine|mesh-list
138458889|NCT01935882|Artemether|artemether|mesh-list
138458890|NCT01935882|Primaquine|primaquine|mesh-list
138458891|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138458892|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
138458893|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138458894|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138458895|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311478|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458896|NCT01935908|Levetiracetam|levetiracetam|mesh-list
138458897|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
138458898|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
138458900|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458901|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138458902|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458903|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458904|NCT01936012|Lisinopril|lisinopril|mesh-list
138193991|NCT01454180|Leucovorin|leucovorin|mesh-list
138193992|NCT01454180|Gemcitabine|gemcitabine|mesh-list
138458905|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138458906|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
138458907|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458908|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458909|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138458910|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138305008|NCT01301963|Plerixafor|plerixafor|mesh-list
138458911|NCT01936012|Protective Agents|protective agents|mesh-ancestor
138458912|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458913|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138458914|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
138458915|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138458916|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458917|NCT01936025|Incretins|incretins|mesh-ancestor
138458918|NCT01936025|Hormones|hormones|mesh-ancestor
138458919|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138458920|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138458921|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
138458922|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458923|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458924|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
138458925|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
138458926|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138458927|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138458928|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188493|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458929|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
138458931|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458932|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
138458933|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458934|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458935|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138458936|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
138458937|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458938|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458939|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138458940|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138458941|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138458942|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138458943|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458945|NCT01936090|Melphalan|melphalan|mesh-list
138458946|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138458947|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138458948|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
138458949|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458950|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138458951|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458952|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
138458953|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458954|NCT01936103|Atorvastatin|atorvastatin|mesh-list
138458955|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138458956|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138458957|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
138458958|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458959|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138458960|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138305175|NCT00378911|Sunitinib|sunitinib|mesh-list
138458961|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458962|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
138458963|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
138458964|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138458965|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
138458966|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458967|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138458968|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458969|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
138458970|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138458971|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138458972|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458973|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138458974|NCT01936233|Aspirin|aspirin|mesh-list
138458975|NCT01936233|Lamivudine|lamivudine|mesh-list
138458976|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138458977|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138458978|NCT01936233|Analgesics|analgesics|mesh-ancestor
138458979|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
138458980|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138458981|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138458982|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138458983|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138458984|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138458985|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138458986|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138458987|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138458988|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138458989|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458990|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
138458991|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138458992|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138458993|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
138458994|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138458995|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138458996|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138458997|NCT01936285|Colchicine|colchicine|mesh-list
138458998|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
138458999|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459000|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138459001|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188494|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138459002|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138459003|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459004|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459005|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
138459006|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
138459007|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138459008|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138459009|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305424|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459010|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459011|NCT01936350|Urological Agents|urological agents|mesh-ancestor
138459012|NCT01936545|Propofol|propofol|mesh-list
138459013|NCT01936545|Desflurane|desflurane|mesh-list
138459014|NCT01936545|Liver Extracts|liver extracts|mesh-list
138459015|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138459016|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459017|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459018|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138459019|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
138459020|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
138459021|NCT01936545|Hematinics|hematinics|mesh-ancestor
138459022|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138459023|NCT06071585|Formaldehyde|formaldehyde|mesh-list
138459024|NCT06071585|Disinfectants|disinfectants|mesh-ancestor
138459025|NCT06071585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459026|NCT06071481|Vitamin D|vitamin d|mesh-list
138459027|NCT06071481|Ergocalciferols|ergocalciferols|mesh-list
138459028|NCT06071481|Cholecalciferol|cholecalciferol|mesh-list
138459030|NCT06071481|Micronutrients|micronutrients|mesh-ancestor
138459031|NCT06071481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459032|NCT06071481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138459033|NCT06071481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459034|NCT06071013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138459035|NCT06071013|Gefitinib|gefitinib|mesh-list
138459036|NCT06071013|Afatinib|afatinib|mesh-list
138459037|NCT06071013|Nintedanib|nintedanib|mesh-list
138459038|NCT06071013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459039|NCT06071013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138459040|NCT06071013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459041|NCT06071013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459042|NCT06070987|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138356069|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356070|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356071|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138356072|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138356073|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138356074|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356075|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138356076|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459043|NCT06070987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138459044|NCT06070987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138459045|NCT06070987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459046|NCT06070987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459047|NCT06070987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138459048|NCT06070987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459049|NCT06070987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459050|NCT06070987|Cholinergic Agents|cholinergic agents|mesh-ancestor
138459051|NCT06070987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305625|NCT01754987|Sorafenib|sorafenib|mesh-list
138459054|NCT06070766|Ketamine|ketamine|mesh-list
138459055|NCT06070766|Analgesics|analgesics|mesh-ancestor
138459056|NCT06070766|Sensory System Agents|sensory system agents|mesh-ancestor
138459057|NCT06070766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459058|NCT06070766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459059|NCT06070766|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138459060|NCT06070766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138459061|NCT06070766|Anesthetics, General|anesthetics, general|mesh-ancestor
138459062|NCT06070766|Anesthetics|anesthetics|mesh-ancestor
138459063|NCT06070766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459064|NCT06070766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138459065|NCT06070766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138459066|NCT06070766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459067|NCT06070766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459069|NCT06070753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138459070|NCT06070753|Protective Agents|protective agents|mesh-ancestor
138459071|NCT06070753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459072|NCT06070753|Nootropic Agents|nootropic agents|mesh-ancestor
138459073|NCT06070740|Capecitabine|capecitabine|mesh-list
138459074|NCT06070740|Oxaliplatin|oxaliplatin|mesh-list
138459076|NCT06070740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459077|NCT06070740|Antimetabolites|antimetabolites|mesh-ancestor
138305726|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
138459078|NCT06070740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459079|NCT06070740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459080|NCT06070740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459082|NCT06070701|Anesthetics|anesthetics|mesh-list
138459083|NCT06070701|Anesthetics, General|anesthetics, general|mesh-list
138459084|NCT06070701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138459085|NCT06070701|Narcotics|narcotics|mesh-ancestor
138459086|NCT06070701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459087|NCT06070701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459088|NCT06070701|Analgesics|analgesics|mesh-ancestor
138459089|NCT06070701|Sensory System Agents|sensory system agents|mesh-ancestor
138459090|NCT06070701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459092|NCT06070636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459093|NCT06070636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138459094|NCT06070636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459095|NCT06070636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459096|NCT06070480|Propofol|propofol|mesh-list
138459097|NCT06070480|Desflurane|desflurane|mesh-list
138459098|NCT06070480|Anesthetics|anesthetics|mesh-ancestor
138305855|NCT00528437|Carboplatin|carboplatin|mesh-list
138459099|NCT06070480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459100|NCT06070480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459101|NCT06070480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138459102|NCT06070480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138459103|NCT06070480|Anesthetics, General|anesthetics, general|mesh-ancestor
138459104|NCT06070480|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138459106|NCT06069856|Trace Elements|trace elements|mesh-list
138356092|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356093|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356094|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
138459109|NCT06069856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459110|NCT06069856|Hematinics|hematinics|mesh-ancestor
138459111|NCT06069856|Vitamin B Complex|vitamin b complex|mesh-ancestor
138459112|NCT06069856|Vitamins|vitamins|mesh-ancestor
138459113|NCT06069830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138459114|NCT06069830|Pegaspargase|pegaspargase|mesh-list
138459115|NCT06069830|Asparaginase|asparaginase|mesh-list
138459116|NCT06069830|Antibodies|antibodies|mesh-list
138459117|NCT06069830|Immunoglobulins|immunoglobulins|mesh-list
138459118|NCT06069830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138459119|NCT06069830|Immunologic Factors|immunologic factors|mesh-ancestor
138459120|NCT06069830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459121|NCT06069830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459122|NCT06067594|Calcitonin|calcitonin|mesh-list
138459123|NCT06067594|Salmon calcitonin|salmon calcitonin|mesh-list
138459124|NCT06067594|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138459125|NCT06067594|Katacalcin|katacalcin|mesh-list
138459126|NCT06067594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459127|NCT06067594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459128|NCT06067594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138459130|NCT06066918|Pregabalin|pregabalin|mesh-list
138459131|NCT06066918|Analgesics|analgesics|mesh-ancestor
138459132|NCT06066918|Sensory System Agents|sensory system agents|mesh-ancestor
138459133|NCT06066918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459134|NCT06066918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459135|NCT06066918|Anticonvulsants|anticonvulsants|mesh-ancestor
138459136|NCT06066918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138459137|NCT06066918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459138|NCT06066918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459139|NCT06066918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459140|NCT06066918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138311681|NCT04850495|Prednisone|prednisone|mesh-list
138459141|NCT06066918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138459142|NCT06066918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459143|NCT06066918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459145|NCT06066866|Anticonvulsants|anticonvulsants|mesh-ancestor
138459146|NCT06066866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138459147|NCT06066866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459148|NCT06066866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459149|NCT06066866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138459150|NCT06066866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138459151|NCT06066866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459152|NCT06066866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418095|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459153|NCT06066866|GABA Modulators|gaba modulators|mesh-ancestor
138459154|NCT06066866|GABA Agents|gaba agents|mesh-ancestor
138459155|NCT06066866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138459156|NCT06066866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138459157|NCT06066866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138459158|NCT06065670|Clemastine|clemastine|mesh-list
138459159|NCT06065670|Antipruritics|antipruritics|mesh-ancestor
138459160|NCT06065670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138459161|NCT06065670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138459162|NCT06065670|Histamine Antagonists|histamine antagonists|mesh-ancestor
138459163|NCT06065670|Histamine Agents|histamine agents|mesh-ancestor
138459164|NCT06065670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459165|NCT06065670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459166|NCT06065670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459167|NCT06065670|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138459168|NCT06065592|Palbociclib|palbociclib|mesh-list
138459169|NCT06065592|Rivaroxaban|rivaroxaban|mesh-list
138459170|NCT06065592|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138459171|NCT06065592|Antithrombins|antithrombins|mesh-ancestor
138356103|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459173|NCT06065592|Protease Inhibitors|protease inhibitors|mesh-ancestor
138459174|NCT06065592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459175|NCT06065592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459176|NCT06065592|Anticoagulants|anticoagulants|mesh-ancestor
138459177|NCT06065592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459178|NCT06065592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138459179|NCT06063538|Amiodarone|amiodarone|mesh-list
138459180|NCT06063538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138459181|NCT06063538|Vasodilator Agents|vasodilator agents|mesh-ancestor
138459182|NCT06063538|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138459183|NCT06063538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459184|NCT06063538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459185|NCT06063538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138459186|NCT06063538|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138459187|NCT06063538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138459188|NCT06063538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459189|NCT06063538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138459190|NCT06063538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138459191|NCT06063538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138459193|NCT06062602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138459194|NCT06062602|Carboplatin|carboplatin|mesh-list
138459195|NCT06062602|Fluorouracil|fluorouracil|mesh-list
138459196|NCT06062602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138459197|NCT06062602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459198|NCT06062602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138459199|NCT06062602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138306293|NCT00000209|Analgesics|analgesics|mesh-ancestor
138459200|NCT06062602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138459201|NCT06062602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459202|NCT06062602|Antimetabolites|antimetabolites|mesh-ancestor
138459203|NCT06062602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459204|NCT06062602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138459205|NCT06062602|Immunologic Factors|immunologic factors|mesh-ancestor
138459206|NCT06062602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459207|NCT06061393|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138459208|NCT06061393|Hematinics|hematinics|mesh-ancestor
138459209|NCT06056869|Scopolamine|scopolamine|mesh-list
138459210|NCT06056869|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138459211|NCT06056869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138459212|NCT06056869|Antiemetics|antiemetics|mesh-ancestor
138459213|NCT06056869|Autonomic Agents|autonomic agents|mesh-ancestor
138459214|NCT06056869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459215|NCT06056869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459216|NCT06056869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459217|NCT06056869|Mydriatics|mydriatics|mesh-ancestor
138459218|NCT06056869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138459219|NCT06056869|Cholinergic Agents|cholinergic agents|mesh-ancestor
138459220|NCT06056869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459221|NCT06056869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459222|NCT06056869|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138459223|NCT06056869|Parasympatholytics|parasympatholytics|mesh-ancestor
138459240|NCT06037135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459241|NCT06037135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459242|NCT06037135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459243|NCT06037135|Analgesics|analgesics|mesh-ancestor
138459244|NCT06037135|Sensory System Agents|sensory system agents|mesh-ancestor
138459245|NCT06037135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459246|NCT06037135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138356116|NCT00002700|Methotrexate|methotrexate|mesh-list
138356117|NCT00002700|Vincristine|vincristine|mesh-list
138459247|NCT06037135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138459248|NCT06037135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138459249|NCT06037135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459250|NCT06037135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459251|NCT06037135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459253|NCT06001762|Letrozole|letrozole|mesh-list
138459254|NCT06001762|Anastrozole|anastrozole|mesh-list
138459255|NCT06001762|Exemestane|exemestane|mesh-list
138459256|NCT06001762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459257|NCT06001762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138459258|NCT06001762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138459259|NCT06001762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459260|NCT06001762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459261|NCT06001762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138459263|NCT06001762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459264|NCT06001762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459265|NCT06001762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138459266|NCT06001762|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138459267|NCT06001762|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138459268|NCT06001762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138194017|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459269|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
138459270|NCT05900401|Rituximab|rituximab|mesh-list
138459271|NCT05900401|Fludarabine|fludarabine|mesh-list
138459272|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138459273|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
138459274|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459275|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459276|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138459278|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459279|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459280|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138459281|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459292|NCT05883358|Clonidine|clonidine|mesh-list
138459293|NCT05883358|Buprenorphine|buprenorphine|mesh-list
138459294|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138459295|NCT05883358|Narcotics|narcotics|mesh-ancestor
138459296|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459297|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459298|NCT05883358|Analgesics|analgesics|mesh-ancestor
138459299|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
138459300|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459301|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138418244|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459302|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138459303|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
138459304|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
138459305|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138311848|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138311849|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459306|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138459307|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138459308|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459309|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459310|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459311|NCT05866315|Remifentanil|remifentanil|mesh-list
138459313|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138459314|NCT05866315|Narcotics|narcotics|mesh-ancestor
138459315|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459316|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459317|NCT05866315|Analgesics|analgesics|mesh-ancestor
138459318|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
138459319|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459320|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138459321|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
138459322|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
138459323|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
138459324|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
138459325|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459326|NCT05839119|Gemcitabine|gemcitabine|mesh-list
138459327|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459328|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459329|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
138459330|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459331|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
138459332|NCT05824767|Giapreza|giapreza|mesh-list
138459333|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
138459334|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138459335|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138459336|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
138459337|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459338|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459339|NCT05824351|Propolis|propolis|mesh-list
138459340|NCT05824351|Pycnogenols|pycnogenols|mesh-list
138459341|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138459342|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
138459343|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459344|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
138459345|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459346|NCT05824351|Protective Agents|protective agents|mesh-ancestor
138459347|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138459348|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459349|NCT05816655|Fulvestrant|fulvestrant|mesh-list
138459350|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138459351|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459352|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138459353|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138459354|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
138459355|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459356|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459359|NCT05741502|Aripiprazole|aripiprazole|mesh-list
138459360|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138459361|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138459362|NCT05741502|Ziprasidone|ziprasidone|mesh-list
138459363|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
138459364|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138459366|NCT05741502|Cariprazine|cariprazine|mesh-list
138459367|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138459368|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
138459369|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459370|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459372|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138459373|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459374|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459375|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138459376|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
138459377|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
138418326|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
138459378|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
138459380|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459381|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138459382|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138459383|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459384|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
138459385|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
138459386|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138459387|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138459388|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138459389|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138356143|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138459390|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138459391|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138459392|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138459393|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459394|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
138459395|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
138459396|NCT05706727|Phenylephrine|phenylephrine|mesh-list
138459397|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
138459398|NCT05706727|Mephentermine|mephentermine|mesh-list
138459399|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138459400|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
138459401|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
138459402|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459403|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459404|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
138459405|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138459406|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
138459407|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138459408|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138459409|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138459410|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138459411|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459412|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459413|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459414|NCT05706727|Protective Agents|protective agents|mesh-ancestor
138459416|NCT05679388|Itraconazole|itraconazole|mesh-list
138459417|NCT05679388|Relugolix|relugolix|mesh-list
138459418|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138459419|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138459420|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138459421|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459422|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459423|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138459424|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138459425|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
138459426|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459427|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138459428|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138459430|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138459431|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138459432|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138459433|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459434|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459435|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
138459436|NCT05655182|Vaccines|vaccines|mesh-list
138459437|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
138459438|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459439|NCT05628038|Leucovorin|leucovorin|mesh-list
138459440|NCT05628038|Folic Acid|folic acid|mesh-list
138459441|NCT05628038|Capecitabine|capecitabine|mesh-list
138459442|NCT05628038|Raltitrexed|raltitrexed|mesh-list
138459443|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
138459444|NCT05628038|Irinotecan|irinotecan|mesh-list
138459445|NCT05628038|Antibodies|antibodies|mesh-list
138459446|NCT05628038|Levoleucovorin|levoleucovorin|mesh-list
138459447|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
138459448|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459449|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459450|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
138459451|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459452|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459453|NCT05628038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138356151|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356152|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138459454|NCT05628038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138459455|NCT05628038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307262|NCT00002327|Cidofovir|cidofovir|mesh-list
138459457|NCT05628038|Protective Agents|protective agents|mesh-ancestor
138459458|NCT05628038|Vitamin B Complex|vitamin b complex|mesh-ancestor
138459459|NCT05628038|Vitamins|vitamins|mesh-ancestor
138459460|NCT05628038|Micronutrients|micronutrients|mesh-ancestor
138459461|NCT05628038|Hematinics|hematinics|mesh-ancestor
138459462|NCT05628038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138459463|NCT05626829|Tranilast|tranilast|mesh-list
138459464|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138459465|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459466|NCT05626829|Analgesics|analgesics|mesh-ancestor
138459467|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
138459468|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459469|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459470|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138459471|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459472|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138459473|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459474|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459475|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459476|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138459477|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
138459478|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
138459479|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459480|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138459481|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138459483|NCT05617625|Melphalan|melphalan|mesh-list
138459484|NCT05617625|Busulfan|busulfan|mesh-list
138459485|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459486|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459487|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138459488|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
138459489|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459490|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138459491|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
138459492|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138459494|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138459495|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459496|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459497|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459498|NCT05566639|Vaccines|vaccines|mesh-list
138459499|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
138459500|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459501|NCT05540275|Bevacizumab|bevacizumab|mesh-list
138194030|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
138459502|NCT05540275|Tislelizumab|tislelizumab|mesh-list
138459503|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459504|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459505|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138459506|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138459507|NCT05540275|Growth Substances|growth substances|mesh-ancestor
138459508|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459509|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
138459510|NCT05539391|Rocuronium|rocuronium|mesh-list
138459511|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138459512|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138459513|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138459514|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356166|NCT00002718|Cytarabine|cytarabine|mesh-list
138356167|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
138459515|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459517|NCT05534750|Tedizolid|tedizolid|mesh-list
138459518|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
138459519|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138459520|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459521|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138459522|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459523|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459524|NCT05526924|Fluorouracil|fluorouracil|mesh-list
138459525|NCT05526924|Tislelizumab|tislelizumab|mesh-list
138459526|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
138459527|NCT05526924|Pamiparib|pamiparib|mesh-list
138459528|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
138459529|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459530|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459531|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459532|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138459533|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
138459534|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459535|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459536|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
138459537|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459538|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138459539|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138459540|NCT05517122|Niacinamide|niacinamide|mesh-list
138459542|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
138459543|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
138459544|NCT05517122|Vitamins|vitamins|mesh-ancestor
138459545|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
138459546|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459547|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138459548|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
138459549|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459550|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138459551|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
138459552|NCT05515575|Niraparib|niraparib|mesh-list
138459553|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138459554|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459555|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459556|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459557|NCT05488522|Bevacizumab|bevacizumab|mesh-list
138459558|NCT05488522|Atezolizumab|atezolizumab|mesh-list
138459559|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459560|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459561|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138459562|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138459563|NCT05488522|Growth Substances|growth substances|mesh-ancestor
138307622|NCT00002465|Megestrol|megestrol|mesh-list
138459564|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459565|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
138459566|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138459567|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459568|NCT05469204|Acetaminophen|acetaminophen|mesh-list
138459569|NCT05469204|Digoxin|digoxin|mesh-list
138459570|NCT05469204|Midazolam|midazolam|mesh-list
138459571|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138459572|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138459573|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138194034|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459574|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459575|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459576|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138459577|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138459578|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459579|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138459580|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
138459581|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
138459582|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
138459583|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
138459584|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459585|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459586|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459587|NCT05469204|Analgesics|analgesics|mesh-ancestor
138459588|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
138459589|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459590|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
138459591|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138459592|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138459593|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459594|NCT05469204|Protective Agents|protective agents|mesh-ancestor
138459596|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459597|NCT05392608|Fulvestrant|fulvestrant|mesh-list
138459598|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138459599|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459600|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138459601|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138459602|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
138459603|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459604|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459605|NCT05360160|Venetoclax|venetoclax|mesh-list
138459606|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138459608|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459609|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
138459610|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459611|NCT05356936|Vitamin D|vitamin d|mesh-list
138459612|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
138459613|NCT05356936|Vitamins|vitamins|mesh-list
138459614|NCT05356936|Vitamin K|vitamin k|mesh-list
138459615|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
138459616|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
138459617|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459618|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138459619|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459620|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138459621|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138459622|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459623|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
138459624|NCT05356936|Coagulants|coagulants|mesh-ancestor
138459625|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
138459626|NCT05355051|Azacitidine|azacitidine|mesh-list
138307691|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138459627|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459628|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459629|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138459630|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459631|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459632|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
138459633|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459634|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
138459635|NCT05265325|Darbepoetin alfa|darbepoetin alfa|mesh-list
138459636|NCT05265325|Hematinics|hematinics|mesh-ancestor
138459637|NCT05255900|Metyrapone|metyrapone|mesh-list
138459638|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
138459639|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459640|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459641|NCT05224336|Niacin|niacin|mesh-list
138459642|NCT05224336|Psilocybin|psilocybin|mesh-list
138459643|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138459644|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
138459645|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459646|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138459647|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138459648|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
138459649|NCT05224336|Vitamins|vitamins|mesh-ancestor
138459651|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459652|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
138459653|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459654|NCT05174065|Apremilast|apremilast|mesh-list
138459655|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138307754|NCT00002495|Doxorubicin|doxorubicin|mesh-list
138459656|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459657|NCT05174065|Analgesics|analgesics|mesh-ancestor
138459658|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
138459659|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459660|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459661|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138459662|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459663|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138459664|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138459665|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459666|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459667|NCT05133804|Methylphenidate|methylphenidate|mesh-list
138459668|NCT05133804|Reboxetine|reboxetine|mesh-list
138459669|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138459670|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459671|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138459672|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138459673|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459674|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459675|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
138459676|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459677|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
138459678|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459679|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138459680|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459681|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138459682|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459683|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459685|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138307860|NCT00002189|Paclitaxel|paclitaxel|mesh-list
138459686|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138459687|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138459688|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459689|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459690|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459691|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459692|NCT05109364|Urological Agents|urological agents|mesh-ancestor
138459693|NCT05097716|Tolbutamide|tolbutamide|mesh-list
138459694|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138459695|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459696|NCT05071703|Carboplatin|carboplatin|mesh-list
138459697|NCT05071703|Etoposide|etoposide|mesh-list
138459698|NCT05071703|Topotecan|topotecan|mesh-list
138459699|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459700|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138459701|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138459702|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138459703|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459704|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459705|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138459706|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
138459707|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138459708|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138459709|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459710|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
138459711|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
138459712|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459713|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
138459714|NCT05041153|Lenvatinib|lenvatinib|mesh-list
138459715|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459716|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459717|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138459718|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459719|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138459720|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356188|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459721|NCT04931225|Landiolol|landiolol|mesh-list
138459722|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138459723|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138459724|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
138459725|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138307915|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138459726|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459727|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459728|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138459729|NCT04930991|Omeprazole|omeprazole|mesh-list
138459730|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138459731|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459732|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138459733|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289116|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138459734|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459735|NCT04905277|Atenolol|atenolol|mesh-list
138459736|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138459737|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138459738|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
138459739|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
138307986|NCT00002261|Vaccines|vaccines|mesh-list
138459740|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459741|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459742|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138459743|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138459744|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138459746|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459747|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459748|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
138459749|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459750|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308010|NCT00002273|Ganciclovir|ganciclovir|mesh-list
138459751|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138459752|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459753|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138459754|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
138459755|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138459757|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138459758|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459759|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459760|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
138459761|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138459762|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459763|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138459764|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459765|NCT04853004|Antibodies|antibodies|mesh-list
138459766|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
138459767|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459768|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
138459769|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
138459770|NCT04836637|Calcium|calcium|mesh-list
138459771|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459772|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459773|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138459774|NCT04836637|Antacids|antacids|mesh-ancestor
138459775|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459776|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459777|NCT04828083|Lidocaine|lidocaine|mesh-list
138459778|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
138459779|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
138459780|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194045|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
138459781|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356201|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356202|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
138459782|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
138459783|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459784|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138459785|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138459786|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138459787|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138312137|NCT01832402|Fentanyl|fentanyl|mesh-list
138459788|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459790|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138459791|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459792|NCT04825678|Analgesics|analgesics|mesh-ancestor
138459793|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
138459794|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459796|NCT04808505|Miglustat|miglustat|mesh-list
138459797|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459798|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459799|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138459800|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138459801|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
138459802|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459803|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138459804|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138459805|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459806|NCT04788654|Acetaminophen|acetaminophen|mesh-list
138459807|NCT04788654|Dexamethasone|dexamethasone|mesh-list
138459808|NCT04788654|Celecoxib|celecoxib|mesh-list
138459809|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138459810|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
138459811|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
138459812|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459813|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459814|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138459815|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
138459817|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459818|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138459819|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459820|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138459821|NCT04788654|Analgesics|analgesics|mesh-ancestor
138459822|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
138459823|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
138459824|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138459825|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459826|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138459827|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138459828|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459829|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459830|NCT04781647|Interferons|interferons|mesh-list
138459831|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
138459832|NCT04781647|Entecavir|entecavir|mesh-list
138459833|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459834|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
138459835|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459836|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
138459837|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459838|NCT04768569|Zonisamide|zonisamide|mesh-list
138459839|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
138459840|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138459841|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459842|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459843|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138459844|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459846|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138459847|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459848|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459849|NCT04734210|Betamethasone|betamethasone|mesh-list
138459850|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
138459852|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
138459853|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138459854|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138459855|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
138459856|NCT04734210|Hormones|hormones|mesh-ancestor
138459857|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459858|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459859|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138459860|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
138459861|NCT04711837|Propofol|propofol|mesh-list
138459862|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138459863|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459864|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459865|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138459866|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
138459867|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
138459868|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
138459869|NCT04660539|Azathioprine|azathioprine|mesh-list
138459870|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138459871|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459872|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138459873|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
138459874|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138459875|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138459876|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459877|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459878|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
138459879|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138459880|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138459881|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
138459882|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459883|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138459884|NCT04652765|Bicalutamide|bicalutamide|mesh-list
138459885|NCT04652765|Camostat|camostat|mesh-list
138459886|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
138459887|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
138459888|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138459890|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459891|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
138459892|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459893|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459894|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138459895|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138459896|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
138459897|NCT04642430|Apixaban|apixaban|mesh-list
138459898|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138459899|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
138459900|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138459901|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
138459902|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418852|NCT06223360|Vitamins|vitamins|mesh-ancestor
138459903|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459904|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
138459905|NCT04624750|Mexiletine|mexiletine|mesh-list
138459906|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138308620|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138459907|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138356223|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138356224|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356226|NCT00002748|Vaccines|vaccines|mesh-list
138459908|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138459909|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459910|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459911|NCT04619797|Carboplatin|carboplatin|mesh-list
138459912|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
138459913|NCT04619797|Pemetrexed|pemetrexed|mesh-list
138459914|NCT04619797|Atezolizumab|atezolizumab|mesh-list
138459915|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459916|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459917|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194061|NCT05504382|Naproxen|naproxen|mesh-list
138289117|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138459918|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459919|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459920|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138459921|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138459923|NCT04604509|Nicotine|nicotine|mesh-list
138459924|NCT04604509|Varenicline|varenicline|mesh-list
138459925|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138459926|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
138459927|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138459928|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459929|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138459930|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138459931|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
138459932|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312202|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
138312203|NCT00003671|Hormones|hormones|mesh-ancestor
138459933|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459934|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138459936|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138459937|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138459938|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138459939|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138459940|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
138459941|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138459942|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138459943|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459944|NCT04594005|Paclitaxel|paclitaxel|mesh-list
138459945|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138459946|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138459947|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138459948|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138459949|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138459950|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459951|NCT04560595|Caffeine|caffeine|mesh-list
138459952|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138459953|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459954|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138459955|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459956|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459957|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138459958|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138459959|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
138459960|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312229|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
138312240|NCT00384605|Hormones|hormones|mesh-ancestor
138289118|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138459989|NCT04549311|Amoxicillin|amoxicillin|mesh-list
138459990|NCT04549311|Metronidazole|metronidazole|mesh-list
138459991|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
138459992|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
138459993|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
138459994|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138459995|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138459996|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356233|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
138459997|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
138459998|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138459999|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138460000|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138460001|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460002|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312253|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
138312254|NCT00003707|Gemcitabine|gemcitabine|mesh-list
138460003|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460004|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460005|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138460006|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138460007|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138460008|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138460010|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
138460011|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
138460012|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460013|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460014|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138460015|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138460016|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138460017|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138460018|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
138460019|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460020|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460021|NCT04471987|Interleukin-12|interleukin-12|mesh-list
138460022|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138460023|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
138460024|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460025|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460026|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460027|NCT04471987|Growth Substances|growth substances|mesh-ancestor
138460028|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460029|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460030|NCT04460352|Leucovorin|leucovorin|mesh-list
138460031|NCT04460352|Paclitaxel|paclitaxel|mesh-list
138460032|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138460033|NCT04460352|Carboplatin|carboplatin|mesh-list
138460034|NCT04460352|Fluorouracil|fluorouracil|mesh-list
138460035|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
138460036|NCT04460352|Calcium|calcium|mesh-list
138460037|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
138460038|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460039|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460040|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460041|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460042|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460043|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460044|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138460045|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460046|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
138460047|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460048|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460049|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
138194064|NCT05504382|Analgesics|analgesics|mesh-ancestor
138194065|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
138194066|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194073|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460051|NCT04460352|Protective Agents|protective agents|mesh-ancestor
138460052|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
138460053|NCT04460352|Vitamins|vitamins|mesh-ancestor
138460054|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
138460055|NCT04419181|Carboplatin|carboplatin|mesh-list
138356242|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138356243|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
138356244|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460057|NCT04419181|Trastuzumab|trastuzumab|mesh-list
138460058|NCT04419181|Pertuzumab|pertuzumab|mesh-list
138460059|NCT04419181|Maytansine|maytansine|mesh-list
138460060|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138460061|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460062|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460063|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460064|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460065|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460066|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460067|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460068|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
138460069|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
138460070|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
138460071|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460072|NCT04388852|Ipilimumab|ipilimumab|mesh-list
138460073|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460074|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460075|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460076|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460077|NCT04386317|Terazosin|terazosin|mesh-list
138460078|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138460079|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138460080|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138460081|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
138460082|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460083|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460084|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460085|NCT04386317|Urological Agents|urological agents|mesh-ancestor
138460086|NCT04380857|Dexamethasone|dexamethasone|mesh-list
138460087|NCT04380857|Prednisolone|prednisolone|mesh-list
138460088|NCT04380857|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138460089|NCT04380857|Methylprednisolone|methylprednisolone|mesh-list
138460090|NCT04380857|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138460091|NCT04380857|Prednisolone acetate|prednisolone acetate|mesh-list
138460092|NCT04380857|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138460093|NCT04380857|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138460094|NCT04380857|Prednisolone phosphate|prednisolone phosphate|mesh-list
138460095|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460096|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
138460097|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
138460098|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460099|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460100|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460101|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
138460103|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460104|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460105|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460106|NCT04380857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138460107|NCT04380857|Protective Agents|protective agents|mesh-ancestor
138460108|NCT04380857|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138460109|NCT04307485|Ticagrelor|ticagrelor|mesh-list
138460110|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194074|NCT03823040|Oxiconazole|oxiconazole|mesh-list
138194075|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
138194076|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460111|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138460112|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138460113|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138460114|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
138460115|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460116|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460117|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460119|NCT04265274|Disulfiram|disulfiram|mesh-list
138460120|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309316|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
138460121|NCT04265274|Trace Elements|trace elements|mesh-ancestor
138460122|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
138460123|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460124|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138460125|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138460126|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460127|NCT04264260|Colchicine|colchicine|mesh-list
138419087|NCT06143891|Prednisone|prednisone|mesh-list
138460128|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
138309383|NCT00001259|Leuprolide|leuprolide|mesh-list
138460129|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460130|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460131|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460132|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460133|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460134|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460135|NCT04247542|Vancomycin|vancomycin|mesh-list
138460136|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
138460137|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460138|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460139|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138460140|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460141|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460142|NCT04218708|Nicotine|nicotine|mesh-list
138460143|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138460144|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
138460145|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460146|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460147|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138460148|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138460149|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
138460150|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312338|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
138312339|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460151|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460152|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
138460153|NCT04189588|Promethazine|promethazine|mesh-list
138460154|NCT04189588|Cetirizine|cetirizine|mesh-list
138460155|NCT04189588|Paclitaxel|paclitaxel|mesh-list
138460156|NCT04189588|Rituximab|rituximab|mesh-list
138460157|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460158|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460159|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460160|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460161|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460162|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460163|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460164|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
138460165|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460166|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460167|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138460168|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138460169|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460170|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
138356264|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356265|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460172|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
138460173|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460175|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
138356266|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460176|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460177|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138460178|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
138460179|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
138460180|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460181|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138460182|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
138460183|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
138194081|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460184|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138460185|NCT04176419|Acetaminophen|acetaminophen|mesh-list
138460186|NCT04176419|Celecoxib|celecoxib|mesh-list
138460187|NCT04176419|Lidocaine|lidocaine|mesh-list
138460188|NCT04176419|Ketamine|ketamine|mesh-list
138460189|NCT04176419|Gabapentin|gabapentin|mesh-list
138460190|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
138460191|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
138460192|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460193|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460194|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
138460195|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460196|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138460197|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138460198|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138460199|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138460200|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460202|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138460203|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138419220|NCT06044935|Niacin|niacin|mesh-list
138289119|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
138460205|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138460206|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138460207|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460208|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138460210|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460211|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460212|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460213|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138460214|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138460215|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460216|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
138460217|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138460218|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138460219|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138460220|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
138460221|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
138460222|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460223|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460224|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460225|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460226|NCT04162210|Dexamethasone|dexamethasone|mesh-list
138460227|NCT04162210|Pomalidomide|pomalidomide|mesh-list
138460228|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460229|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
138460230|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
138460231|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460232|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460234|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
138460235|NCT04162210|Hormones|hormones|mesh-ancestor
138460236|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460237|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356277|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356278|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356279|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460238|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460239|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
138460240|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460241|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460242|NCT04162210|Growth Substances|growth substances|mesh-ancestor
138460243|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460245|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138460246|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138460247|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460248|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
138460250|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
138460251|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138460252|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138460253|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460254|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
138460255|NCT04111822|Coagulants|coagulants|mesh-ancestor
138460256|NCT04086264|Azacitidine|azacitidine|mesh-list
138460257|NCT04086264|Decitabine|decitabine|mesh-list
138460258|NCT04086264|Venetoclax|venetoclax|mesh-list
138460259|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460260|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
138460261|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460262|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460263|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460264|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138460265|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460266|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138460267|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
138460270|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138460271|NCT04066114|Everolimus|everolimus|mesh-list
138460272|NCT04066114|Abatacept|abatacept|mesh-list
138460273|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
138460274|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138460275|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460277|NCT04066114|Hormones|hormones|mesh-ancestor
138460278|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460279|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460280|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460281|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460282|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138460283|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460284|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460285|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460286|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460287|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
138460288|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460289|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138460290|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
138460291|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460292|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460293|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
138460294|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
138460295|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356287|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138356289|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
138356290|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356291|NCT00002784|Tamoxifen|tamoxifen|mesh-list
138356292|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
138356293|NCT00002784|Doxorubicin|doxorubicin|mesh-list
138356294|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138356295|NCT00002784|Fluorouracil|fluorouracil|mesh-list
138356296|NCT00002784|Methotrexate|methotrexate|mesh-list
138460296|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460297|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138356297|NCT00002784|Epirubicin|epirubicin|mesh-list
138356298|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460298|NCT04066114|Protective Agents|protective agents|mesh-ancestor
138460299|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460300|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460301|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460302|NCT04060862|Fulvestrant|fulvestrant|mesh-list
138460303|NCT04060862|Palbociclib|palbociclib|mesh-list
138309816|NCT00003575|Etoposide|etoposide|mesh-list
138460305|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460306|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460307|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138460308|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138460309|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
138460310|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460311|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460312|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460313|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460314|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460315|NCT03971734|Regadenoson|regadenoson|mesh-list
138460316|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138460317|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138460318|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
138460319|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
138460320|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460321|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460322|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460323|NCT03875092|Paclitaxel|paclitaxel|mesh-list
138460324|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138460325|NCT03875092|Carboplatin|carboplatin|mesh-list
138460326|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
138460327|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460328|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460329|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460330|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460331|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460332|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460333|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460334|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460336|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138460337|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460338|NCT03829319|Carboplatin|carboplatin|mesh-list
138460339|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
138460340|NCT03829319|Pemetrexed|pemetrexed|mesh-list
138460341|NCT03829319|Lenvatinib|lenvatinib|mesh-list
138460342|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460343|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460344|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460345|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460347|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138460348|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309930|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
138460349|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460350|NCT03747159|Belimumab|belimumab|mesh-list
138460351|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460352|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
138460353|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460355|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460356|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460357|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460358|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460359|NCT03727100|Clonidine|clonidine|mesh-list
138460361|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
138460362|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460363|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356300|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460364|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138460365|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
138460366|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
138460367|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138460368|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138460369|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138460370|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
138460371|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460372|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460373|NCT03685331|Fulvestrant|fulvestrant|mesh-list
138460374|NCT03685331|Olaparib|olaparib|mesh-list
138460375|NCT03685331|Palbociclib|palbociclib|mesh-list
138460376|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460377|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460378|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138460379|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138460380|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
138460381|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460382|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460383|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138460384|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460385|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310119|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460386|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460387|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
138460388|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460389|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
138460390|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460391|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460392|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138460393|NCT03605719|Dexamethasone|dexamethasone|mesh-list
138460395|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460396|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
138194099|NCT05508516|Analgesics|analgesics|mesh-ancestor
138460397|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
138460398|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460399|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460400|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460401|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
138460402|NCT03605719|Hormones|hormones|mesh-ancestor
138460403|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460404|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460405|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460406|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460407|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460408|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460409|NCT03477175|Sorafenib|sorafenib|mesh-list
138460410|NCT03477175|Lenvatinib|lenvatinib|mesh-list
138460411|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460412|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460414|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460415|NCT03471182|Cocaine|cocaine|mesh-list
138460416|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
138460417|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
138460418|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460419|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460420|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
138356309|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460421|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460422|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138460423|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138460424|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138460425|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138460426|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460428|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460429|NCT03467789|Vitamin D|vitamin d|mesh-list
138460430|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
138460431|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
138460432|NCT03467789|Vitamins|vitamins|mesh-list
138460433|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
138460434|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460435|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138460436|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138460437|NCT03454646|Rivastigmine|rivastigmine|mesh-list
138460438|NCT03454646|Donepezil|donepezil|mesh-list
138460439|NCT03454646|Galantamine|galantamine|mesh-list
138460440|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
138460441|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460442|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460443|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
138460444|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460445|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460446|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
138460447|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138460449|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460450|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138460451|NCT03454646|Protective Agents|protective agents|mesh-ancestor
138460452|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138460453|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460454|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460455|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460456|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
138460457|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
138460458|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
138460459|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460460|NCT03328026|Interferons|interferons|mesh-list
138460461|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
138460462|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460463|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
138460464|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460465|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194101|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460466|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460467|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
138460468|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460469|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460470|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138460471|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
138460472|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460474|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138460475|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460476|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
138460477|NCT03266783|Apixaban|apixaban|mesh-list
138460478|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138460479|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
138460480|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138460481|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138356323|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138356324|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138356325|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138356326|NCT00002790|Cyclosporine|cyclosporine|mesh-list
138356327|NCT00002790|Sirolimus|sirolimus|mesh-list
138310320|NCT00003287|Antidotes|antidotes|mesh-ancestor
138460482|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460483|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460484|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
138460485|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
138460486|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
138460487|NCT03219359|Vedolizumab|vedolizumab|mesh-list
138460488|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
138460489|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460490|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
138460491|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460492|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460493|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460494|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
138460495|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460496|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460497|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138460498|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460499|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
138460500|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
138460501|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460502|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460503|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
138460505|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460506|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138460507|NCT03219359|Protective Agents|protective agents|mesh-ancestor
138460508|NCT03180034|Vaccines|vaccines|mesh-list
138460509|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
138460510|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460511|NCT03158805|Liraglutide|liraglutide|mesh-list
138460512|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138460513|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460514|NCT03158805|Incretins|incretins|mesh-ancestor
138460515|NCT03158805|Hormones|hormones|mesh-ancestor
138460516|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460517|NCT03126331|Nivolumab|nivolumab|mesh-list
138460518|NCT03126331|Ipilimumab|ipilimumab|mesh-list
138460519|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460520|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460521|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460522|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460523|NCT03121352|Paclitaxel|paclitaxel|mesh-list
138460524|NCT03121352|Carboplatin|carboplatin|mesh-list
138460525|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
138460526|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460527|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460528|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460529|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460530|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460531|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460532|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460533|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194110|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
138194112|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460538|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
138310566|NCT00004853|Lenograstim|lenograstim|mesh-list
138460539|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460540|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460541|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460542|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356334|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356335|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
138460544|NCT02975882|Irinotecan|irinotecan|mesh-list
138460545|NCT02975882|Camptothecin|camptothecin|mesh-list
138460546|NCT02975882|Temozolomide|temozolomide|mesh-list
138460547|NCT02975882|Temsirolimus|temsirolimus|mesh-list
138460548|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
138460549|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138460550|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460551|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460552|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460553|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460554|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460555|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
138460556|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460557|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460558|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460559|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
138460560|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460561|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
138460562|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310687|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
138460563|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460564|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460565|NCT02908672|Atezolizumab|atezolizumab|mesh-list
138460566|NCT02908672|Vemurafenib|vemurafenib|mesh-list
138460567|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138460568|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460569|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460570|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460571|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310753|NCT00004985|Nelfinavir|nelfinavir|mesh-list
138460572|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
138460573|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460574|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138419526|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460575|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460576|NCT02811133|Inositol|inositol|mesh-list
138460577|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
138460578|NCT02811133|Vitamins|vitamins|mesh-ancestor
138460579|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
138460580|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460581|NCT02775435|Paclitaxel|paclitaxel|mesh-list
138460582|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138460583|NCT02775435|Carboplatin|carboplatin|mesh-list
138460584|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
138312605|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460585|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460586|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460588|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460589|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460590|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460591|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460592|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460593|NCT02685826|Dexamethasone|dexamethasone|mesh-list
138460594|NCT02685826|Lenalidomide|lenalidomide|mesh-list
138460595|NCT02685826|Durvalumab|durvalumab|mesh-list
138460596|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460598|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
138460599|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460600|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460601|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356347|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138356348|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356349|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460602|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
138460603|NCT02685826|Hormones|hormones|mesh-ancestor
138356350|NCT05751876|Dienogest|dienogest|mesh-list
138460604|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460605|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460606|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460608|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460609|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460610|NCT02685826|Growth Substances|growth substances|mesh-ancestor
138460611|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460612|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460613|NCT02684162|Guadecitabine|guadecitabine|mesh-list
138460614|NCT02684162|Azacitidine|azacitidine|mesh-list
138460615|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460616|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460617|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
138460618|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460619|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460620|NCT02658981|Nivolumab|nivolumab|mesh-list
138460621|NCT02658981|Relatlimab|relatlimab|mesh-list
138460622|NCT02658981|Antibodies|antibodies|mesh-list
138460623|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138460624|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
138460625|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460626|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460627|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460628|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460629|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460630|NCT02575794|Masoprocol|masoprocol|mesh-list
138460631|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
138460632|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460633|NCT02575794|Protective Agents|protective agents|mesh-ancestor
138460634|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460635|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138460636|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460637|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138312620|NCT01946880|Analgesics|analgesics|mesh-ancestor
138460638|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460639|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138460640|NCT02575794|Analgesics|analgesics|mesh-ancestor
138460641|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
138460642|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460643|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460644|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460645|NCT02403505|Vaccines|vaccines|mesh-list
138460646|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
138460647|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
138460648|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460649|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138460650|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138419604|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
138460651|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138460652|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460654|NCT01993810|Etoposide|etoposide|mesh-list
138460655|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
138460657|NCT01993810|Carboplatin|carboplatin|mesh-list
138460658|NCT01993810|Pemetrexed|pemetrexed|mesh-list
138460659|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138460660|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
138460661|NCT01993810|Durvalumab|durvalumab|mesh-list
138356358|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138356359|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
138356361|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460662|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
138460663|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138460664|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
138310965|NCT00005087|Paclitaxel|paclitaxel|mesh-list
138460665|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460666|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460667|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460668|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460669|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460670|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460671|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138460672|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460673|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460674|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138460675|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138460676|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460677|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
138460678|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460679|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
138460680|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
138460681|NCT01962415|Fludarabine|fludarabine|mesh-list
138460682|NCT01962415|Melphalan|melphalan|mesh-list
138460683|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
138460684|NCT01962415|Thiotepa|thiotepa|mesh-list
138460685|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
138460686|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460687|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460688|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460689|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
138460690|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311100|NCT00005585|Vitamins|vitamins|mesh-ancestor
138460691|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460692|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
138460693|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138460694|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460695|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
138460696|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460697|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138460698|NCT01919619|Lenalidomide|lenalidomide|mesh-list
138460699|NCT01919619|Ipilimumab|ipilimumab|mesh-list
138460700|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
138460701|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460702|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460703|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460704|NCT01919619|Growth Substances|growth substances|mesh-ancestor
138460705|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460706|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356374|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356375|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460707|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460708|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138460709|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460710|NCT01918527|Capecitabine|capecitabine|mesh-list
138460711|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
138460712|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460713|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
138460714|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460715|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460717|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138460718|NCT01731236|Vancomycin|vancomycin|mesh-list
138460719|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
138460720|NCT01731236|Neomycin|neomycin|mesh-list
138460721|NCT01731236|Choline|choline|mesh-list
138460722|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460723|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138460724|NCT01731236|Analgesics|analgesics|mesh-ancestor
138460725|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
138460726|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460727|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460728|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460729|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460730|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138460731|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138312657|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460732|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460733|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138460734|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138460735|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194125|NCT05563350|Midazolam|midazolam|mesh-list
138194126|NCT05563350|Omeprazole|omeprazole|mesh-list
138194127|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138194128|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138194129|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460738|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138460739|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460740|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460741|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138460742|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138460743|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
138460744|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138460745|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
138460746|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460747|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138460748|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
138460749|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138460750|NCT01590069|Aldesleukin|aldesleukin|mesh-list
138460751|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460752|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138460753|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138460754|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
138460755|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460756|NCT01529593|Metformin|metformin|mesh-list
138460757|NCT01529593|Sirolimus|sirolimus|mesh-list
138460758|NCT01529593|Temsirolimus|temsirolimus|mesh-list
138356402|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
138356403|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460759|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
138460760|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138460761|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460762|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460763|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460764|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460765|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460766|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
138460767|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460768|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460769|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460770|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460771|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
138460773|NCT01446133|Lenalidomide|lenalidomide|mesh-list
138460774|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460775|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460776|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
138460777|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460778|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460779|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460780|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460781|NCT01446133|Growth Substances|growth substances|mesh-ancestor
138460782|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460784|NCT01349881|Sulindac|sulindac|mesh-list
138460785|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460786|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138460787|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138460788|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138460789|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460790|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138460791|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460792|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460793|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460794|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138460795|NCT01349881|Analgesics|analgesics|mesh-ancestor
138460796|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
138311513|NCT05426031|Protamines|protamines|mesh-list
138460797|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460798|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460799|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460800|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312761|NCT01912872|Budesonide|budesonide|mesh-list
138460801|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138460802|NCT01295645|Cidofovir|cidofovir|mesh-list
138460803|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
138460804|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460805|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460806|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460809|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460810|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460811|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460812|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460813|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460814|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460815|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
138460816|NCT01234025|Hormones|hormones|mesh-ancestor
138460817|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460818|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460819|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460820|NCT01187199|Sirolimus|sirolimus|mesh-list
138460821|NCT01187199|Paclitaxel|paclitaxel|mesh-list
138460822|NCT01187199|Bevacizumab|bevacizumab|mesh-list
138460823|NCT01187199|Carboplatin|carboplatin|mesh-list
138356421|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
138356422|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356423|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460824|NCT01187199|Sorafenib|sorafenib|mesh-list
138460825|NCT01187199|Temsirolimus|temsirolimus|mesh-list
138460826|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
138460827|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460828|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460829|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460830|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460831|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460832|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460833|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460834|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460835|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460836|NCT01187199|Growth Substances|growth substances|mesh-ancestor
138460837|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460838|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460839|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138460840|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460841|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460842|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
138460843|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460844|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460845|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460846|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
138460847|NCT01177683|Doxorubicin|doxorubicin|mesh-list
138460848|NCT01177683|Bortezomib|bortezomib|mesh-list
138460849|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138460850|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460851|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460852|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311758|NCT04723134|Antidotes|antidotes|mesh-ancestor
138460853|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460854|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460855|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460856|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460857|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
138460858|NCT01084252|Dexamethasone|dexamethasone|mesh-list
138460859|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
138460860|NCT01084252|BB 1101|bb 1101|mesh-list
138460861|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460862|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
138460863|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
138460864|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460865|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460866|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460867|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
138460868|NCT01084252|Hormones|hormones|mesh-ancestor
138311818|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138460869|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460870|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138460871|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460872|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
138460873|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460874|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460875|NCT00993044|Bevacizumab|bevacizumab|mesh-list
138460876|NCT00993044|Irinotecan|irinotecan|mesh-list
138460877|NCT00993044|Vincristine|vincristine|mesh-list
138460879|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460880|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356429|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138356430|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138356434|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
138460881|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138460882|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138460883|NCT00993044|Growth Substances|growth substances|mesh-ancestor
138460884|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460885|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
138460886|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312803|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138460887|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138460888|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460889|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460890|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460891|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
138460892|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
138460893|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
138460894|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460895|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
138460896|NCT00955045|Istradefylline|istradefylline|mesh-list
138460897|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138460898|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138460899|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138460900|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
138460901|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460902|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460903|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460904|NCT00579644|Minocycline|minocycline|mesh-list
138460905|NCT00579644|Methotrexate|methotrexate|mesh-list
138460906|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138460907|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
138460908|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138460909|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460910|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460911|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
138460912|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460913|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460914|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
138460915|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460916|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138460917|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460918|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
138460919|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460920|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138460921|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138460922|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460924|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460926|NCT00116272|Analgesics|analgesics|mesh-ancestor
138460927|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
138460928|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460929|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460930|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138460931|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138460932|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460933|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460934|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
138460935|NCT00080886|Cytarabine|cytarabine|mesh-list
138460936|NCT00080886|Rituximab|rituximab|mesh-list
138460937|NCT00080886|Etoposide|etoposide|mesh-list
138460938|NCT00080886|Melphalan|melphalan|mesh-list
138460940|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460941|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460942|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
138194150|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
138460943|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460945|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460946|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138460947|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356447|NCT05312112|Venetoclax|venetoclax|mesh-list
138460948|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460949|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460950|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138460951|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
138460952|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
138460953|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138460954|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460955|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138460956|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
138460957|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138460958|NCT01936636|Fentanyl|fentanyl|mesh-list
138460959|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138460960|NCT01936636|Narcotics|narcotics|mesh-ancestor
138460961|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460962|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460963|NCT01936636|Analgesics|analgesics|mesh-ancestor
138460964|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
138460965|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138460966|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138460967|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138460968|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
138460969|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
138460970|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138460971|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138460972|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138460973|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
138460974|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460975|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312103|NCT02333370|Tamoxifen|tamoxifen|mesh-list
138460976|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138460977|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460979|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
138460980|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460982|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
138460983|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138460984|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460985|NCT01937078|Famotidine|famotidine|mesh-list
138460986|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138460987|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138460988|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138460989|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
138460990|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
138460991|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138460992|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460993|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460994|NCT01937104|Remifentanil|remifentanil|mesh-list
138460996|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138460997|NCT01937104|Narcotics|narcotics|mesh-ancestor
138460998|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460999|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461000|NCT01937104|Analgesics|analgesics|mesh-ancestor
138461001|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
138461002|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461003|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138461004|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
138461005|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
138461006|NCT01937169|Levodopa|levodopa|mesh-list
138461007|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138461008|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138461009|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
138461010|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194156|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194157|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
138194158|NCT01453946|Budesonide|budesonide|mesh-list
138461011|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461012|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461013|NCT01937182|Citalopram|citalopram|mesh-list
138312149|NCT01210625|Psyllium|psyllium|mesh-list
138461014|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138461016|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138461017|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461018|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461019|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461020|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
138461021|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461022|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138461023|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
138461024|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461025|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138461026|NCT01937234|Metoclopramide|metoclopramide|mesh-list
138461027|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
138461028|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
138461029|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461030|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461031|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461032|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138461033|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138461034|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
138461035|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461036|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461037|NCT01937325|Ivacaftor|ivacaftor|mesh-list
138461038|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138461039|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461040|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461042|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138461043|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461044|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461045|NCT01937442|Thalidomide|thalidomide|mesh-list
138461046|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461047|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
138461048|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461049|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
138461050|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461051|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461052|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461053|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461054|NCT01937442|Growth Substances|growth substances|mesh-ancestor
138461055|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
138461056|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461057|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
138461058|NCT01937494|Histamine|histamine|mesh-list
138461059|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
138461060|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
138461061|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461062|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461063|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461064|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
138461065|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
138461066|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461067|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
138461068|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461069|NCT01937611|Midazolam|midazolam|mesh-list
138356453|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138356454|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356455|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461070|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
138461071|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138461072|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461073|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461074|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138461075|NCT01937611|Analgesics|analgesics|mesh-ancestor
138461076|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
138461077|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461078|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138461079|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138461081|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
138461082|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312405|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461083|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461084|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461085|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138461086|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461087|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461088|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138461089|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
138461090|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
138461091|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
138461093|NCT01937650|Metronidazole|metronidazole|mesh-list
138461094|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461095|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461096|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138461097|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138461098|NCT01937728|Interferons|interferons|mesh-list
138461099|NCT01937728|Ribavirin|ribavirin|mesh-list
138461100|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
138461101|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
138461102|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138461103|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461104|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
138461105|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420055|NCT05534620|Treosulfan|treosulfan|mesh-list
138461106|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
138461107|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461109|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461110|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
138461111|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138461112|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
138461113|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461114|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461115|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138461116|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138461117|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138461118|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
138461119|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461120|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312532|NCT02211443|Antibodies|antibodies|mesh-list
138461121|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138461122|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461123|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
138461124|NCT01937754|Protective Agents|protective agents|mesh-ancestor
138461125|NCT01937767|Fentanyl|fentanyl|mesh-list
138461126|NCT01937767|Remifentanil|remifentanil|mesh-list
138461127|NCT01937767|Propofol|propofol|mesh-list
138461128|NCT01937767|Sevoflurane|sevoflurane|mesh-list
138461129|NCT01937767|Rocuronium|rocuronium|mesh-list
138461130|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138356477|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461131|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461132|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461133|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138356478|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
138461134|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
138461135|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
138461136|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138461137|NCT01937767|Narcotics|narcotics|mesh-ancestor
138461138|NCT01937767|Analgesics|analgesics|mesh-ancestor
138461139|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
138461140|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461141|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461142|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138461143|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138461144|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138461145|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138461146|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138461148|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
138461149|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194169|NCT01455896|Exenatide|exenatide|mesh-list
138461150|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138461151|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138461152|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461153|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461154|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138461155|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138461156|NCT01937832|Ertapenem|ertapenem|mesh-list
138461157|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461158|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461159|NCT01938092|Diazepam|diazepam|mesh-list
138461160|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461161|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
138461162|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
138461163|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
138461164|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461165|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461166|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461167|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138461168|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461169|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138461170|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138312623|NCT01946880|Filaricides|filaricides|mesh-ancestor
138461171|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138461172|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461173|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461174|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138461175|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
138461176|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
138461177|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
138461178|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
138461179|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312685|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138461180|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461182|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461183|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461185|NCT01938144|Ibuprofen|ibuprofen|mesh-list
138461186|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138461187|NCT01938144|Analgesics|analgesics|mesh-ancestor
138461188|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
138461189|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461190|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461191|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
138461192|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138461193|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138461194|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461195|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138461196|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312760|NCT01912872|Omalizumab|omalizumab|mesh-list
138461197|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356488|NCT04705818|Durvalumab|durvalumab|mesh-list
138356489|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461198|NCT01938183|Metronidazole|metronidazole|mesh-list
138356491|NCT04610736|Temozolomide|temozolomide|mesh-list
138461199|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461200|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461201|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138461202|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138461204|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138461205|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461206|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138461207|NCT01938235|Incretins|incretins|mesh-ancestor
138461208|NCT01938235|Hormones|hormones|mesh-ancestor
138461209|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461210|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
138461211|NCT01938300|Analgesics|analgesics|mesh-ancestor
138461212|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
138461213|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461214|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461215|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
138461216|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461217|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138461218|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
138461219|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138461220|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461221|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461222|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461223|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
138461224|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461225|NCT01938417|Tobramycin|tobramycin|mesh-list
138461226|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461227|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461228|NCT01938443|Trametinib|trametinib|mesh-list
138461229|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461230|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138461231|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461232|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461234|NCT01938456|Trametinib|trametinib|mesh-list
138461235|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461236|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
138461237|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
138461238|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461239|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461240|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138461241|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461242|NCT01938508|Minocycline|minocycline|mesh-list
138461243|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461244|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461245|NCT01938612|Durvalumab|durvalumab|mesh-list
138461246|NCT01938612|Tremelimumab|tremelimumab|mesh-list
138461247|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461248|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461249|NCT01938729|Dexamethasone|dexamethasone|mesh-list
138461250|NCT01938729|Gemcitabine|gemcitabine|mesh-list
138461251|NCT01938729|Floxuridine|floxuridine|mesh-list
138461252|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138461253|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
138461254|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
138461255|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461256|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461257|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461258|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
138461259|NCT01938729|Hormones|hormones|mesh-ancestor
138461260|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356496|NCT04529538|Vaccines|vaccines|mesh-list
138356497|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
138356500|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
138356501|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138356502|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138356503|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461261|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138461262|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461263|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461264|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
138312903|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138461265|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461266|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
138461267|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
138461268|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
138461269|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461270|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461271|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
138461272|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461273|NCT01938781|Entecavir|entecavir|mesh-list
138461274|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
138461275|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461276|NCT01938820|Entecavir|entecavir|mesh-list
138461277|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
138461278|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461279|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138461280|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138461281|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461282|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138461283|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461284|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461285|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461286|NCT01938872|Paclitaxel|paclitaxel|mesh-list
138461287|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138461288|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461289|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
138461290|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
138461291|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461292|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461294|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
138194179|NCT05560542|Atropine|atropine|mesh-list
138461295|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461296|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461297|NCT01939054|Docetaxel|docetaxel|mesh-list
138461298|NCT01939054|Capecitabine|capecitabine|mesh-list
138461299|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
138461300|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461301|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
138461302|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
138461303|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461304|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461305|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461306|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
138461307|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461308|NCT01939093|Thiamine|thiamine|mesh-list
138461309|NCT01939093|Cinnarizine|cinnarizine|mesh-list
138461310|NCT01939093|Diazepam|diazepam|mesh-list
138461311|NCT01939093|Vitamins|vitamins|mesh-ancestor
138461312|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
138461313|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461314|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
138356508|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
138461315|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461316|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
138461318|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
138461319|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461320|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461321|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138461322|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461323|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138461324|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138461325|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138461326|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461327|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461328|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138461329|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
138461330|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
138461331|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
138461332|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
138461333|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461334|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461335|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138461336|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461337|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461339|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
138461341|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
138313220|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
138461342|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
138461343|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461344|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461345|NCT01939327|Rituximab|rituximab|mesh-list
138461346|NCT01939327|Lenalidomide|lenalidomide|mesh-list
138461347|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461348|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461349|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
138461350|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461351|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461352|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461353|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461354|NCT01939327|Growth Substances|growth substances|mesh-ancestor
138461355|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
138461356|NCT01939379|Acetaminophen|acetaminophen|mesh-list
138461357|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138461358|NCT01939379|Morphine|morphine|mesh-list
138461359|NCT01939379|Oxycodone|oxycodone|mesh-list
138461360|NCT01939379|Analgesics|analgesics|mesh-list
138461361|NCT01939379|Ropivacaine|ropivacaine|mesh-list
138461362|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138461363|NCT01939379|Narcotics|narcotics|mesh-ancestor
138461364|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461365|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461366|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
138194187|NCT05560542|Hormones|hormones|mesh-ancestor
138461367|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461368|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138461369|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
138461370|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138461371|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138461372|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138461373|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461374|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
138461375|NCT01939418|Gemcitabine|gemcitabine|mesh-list
138461376|NCT01939418|Everolimus|everolimus|mesh-list
138356529|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
138356530|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138356531|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
138461377|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461378|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461379|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
138461380|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461381|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138461382|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138461383|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461384|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461385|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
138461386|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461387|NCT01939444|Naloxone|naloxone|mesh-list
138461388|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138313384|NCT01802580|Hormones|hormones|mesh-ancestor
138461389|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461390|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
138461391|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461392|NCT01939457|Misoprostol|misoprostol|mesh-list
138461393|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138461394|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
138461395|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461396|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461397|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138461398|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461399|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
138461401|NCT01939483|Camptothecin|camptothecin|mesh-list
138461402|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138461403|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138461404|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461405|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461406|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461407|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138461409|NCT01939509|Bisoprolol|bisoprolol|mesh-list
138461410|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138461411|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138461412|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
138461413|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
138461414|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461415|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461416|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138461417|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138461418|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138461419|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138461420|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461421|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313509|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138461422|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138461423|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
138461424|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461426|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
138461427|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138461428|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461429|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461430|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461431|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461432|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138461433|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461434|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461435|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461436|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138461437|NCT01939574|Bevacizumab|bevacizumab|mesh-list
138461438|NCT01939574|Temozolomide|temozolomide|mesh-list
138461439|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461440|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461441|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461442|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461443|NCT01939574|Growth Substances|growth substances|mesh-ancestor
138461444|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461445|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
138461446|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138461447|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
138356544|NCT03846570|Hormones|hormones|mesh-ancestor
138461448|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461450|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
138461451|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461452|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461453|NCT01939691|Prednisolone|prednisolone|mesh-list
138461454|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138461455|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
138461456|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138461457|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
138461458|NCT01939691|Nepafenac|nepafenac|mesh-list
138461459|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138461460|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
138461461|NCT01939691|Difluprednate|difluprednate|mesh-list
138461462|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138461463|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
138461464|NCT01939691|Hormones|hormones|mesh-ancestor
138461465|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461466|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461467|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138461468|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461469|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
138461470|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
138461471|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461472|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461473|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138461474|NCT01939691|Protective Agents|protective agents|mesh-ancestor
138461475|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138461476|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138461477|NCT01939691|Analgesics|analgesics|mesh-ancestor
138461478|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
138461479|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461480|NCT01939730|Rituximab|rituximab|mesh-list
138313683|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461481|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138356545|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356546|NCT03838848|Carboplatin|carboplatin|mesh-list
138461482|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461483|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
138461484|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356548|NCT03838848|Antibodies|antibodies|mesh-list
138356549|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
138356550|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
138356551|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356552|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356553|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356554|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356555|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356556|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356557|NCT03787602|Avelumab|avelumab|mesh-list
138356558|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461485|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461487|NCT01939743|Lidocaine|lidocaine|mesh-list
138461488|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
138461489|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
138461490|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461491|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461492|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
138461493|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461494|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138461495|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138461496|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138461497|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461498|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461499|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138461500|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138461502|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138461503|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461504|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138461505|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461506|NCT01939834|Insulin|insulin|mesh-list
138461507|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138461508|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461510|NCT01939886|Lumefantrine|lumefantrine|mesh-list
138461511|NCT01939886|Artemether|artemether|mesh-list
138461512|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138461513|NCT01939886|Mefloquine|mefloquine|mesh-list
138461514|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
138461515|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138461516|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138461517|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461518|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461519|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
138461520|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
138461521|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138461522|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
138461523|NCT01939912|Adenosine|adenosine|mesh-list
138461524|NCT01939912|Analgesics|analgesics|mesh-ancestor
138461525|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
138461526|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461527|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461528|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138461529|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461530|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138461531|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
138461532|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
138461533|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461534|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461535|NCT01939990|Nebivolol|nebivolol|mesh-list
138461536|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138461537|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461538|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138461539|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138461540|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138461541|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
138461542|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461543|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461544|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461545|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138461546|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461547|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461548|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461549|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138461551|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461552|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461553|NCT01940224|Pregabalin|pregabalin|mesh-list
138461554|NCT01940224|Morphine|morphine|mesh-list
138461555|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138461556|NCT01940224|Narcotics|narcotics|mesh-ancestor
138461557|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461558|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461559|NCT01940224|Analgesics|analgesics|mesh-ancestor
138461560|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
138461561|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461562|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
138461563|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138461564|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461565|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461566|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461568|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461569|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461570|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
138461571|NCT01940250|Analgesics|analgesics|mesh-ancestor
138461572|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
138461573|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461574|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461575|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
138461576|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461577|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138194203|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
138461578|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
138461579|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138461580|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461581|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461582|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461583|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
138356597|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138356598|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356599|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356600|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
138356601|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138356602|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356603|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138356604|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356605|NCT02795988|Capecitabine|capecitabine|mesh-list
138356606|NCT02795988|Fluorouracil|fluorouracil|mesh-list
138461584|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461585|NCT01940393|Cetirizine|cetirizine|mesh-list
138461586|NCT01940393|Fexofenadine|fexofenadine|mesh-list
138461587|NCT01940393|Desloratadine|desloratadine|mesh-list
138461588|NCT01940393|Ebastine|ebastine|mesh-list
138461589|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138461590|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138461591|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138461593|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
138461594|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461595|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461596|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461597|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138461599|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
138461600|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138461601|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138461602|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461603|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
138461604|NCT01940419|Coagulants|coagulants|mesh-ancestor
138461605|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
138461606|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138461607|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138314076|NCT01780662|Antibodies|antibodies|mesh-list
138461608|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461609|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
138461610|NCT01940536|Coagulants|coagulants|mesh-ancestor
138461611|NCT01940601|Lenograstim|lenograstim|mesh-list
138461612|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138461613|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
138461614|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461615|NCT01940627|Ubiquinone|ubiquinone|mesh-list
138461616|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
138461617|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
138461618|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461619|NCT01940627|Vitamins|vitamins|mesh-ancestor
138461620|NCT01940653|Estradiol|estradiol|mesh-list
138461621|NCT01940653|Progesterone|progesterone|mesh-list
138461622|NCT01940653|Estrogens|estrogens|mesh-ancestor
138356615|NCT02782104|Esketamine|esketamine|mesh-list
138356616|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
138356617|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138356618|NCT01821690|Buspirone|buspirone|mesh-list
138356619|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138356620|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138356621|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356622|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356623|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138356624|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138461623|NCT01940653|Hormones|hormones|mesh-ancestor
138461624|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461625|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356625|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
138461626|NCT01940653|Progestins|progestins|mesh-ancestor
138461627|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
138461628|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138461629|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138461630|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461631|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
138461632|NCT01940692|Coagulants|coagulants|mesh-ancestor
138461633|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
138461634|NCT01940718|Testosterone|testosterone|mesh-list
138461635|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
138461636|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
138461637|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138420605|NCT04883346|Hormones|hormones|mesh-ancestor
138461638|NCT01940718|Androgens|androgens|mesh-ancestor
138461639|NCT01940718|Hormones|hormones|mesh-ancestor
138461640|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461641|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461642|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138461643|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461644|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
138461645|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138461646|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461647|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461648|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
138461649|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
138461650|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
138314194|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
138461651|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461652|NCT01940952|Donepezil|donepezil|mesh-list
138461653|NCT01940952|Udenafil|udenafil|mesh-list
138461654|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138461655|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461656|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461657|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
138461658|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313221|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138461659|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461660|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
138461661|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138461662|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138461663|NCT01940965|Lixisenatide|lixisenatide|mesh-list
138461664|NCT01940965|Biguanides|biguanides|mesh-list
138461665|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138461666|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461668|NCT01940978|Methylphenidate|methylphenidate|mesh-list
138461669|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138461670|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461671|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138461672|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138461673|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461674|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461675|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
138461676|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138356640|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138356641|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356642|NCT00577200|Midazolam|midazolam|mesh-list
138356643|NCT00577200|Sufentanil|sufentanil|mesh-list
138356644|NCT00577200|Propofol|propofol|mesh-list
138356645|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138356646|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461677|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
138461678|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138461679|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461680|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138461681|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
138461682|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
138461683|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138461684|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
138461685|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138461686|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138461687|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138461688|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461689|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461690|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
138461691|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461692|NCT01941056|Vaccines|vaccines|mesh-list
138461693|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
138313271|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461694|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461695|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
138461696|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138461697|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138461698|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
138461699|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
138461700|NCT01941134|Estradiol|estradiol|mesh-list
138461701|NCT01941134|Estrogens|estrogens|mesh-ancestor
138461702|NCT01941134|Hormones|hormones|mesh-ancestor
138461703|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461704|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461705|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138461706|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461707|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138461708|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138461709|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138461710|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138461712|NCT01941173|Fluorouracil|fluorouracil|mesh-list
138420663|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
138461713|NCT01941173|Irinotecan|irinotecan|mesh-list
138461714|NCT01941173|Aflibercept|aflibercept|mesh-list
138461715|NCT01941173|Calcium|calcium|mesh-list
138461716|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
138461717|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
138461718|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461719|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461720|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
138461721|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461722|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461723|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461724|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461725|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
138461726|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138356647|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356648|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138356649|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
138356650|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
138356651|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138356652|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138356653|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138356654|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138356656|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
138461727|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138461728|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461729|NCT01941173|Antidotes|antidotes|mesh-ancestor
138461730|NCT01941173|Protective Agents|protective agents|mesh-ancestor
138461731|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
138461732|NCT01941173|Vitamins|vitamins|mesh-ancestor
138461733|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
138314576|NCT01721772|Nivolumab|nivolumab|mesh-list
138461734|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461735|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461736|NCT01941173|Growth Substances|growth substances|mesh-ancestor
138461737|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
138461738|NCT01941199|Metformin|metformin|mesh-list
138461739|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138461740|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461742|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138461743|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461744|NCT01941264|Lumefantrine|lumefantrine|mesh-list
138461745|NCT01941264|Artemether|artemether|mesh-list
138314604|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138461746|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138461747|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
138461748|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138461749|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138461750|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461751|NCT01941316|Irinotecan|irinotecan|mesh-list
138461752|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138461753|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138461754|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461755|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461756|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461757|NCT01941329|Ranibizumab|ranibizumab|mesh-list
138461758|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461759|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461760|NCT01941329|Growth Substances|growth substances|mesh-ancestor
138461761|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461762|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
138461763|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461764|NCT01941407|Bevacizumab|bevacizumab|mesh-list
138461765|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138461766|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461767|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138461768|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138461769|NCT01941407|Growth Substances|growth substances|mesh-ancestor
138461770|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461772|NCT01941524|Poractant alfa|poractant alfa|mesh-list
138461773|NCT01941524|Beractant|beractant|mesh-list
138461774|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138461775|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
138461776|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138461777|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
138461778|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461779|NCT01941602|Enoxaparin|enoxaparin|mesh-list
138461780|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
138461781|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138461782|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138461783|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461784|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
138461785|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461786|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138461787|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138194219|NCT01456208|Norepinephrine|norepinephrine|mesh-list
138461789|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461790|NCT01941732|Urological Agents|urological agents|mesh-ancestor
138461791|NCT01941758|Vaccines|vaccines|mesh-list
138461792|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
138461793|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461794|NCT01941771|Capecitabine|capecitabine|mesh-list
138461795|NCT01941771|Vinorelbine|vinorelbine|mesh-list
138461796|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461797|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
138461798|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461799|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461800|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138461801|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138461802|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138461803|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461805|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461806|NCT01941888|Midazolam|midazolam|mesh-list
138461807|NCT01941888|Propofol|propofol|mesh-list
138461808|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138461809|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461810|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461811|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138461812|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
138461813|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
138461814|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461815|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138461816|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461817|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461818|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
138461819|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
138461820|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461821|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461822|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
138461823|NCT01941901|Bleomycin|bleomycin|mesh-list
138461824|NCT01941901|Calcium|calcium|mesh-list
138461825|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461826|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313363|NCT01803282|Growth Substances|growth substances|mesh-ancestor
138461827|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138461828|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138461829|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461830|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
138461831|NCT01941914|Calcium|calcium|mesh-list
138461832|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461833|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461834|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138461835|NCT01941953|Metformin|metformin|mesh-list
138461836|NCT01941953|Fluorouracil|fluorouracil|mesh-list
138461837|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138461838|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461839|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
138461840|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461841|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461842|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461843|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461844|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
138461845|NCT01941966|Capecitabine|capecitabine|mesh-list
138461846|NCT01941966|Mitomycins|mitomycins|mesh-list
138461847|NCT01941966|Mitomycin|mitomycin|mesh-list
138461848|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461849|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
138461850|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356663|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356664|NCT00002796|Interferons|interferons|mesh-list
138461851|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461852|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138461853|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
138461854|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138461855|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461856|NCT01941979|Leucovorin|leucovorin|mesh-list
138461857|NCT01941979|Capecitabine|capecitabine|mesh-list
138461858|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
138461859|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461860|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
138289120|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461861|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461862|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461864|NCT01941979|Protective Agents|protective agents|mesh-ancestor
138461865|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461866|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
138461867|NCT01941979|Vitamins|vitamins|mesh-ancestor
138461868|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
138461869|NCT01942070|Everolimus|everolimus|mesh-list
138461870|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138461871|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138461872|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314879|NCT01691898|Rituximab|rituximab|mesh-list
138461873|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461874|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461875|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
138461876|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461877|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461879|NCT01942109|Furosemide|furosemide|mesh-list
138461880|NCT01942109|Diuretics|diuretics|mesh-ancestor
138461881|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
138461882|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461883|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138461884|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461885|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461886|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138461887|NCT01942174|Methotrexate|methotrexate|mesh-list
138461888|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138314962|NCT01687296|Xhance|xhance|mesh-list
138461889|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138461890|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
138461891|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461892|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461893|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138461894|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
138461895|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461896|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138461897|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
138461898|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461899|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138461900|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138461901|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
138461902|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138461903|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138461905|NCT01942187|Bupropion|bupropion|mesh-list
138461906|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138461907|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
138461908|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461909|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138356677|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356678|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138356679|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138356680|NCT00002796|Analgesics|analgesics|mesh-ancestor
138356681|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
138356682|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356683|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356684|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356685|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
138461910|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138461911|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461912|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461913|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
138461914|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461915|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461916|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138461917|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138461918|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461919|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138461920|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461921|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461922|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
138194228|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194229|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
138194230|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
138194234|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
138461923|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138461924|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138461925|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
138461926|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138461927|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138461928|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138461929|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138461931|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
138461933|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
138461934|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461935|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
138461936|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138461937|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
138461938|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188495|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138461939|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138461940|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461941|NCT01942304|Calcium|calcium|mesh-list
138461942|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138461943|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461944|NCT01942343|Droperidol|droperidol|mesh-list
138461945|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138461946|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
138461947|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
138315065|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138461948|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461949|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461950|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461951|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138461952|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461953|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461954|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461955|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138315149|NCT01565148|Ranibizumab|ranibizumab|mesh-list
138356686|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
138356687|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356688|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138356689|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356691|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
138356692|NCT00002802|Melphalan|melphalan|mesh-list
138356693|NCT00002802|Ifosfamide|ifosfamide|mesh-list
138356694|NCT00002802|Dacarbazine|dacarbazine|mesh-list
138461956|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138461957|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
138461958|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461959|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461960|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138461961|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
138461962|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138461963|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
138315202|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
138461964|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138461965|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461966|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138461967|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138461969|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138461970|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138461971|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461972|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138461973|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461974|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138461975|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138461976|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138461977|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
138461978|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138461979|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461980|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138461981|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138461982|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
138461983|NCT01942447|Vancomycin|vancomycin|mesh-list
138461984|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138461986|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138461987|NCT01942460|Hematinics|hematinics|mesh-ancestor
138461988|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138461989|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138461990|NCT01942551|Tadalafil|tadalafil|mesh-list
138461991|NCT01942551|Dutasteride|dutasteride|mesh-list
138461992|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
138461993|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138194237|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138461994|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138461996|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461997|NCT01942551|Urological Agents|urological agents|mesh-ancestor
138461998|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138461999|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138462000|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462001|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462002|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462003|NCT01942577|Protective Agents|protective agents|mesh-list
138462004|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462005|NCT01942681|Propiverine|propiverine|mesh-list
138462006|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
138462007|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
138462008|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462009|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462010|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138462011|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138462012|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462014|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462015|NCT01942681|Urological Agents|urological agents|mesh-ancestor
138462016|NCT01942889|Antioxidants|antioxidants|mesh-list
138462017|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462018|NCT01942889|Protective Agents|protective agents|mesh-ancestor
138462019|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462020|NCT01943019|Linagliptin|linagliptin|mesh-list
138462021|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138462022|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462023|NCT01943019|Incretins|incretins|mesh-ancestor
138462024|NCT01943019|Hormones|hormones|mesh-ancestor
138462025|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462026|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138462027|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
138462028|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462029|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462030|NCT01943058|Megestrol|megestrol|mesh-list
138462031|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
138462032|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
138462033|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138462034|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
138462035|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462036|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462037|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138462038|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138462039|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138462040|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138462041|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138462042|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462043|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
138313516|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138462044|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138462045|NCT01943136|Mupirocin|mupirocin|mesh-list
138462046|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138462047|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462048|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138462049|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462050|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462051|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
138356733|NCT00002832|Cyclosporins|cyclosporins|mesh-list
138462052|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138462053|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
138462054|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462055|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462056|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138462057|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
138194240|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462058|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462059|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462060|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138462062|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
138462063|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
138462064|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462065|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462066|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
138462067|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462068|NCT01943305|Vaccines|vaccines|mesh-list
138462069|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
138462070|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462071|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138462072|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138462073|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138462074|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138462075|NCT01943422|Interferons|interferons|mesh-list
138315605|NCT01549002|Fentanyl|fentanyl|mesh-list
138462076|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
138462077|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
138462078|NCT01943422|Vemurafenib|vemurafenib|mesh-list
138462079|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462080|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
138462081|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462082|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
138462083|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462084|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462085|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462086|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462087|NCT01943487|Verapamil|verapamil|mesh-list
138462088|NCT01943487|Tamsulosin|tamsulosin|mesh-list
138462089|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
138462090|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138462091|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138462092|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138462093|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138462094|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462095|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462096|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462097|NCT01943487|Urological Agents|urological agents|mesh-ancestor
138462098|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138462099|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138462100|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462101|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138462102|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138462103|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462104|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138462105|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138462107|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
138462108|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356759|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138462109|NCT01943617|Entecavir|entecavir|mesh-list
138462110|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
138462111|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356760|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
138356761|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
138356762|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356763|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
138356764|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356765|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462112|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138462113|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138462114|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
138462115|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462116|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462117|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138462118|NCT01943630|Protective Agents|protective agents|mesh-ancestor
138462119|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138462120|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138462121|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462122|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462123|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
138462124|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462126|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138462127|NCT01943760|Narcotics|narcotics|mesh-ancestor
138462128|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462129|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462130|NCT01943760|Analgesics|analgesics|mesh-ancestor
138462131|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
138462132|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462133|NCT01943786|Cetuximab|cetuximab|mesh-list
138462134|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462135|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462136|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138462137|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138462138|NCT01943812|Estradiol|estradiol|mesh-list
138462139|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138462140|NCT01943812|Progesterone|progesterone|mesh-list
138462141|NCT01943812|Estrogens|estrogens|mesh-ancestor
138462142|NCT01943812|Hormones|hormones|mesh-ancestor
138462143|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462144|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462145|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138462146|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
138462147|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462148|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138462149|NCT01943812|Progestins|progestins|mesh-ancestor
138356767|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
138356768|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356769|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356770|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356771|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
138356772|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356773|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356774|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356776|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
138356777|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356778|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356779|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356780|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356781|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356782|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462150|NCT01943877|Propolis|propolis|mesh-list
138462151|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462152|NCT01943942|Montelukast|montelukast|mesh-list
138462153|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138462154|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
138462155|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138462156|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462157|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462158|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462159|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138462160|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138462161|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289121|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138462163|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138462164|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
138462165|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462166|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462167|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138462168|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
138462169|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
138462170|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
138462171|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462172|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138462173|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138462174|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138462175|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
138462176|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462177|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462178|NCT01944085|Acetaminophen|acetaminophen|mesh-list
138462179|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
138462180|NCT01944085|Ibuprofen|ibuprofen|mesh-list
138462181|NCT01944085|Vitamins|vitamins|mesh-ancestor
138462182|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
138462183|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462184|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138462185|NCT01944085|Analgesics|analgesics|mesh-ancestor
138462186|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
138462187|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462188|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
138462189|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138462190|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462191|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462192|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138462193|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462194|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194255|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
138462195|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
138462196|NCT01944085|Protective Agents|protective agents|mesh-ancestor
138462197|NCT01944176|Simvastatin|simvastatin|mesh-list
138462198|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138462199|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138462200|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
138356788|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
138356789|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356790|NCT00002898|Dactinomycin|dactinomycin|mesh-list
138356791|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
138356793|NCT00002898|Carboplatin|carboplatin|mesh-list
138356794|NCT00002898|Etoposide|etoposide|mesh-list
138356795|NCT00002898|Vincristine|vincristine|mesh-list
138356796|NCT00002898|Epirubicin|epirubicin|mesh-list
138356797|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356798|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
138356799|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462201|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462202|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138462203|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138462204|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462205|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138462206|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
138462207|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138462208|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138462209|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462211|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138462212|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462213|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138462214|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315917|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
138462215|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462216|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138462217|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138462218|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
138462219|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462220|NCT01944384|Spironolactone|spironolactone|mesh-list
138462221|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138462222|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462223|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462224|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462225|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138462226|NCT01944384|Diuretics|diuretics|mesh-ancestor
138462227|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
138462228|NCT01944410|Mitogens|mitogens|mesh-list
138462229|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
138462230|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462231|NCT01944436|Rivastigmine|rivastigmine|mesh-list
138462232|NCT01944436|Donepezil|donepezil|mesh-list
138462233|NCT01944436|Galantamine|galantamine|mesh-list
138462234|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
138462235|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462236|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462237|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462238|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462239|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462240|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
138462241|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138462242|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
138462243|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462244|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138462245|NCT01944436|Protective Agents|protective agents|mesh-ancestor
138462246|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
138462247|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138462248|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462249|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138462250|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462251|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
138462252|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462253|NCT01944683|Midazolam|midazolam|mesh-list
138462254|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138356800|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462255|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138356801|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356802|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
138316173|NCT06175338|Rituximab|rituximab|mesh-list
138462256|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462257|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462258|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138462259|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138462260|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462261|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462262|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
138462263|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
138462265|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
138462266|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462267|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462268|NCT01944735|Mannitol|mannitol|mesh-list
138462269|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138462270|NCT01944735|Diuretics|diuretics|mesh-ancestor
138462271|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
138462272|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462273|NCT01944852|Icodextrin|icodextrin|mesh-list
138462274|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
138462275|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138462276|NCT01945021|Crizotinib|crizotinib|mesh-list
138462277|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462278|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462279|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462280|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462281|NCT01945047|Midazolam|midazolam|mesh-list
138462282|NCT01945047|Ketamine|ketamine|mesh-list
138462283|NCT01945047|Analgesics|analgesics|mesh-ancestor
138462284|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
138462285|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462286|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462287|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138462288|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462289|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
138462290|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
138462291|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462292|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138462293|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138462294|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462295|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462296|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138462297|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138462298|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138462299|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138462300|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462301|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
138462302|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
138462303|NCT01945099|Insulin|insulin|mesh-list
138462304|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138462305|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462306|NCT01945268|Vaccines|vaccines|mesh-list
138462307|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
138462308|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462309|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
138421272|NCT03535688|Cycloserine|cycloserine|mesh-list
138356814|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356815|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356816|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138356817|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356818|NCT00002904|Trabectedin|trabectedin|mesh-list
138356819|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356820|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
138356823|NCT00002928|Paclitaxel|paclitaxel|mesh-list
138462310|NCT01945437|Analgesics|analgesics|mesh-ancestor
138462311|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
138462312|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462313|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462314|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
138462315|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462316|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138462318|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138462319|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313702|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
138462320|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462322|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
138462323|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462324|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138462325|NCT01945450|Clindamycin|clindamycin|mesh-list
138462326|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
138462327|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
138462328|NCT01945450|Gentamicins|gentamicins|mesh-list
138462329|NCT01945450|Ampicillin|ampicillin|mesh-list
138462330|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462331|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138194261|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194263|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
138462333|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462335|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138462336|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138316479|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462337|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462338|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462339|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138462340|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138462341|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462342|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462343|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
138462344|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
138462345|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
138462346|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
138462347|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462348|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462349|NCT01945528|Lidocaine|lidocaine|mesh-list
138462350|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
138462351|NCT01945528|Anesthetics|anesthetics|mesh-list
138462352|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462353|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462354|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
138462355|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462356|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138356824|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356825|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356826|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356827|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356828|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356829|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356830|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
138356831|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356832|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
138356833|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356834|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462357|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138462358|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138462359|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462360|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462361|NCT01945554|Bupivacaine|bupivacaine|mesh-list
138462362|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
138462363|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
138462364|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462365|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462366|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
138462367|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462368|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
138462369|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138462370|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138462371|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138462372|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462373|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462374|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462375|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316595|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
138462377|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138462378|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462379|NCT01945736|Methadone|methadone|mesh-list
138462380|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138462381|NCT01945736|Narcotics|narcotics|mesh-ancestor
138462382|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462383|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462384|NCT01945736|Analgesics|analgesics|mesh-ancestor
138462385|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
138462386|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462387|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
138316642|NCT05559476|Vaccines|vaccines|mesh-list
138462388|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
138462389|NCT01945788|Teriparatide|teriparatide|mesh-list
138462390|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138462391|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462392|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138462393|NCT01945801|Furosemide|furosemide|mesh-list
138462394|NCT01945801|Spironolactone|spironolactone|mesh-list
138462395|NCT01945801|Diuretics|diuretics|mesh-ancestor
138462396|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
138462398|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138462399|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462400|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462401|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138462403|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462404|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138462405|NCT05410626|Methylphenidate|methylphenidate|mesh-list
138462406|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138462407|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462408|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138462409|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138462410|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462411|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462412|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
138462413|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462414|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138462415|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138313753|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462416|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462417|NCT05410483|Docetaxel|docetaxel|mesh-list
138462418|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462420|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
138462421|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
138462422|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462423|NCT05410314|Inositol|inositol|mesh-list
138462424|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
138462425|NCT05410314|Vitamins|vitamins|mesh-ancestor
138462426|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
138462427|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462428|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
138462430|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
138462431|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138462432|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
138462433|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462434|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462435|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
138462436|NCT05410093|Vitamin E|vitamin e|mesh-list
138462437|NCT05410093|Tocopherols|tocopherols|mesh-list
138462438|NCT05410093|Resveratrol|resveratrol|mesh-list
138462439|NCT05410093|Vitamins|vitamins|mesh-ancestor
138462440|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
138462441|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462442|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
138462443|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462444|NCT05410093|Protective Agents|protective agents|mesh-ancestor
138462445|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462446|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138462447|NCT05409820|Anesthetics|anesthetics|mesh-list
138462448|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462449|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462450|NCT05409339|Mannitol|mannitol|mesh-list
138462451|NCT05409339|Caffeine|caffeine|mesh-list
138462452|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138462453|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462454|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138462455|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462456|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462457|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138462458|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138462459|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
138462460|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462461|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138462462|NCT05409339|Diuretics|diuretics|mesh-ancestor
138462463|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
138462464|NCT05155527|Ivermectin|ivermectin|mesh-list
138462465|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138462466|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462467|NCT05151146|Metformin|metformin|mesh-list
138462468|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138462469|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462470|NCT05068063|Bupivacaine|bupivacaine|mesh-list
138462471|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
138462472|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
138462473|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462474|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462475|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
138462476|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356843|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138356844|NCT00002952|Growth Substances|growth substances|mesh-ancestor
138356845|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
138356846|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356847|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138356848|NCT00002964|Trioxsalen|trioxsalen|mesh-list
138356849|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462477|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
138462478|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
138462479|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
138462480|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138462481|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138462482|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462483|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462484|NCT04908657|Urological Agents|urological agents|mesh-ancestor
138462485|NCT04887389|Listerine|listerine|mesh-list
138462487|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
138462488|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
138462489|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
138462490|NCT04887389|Protective Agents|protective agents|mesh-ancestor
138462491|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462492|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138462493|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462494|NCT04724655|Mineral Oil|mineral oil|mesh-list
138462495|NCT04724655|Emollients|emollients|mesh-ancestor
138462496|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
138462497|NCT04722835|Albuterol|albuterol|mesh-list
138317073|NCT04186494|Hormones|hormones|mesh-ancestor
138462499|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138462500|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
138462501|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462502|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462503|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138462504|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
138462505|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
138462506|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462507|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138462509|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138462510|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
138462511|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462512|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462513|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
138462514|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
138462516|NCT04487990|Calcium heparin|calcium heparin|mesh-list
138462517|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
138462518|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138462519|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138462520|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462521|NCT04476979|Dexamethasone|dexamethasone|mesh-list
138462522|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462523|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
138462524|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
138462525|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462526|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462527|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462528|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
138462530|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462531|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138462532|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462533|NCT04411953|Haloperidol|haloperidol|mesh-list
138356862|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138194281|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
138194282|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138462534|NCT04411953|Benztropine|benztropine|mesh-list
138194289|NCT05498064|Ensartinib|ensartinib|mesh-list
138462535|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
138462536|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
138462537|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
138462538|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462539|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462540|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462541|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138462543|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462544|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462545|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138462546|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
138462547|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462548|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462549|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138462550|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138462551|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
138462552|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138462553|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138462554|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462555|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138462556|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138462557|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462558|NCT04411940|Haloperidol|haloperidol|mesh-list
138462559|NCT04411940|Benztropine|benztropine|mesh-list
138462560|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
138462561|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
138462562|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
138462563|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462564|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462565|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462566|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138462567|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138462568|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462569|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462570|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138462571|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
138462572|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462573|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462574|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138462575|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138462576|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
138462577|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138462578|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138462579|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
138462580|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138462581|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138462582|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138462583|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138462584|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462585|NCT04030429|Crizotinib|crizotinib|mesh-list
138462586|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356888|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356889|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356890|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356891|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356892|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356893|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356894|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
138462587|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462588|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462589|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462591|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
138462592|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138462593|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
138462594|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462595|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462596|NCT03941132|Ustekinumab|ustekinumab|mesh-list
138462597|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
138462598|NCT03873246|Varenicline|varenicline|mesh-list
138462599|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138462600|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138462601|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
138194293|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194294|NCT03767062|Topiramate|topiramate|mesh-list
138462602|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462603|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462604|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462605|NCT03714880|Mifepristone|mifepristone|mesh-list
138462606|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138462607|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
138462608|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462609|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421576|NCT02997228|Vitamins|vitamins|mesh-ancestor
138462610|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138462611|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138462612|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138462613|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
138462614|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138462615|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138462616|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462617|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462618|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
138462619|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138462620|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138313844|NCT04414254|Cefprozil|cefprozil|mesh-list
138462622|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138462623|NCT03619850|Hematinics|hematinics|mesh-ancestor
138462624|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138462625|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138462626|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
138462627|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138462628|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462629|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138462630|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
138462631|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462632|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462633|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
138462634|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138317482|NCT02263729|Losartan|losartan|mesh-list
138462635|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462636|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356901|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
138356902|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356903|NCT00002988|Irinotecan|irinotecan|mesh-list
138356904|NCT00002988|Carmustine|carmustine|mesh-list
138356905|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138356906|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356907|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356908|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356909|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462637|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
138462638|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462639|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462640|NCT03532516|Brivaracetam|brivaracetam|mesh-list
138462641|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
138462642|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
138462643|NCT03333005|Clotrimazole|clotrimazole|mesh-list
138462645|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462646|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138462647|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138462648|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138462649|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317519|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462650|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462651|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138462652|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462653|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462654|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462655|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138462656|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138462658|NCT03148366|Bismuth|bismuth|mesh-list
138462659|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138462660|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462661|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138462662|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138462663|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138462664|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317581|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313876|NCT01769508|Lapatinib|lapatinib|mesh-list
138194301|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138462665|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462666|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462667|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138462668|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138462669|NCT03148366|Antacids|antacids|mesh-ancestor
138462670|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462671|NCT03122496|Durvalumab|durvalumab|mesh-list
138462672|NCT03122496|Tremelimumab|tremelimumab|mesh-list
138462673|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462674|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462675|NCT03073694|Melphalan|melphalan|mesh-list
138462676|NCT03073694|Mitomycins|mitomycins|mesh-list
138462677|NCT03073694|Mitomycin|mitomycin|mesh-list
138462678|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138462679|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
138462680|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462681|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462682|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138462683|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138462684|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
138462685|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462686|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138462687|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138462688|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356910|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356911|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
138356913|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356914|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138356915|NCT00002994|Analgesics|analgesics|mesh-ancestor
138356916|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
138356917|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356918|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462689|NCT03069703|Rituximab|rituximab|mesh-list
138462690|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462691|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462692|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
138462693|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462694|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462695|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
138462696|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462697|NCT02818738|Levamisole|levamisole|mesh-list
138462698|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138462699|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
138462700|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462701|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
138462702|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
138462703|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138462704|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462705|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462706|NCT02335099|Ticagrelor|ticagrelor|mesh-list
138462707|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138462708|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138462709|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138462710|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138462711|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
138462712|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462713|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462714|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462715|NCT02330562|Bevacizumab|bevacizumab|mesh-list
138462716|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462717|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462718|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138462719|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138462720|NCT02330562|Growth Substances|growth substances|mesh-ancestor
138462721|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462722|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
138462724|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138462725|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138462726|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462727|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
138462728|NCT02053363|Coagulants|coagulants|mesh-ancestor
138462729|NCT01100775|Galantamine|galantamine|mesh-list
138462730|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138462731|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462732|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462733|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
138356919|NCT00003000|Fentanyl|fentanyl|mesh-list
138356920|NCT00003000|Morphine|morphine|mesh-list
138356921|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138356922|NCT00003000|Narcotics|narcotics|mesh-ancestor
138356925|NCT00003000|Analgesics|analgesics|mesh-ancestor
138194309|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138462734|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462735|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462736|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138462737|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
138462738|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462739|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
138462740|NCT00504712|Testosterone|testosterone|mesh-list
138462741|NCT00504712|Androgens|androgens|mesh-ancestor
138462742|NCT00504712|Hormones|hormones|mesh-ancestor
138462743|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462744|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462745|NCT05413200|Isotretinoin|isotretinoin|mesh-list
138462746|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138462747|NCT05412589|Apatinib|apatinib|mesh-list
138462748|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462749|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462750|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462751|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462752|NCT05412576|Lidocaine|lidocaine|mesh-list
138462754|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
138188461|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165724|NCT05457972|Estradiol|estradiol|mesh-list
138165725|NCT05457972|Estrogens|estrogens|mesh-ancestor
138165726|NCT05457972|Hormones|hormones|mesh-ancestor
138317916|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138165727|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165728|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165729|NCT05453929|Rocuronium|rocuronium|mesh-list
138165730|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138165731|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138165732|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138165733|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165734|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165735|NCT05449145|Vitamin D|vitamin d|mesh-list
138165736|NCT05449145|Vitamins|vitamins|mesh-ancestor
138165737|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
138165738|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165739|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138165740|NCT05426681|Glyburide|glyburide|mesh-list
138165741|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138165742|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165743|NCT05406726|Palmidrol|palmidrol|mesh-list
138165744|NCT05406726|Analgesics|analgesics|mesh-ancestor
138165745|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
138165746|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165747|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165748|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138165749|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165750|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165751|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165752|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
138165753|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165754|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138165755|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138165756|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165757|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165758|NCT05406726|Hormones|hormones|mesh-ancestor
138313961|NCT01809132|Zinc|zinc|mesh-list
138313979|NCT01809132|Hormones|hormones|mesh-ancestor
138165759|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165760|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
138165761|NCT05369468|Bupivacaine|bupivacaine|mesh-list
138165762|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
138165763|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
138165764|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165766|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
138165767|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165768|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138165769|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165770|NCT05369468|Analgesics|analgesics|mesh-ancestor
138165771|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138165772|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138165773|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138165774|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165775|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165776|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165777|NCT05368623|Mydriatics|mydriatics|mesh-list
138165778|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
138165779|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165780|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165781|NCT05367362|Minocycline|minocycline|mesh-list
138165782|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165783|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165784|NCT05272462|Minoxidil|minoxidil|mesh-list
138165785|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138165786|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
138165787|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
138165788|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138165789|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138165790|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138165791|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165792|NCT05137262|Cisplatin|cisplatin|mesh-list
138165793|NCT05137262|Doxorubicin|doxorubicin|mesh-list
138165794|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138165795|NCT05137262|Methotrexate|methotrexate|mesh-list
138165797|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
138165798|NCT05137262|Vinblastine|vinblastine|mesh-list
138165799|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165800|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165801|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138165802|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165803|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165804|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165805|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138165807|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165808|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165809|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165811|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
138165812|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138165813|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165814|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
138165815|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165816|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165817|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165818|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138165819|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
138165820|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165821|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138165822|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165823|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194320|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194321|NCT03765502|Hormones|hormones|mesh-ancestor
138194322|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194323|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194324|NCT03765502|Incretins|incretins|mesh-ancestor
138194325|NCT05285124|Melatonin|melatonin|mesh-list
138194327|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194328|NCT05285124|Protective Agents|protective agents|mesh-ancestor
138356948|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
138165824|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165825|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165827|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
138165828|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138165829|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138165830|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
138165831|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165832|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165833|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138165834|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138165835|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
138165836|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165837|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138165838|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138165840|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138165841|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138165842|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138165843|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138165844|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
138165845|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165846|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165847|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138165848|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
138165849|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
138165850|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
138165851|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138165852|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138165853|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
138165854|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165855|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314026|NCT01766310|Folic Acid|folic acid|mesh-list
138165856|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138165857|NCT05022524|Acetic Acid|acetic acid|mesh-list
138165858|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165859|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165860|NCT04988685|Sirolimus|sirolimus|mesh-list
138165862|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165863|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165864|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165865|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165866|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165867|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165868|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165869|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165870|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165871|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
138165872|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165873|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
138356957|NCT00003048|Amifostine|amifostine|mesh-list
138356958|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138356959|NCT00003048|Protective Agents|protective agents|mesh-ancestor
138356960|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356962|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165874|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165875|NCT04982029|Cannabidiol|cannabidiol|mesh-list
138165876|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
138165877|NCT04953130|Vaccines|vaccines|mesh-list
138165878|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
138165879|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165880|NCT04925505|Anesthetics|anesthetics|mesh-list
138165881|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165882|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165883|NCT04841265|Vitamin D|vitamin d|mesh-list
138165884|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
138165885|NCT04841265|Vitamins|vitamins|mesh-ancestor
138165886|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
138165887|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165888|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138165889|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138165890|NCT04730037|Warfarin|warfarin|mesh-list
138165891|NCT04730037|Edoxaban|edoxaban|mesh-list
138165892|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
138165893|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138165894|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
138165895|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138165898|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165899|NCT04719221|Evolocumab|evolocumab|mesh-list
138165900|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138165901|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138165902|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138165903|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
138165904|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165905|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138165906|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
138165907|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165908|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138165909|NCT04696575|Lamivudine|lamivudine|mesh-list
138165910|NCT04696575|Carboplatin|carboplatin|mesh-list
138165911|NCT04696575|Etoposide|etoposide|mesh-list
138165912|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
138165913|NCT04696575|Atezolizumab|atezolizumab|mesh-list
138165914|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
138165915|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138165916|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165917|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165918|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138165919|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165920|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165921|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165922|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138165923|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165924|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138165925|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165927|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165928|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138165929|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138356982|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356983|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356984|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356985|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356986|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
138356987|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356988|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356989|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356990|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356991|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
138356992|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165930|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
138165931|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165932|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
138165934|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165935|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165936|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165937|NCT04688788|Fexofenadine|fexofenadine|mesh-list
138165938|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
138165939|NCT04688788|Rituximab|rituximab|mesh-list
138165940|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
138194335|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
138194336|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194337|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
138194338|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194339|NCT01450046|Protective Agents|protective agents|mesh-ancestor
138194340|NCT01450124|Boswellic acid|boswellic acid|mesh-list
138194341|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194342|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194343|NCT01450124|Analgesics|analgesics|mesh-ancestor
138194344|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
138194345|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194346|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165942|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165943|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
138165944|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165945|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165946|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165948|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
138165949|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314093|NCT01762800|Xhance|xhance|mesh-list
138165950|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138165953|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165954|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138165956|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138165957|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138165958|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138165959|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
138165960|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
138165961|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165962|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165963|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
138165964|NCT04683679|Olaparib|olaparib|mesh-list
138165965|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165966|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165967|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138165968|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165969|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138165970|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165971|NCT04623775|Paclitaxel|paclitaxel|mesh-list
138165972|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138165973|NCT04623775|Carboplatin|carboplatin|mesh-list
138165974|NCT04623775|Nivolumab|nivolumab|mesh-list
138165975|NCT04623775|Pemetrexed|pemetrexed|mesh-list
138165976|NCT04623775|Relatlimab|relatlimab|mesh-list
138165977|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165978|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165979|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165980|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356995|NCT00003066|Estramustine|estramustine|mesh-list
138356996|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356997|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165981|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165982|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165983|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165984|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138165985|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165986|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138165987|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165988|NCT04586062|Plasminogen|plasminogen|mesh-list
138165989|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138165990|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138165991|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165993|NCT04578938|Analgesics|analgesics|mesh-ancestor
138165994|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
138165995|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165996|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165997|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138165998|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138165999|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
138166001|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166002|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138166003|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138166004|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166005|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314108|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138166006|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
138166007|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138166011|NCT04540380|Rituximab|rituximab|mesh-list
138166012|NCT04540380|Fludarabine|fludarabine|mesh-list
138166013|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166014|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
138166015|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166017|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138166018|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
138166019|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166020|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166021|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138166022|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166023|NCT04510662|Telmisartan|telmisartan|mesh-list
138166024|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138166025|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138166026|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138166027|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166028|NCT04428437|Lenvatinib|lenvatinib|mesh-list
138166029|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166030|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166031|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357014|NCT00003072|Protective Agents|protective agents|mesh-ancestor
138166032|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166034|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166035|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
138166036|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166037|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166038|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
138166039|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166040|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166041|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
138166042|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166043|NCT04406857|Capecitabine|capecitabine|mesh-list
138166044|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
138166045|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166046|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
138166047|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166048|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166050|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138166051|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166052|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138166053|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166054|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
138166055|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166056|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
138314129|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
138166057|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166058|NCT04367051|Spironolactone|spironolactone|mesh-list
138166059|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138166060|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
138166061|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166062|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166063|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138166065|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
138166066|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
138166067|NCT04314219|Methotrexate|methotrexate|mesh-list
138166068|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166069|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
138166070|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166071|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166072|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138166074|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194356|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166075|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166076|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138166077|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138166078|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
138166079|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138166080|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166081|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
138166082|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138166083|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166084|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138166085|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138357038|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357039|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357040|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357041|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
138357042|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357043|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138166086|NCT04230408|Paclitaxel|paclitaxel|mesh-list
138166087|NCT04230408|Carboplatin|carboplatin|mesh-list
138166088|NCT04230408|Durvalumab|durvalumab|mesh-list
138166089|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138166090|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166091|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
138166092|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
138166093|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
138166095|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166096|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138166097|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138166098|NCT04195698|Upadacitinib|upadacitinib|mesh-list
138166099|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138166100|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166101|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166102|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166103|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166104|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
138166105|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138166106|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
138166107|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166109|NCT04052776|Carbidopa|carbidopa|mesh-list
138166110|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138166111|NCT04052776|Buspirone|buspirone|mesh-list
138166112|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138166113|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138166114|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
138314152|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138166115|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166116|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166117|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166118|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138166119|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166120|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138166121|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138166122|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166123|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138166124|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138166125|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
138166126|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138166127|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
138166128|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
138166130|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138166131|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138166132|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
138166133|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166134|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138166135|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138166136|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166137|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166138|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138166139|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
138166140|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166141|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166142|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138166143|NCT04002037|Dexamethasone|dexamethasone|mesh-list
138166144|NCT04002037|Triamcinolone|triamcinolone|mesh-list
138166145|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138194364|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
138166148|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166149|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
138166150|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
138166151|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166152|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166153|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166154|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
138166155|NCT04002037|Hormones|hormones|mesh-ancestor
138166156|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166157|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166158|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166159|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166160|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
138166161|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166162|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166163|NCT03976245|Etanercept|etanercept|mesh-list
138166164|NCT03976245|Tofacitinib|tofacitinib|mesh-list
138314169|NCT01777152|Vincristine|vincristine|mesh-list
138166165|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138166166|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138166167|NCT03976245|Analgesics|analgesics|mesh-ancestor
138166168|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
138166169|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462758|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166170|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166171|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166172|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166173|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166174|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166175|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
138166176|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138166177|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166178|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166179|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166180|NCT03929640|Acetaminophen|acetaminophen|mesh-list
138166181|NCT03929640|Ibuprofen|ibuprofen|mesh-list
138166182|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138166183|NCT03929640|Analgesics|analgesics|mesh-ancestor
138166184|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
138166185|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166186|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166187|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
138166188|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138166189|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166190|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166191|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138166192|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166193|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166194|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138166195|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138166196|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166197|NCT03709459|Doxycycline|doxycycline|mesh-list
138166198|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138357051|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
138357052|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357053|NCT00003090|Aldesleukin|aldesleukin|mesh-list
138357054|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357055|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138357056|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138357057|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
138357058|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166199|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166200|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
138166201|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138166202|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138166203|NCT03690986|Nivolumab|nivolumab|mesh-list
138166204|NCT03690986|Ipilimumab|ipilimumab|mesh-list
138166205|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166206|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166207|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138166208|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166211|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166212|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138166213|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138166214|NCT03597581|Growth Substances|growth substances|mesh-ancestor
138166215|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166216|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138166217|NCT03569085|Sevoflurane|sevoflurane|mesh-list
138166218|NCT03569085|Isoflurane|isoflurane|mesh-list
138166219|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138166220|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138166221|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
138166222|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
138166223|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166224|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166225|NCT03483753|Vasopressins|vasopressins|mesh-list
138166226|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
138166227|NCT03483753|Norepinephrine|norepinephrine|mesh-list
138166228|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138166229|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138166230|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138166231|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166232|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166233|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166235|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
138166236|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166237|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138166238|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
138166239|NCT03483753|Coagulants|coagulants|mesh-ancestor
138166240|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138166241|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
138166242|NCT03452891|Simvastatin|simvastatin|mesh-list
138166243|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138166244|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138166246|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166247|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138166248|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138166249|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166250|NCT03301038|Rifampin|rifampin|mesh-list
138166251|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138357059|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
138166252|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
138357060|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166253|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138166254|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166255|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
138166256|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138166257|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166258|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166259|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138166260|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138166261|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138166262|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138166263|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138166264|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138166266|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
138166267|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
138166268|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138166269|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138166270|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166271|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
138166272|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138166273|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166274|NCT03021330|Cytarabine|cytarabine|mesh-list
138166275|NCT03021330|Daunorubicin|daunorubicin|mesh-list
138166276|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166277|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
138166278|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166279|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166280|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
138166281|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166282|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166283|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
138166284|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166285|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138166286|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138166287|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138166288|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166289|NCT03019081|Isoproterenol|isoproterenol|mesh-list
138166290|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138166291|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138166292|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
138166293|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166294|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166295|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166296|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138166297|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
138166298|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166299|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138166300|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
138166301|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138166302|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
138166303|NCT03019081|Protective Agents|protective agents|mesh-ancestor
138166305|NCT03018418|Mitomycin|mitomycin|mesh-list
138166307|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166308|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
138166309|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166310|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138166311|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166312|NCT02947386|Nivolumab|nivolumab|mesh-list
138166313|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
138166314|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166315|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166316|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138201736|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357082|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138166317|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166318|NCT02824627|Oxytocin|oxytocin|mesh-list
138166320|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138166321|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166322|NCT02705196|Paclitaxel|paclitaxel|mesh-list
138166323|NCT02705196|Gemcitabine|gemcitabine|mesh-list
138166324|NCT02705196|Atezolizumab|atezolizumab|mesh-list
138166325|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138166326|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166327|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
138166328|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
138166329|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
138166330|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166331|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166332|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
138166333|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138166334|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166335|NCT02689440|Venetoclax|venetoclax|mesh-list
138166336|NCT02689440|Dasatinib|dasatinib|mesh-list
138166337|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166338|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166339|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166340|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166341|NCT02668666|Tamoxifen|tamoxifen|mesh-list
138166342|NCT02668666|Palbociclib|palbociclib|mesh-list
138166343|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138166344|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
138166345|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166346|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194380|NCT04042324|Calcium heparin|calcium heparin|mesh-list
138194385|NCT04391660|Ethanol|ethanol|mesh-list
138166347|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166348|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166349|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138166350|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138166351|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138166352|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138314266|NCT01708902|Metformin|metformin|mesh-list
138166353|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166354|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166355|NCT02364713|Paclitaxel|paclitaxel|mesh-list
138166356|NCT02364713|Bevacizumab|bevacizumab|mesh-list
138166357|NCT02364713|Gemcitabine|gemcitabine|mesh-list
138166358|NCT02364713|Doxorubicin|doxorubicin|mesh-list
138166359|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138166360|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138166361|NCT02364713|Topotecan|topotecan|mesh-list
138166362|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138166363|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
138166364|NCT02364713|Antibodies|antibodies|mesh-list
138166365|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
138166366|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138166367|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
138166368|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138166369|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166370|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138166371|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138166372|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138166373|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166374|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138166375|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138166376|NCT02364713|Growth Substances|growth substances|mesh-ancestor
138166377|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166378|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
138166379|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
138166380|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166381|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
138166382|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138166383|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138166384|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138166385|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166386|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138166387|NCT02186600|Vitamin D|vitamin d|mesh-list
138166388|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
138166389|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
138166390|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
138166391|NCT02186600|Calcium|calcium|mesh-list
138166392|NCT02186600|Vitamins|vitamins|mesh-ancestor
138166393|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
138166394|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166395|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138166396|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138166397|NCT02186600|Antacids|antacids|mesh-ancestor
138166398|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166399|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166400|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138166401|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138166402|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
138166403|NCT01873833|Capecitabine|capecitabine|mesh-list
138166404|NCT01873833|Trastuzumab|trastuzumab|mesh-list
138166405|NCT01873833|Lapatinib|lapatinib|mesh-list
138166406|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166407|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
138166408|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166409|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166410|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138166411|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
138166412|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166413|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166414|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138166415|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166416|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
138166417|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166418|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166419|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166420|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138166421|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138166422|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166424|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
138166425|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
138166426|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
138166427|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166428|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166429|NCT01198067|Pomalidomide|pomalidomide|mesh-list
138166430|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
138166431|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166432|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138166433|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138166434|NCT01198067|Growth Substances|growth substances|mesh-ancestor
138166435|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
138314325|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
138166436|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166437|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
138166438|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166439|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166441|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166442|NCT00754208|Methylphenidate|methylphenidate|mesh-list
138166443|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138166444|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166445|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138166446|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138166447|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138166448|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166449|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
138166450|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166451|NCT04193774|Anesthetics|anesthetics|mesh-list
138166452|NCT04193774|Benoxinate|benoxinate|mesh-list
138166453|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138166454|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
138166455|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166456|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166457|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138166458|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
138166459|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
138166460|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166461|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
138166462|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138166463|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138166464|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138166465|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166466|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138166467|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138166468|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166469|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166470|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166471|NCT02985242|Empagliflozin|empagliflozin|mesh-list
138166472|NCT02985242|Glimepiride|glimepiride|mesh-list
138166473|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138166474|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166475|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138166476|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166477|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138166478|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166479|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
138166480|NCT03023774|Lenograstim|lenograstim|mesh-list
138166481|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138166482|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
138166483|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166484|NCT04196426|Calcium|calcium|mesh-list
138166485|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138166486|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166487|NCT00518713|Clobazam|clobazam|mesh-list
138166488|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
138166489|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138166490|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138166491|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166492|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166493|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138166494|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138166495|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
138166496|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
138166497|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166498|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166499|NCT03948464|Morphine|morphine|mesh-list
138166500|NCT03948464|Methadone|methadone|mesh-list
138166501|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138166502|NCT03948464|Narcotics|narcotics|mesh-ancestor
138166503|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138357095|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357096|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138357097|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138357098|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
138357099|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357100|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
138357101|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357102|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357103|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
138357104|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357105|NCT00003144|Gemcitabine|gemcitabine|mesh-list
138357106|NCT00003144|Amifostine|amifostine|mesh-list
138357107|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357109|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
138166504|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166505|NCT03948464|Analgesics|analgesics|mesh-ancestor
138166506|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
138166507|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166508|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
138166509|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138166510|NCT04196270|Ropivacaine|ropivacaine|mesh-list
138166511|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
138166512|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
138166513|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166514|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166515|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
138166516|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166517|NCT04020380|Azithromycin|azithromycin|mesh-list
138166518|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138166519|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166520|NCT00521989|Prednisolone|prednisolone|mesh-list
138166521|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138166522|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
138166523|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138166524|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
138166525|NCT00521989|Dipyridamole|dipyridamole|mesh-list
138314421|NCT01728324|Ribavirin|ribavirin|mesh-list
138166527|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
138166528|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166529|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
138166531|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166532|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166533|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166534|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166535|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
138166536|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
138166537|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166538|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166539|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138166540|NCT00521989|Protective Agents|protective agents|mesh-ancestor
138166541|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138166542|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166543|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166545|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
138166547|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166548|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166549|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166550|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166551|NCT00548197|Bevacizumab|bevacizumab|mesh-list
138166552|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166553|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166554|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138194400|NCT04066426|Acetaminophen|acetaminophen|mesh-list
138166555|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138166557|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166558|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
138166559|NCT04029272|Metformin|metformin|mesh-list
138166560|NCT04029272|Exenatide|exenatide|mesh-list
138166561|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138166562|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166563|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138166564|NCT04029272|Incretins|incretins|mesh-ancestor
138166565|NCT04029272|Hormones|hormones|mesh-ancestor
138166566|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166567|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
138166568|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
138166569|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166570|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138166571|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166572|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166573|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
138314422|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
138166574|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166575|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138166576|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166577|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
138166578|NCT04028804|Fluorides|fluorides|mesh-list
138166579|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
138166580|NCT04028804|Protective Agents|protective agents|mesh-ancestor
138166581|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166582|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
138166583|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166584|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
138166585|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166586|NCT00524017|Cetuximab|cetuximab|mesh-list
138166587|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166588|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166589|NCT02985554|Nivolumab|nivolumab|mesh-list
138166590|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166591|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166592|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138166593|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166594|NCT05560165|Listerine|listerine|mesh-list
138166595|NCT05560165|Anesthetics|anesthetics|mesh-list
138166596|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
138166597|NCT05560165|Fluorides|fluorides|mesh-list
138166598|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
138166599|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
138166600|NCT05560165|Protective Agents|protective agents|mesh-ancestor
138166601|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166602|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166603|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
138166604|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166605|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138166606|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166608|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138166609|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138166610|NCT00525421|Analgesics|analgesics|mesh-ancestor
138166611|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
138166612|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166613|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166614|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166615|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166616|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166618|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166619|NCT00525733|Ritonavir|ritonavir|mesh-list
138166620|NCT00525733|Darunavir|darunavir|mesh-list
138166621|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
138194410|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
138166622|NCT00525733|Maraviroc|maraviroc|mesh-list
138166623|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138166624|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138166625|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166626|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166627|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166628|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138166629|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138166630|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
138357119|NCT00003150|Vincristine|vincristine|mesh-list
138357120|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357121|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
138357122|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357123|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357124|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138166631|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166632|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138166633|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138166634|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138166635|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138166636|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138166637|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138166638|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138166640|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138166641|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138166642|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166643|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166644|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166646|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138166647|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138166648|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166649|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166650|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166651|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
138166652|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166653|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166654|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
138166655|NCT05559619|Vitamin D|vitamin d|mesh-list
138166656|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
138166657|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
138166658|NCT05559619|Calcium|calcium|mesh-list
138166659|NCT05559619|Vitamins|vitamins|mesh-ancestor
138166660|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
138166661|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166662|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138166663|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138166664|NCT05559619|Antacids|antacids|mesh-ancestor
138166665|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166666|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166667|NCT04194086|Posaconazole|posaconazole|mesh-list
138166668|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
138166669|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166670|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138166671|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138166672|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138166673|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138166674|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138166675|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166676|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166677|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138166678|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138166679|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166680|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166681|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
138166682|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138166683|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
138166684|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166685|NCT04023266|Expectorants|expectorants|mesh-ancestor
138166686|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
138166687|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138166688|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
138166689|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166690|NCT04023266|Protective Agents|protective agents|mesh-ancestor
138166691|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166692|NCT04023266|Antidotes|antidotes|mesh-ancestor
138166693|NCT00475085|Dexamethasone|dexamethasone|mesh-list
138357130|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357131|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138462759|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138166696|NCT00475085|Granisetron|granisetron|mesh-list
138166697|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
138166698|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166699|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
138166700|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
138166701|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166702|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166703|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166705|NCT00475085|Hormones|hormones|mesh-ancestor
138166706|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166707|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166708|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166709|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138166710|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166711|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166712|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138166713|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138166714|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
138166715|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138166716|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138166717|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166718|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314502|NCT01725126|Hormones|hormones|mesh-ancestor
138166719|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138166721|NCT00551707|Prednisolone|prednisolone|mesh-list
138166722|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138166723|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
138166724|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138166725|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
138166726|NCT00551707|Dipyridamole|dipyridamole|mesh-list
138166727|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138166728|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
138166729|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166730|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
138166731|NCT00551707|Hormones|hormones|mesh-ancestor
138166732|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166733|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166734|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166735|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166736|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
138166737|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
138166738|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166739|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166740|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138166741|NCT00551707|Protective Agents|protective agents|mesh-ancestor
138166742|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138166743|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166744|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166745|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138166746|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
138166748|NCT04193930|Menotropins|menotropins|mesh-list
138166749|NCT04193930|Hormones|hormones|mesh-list
138166750|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138166751|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166752|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166753|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166754|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138166755|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138166756|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166757|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166758|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138166759|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
138166760|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138166761|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
138166762|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138166763|NCT00445211|Heparin|heparin|mesh-list
138166764|NCT00445211|Calcium heparin|calcium heparin|mesh-list
138166765|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
138166766|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138166767|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138166768|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166770|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138166771|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138166772|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138166774|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138166775|NCT04193852|Nandrolone|nandrolone|mesh-list
138166776|NCT04193852|Estrogens|estrogens|mesh-ancestor
138166777|NCT04193852|Hormones|hormones|mesh-ancestor
138166778|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166779|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166780|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138166781|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
138166782|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138166783|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138166784|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138166785|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138166786|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138166788|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166789|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166790|NCT04193852|Androgens|androgens|mesh-ancestor
138166791|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
138166792|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
138166793|NCT00552409|Vitamin D|vitamin d|mesh-list
138166794|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138166795|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166796|NCT00552409|Vitamins|vitamins|mesh-ancestor
138357177|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
138166797|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
138166798|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138166799|NCT03830918|Temozolomide|temozolomide|mesh-list
138166800|NCT03830918|Atezolizumab|atezolizumab|mesh-list
138166801|NCT03830918|Niraparib|niraparib|mesh-list
138166802|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138166803|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138166804|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
138166805|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166806|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166807|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138166808|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138166809|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
138166810|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166811|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138166812|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166813|NCT00553735|Cyclosporine|cyclosporine|mesh-list
138166814|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
138166815|NCT00553735|Cyclosporins|cyclosporins|mesh-list
138166816|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166817|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166818|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166819|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
138166820|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166821|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
138166822|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166823|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
138166824|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166825|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138166826|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138166827|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138166828|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
138166829|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138166830|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138166831|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
138166832|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166833|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138166834|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138166835|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166836|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166837|NCT04027166|Methadone|methadone|mesh-list
138166838|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138166839|NCT04027166|Narcotics|narcotics|mesh-ancestor
138166840|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166842|NCT04027166|Analgesics|analgesics|mesh-ancestor
138166843|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
138166844|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166845|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
138166846|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
138166847|NCT00543101|Darunavir|darunavir|mesh-list
138166848|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138166849|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138357199|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
138357200|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357201|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357202|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357203|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
138357204|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357205|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357206|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357207|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314586|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166850|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166851|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166852|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166853|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138166854|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138166855|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
138166856|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166859|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138166860|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138166861|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
138166862|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166863|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166864|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166865|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138166866|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
138166867|NCT00553969|Protective Agents|protective agents|mesh-ancestor
138166868|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138166869|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138166870|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138166871|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
138166872|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138166873|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138166874|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138166875|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166876|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166877|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138166878|NCT05533567|Sufentanil|sufentanil|mesh-list
138166879|NCT05533567|Dsuvia|dsuvia|mesh-list
138166880|NCT05533567|Propofol|propofol|mesh-list
138166882|NCT05533567|Atracurium|atracurium|mesh-list
138166883|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138166884|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166885|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166886|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138166887|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
138166888|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
138166889|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138166890|NCT05533567|Narcotics|narcotics|mesh-ancestor
138166891|NCT05533567|Analgesics|analgesics|mesh-ancestor
138166892|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
138166893|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166894|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138166895|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138166896|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138166897|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138166898|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138166899|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138166900|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
138166902|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166905|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138166906|NCT04026464|Analgesics|analgesics|mesh-ancestor
138166907|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
138166908|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166909|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166910|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
138194425|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138194426|NCT04066426|Narcotics|narcotics|mesh-ancestor
138166911|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138166912|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166913|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166914|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138166915|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166916|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357209|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
138357211|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166917|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
138166918|NCT04192916|Apixaban|apixaban|mesh-list
138462760|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138166920|NCT04192916|Dabigatran|dabigatran|mesh-list
138166922|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
138166923|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138166924|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166925|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166926|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166927|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
138166928|NCT01797991|Dexamethasone|dexamethasone|mesh-list
138166929|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
138166930|NCT01797991|BB 1101|bb 1101|mesh-list
138166931|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166932|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
138166933|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
138166934|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166935|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166936|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166937|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
138166939|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138166940|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166941|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166942|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
138166943|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166944|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166945|NCT00475319|Rebamipide|rebamipide|mesh-list
138166946|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138166947|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166948|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
138166949|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166950|NCT00475319|Protective Agents|protective agents|mesh-ancestor
138166951|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166952|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166953|NCT04026074|Clonidine|clonidine|mesh-list
138166954|NCT04026074|Fentanyl|fentanyl|mesh-list
138166955|NCT04026074|Remifentanil|remifentanil|mesh-list
138166956|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138166957|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138166958|NCT04026074|Narcotics|narcotics|mesh-ancestor
138166959|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166960|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166961|NCT04026074|Analgesics|analgesics|mesh-ancestor
138166962|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
138166963|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166964|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138166965|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138166966|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
138166967|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
138166968|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138166969|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
138166970|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
138166971|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138166972|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138166973|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138166974|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
138166975|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166976|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166977|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
138166978|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138166979|NCT00555997|Ziprasidone|ziprasidone|mesh-list
138166980|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138166981|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
138166982|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166983|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138166984|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166985|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138166986|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138166987|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138166988|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138166989|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138166990|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
138166991|NCT00446147|Pyridoxine|pyridoxine|mesh-list
138166992|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
138166993|NCT00446147|Vitamins|vitamins|mesh-ancestor
138166994|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
138166995|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166996|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138166997|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138166998|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138166999|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167000|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167001|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167002|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167003|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
138167004|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167005|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
138167006|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138167007|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
138167008|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167009|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167010|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138167011|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138167012|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138167013|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138167014|NCT04192292|Gliclazide|gliclazide|mesh-list
138167015|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138167017|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167018|NCT04192292|Incretins|incretins|mesh-ancestor
138167019|NCT04192292|Hormones|hormones|mesh-ancestor
138167020|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167021|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
138167022|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167023|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167024|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138167025|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138167027|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167028|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167029|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167030|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167031|NCT00448175|Urological Agents|urological agents|mesh-ancestor
138167032|NCT04176835|Oxytocin|oxytocin|mesh-list
138167033|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
138167034|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167035|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167036|NCT00476645|Fulvestrant|fulvestrant|mesh-list
138167037|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138167038|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167039|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138167040|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138167041|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
138167042|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167043|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167044|NCT00477191|Etanercept|etanercept|mesh-list
138167045|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138167046|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167047|NCT00477191|Analgesics|analgesics|mesh-ancestor
138167048|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
138167049|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167050|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167051|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167052|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167053|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167054|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167055|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
138167056|NCT04025918|Phenylephrine|phenylephrine|mesh-list
138167057|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
138167058|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138167059|NCT04025918|Ephedrine|ephedrine|mesh-list
138167060|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138167061|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
138167062|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
138167063|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167064|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167065|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
138167066|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
138167067|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167068|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138167069|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138462761|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138167072|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167073|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167074|NCT04025918|Protective Agents|protective agents|mesh-ancestor
138167075|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138167077|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138167078|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167079|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
138167080|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138167081|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167082|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138167083|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167084|NCT02115581|Ubiquinone|ubiquinone|mesh-list
138167085|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
138167086|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
138167087|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167088|NCT02115581|Vitamins|vitamins|mesh-ancestor
138167089|NCT00477659|Donepezil|donepezil|mesh-list
138167090|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138167091|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167092|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167093|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167094|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167096|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
138167097|NCT04191278|Varenicline|varenicline|mesh-list
138167098|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138167099|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138167100|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167101|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167102|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167103|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167104|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
138167105|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138167106|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138167107|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167108|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167109|NCT03988387|Tenofovir|tenofovir|mesh-list
138167110|NCT03988387|Emtricitabine|emtricitabine|mesh-list
138167111|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
138167112|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167113|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138167114|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138167115|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167116|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167117|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138167118|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138167119|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
138167120|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138167121|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
138194442|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138167123|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167124|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167125|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167126|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138167127|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
138167128|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167129|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167131|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167132|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
138167133|NCT03748082|Protective Agents|protective agents|mesh-ancestor
138167134|NCT00478361|Paclitaxel|paclitaxel|mesh-list
138167135|NCT00478361|Gemcitabine|gemcitabine|mesh-list
138167136|NCT00478361|Doxorubicin|doxorubicin|mesh-list
138167137|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138167138|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138167139|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167140|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
138167141|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
138167142|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
138167143|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167144|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138167146|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138167147|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138167148|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138167149|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167150|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
138167151|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167152|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167153|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138167154|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138167155|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167156|NCT02129725|Urological Agents|urological agents|mesh-ancestor
138167157|NCT00483509|Doxorubicin|doxorubicin|mesh-list
138167158|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138167159|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167160|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138167161|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138167162|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167163|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167164|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
138167166|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167167|NCT03842839|Albuterol|albuterol|mesh-list
138167168|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
138357236|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167169|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138357237|NCT00003234|Vinorelbine|vinorelbine|mesh-list
138357238|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138167170|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
138167171|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167172|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167173|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167174|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167175|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
138167176|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138167177|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167178|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167179|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167180|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
138167181|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138194446|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194447|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138194448|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138194450|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194451|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138194452|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
138194453|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
138167183|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138167184|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138167185|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
138167186|NCT00450983|Methotrexate|methotrexate|mesh-list
138167187|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
138167188|NCT00450983|Fludarabine|fludarabine|mesh-list
138167190|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
138167191|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138167192|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
138167193|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167194|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167195|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138167196|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
138167197|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167198|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167199|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
138167200|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167201|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138167202|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167203|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
138167204|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167205|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138167206|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138167207|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
138167210|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138167211|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
138167212|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167213|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167214|NCT03649321|Paclitaxel|paclitaxel|mesh-list
138167215|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138167216|NCT03649321|Gemcitabine|gemcitabine|mesh-list
138167217|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138167218|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167220|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
138167221|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
138167222|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167223|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357255|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357256|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357257|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
138357258|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357259|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138357260|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357261|NCT00003252|Amifostine|amifostine|mesh-list
138357262|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138167224|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
138167226|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
138167227|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
138167228|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167229|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167230|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
138167231|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167232|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138167233|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138167234|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138167235|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167236|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167237|NCT01797601|Insulin|insulin|mesh-list
138167238|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138167239|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138167240|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167241|NCT02984930|Esomeprazole|esomeprazole|mesh-list
138167242|NCT02984930|Mosapride|mosapride|mesh-list
138167243|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138167244|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167245|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138167246|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167247|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167248|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138167249|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
138167250|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194455|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138167253|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167254|NCT04149626|Midazolam|midazolam|mesh-list
138167255|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
138167256|NCT04149626|Remifentanil|remifentanil|mesh-list
138167257|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138167258|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167259|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167260|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167262|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
138167263|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167264|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138167265|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138167266|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138167267|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
138167268|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167269|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167270|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138167271|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138167272|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138167273|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167274|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138167275|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
138167276|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
138167277|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
138167278|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
138167279|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138167280|NCT04149626|Narcotics|narcotics|mesh-ancestor
138167281|NCT00486863|Praziquantel|praziquantel|mesh-list
138167282|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
138167283|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138167284|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167285|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
138167286|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138167287|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167288|NCT00452387|Prednisone|prednisone|mesh-list
138167289|NCT00452387|Sorafenib|sorafenib|mesh-list
138357263|NCT00003252|Protective Agents|protective agents|mesh-ancestor
138357264|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357265|NCT00003264|Gemcitabine|gemcitabine|mesh-list
138167290|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
138167291|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167292|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
138167293|NCT00452387|Hormones|hormones|mesh-ancestor
138167294|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167295|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167296|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138167297|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167298|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138167299|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167300|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167301|NCT00452387|Analgesics|analgesics|mesh-ancestor
138167302|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
138167303|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167304|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138167305|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138167306|NCT00452543|Acamprosate|acamprosate|mesh-list
138167307|NCT00452543|Dexetimide|dexetimide|mesh-list
138167308|NCT00452543|Citalopram|citalopram|mesh-list
138167309|NCT00452543|Escitalopram|escitalopram|mesh-list
138167310|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138167311|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138167312|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167313|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167314|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167315|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
138167316|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167317|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138194463|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
138167318|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138167321|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167322|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138167323|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138167324|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167325|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138167326|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
138167327|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167328|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138167330|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
138167331|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167332|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138167333|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167334|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138167335|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167336|NCT04765904|Fluorides|fluorides|mesh-list
138167337|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
138167338|NCT04765904|Protective Agents|protective agents|mesh-ancestor
138167339|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167340|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
138167341|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138167342|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167343|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138167344|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167345|NCT00565669|Cyclosporine|cyclosporine|mesh-list
138167346|NCT00565669|Cyclosporins|cyclosporins|mesh-list
138167347|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357273|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167348|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167349|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167350|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
138167351|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167352|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
138167353|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167354|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
138167355|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167356|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138167357|NCT04165135|Factor VIII|factor viii|mesh-list
138167359|NCT02132533|Nifedipine|nifedipine|mesh-list
138167360|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138167361|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167362|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167363|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138167364|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167365|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167366|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
138167367|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462762|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167368|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138167369|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167372|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138167373|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167374|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
138167375|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167376|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167377|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138167378|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138167379|NCT00567229|Growth Substances|growth substances|mesh-ancestor
138167380|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138167381|NCT04148846|Dexamethasone|dexamethasone|mesh-list
138167382|NCT04148846|Ketoprofen|ketoprofen|mesh-list
138167383|NCT04148846|Theophylline|theophylline|mesh-list
138194470|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138194471|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167385|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167386|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
138167387|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
138167388|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167389|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167390|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167391|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
138167392|NCT04148846|Hormones|hormones|mesh-ancestor
138315029|NCT01687218|Tenofovir|tenofovir|mesh-list
138167393|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167394|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138167395|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167396|NCT04148846|Analgesics|analgesics|mesh-ancestor
138167397|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
138167398|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
138167399|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138167400|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138167401|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167402|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167403|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138167404|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138167405|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138357292|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357293|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357294|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357295|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357296|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357297|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138357298|NCT00003294|Protective Agents|protective agents|mesh-ancestor
138167406|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167407|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
138167408|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138167409|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167410|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167411|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138167412|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167413|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138167414|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167415|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167416|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138167417|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167418|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138167419|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138167420|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
138167421|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
138167422|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138167423|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
138167424|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167425|NCT00568087|Expectorants|expectorants|mesh-ancestor
138167426|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167427|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138167428|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
138167429|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167430|NCT00568087|Protective Agents|protective agents|mesh-ancestor
138167431|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167432|NCT00568087|Antidotes|antidotes|mesh-ancestor
138167433|NCT00487721|Silymarin|silymarin|mesh-list
138167434|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
138167435|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167436|NCT00487721|Protective Agents|protective agents|mesh-ancestor
138167437|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167438|NCT00568633|Cyclosporine|cyclosporine|mesh-list
138167439|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
138167440|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
138167441|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138194478|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194479|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194480|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
138194487|NCT04272788|Infliximab|infliximab|mesh-list
138315047|NCT01686828|Testosterone|testosterone|mesh-list
138167442|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138167443|NCT00568633|Prednisolone|prednisolone|mesh-list
138167444|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
138167445|NCT00568633|Cyclosporins|cyclosporins|mesh-list
138167446|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
138167447|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138167448|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138167449|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
138167450|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167451|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167452|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167453|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
138167454|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167455|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
138167456|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167457|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357299|NCT00003330|Interleukin-12|interleukin-12|mesh-list
138357300|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357301|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
138357302|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357303|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138357304|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138357305|NCT00003330|Growth Substances|growth substances|mesh-ancestor
138357306|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138167458|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167459|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138167460|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138167461|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167462|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138167463|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
138167464|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138167465|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167466|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
138167467|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
138167468|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167469|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167470|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
138167471|NCT00568633|Hormones|hormones|mesh-ancestor
138167472|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167473|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138167474|NCT00568633|Protective Agents|protective agents|mesh-ancestor
138167475|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138167476|NCT03022838|Caffeine|caffeine|mesh-list
138167477|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138167478|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167479|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138167480|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167481|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167482|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138167483|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138167484|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
138167485|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167486|NCT05363449|Naftifine|naftifine|mesh-list
138167487|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
138167488|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167489|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
138167490|NCT00489281|Sirolimus|sirolimus|mesh-list
138167491|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
138167492|NCT00489281|Fludarabine|fludarabine|mesh-list
138167493|NCT00489281|Levetiracetam|levetiracetam|mesh-list
138167494|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
138167495|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138167497|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
138167498|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167499|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167500|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138167501|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
138357310|NCT00003336|Melphalan|melphalan|mesh-list
138357311|NCT00003336|Busulfan|busulfan|mesh-list
138357312|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138357313|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357314|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
138357315|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357316|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357317|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357318|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
138357319|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357320|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357321|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357322|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138357323|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
138167502|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167503|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167504|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138167505|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138167506|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138167507|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
138167508|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138194489|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167509|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167512|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
138167513|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
138167515|NCT05362513|Permethrin|permethrin|mesh-list
138167516|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138167517|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167518|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167519|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167520|NCT04457297|Trifluridine|trifluridine|mesh-list
138167530|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167531|NCT04145804|Insulin|insulin|mesh-list
138167533|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315094|NCT01684722|Vitamins|vitamins|mesh-list
138167534|NCT02120261|Triamcinolone|triamcinolone|mesh-list
138167535|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138167536|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138167537|NCT02120261|Lidocaine|lidocaine|mesh-list
138167538|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138167539|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
138167540|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
138167541|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167542|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167543|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
138167544|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167545|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138167546|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138167547|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138167548|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167549|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167550|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167551|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
138167552|NCT02120261|Hormones|hormones|mesh-ancestor
138167553|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167554|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167555|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
138167556|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167557|NCT00492089|Bevacizumab|bevacizumab|mesh-list
138167558|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138167559|NCT00492089|Antibodies|antibodies|mesh-list
138167560|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
138167561|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138167562|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167563|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138167564|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138167565|NCT00492089|Growth Substances|growth substances|mesh-ancestor
138167566|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167568|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
138167569|NCT01798537|Vancomycin|vancomycin|mesh-list
138357324|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
138357325|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357326|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138357327|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
138357329|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138357330|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138357331|NCT00003336|Protective Agents|protective agents|mesh-ancestor
138357332|NCT00003342|Paclitaxel|paclitaxel|mesh-list
138167570|NCT01798537|Colistin|colistin|mesh-list
138167571|NCT01798537|Neomycin|neomycin|mesh-list
138167572|NCT01798537|Nystatin|nystatin|mesh-list
138167573|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138167574|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167575|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138167576|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167577|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167578|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
138167579|NCT01798537|Ionophores|ionophores|mesh-ancestor
138167580|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167589|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138194496|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
138194497|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
138194498|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167590|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138167592|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138194499|NCT01457690|Protective Agents|protective agents|mesh-ancestor
138167595|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138167596|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167597|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167599|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167600|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138167601|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167602|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167604|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
138167605|NCT04145492|Calcifediol|calcifediol|mesh-list
138167606|NCT04145492|Vitamins|vitamins|mesh-list
138167607|NCT04145492|Vitamin K|vitamin k|mesh-list
138167608|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
138167609|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
138167610|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167611|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138167612|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138167613|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138167614|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138167615|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167616|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
138167617|NCT04145492|Coagulants|coagulants|mesh-ancestor
138167618|NCT04147754|Morphine|morphine|mesh-list
138167619|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167620|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167621|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138167622|NCT04147754|Narcotics|narcotics|mesh-ancestor
138167623|NCT04147754|Analgesics|analgesics|mesh-ancestor
138167624|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
138167625|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167626|NCT00492401|Decitabine|decitabine|mesh-list
138167627|NCT00492401|Azacitidine|azacitidine|mesh-list
138167628|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357333|NCT00003342|Carboplatin|carboplatin|mesh-list
138357334|NCT00003342|Gemcitabine|gemcitabine|mesh-list
138167629|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
138167630|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167631|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167632|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167633|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
138167634|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
138167635|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167637|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138167638|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138167639|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
138167640|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167641|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138167642|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138167643|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167645|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167646|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
138167647|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
138167648|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138167649|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
138167650|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167651|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167652|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138167653|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138167654|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138167655|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138167657|NCT00493805|Ribavirin|ribavirin|mesh-list
138167658|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
138167659|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
138167660|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138167661|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167662|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
138167663|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167664|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
138167665|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167666|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
138167667|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167668|NCT04145102|Propolis|propolis|mesh-list
138167669|NCT04145102|Fluorides|fluorides|mesh-list
138167670|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
138167671|NCT04145102|Protective Agents|protective agents|mesh-ancestor
138167672|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167674|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138167675|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
138167676|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167677|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138167678|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167679|NCT03588494|Endostar protein|endostar protein|mesh-list
138167680|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138167681|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138167682|NCT03588494|Growth Substances|growth substances|mesh-ancestor
138167683|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167684|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
138167685|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167686|NCT00550277|Panobinostat|panobinostat|mesh-list
138167687|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167688|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138167689|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167690|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167691|NCT00550589|Cidofovir|cidofovir|mesh-list
138167692|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
138167693|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167695|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167696|NCT04144712|Caffeine|caffeine|mesh-list
138167697|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
138167698|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167699|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138167700|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167701|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138167702|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167703|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138167704|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138167705|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
138167706|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167707|NCT03588338|Acetaminophen|acetaminophen|mesh-list
138167708|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167709|NCT03588338|Analgesics|analgesics|mesh-ancestor
138167710|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
138167711|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167712|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167713|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
138167714|NCT05099185|Trace Elements|trace elements|mesh-list
138167715|NCT05099185|Micronutrients|micronutrients|mesh-list
138167716|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167717|NCT05068609|Nivolumab|nivolumab|mesh-list
138167718|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138167719|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167720|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138167721|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167722|NCT00496379|Epothilones|epothilones|mesh-list
138167723|NCT00496379|Sagopilone|sagopilone|mesh-list
138167724|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138167725|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138167726|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138167727|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167728|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167729|NCT00497081|Mirtazapine|mirtazapine|mesh-list
138167730|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
138167731|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167732|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138167733|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
138167734|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
138167735|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167737|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167738|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138167739|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138167740|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167741|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138167742|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138167743|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138167744|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
138167745|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138167746|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138167747|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
138167748|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138167749|NCT01796951|Aspirin|aspirin|mesh-list
138167750|NCT01796951|Celecoxib|celecoxib|mesh-list
138167751|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138167752|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167753|NCT01796951|Analgesics|analgesics|mesh-ancestor
138167754|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
138167755|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167756|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167757|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138167758|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167759|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138167760|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138167761|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167762|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138167763|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138167764|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167766|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138167767|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
138167768|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167769|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138167770|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167771|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167772|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
138167773|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138357359|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357361|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138167774|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138167775|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138167776|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167777|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167778|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167779|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167780|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167781|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138167782|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167783|NCT03587558|Flecainide|flecainide|mesh-list
138167784|NCT03587558|Carvedilol|carvedilol|mesh-list
138167785|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138167786|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138167787|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
138167788|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167789|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167790|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167791|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138167792|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
138167793|NCT03587558|Protective Agents|protective agents|mesh-ancestor
138167794|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138167795|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167796|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138167797|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167798|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138167799|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138167801|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138167803|NCT04415905|Propofol|propofol|mesh-list
138167804|NCT04415905|Sevoflurane|sevoflurane|mesh-list
138167805|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138167806|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167807|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167808|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138167809|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
138167810|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
138167811|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138167812|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138167813|NCT02979704|Atorvastatin|atorvastatin|mesh-list
138167814|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138167815|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138167816|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138167818|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167819|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138167820|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138167821|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167822|NCT03587324|Clopidogrel|clopidogrel|mesh-list
138167823|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138167824|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138167825|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138167826|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138167827|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
138167828|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167829|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167830|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167831|NCT01798459|Methylphenidate|methylphenidate|mesh-list
138167832|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138315278|NCT01585038|Efavirenz|efavirenz|mesh-list
138167833|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167834|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138167835|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138357372|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357373|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138167836|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167837|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167838|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
138167839|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167840|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
138167842|NCT00555321|Tacrolimus|tacrolimus|mesh-list
138167843|NCT00555321|Basiliximab|basiliximab|mesh-list
138167844|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167845|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
138167846|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167847|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138167848|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167849|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167850|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138167851|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167852|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138167853|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
138167854|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138167855|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167856|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138167857|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138167858|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138167860|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138167861|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167862|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167863|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138167864|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138167865|NCT05583266|Protective Agents|protective agents|mesh-ancestor
138167866|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167867|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167868|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138167869|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
138167870|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
138167871|NCT04142840|Propofol|propofol|mesh-list
138167872|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138167873|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167874|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167875|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138167876|NCT04142840|Analgesics|analgesics|mesh-ancestor
138167877|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
138315292|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138167878|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167879|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138167880|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138167881|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138167882|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
138167883|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167884|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167885|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138167887|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
138167888|NCT04142762|Itraconazole|itraconazole|mesh-list
138167889|NCT04142762|Rifampin|rifampin|mesh-list
138167890|NCT04142762|Midazolam|midazolam|mesh-list
138167891|NCT04142762|Esomeprazole|esomeprazole|mesh-list
138167893|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138167894|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138167895|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
138167896|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
138167897|NCT04142762|Estradiol|estradiol|mesh-list
138167898|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138167899|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138167900|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167901|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357383|NCT00003396|Melphalan|melphalan|mesh-list
138357384|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138167902|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138167903|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138167904|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138167905|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138167906|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
138167907|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
138167908|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
138167909|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
138167910|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167911|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167912|NCT04142762|Estrogens|estrogens|mesh-ancestor
138167913|NCT04142762|Hormones|hormones|mesh-ancestor
138167914|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138167915|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138167916|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167917|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138167918|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138167919|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167920|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138167921|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167922|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
138167923|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167924|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138167925|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315341|NCT01582854|Actovegin|actovegin|mesh-list
138167926|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138167927|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
138167928|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138167929|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138167930|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138167931|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
138194534|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138167932|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138167933|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
138167934|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138167935|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138167936|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138167937|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138167938|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138167939|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138167940|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138167941|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138167942|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138167943|NCT02139007|Alendronate|alendronate|mesh-list
138167944|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138167945|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167946|NCT01590277|Ethanol|ethanol|mesh-list
138167947|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138167948|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167949|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167950|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167951|NCT03586466|Buprenorphine|buprenorphine|mesh-list
138167952|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138167953|NCT03586466|Naloxone|naloxone|mesh-list
138167954|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138167955|NCT03586466|Narcotics|narcotics|mesh-ancestor
138167956|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167958|NCT03586466|Analgesics|analgesics|mesh-ancestor
138167959|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
138167960|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167961|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138167962|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
138357393|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357394|NCT00003402|Dexamethasone|dexamethasone|mesh-list
138357395|NCT00003402|Paclitaxel|paclitaxel|mesh-list
138167963|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138167964|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
138167965|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167966|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167967|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167968|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138167969|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138167970|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
138167971|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167972|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138167973|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138167974|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
138167975|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
138167976|NCT00570349|Protective Agents|protective agents|mesh-ancestor
138167977|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
138167978|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
138167979|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167980|NCT02985086|Cefoxitin|cefoxitin|mesh-list
138167981|NCT02985086|Misoprostol|misoprostol|mesh-list
138167982|NCT02985086|Oxytocin|oxytocin|mesh-list
138167983|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
138167984|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167985|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315351|NCT01582308|Vildagliptin|vildagliptin|mesh-list
138167986|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138167987|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
138167988|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138167990|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138167991|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167992|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
138167993|NCT04157985|Nivolumab|nivolumab|mesh-list
138167994|NCT04157985|Ipilimumab|ipilimumab|mesh-list
138167995|NCT04157985|Atezolizumab|atezolizumab|mesh-list
138167996|NCT04157985|Cemiplimab|cemiplimab|mesh-list
138167997|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138167998|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138167999|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168000|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168001|NCT00609739|Cytarabine|cytarabine|mesh-list
138168004|NCT00609739|Methotrexate|methotrexate|mesh-list
138168005|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
138168006|NCT00609739|Tretinoin|tretinoin|mesh-list
138168007|NCT00609739|Isotretinoin|isotretinoin|mesh-list
138168008|NCT00609739|Cyclosporins|cyclosporins|mesh-list
138168009|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138168010|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
138168011|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168012|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168013|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168014|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
138168015|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168016|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168017|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
138168018|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168019|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138168020|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168021|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
138168022|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168023|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138168024|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
138168025|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168026|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
138357404|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168027|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138168028|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168029|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
138168030|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
138168031|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168032|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168033|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
138168034|NCT00609739|Hormones|hormones|mesh-ancestor
138168035|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168037|NCT00609739|Protective Agents|protective agents|mesh-ancestor
138168038|NCT00609739|Analgesics|analgesics|mesh-ancestor
138168039|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
138168040|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138315361|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168042|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
138168044|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168045|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168047|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168048|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168050|NCT00574171|Lapatinib|lapatinib|mesh-list
138168051|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168052|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
138168053|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168054|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168055|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168056|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168057|NCT03585998|Cisplatin|cisplatin|mesh-list
138168058|NCT03585998|Etoposide|etoposide|mesh-list
138168059|NCT03585998|Durvalumab|durvalumab|mesh-list
138168060|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168061|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168062|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168063|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168064|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168065|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168066|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168067|NCT00612235|Lamotrigine|lamotrigine|mesh-list
138194546|NCT01187017|Fludarabine|fludarabine|mesh-list
138194547|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138194548|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
138168068|NCT00612235|Carbamazepine|carbamazepine|mesh-list
138168069|NCT00612235|Levetiracetam|levetiracetam|mesh-list
138168070|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
138168071|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
138168072|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138168073|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168074|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168075|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138168076|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168077|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138168078|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138168079|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168080|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138168081|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138168082|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
138168083|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168084|NCT00612235|Analgesics|analgesics|mesh-ancestor
138168085|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
138168086|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168087|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138168088|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138315381|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138168090|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
138168091|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138168092|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138168093|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138168095|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168096|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168097|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138168098|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138168099|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138168100|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168101|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
138168102|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138168103|NCT00499109|Carboplatin|carboplatin|mesh-list
138168104|NCT00499109|Gemcitabine|gemcitabine|mesh-list
138168105|NCT00499109|Docetaxel|docetaxel|mesh-list
138168106|NCT00499109|Vinorelbine|vinorelbine|mesh-list
138168107|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
138168108|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168109|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
138168110|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168111|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
138168112|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
138168113|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168114|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168115|NCT03585530|Raltitrexed|raltitrexed|mesh-list
138168116|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168117|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
138168118|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168119|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168120|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138168121|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168122|NCT03021590|Amoxicillin|amoxicillin|mesh-list
138168123|NCT03021590|Clarithromycin|clarithromycin|mesh-list
138168124|NCT03021590|Levofloxacin|levofloxacin|mesh-list
138168125|NCT03021590|Tinidazole|tinidazole|mesh-list
138168126|NCT03021590|Esomeprazole|esomeprazole|mesh-list
138168127|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168128|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168129|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138168130|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168131|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138168132|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168133|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168134|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138168135|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138168136|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138194556|NCT00378118|Antibodies|antibodies|mesh-list
138168137|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138168138|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168139|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168141|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138168142|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
138168143|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138168145|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138168146|NCT02125721|Penicillamine|penicillamine|mesh-list
138168147|NCT02125721|Antidotes|antidotes|mesh-ancestor
138168148|NCT02125721|Protective Agents|protective agents|mesh-ancestor
138168149|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168150|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
138357428|NCT00003408|Sargramostim|sargramostim|mesh-list
138357429|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357430|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
138168151|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
138168152|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168153|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168154|NCT00552695|Lidocaine|lidocaine|mesh-list
138168155|NCT00552695|Tetracaine|tetracaine|mesh-list
138168156|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
138168157|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
138168158|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168159|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168160|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
138168161|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168162|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138168163|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138168164|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138168165|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168166|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168168|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138168169|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
138168170|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
138168171|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168172|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168173|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168174|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138168175|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138168176|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168178|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138168179|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138168180|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168181|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168182|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168183|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
138168184|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138315435|NCT01579578|Paclitaxel|paclitaxel|mesh-list
138168185|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138168186|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138168187|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138168188|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138168189|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138168190|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138462763|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168191|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138168193|NCT03585374|Acetaminophen|acetaminophen|mesh-list
138168194|NCT03585374|Ketoprofen|ketoprofen|mesh-list
138168195|NCT03585374|Morphine|morphine|mesh-list
138168196|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
138168197|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138168198|NCT03585374|Narcotics|narcotics|mesh-ancestor
138168199|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138357448|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
138357449|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357450|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357451|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168200|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168202|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
138168203|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168204|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168205|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
138168206|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168207|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168208|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168209|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138168210|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168211|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168212|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138168214|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
138168215|NCT00499343|Rituximab|rituximab|mesh-list
138168216|NCT00499343|Etoposide|etoposide|mesh-list
138168217|NCT00499343|Ifosfamide|ifosfamide|mesh-list
138168218|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
138168219|NCT00499343|Sargramostim|sargramostim|mesh-list
138168220|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315463|NCT03028428|Protective Agents|protective agents|mesh-ancestor
138168221|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168222|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
138168223|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168224|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168225|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168226|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168227|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168228|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168229|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168230|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168231|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
138168232|NCT00615589|Fludarabine|fludarabine|mesh-list
138168233|NCT00615589|Busulfan|busulfan|mesh-list
138168234|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168235|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168236|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168237|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
138168238|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168239|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
138168240|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168241|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168242|NCT00499655|Celecoxib|celecoxib|mesh-list
138168243|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138168244|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168245|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168246|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168247|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168248|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168249|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168250|NCT00499655|Analgesics|analgesics|mesh-ancestor
138168251|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
138168252|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168253|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168254|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168255|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168256|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138168257|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138168258|NCT03585140|Doxycycline|doxycycline|mesh-list
138168259|NCT03585140|Adapalene|adapalene|mesh-list
138357470|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357471|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357472|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168260|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138357473|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168261|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168262|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
138315502|NCT01531998|Hormones|hormones|mesh-ancestor
138168265|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168266|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168267|NCT03585140|Analgesics|analgesics|mesh-ancestor
138168268|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
138168269|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168270|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194567|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194568|NCT01451840|Lidocaine|lidocaine|mesh-list
138168273|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
138168274|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138168275|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
138168276|NCT03584984|Coagulants|coagulants|mesh-ancestor
138168277|NCT00575887|Temozolomide|temozolomide|mesh-list
138168278|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168279|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
138168280|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168281|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168283|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138168284|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138168285|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
138168286|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168287|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138168288|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138168289|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168290|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
138168291|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168292|NCT03623828|Apomorphine|apomorphine|mesh-list
138168293|NCT03623828|Emetics|emetics|mesh-ancestor
138168294|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168295|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
138168296|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168297|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138357480|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357481|NCT00003540|Gemcitabine|gemcitabine|mesh-list
138357482|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357483|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
138357484|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357485|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357486|NCT00003546|Gemcitabine|gemcitabine|mesh-list
138357487|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357488|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
138357489|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168298|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
138168299|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
138168300|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168301|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168302|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
138168303|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168304|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
138168305|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168306|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168307|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168308|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
138315535|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
138168309|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168310|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168311|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168313|NCT03589898|Analgesics|analgesics|mesh-ancestor
138168314|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
138168315|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168316|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168317|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
138168318|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138168319|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138168320|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168321|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138168322|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138168323|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138168324|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168325|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168326|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
138168327|NCT00577135|Furosemide|furosemide|mesh-list
138168328|NCT00577135|Diuretics|diuretics|mesh-list
138194578|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138194579|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168329|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138168330|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
138194581|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138168332|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168333|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168335|NCT00502853|Methotrexate|methotrexate|mesh-list
138168336|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168337|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168338|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
138462764|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
138168339|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168340|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168341|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138168342|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
138168343|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168344|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168345|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
138168346|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168347|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
138168348|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168349|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138168350|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168351|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138168352|NCT00617539|Irinotecan|irinotecan|mesh-list
138168353|NCT00617539|Temozolomide|temozolomide|mesh-list
138168354|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138168355|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168356|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168357|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168358|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168359|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168360|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
138168361|NCT03620123|Docetaxel|docetaxel|mesh-list
138168362|NCT03620123|Nivolumab|nivolumab|mesh-list
138168363|NCT03620123|Ipilimumab|ipilimumab|mesh-list
138168364|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168366|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
138168367|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168368|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168369|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168370|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138168371|NCT00578071|Capecitabine|capecitabine|mesh-list
138168372|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
138168373|NCT00578071|Panitumumab|panitumumab|mesh-list
138168374|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168375|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
138168376|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168377|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168378|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168379|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
138168380|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168381|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168382|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168383|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168384|NCT00504023|Imiquimod|imiquimod|mesh-list
138168385|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138168386|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
138168387|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168388|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168389|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
138168390|NCT03589430|Protein C|protein c|mesh-list
138168391|NCT03589430|Antithrombins|antithrombins|mesh-list
138168392|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
138168394|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138168395|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
138168396|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168397|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168398|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
138168399|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138168400|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138168402|NCT05702762|Cephalexin|cephalexin|mesh-list
138168403|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
138168404|NCT05702762|Cefdinir|cefdinir|mesh-list
138168405|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138168406|NCT05702762|Trimethoprim|trimethoprim|mesh-list
138168407|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
138168408|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168409|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168410|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138168411|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168412|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168413|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138168414|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
138168415|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138168416|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138168417|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138168418|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138168419|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138168420|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138168421|NCT03580694|Cemiplimab|cemiplimab|mesh-list
138168422|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168423|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168424|NCT03583892|Gabapentin|gabapentin|mesh-list
138168425|NCT03583892|Analgesics|analgesics|mesh-ancestor
138168426|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
138168427|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168428|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168429|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
138168430|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138168431|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138168432|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138357491|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
138168433|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138168434|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138168435|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138168436|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168437|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168438|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
138168440|NCT03589040|Rilpivirine|rilpivirine|mesh-list
138168441|NCT03589040|Etonogestrel|etonogestrel|mesh-list
138168442|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138168443|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138168444|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138168445|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168446|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168447|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138168448|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138168449|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
138168450|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168451|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138168452|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138315615|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138168453|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138168455|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168456|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168457|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138168458|NCT03583424|Cytarabine|cytarabine|mesh-list
138168459|NCT03583424|Etoposide|etoposide|mesh-list
138168460|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
138168461|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
138168462|NCT03583424|Melphalan|melphalan|mesh-list
138168463|NCT03583424|Venetoclax|venetoclax|mesh-list
138168464|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
138168465|NCT03583424|Carmustine|carmustine|mesh-list
138168466|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138168467|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168468|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168469|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168470|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168471|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168472|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168473|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168474|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
138168475|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
138168476|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168477|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168478|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
138168479|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168480|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168481|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
138168482|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168483|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
138168484|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
138168485|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
138168486|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
138168487|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168488|NCT00578305|Folic Acid|folic acid|mesh-list
138168489|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
138168490|NCT00578305|Rituximab|rituximab|mesh-list
138168491|NCT00578305|Methotrexate|methotrexate|mesh-list
138168492|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168493|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168494|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
138168495|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168496|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357505|NCT00003558|Etoposide|etoposide|mesh-list
138168497|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138168498|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
138357506|NCT00003558|Carboplatin|carboplatin|mesh-list
138168499|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168500|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168501|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
138168502|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168503|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
138168504|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168505|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138168506|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168507|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138168508|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168509|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
138168510|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
138168511|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168512|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168513|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
138168514|NCT00578305|Hormones|hormones|mesh-ancestor
138168515|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168516|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138168517|NCT00578305|Protective Agents|protective agents|mesh-ancestor
138168518|NCT00578305|Hematinics|hematinics|mesh-ancestor
138168519|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
138168520|NCT00578305|Vitamins|vitamins|mesh-ancestor
138168521|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
138168522|NCT00578461|Cytarabine|cytarabine|mesh-list
138168523|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
138168524|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168525|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
138168526|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168527|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168528|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168529|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
138168530|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168531|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168532|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168533|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168534|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
138168535|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
138168536|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168537|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
138315672|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
138168539|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168540|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
138168541|NCT03156296|Bupivacaine|bupivacaine|mesh-list
138168542|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
138168543|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
138168544|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168545|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168546|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
138168547|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168548|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138168549|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168550|NCT03156296|Analgesics|analgesics|mesh-ancestor
138168551|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138168552|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138168553|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138168554|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
138168555|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168556|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168558|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
138168559|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
138168560|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168561|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
138168562|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168564|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168565|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
138168566|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168567|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168568|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168569|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168570|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
138168571|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
138168572|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168573|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168575|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168576|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138168577|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
138168578|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138168579|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168580|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138168581|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138168582|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138168583|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168584|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138168585|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138168586|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138168587|NCT00505895|Rituximab|rituximab|mesh-list
138168588|NCT00505895|Fludarabine|fludarabine|mesh-list
138168589|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
138168590|NCT00505895|Melphalan|melphalan|mesh-list
138168591|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168592|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168593|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
138168594|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168595|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168596|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168597|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
138168598|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168599|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168600|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168601|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
138168602|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168603|NCT03582332|Indomethacin|indomethacin|mesh-list
138168604|NCT03582332|Etoricoxib|etoricoxib|mesh-list
138168605|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168606|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168607|NCT03582332|Analgesics|analgesics|mesh-ancestor
138168608|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
138194608|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138168615|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168616|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138315723|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138168618|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168619|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138168620|NCT00619723|Choline|choline|mesh-list
138168621|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138168622|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
138168623|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138168624|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
138168625|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168626|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168627|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138168628|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
138168629|NCT03582098|Rituximab|rituximab|mesh-list
138168630|NCT03582098|Idelalisib|idelalisib|mesh-list
138168631|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168632|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168634|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168635|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168636|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168637|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168638|NCT00555893|Oseltamivir|oseltamivir|mesh-list
138168639|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
138168640|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168641|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168642|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168643|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138168644|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138357525|NCT00003558|Antidotes|antidotes|mesh-ancestor
138168645|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168646|NCT00578929|Analgesics|analgesics|mesh-ancestor
138168647|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
138315746|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
138168648|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168649|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168650|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168651|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168652|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138168653|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138168654|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138168655|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
138168656|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
138168657|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168658|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168659|NCT00556049|Gemcitabine|gemcitabine|mesh-list
138168660|NCT00556049|Sunitinib|sunitinib|mesh-list
138168661|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168662|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
138168663|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168665|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138194615|NCT05495958|Vitamin D|vitamin d|mesh-list
138168668|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168669|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138168670|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168671|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168672|NCT01797107|Azithromycin|azithromycin|mesh-list
138168673|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168674|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168675|NCT03155984|Antibodies|antibodies|mesh-list
138168676|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
138168677|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168678|NCT00620191|Metformin|metformin|mesh-list
138168679|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138168680|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168681|NCT00506597|Asparaginase|asparaginase|mesh-list
138168682|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168683|NCT03589976|Sirolimus|sirolimus|mesh-list
138168684|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168685|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168686|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138168687|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168688|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
138168689|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168691|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168693|NCT03581630|Bupropion|bupropion|mesh-list
138168694|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138168695|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138168696|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168697|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
138168698|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168699|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138168700|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
138168701|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138168702|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138168703|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138168704|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168705|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168706|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
138168707|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168708|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138168709|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138168710|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168711|NCT00506675|Atropine|atropine|mesh-list
138168712|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138168713|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138168714|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138462765|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138168715|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
138168716|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168717|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168718|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138168719|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
138168720|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
138194618|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
138168721|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
138168722|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138194619|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194620|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138194622|NCT04011592|Ketamine|ketamine|mesh-list
138168725|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168726|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168727|NCT00507767|Dasatinib|dasatinib|mesh-list
138168728|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168729|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168730|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168731|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168733|NCT00621049|Carboplatin|carboplatin|mesh-list
138168734|NCT00621049|Docetaxel|docetaxel|mesh-list
138168735|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138168736|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168737|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168738|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138168739|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138168740|NCT00621049|Growth Substances|growth substances|mesh-ancestor
138168741|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168742|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138168743|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138168744|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138168745|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168746|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168747|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168748|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168749|NCT00508469|Timolol|timolol|mesh-list
138168750|NCT00508469|Travoprost|travoprost|mesh-list
138168751|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138168752|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138168753|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138168754|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138168755|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
138168756|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168757|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168758|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168759|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138168760|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138168761|NCT05702996|Eculizumab|eculizumab|mesh-list
138168762|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138168763|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168764|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
138168765|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168766|NCT00580333|Paclitaxel|paclitaxel|mesh-list
138168767|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
138168768|NCT00580333|Bevacizumab|bevacizumab|mesh-list
138168769|NCT00580333|Doxorubicin|doxorubicin|mesh-list
138168770|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168771|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168772|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138168773|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138168774|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357538|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168775|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168776|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168777|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
138168778|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168779|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168780|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168781|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
138168782|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138168783|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168784|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138168785|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138168786|NCT00580333|Growth Substances|growth substances|mesh-ancestor
138168787|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
138194632|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138168788|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138168789|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168790|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168791|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168792|NCT00580645|Varenicline|varenicline|mesh-list
138168793|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138168794|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138168795|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
138168796|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168797|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168798|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168799|NCT00580957|Trimethaphan|trimethaphan|mesh-list
138168800|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138168801|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138168802|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138168803|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
138168804|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168805|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168806|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138168807|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138168808|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
138168809|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168810|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168811|NCT00509249|Aflibercept|aflibercept|mesh-list
138168812|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
138168813|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138168814|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138168815|NCT00509249|Growth Substances|growth substances|mesh-ancestor
138168816|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168817|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
138168818|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168820|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
138168821|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138168822|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138168823|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138168824|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168825|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168826|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168827|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
138168828|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168829|NCT02121041|Losartan|losartan|mesh-list
138168830|NCT02121041|Amlodipine|amlodipine|mesh-list
138168831|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
138168832|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138168833|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138168834|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168835|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168836|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138168837|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168838|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
138168839|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138168840|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138168841|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138168842|NCT02121041|Diuretics|diuretics|mesh-ancestor
138168843|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
138168844|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138168845|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
138168846|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138168847|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138168848|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138168849|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168850|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138168851|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168852|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168853|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168855|NCT02133781|Vaccines|vaccines|mesh-list
138168856|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
138168857|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462766|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
138168860|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168861|NCT02134951|Ketamine|ketamine|mesh-list
138168862|NCT02134951|Analgesics|analgesics|mesh-ancestor
138168863|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
138168864|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168865|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168866|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138168867|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138168868|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
138168869|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
138168870|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168871|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138168872|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138168873|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168874|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168876|NCT03029780|Ipilimumab|ipilimumab|mesh-list
138168877|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168878|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168879|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138168880|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168882|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138357571|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
138357573|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168883|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168884|NCT00624559|Analgesics|analgesics|mesh-ancestor
138168885|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
138168886|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168887|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168888|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168889|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168890|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138168891|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138168892|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168893|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168894|NCT00510809|Ethanol|ethanol|mesh-list
138168895|NCT00510809|Policosanol|policosanol|mesh-list
138168896|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138168897|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138168898|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315945|NCT01484496|Belimumab|belimumab|mesh-list
138168899|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138168900|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168901|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138168902|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138168903|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
138168904|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168905|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168906|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138168907|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138168908|NCT00625729|Aldesleukin|aldesleukin|mesh-list
138168909|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
138168910|NCT00625729|Rituximab|rituximab|mesh-list
138168911|NCT00625729|Fludarabine|fludarabine|mesh-list
138168912|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
138168913|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168914|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
138168915|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168916|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168917|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138168918|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
138168919|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168920|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168921|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138194645|NCT05025488|Poly ICLC|poly iclc|mesh-list
138168922|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168923|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168924|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
138168925|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138168926|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138168927|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
138168928|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168930|NCT00581971|Paclitaxel|paclitaxel|mesh-list
138168931|NCT00581971|Carboplatin|carboplatin|mesh-list
138168932|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138168933|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168936|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168937|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168938|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168939|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168940|NCT00581971|Analgesics|analgesics|mesh-ancestor
138168941|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
138168942|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168943|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168944|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168945|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315974|NCT01462266|Hormones|hormones|mesh-ancestor
138168946|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138168947|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138168948|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168949|NCT03029234|Dexamethasone|dexamethasone|mesh-list
138168950|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168951|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
138168952|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
138168953|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168954|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168955|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138168956|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
138168957|NCT03029234|Hormones|hormones|mesh-ancestor
138168958|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168959|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138168960|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168961|NCT01670318|Chromium|chromium|mesh-list
138168962|NCT01670318|Everolimus|everolimus|mesh-list
138168963|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138168964|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138168965|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168966|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168967|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138168968|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
138168969|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168970|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168971|NCT01670318|Trace Elements|trace elements|mesh-ancestor
138168972|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
138168973|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
138168974|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138168975|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
138168976|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168977|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168978|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138168979|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138168981|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138168982|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138168983|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168984|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168985|NCT03111992|Spartalizumab|spartalizumab|mesh-list
138316000|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138316003|NCT01508676|Analgesics|analgesics|mesh-ancestor
138168986|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138168987|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168988|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138168989|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168992|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138168993|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168994|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168995|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138168996|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
138168997|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138168998|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138168999|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169000|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138169001|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138169002|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138169003|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169004|NCT00582205|Paclitaxel|paclitaxel|mesh-list
138169005|NCT00582205|Cisplatin|cisplatin|mesh-list
138169006|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138169007|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169008|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138169009|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169010|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138169011|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169012|NCT00626743|Amlodipine|amlodipine|mesh-list
138169013|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169014|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138169015|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169016|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169017|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169018|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169019|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169020|NCT03155048|Estradiol|estradiol|mesh-list
138169021|NCT03155048|Estrogens|estrogens|mesh-list
138169022|NCT03155048|Hormones|hormones|mesh-ancestor
138169023|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169024|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169025|NCT00627367|Hydromorphone|hydromorphone|mesh-list
138169026|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138169027|NCT00627367|Narcotics|narcotics|mesh-ancestor
138169028|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169029|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169030|NCT00627367|Analgesics|analgesics|mesh-ancestor
138169031|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
138169032|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169033|NCT00627679|Budesonide|budesonide|mesh-list
138169034|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169035|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138169036|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
138169037|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169038|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169039|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169040|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169042|NCT00627679|Hormones|hormones|mesh-ancestor
138169043|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169044|NCT00514709|Vaccines|vaccines|mesh-list
138169045|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
138169046|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169048|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138316076|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169049|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138169050|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
138169051|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169052|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169053|NCT00515021|Eplerenone|eplerenone|mesh-list
138169054|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138194657|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169055|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
138169056|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169057|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169058|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138169059|NCT00515021|Diuretics|diuretics|mesh-ancestor
138169060|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
138169061|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169062|NCT00515177|Eszopiclone|eszopiclone|mesh-list
138169063|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138169064|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169065|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169066|NCT01671410|Morphine|morphine|mesh-list
138169067|NCT01671410|Buprenorphine|buprenorphine|mesh-list
138169068|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138169069|NCT01671410|Narcotics|narcotics|mesh-ancestor
138169070|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169071|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169072|NCT01671410|Analgesics|analgesics|mesh-ancestor
138357619|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169073|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
138169074|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169075|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138169076|NCT00630253|Cyclosporine|cyclosporine|mesh-list
138169077|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
138169078|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
138169079|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
138169081|NCT00630253|Cyclosporins|cyclosporins|mesh-list
138169082|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138169083|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138169084|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
138169085|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169086|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169087|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138169088|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
138169089|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169090|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169091|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138169092|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169093|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
138169094|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169095|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138169096|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138169097|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169098|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138169099|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
138169100|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169101|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169103|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
138169104|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169105|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169106|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
138169107|NCT00630253|Hormones|hormones|mesh-ancestor
138169108|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169109|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138169110|NCT00630253|Protective Agents|protective agents|mesh-ancestor
138169111|NCT01671722|Montelukast|montelukast|mesh-list
138169112|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169113|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169114|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138169115|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138169116|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169117|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169118|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138169119|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138194664|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194665|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194667|NCT01458626|Mirtazapine|mirtazapine|mesh-list
138169120|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169121|NCT00584701|Risperidone|risperidone|mesh-list
138169122|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138169123|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
138169124|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169125|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169126|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169127|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138169128|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138169129|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169130|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169131|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138169132|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
138169133|NCT00630409|Gemcitabine|gemcitabine|mesh-list
138169134|NCT00630409|Doxorubicin|doxorubicin|mesh-list
138169135|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169136|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
138357627|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169137|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169138|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169139|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169140|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138169141|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138169142|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169143|NCT00630955|Memantine|memantine|mesh-list
138169144|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138169145|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138169146|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
138169147|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169148|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169149|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169150|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138169151|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138169152|NCT00584857|Paclitaxel|paclitaxel|mesh-list
138169153|NCT00584857|Carboplatin|carboplatin|mesh-list
138169154|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138169155|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169156|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
138169157|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169158|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
138169159|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169160|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
138169161|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138169162|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
138169163|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169164|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169165|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169166|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169167|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138169168|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
138169169|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169170|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169171|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138169172|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169173|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
138169174|NCT00585013|Protective Agents|protective agents|mesh-ancestor
138169176|NCT01672112|Codeine|codeine|mesh-list
138169177|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138169178|NCT01672112|Narcotics|narcotics|mesh-ancestor
138169179|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169180|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169181|NCT01672112|Analgesics|analgesics|mesh-ancestor
138169182|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
138169183|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169184|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
138169185|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169186|NCT00585637|Vitamin D|vitamin d|mesh-list
138169187|NCT00585637|Vitamins|vitamins|mesh-ancestor
138357635|NCT00003666|Irofulven|irofulven|mesh-list
138169188|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
138194673|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169189|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169190|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138169191|NCT03158792|Enoxaparin|enoxaparin|mesh-list
138169192|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
138169193|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
138169194|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138169195|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138169196|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169197|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138169198|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138169199|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
138169200|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
138169201|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
138169202|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169203|NCT00633919|Prednisone|prednisone|mesh-list
138169204|NCT00633919|Budesonide|budesonide|mesh-list
138169205|NCT00633919|Albuterol|albuterol|mesh-list
138169206|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
138169207|NCT00633919|Desloratadine|desloratadine|mesh-list
138169208|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169209|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
138169210|NCT00633919|Hormones|hormones|mesh-ancestor
138169211|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169212|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169213|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138169214|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169215|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138169216|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
138169217|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169218|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169219|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169220|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138169221|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138169222|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138169223|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169224|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169225|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169227|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138169228|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138169229|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
138169230|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138169231|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138169232|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
138169233|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
138169235|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
138169236|NCT03158246|Calcium|calcium|mesh-list
138169237|NCT03158246|Vitamins|vitamins|mesh-ancestor
138169238|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
138169239|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169240|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169241|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138169242|NCT00515411|Leucovorin|leucovorin|mesh-list
138169243|NCT00515411|Cisplatin|cisplatin|mesh-list
138169244|NCT00515411|Docetaxel|docetaxel|mesh-list
138169245|NCT00515411|Fluorouracil|fluorouracil|mesh-list
138169246|NCT00515411|Trastuzumab|trastuzumab|mesh-list
138169247|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169248|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
138169249|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169250|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
138169251|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169252|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
138169253|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169254|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138169255|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
138169256|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169257|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169258|NCT00515411|Antidotes|antidotes|mesh-ancestor
138169259|NCT00515411|Protective Agents|protective agents|mesh-ancestor
138169260|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
138169261|NCT00515411|Vitamins|vitamins|mesh-ancestor
138169262|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
138169263|NCT00586261|Pioglitazone|pioglitazone|mesh-list
138169264|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
138169265|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138169266|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169267|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169268|NCT00515723|Olanzapine|olanzapine|mesh-list
138169269|NCT00515723|Risperidone|risperidone|mesh-list
138169270|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138169271|NCT00515723|Ziprasidone|ziprasidone|mesh-list
138169272|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138169273|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
138169274|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169275|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169276|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169277|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138169278|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138169279|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169280|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169281|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138169282|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
138169283|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
138169284|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
138169285|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169286|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169287|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138169288|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138169289|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169290|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
138169291|NCT04405154|Cisplatin|cisplatin|mesh-list
138169292|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169293|NCT00586573|Memantine|memantine|mesh-list
138169294|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138169295|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138169296|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
138169297|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169298|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169299|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169300|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138169301|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138169302|NCT01799005|Micronutrients|micronutrients|mesh-list
138169303|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169304|NCT00515879|Cycloserine|cycloserine|mesh-list
138169305|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138169306|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169307|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138169308|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
138169309|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169310|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
138169311|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169313|NCT03152942|Progesterone|progesterone|mesh-list
138169314|NCT03152942|Progestins|progestins|mesh-ancestor
138169315|NCT03152942|Hormones|hormones|mesh-ancestor
138169316|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169317|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169318|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138169319|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
138169320|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169321|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169322|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169323|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138169324|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138169325|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414711|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194681|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194682|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138194683|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
138169326|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169327|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138169328|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138169329|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
138169330|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169331|NCT03152942|Protective Agents|protective agents|mesh-ancestor
138169333|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138169334|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169335|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169336|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138169337|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169338|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169339|NCT01672346|Adenosine|adenosine|mesh-list
138169340|NCT01672346|Analgesics|analgesics|mesh-ancestor
138169341|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
138169342|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169343|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169344|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138169345|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169346|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138169347|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
138169348|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
138169349|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169350|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169351|NCT00516503|Ketamine|ketamine|mesh-list
138169352|NCT00516503|Amitriptyline|amitriptyline|mesh-list
138169353|NCT00516503|Baclofen|baclofen|mesh-list
138316288|NCT06173986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138316295|NCT06173934|Insulin|insulin|mesh-list
138169354|NCT00516503|Analgesics|analgesics|mesh-ancestor
138169355|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
138169356|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169357|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169358|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138169359|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138169360|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
138169361|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
138169362|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169363|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138169364|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138169365|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169366|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169367|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138169368|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138169369|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138169370|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
138169371|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
138169372|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138169373|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
138169374|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169375|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138357687|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
138169376|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138169377|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138169378|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169379|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169380|NCT03157310|Gefitinib|gefitinib|mesh-list
138169382|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138169383|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169384|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169386|NCT03157388|Gentamicins|gentamicins|mesh-list
138169387|NCT03157388|Meropenem|meropenem|mesh-list
138169388|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169389|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169390|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138169391|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169392|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169393|NCT03156920|Sumatriptan|sumatriptan|mesh-list
138194688|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138169394|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138169395|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138169396|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138169397|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
138169398|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169399|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169400|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169401|NCT05247385|Ticagrelor|ticagrelor|mesh-list
138169402|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138169403|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138169404|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138169405|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138169406|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138169407|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
138169408|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169409|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169410|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169412|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138169413|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169414|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138169415|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169416|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169417|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169418|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169419|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169420|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138169421|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138169422|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
138169423|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138169424|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138169425|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169427|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
138169428|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169429|NCT00636649|Escitalopram|escitalopram|mesh-list
138169430|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138169431|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138169432|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169433|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169434|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169435|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
138169436|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169437|NCT05061524|Omalizumab|omalizumab|mesh-list
138357702|NCT00003714|NSC 366140|nsc 366140|mesh-list
138169438|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138169439|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138169440|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
138169441|NCT00636805|Dexamethasone|dexamethasone|mesh-list
138169442|NCT00636805|Palonosetron|palonosetron|mesh-list
138169443|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169444|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
138316342|NCT06138691|Analgesics|analgesics|mesh-ancestor
138316343|NCT06138691|Sensory System Agents|sensory system agents|mesh-ancestor
138169445|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
138169446|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169447|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169448|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169449|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
138169451|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169452|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138169453|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169454|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138169458|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169459|NCT05247151|Oxytocin|oxytocin|mesh-list
138169460|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
138169461|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138169462|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169463|NCT01676246|Flupirtine|flupirtine|mesh-list
138194695|NCT00377806|Diclofenac|diclofenac|mesh-list
138169465|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
138169466|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169467|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169469|NCT00517595|Gemcitabine|gemcitabine|mesh-list
138169470|NCT00517595|Pemetrexed|pemetrexed|mesh-list
138169471|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169472|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169473|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138169474|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138169475|NCT00517595|Growth Substances|growth substances|mesh-ancestor
138169476|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169477|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
138169478|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169479|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
138169480|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169481|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169482|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138169483|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138169485|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138169486|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138169487|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
138169488|NCT01672814|Vitamins|vitamins|mesh-ancestor
138169489|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
138169490|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169491|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138169492|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
138169493|NCT00524225|Oprelvekin|oprelvekin|mesh-list
138169494|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169495|NCT00669019|Saracatinib|saracatinib|mesh-list
138169496|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169497|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169498|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169499|NCT05560373|Huperzine A|huperzine a|mesh-list
138169500|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138169501|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357707|NCT00003720|Growth Substances|growth substances|mesh-ancestor
138169502|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169503|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138169504|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169505|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169506|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138169507|NCT05560373|Protective Agents|protective agents|mesh-ancestor
138169508|NCT00670267|Nadolol|nadolol|mesh-list
138169509|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138169510|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138169511|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169512|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169513|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169514|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169515|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138169516|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169517|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
138169518|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
138169519|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169520|NCT05621915|Nadroparin|nadroparin|mesh-list
138169521|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
138169522|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138169523|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138169524|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169525|NCT01673204|Calcitriol|calcitriol|mesh-list
138169526|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169527|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169529|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169530|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169531|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138169533|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
138169534|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138169536|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
138169537|NCT00641563|Remifentanil|remifentanil|mesh-list
138169538|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138169539|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169540|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169541|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138169542|NCT00641563|Analgesics|analgesics|mesh-ancestor
138169543|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
138169544|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169545|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138169546|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138169547|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138316403|NCT06076018|Anesthetics, General|anesthetics, general|mesh-ancestor
138169548|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169549|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169550|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169551|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138169552|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138169553|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138169554|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169555|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138169556|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
138169557|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
138169558|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
138169559|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
138169560|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138169561|NCT00641563|Narcotics|narcotics|mesh-ancestor
138169562|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138169563|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138169564|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169565|NCT00641641|Tenofovir|tenofovir|mesh-list
138169566|NCT00641641|Emtricitabine|emtricitabine|mesh-list
138169567|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
138169568|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
138169569|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169570|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138169571|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138169572|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169573|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169574|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138169575|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138169576|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138169577|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138169578|NCT03152474|Vitamin A|vitamin a|mesh-list
138169579|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
138169580|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138169581|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138169582|NCT03152474|Prednisolone|prednisolone|mesh-list
138169583|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
138169584|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138169585|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
138169586|NCT03152474|Vitamins|vitamins|mesh-ancestor
138169587|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
138169588|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169589|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169590|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
138169591|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
138316457|NCT05894603|Ritonavir|ritonavir|mesh-list
138357751|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357752|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357753|NCT00003792|Lenograstim|lenograstim|mesh-list
138357754|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357755|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
138357756|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169592|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169593|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169594|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
138169595|NCT03152474|Hormones|hormones|mesh-ancestor
138194703|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194704|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194705|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194706|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169596|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169597|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138169600|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169601|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
138169602|NCT00641797|Promethazine|promethazine|mesh-list
138169603|NCT00641797|Meclizine|meclizine|mesh-list
138169604|NCT00641797|Lorazepam|lorazepam|mesh-list
138169605|NCT00641797|Ondansetron|ondansetron|mesh-list
138169607|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
138169608|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169609|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169610|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169611|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
138169612|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
138169613|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138169614|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138169615|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
138169616|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169617|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169618|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138169619|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138169620|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169621|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
138169622|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
138169623|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
138169624|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138169625|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
138169626|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
138169627|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138169628|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
138169629|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138169630|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138169631|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169632|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
138169633|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
138169634|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138169635|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
138169637|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
138316478|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169638|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169640|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138169641|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169642|NCT01893320|Decitabine|decitabine|mesh-list
138169643|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169644|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
138169645|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169646|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169647|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169648|NCT04120766|Nicorandil|nicorandil|mesh-list
138169649|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138169650|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169651|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169652|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
138169653|NCT04120766|Vitamins|vitamins|mesh-ancestor
138169654|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
138169655|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169657|NCT00673075|Nebivolol|nebivolol|mesh-list
138357782|NCT00003834|Leucovorin|leucovorin|mesh-list
138169658|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138169659|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138169660|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169661|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169662|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169663|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169664|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138169665|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
138169666|NCT00673075|Protective Agents|protective agents|mesh-ancestor
138169667|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138194710|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169668|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169669|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169670|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169671|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138169672|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138169673|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138169674|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138169675|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138169676|NCT02250014|Sargramostim|sargramostim|mesh-list
138316510|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138169677|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
138169678|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169679|NCT04022096|Lansoprazole|lansoprazole|mesh-list
138169680|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
138169681|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138169683|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138169685|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169687|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
138169688|NCT00673153|Calicheamicins|calicheamicins|mesh-list
138169689|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169690|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138169691|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169692|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169693|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169694|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
138169695|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
138169696|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
138169697|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169698|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169699|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138169700|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
138169701|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138169702|NCT00654511|Fentanyl|fentanyl|mesh-list
138169703|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
138169704|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138169705|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169706|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169707|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138169708|NCT00654511|Analgesics|analgesics|mesh-ancestor
138169709|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
138169710|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169711|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138169712|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138169713|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138169714|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138169715|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138357792|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169716|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169717|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138169718|NCT00654511|Narcotics|narcotics|mesh-ancestor
138169719|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138169720|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138169721|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
138169722|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
138169724|NCT01670084|Cytarabine|cytarabine|mesh-list
138316541|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316542|NCT05763953|Etripamil|etripamil|mesh-list
138169725|NCT01670084|Dexamethasone|dexamethasone|mesh-list
138169726|NCT01670084|Prednisone|prednisone|mesh-list
138169727|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
138169728|NCT01670084|Rituximab|rituximab|mesh-list
138169729|NCT01670084|Doxorubicin|doxorubicin|mesh-list
138169730|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138169731|NCT01670084|Methotrexate|methotrexate|mesh-list
138169732|NCT01670084|Vincristine|vincristine|mesh-list
138169733|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
138169734|NCT01670084|Mesna|mesna|mesh-list
138169735|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138169736|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
138169737|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194719|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
138169738|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169739|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138169740|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
138169741|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169742|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169743|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138169744|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169745|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
138169746|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
138169747|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169748|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169749|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
138169750|NCT01670084|Hormones|hormones|mesh-ancestor
138169751|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169752|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138169753|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169754|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169755|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138169756|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138169757|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169759|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
138169760|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138169761|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169762|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
138169763|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
138169764|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138169765|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138169766|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
138169767|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316569|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
138316570|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138169769|NCT01670084|Protective Agents|protective agents|mesh-ancestor
138169770|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
138169772|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
138169773|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138169774|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
138169775|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169776|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
138169777|NCT01670162|Aflibercept|aflibercept|mesh-list
138169778|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138169779|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138169780|NCT01670162|Growth Substances|growth substances|mesh-ancestor
138169781|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169782|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
138169783|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169784|NCT04345783|Apatinib|apatinib|mesh-list
138169785|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169786|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138169787|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169788|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169789|NCT00675259|Paclitaxel|paclitaxel|mesh-list
138169790|NCT00675259|Bevacizumab|bevacizumab|mesh-list
138169791|NCT00675259|Carboplatin|carboplatin|mesh-list
138169792|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138169793|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169794|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
138169795|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169796|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
138169797|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169798|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169799|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138169800|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138169801|NCT00675259|Growth Substances|growth substances|mesh-ancestor
138169802|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169803|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
138169804|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
138169805|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169806|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194729|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169808|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138169809|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169810|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169811|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169812|NCT01670240|Adalimumab|adalimumab|mesh-list
138316601|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316602|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
138316605|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
138169813|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138169814|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169815|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169817|NCT04404686|Nifedipine|nifedipine|mesh-list
138169818|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138169819|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169820|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169821|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138169822|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169823|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169824|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
138169825|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138169826|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138169827|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138169828|NCT04404686|Analgesics|analgesics|mesh-ancestor
138169829|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
138169830|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169831|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169832|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169833|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
138169834|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138169835|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169836|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
138169837|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169838|NCT00658411|Deferoxamine|deferoxamine|mesh-list
138169839|NCT00658411|Siderophores|siderophores|mesh-ancestor
138169840|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138169841|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
138169842|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
138169843|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169844|NCT01674530|Lubiprostone|lubiprostone|mesh-list
138169845|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138169846|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169847|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169848|NCT00676897|Simvastatin|simvastatin|mesh-list
138169849|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138169850|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138169851|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
138169852|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169853|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138169854|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138169855|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316628|NCT05603650|Listerine|listerine|mesh-list
138316630|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169857|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138169858|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138169859|NCT02115074|Analgesics|analgesics|mesh-ancestor
138169860|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
138169861|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169862|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169863|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169864|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169865|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138169866|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138169867|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194730|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
138194733|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138169871|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138169872|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138169873|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
138169874|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169875|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138169876|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138169877|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169878|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138169879|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138169880|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138169881|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138169882|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
138169883|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169884|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169885|NCT02082392|Escitalopram|escitalopram|mesh-list
138169886|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138169887|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138169888|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169889|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169890|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169892|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169893|NCT01674842|Cisplatin|cisplatin|mesh-list
138169894|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169895|NCT03161132|Doxorubicin|doxorubicin|mesh-list
138169896|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138169897|NCT03161132|Olaparib|olaparib|mesh-list
138316661|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316662|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316671|NCT05546853|Vitamins|vitamins|mesh-ancestor
138169898|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169899|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169900|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138169901|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138169902|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169903|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357827|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138169904|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138357828|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357829|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357830|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357831|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
138357832|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169905|NCT03844256|Capecitabine|capecitabine|mesh-list
138169906|NCT03844256|Nivolumab|nivolumab|mesh-list
138169907|NCT03844256|Ipilimumab|ipilimumab|mesh-list
138169909|NCT03844256|Mitomycin|mitomycin|mesh-list
138169910|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169911|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
138169912|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169913|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194737|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194738|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194739|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194740|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194741|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138194742|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138169915|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138169916|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138169918|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138169919|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169920|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
138169921|NCT01675076|Apixaban|apixaban|mesh-list
138169922|NCT01675076|Dabigatran|dabigatran|mesh-list
138169923|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138169924|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
138169925|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138169926|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138169927|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169928|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169929|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
138169930|NCT03838796|Lenvatinib|lenvatinib|mesh-list
138169931|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169932|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138169933|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169934|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169935|NCT03719690|Tipifarnib|tipifarnib|mesh-list
138169936|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169937|NCT01675466|Anesthetics|anesthetics|mesh-list
138169938|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138169939|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169940|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
138169941|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138169942|NCT01676558|Rituximab|rituximab|mesh-list
138316697|NCT05367960|BPN14770|bpn14770|mesh-list
138169943|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169945|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
138169946|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169947|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138169949|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138169950|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138169951|NCT02510300|Ledipasvir|ledipasvir|mesh-list
138169952|NCT02510300|Velpatasvir|velpatasvir|mesh-list
138169953|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
138169954|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138169955|NCT00678535|Capecitabine|capecitabine|mesh-list
138169956|NCT00678535|Cetuximab|cetuximab|mesh-list
138169957|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169958|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138169959|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
138169961|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169962|NCT00659737|Scopolamine|scopolamine|mesh-list
138169963|NCT00659737|Aprepitant|aprepitant|mesh-list
138169964|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
138169965|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138169966|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
138169967|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
138169968|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169969|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169970|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138169971|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138357841|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
138169972|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138169973|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169974|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138169975|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
138169976|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138169977|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
138169978|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138169979|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
138169980|NCT04763876|Ketorolac|ketorolac|mesh-list
138169981|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138169982|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194743|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138169983|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138169985|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
138169986|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169987|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169988|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138169989|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316722|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
138316723|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138169991|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169992|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169994|NCT00680797|Estrogens|estrogens|mesh-list
138169995|NCT00680797|Androgens|androgens|mesh-ancestor
138169996|NCT00680797|Hormones|hormones|mesh-ancestor
138169997|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138169998|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169999|NCT02984852|Tenofovir|tenofovir|mesh-list
138170000|NCT02984852|Emtricitabine|emtricitabine|mesh-list
138170001|NCT02984852|Darunavir|darunavir|mesh-list
138170002|NCT02984852|Cobicistat|cobicistat|mesh-list
138170003|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
138170004|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170005|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138170006|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138170007|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170008|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170010|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138170011|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138170012|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138170013|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
138170014|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138170015|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138170016|NCT00660517|Fluticasone|fluticasone|mesh-list
138170017|NCT00660517|Xhance|xhance|mesh-list
138170018|NCT00660517|Azelastine|azelastine|mesh-list
138170019|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170020|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138170021|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
138170022|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170023|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170024|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138170025|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
138170026|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138170027|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138170028|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138170029|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316750|NCT05150938|Heparin|heparin|mesh-list
138170030|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170031|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138170032|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138170033|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
138170034|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
138170035|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170036|NCT02141581|Vaccines|vaccines|mesh-list
138170037|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
138170038|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170039|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138170040|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138170041|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170042|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170043|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138170044|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170045|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170046|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
138170047|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170048|NCT03819530|Micronutrients|micronutrients|mesh-list
138170049|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170050|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138170051|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
138194756|NCT03995680|Mebendazole|mebendazole|mesh-list
138170052|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138170053|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138170054|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170055|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170057|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138170058|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138170059|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170060|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316788|NCT05084196|Protective Agents|protective agents|mesh-ancestor
138170061|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170062|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
138170063|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170065|NCT04763486|Cefazolin|cefazolin|mesh-list
138170066|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138170067|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170068|NCT02988063|Polidocanol|polidocanol|mesh-list
138170069|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138170070|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138170071|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
138170072|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
138170073|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170074|NCT03744026|Carboplatin|carboplatin|mesh-list
138170075|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170076|NCT03869450|Lidocaine|lidocaine|mesh-list
138170077|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
138170078|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
138170079|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
138170080|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170081|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170082|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
138170083|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170084|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138170085|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138170086|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138170087|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201737|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138357868|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
138170088|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170089|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138170090|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
138170091|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
138170092|NCT03869450|Protective Agents|protective agents|mesh-ancestor
138170093|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138170094|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138170095|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138170096|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170097|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170098|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138170099|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170100|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170101|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138170102|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316830|NCT04938557|Insulin|insulin|mesh-list
138170103|NCT01101464|Asenapine|asenapine|mesh-list
138170104|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138170105|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138170106|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170107|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170108|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138170109|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138170110|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
138170111|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170112|NCT03725930|Clonidine|clonidine|mesh-list
138170113|NCT03725930|Analgesics|analgesics|mesh-ancestor
138170114|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
138170115|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170116|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170119|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
138170120|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138170121|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138170122|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138170123|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
138170124|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170125|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170127|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
138170129|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170130|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170131|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
138170132|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170134|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138170135|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170136|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
138170137|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138170138|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
138170139|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
138170140|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170141|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138170142|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170143|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170144|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
138170145|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
138170146|NCT03778580|Vitamins|vitamins|mesh-ancestor
138170147|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
138170148|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170149|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
138170150|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170151|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170152|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316861|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316862|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
138357878|NCT00003888|Docetaxel|docetaxel|mesh-list
138170153|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170154|NCT03722108|Irinotecan|irinotecan|mesh-list
138170155|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138170156|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170157|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170158|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170159|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170160|NCT03775070|Simvastatin|simvastatin|mesh-list
138170161|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138170162|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170163|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
138170164|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170165|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138170166|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138170167|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170168|NCT02083406|Artefenomel|artefenomel|mesh-list
138170169|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
138170170|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138170171|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138170172|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170173|NCT03773666|Durvalumab|durvalumab|mesh-list
138170174|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170175|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170176|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
138170177|NCT04762784|Hormones|hormones|mesh-ancestor
138170178|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170179|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170180|NCT00003644|Paclitaxel|paclitaxel|mesh-list
138170181|NCT00003644|Carboplatin|carboplatin|mesh-list
138170182|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170183|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170184|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
138170185|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
138170186|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170187|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170189|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
138170190|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170191|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138170192|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138170193|NCT02142049|Growth Substances|growth substances|mesh-ancestor
138170194|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138170195|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170196|NCT03715244|Anesthetics|anesthetics|mesh-list
138316886|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
138170198|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170199|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170200|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
138170201|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170202|NCT03714620|Ketamine|ketamine|mesh-list
138170203|NCT03714620|Analgesics|analgesics|mesh-ancestor
138170204|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
138170205|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170206|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170207|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138170209|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
138170210|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
138170211|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170212|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138170213|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138170214|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170215|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170216|NCT03629288|Azithromycin|azithromycin|mesh-list
138170217|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138170218|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170219|NCT04763096|Tacrolimus|tacrolimus|mesh-list
138357888|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
138170220|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170221|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
138170222|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170223|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138170224|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170225|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170226|NCT00680953|Denosumab|denosumab|mesh-list
138170227|NCT00680953|Alendronate|alendronate|mesh-list
138170228|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138170229|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170231|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138170232|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138170233|NCT00660985|Analgesics|analgesics|mesh-ancestor
138170234|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
138170235|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170236|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170237|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170238|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170239|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138170240|NCT03551522|Seladelpar|seladelpar|mesh-list
138316923|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
138170241|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170242|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
138170243|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170244|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138170245|NCT03704714|Prednisone|prednisone|mesh-list
138170246|NCT03704714|Cortisone|cortisone|mesh-list
138170247|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
138170248|NCT03704714|Rituximab|rituximab|mesh-list
138170249|NCT03704714|Doxorubicin|doxorubicin|mesh-list
138170250|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138170251|NCT03704714|Nivolumab|nivolumab|mesh-list
138170252|NCT03704714|Vincristine|vincristine|mesh-list
138170253|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138170255|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
138170256|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138170257|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170258|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
138170259|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170260|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170261|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138170262|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
138170263|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170264|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170265|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138170266|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138170267|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138170268|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170269|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170270|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170271|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
138170272|NCT03704714|Hormones|hormones|mesh-ancestor
138170273|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170274|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138316958|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316959|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316960|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170275|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138170276|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170277|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138170278|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138170279|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170280|NCT00661141|Ethanol|ethanol|mesh-list
138170281|NCT00661141|Fomepizole|fomepizole|mesh-list
138170282|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138357902|NCT00003900|Docetaxel|docetaxel|mesh-list
138170283|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170284|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170285|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170286|NCT00661141|Antidotes|antidotes|mesh-ancestor
138170287|NCT00661141|Protective Agents|protective agents|mesh-ancestor
138170288|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170289|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170290|NCT03616574|Trifluridine|trifluridine|mesh-list
138170291|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
138170292|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170293|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
138170294|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170295|NCT00681265|Glycerol|glycerol|mesh-list
138170296|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138170297|NCT00681265|Protective Agents|protective agents|mesh-ancestor
138170298|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170299|NCT01677104|Liraglutide|liraglutide|mesh-list
138170301|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138170302|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138170303|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170304|NCT01677104|Incretins|incretins|mesh-ancestor
138170305|NCT01677104|Hormones|hormones|mesh-ancestor
138170306|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170307|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138170308|NCT00661453|Valproic Acid|valproic acid|mesh-list
138170309|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
138170310|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170311|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170312|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
138170313|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170314|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170315|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
138170316|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138170317|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170318|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138170320|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138170321|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170322|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170323|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
138170324|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170325|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170326|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138170327|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
138170328|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170329|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
138170330|NCT00681889|Ranibizumab|ranibizumab|mesh-list
138170331|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138170332|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138170333|NCT00681889|Growth Substances|growth substances|mesh-ancestor
138170334|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170335|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
138170336|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170337|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
138170338|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138170339|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138170340|NCT00682357|Prednisolone|prednisolone|mesh-list
138170341|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
138170342|NCT00682357|Lidocaine|lidocaine|mesh-list
138170343|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138170345|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
138357908|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170346|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
138170347|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170348|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170349|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
138170350|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170351|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138170352|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138170353|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138170354|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170355|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170356|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170357|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
138170358|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
138170359|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170360|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
138170361|NCT00682357|Hormones|hormones|mesh-ancestor
138289122|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138170362|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170364|NCT00682357|Protective Agents|protective agents|mesh-ancestor
138170365|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170366|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170367|NCT00662155|Zolpidem|zolpidem|mesh-list
138170368|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138170369|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138170370|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170371|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170372|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138170373|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
138170374|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
138170375|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170376|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170377|NCT03546608|Tepotinib|tepotinib|mesh-list
138170378|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170379|NCT00662545|Tenofovir|tenofovir|mesh-list
138170380|NCT00662545|Lamivudine|lamivudine|mesh-list
138170381|NCT00662545|Emtricitabine|emtricitabine|mesh-list
138170382|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138170383|NCT00662545|Entecavir|entecavir|mesh-list
138170384|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138317089|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317090|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317092|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170386|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194791|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170387|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138170388|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138170389|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170390|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170391|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138170392|NCT03539198|Nivolumab|nivolumab|mesh-list
138357923|NCT00003912|Carboplatin|carboplatin|mesh-list
138170393|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170394|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170395|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138170396|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170397|NCT00663169|Dexamethasone|dexamethasone|mesh-list
138170398|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
138170399|NCT00663169|BB 1101|bb 1101|mesh-list
138170400|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138170401|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170402|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
138170403|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
138170404|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170405|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170406|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170407|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
138170408|NCT00663169|Hormones|hormones|mesh-ancestor
138170409|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170410|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170411|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170412|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
138170413|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170414|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170415|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
138170416|NCT00663403|Daptomycin|daptomycin|mesh-list
138170417|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138170418|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170419|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
138170420|NCT00663793|Finasteride|finasteride|mesh-list
138170422|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
138170423|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
138170424|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138170425|NCT00663793|Acyline|acyline|mesh-list
138170426|NCT00663793|Androgens|androgens|mesh-ancestor
138170427|NCT00663793|Hormones|hormones|mesh-ancestor
138170428|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170429|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170430|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170431|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170432|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
138170433|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138170434|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138170435|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317117|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138317118|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317119|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170436|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170439|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138170440|NCT02336438|Cathartics|cathartics|mesh-ancestor
138170441|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170442|NCT00667615|Prednisone|prednisone|mesh-list
138170443|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
138170444|NCT00667615|Rituximab|rituximab|mesh-list
138170445|NCT00667615|Etoposide|etoposide|mesh-list
138170446|NCT00667615|Vorinostat|vorinostat|mesh-list
138170447|NCT00667615|Lenograstim|lenograstim|mesh-list
138170448|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170449|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
138170450|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170451|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170452|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138170453|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
138170454|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170455|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170456|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138170457|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170458|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170459|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
138170461|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170462|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170463|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170464|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138170465|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170466|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170467|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138170468|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138170469|NCT03683810|Lactoferrin|lactoferrin|mesh-list
138170470|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
138170471|NCT03683810|Hematinics|hematinics|mesh-ancestor
138170472|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170473|NCT01587235|Simvastatin|simvastatin|mesh-list
138170474|NCT01587235|Ezetimibe|ezetimibe|mesh-list
138170475|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138170476|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138170477|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170479|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170480|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138170481|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138170482|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170483|NCT00705133|Treprostinil|treprostinil|mesh-list
138170484|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138170485|NCT00652717|Simvastatin|simvastatin|mesh-list
138170486|NCT00652717|Ezetimibe|ezetimibe|mesh-list
138170487|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138170488|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170489|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
138170490|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170491|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138170492|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138170493|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170494|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
138170496|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
138170497|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138170498|NCT00684775|Naltrexone|naltrexone|mesh-list
138170499|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138170500|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138170501|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170502|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
138170503|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170504|NCT02258451|Everolimus|everolimus|mesh-list
138170505|NCT02258451|Exemestane|exemestane|mesh-list
138170506|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138170507|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138170508|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138170509|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170510|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170511|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170513|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170514|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170515|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138170516|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138170517|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138170518|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
138170519|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170520|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
138170521|NCT02168270|Temozolomide|temozolomide|mesh-list
138170522|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138170523|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
138170524|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170525|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170526|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
138170527|NCT02168270|Protective Agents|protective agents|mesh-ancestor
138170528|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170529|NCT02168270|Vitamins|vitamins|mesh-ancestor
138170530|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
138170531|NCT00395473|Ezetimibe|ezetimibe|mesh-list
138170532|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138170533|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170534|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
138170535|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357947|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170536|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138170538|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170539|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170540|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170541|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138170542|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138170544|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
138170545|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170546|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170547|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138170548|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138170549|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170551|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
138170552|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
138170553|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170554|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170555|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
138170556|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170558|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138170559|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138170560|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170561|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170562|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
138170563|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170564|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
138170565|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
138170566|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
138170567|NCT00269191|Ibuprofen|ibuprofen|mesh-list
138170568|NCT00269191|Etoricoxib|etoricoxib|mesh-list
138170569|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138170570|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138170571|NCT00269191|Analgesics|analgesics|mesh-ancestor
138170572|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
138170573|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170574|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170575|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170576|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170577|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138170578|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170579|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170580|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138170581|NCT00690235|Pramlintide|pramlintide|mesh-list
138170582|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138170583|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170584|NCT00092833|Ezetimibe|ezetimibe|mesh-list
138170585|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138170586|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138170587|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
138317188|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
138342044|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138170588|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170591|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170592|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
138170593|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170594|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170595|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170597|NCT01799161|Vaccines|vaccines|mesh-list
138170598|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
138170599|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170600|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138170601|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
138170602|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170603|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138170604|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
138170605|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138170606|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170607|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170608|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
138170609|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138170610|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138170611|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
138170612|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170614|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
138170615|NCT00006110|Doxorubicin|doxorubicin|mesh-list
138170616|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138170617|NCT00006110|Trastuzumab|trastuzumab|mesh-list
138170618|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170619|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170620|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138170621|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138170622|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170623|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170624|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170625|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
138170626|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170627|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170628|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138170629|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
138170630|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138170631|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138170632|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138170633|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170634|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170635|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170637|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
138170638|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
138170639|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170640|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170641|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170642|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138170643|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138170644|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170645|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138170646|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138170647|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138170648|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170649|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170650|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170651|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
138170652|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
138170653|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
138170654|NCT00692341|Axitinib|axitinib|mesh-list
138170655|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170656|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138170657|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170658|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170659|NCT00694603|Cetuximab|cetuximab|mesh-list
138170660|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170662|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
138170663|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138170664|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170665|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170666|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138170667|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138170668|NCT00590161|Protective Agents|protective agents|mesh-ancestor
138170669|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170670|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
138170671|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138170673|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138170674|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138170675|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170677|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138170678|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
138170679|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138170680|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138317237|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138317238|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138317239|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138317240|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138317241|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317251|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
138170681|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138170682|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170683|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170685|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170686|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170687|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138170688|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138170689|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170690|NCT02123849|Aspirin|aspirin|mesh-list
138170691|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138170692|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138170693|NCT02123849|Analgesics|analgesics|mesh-ancestor
138170694|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
138170695|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170696|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170697|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170698|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170699|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138170700|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138170701|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170702|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138170703|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138170704|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170705|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
138170706|NCT05347160|Calcium|calcium|mesh-list
138170707|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138170708|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170709|NCT00671528|Gentamicins|gentamicins|mesh-list
138170710|NCT00671528|Clotrimazole|clotrimazole|mesh-list
138170711|NCT00671528|Miconazole|miconazole|mesh-list
138170712|NCT00671528|Betamethasone|betamethasone|mesh-list
138170713|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
138170714|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138170715|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
138170716|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138170717|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170718|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
138170719|NCT00671528|Hormones|hormones|mesh-ancestor
138342292|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
138342298|NCT01652040|Hormones|hormones|mesh-ancestor
138170720|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170721|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170723|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
138170724|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138170725|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170726|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138170727|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170728|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170729|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138170730|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
138170731|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138342348|NCT01667796|Vitamin D|vitamin d|mesh-list
138170732|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138170733|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138170734|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
138170735|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138170736|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138170739|NCT00590863|Citalopram|citalopram|mesh-list
138170740|NCT00590863|Bupropion|bupropion|mesh-list
138170741|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138170742|NCT00590863|Escitalopram|escitalopram|mesh-list
138170743|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138170744|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138170745|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138170746|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170747|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170748|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
138170749|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170750|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138170751|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138170752|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
138170753|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
138170754|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170755|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138170756|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138170757|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
138170758|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138170759|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
138170760|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138170761|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138170762|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
138170763|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138170764|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138170765|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170766|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138170767|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138170768|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
138170769|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
138170770|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138170771|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138170772|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170773|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138170774|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138170775|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138170776|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138170777|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138170778|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138170779|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138170781|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138170782|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170783|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138170784|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138170785|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138170786|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170788|NCT02996695|Chloroquine|chloroquine|mesh-list
138170789|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
138170790|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138170791|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138170792|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170793|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170794|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
138170795|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
138170796|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138170797|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
138170798|NCT02996695|Amebicides|amebicides|mesh-ancestor
138170799|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170800|NCT00359138|Cetirizine|cetirizine|mesh-list
138170801|NCT00359138|Loratadine|loratadine|mesh-list
138170802|NCT00359138|Levocetirizine|levocetirizine|mesh-list
138170803|NCT00359138|Desloratadine|desloratadine|mesh-list
138170804|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138170805|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138170806|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
138170807|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
138170808|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170809|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170810|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170811|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138170812|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138170813|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
138170814|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
138170815|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
138170816|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
138170817|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138170818|NCT05503979|Velpatasvir|velpatasvir|mesh-list
138170819|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
138170820|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170822|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
138170823|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
138170824|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138170825|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170826|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
138170827|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170828|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
138170829|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138170830|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138170831|NCT00698035|Testosterone|testosterone|mesh-list
138170832|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
138170833|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
138170834|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138170835|NCT00698035|Estradiol|estradiol|mesh-list
138170836|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138170837|NCT00698035|Androgens|androgens|mesh-ancestor
138170839|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170840|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170841|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170842|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170843|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
138170844|NCT00698035|Estrogens|estrogens|mesh-ancestor
138342767|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
138170845|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138170846|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
138170847|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138170848|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138170849|NCT02129075|Poly I-C|poly i-c|mesh-list
138170850|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138170851|NCT02129075|Poly ICLC|poly iclc|mesh-list
138170852|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
138170853|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
138170854|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
138170855|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170856|NCT02129075|Laxatives|laxatives|mesh-ancestor
138170857|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170858|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
138170859|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170860|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138170861|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138342831|NCT01746264|Vitamins|vitamins|mesh-ancestor
138170862|NCT02129075|Protective Agents|protective agents|mesh-ancestor
138170863|NCT02775903|Azacitidine|azacitidine|mesh-list
138170864|NCT02775903|Durvalumab|durvalumab|mesh-list
138170865|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170866|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
138170867|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170868|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170869|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170870|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170871|NCT01933425|Rocuronium|rocuronium|mesh-list
138170872|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138170873|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138170874|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138194824|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138170875|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138170876|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170877|NCT04239599|Leuprolide|leuprolide|mesh-list
138170878|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138170879|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
138170880|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138317350|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170881|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170882|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170883|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170885|NCT03487016|Gemcitabine|gemcitabine|mesh-list
138170886|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
138170887|NCT03487016|Irinotecan|irinotecan|mesh-list
138170888|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170889|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342893|NCT01759602|Complement C1s|complement c1s|mesh-list
138170890|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138170891|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138170892|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170893|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170894|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170895|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
138170896|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138170897|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170898|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170899|NCT05346926|Calpastatin|calpastatin|mesh-list
138170900|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138170901|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
138170902|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170903|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170904|NCT03023319|Pemetrexed|pemetrexed|mesh-list
138170905|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170906|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170907|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170908|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138170909|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138170910|NCT02980653|Megestrol|megestrol|mesh-list
138170911|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
138170912|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138170913|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138170914|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138170915|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
138170916|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138170917|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170918|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138317383|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
138170919|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138170920|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170921|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170922|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
138170923|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138170924|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138342996|NCT01785186|Rifampin|rifampin|mesh-list
138170925|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138170926|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170927|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
138170928|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
138170929|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170930|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170931|NCT03087968|Prednisolone|prednisolone|mesh-list
138170932|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138170933|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
138170934|NCT03087968|Hormones|hormones|mesh-ancestor
138170935|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170936|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170937|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138170938|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170939|NCT03845049|Aflibercept|aflibercept|mesh-list
138170940|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138170941|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138170942|NCT03845049|Growth Substances|growth substances|mesh-ancestor
138170943|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343068|NCT01791972|Albuterol|albuterol|mesh-list
138170944|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138170945|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170946|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138170947|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138170948|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170949|NCT03790839|Incretins|incretins|mesh-ancestor
138170950|NCT03790839|Hormones|hormones|mesh-ancestor
138170951|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170952|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138170953|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138170954|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170955|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170958|NCT03088046|Hormones|hormones|mesh-ancestor
138170959|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138170960|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170961|NCT01677884|Bevacizumab|bevacizumab|mesh-list
138170962|NCT01677884|Capecitabine|capecitabine|mesh-list
138170963|NCT01677884|Irinotecan|irinotecan|mesh-list
138170964|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170965|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170966|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138170967|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138170968|NCT01677884|Growth Substances|growth substances|mesh-ancestor
138343177|NCT06020300|Pyridoxal|pyridoxal|mesh-list
138170969|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170970|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
138170971|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170972|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
138170973|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170974|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138170975|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138170976|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170977|NCT02124083|Vorinostat|vorinostat|mesh-list
138170978|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170979|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138170980|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170981|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170983|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138170984|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138317446|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317447|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138358025|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
138170985|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170987|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
138170988|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170989|NCT00701389|Sumatriptan|sumatriptan|mesh-list
138170990|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138170991|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138170992|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138170993|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
138170994|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138170995|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170996|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170997|NCT02336594|Verinurad|verinurad|mesh-list
138170998|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
138170999|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171000|NCT01799317|Vitamin D|vitamin d|mesh-list
138171001|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
138171002|NCT01799317|Vitamins|vitamins|mesh-ancestor
138171003|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
138171004|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171005|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138171006|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138171007|NCT01677962|Poly ICLC|poly iclc|mesh-list
138171008|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
138171009|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
138171010|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171011|NCT00595153|Budesonide|budesonide|mesh-list
138194836|NCT05494710|Bleomycin|bleomycin|mesh-list
138171013|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138171014|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
138171015|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343436|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
138171016|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171017|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138171018|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
138171019|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
138171021|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171022|NCT02995291|Phentolamine|phentolamine|mesh-list
138171023|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138171024|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138171025|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171026|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171027|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171028|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317490|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171029|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138171030|NCT00595231|Rufinamide|rufinamide|mesh-list
138171031|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
138171032|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138171033|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138171034|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171035|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171037|NCT02995057|Trace Elements|trace elements|mesh-ancestor
138171038|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
138171039|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171041|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138171042|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171043|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171044|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138171045|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138171046|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138171047|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171049|NCT03482102|Tremelimumab|tremelimumab|mesh-list
138171050|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138171051|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171052|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138171053|NCT02402270|Laxatives|laxatives|mesh-ancestor
138171054|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171055|NCT00701935|Exenatide|exenatide|mesh-list
138171056|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171057|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171058|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138171059|NCT00701935|Incretins|incretins|mesh-ancestor
138171060|NCT00701935|Hormones|hormones|mesh-ancestor
138171061|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171062|NCT02984696|Estradiol|estradiol|mesh-list
138343578|NCT05528848|Fentanyl|fentanyl|mesh-list
138171063|NCT02984696|Estrogens|estrogens|mesh-ancestor
138171064|NCT02984696|Hormones|hormones|mesh-ancestor
138171065|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171066|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171067|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138171068|NCT00596167|Vancomycin|vancomycin|mesh-list
138171071|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171072|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138171073|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138171074|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138317527|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
138171075|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171076|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171077|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171078|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138171079|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138171080|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138171081|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
138171082|NCT03087032|Liraglutide|liraglutide|mesh-list
138171083|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171084|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171085|NCT03087032|Incretins|incretins|mesh-ancestor
138171087|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171088|NCT02994745|Atorvastatin|atorvastatin|mesh-list
138171089|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138171090|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171091|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
138171092|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171093|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138171094|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138171095|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171096|NCT00703261|Atorvastatin|atorvastatin|mesh-list
138171097|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138171098|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171099|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
138171100|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171101|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138171102|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138171103|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171104|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
138171105|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171106|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171108|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171109|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138171110|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138171111|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
138171112|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
138171113|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
138171114|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171115|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138171117|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138171118|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171119|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171120|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
138358041|NCT00003996|Etoposide|etoposide|mesh-list
138171121|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171122|NCT01678352|Imiquimod|imiquimod|mesh-list
138171123|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138171124|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
138343653|NCT05350371|Pirfenidone|pirfenidone|mesh-list
138171125|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317596|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171126|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171127|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
138171128|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138171130|NCT01678430|Ofatumumab|ofatumumab|mesh-list
138171131|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138171132|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
138194858|NCT04303156|Islatravir|islatravir|mesh-list
138171133|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171134|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171136|NCT01678664|Everolimus|everolimus|mesh-list
138171137|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138171138|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171139|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138171140|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138171141|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171142|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171143|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138171144|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171145|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171146|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
138171147|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171148|NCT00597493|Temozolomide|temozolomide|mesh-list
138171149|NCT00597493|Sorafenib|sorafenib|mesh-list
138171150|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138171151|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
138171152|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171153|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171154|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171155|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171156|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
138171157|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
138171158|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171159|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138171161|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
138171162|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171163|NCT04402112|Pitavastatin|pitavastatin|mesh-list
138171164|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138171165|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138171166|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171167|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
138171168|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171169|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171170|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138171172|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138171173|NCT00597727|Protective Agents|protective agents|mesh-ancestor
138171174|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171175|NCT03474770|Huperzine A|huperzine a|mesh-list
138171176|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138171177|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171178|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171179|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171180|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171181|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171182|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138171184|NCT00707863|Escitalopram|escitalopram|mesh-list
138171185|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138171186|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138171187|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171188|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171189|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171190|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
138171191|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171192|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138171193|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
138171194|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138171195|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
138171196|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171197|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
138171198|NCT00565643|Protective Agents|protective agents|mesh-ancestor
138171199|NCT00565643|Laxatives|laxatives|mesh-ancestor
138171200|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171201|NCT01798277|Amiodarone|amiodarone|mesh-list
138171202|NCT01798277|Sotalol|sotalol|mesh-list
138171203|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138171204|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
138171205|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138171206|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171207|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171208|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138343851|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171209|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138171210|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138171211|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171212|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138171213|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138171214|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138171215|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138171217|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171218|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171219|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171220|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
138171221|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
138171222|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171224|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171225|NCT00566813|Exenatide|exenatide|mesh-list
138171226|NCT00566813|Etanercept|etanercept|mesh-list
138171227|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138343969|NCT04530006|Amantadine|amantadine|mesh-list
138171228|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171230|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
138171231|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171232|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171233|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171234|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171235|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171236|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171237|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
138171238|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171239|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138171240|NCT00566813|Incretins|incretins|mesh-ancestor
138171241|NCT00566813|Hormones|hormones|mesh-ancestor
138171242|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171243|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138171244|NCT00088166|Hormones|hormones|mesh-ancestor
138171245|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171246|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171247|NCT00566969|Carvedilol|carvedilol|mesh-list
138171248|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138171249|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138171250|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171251|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171252|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171253|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171254|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138171256|NCT00566969|Protective Agents|protective agents|mesh-ancestor
138171257|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138171258|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171259|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138171260|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
138317714|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138317715|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
138317716|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317717|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194876|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138171261|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138171262|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138171263|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
138171264|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138171267|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171268|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171269|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138171270|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171272|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138171273|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171274|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171275|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
138171276|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
138171277|NCT00704353|Hematinics|hematinics|mesh-ancestor
138171278|NCT00087698|Pemetrexed|pemetrexed|mesh-list
138171279|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171280|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171281|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171282|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138171283|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138171284|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
138171285|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138171286|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171287|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138171288|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171289|NCT05245721|Nalbuphine|nalbuphine|mesh-list
138171290|NCT05245721|Bupivacaine|bupivacaine|mesh-list
138171291|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
138171292|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
138171293|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171294|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171295|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
138171296|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171297|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138171298|NCT05245721|Narcotics|narcotics|mesh-ancestor
138317736|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138317737|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138317738|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171300|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
138171301|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
138171302|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138171303|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358078|NCT00004056|Cytarabine|cytarabine|mesh-list
138171304|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171305|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
138171306|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138171307|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171308|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171309|NCT02987985|Acetaminophen|acetaminophen|mesh-list
138344432|NCT02764541|Tamoxifen|tamoxifen|mesh-list
138171310|NCT02987985|Dexamethasone|dexamethasone|mesh-list
138171311|NCT02987985|Lidocaine|lidocaine|mesh-list
138171312|NCT02987985|Fentanyl|fentanyl|mesh-list
138171313|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
138171314|NCT02987985|Ketamine|ketamine|mesh-list
138171315|NCT02987985|Gabapentin|gabapentin|mesh-list
138171316|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
138171317|NCT02987985|Ondansetron|ondansetron|mesh-list
138171318|NCT02987985|Sevoflurane|sevoflurane|mesh-list
138171319|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171320|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
138171321|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
138171322|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171323|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171325|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
138171326|NCT02987985|Hormones|hormones|mesh-ancestor
138171327|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171328|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138171329|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171330|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
138317769|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317770|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138317771|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138317772|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
138317773|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138171332|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171333|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
138344544|NCT02276495|Ketorolac|ketorolac|mesh-list
138171334|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138171335|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138171336|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138171337|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171338|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171339|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138171340|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171342|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138171343|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138171344|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138171345|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171346|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171347|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138171348|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138171349|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
138171350|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138171351|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138171352|NCT02987985|Narcotics|narcotics|mesh-ancestor
138171353|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138171354|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
138171355|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138171356|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138171357|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
138171358|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138171359|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138171360|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138171361|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
138171362|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
138358088|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
138171363|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138171364|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138171365|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138171366|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
138171367|NCT00708721|Clofarabine|clofarabine|mesh-list
138317811|NCT01492686|Edaravone|edaravone|mesh-list
138171368|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138171369|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
138171370|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171371|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171373|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
138171374|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138171375|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
138171376|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171377|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171378|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171379|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171380|NCT05362799|Metformin|metformin|mesh-list
138171381|NCT05362799|Letrozole|letrozole|mesh-list
138171382|NCT05362799|Lactitol|lactitol|mesh-list
138171383|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171384|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171385|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171386|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138171387|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138171388|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171389|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171390|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138171391|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
138171392|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171393|NCT05362799|Cathartics|cathartics|mesh-ancestor
138171394|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171395|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
138171396|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138171397|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138171398|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171400|NCT01940523|Coagulants|coagulants|mesh-ancestor
138171401|NCT04403282|Eflornithine|eflornithine|mesh-list
138171402|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171403|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138171404|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138171405|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138317850|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171406|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171407|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138171409|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171411|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138171412|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
138171413|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
138171414|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171415|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171416|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171417|NCT02994433|Analgesics|analgesics|mesh-ancestor
138171418|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
138171419|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171420|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138171421|NCT04388189|Bupropion|bupropion|mesh-list
138171422|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138171423|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
138171424|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138171425|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138171426|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138171427|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171428|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171429|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
138171430|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171431|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171432|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138171433|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138171434|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171435|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138171436|NCT04388189|Analgesics|analgesics|mesh-ancestor
138171437|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
138171438|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171439|NCT00599053|Azithromycin|azithromycin|mesh-list
138171440|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138171441|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171442|NCT01941927|Trametinib|trametinib|mesh-list
138344919|NCT01809054|Aspirin|aspirin|mesh-list
138171444|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171445|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171446|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171447|NCT05220917|Insulin|insulin|mesh-list
138171448|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138171449|NCT05220917|Metformin|metformin|mesh-list
138171450|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
138171451|NCT05220917|Pioglitazone|pioglitazone|mesh-list
138317888|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138317889|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
138317890|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138171452|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138171453|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
138171454|NCT05220917|Liraglutide|liraglutide|mesh-list
138171455|NCT05220917|Empagliflozin|empagliflozin|mesh-list
138171456|NCT05220917|Exenatide|exenatide|mesh-list
138171457|NCT05220917|Glimepiride|glimepiride|mesh-list
138171458|NCT05220917|Linagliptin|linagliptin|mesh-list
138171459|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
138171460|NCT05220917|Canagliflozin|canagliflozin|mesh-list
138171461|NCT05220917|Saxagliptin|saxagliptin|mesh-list
138171462|NCT05220917|Alogliptin|alogliptin|mesh-list
138171463|NCT05220917|Dulaglutide|dulaglutide|mesh-list
138171464|NCT05220917|Glyburide|glyburide|mesh-list
138171465|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
138171466|NCT05220917|Lixisenatide|lixisenatide|mesh-list
138171468|NCT05220917|Xultophy|xultophy|mesh-list
138171469|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138171470|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138171472|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
138171473|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171474|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171476|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171477|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
138171478|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171479|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138171480|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138171481|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171482|NCT05220917|Incretins|incretins|mesh-ancestor
138171483|NCT05220917|Hormones|hormones|mesh-ancestor
138171484|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171485|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
138171486|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138171487|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345150|NCT01878006|Narcotics|narcotics|mesh-ancestor
138171489|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
138171490|NCT00086996|Fluorouracil|fluorouracil|mesh-list
138358112|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171491|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
138171492|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
138171493|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358115|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
138171494|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138171495|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171496|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171497|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
138171498|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171499|NCT01943565|Hydromorphone|hydromorphone|mesh-list
138171500|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171501|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171502|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138171503|NCT01943565|Narcotics|narcotics|mesh-ancestor
138171504|NCT01943565|Analgesics|analgesics|mesh-ancestor
138171505|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
138171506|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171507|NCT03316859|Naloxegol|naloxegol|mesh-list
138171508|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138171509|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171510|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
138317917|NCT01445886|Vitamins|vitamins|mesh-ancestor
138171511|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171513|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
138345322|NCT04360044|Dronabinol|dronabinol|mesh-list
138171515|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171516|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171517|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
138171518|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171519|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138171520|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138171521|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138171522|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171523|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171524|NCT05362019|Norethindrone|norethindrone|mesh-list
138171525|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
138171526|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
138345371|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138171527|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138171528|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138171529|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138171530|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
138171531|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138171532|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171533|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138171534|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138171536|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138171537|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171538|NCT03654105|Analgesics|analgesics|mesh-ancestor
138171539|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
138171540|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345433|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138171541|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171542|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171543|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171544|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138171545|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138171546|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171547|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138171548|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138171549|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171550|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
138171551|NCT04388111|Morphine|morphine|mesh-list
138171552|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138171553|NCT04388111|Narcotics|narcotics|mesh-ancestor
138171554|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171555|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171556|NCT04388111|Analgesics|analgesics|mesh-ancestor
138171557|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
138171558|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171559|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
138171561|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171562|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
138171563|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
138171564|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
138171565|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
138171566|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171567|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171568|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
138171569|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171570|NCT01944423|Cycloserine|cycloserine|mesh-list
138171571|NCT01944423|Nicotine|nicotine|mesh-list
138171572|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138171573|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
138171574|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171575|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171577|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138171578|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171579|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171580|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171581|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138171582|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171583|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138171584|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
138171585|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138171586|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
138171587|NCT00600925|Gentamicins|gentamicins|mesh-list
138171588|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317975|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138171589|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171590|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138171591|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171592|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171593|NCT02338973|Interferons|interferons|mesh-list
138171594|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
138171595|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171596|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
138345614|NCT01948518|Urological Agents|urological agents|mesh-ancestor
138171597|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171598|NCT00601627|Gemcitabine|gemcitabine|mesh-list
138171599|NCT00601627|Capecitabine|capecitabine|mesh-list
138171600|NCT00601627|Fluorouracil|fluorouracil|mesh-list
138171601|NCT00601627|Panitumumab|panitumumab|mesh-list
138171602|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138171603|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
138171604|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171605|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171606|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171607|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
138171608|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171609|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138171610|NCT01947153|Metformin|metformin|mesh-list
138171611|NCT01947153|Linagliptin|linagliptin|mesh-list
138171612|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171613|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171614|NCT01947153|Incretins|incretins|mesh-ancestor
138171615|NCT01947153|Hormones|hormones|mesh-ancestor
138171616|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358134|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171617|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138171618|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
138171619|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171620|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171621|NCT02476409|Tolvaptan|tolvaptan|mesh-list
138171622|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138171623|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171624|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
138171625|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171626|NCT02993575|Floxacillin|floxacillin|mesh-list
138171627|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138171628|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171629|NCT00603187|Acyline|acyline|mesh-list
138171630|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
138171631|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171632|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171633|NCT01886937|Phentermine|phentermine|mesh-list
138171634|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138171635|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171637|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138171638|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
138171639|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
138171640|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171641|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171642|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171643|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171644|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
138171645|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138171646|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138171647|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171648|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
138171649|NCT02993341|Coagulants|coagulants|mesh-ancestor
138171650|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
138171651|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
138171652|NCT02987907|Dexamethasone|dexamethasone|mesh-list
138171653|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171654|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
138171655|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
138171656|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171657|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171658|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171659|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
138171660|NCT02987907|Hormones|hormones|mesh-ancestor
138345839|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
138171661|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171662|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138171664|NCT01887171|Tacrolimus|tacrolimus|mesh-list
138171665|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171666|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
138171667|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171669|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194915|NCT05489952|Hematinics|hematinics|mesh-ancestor
138171671|NCT00713479|Varenicline|varenicline|mesh-list
138171672|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138171673|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138171674|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171675|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171676|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171677|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171679|NCT04402580|Rituximab|rituximab|mesh-list
138171680|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138171681|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171682|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
138171683|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171684|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171685|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138171686|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138171687|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
138171688|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138171689|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345974|NCT01086540|Promethazine|promethazine|mesh-list
138171690|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171691|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171692|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138171693|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171694|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171695|NCT02987751|Insulin|insulin|mesh-list
138171696|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
138171697|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171698|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171699|NCT04385719|Remdesivir|remdesivir|mesh-list
138171700|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
138171701|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171702|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
138171703|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171704|NCT00082628|Hormones|hormones|mesh-list
138171705|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171706|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171707|NCT01275859|Letrozole|letrozole|mesh-list
138462767|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171708|NCT01275859|Lapatinib|lapatinib|mesh-list
138171709|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171710|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138171711|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138171712|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171713|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171714|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138171715|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
138171716|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138171717|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171718|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171719|NCT01950039|Betaine|betaine|mesh-list
138171720|NCT01950039|Glycine|glycine|mesh-list
138358161|NCT00004110|Etoposide|etoposide|mesh-list
138358162|NCT00004110|Isotretinoin|isotretinoin|mesh-list
138171721|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
138171722|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171723|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171724|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171725|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171726|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
138171727|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171728|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
138171729|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138171730|NCT01275937|Esomeprazole|esomeprazole|mesh-list
138171731|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138171732|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171733|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138171734|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171735|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171737|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138171738|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
138171739|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171740|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171741|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138171742|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138171743|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171744|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171745|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171746|NCT01889667|Insulin|insulin|mesh-list
138171747|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138171748|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171749|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171750|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
138171751|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138171752|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138171753|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138171754|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171755|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171756|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171757|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171758|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171759|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138171760|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171762|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171763|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171764|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171765|NCT01276093|Amiodarone|amiodarone|mesh-list
138171766|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346324|NCT02047500|Paclitaxel|paclitaxel|mesh-list
138171767|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
138171768|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138171769|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171770|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171771|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138171772|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138358198|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171773|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138171774|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171775|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138171776|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138171777|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138171778|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
138171779|NCT00557973|Baclofen|baclofen|mesh-list
138171780|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138346387|NCT02061384|Calcitriol|calcitriol|mesh-list
138171781|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171782|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138171783|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171784|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138171786|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
138171787|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171788|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171789|NCT00726739|Aldesleukin|aldesleukin|mesh-list
138171790|NCT00726739|Interleukin-2|interleukin-2|mesh-list
138171791|NCT00726739|Vaccines|vaccines|mesh-list
138171792|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
138171793|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171794|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171795|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171796|NCT00726739|Analgesics|analgesics|mesh-ancestor
138171797|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
138171798|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171799|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138171800|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138194929|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
138171801|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
138171802|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171803|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138171804|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
138171805|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171806|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
138171807|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138358219|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
138358221|NCT00004164|Leucovorin|leucovorin|mesh-list
138171808|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138171809|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171810|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171811|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171812|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171813|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138171814|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
138171815|NCT02991781|Varenicline|varenicline|mesh-list
138171816|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138171817|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138171818|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
138171819|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171820|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171821|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171822|NCT01893801|Paclitaxel|paclitaxel|mesh-list
138171823|NCT01893801|Cisplatin|cisplatin|mesh-list
138171824|NCT01893801|Gemcitabine|gemcitabine|mesh-list
138171825|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171826|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171827|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
138171828|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
138171829|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
138171830|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171831|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138171832|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
138171833|NCT00570089|Ranolazine|ranolazine|mesh-list
138171834|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138171835|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171836|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171837|NCT00727597|Efavirenz|efavirenz|mesh-list
138171838|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
138171839|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138171840|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138171841|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171842|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171843|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
138171844|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171845|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138171846|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138171847|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138171848|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138171849|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138171850|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138171851|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138171852|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138171853|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
138171854|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138171855|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138171857|NCT00571259|Heparin|heparin|mesh-list
138171858|NCT00571259|Citric Acid|citric acid|mesh-list
138171859|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
138171860|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
138171861|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138171862|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
138171863|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
138171864|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171865|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138171866|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138171867|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138194937|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
138171868|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171869|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138171870|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171871|NCT01893879|Ketoprofen|ketoprofen|mesh-list
138346664|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171872|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138171873|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138171874|NCT01893879|Analgesics|analgesics|mesh-ancestor
138171875|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
138171876|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171877|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171878|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171879|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171880|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138171881|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171882|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171883|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
138171884|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138171885|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
138171886|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138171887|NCT00571961|Ritonavir|ritonavir|mesh-list
138171888|NCT00571961|Lopinavir|lopinavir|mesh-list
138171890|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138171891|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138171892|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138171893|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171894|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171895|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138171896|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138171897|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
138171898|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171899|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138171900|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138346785|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
138171901|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138171902|NCT00571961|Narcotics|narcotics|mesh-ancestor
138171903|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171904|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171905|NCT00571961|Analgesics|analgesics|mesh-ancestor
138171906|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
138171907|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171908|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138171909|NCT00572117|Topiramate|topiramate|mesh-list
138171910|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
138171911|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138171912|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171913|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
138171914|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138171915|NCT01895127|Antibodies|antibodies|mesh-list
138171916|NCT01895127|Eculizumab|eculizumab|mesh-list
138171917|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
138171918|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171919|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138171920|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171922|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
138171923|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
138171924|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171925|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171926|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138171927|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138171928|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138171929|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
138358273|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138171930|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462768|NCT05412472|Protective Agents|protective agents|mesh-ancestor
138358285|NCT00004194|Fludarabine|fludarabine|mesh-list
138171931|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171934|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171935|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171936|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171937|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
138171938|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171939|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138171940|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
138171941|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138171943|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138171944|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138171945|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171946|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171947|NCT02991157|Nimodipine|nimodipine|mesh-list
138171948|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138171949|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138171950|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138171951|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171952|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138171953|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171954|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
138171955|NCT04386499|Folic Acid|folic acid|mesh-list
138171956|NCT04386499|Resveratrol|resveratrol|mesh-list
138171957|NCT04386499|Hematinics|hematinics|mesh-ancestor
138171958|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
138171959|NCT04386499|Vitamins|vitamins|mesh-ancestor
138171960|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
138171961|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171962|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
138171963|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171964|NCT04386499|Protective Agents|protective agents|mesh-ancestor
138171965|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171966|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138171967|NCT00573287|Risperidone|risperidone|mesh-list
138171968|NCT00573287|Clozapine|clozapine|mesh-list
138171969|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138171970|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
138171971|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171972|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171973|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171974|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138171975|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138171976|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171977|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138171978|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138171979|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
138171980|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
138171981|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
138171982|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
138171983|NCT01896921|Dolutegravir|dolutegravir|mesh-list
138171985|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138171986|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138171987|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
138171988|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171989|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138171990|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138171991|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171992|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171993|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138171995|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138171996|NCT00749749|Bupivacaine|bupivacaine|mesh-list
138171997|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
138171998|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
138171999|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172000|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172001|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
138172002|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172003|NCT02991937|Tazobactam|tazobactam|mesh-list
138172004|NCT02991937|Piperacillin|piperacillin|mesh-list
138172005|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138172006|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172008|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138172009|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172010|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172011|NCT00420667|Enoxaparin|enoxaparin|mesh-list
138172012|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
138172014|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138172015|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172016|NCT01277107|Zaleplon|zaleplon|mesh-list
138172017|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
138172018|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138172019|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172020|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172021|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
138172022|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
138172023|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172024|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172025|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
138172026|NCT01277185|Calcium|calcium|mesh-list
138172027|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138172028|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172029|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138172030|NCT01274533|Lenalidomide|lenalidomide|mesh-list
138172031|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
138172032|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172033|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138172034|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138172035|NCT01274533|Growth Substances|growth substances|mesh-ancestor
138172036|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172037|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172038|NCT01277497|Calcium|calcium|mesh-list
138172039|NCT01277497|Sevelamer|sevelamer|mesh-list
138172040|NCT01277497|Calcium acetate|calcium acetate|mesh-list
138172041|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138172042|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172043|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
138172044|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
138172045|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172046|NCT01270087|Adalimumab|adalimumab|mesh-list
138172047|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138172048|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172049|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172050|NCT01958073|Estradiol|estradiol|mesh-list
138172051|NCT01958073|Estrogens|estrogens|mesh-list
138172052|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138172053|NCT01958073|Hormones|hormones|mesh-ancestor
138172054|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172055|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172056|NCT01270165|Telbivudine|telbivudine|mesh-list
138172057|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
138172058|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172059|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172060|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172061|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172062|NCT05740215|Lenvatinib|lenvatinib|mesh-list
138172063|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172064|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172065|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172066|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172067|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
138172068|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138172069|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138172070|NCT01277731|Prednisolone|prednisolone|mesh-list
138172071|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
138172072|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138172073|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
138172074|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172075|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
138172076|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
138172077|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172078|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172079|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172080|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
138172082|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172086|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172087|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138172088|NCT00751777|Vaccines|vaccines|mesh-list
138172089|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
138172090|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172091|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138172092|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
138172093|NCT01902459|Coagulants|coagulants|mesh-ancestor
138172094|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
138172095|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138172096|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138172097|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138172098|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172099|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172100|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
138172101|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172102|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172103|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138172104|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172105|NCT05735145|Paclitaxel|paclitaxel|mesh-list
138172106|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138172107|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138172108|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172109|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
138172111|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
138172112|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172113|NCT01903005|Buprenorphine|buprenorphine|mesh-list
138172114|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138172115|NCT01903005|Naloxone|naloxone|mesh-list
138358318|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
138172116|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138172117|NCT01903005|Narcotics|narcotics|mesh-ancestor
138172118|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172119|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172120|NCT01903005|Analgesics|analgesics|mesh-ancestor
138172121|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
138172122|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172123|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138172124|NCT00614029|Sumatriptan|sumatriptan|mesh-list
138172125|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138172126|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138172127|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138172128|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
138172129|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172130|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172131|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172132|NCT01905423|Albendazole|albendazole|mesh-list
138172133|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
138172134|NCT01905423|Piperazine|piperazine|mesh-list
138172135|NCT01905423|Mebendazole|mebendazole|mesh-list
138172136|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
138172137|NCT01905423|Citric Acid|citric acid|mesh-list
138172138|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
138172139|NCT01905423|DMP 777|dmp 777|mesh-list
138172140|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
138172141|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138172142|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
138172143|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
138172144|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172145|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
138358341|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172146|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138172147|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347445|NCT05495568|Adalimumab|adalimumab|mesh-list
138172148|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
138172149|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138172150|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138172151|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138172152|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138172153|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
138172154|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172155|NCT01905423|Filaricides|filaricides|mesh-ancestor
138172156|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
138172157|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138172158|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172160|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138172161|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172162|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172163|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172164|NCT01906515|Chrysarobin|chrysarobin|mesh-list
138172165|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138172166|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138172167|NCT01906515|Analgesics|analgesics|mesh-ancestor
138172168|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
138172169|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172170|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172171|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172172|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172173|NCT00730483|Doxorubicin|doxorubicin|mesh-list
138172174|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138172175|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138172176|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172177|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138172178|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138172179|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172180|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172181|NCT01907607|Palbociclib|palbociclib|mesh-list
138172182|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172183|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172184|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172185|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172187|NCT00753337|Trace Elements|trace elements|mesh-ancestor
138172188|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
138172189|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172190|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
138172191|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138172192|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
138172193|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
138172194|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172195|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172196|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138172198|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
138172199|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172200|NCT04385407|Ribavirin|ribavirin|mesh-list
138172202|NCT04385407|Simeprevir|simeprevir|mesh-list
138172203|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
138172204|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172205|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
138172206|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172207|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
138172208|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172209|NCT00573989|Pemetrexed|pemetrexed|mesh-list
138172210|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138172211|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172212|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172213|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172214|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138172215|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172216|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172217|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
138172218|NCT02286921|Testosterone|testosterone|mesh-list
138194966|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172220|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
138172221|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138172222|NCT02286921|Androgens|androgens|mesh-ancestor
138172223|NCT02286921|Hormones|hormones|mesh-ancestor
138172224|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172225|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172226|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138347876|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
138172228|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
138172229|NCT00574067|Buprenorphine|buprenorphine|mesh-list
138172230|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138172231|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138172232|NCT00574067|Narcotics|narcotics|mesh-ancestor
138172233|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172234|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172235|NCT00574067|Analgesics|analgesics|mesh-ancestor
138347939|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172236|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
138172237|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172238|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138172240|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138172241|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172242|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
138172243|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172244|NCT01914159|Ranibizumab|ranibizumab|mesh-list
138172245|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138172246|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138172247|NCT01914159|Growth Substances|growth substances|mesh-ancestor
138172248|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172249|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172250|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172251|NCT00576251|Tobramycin|tobramycin|mesh-list
138172252|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138172253|NCT00576251|Dexamethasone|dexamethasone|mesh-list
138172254|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172255|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
138172256|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
138172257|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172258|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172259|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172260|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
138172261|NCT00576251|Hormones|hormones|mesh-ancestor
138172262|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172263|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172264|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172265|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172266|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172267|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138172268|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138172269|NCT00578279|Ethanol|ethanol|mesh-list
138172270|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138172271|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172272|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172273|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172274|NCT00578669|Fluoxetine|fluoxetine|mesh-list
138172275|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138172276|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138172277|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172278|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172279|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172280|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
138172281|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172282|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138172283|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
138172284|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138172285|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138358384|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172286|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138172287|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172288|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
138172289|NCT00578903|Methotrexate|methotrexate|mesh-list
138172290|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
138172292|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172293|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
138172294|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172295|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172296|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138172297|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
138289123|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138172298|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172299|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172301|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138172302|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
138172303|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138172304|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138172305|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
138172306|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
138172307|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172308|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138172309|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172310|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138172311|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172312|NCT01918761|Pemetrexed|pemetrexed|mesh-list
138172313|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172314|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172315|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172316|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138172317|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172319|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
138172320|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172321|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172323|NCT00580073|Fluorouracil|fluorouracil|mesh-list
138172324|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
138172325|NCT00580073|Cetuximab|cetuximab|mesh-list
138172326|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
138172327|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172328|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138172329|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172330|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172331|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
138172332|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172333|NCT00580073|Antidotes|antidotes|mesh-ancestor
138172334|NCT00580073|Protective Agents|protective agents|mesh-ancestor
138172335|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
138172336|NCT00580073|Vitamins|vitamins|mesh-ancestor
138172337|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
138172338|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172339|NCT00580151|Clonidine|clonidine|mesh-list
138172340|NCT00580151|Analgesics|analgesics|mesh-ancestor
138172341|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
138172342|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172343|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172344|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138172345|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
138172346|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
138172347|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138172348|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138172349|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138172350|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172351|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358397|NCT00004248|Doxorubicin|doxorubicin|mesh-list
138172352|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172353|NCT01919697|Plecanatide|plecanatide|mesh-list
138172354|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138172355|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
138172356|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172357|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172365|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172368|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138172369|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
138172370|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138172371|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138172372|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138172373|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172374|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172375|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
138172376|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172377|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172378|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138172379|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138172380|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172382|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138172383|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
138172384|NCT05739045|Nivolumab|nivolumab|mesh-list
138172385|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172386|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172387|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138172388|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172390|NCT00604019|Norepinephrine|norepinephrine|mesh-list
138172391|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138172392|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138172393|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172394|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172395|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172396|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172397|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
138172398|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
138172399|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172400|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138172401|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138172402|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
138172403|NCT00604019|Protective Agents|protective agents|mesh-ancestor
138172404|NCT01922115|Trospium chloride|trospium chloride|mesh-list
138172405|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
138172406|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
138172407|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348591|NCT02547012|Ofloxacin|ofloxacin|mesh-list
138172408|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172409|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138172410|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138172411|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
138172412|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172413|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172414|NCT01922115|Urological Agents|urological agents|mesh-ancestor
138172415|NCT00081770|Ribavirin|ribavirin|mesh-list
138172416|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138172426|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172427|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
138172428|NCT00605423|Hormones|hormones|mesh-ancestor
138172429|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172430|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172431|NCT01923129|Prazosin|prazosin|mesh-list
138172432|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138172433|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138172434|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138172435|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138172436|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172437|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172438|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172439|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172441|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138172442|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
138172443|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138348695|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172444|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172445|NCT01925469|Benzocaine|benzocaine|mesh-list
138172446|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172447|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
138348758|NCT05247684|Paclitaxel|paclitaxel|mesh-list
138172448|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172449|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172450|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
138172451|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172452|NCT01925781|Nicotine|nicotine|mesh-list
138172453|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138172454|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
138172455|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172456|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172457|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138172459|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
138172460|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172461|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172462|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138172463|NCT01927887|Hematinics|hematinics|mesh-ancestor
138172464|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138172465|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138172466|NCT00081458|Teduglutide|teduglutide|mesh-list
138172467|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172468|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138172469|NCT00081458|Protective Agents|protective agents|mesh-ancestor
138172470|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172471|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
138172472|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
138172473|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
138172474|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172475|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172476|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172477|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138172478|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138172479|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172480|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138172481|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138172482|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
138348872|NCT03560466|Prednisone|prednisone|mesh-list
138172483|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172484|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172485|NCT01929291|Vaccines|vaccines|mesh-list
138172486|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
138172487|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172488|NCT01929759|Tenofovir|tenofovir|mesh-list
138172489|NCT01929759|Emtricitabine|emtricitabine|mesh-list
138172490|NCT01929759|Cobicistat|cobicistat|mesh-list
138172491|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138172492|NCT01929759|Elvitegravir|elvitegravir|mesh-list
138172493|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
138172494|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172495|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138172496|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172497|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348987|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172498|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172499|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138172500|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138172501|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138172502|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138172503|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138172505|NCT03437330|Empagliflozin|empagliflozin|mesh-list
138172506|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138172507|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172508|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138172509|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172510|NCT01271803|Vemurafenib|vemurafenib|mesh-list
138172511|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172512|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172513|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172514|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172515|NCT00585377|Bevacizumab|bevacizumab|mesh-list
138349066|NCT01448616|Tenofovir|tenofovir|mesh-list
138172516|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138172517|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172518|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172519|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138172520|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138172521|NCT00585377|Growth Substances|growth substances|mesh-ancestor
138172522|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172523|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172524|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172525|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172526|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172527|NCT00080288|Modafinil|modafinil|mesh-list
138172528|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138172529|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172530|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138172531|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138172532|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138172533|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172534|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
138172536|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172538|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172539|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172540|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138172541|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
138172542|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172543|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172544|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138172545|NCT00084344|Afimoxifene|afimoxifene|mesh-list
138172546|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172547|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138172548|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
138172549|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172550|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172551|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138172552|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138172553|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
138172555|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138172556|NCT00611897|Analgesics|analgesics|mesh-ancestor
138172557|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
138172558|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172559|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172560|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138172561|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138172562|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
138172563|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
138172564|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349155|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138172565|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138172566|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138172567|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172568|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172569|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
138172570|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172571|NCT00611897|Expectorants|expectorants|mesh-ancestor
138172572|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
138172573|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138172574|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
138172575|NCT00611897|Protective Agents|protective agents|mesh-ancestor
138172576|NCT00611897|Antidotes|antidotes|mesh-ancestor
138172577|NCT03080324|Fentanyl|fentanyl|mesh-list
138172578|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138172579|NCT03080324|Narcotics|narcotics|mesh-ancestor
138172580|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172581|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172582|NCT03080324|Analgesics|analgesics|mesh-ancestor
138172583|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
138172584|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172585|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138172586|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138172587|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
138172588|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
138172589|NCT03083834|Cosyntropin|cosyntropin|mesh-list
138172590|NCT03083834|Hormones|hormones|mesh-ancestor
138172591|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172592|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172593|NCT02780609|Dexamethasone|dexamethasone|mesh-list
138172594|NCT02780609|Melphalan|melphalan|mesh-list
138349281|NCT02653872|Verapamil|verapamil|mesh-list
138172595|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
138172597|NCT02780609|Antiemetics|antiemetics|mesh-list
138172598|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172599|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
138172600|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172601|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172602|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172603|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
138172605|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349329|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172606|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172607|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172608|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138172609|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
138172610|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172611|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138172612|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172613|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
138172614|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138172615|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172616|NCT03086096|Irinotecan|irinotecan|mesh-list
138172617|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138172618|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138349396|NCT02665728|Laxatives|laxatives|mesh-list
138172619|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172620|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172621|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172622|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138172623|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138172624|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138172625|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172626|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172627|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138172628|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138172629|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138172630|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138172631|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172632|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172633|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172634|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138172635|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138172636|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
138172637|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138172638|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138172639|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
138172640|NCT05346146|Paclitaxel|paclitaxel|mesh-list
138172641|NCT05346146|Gemcitabine|gemcitabine|mesh-list
138172642|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138172643|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172645|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138172646|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
138172647|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172648|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138172649|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
138172650|NCT00613379|Leronlimab|leronlimab|mesh-list
138172651|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
138172652|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138172653|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138172654|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349655|NCT03770130|Analgesics|analgesics|mesh-ancestor
138172655|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138172656|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138172657|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
138172658|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172659|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
138172660|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172663|NCT01271725|Afatinib|afatinib|mesh-list
138172664|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138172665|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172666|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
138172667|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
138172668|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
138172669|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172670|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172671|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172673|NCT00587483|Amiodarone|amiodarone|mesh-list
138172674|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172675|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
138172677|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172679|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172680|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138172681|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138172682|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138172683|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172684|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172685|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138172686|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138172687|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138172688|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138172689|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172690|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138172691|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138172692|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138172694|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138172695|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172696|NCT01270321|Everolimus|everolimus|mesh-list
138172697|NCT01270321|Pasireotide|pasireotide|mesh-list
138172698|NCT01270321|Somatostatin|somatostatin|mesh-list
138172699|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138172700|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138172701|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172702|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172703|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172704|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
138172705|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172706|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172707|NCT01270321|Hormones|hormones|mesh-ancestor
138172708|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172709|NCT01271023|Insulin|insulin|mesh-list
138172710|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138172711|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172712|NCT03086486|Linezolid|linezolid|mesh-list
138172713|NCT03086486|Bedaquiline|bedaquiline|mesh-list
138172714|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172715|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172716|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138172717|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349953|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
138172718|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172720|NCT02287779|Volixibat|volixibat|mesh-list
138172721|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138172722|NCT00732901|Escitalopram|escitalopram|mesh-list
138172723|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138172724|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138172725|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172726|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172727|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172728|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
138172729|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172730|NCT03083210|Lanreotide|lanreotide|mesh-list
138358486|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138172731|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172732|NCT00616109|Sunitinib|sunitinib|mesh-list
138172733|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172734|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138172735|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138172736|NCT00616109|Growth Substances|growth substances|mesh-ancestor
138172737|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172738|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172740|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172741|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172742|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138195001|NCT03979066|Atezolizumab|atezolizumab|mesh-list
138172760|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
138172761|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138172762|NCT03434678|Narcotics|narcotics|mesh-ancestor
138172763|NCT03434678|Analgesics|analgesics|mesh-ancestor
138172764|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138172765|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138172766|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138172768|NCT03837873|Cytarabine|cytarabine|mesh-list
138172769|NCT03837873|Dexamethasone|dexamethasone|mesh-list
138172770|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
138172772|NCT03837873|Doxorubicin|doxorubicin|mesh-list
138172773|NCT03837873|Etoposide|etoposide|mesh-list
138172774|NCT03837873|Vincristine|vincristine|mesh-list
138172775|NCT03837873|Lenalidomide|lenalidomide|mesh-list
138172776|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172777|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
138172778|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172779|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172780|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138172781|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
138350200|NCT06084507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172782|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172783|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172784|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138172785|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172787|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
138172788|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172789|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172790|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
138172791|NCT03837873|Hormones|hormones|mesh-ancestor
138289124|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138172792|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172793|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172794|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172795|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138172796|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138172797|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138172798|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172799|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138172800|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138172801|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
138172802|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
138172803|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172804|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138172805|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138172806|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138172807|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138350319|NCT05936489|Aceclidine|aceclidine|mesh-list
138172808|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138172809|NCT03837873|Growth Substances|growth substances|mesh-ancestor
138172810|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172811|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138172813|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138172814|NCT03082742|Diuretics|diuretics|mesh-ancestor
138172815|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
138172816|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172817|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138172818|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172819|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172820|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138172821|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
138172822|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138172823|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138172824|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172825|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
138172826|NCT05434533|Coagulants|coagulants|mesh-ancestor
138172827|NCT03432650|Dexamethasone|dexamethasone|mesh-list
138172828|NCT03432650|Bupivacaine|bupivacaine|mesh-list
138172829|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172830|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
138172831|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
138172832|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172833|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172834|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172837|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172838|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172839|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172840|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172841|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
138172842|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172843|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
138172844|NCT00248833|Vaccines|vaccines|mesh-list
138172845|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
138172846|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172847|NCT00668525|Dexetimide|dexetimide|mesh-list
138172848|NCT00668525|Citalopram|citalopram|mesh-list
138172849|NCT00668525|Escitalopram|escitalopram|mesh-list
138172850|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138172851|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138172852|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172853|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172854|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172855|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
138172856|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172857|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138172858|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138172859|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
138172861|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172862|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138172863|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138172864|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
138172865|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138172866|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
138172867|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138172868|NCT05736549|Dexamethasone|dexamethasone|mesh-list
138172869|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
138172870|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138172871|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138172872|NCT05736549|Prednisolone|prednisolone|mesh-list
138172873|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
138172874|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
138172875|NCT05736549|Bupivacaine|bupivacaine|mesh-list
138172876|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138172877|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
138172878|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138172879|NCT05736549|BB 1101|bb 1101|mesh-list
138172880|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172881|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
138172882|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
138172883|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172884|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172885|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172886|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
138172887|NCT05736549|Hormones|hormones|mesh-ancestor
138172888|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172889|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172890|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172891|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172892|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
138172893|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172894|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
138172895|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138172896|NCT05736549|Protective Agents|protective agents|mesh-ancestor
138172897|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
138172898|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172899|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172901|NCT05688488|Mitomycins|mitomycins|mesh-list
138172904|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172905|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
138172906|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172907|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138172908|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172909|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138172910|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138172911|NCT05688488|Analgesics|analgesics|mesh-ancestor
138172912|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
138172913|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172914|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172915|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172916|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138172917|NCT00669383|Betamethasone|betamethasone|mesh-list
138172918|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172920|NCT00669383|Hormones|hormones|mesh-ancestor
138172921|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172922|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172923|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138172924|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
138172925|NCT00733993|Caffeine|caffeine|mesh-list
138172926|NCT00733993|Amphetamine|amphetamine|mesh-list
138172927|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138172928|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172929|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138172930|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172931|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172932|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138172933|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138172934|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
138172935|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172936|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
138172937|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
138172938|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172939|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
138195018|NCT02558400|Latanoprost|latanoprost|mesh-list
138172940|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172941|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138350778|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172942|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138172943|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138172944|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138172945|NCT01271257|Misoprostol|misoprostol|mesh-list
138358524|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172946|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138172947|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
138172948|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138172949|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172950|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138172951|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138172952|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
138172953|NCT03082352|Metoprolol|metoprolol|mesh-list
138172954|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138172955|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138172956|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
138172957|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
138172958|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172959|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172960|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138172961|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138172962|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138172963|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172964|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172965|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172966|NCT03398252|Doxazosin|doxazosin|mesh-list
138172967|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138172968|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138172969|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138172970|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138172971|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
138172972|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172973|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172974|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172975|NCT02285283|Itraconazole|itraconazole|mesh-list
138172976|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
138172977|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172978|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138172979|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138172980|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172981|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172982|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138172983|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
138172984|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172985|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172986|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138172988|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138172989|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
138172990|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172991|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
138172992|NCT03429140|Protective Agents|protective agents|mesh-ancestor
138172993|NCT03081494|Spartalizumab|spartalizumab|mesh-list
138172994|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350958|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
138172995|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172996|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138172997|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172998|NCT03081728|Acetaminophen|acetaminophen|mesh-list
138172999|NCT03081728|Diclofenac|diclofenac|mesh-list
138173000|NCT03081728|Ropivacaine|ropivacaine|mesh-list
138173001|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
138173002|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
138173003|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173004|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358533|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
138173005|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
138173006|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173007|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138173008|NCT03081728|Analgesics|analgesics|mesh-ancestor
138173009|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
138173010|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138173011|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173012|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173013|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138173014|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173015|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173016|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138173017|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173019|NCT00618917|Paclitaxel|paclitaxel|mesh-list
138173021|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
138173022|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173023|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173024|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
138173025|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
138173026|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
138173027|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173028|NCT00618917|Trace Elements|trace elements|mesh-ancestor
138173029|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
138173030|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173031|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138173032|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
138173033|NCT00618917|Protective Agents|protective agents|mesh-ancestor
138173034|NCT05736081|Dexamethasone|dexamethasone|mesh-list
138173035|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173036|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
138173037|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
138173038|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173039|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173040|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138173041|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
138173042|NCT05736081|Hormones|hormones|mesh-ancestor
138173043|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173044|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173045|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173046|NCT00619073|Aspirin|aspirin|mesh-list
138173047|NCT00619073|Clopidogrel|clopidogrel|mesh-list
138173048|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138173049|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138173050|NCT00619073|Analgesics|analgesics|mesh-ancestor
138173051|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
138173052|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173053|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173054|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173055|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173056|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138173057|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138173058|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173059|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138173060|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138173061|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173062|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
138173063|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138358547|NCT00004446|Fluoxetine|fluoxetine|mesh-list
138173064|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138173065|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138173066|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
138351268|NCT00942331|Bevacizumab|bevacizumab|mesh-list
138173067|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173068|NCT00670241|Betamethasone|betamethasone|mesh-list
138173069|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
138173070|NCT00670241|Calcipotriene|calcipotriene|mesh-list
138173071|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173072|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
138173073|NCT00670241|Hormones|hormones|mesh-ancestor
138173074|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173075|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173076|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138173077|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
138173078|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
138173079|NCT03088670|Metformin|metformin|mesh-list
138351322|NCT00577122|Hormones|hormones|mesh-ancestor
138173080|NCT03088670|Vildagliptin|vildagliptin|mesh-list
138173081|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173082|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173083|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138173084|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
138173085|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173086|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173088|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
138173089|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138173090|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138173091|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173092|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138173093|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138173094|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138173095|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173096|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173097|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173098|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138173099|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138351525|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
138173100|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138173101|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
138173102|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173103|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173104|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138173105|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138173106|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
138173107|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138173108|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138173109|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
138173111|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138173112|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138173113|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
138173114|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173115|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173116|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173117|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138173118|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
138173120|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138173121|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
138173122|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138173123|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173124|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173125|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173128|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138173129|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173130|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173131|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138173132|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173133|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138173134|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138173135|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
138173136|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138173138|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138173139|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138173140|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138173141|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173142|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173143|NCT03382106|Urological Agents|urological agents|mesh-ancestor
138173144|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
138173146|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
138173147|NCT00622895|Tacrolimus|tacrolimus|mesh-list
138173148|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173149|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173150|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
138173151|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173152|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173153|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
138173154|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173155|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138173156|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173157|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173158|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138173159|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
138173160|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138173161|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173162|NCT00672737|Remifentanil|remifentanil|mesh-list
138173163|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173164|NCT00672737|Narcotics|narcotics|mesh-ancestor
138173165|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173166|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173167|NCT00672737|Analgesics|analgesics|mesh-ancestor
138173168|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
138173169|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173170|NCT00673127|Ketoconazole|ketoconazole|mesh-list
138173171|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
138173172|NCT00673127|Dutasteride|dutasteride|mesh-list
138173173|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173174|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
138351751|NCT02937558|Glucagon|glucagon|mesh-list
138173175|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173176|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138173177|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138173178|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173179|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173180|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138173181|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
138173182|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173183|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173184|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138173185|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138173186|NCT00246259|Risperidone|risperidone|mesh-list
138173187|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
138173190|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173191|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358575|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
138358576|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358578|NCT00004482|Hormones|hormones|mesh-ancestor
138173192|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173193|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138173194|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173195|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173196|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138173197|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
138173199|NCT00673439|Warfarin|warfarin|mesh-list
138173200|NCT00673439|Fondaparinux|fondaparinux|mesh-list
138173201|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
138173202|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138173203|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
138173204|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138173205|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
138173206|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173207|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351871|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
138173208|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138173209|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138173210|NCT03316118|Bupivacaine|bupivacaine|mesh-list
138173211|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
138195039|NCT05493618|Hormones|hormones|mesh-ancestor
138173213|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173214|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173215|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
138173216|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173218|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173219|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173220|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173221|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173222|NCT00674219|Memantine|memantine|mesh-list
138173223|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138173224|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138173225|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
138173226|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173227|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173228|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173229|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138173230|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138173231|NCT00246025|Dabigatran|dabigatran|mesh-list
138173232|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
138173233|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138173234|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
138173235|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173236|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173237|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
138173238|NCT03311594|Ethanol|ethanol|mesh-list
138173239|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138173240|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173241|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173242|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173243|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138173244|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
138173245|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138173246|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138173247|NCT00624923|Analgesics|analgesics|mesh-ancestor
138173248|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
138173249|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173250|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173251|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173252|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173253|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138173254|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173255|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173256|NCT05593653|Suvorexant|suvorexant|mesh-list
138173257|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138173258|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138358585|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173259|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351992|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
138173261|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138173263|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173264|NCT00735787|Adalimumab|adalimumab|mesh-list
138173265|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138173266|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173267|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173268|NCT00628589|Loxapine|loxapine|mesh-list
138173269|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138173270|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138352034|NCT03070470|Ritonavir|ritonavir|mesh-list
138173271|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173272|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173273|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173274|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138173275|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
138173276|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195049|NCT02936206|Tamoxifen|tamoxifen|mesh-list
138352088|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138173277|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173278|NCT01271569|Fospropofol|fospropofol|mesh-list
138173279|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138173280|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173281|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173282|NCT05686772|Dopamine|dopamine|mesh-list
138173283|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138173284|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
138173285|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
138173286|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173287|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173288|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
138173289|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173290|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173291|NCT05686772|Protective Agents|protective agents|mesh-ancestor
138173292|NCT04771871|Paclitaxel|paclitaxel|mesh-list
138173293|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
138173294|NCT04771871|Carboplatin|carboplatin|mesh-list
138173295|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138173296|NCT04771871|Epirubicin|epirubicin|mesh-list
138173297|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173298|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173299|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138173300|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138173301|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138173302|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173303|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173304|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
138173305|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173306|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173307|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138173308|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
138173309|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138173310|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173311|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138173312|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138173313|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173314|NCT04386577|Vitamin D|vitamin d|mesh-list
138173315|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
138173316|NCT04386577|Vitamins|vitamins|mesh-ancestor
138173317|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
138173318|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173319|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138358594|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173320|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138173321|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
138173322|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138358600|NCT00004488|Alendronate|alendronate|mesh-list
138173323|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138173324|NCT04270669|Growth Substances|growth substances|mesh-ancestor
138173325|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173326|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138173327|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173328|NCT05680454|Vaccines|vaccines|mesh-list
138173329|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
138173330|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173331|NCT04928703|Ketamine|ketamine|mesh-list
138173332|NCT04928703|Analgesics|analgesics|mesh-ancestor
138173333|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
138173334|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173335|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173337|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138173338|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
138173339|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
138173340|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173341|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138173342|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138173343|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173356|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138173357|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
138173358|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138173360|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
138173361|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138173362|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173363|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173364|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173365|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138173366|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
138173367|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173368|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138173369|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138173370|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173371|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173372|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138173373|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
138173374|NCT00755911|Coagulants|coagulants|mesh-ancestor
138173376|NCT00737737|Oxycodone|oxycodone|mesh-list
138173377|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173378|NCT00737737|Narcotics|narcotics|mesh-ancestor
138173379|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173380|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173382|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
138173383|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173384|NCT00245011|Ifosfamide|ifosfamide|mesh-list
138173385|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138173386|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173387|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138173388|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
138173389|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173390|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173392|NCT00245011|Analgesics|analgesics|mesh-ancestor
138173393|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
138173394|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173407|NCT00629525|Everolimus|everolimus|mesh-list
138173408|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138173409|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173410|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173411|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173412|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173413|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
138173414|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173415|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173416|NCT00244855|Dexamethasone|dexamethasone|mesh-list
138173417|NCT00244855|Rituximab|rituximab|mesh-list
138173418|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358605|NCT00004488|Vitamins|vitamins|mesh-ancestor
138173419|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
138173420|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
138173421|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173422|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173423|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138173424|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
138173425|NCT00244855|Hormones|hormones|mesh-ancestor
138173426|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173427|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173428|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352479|NCT03395808|Narcotics|narcotics|mesh-ancestor
138173429|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138173430|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
138173431|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138173432|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
138173433|NCT00737893|Hematinics|hematinics|mesh-ancestor
138173434|NCT00631319|Hydromorphone|hydromorphone|mesh-list
138173435|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173436|NCT00631319|Narcotics|narcotics|mesh-ancestor
138173437|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173438|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173439|NCT00631319|Analgesics|analgesics|mesh-ancestor
138173440|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
138173441|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173442|NCT00244621|Candesartan|candesartan|mesh-list
138173443|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
138173444|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138173445|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138173446|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138173447|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173448|NCT00680225|Ranibizumab|ranibizumab|mesh-list
138173449|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138173450|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138173451|NCT00680225|Growth Substances|growth substances|mesh-ancestor
138173452|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173453|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
138173454|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173455|NCT04603391|Cannabidiol|cannabidiol|mesh-list
138173456|NCT04603391|Methylphenidate|methylphenidate|mesh-list
138173457|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138173458|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173459|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138173460|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138173461|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173462|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173463|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
138173464|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173467|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138173468|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173469|NCT02291133|Bleomycin|bleomycin|mesh-list
138173470|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173471|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173472|NCT00680459|Ethanol|ethanol|mesh-list
138173473|NCT00680459|Heparin|heparin|mesh-list
138173474|NCT00680459|Anticoagulants|anticoagulants|mesh-list
138173475|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138173476|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138173477|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173478|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138173479|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173480|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173481|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173483|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138173484|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
138358613|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138173485|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173486|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173487|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138173488|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138173489|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
138173490|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173491|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173492|NCT05685836|Bevacizumab|bevacizumab|mesh-list
138173493|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
138173494|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138173495|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173496|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138173497|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138173498|NCT05685836|Growth Substances|growth substances|mesh-ancestor
138173499|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173500|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
138173501|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138352788|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
138173502|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173503|NCT00632489|Capecitabine|capecitabine|mesh-list
138173504|NCT00632489|Lapatinib|lapatinib|mesh-list
138173505|NCT00632489|Panobinostat|panobinostat|mesh-list
138173506|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173507|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
138173508|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173509|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173510|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173511|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173512|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138173514|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
138173515|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173516|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
138173517|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173518|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173520|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138173521|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138173522|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173523|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173524|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138173525|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138173526|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173527|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138173528|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
138173529|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
138173530|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
138173531|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
138173532|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173533|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173535|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138173536|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173537|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173538|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
138173539|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
138173540|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
138173541|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173542|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138173543|NCT01279213|Clozapine|clozapine|mesh-list
138173544|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138352862|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
138173545|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138173546|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173547|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173548|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173549|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138173550|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138173551|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
138173552|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173553|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173554|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138173555|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138173556|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
138173557|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
138173558|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
138173559|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138173560|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138173561|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138173562|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173563|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173564|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173565|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173566|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138173567|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
138173568|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173569|NCT01279291|Paclitaxel|paclitaxel|mesh-list
138173570|NCT01279291|Carboplatin|carboplatin|mesh-list
138173571|NCT01279291|Gemcitabine|gemcitabine|mesh-list
138173572|NCT01279291|Doxorubicin|doxorubicin|mesh-list
138173573|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138173574|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173575|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173576|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138173577|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138173578|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195067|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
138173579|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173580|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173581|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
138173582|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173583|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138173584|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138173585|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173586|NCT04367883|Amantadine|amantadine|mesh-list
138173587|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
138173588|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138173589|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138173590|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138173591|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
138173592|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173593|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
138173594|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173595|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173596|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173597|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138173598|NCT04367883|Analgesics|analgesics|mesh-ancestor
138352989|NCT03042780|Folfirinox|folfirinox|mesh-list
138173599|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
138173600|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173601|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
138173602|NCT04329039|Somatostatin|somatostatin|mesh-list
138173603|NCT04329039|Hormones|hormones|mesh-ancestor
138173604|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358641|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138173605|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173606|NCT00635609|Doxycycline|doxycycline|mesh-list
138173607|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138173608|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173610|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138173611|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138173612|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138173613|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138173614|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138173615|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138173616|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138173617|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
138173618|NCT05315336|Antibodies|antibodies|mesh-list
138173619|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
138173621|NCT04746495|Eplerenone|eplerenone|mesh-list
138173622|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138173623|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
138353188|NCT01851174|Paclitaxel|paclitaxel|mesh-list
138173624|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173625|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173626|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138173628|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
138173629|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138173630|NCT03347786|Verapamil|verapamil|mesh-list
138173631|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138173632|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138173633|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173634|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173635|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138173636|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173637|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
138173639|NCT03286634|Prednisolone|prednisolone|mesh-list
138173640|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
138173641|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
138173642|NCT03286634|Methotrexate|methotrexate|mesh-list
138173643|NCT03286634|Vincristine|vincristine|mesh-list
138173644|NCT03286634|Daunorubicin|daunorubicin|mesh-list
138173645|NCT03286634|Asparaginase|asparaginase|mesh-list
138173646|NCT03286634|Epirubicin|epirubicin|mesh-list
138173647|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
138173648|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173649|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
138173650|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173651|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195075|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
138173654|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173655|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173656|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138173657|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138173658|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
138173659|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138173660|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173661|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
138173663|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173664|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138173665|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138173666|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
138173667|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173668|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173669|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138173670|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138173671|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138173672|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173673|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
138173675|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173676|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173677|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173678|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138173679|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138173680|NCT00637247|Gemcitabine|gemcitabine|mesh-list
138173681|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173682|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
138173683|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173684|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173686|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173687|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173688|NCT04388033|Temozolomide|temozolomide|mesh-list
138173689|NCT04388033|Interleukin-12|interleukin-12|mesh-list
138173690|NCT04388033|Vaccines|vaccines|mesh-list
138173691|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
138173692|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173693|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138173694|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
138173695|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173696|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173697|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138173698|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138173699|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138353550|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173701|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
138173702|NCT02980731|Venetoclax|venetoclax|mesh-list
138173703|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173704|NCT04725591|Insulin|insulin|mesh-list
138173705|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173706|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173708|NCT02980497|Listerine|listerine|mesh-list
138173709|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138173710|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
138173711|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173712|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173713|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173714|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
138173715|NCT02980497|Protective Agents|protective agents|mesh-ancestor
138195077|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
138173717|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138173719|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173720|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173721|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138173722|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
138173723|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138173724|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
138173725|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173726|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173727|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138173728|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
138173729|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
138173730|NCT02652429|Protective Agents|protective agents|mesh-ancestor
138173731|NCT02294253|Buprenorphine|buprenorphine|mesh-list
138173732|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138173733|NCT02294253|Naloxone|naloxone|mesh-list
138173734|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173735|NCT02294253|Narcotics|narcotics|mesh-ancestor
138353753|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
138173736|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173737|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173738|NCT02294253|Analgesics|analgesics|mesh-ancestor
138173739|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
138173740|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173741|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138173742|NCT00684983|Capecitabine|capecitabine|mesh-list
138173743|NCT00684983|Lapatinib|lapatinib|mesh-list
138173744|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138173745|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173746|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
138173747|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173748|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173749|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173750|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173751|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
138173752|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173754|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138173755|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
138173756|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173757|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173758|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
138173760|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138173761|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173762|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138173763|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173764|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
138173765|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138173766|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
138173767|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173768|NCT00685139|Zonisamide|zonisamide|mesh-list
138173769|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
138173770|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138173771|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173772|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173773|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138173774|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173775|NCT00685295|Fentanyl|fentanyl|mesh-list
138173776|NCT00685295|Oxycodone|oxycodone|mesh-list
138173777|NCT00685295|Lansoprazole|lansoprazole|mesh-list
138173778|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
138173779|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173780|NCT00685295|Narcotics|narcotics|mesh-ancestor
138173781|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173782|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173783|NCT00685295|Analgesics|analgesics|mesh-ancestor
138173784|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
138173785|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173786|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138173787|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138195088|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
138173791|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138173792|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138173793|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173794|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173796|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
138173797|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
138173798|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
138173799|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173800|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173801|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
138173802|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173803|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138173804|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138173805|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138173806|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173807|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173808|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
138354124|NCT00000384|Sertraline|sertraline|mesh-list
138358678|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
138173809|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138173810|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138173811|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173813|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138173814|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138173815|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138173816|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173819|NCT03335540|Relatlimab|relatlimab|mesh-list
138173820|NCT03335540|Linrodostat|linrodostat|mesh-list
138173821|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138173822|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173823|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138173824|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173825|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173826|NCT00643097|Temozolomide|temozolomide|mesh-list
138173827|NCT00643097|Sargramostim|sargramostim|mesh-list
138354180|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138173828|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138173829|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
138173830|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173832|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
138173833|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173834|NCT03333668|Guanfacine|guanfacine|mesh-list
138173835|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138173836|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138173837|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173838|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138173839|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138173840|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173841|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173842|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
138173843|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173844|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138354298|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
138173846|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138173847|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138173848|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
138173849|NCT03280160|Ofatumumab|ofatumumab|mesh-list
138173850|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173851|NCT05502146|Norepinephrine|norepinephrine|mesh-list
138173852|NCT05502146|Bupivacaine|bupivacaine|mesh-list
138173853|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
138173854|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
138173855|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173856|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173857|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
138173858|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173859|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138173860|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138173862|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173863|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173864|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
138173865|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
138173866|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138173867|NCT04027361|Amphetamine|amphetamine|mesh-list
138173868|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138173869|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173870|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
138173871|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
138173872|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173873|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
138173874|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173875|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173876|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
138173877|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138354368|NCT00000864|Zidovudine|zidovudine|mesh-list
138173878|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138173879|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173880|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138173881|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138173882|NCT04682847|Hematinics|hematinics|mesh-ancestor
138173883|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138173884|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138173885|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
138173886|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
138173887|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
138173888|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173889|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173890|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
138173891|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173894|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173895|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
138173897|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173898|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173899|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173900|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173901|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138173902|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173903|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173904|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173905|NCT00687167|Zonisamide|zonisamide|mesh-list
138173906|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
138173907|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138173908|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173909|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354538|NCT00000990|Zidovudine|zidovudine|mesh-list
138173910|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138173911|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173912|NCT00687713|Bupropion|bupropion|mesh-list
138173913|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138173914|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
138173915|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173916|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138173917|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138173918|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173919|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173921|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173922|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173923|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138173924|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138173925|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173926|NCT02304159|Ribavirin|ribavirin|mesh-list
138173927|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
138173928|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
138354661|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173929|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173930|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
138173931|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173933|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138173934|NCT02143973|Narcotics|narcotics|mesh-ancestor
138173935|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138173936|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173937|NCT02143973|Analgesics|analgesics|mesh-ancestor
138173938|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
138173939|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173940|NCT03028701|Budesonide|budesonide|mesh-list
138173941|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
138173942|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173943|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138173944|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
138173945|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173946|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173947|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138354731|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
138173948|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
138173949|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
138173950|NCT03028701|Hormones|hormones|mesh-ancestor
138173951|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173952|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138173953|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138173954|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138173955|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
138173956|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173957|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173959|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138173960|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
138173961|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173962|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173963|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138173964|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138173965|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138173966|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
138173967|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173968|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354844|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173969|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138173970|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
138173971|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
138173972|NCT02267655|Protective Agents|protective agents|mesh-ancestor
138173973|NCT04858958|Aflutinib|aflutinib|mesh-list
138173974|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138173975|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173976|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173977|NCT00690833|Desonide|desonide|mesh-list
138173978|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138173979|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
138173980|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
138358725|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138358726|NCT00004758|Pyridoxine|pyridoxine|mesh-list
138173981|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173982|NCT00644657|Clopidogrel|clopidogrel|mesh-list
138173983|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138354905|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138173984|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138173985|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138173986|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138173987|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
138173988|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173989|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173990|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173991|NCT04613024|Topiramate|topiramate|mesh-list
138173992|NCT04613024|Gabapentin|gabapentin|mesh-list
138173993|NCT04613024|Analgesics|analgesics|mesh-ancestor
138173994|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
138173995|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138173996|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173997|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
138173998|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138173999|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138174000|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174001|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138174002|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138174003|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138174004|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174005|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174006|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
138174007|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138174008|NCT01933815|Bevacizumab|bevacizumab|mesh-list
138174009|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174010|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174011|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138354965|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174012|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138174014|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174015|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
138174016|NCT03480971|Tempol|tempol|mesh-list
138174017|NCT03480971|TEMPO|tempo|mesh-list
138174018|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
138174019|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174020|NCT03480971|Protective Agents|protective agents|mesh-ancestor
138174021|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174022|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138174023|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174024|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138174025|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138174026|NCT00646763|Lenograstim|lenograstim|mesh-list
138174027|NCT00646763|Sargramostim|sargramostim|mesh-list
138174028|NCT00646763|Mitogens|mitogens|mesh-list
138174029|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138174030|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
138174031|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174032|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
138174033|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174034|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
138174035|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174036|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174037|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138174038|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174039|NCT02986347|Epinephrine|epinephrine|mesh-list
138174040|NCT02986347|Racepinephrine|racepinephrine|mesh-list
138174041|NCT02986347|Anesthetics|anesthetics|mesh-list
138174042|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
138174043|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174044|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174045|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174046|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174047|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174048|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174049|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174050|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138174051|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138174052|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
138174053|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174054|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174055|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174057|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
138174058|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138174060|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
138174061|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174063|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174064|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174065|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138174066|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138174067|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138174068|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138174069|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138174070|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174071|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174072|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174073|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174074|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174075|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174076|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174077|NCT01781637|Omalizumab|omalizumab|mesh-list
138174078|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138174079|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174080|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174081|NCT00652145|Mesalamine|mesalamine|mesh-list
138174082|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174083|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174084|NCT00652145|Analgesics|analgesics|mesh-ancestor
138174085|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
138174086|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174087|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174088|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174089|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174090|NCT03231722|Leucovorin|leucovorin|mesh-list
138174091|NCT03231722|Fluorouracil|fluorouracil|mesh-list
138174092|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
138174093|NCT03231722|Irinotecan|irinotecan|mesh-list
138174094|NCT03231722|Panitumumab|panitumumab|mesh-list
138174095|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
138174096|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
138174097|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174098|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138174099|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174100|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174101|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
138174102|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174103|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138174104|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138174105|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174107|NCT03231722|Protective Agents|protective agents|mesh-ancestor
138174108|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
138174109|NCT03231722|Vitamins|vitamins|mesh-ancestor
138174110|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
138174111|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174112|NCT02298933|Eculizumab|eculizumab|mesh-list
138174113|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138174114|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174115|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
138174116|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174117|NCT02959775|Vaccines|vaccines|mesh-list
138174118|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
138174119|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174120|NCT04761848|Cilostazol|cilostazol|mesh-list
138174121|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138174122|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
138174123|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174124|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174125|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174126|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174127|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138174128|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138174129|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174130|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138174131|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
138174132|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138174133|NCT04761848|Protective Agents|protective agents|mesh-ancestor
138174134|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138174135|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138174137|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138174138|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
138174139|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174140|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138174141|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174142|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174143|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174144|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174145|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174146|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174147|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174148|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174149|NCT00693719|Irinotecan|irinotecan|mesh-list
138174150|NCT00693719|Etoposide|etoposide|mesh-list
138174151|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138174152|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138174153|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174154|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355334|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
138174155|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174156|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138174157|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138174158|NCT00653861|Lidocaine|lidocaine|mesh-list
138174159|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
138174160|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
138174161|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174162|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174163|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
138174164|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174165|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138174166|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138174167|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138174168|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174169|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174171|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
138174172|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138174173|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174174|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358757|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
138174175|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174176|NCT00654329|Analgesics|analgesics|mesh-ancestor
138174177|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
138174178|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174179|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174180|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174181|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174182|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174183|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174184|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174185|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138174187|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138174188|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138174189|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
138174190|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
138174192|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138174193|NCT00695435|Dexamethasone|dexamethasone|mesh-list
138174194|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138174195|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174196|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
138174197|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
138174198|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174199|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174200|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174201|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
138174202|NCT00695435|Hormones|hormones|mesh-ancestor
138174203|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174204|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138174205|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174206|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138174207|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138174208|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174210|NCT00654953|Sertraline|sertraline|mesh-list
138174211|NCT00654953|Analgesics|analgesics|mesh-ancestor
138174212|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
138174213|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174214|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174215|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
138174216|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138174217|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138174218|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174219|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138174220|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138174221|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138174222|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174223|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174224|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
138174225|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
138174226|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138174227|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138174228|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174229|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
138174230|NCT01790165|Terbinafine|terbinafine|mesh-list
138174231|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
138174232|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174233|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174234|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174236|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174237|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138174238|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174239|NCT00655811|Capsaicin|capsaicin|mesh-list
138174240|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
138358771|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358774|NCT00004800|Vaccines|vaccines|mesh-list
138174241|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174242|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
138174243|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174244|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174245|NCT03931551|Trastuzumab|trastuzumab|mesh-list
138174246|NCT03931551|Olaparib|olaparib|mesh-list
138174247|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174248|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174249|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138174250|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174251|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174252|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138174253|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138174254|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138174255|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174256|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174257|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174258|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174260|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
138174261|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174262|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
138174263|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138355616|NCT00002502|Cytarabine|cytarabine|mesh-list
138174264|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
138174265|NCT00696449|Adapalene|adapalene|mesh-list
138174266|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174267|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174268|NCT00696449|Analgesics|analgesics|mesh-ancestor
138174269|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
138174270|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174271|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174272|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174273|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174274|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174275|NCT00696761|Alfuzosin|alfuzosin|mesh-list
138174276|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138174277|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138174278|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138174279|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174280|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174281|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174282|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174283|NCT00696761|Urological Agents|urological agents|mesh-ancestor
138174284|NCT00656201|Progesterone|progesterone|mesh-list
138174285|NCT00656201|Progestins|progestins|mesh-ancestor
138174286|NCT00656201|Hormones|hormones|mesh-ancestor
138174287|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174288|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174289|NCT00759291|Acipimox|acipimox|mesh-list
138174290|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174291|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
138174292|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174293|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174294|NCT00756405|Antioxidants|antioxidants|mesh-list
138174295|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174296|NCT00756405|Protective Agents|protective agents|mesh-ancestor
138174297|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174298|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138174300|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138174301|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174302|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174303|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174304|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174305|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174306|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174307|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174308|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174309|NCT03889275|Durvalumab|durvalumab|mesh-list
138174310|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174311|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174312|NCT00657917|Gentamicins|gentamicins|mesh-list
138174313|NCT00657917|Paromomycin|paromomycin|mesh-list
138174314|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138174315|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174316|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138174317|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174318|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174319|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138174320|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138174321|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
138174322|NCT01959945|Vaccines|vaccines|mesh-list
138174323|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
138174324|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174325|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
138174326|NCT01959945|Coagulants|coagulants|mesh-ancestor
138174327|NCT00700661|Montelukast|montelukast|mesh-list
138174328|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174329|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174330|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138174331|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174332|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174333|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174334|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138174335|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138174336|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174338|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174339|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174340|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
138355707|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
138174341|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174342|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174344|NCT00652301|Ezetimibe|ezetimibe|mesh-list
138174345|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174346|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174347|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
138174348|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174349|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174350|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138174351|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174353|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138174354|NCT01961271|Narcotics|narcotics|mesh-ancestor
138174355|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174356|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174357|NCT01961271|Analgesics|analgesics|mesh-ancestor
138174358|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
138174359|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174360|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138174361|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
138174362|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138174363|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138174364|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
138174365|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174366|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138174367|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138174368|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174369|NCT01963845|Incretins|incretins|mesh-ancestor
138174370|NCT01963845|Hormones|hormones|mesh-ancestor
138174371|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174372|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138174373|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
138174374|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358783|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174375|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174376|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138174377|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174378|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174379|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174380|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174381|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174382|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174383|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174384|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174385|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
138174386|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138174387|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
138174388|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174389|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174390|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138174391|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174392|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174393|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138174395|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
138174396|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174397|NCT04277702|Montelukast|montelukast|mesh-list
138174398|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174399|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174400|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138174401|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174402|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174403|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174404|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138174405|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138174406|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174408|NCT00699491|Temsirolimus|temsirolimus|mesh-list
138174410|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138174411|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138174412|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174413|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138174414|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174415|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
138174416|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174417|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
138174418|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174419|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138174420|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174421|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174422|NCT03721965|Prednisone|prednisone|mesh-list
138174423|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
138174424|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174425|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
138174426|NCT03721965|Hormones|hormones|mesh-ancestor
138174427|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174428|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174429|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138174430|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174431|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
138174432|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
138174433|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174434|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174435|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138174436|NCT03721965|Protective Agents|protective agents|mesh-ancestor
138174437|NCT04399148|Ketotifen|ketotifen|mesh-list
138174438|NCT04399148|Aprepitant|aprepitant|mesh-list
138174439|NCT04399148|Desloratadine|desloratadine|mesh-list
138174440|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
138174441|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
138358797|NCT00004854|Protective Agents|protective agents|mesh-ancestor
138174442|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174443|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174444|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174445|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138174446|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174447|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174448|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138174449|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
138174450|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138174451|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138174452|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
138174455|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174456|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138174457|NCT04672382|Morphine|morphine|mesh-list
138174458|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138174459|NCT04672382|Narcotics|narcotics|mesh-ancestor
138174460|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174461|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174462|NCT04672382|Analgesics|analgesics|mesh-ancestor
138174463|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
138174464|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174465|NCT00699803|Prednisone|prednisone|mesh-list
138174466|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
138174467|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138174468|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
138174469|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138174470|NCT00699803|Prednisolone|prednisolone|mesh-list
138174471|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138174472|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
138174473|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174474|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
138174475|NCT00699803|Hormones|hormones|mesh-ancestor
138174476|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174477|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174478|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138174479|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174482|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174483|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174484|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138174485|NCT00699803|Protective Agents|protective agents|mesh-ancestor
138174486|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
138174488|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138174489|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138174490|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174491|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174492|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
138174493|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
138174494|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
138174495|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174497|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
138174498|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174499|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138174500|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
138174501|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
138174502|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174503|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174504|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138174505|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
138174506|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174507|NCT00551447|Simvastatin|simvastatin|mesh-list
138356015|NCT00002676|Cobalt|cobalt|mesh-list
138174509|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174510|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174511|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
138174512|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174513|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174514|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138174515|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174516|NCT01968057|Cyclosporine|cyclosporine|mesh-list
138174517|NCT01968057|Cyclosporins|cyclosporins|mesh-list
138174518|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174519|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174520|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174521|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
138174522|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174523|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
138174524|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174525|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174526|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174527|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138174528|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
138174529|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
138174530|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138174531|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138174532|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174533|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138174534|NCT00658697|Bevacizumab|bevacizumab|mesh-list
138174536|NCT00658697|Bicalutamide|bicalutamide|mesh-list
138174537|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174538|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174539|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138174540|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138174541|NCT00658697|Growth Substances|growth substances|mesh-ancestor
138174542|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174543|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
138174544|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138174545|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138174546|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138174547|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174548|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
138174551|NCT03873116|Berotralstat|berotralstat|mesh-list
138174552|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138174553|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
138174554|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174555|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174558|NCT04399226|Propofol|propofol|mesh-list
138174559|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138174560|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174561|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174562|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174563|NCT04399226|Analgesics|analgesics|mesh-ancestor
138174564|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
138174565|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174566|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174567|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174568|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174569|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174570|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174571|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174572|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138174573|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
138174574|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
138174575|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138174576|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138356149|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
138174577|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138174579|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138174580|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
138174581|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
138174582|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138174583|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174584|NCT00542087|Diclofenac|diclofenac|mesh-list
138174585|NCT00542087|Etoricoxib|etoricoxib|mesh-list
138174586|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174587|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174588|NCT00542087|Analgesics|analgesics|mesh-ancestor
138174589|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
138174590|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174591|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174592|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174593|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174594|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138174595|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174596|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174597|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138174598|NCT00541697|Atorvastatin|atorvastatin|mesh-list
138174599|NCT00541697|Simvastatin|simvastatin|mesh-list
138174600|NCT00541697|Ezetimibe|ezetimibe|mesh-list
138174601|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174602|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174603|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
138174604|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174605|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174606|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138174607|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174608|NCT03223376|Paclitaxel|paclitaxel|mesh-list
138174609|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138174610|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138174611|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174612|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
138174613|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
138174614|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195150|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174615|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174616|NCT00395603|Atorvastatin|atorvastatin|mesh-list
138174617|NCT00395603|Simvastatin|simvastatin|mesh-list
138174618|NCT00395603|Ezetimibe|ezetimibe|mesh-list
138174619|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174620|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174621|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
138174622|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174623|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174624|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138174625|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174626|NCT00659633|Lidocaine|lidocaine|mesh-list
138174627|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
138174628|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
138174629|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174630|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356256|NCT00002772|Tamoxifen|tamoxifen|mesh-list
138174631|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
138174632|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174633|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138174634|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138174635|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138174636|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174637|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174639|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174641|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
138174642|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174643|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174644|NCT00701675|Sertraline|sertraline|mesh-list
138174645|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
138174646|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138174647|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138174648|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138174649|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174650|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174651|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174652|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
138174653|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174654|NCT04639310|Ezogabine|ezogabine|mesh-list
138174655|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
138174656|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174657|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174658|NCT02300727|Curcumin|curcumin|mesh-list
138174659|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174660|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174661|NCT02300727|Analgesics|analgesics|mesh-ancestor
138174662|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
138174663|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174664|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174665|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174666|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174667|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174668|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356288|NCT00002778|Sargramostim|sargramostim|mesh-list
138174669|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174672|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174673|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174674|NCT00250445|Analgesics|analgesics|mesh-ancestor
138174675|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
138174676|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174677|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174678|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174680|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138174681|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174682|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174683|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138174690|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174691|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174693|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174694|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138174695|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174696|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174697|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138174698|NCT00659945|Ondansetron|ondansetron|mesh-list
138174699|NCT00659945|Aprepitant|aprepitant|mesh-list
138174700|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
138174702|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174703|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174704|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174705|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
138174706|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174707|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138174708|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138174709|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
138174710|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174711|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174712|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138174714|NCT04387565|Trace Elements|trace elements|mesh-ancestor
138174715|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
138174716|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174717|NCT02141555|Misoprostol|misoprostol|mesh-list
138174718|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138174719|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
138174720|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138174721|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174722|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138174723|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174724|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
138174725|NCT01799057|Metformin|metformin|mesh-list
138174726|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138174727|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174728|NCT00588965|Propranolol|propranolol|mesh-list
138174729|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138174730|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138174731|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174732|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174733|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174734|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174735|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138174736|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174738|NCT00702299|Paclitaxel|paclitaxel|mesh-list
138174739|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138174740|NCT00702299|Cisplatin|cisplatin|mesh-list
138174741|NCT00702299|Pemetrexed|pemetrexed|mesh-list
138174742|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138174743|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174744|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
138174745|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
138174746|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
138174747|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174748|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174749|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138174750|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138174751|NCT00661583|Ranibizumab|ranibizumab|mesh-list
138174752|NCT00661583|Mitomycins|mitomycins|mesh-list
138174753|NCT00661583|Mitomycin|mitomycin|mesh-list
138174754|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138174755|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138174756|NCT00661583|Growth Substances|growth substances|mesh-ancestor
138174757|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174758|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
138174759|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174760|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138174761|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
138174762|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174763|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138174765|NCT00661895|Metoprolol|metoprolol|mesh-list
138174766|NCT00661895|Atenolol|atenolol|mesh-list
138174767|NCT00661895|Amlodipine|amlodipine|mesh-list
138174768|NCT00661895|Valsartan|valsartan|mesh-list
138174769|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138174770|NCT00661895|Clonidine|clonidine|mesh-list
138174771|NCT00661895|Lisinopril|lisinopril|mesh-list
138174772|NCT00661895|Doxazosin|doxazosin|mesh-list
138174773|NCT00661895|Hydralazine|hydralazine|mesh-list
138174774|NCT00661895|Nifedipine|nifedipine|mesh-list
138174775|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174776|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138174777|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138174778|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174779|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138174780|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174781|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
138174782|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138174783|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138174784|NCT00661895|Diuretics|diuretics|mesh-ancestor
138174785|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
138174786|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138174787|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138174788|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
138174789|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
138174790|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174791|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138358842|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138174792|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138174793|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138174794|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138174795|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174797|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
138174798|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138174799|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138174800|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174801|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
138174802|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138174803|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138174804|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
138174805|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174806|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138174807|NCT00661895|Protective Agents|protective agents|mesh-ancestor
138174808|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138174809|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138174810|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
138174811|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174812|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174813|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138174814|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174815|NCT00662675|Pancrelipase|pancrelipase|mesh-list
138174816|NCT00662675|Pancreatin|pancreatin|mesh-list
138174817|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138174818|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138195172|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138174819|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138174820|NCT00591305|Protective Agents|protective agents|mesh-ancestor
138174821|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174822|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174823|NCT01799603|Simeprevir|simeprevir|mesh-list
138174824|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
138174825|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174826|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138174827|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174828|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174829|NCT00666029|Atorvastatin|atorvastatin|mesh-list
138174830|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138174831|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138174832|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
138174833|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174834|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138174835|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138174836|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174837|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
138174838|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138174839|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138174840|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174842|NCT04372940|Coagulants|coagulants|mesh-ancestor
138174844|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138174845|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174846|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
138174847|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174848|NCT01989195|Manganese|manganese|mesh-list
138174849|NCT01989195|Trace Elements|trace elements|mesh-ancestor
138174850|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
138174851|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174852|NCT00592943|Modafinil|modafinil|mesh-list
138174853|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138174854|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174855|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138174856|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138174857|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138358855|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138174858|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174859|NCT01973205|Aspirin|aspirin|mesh-list
138174860|NCT01973205|Acetaminophen|acetaminophen|mesh-list
138174861|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174862|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174863|NCT01973205|Analgesics|analgesics|mesh-ancestor
138174864|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
138356523|NCT03915366|Valganciclovir|valganciclovir|mesh-list
138174865|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174866|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174867|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174868|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174869|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138174870|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138174871|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174872|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138174873|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138174874|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174875|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
138174877|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138174878|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174879|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174880|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174881|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138174882|NCT01990677|Diuretics|diuretics|mesh-ancestor
138174883|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
138174884|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138174885|NCT00593645|Cytarabine|cytarabine|mesh-list
138174886|NCT00593645|Clofarabine|clofarabine|mesh-list
138174887|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
138174888|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138174889|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138174892|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174893|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
138174894|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174895|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174896|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
138174897|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174898|NCT03219086|Bupivacaine|bupivacaine|mesh-list
138174899|NCT03219086|Prilocaine|prilocaine|mesh-list
138174900|NCT03219086|Anesthetics|anesthetics|mesh-list
138174901|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
138174902|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174903|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174904|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
138174905|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174906|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
138174907|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138174908|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
138174909|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174910|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174911|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138174912|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
138174913|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138174914|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
138174915|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174916|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174917|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138174918|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
138174919|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
138174920|NCT04398290|Protective Agents|protective agents|mesh-ancestor
138174922|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
138174923|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138174924|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138174925|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174926|NCT00704717|Ribavirin|ribavirin|mesh-list
138174927|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138174928|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
138174929|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
138174930|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174931|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
138174932|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174933|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
138174934|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174935|NCT03708224|Atezolizumab|atezolizumab|mesh-list
138174936|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138174937|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174938|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138174939|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174940|NCT03632642|Floxacillin|floxacillin|mesh-list
138174941|NCT03632642|Penicillin G|penicillin g|mesh-list
138174942|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138174943|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
138174944|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138174945|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138174946|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138174947|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138174948|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138174949|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174951|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138174952|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138174953|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138174954|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174955|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
138174957|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174958|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174959|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174961|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174962|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174963|NCT04399070|Ketamine|ketamine|mesh-list
138174964|NCT04399070|Esketamine|esketamine|mesh-list
138174965|NCT04399070|Analgesics|analgesics|mesh-ancestor
138174966|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
138174967|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138174968|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174969|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138174971|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
138174972|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
138174973|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174974|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138174975|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138174976|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174977|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174978|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
138174979|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138174980|NCT00667589|Fluocinonide|fluocinonide|mesh-list
138174982|NCT00667589|Emollients|emollients|mesh-list
138174983|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138174984|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
138174985|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138174986|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
138174987|NCT00667589|Hormones|hormones|mesh-ancestor
138174988|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174989|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174990|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138174991|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
138174992|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
138174993|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138174994|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138174995|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174996|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
138174997|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138174998|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138174999|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175001|NCT03173612|Etoposide|etoposide|mesh-list
138175002|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
138175003|NCT03173612|Idarubicin|idarubicin|mesh-list
138175004|NCT03173612|Dasatinib|dasatinib|mesh-list
138175005|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
138175006|NCT03173612|Lenograstim|lenograstim|mesh-list
138175007|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175008|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175009|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175010|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175011|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175012|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175013|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175015|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
138356666|NCT00002796|Indomethacin|indomethacin|mesh-list
138175017|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175018|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
138175019|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175020|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138175021|NCT03173612|Analgesics|analgesics|mesh-ancestor
138175022|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
138175023|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175024|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138175025|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138175026|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138175027|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138175028|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
138175029|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175030|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175031|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138175032|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
138175033|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138175034|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138175035|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138175036|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
138175037|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175038|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175039|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
138175040|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138175041|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175042|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175043|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175044|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175045|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175046|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175047|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138175048|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138175050|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138175051|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
138175052|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
138175053|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175054|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
138175055|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175056|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
138175057|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175058|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138175059|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138175060|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138175061|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
138175062|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175063|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138175064|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138175065|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175067|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
138175068|NCT00240097|Irinotecan|irinotecan|mesh-list
138175069|NCT00240097|Etoposide|etoposide|mesh-list
138175070|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175071|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138175072|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175073|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175074|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175075|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175076|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175077|NCT04270487|Octylonium|octylonium|mesh-list
138175078|NCT04270487|Bromides|bromides|mesh-list
138175079|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
138175080|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138175081|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175082|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175083|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138175084|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175085|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175086|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
138175088|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175089|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138175090|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138175091|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
138175092|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175093|NCT00739999|Atorvastatin|atorvastatin|mesh-list
138175094|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138175095|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138175096|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
138195192|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
138175097|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175098|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138175099|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138175100|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175101|NCT02997995|Durvalumab|durvalumab|mesh-list
138175102|NCT02997995|Tremelimumab|tremelimumab|mesh-list
138175103|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175104|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175105|NCT03620162|Vaccines|vaccines|mesh-list
138175106|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
138175107|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175108|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
138175109|NCT00742573|Bupropion|bupropion|mesh-list
138175110|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138175111|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138175112|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175113|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175114|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175115|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175116|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
138175117|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138175118|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138356878|NCT00002976|Hormones|hormones|mesh-ancestor
138175119|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138175120|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138175121|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175123|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
138175124|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175125|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
138175126|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175127|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175128|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
138175129|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175130|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175131|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138175132|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138175133|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175134|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175135|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138175136|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175137|NCT03809923|Analgesics|analgesics|mesh-ancestor
138175138|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138175139|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138175140|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138175141|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
138175142|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175143|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
138175144|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138175145|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175146|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
138175148|NCT00602225|Clofarabine|clofarabine|mesh-list
138175150|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
138175151|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175152|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175153|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
138175154|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175155|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175156|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
138175157|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175159|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
138175160|NCT00602771|Tipifarnib|tipifarnib|mesh-list
138175161|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175162|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175163|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175164|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175165|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175166|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175167|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
138195197|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175169|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175170|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138175171|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175172|NCT04248998|Metformin|metformin|mesh-list
138175173|NCT04248998|Paclitaxel|paclitaxel|mesh-list
138175174|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
138175175|NCT04248998|Doxorubicin|doxorubicin|mesh-list
138175176|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175177|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175178|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175179|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175180|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175181|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175182|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175183|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
138175184|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175185|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175186|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138175187|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
138175188|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138175189|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138175190|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138175191|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175192|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175193|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175195|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
138175196|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
138175197|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138175198|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138175199|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138175200|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175201|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138175228|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
138175230|NCT04183868|Glimepiride|glimepiride|mesh-list
138175231|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138175232|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175233|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138175234|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175235|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175236|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175237|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
138175238|NCT02997215|Lidocaine|lidocaine|mesh-list
138175239|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175240|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
138175241|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175242|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175243|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
138175244|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175245|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175246|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138175247|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138175248|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138357006|NCT00003072|Amifostine|amifostine|mesh-list
138175249|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175250|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
138175251|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138175252|NCT02990507|Testosterone|testosterone|mesh-list
138175253|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
138175254|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
138175255|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138175256|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195202|NCT05499234|Acetaminophen|acetaminophen|mesh-list
138175257|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
138175259|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175260|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175261|NCT02990507|Androgens|androgens|mesh-ancestor
138175262|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
138175263|NCT03331484|Ticagrelor|ticagrelor|mesh-list
138175264|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138175265|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
138175266|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138175267|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
138175268|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175269|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175270|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
138175271|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138175272|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138175273|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138175274|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138175275|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
138175276|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175277|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175279|NCT00721513|Fluorouracil|fluorouracil|mesh-list
138175280|NCT00721513|Cetuximab|cetuximab|mesh-list
138175281|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175282|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175283|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175284|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175285|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175286|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
138175287|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175288|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175289|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
138175290|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175291|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175292|NCT00706121|Vitamins|vitamins|mesh-list
138175293|NCT00706121|Vitamin E|vitamin e|mesh-list
138175294|NCT00706121|Tocopherols|tocopherols|mesh-list
138175295|NCT00706121|Tocotrienols|tocotrienols|mesh-list
138175296|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
138175297|NCT00706121|Selenium|selenium|mesh-list
138175298|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
138175299|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175300|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
138175301|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175302|NCT00706121|Protective Agents|protective agents|mesh-ancestor
138175303|NCT00706121|Trace Elements|trace elements|mesh-ancestor
138175304|NCT00746863|Bupivacaine|bupivacaine|mesh-list
138175305|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175307|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175308|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175309|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
138175310|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175311|NCT04385563|Docetaxel|docetaxel|mesh-list
138175312|NCT04385563|Trastuzumab|trastuzumab|mesh-list
138175313|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175314|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175315|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175316|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175317|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175318|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175319|NCT03568838|Enoxaparin|enoxaparin|mesh-list
138175320|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
138175321|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138175322|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138175323|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175324|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
138175325|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
138175326|NCT00726713|Vitamins|vitamins|mesh-ancestor
138175327|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
138175328|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175329|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
138175330|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138175331|NCT00759187|Triclosan|triclosan|mesh-list
138175332|NCT00759187|Fluorides|fluorides|mesh-list
138175333|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
138175334|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
138175335|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
138175336|NCT00759187|Protective Agents|protective agents|mesh-ancestor
138175337|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175338|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138175339|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175340|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
138175341|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175342|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138175343|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138175344|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
138175345|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175346|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138175347|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
138175348|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
138175349|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138175350|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138175351|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175352|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175353|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175354|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175355|NCT01279915|Linaclotide|linaclotide|mesh-list
138175356|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138175357|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
138175358|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175359|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175360|NCT03809455|Fentanyl|fentanyl|mesh-list
138175361|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138175362|NCT03809455|Narcotics|narcotics|mesh-ancestor
138175363|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175364|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175366|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
138175367|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175368|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138175369|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138175370|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
138175371|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
138175372|NCT02997059|Fluconazole|fluconazole|mesh-list
138175373|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
138175374|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175375|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138175376|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138175377|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175378|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175379|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138175381|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175382|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175383|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138175384|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138175385|NCT00759811|Methotrexate|methotrexate|mesh-list
138175386|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138175387|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
138175388|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138175389|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175390|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175391|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
138175392|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175393|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175394|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175395|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175396|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138175397|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175398|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
138175399|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175400|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138175401|NCT03085628|Oxytocin|oxytocin|mesh-list
138175402|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
138195214|NCT01269034|Insulin|insulin|mesh-list
138175403|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138175404|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175405|NCT01276613|Gemcitabine|gemcitabine|mesh-list
138175406|NCT01276613|Losartan|losartan|mesh-list
138175407|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175408|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
138175409|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358946|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
138175410|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175411|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175412|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138175413|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138175414|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138175415|NCT02428205|Propranolol|propranolol|mesh-list
138175416|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138175417|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138175418|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
138175419|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175420|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175421|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175422|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175423|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138175424|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
138175425|NCT01276691|Aspirin|aspirin|mesh-list
138175426|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138175427|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175428|NCT01276691|Analgesics|analgesics|mesh-ancestor
138175429|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
138175430|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175431|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175432|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175433|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175434|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138175435|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138175436|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175437|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138175438|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138175439|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175441|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
138175442|NCT03081416|Dexamethasone|dexamethasone|mesh-list
138175443|NCT03081416|Ketorolac|ketorolac|mesh-list
138175444|NCT03081416|Ketamine|ketamine|mesh-list
138175445|NCT03081416|Metoclopramide|metoclopramide|mesh-list
138175446|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175447|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
138175448|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
138175449|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175450|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175451|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175453|NCT03081416|Hormones|hormones|mesh-ancestor
138175454|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175455|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138175456|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175457|NCT03081416|Analgesics|analgesics|mesh-ancestor
138175458|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
138175459|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138175460|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138175461|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
138175462|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
138175463|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175464|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138175465|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138175466|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175467|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358956|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358959|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
138175468|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138175469|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175471|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138175474|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138175475|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
138175476|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138175477|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138175478|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175479|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138175480|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
138175481|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
138175482|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138175484|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
138175485|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138175486|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138175487|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138175488|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175489|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175490|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
138175491|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
138175492|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175493|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175494|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138175495|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138175496|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
138175497|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138175498|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138175499|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138175500|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138175501|NCT01276769|Paclitaxel|paclitaxel|mesh-list
138175502|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138175503|NCT01276769|Carboplatin|carboplatin|mesh-list
138175504|NCT01276769|Epirubicin|epirubicin|mesh-list
138175505|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175506|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175507|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175508|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175509|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175510|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175511|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138175512|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175513|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175514|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175515|NCT01279681|Leucovorin|leucovorin|mesh-list
138175516|NCT01279681|Bevacizumab|bevacizumab|mesh-list
138175517|NCT01279681|Capecitabine|capecitabine|mesh-list
138175518|NCT01279681|Fluorouracil|fluorouracil|mesh-list
138175519|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
138175520|NCT01279681|Calcium|calcium|mesh-list
138175521|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
138357210|NCT00003204|Hormones|hormones|mesh-ancestor
138175522|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175523|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175524|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138175525|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138175526|NCT01279681|Growth Substances|growth substances|mesh-ancestor
138175527|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175528|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
138175529|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138175530|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175531|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
138175532|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195226|NCT05599126|Lorazepam|lorazepam|mesh-list
138175533|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175534|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
138175535|NCT01279681|Antidotes|antidotes|mesh-ancestor
138175536|NCT01279681|Protective Agents|protective agents|mesh-ancestor
138175537|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
138175539|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
138175540|NCT01276925|Bupivacaine|bupivacaine|mesh-list
138175541|NCT01276925|Ropivacaine|ropivacaine|mesh-list
138175542|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175543|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
138175544|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175546|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
138175547|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175548|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
138175549|NCT00728507|Rifampin|rifampin|mesh-list
138175550|NCT00728507|Isoniazid|isoniazid|mesh-list
138359045|NCT00005586|Leucovorin|leucovorin|mesh-list
138175551|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
138175552|NCT00728507|Ethambutol|ethambutol|mesh-list
138175553|NCT00728507|Rifapentine|rifapentine|mesh-list
138175554|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138175555|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175556|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175557|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175558|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175559|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175560|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175561|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138175562|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
138175563|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
138175564|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138175565|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138175566|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138175567|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138175568|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138175569|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138175570|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138175571|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138175572|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138175573|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
138175574|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138175575|NCT01279057|Fluticasone|fluticasone|mesh-list
138175577|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175578|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138175580|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175581|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175582|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138175583|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
138175584|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175585|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138175586|NCT04384783|Hormones|hormones|mesh-list
138175587|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175588|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175589|NCT03186326|Bevacizumab|bevacizumab|mesh-list
138175590|NCT03186326|Cetuximab|cetuximab|mesh-list
138175591|NCT03186326|Avelumab|avelumab|mesh-list
138175592|NCT03186326|Panitumumab|panitumumab|mesh-list
138175593|NCT03186326|Aflibercept|aflibercept|mesh-list
138175594|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175595|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175596|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138175597|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138175598|NCT03186326|Growth Substances|growth substances|mesh-ancestor
138175599|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175600|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
138175601|NCT02999633|Acetaminophen|acetaminophen|mesh-list
138175602|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
138175603|NCT02999633|Promethazine|promethazine|mesh-list
138175604|NCT02999633|Dexamethasone|dexamethasone|mesh-list
138175605|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
138175606|NCT02999633|Ranitidine|ranitidine|mesh-list
138175607|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138175608|NCT02999633|BB 1101|bb 1101|mesh-list
138175609|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175611|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
138175612|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175613|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175614|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175615|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
138175617|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175618|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138175619|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175620|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
138175622|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175623|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175624|NCT02999633|Analgesics|analgesics|mesh-ancestor
138175625|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
138175626|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
138175627|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138175628|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138175629|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175630|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175632|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138175633|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
138175634|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
138175635|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175636|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138175637|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
138175638|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175639|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138175640|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138175641|NCT02991599|Vaccines|vaccines|mesh-list
138175642|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
138175643|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175644|NCT02996513|Vitamin A|vitamin a|mesh-list
138175645|NCT02996513|Vitamins|vitamins|mesh-ancestor
138175646|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
138175648|NCT04276688|Interferons|interferons|mesh-list
138175649|NCT04276688|Ritonavir|ritonavir|mesh-list
138175650|NCT04276688|Ribavirin|ribavirin|mesh-list
138175651|NCT04276688|Lopinavir|lopinavir|mesh-list
138175652|NCT04276688|Interferon-beta|interferon-beta|mesh-list
138175653|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
138175654|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175655|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
138175656|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175657|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138175658|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138175659|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
138175660|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175661|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357360|NCT00003372|Topotecan|topotecan|mesh-list
138175662|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138175663|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138175664|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138175665|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138175666|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
138175667|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
138175668|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175669|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138175670|NCT01277627|Efavirenz|efavirenz|mesh-list
138175671|NCT01277627|Nevirapine|nevirapine|mesh-list
138175672|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138175673|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
138175674|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138175675|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138175676|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175677|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175678|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
138175679|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175680|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138175681|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138175682|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138175683|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138175684|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138175685|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138175687|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138175688|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138175690|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138175691|NCT01270451|Insulin|insulin|mesh-list
138175692|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138175693|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175694|NCT00706979|Nicotine|nicotine|mesh-list
138175695|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138175696|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
138175697|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175698|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175699|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138175700|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138175701|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
138175702|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175703|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175704|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
138462769|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175705|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138175706|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175707|NCT00716963|Fluticasone|fluticasone|mesh-list
138175708|NCT00716963|Xhance|xhance|mesh-list
138175709|NCT00716963|Budesonide|budesonide|mesh-list
138175710|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175711|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138175712|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
138175713|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175714|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175715|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138175716|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
138175717|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175718|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138175719|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
138175720|NCT00716963|Hormones|hormones|mesh-ancestor
138175721|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175722|NCT01270997|Etanercept|etanercept|mesh-list
138175723|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138175724|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175725|NCT01270997|Analgesics|analgesics|mesh-ancestor
138175726|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
138175727|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175728|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175729|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175730|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175731|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175732|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175733|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
138175735|NCT01278745|Tacrolimus|tacrolimus|mesh-list
138175736|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175737|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175738|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
138175739|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175740|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175741|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175742|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138175743|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175744|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175745|NCT02995655|Azacitidine|azacitidine|mesh-list
138175746|NCT02995655|Heparin|heparin|mesh-list
138175747|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175748|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
138175749|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175750|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175751|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175752|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
138175753|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138175754|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138175755|NCT01271153|Dobutamine|dobutamine|mesh-list
138175756|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138175757|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
138175758|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
138175759|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175760|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175761|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138175762|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138175763|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138175764|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
138175765|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175766|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175767|NCT01271153|Protective Agents|protective agents|mesh-ancestor
138175768|NCT03809065|Labetalol|labetalol|mesh-list
138175769|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
138175770|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
138175771|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138175772|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138357551|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
138175774|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175775|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175776|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175777|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138175778|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
138175779|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
138175780|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175781|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138175782|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138175783|NCT02995187|Apatinib|apatinib|mesh-list
138175784|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175785|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138175786|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175787|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175788|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138175789|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138175790|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138175791|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138175792|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175794|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
138175795|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175796|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175797|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175798|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175799|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138175800|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138175801|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138175802|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
138175803|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
138175804|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175805|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175806|NCT00748657|Bevacizumab|bevacizumab|mesh-list
138175807|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138175808|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
138175809|NCT00748657|Antibodies|antibodies|mesh-list
138175810|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
138175811|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138175812|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
138175813|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175814|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138175815|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138175816|NCT00748657|Growth Substances|growth substances|mesh-ancestor
138175817|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175818|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138175819|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
138175820|NCT02994953|Avelumab|avelumab|mesh-list
138175821|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138175822|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175823|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175824|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
138175825|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175826|NCT01273051|Capecitabine|capecitabine|mesh-list
138175827|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175828|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
138175829|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175830|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175831|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
138175832|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138175833|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
138175834|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175835|NCT02994875|Expectorants|expectorants|mesh-ancestor
138175836|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
138175837|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138175838|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
138175839|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175840|NCT02994875|Protective Agents|protective agents|mesh-ancestor
138175841|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175842|NCT02994875|Antidotes|antidotes|mesh-ancestor
138175843|NCT03809143|Buprenorphine|buprenorphine|mesh-list
138175844|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138175845|NCT03809143|Narcotics|narcotics|mesh-ancestor
138175846|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175847|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175848|NCT03809143|Analgesics|analgesics|mesh-ancestor
138175849|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
138175850|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175851|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138175852|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
138175853|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
138175854|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138175855|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138462770|NCT05412147|Vitamins|vitamins|mesh-list
138175856|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175857|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175858|NCT02390960|Urological Agents|urological agents|mesh-ancestor
138175859|NCT00720473|Lamotrigine|lamotrigine|mesh-list
138175860|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
138175861|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138357697|NCT00003708|Temozolomide|temozolomide|mesh-list
138175862|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175863|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175864|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138175865|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175866|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138175867|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138175868|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175869|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138175870|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138175872|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
138175873|NCT00637832|Rituximab|rituximab|mesh-list
138175874|NCT00637832|Doxorubicin|doxorubicin|mesh-list
138175875|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138175876|NCT00637832|Vincristine|vincristine|mesh-list
138175877|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175878|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
138175879|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175880|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359094|NCT00005604|Growth Substances|growth substances|mesh-ancestor
138175881|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138175882|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
138195268|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138175883|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175884|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175885|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138175886|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175887|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138175888|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138175889|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175890|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175891|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175892|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175893|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175894|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175895|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175896|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
138175897|NCT00637832|Hormones|hormones|mesh-ancestor
138175898|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175899|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138175901|NCT00720629|Tacrolimus|tacrolimus|mesh-list
138175902|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
138175903|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138175904|NCT00720629|Visilizumab|visilizumab|mesh-list
138175905|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138175906|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
138175907|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138175908|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175909|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175910|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
138175911|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175912|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175913|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175914|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175915|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138175916|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175917|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
138175918|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175919|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138175920|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138175921|NCT01276327|Pioglitazone|pioglitazone|mesh-list
138175922|NCT01276327|Linagliptin|linagliptin|mesh-list
138175923|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138175924|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175925|NCT01276327|Incretins|incretins|mesh-ancestor
138175926|NCT01276327|Hormones|hormones|mesh-ancestor
138175927|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138175928|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138175929|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138175930|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175931|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175932|NCT05245760|Paclitaxel|paclitaxel|mesh-list
138175933|NCT05245760|Carboplatin|carboplatin|mesh-list
138175934|NCT05245760|Tislelizumab|tislelizumab|mesh-list
138175935|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138175936|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175937|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
138175938|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
138175939|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175940|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359111|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175941|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138175942|NCT02674958|Aspirin|aspirin|mesh-list
138175943|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138175944|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138175945|NCT02674958|Analgesics|analgesics|mesh-ancestor
138175947|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175948|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175949|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175950|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175951|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138175952|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138175953|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175954|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138175955|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138175956|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175957|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
138175958|NCT00760435|Infliximab|infliximab|mesh-list
138175959|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138175960|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138175961|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
138175962|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138175963|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175964|NCT03808129|Lidocaine|lidocaine|mesh-list
138175965|NCT03808129|Bupivacaine|bupivacaine|mesh-list
138175966|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
138175967|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
138175968|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175969|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175970|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
138175971|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175972|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138175973|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138175974|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138175975|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175976|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175977|NCT00749125|Escitalopram|escitalopram|mesh-list
138175978|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138175979|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138175980|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175981|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175982|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175983|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
138175984|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175986|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
138175988|NCT02144675|Idarubicin|idarubicin|mesh-list
138175989|NCT02144675|Choline|choline|mesh-list
138175990|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138175991|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
138175992|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175993|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175994|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
138175995|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175996|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138175997|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
138175998|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175999|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176000|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138176001|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138176002|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176003|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
138195280|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138176004|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176005|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176006|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176007|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
138176008|NCT02144675|Analgesics|analgesics|mesh-ancestor
138176009|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
138176010|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176011|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138176012|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176013|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176014|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176015|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138176016|NCT00749515|Deferasirox|deferasirox|mesh-list
138176017|NCT00749515|Deferoxamine|deferoxamine|mesh-list
138176018|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138176019|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
138176020|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
138176021|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176022|NCT00749515|Siderophores|siderophores|mesh-ancestor
138176023|NCT01272557|Doxorubicin|doxorubicin|mesh-list
138176024|NCT01272557|Sorafenib|sorafenib|mesh-list
138176025|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176026|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176027|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138176028|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138176029|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176030|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176031|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176032|NCT00639002|Dexamethasone|dexamethasone|mesh-list
138176033|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176034|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
138176035|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
138176036|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176037|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176038|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176039|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
138176040|NCT00639002|Hormones|hormones|mesh-ancestor
138176041|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176042|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176043|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176044|NCT00761137|Tropicamide|tropicamide|mesh-list
138176045|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
138176046|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
138176047|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176048|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176049|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138176050|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138176051|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
138176052|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176053|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176054|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138176055|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176056|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176057|NCT01273493|Dexamethasone|dexamethasone|mesh-list
138176058|NCT01273493|Trabectedin|trabectedin|mesh-list
138176059|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176060|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
138176061|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
138176062|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176063|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176064|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176065|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
138176066|NCT01273493|Hormones|hormones|mesh-ancestor
138176067|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176068|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176069|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176070|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138176071|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
138176072|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176075|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
138176076|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138462771|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
138176077|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138176078|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
138176079|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176080|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176081|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138176082|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
138176083|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
138176084|NCT00638456|Hormones|hormones|mesh-ancestor
138176085|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176086|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138176087|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176088|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138176089|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176090|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176091|NCT01273571|Metformin|metformin|mesh-list
138176092|NCT01273571|Canagliflozin|canagliflozin|mesh-list
138176093|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176094|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176095|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138176096|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176097|NCT02147899|Secnidazole|secnidazole|mesh-list
138176098|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138176099|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138176100|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176101|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
138176102|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176103|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176104|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138176105|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176106|NCT00762619|Triclosan|triclosan|mesh-list
138176107|NCT00762619|Fluorides|fluorides|mesh-list
138176108|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
138176109|NCT00762619|Protective Agents|protective agents|mesh-ancestor
138176110|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176111|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138357982|NCT00003960|Busulfan|busulfan|mesh-list
138176112|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176113|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138176114|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176115|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
138176116|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176117|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176118|NCT00735449|Timolol|timolol|mesh-list
138176119|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138176120|NCT00735449|Latanoprost|latanoprost|mesh-list
138176121|NCT00735449|Maleic acid|maleic acid|mesh-list
138176122|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176123|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176124|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138176125|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138176126|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
138176127|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176128|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176129|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138176130|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138176131|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138176132|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138176133|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138176134|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138176135|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138176136|NCT01273831|Cisatracurium|cisatracurium|mesh-list
138176137|NCT01273831|Atracurium|atracurium|mesh-list
138176138|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138176139|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138176140|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176141|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176142|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138176143|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138176144|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138359132|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176145|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
138176146|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176147|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176149|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138176150|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138176151|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176153|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176154|NCT00736073|Aprepitant|aprepitant|mesh-list
138176155|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
138176156|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
138176158|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176159|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176160|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138176161|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176162|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176163|NCT00736229|Exenatide|exenatide|mesh-list
138176164|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176165|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176166|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138176167|NCT00736229|Incretins|incretins|mesh-ancestor
138176168|NCT00736229|Hormones|hormones|mesh-ancestor
138176169|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176170|NCT00737243|Paclitaxel|paclitaxel|mesh-list
138176171|NCT00737243|Bevacizumab|bevacizumab|mesh-list
138176172|NCT00737243|Carboplatin|carboplatin|mesh-list
138176173|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138176174|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138176175|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176176|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138176177|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138176178|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138176179|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176180|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176181|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138176182|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138176183|NCT00737243|Growth Substances|growth substances|mesh-ancestor
138176184|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176185|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
138176186|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176187|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176188|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
138176189|NCT00707759|Prednisone|prednisone|mesh-list
138176190|NCT00707759|Prednisolone|prednisolone|mesh-list
138176191|NCT00707759|Tacrolimus|tacrolimus|mesh-list
138176192|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176193|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
138176194|NCT00707759|Hormones|hormones|mesh-ancestor
138176195|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176196|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176197|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176198|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176199|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176200|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
138176201|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138176203|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176204|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176205|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138176206|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
138176207|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138176208|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176209|NCT01273727|Dexamethasone|dexamethasone|mesh-list
138176212|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176213|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
138176214|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
138176215|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176216|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176217|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176218|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
138176219|NCT01273727|Hormones|hormones|mesh-ancestor
138176220|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176221|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176222|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176223|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
138176224|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188462|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176225|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176227|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138176229|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
138176230|NCT00708071|Coagulants|coagulants|mesh-ancestor
138176231|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138176232|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138176233|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
138176234|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176235|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176236|NCT02994485|Simvastatin|simvastatin|mesh-list
138176237|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138176238|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176239|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
138176240|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176241|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176242|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138176243|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176244|NCT02994173|Ketamine|ketamine|mesh-list
138176245|NCT02994173|Oxycodone|oxycodone|mesh-list
138176246|NCT02994173|Esketamine|esketamine|mesh-list
138176247|NCT02994173|Analgesics|analgesics|mesh-ancestor
138176248|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
138176249|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176250|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176251|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138176252|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176253|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
138176254|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
138176255|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176256|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138176257|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138176258|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176259|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176260|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176261|NCT02994173|Narcotics|narcotics|mesh-ancestor
138176262|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
138176263|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138176264|NCT00723749|Buprenorphine|buprenorphine|mesh-list
138176265|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138176267|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176268|NCT00723749|Narcotics|narcotics|mesh-ancestor
138176269|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176270|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176271|NCT00723749|Analgesics|analgesics|mesh-ancestor
138176272|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
138176273|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176274|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138176275|NCT00723827|Temozolomide|temozolomide|mesh-list
138195316|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176277|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
138176278|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176279|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176280|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
138176281|NCT00779311|Bevacizumab|bevacizumab|mesh-list
138176282|NCT00779311|Sorafenib|sorafenib|mesh-list
138176283|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176284|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176285|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138176286|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138176287|NCT00779311|Growth Substances|growth substances|mesh-ancestor
138176288|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176289|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
138176290|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176291|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176292|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176293|NCT01274039|Acetazolamide|acetazolamide|mesh-list
138176294|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
138176295|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138176296|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176297|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176298|NCT01274039|Diuretics|diuretics|mesh-ancestor
138176299|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
138176300|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176301|NCT01274195|Busulfan|busulfan|mesh-list
138176302|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
138176303|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176304|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176305|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
138176306|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176307|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138176309|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138176310|NCT00779701|Insulin|insulin|mesh-list
138176311|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176312|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176313|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
138176314|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138176315|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176316|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176317|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138176318|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138176319|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138176320|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138176321|NCT03809221|Hormones|hormones|mesh-list
138176322|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138176323|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176324|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176326|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138176327|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
138176328|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176330|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176331|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176332|NCT02993159|Tamoxifen|tamoxifen|mesh-list
138176333|NCT02993159|Afimoxifene|afimoxifene|mesh-list
138176334|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138176335|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
138176336|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176337|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176338|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176339|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195326|NCT02549716|Acetaminophen|acetaminophen|mesh-list
138176340|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138176341|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138176342|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138176343|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138176344|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
138176345|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176346|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
138176347|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138176348|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176349|NCT00762853|Triclosan|triclosan|mesh-list
138176350|NCT00762853|Fluorides|fluorides|mesh-list
138176351|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
138176352|NCT00762853|Protective Agents|protective agents|mesh-ancestor
138176353|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176354|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138176355|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176356|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138176357|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176358|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
138176359|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176360|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176361|NCT00724009|Clofarabine|clofarabine|mesh-list
138176362|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176363|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
138176364|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176365|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176366|NCT01279499|Remifentanil|remifentanil|mesh-list
138176367|NCT01279499|Propofol|propofol|mesh-list
138176368|NCT01279499|Sevoflurane|sevoflurane|mesh-list
138176369|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138176370|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176371|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176372|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176373|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
138176375|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138176376|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138176377|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176378|NCT01279499|Narcotics|narcotics|mesh-ancestor
138176380|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
138176381|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176383|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
138176384|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176385|NCT00780715|Metformin|metformin|mesh-list
138176386|NCT00780715|Pioglitazone|pioglitazone|mesh-list
138176387|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138176388|NCT00780715|Gliclazide|gliclazide|mesh-list
138176389|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176390|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176391|NCT00780715|Incretins|incretins|mesh-ancestor
138176392|NCT00780715|Hormones|hormones|mesh-ancestor
138176393|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176394|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138176395|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
138176396|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176397|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176398|NCT00740831|Leuprolide|leuprolide|mesh-list
138176399|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
138176400|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138176401|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
138176402|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176403|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176404|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176405|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176406|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138176407|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
138176408|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138176410|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138176411|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176412|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
138176413|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176414|NCT01275443|Rilpivirine|rilpivirine|mesh-list
138176415|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138176416|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138176417|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176418|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176419|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
138176420|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176421|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138176422|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138176423|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138176424|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138176425|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176426|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138176427|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138176428|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138176429|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176430|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
138176431|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176433|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
138176434|NCT00741455|Methotrexate|methotrexate|mesh-list
138176435|NCT00741455|Fludarabine|fludarabine|mesh-list
138176436|NCT00741455|Cyclosporins|cyclosporins|mesh-list
138176437|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176438|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
138176439|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176440|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176441|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138176442|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
138176443|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176444|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176445|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138176446|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138176447|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
138176448|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176449|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176450|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
138176451|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
138176452|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176453|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138176454|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138176455|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
138176456|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176457|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138176458|NCT00742313|Hemostatics|hemostatics|mesh-list
138176459|NCT00742313|Coagulants|coagulants|mesh-ancestor
138176461|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138176462|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176463|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176464|NCT01275599|Buprenorphine|buprenorphine|mesh-list
138176465|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138176466|NCT01275599|Naloxone|naloxone|mesh-list
138176467|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176468|NCT01275599|Narcotics|narcotics|mesh-ancestor
138176469|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176470|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176471|NCT01275599|Analgesics|analgesics|mesh-ancestor
138176472|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
138358485|NCT00004380|Methocarbamol|methocarbamol|mesh-list
138176480|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176481|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
138176482|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176483|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176484|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176485|NCT00743093|Acetaminophen|acetaminophen|mesh-list
138176486|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176487|NCT00743093|Analgesics|analgesics|mesh-ancestor
138176488|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
138176489|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176490|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176491|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
138176492|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
138176493|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138176494|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176495|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176496|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176498|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
138176499|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176500|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138176501|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138176502|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138176503|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
138176504|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176505|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176506|NCT02992301|Alirocumab|alirocumab|mesh-list
138176507|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138176508|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138176509|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176510|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
138176511|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176512|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138176513|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138176514|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176515|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176517|NCT00743717|Trace Elements|trace elements|mesh-ancestor
138176518|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
138176519|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176520|NCT00744965|Glyburide|glyburide|mesh-list
138176521|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176522|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176523|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
138176524|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
138176525|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138176526|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138176527|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176528|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176529|NCT00763867|Urological Agents|urological agents|mesh-ancestor
138176530|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
138176531|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138176532|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
138176533|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176534|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
138176535|NCT00711347|Protective Agents|protective agents|mesh-ancestor
138176536|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
138176537|NCT01276223|Difluprednate|difluprednate|mesh-list
138176538|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
138176539|NCT01276223|Hormones|hormones|mesh-ancestor
138176540|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176541|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176542|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176543|NCT00784225|Vitamins|vitamins|mesh-list
138176544|NCT00784225|Vitamin E|vitamin e|mesh-list
138176545|NCT00784225|Tocopherols|tocopherols|mesh-list
138176546|NCT00784225|Tocotrienols|tocotrienols|mesh-list
138176547|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
138176548|NCT00784225|Selenium|selenium|mesh-list
138176549|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
138176550|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176551|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
138176552|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176553|NCT00784225|Protective Agents|protective agents|mesh-ancestor
138176556|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
138176557|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
138176558|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176559|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
138176560|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176561|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176562|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
138176563|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
138176564|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138176565|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138195340|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176566|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176567|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176568|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176569|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176570|NCT01273181|Aldesleukin|aldesleukin|mesh-list
138176571|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
138176572|NCT01273181|Fludarabine|fludarabine|mesh-list
138176573|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176574|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
138176575|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176576|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176577|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138176578|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
138201738|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138359179|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
138176579|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176580|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176581|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138176582|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138176583|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138176584|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
138176585|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176586|NCT01272947|Diclofenac|diclofenac|mesh-list
138176587|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138176588|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176589|NCT01272947|Analgesics|analgesics|mesh-ancestor
138176590|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
138176591|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176592|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176593|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176594|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176595|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138176597|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176599|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138176600|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
138176601|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176602|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176603|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138176604|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176606|NCT01278797|Amlodipine|amlodipine|mesh-list
138176607|NCT01278797|Telmisartan|telmisartan|mesh-list
138176608|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138176609|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138176610|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138176611|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138176612|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176613|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138176614|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176615|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
138176616|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138176617|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138176618|NCT01272635|Azithromycin|azithromycin|mesh-list
138176619|NCT01272635|Prednisolone|prednisolone|mesh-list
138176620|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138176621|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
138176622|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138176624|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138176625|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
138176626|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176627|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
138176629|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176630|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176631|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176632|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176633|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
138176634|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
138176635|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176636|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176637|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138176638|NCT01272635|Protective Agents|protective agents|mesh-ancestor
138176639|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138176640|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176641|NCT04387097|Remifentanil|remifentanil|mesh-list
138176642|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176643|NCT04387097|Narcotics|narcotics|mesh-ancestor
138176644|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176645|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176647|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
138176648|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176649|NCT01270841|Enclomiphene|enclomiphene|mesh-list
138176651|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
138176652|NCT01270841|Testosterone|testosterone|mesh-list
138176653|NCT01270841|Androgens|androgens|mesh-ancestor
138176655|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176656|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176657|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138176658|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
138176659|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138201739|NCT01212445|Laxatives|laxatives|mesh-list
138176661|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138176662|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138176663|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138176664|NCT01278407|Donepezil|donepezil|mesh-list
138176665|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138176666|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176667|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176668|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
138176669|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176670|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176671|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
138176672|NCT01278173|Vigabatrin|vigabatrin|mesh-list
138176674|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176675|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176677|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176678|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176679|NCT00784303|Lenvatinib|lenvatinib|mesh-list
138176680|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176681|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176682|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176683|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176684|NCT00750815|Dexamethasone|dexamethasone|mesh-list
138176685|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
138176686|NCT00750815|Doxorubicin|doxorubicin|mesh-list
138176687|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138176689|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176690|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
138176691|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176692|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176693|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138176694|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
138176695|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176696|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176697|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138176698|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176699|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
138176700|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
138176701|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176702|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176703|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
138176704|NCT00750815|Hormones|hormones|mesh-ancestor
138289126|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138176705|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176706|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176707|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176708|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138176709|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138195354|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
138176710|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176711|NCT00784849|Methylene Blue|methylene blue|mesh-list
138358859|NCT00004920|Raltitrexed|raltitrexed|mesh-list
138176712|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176713|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176714|NCT01277861|Fentanyl|fentanyl|mesh-list
138176715|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138176716|NCT01277861|Narcotics|narcotics|mesh-ancestor
138176717|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176718|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176719|NCT01277861|Analgesics|analgesics|mesh-ancestor
138176720|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
138176721|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176722|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138176723|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176724|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
138176725|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
138176726|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138176727|NCT00786487|Glycerol|glycerol|mesh-list
138359190|NCT00005814|Cetuximab|cetuximab|mesh-list
138176728|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138358902|NCT00004998|Capravirine|capravirine|mesh-list
138176729|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138176731|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138176732|NCT00786487|Protective Agents|protective agents|mesh-ancestor
138176733|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176734|NCT03805633|Pancrelipase|pancrelipase|mesh-list
138176735|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176736|NCT01276847|Etanercept|etanercept|mesh-list
138176737|NCT01276847|Ustekinumab|ustekinumab|mesh-list
138176738|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138176739|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176740|NCT01276847|Analgesics|analgesics|mesh-ancestor
138176741|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
138176742|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176743|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176744|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176745|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176746|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176747|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176748|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
138176749|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138176750|NCT00945269|Aldesleukin|aldesleukin|mesh-list
138176751|NCT00945269|Interleukin-2|interleukin-2|mesh-list
138176752|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
138176754|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176755|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176756|NCT00945269|Analgesics|analgesics|mesh-ancestor
138176757|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
138176758|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176759|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176760|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138176761|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138176762|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
138176763|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176764|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
138176765|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
138176766|NCT01272791|Gemcitabine|gemcitabine|mesh-list
138176767|NCT01272791|Bavituximab|bavituximab|mesh-list
138176768|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176769|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
138176770|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176771|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176772|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176773|NCT00765661|Tacrolimus|tacrolimus|mesh-list
138176774|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176775|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
138176776|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176777|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138176778|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176779|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176780|NCT00765895|Nortriptyline|nortriptyline|mesh-list
138176781|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138176782|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
138176783|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138176784|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138176785|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138176786|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359012|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
138176787|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176788|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138176789|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176790|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176791|NCT01276457|Cyclosporine|cyclosporine|mesh-list
138176793|NCT01276457|Cyclosporins|cyclosporins|mesh-list
138176794|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176795|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176796|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176797|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
138176798|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176799|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
138176800|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176801|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138176802|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176803|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138176804|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138176805|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176806|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176807|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138176810|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176811|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
138176812|NCT03804931|Hormones|hormones|mesh-ancestor
138176813|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176814|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176815|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138176816|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176817|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138176818|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176819|NCT03804931|Analgesics|analgesics|mesh-ancestor
138176820|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
138176821|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462772|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176822|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176823|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
138176824|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138176825|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176827|NCT02991131|Tedizolid|tedizolid|mesh-list
138176828|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
138176829|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138176830|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176831|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138176832|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176833|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176834|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138176835|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
138176836|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138176837|NCT00766753|Vaccines|vaccines|mesh-list
138176838|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
138176839|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176840|NCT00767767|Thiopental|thiopental|mesh-list
138176841|NCT00767767|Propofol|propofol|mesh-list
138176842|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138176843|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176844|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176845|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176846|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
138176847|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
138176848|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
138176849|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
138176850|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
138176851|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176852|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176855|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176857|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176858|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176859|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138176860|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176861|NCT00762515|Triclosan|triclosan|mesh-list
138176862|NCT00762515|Fluorides|fluorides|mesh-list
138176863|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
138176864|NCT00762515|Protective Agents|protective agents|mesh-ancestor
138176865|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176866|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138176867|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176868|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138176869|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138176870|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
138176871|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176872|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138176873|NCT00753935|Aspirin|aspirin|mesh-list
138176874|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138176875|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138176876|NCT00753935|Analgesics|analgesics|mesh-ancestor
138176877|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
138176878|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176879|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176880|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138176881|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176882|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138176883|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138201740|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138176884|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176885|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138176886|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138176887|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176888|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
138176889|NCT00779285|Doxorubicin|doxorubicin|mesh-list
138176890|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138176891|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176892|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176893|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138176894|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138176895|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176896|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176897|NCT00786643|Leucovorin|leucovorin|mesh-list
138176898|NCT00786643|Interferons|interferons|mesh-list
138176899|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
138176900|NCT00786643|Bevacizumab|bevacizumab|mesh-list
138176901|NCT00786643|Fluorouracil|fluorouracil|mesh-list
138176902|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
138176903|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176904|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176905|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138176906|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138176907|NCT00786643|Growth Substances|growth substances|mesh-ancestor
138176908|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176909|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138176910|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
138176911|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176912|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176913|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176914|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
138176915|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
138176916|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176918|NCT00786643|Protective Agents|protective agents|mesh-ancestor
138176919|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
138176920|NCT00786643|Vitamins|vitamins|mesh-ancestor
138176921|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
138176923|NCT01276379|Folic Acid|folic acid|mesh-list
138176924|NCT01276379|Fluorouracil|fluorouracil|mesh-list
138176925|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
138176926|NCT01276379|Irinotecan|irinotecan|mesh-list
138176927|NCT01276379|Cetuximab|cetuximab|mesh-list
138176928|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
138176929|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
138176930|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176931|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176932|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176933|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138176934|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
138176935|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176936|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138176937|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138176938|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176939|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138176940|NCT01276379|Antidotes|antidotes|mesh-ancestor
138176941|NCT01276379|Protective Agents|protective agents|mesh-ancestor
138176942|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
138176944|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
138176945|NCT01276379|Hematinics|hematinics|mesh-ancestor
138176946|NCT01275547|Midazolam|midazolam|mesh-list
138176947|NCT01275547|Ketamine|ketamine|mesh-list
138176948|NCT01275547|Morphine|morphine|mesh-list
138176949|NCT01275547|Esketamine|esketamine|mesh-list
138176950|NCT01275547|Analgesics|analgesics|mesh-ancestor
138176951|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
138176952|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176953|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176954|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138176955|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176956|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
138176957|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
138289127|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
138176958|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176959|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138176960|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138176961|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176962|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176964|NCT01275547|Narcotics|narcotics|mesh-ancestor
138176965|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138176966|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138176967|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138359225|NCT00355602|Metronidazole|metronidazole|mesh-list
138176969|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138176970|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
138176972|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
138176973|NCT00789685|Interferons|interferons|mesh-list
138176974|NCT00789685|Interferon-beta|interferon-beta|mesh-list
138176975|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138176976|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
138176977|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138176978|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
138176979|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176980|NCT02149303|Dabigatran|dabigatran|mesh-list
138176981|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
138176982|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138176983|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
138176984|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176985|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176986|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
138176989|NCT03803449|Propofol|propofol|mesh-list
138176990|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138176991|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138176992|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176993|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138176994|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
138176995|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
138176996|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138176997|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138176998|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138176999|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177000|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
138177001|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
138177002|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177003|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177004|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138177005|NCT03803449|Narcotics|narcotics|mesh-ancestor
138177006|NCT03803449|Analgesics|analgesics|mesh-ancestor
138177007|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
138177008|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177009|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
138177010|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138177011|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177012|NCT00789997|Levofloxacin|levofloxacin|mesh-list
138177014|NCT00789997|Etanercept|etanercept|mesh-list
138177015|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177016|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
138177017|NCT00789997|Hormones|hormones|mesh-ancestor
138177018|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177019|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177020|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177021|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177022|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177023|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177024|NCT00789997|Analgesics|analgesics|mesh-ancestor
138177025|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
138177026|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177027|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177028|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177029|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177030|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
138177031|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138177032|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177033|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138177034|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138177035|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138359193|NCT00354900|Aprotinin|aprotinin|mesh-list
138177036|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177037|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177038|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138177039|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138177041|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138177042|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
138177043|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177044|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177045|NCT03803215|Theophylline|theophylline|mesh-list
138177046|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138177047|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
138177048|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177049|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177050|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138177051|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
138177052|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138177053|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177054|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177055|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
138177056|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138177057|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138177058|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
138177059|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177060|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138177061|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138177062|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
138177063|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177064|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177065|NCT03802747|Durvalumab|durvalumab|mesh-list
138177066|NCT03802747|Tremelimumab|tremelimumab|mesh-list
138177067|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138177068|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138177069|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177070|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
138177071|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177074|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
138177075|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138177076|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177077|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177078|NCT00791323|Analgesics|analgesics|mesh-ancestor
138177079|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
138177080|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177081|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177082|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177083|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177084|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138177085|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177086|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177087|NCT00772915|Dexamethasone|dexamethasone|mesh-list
138177088|NCT00772915|Lenalidomide|lenalidomide|mesh-list
138177089|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177090|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
138177091|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
138177092|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177093|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177094|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177095|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
138177096|NCT00772915|Hormones|hormones|mesh-ancestor
138177097|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177098|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177099|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177100|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
138359472|NCT00359190|Lapatinib|lapatinib|mesh-list
138177102|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138177103|NCT00772915|Growth Substances|growth substances|mesh-ancestor
138177104|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
138177105|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
138177106|NCT03801733|Atorvastatin|atorvastatin|mesh-list
138177107|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138177108|NCT03801733|Simvastatin|simvastatin|mesh-list
138177109|NCT03801733|Pravastatin|pravastatin|mesh-list
138177110|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138177111|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138177112|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
138177113|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177114|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138177115|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138177116|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177117|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177118|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177119|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177120|NCT03801733|Analgesics|analgesics|mesh-ancestor
138177121|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
138177122|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177123|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177124|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177125|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177126|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177127|NCT00775411|Dexamethasone|dexamethasone|mesh-list
138177128|NCT00775411|Ranibizumab|ranibizumab|mesh-list
138177129|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177130|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
138177131|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
138177132|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177133|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359497|NCT00359814|Cyclosporins|cyclosporins|mesh-list
138177134|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177137|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177138|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177139|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177140|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138177141|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138177143|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
138177144|NCT03801499|Lenvatinib|lenvatinib|mesh-list
138177145|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177146|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138177147|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177148|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177149|NCT00808405|Acyclovir|acyclovir|mesh-list
138177150|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
138177151|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177152|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
138177153|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
138177154|NCT00775645|Vitamins|vitamins|mesh-ancestor
138177155|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
138177156|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177157|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
138177158|NCT01974687|Itraconazole|itraconazole|mesh-list
138177159|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
138177160|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
138177162|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138177163|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138177164|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177165|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177166|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138177167|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138177168|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177169|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359540|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177171|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
138177172|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
138177173|NCT00795145|Linezolid|linezolid|mesh-list
138177174|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138177175|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177176|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138177177|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138177178|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177179|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177180|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177181|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138177182|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
138177183|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138177184|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177185|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
138177186|NCT00809185|Everolimus|everolimus|mesh-list
138177187|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138177188|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138177189|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177190|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177192|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
138177193|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177194|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177195|NCT03800953|Avelumab|avelumab|mesh-list
138177196|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138177197|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177198|NCT00795769|Ondansetron|ondansetron|mesh-list
138177199|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
138177200|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
138177201|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177202|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177203|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177204|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
138177205|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
138177206|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138177207|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138177208|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
138177210|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177211|NCT01975935|Amlexanox|amlexanox|mesh-list
138177212|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138177213|NCT02305017|Acetaminophen|acetaminophen|mesh-list
138177214|NCT02305017|Opicapone|opicapone|mesh-list
138177215|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177216|NCT02305017|Analgesics|analgesics|mesh-ancestor
138177217|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
138177218|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177219|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177221|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138177222|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177223|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177224|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138177225|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138177226|NCT01976871|Rotigotine|rotigotine|mesh-list
138177227|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
138177228|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
138177229|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177230|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177231|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177232|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
138177233|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138177234|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
138177235|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177236|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177237|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138177238|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
138177239|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138177240|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
138177241|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177242|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177243|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138177244|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
138177245|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
138177246|NCT03602781|Protective Agents|protective agents|mesh-ancestor
138177247|NCT02280239|Acetaminophen|acetaminophen|mesh-list
138177248|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177249|NCT02280239|Analgesics|analgesics|mesh-ancestor
138177250|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
138177251|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177252|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177253|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
138177254|NCT01993875|Lubiprostone|lubiprostone|mesh-list
138177255|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138177256|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177257|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177259|NCT00796705|Etanercept|etanercept|mesh-list
138177260|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138177261|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177262|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177263|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177264|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177265|NCT00796705|Analgesics|analgesics|mesh-ancestor
138177267|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177268|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177270|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177271|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
138177272|NCT00809809|Zinc|zinc|mesh-list
138177273|NCT00809809|Trace Elements|trace elements|mesh-ancestor
138177274|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
138177275|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177276|NCT00248651|Amitriptyline|amitriptyline|mesh-list
138177277|NCT00248651|Escitalopram|escitalopram|mesh-list
138177278|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138177279|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138177280|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177281|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177282|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195401|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
138177283|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
138177284|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177285|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177286|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
138177287|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177288|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138177289|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177291|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
138177292|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138177293|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138177294|NCT03800797|Loxoprofen|loxoprofen|mesh-list
138177295|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177296|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177297|NCT03800797|Analgesics|analgesics|mesh-ancestor
138177298|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
138177299|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177300|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177301|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177302|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177303|NCT04383067|Aldesleukin|aldesleukin|mesh-list
138177304|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177305|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138177306|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138177307|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
138177308|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177310|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
138177311|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138177312|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177313|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177314|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
138177315|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359219|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138177316|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177317|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138177318|NCT00248495|Pemetrexed|pemetrexed|mesh-list
138177319|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177320|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177321|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177322|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138177323|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138177324|NCT03809767|Antibodies|antibodies|mesh-list
138177325|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138177326|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
138177327|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177328|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
138177329|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138177330|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177331|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177332|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177333|NCT03800641|Analgesics|analgesics|mesh-ancestor
138177334|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
138177335|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177336|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138177337|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138177338|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138177339|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
138177340|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177341|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177342|NCT03807011|Fentanyl|fentanyl|mesh-list
138177343|NCT03807011|Remifentanil|remifentanil|mesh-list
138177344|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138177345|NCT03807011|Narcotics|narcotics|mesh-ancestor
138177346|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177347|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177348|NCT03807011|Analgesics|analgesics|mesh-ancestor
138177349|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
138177350|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359845|NCT00368862|Memantine|memantine|mesh-list
138177351|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138177352|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138177353|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
138177356|NCT02986503|Doxorubicin|doxorubicin|mesh-list
138177357|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138177358|NCT02986503|Methotrexate|methotrexate|mesh-list
138177359|NCT02986503|Ifosfamide|ifosfamide|mesh-list
138177360|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
138177361|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177362|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138177363|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138177364|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138177365|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177366|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177367|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138177368|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
138177369|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138177370|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177371|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138177372|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
138177373|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
138177374|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138177375|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177376|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
138177377|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177378|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138177379|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138177380|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
138177381|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
138359863|NCT00369096|Bemiparin|bemiparin|mesh-list
138177382|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138177383|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138177384|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
138177385|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177386|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138177387|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138177388|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177389|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177391|NCT00763061|Travoprost|travoprost|mesh-list
138177392|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138177393|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138177394|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138177395|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138177396|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138177397|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177398|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177399|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177400|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138177401|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138177403|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177404|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177405|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
138177406|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138359911|NCT00370422|Hormones|hormones|mesh-ancestor
138177408|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177409|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177410|NCT03806777|Analgesics|analgesics|mesh-ancestor
138177411|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
138177412|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177413|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138177414|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138177415|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138359960|NCT00371124|Atropine|atropine|mesh-list
138177417|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177418|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177419|NCT00754247|Vitamin E|vitamin e|mesh-list
138177420|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
138177421|NCT00754247|Vitamins|vitamins|mesh-ancestor
138177422|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
138177423|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177424|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177425|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
138177426|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177427|NCT00754247|Protective Agents|protective agents|mesh-ancestor
138177429|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138177430|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177431|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177432|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138177433|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138177434|NCT01979445|Clopidogrel|clopidogrel|mesh-list
138177435|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138177437|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138177438|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138177439|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138360083|NCT00373542|Ropinirole|ropinirole|mesh-list
138177440|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138177441|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
138177442|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177443|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177444|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177446|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138177447|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177448|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138177449|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177452|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177453|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138177454|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138177455|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138177456|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177457|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177458|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138177459|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138177460|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
138177461|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138177462|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138177463|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177464|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
138177465|NCT01981863|Coagulants|coagulants|mesh-ancestor
138177466|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
138177467|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138177468|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177469|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177470|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
138177471|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177472|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177473|NCT01995045|Triamcinolone|triamcinolone|mesh-list
138177474|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138177475|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138177476|NCT01995045|Bupivacaine|bupivacaine|mesh-list
138177477|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138177478|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
138177479|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
138177480|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177481|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177482|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
138177483|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177484|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177485|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
138177486|NCT01995045|Hormones|hormones|mesh-ancestor
138177488|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177489|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
138177490|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177491|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177492|NCT01982643|Naltrexone|naltrexone|mesh-list
138177493|NCT01982643|Bupropion|bupropion|mesh-list
138177494|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138177495|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138177496|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177497|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
138177498|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177499|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138177500|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
138177501|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177502|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138177503|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138177504|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177505|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177506|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
138177507|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177508|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138177509|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138177510|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177511|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138177512|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138177513|NCT00797797|Milnacipran|milnacipran|mesh-list
138177514|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
138177515|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138177516|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138177517|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177518|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177519|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177520|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177521|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177522|NCT00797797|Analgesics|analgesics|mesh-ancestor
138177523|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
138177524|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177525|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
138177526|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177527|NCT03496233|Grazoprevir|grazoprevir|mesh-list
138177528|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138177529|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
138177530|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177531|NCT04482673|Vitamin D|vitamin d|mesh-list
138177532|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
138177533|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
138177534|NCT04482673|Vitamins|vitamins|mesh-list
138177535|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
138177536|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177537|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138177538|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138177539|NCT00245063|Cediranib|cediranib|mesh-list
138177540|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177541|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177542|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177545|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
138177546|NCT02151487|Clonidine|clonidine|mesh-list
138177547|NCT02151487|Ropivacaine|ropivacaine|mesh-list
138177548|NCT02151487|BB 1101|bb 1101|mesh-list
138177549|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177550|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
138177551|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
138177552|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177553|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177554|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177555|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
138177556|NCT02151487|Hormones|hormones|mesh-ancestor
138177557|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177558|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177559|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177560|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
138177561|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177562|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177563|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138177564|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
138177565|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177566|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
138177567|NCT02151487|Analgesics|analgesics|mesh-ancestor
138177568|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138177569|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
138177570|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138195423|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
138177571|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138177572|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138177573|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138177574|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177575|NCT05318339|Trastuzumab|trastuzumab|mesh-list
138360330|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177577|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177578|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
138177579|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138177580|NCT00764309|Dasatinib|dasatinib|mesh-list
138177581|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177582|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138177583|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177584|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177585|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
138177586|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138177587|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
138177588|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177589|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177590|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138177591|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
138177592|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138177593|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
138177594|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177595|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177596|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138177597|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
138177598|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
138177599|NCT02151877|Protective Agents|protective agents|mesh-ancestor
138177600|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138177601|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138177602|NCT00799435|Exenatide|exenatide|mesh-list
138177603|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138177604|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177605|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138177606|NCT00799435|Incretins|incretins|mesh-ancestor
138177607|NCT00799435|Hormones|hormones|mesh-ancestor
138177608|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177609|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
138177610|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138360373|NCT00383682|Analgesics|analgesics|mesh-ancestor
138177612|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177613|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177614|NCT04329091|Analgesics|analgesics|mesh-ancestor
138177615|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
138177616|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177617|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138177618|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138177619|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138177620|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
138177621|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177622|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177623|NCT04382209|Meperidine|meperidine|mesh-list
138177624|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138177625|NCT04382209|Narcotics|narcotics|mesh-ancestor
138177626|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177627|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177628|NCT04382209|Analgesics|analgesics|mesh-ancestor
138177629|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
138177630|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177631|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138177632|NCT04634071|Bupropion|bupropion|mesh-list
138177633|NCT04634071|Nicotine|nicotine|mesh-list
138177634|NCT04634071|Varenicline|varenicline|mesh-list
138177635|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138177636|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
138177637|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177638|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195428|NCT02518750|Hormones|hormones|mesh-ancestor
138177639|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138177640|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138177641|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
138177642|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177643|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177644|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138177645|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
138177646|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177647|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138177648|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138177649|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177650|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
138177651|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138177652|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138177653|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177655|NCT03417921|Gemcitabine|gemcitabine|mesh-list
138177656|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138177658|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138177659|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138177660|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138177661|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177662|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138177663|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
138177664|NCT03378297|Aspirin|aspirin|mesh-list
138177665|NCT03378297|Metformin|metformin|mesh-list
138177666|NCT03378297|Letrozole|letrozole|mesh-list
138177667|NCT03378297|Olaparib|olaparib|mesh-list
138177668|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138177669|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177670|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177671|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138177672|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138177673|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177674|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177675|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138177676|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
138360446|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177677|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177678|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138177679|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177681|NCT03378297|Analgesics|analgesics|mesh-ancestor
138177682|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
138177683|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177684|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177685|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177686|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138177687|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138177688|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138177689|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138177690|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
138177692|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138177693|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177694|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177695|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177696|NCT00243659|Factor VIII|factor viii|mesh-list
138177697|NCT00243659|Coagulants|coagulants|mesh-ancestor
138177698|NCT00814177|Warfarin|warfarin|mesh-list
138177699|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
138177700|NCT00243347|Cediranib|cediranib|mesh-list
138177701|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360493|NCT00421980|Etanercept|etanercept|mesh-list
138177703|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177704|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177705|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
138177706|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138177707|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138177708|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177709|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
138177710|NCT03364491|Coagulants|coagulants|mesh-ancestor
138177711|NCT04294069|Azithromycin|azithromycin|mesh-list
138177712|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138177713|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177714|NCT01997229|Eculizumab|eculizumab|mesh-list
138177715|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138177716|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177718|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177719|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
138177720|NCT00800839|Busulfan|busulfan|mesh-list
138177722|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
138177723|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177724|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
138177725|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177726|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177727|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138177728|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
138177729|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177730|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177731|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138177732|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138177733|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
138177734|NCT00814255|Adalimumab|adalimumab|mesh-list
138177735|NCT00814255|Losartan|losartan|mesh-list
138177736|NCT00814255|Lisinopril|lisinopril|mesh-list
138177737|NCT00814255|Atorvastatin|atorvastatin|mesh-list
138177738|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138177739|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138177740|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
138177741|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177742|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138177743|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138177744|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177745|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138177746|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177747|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177748|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138177749|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138177750|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138177751|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138360591|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
138177752|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138177753|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
138177754|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138177755|NCT00814255|Protective Agents|protective agents|mesh-ancestor
138177756|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177757|NCT02000973|Lidocaine|lidocaine|mesh-list
138177759|NCT02000973|Ropivacaine|ropivacaine|mesh-list
138177760|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
138177761|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
138177762|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177763|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177764|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
138177765|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177766|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138177767|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138177768|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138177769|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177770|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177771|NCT02002767|Velpatasvir|velpatasvir|mesh-list
138177772|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
138177773|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177774|NCT01985685|Thiamine|thiamine|mesh-list
138177775|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
138177776|NCT01985685|Vitamins|vitamins|mesh-ancestor
138177777|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
138177778|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177779|NCT00815347|Bosentan|bosentan|mesh-list
138177781|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138177782|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177783|NCT01985763|Genistein|genistein|mesh-list
138177784|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138177785|NCT01985763|Protective Agents|protective agents|mesh-ancestor
138177786|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177787|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177788|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138177789|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177790|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177791|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
138177792|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138177793|NCT01985763|Estrogens|estrogens|mesh-ancestor
138177795|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177796|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
138177797|NCT02061969|Linagliptin|linagliptin|mesh-list
138177798|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138177799|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177800|NCT02061969|Incretins|incretins|mesh-ancestor
138177801|NCT02061969|Hormones|hormones|mesh-ancestor
138177802|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177803|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138177804|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138177805|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177806|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177808|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177809|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177810|NCT02003625|Analgesics|analgesics|mesh-ancestor
138177811|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
138177812|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177813|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177814|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177815|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177816|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138177817|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138177818|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177819|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177821|NCT04037683|Oxytocin|oxytocin|mesh-list
138177822|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
138177823|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138177824|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177825|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138177826|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
138177827|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138177828|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177829|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
138177830|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138177831|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138177832|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177836|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138177837|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177838|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138177839|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138177840|NCT02396511|Growth Substances|growth substances|mesh-ancestor
138177842|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138177844|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138177845|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
138177846|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177847|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138177848|NCT02062359|Aldesleukin|aldesleukin|mesh-list
138177849|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
138177850|NCT02062359|Fludarabine|fludarabine|mesh-list
138177851|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138177852|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
138177853|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177854|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138177855|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138177856|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
138177857|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177858|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177859|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138177860|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138177861|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138177862|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
138177863|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138177864|NCT02397291|Inositol|inositol|mesh-list
138177865|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
138177866|NCT02397291|Vitamins|vitamins|mesh-ancestor
138177867|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
138177868|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177870|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138177871|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177872|NCT00817219|Betamethasone|betamethasone|mesh-list
138177873|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
138177874|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138177875|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
138177876|NCT00817219|Calcipotriene|calcipotriene|mesh-list
138177877|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138177878|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177879|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
138177880|NCT00817219|Hormones|hormones|mesh-ancestor
138289128|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138177881|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177882|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177883|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138177884|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
138177885|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138177887|NCT00817843|Ezetimibe|ezetimibe|mesh-list
138177888|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138462773|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138177889|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138177890|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
138177891|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177892|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138177893|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138177894|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177895|NCT00817999|Clopidogrel|clopidogrel|mesh-list
138177896|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138177897|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138177898|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138177899|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138177900|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
138177901|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177902|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177903|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177905|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138177906|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359243|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138177907|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
138177909|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
138177910|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
138177911|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177912|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177913|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
138177914|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177915|NCT03839251|Aripiprazole|aripiprazole|mesh-list
138177916|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
138177917|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138177918|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138177919|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138177920|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177921|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177922|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
138177923|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
138177924|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177925|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177926|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138177927|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138177929|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138177930|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138360945|NCT01273662|Axitinib|axitinib|mesh-list
138177931|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138177932|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138177933|NCT00819403|Simvastatin|simvastatin|mesh-list
138177934|NCT00819403|Ezetimibe|ezetimibe|mesh-list
138177935|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138177936|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138177937|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138177938|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
138177939|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177940|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138177941|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138177943|NCT02010021|Letrozole|letrozole|mesh-list
138177944|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177945|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138177946|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138177947|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177948|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177949|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138177950|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
138177951|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177952|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177954|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177955|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
138177956|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
138177957|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177958|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177959|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138177960|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
138177962|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177963|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177964|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177965|NCT00820573|Metformin|metformin|mesh-list
138177966|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138177967|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138177968|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177969|NCT00820573|Incretins|incretins|mesh-ancestor
138177970|NCT00820573|Hormones|hormones|mesh-ancestor
138177971|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138177972|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138177973|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
138177974|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177975|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177976|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
138177977|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138177978|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138177979|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138177980|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138177981|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177983|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361026|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
138177984|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177985|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138177986|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138177987|NCT02010645|Decitabine|decitabine|mesh-list
138177988|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138177989|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
138177990|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177991|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177992|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177993|NCT02065479|Ticagrelor|ticagrelor|mesh-list
138177994|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138177995|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138177996|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138177997|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138177998|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138195452|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138178001|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178002|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178004|NCT05236621|Pomalidomide|pomalidomide|mesh-list
138178005|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178006|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
138178007|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
138178008|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178009|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178010|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178011|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
138178012|NCT05236621|Hormones|hormones|mesh-ancestor
138178013|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178014|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178015|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178016|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
138178017|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178018|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138178019|NCT05236621|Growth Substances|growth substances|mesh-ancestor
138178020|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
138178021|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
138178022|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178023|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178024|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178025|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178026|NCT02066727|Analgesics|analgesics|mesh-ancestor
138178027|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
138178028|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178029|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138361136|NCT01274988|Narcotics|narcotics|mesh-ancestor
138178030|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138178031|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138178032|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138178033|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462774|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138178034|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178035|NCT04349241|Favipiravir|favipiravir|mesh-list
138178036|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
138178037|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178038|NCT02812615|Micronutrients|micronutrients|mesh-list
138178039|NCT02812615|Trace Elements|trace elements|mesh-list
138178040|NCT02812615|Albendazole|albendazole|mesh-list
138178041|NCT02812615|Pyrantel|pyrantel|mesh-list
138178042|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
138178043|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
138178044|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138178045|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178046|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
138178047|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138178048|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138178049|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138178050|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
138178051|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138361185|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
138178052|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178053|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178054|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178055|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
138178056|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138178057|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138178058|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138195459|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138178059|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178060|NCT02151253|Modafinil|modafinil|mesh-list
138178061|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138178062|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178063|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138178064|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138178065|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138178066|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178067|NCT02069847|Budesonide|budesonide|mesh-list
138178068|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178069|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138178070|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
138178071|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178072|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178073|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138178074|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
138178075|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
138178076|NCT02069847|Hormones|hormones|mesh-ancestor
138178077|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178079|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
138178080|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138178081|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138178082|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178083|NCT02071095|Poly I-C|poly i-c|mesh-list
138178084|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138178085|NCT02071095|Poly ICLC|poly iclc|mesh-list
138178086|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
138178087|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
138178088|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359294|NCT00356772|Azithromycin|azithromycin|mesh-list
138178089|NCT02071095|Laxatives|laxatives|mesh-ancestor
138178090|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178091|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
138178092|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178093|NCT02348359|Ranibizumab|ranibizumab|mesh-list
138178094|NCT02348359|Aflibercept|aflibercept|mesh-list
138178095|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178096|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178097|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138178098|NCT02348359|Growth Substances|growth substances|mesh-ancestor
138178099|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178100|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138178102|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138178103|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
138178104|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138178105|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
138178106|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178107|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178109|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
138178110|NCT02408445|Testosterone|testosterone|mesh-list
138178111|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
138178112|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
138178113|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138178114|NCT02408445|Androgens|androgens|mesh-ancestor
138178115|NCT02408445|Hormones|hormones|mesh-ancestor
138178116|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178117|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178118|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178119|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178120|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
138178121|NCT00388921|Vitamin A|vitamin a|mesh-list
138178122|NCT00388921|Vitamins|vitamins|mesh-ancestor
138178123|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
138178124|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178125|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
138178126|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138178127|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138178128|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138178129|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178130|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178131|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178132|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178133|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
138178134|NCT00142285|Astringents|astringents|mesh-ancestor
138178135|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178136|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178137|NCT02342379|Bevacizumab|bevacizumab|mesh-list
138178138|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178139|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178140|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178141|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138178142|NCT02342379|Growth Substances|growth substances|mesh-ancestor
138178143|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178144|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138178146|NCT02019069|Daunorubicin|daunorubicin|mesh-list
138178147|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138178148|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
138178149|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178150|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178151|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
138178152|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178153|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178154|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
138178155|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178156|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138178157|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138178158|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138178159|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178160|NCT00821821|Edaravone|edaravone|mesh-list
138361513|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
138178161|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138178162|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
138178163|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178164|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138178165|NCT00821821|Protective Agents|protective agents|mesh-ancestor
138178166|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178167|NCT00816751|Lidocaine|lidocaine|mesh-list
138178168|NCT00816751|Vasopressins|vasopressins|mesh-list
138178169|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
138178170|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
138178171|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
138178172|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178173|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178174|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
138178175|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178176|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138178177|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138178178|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138178179|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178180|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178181|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
138178182|NCT00816751|Coagulants|coagulants|mesh-ancestor
138178183|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138178184|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138178185|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
138178186|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
138178187|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138178188|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138178189|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138178190|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178191|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178192|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178193|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178194|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178195|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138178196|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178197|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
138178199|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178200|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178201|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178202|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138178203|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
138178204|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
138178205|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138178206|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178207|NCT02410707|Analgesics|analgesics|mesh-ancestor
138178208|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
138178209|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178210|NCT02343081|Temozolomide|temozolomide|mesh-list
138178211|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138178212|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
138178213|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178214|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178215|NCT00823303|Calcitriol|calcitriol|mesh-list
138178216|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138178217|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178219|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178220|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178221|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138178222|NCT00823303|Vitamins|vitamins|mesh-ancestor
138178223|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
138178224|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138178225|NCT00823459|Everolimus|everolimus|mesh-list
138178226|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138178227|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138178228|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178229|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178230|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178232|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178233|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178234|NCT00825565|Allantoin|allantoin|mesh-list
138178235|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178236|NCT00803647|Leucovorin|leucovorin|mesh-list
138178237|NCT00803647|Fluorouracil|fluorouracil|mesh-list
138178238|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
138178239|NCT00803647|Cetuximab|cetuximab|mesh-list
138178240|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
138178241|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178242|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138178243|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178244|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178245|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
138178246|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178247|NCT00803647|Antidotes|antidotes|mesh-ancestor
138178248|NCT00803647|Protective Agents|protective agents|mesh-ancestor
138178249|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
138178250|NCT00803647|Vitamins|vitamins|mesh-ancestor
138178251|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
138178252|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178254|NCT00827983|Progestins|progestins|mesh-ancestor
138178255|NCT00827983|Hormones|hormones|mesh-ancestor
138178256|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178257|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178261|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
138178262|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178263|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178265|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138178266|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
138178267|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178268|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178269|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138178270|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138178271|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178272|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178273|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178275|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
138178276|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178277|NCT02413203|Celecoxib|celecoxib|mesh-list
138178278|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138178279|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178280|NCT02413203|Analgesics|analgesics|mesh-ancestor
138178282|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178283|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178284|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178285|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178286|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138178287|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138178288|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178289|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178291|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
138178292|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178293|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138178294|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138178295|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
138178296|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178297|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178298|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
138178299|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138178300|NCT02348775|Glycine|glycine|mesh-list
138178301|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
138178302|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178303|NCT02348775|Expectorants|expectorants|mesh-ancestor
138178304|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
138178305|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138178306|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
138178307|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178308|NCT02348775|Protective Agents|protective agents|mesh-ancestor
138178309|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178311|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
138178312|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178314|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178315|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
138178316|NCT00828061|Hormones|hormones|mesh-ancestor
138178317|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178318|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178319|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178320|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178321|NCT00849121|Vaccines|vaccines|mesh-list
138178322|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
138178323|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178324|NCT02023125|Esomeprazole|esomeprazole|mesh-list
138178325|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138178326|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178327|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138178328|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178329|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178330|NCT02349477|Gabapentin|gabapentin|mesh-list
138178331|NCT02349477|Analgesics|analgesics|mesh-ancestor
138178332|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
138178333|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178334|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178335|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
138178336|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138178337|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138178338|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178339|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178340|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138178341|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138178342|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178343|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178345|NCT00828295|Palonosetron|palonosetron|mesh-list
138178346|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
138178347|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
138178348|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178349|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178350|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178351|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138178352|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138178353|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
138178354|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178355|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178357|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138178358|NCT02350569|Ledipasvir|ledipasvir|mesh-list
138178359|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
138178360|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178361|NCT02351115|Alprazolam|alprazolam|mesh-list
138178362|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178363|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178364|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178365|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138178366|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138178367|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178368|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
138178369|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
138178370|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178371|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178372|NCT02025075|Rocuronium|rocuronium|mesh-list
138178373|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138178374|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138178375|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138178376|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178377|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178378|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
138178379|NCT00242567|Androgens|androgens|mesh-list
138178380|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361969|NCT01724268|Hormones|hormones|mesh-ancestor
138178381|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178382|NCT00242567|Hormones|hormones|mesh-ancestor
138178383|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178384|NCT00241631|Fluticasone|fluticasone|mesh-list
138178386|NCT00241631|Theophylline|theophylline|mesh-list
138178387|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178388|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138178390|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178391|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178392|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138178393|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
138178394|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178395|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138178396|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138178397|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178398|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178399|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
138178400|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138178401|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138178402|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
138178403|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178404|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
138178405|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
138178406|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178407|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178408|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138178409|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178411|NCT00240071|Bevacizumab|bevacizumab|mesh-list
138178413|NCT00240071|Exemestane|exemestane|mesh-list
138178414|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178415|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178416|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178417|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138178419|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178420|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
138178422|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138178423|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178424|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178425|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138178426|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
138178427|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178428|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178429|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138178430|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138178431|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138178433|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138178434|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138178435|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
138178436|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178437|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178438|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178439|NCT00765947|Amlodipine|amlodipine|mesh-list
138178440|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138178441|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138178442|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138178443|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178444|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178445|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138178447|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
138178448|NCT00765947|Diuretics|diuretics|mesh-ancestor
138178449|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
138178450|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138178451|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
138178452|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138178453|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178454|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138178455|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178457|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138178458|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178459|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138178460|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178461|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
138178462|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178463|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
138178464|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178466|NCT02352831|Tosedostat|tosedostat|mesh-list
138178467|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138178468|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
138178469|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178470|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178471|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178472|NCT02353299|Zolpidem|zolpidem|mesh-list
138178473|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138178474|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178475|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178476|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178477|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138178478|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
138178479|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
138178480|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178481|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178482|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138178483|NCT00756977|Laxatives|laxatives|mesh-ancestor
138178484|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178486|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178487|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
138178489|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138178490|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178491|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178492|NCT00421551|Ritonavir|ritonavir|mesh-list
138178493|NCT00421551|Darunavir|darunavir|mesh-list
138178494|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138178495|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138178496|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
138178497|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178498|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178499|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138178500|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138178501|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
138178502|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178503|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138178504|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138178505|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138178506|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138178507|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
138178508|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178510|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138178511|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138178512|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138178513|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138178514|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
138178515|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178516|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178517|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178518|NCT02029755|Anesthetics|anesthetics|mesh-list
138178519|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
138178520|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178521|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178522|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
138178523|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178524|NCT03804749|Suramin|suramin|mesh-list
138178525|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
138178526|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
138178527|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138178528|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178529|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178530|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138178531|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138178532|NCT02312739|Ketorolac|ketorolac|mesh-list
138178533|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138178534|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
138178535|NCT02312739|Analgesics|analgesics|mesh-list
138178536|NCT02312739|Lorazepam|lorazepam|mesh-list
138362262|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138178538|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178539|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
138178540|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178541|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178542|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178544|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138178545|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178546|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178547|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138178548|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
138178550|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178551|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
138178552|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
138178553|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
138178554|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178555|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178556|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138178557|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138178558|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178559|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
138178560|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
138178561|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178562|NCT02351037|Azacitidine|azacitidine|mesh-list
138178563|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138178564|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
138178565|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178566|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178567|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178568|NCT05718609|Amoxicillin|amoxicillin|mesh-list
138178569|NCT05718609|Clarithromycin|clarithromycin|mesh-list
138178570|NCT05718609|Furazolidone|furazolidone|mesh-list
138178571|NCT05718609|Rabeprazole|rabeprazole|mesh-list
138178573|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138178574|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178575|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138178576|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178577|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178578|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138178579|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138178580|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138178581|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178582|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138178584|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138178585|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138178586|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138178587|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138178588|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138178589|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138178590|NCT02359305|Acetaminophen|acetaminophen|mesh-list
138178591|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178592|NCT02359305|Analgesics|analgesics|mesh-ancestor
138178593|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
138178594|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178595|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178596|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
138178597|NCT02360319|Aripiprazole|aripiprazole|mesh-list
138178598|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
138178599|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
138178600|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178601|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138178602|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178603|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178604|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
138178605|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
138178606|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178607|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178608|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138178609|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138178610|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
138178611|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138178612|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138178613|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138178614|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138178615|NCT05718531|Aspirin|aspirin|mesh-list
138178616|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
138178617|NCT05718531|Clopidogrel|clopidogrel|mesh-list
138178618|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138178619|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178620|NCT05718531|Analgesics|analgesics|mesh-ancestor
138178621|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
138178622|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178623|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178624|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178625|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178626|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138178627|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138178628|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178629|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138178630|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138178631|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178632|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
138178633|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138195503|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138178634|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138178635|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138178636|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
138178637|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178638|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138178639|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
138178640|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138178641|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
138178642|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
138178643|NCT02360631|Varenicline|varenicline|mesh-list
138178644|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138178645|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138178646|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178647|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178648|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178649|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178650|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
138178651|NCT00355095|Hematinics|hematinics|mesh-ancestor
138178652|NCT02366871|Enoxaparin|enoxaparin|mesh-list
138178653|NCT02366871|Apixaban|apixaban|mesh-list
138178654|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
138178655|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138178656|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138178657|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178658|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138178659|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
138178660|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138178661|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
138178662|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178664|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
138178665|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138178666|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178667|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178668|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138178669|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178670|NCT03836651|Antioxidants|antioxidants|mesh-list
138178671|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178672|NCT03836651|Protective Agents|protective agents|mesh-ancestor
138178674|NCT02037555|Antithrombins|antithrombins|mesh-list
138178675|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
138178676|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138178677|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
138178678|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178679|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178680|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
138178681|NCT03804359|Rituximab|rituximab|mesh-list
138178682|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178683|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178684|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
138178685|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178686|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178687|NCT02369211|Acetaminophen|acetaminophen|mesh-list
138178688|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178689|NCT02369211|Analgesics|analgesics|mesh-ancestor
138178690|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
138178691|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178692|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178693|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
138178695|NCT02038023|Dextrans|dextrans|mesh-list
138178696|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
138178697|NCT02038023|Trace Elements|trace elements|mesh-ancestor
138178698|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
138178699|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178700|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
138362654|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
138178701|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
138178702|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
138178703|NCT02038023|Hematinics|hematinics|mesh-ancestor
138178704|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
138178705|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138178706|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
138195510|NCT05487300|Levodopa|levodopa|mesh-list
138178707|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178708|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178709|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138178710|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
138178711|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138178712|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
138188463|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289129|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178713|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178715|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138178716|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
138178717|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
138178718|NCT04384133|Protective Agents|protective agents|mesh-ancestor
138178719|NCT02038179|Allopurinol|allopurinol|mesh-list
138178720|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
138178721|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178722|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178723|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
138178724|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178725|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138178726|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
138178727|NCT02038179|Protective Agents|protective agents|mesh-ancestor
138178728|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178734|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138178735|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138178736|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138178737|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178738|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178739|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178740|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178741|NCT00768521|Urological Agents|urological agents|mesh-ancestor
138178743|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
138178744|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178745|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138178746|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138178747|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178748|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178749|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138178750|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
138178751|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178752|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178753|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
138178754|NCT02370693|Bortezomib|bortezomib|mesh-list
138178755|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138178756|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178757|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138178758|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
138178759|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138178760|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178761|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178762|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178763|NCT02039115|Prednisone|prednisone|mesh-list
138178764|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178765|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
138178766|NCT02039115|Hormones|hormones|mesh-ancestor
138178767|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178768|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178769|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178770|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178771|NCT00759473|Cycloserine|cycloserine|mesh-list
138178772|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138178773|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178774|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138178775|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
138178776|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138178777|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
138362849|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
138178778|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178780|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178781|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178782|NCT03809273|Trimetazidine|trimetazidine|mesh-list
138178783|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
138178784|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138178785|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138462775|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178787|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138178788|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138178789|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178790|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178791|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
138178792|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178794|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138178795|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
138178796|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138178797|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138178798|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138178799|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
138178800|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178801|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178802|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178803|NCT03808805|Aprepitant|aprepitant|mesh-list
138178804|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
138178805|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
138178806|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
138178807|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
138178808|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178809|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178810|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178811|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138178812|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178813|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178815|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178816|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138178817|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
138178818|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
138178819|NCT03803267|Fentanyl|fentanyl|mesh-list
138178820|NCT03803267|Propofol|propofol|mesh-list
138178821|NCT03803267|Atracurium|atracurium|mesh-list
138178822|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
138178823|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178824|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178825|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178826|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138178827|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
138178828|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138178829|NCT03803267|Narcotics|narcotics|mesh-ancestor
138178830|NCT03803267|Analgesics|analgesics|mesh-ancestor
138178831|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
138178832|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178833|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138178834|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138178835|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138178837|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138178838|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138178839|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
138178840|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178841|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178842|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138178843|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178844|NCT03808649|Mannitol|mannitol|mesh-list
138178845|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138178846|NCT03808649|Diuretics|diuretics|mesh-ancestor
138178847|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
138178848|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178849|NCT00788255|Oxytocin|oxytocin|mesh-list
138178850|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
138178851|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138178852|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178853|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138178854|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
138178855|NCT02379195|Fludarabine|fludarabine|mesh-list
138178856|NCT02379195|Interleukin-2|interleukin-2|mesh-list
138178857|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178858|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
138178859|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178860|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178861|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138178862|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
138178863|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178864|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178865|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138178866|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178867|NCT02379195|Analgesics|analgesics|mesh-ancestor
138178868|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
138178869|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178870|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
138178871|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178872|NCT00771875|Acetaminophen|acetaminophen|mesh-list
138178873|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
138178874|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
138178876|NCT00771875|Bortezomib|bortezomib|mesh-list
138178877|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
138178878|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138178879|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138178880|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
138178881|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178882|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178883|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
138178884|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178886|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178887|NCT00771875|Analgesics|analgesics|mesh-ancestor
138178888|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
138178889|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178890|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
138178891|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178892|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
138178893|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
138178894|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138178895|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
138178896|NCT00771875|Hormones|hormones|mesh-ancestor
138178897|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138178898|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138178899|NCT00771875|Protective Agents|protective agents|mesh-ancestor
138178900|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138178901|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138178902|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178903|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178904|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
138178906|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
138178907|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178908|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178909|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138178910|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138178911|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138178912|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178913|NCT00760019|Analgesics|analgesics|mesh-ancestor
138178914|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
138178915|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195526|NCT01108666|Nelfinavir|nelfinavir|mesh-list
138178916|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178917|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138178918|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138178919|NCT00789113|Lamotrigine|lamotrigine|mesh-list
138178920|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
138178921|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138178922|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138178923|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178924|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138178925|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178926|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138178927|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138178929|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178930|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138178931|NCT03808259|Ketamine|ketamine|mesh-list
138178932|NCT03808259|Esketamine|esketamine|mesh-list
138178933|NCT03808259|Analgesics|analgesics|mesh-ancestor
138178934|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
138178935|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178936|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178937|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138178938|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138178939|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
138178940|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
138178941|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178942|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138178943|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138178944|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178945|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178946|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138178947|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138178949|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138178950|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138178951|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138178952|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
138178953|NCT05742503|Etonogestrel|etonogestrel|mesh-list
138178954|NCT05742503|Norgestrel|norgestrel|mesh-list
138178955|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138178956|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
138178957|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138178958|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178959|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138178960|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138178961|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138178963|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178964|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178965|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138178966|NCT02388321|Fentanyl|fentanyl|mesh-list
138178967|NCT02388321|Ketamine|ketamine|mesh-list
138178968|NCT02388321|Analgesics|analgesics|mesh-ancestor
138178969|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
138178970|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178971|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178972|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138178973|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138178974|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
138178975|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
138178976|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178977|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138178978|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138178979|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178980|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178981|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138178982|NCT02388321|Narcotics|narcotics|mesh-ancestor
138178983|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138178984|NCT05742425|Bevacizumab|bevacizumab|mesh-list
138178985|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138178986|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138178987|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178988|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138178989|NCT05742425|Growth Substances|growth substances|mesh-ancestor
138178991|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
138178992|NCT02313675|Acetaminophen|acetaminophen|mesh-list
138178993|NCT02313675|Ketorolac|ketorolac|mesh-list
138178994|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138178995|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138178996|NCT02313675|Analgesics|analgesics|mesh-ancestor
138178997|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
138178998|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178999|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179000|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
138179001|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179002|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179003|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179004|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138363292|NCT05767229|Carvedilol|carvedilol|mesh-list
138179005|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179006|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179008|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179009|NCT03801629|Narcotics|narcotics|mesh-ancestor
138179010|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179011|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179012|NCT03801629|Analgesics|analgesics|mesh-ancestor
138179013|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
138179014|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179016|NCT05741021|Carboplatin|carboplatin|mesh-list
138179017|NCT05741021|Pemetrexed|pemetrexed|mesh-list
138179018|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138179019|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179020|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138179021|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138179022|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179023|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179024|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179025|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138179026|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138179028|NCT04383977|Apatinib|apatinib|mesh-list
138179029|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138179030|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179031|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138179032|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179033|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179034|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179035|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179036|NCT02389959|Bevacizumab|bevacizumab|mesh-list
138179037|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179038|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179039|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138179040|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138179041|NCT02389959|Growth Substances|growth substances|mesh-ancestor
138179042|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179043|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
138179045|NCT00775931|Busulfan|busulfan|mesh-list
138179046|NCT00775931|Fludarabine|fludarabine|mesh-list
138179047|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
138179048|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
138179049|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179050|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
138179051|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179052|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179053|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138179054|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
138179055|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179056|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179057|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138179058|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179059|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
138179060|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195539|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138179061|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138179062|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138179063|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179064|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
138179065|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179066|NCT05734235|Vitamins|vitamins|mesh-list
138179067|NCT05734235|Vitamin E|vitamin e|mesh-list
138179068|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
138179069|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179070|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
138179071|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179072|NCT05734235|Protective Agents|protective agents|mesh-ancestor
138179073|NCT05732129|Irinotecan|irinotecan|mesh-list
138179074|NCT05732129|Fluzoparib|fluzoparib|mesh-list
138179075|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138179076|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179077|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179078|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179079|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179080|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138179081|NCT02394951|Pregabalin|pregabalin|mesh-list
138179082|NCT02394951|Analgesics|analgesics|mesh-ancestor
138179083|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
138179084|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179085|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179087|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138179088|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179089|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179090|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138179091|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138179092|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179093|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179094|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179095|NCT03838367|Leronlimab|leronlimab|mesh-list
138179096|NCT03838367|Carboplatin|carboplatin|mesh-list
138179097|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
138179098|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179099|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138179100|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138179101|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363526|NCT04759144|Insulin|insulin|mesh-list
138179102|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138179103|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138179104|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
138179105|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179106|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
138179107|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179108|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
138179109|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138179110|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
138179111|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179112|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
138179113|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138179114|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138179115|NCT04345445|Prednisolone|prednisolone|mesh-list
138179116|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
138359378|NCT00357474|Ethanol|ethanol|mesh-list
138179117|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138179118|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
138179119|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179121|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
138179122|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179123|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179124|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179125|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
138179127|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179128|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138179129|NCT04345445|Protective Agents|protective agents|mesh-ancestor
138179130|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138179131|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179132|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
138179133|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179134|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179136|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
138179137|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179138|NCT05713877|Protective Agents|protective agents|mesh-ancestor
138179139|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179140|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179141|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138179142|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179143|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179144|NCT00795275|Incretins|incretins|mesh-ancestor
138179146|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179147|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138179148|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
138179149|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179150|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179151|NCT00777335|Panobinostat|panobinostat|mesh-list
138179152|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179153|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138179156|NCT05644587|Buprenorphine|buprenorphine|mesh-list
138179157|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138179158|NCT05644587|Naloxone|naloxone|mesh-list
138179159|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179160|NCT05644587|Narcotics|narcotics|mesh-ancestor
138179161|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179162|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179163|NCT05644587|Analgesics|analgesics|mesh-ancestor
138179164|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
138179165|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179166|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138179167|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
138179168|NCT00355407|Hematinics|hematinics|mesh-ancestor
138179169|NCT00355251|Atorvastatin|atorvastatin|mesh-list
138179170|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138179171|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138179172|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
138179173|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179174|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138179175|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138179176|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179177|NCT03832127|Fludarabine|fludarabine|mesh-list
138179178|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179179|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138179180|NCT04876131|Gentamicins|gentamicins|mesh-list
138179181|NCT04876131|Cephalexin|cephalexin|mesh-list
138179182|NCT04876131|Penicillin G|penicillin g|mesh-list
138179183|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138179184|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
138179185|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179186|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138179187|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179188|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179189|NCT00791219|Itraconazole|itraconazole|mesh-list
138179190|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138179191|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
138179192|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179193|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138179194|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138179195|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179196|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179197|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138179198|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
138179199|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179200|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179201|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138179202|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
138179203|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138179204|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
138179205|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179206|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
138179207|NCT00797459|Protective Agents|protective agents|mesh-ancestor
138179208|NCT04807101|Midazolam|midazolam|mesh-list
138179209|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138179210|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138179211|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179212|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179213|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138179214|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179215|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179216|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138179217|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
138179218|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
138179219|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
138179220|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
138179221|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179222|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179223|NCT00355953|Genistein|genistein|mesh-list
138179224|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138179225|NCT00355953|Protective Agents|protective agents|mesh-ancestor
138179226|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179227|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179228|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179229|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179230|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179231|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
138179232|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138179234|NCT00355953|Hormones|hormones|mesh-ancestor
138179235|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179236|NCT05416073|Sufentanil|sufentanil|mesh-list
138179237|NCT05416073|Esketamine|esketamine|mesh-list
138179238|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179239|NCT05416073|Narcotics|narcotics|mesh-ancestor
138179240|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179241|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179242|NCT05416073|Analgesics|analgesics|mesh-ancestor
138179243|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
138179244|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179245|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138179246|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138179247|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
138179248|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
138179249|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
138179250|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179252|NCT05664971|Etoposide|etoposide|mesh-list
138179253|NCT05664971|Docetaxel|docetaxel|mesh-list
138179254|NCT05664971|Carboplatin|carboplatin|mesh-list
138179255|NCT05664971|Pemetrexed|pemetrexed|mesh-list
138179256|NCT05664971|Antibodies|antibodies|mesh-list
138179257|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138179258|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138179259|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179260|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138179261|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138179262|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179263|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179266|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138179267|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179269|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138179270|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138179272|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
138179273|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179274|NCT04812509|Denosumab|denosumab|mesh-list
138179275|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138179276|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179277|NCT05446623|Sufentanil|sufentanil|mesh-list
138179278|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
138179279|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138179280|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179281|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179282|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179283|NCT05446623|Analgesics|analgesics|mesh-ancestor
138179284|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
138179285|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179286|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138179287|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138179288|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138179289|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
138179290|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179291|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179292|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179293|NCT05446623|Narcotics|narcotics|mesh-ancestor
138179294|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138179295|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138179296|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
138179297|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
138179298|NCT00792077|Lenalidomide|lenalidomide|mesh-list
138179299|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
138179300|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179301|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138179302|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138179303|NCT00792077|Growth Substances|growth substances|mesh-ancestor
138179305|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179306|NCT02979015|Alirocumab|alirocumab|mesh-list
138179307|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138179308|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138179309|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138179310|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
138179311|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179312|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138179313|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
138179314|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179315|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138179316|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138179318|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179319|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179320|NCT00799643|Analgesics|analgesics|mesh-ancestor
138179321|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
138179322|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179323|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179324|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179325|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179326|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138179327|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179328|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179330|NCT03835013|Glucagon|glucagon|mesh-list
138179331|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138179332|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179333|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179334|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138179335|NCT03835013|Incretins|incretins|mesh-ancestor
138179336|NCT03835013|Hormones|hormones|mesh-ancestor
138179337|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179338|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179339|NCT00800345|Topotecan|topotecan|mesh-list
138179340|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138179341|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179342|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179343|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179344|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179345|NCT03806751|Acetazolamide|acetazolamide|mesh-list
138179346|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
138179347|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138179348|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179349|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179350|NCT03806751|Diuretics|diuretics|mesh-ancestor
138179351|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
138363864|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
138179354|NCT04383275|Trastuzumab|trastuzumab|mesh-list
138179355|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179356|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
138179357|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179358|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179359|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179360|NCT03973229|Estradiol|estradiol|mesh-list
138179361|NCT03973229|Estrogens|estrogens|mesh-ancestor
138179362|NCT03973229|Hormones|hormones|mesh-ancestor
138363913|NCT02932826|Insulin|insulin|mesh-list
138179363|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179364|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179366|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
138179367|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138179368|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138179369|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179370|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179371|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179372|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
138195634|NCT05484648|Analgesics|analgesics|mesh-ancestor
138179373|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138179374|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
138179375|NCT05319015|Lenvatinib|lenvatinib|mesh-list
138179376|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179377|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179378|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138179379|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179380|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179382|NCT00810719|Gemcitabine|gemcitabine|mesh-list
138179383|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138179384|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179385|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
138179386|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179387|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179388|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179389|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179391|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179393|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179394|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179395|NCT03761277|Analgesics|analgesics|mesh-ancestor
138179396|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
138179397|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179398|NCT00810797|Exemestane|exemestane|mesh-list
138179399|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179400|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138179401|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138179402|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179403|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179404|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138179405|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289130|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179406|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179407|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179408|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138179409|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179410|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
138179412|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179413|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179414|NCT00355641|Ropinirole|ropinirole|mesh-list
138179415|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138179416|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138179417|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
138179418|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
138179419|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179420|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179421|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179422|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
138179423|NCT00356733|Hematinics|hematinics|mesh-ancestor
138179425|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138179426|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179427|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179428|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138179429|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138179430|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195792|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
138179432|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138179433|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138179434|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138179435|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179436|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179437|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
138179438|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179439|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179440|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138179441|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179443|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138179444|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138179445|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
138179447|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179448|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179449|NCT00802685|Ibuprofen|ibuprofen|mesh-list
138179450|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179451|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179452|NCT00802685|Analgesics|analgesics|mesh-ancestor
138179453|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
138179454|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364009|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
138179455|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179456|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179458|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138179459|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195914|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
138195915|NCT05474898|Analgesics|analgesics|mesh-ancestor
138179460|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179462|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138179463|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138179464|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
138179465|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179466|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179467|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179469|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
138179470|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179471|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
138179472|NCT04099641|Bavituximab|bavituximab|mesh-list
138179473|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179474|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179475|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138179476|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179477|NCT05051735|Acetaminophen|acetaminophen|mesh-list
138179478|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179479|NCT05051735|Analgesics|analgesics|mesh-ancestor
138179480|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
138179481|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179482|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179483|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
138179484|NCT03357627|Venetoclax|venetoclax|mesh-list
138179485|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179486|NCT04923113|Amoxicillin|amoxicillin|mesh-list
138179487|NCT04923113|Minocycline|minocycline|mesh-list
138179488|NCT04923113|Rabeprazole|rabeprazole|mesh-list
138179490|NCT04923113|Antibodies|antibodies|mesh-list
138179491|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
138179492|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179493|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138179494|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179495|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138179496|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179497|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138179498|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179499|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179501|NCT03250923|Acemannan|acemannan|mesh-list
138179502|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138179503|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
138179504|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179505|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179506|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
138179507|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179508|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179509|NCT00805493|Riluzole|riluzole|mesh-list
138179510|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
138179511|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138196019|NCT00850720|Vasopressins|vasopressins|mesh-list
138179512|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138179513|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179514|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179515|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179516|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138179517|NCT00805493|Protective Agents|protective agents|mesh-ancestor
138179519|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179520|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179521|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179522|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179524|NCT00807209|Bupivacaine|bupivacaine|mesh-list
138179525|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
138179526|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
138179527|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179528|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179529|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
138179530|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179531|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179532|NCT00807209|Narcotics|narcotics|mesh-ancestor
138179533|NCT00807209|Analgesics|analgesics|mesh-ancestor
138179534|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138179535|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138179536|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
138179537|NCT00807989|Lamotrigine|lamotrigine|mesh-list
138179538|NCT00807989|Carbamazepine|carbamazepine|mesh-list
138179539|NCT00807989|Valproic Acid|valproic acid|mesh-list
138179540|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
138179542|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179543|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179544|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138179547|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179548|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179549|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179550|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138179551|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179552|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
138179553|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179554|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
138179555|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179556|NCT00807989|Analgesics|analgesics|mesh-ancestor
138179557|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
138179558|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179559|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138179560|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138179561|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138179562|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
138179563|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138179565|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
138179566|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179567|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138179568|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138179569|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179570|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179572|NCT04845490|Mitomycin|mitomycin|mesh-list
138179573|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138179574|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179575|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
138179576|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179577|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138179578|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179579|NCT00357045|Paroxetine|paroxetine|mesh-list
138179580|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138179581|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138179582|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289131|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
138196169|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179583|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179584|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179585|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
138179586|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179587|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138179588|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
138179589|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179590|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138179591|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138179592|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179593|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
138179594|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138179595|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138179596|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179597|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179598|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138179599|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179600|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179601|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
138179602|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179603|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138179604|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138179605|NCT04819360|Urological Agents|urological agents|mesh-ancestor
138179606|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138179607|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138179608|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138179610|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179611|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138179612|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138179613|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179614|NCT04436458|Niclosamide|niclosamide|mesh-list
138179615|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
138179616|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138179617|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
138179618|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138179619|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179620|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
138179621|NCT03834753|Bevacizumab|bevacizumab|mesh-list
138179622|NCT03834753|Ranibizumab|ranibizumab|mesh-list
138179623|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179624|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179625|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138179627|NCT03834753|Growth Substances|growth substances|mesh-ancestor
138179628|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179629|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138179630|NCT00845039|Irinotecan|irinotecan|mesh-list
138179631|NCT00845039|Cetuximab|cetuximab|mesh-list
138179632|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138179633|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138179634|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179635|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179636|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179637|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179638|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179639|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
138179640|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179641|NCT00845195|Azelastine|azelastine|mesh-list
138179642|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138179643|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138179645|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179646|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196336|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
138179648|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138179649|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138179650|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179651|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179652|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138179653|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138179654|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138179655|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
138179656|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
138179657|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179658|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179659|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179660|NCT00845195|Analgesics|analgesics|mesh-ancestor
138179661|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
138179662|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179663|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179664|NCT00845507|Exenatide|exenatide|mesh-list
138179665|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179666|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179667|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138179668|NCT00845507|Incretins|incretins|mesh-ancestor
138179670|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179671|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
138179672|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179673|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179674|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138179675|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179676|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
138179677|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138179678|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179679|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179680|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
138179681|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179682|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179684|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179685|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179686|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179687|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179688|NCT03839771|Ivosidenib|ivosidenib|mesh-list
138179689|NCT03839771|Glycine|glycine|mesh-list
138179690|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179691|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179692|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179693|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
138179694|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179695|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179696|NCT02593396|Bupropion|bupropion|mesh-list
138179697|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138179698|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
138179699|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179700|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138179701|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138179702|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179703|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179704|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
138179705|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179706|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179707|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138179708|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138179709|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179710|NCT00848783|Capecitabine|capecitabine|mesh-list
138179711|NCT00848783|Irinotecan|irinotecan|mesh-list
138179712|NCT00848783|Floxuridine|floxuridine|mesh-list
138179713|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179714|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179715|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
138179716|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196492|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138196501|NCT00000802|Dapsone|dapsone|mesh-list
138179717|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138179718|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179719|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179720|NCT05372536|Cytarabine|cytarabine|mesh-list
138179721|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179722|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
138179723|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179724|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179725|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
138179726|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179727|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179728|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
138179729|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179730|NCT00849251|Dexamethasone|dexamethasone|mesh-list
138179731|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
138179733|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138179735|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179736|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
138179737|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179738|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179739|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138179740|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
138179741|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196536|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
138179742|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179743|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138179744|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179746|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
138179748|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179749|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
138179750|NCT00849251|Hormones|hormones|mesh-ancestor
138179751|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179752|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138179753|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138179754|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138179755|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138179756|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179757|NCT00850889|Lidocaine|lidocaine|mesh-list
138179758|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
138179759|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138462776|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179760|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
138179761|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196587|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
138179762|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179763|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
138179764|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179765|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138179766|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138179767|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138179768|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179769|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179770|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138179771|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
138179772|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
138179773|NCT00850889|Protective Agents|protective agents|mesh-ancestor
138179775|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138179777|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
138179779|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138179780|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
138179781|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179782|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179783|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138179785|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
138179786|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179787|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196636|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
138179789|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179790|NCT05105074|Narcotics|narcotics|mesh-ancestor
138179791|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179792|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179793|NCT05105074|Analgesics|analgesics|mesh-ancestor
138179794|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
138179795|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179796|NCT00364702|Methylphenidate|methylphenidate|mesh-list
138364540|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179797|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138196684|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
138179798|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179799|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138179800|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138179801|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179802|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179803|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
138179804|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179806|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179807|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
138179808|NCT00852761|Hormones|hormones|mesh-ancestor
138179809|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138179810|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179811|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
138196746|NCT02344472|Docetaxel|docetaxel|mesh-list
138179812|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
138179813|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138179815|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179816|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179817|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138179818|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
138179819|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138179820|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
138179821|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179822|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179823|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138179824|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
138179825|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
138179826|NCT03839537|Protective Agents|protective agents|mesh-ancestor
138179827|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
138179828|NCT04082806|Trazodone|trazodone|mesh-list
138179829|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138179830|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179831|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179832|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179833|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138196807|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179834|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138462777|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138179835|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138179836|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179837|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179838|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179839|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
138364604|NCT01386996|Budesonide|budesonide|mesh-list
138179841|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
138179842|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138179843|NCT05635786|Tenecteplase|tenecteplase|mesh-list
138179844|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138179845|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138179846|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179847|NCT00365950|Warfarin|warfarin|mesh-list
138179848|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
138179849|NCT02487797|Oxytocin|oxytocin|mesh-list
138179850|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
138179851|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138196851|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196854|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
138179852|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179854|NCT01733693|Methadone|methadone|mesh-list
138179855|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138179856|NCT01733693|Narcotics|narcotics|mesh-ancestor
138179857|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179859|NCT01733693|Analgesics|analgesics|mesh-ancestor
138179860|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
138179861|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179862|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138179863|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
138179864|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
138179865|NCT00855413|Ritonavir|ritonavir|mesh-list
138179866|NCT00855413|Darunavir|darunavir|mesh-list
138179867|NCT00855413|Etravirine|etravirine|mesh-list
138179868|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138179869|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138364615|NCT01386996|Hormones|hormones|mesh-ancestor
138179871|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179872|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179873|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138179874|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138179875|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
138179876|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179877|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138179878|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138179879|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138179880|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138179881|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
138179882|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138179884|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179885|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179886|NCT00366262|Analgesics|analgesics|mesh-ancestor
138179887|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
138179888|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179889|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179890|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179891|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179892|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
138179893|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138179894|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196950|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
138179895|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179896|NCT00818363|Bupivacaine|bupivacaine|mesh-list
138179898|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
138179899|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179900|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179901|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
138364664|NCT01387399|Cisplatin|cisplatin|mesh-list
138179905|NCT00828841|Gemcitabine|gemcitabine|mesh-list
138179906|NCT00828841|Cetuximab|cetuximab|mesh-list
138179907|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138179908|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179909|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
138179910|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
138179911|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179912|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179913|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179914|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
138179915|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138179916|NCT05445310|Aflutinib|aflutinib|mesh-list
138179917|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138179918|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179919|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179920|NCT00858689|Minocycline|minocycline|mesh-list
138179921|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138179922|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179923|NCT00821795|Insulin|insulin|mesh-list
138179924|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
138179925|NCT00821795|Protamines|protamines|mesh-list
138179926|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179927|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179928|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
138179929|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179932|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138179933|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179934|NCT00833365|Analgesics|analgesics|mesh-ancestor
138179936|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179937|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179938|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179939|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179940|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138179941|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179942|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197057|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
138179943|NCT00821951|Vorinostat|vorinostat|mesh-list
138179944|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179945|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138179946|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179947|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179948|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138179949|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
138179950|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179951|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138179952|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179953|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179954|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179955|NCT00860015|Gemcitabine|gemcitabine|mesh-list
138179956|NCT00860015|Pemetrexed|pemetrexed|mesh-list
138179957|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179958|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
138179959|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179960|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179961|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179962|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138179963|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138179964|NCT00853333|Midazolam|midazolam|mesh-list
138179965|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
138179966|NCT00853333|Propofol|propofol|mesh-list
138179967|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138179968|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179969|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179970|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138179972|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
138179973|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179974|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138179975|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138179976|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138179977|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
138179978|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138179979|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179980|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138179981|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
138462778|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179983|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138179984|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138179985|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138179986|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138179987|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
138179988|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
138179989|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138179990|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138179991|NCT00822107|Diuretics|diuretics|mesh-ancestor
138179992|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
138179993|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179994|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138364785|NCT01388517|Petrolatum|petrolatum|mesh-list
138179995|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138179996|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179998|NCT05236907|Melatonin|melatonin|mesh-list
138179999|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138180000|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138180002|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180003|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138180004|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138180005|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180006|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138180007|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
138180009|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
138180010|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
138180011|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180012|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180013|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
138180014|NCT05236907|Protective Agents|protective agents|mesh-ancestor
138180015|NCT05217706|Ketamine|ketamine|mesh-list
138180016|NCT05217706|Analgesics|analgesics|mesh-ancestor
138180017|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
138180018|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180019|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180020|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138180021|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138180022|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
138180023|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
138180024|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180025|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138180026|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138180027|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180028|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180029|NCT00833443|Bupropion|bupropion|mesh-list
138180030|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138180031|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
138180032|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180033|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138180034|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197257|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
138197258|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197262|NCT01226719|Leucovorin|leucovorin|mesh-list
138180035|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180036|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180038|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180039|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180040|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138180041|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138180042|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180043|NCT05207722|Aldesleukin|aldesleukin|mesh-list
138180044|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
138180045|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
138180046|NCT05207722|Trastuzumab|trastuzumab|mesh-list
138180047|NCT05207722|Fludarabine|fludarabine|mesh-list
138180048|NCT05207722|Interleukin-2|interleukin-2|mesh-list
138180049|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180050|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
138180051|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180052|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180053|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138180054|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
138197314|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
138180056|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180057|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138180058|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180059|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138180060|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138180061|NCT05207722|Analgesics|analgesics|mesh-ancestor
138180063|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180064|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138180065|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138180066|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
138180067|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180069|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
138180070|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138180072|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
138180073|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138180074|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
138180075|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180076|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197372|NCT00000274|Flupenthixol|flupenthixol|mesh-list
138197380|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
138180077|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138180079|NCT00860171|Trace Elements|trace elements|mesh-ancestor
138180080|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
138180081|NCT00366418|Rituximab|rituximab|mesh-list
138180082|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180084|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
138180085|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180086|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180088|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180089|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138180090|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138180091|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180092|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180093|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180094|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138180095|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138180096|NCT00862745|Fesoterodine|fesoterodine|mesh-list
138180097|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138180098|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138180099|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180100|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180101|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197440|NCT00000292|Cocaine|cocaine|mesh-list
138180102|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180103|NCT00862745|Urological Agents|urological agents|mesh-ancestor
138180104|NCT02150759|Fentanyl|fentanyl|mesh-list
138180105|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
138180106|NCT02150759|Ketamine|ketamine|mesh-list
138180107|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138359464|NCT00358566|Gemcitabine|gemcitabine|mesh-list
138180108|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180109|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180110|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138180111|NCT02150759|Analgesics|analgesics|mesh-ancestor
138180112|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
138180113|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180114|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138180115|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138180116|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138180117|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180118|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180119|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180120|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138180121|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138180122|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
138180123|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
138180124|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138180125|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138180126|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138180127|NCT02150759|Narcotics|narcotics|mesh-ancestor
138180128|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138180129|NCT04991350|Bevacizumab|bevacizumab|mesh-list
138197468|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197480|NCT02548650|Aspirin|aspirin|mesh-list
138180130|NCT04991350|Ranibizumab|ranibizumab|mesh-list
138180131|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180132|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180133|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180134|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180135|NCT04991350|Growth Substances|growth substances|mesh-ancestor
138180136|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180137|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180138|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138180139|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
138180140|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180143|NCT04952194|Entacapone|entacapone|mesh-list
138180144|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138180145|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138180146|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
138180147|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180148|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180149|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180150|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138180151|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180152|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138180153|NCT00835159|Rivastigmine|rivastigmine|mesh-list
138180154|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138180155|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180156|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180157|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180158|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180159|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180160|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138180161|NCT00835159|Protective Agents|protective agents|mesh-ancestor
138180163|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
138180164|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
138180165|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180166|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180167|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
138197572|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138180168|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180169|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
138180171|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
138180173|NCT00827099|Tacrolimus|tacrolimus|mesh-list
138180174|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138180175|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180176|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138180177|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
138180178|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180179|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180180|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
138180181|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180182|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138197627|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180184|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138180185|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138180186|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
138180187|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138180188|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180189|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138180190|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
138180191|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138180192|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138180193|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138180194|NCT00366652|Desipramine|desipramine|mesh-list
138180195|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138180196|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180197|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180198|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180200|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180201|NCT00366652|Analgesics|analgesics|mesh-ancestor
138180202|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
138180203|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180204|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
138180205|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180206|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
138180207|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138180208|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180209|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138180210|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180211|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
138180212|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138180213|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180215|NCT02617888|Antacids|antacids|mesh-ancestor
138180216|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180217|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180218|NCT02625298|Pemetrexed|pemetrexed|mesh-list
138180219|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180220|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180221|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180222|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138180223|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138180224|NCT00858013|Glimepiride|glimepiride|mesh-list
138180225|NCT00858013|Nateglinide|nateglinide|mesh-list
138180226|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138180227|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180228|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180229|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180230|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
138180231|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
138180232|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180233|NCT00835861|Insulin|insulin|mesh-list
138180234|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138180235|NCT00835861|Metformin|metformin|mesh-list
138180236|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
138180237|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
138180238|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180239|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180240|NCT00804973|Sumatriptan|sumatriptan|mesh-list
138180241|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138180242|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138180243|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138180244|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
138180245|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180246|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180247|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180248|NCT02628106|Alprostadil|alprostadil|mesh-list
138180249|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138180250|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138180251|NCT02628106|Urological Agents|urological agents|mesh-ancestor
138180252|NCT02629354|Ibuprofen|ibuprofen|mesh-list
138180253|NCT02629354|Caffeine|caffeine|mesh-list
138180254|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138180255|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138180256|NCT02629354|Analgesics|analgesics|mesh-ancestor
138180257|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
138180258|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365119|NCT01390051|Tinzaparin|tinzaparin|mesh-list
138180260|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138180261|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180262|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138180263|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180264|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180265|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138180266|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138180267|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138180268|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138180269|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
138180270|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180272|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180273|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180274|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138180275|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180276|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
138180277|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
138180278|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138180279|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180280|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197779|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
138180282|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180283|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138180285|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
138180286|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
138180287|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138180288|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138180289|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180290|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138180291|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180292|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180295|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
138180296|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180297|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180298|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180299|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138180300|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180301|NCT02631772|Ribavirin|ribavirin|mesh-list
138180302|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
138180303|NCT02631772|Ledipasvir|ledipasvir|mesh-list
138180304|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
138180305|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180307|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180309|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180310|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180311|NCT00859339|Gemcitabine|gemcitabine|mesh-list
138180312|NCT00859339|Sunitinib|sunitinib|mesh-list
138180313|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180314|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138180315|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
138180316|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180317|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180318|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180319|NCT00859339|Growth Substances|growth substances|mesh-ancestor
138180320|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180321|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180322|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138180323|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180324|NCT00859495|Doxorubicin|doxorubicin|mesh-list
138180325|NCT00859495|Pemetrexed|pemetrexed|mesh-list
138180326|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180327|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138180328|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138180329|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138180330|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180331|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180332|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138180333|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138180334|NCT00355719|Ritonavir|ritonavir|mesh-list
138180335|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138180336|NCT00355719|Nevirapine|nevirapine|mesh-list
138197834|NCT02483936|Olmesartan|olmesartan|mesh-list
138180339|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
138180340|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180341|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180342|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138180343|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138180345|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180346|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138180347|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138180348|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138180349|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138180350|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138180351|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138180353|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
138180354|NCT00859651|Vitamins|vitamins|mesh-ancestor
138180355|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
138180356|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180357|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138180358|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138180359|NCT02633956|Atorvastatin|atorvastatin|mesh-list
138180360|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138180361|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138180362|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
138180363|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180364|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138180365|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138180366|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180367|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138180368|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
138180369|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180371|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
138180374|NCT02635828|Dexamethasone|dexamethasone|mesh-list
138180375|NCT02635828|Palonosetron|palonosetron|mesh-list
138180376|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138180377|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
138180378|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
138180379|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180380|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180381|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180382|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
138180383|NCT02635828|Hormones|hormones|mesh-ancestor
138180384|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138180385|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138180386|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180387|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138180388|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138180389|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
138180390|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180391|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180392|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
138180393|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138180394|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138180395|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138180396|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
138180397|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138180398|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138180399|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138180400|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197886|NCT00001282|Zidovudine|zidovudine|mesh-list
138180401|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
138180403|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
138180404|NCT02638168|Methylphenidate|methylphenidate|mesh-list
138180405|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138180406|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180407|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138180408|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180409|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180410|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180412|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180413|NCT00837031|Gemcitabine|gemcitabine|mesh-list
138180414|NCT00837031|Lenalidomide|lenalidomide|mesh-list
138180415|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138180416|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
138180417|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180418|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180419|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
138180420|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180421|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180422|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180423|NCT00837031|Growth Substances|growth substances|mesh-ancestor
138180424|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180425|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138180426|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138180428|NCT04344483|Epinephrine|epinephrine|mesh-list
138180429|NCT04344483|Racepinephrine|racepinephrine|mesh-list
138180430|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
138180431|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
138180432|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
138180434|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180436|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180437|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138180438|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138180439|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138180440|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180441|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180442|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138180444|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180445|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180446|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138180447|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138180448|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
138180449|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138180450|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180451|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
138180452|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
138180453|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138180454|NCT02154763|Ropivacaine|ropivacaine|mesh-list
138180455|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
138180456|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
138180457|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197964|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
138180458|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180459|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
138180460|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180462|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180463|NCT04964427|Methylphenidate|methylphenidate|mesh-list
138180464|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138180465|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180466|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138180467|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180468|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365371|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180469|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180470|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
138180471|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180472|NCT00357669|Brivaracetam|brivaracetam|mesh-list
138180473|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
138359476|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180474|NCT00863551|Trospium chloride|trospium chloride|mesh-list
138180475|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
138180476|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
138180477|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180478|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180479|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138180480|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138180481|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180482|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180483|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180484|NCT00863551|Urological Agents|urological agents|mesh-ancestor
138180486|NCT03838575|Gentamicins|gentamicins|mesh-list
138180487|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
138180489|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138180490|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
138180491|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138180492|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180493|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180495|NCT02620774|Ceftolozane|ceftolozane|mesh-list
138365406|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
138180497|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198105|NCT00001354|Zidovudine|zidovudine|mesh-list
138180499|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138180500|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180501|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180502|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138180503|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138180504|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138180505|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138180506|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
138180507|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180508|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138180509|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138180510|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180511|NCT04339816|Azithromycin|azithromycin|mesh-list
138180512|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
138180513|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138180514|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180515|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
138180516|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138180517|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138180518|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198123|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138180520|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180521|NCT05588908|Betamethasone|betamethasone|mesh-list
138180522|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138180523|NCT05588908|Antibodies|antibodies|mesh-list
138180524|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
138180525|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138180526|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
138180527|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180528|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180529|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138180530|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
138180532|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138180533|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138180534|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180535|NCT05588830|Belimumab|belimumab|mesh-list
138180536|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180537|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
138180538|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180539|NCT04740190|Carboplatin|carboplatin|mesh-list
138180540|NCT04740190|Talazoparib|talazoparib|mesh-list
138180541|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180542|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138180543|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180544|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180545|NCT00865969|Belinostat|belinostat|mesh-list
138180546|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180547|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138180548|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180549|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180551|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180552|NCT00866749|Cytarabine|cytarabine|mesh-list
138180553|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
138180554|NCT00866749|Doxorubicin|doxorubicin|mesh-list
138180555|NCT00866749|Methotrexate|methotrexate|mesh-list
138180556|NCT00866749|Vincristine|vincristine|mesh-list
138180557|NCT00866749|Daunorubicin|daunorubicin|mesh-list
138180558|NCT00866749|Asparaginase|asparaginase|mesh-list
138180559|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
138180560|NCT00866749|Thioguanine|thioguanine|mesh-list
138180561|NCT00866749|Pegaspargase|pegaspargase|mesh-list
138180562|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180563|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
138180564|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180565|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180566|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138180567|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
138180568|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180569|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180570|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138180571|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138180572|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138180573|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138180574|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180575|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138180576|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
138180577|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138180578|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138180579|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
138180580|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138180581|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138180582|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138180583|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
138180584|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180585|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138180586|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
138180587|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
138180588|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
138180589|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
138180590|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180591|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
138180592|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180593|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180594|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138180595|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
138180596|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180597|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180598|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138180600|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180601|NCT00867139|Oseltamivir|oseltamivir|mesh-list
138180602|NCT00867139|Ribavirin|ribavirin|mesh-list
138180603|NCT00867139|Zanamivir|zanamivir|mesh-list
138180604|NCT00867139|Amantadine|amantadine|mesh-list
138180606|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
138198226|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138180608|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180609|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180611|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138180612|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138180613|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
138180614|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180615|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180616|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138180617|NCT00867139|Analgesics|analgesics|mesh-ancestor
138180618|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
138180619|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180620|NCT05342818|Ondansetron|ondansetron|mesh-list
138180621|NCT05342818|Metoclopramide|metoclopramide|mesh-list
138180622|NCT05342818|Neostigmine|neostigmine|mesh-list
138180623|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
138180624|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
138180625|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180626|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180627|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180628|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
138180630|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138180631|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138180632|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
138180633|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180634|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180635|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138180636|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180637|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180638|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138180639|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138180640|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138180641|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
138180642|NCT00867217|Vitamin D|vitamin d|mesh-list
138180643|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
138180644|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
138180645|NCT00867217|Vitamins|vitamins|mesh-list
138180646|NCT00867217|Letrozole|letrozole|mesh-list
138180648|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180649|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138180650|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138180651|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180652|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138180653|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138180654|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180655|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180656|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138180657|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
138365535|NCT01392807|Naloxegol|naloxegol|mesh-list
138180658|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138180661|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180662|NCT00867451|Protective Agents|protective agents|mesh-ancestor
138180663|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180664|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180666|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180667|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180669|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180670|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180671|NCT05197270|Aflibercept|aflibercept|mesh-list
138180672|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180673|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180674|NCT05197270|Growth Substances|growth substances|mesh-ancestor
138180675|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180676|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180677|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180678|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
138180680|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180681|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138180682|NCT00889915|Methylphenidate|methylphenidate|mesh-list
138180683|NCT00889915|Amphetamine|amphetamine|mesh-list
138180684|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138180685|NCT00889915|Adderall|adderall|mesh-list
138180686|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138180687|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180688|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138180689|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180690|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138198425|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138180691|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180692|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
138180693|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180694|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
138180695|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
138180696|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180697|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180698|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138180699|NCT00841087|Insulin|insulin|mesh-list
138180700|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138180701|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
138180702|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
138180703|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180704|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180705|NCT02685436|Domperidone|domperidone|mesh-list
138180706|NCT02685436|Omeprazole|omeprazole|mesh-list
138180707|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138180708|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180709|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138180710|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180711|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180712|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
138180713|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
138180715|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180716|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138180717|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
138180718|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180719|NCT00841555|Temozolomide|temozolomide|mesh-list
138180720|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138180721|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
138365626|NCT01393288|Lorazepam|lorazepam|mesh-list
138180722|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180723|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180724|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138180726|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
138180727|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
138180728|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180729|NCT00868309|Antivenins|antivenins|mesh-list
138180730|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
138180731|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180732|NCT00368134|Vildagliptin|vildagliptin|mesh-list
138180733|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180734|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180735|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138180736|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
138198524|NCT00000658|Leucovorin|leucovorin|mesh-list
138180737|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180738|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180739|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
138180740|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138180742|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
138180743|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138180744|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
138180745|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180746|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
138180747|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138180748|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180749|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180750|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180751|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138180752|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138180753|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138180754|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180755|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180756|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180757|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138180758|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138198571|NCT00000658|Vitamins|vitamins|mesh-ancestor
138180759|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138180760|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180761|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180762|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180763|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138180764|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138180765|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
138180766|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138180767|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138180768|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
138180769|NCT02701582|Phenylephrine|phenylephrine|mesh-list
138180770|NCT02701582|Epinephrine|epinephrine|mesh-list
138180771|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
138180772|NCT02701582|Synephrine|synephrine|mesh-list
138180773|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138180774|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138180775|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180776|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180777|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180778|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180779|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138180780|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138180781|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
138180782|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180783|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138180784|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180785|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
138180786|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
138180787|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138180788|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138180789|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
138180790|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138180791|NCT02701582|Protective Agents|protective agents|mesh-ancestor
138180792|NCT00869791|Levodopa|levodopa|mesh-list
138180793|NCT00869791|Carbidopa|carbidopa|mesh-list
138198624|NCT00000664|Analgesics|analgesics|mesh-ancestor
138180795|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138180796|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138180797|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
138180798|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180799|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180800|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180801|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138180802|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180803|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138180804|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
138180805|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
138180806|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138180807|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138180808|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138180809|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
138180810|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180811|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138180812|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138180813|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180815|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138180816|NCT00895531|Narcotics|narcotics|mesh-ancestor
138198662|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
138180817|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180818|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180819|NCT00895531|Analgesics|analgesics|mesh-ancestor
138180820|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
138180821|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180822|NCT03215875|Torsemide|torsemide|mesh-list
138180823|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138180825|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
138180826|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180827|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138180828|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180829|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180830|NCT02710630|Dabigatran|dabigatran|mesh-list
138180831|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
138180832|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138180834|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180835|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180836|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
138180837|NCT02715700|Methadone|methadone|mesh-list
138180838|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138180839|NCT02715700|Narcotics|narcotics|mesh-ancestor
138180840|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180841|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180843|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
138180844|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180845|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
138180846|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180847|NCT00895921|Olanzapine|olanzapine|mesh-list
138180848|NCT00895921|Aripiprazole|aripiprazole|mesh-list
138180849|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
138180850|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
138180851|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180852|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180853|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180854|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138180855|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138180856|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180857|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180858|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138180859|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180861|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180862|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180863|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
138180864|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
138180865|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
138180866|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
138180867|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138180868|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138180869|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138180870|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138180871|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138180872|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138180873|NCT00883675|Carboplatin|carboplatin|mesh-list
138180874|NCT00883675|Docetaxel|docetaxel|mesh-list
138180875|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180876|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
138180877|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
138180878|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
138180879|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180881|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138180883|NCT03215407|Hormones|hormones|mesh-ancestor
138180884|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138180885|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180886|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138180887|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180889|NCT05310331|Antibodies|antibodies|mesh-list
138180890|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138180891|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180892|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
138180893|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
138180894|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
138180895|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180897|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180898|NCT00885079|Rebamipide|rebamipide|mesh-list
138180899|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138180900|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138180901|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138180902|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138180903|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
138359533|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138180904|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180905|NCT00885079|Protective Agents|protective agents|mesh-ancestor
138180906|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180907|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180908|NCT00896779|Ranibizumab|ranibizumab|mesh-list
138180909|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180910|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180911|NCT00896779|Growth Substances|growth substances|mesh-ancestor
138180912|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180913|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180914|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180915|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
138180916|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
138180917|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198928|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138180918|NCT03376477|Lenalidomide|lenalidomide|mesh-list
138180919|NCT03376477|Molgramostim|molgramostim|mesh-list
138180920|NCT03376477|Vaccines|vaccines|mesh-list
138180921|NCT03376477|Sargramostim|sargramostim|mesh-list
138180922|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138180923|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
138180924|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180925|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138180926|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138180927|NCT03376477|Growth Substances|growth substances|mesh-ancestor
138180928|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180929|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180930|NCT02726620|Lidocaine|lidocaine|mesh-list
138180931|NCT02726620|Atropine|atropine|mesh-list
138180932|NCT02726620|Terlipressin|terlipressin|mesh-list
138180933|NCT02726620|Phenylephrine|phenylephrine|mesh-list
138180934|NCT02726620|Dobutamine|dobutamine|mesh-list
138180935|NCT02726620|Dopamine|dopamine|mesh-list
138180936|NCT02726620|Milrinone|milrinone|mesh-list
138180937|NCT02726620|Isoproterenol|isoproterenol|mesh-list
138180938|NCT02726620|Vasopressins|vasopressins|mesh-list
138180940|NCT02726620|Norepinephrine|norepinephrine|mesh-list
138180941|NCT02726620|Ephedrine|ephedrine|mesh-list
138180942|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
138180943|NCT02726620|Bupivacaine|bupivacaine|mesh-list
138180944|NCT02726620|Ropivacaine|ropivacaine|mesh-list
138180945|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
138180946|NCT02726620|Tetracaine|tetracaine|mesh-list
138180947|NCT02726620|Prilocaine|prilocaine|mesh-list
138180948|NCT02726620|Mepivacaine|mepivacaine|mesh-list
138180949|NCT02726620|Benzocaine|benzocaine|mesh-list
138180950|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
138180951|NCT02726620|Procaine|procaine|mesh-list
138180952|NCT02726620|Anesthetics|anesthetics|mesh-list
138180954|NCT02726620|Sevoflurane|sevoflurane|mesh-list
138180955|NCT02726620|Desflurane|desflurane|mesh-list
138180956|NCT02726620|Isoflurane|isoflurane|mesh-list
138180957|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138180958|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
138180959|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138180960|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138180961|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180962|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
138180963|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180964|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138180965|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138180966|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138180967|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180968|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180969|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138199022|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138180970|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138359546|NCT00360984|Insulin|insulin|mesh-list
138180972|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138180973|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138180974|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138180975|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138180976|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180977|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180978|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138180979|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138180980|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
138180981|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138180982|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
138180985|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138180986|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138180987|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
138180988|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138180989|NCT02726620|Protective Agents|protective agents|mesh-ancestor
138180990|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138180991|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
138180992|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138180993|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138180994|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180995|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
138180996|NCT02726620|Coagulants|coagulants|mesh-ancestor
138180997|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138180998|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
138365888|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180999|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138181000|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181001|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138181002|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
138181003|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181004|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138181005|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138181006|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181009|NCT00887575|Carboplatin|carboplatin|mesh-list
138181010|NCT00887575|Sunitinib|sunitinib|mesh-list
138181011|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181012|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181013|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181014|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181015|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138181016|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181017|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138181018|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138181019|NCT00887575|Growth Substances|growth substances|mesh-ancestor
138181020|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181021|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138181022|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181023|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181024|NCT03352843|Primaquine|primaquine|mesh-list
138181025|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
138181026|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138181027|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138181028|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181029|NCT03238027|Durvalumab|durvalumab|mesh-list
138181030|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181031|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181032|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
138181033|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138181034|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138181035|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
138181036|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181038|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138181040|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181041|NCT00887965|Denosumab|denosumab|mesh-list
138181042|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138181043|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181044|NCT02729038|Gepotidacin|gepotidacin|mesh-list
138181045|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181046|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181047|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181048|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181049|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
138181050|NCT05311813|Enoxaparin|enoxaparin|mesh-list
138181051|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
138181052|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138181053|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138181054|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181055|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181056|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181057|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181059|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138181060|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138181064|NCT03214627|Trace Elements|trace elements|mesh-ancestor
138181065|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
138181066|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181067|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138181068|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181069|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181070|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181071|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181072|NCT03214393|Antibodies|antibodies|mesh-list
138181073|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
138181074|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181075|NCT00888979|Nicotine|nicotine|mesh-list
138181076|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138199159|NCT02168855|Nicotine|nicotine|mesh-list
138181077|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
138181078|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181079|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181080|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138366028|NCT01395433|Dexetimide|dexetimide|mesh-list
138181081|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138181082|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
138181083|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181084|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181086|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138181087|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138181088|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
138181089|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181090|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181091|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138366085|NCT01395667|Leucovorin|leucovorin|mesh-list
138181093|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
138181094|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181095|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138181096|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138181097|NCT02737072|Durvalumab|durvalumab|mesh-list
138181098|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181099|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181100|NCT05446480|Desloratadine|desloratadine|mesh-list
138181101|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138181102|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
138181103|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181104|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181105|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181106|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138181107|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138181108|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
138181109|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
138181110|NCT03213145|Rifampin|rifampin|mesh-list
138181111|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138181112|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
138181113|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181114|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181115|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
138181116|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138181117|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181118|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181119|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138181120|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138181121|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138181122|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138181123|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138181124|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138181126|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138181127|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181128|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181129|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181130|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
138181131|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138181132|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
138181133|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181134|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181135|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138181136|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
138181137|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138181138|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
138199253|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138181140|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181141|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138181142|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181143|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
138181144|NCT05446090|Protective Agents|protective agents|mesh-ancestor
138181145|NCT05444998|Paclitaxel|paclitaxel|mesh-list
138181146|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181147|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181148|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181149|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181150|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366185|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181151|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181152|NCT05444842|Insulin|insulin|mesh-list
138181153|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138181154|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181155|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181156|NCT04381741|Antibodies|antibodies|mesh-list
138181157|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138181158|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
138181159|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181161|NCT05444452|Everolimus|everolimus|mesh-list
138181162|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138181163|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181164|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181165|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181166|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181167|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
138181168|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181169|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181170|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181171|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181172|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138181173|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
138181174|NCT05444374|Bevacizumab|bevacizumab|mesh-list
138181175|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181176|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181177|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138181178|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138181179|NCT05444374|Growth Substances|growth substances|mesh-ancestor
138181180|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181181|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
138181182|NCT05444218|Amoxicillin|amoxicillin|mesh-list
138181183|NCT05444218|Metronidazole|metronidazole|mesh-list
138181184|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181185|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181186|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138181188|NCT01830361|Midostaurin|midostaurin|mesh-list
138181189|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181190|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181191|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181192|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181193|NCT01830517|Losartan|losartan|mesh-list
138181194|NCT01830517|Amlodipine|amlodipine|mesh-list
138181195|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181196|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138181197|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138181198|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181199|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138181200|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181201|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181202|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138181203|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138199316|NCT01200433|Analgesics|analgesics|mesh-ancestor
138181206|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181207|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181208|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
138181209|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
138181210|NCT05443360|Calcium|calcium|mesh-list
138181211|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138181212|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181213|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138181214|NCT05443360|Antacids|antacids|mesh-ancestor
138181215|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181216|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181217|NCT05443282|Hormones|hormones|mesh-list
138181218|NCT05443282|Estradiol|estradiol|mesh-list
138181219|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138199365|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138181221|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181222|NCT05443282|Estrogens|estrogens|mesh-ancestor
138181224|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181225|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181226|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
138181227|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181228|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181229|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138181230|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181231|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181232|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181233|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181234|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138181235|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138181236|NCT01830829|Tamsulosin|tamsulosin|mesh-list
138181237|NCT01830829|Dutasteride|dutasteride|mesh-list
138181238|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138181239|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138181240|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138181241|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181242|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181243|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181244|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181245|NCT01830829|Urological Agents|urological agents|mesh-ancestor
138181246|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138181247|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138181248|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181249|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138181250|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181251|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
138181252|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138181253|NCT03212755|Antibodies|antibodies|mesh-list
138181254|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
138181255|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
138181256|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181257|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
138181258|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138181259|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138181260|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181261|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
138181262|NCT05437822|Coagulants|coagulants|mesh-ancestor
138181265|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138181266|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181267|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181268|NCT03212053|Hemostatics|hemostatics|mesh-list
138181269|NCT03212053|Coagulants|coagulants|mesh-ancestor
138181270|NCT05311189|Trastuzumab|trastuzumab|mesh-list
138181271|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181272|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181273|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
138181274|NCT00369772|Hematinics|hematinics|mesh-ancestor
138181276|NCT03211897|Haloperidol|haloperidol|mesh-list
138181277|NCT03211897|Olanzapine|olanzapine|mesh-list
138181278|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
138181279|NCT03211897|Ziprasidone|ziprasidone|mesh-list
138181280|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138181281|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138181282|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181283|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181284|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138181285|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138181286|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138181288|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
138181289|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
138181290|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
138181291|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
138181292|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366344|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138181293|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181294|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
138181295|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
138181296|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181297|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181298|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138181299|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138181300|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138181301|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138181302|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
138181303|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138181304|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
138181305|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138181306|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138181308|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138181309|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138181310|NCT01831687|Analgesics|analgesics|mesh-ancestor
138181311|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
138181312|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181313|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181314|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181315|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181317|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138181318|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181319|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181320|NCT05441254|Paclitaxel|paclitaxel|mesh-list
138181321|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181322|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181323|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181324|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181325|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
138181326|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181327|NCT00369148|Nateglinide|nateglinide|mesh-list
138181328|NCT00369148|Mitiglinide|mitiglinide|mesh-list
138181329|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181330|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181331|NCT01832467|Cetuximab|cetuximab|mesh-list
138181332|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181333|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181334|NCT03211351|Dextrans|dextrans|mesh-list
138181335|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
138181336|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
138181337|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
138181339|NCT01832623|Vitamins|vitamins|mesh-ancestor
138181340|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
138181341|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181342|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138181343|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138181344|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138199698|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181345|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181346|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181347|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181349|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138181351|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181352|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181353|NCT02470390|Analgesics|analgesics|mesh-ancestor
138181354|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
138181355|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181356|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138181357|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138181358|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
138199753|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138181359|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
138181360|NCT00363532|Calcitonin|calcitonin|mesh-list
138181361|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
138181362|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138181363|NCT00363532|Katacalcin|katacalcin|mesh-list
138181364|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138181365|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181366|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138181367|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181368|NCT00363610|Pegaspargase|pegaspargase|mesh-list
138181369|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181370|NCT00363688|Penicillins|penicillins|mesh-list
138181371|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181372|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181374|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138181375|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
138181376|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
138181377|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
138181378|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
138181379|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181380|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181381|NCT04380181|Milrinone|milrinone|mesh-list
138181382|NCT04380181|Epinephrine|epinephrine|mesh-list
138181383|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138181384|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138181385|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181386|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199814|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
138181387|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181389|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138181390|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138181391|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
138181392|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181393|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138181394|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
138181395|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
138181396|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
138181397|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138181398|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138181399|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138181400|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181401|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138181402|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138181403|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181404|NCT04380181|Protective Agents|protective agents|mesh-ancestor
138181405|NCT01833559|Insulin|insulin|mesh-list
138181406|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138181407|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
138181408|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181409|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181412|NCT05394142|Spironolactone|spironolactone|mesh-list
138181413|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181414|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181415|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138181416|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
138181417|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181418|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138181419|NCT05394142|Diuretics|diuretics|mesh-ancestor
138181420|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
138181421|NCT00901225|Plerixafor|plerixafor|mesh-list
138181422|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138181423|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138181424|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
138181425|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181426|NCT05393050|Methotrexate|methotrexate|mesh-list
138181427|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138181428|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
138181429|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138181430|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181431|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181433|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181434|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181435|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138181436|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181437|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138181438|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181439|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
138181440|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181441|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138181443|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
138181444|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366709|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
138181445|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181446|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181447|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
138181448|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138181449|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
138181450|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138181451|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181452|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138181453|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138181454|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138181455|NCT03154996|Topotecan|topotecan|mesh-list
138181456|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138181457|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181458|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199998|NCT01203319|Vaccines|vaccines|mesh-list
138181459|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181460|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181462|NCT02475070|Vildagliptin|vildagliptin|mesh-list
138181463|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138181464|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181465|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181466|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181467|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138181468|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138181469|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181470|NCT00902161|Propranolol|propranolol|mesh-list
138181471|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138181472|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138181473|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181474|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366769|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
138181475|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181476|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181477|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138181478|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181479|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181481|NCT01834183|Tivozanib|tivozanib|mesh-list
138181482|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181483|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
138181484|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181485|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181486|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181487|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181488|NCT02478580|Modafinil|modafinil|mesh-list
138181489|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138181490|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181491|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138181492|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138181493|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138181494|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181496|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
138181497|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181498|NCT03210025|Methyldopa|methyldopa|mesh-list
138181499|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181500|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
138181501|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
138181502|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181503|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181504|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138181505|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138181506|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138181507|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181508|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181509|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181511|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
138181512|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181513|NCT03219853|Protective Agents|protective agents|mesh-ancestor
138200199|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
138181514|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181515|NCT03219853|Trace Elements|trace elements|mesh-ancestor
138181516|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
138181517|NCT02480998|Vaccines|vaccines|mesh-list
138181519|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181520|NCT03215797|Phenylephrine|phenylephrine|mesh-list
138181521|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
138181522|NCT03215797|Norepinephrine|norepinephrine|mesh-list
138181523|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
138181524|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138181525|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
138181526|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
138181527|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181528|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181529|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
138181530|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138181531|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
138181532|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
138200261|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181533|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138181534|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138181535|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181536|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181537|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181538|NCT03215797|Protective Agents|protective agents|mesh-ancestor
138181539|NCT02485834|Docetaxel|docetaxel|mesh-list
138181540|NCT02485834|Capecitabine|capecitabine|mesh-list
138181541|NCT02485834|Irinotecan|irinotecan|mesh-list
138181542|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181543|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181544|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181545|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
138181546|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181547|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181548|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
138181549|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138181550|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181551|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181553|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138181554|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138181555|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181556|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138181557|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
138181558|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181559|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181560|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138181561|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
138181562|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
138181563|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138181564|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138181565|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138181566|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138181567|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181568|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181569|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181570|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
138181572|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181573|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
138181574|NCT01834963|Interferons|interferons|mesh-list
138181577|NCT01834963|Fluorouracil|fluorouracil|mesh-list
138181578|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181579|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
138181580|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181581|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181582|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181583|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
138181584|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181585|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
138181586|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181588|NCT04380103|Capecitabine|capecitabine|mesh-list
138181589|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
138181590|NCT04380103|Irinotecan|irinotecan|mesh-list
138181591|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181592|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181593|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138181594|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138181595|NCT04380103|Growth Substances|growth substances|mesh-ancestor
138181596|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181597|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
138181598|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181599|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
138181600|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181601|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138181602|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181603|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181604|NCT01954966|Progesterone|progesterone|mesh-list
138181605|NCT01954966|Progestins|progestins|mesh-ancestor
138181606|NCT01954966|Hormones|hormones|mesh-ancestor
138181607|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181608|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181609|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138181610|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138181611|NCT03836599|Allopurinol|allopurinol|mesh-list
138181612|NCT03836599|Verinurad|verinurad|mesh-list
138181613|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
138181614|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181615|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181616|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
138181617|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181618|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138181619|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
138181620|NCT03836599|Protective Agents|protective agents|mesh-ancestor
138181621|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181622|NCT01839097|Prednisone|prednisone|mesh-list
138181623|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
138181624|NCT01839097|Doxorubicin|doxorubicin|mesh-list
138181625|NCT01839097|Vincristine|vincristine|mesh-list
138181626|NCT01839097|Belinostat|belinostat|mesh-list
138181627|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181629|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181630|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181631|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138366997|NCT04920708|Fulvestrant|fulvestrant|mesh-list
138181632|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
138181633|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181634|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181635|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138181636|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138181637|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138181638|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181639|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181640|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181641|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
138181643|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181644|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138181645|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181646|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181647|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181649|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138181650|NCT01835665|Nimodipine|nimodipine|mesh-list
138181651|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181652|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138181653|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138181654|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181655|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138181656|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181657|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181658|NCT01839175|Vaccines|vaccines|mesh-list
138181659|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138181660|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
138181661|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181662|NCT01839253|Atenolol|atenolol|mesh-list
138181663|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138181664|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138181665|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181666|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
138181667|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
138181668|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181669|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181670|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138181671|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138181672|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138181674|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181675|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181676|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
138181677|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181678|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
138181679|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181680|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
138181681|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181684|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
138181685|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181686|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181687|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138181689|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138181690|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138181691|NCT01839643|Analgesics|analgesics|mesh-ancestor
138181692|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
138181693|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181694|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181695|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181696|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181697|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138181698|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138181699|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181700|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181701|NCT04380025|Pycnogenols|pycnogenols|mesh-list
138181702|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138181703|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
138181704|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181705|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
138181706|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181708|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138181709|NCT01836679|Paclitaxel|paclitaxel|mesh-list
138181710|NCT01836679|Carboplatin|carboplatin|mesh-list
138181711|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138181712|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181713|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138181714|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138181715|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138181716|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181717|NCT00369538|Losartan|losartan|mesh-list
138181718|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138181721|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138181722|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138181723|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181724|NCT00369538|Diuretics|diuretics|mesh-ancestor
138181725|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
138181726|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181727|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138181728|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138181730|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138181732|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
138181733|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
138181734|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181735|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181737|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181738|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181740|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181741|NCT05451472|Calcium|calcium|mesh-list
138181742|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
138181743|NCT05451472|Hormones|hormones|mesh-list
138181744|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138367182|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181745|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181746|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181748|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138181749|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
138181750|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138181751|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181752|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181754|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181755|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181756|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
138181757|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181758|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138181759|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181760|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
138181761|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138181762|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138181763|NCT01839955|Quinacrine|quinacrine|mesh-list
138181764|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138181765|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367240|NCT03914820|Mitomycins|mitomycins|mesh-list
138181766|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181767|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181768|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181769|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
138181770|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138181771|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
138181772|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138181773|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181774|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
138181775|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138181776|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
138181777|NCT02494102|Modafinil|modafinil|mesh-list
138181778|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138181780|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138181781|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138181782|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138181783|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181784|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
138181785|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138181786|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138181787|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138181788|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138181789|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181790|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
138181791|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181792|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181793|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138200828|NCT00002716|Calcium|calcium|mesh-list
138181795|NCT01838395|Cytarabine|cytarabine|mesh-list
138181796|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138181797|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
138181798|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181799|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181800|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
138181801|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181802|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181803|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
138181804|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181805|NCT00422578|Tadalafil|tadalafil|mesh-list
138181806|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
138181807|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138181808|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138181809|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181810|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181811|NCT00422578|Urological Agents|urological agents|mesh-ancestor
138181812|NCT02494180|Midazolam|midazolam|mesh-list
138181813|NCT02494180|Fentanyl|fentanyl|mesh-list
138181814|NCT02494180|Diazepam|diazepam|mesh-list
138181815|NCT02494180|Meperidine|meperidine|mesh-list
138181816|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138181817|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138181818|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181819|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181820|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138181821|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138181822|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138181823|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138181824|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
138181825|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
138181826|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
138200946|NCT01049945|Hormones|hormones|mesh-ancestor
138181829|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181830|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138181832|NCT02494180|Analgesics|analgesics|mesh-ancestor
138181833|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
138181834|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181835|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
138181836|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
138181837|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
138181838|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181839|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138181840|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138181841|NCT02494336|Ropivacaine|ropivacaine|mesh-list
138181842|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
138181843|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
138367390|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
138181844|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181845|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181846|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
138181847|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181849|NCT02495038|Atracurium|atracurium|mesh-list
138181850|NCT02495038|Cisatracurium|cisatracurium|mesh-list
138181851|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138181852|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138181853|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138201000|NCT00002590|Leucovorin|leucovorin|mesh-list
138181854|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181855|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181856|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138181857|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138181858|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
138359607|NCT00362700|Clevudine|clevudine|mesh-list
138181859|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181860|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181862|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181863|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
138181864|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181865|NCT05450458|Sorbitol|sorbitol|mesh-list
138181866|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
138181867|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138181868|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
138181869|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181870|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
138181871|NCT05450458|Protective Agents|protective agents|mesh-ancestor
138181872|NCT05450458|Cathartics|cathartics|mesh-ancestor
138181873|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181874|NCT01720615|Remifentanil|remifentanil|mesh-list
138181875|NCT01720615|Propofol|propofol|mesh-list
138181876|NCT01720615|Sevoflurane|sevoflurane|mesh-list
138181877|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138181878|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181879|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181880|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138181881|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
138181882|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
138181883|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138181884|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138181885|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138181886|NCT01720615|Narcotics|narcotics|mesh-ancestor
138181887|NCT01720615|Analgesics|analgesics|mesh-ancestor
138181888|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
138181889|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181890|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
138181891|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
138181892|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138181893|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
138181894|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181895|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181896|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138181897|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138201091|NCT01676402|Vaccines|vaccines|mesh-list
138181898|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
138181899|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138181900|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
138181901|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181902|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181903|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138181904|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138181905|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
138181906|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138181907|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181908|NCT02504554|Vancomycin|vancomycin|mesh-list
138181909|NCT02504554|Omeprazole|omeprazole|mesh-list
138181910|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138181911|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181912|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138181913|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181914|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138181915|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181916|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181917|NCT01838473|Lobeline|lobeline|mesh-list
138181918|NCT01838473|Nicotine|nicotine|mesh-list
138181919|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138181920|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
138181921|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201149|NCT04330300|Protective Agents|protective agents|mesh-ancestor
138181922|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181923|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138181924|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138181925|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
138181926|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181927|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181928|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138181930|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
138181931|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
138181932|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181933|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181934|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181936|NCT01838707|Morphine|morphine|mesh-list
138181937|NCT01838707|Bupivacaine|bupivacaine|mesh-list
138181938|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
138181939|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
138181940|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181941|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181943|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181944|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138181945|NCT01838707|Narcotics|narcotics|mesh-ancestor
138181946|NCT01838707|Analgesics|analgesics|mesh-ancestor
138181947|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138181948|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138181949|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
138181950|NCT02506114|Ipilimumab|ipilimumab|mesh-list
138181951|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138181952|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181953|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138181954|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181955|NCT04920994|Bupivacaine|bupivacaine|mesh-list
138181956|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
138181957|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
138181958|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181959|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181960|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
138181961|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181962|NCT02506660|Dexamethasone|dexamethasone|mesh-list
138181963|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
138181964|NCT02506660|Bupivacaine|bupivacaine|mesh-list
138181965|NCT02506660|BB 1101|bb 1101|mesh-list
138181967|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
138181968|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
138181969|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181970|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181971|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138181972|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
138181974|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181975|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138181976|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181977|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
138181978|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181979|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181980|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
138181981|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
138201294|NCT00866840|Riluzole|riluzole|mesh-list
138181983|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
138181984|NCT02509624|Selonsertib|selonsertib|mesh-list
138181985|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138181986|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181987|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181988|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138181989|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138181990|NCT01726075|Somatostatin|somatostatin|mesh-list
138181991|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138181992|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181993|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138181994|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138181995|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138181996|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
138181997|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181998|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181999|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182000|NCT01726075|Hormones|hormones|mesh-ancestor
138182001|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182002|NCT00369694|Terlipressin|terlipressin|mesh-list
138182003|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138201341|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138182004|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138182006|NCT01721707|Brinzolamide|brinzolamide|mesh-list
138182007|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138182008|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138182009|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138182010|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182011|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182012|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
138182013|NCT05448586|Narcotics|narcotics|mesh-ancestor
138182014|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182015|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182016|NCT05448586|Analgesics|analgesics|mesh-ancestor
138182017|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
138182018|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182019|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
138182020|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
138182021|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138182022|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138182023|NCT01726465|Prednisolone|prednisolone|mesh-list
138182024|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
138182025|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138182026|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
138182027|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138182028|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182029|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
138182030|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
138201391|NCT01059851|Suvorexant|suvorexant|mesh-list
138182031|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182032|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182033|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182034|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
138182036|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182037|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138182038|NCT01726465|Protective Agents|protective agents|mesh-ancestor
138182039|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138182040|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182041|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
138182042|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182044|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
138182045|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138182047|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182048|NCT01726465|Antidotes|antidotes|mesh-ancestor
138182049|NCT01720303|Insulin|insulin|mesh-list
138182050|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138182051|NCT01720303|Repaglinide|repaglinide|mesh-list
138182052|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
138182053|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
138182054|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
138182055|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138182056|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182057|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138182058|NCT00912301|Cathartics|cathartics|mesh-ancestor
138182059|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182060|NCT04850638|Furosemide|furosemide|mesh-list
138182061|NCT04850638|Diuretics|diuretics|mesh-ancestor
138182062|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
138182063|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182064|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138182065|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182066|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182067|NCT01726777|Vitamin D|vitamin d|mesh-list
138182068|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
138182069|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
138182070|NCT01726777|Vitamins|vitamins|mesh-list
138182071|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
138182073|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138182074|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138182076|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
138182077|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182078|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
138182079|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182080|NCT05602038|Morphine|morphine|mesh-list
138182081|NCT05602038|Bupivacaine|bupivacaine|mesh-list
138182082|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
138182083|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
138182084|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182085|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182086|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
138182087|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182088|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138182089|NCT05602038|Narcotics|narcotics|mesh-ancestor
138182090|NCT05602038|Analgesics|analgesics|mesh-ancestor
138182091|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
138182092|NCT01722409|Sevoflurane|sevoflurane|mesh-list
138182093|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138182094|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182095|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182096|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182097|NCT01722409|Analgesics|analgesics|mesh-ancestor
138182098|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
138182099|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182100|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138182101|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138182102|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138182103|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
138182104|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182105|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182106|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138182107|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138182108|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
138182109|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
138201543|NCT00382954|Bortezomib|bortezomib|mesh-list
138182110|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138182111|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
138182112|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182113|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
138182114|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182116|NCT01727401|Fondaparinux|fondaparinux|mesh-list
138182118|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
138182119|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138182120|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
138182121|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182122|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182123|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
138182125|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138182126|NCT02513212|Fluorides|fluorides|mesh-list
138182127|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
138182128|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
138182129|NCT02513212|Protective Agents|protective agents|mesh-ancestor
138182130|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182131|NCT02513446|Itraconazole|itraconazole|mesh-list
138182132|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
138182133|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182134|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138182135|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138182136|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201566|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138182137|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182139|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138182141|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182142|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138182143|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138182144|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138182145|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182147|NCT00363844|Hormones|hormones|mesh-ancestor
138182148|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182149|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138182150|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
138182151|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182152|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182153|NCT04687800|Dexamethasone|dexamethasone|mesh-list
138182154|NCT04687800|Difluprednate|difluprednate|mesh-list
138182155|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182156|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
138182157|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
138182158|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182159|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182160|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182161|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
138182163|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182164|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138182165|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182166|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
138182167|NCT00864383|Rifampin|rifampin|mesh-list
138182168|NCT00864383|Isoniazid|isoniazid|mesh-list
138201616|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
138182169|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
138182171|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182172|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182173|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138182174|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138182175|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182176|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182177|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182178|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138182179|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
138182180|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
138182181|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138182182|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138182183|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138182184|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138182185|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138182186|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138182187|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138182188|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138201669|NCT03786796|Olaparib|olaparib|mesh-list
138182189|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138182191|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138182193|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
138182194|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138182195|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138182196|NCT05532072|Prednisolone|prednisolone|mesh-list
138182197|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
138182198|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138182199|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
138182200|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182201|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182202|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138182203|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182204|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
138182205|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182206|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
138182207|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182208|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182209|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
138182210|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
138201703|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182212|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182213|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
138182214|NCT05532072|Hormones|hormones|mesh-ancestor
138182215|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182216|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138182217|NCT05532072|Protective Agents|protective agents|mesh-ancestor
138182218|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138182220|NCT00864539|Calcium|calcium|mesh-list
138182221|NCT00864539|Vitamins|vitamins|mesh-ancestor
138182222|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
138182223|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182224|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138182225|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138182226|NCT00827255|Cyclosporine|cyclosporine|mesh-list
138182227|NCT00827255|Cyclosporins|cyclosporins|mesh-list
138182228|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182229|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182230|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182231|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
138182232|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182233|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
138182234|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182235|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
138182236|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182237|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138182239|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
138182240|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
138182241|NCT04627012|Tislelizumab|tislelizumab|mesh-list
138182242|NCT04627012|Lenvatinib|lenvatinib|mesh-list
138182243|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182244|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182245|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138182246|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182247|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138182248|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182249|NCT00866879|Sirolimus|sirolimus|mesh-list
138182250|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182251|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182252|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138182253|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182254|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
138182255|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182257|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182258|NCT02311920|Nivolumab|nivolumab|mesh-list
138182259|NCT02311920|Ipilimumab|ipilimumab|mesh-list
138182260|NCT02311920|Temozolomide|temozolomide|mesh-list
138182261|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182262|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182263|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138182264|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182265|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138182266|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
138182267|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
138182268|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
138182269|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138182270|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
138182271|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182272|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182273|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182274|NCT00828191|Progesterone|progesterone|mesh-list
138182275|NCT00828191|Progestins|progestins|mesh-ancestor
138182276|NCT00828191|Hormones|hormones|mesh-ancestor
138182277|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182278|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182279|NCT00867659|Cetrorelix|cetrorelix|mesh-list
138182280|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138182281|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
138182282|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182283|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182284|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
138182285|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182286|NCT05531058|Vaccines|vaccines|mesh-list
138182287|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
138368072|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
138182288|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182290|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138182291|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138182292|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182293|NCT00828347|Vitamins|vitamins|mesh-ancestor
138182294|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
138182295|NCT00829049|Adapalene|adapalene|mesh-list
138182296|NCT00829049|Tazarotene|tazarotene|mesh-list
138182297|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138182298|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182299|NCT00829049|Analgesics|analgesics|mesh-ancestor
138182300|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
138182301|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182302|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182303|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182304|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182305|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
138182306|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
138182307|NCT04303702|Oxytocin|oxytocin|mesh-list
138182308|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
138182309|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182310|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182311|NCT01727557|Anesthetics|anesthetics|mesh-list
138201839|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182312|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182313|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182314|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138182315|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182316|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138182318|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
138182319|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
138182320|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182321|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182322|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
138182323|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182325|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138182326|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138182327|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182328|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182329|NCT00869141|Timolol|timolol|mesh-list
138182331|NCT00869141|Dorzolamide|dorzolamide|mesh-list
138182332|NCT00869141|Brinzolamide|brinzolamide|mesh-list
138182333|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138182334|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138182335|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
138182336|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182337|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182338|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182339|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138182340|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138182341|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138182342|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138182343|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138182344|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138182345|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182346|NCT01722799|Paclitaxel|paclitaxel|mesh-list
138182347|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138182348|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182350|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
138182351|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
138182352|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182353|NCT01606176|Nabiximols|nabiximols|mesh-list
138182354|NCT01606176|Analgesics|analgesics|mesh-ancestor
138182355|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
138182356|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182357|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182358|NCT00913081|Quercetin|quercetin|mesh-list
138182359|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
138182360|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182361|NCT00913081|Protective Agents|protective agents|mesh-ancestor
138182362|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182363|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
138182364|NCT04077424|Vaccines|vaccines|mesh-list
138182365|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
138368154|NCT05064137|Listerine|listerine|mesh-list
138182366|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182368|NCT04077424|Coagulants|coagulants|mesh-ancestor
138182369|NCT01727869|Cetuximab|cetuximab|mesh-list
138182370|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138182371|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182372|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201920|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
138182374|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182375|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182376|NCT00371020|Heparin|heparin|mesh-list
138182377|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138182378|NCT00371020|Tinzaparin|tinzaparin|mesh-list
138182379|NCT00371020|Dalteparin|dalteparin|mesh-list
138182381|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138182382|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138182383|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182384|NCT04476628|Budesonide|budesonide|mesh-list
138182385|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182386|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138182387|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
138182388|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182389|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182390|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138182391|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
138182392|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
138182393|NCT04476628|Hormones|hormones|mesh-ancestor
138182394|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182395|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138182396|NCT01728181|Tivozanib|tivozanib|mesh-list
138182397|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182398|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138182399|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182400|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182401|NCT04378231|Amoxicillin|amoxicillin|mesh-list
138182404|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138182405|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182406|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182407|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138182408|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182409|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182410|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
138182411|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138182412|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
138182413|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182414|NCT01728571|Vitamin D|vitamin d|mesh-list
138182415|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
138182416|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
138182417|NCT01728571|Vitamins|vitamins|mesh-list
138182418|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
138182419|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182420|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138182421|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138182422|NCT00832637|Gemcitabine|gemcitabine|mesh-list
138182423|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138182424|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182425|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138182426|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
138182427|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182428|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138182429|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182430|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138182431|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182432|NCT00370240|Ropivacaine|ropivacaine|mesh-list
138182433|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
138182434|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
138182436|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182437|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
138182438|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182439|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
138182440|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138182441|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
138182442|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182443|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
138182444|NCT03408145|Protective Agents|protective agents|mesh-ancestor
138182445|NCT02475772|Cisplatin|cisplatin|mesh-list
138182446|NCT02475772|Doxorubicin|doxorubicin|mesh-list
138182447|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138182448|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182449|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138182450|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138182451|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138182453|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182454|NCT00915655|Ritonavir|ritonavir|mesh-list
138182455|NCT00915655|Darunavir|darunavir|mesh-list
138182456|NCT00915655|Lamivudine|lamivudine|mesh-list
138182457|NCT00915655|Zidovudine|zidovudine|mesh-list
138182458|NCT00915655|Abacavir|abacavir|mesh-list
138182459|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138182460|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138182461|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
138182462|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182463|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182464|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138182465|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138182466|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
138182467|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182468|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138182469|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138182470|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138182471|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138182472|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
138182473|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
138182474|NCT03835507|Hematinics|hematinics|mesh-ancestor
138182475|NCT05524974|Paclitaxel|paclitaxel|mesh-list
138182476|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
138182477|NCT05524974|Apatinib|apatinib|mesh-list
138182478|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138182479|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182480|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
138182481|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
138182482|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138182483|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182484|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138182485|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182486|NCT00870467|Adalimumab|adalimumab|mesh-list
138182487|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138202094|NCT00002974|Ifosfamide|ifosfamide|mesh-list
138182488|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182489|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182490|NCT00370318|Acetaminophen|acetaminophen|mesh-list
138182491|NCT00370318|Vaccines|vaccines|mesh-list
138182492|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138182493|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
138368385|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182494|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182495|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182496|NCT00370318|Analgesics|analgesics|mesh-ancestor
138182497|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
138182498|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182499|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
138182500|NCT01728961|Lumefantrine|lumefantrine|mesh-list
138182501|NCT01728961|Artemether|artemether|mesh-list
138182503|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
138182504|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138182505|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138182506|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182507|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
138182508|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138182509|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182510|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
138182511|NCT00872027|Escitalopram|escitalopram|mesh-list
138182512|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138182513|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138182514|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182515|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182516|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182517|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
138182518|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182519|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
138182520|NCT01854814|Losartan|losartan|mesh-list
138182521|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138182522|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182523|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138182524|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
138182525|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182526|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182527|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182528|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182529|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138182530|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138182531|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138182532|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138182533|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
138182534|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182535|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182536|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
138182537|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
138182538|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
138182539|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182540|NCT02576652|Tetracycline|tetracycline|mesh-list
138182541|NCT02576652|Demeclocycline|demeclocycline|mesh-list
138182542|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182543|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182544|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138182546|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182547|NCT01743742|Vitamins|vitamins|mesh-list
138182548|NCT01743742|Vitamin E|vitamin e|mesh-list
138182549|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
138182550|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182551|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
138182552|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182553|NCT01743742|Protective Agents|protective agents|mesh-ancestor
138182554|NCT01723735|Ezetimibe|ezetimibe|mesh-list
138182555|NCT01723735|Alirocumab|alirocumab|mesh-list
138182556|NCT01723735|Fenofibrate|fenofibrate|mesh-list
138182557|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138182558|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138182559|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
138182560|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182561|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138182562|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138182563|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138182564|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
138182565|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182566|NCT00872729|Cysteamine|cysteamine|mesh-list
138182567|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138182568|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182569|NCT04640376|Acetaminophen|acetaminophen|mesh-list
138182570|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182571|NCT04640376|Analgesics|analgesics|mesh-ancestor
138182572|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
138182573|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182574|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182576|NCT00832871|Mifepristone|mifepristone|mesh-list
138182577|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138182578|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
138182579|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182580|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182581|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138182582|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138182583|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138182584|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
138182585|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138182586|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138182587|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
138182588|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182589|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
138182590|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138182591|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138182592|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138182593|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182594|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182595|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182596|NCT01729663|Interferons|interferons|mesh-list
138182597|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
138182598|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
138182599|NCT01729663|Molgramostim|molgramostim|mesh-list
138182600|NCT01729663|Sargramostim|sargramostim|mesh-list
138182601|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
138182602|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182603|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
138182604|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182605|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
138182606|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182607|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138182608|NCT05530122|Adalimumab|adalimumab|mesh-list
138182609|NCT05530122|Infliximab|infliximab|mesh-list
138182611|NCT05530122|Ustekinumab|ustekinumab|mesh-list
138182612|NCT05530122|Vedolizumab|vedolizumab|mesh-list
138182613|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138182614|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182615|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182616|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
138182617|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182618|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182619|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
138182620|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182622|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
138182623|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138182624|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368639|NCT03071601|Prilocaine|prilocaine|mesh-list
138182625|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182627|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
138182628|NCT05518578|Huperzine A|huperzine a|mesh-list
138182629|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138182630|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182631|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182632|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138182633|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182634|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182635|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138182636|NCT05518578|Protective Agents|protective agents|mesh-ancestor
138182637|NCT05518500|Vaccines|vaccines|mesh-list
138182638|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
138182639|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182640|NCT03058978|Etonogestrel|etonogestrel|mesh-list
138182641|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138182642|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
138182643|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182644|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182645|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138182646|NCT00212134|Dipivefrin|dipivefrin|mesh-list
138182647|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138182648|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
138182649|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182650|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182651|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182653|NCT00913627|Naproxen|naproxen|mesh-list
138182654|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138182655|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182656|NCT00913627|Analgesics|analgesics|mesh-ancestor
138182658|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182659|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182660|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182661|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182662|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138182663|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182664|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182665|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
138182666|NCT04297176|Vancomycin|vancomycin|mesh-list
138182667|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182668|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182669|NCT05523102|Acetaminophen|acetaminophen|mesh-list
138182670|NCT05523102|Ketorolac|ketorolac|mesh-list
138182671|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182672|NCT05523102|Analgesics|analgesics|mesh-ancestor
138182673|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
138368740|NCT03011775|Analgesics|analgesics|mesh-ancestor
138182675|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182676|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
138182677|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138182678|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182679|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182680|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138182681|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182682|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182683|NCT03407209|Anesthetics|anesthetics|mesh-list
138182684|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
138182685|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182686|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182687|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
138182688|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182689|NCT03999268|Insulin|insulin|mesh-list
138182690|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138182691|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182692|NCT01729897|Fentanyl|fentanyl|mesh-list
138182693|NCT01729897|Propofol|propofol|mesh-list
138182694|NCT01729897|Etomidate|etomidate|mesh-list
138182695|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138182696|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182697|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182698|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138182699|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
138182700|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
138182701|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138182702|NCT01729897|Narcotics|narcotics|mesh-ancestor
138182704|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
138182705|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182706|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138182707|NCT01048177|Lidocaine|lidocaine|mesh-list
138182708|NCT01048177|Heparin|heparin|mesh-list
138182709|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
138182710|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
138182711|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182712|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182713|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
138182714|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182715|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138182716|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138182717|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138182718|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182719|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182720|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
138182722|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138182723|NCT02740582|Tolcapone|tolcapone|mesh-list
138182724|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138182725|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138182726|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138182727|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182728|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182729|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
138182730|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138182731|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138182732|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138182733|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182734|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
138182735|NCT05453266|Coagulants|coagulants|mesh-ancestor
138182736|NCT02740660|Caffeine|caffeine|mesh-list
138182737|NCT02740660|Albuterol|albuterol|mesh-list
138182738|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138182739|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182740|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138182741|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182742|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182743|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138182744|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138182746|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182747|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138182748|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
138182749|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182750|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138182751|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
138182752|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
138182753|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182754|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138182755|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138182756|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138182757|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
138182758|NCT03929068|Levodopa|levodopa|mesh-list
138182759|NCT03929068|Carbidopa|carbidopa|mesh-list
138182760|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138182761|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138182762|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138182763|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
138182764|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182765|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182766|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182767|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138182768|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182769|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138182770|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
138182771|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
138182772|NCT05516784|Clopidogrel|clopidogrel|mesh-list
138182773|NCT05516784|Ticagrelor|ticagrelor|mesh-list
138182774|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138182775|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138182776|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138182777|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138182778|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
138182779|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182780|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182781|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182782|NCT02571972|Timolol|timolol|mesh-list
138182783|NCT02571972|Dorzolamide|dorzolamide|mesh-list
138182784|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138182785|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138182786|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
138182787|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182788|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182789|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182790|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138182791|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138182792|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138182793|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182794|NCT04996134|Domperidone|domperidone|mesh-list
138182795|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
138182796|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
138182797|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182798|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182799|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182800|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138368938|NCT02293109|Leucovorin|leucovorin|mesh-list
138182801|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
138182802|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182803|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182804|NCT00371332|Minocycline|minocycline|mesh-list
138182805|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182806|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182807|NCT00842075|Pramlintide|pramlintide|mesh-list
138182808|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138202542|NCT00003124|Leuprolide|leuprolide|mesh-list
138182810|NCT00879359|Paclitaxel|paclitaxel|mesh-list
138182811|NCT00879359|Bevacizumab|bevacizumab|mesh-list
138182812|NCT00879359|Carboplatin|carboplatin|mesh-list
138182813|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138182814|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182815|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
138182816|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138182817|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138182818|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182819|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182820|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138182821|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182822|NCT00879359|Growth Substances|growth substances|mesh-ancestor
138182823|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182824|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138182825|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138182826|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138182827|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138182828|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138182829|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138182830|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182831|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182832|NCT00880997|Doxazosin|doxazosin|mesh-list
138182833|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138182834|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138182835|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138182836|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138368970|NCT02293109|Hormones|hormones|mesh-ancestor
138182838|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182839|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182840|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182843|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
138182844|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182845|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182846|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
138182847|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182848|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138182849|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138182850|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138182851|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182852|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182853|NCT02742532|Oxytocin|oxytocin|mesh-list
138182854|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
138182855|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138182856|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182857|NCT05521386|Caffeine|caffeine|mesh-list
138182858|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138182859|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182860|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138182861|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182862|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182863|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138182864|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138182865|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
138182866|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138182867|NCT00370630|Triamcinolone|triamcinolone|mesh-list
138182868|NCT00370630|Bevacizumab|bevacizumab|mesh-list
138369006|NCT01982630|Incretins|incretins|mesh-ancestor
138182869|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182870|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182871|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138182872|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182873|NCT00370630|Growth Substances|growth substances|mesh-ancestor
138182874|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182875|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
138182876|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182877|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
138182879|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182880|NCT04984980|Bevacizumab|bevacizumab|mesh-list
138182881|NCT04984980|Gemcitabine|gemcitabine|mesh-list
138182882|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
138182883|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182884|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182885|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138182886|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182887|NCT04984980|Growth Substances|growth substances|mesh-ancestor
138182888|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182889|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
138182890|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138182891|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
138182892|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182893|NCT00370786|Bevacizumab|bevacizumab|mesh-list
138182894|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182895|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182896|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138182897|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182898|NCT00370786|Growth Substances|growth substances|mesh-ancestor
138182899|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182900|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138182901|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138182902|NCT03387670|Simvastatin|simvastatin|mesh-list
138182903|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138182904|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138182905|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
138182906|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182907|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138182908|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138182909|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182910|NCT04979832|Metronidazole|metronidazole|mesh-list
138182911|NCT04979832|Fosfomycin|fosfomycin|mesh-list
138182912|NCT04979832|Molgramostim|molgramostim|mesh-list
138182913|NCT04979832|Sargramostim|sargramostim|mesh-list
138182914|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182915|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138182917|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138182918|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
138182919|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182920|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182922|NCT02740114|Bupivacaine|bupivacaine|mesh-list
138182923|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
138182924|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
138182925|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182926|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182927|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
138182928|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182929|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138182930|NCT02740114|Narcotics|narcotics|mesh-ancestor
138182931|NCT02740114|Analgesics|analgesics|mesh-ancestor
138182932|NCT00371410|Triamcinolone|triamcinolone|mesh-list
138182933|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138182934|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138182935|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138182936|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182937|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
138182939|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182940|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182941|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182942|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
138182943|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182944|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182945|NCT04295850|Aspirin|aspirin|mesh-list
138182946|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138182947|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138182948|NCT04295850|Analgesics|analgesics|mesh-ancestor
138182949|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
138182950|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182951|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182952|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182953|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138182954|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138182955|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138202669|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138182956|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182957|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138182958|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138182959|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182961|NCT02166905|Poly I-C|poly i-c|mesh-list
138182962|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138182963|NCT02166905|Poly ICLC|poly iclc|mesh-list
138182965|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
138182966|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182967|NCT02166905|Laxatives|laxatives|mesh-ancestor
138182968|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138182969|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
138182970|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182971|NCT02743078|Bevacizumab|bevacizumab|mesh-list
138182972|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182973|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182974|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138182975|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182976|NCT02743078|Growth Substances|growth substances|mesh-ancestor
138182977|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182978|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
138182979|NCT03323398|Durvalumab|durvalumab|mesh-list
138182980|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138182981|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182982|NCT00890981|Denosumab|denosumab|mesh-list
138182983|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138182984|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182986|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138182988|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182989|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182990|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138182991|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138182992|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
138182993|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182994|NCT04480138|Interferons|interferons|mesh-list
138182995|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182996|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
138182997|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138182998|NCT00371488|Lapatinib|lapatinib|mesh-list
138182999|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183000|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183001|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183002|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183003|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
138183004|NCT00883415|Hematinics|hematinics|mesh-ancestor
138183005|NCT04337632|Paclitaxel|paclitaxel|mesh-list
138183006|NCT04337632|Carboplatin|carboplatin|mesh-list
138183007|NCT04337632|Doxorubicin|doxorubicin|mesh-list
138183008|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138183009|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138183010|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183011|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
138183012|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
138183013|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
138183014|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183015|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138183016|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138183017|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183018|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183019|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138183020|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183021|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183022|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183024|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
138183025|NCT05348980|Synephrine|synephrine|mesh-list
138183026|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138183027|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
138183028|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
138183029|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183030|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183031|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
138183032|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138183033|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
138183034|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183035|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138183036|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138369289|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
138183037|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138202757|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183038|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183039|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183040|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183041|NCT05348980|Protective Agents|protective agents|mesh-ancestor
138183042|NCT00884585|Cyclosporine|cyclosporine|mesh-list
138183043|NCT00884585|Cyclosporins|cyclosporins|mesh-list
138183044|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183045|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183046|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183047|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
138183048|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183049|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
138183050|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183051|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183052|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183053|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138183054|NCT00884897|Oxytocin|oxytocin|mesh-list
138183055|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
138183056|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138183057|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183058|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
138183059|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138183060|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138183061|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138462779|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183062|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183063|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183064|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
138183065|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183066|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183067|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138183069|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
138183070|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138183071|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369333|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
138183072|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183074|NCT03384563|Analgesics|analgesics|mesh-ancestor
138183075|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
138183076|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183077|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138183078|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138183079|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183080|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183081|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183082|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183083|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
138183084|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
138183085|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183086|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183087|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183088|NCT02748070|Fluticasone|fluticasone|mesh-list
138183090|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183091|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
138183092|NCT02748070|Hormones|hormones|mesh-ancestor
138369367|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
138183093|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183094|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183095|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138183096|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183097|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183098|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
138183099|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183101|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183102|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183103|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138183105|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138183106|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183107|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183108|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183109|NCT05310383|Tislelizumab|tislelizumab|mesh-list
138183110|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183111|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183112|NCT05310305|Antibodies|antibodies|mesh-list
138183113|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
138183114|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183115|NCT05519670|Niraparib|niraparib|mesh-list
138183116|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138183117|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183118|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183119|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183120|NCT05519592|Ropivacaine|ropivacaine|mesh-list
138183121|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
138183122|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
138183123|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183124|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183125|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
138183126|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183127|NCT05519514|Budesonide|budesonide|mesh-list
138183128|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183129|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183130|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
138183131|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183132|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183133|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183134|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183135|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
138183137|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183140|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
138183141|NCT02756572|Sirolimus|sirolimus|mesh-list
138183142|NCT02756572|Fludarabine|fludarabine|mesh-list
138183143|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
138183144|NCT02756572|Melphalan|melphalan|mesh-list
138183145|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
138183146|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
138183147|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138183148|NCT02756572|Cladribine|cladribine|mesh-list
138183149|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138183150|NCT02756572|Cyclosporins|cyclosporins|mesh-list
138183151|NCT02756572|Lenograstim|lenograstim|mesh-list
138183152|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183153|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183154|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
138183155|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183156|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183157|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
138183158|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183159|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
138183160|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183161|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138183162|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183163|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
138183164|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183165|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183166|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138183167|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138183168|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138183169|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
138183170|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138202906|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183171|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183174|NCT02756572|Analgesics|analgesics|mesh-ancestor
138183175|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
138183176|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183177|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138183178|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183180|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138183181|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
138183182|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183183|NCT05131698|Lenvatinib|lenvatinib|mesh-list
138183184|NCT05131698|Tislelizumab|tislelizumab|mesh-list
138183185|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183186|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183187|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183188|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183189|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183190|NCT01724983|Fentanyl|fentanyl|mesh-list
138183191|NCT01724983|Ketamine|ketamine|mesh-list
138183192|NCT01724983|Analgesics|analgesics|mesh-ancestor
138183193|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
138183194|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183195|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183196|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138183197|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138183198|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
138183199|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
138183200|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183201|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138183202|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138183203|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183204|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183205|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183206|NCT01724983|Narcotics|narcotics|mesh-ancestor
138183207|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138183208|NCT02973958|Acetaminophen|acetaminophen|mesh-list
138183209|NCT02973958|Ibuprofen|ibuprofen|mesh-list
138183211|NCT02973958|Bupivacaine|bupivacaine|mesh-list
138183212|NCT02973958|Sevoflurane|sevoflurane|mesh-list
138183213|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
138183214|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
138183215|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183216|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183217|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
138183218|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183219|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183220|NCT02973958|Analgesics|analgesics|mesh-ancestor
138183221|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
138183222|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138183223|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183224|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183225|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138183226|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183227|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183228|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138183229|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138183230|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
138183231|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
138183232|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138183233|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183234|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
138183235|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183236|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183237|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183238|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183239|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138183240|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138183241|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183242|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183243|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183244|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183245|NCT05513976|Febuxostat|febuxostat|mesh-list
138183246|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
138183247|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183248|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
138183249|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138183250|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138183251|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
138183252|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183253|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138183255|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138183256|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
138183257|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
138183258|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183259|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183260|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
138183261|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183262|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
138183263|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138183264|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
138183265|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183266|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
138183267|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183268|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
138183269|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183271|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183272|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183273|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138183274|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138183275|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183276|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183277|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183278|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183279|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
138183280|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138183282|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138183283|NCT02760862|Mannitol|mannitol|mesh-list
138183284|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183285|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138183286|NCT02760862|Diuretics|diuretics|mesh-ancestor
138183287|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
138183288|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183289|NCT05720637|Serotonin|serotonin|mesh-list
138183290|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138183291|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
138183292|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183293|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183294|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183295|NCT05720559|Folic Acid|folic acid|mesh-list
138183296|NCT05720559|Vitamin A|vitamin a|mesh-list
138183297|NCT05720559|Metronidazole|metronidazole|mesh-list
138183298|NCT05720559|Capecitabine|capecitabine|mesh-list
138183299|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
138359651|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183300|NCT05720559|Cetuximab|cetuximab|mesh-list
138183301|NCT05720559|Vitamins|vitamins|mesh-ancestor
138183302|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
138183303|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183304|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183305|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
138183306|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183307|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183308|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183309|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183310|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183311|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138183312|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138183313|NCT05720559|Hematinics|hematinics|mesh-ancestor
138183314|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
138183315|NCT02761252|Montelukast|montelukast|mesh-list
138183316|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183317|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183318|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138183319|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138183320|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369744|NCT01400867|Clindamycin|clindamycin|mesh-list
138183321|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183322|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138183323|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138183324|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183325|NCT05714475|Pancrelipase|pancrelipase|mesh-list
138183326|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183327|NCT05443984|Esomeprazole|esomeprazole|mesh-list
138183328|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138183329|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183330|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138183331|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183332|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183333|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
138183334|NCT01725607|Anesthetics|anesthetics|mesh-list
138183335|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183336|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183337|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138183338|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183339|NCT01725607|Analgesics|analgesics|mesh-ancestor
138183340|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
138183341|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183342|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138183343|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138183344|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183345|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183346|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183347|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183348|NCT03304379|Celecoxib|celecoxib|mesh-list
138183349|NCT03304379|Diclofenac|diclofenac|mesh-list
138183350|NCT03304379|Fasinumab|fasinumab|mesh-list
138183351|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138183352|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183353|NCT03304379|Analgesics|analgesics|mesh-ancestor
138183354|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
138183355|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183356|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183357|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183358|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183359|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138183360|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138183361|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183362|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183363|NCT00915967|Vancomycin|vancomycin|mesh-list
138183364|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183365|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183366|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138183367|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183368|NCT05031078|Lidocaine|lidocaine|mesh-list
138183369|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183370|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
138203086|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183371|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
138203087|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
138183372|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183373|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
138183374|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183375|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138183376|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138183377|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138183378|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369829|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138183379|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183381|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183382|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183383|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183384|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183385|NCT03216395|Epinephrine|epinephrine|mesh-list
138183386|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138183387|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183388|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183389|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183390|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183391|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183392|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138183393|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183394|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
138183395|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183396|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183397|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183398|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
138183399|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
138183400|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138183401|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138183402|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183403|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
138183404|NCT02767492|Hormones|hormones|mesh-ancestor
138183405|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183406|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183407|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183408|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
138183409|NCT01044433|Capecitabine|capecitabine|mesh-list
138183411|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183412|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
138183413|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183414|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183415|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138359681|NCT00364806|Metoclopramide|metoclopramide|mesh-list
138183416|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183417|NCT03400969|Glycerol|glycerol|mesh-list
138183418|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138183419|NCT03400969|Protective Agents|protective agents|mesh-ancestor
138203114|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183420|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183421|NCT04334512|Vitamin D|vitamin d|mesh-list
138183422|NCT04334512|Vitamins|vitamins|mesh-list
138183423|NCT04334512|Azithromycin|azithromycin|mesh-list
138183424|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
138183425|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
138183426|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183427|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138183428|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183429|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183431|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138183432|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138183433|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369907|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138183434|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183435|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183436|NCT01043185|Lesogaberan|lesogaberan|mesh-list
138183437|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183438|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138183439|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
138183440|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
138183441|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183442|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183443|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183444|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138183445|NCT01042093|Clonidine|clonidine|mesh-list
138183446|NCT01042093|Epinephrine|epinephrine|mesh-list
138183447|NCT01042093|Ropivacaine|ropivacaine|mesh-list
138183448|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
138183449|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
138183450|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183451|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183452|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
138183453|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203153|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
138183455|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138183456|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183457|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183458|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183459|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138183460|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183461|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
138183462|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183463|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183464|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
138183465|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
138183466|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138183467|NCT01042093|Analgesics|analgesics|mesh-ancestor
138183468|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138183469|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
138183470|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138183471|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138183473|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183474|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183475|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138183476|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183478|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183479|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183480|NCT04737928|Latanoprost|latanoprost|mesh-list
138183481|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138183482|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138183484|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183485|NCT01041859|Narcotics|narcotics|mesh-ancestor
138183486|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183487|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183488|NCT01041859|Analgesics|analgesics|mesh-ancestor
138183489|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
138183490|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183491|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138183492|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138183493|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183494|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183495|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183496|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183497|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138183498|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
138183499|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183500|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138183501|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
138183502|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183503|NCT03400423|Caffeine|caffeine|mesh-list
138183504|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138183505|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183506|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138183507|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462780|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
138183508|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183509|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138183511|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
138183512|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183513|NCT01040845|Colchicine|colchicine|mesh-list
138183514|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138183515|NCT01040845|Norethindrone|norethindrone|mesh-list
138183516|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
138183517|NCT01040845|Estradiol|estradiol|mesh-list
138183518|NCT01040845|Estrogens|estrogens|mesh-ancestor
138183519|NCT01040845|Hormones|hormones|mesh-ancestor
138183520|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183521|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183522|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138183524|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138183525|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138183526|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
138183527|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183528|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138183529|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138183530|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138183531|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183532|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183533|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138183534|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138183535|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138183536|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138183537|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138183538|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
138183539|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183540|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183541|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138183542|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138183546|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183547|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
138359690|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
138183548|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183549|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183550|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183551|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183552|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
138183553|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138183554|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
138183555|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183556|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183557|NCT00372658|Lidocaine|lidocaine|mesh-list
138183558|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
138183559|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
138183560|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183562|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
138183563|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183564|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138183565|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138183566|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138370151|NCT01403662|Minocycline|minocycline|mesh-list
138183567|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183568|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183571|NCT01043029|Pioglitazone|pioglitazone|mesh-list
138183572|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138183573|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183574|NCT04282954|Esomeprazole|esomeprazole|mesh-list
138183575|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138203251|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
138183577|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138183578|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183579|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183581|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138183582|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183583|NCT04755712|Sufentanil|sufentanil|mesh-list
138183584|NCT04755712|Morphine|morphine|mesh-list
138183585|NCT04755712|Bupivacaine|bupivacaine|mesh-list
138183586|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
138183587|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
138183588|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183589|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183590|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
138183591|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183592|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183593|NCT04755712|Narcotics|narcotics|mesh-ancestor
138183594|NCT04755712|Analgesics|analgesics|mesh-ancestor
138183595|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138183596|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138183597|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
138183598|NCT02415712|Fomepizole|fomepizole|mesh-list
138183599|NCT02415712|Antidotes|antidotes|mesh-ancestor
138183600|NCT02415712|Protective Agents|protective agents|mesh-ancestor
138183601|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183602|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183603|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183604|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138183605|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183606|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183607|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138183608|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
138183609|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
138183610|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
138183611|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183612|NCT02973724|Remifentanil|remifentanil|mesh-list
138183614|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
138183615|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183616|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183617|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138203296|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183618|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138183619|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
138183620|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183621|NCT02973724|Narcotics|narcotics|mesh-ancestor
138183622|NCT02973724|Analgesics|analgesics|mesh-ancestor
138183623|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
138183624|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183627|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138183628|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183629|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138183630|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138183631|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138183632|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183633|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183634|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
138183635|NCT00889187|Capecitabine|capecitabine|mesh-list
138183636|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183637|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
138183638|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183639|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183640|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138183641|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138183642|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138183643|NCT04334824|Diuretics|diuretics|mesh-ancestor
138183644|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
138183645|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183646|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138183647|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183648|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183649|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138183650|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183651|NCT05314127|Fluorouracil|fluorouracil|mesh-list
138183653|NCT05314127|Tazarotene|tazarotene|mesh-list
138183654|NCT05314127|Petrolatum|petrolatum|mesh-list
138183655|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
138183656|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183657|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183658|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183659|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183660|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
138183661|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183662|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138183663|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
138183664|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183665|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
138183666|NCT05314127|Emollients|emollients|mesh-ancestor
138183667|NCT03130127|Terlipressin|terlipressin|mesh-list
138183668|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138183669|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138183670|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
138183671|NCT04225078|Loperamide|loperamide|mesh-list
138183672|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
138183673|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183674|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183675|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138183676|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183677|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183678|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183679|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183680|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183681|NCT00373048|Mefloquine|mefloquine|mesh-list
138183682|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
138183683|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138183684|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138183685|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183686|NCT00372892|Rituximab|rituximab|mesh-list
138183687|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183688|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183689|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
138183690|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183691|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183694|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183695|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138183696|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
138183697|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183698|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183699|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183700|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183701|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183702|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138183703|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138183704|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183705|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138183706|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183707|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183708|NCT03020303|Spironolactone|spironolactone|mesh-list
138183709|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138183710|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
138183711|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183712|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183713|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138183714|NCT03020303|Diuretics|diuretics|mesh-ancestor
138183715|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
138183716|NCT04825522|Vancomycin|vancomycin|mesh-list
138183717|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183718|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183719|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
138183720|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183721|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138183722|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
138183723|NCT00373282|Triamcinolone|triamcinolone|mesh-list
138183724|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138183725|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138183726|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138183727|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183728|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
138183729|NCT00373282|Hormones|hormones|mesh-ancestor
138183730|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183731|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183732|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183733|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
138183734|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188465|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183735|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183737|NCT04382027|Vitamin K|vitamin k|mesh-list
138183738|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
138183739|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
138183740|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183743|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183744|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
138183745|NCT04382027|Coagulants|coagulants|mesh-ancestor
138183746|NCT00896441|Citalopram|citalopram|mesh-list
138183747|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138183748|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138183749|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183750|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183753|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183754|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138183755|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
138183756|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138183757|NCT02790515|Sirolimus|sirolimus|mesh-list
138183758|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
138183759|NCT02790515|Melphalan|melphalan|mesh-list
138183760|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
138183761|NCT02790515|Thiotepa|thiotepa|mesh-list
138183762|NCT02790515|Rituximab|rituximab|mesh-list
138183763|NCT02790515|Fludarabine|fludarabine|mesh-list
138183764|NCT02790515|Blinatumomab|blinatumomab|mesh-list
138183765|NCT02790515|Tacrolimus|tacrolimus|mesh-list
138183766|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
138183767|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138183768|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183769|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
138183770|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183772|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183773|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
138183774|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183775|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183776|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138183777|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183778|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138183779|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183780|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183781|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183782|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138183783|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
138183785|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183786|NCT03400111|Analgesics|analgesics|mesh-ancestor
138183787|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
138183788|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183789|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183790|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
138183791|NCT03404791|Gemcitabine|gemcitabine|mesh-list
138183792|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138183793|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
138183794|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183795|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183796|NCT00918931|Obatoclax|obatoclax|mesh-list
138183797|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183798|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183799|NCT03404011|Glycerol|glycerol|mesh-list
138183800|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138183801|NCT03404011|Protective Agents|protective agents|mesh-ancestor
138183802|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183803|NCT01830491|Aspirin|aspirin|mesh-list
138183804|NCT01830491|Clopidogrel|clopidogrel|mesh-list
138183805|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138183806|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183807|NCT01830491|Analgesics|analgesics|mesh-ancestor
138183808|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
138183809|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183810|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183811|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183812|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183813|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138183814|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138370611|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138183815|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183816|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138183817|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138183818|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183819|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
138183820|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138183821|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138183822|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138183823|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
138183824|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183826|NCT02778880|Ketamine|ketamine|mesh-list
138183827|NCT02778880|Analgesics|analgesics|mesh-ancestor
138183828|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
138183829|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183830|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183831|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138183832|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138183833|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
138183834|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
138183835|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183836|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138183837|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138183838|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183839|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183840|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183841|NCT02778880|Narcotics|narcotics|mesh-ancestor
138183842|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138183843|NCT05310929|Labetalol|labetalol|mesh-list
138183844|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
138183845|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138183846|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138183847|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138183848|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
138183849|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183850|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183851|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183852|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138183853|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
138183854|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
138183855|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183856|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138183857|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138183859|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138183860|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183861|NCT02781454|Mexiletine|mexiletine|mesh-list
138183862|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138183863|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138183864|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138183865|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183866|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183867|NCT00892697|Ribavirin|ribavirin|mesh-list
138183868|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138183869|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
138183870|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183871|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
138183872|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183873|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138183874|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183875|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183876|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183877|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183878|NCT01831193|Curcumin|curcumin|mesh-list
138183879|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138183880|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183881|NCT01831193|Analgesics|analgesics|mesh-ancestor
138183882|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
138183883|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183884|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183885|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183886|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183887|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183888|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183889|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183890|NCT01831505|Prednisolone|prednisolone|mesh-list
138183891|NCT01831505|Rituximab|rituximab|mesh-list
138183892|NCT01831505|Doxorubicin|doxorubicin|mesh-list
138183893|NCT01831505|Vincristine|vincristine|mesh-list
138183894|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138183895|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183896|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183897|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
138183898|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183899|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138183900|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138183901|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138183902|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183903|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183904|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183905|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138183906|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
138183907|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
138183908|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
138183909|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138183910|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
138183911|NCT01831505|Hormones|hormones|mesh-ancestor
138183912|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183913|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138183914|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183915|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
138183916|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138183917|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183918|NCT03214055|Mannitol|mannitol|mesh-list
138183919|NCT03214055|Diuretics|diuretics|mesh-list
138183920|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138183921|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
138183922|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183923|NCT03405337|Factor VIII|factor viii|mesh-list
138183924|NCT03405337|Coagulants|coagulants|mesh-ancestor
138183925|NCT01831661|Metformin|metformin|mesh-list
138183926|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138183927|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203582|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138183930|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138183931|NCT03400267|Narcotics|narcotics|mesh-ancestor
138183932|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183933|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183934|NCT03400267|Analgesics|analgesics|mesh-ancestor
138183935|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
138183936|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183937|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138183938|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138183939|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
138183940|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
138183941|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183942|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
138183943|NCT01832051|Trastuzumab|trastuzumab|mesh-list
138183944|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183945|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183947|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
138183948|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
138183949|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
138183950|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
138183951|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183952|NCT01832129|Hematinics|hematinics|mesh-ancestor
138183953|NCT02903446|Denosumab|denosumab|mesh-list
138183954|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138183955|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183956|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
138183957|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138462781|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183958|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138183959|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183960|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183961|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138183962|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138183963|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138183964|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138183965|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183966|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183967|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
138203615|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138183968|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138183969|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
138183970|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138183971|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138183973|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138183976|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
138183977|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
138183978|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183979|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183980|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
138183981|NCT02903836|Nafithromycin|nafithromycin|mesh-list
138183982|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138183983|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183984|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138183985|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138183986|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183987|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183988|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183989|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138183991|NCT00014911|Pentamidine|pentamidine|mesh-list
138183992|NCT00014911|Trimethoprim|trimethoprim|mesh-list
138183993|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
138183994|NCT00014911|Ganciclovir|ganciclovir|mesh-list
138183995|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138183996|NCT00014911|Tacrolimus|tacrolimus|mesh-list
138183997|NCT00014911|Daclizumab|daclizumab|mesh-list
138183998|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138183999|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
138184000|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184001|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138184002|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370790|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138184003|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184004|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184005|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184006|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138184007|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184008|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
138203653|NCT00003742|Irinotecan|irinotecan|mesh-list
138184009|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138184011|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138184012|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184013|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138184014|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138184015|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138184016|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138184017|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
138184018|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138184019|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138184020|NCT01832675|Bupivacaine|bupivacaine|mesh-list
138184021|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184022|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
138184023|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184024|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184025|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
138184026|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184027|NCT03213587|Apatinib|apatinib|mesh-list
138184028|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184029|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138184030|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184031|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184032|NCT00013897|Lamivudine|lamivudine|mesh-list
138184033|NCT00013897|Zidovudine|zidovudine|mesh-list
138203688|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138462783|NCT05411757|Lenvatinib|lenvatinib|mesh-list
138184035|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138184036|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138184037|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138184038|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138184039|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184040|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184041|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
138184042|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184043|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138184044|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138184045|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
138184046|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138184047|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138184048|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138184050|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138184051|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138184052|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138184053|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138184054|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
138184056|NCT03219983|Ropivacaine|ropivacaine|mesh-list
138184057|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184058|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
138184059|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184060|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184061|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
138184062|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184063|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138184064|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138184065|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138184066|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138370873|NCT01407432|Folic Acid|folic acid|mesh-list
138184067|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184068|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184069|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184071|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
138184072|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184073|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
138184074|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184075|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
138184076|NCT02240017|Carboplatin|carboplatin|mesh-list
138184077|NCT02240017|Gemcitabine|gemcitabine|mesh-list
138184078|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184079|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184080|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
138184081|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184082|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
138184083|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184084|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
138184085|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
138184086|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184087|NCT03219593|Apatinib|apatinib|mesh-list
138184088|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184089|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138184090|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184091|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184092|NCT03836807|Ketoprofen|ketoprofen|mesh-list
138184093|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
138184094|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138184095|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184096|NCT03836807|Analgesics|analgesics|mesh-ancestor
138184097|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
138184098|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184099|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184100|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184101|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184102|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138184103|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184104|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184105|NCT02240173|Haloperidol|haloperidol|mesh-list
138184106|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
138184107|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
138184109|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184110|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184111|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184112|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138184113|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138184114|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184115|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184116|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138184117|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
138184118|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184119|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184120|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138184121|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
138184122|NCT02240641|Lacidipine|lacidipine|mesh-list
138184123|NCT02240641|Diuretics|diuretics|mesh-list
138184124|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138184125|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138184126|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138184127|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138184128|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
138184129|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184130|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138184131|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
138184132|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370970|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184133|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184134|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
138184135|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138184136|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184137|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184139|NCT03219671|Ipilimumab|ipilimumab|mesh-list
138184140|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184141|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184142|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138184143|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184144|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
138184145|NCT03404635|Apixaban|apixaban|mesh-list
138184146|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138184147|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
138184148|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138184149|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
138184150|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184151|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184152|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
138184153|NCT01832987|Trimethoprim|trimethoprim|mesh-list
138371007|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184154|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138184155|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
138184156|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138184157|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184158|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
138184159|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138203804|NCT00004030|Doxorubicin|doxorubicin|mesh-list
138184161|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138184163|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184164|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138184165|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138184166|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138184167|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184168|NCT03404479|Celecoxib|celecoxib|mesh-list
138184169|NCT03404479|Diacerein|diacerein|mesh-list
138184170|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138184171|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184172|NCT03404479|Analgesics|analgesics|mesh-ancestor
138184173|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
138184174|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184175|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184176|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184177|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184178|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138184179|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138184180|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184181|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184182|NCT04380467|Vitamin D|vitamin d|mesh-list
138184183|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
138184184|NCT04380467|Vitamins|vitamins|mesh-ancestor
138184185|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
138184186|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184187|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138184188|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184189|NCT03218657|Cyclosporine|cyclosporine|mesh-list
138184190|NCT03218657|Levamisole|levamisole|mesh-list
138184191|NCT03218657|Cyclosporins|cyclosporins|mesh-list
138184192|NCT03218657|Androgens|androgens|mesh-list
138184193|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184194|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184195|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184196|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
138184197|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184198|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
138184199|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184200|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184201|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184202|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138184203|NCT03218657|Hormones|hormones|mesh-ancestor
138184204|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184205|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138184206|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
138184207|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
138184208|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184209|NCT02240719|Everolimus|everolimus|mesh-list
138184210|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138184212|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138184213|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184214|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184215|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184216|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
138184217|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184218|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184219|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138184220|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
138184221|NCT01833299|Sorafenib|sorafenib|mesh-list
138184222|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
138184223|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184224|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138184225|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184226|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184227|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138184228|NCT01833299|Estrogens|estrogens|mesh-ancestor
138184229|NCT01833299|Hormones|hormones|mesh-ancestor
138184230|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184231|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184232|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138184234|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
138184235|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184236|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184237|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138184238|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184239|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138184240|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
138184241|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184243|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
138184244|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184245|NCT02240953|Warfarin|warfarin|mesh-list
138184246|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
138184247|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
138184248|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138184249|NCT02241031|Oprelvekin|oprelvekin|mesh-list
138184251|NCT03212807|Lenalidomide|lenalidomide|mesh-list
138184252|NCT03212807|Durvalumab|durvalumab|mesh-list
138184253|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
138184254|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184255|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138184256|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138184257|NCT03212807|Growth Substances|growth substances|mesh-ancestor
138184258|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184259|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184260|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184261|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
138184262|NCT01833767|Interleukin-2|interleukin-2|mesh-list
138184263|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184264|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
138184265|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184266|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359755|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184267|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138184268|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
138184269|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184270|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184271|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138184272|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184274|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
138184275|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184276|NCT03213353|Acetaminophen|acetaminophen|mesh-list
138184277|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
138184278|NCT03213353|Phenylephrine|phenylephrine|mesh-list
138184279|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
138184280|NCT03213353|Guaifenesin|guaifenesin|mesh-list
138184281|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138184282|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184283|NCT03213353|Analgesics|analgesics|mesh-ancestor
138184284|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
138184285|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184286|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184288|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138184289|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
138184290|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
138184291|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
138184292|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138184293|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
138184294|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
138184295|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138184296|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138184297|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138184298|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
138184299|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184300|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203951|NCT00004048|Antibodies|antibodies|mesh-list
138184301|NCT03213353|Protective Agents|protective agents|mesh-ancestor
138184303|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
138184304|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138184306|NCT01834235|Gemcitabine|gemcitabine|mesh-list
138184307|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138184308|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184309|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138184310|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138184311|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138184312|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184313|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184314|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
138184315|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
138184316|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138184317|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184318|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184319|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184320|NCT03211871|Analgesics|analgesics|mesh-ancestor
138184321|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
138184322|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184323|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138184324|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138184325|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138184326|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
138184327|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184328|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184329|NCT03838133|Bupivacaine|bupivacaine|mesh-list
138184330|NCT03838133|Ropivacaine|ropivacaine|mesh-list
138184331|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184332|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
138184333|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184334|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184335|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
138184336|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184337|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138184339|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138184340|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138184341|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
138184342|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184343|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138184344|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138184345|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184346|NCT00895193|Aspirin|aspirin|mesh-list
138184347|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138184348|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184349|NCT00895193|Analgesics|analgesics|mesh-ancestor
138184350|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
138184351|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184352|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184353|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184354|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184355|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138184356|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138184357|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184358|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138184359|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138184360|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184361|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
138204027|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138184362|NCT01834547|Caffeine|caffeine|mesh-list
138184363|NCT01834547|Methylphenidate|methylphenidate|mesh-list
138184364|NCT01834547|Modafinil|modafinil|mesh-list
138184365|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138184366|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184367|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138184368|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184369|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184370|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138184371|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138184372|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
138184373|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184374|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138184375|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138184376|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184377|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
138184378|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138184379|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138184380|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138184381|NCT03216941|Ketamine|ketamine|mesh-list
138184382|NCT03216941|Olanzapine|olanzapine|mesh-list
138184383|NCT03216941|Analgesics|analgesics|mesh-ancestor
138184384|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
138184385|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184386|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184387|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138184388|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138359776|NCT00367302|Buprenorphine|buprenorphine|mesh-list
138359777|NCT00367302|Methadone|methadone|mesh-list
138184389|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
138184390|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
138184391|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184392|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138184393|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138184394|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184395|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184397|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
138184398|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184399|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138184400|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138184402|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138184403|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138184404|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184405|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
138184406|NCT03216707|Capsaicin|capsaicin|mesh-list
138184407|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
138184408|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184409|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
138371418|NCT01411124|Analgesics|analgesics|mesh-ancestor
138184410|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184411|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184412|NCT01838993|Lidocaine|lidocaine|mesh-list
138184413|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184414|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
138184415|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184416|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184417|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
138184418|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184419|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138184420|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138184421|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138184422|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184423|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184424|NCT03211013|Oxytocin|oxytocin|mesh-list
138184425|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
138204101|NCT00003814|Eflornithine|eflornithine|mesh-list
138184426|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138184427|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184428|NCT01835561|Thalidomide|thalidomide|mesh-list
138184429|NCT01835561|Pomalidomide|pomalidomide|mesh-list
138184430|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
138184431|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184432|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138184433|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138184434|NCT01835561|Growth Substances|growth substances|mesh-ancestor
138184435|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184436|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184438|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
138184439|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184440|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184441|NCT01835639|Vitamin D|vitamin d|mesh-list
138184442|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
138184443|NCT01835639|Vitamins|vitamins|mesh-ancestor
138184444|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
138184445|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184446|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138184447|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184448|NCT01839149|Oxytocin|oxytocin|mesh-list
138184449|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
138184450|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138184451|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184452|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
138184453|NCT01839383|Calcium|calcium|mesh-list
138184454|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184455|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184456|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138184457|NCT00901199|Deferasirox|deferasirox|mesh-list
138184458|NCT00901199|Deferoxamine|deferoxamine|mesh-list
138184459|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138184460|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
138184461|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
138184462|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184463|NCT00901199|Siderophores|siderophores|mesh-ancestor
138184464|NCT01836341|Carboplatin|carboplatin|mesh-list
138184465|NCT01836341|Pemetrexed|pemetrexed|mesh-list
138184466|NCT01836341|Afatinib|afatinib|mesh-list
138184467|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184468|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184469|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184470|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138184471|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138184472|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138184473|NCT00906503|Dexamethasone|dexamethasone|mesh-list
138371595|NCT01412385|Antibodies|antibodies|mesh-list
138184474|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138184475|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184476|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
138184477|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
138184478|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184479|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184480|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184481|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
138184482|NCT00906503|Hormones|hormones|mesh-ancestor
138184483|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184484|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138184485|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184486|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138371644|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184487|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184489|NCT01836575|Pemetrexed|pemetrexed|mesh-list
138184490|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184491|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184492|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184493|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138184494|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138184495|NCT01836653|Bevacizumab|bevacizumab|mesh-list
138184496|NCT01836653|Cetuximab|cetuximab|mesh-list
138184497|NCT01836653|Fluorouracil|fluorouracil|mesh-list
138184498|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
138371707|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
138184499|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184500|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184501|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138184502|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138184503|NCT01836653|Growth Substances|growth substances|mesh-ancestor
138184504|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184505|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184507|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184508|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184509|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184510|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
138184511|NCT03836885|Apremilast|apremilast|mesh-list
138184512|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138184514|NCT03836885|Analgesics|analgesics|mesh-ancestor
138184515|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
138184516|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184517|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184518|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184519|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184520|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138184521|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138184522|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342257|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
138184523|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184525|NCT01837043|Abatacept|abatacept|mesh-list
138184526|NCT01837043|Tacrolimus|tacrolimus|mesh-list
138184527|NCT01837043|Cyclosporins|cyclosporins|mesh-list
138184528|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138184529|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184530|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
138184531|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184532|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184533|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184534|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
138184535|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184536|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184537|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184538|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138184539|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184540|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184541|NCT01839773|Paclitaxel|paclitaxel|mesh-list
138184542|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138184543|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204236|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
138184544|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184545|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
138184546|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
138184547|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
138184548|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184549|NCT00909155|Fluoxetine|fluoxetine|mesh-list
138184550|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138184551|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138184552|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138184553|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184554|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184555|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184556|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
138184557|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184558|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138184559|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
138184560|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184561|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138184562|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138184563|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184564|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138184565|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
138184566|NCT01839851|Hormones|hormones|mesh-ancestor
138184567|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184568|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184569|NCT01839929|Tacrolimus|tacrolimus|mesh-list
138184570|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184571|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
138342324|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
138184572|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204269|NCT00004102|Vitamins|vitamins|mesh-ancestor
138184573|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138184574|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184575|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184576|NCT04373083|Cemiplimab|cemiplimab|mesh-list
138184577|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184578|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184579|NCT03210545|Betamethasone|betamethasone|mesh-list
138184580|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184581|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
138184582|NCT03210545|Hormones|hormones|mesh-ancestor
138184583|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184584|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184585|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138184586|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
138184588|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138184589|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184590|NCT03403777|Avelumab|avelumab|mesh-list
138184591|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184592|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184594|NCT02241421|Vancomycin|vancomycin|mesh-list
138184595|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184596|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184597|NCT01837199|Amoxicillin|amoxicillin|mesh-list
138184598|NCT01837199|Metronidazole|metronidazole|mesh-list
138184599|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184600|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184601|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138184602|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184603|NCT00926185|Lifitegrast|lifitegrast|mesh-list
138184604|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138184605|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138184606|NCT02241499|Fluorouracil|fluorouracil|mesh-list
138184607|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
138184608|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
138184609|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184610|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184611|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184612|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184613|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
138184614|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184615|NCT01837667|Docetaxel|docetaxel|mesh-list
138184616|NCT01837667|LB100|lb100|mesh-list
138184617|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184618|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
138184619|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
138184620|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
138184621|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184622|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184623|NCT03833947|Dexamethasone|dexamethasone|mesh-list
138184624|NCT03833947|Lidocaine|lidocaine|mesh-list
138184625|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184626|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
138184627|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
138184628|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184629|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184630|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184631|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
138184632|NCT03833947|Hormones|hormones|mesh-ancestor
138184633|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184634|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138184635|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184636|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184637|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
138184638|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372028|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
138184639|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
138184640|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138184641|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138184642|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138184643|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184644|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184645|NCT03219437|Methotrexate|methotrexate|mesh-list
138184646|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138204359|NCT00004918|Sargramostim|sargramostim|mesh-list
138184647|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
138184648|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138184649|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184650|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184651|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
138184652|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184653|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184654|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184655|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184656|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138184657|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184658|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
138184659|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184661|NCT03212963|Clobetasol|clobetasol|mesh-list
138184662|NCT03212963|Halobetasol|halobetasol|mesh-list
138184663|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138184664|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184665|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
138184666|NCT03212963|Hormones|hormones|mesh-ancestor
138184667|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184668|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184669|NCT03218969|Ecopipam|ecopipam|mesh-list
138184670|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138184671|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138184672|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184673|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184674|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184676|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
138184677|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184678|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184679|NCT01830101|Temozolomide|temozolomide|mesh-list
138184680|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138184681|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
138184682|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184683|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184684|NCT01830335|Indomethacin|indomethacin|mesh-list
138184685|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138184686|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138184687|NCT01830335|Analgesics|analgesics|mesh-ancestor
138184688|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
138184689|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184690|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184691|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184692|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184693|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
138184694|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
138184695|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138184696|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138184697|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184698|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184699|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
138184700|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138184701|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184702|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184703|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138184704|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138184705|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184706|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184707|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184708|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184709|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
138184710|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
138184711|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138184712|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
138184713|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184714|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184715|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138184716|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
138184717|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
138184718|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138184719|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
138184720|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184721|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184722|NCT04371757|Doxazosin|doxazosin|mesh-list
138184723|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
138184724|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138184725|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138184726|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138184727|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138184728|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184729|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184730|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184731|NCT04371601|Oseltamivir|oseltamivir|mesh-list
138184732|NCT04371601|Hormones|hormones|mesh-list
138184733|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184734|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372153|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138184736|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184737|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184738|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184739|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
138184740|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
138184741|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138184742|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184743|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184744|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184745|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184746|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184747|NCT02242357|Telmisartan|telmisartan|mesh-list
138184748|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138184749|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138184750|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138184751|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184753|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
138184754|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
138184755|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184756|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184757|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184758|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138184759|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
138184760|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184761|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184762|NCT02242513|Lidocaine|lidocaine|mesh-list
138184763|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184764|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
138184765|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372199|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
138184766|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184767|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
138184768|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184769|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138184770|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138184771|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138184772|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184773|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184774|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138184775|NCT03409679|Murepavadin|murepavadin|mesh-list
138184776|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184777|NCT04371367|Avdoralimab|avdoralimab|mesh-list
138184778|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184779|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
138184780|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184781|NCT02242591|Ropivacaine|ropivacaine|mesh-list
138462784|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184782|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184783|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
138184784|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184785|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184786|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
138184787|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184788|NCT02982577|Pilocarpine|pilocarpine|mesh-list
138184790|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
138184791|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184792|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342713|NCT05315388|Vitamins|vitamins|mesh-list
138184793|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138184795|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
138184796|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184797|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184798|NCT01726205|Pregabalin|pregabalin|mesh-list
138184799|NCT01726205|Ropivacaine|ropivacaine|mesh-list
138184800|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
138184801|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
138184802|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184803|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184804|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
138184805|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184806|NCT01726205|Analgesics|analgesics|mesh-ancestor
138184807|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
138184808|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138372311|NCT01417494|Vitamins|vitamins|mesh-ancestor
138184809|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184810|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184811|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184812|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138184813|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138184814|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184815|NCT02242825|Telmisartan|telmisartan|mesh-list
138184816|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138184818|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138184819|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138184820|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184821|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138184822|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184823|NCT02242825|Diuretics|diuretics|mesh-ancestor
138184824|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
138184825|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184826|NCT04370977|Artesunate|artesunate|mesh-list
138184827|NCT04370977|Lumefantrine|lumefantrine|mesh-list
138184828|NCT04370977|Artemether|artemether|mesh-list
138184829|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138184830|NCT04370977|Amodiaquine|amodiaquine|mesh-list
138184831|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
138184832|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138184833|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184834|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184835|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184837|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
138184838|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138184839|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
138184840|NCT01726283|Riboflavin|riboflavin|mesh-list
138184841|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
138184842|NCT01726283|Vitamins|vitamins|mesh-ancestor
138184843|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
138184844|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184845|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138184846|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184847|NCT04370431|Edaravone|edaravone|mesh-list
138184848|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138184849|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
138184850|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184851|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138184852|NCT04370431|Protective Agents|protective agents|mesh-ancestor
138184853|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184854|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138184855|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184856|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184858|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184859|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
138184860|NCT03835871|Hormones|hormones|mesh-ancestor
138372406|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184861|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184862|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184863|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138184864|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
138184865|NCT03402295|Thalidomide|thalidomide|mesh-list
138184866|NCT03402295|Dexamethasone|dexamethasone|mesh-list
138184867|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
138184869|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184870|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
138184871|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184872|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184873|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138184874|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
138184875|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184876|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342836|NCT01746420|Becaplermin|becaplermin|mesh-list
138184877|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138184878|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138184879|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
138184880|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
138184881|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184882|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138184883|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
138184884|NCT03402295|Hormones|hormones|mesh-ancestor
138184885|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184886|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138184887|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
138184888|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138184889|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184890|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138184891|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138184892|NCT03402295|Growth Substances|growth substances|mesh-ancestor
138184893|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184894|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138184895|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138184896|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184897|NCT02244073|Insulin|insulin|mesh-list
138184898|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138184899|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359805|NCT00368160|Zopiclone|zopiclone|mesh-list
138342879|NCT01753362|Liraglutide|liraglutide|mesh-list
138184900|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184901|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138184902|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
138184903|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138184904|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
138184905|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138184906|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184908|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138184909|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184910|NCT03401827|Paclitaxel|paclitaxel|mesh-list
138184911|NCT03401827|Gemcitabine|gemcitabine|mesh-list
138184912|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138184913|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184914|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138184915|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138184916|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138184917|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372553|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138184918|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138184919|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
138184920|NCT00909545|Isradipine|isradipine|mesh-list
138184921|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138184922|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138184923|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184924|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184925|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138184926|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184927|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
138184928|NCT02244229|Tamsulosin|tamsulosin|mesh-list
138184929|NCT02244229|Finasteride|finasteride|mesh-list
138184930|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138184931|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138184932|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138184933|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
138184934|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184935|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184936|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184937|NCT02244229|Urological Agents|urological agents|mesh-ancestor
138184938|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138184939|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138184940|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184941|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
138184942|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138184943|NCT02157103|Bevacizumab|bevacizumab|mesh-list
138184944|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184945|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138184948|NCT02157103|Growth Substances|growth substances|mesh-ancestor
138184949|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184950|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184951|NCT00924001|Aldesleukin|aldesleukin|mesh-list
138184952|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
138184953|NCT00924001|Fludarabine|fludarabine|mesh-list
138184954|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138184955|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
138184956|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184957|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138184958|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138184959|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
138372660|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
138184960|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184961|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204715|NCT04895566|Antibodies|antibodies|mesh-list
138184962|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138184963|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138184964|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138184965|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
138184966|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138184967|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
138184968|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138184969|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138184970|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184971|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184972|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184974|NCT03401593|Fentanyl|fentanyl|mesh-list
138343034|NCT01786902|Hormones|hormones|mesh-list
138184975|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138184976|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138184977|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184978|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184979|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138184980|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138184981|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138184982|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138184983|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
138184984|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
138184985|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
138184986|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
138184987|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184988|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343084|NCT01794702|Decitabine|decitabine|mesh-list
138184989|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138184991|NCT03401593|Analgesics|analgesics|mesh-ancestor
138184992|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
138184993|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138184994|NCT03401515|Propranolol|propranolol|mesh-list
138184995|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138184996|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138184997|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
138184998|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138184999|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185000|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185001|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185002|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138185003|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
138185004|NCT01726829|Pancrelipase|pancrelipase|mesh-list
138185005|NCT01726829|Pancreatin|pancreatin|mesh-list
138185006|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185007|NCT03834233|Nivolumab|nivolumab|mesh-list
138185008|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185009|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185010|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138185011|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185012|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
138185013|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138185014|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138372830|NCT01420913|Pregabalin|pregabalin|mesh-list
138185016|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
138185017|NCT04367155|Coagulants|coagulants|mesh-ancestor
138185018|NCT01727453|Warfarin|warfarin|mesh-list
138185019|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
138185020|NCT01727531|Chloroquine|chloroquine|mesh-list
138185021|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138185022|NCT01727531|Amebicides|amebicides|mesh-ancestor
138185023|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185024|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185025|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185026|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
138185027|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185028|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138185029|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138185030|NCT01727531|Analgesics|analgesics|mesh-ancestor
138185031|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
138185032|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343207|NCT06019520|Antioxidants|antioxidants|mesh-ancestor
138185033|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185034|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185035|NCT01727531|Filaricides|filaricides|mesh-ancestor
138185036|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
138185037|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
138359810|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
138185038|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
138185039|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138185040|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138185041|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185042|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138185043|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185044|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372890|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138185045|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185046|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185047|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138185048|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
138185049|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138185050|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185051|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138185052|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138185053|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138185054|NCT00929071|Lidocaine|lidocaine|mesh-list
138185056|NCT00929071|Anesthetics|anesthetics|mesh-list
138185057|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185058|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185059|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
138185060|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185061|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185062|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138185063|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138185064|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185065|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185066|NCT01721525|Ribavirin|ribavirin|mesh-list
138185067|NCT01721525|Paclitaxel|paclitaxel|mesh-list
138185068|NCT01721525|Carboplatin|carboplatin|mesh-list
138185069|NCT01721525|Afatinib|afatinib|mesh-list
138185070|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138185071|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185072|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
138185073|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
138185074|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
138185075|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185076|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
138185077|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
138185079|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138185080|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185081|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
138185082|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138185083|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138185084|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185088|NCT01721915|Vitamins|vitamins|mesh-ancestor
138185089|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
138185090|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185091|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138185092|NCT04357483|Thrombin|thrombin|mesh-list
138185093|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
138185094|NCT04357483|Coagulants|coagulants|mesh-ancestor
138185095|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
138185096|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138185097|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185099|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138185100|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185101|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138185102|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138185103|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185104|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185105|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
138185106|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185108|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185109|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185110|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138185111|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185112|NCT01722227|Liraglutide|liraglutide|mesh-list
138185113|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185114|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185115|NCT01722227|Incretins|incretins|mesh-ancestor
138185116|NCT01722227|Hormones|hormones|mesh-ancestor
138185117|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185118|NCT01722305|Dexamethasone|dexamethasone|mesh-list
138185119|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
138185120|NCT01722305|Pomalidomide|pomalidomide|mesh-list
138185121|NCT01722305|Ichthammol|ichthammol|mesh-list
138185122|NCT01722305|BB 1101|bb 1101|mesh-list
138185123|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185124|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
138185125|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
138185126|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185127|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185128|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185130|NCT01722305|Hormones|hormones|mesh-ancestor
138185131|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185132|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138185133|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185134|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
138185135|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343420|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
138185136|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185137|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
138185138|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138185139|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138185140|NCT01722305|Growth Substances|growth substances|mesh-ancestor
138185141|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
138185142|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
138185143|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138185144|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185145|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185146|NCT04365517|Incretins|incretins|mesh-ancestor
138185147|NCT04365517|Hormones|hormones|mesh-ancestor
138185148|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185149|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138185150|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
138185151|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185152|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185153|NCT03406871|Nivolumab|nivolumab|mesh-list
138185154|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185156|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138185157|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185158|NCT04357093|Listerine|listerine|mesh-list
138185159|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
138185160|NCT04357093|Fluorides|fluorides|mesh-list
138185161|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
138185162|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
138185163|NCT04357093|Protective Agents|protective agents|mesh-ancestor
138185164|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185165|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138185166|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185167|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138185168|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185169|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
138185170|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185172|NCT03406793|Zinc|zinc|mesh-list
138185173|NCT03406793|Trace Elements|trace elements|mesh-ancestor
138185174|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
138185175|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185176|NCT04365127|Progesterone|progesterone|mesh-list
138185177|NCT04365127|Progestins|progestins|mesh-ancestor
138185178|NCT04365127|Hormones|hormones|mesh-ancestor
138185179|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185180|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185181|NCT00929383|Hemostatics|hemostatics|mesh-list
138185182|NCT00929383|Coagulants|coagulants|mesh-ancestor
138185183|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
138185185|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
138185186|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138185187|NCT01722539|Albendazole|albendazole|mesh-list
138185188|NCT01722539|Praziquantel|praziquantel|mesh-list
138185189|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
138185190|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185191|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185192|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185193|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138185194|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185195|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185196|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138185197|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
138185198|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
138185199|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138185200|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
138185201|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
138185202|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138185203|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185204|NCT03406403|Anesthetics|anesthetics|mesh-list
138185205|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185206|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185207|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
138185208|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
138185209|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
138185210|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138185211|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138185212|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185213|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185214|NCT03406169|Urological Agents|urological agents|mesh-ancestor
138185215|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138185216|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138185217|NCT03406169|Protective Agents|protective agents|mesh-ancestor
138185218|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185219|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138185220|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
138185221|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
138185222|NCT04357015|Carbetocin|carbetocin|mesh-list
138185223|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138185224|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138185225|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185226|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
138185227|NCT04357015|Coagulants|coagulants|mesh-ancestor
138185228|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
138185229|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138373168|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138185230|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185231|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138185232|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138185233|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138185234|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185235|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
138185236|NCT03406091|Plerixafor|plerixafor|mesh-list
138185237|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138185238|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138185239|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
138185240|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185241|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
138185242|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
138185243|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185244|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185245|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185246|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185247|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185248|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185249|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138185250|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
138185251|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185252|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138185253|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138185254|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
138185255|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185256|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185257|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138185258|NCT02245243|Delafloxacin|delafloxacin|mesh-list
138185259|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185260|NCT01728935|Tenofovir|tenofovir|mesh-list
138185261|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
138373208|NCT01423123|Paclitaxel|paclitaxel|mesh-list
138185262|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185263|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138185264|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138185265|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185266|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185267|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138185268|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138185269|NCT03833999|Ondansetron|ondansetron|mesh-list
138185270|NCT03833999|Lactulose|lactulose|mesh-list
138185271|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
138185272|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
138185273|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185274|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185275|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185276|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
138185277|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
138185278|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138185279|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138185280|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
138185281|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373247|NCT01423305|Budesonide|budesonide|mesh-list
138185282|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185283|NCT04379219|Methotrexate|methotrexate|mesh-list
138185284|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138185285|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
138185286|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138204966|NCT00603109|Hormones|hormones|mesh-ancestor
138185287|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185288|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185290|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185291|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185292|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138185293|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185294|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138185295|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185296|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
138185297|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185298|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138185300|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
138185301|NCT04347031|Mefloquine|mefloquine|mesh-list
138185302|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138185303|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185304|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
138185305|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185306|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185307|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185308|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185309|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185310|NCT02906566|Vitamin A|vitamin a|mesh-list
138185311|NCT02906566|Vitamins|vitamins|mesh-ancestor
138185312|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
138185313|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185314|NCT00913133|Desirudin|desirudin|mesh-list
138185316|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138185317|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138185318|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185319|NCT00373126|Nicotine|nicotine|mesh-list
138185320|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138185321|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
138185322|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185323|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185324|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138185325|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138185326|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
138185327|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185328|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185330|NCT04378283|Epinephrine|epinephrine|mesh-list
138185331|NCT04378283|Tetracaine|tetracaine|mesh-list
138185332|NCT04378283|Anesthetics|anesthetics|mesh-list
138185333|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138185334|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185335|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185336|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
138185337|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185338|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185339|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138185340|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138185341|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185342|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185343|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138185344|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138185346|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185347|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138185348|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138185349|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
138185350|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138185351|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138185352|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
138185353|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
138185354|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138185356|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138185357|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138185358|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138185359|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
138185360|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185361|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185362|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185364|NCT02789410|Hydromorphone|hydromorphone|mesh-list
138185365|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138185366|NCT02789410|Narcotics|narcotics|mesh-ancestor
138185367|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185368|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185369|NCT02789410|Analgesics|analgesics|mesh-ancestor
138185370|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
138205097|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
138185371|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185372|NCT01729481|Leucovorin|leucovorin|mesh-list
138185373|NCT01729481|Folic Acid|folic acid|mesh-list
138185374|NCT01729481|Gemcitabine|gemcitabine|mesh-list
138185376|NCT01729481|Irinotecan|irinotecan|mesh-list
138185377|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
138185378|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185379|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
138185380|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185381|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185382|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138185383|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185384|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185385|NCT01729481|Antidotes|antidotes|mesh-ancestor
138185386|NCT01729481|Protective Agents|protective agents|mesh-ancestor
138185387|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185388|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
138185389|NCT01729481|Vitamins|vitamins|mesh-ancestor
138185390|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
138185391|NCT01729481|Hematinics|hematinics|mesh-ancestor
138185392|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
138185393|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138185394|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
138373519|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
138185396|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185397|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138185398|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
138185399|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
138185400|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138185401|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
138185402|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185403|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185404|NCT02793154|Exenatide|exenatide|mesh-list
138185405|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
138185406|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185407|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185409|NCT02793154|Incretins|incretins|mesh-ancestor
138185410|NCT02793154|Hormones|hormones|mesh-ancestor
138185411|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185413|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185414|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138185415|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138185416|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138185417|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185418|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185419|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138205149|NCT00004924|Irinotecan|irinotecan|mesh-list
138185420|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185421|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185422|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
138185423|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185426|NCT02909140|Epinephrine|epinephrine|mesh-list
138185427|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
138185428|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
138185429|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
138185430|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
138185431|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185432|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185433|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
138185434|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185435|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185436|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138185438|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185439|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185440|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138185441|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138185442|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
138185443|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185444|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138185445|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138185446|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
138343792|NCT04921527|Chiauranib|chiauranib|mesh-list
138185448|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
138185449|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
138185450|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
138185451|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138185452|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138185453|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
138185454|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138185455|NCT02909140|Protective Agents|protective agents|mesh-ancestor
138185456|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
138185457|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138185458|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138185459|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
138185461|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185462|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138185463|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185464|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185465|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
138185466|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185467|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
138185469|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185470|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138185471|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
138185472|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185473|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185474|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138185476|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138185477|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185478|NCT04364425|Triamcinolone|triamcinolone|mesh-list
138185479|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138185480|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138185481|NCT04364425|Lidocaine|lidocaine|mesh-list
138185482|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138185483|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
138185484|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
138185485|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185486|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185487|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
138185488|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185489|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185490|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138185491|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138185492|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373714|NCT01425658|Clonidine|clonidine|mesh-list
138185493|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185494|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185495|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
138185497|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185498|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185499|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
138185500|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185501|NCT02911324|Nabilone|nabilone|mesh-list
138185502|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
138185503|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
138185504|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185505|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185506|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185507|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138185508|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138185509|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185510|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138185511|NCT01729403|Metformin|metformin|mesh-list
138185512|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185513|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185514|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138185515|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185516|NCT04355455|Citalopram|citalopram|mesh-list
138185517|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138185518|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138185519|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185520|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185521|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185523|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185524|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138185525|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
138185526|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138185527|NCT00913913|Bevacizumab|bevacizumab|mesh-list
138185528|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185529|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185530|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138185531|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138185532|NCT00913913|Growth Substances|growth substances|mesh-ancestor
138185533|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185534|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
138185535|NCT00373594|Rituximab|rituximab|mesh-list
138185536|NCT00373594|Fludarabine|fludarabine|mesh-list
138185537|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373827|NCT05385861|Irinotecan|irinotecan|mesh-list
138185539|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
138185540|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185541|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185542|NCT03403829|Gemcitabine|gemcitabine|mesh-list
138185543|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185544|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
138185545|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185546|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185547|NCT04364113|Benzocaine|benzocaine|mesh-list
138185548|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138185549|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
138185550|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205324|NCT00004204|Temozolomide|temozolomide|mesh-list
138185551|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185552|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
138185553|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185554|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
138185555|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138185556|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185557|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
138185558|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138185559|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138185560|NCT03834935|Analgesics|analgesics|mesh-ancestor
138185561|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
138185562|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185563|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185564|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185565|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185566|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138185567|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185568|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
138185569|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138185570|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185571|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185572|NCT02796352|Interleukin-2|interleukin-2|mesh-list
138185573|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185574|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138185575|NCT02796352|Analgesics|analgesics|mesh-ancestor
138185576|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
138373923|NCT04809103|Cisplatin|cisplatin|mesh-list
138185577|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185578|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185580|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138185581|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138185582|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185583|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185584|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138185585|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
138185587|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185588|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185589|NCT04347187|Anticoagulants|anticoagulants|mesh-list
138185590|NCT00920075|Alendronate|alendronate|mesh-list
138185591|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138185592|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185593|NCT04364035|Vesatolimod|vesatolimod|mesh-list
138185594|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
138185595|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185596|NCT03403439|Itraconazole|itraconazole|mesh-list
138185597|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
138185598|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185599|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138185600|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138185601|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185602|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185603|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138185604|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
138185605|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344070|NCT04367311|Docetaxel|docetaxel|mesh-list
138185606|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185607|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138185608|NCT04346797|Eculizumab|eculizumab|mesh-list
138185611|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
138185612|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185613|NCT04364581|Letrozole|letrozole|mesh-list
138185614|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185615|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138185616|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138185617|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185618|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185619|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138185620|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
138185621|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185622|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185623|NCT01049009|Metoprolol|metoprolol|mesh-list
138185624|NCT01049009|Nebivolol|nebivolol|mesh-list
138185625|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138185626|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138185627|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
138185628|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
138185629|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185630|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185631|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138185632|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138185633|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138185634|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
138185635|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185636|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185637|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
138185638|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138185639|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138185640|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138185641|NCT02850874|Gemcitabine|gemcitabine|mesh-list
138185642|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185643|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
138185644|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185646|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138185647|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138185648|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138185649|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138185650|NCT02920918|Canagliflozin|canagliflozin|mesh-list
138185651|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185652|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185654|NCT02920918|Hormones|hormones|mesh-ancestor
138185655|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185656|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138185657|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138185658|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185659|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185660|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138185661|NCT03403049|Gemcitabine|gemcitabine|mesh-list
138185662|NCT03403049|Capecitabine|capecitabine|mesh-list
138185663|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138185664|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185665|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185666|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
138185667|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185668|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138185669|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185671|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
138185672|NCT00944047|Doxorubicin|doxorubicin|mesh-list
138185673|NCT00944047|Trastuzumab|trastuzumab|mesh-list
138185674|NCT00944047|Mitogens|mitogens|mesh-list
138185675|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138185676|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185677|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
138185678|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
138185679|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138185680|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185681|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185682|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
138185683|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185684|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185685|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138185686|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
138185687|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138185688|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138185689|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138185690|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185691|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185692|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185693|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
138185694|NCT02921386|Testosterone|testosterone|mesh-list
138185695|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
138185696|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
138185697|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138185698|NCT02921386|Androgens|androgens|mesh-ancestor
138185699|NCT02921386|Hormones|hormones|mesh-ancestor
138185700|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185701|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185702|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138185704|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
138185705|NCT03402815|Maraviroc|maraviroc|mesh-list
138185706|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138185707|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138185708|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185709|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138185710|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138185711|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
138185712|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185713|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138185714|NCT02245555|Tamsulosin|tamsulosin|mesh-list
138185715|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138185716|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138185717|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138185718|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
138185719|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185720|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185721|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185722|NCT02245555|Urological Agents|urological agents|mesh-ancestor
138185723|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
138185724|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
138185725|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185726|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185727|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185728|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185729|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185730|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185731|NCT02802514|Exenatide|exenatide|mesh-list
138185732|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
138185733|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138185734|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185735|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185737|NCT02802514|Incretins|incretins|mesh-ancestor
138185738|NCT02802514|Hormones|hormones|mesh-ancestor
138185739|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185740|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
138185741|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
138185742|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
138185743|NCT00944671|Famotidine|famotidine|mesh-list
138185744|NCT00944671|Calcium|calcium|mesh-list
138185745|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138185746|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185747|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138185748|NCT00944671|Antacids|antacids|mesh-ancestor
138185749|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185750|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185751|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138185752|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138185753|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
138185754|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
138185755|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185756|NCT00944749|Cyclosporine|cyclosporine|mesh-list
138185757|NCT00944749|Cyclosporins|cyclosporins|mesh-list
138185758|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216493|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
138216494|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138216495|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138216496|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216497|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216498|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216499|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216500|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
138216501|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
138216502|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216503|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138216505|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216506|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216508|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138216509|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138216510|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216511|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138216512|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216513|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216514|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216515|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216516|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138216517|NCT00667004|Protective Agents|protective agents|mesh-ancestor
138216518|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216519|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216520|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
138216521|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138216522|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216524|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216525|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138216526|NCT04386122|Loxoprofen|loxoprofen|mesh-list
138216527|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138205610|NCT00005596|Antidotes|antidotes|mesh-ancestor
138216528|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138216529|NCT04386122|Analgesics|analgesics|mesh-ancestor
138216530|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
138344346|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
138216531|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216532|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216533|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216534|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216535|NCT03009461|Sorafenib|sorafenib|mesh-list
138216536|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216537|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216538|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216539|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216540|NCT02990702|Bupivacaine|bupivacaine|mesh-list
138216541|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
138216542|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
138216543|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216544|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216545|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
138216546|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216547|NCT02995304|Midazolam|midazolam|mesh-list
138216548|NCT02995304|Morphine|morphine|mesh-list
138216549|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138216550|NCT02995304|Narcotics|narcotics|mesh-ancestor
138216551|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216552|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216553|NCT02995304|Analgesics|analgesics|mesh-ancestor
138205654|NCT00005074|Alvocidib|alvocidib|mesh-list
138216555|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216556|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216557|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138216558|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216559|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216560|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138344380|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
138216561|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216563|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
138216564|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
138216565|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
138216566|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216567|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216568|NCT02990858|Leronlimab|leronlimab|mesh-list
138216569|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138216570|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138216571|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216572|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138216573|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138216574|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
138216575|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216576|NCT00725504|Lidocaine|lidocaine|mesh-list
138216577|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
138216578|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
138216579|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216580|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216581|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
138216582|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216583|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138216584|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138216586|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216587|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216588|NCT03830684|Baicalein|baicalein|mesh-list
138216589|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
138216590|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216591|NCT03830684|Protective Agents|protective agents|mesh-ancestor
138216592|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216595|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
138344476|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
138216596|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216597|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138216598|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138216599|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138216600|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138216601|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216602|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216603|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216604|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216605|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138216606|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
138216609|NCT01294163|Sevoflurane|sevoflurane|mesh-list
138216610|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138216611|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216612|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216613|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216614|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
138216615|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
138216616|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138216617|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138216618|NCT01294319|Dexamethasone|dexamethasone|mesh-list
138216619|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
138216620|NCT01294319|Spironolactone|spironolactone|mesh-list
138216621|NCT01294319|Mifepristone|mifepristone|mesh-list
138216622|NCT01294319|BB 1101|bb 1101|mesh-list
138216623|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205733|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
138216625|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
138216626|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216627|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216628|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216629|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
138216630|NCT01294319|Hormones|hormones|mesh-ancestor
138216631|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216632|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138216633|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216634|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216635|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216636|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216637|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138216638|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
138216639|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138216640|NCT01294319|Diuretics|diuretics|mesh-ancestor
138216641|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
138216642|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138216643|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
138216644|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138216645|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138216646|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138216647|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138216648|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
138216649|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138216650|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138216651|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
138216652|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138216653|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138216654|NCT00727298|Infliximab|infliximab|mesh-list
138216655|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138216656|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216657|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
138216658|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216659|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216660|NCT02990312|Sirolimus|sirolimus|mesh-list
138216662|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138216663|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216664|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138216665|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216666|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
138216667|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216668|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
138216669|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216670|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216671|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138216672|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138216673|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138216674|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138216675|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
138216676|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138216677|NCT01295879|Vitamin D|vitamin d|mesh-list
138216678|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
138216679|NCT01295879|Vitamins|vitamins|mesh-ancestor
138216680|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
138216681|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216683|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138216684|NCT01244633|Ecopipam|ecopipam|mesh-list
138344624|NCT01740557|Aldesleukin|aldesleukin|mesh-list
138216685|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138216686|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216687|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216688|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216689|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216690|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138216691|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
138216692|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216693|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216694|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
138216695|NCT01296191|Besifloxacin|besifloxacin|mesh-list
138216696|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138216697|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216698|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138216699|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138216700|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216701|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216702|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216703|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138205815|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
138216704|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
138216705|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216706|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138216707|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216708|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216709|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216710|NCT01210079|Gabapentin|gabapentin|mesh-list
138216711|NCT01210079|Analgesics|analgesics|mesh-ancestor
138216712|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
138344678|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
138216713|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216714|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216716|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216717|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216718|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216719|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216720|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138216721|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138216722|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216723|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216724|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
138216726|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138216727|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138216728|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216729|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
138216730|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216731|NCT00708110|Dolutegravir|dolutegravir|mesh-list
138216732|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138216733|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138216734|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216735|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216736|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138216737|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138216738|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
138216739|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216740|NCT01296815|Bevacizumab|bevacizumab|mesh-list
138216741|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216742|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216743|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138216744|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138216745|NCT01296815|Growth Substances|growth substances|mesh-ancestor
138216746|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216747|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
138216748|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
138216749|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138216750|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138216751|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
138216752|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138216753|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216754|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138216755|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138216756|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138216757|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138216758|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138216759|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138216760|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138216761|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138216762|NCT01276496|Paclitaxel|paclitaxel|mesh-list
138216763|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138216764|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138216765|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216766|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216767|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
138216768|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216769|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216770|NCT01297595|Crizotinib|crizotinib|mesh-list
138216771|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216772|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216773|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216774|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216775|NCT02992418|Vaccines|vaccines|mesh-list
138216776|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
138205939|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
138216777|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216778|NCT01276730|Interferons|interferons|mesh-list
138216779|NCT01276730|Tretinoin|tretinoin|mesh-list
138216780|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216781|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
138216782|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216783|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
138216784|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
138216785|NCT01298063|Afatinib|afatinib|mesh-list
138216786|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216787|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216789|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216790|NCT02999594|Tramadol|tramadol|mesh-list
138216791|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138216792|NCT02999594|Narcotics|narcotics|mesh-ancestor
138216793|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216794|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216795|NCT02999594|Analgesics|analgesics|mesh-ancestor
138216796|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
138216797|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216798|NCT01298219|Lubiprostone|lubiprostone|mesh-list
138216799|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138216800|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216801|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216802|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138216803|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216804|NCT02322242|Dexamethasone|dexamethasone|mesh-list
138216805|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
138216806|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138216807|NCT02322242|BB 1101|bb 1101|mesh-list
138216808|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216809|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
138216810|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
138216811|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216812|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216813|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216814|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
138216816|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216817|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138216818|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216819|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216820|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216821|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216822|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138216823|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
138216824|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
138216825|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216826|NCT02993588|Melatonin|melatonin|mesh-list
138216827|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
138216828|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216830|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216831|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216832|NCT01270178|Entecavir|entecavir|mesh-list
138216833|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
138216834|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216836|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
138216837|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216838|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216839|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138216840|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
138216841|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216842|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
138216843|NCT01270412|Protective Agents|protective agents|mesh-ancestor
138216844|NCT02992496|Midazolam|midazolam|mesh-list
138216845|NCT02992496|Ketamine|ketamine|mesh-list
138216846|NCT02992496|Analgesics|analgesics|mesh-ancestor
138216847|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
138216848|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216849|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216850|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138216851|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216852|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
138216853|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
138216854|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216855|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138216856|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138216857|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216858|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216859|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216860|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138216861|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216862|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216863|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216864|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
138216865|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
138216867|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138216868|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216869|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216870|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216871|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216873|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216874|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216875|NCT01270490|Interferons|interferons|mesh-list
138216876|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
138216877|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216878|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
138216879|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216880|NCT01278056|Deferasirox|deferasirox|mesh-list
138216883|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
138216884|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216886|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
138216887|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216888|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216889|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
138216890|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216891|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138216892|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
138216893|NCT02992652|Protective Agents|protective agents|mesh-ancestor
138216894|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216895|NCT01270724|Paclitaxel|paclitaxel|mesh-list
138216896|NCT01270724|Gemcitabine|gemcitabine|mesh-list
138216897|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
138216898|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138216899|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216900|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216901|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138216902|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216903|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344941|NCT01833546|Gemcitabine|gemcitabine|mesh-list
138216904|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216905|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
138216906|NCT00709826|Gemcitabine|gemcitabine|mesh-list
138216907|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138216908|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216909|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
138206103|NCT01290913|Omalizumab|omalizumab|mesh-list
138216911|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216912|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216913|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216914|NCT01271114|Terlipressin|terlipressin|mesh-list
138216915|NCT01271114|Norepinephrine|norepinephrine|mesh-list
138216916|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138216917|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138216918|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216919|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216920|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216921|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216922|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
138216923|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
138216924|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216925|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138216926|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216927|NCT02992340|Gemcitabine|gemcitabine|mesh-list
138216928|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216929|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216930|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
138216931|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216932|NCT00711464|Modafinil|modafinil|mesh-list
138216933|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138216934|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216935|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138216936|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138216937|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138216938|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216939|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138216940|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138216941|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
138216942|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138216943|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
138206145|NCT01268527|Calcipotriene|calcipotriene|mesh-list
138216944|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138216945|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216946|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138216947|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138216949|NCT01278290|Hormones|hormones|mesh-ancestor
138216950|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216951|NCT01278446|Caseins|caseins|mesh-list
138216952|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
138216953|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
138216954|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216955|NCT02339558|Nivolumab|nivolumab|mesh-list
138216956|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216957|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216958|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138216959|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216961|NCT00731198|Scopolamine|scopolamine|mesh-list
138216962|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138216963|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216964|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
138216965|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
138216966|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216967|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216968|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216969|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
138216970|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138216971|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
138216972|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216973|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216974|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138216975|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
138216976|NCT00731198|Analgesics|analgesics|mesh-ancestor
138216978|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
138216979|NCT01278602|Rituximab|rituximab|mesh-list
138216980|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216981|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216982|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
138216983|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216984|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216985|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
138216986|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138216987|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
138216988|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216989|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
138216990|NCT00712244|Protective Agents|protective agents|mesh-ancestor
138216991|NCT02991950|Parnaparin|parnaparin|mesh-list
138216992|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
138216993|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138216994|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138216995|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216996|NCT01271582|Leucovorin|leucovorin|mesh-list
138216997|NCT01271582|Irinotecan|irinotecan|mesh-list
138216998|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138216999|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138217000|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217001|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217002|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217004|NCT01271582|Protective Agents|protective agents|mesh-ancestor
138217005|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217006|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
138217007|NCT01271582|Vitamins|vitamins|mesh-ancestor
138217008|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
138217009|NCT01271660|Pregabalin|pregabalin|mesh-list
138217010|NCT01271660|Analgesics|analgesics|mesh-ancestor
138217011|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
138217012|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217013|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217014|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
138217015|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138217017|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217018|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138217020|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217021|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217022|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217023|NCT00731588|Biotin|biotin|mesh-list
138217024|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
138217025|NCT00731588|Vitamins|vitamins|mesh-ancestor
138217026|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
138217027|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217028|NCT01271894|Efavirenz|efavirenz|mesh-list
138217029|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138217030|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138217031|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217032|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217033|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
138217034|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217035|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138217036|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138217037|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138217038|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138217039|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138217040|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138217041|NCT01278758|Vadimezan|vadimezan|mesh-list
138217042|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217043|NCT00717626|Factor VIII|factor viii|mesh-list
138217044|NCT00717626|Coagulants|coagulants|mesh-ancestor
138217045|NCT01272128|Interferons|interferons|mesh-list
138217046|NCT01272128|Interferon-beta|interferon-beta|mesh-list
138206262|NCT00004816|Antibodies|antibodies|mesh-list
138217047|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
138217048|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217049|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
138217050|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217051|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
138217052|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217053|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138217054|NCT00719186|Letrozole|letrozole|mesh-list
138217055|NCT00719186|Clomiphene|clomiphene|mesh-list
138217056|NCT00719186|Enclomiphene|enclomiphene|mesh-list
138217057|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
138217058|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217059|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217061|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138217062|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217063|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138217064|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
138217065|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217066|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217067|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138217068|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
138217069|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138217070|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138217071|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138217072|NCT00721136|Heparin|heparin|mesh-list
138217073|NCT00721136|Warfarin|warfarin|mesh-list
138217074|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
138217075|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138217076|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138217077|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217079|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138217080|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217081|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138217082|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138217083|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138217084|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217085|NCT00722072|Sorafenib|sorafenib|mesh-list
138217086|NCT00722072|Fulvestrant|fulvestrant|mesh-list
138217087|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217088|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138217089|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217090|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217091|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217092|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138217094|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
138217095|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217096|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217098|NCT01275170|Relebactam|relebactam|mesh-list
138217099|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138217100|NCT01275170|Midazolam|midazolam|mesh-list
138217101|NCT01275170|Caffeine|caffeine|mesh-list
138217102|NCT01275170|Omeprazole|omeprazole|mesh-list
138217103|NCT01275170|Cilastatin|cilastatin|mesh-list
138217104|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138217105|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138217106|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217107|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217108|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138217109|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217110|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217111|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138217112|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
138217113|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
138217114|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
138217115|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
138217116|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217117|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217118|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138217119|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138217120|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359854|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138217121|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138217122|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138217123|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
138217124|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138217125|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217126|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138217127|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217128|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217129|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
138217130|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138217131|NCT04385654|Axitinib|axitinib|mesh-list
138217132|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217133|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138217134|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217135|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217136|NCT01273064|Interferons|interferons|mesh-list
138217137|NCT01273064|Ribavirin|ribavirin|mesh-list
138217138|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217139|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
138217140|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217141|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
138217142|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217143|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
138217144|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
138217145|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217147|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217148|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217149|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
138217150|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217151|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217152|NCT01271504|Sorafenib|sorafenib|mesh-list
138217153|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217154|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138217155|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345475|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138217156|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217157|NCT02144714|Adalimumab|adalimumab|mesh-list
138217158|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138217159|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217160|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217161|NCT00741026|Olanzapine|olanzapine|mesh-list
138217162|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
138217163|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
138217164|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217165|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206428|NCT00104858|Antibodies|antibodies|mesh-list
138217166|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217167|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138217168|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217169|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217170|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217171|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138217172|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138217173|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217174|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217175|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217176|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
138217177|NCT00741104|Infliximab|infliximab|mesh-list
138345515|NCT01912716|Analgesics|analgesics|mesh-ancestor
138217178|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138359868|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
138217180|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
138217181|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217182|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217183|NCT01273298|Bisoprolol|bisoprolol|mesh-list
138217184|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138217185|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
138217186|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
138217187|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217188|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217189|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138217190|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138217191|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138217192|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217193|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345565|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
138217194|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217196|NCT01270802|Emtricitabine|emtricitabine|mesh-list
138217197|NCT01270802|Efavirenz|efavirenz|mesh-list
138217198|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
138217199|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
138217200|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217201|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138217202|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138217203|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217204|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217206|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217207|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138217208|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138217209|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138217210|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138217211|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138217212|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138217213|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138217214|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138217216|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138217217|NCT01273454|Narcotics|narcotics|mesh-ancestor
138217218|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217219|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217220|NCT01273454|Analgesics|analgesics|mesh-ancestor
138217221|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
138217222|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217223|NCT01270256|Budesonide|budesonide|mesh-list
138217224|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217225|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138217226|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
138217227|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217228|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217229|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138217230|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138217232|NCT01270256|Hormones|hormones|mesh-ancestor
138217233|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217234|NCT01279694|Prednisone|prednisone|mesh-list
138206524|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
138217236|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217237|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
138217238|NCT01279694|Hormones|hormones|mesh-ancestor
138217239|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217240|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217241|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217242|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217243|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138217244|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
138217245|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217246|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138217247|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138217248|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
138217249|NCT01273532|Tapentadol|tapentadol|mesh-list
138217251|NCT01273532|Narcotics|narcotics|mesh-ancestor
138217252|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217253|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217254|NCT01273532|Analgesics|analgesics|mesh-ancestor
138217255|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
138217256|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217257|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138217258|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138217259|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217260|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217261|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217262|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217263|NCT00744380|Midazolam|midazolam|mesh-list
138217264|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
138217265|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138217266|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217267|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217268|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138217269|NCT00744380|Analgesics|analgesics|mesh-ancestor
138217270|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
138217271|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217272|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138217273|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138217274|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138217275|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217276|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217277|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217278|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138217279|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138217280|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217281|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217282|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138217283|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
138217284|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
138217285|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
138217287|NCT00744692|Fludarabine|fludarabine|mesh-list
138217288|NCT00744692|Melphalan|melphalan|mesh-list
138217289|NCT00744692|Thiotepa|thiotepa|mesh-list
138217290|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
138217291|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217292|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217293|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138217294|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
138217295|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359883|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217296|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138217297|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
138217298|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138217299|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
138217300|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217301|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138217302|NCT00744848|Epinephrine|epinephrine|mesh-list
138217303|NCT00744848|Bupivacaine|bupivacaine|mesh-list
138217304|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
138217305|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
138217306|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217307|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217308|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
138217309|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217310|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138217311|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138217312|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217313|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217314|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217316|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138217317|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
138217318|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138217319|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
138217320|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
138217321|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
138217322|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138217323|NCT03830606|Paclitaxel|paclitaxel|mesh-list
138217324|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138217325|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217326|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
138217327|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
138217328|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138217329|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217330|NCT01278134|Ritonavir|ritonavir|mesh-list
138217331|NCT01278134|Ribavirin|ribavirin|mesh-list
138217332|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138217333|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138217334|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138217335|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
138345824|NCT05242692|Analgesics|analgesics|mesh-ancestor
138217336|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217337|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217338|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138217339|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217340|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
138217341|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217342|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138217343|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138217344|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
138217345|NCT01273844|Bortezomib|bortezomib|mesh-list
138217346|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217347|NCT01271348|Etoricoxib|etoricoxib|mesh-list
138217349|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138217350|NCT01271348|Analgesics|analgesics|mesh-ancestor
138217351|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
138217352|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217353|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217354|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217355|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217356|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138217357|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138217358|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217359|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217360|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
138217361|NCT04385264|Mannitol|mannitol|mesh-list
138217362|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
138217363|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138217364|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138217365|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217366|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217367|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217368|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217369|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138217370|NCT04385264|Diuretics|diuretics|mesh-ancestor
138217371|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
138217372|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217374|NCT00746954|Buspirone|buspirone|mesh-list
138217375|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
138217376|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138217377|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217378|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217379|NCT00746954|Diuretics|diuretics|mesh-ancestor
138217380|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
138217381|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217382|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138217383|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217384|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217385|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217386|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138217387|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
138217388|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217389|NCT00752102|Calcitriol|calcitriol|mesh-list
138217390|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138217391|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217392|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138217393|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217394|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217395|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138217396|NCT00752102|Vitamins|vitamins|mesh-ancestor
138217397|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
138217398|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138217400|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138217401|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
138217402|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217403|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
138217404|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217405|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
138217406|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
138217407|NCT01279616|Busulfan|busulfan|mesh-list
138217408|NCT01279616|Rituximab|rituximab|mesh-list
138217409|NCT01279616|Fludarabine|fludarabine|mesh-list
138217410|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
138217411|NCT01279616|Tacrolimus|tacrolimus|mesh-list
138217412|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
138217413|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138217414|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
138217415|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217416|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217417|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138217418|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
138217419|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217420|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217421|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138217422|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217423|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138217424|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
138217425|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138217426|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217427|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138217428|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138217430|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217431|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217432|NCT01275638|Prednisolone|prednisolone|mesh-list
138217433|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138217434|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
138217435|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138217436|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
138217437|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138217438|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
138217439|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217440|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
138217442|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217443|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217444|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217445|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217446|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
138217447|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
138217448|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206694|NCT01364623|Hormones|hormones|mesh-ancestor
138217449|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217450|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138217451|NCT01275638|Protective Agents|protective agents|mesh-ancestor
138217452|NCT00724568|Dexamethasone|dexamethasone|mesh-list
138217453|NCT00724568|Lenalidomide|lenalidomide|mesh-list
138217455|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217456|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
138217457|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
138217458|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217459|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217460|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217461|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
138217462|NCT00724568|Hormones|hormones|mesh-ancestor
138217463|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217464|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217465|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217466|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
138217467|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138217468|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138217469|NCT00724568|Growth Substances|growth substances|mesh-ancestor
138217470|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
138217471|NCT01274000|Ramosetron|ramosetron|mesh-list
138217472|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
138217473|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
138217474|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217475|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217476|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217477|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138217479|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217480|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217482|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
138217483|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
138217484|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217485|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217486|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
138217487|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217488|NCT01277744|Cisplatin|cisplatin|mesh-list
138217489|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217490|NCT01277822|Losartan|losartan|mesh-list
138217491|NCT01277822|Amlodipine|amlodipine|mesh-list
138217492|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138217493|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138217494|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206723|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217495|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217496|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138217497|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217498|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
138217499|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138217500|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138217501|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138217503|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138217505|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217506|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
138217507|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
138217508|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
138206753|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217509|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217510|NCT00748826|Infliximab|infliximab|mesh-list
138217511|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138217512|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217513|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
138217514|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138206754|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138217515|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217517|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217518|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217519|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
138217520|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138217522|NCT01274624|Leucovorin|leucovorin|mesh-list
138217523|NCT01274624|Bevacizumab|bevacizumab|mesh-list
138217524|NCT01274624|Fluorouracil|fluorouracil|mesh-list
138217525|NCT01274624|Irinotecan|irinotecan|mesh-list
138217526|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217527|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217528|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138217529|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138217530|NCT01274624|Growth Substances|growth substances|mesh-ancestor
138217531|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217532|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
138217533|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
138217534|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217535|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138217536|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138217537|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
138217538|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138217539|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138217540|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217541|NCT01274624|Antidotes|antidotes|mesh-ancestor
138217542|NCT01274624|Protective Agents|protective agents|mesh-ancestor
138217543|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
138217544|NCT01274624|Vitamins|vitamins|mesh-ancestor
138217545|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
138217546|NCT00761930|Listerine|listerine|mesh-list
138217547|NCT00761930|Triclosan|triclosan|mesh-list
138217548|NCT00761930|Fluorides|fluorides|mesh-list
138217549|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
138217550|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
138217551|NCT00761930|Protective Agents|protective agents|mesh-ancestor
138217552|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217553|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138217554|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217555|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138217556|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138217557|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
138217558|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217559|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138217560|NCT00245102|Sorafenib|sorafenib|mesh-list
138217561|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217562|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138217563|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217564|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217565|NCT01275014|Dexamethasone|dexamethasone|mesh-list
138217566|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217567|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
138217569|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217570|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217571|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217572|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
138217573|NCT01275014|Hormones|hormones|mesh-ancestor
138206847|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206848|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206849|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138206850|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138206851|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
138206852|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138206853|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206854|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
138206855|NCT00166166|Fluconazole|fluconazole|mesh-list
138206856|NCT00166166|Nitroprusside|nitroprusside|mesh-list
138206857|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
138206858|NCT00166166|Acetylcholine|acetylcholine|mesh-list
138206859|NCT00166166|Bradykinin|bradykinin|mesh-list
138206860|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138217574|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217575|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217576|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217577|NCT01275248|Ondansetron|ondansetron|mesh-list
138217578|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
138217579|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
138217580|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217581|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217582|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217583|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
138217584|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138217585|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138217586|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138217587|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
138217588|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217589|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217591|NCT00756236|Esmolol|esmolol|mesh-list
138217592|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138217593|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138217594|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
138217595|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
138217596|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217597|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217598|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138217599|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138217600|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138217601|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217602|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206879|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206880|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138206881|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
138206882|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138206883|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206884|NCT00118352|Cyclosporine|cyclosporine|mesh-list
138206885|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
138206886|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138206887|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
138217604|NCT00762320|Ritonavir|ritonavir|mesh-list
138217605|NCT00762320|Lopinavir|lopinavir|mesh-list
138217606|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138217607|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138217608|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138217609|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217610|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217611|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138217612|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217613|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
138217614|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217615|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138217616|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138217619|NCT00244712|Emtricitabine|emtricitabine|mesh-list
138217620|NCT00244712|Abacavir|abacavir|mesh-list
138217621|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
138217622|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217623|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138217624|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138217625|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217626|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217627|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138217628|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217629|NCT00725270|Mifepristone|mifepristone|mesh-list
138217630|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138217631|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
138217632|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138217633|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217634|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138217635|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138217636|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138217637|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
138217638|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138217639|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138217640|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
138217641|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217642|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
138346488|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
138217643|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138217644|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138217645|NCT00243932|Ubiquinone|ubiquinone|mesh-list
138217646|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
138217647|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
138217648|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217649|NCT00243932|Vitamins|vitamins|mesh-ancestor
138206915|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206916|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138217651|NCT00243386|Coagulants|coagulants|mesh-ancestor
138217653|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138217654|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138217656|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217657|NCT01275560|Metronidazole|metronidazole|mesh-list
138217658|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217659|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217660|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138217661|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138217662|NCT00762710|Prazosin|prazosin|mesh-list
138217663|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138217664|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138217665|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138217666|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138346533|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
138217667|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217668|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217669|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217670|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217671|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138217672|NCT00756548|Laxatives|laxatives|mesh-ancestor
138217673|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217674|NCT00243074|Cediranib|cediranib|mesh-list
138217675|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217676|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217678|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138217680|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138217681|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217682|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
138217683|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217684|NCT00778310|Methylphenidate|methylphenidate|mesh-list
138217685|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138217686|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217687|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138217688|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138217689|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217690|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217691|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
138217692|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217693|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
138217694|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217695|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217696|NCT01247285|Fluoxetine|fluoxetine|mesh-list
138217697|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138217698|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138217699|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217700|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217701|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217703|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217704|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138217705|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
138217706|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217707|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138217708|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138217709|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217710|NCT03806582|Norepinephrine|norepinephrine|mesh-list
138217711|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138217712|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138217713|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
138217714|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217715|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217716|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217717|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
138217718|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
138217719|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217721|NCT00779558|Heparin|heparin|mesh-list
138217722|NCT00779558|Calcium heparin|calcium heparin|mesh-list
138217723|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
138217724|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138217725|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138217726|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217727|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138217728|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138217730|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138217731|NCT01301183|Mecasermin|mecasermin|mesh-list
138217732|NCT01301183|Estrogens|estrogens|mesh-ancestor
138217733|NCT01301183|Hormones|hormones|mesh-ancestor
138217734|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217735|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217736|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138217737|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
138217738|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138217739|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138217740|NCT01301183|Growth Substances|growth substances|mesh-ancestor
138217741|NCT00758420|Polidocanol|polidocanol|mesh-list
138217742|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138217743|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138217744|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
138217745|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138217746|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359981|NCT00371904|Rituximab|rituximab|mesh-list
138217747|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217748|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138217749|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138217751|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138217753|NCT01213199|Analgesics|analgesics|mesh-ancestor
138217754|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
138217755|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217756|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217757|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217758|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217759|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
138217760|NCT03809702|Pregabalin|pregabalin|mesh-list
138217761|NCT03809702|Analgesics|analgesics|mesh-ancestor
138217762|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
138217763|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217764|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217765|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
138217766|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138217767|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138217768|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217769|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138217770|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138217771|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217772|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217773|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217774|NCT03806036|Vitamin D|vitamin d|mesh-list
138217775|NCT03806036|Clomiphene|clomiphene|mesh-list
138217776|NCT03806036|Enclomiphene|enclomiphene|mesh-list
138217777|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
138217778|NCT03806036|Vitamins|vitamins|mesh-ancestor
138217779|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
138207064|NCT03008551|Empagliflozin|empagliflozin|mesh-list
138217781|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138217782|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138217783|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
138217784|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217785|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138217786|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
138217787|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138217788|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138217789|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138217791|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138217792|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217793|NCT01214057|Remifentanil|remifentanil|mesh-list
138217794|NCT01214057|Propofol|propofol|mesh-list
138217795|NCT01214057|Sevoflurane|sevoflurane|mesh-list
138217796|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138217797|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217798|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217799|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138217800|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
138217801|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
138217803|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138217804|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138217805|NCT01214057|Narcotics|narcotics|mesh-ancestor
138217806|NCT01214057|Analgesics|analgesics|mesh-ancestor
138217807|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
138217808|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217809|NCT03809546|Dronabinol|dronabinol|mesh-list
138217810|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
138217811|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217812|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138217813|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138217814|NCT03809546|Analgesics|analgesics|mesh-ancestor
138217815|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
138346772|NCT02233296|Lasmiditan|lasmiditan|mesh-list
138217816|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217817|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138359988|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
138217818|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138207105|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207106|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
138217820|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217821|NCT03809546|Hormones|hormones|mesh-ancestor
138217822|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217823|NCT03809312|Amoxicillin|amoxicillin|mesh-list
138217824|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
138217825|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
138217826|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217827|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217828|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217829|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217830|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138217831|NCT01247363|Globalagliatin|globalagliatin|mesh-list
138217832|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
138217833|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217834|NCT00780494|Bevacizumab|bevacizumab|mesh-list
138217835|NCT00780494|Carboplatin|carboplatin|mesh-list
138217837|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217838|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217839|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138217840|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138217841|NCT00780494|Growth Substances|growth substances|mesh-ancestor
138217842|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217843|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
138217844|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138217845|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
138217846|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217847|NCT00763412|Repaglinide|repaglinide|mesh-list
138217848|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138217849|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217850|NCT01302743|Metformin|metformin|mesh-list
138217851|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138217852|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217853|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
138217854|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138217855|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217856|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138217857|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
138217858|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138217859|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217860|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217861|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217862|NCT01214759|Tenofovir|tenofovir|mesh-list
138217863|NCT01214759|Emtricitabine|emtricitabine|mesh-list
138217864|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
138217865|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138217866|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
138207194|NCT01319851|Alefacept|alefacept|mesh-list
138217867|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217868|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138217869|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138217870|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217871|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217873|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138217874|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138217875|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138217876|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
138217877|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138217878|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
138217879|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217880|NCT00780962|Expectorants|expectorants|mesh-ancestor
138217881|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
138217882|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138217883|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
138217884|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217885|NCT00780962|Protective Agents|protective agents|mesh-ancestor
138217886|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217887|NCT00780962|Antidotes|antidotes|mesh-ancestor
138217888|NCT00764738|Ranibizumab|ranibizumab|mesh-list
138217889|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138217890|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138217891|NCT00764738|Growth Substances|growth substances|mesh-ancestor
138217892|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217893|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
138346866|NCT02251938|Sirolimus|sirolimus|mesh-list
138217894|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217895|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
138217896|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
138217897|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138217898|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138217899|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217900|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217901|NCT00781508|Urological Agents|urological agents|mesh-ancestor
138217902|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
138217903|NCT03805568|Remifentanil|remifentanil|mesh-list
138217904|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138217905|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217906|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217907|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138217908|NCT03805568|Analgesics|analgesics|mesh-ancestor
138217909|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
138217910|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217911|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138217912|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138217913|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138217915|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217916|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217917|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138217918|NCT03805568|Narcotics|narcotics|mesh-ancestor
138217919|NCT00781898|Naltrexone|naltrexone|mesh-list
138217920|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138217921|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138217922|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217923|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
138217924|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217925|NCT00765128|Ketorolac|ketorolac|mesh-list
138217926|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138360013|NCT00372294|Hormones|hormones|mesh-ancestor
138217927|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138217928|NCT00765128|Analgesics|analgesics|mesh-ancestor
138217929|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
138217930|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217931|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217932|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217933|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217934|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138217935|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217936|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217937|NCT00765206|Omeprazole|omeprazole|mesh-list
138217938|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138217939|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138217940|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217941|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138217942|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217943|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217944|NCT03809156|Ambrisentan|ambrisentan|mesh-list
138217945|NCT03809156|Riociguat|riociguat|mesh-list
138217946|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
138217947|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217948|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138217950|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138217951|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217952|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217953|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138217954|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
138217955|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
138217957|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138217958|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138217959|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217960|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217961|NCT03805178|Abatacept|abatacept|mesh-list
138217962|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138217963|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217964|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207323|NCT00176852|Busulfan|busulfan|mesh-list
138217966|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138217967|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
138346967|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217968|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217969|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217970|NCT01303835|Naltrexone|naltrexone|mesh-list
138217971|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138217972|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138217973|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217974|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
138217975|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217976|NCT01250717|Dexamethasone|dexamethasone|mesh-list
138217977|NCT01250717|Goserelin|goserelin|mesh-list
138217978|NCT01250717|Estramustine|estramustine|mesh-list
138217979|NCT01250717|Docetaxel|docetaxel|mesh-list
138217980|NCT01250717|Bicalutamide|bicalutamide|mesh-list
138217981|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138217982|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
138217983|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
138217984|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138217985|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217986|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138217987|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
138217988|NCT01250717|Hormones|hormones|mesh-ancestor
138217989|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138217990|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138217991|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207383|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
138217992|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138217993|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138217994|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138217995|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217996|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
138217997|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
138217998|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138217999|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
138218001|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138218002|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138218003|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218004|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138218005|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138218006|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207411|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138207412|NCT01325311|Estrogens|estrogens|mesh-ancestor
138218007|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218008|NCT01251575|Cyclosporine|cyclosporine|mesh-list
138218009|NCT01251575|Sirolimus|sirolimus|mesh-list
138218010|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
138218011|NCT01251575|Fludarabine|fludarabine|mesh-list
138218012|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
138218013|NCT01251575|Cyclosporins|cyclosporins|mesh-list
138218014|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218015|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138218016|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
138218017|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347081|NCT02289222|Hormones|hormones|mesh-ancestor
138218018|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218019|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
138218020|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218021|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218022|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
138218023|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218024|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
138218025|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218026|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138218027|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138218028|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138218029|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
138218030|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218032|NCT00782756|Temozolomide|temozolomide|mesh-list
138218033|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218034|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218035|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138218036|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138218037|NCT00782756|Growth Substances|growth substances|mesh-ancestor
138218038|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218039|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138218040|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138218041|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
138218042|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218044|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138218045|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
138218046|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218047|NCT01306175|Empagliflozin|empagliflozin|mesh-list
138218048|NCT01306175|Digoxin|digoxin|mesh-list
138218049|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218050|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138218051|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218052|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218053|NCT01306175|Protective Agents|protective agents|mesh-ancestor
138218054|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218055|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138218056|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138218057|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
138218058|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138218059|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218060|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138218061|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138218062|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207466|NCT01433107|Terbinafine|terbinafine|mesh-list
138218063|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218064|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
138218065|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218066|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
138218067|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218069|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218070|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218071|NCT01216397|Metformin|metformin|mesh-list
138218072|NCT01216397|Linagliptin|linagliptin|mesh-list
138218073|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138218074|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218075|NCT01216397|Incretins|incretins|mesh-ancestor
138218076|NCT01216397|Hormones|hormones|mesh-ancestor
138218077|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218078|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138218079|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138218080|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218081|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218082|NCT04345406|Chloroquine|chloroquine|mesh-list
138218083|NCT04345406|Enalapril|enalapril|mesh-list
138218084|NCT04345406|Captopril|captopril|mesh-list
138218085|NCT04345406|Amebicides|amebicides|mesh-ancestor
138218086|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138218087|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138218088|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218089|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
138218090|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218091|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138218092|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
138218093|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218094|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218095|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138218096|NCT01216943|Timolol|timolol|mesh-list
138347216|NCT02351700|Ibuprofen|ibuprofen|mesh-list
138218098|NCT01216943|Bimatoprost|bimatoprost|mesh-list
138218099|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138218101|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138218102|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138218103|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
138218104|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218105|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218106|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218107|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218108|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138218109|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138218110|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138218111|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138218112|NCT00783614|Aspirin|aspirin|mesh-list
138218113|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138218114|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138218115|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218116|NCT00783614|Analgesics|analgesics|mesh-ancestor
138218117|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
138218118|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218119|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218120|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218121|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218122|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138218123|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138218124|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218125|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138218126|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138218127|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218128|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
138218129|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
138218130|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218131|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
138218132|NCT01252745|Testosterone|testosterone|mesh-list
138218134|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
138218135|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138218136|NCT01252745|Androgens|androgens|mesh-ancestor
138218137|NCT01252745|Hormones|hormones|mesh-ancestor
138218138|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218139|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218140|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138218141|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218142|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
138218145|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218147|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
138218148|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138218149|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
138218150|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218151|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
138218152|NCT03807596|Protective Agents|protective agents|mesh-ancestor
138218153|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138218154|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138218155|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218156|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218157|NCT01253525|Paclitaxel|paclitaxel|mesh-list
138218158|NCT01253525|Ramucirumab|ramucirumab|mesh-list
138218159|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138218160|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218161|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
138218162|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
138218163|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218164|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218165|NCT05310968|Aspirin|aspirin|mesh-list
138218166|NCT05310968|Tirofiban|tirofiban|mesh-list
138218167|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138218168|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218169|NCT05310968|Analgesics|analgesics|mesh-ancestor
138218170|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
138218171|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218173|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218175|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138218177|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218178|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138218179|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138218180|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218181|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
138218182|NCT00768716|Acetaminophen|acetaminophen|mesh-list
138218183|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218184|NCT00768716|Analgesics|analgesics|mesh-ancestor
138218185|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
138218186|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218187|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218188|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
138218189|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138218190|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138218191|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138218192|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218193|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347413|NCT05718492|Leucovorin|leucovorin|mesh-list
138218194|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138218195|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218196|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218197|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
138207594|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138218198|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218199|NCT05583188|Paclitaxel|paclitaxel|mesh-list
138218200|NCT05583188|Vinorelbine|vinorelbine|mesh-list
138218201|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138218202|NCT05583188|Gemcitabine|gemcitabine|mesh-list
138218203|NCT05583188|Nivolumab|nivolumab|mesh-list
138218204|NCT05583188|Pemetrexed|pemetrexed|mesh-list
138218205|NCT05583188|Carboplatin|carboplatin|mesh-list
138218206|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138218207|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218208|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138218209|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138218210|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218211|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218212|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138218213|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
138218214|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218215|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138218216|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218217|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138218218|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138218220|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138218221|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138207638|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207639|NCT01384591|Expectorants|expectorants|mesh-ancestor
138207646|NCT01086605|Pixantrone|pixantrone|mesh-list
138218222|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218223|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
138218224|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218226|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
138218227|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138218228|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218229|NCT04351919|Azithromycin|azithromycin|mesh-list
138218230|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
138218231|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218232|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218233|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
138218234|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138218235|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138218236|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218237|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218238|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218239|NCT00769886|Ketotifen|ketotifen|mesh-list
138218240|NCT00769886|Naphazoline|naphazoline|mesh-list
138218241|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
138218242|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138218243|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138218244|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218245|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
138218246|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218247|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218248|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218249|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138347521|NCT04317300|Varenicline|varenicline|mesh-list
138218250|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138218251|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138218252|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138218253|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
138218254|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138218255|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218256|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138218258|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218260|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
138218261|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218262|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218263|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218264|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218265|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138218266|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138218267|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138218268|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218269|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
138218270|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218271|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218272|NCT01309451|Dexamethasone|dexamethasone|mesh-list
138218273|NCT01309451|Bevacizumab|bevacizumab|mesh-list
138218274|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218275|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218276|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138218277|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138218278|NCT01309451|Growth Substances|growth substances|mesh-ancestor
138218279|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347554|NCT03149874|Vaccines|vaccines|mesh-list
138218280|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138218281|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218282|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
138218283|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
138218284|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218285|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218286|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
138218287|NCT01309451|Hormones|hormones|mesh-ancestor
138218288|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218289|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138218290|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
138218291|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
138218292|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138218293|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138218294|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218295|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218296|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218297|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218298|NCT00795002|Cytarabine|cytarabine|mesh-list
138218299|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
138218300|NCT00795002|Alvocidib|alvocidib|mesh-list
138218301|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138218302|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
138218303|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218304|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218305|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
138218306|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218307|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218308|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
138218309|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218310|NCT00795002|Analgesics|analgesics|mesh-ancestor
138218311|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
138218312|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360091|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
138218313|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138218314|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138218315|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218316|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
138218317|NCT00795002|Growth Substances|growth substances|mesh-ancestor
138218318|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138218319|NCT03802838|Amisulpride|amisulpride|mesh-list
138218320|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138218321|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138218322|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218323|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218324|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218325|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138218326|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
138218327|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218328|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218329|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138218330|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
138218332|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138218333|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138218334|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
138218335|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218336|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218337|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138218338|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218339|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138218340|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218341|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218342|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138218343|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138218344|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138218345|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218346|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
138218347|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218348|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138218349|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218351|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
138218352|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218353|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218354|NCT01310231|Metformin|metformin|mesh-list
138218355|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138218356|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218357|NCT00789074|Varenicline|varenicline|mesh-list
138218358|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138218359|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138218360|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138218361|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218362|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218363|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218364|NCT01338857|Sorafenib|sorafenib|mesh-list
138218365|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218366|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138218367|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218368|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218369|NCT01339013|Anesthetics|anesthetics|mesh-list
138218370|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218371|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218372|NCT01339091|Vancomycin|vancomycin|mesh-list
138207794|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218375|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218376|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218377|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138218378|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218379|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218380|NCT01339247|Halofantrine|halofantrine|mesh-list
138218381|NCT01339247|Paroxetine|paroxetine|mesh-list
138218382|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138218383|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138218384|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218385|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218386|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218387|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
138218388|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218389|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138218390|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
138218391|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218392|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138218393|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138218394|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218395|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
138218397|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138218398|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218401|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
138218402|NCT00772772|Vitamins|vitamins|mesh-list
138218403|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
138218404|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218405|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138218406|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138218407|NCT00773474|Lonafarnib|lonafarnib|mesh-list
138218408|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218409|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218410|NCT01310855|Gefitinib|gefitinib|mesh-list
138218411|NCT01310855|Cediranib|cediranib|mesh-list
138218412|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218413|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218414|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218415|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138218416|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
138218417|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138218418|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
138218419|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218420|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218422|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218423|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138218424|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138218425|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138218426|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
138218427|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218428|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218429|NCT01258049|Artemether|artemether|mesh-list
138218430|NCT01258049|Quinine|quinine|mesh-list
138218431|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
138218432|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138218433|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138218434|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218435|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138218436|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218437|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138218438|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218439|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218440|NCT01258049|Analgesics|analgesics|mesh-ancestor
138218441|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
138218443|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218444|NCT03801746|Cyclosporine|cyclosporine|mesh-list
138218445|NCT03801746|Rifampin|rifampin|mesh-list
138218446|NCT03801746|Probenecid|probenecid|mesh-list
138218447|NCT03801746|Cyclosporins|cyclosporins|mesh-list
138347906|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218448|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218449|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218450|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218451|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
138218452|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218453|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
138218454|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218455|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138218456|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218457|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138218458|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138218459|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
138218460|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218461|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
138218462|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138218463|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138218464|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138218465|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138218466|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138218467|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138218468|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138218469|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
138218470|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
138218472|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
138218473|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138218474|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138218475|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218476|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138218477|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138218478|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218479|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218480|NCT05414006|Ketamine|ketamine|mesh-list
138218481|NCT05414006|Esketamine|esketamine|mesh-list
138218482|NCT05414006|Analgesics|analgesics|mesh-ancestor
138218483|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
138218484|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218485|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218486|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138218487|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138218488|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
138218489|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
138218490|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218491|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138218492|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138218493|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218494|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218495|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
138218496|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218497|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
138218498|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
138218499|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138218500|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138218501|NCT02199041|Prednisolone|prednisolone|mesh-list
138218502|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
138218503|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
138218505|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
138218506|NCT02199041|Thiotepa|thiotepa|mesh-list
138218507|NCT02199041|Fludarabine|fludarabine|mesh-list
138218508|NCT02199041|Tacrolimus|tacrolimus|mesh-list
138218509|NCT02199041|Lenograstim|lenograstim|mesh-list
138207960|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
138218510|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138218511|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
138218512|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218513|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
138218514|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218515|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218516|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138218517|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
138218518|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218519|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218520|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138218521|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138218522|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218523|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138218524|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138218525|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
138218526|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218527|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218528|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218529|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
138218530|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
138218531|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218532|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218533|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
138218534|NCT02199041|Hormones|hormones|mesh-ancestor
138218535|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218536|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138218537|NCT02199041|Protective Agents|protective agents|mesh-ancestor
138218538|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138218539|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138218540|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
138218542|NCT00789776|Fludarabine|fludarabine|mesh-list
138218543|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
138218544|NCT00789776|Tacrolimus|tacrolimus|mesh-list
138218545|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218546|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
138218547|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218548|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218549|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138218550|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
138218551|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218552|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218554|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138218555|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
138218556|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138218557|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218558|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138218559|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138218560|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
138218561|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218562|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218563|NCT03801590|Riboflavin|riboflavin|mesh-list
138218564|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
138218565|NCT03801590|Vitamins|vitamins|mesh-ancestor
138218566|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
138218567|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218568|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138218569|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138218570|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138218571|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138218572|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218573|NCT00775658|Analgesics|analgesics|mesh-ancestor
138360135|NCT00377442|Simvastatin|simvastatin|mesh-list
138218574|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
138218575|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218576|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218578|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138218579|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138218580|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138218581|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138218582|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218583|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
138218584|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218585|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218586|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138218587|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218588|NCT00799604|Clevidipine|clevidipine|mesh-list
138218589|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138218590|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218591|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218592|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138218593|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218595|NCT01259063|Everolimus|everolimus|mesh-list
138218596|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138218597|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
138218598|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218599|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218600|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138218601|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138218602|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218603|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138218604|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
138218605|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218606|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
138218607|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138218608|NCT04383548|Antibodies|antibodies|mesh-list
138218609|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
138218610|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218611|NCT01313897|Bortezomib|bortezomib|mesh-list
138218612|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218613|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138218614|NCT04351763|Amiodarone|amiodarone|mesh-list
138218615|NCT04351763|Verapamil|verapamil|mesh-list
138218616|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218617|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
138218618|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138218619|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218620|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218621|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138218622|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138218623|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138218624|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218625|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138218626|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138218627|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138218628|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138218629|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208043|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138218632|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138218633|NCT00801398|Narcotics|narcotics|mesh-ancestor
138218634|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218635|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218636|NCT00801398|Analgesics|analgesics|mesh-ancestor
138218637|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
138218638|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218639|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138360156|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138218641|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138218642|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
138218644|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218645|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138218646|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138218647|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
138218648|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218649|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218650|NCT01342757|Temozolomide|temozolomide|mesh-list
138218651|NCT01342757|Vorinostat|vorinostat|mesh-list
138218652|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138208093|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
138218653|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
138218654|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218655|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218656|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138218657|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218658|NCT02199743|Haloperidol|haloperidol|mesh-list
138218659|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
138218660|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138218661|NCT02199743|Perphenazine|perphenazine|mesh-list
138218662|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
138218663|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
138218664|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218665|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218666|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218667|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138218668|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138218669|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218670|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218671|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138218672|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
138218673|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218674|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218676|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138218677|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138218678|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208141|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
138218680|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138218681|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138218682|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
138218683|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138218684|NCT00776594|Bevacizumab|bevacizumab|mesh-list
138218685|NCT00776594|Bicalutamide|bicalutamide|mesh-list
138218686|NCT00776594|Androgens|androgens|mesh-list
138218687|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218688|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218689|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138218690|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138218691|NCT00776594|Growth Substances|growth substances|mesh-ancestor
138218692|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218693|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138218695|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218696|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
138218697|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
138218698|NCT00777062|Naltrexone|naltrexone|mesh-list
138218699|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138218700|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138218701|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218702|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
138208183|NCT00189098|Trimethoprim|trimethoprim|mesh-list
138218703|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218704|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138218705|NCT01318967|Furosemide|furosemide|mesh-list
138218706|NCT01318967|Diuretics|diuretics|mesh-ancestor
138218707|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
138218708|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218709|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138218710|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218711|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218712|NCT01319045|Iloprost|iloprost|mesh-list
138348461|NCT02525718|Dexamethasone|dexamethasone|mesh-list
138218713|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138218714|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138218715|NCT01348607|Methylphenidate|methylphenidate|mesh-list
138218716|NCT01348607|Modafinil|modafinil|mesh-list
138218717|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138218718|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218719|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138218720|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138218721|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218722|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218723|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
138218724|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218725|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138218726|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138218727|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138218728|NCT06214572|Paclitaxel|paclitaxel|mesh-list
138218729|NCT06214572|Cisplatin|cisplatin|mesh-list
138218730|NCT06214572|Gemcitabine|gemcitabine|mesh-list
138218732|NCT06214572|Durvalumab|durvalumab|mesh-list
138218733|NCT06214572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138218734|NCT06214572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218735|NCT06214572|Tubulin Modulators|tubulin modulators|mesh-ancestor
138218736|NCT06214572|Antimitotic Agents|antimitotic agents|mesh-ancestor
138218737|NCT06214572|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218738|NCT06214572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218739|NCT06214572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208230|NCT01447225|Pemetrexed|pemetrexed|mesh-list
138218741|NCT06214572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218743|NCT06214533|Anesthetics, Local|anesthetics, local|mesh-ancestor
138218744|NCT06214533|Anesthetics|anesthetics|mesh-ancestor
138218745|NCT06214533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218746|NCT06214533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218747|NCT06214533|Sensory System Agents|sensory system agents|mesh-ancestor
138218748|NCT06214533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218750|NCT06214468|Niacinamide|niacinamide|mesh-list
138218752|NCT06214468|Nicotinic Acids|nicotinic acids|mesh-list
138218753|NCT06214468|Vitamins|vitamins|mesh-ancestor
138218754|NCT06214468|Micronutrients|micronutrients|mesh-ancestor
138218755|NCT06214468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218756|NCT06214468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218757|NCT06214468|Analgesics|analgesics|mesh-ancestor
138218758|NCT06214468|Sensory System Agents|sensory system agents|mesh-ancestor
138218759|NCT06214468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218760|NCT06214468|Antipyretics|antipyretics|mesh-ancestor
138218761|NCT06214468|Vitamin B Complex|vitamin b complex|mesh-ancestor
138218762|NCT06214468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138218763|NCT06214468|Antimetabolites|antimetabolites|mesh-ancestor
138218764|NCT06214468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218765|NCT06214468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138218766|NCT06214468|Vasodilator Agents|vasodilator agents|mesh-ancestor
138218767|NCT06214377|Dopamine|dopamine|mesh-list
138218768|NCT06214377|Dopamine Agonists|dopamine agonists|mesh-list
138218769|NCT06214377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138218770|NCT06214377|Sympathomimetics|sympathomimetics|mesh-ancestor
138218771|NCT06214377|Autonomic Agents|autonomic agents|mesh-ancestor
138218772|NCT06214377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348555|NCT02541864|Bismuth|bismuth|mesh-list
138218773|NCT06214377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208268|NCT01474213|Remifentanil|remifentanil|mesh-list
138218774|NCT06214377|Dopamine Agents|dopamine agents|mesh-ancestor
138218775|NCT06214377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360168|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
138218776|NCT06214377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218777|NCT06214377|Protective Agents|protective agents|mesh-ancestor
138218779|NCT06214169|Cisatracurium|cisatracurium|mesh-list
138218780|NCT06214169|Anesthetics, Local|anesthetics, local|mesh-ancestor
138218781|NCT06214169|Anesthetics|anesthetics|mesh-ancestor
138218782|NCT06214169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218783|NCT06214169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218784|NCT06214169|Sensory System Agents|sensory system agents|mesh-ancestor
138218785|NCT06214169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218786|NCT06214169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218787|NCT06214169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138218788|NCT06214169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138218789|NCT06214169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218790|NCT06214169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218791|NCT06214169|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138218792|NCT06214169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138218793|NCT06214117|Anesthetics|anesthetics|mesh-list
138218794|NCT06214117|Sevoflurane|sevoflurane|mesh-list
138218795|NCT06214117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218796|NCT06214117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218797|NCT06214117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138218798|NCT06214117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138218799|NCT06214117|Anesthetics, General|anesthetics, general|mesh-ancestor
138218800|NCT06214078|Niacinamide|niacinamide|mesh-list
138218802|NCT06214078|Nicotinic Acids|nicotinic acids|mesh-list
138218803|NCT06214078|Vitamin B Complex|vitamin b complex|mesh-ancestor
138218805|NCT06214078|Micronutrients|micronutrients|mesh-ancestor
138218806|NCT06214078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218807|NCT06214078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138218808|NCT06214078|Antimetabolites|antimetabolites|mesh-ancestor
138218809|NCT06214078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218810|NCT06214078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138218811|NCT06214078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138218813|NCT06213987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218814|NCT06213987|Keratolytic Agents|keratolytic agents|mesh-ancestor
138218815|NCT06213987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138218816|NCT06213948|Mirtazapine|mirtazapine|mesh-list
138218817|NCT06213948|Antidepressive Agents|antidepressive agents|mesh-ancestor
138218818|NCT06213948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218819|NCT06213948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138218820|NCT06213948|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218821|NCT06213948|Histamine Agents|histamine agents|mesh-ancestor
138218822|NCT06213948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218823|NCT06213948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218824|NCT06213948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218825|NCT06213948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138218826|NCT06213948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138218827|NCT06213948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218828|NCT06213948|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138218830|NCT06213948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138218831|NCT06213948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138218832|NCT06213948|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138218833|NCT06213948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138218834|NCT06213948|Serotonin Agents|serotonin agents|mesh-ancestor
138218835|NCT06213948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138218836|NCT06213935|Norepinephrine|norepinephrine|mesh-list
138218837|NCT06213935|Midodrine|midodrine|mesh-list
138218838|NCT06213935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138218839|NCT06213935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138218840|NCT06213935|Adrenergic Agents|adrenergic agents|mesh-ancestor
138218841|NCT06213935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218842|NCT06213935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218843|NCT06213935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218844|NCT06213935|Sympathomimetics|sympathomimetics|mesh-ancestor
138218845|NCT06213935|Autonomic Agents|autonomic agents|mesh-ancestor
138218846|NCT06213935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218847|NCT06213935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138218848|NCT06213935|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138218849|NCT06213857|Silymarin|silymarin|mesh-list
138218850|NCT06213857|Antioxidants|antioxidants|mesh-ancestor
138218851|NCT06213857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218852|NCT06213857|Protective Agents|protective agents|mesh-ancestor
138218853|NCT06213857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218854|NCT06213818|Esomeprazole|esomeprazole|mesh-list
138218855|NCT06213818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138218856|NCT06213818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218857|NCT06213818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138218858|NCT06213818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218859|NCT06213818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218860|NCT06213727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138218861|NCT06213727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138218862|NCT06213662|Botulinum Toxins|botulinum toxins|mesh-list
138218863|NCT06213662|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138218864|NCT06213662|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138218865|NCT06213662|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138218866|NCT06213662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218867|NCT06213662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218868|NCT06213662|Cholinergic Agents|cholinergic agents|mesh-ancestor
138218869|NCT06213662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218870|NCT06213662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218871|NCT06213662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138218872|NCT06213662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218873|NCT06213610|Perindopril|perindopril|mesh-list
138218874|NCT06213610|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138218875|NCT06213610|Protease Inhibitors|protease inhibitors|mesh-ancestor
138218876|NCT06213610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218877|NCT06213610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348735|NCT05248152|Acetaminophen|acetaminophen|mesh-list
138218878|NCT06213610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138218879|NCT06213519|Oxaliplatin|oxaliplatin|mesh-list
138218880|NCT06213519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218881|NCT06213506|Vaccines|vaccines|mesh-list
138360176|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208464|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
138218896|NCT06213324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218897|NCT06213324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138218898|NCT06213324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138218899|NCT06213324|Anesthetics, General|anesthetics, general|mesh-ancestor
138218900|NCT06213324|Anesthetics|anesthetics|mesh-ancestor
138218901|NCT06213324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218902|NCT06213324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138348805|NCT02056236|Midazolam|midazolam|mesh-list
138218903|NCT06213324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138218904|NCT06213324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218905|NCT06213324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218906|NCT06213311|Obinutuzumab|obinutuzumab|mesh-list
138218907|NCT06213311|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138218908|NCT06213311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138218909|NCT06213311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218911|NCT06213116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138218912|NCT06213116|Anesthetics|anesthetics|mesh-ancestor
138218913|NCT06213116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218914|NCT06213116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218915|NCT06213116|Sensory System Agents|sensory system agents|mesh-ancestor
138218916|NCT06213116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218917|NCT06213116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218918|NCT06213116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138218919|NCT06213116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138218920|NCT06213116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138218921|NCT06213116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218923|NCT06213077|Tadalafil|tadalafil|mesh-list
138218924|NCT06213077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138218925|NCT06213077|Autonomic Agents|autonomic agents|mesh-ancestor
138218926|NCT06213077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218927|NCT06213077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218928|NCT06213077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138218929|NCT06213077|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218930|NCT06213077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138218932|NCT06213077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218933|NCT06213077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218934|NCT06213077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138218935|NCT06213077|Vasodilator Agents|vasodilator agents|mesh-ancestor
138218936|NCT06213077|Gasotransmitters|gasotransmitters|mesh-ancestor
138218937|NCT06213077|Protective Agents|protective agents|mesh-ancestor
138218938|NCT06213077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138218939|NCT06213077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138218940|NCT06213077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218941|NCT06213077|Urological Agents|urological agents|mesh-ancestor
138218943|NCT06212973|Epinastine|epinastine|mesh-list
138218944|NCT06212973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138218945|NCT06212973|Autonomic Agents|autonomic agents|mesh-ancestor
138218946|NCT06212973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218947|NCT06212973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218948|NCT06212973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138218949|NCT06212973|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218950|NCT06212973|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138218951|NCT06212973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218952|NCT06212973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218953|NCT06212973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138218954|NCT06212973|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138218955|NCT06212973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138360227|NCT00378690|Leuprolide|leuprolide|mesh-list
138218956|NCT06212973|Histamine Antagonists|histamine antagonists|mesh-ancestor
138218957|NCT06212973|Histamine Agents|histamine agents|mesh-ancestor
138218958|NCT06212973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218959|NCT06212934|Estazolam|estazolam|mesh-list
138218960|NCT06212934|Anticonvulsants|anticonvulsants|mesh-ancestor
138218961|NCT06212934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138218962|NCT06212934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138218963|NCT06212934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218964|NCT06212934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218965|NCT06212934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218966|NCT06212934|GABA Modulators|gaba modulators|mesh-ancestor
138208656|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138218967|NCT06212934|GABA Agents|gaba agents|mesh-ancestor
138218968|NCT06212934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218969|NCT06212934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218971|NCT06212830|Gabapentin|gabapentin|mesh-list
138218972|NCT06212830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138218973|NCT06212830|Analgesics|analgesics|mesh-ancestor
138218974|NCT06212830|Sensory System Agents|sensory system agents|mesh-ancestor
138218975|NCT06212830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218976|NCT06212830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218977|NCT06212830|Antipyretics|antipyretics|mesh-ancestor
138218978|NCT06212830|Anticonvulsants|anticonvulsants|mesh-ancestor
138218979|NCT06212830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138218980|NCT06212830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138218981|NCT06212830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218982|NCT06212830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138218983|NCT06212830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138218984|NCT06212830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138218985|NCT06212830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218986|NCT06212830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218988|NCT06212752|Paclitaxel|paclitaxel|mesh-list
138218989|NCT06212752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138218990|NCT06212752|Carboplatin|carboplatin|mesh-list
138218991|NCT06212752|Pembrolizumab|pembrolizumab|mesh-list
138218992|NCT06212752|Pemetrexed|pemetrexed|mesh-list
138218993|NCT06212752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208703|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
138218995|NCT06212752|Tubulin Modulators|tubulin modulators|mesh-ancestor
138218996|NCT06212752|Antimitotic Agents|antimitotic agents|mesh-ancestor
138218997|NCT06212752|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218998|NCT06212752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218999|NCT06212752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219000|NCT06212752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219001|NCT06212752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219002|NCT06212752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138219003|NCT06212752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138219006|NCT06212661|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138219007|NCT06212661|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138219008|NCT06212661|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138219009|NCT06212661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138219010|NCT06212661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219011|NCT06212661|Cholinergic Agents|cholinergic agents|mesh-ancestor
138219012|NCT06212661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219013|NCT06212661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219014|NCT06212661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138219015|NCT06212661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219016|NCT06212661|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138219017|NCT06212661|Analgesics|analgesics|mesh-ancestor
138219018|NCT06212661|Sensory System Agents|sensory system agents|mesh-ancestor
138219019|NCT06212648|Amlodipine|amlodipine|mesh-list
138219020|NCT06212648|Candesartan|candesartan|mesh-list
138219021|NCT06212648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138219022|NCT06212648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138219023|NCT06212648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138219024|NCT06212648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219025|NCT06212648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138219026|NCT06212648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219028|NCT06212648|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138219029|NCT06212648|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138219030|NCT06212622|Oxycodone|oxycodone|mesh-list
138219031|NCT06212622|Alfentanil|alfentanil|mesh-list
138219032|NCT06212622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138219033|NCT06212622|Narcotics|narcotics|mesh-ancestor
138219034|NCT06212622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219035|NCT06212622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219036|NCT06212622|Analgesics|analgesics|mesh-ancestor
138219037|NCT06212622|Sensory System Agents|sensory system agents|mesh-ancestor
138219038|NCT06212622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219039|NCT06212622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138219040|NCT06212622|Anesthetics, General|anesthetics, general|mesh-ancestor
138219041|NCT06212622|Anesthetics|anesthetics|mesh-ancestor
138219042|NCT06212596|Prednisone|prednisone|mesh-list
138219043|NCT06212596|Cyclophosphamide|cyclophosphamide|mesh-list
138219044|NCT06212596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219045|NCT06212596|Immunologic Factors|immunologic factors|mesh-ancestor
138219046|NCT06212596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219047|NCT06212596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219048|NCT06212596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138219049|NCT06212596|Alkylating Agents|alkylating agents|mesh-ancestor
138219050|NCT06212596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219051|NCT06212596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349028|NCT03958344|Hormones|hormones|mesh-ancestor
138219052|NCT06212596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138219053|NCT06212596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219054|NCT06212596|Glucocorticoids|glucocorticoids|mesh-ancestor
138219055|NCT06212596|Hormones|hormones|mesh-ancestor
138219056|NCT06212596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219057|NCT06212596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138219058|NCT06212583|Abiraterone Acetate|abiraterone acetate|mesh-list
138219059|NCT06212583|Niraparib|niraparib|mesh-list
138219060|NCT06212583|Androgens|androgens|mesh-list
138219061|NCT06212583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208849|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
138208850|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219062|NCT06212583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138219064|NCT06212583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219066|NCT06212583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219067|NCT06212583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219068|NCT06212583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349071|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219069|NCT06212583|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138219071|NCT06210776|Trastuzumab|trastuzumab|mesh-list
138219072|NCT06210776|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138219073|NCT06210776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219074|NCT06210776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219075|NCT06210776|Immunoconjugates|immunoconjugates|mesh-ancestor
138219076|NCT06210776|Immunologic Factors|immunologic factors|mesh-ancestor
138219077|NCT06210776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219078|NCT06210126|Anesthetics|anesthetics|mesh-list
138219079|NCT06210126|Anesthetics, Local|anesthetics, local|mesh-list
138219080|NCT06210126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219081|NCT06210126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219082|NCT06210126|Sensory System Agents|sensory system agents|mesh-ancestor
138219083|NCT06210126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219084|NCT06209606|Methylprednisolone|methylprednisolone|mesh-list
138219085|NCT06209606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138219086|NCT06209606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138219087|NCT06209606|Prednisolone|prednisolone|mesh-list
138219088|NCT06209606|Prednisolone acetate|prednisolone acetate|mesh-list
138219089|NCT06209606|Lenalidomide|lenalidomide|mesh-list
138219090|NCT06209606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138219091|NCT06209606|Prednisolone phosphate|prednisolone phosphate|mesh-list
138219092|NCT06209606|Immunologic Factors|immunologic factors|mesh-ancestor
138219093|NCT06209606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219094|NCT06209606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138219095|NCT06209606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138219096|NCT06209606|Growth Substances|growth substances|mesh-ancestor
138219097|NCT06209606|Growth Inhibitors|growth inhibitors|mesh-ancestor
138219098|NCT06209606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219099|NCT06209606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219101|NCT06209606|Autonomic Agents|autonomic agents|mesh-ancestor
138219102|NCT06209606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219103|NCT06209606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219104|NCT06209606|Glucocorticoids|glucocorticoids|mesh-ancestor
138219105|NCT06209606|Hormones|hormones|mesh-ancestor
138219106|NCT06209606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219107|NCT06209606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138219108|NCT06209606|Protective Agents|protective agents|mesh-ancestor
138219109|NCT06209606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138219110|NCT06202014|Capecitabine|capecitabine|mesh-list
138219111|NCT06202014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219112|NCT06202014|Antimetabolites|antimetabolites|mesh-ancestor
138219113|NCT06202014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219114|NCT06202014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208940|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138219116|NCT06200194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138219117|NCT06200194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138219118|NCT06200194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138219119|NCT06200194|Autonomic Agents|autonomic agents|mesh-ancestor
138219120|NCT06200194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219121|NCT06200194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219122|NCT06200194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138219123|NCT06200194|Respiratory System Agents|respiratory system agents|mesh-ancestor
138219125|NCT06200194|Parasympatholytics|parasympatholytics|mesh-ancestor
138219126|NCT06200194|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138219127|NCT06200194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138219128|NCT06200194|Cholinergic Agents|cholinergic agents|mesh-ancestor
138219129|NCT06200194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219130|NCT06200194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219131|NCT06198556|Rifampin|rifampin|mesh-list
138219132|NCT06198556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138219133|NCT06198556|Antitubercular Agents|antitubercular agents|mesh-ancestor
138219134|NCT06198556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138219135|NCT06198556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219136|NCT06198556|Leprostatic Agents|leprostatic agents|mesh-ancestor
138219137|NCT06198556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138219138|NCT06198556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219139|NCT06198556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219140|NCT06198556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138219141|NCT06198556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138219142|NCT06198556|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138219143|NCT06198556|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138219144|NCT06198556|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138219145|NCT06198556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138219147|NCT06190249|Cyclophosphamide|cyclophosphamide|mesh-list
138219148|NCT06190249|Pembrolizumab|pembrolizumab|mesh-list
138219149|NCT06190249|Fludarabine|fludarabine|mesh-list
138219150|NCT06190249|Interleukin-2|interleukin-2|mesh-list
138219151|NCT06190249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219152|NCT06190249|Immunologic Factors|immunologic factors|mesh-ancestor
138219153|NCT06190249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219154|NCT06190249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219155|NCT06190249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138219156|NCT06190249|Alkylating Agents|alkylating agents|mesh-ancestor
138219157|NCT06190249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219158|NCT06190249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219159|NCT06190249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138209038|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219160|NCT06190249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219161|NCT06190249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219162|NCT06190249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138219164|NCT06190249|Sensory System Agents|sensory system agents|mesh-ancestor
138219165|NCT06190249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219166|NCT06190249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138219167|NCT06190249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138219168|NCT06190249|Antiviral Agents|antiviral agents|mesh-ancestor
138219169|NCT06190249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219170|NCT06174688|Botulinum Toxins|botulinum toxins|mesh-list
138219171|NCT06174688|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138219172|NCT06174688|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138219173|NCT06174688|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138219174|NCT06174688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138219175|NCT06174688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219176|NCT06174688|Cholinergic Agents|cholinergic agents|mesh-ancestor
138219177|NCT06174688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219178|NCT06174688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349282|NCT02653872|Diltiazem|diltiazem|mesh-list
138219180|NCT06174688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219187|NCT06164951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219188|NCT06150183|Pembrolizumab|pembrolizumab|mesh-list
138219189|NCT06150183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219190|NCT06150183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219191|NCT06150183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219192|NCT06150183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219193|NCT06140836|Crizotinib|crizotinib|mesh-list
138219194|NCT06140836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219195|NCT06140836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138219196|NCT06140836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219197|NCT06140836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219199|NCT06132958|Doxorubicin|doxorubicin|mesh-list
138219200|NCT06132958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219201|NCT06132958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219202|NCT06132958|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219203|NCT06132958|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219205|NCT06132958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219206|NCT06132958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138219207|NCT06132958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138219208|NCT06132958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138219209|NCT06132958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219211|NCT06120972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138219212|NCT06120972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219213|NCT06120972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219214|NCT06120972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219216|NCT06108830|Esketamine|esketamine|mesh-list
138219217|NCT06108830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138219218|NCT06108830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219219|NCT06108830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219220|NCT06108830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138219221|NCT06108830|Anesthetics, General|anesthetics, general|mesh-ancestor
138219222|NCT06108830|Anesthetics|anesthetics|mesh-ancestor
138219223|NCT06108830|Antidepressive Agents|antidepressive agents|mesh-ancestor
138219224|NCT06108830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138219225|NCT06099782|Pembrolizumab|pembrolizumab|mesh-list
138219226|NCT06099782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219227|NCT06099782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219228|NCT06099782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219229|NCT06099782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219230|NCT06089577|Cangrelor|cangrelor|mesh-list
138219231|NCT06089577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138219232|NCT06089577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138349357|NCT02657928|Letrozole|letrozole|mesh-list
138219264|NCT06074588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219265|NCT06074588|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219266|NCT06074588|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219267|NCT06074588|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219268|NCT06074588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219292|NCT06047548|Tirzepatide|tirzepatide|mesh-list
138219293|NCT06047548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219294|NCT06047548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219295|NCT06047548|Incretins|incretins|mesh-ancestor
138219297|NCT06047548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219298|NCT06013241|Mometasone Furoate|mometasone furoate|mesh-list
138219299|NCT06013241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219300|NCT06013241|Dermatologic Agents|dermatologic agents|mesh-ancestor
138219301|NCT06013241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138219302|NCT05952453|Carboplatin|carboplatin|mesh-list
138219303|NCT05952453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219304|NCT05942300|Carboplatin|carboplatin|mesh-list
138219305|NCT05942300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219306|NCT05927142|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138219307|NCT05927142|Durvalumab|durvalumab|mesh-list
138219308|NCT05927142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219309|NCT05927142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219310|NCT05927142|Antiviral Agents|antiviral agents|mesh-ancestor
138219311|NCT05927142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219313|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219314|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138219315|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
138219316|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138219317|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138219318|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219319|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
138219320|NCT05899465|Coagulants|coagulants|mesh-ancestor
138219341|NCT05885074|Empagliflozin|empagliflozin|mesh-list
138219342|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138219343|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219344|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219345|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219346|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
138219347|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138219348|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138219349|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138219350|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138219355|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219357|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219358|NCT05869591|Apixaban|apixaban|mesh-list
138219359|NCT05869591|Edoxaban|edoxaban|mesh-list
138219360|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138219361|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
138219362|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138219363|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138219364|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219365|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219366|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
138219367|NCT05867121|Paclitaxel|paclitaxel|mesh-list
138219368|NCT05867121|Gemcitabine|gemcitabine|mesh-list
138219369|NCT05867121|Capecitabine|capecitabine|mesh-list
138219370|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
138219371|NCT05867121|Nivolumab|nivolumab|mesh-list
138219372|NCT05867121|Atezolizumab|atezolizumab|mesh-list
138219373|NCT05867121|Tegafur|tegafur|mesh-list
138219374|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219375|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219376|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219377|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219378|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219379|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219380|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219381|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
138209201|NCT02099006|Ketamine|ketamine|mesh-list
138219382|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219383|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219389|NCT05834738|Atrasentan|atrasentan|mesh-list
138219390|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219392|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138219393|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219394|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
138219395|NCT05805501|Axitinib|axitinib|mesh-list
138219396|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219397|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219398|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219399|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219400|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138219401|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219402|NCT05782608|Ibuprofen|ibuprofen|mesh-list
138219403|NCT05782608|Ketorolac|ketorolac|mesh-list
138219404|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138219405|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138219406|NCT05782608|Analgesics|analgesics|mesh-ancestor
138219407|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
138219408|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219409|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219410|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219411|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219412|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138219413|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219414|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219415|NCT05776875|Bevacizumab|bevacizumab|mesh-list
138219416|NCT05776875|Atezolizumab|atezolizumab|mesh-list
138219417|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219418|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219419|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138219420|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138349598|NCT05266404|Incretins|incretins|mesh-ancestor
138219422|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219423|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
138219424|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219452|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138219453|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
138219454|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138219455|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
138219456|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
138219457|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138219458|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138219459|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138219460|NCT05761171|Cortisone|cortisone|mesh-list
138219461|NCT05761171|Methotrexate|methotrexate|mesh-list
138219462|NCT05761171|Fludarabine|fludarabine|mesh-list
138219463|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
138219464|NCT05761171|Vincristine|vincristine|mesh-list
138219465|NCT05761171|Asparaginase|asparaginase|mesh-list
138219466|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138219467|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
138219468|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219469|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
138219470|NCT05761171|Hormones|hormones|mesh-ancestor
138414712|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219471|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219473|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138219474|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219475|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138219476|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
138219477|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138219478|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219479|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
138219480|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219481|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
138219482|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219483|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138219484|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219485|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
138219486|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219487|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138219488|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
138219489|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219490|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219491|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219492|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219493|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219495|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
138219501|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219504|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219505|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219506|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219507|NCT05737693|Midazolam|midazolam|mesh-list
138219508|NCT05737693|Ketamine|ketamine|mesh-list
138219509|NCT05737693|Analgesics|analgesics|mesh-ancestor
138219510|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
138219511|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219512|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219513|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138219514|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138219515|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
138219516|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
138219517|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219518|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138349747|NCT04176354|Letrozole|letrozole|mesh-list
138219519|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138219520|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219521|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219522|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138219523|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138219524|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138219525|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138219526|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138219527|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
138219528|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
138209380|NCT00327392|Fospropofol|fospropofol|mesh-list
138349790|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209385|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
138219562|NCT05691712|Hormones|hormones|mesh-ancestor
138219563|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219564|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
138219565|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219566|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
138349851|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209416|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219568|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
138219569|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
138219570|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219571|NCT05674643|Acetaminophen|acetaminophen|mesh-list
138219572|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138219573|NCT05674643|Analgesics|analgesics|mesh-ancestor
138219574|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
138219575|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219576|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219577|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
138219578|NCT05671510|Docetaxel|docetaxel|mesh-list
138219579|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219580|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219581|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219582|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219583|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219584|NCT05670236|Lidocaine|lidocaine|mesh-list
138219585|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138219586|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
138219587|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219588|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219589|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
138219590|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219591|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138219592|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138219593|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138219595|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219601|NCT05643651|Aspirin|aspirin|mesh-list
138219602|NCT05643651|Vitamin K|vitamin k|mesh-list
138219603|NCT05643651|Warfarin|warfarin|mesh-list
138219604|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
138219605|NCT05643651|Clopidogrel|clopidogrel|mesh-list
138219606|NCT05643651|Vitamins|vitamins|mesh-ancestor
138209481|NCT01183169|Ribavirin|ribavirin|mesh-list
138219607|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
138219608|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219609|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138219610|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138219611|NCT05643651|Analgesics|analgesics|mesh-ancestor
138219612|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
138219613|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219614|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219615|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219616|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138219617|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138219618|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219619|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138219620|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138219621|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219622|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
138219623|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138219624|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138219625|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138219626|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
138219627|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219628|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
138219629|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138219630|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
138219631|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138219632|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
138219633|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138219634|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
138219635|NCT05643651|Coagulants|coagulants|mesh-ancestor
138219636|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
138219638|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219639|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219640|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219641|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219642|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138219643|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219644|NCT05615220|Ecopipam|ecopipam|mesh-list
138219645|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138219646|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138219647|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219665|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
138219666|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
138219667|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219671|NCT05585320|Paclitaxel|paclitaxel|mesh-list
138219672|NCT05585320|Gemcitabine|gemcitabine|mesh-list
138219673|NCT05585320|Folfirinox|folfirinox|mesh-list
138219674|NCT05585320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219675|NCT05585320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219676|NCT05585320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219677|NCT05585320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219678|NCT05585320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219679|NCT05585320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219680|NCT05585320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219681|NCT05585320|Antimetabolites|antimetabolites|mesh-ancestor
138219682|NCT05562947|Ranibizumab|ranibizumab|mesh-list
138219683|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138219684|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138219685|NCT05562947|Growth Substances|growth substances|mesh-ancestor
138219686|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219687|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
138219688|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219697|NCT05548075|Psilocybin|psilocybin|mesh-list
138219698|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138219699|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
138219700|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219701|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138219702|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138219703|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
138219704|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219705|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219706|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138219707|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138219708|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138219709|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219711|NCT05498025|Charcoal|charcoal|mesh-list
138219712|NCT05498025|Antidotes|antidotes|mesh-ancestor
138219713|NCT05498025|Protective Agents|protective agents|mesh-ancestor
138219714|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219715|NCT05497778|Paclitaxel|paclitaxel|mesh-list
138219716|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138219717|NCT05497778|Gemcitabine|gemcitabine|mesh-list
138219718|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138219719|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219720|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219721|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138219722|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219723|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219724|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138219726|NCT05497557|Sotorasib|sotorasib|mesh-list
138219727|NCT05497557|Omeprazole|omeprazole|mesh-list
138219728|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138219729|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219730|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138219731|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219732|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219733|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219734|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219735|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219736|NCT05487235|Atezolizumab|atezolizumab|mesh-list
138219737|NCT05487235|Omeprazole|omeprazole|mesh-list
138219738|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219739|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219740|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219741|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219742|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138350218|NCT06084130|GABA Agents|gaba agents|mesh-ancestor
138219744|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138219745|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219749|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
138219750|NCT05466799|Irinotecan|irinotecan|mesh-list
138219751|NCT05466799|Folfirinox|folfirinox|mesh-list
138219752|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219753|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138219754|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138219755|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219756|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219758|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219759|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219760|NCT05444699|Prednisolone|prednisolone|mesh-list
138219761|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138219762|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
138219763|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138219764|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
138219765|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138219766|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
138219767|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219768|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
138219769|NCT05444699|Hormones|hormones|mesh-ancestor
138219770|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219771|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219772|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138219773|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219775|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
138219776|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219777|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219778|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138219779|NCT05444699|Protective Agents|protective agents|mesh-ancestor
138219804|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
138219805|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
138209594|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219806|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138219807|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138219808|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350271|NCT06082232|Midazolam|midazolam|mesh-list
138219809|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138219828|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219829|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219830|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138219831|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219832|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219834|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219835|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219836|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138219837|NCT05356104|Incretins|incretins|mesh-ancestor
138219838|NCT05356104|Hormones|hormones|mesh-ancestor
138219839|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219840|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
138219841|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138219842|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138219862|NCT05328908|Trifluridine|trifluridine|mesh-list
138219863|NCT05328908|Nivolumab|nivolumab|mesh-list
138219864|NCT05328908|Relatlimab|relatlimab|mesh-list
138219865|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219866|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219868|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219869|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
138219870|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
138219871|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219945|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138219946|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138219947|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138219967|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
138219968|NCT05289167|Bortezomib|bortezomib|mesh-list
138219969|NCT05289167|Abatacept|abatacept|mesh-list
138219970|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219971|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
138219972|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219973|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209648|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
138219974|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138219975|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
138219976|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219977|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219978|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138219979|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138219980|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138219981|NCT05257083|Dexamethasone|dexamethasone|mesh-list
138219982|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
138219983|NCT05257083|Fludarabine|fludarabine|mesh-list
138219984|NCT05257083|Lenalidomide|lenalidomide|mesh-list
138219985|NCT05257083|Bortezomib|bortezomib|mesh-list
138219986|NCT05257083|Daratumumab|daratumumab|mesh-list
138219987|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219988|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
138219989|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219990|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138219991|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138219992|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
138219993|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219994|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219995|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138220012|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209670|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220013|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220014|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
138220015|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
138220022|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
138220023|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220024|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220025|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220026|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220027|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
138220028|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220029|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220030|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220031|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220032|NCT05176223|Edetic Acid|edetic acid|mesh-list
138220033|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138220034|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
138220035|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
138220036|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220037|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
138220038|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138220039|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138220041|NCT05171075|Tinzaparin|tinzaparin|mesh-list
138220042|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138220043|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
138220044|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138220045|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138220046|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220047|NCT05171049|Apixaban|apixaban|mesh-list
138220048|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138220049|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
138220050|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138220051|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
138220052|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220053|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220054|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
138220055|NCT05170204|Durvalumab|durvalumab|mesh-list
138220056|NCT05170204|Entrectinib|entrectinib|mesh-list
138220057|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220058|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220059|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220060|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220061|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220062|NCT05164549|Buprenorphine|buprenorphine|mesh-list
138220063|NCT05164549|Methadone|methadone|mesh-list
138220064|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138220065|NCT05164549|Narcotics|narcotics|mesh-ancestor
138220066|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220067|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220068|NCT05164549|Analgesics|analgesics|mesh-ancestor
138220069|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
138220070|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220071|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138220072|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
138220073|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
138220092|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220093|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
138220094|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220095|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
138220096|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220099|NCT05079230|Magrolimab|magrolimab|mesh-list
138220100|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220101|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
138350500|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220102|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220104|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220105|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220106|NCT05077904|Alprazolam|alprazolam|mesh-list
138209752|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220107|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138220108|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220109|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220110|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138220111|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138220112|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138220113|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
138220114|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
138220115|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220116|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220117|NCT05076617|Alprazolam|alprazolam|mesh-list
138220118|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138220119|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220120|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220121|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138220122|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138220123|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138220124|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
138220125|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
138220126|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220127|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220128|NCT05061134|Durvalumab|durvalumab|mesh-list
138220129|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220130|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220131|NCT05032235|Fluzoparib|fluzoparib|mesh-list
138220132|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138220133|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220134|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209780|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220135|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220136|NCT05028062|Naltrexone|naltrexone|mesh-list
138220137|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138220138|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138220139|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220141|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220142|NCT05024032|Tirzepatide|tirzepatide|mesh-list
138220143|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138220144|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220145|NCT05024032|Incretins|incretins|mesh-ancestor
138220146|NCT05024032|Hormones|hormones|mesh-ancestor
138220147|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220148|NCT05020236|Dexamethasone|dexamethasone|mesh-list
138220149|NCT05020236|Daratumumab|daratumumab|mesh-list
138220150|NCT05020236|Pomalidomide|pomalidomide|mesh-list
138220151|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220152|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
138220153|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
138220154|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220155|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220156|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138220157|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
138220158|NCT05020236|Hormones|hormones|mesh-ancestor
138220159|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220160|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138220163|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220164|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220165|NCT05020236|Growth Substances|growth substances|mesh-ancestor
138220166|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220167|NCT05004350|Fluorouracil|fluorouracil|mesh-list
138220168|NCT05004350|Irinotecan|irinotecan|mesh-list
138220169|NCT05004350|Cetuximab|cetuximab|mesh-list
138220170|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
138220171|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220172|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220173|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220174|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220175|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
138220176|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220177|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138220178|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138220179|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220180|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220182|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
138220183|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220184|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
138220185|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
138220186|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220187|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
138220188|NCT04949256|Leucovorin|leucovorin|mesh-list
138220189|NCT04949256|Paclitaxel|paclitaxel|mesh-list
138220190|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
138220191|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
138220192|NCT04949256|Lenvatinib|lenvatinib|mesh-list
138220193|NCT04949256|Calcium|calcium|mesh-list
138220194|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
138220195|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138220196|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220197|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138220198|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138220199|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138220200|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220201|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220202|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220203|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138220204|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220205|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138220206|NCT04949256|Antidotes|antidotes|mesh-ancestor
138220207|NCT04949256|Protective Agents|protective agents|mesh-ancestor
138220208|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138220209|NCT04949256|Vitamins|vitamins|mesh-ancestor
138220210|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
138220211|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220212|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220213|NCT04899765|Vaccines|vaccines|mesh-list
138220214|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
138220215|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
138220216|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220217|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138220218|NCT04891991|Infliximab|infliximab|mesh-list
138220219|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138220220|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220221|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
138220222|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138220223|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220225|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138220226|NCT04858009|Cisplatin|cisplatin|mesh-list
138220227|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138220228|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220229|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
138220337|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220338|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220339|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220340|NCT04674254|Bevacizumab|bevacizumab|mesh-list
138220341|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220342|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220343|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220344|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220345|NCT04674254|Growth Substances|growth substances|mesh-ancestor
138220346|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220347|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220348|NCT04666610|Brivaracetam|brivaracetam|mesh-list
138220349|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
138220350|NCT04665843|Atezolizumab|atezolizumab|mesh-list
138220351|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220352|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220353|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220354|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220355|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
138220356|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220357|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220359|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220360|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
138220361|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220362|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220363|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220364|NCT04583501|Omalizumab|omalizumab|mesh-list
138220365|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138220366|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138220367|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
138220368|NCT04580771|Cisplatin|cisplatin|mesh-list
138220369|NCT04580771|Vaccines|vaccines|mesh-list
138220370|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
138220371|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220372|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220374|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
138220375|NCT04569032|Doxorubicin|doxorubicin|mesh-list
138220376|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138220377|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220378|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
138220379|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220380|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220381|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138220382|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
138220383|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220384|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220385|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138220386|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138220387|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138220388|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138220389|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220390|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220391|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
138220392|NCT04569032|Hormones|hormones|mesh-ancestor
138220393|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220394|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138220395|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220396|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
138220397|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
138220398|NCT04527991|Paclitaxel|paclitaxel|mesh-list
138220400|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138220401|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138220402|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220403|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
138209951|NCT00315302|Atropine|atropine|mesh-list
138220405|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
138220406|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220407|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
138220408|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
138220410|NCT04496960|Tofacitinib|tofacitinib|mesh-list
138220411|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138220412|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220413|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220414|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220415|NCT04496063|Ustekinumab|ustekinumab|mesh-list
138220416|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138220417|NCT04493060|Niraparib|niraparib|mesh-list
138220418|NCT04493060|Dostarlimab|dostarlimab|mesh-list
138220430|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
138220431|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220433|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
138220434|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220435|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138220436|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138220437|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220438|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220439|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138220440|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
138220441|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220442|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220443|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138220444|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138220445|NCT04430426|Glycolic acid|glycolic acid|mesh-list
138220446|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
138220447|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
138220459|NCT04412096|Timolol|timolol|mesh-list
138209964|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
138220466|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220467|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220468|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220469|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138220470|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138220471|NCT04409834|Heparin|heparin|mesh-list
138220472|NCT04409834|Calcium heparin|calcium heparin|mesh-list
138220473|NCT04409834|Enoxaparin|enoxaparin|mesh-list
138220474|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
138220475|NCT04409834|Clopidogrel|clopidogrel|mesh-list
138220476|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138220477|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138220478|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138220479|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138220480|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
138220481|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220482|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220483|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220484|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
138220485|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138220486|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138220487|NCT04340076|Ixekizumab|ixekizumab|mesh-list
138220488|NCT04340076|Brodalumab|brodalumab|mesh-list
138220489|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
138220490|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
138220491|NCT04332211|Ephedrine|ephedrine|mesh-list
138220492|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138220494|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220495|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220496|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138220497|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
138220498|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
138220499|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138220500|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138220501|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
138220502|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
138220503|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220504|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220505|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138220506|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
138220507|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220508|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138220509|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
138220510|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220511|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220512|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138220513|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138220514|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138220515|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
138220516|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
138220517|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220518|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220519|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220520|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220521|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138220522|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220523|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220525|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
138220527|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220528|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
138220529|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220530|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220531|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220532|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220533|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
138220534|NCT04201457|Trametinib|trametinib|mesh-list
138220535|NCT04201457|Dabrafenib|dabrafenib|mesh-list
138220536|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138220537|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
138220538|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138220539|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138220540|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220542|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220543|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220544|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220545|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220546|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138220547|NCT04201457|Protective Agents|protective agents|mesh-ancestor
138220548|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220549|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138220550|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
138220551|NCT04199117|Nicotine|nicotine|mesh-list
138220552|NCT04199117|Varenicline|varenicline|mesh-list
138220553|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138220554|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
138220555|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220556|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220557|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138220558|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138220559|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
138220560|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220561|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220562|NCT04185402|Azithromycin|azithromycin|mesh-list
138220563|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138220564|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220565|NCT04112641|Niacinamide|niacinamide|mesh-list
138220566|NCT04112641|Niacin|niacin|mesh-list
138220567|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
138220568|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
138220569|NCT04112641|Vitamins|vitamins|mesh-ancestor
138220570|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
138351298|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
138220571|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220572|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138220573|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
138220574|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220575|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138220576|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
138220577|NCT04074967|Nivolumab|nivolumab|mesh-list
138220578|NCT04074967|Ipilimumab|ipilimumab|mesh-list
138220579|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220580|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220581|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138210214|NCT05902169|Temozolomide|temozolomide|mesh-list
138220582|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220584|NCT04008030|Bevacizumab|bevacizumab|mesh-list
138220585|NCT04008030|Nivolumab|nivolumab|mesh-list
138220586|NCT04008030|Cetuximab|cetuximab|mesh-list
138220587|NCT04008030|Ipilimumab|ipilimumab|mesh-list
138220588|NCT04008030|Fluorouracil|fluorouracil|mesh-list
138220589|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
138220590|NCT04008030|Irinotecan|irinotecan|mesh-list
138220591|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220592|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220593|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220594|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220595|NCT04008030|Growth Substances|growth substances|mesh-ancestor
138220596|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220597|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220598|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
138220599|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220600|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220601|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220603|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220604|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138220605|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138220606|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220607|NCT04008030|Antidotes|antidotes|mesh-ancestor
138220608|NCT04008030|Protective Agents|protective agents|mesh-ancestor
138220609|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
138220610|NCT04008030|Vitamins|vitamins|mesh-ancestor
138210240|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
138220611|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
138220612|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
138220613|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138220614|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138220615|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138220616|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138220617|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138220618|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220619|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138220620|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220621|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220622|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138220623|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220624|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
138220626|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
138220627|NCT03983850|Busulfan|busulfan|mesh-list
138220628|NCT03983850|Fludarabine|fludarabine|mesh-list
138220629|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220630|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
138220631|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220632|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220633|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138220634|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
138220635|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220636|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220637|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138220638|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138220639|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138220640|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
138220750|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220751|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
138220752|NCT03849651|Melphalan|melphalan|mesh-list
138220753|NCT03849651|Thiotepa|thiotepa|mesh-list
138220754|NCT03849651|Fludarabine|fludarabine|mesh-list
138220755|NCT03849651|Blinatumomab|blinatumomab|mesh-list
138220756|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
138220757|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220758|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
138220759|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220760|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220761|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138220762|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
138220763|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220764|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220765|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138220766|NCT03810417|Digoxin|digoxin|mesh-list
138220767|NCT03810417|Antibodies|antibodies|mesh-list
138220773|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220774|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220775|NCT03810417|Protective Agents|protective agents|mesh-ancestor
138220776|NCT03808818|Nicotine|nicotine|mesh-list
138220777|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138220778|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
138220779|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220780|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220781|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138220782|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138220783|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
138220784|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351713|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138220786|NCT03761173|Anticoagulants|anticoagulants|mesh-list
138220792|NCT03742349|Spartalizumab|spartalizumab|mesh-list
138220793|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220794|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220795|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220796|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220797|NCT03733314|Quetmolimab|quetmolimab|mesh-list
138220798|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220804|NCT03703492|Estradiol|estradiol|mesh-list
138220805|NCT03703492|Estrogens|estrogens|mesh-ancestor
138220806|NCT03703492|Hormones|hormones|mesh-ancestor
138220807|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220808|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220809|NCT03692052|Mitapivat|mitapivat|mesh-list
138220810|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
138220811|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220812|NCT03683251|Ranibizumab|ranibizumab|mesh-list
138210330|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
138210331|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210332|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210333|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210334|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138220813|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220814|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220815|NCT03683251|Growth Substances|growth substances|mesh-ancestor
138220816|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220817|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220824|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138220825|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220826|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220827|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138220828|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
138220829|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220830|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220831|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138220837|NCT03568656|Atezolizumab|atezolizumab|mesh-list
138220838|NCT03568656|Olaparib|olaparib|mesh-list
138360300|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220839|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
138220840|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220843|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220844|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138220845|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220846|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138220847|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138220848|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220849|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220850|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138220869|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138220870|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
138220871|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
138220872|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220873|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138220874|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138220875|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220876|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220877|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138220878|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138220879|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138220880|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220881|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220882|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138220883|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138220884|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138220885|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138220887|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220888|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220889|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138220890|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138220891|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
138220892|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138220894|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
138220896|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138220897|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220898|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220899|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220900|NCT03323463|Carboplatin|carboplatin|mesh-list
138220901|NCT03323463|Fluorouracil|fluorouracil|mesh-list
138220902|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220903|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
138220904|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220905|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220906|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220907|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
138220908|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220918|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220920|NCT03298061|Prednisolone|prednisolone|mesh-list
138220921|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220922|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
138220923|NCT03298061|Hormones|hormones|mesh-ancestor
138220924|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220925|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220926|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138220927|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220928|NCT03213652|Ensartinib|ensartinib|mesh-list
138220929|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220930|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220931|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220932|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220933|NCT03178552|Bevacizumab|bevacizumab|mesh-list
138220934|NCT03178552|Atezolizumab|atezolizumab|mesh-list
138220935|NCT03178552|Carboplatin|carboplatin|mesh-list
138220936|NCT03178552|Gemcitabine|gemcitabine|mesh-list
138220937|NCT03178552|Docetaxel|docetaxel|mesh-list
138220938|NCT03178552|Pemetrexed|pemetrexed|mesh-list
138220939|NCT03178552|Vemurafenib|vemurafenib|mesh-list
138220940|NCT03178552|Entrectinib|entrectinib|mesh-list
138220941|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220942|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220943|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220944|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138220945|NCT03178552|Growth Substances|growth substances|mesh-ancestor
138220946|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220947|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220948|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138220949|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
138220950|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220951|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138220952|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
138220953|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
138220954|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220955|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138220956|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138220957|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138210467|NCT05659056|Paclitaxel|paclitaxel|mesh-list
138220958|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138220959|NCT03141359|Paclitaxel|paclitaxel|mesh-list
138220960|NCT03141359|Etoposide|etoposide|mesh-list
138220961|NCT03141359|Carboplatin|carboplatin|mesh-list
138220962|NCT03141359|Durvalumab|durvalumab|mesh-list
138220963|NCT03141359|Cisplatin|cisplatin|mesh-list
138220964|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138220966|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
138220967|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138220968|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138220969|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220970|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138220971|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138220972|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220973|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220974|NCT02983682|Lidocaine|lidocaine|mesh-list
138220975|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
138220976|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
138220977|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220978|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220979|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
138220980|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220981|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138220982|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138220983|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138210530|NCT05320406|Leuprolide|leuprolide|mesh-list
138220985|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220986|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
138220987|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220989|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138220990|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220992|NCT02861573|Prednisone|prednisone|mesh-list
138220993|NCT02861573|Carboplatin|carboplatin|mesh-list
138220994|NCT02861573|Docetaxel|docetaxel|mesh-list
138220995|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
138220996|NCT02861573|Etoposide|etoposide|mesh-list
138220997|NCT02861573|Lenvatinib|lenvatinib|mesh-list
138220998|NCT02861573|Olaparib|olaparib|mesh-list
138220999|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
138221000|NCT02861573|Belzutifan|belzutifan|mesh-list
138221001|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221002|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
138221003|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
138221004|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221005|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221006|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221007|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
138221008|NCT02861573|Hormones|hormones|mesh-ancestor
138352105|NCT03096444|Analgesics|analgesics|mesh-ancestor
138221009|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221010|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221011|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221012|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138221013|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138221014|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138221015|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221016|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221017|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221018|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138221019|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138221020|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138221021|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221022|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138221023|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138221024|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138221025|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
138221026|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138221027|NCT02807558|Azacitidine|azacitidine|mesh-list
138221028|NCT02807558|Daratumumab|daratumumab|mesh-list
138221029|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221030|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
138221031|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221032|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221033|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221034|NCT02711553|Gemcitabine|gemcitabine|mesh-list
138221035|NCT02711553|Ramucirumab|ramucirumab|mesh-list
138221036|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221037|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221038|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
138221039|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221042|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221043|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221044|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221045|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221046|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138221047|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
138221048|NCT02576509|Nivolumab|nivolumab|mesh-list
138221049|NCT02576509|Sorafenib|sorafenib|mesh-list
138221050|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221051|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221052|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221053|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221054|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138221055|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221056|NCT02476916|Mitapivat|mitapivat|mesh-list
138221057|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
138221058|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221059|NCT02296229|Androgens|androgens|mesh-list
138221060|NCT02296229|Hormones|hormones|mesh-ancestor
138221061|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221062|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221063|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
138221064|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
138221065|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221066|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
138221067|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221068|NCT02135419|Fluorouracil|fluorouracil|mesh-list
138221069|NCT02135419|Imiquimod|imiquimod|mesh-list
138221070|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
138221071|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221072|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138210577|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
138221073|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221074|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221075|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
138221076|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221077|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138221079|NCT02043678|Prednisone|prednisone|mesh-list
138221080|NCT02043678|Prednisolone|prednisolone|mesh-list
138221081|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138221082|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221083|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
138221084|NCT02043678|Hormones|hormones|mesh-ancestor
138221085|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221086|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221087|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221088|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221090|NCT01853748|Maytansine|maytansine|mesh-list
138221091|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138221092|NCT01853748|Trastuzumab|trastuzumab|mesh-list
138221093|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138221094|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221095|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138221096|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138221097|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138221098|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221099|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221100|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
138221101|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
138221102|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
138221103|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221104|NCT01843374|Tremelimumab|tremelimumab|mesh-list
138221105|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221106|NCT01810913|Cisplatin|cisplatin|mesh-list
138221107|NCT01810913|Docetaxel|docetaxel|mesh-list
138221108|NCT01810913|Cetuximab|cetuximab|mesh-list
138221109|NCT01810913|Atezolizumab|atezolizumab|mesh-list
138221110|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138221111|NCT01810913|Antibodies|antibodies|mesh-list
138221112|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
138221113|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138221114|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
138221115|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221116|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221117|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
138221118|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138221119|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138221120|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221121|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221122|NCT01757535|Azacitidine|azacitidine|mesh-list
138221123|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221124|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
138221125|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221126|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221127|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221128|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138221130|NCT00923013|Cladribine|cladribine|mesh-list
138221131|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221132|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221133|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
138221134|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221135|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221136|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221137|NCT00840801|Vaccines|vaccines|mesh-list
138221138|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
138221139|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221140|NCT00515359|Propofol|propofol|mesh-list
138221141|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138221142|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221143|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221144|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138221145|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
138221146|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
138221147|NCT00494234|Olaparib|olaparib|mesh-list
138221148|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138221149|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352265|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138221150|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221151|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221152|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
138221153|NCT01268111|Vitamin D|vitamin d|mesh-list
138221154|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210649|NCT04757662|Tadalafil|tadalafil|mesh-list
138221156|NCT01268111|Vitamins|vitamins|mesh-ancestor
138221157|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
138221158|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138221159|NCT01349231|Ketamine|ketamine|mesh-list
138221160|NCT01349231|Analgesics|analgesics|mesh-ancestor
138221161|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
138221162|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221163|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221164|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138221165|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138221166|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
138221167|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
138221168|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221169|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138221170|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138221171|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221172|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221173|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
138221174|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
138221175|NCT01350245|Tacrolimus|tacrolimus|mesh-list
138221176|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221177|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
138221178|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221179|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210679|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
138210681|NCT04731103|Lamivudine|lamivudine|mesh-list
138221180|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138221181|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
138221182|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221183|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221184|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138221185|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138221186|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221187|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138221188|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138221189|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
138221190|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138221191|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221193|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
138221194|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221195|NCT01321151|Protective Agents|protective agents|mesh-ancestor
138221196|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221197|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221198|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138221199|NCT01350947|Azacitidine|azacitidine|mesh-list
138221200|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221201|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
138221202|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221203|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221204|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221205|NCT01269047|Exenatide|exenatide|mesh-list
138221206|NCT01269047|Pramlintide|pramlintide|mesh-list
138221207|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221208|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221209|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138221210|NCT01269047|Incretins|incretins|mesh-ancestor
138221212|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221213|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
138221214|NCT03800264|Bisoprolol|bisoprolol|mesh-list
138221215|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221216|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138221217|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
138221218|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
138221219|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221220|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221221|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138221222|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138221223|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138221224|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221225|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221226|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221227|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
138221228|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138221229|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
138221230|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221231|NCT05287724|Expectorants|expectorants|mesh-ancestor
138221232|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
138221233|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138221234|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
138221235|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221236|NCT05287724|Protective Agents|protective agents|mesh-ancestor
138221237|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221238|NCT05287724|Antidotes|antidotes|mesh-ancestor
138221239|NCT01321541|Rituximab|rituximab|mesh-list
138221240|NCT01321541|Gemcitabine|gemcitabine|mesh-list
138221241|NCT01321541|Pixantrone|pixantrone|mesh-list
138221242|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221243|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221244|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
138221245|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221246|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221247|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221249|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221250|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138221251|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138221252|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221253|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138221254|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138221255|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221256|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221257|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
138221258|NCT05201612|Olaparib|olaparib|mesh-list
138221259|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221260|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221261|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221262|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221263|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138221264|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221266|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221267|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138221268|NCT01271855|Protective Agents|protective agents|mesh-ancestor
138221270|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138221272|NCT01354145|Analgesics|analgesics|mesh-ancestor
138221273|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
138221274|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221275|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221276|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221277|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221278|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138221279|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138221280|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221281|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221283|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138221284|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138221285|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221286|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221287|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221288|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221289|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
138221290|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
138221291|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221292|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138221293|NCT02196857|Azacitidine|azacitidine|mesh-list
138221294|NCT02196857|Sorafenib|sorafenib|mesh-list
138221295|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221296|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
138221297|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221298|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221299|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221300|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138221301|NCT01272245|Cytarabine|cytarabine|mesh-list
138221302|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
138221303|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221304|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
138221305|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221306|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221307|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
138221308|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221309|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221310|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
138221311|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221312|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138221313|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138221314|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221315|NCT00802100|Metformin|metformin|mesh-list
138221316|NCT00802100|Benztropine|benztropine|mesh-list
138221317|NCT00802100|Olanzapine|olanzapine|mesh-list
138221318|NCT00802100|Aripiprazole|aripiprazole|mesh-list
138221319|NCT00802100|Perphenazine|perphenazine|mesh-list
138221320|NCT00802100|Simvastatin|simvastatin|mesh-list
138352546|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
138221322|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221323|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138221324|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138221325|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
138221326|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221327|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138221328|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138221329|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221330|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
138221331|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
138221332|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221333|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221334|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138221335|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138221336|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221337|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138221338|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138221339|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138221340|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221341|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221342|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
138221343|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
138221344|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
138221345|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
138221346|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138221347|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138221348|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138221349|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138221350|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138352593|NCT03506724|Labetalol|labetalol|mesh-list
138221351|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138221352|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138221353|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138221354|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
138221355|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138221356|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138221357|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138221358|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138221359|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
138221360|NCT00809276|Busulfan|busulfan|mesh-list
138221361|NCT00809276|Fludarabine|fludarabine|mesh-list
138221362|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221363|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
138221364|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221365|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221366|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138221367|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
138221368|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221370|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138221371|NCT00802412|Topiramate|topiramate|mesh-list
138221372|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
138221373|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221374|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221375|NCT01355705|Aspirin|aspirin|mesh-list
138221376|NCT01355705|Dexamethasone|dexamethasone|mesh-list
138221377|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
138221378|NCT01355705|Lenalidomide|lenalidomide|mesh-list
138221379|NCT01355705|Amrubicin|amrubicin|mesh-list
138221380|NCT01355705|BB 1101|bb 1101|mesh-list
138221381|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221382|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
138221383|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
138221384|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221385|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221386|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221387|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
138221388|NCT01355705|Hormones|hormones|mesh-ancestor
138221389|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221390|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221391|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221392|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
138221393|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221394|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221395|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138221396|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221397|NCT01355705|Analgesics|analgesics|mesh-ancestor
138221398|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
138221399|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221400|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138221401|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138221402|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138221403|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138221404|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
138221405|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
138221406|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138221407|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138221408|NCT01355705|Growth Substances|growth substances|mesh-ancestor
138221409|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
138221410|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
138221411|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221412|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
138352691|NCT03655080|Paclitaxel|paclitaxel|mesh-list
138221414|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
138221415|NCT00802880|Dacarbazine|dacarbazine|mesh-list
138221416|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138221417|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
138414713|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221418|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221419|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221421|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138221422|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138221423|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138221424|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
138221425|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221426|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221427|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138221428|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
138221429|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
138221430|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
138221431|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138221432|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138221434|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221435|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221436|NCT05089526|Lidocaine|lidocaine|mesh-list
138221437|NCT05089526|Fentanyl|fentanyl|mesh-list
138221438|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
138221439|NCT05089526|Ketamine|ketamine|mesh-list
138221440|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
138221441|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
138221442|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221443|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221444|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
138221445|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221446|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138221447|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138221448|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138221449|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221450|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221451|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138221452|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221453|NCT05089526|Analgesics|analgesics|mesh-ancestor
138221454|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138221455|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138221456|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138221457|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221458|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221459|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138221460|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138221461|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
138414715|NCT01655108|Minoxidil|minoxidil|mesh-list
138221462|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138221463|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138221464|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138221465|NCT05089526|Narcotics|narcotics|mesh-ancestor
138221466|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138221467|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
138221468|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138221469|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221470|NCT01274897|Lactitol|lactitol|mesh-list
138221471|NCT01274897|Cathartics|cathartics|mesh-ancestor
138221472|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221473|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
138221474|NCT02323217|Idazoxan|idazoxan|mesh-list
138221475|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138221476|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138221477|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138221478|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221479|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221480|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221481|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221482|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
138221483|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138221484|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138221485|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221486|NCT04382768|Ibuprofen|ibuprofen|mesh-list
138221487|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138221488|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221489|NCT04382768|Analgesics|analgesics|mesh-ancestor
138221490|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
138221491|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221492|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221493|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221494|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221495|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138221496|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221497|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221498|NCT04155164|Metformin|metformin|mesh-list
138221499|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221500|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221501|NCT00806078|Quinine|quinine|mesh-list
138221502|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
138221503|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138221505|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221506|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138221507|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221508|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138221509|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221510|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221511|NCT00806078|Analgesics|analgesics|mesh-ancestor
138221512|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
138221513|NCT00806234|Metformin|metformin|mesh-list
138221514|NCT00806234|Olanzapine|olanzapine|mesh-list
138221515|NCT00806234|Risperidone|risperidone|mesh-list
138221516|NCT00806234|Aripiprazole|aripiprazole|mesh-list
138221517|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138221518|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138221519|NCT00806234|Ziprasidone|ziprasidone|mesh-list
138221520|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138221521|NCT00806234|Asenapine|asenapine|mesh-list
138221522|NCT00806234|Iloperidone|iloperidone|mesh-list
138221523|NCT00806234|Perphenazine|perphenazine|mesh-list
138221524|NCT00806234|Fluoxetine|fluoxetine|mesh-list
138221525|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221526|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221527|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138221528|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
138221529|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221530|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221531|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138221532|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138221533|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221534|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138221535|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138221536|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
138221537|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
138221538|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
138221539|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221540|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221541|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138221542|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138221543|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221544|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
138221545|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
138221546|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138210987|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
138221547|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138221548|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138221549|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138221550|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138221551|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138221552|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138221553|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221554|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138221555|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138221556|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138221557|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221559|NCT01275365|Testosterone|testosterone|mesh-list
138221560|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
138221561|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
138221562|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138221563|NCT01275365|Androgens|androgens|mesh-ancestor
138221565|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221566|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221567|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221568|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221569|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
138221570|NCT00811850|Timolol|timolol|mesh-list
138221571|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138221572|NCT00811850|Dorzolamide|dorzolamide|mesh-list
138221573|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138221574|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138221575|NCT00811850|Maleic acid|maleic acid|mesh-list
138221576|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221577|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221578|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138221579|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138221580|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221581|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221582|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221583|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138221584|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138221585|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138221586|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138221587|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138221588|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138221590|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138221591|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
138221592|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138221593|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
138221594|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221595|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352968|NCT03161964|Propranolol|propranolol|mesh-list
138221597|NCT00844298|Cytarabine|cytarabine|mesh-list
138221598|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138221599|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
138221600|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221601|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221602|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
138221603|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221604|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221605|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
138221606|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221607|NCT01329185|Valganciclovir|valganciclovir|mesh-list
138221608|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
138221609|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221610|NCT01276301|Empagliflozin|empagliflozin|mesh-list
138221611|NCT01276301|Verapamil|verapamil|mesh-list
138221612|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138221613|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221614|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221615|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221616|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138221617|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138221618|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221619|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138221620|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138221621|NCT00845000|Levodopa|levodopa|mesh-list
138221622|NCT00845000|Carbidopa|carbidopa|mesh-list
138221623|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138221624|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138221625|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
138221626|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221627|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221628|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221629|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138221630|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221631|NCT01330043|Bupropion|bupropion|mesh-list
138221632|NCT01330043|Nicotine|nicotine|mesh-list
138221633|NCT01330043|Varenicline|varenicline|mesh-list
138221634|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138221635|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
138221636|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221637|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221639|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138221640|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
138221641|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221642|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221643|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138221644|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
138221645|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138221646|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138221647|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138221648|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221650|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138221651|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138221652|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221653|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
138221654|NCT01330355|Besifloxacin|besifloxacin|mesh-list
138221655|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138221656|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221657|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138221658|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138221659|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138221660|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138221661|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221662|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221663|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221665|NCT02193815|Calcipotriene|calcipotriene|mesh-list
138221666|NCT02193815|Tofacitinib|tofacitinib|mesh-list
138221667|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138221668|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138221669|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221670|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221671|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138221672|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138221673|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221674|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138221675|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221676|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138221677|NCT02193815|Vitamins|vitamins|mesh-ancestor
138221678|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
138221679|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138221680|NCT01277081|Acetaminophen|acetaminophen|mesh-list
138221681|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221682|NCT01277081|Analgesics|analgesics|mesh-ancestor
138221683|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
138221684|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353134|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
138221685|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221686|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
138221687|NCT01361633|Cycloserine|cycloserine|mesh-list
138221688|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138221689|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221690|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138221691|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
138221692|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138221693|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
138221694|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221695|NCT01331213|Pregabalin|pregabalin|mesh-list
138221696|NCT01331213|Analgesics|analgesics|mesh-ancestor
138221697|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
138221698|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221699|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221700|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
138221701|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138221702|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221703|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353200|NCT01846182|Analgesics|analgesics|mesh-ancestor
138221704|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138221705|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138221706|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138221707|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221708|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138221709|NCT01332071|Metformin|metformin|mesh-list
138221710|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
138221711|NCT01332071|Maleic acid|maleic acid|mesh-list
138221712|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221713|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221714|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221715|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221716|NCT01277159|Dexamethasone|dexamethasone|mesh-list
138221717|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
138221718|NCT01277159|Buprenorphine|buprenorphine|mesh-list
138221719|NCT01277159|BB 1101|bb 1101|mesh-list
138221720|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221721|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
138221722|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
138221723|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221724|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221725|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221726|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
138221727|NCT01277159|Hormones|hormones|mesh-ancestor
138221728|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221729|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221730|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221731|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
138221732|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221733|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221734|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138221735|NCT01277159|Narcotics|narcotics|mesh-ancestor
138221736|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221737|NCT01277159|Analgesics|analgesics|mesh-ancestor
138221738|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
138221739|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138221740|NCT01362959|Nicotine|nicotine|mesh-list
138221741|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138221742|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
138221743|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221744|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221745|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138221746|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138221747|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
138221748|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221749|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221750|NCT01332461|Fluticasone|fluticasone|mesh-list
138221752|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138221753|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221754|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138221755|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
138221756|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221757|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221758|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138221759|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
138221760|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
138221761|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138221762|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138221763|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138221764|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138221765|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
138221766|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221767|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221768|NCT01279187|Teriparatide|teriparatide|mesh-list
138221770|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221771|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138221772|NCT01280123|Pioglitazone|pioglitazone|mesh-list
138221773|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138221774|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221775|NCT03608696|Buprenorphine|buprenorphine|mesh-list
138221776|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138221777|NCT03608696|Narcotics|narcotics|mesh-ancestor
138221778|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353291|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221779|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221780|NCT03608696|Analgesics|analgesics|mesh-ancestor
138221781|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
138221782|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221783|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138221784|NCT01334723|Finasteride|finasteride|mesh-list
138221785|NCT01334723|Dutasteride|dutasteride|mesh-list
138221786|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
138221787|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138221788|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221789|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221790|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
138221791|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221792|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221793|NCT01334723|Urological Agents|urological agents|mesh-ancestor
138221795|NCT04311710|Ipilimumab|ipilimumab|mesh-list
138221796|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138221797|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221798|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138221799|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221800|NCT01334957|Ibuprofen|ibuprofen|mesh-list
138211155|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138221801|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138221802|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221804|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
138221805|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221806|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221807|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221808|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221809|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138221810|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221811|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221812|NCT01402427|Verapamil|verapamil|mesh-list
138221813|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138221814|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138221815|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221816|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221817|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138221818|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221819|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
138221820|NCT01365611|Fluticasone|fluticasone|mesh-list
138221822|NCT01365611|Ketorolac|ketorolac|mesh-list
138221823|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138221824|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221825|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138221826|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
138221827|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221828|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221829|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138221830|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
138221831|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
138221832|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138221833|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138221834|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138221835|NCT01365611|Analgesics|analgesics|mesh-ancestor
138221836|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
138221837|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221838|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138221839|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221840|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221842|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
138221843|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138221844|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221845|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221846|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221847|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
138221848|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138221849|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138221850|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221851|NCT01404923|Mebeverine|mebeverine|mesh-list
138221852|NCT01404923|Alverine|alverine|mesh-list
138221853|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
138221854|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
138221855|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221856|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221857|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
138221858|NCT01368263|Letrozole|letrozole|mesh-list
138221859|NCT01368263|Anastrozole|anastrozole|mesh-list
138221860|NCT01368263|Goserelin|goserelin|mesh-list
138221861|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221862|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138221863|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138353419|NCT01031550|Propofol|propofol|mesh-list
138221864|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221865|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221866|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138221867|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
138221868|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221869|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221870|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221871|NCT00815360|Triamcinolone|triamcinolone|mesh-list
138221872|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138221874|NCT00815360|Ranibizumab|ranibizumab|mesh-list
138221875|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138221876|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138221877|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138221878|NCT00815360|Growth Substances|growth substances|mesh-ancestor
138221879|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221880|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
138221881|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221882|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221883|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
138221885|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221886|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138221887|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
138221888|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221889|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221891|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138221892|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138221893|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221894|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138221895|NCT01405937|Ribavirin|ribavirin|mesh-list
138221896|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
138221897|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353465|NCT00875394|Hormones|hormones|mesh-ancestor
138221898|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
138221899|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221900|NCT01368653|Nicotine|nicotine|mesh-list
138221901|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138221902|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
138221903|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221904|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211260|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138221906|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138221907|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
138221908|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221909|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221910|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
138221911|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
138221912|NCT01368809|Fentanyl|fentanyl|mesh-list
138221913|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138221914|NCT01368809|Narcotics|narcotics|mesh-ancestor
138221915|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221916|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221917|NCT01368809|Analgesics|analgesics|mesh-ancestor
138221918|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
138221919|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221920|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138221921|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138221922|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
138221923|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
138221924|NCT01369745|Prednisone|prednisone|mesh-list
138221925|NCT01369745|Prednisolone|prednisolone|mesh-list
138221926|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138221927|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
138221928|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138221929|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
138221930|NCT01369745|Dipyridamole|dipyridamole|mesh-list
138221931|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138221932|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
138221933|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221934|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
138221935|NCT01369745|Hormones|hormones|mesh-ancestor
138221936|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221937|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221938|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138221942|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221943|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138221944|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138221945|NCT01369745|Protective Agents|protective agents|mesh-ancestor
138221946|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138221947|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211300|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
138221948|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221949|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138221952|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138221953|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138221954|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138221955|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138221956|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138221957|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221958|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221959|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221960|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138221961|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
138221962|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138221963|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221964|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138221965|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138221966|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138221967|NCT01407575|Buprenorphine|buprenorphine|mesh-list
138221968|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138221969|NCT01407575|Narcotics|narcotics|mesh-ancestor
138221970|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138221971|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221972|NCT01407575|Analgesics|analgesics|mesh-ancestor
138221973|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
138221974|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221975|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138221977|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138221978|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138221979|NCT01476449|Growth Substances|growth substances|mesh-ancestor
138221980|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221981|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138221982|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221983|NCT01370369|Testosterone|testosterone|mesh-list
138221984|NCT01370369|Androgens|androgens|mesh-ancestor
138221986|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138221987|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221988|NCT01477463|Vitamin D|vitamin d|mesh-list
138221989|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
138221990|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
138221991|NCT01477463|Vitamins|vitamins|mesh-list
138221992|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
138221993|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221994|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138221995|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138221996|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138221998|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138221999|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
138222000|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222001|NCT01375127|Tofacitinib|tofacitinib|mesh-list
138222002|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138222003|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222004|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222005|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222006|NCT00857714|Lapatinib|lapatinib|mesh-list
138222007|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222008|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222009|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222010|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222011|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
138222012|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138222013|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138222014|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
138222015|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222016|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138222017|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138222018|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222019|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222020|NCT01376297|Dexamethasone|dexamethasone|mesh-list
138222021|NCT01376297|Aprepitant|aprepitant|mesh-list
138222022|NCT01376297|Palonosetron|palonosetron|mesh-list
138222023|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222024|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
138222025|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
138222026|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222027|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222028|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222029|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
138222030|NCT01376297|Hormones|hormones|mesh-ancestor
138222031|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222032|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138222033|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222034|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138222035|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353609|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138222038|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138222039|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
138222040|NCT00859040|Pasireotide|pasireotide|mesh-list
138222041|NCT00859040|Hormones|hormones|mesh-ancestor
138222042|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222043|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222044|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138222045|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138222046|NCT00859508|Estradiol|estradiol|mesh-list
138222047|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138222048|NCT00859508|Estrogens|estrogens|mesh-ancestor
138222049|NCT00859508|Hormones|hormones|mesh-ancestor
138222050|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222051|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222052|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138222053|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
138222054|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222055|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138222056|NCT01377467|Denosumab|denosumab|mesh-list
138211403|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222057|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138222059|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
138222060|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138222061|NCT02348762|Glycine|glycine|mesh-list
138222062|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
138222063|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222064|NCT02348762|Expectorants|expectorants|mesh-ancestor
138222065|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
138222066|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138222067|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
138353656|NCT05001048|Protective Agents|protective agents|mesh-ancestor
138222068|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222069|NCT02348762|Protective Agents|protective agents|mesh-ancestor
138222070|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222071|NCT02348762|Antidotes|antidotes|mesh-ancestor
138222072|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
138222073|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222074|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
138222075|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222076|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222077|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222078|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222079|NCT01377623|Analgesics|analgesics|mesh-ancestor
138222080|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
138222081|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222082|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138222083|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138222084|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222085|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222086|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222087|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222088|NCT01486043|Metformin|metformin|mesh-list
138222089|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222090|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222092|NCT01490723|Rituximab|rituximab|mesh-list
138222093|NCT01490723|Methotrexate|methotrexate|mesh-list
138222094|NCT01490723|Fludarabine|fludarabine|mesh-list
138222095|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
138222096|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138222097|NCT01490723|Tacrolimus|tacrolimus|mesh-list
138222098|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
138222099|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138222100|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138353705|NCT00564876|Dasatinib|dasatinib|mesh-list
138222101|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138222102|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222103|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
138222104|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222105|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222106|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138222107|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
138222108|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222109|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138222110|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
138222111|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222112|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222113|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222114|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138222115|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222116|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138222117|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222118|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138222119|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138222120|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138222121|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
138222122|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222123|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138222124|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
138222126|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
138222127|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
138222128|NCT03839498|Axitinib|axitinib|mesh-list
138222129|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222130|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222131|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222132|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222133|NCT02252432|Ketamine|ketamine|mesh-list
138222134|NCT02252432|Methadone|methadone|mesh-list
138222135|NCT02252432|Analgesics|analgesics|mesh-ancestor
138222136|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
138222137|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222138|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222139|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138222140|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138222141|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
138222142|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
138222143|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222144|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138222145|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138222146|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222147|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222148|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138222149|NCT02252432|Narcotics|narcotics|mesh-ancestor
138222150|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
138222151|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
138222152|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
138222153|NCT01492673|Bevacizumab|bevacizumab|mesh-list
138222154|NCT01492673|Topotecan|topotecan|mesh-list
138222155|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222156|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
138222157|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222158|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222159|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138222160|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
138222161|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222162|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222163|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138222164|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138222166|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138222167|NCT01492673|Growth Substances|growth substances|mesh-ancestor
138222168|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138222169|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138222170|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138222171|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222173|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138222174|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222175|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
138222176|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222177|NCT00818324|Protective Agents|protective agents|mesh-ancestor
138222178|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222179|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222180|NCT01419275|Xenon|xenon|mesh-list
138222181|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138222182|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
138222183|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
138222184|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222185|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222186|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
138222187|NCT02155010|Bupivacaine|bupivacaine|mesh-list
138222188|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
138222189|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
138222190|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222191|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222192|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
138353763|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
138222193|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222194|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222195|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222196|NCT02155010|Analgesics|analgesics|mesh-ancestor
138222197|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138222198|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138222199|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222200|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222201|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222202|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222203|NCT01495481|Adenosine|adenosine|mesh-list
138222204|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
138222205|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222206|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222207|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222208|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222209|NCT01495481|Analgesics|analgesics|mesh-ancestor
138222210|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
138222211|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222212|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138222213|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138222214|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222215|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222216|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222217|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222218|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138222219|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222220|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138222221|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
138222222|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
138222223|NCT01379183|Erythromycin|erythromycin|mesh-list
138222224|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
138222225|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138222226|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
138222227|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222228|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222229|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222230|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138222231|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222232|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222233|NCT01380197|Morphine|morphine|mesh-list
138222234|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138222235|NCT01380197|Narcotics|narcotics|mesh-ancestor
138222236|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353796|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222237|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222238|NCT01380197|Analgesics|analgesics|mesh-ancestor
138222239|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
138222240|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222241|NCT00862784|Leucovorin|leucovorin|mesh-list
138222242|NCT00862784|Folic Acid|folic acid|mesh-list
138222243|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
138222244|NCT00862784|Fluorouracil|fluorouracil|mesh-list
138222245|NCT00862784|Ramucirumab|ramucirumab|mesh-list
138222246|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138222247|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
138222248|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222249|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
138222250|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222251|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138222252|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222253|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
138222254|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222255|NCT00862784|Antidotes|antidotes|mesh-ancestor
138222256|NCT00862784|Protective Agents|protective agents|mesh-ancestor
138222257|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
138222258|NCT00862784|Vitamins|vitamins|mesh-ancestor
138222259|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
138222260|NCT00862784|Hematinics|hematinics|mesh-ancestor
138222261|NCT00864032|Sorafenib|sorafenib|mesh-list
138222262|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222263|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222264|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222265|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222268|NCT00820664|Estradiol|estradiol|mesh-list
138222269|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138222270|NCT00820664|Estrogens|estrogens|mesh-ancestor
138222271|NCT00820664|Hormones|hormones|mesh-ancestor
138222272|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222273|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222274|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138222276|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222277|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138222278|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138222279|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
138222280|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222281|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222282|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222283|NCT01419977|Dalteparin|dalteparin|mesh-list
138222284|NCT01419977|Tinzaparin|tinzaparin|mesh-list
138222285|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138222286|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
138222287|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138222288|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138222289|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222290|NCT01499147|Vidarabine|vidarabine|mesh-list
138222291|NCT01499147|Fludarabine|fludarabine|mesh-list
138222292|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
138222293|NCT01499147|Melphalan|melphalan|mesh-list
138222294|NCT01499147|Busulfan|busulfan|mesh-list
138222295|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
138222296|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222297|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138222298|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
138222299|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222300|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222301|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
138222302|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222303|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
138222304|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222305|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138222306|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
138222307|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138222308|NCT00823082|Antithrombins|antithrombins|mesh-list
138222309|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
138222310|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138222311|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
138222312|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222313|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222314|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
138222315|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
138222316|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138222318|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222319|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138222320|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138222321|NCT01382303|Protective Agents|protective agents|mesh-ancestor
138222322|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222323|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222324|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138222325|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
138222326|NCT05236634|Tadalafil|tadalafil|mesh-list
138222327|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138222328|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138222329|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222330|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138222331|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222332|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222333|NCT05236634|Urological Agents|urological agents|mesh-ancestor
138222334|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138222335|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222336|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222337|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222338|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
138222339|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138222340|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138222341|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138222342|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222343|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138222344|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222345|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222346|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138222347|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222349|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138222350|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
138222351|NCT00865202|Tryptophan|tryptophan|mesh-list
138222352|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138222353|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
138222354|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138222355|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
138222356|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138222357|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
138222358|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222359|NCT01424033|Expectorants|expectorants|mesh-ancestor
138222360|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
138222361|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138222362|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
138222363|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222364|NCT01424033|Protective Agents|protective agents|mesh-ancestor
138222365|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222366|NCT01424033|Antidotes|antidotes|mesh-ancestor
138222367|NCT01503749|Lenograstim|lenograstim|mesh-list
138222368|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138222369|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
138222370|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222371|NCT00867932|Eculizumab|eculizumab|mesh-list
138222372|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138222373|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222374|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
138222375|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222376|NCT00825266|Pioglitazone|pioglitazone|mesh-list
138222377|NCT00825266|Bosentan|bosentan|mesh-list
138222378|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222379|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211479|NCT01793480|Methadone|methadone|mesh-list
138222380|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222381|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138222382|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222383|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138222384|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138222385|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
138222386|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222387|NCT01385189|Antacids|antacids|mesh-ancestor
138222388|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222389|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222390|NCT01386983|Finasteride|finasteride|mesh-list
138222391|NCT01386983|Dutasteride|dutasteride|mesh-list
138222392|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138222393|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138222394|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222395|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222396|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
138222397|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222398|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222399|NCT01386983|Urological Agents|urological agents|mesh-ancestor
138222400|NCT01387139|Ketamine|ketamine|mesh-list
138222401|NCT01387139|Propofol|propofol|mesh-list
138222402|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222403|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222404|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222405|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138222406|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
138222407|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
138222408|NCT01387139|Analgesics|analgesics|mesh-ancestor
138222409|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
138222410|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222411|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138222412|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138222413|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138222414|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222415|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222417|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138222418|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
138222419|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222420|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222421|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138222422|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
138222423|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
138222424|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138222425|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
138222426|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222427|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222428|NCT00825344|Etanercept|etanercept|mesh-list
138222429|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138222430|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222431|NCT00825344|Analgesics|analgesics|mesh-ancestor
138222432|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
138222433|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222434|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222435|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222436|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222437|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222438|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222439|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
138222440|NCT01426763|Complement C1s|complement c1s|mesh-list
138222441|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138222442|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138222443|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
138222444|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222445|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138211487|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
138222446|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222448|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138222449|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138222450|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222451|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222452|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138222453|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138222454|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
138222455|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222456|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222457|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
138222458|NCT01505933|Propofol|propofol|mesh-list
138222459|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222460|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222461|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222462|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222463|NCT01505933|Analgesics|analgesics|mesh-ancestor
138222464|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
138222465|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222466|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138222467|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138222468|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222469|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222470|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222471|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222472|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138222473|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
138222476|NCT00825734|Epothilones|epothilones|mesh-list
138222477|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222478|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222479|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222480|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222481|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138222482|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138222483|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138222484|NCT00872534|Aspirin|aspirin|mesh-list
138222485|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138222486|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222487|NCT00872534|Analgesics|analgesics|mesh-ancestor
138222488|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
138222489|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222490|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222491|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222492|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222493|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138222494|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138222495|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222496|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138222497|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138222498|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222501|NCT02513160|Albuterol|albuterol|mesh-list
138222502|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138222503|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
138222504|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222505|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222506|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138222507|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
138222508|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
138222509|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222510|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138222511|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138222512|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222513|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222514|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222515|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222516|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222517|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
138222518|NCT02513160|Hormones|hormones|mesh-ancestor
138222519|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222520|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
138222521|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222522|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
138222523|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222524|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360335|NCT00382668|Dasatinib|dasatinib|mesh-list
138222525|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138222526|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
138222527|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222528|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222529|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138222530|NCT02480010|Pertuzumab|pertuzumab|mesh-list
138222531|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138222532|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222533|NCT00876200|Minoxidil|minoxidil|mesh-list
138222534|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222535|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222536|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
138222537|NCT02512302|Bromides|bromides|mesh-list
138222538|NCT02512302|Charcoal|charcoal|mesh-list
138222539|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
138222540|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138222541|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138222542|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138222543|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
138222544|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222545|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222546|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222547|NCT02512302|Antidotes|antidotes|mesh-ancestor
138222548|NCT02512302|Protective Agents|protective agents|mesh-ancestor
138222549|NCT01507181|Midazolam|midazolam|mesh-list
138222551|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
138222552|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
138222553|NCT01507181|Analgesics|analgesics|mesh-ancestor
138222554|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
138222555|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222556|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222557|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138222558|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138222559|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
138222560|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
138222561|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222562|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138222563|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222564|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222565|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138222566|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222567|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138222568|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138222569|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138222570|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
138222571|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
138222572|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138222573|NCT01428245|Estradiol|estradiol|mesh-list
138222574|NCT01428245|Estrogens|estrogens|mesh-list
138222575|NCT01428245|Progesterone|progesterone|mesh-list
138222576|NCT01428245|Hormones|hormones|mesh-ancestor
138222577|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222578|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222579|NCT01428245|Progestins|progestins|mesh-ancestor
138222580|NCT00877370|Ertapenem|ertapenem|mesh-list
138222581|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222582|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222583|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138222584|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138211499|NCT05258292|Insulin|insulin|mesh-list
138222586|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
138222587|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222588|NCT01508117|Axitinib|axitinib|mesh-list
138222589|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222590|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222591|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222592|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222594|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
138222595|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
138222596|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222597|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222598|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222599|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
138222600|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222601|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138222602|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138222603|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
138222604|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222605|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222606|NCT01391273|Bimatoprost|bimatoprost|mesh-list
138222607|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138222608|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222609|NCT01429259|Meropenem|meropenem|mesh-list
138222610|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222611|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222612|NCT05177198|Clindamycin|clindamycin|mesh-list
138222613|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
138222614|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
138222615|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222616|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222617|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138222618|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222619|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222620|NCT01392989|Cyclosporine|cyclosporine|mesh-list
138222621|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
138222622|NCT01392989|Cyclosporins|cyclosporins|mesh-list
138222623|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
138222624|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138222625|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222626|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222627|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222628|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
138222629|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222630|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
138222631|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222632|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222633|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222634|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138222635|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138222636|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222637|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138222638|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
138222639|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222641|NCT01393457|Carbidopa|carbidopa|mesh-list
138222642|NCT01393457|Ropinirole|ropinirole|mesh-list
138222643|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138222644|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138222645|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
138222646|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211510|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
138222648|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222649|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138222650|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222651|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
138222652|NCT02518464|Ticagrelor|ticagrelor|mesh-list
138222653|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138222654|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138222655|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138222656|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138222657|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
138222658|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222659|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222660|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222661|NCT02479230|Gemcitabine|gemcitabine|mesh-list
138222662|NCT02479230|Vaccines|vaccines|mesh-list
138222663|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
138222664|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222665|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138222666|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
138222667|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222668|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222669|NCT04985136|Sorafenib|sorafenib|mesh-list
138222670|NCT04985136|Apatinib|apatinib|mesh-list
138222671|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222672|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222673|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222674|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222675|NCT04411446|Vitamin D|vitamin d|mesh-list
138222676|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
138222677|NCT04411446|Vitamins|vitamins|mesh-ancestor
138222678|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
138222679|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222680|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138222681|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138222682|NCT01510379|Promethazine|promethazine|mesh-list
138222683|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
138222684|NCT01510379|Ondansetron|ondansetron|mesh-list
138222685|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
138222686|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
138222687|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222688|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222689|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222690|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
138222691|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222692|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138222693|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138222694|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
138222695|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222696|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222697|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138222698|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
138222699|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
138222700|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138222701|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138222702|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222703|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222704|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138222705|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
138222706|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
138222707|NCT01363986|Trastuzumab|trastuzumab|mesh-list
138222708|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211516|NCT00379574|Prednisolone|prednisolone|mesh-list
138222709|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222710|NCT01510457|Milnacipran|milnacipran|mesh-list
138222711|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
138222712|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138222713|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138222714|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138222715|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222716|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222717|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222718|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222720|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
138222721|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222722|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
138222723|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138222724|NCT02478372|Bupivacaine|bupivacaine|mesh-list
138222725|NCT02478372|Ropivacaine|ropivacaine|mesh-list
138222726|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
138222727|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
138222728|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
138222729|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222730|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222731|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
138222732|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222733|NCT01511315|Ustekinumab|ustekinumab|mesh-list
138222734|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222736|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
138222738|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222739|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222740|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138222741|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
138222742|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222743|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222744|NCT02509026|Etanercept|etanercept|mesh-list
138222745|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138222746|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222747|NCT02509026|Analgesics|analgesics|mesh-ancestor
138222748|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
138222749|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222750|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222751|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222752|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222753|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222754|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222755|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
138222756|NCT03439280|Dexamethasone|dexamethasone|mesh-list
138222757|NCT03439280|Pomalidomide|pomalidomide|mesh-list
138222758|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222759|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
138222760|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
138222761|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222762|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222763|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138222764|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
138222765|NCT03439280|Hormones|hormones|mesh-ancestor
138222766|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222767|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138222768|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222769|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
138222770|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138222771|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138222772|NCT03439280|Growth Substances|growth substances|mesh-ancestor
138222773|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
138222774|NCT00828074|Sorafenib|sorafenib|mesh-list
138222775|NCT00828074|Vinorelbine|vinorelbine|mesh-list
138222776|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222777|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222778|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222779|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211522|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222780|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138222781|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
138222782|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
138222783|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
138222784|NCT03434444|Propranolol|propranolol|mesh-list
138222785|NCT03434444|Oxytocin|oxytocin|mesh-list
138222786|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
138222787|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222788|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222789|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138222790|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138222791|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222792|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222793|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222794|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138222795|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222796|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222797|NCT04382300|Thalidomide|thalidomide|mesh-list
138222798|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222799|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
138222800|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222801|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
138222802|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222803|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222804|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138222805|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138222806|NCT04382300|Growth Substances|growth substances|mesh-ancestor
138222807|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
138222808|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222809|NCT01430819|Vaccines|vaccines|mesh-list
138222810|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
138222811|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222812|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138222813|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
138222814|NCT00828542|Desogestrel|desogestrel|mesh-list
138222815|NCT00828542|Etonogestrel|etonogestrel|mesh-list
138222816|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138222817|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138222818|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138222819|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
138222820|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222821|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222822|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138222823|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138222824|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138222825|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138222826|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222827|NCT00828542|Progestins|progestins|mesh-ancestor
138222828|NCT00828542|Hormones|hormones|mesh-ancestor
138222829|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222830|NCT01395329|Metoprolol|metoprolol|mesh-list
138222831|NCT01395329|Nebivolol|nebivolol|mesh-list
138222832|NCT01395329|Nitroprusside|nitroprusside|mesh-list
138354313|NCT00000750|Zidovudine|zidovudine|mesh-list
138222833|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138222835|NCT01395329|Acetylcholine|acetylcholine|mesh-list
138222836|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138222837|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222838|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
138222839|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
138222840|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222841|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222842|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138222843|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138222844|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138222845|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222846|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222847|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222853|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138222854|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
138222855|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138222856|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138222857|NCT00882206|Cytarabine|cytarabine|mesh-list
138222858|NCT00882206|Prednisone|prednisone|mesh-list
138222859|NCT00882206|Doxorubicin|doxorubicin|mesh-list
138222860|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138222861|NCT00882206|Methotrexate|methotrexate|mesh-list
138222862|NCT00882206|Vincristine|vincristine|mesh-list
138222863|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
138222864|NCT00882206|Decitabine|decitabine|mesh-list
138222865|NCT00882206|Asparaginase|asparaginase|mesh-list
138222866|NCT00882206|Vorinostat|vorinostat|mesh-list
138222867|NCT00882206|Pegaspargase|pegaspargase|mesh-list
138222868|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138222869|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222870|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138222871|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138222872|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222873|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222874|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222875|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
138222877|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222878|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222879|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138222880|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138222881|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
138222882|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138222883|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138222884|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
138222885|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
138222886|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138222887|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138222888|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
138222889|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138222890|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138222891|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
138222892|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222893|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138222894|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138222895|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138222896|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138222897|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222898|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138222899|NCT00831272|Naltrexone|naltrexone|mesh-list
138222900|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138222901|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138222902|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222903|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
138222904|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222905|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138222906|NCT01512251|Vemurafenib|vemurafenib|mesh-list
138222907|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222908|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138222909|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211531|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138222910|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222911|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138222912|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222913|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222914|NCT00885638|Incretins|incretins|mesh-ancestor
138222915|NCT00885638|Hormones|hormones|mesh-ancestor
138222916|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222917|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138222918|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
138222919|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222920|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222921|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138222922|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222923|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222924|NCT01512797|Incretins|incretins|mesh-ancestor
138222926|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138222927|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138222928|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
138222929|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222930|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222931|NCT05620940|Naltrexone|naltrexone|mesh-list
138222932|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138222933|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138222934|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222935|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
138222936|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222937|NCT01395797|Pioglitazone|pioglitazone|mesh-list
138222938|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138222939|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222940|NCT05124704|Ropivacaine|ropivacaine|mesh-list
138222941|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
138222942|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
138222943|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222944|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222945|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
138222946|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222947|NCT02203019|Fentanyl|fentanyl|mesh-list
138222948|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
138222949|NCT02203019|Propofol|propofol|mesh-list
138222950|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138222951|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138222952|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222953|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138222955|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
138222956|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222957|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138222958|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138222959|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222960|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138222961|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222962|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222963|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138222964|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
138222965|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
138222966|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138222967|NCT02203019|Narcotics|narcotics|mesh-ancestor
138222968|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138222969|NCT00886262|Vasopressins|vasopressins|mesh-list
138222970|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
138222971|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
138222972|NCT00886262|Coagulants|coagulants|mesh-ancestor
138222973|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138222974|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138222975|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
138222976|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222977|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138211539|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138222978|NCT00887510|Trandolapril|trandolapril|mesh-list
138222979|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138222980|NCT00887510|Diuretics|diuretics|mesh-ancestor
138222981|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
138222982|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222983|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138222984|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138222985|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222986|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138222987|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
138222988|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222989|NCT01431989|Amoxicillin|amoxicillin|mesh-list
138222990|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138222991|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138222993|NCT01397591|Ofatumumab|ofatumumab|mesh-list
138222994|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222996|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
138222997|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222998|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138222999|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138223000|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223001|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223002|NCT03855332|Urological Agents|urological agents|mesh-ancestor
138223003|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138223004|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
138223005|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223006|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223007|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138223008|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
138223009|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138223010|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138223011|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138223012|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138223013|NCT03855332|Protective Agents|protective agents|mesh-ancestor
138223014|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138223015|NCT02335580|Somatostatin|somatostatin|mesh-list
138223016|NCT02335580|Hormones|hormones|mesh-ancestor
138223017|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223018|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223019|NCT02476968|Olaparib|olaparib|mesh-list
138223020|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138223021|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223022|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223023|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223024|NCT01514513|Permethrin|permethrin|mesh-list
138223025|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223026|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223027|NCT01432145|Methotrexate|methotrexate|mesh-list
138223028|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
138223029|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138223030|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
138223031|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223032|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223033|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138223035|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223036|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223037|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
138223038|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223039|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138223041|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
138223042|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223043|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138223044|NCT04979520|Brodalumab|brodalumab|mesh-list
138211548|NCT05256108|Narcotics|narcotics|mesh-ancestor
138223046|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
138223047|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138223048|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138223049|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138223050|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223051|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223052|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
138223053|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223054|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223055|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138223056|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223057|NCT02504892|Everolimus|everolimus|mesh-list
138223058|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138223059|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223060|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223061|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223062|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223063|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
138223064|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223065|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223066|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138223067|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
138223068|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223069|NCT05946811|Macitentan|macitentan|mesh-list
138223070|NCT05946811|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138223071|NCT05946811|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138223072|NCT05946811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223073|NCT05946811|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138223075|NCT05946772|Cyclosporins|cyclosporins|mesh-list
138223076|NCT05946772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354507|NCT00000954|Doxorubicin|doxorubicin|mesh-list
138223077|NCT05946772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223078|NCT05946772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223079|NCT05946772|Immunologic Factors|immunologic factors|mesh-ancestor
138223080|NCT05946772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223081|NCT05946772|Antifungal Agents|antifungal agents|mesh-ancestor
138223082|NCT05946772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223083|NCT05946772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138223084|NCT05946772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223085|NCT05946772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138223086|NCT05946564|Pioglitazone|pioglitazone|mesh-list
138223087|NCT05946564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223088|NCT05946564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223089|NCT05946486|Rituximab|rituximab|mesh-list
138223090|NCT05946486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223091|NCT05946486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223092|NCT05946486|Immunologic Factors|immunologic factors|mesh-ancestor
138223093|NCT05946486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360374|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
138223094|NCT05946486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223095|NCT05946148|Empagliflozin|empagliflozin|mesh-list
138223096|NCT05946148|Dulaglutide|dulaglutide|mesh-list
138223097|NCT05946148|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138223098|NCT05946148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223099|NCT05946148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223100|NCT05946148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223101|NCT05946135|Lansoprazole|lansoprazole|mesh-list
138223102|NCT05946135|Dexlansoprazole|dexlansoprazole|mesh-list
138223103|NCT05946135|Fexuprazan|fexuprazan|mesh-list
138223104|NCT05946135|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138223105|NCT05946135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223106|NCT05946135|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138223107|NCT05946135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223108|NCT05946135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223109|NCT05946122|Atorvastatin|atorvastatin|mesh-list
138223110|NCT05946122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138223111|NCT05946122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138223112|NCT05946122|Antimetabolites|antimetabolites|mesh-ancestor
138354560|NCT00001044|Antacids|antacids|mesh-ancestor
138223113|NCT05946122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223114|NCT05946122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138223115|NCT05946122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138223116|NCT05946122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223117|NCT05946005|Povidone-Iodine|povidone-iodine|mesh-list
138223118|NCT05946005|Lidocaine|lidocaine|mesh-list
138223119|NCT05946005|Povidone|povidone|mesh-list
138223120|NCT05946005|Anesthetics, Local|anesthetics, local|mesh-ancestor
138223121|NCT05946005|Anesthetics|anesthetics|mesh-ancestor
138223122|NCT05946005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223123|NCT05946005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223124|NCT05946005|Sensory System Agents|sensory system agents|mesh-ancestor
138223125|NCT05946005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223126|NCT05946005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223127|NCT05946005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138223128|NCT05946005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138223129|NCT05946005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223130|NCT05946005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223131|NCT05946005|Plasma Substitutes|plasma substitutes|mesh-ancestor
138223132|NCT05946005|Blood Substitutes|blood substitutes|mesh-ancestor
138223133|NCT05946005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138223134|NCT05946005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223135|NCT05945979|Biotin|biotin|mesh-list
138223136|NCT05945979|Vitamin B Complex|vitamin b complex|mesh-ancestor
138223137|NCT05945979|Vitamins|vitamins|mesh-ancestor
138223138|NCT05945979|Micronutrients|micronutrients|mesh-ancestor
138223139|NCT05945979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223140|NCT05945771|Grape Seed Extract|grape seed extract|mesh-list
138223141|NCT05945771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138223142|NCT05945771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223143|NCT05945771|Antioxidants|antioxidants|mesh-ancestor
138223144|NCT05945771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223145|NCT05945771|Protective Agents|protective agents|mesh-ancestor
138223146|NCT05945771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223147|NCT05945745|Immunomodulating Agents|immunomodulating agents|mesh-list
138223148|NCT05945745|Immunologic Factors|immunologic factors|mesh-ancestor
138223149|NCT05945745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223150|NCT05945420|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138223151|NCT05945420|Hemostatics|hemostatics|mesh-ancestor
138223152|NCT05945420|Coagulants|coagulants|mesh-ancestor
138223153|NCT05945420|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138223154|NCT05945420|Natriuretic Agents|natriuretic agents|mesh-ancestor
138223155|NCT05945420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223156|NCT05945368|Trastuzumab|trastuzumab|mesh-list
138223157|NCT05945368|Pertuzumab|pertuzumab|mesh-list
138223158|NCT05945368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223159|NCT05945368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223160|NCT05945342|Fluoxetine|fluoxetine|mesh-list
138223161|NCT05945342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138223162|NCT05945342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138223163|NCT05945342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354588|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
138223164|NCT05945342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223166|NCT05945342|Serotonin Agents|serotonin agents|mesh-ancestor
138223167|NCT05945342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223168|NCT05945342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138223170|NCT05945342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138223171|NCT05945342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138223172|NCT05945342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138223173|NCT05945342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223174|NCT05945173|Ethanol|ethanol|mesh-list
138223175|NCT05945173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138223177|NCT05945173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223178|NCT05945173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223179|NCT05944952|Buprenorphine|buprenorphine|mesh-list
138223180|NCT05944952|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138223181|NCT05944952|Naloxone|naloxone|mesh-list
138223182|NCT05944952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138223183|NCT05944952|Narcotics|narcotics|mesh-ancestor
138223184|NCT05944952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223185|NCT05944952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223186|NCT05944952|Analgesics|analgesics|mesh-ancestor
138223187|NCT05944952|Sensory System Agents|sensory system agents|mesh-ancestor
138223188|NCT05944952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223189|NCT05944952|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138223190|NCT05944107|Heparin|heparin|mesh-list
138223191|NCT05944107|Anticoagulants|anticoagulants|mesh-ancestor
138223192|NCT05944107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138223193|NCT05944107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138223194|NCT05944107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223195|NCT05943080|Epinephrine|epinephrine|mesh-list
138223196|NCT05943080|Racepinephrine|racepinephrine|mesh-list
138223197|NCT05943080|Bupivacaine|bupivacaine|mesh-list
138223198|NCT05943080|Epinephryl borate|epinephryl borate|mesh-list
138223199|NCT05943080|Anesthetics, Local|anesthetics, local|mesh-ancestor
138223200|NCT05943080|Anesthetics|anesthetics|mesh-ancestor
138223201|NCT05943080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223202|NCT05943080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223203|NCT05943080|Sensory System Agents|sensory system agents|mesh-ancestor
138223204|NCT05943080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223205|NCT05943080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138223206|NCT05943080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138223207|NCT05943080|Adrenergic Agents|adrenergic agents|mesh-ancestor
138223208|NCT05943080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223209|NCT05943080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223210|NCT05943080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138223211|NCT05943080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138223212|NCT05943080|Autonomic Agents|autonomic agents|mesh-ancestor
138223213|NCT05943080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138223214|NCT05943080|Respiratory System Agents|respiratory system agents|mesh-ancestor
138223215|NCT05943080|Mydriatics|mydriatics|mesh-ancestor
138223216|NCT05943080|Sympathomimetics|sympathomimetics|mesh-ancestor
138223217|NCT05943080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138223218|NCT05938946|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138223219|NCT05929495|Metformin|metformin|mesh-list
138223220|NCT05929495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223221|NCT05929495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223222|NCT05889468|Aspirin|aspirin|mesh-list
138223223|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138223224|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223225|NCT05889468|Analgesics|analgesics|mesh-ancestor
138223226|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
138223227|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223228|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223229|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223230|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223231|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138223232|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138223233|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223234|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138223235|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138223236|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223237|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
138223238|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
138223239|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138223240|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223241|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223242|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138223243|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138223244|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223245|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223246|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223247|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138223248|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
138223249|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223250|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223251|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138223252|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138223253|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138223254|NCT05827484|Losartan|losartan|mesh-list
138223255|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223256|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138223257|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138223258|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138223259|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223260|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
138223261|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223262|NCT05806567|Belumosudil|belumosudil|mesh-list
138223263|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223264|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223265|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223266|NCT05731518|Irinotecan|irinotecan|mesh-list
138223267|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138223268|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138223269|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223270|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223271|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223272|NCT05696795|Abrocitinib|abrocitinib|mesh-list
138223273|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223274|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223275|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223276|NCT05687110|Novobiocin|novobiocin|mesh-list
138223277|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223278|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223279|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223280|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223281|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138223282|NCT05683392|Insulin|insulin|mesh-list
138223283|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223284|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223285|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
138223286|NCT05674565|Analgesics|analgesics|mesh-ancestor
138223287|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
138223288|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223289|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223290|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
138223291|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223294|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138223295|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223296|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223297|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223298|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
138223299|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223300|NCT05554276|Antibodies|antibodies|mesh-list
138223301|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
138223302|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223303|NCT05531942|Aspirin|aspirin|mesh-list
138223304|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138223305|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223306|NCT05531942|Analgesics|analgesics|mesh-ancestor
138223307|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
138223308|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223309|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223310|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223311|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223312|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138223313|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138223345|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223346|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138223348|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223349|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223350|NCT05422664|Lacosamide|lacosamide|mesh-list
138223351|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
138223352|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138223353|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138223354|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223355|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223356|NCT05341583|Ensartinib|ensartinib|mesh-list
138223357|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223358|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223359|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223360|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223361|NCT05256069|Propranolol|propranolol|mesh-list
138223362|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138223363|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138223364|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
138223365|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223366|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223367|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223368|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223369|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138223370|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
138223371|NCT05199571|Ofatumumab|ofatumumab|mesh-list
138223372|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223373|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138223374|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138223375|NCT05155436|Amlodipine|amlodipine|mesh-list
138223376|NCT05155436|Telmisartan|telmisartan|mesh-list
138223377|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138223378|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138223379|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223380|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223381|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223382|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223383|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138223384|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138223385|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138223386|NCT05103696|Propofol|propofol|mesh-list
138223387|NCT05103696|Etomidate|etomidate|mesh-list
138223388|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138223389|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223390|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223391|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138223392|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
138223394|NCT04981041|Clopidogrel|clopidogrel|mesh-list
138223395|NCT04981041|Ticagrelor|ticagrelor|mesh-list
138223396|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138223397|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138223399|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138223400|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138223401|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
138223402|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223403|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223404|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223405|NCT04898725|Vitamin D|vitamin d|mesh-list
138223406|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
138223407|NCT04898725|Vitamins|vitamins|mesh-ancestor
138223408|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
138223409|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223410|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138223411|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223412|NCT04894435|Vaccines|vaccines|mesh-list
138223413|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
138223414|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223415|NCT04840550|Lansoprazole|lansoprazole|mesh-list
138223416|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
138223417|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138223418|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223419|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138223420|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223421|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223423|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138223424|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138223425|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138223426|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223427|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223428|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
138223429|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223430|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223431|NCT04731844|Curcumin|curcumin|mesh-list
138223432|NCT04731844|Piperine|piperine|mesh-list
138354766|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223433|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138223434|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223435|NCT04731844|Analgesics|analgesics|mesh-ancestor
138223436|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
138223437|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223438|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223439|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223440|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223441|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223442|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223443|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223444|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138223446|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
138223447|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223448|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138223449|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223450|NCT04512365|Analgesics|analgesics|mesh-ancestor
138223451|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
138223452|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223453|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138223454|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138223455|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223456|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223457|NCT04512365|Hormones|hormones|mesh-ancestor
138223458|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223459|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138223460|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138223461|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223462|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223463|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
138223464|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223465|NCT04452214|Carboplatin|carboplatin|mesh-list
138223466|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
138223468|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223469|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223470|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138223471|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223472|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223473|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138223474|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138360404|NCT00384306|Hormones|hormones|mesh-ancestor
138223475|NCT04398719|Capsaicin|capsaicin|mesh-list
138223476|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
138223477|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
138223478|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
138223479|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223480|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223481|NCT04373317|Pimavanserin|pimavanserin|mesh-list
138223482|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138223483|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
138223484|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138223485|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138223486|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138223487|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223488|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223489|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138223490|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138223491|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138223492|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138223493|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
138223494|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223495|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223496|NCT04339270|Azithromycin|azithromycin|mesh-list
138223497|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223498|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223499|NCT04207944|Sulindac|sulindac|mesh-list
138223500|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138223501|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223502|NCT04207944|Analgesics|analgesics|mesh-ancestor
138223503|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
138223504|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223505|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223506|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223507|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223508|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223509|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138223510|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223511|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223512|NCT04184622|Tirzepatide|tirzepatide|mesh-list
138223513|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223514|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223515|NCT04184622|Incretins|incretins|mesh-ancestor
138223516|NCT04184622|Hormones|hormones|mesh-ancestor
138223517|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223518|NCT04080427|Dronabinol|dronabinol|mesh-list
138223519|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
138223520|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223521|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138223522|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223523|NCT04080427|Analgesics|analgesics|mesh-ancestor
138223524|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
138223525|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223526|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138223527|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138223528|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223529|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223530|NCT04080427|Hormones|hormones|mesh-ancestor
138223531|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223532|NCT03933631|Ofloxacin|ofloxacin|mesh-list
138223533|NCT03933631|Prednisolone|prednisolone|mesh-list
138223534|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
138223535|NCT03933631|Pilocarpine|pilocarpine|mesh-list
138223536|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223537|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
138223538|NCT03933631|Hormones|hormones|mesh-ancestor
138223539|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223540|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223541|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138223542|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223543|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
138223544|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223545|NCT03933631|Miotics|miotics|mesh-ancestor
138223546|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138223547|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138223548|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
138223549|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223550|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223551|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138223552|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223553|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223554|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138223555|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138223557|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138223558|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138223560|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138223561|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
138223562|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138223563|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223564|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
138223565|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138223566|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138223567|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138223568|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223569|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223570|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138223571|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138223572|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138223573|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223574|NCT03911414|Inositol|inositol|mesh-list
138223575|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
138223576|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138223577|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
138223578|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223580|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
138223581|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138223582|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
138223583|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223584|NCT03911414|Protective Agents|protective agents|mesh-ancestor
138223585|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223586|NCT03911414|Antidotes|antidotes|mesh-ancestor
138223587|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
138223588|NCT03911414|Vitamins|vitamins|mesh-ancestor
138223589|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
138223590|NCT03900754|Oxytocin|oxytocin|mesh-list
138223591|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
138223592|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223593|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223594|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
138223595|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138223596|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223597|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223598|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223599|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223600|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138223601|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
138223602|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138223603|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
138223604|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138223605|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
138223606|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223607|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
138223608|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223609|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223610|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223612|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
138354971|NCT00002112|Ionophores|ionophores|mesh-ancestor
138223613|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223614|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223615|NCT03456700|Sirolimus|sirolimus|mesh-list
138223616|NCT03456700|Auranofin|auranofin|mesh-list
138223617|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223618|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223619|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138223620|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223621|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
138223622|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223623|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
138223625|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223626|NCT03401450|Bupivacaine|bupivacaine|mesh-list
138223627|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
138223628|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
138223629|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223630|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223631|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
138223632|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223634|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
138223635|NCT03356483|Psilocybin|psilocybin|mesh-list
138223636|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138223637|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
138223638|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223639|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138223640|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138223641|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
138223643|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
138223644|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223645|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
138223646|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138223647|NCT03326063|Ifetroban|ifetroban|mesh-list
138223648|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138223649|NCT03324984|Bupivacaine|bupivacaine|mesh-list
138223650|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
138223651|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
138223652|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
138223653|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223654|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223655|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
138223656|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223657|NCT03275857|Cisplatin|cisplatin|mesh-list
138223658|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223659|NCT02764762|Adalimumab|adalimumab|mesh-list
138223660|NCT02764762|Methotrexate|methotrexate|mesh-list
138223661|NCT02764762|Vedolizumab|vedolizumab|mesh-list
138223662|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138223663|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
138223664|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223665|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223666|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138223667|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
138223668|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223669|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223670|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
138223671|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223672|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138223673|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223674|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
138223675|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223676|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138223677|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138223678|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223679|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223680|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138223681|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138223682|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223683|NCT02521363|Taxane|taxane|mesh-list
138223684|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223685|NCT02407509|Everolimus|everolimus|mesh-list
138223686|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138223687|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223688|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223689|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223690|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223691|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
138223692|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223693|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223694|NCT02340962|Interferons|interferons|mesh-list
138223696|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
138223697|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
138223698|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223699|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
138223700|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223701|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
138223702|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223703|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
138223704|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223705|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138223706|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
138223707|NCT02309645|Coagulants|coagulants|mesh-ancestor
138223708|NCT01120249|Everolimus|everolimus|mesh-list
138223709|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138223710|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223711|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223712|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223713|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223714|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
138223715|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223716|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223717|NCT00788125|Carboplatin|carboplatin|mesh-list
138223719|NCT00788125|Dasatinib|dasatinib|mesh-list
138223720|NCT00788125|Ifosfamide|ifosfamide|mesh-list
138223721|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
138223722|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223723|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138223724|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138223725|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138223726|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223727|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223728|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138223729|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138223731|NCT00516373|Olaparib|olaparib|mesh-list
138223732|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138223733|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223734|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223735|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223736|NCT00890162|Omalizumab|omalizumab|mesh-list
138223737|NCT00890162|Epinephrine|epinephrine|mesh-list
138223738|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138223739|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138223740|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
138223741|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223742|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223743|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223744|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138223745|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138223746|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
138223747|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223748|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138223749|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
138223750|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
138223751|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
138223752|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138223753|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138223754|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
138223755|NCT01433081|Analgesics|analgesics|mesh-ancestor
138223756|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
138223757|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223758|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223759|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
138223760|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223761|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223762|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
138223763|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138223764|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223765|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223766|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223767|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
138223768|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223769|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
138355116|NCT00002202|Indinavir|indinavir|mesh-list
138223770|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223771|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
138223772|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223773|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223774|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138223775|NCT01401023|Tigecycline|tigecycline|mesh-list
138223776|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223777|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223778|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138223779|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223780|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223781|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
138223782|NCT01515995|Analgesics|analgesics|mesh-ancestor
138223783|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
138223793|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223794|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
138223795|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223796|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
138223797|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223798|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223799|NCT01519271|Rivastigmine|rivastigmine|mesh-list
138223800|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138223801|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223802|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223803|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
138223804|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223805|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223806|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138223807|NCT01519271|Protective Agents|protective agents|mesh-ancestor
138223808|NCT01436279|Mifepristone|mifepristone|mesh-list
138223809|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138223811|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223812|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223813|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138223814|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138223815|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138223816|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
138223817|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138223818|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138223819|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
138223820|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223821|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
138223822|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138223823|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138223824|NCT02210195|Aprepitant|aprepitant|mesh-list
138223825|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
138223826|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
138223827|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223828|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223829|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223830|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138223831|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223832|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355176|NCT00002226|Semaxinib|semaxinib|mesh-list
138223843|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223844|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223845|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138201744|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223846|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223847|NCT02262026|Saracatinib|saracatinib|mesh-list
138223848|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223850|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223851|NCT00889226|Atorvastatin|atorvastatin|mesh-list
138223852|NCT00889226|Pitavastatin|pitavastatin|mesh-list
138223853|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138223854|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138223855|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
138223856|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223857|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138223858|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138223859|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223860|NCT00837200|Doxorubicin|doxorubicin|mesh-list
138223861|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138223862|NCT00837200|Asparaginase|asparaginase|mesh-list
138223863|NCT00837200|Pegaspargase|pegaspargase|mesh-list
138223864|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138223865|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223866|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138223867|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138223868|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223869|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223870|NCT00837512|Insulin|insulin|mesh-list
138223871|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138223872|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223873|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223875|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
138223876|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138223877|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138223878|NCT00837590|Analgesics|analgesics|mesh-ancestor
138223879|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
138223880|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223881|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223882|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138223883|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223884|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138223885|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223886|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223887|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138223888|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
138223889|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223890|NCT00839540|Caspofungin|caspofungin|mesh-list
138223892|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
138223893|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223894|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211663|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138223898|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223899|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223900|NCT01437605|Poly I-C|poly i-c|mesh-list
138223901|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
138223902|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
138223903|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223904|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
138223905|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223906|NCT01541735|Pantoprazole|pantoprazole|mesh-list
138223907|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138223908|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138223909|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138223910|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223911|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223912|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138223913|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138223914|NCT01520207|Mannitol|mannitol|mesh-list
138223915|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138223916|NCT01520207|Diuretics|diuretics|mesh-ancestor
138223917|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
138223918|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223919|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
138223920|NCT01203722|Sirolimus|sirolimus|mesh-list
138223921|NCT01203722|Fludarabine|fludarabine|mesh-list
138223922|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
138223924|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223925|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223926|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138223927|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
138223928|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223929|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138223930|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223931|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138223932|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138223933|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
138223934|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138223935|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138223936|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138223937|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
138223938|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138223939|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138223940|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
138223941|NCT01520519|Rituximab|rituximab|mesh-list
138223942|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223943|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223944|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
138223945|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223947|NCT03008057|Vitamin D|vitamin d|mesh-list
138223948|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
138223949|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
138223950|NCT03008057|Vitamins|vitamins|mesh-list
138223951|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
138223952|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211689|NCT00382148|Omalizumab|omalizumab|mesh-list
138223954|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138223955|NCT01542125|Lidocaine|lidocaine|mesh-list
138223956|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
138223957|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
138223958|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223959|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223960|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
138223961|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223962|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223963|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138223964|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138223965|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223966|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223967|NCT03216668|Silymarin|silymarin|mesh-list
138223968|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
138223969|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223970|NCT03216668|Protective Agents|protective agents|mesh-ancestor
138223971|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223972|NCT02548832|Bezafibrate|bezafibrate|mesh-list
138223973|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138223974|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
138223975|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223976|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138223977|NCT03216278|Metformin|metformin|mesh-list
138223978|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
138223979|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223980|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223981|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138223982|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223983|NCT05310344|Paclitaxel|paclitaxel|mesh-list
138223985|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138223986|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138223987|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223988|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
138223989|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
138223990|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201745|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
138223991|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223992|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138223993|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138223994|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138223995|NCT05310344|Growth Substances|growth substances|mesh-ancestor
138223996|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223997|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138223998|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
138224000|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138224001|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224002|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
138224003|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
138224004|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224005|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224006|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138224007|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138224008|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138224009|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
138224010|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224011|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224012|NCT04382144|Bupivacaine|bupivacaine|mesh-list
138224013|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
138224015|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224017|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
138224018|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224019|NCT03215966|Tadalafil|tadalafil|mesh-list
138224020|NCT03215966|Macitentan|macitentan|mesh-list
138224021|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
138224022|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138224023|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138224024|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224025|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224026|NCT03215966|Urological Agents|urological agents|mesh-ancestor
138224027|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138224028|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138355366|NCT00002376|Stavudine|stavudine|mesh-list
138224029|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138224030|NCT03215498|Insulin|insulin|mesh-list
138224031|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138224032|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
138224033|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
138224034|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138224035|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138224036|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224037|NCT01441037|Danazol|danazol|mesh-list
138224038|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138224039|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
138224040|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224041|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224042|NCT00891878|Capecitabine|capecitabine|mesh-list
138224043|NCT00891878|Sunitinib|sunitinib|mesh-list
138224044|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138224045|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
138224046|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224047|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224048|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138224049|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138224050|NCT00891878|Growth Substances|growth substances|mesh-ancestor
138224051|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224052|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
138224053|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138224054|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224055|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
138224056|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138224057|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224059|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138224060|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138224061|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224062|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
138224063|NCT03838328|Coagulants|coagulants|mesh-ancestor
138224064|NCT01526213|Fexofenadine|fexofenadine|mesh-list
138224065|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138224066|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138224067|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138224068|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
138224069|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
138224070|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224071|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224072|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224073|NCT01549223|Misoprostol|misoprostol|mesh-list
138224075|NCT01549223|Methylergonovine|methylergonovine|mesh-list
138224076|NCT01549223|Carboprost|carboprost|mesh-list
138224077|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
138224078|NCT01549223|Maleic acid|maleic acid|mesh-list
138224079|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
138224080|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138224081|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224082|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138224083|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
138224084|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138224085|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224086|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224087|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224088|NCT00895934|Azacitidine|azacitidine|mesh-list
138224089|NCT00895934|Vorinostat|vorinostat|mesh-list
138224090|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
138224091|NCT00895934|Calicheamicins|calicheamicins|mesh-list
138355451|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
138224094|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224095|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224096|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224097|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138224098|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224099|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
138224100|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
138224101|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
138224102|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224103|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138224104|NCT01550471|Ciclesonide|ciclesonide|mesh-list
138224105|NCT01550471|Beclomethasone|beclomethasone|mesh-list
138224106|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224107|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
138224108|NCT01550471|Hormones|hormones|mesh-ancestor
138224109|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224110|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224111|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138224112|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
138224113|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138224114|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
138224115|NCT03215264|Entinostat|entinostat|mesh-list
138224116|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
138224117|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138224118|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138224119|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224120|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224121|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224122|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224123|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224124|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138224125|NCT01447511|Rifampin|rifampin|mesh-list
138224126|NCT01447511|Fluconazole|fluconazole|mesh-list
138224127|NCT01447511|Warfarin|warfarin|mesh-list
138224128|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
138224129|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138224130|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
138224131|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224132|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224133|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
138224134|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138360463|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
138224135|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224136|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224137|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138224138|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138224139|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138224140|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138224141|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138224142|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138224143|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
138224144|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138224145|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138224146|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138224147|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
138224148|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224149|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224150|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138360472|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
138360473|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138360475|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138224151|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138224152|NCT01831622|Methylphenidate|methylphenidate|mesh-list
138355557|NCT00002466|Ifosfamide|ifosfamide|mesh-list
138224153|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138224154|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224155|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138224156|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138224157|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224158|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224159|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
138224160|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224161|NCT04380818|Ritonavir|ritonavir|mesh-list
138224162|NCT04380818|Lopinavir|lopinavir|mesh-list
138224163|NCT04380818|Azithromycin|azithromycin|mesh-list
138224164|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
138224165|NCT04380818|Heparin|heparin|mesh-list
138224166|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138224167|NCT04380818|Tinzaparin|tinzaparin|mesh-list
138224168|NCT04380818|Dalteparin|dalteparin|mesh-list
138224169|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138224170|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138224171|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
138224172|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224173|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224174|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138224175|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138224176|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
138224177|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224178|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138224179|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138224182|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138224183|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224184|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
138224185|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138224186|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138224187|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224189|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
138224190|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224191|NCT01550705|Isoniazid|isoniazid|mesh-list
138224192|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
138224193|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224194|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224195|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138224196|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138224197|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
138224198|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224199|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138224200|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138224201|NCT01831700|Lisinopril|lisinopril|mesh-list
138224202|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
138224203|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224204|NCT01831700|Diuretics|diuretics|mesh-ancestor
138224205|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
138224206|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224207|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138224208|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224209|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224210|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138224211|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
138224212|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224213|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138224214|NCT01831700|Protective Agents|protective agents|mesh-ancestor
138224216|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138224217|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224218|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
138224219|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224220|NCT03214874|Torsemide|torsemide|mesh-list
138224221|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224222|NCT03214874|Diuretics|diuretics|mesh-ancestor
138224223|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
138224224|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224225|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138224226|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224227|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224229|NCT02504268|Abatacept|abatacept|mesh-list
138224230|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138224231|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
138224232|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138224233|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224234|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138224235|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
138224236|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224237|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224238|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
138224239|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224240|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138224241|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224242|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
138224243|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224244|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138224245|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138224246|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224248|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138224249|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224250|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
138224251|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224253|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138224254|NCT01448525|Bimatoprost|bimatoprost|mesh-list
138224255|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138224256|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138224257|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224258|NCT01654302|Lidocaine|lidocaine|mesh-list
138224259|NCT01654302|Tetracaine|tetracaine|mesh-list
138224260|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
138224262|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224263|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224264|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
138224265|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224266|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138224267|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138224268|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138224269|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224270|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224272|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138224273|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
138224274|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224275|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224276|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138224278|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
138224279|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224280|NCT02476422|Ibuprofen|ibuprofen|mesh-list
138224281|NCT02476422|Diclofenac|diclofenac|mesh-list
138224282|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138224283|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138224284|NCT02476422|Analgesics|analgesics|mesh-ancestor
138224285|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
138224286|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224287|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224288|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224289|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224290|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138224291|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224292|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224294|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224295|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224296|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138224298|NCT01552343|Coagulants|coagulants|mesh-ancestor
138224299|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138224300|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
138224303|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
138224304|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224305|NCT02475564|Protective Agents|protective agents|mesh-ancestor
138224306|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224307|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224308|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138224309|NCT00893984|Nebivolol|nebivolol|mesh-list
138224310|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224311|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
138224312|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138224313|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138224314|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138224315|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
138224316|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224317|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224318|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224319|NCT01832870|Ipilimumab|ipilimumab|mesh-list
138224320|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224321|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224322|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138224323|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224324|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
138224325|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138224326|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224327|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224328|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
138224329|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224330|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224331|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
138224332|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138224333|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
138224334|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138224335|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
138224336|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224337|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224338|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
138224339|NCT01832948|Leucovorin|leucovorin|mesh-list
138224340|NCT01832948|Folic Acid|folic acid|mesh-list
138224341|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
138224342|NCT01832948|Endostar protein|endostar protein|mesh-list
138224343|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
138224344|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224345|NCT01832948|Antidotes|antidotes|mesh-ancestor
138224346|NCT01832948|Protective Agents|protective agents|mesh-ancestor
138224347|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224348|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
138224349|NCT01832948|Vitamins|vitamins|mesh-ancestor
138224350|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
138224351|NCT01832948|Hematinics|hematinics|mesh-ancestor
138224352|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138224353|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138224354|NCT01832948|Growth Substances|growth substances|mesh-ancestor
138211769|NCT05290116|Apatinib|apatinib|mesh-list
138224356|NCT01533077|Levodopa|levodopa|mesh-list
138224357|NCT01533077|Carbidopa|carbidopa|mesh-list
138224358|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138224359|NCT01533077|Opicapone|opicapone|mesh-list
138224360|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138224361|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138224362|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
138224363|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224364|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224365|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224366|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138224368|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138224369|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
138224370|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
138224371|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138224372|NCT01534013|Insulin|insulin|mesh-list
138224373|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138224374|NCT01534013|Pancrelipase|pancrelipase|mesh-list
138224375|NCT01534013|Pancreatin|pancreatin|mesh-list
138224376|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138201746|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
138224377|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224378|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224379|NCT03211988|Entinostat|entinostat|mesh-list
138224380|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224381|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138224382|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224383|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224384|NCT01833728|Acetaminophen|acetaminophen|mesh-list
138224385|NCT01833728|Propacetamol|propacetamol|mesh-list
138224386|NCT01833728|Nefopam|nefopam|mesh-list
138224387|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138224388|NCT01833728|Analgesics|analgesics|mesh-ancestor
138224389|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
138224390|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224391|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224392|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138224393|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224394|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224395|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
138224396|NCT03213392|Anesthetics|anesthetics|mesh-list
138224397|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224398|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224399|NCT03219788|Remifentanil|remifentanil|mesh-list
138224400|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224401|NCT03219788|Narcotics|narcotics|mesh-ancestor
138224402|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224403|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224404|NCT03219788|Analgesics|analgesics|mesh-ancestor
138224405|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
138224406|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224407|NCT03219710|Dexamethasone|dexamethasone|mesh-list
138224408|NCT03219710|Ondansetron|ondansetron|mesh-list
138224409|NCT03219710|Olanzapine|olanzapine|mesh-list
138224410|NCT03219710|Aprepitant|aprepitant|mesh-list
138224411|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224412|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
138224413|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
138224414|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224415|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224416|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224417|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
138224419|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224420|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138224421|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224422|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
138224423|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138224424|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138224426|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
138224427|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224428|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224429|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138224430|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138224431|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224433|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138224434|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138224435|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224436|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138224437|NCT01532141|Opicapone|opicapone|mesh-list
138224438|NCT01532141|Rasagiline|rasagiline|mesh-list
138224439|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138224440|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224441|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224442|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138224444|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224445|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138224446|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138224447|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138224448|NCT00899600|Ketamine|ketamine|mesh-list
138224449|NCT00899600|Analgesics|analgesics|mesh-ancestor
138224450|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
138224451|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224452|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224453|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138224454|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138224455|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
138224457|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224458|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138224459|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138224460|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224461|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224462|NCT03219554|Palbociclib|palbociclib|mesh-list
138224463|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224464|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138224465|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224466|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224467|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
138224468|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224469|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
138224470|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224471|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224472|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224473|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
138224474|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224475|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224476|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224478|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138224479|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224480|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
138224481|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224482|NCT03837938|Dipropizine|dipropizine|mesh-list
138224483|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
138355884|NCT00002610|Etoposide|etoposide|mesh-list
138224485|NCT01554683|Levetiracetam|levetiracetam|mesh-list
138224486|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
138224487|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
138224488|NCT00905060|Temozolomide|temozolomide|mesh-list
138224489|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224490|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
138224491|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224492|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224493|NCT01535573|Dexetimide|dexetimide|mesh-list
138224494|NCT01535573|Citalopram|citalopram|mesh-list
138224495|NCT01535573|Escitalopram|escitalopram|mesh-list
138224496|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138224497|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138224498|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224499|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224500|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224501|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
138224502|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224503|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138224504|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
138224505|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138224506|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138224507|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138224508|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
138224509|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
138224510|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224511|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138224512|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138224513|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138224514|NCT01834508|Entecavir|entecavir|mesh-list
138224515|NCT01834508|Adefovir|adefovir|mesh-list
138224516|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
138224517|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224518|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138224519|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138224520|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224521|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224522|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
138224523|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138224524|NCT01556633|Oseltamivir|oseltamivir|mesh-list
138224525|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
138224526|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224527|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224528|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224529|NCT03218852|Prednisone|prednisone|mesh-list
138224530|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
138224531|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224532|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
138224533|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224534|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224535|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224536|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
138224537|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224538|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224539|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224540|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224541|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
138224542|NCT03218852|Hormones|hormones|mesh-ancestor
138224543|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224544|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138224545|NCT01834898|Oxycodone|oxycodone|mesh-list
138224546|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138355973|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138224547|NCT01834898|Narcotics|narcotics|mesh-ancestor
138224548|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224549|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224550|NCT01834898|Analgesics|analgesics|mesh-ancestor
138224551|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
138211794|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138224553|NCT01557959|Docetaxel|docetaxel|mesh-list
138224554|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138224555|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224556|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
138224557|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
138224558|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
138224559|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224560|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138224561|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224562|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
138224563|NCT03212456|Ropivacaine|ropivacaine|mesh-list
138224564|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
138224565|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
138224566|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224567|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224568|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
138224569|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224570|NCT03212456|Narcotics|narcotics|mesh-ancestor
138224571|NCT03212456|Analgesics|analgesics|mesh-ancestor
138224572|NCT03217838|Azacitidine|azacitidine|mesh-list
138224573|NCT03217838|Venetoclax|venetoclax|mesh-list
138211804|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138224575|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138224576|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
138356016|NCT00002676|Cytarabine|cytarabine|mesh-list
138224577|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224578|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224579|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224581|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224582|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138224583|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224584|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224585|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
138224586|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224587|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
138224588|NCT02502864|Docetaxel|docetaxel|mesh-list
138224589|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224590|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
138224591|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224592|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224593|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224594|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
138224595|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224596|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224597|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224598|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138224599|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138224600|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138224601|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
138224602|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224603|NCT03217292|Tramadol|tramadol|mesh-list
138224604|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224605|NCT03217292|Narcotics|narcotics|mesh-ancestor
138224606|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224607|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224608|NCT03217292|Analgesics|analgesics|mesh-ancestor
138224609|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
138224610|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224611|NCT03217448|Warfarin|warfarin|mesh-list
138224613|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
138224614|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
138224615|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138224616|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138224617|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224618|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224619|NCT01457573|Tamsulosin|tamsulosin|mesh-list
138224620|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
138224621|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138224622|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138224623|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138224624|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
138224625|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224626|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224627|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224628|NCT01457573|Urological Agents|urological agents|mesh-ancestor
138224629|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138224631|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138224632|NCT01560143|Tigecycline|tigecycline|mesh-list
138224633|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224634|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224635|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138224637|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224638|NCT01836224|Terlipressin|terlipressin|mesh-list
138224639|NCT01836224|Norepinephrine|norepinephrine|mesh-list
138224640|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224641|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138224642|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138224643|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138224644|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
138224645|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224646|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224647|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224649|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
138224650|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224651|NCT01836536|Bevacizumab|bevacizumab|mesh-list
138224652|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224653|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224654|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138224655|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138224656|NCT01836536|Growth Substances|growth substances|mesh-ancestor
138224657|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224658|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
138224659|NCT03216980|Antioxidants|antioxidants|mesh-list
138224660|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224661|NCT03216980|Protective Agents|protective agents|mesh-ancestor
138224662|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224664|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138224665|NCT00895232|Trace Elements|trace elements|mesh-ancestor
138224666|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
138224667|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224668|NCT00895232|Hematinics|hematinics|mesh-ancestor
138224669|NCT03211052|Leuprolide|leuprolide|mesh-list
138224670|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138224671|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
138224672|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138224673|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224674|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138224675|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224676|NCT01560923|Tryptophan|tryptophan|mesh-list
138224677|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138224678|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
138224679|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138224680|NCT01839032|Vinorelbine|vinorelbine|mesh-list
138224681|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224682|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138224683|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138224684|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138224685|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138224686|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224688|NCT01457885|Clofarabine|clofarabine|mesh-list
138224690|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224691|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224692|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
138224693|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224694|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224695|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224696|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224697|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138224698|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
138224700|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138224701|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211873|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
138224702|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224703|NCT01561469|Vancomycin|vancomycin|mesh-list
138224704|NCT01561469|Linezolid|linezolid|mesh-list
138224705|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224706|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224707|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138224708|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224709|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356190|NCT00002718|Hormones|hormones|mesh-ancestor
138224710|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138360576|NCT01792050|Paclitaxel|paclitaxel|mesh-list
138224711|NCT01561703|Amoxicillin|amoxicillin|mesh-list
138224712|NCT01561703|Azithromycin|azithromycin|mesh-list
138224713|NCT01561703|Clindamycin|clindamycin|mesh-list
138224714|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
138224715|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138224716|NCT01561703|Cephalexin|cephalexin|mesh-list
138224717|NCT01561703|Cefdinir|cefdinir|mesh-list
138224718|NCT01561703|Cefaclor|cefaclor|mesh-list
138224719|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224720|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138224721|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224722|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224723|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138224724|NCT01839500|Trastuzumab|trastuzumab|mesh-list
138224725|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224726|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224727|NCT02501928|Fesoterodine|fesoterodine|mesh-list
138224728|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138224729|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138224730|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138224731|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224732|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224733|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224734|NCT02501928|Urological Agents|urological agents|mesh-ancestor
138224735|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
138224736|NCT01462253|Clofarabine|clofarabine|mesh-list
138224737|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224738|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
138224739|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224740|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224741|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224742|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
138224743|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224744|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224745|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224746|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138224747|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
138224748|NCT01837394|Acetaminophen|acetaminophen|mesh-list
138224750|NCT01837394|Ondansetron|ondansetron|mesh-list
138224751|NCT01837394|Metoclopramide|metoclopramide|mesh-list
138224752|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224753|NCT01837394|Narcotics|narcotics|mesh-ancestor
138224754|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224755|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224756|NCT01837394|Analgesics|analgesics|mesh-ancestor
138224757|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
138224758|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224759|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138224760|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
138224761|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
138224762|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
138224763|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224764|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
138224765|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
138224766|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138224767|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138224768|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
138224769|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224770|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224771|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138224772|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138224773|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
138224774|NCT01462565|Epoprostenol|epoprostenol|mesh-list
138224775|NCT01462565|Tezosentan|tezosentan|mesh-list
138211953|NCT00456014|Desipramine|desipramine|mesh-list
138224777|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138224778|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138224780|NCT01837628|Mineral Oil|mineral oil|mesh-list
138224781|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138224782|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
138224783|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224784|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224785|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
138224786|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224787|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138224788|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138224789|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138224790|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224791|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224793|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
138224794|NCT01462877|Fenofibrate|fenofibrate|mesh-list
138224795|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138224796|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
138224797|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224798|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138224799|NCT04972656|Ambrisentan|ambrisentan|mesh-list
138224800|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224801|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138224802|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
138224803|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224804|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
138224805|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138224806|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224807|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
138224808|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
138224809|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138224810|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
138224811|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138224812|NCT01839812|Cosyntropin|cosyntropin|mesh-list
138224813|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138224814|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138224815|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
138224816|NCT01839812|Hormones|hormones|mesh-ancestor
138224817|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224818|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224819|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224820|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224821|NCT01839890|Paclitaxel|paclitaxel|mesh-list
138211978|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138211979|NCT05231694|Mitogens|mitogens|mesh-list
138224822|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138224824|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138224825|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138224826|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138224827|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224828|NCT02205983|Acetaminophen|acetaminophen|mesh-list
138224829|NCT02205983|Hydromorphone|hydromorphone|mesh-list
138224830|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138224831|NCT02205983|Analgesics|analgesics|mesh-ancestor
138224832|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
138224833|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224834|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224835|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
138224836|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224837|NCT02205983|Narcotics|narcotics|mesh-ancestor
138224838|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224839|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138224840|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138224841|NCT03210038|Lidocaine|lidocaine|mesh-list
138224842|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
138224843|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
138224844|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224845|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224846|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
138224847|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224848|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138224849|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138224850|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138224851|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138224852|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224853|NCT02472756|Rituximab|rituximab|mesh-list
138224854|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138224856|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
138224857|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224858|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224859|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
138224860|NCT01464359|Busulfan|busulfan|mesh-list
138224861|NCT01464359|Fludarabine|fludarabine|mesh-list
138224862|NCT01464359|Interleukin-2|interleukin-2|mesh-list
138224863|NCT01464359|Allopurinol|allopurinol|mesh-list
138224864|NCT01464359|Levetiracetam|levetiracetam|mesh-list
138224865|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138224866|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
138224867|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224868|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224869|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224870|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
138224871|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224872|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224873|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138224874|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
138224875|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138224876|NCT01464359|Analgesics|analgesics|mesh-ancestor
138224877|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
138224878|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224879|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
138224880|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
138224881|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224882|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
138224883|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138224884|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
138224885|NCT01464359|Protective Agents|protective agents|mesh-ancestor
138224887|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138224888|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
138224889|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224890|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
138224891|NCT01838252|Protective Agents|protective agents|mesh-ancestor
138224892|NCT01838330|Psyllium|psyllium|mesh-list
138224893|NCT01838330|Cathartics|cathartics|mesh-ancestor
138224894|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224895|NCT02498652|Allopurinol|allopurinol|mesh-list
138224896|NCT02498652|Verinurad|verinurad|mesh-list
138224897|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
138356380|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138224898|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224899|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224900|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
138224901|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224902|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138224904|NCT02498652|Protective Agents|protective agents|mesh-ancestor
138224905|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224906|NCT03213158|Ixazomib|ixazomib|mesh-list
138224907|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224908|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
138224909|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224910|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224911|NCT02498418|Rifaximin|rifaximin|mesh-list
138224912|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224913|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224914|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224915|NCT03219476|Tamoxifen|tamoxifen|mesh-list
138224916|NCT03219476|Letrozole|letrozole|mesh-list
138224917|NCT03219476|Anastrozole|anastrozole|mesh-list
138224918|NCT03219476|Exemestane|exemestane|mesh-list
138224919|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224920|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138224921|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138224922|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224923|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224924|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138224925|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
138201747|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
138224926|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224927|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224928|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138224929|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138224930|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138224932|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138224933|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224934|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
138224935|NCT02472366|Hormones|hormones|mesh-ancestor
138224936|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224937|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224938|NCT01724606|Sorafenib|sorafenib|mesh-list
138224939|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138224940|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138224941|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224942|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224943|NCT03219164|Aztreonam|aztreonam|mesh-list
138224944|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138224945|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224946|NCT01720238|Lamivudine|lamivudine|mesh-list
138224947|NCT01720238|Adefovir|adefovir|mesh-list
138224948|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138224949|NCT01720238|Entecavir|entecavir|mesh-list
138224950|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138224951|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138224952|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224953|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224954|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
138224955|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138224956|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138224957|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138224958|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
138224959|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138224961|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224962|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138224963|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138224964|NCT03836222|Protective Agents|protective agents|mesh-ancestor
138224965|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224966|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
138212061|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
138224968|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
138224969|NCT01830218|Anesthetics|anesthetics|mesh-list
138224970|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224971|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224972|NCT00910208|Morphine|morphine|mesh-list
138224973|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224974|NCT00910208|Narcotics|narcotics|mesh-ancestor
138224975|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224976|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224978|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
138224979|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224980|NCT01566539|Vasopressins|vasopressins|mesh-list
138224981|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
138224982|NCT01566539|Lorazepam|lorazepam|mesh-list
138224983|NCT01566539|Oxytocin|oxytocin|mesh-list
138224984|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
138224985|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138224986|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224987|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
138224988|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
138224989|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
138224990|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224991|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224992|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138224993|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138224994|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138224995|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138224996|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138224997|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
138224998|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
138224999|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225000|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225001|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
138225002|NCT01566539|Coagulants|coagulants|mesh-ancestor
138225003|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138225004|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138225005|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
138225006|NCT01725776|Milrinone|milrinone|mesh-list
138225007|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138225008|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138225009|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138225010|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138225011|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138356547|NCT03838848|Pemetrexed|pemetrexed|mesh-list
138225013|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225014|NCT01725776|Protective Agents|protective agents|mesh-ancestor
138225015|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225016|NCT01830296|Morphine|morphine|mesh-list
138225017|NCT01830296|Remifentanil|remifentanil|mesh-list
138225018|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138225019|NCT01830296|Narcotics|narcotics|mesh-ancestor
138225020|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225021|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225022|NCT01830296|Analgesics|analgesics|mesh-ancestor
138225023|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
138225024|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225025|NCT05564819|Acetaminophen|acetaminophen|mesh-list
138225026|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225027|NCT05564819|Analgesics|analgesics|mesh-ancestor
138225028|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
138225029|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225030|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225031|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
138225032|NCT01720394|Dinoprostone|dinoprostone|mesh-list
138225033|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
138225034|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225035|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225036|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138225037|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138225038|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138225039|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225040|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
138225041|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225042|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
138225043|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138225044|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138356592|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
138225045|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138225046|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225047|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225048|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
138225049|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225050|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225051|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138225052|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225053|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
138225054|NCT01568255|Vitamin D|vitamin d|mesh-list
138225055|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138225056|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225057|NCT01568255|Vitamins|vitamins|mesh-ancestor
138225058|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
138225059|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138225060|NCT01720628|Angiogenin|angiogenin|mesh-list
138225061|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138225062|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138225063|NCT01720628|Growth Substances|growth substances|mesh-ancestor
138225064|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225065|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
138225066|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138225067|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
138225069|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138225070|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138225071|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
138225077|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138225078|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225079|NCT03409874|Analgesics|analgesics|mesh-ancestor
138225080|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
138225081|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225082|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225083|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225084|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225085|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138225086|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225087|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225088|NCT01726088|Modafinil|modafinil|mesh-list
138225089|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138225090|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225091|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138225092|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138225093|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138225094|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225100|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138356690|NCT00002802|Cobalt|cobalt|mesh-list
138225101|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138225102|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138225103|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
138225104|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225105|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138225107|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138225108|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225109|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138225110|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138225111|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138225112|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225113|NCT01726478|Oxytocin|oxytocin|mesh-list
138225114|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
138225115|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225116|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225117|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
138225118|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
138225119|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138225120|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138225121|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225122|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225123|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225124|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225125|NCT03409250|Ranibizumab|ranibizumab|mesh-list
138225126|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138356732|NCT00002832|Decitabine|decitabine|mesh-list
138225127|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138225128|NCT03409250|Growth Substances|growth substances|mesh-ancestor
138225129|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225130|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
138225131|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225132|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138225133|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138225134|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225136|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138225137|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225138|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
138225139|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138225140|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138225141|NCT01720940|Vancomycin|vancomycin|mesh-list
138225142|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138225143|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225144|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138225145|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225147|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
138225148|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138225149|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
138225150|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225151|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225152|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138225153|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138225154|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138225155|NCT01721798|Trace Elements|trace elements|mesh-ancestor
138225156|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
138225157|NCT02497404|Fludarabine|fludarabine|mesh-list
138225158|NCT02497404|Azacitidine|azacitidine|mesh-list
138225159|NCT02497404|Melphalan|melphalan|mesh-list
138225160|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
138225161|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225162|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356792|NCT00002898|Ifosfamide|ifosfamide|mesh-list
138225164|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225165|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225166|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
138225167|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225168|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225169|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138225170|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
138225171|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138225172|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225173|NCT01573169|Enoxaparin|enoxaparin|mesh-list
138225174|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
138225175|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138225176|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138225177|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225178|NCT04205994|Tolcapone|tolcapone|mesh-list
138225179|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138225180|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138225181|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138225182|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225183|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225184|NCT02218307|Mupirocin|mupirocin|mesh-list
138225185|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138225186|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225187|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138225188|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225189|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225190|NCT01722110|Indomethacin|indomethacin|mesh-list
138225191|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138212110|NCT00528398|Cytarabine|cytarabine|mesh-list
138225192|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225194|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
138225195|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225196|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225197|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225198|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225199|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
138225200|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
138225201|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225202|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138360631|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356859|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
138225203|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225204|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225206|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138225207|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225208|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138225209|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
138225210|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225211|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138225212|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138225213|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225214|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225215|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225216|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
138225217|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225218|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138225219|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138225221|NCT01574807|Mepivacaine|mepivacaine|mesh-list
138225222|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
138225223|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
138225224|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225225|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225226|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
138225227|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225228|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138225229|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138225230|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138225231|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225232|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225233|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138225234|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138225235|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
138225236|NCT01728272|Metoprolol|metoprolol|mesh-list
138225237|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138356935|NCT00003012|Epirubicin|epirubicin|mesh-list
138225239|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
138225240|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
138225241|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225242|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225243|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138225244|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138225245|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138225246|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225247|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225248|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225249|NCT04377386|Vitamin D|vitamin d|mesh-list
138225250|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
138225251|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
138225252|NCT04377386|Vitamins|vitamins|mesh-list
138225253|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
138225254|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225255|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138225256|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138225257|NCT01728740|Metformin|metformin|mesh-list
138225258|NCT01728740|Acarbose|acarbose|mesh-list
138225259|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138225260|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225261|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138225262|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225263|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225264|NCT01728818|Gemcitabine|gemcitabine|mesh-list
138225265|NCT01728818|Afatinib|afatinib|mesh-list
138225266|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138225267|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
138225268|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225269|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225270|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138225271|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225272|NCT01728974|Anesthetics|anesthetics|mesh-list
138225273|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225274|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225275|NCT03407300|Docetaxel|docetaxel|mesh-list
138225276|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225277|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138225278|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138225279|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356961|NCT00003054|Paclitaxel|paclitaxel|mesh-list
138225280|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225281|NCT01722968|Paclitaxel|paclitaxel|mesh-list
138225282|NCT01722968|Bevacizumab|bevacizumab|mesh-list
138225283|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138225284|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225285|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138225286|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138225287|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138225288|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225289|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225290|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138225291|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138225292|NCT01722968|Growth Substances|growth substances|mesh-ancestor
138225293|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225294|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
138225295|NCT04379180|Bosentan|bosentan|mesh-list
138225296|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
138225297|NCT04379180|Tadalafil|tadalafil|mesh-list
138225298|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
138225299|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138225300|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138225301|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225302|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225303|NCT04379180|Urological Agents|urological agents|mesh-ancestor
138225304|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138225305|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138225306|NCT01576523|Complement C1s|complement c1s|mesh-list
138225307|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138225308|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138225309|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
138225310|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225311|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138225312|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225313|NCT03406676|Methylene Blue|methylene blue|mesh-list
138225314|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225315|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225316|NCT03001739|Urapidil|urapidil|mesh-list
138212128|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212129|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138212134|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138212135|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138212137|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212138|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212139|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138212140|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138212141|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
138212142|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225319|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138225320|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
138225322|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225323|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225324|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138357065|NCT00003114|Lomustine|lomustine|mesh-list
138225326|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138212143|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138212144|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138212145|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138212146|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138212147|NCT01795664|Fluticasone|fluticasone|mesh-list
138212148|NCT01795664|Xhance|xhance|mesh-list
138212149|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138225329|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
138225330|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225331|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225332|NCT03006965|Factor VIII|factor viii|mesh-list
138225334|NCT03006965|Coagulants|coagulants|mesh-ancestor
138225335|NCT04379102|Anesthetics|anesthetics|mesh-list
138225336|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
138225337|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225338|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225339|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
138225340|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225341|NCT02469246|Lamivudine|lamivudine|mesh-list
138225342|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138225343|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138225344|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225345|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225346|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
138225347|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225348|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138225349|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138225351|NCT01723202|Dabrafenib|dabrafenib|mesh-list
138225352|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225353|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138225354|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225355|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225356|NCT01578317|Vaccines|vaccines|mesh-list
138225357|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
138225358|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225359|NCT03830216|Insulin|insulin|mesh-list
138225360|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138225361|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138225362|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225363|NCT01726946|Ribavirin|ribavirin|mesh-list
138225364|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
138225365|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225366|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
138225367|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225368|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
138225369|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138225370|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225371|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225372|NCT01723748|Hormones|hormones|mesh-list
138225373|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138225374|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225375|NCT02469090|Apomorphine|apomorphine|mesh-list
138225376|NCT02469090|Emetics|emetics|mesh-ancestor
138225377|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225378|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
138225379|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225380|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225381|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
138225382|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
138225383|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225384|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225385|NCT02496000|Insulin|insulin|mesh-list
138225386|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138225387|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225388|NCT02517528|Ritonavir|ritonavir|mesh-list
138225389|NCT02517528|Ribavirin|ribavirin|mesh-list
138225390|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138225391|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138225392|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
138225393|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225394|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225395|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138225396|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138225397|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
138225398|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225399|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138225400|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138225401|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
138225402|NCT01727336|Axitinib|axitinib|mesh-list
138225403|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225404|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138225405|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225406|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225408|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225409|NCT03835442|Baclofen|baclofen|mesh-list
138225410|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138225411|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225412|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138225413|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225414|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138225415|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
138225416|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
138225417|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225418|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225419|NCT01722656|Aflibercept|aflibercept|mesh-list
138225420|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138225421|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138225423|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225424|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
138225425|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225426|NCT04963764|Amoxicillin|amoxicillin|mesh-list
138225427|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138225428|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225429|NCT03405584|Amoxicillin|amoxicillin|mesh-list
138225430|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
138225431|NCT03405584|Esomeprazole|esomeprazole|mesh-list
138225432|NCT03405584|Bismuth|bismuth|mesh-list
138225433|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225434|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138225435|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225436|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138225437|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225438|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138225439|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225440|NCT03405584|Antacids|antacids|mesh-ancestor
138225441|NCT03405584|Diuretics|diuretics|mesh-ancestor
138225442|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
138225443|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225444|NCT03405584|Expectorants|expectorants|mesh-ancestor
138225445|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138225446|NCT03007121|Sufentanil|sufentanil|mesh-list
138225447|NCT03007121|Morphine|morphine|mesh-list
138225448|NCT03007121|Dsuvia|dsuvia|mesh-list
138225449|NCT03007121|Bupivacaine|bupivacaine|mesh-list
138225450|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
138225451|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
138225452|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225453|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225454|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
138225455|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225456|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138225459|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138225460|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138225461|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
138225462|NCT01725152|Ganaxolone|ganaxolone|mesh-list
138225463|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
138225464|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225465|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225466|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225467|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
138225468|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
138225469|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138225470|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138225471|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
138357350|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138225472|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225473|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225474|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138225475|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225476|NCT02981459|Mirabegron|mirabegron|mesh-list
138225477|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138225478|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138225479|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138225480|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225481|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225482|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225483|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225484|NCT02981459|Urological Agents|urological agents|mesh-ancestor
138225485|NCT01724138|Deferasirox|deferasirox|mesh-list
138225486|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138225487|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
138225488|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
138225489|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225490|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138225491|NCT03006809|Metronidazole|metronidazole|mesh-list
138225492|NCT03006809|Vancomycin|vancomycin|mesh-list
138225493|NCT03006809|Neomycin|neomycin|mesh-list
138225494|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225495|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138225496|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138225497|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138225498|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357412|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138225499|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225501|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
138225502|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
138225503|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225504|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225505|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225506|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138225507|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225508|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225509|NCT01049984|Rasagiline|rasagiline|mesh-list
138225510|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138225511|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225513|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138225514|NCT01049984|Protective Agents|protective agents|mesh-ancestor
138225515|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225516|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138225517|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138225518|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
138225519|NCT03001349|Octreotide|octreotide|mesh-list
138225520|NCT03001349|Edotreotide|edotreotide|mesh-list
138225521|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225522|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225523|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138225524|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225525|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138225526|NCT03001193|Oxytocin|oxytocin|mesh-list
138225527|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
138225528|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225529|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225530|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
138225531|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138225532|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
138225533|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225534|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225535|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138357462|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
138225536|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
138225537|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138225538|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138225539|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138225540|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225541|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225542|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225544|NCT02494596|Pertuzumab|pertuzumab|mesh-list
138225545|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138225546|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
138225547|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225548|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225549|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225550|NCT01048502|Fenofibrate|fenofibrate|mesh-list
138225551|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138225552|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
138225553|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225554|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138225555|NCT01583543|Olaparib|olaparib|mesh-list
138225556|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138225557|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225558|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225559|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225560|NCT01724372|Aripiprazole|aripiprazole|mesh-list
138225561|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
138225562|NCT01724372|Fluoxetine|fluoxetine|mesh-list
138225563|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
138225564|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225565|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138225566|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225567|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225568|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
138225569|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
138225570|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225571|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225573|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138225575|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138225576|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138225577|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138225578|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138225579|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138225580|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138225581|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225582|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138225583|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138225584|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138225585|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225586|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
138225587|NCT02464410|Narcotics|narcotics|mesh-ancestor
138225588|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225589|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225590|NCT02464410|Analgesics|analgesics|mesh-ancestor
138225591|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
138225592|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225593|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
138225594|NCT03006419|Basiliximab|basiliximab|mesh-list
138225595|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
138225596|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225597|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225598|NCT03405272|Antibodies|antibodies|mesh-list
138225599|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138225600|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
138225601|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225602|NCT03405194|Efavirenz|efavirenz|mesh-list
138225603|NCT03405194|Cobicistat|cobicistat|mesh-list
138225604|NCT03405194|Elvitegravir|elvitegravir|mesh-list
138225605|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138225606|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138225608|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225609|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
138225610|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225611|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138225612|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138225613|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138225615|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138225616|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138225617|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138225618|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138225619|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138225620|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138225622|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138225623|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225624|NCT03006107|Analgesics|analgesics|mesh-ancestor
138225625|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
138225627|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225628|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225629|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225630|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138225631|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225632|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225633|NCT01046396|Adapalene|adapalene|mesh-list
138225634|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138225635|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225637|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
138225638|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225639|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225640|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225641|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225642|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
138225643|NCT01046084|Lansoprazole|lansoprazole|mesh-list
138225644|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
138225645|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138225646|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225647|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138225648|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357732|NCT00003762|Docetaxel|docetaxel|mesh-list
138225649|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225650|NCT01045694|Triamcinolone|triamcinolone|mesh-list
138225651|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138225652|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138225653|NCT01045694|Lidocaine|lidocaine|mesh-list
138225654|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
138225655|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138225656|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138225657|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138225658|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
138225659|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
138225660|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225661|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225662|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
138225663|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225664|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138225665|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138225666|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138225667|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225668|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225669|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138225670|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
138225671|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225672|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138225673|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225674|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
138357757|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
138225676|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138225677|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225678|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
138225679|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225680|NCT01586975|Aspirin|aspirin|mesh-list
138225681|NCT01586975|Clopidogrel|clopidogrel|mesh-list
138225682|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138225684|NCT01586975|Analgesics|analgesics|mesh-ancestor
138225685|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
138225686|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225687|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225688|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225689|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225690|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138225691|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138225692|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225693|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138225694|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138225695|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225696|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
138225697|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138225698|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138225699|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138225700|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
138225701|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225702|NCT03000413|Fentanyl|fentanyl|mesh-list
138225703|NCT03000413|Ketamine|ketamine|mesh-list
138225704|NCT03000413|Analgesics|analgesics|mesh-ancestor
138225705|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
138225706|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225707|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225708|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138225709|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138225710|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
138225711|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
138225712|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225713|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138225714|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138225715|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225716|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225717|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138225718|NCT03000413|Narcotics|narcotics|mesh-ancestor
138225719|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138225720|NCT01724918|Lacosamide|lacosamide|mesh-list
138225721|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
138225722|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138225723|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138225724|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225725|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225726|NCT01588457|Lamotrigine|lamotrigine|mesh-list
138225727|NCT01588457|Valproic Acid|valproic acid|mesh-list
138225728|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138225729|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
138225730|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
138225731|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225732|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138225733|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138225734|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225735|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225736|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225737|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225738|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
138225739|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
138225740|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138212259|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
138225741|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225742|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138225743|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138225744|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
138225745|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225746|NCT03005639|Vemurafenib|vemurafenib|mesh-list
138225747|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225748|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138357912|NCT00003906|Tamoxifen|tamoxifen|mesh-list
138225749|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225750|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225751|NCT01590875|Adenosine|adenosine|mesh-list
138225752|NCT01590875|Analgesics|analgesics|mesh-ancestor
138225753|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
138225754|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225755|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225756|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138225757|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
138225758|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138225759|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
138225760|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
138225761|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225762|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225763|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138225764|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138225765|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225766|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138225767|NCT01725230|Simvastatin|simvastatin|mesh-list
138225768|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138225769|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138225770|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
138225771|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225772|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138225773|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138225774|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225775|NCT01591733|Capecitabine|capecitabine|mesh-list
138225776|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
138225777|NCT01591733|Irinotecan|irinotecan|mesh-list
138225779|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138225780|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
138225781|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225782|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225783|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138225784|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138225785|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225786|NCT03005405|Methamphetamine|methamphetamine|mesh-list
138225787|NCT03005405|Fluorides|fluorides|mesh-list
138225788|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
138225789|NCT03005405|Protective Agents|protective agents|mesh-ancestor
138225790|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225791|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138225792|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
138225793|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
138225794|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225795|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
138225797|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225798|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225799|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138225800|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138225801|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225802|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138225803|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138225804|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138225805|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
138225806|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225807|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225808|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138225809|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
138225810|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138225811|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138225812|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138225813|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225814|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225815|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225817|NCT03005483|Analgesics|analgesics|mesh-ancestor
138225818|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
138225819|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225820|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225822|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138225823|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138225824|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225825|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225826|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138225827|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138225828|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225829|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225830|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
138225831|NCT01593215|Yohimbine|yohimbine|mesh-list
138225832|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
138225833|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
138225834|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225835|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225836|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138225837|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138225838|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138225839|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225840|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225841|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225842|NCT01593215|Urological Agents|urological agents|mesh-ancestor
138225843|NCT03005015|Doxorubicin|doxorubicin|mesh-list
138225844|NCT03005015|Lenvatinib|lenvatinib|mesh-list
138225845|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138225846|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225847|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138225848|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138225849|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225850|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225851|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138225853|NCT03005171|Bupivacaine|bupivacaine|mesh-list
138225854|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
138225855|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
138225856|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225858|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
138225859|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225860|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138225861|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138225862|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138225863|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225864|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225866|NCT01041638|Aldesleukin|aldesleukin|mesh-list
138225867|NCT01041638|Interleukin-2|interleukin-2|mesh-list
138225868|NCT01041638|Tretinoin|tretinoin|mesh-list
138225869|NCT01041638|Dinutuximab|dinutuximab|mesh-list
138225870|NCT01041638|Isotretinoin|isotretinoin|mesh-list
138358107|NCT00004068|Irinotecan|irinotecan|mesh-list
138225871|NCT01041638|Sargramostim|sargramostim|mesh-list
138225872|NCT01041638|Vitamins|vitamins|mesh-ancestor
138225873|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
138225874|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225875|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225876|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225877|NCT01041638|Analgesics|analgesics|mesh-ancestor
138225878|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
138225879|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225880|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
138225881|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138225882|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138225883|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
138225884|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225885|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
138225886|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
138225887|NCT03004625|Ribavirin|ribavirin|mesh-list
138225888|NCT03004625|Asunaprevir|asunaprevir|mesh-list
138225889|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
138225890|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225891|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
138225892|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225893|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
138225894|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225895|NCT03404024|Mitogens|mitogens|mesh-list
138225896|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
138225897|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225898|NCT01725542|Ribavirin|ribavirin|mesh-list
138225899|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138225900|NCT01725542|Asunaprevir|asunaprevir|mesh-list
138225901|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
138225902|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225903|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
138225904|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225905|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
138225906|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225907|NCT01725620|Etanercept|etanercept|mesh-list
138358126|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138225908|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138225909|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138225910|NCT01725620|Analgesics|analgesics|mesh-ancestor
138225911|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
138225912|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225913|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225914|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138225915|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225916|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138225917|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225918|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
138225919|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
138225920|NCT01045460|Melphalan|melphalan|mesh-list
138225921|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138225922|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
138225923|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225925|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138225927|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225928|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225929|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138225930|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138225931|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
138225932|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225933|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138225934|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138225935|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225936|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225938|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138225939|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138225940|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138225941|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138225942|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225943|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225944|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138225945|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138225946|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225947|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225949|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
138225950|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138225951|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138225952|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138225953|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138225954|NCT05672537|Gemcitabine|gemcitabine|mesh-list
138225956|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225957|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138225958|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
138225959|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225960|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225962|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
138225963|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138225964|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138225965|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138225966|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225967|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225968|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138225969|NCT02218463|Estradiol|estradiol|mesh-list
138225970|NCT02218463|Estrogens|estrogens|mesh-ancestor
138225971|NCT02218463|Hormones|hormones|mesh-ancestor
138225972|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212298|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212299|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212300|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212301|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212305|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
138225973|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225975|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
138225976|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138225977|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225978|NCT02222129|Bupivacaine|bupivacaine|mesh-list
138225979|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
138225980|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
138225981|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225982|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225983|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
138360673|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138360674|NCT02996058|Analgesics|analgesics|mesh-ancestor
138225984|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225985|NCT03003611|Anesthetics|anesthetics|mesh-list
138225986|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225987|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225988|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
138225989|NCT03402698|Vitamin D|vitamin d|mesh-list
138225990|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138225991|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225992|NCT03402698|Vitamins|vitamins|mesh-ancestor
138225993|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
138225994|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138225995|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
138225996|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138225997|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225998|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
138225999|NCT02248181|Pramipexole|pramipexole|mesh-list
138226000|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
138226001|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226002|NCT02248181|Protective Agents|protective agents|mesh-ancestor
138226003|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226004|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138226005|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138226006|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
138226007|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
138226008|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226009|NCT03003143|Vigabatrin|vigabatrin|mesh-list
138226010|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
138226011|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226012|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226013|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
138226014|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358253|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
138226015|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226017|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138226018|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138226019|NCT02462928|Growth Substances|growth substances|mesh-ancestor
138226020|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226021|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
138226022|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226023|NCT03002831|Tegafur|tegafur|mesh-list
138226024|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138226025|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
138226026|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226027|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226028|NCT02248259|Itraconazole|itraconazole|mesh-list
138226029|NCT02248259|BI 409306|bi 409306|mesh-list
138226030|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
138226031|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226032|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138226033|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138226034|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226035|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226036|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138226037|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
138226038|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226039|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226040|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138226041|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138226043|NCT04526951|Tenecteplase|tenecteplase|mesh-list
138226044|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138226045|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226047|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
138226048|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226049|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226051|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226052|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138226053|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138226054|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226055|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138226056|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138226057|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226058|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
138226059|NCT02248415|Anesthetics|anesthetics|mesh-list
138226060|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226061|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226062|NCT02248571|Bevacizumab|bevacizumab|mesh-list
138226063|NCT02248571|Capecitabine|capecitabine|mesh-list
138226064|NCT02248571|Everolimus|everolimus|mesh-list
138226065|NCT02248571|Exemestane|exemestane|mesh-list
138226066|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226067|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226068|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138226069|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138226070|NCT02248571|Growth Substances|growth substances|mesh-ancestor
138226071|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226072|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
138226073|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138226074|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
138226075|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226076|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138226077|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138226078|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226079|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226080|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
138226081|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138212329|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138226082|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138226083|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138226084|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
138226085|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226086|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138226087|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138226088|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226090|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138226091|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226092|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138226094|NCT03002675|Hormones|hormones|mesh-ancestor
138226095|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226096|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138226097|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138226098|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138226099|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226100|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226101|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138226102|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226103|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226104|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
138226105|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226106|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
138226107|NCT04374188|Levofloxacin|levofloxacin|mesh-list
138358416|NCT00004260|Rituximab|rituximab|mesh-list
138226108|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226109|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226110|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138226111|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138226112|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226113|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226114|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226115|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138226116|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138226117|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138226118|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
138226119|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226120|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226121|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226122|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
138226123|NCT03401606|Remifentanil|remifentanil|mesh-list
138226124|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138226125|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226126|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226127|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226128|NCT03401606|Analgesics|analgesics|mesh-ancestor
138226129|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
138226130|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226131|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138226132|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138226133|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138226134|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226135|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226136|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226137|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138226138|NCT03401606|Narcotics|narcotics|mesh-ancestor
138226139|NCT02516592|Fluticasone|fluticasone|mesh-list
138226140|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138226142|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138226143|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
138226144|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226145|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226146|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138226147|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
138226148|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
138226150|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138226151|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138226152|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138226153|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226154|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226155|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226156|NCT03401372|Doxycycline|doxycycline|mesh-list
138226157|NCT03401372|Dexamethasone|dexamethasone|mesh-list
138226158|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
138226160|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226161|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
138226162|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226163|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226164|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138226165|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
138226166|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226167|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226168|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138226169|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138226170|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
138226171|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
138226172|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226173|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138226174|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
138226175|NCT03401372|Hormones|hormones|mesh-ancestor
138226176|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226177|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138226178|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226179|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226180|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
138226181|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226182|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226183|NCT04934904|Ropivacaine|ropivacaine|mesh-list
138226184|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
138226185|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
138226186|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226187|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226188|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
138226189|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226190|NCT02219321|Lidocaine|lidocaine|mesh-list
138226191|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
138226192|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
138226193|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226194|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226195|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
138226196|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226197|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138226198|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138226199|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138226200|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215506|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360688|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
138226201|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226202|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138226203|NCT04955574|Metronidazole|metronidazole|mesh-list
138212358|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138226205|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226206|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
138226207|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226208|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138358571|NCT00004482|Cyclosporine|cyclosporine|mesh-list
138226210|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
138226211|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226212|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226213|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138226214|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226215|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226216|NCT02221349|Listerine|listerine|mesh-list
138226217|NCT02221349|Fluorides|fluorides|mesh-list
138226218|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
138226219|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
138226220|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
138226221|NCT02221349|Protective Agents|protective agents|mesh-ancestor
138226222|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226223|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138226224|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226226|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
138226227|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226228|NCT02461290|Rituximab|rituximab|mesh-list
138226229|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226230|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226231|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
138226232|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226233|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226234|NCT04376528|Cyclosporine|cyclosporine|mesh-list
138226235|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
138226236|NCT04376528|Cyclosporins|cyclosporins|mesh-list
138226237|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226238|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226239|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226241|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226242|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
138226243|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226244|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
138226245|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226246|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138358611|NCT00004554|Naltrexone|naltrexone|mesh-list
138226247|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138226248|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226249|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138226250|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
138226251|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226252|NCT02461134|Ponesimod|ponesimod|mesh-list
138226253|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138226254|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226255|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226256|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
138226257|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226258|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
138226259|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138212372|NCT05096832|Vaccines|vaccines|mesh-list
138226263|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138226264|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226265|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
138226266|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138226270|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
138226271|NCT02223065|Saxagliptin|saxagliptin|mesh-list
138226272|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138226273|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226274|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138226275|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226277|NCT02223065|Hormones|hormones|mesh-ancestor
138226278|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226279|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138226280|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
138226281|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358649|NCT00004650|Estrogens|estrogens|mesh-list
138226283|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226284|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
138226285|NCT02241200|Hematinics|hematinics|mesh-ancestor
138226286|NCT02241278|Ketamine|ketamine|mesh-list
138226287|NCT02241278|Analgesics|analgesics|mesh-ancestor
138226288|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
138226289|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226290|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226291|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138226292|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138226293|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
138226294|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
138226295|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226296|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138226297|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138226298|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226299|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226300|NCT04347512|Azithromycin|azithromycin|mesh-list
138226301|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
138226302|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226303|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226304|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
138226305|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226306|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226307|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358689|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138226308|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226309|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226310|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
138226311|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138226312|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226313|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138226314|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226315|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
138226316|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
138226317|NCT04372316|Vitamins|vitamins|mesh-ancestor
138226318|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
138226319|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226320|NCT02221739|Ipilimumab|ipilimumab|mesh-list
138226321|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226322|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226323|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138226324|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226325|NCT02241356|Methamphetamine|methamphetamine|mesh-list
138226326|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138226327|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226328|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
138226329|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
138226330|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226331|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
138226332|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226333|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226335|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138226336|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138226337|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226338|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138226339|NCT04365686|Propofol|propofol|mesh-list
138226340|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138226341|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226342|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226343|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138226344|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
138226345|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
138226346|NCT02241590|Entecavir|entecavir|mesh-list
138226347|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
138226348|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226349|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
138226350|NCT04083755|Hematinics|hematinics|mesh-ancestor
138226351|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
138226352|NCT04372082|Niclosamide|niclosamide|mesh-list
138226353|NCT04372082|Diltiazem|diltiazem|mesh-list
138226354|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
138226355|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226356|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226357|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226358|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226359|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226360|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226361|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138226362|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138226363|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226364|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212394|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226365|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226366|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
138226367|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
138226368|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138226369|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
138226370|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
138226371|NCT02489448|Durvalumab|durvalumab|mesh-list
138226373|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226374|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226375|NCT00926588|Analgesics|analgesics|mesh-list
138226376|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
138226377|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226378|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226379|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
138226380|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
138226381|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226382|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226383|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226384|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226385|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226386|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226387|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
138226388|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226389|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226390|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138226391|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138226392|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226393|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226394|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226396|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226397|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226398|NCT04134845|Dantrolene|dantrolene|mesh-list
138226399|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138226400|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226401|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138226402|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226403|NCT02488980|Mefloquine|mefloquine|mesh-list
138226404|NCT02488980|Tafenoquine|tafenoquine|mesh-list
138226405|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
138226406|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226407|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226408|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226409|NCT02227667|Durvalumab|durvalumab|mesh-list
138226410|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226411|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226412|NCT02242214|Misoprostol|misoprostol|mesh-list
138226413|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138226414|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
138226415|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138226416|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226417|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138226418|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138226419|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
138226420|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
138226421|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138226422|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226423|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226424|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226425|NCT02245256|Analgesics|analgesics|mesh-ancestor
138226426|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
138226427|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226428|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138226429|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138226430|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138226431|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226432|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212411|NCT00538850|Fentanyl|fentanyl|mesh-list
138226433|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226435|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
138226436|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226437|NCT02242292|Scopolamine|scopolamine|mesh-list
138226438|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138226439|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138226440|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
138226441|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
138226442|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226443|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226444|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138226445|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
138226446|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138226447|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138226448|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226449|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226450|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138226451|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
138226452|NCT02242370|Telmisartan|telmisartan|mesh-list
138226453|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138226454|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138226455|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138226456|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226457|NCT04371146|Methylphenidate|methylphenidate|mesh-list
138226458|NCT04371146|Reboxetine|reboxetine|mesh-list
138226459|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138226460|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226461|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138358924|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226463|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226464|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226465|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
138226466|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226467|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
138226468|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226469|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138226470|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226471|NCT01623479|Bimatoprost|bimatoprost|mesh-list
138226472|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138226473|NCT04347200|Anticoagulants|anticoagulants|mesh-list
138226474|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138226475|NCT04364516|Vitamin K|vitamin k|mesh-list
138226476|NCT04364516|Anticoagulants|anticoagulants|mesh-list
138226477|NCT04364516|Vitamins|vitamins|mesh-ancestor
138226478|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
138226479|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226480|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138226481|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138226482|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226483|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
138226484|NCT04364516|Coagulants|coagulants|mesh-ancestor
138226485|NCT01623869|Trebananib|trebananib|mesh-list
138226486|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138226487|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138226488|NCT01623869|Growth Substances|growth substances|mesh-ancestor
138226489|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226490|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
138226491|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226494|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138226495|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138226496|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226497|NCT03207347|Niraparib|niraparib|mesh-list
138226498|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138226499|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226500|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226501|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226502|NCT02249039|Clonidine|clonidine|mesh-list
138226503|NCT02249039|Analgesics|analgesics|mesh-ancestor
138215507|NCT03005665|Acetazolamide|acetazolamide|mesh-list
138226504|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
138226505|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226506|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226507|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138226509|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
138226510|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138226511|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138226512|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138226513|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226514|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226515|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226516|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
138226517|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138226518|NCT04370288|Methylene Blue|methylene blue|mesh-list
138226519|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226520|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
138226521|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226522|NCT04370288|Protective Agents|protective agents|mesh-ancestor
138226523|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
138226524|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226533|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226535|NCT02243618|Rebamipide|rebamipide|mesh-list
138226536|NCT02243618|Polaprezinc|polaprezinc|mesh-list
138226537|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138226538|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138226539|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
138226540|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226541|NCT02243618|Protective Agents|protective agents|mesh-ancestor
138226542|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226543|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226544|NCT02243852|Hormones|hormones|mesh-list
138226545|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226546|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226556|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
138226557|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226558|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
138226559|NCT02231177|Olodaterol|olodaterol|mesh-list
138226560|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138226561|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
138226562|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226563|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226564|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138226565|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
138226566|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
138226567|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138226569|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226570|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226571|NCT03283007|Nintedanib|nintedanib|mesh-list
138226572|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226573|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138226574|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226575|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226576|NCT02244086|Bupivacaine|bupivacaine|mesh-list
138226577|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
138226578|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
138226579|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226580|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226581|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
138226582|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226583|NCT01630109|Metoclopramide|metoclopramide|mesh-list
138226585|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
138226586|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226587|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226588|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138226589|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138226590|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138226591|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
138226592|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226593|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226594|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138226595|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138226596|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226597|NCT01632215|Gabapentin|gabapentin|mesh-list
138226598|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
138226599|NCT01632215|Analgesics|analgesics|mesh-ancestor
138226600|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
138226601|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226602|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226603|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138226604|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138226605|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226606|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226607|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138226608|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138226609|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226610|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226613|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138226614|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138226615|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138226616|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226617|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226618|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226619|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226621|NCT02244320|Tamsulosin|tamsulosin|mesh-list
138226622|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138226623|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138226624|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138226625|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226626|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226627|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226628|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226629|NCT02244320|Urological Agents|urological agents|mesh-ancestor
138226630|NCT02244632|Bevacizumab|bevacizumab|mesh-list
138226631|NCT02244632|Fluorouracil|fluorouracil|mesh-list
138226634|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226635|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226636|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138226637|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138226638|NCT02244632|Growth Substances|growth substances|mesh-ancestor
138226639|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226640|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
138226641|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
138226642|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226643|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138226644|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226645|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
138226646|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138226647|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138226648|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226649|NCT03060083|Nicotine|nicotine|mesh-list
138226652|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226653|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226654|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138226655|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138226656|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
138226657|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226658|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226659|NCT02244710|Clopidogrel|clopidogrel|mesh-list
138226660|NCT02244710|Ticagrelor|ticagrelor|mesh-list
138226661|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138226662|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138226663|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138226664|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138226665|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
138226666|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215508|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
138226667|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226668|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226669|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
138226670|NCT04362332|Chloroquine|chloroquine|mesh-list
138226671|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138226672|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
138226673|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226674|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226675|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226676|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226677|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226678|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226680|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138226681|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226682|NCT04362332|Analgesics|analgesics|mesh-ancestor
138226683|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
138226684|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226685|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226686|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138226687|NCT04362332|Filaricides|filaricides|mesh-ancestor
138226688|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
138226689|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
138226690|NCT02308241|Ribavirin|ribavirin|mesh-list
138226691|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
138226692|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226693|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
138226694|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226695|NCT00932282|Omalizumab|omalizumab|mesh-list
138226696|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138226697|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138226698|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
138226699|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138226700|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138226701|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138226702|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226703|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226704|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
138226705|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226706|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138226707|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138226708|NCT02245022|Tenofovir|tenofovir|mesh-list
138226709|NCT02245022|Lamivudine|lamivudine|mesh-list
138226710|NCT02245022|Efavirenz|efavirenz|mesh-list
138226711|NCT02245022|Dolutegravir|dolutegravir|mesh-list
138226712|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
138226713|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226714|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138226715|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138226716|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226717|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226718|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138226719|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138226720|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138226721|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138226722|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138359284|NCT00356616|Tenofovir|tenofovir|mesh-list
138226723|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138226724|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138226725|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138226726|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138226727|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138226728|NCT02224313|Estradiol|estradiol|mesh-list
138226729|NCT02224313|Progesterone|progesterone|mesh-list
138226730|NCT02224313|Estrogens|estrogens|mesh-ancestor
138226731|NCT02224313|Hormones|hormones|mesh-ancestor
138226732|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226733|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226735|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138226736|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
138226737|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226738|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
138226739|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226740|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226741|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138226742|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226743|NCT01633853|Vitamin D|vitamin d|mesh-list
138226744|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
138226745|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
138226746|NCT01633853|Vitamins|vitamins|mesh-list
138226747|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
138226748|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226749|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138226750|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138226751|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
138226752|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
138226753|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
138226754|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226755|NCT04376216|Prednisone|prednisone|mesh-list
138226756|NCT04376216|Prednisolone|prednisolone|mesh-list
138226757|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138226758|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
138226759|NCT04376216|Hormones|hormones|mesh-ancestor
138226760|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226761|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226762|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138226763|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226764|NCT02452320|Acetaminophen|acetaminophen|mesh-list
138226765|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226766|NCT02452320|Analgesics|analgesics|mesh-ancestor
138226767|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
138226768|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226769|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226770|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
138226771|NCT02459964|Fentanyl|fentanyl|mesh-list
138226772|NCT02459964|Hydromorphone|hydromorphone|mesh-list
138226773|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138226774|NCT02459964|Narcotics|narcotics|mesh-ancestor
138226775|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226776|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226778|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
138226779|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226780|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138226781|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138226782|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
138226783|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
138226784|NCT01635101|Acetaminophen|acetaminophen|mesh-list
138226785|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226786|NCT01635101|Analgesics|analgesics|mesh-ancestor
138226787|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
138226788|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226789|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226791|NCT02087111|Interferons|interferons|mesh-list
138226792|NCT02087111|Ribavirin|ribavirin|mesh-list
138226793|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
138226794|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
138226795|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138226796|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226797|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
138226798|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226799|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
138360720|NCT02993094|Carboplatin|carboplatin|mesh-list
138226800|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226801|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
138226802|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226803|NCT00932438|Leucovorin|leucovorin|mesh-list
138226804|NCT00932438|Bevacizumab|bevacizumab|mesh-list
138226805|NCT00932438|Fluorouracil|fluorouracil|mesh-list
138226806|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
138226807|NCT00932438|Irinotecan|irinotecan|mesh-list
138226808|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226809|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226810|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138226811|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138226812|NCT00932438|Growth Substances|growth substances|mesh-ancestor
138226813|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226814|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
138226815|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
138226816|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226817|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138226818|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226819|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
138359408|NCT00357864|Analgesics|analgesics|mesh-ancestor
138226820|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138226821|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138226822|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226823|NCT00932438|Antidotes|antidotes|mesh-ancestor
138226824|NCT00932438|Protective Agents|protective agents|mesh-ancestor
138226825|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
138226826|NCT00932438|Vitamins|vitamins|mesh-ancestor
138226827|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
138226828|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
138226829|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138226830|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138226831|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226832|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
138226833|NCT01869413|Coagulants|coagulants|mesh-ancestor
138226834|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
138226835|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138226836|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226837|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226838|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226839|NCT02982512|Analgesics|analgesics|mesh-ancestor
138226840|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
138226841|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226842|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138226843|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138226844|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138226845|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
138226846|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226847|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226848|NCT01555697|Memantine|memantine|mesh-list
138226849|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138226850|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138226852|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226853|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226855|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138226856|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138226858|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138226859|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226860|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226861|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138226862|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226863|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226866|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138226867|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226868|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138226869|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226870|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
138226871|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138226872|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
138226873|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226874|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
138226875|NCT04358120|Protective Agents|protective agents|mesh-ancestor
138226876|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
138226877|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
138226878|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226879|NCT00928694|Fenofibrate|fenofibrate|mesh-list
138226880|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138226881|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
138226882|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226883|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138226884|NCT01639157|Buspirone|buspirone|mesh-list
138226885|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138359496|NCT00359814|Cyclosporine|cyclosporine|mesh-list
138226886|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138226887|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226888|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226889|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226890|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138226891|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
138226892|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226893|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226894|NCT02451696|Everolimus|everolimus|mesh-list
138226895|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138226896|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138226897|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226898|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226899|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226901|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226902|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226903|NCT00928772|Midazolam|midazolam|mesh-list
138226904|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138226905|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138226906|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226907|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226908|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138226909|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138226910|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226911|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138226912|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
138226915|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
138226916|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226917|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226918|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138226920|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226921|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226922|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
138226923|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
138226924|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
138226925|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138226926|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138226927|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226928|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226929|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226930|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226932|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138226933|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226934|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226935|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226936|NCT01598207|Dronabinol|dronabinol|mesh-list
138226937|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
138226938|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226939|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138226940|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226941|NCT01598207|Analgesics|analgesics|mesh-ancestor
138226942|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
138226943|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226944|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138226945|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138226946|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226947|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226948|NCT01598207|Hormones|hormones|mesh-ancestor
138226949|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226950|NCT01640171|Ketorolac|ketorolac|mesh-list
138226951|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138226952|NCT01640171|Lidocaine|lidocaine|mesh-list
138226953|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
138226954|NCT01640171|Anesthetics|anesthetics|mesh-list
138226955|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
138226956|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138226957|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226958|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
138226959|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226960|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138226961|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138226962|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138226963|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138226964|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226965|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138226966|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138226967|NCT01640171|Analgesics|analgesics|mesh-ancestor
138226968|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138226969|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138226970|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226972|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138226974|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
138226975|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138226976|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226977|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138226978|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
138226979|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
138226980|NCT04361474|Hormones|hormones|mesh-ancestor
138226981|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138226982|NCT04366622|Riociguat|riociguat|mesh-list
138226983|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
138226984|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226985|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
138226986|NCT02245334|Povidone|povidone|mesh-list
138226987|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
138226988|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
138226989|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138226990|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226991|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
138360758|NCT02991768|Hormones|hormones|mesh-ancestor
138226992|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138226993|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138226994|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138226995|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
138226996|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226997|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226998|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226999|NCT04356872|Doxorubicin|doxorubicin|mesh-list
138227000|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138227002|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227003|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227004|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138227005|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227006|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227007|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227008|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138227009|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
138227010|NCT02487108|Acetaminophen|acetaminophen|mesh-list
138227011|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138227012|NCT02487108|Hydrocodone|hydrocodone|mesh-list
138227013|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227014|NCT02487108|Analgesics|analgesics|mesh-ancestor
138227015|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
138227016|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227017|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227018|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
138227019|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138227020|NCT02487108|Narcotics|narcotics|mesh-ancestor
138227021|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227022|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
138227023|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
138227024|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138227025|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227026|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138227027|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
138227028|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138227029|NCT02487030|Ledipasvir|ledipasvir|mesh-list
138227030|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
138227031|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227032|NCT02486952|Prednisone|prednisone|mesh-list
138227033|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
138227034|NCT02486952|Rituximab|rituximab|mesh-list
138227035|NCT02486952|Vincristine|vincristine|mesh-list
138227036|NCT02486952|Doxorubicin|doxorubicin|mesh-list
138227037|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138227038|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227039|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
138227040|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227041|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138227042|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138227043|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
138227044|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227045|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227046|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138227047|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227048|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227049|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
138227050|NCT02486952|Hormones|hormones|mesh-ancestor
138227051|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227052|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138227053|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138227054|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
138227055|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
138227056|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360780|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
138360781|NCT02999958|Antioxidants|antioxidants|mesh-list
138227057|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227058|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138227059|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227060|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227061|NCT02486796|Ubiquinone|ubiquinone|mesh-list
138227062|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
138227063|NCT02486796|Melatonin|melatonin|mesh-list
138227064|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
138227065|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227066|NCT02486796|Protective Agents|protective agents|mesh-ancestor
138227067|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227068|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227069|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
138227070|NCT02486796|Vitamins|vitamins|mesh-ancestor
138227071|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
138227072|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
138227073|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
138227074|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227075|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227076|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
138227077|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227078|NCT01641653|Midazolam|midazolam|mesh-list
138227079|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138227080|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138227081|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227082|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227083|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138227084|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138227085|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227086|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138227087|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
138227088|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
138227089|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
138227090|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
138227091|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227092|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227093|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138227094|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138227095|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227096|NCT01600703|Incretins|incretins|mesh-ancestor
138227097|NCT01600703|Hormones|hormones|mesh-ancestor
138227098|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227099|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138227101|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227102|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227103|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
138227104|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138227105|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138227106|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138227107|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227108|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227109|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
138227110|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227111|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227112|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138227113|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227114|NCT01605539|Cannabidiol|cannabidiol|mesh-list
138227115|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
138227116|NCT02458638|Atezolizumab|atezolizumab|mesh-list
138227117|NCT02458638|Antibodies|antibodies|mesh-list
138227118|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
138227119|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227120|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227121|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227122|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227123|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227124|NCT01607411|Fluorides|fluorides|mesh-list
138227125|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
138227126|NCT01607411|Protective Agents|protective agents|mesh-ancestor
138227127|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227128|NCT01691339|Vaccines|vaccines|mesh-list
138227129|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
138227130|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227131|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
138227132|NCT02233751|Testosterone|testosterone|mesh-list
138227133|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
138227134|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
138227135|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138227136|NCT02233751|Androgens|androgens|mesh-ancestor
138227138|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227139|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227140|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138227141|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227142|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
138227143|NCT01607645|Cytarabine|cytarabine|mesh-list
138227144|NCT01607645|Decitabine|decitabine|mesh-list
138227145|NCT01607645|Azacitidine|azacitidine|mesh-list
138227146|NCT01607645|Idarubicin|idarubicin|mesh-list
138227147|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227148|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
138227149|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227150|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227151|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
138227152|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227153|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227154|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
138227155|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227156|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227157|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227158|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138227159|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227160|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138227161|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138227162|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
138227163|NCT01647581|Hormones|hormones|mesh-ancestor
138227164|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227166|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227167|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227168|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
138227169|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138227170|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138227171|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138227172|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227173|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227174|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138227175|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227176|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227177|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138227178|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227179|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
138227180|NCT01649609|Sirolimus|sirolimus|mesh-list
138227181|NCT01649609|Tacrolimus|tacrolimus|mesh-list
138227182|NCT01649609|Antimetabolites|antimetabolites|mesh-list
138227183|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227184|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
138227185|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227186|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138227187|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227188|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227189|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227190|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227191|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138227192|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
138227193|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138227194|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227195|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
138227196|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138227197|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138227199|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138227200|NCT02449902|Estrogens|estrogens|mesh-ancestor
138227201|NCT02449902|Hormones|hormones|mesh-ancestor
138227202|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227203|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227204|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138227205|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
138359871|NCT00369408|Naltrexone|naltrexone|mesh-list
138227206|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138227207|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138227208|NCT02449044|Tolvaptan|tolvaptan|mesh-list
138227209|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138227210|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227211|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
138227212|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227214|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227215|NCT00942578|Prednisone|prednisone|mesh-list
138227216|NCT00942578|Bevacizumab|bevacizumab|mesh-list
138227218|NCT00942578|Docetaxel|docetaxel|mesh-list
138227219|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227220|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227222|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138227223|NCT00942578|Growth Substances|growth substances|mesh-ancestor
138227224|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227225|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
138227226|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138227227|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138227228|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138227229|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227230|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227231|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
138227232|NCT00942578|Hormones|hormones|mesh-ancestor
138227233|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227234|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138227235|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
138227236|NCT02229461|Aspirin|aspirin|mesh-list
138227237|NCT02229461|Naproxen|naproxen|mesh-list
138227238|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138227239|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227240|NCT02229461|Analgesics|analgesics|mesh-ancestor
138227241|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
138227242|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227243|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227244|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227245|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138227246|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138227247|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138227248|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227249|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138227250|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138227252|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
138227253|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
138227255|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
138227256|NCT04641104|Vitamins|vitamins|mesh-ancestor
138227257|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
138227258|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227259|NCT02237417|Aripiprazole|aripiprazole|mesh-list
138227260|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
138227261|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227262|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227263|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138227264|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227265|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227266|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
138227267|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
138227268|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227269|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227270|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138227271|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138227272|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
138227273|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138227274|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138227275|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138227277|NCT02245490|Tamsulosin|tamsulosin|mesh-list
138360792|NCT02999958|Expectorants|expectorants|mesh-ancestor
138227278|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138227279|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138227280|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138227281|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227282|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227284|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227285|NCT02245490|Urological Agents|urological agents|mesh-ancestor
138227286|NCT04355936|Telmisartan|telmisartan|mesh-list
138227287|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138227288|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138227289|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138227290|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227291|NCT00934934|Anidulafungin|anidulafungin|mesh-list
138227292|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
138227293|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227295|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138227296|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227297|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138227298|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359978|NCT00371592|Acyclovir|acyclovir|mesh-list
138227299|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227300|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138227301|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138227302|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
138227303|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227304|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
138227305|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138227306|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138227307|NCT01652495|Prednisolone|prednisolone|mesh-list
138227308|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
138227309|NCT01652495|Triamcinolone|triamcinolone|mesh-list
138227310|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138227311|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138227312|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138227313|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
138227314|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138227315|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227316|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
138227317|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
138227318|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227319|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227320|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138227321|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
138227322|NCT01652495|Hormones|hormones|mesh-ancestor
138227323|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227324|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138227325|NCT01652495|Protective Agents|protective agents|mesh-ancestor
138227326|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138227327|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227328|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227329|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
138227330|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227331|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227332|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138227334|NCT00935792|Everolimus|everolimus|mesh-list
138227335|NCT00935792|Antibodies|antibodies|mesh-list
138227336|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
138227337|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138227338|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
138227341|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138227342|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138227343|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227344|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227345|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227346|NCT01699607|Amphetamine|amphetamine|mesh-list
138227347|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
138360804|NCT02995746|Hormones|hormones|mesh-ancestor
138227348|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138227349|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227350|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
138227351|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
138227352|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227353|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
138227354|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227355|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227356|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227357|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138227358|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138227359|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227360|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138227361|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
138227363|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227364|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227366|NCT04355468|Analgesics|analgesics|mesh-ancestor
138227367|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
138227368|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227370|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
138227371|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227373|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138227374|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138227375|NCT01614509|Bevacizumab|bevacizumab|mesh-list
138227376|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138227377|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227378|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227379|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138227380|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138227381|NCT01614509|Growth Substances|growth substances|mesh-ancestor
138227382|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227383|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
138227384|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227385|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
138227386|NCT01614509|Hormones|hormones|mesh-ancestor
138227387|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227388|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227389|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
138227390|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227391|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227392|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138227393|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138227394|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227395|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227396|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138227397|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227398|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227399|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
138227400|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227402|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
138227403|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227405|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138227406|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138227407|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227408|NCT01703039|Riluzole|riluzole|mesh-list
138227409|NCT01703039|Sertraline|sertraline|mesh-list
138227410|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227411|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227412|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138227413|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138227414|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227415|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227416|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227417|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
138360302|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138227419|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
138227420|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138227421|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138227422|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138227423|NCT01703039|Protective Agents|protective agents|mesh-ancestor
138227425|NCT01656629|Alendronate|alendronate|mesh-list
138227426|NCT01656629|Teriparatide|teriparatide|mesh-list
138227427|NCT01656629|Calcium|calcium|mesh-list
138227428|NCT01656629|Vitamins|vitamins|mesh-ancestor
138227429|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
138227430|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227431|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227432|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227433|NCT01703507|Ipilimumab|ipilimumab|mesh-list
138227434|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227435|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360364|NCT00383526|Vaccines|vaccines|mesh-list
138227436|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227437|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227438|NCT02158520|Paclitaxel|paclitaxel|mesh-list
138227439|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138227441|NCT02158520|Ipilimumab|ipilimumab|mesh-list
138227442|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138227443|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
138227444|NCT02158520|Antibodies|antibodies|mesh-list
138227445|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
138227446|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138227447|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
138227448|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138227449|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227450|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138227451|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138227452|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138227453|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227454|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138227455|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138227456|NCT02158520|Growth Substances|growth substances|mesh-ancestor
138227457|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227458|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
138227459|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
138227460|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227461|NCT01704521|Ribavirin|ribavirin|mesh-list
138227462|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
138227463|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227464|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
138212604|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
138227465|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227467|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360424|NCT00384618|Vitamin E|vitamin e|mesh-list
138227468|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227469|NCT04359524|Vitamin D|vitamin d|mesh-list
138227470|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
138227471|NCT04359524|Vitamins|vitamins|mesh-ancestor
138227472|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
138227473|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227474|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227475|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227476|NCT01658657|Metoprolol|metoprolol|mesh-list
138227477|NCT01658657|Amlodipine|amlodipine|mesh-list
138227478|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138227479|NCT01658657|Lisinopril|lisinopril|mesh-list
138227480|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
138227481|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138227482|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138227483|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227484|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227485|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227486|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227487|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
138227488|NCT01658657|Diuretics|diuretics|mesh-ancestor
138227489|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
138227490|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138227491|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138227492|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
138227493|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
138227494|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227495|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138227496|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138227497|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138227498|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227499|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227500|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138227501|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
138227502|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227503|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138227504|NCT01658657|Protective Agents|protective agents|mesh-ancestor
138227505|NCT04359212|Heparin|heparin|mesh-list
138227506|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138227507|NCT04359212|Tinzaparin|tinzaparin|mesh-list
138227508|NCT04359212|Dalteparin|dalteparin|mesh-list
138227510|NCT04359212|Fondaparinux|fondaparinux|mesh-list
138227511|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
138360514|NCT00422526|Hormones|hormones|mesh-ancestor
138227512|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138227513|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138227514|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227515|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138227516|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
138227517|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138227518|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
138227521|NCT01620047|Ropivacaine|ropivacaine|mesh-list
138227522|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
138227523|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
138227524|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227525|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227526|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
138227527|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227528|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138227530|NCT01620047|Analgesics|analgesics|mesh-ancestor
138227531|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138227532|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138227533|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
138227534|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138227535|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138227536|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227537|NCT00944450|Incretins|incretins|mesh-ancestor
138227538|NCT00944450|Hormones|hormones|mesh-ancestor
138227539|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227540|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138227541|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138227542|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227543|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227544|NCT01661621|Doxazosin|doxazosin|mesh-list
138227545|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138227546|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138227547|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138227548|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138227549|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138227550|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227551|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227552|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227553|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227554|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138227555|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138227556|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
138227557|NCT01661621|Urological Agents|urological agents|mesh-ancestor
138227558|NCT01620593|Metformin|metformin|mesh-list
138227559|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138227560|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227561|NCT00939536|Zolpidem|zolpidem|mesh-list
138227562|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138227563|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138227564|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360625|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138227565|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227566|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138227567|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
138227568|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
138227569|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227570|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227571|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138227572|NCT04358354|Fluorouracil|fluorouracil|mesh-list
138227573|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
138227575|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
138227576|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227577|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227578|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227579|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227580|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
138227581|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227582|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138227583|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227584|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227585|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
138227587|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227588|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227589|NCT03516968|Vitamins|vitamins|mesh-ancestor
138227590|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
138227591|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227592|NCT04355156|Axitinib|axitinib|mesh-list
138227593|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227594|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138227596|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227597|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
138227598|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138227599|NCT03032666|Velpatasvir|velpatasvir|mesh-list
138227600|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
138227601|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227602|NCT04354376|Telmisartan|telmisartan|mesh-list
138227603|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
138227604|NCT04354376|Diuretics|diuretics|mesh-list
138227605|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138227606|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138227607|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138227608|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138227609|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138227610|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227611|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
138227612|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227613|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227614|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138227615|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227617|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227618|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227619|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138227620|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138227621|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227622|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227623|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227624|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
138227625|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227627|NCT03032042|Albendazole|albendazole|mesh-list
138227628|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138227629|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227630|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
138227631|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138227632|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
138227633|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138227634|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138227635|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138227636|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138227637|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138227638|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227639|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227640|NCT01623323|Fluticasone|fluticasone|mesh-list
138227642|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227643|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138227644|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
138227645|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227646|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227647|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138227648|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
138227649|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138227650|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138227651|NCT01709747|Hydromorphone|hydromorphone|mesh-list
138227652|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138227653|NCT01709747|Narcotics|narcotics|mesh-ancestor
138227654|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227655|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227656|NCT01709747|Analgesics|analgesics|mesh-ancestor
138227657|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
138227658|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227660|NCT03031808|Rocuronium|rocuronium|mesh-list
138227661|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
138227662|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
138227663|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227664|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227665|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
138227666|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227667|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138227668|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138227669|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138227670|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227671|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227672|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138227673|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138227674|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138227676|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138227677|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227678|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138227679|NCT03035084|Vitamin D|vitamin d|mesh-list
138227680|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
138227681|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
138227682|NCT03035084|Vitamins|vitamins|mesh-list
138227683|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
138227684|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227685|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227686|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227687|NCT03034850|Doxorubicin|doxorubicin|mesh-list
138227688|NCT03034850|Fluorouracil|fluorouracil|mesh-list
138227689|NCT03034850|Ifosfamide|ifosfamide|mesh-list
138227690|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227691|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227693|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227694|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227695|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227696|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
138227697|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227698|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227699|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
138227700|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227701|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138227702|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
138227703|NCT01663259|Cetuximab|cetuximab|mesh-list
138227704|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138227705|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227706|NCT03031184|Mirtazapine|mirtazapine|mesh-list
138227707|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227708|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227709|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138227710|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
138227711|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
138227712|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227713|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227714|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227715|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138227717|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227718|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138227719|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138227720|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138227721|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227722|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138227723|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138227724|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
138227725|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138227727|NCT02238977|Fluoxetine|fluoxetine|mesh-list
138227728|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138227729|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227730|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227731|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138227732|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138227733|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227734|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227736|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227737|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227738|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138227739|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138227740|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227741|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138227742|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
138227744|NCT03034382|Epinephrine|epinephrine|mesh-list
138227745|NCT03034382|Morphine|morphine|mesh-list
138227746|NCT03034382|Nalbuphine|nalbuphine|mesh-list
138227747|NCT03034382|Bupivacaine|bupivacaine|mesh-list
138227748|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
138227750|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227751|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227752|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
138227753|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227754|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138227755|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138227756|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138227757|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227758|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227759|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138227760|NCT03034382|Narcotics|narcotics|mesh-ancestor
138227761|NCT03034382|Analgesics|analgesics|mesh-ancestor
138227762|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138227763|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138227764|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227765|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227766|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138227767|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138227768|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
138227769|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138227770|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138227771|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
138227772|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
138227773|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138227774|NCT01664741|Nicotine|nicotine|mesh-list
138227775|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138227776|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
138227777|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227778|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227779|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138227780|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138227782|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227783|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227785|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138227786|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227787|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227788|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227790|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
138227791|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227792|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138227793|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138227794|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138227795|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138227796|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227797|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227799|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138227800|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227801|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227802|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227803|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227804|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138227805|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227806|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138227807|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227808|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227809|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
138227810|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
138227811|NCT03030716|Procyanidin|procyanidin|mesh-list
138227812|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138227813|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227814|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
138227815|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227816|NCT03030716|Protective Agents|protective agents|mesh-ancestor
138227817|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227818|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138361029|NCT01278342|Octreotide|octreotide|mesh-list
138227819|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138227820|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227822|NCT04353362|Metronidazole|metronidazole|mesh-list
138227823|NCT04353362|Ofloxacin|ofloxacin|mesh-list
138227824|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138227825|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227826|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138227827|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138227828|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138227829|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138227830|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227831|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227832|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227833|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361086|NCT01271010|Rituximab|rituximab|mesh-list
138227834|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138227835|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138227836|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
138212723|NCT00493064|Prednisolone|prednisolone|mesh-list
138227837|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138227838|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227839|NCT00946478|Analgesics|analgesics|mesh-ancestor
138227840|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
138227841|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227842|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227843|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138227844|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138227845|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138227846|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227847|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
138227848|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138227849|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227850|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227851|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
138227852|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227853|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227854|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138227855|NCT03033836|Dolutegravir|dolutegravir|mesh-list
138227856|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138227857|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138227858|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227859|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227860|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
138227861|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227862|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138227863|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138227864|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138227865|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138227867|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
138227868|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
138227869|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227870|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227871|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
138227872|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227873|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138227874|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138227875|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138227876|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138227877|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227879|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138227880|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138227881|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227882|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227883|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
138227884|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227885|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138227886|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138227887|NCT03031262|Cytarabine|cytarabine|mesh-list
138227888|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227890|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361190|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
138227891|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227892|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
138227893|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212731|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
138227894|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227895|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
138227896|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227897|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
138227899|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138227900|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227901|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138227902|NCT03030248|Vancomycin|vancomycin|mesh-list
138227903|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138227904|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227905|NCT03028532|Clomiphene|clomiphene|mesh-list
138227906|NCT03028532|Enclomiphene|enclomiphene|mesh-list
138227907|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
138227908|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138227909|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
138227910|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138227911|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227912|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138227913|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
138227914|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138227915|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138227916|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138227917|NCT03017768|Tryptophan|tryptophan|mesh-list
138227918|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138227919|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
138227920|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138227921|NCT01006538|Ranibizumab|ranibizumab|mesh-list
138227922|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138227923|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138227924|NCT01006538|Growth Substances|growth substances|mesh-ancestor
138227925|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227926|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138227927|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227928|NCT03017222|Ondansetron|ondansetron|mesh-list
138227931|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
138227932|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138227933|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227934|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138227935|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
138227936|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138227937|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138227938|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138227939|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
138227940|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227941|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227942|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138227943|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138227944|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138227945|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138227946|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
138227947|NCT01010282|Glycerol|glycerol|mesh-list
138227948|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138227949|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138227950|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138227951|NCT01010282|Protective Agents|protective agents|mesh-ancestor
138227952|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227953|NCT01010282|Laxatives|laxatives|mesh-ancestor
138227955|NCT03016988|Cytarabine|cytarabine|mesh-list
138227956|NCT03016988|Fludarabine|fludarabine|mesh-list
138227957|NCT03016988|Bortezomib|bortezomib|mesh-list
138227958|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227959|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227960|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
138227961|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227963|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
138227964|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227965|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
138227966|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227967|NCT03017066|Anesthetics|anesthetics|mesh-list
138227968|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227969|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227970|NCT03016832|Irbesartan|irbesartan|mesh-list
138227971|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138227972|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138227973|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138227974|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227975|NCT00955916|Cytarabine|cytarabine|mesh-list
138227976|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
138227977|NCT00955916|Cladribine|cladribine|mesh-list
138227978|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138227979|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
138227980|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227981|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227982|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
138227983|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138227984|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138227985|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
138227986|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227987|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138227988|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227989|NCT01668017|Niacinamide|niacinamide|mesh-list
138227990|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
138227991|NCT01668017|Vitamins|vitamins|mesh-ancestor
138227992|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
138227993|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227994|NCT01010984|Doxorubicin|doxorubicin|mesh-list
138227995|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138227997|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138227998|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138227999|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228000|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228002|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138228003|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228004|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138228005|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138228006|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138228007|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228008|NCT03023306|Antiemetics|antiemetics|mesh-list
138228009|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
138228010|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228011|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228012|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228013|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
138361430|NCT03215940|Hormones|hormones|mesh-ancestor
138228014|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138228015|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228016|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138228017|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228018|NCT00957242|Warfarin|warfarin|mesh-list
138228019|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
138228020|NCT01014728|Propofol|propofol|mesh-list
138228021|NCT01014728|Sevoflurane|sevoflurane|mesh-list
138228022|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138212758|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
138228023|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228024|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228025|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138228026|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
138228027|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
138228028|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138228029|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138228030|NCT01015586|Lamotrigine|lamotrigine|mesh-list
138228031|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
138228032|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138228033|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228034|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228035|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228036|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228037|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138228038|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138228039|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228040|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228041|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138228043|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138228044|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228045|NCT01680653|Hormones|hormones|mesh-ancestor
138228046|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228047|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228048|NCT01680653|Incretins|incretins|mesh-ancestor
138228049|NCT02448810|Fluorouracil|fluorouracil|mesh-list
138228050|NCT02448810|Panitumumab|panitumumab|mesh-list
138228051|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
138228052|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228053|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228054|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228055|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228056|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
138228057|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228058|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228059|NCT01680887|Varenicline|varenicline|mesh-list
138228060|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138228061|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138228062|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
138228063|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228064|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228065|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228066|NCT01016678|Naproxen|naproxen|mesh-list
138228067|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138228068|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138228069|NCT01016678|Analgesics|analgesics|mesh-ancestor
138228070|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
138228071|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228072|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228073|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228074|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228075|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
138228076|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138228077|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228078|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228079|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138228080|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
138228081|NCT02457546|Coagulants|coagulants|mesh-ancestor
138228082|NCT01016834|Sumatriptan|sumatriptan|mesh-list
138228083|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138361584|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
138228088|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228089|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228090|NCT04923594|Mazindol|mazindol|mesh-list
138228091|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138228092|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228093|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138228094|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228095|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228096|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228097|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228098|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228099|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138228100|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
138228101|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138228103|NCT00961532|Coagulants|coagulants|mesh-ancestor
138228104|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138228105|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
138228106|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228107|NCT02447718|Vaccines|vaccines|mesh-list
138228108|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138228109|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
138228111|NCT03016442|Dinoprostone|dinoprostone|mesh-list
138228112|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
138361637|NCT01831674|Metformin|metformin|mesh-list
138228113|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138228114|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228115|NCT01682135|Ramucirumab|ramucirumab|mesh-list
138228116|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228117|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
138228118|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138228119|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138228120|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
138228121|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228122|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138228123|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
138228124|NCT00963872|Fludarabine|fludarabine|mesh-list
138228125|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
138228126|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228127|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
138228128|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228129|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228130|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138228131|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
138228132|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228133|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228134|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138228135|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228137|NCT00964496|Thalidomide|thalidomide|mesh-list
138228138|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
138228139|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228140|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
138228141|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228142|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
138228144|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228145|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138212775|NCT00433550|Capecitabine|capecitabine|mesh-list
138228146|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138228148|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
138228149|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228150|NCT00964496|Hematinics|hematinics|mesh-ancestor
138228151|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
138228152|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
138228153|NCT01685411|Busulfan|busulfan|mesh-list
138228154|NCT01685411|Allopurinol|allopurinol|mesh-list
138228155|NCT01685411|Levetiracetam|levetiracetam|mesh-list
138228156|NCT01685411|Tacrolimus|tacrolimus|mesh-list
138228157|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138228158|NCT01685411|Lenograstim|lenograstim|mesh-list
138228159|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228160|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
138228161|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228162|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228163|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138228164|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
138228165|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228166|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361734|NCT01838538|Paclitaxel|paclitaxel|mesh-list
138228167|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138228168|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138228169|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138228170|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228171|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138228172|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138228173|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
138228174|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138228175|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228177|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
138228178|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
138228179|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
138228180|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138228181|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
138228182|NCT01685411|Protective Agents|protective agents|mesh-ancestor
138228183|NCT02243813|Psilocybin|psilocybin|mesh-list
138228184|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
138228185|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228186|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228187|NCT02991209|Testosterone|testosterone|mesh-list
138228188|NCT02991209|Androgens|androgens|mesh-ancestor
138228190|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228191|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228193|NCT03019562|Oxycodone|oxycodone|mesh-list
138228194|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138228195|NCT03019562|Narcotics|narcotics|mesh-ancestor
138228196|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228197|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228198|NCT03019562|Analgesics|analgesics|mesh-ancestor
138228199|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
138228200|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228201|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138228202|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138228203|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
138228204|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
138228205|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138228206|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138228207|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138228208|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
138228209|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228210|NCT00969878|Antacids|antacids|mesh-ancestor
138360869|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138360875|NCT01271166|Leucovorin|leucovorin|mesh-list
138228211|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228212|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228213|NCT00970814|Levetiracetam|levetiracetam|mesh-list
138228214|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
138228216|NCT02486406|Ritonavir|ritonavir|mesh-list
138228217|NCT02486406|Ribavirin|ribavirin|mesh-list
138228218|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138228219|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138228220|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
138228221|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228222|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228224|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138228225|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
138228226|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228227|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138228228|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138228229|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
138228230|NCT01688609|Paclitaxel|paclitaxel|mesh-list
138228231|NCT01688609|Trastuzumab|trastuzumab|mesh-list
138228232|NCT01688609|Lapatinib|lapatinib|mesh-list
138228233|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138228234|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228235|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
138228236|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
138361907|NCT01722396|Vitamin D|vitamin d|mesh-list
138228237|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
138228238|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228239|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228240|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138228241|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228242|NCT02485158|Dronabinol|dronabinol|mesh-list
138228243|NCT02485158|Amphetamine|amphetamine|mesh-list
138228244|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
138228245|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138228246|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228247|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
138228248|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
138228249|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228250|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
138228251|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228252|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228253|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228254|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138228255|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228256|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361942|NCT01724190|Vitamin D|vitamin d|mesh-list
138228257|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138228258|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
138228259|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228260|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138228262|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
138228263|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138228264|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138228266|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228269|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138228270|NCT02455518|Oxycodone|oxycodone|mesh-list
138228271|NCT02455518|Hydrocodone|hydrocodone|mesh-list
138228272|NCT02455518|Codeine|codeine|mesh-list
138228273|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138228274|NCT02455518|Analgesics|analgesics|mesh-ancestor
138228275|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
138228276|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228277|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228278|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
138360892|NCT01271166|Antidotes|antidotes|mesh-ancestor
138228279|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138228280|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228281|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228282|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138228283|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228284|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228285|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138228286|NCT02455518|Narcotics|narcotics|mesh-ancestor
138228287|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228288|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
138228289|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228290|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138228291|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138228292|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138228294|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138228295|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228296|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228297|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228298|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228299|NCT03018626|Prednisone|prednisone|mesh-list
138228300|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
138228301|NCT03018626|Rituximab|rituximab|mesh-list
138228302|NCT03018626|Doxorubicin|doxorubicin|mesh-list
138228303|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138228304|NCT03018626|Etoposide|etoposide|mesh-list
138228305|NCT03018626|Vincristine|vincristine|mesh-list
138228306|NCT03018626|Bleomycin|bleomycin|mesh-list
138228307|NCT03018626|Vindesine|vindesine|mesh-list
138228308|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228309|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
138228310|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228311|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228312|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138228313|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
138228314|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228315|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228316|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138228317|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228318|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138228319|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138212820|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138228320|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138228321|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228322|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228324|NCT03018626|Hormones|hormones|mesh-ancestor
138228325|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228326|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138228327|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360895|NCT01271166|Vitamins|vitamins|mesh-ancestor
138228328|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138228329|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138228330|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138228331|NCT01689779|Vitamin D|vitamin d|mesh-list
138228332|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
138228333|NCT01689779|Vitamins|vitamins|mesh-ancestor
138228334|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
138228335|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228336|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138228337|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228340|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138228341|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228342|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
138228343|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
138228344|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
138228345|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228346|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228347|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138228348|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138228349|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
138228350|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228351|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228352|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138228353|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228354|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
138228355|NCT00974246|Hormones|hormones|mesh-ancestor
138228356|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228357|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
138228358|NCT00974480|Tretinoin|tretinoin|mesh-list
138228359|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228360|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
138228361|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228362|NCT00975650|Testosterone|testosterone|mesh-list
138228363|NCT00975650|Androgens|androgens|mesh-ancestor
138228364|NCT00975650|Hormones|hormones|mesh-ancestor
138228365|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228366|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228367|NCT00979940|Atorvastatin|atorvastatin|mesh-list
138228368|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138228369|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138228370|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
138228371|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228372|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138228373|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138228374|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228375|NCT03018236|Ethanol|ethanol|mesh-list
138228376|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
138228377|NCT03018236|Cocaine|cocaine|mesh-list
138228378|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138228379|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138228380|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228381|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362194|NCT01048788|Tolvaptan|tolvaptan|mesh-list
138228383|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
138228384|NCT03018236|Expectorants|expectorants|mesh-ancestor
138228385|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228386|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138228387|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
138228388|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228389|NCT03018236|Protective Agents|protective agents|mesh-ancestor
138228390|NCT03018236|Antidotes|antidotes|mesh-ancestor
138228391|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138228392|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
138228393|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
138228394|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228396|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138228397|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228398|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228399|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
138228400|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228401|NCT00982592|Leucovorin|leucovorin|mesh-list
138228402|NCT00982592|Fluorouracil|fluorouracil|mesh-list
138228403|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
138228404|NCT00982592|Calcium|calcium|mesh-list
138228405|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
138228406|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228407|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228408|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
138228409|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228410|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228411|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362304|NCT03402984|Z 338|z 338|mesh-list
138228413|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
138228414|NCT00982592|Antidotes|antidotes|mesh-ancestor
138228416|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
138228417|NCT00982592|Vitamins|vitamins|mesh-ancestor
138228418|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
138228419|NCT00983216|Ketoconazole|ketoconazole|mesh-list
138228420|NCT00983216|Colchicine|colchicine|mesh-list
138228421|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
138228422|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228423|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
138228425|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
138228426|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228427|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228428|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
138228429|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228430|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138228431|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138228432|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228433|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138228434|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
138228435|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228436|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228437|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138228438|NCT02249585|Iodine|iodine|mesh-list
138228439|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138228440|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228441|NCT02249585|Trace Elements|trace elements|mesh-ancestor
138228442|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
138228443|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228445|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
138228446|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
138228447|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228448|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228449|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
138228450|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228451|NCT00988832|Infliximab|infliximab|mesh-list
138228452|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138362421|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138228453|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228454|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228455|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228456|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228457|NCT01023776|Vaccines|vaccines|mesh-list
138228458|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
138228459|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228460|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
138228461|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138228462|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138228463|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138228464|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228465|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228466|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
138228467|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228468|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228469|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138228470|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228471|NCT00990236|Enoxaparin|enoxaparin|mesh-list
138228472|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
138228473|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
138228474|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138228475|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138362470|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228476|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228478|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
138228479|NCT01024010|Ofatumumab|ofatumumab|mesh-list
138228480|NCT01024010|Pentostatin|pentostatin|mesh-list
138228481|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138228482|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228483|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
138228484|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228485|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228486|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138228487|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
138228488|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228489|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228490|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138228491|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138228492|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228493|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
138228494|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
138362522|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
138228496|NCT02484690|Ranibizumab|ranibizumab|mesh-list
138228497|NCT02484690|Faricimab|faricimab|mesh-list
138228498|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138228499|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138228500|NCT02484690|Growth Substances|growth substances|mesh-ancestor
138228501|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228502|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
138228503|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228504|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138228505|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228506|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138228507|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228509|NCT01654224|Vaccines|vaccines|mesh-list
138228510|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
138228511|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228512|NCT02447328|Fulvestrant|fulvestrant|mesh-list
138228513|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138228514|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228515|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138228516|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138228517|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
138228518|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228519|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228520|NCT02447250|Albuterol|albuterol|mesh-list
138228521|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138228522|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
138228523|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228524|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228525|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138228526|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228527|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
138228528|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138228529|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138228530|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138228531|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138228532|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228533|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228534|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228535|NCT00993200|Warfarin|warfarin|mesh-list
138228536|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
138228537|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138228538|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138228539|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138228540|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
138228541|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228542|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138228543|NCT02447172|Gentamicins|gentamicins|mesh-list
138362634|NCT02247648|Narcotics|narcotics|mesh-ancestor
138228545|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228546|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138228547|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228548|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228549|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138228550|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138228551|NCT04200066|Tamoxifen|tamoxifen|mesh-list
138228552|NCT04200066|Temozolomide|temozolomide|mesh-list
138228553|NCT04200066|Maprotiline|maprotiline|mesh-list
138228554|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138228555|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
138228556|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228557|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228558|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138228559|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
138228560|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212876|NCT00555152|Lapatinib|lapatinib|mesh-list
138228561|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228562|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138228563|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138228564|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138228565|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138228566|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138228567|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
138228568|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228569|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138228570|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228571|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228572|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228573|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228574|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138228575|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138228576|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138228578|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228580|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138228581|NCT00994760|Narcotics|narcotics|mesh-ancestor
138228582|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228583|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228584|NCT00994760|Analgesics|analgesics|mesh-ancestor
138228585|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
138228586|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228587|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138228588|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138228589|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
138228590|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
138228591|NCT00995072|Metoprolol|metoprolol|mesh-list
138228592|NCT00995072|Nebivolol|nebivolol|mesh-list
138228593|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138228594|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138228595|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
138228596|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
138228598|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228599|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138228600|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138228601|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138228602|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228603|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228604|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228605|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
138228606|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138228607|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138228608|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138228609|NCT01027910|Doxorubicin|doxorubicin|mesh-list
138228610|NCT01027910|Abexinostat|abexinostat|mesh-list
138228611|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138228612|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228613|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138228614|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138228615|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228616|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228617|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138228618|NCT01031420|Doxorubicin|doxorubicin|mesh-list
138228619|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138228620|NCT01031420|Methotrexate|methotrexate|mesh-list
138228621|NCT01031420|Vinblastine|vinblastine|mesh-list
138212881|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138228622|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138228624|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138228625|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138228626|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228627|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228628|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138228629|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
138228630|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138228631|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228632|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228633|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
138228634|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228635|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138228636|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228637|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
138228638|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228639|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138228640|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138228641|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138228642|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138228643|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138228645|NCT01031498|Palonosetron|palonosetron|mesh-list
138228646|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
138228647|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
138228648|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228649|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228650|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138228651|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
138228652|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228653|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138228654|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138228655|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
138228656|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228657|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228658|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
138228659|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
138228660|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228661|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138228662|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228663|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228664|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138228665|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138228666|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228667|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228668|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
138228670|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
138228671|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138228672|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138228673|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
138228674|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
138228675|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228676|NCT00998582|Tenofovir|tenofovir|mesh-list
138228677|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
138228678|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228679|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138228680|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138228681|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228682|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228683|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138228684|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138228685|NCT02168660|Vitamin D|vitamin d|mesh-list
138228686|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
138228687|NCT02168660|Vitamins|vitamins|mesh-ancestor
138228688|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
138228689|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212888|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
138228690|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138228691|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228692|NCT01003106|Ranibizumab|ranibizumab|mesh-list
138228693|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138228694|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138228695|NCT01003106|Growth Substances|growth substances|mesh-ancestor
138228696|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228697|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
138228698|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228699|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138228700|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
138228701|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228702|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
138228703|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138228704|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138228705|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138228706|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228707|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228708|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
138228709|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228710|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228711|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138228712|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228713|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
138228715|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228716|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228717|NCT01004354|Vitamins|vitamins|mesh-ancestor
138228718|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
138228719|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138228720|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138228721|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138228722|NCT02417064|Sertraline|sertraline|mesh-list
138228723|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
138228724|NCT02417064|Esketamine|esketamine|mesh-list
138228725|NCT02417064|Escitalopram|escitalopram|mesh-list
138228726|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138228727|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228728|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228729|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228730|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228731|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
138228732|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228733|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228735|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138228736|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138228737|NCT02417064|Analgesics|analgesics|mesh-ancestor
138228738|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
138228739|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
138228740|NCT01004744|Anastrozole|anastrozole|mesh-list
138228741|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138228742|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228743|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138228744|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138228745|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228746|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228747|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138228748|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138228749|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228750|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228751|NCT01005290|Ramipril|ramipril|mesh-list
138228752|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138228753|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
138228754|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228755|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228756|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138228757|NCT05592860|Insulin|insulin|mesh-list
138228758|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138228759|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228761|NCT01051778|Heparin|heparin|mesh-list
138228762|NCT01051778|Enoxaparin|enoxaparin|mesh-list
138228763|NCT01051778|Calcium heparin|calcium heparin|mesh-list
138228764|NCT01051778|Calcium|calcium|mesh-list
138228765|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138228766|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228767|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138228768|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138228769|NCT01051778|Analgesics|analgesics|mesh-ancestor
138228770|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
138228771|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228772|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228773|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228774|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138228775|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138228776|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228777|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138228778|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138228779|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228780|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
138228781|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
138228782|NCT02169440|Opicapone|opicapone|mesh-list
138228783|NCT02169440|Warfarin|warfarin|mesh-list
138228784|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
138228785|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138228786|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228787|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228788|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138228789|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138228790|NCT03015350|Sevoflurane|sevoflurane|mesh-list
138228791|NCT03015350|Desflurane|desflurane|mesh-list
138228792|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138228793|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138228794|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
138228795|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
138228796|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228797|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228799|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138228800|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
138228801|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228802|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
138228803|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228804|NCT04171466|Metronidazole|metronidazole|mesh-list
138228805|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
138228806|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228807|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138228808|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138228809|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138228810|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138228811|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138228812|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228813|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228815|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138228816|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138228819|NCT02170376|Opicapone|opicapone|mesh-list
138228820|NCT02170376|Entacapone|entacapone|mesh-list
138228821|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138228822|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138228823|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
138228824|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228825|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228826|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228827|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138228828|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228829|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138228830|NCT02170532|Albuterol|albuterol|mesh-list
138228831|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138228832|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
138228833|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228834|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228835|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138228836|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228837|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
138228838|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138363150|NCT05768464|Axitinib|axitinib|mesh-list
138228839|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138228841|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138228842|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
138228843|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228844|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228845|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
138228846|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138228847|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
138228848|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
138228850|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138228851|NCT02175212|Hormones|hormones|mesh-ancestor
138228852|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228853|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228854|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
138228855|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228856|NCT02175212|Protective Agents|protective agents|mesh-ancestor
138228857|NCT02175212|Vitamins|vitamins|mesh-ancestor
138228858|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
138228859|NCT02175212|Estrogens|estrogens|mesh-ancestor
138228860|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138228861|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228862|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
138228863|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
138228864|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138228865|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
138228866|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228867|NCT03014882|Expectorants|expectorants|mesh-ancestor
138228868|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138228869|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138228870|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
138228871|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228872|NCT03014882|Protective Agents|protective agents|mesh-ancestor
138228873|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228874|NCT03014882|Antidotes|antidotes|mesh-ancestor
138228875|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138228876|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
138228877|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138228878|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138228879|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228880|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228881|NCT01061528|Nicotine|nicotine|mesh-list
138228882|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138228883|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
138228884|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228885|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228886|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138228887|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138228888|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
138228889|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228890|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228893|NCT01064882|Bimatoprost|bimatoprost|mesh-list
138228894|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138228895|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138228896|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138228897|NCT01065506|Nicotine|nicotine|mesh-list
138228898|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138228899|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
138228900|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228901|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228902|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138228903|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138228904|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
138228905|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228906|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228907|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138228908|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228909|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228910|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228911|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138228912|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138228913|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138228914|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
138228915|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228916|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138228918|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138228919|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138228920|NCT01066520|Analgesics|analgesics|mesh-ancestor
138228921|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
138228922|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228923|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228924|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138228925|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228926|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138228927|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138228928|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228929|NCT03014804|Nivolumab|nivolumab|mesh-list
138228930|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138228931|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228932|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138228933|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228934|NCT05224388|Heparin|heparin|mesh-list
138228935|NCT05224388|Enoxaparin|enoxaparin|mesh-list
138228936|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
138228937|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138228938|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138228939|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228940|NCT02416908|Cytarabine|cytarabine|mesh-list
138228941|NCT02416908|Plerixafor|plerixafor|mesh-list
138228942|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
138228943|NCT02416908|Cladribine|cladribine|mesh-list
138228944|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228945|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
138228946|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228947|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228948|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
138228949|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228950|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228951|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
138228952|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228953|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138228954|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138228955|NCT01070810|Thiamine|thiamine|mesh-list
138228956|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
138228957|NCT01070810|Vitamins|vitamins|mesh-ancestor
138228960|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138228961|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138228962|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228963|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138228964|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138228965|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228966|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228968|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138228969|NCT05150756|Lidocaine|lidocaine|mesh-list
138228970|NCT05150756|Morphine|morphine|mesh-list
138228971|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
138228972|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
138228973|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138228974|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228975|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
138228976|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228977|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138228978|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138228979|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138228980|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228981|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228982|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138228983|NCT05150756|Narcotics|narcotics|mesh-ancestor
138228984|NCT05150756|Analgesics|analgesics|mesh-ancestor
138228985|NCT01072136|Azithromycin|azithromycin|mesh-list
138228986|NCT01072136|Cefixime|cefixime|mesh-list
138228987|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138228989|NCT05135858|Methotrexate|methotrexate|mesh-list
138228990|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138228991|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
138228992|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138228993|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228994|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138228995|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
138228996|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228997|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228998|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228999|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229000|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138229001|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229002|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
138229003|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229004|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138229005|NCT03005444|Enoxaparin|enoxaparin|mesh-list
138229006|NCT03005444|Nadroparin|nadroparin|mesh-list
138229007|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
138229008|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138229009|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
138229010|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138229011|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
138229012|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229013|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229014|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
138229015|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138229016|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138229017|NCT01076270|Plerixafor|plerixafor|mesh-list
138229019|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138229020|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
138229021|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229023|NCT01076504|Amrubicin|amrubicin|mesh-list
138229024|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229025|NCT01076972|Ritonavir|ritonavir|mesh-list
138229026|NCT01076972|Lopinavir|lopinavir|mesh-list
138229027|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138229028|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138229029|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
138229030|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229031|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229032|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229033|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138229034|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
138229035|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229036|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138229037|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229039|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138229040|NCT02174432|Narcotics|narcotics|mesh-ancestor
138229041|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229042|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229043|NCT02174432|Analgesics|analgesics|mesh-ancestor
138229044|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
138229045|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229046|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
138229047|NCT02176382|Denosumab|denosumab|mesh-list
138229048|NCT02176382|Teriparatide|teriparatide|mesh-list
138229049|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138229050|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229051|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138229052|NCT01077596|Bupropion|bupropion|mesh-list
138229053|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
138229054|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
138229055|NCT01077596|Serotonin|serotonin|mesh-list
138229056|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138229057|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138363537|NCT04679376|Atorvastatin|atorvastatin|mesh-list
138229059|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138229060|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138229061|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229062|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229063|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
138229064|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229065|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229066|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138229067|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229068|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229069|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138229070|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
138229071|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
138229072|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
138229073|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229075|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138229076|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
138229077|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
138229078|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229079|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229080|NCT02414958|Empagliflozin|empagliflozin|mesh-list
138229081|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138229082|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229083|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229084|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229085|NCT03016208|Misoprostol|misoprostol|mesh-list
138229086|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138229087|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
138229088|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138229089|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229090|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138229091|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229095|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229096|NCT03013790|Protective Agents|protective agents|mesh-ancestor
138229097|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229098|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229099|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138229100|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138229101|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138229102|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229103|NCT02485184|Propranolol|propranolol|mesh-list
138229104|NCT02485184|Warfarin|warfarin|mesh-list
138229105|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138229106|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
138229107|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138229108|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138229109|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229110|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229111|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229112|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138229113|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138229114|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
138229115|NCT03015818|Calcium|calcium|mesh-list
138229116|NCT03015818|Fluorides|fluorides|mesh-list
138229117|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138229118|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229119|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
138229120|NCT03015818|Protective Agents|protective agents|mesh-ancestor
138229121|NCT01080248|Gemcitabine|gemcitabine|mesh-list
138229122|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138229123|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
138229124|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229125|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229126|NCT02452476|Poractant alfa|poractant alfa|mesh-list
138229127|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138229128|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
138229129|NCT01082588|Pravastatin|pravastatin|mesh-list
138229130|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138229131|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138229132|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
138229133|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229134|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138229135|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138229137|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
138229138|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138229139|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229140|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229141|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229142|NCT02441946|Anastrozole|anastrozole|mesh-list
138229143|NCT02441946|Loperamide|loperamide|mesh-list
138229145|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138229146|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229147|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138229148|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138229149|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229150|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229151|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138229152|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138229153|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229154|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229156|NCT01083368|Sirolimus|sirolimus|mesh-list
138229157|NCT01083368|Bevacizumab|bevacizumab|mesh-list
138229158|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138229159|NCT01083368|Temsirolimus|temsirolimus|mesh-list
138229160|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
138229161|NCT01083368|Antibodies|antibodies|mesh-list
138229162|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
138229163|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138229164|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229166|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138229167|NCT01083368|Growth Substances|growth substances|mesh-ancestor
138229168|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229169|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
138229170|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
138229171|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229172|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229173|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138229174|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
138229175|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229176|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229177|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229178|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229179|NCT02387580|Artefenomel|artefenomel|mesh-list
138229180|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
138229181|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138229182|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138229183|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229185|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229186|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229187|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229188|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229189|NCT01084148|V0034CR|v0034cr|mesh-list
138229190|NCT01084148|Emollients|emollients|mesh-ancestor
138229191|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138229192|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
138360980|NCT01277640|Dapivirine|dapivirine|mesh-list
138229193|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138229194|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138229195|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229196|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
138229197|NCT01085006|Coagulants|coagulants|mesh-ancestor
138229198|NCT01085786|Amoxicillin|amoxicillin|mesh-list
138229200|NCT01085786|Clarithromycin|clarithromycin|mesh-list
138229201|NCT01085786|Esomeprazole|esomeprazole|mesh-list
138229202|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229203|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229204|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138229205|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138229206|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138229207|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229208|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138229209|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229210|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229211|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138229212|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138229213|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229214|NCT02170220|Vortioxetine|vortioxetine|mesh-list
138229215|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
138229216|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229217|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138229218|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138229219|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229220|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229221|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138229222|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138229223|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229224|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229225|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229226|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
138229227|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138229228|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138229229|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138229230|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138229235|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229236|NCT02386098|Ritonavir|ritonavir|mesh-list
138229237|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138229238|NCT02386098|Tenofovir|tenofovir|mesh-list
138229239|NCT02386098|Dolutegravir|dolutegravir|mesh-list
138229240|NCT02386098|BMS-955176|bms-955176|mesh-list
138229241|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138229242|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138229243|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
138229244|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229245|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229246|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229247|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138229248|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
138229249|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229250|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138229251|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229252|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138360996|NCT01279434|Vitamins|vitamins|mesh-list
138229253|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138363865|NCT03426904|Vitamins|vitamins|mesh-ancestor
138229255|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138229256|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
138229257|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138229258|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
138229259|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
138229260|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229261|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229262|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229263|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138229264|NCT01089062|Analgesics|analgesics|mesh-ancestor
138229265|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
138229266|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229267|NCT02412618|Misoprostol|misoprostol|mesh-list
138229268|NCT02412618|Mifepristone|mifepristone|mesh-list
138229269|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138229270|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
138229271|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138229272|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229273|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138229274|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229275|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
138229276|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138229277|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138229278|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138229279|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138229280|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
138229281|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138229282|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138229283|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
138229285|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
138229286|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138229287|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138229288|NCT02179892|Acetaminophen|acetaminophen|mesh-list
138229289|NCT02179892|Dexamethasone|dexamethasone|mesh-list
138229290|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
138229291|NCT02179892|Bupivacaine|bupivacaine|mesh-list
138229292|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229293|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
138229294|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
138229295|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229296|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212949|NCT05081466|Vitamins|vitamins|mesh-ancestor
138229297|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229298|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
138229299|NCT02179892|Hormones|hormones|mesh-ancestor
138229300|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229301|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138229302|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229303|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
138229304|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
138229305|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229306|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
138229307|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138229308|NCT02179892|Analgesics|analgesics|mesh-ancestor
138229309|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
138229310|NCT01092338|Vitamin D|vitamin d|mesh-list
138229311|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
138229312|NCT01092338|Vitamins|vitamins|mesh-ancestor
138229313|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
138229314|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229315|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138229316|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138229318|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
138229319|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229320|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229321|NCT01042496|Lamotrigine|lamotrigine|mesh-list
138229322|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
138229323|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138229324|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229325|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229326|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138229327|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229328|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138229329|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138229330|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229331|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229332|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138229333|NCT01111058|Everolimus|everolimus|mesh-list
138229334|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138229335|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229336|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229337|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229338|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229339|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
138229340|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229341|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229343|NCT01094522|Methadone|methadone|mesh-list
138229344|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138229345|NCT01094522|Narcotics|narcotics|mesh-ancestor
138229346|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229347|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229348|NCT01094522|Analgesics|analgesics|mesh-ancestor
138229349|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
138229350|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229351|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
138229352|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
138229354|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138229355|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138229356|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229357|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229358|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229359|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138229360|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
138229361|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229363|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138229364|NCT01044212|Cathartics|cathartics|mesh-ancestor
138229365|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229366|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
138229367|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138229368|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138229371|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229372|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229373|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138229374|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138229375|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138229376|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364185|NCT04823442|Bisoprolol|bisoprolol|mesh-list
138229377|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229378|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229379|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138229380|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138229381|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
138229382|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138229383|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138229384|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
138229385|NCT00585195|Itraconazole|itraconazole|mesh-list
138229387|NCT00585195|Crizotinib|crizotinib|mesh-list
138229388|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
138229390|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138229391|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229392|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229393|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229394|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138229395|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
138229396|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229397|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364249|NCT01384695|Proflavine|proflavine|mesh-list
138229398|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138229399|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138229400|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
138229401|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229402|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
138229403|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138229404|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138229405|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138229406|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138229407|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138229408|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138229409|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138229410|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229411|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229413|NCT01113398|Rilotumumab|rilotumumab|mesh-list
138229414|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229415|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229416|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138229417|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138229418|NCT01113398|Growth Substances|growth substances|mesh-ancestor
138229419|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229421|NCT03013556|Tenofovir|tenofovir|mesh-list
138229422|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138229423|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
138229424|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
138229425|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229426|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138229427|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138229428|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229429|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229430|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229431|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138229432|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
138229433|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229435|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229436|NCT00458835|Ciclesonide|ciclesonide|mesh-list
138229437|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
138229438|NCT00458835|Hormones|hormones|mesh-ancestor
138229439|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229440|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229441|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138229443|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
138229444|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
138229445|NCT03013400|Ebselen|ebselen|mesh-list
138229446|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138229447|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138229448|NCT03013400|Analgesics|analgesics|mesh-ancestor
138229449|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
138229450|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229451|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229452|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229453|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229454|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138229455|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229456|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
138229457|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229458|NCT03013400|Protective Agents|protective agents|mesh-ancestor
138229459|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138229460|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229461|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138229462|NCT02439138|Idelalisib|idelalisib|mesh-list
138229463|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229464|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229465|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229466|NCT01097642|Cetuximab|cetuximab|mesh-list
138229467|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229468|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229469|NCT01048658|Sevoflurane|sevoflurane|mesh-list
138229470|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138229471|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138229472|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
138229473|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
138229474|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229475|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229476|NCT04341675|Sirolimus|sirolimus|mesh-list
138229477|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229478|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229479|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138229480|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229481|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
138229482|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229483|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
138229484|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229485|NCT02445807|Clobetasol|clobetasol|mesh-list
138229486|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229487|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
138229488|NCT02445807|Hormones|hormones|mesh-ancestor
138229489|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229490|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229491|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138229492|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138229493|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229494|NCT01116986|Nicotine|nicotine|mesh-list
138229495|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138229496|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
138229497|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229498|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229499|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138229500|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138229501|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
138229502|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229503|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229504|NCT01098500|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138229505|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229507|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229509|NCT01099202|Hematinics|hematinics|mesh-ancestor
138229510|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
138229511|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
138229512|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229513|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229514|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138229515|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229516|NCT02415855|Dabigatran|dabigatran|mesh-list
138229517|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
138229518|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138229519|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138229520|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229521|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229522|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
138229523|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
138229525|NCT00363285|Cyproterone|cyproterone|mesh-list
138229526|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229527|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229528|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
138229529|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138229530|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229531|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138229532|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
138229533|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138229534|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
138229535|NCT02424357|Povidone|povidone|mesh-list
138229536|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138229537|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138229539|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
138229540|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138229541|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229542|NCT02425449|Succinylcholine|succinylcholine|mesh-list
138229543|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138229544|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138229545|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138229546|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229547|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229548|NCT02455167|Ribavirin|ribavirin|mesh-list
138229549|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
138229550|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
138229551|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229552|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
138229553|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229554|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138229555|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138229556|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138229557|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
138229558|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229559|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138229560|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138229561|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229562|NCT02435901|Cyclosporine|cyclosporine|mesh-list
138229563|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
138229565|NCT02435901|Melphalan|melphalan|mesh-list
138229566|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
138229567|NCT02435901|Tacrolimus|tacrolimus|mesh-list
138229568|NCT02435901|Cyclosporins|cyclosporins|mesh-list
138229569|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229570|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229571|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229572|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
138229573|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229574|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138229575|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229576|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
138229577|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229578|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138229579|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229580|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138229581|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138229582|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
138229584|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138229585|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
138229586|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138229587|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229588|NCT02437383|Propranolol|propranolol|mesh-list
138229589|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138229590|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138229591|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
138229592|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229593|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229594|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229595|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138229596|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138229597|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
138229598|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
138229599|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138229600|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138229601|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229602|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
138229603|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
138229604|NCT01099358|Fluorouracil|fluorouracil|mesh-list
138229605|NCT01099358|Cetuximab|cetuximab|mesh-list
138229606|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229607|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
138229608|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229609|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138229611|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
138229612|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229613|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229614|NCT01118624|Vitamins|vitamins|mesh-list
138229615|NCT01118624|Folic Acid|folic acid|mesh-list
138229616|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
138229620|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
138229621|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229622|NCT01118624|Hematinics|hematinics|mesh-ancestor
138229623|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138212990|NCT03246620|Olanzapine|olanzapine|mesh-list
138229626|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229627|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
138229628|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
138229629|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229630|NCT02439879|Protective Agents|protective agents|mesh-ancestor
138229631|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229633|NCT02439879|Vitamins|vitamins|mesh-ancestor
138229634|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
138229635|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
138229636|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229637|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229639|NCT01100606|Pancreatin|pancreatin|mesh-list
138229640|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229642|NCT03013010|Tegafur|tegafur|mesh-list
138229643|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229644|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138229646|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229647|NCT02518191|Goserelin|goserelin|mesh-list
138229648|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138229649|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229650|NCT01119794|Bortezomib|bortezomib|mesh-list
138229651|NCT01119794|Ofatumumab|ofatumumab|mesh-list
138229652|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229653|NCT01103414|Pioglitazone|pioglitazone|mesh-list
138229654|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229661|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138229662|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364811|NCT01388582|Trace Elements|trace elements|mesh-ancestor
138229664|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229665|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138229667|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229668|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229669|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138364941|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365014|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229670|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138229671|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138229672|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138229674|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229675|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229676|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
138229677|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229678|NCT02528409|Vortioxetine|vortioxetine|mesh-list
138229679|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138229680|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229681|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138229682|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138365375|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
138229683|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229684|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229685|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138229686|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138229690|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
138361048|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138229691|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138229692|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138229693|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138229694|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138229695|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
138229696|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138229700|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229701|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365878|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
138229702|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229703|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
138229704|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138229705|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229706|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229707|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138229709|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
138229710|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229711|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138229712|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138229713|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138229714|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138229715|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229716|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229717|NCT02980094|Vitamins|vitamins|mesh-list
138229718|NCT02980094|Vitamin E|vitamin e|mesh-list
138229719|NCT02980094|Tocopherols|tocopherols|mesh-list
138229720|NCT02980094|Tocotrienols|tocotrienols|mesh-list
138229721|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
138229722|NCT02980094|Selenium|selenium|mesh-list
138229723|NCT02980094|Antioxidants|antioxidants|mesh-list
138229724|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
138229725|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229726|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229727|NCT02980094|Protective Agents|protective agents|mesh-ancestor
138229728|NCT02980094|Trace Elements|trace elements|mesh-ancestor
138229729|NCT03013322|Physostigmine|physostigmine|mesh-list
138229730|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138229732|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229733|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
138229734|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229735|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229738|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229739|NCT02469597|Furosemide|furosemide|mesh-list
138229740|NCT02469597|Diuretics|diuretics|mesh-ancestor
138229741|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
138229742|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229743|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138229744|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229745|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229747|NCT02183792|Tolvaptan|tolvaptan|mesh-list
138229748|NCT02183792|Diuretics|diuretics|mesh-ancestor
138229749|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
138229750|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229751|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138229752|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229753|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229754|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138229755|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138229756|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229757|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229758|NCT00363519|Incretins|incretins|mesh-ancestor
138229759|NCT00363519|Hormones|hormones|mesh-ancestor
138229760|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229761|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138229764|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366790|NCT05430230|Analgesics|analgesics|mesh-ancestor
138229766|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229767|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229768|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366865|NCT05253573|Nicotine|nicotine|mesh-list
138229769|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229770|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
138229771|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138229772|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229773|NCT02475837|Vorapaxar|vorapaxar|mesh-list
138229774|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138229775|NCT01124786|Gemcitabine|gemcitabine|mesh-list
138229776|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138229777|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
138229778|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229781|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
138229782|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138229783|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229784|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229785|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138229786|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229787|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229788|NCT02478489|Naltrexone|naltrexone|mesh-list
138229789|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138229790|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138229791|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229792|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
138229793|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229795|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
138367079|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229796|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229797|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138229798|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138229799|NCT02322320|Growth Substances|growth substances|mesh-ancestor
138229800|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
138229801|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229803|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138229804|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229805|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138229806|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229807|NCT01127438|Fospropofol|fospropofol|mesh-list
138229809|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138229810|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229811|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229812|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138229813|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
138229814|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
138229815|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
138229816|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138229817|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229818|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229819|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138229820|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138229821|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367363|NCT03470675|Ketamine|ketamine|mesh-list
138229822|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229823|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229824|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138213018|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
138229826|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138229827|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229828|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138229829|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138229830|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138229833|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138229837|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138229838|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
138229839|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
138229840|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229841|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229842|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229843|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138229844|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138229845|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
138229846|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367634|NCT00777998|Trace Elements|trace elements|mesh-ancestor
138229847|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229848|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229849|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229850|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138229851|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229852|NCT02481219|Cathartics|cathartics|mesh-ancestor
138229853|NCT02481219|Laxatives|laxatives|mesh-ancestor
138229854|NCT02481297|Rituximab|rituximab|mesh-list
138229855|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367772|NCT05274139|Temozolomide|temozolomide|mesh-list
138229856|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229858|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229859|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229860|NCT02481375|Iron|iron|mesh-list
138229862|NCT02481375|Micronutrients|micronutrients|mesh-list
138229863|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229864|NCT01164098|Rituximab|rituximab|mesh-list
138229865|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229866|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229867|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
138229872|NCT01165112|Etoposide|etoposide|mesh-list
138229873|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138229874|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138229875|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229876|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
138368213|NCT05007561|Naltrexone|naltrexone|mesh-list
138229877|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229878|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368279|NCT04760912|Anesthetics|anesthetics|mesh-list
138229879|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138229880|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138229881|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138229883|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229884|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138229885|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
138229887|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138229888|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138229889|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138229890|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229891|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229892|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229895|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
138229896|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229897|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138229898|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138229900|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229901|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138229903|NCT01166126|Sirolimus|sirolimus|mesh-list
138229904|NCT01166126|Temsirolimus|temsirolimus|mesh-list
138229905|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
138229907|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229908|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229909|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229911|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229913|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229914|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229916|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
138229917|NCT05306990|Atorvastatin|atorvastatin|mesh-list
138229918|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138229919|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138229920|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138229921|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
138229922|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229923|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138229924|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138229925|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229926|NCT02557035|Dexamethasone|dexamethasone|mesh-list
138229927|NCT02557035|Palonosetron|palonosetron|mesh-list
138229928|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229929|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
138229930|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
138229931|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229932|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229933|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138229934|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
138229936|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229937|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138229938|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229939|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138229940|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138229941|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
138229942|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229943|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229944|NCT04341207|Azithromycin|azithromycin|mesh-list
138229945|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
138229946|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229947|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229948|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
138229949|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138229950|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138229951|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229952|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229953|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229955|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
138229958|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229961|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138229962|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
138229963|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229964|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
138229965|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229966|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229967|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229968|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138229970|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
138229971|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229972|NCT01167452|Trimethoprim|trimethoprim|mesh-list
138229973|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138213094|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138229975|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138229976|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229977|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
138229978|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138229979|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138229980|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138229981|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215509|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138361082|NCT01272180|Vaccines|vaccines|mesh-list
138229982|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229983|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138229984|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138229985|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138229986|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138229987|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
138229988|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138229989|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229990|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229991|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138229992|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138229993|NCT02487225|Protective Agents|protective agents|mesh-ancestor
138229994|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229995|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
138229996|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138229997|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
138230000|NCT02384850|Fluorouracil|fluorouracil|mesh-list
138230002|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
138230003|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
138230004|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230009|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230011|NCT02384850|Protective Agents|protective agents|mesh-ancestor
138230012|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
138230013|NCT02384850|Vitamins|vitamins|mesh-ancestor
138230014|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
138230015|NCT02384850|Hematinics|hematinics|mesh-ancestor
138230016|NCT02558829|Insulin|insulin|mesh-list
138230017|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138230018|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230019|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230020|NCT02487303|Acetaminophen|acetaminophen|mesh-list
138230021|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230024|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230025|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230027|NCT01168934|Crizotinib|crizotinib|mesh-list
138230028|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230029|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138230031|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230032|NCT05305508|Mannitol|mannitol|mesh-list
138230033|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
138230035|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138230036|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230037|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138230038|NCT05305508|Diuretics|diuretics|mesh-ancestor
138368902|NCT02535650|Tipifarnib|tipifarnib|mesh-list
138230039|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
138230040|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
138230041|NCT05305508|Coagulants|coagulants|mesh-ancestor
138230042|NCT01170884|Timolol|timolol|mesh-list
138361098|NCT01270620|Propofol|propofol|mesh-list
138230043|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138230044|NCT01170884|Bimatoprost|bimatoprost|mesh-list
138230045|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138230046|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138230047|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230048|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138230049|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138230050|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
138230051|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230059|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138230060|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230061|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230062|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230063|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230064|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230066|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
138230067|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230068|NCT03011918|Vitamin D|vitamin d|mesh-list
138230069|NCT03011918|Vitamins|vitamins|mesh-ancestor
138369031|NCT01879228|Hormones|hormones|mesh-ancestor
138230070|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
138230071|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230072|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138230073|NCT05296460|Dapsone|dapsone|mesh-list
138230074|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230075|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
138230076|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138230077|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138230078|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138230079|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369091|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
138230080|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230082|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230083|NCT01136798|Exenatide|exenatide|mesh-list
138230084|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230085|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369184|NCT00678730|Dronabinol|dronabinol|mesh-list
138230086|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138230087|NCT01136798|Incretins|incretins|mesh-ancestor
138230088|NCT01136798|Hormones|hormones|mesh-ancestor
138230089|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230091|NCT01172522|Terfenadine|terfenadine|mesh-list
138230092|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138230093|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138230094|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138230095|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
138230097|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230098|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230099|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230102|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138230103|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
138230104|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
138230105|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230106|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230107|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230115|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230116|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230117|NCT02246816|Analgesics|analgesics|mesh-ancestor
138230118|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
138230119|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230121|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230122|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
138230123|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
138230124|NCT01137890|Zonisamide|zonisamide|mesh-list
138230125|NCT01137890|Cocaine|cocaine|mesh-list
138230126|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
138230127|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138230128|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369287|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138230129|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230130|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138230131|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230132|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
138230134|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230135|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
138230136|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230137|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138230138|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138230139|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138230140|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
138230141|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230143|NCT01138124|Analgesics|analgesics|mesh-ancestor
138230144|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
138230145|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230146|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230147|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
138230148|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138230149|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138230150|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230152|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138230154|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230155|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230157|NCT02560779|Sorafenib|sorafenib|mesh-list
138230158|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230159|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138230160|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230161|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230162|NCT01138514|Clindamycin|clindamycin|mesh-list
138230164|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
138230165|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138230166|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230167|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230168|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138230170|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230171|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
138230172|NCT02561481|Sulforaphane|sulforaphane|mesh-list
138230173|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138230174|NCT02561481|Protective Agents|protective agents|mesh-ancestor
138369608|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
138230175|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230176|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230177|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
138230178|NCT01173848|Vitamin D|vitamin d|mesh-list
138230179|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
138230180|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138230181|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230183|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
138230184|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138230186|NCT01174082|Sargramostim|sargramostim|mesh-list
138230187|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
138230188|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230189|NCT01175798|Vitamin D|vitamin d|mesh-list
138230191|NCT01175798|Vitamins|vitamins|mesh-ancestor
138230192|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
138230193|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230194|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138230195|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138230197|NCT02246894|Coagulants|coagulants|mesh-ancestor
138230198|NCT03011996|Amoxicillin|amoxicillin|mesh-list
138230199|NCT03011996|Clarithromycin|clarithromycin|mesh-list
138230200|NCT03011996|Pantoprazole|pantoprazole|mesh-list
138230201|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230202|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230203|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138230204|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230205|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230206|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138230207|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138230208|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138230209|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230210|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138230212|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230213|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230214|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
138230215|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230216|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230218|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138230219|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138230220|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370081|NCT01403415|Methotrexate|methotrexate|mesh-list
138230221|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230222|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230223|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370234|NCT01404130|Isotretinoin|isotretinoin|mesh-list
138230225|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
138230226|NCT01178528|Protective Agents|protective agents|mesh-ancestor
138230228|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230229|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138230230|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
138230231|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138230232|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138230234|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
138230235|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
138230236|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230237|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230238|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230239|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138230240|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
138230241|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230242|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230245|NCT02491437|Progestins|progestins|mesh-ancestor
138230246|NCT02491437|Hormones|hormones|mesh-ancestor
138213142|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138230248|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230252|NCT02383758|Protective Agents|protective agents|mesh-ancestor
138230253|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230254|NCT02383758|Cathartics|cathartics|mesh-ancestor
138230255|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230256|NCT02383758|Laxatives|laxatives|mesh-ancestor
138230257|NCT02492451|Progesterone|progesterone|mesh-list
138230258|NCT02492451|Progestins|progestins|mesh-ancestor
138230259|NCT02492451|Hormones|hormones|mesh-ancestor
138230260|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230261|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230262|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138230263|NCT02410278|Montelukast|montelukast|mesh-list
138370578|NCT01405326|Adalimumab|adalimumab|mesh-list
138230264|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138230265|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138230266|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138230267|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
138230268|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230269|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230270|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138230271|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138230272|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230273|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
138230274|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230275|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
138230276|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
138230277|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
138230279|NCT01181258|Fludarabine|fludarabine|mesh-list
138230280|NCT01181258|Interleukin-2|interleukin-2|mesh-list
138230281|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230282|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
138230283|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230284|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230285|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230286|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
138230287|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230288|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230289|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138230290|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230291|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230293|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
138230294|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230295|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230296|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
138230297|NCT01181258|Hormones|hormones|mesh-ancestor
138230298|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230300|NCT01181258|Protective Agents|protective agents|mesh-ancestor
138230301|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230302|NCT01181258|Analgesics|analgesics|mesh-ancestor
138230303|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
138230304|NCT02570139|Protective Agents|protective agents|mesh-list
138230305|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230306|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138230307|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138230308|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230312|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138230313|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138230314|NCT02494713|Ketoconazole|ketoconazole|mesh-list
138230315|NCT02494713|Docetaxel|docetaxel|mesh-list
138230316|NCT02494713|Doxorubicin|doxorubicin|mesh-list
138230317|NCT02494713|Estramustine|estramustine|mesh-list
138230318|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230319|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138230320|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138230321|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138230322|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230323|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138230324|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138230325|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138230326|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230327|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
138230328|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230329|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138230330|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138230331|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138371875|NCT01414972|Vitamin A|vitamin a|mesh-list
138230333|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230335|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138230336|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230337|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
138372003|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
138230338|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230339|NCT02495103|Metformin|metformin|mesh-list
138230340|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230341|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230342|NCT02382276|Nalmefene|nalmefene|mesh-list
138230343|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138230344|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230346|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230347|NCT02571153|Ketamine|ketamine|mesh-list
138230348|NCT02571153|Analgesics|analgesics|mesh-ancestor
138230349|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
138230350|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230351|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230352|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138230353|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138230355|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
138230356|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230357|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138230358|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138230359|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230360|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230361|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138230362|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
138372529|NCT01418651|Milnacipran|milnacipran|mesh-list
138230363|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230364|NCT04573322|Protective Agents|protective agents|mesh-ancestor
138230365|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230366|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138230367|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230368|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
138230369|NCT01143818|Testosterone|testosterone|mesh-list
138230370|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
138230371|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
138372795|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
138230375|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230376|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230377|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230378|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230379|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
138372945|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
138230380|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138230381|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
138230382|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230383|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
138230384|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138230385|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138230386|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138230387|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230388|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230390|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230391|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230392|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138230393|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230394|NCT01650558|Chloroquine|chloroquine|mesh-list
138230395|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138230396|NCT01650558|Amebicides|amebicides|mesh-ancestor
138230397|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138230398|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138230399|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230400|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
138230401|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230402|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138230403|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230405|NCT02579343|Citalopram|citalopram|mesh-list
138230406|NCT02579343|Escitalopram|escitalopram|mesh-list
138230407|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138230408|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138230409|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230411|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230412|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
138230413|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230414|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138230415|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138230416|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
138230418|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230420|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138230421|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230422|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138373650|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
138230423|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
138373715|NCT01425658|Fentanyl|fentanyl|mesh-list
138230425|NCT01144442|Paclitaxel|paclitaxel|mesh-list
138230426|NCT01144442|Carboplatin|carboplatin|mesh-list
138230427|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373788|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230428|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230430|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138230431|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
138230432|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230433|NCT02499081|Ixazomib|ixazomib|mesh-list
138230442|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138230443|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
138230444|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230445|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230446|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138230448|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230449|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230450|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230451|NCT02408016|Aldesleukin|aldesleukin|mesh-list
138230452|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
138230453|NCT02408016|Interleukin-2|interleukin-2|mesh-list
138230454|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230455|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
138230456|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374146|NCT01425827|Analgesics|analgesics|mesh-ancestor
138230457|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230458|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230459|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
138230460|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230461|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230463|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230464|NCT02408016|Analgesics|analgesics|mesh-ancestor
138230465|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
138230466|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230467|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138230468|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138230469|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
138230470|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230471|NCT02579421|Progesterone|progesterone|mesh-list
138230472|NCT02579421|Progestins|progestins|mesh-ancestor
138230473|NCT02579421|Hormones|hormones|mesh-ancestor
138230474|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230475|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230476|NCT00422175|Siponimod|siponimod|mesh-list
138361179|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138230477|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138230478|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230479|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230480|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
138230481|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230482|NCT01186250|Pioglitazone|pioglitazone|mesh-list
138230483|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230484|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230485|NCT01186406|Bevacizumab|bevacizumab|mesh-list
138230486|NCT01186406|Temozolomide|temozolomide|mesh-list
138230487|NCT01186406|Carmustine|carmustine|mesh-list
138230488|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230489|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230490|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138230491|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138230492|NCT01186406|Growth Substances|growth substances|mesh-ancestor
138230493|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230494|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138230508|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138230509|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
138230510|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
138230511|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
138230512|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230513|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230515|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230516|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138230517|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138230518|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
138230519|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
138230520|NCT02581839|Dexamethasone|dexamethasone|mesh-list
138230521|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
138230523|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230524|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
138230525|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
138230526|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230527|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230528|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230529|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
138230531|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230532|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230533|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230534|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138230535|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230536|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230538|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230539|NCT02504775|Analgesics|analgesics|mesh-ancestor
138230541|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230542|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230543|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
138230544|NCT02504931|Sertraline|sertraline|mesh-list
138230545|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
138230546|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138230547|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138230548|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138230549|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230550|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230551|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230552|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
138230553|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230554|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
138230564|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230565|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138230566|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138230567|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230568|NCT01186562|Incretins|incretins|mesh-ancestor
138230569|NCT01186562|Hormones|hormones|mesh-ancestor
138215510|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230570|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230571|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138230572|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
138230573|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230574|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230575|NCT01187498|Oxybutynin|oxybutynin|mesh-list
138230576|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
138230579|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230580|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138230581|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138230582|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230583|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230584|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230585|NCT01187498|Urological Agents|urological agents|mesh-ancestor
138230586|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138230587|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
138230588|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138230589|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138230590|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138230591|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
138230592|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230593|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230594|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138230595|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138230597|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230598|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230599|NCT01149434|Everolimus|everolimus|mesh-list
138230600|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138230601|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138230602|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230603|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230604|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230605|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
138230606|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230607|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230609|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230610|NCT01150838|Propofol|propofol|mesh-list
138230611|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138230617|NCT01189292|Dexamethasone|dexamethasone|mesh-list
138230618|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230620|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
138230621|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230622|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230623|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230627|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230628|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230630|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230631|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138230632|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230633|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230634|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138230635|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138230636|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138230637|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230638|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230639|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138230640|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230641|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230642|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230643|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230644|NCT03010202|Dexamethasone|dexamethasone|mesh-list
138230645|NCT03010202|Rituximab|rituximab|mesh-list
138361202|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
138230646|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230647|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
138230648|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
138230649|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230650|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230651|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230652|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
138230653|NCT03010202|Hormones|hormones|mesh-ancestor
138230654|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230655|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230656|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230657|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230658|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
138230659|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230661|NCT01191320|Clomiphene|clomiphene|mesh-list
138230662|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
138230663|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138230669|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230670|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138230671|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138230673|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230674|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138230675|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230676|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230677|NCT01191398|Atropine|atropine|mesh-list
138230678|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
138230679|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138230680|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138230681|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138230682|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
138230686|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
138230687|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
138230688|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
138230689|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138230690|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138230691|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230692|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230693|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230695|NCT01191476|Sevoflurane|sevoflurane|mesh-list
138230696|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138230697|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230698|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230699|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138230700|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
138230702|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138230703|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138230705|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138230706|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230707|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230708|NCT02509065|Pancrelipase|pancrelipase|mesh-list
138230709|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230717|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138230718|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138361214|NCT00247416|Hormones|hormones|mesh-ancestor
138230719|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
138230720|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230721|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230722|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138230723|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138230724|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138230725|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230726|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230727|NCT01154192|Dexamethasone|dexamethasone|mesh-list
138230728|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138230729|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230730|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
138230731|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
138230732|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230733|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230734|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230735|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
138230736|NCT01154192|Hormones|hormones|mesh-ancestor
138230737|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230738|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230739|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230740|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230741|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
138230742|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230743|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230744|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138230745|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138230746|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230747|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230748|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230749|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138230750|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138230752|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230753|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213232|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230755|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230756|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
138230757|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230758|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
138230759|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230761|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230762|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
138230763|NCT02512575|Hormones|hormones|mesh-ancestor
138230764|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230765|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230766|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230767|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230768|NCT01199744|Zanamivir|zanamivir|mesh-list
138230769|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
138230770|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230771|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230772|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230773|NCT03702374|Antioxidants|antioxidants|mesh-list
138361243|NCT00242580|Hormones|hormones|mesh-ancestor
138230774|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230775|NCT03702374|Protective Agents|protective agents|mesh-ancestor
138230776|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230777|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
138230779|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138230780|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230781|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230782|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230784|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
138230785|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230786|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138230787|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138230788|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138230789|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
138230790|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230791|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230793|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
138230794|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
138230795|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138230796|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138230797|NCT01202162|Sevoflurane|sevoflurane|mesh-list
138230798|NCT01202162|Desflurane|desflurane|mesh-list
138230799|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138230801|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
138230802|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
138230803|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230804|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230805|NCT01159262|Midazolam|midazolam|mesh-list
138230806|NCT01159262|Fentanyl|fentanyl|mesh-list
138230807|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
138230808|NCT01159262|Morphine|morphine|mesh-list
138230809|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138230810|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230811|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230812|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230813|NCT01159262|Analgesics|analgesics|mesh-ancestor
138230814|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
138230815|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230816|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138230817|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138230818|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138230819|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
138230820|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230821|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230822|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138230824|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138230825|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138230826|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138230827|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138230828|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138230829|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
138230830|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
138230831|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
138230832|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
138230833|NCT03011060|Capecitabine|capecitabine|mesh-list
138230834|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138230835|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
138230836|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230837|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230838|NCT03010670|Oxytocin|oxytocin|mesh-list
138230839|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
138230840|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230841|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230842|NCT04377711|Ciclesonide|ciclesonide|mesh-list
138230843|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
138230844|NCT04377711|Hormones|hormones|mesh-ancestor
138230845|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230846|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230847|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138230848|NCT04366713|Capecitabine|capecitabine|mesh-list
138230849|NCT04366713|Loperamide|loperamide|mesh-list
138230850|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
138230851|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138230852|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
138230853|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230854|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230855|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230856|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
138230857|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230858|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230859|NCT02976441|Temozolomide|temozolomide|mesh-list
138230860|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230862|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230863|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230864|NCT00363753|Aspirin|aspirin|mesh-list
138230865|NCT00363753|Clopidogrel|clopidogrel|mesh-list
138230866|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138230867|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138230868|NCT00363753|Analgesics|analgesics|mesh-ancestor
138230869|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
138230870|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230871|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230872|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230873|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230874|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138230875|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138230876|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230877|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138230878|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138230879|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230881|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138230882|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138230884|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
138230885|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230886|NCT02434770|Vaccines|vaccines|mesh-list
138230887|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
138230888|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230889|NCT01203644|Bupivacaine|bupivacaine|mesh-list
138230890|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
138230894|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
138230895|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230896|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
138230897|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230898|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
138230899|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138230900|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138230901|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138230902|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138230903|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230904|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230905|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230906|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230907|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138230908|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
138230909|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230910|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138230911|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
138230912|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138230913|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138230914|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138230915|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138230916|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
138230917|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138230918|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230920|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230921|NCT00363909|Dexetimide|dexetimide|mesh-list
138230923|NCT00363909|Escitalopram|escitalopram|mesh-list
138230924|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138230925|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138230926|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230927|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230928|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230929|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
138230930|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230931|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138230932|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
138230933|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138230934|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138230935|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138230936|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
138230937|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
138230938|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230939|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138230940|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138230941|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
138230943|NCT01205828|Veliparib|veliparib|mesh-list
138230944|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230945|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
138230946|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230947|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213318|NCT05067894|Vaccines|vaccines|mesh-list
138230951|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
138230952|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
138230953|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138230954|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138230955|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230956|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138230957|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230958|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230959|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
138230961|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230962|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
138230963|NCT01206452|Hormones|hormones|mesh-ancestor
138230964|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230965|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230966|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230967|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230968|NCT01206608|Bupivacaine|bupivacaine|mesh-list
138230969|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
138230970|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
138230971|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230972|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230973|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
138230974|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230975|NCT03010436|Benralizumab|benralizumab|mesh-list
138230976|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138230977|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
138230978|NCT02432040|Atorvastatin|atorvastatin|mesh-list
138230979|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138230980|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138230981|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
138230982|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230983|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138230984|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138230985|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230986|NCT02517021|Dexamethasone|dexamethasone|mesh-list
138230988|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230989|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
138230990|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
138230991|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230992|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230993|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230994|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
138230996|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230997|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138230998|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230999|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138231000|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138231001|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
138231013|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231014|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231015|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138231016|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
138231017|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
138231018|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138231019|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231020|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
138231021|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138231022|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138231023|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231024|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231035|NCT05858177|Temozolomide|temozolomide|mesh-list
138231036|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138231037|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
138231038|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231039|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231040|NCT05857982|Dexamethasone|dexamethasone|mesh-list
138231041|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
138231042|NCT05857982|Daratumumab|daratumumab|mesh-list
138231043|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231044|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
138231045|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
138231046|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231047|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231048|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231049|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
138231050|NCT05857982|Hormones|hormones|mesh-ancestor
138231051|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231052|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138231053|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231054|NCT05857982|Analgesics|analgesics|mesh-ancestor
138231055|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
138231056|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138231057|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231058|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231059|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231061|NCT05857891|Hematinics|hematinics|mesh-ancestor
138231062|NCT05844618|Triamcinolone|triamcinolone|mesh-list
138231063|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138231064|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138231065|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138231066|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231069|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231070|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231071|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231072|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
138231073|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231074|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231075|NCT05836025|Sirolimus|sirolimus|mesh-list
138231076|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231077|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231078|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138231079|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231080|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
138231081|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231082|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
138231083|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231084|NCT05796752|Memantine|memantine|mesh-list
138231085|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138231086|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138231087|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
138231088|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231089|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231090|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231091|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138231092|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138231094|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138231095|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231096|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231097|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231098|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231099|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
138231100|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138231101|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
138231102|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231103|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231104|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138231105|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231106|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138231107|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
138231108|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231109|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231110|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138231111|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231113|NCT05785195|Protective Agents|protective agents|mesh-ancestor
138231114|NCT05693675|Methadone|methadone|mesh-list
138231115|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138231116|NCT05693675|Narcotics|narcotics|mesh-ancestor
138231117|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231118|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231119|NCT05693675|Analgesics|analgesics|mesh-ancestor
138231120|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
138231121|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231122|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
138231123|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231124|NCT05655273|Tacrolimus|tacrolimus|mesh-list
138231125|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231126|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
138231127|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231128|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138231130|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231132|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
138231133|NCT05624151|Bupivacaine|bupivacaine|mesh-list
138231134|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
138231135|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
138231136|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231137|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231138|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
138231139|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231140|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138231141|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231142|NCT05624151|Analgesics|analgesics|mesh-ancestor
138231143|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138231144|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138231146|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138231147|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231148|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231149|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231150|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
138231151|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138231152|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231153|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138231154|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
138231155|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361282|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231156|NCT05584007|Floxacillin|floxacillin|mesh-list
138231157|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231158|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231160|NCT05570292|Domperidone|domperidone|mesh-list
138231161|NCT05570292|Hematinics|hematinics|mesh-ancestor
138231162|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
138231163|NCT05570292|Vitamins|vitamins|mesh-ancestor
138231164|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
138231165|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231166|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
138231167|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
138231168|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231169|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231170|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138231171|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
138231172|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231173|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231174|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
138231175|NCT05554939|Mechlorethamine|mechlorethamine|mesh-list
138231177|NCT05554939|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138231178|NCT05554939|Fludarabine|fludarabine|mesh-list
138231179|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
138231180|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231181|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
138231182|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231183|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213353|NCT01495819|Nicotine|nicotine|mesh-list
138231187|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231188|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138231189|NCT05554939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138231190|NCT05554939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138231191|NCT05554939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231192|NCT05554939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231193|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231194|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
138231195|NCT05545891|Aripiprazole|aripiprazole|mesh-list
138231196|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
138231197|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138231198|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138231199|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138231200|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231201|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231202|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
138231203|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
138231204|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231205|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231206|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138231207|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138231208|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
138231209|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138231210|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138231211|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138231212|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138231213|NCT05528458|Osimertinib|osimertinib|mesh-list
138231214|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231215|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138231216|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231217|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231226|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231227|NCT05379530|Anesthetics|anesthetics|mesh-list
138231228|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231229|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231240|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231241|NCT05265286|Factor VIII|factor viii|mesh-list
138231242|NCT05265286|Coagulants|coagulants|mesh-ancestor
138231243|NCT05233202|Simendan|simendan|mesh-list
138231244|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138231245|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231246|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138231247|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138231248|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231249|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231250|NCT05233202|Protective Agents|protective agents|mesh-ancestor
138231251|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231253|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
138231254|NCT05229055|Ketamine|ketamine|mesh-list
138231255|NCT05229055|Analgesics|analgesics|mesh-ancestor
138231256|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
138231257|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231258|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231259|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138213375|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231263|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231264|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138231265|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138231266|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231267|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231268|NCT04986072|Nitroprusside|nitroprusside|mesh-list
138231269|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231270|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231271|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138231272|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231273|NCT04964869|Epinephrine|epinephrine|mesh-list
138231274|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138231275|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138231276|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
138231277|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231278|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231279|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231280|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138231281|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138231282|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
138231283|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231284|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138231285|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231287|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
138231288|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138231289|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
138231290|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231291|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231293|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231294|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
138231295|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231296|NCT04893291|Sirolimus|sirolimus|mesh-list
138231297|NCT04893291|Everolimus|everolimus|mesh-list
138231298|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138231299|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138231300|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231301|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231304|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231305|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231306|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231307|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231308|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138231309|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
138231310|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138231311|NCT04803422|Amoxicillin|amoxicillin|mesh-list
138231312|NCT04803422|Metronidazole|metronidazole|mesh-list
138231314|NCT04803422|Piperacillin|piperacillin|mesh-list
138231315|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
138231316|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
138231317|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138231318|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231319|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138231320|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138231321|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138231322|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231323|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231324|NCT04770532|Insulin|insulin|mesh-list
138231325|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138231326|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138231327|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231328|NCT04731779|Cannabidiol|cannabidiol|mesh-list
138231329|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
138231331|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
138231332|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
138231333|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138231334|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231335|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138231336|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231337|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138231338|NCT04658849|Pioglitazone|pioglitazone|mesh-list
138231339|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138231340|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231342|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138231343|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
138231344|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
138231345|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231346|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231347|NCT04577404|Edaravone|edaravone|mesh-list
138231348|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138231349|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
138231350|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231351|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138231352|NCT04577404|Protective Agents|protective agents|mesh-ancestor
138231353|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231354|NCT04452747|Dinoprostone|dinoprostone|mesh-list
138231356|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138231357|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231359|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
138231360|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231361|NCT04421339|Protective Agents|protective agents|mesh-ancestor
138231362|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231363|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231364|NCT04342572|Melphalan|melphalan|mesh-list
138231365|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138231366|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
138231367|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231368|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231369|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138231370|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231371|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
138231372|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231373|NCT04250051|Vidarabine|vidarabine|mesh-list
138231374|NCT04250051|Cytarabine|cytarabine|mesh-list
138231375|NCT04250051|Fludarabine|fludarabine|mesh-list
138231376|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
138231378|NCT04250051|Lenograstim|lenograstim|mesh-list
138231379|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231380|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231381|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
138231382|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231383|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231384|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
138231385|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231388|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138231389|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231390|NCT04204980|Daratumumab|daratumumab|mesh-list
138231391|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138231392|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231393|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
138231394|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231396|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138231397|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
138231398|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231399|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138231400|NCT04165824|Protective Agents|protective agents|mesh-ancestor
138231401|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231403|NCT04108039|Progesterone|progesterone|mesh-list
138231404|NCT04108039|Ganirelix|ganirelix|mesh-list
138231405|NCT04108039|Progestins|progestins|mesh-ancestor
138231406|NCT04108039|Hormones|hormones|mesh-ancestor
138231407|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231408|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231409|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
138231410|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138231411|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
138231412|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138231413|NCT04069169|Lidocaine|lidocaine|mesh-list
138231414|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
138231415|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
138231416|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231417|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231418|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
138231419|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231420|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231421|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138231422|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138231423|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231424|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231425|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
138231426|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231427|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138231428|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138231430|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231431|NCT03997097|Urological Agents|urological agents|mesh-ancestor
138231432|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
138231433|NCT03988036|Trastuzumab|trastuzumab|mesh-list
138231434|NCT03988036|Pertuzumab|pertuzumab|mesh-list
138231435|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231436|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231437|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138231438|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231439|NCT03899987|Aspirin|aspirin|mesh-list
138231440|NCT03899987|Interferons|interferons|mesh-list
138231441|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
138231442|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
138231443|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138231444|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231445|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
138231446|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414716|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231448|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231449|NCT03899987|Analgesics|analgesics|mesh-ancestor
138231450|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
138231451|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231452|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231453|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231454|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138231455|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138231456|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138231457|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231458|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138231459|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138231460|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231462|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
138231463|NCT03850028|Atezolizumab|atezolizumab|mesh-list
138231464|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138231465|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231466|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231467|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231468|NCT03554044|Tamoxifen|tamoxifen|mesh-list
138231469|NCT03554044|Paclitaxel|paclitaxel|mesh-list
138231470|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138231471|NCT03554044|Carboplatin|carboplatin|mesh-list
138231472|NCT03554044|Gemcitabine|gemcitabine|mesh-list
138231473|NCT03554044|Letrozole|letrozole|mesh-list
138231474|NCT03554044|Fulvestrant|fulvestrant|mesh-list
138231475|NCT03554044|Anastrozole|anastrozole|mesh-list
138231476|NCT03554044|Exemestane|exemestane|mesh-list
138231477|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138231478|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138231479|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231480|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231481|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
138231482|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231483|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231484|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231485|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
138231486|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138231487|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138231488|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231489|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138231490|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
138231491|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231493|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138231494|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138231495|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138231496|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138231497|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138231498|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231500|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
138231501|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231502|NCT03524937|Protective Agents|protective agents|mesh-ancestor
138231503|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231504|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231505|NCT03505710|Trastuzumab|trastuzumab|mesh-list
138231506|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138231507|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231508|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231509|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
138231510|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
138231511|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231513|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138231514|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
138231515|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138231516|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231517|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138231518|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231519|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
138231520|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
138231521|NCT03184194|Nivolumab|nivolumab|mesh-list
138231522|NCT03184194|Daratumumab|daratumumab|mesh-list
138231523|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138231524|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231525|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
138231526|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231527|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138231528|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138231529|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
138231532|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138231533|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231534|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138231536|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
138231537|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231538|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231540|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138231541|NCT03018366|Estradiol|estradiol|mesh-list
138231542|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138231543|NCT03018366|Progesterone|progesterone|mesh-list
138231544|NCT03018366|Estrogens|estrogens|mesh-ancestor
138231545|NCT03018366|Hormones|hormones|mesh-ancestor
138231546|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231547|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231548|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138231549|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
138231550|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138231551|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138231552|NCT03018366|Progestins|progestins|mesh-ancestor
138231553|NCT02889159|Imiquimod|imiquimod|mesh-list
138231554|NCT02889159|Histamine|histamine|mesh-list
138231555|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
138231556|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138231557|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
138231558|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231559|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231560|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
138231561|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
138231562|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
138231563|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231564|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231565|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
138231566|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231567|NCT02841280|Diuretics|diuretics|mesh-ancestor
138231568|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
138231569|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231570|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138231571|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231572|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231573|NCT02813356|Naloxegol|naloxegol|mesh-list
138231574|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138231575|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231576|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
138231577|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231578|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
138231579|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138231580|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
138231581|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231585|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138231587|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231588|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231589|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138231590|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231591|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
138231592|NCT02760329|Protective Agents|protective agents|mesh-ancestor
138231594|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138231595|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
138231596|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
138231597|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231598|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231599|NCT02678182|Capecitabine|capecitabine|mesh-list
138231600|NCT02678182|Trastuzumab|trastuzumab|mesh-list
138231601|NCT02678182|Durvalumab|durvalumab|mesh-list
138231602|NCT02678182|Ramucirumab|ramucirumab|mesh-list
138231603|NCT02678182|Rucaparib|rucaparib|mesh-list
138231604|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231605|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
138231606|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231607|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231608|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231609|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138231610|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231611|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
138231612|NCT02620865|Leucovorin|leucovorin|mesh-list
138231613|NCT02620865|Folic Acid|folic acid|mesh-list
138231614|NCT02620865|Aldesleukin|aldesleukin|mesh-list
138231615|NCT02620865|Paclitaxel|paclitaxel|mesh-list
138231616|NCT02620865|Camptothecin|camptothecin|mesh-list
138231617|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138231618|NCT02620865|Gemcitabine|gemcitabine|mesh-list
138231619|NCT02620865|Fluorouracil|fluorouracil|mesh-list
138231620|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
138231621|NCT02620865|Irinotecan|irinotecan|mesh-list
138231622|NCT02620865|Interleukin-2|interleukin-2|mesh-list
138231623|NCT02620865|Antibodies|antibodies|mesh-list
138231624|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
138231625|NCT02620865|Sargramostim|sargramostim|mesh-list
138231626|NCT02620865|Calcium|calcium|mesh-list
138231627|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
138231628|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138231629|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231630|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231631|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
138231632|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231633|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231634|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
138231635|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231636|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231637|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
138231638|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138231639|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138231640|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231641|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138231642|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231643|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231645|NCT02620865|Protective Agents|protective agents|mesh-ancestor
138231646|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
138231648|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
138231649|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231651|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
138231652|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231655|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138231657|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231658|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
138231659|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138231660|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
138231661|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231662|NCT02505477|Expectorants|expectorants|mesh-ancestor
138231663|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231664|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138231665|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
138231666|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231667|NCT02505477|Protective Agents|protective agents|mesh-ancestor
138231668|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231669|NCT02505477|Antidotes|antidotes|mesh-ancestor
138231670|NCT02484885|Xenon|xenon|mesh-list
138231671|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138231672|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
138231673|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
138231674|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231675|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231676|NCT02418572|Testosterone|testosterone|mesh-list
138231677|NCT02418572|Androgens|androgens|mesh-ancestor
138231678|NCT02418572|Hormones|hormones|mesh-ancestor
138231679|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231680|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231681|NCT02345330|Interleukin-12|interleukin-12|mesh-list
138231682|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138231683|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
138231684|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231685|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138231686|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138231687|NCT02345330|Growth Substances|growth substances|mesh-ancestor
138231688|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138231689|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231690|NCT01665677|Atorvastatin|atorvastatin|mesh-list
138231692|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138231693|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231694|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138231695|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138231696|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
138231697|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231698|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138231699|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138231700|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231701|NCT01530373|Clonidine|clonidine|mesh-list
138231702|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
138231703|NCT01530373|Analgesics|analgesics|mesh-ancestor
138231704|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
138231705|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231706|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231707|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231708|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
138231709|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
138231710|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138231711|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138231713|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
138231714|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231715|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231716|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138231717|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138231718|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138231719|NCT01530373|Urological Agents|urological agents|mesh-ancestor
138231721|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
138231722|NCT01499953|Fondaparinux|fondaparinux|mesh-list
138231723|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138231724|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
138231725|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138231726|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
138231727|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231728|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231729|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
138231730|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138231731|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138231732|NCT01440816|Interleukin-12|interleukin-12|mesh-list
138231733|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138231735|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231736|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138231737|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138231738|NCT01440816|Growth Substances|growth substances|mesh-ancestor
138231739|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
138231740|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231741|NCT01348919|Dexamethasone|dexamethasone|mesh-list
138231742|NCT01348919|Lenalidomide|lenalidomide|mesh-list
138231743|NCT01348919|Delanzomib|delanzomib|mesh-list
138231744|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231745|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
138231746|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
138231747|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231748|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231749|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231750|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
138231751|NCT01348919|Hormones|hormones|mesh-ancestor
138231752|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231753|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138231754|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231755|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
138231756|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138231757|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138231758|NCT01348919|Growth Substances|growth substances|mesh-ancestor
138231759|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
138231760|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
138231761|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
138231762|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231763|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231764|NCT01333046|Azacitidine|azacitidine|mesh-list
138231765|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138231766|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
138231767|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231768|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231769|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231770|NCT01217970|Ibudilast|ibudilast|mesh-list
138231771|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138231772|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
138231773|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213516|NCT01796366|Insulin|insulin|mesh-list
138231775|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138231776|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231777|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138231778|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231779|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231780|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138231781|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231782|NCT02431806|Milnacipran|milnacipran|mesh-list
138231784|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
138231785|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138231786|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138231787|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231788|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231789|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231790|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
138231791|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231792|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138231793|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
138231794|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138231795|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138231796|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138231797|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231798|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138231799|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231800|NCT02431806|Analgesics|analgesics|mesh-ancestor
138231801|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
138231802|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231803|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
138231804|NCT05159193|Carboplatin|carboplatin|mesh-list
138231806|NCT05159193|Doxorubicin|doxorubicin|mesh-list
138231807|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138231808|NCT05159193|Trastuzumab|trastuzumab|mesh-list
138231809|NCT05159193|Pertuzumab|pertuzumab|mesh-list
138231810|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231811|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
138231812|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231813|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138231814|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138231815|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
138231816|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231817|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231818|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138231819|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231820|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
138231821|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231822|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138231823|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138231824|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231825|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231826|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231827|NCT05220813|Lidocaine|lidocaine|mesh-list
138231828|NCT05220813|Bupivacaine|bupivacaine|mesh-list
138231829|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
138231830|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
138231835|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231836|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138231837|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138231838|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231839|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231841|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
138231842|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138231843|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
138231845|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231846|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231847|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138231848|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138231849|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138231850|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138231851|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
138231852|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231853|NCT01284296|Chrysarobin|chrysarobin|mesh-list
138231854|NCT01284296|Lidocaine|lidocaine|mesh-list
138231855|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
138231856|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
138231857|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231858|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231859|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
138231860|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231861|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231862|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138231863|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138231864|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231865|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231866|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138231867|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231868|NCT01284296|Analgesics|analgesics|mesh-ancestor
138231869|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231870|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138231872|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138231873|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138231874|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231875|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231876|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231877|NCT01652664|Timolol|timolol|mesh-list
138231878|NCT01652664|Travoprost|travoprost|mesh-list
138231879|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138231880|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138231881|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138231882|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138231883|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
138231884|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231885|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231886|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231887|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138231888|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231889|NCT04055649|Paclitaxel|paclitaxel|mesh-list
138231890|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138231891|NCT04055649|TIC10 compound|tic10 compound|mesh-list
138231893|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231894|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231895|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
138231896|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231897|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231899|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138231900|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
138231901|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231902|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231903|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138231904|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138231905|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
138231906|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231907|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231908|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
138231909|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138231910|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231911|NCT01286402|Bupropion|bupropion|mesh-list
138231912|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138231913|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
138231914|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138231915|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138231916|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138231917|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231918|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231919|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
138231920|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138231921|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231922|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138231923|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138231924|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231925|NCT01222832|Bacitracin|bacitracin|mesh-list
138231926|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138231927|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231928|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231929|NCT04297605|Paclitaxel|paclitaxel|mesh-list
138231930|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
138231931|NCT04297605|Pemetrexed|pemetrexed|mesh-list
138231932|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138231933|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231934|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231935|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
138231936|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231937|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231938|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231939|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138231940|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231941|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138231942|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138231943|NCT02379390|Prednisone|prednisone|mesh-list
138231944|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
138231945|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231947|NCT02379390|Hormones|hormones|mesh-ancestor
138231948|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138231949|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414717|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
138231953|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231954|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231955|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
138231956|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138231957|NCT04932915|Niclosamide|niclosamide|mesh-list
138231958|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
138231959|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138231960|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
138231961|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138231962|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231963|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
138231964|NCT01223378|Latanoprost|latanoprost|mesh-list
138231965|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138231966|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138231967|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
138231968|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138231969|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231970|NCT01224626|Linezolid|linezolid|mesh-list
138231971|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231972|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231973|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138231974|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231975|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231976|NCT01289522|Cetuximab|cetuximab|mesh-list
138231977|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231978|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231979|NCT01226420|Alefacept|alefacept|mesh-list
138231980|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
138231981|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
138231982|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231983|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
138231984|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138231985|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231986|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138231987|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231988|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
138231989|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138231990|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
138231991|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138231992|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231993|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
138231994|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138231995|NCT00365001|Methotrexate|methotrexate|mesh-list
138231996|NCT00365001|Simvastatin|simvastatin|mesh-list
138361348|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361349|NCT03467256|Cytarabine|cytarabine|mesh-list
138231997|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138231998|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
138231999|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138232000|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232001|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232002|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
138232003|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232004|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232008|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232009|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
138232010|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232011|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138232012|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138232013|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138232014|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138232015|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138232018|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138232019|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232020|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232021|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232022|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
138232023|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232024|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232026|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232027|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232028|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138232029|NCT03069963|Antacids|antacids|mesh-ancestor
138232030|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232031|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232032|NCT01227434|Palbociclib|palbociclib|mesh-list
138232033|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232034|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138232035|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232036|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232037|NCT01714739|Nivolumab|nivolumab|mesh-list
138232038|NCT01714739|Ipilimumab|ipilimumab|mesh-list
138232039|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
138232040|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232041|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232042|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138232043|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232044|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
138232045|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232046|NCT02377479|Letrozole|letrozole|mesh-list
138232047|NCT02377479|Clomiphene|clomiphene|mesh-list
138232048|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232049|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138232050|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138232051|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232052|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232053|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138232054|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
138232055|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232056|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232057|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138232058|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
138232059|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138232060|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138232061|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138232063|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138232064|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
138232065|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232067|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
138232068|NCT05457647|Vitamins|vitamins|mesh-ancestor
138232069|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
138232070|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232071|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138232072|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232073|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
138232074|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138232075|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138232076|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
138213578|NCT00526058|Miconazole|miconazole|mesh-list
138232078|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138232079|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138232080|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232081|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232082|NCT05439629|Ranibizumab|ranibizumab|mesh-list
138232083|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232084|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232085|NCT05439629|Growth Substances|growth substances|mesh-ancestor
138232086|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232087|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232088|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232089|NCT01229228|Naproxen|naproxen|mesh-list
138232090|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232091|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232092|NCT01229228|Analgesics|analgesics|mesh-ancestor
138232093|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
138232094|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232095|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232096|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232097|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232098|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
138232099|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232100|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232101|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232102|NCT01292252|Teriparatide|teriparatide|mesh-list
138232103|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
138232104|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232105|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138232106|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138232107|NCT02192684|Pioglitazone|pioglitazone|mesh-list
138232108|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138232109|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232110|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
138232111|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232112|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232113|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138232114|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232116|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
138232118|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232119|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
138232120|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232121|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232122|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
138232123|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232124|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232125|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
138232126|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232127|NCT00003407|Analgesics|analgesics|mesh-ancestor
138232128|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
138232129|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232130|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232131|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232132|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232133|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138232134|NCT00003407|Protective Agents|protective agents|mesh-ancestor
138232135|NCT04838717|Doxycycline|doxycycline|mesh-list
138232136|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232137|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232138|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
138232139|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138232140|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138232141|NCT01710137|Varenicline|varenicline|mesh-list
138232142|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138232144|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232145|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232146|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232147|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232148|NCT01710839|Ranibizumab|ranibizumab|mesh-list
138232149|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232150|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232151|NCT01710839|Growth Substances|growth substances|mesh-ancestor
138232152|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232153|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232154|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232155|NCT01215110|Bedaquiline|bedaquiline|mesh-list
138232156|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
138232157|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232158|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232159|NCT02980757|Gliclazide|gliclazide|mesh-list
138232160|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138232161|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232162|NCT01229462|Timolol|timolol|mesh-list
138232163|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138232164|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138232165|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138232166|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138232167|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138232168|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
138232169|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232170|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232171|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232172|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232173|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138232174|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138232176|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138232177|NCT01292642|Nicotine|nicotine|mesh-list
138232178|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138232179|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
138232180|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232181|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232182|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138232183|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138232184|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232185|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232186|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232187|NCT01231334|Clindamycin|clindamycin|mesh-list
138232188|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
138232189|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
138232190|NCT01231334|Dapsone|dapsone|mesh-list
138232191|NCT01231334|Adapalene|adapalene|mesh-list
138232193|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232194|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232195|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138232196|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232197|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232198|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232199|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232200|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232201|NCT01231334|Analgesics|analgesics|mesh-ancestor
138232202|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
138232203|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232204|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232205|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232206|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232207|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
138232208|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138232209|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138232210|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138232211|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
138232212|NCT01292798|Ranibizumab|ranibizumab|mesh-list
138232213|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232214|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232215|NCT01292798|Growth Substances|growth substances|mesh-ancestor
138232216|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232217|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232218|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232219|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
138232220|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138232221|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138232222|NCT03009500|Prednisolone|prednisolone|mesh-list
138232223|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
138232224|NCT03009500|Lidocaine|lidocaine|mesh-list
138232225|NCT03009500|Bupivacaine|bupivacaine|mesh-list
138232226|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138232227|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
138232228|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138232229|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
138232230|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232231|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232232|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
138232233|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232234|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232235|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138232236|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138232237|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414718|NCT01655147|Rifampin|rifampin|mesh-list
138232238|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232239|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232242|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232243|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
138232244|NCT03009500|Hormones|hormones|mesh-ancestor
138232245|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232246|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138232247|NCT03009500|Protective Agents|protective agents|mesh-ancestor
138232248|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138232249|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232250|NCT01715207|Atenolol|atenolol|mesh-list
138232251|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232252|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138232253|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
138232254|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
138232255|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232256|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232257|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138232258|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138232259|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138232260|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
138232261|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232262|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232263|NCT01716221|Dexetimide|dexetimide|mesh-list
138232264|NCT01716221|Bupropion|bupropion|mesh-list
138361373|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
138232265|NCT01716221|Citalopram|citalopram|mesh-list
138232266|NCT01716221|Escitalopram|escitalopram|mesh-list
138232267|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138232268|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
138232269|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138232270|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138232271|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138232272|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138232273|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232274|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
138232275|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232276|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232277|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138232278|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138232279|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232280|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138232281|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
138232282|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138232283|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138232284|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
138232287|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138232289|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232290|NCT01215344|Diphosphonates|diphosphonates|mesh-list
138232291|NCT01215344|Dexamethasone|dexamethasone|mesh-list
138232292|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
138232293|NCT01215344|Doxorubicin|doxorubicin|mesh-list
138232294|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138232295|NCT01215344|Lenalidomide|lenalidomide|mesh-list
138232296|NCT01215344|Bortezomib|bortezomib|mesh-list
138232297|NCT01215344|BB 1101|bb 1101|mesh-list
138232298|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232299|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
138232300|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
138232301|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232302|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232303|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232304|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
138232305|NCT01215344|Hormones|hormones|mesh-ancestor
138232306|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232307|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138232308|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232309|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
138232310|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232311|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232312|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138232313|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232314|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232315|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
138232316|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232317|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232318|NCT01215344|Growth Substances|growth substances|mesh-ancestor
138232319|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232320|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138232321|NCT01231412|Cyclosporine|cyclosporine|mesh-list
138232322|NCT01231412|Sirolimus|sirolimus|mesh-list
138232323|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
138232324|NCT01231412|Fludarabine|fludarabine|mesh-list
138232325|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
138232326|NCT01231412|Cyclosporins|cyclosporins|mesh-list
138232327|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232328|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232329|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
138232330|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232331|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232332|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
138232333|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232334|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232335|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
138232336|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232337|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232338|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232339|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138232340|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138232341|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138232342|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
138232343|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232344|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138232345|NCT01719653|Laxatives|laxatives|mesh-ancestor
138232346|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232347|NCT01720277|Vaccines|vaccines|mesh-list
138232348|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
138232349|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232350|NCT04514393|Methotrexate|methotrexate|mesh-list
138232351|NCT04514393|Temozolomide|temozolomide|mesh-list
138232352|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138232354|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138232355|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232356|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232357|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
138232358|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232359|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232360|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232361|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232362|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138232363|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232364|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
138232365|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232366|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138232367|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138232368|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
138232369|NCT01232504|Molgramostim|molgramostim|mesh-list
138232370|NCT01232504|Lenograstim|lenograstim|mesh-list
138232371|NCT01232504|Sargramostim|sargramostim|mesh-list
138232372|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138232373|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
138232374|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232375|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232376|NCT01737593|Acetaminophen|acetaminophen|mesh-list
138232377|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232378|NCT01737593|Analgesics|analgesics|mesh-ancestor
138232379|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
138232380|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232381|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232382|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
138232383|NCT01217840|Vitamin D|vitamin d|mesh-list
138232384|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
138232385|NCT01217840|Vitamins|vitamins|mesh-ancestor
138232386|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
138232387|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232388|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138232389|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138232391|NCT01721603|Dabrafenib|dabrafenib|mesh-list
138232392|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232393|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138232394|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232395|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232396|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
138232397|NCT01296542|Besifloxacin|besifloxacin|mesh-list
138232399|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232400|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232401|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232402|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232403|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232404|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232405|NCT01234766|Rituximab|rituximab|mesh-list
138232406|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138232407|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232408|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232411|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232412|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138232413|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
138232414|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232415|NCT01234922|Losartan|losartan|mesh-list
138232416|NCT01234922|Ramipril|ramipril|mesh-list
138232417|NCT01234922|Lisinopril|lisinopril|mesh-list
138232418|NCT01234922|Benazepril|benazepril|mesh-list
138232419|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232420|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138232421|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138232422|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138232423|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232424|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138232425|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
138232426|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232427|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138232428|NCT01234922|Protective Agents|protective agents|mesh-ancestor
138232429|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232430|NCT01337336|Fluticasone|fluticasone|mesh-list
138232432|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
138232433|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138232434|NCT01337336|Ipratropium|ipratropium|mesh-list
138232435|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138232436|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232437|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138232438|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
138232439|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232440|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232441|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138232442|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
138232443|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232444|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138232445|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
138232446|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232447|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232448|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232449|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138232450|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138232451|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138232452|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
138232453|NCT01239212|Levetiracetam|levetiracetam|mesh-list
138232454|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
138232455|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
138232457|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138232458|NCT01242644|Morphine|morphine|mesh-list
138232459|NCT01242644|Ropivacaine|ropivacaine|mesh-list
138232460|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138232461|NCT01242644|Narcotics|narcotics|mesh-ancestor
138232462|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232463|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232464|NCT01242644|Analgesics|analgesics|mesh-ancestor
138232465|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
138232466|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232467|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
138232468|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
138213731|NCT01508455|Narcotics|narcotics|mesh-ancestor
138232471|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361403|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138232472|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232473|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232474|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232475|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232477|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
138232478|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232479|NCT01303406|Protective Agents|protective agents|mesh-ancestor
138232480|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232481|NCT02597907|Aprepitant|aprepitant|mesh-list
138232482|NCT02597907|Palonosetron|palonosetron|mesh-list
138232483|NCT02597907|Ramosetron|ramosetron|mesh-list
138232484|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
138232485|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
138232486|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232487|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232488|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232489|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138232490|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232491|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232492|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138232493|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138232494|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
138232495|NCT02600325|Grazoprevir|grazoprevir|mesh-list
138232496|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138232497|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
138232498|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232499|NCT02600715|Morphine|morphine|mesh-list
138232500|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138232501|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138232502|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138232503|NCT02600715|Narcotics|narcotics|mesh-ancestor
138232505|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232506|NCT02600715|Analgesics|analgesics|mesh-ancestor
138232507|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
138232508|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232509|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138232510|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138232511|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138232512|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232513|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232514|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232515|NCT04743297|Dinoprostone|dinoprostone|mesh-list
138232516|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
138232517|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138232518|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232519|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
138232520|NCT04176783|Narcotics|narcotics|mesh-ancestor
138232521|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232522|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232523|NCT04176783|Analgesics|analgesics|mesh-ancestor
138232524|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
138232525|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361434|NCT03218514|Dalteparin|dalteparin|mesh-list
138232527|NCT00365313|Esomeprazole|esomeprazole|mesh-list
138232528|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232529|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232530|NCT00365313|Analgesics|analgesics|mesh-ancestor
138232531|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
138232532|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232533|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232534|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232537|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232539|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232540|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138232541|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232542|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138232543|NCT02605395|Rabeprazole|rabeprazole|mesh-list
138232544|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138232545|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138232546|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138232547|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232548|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232549|NCT04343001|Aspirin|aspirin|mesh-list
138232550|NCT04343001|Losartan|losartan|mesh-list
138232551|NCT04343001|Simvastatin|simvastatin|mesh-list
138232552|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232553|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232555|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
138232556|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232557|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232558|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232559|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232560|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138232561|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232562|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232563|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232564|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232565|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232566|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
138232567|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138232568|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138232569|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
138232570|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138232571|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138232572|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232573|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138232574|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138232575|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138232576|NCT04743063|Losartan|losartan|mesh-list
138232577|NCT04743063|Valsartan|valsartan|mesh-list
138232578|NCT04743063|Telmisartan|telmisartan|mesh-list
138232579|NCT04743063|Candesartan|candesartan|mesh-list
138232580|NCT04743063|Olmesartan|olmesartan|mesh-list
138232581|NCT04743063|Irbesartan|irbesartan|mesh-list
138232582|NCT04743063|Eprosartan|eprosartan|mesh-list
138232583|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
138232584|NCT04743063|Giapreza|giapreza|mesh-list
138232585|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138232586|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138232587|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
138232588|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138232589|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138232590|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232591|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232592|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138232593|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138232594|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
138232595|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232596|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138232597|NCT01739699|Acetaminophen|acetaminophen|mesh-list
138232598|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232599|NCT01739699|Analgesics|analgesics|mesh-ancestor
138232600|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
138232601|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232602|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232603|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
138232605|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232606|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232607|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
138232608|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232609|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232610|NCT01740713|Deferiprone|deferiprone|mesh-list
138232611|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138232612|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
138232613|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
138232614|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232615|NCT02613117|Fluorides|fluorides|mesh-list
138232616|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
138232617|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
138232618|NCT02613117|Protective Agents|protective agents|mesh-ancestor
138232619|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232620|NCT01742117|Clopidogrel|clopidogrel|mesh-list
138232621|NCT01742117|Ticagrelor|ticagrelor|mesh-list
138232622|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232623|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138232624|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138232625|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138232626|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
138232627|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232628|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232629|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232630|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
138232631|NCT02613897|Saxagliptin|saxagliptin|mesh-list
138232632|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138232633|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232634|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138232635|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232636|NCT02613897|Incretins|incretins|mesh-ancestor
138232638|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232639|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138232640|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
138232641|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232643|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232644|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
138232645|NCT02615535|Urological Agents|urological agents|mesh-ancestor
138232647|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
138232648|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
138232649|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232650|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232651|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
138232652|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232653|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232654|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138232655|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138232656|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138232657|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232658|NCT01342172|Lenalidomide|lenalidomide|mesh-list
138232661|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232662|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232663|NCT01342172|Growth Substances|growth substances|mesh-ancestor
138232664|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232665|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232667|NCT01243112|Epinephrine|epinephrine|mesh-list
138232668|NCT01243112|Racepinephrine|racepinephrine|mesh-list
138232669|NCT01243112|Bupivacaine|bupivacaine|mesh-list
138232670|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
138232671|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
138232672|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
138232673|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232674|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232675|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
138232676|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232677|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138232678|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138232679|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138232680|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138232681|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232682|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138232683|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138232684|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
138232685|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232686|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138232687|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138232688|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
138232689|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138232690|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
138232692|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
138232693|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138232694|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
138232695|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
138232696|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138232697|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
138232698|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138232699|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232701|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232702|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232703|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232704|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232705|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232706|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232707|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232708|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138232709|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138232710|NCT01743521|Ribavirin|ribavirin|mesh-list
138232711|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
138232712|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232713|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
138232714|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232716|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138232717|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232718|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232719|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232720|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232721|NCT00361881|Acyclovir|acyclovir|mesh-list
138232722|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
138232723|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
138232724|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232725|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232727|NCT01743677|Tofacitinib|tofacitinib|mesh-list
138232728|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232729|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232730|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232731|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232732|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232733|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232734|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232735|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138232736|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138232737|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138232738|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138232739|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
138232740|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232741|NCT01246076|Lenalidomide|lenalidomide|mesh-list
138232742|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
138232743|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232744|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232745|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232746|NCT01246076|Growth Substances|growth substances|mesh-ancestor
138232747|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232748|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232750|NCT00364455|Hematinics|hematinics|mesh-ancestor
138232751|NCT01307462|Fluticasone|fluticasone|mesh-list
138232752|NCT01307462|Xhance|xhance|mesh-list
138232753|NCT01307462|Azithromycin|azithromycin|mesh-list
138213771|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232754|NCT01307462|Montelukast|montelukast|mesh-list
138232755|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232756|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138232757|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
138232759|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232760|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138232761|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
138232762|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232763|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138232764|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232765|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232766|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138232767|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
138232768|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232769|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138232770|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138232771|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232772|NCT05731089|Aflibercept|aflibercept|mesh-list
138232773|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232774|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232775|NCT05731089|Growth Substances|growth substances|mesh-ancestor
138232776|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232777|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232778|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232779|NCT01307618|Interleukin-12|interleukin-12|mesh-list
138232780|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138232781|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
138232782|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232783|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138232784|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138232785|NCT01307618|Growth Substances|growth substances|mesh-ancestor
138232786|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232787|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232789|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
138232790|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232791|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138232792|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232793|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232794|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232796|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232797|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232798|NCT05730777|Paclitaxel|paclitaxel|mesh-list
138232799|NCT05730777|Carboplatin|carboplatin|mesh-list
138232800|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138232801|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232802|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
138232803|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
138232804|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
138232805|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232806|NCT04425239|Leucovorin|leucovorin|mesh-list
138232807|NCT04425239|Folic Acid|folic acid|mesh-list
138232808|NCT04425239|Fluorouracil|fluorouracil|mesh-list
138232809|NCT04425239|Irinotecan|irinotecan|mesh-list
138232810|NCT04425239|Panitumumab|panitumumab|mesh-list
138232811|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
138232812|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
138232813|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232814|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232815|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232816|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232817|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
138232818|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232819|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138232820|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232821|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232822|NCT04425239|Antidotes|antidotes|mesh-ancestor
138232826|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
138232828|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138232829|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
138232830|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138232831|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138232832|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138232833|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138232834|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232835|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232836|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232837|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232838|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138232839|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232840|NCT00366093|Eszopiclone|eszopiclone|mesh-list
138232841|NCT00366093|Zopiclone|zopiclone|mesh-list
138232842|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138232843|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232844|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232845|NCT04379999|Aspirin|aspirin|mesh-list
138232846|NCT04379999|Atorvastatin|atorvastatin|mesh-list
138232847|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232848|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232849|NCT04379999|Analgesics|analgesics|mesh-ancestor
138232850|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
138232851|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232852|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232853|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232854|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232855|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138232856|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232857|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232858|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232859|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232860|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232861|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
138232862|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138232863|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138232864|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
138232865|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138232866|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138232867|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138232868|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138232869|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138232870|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232871|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
138232873|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
138232875|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
138232876|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232877|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232878|NCT05730621|Analgesics|analgesics|mesh-ancestor
138232879|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
138232881|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232882|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232883|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232884|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138232885|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232886|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232887|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232888|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232889|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232891|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138232892|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
138232893|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232895|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138232896|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232897|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
138232898|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232899|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
138232900|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138232901|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
138232902|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232903|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232904|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138232905|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
138232906|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138232907|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
138232908|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232909|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138232910|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138232912|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
138232913|NCT04292483|Protective Agents|protective agents|mesh-ancestor
138232914|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
138232915|NCT01347008|Citric Acid|citric acid|mesh-list
138232916|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
138232917|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
138232918|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138232919|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
138232920|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
138232921|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232922|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
138232923|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138232924|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138232925|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232926|NCT01347008|Urological Agents|urological agents|mesh-ancestor
138232927|NCT05343429|Aspirin|aspirin|mesh-list
138232928|NCT05343429|Benzydamine|benzydamine|mesh-list
138232929|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232930|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232931|NCT05343429|Analgesics|analgesics|mesh-ancestor
138232932|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
138232933|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232934|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232935|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138232939|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232940|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232941|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138232942|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232945|NCT01310582|Desflurane|desflurane|mesh-list
138232946|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138232947|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138232948|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
138232949|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
138232950|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232951|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232952|NCT01311674|Vaccines|vaccines|mesh-list
138232953|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
138232954|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232955|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
138232956|NCT05081193|Testosterone|testosterone|mesh-list
138232957|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
138232958|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
138232959|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138232960|NCT05081193|Androgens|androgens|mesh-ancestor
138232961|NCT05081193|Hormones|hormones|mesh-ancestor
138232962|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138232963|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232964|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138232965|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232966|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
138232967|NCT01349972|Cytarabine|cytarabine|mesh-list
138232968|NCT01349972|Daunorubicin|daunorubicin|mesh-list
138232969|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
138232970|NCT01349972|Alvocidib|alvocidib|mesh-list
138232971|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138232972|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
138232973|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232974|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232975|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
138232976|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232977|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138232978|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
138232979|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232980|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138232981|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138232982|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232983|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232985|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
138232986|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232987|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
138232988|NCT01349972|Growth Substances|growth substances|mesh-ancestor
138232989|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138232990|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
138232991|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
138232992|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138232993|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232994|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232996|NCT01248104|Coagulants|coagulants|mesh-ancestor
138232997|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
138233001|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233002|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138233003|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233004|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138233006|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233007|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233008|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138233009|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138233010|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
138233011|NCT01748045|Protective Agents|protective agents|mesh-ancestor
138233012|NCT01312766|Menotropins|menotropins|mesh-list
138233013|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138233014|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
138233015|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138233016|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233017|NCT01749215|Topiramate|topiramate|mesh-list
138233018|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
138233019|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138233020|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233021|NCT04522167|Aflibercept|aflibercept|mesh-list
138233022|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138233023|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138233025|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233026|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138233027|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233028|NCT01248416|Letrozole|letrozole|mesh-list
138233029|NCT01248416|Anastrozole|anastrozole|mesh-list
138233030|NCT01248416|Hormones|hormones|mesh-list
138233031|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138233032|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233033|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233034|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233035|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138233036|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233037|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233038|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138233039|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
138233040|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138233041|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
138233043|NCT01749293|Fludarabine|fludarabine|mesh-list
138233044|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138233045|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
138233046|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233047|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233048|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138233049|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
138233050|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233051|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233052|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138233053|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
138233055|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138233056|NCT01250210|Estradiol|estradiol|mesh-list
138233057|NCT01250210|Estrogens|estrogens|mesh-ancestor
138233058|NCT01250210|Hormones|hormones|mesh-ancestor
138233059|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233060|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233061|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138233062|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
138233063|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138233064|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138233065|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138233066|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138233067|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138233068|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138233069|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
138233070|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
138233071|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233072|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233073|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138233074|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138233075|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233076|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233077|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233079|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138233080|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138233081|NCT01312844|Scopolamine|scopolamine|mesh-list
138233082|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138233083|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138233084|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
138233085|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
138233086|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233087|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233088|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138233089|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
138233090|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138233091|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233092|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233093|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233094|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138233095|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
138233096|NCT01750931|Meloxicam|meloxicam|mesh-list
138233097|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138233098|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233099|NCT01750931|Analgesics|analgesics|mesh-ancestor
138233100|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
138233101|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233102|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233103|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233104|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233105|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138233106|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138233107|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233108|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233109|NCT01731041|Ticagrelor|ticagrelor|mesh-list
138233110|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138233111|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138233112|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138233113|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138233114|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
138233115|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233116|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233117|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233118|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138233119|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233120|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233121|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233122|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138233123|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
138233124|NCT01752413|Hematinics|hematinics|mesh-ancestor
138233125|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138233126|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138233128|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233129|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233130|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233131|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138233132|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138233133|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138233134|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
138233135|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233136|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233137|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138233138|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138233139|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
138233140|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138233141|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138233142|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
138233143|NCT01732445|Danazol|danazol|mesh-list
138233144|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138233145|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138233146|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
138233147|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233148|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233149|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138233150|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233151|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233152|NCT01250834|Dulaglutide|dulaglutide|mesh-list
138233153|NCT01250834|Atorvastatin|atorvastatin|mesh-list
138233155|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138233156|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
138233157|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233158|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138233159|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138233160|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233161|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138233162|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233163|NCT04387695|Sorafenib|sorafenib|mesh-list
138233164|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233165|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138233166|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233167|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233168|NCT01354652|Lamivudine|lamivudine|mesh-list
138233169|NCT01354652|Entecavir|entecavir|mesh-list
138233170|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138233171|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138233172|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233173|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233175|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233176|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138233177|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138233178|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
138233179|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138233180|NCT01250990|Niacin|niacin|mesh-list
138233181|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138233182|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
138233183|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233184|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138233185|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
138233187|NCT01250990|Vitamins|vitamins|mesh-ancestor
138233188|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
138233189|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233190|NCT02990975|Ketamine|ketamine|mesh-list
138361507|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138233191|NCT02990975|Analgesics|analgesics|mesh-ancestor
138233192|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
138233193|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233194|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233195|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138233196|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233197|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
138233198|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
138233199|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233200|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138233201|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138233202|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233205|NCT01315574|Latanoprost|latanoprost|mesh-list
138233206|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138233207|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138233208|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138233209|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
138233210|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
138233211|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233212|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233213|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233214|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
138233215|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138233216|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233217|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233219|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138233222|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138233223|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
138233224|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233225|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233226|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138233227|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
138233228|NCT04340349|Bromhexine|bromhexine|mesh-list
138233229|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
138233230|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138233231|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138233232|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233233|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233234|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233235|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233236|NCT04340349|Expectorants|expectorants|mesh-ancestor
138233237|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233239|NCT04267809|Metformin|metformin|mesh-list
138233240|NCT04267809|Calcium|calcium|mesh-list
138233241|NCT04267809|Vitamins|vitamins|mesh-ancestor
138233242|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
138233243|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233244|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138233245|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138233246|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138233247|NCT02242409|Paclitaxel|paclitaxel|mesh-list
138233248|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138233249|NCT02242409|Gemcitabine|gemcitabine|mesh-list
138233250|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138233251|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233252|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138233253|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138233254|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138233255|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233256|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138233257|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
138233258|NCT00366873|Calcium|calcium|mesh-list
138233259|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138233260|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233261|NCT05317325|Vaccines|vaccines|mesh-list
138233262|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
138233263|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233264|NCT04182399|Zonisamide|zonisamide|mesh-list
138233265|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
138233266|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138233267|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233268|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233269|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138233270|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233272|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138233273|NCT04246619|Analgesics|analgesics|mesh-ancestor
138233274|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
138233275|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233276|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233277|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
138233278|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138213961|NCT01558063|Ketamine|ketamine|mesh-list
138213962|NCT01558063|Analgesics|analgesics|mesh-ancestor
138233280|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233281|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138233282|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138233283|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138233284|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233285|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233286|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138233287|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138233288|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233289|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
138233290|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
138233291|NCT01757561|Propofol|propofol|mesh-list
138233292|NCT01757561|Sevoflurane|sevoflurane|mesh-list
138233293|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233294|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233295|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233296|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233297|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
138233298|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
138233299|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138233300|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138233301|NCT02618187|Vancomycin|vancomycin|mesh-list
138233302|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233303|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233304|NCT05316857|Itraconazole|itraconazole|mesh-list
138233305|NCT05316857|Rifampin|rifampin|mesh-list
138233306|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
138233307|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233308|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138233309|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138233310|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233311|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233312|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138233313|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
138233314|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233315|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233316|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138233317|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138233318|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
138233319|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233320|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
138233321|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138233322|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138233323|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138233324|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138233325|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138233326|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138233327|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138233329|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
138233330|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233331|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233332|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
138233333|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233334|NCT02618343|Ondansetron|ondansetron|mesh-list
138233335|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
138233336|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
138233338|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233339|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138233340|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
138233342|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138233344|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
138233345|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233346|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233348|NCT02991053|Analgesics|analgesics|mesh-ancestor
138233349|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
138233350|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233351|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233352|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138233353|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233354|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
138233355|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
138233356|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233357|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138233358|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138233359|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233360|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233361|NCT01251536|Cetuximab|cetuximab|mesh-list
138233362|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138233363|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233364|NCT02620683|Lidocaine|lidocaine|mesh-list
138233365|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
138233366|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
138233367|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233368|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233369|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
138233370|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233371|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138233372|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138233373|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138233374|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233375|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233376|NCT01355588|Ketorolac|ketorolac|mesh-list
138233377|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138233378|NCT01355588|Lidocaine|lidocaine|mesh-list
138233379|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
138233380|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
138233381|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233382|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233383|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
138233384|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233385|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138233386|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138233387|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138233388|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233389|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233390|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138233391|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233392|NCT01355588|Analgesics|analgesics|mesh-ancestor
138233393|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233394|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233395|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138233396|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233397|NCT02621619|Acetaminophen|acetaminophen|mesh-list
138233398|NCT02621619|Hydromorphone|hydromorphone|mesh-list
138233402|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233403|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233405|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138233406|NCT02621619|Narcotics|narcotics|mesh-ancestor
138233407|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233409|NCT01253642|Phenelzine|phenelzine|mesh-list
138233410|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233411|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
138233412|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
138233413|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138233414|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233415|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
138233416|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233417|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138233418|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233420|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138233421|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138233422|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233423|NCT01357148|Incretins|incretins|mesh-ancestor
138233424|NCT01357148|Hormones|hormones|mesh-ancestor
138233425|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233426|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138233427|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
138233428|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233429|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233430|NCT02623803|Lidocaine|lidocaine|mesh-list
138233431|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
138233432|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
138233433|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233434|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233435|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
138233436|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233437|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138233438|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138233439|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138233440|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233441|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233443|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138233444|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
138233445|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233446|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233447|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138233448|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233449|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
138233450|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
138233451|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138233452|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138233453|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138233454|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138233455|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
138233456|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233457|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233458|NCT02625207|Maraviroc|maraviroc|mesh-list
138233459|NCT02625207|Darunavir|darunavir|mesh-list
138213984|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
138233460|NCT02625207|Cobicistat|cobicistat|mesh-list
138233461|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138233463|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138361551|NCT03211728|Pregabalin|pregabalin|mesh-list
138233464|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233466|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138233467|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
138233468|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233470|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138233471|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138233472|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
138233473|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233474|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138233475|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138233477|NCT02253173|Estrogens|estrogens|mesh-ancestor
138233478|NCT02253173|Hormones|hormones|mesh-ancestor
138233479|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233480|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233481|NCT01318694|Ribavirin|ribavirin|mesh-list
138233482|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138233483|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
138233484|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233485|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
138233486|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233487|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138233488|NCT03009578|Hematinics|hematinics|mesh-ancestor
138233489|NCT01361048|Metronidazole|metronidazole|mesh-list
138233490|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233491|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233492|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138233493|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138233494|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
138233495|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
138233496|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233497|NCT01766219|Protective Agents|protective agents|mesh-ancestor
138233498|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233499|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
138233500|NCT01766219|Vitamins|vitamins|mesh-ancestor
138233501|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
138233502|NCT01767155|Doxorubicin|doxorubicin|mesh-list
138233503|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138233504|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138233505|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233506|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138233507|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138233508|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233509|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233510|NCT01362686|Rivastigmine|rivastigmine|mesh-list
138233511|NCT01362686|Donepezil|donepezil|mesh-list
138233512|NCT01362686|Galantamine|galantamine|mesh-list
138233513|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138233514|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233515|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233516|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233517|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233518|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233519|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
138233520|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138233521|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
138233522|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233523|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138233524|NCT01362686|Protective Agents|protective agents|mesh-ancestor
138233525|NCT01322048|Propranolol|propranolol|mesh-list
138233526|NCT01322048|Clonidine|clonidine|mesh-list
138233527|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138233528|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138233529|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138233530|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233531|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233532|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233533|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138233534|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138233536|NCT01322048|Analgesics|analgesics|mesh-ancestor
138233537|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
138233538|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233541|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138233542|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138233543|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138233545|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138233546|NCT01322360|Narcotics|narcotics|mesh-ancestor
138233547|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233548|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233549|NCT01322360|Analgesics|analgesics|mesh-ancestor
138233550|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
138233551|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233552|NCT04351724|Ritonavir|ritonavir|mesh-list
138233553|NCT04351724|Lopinavir|lopinavir|mesh-list
138233554|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
138233555|NCT04351724|Chloroquine|chloroquine|mesh-list
138233556|NCT04351724|Remdesivir|remdesivir|mesh-list
138233557|NCT04351724|Candesartan|candesartan|mesh-list
138233558|NCT04351724|Candesartan cilexetil|candesartan cilexetil|mesh-list
138233559|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
138233560|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
138233561|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138233562|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138233563|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
138233564|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233565|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233567|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138233569|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233570|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138233571|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138233572|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138233573|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
138233574|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138233575|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
138233576|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
138233577|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138233578|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138233579|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233580|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138233581|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138233582|NCT04351724|Amebicides|amebicides|mesh-ancestor
138233583|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
138233584|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
138233585|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138233586|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138233587|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
138233588|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233589|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138233590|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138233591|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233592|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233594|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
138233595|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
138233596|NCT04351412|Protective Agents|protective agents|mesh-ancestor
138233597|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233598|NCT01364090|Interferons|interferons|mesh-list
138233599|NCT01364090|Ribavirin|ribavirin|mesh-list
138233600|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
138233601|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
138233602|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138233603|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233604|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
138233605|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233606|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
138414719|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
138233608|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
138233609|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233611|NCT03684785|Cemiplimab|cemiplimab|mesh-list
138233612|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138233613|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233614|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138233615|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233616|NCT01364558|Diazepam|diazepam|mesh-list
138233617|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138233618|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
138233619|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
138233620|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
138233621|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233622|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233623|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138233624|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233625|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233626|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138233627|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138233628|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138233629|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138233630|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233631|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233632|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
138233634|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
138233635|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
138233636|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233637|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233639|NCT01323140|Androgens|androgens|mesh-ancestor
138233640|NCT01323140|Hormones|hormones|mesh-ancestor
138233641|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233642|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233643|NCT03516305|Alprazolam|alprazolam|mesh-list
138233644|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233645|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233646|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233647|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138233649|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233650|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
138233651|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
138233652|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233653|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233654|NCT03823287|Aflibercept|aflibercept|mesh-list
138233655|NCT03823287|Faricimab|faricimab|mesh-list
138233656|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138233657|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138233658|NCT03823287|Growth Substances|growth substances|mesh-ancestor
138233659|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233660|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
138233661|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233662|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
138233663|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138233664|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233665|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233666|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233667|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214070|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214072|NCT03258320|Analgesics|analgesics|mesh-ancestor
138233670|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138233671|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138233672|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233673|NCT01260662|Ketamine|ketamine|mesh-list
138233674|NCT01260662|Propofol|propofol|mesh-list
138233675|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233676|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233677|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233678|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233679|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
138233680|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
138233681|NCT01260662|Analgesics|analgesics|mesh-ancestor
138233682|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
138233683|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233684|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138233685|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138233686|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138233687|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233688|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233689|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
138233690|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138233691|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138233692|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233694|NCT02327117|Coagulants|coagulants|mesh-ancestor
138233695|NCT01365650|Fluticasone|fluticasone|mesh-list
138233696|NCT01365650|Xhance|xhance|mesh-list
138233698|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138233699|NCT01365650|Phenylephrine|phenylephrine|mesh-list
138233700|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
138233701|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233702|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138233703|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
138233704|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233705|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233706|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138233707|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233708|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
138233709|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138233710|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138233711|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233712|NCT01365650|Analgesics|analgesics|mesh-ancestor
138233713|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
138233714|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233715|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138233716|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233717|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233718|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138233719|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138233720|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
138233721|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233722|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
138233723|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
138233724|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138233725|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138233726|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
138233727|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138233728|NCT01365650|Protective Agents|protective agents|mesh-ancestor
138233729|NCT01324700|Dexetimide|dexetimide|mesh-list
138233730|NCT01324700|Citalopram|citalopram|mesh-list
138233731|NCT01324700|Escitalopram|escitalopram|mesh-list
138233732|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138233733|NCT01324700|Serotonin|serotonin|mesh-list
138233734|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138233735|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214080|NCT01797926|Amlodipine|amlodipine|mesh-list
138233737|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233738|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
138233739|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233740|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138233741|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138233742|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
138233743|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
138233744|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233745|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138233746|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138233747|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233748|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138233749|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138233750|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233751|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138233753|NCT04769297|Analgesics|analgesics|mesh-ancestor
138233754|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
138233755|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233756|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233757|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138233758|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233759|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
138233760|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
138233761|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233762|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138233763|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138233764|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233765|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233767|NCT02631057|Dabigatran|dabigatran|mesh-list
138233768|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
138233769|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
138233770|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138233771|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
138233772|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233773|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233774|NCT02631525|Propofol|propofol|mesh-list
138233775|NCT02631525|Desflurane|desflurane|mesh-list
138233776|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233777|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233778|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233779|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233780|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
138233781|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
138233782|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138233783|NCT03162497|Azithromycin|azithromycin|mesh-list
138233784|NCT03162497|Doxycycline|doxycycline|mesh-list
138233785|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233786|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233788|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138233789|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138233792|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233793|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138233794|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138233795|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233796|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233797|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138233798|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
138233799|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233800|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233801|NCT01366196|Pregabalin|pregabalin|mesh-list
138233802|NCT01366196|Analgesics|analgesics|mesh-ancestor
138233807|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138233808|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233809|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233810|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138233811|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138233813|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233814|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233816|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233817|NCT01366976|Analgesics|analgesics|mesh-ancestor
138233818|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
138233819|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233820|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233821|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
138233822|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
138233823|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138233824|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138233825|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233826|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233827|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233828|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233829|NCT01777217|Urological Agents|urological agents|mesh-ancestor
138233830|NCT02251379|Fluticasone|fluticasone|mesh-list
138233832|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138233833|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138233834|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
138233835|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233836|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233837|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138233838|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
138233839|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
138233840|NCT02251379|Hormones|hormones|mesh-ancestor
138233841|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233842|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
138233843|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233844|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
138233845|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138233846|NCT02255513|Methylphenidate|methylphenidate|mesh-list
138233847|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138233849|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138233852|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233854|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233855|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
138233856|NCT01778465|Salicylates|salicylates|mesh-list
138233857|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138233858|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233859|NCT01778465|Analgesics|analgesics|mesh-ancestor
138233860|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
138233861|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233862|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233863|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233864|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233865|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138233866|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233867|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233868|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233869|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
138233870|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
138233871|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
138233872|NCT01779167|Thalidomide|thalidomide|mesh-list
138233873|NCT01779167|Rituximab|rituximab|mesh-list
138233874|NCT01779167|Lenalidomide|lenalidomide|mesh-list
138233875|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138233876|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233877|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
138233878|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233879|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233880|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138233881|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138233882|NCT01779167|Growth Substances|growth substances|mesh-ancestor
138233883|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138233884|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138233885|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
138233886|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233887|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138233888|NCT01780337|Oxytocin|oxytocin|mesh-list
138233889|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
138233890|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138233891|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233892|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138233893|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138233894|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138233895|NCT02251613|Epinastine|epinastine|mesh-list
138233896|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138233897|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233898|NCT02251613|Analgesics|analgesics|mesh-ancestor
138233899|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
138233900|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233901|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233902|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233903|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138233904|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138233905|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138233906|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138233907|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
138233908|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
138233909|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233910|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233911|NCT02865473|Pilocarpine|pilocarpine|mesh-list
138233912|NCT02865473|Miotics|miotics|mesh-ancestor
138233913|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
138233916|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138233917|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138233918|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233919|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233920|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233921|NCT02850419|Doxorubicin|doxorubicin|mesh-list
138233922|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138233923|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138233924|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233925|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138233926|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138233927|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233928|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233929|NCT02841371|Edetic Acid|edetic acid|mesh-list
138233930|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
138233931|NCT02841371|Antidotes|antidotes|mesh-ancestor
138233932|NCT02841371|Protective Agents|protective agents|mesh-ancestor
138233933|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233934|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
138233935|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
138233936|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233937|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138233938|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
138233939|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138233940|NCT01783847|Prednisolone|prednisolone|mesh-list
138233942|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
138233943|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138233944|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
138233945|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
138233946|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138233947|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
138233948|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138233949|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
138233951|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233952|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233953|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138233954|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233955|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
138233956|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
138233957|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233958|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138233959|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138233960|NCT01783847|Protective Agents|protective agents|mesh-ancestor
138233961|NCT01783847|Hematinics|hematinics|mesh-ancestor
138233962|NCT02585375|Latanoprost|latanoprost|mesh-list
138233963|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138233964|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138233965|NCT02516813|Peposertib|peposertib|mesh-list
138233966|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138233967|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233968|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233969|NCT01785095|Hormones|hormones|mesh-list
138233970|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138233971|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233972|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214128|NCT01522417|Tirofiban|tirofiban|mesh-list
138233974|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138233976|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233977|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233978|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233979|NCT03362775|Propofol|propofol|mesh-list
138233980|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138233981|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233982|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233983|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138233984|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
138233985|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
138233986|NCT01786967|Fesoterodine|fesoterodine|mesh-list
138233987|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138233988|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138233989|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
138233990|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233991|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233992|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233993|NCT01786967|Urological Agents|urological agents|mesh-ancestor
138233994|NCT02392871|Trametinib|trametinib|mesh-list
138233995|NCT02392871|Dabrafenib|dabrafenib|mesh-list
138233996|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233997|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138233998|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138233999|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234000|NCT02382575|Rituximab|rituximab|mesh-list
138234001|NCT02382575|Tacrolimus|tacrolimus|mesh-list
138234002|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138234003|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138234004|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234005|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
138234006|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234007|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234008|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234009|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234010|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234011|NCT01807871|Nicotine|nicotine|mesh-list
138234012|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138234013|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
138234014|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234015|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234016|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138234017|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138234018|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
138234019|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234020|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234022|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138234023|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138234024|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
138234025|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234026|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138234027|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138234028|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234029|NCT02327741|Clopidogrel|clopidogrel|mesh-list
138234030|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138234031|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138234032|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138234035|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234036|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234037|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234038|NCT00367185|Thalidomide|thalidomide|mesh-list
138234039|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234040|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
138234041|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234042|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
138234043|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234044|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234045|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138234046|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138234047|NCT00367185|Growth Substances|growth substances|mesh-ancestor
138234053|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138234054|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234055|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234056|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234057|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
138234058|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234064|NCT01267136|Acetaminophen|acetaminophen|mesh-list
138234066|NCT01267136|Codeine|codeine|mesh-list
138234067|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234068|NCT01267136|Analgesics|analgesics|mesh-ancestor
138234069|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
138234070|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234071|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234072|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
138234073|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138234074|NCT01267136|Narcotics|narcotics|mesh-ancestor
138234075|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234076|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
138234077|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234078|NCT01370564|Diuretics|diuretics|mesh-list
138234079|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
138234081|NCT00367263|Ciclesonide|ciclesonide|mesh-list
138234082|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
138234084|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234085|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234086|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138234087|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138234088|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
138234089|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
138234090|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234091|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234092|NCT01371110|Midazolam|midazolam|mesh-list
138234093|NCT01371110|Ketamine|ketamine|mesh-list
138234094|NCT01371110|Analgesics|analgesics|mesh-ancestor
138234095|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
138234096|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234097|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234098|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138214141|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
138234102|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234103|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138234104|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138234105|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234106|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234107|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138234108|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138234109|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138234110|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138234111|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234112|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
138234113|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
138234114|NCT01791491|Abatacept|abatacept|mesh-list
138234115|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138234116|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234117|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138234118|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234119|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234120|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
138234121|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234122|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234123|NCT00367419|Erythromycin|erythromycin|mesh-list
138234124|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
138234125|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138234126|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
138234127|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234128|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234129|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234130|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138234131|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234132|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234134|NCT01372202|Fluorouracil|fluorouracil|mesh-list
138234135|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
138234136|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138234137|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234138|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138234139|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138234140|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138234141|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234142|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
138234143|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138234144|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234145|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
138234146|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234147|NCT01811147|Norepinephrine|norepinephrine|mesh-list
138234148|NCT01811147|Serotonin|serotonin|mesh-list
138234149|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138234150|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138234151|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234152|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234153|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234154|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234155|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234156|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
138234157|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
138234158|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234159|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138214161|NCT05533580|Atracurium|atracurium|mesh-list
138234162|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234163|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234164|NCT01373450|Liraglutide|liraglutide|mesh-list
138234165|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138234166|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234167|NCT01373450|Incretins|incretins|mesh-ancestor
138234169|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234170|NCT01793285|Etanercept|etanercept|mesh-list
138234171|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234172|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234173|NCT01793285|Analgesics|analgesics|mesh-ancestor
138234174|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
138234175|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234176|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234177|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234178|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234179|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234180|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234181|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
138234182|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
138234183|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138234184|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138234185|NCT02639637|Valsartan|valsartan|mesh-list
138234186|NCT02639637|Enalaprilat|enalaprilat|mesh-list
138234187|NCT02639637|Enalapril|enalapril|mesh-list
138234188|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138234189|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234190|NCT02639637|Incretins|incretins|mesh-ancestor
138234191|NCT02639637|Hormones|hormones|mesh-ancestor
138234192|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234193|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138234194|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138234196|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234197|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234198|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138234199|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138234200|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138234201|NCT01332188|Cetirizine|cetirizine|mesh-list
138234202|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138234203|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138234204|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138234205|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
138234206|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
138234207|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214170|NCT05533580|Analgesics|analgesics|mesh-ancestor
138234208|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234210|NCT01794455|Candesartan|candesartan|mesh-list
138234211|NCT01794455|Candesartan cilexetil|candesartan cilexetil|mesh-list
138234212|NCT01794455|Sertraline|sertraline|mesh-list
138234213|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
138234214|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234215|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138234216|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234217|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234218|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234219|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234220|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
138234221|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234222|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234223|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138234224|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138234225|NCT01332500|Naproxen|naproxen|mesh-list
138234226|NCT01332500|Sumatriptan|sumatriptan|mesh-list
138234227|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234228|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234229|NCT01332500|Analgesics|analgesics|mesh-ancestor
138234230|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
138234231|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234232|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234233|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234234|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234235|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
138234236|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138234237|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234238|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234239|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138234240|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138234241|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138234242|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
138234243|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234245|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138234246|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234247|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
138234248|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234249|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234250|NCT01332578|Acetaminophen|acetaminophen|mesh-list
138234251|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
138234252|NCT01332578|Phenylephrine|phenylephrine|mesh-list
138234253|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
138234254|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234255|NCT01332578|Analgesics|analgesics|mesh-ancestor
138234256|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
138234257|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234258|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234260|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
138234261|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234262|NCT01332578|Protective Agents|protective agents|mesh-ancestor
138234263|NCT01332578|Vitamins|vitamins|mesh-ancestor
138234264|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
138234265|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138234266|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
138234268|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
138234269|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138234270|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
138234271|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138214194|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234273|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138234274|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234275|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234276|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234277|NCT01333592|Mitiglinide|mitiglinide|mesh-list
138234278|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138234279|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234281|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138234282|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234283|NCT01267292|Buspirone|buspirone|mesh-list
138234284|NCT01267292|Methylphenidate|methylphenidate|mesh-list
138234285|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138234286|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234287|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138234288|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234289|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361617|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138234290|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234291|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
138234292|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234293|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138234294|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138234295|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234296|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234297|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138234298|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
138234299|NCT01734161|Dexamethasone|dexamethasone|mesh-list
138234300|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234301|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
138234302|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
138234303|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234304|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234305|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234306|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
138234307|NCT01734161|Hormones|hormones|mesh-ancestor
138234308|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234309|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234310|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234311|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138234312|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
138234313|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234314|NCT01797575|Aspirin|aspirin|mesh-list
138234315|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
138234316|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138234317|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234318|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234319|NCT01797575|Analgesics|analgesics|mesh-ancestor
138234320|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
138234321|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234322|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234323|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234324|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234325|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138234326|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138234327|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234328|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138234329|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138234330|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234331|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
138234332|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
138234333|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234334|NCT01797575|Expectorants|expectorants|mesh-ancestor
138234335|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234336|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138234339|NCT01797575|Antidotes|antidotes|mesh-ancestor
138234340|NCT02641353|Thalidomide|thalidomide|mesh-list
138234341|NCT02641353|Apremilast|apremilast|mesh-list
138234342|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234343|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234344|NCT02641353|Analgesics|analgesics|mesh-ancestor
138234345|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
138234347|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234348|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234349|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234350|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138234351|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138234352|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414720|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138234354|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234355|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
138234356|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
138234357|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234358|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234359|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138234360|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138234361|NCT02641353|Growth Substances|growth substances|mesh-ancestor
138234362|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
138234363|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234364|NCT01378520|Ketoconazole|ketoconazole|mesh-list
138234365|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
138234366|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234367|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138234368|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138234370|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234371|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138234372|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
138234373|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234374|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234375|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138234376|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
138234377|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138234378|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234379|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234380|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234381|NCT01378988|Analgesics|analgesics|mesh-ancestor
138234382|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
138234383|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234384|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138234385|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138234386|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234387|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234388|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234389|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234390|NCT01335620|Tenofovir|tenofovir|mesh-list
138234391|NCT01335620|Emtricitabine|emtricitabine|mesh-list
138234392|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
138361663|NCT01833312|Analgesics|analgesics|mesh-ancestor
138234393|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
138234394|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234395|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138234396|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138234397|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234398|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234399|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138234400|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138234401|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138234404|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138234406|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234407|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138234408|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234409|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234410|NCT01273766|Deferasirox|deferasirox|mesh-list
138234411|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138234412|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
138234413|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
138234414|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234415|NCT01403246|Lenalidomide|lenalidomide|mesh-list
138234416|NCT01403246|Chlorambucil|chlorambucil|mesh-list
138234417|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
138234418|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234419|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138234420|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138234421|NCT01403246|Growth Substances|growth substances|mesh-ancestor
138234422|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138234423|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234424|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138234425|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
138234426|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234427|NCT01734551|Clonidine|clonidine|mesh-list
138234428|NCT01734551|Morphine|morphine|mesh-list
138234429|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138234430|NCT01734551|Narcotics|narcotics|mesh-ancestor
138234431|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234432|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234433|NCT01734551|Analgesics|analgesics|mesh-ancestor
138234434|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
138234435|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234436|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234437|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
138234439|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138234440|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138234441|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234442|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234443|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234444|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234445|NCT01404260|Carboplatin|carboplatin|mesh-list
138234446|NCT01404260|Gemcitabine|gemcitabine|mesh-list
138234448|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234449|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138234451|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234452|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138234453|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234455|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138234456|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138234457|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234458|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138234459|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138234460|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234469|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
138234470|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234471|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
138234472|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138234473|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
138234474|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234475|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234476|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138234477|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234478|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
138234479|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138234480|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
138234481|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234482|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234483|NCT01799213|Meloxicam|meloxicam|mesh-list
138234484|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234485|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234486|NCT01799213|Analgesics|analgesics|mesh-ancestor
138234487|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
138234488|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234489|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234490|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234491|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234492|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138234493|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138234494|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234495|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234497|NCT01383200|Tetracaine|tetracaine|mesh-list
138234498|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
138234499|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
138234500|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234501|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234502|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
138234503|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234504|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138234505|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138234506|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138234507|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234508|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234510|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
138234511|NCT05588037|BB 1101|bb 1101|mesh-list
138234512|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234513|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
138234514|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
138234515|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234516|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234517|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234518|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
138234519|NCT05588037|Hormones|hormones|mesh-ancestor
138234524|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234525|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234527|NCT02194088|Atropine|atropine|mesh-list
138234528|NCT02194088|Analgesics|analgesics|mesh-list
138234529|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234530|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234531|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
138234532|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234533|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234534|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234535|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234536|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138234537|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234538|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234539|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138234541|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138234542|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
138234543|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138234544|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234545|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
138234546|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
138234547|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138234548|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138234549|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
138234550|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234551|NCT02023593|Leucovorin|leucovorin|mesh-list
138234552|NCT02023593|Fluorouracil|fluorouracil|mesh-list
138234553|NCT02023593|Irinotecan|irinotecan|mesh-list
138361711|NCT01836822|Dimercaprol|dimercaprol|mesh-list
138361712|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
138234554|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
138234555|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234556|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138234557|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234558|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234559|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
138234560|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234561|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138234562|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138234563|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234564|NCT02023593|Antidotes|antidotes|mesh-ancestor
138234565|NCT02023593|Protective Agents|protective agents|mesh-ancestor
138234566|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
138234567|NCT02023593|Vitamins|vitamins|mesh-ancestor
138234568|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
138234569|NCT01978431|Cocaine|cocaine|mesh-list
138234570|NCT01978431|Methylphenidate|methylphenidate|mesh-list
138234571|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138234572|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234573|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138234574|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234575|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234576|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234577|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
138234578|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234579|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
138234581|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234582|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
138234583|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234584|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138234585|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
138234586|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138234587|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234588|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234589|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138234590|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234591|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138234592|NCT02685267|Prednisone|prednisone|mesh-list
138234593|NCT02685267|Docetaxel|docetaxel|mesh-list
138234594|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234595|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
138234596|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
138234597|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
138234598|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234599|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234600|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
138234601|NCT02685267|Hormones|hormones|mesh-ancestor
138234602|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234603|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234604|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234606|NCT02257541|Infigratinib|infigratinib|mesh-list
138234607|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234608|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138234609|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234610|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234612|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361749|NCT01838772|Interferons|interferons|mesh-list
138234613|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234614|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234615|NCT00368121|Dexamethasone|dexamethasone|mesh-list
138234616|NCT00368121|Cetuximab|cetuximab|mesh-list
138234617|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234618|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
138234619|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
138234620|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234621|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234622|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234623|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
138234624|NCT00368121|Hormones|hormones|mesh-ancestor
138234625|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234626|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234627|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234628|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138234629|NCT00367497|Cytarabine|cytarabine|mesh-list
138234630|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
138234631|NCT00367497|Rituximab|rituximab|mesh-list
138234632|NCT00367497|Etoposide|etoposide|mesh-list
138234633|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138234634|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234636|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234637|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234638|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138234639|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138234640|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138234641|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214363|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234642|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234643|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138234644|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
138234645|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
138234646|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234647|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234648|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234649|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
138234650|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
138234651|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234652|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138234653|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
138234655|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234656|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138234657|NCT00367497|Protective Agents|protective agents|mesh-ancestor
138234658|NCT01387178|Fluticasone|fluticasone|mesh-list
138234659|NCT01387178|Xhance|xhance|mesh-list
138234661|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
138234662|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138234663|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234664|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138234665|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
138234666|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234667|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234668|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138234669|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234670|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138234671|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138234672|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
138234673|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138234674|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
138234676|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234677|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138234678|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138234679|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234680|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234681|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
138234682|NCT01389284|Naproxen|naproxen|mesh-list
138234683|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234684|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234686|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
138234687|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234688|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234689|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234690|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234691|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
138234692|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138234693|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234694|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234698|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138234699|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138234700|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234701|NCT01794143|Incretins|incretins|mesh-ancestor
138234702|NCT01794143|Hormones|hormones|mesh-ancestor
138234703|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234704|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
138234706|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234707|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138234708|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234709|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
138234710|NCT01547741|Paclitaxel|paclitaxel|mesh-list
138234711|NCT01547741|Docetaxel|docetaxel|mesh-list
138234712|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
138234713|NCT01547741|Doxorubicin|doxorubicin|mesh-list
138234714|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138234715|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234716|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
138234717|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
138234718|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
138234719|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234720|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234721|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
138234722|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234723|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234724|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138234725|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
138234726|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138234727|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138234728|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138234729|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138234730|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234731|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138234732|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138234733|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
138234734|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234736|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
138234737|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
138234738|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138234739|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234740|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234741|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138234742|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234743|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234744|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
138234745|NCT04351490|Vitamin D|vitamin d|mesh-list
138234746|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138234747|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234748|NCT04351490|Vitamins|vitamins|mesh-ancestor
138361769|NCT01839240|Cytarabine|cytarabine|mesh-list
138234749|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
138234750|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138234751|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
138234752|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138234753|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138234754|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138234755|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234756|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234758|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234760|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138234761|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234762|NCT03008252|Caseins|caseins|mesh-list
138234763|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
138234764|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
138234765|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234766|NCT05328635|Candesartan|candesartan|mesh-list
138234767|NCT05328635|Candesartan cilexetil|candesartan cilexetil|mesh-list
138234768|NCT05328635|Gabapentin|gabapentin|mesh-list
138234769|NCT05328635|Analgesics|analgesics|mesh-ancestor
138234770|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
138234771|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234772|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234773|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
138234774|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138234775|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138234776|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234777|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234778|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138234779|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138234780|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234781|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234782|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
138234783|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234784|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138234785|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138234786|NCT01391858|Pregabalin|pregabalin|mesh-list
138234787|NCT01391858|Analgesics|analgesics|mesh-ancestor
138234788|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
138234789|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234790|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234791|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
138234792|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138234793|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138234794|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234795|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138234796|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138234797|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138234798|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234799|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234800|NCT05587257|Minoxidil|minoxidil|mesh-list
138234801|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138234802|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
138234803|NCT01825655|Cetirizine|cetirizine|mesh-list
138234804|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138234805|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138234806|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138234807|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
138234808|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
138234809|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234810|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234811|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234813|NCT02249663|Xhance|xhance|mesh-list
138234814|NCT02249663|Azelastine|azelastine|mesh-list
138234815|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234816|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138234817|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
138234818|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234819|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234820|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138234821|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234822|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
138234823|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138234824|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138234825|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234826|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234827|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138234828|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138234829|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
138234830|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
138234831|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234832|NCT01825889|Evacetrapib|evacetrapib|mesh-list
138234833|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138234834|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138234835|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
138234836|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234837|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138234838|NCT02692755|Letrozole|letrozole|mesh-list
138234839|NCT02692755|Fulvestrant|fulvestrant|mesh-list
138234840|NCT02692755|Palbociclib|palbociclib|mesh-list
138234841|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234842|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138234843|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138234844|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234845|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234846|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138234847|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
138234848|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234849|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234850|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234851|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138234852|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138234853|NCT01829399|Epinephrine|epinephrine|mesh-list
138234854|NCT01829399|Bupivacaine|bupivacaine|mesh-list
138234855|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
138234857|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234858|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234859|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
138234860|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234861|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138234862|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138234863|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
138234864|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234865|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234866|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138234867|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138234868|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
138234869|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138234870|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234871|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
138234872|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
138234873|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138234874|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
138234875|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138234876|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
138234877|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234878|NCT01394510|Expectorants|expectorants|mesh-ancestor
138234879|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234880|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138361814|NCT01834248|Decitabine|decitabine|mesh-list
138234881|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
138234882|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234883|NCT01394510|Protective Agents|protective agents|mesh-ancestor
138234885|NCT01394510|Antidotes|antidotes|mesh-ancestor
138234886|NCT05580549|Ethanol|ethanol|mesh-list
138234887|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138234888|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234889|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234890|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234891|NCT05327621|Pamiparib|pamiparib|mesh-list
138234892|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138234893|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234894|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234895|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234896|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138234897|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
138234898|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234899|NCT05326841|Vitamin D|vitamin d|mesh-list
138234900|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
138234901|NCT05326841|Vitamins|vitamins|mesh-ancestor
138234902|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
138234903|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234904|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138234905|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138234907|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138234909|NCT01412372|Analgesics|analgesics|mesh-ancestor
138234910|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
138234911|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234912|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234913|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234914|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234916|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234918|NCT01415960|Leuprolide|leuprolide|mesh-list
138234919|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138234920|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
138234921|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138234922|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234923|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234924|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234926|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
138234927|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
138234928|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234929|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
138234930|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234931|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
138234932|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138234933|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138234934|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234935|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138234936|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138234937|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
138234938|NCT01416194|Diphosphonates|diphosphonates|mesh-list
138234939|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138234940|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
138234941|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234942|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234943|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138234944|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138234945|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138234946|NCT01416584|Methadone|methadone|mesh-list
138234947|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138234948|NCT01416584|Narcotics|narcotics|mesh-ancestor
138234949|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234950|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234951|NCT01416584|Analgesics|analgesics|mesh-ancestor
138234952|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
138234953|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234954|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
138234955|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138234957|NCT02698215|Varenicline|varenicline|mesh-list
138234958|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138234959|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138234960|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234961|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
138234962|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234963|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138234964|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138234966|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234967|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234968|NCT04172961|Cyclosporine|cyclosporine|mesh-list
138234969|NCT04172961|Lifitegrast|lifitegrast|mesh-list
138234970|NCT04172961|Cyclosporins|cyclosporins|mesh-list
138234971|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234972|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234973|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138234974|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
138234975|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234976|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
138234977|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234978|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138234979|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214436|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
138234982|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138234983|NCT01480232|Nicotine|nicotine|mesh-list
138234984|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138234985|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
138234986|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138234987|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234988|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138234989|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138234990|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
138234991|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234992|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234993|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
138234994|NCT04049799|Narcotics|narcotics|mesh-ancestor
138234995|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234996|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234997|NCT04049799|Analgesics|analgesics|mesh-ancestor
138234998|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
138234999|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235000|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
138235001|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235002|NCT03008876|Acetaminophen|acetaminophen|mesh-list
138235003|NCT03008876|Ibuprofen|ibuprofen|mesh-list
138235004|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235005|NCT03008876|Analgesics|analgesics|mesh-ancestor
138235006|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
138235007|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235008|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235009|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
138235010|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138235011|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235012|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235013|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138235014|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235015|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235016|NCT05414487|Ofatumumab|ofatumumab|mesh-list
138235017|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235018|NCT02701257|Glucagon|glucagon|mesh-list
138235019|NCT02701257|Pancrelipase|pancrelipase|mesh-list
138235020|NCT02701257|Pancreatin|pancreatin|mesh-list
138235021|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138235022|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235023|NCT02701257|Hormones|hormones|mesh-ancestor
138235024|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235025|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235026|NCT02701257|Incretins|incretins|mesh-ancestor
138235027|NCT01836029|Carboplatin|carboplatin|mesh-list
138235028|NCT01836029|Fluorouracil|fluorouracil|mesh-list
138235029|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235030|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
138235031|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235032|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138235033|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235034|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
138235035|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235036|NCT02703909|Rocuronium|rocuronium|mesh-list
138235037|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138235038|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138235039|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138235040|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235041|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214442|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
138235049|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
138235050|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138235051|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138235052|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235053|NCT04740021|Carboplatin|carboplatin|mesh-list
138235054|NCT04740021|Etoposide|etoposide|mesh-list
138235056|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138235057|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138235058|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138235059|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235060|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235061|NCT02708433|Lidocaine|lidocaine|mesh-list
138235062|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235063|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
138235064|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235065|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235066|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
138235067|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235068|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138235069|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138235070|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138235071|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235072|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235073|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
138235074|NCT00559637|Hematinics|hematinics|mesh-ancestor
138235075|NCT03349281|Cytarabine|cytarabine|mesh-list
138235076|NCT03349281|Dexamethasone|dexamethasone|mesh-list
138235077|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
138235078|NCT03349281|Doxorubicin|doxorubicin|mesh-list
138235079|NCT03349281|Methotrexate|methotrexate|mesh-list
138235080|NCT03349281|Vincristine|vincristine|mesh-list
138235081|NCT03349281|Asparaginase|asparaginase|mesh-list
138235082|NCT03349281|Pegaspargase|pegaspargase|mesh-list
138235083|NCT03349281|Pevonedistat|pevonedistat|mesh-list
138235084|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235085|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
138235086|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
138235087|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235088|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235089|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235090|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
138235091|NCT03349281|Hormones|hormones|mesh-ancestor
138235092|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235093|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235094|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235095|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138235096|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138235097|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138235098|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235099|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235100|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138235101|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
138235102|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138214452|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138235109|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235110|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138235111|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
138235112|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235113|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138235114|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
138235115|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
138235116|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
138235119|NCT03206151|Fluorouracil|fluorouracil|mesh-list
138235120|NCT03206151|Irinotecan|irinotecan|mesh-list
138235121|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
138235122|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
138235123|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235124|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138235125|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235126|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235127|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
138235128|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235129|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138235130|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138235131|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235132|NCT03206151|Antidotes|antidotes|mesh-ancestor
138235133|NCT03206151|Protective Agents|protective agents|mesh-ancestor
138235134|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
138235135|NCT03206151|Vitamins|vitamins|mesh-ancestor
138235136|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
138235137|NCT03206151|Hematinics|hematinics|mesh-ancestor
138235138|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138235139|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
138235140|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138235141|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235142|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
138235143|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
138235144|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235145|NCT02714283|Azithromycin|azithromycin|mesh-list
138235146|NCT02714283|Erythromycin|erythromycin|mesh-list
138235147|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235148|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235149|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235150|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138235151|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235152|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235153|NCT04810949|Vitamin D|vitamin d|mesh-list
138235154|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
138235155|NCT04810949|Vitamins|vitamins|mesh-ancestor
138235157|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235158|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138235159|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138235161|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235162|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
138235163|NCT04795583|Hormones|hormones|mesh-ancestor
138235164|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235165|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235166|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235167|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235168|NCT02722239|Metformin|metformin|mesh-list
138235169|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
138235170|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138235171|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235172|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138235173|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235174|NCT02578641|Carboplatin|carboplatin|mesh-list
138235175|NCT02578641|Gemcitabine|gemcitabine|mesh-list
138235176|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235177|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138235178|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
138235179|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235180|NCT05084859|Prednisone|prednisone|mesh-list
138235181|NCT05084859|Docetaxel|docetaxel|mesh-list
138235182|NCT05084859|Panitumumab|panitumumab|mesh-list
138235183|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235184|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
138235185|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138235186|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
138235187|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235189|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
138235190|NCT05084859|Hormones|hormones|mesh-ancestor
138235191|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235192|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235193|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235194|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138235195|NCT01846871|Tivozanib|tivozanib|mesh-list
138235196|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138235197|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235198|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235199|NCT02431260|INCB054329|incb054329|mesh-list
138235200|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235201|NCT02055963|Minocycline|minocycline|mesh-list
138235202|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235203|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235204|NCT01848041|Phenylephrine|phenylephrine|mesh-list
138235205|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
138235206|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138235207|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138235208|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138235209|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138235210|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
138235211|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235212|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235213|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235214|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
138235215|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
138235217|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
138235218|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138235219|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235220|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138235222|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138235223|NCT01848041|Protective Agents|protective agents|mesh-ancestor
138235224|NCT02724033|Dexamethasone|dexamethasone|mesh-list
138235225|NCT02724033|Ondansetron|ondansetron|mesh-list
138235226|NCT02724033|Antiemetics|antiemetics|mesh-list
138235227|NCT02724033|Bupivacaine|bupivacaine|mesh-list
138235228|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235229|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
138235230|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235231|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235232|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235233|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
138235235|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235236|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235237|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235238|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235239|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235240|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
138235241|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235244|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
138235245|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138235246|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138235247|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
138235248|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235249|NCT02724423|Diazepam|diazepam|mesh-list
138235250|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138235251|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
138235252|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
138235253|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
138235254|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235255|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235256|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235257|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138235258|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235259|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138235260|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138235261|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138235262|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138235264|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138235265|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
138235267|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
138235268|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
138235269|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235270|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235271|NCT02989259|Apatinib|apatinib|mesh-list
138235272|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235273|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138235274|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235275|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235276|NCT04950621|Propofol|propofol|mesh-list
138235277|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138235278|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235279|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235280|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138235281|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
138235282|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
138235283|NCT01848899|Bivalirudin|bivalirudin|mesh-list
138235284|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
138235285|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138235289|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
138235291|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
138235292|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
138235293|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
138235294|NCT02731833|Protective Agents|protective agents|mesh-ancestor
138235295|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235296|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138235297|NCT01852019|Cangrelor|cangrelor|mesh-list
138235298|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138235299|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138235300|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138235301|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138235302|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
138235303|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235304|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235305|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235307|NCT04457219|Coagulants|coagulants|mesh-ancestor
138235308|NCT01852175|Ticagrelor|ticagrelor|mesh-list
138235309|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138235310|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138235311|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138235312|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138235313|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138235314|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
138235315|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235316|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235317|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235318|NCT02429934|Abatacept|abatacept|mesh-list
138235319|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138235320|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235321|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361869|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235322|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235323|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235324|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
138235325|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214501|NCT05245448|Tetrandrine|tetrandrine|mesh-list
138235326|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235328|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235329|NCT01852955|Analgesics|analgesics|mesh-ancestor
138235330|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
138235331|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235332|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235333|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
138235334|NCT00558467|Pramipexole|pramipexole|mesh-list
138235335|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
138235336|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235337|NCT00558467|Protective Agents|protective agents|mesh-ancestor
138235338|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235339|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138235340|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138235341|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
138235342|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
138235343|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235344|NCT02401230|Tenofovir|tenofovir|mesh-list
138235345|NCT02401230|Emtricitabine|emtricitabine|mesh-list
138235346|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138235347|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
138235348|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235349|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138235350|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138235351|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235352|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235353|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138235355|NCT01854359|Idebenone|idebenone|mesh-list
138235356|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
138235357|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235358|NCT01854359|Protective Agents|protective agents|mesh-ancestor
138235359|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235360|NCT01854593|Bevacizumab|bevacizumab|mesh-list
138235361|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138235362|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235363|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138235364|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138235365|NCT01854593|Growth Substances|growth substances|mesh-ancestor
138235366|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235367|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
138235368|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138235369|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
138235370|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
138235371|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235372|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235373|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
138235374|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138235375|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
138235376|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235377|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235378|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138235379|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235382|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235383|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235384|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138235385|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
138235386|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
138235387|NCT02734953|Protective Agents|protective agents|mesh-ancestor
138235388|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138235389|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138235390|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235391|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235392|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138235393|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235394|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235395|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
138235396|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235398|NCT02735187|Vitamins|vitamins|mesh-ancestor
138235399|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
138235400|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235401|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138235403|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235404|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235405|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138235406|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235407|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
138235408|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235409|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
138235410|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235411|NCT02643615|Propofol|propofol|mesh-list
138235412|NCT02643615|Desflurane|desflurane|mesh-list
138235413|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138235414|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235415|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235416|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138235417|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
138235418|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
138235419|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138235420|NCT02265341|Ponatinib|ponatinib|mesh-list
138235421|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235422|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138235423|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235424|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235425|NCT05679479|Meplazumab|meplazumab|mesh-list
138235426|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
138235427|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235429|NCT01421186|Lenalidomide|lenalidomide|mesh-list
138235430|NCT01421186|Pomalidomide|pomalidomide|mesh-list
138235431|NCT01421186|Felzartamab|felzartamab|mesh-list
138235432|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235433|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
138235434|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
138235435|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235436|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235437|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235440|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235441|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235442|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235443|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
138235444|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138235445|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138235446|NCT01421186|Growth Substances|growth substances|mesh-ancestor
138235447|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138235449|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138235450|NCT01860287|Narcotics|narcotics|mesh-ancestor
138235451|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235452|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235453|NCT01860287|Analgesics|analgesics|mesh-ancestor
138235454|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
138235455|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235456|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138235457|NCT01421498|Lifitegrast|lifitegrast|mesh-list
138235458|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138235459|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138235460|NCT01422200|Vaccines|vaccines|mesh-list
138235461|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
138235462|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235464|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
138235465|NCT01860521|Gemeprost|gemeprost|mesh-list
138235466|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138235467|NCT01860521|Narcotics|narcotics|mesh-ancestor
138235468|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235469|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235470|NCT01860521|Analgesics|analgesics|mesh-ancestor
138235471|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
138235472|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235473|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138235474|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138235475|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
138235476|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
138235477|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235478|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138235479|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
138235480|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138235481|NCT01400906|Fluticasone|fluticasone|mesh-list
138235483|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235484|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138235485|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
138235486|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235487|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235488|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138235489|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235490|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138235491|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138235492|NCT00367653|Azithromycin|azithromycin|mesh-list
138235493|NCT00367653|Chloroquine|chloroquine|mesh-list
138235494|NCT00367653|Mefloquine|mefloquine|mesh-list
138235495|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235496|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235497|NCT00367653|Amebicides|amebicides|mesh-ancestor
138235498|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138235499|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138235500|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
138235501|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235502|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
138235503|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138235504|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235506|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235507|NCT01485380|Analgesics|analgesics|mesh-ancestor
138235508|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
138235509|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235510|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138235511|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138235512|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138235513|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
138235514|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235515|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235516|NCT05445297|Amiodarone|amiodarone|mesh-list
138235517|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138235518|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
138235519|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138235520|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235521|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235522|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138235523|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138235524|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138235525|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235526|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138235527|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138235528|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138235529|NCT00556673|Fluticasone|fluticasone|mesh-list
138235531|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138235532|NCT00556673|Maleic acid|maleic acid|mesh-list
138235533|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235534|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138235535|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
138235536|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235537|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235547|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235548|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235549|NCT05437029|Plant Lectins|plant lectins|mesh-list
138235550|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
138235551|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
138235552|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235553|NCT05437029|Coagulants|coagulants|mesh-ancestor
138235554|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
138235555|NCT01422434|Calcitriol|calcitriol|mesh-list
138235556|NCT01422434|Betamethasone|betamethasone|mesh-list
138235557|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
138235558|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138235559|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
138235560|NCT01422434|Calcipotriene|calcipotriene|mesh-list
138235561|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138235562|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235563|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
138235564|NCT01422434|Hormones|hormones|mesh-ancestor
138235565|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235566|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235567|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138235568|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235570|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138235571|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138235572|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235573|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235574|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138235575|NCT01422434|Vitamins|vitamins|mesh-ancestor
138235576|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
138235577|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138235578|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138235579|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235580|NCT02270255|Lidocaine|lidocaine|mesh-list
138235581|NCT02270255|Ropivacaine|ropivacaine|mesh-list
138235582|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235583|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
138235584|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235585|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235586|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
138235587|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235588|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138235589|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138235590|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138235591|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235592|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235594|NCT02651259|Pyridoxine|pyridoxine|mesh-list
138235595|NCT02651259|Pyridoxal|pyridoxal|mesh-list
138235596|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
138235597|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
138235602|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
138235603|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235604|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
138235605|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235606|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235607|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138235608|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138235609|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
138235610|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235611|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138235612|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138235613|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
138235614|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235615|NCT02271425|Evacetrapib|evacetrapib|mesh-list
138235616|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138235617|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138235618|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
138235619|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235620|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138235621|NCT05442411|Parecoxib|parecoxib|mesh-list
138235622|NCT05442411|Ropivacaine|ropivacaine|mesh-list
138235623|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235624|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
138235625|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235626|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235627|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
138235628|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235629|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138235630|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138235631|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235632|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235633|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138235634|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235635|NCT05442411|Analgesics|analgesics|mesh-ancestor
138235636|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235637|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235638|NCT02651415|Perindopril|perindopril|mesh-list
138235639|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138235640|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
138235641|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235642|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235643|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138235644|NCT00555425|Buprenorphine|buprenorphine|mesh-list
138235645|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138235646|NCT00555425|Naloxone|naloxone|mesh-list
138235647|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138235648|NCT00555425|Narcotics|narcotics|mesh-ancestor
138235649|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235650|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235651|NCT00555425|Analgesics|analgesics|mesh-ancestor
138235652|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
138235653|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235654|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138235655|NCT05444673|Cisplatin|cisplatin|mesh-list
138235656|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235657|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
138235658|NCT04338633|Calcium|calcium|mesh-list
138235660|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235661|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138235662|NCT01488188|Vaccines|vaccines|mesh-list
138235663|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
138235664|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235665|NCT01489670|Bimatoprost|bimatoprost|mesh-list
138235666|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138235667|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138235668|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138235670|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138235671|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138235672|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235673|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235674|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
138235675|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235676|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
138235677|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138235678|NCT03021083|Fentanyl|fentanyl|mesh-list
138235679|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138235680|NCT03021083|Narcotics|narcotics|mesh-ancestor
138235681|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235682|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235683|NCT03021083|Analgesics|analgesics|mesh-ancestor
138235684|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
138235685|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235686|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138235687|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138235688|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
138235689|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
138235690|NCT03000257|Venetoclax|venetoclax|mesh-list
138235691|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
138235692|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235693|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
138235694|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
138235695|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235697|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138235698|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235699|NCT05442801|Tropicamide|tropicamide|mesh-list
138235700|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
138235701|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
138235702|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
138235703|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235704|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235705|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138235706|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138235707|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
138235708|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235709|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235710|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
138235711|NCT05339373|Aceclofenac|aceclofenac|mesh-list
138235712|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138235713|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235714|NCT05339373|Analgesics|analgesics|mesh-ancestor
138235715|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
138235716|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235717|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235718|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235719|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235721|NCT05439993|Tepotinib|tepotinib|mesh-list
138235722|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138235723|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235724|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138235725|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214618|NCT04257188|Anesthetics|anesthetics|mesh-list
138235727|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235728|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138235730|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235731|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138235732|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138235733|NCT00554099|Analgesics|analgesics|mesh-ancestor
138235734|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
138235735|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235736|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235737|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235738|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235739|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
138235740|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138235741|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138235742|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235743|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
138235744|NCT02664909|Coagulants|coagulants|mesh-ancestor
138235745|NCT00368589|Atorvastatin|atorvastatin|mesh-list
138235746|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138235747|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138235748|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
138235749|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235750|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138235751|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138235752|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235753|NCT00553319|Amphetamine|amphetamine|mesh-list
138235754|NCT00553319|Adderall|adderall|mesh-list
138235755|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138235756|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235757|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
138235758|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
138235759|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235760|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
138235761|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235762|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235763|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
138235764|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138235765|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138235766|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235767|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138235768|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138235769|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138235770|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
138235771|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235772|NCT01868633|Dexamethasone|dexamethasone|mesh-list
138235773|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138235774|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
138235775|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
138235776|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235777|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235778|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235779|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
138235780|NCT01868633|Hormones|hormones|mesh-ancestor
138235781|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235782|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138235783|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235784|NCT04738773|Naltrexone|naltrexone|mesh-list
138235785|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138235786|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138214621|NCT04224428|Fexofenadine|fexofenadine|mesh-list
138235789|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235791|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138235792|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138235793|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138235794|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235795|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235796|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
138235797|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235799|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138235800|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235801|NCT02676375|Bupropion|bupropion|mesh-list
138235802|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138235803|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138235804|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138235805|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138235806|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138235807|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235808|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235809|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
138235810|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235811|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235812|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138235813|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138235815|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
138235816|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
138235817|NCT01871441|Tacrolimus|tacrolimus|mesh-list
138235818|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235819|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
138235820|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235821|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235822|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138235823|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
138235824|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235825|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235826|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138235827|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138235828|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235829|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138235830|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138235831|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
138235832|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235833|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235834|NCT04338711|Tofacitinib|tofacitinib|mesh-list
138235835|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138235836|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138235837|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235838|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235841|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138235842|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235843|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
138235844|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235845|NCT04739241|Insulin|insulin|mesh-list
138235846|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138235847|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138214627|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235848|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235849|NCT03024437|Bevacizumab|bevacizumab|mesh-list
138235850|NCT03024437|Atezolizumab|atezolizumab|mesh-list
138235851|NCT03024437|Entinostat|entinostat|mesh-list
138235852|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138235853|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235854|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138235855|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138235856|NCT03024437|Growth Substances|growth substances|mesh-ancestor
138235857|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235858|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
138235859|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138235860|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235861|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138235862|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235864|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138235865|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
138235866|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
138235867|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235868|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235869|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235870|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138235871|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138235872|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235873|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235874|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138235875|NCT01489826|Protective Agents|protective agents|mesh-ancestor
138235876|NCT02677623|Mannitol|mannitol|mesh-list
138235877|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138235878|NCT02677623|Diuretics|diuretics|mesh-ancestor
138235879|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
138235880|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235881|NCT02677701|Azithromycin|azithromycin|mesh-list
138235882|NCT02677701|Tobramycin|tobramycin|mesh-list
138235883|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235884|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235885|NCT01543178|Rifaximin|rifaximin|mesh-list
138235886|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138235887|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235888|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235889|NCT01649856|Rituximab|rituximab|mesh-list
138235890|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138235891|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235892|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
138235893|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235894|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235895|NCT01543568|Aflibercept|aflibercept|mesh-list
138214643|NCT00605072|Metoprolol|metoprolol|mesh-list
138235896|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138235897|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138235899|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235900|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
138235901|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235902|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138235903|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235905|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
138235906|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138235907|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138235908|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
138235909|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235910|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235911|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138235912|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235913|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138235914|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138235915|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138235916|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
138235917|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235918|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235920|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
138235921|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235922|NCT02424630|Ropivacaine|ropivacaine|mesh-list
138235923|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235924|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
138235925|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235926|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235927|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
138235928|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235929|NCT02397408|Choline|choline|mesh-list
138235930|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
138235931|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138235932|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
138235933|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235934|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235935|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138235936|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
138235937|NCT02397096|Ritonavir|ritonavir|mesh-list
138235939|NCT02397096|Tenofovir|tenofovir|mesh-list
138235940|NCT02397096|Lamivudine|lamivudine|mesh-list
138235941|NCT02397096|Cobicistat|cobicistat|mesh-list
138235942|NCT02397096|Elvitegravir|elvitegravir|mesh-list
138235943|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138235944|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
138235945|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138235946|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235947|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235948|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138235949|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138235950|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
138235951|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235952|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138235953|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138235954|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138235955|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138235956|NCT02396316|Aflibercept|aflibercept|mesh-list
138235957|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138235958|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138235959|NCT02396316|Growth Substances|growth substances|mesh-ancestor
138235960|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235961|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
138235962|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235964|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235965|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138235966|NCT02682381|Protective Agents|protective agents|mesh-ancestor
138235967|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214670|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
138214673|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
138235978|NCT02683161|Varenicline|varenicline|mesh-list
138235979|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138235980|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138235981|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138235982|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235983|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235984|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235985|NCT02683707|Lidocaine|lidocaine|mesh-list
138235986|NCT02683707|Midazolam|midazolam|mesh-list
138235987|NCT02683707|Fentanyl|fentanyl|mesh-list
138235988|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
138235989|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
138235990|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235991|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235992|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
138235993|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235994|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138235995|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138235996|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138235997|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235998|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235999|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138236000|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138236001|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138236002|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138236003|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236004|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138236005|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
138236006|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
138236007|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
138236008|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236009|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138236010|NCT02683707|Narcotics|narcotics|mesh-ancestor
138236011|NCT02683707|Analgesics|analgesics|mesh-ancestor
138236012|NCT02371980|Vortioxetine|vortioxetine|mesh-list
138236013|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
138236014|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236015|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138236016|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138236017|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236018|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236019|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138236020|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138236025|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138236026|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138236027|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138236028|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138236030|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236031|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236032|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
138236033|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236034|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
138236035|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
138236037|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236038|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236039|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
138236040|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236041|NCT05447871|Bupivacaine|bupivacaine|mesh-list
138236042|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
138236043|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
138236044|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236045|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236046|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
138236047|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236048|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
138236049|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236050|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236051|NCT04772235|Osimertinib|osimertinib|mesh-list
138236052|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236053|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138236054|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236055|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236057|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138236058|NCT04766463|Narcotics|narcotics|mesh-ancestor
138236059|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236060|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236061|NCT04766463|Analgesics|analgesics|mesh-ancestor
138236062|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
138236063|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236064|NCT05447169|Antibodies|antibodies|mesh-list
138236065|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
138236066|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236067|NCT04652193|Anesthetics|anesthetics|mesh-list
138236068|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236069|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236070|NCT05451147|Metformin|metformin|mesh-list
138236071|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236072|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236073|NCT04553367|Meropenem|meropenem|mesh-list
138236074|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236075|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236077|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138236078|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236079|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236080|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138236081|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236082|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
138236083|NCT05449899|Busulfan|busulfan|mesh-list
138236084|NCT05449899|Fludarabine|fludarabine|mesh-list
138236085|NCT05449899|Decitabine|decitabine|mesh-list
138236090|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138236091|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138236092|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
138236093|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236094|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236095|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138236096|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236097|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
138236098|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236099|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138236100|NCT05441631|Insulin|insulin|mesh-list
138236101|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138236102|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236103|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236104|NCT01546454|Leuprolide|leuprolide|mesh-list
138236105|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138236106|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138236107|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
138236108|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138236109|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138236110|NCT01546454|Estradiol|estradiol|mesh-list
138236111|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138236112|NCT01546454|Progesterone|progesterone|mesh-list
138236113|NCT01546454|Estrogens|estrogens|mesh-ancestor
138236114|NCT01546454|Hormones|hormones|mesh-ancestor
138236115|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236116|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236117|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138236118|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
138236119|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138236120|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138236121|NCT01546454|Progestins|progestins|mesh-ancestor
138236122|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138236123|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
138236124|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138236125|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236126|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138236127|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138236128|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138236129|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138236130|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
138236131|NCT00368901|Hematinics|hematinics|mesh-ancestor
138236132|NCT05430867|Memantine|memantine|mesh-list
138236133|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138236134|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138236135|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
138236136|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236137|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236138|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236139|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138236140|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138236141|NCT05448885|Cisplatin|cisplatin|mesh-list
138236142|NCT05448885|Gemcitabine|gemcitabine|mesh-list
138236143|NCT05448885|Tislelizumab|tislelizumab|mesh-list
138236144|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236145|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236146|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
138414721|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
138214764|NCT04527770|Midazolam|midazolam|mesh-list
138236157|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236158|NCT02980016|Isoniazid|isoniazid|mesh-list
138236159|NCT02980016|Rifapentine|rifapentine|mesh-list
138236160|NCT02980016|Rifampin|rifampin|mesh-list
138236161|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
138236162|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236163|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236164|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138236165|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138236166|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
138236167|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236168|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138236169|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138236170|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
138236171|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138236172|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236173|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138236174|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138236175|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138236176|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138236177|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138236178|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138236179|NCT01493180|Rebamipide|rebamipide|mesh-list
138361992|NCT01725048|Mirtazapine|mirtazapine|mesh-list
138236180|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138236181|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
138236182|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138236183|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138236184|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
138236185|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236186|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
138236187|NCT01493180|Protective Agents|protective agents|mesh-ancestor
138236188|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138236189|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236190|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
138236191|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236192|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236193|NCT01431014|Dexamethasone|dexamethasone|mesh-list
138236194|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
138236196|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236197|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
138236198|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
138236199|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236200|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236201|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236202|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
138236206|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236207|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
138236208|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236209|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236211|NCT01431170|Polymyxins|polymyxins|mesh-list
138236212|NCT01431170|Polymyxin B|polymyxin b|mesh-list
138236213|NCT01431170|Besifloxacin|besifloxacin|mesh-list
138236214|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
138236215|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138236216|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236217|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
138236218|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138236219|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138236220|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138236221|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236222|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236223|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138236224|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138236225|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138236226|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236227|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138236228|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236229|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236230|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138236231|NCT05448183|Gemcitabine|gemcitabine|mesh-list
138236232|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
138236233|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236234|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
138236235|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236236|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236237|NCT04732455|Lidocaine|lidocaine|mesh-list
138236238|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138236239|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
138236240|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
138236241|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236242|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236243|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
138236244|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236245|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138236246|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138236247|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138236248|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236249|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236250|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138236251|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138236252|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236253|NCT04732455|Analgesics|analgesics|mesh-ancestor
138236254|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
138236255|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236256|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
138236257|NCT04306965|Apremilast|apremilast|mesh-list
138236258|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138236259|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138236260|NCT04306965|Analgesics|analgesics|mesh-ancestor
138236261|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
138236262|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236263|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236264|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236265|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138236266|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138236267|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138236268|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236269|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236270|NCT02371746|Travoprost|travoprost|mesh-list
138236271|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138236272|NCT01431794|Paclitaxel|paclitaxel|mesh-list
138236273|NCT01431794|Gemcitabine|gemcitabine|mesh-list
138236274|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236275|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236276|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236277|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236278|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236279|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236280|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236281|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
138236282|NCT01497860|Vinorelbine|vinorelbine|mesh-list
138236283|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236284|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236285|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236286|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236287|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236288|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236289|NCT02213900|Haloperidol|haloperidol|mesh-list
138236290|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
138236291|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
138236292|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
138236293|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236294|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236295|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236296|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138236297|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138236298|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236299|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236300|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138236301|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
138236302|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236303|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236304|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138236305|NCT02370888|Lenalidomide|lenalidomide|mesh-list
138236306|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
138236307|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236308|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138236309|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138236310|NCT02370888|Growth Substances|growth substances|mesh-ancestor
138236311|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
138236312|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236315|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236316|NCT02214290|Caffeine|caffeine|mesh-list
138236317|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138236318|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236319|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138236320|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236321|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236322|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138236323|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138214784|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
138236325|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236326|NCT03160911|Hemostatics|hemostatics|mesh-list
138236327|NCT03160911|Coagulants|coagulants|mesh-ancestor
138236328|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
138236329|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236330|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236331|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138236332|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236333|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138236334|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
138236335|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236336|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138236337|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236338|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236339|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236340|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236341|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138236342|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138236344|NCT00369603|Galantamine|galantamine|mesh-list
138236345|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138236346|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236347|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236348|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138236349|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236350|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236351|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
138236352|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138236353|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
138236354|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236356|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138236357|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138236358|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138236359|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
138236360|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
138236361|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236362|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236363|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236364|NCT05227131|Capecitabine|capecitabine|mesh-list
138236365|NCT05227131|Tucatinib|tucatinib|mesh-list
138236366|NCT05227131|Margetuximab|margetuximab|mesh-list
138236367|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236368|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
138236369|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236370|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236371|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138236372|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236373|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
138236374|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
138236375|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138236376|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138236378|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236379|NCT01499498|Urological Agents|urological agents|mesh-ancestor
138236380|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138236381|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138236382|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236383|NCT02421588|Doxorubicin|doxorubicin|mesh-list
138236384|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138236385|NCT02421588|Topotecan|topotecan|mesh-list
138214797|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236388|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138236389|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236390|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236391|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236392|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138236393|NCT02768727|Xenon|xenon|mesh-list
138236394|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138236395|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
138236396|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
138236397|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236398|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236399|NCT02688309|Dexamethasone|dexamethasone|mesh-list
138236400|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236401|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
138236402|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
138236403|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236404|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236405|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236406|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
138236407|NCT02688309|Hormones|hormones|mesh-ancestor
138236408|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236409|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138236410|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236412|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236413|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236414|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138236415|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138236416|NCT00370851|Growth Substances|growth substances|mesh-ancestor
138236417|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236418|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
138236419|NCT05124171|Vaccines|vaccines|mesh-list
138236420|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
138236421|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236422|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
138236423|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236424|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236425|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138236426|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236427|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236428|NCT00371007|Incretins|incretins|mesh-ancestor
138236429|NCT00371007|Hormones|hormones|mesh-ancestor
138236430|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236431|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138236432|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
138236433|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236434|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414722|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414723|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236436|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138236437|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236438|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236439|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236440|NCT00552617|Rocuronium|rocuronium|mesh-list
138236441|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
138236442|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138236443|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138236444|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138236445|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236446|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236447|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138236448|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138236449|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
138236450|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236451|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236452|NCT02421120|Tazobactam|tazobactam|mesh-list
138236453|NCT02421120|Ceftolozane|ceftolozane|mesh-list
138236454|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138236455|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236456|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236457|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138236458|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236459|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236460|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138236461|NCT03022877|Simendan|simendan|mesh-list
138236462|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138236463|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
138236464|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138236465|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138236466|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236467|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236468|NCT03022877|Protective Agents|protective agents|mesh-ancestor
138236469|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236471|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138236472|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
138236473|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
138236474|NCT02420262|Liraglutide|liraglutide|mesh-list
138236475|NCT02420262|Xultophy|xultophy|mesh-list
138236476|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236477|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236478|NCT02420262|Incretins|incretins|mesh-ancestor
138236479|NCT02420262|Hormones|hormones|mesh-ancestor
138236480|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236481|NCT00369993|Fluticasone|fluticasone|mesh-list
138236482|NCT00369993|Xhance|xhance|mesh-list
138236483|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138236484|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236485|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138236486|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
138236487|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236488|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236489|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138236490|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
138236491|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236492|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138236494|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138236495|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138236496|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138236497|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236498|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236500|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
138236501|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138236502|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138236503|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236504|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236505|NCT04135989|Everolimus|everolimus|mesh-list
138236506|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138236507|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138236508|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236509|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236510|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138236511|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
138236512|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236513|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236514|NCT01854255|Cisplatin|cisplatin|mesh-list
138236515|NCT01854255|Doxorubicin|doxorubicin|mesh-list
138236516|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138236517|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236518|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138236519|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138236520|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236521|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236522|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236523|NCT01555281|Nelfinavir|nelfinavir|mesh-list
138236524|NCT01555281|Dexamethasone|dexamethasone|mesh-list
138236525|NCT01555281|Lenalidomide|lenalidomide|mesh-list
138236526|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236527|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
138236528|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
138236529|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236530|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236531|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236532|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
138236534|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236535|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138236536|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236537|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
138236538|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138236539|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138236540|NCT01555281|Growth Substances|growth substances|mesh-ancestor
138236541|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
138236542|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138236543|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138236544|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
138236545|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236546|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236547|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138236548|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138236549|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
138236550|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236551|NCT00370539|Triamcinolone|triamcinolone|mesh-list
138236552|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138236553|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138236554|NCT00370539|Bevacizumab|bevacizumab|mesh-list
138236555|NCT00370539|Verteporfin|verteporfin|mesh-list
138236556|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138236557|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214838|NCT02137382|Pancreatin|pancreatin|mesh-list
138236561|NCT00370539|Growth Substances|growth substances|mesh-ancestor
138236562|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236563|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
138236564|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236565|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
138236567|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236568|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138236569|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
138236570|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236571|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236572|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138236573|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236574|NCT03996057|Methenamine|methenamine|mesh-list
138236575|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
138236576|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
138236577|NCT03996057|Estrogens|estrogens|mesh-list
138236578|NCT03996057|Hormones|hormones|mesh-ancestor
138236579|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236580|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236581|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138236582|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236583|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236584|NCT03150875|Docetaxel|docetaxel|mesh-list
138236585|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236586|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236587|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236588|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236589|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236590|NCT00552071|Octreotide|octreotide|mesh-list
138236591|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236592|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138236593|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236594|NCT00673335|Letrozole|letrozole|mesh-list
138236595|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236596|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138236597|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138236598|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236599|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236600|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138236601|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138236602|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236603|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236604|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
138236605|NCT04880889|Thiamine|thiamine|mesh-list
138236606|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
138236607|NCT04880889|Vitamins|vitamins|mesh-ancestor
138236608|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
138236609|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236610|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
138236611|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236612|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236613|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138236614|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236618|NCT05511779|Brincidofovir|brincidofovir|mesh-list
138236619|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
138236620|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236621|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138236622|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138236623|NCT00551525|Analgesics|analgesics|mesh-ancestor
138236624|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
138236625|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236626|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236627|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138236628|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
138236629|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236630|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
138236631|NCT05454345|Rifampin|rifampin|mesh-list
138236632|NCT05454345|Isoniazid|isoniazid|mesh-list
138236633|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
138236634|NCT05454345|Ethambutol|ethambutol|mesh-list
138236635|NCT05454345|Rifapentine|rifapentine|mesh-list
138236636|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
138236637|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236638|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236639|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138236640|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236641|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236642|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236643|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236644|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138236645|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
138236646|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
138236647|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138236648|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138236649|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138236650|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138236651|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138236652|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138236653|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138236654|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138236655|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138236657|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138236658|NCT04459611|Paclitaxel|paclitaxel|mesh-list
138236659|NCT04459611|Carboplatin|carboplatin|mesh-list
138236660|NCT04459611|Pemetrexed|pemetrexed|mesh-list
138236661|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138236662|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236663|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236664|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236665|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236666|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236667|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236668|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214858|NCT00670982|Trastuzumab|trastuzumab|mesh-list
138236670|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138236672|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236673|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236674|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
138236675|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138236676|NCT01553708|Mitogens|mitogens|mesh-list
138236677|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236678|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236679|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236680|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236681|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138236682|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138236683|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
138236684|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138236685|NCT02370498|Paclitaxel|paclitaxel|mesh-list
138236686|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
138236687|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236688|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236689|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236690|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236691|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236692|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236693|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236694|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138236695|NCT01554488|Fluticasone|fluticasone|mesh-list
138236697|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138236698|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138236699|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
138236700|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236701|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236702|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138236703|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
138236704|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236705|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138236706|NCT02347332|Methotrexate|methotrexate|mesh-list
138236707|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138236708|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
138236709|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138236710|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236711|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138236712|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
138236713|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236714|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236715|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236716|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236717|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138236718|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138236719|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
138236720|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138236721|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138236722|NCT01502306|Nicotine|nicotine|mesh-list
138236723|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138236724|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
138236725|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236726|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236727|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138236728|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138236729|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
138236730|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236731|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236734|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
138236735|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236736|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236737|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236738|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236739|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236740|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138236741|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138236742|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362109|NCT01729260|Mebendazole|mebendazole|mesh-list
138236743|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
138236744|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
138236745|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138236746|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
138236747|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236748|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
138236749|NCT05451381|Propofol|propofol|mesh-list
138236750|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138236751|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236752|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236753|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138236755|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
138236756|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236757|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138236759|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138236760|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
138236761|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236762|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236763|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138236764|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
138236766|NCT05450913|Lidocaine|lidocaine|mesh-list
138236767|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
138236768|NCT05450913|Anesthetics|anesthetics|mesh-list
138236769|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236770|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236771|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
138236772|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236773|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138236774|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138236775|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138236776|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236777|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236778|NCT02215070|Pasireotide|pasireotide|mesh-list
138236779|NCT02215070|Hormones|hormones|mesh-ancestor
138236780|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236781|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236782|NCT04000737|Sorafenib|sorafenib|mesh-list
138236783|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236784|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138236785|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236786|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236787|NCT02347098|Atorvastatin|atorvastatin|mesh-list
138236788|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138236789|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138236790|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138236791|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
138236792|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236793|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138236797|NCT03708237|Analgesics|analgesics|mesh-ancestor
138236798|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
138236799|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236800|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236801|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
138236802|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138236803|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138236804|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236805|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236806|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138236807|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138236808|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236809|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236810|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
138236811|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138236812|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138236813|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
138236814|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
138236816|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138236817|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236818|NCT01556594|Hormones|hormones|mesh-ancestor
138236819|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236820|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236821|NCT01556594|Incretins|incretins|mesh-ancestor
138236822|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
138236823|NCT00371319|Tacrolimus|tacrolimus|mesh-list
138236824|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138236825|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
138236826|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236827|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138236828|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236829|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236830|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138236831|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236832|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138236833|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
138236834|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138236835|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236836|NCT01439672|Insulin|insulin|mesh-list
138236837|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236838|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236839|NCT01440764|Furosemide|furosemide|mesh-list
138236840|NCT01440764|Diuretics|diuretics|mesh-ancestor
138236841|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
138236842|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236843|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138236844|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236845|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236846|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138236847|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138236848|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236849|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236850|NCT05283837|Pertuzumab|pertuzumab|mesh-list
138236852|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236853|NCT02209610|Fentanyl|fentanyl|mesh-list
138236854|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138236855|NCT02209610|Narcotics|narcotics|mesh-ancestor
138236856|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236857|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236858|NCT02209610|Analgesics|analgesics|mesh-ancestor
138236859|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
138236860|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236861|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138236862|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138236863|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
138236864|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
138236865|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138236866|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138236867|NCT05244993|Paclitaxel|paclitaxel|mesh-list
138236868|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236869|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236870|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236871|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236872|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236873|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236874|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138236875|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138236876|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138236877|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236878|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236879|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236881|NCT01558700|Analgesics|analgesics|mesh-ancestor
138236882|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
138236883|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236884|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138236885|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138236886|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
138236887|NCT02757105|Ondansetron|ondansetron|mesh-list
138236888|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
138236889|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
138236890|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236891|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236892|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236893|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
138236894|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236895|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138236896|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138236897|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
138236898|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236899|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236900|NCT05083845|Anesthetics|anesthetics|mesh-list
138236901|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
138236902|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236903|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236904|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
138236905|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236907|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236908|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138236909|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138236910|NCT00371553|Growth Substances|growth substances|mesh-ancestor
138236911|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236912|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
138236914|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236915|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236917|NCT01507220|Bupivacaine|bupivacaine|mesh-list
138236921|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236923|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236924|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138236925|NCT01507220|Narcotics|narcotics|mesh-ancestor
138236926|NCT01507220|Analgesics|analgesics|mesh-ancestor
138236927|NCT01509404|Valganciclovir|valganciclovir|mesh-list
138236928|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
138236929|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236930|NCT01562132|Fluconazole|fluconazole|mesh-list
138236931|NCT01562132|Flucytosine|flucytosine|mesh-list
138236932|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
138236933|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236934|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138236935|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138236936|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236937|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236938|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138236939|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
138236940|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236941|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236942|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138236943|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138236945|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
138236946|NCT02762331|Vitamins|vitamins|mesh-ancestor
138236947|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
138236948|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236949|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
138236950|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236951|NCT02762331|Protective Agents|protective agents|mesh-ancestor
138236952|NCT02762799|Lenograstim|lenograstim|mesh-list
138236953|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138236954|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
138236955|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236956|NCT01447706|Paclitaxel|paclitaxel|mesh-list
138236957|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138236958|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236959|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138236960|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236961|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236962|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236963|NCT01509638|Bupivacaine|bupivacaine|mesh-list
138236964|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
138236965|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
138236966|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236967|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236968|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
138236969|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236970|NCT04336917|Lidocaine|lidocaine|mesh-list
138236971|NCT04336917|Bupivacaine|bupivacaine|mesh-list
138236972|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
138236973|NCT04336917|Anesthetics|anesthetics|mesh-list
138236974|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138236975|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236976|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
138236977|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138236978|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138236979|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138236980|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138236981|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414724|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
138236984|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138236985|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138236986|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
138236987|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236988|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138236989|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138236990|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236991|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236992|NCT01562678|Liraglutide|liraglutide|mesh-list
138236993|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138236994|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236995|NCT01562678|Incretins|incretins|mesh-ancestor
138236996|NCT01562678|Hormones|hormones|mesh-ancestor
138236997|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236998|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
138236999|NCT02767869|Antacids|antacids|mesh-ancestor
138237000|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237001|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237002|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138237004|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
138237005|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237006|NCT02767947|Luliconazole|luliconazole|mesh-list
138237007|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
138237008|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237009|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138237010|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138237011|NCT02770365|Estradiol|estradiol|mesh-list
138237012|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138237013|NCT02770365|Estrogens|estrogens|mesh-ancestor
138237014|NCT02770365|Hormones|hormones|mesh-ancestor
138237015|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237016|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237017|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138237018|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
138237019|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237020|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138237021|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
138237023|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138237024|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237025|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138237026|NCT02346240|Etanercept|etanercept|mesh-list
138237027|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
138237028|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138237029|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237030|NCT02346240|Analgesics|analgesics|mesh-ancestor
138237031|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
138237032|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237033|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237034|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237035|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237036|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237037|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138237038|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
138237039|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138362125|NCT01729806|Ipilimumab|ipilimumab|mesh-list
138237040|NCT01511978|Amifampridine|amifampridine|mesh-list
138237041|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138237042|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237043|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237045|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237046|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237048|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138237049|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138237050|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237051|NCT02774343|Pioglitazone|pioglitazone|mesh-list
138237052|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138237053|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237054|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138237055|NCT05349045|Antibodies|antibodies|mesh-list
138237056|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
138237057|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237058|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138237059|NCT05349045|Growth Substances|growth substances|mesh-ancestor
138237060|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
138237061|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237062|NCT02392104|Warfarin|warfarin|mesh-list
138237063|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
138237064|NCT04336605|Analgesics|analgesics|mesh-list
138237065|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
138237066|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237067|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237068|NCT01450826|Ondansetron|ondansetron|mesh-list
138237069|NCT01450826|Aprepitant|aprepitant|mesh-list
138237070|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
138237071|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
138237073|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237074|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237075|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
138237076|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
138237077|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138237078|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138237080|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237081|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237082|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138237083|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138237084|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
138237085|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237086|NCT05349903|Protective Agents|protective agents|mesh-ancestor
138237087|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237088|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138237089|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138237090|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237091|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138237092|NCT05349825|Losartan|losartan|mesh-list
138237093|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138237094|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362141|NCT01724658|Hormones|hormones|mesh-ancestor
138237095|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138237096|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138237097|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237098|NCT01451996|Loratadine|loratadine|mesh-list
138237099|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
138237100|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
138237102|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138237104|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
138237105|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
138237106|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237107|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237108|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237109|NCT01512446|Alendronate|alendronate|mesh-list
138237110|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138237111|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237112|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
138237113|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
138237114|NCT04334967|Vitamins|vitamins|mesh-ancestor
138237115|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
138237116|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237117|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
138237118|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138237119|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138237120|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237121|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237122|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237123|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237124|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
138237125|NCT04334967|Protective Agents|protective agents|mesh-ancestor
138237126|NCT04335123|Losartan|losartan|mesh-list
138237127|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138237128|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138237129|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138237130|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138237131|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237132|NCT02742987|Clopidogrel|clopidogrel|mesh-list
138237133|NCT02742987|Ticagrelor|ticagrelor|mesh-list
138237134|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138237135|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138237136|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138237137|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138237138|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
138237139|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237140|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237141|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237142|NCT05450055|Lidocaine|lidocaine|mesh-list
138237143|NCT05450055|Analgesics|analgesics|mesh-list
138237144|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
138237145|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
138237146|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237147|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237148|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
138362160|NCT01048944|Nicotine|nicotine|mesh-list
138237149|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237150|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138237151|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138237152|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138237153|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237154|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237156|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138237157|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237158|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138237159|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138237160|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237161|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237165|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237166|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237167|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
138237168|NCT00372099|Calcitonin|calcitonin|mesh-list
138237169|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
138237170|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138237171|NCT00372099|Katacalcin|katacalcin|mesh-list
138237172|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138237173|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237174|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138237175|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
138237176|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
138237177|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138237178|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237179|NCT01454414|Permethrin|permethrin|mesh-list
138237180|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237181|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237182|NCT04335513|Insulin|insulin|mesh-list
138237183|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138237184|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237185|NCT01568528|Oxytocin|oxytocin|mesh-list
138237186|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
138237187|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237188|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237189|NCT05013255|Pioglitazone|pioglitazone|mesh-list
138237190|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138237191|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237192|NCT01461668|Retapamulin|retapamulin|mesh-list
138237193|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237194|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237195|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
138237196|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
138237197|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237198|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138237199|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
138237201|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138362186|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237202|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138237203|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
138237204|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237205|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237206|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138237207|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138237208|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138237209|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138237210|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237211|NCT04080843|Capecitabine|capecitabine|mesh-list
138237212|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
138237213|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138237214|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
138237215|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237216|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237217|NCT04737837|Lacosamide|lacosamide|mesh-list
138237218|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
138237219|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138237220|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138237221|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237222|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237223|NCT05456763|Butyric Acid|butyric acid|mesh-list
138237224|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
138237225|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
138237229|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138237230|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138237232|NCT02369874|Tremelimumab|tremelimumab|mesh-list
138237233|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138237234|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237235|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237236|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
138237237|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237238|NCT00372645|Folic Acid|folic acid|mesh-list
138237239|NCT00372645|Hematinics|hematinics|mesh-ancestor
138237240|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
138237241|NCT00372645|Vitamins|vitamins|mesh-ancestor
138237242|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
138237243|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237244|NCT00372723|Infliximab|infliximab|mesh-list
138237245|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138237246|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237247|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
138237248|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237249|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237250|NCT00372801|Ibuprofen|ibuprofen|mesh-list
138237251|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138237252|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237253|NCT00372801|Analgesics|analgesics|mesh-ancestor
138237254|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
138237255|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237256|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237257|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237258|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237259|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138237260|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237261|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237263|NCT05455359|Prucalopride|prucalopride|mesh-list
138237264|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138237265|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237266|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138237267|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
138237268|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
138237269|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237270|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237271|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237272|NCT05455359|Laxatives|laxatives|mesh-ancestor
138237273|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138237274|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138237275|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
138237276|NCT00373503|Lofexidine|lofexidine|mesh-list
138237277|NCT00373503|Dronabinol|dronabinol|mesh-list
138237278|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
138237279|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237280|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237281|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237282|NCT00373503|Analgesics|analgesics|mesh-ancestor
138237283|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
138214956|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237284|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237285|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138237286|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138237287|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237290|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237291|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138237292|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138237293|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138237294|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138237296|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
138237298|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138237299|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237300|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
138237301|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237302|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138237303|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138237304|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
138237305|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237306|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138237307|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138237308|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
138237309|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
138237310|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237311|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237312|NCT01515566|Fentanyl|fentanyl|mesh-list
138237313|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138237314|NCT01515566|Narcotics|narcotics|mesh-ancestor
138237315|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237316|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237317|NCT01515566|Analgesics|analgesics|mesh-ancestor
138237318|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
138237319|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237320|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138237321|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138237322|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
138237323|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
138237324|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
138237325|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
138237326|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237327|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
138237328|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237329|NCT01516268|Sufentanil|sufentanil|mesh-list
138237330|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138237331|NCT01516268|Narcotics|narcotics|mesh-ancestor
138237332|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237333|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237334|NCT01516268|Analgesics|analgesics|mesh-ancestor
138237335|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
138237336|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237337|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138237338|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138237339|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
138237340|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
138237341|NCT05440968|Chrysarobin|chrysarobin|mesh-list
138237342|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138237343|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237344|NCT05440968|Analgesics|analgesics|mesh-ancestor
138237345|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
138237346|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237347|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237348|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237349|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237352|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
138237353|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237354|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237355|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237356|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138237357|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237358|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237359|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237360|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138237361|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
138237362|NCT02368314|Enoxaparin|enoxaparin|mesh-list
138237363|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
138237364|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
138237365|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138237366|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138237367|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237368|NCT01463384|Minocycline|minocycline|mesh-list
138237369|NCT01463384|Tetracycline|tetracycline|mesh-list
138237370|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237371|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237372|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138237373|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237374|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237375|NCT02785185|Clobetasol|clobetasol|mesh-list
138237376|NCT02785185|Halobetasol|halobetasol|mesh-list
138237377|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138237378|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237379|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
138237380|NCT02785185|Hormones|hormones|mesh-ancestor
138237381|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237382|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237383|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
138237384|NCT02787057|Vancomycin|vancomycin|mesh-list
138237385|NCT02787057|Ceftazidime|ceftazidime|mesh-list
138237386|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237387|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237388|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138237389|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138237391|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237392|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237393|NCT01468532|Prednisone|prednisone|mesh-list
138237394|NCT01468532|Docetaxel|docetaxel|mesh-list
138237395|NCT01468532|Pasireotide|pasireotide|mesh-list
138237396|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237397|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
138237398|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
138237399|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
138237400|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237401|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237402|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
138237403|NCT01468532|Hormones|hormones|mesh-ancestor
138237404|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237405|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237406|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138237407|NCT01469234|Loratadine|loratadine|mesh-list
138237408|NCT01469234|Fexofenadine|fexofenadine|mesh-list
138237409|NCT01469234|Terfenadine|terfenadine|mesh-list
138237410|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
138237411|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
138237412|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138237413|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138237414|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138237415|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
138237416|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
138237417|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237418|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237424|NCT06196021|Viscosupplements|viscosupplements|mesh-ancestor
138237425|NCT06196021|Protective Agents|protective agents|mesh-ancestor
138237426|NCT06195670|Capecitabine|capecitabine|mesh-list
138237427|NCT06195670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237428|NCT06195670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138237429|NCT06195670|Antimetabolites|antimetabolites|mesh-ancestor
138237430|NCT06195670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237431|NCT06195306|Tamoxifen|tamoxifen|mesh-list
138237432|NCT06195306|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138237433|NCT06195306|Hormone Antagonists|hormone antagonists|mesh-ancestor
138237434|NCT06195306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237435|NCT06195306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237436|NCT06195306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138237437|NCT06195306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237438|NCT06195306|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138237439|NCT06195306|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138237440|NCT06195306|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138237442|NCT06195267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138237443|NCT06195267|Protease Inhibitors|protease inhibitors|mesh-ancestor
138237444|NCT06195267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237445|NCT06195267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237446|NCT06195254|Antibodies|antibodies|mesh-list
138237447|NCT06195254|Antibodies, Blocking|antibodies, blocking|mesh-list
138237448|NCT06195254|Immunologic Factors|immunologic factors|mesh-ancestor
138237449|NCT06195254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237450|NCT06195137|Thioctic Acid|thioctic acid|mesh-list
138237451|NCT06195137|Caffeine|caffeine|mesh-list
138237452|NCT06195137|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138237453|NCT06195137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237454|NCT06195137|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138237455|NCT06195137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237456|NCT06195137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237457|NCT06195137|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138237458|NCT06195137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138237459|NCT06195137|Purinergic Agents|purinergic agents|mesh-ancestor
138237460|NCT06195137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237462|NCT06195137|Protective Agents|protective agents|mesh-ancestor
138237463|NCT06195137|Vitamin B Complex|vitamin b complex|mesh-ancestor
138237464|NCT06195137|Vitamins|vitamins|mesh-ancestor
138237465|NCT06195137|Micronutrients|micronutrients|mesh-ancestor
138237466|NCT06195111|Trifluridine|trifluridine|mesh-list
138237467|NCT06195111|Antimetabolites|antimetabolites|mesh-ancestor
138237468|NCT06195111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237469|NCT06195111|Antiviral Agents|antiviral agents|mesh-ancestor
138237470|NCT06195111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237471|NCT06194968|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138237472|NCT06194968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138237473|NCT06194968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138237517|NCT06194734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237518|NCT06194734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138237519|NCT06194734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138237520|NCT06194734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138237521|NCT06194734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237522|NCT06194734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138237523|NCT06194734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138214979|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138237528|NCT06194721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237529|NCT06194721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237530|NCT06194656|Cetuximab|cetuximab|mesh-list
138237531|NCT06194656|Antibodies|antibodies|mesh-list
138237532|NCT06194656|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138237533|NCT06194656|Immunologic Factors|immunologic factors|mesh-ancestor
138237534|NCT06194656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237535|NCT06194656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237536|NCT06194656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237538|NCT06194448|Paclitaxel|paclitaxel|mesh-list
138237539|NCT06194448|Carboplatin|carboplatin|mesh-list
138237540|NCT06194448|Pemetrexed|pemetrexed|mesh-list
138237541|NCT06194448|Osimertinib|osimertinib|mesh-list
138237542|NCT06194448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138237543|NCT06194448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237544|NCT06194448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138237545|NCT06194448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138237546|NCT06194448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138237547|NCT06194448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237548|NCT06194448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237549|NCT06194448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138237550|NCT06194448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138237551|NCT06194448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237552|NCT06194396|Chlorhexidine|chlorhexidine|mesh-list
138237553|NCT06194396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138237554|NCT06194396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237555|NCT06194396|Disinfectants|disinfectants|mesh-ancestor
138237556|NCT06194214|Digoxin|digoxin|mesh-list
138237557|NCT06194214|Pirtobrutinib|pirtobrutinib|mesh-list
138237558|NCT06194214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138237559|NCT06194214|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138237560|NCT06194214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237561|NCT06194214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237562|NCT06194214|Protective Agents|protective agents|mesh-ancestor
138237563|NCT06194214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237564|NCT06194214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237565|NCT06194201|Caspofungin|caspofungin|mesh-list
138237566|NCT06194201|Antifungal Agents|antifungal agents|mesh-ancestor
138237567|NCT06194201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237568|NCT06194201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237569|NCT06194201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237570|NCT06194058|Anesthetics|anesthetics|mesh-list
138237571|NCT06194058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237574|NCT06194032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237575|NCT06194032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237576|NCT06194032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138237577|NCT06194032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138237578|NCT06194032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237579|NCT06194032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237580|NCT06194032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237581|NCT06193993|Abiraterone Acetate|abiraterone acetate|mesh-list
138237582|NCT06193993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237583|NCT06193993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138237584|NCT06193993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237585|NCT06193993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237586|NCT06193993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138237587|NCT06193993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237588|NCT06193993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237589|NCT06193993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138237591|NCT06191640|Elexacaftor|elexacaftor|mesh-list
138237592|NCT06191640|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138237597|NCT06191497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237598|NCT06191497|Disinfectants|disinfectants|mesh-ancestor
138237599|NCT06191458|Primaquine|primaquine|mesh-list
138237600|NCT06191458|Antimalarials|antimalarials|mesh-ancestor
138237601|NCT06191458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138237602|NCT06191458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138237603|NCT06191458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237604|NCT06191289|Estradiol|estradiol|mesh-list
138237605|NCT06191289|Estrogens|estrogens|mesh-ancestor
138237606|NCT06191289|Hormones|hormones|mesh-ancestor
138237607|NCT06191289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237608|NCT06191289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237609|NCT06191250|Durvalumab|durvalumab|mesh-list
138237610|NCT06191250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237611|NCT06191250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237612|NCT06191133|Fenofibrate|fenofibrate|mesh-list
138237613|NCT06191133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138237614|NCT06191133|Antimetabolites|antimetabolites|mesh-ancestor
138237615|NCT06191133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237616|NCT06191133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138237617|NCT06191094|Faricimab|faricimab|mesh-list
138237618|NCT06191094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138237619|NCT06191094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138237620|NCT06191094|Growth Substances|growth substances|mesh-ancestor
138237622|NCT06191094|Growth Inhibitors|growth inhibitors|mesh-ancestor
138237623|NCT06191094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237624|NCT06190951|Pembrolizumab|pembrolizumab|mesh-list
138237625|NCT06190951|Cemiplimab|cemiplimab|mesh-list
138237626|NCT06190951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237627|NCT06190951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237628|NCT06190951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138237629|NCT06190951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237630|NCT06190912|Bryostatin 1|bryostatin 1|mesh-list
138237631|NCT06190912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138237632|NCT06190912|Immunologic Factors|immunologic factors|mesh-ancestor
138237633|NCT06190912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237634|NCT06190912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237635|NCT06190899|Gedatolisib|gedatolisib|mesh-list
138237636|NCT06190899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237637|NCT06190899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237638|NCT06190899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237639|NCT06190782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138237640|NCT06190782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237641|NCT06190782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237643|NCT06190691|Pirtobrutinib|pirtobrutinib|mesh-list
138237644|NCT06190691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237645|NCT06190691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237646|NCT06190691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237647|NCT06190678|Pirtobrutinib|pirtobrutinib|mesh-list
138237648|NCT06190678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237649|NCT06190678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237650|NCT06190678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237651|NCT06190652|Immunomodulating Agents|immunomodulating agents|mesh-list
138237652|NCT06190652|Immunologic Factors|immunologic factors|mesh-ancestor
138237653|NCT06190652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237658|NCT06190600|Pertuzumab|pertuzumab|mesh-list
138237659|NCT06190600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138237660|NCT06190600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237661|NCT06190600|Tubulin Modulators|tubulin modulators|mesh-ancestor
138237662|NCT06190600|Antimitotic Agents|antimitotic agents|mesh-ancestor
138237663|NCT06190600|Mitosis Modulators|mitosis modulators|mesh-ancestor
138237664|NCT06190600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237665|NCT06190600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138237666|NCT06190600|Immunologic Factors|immunologic factors|mesh-ancestor
138237668|NCT06190600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237669|NCT06190600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138237670|NCT06190600|Alkylating Agents|alkylating agents|mesh-ancestor
138237671|NCT06190600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138237672|NCT06190600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138237673|NCT06190600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138237674|NCT06190600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138237675|NCT06190600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237676|NCT06190600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237677|NCT06190535|Ethamsylate|ethamsylate|mesh-list
138237678|NCT06190535|Hemostatics|hemostatics|mesh-ancestor
138237679|NCT06190535|Coagulants|coagulants|mesh-ancestor
138237680|NCT06190483|Ascorbic Acid|ascorbic acid|mesh-list
138237682|NCT06190483|Antioxidants|antioxidants|mesh-ancestor
138237683|NCT06190483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237684|NCT06190483|Protective Agents|protective agents|mesh-ancestor
138237685|NCT06190483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237686|NCT06190483|Vitamins|vitamins|mesh-ancestor
138237687|NCT06190483|Micronutrients|micronutrients|mesh-ancestor
138237688|NCT06190483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138362256|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237689|NCT06190483|Anticonvulsants|anticonvulsants|mesh-ancestor
138237690|NCT06190483|Antiemetics|antiemetics|mesh-ancestor
138237691|NCT06190483|Autonomic Agents|autonomic agents|mesh-ancestor
138237692|NCT06190483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237693|NCT06190483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237694|NCT06190483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138237695|NCT06190483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237696|NCT06190483|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138237697|NCT06190483|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138237698|NCT06190483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138237700|NCT06190483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237701|NCT06190483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138237702|NCT06190483|Anesthetics, General|anesthetics, general|mesh-ancestor
138237704|NCT06190483|GABA Modulators|gaba modulators|mesh-ancestor
138237705|NCT06190483|GABA Agents|gaba agents|mesh-ancestor
138237706|NCT06190483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237707|NCT06190457|Rituximab|rituximab|mesh-list
138237708|NCT06190457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237709|NCT06190457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237710|NCT06190457|Immunologic Factors|immunologic factors|mesh-ancestor
138237711|NCT06190457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237712|NCT06190457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237713|NCT06190405|Chrysarobin|chrysarobin|mesh-list
138237714|NCT06190405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138237715|NCT06190405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237716|NCT06190405|Analgesics|analgesics|mesh-ancestor
138237717|NCT06190405|Sensory System Agents|sensory system agents|mesh-ancestor
138237718|NCT06190405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237719|NCT06190405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237720|NCT06190405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237721|NCT06190405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237734|NCT06190301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237735|NCT06190288|Imidacloprid|imidacloprid|mesh-list
138237736|NCT06190288|Cholinergic Agents|cholinergic agents|mesh-ancestor
138237737|NCT06190288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237738|NCT06190288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237739|NCT06190288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237742|NCT06190158|Dexamethasone|dexamethasone|mesh-list
138237743|NCT06190158|Captopril|captopril|mesh-list
138237744|NCT06190158|Cosyntropin|cosyntropin|mesh-list
138237745|NCT06190158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237747|NCT06190158|Autonomic Agents|autonomic agents|mesh-ancestor
138237755|NCT06190158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237756|NCT06190158|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138237757|NCT06190158|Protease Inhibitors|protease inhibitors|mesh-ancestor
138237758|NCT06190158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237759|NCT06190158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237760|NCT06190158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138237762|NCT06190145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138237763|NCT06190145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237764|NCT06190145|Analgesics|analgesics|mesh-ancestor
138237765|NCT06190145|Sensory System Agents|sensory system agents|mesh-ancestor
138237766|NCT06190145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237767|NCT06190145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237768|NCT06190145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237769|NCT06190145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237770|NCT06190145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138237771|NCT06190145|Immunologic Factors|immunologic factors|mesh-ancestor
138237773|NCT06190132|Analgesics|analgesics|mesh-ancestor
138237774|NCT06190132|Sensory System Agents|sensory system agents|mesh-ancestor
138237775|NCT06190132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237776|NCT06190132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237777|NCT06190132|Anticonvulsants|anticonvulsants|mesh-ancestor
138237778|NCT06190132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138237779|NCT06190132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237780|NCT06190132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237781|NCT06190132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237782|NCT06190132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138237783|NCT06190132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138237784|NCT06190132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237785|NCT06190132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237786|NCT06190132|Antimanic Agents|antimanic agents|mesh-ancestor
138237787|NCT06190106|Psychotropic Drugs|psychotropic drugs|mesh-list
138237803|NCT06189898|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138237804|NCT06189898|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138237805|NCT06189898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237806|NCT06189885|Vancomycin|vancomycin|mesh-list
138237807|NCT06189885|Cefazolin|cefazolin|mesh-list
138237808|NCT06189885|Daptomycin|daptomycin|mesh-list
138237809|NCT06189885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237810|NCT06189885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237811|NCT06189833|Dexamethasone|dexamethasone|mesh-list
138237812|NCT06189833|Lenalidomide|lenalidomide|mesh-list
138237813|NCT06189833|Bortezomib|bortezomib|mesh-list
138237814|NCT06189833|Daratumumab|daratumumab|mesh-list
138237815|NCT06189833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237816|NCT06189833|Antiemetics|antiemetics|mesh-ancestor
138237817|NCT06189833|Autonomic Agents|autonomic agents|mesh-ancestor
138237818|NCT06189833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237819|NCT06189833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237820|NCT06189833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237821|NCT06189833|Glucocorticoids|glucocorticoids|mesh-ancestor
138237822|NCT06189833|Hormones|hormones|mesh-ancestor
138237823|NCT06189833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237824|NCT06189833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138237825|NCT06189833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237826|NCT06189833|Immunologic Factors|immunologic factors|mesh-ancestor
138237827|NCT06189833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138237828|NCT06189833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138237829|NCT06189833|Growth Substances|growth substances|mesh-ancestor
138237830|NCT06189833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138237831|NCT06188260|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138237832|NCT06188260|Lubricant Eye Drops|lubricant eye drops|mesh-list
138237833|NCT06188260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138237835|NCT06188026|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138237836|NCT06188026|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138237837|NCT06188026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138237838|NCT06188026|Contraceptive Agents|contraceptive agents|mesh-ancestor
138237839|NCT06188026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237840|NCT06188026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237841|NCT06188026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138237842|NCT06188026|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138237843|NCT06188026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138237844|NCT06188026|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138237845|NCT06188026|Estrogens|estrogens|mesh-ancestor
138237846|NCT06188026|Hormones|hormones|mesh-ancestor
138237847|NCT06188026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237848|NCT06188026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138237849|NCT06187597|Tegafur|tegafur|mesh-list
138237850|NCT06187597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138237851|NCT06187597|Antimetabolites|antimetabolites|mesh-ancestor
138237852|NCT06187597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237853|NCT06187597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237854|NCT06187311|Rivaroxaban|rivaroxaban|mesh-list
138237855|NCT06187311|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138237856|NCT06187311|Antithrombins|antithrombins|mesh-ancestor
138237857|NCT06187311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138237858|NCT06187311|Protease Inhibitors|protease inhibitors|mesh-ancestor
138237859|NCT06187311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237860|NCT06187311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237861|NCT06187311|Anticoagulants|anticoagulants|mesh-ancestor
138237862|NCT06186622|Acetaminophen|acetaminophen|mesh-list
138237863|NCT06186622|Digoxin|digoxin|mesh-list
138237864|NCT06186622|Midazolam|midazolam|mesh-list
138237865|NCT06186622|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138237866|NCT06186622|Simvastatin|simvastatin|mesh-list
138237867|NCT06186622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138237868|NCT06186622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138237869|NCT06186622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237870|NCT06186622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237871|NCT06186622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138237872|NCT06186622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237873|NCT06186622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237874|NCT06186622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138237878|NCT06186622|GABA Agents|gaba agents|mesh-ancestor
138237879|NCT06186622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237880|NCT06186622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237881|NCT06186622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237882|NCT06186622|Analgesics|analgesics|mesh-ancestor
138237883|NCT06186622|Sensory System Agents|sensory system agents|mesh-ancestor
138237884|NCT06186622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237885|NCT06186622|Antipyretics|antipyretics|mesh-ancestor
138237886|NCT06186622|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138237887|NCT06186622|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138237888|NCT06186622|Antimetabolites|antimetabolites|mesh-ancestor
138237889|NCT06186622|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138237890|NCT06186622|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138237891|NCT06186622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237892|NCT06186622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138237893|NCT06186622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138237894|NCT06186622|Protective Agents|protective agents|mesh-ancestor
138237896|NCT06185985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138237897|NCT06185985|Antidepressive Agents|antidepressive agents|mesh-ancestor
138237898|NCT06185985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237899|NCT06185985|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138237900|NCT06185985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138237901|NCT06185985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237902|NCT06185985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237903|NCT06185985|Adrenergic Agents|adrenergic agents|mesh-ancestor
138237904|NCT06185985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237905|NCT06185985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237906|NCT06184581|Lamotrigine|lamotrigine|mesh-list
138237907|NCT06184581|Lithium Carbonate|lithium carbonate|mesh-list
138237908|NCT06184581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237909|NCT06184581|Antidepressive Agents|antidepressive agents|mesh-ancestor
138237910|NCT06184581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237911|NCT06184581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237912|NCT06184581|Antimanic Agents|antimanic agents|mesh-ancestor
138237913|NCT06184581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237914|NCT06184581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138237915|NCT06184581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237916|NCT06184581|Anticonvulsants|anticonvulsants|mesh-ancestor
138237917|NCT06184581|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138237918|NCT06184581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237919|NCT06184581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138237920|NCT06184581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138237921|NCT06184581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138237923|NCT06179160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237924|NCT06179160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237925|NCT06178640|Simvastatin|simvastatin|mesh-list
138237926|NCT06178640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138237927|NCT06178640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138237928|NCT06178640|Antimetabolites|antimetabolites|mesh-ancestor
138237929|NCT06178640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237930|NCT06178640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138237931|NCT06178640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138237932|NCT06178640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237933|NCT06173531|Carbetocin|carbetocin|mesh-list
138237934|NCT06173531|Oxytocics|oxytocics|mesh-ancestor
138237935|NCT06173531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237941|NCT06171178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237947|NCT06157827|Etoposide|etoposide|mesh-list
138237948|NCT06157827|Etoposide phosphate|etoposide phosphate|mesh-list
138237949|NCT06157827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237950|NCT06157827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138237951|NCT06157827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138237952|NCT06157827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138237953|NCT06157827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237954|NCT06157827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237955|NCT06149286|Rituximab|rituximab|mesh-list
138237956|NCT06149286|Lenalidomide|lenalidomide|mesh-list
138237957|NCT06149286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237958|NCT06149286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237959|NCT06149286|Immunologic Factors|immunologic factors|mesh-ancestor
138237960|NCT06149286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237961|NCT06149286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138237962|NCT06149286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138237963|NCT06149286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138237964|NCT06149286|Growth Substances|growth substances|mesh-ancestor
138237965|NCT06149286|Growth Inhibitors|growth inhibitors|mesh-ancestor
138237966|NCT06148090|Clobetasol|clobetasol|mesh-list
138237967|NCT06148090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237968|NCT06148090|Glucocorticoids|glucocorticoids|mesh-ancestor
138237969|NCT06148090|Hormones|hormones|mesh-ancestor
138237970|NCT06148090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237971|NCT06148090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237972|NCT06145373|Antithrombins|antithrombins|mesh-list
138237973|NCT06145373|Antithrombin III|antithrombin iii|mesh-list
138237974|NCT06145373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138237975|NCT06145373|Protease Inhibitors|protease inhibitors|mesh-ancestor
138237976|NCT06145373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237977|NCT06145373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237978|NCT06145373|Anticoagulants|anticoagulants|mesh-ancestor
138237979|NCT06143878|Deucravacitinib|deucravacitinib|mesh-list
138237980|NCT06143878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138237981|NCT06143878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237982|NCT06143878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237983|NCT06143878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237984|NCT06142552|Factor VIII|factor viii|mesh-list
138237985|NCT06142552|Coagulants|coagulants|mesh-ancestor
138237987|NCT06137469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138237988|NCT06137469|Analgesics|analgesics|mesh-ancestor
138237989|NCT06137469|Sensory System Agents|sensory system agents|mesh-ancestor
138237990|NCT06137469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237991|NCT06137469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237992|NCT06137469|Antipyretics|antipyretics|mesh-ancestor
138237993|NCT06136650|Dexamethasone|dexamethasone|mesh-list
138237994|NCT06136650|Prednisone|prednisone|mesh-list
138237995|NCT06136650|Hydrocortisone|hydrocortisone|mesh-list
138237996|NCT06136650|Fludrocortisone|fludrocortisone|mesh-list
138215031|NCT03007303|Risperidone|risperidone|mesh-list
138237997|NCT06136650|Abiraterone Acetate|abiraterone acetate|mesh-list
138237998|NCT06136650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237999|NCT06136650|Antiemetics|antiemetics|mesh-ancestor
138238000|NCT06136650|Autonomic Agents|autonomic agents|mesh-ancestor
138238011|NCT06136650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238013|NCT06136650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138238014|NCT06136507|Factor VIII|factor viii|mesh-list
138238015|NCT06136507|Coagulants|coagulants|mesh-ancestor
138238016|NCT06132685|Dexamethasone|dexamethasone|mesh-list
138238017|NCT06132685|Dexamethasone acetate|dexamethasone acetate|mesh-list
138238018|NCT06132685|Ichthammol|ichthammol|mesh-list
138238029|NCT06132685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238030|NCT06132685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238031|NCT06132685|Protease Inhibitors|protease inhibitors|mesh-ancestor
138238032|NCT06132685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238033|NCT06132685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238034|NCT06132685|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238054|NCT06120140|Chlorhexidine|chlorhexidine|mesh-list
138238055|NCT06120140|Doxycycline|doxycycline|mesh-list
138238056|NCT06120140|Minocycline|minocycline|mesh-list
138238057|NCT06120140|Clindamycin|clindamycin|mesh-list
138238058|NCT06120140|Clindamycin palmitate|clindamycin palmitate|mesh-list
138238059|NCT06120140|Clindamycin phosphate|clindamycin phosphate|mesh-list
138238060|NCT06120140|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138238061|NCT06120140|Lazertinib|lazertinib|mesh-list
138238062|NCT06120140|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138238063|NCT06120140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238064|NCT06120140|Disinfectants|disinfectants|mesh-ancestor
138238065|NCT06120140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238066|NCT06120140|Antimalarials|antimalarials|mesh-ancestor
138238067|NCT06120140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138238068|NCT06120140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138238069|NCT06120140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138238070|NCT06120140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238071|NCT06120140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238072|NCT06120140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138238073|NCT06120140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238076|NCT06113913|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138238077|NCT06113913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238078|NCT06113913|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238079|NCT06113913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238080|NCT06113913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238081|NCT06104449|Dexamethasone|dexamethasone|mesh-list
138238097|NCT06101134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238098|NCT06101134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238099|NCT06101134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138238100|NCT06101134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238101|NCT06100822|Metformin|metformin|mesh-list
138238102|NCT06100822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138238103|NCT06100822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238104|NCT06099639|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
138238105|NCT06099639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238106|NCT06099639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238118|NCT06096779|Bevacizumab|bevacizumab|mesh-list
138238119|NCT06096779|Atezolizumab|atezolizumab|mesh-list
138238120|NCT06096779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238121|NCT06096779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238123|NCT06096779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138238124|NCT06096779|Growth Substances|growth substances|mesh-ancestor
138238125|NCT06096779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238126|NCT06096779|Growth Inhibitors|growth inhibitors|mesh-ancestor
138238127|NCT06096779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138238128|NCT06096779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238130|NCT06094010|Antiviral Agents|antiviral agents|mesh-ancestor
138238131|NCT06094010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238132|NCT06094010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238133|NCT06094010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238134|NCT06084936|Rituximab|rituximab|mesh-list
138238135|NCT06084936|Obinutuzumab|obinutuzumab|mesh-list
138238136|NCT06084936|Lenalidomide|lenalidomide|mesh-list
138238137|NCT06084936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138238138|NCT06084936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238139|NCT06084936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238140|NCT06084936|Immunologic Factors|immunologic factors|mesh-ancestor
138238141|NCT06084936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238142|NCT06084936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238143|NCT06084936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138238144|NCT06084936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138238145|NCT06084936|Growth Substances|growth substances|mesh-ancestor
138238146|NCT06084936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138238147|NCT06084936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138238148|NCT06084936|Alkylating Agents|alkylating agents|mesh-ancestor
138238149|NCT06084936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238182|NCT06059495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238189|NCT06047171|Rituximab|rituximab|mesh-list
138238190|NCT06047171|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138238191|NCT06047171|Glucocorticoids|glucocorticoids|mesh-list
138238192|NCT06047171|Immunologic Factors|immunologic factors|mesh-ancestor
138238193|NCT06047171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238194|NCT06047171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238195|NCT06047171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138238196|NCT06047171|Alkylating Agents|alkylating agents|mesh-ancestor
138238197|NCT06047171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238198|NCT06047171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238199|NCT06047171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138238200|NCT06047171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238201|NCT06047171|Hormones|hormones|mesh-ancestor
138238202|NCT06047171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238203|NCT06047080|Prednisone|prednisone|mesh-list
138238204|NCT06047080|Cyclophosphamide|cyclophosphamide|mesh-list
138238205|NCT06047080|Rituximab|rituximab|mesh-list
138238206|NCT06047080|Doxorubicin|doxorubicin|mesh-list
138238207|NCT06047080|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138238208|NCT06047080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238209|NCT06047080|Immunologic Factors|immunologic factors|mesh-ancestor
138238210|NCT06047080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238211|NCT06047080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238212|NCT06047080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138238213|NCT06047080|Alkylating Agents|alkylating agents|mesh-ancestor
138238214|NCT06047080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238215|NCT06047080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238216|NCT06047080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138238217|NCT06047080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238218|NCT06047080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138238219|NCT06047080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138238220|NCT06047080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138238221|NCT06047080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238222|NCT06047080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238223|NCT06047080|Glucocorticoids|glucocorticoids|mesh-ancestor
138238224|NCT06047080|Hormones|hormones|mesh-ancestor
138238225|NCT06047080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238226|NCT06047080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238227|NCT06047080|Immunoconjugates|immunoconjugates|mesh-ancestor
138238228|NCT06044025|Metformin|metformin|mesh-list
138238229|NCT06044025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138238230|NCT06044025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238231|NCT06040099|Bevacizumab|bevacizumab|mesh-list
138238232|NCT06040099|Durvalumab|durvalumab|mesh-list
138238233|NCT06040099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238234|NCT06040099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238235|NCT06040099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138238236|NCT06040099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138238237|NCT06040099|Growth Substances|growth substances|mesh-ancestor
138238238|NCT06040099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238239|NCT06040099|Growth Inhibitors|growth inhibitors|mesh-ancestor
138238240|NCT06039020|Immunoglobulins|immunoglobulins|mesh-list
138238241|NCT06039020|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138238242|NCT06039020|Antibodies|antibodies|mesh-list
138238243|NCT06039020|Immunologic Factors|immunologic factors|mesh-ancestor
138238244|NCT06039020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238245|NCT06035874|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138238246|NCT06035874|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138238247|NCT06035874|Antimetabolites|antimetabolites|mesh-ancestor
138238248|NCT06035874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238249|NCT06035874|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138238250|NCT06035874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238251|NCT06035874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138238252|NCT06035874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362302|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238253|NCT06029998|Bortezomib|bortezomib|mesh-list
138238254|NCT06029998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238255|NCT06026852|Meropenem|meropenem|mesh-list
138238257|NCT06026852|Piperacillin|piperacillin|mesh-list
138238258|NCT06026852|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138238259|NCT06026852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238260|NCT06026852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238262|NCT06026852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238263|NCT06026852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238264|NCT06023576|Antihypertensive Agents|antihypertensive agents|mesh-list
138238266|NCT06023329|Anesthetics, Local|anesthetics, local|mesh-ancestor
138238267|NCT06023329|Anesthetics|anesthetics|mesh-ancestor
138238268|NCT06023329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238269|NCT06023329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238270|NCT06023329|Sensory System Agents|sensory system agents|mesh-ancestor
138238271|NCT06023329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238272|NCT06010329|Maleic acid|maleic acid|mesh-list
138238273|NCT06010329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238274|NCT06010329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238275|NCT06008860|Azelastine|azelastine|mesh-list
138238276|NCT06008860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138238277|NCT06008860|Autonomic Agents|autonomic agents|mesh-ancestor
138238278|NCT06008860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238279|NCT06008860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238280|NCT06008860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138238281|NCT06008860|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238282|NCT06008860|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138238284|NCT06008860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238285|NCT06008860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138238286|NCT06008860|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138238287|NCT06008860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138238288|NCT06008860|Histamine Antagonists|histamine antagonists|mesh-ancestor
138238289|NCT06008860|Histamine Agents|histamine agents|mesh-ancestor
138238290|NCT06008860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238291|NCT06008821|Epinephrine|epinephrine|mesh-list
138238292|NCT06008821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138238293|NCT06008821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138238294|NCT06008821|Adrenergic Agents|adrenergic agents|mesh-ancestor
138238295|NCT06008821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238296|NCT06008821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238297|NCT06008821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238298|NCT06008821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138238299|NCT06008821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138238300|NCT06008821|Autonomic Agents|autonomic agents|mesh-ancestor
138238301|NCT06008821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238302|NCT06008821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138238303|NCT06008821|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238304|NCT06008821|Mydriatics|mydriatics|mesh-ancestor
138238305|NCT06008821|Sympathomimetics|sympathomimetics|mesh-ancestor
138238306|NCT06008821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138238307|NCT06001658|Gemcitabine|gemcitabine|mesh-list
138238308|NCT06001658|Pembrolizumab|pembrolizumab|mesh-list
138238309|NCT06001658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238310|NCT06001658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238311|NCT06001658|Antimetabolites|antimetabolites|mesh-ancestor
138238312|NCT06001658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238313|NCT06001658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238314|NCT06001658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138238315|NCT05980559|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138238316|NCT05980559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138238317|NCT05980559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238318|NCT05980559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238319|NCT05980559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138238320|NCT05980559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238321|NCT05980559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238322|NCT05980559|Cholinergic Agents|cholinergic agents|mesh-ancestor
138238323|NCT05980559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238325|NCT05979415|Emetics|emetics|mesh-ancestor
138238326|NCT05979415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238327|NCT05979415|Autonomic Agents|autonomic agents|mesh-ancestor
138238328|NCT05979415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238329|NCT05979415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238330|NCT05979415|Dopamine Agonists|dopamine agonists|mesh-ancestor
138238331|NCT05979415|Dopamine Agents|dopamine agents|mesh-ancestor
138238332|NCT05979415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238333|NCT05979415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238334|NCT05950945|Trastuzumab|trastuzumab|mesh-list
138238335|NCT05950945|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138238336|NCT05950945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238338|NCT05950945|Immunoconjugates|immunoconjugates|mesh-ancestor
138238339|NCT05950945|Immunologic Factors|immunologic factors|mesh-ancestor
138238340|NCT05950945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238341|NCT05947760|Magnesium Sulfate|magnesium sulfate|mesh-list
138238342|NCT05947760|Analgesics|analgesics|mesh-ancestor
138238343|NCT05947760|Sensory System Agents|sensory system agents|mesh-ancestor
138238344|NCT05947760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238345|NCT05947760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238346|NCT05947760|Anesthetics|anesthetics|mesh-ancestor
138238347|NCT05947760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238348|NCT05947760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138238349|NCT05947760|Anticonvulsants|anticonvulsants|mesh-ancestor
138238350|NCT05947760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138238351|NCT05947760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238352|NCT05947760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238354|NCT05947760|Tocolytic Agents|tocolytic agents|mesh-ancestor
138238355|NCT05947760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238357|NCT05947448|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138238358|NCT05947448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238359|NCT05947448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138238360|NCT05947448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238361|NCT05947448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138238362|NCT05947448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238363|NCT05947448|Vasodilator Agents|vasodilator agents|mesh-ancestor
138238364|NCT05947448|Tocolytic Agents|tocolytic agents|mesh-ancestor
138238365|NCT05947448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238366|NCT05947448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138238367|NCT05947448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138238368|NCT05945927|Trastuzumab|trastuzumab|mesh-list
138238369|NCT05945927|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138238370|NCT05945927|Maytansine|maytansine|mesh-list
138238371|NCT05945927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238372|NCT05945927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238373|NCT05945927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138238374|NCT05945927|Tubulin Modulators|tubulin modulators|mesh-ancestor
138238375|NCT05945927|Antimitotic Agents|antimitotic agents|mesh-ancestor
138238376|NCT05945927|Mitosis Modulators|mitosis modulators|mesh-ancestor
138238377|NCT05945927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238378|NCT05945927|Immunotoxins|immunotoxins|mesh-ancestor
138238379|NCT05945927|Immunoconjugates|immunoconjugates|mesh-ancestor
138238380|NCT05945927|Immunologic Factors|immunologic factors|mesh-ancestor
138238381|NCT05945927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238382|NCT05941741|Cisplatin|cisplatin|mesh-list
138238383|NCT05941741|Gemcitabine|gemcitabine|mesh-list
138238384|NCT05941741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138238385|NCT05941741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238386|NCT05941741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238387|NCT05941741|Antimetabolites|antimetabolites|mesh-ancestor
138238388|NCT05941741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238389|NCT05941741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238390|NCT05941507|Antibodies|antibodies|mesh-list
138238391|NCT05941507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138238392|NCT05941507|Immunologic Factors|immunologic factors|mesh-ancestor
138238393|NCT05941507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238394|NCT05938608|Primaquine|primaquine|mesh-list
138362337|NCT03402048|Docetaxel|docetaxel|mesh-list
138238395|NCT05938608|Antimalarials|antimalarials|mesh-ancestor
138238396|NCT05938608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138238397|NCT05938608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138238398|NCT05938608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238399|NCT05934448|Cyclophosphamide|cyclophosphamide|mesh-list
138238401|NCT05934448|Fludarabine|fludarabine|mesh-list
138238402|NCT05934448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238403|NCT05934448|Immunologic Factors|immunologic factors|mesh-ancestor
138238404|NCT05934448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238405|NCT05934448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238406|NCT05934448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138238407|NCT05934448|Alkylating Agents|alkylating agents|mesh-ancestor
138238408|NCT05934448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238409|NCT05934448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238410|NCT05934448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138238411|NCT05934448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238412|NCT05934448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138238413|NCT05930197|Bismuth|bismuth|mesh-list
138238414|NCT05930197|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138238415|NCT05930197|Antacids|antacids|mesh-ancestor
138238416|NCT05930197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238417|NCT05930197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238418|NCT05930197|Antidiarrheals|antidiarrheals|mesh-ancestor
138238419|NCT05926804|Amoxicillin|amoxicillin|mesh-list
138238420|NCT05926804|Metronidazole|metronidazole|mesh-list
138238421|NCT05926804|Clarithromycin|clarithromycin|mesh-list
138238422|NCT05926804|Lansoprazole|lansoprazole|mesh-list
138238423|NCT05926804|Dexlansoprazole|dexlansoprazole|mesh-list
138238424|NCT05926804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238425|NCT05926804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238426|NCT05926804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138238427|NCT05926804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138238428|NCT05926804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138238429|NCT05926804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238430|NCT05926804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238431|NCT05926804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138238432|NCT05926804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138238433|NCT05926804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138238434|NCT05926804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238435|NCT05926804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138238436|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138238437|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
138238438|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
138238439|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238440|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138238441|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138238442|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138238443|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
138238444|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238445|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238446|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138238447|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138238448|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138238449|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138238450|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138238451|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138238452|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138238457|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138238458|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238459|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238460|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
138238461|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238462|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238463|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138238464|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138238465|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238466|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238467|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238468|NCT05889624|Amitriptyline|amitriptyline|mesh-list
138238469|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138238470|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
138238471|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138238472|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138238473|NCT05889624|Analgesics|analgesics|mesh-ancestor
138238474|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
138238475|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238476|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238477|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138238478|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138238479|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238480|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238481|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
138238482|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238483|NCT05883644|Durvalumab|durvalumab|mesh-list
138238484|NCT05883644|Tremelimumab|tremelimumab|mesh-list
138238485|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238486|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238487|NCT05867914|Nitric Oxide|nitric oxide|mesh-list
138238488|NCT05867914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138238489|NCT05867914|Autonomic Agents|autonomic agents|mesh-ancestor
138238490|NCT05867914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238491|NCT05867914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238492|NCT05867914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138238493|NCT05867914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238494|NCT05867914|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138238495|NCT05867914|Antioxidants|antioxidants|mesh-ancestor
138238496|NCT05867914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238497|NCT05867914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238498|NCT05867914|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138238499|NCT05867914|Vasodilator Agents|vasodilator agents|mesh-ancestor
138238500|NCT05867914|Gasotransmitters|gasotransmitters|mesh-ancestor
138238501|NCT05867914|Protective Agents|protective agents|mesh-ancestor
138238502|NCT05861336|Paclitaxel|paclitaxel|mesh-list
138238503|NCT05861336|Gemcitabine|gemcitabine|mesh-list
138238504|NCT05861336|Losartan|losartan|mesh-list
138238505|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138238506|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238507|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138238508|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138238509|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215078|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
138238514|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138238515|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138238516|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138238517|NCT05848687|Dexamethasone|dexamethasone|mesh-list
138238518|NCT05848687|Methotrexate|methotrexate|mesh-list
138238519|NCT05848687|Bortezomib|bortezomib|mesh-list
138238520|NCT05848687|Asparaginase|asparaginase|mesh-list
138238521|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
138238522|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
138238523|NCT05848687|Vorinostat|vorinostat|mesh-list
138238524|NCT05848687|Blinatumomab|blinatumomab|mesh-list
138238525|NCT05848687|Pegaspargase|pegaspargase|mesh-list
138238526|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238527|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
138238528|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
138238529|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238530|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238532|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
138238534|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238535|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238536|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238537|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138238538|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
138238539|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238540|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238541|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
138238542|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238543|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238544|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238545|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138238546|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238547|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
138238548|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238549|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138238550|NCT05848687|Analgesics|analgesics|mesh-ancestor
138238551|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
138238552|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138238553|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138238554|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138238555|NCT05844501|Ondansetron|ondansetron|mesh-list
138238556|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
138238557|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
138238558|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238559|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238560|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238561|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
138238562|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238563|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138238564|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138238565|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
138238566|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238567|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238569|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238570|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238571|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
138238572|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
138238573|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238574|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238575|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138238577|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238578|NCT05819619|Ibuprofen|ibuprofen|mesh-list
138238579|NCT05819619|Ondansetron|ondansetron|mesh-list
138238580|NCT05819619|Misoprostol|misoprostol|mesh-list
138238581|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138238582|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138238583|NCT05819619|Analgesics|analgesics|mesh-ancestor
138238584|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
138238585|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238586|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238587|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238588|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238589|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138238590|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238591|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238592|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138238593|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
138238594|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238595|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138238596|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238597|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
138238598|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
138238599|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
138238600|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
138238601|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238602|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138238603|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138238604|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
138238605|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238607|NCT05817851|Thiamine|thiamine|mesh-list
138238608|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
138238609|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238610|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
138238611|NCT05799105|Omeprazole|omeprazole|mesh-list
138238612|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138238614|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138238615|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238616|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238617|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
138238618|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238619|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
138238620|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238621|NCT05766501|Islatravir|islatravir|mesh-list
138238622|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
138238623|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238624|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238625|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238626|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138238627|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138238628|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138238629|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
138238630|NCT05766267|Rifampin|rifampin|mesh-list
138238631|NCT05766267|Isoniazid|isoniazid|mesh-list
138238632|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
138238633|NCT05766267|Ethambutol|ethambutol|mesh-list
138238634|NCT05766267|Rifabutin|rifabutin|mesh-list
138238635|NCT05766267|Bedaquiline|bedaquiline|mesh-list
138238636|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238637|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238638|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138238639|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138238641|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238642|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238643|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138238644|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
138238645|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
138238646|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138238647|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138238648|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138238649|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138238650|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138238651|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138238652|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138238653|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138238654|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138238655|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
138238656|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138238657|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
138238658|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138238659|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138238660|NCT05765266|Prednisolone|prednisolone|mesh-list
138238661|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
138238662|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138238663|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
138362382|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
138238664|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238665|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
138238666|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
138238667|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238668|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238669|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238670|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
138238672|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238673|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138238674|NCT05765266|Protective Agents|protective agents|mesh-ancestor
138238675|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238676|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238677|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138238678|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238679|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238680|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138238681|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
138238682|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
138238683|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
138238684|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238685|NCT05743244|Abrocitinib|abrocitinib|mesh-list
138238686|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138238687|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238688|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238689|NCT05735431|Fluticasone|fluticasone|mesh-list
138238690|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
138238691|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238692|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138238693|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
138238694|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238695|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238696|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138238697|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238698|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238699|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138238700|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138238701|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138238702|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138238703|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
138238704|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238705|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238707|NCT05730920|Bupivacaine|bupivacaine|mesh-list
138238708|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
138238709|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
138238710|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238711|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238712|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
138238713|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238714|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138238715|NCT05730920|Narcotics|narcotics|mesh-ancestor
138238716|NCT05730920|Analgesics|analgesics|mesh-ancestor
138238717|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
138238718|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238719|NCT05726916|Eculizumab|eculizumab|mesh-list
138238720|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138238721|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238722|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
138238723|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238724|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138238725|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138238726|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238727|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138238728|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138238729|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362398|NCT03400020|Protective Agents|protective agents|mesh-ancestor
138238730|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238731|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
138238732|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238733|NCT05703672|Varenicline|varenicline|mesh-list
138238734|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138238735|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138238736|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
138238737|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238738|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238739|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238740|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
138238741|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
138238742|NCT05699473|Calcium|calcium|mesh-list
138238743|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138238744|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238745|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138238747|NCT05699473|Vitamins|vitamins|mesh-ancestor
138238748|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
138238749|NCT05689671|Paclitaxel|paclitaxel|mesh-list
138238750|NCT05689671|Carboplatin|carboplatin|mesh-list
138238751|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
138238752|NCT05689671|Pemetrexed|pemetrexed|mesh-list
138238753|NCT05689671|Atezolizumab|atezolizumab|mesh-list
138238754|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138238755|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238756|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138238757|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138238758|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138238759|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238760|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238761|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138238762|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238763|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138238764|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138238765|NCT05688475|Dexamethasone|dexamethasone|mesh-list
138238766|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238767|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
138238768|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
138238769|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238770|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238771|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238772|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
138238773|NCT05688475|Hormones|hormones|mesh-ancestor
138238774|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238775|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238776|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238777|NCT05687123|Sunitinib|sunitinib|mesh-list
138238778|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138238779|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238780|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138238781|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138238782|NCT05687123|Growth Substances|growth substances|mesh-ancestor
138238783|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238784|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
138238785|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138238786|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238787|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238788|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138238789|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138238790|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138238791|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238792|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138238793|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138238794|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238795|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238796|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
138238797|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238798|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138238799|NCT05685277|Ramipril|ramipril|mesh-list
138238800|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138238801|NCT05685277|Diuretics|diuretics|mesh-ancestor
138238802|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
138238803|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238804|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138238805|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238806|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238807|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138238808|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
138238810|NCT05681299|Liraglutide|liraglutide|mesh-list
138238811|NCT05681299|Hormones|hormones|mesh-list
138238812|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238813|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238814|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138238815|NCT05681299|Incretins|incretins|mesh-ancestor
138238816|NCT05675813|Azacitidine|azacitidine|mesh-list
138238817|NCT05675813|Tislelizumab|tislelizumab|mesh-list
138238818|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238819|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
138238820|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238821|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238822|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238823|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238825|NCT05669482|Gemcitabine|gemcitabine|mesh-list
138238826|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138238827|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238828|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
138238829|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
138238830|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
138238831|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238832|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238833|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
138238834|NCT05664737|Luspatercept|luspatercept|mesh-list
138238835|NCT05664737|Hematinics|hematinics|mesh-ancestor
138238836|NCT05651711|KHK4083|khk4083|mesh-list
138238837|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238838|NCT05646862|Fulvestrant|fulvestrant|mesh-list
138238839|NCT05646862|Inavolisib|inavolisib|mesh-list
138238840|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238841|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238842|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138238843|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138238844|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
138238845|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238846|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238847|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138238848|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238849|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238851|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138238852|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238853|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238854|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
138238855|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238856|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138215598|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138238857|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238858|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138238859|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238860|NCT05639647|Aztreonam|aztreonam|mesh-list
138238861|NCT05639647|Avibactam|avibactam|mesh-list
138238862|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238863|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138238864|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138238865|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238866|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238867|NCT05627557|Acetaminophen|acetaminophen|mesh-list
138238868|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
138238869|NCT05627557|Promethazine|promethazine|mesh-list
138238870|NCT05627557|Prednisone|prednisone|mesh-list
138238871|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
138238872|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
138238873|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238874|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
138238876|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238877|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238878|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238880|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138238881|NCT05627557|Analgesics|analgesics|mesh-ancestor
138238882|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
138238883|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238884|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
138238885|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
138238886|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
138238887|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238888|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138238889|NCT05627557|Protective Agents|protective agents|mesh-ancestor
138238890|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238891|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138238892|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138238893|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238894|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
138238895|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
138238896|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138238897|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
138238898|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
138238899|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238900|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238901|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138238902|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
138238903|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238904|NCT05623020|Dexamethasone|dexamethasone|mesh-list
138238905|NCT05623020|Lenalidomide|lenalidomide|mesh-list
138238906|NCT05623020|Daratumumab|daratumumab|mesh-list
138238907|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238908|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
138238909|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
138238910|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238911|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238913|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
138238914|NCT05623020|Hormones|hormones|mesh-ancestor
138238915|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238916|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238917|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238919|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138238920|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138238921|NCT05623020|Growth Substances|growth substances|mesh-ancestor
138238922|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
138238923|NCT05613608|Cannabidiol|cannabidiol|mesh-list
138238924|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
138238925|NCT05610085|Levetiracetam|levetiracetam|mesh-list
138238926|NCT05610085|Phenobarbital|phenobarbital|mesh-list
138238927|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
138238928|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
138238929|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138238930|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138238931|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238932|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138238933|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138238934|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238935|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238936|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
138238937|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
138238938|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138238939|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138238940|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138238941|NCT05593575|Valsartan|valsartan|mesh-list
138238942|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138238943|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138238944|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138238945|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238946|NCT05592678|Donepezil|donepezil|mesh-list
138238947|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138238948|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238949|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238950|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
138238951|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238952|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238953|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
138238954|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
138238955|NCT05590221|Fludarabine|fludarabine|mesh-list
138238956|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138238957|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
138238958|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238959|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138238960|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138238961|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
138238962|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238963|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238964|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138238965|NCT05586802|Anastrozole|anastrozole|mesh-list
138238966|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138238967|NCT05586802|Testosterone|testosterone|mesh-list
138238968|NCT05586802|Androgens|androgens|mesh-ancestor
138238969|NCT05586802|Hormones|hormones|mesh-ancestor
138238970|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238971|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238972|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238973|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238974|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138238977|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238978|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138238979|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
138238980|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138238982|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138238983|NCT05583474|Latanoprost|latanoprost|mesh-list
138238984|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138238985|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138238986|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138238987|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
138238988|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238989|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238990|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238991|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138238992|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138238994|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
138238995|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238997|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238998|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
138238999|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138239000|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239001|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
138239002|NCT05570409|Prednisolone|prednisolone|mesh-list
138239003|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138239004|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
138239005|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138239006|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
138239007|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138239008|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
138239010|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239011|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138239012|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
138239013|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138239014|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239015|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239016|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239017|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239018|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
138239020|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239021|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239022|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138239023|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
138239024|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
138239025|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239026|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138239027|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138239028|NCT05570409|Protective Agents|protective agents|mesh-ancestor
138239029|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
138239030|NCT05562973|Psilocybin|psilocybin|mesh-list
138239031|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
138239032|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239033|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239034|NCT05561738|Niacinamide|niacinamide|mesh-list
138239035|NCT05561738|Niacin|niacin|mesh-list
138239036|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
138239037|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138239038|NCT05561738|Vitamins|vitamins|mesh-ancestor
138239039|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
138239040|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239041|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138239042|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
138239043|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239044|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138239045|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
138239046|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138239047|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
138239048|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239049|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239050|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138239051|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
138239052|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239053|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239054|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138239056|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138239057|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138239058|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138239059|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138239060|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239061|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239062|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239063|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138239064|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138239065|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
138239066|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239067|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239068|NCT05547542|Carfentanil|carfentanil|mesh-list
138239069|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138239070|NCT05547542|Narcotics|narcotics|mesh-ancestor
138239071|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239072|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239073|NCT05547542|Analgesics|analgesics|mesh-ancestor
138239074|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
138239075|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239076|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138239077|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
138239078|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239079|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138239080|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239081|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239082|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239083|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138239084|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138239085|NCT05523895|Pimavanserin|pimavanserin|mesh-list
138239086|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138239087|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138239088|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138239089|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138239090|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239091|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239092|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239093|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138239094|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138239095|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
138239096|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239097|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239098|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138239099|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239100|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239101|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239102|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
138239103|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138239105|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215142|NCT03376646|Paclitaxel|paclitaxel|mesh-list
138239128|NCT05494762|Tislelizumab|tislelizumab|mesh-list
138239129|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239130|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239131|NCT05492123|Cisplatin|cisplatin|mesh-list
138239132|NCT05492123|Nivolumab|nivolumab|mesh-list
138239133|NCT05492123|Ipilimumab|ipilimumab|mesh-list
138239134|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239135|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239136|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239137|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239138|NCT05461053|Lidocaine|lidocaine|mesh-list
138239139|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
138239140|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
138239141|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239142|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239143|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
138239144|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239145|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138239146|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138239147|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138239148|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138239149|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215151|NCT00676364|Anesthetics|anesthetics|mesh-list
138239177|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138239178|NCT05455697|Vincristine|vincristine|mesh-list
138239179|NCT05455697|Daunorubicin|daunorubicin|mesh-list
138239180|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
138239181|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138239182|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138239183|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
138239184|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239185|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239186|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138239187|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
138239188|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239189|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239190|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138239191|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239192|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138239193|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138239194|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138239195|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239196|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239198|NCT05455697|Hormones|hormones|mesh-ancestor
138239199|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239200|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138239201|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239202|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239204|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239205|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138239206|NCT05444543|Fluticasone|fluticasone|mesh-list
138239207|NCT05444543|Xhance|xhance|mesh-list
138239208|NCT05444543|Budesonide|budesonide|mesh-list
138239209|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239210|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138239211|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
138239212|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239213|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239214|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138239215|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
138239216|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239217|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138239218|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
138239219|NCT05444543|Hormones|hormones|mesh-ancestor
138239220|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239222|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
138239223|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138239224|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
138239225|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239226|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239227|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
138239228|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239229|NCT05418868|Cabotegravir|cabotegravir|mesh-list
138239230|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138239231|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138239232|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239233|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239234|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138239235|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138239236|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
138239237|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239238|NCT05417594|Trastuzumab|trastuzumab|mesh-list
138239239|NCT05417594|Temozolomide|temozolomide|mesh-list
138239241|NCT05417594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239242|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239243|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138239244|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
138239245|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239246|NCT05417594|Immunoconjugates|immunoconjugates|mesh-ancestor
138239247|NCT05417594|Immunologic Factors|immunologic factors|mesh-ancestor
138239248|NCT05417594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239249|NCT05413018|Azacitidine|azacitidine|mesh-list
138239250|NCT05413018|Cc-486|cc-486|mesh-list
138239251|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239252|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
138239253|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239254|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239255|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239256|NCT05406583|Dolutegravir|dolutegravir|mesh-list
138239257|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138239258|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138239259|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239260|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239261|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138239262|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138239263|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
138239264|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239265|NCT05382559|Cetuximab|cetuximab|mesh-list
138239266|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239267|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239268|NCT05377242|Curcumin|curcumin|mesh-list
138239269|NCT05377242|Resveratrol|resveratrol|mesh-list
138239270|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138239271|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138239272|NCT05377242|Analgesics|analgesics|mesh-ancestor
138239273|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
138239274|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239275|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239276|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239277|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239278|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239279|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239280|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239281|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
138239287|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138239288|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
138239289|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239297|NCT05359861|Atezolizumab|atezolizumab|mesh-list
138239298|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239299|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239300|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138239301|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239302|NCT05359861|Growth Substances|growth substances|mesh-ancestor
138239303|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239304|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239305|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239306|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239307|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
138239308|NCT05359211|Fludarabine|fludarabine|mesh-list
138239309|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138239310|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
138239311|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239312|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239313|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138239314|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
138239315|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239316|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239324|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138239325|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138239326|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138239327|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239328|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
138239329|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239330|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138239331|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138239332|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239333|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138239334|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
138239335|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
138239336|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239337|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138239338|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
138239339|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138239340|NCT05327699|Ketamine|ketamine|mesh-list
138239341|NCT05327699|Analgesics|analgesics|mesh-ancestor
138239342|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
138239343|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239344|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239345|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138239346|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138239347|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
138239348|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
138239349|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239350|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138239351|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138239352|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239353|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239354|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
138239355|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
138239356|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
138239357|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239358|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239359|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
138239360|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239361|NCT05298592|Paclitaxel|paclitaxel|mesh-list
138239362|NCT05298592|Carboplatin|carboplatin|mesh-list
138239363|NCT05298592|Nivolumab|nivolumab|mesh-list
138239364|NCT05298592|Pemetrexed|pemetrexed|mesh-list
138239365|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239366|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239367|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239368|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239369|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239370|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239371|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239372|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239373|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239374|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138239375|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239376|NCT05259566|Menthol|menthol|mesh-list
138239377|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
138239383|NCT05257824|Analgesics|analgesics|mesh-ancestor
138239385|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239386|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239387|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239390|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138239391|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239392|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138239393|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138239394|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239395|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
138239396|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138239397|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138239398|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138239399|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
138239400|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239401|NCT05255601|Nivolumab|nivolumab|mesh-list
138239402|NCT05255601|Relatlimab|relatlimab|mesh-list
138239403|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239404|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239405|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239406|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239407|NCT05251948|Capecitabine|capecitabine|mesh-list
138239408|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
138239409|NCT05251948|Atezolizumab|atezolizumab|mesh-list
138239410|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239411|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
138239412|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239413|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239414|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239415|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239417|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138239418|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138239419|NCT05248984|Analgesics|analgesics|mesh-ancestor
138239420|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
138239421|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239422|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239423|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239424|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239425|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138239426|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239427|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239428|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
138239429|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239430|NCT05221502|Bedaquiline|bedaquiline|mesh-list
138239431|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
138239432|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
138239433|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138239434|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239435|NCT05209152|Azacitidine|azacitidine|mesh-list
138239436|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239437|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
138239438|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239439|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239440|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239441|NCT05199311|Dexamethasone|dexamethasone|mesh-list
138239442|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239443|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
138239444|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
138239445|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239446|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239447|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138239448|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
138239449|NCT05199311|Hormones|hormones|mesh-ancestor
138239450|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239451|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215185|NCT00621686|Sorafenib|sorafenib|mesh-list
138239458|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138239459|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239460|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138239461|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
138239463|NCT05171686|Furosemide|furosemide|mesh-list
138239464|NCT05171686|Bumetanide|bumetanide|mesh-list
138239465|NCT05171686|Diuretics|diuretics|mesh-list
138239466|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138239467|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
138239468|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239469|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138239470|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138239471|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239472|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138239473|NCT05171647|Rituximab|rituximab|mesh-list
138239474|NCT05171647|Gemcitabine|gemcitabine|mesh-list
138239475|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
138239477|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239479|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
138239480|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239481|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239482|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239483|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
138239484|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239485|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
138239489|NCT05168202|Azacitidine|azacitidine|mesh-list
138239490|NCT05168202|Venetoclax|venetoclax|mesh-list
138239491|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239492|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
138239493|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239494|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239495|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239496|NCT05139420|Topiramate|topiramate|mesh-list
138239498|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
138239499|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138239500|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239501|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138239502|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
138239503|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138239504|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
138239505|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
138239506|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239507|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
138239508|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215599|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138239509|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239510|NCT05120349|Osimertinib|osimertinib|mesh-list
138239511|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239512|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239513|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239514|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239515|NCT05116202|Nivolumab|nivolumab|mesh-list
138239516|NCT05116202|Ipilimumab|ipilimumab|mesh-list
138239517|NCT05116202|Atezolizumab|atezolizumab|mesh-list
138239518|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239519|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239520|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239521|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239522|NCT05112965|Paclitaxel|paclitaxel|mesh-list
138239523|NCT05112965|Bevacizumab|bevacizumab|mesh-list
138239525|NCT05112965|Atezolizumab|atezolizumab|mesh-list
138239526|NCT05112965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239527|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239529|NCT05112965|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239530|NCT05112965|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239531|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239532|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239533|NCT05112965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138239534|NCT05112965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239535|NCT05112965|Growth Substances|growth substances|mesh-ancestor
138239536|NCT05112965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239537|NCT05112965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239538|NCT05112965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239539|NCT05112965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138239540|NCT05112965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239541|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239542|NCT05100017|Methocarbamol|methocarbamol|mesh-list
138239544|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
138239545|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
138239546|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239547|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239548|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138239549|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138239550|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
138239552|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239553|NCT05100017|Urological Agents|urological agents|mesh-ancestor
138239554|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138239555|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138239556|NCT05081492|Antibodies|antibodies|mesh-list
138239557|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
138239558|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
138239559|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239560|NCT05081102|Ibuprofen|ibuprofen|mesh-list
138239561|NCT05081102|Oxycodone|oxycodone|mesh-list
138239562|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138239563|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138239564|NCT05081102|Analgesics|analgesics|mesh-ancestor
138239565|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
138239566|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239567|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239568|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239569|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239570|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138239571|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239572|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239573|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138239574|NCT05081102|Narcotics|narcotics|mesh-ancestor
138239575|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239576|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
138239577|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239578|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239579|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239580|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239581|NCT05061550|Paclitaxel|paclitaxel|mesh-list
138239582|NCT05061550|Cisplatin|cisplatin|mesh-list
138239583|NCT05061550|Carboplatin|carboplatin|mesh-list
138239584|NCT05061550|Pemetrexed|pemetrexed|mesh-list
138239585|NCT05061550|Durvalumab|durvalumab|mesh-list
138239586|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239590|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239591|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239592|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239593|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138239594|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239595|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239596|NCT05057806|Empagliflozin|empagliflozin|mesh-list
138239597|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138414725|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239600|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239602|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138239603|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138239604|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
138239608|NCT05047250|Atezolizumab|atezolizumab|mesh-list
138239609|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239610|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239611|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239612|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239613|NCT05045443|Curcumin|curcumin|mesh-list
138239614|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138239616|NCT05045443|Analgesics|analgesics|mesh-ancestor
138239617|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
138239618|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239619|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239620|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239621|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239622|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239623|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239624|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239625|NCT05036408|Coal Tar|coal tar|mesh-list
138239626|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
138239627|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239628|NCT05032820|Lenalidomide|lenalidomide|mesh-list
138239629|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
138239630|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239631|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138239632|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239633|NCT05032820|Growth Substances|growth substances|mesh-ancestor
138239634|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239635|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239636|NCT05017012|Paclitaxel|paclitaxel|mesh-list
138239637|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138239638|NCT05017012|Carboplatin|carboplatin|mesh-list
138239639|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
138239640|NCT05017012|Pemetrexed|pemetrexed|mesh-list
138239641|NCT05017012|Axitinib|axitinib|mesh-list
138239642|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239643|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239644|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239645|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239646|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239647|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239648|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239649|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239650|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239651|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138239652|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138239653|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239654|NCT05011058|Valganciclovir|valganciclovir|mesh-list
138239655|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
138239656|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239658|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
138239659|NCT04963296|Promethazine|promethazine|mesh-list
138239660|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
138239661|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
138239662|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138239663|NCT04963296|Analgesics|analgesics|mesh-ancestor
138239664|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
138239667|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
138239668|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239669|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
138239670|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
138239671|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138239672|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
138239674|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239675|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138239676|NCT04963296|Protective Agents|protective agents|mesh-ancestor
138239677|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239678|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239679|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138239680|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138239681|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239682|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
138239683|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
138239684|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138239685|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
138239686|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
138239687|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239688|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239689|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138239690|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
138239691|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239692|NCT04961619|Trametinib|trametinib|mesh-list
138239693|NCT04961619|Dabrafenib|dabrafenib|mesh-list
138239694|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239695|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239696|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239697|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239698|NCT04932434|Psilocybin|psilocybin|mesh-list
138239699|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138239700|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
138239701|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239702|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239703|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138239704|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
138239706|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239708|NCT04931017|Metformin|metformin|mesh-list
138239709|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138239710|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239711|NCT04929223|Bevacizumab|bevacizumab|mesh-list
138239712|NCT04929223|Cetuximab|cetuximab|mesh-list
138239713|NCT04929223|Atezolizumab|atezolizumab|mesh-list
138239714|NCT04929223|Inavolisib|inavolisib|mesh-list
138239715|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239716|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239717|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138239718|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239719|NCT04929223|Growth Substances|growth substances|mesh-ancestor
138239720|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239721|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239722|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239723|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239724|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138239725|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239726|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
138239727|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
138239728|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239729|NCT04919564|Furosemide|furosemide|mesh-list
138239730|NCT04919564|Diuretics|diuretics|mesh-ancestor
138239731|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
138239735|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239736|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
138239737|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239738|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239739|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239740|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239741|NCT04908800|Itraconazole|itraconazole|mesh-list
138239742|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
138239743|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239744|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138239745|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138239746|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239747|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239748|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138239749|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
138239750|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239751|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239752|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138239753|NCT04902911|Antibodies|antibodies|mesh-list
138239754|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
138239755|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
138239756|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239757|NCT04902703|Molgramostim|molgramostim|mesh-list
138239758|NCT04902703|Sargramostim|sargramostim|mesh-list
138239759|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
138239760|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239761|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239762|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
138239763|NCT04894864|Anesthetics|anesthetics|mesh-list
138239764|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239765|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239766|NCT04894864|Narcotics|narcotics|mesh-ancestor
138239767|NCT04894864|Analgesics|analgesics|mesh-ancestor
138239768|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
138239769|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239776|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239777|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239778|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239780|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239781|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239782|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
138239783|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
138239784|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
138239785|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239787|NCT04868409|Succinylcholine|succinylcholine|mesh-list
138239788|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138239789|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138239790|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138239791|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239792|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362525|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
138239793|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138239794|NCT04857138|Atezolizumab|atezolizumab|mesh-list
138239795|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239796|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239797|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239798|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239799|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138239800|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138239801|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239806|NCT04831320|Paclitaxel|paclitaxel|mesh-list
138239808|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239809|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239810|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239811|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239812|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239813|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239815|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239817|NCT04793958|Adagrasib|adagrasib|mesh-list
138239818|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239819|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239820|NCT04792073|Avelumab|avelumab|mesh-list
138239821|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239822|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239823|NCT04791943|Melatonin|melatonin|mesh-list
138239824|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
138239825|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239826|NCT04791943|Protective Agents|protective agents|mesh-ancestor
138239827|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239828|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239829|NCT04776018|Daratumumab|daratumumab|mesh-list
138239830|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239831|NCT04770896|Sorafenib|sorafenib|mesh-list
138239832|NCT04770896|Atezolizumab|atezolizumab|mesh-list
138239833|NCT04770896|Lenvatinib|lenvatinib|mesh-list
138239834|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239835|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239836|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239837|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239838|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239839|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239840|NCT04763759|Antibodies|antibodies|mesh-list
138239841|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138239842|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
138239843|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239844|NCT04720768|Palbociclib|palbociclib|mesh-list
138239845|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239846|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239848|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239849|NCT04717414|Luspatercept|luspatercept|mesh-list
138239850|NCT04717414|Hematinics|hematinics|mesh-ancestor
138239851|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
138239852|NCT04678401|Thiotepa|thiotepa|mesh-list
138239853|NCT04678401|Fludarabine|fludarabine|mesh-list
138239854|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138239855|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
138239856|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239857|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239858|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138239859|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
138239860|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239861|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239862|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138239863|NCT04659044|Rituximab|rituximab|mesh-list
138239864|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138239865|NCT04659044|Venetoclax|venetoclax|mesh-list
138239866|NCT04659044|Antibodies|antibodies|mesh-list
138239867|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
138239868|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138239869|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
138239870|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138239871|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
138239872|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239873|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239874|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239875|NCT04657081|Decitabine|decitabine|mesh-list
138239876|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138239877|NCT04657081|Venetoclax|venetoclax|mesh-list
138239882|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239885|NCT04653246|Bortezomib|bortezomib|mesh-list
138239886|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239887|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
138239888|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
138239889|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239890|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239891|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138239892|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
138239894|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239895|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138239896|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239897|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
138239898|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138239899|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239900|NCT04653246|Growth Substances|growth substances|mesh-ancestor
138239901|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239902|NCT04640545|Axitinib|axitinib|mesh-list
138239903|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239904|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239905|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239906|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239907|NCT04629248|Acetaminophen|acetaminophen|mesh-list
138239908|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
138239909|NCT04629248|Promethazine|promethazine|mesh-list
138239910|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
138239911|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
138239912|NCT04629248|Tacrolimus|tacrolimus|mesh-list
138239913|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138239914|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
138239915|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239916|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138239917|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239918|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239919|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138239920|NCT04629248|Analgesics|analgesics|mesh-ancestor
138239921|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
138239922|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239923|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
138239924|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138239925|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
138239926|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
138239927|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138239928|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
138239929|NCT04629248|Hormones|hormones|mesh-ancestor
138239930|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239931|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138239932|NCT04629248|Protective Agents|protective agents|mesh-ancestor
138239933|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239934|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239935|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138239936|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138239937|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138239938|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
138239939|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
138239940|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138239941|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
138239942|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
138239943|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239944|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138239945|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
138239946|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239947|NCT04624230|Tofacitinib|tofacitinib|mesh-list
138239951|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239953|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
138239954|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239955|NCT04589845|Trastuzumab|trastuzumab|mesh-list
138239956|NCT04589845|Atezolizumab|atezolizumab|mesh-list
138239957|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138239958|NCT04589845|Maytansine|maytansine|mesh-list
138239959|NCT04589845|Ipatasertib|ipatasertib|mesh-list
138239960|NCT04589845|Pralsetinib|pralsetinib|mesh-list
138239961|NCT04589845|Entrectinib|entrectinib|mesh-list
138239962|NCT04589845|Inavolisib|inavolisib|mesh-list
138239963|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239964|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239965|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138239966|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239967|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138239968|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239969|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138239970|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138239971|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
138239972|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
138239973|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
138239974|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239975|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239976|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239977|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138239978|NCT04586660|Denosumab|denosumab|mesh-list
138239979|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138239980|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239981|NCT04563520|Coagulants|coagulants|mesh-list
138239982|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138239983|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
138239984|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138239985|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138239986|NCT04551144|Estradiol|estradiol|mesh-list
138239987|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138239988|NCT04551144|Testosterone|testosterone|mesh-list
138239989|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
138239990|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
138239991|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138239993|NCT04551144|Hormones|hormones|mesh-ancestor
138239994|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138239995|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239996|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138239997|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
138239998|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138239999|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138240001|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240002|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240004|NCT04546425|Vaccines|vaccines|mesh-list
138240005|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138240006|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
138240007|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240008|NCT04540705|Nivolumab|nivolumab|mesh-list
138240009|NCT04540705|Axitinib|axitinib|mesh-list
138240010|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215240|NCT02174822|Analgesics|analgesics|mesh-ancestor
138240011|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240012|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240013|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240014|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240016|NCT04534881|Progesterone|progesterone|mesh-list
138240017|NCT04534881|Progestins|progestins|mesh-ancestor
138240018|NCT04534881|Hormones|hormones|mesh-ancestor
138240019|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240020|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240022|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
138240023|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138240024|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240025|NCT04513522|Nivolumab|nivolumab|mesh-list
138240026|NCT04513522|Ipilimumab|ipilimumab|mesh-list
138240027|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240028|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240029|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240030|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240031|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
138240032|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138240033|NCT04509791|Antibodies|antibodies|mesh-list
138240034|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
138240035|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
138240036|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240037|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240043|NCT04449874|Bevacizumab|bevacizumab|mesh-list
138240044|NCT04449874|Cetuximab|cetuximab|mesh-list
138240045|NCT04449874|Atezolizumab|atezolizumab|mesh-list
138240046|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138240047|NCT04449874|Inavolisib|inavolisib|mesh-list
138240048|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240049|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240050|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240051|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240052|NCT04449874|Growth Substances|growth substances|mesh-ancestor
138240053|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240054|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240055|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240056|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240057|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240058|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240059|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138240060|NCT04439201|Palbociclib|palbociclib|mesh-list
138240061|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240062|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240063|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240064|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240066|NCT04429321|Ipilimumab|ipilimumab|mesh-list
138240067|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240068|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240069|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240070|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240071|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
138240072|NCT04425902|Metoprolol|metoprolol|mesh-list
138240073|NCT04425902|Digoxin|digoxin|mesh-list
138240074|NCT04425902|Midazolam|midazolam|mesh-list
138240075|NCT04425902|Caffeine|caffeine|mesh-list
138240076|NCT04425902|Omeprazole|omeprazole|mesh-list
138240077|NCT04425902|Pravastatin|pravastatin|mesh-list
138240078|NCT04425902|Montelukast|montelukast|mesh-list
138240079|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138240080|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138240081|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138240082|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240083|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138240084|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138240085|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138240091|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138240092|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240093|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138240094|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138240095|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240096|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138240097|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138240098|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
138240099|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138240100|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240101|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138240102|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138240103|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
138240104|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138240105|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
138240106|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240107|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138240108|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138240109|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138240110|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138240111|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
138240112|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
138240113|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240114|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138240115|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138240116|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138240118|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138240119|NCT04425902|Protective Agents|protective agents|mesh-ancestor
138240120|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138240121|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138240122|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
138240123|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138240124|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138240125|NCT04425902|Analgesics|analgesics|mesh-ancestor
138240126|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
138240127|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138240128|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240129|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240130|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240131|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138240132|NCT04413799|Lidocaine|lidocaine|mesh-list
138240133|NCT04413799|Ketamine|ketamine|mesh-list
138240134|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
138240135|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
138240136|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138240137|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240138|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
138240139|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240140|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138240141|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138240144|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240146|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138240147|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138240148|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
138240149|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138240150|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138240151|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138240152|NCT04410796|Carboplatin|carboplatin|mesh-list
138240153|NCT04410796|Pemetrexed|pemetrexed|mesh-list
138240154|NCT04410796|Osimertinib|osimertinib|mesh-list
138240155|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240156|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240157|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240158|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138240159|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138240160|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240161|NCT04407234|Acetaminophen|acetaminophen|mesh-list
138240162|NCT04407234|Tirzepatide|tirzepatide|mesh-list
138240163|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240164|NCT04407234|Analgesics|analgesics|mesh-ancestor
138240165|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
138240166|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240167|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240168|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
138240169|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138240170|NCT04407234|Incretins|incretins|mesh-ancestor
138240171|NCT04407234|Hormones|hormones|mesh-ancestor
138240172|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240173|NCT04380545|Interferons|interferons|mesh-list
138240174|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
138240175|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
138240176|NCT04380545|Fluorouracil|fluorouracil|mesh-list
138240177|NCT04380545|Nivolumab|nivolumab|mesh-list
138240178|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
138240179|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240180|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240181|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240182|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240183|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
138240184|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240185|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240186|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240188|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240189|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
138240190|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240191|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240192|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240194|NCT04372433|Azacitidine|azacitidine|mesh-list
138240195|NCT04372433|Venetoclax|venetoclax|mesh-list
138240196|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240197|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
138240198|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240199|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240203|NCT04349267|Nivolumab|nivolumab|mesh-list
138240204|NCT04349267|Cetuximab|cetuximab|mesh-list
138240205|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240206|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240207|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240208|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240210|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240211|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240212|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240213|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240214|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240215|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
138240216|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240217|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240218|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
138240219|NCT04336189|Piperaquine|piperaquine|mesh-list
138240220|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
138240221|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138240222|NCT04336189|Artenimol|artenimol|mesh-list
138240223|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
138240224|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138240225|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138240226|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240227|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138240228|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240229|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240230|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138240231|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
138240232|NCT04322643|Nivolumab|nivolumab|mesh-list
138240233|NCT04322643|Atezolizumab|atezolizumab|mesh-list
138240234|NCT04322643|Durvalumab|durvalumab|mesh-list
138240235|NCT04322643|Avelumab|avelumab|mesh-list
138240236|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240237|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240238|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240239|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240240|NCT04310540|Edetic Acid|edetic acid|mesh-list
138240241|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138240242|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
138240243|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
138240244|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240245|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
138240246|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138240248|NCT04270747|Aflibercept|aflibercept|mesh-list
138240249|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240250|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240251|NCT04270747|Growth Substances|growth substances|mesh-ancestor
138240252|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240253|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240254|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240255|NCT04269213|Cytarabine|cytarabine|mesh-list
138240256|NCT04269213|Daunorubicin|daunorubicin|mesh-list
138240257|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240258|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
138240259|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240260|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240261|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
138240262|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240263|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240264|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
138240265|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240266|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138240267|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138240272|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240273|NCT04236414|Olaparib|olaparib|mesh-list
138240274|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138240275|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240276|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240277|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240278|NCT04231877|Prednisone|prednisone|mesh-list
138240279|NCT04231877|Cortisone|cortisone|mesh-list
138240280|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
138240281|NCT04231877|Rituximab|rituximab|mesh-list
138240282|NCT04231877|Doxorubicin|doxorubicin|mesh-list
138240283|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138240284|NCT04231877|Etoposide|etoposide|mesh-list
138240285|NCT04231877|Daunorubicin|daunorubicin|mesh-list
138240286|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
138240287|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138240288|NCT04231877|Antibodies|antibodies|mesh-list
138240289|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
138240290|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138240291|NCT04231877|Lenograstim|lenograstim|mesh-list
138240292|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
138240293|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138240294|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240295|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
138240296|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240297|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240298|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138240299|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
138240300|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240301|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240302|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138240303|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138240304|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138240305|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138240306|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240307|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240308|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
138240309|NCT04231877|Hormones|hormones|mesh-ancestor
138240310|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240312|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138240313|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138240314|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
138240315|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138240316|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
138240317|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
138240318|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
138240319|NCT04224636|Bevacizumab|bevacizumab|mesh-list
138240320|NCT04224636|Atezolizumab|atezolizumab|mesh-list
138240321|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240322|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240323|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240324|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240325|NCT04224636|Growth Substances|growth substances|mesh-ancestor
138240326|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240327|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
138215292|NCT00653276|Ezetimibe|ezetimibe|mesh-list
138240328|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240329|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240330|NCT04191304|Benralizumab|benralizumab|mesh-list
138240331|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138240332|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138240333|NCT04126278|Dexamethasone|dexamethasone|mesh-list
138240334|NCT04126278|Cortisone|cortisone|mesh-list
138240335|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240336|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
138240337|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
138240338|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240339|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240340|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240341|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
138240342|NCT04126278|Hormones|hormones|mesh-ancestor
138240343|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240344|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240345|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240346|NCT04118010|Vitamin D|vitamin d|mesh-list
138240347|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
138240348|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
138240349|NCT04118010|Vitamins|vitamins|mesh-list
138240350|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
138240351|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240352|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138240353|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138240354|NCT04106557|Gaboxadol|gaboxadol|mesh-list
138240356|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
138240357|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240358|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240359|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
138240360|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
138240361|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
138240362|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138240363|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240366|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
138240367|NCT04094298|Hormones|hormones|mesh-ancestor
138240368|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240369|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240370|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240371|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
138240372|NCT04083950|Aspirin|aspirin|mesh-list
138240373|NCT04083950|Vaccines|vaccines|mesh-list
138240374|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
138240375|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240376|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138240377|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240378|NCT04083950|Analgesics|analgesics|mesh-ancestor
138240379|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
138240380|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240381|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240382|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240383|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138240384|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138240385|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240386|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138240387|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138240388|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240389|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
138240390|NCT04064359|Antibodies|antibodies|mesh-list
138240391|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
138240392|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
138240393|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240395|NCT04046887|Gemcitabine|gemcitabine|mesh-list
138240396|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138240397|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240398|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
138240399|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
138240400|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
138240401|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240402|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240403|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
138240405|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
138240406|NCT04045431|Protective Agents|protective agents|mesh-ancestor
138240407|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240408|NCT04036448|Lenalidomide|lenalidomide|mesh-list
138240409|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
138240410|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240411|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240412|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240413|NCT04036448|Growth Substances|growth substances|mesh-ancestor
138240414|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240415|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240416|NCT04030052|Factor VIII|factor viii|mesh-list
138240417|NCT04030052|Coagulants|coagulants|mesh-ancestor
138240418|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138240420|NCT04021043|Ipilimumab|ipilimumab|mesh-list
138240421|NCT04021043|Antibodies|antibodies|mesh-list
138240422|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
138240423|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138240424|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
138240425|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240426|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240427|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240428|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240429|NCT04015180|Aflibercept|aflibercept|mesh-list
138240431|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240432|NCT04015180|Growth Substances|growth substances|mesh-ancestor
138240433|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240434|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240435|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240436|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138240437|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138240438|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240439|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240440|NCT04007289|Apixaban|apixaban|mesh-list
138240441|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138240442|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
138240443|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138240444|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
138240445|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240446|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240447|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
138240448|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
138240449|NCT03984578|Capecitabine|capecitabine|mesh-list
138240450|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240451|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240452|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240453|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240454|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240455|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
138240457|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138240458|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138240459|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138240460|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138240461|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138240462|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138240463|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240464|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240466|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
138240467|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240468|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240469|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240470|NCT03944772|Carboplatin|carboplatin|mesh-list
138240472|NCT03944772|Pemetrexed|pemetrexed|mesh-list
138240473|NCT03944772|Durvalumab|durvalumab|mesh-list
138240474|NCT03944772|Gefitinib|gefitinib|mesh-list
138240475|NCT03944772|Osimertinib|osimertinib|mesh-list
138240476|NCT03944772|Necitumumab|necitumumab|mesh-list
138240477|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240478|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138240479|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138240480|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138240481|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240482|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240483|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138240484|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138240485|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240486|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240487|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138240488|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138240489|NCT03941730|Estradiol|estradiol|mesh-list
138240490|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138240491|NCT03941730|Estrogens|estrogens|mesh-ancestor
138240492|NCT03941730|Hormones|hormones|mesh-ancestor
138240493|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240494|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240495|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138240496|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
138240497|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138240498|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138240499|NCT03936218|Goserelin|goserelin|mesh-list
138240500|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240501|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240502|NCT03935451|Apixaban|apixaban|mesh-list
138240503|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138240504|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
138240505|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138240506|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
138240507|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362575|NCT02245464|Telmisartan|telmisartan|mesh-list
138240508|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240509|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
138240510|NCT03917459|Enalapril|enalapril|mesh-list
138240511|NCT03917459|Enalaprilat|enalaprilat|mesh-list
138240512|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138240513|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138240514|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
138240515|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240516|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240517|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138240518|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138240521|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138240522|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138240523|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138240524|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240525|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240526|NCT03904693|Urological Agents|urological agents|mesh-ancestor
138215321|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
138240529|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138240530|NCT03884998|Nivolumab|nivolumab|mesh-list
138240531|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240532|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240533|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240534|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240536|NCT03869190|Atezolizumab|atezolizumab|mesh-list
138240537|NCT03869190|Niraparib|niraparib|mesh-list
138240538|NCT03869190|Magrolimab|magrolimab|mesh-list
138240539|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138240540|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240541|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240542|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
138240543|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240544|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240545|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240546|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138240547|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240548|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
138240549|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
138240550|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240551|NCT03856658|Floxuridine|floxuridine|mesh-list
138240552|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240553|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
138240554|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240555|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240556|NCT03850418|Azacitidine|azacitidine|mesh-list
138240557|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240559|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240560|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240561|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240562|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
138240563|NCT03850366|Bortezomib|bortezomib|mesh-list
138240564|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240565|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
138240566|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240567|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240568|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138240569|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
138240570|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240571|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240572|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138240574|NCT03834883|Progesterone|progesterone|mesh-list
138240575|NCT03834883|Progestins|progestins|mesh-ancestor
138240576|NCT03834883|Hormones|hormones|mesh-ancestor
138240577|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240578|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240579|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138240581|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240582|NCT03754049|Dexamethasone|dexamethasone|mesh-list
138240583|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
138240584|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138240585|NCT03754049|BB 1101|bb 1101|mesh-list
138240586|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240587|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
138240588|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
138240589|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240590|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240591|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240592|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
138240593|NCT03754049|Hormones|hormones|mesh-ancestor
138240594|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240595|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240596|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240597|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
138240598|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240599|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240600|NCT03747939|Thalidomide|thalidomide|mesh-list
138240601|NCT03747939|Apremilast|apremilast|mesh-list
138240602|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138240603|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240604|NCT03747939|Analgesics|analgesics|mesh-ancestor
138240605|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
138240606|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240607|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240608|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240609|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240610|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138240611|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138240612|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240613|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240614|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240615|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
138240616|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
138240618|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240619|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240620|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240622|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240623|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240624|NCT03702725|Dexamethasone|dexamethasone|mesh-list
138240625|NCT03702725|Lenalidomide|lenalidomide|mesh-list
138240626|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240627|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
138240628|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
138240629|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240630|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240631|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240632|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
138240633|NCT03702725|Hormones|hormones|mesh-ancestor
138240634|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240635|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240636|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240637|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
138240638|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240639|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240640|NCT03702725|Growth Substances|growth substances|mesh-ancestor
138240641|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240642|NCT03671811|Megestrol|megestrol|mesh-list
138240643|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
138240644|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138240645|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138240648|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138240649|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240650|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138240651|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138240652|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240654|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
138240655|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138240656|NCT03656536|Gemcitabine|gemcitabine|mesh-list
138240657|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240658|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240659|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
138240660|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240662|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240663|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240664|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240665|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240666|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240667|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
138240668|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240669|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240670|NCT03652064|Dexamethasone|dexamethasone|mesh-list
138240671|NCT03652064|Lenalidomide|lenalidomide|mesh-list
138240672|NCT03652064|Bortezomib|bortezomib|mesh-list
138240673|NCT03652064|Daratumumab|daratumumab|mesh-list
138240674|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240675|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
138240676|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
138240677|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240678|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240679|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240680|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
138240681|NCT03652064|Hormones|hormones|mesh-ancestor
138240682|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240683|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240684|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240685|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
138240686|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240687|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240688|NCT03652064|Growth Substances|growth substances|mesh-ancestor
138240689|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240691|NCT03646617|Ipilimumab|ipilimumab|mesh-list
138240692|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240693|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240694|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240695|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240696|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138240697|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240698|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240699|NCT03624517|Octreotide|octreotide|mesh-list
138240700|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240701|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240702|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240703|NCT03592576|Venetoclax|venetoclax|mesh-list
138240704|NCT03592576|Navitoclax|navitoclax|mesh-list
138240705|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240706|NCT03590821|Aspirin|aspirin|mesh-list
138240707|NCT03590821|Celecoxib|celecoxib|mesh-list
138240708|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138240709|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240710|NCT03590821|Analgesics|analgesics|mesh-ancestor
138215356|NCT03006679|Meropenem|meropenem|mesh-list
138240711|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
138240712|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240713|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240714|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240715|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240716|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138240717|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138240718|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240719|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138240720|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138240721|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240722|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
138240723|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138240724|NCT03535727|Paclitaxel|paclitaxel|mesh-list
138240725|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138240727|NCT03535727|Gemcitabine|gemcitabine|mesh-list
138240728|NCT03535727|Capecitabine|capecitabine|mesh-list
138240729|NCT03535727|Irinotecan|irinotecan|mesh-list
138240730|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138240731|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240732|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138240733|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138240734|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138240735|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240736|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240737|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
138240738|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138240739|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138240740|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240741|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138240742|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240743|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240744|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240747|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138240748|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240749|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
138240750|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240751|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240752|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138240753|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
138240754|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240755|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240756|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138240757|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240759|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138240761|NCT03491540|Ornidazole|ornidazole|mesh-list
138240762|NCT03491540|Sennosides|sennosides|mesh-list
138240763|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138240764|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240765|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138240766|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240767|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240768|NCT03491540|Laxatives|laxatives|mesh-ancestor
138240769|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240770|NCT03491540|Amebicides|amebicides|mesh-ancestor
138240771|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138240772|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138240773|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138240774|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138240775|NCT03479268|Pevonedistat|pevonedistat|mesh-list
138240776|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240777|NCT03478514|Palbociclib|palbociclib|mesh-list
138240778|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240779|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240780|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240781|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240783|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240784|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240785|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240786|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240787|NCT03462719|Venetoclax|venetoclax|mesh-list
138240788|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
138240789|NCT03462719|Chlorambucil|chlorambucil|mesh-list
138240790|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240791|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240792|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138240793|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
138240794|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240795|NCT03431350|Prednisone|prednisone|mesh-list
138240796|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
138240797|NCT03431350|Niraparib|niraparib|mesh-list
138240798|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240799|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
138240800|NCT03431350|Hormones|hormones|mesh-ancestor
138240801|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240802|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240803|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240804|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240805|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138240806|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240807|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240808|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
138240809|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138240810|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138240811|NCT03341078|Ibudilast|ibudilast|mesh-list
138240812|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138240813|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
138240814|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240815|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240816|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138240817|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
138240818|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138240819|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240820|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240821|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138240823|NCT03337698|Linagliptin|linagliptin|mesh-list
138240824|NCT03337698|Bevacizumab|bevacizumab|mesh-list
138240825|NCT03337698|Atezolizumab|atezolizumab|mesh-list
138240826|NCT03337698|Carboplatin|carboplatin|mesh-list
138240827|NCT03337698|Gemcitabine|gemcitabine|mesh-list
138240828|NCT03337698|Docetaxel|docetaxel|mesh-list
138240829|NCT03337698|Pemetrexed|pemetrexed|mesh-list
138240830|NCT03337698|Ipatasertib|ipatasertib|mesh-list
138240831|NCT03337698|Evolocumab|evolocumab|mesh-list
138240832|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138240833|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240834|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240835|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138240836|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138240837|NCT03337698|Growth Substances|growth substances|mesh-ancestor
138240838|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240839|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138240840|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240841|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
138240842|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240843|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138240844|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138240845|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138240846|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240847|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138240848|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138240856|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138240857|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138240858|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138240859|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138240860|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138240861|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
138240862|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
138240863|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138240864|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
138240865|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240866|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240867|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240868|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240869|NCT03300427|Valsartan|valsartan|mesh-list
138240870|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138240871|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138240872|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138240873|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138240874|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240875|NCT03299049|Rilpivirine|rilpivirine|mesh-list
138240876|NCT03299049|Cabotegravir|cabotegravir|mesh-list
138240877|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138240878|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138240879|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240880|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240881|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
138240882|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240883|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138240884|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138240885|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138240886|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138240887|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138240889|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240890|NCT03247413|Dexamethasone|dexamethasone|mesh-list
138240891|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240892|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
138240893|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
138240894|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240895|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240896|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240897|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
138362580|NCT02246244|Escitalopram|escitalopram|mesh-list
138240898|NCT03247413|Hormones|hormones|mesh-ancestor
138240899|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240900|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240901|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240902|NCT03232073|Ponesimod|ponesimod|mesh-list
138240903|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138240904|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240905|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240906|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
138240907|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240908|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
138240909|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138240910|NCT03222531|Velpatasvir|velpatasvir|mesh-list
138240913|NCT03206203|Carboplatin|carboplatin|mesh-list
138240914|NCT03206203|Atezolizumab|atezolizumab|mesh-list
138240915|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240916|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240917|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240918|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138240919|NCT03201965|Dexamethasone|dexamethasone|mesh-list
138240920|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
138240921|NCT03201965|Bortezomib|bortezomib|mesh-list
138240922|NCT03201965|Daratumumab|daratumumab|mesh-list
138240923|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240924|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
138240925|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240926|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240927|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138240928|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
138240929|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240930|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240931|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138240932|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138240933|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
138240934|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
138240935|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240936|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138240937|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
138240938|NCT03201965|Hormones|hormones|mesh-ancestor
138240939|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240940|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138240941|NCT03188796|Vitamin D|vitamin d|mesh-list
138240942|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
138240943|NCT03188796|Vitamins|vitamins|mesh-ancestor
138240944|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
138240945|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240946|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138240947|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138240948|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138240949|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138240950|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240952|NCT03167905|Meperidine|meperidine|mesh-list
138240953|NCT03167905|Remifentanil|remifentanil|mesh-list
138240954|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
138240955|NCT03167905|Ropivacaine|ropivacaine|mesh-list
138240956|NCT03167905|Entonox|entonox|mesh-list
138240957|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
138240958|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
138240959|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138240960|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240961|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
138240962|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240963|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138240964|NCT03167905|Narcotics|narcotics|mesh-ancestor
138240965|NCT03167905|Analgesics|analgesics|mesh-ancestor
138240966|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138240967|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138240968|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
138240969|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138240970|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138240971|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138240972|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
138240973|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
138240974|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240975|NCT03161028|Protective Agents|protective agents|mesh-ancestor
138240977|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
138240978|NCT03161028|Vitamins|vitamins|mesh-ancestor
138240979|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
138240980|NCT03132129|Manganese|manganese|mesh-list
138240981|NCT03132129|Calcium|calcium|mesh-list
138240982|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138240983|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240984|NCT03132129|Trace Elements|trace elements|mesh-ancestor
138240985|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
138240986|NCT03128021|Milnacipran|milnacipran|mesh-list
138240987|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
138240988|NCT03128021|Escitalopram|escitalopram|mesh-list
138240989|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138240990|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138240991|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138240992|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240993|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138240994|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
138240995|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240996|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240997|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
138240998|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138240999|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138241000|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241001|NCT03128021|Analgesics|analgesics|mesh-ancestor
138241002|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
138241004|NCT03126214|Anticoagulants|anticoagulants|mesh-list
138241005|NCT03110107|Nivolumab|nivolumab|mesh-list
138241006|NCT03110107|Ipilimumab|ipilimumab|mesh-list
138241007|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241008|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241009|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241010|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241011|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
138241012|NCT03087136|Antibodies|antibodies|mesh-list
138241013|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
138241014|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241015|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138241016|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138241017|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241018|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
138241019|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241020|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
138241021|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138241022|NCT03087136|Protective Agents|protective agents|mesh-ancestor
138241024|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138241025|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
138241026|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
138241027|NCT03006172|Metformin|metformin|mesh-list
138241028|NCT03006172|Trastuzumab|trastuzumab|mesh-list
138241029|NCT03006172|Pertuzumab|pertuzumab|mesh-list
138241030|NCT03006172|Letrozole|letrozole|mesh-list
138241031|NCT03006172|Fulvestrant|fulvestrant|mesh-list
138241032|NCT03006172|Palbociclib|palbociclib|mesh-list
138241033|NCT03006172|Inavolisib|inavolisib|mesh-list
138241034|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241035|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241036|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241037|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241038|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138241039|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138241040|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241041|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241042|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138241043|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241045|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241046|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138241047|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138241048|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138362588|NCT02246712|Tramadol|tramadol|mesh-list
138241050|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138241051|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138241052|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241053|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138241055|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241056|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241057|NCT02913482|Risdiplam|risdiplam|mesh-list
138241058|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138241059|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241060|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241061|NCT02838420|Crizotinib|crizotinib|mesh-list
138241062|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241063|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138241064|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241065|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241066|NCT02759419|Riociguat|riociguat|mesh-list
138241067|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
138241068|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241069|NCT02757859|Pancrelipase|pancrelipase|mesh-list
138241070|NCT02757859|Pancreatin|pancreatin|mesh-list
138241071|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241072|NCT02719613|Dexamethasone|dexamethasone|mesh-list
138241073|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
138241074|NCT02719613|Nivolumab|nivolumab|mesh-list
138241075|NCT02719613|Lenalidomide|lenalidomide|mesh-list
138241076|NCT02719613|Bortezomib|bortezomib|mesh-list
138241077|NCT02719613|Pomalidomide|pomalidomide|mesh-list
138241078|NCT02719613|Elotuzumab|elotuzumab|mesh-list
138241079|NCT02719613|BB 1101|bb 1101|mesh-list
138241080|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241081|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
138241082|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
138241083|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241084|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241085|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241086|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
138241087|NCT02719613|Hormones|hormones|mesh-ancestor
138241088|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241089|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241090|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241091|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
138241092|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241093|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241094|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241095|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241096|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
138241097|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138241098|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138241099|NCT02719613|Growth Substances|growth substances|mesh-ancestor
138241100|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241101|NCT02696993|Nivolumab|nivolumab|mesh-list
138241102|NCT02696993|Ipilimumab|ipilimumab|mesh-list
138241103|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241104|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241105|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241106|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241107|NCT02635061|Nivolumab|nivolumab|mesh-list
138241108|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241109|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241175|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362597|NCT02246868|Coagulants|coagulants|mesh-ancestor
138362598|NCT02247258|Azathioprine|azathioprine|mesh-list
138362599|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
138241176|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241178|NCT02477826|Carboplatin|carboplatin|mesh-list
138241181|NCT02477826|Pemetrexed|pemetrexed|mesh-list
138241182|NCT02477826|Ipilimumab|ipilimumab|mesh-list
138241183|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241184|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241185|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241186|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241187|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241188|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241189|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138241190|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
138241191|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241192|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241193|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241194|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138241195|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241196|NCT02386774|Benoxinate|benoxinate|mesh-list
138241197|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138241198|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138241199|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
138241200|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
138241201|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241202|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241203|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
138241204|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241205|NCT02277444|Golimumab|golimumab|mesh-list
138241206|NCT02277444|Methotrexate|methotrexate|mesh-list
138241207|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138241208|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
138241209|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241210|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241211|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138241212|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
138241213|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241214|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241215|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241216|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241217|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138241218|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241219|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
138241220|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241221|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241222|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138241223|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241225|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
138241226|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241227|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
138241228|NCT02257736|Hormones|hormones|mesh-ancestor
138241229|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241230|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241231|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241232|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241233|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138241234|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241235|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241236|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241237|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138241238|NCT02252172|Dexamethasone|dexamethasone|mesh-list
138241239|NCT02252172|Lenalidomide|lenalidomide|mesh-list
138241240|NCT02252172|Daratumumab|daratumumab|mesh-list
138241241|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138414726|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241244|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
138241245|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241246|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241247|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241248|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
138241249|NCT02252172|Hormones|hormones|mesh-ancestor
138241250|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241251|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241252|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241253|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
138241254|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138241255|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138241256|NCT02252172|Growth Substances|growth substances|mesh-ancestor
138241257|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241258|NCT02195479|Dexamethasone|dexamethasone|mesh-list
138241259|NCT02195479|Prednisone|prednisone|mesh-list
138241260|NCT02195479|Melphalan|melphalan|mesh-list
138241261|NCT02195479|Bortezomib|bortezomib|mesh-list
138241262|NCT02195479|Daratumumab|daratumumab|mesh-list
138241263|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138241264|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241265|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
138241266|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
138241267|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241268|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241269|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241270|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
138241271|NCT02195479|Hormones|hormones|mesh-ancestor
138241272|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241273|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241274|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241275|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241276|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
138241277|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241278|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241279|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241280|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
138241282|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138241283|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138241284|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138241285|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138241286|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
138241287|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241288|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241289|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241290|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
138241292|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
138241293|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241294|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
138241295|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241296|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241297|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241298|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
138241299|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241300|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241301|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241302|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241303|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241304|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241305|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241306|NCT02076009|Dexamethasone|dexamethasone|mesh-list
138241307|NCT02076009|Lenalidomide|lenalidomide|mesh-list
138241308|NCT02076009|Daratumumab|daratumumab|mesh-list
138241309|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241311|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
138241312|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241313|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241314|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241315|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
138241317|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241318|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241319|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241320|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
138241321|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138241322|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138241323|NCT02076009|Growth Substances|growth substances|mesh-ancestor
138241324|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241325|NCT02069730|Androgens|androgens|mesh-list
138241326|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
138241327|NCT02069730|Hormones|hormones|mesh-ancestor
138241328|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241329|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241330|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241331|NCT02037048|Leucovorin|leucovorin|mesh-list
138241332|NCT02037048|Paclitaxel|paclitaxel|mesh-list
138241333|NCT02037048|Carboplatin|carboplatin|mesh-list
138241334|NCT02037048|Fluorouracil|fluorouracil|mesh-list
138241335|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
138241336|NCT02037048|Calcium|calcium|mesh-list
138241337|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
138241338|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241339|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241340|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241341|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241342|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241343|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241344|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138241345|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241346|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
138241347|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138241348|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241349|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
138241351|NCT02037048|Protective Agents|protective agents|mesh-ancestor
138241352|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
138241353|NCT02037048|Vitamins|vitamins|mesh-ancestor
138241354|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
138241355|NCT01979367|Analgesics|analgesics|mesh-list
138241356|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
138241357|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241358|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241359|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
138241360|NCT01804634|Melphalan|melphalan|mesh-list
138241361|NCT01804634|Fludarabine|fludarabine|mesh-list
138241362|NCT01804634|Tacrolimus|tacrolimus|mesh-list
138241363|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241364|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
138241365|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241366|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241367|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241368|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
138241369|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241370|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241371|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241372|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138241373|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241374|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
138241375|NCT01780844|Prednisone|prednisone|mesh-list
138241376|NCT01780844|Tacrolimus|tacrolimus|mesh-list
138241377|NCT01780844|Basiliximab|basiliximab|mesh-list
138241378|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241379|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
138241380|NCT01780844|Hormones|hormones|mesh-ancestor
138241381|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241382|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241383|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241384|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241385|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241386|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
138241387|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138241388|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241389|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241390|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138241391|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138241392|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
138241393|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138241394|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241396|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138241397|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241398|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241399|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
138241400|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241401|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241402|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241403|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
138241404|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241405|NCT01615029|Dexamethasone|dexamethasone|mesh-list
138241406|NCT01615029|Lenalidomide|lenalidomide|mesh-list
138241407|NCT01615029|Daratumumab|daratumumab|mesh-list
138241408|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138241409|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241410|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
138241411|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
138241412|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241413|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241414|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241415|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
138241416|NCT01615029|Hormones|hormones|mesh-ancestor
138241417|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241418|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241419|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241420|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
138241421|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138241422|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138241423|NCT01615029|Growth Substances|growth substances|mesh-ancestor
138241424|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241426|NCT01606878|Doxorubicin|doxorubicin|mesh-list
138241427|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138241428|NCT01606878|Vincristine|vincristine|mesh-list
138241429|NCT01606878|Topotecan|topotecan|mesh-list
138241430|NCT01606878|Crizotinib|crizotinib|mesh-list
138241431|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
138241432|NCT01606878|Razoxane|razoxane|mesh-list
138241433|NCT01606878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138241434|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241435|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
138241436|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241437|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241438|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241439|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
138241440|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241441|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241442|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241443|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138241444|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241445|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241446|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241447|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241448|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241449|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241450|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241451|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138241452|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138241453|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138241454|NCT01606878|Protective Agents|protective agents|mesh-ancestor
138241455|NCT01314118|Prednisone|prednisone|mesh-list
138241456|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
138241457|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241458|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
138241459|NCT01314118|Hormones|hormones|mesh-ancestor
138241460|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241461|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241462|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138241463|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241464|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138241465|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241466|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241467|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241468|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138241469|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
138241470|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138241471|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138241472|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241473|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138241474|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138241475|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
138241476|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138241477|NCT01175356|Vitamin A|vitamin a|mesh-list
138241478|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
138241479|NCT01175356|Melphalan|melphalan|mesh-list
138241480|NCT01175356|Busulfan|busulfan|mesh-list
138241481|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
138241482|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138241483|NCT01175356|Cisplatin|cisplatin|mesh-list
138241484|NCT01175356|Doxorubicin|doxorubicin|mesh-list
138241485|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138241486|NCT01175356|Etoposide|etoposide|mesh-list
138241487|NCT01175356|Vincristine|vincristine|mesh-list
138241489|NCT01175356|Tretinoin|tretinoin|mesh-list
138241490|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
138241491|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138241492|NCT01175356|Isotretinoin|isotretinoin|mesh-list
138241493|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241494|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
138241495|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241496|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241497|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241498|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
138241499|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241500|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241501|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241502|NCT01175356|Vitamins|vitamins|mesh-ancestor
138241503|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
138241504|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138241505|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241506|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241508|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241509|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241510|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241511|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241512|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138241513|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
138241514|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241515|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138241516|NCT01151605|Insulin|insulin|mesh-list
138241517|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138241518|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241519|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241520|NCT01064466|Etoposide|etoposide|mesh-list
138241522|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241523|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241524|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241525|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241526|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241527|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241528|NCT01005745|Aldesleukin|aldesleukin|mesh-list
138241529|NCT01005745|Interleukin-2|interleukin-2|mesh-list
138241530|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241531|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241532|NCT01005745|Analgesics|analgesics|mesh-ancestor
138241533|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
138241534|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241535|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241537|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138241538|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
138241539|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241540|NCT00980538|Etravirine|etravirine|mesh-list
138241541|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138241542|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241543|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241544|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241546|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241547|NCT00781612|Paclitaxel|paclitaxel|mesh-list
138241548|NCT00781612|Maytansine|maytansine|mesh-list
138241549|NCT00781612|Docetaxel|docetaxel|mesh-list
138241550|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138241551|NCT00781612|Trastuzumab|trastuzumab|mesh-list
138241552|NCT00781612|Atezolizumab|atezolizumab|mesh-list
138241553|NCT00781612|Pertuzumab|pertuzumab|mesh-list
138362621|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362623|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138362624|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362625|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138241554|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241555|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241556|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241557|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241558|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241559|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241560|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241561|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241562|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
138241565|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241566|NCT00676715|Interferons|interferons|mesh-list
138241567|NCT00676715|Interferon-beta|interferon-beta|mesh-list
138241568|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
138241569|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241570|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
138241571|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241572|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
138241573|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241574|NCT00335816|Leucovorin|leucovorin|mesh-list
138241575|NCT00335816|Fluorouracil|fluorouracil|mesh-list
138241576|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
138241577|NCT00335816|Calcium|calcium|mesh-list
138241578|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
138241579|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138241580|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241581|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
138241582|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241583|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138241584|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241585|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241586|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
138241587|NCT00335816|Antidotes|antidotes|mesh-ancestor
138241588|NCT00335816|Protective Agents|protective agents|mesh-ancestor
138241589|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
138241590|NCT00335816|Vitamins|vitamins|mesh-ancestor
138215456|NCT00684554|Buprenorphine|buprenorphine|mesh-list
138241594|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
138241595|NCT00295893|Carboplatin|carboplatin|mesh-list
138241596|NCT00295893|Doxorubicin|doxorubicin|mesh-list
138241597|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138241598|NCT00295893|Trastuzumab|trastuzumab|mesh-list
138241599|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138241600|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241601|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
138241602|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
138241603|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
138241604|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241605|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241606|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
138241607|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241608|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241609|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241610|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
138241611|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241612|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138241613|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241614|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241615|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241616|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241617|NCT05045937|Vitamin D|vitamin d|mesh-list
138241618|NCT05045937|Vitamins|vitamins|mesh-list
138241619|NCT05045937|Ivermectin|ivermectin|mesh-list
138241620|NCT05045937|Remdesivir|remdesivir|mesh-list
138241621|NCT05045937|Ibuprofen|ibuprofen|mesh-list
138241622|NCT05045937|Budesonide|budesonide|mesh-list
138241623|NCT05045937|Melatonin|melatonin|mesh-list
138241624|NCT05045937|Albuterol|albuterol|mesh-list
138241625|NCT05045937|Quercetin|quercetin|mesh-list
138241626|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241627|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
138241628|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138241629|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241630|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241631|NCT05045937|Analgesics|analgesics|mesh-ancestor
138241632|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
138241633|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241634|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241635|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215600|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138241636|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241637|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138241638|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241639|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138241640|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
138241641|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241642|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241643|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
138241644|NCT05045937|Hormones|hormones|mesh-ancestor
138241645|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241646|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
138241647|NCT05045937|Protective Agents|protective agents|mesh-ancestor
138241648|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241649|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
138241650|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241651|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138241652|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138241653|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138241654|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
138241655|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241656|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138241657|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241659|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
138241661|NCT00373581|Vigabatrin|vigabatrin|mesh-list
138241662|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
138241663|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
138241664|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241665|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241666|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
138241667|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241668|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138241669|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138241670|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138241671|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138241672|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241673|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
138241674|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241675|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
138241676|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241678|NCT01470170|Alfentanil|alfentanil|mesh-list
138241679|NCT01470170|Propofol|propofol|mesh-list
138241680|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138241681|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241682|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241683|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138241684|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
138241685|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
138241686|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138241687|NCT01470170|Narcotics|narcotics|mesh-ancestor
138241688|NCT01470170|Analgesics|analgesics|mesh-ancestor
138241689|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
138241690|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241691|NCT04311567|Methotrexate|methotrexate|mesh-list
138241692|NCT04311567|Tofacitinib|tofacitinib|mesh-list
138241693|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138241694|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
138241695|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241696|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241697|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138241698|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
138241699|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241700|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241701|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241702|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241703|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138241704|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241705|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
138241706|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241707|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241708|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138241709|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138241710|NCT04259775|Insulin|insulin|mesh-list
138241711|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241712|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241713|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138241714|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241715|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241716|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241717|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
138241718|NCT01573052|Gabapentin|gabapentin|mesh-list
138241719|NCT01573052|Analgesics|analgesics|mesh-ancestor
138241720|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
138241721|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241722|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241723|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
138241727|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138241728|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138241729|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138241730|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241731|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241732|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
138241733|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138241734|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138241735|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
138241737|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
138241738|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138241739|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241740|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
138241741|NCT01523834|Panobinostat|panobinostat|mesh-list
138241742|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241743|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138241744|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241745|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241746|NCT01472432|Vildagliptin|vildagliptin|mesh-list
138241747|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241748|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241749|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138241750|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
138241751|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241752|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241753|NCT01524302|Levofloxacin|levofloxacin|mesh-list
138241754|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138241755|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138241756|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241757|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138241758|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138241759|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241760|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241761|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241762|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241763|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138241764|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138241766|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138241767|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
138241768|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241769|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241770|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241771|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241772|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
138241773|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241774|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138241775|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138241776|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138241777|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
138241778|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241779|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241781|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
138241782|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241783|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241784|NCT01576952|Bromfenac|bromfenac|mesh-list
138241785|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241786|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241787|NCT01576952|Analgesics|analgesics|mesh-ancestor
138241788|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
138241791|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241792|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241793|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
138241794|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241795|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241796|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241797|NCT01577966|Analgesics|analgesics|mesh-ancestor
138241798|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
138241799|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241800|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241801|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241802|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241803|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241804|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138241805|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138241806|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241807|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241808|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241809|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
138241810|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241811|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138241812|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138241813|NCT02802501|Piperaquine|piperaquine|mesh-list
138241815|NCT02802501|Artenimol|artenimol|mesh-list
138241816|NCT02802501|Tafenoquine|tafenoquine|mesh-list
138241817|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
138241818|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138241819|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138241820|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241821|NCT01528592|Levodopa|levodopa|mesh-list
138241822|NCT01528592|Carbidopa|carbidopa|mesh-list
138241823|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138241824|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138241825|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138241826|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
138241827|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241828|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241829|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241830|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138241831|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241832|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138241833|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
138241834|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
138241837|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
138241838|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241839|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138241840|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
138241841|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241842|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241843|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241844|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241845|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241846|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138241848|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138241849|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138362626|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138362627|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362628|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
138362629|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
138362630|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138362631|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
138241850|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241851|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241852|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138241853|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138241854|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
138241855|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241856|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241858|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241859|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138241860|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241861|NCT00372879|Vitamin E|vitamin e|mesh-list
138241862|NCT00372879|Vitamins|vitamins|mesh-ancestor
138241863|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
138241864|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241865|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
138241866|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241867|NCT00372879|Protective Agents|protective agents|mesh-ancestor
138241868|NCT02806869|Ibuprofen|ibuprofen|mesh-list
138241869|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241870|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241872|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
138241873|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241874|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241875|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241876|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241877|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138241878|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241879|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241880|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
138241881|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138241882|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138241883|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241884|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138241885|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241886|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241887|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138241888|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138241889|NCT05564858|Antibodies|antibodies|mesh-list
138241890|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138241891|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
138241892|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
138241893|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241894|NCT02814279|Dipyrone|dipyrone|mesh-list
138241895|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
138241896|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138241897|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241898|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
138241899|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241900|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241901|NCT02814279|Analgesics|analgesics|mesh-ancestor
138241902|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
138241903|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241904|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241905|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241906|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241907|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
138241908|NCT00373659|Ranibizumab|ranibizumab|mesh-list
138241909|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138241910|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138241911|NCT00373659|Growth Substances|growth substances|mesh-ancestor
138241912|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241913|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241914|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241915|NCT02885025|Fluticasone|fluticasone|mesh-list
138241916|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241917|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138241918|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
138241919|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241920|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241921|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241922|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241923|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241924|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138241925|NCT01580618|Tenecteplase|tenecteplase|mesh-list
138241926|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138241927|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138241928|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241929|NCT01581710|Montelukast|montelukast|mesh-list
138241930|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241931|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241932|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138241933|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241934|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138241935|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241936|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138241937|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138241938|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241939|NCT01582490|Bupivacaine|bupivacaine|mesh-list
138241940|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
138241941|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
138241942|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241943|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241944|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
138241945|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241946|NCT01582880|Riboflavin|riboflavin|mesh-list
138241947|NCT01582880|Vitamins|vitamins|mesh-ancestor
138241948|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
138241949|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241950|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
138241951|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138241952|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138241953|NCT02889393|Teduglutide|teduglutide|mesh-list
138241954|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241955|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138241956|NCT02889393|Protective Agents|protective agents|mesh-ancestor
138241957|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241958|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
138241959|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138241960|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241961|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241962|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241963|NCT02818569|Analgesics|analgesics|mesh-ancestor
138241964|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
138241965|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241966|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138241967|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138241968|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138241969|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
138241970|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241971|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241972|NCT03581409|Aspirin|aspirin|mesh-list
138241973|NCT03581409|Cilostazol|cilostazol|mesh-list
138241974|NCT03581409|Clopidogrel|clopidogrel|mesh-list
138241975|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138241976|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138241981|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241982|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241983|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241984|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138241985|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138241986|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241987|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138241988|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138241989|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241990|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
138241991|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138241992|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138241993|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138241994|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
138241995|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138241996|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138241997|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
138241998|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138241999|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242000|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
138242001|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138242002|NCT03581409|Protective Agents|protective agents|mesh-ancestor
138242003|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138242004|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138242005|NCT01533116|Levodopa|levodopa|mesh-list
138242006|NCT01533116|Carbidopa|carbidopa|mesh-list
138242007|NCT01533116|Opicapone|opicapone|mesh-list
138242008|NCT01533116|Benserazide|benserazide|mesh-list
138242009|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138242010|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138242011|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
138242012|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242013|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242014|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242015|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138242016|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242017|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138242018|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
138242019|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
138242020|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138242021|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
138242030|NCT03510741|Antidotes|antidotes|mesh-ancestor
138242031|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
138242032|NCT05556044|Empagliflozin|empagliflozin|mesh-list
138242033|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138242034|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242035|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242036|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242038|NCT01584518|Diuretics|diuretics|mesh-ancestor
138242039|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
138242040|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242041|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138242042|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242043|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242044|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
138242045|NCT02901249|Sertraline|sertraline|mesh-list
138242046|NCT02901249|Nortriptyline|nortriptyline|mesh-list
138242047|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
138242048|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138242049|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138242050|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138242051|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242052|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242053|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242054|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
138242055|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242056|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242057|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
138242059|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242060|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138242061|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138242062|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
138242063|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138242064|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138242065|NCT00373815|Everolimus|everolimus|mesh-list
138242066|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138242067|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138242068|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242069|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242070|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242071|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
138242072|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242073|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242075|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138242076|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
138242077|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242078|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
138242079|NCT01586312|Protective Agents|protective agents|mesh-ancestor
138242080|NCT00373893|Lidocaine|lidocaine|mesh-list
138242081|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
138242082|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
138242083|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242084|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242085|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
138242086|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242087|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242088|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138242089|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138242090|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242091|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242092|NCT02977299|Aripiprazole|aripiprazole|mesh-list
138242093|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138242094|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
138242095|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138242096|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138242097|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138242098|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242099|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242100|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
138242101|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
138242102|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242103|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242104|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138242105|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138242107|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138242108|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138242109|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138242110|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138242111|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138242112|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138242113|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242114|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138242115|NCT02212106|Vaccines|vaccines|mesh-list
138242116|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
138242117|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242118|NCT02903121|Tamoxifen|tamoxifen|mesh-list
138242119|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138242120|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
138242121|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242122|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242123|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138242124|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242125|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138242126|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138242127|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138242129|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
138242131|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242132|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242133|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
138242134|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242135|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242136|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138242137|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138242138|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242139|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242140|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138242141|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138242142|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242143|NCT01535924|Gemcitabine|gemcitabine|mesh-list
138242144|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138242145|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242146|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
138242147|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242148|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242149|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138242150|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
138242151|NCT02909439|Neostigmine|neostigmine|mesh-list
138242152|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138242153|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242154|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242155|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242156|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242157|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242158|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138242159|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
138242160|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242161|NCT01536938|Calcitriol|calcitriol|mesh-list
138242162|NCT01536938|Betamethasone|betamethasone|mesh-list
138242163|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
138242164|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138242165|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
138242166|NCT01536938|Calcipotriene|calcipotriene|mesh-list
138242167|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138242168|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242169|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
138242170|NCT01536938|Hormones|hormones|mesh-ancestor
138242171|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242172|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242173|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138242174|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242175|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
138242176|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138242177|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138242178|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242179|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242180|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138242182|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
138242183|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138242184|NCT01588418|Exenatide|exenatide|mesh-list
138242185|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242186|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242187|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138242188|NCT01588418|Incretins|incretins|mesh-ancestor
138242189|NCT01588418|Hormones|hormones|mesh-ancestor
138242190|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242191|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
138242192|NCT03007160|Diuretics|diuretics|mesh-ancestor
138242193|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
138242194|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242195|NCT03007160|Expectorants|expectorants|mesh-ancestor
138242196|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242197|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138242198|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
138242199|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138242200|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138242201|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138242202|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215524|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138242204|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242205|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242206|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242207|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138242208|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242209|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138242211|NCT02914119|Mivacurium|mivacurium|mesh-list
138242212|NCT02914119|Cisatracurium|cisatracurium|mesh-list
138242213|NCT02914119|Succinylcholine|succinylcholine|mesh-list
138242214|NCT02914119|Neostigmine|neostigmine|mesh-list
138242215|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138242216|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138242217|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138242218|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242219|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242220|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138242221|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242222|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242223|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242224|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242225|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138242226|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
138242227|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138242228|NCT01589510|Bimatoprost|bimatoprost|mesh-list
138242229|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138242230|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138242231|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138242232|NCT02914509|Travoprost|travoprost|mesh-list
138242233|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138242234|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
138242235|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138242236|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138242237|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242238|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
138242239|NCT02840097|Coagulants|coagulants|mesh-ancestor
138242240|NCT02841033|Daratumumab|daratumumab|mesh-list
138242241|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242242|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138242243|NCT02988089|Amoxicillin|amoxicillin|mesh-list
138242244|NCT02988089|Metronidazole|metronidazole|mesh-list
138242245|NCT02988089|Clarithromycin|clarithromycin|mesh-list
138242246|NCT02988089|Levofloxacin|levofloxacin|mesh-list
138242248|NCT02988089|Tetracycline|tetracycline|mesh-list
138242249|NCT02988089|Tinidazole|tinidazole|mesh-list
138242250|NCT02988089|Furazolidone|furazolidone|mesh-list
138242251|NCT02988089|Bismuth|bismuth|mesh-list
138242252|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138242253|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242254|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138242255|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138242256|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138242257|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242258|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242259|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138242260|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138242261|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138242262|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138242263|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242264|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242265|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138242266|NCT02988089|Antacids|antacids|mesh-ancestor
138242267|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242268|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138242269|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138242270|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138242271|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
138242272|NCT02430233|Progesterone|progesterone|mesh-list
138242273|NCT02430233|Progestins|progestins|mesh-ancestor
138242274|NCT02430233|Hormones|hormones|mesh-ancestor
138242275|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242276|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242277|NCT01589978|Aspirin|aspirin|mesh-list
138242278|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
138242279|NCT01589978|Salicylates|salicylates|mesh-list
138242280|NCT01589978|Ticlopidine|ticlopidine|mesh-list
138242281|NCT01589978|Clopidogrel|clopidogrel|mesh-list
138242282|NCT01589978|Ticagrelor|ticagrelor|mesh-list
138242283|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138242284|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138242285|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138242287|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
138242288|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242289|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242290|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242291|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138242292|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138242293|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138242294|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242295|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138242296|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138242297|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242298|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
138242299|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138242300|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138242301|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138242302|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
138242303|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242304|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242305|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
138242306|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
138242307|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138242308|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138242309|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138242311|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138242312|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
138242313|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242314|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
138242315|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242316|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
138242317|NCT00551291|Prednisone|prednisone|mesh-list
138242318|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
138242319|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242320|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
138242322|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242323|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242324|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138242325|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242326|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138242327|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138242328|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
138242329|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138242330|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242331|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242332|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242333|NCT00551291|Hematinics|hematinics|mesh-ancestor
138242334|NCT02981264|Lidocaine|lidocaine|mesh-list
138242335|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
138242336|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
138242337|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242338|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242339|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
138242340|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242341|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242342|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138242343|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138242344|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242345|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242346|NCT01593722|Ivermectin|ivermectin|mesh-list
138242347|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
138242348|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138242349|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242350|NCT01593722|Filaricides|filaricides|mesh-ancestor
138242351|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
138242352|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
138242353|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138242354|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242355|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242356|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
138242357|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138242359|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
138242360|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138242361|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
138242362|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242363|NCT01595282|Ibuprofen|ibuprofen|mesh-list
138242364|NCT01595282|Ketorolac|ketorolac|mesh-list
138242365|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138242366|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138242367|NCT01595282|Analgesics|analgesics|mesh-ancestor
138242368|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
138242369|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242370|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242371|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242373|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138242374|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242375|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242376|NCT01595516|Metoprolol|metoprolol|mesh-list
138242377|NCT01595516|Nebivolol|nebivolol|mesh-list
138242378|NCT01595516|Bradykinin|bradykinin|mesh-list
138242379|NCT01595516|Kininogens|kininogens|mesh-list
138242380|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242381|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242382|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242383|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138242384|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
138242385|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
138242386|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242387|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138242388|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138242389|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138242390|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
138242391|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242392|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
138242393|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138242394|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138242395|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138242396|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138242397|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
138242398|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242399|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
138242400|NCT01596842|Vitamin D|vitamin d|mesh-list
138242401|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138242402|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242403|NCT01596842|Vitamins|vitamins|mesh-ancestor
138242404|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
138242405|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138242406|NCT02217800|Octreotide|octreotide|mesh-list
138242407|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242408|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138242409|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242410|NCT02218190|Alvimopan|alvimopan|mesh-list
138242411|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242412|NCT03006614|Cisplatin|cisplatin|mesh-list
138242413|NCT03006614|Gemcitabine|gemcitabine|mesh-list
138242416|NCT03006614|Trastuzumab|trastuzumab|mesh-list
138242417|NCT03006614|Vinorelbine|vinorelbine|mesh-list
138242418|NCT03006614|Epirubicin|epirubicin|mesh-list
138242419|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242420|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242421|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
138242422|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242423|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
138242424|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
138242425|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
138242426|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138242427|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138242428|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138242429|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138242430|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242431|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242432|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138242433|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138242434|NCT03006380|Oxytocin|oxytocin|mesh-list
138242435|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
138242436|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138242437|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242438|NCT02981030|Misoprostol|misoprostol|mesh-list
138242441|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
138242442|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138242443|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242444|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138242445|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242447|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138242448|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138242449|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138242450|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138242451|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
138242452|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138242453|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138242454|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
138242455|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242457|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138242458|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138242459|NCT03006146|Molgramostim|molgramostim|mesh-list
138242460|NCT03006146|Sargramostim|sargramostim|mesh-list
138242461|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
138242462|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242463|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242464|NCT00551213|Capecitabine|capecitabine|mesh-list
138242465|NCT00551213|Irinotecan|irinotecan|mesh-list
138242466|NCT00551213|Cetuximab|cetuximab|mesh-list
138242467|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242468|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
138242469|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242470|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242471|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138242472|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242473|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242474|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138242475|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
138242476|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138242477|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242478|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138242479|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
138242480|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138242481|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242482|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242483|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242485|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138242486|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242487|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242488|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242490|NCT03005678|Alendronate|alendronate|mesh-list
138242491|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138242492|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242493|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
138242494|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138242495|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
138242496|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242497|NCT03008889|Expectorants|expectorants|mesh-ancestor
138242498|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242499|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138242500|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
138242501|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242502|NCT03008889|Protective Agents|protective agents|mesh-ancestor
138242503|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242504|NCT03008889|Antidotes|antidotes|mesh-ancestor
138242507|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242509|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138242510|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242511|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242512|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138242513|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242514|NCT03010683|Metformin|metformin|mesh-list
138242515|NCT03010683|Liraglutide|liraglutide|mesh-list
138242516|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242517|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242518|NCT03010683|Incretins|incretins|mesh-ancestor
138242519|NCT03010683|Hormones|hormones|mesh-ancestor
138242520|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242521|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
138242522|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138242523|NCT02918097|Risperidone|risperidone|mesh-list
138242524|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
138242525|NCT02918097|Sertraline|sertraline|mesh-list
138242526|NCT02918097|Nortriptyline|nortriptyline|mesh-list
138242527|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138242528|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
138242529|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242530|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242531|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242532|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138242533|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138242534|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242535|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138242536|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138242537|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
138242538|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
138242539|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138242540|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138242541|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242542|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242543|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
138242544|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138242545|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138242546|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
138242547|NCT05408585|Anesthetics|anesthetics|mesh-list
138242548|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242549|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242550|NCT02999204|Vitamin D|vitamin d|mesh-list
138242551|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
138242552|NCT02999204|Vitamins|vitamins|mesh-ancestor
138242553|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
138242554|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242555|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138242556|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138242557|NCT03012477|Adavosertib|adavosertib|mesh-list
138242558|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242559|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242560|NCT02919111|Edetic Acid|edetic acid|mesh-list
138242561|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138242562|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
138242563|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
138242564|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242565|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
138242566|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138242567|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138242568|NCT02999126|Remifentanil|remifentanil|mesh-list
138242570|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138242571|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242572|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242574|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
138242575|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
138242576|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138242577|NCT02999126|Narcotics|narcotics|mesh-ancestor
138242578|NCT02999126|Analgesics|analgesics|mesh-ancestor
138242579|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
138242580|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242581|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
138242582|NCT03019887|Haloperidol|haloperidol|mesh-list
138242583|NCT03019887|Olanzapine|olanzapine|mesh-list
138242584|NCT03019887|Risperidone|risperidone|mesh-list
138242585|NCT03019887|Aripiprazole|aripiprazole|mesh-list
138242586|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138242587|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138242588|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
138242589|NCT03019887|Perphenazine|perphenazine|mesh-list
138242590|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138242591|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
138242592|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242593|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242594|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242595|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138242596|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138242597|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242598|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138242599|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138242600|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
138242601|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
138242602|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
138242603|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242604|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242605|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138242606|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138242608|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
138242609|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
138242610|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138242611|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138242612|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138242613|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138242614|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138242615|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138242616|NCT03019887|Analgesics|analgesics|mesh-ancestor
138242617|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
138242618|NCT02998970|Empagliflozin|empagliflozin|mesh-list
138242619|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138242620|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242621|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242622|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242623|NCT05406752|Acetaminophen|acetaminophen|mesh-list
138242624|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138242625|NCT05406752|Analgesics|analgesics|mesh-ancestor
138242626|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
138242627|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242628|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242629|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
138242630|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
138242632|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
138242633|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242634|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
138242635|NCT02247362|Coagulants|coagulants|mesh-ancestor
138242636|NCT02920749|Anesthetics|anesthetics|mesh-list
138242638|NCT02920749|Sevoflurane|sevoflurane|mesh-list
138242639|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242640|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242644|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138242645|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138242646|NCT02248142|Pramipexole|pramipexole|mesh-list
138242647|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
138242648|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242650|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242652|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138242653|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
138242654|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
138242655|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242656|NCT04667780|Colchicine|colchicine|mesh-list
138242657|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
138242658|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138242659|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
138242660|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
138242661|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138242662|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242663|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242664|NCT02248220|Pramipexole|pramipexole|mesh-list
138242665|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
138242666|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242667|NCT02248220|Protective Agents|protective agents|mesh-ancestor
138242668|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242669|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138242670|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138242671|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
138242672|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
138242673|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242674|NCT02921061|Cytarabine|cytarabine|mesh-list
138242675|NCT02921061|Decitabine|decitabine|mesh-list
138242676|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138242677|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
138242678|NCT02921061|Cladribine|cladribine|mesh-list
138242679|NCT02921061|Lenograstim|lenograstim|mesh-list
138242680|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242681|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
138242682|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242683|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242684|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
138242685|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242687|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
138242688|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242689|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138242690|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242691|NCT02921061|Analgesics|analgesics|mesh-ancestor
138242692|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
138242693|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242694|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138242695|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242696|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138242697|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138242698|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138242699|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138242700|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242701|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
138242702|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138242703|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242704|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
138242711|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138242712|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138242713|NCT02859441|Growth Substances|growth substances|mesh-ancestor
138242714|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242715|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
138242716|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242717|NCT01880099|Galantamine|galantamine|mesh-list
138242718|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
138242719|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242720|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242721|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242722|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242723|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242724|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138242725|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
138242726|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242727|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
138242728|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
138242729|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138242730|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
138242731|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
138242732|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242733|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242734|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138242735|NCT02860845|Clindamycin|clindamycin|mesh-list
138242736|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
138242737|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
138242738|NCT02860845|Clotrimazole|clotrimazole|mesh-list
138242739|NCT02860845|Miconazole|miconazole|mesh-list
138242740|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
138242741|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242742|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138242743|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242744|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242745|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138242746|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138242747|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138242748|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138242749|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
138242750|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242751|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242752|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138242753|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138242755|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138242756|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242757|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242758|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138242759|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
138242760|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
138242761|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
138242762|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242763|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242764|NCT01881113|Cetirizine|cetirizine|mesh-list
138242765|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138242766|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138242767|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138242768|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
138242769|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
138242770|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242771|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242772|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242773|NCT05140694|Empagliflozin|empagliflozin|mesh-list
138242774|NCT05140694|Dulaglutide|dulaglutide|mesh-list
138242775|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138242776|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138242777|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215614|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
138242780|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
138242781|NCT02987699|Leucovorin|leucovorin|mesh-list
138242782|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
138242783|NCT02987699|Fluorouracil|fluorouracil|mesh-list
138242784|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
138242785|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242786|NCT02987699|Antidotes|antidotes|mesh-ancestor
138242787|NCT02987699|Protective Agents|protective agents|mesh-ancestor
138242788|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242789|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
138242790|NCT02987699|Vitamins|vitamins|mesh-ancestor
138242791|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
138242792|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
138242793|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242794|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242795|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242796|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
138242797|NCT03003728|Melphalan|melphalan|mesh-list
138242798|NCT03003728|Elotuzumab|elotuzumab|mesh-list
138242799|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138242800|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
138242801|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242802|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242803|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138242804|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242805|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
138242806|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242807|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
138242808|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138242809|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138242810|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242812|NCT05672810|Coagulants|coagulants|mesh-ancestor
138242813|NCT00559247|Asunaprevir|asunaprevir|mesh-list
138242814|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
138242815|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242816|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242817|NCT03003416|Dexamethasone|dexamethasone|mesh-list
138242818|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242819|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
138242820|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
138242821|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242822|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242823|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242824|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
138242825|NCT03003416|Hormones|hormones|mesh-ancestor
138242826|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242827|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138242828|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242829|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
138242830|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
138242831|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138242832|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
138242833|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242834|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242835|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138242836|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242837|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138242838|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138242839|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138242840|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
138242841|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242842|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242844|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138242845|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242846|NCT03028467|Folic Acid|folic acid|mesh-list
138242847|NCT03028467|Methotrexate|methotrexate|mesh-list
138242848|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138242849|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
138242850|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138242851|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242852|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362659|NCT02248428|Hormones|hormones|mesh-ancestor
138362660|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362661|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138362663|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362664|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138242853|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
138242854|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242855|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242856|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
138242857|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242858|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138242859|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242860|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
138242861|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138242862|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138242863|NCT03028467|Hematinics|hematinics|mesh-ancestor
138242864|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
138242865|NCT03028467|Vitamins|vitamins|mesh-ancestor
138242866|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
138242867|NCT02222870|Vaccines|vaccines|mesh-list
138242868|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
138242869|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242870|NCT02223260|Dabigatran|dabigatran|mesh-list
138242871|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
138242872|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138242873|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
138242874|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242875|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242876|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
138242877|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
138242879|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
138242880|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
138242881|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138242882|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242883|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
138242884|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138242885|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242886|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138242887|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242888|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242889|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242890|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242891|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138242892|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138242893|NCT01887587|Dexamethasone|dexamethasone|mesh-list
138242894|NCT01887587|Doxorubicin|doxorubicin|mesh-list
138242895|NCT01887587|Vincristine|vincristine|mesh-list
138242897|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242898|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
138242899|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
138242900|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242901|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242902|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138242903|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
138242904|NCT01887587|Hormones|hormones|mesh-ancestor
138242905|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242906|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138242907|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242908|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215629|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242909|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138242910|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138242911|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242912|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242913|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138242914|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138242915|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138242916|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138242917|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
138242918|NCT03029091|Losartan|losartan|mesh-list
138242919|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242920|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362683|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
138242921|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138242922|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138242923|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242924|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
138242925|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242926|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
138242927|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
138242928|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
138242930|NCT00374205|Lumefantrine|lumefantrine|mesh-list
138242932|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138242933|NCT00374205|Amodiaquine|amodiaquine|mesh-list
138242934|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
138242935|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138242936|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138242937|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242938|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242939|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
138242940|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
138242941|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138242942|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
138242943|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
138242944|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138242945|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138242946|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138242947|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242948|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242949|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
138242950|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242951|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242952|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138242953|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242954|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
138242955|NCT03029715|Remifentanil|remifentanil|mesh-list
138242956|NCT03029715|Propofol|propofol|mesh-list
138242957|NCT03029715|Desflurane|desflurane|mesh-list
138242958|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138242959|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242960|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242961|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138242962|NCT03029715|Analgesics|analgesics|mesh-ancestor
138242963|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
138242964|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242965|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138242966|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138242967|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138242968|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
138242969|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242970|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242971|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138242972|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
138242973|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
138242974|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138242975|NCT03029715|Narcotics|narcotics|mesh-ancestor
138242976|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138242977|NCT00555035|Dolutegravir|dolutegravir|mesh-list
138242978|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138215637|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
138242980|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242981|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242982|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138242983|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138242984|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
138242985|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242986|NCT03035955|Azelaic acid|azelaic acid|mesh-list
138242987|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242988|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
138242989|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
138242990|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138242991|NCT02927223|Atropine|atropine|mesh-list
138242992|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138242993|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138242994|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138242995|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
138242996|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242997|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242998|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138242999|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243000|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
138243001|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
138243002|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138243004|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
138243005|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243006|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243007|NCT03002792|Anesthetics|anesthetics|mesh-list
138243008|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243009|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243010|NCT02927457|GSK2646264|gsk2646264|mesh-list
138243011|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138243012|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243013|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243014|NCT01891331|Fluconazole|fluconazole|mesh-list
138243015|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
138243016|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243017|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138243018|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138243019|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243020|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243021|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138243022|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
138243023|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243024|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243025|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138243026|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138243027|NCT02247518|Tadalafil|tadalafil|mesh-list
138243028|NCT02247518|Tamsulosin|tamsulosin|mesh-list
138243029|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
138243030|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138243031|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138243032|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243033|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243034|NCT02247518|Urological Agents|urological agents|mesh-ancestor
138243035|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138243036|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138243037|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138243038|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243039|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243040|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243041|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
138243042|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138243043|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138215644|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138243044|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243046|NCT02867163|Coagulants|coagulants|mesh-ancestor
138243047|NCT04067609|Dexamethasone|dexamethasone|mesh-list
138243048|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243049|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
138243050|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
138243051|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243052|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243053|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243054|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
138243055|NCT04067609|Hormones|hormones|mesh-ancestor
138243056|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243057|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243058|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243059|NCT03022097|Bromides|bromides|mesh-list
138243060|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
138243061|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138243062|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
138243063|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243064|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243065|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138243066|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243067|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138243068|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138243069|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138243070|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243071|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215601|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138243072|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243073|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
138243074|NCT03002636|Anesthetics|anesthetics|mesh-list
138243075|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243076|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243077|NCT03039543|Rocuronium|rocuronium|mesh-list
138243078|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138243079|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138243080|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138243081|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243082|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243083|NCT04047875|Norethindrone|norethindrone|mesh-list
138243084|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
138243085|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138243086|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138243087|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138243088|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
138243089|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243090|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243091|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138243092|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138243093|NCT03002090|Iron|iron|mesh-list
138243094|NCT03002090|Trace Elements|trace elements|mesh-ancestor
138243095|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
138243096|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243097|NCT02328755|Methotrexate|methotrexate|mesh-list
138243098|NCT02328755|Tacrolimus|tacrolimus|mesh-list
138243099|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138243100|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
138243101|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243102|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243103|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138243104|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
138243105|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243106|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243107|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243108|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243109|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138243110|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138215653|NCT00689078|Hormones|hormones|mesh-ancestor
138243112|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243113|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138243114|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138243116|NCT02870283|Valproic Acid|valproic acid|mesh-list
138243117|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243118|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243119|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243120|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
138243121|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243122|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243123|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243124|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
138243125|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
138243126|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243127|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243128|NCT02870283|Analgesics|analgesics|mesh-ancestor
138243129|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
138243130|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243131|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138243132|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243133|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138243134|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138243135|NCT02931045|Clopidogrel|clopidogrel|mesh-list
138243136|NCT02931045|Ticagrelor|ticagrelor|mesh-list
138243137|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138243138|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138243139|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138243140|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138243141|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
138243142|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243143|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243144|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243145|NCT03040011|Dexamethasone|dexamethasone|mesh-list
138243146|NCT03040011|Bupivacaine|bupivacaine|mesh-list
138243147|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243148|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
138243149|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
138243150|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243151|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243152|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243153|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
138243154|NCT03040011|Hormones|hormones|mesh-ancestor
138243155|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243156|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243157|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243158|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
138243159|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
138243160|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243161|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
138243162|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
138243163|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243164|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
138243165|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243166|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243167|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138243168|NCT03040479|Lasmiditan|lasmiditan|mesh-list
138243169|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138243170|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
138243171|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243172|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243173|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243174|NCT02872857|Galantamine|galantamine|mesh-list
138243177|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243178|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
138243179|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243180|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243181|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138243182|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
138243183|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243184|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
138243185|NCT02996318|Sirolimus|sirolimus|mesh-list
138243186|NCT02996318|Paclitaxel|paclitaxel|mesh-list
138243187|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138243188|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243189|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138243190|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138243191|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138243192|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243193|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243194|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243195|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138243196|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
138243197|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138243198|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
138243199|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243200|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138243201|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138243202|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
138243203|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243205|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243206|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243207|NCT02994602|ST 1435|st 1435|mesh-list
138243208|NCT02994602|Testosterone|testosterone|mesh-list
138243209|NCT02994602|Androgens|androgens|mesh-ancestor
138243210|NCT02994602|Hormones|hormones|mesh-ancestor
138243211|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243212|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362686|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138362689|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
138243213|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138243214|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
138243215|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243216|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138243217|NCT03297710|Trifluridine|trifluridine|mesh-list
138243218|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
138243219|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243220|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
138243221|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243222|NCT04350671|Interferons|interferons|mesh-list
138243223|NCT04350671|Ritonavir|ritonavir|mesh-list
138243224|NCT04350671|Lopinavir|lopinavir|mesh-list
138243225|NCT04350671|Interferon-beta|interferon-beta|mesh-list
138243226|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
138243227|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
138243228|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243229|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
138243230|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243231|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138243232|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138243233|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
138243234|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243235|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243236|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138243237|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138243238|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138243239|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138243241|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138243242|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138243243|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243244|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
138243245|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243246|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138243248|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138243249|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243250|NCT05166083|Testosterone|testosterone|mesh-list
138243251|NCT05166083|Androgens|androgens|mesh-ancestor
138243253|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243254|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243255|NCT02759588|Bevacizumab|bevacizumab|mesh-list
138243256|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138243257|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243258|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138243259|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138243260|NCT02759588|Growth Substances|growth substances|mesh-ancestor
138243261|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243262|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
138243263|NCT03045861|Cobicistat|cobicistat|mesh-list
138243264|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
138243265|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138243267|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
138243268|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243269|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138243270|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138243271|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243272|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243273|NCT02249078|Quetmolimab|quetmolimab|mesh-list
138243274|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243275|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
138243276|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138243277|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
138243278|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243279|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138243280|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243281|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138243282|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243283|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243284|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243285|NCT01907321|Capsaicin|capsaicin|mesh-list
138243286|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
138243287|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243288|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
138243289|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243290|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243291|NCT02219516|Verinurad|verinurad|mesh-list
138243292|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
138243293|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243294|NCT04976777|Dexamethasone|dexamethasone|mesh-list
138243295|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243296|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
138243297|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
138243298|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243299|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243300|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243301|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
138243302|NCT04976777|Hormones|hormones|mesh-ancestor
138243303|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243304|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243305|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243306|NCT02247596|Resveratrol|resveratrol|mesh-list
138243307|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
138243308|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243309|NCT02247596|Protective Agents|protective agents|mesh-ancestor
138243310|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243311|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243314|NCT03686657|Celecoxib|celecoxib|mesh-list
138243315|NCT03686657|Valsartan|valsartan|mesh-list
138243316|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138243317|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243318|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138243319|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243320|NCT03686657|Analgesics|analgesics|mesh-ancestor
138243321|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
138243322|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243323|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243326|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138243327|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243328|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243329|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138243330|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138243331|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138243332|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
138243333|NCT02476058|Promethazine|promethazine|mesh-list
138243334|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138243335|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138243336|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243337|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243338|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
138243339|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
138243340|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
138243341|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243342|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
138243343|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
138243344|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243345|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138243346|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
138243347|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
138243348|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243349|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243350|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138243351|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
138243352|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243353|NCT03050619|Empagliflozin|empagliflozin|mesh-list
138243354|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138243355|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243356|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138243357|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243359|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138243360|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
138243361|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
138243362|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243363|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243364|NCT01911065|Vaccines|vaccines|mesh-list
138243365|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
138243366|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243367|NCT02995772|Tamoxifen|tamoxifen|mesh-list
138243368|NCT02995772|Fluorouracil|fluorouracil|mesh-list
138243369|NCT02995772|Letrozole|letrozole|mesh-list
138243370|NCT02995772|Anastrozole|anastrozole|mesh-list
138243371|NCT02995772|Exemestane|exemestane|mesh-list
138243376|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243377|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138243378|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
138243379|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243380|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243382|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138243383|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138243384|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243385|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243386|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138243387|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138243388|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138243389|NCT02987465|Norepinephrine|norepinephrine|mesh-list
138243390|NCT02987465|Acetylcholine|acetylcholine|mesh-list
138243391|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
138243392|NCT02987465|Hematinics|hematinics|mesh-ancestor
138243393|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138243394|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138243395|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243396|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243397|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243398|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243399|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
138243400|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
138243401|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243402|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138243403|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
138243404|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138243405|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
138243407|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138243408|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243409|NCT02227316|Acetaminophen|acetaminophen|mesh-list
138243410|NCT02227316|Ibuprofen|ibuprofen|mesh-list
138243411|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243412|NCT02227316|Analgesics|analgesics|mesh-ancestor
138243413|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
138243414|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243415|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243416|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
138243417|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138243418|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243419|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243420|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138243421|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243422|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243423|NCT00555971|Omalizumab|omalizumab|mesh-list
138243424|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138243425|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138243426|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243427|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
138243428|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
138243429|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
138243430|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243431|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243432|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243433|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138215690|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138243434|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243435|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243436|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243437|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138243438|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
138243439|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243440|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243441|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
138243443|NCT01822652|Fludarabine|fludarabine|mesh-list
138243444|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
138243445|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138243446|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
138243447|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243448|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243449|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138243450|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
138243451|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243452|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243453|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138243454|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138243455|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138243456|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138243457|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
138243458|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138243459|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138243460|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243461|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243462|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138243463|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243464|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243465|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
138243466|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243468|NCT01338740|Infliximab|infliximab|mesh-list
138243469|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138243470|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243471|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243472|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243473|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243474|NCT02944461|Dapsone|dapsone|mesh-list
138243475|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243476|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
138243477|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138243478|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138243479|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138243480|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243481|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243482|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
138243483|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243484|NCT05376722|Prednisone|prednisone|mesh-list
138243485|NCT05376722|Pamiparib|pamiparib|mesh-list
138243486|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243487|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
138243490|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243491|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243492|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243493|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138243494|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243495|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243496|NCT04737057|Fluorides|fluorides|mesh-list
138243497|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
138243498|NCT04737057|Protective Agents|protective agents|mesh-ancestor
138243499|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243501|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138243502|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243503|NCT03111381|Analgesics|analgesics|mesh-ancestor
138243504|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
138243505|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243506|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243507|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243509|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138243510|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243511|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243512|NCT02946489|Ketamine|ketamine|mesh-list
138243513|NCT02946489|Analgesics|analgesics|mesh-ancestor
138243514|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
138243515|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243516|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243517|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138243518|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138243519|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
138243520|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
138243521|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243522|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138243523|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138243524|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243525|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243527|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
138243528|NCT02227706|Coagulants|coagulants|mesh-ancestor
138243529|NCT03112863|Vitamin A|vitamin a|mesh-list
138243530|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
138243531|NCT03112863|Vitamins|vitamins|mesh-ancestor
138243532|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
138243533|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243534|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
138243535|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243536|NCT03112863|Protective Agents|protective agents|mesh-ancestor
138243537|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138243538|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243545|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
138243546|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243547|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243548|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138243549|NCT01930487|Antioxidants|antioxidants|mesh-list
138243550|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243551|NCT01930487|Protective Agents|protective agents|mesh-ancestor
138243552|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243553|NCT03063255|Anesthetics|anesthetics|mesh-list
138243554|NCT03063255|Mepivacaine|mepivacaine|mesh-list
138243555|NCT03063255|Rocuronium|rocuronium|mesh-list
138243556|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243557|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243558|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138243559|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138243560|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138243561|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243562|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138243563|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
138243564|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138243565|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138243566|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243567|NCT03115827|Carbidopa|carbidopa|mesh-list
138243568|NCT03115827|Droxidopa|droxidopa|mesh-list
138243569|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138243571|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
138243572|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243573|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243574|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243575|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138243576|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243577|NCT01915823|Fluticasone|fluticasone|mesh-list
138243579|NCT01915823|Azelastine|azelastine|mesh-list
138243580|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243581|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138243582|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
138243583|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243584|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243585|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138243586|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243587|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243588|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138243589|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138243590|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243591|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243592|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138243593|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138243594|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
138243596|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243601|NCT01916681|Misoprostol|misoprostol|mesh-list
138243604|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243605|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243606|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138243608|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138243609|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243610|NCT05735951|Stiripentol|stiripentol|mesh-list
138243611|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
138243612|NCT01917773|Octreotide|octreotide|mesh-list
138243613|NCT01917773|Bisacodyl|bisacodyl|mesh-list
138243614|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243615|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243616|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243617|NCT01917773|Cathartics|cathartics|mesh-ancestor
138243618|NCT01917773|Laxatives|laxatives|mesh-ancestor
138243619|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138243620|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243621|NCT01934231|Amoxicillin|amoxicillin|mesh-list
138243622|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
138243623|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
138243624|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138243625|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243626|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243627|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138243628|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243629|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243630|NCT01935791|Glucagon|glucagon|mesh-list
138243631|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138243632|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243633|NCT01935791|Hormones|hormones|mesh-ancestor
138243634|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243635|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243636|NCT01935791|Incretins|incretins|mesh-ancestor
138243637|NCT03074409|Oxytocin|oxytocin|mesh-list
138243638|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
138243639|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243640|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243641|NCT02955147|Prednisone|prednisone|mesh-list
138243643|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243644|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
138243645|NCT02955147|Hormones|hormones|mesh-ancestor
138243646|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243647|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243648|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243649|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243650|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243651|NCT03119181|Lidocaine|lidocaine|mesh-list
138243652|NCT03119181|Epinephrine|epinephrine|mesh-list
138243653|NCT03119181|Racepinephrine|racepinephrine|mesh-list
138243654|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138243655|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
138243656|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
138243657|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
138243658|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243659|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243660|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
138243661|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243662|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138243663|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138243664|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138243665|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243666|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243667|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138243669|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243670|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243671|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138243672|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138243673|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
138243674|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138243675|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243676|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
138243677|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
138243678|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138243679|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
138243680|NCT01691534|Clofazimine|clofazimine|mesh-list
138243682|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243683|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243684|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243685|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
138243686|NCT01691690|Acetaminophen|acetaminophen|mesh-list
138243687|NCT01691690|Dexamethasone|dexamethasone|mesh-list
138243688|NCT01691690|Midazolam|midazolam|mesh-list
138243689|NCT01691690|Morphine|morphine|mesh-list
138243690|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
138243691|NCT01691690|Ondansetron|ondansetron|mesh-list
138243692|NCT01691690|Propofol|propofol|mesh-list
138243693|NCT01691690|Sevoflurane|sevoflurane|mesh-list
138243694|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243695|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
138243696|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
138243697|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243698|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243699|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138243700|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
138243701|NCT01691690|Hormones|hormones|mesh-ancestor
138243702|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243703|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138243705|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138243706|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243707|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138243709|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
138243710|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138243711|NCT01691690|Narcotics|narcotics|mesh-ancestor
138243713|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
138243714|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138243715|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138243716|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243717|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243718|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
138243719|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
138243720|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243721|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243722|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243723|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
138243724|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138243725|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138243726|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
138243727|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243728|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138243729|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138243730|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
138243731|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
138243732|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138243733|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
138243734|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243735|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138243736|NCT02283827|Phenytoin|phenytoin|mesh-list
138243737|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
138243738|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138243739|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138243740|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243741|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243742|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138243743|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138243744|NCT01626092|Cyclosporine|cyclosporine|mesh-list
138243745|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
138243746|NCT01626092|Melphalan|melphalan|mesh-list
138243747|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
138243748|NCT01626092|Clofarabine|clofarabine|mesh-list
138243750|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243751|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243752|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138243753|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
138243754|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243755|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
138243756|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243757|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243758|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243759|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138243760|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138243761|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243762|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138362707|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138243763|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
138243764|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243765|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138243766|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
138243768|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138243769|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138243770|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
138243772|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243773|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243774|NCT01937975|Grazoprevir|grazoprevir|mesh-list
138243775|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
138243776|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243777|NCT01628588|Bimatoprost|bimatoprost|mesh-list
138243778|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138243779|NCT00374985|Docetaxel|docetaxel|mesh-list
138243780|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
138243781|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243782|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138243783|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138243784|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138243785|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243786|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138243787|NCT01695668|Cyclosporine|cyclosporine|mesh-list
138243788|NCT01695668|Cyclosporins|cyclosporins|mesh-list
138243789|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243790|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243791|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138243792|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
138243793|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243794|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
138243795|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243796|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138243797|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243798|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138243799|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138243801|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138243802|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243804|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138243805|NCT01921751|Gemcitabine|gemcitabine|mesh-list
138243806|NCT01921751|Capecitabine|capecitabine|mesh-list
138243807|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138243808|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243809|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
138243810|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
138243811|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
138243812|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243813|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138243814|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
138243815|NCT02958345|Vaccines|vaccines|mesh-list
138243816|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
138243817|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243818|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
138243819|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138243820|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
138243821|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243822|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
138243823|NCT01629134|Protective Agents|protective agents|mesh-ancestor
138243824|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138243825|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
138243826|NCT01629290|Protective Agents|protective agents|mesh-ancestor
138243827|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243828|NCT01696760|Aspirin|aspirin|mesh-list
138243829|NCT01696760|Enoxaparin|enoxaparin|mesh-list
138243830|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
138243831|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
138243832|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138243833|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138243834|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243836|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138243837|NCT01696760|Analgesics|analgesics|mesh-ancestor
138243838|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
138243839|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243840|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243841|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138243842|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243843|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138243844|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138243845|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243846|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
138243847|NCT01924169|Lenalidomide|lenalidomide|mesh-list
138243848|NCT01924169|Vaccines|vaccines|mesh-list
138243849|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
138243850|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243851|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138243852|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138243853|NCT01924169|Growth Substances|growth substances|mesh-ancestor
138243854|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138243855|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243856|NCT02958969|Apixaban|apixaban|mesh-list
138243857|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138243858|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
138243859|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138243860|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138243861|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243862|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243863|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
138243864|NCT01924871|Remifentanil|remifentanil|mesh-list
138243865|NCT01924871|Desflurane|desflurane|mesh-list
138243866|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138243867|NCT01924871|Narcotics|narcotics|mesh-ancestor
138243868|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243869|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243870|NCT01924871|Analgesics|analgesics|mesh-ancestor
138243871|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
138243872|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243873|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138243874|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
138243875|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
138243876|NCT01698710|Paclitaxel|paclitaxel|mesh-list
138243877|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138243878|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138243879|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243880|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138243881|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138243882|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138243883|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243884|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
138243885|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138243886|NCT01924949|Ledipasvir|ledipasvir|mesh-list
138243887|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
138243888|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243889|NCT01938989|Methamphetamine|methamphetamine|mesh-list
138243890|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
138243891|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138243892|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138243893|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138243894|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243895|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
138243896|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
138243897|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243898|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
138243899|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243900|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243901|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243902|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138243903|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138243904|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243905|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138243907|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138243909|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138243910|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
138243911|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243912|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243913|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138243914|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
138243915|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138243916|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
138243917|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243918|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243919|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138243920|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138243921|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
138243922|NCT01939301|Protective Agents|protective agents|mesh-ancestor
138243923|NCT03078075|Naltrexone|naltrexone|mesh-list
138243924|NCT03078075|Bupropion|bupropion|mesh-list
138243925|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138243926|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138243927|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243928|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
138243929|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215827|NCT00595790|Vaccines|vaccines|mesh-list
138243933|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138243934|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138243935|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138243936|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243937|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
138243938|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243939|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138243940|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138243941|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243942|NCT01926977|Ranibizumab|ranibizumab|mesh-list
138243943|NCT01926977|Aflibercept|aflibercept|mesh-list
138243944|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138243945|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138243946|NCT01926977|Growth Substances|growth substances|mesh-ancestor
138243947|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243948|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
138243949|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243950|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
138243951|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
138243952|NCT01928693|Besifloxacin|besifloxacin|mesh-list
138243953|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138243954|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138243955|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138243956|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138243957|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243958|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138243959|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138243960|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243961|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243962|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243963|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138243964|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
138243965|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138243966|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243967|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138243968|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138243969|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138243970|NCT01928849|Valproic Acid|valproic acid|mesh-list
138243971|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
138243972|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243973|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243974|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
138243975|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243976|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243977|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
138243978|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243979|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243980|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243981|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138243982|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
138243983|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
138243984|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243985|NCT03081117|Insulin|insulin|mesh-list
138243986|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138243987|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243988|NCT01944293|Midazolam|midazolam|mesh-list
138243989|NCT01944293|Ketamine|ketamine|mesh-list
138243990|NCT01944293|Analgesics|analgesics|mesh-ancestor
138243991|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
138243992|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243993|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243994|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138243995|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138243996|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
138243997|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
138243998|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243999|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138244000|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138244001|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244002|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244003|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138244004|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138244005|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138244006|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138244007|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138244008|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
138244009|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
138244010|NCT01944371|Disulfiram|disulfiram|mesh-list
138244011|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138244012|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138244013|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244014|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244015|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
138244016|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244017|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244018|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244019|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244020|NCT01631630|Pioglitazone|pioglitazone|mesh-list
138244021|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138244022|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244023|NCT03837860|Oxycodone|oxycodone|mesh-list
138244024|NCT03837860|Risperidone|risperidone|mesh-list
138244025|NCT03837860|Ziprasidone|ziprasidone|mesh-list
138244026|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138244028|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244029|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244030|NCT03837860|Analgesics|analgesics|mesh-ancestor
138244031|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
138244032|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244033|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138244034|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
138244035|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244036|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244037|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138244038|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138244039|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138244040|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138244041|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
138244042|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
138244043|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244044|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138244045|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
138244046|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138244047|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244048|NCT03076112|Incretins|incretins|mesh-ancestor
138244051|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138244052|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
138244053|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244054|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244055|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138244056|NCT03129945|Indomethacin|indomethacin|mesh-list
138244057|NCT03129945|Nifedipine|nifedipine|mesh-list
138244058|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138244059|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244060|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244061|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138244062|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244063|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
138244064|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
138244065|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138244066|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138244067|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138244068|NCT03129945|Analgesics|analgesics|mesh-ancestor
138244069|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
138244070|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244071|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244072|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244073|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
138244074|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138244076|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138244077|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
138244078|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138244079|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138244080|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
138244081|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244082|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244083|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138244084|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244086|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138244087|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138244088|NCT03093207|Analgesics|analgesics|mesh-ancestor
138244089|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
138244090|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215873|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138244091|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244092|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244093|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244094|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138244095|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138244096|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244097|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138244098|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138244099|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244102|NCT05482451|Tretinoin|tretinoin|mesh-list
138244103|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138244104|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244105|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138244106|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244107|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
138244108|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138244109|NCT02228408|Hydralazine|hydralazine|mesh-list
138244110|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138244111|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
138244112|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138244113|NCT01951391|Triclocarban|triclocarban|mesh-list
138244114|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138244115|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244116|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
138244117|NCT02342886|Rifampin|rifampin|mesh-list
138244118|NCT02342886|Isoniazid|isoniazid|mesh-list
138244119|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
138244120|NCT02342886|Ethambutol|ethambutol|mesh-list
138244121|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138244122|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244123|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138244124|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138244125|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244126|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244127|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244128|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138244129|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
138244130|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
138244131|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138244132|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138244133|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138244134|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138244135|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138244136|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138244137|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138244138|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138244139|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138244140|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
138244141|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138244142|NCT04350281|Interferons|interferons|mesh-list
138244143|NCT04350281|Interferon-beta|interferon-beta|mesh-list
138244144|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
138244145|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
138244146|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244147|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
138244148|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244149|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
138244150|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138244151|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138244152|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244153|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244154|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244155|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
138244156|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244157|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138244158|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
138244159|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138215905|NCT00692978|Xhance|xhance|mesh-list
138244161|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138244162|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
138244163|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244164|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244165|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138244166|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
138244167|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
138244168|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
138244169|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138244170|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138244171|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
138244172|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244173|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244174|NCT02389764|Nintedanib|nintedanib|mesh-list
138244175|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244176|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244177|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244178|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244179|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138244181|NCT01647932|Diuretics|diuretics|mesh-ancestor
138244182|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
138244183|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244184|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138244185|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244186|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244187|NCT02366130|Denosumab|denosumab|mesh-list
138244188|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138244189|NCT02366130|Hormones|hormones|mesh-list
138244190|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244191|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244192|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138244193|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244194|NCT01635062|Calcitriol|calcitriol|mesh-list
138244196|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138244197|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244198|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138244199|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244200|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244201|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138244203|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
138244204|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138244205|NCT01637090|Everolimus|everolimus|mesh-list
138244207|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244208|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244209|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244210|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244211|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
138244212|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244213|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244214|NCT02389452|Hylan|hylan|mesh-list
138244216|NCT02389452|Protective Agents|protective agents|mesh-ancestor
138244217|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244218|NCT02365584|Lanreotide|lanreotide|mesh-list
138244219|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244220|NCT02342418|Tedizolid|tedizolid|mesh-list
138244221|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
138244222|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138244223|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244224|NCT05727449|Anesthetics|anesthetics|mesh-list
138244225|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244226|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244227|NCT03102645|Imipramine|imipramine|mesh-list
138244228|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138244229|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138244230|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138244231|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138244232|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138244233|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244234|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244235|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
138244236|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244237|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244238|NCT01639352|Pasireotide|pasireotide|mesh-list
138244239|NCT01639352|Hormones|hormones|mesh-ancestor
138244240|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244241|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244242|NCT01705496|Fialuridine|fialuridine|mesh-list
138244243|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
138244244|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244245|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138244246|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244247|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244248|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138244250|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
138244251|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
138244252|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138244253|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138244254|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244255|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244256|NCT02312934|Nicotine|nicotine|mesh-list
138244257|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138244258|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
138244259|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244260|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244261|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138244262|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138244263|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
138244264|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244265|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244267|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138244268|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138244269|NCT04707027|Growth Substances|growth substances|mesh-ancestor
138244270|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244271|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
138244272|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244274|NCT01602068|Citric Acid|citric acid|mesh-list
138244275|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
138244276|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138244277|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244278|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
138244279|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
138244280|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244281|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244285|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244286|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138244287|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244288|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
138244289|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138244290|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
138244291|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
138215602|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362718|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362719|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362720|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138362722|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
138244292|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244293|NCT02978157|Amoxicillin|amoxicillin|mesh-list
138244294|NCT02978157|Levofloxacin|levofloxacin|mesh-list
138244295|NCT02978157|Ofloxacin|ofloxacin|mesh-list
138244296|NCT02978157|Tetracycline|tetracycline|mesh-list
138244297|NCT02978157|Esomeprazole|esomeprazole|mesh-list
138244298|NCT02978157|Bismuth|bismuth|mesh-list
138244300|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244301|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138244302|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244303|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138244304|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244305|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244306|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138244307|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138244308|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138244309|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244310|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138244311|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138244313|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138244314|NCT01705964|Epinephrine|epinephrine|mesh-list
138244315|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138244316|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138244317|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
138244318|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244319|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244320|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244321|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138244322|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138244323|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
138244324|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244325|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138244326|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
138244327|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
138244328|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
138244329|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138244330|NCT02341482|Itraconazole|itraconazole|mesh-list
138244331|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
138244332|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244333|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138244334|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138244335|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244336|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244337|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138244338|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
138244339|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244340|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244341|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138244342|NCT03140631|Protamines|protamines|mesh-list
138244343|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
138244344|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244345|NCT03140631|Coagulants|coagulants|mesh-ancestor
138244346|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138244347|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
138244348|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244349|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
138244350|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138244351|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
138362735|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138244352|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244353|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
138244354|NCT00422643|Protective Agents|protective agents|mesh-ancestor
138244356|NCT05405907|Coagulants|coagulants|mesh-ancestor
138244357|NCT01706588|Diclofenac|diclofenac|mesh-list
138244358|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138244359|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138244360|NCT01706588|Analgesics|analgesics|mesh-ancestor
138244361|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
138244362|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244363|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244364|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244365|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244366|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138244367|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244368|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244369|NCT01602692|Lidocaine|lidocaine|mesh-list
138244370|NCT01602692|Epinephrine|epinephrine|mesh-list
138244371|NCT01602692|Racepinephrine|racepinephrine|mesh-list
138244372|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138244373|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
138244374|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
138244375|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
138244376|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244377|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244378|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
138244379|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244380|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138244381|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138244382|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138244383|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244384|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244385|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138244386|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138244387|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
138244388|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244389|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138244390|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138244391|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
138244392|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138244393|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138244394|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
138244395|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
138244396|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138244397|NCT01603940|Losartan|losartan|mesh-list
138244398|NCT01603940|Benazepril|benazepril|mesh-list
138244399|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138244400|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138244401|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138244402|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138244403|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244404|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138244405|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138244406|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244407|NCT01605032|Bortezomib|bortezomib|mesh-list
138244408|NCT01605032|Melphalan|melphalan|mesh-list
138215939|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244410|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244411|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138244412|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
138244413|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244414|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138244415|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244416|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
138244417|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244418|NCT01706666|Dexamethasone|dexamethasone|mesh-list
138244419|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
138244420|NCT01706666|Lenalidomide|lenalidomide|mesh-list
138244421|NCT01706666|Bortezomib|bortezomib|mesh-list
138244422|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244423|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
138244424|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244425|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244426|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138244427|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
138244428|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244429|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244430|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138244431|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244432|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
138244433|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
138244434|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244435|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244437|NCT01706666|Hormones|hormones|mesh-ancestor
138244438|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244439|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138244440|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138244441|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138244442|NCT01706666|Growth Substances|growth substances|mesh-ancestor
138244443|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
138244444|NCT03149991|Ketamine|ketamine|mesh-list
138244445|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
138244446|NCT03149991|Analgesics|analgesics|mesh-ancestor
138244447|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
138244448|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244449|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244450|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138244451|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138244452|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
138244453|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
138244454|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244455|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138244456|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138244457|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244458|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244459|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
138244460|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
138244461|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
138244462|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
138244463|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
138244464|NCT05400993|Docetaxel|docetaxel|mesh-list
138244465|NCT05400993|Epirubicin|epirubicin|mesh-list
138244466|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244467|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
138244468|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244469|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244470|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138244471|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
138244472|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244474|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138244475|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138244476|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138244477|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138244478|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138244479|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138244480|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138244481|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244482|NCT01605890|Tenofovir|tenofovir|mesh-list
138244483|NCT01605890|Emtricitabine|emtricitabine|mesh-list
138244484|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
138244485|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138244486|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
138244487|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244488|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138244489|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138244490|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244491|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244492|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138244493|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138244494|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138244495|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138244496|NCT02288273|Exenatide|exenatide|mesh-list
138244497|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138244498|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244499|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138244500|NCT02288273|Incretins|incretins|mesh-ancestor
138244501|NCT02288273|Hormones|hormones|mesh-ancestor
138244502|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244503|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138244504|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
138244505|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244506|NCT01606124|Protective Agents|protective agents|mesh-ancestor
138244507|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244508|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138244509|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138244510|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244511|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138244512|NCT01607450|Glucagon|glucagon|mesh-list
138244513|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138244514|NCT01607450|Incretins|incretins|mesh-ancestor
138244515|NCT01607450|Hormones|hormones|mesh-ancestor
138244516|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244517|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244518|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244519|NCT05738993|Pertuzumab|pertuzumab|mesh-list
138244520|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138244521|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244522|NCT01709474|Vitamin D|vitamin d|mesh-list
138244523|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
138244524|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
138244525|NCT01709474|Vitamins|vitamins|mesh-list
138244526|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
138244527|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244528|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138244529|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138244530|NCT02992808|Menotropins|menotropins|mesh-list
138244531|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138244532|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
138244533|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138215961|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138244536|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138244537|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
138244538|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244539|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244540|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138244541|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244542|NCT02331095|Warfarin|warfarin|mesh-list
138244543|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
138244544|NCT02331095|Atorvastatin|atorvastatin|mesh-list
138244545|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138244546|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138244547|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
138244548|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244549|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138244550|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138244551|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244552|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
138244553|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138244554|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
138244555|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138244557|NCT01640834|Glucagon|glucagon|mesh-list
138244558|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244559|NCT01640834|Hormones|hormones|mesh-ancestor
138244560|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244561|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244562|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
138244563|NCT03029273|Fludarabine|fludarabine|mesh-list
138244564|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244565|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
138244566|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244567|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244568|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138244569|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
138244570|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244571|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244572|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138244573|NCT05316935|Letrozole|letrozole|mesh-list
138244574|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138244576|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
138244577|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244578|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138244579|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138244580|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244581|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244582|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138244583|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
138244584|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244585|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244586|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138244587|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138244588|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138244589|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
138244590|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138244591|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138244592|NCT05316935|Estrogens|estrogens|mesh-ancestor
138244593|NCT05316935|Hormones|hormones|mesh-ancestor
138244594|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
138244596|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244598|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
138244599|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138244600|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
138244601|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244603|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
138244604|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138244605|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
138244606|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244607|NCT05738681|Protective Agents|protective agents|mesh-ancestor
138244608|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244609|NCT05738681|Antidotes|antidotes|mesh-ancestor
138244610|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138244611|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
138244612|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244613|NCT02288819|Diuretics|diuretics|mesh-list
138244614|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138244615|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
138244616|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244617|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244618|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244619|NCT01642238|Aspirin|aspirin|mesh-list
138244620|NCT01642238|Hirudins|hirudins|mesh-list
138244621|NCT01642238|Bivalirudin|bivalirudin|mesh-list
138244622|NCT01642238|Clopidogrel|clopidogrel|mesh-list
138244623|NCT01642238|Ticagrelor|ticagrelor|mesh-list
138244624|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138244625|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138244626|NCT01642238|Analgesics|analgesics|mesh-ancestor
138244627|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
138244628|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244629|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244631|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244632|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138244633|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138244634|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244635|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138244636|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138244637|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244638|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
138244639|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138244640|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138244641|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138244642|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
138244643|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244644|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
138244645|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138244646|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
138244647|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
138244648|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
138244649|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138244650|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138244651|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
138244652|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244653|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244654|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244655|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
138244657|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244658|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
138244659|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138244660|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138244662|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138244663|NCT03028883|Narcotics|narcotics|mesh-ancestor
138244664|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244665|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244666|NCT03028883|Analgesics|analgesics|mesh-ancestor
138244667|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
138244668|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244669|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138244670|NCT05238467|Antibodies|antibodies|mesh-list
138244671|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
138244672|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244674|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138244675|NCT02986685|Rabeprazole|rabeprazole|mesh-list
138244676|NCT02986685|Trimebutine|trimebutine|mesh-list
138244677|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244678|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244679|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138244680|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244681|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138244682|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
138244683|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
138244684|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244685|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244686|NCT01610570|Plicamycin|plicamycin|mesh-list
138244687|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138244688|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244689|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138244690|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244691|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138244692|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244693|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244694|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138244695|NCT01611662|Gemcitabine|gemcitabine|mesh-list
138244696|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244697|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138244698|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
138244699|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244700|NCT05200481|Carboplatin|carboplatin|mesh-list
138244701|NCT05200481|Pemetrexed|pemetrexed|mesh-list
138244702|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244703|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244704|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244705|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138244706|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138244707|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138244708|NCT01646762|Paclitaxel|paclitaxel|mesh-list
138244709|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138244710|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138244711|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244712|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138244713|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
138244714|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138244715|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244716|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138244718|NCT04997525|Progesterone|progesterone|mesh-list
138244719|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138244720|NCT04997525|Estrogens|estrogens|mesh-ancestor
138244722|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244723|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244724|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138244725|NCT04997525|Progestins|progestins|mesh-ancestor
138244726|NCT01649180|Axitinib|axitinib|mesh-list
138244727|NCT01649180|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138244728|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244729|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244730|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244731|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244732|NCT04408313|Naltrexone|naltrexone|mesh-list
138244733|NCT04408313|Buprenorphine|buprenorphine|mesh-list
138244734|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138244735|NCT04408313|Narcotics|narcotics|mesh-ancestor
138244736|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244737|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244738|NCT04408313|Analgesics|analgesics|mesh-ancestor
138244739|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
138244740|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244741|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138244742|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138244743|NCT01619774|Trametinib|trametinib|mesh-list
138244744|NCT01619774|Dabrafenib|dabrafenib|mesh-list
138244745|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244746|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244747|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244748|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244749|NCT01651442|Zolpidem|zolpidem|mesh-list
138244750|NCT01651442|Trazodone|trazodone|mesh-list
138244751|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138244752|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138244753|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244754|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244755|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138244756|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
138244757|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
138244758|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244759|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244760|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138244761|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138244762|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138244763|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138244764|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138244765|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244766|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
138244767|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138244768|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
138244769|NCT04901975|Spironolactone|spironolactone|mesh-list
138244770|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138244771|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
138244772|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244773|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244774|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138244775|NCT04901975|Diuretics|diuretics|mesh-ancestor
138244776|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
138244777|NCT05421416|Loratadine|loratadine|mesh-list
138244778|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
138244779|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
138244780|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138244781|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138244782|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138244783|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
138244784|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
138244785|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244786|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244789|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
138244790|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244791|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244792|NCT04803539|Capecitabine|capecitabine|mesh-list
138244793|NCT04803539|Apatinib|apatinib|mesh-list
138244794|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138244795|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
138244796|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244797|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244798|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138244799|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244800|NCT04799015|Dexamethasone|dexamethasone|mesh-list
138244801|NCT04799015|Metoclopramide|metoclopramide|mesh-list
138244802|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244803|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
138244804|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
138244805|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244806|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244807|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244808|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
138244809|NCT04799015|Hormones|hormones|mesh-ancestor
138244810|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244811|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138244812|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244813|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138244814|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138244816|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215603|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138244817|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244818|NCT01658228|Donepezil|donepezil|mesh-list
138244819|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138244820|NCT01658228|Citalopram|citalopram|mesh-list
138244821|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138244822|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244823|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244824|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
138244825|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244826|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244828|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138244829|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138244830|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244831|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138244832|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
138244833|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138244834|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138244835|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
138244836|NCT05709938|Insulin|insulin|mesh-list
138244837|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138244838|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138244839|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244840|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
138244841|NCT01659866|Gentamicins|gentamicins|mesh-list
138244842|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
138244843|NCT01659866|Imipenem|imipenem|mesh-list
138244844|NCT01659866|Amikacin|amikacin|mesh-list
138244845|NCT01659866|Cefuroxime|cefuroxime|mesh-list
138244846|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138244847|NCT01659866|Aztreonam|aztreonam|mesh-list
138244848|NCT01659866|Trimethoprim|trimethoprim|mesh-list
138244849|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
138244850|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138244851|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244852|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138244853|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138244854|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244855|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244856|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244857|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138244858|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138244859|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138244860|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138244861|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
138244862|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138244863|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138244864|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138244865|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138244866|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138244867|NCT02249702|Gemcitabine|gemcitabine|mesh-list
138244868|NCT02249702|Docetaxel|docetaxel|mesh-list
138244869|NCT02249702|Trabectedin|trabectedin|mesh-list
138244870|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138244871|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
138244872|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244873|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244874|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138244875|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138244876|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138244877|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138244878|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
138244879|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
138244880|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138244881|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138244882|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244883|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
138244884|NCT02947529|Coagulants|coagulants|mesh-ancestor
138244885|NCT01660802|Dexamethasone|dexamethasone|mesh-list
138244886|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244887|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
138244888|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
138244889|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244890|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244891|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244892|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
138244893|NCT01660802|Hormones|hormones|mesh-ancestor
138244894|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244895|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138244896|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244897|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138244898|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138244899|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244900|NCT01661114|Gemcitabine|gemcitabine|mesh-list
138244901|NCT01661114|Fluorouracil|fluorouracil|mesh-list
138244902|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244903|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138244904|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
138244905|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244906|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244907|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
138244908|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244909|NCT02683265|Methylphenidate|methylphenidate|mesh-list
138244910|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138244911|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244912|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138244913|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138216023|NCT00650078|Prednisone|prednisone|mesh-list
138244917|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138244918|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138244919|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
138244920|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138244921|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138244922|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244923|NCT02988843|Bevacizumab|bevacizumab|mesh-list
138244924|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138244925|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138244926|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244927|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138244928|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138244929|NCT02988843|Growth Substances|growth substances|mesh-ancestor
138244930|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244931|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
138244932|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
138244933|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
138244934|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
138244935|NCT01661270|Aflibercept|aflibercept|mesh-list
138244936|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138244937|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138244938|NCT01661270|Growth Substances|growth substances|mesh-ancestor
138244939|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244940|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
138244941|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138244943|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138244944|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138244945|NCT03000309|Analgesics|analgesics|mesh-ancestor
138244947|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244948|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244949|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244950|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138244951|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138244952|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138244953|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244954|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244956|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
138244957|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244958|NCT03165981|Vaccines|vaccines|mesh-list
138244959|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138244960|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
138244961|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244962|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
138244963|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138244964|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244966|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138244967|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138244968|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138244969|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138244970|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244971|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138244972|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244973|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244974|NCT01662908|Heparin|heparin|mesh-list
138244975|NCT01662908|Enoxaparin|enoxaparin|mesh-list
138244977|NCT01662908|Warfarin|warfarin|mesh-list
138244978|NCT01662908|Edoxaban|edoxaban|mesh-list
138244979|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
138244980|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138244981|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138244982|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244983|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138244984|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
138244985|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138244986|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
138244987|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244988|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
138244989|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
138244990|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138244991|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138244992|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138244993|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244994|NCT00375297|Urological Agents|urological agents|mesh-ancestor
138244995|NCT02234570|Oxfendazole|oxfendazole|mesh-list
138244996|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
138244998|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138244999|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
138245000|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138245001|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
138245002|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245003|NCT02240030|Levodopa|levodopa|mesh-list
138245004|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138245005|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138245006|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
138245007|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245008|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245009|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245010|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
138245011|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138245012|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245013|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138245014|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245015|NCT01664858|Calcium|calcium|mesh-list
138245016|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245017|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245019|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138245020|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138245021|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
138245022|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245023|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138245024|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138245025|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245026|NCT04316871|Morphine|morphine|mesh-list
138245027|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245028|NCT04316871|Narcotics|narcotics|mesh-ancestor
138245029|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245030|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245031|NCT04316871|Analgesics|analgesics|mesh-ancestor
138245032|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
138245033|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245034|NCT05364567|Vitamin D|vitamin d|mesh-list
138245035|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
138245036|NCT05364567|Vitamins|vitamins|mesh-ancestor
138245037|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
138245038|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245039|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138245040|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245041|NCT00375765|Dutasteride|dutasteride|mesh-list
138245042|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138245043|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138245044|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245052|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
138245053|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138245054|NCT03325647|Androgens|androgens|mesh-ancestor
138245055|NCT03325647|Hormones|hormones|mesh-ancestor
138245056|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245057|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245058|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245059|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245060|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
138245061|NCT01665950|Simvastatin|simvastatin|mesh-list
138245062|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138245063|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138245064|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
138245065|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245066|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138245067|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138245068|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245069|NCT01667978|Ritonavir|ritonavir|mesh-list
138245070|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138245071|NCT01667978|Norethindrone|norethindrone|mesh-list
138245072|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
138245073|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
138245074|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138245075|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138245076|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245077|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245078|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138245079|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138245080|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
138245081|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245082|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138245083|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138245084|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138245085|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138245086|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138245087|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
138245088|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138245089|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245090|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138245091|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138245092|NCT03282669|Morphine|morphine|mesh-list
138245094|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245095|NCT03282669|Narcotics|narcotics|mesh-ancestor
138245096|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245097|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245098|NCT03282669|Analgesics|analgesics|mesh-ancestor
138245099|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
138245100|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245101|NCT00375843|Sertraline|sertraline|mesh-list
138245102|NCT00375843|Escitalopram|escitalopram|mesh-list
138216043|NCT00650546|Incretins|incretins|mesh-ancestor
138245105|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245106|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245107|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245108|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
138245109|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245110|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
138245111|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138245112|NCT03247569|Edoxaban|edoxaban|mesh-list
138245113|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138245114|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
138245115|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138245116|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
138245117|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245118|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245119|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
138245120|NCT01668836|Resveratrol|resveratrol|mesh-list
138245121|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
138245122|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245123|NCT01668836|Protective Agents|protective agents|mesh-ancestor
138245124|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245125|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245126|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138245127|NCT03744663|Buprenorphine|buprenorphine|mesh-list
138245128|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138245129|NCT03744663|Naloxone|naloxone|mesh-list
138245130|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245131|NCT03744663|Narcotics|narcotics|mesh-ancestor
138245132|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245133|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245134|NCT03744663|Analgesics|analgesics|mesh-ancestor
138245135|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
138245136|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245137|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138245138|NCT01669538|Galantamine|galantamine|mesh-list
138245139|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138245140|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245141|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245142|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
138245143|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245144|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245145|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138245146|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
138245147|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245148|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
138245149|NCT00375375|Lactulose|lactulose|mesh-list
138245150|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245151|NCT04333095|Bupivacaine|bupivacaine|mesh-list
138245152|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
138245153|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
138245154|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245155|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245156|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
138245157|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245159|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
138245161|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
138245162|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138245163|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245164|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138245165|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245166|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245167|NCT01658241|Panobinostat|panobinostat|mesh-list
138245169|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138245171|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245172|NCT01455051|Ofatumumab|ofatumumab|mesh-list
138245173|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245174|NCT01673828|Pregnanolone|pregnanolone|mesh-list
138245175|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138245176|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
138245177|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245178|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245179|NCT05325099|Azacitidine|azacitidine|mesh-list
138245180|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245181|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
138245182|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245183|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245184|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245185|NCT02296775|Rituximab|rituximab|mesh-list
138245186|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245187|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245188|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
138245189|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245190|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245191|NCT01675778|Hydromorphone|hydromorphone|mesh-list
138245192|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245193|NCT01675778|Narcotics|narcotics|mesh-ancestor
138245194|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245195|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245196|NCT01675778|Analgesics|analgesics|mesh-ancestor
138245197|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
138245198|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245199|NCT04736589|Sirolimus|sirolimus|mesh-list
138245200|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138245201|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245202|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138245203|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245204|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
138245205|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245206|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
138245207|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245209|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245210|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
138245211|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245212|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245213|NCT02594111|Colchicine|colchicine|mesh-list
138245214|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
138245215|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245216|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
138245217|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
138245218|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245219|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245220|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245222|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138245223|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138245224|NCT03186261|Fluorides|fluorides|mesh-list
138245225|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
138245226|NCT03186261|Protective Agents|protective agents|mesh-ancestor
138245227|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245228|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138245229|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245230|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
138245231|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
138245232|NCT02589353|Acarbose|acarbose|mesh-list
138245233|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138245246|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245247|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245248|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138245249|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138245252|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245253|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138245254|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245255|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245256|NCT03190005|Clopidogrel|clopidogrel|mesh-list
138245257|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138245258|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138245259|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138245260|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138245261|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
138245262|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245263|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245264|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245265|NCT01461915|Paclitaxel|paclitaxel|mesh-list
138245266|NCT01461915|Gemcitabine|gemcitabine|mesh-list
138245267|NCT01461915|Heparin|heparin|mesh-list
138245268|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138245269|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245270|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138245271|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138245272|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245273|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245274|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245275|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
138245276|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
138245277|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138245278|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138245279|NCT01682642|Goserelin|goserelin|mesh-list
138245280|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245281|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245282|NCT01683422|Gemcitabine|gemcitabine|mesh-list
138245283|NCT01683422|Capecitabine|capecitabine|mesh-list
138245284|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138245285|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245286|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
138245287|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245294|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138245295|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245296|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245297|NCT05066061|Analgesics|analgesics|mesh-list
138245298|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
138245299|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
138362750|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362751|NCT02242734|Analgesics|analgesics|mesh-ancestor
138362752|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
138245300|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245301|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245302|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138245303|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245304|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138245305|NCT03197025|Aldesleukin|aldesleukin|mesh-list
138245306|NCT03197025|Interleukin-2|interleukin-2|mesh-list
138245307|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245308|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138245309|NCT03197025|Analgesics|analgesics|mesh-ancestor
138245310|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
138245311|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245312|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245313|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138245314|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138245315|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
138245316|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245317|NCT02249546|Amoxicillin|amoxicillin|mesh-list
138245318|NCT02249546|Clarithromycin|clarithromycin|mesh-list
138245319|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
138245320|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138245321|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138245322|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245323|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138245324|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245325|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245326|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138245327|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138245328|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
138245329|NCT02249546|Expectorants|expectorants|mesh-ancestor
138245330|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138245331|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138245333|NCT02249546|Protective Agents|protective agents|mesh-ancestor
138245334|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245335|NCT02249546|Antidotes|antidotes|mesh-ancestor
138245336|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
138245337|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138245338|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138245339|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
138245340|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245341|NCT04960215|Ubiquinone|ubiquinone|mesh-list
138245342|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
138245343|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
138245344|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245345|NCT04960215|Vitamins|vitamins|mesh-ancestor
138245346|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138245347|NCT02333045|Maraviroc|maraviroc|mesh-list
138245348|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138245349|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138245350|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216073|NCT00654836|Growth Substances|growth substances|mesh-ancestor
138245355|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138245356|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138245357|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138245358|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138245359|NCT01684748|Olmesartan|olmesartan|mesh-list
138245360|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138245361|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138245362|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138245363|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138245364|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245365|NCT01685684|Oxycodone|oxycodone|mesh-list
138245366|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245367|NCT01685684|Narcotics|narcotics|mesh-ancestor
138245368|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245369|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245370|NCT01685684|Analgesics|analgesics|mesh-ancestor
138245371|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
138245372|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245373|NCT03978767|Acetaminophen|acetaminophen|mesh-list
138245374|NCT03978767|Ibuprofen|ibuprofen|mesh-list
138245375|NCT03978767|Ketorolac|ketorolac|mesh-list
138245376|NCT03978767|Oxycodone|oxycodone|mesh-list
138245377|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138245378|NCT03978767|Analgesics|analgesics|mesh-ancestor
138245379|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
138245380|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245381|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245382|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
138216082|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245383|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138245384|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245385|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216083|NCT02997800|Analgesics|analgesics|mesh-ancestor
138216084|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
138245386|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138245387|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216085|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216086|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216087|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216088|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
138216089|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
138216090|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138216091|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138216092|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138216093|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216094|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216095|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245388|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245389|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245390|NCT03978767|Narcotics|narcotics|mesh-ancestor
138245391|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245392|NCT04436133|Vaccines|vaccines|mesh-list
138245393|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
138245394|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245395|NCT01685996|Zonisamide|zonisamide|mesh-list
138245396|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
138245397|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138245398|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245399|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245400|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245401|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245402|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138245403|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
138245404|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245405|NCT02196155|Cortisone|cortisone|mesh-list
138245406|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
138245407|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138245408|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138245409|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138245410|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245411|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245412|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138245413|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245414|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245415|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245416|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138245417|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245418|NCT02175173|Rufinamide|rufinamide|mesh-list
138245419|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
138245420|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138245421|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138245422|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245423|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245425|NCT04121403|Cladribine|cladribine|mesh-list
138245426|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245427|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245429|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245430|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245431|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245434|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138245435|NCT03224403|Analgesics|analgesics|mesh-ancestor
138362756|NCT02244606|Fluconazole|fluconazole|mesh-list
138362757|NCT02244606|Micafungin|micafungin|mesh-list
138362758|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
138362759|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
138362760|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245436|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
138245437|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245438|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245439|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
138245440|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138245441|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245442|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216096|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216098|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
138245443|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138216099|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138216100|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138216101|NCT00701636|Daptomycin|daptomycin|mesh-list
138216102|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138245445|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245446|NCT02334059|Ketamine|ketamine|mesh-list
138245447|NCT02334059|Analgesics|analgesics|mesh-ancestor
138245448|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
138245449|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245450|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245451|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138245452|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138245453|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
138245454|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
138245455|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245456|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138245457|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138245458|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245459|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245460|NCT04501523|Capecitabine|capecitabine|mesh-list
138245461|NCT04501523|Tislelizumab|tislelizumab|mesh-list
138245462|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245463|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
138245464|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245465|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245466|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245468|NCT04499573|Dexamethasone|dexamethasone|mesh-list
138245469|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
138245470|NCT04499573|Fludarabine|fludarabine|mesh-list
138245471|NCT04499573|Etoposide|etoposide|mesh-list
138245472|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245475|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245476|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138245477|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
138245478|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245479|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245480|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138245481|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245483|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
138245484|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245485|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245486|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
138245488|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245489|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245490|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245491|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245492|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
138245493|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138245494|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138245495|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138245496|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
138245497|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245498|NCT03425097|Fexofenadine|fexofenadine|mesh-list
138245499|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138245500|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138245501|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138245502|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
138245503|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
138245504|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245505|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245506|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245507|NCT01926041|Varenicline|varenicline|mesh-list
138245508|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138245509|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138245510|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
138245511|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216105|NCT00701714|Hematinics|hematinics|mesh-ancestor
138216106|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
138245513|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245514|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138245516|NCT01769027|Penicillins|penicillins|mesh-list
138245517|NCT01769027|Sertraline|sertraline|mesh-list
138245518|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138245519|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245525|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245526|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245527|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
138245528|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245529|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
138245530|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
138245531|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138245532|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245533|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138245534|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245535|NCT04706949|Carboplatin|carboplatin|mesh-list
138245536|NCT04706949|Pemetrexed|pemetrexed|mesh-list
138245537|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245538|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245539|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245540|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138245541|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138245542|NCT02299349|Epinephrine|epinephrine|mesh-list
138245543|NCT02299349|Racepinephrine|racepinephrine|mesh-list
138245544|NCT02299349|Morphine|morphine|mesh-list
138245545|NCT02299349|Bupivacaine|bupivacaine|mesh-list
138245546|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
138245547|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
138245548|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
138245549|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245550|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245551|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
138245552|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245553|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245554|NCT02299349|Narcotics|narcotics|mesh-ancestor
138245555|NCT02299349|Analgesics|analgesics|mesh-ancestor
138245556|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138245557|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138245558|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138245559|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245560|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245561|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138245562|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138245563|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
138245564|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138245565|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138245566|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
138245567|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
138245568|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138245570|NCT03296163|Bevacizumab|bevacizumab|mesh-list
138245571|NCT03296163|Carboplatin|carboplatin|mesh-list
138245572|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138245573|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216114|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138245574|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
138245575|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
138245576|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245577|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245578|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245579|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138245580|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138245581|NCT03296163|Growth Substances|growth substances|mesh-ancestor
138245582|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245585|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
138245586|NCT00376155|Amodiaquine|amodiaquine|mesh-list
138245587|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
138245588|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138245589|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138245590|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245591|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138245592|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245593|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245594|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138245595|NCT01989221|Granisetron|granisetron|mesh-list
138245596|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
138245597|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
138245598|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245599|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245600|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245601|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138245602|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138245604|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245606|NCT03226899|Colchicine|colchicine|mesh-list
138245607|NCT03226899|Allopurinol|allopurinol|mesh-list
138245608|NCT03226899|Febuxostat|febuxostat|mesh-list
138245609|NCT03226899|Lesinurad|lesinurad|mesh-list
138245610|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
138245611|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245612|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
138245613|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
138245614|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245615|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245616|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245617|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
138245618|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245619|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138245620|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
138245621|NCT03226899|Protective Agents|protective agents|mesh-ancestor
138245622|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245623|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
138245624|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
138245625|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138245626|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
138245627|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138245628|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245629|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138245630|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138245631|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138245632|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138245633|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245634|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
138245635|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138245636|NCT01992185|Protective Agents|protective agents|mesh-ancestor
138245637|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245638|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
138245640|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138245641|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245642|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245643|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
138245644|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245645|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245646|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138245647|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
138245648|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245649|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138245650|NCT03440229|Laxatives|laxatives|mesh-ancestor
138245651|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245653|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
138245654|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138245656|NCT02306759|Ketamine|ketamine|mesh-list
138245657|NCT02306759|Analgesics|analgesics|mesh-ancestor
138245658|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
138245659|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245660|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245661|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138245662|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138245663|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
138245664|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
138245665|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245666|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138245667|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138245668|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245669|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245670|NCT03298113|Protective Agents|protective agents|mesh-list
138245671|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245672|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
138245673|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138245674|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245675|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
138245676|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
138245677|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245678|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245679|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245680|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
138245681|NCT03232749|Hormones|hormones|mesh-ancestor
138245682|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245683|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138245684|NCT03232749|Protective Agents|protective agents|mesh-ancestor
138245685|NCT01687400|Decitabine|decitabine|mesh-list
138245686|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245687|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
138245688|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245689|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245690|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245691|NCT01688102|Vitamin D|vitamin d|mesh-list
138245692|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
138245693|NCT01688102|Vitamins|vitamins|mesh-ancestor
138245694|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
138245695|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245696|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138245697|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245698|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138245699|NCT01994993|Metronidazole|metronidazole|mesh-list
138245700|NCT01994993|Clindamycin|clindamycin|mesh-list
138245702|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
138245703|NCT01994993|Gentamicins|gentamicins|mesh-list
138245704|NCT01994993|Tazobactam|tazobactam|mesh-list
138245705|NCT01994993|Piperacillin|piperacillin|mesh-list
138245706|NCT01994993|Ampicillin|ampicillin|mesh-list
138245707|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138245708|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245709|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138245710|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138245711|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138245712|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245713|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245714|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138245715|NCT01688336|Leucovorin|leucovorin|mesh-list
138245716|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
138245717|NCT01688336|Irinotecan|irinotecan|mesh-list
138245718|NCT01688336|Folfirinox|folfirinox|mesh-list
138245719|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245720|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138245721|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138245722|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245723|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245724|NCT01688336|Antidotes|antidotes|mesh-ancestor
138245725|NCT01688336|Protective Agents|protective agents|mesh-ancestor
138245726|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245727|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
138245728|NCT01688336|Vitamins|vitamins|mesh-ancestor
138245729|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
138245730|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
138245731|NCT01963481|Exemestane|exemestane|mesh-list
138245732|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245733|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
138245734|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245735|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245736|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138245737|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
138245738|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245739|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245740|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138245741|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138245742|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138245743|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245744|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138245745|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
138245746|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245747|NCT04436744|Palbociclib|palbociclib|mesh-list
138245748|NCT04436744|Anastrozole|anastrozole|mesh-list
138245749|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245750|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138245751|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245752|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245753|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245754|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138245755|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138245756|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138245757|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138245758|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245759|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245760|NCT01963793|Aprepitant|aprepitant|mesh-list
138245761|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
138245762|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
138245763|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
138245764|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245765|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245766|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245767|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138245768|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245769|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245770|NCT03449433|Insulin|insulin|mesh-list
138245771|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138245772|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
138245773|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
138245774|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138245775|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
138245776|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138245777|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245778|NCT03241485|Morphine|morphine|mesh-list
138245779|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138245780|NCT03241485|Narcotics|narcotics|mesh-ancestor
138245781|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245782|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245783|NCT03241485|Analgesics|analgesics|mesh-ancestor
138245784|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
138245785|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245786|NCT04313504|Niraparib|niraparib|mesh-list
138245787|NCT04313504|Dostarlimab|dostarlimab|mesh-list
138245789|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245790|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245791|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245792|NCT01996943|Ethanol|ethanol|mesh-list
138245793|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138245795|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245796|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245797|NCT04812626|Triamcinolone|triamcinolone|mesh-list
138245798|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138245799|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138245800|NCT04812626|Fluorouracil|fluorouracil|mesh-list
138245801|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138245802|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
138245803|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245804|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245805|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245806|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245807|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
138245808|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245809|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245810|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
138245811|NCT04812626|Hormones|hormones|mesh-ancestor
138245812|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245813|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245814|NCT04197986|Infigratinib|infigratinib|mesh-list
138245815|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245816|NCT01997411|Glucagon|glucagon|mesh-list
138245817|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138245818|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245819|NCT01997411|Hormones|hormones|mesh-ancestor
138245820|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245821|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245822|NCT01997411|Incretins|incretins|mesh-ancestor
138245823|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
138245824|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245825|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245826|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138245827|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245828|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
138245829|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
138245830|NCT02657486|Infigratinib|infigratinib|mesh-list
138245831|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245832|NCT01999985|Dasatinib|dasatinib|mesh-list
138245833|NCT01999985|Afatinib|afatinib|mesh-list
138245834|NCT01999985|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138245835|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245836|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138245838|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245839|NCT01968317|Metformin|metformin|mesh-list
138245840|NCT01968317|Megestrol|megestrol|mesh-list
138245841|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
138245842|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138245843|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245844|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138245845|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138245846|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138245847|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
138245848|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138245849|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138245850|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138245851|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245852|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245853|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
138245854|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138216157|NCT00702884|Sunitinib|sunitinib|mesh-list
138245863|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138245864|NCT02986451|Clarithromycin|clarithromycin|mesh-list
138245865|NCT02986451|Dexamethasone|dexamethasone|mesh-list
138245866|NCT02986451|Lenalidomide|lenalidomide|mesh-list
138245867|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245868|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
138245869|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
138245870|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245871|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245872|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138245873|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
138245874|NCT02986451|Hormones|hormones|mesh-ancestor
138245875|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245876|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245877|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245879|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138245880|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138245881|NCT02986451|Growth Substances|growth substances|mesh-ancestor
138245882|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138245883|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138245884|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245885|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138245886|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245887|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245888|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138245889|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138245897|NCT01974245|Vitamin D|vitamin d|mesh-list
138245898|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245899|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245900|NCT01974245|Vitamins|vitamins|mesh-ancestor
138245901|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
138245902|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138245903|NCT03307005|Zolpidem|zolpidem|mesh-list
138245904|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138245905|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138245906|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245907|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245908|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138245909|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
138245910|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
138245911|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245912|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245913|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138245914|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138245915|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138245916|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245917|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245918|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216167|NCT00703508|Metformin|metformin|mesh-list
138245920|NCT02005601|Analgesics|analgesics|mesh-ancestor
138245921|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
138245922|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245923|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
138245924|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138245925|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
138245926|NCT02007863|Fludarabine|fludarabine|mesh-list
138245928|NCT02007863|Busulfan|busulfan|mesh-list
138245929|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245930|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245931|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138245932|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
138245933|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245934|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138245935|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
138245936|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138245937|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138245938|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245939|NCT02305277|Opicapone|opicapone|mesh-list
138245940|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138245941|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245942|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245943|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138245944|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138245945|NCT03309657|Tazobactam|tazobactam|mesh-list
138245946|NCT03309657|Ceftolozane|ceftolozane|mesh-list
138245947|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138245948|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138245949|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245950|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138245952|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245953|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138245954|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
138245955|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138245956|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245957|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138245958|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245959|NCT03467685|Anesthetics|anesthetics|mesh-list
138245960|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138245961|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245962|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
138245963|NCT03468075|Gemcitabine|gemcitabine|mesh-list
138245964|NCT03468075|Vitamins|vitamins|mesh-ancestor
138245965|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
138245966|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245967|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138245968|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
138245969|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245970|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245971|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
138245972|NCT03468075|Protective Agents|protective agents|mesh-ancestor
138245973|NCT03468933|Plasminogen|plasminogen|mesh-list
138245974|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138245975|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138245976|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138245977|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245978|NCT03472287|Diacerein|diacerein|mesh-list
138245979|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138245980|NCT02219984|Anticoagulants|anticoagulants|mesh-list
138245981|NCT02067416|Paclitaxel|paclitaxel|mesh-list
138245982|NCT02067416|Docetaxel|docetaxel|mesh-list
138245983|NCT02067416|Epirubicin|epirubicin|mesh-list
138245984|NCT02067416|Taxane|taxane|mesh-list
138216171|NCT01284335|Docetaxel|docetaxel|mesh-list
138245988|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
138245989|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245990|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245991|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138245992|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138245993|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138245994|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245995|NCT03258645|Dabigatran|dabigatran|mesh-list
138245996|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
138245997|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138245998|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
138245999|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246000|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246001|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
138246002|NCT03482583|Nicotine|nicotine|mesh-list
138246003|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138246004|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
138246005|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246006|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246007|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138246008|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138246009|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
138246010|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246011|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246012|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
138246013|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138246014|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
138246015|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246016|NCT03261999|Leuprolide|leuprolide|mesh-list
138246017|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138246018|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
138246019|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138246020|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246021|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246022|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246023|NCT03482973|Bupivacaine|bupivacaine|mesh-list
138246024|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
138246025|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
138246026|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246027|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246028|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
138246029|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246030|NCT01602380|Fulvestrant|fulvestrant|mesh-list
138246031|NCT01602380|Anastrozole|anastrozole|mesh-list
138246032|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246033|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246034|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138246035|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138246036|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246037|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246038|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246039|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138246040|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138246041|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246042|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246043|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138246044|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
138246045|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246046|NCT03327051|Omeprazole|omeprazole|mesh-list
138216179|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
138246051|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246053|NCT02057939|Androgens|androgens|mesh-list
138246054|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138246055|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
138246056|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138246057|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246058|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246059|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246060|NCT02057939|Hormones|hormones|mesh-ancestor
138246061|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246062|NCT03496467|Nepafenac|nepafenac|mesh-list
138246063|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138246064|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246065|NCT03496467|Analgesics|analgesics|mesh-ancestor
138246066|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
138246067|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246068|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246069|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246070|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246072|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
138246073|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138246074|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246075|NCT03329937|Niraparib|niraparib|mesh-list
138246076|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138246077|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246078|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246079|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246080|NCT01710254|Regadenoson|regadenoson|mesh-list
138246081|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138246082|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138246083|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
138246084|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
138246085|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246086|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246087|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246088|NCT03496545|Acetaminophen|acetaminophen|mesh-list
138246089|NCT03496545|Bromocriptine|bromocriptine|mesh-list
138246090|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246091|NCT03496545|Analgesics|analgesics|mesh-ancestor
138246092|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
138246093|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246094|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246095|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
138246096|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138246097|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138246098|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246099|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246100|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
138246101|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
138246102|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246103|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246105|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138246106|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138246107|NCT01710332|Growth Substances|growth substances|mesh-ancestor
138246108|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246109|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138246110|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246111|NCT02311907|Paclitaxel|paclitaxel|mesh-list
138246112|NCT02311907|Carboplatin|carboplatin|mesh-list
138246115|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246116|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138246117|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138246118|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138246119|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246121|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
138246122|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246123|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
138246124|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
138246125|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246126|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
138246127|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246128|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246129|NCT01981967|Vaccines|vaccines|mesh-list
138246130|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
138246131|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246132|NCT01982123|Edetic Acid|edetic acid|mesh-list
138246133|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
138246134|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
138246135|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
138246136|NCT01982123|Antidotes|antidotes|mesh-ancestor
138246137|NCT01982123|Protective Agents|protective agents|mesh-ancestor
138246138|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246139|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
138246140|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
138246141|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246142|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138246143|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
138246144|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138246145|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138246147|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246148|NCT01712360|Naftifine|naftifine|mesh-list
138246149|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
138246150|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246151|NCT02396147|Relugolix|relugolix|mesh-list
138246152|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
138246153|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246154|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246155|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246156|NCT01713608|Artefenomel|artefenomel|mesh-list
138246157|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
138246158|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138246159|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138246160|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246161|NCT02018627|Glucagon|glucagon|mesh-list
138246162|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138246163|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246164|NCT02018627|Hormones|hormones|mesh-ancestor
138246165|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246166|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246167|NCT02018627|Incretins|incretins|mesh-ancestor
138246168|NCT04413344|Bromocriptine|bromocriptine|mesh-list
138246169|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138246170|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138246171|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246172|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246173|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246174|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
138246175|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
138246176|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246177|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246178|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138246180|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138246181|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138246182|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246183|NCT01717898|Prednisone|prednisone|mesh-list
138246184|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
138246185|NCT01717898|Dactolisib|dactolisib|mesh-list
138246186|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246187|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
138246188|NCT01717898|Hormones|hormones|mesh-ancestor
138246189|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246190|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246191|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246192|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246193|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138246194|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246195|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246196|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246197|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138246198|NCT01737944|Methotrexate|methotrexate|mesh-list
138246199|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138246200|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
138246201|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138246202|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246203|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138246205|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246206|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246207|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246208|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246209|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138246210|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138246211|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
138246212|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246213|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138246214|NCT01740206|Methylphenidate|methylphenidate|mesh-list
138246215|NCT01740206|Amphetamine|amphetamine|mesh-list
138362761|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138362762|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362763|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362764|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362765|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138362766|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
138246216|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138246217|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246218|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138246219|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138246220|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246221|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246222|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
138246223|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246224|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
138246225|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
138246226|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246227|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246228|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138246229|NCT01740362|Tofacitinib|tofacitinib|mesh-list
138246230|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138246231|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138246232|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246233|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246234|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138246235|NCT02068157|Trioxsalen|trioxsalen|mesh-list
138246236|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246237|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246238|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138246239|NCT01741454|Tamsulosin|tamsulosin|mesh-list
138246240|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138246241|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138246242|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138246243|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138246244|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246245|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246246|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216204|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
138216205|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
138246250|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138246251|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
138246252|NCT01720316|Glycine|glycine|mesh-list
138246253|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
138246254|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246255|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246256|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246257|NCT02399345|Ritonavir|ritonavir|mesh-list
138246258|NCT02399345|Ribavirin|ribavirin|mesh-list
138246259|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
138246260|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138246261|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138246262|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246263|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246264|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246265|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138246266|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138246267|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
138246268|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246269|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138246270|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138246271|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
138246272|NCT02400437|Dexamethasone|dexamethasone|mesh-list
138246273|NCT02400437|Rituximab|rituximab|mesh-list
138246274|NCT02400437|Ixazomib|ixazomib|mesh-list
138246275|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246276|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
138246277|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
138246278|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246279|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246280|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246281|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
138246282|NCT02400437|Hormones|hormones|mesh-ancestor
138246283|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246284|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246285|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246286|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138246287|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
138246288|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246289|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246290|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246291|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246292|NCT02024477|Saxagliptin|saxagliptin|mesh-list
138246293|NCT02024477|Incretins|incretins|mesh-ancestor
138246294|NCT02024477|Hormones|hormones|mesh-ancestor
138246295|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246296|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246297|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138246298|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246299|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246300|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246301|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138246302|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
138246303|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138246304|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
138246305|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246306|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
138246307|NCT02024711|Protective Agents|protective agents|mesh-ancestor
138246308|NCT02071823|Opicapone|opicapone|mesh-list
138246309|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138246310|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246312|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138246313|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138246314|NCT02029703|Hylan|hylan|mesh-list
138246315|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
138246316|NCT02029703|Protective Agents|protective agents|mesh-ancestor
138246317|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246318|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138246319|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138246321|NCT02406443|Incretins|incretins|mesh-ancestor
138246322|NCT02406443|Hormones|hormones|mesh-ancestor
138246323|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246324|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138246325|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246326|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246327|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246328|NCT02032433|Naltrexone|naltrexone|mesh-list
138246329|NCT02032433|Buprenorphine|buprenorphine|mesh-list
138246330|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138246331|NCT02032433|Naloxone|naloxone|mesh-list
138246332|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138246333|NCT02032433|Narcotics|narcotics|mesh-ancestor
138246334|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246335|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246336|NCT02032433|Analgesics|analgesics|mesh-ancestor
138246337|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
138246338|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246339|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138246340|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138246341|NCT02342015|Atorvastatin|atorvastatin|mesh-list
138246342|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138246343|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138246344|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
138246345|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246346|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138246347|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138246348|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246349|NCT02342327|Menthol|menthol|mesh-list
138246350|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
138246352|NCT01721564|Bosentan|bosentan|mesh-list
138246353|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246354|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138246355|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246356|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
138246357|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138246358|NCT02343575|Valproic Acid|valproic acid|mesh-list
138246359|NCT02343575|Haloperidol|haloperidol|mesh-list
138246360|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
138246361|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
138246362|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
138246363|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246364|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246365|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246366|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138246367|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138246368|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246369|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138246370|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138246371|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
138246372|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246373|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216221|NCT01195025|Chrysarobin|chrysarobin|mesh-list
138246374|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138246375|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
138246376|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246377|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
138246381|NCT01744574|Hormones|hormones|mesh-ancestor
138246382|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246383|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246384|NCT01744730|Clindamycin|clindamycin|mesh-list
138246385|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
138246386|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
138246387|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246388|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246389|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138246390|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246391|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246392|NCT00354965|Amoxicillin|amoxicillin|mesh-list
138246393|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
138246394|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
138246395|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138246396|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246397|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246398|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138246399|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246400|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246401|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138246402|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138246403|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138246404|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246405|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246406|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138246407|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246408|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246409|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
138246410|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246411|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
138246412|NCT00355043|Astringents|astringents|mesh-ancestor
138246413|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246414|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246415|NCT02037893|Antipyrine|antipyrine|mesh-list
138246416|NCT02037893|Benzocaine|benzocaine|mesh-list
138246417|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138246418|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
138246419|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
138246420|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246421|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246422|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
138246423|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246424|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138246425|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246427|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246428|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246429|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138246430|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138246431|NCT02041325|Lenalidomide|lenalidomide|mesh-list
138246432|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
138246433|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246434|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138246435|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138246436|NCT02041325|Growth Substances|growth substances|mesh-ancestor
138246437|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
138246438|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246440|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138246441|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246442|NCT01723514|Analgesics|analgesics|mesh-ancestor
138216233|NCT00703664|Bortezomib|bortezomib|mesh-list
138246445|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246447|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
138246448|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138246449|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246450|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246451|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246452|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
138246453|NCT01745822|Tenofovir|tenofovir|mesh-list
138246454|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
138246455|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246456|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138246457|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138246458|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246459|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246460|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138246461|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138246462|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
138246463|NCT02354339|Antacids|antacids|mesh-ancestor
138246464|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246465|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246466|NCT01747850|Ethanol|ethanol|mesh-list
138246467|NCT01747850|Nabiximols|nabiximols|mesh-list
138246468|NCT01747850|Dronabinol|dronabinol|mesh-list
138246469|NCT01747850|Cannabidiol|cannabidiol|mesh-list
138246470|NCT01747850|Peppermint oil|peppermint oil|mesh-list
138246471|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
138246472|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138246473|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246474|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246475|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246477|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
138246478|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246479|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
138246480|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138246481|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246482|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138246483|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138246484|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246485|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246486|NCT01747850|Hormones|hormones|mesh-ancestor
138246487|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246488|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
138246489|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
138246490|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246491|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
138246492|NCT01727414|Methylphenidate|methylphenidate|mesh-list
138246493|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138246494|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246495|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138246496|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138246497|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246498|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246500|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246501|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138246502|NCT02048891|Progesterone|progesterone|mesh-list
138246503|NCT02048891|Progestins|progestins|mesh-ancestor
138246504|NCT02048891|Hormones|hormones|mesh-ancestor
138246505|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246506|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246507|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
138246508|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138246511|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138246512|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246513|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246514|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138246515|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
138246516|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
138246517|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138246518|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138246519|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138246520|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246521|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246522|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
138246523|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246524|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246525|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
138246526|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
138246529|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246530|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
138246532|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246533|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246534|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138246535|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138246536|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138246537|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246538|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246539|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246540|NCT01748240|Azacitidine|azacitidine|mesh-list
138246541|NCT01748240|Vorinostat|vorinostat|mesh-list
138246542|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138246543|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
138246544|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246545|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246546|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246547|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138246548|NCT01748942|Dexamethasone|dexamethasone|mesh-list
138246549|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
138246550|NCT01748942|Ichthammol|ichthammol|mesh-list
138246551|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138246552|NCT01748942|BB 1101|bb 1101|mesh-list
138246553|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246554|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
138246555|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
138246556|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246557|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246558|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246559|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
138246560|NCT01748942|Hormones|hormones|mesh-ancestor
138246561|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246562|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246563|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246564|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246565|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246566|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246567|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246568|NCT02355977|Minocycline|minocycline|mesh-list
138246569|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246570|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246571|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
138246572|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138246573|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138246574|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138246575|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216246|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246576|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246578|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246579|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246580|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138246581|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246582|NCT01729598|Valproic Acid|valproic acid|mesh-list
138246583|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
138246584|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246585|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246586|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
138246587|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246588|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246589|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
138246590|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138246591|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246592|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138246593|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
138246595|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138246596|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246597|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246598|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246599|NCT05718011|Analgesics|analgesics|mesh-ancestor
138246600|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
138246601|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246602|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138246603|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138246604|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138246605|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246606|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246607|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246608|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138246609|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138246610|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
138246611|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
138246612|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138246613|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138246615|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246616|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246617|NCT01730846|Doxazosin|doxazosin|mesh-list
138246618|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246619|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138246620|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138246621|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138246622|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246623|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246624|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246625|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246626|NCT02314403|Rituximab|rituximab|mesh-list
138246627|NCT02314403|Abatacept|abatacept|mesh-list
138246628|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138246629|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246630|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
138246631|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246632|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216254|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246633|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138246634|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246635|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138246636|NCT02052557|Bupivacaine|bupivacaine|mesh-list
138246637|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
138246638|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
138246639|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246640|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246641|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
138246642|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246643|NCT02052635|Clopidogrel|clopidogrel|mesh-list
138246644|NCT02052635|Ticagrelor|ticagrelor|mesh-list
138246645|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138246646|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138246647|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138246648|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138246649|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
138246650|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246651|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246652|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246653|NCT01732718|Atorvastatin|atorvastatin|mesh-list
138246654|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138246655|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138246656|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
138246657|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246658|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138246659|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138246660|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246661|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
138246662|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138246665|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246666|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138246667|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138246668|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138246669|NCT02363621|Ranibizumab|ranibizumab|mesh-list
138246670|NCT02363621|Aflibercept|aflibercept|mesh-list
138246671|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138246672|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138246673|NCT02363621|Growth Substances|growth substances|mesh-ancestor
138246674|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246675|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
138246676|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246678|NCT01749956|Fluorouracil|fluorouracil|mesh-list
138246679|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
138246680|NCT01749956|Aflibercept|aflibercept|mesh-list
138246681|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
138246682|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246683|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138246684|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246685|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138246686|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
138246687|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246688|NCT01749956|Antidotes|antidotes|mesh-ancestor
138246689|NCT01749956|Protective Agents|protective agents|mesh-ancestor
138246690|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
138246691|NCT01749956|Vitamins|vitamins|mesh-ancestor
138246692|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
138246693|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138246694|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138246695|NCT01749956|Growth Substances|growth substances|mesh-ancestor
138246696|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
138246697|NCT02365961|Clonidine|clonidine|mesh-list
138246698|NCT02365961|Epinephrine|epinephrine|mesh-list
138246699|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138246700|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138246701|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246702|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246703|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246704|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246705|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138246706|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138246707|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
138246708|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246709|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138246710|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138246711|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
138246712|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
138246713|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138246714|NCT02365961|Analgesics|analgesics|mesh-ancestor
138246715|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
138246716|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246717|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
138246718|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138246719|NCT03809234|Ondansetron|ondansetron|mesh-list
138246720|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
138246721|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
138246722|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246723|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246724|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246725|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
138246726|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246727|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138246728|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138246729|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
138246730|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246731|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246733|NCT03711188|Ipilimumab|ipilimumab|mesh-list
138246734|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138246735|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246736|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138246737|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246738|NCT02366663|Cytarabine|cytarabine|mesh-list
138246739|NCT02366663|Rituximab|rituximab|mesh-list
138246740|NCT02366663|Etoposide|etoposide|mesh-list
138246741|NCT02366663|Melphalan|melphalan|mesh-list
138246742|NCT02366663|Carmustine|carmustine|mesh-list
138246743|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138246744|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246745|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
138246746|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246747|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246748|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138246749|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138246750|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138246751|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246752|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216293|NCT01235195|Sertraline|sertraline|mesh-list
138246753|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138246754|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
138246756|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246757|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138246758|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138246759|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
138246760|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138246761|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138246762|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
138246764|NCT02367599|Vitamin D|vitamin d|mesh-list
138246765|NCT02367599|Vitamins|vitamins|mesh-ancestor
138246766|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
138246767|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246768|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138246769|NCT02368457|Tocopherols|tocopherols|mesh-list
138246770|NCT02368457|Vitamin E|vitamin e|mesh-list
138246771|NCT02368457|Tocotrienols|tocotrienols|mesh-list
138246772|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
138246773|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
138246774|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138246775|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246776|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246777|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138246778|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138246779|NCT02368457|Protective Agents|protective agents|mesh-ancestor
138246780|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246781|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
138246782|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138246784|NCT02368457|Vitamins|vitamins|mesh-ancestor
138246785|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
138246786|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
138246787|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138246788|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246789|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138246790|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246791|NCT02373137|Ofloxacin|ofloxacin|mesh-list
138246792|NCT02373137|Prednisolone|prednisolone|mesh-list
138246793|NCT02373137|Phenylephrine|phenylephrine|mesh-list
138246794|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
138246795|NCT02373137|Tropicamide|tropicamide|mesh-list
138246796|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246797|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
138246798|NCT02373137|Hormones|hormones|mesh-ancestor
138246799|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138246800|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246801|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138246802|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246803|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
138246804|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246805|NCT02373137|Protective Agents|protective agents|mesh-ancestor
138246806|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138246807|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
138246808|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
138246809|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138246810|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
138246811|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
138246812|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138246813|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138246814|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138246815|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246816|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246817|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246818|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138246819|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138246820|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
138216300|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246821|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138246822|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246823|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246825|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138246826|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246827|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138246828|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138246829|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138246830|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138246831|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246833|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138246834|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138246835|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246836|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246837|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
138246838|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246839|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138246840|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138246841|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
138246842|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138246843|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246844|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246845|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138246846|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138246847|NCT00354731|Protective Agents|protective agents|mesh-ancestor
138246848|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246849|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
138246850|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138246851|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
138246852|NCT00354809|Casopitant|casopitant|mesh-list
138246853|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
138246854|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
138246855|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246856|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246858|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138246859|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246860|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246862|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
138246863|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246864|NCT01762904|Ethanol|ethanol|mesh-list
138246865|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
138246866|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138246867|NCT01762904|Triclosan|triclosan|mesh-list
138246868|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138246869|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246870|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246871|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246872|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
138246873|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246874|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138246875|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138246876|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
138246877|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246878|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138246879|NCT02376257|Cycloserine|cycloserine|mesh-list
138246880|NCT02376257|Modafinil|modafinil|mesh-list
138246881|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138246882|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246883|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138246884|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138362770|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138362771|NCT02245308|Bupropion|bupropion|mesh-list
138362772|NCT02245308|Nicotine|nicotine|mesh-list
138362773|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138362774|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
138362775|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246885|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138246886|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246887|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138246888|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246889|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138216308|NCT01199237|Rocuronium|rocuronium|mesh-list
138216309|NCT01199237|Neostigmine|neostigmine|mesh-list
138246891|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246892|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
138246893|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138246894|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138246895|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246896|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
138246897|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138246898|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138246899|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138246900|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246901|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
138246902|NCT03211286|Coagulants|coagulants|mesh-ancestor
138246904|NCT01763606|Enoxaparin|enoxaparin|mesh-list
138246905|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138246906|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246907|NCT01763606|Analgesics|analgesics|mesh-ancestor
138246908|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
138246909|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246910|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246911|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246912|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246913|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138246914|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138246915|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246916|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138246917|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138246918|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246919|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
138246920|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
138246921|NCT03161756|Denosumab|denosumab|mesh-list
138246922|NCT03161756|Nivolumab|nivolumab|mesh-list
138246923|NCT03161756|Ipilimumab|ipilimumab|mesh-list
138246924|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138246925|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246926|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138246927|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246928|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138246929|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246930|NCT01766024|Interferons|interferons|mesh-list
138246931|NCT01766024|Interferon-beta|interferon-beta|mesh-list
138246932|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
138246933|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246934|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
138246935|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246936|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
138246937|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246938|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138246939|NCT01767506|Azithromycin|azithromycin|mesh-list
138246940|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138246941|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246942|NCT02383043|Cocaine|cocaine|mesh-list
138246943|NCT02383043|Amphetamine|amphetamine|mesh-list
138246944|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
138246945|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138246946|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246947|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
138246948|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
138246949|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246950|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
138246951|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138246952|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246953|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138246954|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138216316|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138216321|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246956|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246957|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138246959|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
138246960|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246961|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
138246962|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138246963|NCT01768520|Celecoxib|celecoxib|mesh-list
138246964|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138246965|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138246966|NCT01768520|Analgesics|analgesics|mesh-ancestor
138246967|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
138246968|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246969|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246970|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138246971|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246972|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138246973|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138246974|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246975|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246976|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138246977|NCT00355589|Ramipril|ramipril|mesh-list
138246978|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138246979|NCT00355589|Diuretics|diuretics|mesh-ancestor
138246980|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
138246981|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246982|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138246983|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246984|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246985|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138246986|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
138246987|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246988|NCT02386319|Melatonin|melatonin|mesh-list
138246989|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
138246990|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138246991|NCT02386319|Protective Agents|protective agents|mesh-ancestor
138246992|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246993|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246994|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138246995|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
138246996|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246997|NCT02387801|Ixekizumab|ixekizumab|mesh-list
138246998|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138246999|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
138247000|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138247001|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
138247002|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247003|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138247004|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
138247005|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247006|NCT02326844|Talazoparib|talazoparib|mesh-list
138247007|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138247008|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247009|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247010|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247011|NCT02239874|Vitamin D|vitamin d|mesh-list
138247012|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
138247013|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
138247014|NCT02239874|Vitamins|vitamins|mesh-list
138247015|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
138216324|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247016|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247017|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138247018|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138247020|NCT01771952|Hylan|hylan|mesh-list
138247021|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138247022|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
138247023|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247024|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
138247025|NCT01771952|Protective Agents|protective agents|mesh-ancestor
138247026|NCT02389361|Acetaminophen|acetaminophen|mesh-list
138247027|NCT02389361|Tramadol|tramadol|mesh-list
138247028|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247029|NCT02389361|Analgesics|analgesics|mesh-ancestor
138247030|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
138247031|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247032|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247033|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
138247034|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138247035|NCT02389361|Narcotics|narcotics|mesh-ancestor
138247036|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247037|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138247038|NCT02252354|Relugolix|relugolix|mesh-list
138247039|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
138247040|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
138247041|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247042|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247043|NCT02393339|Acetaminophen|acetaminophen|mesh-list
138247044|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247045|NCT02393339|Analgesics|analgesics|mesh-ancestor
138247046|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
138247047|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247048|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247049|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
138247050|NCT05235191|Methadone|methadone|mesh-list
138247051|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138247052|NCT05235191|Narcotics|narcotics|mesh-ancestor
138247053|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247054|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247055|NCT05235191|Analgesics|analgesics|mesh-ancestor
138247056|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
138247057|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247058|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
138247059|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
138247060|NCT01774604|Indomethacin|indomethacin|mesh-list
138247061|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138247062|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247063|NCT01774604|Analgesics|analgesics|mesh-ancestor
138247064|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
138247065|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247066|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247067|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247068|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247069|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
138247070|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
138247071|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138247072|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138247073|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247074|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247075|NCT01777412|Bevacizumab|bevacizumab|mesh-list
138247076|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247077|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247078|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138247079|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138247080|NCT01777412|Growth Substances|growth substances|mesh-ancestor
138247081|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247082|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
138247086|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
138247087|NCT01780454|Rituximab|rituximab|mesh-list
138247088|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247089|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247090|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
138247091|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247092|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247093|NCT00355901|Visilizumab|visilizumab|mesh-list
138247094|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
138247095|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247096|NCT00355667|Furosemide|furosemide|mesh-list
138247097|NCT00355667|Azosemide|azosemide|mesh-list
138247098|NCT00355667|Diuretics|diuretics|mesh-ancestor
138247099|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
138247100|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247101|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138247102|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247103|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247105|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
138247106|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247107|NCT04419948|Ibuprofen|ibuprofen|mesh-list
138247108|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138247109|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247110|NCT04419948|Analgesics|analgesics|mesh-ancestor
138247111|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
138247112|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247113|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247114|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247115|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247116|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138247117|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247118|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247119|NCT01312922|Dexetimide|dexetimide|mesh-list
138247120|NCT01312922|Pipamperone|pipamperone|mesh-list
138247121|NCT01312922|Citalopram|citalopram|mesh-list
138247122|NCT01312922|Escitalopram|escitalopram|mesh-list
138247123|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138247124|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138247125|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247126|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247127|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247128|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
138247129|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247130|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138247131|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
138247132|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138247133|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138247134|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138247135|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
138247136|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
138247137|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247138|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138247139|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138247140|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
138247141|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138247142|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138247143|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216344|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
138247147|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
138247149|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138247150|NCT01783574|Androgens|androgens|mesh-ancestor
138247151|NCT01783574|Hormones|hormones|mesh-ancestor
138247152|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247153|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247154|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247155|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247156|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
138247157|NCT03656783|Tenofovir|tenofovir|mesh-list
138247158|NCT03656783|Emtricitabine|emtricitabine|mesh-list
138247159|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138247160|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
138247161|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247162|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138247163|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138247164|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247165|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247166|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138247167|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138247168|NCT01784666|Isradipine|isradipine|mesh-list
138247169|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138247170|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138247171|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247172|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247173|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138247174|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247175|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
138247176|NCT04296695|Tenofovir|tenofovir|mesh-list
138247177|NCT04296695|Efavirenz|efavirenz|mesh-list
138247178|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
138247180|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138247181|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138247182|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247183|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247184|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138247185|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138247186|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138247187|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138247188|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138247189|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138247190|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138247191|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138247192|NCT04259645|Bupivacaine|bupivacaine|mesh-list
138247193|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247195|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247196|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247197|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
138247198|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247199|NCT01787006|Fluorouracil|fluorouracil|mesh-list
138247200|NCT01787006|Cetuximab|cetuximab|mesh-list
138247201|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247202|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
138247203|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247204|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247205|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216354|NCT00703976|Bevacizumab|bevacizumab|mesh-list
138216355|NCT00703976|Cetuximab|cetuximab|mesh-list
138247207|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247208|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247210|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
138247211|NCT02260622|Clopidogrel|clopidogrel|mesh-list
138247212|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138247213|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247214|NCT02260622|Analgesics|analgesics|mesh-ancestor
138247215|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
138247216|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247217|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247218|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247219|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247220|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138247221|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138247222|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247223|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138247224|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138247225|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247226|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
138247227|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138247228|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138247229|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138247230|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
138247231|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247232|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138247233|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
138247234|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138247235|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
138247236|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
138247237|NCT03186209|Benralizumab|benralizumab|mesh-list
138247238|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138247239|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138247241|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138247242|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
138247243|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138247244|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138247245|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247246|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247247|NCT02261948|Protective Agents|protective agents|mesh-ancestor
138247248|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247250|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138247251|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138247252|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247253|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247254|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247255|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
138247256|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247257|NCT00357149|Cisplatin|cisplatin|mesh-list
138247258|NCT00357149|Docetaxel|docetaxel|mesh-list
138247259|NCT00357149|Fluorouracil|fluorouracil|mesh-list
138247260|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247261|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138247262|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138247263|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215604|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138247264|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247265|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
138247266|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247267|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138247268|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
138216363|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
138247272|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247273|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
138247274|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
138247275|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
138247276|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247277|NCT04071821|Cetirizine|cetirizine|mesh-list
138247278|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138247279|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138247280|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138247281|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
138247284|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247285|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247287|NCT03064295|Regadenoson|regadenoson|mesh-list
138247288|NCT03064295|Analgesics|analgesics|mesh-ancestor
138247289|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
138247290|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247291|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247292|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138247293|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
138247294|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138247295|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
138247296|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
138247297|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247298|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216381|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
138247299|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138247300|NCT01789814|Clopidogrel|clopidogrel|mesh-list
138247301|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138247302|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138247303|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138247304|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138247305|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138247306|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
138247307|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247308|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247309|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247310|NCT00356447|Estradiol|estradiol|mesh-list
138247311|NCT00356447|Estrogens|estrogens|mesh-ancestor
138247312|NCT00356447|Hormones|hormones|mesh-ancestor
138247313|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247314|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247315|NCT01736852|Oxytocin|oxytocin|mesh-list
138247318|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247319|NCT01810952|Insulin|insulin|mesh-list
138247320|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138247321|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
138247322|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
138247323|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
138247324|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
138247325|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
138247326|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138247327|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247328|NCT04059887|Atezolizumab|atezolizumab|mesh-list
138247329|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138247330|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247331|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247332|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247334|NCT01877642|Loxapine|loxapine|mesh-list
138247335|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
138247336|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
138247337|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
138247349|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247350|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138247351|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138247352|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
138247353|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138247354|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247355|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247357|NCT01878656|Desflurane|desflurane|mesh-list
138247358|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138247359|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138247360|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
138247361|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
138247362|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247363|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247364|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
138247365|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138247366|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
138247367|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247368|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
138247369|NCT01811654|Protective Agents|protective agents|mesh-ancestor
138247371|NCT02266472|Empagliflozin|empagliflozin|mesh-list
138247372|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138247373|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247374|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138247375|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247376|NCT03500289|Midazolam|midazolam|mesh-list
138247377|NCT03500289|Ketamine|ketamine|mesh-list
138247378|NCT03500289|Analgesics|analgesics|mesh-ancestor
138216383|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138247379|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
138247380|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247381|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247382|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138247383|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138247384|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
138247385|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
138247386|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247387|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138247388|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138247389|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247390|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247391|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138247393|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247394|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138247395|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138247396|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
138247397|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
138247398|NCT01812044|Lidocaine|lidocaine|mesh-list
138247399|NCT01812044|Bupivacaine|bupivacaine|mesh-list
138247400|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
138247401|NCT01812044|Anesthetics|anesthetics|mesh-list
138247402|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247403|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247404|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
138247405|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247406|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138247407|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138247408|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138247409|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247410|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247411|NCT03974789|Dexamethasone|dexamethasone|mesh-list
138247412|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247413|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
138247414|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
138247415|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247416|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247417|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247418|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
138247420|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247421|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247422|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247423|NCT01812668|Fluorides|fluorides|mesh-list
138247424|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
138247425|NCT01812668|Protective Agents|protective agents|mesh-ancestor
138247426|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247427|NCT02570477|Vancomycin|vancomycin|mesh-list
138247428|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247429|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247430|NCT04344821|Calcium|calcium|mesh-list
138247431|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138247432|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247433|NCT04351100|Diacerein|diacerein|mesh-list
138247434|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247435|NCT05328674|Mitogens|mitogens|mesh-list
138247437|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247438|NCT01798316|Acetaminophen|acetaminophen|mesh-list
138247439|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247440|NCT01798316|Analgesics|analgesics|mesh-ancestor
138247441|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
138247442|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247443|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247444|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
138247445|NCT03883763|Bupivacaine|bupivacaine|mesh-list
138247446|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247447|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
138247448|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247449|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247450|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
138247451|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247452|NCT01798394|Progesterone|progesterone|mesh-list
138247453|NCT01798394|Progestins|progestins|mesh-ancestor
138247454|NCT01798394|Hormones|hormones|mesh-ancestor
138247455|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247456|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247457|NCT01798550|Enoxaparin|enoxaparin|mesh-list
138247458|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
138247459|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138247460|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138247461|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247469|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138247470|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247471|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247472|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247473|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
138247474|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
138247475|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247476|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138247477|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
138247478|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247479|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138247480|NCT02340000|Amoxicillin|amoxicillin|mesh-list
138247481|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
138247482|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
138247483|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138247484|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247485|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247486|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138247487|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247488|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247489|NCT01813214|Vemurafenib|vemurafenib|mesh-list
138247490|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247491|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138247492|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247493|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247494|NCT01815008|Aspirin|aspirin|mesh-list
138247495|NCT01815008|Clopidogrel|clopidogrel|mesh-list
138247496|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138247497|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247498|NCT01815008|Analgesics|analgesics|mesh-ancestor
138247499|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
138247500|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247501|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247502|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247503|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247504|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138247505|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138247506|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247507|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138247508|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138247509|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247511|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138247512|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138247513|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138247514|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
138247515|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247516|NCT01801124|Bupivacaine|bupivacaine|mesh-list
138247517|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247518|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
138247519|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247520|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247521|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
138247522|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247527|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247528|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247529|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247530|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138247531|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247532|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138247534|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247535|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247536|NCT03331965|Metoclopramide|metoclopramide|mesh-list
138247537|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
138247538|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
138247539|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247540|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247541|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247542|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138247543|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138247544|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
138247545|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247546|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247547|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138247548|NCT03279237|Leucovorin|leucovorin|mesh-list
138247549|NCT03279237|Paclitaxel|paclitaxel|mesh-list
138247550|NCT03279237|Carboplatin|carboplatin|mesh-list
138247551|NCT03279237|Fluorouracil|fluorouracil|mesh-list
138247552|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
138247553|NCT03279237|Irinotecan|irinotecan|mesh-list
138247554|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138247555|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247556|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138247557|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138247558|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138247559|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247560|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
138247561|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247562|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138247563|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
138247564|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247565|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138247566|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138247567|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247568|NCT03279237|Antidotes|antidotes|mesh-ancestor
138247569|NCT03279237|Protective Agents|protective agents|mesh-ancestor
138247570|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
138247571|NCT03279237|Vitamins|vitamins|mesh-ancestor
138247572|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
138247573|NCT03282591|Serlopitant|serlopitant|mesh-list
138247574|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138247575|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247576|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247577|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247578|NCT03509883|Apixaban|apixaban|mesh-list
138247580|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
138247581|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138247582|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
138247583|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216407|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247584|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247585|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
138247586|NCT03336645|Midazolam|midazolam|mesh-list
138247587|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138247588|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138247593|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138247594|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138247595|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
138247596|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
138247597|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
138247598|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
138247599|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247600|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247601|NCT00376311|Calcitonin|calcitonin|mesh-list
138247602|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
138247603|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138247604|NCT00376311|Katacalcin|katacalcin|mesh-list
138247605|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138247606|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247607|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138247608|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138247609|NCT03511521|Insulin|insulin|mesh-list
138247610|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138247611|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
138247612|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
138247613|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
138247614|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
138247615|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138247616|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247617|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
138247618|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138247619|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138247620|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
138247622|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247623|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
138247624|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
138247625|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247626|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247627|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247628|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
138247629|NCT00376077|Hormones|hormones|mesh-ancestor
138247630|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247631|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138247633|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247635|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
138247637|NCT03519243|Hematinics|hematinics|mesh-ancestor
138247638|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
138247639|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247640|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247641|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138247642|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138247643|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247644|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247645|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247646|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
138247647|NCT03521505|Propofol|propofol|mesh-list
138247649|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247650|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247651|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247652|NCT03521505|Analgesics|analgesics|mesh-ancestor
138247653|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
138247654|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247655|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138216414|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138247682|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138247683|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
138247684|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247685|NCT03594045|Apixaban|apixaban|mesh-list
138247686|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138247687|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
138247688|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138247689|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
138247690|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247691|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247692|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
138247693|NCT03595449|Lidocaine|lidocaine|mesh-list
138247694|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247695|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
138247696|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247697|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216422|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138247698|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
138247715|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
138247716|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247717|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247718|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247719|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
138247720|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
138247721|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247722|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
138247723|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138247724|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
138247725|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138247727|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138247728|NCT03352323|Protective Agents|protective agents|mesh-ancestor
138247729|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
138247730|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247731|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247733|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
138247734|NCT03357393|Scopolamine|scopolamine|mesh-list
138247735|NCT03357393|Morphine|morphine|mesh-list
138247736|NCT03357393|Propofol|propofol|mesh-list
138247737|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138247738|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138247739|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247740|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247741|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138247742|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
138247743|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
138247744|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138247745|NCT03357393|Narcotics|narcotics|mesh-ancestor
138247746|NCT03357393|Analgesics|analgesics|mesh-ancestor
138247747|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
138247748|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247749|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138247750|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247751|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138247752|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216430|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
138247765|NCT03541941|Bupivacaine|bupivacaine|mesh-list
138247766|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247767|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
138247768|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247769|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247770|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
138247771|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247772|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
138247773|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247774|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138247775|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247776|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247778|NCT03556761|Diuretics|diuretics|mesh-ancestor
138247779|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
138247780|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247781|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138247782|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247783|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247784|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
138247785|NCT03559179|Narcotics|narcotics|mesh-ancestor
138247786|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247787|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247789|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
138247790|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247791|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
138247792|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247793|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247794|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138247795|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138247796|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247797|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247798|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247799|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138247800|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138247801|NCT03368235|Prednisolone|prednisolone|mesh-list
138247802|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247803|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
138247805|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247806|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247807|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247808|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247809|NCT02310750|PF-06700841|pf-06700841|mesh-list
138216436|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138247819|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138247821|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138247822|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247823|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247825|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138247826|NCT04373421|Benzydamine|benzydamine|mesh-list
138247827|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138247828|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247829|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
138247830|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
138247831|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247832|NCT03632109|Gentamicins|gentamicins|mesh-list
138247833|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247834|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247835|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138247836|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247837|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247838|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
138247839|NCT02363946|Promethazine|promethazine|mesh-list
138247840|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138247841|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138247842|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247843|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247844|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
138247845|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
138247846|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
138247847|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247848|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
138247849|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
138247850|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247851|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138247852|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
138247853|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
138247854|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247855|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247856|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138247857|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
138247858|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138247860|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247861|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138247862|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247863|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247864|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138247865|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138247866|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
138247867|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247868|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216448|NCT02189213|Sertraline|sertraline|mesh-list
138247882|NCT01803074|Tenofovir|tenofovir|mesh-list
138247884|NCT01803074|BMS-955176|bms-955176|mesh-list
138247885|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138247886|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138247887|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
138247888|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247889|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247890|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138247891|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138247893|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247894|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138247895|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138247896|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138247897|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138247898|NCT05327894|Blinatumomab|blinatumomab|mesh-list
138247899|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138247900|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247901|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
138247902|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247903|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
138247904|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
138247905|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247906|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
138247907|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247908|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247909|NCT01822886|Gemcitabine|gemcitabine|mesh-list
138247911|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247912|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
138247913|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247915|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138247916|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138247917|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247918|NCT01823510|Aspirin|aspirin|mesh-list
138247919|NCT01823510|Clopidogrel|clopidogrel|mesh-list
138247920|NCT01823510|Ticagrelor|ticagrelor|mesh-list
138247921|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138247922|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247923|NCT01823510|Analgesics|analgesics|mesh-ancestor
138247924|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
138247925|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247926|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247927|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216452|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138247930|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138247931|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247932|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138247933|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138247935|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
138247936|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138247937|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138247938|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138247939|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
138247941|NCT05327582|Paclitaxel|paclitaxel|mesh-list
138247942|NCT05327582|Durvalumab|durvalumab|mesh-list
138247943|NCT05327582|Lenvatinib|lenvatinib|mesh-list
138247944|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138247945|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247946|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138247947|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138247948|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138247949|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247950|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247951|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138247952|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247954|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
138247955|NCT02271698|BB 1101|bb 1101|mesh-list
138247956|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247957|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
138247958|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
138247959|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247960|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247961|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247963|NCT02271698|Hormones|hormones|mesh-ancestor
138247964|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247965|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247966|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247967|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
138247968|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247969|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247971|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
138247972|NCT02328404|Vitamins|vitamins|mesh-ancestor
138247973|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
138247974|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247975|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138247976|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138247977|NCT01829516|Oxytocin|oxytocin|mesh-list
138247978|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
138247979|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138247980|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247981|NCT01830140|Bimatoprost|bimatoprost|mesh-list
138247982|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138247983|NCT01830842|Nicotine|nicotine|mesh-list
138247985|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
138247986|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247988|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138247989|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138247990|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
138247991|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247992|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247993|NCT01831232|Cytarabine|cytarabine|mesh-list
138247994|NCT01831232|Idarubicin|idarubicin|mesh-list
138247995|NCT01831232|Pravastatin|pravastatin|mesh-list
138247996|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247997|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
138247998|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247999|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248001|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248002|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248003|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
138248004|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248005|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138248006|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138248007|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138248008|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248009|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138248010|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138248011|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138248012|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138248014|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
138248015|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248016|NCT01833026|Albuterol|albuterol|mesh-list
138248017|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138248018|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
138248019|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248020|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248021|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138248022|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248024|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138248025|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138248026|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138248027|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138248028|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
138248029|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248030|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248031|NCT03383523|Praziquantel|praziquantel|mesh-list
138248033|NCT03383523|Toltrazuril|toltrazuril|mesh-list
138248034|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
138248035|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138248036|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248037|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
138248038|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138248040|NCT00377091|Fondaparinux|fondaparinux|mesh-list
138248041|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138248042|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
138248043|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138248044|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138248045|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248046|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248047|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
138248048|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138248049|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248050|NCT01835912|Citric Acid|citric acid|mesh-list
138362777|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138362778|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138362779|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
138362780|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362781|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362782|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138362783|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
138248051|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
138248052|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
138248053|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138248055|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
138248056|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248057|NCT05747768|Midazolam|midazolam|mesh-list
138248058|NCT05747768|Dabigatran|dabigatran|mesh-list
138248059|NCT05747768|Atorvastatin|atorvastatin|mesh-list
138248060|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138248061|NCT05747768|Pitavastatin|pitavastatin|mesh-list
138248062|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138248063|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138248064|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248065|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248066|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216474|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138248067|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138248068|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138248069|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138248070|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
138248071|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
138248072|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
138248073|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
138248074|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248075|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248076|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138248077|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138248078|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
138248079|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138248080|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138248081|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248082|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
138248083|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138248084|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
138248085|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
138248086|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
138248087|NCT04410159|Listerine|listerine|mesh-list
138248088|NCT04410159|Povidone|povidone|mesh-list
138248089|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
138248090|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
138248091|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138248092|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248093|NCT03398421|Itraconazole|itraconazole|mesh-list
138248094|NCT03398421|Nemiralisib|nemiralisib|mesh-list
138248095|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
138248096|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248097|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138248098|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138248099|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248100|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248101|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138248103|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248104|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248105|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138248106|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248107|NCT01839110|Ranolazine|ranolazine|mesh-list
138248108|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138248109|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248110|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248111|NCT00559754|Bevacizumab|bevacizumab|mesh-list
138248112|NCT00559754|Docetaxel|docetaxel|mesh-list
138248113|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248114|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248115|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248116|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248117|NCT00559754|Growth Substances|growth substances|mesh-ancestor
138248118|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248119|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248120|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248121|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248122|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248123|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248124|NCT03402243|Menthol|menthol|mesh-list
138248125|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
138248126|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248127|NCT01841606|Ondansetron|ondansetron|mesh-list
138248128|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
138248129|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
138248130|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248131|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248132|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248133|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
138248134|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248136|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138248137|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
138248138|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216480|NCT01287377|Nicotine|nicotine|mesh-list
138248139|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248141|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
138248142|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248143|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248144|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248145|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248146|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248147|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248148|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
138248149|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
138248150|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
138248151|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248152|NCT00559364|Omeprazole|omeprazole|mesh-list
138248153|NCT00559364|Pancrelipase|pancrelipase|mesh-list
138248154|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138248155|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138248156|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248157|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248158|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248159|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
138248160|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248161|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138248162|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
138248163|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
138248164|NCT05746676|Protective Agents|protective agents|mesh-ancestor
138248165|NCT05746598|Cisplatin|cisplatin|mesh-list
138248166|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248167|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
138248168|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138248169|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248170|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248171|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
138248172|NCT05745974|Coagulants|coagulants|mesh-ancestor
138248173|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
138248174|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248175|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248176|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138248177|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248178|NCT02306694|Factor VIII|factor viii|mesh-list
138248179|NCT02306694|Coagulants|coagulants|mesh-ancestor
138248180|NCT01648140|Interferons|interferons|mesh-list
138248182|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
138248183|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
138248184|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138248185|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248186|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
138248187|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248188|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
138248189|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248190|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
138248191|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248192|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
138248193|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
138248194|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138248196|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248197|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248198|NCT02335242|Urological Agents|urological agents|mesh-ancestor
138248199|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
138248200|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138248201|NCT02305758|Bevacizumab|bevacizumab|mesh-list
138248202|NCT02305758|Fluorouracil|fluorouracil|mesh-list
138248203|NCT02305758|Veliparib|veliparib|mesh-list
138248204|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248205|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248206|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248207|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248212|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248214|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248215|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
138248216|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138248217|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248218|NCT04392219|Molnupiravir|molnupiravir|mesh-list
138248219|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
138248220|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248221|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138248222|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
138248223|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248224|NCT03654417|Lidocaine|lidocaine|mesh-list
138248225|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248226|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
138248227|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248228|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248229|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
138248230|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248231|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138248232|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138248233|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138248234|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248235|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248236|NCT00376701|Bevacizumab|bevacizumab|mesh-list
138248237|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248238|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248239|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248240|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248241|NCT00376701|Growth Substances|growth substances|mesh-ancestor
138248242|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248243|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248244|NCT04358991|Ceftazidime|ceftazidime|mesh-list
138248245|NCT04358991|Avibactam|avibactam|mesh-list
138248246|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138248247|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138248248|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248250|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248251|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248252|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138248253|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
138248254|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248255|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248256|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138248257|NCT02354976|Fenofibrate|fenofibrate|mesh-list
138248258|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138248259|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
138248260|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248261|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138248262|NCT02303262|Gemcitabine|gemcitabine|mesh-list
138248263|NCT02303262|Mocetinostat|mocetinostat|mesh-list
138248264|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138248265|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
138248266|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248267|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248268|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138248269|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248270|NCT00558896|Dexamethasone|dexamethasone|mesh-list
138248275|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248276|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248277|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248278|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
138248279|NCT00558896|Hormones|hormones|mesh-ancestor
138248280|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248281|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248282|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248283|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
138248284|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248285|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248286|NCT00558896|Growth Substances|growth substances|mesh-ancestor
138248287|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248288|NCT01857362|Nitisinone|nitisinone|mesh-list
138248289|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248290|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248291|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
138248292|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138248293|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
138248294|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248295|NCT02265224|Expectorants|expectorants|mesh-ancestor
138248296|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248297|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138248298|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
138248299|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248300|NCT02265224|Protective Agents|protective agents|mesh-ancestor
138248301|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248303|NCT01859078|Digoxin|digoxin|mesh-list
138248304|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138248305|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138248306|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248307|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248308|NCT01859078|Protective Agents|protective agents|mesh-ancestor
138248309|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248310|NCT00558428|Amlodipine|amlodipine|mesh-list
138248311|NCT00558428|Telmisartan|telmisartan|mesh-list
138248312|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138248313|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138248314|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138248315|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248316|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248317|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138248318|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248319|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
138248320|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138248321|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138248322|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138248323|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248325|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248326|NCT04310085|Lumefantrine|lumefantrine|mesh-list
138248327|NCT04310085|Artemether|artemether|mesh-list
138248328|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138248329|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
138248330|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138248331|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138248332|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248333|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
138248334|NCT00558272|Saracatinib|saracatinib|mesh-list
138248336|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248337|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248338|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248339|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248340|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
138248341|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138248342|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248343|NCT03407625|Misoprostol|misoprostol|mesh-list
138248344|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138248345|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
138248346|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138248347|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248348|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138248349|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248350|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
138248352|NCT03666663|Bupivacaine|bupivacaine|mesh-list
138248353|NCT03666663|Ropivacaine|ropivacaine|mesh-list
138248354|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248355|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
138248356|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248357|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248358|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
138248359|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248360|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138248361|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138248362|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138248363|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248364|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248365|NCT01863134|Eptifibatide|eptifibatide|mesh-list
138248366|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138248367|NCT03415581|Oxycodone|oxycodone|mesh-list
138248368|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138248369|NCT03415581|Narcotics|narcotics|mesh-ancestor
138248370|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248371|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248372|NCT03415581|Analgesics|analgesics|mesh-ancestor
138248373|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
138248374|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248375|NCT00557492|Bevacizumab|bevacizumab|mesh-list
138248376|NCT00557492|Gemcitabine|gemcitabine|mesh-list
138248377|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248378|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248379|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248380|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248381|NCT00557492|Growth Substances|growth substances|mesh-ancestor
138248382|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248383|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248384|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138248385|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
138248386|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248388|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138248389|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248390|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248391|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248392|NCT04203225|Lidocaine|lidocaine|mesh-list
138248393|NCT04203225|Epinephrine|epinephrine|mesh-list
138248394|NCT04203225|Tetracaine|tetracaine|mesh-list
138248395|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248396|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
138248397|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248398|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248399|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
138248400|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248401|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138248402|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138248403|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138248404|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248405|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248406|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138248408|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
138248409|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248410|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138248411|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138248412|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
138248413|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138248414|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248415|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
138248416|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
138248417|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138248418|NCT05314257|Granisetron|granisetron|mesh-list
138248419|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
138248420|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
138248421|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248422|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248423|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248424|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138248425|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138248426|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
138248427|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248428|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248429|NCT02354586|Niraparib|niraparib|mesh-list
138248430|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138248431|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248432|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248433|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248434|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138248435|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248436|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248437|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248438|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248439|NCT00377325|Cyclosporine|cyclosporine|mesh-list
138248440|NCT00377325|Cyclosporins|cyclosporins|mesh-list
138248441|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248442|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248443|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248444|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
138248445|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248446|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
138248447|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248448|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248449|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248450|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138248452|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
138248453|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
138248454|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138248455|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138248456|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138248457|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248458|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248459|NCT03701061|Vaccines|vaccines|mesh-list
138248460|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
138248461|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248462|NCT03705273|Dexamethasone|dexamethasone|mesh-list
138248463|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
138248467|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
138248468|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248469|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248470|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248471|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
138248472|NCT03705273|Hormones|hormones|mesh-ancestor
138248473|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248474|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248475|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248476|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
138248477|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248478|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248479|NCT04184271|Fluorides|fluorides|mesh-list
138248480|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
138248481|NCT04184271|Protective Agents|protective agents|mesh-ancestor
138248482|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248483|NCT03936387|Ropivacaine|ropivacaine|mesh-list
138248484|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248485|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
138248486|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248487|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248488|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
138248489|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248490|NCT04173429|Nadroparin|nadroparin|mesh-list
138248491|NCT04173429|Warfarin|warfarin|mesh-list
138248492|NCT04173429|Calcium|calcium|mesh-list
138248493|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138248494|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248495|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
138248496|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138248497|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248498|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248500|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248501|NCT04167189|Lidocaine|lidocaine|mesh-list
138248502|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248503|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
138248504|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248505|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248506|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
138248507|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248508|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138248509|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138248510|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138248511|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248512|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248513|NCT03929367|Oxytocin|oxytocin|mesh-list
138248514|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
138248515|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138248516|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248517|NCT04149405|Diphosphonates|diphosphonates|mesh-list
138248518|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138248519|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248520|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138248521|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248522|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248523|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248524|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248525|NCT03717051|Nicotine|nicotine|mesh-list
138248526|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138248527|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
138248528|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248529|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248530|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138248531|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138248532|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
138248533|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248534|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248535|NCT04350320|Colchicine|colchicine|mesh-list
138248536|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
138248537|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248538|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248539|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248540|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248541|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248542|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248543|NCT03920865|Risdiplam|risdiplam|mesh-list
138248544|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138248545|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248546|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248547|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138248548|NCT00556322|Docetaxel|docetaxel|mesh-list
138248549|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248550|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248551|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248552|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248553|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248554|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248555|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248556|NCT04137627|Melatonin|melatonin|mesh-list
138248557|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
138248558|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248559|NCT04137627|Protective Agents|protective agents|mesh-ancestor
138248560|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248561|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248562|NCT04136145|Belimumab|belimumab|mesh-list
138248563|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248564|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
138248565|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248566|NCT01869686|Denosumab|denosumab|mesh-list
138248567|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138248568|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248569|NCT03360890|Docetaxel|docetaxel|mesh-list
138248570|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
138248571|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248572|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248573|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248574|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248575|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248576|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248577|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138248578|NCT03862755|Heparin|heparin|mesh-list
138248579|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138248580|NCT03862755|Tinzaparin|tinzaparin|mesh-list
138248581|NCT03862755|Dalteparin|dalteparin|mesh-list
138248582|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
138248583|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138248584|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248585|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248586|NCT02332590|Adalimumab|adalimumab|mesh-list
138248587|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138248588|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248589|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248590|NCT04076787|Sunitinib|sunitinib|mesh-list
138248591|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248593|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138248595|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248596|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248597|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248598|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248599|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248600|NCT00554840|Varenicline|varenicline|mesh-list
138248601|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138248602|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138248603|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
138248604|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248605|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248606|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248608|NCT04069221|Artefenomel|artefenomel|mesh-list
138248609|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138248610|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138248611|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
138248612|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248613|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138248614|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138248615|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248616|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248617|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
138248618|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138248619|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138248620|NCT03054038|Afatinib|afatinib|mesh-list
138248621|NCT03054038|Necitumumab|necitumumab|mesh-list
138248622|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248623|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248624|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248625|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248626|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248627|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138248628|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248629|NCT03958071|Pirfenidone|pirfenidone|mesh-list
138248630|NCT03958071|Nintedanib|nintedanib|mesh-list
138248631|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248632|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248633|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248634|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248635|NCT03958071|Analgesics|analgesics|mesh-ancestor
138248636|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
138248637|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248638|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248639|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138248640|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138248641|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248642|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248643|NCT04066647|Dexamethasone|dexamethasone|mesh-list
138248644|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248645|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
138248646|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
138248647|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248648|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248649|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248650|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
138248652|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248653|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248654|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248655|NCT04041453|Ivermectin|ivermectin|mesh-list
138248656|NCT04041453|Albendazole|albendazole|mesh-list
138248657|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138248659|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
138248660|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
138248661|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138248662|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138248663|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248664|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248665|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248666|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248667|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248668|NCT02354508|Pasireotide|pasireotide|mesh-list
138248669|NCT02354508|Hormones|hormones|mesh-ancestor
138248670|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248671|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248672|NCT00554216|Topiramate|topiramate|mesh-list
138248673|NCT00554216|Phentermine|phentermine|mesh-list
138248674|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
138248675|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138248676|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248677|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138248678|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
138248679|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138248680|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
138248681|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
138248682|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248683|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
138248684|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248685|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248687|NCT02353572|Bortezomib|bortezomib|mesh-list
138248688|NCT02353572|Melphalan|melphalan|mesh-list
138248689|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248691|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
138248692|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248693|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248694|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248695|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
138248696|NCT02353572|Hormones|hormones|mesh-ancestor
138248697|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248698|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248699|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248700|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138248701|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
138248702|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248703|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138248704|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248705|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
138248706|NCT03886701|Isoniazid|isoniazid|mesh-list
138248707|NCT03886701|Rifapentine|rifapentine|mesh-list
138248708|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
138248709|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138248710|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248711|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138248712|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138248713|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
138248714|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248715|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138248716|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138248717|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
138248718|NCT00552578|Buprenorphine|buprenorphine|mesh-list
138248719|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138248720|NCT00552578|Naloxone|naloxone|mesh-list
138248721|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138248722|NCT00552578|Narcotics|narcotics|mesh-ancestor
138248723|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248724|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248728|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138248729|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
138248730|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138248731|NCT02301936|Ledipasvir|ledipasvir|mesh-list
138248732|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
138248733|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248734|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
138248735|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138248736|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
138248737|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248738|NCT03881163|Expectorants|expectorants|mesh-ancestor
138248739|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248740|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138248741|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
138248742|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248743|NCT03881163|Protective Agents|protective agents|mesh-ancestor
138248744|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248746|NCT03848871|Betamethasone|betamethasone|mesh-list
138248747|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
138248748|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138248749|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
138248750|NCT03848871|Calcipotriene|calcipotriene|mesh-list
138248751|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138248752|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248753|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
138248754|NCT03848871|Hormones|hormones|mesh-ancestor
138248755|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248756|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248757|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138248758|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248759|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248760|NCT04032327|Bupivacaine|bupivacaine|mesh-list
138248761|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
138248762|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
138248763|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248764|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248765|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
138248766|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248767|NCT04041219|Tacrolimus|tacrolimus|mesh-list
138248768|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248769|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
138248770|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248771|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138248772|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248773|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248774|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
138248775|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138248776|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248777|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248778|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
138248779|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248780|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248781|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138248782|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138248783|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248784|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138248785|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138248786|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
138248787|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248788|NCT03879603|Antacids|antacids|mesh-ancestor
138248789|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248790|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248791|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138248792|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138248793|NCT00553514|Hormones|hormones|mesh-ancestor
138248794|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248795|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248796|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138248797|NCT02813642|Mitogens|mitogens|mesh-list
138248798|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248799|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248801|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138248802|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138248803|NCT03852537|Prednisolone|prednisolone|mesh-list
138248804|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
138248805|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138248806|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
138248807|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248808|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
138248809|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
138248810|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248811|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248812|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248814|NCT03852537|Hormones|hormones|mesh-ancestor
138248815|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248816|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138248817|NCT03852537|Protective Agents|protective agents|mesh-ancestor
138248818|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248819|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248820|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
138248821|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
138248822|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248823|NCT00553202|Cyclosporine|cyclosporine|mesh-list
138248824|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
138248825|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138248826|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138248827|NCT00553202|Prednisolone|prednisolone|mesh-list
138248828|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
138248829|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
138248830|NCT00553202|Busulfan|busulfan|mesh-list
138248831|NCT00553202|Methotrexate|methotrexate|mesh-list
138248832|NCT00553202|Tacrolimus|tacrolimus|mesh-list
138248833|NCT00553202|Cyclosporins|cyclosporins|mesh-list
138248834|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
138248835|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138248836|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138248837|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
138248838|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248839|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
138248840|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248841|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248842|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138248843|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
138248844|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248845|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248846|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138248847|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138248848|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
138248849|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138248850|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138248852|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248853|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248854|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138248855|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138248856|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138248857|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
138248858|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248859|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248860|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
138248862|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248863|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248866|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248867|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138248868|NCT00553202|Protective Agents|protective agents|mesh-ancestor
138248869|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138248870|NCT00552188|Atreleuton|atreleuton|mesh-list
138248871|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138248872|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248873|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248874|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138248875|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
138248876|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138248877|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138248878|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248879|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248880|NCT00377793|Urological Agents|urological agents|mesh-ancestor
138248881|NCT04027803|Eculizumab|eculizumab|mesh-list
138248882|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138248883|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248884|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
138248885|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248886|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
138248887|NCT00552110|Phenylephrine|phenylephrine|mesh-list
138248888|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
138248889|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248890|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248891|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138248892|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138248893|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138248894|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
138248895|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248896|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248897|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248898|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
138248899|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
138248900|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248901|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
138248902|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138248903|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248904|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138248905|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
138248906|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138248907|NCT00552110|Protective Agents|protective agents|mesh-ancestor
138248908|NCT02301624|Eculizumab|eculizumab|mesh-list
138248909|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138248910|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248911|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
138248912|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248913|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138248914|NCT02007122|Cephalosporins|cephalosporins|mesh-list
138248915|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138248916|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138248918|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
138248919|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138248920|NCT03250520|Protective Agents|protective agents|mesh-ancestor
138248921|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248922|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
138248923|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138248925|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248926|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
138248927|NCT03847389|Hormones|hormones|mesh-ancestor
138248928|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138248929|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248930|NCT02351934|Celecoxib|celecoxib|mesh-list
138248931|NCT02351934|Furosemide|furosemide|mesh-list
138248932|NCT02351934|Gabapentin|gabapentin|mesh-list
138248933|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138248934|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138248935|NCT02351934|Analgesics|analgesics|mesh-ancestor
138248936|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
138248937|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248938|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248939|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248940|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248941|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138248942|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138248943|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248944|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248945|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
138248946|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138248947|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138248948|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138248949|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138248950|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138248951|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138248952|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138248953|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
138248954|NCT02351934|Diuretics|diuretics|mesh-ancestor
138248955|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
138248956|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138248957|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138248958|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
138248959|NCT00377481|Hematinics|hematinics|mesh-ancestor
138248960|NCT00377559|Docetaxel|docetaxel|mesh-list
138248961|NCT00377559|Doxorubicin|doxorubicin|mesh-list
138248962|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138248963|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248964|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248965|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248966|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248967|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248968|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138248969|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138248970|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138248971|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248972|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
138248974|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
138248975|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248976|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138248977|NCT03026348|Antacids|antacids|mesh-ancestor
138248978|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248979|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138248980|NCT04763408|Sorafenib|sorafenib|mesh-list
138248981|NCT04763408|Lenvatinib|lenvatinib|mesh-list
138248982|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248983|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138248984|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248985|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248987|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138248988|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248989|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248990|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
138248991|NCT03825939|Coagulants|coagulants|mesh-ancestor
138248992|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
138248993|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138248994|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138248995|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138248996|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138248997|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
138248998|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138248999|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
138249000|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249001|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249002|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249003|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249004|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138249005|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
138249006|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249007|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249008|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138249009|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249010|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
138249011|NCT00551642|Protective Agents|protective agents|mesh-ancestor
138249012|NCT04690322|Factor VIII|factor viii|mesh-list
138249014|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138249015|NCT04690322|Coagulants|coagulants|mesh-ancestor
138249016|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
138249017|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249018|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
138249019|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
138249020|NCT02648282|Vaccines|vaccines|mesh-list
138249021|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
138249022|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249023|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249024|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249025|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138249026|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
138249027|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249028|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249029|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138249030|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138249031|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138249032|NCT04004481|Morphine|morphine|mesh-list
138249033|NCT04004481|Tramadol|tramadol|mesh-list
138249034|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138249035|NCT04004481|Narcotics|narcotics|mesh-ancestor
138249036|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249037|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249038|NCT04004481|Analgesics|analgesics|mesh-ancestor
138249039|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
138249040|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249041|NCT03997851|Acetaminophen|acetaminophen|mesh-list
138249042|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138249044|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
138249045|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249046|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249047|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
138249048|NCT03989427|Listerine|listerine|mesh-list
138249049|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
138249050|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
138249051|NCT03989427|Protective Agents|protective agents|mesh-ancestor
138249052|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249054|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249055|NCT03007719|Fluorides|fluorides|mesh-list
138249056|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
138249057|NCT03007719|Protective Agents|protective agents|mesh-ancestor
138249058|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249060|NCT02985801|Pancreatin|pancreatin|mesh-list
138249061|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249062|NCT02988362|Amlodipine|amlodipine|mesh-list
138249063|NCT02988362|Candesartan|candesartan|mesh-list
138249064|NCT02988362|Candesartan cilexetil|candesartan cilexetil|mesh-list
138249065|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138249066|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138249067|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249068|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249069|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138249070|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249071|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249072|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138249073|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138249074|NCT02988440|Sorafenib|sorafenib|mesh-list
138249075|NCT02988440|Spartalizumab|spartalizumab|mesh-list
138249076|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249077|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249078|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249079|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249081|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138249082|NCT05405192|Dostarlimab|dostarlimab|mesh-list
138249083|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249084|NCT00550550|Fluticasone|fluticasone|mesh-list
138249085|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
138249086|NCT00550550|Loratadine|loratadine|mesh-list
138249087|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138249088|NCT00550550|Prednisone|prednisone|mesh-list
138249089|NCT00550550|Albuterol|albuterol|mesh-list
138249090|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249091|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
138249092|NCT00550550|Hormones|hormones|mesh-ancestor
138249093|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249094|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249095|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249096|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249097|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138249098|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
138249099|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249100|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249101|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249102|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249103|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138249104|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
138249105|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249106|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138249107|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138249108|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138249109|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138249110|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249111|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249113|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138249114|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138249115|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
138249116|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
138249117|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138249118|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138249119|NCT00550550|Analgesics|analgesics|mesh-ancestor
138249120|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
138249121|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249122|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138249124|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249125|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249126|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138249129|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249130|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249131|NCT02974803|Trametinib|trametinib|mesh-list
138249132|NCT02974803|Dabrafenib|dabrafenib|mesh-list
138249133|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249134|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249135|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249136|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249137|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138249138|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138249139|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249141|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249142|NCT01507233|Morphine|morphine|mesh-list
138249143|NCT01507233|Bupivacaine|bupivacaine|mesh-list
138249144|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
138249145|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
138249146|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249147|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249148|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
138249149|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249150|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138249151|NCT01507233|Narcotics|narcotics|mesh-ancestor
138249152|NCT01507233|Analgesics|analgesics|mesh-ancestor
138249153|NCT02301390|Amiodarone|amiodarone|mesh-list
138249154|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138249155|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249156|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138249157|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249158|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249159|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138249160|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138249161|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138249162|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249163|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138249164|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138249165|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138249166|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138249167|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249169|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
138249170|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249171|NCT01487499|Cisplatin|cisplatin|mesh-list
138249172|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249173|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
138249174|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138249175|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138249176|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138249177|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249178|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249179|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
138249180|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249181|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249182|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138249183|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249184|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138249185|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
138249186|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
138249187|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138249188|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249189|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249190|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
138249191|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138249192|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138249193|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249194|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249195|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138249196|NCT00378729|Metformin|metformin|mesh-list
138249197|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138249198|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249199|NCT00378495|Miltefosine|miltefosine|mesh-list
138249200|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
138249201|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249202|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249203|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138249204|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138249205|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138249207|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138362787|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362788|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
138249208|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138249209|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249210|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249212|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138249213|NCT03802227|Narcotics|narcotics|mesh-ancestor
138249214|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249215|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249216|NCT03802227|Analgesics|analgesics|mesh-ancestor
138249217|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
138249218|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249219|NCT02749617|Apixaban|apixaban|mesh-list
138249220|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138249221|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
138249222|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138249223|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
138249224|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249225|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249226|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
138249227|NCT02749227|Pasireotide|pasireotide|mesh-list
138249229|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249230|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249231|NCT02746263|Acetaminophen|acetaminophen|mesh-list
138249232|NCT02746263|Morphine|morphine|mesh-list
138249233|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138249234|NCT02746263|Narcotics|narcotics|mesh-ancestor
138249235|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249236|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249237|NCT02746263|Analgesics|analgesics|mesh-ancestor
138249238|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
138249239|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249240|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138249241|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
138249242|NCT01394211|Anastrozole|anastrozole|mesh-list
138249243|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249244|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249245|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138249246|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138249247|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249248|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249251|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249252|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249254|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
138249255|NCT02717949|Ledipasvir|ledipasvir|mesh-list
138249256|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
138249257|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249258|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
138249259|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249260|NCT02300610|Cisplatin|cisplatin|mesh-list
138249261|NCT02300610|Gemcitabine|gemcitabine|mesh-list
138249262|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249263|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249264|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
138249265|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249266|NCT01880840|Azelastine|azelastine|mesh-list
138249267|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138249268|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
138249269|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249270|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249271|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249272|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249273|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138249274|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249275|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249276|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138249277|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138249278|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138249279|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
138249280|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
138249281|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249282|NCT01377441|Ibuprofen|ibuprofen|mesh-list
138249283|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138249285|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138249286|NCT01377441|Analgesics|analgesics|mesh-ancestor
138249287|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
138249288|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249289|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249290|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249291|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138249292|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249293|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249294|NCT01882868|Leucovorin|leucovorin|mesh-list
138249295|NCT01882868|Irinotecan|irinotecan|mesh-list
138249296|NCT01882868|Aflibercept|aflibercept|mesh-list
138249297|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
138249298|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138249299|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138249300|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249301|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249302|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249303|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138249304|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138249305|NCT01882868|Growth Substances|growth substances|mesh-ancestor
138249306|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249307|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
138249308|NCT01882868|Antidotes|antidotes|mesh-ancestor
138249309|NCT01882868|Protective Agents|protective agents|mesh-ancestor
138249310|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
138249311|NCT01882868|Vitamins|vitamins|mesh-ancestor
138249312|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
138249313|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
138249314|NCT01383447|Entinostat|entinostat|mesh-list
138249315|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138249317|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249318|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249319|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249320|NCT02300298|Docetaxel|docetaxel|mesh-list
138249321|NCT02300298|Nintedanib|nintedanib|mesh-list
138249322|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249323|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
138249324|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
138249325|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249326|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249327|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249328|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249329|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
138249330|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138249331|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249332|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138249333|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138249334|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249335|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249336|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249337|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138249338|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138249339|NCT01379469|Carbamazepine|carbamazepine|mesh-list
138249340|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
138249341|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
138249342|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138249343|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249344|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249345|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249346|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138249347|NCT01379469|Analgesics|analgesics|mesh-ancestor
138249348|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
138249349|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249350|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138249351|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249352|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249353|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138249354|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138249355|NCT01309581|Ketamine|ketamine|mesh-list
138249356|NCT01309581|Methohexital|methohexital|mesh-list
138249366|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138249367|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138249368|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249369|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249371|NCT05289050|Esketamine|esketamine|mesh-list
138249372|NCT05289050|Analgesics|analgesics|mesh-ancestor
138249373|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
138249374|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249375|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249376|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138249377|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138249378|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
138249379|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
138249380|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249381|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138249382|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138249383|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249384|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249385|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
138249386|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249387|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
138249388|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138249389|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249390|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138249391|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249392|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
138249393|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138249394|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249395|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249396|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
138249397|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249398|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249399|NCT01885910|Doxycycline|doxycycline|mesh-list
138249400|NCT01885910|Dapsone|dapsone|mesh-list
138249401|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138249408|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249409|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
138249410|NCT02658357|Risperidone|risperidone|mesh-list
138249411|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138249412|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
138249413|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249414|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249415|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249416|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138249417|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138249418|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249419|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249420|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138249421|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
138249422|NCT02988908|Donepezil|donepezil|mesh-list
138249423|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138249424|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249425|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249426|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
138249427|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249428|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249429|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
138249430|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
138249431|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138249432|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249433|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249434|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
138249435|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249436|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249437|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
138249438|NCT02325414|Diphosphonates|diphosphonates|mesh-list
138249439|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138249440|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249441|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
138249442|NCT02349048|Simeprevir|simeprevir|mesh-list
138249443|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
138249444|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249445|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
138249446|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249447|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249448|NCT01280643|Leucovorin|leucovorin|mesh-list
138249449|NCT01280643|Bevacizumab|bevacizumab|mesh-list
138249450|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138249451|NCT01280643|Cetuximab|cetuximab|mesh-list
138249452|NCT01280643|Capecitabine|capecitabine|mesh-list
138249453|NCT01280643|Fluorouracil|fluorouracil|mesh-list
138249454|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
138249455|NCT01280643|Irinotecan|irinotecan|mesh-list
138249457|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
138249458|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138249459|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
138249461|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138249462|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138249463|NCT01280643|Growth Substances|growth substances|mesh-ancestor
138249464|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249465|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138249466|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
138249467|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249468|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
138249469|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249470|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249471|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138249472|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138249473|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249474|NCT01280643|Antidotes|antidotes|mesh-ancestor
138249475|NCT01280643|Protective Agents|protective agents|mesh-ancestor
138249476|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
138249477|NCT01280643|Vitamins|vitamins|mesh-ancestor
138249478|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
138249479|NCT01888952|Prednisone|prednisone|mesh-list
138249480|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249481|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
138249482|NCT01888952|Hormones|hormones|mesh-ancestor
138249483|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249484|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249485|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249486|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249487|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
138249488|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249489|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
138249490|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138249491|NCT02299206|Protective Agents|protective agents|mesh-ancestor
138249492|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249493|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
138249494|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249495|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
138249496|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249497|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249501|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138249502|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249503|NCT02298192|Incretins|incretins|mesh-ancestor
138249504|NCT02298192|Hormones|hormones|mesh-ancestor
138249505|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249506|NCT01893632|Gabapentin|gabapentin|mesh-list
138249507|NCT01893632|Analgesics|analgesics|mesh-ancestor
138249508|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
138249509|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249510|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249511|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
138249514|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249515|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249516|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138249517|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138249518|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249519|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249520|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
138249521|NCT01272141|Everolimus|everolimus|mesh-list
138249522|NCT01272141|Lapatinib|lapatinib|mesh-list
138249523|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138249524|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249525|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249526|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249527|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249528|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
138249529|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249530|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249531|NCT01895036|Naltrexone|naltrexone|mesh-list
138249532|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138249533|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138249534|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249535|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
138249536|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249538|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138249539|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249540|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249541|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138249542|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249543|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249544|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138249545|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138249546|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138249547|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249548|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249549|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249550|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249551|NCT01223001|Analgesics|analgesics|mesh-ancestor
138249552|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
138249553|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249554|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
138249555|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249556|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
138249557|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
138249558|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138249559|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249560|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138249561|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249562|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
138249563|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138249564|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249565|NCT01189071|Darifenacin|darifenacin|mesh-list
138249566|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138249567|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138249568|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
138249569|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249570|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249571|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249572|NCT01189071|Urological Agents|urological agents|mesh-ancestor
138249573|NCT02515851|Bupivacaine|bupivacaine|mesh-list
138249574|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
138249576|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249577|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249578|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
138249579|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249580|NCT02492295|Propofol|propofol|mesh-list
138249581|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138249582|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249583|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249584|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138249585|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
138249586|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
138249587|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138249588|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
138249589|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249590|NCT03763929|Protective Agents|protective agents|mesh-ancestor
138249591|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249592|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138249593|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249594|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
138249595|NCT01118013|Methotrexate|methotrexate|mesh-list
138249596|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
138249597|NCT01118013|Fludarabine|fludarabine|mesh-list
138249598|NCT01118013|Busulfan|busulfan|mesh-list
138249599|NCT01118013|Tacrolimus|tacrolimus|mesh-list
138249600|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138249601|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138249602|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
138249603|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249604|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249605|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249606|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
138249607|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249608|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249609|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249610|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249611|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138249612|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249613|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
138249614|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249615|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138249616|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138249617|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138249618|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138249620|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138249621|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249622|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
138249623|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138249624|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138249626|NCT00378027|Fondaparinux|fondaparinux|mesh-list
138249627|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138249628|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
138249629|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138249630|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
138249631|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249632|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249633|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
138249634|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138249635|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138249636|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
138249637|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249638|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249639|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138249641|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
138249642|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249643|NCT02413047|Methotrexate|methotrexate|mesh-list
138249644|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
138249646|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138249647|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
138249648|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249649|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249650|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249651|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
138249652|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249653|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249654|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249655|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249656|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138249657|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249658|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
138249659|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249660|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138249661|NCT02277548|Pregabalin|pregabalin|mesh-list
138249662|NCT02277548|Analgesics|analgesics|mesh-ancestor
138249663|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
138249664|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249665|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249666|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
138249667|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138249668|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249669|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249670|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138249671|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138249672|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138249673|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249674|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249675|NCT02411643|Calcipotriene|calcipotriene|mesh-list
138249676|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
138249677|NCT01085643|Lubiprostone|lubiprostone|mesh-list
138249678|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138249679|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138249680|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249681|NCT03028766|Adavosertib|adavosertib|mesh-list
138249682|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249683|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249684|NCT01071993|Atorvastatin|atorvastatin|mesh-list
138249685|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138249686|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138249687|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
138249688|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249689|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138249690|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138249691|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249692|NCT03756818|Paclitaxel|paclitaxel|mesh-list
138249693|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138249694|NCT03756818|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138249695|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138249696|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249697|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
138249698|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
138249699|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249700|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249701|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249702|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249703|NCT01065051|Riociguat|riociguat|mesh-list
138249704|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
138249705|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249708|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
138249709|NCT02379585|Doxorubicin|doxorubicin|mesh-list
138249710|NCT02379585|Trastuzumab|trastuzumab|mesh-list
138249711|NCT02379585|Pertuzumab|pertuzumab|mesh-list
138249714|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138249715|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138249716|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249717|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249718|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249719|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
138249720|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249721|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138249722|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138249723|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
138249724|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138249725|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138249726|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138249727|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138249728|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249729|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138249731|NCT01048125|Phenylephrine|phenylephrine|mesh-list
138249732|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
138249733|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138249734|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
138249735|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
138249736|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249737|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249738|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
138249739|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138249740|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
138249741|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249742|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138249743|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138249744|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138249745|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138249746|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249747|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249748|NCT01048125|Protective Agents|protective agents|mesh-ancestor
138249749|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138249750|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249751|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138249753|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138249754|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249757|NCT01901588|Analgesics|analgesics|mesh-ancestor
138249758|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
138249759|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249760|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138249761|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138249762|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138249763|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
138249764|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249765|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249766|NCT03673124|Letrozole|letrozole|mesh-list
138249767|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249768|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138249769|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138249770|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249771|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249772|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138249773|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138249774|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249775|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249776|NCT01025271|Daptomycin|daptomycin|mesh-list
138249777|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138249778|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249782|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
138249783|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249784|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249785|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249786|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249787|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138249788|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249795|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138249797|NCT02318901|Trastuzumab|trastuzumab|mesh-list
138249799|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138249800|NCT02318901|Maytansine|maytansine|mesh-list
138249801|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138249802|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249803|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138249804|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249805|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138249806|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138249807|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138249808|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249809|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
138249810|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
138249811|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
138249812|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249813|NCT01904864|Iron|iron|mesh-list
138249814|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
138249815|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249816|NCT01904864|Trace Elements|trace elements|mesh-ancestor
138249817|NCT01016847|Montelukast|montelukast|mesh-list
138249818|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249819|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249820|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138249821|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
138249822|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249823|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249824|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138249825|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138249826|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249828|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
138249829|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249830|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249831|NCT00982995|Palonosetron|palonosetron|mesh-list
138249832|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
138249833|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
138249834|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249835|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249836|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249837|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138249838|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138249839|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
138249840|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249841|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249842|NCT00965055|Atorvastatin|atorvastatin|mesh-list
138362801|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138362802|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
138362803|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362804|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138249852|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249853|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
138249854|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
138249855|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249856|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249857|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249858|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
138249860|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249861|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249862|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249863|NCT00378183|Risperidone|risperidone|mesh-list
138249864|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138249865|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
138249866|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249867|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249868|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249869|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138249870|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138249871|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249872|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249873|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138249874|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
138249875|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138249876|NCT01906658|Hormones|hormones|mesh-ancestor
138249877|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249878|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249879|NCT01908062|Naltrexone|naltrexone|mesh-list
138249880|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138249881|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138249882|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249883|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
138249884|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249885|NCT00924807|Sorafenib|sorafenib|mesh-list
138249886|NCT00924807|Leuprolide|leuprolide|mesh-list
138249887|NCT00924807|Bicalutamide|bicalutamide|mesh-list
138249888|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249889|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249890|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249891|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249892|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138249893|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
138249894|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138249895|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249896|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249897|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
138249898|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
138249899|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249900|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
138249901|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138249902|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
138249903|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249904|NCT00896025|Expectorants|expectorants|mesh-ancestor
138249905|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249906|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138249907|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
138249908|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249909|NCT00896025|Protective Agents|protective agents|mesh-ancestor
138249910|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249911|NCT00896025|Antidotes|antidotes|mesh-ancestor
138249912|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
138249913|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249914|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138249915|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138249916|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249917|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249918|NCT02162979|Urological Agents|urological agents|mesh-ancestor
138249919|NCT01908842|Buprenorphine|buprenorphine|mesh-list
138249920|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138249921|NCT01908842|Narcotics|narcotics|mesh-ancestor
138249922|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249923|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249925|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
138249927|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138249928|NCT00833859|Gemcitabine|gemcitabine|mesh-list
138249929|NCT00833859|Capecitabine|capecitabine|mesh-list
138249930|NCT00833859|Docetaxel|docetaxel|mesh-list
138249931|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249932|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
138249933|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249934|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249935|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
138249936|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138249937|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249938|NCT00832299|Leucovorin|leucovorin|mesh-list
138249939|NCT00832299|Fluorouracil|fluorouracil|mesh-list
138249940|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
138249941|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
138249942|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249943|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138249944|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249945|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138249946|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
138249947|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249948|NCT00832299|Antidotes|antidotes|mesh-ancestor
138249949|NCT00832299|Protective Agents|protective agents|mesh-ancestor
138249950|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
138249952|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
138249953|NCT03723447|Dexamethasone|dexamethasone|mesh-list
138249954|NCT03723447|Epinephrine|epinephrine|mesh-list
138249955|NCT03723447|Bupivacaine|bupivacaine|mesh-list
138249956|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138249957|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
138249958|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
138249959|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249960|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249961|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249962|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
138249963|NCT03723447|Hormones|hormones|mesh-ancestor
138249964|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138249965|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138249966|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249967|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
138249968|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
138249969|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138249970|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
138249971|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138249972|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138249973|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
138249974|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249975|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249977|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138249978|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138249979|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
138249980|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
138249981|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
138249982|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138249983|NCT00836355|Minocycline|minocycline|mesh-list
138249984|NCT00836355|Enoxaparin|enoxaparin|mesh-list
138249985|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
138249986|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138249987|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138249988|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249989|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138249990|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249991|NCT00816777|Irinotecan|irinotecan|mesh-list
138249992|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138249993|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138249994|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249995|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249998|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138250000|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250001|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250002|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138250003|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
138250004|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138250005|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
138250007|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250008|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138250009|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
138250010|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
138250011|NCT00823095|Protective Agents|protective agents|mesh-ancestor
138250012|NCT00803283|Morphine|morphine|mesh-list
138250013|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250014|NCT00803283|Narcotics|narcotics|mesh-ancestor
138250015|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250016|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250017|NCT00803283|Analgesics|analgesics|mesh-ancestor
138250018|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
138250019|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250020|NCT00799773|Rituximab|rituximab|mesh-list
138250021|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250022|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250023|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
138250024|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250025|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250026|NCT00760461|Domperidone|domperidone|mesh-list
138250027|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
138250028|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
138250029|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250030|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250031|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138250032|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138250033|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
138250034|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250035|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250036|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138250037|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250038|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138250039|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250040|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250041|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138250042|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138250043|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138250044|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
138250045|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138250046|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250047|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138250048|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138250049|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138250050|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138250051|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138250052|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138250053|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138250054|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138250056|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138250057|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250058|NCT01901679|Analgesics|analgesics|mesh-ancestor
138250059|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
138250061|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250063|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362813|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362814|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362816|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
138250064|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138250065|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138250066|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250067|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250068|NCT00688935|Melatonin|melatonin|mesh-list
138250069|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
138250070|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250071|NCT00688935|Protective Agents|protective agents|mesh-ancestor
138250072|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250073|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250074|NCT00684255|Fludarabine|fludarabine|mesh-list
138250075|NCT00684255|Busulfan|busulfan|mesh-list
138250076|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
138250077|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250078|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250079|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250080|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
138250081|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250082|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
138250083|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250084|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250085|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250086|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138250087|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250088|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250089|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138250090|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138250091|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250092|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250093|NCT01856361|Ramipril|ramipril|mesh-list
138250094|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138250095|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
138250096|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250097|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250098|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250100|NCT00642603|Capecitabine|capecitabine|mesh-list
138250101|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
138250102|NCT00642603|Irinotecan|irinotecan|mesh-list
138250103|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250104|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250105|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138250106|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138250107|NCT00642603|Growth Substances|growth substances|mesh-ancestor
138250108|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250109|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
138250110|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250111|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
138250112|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250113|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138250114|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138250115|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250116|NCT01841931|Buprenorphine|buprenorphine|mesh-list
138250117|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138250118|NCT01841931|Naloxone|naloxone|mesh-list
138250119|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250120|NCT01841931|Narcotics|narcotics|mesh-ancestor
138250121|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250123|NCT01841931|Analgesics|analgesics|mesh-ancestor
138250124|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
138250125|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250126|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250127|NCT04713891|Atezolizumab|atezolizumab|mesh-list
138250128|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138250129|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138250130|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250131|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250132|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250133|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
138250134|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250135|NCT00379509|Lapatinib|lapatinib|mesh-list
138250136|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250137|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138250138|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250139|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250141|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250142|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250143|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
138250144|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
138250145|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250146|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
138250147|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250148|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250150|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250151|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
138250152|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138250153|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250154|NCT00588471|Simvastatin|simvastatin|mesh-list
138250155|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138250156|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138250157|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
138250158|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250159|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138250160|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138250161|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250163|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250165|NCT01784991|Hydromorphone|hydromorphone|mesh-list
138250166|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250167|NCT01784991|Narcotics|narcotics|mesh-ancestor
138250168|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250169|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250171|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
138250172|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250173|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138250174|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138250175|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250176|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138250177|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138250178|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250179|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250180|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
138250181|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250182|NCT05600517|Fluorides|fluorides|mesh-list
138250183|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
138250184|NCT05600517|Protective Agents|protective agents|mesh-ancestor
138250185|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250186|NCT01745913|Fludarabine|fludarabine|mesh-list
138250187|NCT01745913|Melphalan|melphalan|mesh-list
138250188|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
138250190|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250191|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250192|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
138250196|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250199|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
138250200|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138250201|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
138250202|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250203|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250204|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138250205|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
138250206|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138250207|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
138250208|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250209|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250210|NCT01673061|Lidocaine|lidocaine|mesh-list
138250211|NCT01673061|Epinephrine|epinephrine|mesh-list
138250212|NCT01673061|Norflurane|norflurane|mesh-list
138250213|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
138250214|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
138250215|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250216|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250217|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
138250218|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250219|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138250220|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138250221|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138250222|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250223|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250224|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138250225|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138250226|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138250227|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250228|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138250229|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138250230|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
138250231|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138250232|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
138250233|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
138250234|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
138250235|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138250237|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
138250238|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138250239|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250240|NCT00379665|Cisplatin|cisplatin|mesh-list
138250241|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250243|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250244|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250245|NCT01598025|Fludarabine|fludarabine|mesh-list
138250246|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
138250247|NCT01598025|Melphalan|melphalan|mesh-list
138250248|NCT01598025|Thiotepa|thiotepa|mesh-list
138250249|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138250250|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250251|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250252|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
138250253|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250254|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250258|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
138250259|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250261|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
138250262|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250263|NCT01587963|Protective Agents|protective agents|mesh-ancestor
138250264|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250265|NCT01587963|Vitamins|vitamins|mesh-ancestor
138250266|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
138250267|NCT01648751|Estrogens|estrogens|mesh-list
138250268|NCT01648751|Hormones|hormones|mesh-ancestor
138250269|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250270|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250271|NCT05550519|Tenofovir|tenofovir|mesh-list
138250272|NCT05550519|Entecavir|entecavir|mesh-list
138250273|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
138250274|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250275|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138250276|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138250277|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250278|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250279|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138250283|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138250284|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138250285|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138250286|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138250287|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250288|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250289|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250290|NCT01203371|Urological Agents|urological agents|mesh-ancestor
138250291|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250292|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138250293|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250294|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138250295|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138250297|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
138250298|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250299|NCT00357617|Celecoxib|celecoxib|mesh-list
138250300|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138250301|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250302|NCT00357617|Analgesics|analgesics|mesh-ancestor
138250303|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
138250304|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250305|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250306|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250307|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250308|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138250309|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138250310|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250311|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250313|NCT01548651|Incretins|incretins|mesh-ancestor
138250314|NCT01548651|Hormones|hormones|mesh-ancestor
138250315|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250316|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250317|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138250318|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
138250319|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250320|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250321|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138250322|NCT01533753|Gabapentin|gabapentin|mesh-list
138250323|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138250327|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250328|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
138250329|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138250330|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138250331|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250332|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250333|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138250334|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138250335|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250336|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250337|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
138250338|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138250339|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138250340|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250341|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138250342|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250343|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
138250344|NCT05722301|Testosterone|testosterone|mesh-list
138250346|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
138250347|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138250348|NCT05722301|Androgens|androgens|mesh-ancestor
138250350|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250351|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250352|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138250353|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250354|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
138250355|NCT01534143|Sirolimus|sirolimus|mesh-list
138250356|NCT01534143|Fludarabine|fludarabine|mesh-list
138250357|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
138250358|NCT01534143|Bortezomib|bortezomib|mesh-list
138250359|NCT01534143|Busulfan|busulfan|mesh-list
138250360|NCT01534143|Tacrolimus|tacrolimus|mesh-list
138250361|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
138250362|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138250363|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
138250364|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250365|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250366|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
138250367|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250368|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250369|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
138250370|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250371|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138250372|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250373|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250374|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250375|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138250376|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
138250377|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
138250378|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250379|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250380|NCT05722067|Calcium|calcium|mesh-list
138250381|NCT05722067|Ionophores|ionophores|mesh-list
138250382|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
138250383|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138250384|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250385|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250386|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250387|NCT01692171|Heparin|heparin|mesh-list
138250388|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138250389|NCT01692171|Tinzaparin|tinzaparin|mesh-list
138250390|NCT01692171|Dalteparin|dalteparin|mesh-list
138250391|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
138250392|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138250393|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250394|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250395|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138250396|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
138250397|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250398|NCT00570531|Paclitaxel|paclitaxel|mesh-list
138250399|NCT00570531|Bevacizumab|bevacizumab|mesh-list
138250400|NCT00570531|Fluorouracil|fluorouracil|mesh-list
138250401|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138250402|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250403|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138250404|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138250405|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138250406|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250407|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250408|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138250409|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138250410|NCT00570531|Growth Substances|growth substances|mesh-ancestor
138250411|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250412|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
138250413|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
138250414|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250415|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250416|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
138250417|NCT05258565|Plasminogen|plasminogen|mesh-list
138250419|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138250420|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250421|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250422|NCT05715437|Ketamine|ketamine|mesh-list
138250423|NCT05715437|Bupivacaine|bupivacaine|mesh-list
138250424|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
138250425|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
138250426|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250427|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250428|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
138250429|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250431|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138250432|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138250433|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
138250434|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138250435|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138250436|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250437|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250438|NCT05721443|Cetuximab|cetuximab|mesh-list
138250439|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250440|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250441|NCT00523809|Bevacizumab|bevacizumab|mesh-list
138250442|NCT00523809|Fludarabine|fludarabine|mesh-list
138250443|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
138250444|NCT00523809|Melphalan|melphalan|mesh-list
138250445|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
138250446|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138250447|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250448|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250449|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138250450|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138250451|NCT00523809|Growth Substances|growth substances|mesh-ancestor
138250452|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250454|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250455|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
138250456|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250458|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
138250460|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
138250461|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250462|NCT00501345|Aspirin|aspirin|mesh-list
138250463|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138250464|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250465|NCT00501345|Analgesics|analgesics|mesh-ancestor
138250466|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
138250467|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250468|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250469|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250470|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250471|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138250472|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250473|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250474|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138250475|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138250477|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
138250478|NCT00357773|Azithromycin|azithromycin|mesh-list
138250479|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250480|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250481|NCT00487461|Simvastatin|simvastatin|mesh-list
138250482|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138250483|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138250484|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
138250485|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250486|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138250487|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138250488|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250489|NCT00356187|Propranolol|propranolol|mesh-list
138250490|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138250491|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138250492|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
138250493|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250494|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250495|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250496|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138250497|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250498|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
138250499|NCT02224729|Dexamethasone|dexamethasone|mesh-list
138250500|NCT02224729|Bortezomib|bortezomib|mesh-list
138250501|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138250502|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250503|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
138250504|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
138250506|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250507|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138250508|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
138250509|NCT02224729|Hormones|hormones|mesh-ancestor
138250510|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250511|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138250512|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250513|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250514|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
138250515|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250516|NCT00305643|Celecoxib|celecoxib|mesh-list
138250517|NCT00305643|Capecitabine|capecitabine|mesh-list
138250518|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138250521|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250522|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138250523|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250524|NCT00305643|Analgesics|analgesics|mesh-ancestor
138250525|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
138250526|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250527|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250528|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250529|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250530|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138250532|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250534|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250535|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250536|NCT00271011|Irinotecan|irinotecan|mesh-list
138250537|NCT00271011|Cetuximab|cetuximab|mesh-list
138250538|NCT00271011|Mitomycins|mitomycins|mesh-list
138250539|NCT00271011|Mitomycin|mitomycin|mesh-list
138250540|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138250541|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138250542|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250543|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250544|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250545|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250546|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138250547|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
138250548|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138250549|NCT03312530|Atezolizumab|atezolizumab|mesh-list
138250550|NCT03312530|Venetoclax|venetoclax|mesh-list
138250551|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138250552|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250553|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250554|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250555|NCT05697965|Vancomycin|vancomycin|mesh-list
138250556|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250557|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250558|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
138250559|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138250561|NCT05720273|Calcitriol|calcitriol|mesh-list
138250562|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138250563|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250564|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138250565|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250566|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250567|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138250568|NCT05720273|Vitamins|vitamins|mesh-ancestor
138250569|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
138250571|NCT00183963|Tamoxifen|tamoxifen|mesh-list
138250572|NCT00183963|Fulvestrant|fulvestrant|mesh-list
138250573|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138250574|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
138250575|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250576|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250577|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138250578|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250580|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138250581|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138250582|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138250584|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138250585|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
138250586|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
138250587|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138250589|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250591|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
138250592|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250593|NCT00118053|Carboplatin|carboplatin|mesh-list
138250594|NCT00118053|Docetaxel|docetaxel|mesh-list
138250595|NCT00118053|Trastuzumab|trastuzumab|mesh-list
138250596|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250597|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138250598|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138250599|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138250600|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250601|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138250603|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250604|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
138250605|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
138250606|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250607|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250608|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138250609|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
138250610|NCT04225611|Hormones|hormones|mesh-ancestor
138250611|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250612|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138250613|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250614|NCT00379977|Vaccines|vaccines|mesh-list
138250615|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
138250616|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250617|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
138250618|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138250619|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138250620|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138250621|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250622|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250623|NCT05669885|Urological Agents|urological agents|mesh-ancestor
138250624|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
138250625|NCT00955929|Alprostadil|alprostadil|mesh-list
138250626|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138250627|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138250629|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250630|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250631|NCT00955929|Urological Agents|urological agents|mesh-ancestor
138250632|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138250633|NCT00357851|Aprotinin|aprotinin|mesh-list
138250634|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
138250635|NCT00357851|Coagulants|coagulants|mesh-ancestor
138250636|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138250637|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138250638|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
138250639|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250640|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250641|NCT00358319|Valproic Acid|valproic acid|mesh-list
138250642|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
138250643|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250644|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250645|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
138250646|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250647|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250648|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
138250650|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250651|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250652|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
138250653|NCT05663801|Ketamine|ketamine|mesh-list
138250654|NCT05663801|Bupivacaine|bupivacaine|mesh-list
138250655|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
138250656|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
138250657|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250658|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250659|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
138250661|NCT05663801|Analgesics|analgesics|mesh-ancestor
138250662|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138250663|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138250664|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
138250665|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138250666|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138250667|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250668|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250669|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138250670|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
138250671|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138250672|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250673|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138250674|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
138250675|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138250676|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138250677|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
138250678|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138250679|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
138250680|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250681|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
138250682|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138250684|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
138250685|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250686|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138250687|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
138250688|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138250689|NCT00000123|Protective Agents|protective agents|mesh-ancestor
138250690|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250691|NCT00380133|Prednisolone|prednisolone|mesh-list
138250692|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250693|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
138250694|NCT00380133|Hormones|hormones|mesh-ancestor
138250695|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250696|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250697|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138250700|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250701|NCT02953665|Liraglutide|liraglutide|mesh-list
138250702|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138250703|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250704|NCT02953665|Incretins|incretins|mesh-ancestor
138250705|NCT02953665|Hormones|hormones|mesh-ancestor
138250706|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250707|NCT00000189|Gepirone|gepirone|mesh-list
138250708|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250709|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250710|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138250714|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138250715|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
138250716|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250717|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250719|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138250720|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250721|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250722|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
138250723|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250724|NCT00000201|Selegiline|selegiline|mesh-list
138250725|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250726|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250727|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138250728|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138250729|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138250730|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250731|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250732|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138250733|NCT00000201|Protective Agents|protective agents|mesh-ancestor
138250734|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250735|NCT00000207|Buprenorphine|buprenorphine|mesh-list
138250736|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250737|NCT00000207|Narcotics|narcotics|mesh-ancestor
138250739|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250740|NCT00000207|Analgesics|analgesics|mesh-ancestor
138250741|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
138250742|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250743|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250744|NCT02295774|Methylene Blue|methylene blue|mesh-list
138250745|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250746|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250747|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
138250748|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
138250750|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
138250751|NCT01807611|Thiotepa|thiotepa|mesh-list
138250752|NCT01807611|Fludarabine|fludarabine|mesh-list
138250753|NCT01807611|Lenograstim|lenograstim|mesh-list
138250754|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138250755|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
138250756|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250757|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250758|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250759|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
138250760|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250761|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250762|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138250763|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138250764|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138250765|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
138250766|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250767|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250768|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250769|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138250770|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138250771|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138250772|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
138250773|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250774|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250775|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138250776|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138250777|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138250778|NCT02294682|Gepotidacin|gepotidacin|mesh-list
138250779|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138250780|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250781|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250782|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250783|NCT01692717|Losartan|losartan|mesh-list
138250784|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138250785|NCT01692717|Atorvastatin|atorvastatin|mesh-list
138250786|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138250788|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
138250789|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250790|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138250791|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138250792|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250794|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250795|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138250797|NCT01692717|Diuretics|diuretics|mesh-ancestor
138250798|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
138250799|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250800|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138250801|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250802|NCT00355277|Amitriptyline|amitriptyline|mesh-list
138250803|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138250804|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250805|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250806|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250807|NCT00355277|Analgesics|analgesics|mesh-ancestor
138250808|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
138250809|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250810|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250811|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138250812|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138250813|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250814|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250816|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250817|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138250818|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
138250819|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250820|NCT00000213|Fluoxetine|fluoxetine|mesh-list
138250821|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138250822|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138250823|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250824|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250825|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250826|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
138250827|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250828|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138250829|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250830|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250831|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138250832|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138250833|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250834|NCT00000219|Buprenorphine|buprenorphine|mesh-list
138250835|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250836|NCT00000219|Narcotics|narcotics|mesh-ancestor
138250837|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250838|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250839|NCT00000219|Analgesics|analgesics|mesh-ancestor
138250840|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
138250841|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250842|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250843|NCT00000225|Buprenorphine|buprenorphine|mesh-list
138250844|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250845|NCT00000225|Narcotics|narcotics|mesh-ancestor
138250846|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250847|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250848|NCT00000225|Analgesics|analgesics|mesh-ancestor
138250849|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
138250850|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250851|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250852|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
138250853|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138250854|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
138250856|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138250857|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250858|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
138250859|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138250860|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
138250861|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
138250862|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
138250863|NCT01645176|Atorvastatin|atorvastatin|mesh-list
138250864|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138250865|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138250866|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
138250867|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250869|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138250871|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
138250872|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138250873|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138250874|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250876|NCT03465735|Heparin|heparin|mesh-list
138250877|NCT03465735|Enoxaparin|enoxaparin|mesh-list
138250878|NCT03465735|Dalteparin|dalteparin|mesh-list
138250879|NCT03465735|Warfarin|warfarin|mesh-list
138250881|NCT03465735|Dabigatran|dabigatran|mesh-list
138250882|NCT03465735|Apixaban|apixaban|mesh-list
138250883|NCT03465735|Edoxaban|edoxaban|mesh-list
138250884|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
138250885|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138250886|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250887|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250888|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138250889|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
138250890|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138250891|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
138250892|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250893|NCT05637671|Paroxetine|paroxetine|mesh-list
138250894|NCT05637671|Oxybutynin|oxybutynin|mesh-list
138250895|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138250896|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138250897|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250898|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250899|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250900|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
138250901|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250902|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138250903|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250904|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250905|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138250906|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138250907|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250908|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
138250909|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
138250910|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250911|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138250912|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138250913|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
138250914|NCT05637671|Urological Agents|urological agents|mesh-ancestor
138250915|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138250917|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138250918|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138250919|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138250921|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
138250922|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250923|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250924|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138250925|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138250926|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138250927|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138250928|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138250929|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
138250930|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
138250931|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250932|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250933|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
138250934|NCT03447639|Povidone|povidone|mesh-list
138250935|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
138250936|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
138250937|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138250938|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250939|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
138250940|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138250941|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250942|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250943|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
138250944|NCT03425799|Coagulants|coagulants|mesh-ancestor
138250945|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
138250946|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138250947|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138250949|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138250950|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250951|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138250952|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250953|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250954|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138250955|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138250956|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
138250957|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250958|NCT00000231|Buprenorphine|buprenorphine|mesh-list
138250959|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250960|NCT00000231|Narcotics|narcotics|mesh-ancestor
138250961|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250962|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250963|NCT00000231|Analgesics|analgesics|mesh-ancestor
138250964|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
138250965|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250966|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250967|NCT00000237|Buprenorphine|buprenorphine|mesh-list
138250968|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250969|NCT00000237|Narcotics|narcotics|mesh-ancestor
138250970|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250971|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250972|NCT00000237|Analgesics|analgesics|mesh-ancestor
138250973|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
138250974|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250975|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250976|NCT00000765|Zidovudine|zidovudine|mesh-list
138250977|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
138250978|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250979|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138250980|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138250982|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
138250985|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138250986|NCT00000243|Buprenorphine|buprenorphine|mesh-list
138250987|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138250988|NCT00000243|Narcotics|narcotics|mesh-ancestor
138250989|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250990|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250991|NCT00000243|Analgesics|analgesics|mesh-ancestor
138250992|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
138250993|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250994|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138250995|NCT00000771|Paromomycin|paromomycin|mesh-list
138250996|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138250997|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250998|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138250999|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251000|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
138251001|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138251002|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251003|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251004|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138251005|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138251007|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251008|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
138251009|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138251010|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
138251011|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
138251012|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138251013|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
138251014|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
138251015|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138251016|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251017|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138251018|NCT00000249|Analgesics|analgesics|mesh-ancestor
138251019|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
138251020|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251021|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
138251022|NCT00000261|Sevoflurane|sevoflurane|mesh-list
138251023|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138251024|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138251025|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
138251026|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
138251027|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138251028|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251029|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138251030|NCT00000261|Analgesics|analgesics|mesh-ancestor
138251031|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
138251032|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251033|NCT00000801|Cytarabine|cytarabine|mesh-list
138251034|NCT00000801|Dexamethasone|dexamethasone|mesh-list
138251036|NCT00000801|Doxorubicin|doxorubicin|mesh-list
138251037|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138251038|NCT00000801|Vincristine|vincristine|mesh-list
138251039|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251040|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
138251041|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251042|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251043|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138251044|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
138251045|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251046|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251047|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138251048|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251049|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
138251050|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
138251051|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251052|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138251053|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
138251054|NCT00000801|Hormones|hormones|mesh-ancestor
138251055|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251056|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251058|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251059|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251060|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251061|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138251062|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
138251063|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
138251064|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251065|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251066|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251067|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251068|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251069|NCT00000267|Risperidone|risperidone|mesh-list
138251070|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138251071|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
138251072|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251073|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251074|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251075|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138251077|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138251078|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138251079|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138251080|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
138251081|NCT00000807|Etoposide|etoposide|mesh-list
138251082|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251083|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251084|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251085|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251086|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251087|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251089|NCT00001677|Fludarabine|fludarabine|mesh-list
138251090|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138251091|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
138251092|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138251093|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251094|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138251095|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
138251096|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251097|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251098|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
138251099|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251100|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138251101|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251102|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
138251103|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251104|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251105|NCT00001689|Vincristine|vincristine|mesh-list
138251106|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251108|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251109|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251110|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251111|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251112|NCT00001713|Heparin|heparin|mesh-list
138251114|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138251115|NCT00001713|Warfarin|warfarin|mesh-list
138251116|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
138251117|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138251123|NCT00000273|Buprenorphine|buprenorphine|mesh-list
138251124|NCT00000273|Methadone|methadone|mesh-list
138251125|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138251126|NCT00000273|Narcotics|narcotics|mesh-ancestor
138251127|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138251128|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251129|NCT00000273|Analgesics|analgesics|mesh-ancestor
138251130|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
138251131|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251132|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138251133|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138251134|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
138251135|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
138251136|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138251137|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
138251138|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
138251139|NCT00000819|Prednisone|prednisone|mesh-list
138251140|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251141|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
138251142|NCT00000819|Hormones|hormones|mesh-ancestor
138251143|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251144|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251145|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251146|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251147|NCT00000279|Clonidine|clonidine|mesh-list
138251148|NCT00000279|Analgesics|analgesics|mesh-ancestor
138251149|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
138251150|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251151|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251152|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138251153|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
138251154|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
138251155|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138251156|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138251157|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138251158|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
138251159|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251160|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251161|NCT00000825|Aldesleukin|aldesleukin|mesh-list
138251162|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251163|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251164|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251165|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
138251166|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251167|NCT00000285|Phenytoin|phenytoin|mesh-list
138251168|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
138251169|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138251170|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138251171|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251172|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251173|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138251174|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138251175|NCT00001737|Cyclosporine|cyclosporine|mesh-list
138251176|NCT00001737|Cyclosporins|cyclosporins|mesh-list
138251177|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251178|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251180|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
138251181|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251183|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251186|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138251187|NCT00000843|Adefovir|adefovir|mesh-list
138251188|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138251189|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
138251190|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251191|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251192|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251193|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251194|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251195|NCT05362487|Bromides|bromides|mesh-list
138251196|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
138251197|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138251198|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
138251199|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251200|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251201|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138251202|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138251203|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
138251204|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138251205|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
138251206|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251207|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251208|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
138251209|NCT00000291|Labetalol|labetalol|mesh-list
138251210|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138251211|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138251212|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
138251213|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251214|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251215|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251216|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138251217|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
138251218|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
138251219|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251220|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138251221|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138251222|NCT00000861|Indinavir|indinavir|mesh-list
138251223|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138251224|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138251225|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
138251226|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251227|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251228|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251229|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251230|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
138251231|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251232|NCT00000297|Labetalol|labetalol|mesh-list
138251233|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138251234|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138251235|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
138251236|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251237|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251238|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251240|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
138251241|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
138251242|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251243|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138251244|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138251246|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138251247|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251248|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138251249|NCT00359879|Incretins|incretins|mesh-ancestor
138251250|NCT00359879|Hormones|hormones|mesh-ancestor
138251251|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251253|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138251254|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251255|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138251256|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251257|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138251258|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
138251260|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251261|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251262|NCT00001785|Interferons|interferons|mesh-list
138251263|NCT00001785|Interferon-beta|interferon-beta|mesh-list
138251264|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
138251265|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251266|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
138251267|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251268|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
138251269|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251270|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251271|NCT00001827|Aldesleukin|aldesleukin|mesh-list
138251272|NCT00001827|Sargramostim|sargramostim|mesh-list
138251273|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
138251274|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
138251275|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251276|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251277|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251278|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251279|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
138251280|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251281|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251282|NCT01647516|Ozanimod|ozanimod|mesh-list
138251283|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138251284|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251285|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251286|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
138251287|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251288|NCT00001839|Cyclosporine|cyclosporine|mesh-list
138251289|NCT00001839|Cyclosporins|cyclosporins|mesh-list
138251290|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138251291|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251292|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251293|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251294|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
138251295|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251296|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
138251297|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251298|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138251299|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251300|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138251301|NCT00000885|Lamivudine|lamivudine|mesh-list
138251302|NCT00000885|Zidovudine|zidovudine|mesh-list
138251303|NCT00000885|Efavirenz|efavirenz|mesh-list
138251305|NCT00000885|Didanosine|didanosine|mesh-list
138251306|NCT00000885|Stavudine|stavudine|mesh-list
138251309|NCT00000885|Nelfinavir|nelfinavir|mesh-list
138251310|NCT00000885|Indinavir|indinavir|mesh-list
138251311|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251312|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251313|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251314|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251315|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
138251316|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251317|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251318|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251319|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
138251320|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138251321|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138251322|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138251323|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138251324|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138251325|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138251326|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138251329|NCT01647282|Minocycline|minocycline|mesh-list
138251330|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251331|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251333|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
138251334|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251335|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251336|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251337|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251338|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
138251339|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251340|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251341|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251342|NCT05347979|Dabigatran|dabigatran|mesh-list
138251343|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
138251344|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138251345|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
138251346|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215605|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138251347|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251348|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
138251349|NCT00000909|Aldesleukin|aldesleukin|mesh-list
138251350|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251351|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251352|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251353|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
138251354|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251358|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251359|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
138251360|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251361|NCT00000921|Prednisone|prednisone|mesh-list
138251362|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251363|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
138251364|NCT00000921|Hormones|hormones|mesh-ancestor
138251365|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251366|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251367|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251368|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251369|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
138251370|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138251371|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138251372|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138251373|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251374|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251375|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
138251376|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251377|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251378|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138251379|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251380|NCT05325515|Alendronate|alendronate|mesh-list
138251381|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138251382|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251383|NCT00000939|Efavirenz|efavirenz|mesh-list
138251384|NCT00000939|Didanosine|didanosine|mesh-list
138251385|NCT00000939|Stavudine|stavudine|mesh-list
138251386|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
138251387|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251388|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251389|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251390|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251391|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
138251392|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251393|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138251395|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138251397|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138251398|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138251401|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
138251402|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251403|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251404|NCT00000945|Cidofovir|cidofovir|mesh-list
138251405|NCT00000945|Probenecid|probenecid|mesh-list
138251406|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
138251407|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
138251408|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251409|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
138251410|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251411|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251412|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251413|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
138251414|NCT04344041|Vitamin D|vitamin d|mesh-list
138251415|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138251416|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251417|NCT04344041|Vitamins|vitamins|mesh-ancestor
138251418|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
138251419|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138251420|NCT00000963|Didanosine|didanosine|mesh-list
138251421|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
138251422|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251423|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251424|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251425|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251426|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
138251427|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251428|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251429|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251430|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
138251431|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138251432|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251433|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251434|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
138251435|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251436|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251437|NCT00001893|Etanercept|etanercept|mesh-list
138251449|NCT00000981|Fiacitabine|fiacitabine|mesh-list
138251450|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251451|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
138251452|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251453|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
138251454|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138251455|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251456|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251457|NCT00001905|Interferons|interferons|mesh-list
138251458|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
138251459|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251460|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
138251461|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251462|NCT00000987|Zidovudine|zidovudine|mesh-list
138251463|NCT00000987|Doxorubicin|doxorubicin|mesh-list
138251464|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138251465|NCT00000987|Bleomycin|bleomycin|mesh-list
138251466|NCT00000987|Vincristine|vincristine|mesh-list
138251467|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138251468|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251469|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251470|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251471|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251472|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251473|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251475|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251476|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251478|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251480|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
138251481|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251482|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251483|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251484|NCT00001911|Interleukin-12|interleukin-12|mesh-list
138251485|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251486|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
138251487|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251488|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138251489|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138251490|NCT00001911|Growth Substances|growth substances|mesh-ancestor
138251491|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138251492|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251493|NCT00001929|Eliprodil|eliprodil|mesh-list
138251494|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138251495|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138251496|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251497|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362834|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251498|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251499|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138251500|NCT00001929|Protective Agents|protective agents|mesh-ancestor
138362835|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362836|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362837|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
138251501|NCT00358553|Insulin|insulin|mesh-list
138251502|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138251503|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251504|NCT00000993|Zidovudine|zidovudine|mesh-list
138251505|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
138251506|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251507|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251508|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251509|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251510|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
138251511|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251512|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251513|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251514|NCT00359177|Casopitant|casopitant|mesh-list
138251515|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
138251516|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
138251517|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251518|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251520|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138251521|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251522|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251523|NCT00001017|Fluconazole|fluconazole|mesh-list
138251524|NCT00001017|Amphotericin B|amphotericin b|mesh-list
138251525|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138251526|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
138251527|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251528|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138251529|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138251530|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251531|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251532|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138251533|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
138251534|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251535|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251536|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138251537|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138251540|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251541|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251542|NCT02279862|Ipilimumab|ipilimumab|mesh-list
138251543|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138251544|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251545|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138251546|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251548|NCT00001965|Cyclosporins|cyclosporins|mesh-list
138251549|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251550|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251551|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251552|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
138251553|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251554|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
138251555|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251556|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
138251557|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251558|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138251559|NCT00001023|Azithromycin|azithromycin|mesh-list
138251560|NCT00001023|Clarithromycin|clarithromycin|mesh-list
138251561|NCT00001023|Rifabutin|rifabutin|mesh-list
138251562|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251563|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251564|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138251565|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251566|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251567|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138251568|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138251569|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138251570|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
138251571|NCT00001035|Interferons|interferons|mesh-list
138251572|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
138251573|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
138251574|NCT00001035|Zidovudine|zidovudine|mesh-list
138251575|NCT00001035|Didanosine|didanosine|mesh-list
138251576|NCT00001035|Zalcitabine|zalcitabine|mesh-list
138251577|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251578|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
138251579|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251580|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
138251581|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251583|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251584|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251585|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251586|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251588|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251590|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138251591|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138251592|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138251593|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138251594|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
138251595|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251596|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251597|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251598|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138251599|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138251601|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251602|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
138251603|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251604|NCT00001053|Antacids|antacids|mesh-ancestor
138251605|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251606|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138251607|NCT00001989|Zidovudine|zidovudine|mesh-list
138251608|NCT00001989|Trichosanthin|trichosanthin|mesh-list
138251609|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
138251611|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251612|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251613|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251614|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
138251615|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251616|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251617|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251618|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138251619|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
138251620|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138251621|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251622|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251623|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251624|NCT00001059|Doxorubicin|doxorubicin|mesh-list
138251626|NCT00001059|Bleomycin|bleomycin|mesh-list
138251627|NCT00001059|Vincristine|vincristine|mesh-list
138251628|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138251629|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251630|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251632|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251633|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251634|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251635|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251636|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251637|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251638|NCT00001065|Amphotericin B|amphotericin b|mesh-list
138251639|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138251640|NCT00001065|Amebicides|amebicides|mesh-ancestor
138251641|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251642|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251643|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251644|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251645|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
138251646|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138251647|NCT02977637|Hematinics|hematinics|mesh-ancestor
138251648|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138251649|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138251650|NCT00001995|Rifabutin|rifabutin|mesh-list
138251651|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251652|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251653|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138251654|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
138251655|NCT00002001|Zidovudine|zidovudine|mesh-list
138251656|NCT00002001|Didanosine|didanosine|mesh-list
138251657|NCT00002001|Zalcitabine|zalcitabine|mesh-list
138251658|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
138251659|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251660|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251661|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251662|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251663|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
138251664|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251665|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251666|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251667|NCT00002007|Zidovudine|zidovudine|mesh-list
138251668|NCT00002007|Sargramostim|sargramostim|mesh-list
138251669|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
138251670|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251671|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251672|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251673|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251674|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
138251675|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251676|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251677|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251678|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
138251681|NCT00001095|Zidovudine|zidovudine|mesh-list
138251682|NCT00001095|Nevirapine|nevirapine|mesh-list
138251683|NCT00001095|Stavudine|stavudine|mesh-list
138251684|NCT00001095|Indinavir|indinavir|mesh-list
138251685|NCT00001095|Amprenavir|amprenavir|mesh-list
138251686|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251687|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251688|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251689|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251690|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
138251691|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251692|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251693|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251694|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
138251695|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138251696|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138251697|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138251698|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138251699|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
138251700|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138251701|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
138251702|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251704|NCT02294058|Interferon-beta|interferon-beta|mesh-list
138251705|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
138251706|NCT02294058|Ozanimod|ozanimod|mesh-list
138251707|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251708|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
138251709|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251710|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
138251711|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251712|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251713|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138251714|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251715|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251717|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
138251718|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251719|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251720|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251721|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251722|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
138251723|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251724|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251725|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251726|NCT00359333|Gemcitabine|gemcitabine|mesh-list
138251727|NCT00359333|Docetaxel|docetaxel|mesh-list
138251728|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138251729|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
138251730|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251731|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251732|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251733|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251734|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251735|NCT00001101|Doxycycline|doxycycline|mesh-list
138251736|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
138251737|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251738|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251739|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
138251740|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251741|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251742|NCT00001107|Fluconazole|fluconazole|mesh-list
138251743|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138251744|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
138251745|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251748|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251749|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251750|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138251751|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
138251752|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251753|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251754|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138251755|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138251756|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251757|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251759|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138251760|NCT00002019|Amebicides|amebicides|mesh-ancestor
138251761|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251762|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251763|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251764|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251765|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
138251766|NCT00002025|Ganciclovir|ganciclovir|mesh-list
138251767|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138251768|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
138251769|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251770|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251771|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251772|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251773|NCT00001131|Aldesleukin|aldesleukin|mesh-list
138251774|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251776|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251777|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
138251778|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251779|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
138251780|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251781|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
138251782|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251783|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251784|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138251785|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
138251786|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251787|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251788|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138251789|NCT00002037|Trifluridine|trifluridine|mesh-list
138251790|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
138251791|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251792|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
138251793|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251794|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
138251795|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251796|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
138251797|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251799|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251801|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
138251802|NCT05270057|Rituximab|rituximab|mesh-list
138251803|NCT05270057|Doxorubicin|doxorubicin|mesh-list
138251804|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138251805|NCT05270057|Etoposide|etoposide|mesh-list
138251806|NCT05270057|Vincristine|vincristine|mesh-list
138251807|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138251808|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251809|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
138251810|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251811|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251812|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138251813|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
138251815|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251816|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138251817|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138251818|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138251819|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251820|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251821|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251822|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251823|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
138251824|NCT05270057|Hormones|hormones|mesh-ancestor
138251825|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138251826|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251827|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251828|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251829|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251830|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251831|NCT00002043|Dapsone|dapsone|mesh-list
138251832|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251833|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
138251834|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251835|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251836|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138251837|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251838|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251839|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
138251840|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251841|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
138251842|NCT00001209|Ifosfamide|ifosfamide|mesh-list
138251843|NCT00001209|Vincristine|vincristine|mesh-list
138251844|NCT00001209|Doxorubicin|doxorubicin|mesh-list
138251845|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138251846|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251847|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
138251848|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251849|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251850|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138251851|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
138251852|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251853|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251854|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138251855|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251856|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251857|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251858|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251859|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138251860|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138251861|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251862|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251863|NCT00002049|Thymopentin|thymopentin|mesh-list
138251864|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251865|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
138251866|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251867|NCT05044637|Primaquine|primaquine|mesh-list
138251868|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
138251869|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251870|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251871|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251872|NCT05043077|Phenylephrine|phenylephrine|mesh-list
138251873|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
138251874|NCT05043077|Tropicamide|tropicamide|mesh-list
138251875|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138251876|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
138251877|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
138251878|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251879|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251880|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
138251882|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
138251883|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
138251884|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138251885|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138251886|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138251887|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138251888|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138251889|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251890|NCT05043077|Protective Agents|protective agents|mesh-ancestor
138251891|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138251892|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138251893|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
138251894|NCT00002055|Pentamidine|pentamidine|mesh-list
138251895|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
138251896|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251897|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138251898|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138251899|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138251900|NCT05031455|Aspirin|aspirin|mesh-list
138251901|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138251902|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138251904|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
138251905|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251906|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251907|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251908|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251909|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138251910|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138251911|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251912|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138251913|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138251914|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251915|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
138251916|NCT05029973|Bevacizumab|bevacizumab|mesh-list
138251917|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138251918|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251919|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138251920|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138251921|NCT05029973|Growth Substances|growth substances|mesh-ancestor
138251922|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251923|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
138251924|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
138251925|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138251926|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
138251927|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251928|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
138251929|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251930|NCT00002067|Megestrol|megestrol|mesh-list
138251931|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
138251932|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138251933|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138251934|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138251937|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251938|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138251939|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138251940|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251941|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251942|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
138251943|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138251945|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251946|NCT00001311|Heparin|heparin|mesh-list
138251947|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
138251948|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138251950|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251951|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
138251952|NCT05016713|Fluorides|fluorides|mesh-list
138251953|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
138251954|NCT05016713|Protective Agents|protective agents|mesh-ancestor
138251955|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251956|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138251957|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251958|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
138251959|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
138251960|NCT00002073|Hematinics|hematinics|mesh-ancestor
138251961|NCT00001317|Interferons|interferons|mesh-list
138251962|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
138251963|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251964|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
138251965|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251966|NCT00001335|Topotecan|topotecan|mesh-list
138251967|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138251968|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138251969|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251970|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251971|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251972|NCT00002079|Miglustat|miglustat|mesh-list
138251973|NCT00002079|Zidovudine|zidovudine|mesh-list
138251974|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
138251975|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251976|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138251977|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138251978|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251979|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
138251980|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251981|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251982|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251983|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138251984|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138251985|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251986|NCT00002085|Azithromycin|azithromycin|mesh-list
138251987|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138251988|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251989|NCT00001383|Paclitaxel|paclitaxel|mesh-list
138251990|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138251991|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251992|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251993|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138251994|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251995|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251996|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
138251997|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138251998|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251999|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252000|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138252001|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138252002|NCT00002091|Protective Agents|protective agents|mesh-ancestor
138252003|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252004|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
138252005|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138252006|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
138252007|NCT00001407|Interferons|interferons|mesh-list
138252008|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
138252009|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252011|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252013|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252014|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252015|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
138252016|NCT00002097|Ionophores|ionophores|mesh-ancestor
138252017|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138252019|NCT00001431|Gemcitabine|gemcitabine|mesh-list
138252020|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252021|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
138252022|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252023|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252025|NCT00002103|Trimetrexate|trimetrexate|mesh-list
138252026|NCT00002103|Calcium|calcium|mesh-list
138252027|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
138252028|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138252029|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252030|NCT00002103|Antidotes|antidotes|mesh-ancestor
138252031|NCT00002103|Protective Agents|protective agents|mesh-ancestor
138252032|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
138252034|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
138252035|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
138252036|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252037|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252038|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
138252039|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252040|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252041|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252042|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252043|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
138252044|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138252045|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252046|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252047|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138252048|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138252049|NCT00001437|Protective Agents|protective agents|mesh-ancestor
138252050|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252051|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
138252052|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138252053|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
138252054|NCT00360191|Buspirone|buspirone|mesh-list
138252055|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138252056|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138252057|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138252058|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252059|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138252060|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138252061|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
138252062|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252063|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252064|NCT00001443|Indinavir|indinavir|mesh-list
138252065|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252066|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252067|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252068|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252069|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252070|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252071|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252072|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
138252073|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252078|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
138252079|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252080|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252081|NCT00001449|Antidotes|antidotes|mesh-ancestor
138252082|NCT00001449|Protective Agents|protective agents|mesh-ancestor
138252083|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252084|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
138252085|NCT00001449|Vitamins|vitamins|mesh-ancestor
138252086|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
138252087|NCT00002109|Zidovudine|zidovudine|mesh-list
138252088|NCT00002109|Didanosine|didanosine|mesh-list
138252089|NCT00002109|Stavudine|stavudine|mesh-list
138252090|NCT00002109|Zalcitabine|zalcitabine|mesh-list
138252091|NCT00002109|Thymopentin|thymopentin|mesh-list
138252092|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
138252093|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252094|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252095|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252096|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252097|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
138252098|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252099|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252100|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252101|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138252102|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
138252103|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252104|NCT00359567|Palonosetron|palonosetron|mesh-list
138252105|NCT00359567|Granisetron|granisetron|mesh-list
138252106|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
138362860|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252107|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
138252108|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252109|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252110|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362861|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252112|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138252114|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252115|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252116|NCT00381147|Clarithromycin|clarithromycin|mesh-list
138252117|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252118|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252119|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138252120|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252121|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252122|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252123|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252125|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138252126|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
138252127|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
138252128|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252129|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252130|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138252131|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138252132|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138252133|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
138252134|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252135|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252137|NCT00002115|Adefovir|adefovir|mesh-list
138252138|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
138252139|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252140|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252141|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252142|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252143|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252144|NCT00001569|Paclitaxel|paclitaxel|mesh-list
138252145|NCT00001569|Cisplatin|cisplatin|mesh-list
138252146|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252147|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252148|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138252149|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138252150|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138252151|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252152|NCT00001587|Melphalan|melphalan|mesh-list
138252153|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138252154|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
138252155|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252156|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252157|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138252158|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252159|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
138252160|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252162|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252163|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
138252164|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252165|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
138252166|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252167|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252168|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138252169|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138252170|NCT00002127|Growth Substances|growth substances|mesh-ancestor
138252171|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
138252172|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252173|NCT00001599|Thalidomide|thalidomide|mesh-list
138252174|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252175|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
138252176|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252177|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
138252178|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252179|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252180|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138252181|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138252182|NCT00001599|Growth Substances|growth substances|mesh-ancestor
138252183|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
138252184|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252186|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
138252187|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
138252188|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252189|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252190|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252191|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138252192|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138252193|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138252194|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138252195|NCT00002133|Itraconazole|itraconazole|mesh-list
138252196|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
138252197|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252198|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138252199|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252200|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252203|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
138252204|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252205|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252206|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252207|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
138252209|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
138252210|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
138252211|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138252212|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138252213|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252214|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252215|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252216|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138252217|NCT00002139|Azithromycin|azithromycin|mesh-list
138252218|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252219|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252220|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
138252221|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138252222|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
138252223|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252224|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
138252225|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252226|NCT00002145|Foscarnet|foscarnet|mesh-list
138252227|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138252228|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
138252229|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252230|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252231|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252232|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252233|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252234|NCT00002301|Foscarnet|foscarnet|mesh-list
138252235|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138252236|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
138252237|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252238|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252239|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252240|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252241|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252242|NCT00002307|Zidovudine|zidovudine|mesh-list
138252243|NCT00002307|Stavudine|stavudine|mesh-list
138252244|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
138252245|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252246|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252247|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252248|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252249|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
138252250|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252251|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252252|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252253|NCT00002313|Didanosine|didanosine|mesh-list
138252254|NCT00002313|Nystatin|nystatin|mesh-list
138252255|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
138252256|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252257|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252258|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252259|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252260|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
138252261|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252263|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252264|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252265|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
138252267|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138252268|NCT00002157|Thalidomide|thalidomide|mesh-list
138252269|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252270|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
138252271|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252272|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
138252273|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252274|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252275|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138252276|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138252277|NCT00002157|Growth Substances|growth substances|mesh-ancestor
138252278|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
138252279|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252280|NCT00002319|Doxorubicin|doxorubicin|mesh-list
138252281|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138252282|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138252283|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252284|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252285|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252286|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252287|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252288|NCT00002163|Abacavir|abacavir|mesh-list
138252289|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252290|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252291|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252292|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252293|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
138252294|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252295|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252296|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252298|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
138252299|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252300|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138252301|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252302|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252303|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252304|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138252306|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252307|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252308|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138252309|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138252310|NCT00002331|Clarithromycin|clarithromycin|mesh-list
138252311|NCT00002331|Ethambutol|ethambutol|mesh-list
138252312|NCT00002331|Clofazimine|clofazimine|mesh-list
138252313|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252314|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252315|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138252316|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252317|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252318|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252319|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252320|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
138252321|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138252322|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
138252323|NCT00002337|Vesnarinone|vesnarinone|mesh-list
138252324|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138252325|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
138252326|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252327|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252328|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
138252329|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252330|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138252332|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252333|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252334|NCT00002337|Protective Agents|protective agents|mesh-ancestor
138252336|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252337|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252338|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252339|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252340|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252341|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252342|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252343|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
138252344|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252346|NCT02293902|Methotrexate|methotrexate|mesh-list
138252347|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138252348|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
138252349|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138252350|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252351|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252352|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
138252353|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252354|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252355|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252356|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252357|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252358|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252359|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
138252360|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252361|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252362|NCT02293902|Hematinics|hematinics|mesh-ancestor
138252363|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
138252364|NCT02293902|Vitamins|vitamins|mesh-ancestor
138252365|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
138252366|NCT00002343|Ethambutol|ethambutol|mesh-list
138252367|NCT00002343|Rifabutin|rifabutin|mesh-list
138252368|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
138252369|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252370|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252371|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138252372|NCT00002349|Stavudine|stavudine|mesh-list
138252373|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
138252374|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252376|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252377|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252378|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
138252379|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252380|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252381|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252383|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
138252384|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252385|NCT02278614|Timolol|timolol|mesh-list
138252386|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138252387|NCT02278614|Latanoprost|latanoprost|mesh-list
138252388|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138252389|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138252390|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138252391|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138252393|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252394|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252395|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138252396|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138252398|NCT00002361|Indinavir|indinavir|mesh-list
138252399|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252400|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252401|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252402|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252403|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252404|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252405|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252406|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
138252407|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252408|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252409|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252410|NCT00002181|Cidofovir|cidofovir|mesh-list
138252411|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
138252412|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252413|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252414|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252415|NCT00002367|Lamivudine|lamivudine|mesh-list
138252416|NCT00002367|Zidovudine|zidovudine|mesh-list
138252418|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252419|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252420|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252421|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252422|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
138252423|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252424|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252425|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252426|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
138252427|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252428|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252429|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252430|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252431|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252432|NCT00002187|Fomivirsen|fomivirsen|mesh-list
138252433|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
138252434|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252435|NCT00002373|Maribavir|maribavir|mesh-list
138252436|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
138252437|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252438|NCT00002379|Lamivudine|lamivudine|mesh-list
138252439|NCT00002379|Zidovudine|zidovudine|mesh-list
138252441|NCT00002379|Adefovir|adefovir|mesh-list
138252442|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138252443|NCT00002379|Indinavir|indinavir|mesh-list
138252445|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252446|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252447|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252448|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
138252449|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252450|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252451|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252452|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
138252453|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252454|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252455|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252456|NCT00359723|Methylphenidate|methylphenidate|mesh-list
138252457|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138252458|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252459|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138252460|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138252461|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138252462|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252463|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
138252464|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252466|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138252467|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
138252468|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252469|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252470|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252471|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252472|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252473|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252474|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252475|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252476|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252477|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
138252478|NCT00002391|Lamivudine|lamivudine|mesh-list
138252479|NCT00002391|Zidovudine|zidovudine|mesh-list
138252480|NCT00002391|Abacavir|abacavir|mesh-list
138252481|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252482|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252483|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252484|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252485|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
138252486|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252487|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252488|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252489|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
138252492|NCT00002199|Abacavir|abacavir|mesh-list
138252493|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138252494|NCT00002199|Indinavir|indinavir|mesh-list
138252495|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252496|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252497|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252498|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252500|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252501|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252502|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252503|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
138252504|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252505|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252506|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252507|NCT00002397|Lamivudine|lamivudine|mesh-list
138252508|NCT00002397|Stavudine|stavudine|mesh-list
138252509|NCT00002397|Nelfinavir|nelfinavir|mesh-list
138252510|NCT00002397|Saquinavir|saquinavir|mesh-list
138252511|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252513|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252514|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252516|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252517|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252519|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252520|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252521|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252522|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
138252523|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252524|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252525|NCT00002205|Abacavir|abacavir|mesh-list
138252526|NCT00002205|Amprenavir|amprenavir|mesh-list
138252527|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252528|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252529|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252530|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252531|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
138252532|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252533|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252534|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252535|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138252536|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
138252537|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252538|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252539|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252540|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252541|NCT02977169|Cisplatin|cisplatin|mesh-list
138252542|NCT02977169|Carboplatin|carboplatin|mesh-list
138252543|NCT02977169|Pemetrexed|pemetrexed|mesh-list
138252544|NCT02977169|Vinorelbine|vinorelbine|mesh-list
138252545|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252546|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252547|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252548|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252549|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252550|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252551|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
138252552|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
138252553|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
138252554|NCT00002409|Lamivudine|lamivudine|mesh-list
138252555|NCT00002409|Zidovudine|zidovudine|mesh-list
138252556|NCT00002409|Abacavir|abacavir|mesh-list
138252557|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138252558|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252559|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252560|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252561|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252562|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
138252563|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252564|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252565|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252566|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
138252567|NCT00002211|Nelfinavir|nelfinavir|mesh-list
138252568|NCT00002211|Didanosine|didanosine|mesh-list
138252569|NCT00002211|Stavudine|stavudine|mesh-list
138252570|NCT00002211|Delavirdine|delavirdine|mesh-list
138252571|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252575|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252576|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252577|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252578|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
138252579|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252580|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
138252581|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252582|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252583|NCT00002415|Tenofovir|tenofovir|mesh-list
138252584|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
138252585|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252586|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252587|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252588|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252589|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252590|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252591|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252592|NCT00381537|Carbamazepine|carbamazepine|mesh-list
138252593|NCT00381537|Phenobarbital|phenobarbital|mesh-list
138252594|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
138252595|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
138252596|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138252597|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138252598|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252599|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138252600|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138252601|NCT00381537|Analgesics|analgesics|mesh-ancestor
138252602|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
138252603|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252604|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138252606|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252607|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138252608|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138252609|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138252610|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138252611|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138252612|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252613|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
138252614|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
138252615|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138252616|NCT00002427|Didanosine|didanosine|mesh-list
138252617|NCT00002427|Stavudine|stavudine|mesh-list
138252618|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
138252619|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252620|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
138252621|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252622|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252623|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252626|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
138252627|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252628|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252629|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252632|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252633|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252634|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252635|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252636|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252637|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252638|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252639|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
138252640|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252641|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252642|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252643|NCT00002433|Interferons|interferons|mesh-list
138252644|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
138252645|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252646|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
138252647|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252648|NCT00002439|Alitretinoin|alitretinoin|mesh-list
138252649|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252650|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252651|NCT00002229|Saquinavir|saquinavir|mesh-list
138252652|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252653|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252654|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252655|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252656|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252657|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252658|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252659|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
138252660|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252661|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252662|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252666|NCT00002451|Stavudine|stavudine|mesh-list
138252667|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252668|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252669|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252670|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252671|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252672|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252673|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252674|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
138252675|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252676|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138252677|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252678|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252679|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252680|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
138252681|NCT00002235|Efavirenz|efavirenz|mesh-list
138252682|NCT00002235|Nelfinavir|nelfinavir|mesh-list
138252683|NCT00002235|Indinavir|indinavir|mesh-list
138252684|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252685|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252686|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252687|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252688|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
138252689|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252690|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138252691|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252692|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138252693|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138252694|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138252695|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138252696|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138252697|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138252698|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252699|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252701|NCT00002463|Leucovorin|leucovorin|mesh-list
138252702|NCT00002463|Prednisone|prednisone|mesh-list
138252703|NCT00002463|Methotrexate|methotrexate|mesh-list
138252704|NCT00002463|Vincristine|vincristine|mesh-list
138252705|NCT00002463|Procarbazine|procarbazine|mesh-list
138252706|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
138252707|NCT00002463|Calcium|calcium|mesh-list
138252708|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
138252709|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138252710|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252711|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138252712|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
138252713|NCT00002463|Hormones|hormones|mesh-ancestor
138252714|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252715|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252716|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252717|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138252718|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
138252719|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138252720|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252722|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252723|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252724|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252725|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252726|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252727|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
138252728|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252729|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252730|NCT00002463|Antidotes|antidotes|mesh-ancestor
138252731|NCT00002463|Protective Agents|protective agents|mesh-ancestor
138252732|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
138252733|NCT00002463|Vitamins|vitamins|mesh-ancestor
138252734|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
138252735|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252736|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
138252737|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
138252738|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
138252739|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
138252740|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138252741|NCT00002247|Ganciclovir|ganciclovir|mesh-list
138252742|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138252743|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
138252744|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252745|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252746|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252748|NCT00002475|Interferons|interferons|mesh-list
138252749|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
138252750|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
138252751|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
138252752|NCT00002475|Vaccines|vaccines|mesh-list
138252753|NCT00002475|Sargramostim|sargramostim|mesh-list
138252754|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
138252755|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252756|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252757|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252758|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138252759|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
138252760|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252761|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252762|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138252763|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
138252764|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252765|NCT00002481|Cytarabine|cytarabine|mesh-list
138252766|NCT00002481|Dexamethasone|dexamethasone|mesh-list
138252767|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
138252768|NCT00002481|Etoposide|etoposide|mesh-list
138252769|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252770|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
138252771|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252772|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252773|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138252774|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
138252775|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252776|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252777|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138252778|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138252779|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
138252780|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
138252781|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252782|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252783|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
138252784|NCT00002481|Hormones|hormones|mesh-ancestor
138252785|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252786|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252787|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252788|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252789|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252790|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252791|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252792|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
138252793|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
138252794|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252795|NCT00002253|Octreotide|octreotide|mesh-list
138252796|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252797|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252798|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252799|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
138252800|NCT04862585|Promethazine|promethazine|mesh-list
138252801|NCT04862585|Dexamethasone|dexamethasone|mesh-list
138252802|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
138252804|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138252805|NCT04862585|Famotidine|famotidine|mesh-list
138252806|NCT04862585|Ranitidine|ranitidine|mesh-list
138252807|NCT04862585|Cimetidine|cimetidine|mesh-list
138252808|NCT04862585|BB 1101|bb 1101|mesh-list
138252810|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252811|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138252812|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138252813|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138252814|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252815|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138252818|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252819|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252820|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252821|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
138374393|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138374395|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374396|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374397|NCT01427270|Analgesics|analgesics|mesh-ancestor
138374398|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
138374399|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374400|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138374402|NCT01427283|Naloxone|naloxone|mesh-list
138374403|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138374404|NCT01427283|Narcotics|narcotics|mesh-ancestor
138374405|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374406|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374407|NCT01427283|Analgesics|analgesics|mesh-ancestor
138374408|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
138374409|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374410|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138374411|NCT01427322|Lapatinib|lapatinib|mesh-list
138374412|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374413|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374414|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374415|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374416|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
138374417|NCT01427335|Calcium|calcium|mesh-list
138374418|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374419|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374420|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138374421|NCT01427387|Linaclotide|linaclotide|mesh-list
138374422|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138374423|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
138374424|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374426|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
138374427|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138374428|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138374429|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138374430|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374431|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374432|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
138374433|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374434|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374435|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138374436|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374437|NCT01427478|Afatinib|afatinib|mesh-list
138374438|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374439|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374440|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374441|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374446|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138374447|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
138374448|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374449|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374450|NCT01427686|Dobutamine|dobutamine|mesh-list
138374451|NCT01427686|Dopamine|dopamine|mesh-list
138374452|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138374453|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
138374454|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
138374455|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374456|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374457|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138374458|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138374459|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138374460|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
138374461|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374462|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374464|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
138374465|NCT01427699|Antibodies|antibodies|mesh-list
138374466|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
138374467|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374468|NCT01427842|Vancomycin|vancomycin|mesh-list
138374469|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138374470|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374471|NCT01427868|Maleic acid|maleic acid|mesh-list
138374472|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374473|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374474|NCT01427946|Everolimus|everolimus|mesh-list
138374475|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138374476|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374477|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374478|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374479|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374480|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
138374481|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374482|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374484|NCT01427985|Fentanyl|fentanyl|mesh-list
138374485|NCT01427985|Mivacurium|mivacurium|mesh-list
138374486|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138374487|NCT01427985|Narcotics|narcotics|mesh-ancestor
138374488|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374489|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374490|NCT01427985|Analgesics|analgesics|mesh-ancestor
138374491|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
138374492|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374494|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138374495|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
138374496|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
138374497|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374498|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138374499|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
138374500|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138374501|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374502|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
138374503|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
138374504|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138374505|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138374506|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
138374507|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374508|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374510|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138374511|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138374512|NCT01428037|Misoprostol|misoprostol|mesh-list
138374513|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138374514|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
138374515|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374516|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374517|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138374518|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374519|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
138374520|NCT01427127|Ramosetron|ramosetron|mesh-list
138374521|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
138374522|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
138374523|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374524|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374525|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374526|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138374527|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
138374528|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374529|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374530|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138374531|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
138374532|NCT01428154|Hematinics|hematinics|mesh-ancestor
138374533|NCT01428180|Ibuprofen|ibuprofen|mesh-list
138374534|NCT01428180|Indomethacin|indomethacin|mesh-list
138374535|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138374536|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374537|NCT01428180|Analgesics|analgesics|mesh-ancestor
138374538|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
138374539|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374540|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374541|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374542|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374543|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138374544|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374545|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374546|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
138374547|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
138374548|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374549|NCT01428284|Canagliflozin|canagliflozin|mesh-list
138374550|NCT01428284|Probenecid|probenecid|mesh-list
138374551|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138374552|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374553|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374554|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374555|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
138374556|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
138374557|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374558|NCT01428375|Acetaminophen|acetaminophen|mesh-list
138374559|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374560|NCT01428375|Analgesics|analgesics|mesh-ancestor
138374561|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
138374562|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374563|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374564|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
138374565|NCT01428388|Bevacizumab|bevacizumab|mesh-list
138374566|NCT01428388|Ranibizumab|ranibizumab|mesh-list
138374568|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374569|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138374570|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138374571|NCT01428388|Growth Substances|growth substances|mesh-ancestor
138374572|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374573|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
138374575|NCT01428414|Carboplatin|carboplatin|mesh-list
138374576|NCT01428414|Trastuzumab|trastuzumab|mesh-list
138374578|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138374579|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374580|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138374581|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138374582|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138374583|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374584|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374585|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138374586|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138374587|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138374588|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374589|NCT01428427|Gemcitabine|gemcitabine|mesh-list
138374590|NCT01428427|Trametinib|trametinib|mesh-list
138374591|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138374592|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
138374593|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374594|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374595|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374596|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374597|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138374598|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374599|NCT01428492|Dexamethasone|dexamethasone|mesh-list
138374600|NCT01428492|Bortezomib|bortezomib|mesh-list
138374601|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374602|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
138374603|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
138374604|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374605|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374606|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374607|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
138374609|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374610|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374611|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374612|NCT01428518|Lamotrigine|lamotrigine|mesh-list
138374613|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
138374614|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138374615|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374616|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374617|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374618|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374619|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138374620|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138374621|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374622|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138374623|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138374624|NCT01428531|PENTA|penta|mesh-list
138374625|NCT01428531|Fondaparinux|fondaparinux|mesh-list
138374626|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138374627|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
138374628|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138374629|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
138374630|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374631|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374632|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
138374633|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138374634|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138374635|NCT01428544|PENTA|penta|mesh-list
138374636|NCT01428544|Fondaparinux|fondaparinux|mesh-list
138374637|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138374638|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
138374640|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
138374641|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374642|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374644|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138374647|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138374648|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
138374649|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374650|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374651|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138374652|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374653|NCT01428817|Carbetocin|carbetocin|mesh-list
138374654|NCT01428817|Oxytocin|oxytocin|mesh-list
138374655|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
138374657|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374658|NCT01428908|Vaccines|vaccines|mesh-list
138374659|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
138374660|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374661|NCT01428986|Maraviroc|maraviroc|mesh-list
138374662|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138374663|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138374664|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374665|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138374666|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138374667|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
138374668|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374669|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138374670|NCT01429025|Rituximab|rituximab|mesh-list
138374671|NCT01429025|Lenalidomide|lenalidomide|mesh-list
138374672|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138374673|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374674|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374675|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
138374676|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374677|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374678|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138374679|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138374680|NCT01429025|Growth Substances|growth substances|mesh-ancestor
138374681|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
138374682|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138374683|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
138374684|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374685|NCT01429090|Methantheline|methantheline|mesh-list
138374686|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138374687|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138374688|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
138374689|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374690|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374691|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374692|NCT01429129|Nicotine|nicotine|mesh-list
138374693|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138374694|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
138374695|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374696|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374697|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138374699|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
138374700|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374701|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374702|NCT01429181|Methadone|methadone|mesh-list
138374703|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138374704|NCT01429181|Narcotics|narcotics|mesh-ancestor
138374705|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374709|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374710|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
138374711|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374712|NCT01429337|Midostaurin|midostaurin|mesh-list
138374713|NCT01429337|Staurosporine|staurosporine|mesh-list
138374714|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374715|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374716|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374717|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374718|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
138374719|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138374720|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138374721|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138374722|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374723|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374724|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
138374725|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374726|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374727|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138374728|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374729|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
138374730|NCT01429415|Analgesics|analgesics|mesh-ancestor
138374731|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
138374732|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374733|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374734|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
138374735|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374736|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374737|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
138374738|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138374739|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374740|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374741|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374743|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374745|NCT01429545|Vasotocin|vasotocin|mesh-list
138374746|NCT01429545|Atosiban|atosiban|mesh-list
138374747|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138374748|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374749|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374750|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374751|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374753|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
138374754|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374755|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
138374756|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374757|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
138374758|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138374759|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138374760|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374761|NCT01429610|Cytarabine|cytarabine|mesh-list
138374762|NCT01429610|Rituximab|rituximab|mesh-list
138374763|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374764|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374765|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
138374766|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374767|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374768|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138374769|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
138374770|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374772|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374773|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374774|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
138374775|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138374776|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374778|NCT01429701|Polymyxins|polymyxins|mesh-list
138374779|NCT01429701|Polymyxin B|polymyxin b|mesh-list
138374780|NCT01429701|Prednisolone|prednisolone|mesh-list
138374781|NCT01429701|Betamethasone|betamethasone|mesh-list
138374782|NCT01429701|Benzocaine|benzocaine|mesh-list
138374783|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374784|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
138374785|NCT01429701|Hormones|hormones|mesh-ancestor
138374786|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374787|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374788|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374789|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374790|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374791|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138374792|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374793|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138374794|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374795|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138374796|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374797|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374798|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
138374799|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
138374800|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374801|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
138374802|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
138374803|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138374804|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138374805|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138374806|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374807|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374808|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374809|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
138374810|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
138374811|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374812|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
138374813|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138374814|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374815|NCT01429818|Metformin|metformin|mesh-list
138374816|NCT01429818|Glimepiride|glimepiride|mesh-list
138374817|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374818|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374819|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374820|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374821|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
138374822|NCT01429831|Aripiprazole|aripiprazole|mesh-list
138374823|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
138374824|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138374825|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138374827|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374828|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374829|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
138374830|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
138374831|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374832|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374833|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138374834|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138374835|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
138374837|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138374838|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138374839|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138374840|NCT01429844|Cyclosporine|cyclosporine|mesh-list
138374841|NCT01429844|Tacrolimus|tacrolimus|mesh-list
138374842|NCT01429844|Cyclosporins|cyclosporins|mesh-list
138374843|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374844|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
138374845|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374846|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138374847|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374848|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374849|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
138374850|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374851|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374852|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374853|NCT01429870|Triamcinolone|triamcinolone|mesh-list
138374854|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374855|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
138374856|NCT01429870|Hormones|hormones|mesh-ancestor
138374857|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374858|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374860|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138374861|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374862|NCT01429935|Analgesics|analgesics|mesh-ancestor
138374863|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
138374864|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374865|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374866|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374867|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374868|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138374869|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374870|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374871|NCT01430013|Endostar protein|endostar protein|mesh-list
138374872|NCT01430013|Endostatins|endostatins|mesh-list
138374873|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138374874|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138374875|NCT01430013|Growth Substances|growth substances|mesh-ancestor
138374876|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374877|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
138374878|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374879|NCT01430052|Gemcitabine|gemcitabine|mesh-list
138374880|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138374881|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
138374882|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374883|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374884|NCT01430065|Tacrolimus|tacrolimus|mesh-list
138374885|NCT01430065|Peficitinib|peficitinib|mesh-list
138374886|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374887|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
138374888|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374889|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138374890|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374891|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374892|NCT01430078|Niacinamide|niacinamide|mesh-list
138374893|NCT01430078|Peficitinib|peficitinib|mesh-list
138374894|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374895|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374896|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374897|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
138374898|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374900|NCT01430078|Vitamins|vitamins|mesh-ancestor
138374904|NCT01430234|Pancreatin|pancreatin|mesh-list
138374906|NCT01430260|Ciclesonide|ciclesonide|mesh-list
138374907|NCT01430260|Cetirizine|cetirizine|mesh-list
138374908|NCT01430260|Levocetirizine|levocetirizine|mesh-list
138374909|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
138374910|NCT01430260|Hormones|hormones|mesh-ancestor
138374911|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374912|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374913|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138374914|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138374915|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138374916|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
138374917|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
138374918|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374919|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374920|NCT01430312|Azelaic acid|azelaic acid|mesh-list
138374921|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374922|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374923|NCT01430520|Escitalopram|escitalopram|mesh-list
138374924|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138374925|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138374926|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374927|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374928|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374929|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
138374930|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374931|NCT01430533|Azelaic acid|azelaic acid|mesh-list
138374932|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374933|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374934|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
138374935|NCT01430650|Urological Agents|urological agents|mesh-ancestor
138374936|NCT01430689|Vaccines|vaccines|mesh-list
138374937|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
138374938|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374939|NCT01430793|Vitamin D|vitamin d|mesh-list
138374940|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
138374941|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
138374942|NCT01430793|Vitamins|vitamins|mesh-list
138374943|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
138374945|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138374946|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374947|NCT01430806|Dronedarone|dronedarone|mesh-list
138374948|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374949|NCT01430910|Ceftazidime|ceftazidime|mesh-list
138374950|NCT01430910|Avibactam|avibactam|mesh-list
138374951|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138374952|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374953|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138374955|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374956|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138374958|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138374962|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374963|NCT01431053|Analgesics|analgesics|mesh-ancestor
138374964|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
138374965|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374966|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374967|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374968|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374969|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138374970|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138374971|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374972|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138374973|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138374975|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
138374976|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374977|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138374978|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138374979|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138374980|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
138374981|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374983|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
138374984|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374985|NCT01431092|Protective Agents|protective agents|mesh-ancestor
138374986|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374987|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374989|NCT01431118|Salicylates|salicylates|mesh-list
138374990|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
138374991|NCT01431118|Menthol|menthol|mesh-list
138374992|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138374993|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374994|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
138374995|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374996|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138374997|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374998|NCT01431118|Analgesics|analgesics|mesh-ancestor
138374999|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
138375000|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375001|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375002|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375003|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138375004|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138375005|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375006|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375007|NCT01431352|Letrozole|letrozole|mesh-list
138375008|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375009|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138375010|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138375011|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375012|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375013|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138375014|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375015|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375016|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375018|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138375019|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375020|NCT01431404|Analgesics|analgesics|mesh-ancestor
138375021|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
138375022|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375026|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138375027|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375028|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
138375029|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
138375030|NCT01431430|Vitamin D|vitamin d|mesh-list
138375031|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138375032|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375033|NCT01431430|Vitamins|vitamins|mesh-ancestor
138375034|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
138375035|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138375036|NCT01431443|Theobromine|theobromine|mesh-list
138375037|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138375038|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
138375039|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375040|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375041|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138375042|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375043|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
138375044|NCT01431456|Nadroparin|nadroparin|mesh-list
138375045|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
138375046|NCT01431456|Dabigatran|dabigatran|mesh-list
138375047|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138375048|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
138375049|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138375050|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
138375051|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375052|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375053|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
138375054|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138375055|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138375056|NCT01431495|Clopidogrel|clopidogrel|mesh-list
138375057|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138375058|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138375059|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138375060|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138375061|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
138375063|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375064|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375065|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138375066|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
138375067|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375070|NCT01431612|Esmolol|esmolol|mesh-list
138375071|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138375072|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
138375073|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
138375074|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375075|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375076|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
138375077|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138375078|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
138375079|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375080|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138375081|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138375082|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138375086|NCT01431612|Protective Agents|protective agents|mesh-ancestor
138375087|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138375088|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138375089|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375090|NCT01431690|Warfarin|warfarin|mesh-list
138375091|NCT01431690|Anticoagulants|anticoagulants|mesh-list
138375092|NCT01431729|Propolis|propolis|mesh-list
138375093|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375094|NCT01431742|Buprenorphine|buprenorphine|mesh-list
138375096|NCT01431742|Narcotics|narcotics|mesh-ancestor
138375097|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375098|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375099|NCT01431742|Analgesics|analgesics|mesh-ancestor
138375100|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
138375101|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375102|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138375104|NCT01431781|Somatostatin|somatostatin|mesh-list
138375105|NCT01431781|Hormones|hormones|mesh-ancestor
138375106|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375107|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375108|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
138375109|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138375110|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375111|NCT01431924|Fluticasone|fluticasone|mesh-list
138375113|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138375114|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375115|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138375116|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
138375117|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375118|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375119|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138375120|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375121|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138375122|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138375123|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138375124|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138375125|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138375126|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375127|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375128|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375129|NCT01432028|Drospirenone|drospirenone|mesh-list
138375130|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138375131|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138375132|NCT01432028|Estradiol|estradiol|mesh-list
138375133|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138375134|NCT01432028|Progesterone|progesterone|mesh-list
138375135|NCT01432028|Estrogens|estrogens|mesh-ancestor
138375136|NCT01432028|Hormones|hormones|mesh-ancestor
138375137|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375138|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375142|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138375143|NCT01432028|Progestins|progestins|mesh-ancestor
138375144|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138375148|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
138375149|NCT01432080|Azithromycin|azithromycin|mesh-list
138375151|NCT01432080|Budesonide|budesonide|mesh-list
138375152|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
138375153|NCT01432080|Montelukast|montelukast|mesh-list
138375154|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138375155|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375156|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
138375157|NCT01432080|Hormones|hormones|mesh-ancestor
138375158|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375159|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375160|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138375161|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375162|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138375163|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
138375164|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375165|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138375166|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375167|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138375168|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375169|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138375170|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138375171|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138375172|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375173|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375174|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375175|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138375176|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375177|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138375178|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138375179|NCT01432106|Valsartan|valsartan|mesh-list
138375180|NCT01432106|Ramipril|ramipril|mesh-list
138375181|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375182|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138375184|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375185|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138375186|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
138375187|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375188|NCT01432119|Cetuximab|cetuximab|mesh-list
138375189|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138375190|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375191|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375192|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138375193|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375194|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375195|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138375196|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
138375197|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375198|NCT01432223|Paclitaxel|paclitaxel|mesh-list
138375199|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138375200|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375201|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
138375202|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
138375203|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
138375206|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138375207|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375208|NCT01432249|Analgesics|analgesics|mesh-ancestor
138375209|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
138375210|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375211|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375212|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375213|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138375214|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138375215|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375216|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
138375217|NCT01432470|Oxytocin|oxytocin|mesh-list
138375218|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
138375219|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138375220|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375221|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
138375222|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375223|NCT01432496|Ropivacaine|ropivacaine|mesh-list
138375224|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
138375225|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
138375226|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375227|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375228|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
138375229|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375230|NCT01432522|Epinephrine|epinephrine|mesh-list
138375231|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138375232|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138375233|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375234|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375235|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375236|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375237|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138375238|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138375239|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
138375240|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375241|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138375242|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375243|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
138375244|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
138375245|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138375246|NCT01432587|Diflunisal|diflunisal|mesh-list
138375247|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138375248|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375249|NCT01432587|Analgesics|analgesics|mesh-ancestor
138375250|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
138375251|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375252|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375253|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375254|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138375255|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138375256|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375257|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375258|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
138375259|NCT01432665|Testosterone|testosterone|mesh-list
138375260|NCT01432665|Androgens|androgens|mesh-ancestor
138375261|NCT01432665|Hormones|hormones|mesh-ancestor
138375262|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375263|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375264|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
138375265|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138375266|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138375267|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375271|NCT01432704|Vitamin D|vitamin d|mesh-list
138375272|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138375273|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375274|NCT01432704|Vitamins|vitamins|mesh-ancestor
138375275|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
138375276|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138375277|NCT01432717|Luspatercept|luspatercept|mesh-list
138375278|NCT01432717|Hematinics|hematinics|mesh-ancestor
138375279|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
138375280|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138375281|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138375282|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138375283|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138375284|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375285|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
138375286|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375287|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375289|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375290|NCT01432821|Apomorphine|apomorphine|mesh-list
138375291|NCT01432821|Emetics|emetics|mesh-ancestor
138375292|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375293|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
138375294|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375296|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
138375297|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
138375298|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375299|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375300|NCT01432873|Selenium|selenium|mesh-list
138375301|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
138375302|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375303|NCT01432873|Protective Agents|protective agents|mesh-ancestor
138375304|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375305|NCT01432873|Trace Elements|trace elements|mesh-ancestor
138375306|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
138375307|NCT01432977|Acetaminophen|acetaminophen|mesh-list
138375308|NCT01432977|Droperidol|droperidol|mesh-list
138375309|NCT01432977|Ondansetron|ondansetron|mesh-list
138375310|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375311|NCT01432977|Analgesics|analgesics|mesh-ancestor
138375312|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
138375313|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375314|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375315|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
138375316|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
138375317|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
138375318|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138375319|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
138375320|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
138375321|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138375322|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138375323|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
138375324|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375325|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375326|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138375327|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138375328|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138375329|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375330|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138375331|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138375332|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138375333|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
138375334|NCT01433445|Panobinostat|panobinostat|mesh-list
138375335|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375336|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138375337|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375338|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375339|NCT01433614|Paclitaxel|paclitaxel|mesh-list
138375340|NCT01433614|Capecitabine|capecitabine|mesh-list
138375341|NCT01433614|Epirubicin|epirubicin|mesh-list
138375342|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138375343|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375344|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
138375346|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
138375347|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375348|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375349|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
138375350|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138375351|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138375352|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138375353|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375354|NCT01433627|Hirudins|hirudins|mesh-list
138375355|NCT01433627|Bivalirudin|bivalirudin|mesh-list
138375356|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
138375357|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138375358|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
138375359|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375360|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375361|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
138375362|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138375363|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138375364|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
138375365|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138375366|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375367|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375368|NCT01433705|Regadenoson|regadenoson|mesh-list
138375369|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375370|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138375371|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138375372|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
138375373|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
138375374|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375375|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375376|NCT01433757|Ampicillin|ampicillin|mesh-list
138375377|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138375378|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375379|NCT01433770|Alefacept|alefacept|mesh-list
138375380|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138375381|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
138375382|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375383|NCT01433887|Ribavirin|ribavirin|mesh-list
138375384|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138375385|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
138375386|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375388|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375389|NCT01433900|Latanoprost|latanoprost|mesh-list
138375390|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138375391|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138375392|NCT01433952|Thiamine|thiamine|mesh-list
138375393|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
138375394|NCT01433952|Vitamins|vitamins|mesh-ancestor
138375395|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
138375396|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375397|NCT01434017|Dexamethasone|dexamethasone|mesh-list
138375398|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
138375399|NCT01434017|Droperidol|droperidol|mesh-list
138375400|NCT01434017|Ondansetron|ondansetron|mesh-list
138375401|NCT01434017|BB 1101|bb 1101|mesh-list
138375402|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375403|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
138375404|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
138375405|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375406|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375407|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138375408|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
138375409|NCT01434017|Hormones|hormones|mesh-ancestor
138375410|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375411|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138375412|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375413|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
138375414|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375415|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375416|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
138375417|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
138375418|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138375419|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138375420|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
138375421|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375422|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138375423|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138375426|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138375427|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138375428|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138375429|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
138375430|NCT01434069|Leucovorin|leucovorin|mesh-list
138375431|NCT01434069|Fluorouracil|fluorouracil|mesh-list
138375432|NCT01434069|Pasireotide|pasireotide|mesh-list
138375433|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
138375434|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375435|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375436|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375437|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375438|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
138375439|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375441|NCT01434069|Protective Agents|protective agents|mesh-ancestor
138375442|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
138375443|NCT01434069|Vitamins|vitamins|mesh-ancestor
138375444|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
138375445|NCT01434069|Hormones|hormones|mesh-ancestor
138375446|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375447|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
138375448|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375449|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
138375450|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375451|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375452|NCT01434134|Metoprolol|metoprolol|mesh-list
138375453|NCT01434134|Candesartan|candesartan|mesh-list
138375454|NCT01434134|Candesartan cilexetil|candesartan cilexetil|mesh-list
138375455|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138375456|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375457|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
138375458|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
138375459|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375460|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375461|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138375462|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138375463|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375464|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375465|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375466|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375467|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138375468|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138375470|NCT01434147|Capecitabine|capecitabine|mesh-list
138375471|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
138375472|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375473|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375474|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138375478|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
138375479|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375480|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
138375481|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375482|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
138375484|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
138375485|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138375486|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375487|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138375488|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138375489|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138375490|NCT01434173|Amoxicillin|amoxicillin|mesh-list
138375491|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
138375492|NCT01434173|Clarithromycin|clarithromycin|mesh-list
138375493|NCT01434173|Doxycycline|doxycycline|mesh-list
138375494|NCT01434173|Levofloxacin|levofloxacin|mesh-list
138375495|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
138375496|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
138375497|NCT01434173|Cefuroxime|cefuroxime|mesh-list
138375498|NCT01434173|Telithromycin|telithromycin|mesh-list
138375499|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138375500|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138375501|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375502|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138375503|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138375504|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375505|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375506|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375507|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138375508|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
138375509|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138375510|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375511|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138375512|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138375513|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138375514|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138375515|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138375516|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138375517|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
138375518|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138375519|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138375520|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138375521|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138375522|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138375523|NCT01434212|Interferons|interferons|mesh-list
138375525|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
138375526|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
138375527|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375528|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
138375529|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375530|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
138375531|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375532|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
138375533|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375535|NCT01434225|Diuretics|diuretics|mesh-ancestor
138375536|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
138375537|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375539|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138375540|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375541|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
138375542|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138375543|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138375544|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138375546|NCT01434303|Lapatinib|lapatinib|mesh-list
138375547|NCT01434303|Entinostat|entinostat|mesh-list
138375548|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138375549|NCT01434303|Antibodies|antibodies|mesh-list
138375550|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
138375551|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138375552|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138375553|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
138375554|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375555|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375556|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138375557|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375558|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375559|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138375560|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138375561|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
138375562|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375563|NCT01434381|Antacids|antacids|mesh-ancestor
138375564|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375565|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138375566|NCT01434394|Cetuximab|cetuximab|mesh-list
138375567|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375568|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375569|NCT01434459|Gemcitabine|gemcitabine|mesh-list
138375570|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375571|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
138375572|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375573|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375575|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375576|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138375577|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375578|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375579|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375580|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375581|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138375582|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375584|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138375585|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138375586|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375587|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
138375588|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138375589|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138375590|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375591|NCT01434888|Timolol|timolol|mesh-list
138375592|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138375593|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138375594|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138375595|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375596|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375597|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375598|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375599|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375600|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138375601|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375602|NCT01434901|Bethanechol|bethanechol|mesh-list
138375603|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138375604|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
138375605|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375606|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375608|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138375609|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
138375610|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375611|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375613|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375614|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138375615|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138375616|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
138375617|NCT01435083|Coagulants|coagulants|mesh-ancestor
138375618|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138375619|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
138375620|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375621|NCT01435161|Telmisartan|telmisartan|mesh-list
138375622|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
138375623|NCT01435161|Nifedipine|nifedipine|mesh-list
138375624|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138375625|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138375626|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375627|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138375629|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138375630|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375631|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
138375632|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
138375633|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138375634|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138375635|NCT01435200|Hematinics|hematinics|mesh-ancestor
138375636|NCT01435213|Insulin|insulin|mesh-list
138375637|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138375638|NCT01435213|Ketamine|ketamine|mesh-list
138375639|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138375640|NCT01435213|Atipamezole|atipamezole|mesh-list
138375641|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138375642|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375643|NCT01435213|Analgesics|analgesics|mesh-ancestor
138375644|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
138375645|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375646|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138375647|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138375648|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
138375649|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
138375650|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375651|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138375652|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138375653|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375654|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375655|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138375656|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138375657|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138375658|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375659|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138375660|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138375661|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375663|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375665|NCT01435291|Tacrolimus|tacrolimus|mesh-list
138375666|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375667|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
138375668|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375669|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138375671|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375673|NCT01435343|Plerixafor|plerixafor|mesh-list
138375674|NCT01435343|Fludarabine|fludarabine|mesh-list
138375675|NCT01435343|Idarubicin|idarubicin|mesh-list
138375676|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375677|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375678|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
138375679|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375680|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375681|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
138375682|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375683|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
138375684|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375685|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138362863|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362864|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138362865|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138375686|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138375687|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138375688|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375689|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138375690|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138375691|NCT01435395|Bevacizumab|bevacizumab|mesh-list
138375692|NCT01435395|Temozolomide|temozolomide|mesh-list
138375693|NCT01435395|Bortezomib|bortezomib|mesh-list
138375694|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375696|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138375697|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138375698|NCT01435395|Growth Substances|growth substances|mesh-ancestor
138375699|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375700|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
138375701|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138375702|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
138375703|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375704|NCT01435486|Caffeine|caffeine|mesh-list
138375705|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
138375706|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375707|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138375708|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375709|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138375710|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375711|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138375712|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138375713|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
138375714|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375715|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
138375716|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375717|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
138375720|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138375721|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
138375722|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375723|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375724|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138375725|NCT01435707|Triamcinolone|triamcinolone|mesh-list
138375726|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138375727|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138375728|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138375729|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375730|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
138375732|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375733|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375734|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375735|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
138375736|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375737|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375739|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138375740|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375741|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138375742|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375743|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375744|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138375746|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
138375747|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375749|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138375750|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138375751|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
138375752|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
138375753|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375754|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375755|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375756|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138375757|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138375758|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375759|NCT01435941|Analgesics|analgesics|mesh-ancestor
138375760|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
138375761|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375762|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375763|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138375765|NCT01435954|Tamsulosin|tamsulosin|mesh-list
138375766|NCT01435954|Finasteride|finasteride|mesh-list
138375767|NCT01435954|Silodosin|silodosin|mesh-list
138375768|NCT01435954|Terazosin|terazosin|mesh-list
138375769|NCT01435954|Alfuzosin|alfuzosin|mesh-list
138375770|NCT01435954|Dutasteride|dutasteride|mesh-list
138375771|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138375772|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138375773|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375774|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375775|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375776|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375777|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375778|NCT01435954|Urological Agents|urological agents|mesh-ancestor
138375779|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138375780|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138375782|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375783|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375784|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375786|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138375787|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375788|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138375790|NCT01435980|Hormones|hormones|mesh-ancestor
138375791|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375792|NCT01436123|Everolimus|everolimus|mesh-list
138375793|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138375794|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138375795|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375796|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375797|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375798|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
138375799|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375800|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375801|NCT01436188|Ibuprofen|ibuprofen|mesh-list
138375802|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138375803|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138375804|NCT01436188|Analgesics|analgesics|mesh-ancestor
138375805|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
138375807|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375809|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138375810|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138375811|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375812|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375813|NCT01436422|Vaccines|vaccines|mesh-list
138375814|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
138375815|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375816|NCT01435902|Fluticasone|fluticasone|mesh-list
138375818|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375819|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138375820|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
138375821|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375822|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375823|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138375824|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
138375825|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
138375826|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138375827|NCT01436474|Varenicline|varenicline|mesh-list
138375828|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138375829|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138375830|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
138375831|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375832|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375833|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375834|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138375836|NCT01436513|Hormones|hormones|mesh-ancestor
138375837|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375838|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375839|NCT01436539|Adefovir|adefovir|mesh-list
138375840|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138375841|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138375842|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
138375843|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375844|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138375845|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138375846|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375847|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375848|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138375849|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
138375850|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138375851|NCT01436578|Posaconazole|posaconazole|mesh-list
138375852|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
138375853|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375854|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138375855|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138375857|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138375858|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138375859|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375860|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375861|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138375862|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375863|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375864|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375865|NCT01436825|Factor VIII|factor viii|mesh-list
138375866|NCT01436825|Coagulants|coagulants|mesh-ancestor
138375879|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375881|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
138375882|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138375883|NCT01436929|Silymarin|silymarin|mesh-list
138375884|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
138375885|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375886|NCT01436929|Protective Agents|protective agents|mesh-ancestor
138375887|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375888|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
138375889|NCT01436994|Carbimazole|carbimazole|mesh-list
138375890|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
138375891|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375892|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
138375893|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375894|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375895|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375897|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138375898|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375899|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375900|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138375901|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
138375902|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375903|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138375904|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138375906|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375907|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138375908|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138375909|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138375910|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375911|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375912|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375913|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375924|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
138375925|NCT01437228|Povidone|povidone|mesh-list
138375926|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
138375927|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
138375928|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138375929|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375930|NCT01437293|Carbidopa|carbidopa|mesh-list
138375931|NCT01437293|Entacapone|entacapone|mesh-list
138375932|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138375933|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138375935|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375936|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375938|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138375939|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375940|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138375941|NCT01437306|Lofexidine|lofexidine|mesh-list
138375942|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375943|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138375944|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375945|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
138375946|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375947|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138375948|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138375949|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138375950|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375951|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375952|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375953|NCT01437371|Ramipril|ramipril|mesh-list
138375954|NCT01437371|Enalapril|enalapril|mesh-list
138375955|NCT01437371|Lisinopril|lisinopril|mesh-list
138375956|NCT01437371|Captopril|captopril|mesh-list
138375957|NCT01437371|Trandolapril|trandolapril|mesh-list
138375958|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138375959|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138375960|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
138375961|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375962|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375963|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138375965|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375966|NCT01437462|Propofol|propofol|mesh-list
138375967|NCT01437462|Sevoflurane|sevoflurane|mesh-list
138375968|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138375969|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375970|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375971|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138375972|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
138375974|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138375975|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138375976|NCT01437566|Fulvestrant|fulvestrant|mesh-list
138375977|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138375978|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375979|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138375980|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138375981|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375982|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138375983|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375984|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
138375985|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138375986|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138375987|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375988|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
138375989|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375990|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375992|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138375994|NCT01437618|Bevacizumab|bevacizumab|mesh-list
138375995|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138375997|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138375998|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138375999|NCT01437618|Growth Substances|growth substances|mesh-ancestor
138376000|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376004|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376005|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376007|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376008|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376009|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
138376010|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138376011|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138376012|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376013|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376014|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376015|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376016|NCT01437670|Urological Agents|urological agents|mesh-ancestor
138376017|NCT01437696|Vitamin D|vitamin d|mesh-list
138376018|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
138376019|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
138376020|NCT01437696|Vitamins|vitamins|mesh-list
138376021|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
138376022|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376023|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138376024|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138376026|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
138376027|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138376028|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
138376029|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376030|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376031|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138376033|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
138376034|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138376035|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376036|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376037|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376038|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
138376039|NCT01437800|Metformin|metformin|mesh-list
138376040|NCT01437800|Glimepiride|glimepiride|mesh-list
138376041|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376042|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376043|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138376044|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376045|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
138376046|NCT01437813|Metformin|metformin|mesh-list
138376047|NCT01437813|Glimepiride|glimepiride|mesh-list
138376048|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376049|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376050|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138376051|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376052|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
138376053|NCT01437826|Selenium|selenium|mesh-list
138376055|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376056|NCT01437826|Protective Agents|protective agents|mesh-ancestor
138376057|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376058|NCT01437826|Trace Elements|trace elements|mesh-ancestor
138376062|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
138376063|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138376064|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376065|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376066|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376067|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
138376068|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138376069|NCT01437982|Prednisolone|prednisolone|mesh-list
138376070|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138376071|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
138376072|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138376073|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
138376074|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138376075|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
138376076|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376077|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
138376079|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376080|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376081|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138376082|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376083|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
138376084|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
138376085|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376086|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376087|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138376088|NCT01437982|Protective Agents|protective agents|mesh-ancestor
138376089|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138376090|NCT01438021|Methotrexate|methotrexate|mesh-list
138376091|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138376092|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
138376093|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138376096|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
138376097|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376098|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376099|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
138376100|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376101|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138376102|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376103|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
138376104|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376105|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376106|NCT01438086|Mecasermin|mecasermin|mesh-list
138376107|NCT01438086|Growth Substances|growth substances|mesh-ancestor
138376108|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376109|NCT01438112|Interferons|interferons|mesh-list
138376110|NCT01438112|Gemcitabine|gemcitabine|mesh-list
138376111|NCT01438112|Mitomycins|mitomycins|mesh-list
138376112|NCT01438112|Mitomycin|mitomycin|mesh-list
138376113|NCT01438112|Valrubicin|valrubicin|mesh-list
138376114|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138376115|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
138376116|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376117|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376118|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
138376119|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376120|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138376121|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
138376122|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376123|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376124|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138376125|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138376126|NCT01438190|Metformin|metformin|mesh-list
138376131|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376132|NCT01438320|Protective Agents|protective agents|mesh-ancestor
138376133|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376134|NCT05578859|Sotorasib|sotorasib|mesh-list
138376135|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138376136|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376137|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376138|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376139|NCT05525013|Simvastatin|simvastatin|mesh-list
138376140|NCT05525013|Calcium|calcium|mesh-list
138376141|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138376142|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376143|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138376144|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138376145|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
138376146|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376147|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138376148|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138376149|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376150|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
138376151|NCT05418088|Fludarabine|fludarabine|mesh-list
138376152|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
138376155|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376156|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376157|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138376158|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
138376159|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376160|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376161|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138376162|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138376163|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
138376164|NCT05387525|Diclofenac|diclofenac|mesh-list
138376165|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
138376166|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138376167|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138376168|NCT05387525|Analgesics|analgesics|mesh-ancestor
138376169|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
138376170|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376171|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376172|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376173|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376174|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138376175|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376176|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376178|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376179|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138376180|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376181|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376182|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138376183|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362868|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362869|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362870|NCT00557310|Teriparatide|teriparatide|mesh-list
138376184|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376186|NCT05343507|Analgesics|analgesics|mesh-ancestor
138376187|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
138376188|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376189|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376190|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138376191|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376192|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
138376193|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
138376194|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376195|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138376197|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376198|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376199|NCT05213832|Isoflurane|isoflurane|mesh-list
138376200|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138376201|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
138376202|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
138376203|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376204|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376206|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138376207|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376208|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376209|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376210|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
138376211|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
138376212|NCT05164146|Propofol|propofol|mesh-list
138376213|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138376214|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376215|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376216|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376217|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
138376218|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
138376219|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
138376220|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138376221|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376222|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376223|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138376224|NCT05111431|Analgesics|analgesics|mesh-ancestor
138376225|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
138376226|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376227|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138376228|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138376229|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138376230|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
138376231|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376232|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376235|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138376236|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
138376237|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376238|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376239|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376240|NCT04955470|Midazolam|midazolam|mesh-list
138376241|NCT04955470|Ketamine|ketamine|mesh-list
138376242|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138376243|NCT04955470|Analgesics|analgesics|mesh-ancestor
138376244|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
138376245|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376246|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376247|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138376248|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376249|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
138376250|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
138376251|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376252|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138376253|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138376254|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376255|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376260|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138376261|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
138376262|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
138376263|NCT04922567|Prednisone|prednisone|mesh-list
138376264|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
138376265|NCT04922567|Doxorubicin|doxorubicin|mesh-list
138376266|NCT04922567|Vincristine|vincristine|mesh-list
138376267|NCT04922567|Lenalidomide|lenalidomide|mesh-list
138376268|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376269|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
138376270|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376271|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376272|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138376273|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
138376274|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376275|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376276|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138376277|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138376278|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138376279|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138376280|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376281|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376282|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
138376283|NCT04922567|Hormones|hormones|mesh-ancestor
138376284|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376285|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138376286|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138376288|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376289|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376290|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138376291|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138376292|NCT04922567|Growth Substances|growth substances|mesh-ancestor
138376293|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376294|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
138376295|NCT04636632|Aprepitant|aprepitant|mesh-list
138376297|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
138376298|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376299|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376300|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376301|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138376302|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376303|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376304|NCT04545060|Sotrovimab|sotrovimab|mesh-list
138376305|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
138376306|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376308|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
138376309|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376310|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376311|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376312|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376313|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376314|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376315|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
138376316|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138376317|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138376318|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376319|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
138376320|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138376321|NCT04329572|Azithromycin|azithromycin|mesh-list
138376322|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
138376323|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138376327|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138376328|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376329|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376330|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376331|NCT04322552|Apatinib|apatinib|mesh-list
138376332|NCT04322552|Digoxin|digoxin|mesh-list
138376333|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376334|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138376335|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376336|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376337|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138376338|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138376340|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376342|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376343|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376344|NCT04189848|Dulaglutide|dulaglutide|mesh-list
138376345|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376346|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376347|NCT04156334|Anesthetics|anesthetics|mesh-list
138376348|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376349|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376350|NCT04078906|SMOFlipid|smoflipid|mesh-list
138376351|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138376352|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138376353|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138376354|NCT03980171|Lenalidomide|lenalidomide|mesh-list
138376355|NCT03980171|Venetoclax|venetoclax|mesh-list
138376356|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
138376357|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
138376358|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376359|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138376360|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138376361|NCT03980171|Growth Substances|growth substances|mesh-ancestor
138376362|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376363|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376364|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376366|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138376367|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
138376368|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376369|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376370|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138376371|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138376372|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376374|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376376|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376377|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376378|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138376379|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138376380|NCT03558724|Growth Substances|growth substances|mesh-ancestor
138376381|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376382|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376383|NCT03512496|Caffeine|caffeine|mesh-list
138376384|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138376385|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376386|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138376387|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376390|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138376391|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
138376392|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376393|NCT03416127|Metformin|metformin|mesh-list
138376394|NCT03416127|Propolis|propolis|mesh-list
138376395|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376397|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376398|NCT03293069|Deferiprone|deferiprone|mesh-list
138376399|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138376400|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
138376401|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
138376402|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376403|NCT03232346|Buprenorphine|buprenorphine|mesh-list
138376404|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138376405|NCT03232346|Narcotics|narcotics|mesh-ancestor
138376406|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376407|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376408|NCT03232346|Analgesics|analgesics|mesh-ancestor
138376409|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
138376410|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376411|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138376413|NCT03227731|Emtricitabine|emtricitabine|mesh-list
138376414|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138376415|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
138376416|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376417|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138376418|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376419|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376420|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376421|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138376422|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138376424|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376425|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376426|NCT03149640|Amikacin|amikacin|mesh-list
138376427|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138376428|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376429|NCT03098355|Interleukin-2|interleukin-2|mesh-list
138376430|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376431|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138376432|NCT03098355|Analgesics|analgesics|mesh-ancestor
138376433|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
138376434|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376435|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376436|NCT02986334|Naproxen|naproxen|mesh-list
138376437|NCT02986334|Omeprazole|omeprazole|mesh-list
138376438|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138376439|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376440|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138376441|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376442|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376443|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138376444|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138376447|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376448|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376449|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376450|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376451|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
138376452|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138376453|NCT02668289|Anesthetics|anesthetics|mesh-list
138376454|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376455|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376457|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138376458|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
138376460|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376462|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376463|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376464|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376465|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138376466|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376467|NCT02426502|Cyclosporine|cyclosporine|mesh-list
138376468|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
138376469|NCT02426502|Prednisone|prednisone|mesh-list
138376470|NCT02426502|Azathioprine|azathioprine|mesh-list
138376471|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
138376472|NCT02426502|Cyclosporins|cyclosporins|mesh-list
138376473|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376474|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
138376475|NCT02426502|Hormones|hormones|mesh-ancestor
138376476|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376477|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376478|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138376479|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376480|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376481|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376482|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376483|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
138376484|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
138376485|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376486|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
138376487|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376488|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138376489|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138376490|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138376491|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
138376492|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138376493|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
138376494|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138376495|NCT02275156|Evolocumab|evolocumab|mesh-list
138376496|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138376497|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138376498|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138376499|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
138376500|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376501|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138376502|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376503|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376504|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138376505|NCT02124902|Carboplatin|carboplatin|mesh-list
138376506|NCT02124902|Docetaxel|docetaxel|mesh-list
138376508|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376509|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376510|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376511|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376512|NCT02067182|Dabigatran|dabigatran|mesh-list
138376513|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
138376514|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138376515|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376516|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376517|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376518|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
138376519|NCT01877837|Fludarabine|fludarabine|mesh-list
138376520|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
138376522|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
138376523|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376524|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138376525|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
138376526|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376528|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
138376529|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376530|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138376531|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
138376532|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138376533|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376534|NCT01624142|Evolocumab|evolocumab|mesh-list
138376535|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138376536|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138376537|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138376538|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
138376539|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376540|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138376541|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376542|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376543|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138376544|NCT01375764|Ezetimibe|ezetimibe|mesh-list
138376545|NCT01375764|Evolocumab|evolocumab|mesh-list
138376546|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138376547|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138376548|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138376549|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
138376550|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376551|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138376553|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138376554|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376555|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376556|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
138376557|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376558|NCT00523341|Denosumab|denosumab|mesh-list
138376559|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138376560|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376561|NCT00364013|Panitumumab|panitumumab|mesh-list
138376562|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376563|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376564|NCT00345839|Cinacalcet|cinacalcet|mesh-list
138376565|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138376566|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376567|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138376568|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
138376569|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376570|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
138376571|NCT00330759|Denosumab|denosumab|mesh-list
138376572|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138376573|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376574|NCT00113763|Panitumumab|panitumumab|mesh-list
138376575|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376576|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376577|NCT01438359|Furosemide|furosemide|mesh-list
138376578|NCT01438359|Diuretics|diuretics|mesh-ancestor
138376579|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
138376580|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376581|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138376582|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376583|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376584|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138376585|NCT01438372|Hematinics|hematinics|mesh-ancestor
138376586|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
138376587|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138376588|NCT01438515|Doxycycline|doxycycline|mesh-list
138376589|NCT01438515|Rifampin|rifampin|mesh-list
138376590|NCT01438515|Mupirocin|mupirocin|mesh-list
138376591|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138376592|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376595|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138376596|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
138376597|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138376598|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138376599|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138376601|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
138376602|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376603|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376604|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376605|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138376606|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138376607|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138376608|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138376609|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138376610|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138376611|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138376613|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376614|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138376615|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376616|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376617|NCT01438567|Oxycodone|oxycodone|mesh-list
138376620|NCT01438567|Narcotics|narcotics|mesh-ancestor
138376621|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376622|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376623|NCT01438567|Analgesics|analgesics|mesh-ancestor
138376624|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
138376625|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376626|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138376627|NCT01438580|Aspirin|aspirin|mesh-list
138376628|NCT01438580|Warfarin|warfarin|mesh-list
138376629|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138376630|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138376631|NCT01438580|Analgesics|analgesics|mesh-ancestor
138376632|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
138376633|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376634|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376635|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376636|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138376637|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138376638|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138376639|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376640|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138376641|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138376642|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376643|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
138376644|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
138376645|NCT01438632|Insulin|insulin|mesh-list
138376646|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376647|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376648|NCT01438723|Metformin|metformin|mesh-list
138376649|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376650|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376651|NCT01438736|Etonogestrel|etonogestrel|mesh-list
138376652|NCT01438736|Desogestrel|desogestrel|mesh-list
138376653|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138376654|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
138376655|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138376656|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376657|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138376658|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138376659|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138376660|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138376663|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376664|NCT01438749|Diazepam|diazepam|mesh-list
138376665|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138376666|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
138376667|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
138376668|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
138376669|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376670|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376671|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376672|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138376673|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376674|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138376675|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138376676|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138376677|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138376678|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138376679|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376680|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
138376681|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
138376682|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
138376683|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
138376684|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376685|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376686|NCT01438866|Fluorides|fluorides|mesh-list
138376687|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
138376688|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
138376689|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
138376691|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376693|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138376695|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376696|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376697|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138376698|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138376699|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376700|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376701|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376702|NCT01439100|Oxycodone|oxycodone|mesh-list
138376703|NCT01439100|Naloxone|naloxone|mesh-list
138376704|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138376705|NCT01439100|Narcotics|narcotics|mesh-ancestor
138376706|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376707|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376708|NCT01439100|Analgesics|analgesics|mesh-ancestor
138376709|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
138376710|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376711|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138376712|NCT01439152|Maytansine|maytansine|mesh-list
138376713|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
138376714|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
138376715|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
138376716|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376717|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138376718|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376724|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376725|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376726|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138376727|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138376729|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376731|NCT01439191|Vinorelbine|vinorelbine|mesh-list
138376732|NCT01439191|Antibodies|antibodies|mesh-list
138376733|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
138376734|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376735|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138376736|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376737|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376738|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376739|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376740|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376741|NCT01439230|Donepezil|donepezil|mesh-list
138376742|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138376743|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376744|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376745|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376746|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376747|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376748|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
138376749|NCT01439243|Donepezil|donepezil|mesh-list
138376750|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138376751|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376752|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376753|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376754|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376755|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376756|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
138376757|NCT01439399|Lidocaine|lidocaine|mesh-list
138376758|NCT01439399|Ketamine|ketamine|mesh-list
138376759|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
138376760|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
138376761|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376762|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376763|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
138376764|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376765|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138376766|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138376767|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138376768|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376769|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376770|NCT01439399|Analgesics|analgesics|mesh-ancestor
138376771|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138376772|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376773|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
138376774|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138376775|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138376776|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376777|NCT01439438|Topiramate|topiramate|mesh-list
138376778|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
138376779|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376780|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376781|NCT01439542|Hormones|hormones|mesh-list
138376783|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376785|NCT01439750|Rituximab|rituximab|mesh-list
138376786|NCT01439750|Bortezomib|bortezomib|mesh-list
138376787|NCT01439750|Cladribine|cladribine|mesh-list
138376788|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376789|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376790|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
138376791|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376793|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376794|NCT01439984|Clomipramine|clomipramine|mesh-list
138376795|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138376796|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
138376797|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138376798|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138376799|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138376800|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376801|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376802|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376803|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
138376804|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376805|NCT01440062|Vitamin D|vitamin d|mesh-list
138376806|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
138376807|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
138376808|NCT01440062|Vitamins|vitamins|mesh-list
138376809|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
138376810|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376811|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138376812|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138376813|NCT01440088|Doxorubicin|doxorubicin|mesh-list
138376814|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138376815|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138376816|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376817|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138376818|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138376819|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376820|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376821|NCT01440114|Fentanyl|fentanyl|mesh-list
138376822|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138376823|NCT01440114|Narcotics|narcotics|mesh-ancestor
138376824|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376825|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376826|NCT01440114|Analgesics|analgesics|mesh-ancestor
138376827|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
138376828|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376829|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138376830|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138376831|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
138376832|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
138376834|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376835|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376836|NCT01440140|Insulin|insulin|mesh-list
138376837|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376838|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376839|NCT01440270|Cetuximab|cetuximab|mesh-list
138376840|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376841|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376843|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138376844|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376848|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376849|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376850|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138376851|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
138376852|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
138376853|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
138376854|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138376855|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138376856|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138376857|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138376858|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
138376859|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376860|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376861|NCT01440361|Belimumab|belimumab|mesh-list
138376862|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376863|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
138376864|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376865|NCT01440400|Anesthetics|anesthetics|mesh-list
138376866|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376867|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376869|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138376870|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
138376871|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
138376872|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376873|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376874|NCT01440582|Dexamethasone|dexamethasone|mesh-list
138376875|NCT01440582|Lenalidomide|lenalidomide|mesh-list
138376876|NCT01440582|Bortezomib|bortezomib|mesh-list
138376877|NCT01440582|Panobinostat|panobinostat|mesh-list
138376878|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138376879|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
138376880|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
138376881|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376882|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376883|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376885|NCT01440582|Hormones|hormones|mesh-ancestor
138376886|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138376887|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138376888|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376889|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
138376890|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138376891|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138376892|NCT01440582|Growth Substances|growth substances|mesh-ancestor
138376893|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376894|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138376895|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376896|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376897|NCT01440608|Albendazole|albendazole|mesh-list
138376899|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138376900|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376901|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
138376902|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138376903|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138376904|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376905|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376906|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376907|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376908|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376909|NCT01440621|Pyridoxine|pyridoxine|mesh-list
138376910|NCT01440621|Modafinil|modafinil|mesh-list
138376911|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138376912|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376913|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138376914|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138376915|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138376916|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376918|NCT01440621|Vitamins|vitamins|mesh-ancestor
138376919|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
138376920|NCT01440673|Aprepitant|aprepitant|mesh-list
138376921|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
138376922|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
138376923|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376924|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376925|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376926|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138376927|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376929|NCT01440725|Mitogens|mitogens|mesh-list
138376930|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376931|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376932|NCT01440751|Mitomycins|mitomycins|mesh-list
138376933|NCT01440751|Mitomycin|mitomycin|mesh-list
138376934|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138376935|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376936|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
138376937|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376938|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138376939|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376940|NCT01440790|Vitamins|vitamins|mesh-list
138376941|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
138376942|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
138376943|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376944|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
138376945|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376951|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376952|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376954|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138376955|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376956|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376957|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
138376959|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
138376960|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376961|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376962|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
138376963|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376964|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138376965|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
138376966|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138376967|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376968|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376969|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138376970|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
138376971|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138376973|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138376974|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
138376975|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376976|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376979|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
138376980|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376981|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376982|NCT01440998|Paclitaxel|paclitaxel|mesh-list
138376983|NCT01440998|Carboplatin|carboplatin|mesh-list
138376984|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138376985|NCT01440998|Dasatinib|dasatinib|mesh-list
138376986|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138376987|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376988|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376989|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376990|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376991|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376992|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138376993|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376994|NCT01441128|Crizotinib|crizotinib|mesh-list
138376995|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376996|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138376998|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376999|NCT01441193|Vaccines|vaccines|mesh-list
138377000|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
138377001|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377002|NCT01441206|Rifampin|rifampin|mesh-list
138377003|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138377004|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
138377005|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138377006|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377007|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
138377008|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377011|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138377012|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138377013|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138377014|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138377015|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138377016|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138377017|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138377018|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138377019|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377020|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377021|NCT01441232|Incretins|incretins|mesh-ancestor
138377022|NCT01441232|Hormones|hormones|mesh-ancestor
138377023|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138377024|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138377025|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377026|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377027|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377028|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138377029|NCT01441284|Pramipexole|pramipexole|mesh-list
138377030|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
138377031|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377032|NCT01441284|Protective Agents|protective agents|mesh-ancestor
138377033|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377034|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138377035|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138377036|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
138377037|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
138377043|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377045|NCT01441388|Sunitinib|sunitinib|mesh-list
138377046|NCT01441388|Sorafenib|sorafenib|mesh-list
138377047|NCT01441388|Axitinib|axitinib|mesh-list
138377048|NCT01441388|Crizotinib|crizotinib|mesh-list
138377049|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377050|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377051|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138377052|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138377053|NCT01441388|Growth Substances|growth substances|mesh-ancestor
138377054|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377055|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
138377056|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377057|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377058|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377059|NCT01441427|Lenograstim|lenograstim|mesh-list
138377060|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138377061|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
138377062|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377065|NCT01441505|Analgesics|analgesics|mesh-ancestor
138377066|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
138377067|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377068|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377069|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138377070|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138377071|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
138377072|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
138377075|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138377076|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377077|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377078|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138377079|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138377080|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377081|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377082|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377083|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
138377084|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
138377085|NCT01441531|Gabapentin|gabapentin|mesh-list
138377086|NCT01441531|Analgesics|analgesics|mesh-ancestor
138377087|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
138377088|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377089|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377090|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
138377091|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377092|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377093|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377094|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377095|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138377096|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138377097|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377098|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377100|NCT01441557|Amifampridine|amifampridine|mesh-list
138377101|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138377102|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377103|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377104|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138377105|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377106|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377107|NCT01441700|Anesthetics|anesthetics|mesh-list
138377108|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377109|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377111|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138377112|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
138377113|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
138377114|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377115|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
138377116|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377117|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
138377118|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377119|NCT01441869|Metformin|metformin|mesh-list
138377120|NCT01441869|Saxagliptin|saxagliptin|mesh-list
138377121|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377122|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377123|NCT01441869|Incretins|incretins|mesh-ancestor
138377124|NCT01441869|Hormones|hormones|mesh-ancestor
138377125|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138377126|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138377127|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377128|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377129|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377130|NCT01441908|Pravastatin|pravastatin|mesh-list
138377131|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138377132|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138377133|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
138377134|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377135|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138377136|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138377137|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377139|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377140|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
138377141|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138377143|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377144|NCT01441934|Urological Agents|urological agents|mesh-ancestor
138377146|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
138377147|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
138377148|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
138377149|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138377150|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138377152|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377153|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377154|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138377155|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138377156|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
138377157|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377158|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
138377159|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138377160|NCT01441986|Analgesics|analgesics|mesh-ancestor
138377161|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
138377162|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377163|NCT01442025|Infliximab|infliximab|mesh-list
138377164|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138377165|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138377166|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377167|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138377168|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377169|NCT01442168|Atovaquone|atovaquone|mesh-list
138377170|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377171|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
138377172|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138377173|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138377174|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377175|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377176|NCT01442272|Calcifediol|calcifediol|mesh-list
138377181|NCT01442311|Interferons|interferons|mesh-list
138377182|NCT01442311|Ribavirin|ribavirin|mesh-list
138377183|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
138377184|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
138377185|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138377186|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377187|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
138377188|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377189|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
138377190|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377191|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
138377192|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377193|NCT01442428|Dexamethasone|dexamethasone|mesh-list
138377195|NCT01442428|Atorvastatin|atorvastatin|mesh-list
138377196|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138377197|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
138377198|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
138377199|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377200|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377201|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138377202|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
138377203|NCT01442428|Hormones|hormones|mesh-ancestor
138377204|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138377205|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138377206|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377207|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138377208|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138377210|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377211|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138377212|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138377213|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377214|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138377215|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138377216|NCT01442428|Analgesics|analgesics|mesh-ancestor
138377217|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
138377218|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377219|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
138377220|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138377221|NCT01442519|Mitomycins|mitomycins|mesh-list
138377222|NCT01442519|Mitomycin|mitomycin|mesh-list
138377224|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377225|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377226|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
138377227|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377228|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377229|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377230|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138377231|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
138377232|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377234|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138377235|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138377236|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377242|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
138377243|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
138377244|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
138377245|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
138377246|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377247|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377248|NCT01442558|Bupivacaine|bupivacaine|mesh-list
138377249|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
138377250|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
138377251|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377252|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377253|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
138377254|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377255|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
138377256|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138377257|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
138377258|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377259|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
138377260|NCT01442571|Protective Agents|protective agents|mesh-ancestor
138377261|NCT01442610|Rasagiline|rasagiline|mesh-list
138377262|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138377263|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377264|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377265|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138377266|NCT01442610|Protective Agents|protective agents|mesh-ancestor
138377267|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377268|NCT01442662|Gemcitabine|gemcitabine|mesh-list
138377269|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377270|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
138377271|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377272|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377275|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377276|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138377278|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
138377279|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377280|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138377282|NCT01442727|Selenious Acid|selenious acid|mesh-list
138377283|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
138377284|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
138377285|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377286|NCT01442727|Protective Agents|protective agents|mesh-ancestor
138377287|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377288|NCT01442727|Trace Elements|trace elements|mesh-ancestor
138377289|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
138377290|NCT01442766|Donepezil|donepezil|mesh-list
138377291|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138377292|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377293|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377294|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
138377295|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377296|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377297|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
138377298|NCT01442818|Hydromorphone|hydromorphone|mesh-list
138377299|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138377300|NCT01442818|Narcotics|narcotics|mesh-ancestor
138377301|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377302|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377303|NCT01442818|Analgesics|analgesics|mesh-ancestor
138377304|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
138377305|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377306|NCT01442870|Metformin|metformin|mesh-list
138377310|NCT01442909|Pemetrexed|pemetrexed|mesh-list
138377311|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377312|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138377313|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138377314|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138377315|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377316|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377317|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138377318|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377320|NCT01442935|Folic Acid|folic acid|mesh-list
138377321|NCT01442935|Bevacizumab|bevacizumab|mesh-list
138377322|NCT01442935|Cetuximab|cetuximab|mesh-list
138377324|NCT01442935|Irinotecan|irinotecan|mesh-list
138377325|NCT01442935|Fluorouracil|fluorouracil|mesh-list
138377327|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377328|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377329|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138377330|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138377331|NCT01442935|Growth Substances|growth substances|mesh-ancestor
138377332|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377333|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
138377334|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138377335|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138377336|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377337|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377338|NCT01442935|Antidotes|antidotes|mesh-ancestor
138377339|NCT01442935|Protective Agents|protective agents|mesh-ancestor
138377340|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
138377341|NCT01442935|Vitamins|vitamins|mesh-ancestor
138377342|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
138377343|NCT01442935|Hematinics|hematinics|mesh-ancestor
138377344|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
138377345|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377346|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377347|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
138377349|NCT01442974|Gemcitabine|gemcitabine|mesh-list
138377350|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138377359|NCT01442987|Atorvastatin|atorvastatin|mesh-list
138377360|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138377361|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138377362|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
138377363|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377364|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138377365|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138377366|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377367|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377368|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138377369|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138377371|NCT01443065|Folic Acid|folic acid|mesh-list
138377372|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
138377373|NCT01443065|Panitumumab|panitumumab|mesh-list
138377377|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377378|NCT01443065|Antidotes|antidotes|mesh-ancestor
138377379|NCT01443065|Protective Agents|protective agents|mesh-ancestor
138377380|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377381|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
138377383|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
138377384|NCT01443065|Hematinics|hematinics|mesh-ancestor
138377385|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377386|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
138377387|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377388|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377389|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377390|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
138377391|NCT01443104|Sirolimus|sirolimus|mesh-list
138377392|NCT01443104|Everolimus|everolimus|mesh-list
138377393|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138377394|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377395|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377396|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377399|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377400|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377401|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138377402|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377403|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377406|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
138377407|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377408|NCT01443169|Pregabalin|pregabalin|mesh-list
138377409|NCT01443169|Analgesics|analgesics|mesh-ancestor
138377410|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
138377411|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377412|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377413|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
138377414|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138377415|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377416|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377417|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138377418|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377419|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377420|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377421|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377422|NCT01443195|Iron|iron|mesh-list
138377423|NCT01443195|Trace Elements|trace elements|mesh-ancestor
138377424|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
138377426|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138377427|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138377428|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138377429|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377430|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377432|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377433|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
138377434|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377435|NCT01443221|Metformin|metformin|mesh-list
138377436|NCT01443221|Mitiglinide|mitiglinide|mesh-list
138377437|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377438|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377439|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
138377440|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138377441|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138377442|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
138377443|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377444|NCT01443325|Lidocaine|lidocaine|mesh-list
138377445|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
138377446|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
138377447|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377448|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377449|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
138377450|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377451|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138377452|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138377453|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138377454|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377455|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377456|NCT01443338|Acitretin|acitretin|mesh-list
138377457|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
138377458|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377459|NCT01443377|Panitumumab|panitumumab|mesh-list
138377460|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377461|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377462|NCT01443416|Vaccines|vaccines|mesh-list
138377464|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
138377465|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377466|NCT01443429|Beraprost|beraprost|mesh-list
138377467|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138377468|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
138377469|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138377470|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138377471|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138377472|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138377473|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377474|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377475|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377476|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377477|NCT01443520|Analgesics|analgesics|mesh-ancestor
138377478|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
138377480|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
138377481|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377482|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
138377483|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138377484|NCT01443572|Anesthetics|anesthetics|mesh-list
138377485|NCT01443572|Sevoflurane|sevoflurane|mesh-list
138377487|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377488|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377489|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138377490|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138377491|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
138377492|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138377494|NCT01443650|Alirocumab|alirocumab|mesh-list
138377495|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138377496|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138377497|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138377498|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
138377499|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377500|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138377501|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377502|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377503|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138377504|NCT01443676|Bevacizumab|bevacizumab|mesh-list
138377505|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377506|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377507|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138377508|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138377509|NCT01443676|Growth Substances|growth substances|mesh-ancestor
138377510|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377511|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
138377512|NCT01443741|Insulin|insulin|mesh-list
138377514|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377515|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377516|NCT01443780|Selenium|selenium|mesh-list
138377517|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
138377518|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377520|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377521|NCT01443780|Trace Elements|trace elements|mesh-ancestor
138377522|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
138377523|NCT01443806|Oseltamivir|oseltamivir|mesh-list
138377524|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
138377525|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377526|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377527|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377528|NCT01443897|Vitamin D|vitamin d|mesh-list
138377532|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
138377533|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377534|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138377535|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138377536|NCT01443988|Travoprost|travoprost|mesh-list
138377537|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377538|NCT01444001|Vaccines|vaccines|mesh-list
138377539|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138377540|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
138377541|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377542|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
138377543|NCT01444118|Vaccines|vaccines|mesh-list
138377544|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138377545|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
138377546|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377547|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377548|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377549|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138377550|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
138377551|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377552|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377553|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138377554|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138377555|NCT01444131|Nicotine|nicotine|mesh-list
138377556|NCT01444131|Varenicline|varenicline|mesh-list
138377557|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138377558|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
138377559|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377560|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377561|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138377562|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138377563|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
138377564|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377565|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377566|NCT01444196|Desloratadine|desloratadine|mesh-list
138377567|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138377568|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
138377569|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377570|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377571|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377572|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138377573|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138377574|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
138377575|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
138377577|NCT01444248|Glimepiride|glimepiride|mesh-list
138377578|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377579|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377580|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138377581|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377582|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
138377583|NCT01444339|Vaccines|vaccines|mesh-list
138377584|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138377585|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
138377586|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377587|NCT01444352|Vaccines|vaccines|mesh-list
138377588|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138377589|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
138377590|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377591|NCT01444521|Irinotecan|irinotecan|mesh-list
138377592|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377593|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138377594|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138377595|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377596|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377598|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138377599|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138377600|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377601|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
138377602|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
138377603|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
138377605|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
138377606|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138377607|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
138377608|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138377609|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377610|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377611|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377612|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
138377613|NCT01444612|Heparin|heparin|mesh-list
138377614|NCT01444612|Calcium heparin|calcium heparin|mesh-list
138377615|NCT01444612|Enoxaparin|enoxaparin|mesh-list
138377616|NCT01444612|Dalteparin|dalteparin|mesh-list
138377617|NCT01444612|Tinzaparin|tinzaparin|mesh-list
138377618|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138377619|NCT01444612|PENTA|penta|mesh-list
138377620|NCT01444612|Fondaparinux|fondaparinux|mesh-list
138377621|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
138377622|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138377623|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138377624|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377625|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138377626|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
138377627|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138377628|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377629|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377630|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
138377631|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377632|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138377633|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377634|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377635|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377636|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
138377637|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138377638|NCT01444807|Sorafenib|sorafenib|mesh-list
138377640|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377641|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377642|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377643|NCT01444833|Candesartan|candesartan|mesh-list
138377644|NCT01444833|Candesartan cilexetil|candesartan cilexetil|mesh-list
138377645|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377646|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138377647|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138377648|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377650|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138377651|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138377652|NCT01444846|Analgesics|analgesics|mesh-ancestor
138377653|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
138377654|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377655|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377656|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138377657|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377658|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138377659|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138377660|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
138377661|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377662|NCT01444846|Protective Agents|protective agents|mesh-ancestor
138377663|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138377664|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377665|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138377666|NCT01444885|Amlodipine|amlodipine|mesh-list
138377667|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
138377668|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377669|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138377670|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377671|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377675|NCT01444976|Midazolam|midazolam|mesh-list
138377679|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138377680|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138377681|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377682|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377683|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377684|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138377685|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
138377686|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
138377687|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
138377688|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377689|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377690|NCT01445106|Nelfinavir|nelfinavir|mesh-list
138377691|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138377692|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138377693|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377694|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377695|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377696|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138377697|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138377698|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
138377700|NCT01445119|Carboplatin|carboplatin|mesh-list
138377701|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377702|NCT01445210|Ropivacaine|ropivacaine|mesh-list
138377703|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
138377704|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
138377705|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377706|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377707|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
138377709|NCT01445223|Ritonavir|ritonavir|mesh-list
138377710|NCT01445223|Lopinavir|lopinavir|mesh-list
138377711|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138377712|NCT01445223|Efavirenz|efavirenz|mesh-list
138377713|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138377714|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138377715|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
138377716|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377717|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377718|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138377719|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138377720|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
138377721|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377722|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138377723|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138377724|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138377725|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377726|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138377727|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138377728|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138377729|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138377730|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138377731|NCT01445236|Cyclosporine|cyclosporine|mesh-list
138377732|NCT01445236|Tacrolimus|tacrolimus|mesh-list
138377733|NCT01445236|Cyclosporins|cyclosporins|mesh-list
138377734|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377735|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
138377736|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377737|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138377738|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377741|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377742|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377743|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377744|NCT01445262|Levocetirizine|levocetirizine|mesh-list
138377745|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138377746|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138377747|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
138377748|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
138377749|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377750|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377751|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377752|NCT01445340|Romidepsin|romidepsin|mesh-list
138377753|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377754|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377755|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138377756|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377757|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377758|NCT01445379|Ipilimumab|ipilimumab|mesh-list
138377759|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377760|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377761|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138377762|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377763|NCT01445392|Pemetrexed|pemetrexed|mesh-list
138377764|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138377765|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377766|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377767|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377768|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138377769|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377770|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
138377771|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377772|NCT01445405|Cetuximab|cetuximab|mesh-list
138377776|NCT01445418|Carboplatin|carboplatin|mesh-list
138377777|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377779|NCT01445431|Emollients|emollients|mesh-ancestor
138377780|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377781|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
138377782|NCT01445522|Veliparib|veliparib|mesh-list
138377784|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
138377785|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377786|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377787|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138377788|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
138377789|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377790|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377791|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138377792|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138377793|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377794|NCT01445561|Interleukin-2|interleukin-2|mesh-list
138377795|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377796|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138377797|NCT01445561|Analgesics|analgesics|mesh-ancestor
138377798|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
138377799|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377800|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377801|NCT01445587|Bortezomib|bortezomib|mesh-list
138377802|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377803|NCT01445600|Retapamulin|retapamulin|mesh-list
138377804|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138377805|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377806|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
138377807|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138377809|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377810|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138377811|NCT01445639|Analgesics|analgesics|mesh-ancestor
138377812|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
138377813|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377814|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138377815|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138377816|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138377817|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
138377818|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377819|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377820|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138377821|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138377822|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377823|NCT01445743|Vaccines|vaccines|mesh-list
138377824|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
138377825|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377826|NCT01445756|Lidocaine|lidocaine|mesh-list
138377827|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
138377828|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
138377829|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377830|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377831|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
138377832|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377833|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138377834|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138377835|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138377836|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377837|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377844|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138377845|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377846|NCT01445938|Lumefantrine|lumefantrine|mesh-list
138377847|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
138377848|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138377849|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138377850|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377851|NCT01445964|Atenolol|atenolol|mesh-list
138377852|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138377853|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377855|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
138377856|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377857|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377858|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138377859|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138377860|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138377861|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
138377862|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377863|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377864|NCT01446094|Regadenoson|regadenoson|mesh-list
138377865|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138377870|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377871|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377874|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
138377875|NCT01446107|Protective Agents|protective agents|mesh-ancestor
138377876|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377878|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138377879|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
138377880|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
138377881|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
138377882|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377883|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377884|NCT01446211|Gusperimus|gusperimus|mesh-list
138377885|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
138377886|NCT01446211|Methotrexate|methotrexate|mesh-list
138377887|NCT01446211|Azathioprine|azathioprine|mesh-list
138377888|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
138377889|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377890|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
138377891|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377892|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377893|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138377894|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
138377895|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377896|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377897|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138377898|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138377899|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
138377900|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138377901|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377902|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
138377903|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377904|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377905|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138377906|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377908|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138377909|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377910|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377911|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138377912|NCT01446211|Protective Agents|protective agents|mesh-ancestor
138377913|NCT01446276|Resveratrol|resveratrol|mesh-list
138377917|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377918|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377919|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138377920|NCT01446328|Olanzapine|olanzapine|mesh-list
138377921|NCT01446328|Aripiprazole|aripiprazole|mesh-list
138377922|NCT01446328|Amisulpride|amisulpride|mesh-list
138377923|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
138377924|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
138377925|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377926|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377927|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138377928|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138377929|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377930|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377931|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377932|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138377933|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138377934|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377935|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377937|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
138377938|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
138377939|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
138377940|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
138377941|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138377942|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138377943|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138377944|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138377945|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138377946|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138377947|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138377948|NCT01446445|Valganciclovir|valganciclovir|mesh-list
138377949|NCT01446445|Ganciclovir|ganciclovir|mesh-list
138377950|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138377951|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
138377952|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377953|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377955|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377956|NCT01446458|Folfirinox|folfirinox|mesh-list
138377957|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377958|NCT01446484|Cyclosporine|cyclosporine|mesh-list
138377959|NCT01446484|Sirolimus|sirolimus|mesh-list
138377960|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
138377962|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
138377963|NCT01446484|Tacrolimus|tacrolimus|mesh-list
138377964|NCT01446484|Cyclosporins|cyclosporins|mesh-list
138377965|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138377966|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
138377967|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377968|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138377969|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377970|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377971|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
138377972|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377973|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138377974|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377976|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377977|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377978|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377979|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138377980|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
138377981|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138377982|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138377983|NCT01446497|Timolol|timolol|mesh-list
138377984|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138377985|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138377986|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138377987|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
138377988|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377989|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377990|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377991|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138377992|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138377993|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138377994|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138377995|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138378000|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378002|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378003|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378004|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
138378005|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378006|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378007|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138378008|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378009|NCT01446731|Docetaxel|docetaxel|mesh-list
138378010|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378011|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
138378012|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
138378013|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
138378014|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378016|NCT01446783|Growth Substances|growth substances|mesh-ancestor
138378017|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378018|NCT01446900|Rituximab|rituximab|mesh-list
138378019|NCT01446900|Cladribine|cladribine|mesh-list
138378020|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378021|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378022|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
138378023|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378024|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378025|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378026|NCT01446926|Vaccines|vaccines|mesh-list
138378027|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138378028|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
138378029|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378031|NCT01446952|Tocopherols|tocopherols|mesh-list
138378034|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
138378035|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378036|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
138378037|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378038|NCT01446952|Protective Agents|protective agents|mesh-ancestor
138378039|NCT01446978|Vaccines|vaccines|mesh-list
138378040|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
138378041|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378042|NCT01447043|Ranibizumab|ranibizumab|mesh-list
138378043|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138378044|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138378045|NCT01447043|Growth Substances|growth substances|mesh-ancestor
138378046|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378047|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138378048|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378050|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138378051|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
138378052|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378053|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378054|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138378055|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
138378056|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
138378057|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138378058|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138378060|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138378061|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
138378062|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378063|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378064|NCT01447095|Epoprostenol|epoprostenol|mesh-list
138378065|NCT01447095|Tezosentan|tezosentan|mesh-list
138378066|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378067|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378068|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
138378069|NCT01447160|Cortisone|cortisone|mesh-list
138378070|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378071|NCT01447173|Vitamin D|vitamin d|mesh-list
138378072|NCT01447173|Vitamins|vitamins|mesh-ancestor
138378073|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
138378074|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378075|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138378076|NCT01447212|Hydromorphone|hydromorphone|mesh-list
138378078|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138378080|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378081|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378082|NCT01447212|Analgesics|analgesics|mesh-ancestor
138378083|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
138378084|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378085|NCT01447355|Vitamin D|vitamin d|mesh-list
138378086|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
138378087|NCT01447355|Vitamins|vitamins|mesh-ancestor
138378088|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
138378089|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378090|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138378091|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378096|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
138378097|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378098|NCT01447394|Interferons|interferons|mesh-list
138378099|NCT01447394|Ribavirin|ribavirin|mesh-list
138378100|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
138378101|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
138378102|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138378103|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378104|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
138378108|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
138378109|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378110|NCT01447485|Valsartan|valsartan|mesh-list
138378111|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378112|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138378113|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138378114|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378115|NCT01447550|Bosentan|bosentan|mesh-list
138378116|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378117|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138378118|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378119|NCT01447563|Clopidogrel|clopidogrel|mesh-list
138378120|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378121|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138378122|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138378123|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138378124|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
138378125|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378126|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378127|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378128|NCT01447589|Nelfinavir|nelfinavir|mesh-list
138378129|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138378130|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138378131|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378132|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378133|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378134|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138378135|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138378136|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
138378137|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378138|NCT01447654|Losartan|losartan|mesh-list
138378139|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138378143|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378145|NCT01447797|Atorvastatin|atorvastatin|mesh-list
138378146|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378147|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378148|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
138378149|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378150|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378151|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138378152|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378153|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378154|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138378156|NCT01447862|Ibutilide|ibutilide|mesh-list
138378157|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138378158|NCT01447875|Propofol|propofol|mesh-list
138378159|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138378160|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378161|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378162|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138378163|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
138378164|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
138378165|NCT01447979|Pancrelipase|pancrelipase|mesh-list
138378166|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378167|NCT01448018|Ranibizumab|ranibizumab|mesh-list
138378169|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138378170|NCT01448018|Growth Substances|growth substances|mesh-ancestor
138378171|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378172|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
138378173|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378174|NCT01448031|Esomeprazole|esomeprazole|mesh-list
138378175|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138378176|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378177|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138378178|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378179|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378181|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138378182|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138378183|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378184|NCT01448096|Rituximab|rituximab|mesh-list
138378185|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378186|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378188|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378189|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378190|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
138378191|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138378192|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378193|NCT01448174|Atorvastatin|atorvastatin|mesh-list
138378194|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378195|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378196|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
138378197|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378198|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378200|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378201|NCT01448239|Alirocumab|alirocumab|mesh-list
138378202|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138378203|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138378204|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378205|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378206|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
138378207|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378208|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138378209|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378210|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378211|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378212|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
138378213|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378214|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138378215|NCT01448291|Etonogestrel|etonogestrel|mesh-list
138378216|NCT01448291|NuvaRing|nuvaring|mesh-list
138378217|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
138378218|NCT01448291|Estradiol|estradiol|mesh-list
138378219|NCT01448291|Estrogens|estrogens|mesh-ancestor
138378220|NCT01448291|Hormones|hormones|mesh-ancestor
138378221|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378222|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378223|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138378224|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138378225|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138378226|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138378227|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138378228|NCT01448304|Alirocumab|alirocumab|mesh-list
138378229|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138378230|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378231|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378232|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
138378233|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378234|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138378236|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378237|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378239|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138378240|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138378241|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138378242|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378243|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378244|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
138378245|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378246|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138378248|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378249|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378250|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
138378251|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378252|NCT01448330|Aspirin|aspirin|mesh-list
138378254|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378255|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378256|NCT01448330|Analgesics|analgesics|mesh-ancestor
138378257|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
138378258|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378259|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378260|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378261|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378262|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378263|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378264|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378265|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378266|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378267|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378268|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
138378269|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138378270|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138378271|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138378272|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
138378273|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378276|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378277|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378278|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378279|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378280|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
138378282|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138378283|NCT01448499|Clozapine|clozapine|mesh-list
138378284|NCT01448499|Amisulpride|amisulpride|mesh-list
138378285|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138378286|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
138378287|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378288|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378289|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378290|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138378291|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138378293|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378294|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
138378295|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
138378296|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138378297|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
138378298|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138378299|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
138378300|NCT01448642|Atorvastatin|atorvastatin|mesh-list
138378301|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138378302|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138378303|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
138378304|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378305|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378306|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138378307|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378308|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138378309|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138378310|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138378311|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378312|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378313|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378314|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138378315|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138378316|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
138378319|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138378320|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138378324|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
138378325|NCT01448733|Tretinoin|tretinoin|mesh-list
138378326|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138378327|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378328|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378329|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138362872|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378330|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378331|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378332|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
138378333|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378334|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
138378335|NCT01448746|Heparin|heparin|mesh-list
138378336|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138378337|NCT01448746|Tinzaparin|tinzaparin|mesh-list
138378338|NCT01448746|Dalteparin|dalteparin|mesh-list
138378339|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
138378340|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378341|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378342|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378344|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
138378345|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378346|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378347|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378348|NCT01448772|Analgesics|analgesics|mesh-ancestor
138378349|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
138378350|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378351|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138378352|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138378353|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378354|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378355|NCT01448772|Hormones|hormones|mesh-ancestor
138378356|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378357|NCT01448798|Hemostatics|hemostatics|mesh-list
138378358|NCT01448798|Thrombin|thrombin|mesh-list
138378359|NCT01448798|Coagulants|coagulants|mesh-ancestor
138378360|NCT01448837|Timolol|timolol|mesh-list
138378361|NCT01448837|Bimatoprost|bimatoprost|mesh-list
138378362|NCT01448837|Latanoprost|latanoprost|mesh-list
138378363|NCT01448837|Cloprostenol|cloprostenol|mesh-list
138378364|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138378365|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138378366|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
138378367|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378368|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378369|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378370|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138378373|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138378374|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
138378375|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138378376|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
138378377|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138378378|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138378380|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378381|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378384|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138378386|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138378387|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138378388|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378389|NCT01449110|Resveratrol|resveratrol|mesh-list
138378390|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
138378391|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378392|NCT01449110|Protective Agents|protective agents|mesh-ancestor
138378393|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378394|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378395|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378397|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138378398|NCT01449123|Diuretics|diuretics|mesh-ancestor
138378399|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
138378400|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378401|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138378402|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378403|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
138378404|NCT01449188|Ondansetron|ondansetron|mesh-list
138378406|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378407|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138378408|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138378409|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378410|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378411|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378412|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378413|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
138378414|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
138378415|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378416|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378417|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
138378418|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138378419|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138378420|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138378421|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
138378422|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378423|NCT01449253|Bosentan|bosentan|mesh-list
138378424|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
138378425|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138378426|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138378427|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138378428|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378429|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378430|NCT01449253|Urological Agents|urological agents|mesh-ancestor
138378431|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378432|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138378434|NCT01449344|Dexamethasone|dexamethasone|mesh-list
138378435|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
138378436|NCT01449344|Rituximab|rituximab|mesh-list
138378439|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378440|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
138378441|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
138378442|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378443|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378444|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378445|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
138378446|NCT01449344|Hormones|hormones|mesh-ancestor
138378447|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378448|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138378449|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378450|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378451|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378452|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378453|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378454|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
138378455|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378456|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138378458|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
138378459|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378460|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378462|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378463|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378464|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
138378466|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
138378467|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378468|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378469|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138378470|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138378471|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138378472|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138378473|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138378479|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378480|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
138378481|NCT01449448|Hormones|hormones|mesh-ancestor
138378482|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378483|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378485|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378486|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378487|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378489|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
138378490|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378491|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378492|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378493|NCT01447992|Pancrelipase|pancrelipase|mesh-list
138378494|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378495|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
138378496|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138378497|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378498|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378500|NCT01449552|Coagulants|coagulants|mesh-ancestor
138378501|NCT01449565|Naltrexone|naltrexone|mesh-list
138378502|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138378503|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138378504|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378505|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
138378506|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378507|NCT01449578|Pramipexole|pramipexole|mesh-list
138378509|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378511|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378512|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138378513|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138378514|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
138378515|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
138378516|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378517|NCT01449617|Aspirin|aspirin|mesh-list
138378518|NCT01449617|Clopidogrel|clopidogrel|mesh-list
138378519|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378522|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
138378523|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378524|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378525|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378526|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378527|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378528|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378529|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378530|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378531|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378532|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378533|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
138378534|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138378542|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138378543|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
138378544|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378545|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378546|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138378547|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138378548|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138378549|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138378550|NCT01449825|Bevacizumab|bevacizumab|mesh-list
138378552|NCT01449825|Sorafenib|sorafenib|mesh-list
138378553|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378554|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378555|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138378556|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138378557|NCT01449825|Growth Substances|growth substances|mesh-ancestor
138378558|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378559|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
138378560|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138378561|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378562|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378563|NCT01449877|Trimethoprim|trimethoprim|mesh-list
138378564|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138378565|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
138378566|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138378567|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378568|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
138378569|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138378570|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138378572|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378573|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378574|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138378575|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138378576|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138378577|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378578|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
138378580|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378581|NCT01450163|Analgesics|analgesics|mesh-ancestor
138378582|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
138378583|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378584|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378585|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
138378586|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138378587|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378588|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378589|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378590|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138378591|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138378592|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378593|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378594|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138378595|NCT01450995|Sumatriptan|sumatriptan|mesh-list
138378596|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138378597|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138378598|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138378599|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
138378600|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378601|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378602|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378603|NCT01451320|Plasminogen|plasminogen|mesh-list
138378604|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138378605|NCT01451320|Streptokinase|streptokinase|mesh-list
138378606|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378607|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378609|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
138378610|NCT01451489|Tacrolimus|tacrolimus|mesh-list
138378611|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378612|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
138378613|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378614|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378615|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138378616|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
138378617|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378618|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378619|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138378620|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138378621|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378622|NCT01451853|Ebselen|ebselen|mesh-list
138378623|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378624|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378625|NCT01451853|Analgesics|analgesics|mesh-ancestor
138378626|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
138378627|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378628|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378629|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378630|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378631|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138378632|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378633|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
138378634|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378638|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138378639|NCT01452243|Vitamin D|vitamin d|mesh-list
138378640|NCT01452243|Calcium|calcium|mesh-list
138378641|NCT01452243|Vitamins|vitamins|mesh-ancestor
138378642|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
138378643|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378644|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378645|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138378646|NCT01452256|Propofol|propofol|mesh-list
138378647|NCT01452256|Desflurane|desflurane|mesh-list
138378648|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138378649|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378650|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378651|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138378652|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
138378653|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
138378654|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138378655|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138378656|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138378657|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
138378658|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378659|NCT01452607|Ebselen|ebselen|mesh-list
138378660|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378661|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378662|NCT01452607|Analgesics|analgesics|mesh-ancestor
138378663|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
138378664|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378665|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378666|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378667|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378668|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138378669|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378672|NCT01452607|Protective Agents|protective agents|mesh-ancestor
138378673|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378674|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378675|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138378677|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378678|NCT01453283|Trabectedin|trabectedin|mesh-list
138378679|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138378680|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
138378681|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378682|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378683|NCT01454700|Insulin|insulin|mesh-list
138378684|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138378685|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138378686|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378687|NCT01454869|Heparin|heparin|mesh-list
138378688|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
138378689|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378690|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378691|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378693|NCT05964387|Epinephrine|epinephrine|mesh-list
138378694|NCT05964387|Anesthetics, Local|anesthetics, local|mesh-ancestor
138378695|NCT05964387|Anesthetics|anesthetics|mesh-ancestor
138378696|NCT05964387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378697|NCT05964387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378698|NCT05964387|Sensory System Agents|sensory system agents|mesh-ancestor
138378699|NCT05964387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378700|NCT05964387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138378701|NCT05964387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138378702|NCT05964387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138378703|NCT05964387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378704|NCT05964387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378705|NCT05964387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138378706|NCT05964387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138378707|NCT05964387|Adrenergic Agents|adrenergic agents|mesh-ancestor
138378711|NCT05964387|Autonomic Agents|autonomic agents|mesh-ancestor
138378712|NCT05964387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138378713|NCT05964387|Respiratory System Agents|respiratory system agents|mesh-ancestor
138378714|NCT05964387|Mydriatics|mydriatics|mesh-ancestor
138378715|NCT05964387|Sympathomimetics|sympathomimetics|mesh-ancestor
138378716|NCT05964387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138378717|NCT05964257|Botulinum Toxins|botulinum toxins|mesh-list
138378718|NCT05964257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138378719|NCT05964257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138378720|NCT05964257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138378721|NCT05964257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378722|NCT05964257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378723|NCT05964257|Cholinergic Agents|cholinergic agents|mesh-ancestor
138378724|NCT05964257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378725|NCT05964257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378726|NCT05964257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138378727|NCT05964257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378728|NCT05964140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138378729|NCT05964140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378732|NCT05964114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378733|NCT05964101|Paclitaxel|paclitaxel|mesh-list
138378734|NCT05964101|Carboplatin|carboplatin|mesh-list
138378735|NCT05964101|Nivolumab|nivolumab|mesh-list
138378736|NCT05964101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138378737|NCT05964101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378738|NCT05964101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138378739|NCT05964101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138378740|NCT05964101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138378741|NCT05964101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378742|NCT05964101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378743|NCT05964101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138378744|NCT05963711|Chlorhexidine|chlorhexidine|mesh-list
138378745|NCT05963711|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138378746|NCT05963711|Clindamycin|clindamycin|mesh-list
138378747|NCT05963711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138378748|NCT05963711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378749|NCT05963711|Disinfectants|disinfectants|mesh-ancestor
138378750|NCT05963711|Dermatologic Agents|dermatologic agents|mesh-ancestor
138378751|NCT05963711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378752|NCT05963711|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138378753|NCT05963711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378754|NCT05963711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378755|NCT05963334|Paclitaxel|paclitaxel|mesh-list
138378756|NCT05963334|Carboplatin|carboplatin|mesh-list
138378757|NCT05963334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138378758|NCT05963334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378759|NCT05963334|Tubulin Modulators|tubulin modulators|mesh-ancestor
138378764|NCT05963217|Fludarabine|fludarabine|mesh-list
138378765|NCT05963217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378766|NCT05963217|Immunologic Factors|immunologic factors|mesh-ancestor
138378767|NCT05963217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378768|NCT05963217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378769|NCT05963217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138378770|NCT05963217|Alkylating Agents|alkylating agents|mesh-ancestor
138378771|NCT05963217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378772|NCT05963217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378773|NCT05963217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138378775|NCT05963204|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138378776|NCT05963204|Diuretics|diuretics|mesh-ancestor
138378777|NCT05963204|Natriuretic Agents|natriuretic agents|mesh-ancestor
138378778|NCT05963204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378779|NCT05963087|Cetuximab|cetuximab|mesh-list
138378780|NCT05963087|Tislelizumab|tislelizumab|mesh-list
138378781|NCT05963087|Dabrafenib|dabrafenib|mesh-list
138378782|NCT05963087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378783|NCT05963087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378784|NCT05963087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138378785|NCT05963087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378786|NCT05963087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378787|NCT05962775|Ethanol|ethanol|mesh-list
138378788|NCT05962775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138378789|NCT05962775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378790|NCT05962775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378793|NCT05962671|Anesthetics|anesthetics|mesh-list
138378794|NCT05962671|Sevoflurane|sevoflurane|mesh-list
138378795|NCT05962671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378796|NCT05962671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378797|NCT05962671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378798|NCT05962671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138378799|NCT05962671|Anesthetics, General|anesthetics, general|mesh-ancestor
138378800|NCT05962671|Narcotics|narcotics|mesh-ancestor
138378801|NCT05962671|Analgesics|analgesics|mesh-ancestor
138378802|NCT05962671|Sensory System Agents|sensory system agents|mesh-ancestor
138378803|NCT05962671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378804|NCT05962632|Fluorides|fluorides|mesh-list
138378805|NCT05962632|Cariostatic Agents|cariostatic agents|mesh-ancestor
138378806|NCT05962632|Protective Agents|protective agents|mesh-ancestor
138378807|NCT05962632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378808|NCT05962619|Hyaluronic Acid|hyaluronic acid|mesh-list
138378809|NCT05962619|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138378810|NCT05962619|Immunologic Factors|immunologic factors|mesh-ancestor
138378811|NCT05962619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378812|NCT05962619|Viscosupplements|viscosupplements|mesh-ancestor
138378813|NCT05962619|Protective Agents|protective agents|mesh-ancestor
138378814|NCT05962320|Analgesics, Opioid|analgesics, opioid|mesh-list
138378815|NCT05962320|Narcotics|narcotics|mesh-ancestor
138378816|NCT05962320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378817|NCT05962320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378818|NCT05962320|Analgesics|analgesics|mesh-ancestor
138378819|NCT05962320|Sensory System Agents|sensory system agents|mesh-ancestor
138378820|NCT05962320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378821|NCT05962255|Furosemide|furosemide|mesh-list
138378822|NCT05962255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138378823|NCT05962255|Diuretics|diuretics|mesh-ancestor
138378824|NCT05962255|Natriuretic Agents|natriuretic agents|mesh-ancestor
138378825|NCT05962255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378826|NCT05962255|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138378827|NCT05962255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378828|NCT05962255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378829|NCT05962216|Brexpiprazole|brexpiprazole|mesh-list
138378830|NCT05962216|Serotonin Agents|serotonin agents|mesh-ancestor
138378831|NCT05962216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378832|NCT05962216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378833|NCT05962216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378834|NCT05962216|Dopamine Agonists|dopamine agonists|mesh-ancestor
138378835|NCT05962216|Dopamine Agents|dopamine agents|mesh-ancestor
138378837|NCT05961761|Propranolol|propranolol|mesh-list
138378838|NCT05961761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378839|NCT05961761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378840|NCT05961761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138378841|NCT05961761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378842|NCT05961761|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138378843|NCT05961761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138378845|NCT05961761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378846|NCT05961761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378847|NCT05961761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138378848|NCT05961761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138378850|NCT05961709|Cemiplimab|cemiplimab|mesh-list
138378851|NCT05961709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378852|NCT05961709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378853|NCT05961501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138378854|NCT05961488|Calcium|calcium|mesh-list
138378855|NCT05961488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378856|NCT05961488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378862|NCT05961202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378863|NCT05961202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378864|NCT05961202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138378865|NCT05961202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378867|NCT05961202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138378868|NCT05961202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138378869|NCT05961202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378870|NCT05961202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378871|NCT05961202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378872|NCT05961202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378873|NCT05961007|Aflibercept|aflibercept|mesh-list
138378874|NCT05961007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138378875|NCT05961007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138378876|NCT05961007|Growth Substances|growth substances|mesh-ancestor
138378877|NCT05961007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378878|NCT05961007|Growth Inhibitors|growth inhibitors|mesh-ancestor
138378879|NCT05961007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378883|NCT05960721|Aspirin|aspirin|mesh-list
138378884|NCT05960721|Rivaroxaban|rivaroxaban|mesh-list
138378885|NCT05960721|Clopidogrel|clopidogrel|mesh-list
138378888|NCT05960721|Analgesics|analgesics|mesh-ancestor
138378889|NCT05960721|Sensory System Agents|sensory system agents|mesh-ancestor
138378890|NCT05960721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378891|NCT05960721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378892|NCT05960721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378893|NCT05960721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378894|NCT05960721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138378895|NCT05960721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138378896|NCT05960721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378897|NCT05960721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138378898|NCT05960721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378899|NCT05960721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378900|NCT05960721|Antipyretics|antipyretics|mesh-ancestor
138378901|NCT05960721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138378902|NCT05960721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138378903|NCT05960721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138378905|NCT05960721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378906|NCT05960721|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138378907|NCT05960721|Antithrombins|antithrombins|mesh-ancestor
138378908|NCT05960721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138378909|NCT05960721|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378910|NCT05960721|Anticoagulants|anticoagulants|mesh-ancestor
138378912|NCT05960617|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138378913|NCT05960617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378914|NCT05960617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138378915|NCT05960617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378916|NCT05928611|Dexamethasone|dexamethasone|mesh-list
138378917|NCT05928611|Dexamethasone acetate|dexamethasone acetate|mesh-list
138378918|NCT05928611|BB 1101|bb 1101|mesh-list
138378919|NCT05928611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378920|NCT05928611|Antiemetics|antiemetics|mesh-ancestor
138378921|NCT05928611|Autonomic Agents|autonomic agents|mesh-ancestor
138378922|NCT05928611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378923|NCT05928611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378924|NCT05928611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378925|NCT05928611|Glucocorticoids|glucocorticoids|mesh-ancestor
138378926|NCT05928611|Hormones|hormones|mesh-ancestor
138378927|NCT05928611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378929|NCT05928611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378930|NCT05928611|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378939|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
138378940|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378941|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378942|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138378943|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138378944|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378945|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378946|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
138378947|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378948|NCT05888389|Anesthetics|anesthetics|mesh-list
138378949|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138378950|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378951|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378952|NCT05887726|Prednisone|prednisone|mesh-list
138378953|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
138378954|NCT05887726|Rituximab|rituximab|mesh-list
138378955|NCT05887726|Vincristine|vincristine|mesh-list
138378956|NCT05887726|Epirubicin|epirubicin|mesh-list
138378957|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
138378958|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378959|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
138378960|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378961|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138378962|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138378963|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
138378967|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378968|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378969|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
138378970|NCT05887726|Hormones|hormones|mesh-ancestor
138378971|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138378972|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138378973|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138378974|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
138378975|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
138378976|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
138378977|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138378978|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138378979|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138378980|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378981|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138378982|NCT05867550|Rifaximin|rifaximin|mesh-list
138378983|NCT05867550|Amitriptyline|amitriptyline|mesh-list
138378984|NCT05867550|Mebeverine|mebeverine|mesh-list
138378985|NCT05867550|Psyllium|psyllium|mesh-list
138378986|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
138378987|NCT05867550|Alverine|alverine|mesh-list
138378988|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378989|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378990|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378991|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138378992|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
138378993|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378994|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378996|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
138378997|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378998|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378999|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138379000|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138379001|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379002|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379003|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379004|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379005|NCT05867550|Cathartics|cathartics|mesh-ancestor
138379006|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
138379007|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
138379008|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
138379009|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
138379022|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138379023|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138379024|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379025|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379027|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
138379028|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138379029|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138379030|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379031|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138379032|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138379033|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379034|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379035|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379036|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138379037|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
138379038|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379039|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379040|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138379041|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138379053|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
138379054|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379055|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379056|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379057|NCT05798403|Urological Agents|urological agents|mesh-ancestor
138379058|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
138379059|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379060|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379061|NCT05772429|Cannabidiol|cannabidiol|mesh-list
138379062|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
138379063|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
138379064|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138379065|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138379066|NCT05734625|Prednisolone|prednisolone|mesh-list
138379067|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
138379068|NCT05734625|Bupivacaine|bupivacaine|mesh-list
138379069|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138379070|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
138379071|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
138379072|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
138379073|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379074|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379075|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
138379076|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379077|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379078|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
138379079|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
138379080|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138379081|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
138379083|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379084|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138379085|NCT05734625|Protective Agents|protective agents|mesh-ancestor
138379093|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
138379094|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379095|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379096|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
138379097|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379098|NCT05645913|Anticoagulants|anticoagulants|mesh-list
138379099|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
138379100|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138379101|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
138379102|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138379103|NCT05620901|Prednisolone|prednisolone|mesh-list
138379104|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138379105|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
138379106|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379107|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
138379108|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
138379109|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379110|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379111|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138379112|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
138379113|NCT05620901|Hormones|hormones|mesh-ancestor
138379114|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379115|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379116|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379117|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138379118|NCT05620901|Protective Agents|protective agents|mesh-ancestor
138379119|NCT05618314|Probenecid|probenecid|mesh-list
138379124|NCT05603104|Ketamine|ketamine|mesh-list
138379125|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138379126|NCT05603104|Valproic Acid|valproic acid|mesh-list
138379127|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138379128|NCT05603104|Clozapine|clozapine|mesh-list
138379129|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
138379130|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138379131|NCT05603104|Sertraline|sertraline|mesh-list
138379132|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
138379133|NCT05603104|Esketamine|esketamine|mesh-list
138379134|NCT05603104|Escitalopram|escitalopram|mesh-list
138379135|NCT05603104|Analgesics|analgesics|mesh-ancestor
138379136|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
138379137|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379138|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379139|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138379140|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138379141|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
138379142|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
138379143|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379144|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138379145|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138379146|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379147|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379148|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138379160|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138379161|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138379162|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138379163|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
138379164|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138379165|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
138379166|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138379167|NCT05601973|Lazertinib|lazertinib|mesh-list
138379168|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138379169|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379170|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379171|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379172|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379173|NCT05586789|Tryptophan|tryptophan|mesh-list
138379174|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138379175|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
138379176|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138379177|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
138379178|NCT05568550|Olaparib|olaparib|mesh-list
138379179|NCT05568550|Androgens|androgens|mesh-list
138379180|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379181|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379182|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138379183|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379184|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138379185|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379186|NCT05568550|Hormones|hormones|mesh-ancestor
138379187|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379188|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379189|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138379193|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138379194|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379195|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379196|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379197|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379198|NCT05523934|Capsaicin|capsaicin|mesh-list
138379199|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
138379200|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379201|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
138379202|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379203|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379204|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
138379205|NCT05508100|Tislelizumab|tislelizumab|mesh-list
138379206|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379207|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379208|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138379209|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379210|NCT05498233|Pyridoxine|pyridoxine|mesh-list
138379211|NCT05498233|Doxylamine|doxylamine|mesh-list
138379212|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138379213|NCT05498233|Vitamins|vitamins|mesh-ancestor
138379214|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
138379215|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379217|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
138379218|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379220|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138379221|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
138379222|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
138379223|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379224|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379225|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
138379226|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379227|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
138379228|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379229|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379230|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138379231|NCT05433480|Fulvestrant|fulvestrant|mesh-list
138379232|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379233|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379234|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138379235|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138379236|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
138379237|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379238|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379239|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138379240|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138379241|NCT05428215|Estradiol|estradiol|mesh-list
138379242|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138379243|NCT05428215|Estrogens|estrogens|mesh-ancestor
138379244|NCT05428215|Hormones|hormones|mesh-ancestor
138379245|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379246|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379247|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138379250|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138379252|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138379253|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379254|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379255|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379256|NCT05412173|Molnupiravir|molnupiravir|mesh-list
138379257|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
138379258|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379259|NCT05396859|Decitabine|decitabine|mesh-list
138379260|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138379261|NCT05396859|Entrectinib|entrectinib|mesh-list
138379262|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379263|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
138379264|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379265|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379266|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379267|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138379268|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138379269|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379270|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379271|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379272|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
138379273|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138379274|NCT05289323|Neostigmine|neostigmine|mesh-list
138379275|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138379276|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379277|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379278|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
138379280|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379282|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
138379283|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379284|NCT05275738|Niacinamide|niacinamide|mesh-list
138379286|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
138379287|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138379288|NCT05275738|Vitamins|vitamins|mesh-ancestor
138379289|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
138379290|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379291|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138379292|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
138379293|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379294|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138379295|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
138379296|NCT05269849|Sirolimus|sirolimus|mesh-list
138379297|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138379298|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379299|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138379300|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379301|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
138379302|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138379303|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
138379304|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379306|NCT05264168|Apixaban|apixaban|mesh-list
138379307|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138379308|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
138379309|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138379310|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379311|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379312|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379313|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
138379314|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
138379315|NCT05256797|Apixaban|apixaban|mesh-list
138379316|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138379317|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
138379318|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138379319|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379320|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379321|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379322|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
138379323|NCT05213650|Methamphetamine|methamphetamine|mesh-list
138379325|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379326|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
138379327|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
138379328|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379329|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
138379330|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379331|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379332|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379333|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138379334|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138379335|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379336|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138379338|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
138379339|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138379340|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138379341|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379342|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379343|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
138379344|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379345|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379346|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138379347|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379348|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379361|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379363|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138379364|NCT05164081|Clindamycin|clindamycin|mesh-list
138379365|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
138379366|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
138379367|NCT05164081|Gentamicins|gentamicins|mesh-list
138379368|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138379369|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379370|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
138379372|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379373|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379374|NCT05162183|Liraglutide|liraglutide|mesh-list
138379375|NCT05162183|Glimepiride|glimepiride|mesh-list
138379376|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379377|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379380|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379381|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379382|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138379383|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
138379384|NCT05153395|Insulin|insulin|mesh-list
138379385|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138379386|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379387|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379388|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138379389|NCT05099198|Glimepiride|glimepiride|mesh-list
138379390|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379391|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379393|NCT05099198|Hormones|hormones|mesh-ancestor
138379394|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379395|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138379396|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379397|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379398|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379399|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379400|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138379401|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
138379402|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138379403|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
138379404|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379405|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379406|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379407|NCT05086081|Ticagrelor|ticagrelor|mesh-list
138379408|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138379409|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138379410|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138379411|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138379412|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138379413|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
138379414|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379415|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379416|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379417|NCT05083949|Metformin|metformin|mesh-list
138379418|NCT05083949|Empagliflozin|empagliflozin|mesh-list
138379419|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379420|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379421|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138379422|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379423|NCT05083455|Enoxaparin|enoxaparin|mesh-list
138379424|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
138379425|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138379426|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
138379427|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138379428|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379429|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379430|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379431|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
138379435|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138379436|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379437|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
138379438|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379439|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379440|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138379441|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379442|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
138379443|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138379444|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
138379445|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379446|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379447|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138379448|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138379449|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138379450|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379451|NCT05078879|Empagliflozin|empagliflozin|mesh-list
138379452|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138379453|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379454|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379455|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379457|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379458|NCT05063201|Cariprazine|cariprazine|mesh-list
138379459|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138379460|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138379461|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379462|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379463|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138379464|NCT05062304|Fluticasone|fluticasone|mesh-list
138379466|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379467|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379468|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
138379469|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379470|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379471|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138379472|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379473|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379474|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138379475|NCT05029466|Psilocybin|psilocybin|mesh-list
138379476|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
138379477|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379478|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138379480|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138379481|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
138379482|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379483|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
138379484|NCT05018481|Protective Agents|protective agents|mesh-ancestor
138379485|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138379486|NCT05001750|Doxycycline|doxycycline|mesh-list
138379487|NCT05001750|Nafcillin|nafcillin|mesh-list
138379488|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138379489|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379490|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
138379491|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
138379492|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138379493|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138379494|NCT04979884|Cyclosporine|cyclosporine|mesh-list
138379495|NCT04979884|Interleukin-2|interleukin-2|mesh-list
138379496|NCT04979884|Cyclosporins|cyclosporins|mesh-list
138379497|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379498|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379499|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138379500|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
138379501|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379502|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
138379503|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379504|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379505|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379506|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138379507|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379508|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138379509|NCT04979884|Analgesics|analgesics|mesh-ancestor
138379510|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
138379511|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379512|NCT04971304|Lenograstim|lenograstim|mesh-list
138379513|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138379514|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
138379515|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379516|NCT04968366|Temozolomide|temozolomide|mesh-list
138379517|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138379518|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
138379519|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379520|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379521|NCT04951115|Carboplatin|carboplatin|mesh-list
138379522|NCT04951115|Etoposide|etoposide|mesh-list
138379524|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379525|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138379526|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138379527|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138379528|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379529|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379530|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379531|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
138379532|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379533|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379534|NCT04938466|Hormones|hormones|mesh-list
138379535|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379536|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379537|NCT04934514|Gemcitabine|gemcitabine|mesh-list
138379538|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379539|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379540|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
138379541|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379542|NCT04932980|Aflibercept|aflibercept|mesh-list
138379543|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138379544|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138379545|NCT04932980|Growth Substances|growth substances|mesh-ancestor
138379546|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379547|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
138379548|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379549|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
138379550|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138379551|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379552|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138379553|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
138379559|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138379561|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
138379562|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138379563|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
138379564|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379565|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379566|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138379567|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138379568|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138379569|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138379570|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138379571|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379572|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379574|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138379576|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379577|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138379578|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138379579|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379580|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379581|NCT04909333|Exenatide|exenatide|mesh-list
138379582|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138379583|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379584|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379585|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138379586|NCT04909333|Incretins|incretins|mesh-ancestor
138379587|NCT04909333|Hormones|hormones|mesh-ancestor
138379588|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379589|NCT04897958|Leuprolide|leuprolide|mesh-list
138379590|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138379591|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
138379592|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379593|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362884|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138362885|NCT00553644|Lenalidomide|lenalidomide|mesh-list
138362886|NCT00553644|Bortezomib|bortezomib|mesh-list
138362887|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
138362888|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362889|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138379594|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379595|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379596|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
138379597|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
138379603|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379604|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138379605|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138379606|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138379607|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379609|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379611|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379612|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138379613|NCT04892732|Budesonide|budesonide|mesh-list
138379614|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
138379615|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379616|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379617|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
138379618|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379619|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379620|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138379621|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379622|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
138379623|NCT04892732|Hormones|hormones|mesh-ancestor
138379624|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379625|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138379626|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138379627|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138379628|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379629|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379630|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379632|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
138379633|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138379638|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379640|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379641|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379642|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
138379643|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
138379644|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
138379645|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379646|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
138379647|NCT04848519|Nivolumab|nivolumab|mesh-list
138379648|NCT04848519|Avelumab|avelumab|mesh-list
138379649|NCT04848519|Propranolol|propranolol|mesh-list
138379650|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379651|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379652|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138379653|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379654|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138379655|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138379656|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379657|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379658|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379659|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379660|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138379661|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138379662|NCT04808323|Capecitabine|capecitabine|mesh-list
138379663|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
138379664|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379665|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
138362897|NCT00552240|Emtricitabine|emtricitabine|mesh-list
138379666|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379667|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379668|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
138379669|NCT04793529|Vitamin D|vitamin d|mesh-list
138379670|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138379671|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379672|NCT04793529|Vitamins|vitamins|mesh-ancestor
138379673|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
138379674|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138379675|NCT06040684|Antibodies|antibodies|mesh-list
138379676|NCT06040684|Immunologic Factors|immunologic factors|mesh-ancestor
138379677|NCT06040684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379678|NCT06040489|Amphotericin B|amphotericin b|mesh-list
138379680|NCT06040489|Miltefosine|miltefosine|mesh-list
138379681|NCT06040489|Pentoxifylline|pentoxifylline|mesh-list
138379682|NCT06040489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138379683|NCT06040489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379684|NCT06040489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379685|NCT06040489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138379686|NCT06040489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138379687|NCT06040489|Protective Agents|protective agents|mesh-ancestor
138379688|NCT06040489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379689|NCT06040489|Vasodilator Agents|vasodilator agents|mesh-ancestor
138379690|NCT06040489|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138379691|NCT06040489|Antioxidants|antioxidants|mesh-ancestor
138379692|NCT06040489|Amebicides|amebicides|mesh-ancestor
138379693|NCT06040489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138379694|NCT06040489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138379695|NCT06040489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379696|NCT06040489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138379697|NCT06040489|Antifungal Agents|antifungal agents|mesh-ancestor
138379700|NCT06040346|Antiviral Agents|antiviral agents|mesh-ancestor
138379701|NCT06040346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379703|NCT06040255|Methylprednisolone|methylprednisolone|mesh-list
138379704|NCT06040255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138379705|NCT06040255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138379706|NCT06040255|Prednisolone|prednisolone|mesh-list
138379707|NCT06040255|Prednisolone acetate|prednisolone acetate|mesh-list
138379708|NCT06040255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138379710|NCT06040255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379711|NCT06040255|Glucocorticoids|glucocorticoids|mesh-ancestor
138379712|NCT06040255|Hormones|hormones|mesh-ancestor
138379713|NCT06040255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379714|NCT06040255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379715|NCT06040255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379716|NCT06040255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379717|NCT06040255|Antiemetics|antiemetics|mesh-ancestor
138379718|NCT06040255|Autonomic Agents|autonomic agents|mesh-ancestor
138379719|NCT06040255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379720|NCT06040255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138379721|NCT06040255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138379722|NCT06040255|Protective Agents|protective agents|mesh-ancestor
138379723|NCT06040190|Thioctic Acid|thioctic acid|mesh-list
138379724|NCT06040190|Clonazepam|clonazepam|mesh-list
138379725|NCT06040190|Capsaicin|capsaicin|mesh-list
138379726|NCT06040190|Antipruritics|antipruritics|mesh-ancestor
138379727|NCT06040190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379728|NCT06040190|Sensory System Agents|sensory system agents|mesh-ancestor
138379729|NCT06040190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379730|NCT06040190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379731|NCT06040190|Antioxidants|antioxidants|mesh-ancestor
138379732|NCT06040190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379733|NCT06040190|Protective Agents|protective agents|mesh-ancestor
138379734|NCT06040190|Vitamin B Complex|vitamin b complex|mesh-ancestor
138379735|NCT06040190|Vitamins|vitamins|mesh-ancestor
138379736|NCT06040190|Micronutrients|micronutrients|mesh-ancestor
138379737|NCT06040190|Anticonvulsants|anticonvulsants|mesh-ancestor
138379738|NCT06040190|GABA Modulators|gaba modulators|mesh-ancestor
138379739|NCT06040190|GABA Agents|gaba agents|mesh-ancestor
138379740|NCT06040190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379741|NCT06040112|Lidocaine|lidocaine|mesh-list
138379742|NCT06040112|Anesthetics, Local|anesthetics, local|mesh-ancestor
138379743|NCT06040112|Anesthetics|anesthetics|mesh-ancestor
138379744|NCT06040112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379745|NCT06040112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379746|NCT06040112|Sensory System Agents|sensory system agents|mesh-ancestor
138379747|NCT06040112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379748|NCT06040112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379750|NCT06040112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138379751|NCT06040112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379752|NCT06040112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379753|NCT06039891|Tislelizumab|tislelizumab|mesh-list
138379754|NCT06039891|Nimotuzumab|nimotuzumab|mesh-list
138379755|NCT06039891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379756|NCT06039891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379758|NCT06039592|Captopril|captopril|mesh-list
138379759|NCT06039592|Torsemide|torsemide|mesh-list
138379760|NCT06039592|Spironolactone|spironolactone|mesh-list
138379761|NCT06039592|Potassium Citrate|potassium citrate|mesh-list
138379762|NCT06039592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379763|NCT06039592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379764|NCT06039592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138379765|NCT06039592|Sympatholytics|sympatholytics|mesh-ancestor
138379766|NCT06039592|Autonomic Agents|autonomic agents|mesh-ancestor
138379767|NCT06039592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379768|NCT06039592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379769|NCT06039592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138379770|NCT06039592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138379771|NCT06039592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138379772|NCT06039592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379773|NCT06039592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379774|NCT06039592|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138379775|NCT06039592|Hormone Antagonists|hormone antagonists|mesh-ancestor
138379776|NCT06039592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379777|NCT06039592|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138379778|NCT06039592|Diuretics|diuretics|mesh-ancestor
138379779|NCT06039592|Natriuretic Agents|natriuretic agents|mesh-ancestor
138379780|NCT06039592|Expectorants|expectorants|mesh-ancestor
138379781|NCT06039592|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379792|NCT06039540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379793|NCT06039540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379794|NCT06039540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138379795|NCT06039540|Sympatholytics|sympatholytics|mesh-ancestor
138379796|NCT06039540|Autonomic Agents|autonomic agents|mesh-ancestor
138379797|NCT06039540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379798|NCT06039540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379799|NCT06039540|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138379800|NCT06039540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138379801|NCT06039540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138379802|NCT06039540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379803|NCT06039540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379804|NCT06039540|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138379805|NCT06039540|Hormone Antagonists|hormone antagonists|mesh-ancestor
138379806|NCT06039540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379808|NCT06039540|Diuretics|diuretics|mesh-ancestor
138379809|NCT06039540|Natriuretic Agents|natriuretic agents|mesh-ancestor
138379810|NCT06039540|Expectorants|expectorants|mesh-ancestor
138379811|NCT06039540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379812|NCT06039540|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138379813|NCT06039540|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379814|NCT06039540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379815|NCT06039540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138379816|NCT06039540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379818|NCT06039423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138379819|NCT06039423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138379820|NCT06039423|Analgesics|analgesics|mesh-ancestor
138379821|NCT06039423|Sensory System Agents|sensory system agents|mesh-ancestor
138379822|NCT06039423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379823|NCT06039423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379824|NCT06039423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379825|NCT06039423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379826|NCT06039423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138379827|NCT06039423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379828|NCT06039423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379829|NCT06039280|Acetylcysteine|acetylcysteine|mesh-list
138379830|NCT06039280|Dexamethasone|dexamethasone|mesh-list
138379831|NCT06039280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138379832|NCT06039280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379833|NCT06039280|Antiemetics|antiemetics|mesh-ancestor
138379834|NCT06039280|Autonomic Agents|autonomic agents|mesh-ancestor
138379835|NCT06039280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379836|NCT06039280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379837|NCT06039280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138379838|NCT06039280|Glucocorticoids|glucocorticoids|mesh-ancestor
138379839|NCT06039280|Hormones|hormones|mesh-ancestor
138379840|NCT06039280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379841|NCT06039280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379842|NCT06039280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379843|NCT06039280|Antiviral Agents|antiviral agents|mesh-ancestor
138379844|NCT06039280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379845|NCT06039280|Expectorants|expectorants|mesh-ancestor
138379846|NCT06039280|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379847|NCT06039280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138379848|NCT06039280|Antioxidants|antioxidants|mesh-ancestor
138379849|NCT06039280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379850|NCT06039280|Protective Agents|protective agents|mesh-ancestor
138379851|NCT06039280|Antidotes|antidotes|mesh-ancestor
138379852|NCT06039202|Trifluridine|trifluridine|mesh-list
138379853|NCT06039202|Bevacizumab|bevacizumab|mesh-list
138379854|NCT06039202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379855|NCT06039202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379856|NCT06039202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138379857|NCT06039202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138379862|NCT06039202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379863|NCT06039202|Antiviral Agents|antiviral agents|mesh-ancestor
138379864|NCT06039202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379865|NCT06039150|Anesthetics|anesthetics|mesh-list
138379866|NCT06039150|Anesthetics, Local|anesthetics, local|mesh-list
138379867|NCT06039150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379868|NCT06039150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379869|NCT06039150|Sensory System Agents|sensory system agents|mesh-ancestor
138379870|NCT06039150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379872|NCT06039137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138379873|NCT06039137|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138379874|NCT06039137|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138379875|NCT06039137|Histamine Antagonists|histamine antagonists|mesh-ancestor
138379876|NCT06039137|Histamine Agents|histamine agents|mesh-ancestor
138379877|NCT06039137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379878|NCT06039137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379879|NCT06039137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379881|NCT06039124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138379882|NCT06039124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379883|NCT06039124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138379884|NCT06039124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138379885|NCT06039124|Growth Substances|growth substances|mesh-ancestor
138379886|NCT06039124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379887|NCT06039124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138379888|NCT06038968|Methotrexate|methotrexate|mesh-list
138379889|NCT06038968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138379890|NCT06038968|Abortifacient Agents|abortifacient agents|mesh-ancestor
138379891|NCT06038968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379892|NCT06038968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379893|NCT06038968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379894|NCT06038968|Antimetabolites|antimetabolites|mesh-ancestor
138379895|NCT06038968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379896|NCT06038968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379897|NCT06038968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138379898|NCT06038968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379899|NCT06038968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138379900|NCT06038968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138379901|NCT06038968|Immunologic Factors|immunologic factors|mesh-ancestor
138379902|NCT06038968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379903|NCT06038968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138379904|NCT06038695|Mitogens|mitogens|mesh-list
138379905|NCT06038695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138379906|NCT06038695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379907|NCT06038552|Imatinib Mesylate|imatinib mesylate|mesh-list
138379911|NCT06038552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379912|NCT06037811|Prednisone|prednisone|mesh-list
138379913|NCT06037811|Adalimumab|adalimumab|mesh-list
138379914|NCT06037811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379915|NCT06037811|Glucocorticoids|glucocorticoids|mesh-ancestor
138379916|NCT06037811|Hormones|hormones|mesh-ancestor
138379917|NCT06037811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379918|NCT06037811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379919|NCT06037811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138379921|NCT06037811|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138379922|NCT06037811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379923|NCT06037434|Metoprolol|metoprolol|mesh-list
138379924|NCT06037434|Captopril|captopril|mesh-list
138379925|NCT06037434|Torsemide|torsemide|mesh-list
138379926|NCT06037434|Spironolactone|spironolactone|mesh-list
138379927|NCT06037434|Potassium Citrate|potassium citrate|mesh-list
138379928|NCT06037434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379929|NCT06037434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379930|NCT06037434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138379931|NCT06037434|Sympatholytics|sympatholytics|mesh-ancestor
138379932|NCT06037434|Autonomic Agents|autonomic agents|mesh-ancestor
138379933|NCT06037434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379934|NCT06037434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379935|NCT06037434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138379936|NCT06037434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138379937|NCT06037434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138379938|NCT06037434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379939|NCT06037434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379940|NCT06037434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138379941|NCT06037434|Hormone Antagonists|hormone antagonists|mesh-ancestor
138379942|NCT06037434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379943|NCT06037434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138379944|NCT06037434|Diuretics|diuretics|mesh-ancestor
138379945|NCT06037434|Natriuretic Agents|natriuretic agents|mesh-ancestor
138379946|NCT06037434|Expectorants|expectorants|mesh-ancestor
138379947|NCT06037434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138379948|NCT06037434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138379952|NCT06037434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379953|NCT06035523|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138379954|NCT06035523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379955|NCT06031740|Polidocanol|polidocanol|mesh-list
138379956|NCT06031740|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138379957|NCT06031740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138379961|NCT06010927|Sensory System Agents|sensory system agents|mesh-ancestor
138379962|NCT06010927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379963|NCT06010927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379964|NCT06010927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138379965|NCT06010927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138379966|NCT06010927|Anesthetics, General|anesthetics, general|mesh-ancestor
138379967|NCT06010927|Anesthetics|anesthetics|mesh-ancestor
138379968|NCT06010927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379969|NCT06010927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138379970|NCT06010927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138379971|NCT06010927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379972|NCT06010927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379973|NCT06010927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138379974|NCT06010927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138379975|NCT06010927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138379976|NCT06010927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138379977|NCT06010927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138379978|NCT06010927|GABA Modulators|gaba modulators|mesh-ancestor
138379979|NCT06010927|GABA Agents|gaba agents|mesh-ancestor
138379980|NCT05912946|Interferons|interferons|mesh-list
138379981|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
138379982|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379983|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
138379984|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379985|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138379986|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
138379987|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379988|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
138379989|NCT05912946|Protective Agents|protective agents|mesh-ancestor
138379990|NCT05814523|Ganaxolone|ganaxolone|mesh-list
138379991|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
138379992|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379993|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379994|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379995|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
138379997|NCT05813587|Meplazumab|meplazumab|mesh-list
138379998|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
138379999|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380000|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
138380001|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138380002|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
138380005|NCT05810649|Protective Agents|protective agents|mesh-ancestor
138380006|NCT05806931|Bevacizumab|bevacizumab|mesh-list
138380007|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
138380008|NCT05806931|Irinotecan|irinotecan|mesh-list
138380009|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380010|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380011|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380012|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380014|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380016|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138380017|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380018|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380019|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380020|NCT05799326|Levofloxacin|levofloxacin|mesh-list
138380021|NCT05799326|Ofloxacin|ofloxacin|mesh-list
138380022|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138380023|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380024|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380025|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380026|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380027|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380028|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380029|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380030|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138380031|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138380032|NCT05775731|Hemostatics|hemostatics|mesh-list
138380033|NCT05775731|Coagulants|coagulants|mesh-ancestor
138380035|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
138380036|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380037|NCT05696847|Tirzepatide|tirzepatide|mesh-list
138380038|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138380039|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380040|NCT05696847|Incretins|incretins|mesh-ancestor
138380041|NCT05696847|Hormones|hormones|mesh-ancestor
138380042|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380043|NCT05679492|Meplazumab|meplazumab|mesh-list
138380044|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
138380045|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380046|NCT05548985|Midodrine|midodrine|mesh-list
138380047|NCT05548985|Metoclopramide|metoclopramide|mesh-list
138380048|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
138380049|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
138380050|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380051|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380052|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138380053|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138380054|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138380055|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
138380056|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380062|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380063|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380064|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
138380065|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380066|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380067|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380068|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380070|NCT05473741|Aripiprazole|aripiprazole|mesh-list
138380071|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138380072|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
138380073|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138380074|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
138380075|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380076|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380077|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380078|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138380079|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138380080|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138380081|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138380083|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
138380084|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
138380085|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138380086|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138380087|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138380088|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138380089|NCT05435053|Nivolumab|nivolumab|mesh-list
138380090|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380091|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380092|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380093|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380094|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
138380095|NCT05433116|Lenvatinib|lenvatinib|mesh-list
138380096|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380100|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380101|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380102|NCT05401214|Prednisone|prednisone|mesh-list
138380103|NCT05401214|Prednisolone|prednisolone|mesh-list
138380104|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
138380106|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380107|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
138380108|NCT05401214|Hormones|hormones|mesh-ancestor
138380110|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380111|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138380112|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380113|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138380114|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380115|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380116|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
138380117|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138380118|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138380119|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
138380120|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138380121|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380122|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
138380123|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138380124|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380125|NCT05353361|Paclitaxel|paclitaxel|mesh-list
138380127|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380128|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380129|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380130|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380131|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380132|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380133|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380134|NCT05284214|Ipilimumab|ipilimumab|mesh-list
138380135|NCT05284214|Sargramostim|sargramostim|mesh-list
138380136|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380137|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380138|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380139|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380140|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
138380141|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380143|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
138380144|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380145|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
138380146|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380148|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138380149|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380150|NCT05192889|Leucovorin|leucovorin|mesh-list
138380151|NCT05192889|Cytarabine|cytarabine|mesh-list
138380152|NCT05192889|Dexamethasone|dexamethasone|mesh-list
138380153|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
138380154|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
138380155|NCT05192889|Methotrexate|methotrexate|mesh-list
138380156|NCT05192889|Etoposide|etoposide|mesh-list
138380157|NCT05192889|Vincristine|vincristine|mesh-list
138380158|NCT05192889|Venetoclax|venetoclax|mesh-list
138380159|NCT05192889|Asparaginase|asparaginase|mesh-list
138380160|NCT05192889|Dasatinib|dasatinib|mesh-list
138380161|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
138380162|NCT05192889|Pegaspargase|pegaspargase|mesh-list
138380163|NCT05192889|Blinatumomab|blinatumomab|mesh-list
138380164|NCT05192889|Navitoclax|navitoclax|mesh-list
138380165|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380166|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
138380167|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380168|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380169|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380170|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
138380171|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380173|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380174|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380176|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
138380177|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380178|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138380179|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
138380181|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380182|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138380183|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138380184|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
138380185|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380186|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380187|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
138380188|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
138380189|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380190|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138380212|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380213|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380214|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380215|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
138380216|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380237|NCT05122182|Propagermanium|propagermanium|mesh-list
138380238|NCT05122182|Candesartan|candesartan|mesh-list
138380242|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138380243|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380244|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380245|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
138380246|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
138380247|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380249|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
138380250|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380251|NCT05113186|Lenvatinib|lenvatinib|mesh-list
138380252|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380253|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380254|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380255|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380256|NCT05086627|Capecitabine|capecitabine|mesh-list
138380258|NCT05086627|Tislelizumab|tislelizumab|mesh-list
138380259|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380260|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
138380261|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380262|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380263|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380264|NCT05069597|Pancrelipase|pancrelipase|mesh-list
138380265|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138380266|NCT05011188|Antibodies|antibodies|mesh-list
138380267|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
138380268|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
138380269|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
138380270|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380271|NCT04917861|Vaccines|vaccines|mesh-list
138380272|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
138380273|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380274|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138380275|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138380276|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380277|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380278|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138380279|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138380280|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380281|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
138380282|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380283|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
138380284|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380285|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380286|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380287|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380288|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380289|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380290|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380291|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
138380292|NCT04809766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138380296|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380297|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380298|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380299|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
138380300|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380301|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380302|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380303|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138380304|NCT04785287|Nivolumab|nivolumab|mesh-list
138380305|NCT04785287|Antibodies|antibodies|mesh-list
138380306|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
138380307|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138380308|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
138380309|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380310|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380311|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380312|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380313|NCT04780269|Dinoprostone|dinoprostone|mesh-list
138380314|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
138380315|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380316|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380317|NCT04735926|Calcifediol|calcifediol|mesh-list
138380318|NCT04735926|Vitamins|vitamins|mesh-ancestor
138380319|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
138380320|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380321|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138380324|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
138380325|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380326|NCT04594772|Paclitaxel|paclitaxel|mesh-list
138380327|NCT04594772|Gemcitabine|gemcitabine|mesh-list
138380328|NCT04594772|Fluorouracil|fluorouracil|mesh-list
138380329|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
138380330|NCT04594772|Irinotecan|irinotecan|mesh-list
138380331|NCT04594772|Folfirinox|folfirinox|mesh-list
138380332|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380333|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380334|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380335|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380336|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380337|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380338|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380339|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
138380340|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380341|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
138380342|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380343|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138380346|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138380348|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138380350|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
138380351|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138380352|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
138380355|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380356|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380357|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380358|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
138380359|NCT04536363|Alprostadil|alprostadil|mesh-list
138380360|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138380361|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
138380362|NCT04536363|Urological Agents|urological agents|mesh-ancestor
138380363|NCT04481919|Diuretics|diuretics|mesh-list
138380364|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
138380365|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380366|NCT04427306|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138380367|NCT04427306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380368|NCT04427306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380369|NCT04421222|Abiraterone Acetate|abiraterone acetate|mesh-list
138380370|NCT04421222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380371|NCT04421222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138380372|NCT04421222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380373|NCT04421222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380374|NCT04421222|Hormone Antagonists|hormone antagonists|mesh-ancestor
138380375|NCT04421222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380376|NCT04421222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380377|NCT04421222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138380379|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
138380380|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380381|NCT04421079|Protective Agents|protective agents|mesh-ancestor
138380382|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380384|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138380385|NCT04328714|Interferons|interferons|mesh-list
138380386|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
138380387|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380388|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
138380389|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380390|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138380391|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380392|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380393|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380394|NCT04294264|Trifluridine|trifluridine|mesh-list
138380395|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
138380396|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380397|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
138380398|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380399|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
138380400|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380401|NCT04237649|Spartalizumab|spartalizumab|mesh-list
138380403|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380404|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380405|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380407|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380408|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
138380409|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380410|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138380411|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380412|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380413|NCT04023253|Mirabegron|mirabegron|mesh-list
138380414|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
138380415|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138380416|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138380417|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380418|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380419|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380420|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380421|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380422|NCT04023253|Urological Agents|urological agents|mesh-ancestor
138380423|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138380424|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138380425|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
138380426|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
138380427|NCT04007029|Fludarabine|fludarabine|mesh-list
138380428|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
138380429|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
138380430|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
138380431|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380432|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
138380433|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380434|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380435|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380436|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
138380437|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380438|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380439|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380440|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380441|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
138380442|NCT03887650|Dexamethasone|dexamethasone|mesh-list
138380444|NCT03887650|Bupivacaine|bupivacaine|mesh-list
138380445|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380446|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
138380447|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
138380448|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380449|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380450|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138380451|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
138380452|NCT03887650|Hormones|hormones|mesh-ancestor
138380453|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380454|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138380455|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380456|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380457|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
138380458|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
138380459|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138380460|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
138380461|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138380462|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380463|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380465|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138380466|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138380467|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138380468|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
138380469|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
138380470|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
138380471|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138380472|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138380473|NCT03854500|Tenecteplase|tenecteplase|mesh-list
138380474|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138380475|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138380476|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380477|NCT03783949|Paclitaxel|paclitaxel|mesh-list
138380478|NCT03783949|Carboplatin|carboplatin|mesh-list
138380479|NCT03783949|Gemcitabine|gemcitabine|mesh-list
138380480|NCT03783949|Niraparib|niraparib|mesh-list
138380481|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380482|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380483|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380484|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380485|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380486|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380487|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380488|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
138380489|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138380490|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380491|NCT03777657|Capecitabine|capecitabine|mesh-list
138380492|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
138380493|NCT03777657|Tislelizumab|tislelizumab|mesh-list
138380494|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380495|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380496|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
138380497|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380498|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380499|NCT03699254|Valganciclovir|valganciclovir|mesh-list
138380500|NCT03699254|Ganciclovir|ganciclovir|mesh-list
138380501|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138380502|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
138380503|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380504|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138380506|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380508|NCT03522246|Rucaparib|rucaparib|mesh-list
138380509|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380510|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380511|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380512|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380513|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138380514|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380515|NCT03513328|Thiotepa|thiotepa|mesh-list
138380516|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380517|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
138380518|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380519|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380520|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380521|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380522|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
138380523|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380524|NCT03498716|Paclitaxel|paclitaxel|mesh-list
138380525|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
138380526|NCT03498716|Doxorubicin|doxorubicin|mesh-list
138380527|NCT03498716|Atezolizumab|atezolizumab|mesh-list
138380528|NCT03498716|Epirubicin|epirubicin|mesh-list
138380529|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380530|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380531|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380532|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380533|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380534|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380536|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
138380537|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380538|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380539|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380540|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
138380542|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138380543|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380544|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380545|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380546|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380547|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380548|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
138380550|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138380551|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138380552|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380553|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138380555|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
138380556|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380557|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138380558|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138380559|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380560|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380561|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380562|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380563|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138380567|NCT03390686|Bevacizumab|bevacizumab|mesh-list
138380568|NCT03390686|Carboplatin|carboplatin|mesh-list
138380569|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380570|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380571|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380572|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380573|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380574|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380575|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380576|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380577|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380578|NCT03390686|Growth Substances|growth substances|mesh-ancestor
138380579|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380580|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
138380581|NCT03270969|Tenofovir|tenofovir|mesh-list
138380582|NCT03270969|Emtricitabine|emtricitabine|mesh-list
138380583|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
138380584|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380585|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138380586|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138380587|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380588|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380589|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138380590|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138380591|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138380593|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380594|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
138380598|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138380599|NCT03233347|Nivolumab|nivolumab|mesh-list
138380600|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138380601|NCT03233347|Doxorubicin|doxorubicin|mesh-list
138380602|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138380603|NCT03233347|Daunorubicin|daunorubicin|mesh-list
138380604|NCT03233347|Dacarbazine|dacarbazine|mesh-list
138380605|NCT03233347|Vinblastine|vinblastine|mesh-list
138380606|NCT03233347|Antibodies|antibodies|mesh-list
138380607|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
138380608|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138380609|NCT03233347|Imidazole|imidazole|mesh-list
138380610|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
138380611|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
138380612|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380613|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380614|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138380615|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380616|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380617|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380618|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380619|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380620|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
138380621|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380622|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
138380623|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380624|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380625|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380626|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380627|NCT03016013|Methotrexate|methotrexate|mesh-list
138380628|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138380629|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
138380630|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380631|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380632|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380633|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
138380634|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380637|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380638|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138380639|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380640|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
138380641|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380642|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138380643|NCT02988297|RNS60|rns60|mesh-list
138380644|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138380645|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138380646|NCT02988297|Analgesics|analgesics|mesh-ancestor
138380649|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380650|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380651|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380652|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138380654|NCT02940496|Grazoprevir|grazoprevir|mesh-list
138380655|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138380656|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
138380657|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380658|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380659|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380660|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380661|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
138380662|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
138380663|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380664|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
138380665|NCT02828761|Calcium|calcium|mesh-list
138380666|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138380667|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380668|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138380669|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
138380670|NCT02807207|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138380671|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380672|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380673|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380674|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380675|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380676|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380677|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380679|NCT02807207|Contraceptive Agents|contraceptive agents|mesh-ancestor
138380680|NCT02807207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380681|NCT02807207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380684|NCT02807207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138380686|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138380687|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
138380688|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380689|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380690|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
138380691|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138380692|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380693|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380694|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138380695|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138380696|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138380697|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138380698|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138380699|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138380700|NCT02456857|Bevacizumab|bevacizumab|mesh-list
138380701|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138380702|NCT02456857|Doxorubicin|doxorubicin|mesh-list
138380703|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138380704|NCT02456857|Everolimus|everolimus|mesh-list
138380705|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
138380706|NCT02456857|Antibodies|antibodies|mesh-list
138380707|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
138380708|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138380709|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
138380710|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380711|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380712|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380713|NCT02456857|Growth Substances|growth substances|mesh-ancestor
138380714|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380715|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
138380716|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
138380717|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138380718|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380719|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380720|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380721|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380722|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138380723|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380725|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
138380726|NCT02265770|Cisplatin|cisplatin|mesh-list
138380727|NCT02265770|Carboplatin|carboplatin|mesh-list
138380729|NCT02265770|Etoposide|etoposide|mesh-list
138380730|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
138380731|NCT02265770|Vincristine|vincristine|mesh-list
138380732|NCT02265770|Valproic Acid|valproic acid|mesh-list
138380733|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380734|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
138380735|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380736|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380737|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380738|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
138380739|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380740|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380741|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380742|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138380743|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
138380744|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380745|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380746|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
138380747|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138380748|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380749|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138380750|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138380751|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380752|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380753|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380754|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380755|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380756|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380757|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
138380758|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
138380759|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380760|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
138380761|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138380763|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138380764|NCT02140242|Daunorubicin|daunorubicin|mesh-list
138380765|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138380766|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380767|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380768|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380770|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380772|NCT01990196|Trametinib|trametinib|mesh-list
138380773|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380774|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380775|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380776|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380777|NCT01968109|Nivolumab|nivolumab|mesh-list
138380778|NCT01968109|Relatlimab|relatlimab|mesh-list
138380779|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380780|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380782|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380783|NCT01612351|Paclitaxel|paclitaxel|mesh-list
138380784|NCT01612351|Cisplatin|cisplatin|mesh-list
138380785|NCT01612351|Carboplatin|carboplatin|mesh-list
138380786|NCT01612351|Lapatinib|lapatinib|mesh-list
138380787|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380788|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380789|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380790|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380791|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380792|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380793|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380794|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380795|NCT01506856|Paclitaxel|paclitaxel|mesh-list
138380796|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138380797|NCT01506856|Carboplatin|carboplatin|mesh-list
138380799|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380800|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380801|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380802|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380803|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380805|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
138380807|NCT01256593|Pregabalin|pregabalin|mesh-list
138380808|NCT01256593|Analgesics|analgesics|mesh-ancestor
138380809|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
138380810|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380811|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380812|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
138380813|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138380814|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138380815|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380816|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138380817|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138380818|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138380819|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138380820|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138380821|NCT01179009|Clonidine|clonidine|mesh-list
138380822|NCT01179009|Ketamine|ketamine|mesh-list
138380823|NCT01179009|Analgesics|analgesics|mesh-ancestor
138380824|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
138380825|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380826|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380827|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138380828|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138380829|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
138380830|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
138380831|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138380833|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138380834|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380835|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380836|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138380838|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
138380839|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138380840|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138380841|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380847|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
138380848|NCT00716066|Melphalan|melphalan|mesh-list
138380849|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
138380850|NCT00716066|Carmustine|carmustine|mesh-list
138380851|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
138380852|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138380853|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
138380854|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138380855|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380856|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
138380857|NCT00716066|Hormones|hormones|mesh-ancestor
138380858|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380859|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380860|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138380861|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380865|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380866|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380867|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138380868|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
138380869|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
138380870|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380871|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380872|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
138380873|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380874|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
138380875|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380876|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
138380877|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
138380878|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380879|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380880|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380881|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
138380882|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380883|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
138380884|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380885|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138380886|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380887|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
138380888|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380889|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380890|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138380891|NCT04787289|Bevacizumab|bevacizumab|mesh-list
138380892|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380893|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380894|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380895|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380897|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380900|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
138380901|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380902|NCT04745299|Riluzole|riluzole|mesh-list
138380903|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
138380904|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138380905|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138380906|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380907|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380908|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380909|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138380910|NCT04745299|Protective Agents|protective agents|mesh-ancestor
138380912|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380913|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380914|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138380915|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380916|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
138380917|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380918|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
138380919|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380920|NCT04725201|Heparin|heparin|mesh-list
138380921|NCT04725201|Calcium heparin|calcium heparin|mesh-list
138380922|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
138380923|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138380924|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138380925|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380926|NCT04724239|Bevacizumab|bevacizumab|mesh-list
138380927|NCT04724239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380928|NCT04724239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380929|NCT04724239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380930|NCT04724239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380931|NCT04724239|Growth Substances|growth substances|mesh-ancestor
138380932|NCT04724239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380933|NCT04724239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138380934|NCT04705727|Budesonide|budesonide|mesh-list
138380935|NCT04705727|Terbutaline|terbutaline|mesh-list
138380936|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
138380945|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
138380946|NCT04705727|Hormones|hormones|mesh-ancestor
138380947|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380948|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138380949|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138380950|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138380951|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380952|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380953|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380954|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
138380955|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
138380956|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138380957|NCT04674683|Nivolumab|nivolumab|mesh-list
138380958|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138380959|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380960|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380961|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380962|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
138380965|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380966|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380967|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380968|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138380969|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380970|NCT04662944|Ranibizumab|ranibizumab|mesh-list
138380971|NCT04662944|Aflibercept|aflibercept|mesh-list
138380972|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138380973|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380974|NCT04662944|Growth Substances|growth substances|mesh-ancestor
138380975|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380976|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
138380977|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380985|NCT04635826|Adderall|adderall|mesh-list
138380986|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138380987|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380988|NCT04629781|Docetaxel|docetaxel|mesh-list
138380989|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380992|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380993|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380994|NCT04624945|Thromboplastin|thromboplastin|mesh-list
138380995|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
138380996|NCT04624945|Coagulants|coagulants|mesh-ancestor
138380997|NCT04608474|Evolocumab|evolocumab|mesh-list
138380998|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138380999|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138381000|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138381001|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138381002|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
138381003|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381004|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138381005|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381006|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381007|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138381009|NCT04600414|Narcotics|narcotics|mesh-ancestor
138381010|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381011|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381012|NCT04600414|Analgesics|analgesics|mesh-ancestor
138381013|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
138381014|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381015|NCT04593043|Warfarin|warfarin|mesh-list
138381016|NCT04593043|Dabigatran|dabigatran|mesh-list
138381017|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
138381018|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
138381019|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138381020|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381021|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381022|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381023|NCT04593030|Warfarin|warfarin|mesh-list
138381024|NCT04593030|Apixaban|apixaban|mesh-list
138381026|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138381027|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
138381028|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138381030|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381031|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381032|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
138381033|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381034|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381035|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138381036|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
138381039|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
138381040|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138381041|NCT04518410|Antibodies|antibodies|mesh-list
138381042|NCT04518410|Camostat|camostat|mesh-list
138381043|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
138381044|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381045|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
138381046|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381047|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381048|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381049|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381050|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138381051|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138381052|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
138381053|NCT04507204|Methylphenidate|methylphenidate|mesh-list
138381054|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138381055|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381056|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138381057|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138381058|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138381059|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381061|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381062|NCT04486391|Tislelizumab|tislelizumab|mesh-list
138381063|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381064|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381065|NCT04332744|Talazoparib|talazoparib|mesh-list
138381066|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138381067|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381068|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381069|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381070|NCT04331002|Triamcinolone|triamcinolone|mesh-list
138381071|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138381072|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138381073|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138381074|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381075|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
138381076|NCT04331002|Hormones|hormones|mesh-ancestor
138381077|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381078|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381079|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381081|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381082|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381084|NCT04291820|Sevoflurane|sevoflurane|mesh-list
138381085|NCT04291820|Desflurane|desflurane|mesh-list
138381086|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381087|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381088|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138381089|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138381090|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
138381092|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138381094|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381097|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
138381098|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381099|NCT04263051|Nivolumab|nivolumab|mesh-list
138381100|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381101|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381102|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381103|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381104|NCT04237935|Clopidogrel|clopidogrel|mesh-list
138381105|NCT04237935|Ticagrelor|ticagrelor|mesh-list
138381106|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138381107|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138381108|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138381109|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138381110|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
138381111|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381112|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381113|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381114|NCT04237922|Clopidogrel|clopidogrel|mesh-list
138381115|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138381116|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138381118|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138381119|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138381120|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
138381121|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381122|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381123|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381124|NCT04233021|Osimertinib|osimertinib|mesh-list
138381125|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381126|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381127|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381128|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381130|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
138381131|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381132|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381133|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138381134|NCT04215536|Empagliflozin|empagliflozin|mesh-list
138381135|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138381136|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138381137|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381138|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381141|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381142|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
138381143|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138381144|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138381146|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381147|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381148|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381149|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381150|NCT04169347|Leucovorin|leucovorin|mesh-list
138381151|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
138381152|NCT04169347|Irinotecan|irinotecan|mesh-list
138381153|NCT04169347|Panitumumab|panitumumab|mesh-list
138381154|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381155|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138381156|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381157|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381159|NCT04169347|Antidotes|antidotes|mesh-ancestor
138381160|NCT04169347|Protective Agents|protective agents|mesh-ancestor
138381161|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381162|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
138381163|NCT04169347|Vitamins|vitamins|mesh-ancestor
138381164|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
138381165|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381166|NCT04135937|Bupropion|bupropion|mesh-list
138381167|NCT04135937|Nicotine|nicotine|mesh-list
138381168|NCT04135937|Varenicline|varenicline|mesh-list
138381169|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138381170|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
138381171|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381172|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381173|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138381174|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138381175|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
138381176|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381178|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138381179|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
138381181|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138381182|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138381183|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138381184|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
138381185|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138381186|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138381187|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381189|NCT04126070|Nivolumab|nivolumab|mesh-list
138381190|NCT04126070|Leuprolide|leuprolide|mesh-list
138381191|NCT04126070|Goserelin|goserelin|mesh-list
138381192|NCT04126070|Androgens|androgens|mesh-list
138381193|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381194|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138381195|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138381196|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138381197|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381198|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381199|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381200|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138381201|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
138381202|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381203|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381204|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138381205|NCT04126070|Hormones|hormones|mesh-ancestor
138381206|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381207|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138381208|NCT04120987|Lifitegrast|lifitegrast|mesh-list
138381209|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138381211|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138381212|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381213|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381214|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381216|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381217|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381218|NCT03936062|Incretins|incretins|mesh-ancestor
138381220|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381221|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138381222|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381223|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381224|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381225|NCT03936049|Liraglutide|liraglutide|mesh-list
138381226|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138381227|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381228|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381229|NCT03936049|Incretins|incretins|mesh-ancestor
138381230|NCT03936049|Hormones|hormones|mesh-ancestor
138381231|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381232|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381233|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381234|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381235|NCT03936036|Linagliptin|linagliptin|mesh-list
138381237|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381238|NCT03936036|Incretins|incretins|mesh-ancestor
138381239|NCT03936036|Hormones|hormones|mesh-ancestor
138381240|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381241|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138381242|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381243|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381244|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381246|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138381247|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138381248|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381249|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381250|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381251|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381252|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381254|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381255|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381256|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138381257|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138381258|NCT03919448|Growth Substances|growth substances|mesh-ancestor
138381259|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381260|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138381261|NCT03900637|Letrozole|letrozole|mesh-list
138381262|NCT03900637|Leuprolide|leuprolide|mesh-list
138381263|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381264|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138381265|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138381266|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381267|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381268|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138381269|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
138381270|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381271|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381272|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138381273|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
138381274|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381275|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138381276|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138381277|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138381278|NCT03893045|Hematinics|hematinics|mesh-ancestor
138381279|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138381281|NCT03877354|Anesthetics|anesthetics|mesh-list
138381282|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381283|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381284|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138381285|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381287|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
138381288|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381289|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
138381290|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138381291|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381292|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
138381293|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
138381294|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381295|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381296|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138381297|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
138381298|NCT03818737|Hormones|hormones|mesh-ancestor
138381299|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381300|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138381301|NCT03818737|Protective Agents|protective agents|mesh-ancestor
138381302|NCT03777982|Prednisone|prednisone|mesh-list
138381303|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
138381304|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381305|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
138381307|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381308|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381309|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138381310|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381311|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138381313|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381314|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
138381315|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138381316|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138381317|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138381318|NCT03769025|Narcotics|narcotics|mesh-ancestor
138381319|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381320|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381321|NCT03769025|Analgesics|analgesics|mesh-ancestor
138381322|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
138381323|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381324|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138381325|NCT03762473|Tacrolimus|tacrolimus|mesh-list
138381326|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381327|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
138381328|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381329|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138381330|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381331|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381332|NCT03648021|Acetaminophen|acetaminophen|mesh-list
138381333|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138381334|NCT03648021|Analgesics|analgesics|mesh-ancestor
138381335|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
138381336|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381337|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381339|NCT03613792|Midazolam|midazolam|mesh-list
138381343|NCT03613792|Analgesics|analgesics|mesh-ancestor
138381344|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
138381345|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381346|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381347|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138381348|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138381349|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
138381350|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
138381351|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381352|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138381353|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138381354|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381355|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381356|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138381357|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138381358|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138381359|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138381360|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138381361|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
138381362|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
138381363|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138381364|NCT03613792|Narcotics|narcotics|mesh-ancestor
138381365|NCT03611881|Nicotine|nicotine|mesh-list
138381366|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138381367|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
138381368|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381369|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381370|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138381371|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138381372|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
138381374|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381375|NCT03575598|Nivolumab|nivolumab|mesh-list
138381376|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381377|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381378|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381379|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381380|NCT03440567|Rituximab|rituximab|mesh-list
138381381|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138381382|NCT03440567|Avelumab|avelumab|mesh-list
138381383|NCT03440567|Carboplatin|carboplatin|mesh-list
138381384|NCT03440567|Etoposide|etoposide|mesh-list
138381385|NCT03440567|Ifosfamide|ifosfamide|mesh-list
138381386|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
138381387|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
138381388|NCT03440567|Antibodies|antibodies|mesh-list
138381389|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
138381390|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138381391|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
138381395|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381396|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381397|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381398|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381399|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381400|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381402|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
138381403|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
138381404|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138381405|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
138381406|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381407|NCT03423667|Expectorants|expectorants|mesh-ancestor
138381408|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
138381409|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138381410|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
138362913|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138362914|NCT00550836|Gemcitabine|gemcitabine|mesh-list
138362915|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138362916|NCT00550836|Panitumumab|panitumumab|mesh-list
138362917|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362918|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
138362919|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362924|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
138381411|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381412|NCT03423667|Protective Agents|protective agents|mesh-ancestor
138381413|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381414|NCT03423667|Antidotes|antidotes|mesh-ancestor
138381415|NCT03419897|Tislelizumab|tislelizumab|mesh-list
138381416|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381417|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381418|NCT03377049|Acetazolamide|acetazolamide|mesh-list
138381419|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
138381420|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138381421|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381422|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381423|NCT03377049|Diuretics|diuretics|mesh-ancestor
138381425|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381426|NCT03355976|Nivolumab|nivolumab|mesh-list
138381427|NCT03355976|Ipilimumab|ipilimumab|mesh-list
138381428|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381429|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381430|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381431|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381432|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138381433|NCT03335488|Glycerol|glycerol|mesh-list
138381434|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138381435|NCT03335488|Protective Agents|protective agents|mesh-ancestor
138381436|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381437|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381438|NCT03323437|Risperidone|risperidone|mesh-list
138381439|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138381440|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
138381441|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381442|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381443|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381444|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138381445|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138381446|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381447|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138381448|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138381449|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
138381450|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
138381451|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138381452|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381453|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381454|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381458|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
138381459|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138381460|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381461|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381462|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
138381463|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381464|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381465|NCT03214510|Fentanyl|fentanyl|mesh-list
138381466|NCT03214510|Hydromorphone|hydromorphone|mesh-list
138381467|NCT03214510|Bupivacaine|bupivacaine|mesh-list
138381468|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
138381469|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
138381470|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381471|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381472|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
138381473|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381474|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138381475|NCT03214510|Narcotics|narcotics|mesh-ancestor
138381476|NCT03214510|Analgesics|analgesics|mesh-ancestor
138381477|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138381478|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138381479|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
138381480|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138381498|NCT02911701|Acetaminophen|acetaminophen|mesh-list
138381499|NCT02911701|Ibuprofen|ibuprofen|mesh-list
138381500|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138381501|NCT02911701|Analgesics|analgesics|mesh-ancestor
138381502|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
138381503|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381504|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381505|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
138381506|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138381507|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381508|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381509|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138381511|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381513|NCT02874742|Lenalidomide|lenalidomide|mesh-list
138381514|NCT02874742|Bortezomib|bortezomib|mesh-list
138381515|NCT02874742|Daratumumab|daratumumab|mesh-list
138381516|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381517|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
138381518|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
138381519|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381520|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381521|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138381522|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
138381523|NCT02874742|Hormones|hormones|mesh-ancestor
138381524|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381525|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138381526|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381527|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
138381528|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138381529|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138381530|NCT02874742|Growth Substances|growth substances|mesh-ancestor
138381531|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
138381532|NCT02749292|Rituximab|rituximab|mesh-list
138381533|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381534|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381535|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
138381536|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381539|NCT02715609|Temozolomide|temozolomide|mesh-list
138381540|NCT02715609|Disulfiram|disulfiram|mesh-list
138381541|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138381542|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
138381543|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381544|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381545|NCT02715609|Trace Elements|trace elements|mesh-ancestor
138381546|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
138381547|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381548|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138381549|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138381550|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381551|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
138381552|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138381553|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381554|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381555|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
138381556|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381557|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381559|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381560|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381561|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381562|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381563|NCT02511106|Osimertinib|osimertinib|mesh-list
138381564|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381565|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381566|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381567|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381568|NCT02494882|Dexamethasone|dexamethasone|mesh-list
138381569|NCT02494882|Dasatinib|dasatinib|mesh-list
138381570|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381573|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381574|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381575|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138381576|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
138381577|NCT02494882|Hormones|hormones|mesh-ancestor
138381578|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381579|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138381580|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381581|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381582|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381583|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381584|NCT02481830|Nivolumab|nivolumab|mesh-list
138381585|NCT02481830|Topotecan|topotecan|mesh-list
138381586|NCT02481830|Amrubicin|amrubicin|mesh-list
138381587|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381588|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381589|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381590|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381591|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138381592|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381593|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381594|NCT02425943|Mannitol|mannitol|mesh-list
138381595|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138381596|NCT02425943|Diuretics|diuretics|mesh-ancestor
138381597|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
138381598|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381599|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138381601|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381602|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
138381603|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381605|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381606|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381607|NCT02220426|Xenon|xenon|mesh-list
138381608|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138381609|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
138381610|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
138381611|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381612|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381613|NCT02123121|Resveratrol|resveratrol|mesh-list
138381614|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
138381615|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381616|NCT02123121|Protective Agents|protective agents|mesh-ancestor
138381617|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381618|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381619|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138381620|NCT02009579|Nintedanib|nintedanib|mesh-list
138381621|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381622|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381623|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381624|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381625|NCT01959698|Rituximab|rituximab|mesh-list
138381626|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138381627|NCT01959698|Carboplatin|carboplatin|mesh-list
138381628|NCT01959698|Etoposide|etoposide|mesh-list
138381629|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
138381630|NCT01959698|Ifosfamide|ifosfamide|mesh-list
138381631|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
138381632|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
138381633|NCT01959698|Antibodies|antibodies|mesh-list
138381634|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
138381635|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138381636|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
138381637|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381638|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381639|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381641|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381642|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381643|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381644|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381645|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138381646|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
138381647|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
138381648|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
138381649|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138381650|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138381651|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138381653|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138381654|NCT01910402|Tenofovir|tenofovir|mesh-list
138381655|NCT01910402|Lamivudine|lamivudine|mesh-list
138381656|NCT01910402|Emtricitabine|emtricitabine|mesh-list
138381657|NCT01910402|Dolutegravir|dolutegravir|mesh-list
138381658|NCT01910402|Abacavir|abacavir|mesh-list
138381659|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138381660|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138381661|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381662|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381663|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381664|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138381665|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138381666|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
138381667|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381668|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138381669|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138381670|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138381671|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138381672|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138381673|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138381674|NCT01772420|Lenalidomide|lenalidomide|mesh-list
138381675|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
138381676|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381677|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138381678|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138381679|NCT01772420|Growth Substances|growth substances|mesh-ancestor
138381680|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138381681|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381682|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138381683|NCT01728363|Rifampin|rifampin|mesh-list
138381684|NCT01728363|Clindamycin|clindamycin|mesh-list
138381685|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
138381686|NCT01728363|Ticarcillin|ticarcillin|mesh-list
138381687|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
138381688|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381689|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138381692|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138381693|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381694|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381695|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138381696|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138381697|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138381698|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138381699|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138381700|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138381701|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138381702|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138381704|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
138381705|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138381706|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138381707|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138381708|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
138381709|NCT01614197|Methotrexate|methotrexate|mesh-list
138381710|NCT01614197|Etoposide|etoposide|mesh-list
138381711|NCT01614197|Temsirolimus|temsirolimus|mesh-list
138381712|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381713|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
138381714|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381715|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381716|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138381717|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
138381718|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381719|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381720|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138381721|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138381722|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
138381723|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381724|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138381725|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
138381726|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
138381728|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138381729|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138381730|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381731|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381732|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381734|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362931|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381735|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381736|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138381737|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381739|NCT01422148|Amiodarone|amiodarone|mesh-list
138381740|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138381741|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381743|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
138381744|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138381745|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138381746|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381747|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138381748|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138381749|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138381750|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381751|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138381752|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138381753|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138381754|NCT01341964|Aspirin|aspirin|mesh-list
138381755|NCT01341964|Clopidogrel|clopidogrel|mesh-list
138381756|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138381757|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138381758|NCT01341964|Analgesics|analgesics|mesh-ancestor
138381759|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
138381760|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381761|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381762|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381763|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381764|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138381765|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138381766|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381767|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138381768|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138381769|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381770|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
138381771|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138381772|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138381773|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138381774|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
138381775|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381778|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381779|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381780|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
138381781|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381782|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381783|NCT01236521|Analgesics|analgesics|mesh-list
138381784|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
138381785|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381786|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381788|NCT01042379|Paclitaxel|paclitaxel|mesh-list
138381789|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138381790|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138381791|NCT01042379|Carboplatin|carboplatin|mesh-list
138381792|NCT01042379|Doxorubicin|doxorubicin|mesh-list
138381793|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
138381794|NCT01042379|Trastuzumab|trastuzumab|mesh-list
138381795|NCT01042379|Irinotecan|irinotecan|mesh-list
138381796|NCT01042379|Durvalumab|durvalumab|mesh-list
138381797|NCT01042379|Letrozole|letrozole|mesh-list
138381798|NCT01042379|Olaparib|olaparib|mesh-list
138381799|NCT01042379|Pertuzumab|pertuzumab|mesh-list
138381800|NCT01042379|Cemiplimab|cemiplimab|mesh-list
138381801|NCT01042379|Veliparib|veliparib|mesh-list
138381802|NCT01042379|Talazoparib|talazoparib|mesh-list
138381803|NCT01042379|Dostarlimab|dostarlimab|mesh-list
138381804|NCT01042379|Trebananib|trebananib|mesh-list
138381805|NCT01042379|Tucatinib|tucatinib|mesh-list
138381806|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138381807|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
138381808|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381809|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381810|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138381811|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138381812|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138381813|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381814|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381815|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381816|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138381817|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381818|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381819|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381820|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381821|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381822|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138381823|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
138381824|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138381825|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138381826|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138381827|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
138381828|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381829|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138381830|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
138381831|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
138381832|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138381833|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138381834|NCT01042379|Growth Substances|growth substances|mesh-ancestor
138381836|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381839|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
138381840|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
138381841|NCT00544115|Melphalan|melphalan|mesh-list
138381842|NCT00544115|Busulfan|busulfan|mesh-list
138381843|NCT00544115|Methotrexate|methotrexate|mesh-list
138381844|NCT00544115|Fludarabine|fludarabine|mesh-list
138381845|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
138381846|NCT00544115|Etoposide|etoposide|mesh-list
138381847|NCT00544115|Tacrolimus|tacrolimus|mesh-list
138381848|NCT00544115|Cyclosporins|cyclosporins|mesh-list
138381849|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138381850|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
138381852|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381853|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138381854|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
138381855|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381856|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381857|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138381858|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138381859|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
138381860|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381861|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138381862|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
138381863|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138381864|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381865|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138381866|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138381867|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381868|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381870|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138381871|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
138381872|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381873|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138381874|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138381875|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
138381876|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138381877|NCT01455350|Lidocaine|lidocaine|mesh-list
138381878|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
138381879|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
138381880|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381881|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381882|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
138381883|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381884|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138381885|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138381886|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138381889|NCT01455636|Micronutrients|micronutrients|mesh-list
138381890|NCT01455636|Trace Elements|trace elements|mesh-list
138381891|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
138381892|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381893|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138381894|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381896|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138381897|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138381898|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381899|NCT01456507|Naltrexone|naltrexone|mesh-list
138381900|NCT01456507|Oxycodone|oxycodone|mesh-list
138381901|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138381902|NCT01456507|Narcotics|narcotics|mesh-ancestor
138381903|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381904|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381905|NCT01456507|Analgesics|analgesics|mesh-ancestor
138381906|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
138381907|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381908|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138381909|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138381910|NCT01456585|Gemcitabine|gemcitabine|mesh-list
138381911|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138381912|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
138381913|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381914|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381915|NCT01456650|Glyburide|glyburide|mesh-list
138381916|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381917|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381918|NCT01457040|Etoposide|etoposide|mesh-list
138381919|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
138381920|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381921|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381922|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381923|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138381924|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381925|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381926|NCT01457508|Edetic Acid|edetic acid|mesh-list
138381927|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
138381929|NCT01457508|Protective Agents|protective agents|mesh-ancestor
138381930|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381931|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
138381932|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
138381933|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381934|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138381935|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
138381936|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138381937|NCT01458431|Anesthetics|anesthetics|mesh-list
138381938|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
138381939|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
138381940|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381941|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381942|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
138381943|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138381944|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
138381947|NCT01459445|Drospirenone|drospirenone|mesh-list
138381948|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138381949|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381950|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381951|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138381952|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138381953|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138381954|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
138381955|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138381956|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138381957|NCT01459445|Estrogens|estrogens|mesh-ancestor
138381959|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381963|NCT01459445|Diuretics|diuretics|mesh-ancestor
138381964|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
138381966|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138381967|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381968|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138381969|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
138381970|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381971|NCT01460069|Liraglutide|liraglutide|mesh-list
138381972|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138381973|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381974|NCT01460069|Incretins|incretins|mesh-ancestor
138381975|NCT01460069|Hormones|hormones|mesh-ancestor
138381976|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138381977|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138381978|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
138381979|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381980|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
138381981|NCT01460212|Citalopram|citalopram|mesh-list
138381982|NCT01460212|Fluoxetine|fluoxetine|mesh-list
138381983|NCT01460212|Paroxetine|paroxetine|mesh-list
138381984|NCT01460212|Sertraline|sertraline|mesh-list
138381985|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
138381986|NCT01460212|Escitalopram|escitalopram|mesh-list
138381989|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138381990|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381991|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381992|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
138381993|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381994|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138381995|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138381996|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138381997|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138381998|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382000|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138382001|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382002|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138382003|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138382004|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
138382005|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138382007|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138382008|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382009|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382011|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382012|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382013|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138382014|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382016|NCT01460420|Bortezomib|bortezomib|mesh-list
138382018|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382019|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138382020|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138382021|NCT01460420|Growth Substances|growth substances|mesh-ancestor
138382022|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138382023|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382024|NCT01460498|Azacitidine|azacitidine|mesh-list
138382025|NCT01460498|Decitabine|decitabine|mesh-list
138382026|NCT01460498|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138382027|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138382028|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
138382029|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382030|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382031|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382032|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382034|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382035|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138382036|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
138382037|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382038|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
138382039|NCT01460563|Analgesics|analgesics|mesh-ancestor
138382040|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
138382041|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382042|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382043|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
138382044|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382045|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138382046|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
138382047|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138382048|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382049|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382050|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382051|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
138382052|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138382053|NCT01460602|Rituximab|rituximab|mesh-list
138382054|NCT01460602|Bortezomib|bortezomib|mesh-list
138382055|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138382058|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382059|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138382060|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
138382061|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382062|NCT01460667|Acetaminophen|acetaminophen|mesh-list
138382063|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382064|NCT01460667|Analgesics|analgesics|mesh-ancestor
138382065|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
138382066|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382067|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382068|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
138382069|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
138382071|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382072|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382073|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382074|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382075|NCT01460706|Edotreotide|edotreotide|mesh-list
138382076|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138382077|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382078|NCT01460797|Metformin|metformin|mesh-list
138382079|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382080|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382081|NCT01460836|Tobramycin|tobramycin|mesh-list
138382083|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382084|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382085|NCT01460888|Olaparib|olaparib|mesh-list
138382086|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138382087|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382088|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382090|NCT01460979|Sirolimus|sirolimus|mesh-list
138382091|NCT01460979|Temsirolimus|temsirolimus|mesh-list
138382092|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
138382093|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382094|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382095|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382096|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382097|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
138382098|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382099|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382100|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382101|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382102|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382103|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
138382104|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
138382106|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
138382108|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138382109|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
138382110|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382111|NCT01461031|Nefopam|nefopam|mesh-list
138382112|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382113|NCT01461031|Analgesics|analgesics|mesh-ancestor
138382114|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
138382115|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382116|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382117|NCT01461174|Memantine|memantine|mesh-list
138382118|NCT01461174|Modafinil|modafinil|mesh-list
138382119|NCT01461174|Donepezil|donepezil|mesh-list
138382120|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138382121|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382122|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382124|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382125|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382126|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
138382127|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138382128|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138382129|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
138382130|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138382131|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138382132|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138382133|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138382134|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138382135|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138382136|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
138382137|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
138382138|NCT01461460|Tedizolid|tedizolid|mesh-list
138382139|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
138382140|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382141|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382142|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138382143|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382144|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382147|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138382148|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
138382149|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382150|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382151|NCT01461616|Insulin|insulin|mesh-list
138382152|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382153|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
138382155|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382156|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382157|NCT01461746|Docetaxel|docetaxel|mesh-list
138382158|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382159|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
138382160|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
138382161|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
138382162|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382163|NCT01461759|Cisplatin|cisplatin|mesh-list
138382164|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382165|NCT01461772|Carboplatin|carboplatin|mesh-list
138382166|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382167|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138382169|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382170|NCT01462006|Sirolimus|sirolimus|mesh-list
138382171|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382172|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382173|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382174|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382175|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
138382178|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382180|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
138382181|NCT01462058|Vitamins|vitamins|mesh-ancestor
138382183|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382185|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382186|NCT01462149|Carboplatin|carboplatin|mesh-list
138382187|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382189|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138382190|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382191|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382192|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382193|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382194|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
138382195|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382196|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382197|NCT01462422|Misoprostol|misoprostol|mesh-list
138382198|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138382199|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
138382200|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138382201|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382202|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138382205|NCT01462474|Cisplatin|cisplatin|mesh-list
138382206|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382207|NCT01462487|Zanamivir|zanamivir|mesh-list
138382208|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
138382209|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382211|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382213|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
138382214|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382215|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382216|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138382217|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138382218|NCT01462617|Nemiralisib|nemiralisib|mesh-list
138382219|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382220|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382221|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382223|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
138382224|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382225|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382226|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
138382227|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
138382228|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382229|NCT01462968|Heparin|heparin|mesh-list
138382230|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
138382231|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138382232|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138382234|NCT01463046|Cytarabine|cytarabine|mesh-list
138382235|NCT01463046|Daunorubicin|daunorubicin|mesh-list
138382236|NCT01463046|Panobinostat|panobinostat|mesh-list
138382237|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138382238|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
138382239|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382240|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382241|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
138382242|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382243|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382244|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
138382245|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382246|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382247|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138382248|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382249|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382250|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138382251|NCT01463150|Clopidogrel|clopidogrel|mesh-list
138382252|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138382253|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138382254|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138382255|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138382256|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138382257|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
138382258|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382259|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382260|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382262|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138382263|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138382264|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138382265|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138382266|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138382267|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
138382268|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382269|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382270|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382271|NCT01463215|Ambroxol|ambroxol|mesh-list
138382272|NCT01463215|Expectorants|expectorants|mesh-ancestor
138382273|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
138382274|NCT01463228|Metformin|metformin|mesh-list
138382275|NCT01463228|Canagliflozin|canagliflozin|mesh-list
138382276|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382277|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362953|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138362954|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362955|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362956|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
138362957|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138362958|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362959|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382278|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138382279|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382281|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
138382282|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
138382283|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382284|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382285|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
138382286|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382287|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138382288|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138382289|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138382290|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382291|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382293|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138382294|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382295|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382296|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382298|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
138382299|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382300|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138382301|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138382303|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
138382304|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382305|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382307|NCT01463592|Interferons|interferons|mesh-list
138382308|NCT01463592|Ribavirin|ribavirin|mesh-list
138382309|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
138382310|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
138382311|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
138382312|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382313|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
138382314|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382315|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
138382316|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382317|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
138382318|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382319|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138382320|NCT01463592|Trace Elements|trace elements|mesh-ancestor
138382321|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
138382322|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
138382323|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138382324|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382325|NCT01463735|Vitamin E|vitamin e|mesh-list
138382328|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382329|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
138382330|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382331|NCT01463735|Protective Agents|protective agents|mesh-ancestor
138382332|NCT01463774|Metformin|metformin|mesh-list
138382333|NCT01463774|Canagliflozin|canagliflozin|mesh-list
138382334|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382335|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382336|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138382337|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382338|NCT01463813|Vitamin D|vitamin d|mesh-list
138382339|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
138382340|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
138382341|NCT01463813|Vitamins|vitamins|mesh-list
138382342|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
138382343|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382344|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138382345|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382346|NCT01463852|Vincristine|vincristine|mesh-list
138382347|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138382348|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382349|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138382350|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138382351|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138382352|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382353|NCT01463865|Ropivacaine|ropivacaine|mesh-list
138382354|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
138382357|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382359|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382362|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382363|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
138382364|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382365|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
138382366|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382368|NCT01464008|Ribavirin|ribavirin|mesh-list
138382369|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
138382370|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
138382371|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138382372|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382373|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
138382374|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382375|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
138382376|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382377|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
138382378|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382379|NCT01464060|Amoxicillin|amoxicillin|mesh-list
138382380|NCT01464060|Metronidazole|metronidazole|mesh-list
138382382|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382383|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382384|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138382385|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138382386|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138382387|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382388|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382389|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138382390|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138382392|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382393|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
138382394|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
138382395|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138382396|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382397|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382398|NCT01464112|Dexamethasone|dexamethasone|mesh-list
138382399|NCT01464112|Bortezomib|bortezomib|mesh-list
138382400|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382401|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
138382402|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
138382403|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382404|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382405|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138382406|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
138382407|NCT01464112|Hormones|hormones|mesh-ancestor
138382408|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382409|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138382410|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382413|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382414|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382416|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
138382417|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
138382418|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
138382419|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382420|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382421|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138382422|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382423|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382424|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138382425|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
138382426|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138382427|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382428|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382429|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138362961|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138362962|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138362963|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
138362964|NCT00556374|Denosumab|denosumab|mesh-list
138362965|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138362966|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138382430|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138382431|NCT01464242|Protective Agents|protective agents|mesh-ancestor
138382432|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382433|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
138382434|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138382435|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
138382436|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138382437|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138382438|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382439|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138382440|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
138382441|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382442|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
138382443|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138382444|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
138382445|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138382446|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138382447|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382448|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382451|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138382452|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138382453|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382454|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382455|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382456|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382459|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138382460|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138382461|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
138382462|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382463|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382464|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138382465|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138382467|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
138382468|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138382471|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382472|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382473|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138382474|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138382475|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138382476|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
138382477|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382478|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138382479|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138382480|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382481|NCT01466712|Beclomethasone|beclomethasone|mesh-list
138382482|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
138382483|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
138382484|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138382486|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362968|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138362969|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362970|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362971|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138362972|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
138362973|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362975|NCT03029676|Fentanyl|fentanyl|mesh-list
138382487|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382488|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138382489|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
138382490|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138382492|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138382493|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
138382494|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382495|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382496|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
138382497|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138382498|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
138382499|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382500|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
138382501|NCT01466712|Hormones|hormones|mesh-ancestor
138382502|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382503|NCT01466829|Hormones|hormones|mesh-list
138382504|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
138382505|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382506|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382507|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382508|NCT01466855|Topotecan|topotecan|mesh-list
138382509|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138382512|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382513|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382514|NCT01466959|Acetic Acid|acetic acid|mesh-list
138382515|NCT01466959|Retinol acetate|retinol acetate|mesh-list
138382516|NCT01466959|Citric Acid|citric acid|mesh-list
138382517|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
138382518|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
138382519|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138382520|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
138382521|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
138382522|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382523|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138382524|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382525|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382526|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138382527|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
138382528|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382529|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138382530|NCT01466959|Protective Agents|protective agents|mesh-ancestor
138382531|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382532|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
138382533|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382534|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382535|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138382536|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
138382537|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382538|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382539|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382540|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382543|NCT01467115|Fluorouracil|fluorouracil|mesh-list
138382544|NCT01467115|Cetuximab|cetuximab|mesh-list
138382545|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
138382546|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
138382547|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382548|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
138382549|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
138382550|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
138382551|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382552|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
138382553|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138382554|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382555|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
138382556|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382557|NCT01467115|Antidotes|antidotes|mesh-ancestor
138382558|NCT01467115|Protective Agents|protective agents|mesh-ancestor
138382559|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
138382560|NCT01467115|Vitamins|vitamins|mesh-ancestor
138382561|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
138382562|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138382563|NCT01467115|Hematinics|hematinics|mesh-ancestor
138382564|NCT01467141|Insulin|insulin|mesh-list
138382565|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382566|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
138382567|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
138382571|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382572|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138382573|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138382574|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382575|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138382576|NCT01467258|Amantadine|amantadine|mesh-list
138382577|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138382578|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138382579|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
138382580|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382581|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
138382582|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382583|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382585|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382586|NCT01467258|Analgesics|analgesics|mesh-ancestor
138382588|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382589|NCT01467297|Levofloxacin|levofloxacin|mesh-list
138382590|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138382591|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382592|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382593|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138382594|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382595|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382596|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382597|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382598|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138382599|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138382600|NCT01467310|Trametinib|trametinib|mesh-list
138382601|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382602|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382603|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382604|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382605|NCT01467323|Insulin|insulin|mesh-list
138382606|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382607|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
138382608|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
138382609|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382610|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382611|NCT01467362|Desonide|desonide|mesh-list
138382612|NCT01467362|V0034CR|v0034cr|mesh-list
138382613|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382614|NCT01467362|Emollients|emollients|mesh-ancestor
138382615|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
138382616|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
138382617|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
138382622|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
138382623|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
138382624|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382625|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382626|NCT01467414|Insulin|insulin|mesh-list
138382627|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382628|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382629|NCT01467518|Dolutegravir|dolutegravir|mesh-list
138382630|NCT01467518|Methadone|methadone|mesh-list
138382640|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138382641|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138382642|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382643|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382645|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138382646|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
138382647|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382649|NCT01467531|Cabotegravir|cabotegravir|mesh-list
138382650|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138382651|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138382652|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382653|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382654|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138382655|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138382656|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
138382657|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382659|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
138382660|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
138382661|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
138382662|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382663|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382664|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
138382665|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382667|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138382668|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138382669|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382670|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382672|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382673|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382674|NCT01467687|Verapamil|verapamil|mesh-list
138382675|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138382676|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138382677|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382678|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382679|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382680|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382681|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
138382682|NCT01467804|Sertraline|sertraline|mesh-list
138382683|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
138382684|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138382685|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138382686|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138382687|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382688|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382689|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382690|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
138382691|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382693|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382694|NCT01467986|Sirolimus|sirolimus|mesh-list
138382695|NCT01467986|Irinotecan|irinotecan|mesh-list
138382699|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382700|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382701|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382702|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382703|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138382704|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
138382705|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382706|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382707|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382708|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
138382709|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382710|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
138382711|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382712|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382713|NCT01468025|Naproxen|naproxen|mesh-list
138382714|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138382715|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382716|NCT01468025|Analgesics|analgesics|mesh-ancestor
138382717|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
138382718|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382719|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382720|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382721|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138382722|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
138382723|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138382724|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382725|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382726|NCT01468038|Trazodone|trazodone|mesh-list
138382727|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138382730|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382731|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138382732|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138382733|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138382734|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382737|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
138382738|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138382739|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
138382740|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138382741|NCT01468051|Vaccines|vaccines|mesh-list
138382742|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
138382743|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382744|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138382745|NCT01468051|Antacids|antacids|mesh-ancestor
138382746|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382747|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138382748|NCT01468155|Dabigatran|dabigatran|mesh-list
138382749|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
138382750|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138382751|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
138382752|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382753|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382754|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
138382755|NCT01468259|Droxidopa|droxidopa|mesh-list
138382756|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138382757|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138382758|NCT01468272|Beclomethasone|beclomethasone|mesh-list
138382759|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
138382760|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138382761|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
138382762|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382763|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382764|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138382765|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
138382766|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138382767|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138382768|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138382769|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
138382770|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382771|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382772|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382773|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
138382774|NCT01468272|Hormones|hormones|mesh-ancestor
138414727|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382776|NCT01468285|Betahistine|betahistine|mesh-list
138382777|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
138382778|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
138382779|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
138382780|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382781|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382782|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382783|NCT01468389|Capecitabine|capecitabine|mesh-list
138382784|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138382785|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
138382786|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382787|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382789|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138382790|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382791|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
138382793|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138382794|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138382796|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
138382797|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138382798|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
138382799|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138382800|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382801|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138382802|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138382803|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382804|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138382805|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
138382806|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
138382807|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382808|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
138382810|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382811|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382812|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138382813|NCT01468519|Insulin|insulin|mesh-list
138382814|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382815|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382816|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382818|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138382819|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
138382820|NCT01468571|Spironolactone|spironolactone|mesh-list
138382821|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138382823|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382827|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
138382828|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138382829|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138382830|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138382832|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382833|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382834|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382835|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
138382838|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382839|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138382840|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382841|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382842|NCT01468714|Ketoconazole|ketoconazole|mesh-list
138382843|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
138382844|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382845|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138382846|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138382847|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382848|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382849|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138382850|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138382851|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382852|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382853|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138382854|NCT01468740|Prednisone|prednisone|mesh-list
138382855|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
138382856|NCT01468740|Dacarbazine|dacarbazine|mesh-list
138382857|NCT01468740|Doxorubicin|doxorubicin|mesh-list
138382858|NCT01468740|Etoposide|etoposide|mesh-list
138382859|NCT01468740|Vincristine|vincristine|mesh-list
138382862|NCT01468740|Procarbazine|procarbazine|mesh-list
138382863|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382864|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
138382865|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382866|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138382867|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138382868|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
138382869|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382870|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382871|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138382872|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382873|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138382874|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382875|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382876|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382877|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
138382878|NCT01468740|Hormones|hormones|mesh-ancestor
138382879|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382881|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138382882|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138382883|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138382884|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138382886|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138382887|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
138382888|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
138382889|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138382891|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382893|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138382895|NCT06078449|Hyaluronic Acid|hyaluronic acid|mesh-list
138382896|NCT06078449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138382897|NCT06078449|Immunologic Factors|immunologic factors|mesh-ancestor
138382898|NCT06078449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382899|NCT06078449|Viscosupplements|viscosupplements|mesh-ancestor
138382900|NCT06078449|Protective Agents|protective agents|mesh-ancestor
138382901|NCT06078423|Vaccines|vaccines|mesh-list
138382902|NCT06078423|Immunologic Factors|immunologic factors|mesh-ancestor
138382903|NCT06078423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382904|NCT06078371|Analgesics, Opioid|analgesics, opioid|mesh-list
138382905|NCT06078371|Narcotics|narcotics|mesh-ancestor
138382906|NCT06078371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382907|NCT06078371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382908|NCT06078371|Analgesics|analgesics|mesh-ancestor
138382909|NCT06078371|Sensory System Agents|sensory system agents|mesh-ancestor
138382910|NCT06078371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382911|NCT06077708|Vitamin D|vitamin d|mesh-list
138382912|NCT06077708|Cholecalciferol|cholecalciferol|mesh-list
138382913|NCT06077708|Vitamins|vitamins|mesh-ancestor
138382914|NCT06077708|Micronutrients|micronutrients|mesh-ancestor
138382915|NCT06077708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382916|NCT06077708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138382917|NCT06077708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138382918|NCT06077682|Tropicamide|tropicamide|mesh-list
138382919|NCT06077682|Cyclopentolate|cyclopentolate|mesh-list
138382920|NCT06077682|Mydriatics|mydriatics|mesh-ancestor
138382921|NCT06077682|Autonomic Agents|autonomic agents|mesh-ancestor
138382922|NCT06077682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382923|NCT06077682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382924|NCT06077682|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138382925|NCT06077682|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138382926|NCT06077682|Cholinergic Agents|cholinergic agents|mesh-ancestor
138382927|NCT06077682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382928|NCT06077682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382929|NCT06077682|Parasympatholytics|parasympatholytics|mesh-ancestor
138382930|NCT06077539|Dexmedetomidine|dexmedetomidine|mesh-list
138382931|NCT06077539|Ketamine|ketamine|mesh-list
138382932|NCT06077539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138382933|NCT06077539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382935|NCT06077539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382936|NCT06077539|Analgesics|analgesics|mesh-ancestor
138382937|NCT06077539|Sensory System Agents|sensory system agents|mesh-ancestor
138382938|NCT06077539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382939|NCT06077539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138382940|NCT06077539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138382942|NCT06077539|Adrenergic Agents|adrenergic agents|mesh-ancestor
138382944|NCT06077539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382945|NCT06077539|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138382946|NCT06077539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138382947|NCT06077539|Anesthetics, General|anesthetics, general|mesh-ancestor
138382948|NCT06077539|Anesthetics|anesthetics|mesh-ancestor
138382949|NCT06077539|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138382950|NCT06077539|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138382952|NCT06077292|Hallucinogens|hallucinogens|mesh-ancestor
138382953|NCT06077292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382954|NCT06077292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138382955|NCT06077292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382957|NCT06077292|Sensory System Agents|sensory system agents|mesh-ancestor
138382958|NCT06077292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382959|NCT06077292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138382960|NCT06077292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138382961|NCT06077292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382962|NCT06077292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382963|NCT06077292|Hormones|hormones|mesh-ancestor
138382964|NCT06077292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382965|NCT06077058|Nicotine|nicotine|mesh-list
138382966|NCT06077058|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138382967|NCT06077058|Autonomic Agents|autonomic agents|mesh-ancestor
138382968|NCT06077058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382969|NCT06077058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382972|NCT06077058|Cholinergic Agents|cholinergic agents|mesh-ancestor
138382973|NCT06077058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382974|NCT06077058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382975|NCT06077019|Fluticasone|fluticasone|mesh-list
138382976|NCT06077019|Xhance|xhance|mesh-list
138362976|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
138362977|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362978|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362979|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138362980|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138382977|NCT06077019|Mometasone Furoate|mometasone furoate|mesh-list
138382978|NCT06077019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382979|NCT06077019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138382980|NCT06077019|Autonomic Agents|autonomic agents|mesh-ancestor
138382981|NCT06077019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382982|NCT06077019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382983|NCT06077019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138382984|NCT06077019|Respiratory System Agents|respiratory system agents|mesh-ancestor
138382985|NCT06077019|Dermatologic Agents|dermatologic agents|mesh-ancestor
138382986|NCT06077019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138382987|NCT06076837|Chloroquine|chloroquine|mesh-list
138382989|NCT06076837|Celecoxib|celecoxib|mesh-list
138382990|NCT06076837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138382991|NCT06076837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138382993|NCT06076837|Sensory System Agents|sensory system agents|mesh-ancestor
138382994|NCT06076837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382995|NCT06076837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382996|NCT06076837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138382997|NCT06076837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138382998|NCT06076837|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138382999|NCT06076837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138383000|NCT06076837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383001|NCT06076837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383003|NCT06076837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138383004|NCT06076837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138383005|NCT06076837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383006|NCT06076837|Antimalarials|antimalarials|mesh-ancestor
138383007|NCT06076837|Filaricides|filaricides|mesh-ancestor
138383008|NCT06076837|Antinematodal Agents|antinematodal agents|mesh-ancestor
138383009|NCT06076837|Anthelmintics|anthelmintics|mesh-ancestor
138383010|NCT06076824|Methylprednisolone|methylprednisolone|mesh-list
138383011|NCT06076824|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138383012|NCT06076824|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138383013|NCT06076824|Prednisolone|prednisolone|mesh-list
138383014|NCT06076824|Prednisolone acetate|prednisolone acetate|mesh-list
138383015|NCT06076824|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138383016|NCT06076824|Prednisolone phosphate|prednisolone phosphate|mesh-list
138383017|NCT06076824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383018|NCT06076824|Antiemetics|antiemetics|mesh-ancestor
138383019|NCT06076824|Autonomic Agents|autonomic agents|mesh-ancestor
138383020|NCT06076824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383021|NCT06076824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383022|NCT06076824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383023|NCT06076824|Glucocorticoids|glucocorticoids|mesh-ancestor
138383024|NCT06076824|Hormones|hormones|mesh-ancestor
138383025|NCT06076824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383026|NCT06076824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138383027|NCT06076824|Protective Agents|protective agents|mesh-ancestor
138383028|NCT06076824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138383029|NCT06076824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383031|NCT06076772|Palbociclib|palbociclib|mesh-list
138383032|NCT06076772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383033|NCT06076772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138383034|NCT06076772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383035|NCT06076772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383036|NCT06076772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138383037|NCT06076772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383038|NCT06076759|Dexmedetomidine|dexmedetomidine|mesh-list
138383040|NCT06076759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383041|NCT06076759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383043|NCT06076759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383045|NCT06076759|Sensory System Agents|sensory system agents|mesh-ancestor
138383047|NCT06076759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138383048|NCT06076759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383050|NCT06076759|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383051|NCT06076759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383052|NCT06076759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383053|NCT06076759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138383054|NCT06076759|Narcotics|narcotics|mesh-ancestor
138383055|NCT06076746|Psychotropic Drugs|psychotropic drugs|mesh-list
138383056|NCT06076642|Immunoglobulins|immunoglobulins|mesh-list
138383057|NCT06076642|gamma-Globulins|gamma-globulins|mesh-list
138383058|NCT06076642|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138383059|NCT06076642|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138383060|NCT06076642|Immunologic Factors|immunologic factors|mesh-ancestor
138383061|NCT06076642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383062|NCT06076603|Polymyxins|polymyxins|mesh-list
138383063|NCT06076603|Polymyxin B|polymyxin b|mesh-list
138383064|NCT06076603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383065|NCT06076603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383066|NCT06074380|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138383067|NCT06074380|Respiratory System Agents|respiratory system agents|mesh-ancestor
138383068|NCT06074367|Vitamins|vitamins|mesh-list
138383069|NCT06074367|Ascorbic Acid|ascorbic acid|mesh-list
138383070|NCT06074367|Micronutrients|micronutrients|mesh-ancestor
138383071|NCT06074367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383072|NCT06074367|Antioxidants|antioxidants|mesh-ancestor
138383073|NCT06074367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383074|NCT06074367|Protective Agents|protective agents|mesh-ancestor
138383075|NCT06074185|Dexamethasone|dexamethasone|mesh-list
138383076|NCT06074185|Bromides|bromides|mesh-list
138383077|NCT06074185|Ipratropium|ipratropium|mesh-list
138383078|NCT06074185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383079|NCT06074185|Antiemetics|antiemetics|mesh-ancestor
138383080|NCT06074185|Autonomic Agents|autonomic agents|mesh-ancestor
138383082|NCT06074185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383083|NCT06074185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383084|NCT06074185|Glucocorticoids|glucocorticoids|mesh-ancestor
138383086|NCT06074185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383087|NCT06074185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138383088|NCT06074185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383089|NCT06074185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383090|NCT06074185|Anticonvulsants|anticonvulsants|mesh-ancestor
138383091|NCT06074185|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138383092|NCT06074185|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138383093|NCT06074185|Respiratory System Agents|respiratory system agents|mesh-ancestor
138383094|NCT06074185|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138383095|NCT06074185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383096|NCT06074185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383097|NCT06074172|Cannabidiol|cannabidiol|mesh-list
138383098|NCT06074172|Anticonvulsants|anticonvulsants|mesh-ancestor
138383099|NCT06074029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138383100|NCT06074029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383101|NCT06074029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383102|NCT06074029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383103|NCT06073873|Ozanimod|ozanimod|mesh-list
138383104|NCT06073873|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138383105|NCT06073873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383106|NCT06073873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362981|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138362982|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138362983|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138362984|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138362985|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
138362986|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
138362987|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
138362988|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383107|NCT06073873|Immunologic Factors|immunologic factors|mesh-ancestor
138383108|NCT06073873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383109|NCT06073860|Luspatercept|luspatercept|mesh-list
138383110|NCT06073860|Hematinics|hematinics|mesh-ancestor
138383111|NCT06073769|Azacitidine|azacitidine|mesh-list
138383112|NCT06073769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383113|NCT06073769|Antimetabolites|antimetabolites|mesh-ancestor
138383114|NCT06073769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383115|NCT06073769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383116|NCT06073769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383117|NCT06073730|Azacitidine|azacitidine|mesh-list
138383118|NCT06073730|Decitabine|decitabine|mesh-list
138383119|NCT06073730|Sorafenib|sorafenib|mesh-list
138383120|NCT06073730|Venetoclax|venetoclax|mesh-list
138383121|NCT06073730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383122|NCT06073730|Antimetabolites|antimetabolites|mesh-ancestor
138383123|NCT06073730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383124|NCT06073730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383125|NCT06073730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383126|NCT06073730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138383127|NCT06073015|Esketamine|esketamine|mesh-list
138383129|NCT06073015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138383131|NCT06072963|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138383132|NCT06072963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383133|NCT06072963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383135|NCT06072898|Psilocybin|psilocybin|mesh-list
138383136|NCT06072898|Vitamins|vitamins|mesh-ancestor
138383137|NCT06072898|Micronutrients|micronutrients|mesh-ancestor
138383138|NCT06072898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383139|NCT06072898|Vitamin B Complex|vitamin b complex|mesh-ancestor
138383140|NCT06072898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138383141|NCT06072898|Antimetabolites|antimetabolites|mesh-ancestor
138383142|NCT06072898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383143|NCT06072898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138383144|NCT06072898|Vasodilator Agents|vasodilator agents|mesh-ancestor
138383148|NCT06072729|Analgesics|analgesics|mesh-ancestor
138383149|NCT06072729|Sensory System Agents|sensory system agents|mesh-ancestor
138383150|NCT06072729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383151|NCT06072729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383152|NCT06072729|Anesthetics|anesthetics|mesh-ancestor
138383153|NCT06072729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383154|NCT06072729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138362989|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362990|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138383155|NCT06072729|Anticonvulsants|anticonvulsants|mesh-ancestor
138383156|NCT06072729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138362991|NCT03029676|Narcotics|narcotics|mesh-ancestor
138362993|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
138362994|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362995|NCT04270344|Valsartan|valsartan|mesh-list
138362996|NCT04270344|Pitavastatin|pitavastatin|mesh-list
138362997|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362998|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138362999|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138363000|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363001|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138363002|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138363003|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138363004|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
138383157|NCT06072729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383158|NCT06072729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383159|NCT06072729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138383160|NCT06072729|Tocolytic Agents|tocolytic agents|mesh-ancestor
138383161|NCT06072729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138383162|NCT06072716|Chitosan|chitosan|mesh-list
138383171|NCT06072716|Coagulants|coagulants|mesh-ancestor
138383172|NCT06072547|Nicotine|nicotine|mesh-list
138383173|NCT06072547|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138383174|NCT06072547|Autonomic Agents|autonomic agents|mesh-ancestor
138383175|NCT06072547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383176|NCT06072547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383177|NCT06072547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138383178|NCT06072547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138383179|NCT06072547|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383180|NCT06072547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383181|NCT06072547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383188|NCT06072352|Chlorhexidine|chlorhexidine|mesh-list
138383189|NCT06072352|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138383191|NCT06072352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383192|NCT06072352|Disinfectants|disinfectants|mesh-ancestor
138383193|NCT06072352|Dermatologic Agents|dermatologic agents|mesh-ancestor
138383195|NCT06072248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383196|NCT06072248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383197|NCT06072222|Meropenem|meropenem|mesh-list
138383198|NCT06072222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383199|NCT06072222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383200|NCT06072118|Adrenomedullin|adrenomedullin|mesh-list
138383202|NCT06072118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138383203|NCT06072118|Autonomic Agents|autonomic agents|mesh-ancestor
138383204|NCT06072118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383205|NCT06072118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383206|NCT06072118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138383207|NCT06072118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138383209|NCT06072118|Vasodilator Agents|vasodilator agents|mesh-ancestor
138383210|NCT06072118|Protective Agents|protective agents|mesh-ancestor
138383211|NCT06071897|Antibodies|antibodies|mesh-list
138383212|NCT06071897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138383213|NCT06071897|Immunologic Factors|immunologic factors|mesh-ancestor
138383214|NCT06071897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383215|NCT06071871|Obinutuzumab|obinutuzumab|mesh-list
138383216|NCT06071871|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138383220|NCT06071871|Immunologic Factors|immunologic factors|mesh-ancestor
138383221|NCT06071871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383223|NCT06071806|Antimetabolites|antimetabolites|mesh-ancestor
138383224|NCT06071806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383225|NCT06071806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383226|NCT06071806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383227|NCT06071806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383228|NCT06071806|Immunologic Factors|immunologic factors|mesh-ancestor
138383229|NCT06071806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383230|NCT06071208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138383231|NCT06071208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383232|NCT06071208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383233|NCT06071208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383234|NCT06067698|Thioctic Acid|thioctic acid|mesh-list
138383235|NCT06067698|Mesalamine|mesalamine|mesh-list
138383236|NCT06067698|Antioxidants|antioxidants|mesh-ancestor
138383237|NCT06067698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383238|NCT06067698|Protective Agents|protective agents|mesh-ancestor
138383239|NCT06067698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383240|NCT06067698|Vitamin B Complex|vitamin b complex|mesh-ancestor
138383241|NCT06067698|Vitamins|vitamins|mesh-ancestor
138383242|NCT06067698|Micronutrients|micronutrients|mesh-ancestor
138383243|NCT06067698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138383244|NCT06067698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383245|NCT06067698|Analgesics|analgesics|mesh-ancestor
138383246|NCT06067698|Sensory System Agents|sensory system agents|mesh-ancestor
138383247|NCT06067698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383248|NCT06067698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383249|NCT06067698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383250|NCT06066827|Minoxidil|minoxidil|mesh-list
138383251|NCT06066827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138383252|NCT06066827|Vasodilator Agents|vasodilator agents|mesh-ancestor
138383253|NCT06064864|Infliximab|infliximab|mesh-list
138383254|NCT06064864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138383255|NCT06064864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383256|NCT06064864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138383257|NCT06064864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383258|NCT06064864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383259|NCT06060704|Trifluridine|trifluridine|mesh-list
138383260|NCT06060704|Bevacizumab|bevacizumab|mesh-list
138383261|NCT06060704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383263|NCT06060704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138383264|NCT06060704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383265|NCT06060704|Growth Substances|growth substances|mesh-ancestor
138383266|NCT06060704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383267|NCT06060704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383268|NCT06060704|Antimetabolites|antimetabolites|mesh-ancestor
138383269|NCT06060704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383270|NCT06060704|Antiviral Agents|antiviral agents|mesh-ancestor
138383271|NCT06060704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383272|NCT06058884|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138383273|NCT06058884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138383274|NCT06058884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138383275|NCT06058884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383276|NCT06048588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138383277|NCT06048588|Calcium|calcium|mesh-list
138383278|NCT06048588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138383279|NCT06048588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383281|NCT06048588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138383283|NCT06048588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383284|NCT06048588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138383285|NCT06048588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138383286|NCT06048588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383287|NCT06021600|Cladribine|cladribine|mesh-list
138383288|NCT06021600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383289|NCT06021600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383290|NCT06021600|Immunologic Factors|immunologic factors|mesh-ancestor
138383291|NCT06021600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383292|NCT06020781|Dexmedetomidine|dexmedetomidine|mesh-list
138383293|NCT06020781|Bupivacaine|bupivacaine|mesh-list
138383294|NCT06020781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138383295|NCT06020781|Anesthetics|anesthetics|mesh-ancestor
138383296|NCT06020781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383297|NCT06020781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383298|NCT06020781|Sensory System Agents|sensory system agents|mesh-ancestor
138383299|NCT06020781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383300|NCT06020781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383301|NCT06020781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383303|NCT06020781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138383304|NCT06020781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383305|NCT06020781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138383306|NCT06020781|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383307|NCT06020781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383308|NCT06020781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383310|NCT06017583|Oxaliplatin|oxaliplatin|mesh-list
138383311|NCT06017583|Tislelizumab|tislelizumab|mesh-list
138383312|NCT06017583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383313|NCT06017583|Antimetabolites|antimetabolites|mesh-ancestor
138383314|NCT06017583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383315|NCT06017583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383316|NCT06017583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383318|NCT05999955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383319|NCT05999955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383320|NCT05999955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138383321|NCT05999955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383322|NCT05999955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383326|NCT05998317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383327|NCT05998317|Antiemetics|antiemetics|mesh-ancestor
138383328|NCT05998317|Autonomic Agents|autonomic agents|mesh-ancestor
138383329|NCT05998317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383330|NCT05998317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383331|NCT05998317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383332|NCT05998317|Glucocorticoids|glucocorticoids|mesh-ancestor
138383333|NCT05998317|Hormones|hormones|mesh-ancestor
138363005|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383334|NCT05998317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383335|NCT05998317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138383336|NCT05998317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383337|NCT05998317|Protease Inhibitors|protease inhibitors|mesh-ancestor
138383338|NCT05998317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383339|NCT05998317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383340|NCT05978713|Tirzepatide|tirzepatide|mesh-list
138383341|NCT05978713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383342|NCT05978713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383343|NCT05978713|Incretins|incretins|mesh-ancestor
138383344|NCT05978713|Hormones|hormones|mesh-ancestor
138383345|NCT05978713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383346|NCT05974852|Ocrelizumab|ocrelizumab|mesh-list
138383348|NCT05974852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383349|NCT05974839|Ocrelizumab|ocrelizumab|mesh-list
138383350|NCT05974839|Immunologic Factors|immunologic factors|mesh-ancestor
138383351|NCT05974839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383354|NCT05965895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383355|NCT05965895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383356|NCT05965895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383358|NCT05965895|Sensory System Agents|sensory system agents|mesh-ancestor
138383359|NCT05965895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383360|NCT05965895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138383361|NCT05965895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383362|NCT05965895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138383363|NCT05965895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383364|NCT05965895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383365|NCT05965895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383370|NCT05939674|Antidotes|antidotes|mesh-ancestor
138383371|NCT05939674|Protective Agents|protective agents|mesh-ancestor
138383372|NCT05939674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383373|NCT05939674|GABA Modulators|gaba modulators|mesh-ancestor
138383374|NCT05939674|GABA Agents|gaba agents|mesh-ancestor
138383375|NCT05939674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383376|NCT05939674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383377|NCT05935306|Ibuprofen|ibuprofen|mesh-list
138383378|NCT05935306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138383380|NCT05935306|Analgesics|analgesics|mesh-ancestor
138383381|NCT05935306|Sensory System Agents|sensory system agents|mesh-ancestor
138383382|NCT05935306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383383|NCT05935306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383384|NCT05935306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383385|NCT05935306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383386|NCT05935306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138383387|NCT05935306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383388|NCT05935306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383389|NCT05900466|Metformin|metformin|mesh-list
138383390|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383391|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383392|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138383393|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138363009|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
138363010|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383394|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
138383397|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383398|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383399|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138383400|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383401|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
138383402|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383403|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
138383404|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383405|NCT05847244|Metformin|metformin|mesh-list
138383406|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383407|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383408|NCT05801913|Vaccines|vaccines|mesh-list
138383409|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
138383410|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383412|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138383413|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
138383414|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383415|NCT05798481|Expectorants|expectorants|mesh-ancestor
138383416|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
138383417|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138383418|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
138383419|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383420|NCT05798481|Protective Agents|protective agents|mesh-ancestor
138383421|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383422|NCT05798481|Antidotes|antidotes|mesh-ancestor
138383425|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383426|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
138383427|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
138383428|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383429|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383430|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383431|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
138383433|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383434|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138383435|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383438|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383439|NCT05789303|Growth Substances|growth substances|mesh-ancestor
138383440|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383442|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138383443|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138383444|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138383445|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
138383446|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383447|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138383450|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
138383451|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138383452|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
138383453|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
138383454|NCT05784311|Metronidazole|metronidazole|mesh-list
138383455|NCT05784311|Cefuroxime|cefuroxime|mesh-list
138383456|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
138383457|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383458|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383459|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138383460|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138383461|NCT05777824|Antibodies|antibodies|mesh-list
138383462|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
138383463|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383464|NCT05775159|Bevacizumab|bevacizumab|mesh-list
138383465|NCT05775159|Gemcitabine|gemcitabine|mesh-list
138383466|NCT05775159|Lenvatinib|lenvatinib|mesh-list
138383467|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383468|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383469|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138383470|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383471|NCT05775159|Growth Substances|growth substances|mesh-ancestor
138383472|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383474|NCT05775159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383475|NCT05775159|Antimetabolites|antimetabolites|mesh-ancestor
138383476|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383477|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138383478|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383479|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138383480|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
138383481|NCT05767086|Cetrorelix|cetrorelix|mesh-list
138383482|NCT05767086|Hormones|hormones|mesh-list
138383483|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
138383484|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
138383485|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383486|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383487|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138383488|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138383489|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138383490|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
138383491|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138383492|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138383493|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138383494|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138383495|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138383496|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383498|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138383499|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
138383500|NCT05750745|Fluorides|fluorides|mesh-list
138383501|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
138383502|NCT05750745|Protective Agents|protective agents|mesh-ancestor
138383503|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383505|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138383506|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
138383507|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383508|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383509|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138383510|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138383511|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383512|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383513|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383514|NCT05746273|Nicotine|nicotine|mesh-list
138383515|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138383516|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
138383517|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383518|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383519|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138383520|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138383521|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383522|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383523|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383524|NCT05742295|Vitamin K|vitamin k|mesh-list
138383525|NCT05742295|Vitamins|vitamins|mesh-ancestor
138383526|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
138383527|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383528|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138383529|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138383530|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383531|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
138383532|NCT05742295|Coagulants|coagulants|mesh-ancestor
138383536|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383538|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
138383539|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383540|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383541|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138383542|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383543|NCT05728372|Trace Elements|trace elements|mesh-ancestor
138383544|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
138383545|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383546|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
138383547|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383549|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383550|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383551|NCT05700045|Analgesics|analgesics|mesh-ancestor
138383552|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
138383553|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383554|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138383555|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383556|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138383557|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383558|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383559|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383560|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138383561|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138383562|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383563|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
138383564|NCT05684692|Siltuximab|siltuximab|mesh-list
138383565|NCT05684692|Erenumab|erenumab|mesh-list
138383566|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138383568|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383570|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
138383571|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383572|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383573|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
138383574|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383575|NCT05678257|Leucovorin|leucovorin|mesh-list
138383576|NCT05678257|Bevacizumab|bevacizumab|mesh-list
138383577|NCT05678257|Fluorouracil|fluorouracil|mesh-list
138383578|NCT05678257|Irinotecan|irinotecan|mesh-list
138383579|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
138383580|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383581|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383582|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138383583|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383584|NCT05678257|Growth Substances|growth substances|mesh-ancestor
138383585|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383586|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383587|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
138383588|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383590|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383591|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
138383592|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138383593|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383594|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383595|NCT05678257|Antidotes|antidotes|mesh-ancestor
138383596|NCT05678257|Protective Agents|protective agents|mesh-ancestor
138383597|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
138383598|NCT05678257|Vitamins|vitamins|mesh-ancestor
138383599|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
138383600|NCT05658146|Sulconazole|sulconazole|mesh-list
138383601|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
138383602|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383603|NCT05656248|Cytarabine|cytarabine|mesh-list
138383604|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
138383605|NCT05656248|Methotrexate|methotrexate|mesh-list
138383606|NCT05656248|Daunorubicin|daunorubicin|mesh-list
138383607|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138383608|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
138383609|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138383610|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383611|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383612|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
138383613|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383614|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383615|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138383616|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383617|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138383618|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383619|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
138383620|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383622|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
138383623|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383624|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383625|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138383626|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138383627|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383629|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138383630|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363031|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363032|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383631|NCT05641649|Valproic Acid|valproic acid|mesh-list
138383632|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
138383633|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363033|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138363034|NCT03834012|Beclomethasone|beclomethasone|mesh-list
138363037|NCT03834012|Hormones|hormones|mesh-ancestor
138383634|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383636|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383637|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383638|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
138383639|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138383640|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383641|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138383642|NCT05639972|Aldesleukin|aldesleukin|mesh-list
138383643|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383644|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138383645|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138383646|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
138383647|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383648|NCT05632211|Golimumab|golimumab|mesh-list
138383649|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138383650|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383651|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383652|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
138383653|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383654|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138383655|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138383656|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138383657|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383658|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383659|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138383660|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383661|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383662|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383663|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383665|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
138383666|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383667|NCT05570422|Cisplatin|cisplatin|mesh-list
138383668|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383669|NCT05569148|Faricimab|faricimab|mesh-list
138383670|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138383671|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383672|NCT05569148|Growth Substances|growth substances|mesh-ancestor
138383673|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383674|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383675|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383677|NCT05558124|Daunorubicin|daunorubicin|mesh-list
138383678|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
138383679|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383681|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383682|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383684|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383685|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383686|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
138383687|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383688|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138383689|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138383690|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383691|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383692|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383693|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
138383694|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
138383695|NCT05487196|Clonidine|clonidine|mesh-list
138383698|NCT05487196|Ropivacaine|ropivacaine|mesh-list
138383699|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383700|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383701|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383702|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383703|NCT05487196|Analgesics|analgesics|mesh-ancestor
138383704|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
138383705|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383706|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138383707|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383708|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138383709|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383710|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215606|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138383711|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383712|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
138383715|NCT05487196|Narcotics|narcotics|mesh-ancestor
138383716|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138383717|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138383718|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
138383719|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138383720|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
138383721|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
138383722|NCT05471700|Azacitidine|azacitidine|mesh-list
138383724|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383725|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
138383726|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383727|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383728|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383729|NCT05469178|Carboplatin|carboplatin|mesh-list
138383730|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
138383732|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383733|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383734|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138383735|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383736|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383737|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138383738|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138383739|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138383740|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
138383741|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383742|NCT05447286|Oxycodone|oxycodone|mesh-list
138383743|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138383744|NCT05447286|Narcotics|narcotics|mesh-ancestor
138383745|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383748|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
138383749|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383750|NCT05431595|Valproic Acid|valproic acid|mesh-list
138383751|NCT05431595|Haloperidol|haloperidol|mesh-list
138383752|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
138383753|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
138383754|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
138383755|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
138383756|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383757|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383758|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383759|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138383760|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138383765|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383766|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383770|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
138383771|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
138383772|NCT05412914|Propofol|propofol|mesh-list
138383773|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383774|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383775|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383776|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138383777|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
138383778|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
138383779|NCT05406856|Cisplatin|cisplatin|mesh-list
138383780|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383781|NCT05307198|Capecitabine|capecitabine|mesh-list
138383782|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
138383783|NCT05307198|Antibodies|antibodies|mesh-list
138383784|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138383785|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
138383786|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383787|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383788|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
138383789|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383790|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383791|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138383792|NCT05293938|Cathartics|cathartics|mesh-ancestor
138383793|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383794|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
138383795|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
138383796|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383797|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383798|NCT05287100|Midodrine|midodrine|mesh-list
138383799|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
138383800|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
138383802|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383803|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138383804|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138383805|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138383806|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138383807|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
138383808|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383809|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383810|NCT05275426|Gemcitabine|gemcitabine|mesh-list
138383811|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383812|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
138383813|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383814|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383816|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
138383817|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383818|NCT05224141|Carboplatin|carboplatin|mesh-list
138383819|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
138383820|NCT05224141|Etoposide|etoposide|mesh-list
138383821|NCT05224141|Atezolizumab|atezolizumab|mesh-list
138383822|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383823|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383824|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138383825|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383826|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138383830|NCT05211570|Azacitidine|azacitidine|mesh-list
138383831|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383832|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
138383833|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383835|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383836|NCT05206435|Nicotine|nicotine|mesh-list
138383837|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138383838|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
138383839|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383840|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383841|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138383842|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138383843|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383844|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383845|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383846|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138383847|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138383848|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383849|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383850|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138383851|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383852|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383853|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
138383854|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383856|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138383858|NCT05168618|Atezolizumab|atezolizumab|mesh-list
138383859|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138383860|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138383861|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383862|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383863|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383864|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
138383865|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383866|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138383867|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
138383868|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138363038|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363039|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363040|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138363042|NCT03833466|Metformin|metformin|mesh-list
138383869|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383871|NCT05104866|Capecitabine|capecitabine|mesh-list
138383872|NCT05104866|Vinorelbine|vinorelbine|mesh-list
138383873|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383874|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
138383875|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383877|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138383878|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
138383879|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
138383880|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
138383881|NCT05090371|Ofatumumab|ofatumumab|mesh-list
138383882|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383883|NCT05085574|Celecoxib|celecoxib|mesh-list
138383884|NCT05085574|Famotidine|famotidine|mesh-list
138383885|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138383886|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383887|NCT05085574|Analgesics|analgesics|mesh-ancestor
138383888|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
138383889|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383890|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383891|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383892|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383893|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138383894|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138383895|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383896|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383897|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138383898|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383899|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138383900|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
138383901|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
138383902|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383903|NCT05084248|Vitamin D|vitamin d|mesh-list
138383904|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
138383905|NCT05084248|Vitamins|vitamins|mesh-ancestor
138383906|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
138383907|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383908|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138383909|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138383912|NCT05081687|Folfirinox|folfirinox|mesh-list
138383913|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383914|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138383915|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383916|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383917|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383918|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
138383919|NCT05081674|Nivolumab|nivolumab|mesh-list
138383920|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138383921|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383922|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383923|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138414728|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138383926|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383927|NCT05077332|Celecoxib|celecoxib|mesh-list
138383928|NCT05077332|Famotidine|famotidine|mesh-list
138383929|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138383930|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383931|NCT05077332|Analgesics|analgesics|mesh-ancestor
138383932|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
138383933|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383935|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383936|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383937|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138383938|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138383939|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383940|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383941|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138383942|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383943|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138383944|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
138383945|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
138383946|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138383947|NCT05076006|PF-06700841|pf-06700841|mesh-list
138383948|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138383949|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383950|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383952|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
138383953|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
138383954|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383955|NCT05067998|Vitamins|vitamins|mesh-list
138383956|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
138383957|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383958|NCT05062317|Leucovorin|leucovorin|mesh-list
138383959|NCT05062317|Bevacizumab|bevacizumab|mesh-list
138383960|NCT05062317|Capecitabine|capecitabine|mesh-list
138383961|NCT05062317|Fluorouracil|fluorouracil|mesh-list
138383962|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
138383964|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383965|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383966|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138383967|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138383968|NCT05062317|Growth Substances|growth substances|mesh-ancestor
138383969|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383970|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383971|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383972|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
138383973|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383974|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383975|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
138383976|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138383977|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383978|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383979|NCT05062317|Antidotes|antidotes|mesh-ancestor
138383980|NCT05062317|Protective Agents|protective agents|mesh-ancestor
138383981|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
138383982|NCT05062317|Vitamins|vitamins|mesh-ancestor
138383983|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
138383984|NCT05036109|Aspirin|aspirin|mesh-list
138383985|NCT05036109|Vitamin D|vitamin d|mesh-list
138383986|NCT05036109|Vitamins|vitamins|mesh-ancestor
138383987|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
138383988|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383989|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138383990|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138383991|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138383992|NCT05036109|Analgesics|analgesics|mesh-ancestor
138383993|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
138383994|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383995|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138383996|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383997|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138383998|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138383999|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384001|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138384002|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384004|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
138384005|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138384006|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138384007|NCT04988282|Prednisolone|prednisolone|mesh-list
138384008|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
138384009|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138384010|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
138384011|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384012|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
138384013|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
138384014|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384015|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384016|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138363043|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363044|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363045|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138363046|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138384017|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
138384018|NCT04988282|Hormones|hormones|mesh-ancestor
138384019|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384020|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138384021|NCT04988282|Protective Agents|protective agents|mesh-ancestor
138384022|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384023|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384025|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
138384026|NCT04962230|Carbamazepine|carbamazepine|mesh-list
138384027|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138384028|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138384029|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384030|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384031|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384033|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138384034|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
138384035|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384036|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138384037|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138384038|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
138384039|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
138384040|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138384041|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384042|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384043|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138384044|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384046|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
138384047|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384048|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138384049|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384051|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138384052|NCT04943445|Paclitaxel|paclitaxel|mesh-list
138384053|NCT04943445|Carboplatin|carboplatin|mesh-list
138384054|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
138384055|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
138384056|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
138384057|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138384058|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384059|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384060|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
138384061|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
138384062|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384063|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384064|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384065|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384066|NCT04939883|Carvedilol|carvedilol|mesh-list
138384067|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138384068|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138384069|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
138384070|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384071|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384072|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384073|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138384074|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
138384075|NCT04939883|Protective Agents|protective agents|mesh-ancestor
138384076|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138384077|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384078|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138384080|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138384081|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138384083|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384084|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384085|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384088|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138384089|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138384091|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384092|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
138384093|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384094|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138215753|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384095|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384096|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384097|NCT04919317|Dexamethasone|dexamethasone|mesh-list
138384098|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384099|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
138384100|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
138384101|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384102|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384104|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
138384105|NCT04919317|Hormones|hormones|mesh-ancestor
138384106|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384107|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384108|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384109|NCT04915248|Dexamethasone|dexamethasone|mesh-list
138384110|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
138384111|NCT04915248|Bortezomib|bortezomib|mesh-list
138384112|NCT04915248|Daratumumab|daratumumab|mesh-list
138384113|NCT04915248|BB 1101|bb 1101|mesh-list
138384114|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138384115|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384116|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
138384118|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384119|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384120|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384121|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
138384122|NCT04915248|Hormones|hormones|mesh-ancestor
138384123|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384124|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384126|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384127|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384128|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384129|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
138384130|NCT04901494|Serotonin|serotonin|mesh-list
138384131|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138384134|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384135|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384136|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384137|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138384138|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384139|NCT04877522|Niacinamide|niacinamide|mesh-list
138384140|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
138384141|NCT04877522|Dasatinib|dasatinib|mesh-list
138384142|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384143|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384144|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384145|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384146|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
138384147|NCT04877522|Vitamins|vitamins|mesh-ancestor
138384148|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
138384149|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384150|NCT04871594|Nivolumab|nivolumab|mesh-list
138384151|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384152|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384154|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384155|NCT04848857|Colchicine|colchicine|mesh-list
138384156|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
138384157|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384158|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384159|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
138384160|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
138384161|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384162|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384163|NCT04826562|Lamivudine|lamivudine|mesh-list
138384164|NCT04826562|Dolutegravir|dolutegravir|mesh-list
138384165|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138384166|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138384167|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384168|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384169|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
138384170|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384171|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138384174|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138384175|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
138384176|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384177|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384178|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384179|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384180|NCT04733183|Dacarbazine|dacarbazine|mesh-list
138384181|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384182|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
138384183|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384184|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384186|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138384187|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138384188|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138384189|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384190|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384191|NCT04664829|Capecitabine|capecitabine|mesh-list
138384193|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384194|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
138384195|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384196|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384197|NCT04651400|Antithrombins|antithrombins|mesh-list
138384198|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
138384199|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138384200|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384201|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384202|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384203|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
138384204|NCT04650984|Doxorubicin|doxorubicin|mesh-list
138384205|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384206|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384207|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138384214|NCT04629651|Captopril|captopril|mesh-list
138384215|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138384216|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384217|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384218|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384219|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138384220|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
138384221|NCT04601857|Futibatinib|futibatinib|mesh-list
138384222|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384223|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384224|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384225|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384227|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
138384228|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384229|NCT04557085|Cenobamate|cenobamate|mesh-list
138384230|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
138384231|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138384232|NCT04555694|Cyclosporine|cyclosporine|mesh-list
138384233|NCT04555694|Dexamethasone|dexamethasone|mesh-list
138384234|NCT04555694|Cyclosporins|cyclosporins|mesh-list
138384235|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384237|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
138384238|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384239|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384240|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384241|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
138384242|NCT04555694|Hormones|hormones|mesh-ancestor
138384243|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384244|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384245|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384246|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384247|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384248|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384249|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
138384250|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
138384251|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384252|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
138384253|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384254|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138384255|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138384257|NCT04527003|Norethindrone|norethindrone|mesh-list
138384258|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
138384261|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138384262|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138384263|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
138384264|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138384265|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384266|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138384267|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138384268|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
138384269|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384271|NCT04510051|Fludarabine|fludarabine|mesh-list
138384272|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384273|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
138384274|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384275|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384276|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384277|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
138384278|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384279|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384280|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138384281|NCT04480463|Aflibercept|aflibercept|mesh-list
138384282|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138384283|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138384284|NCT04480463|Growth Substances|growth substances|mesh-ancestor
138384286|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
138384287|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384289|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
138384290|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384291|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
138384292|NCT04464759|Nivolumab|nivolumab|mesh-list
138384293|NCT04464759|Ipilimumab|ipilimumab|mesh-list
138384294|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384295|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384299|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138384300|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138384301|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384302|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384303|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384304|NCT04443010|Temozolomide|temozolomide|mesh-list
138384305|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384306|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
138384307|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384308|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384309|NCT04423237|Deferasirox|deferasirox|mesh-list
138384310|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138384311|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
138384312|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
138384313|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384314|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
138384315|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384316|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384317|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384318|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384319|NCT04412538|Vaccines|vaccines|mesh-list
138384320|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
138384321|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384322|NCT04407247|Infliximab|infliximab|mesh-list
138384323|NCT04407247|Vedolizumab|vedolizumab|mesh-list
138384324|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
138384326|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
138384327|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384328|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138384329|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384330|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
138384331|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384332|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384334|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
138384335|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384336|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
138384337|NCT04332341|Niacinamide|niacinamide|mesh-list
138384339|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
138384340|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
138384341|NCT04332341|Vitamins|vitamins|mesh-ancestor
138384342|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
138384343|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384344|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138384345|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
138384346|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384347|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138384348|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
138384349|NCT04325659|Lofexidine|lofexidine|mesh-list
138384350|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138384351|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138384352|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384353|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
138384354|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384355|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138384356|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138384357|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138384358|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
138384359|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384360|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363052|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363053|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
138363054|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
138363055|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384362|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384363|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138384365|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384366|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384367|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138384368|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
138384370|NCT04314375|Hormones|hormones|mesh-ancestor
138384371|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384372|NCT04310397|Trametinib|trametinib|mesh-list
138384373|NCT04310397|Dabrafenib|dabrafenib|mesh-list
138384374|NCT04310397|Spartalizumab|spartalizumab|mesh-list
138384375|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384376|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384377|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384378|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384379|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384380|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384382|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384385|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384387|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
138384388|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384389|NCT04286178|Vitamins|vitamins|mesh-ancestor
138384390|NCT04285853|Oxycodone|oxycodone|mesh-list
138384391|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138384392|NCT04285853|Narcotics|narcotics|mesh-ancestor
138384393|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384394|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384395|NCT04285853|Analgesics|analgesics|mesh-ancestor
138384396|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
138384418|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384419|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384420|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384421|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384423|NCT04093362|Futibatinib|futibatinib|mesh-list
138384424|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384425|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384426|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
138384427|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384428|NCT04061239|Cytarabine|cytarabine|mesh-list
138384429|NCT04061239|Azacitidine|azacitidine|mesh-list
138384430|NCT04061239|Daunorubicin|daunorubicin|mesh-list
138384431|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384432|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
138384433|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384434|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384435|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
138384436|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384437|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384438|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
138384439|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384440|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384441|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384442|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138384443|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138384444|NCT04034004|Naloxone|naloxone|mesh-list
138384445|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138384446|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384447|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
138384451|NCT04033029|Piperacillin|piperacillin|mesh-list
138384452|NCT04033029|Daptomycin|daptomycin|mesh-list
138384453|NCT04033029|Ceftazidime|ceftazidime|mesh-list
138384454|NCT04033029|Cefepime|cefepime|mesh-list
138384455|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138384456|NCT04033029|Ceftolozane|ceftolozane|mesh-list
138384457|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384458|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138384459|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384460|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384463|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384464|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384465|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138384466|NCT03995641|Bupivacaine|bupivacaine|mesh-list
138384467|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
138384468|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
138384469|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384470|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384471|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
138384472|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384473|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384474|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
138384475|NCT03995641|Hormones|hormones|mesh-ancestor
138384476|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384477|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384478|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
138384479|NCT03862950|Metformin|metformin|mesh-list
138384480|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138384481|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384482|NCT03848065|Vaccines|vaccines|mesh-list
138384483|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
138384484|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384485|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
138384486|NCT03844750|Vactosertib|vactosertib|mesh-list
138384487|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384488|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384489|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384490|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384491|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384493|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138384494|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384495|NCT03792867|Doxorubicin|doxorubicin|mesh-list
138384496|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384497|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384498|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138384501|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384503|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
138384504|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384505|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384506|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384507|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384508|NCT03756896|Dexamethasone|dexamethasone|mesh-list
138384509|NCT03756896|Pomalidomide|pomalidomide|mesh-list
138384510|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384511|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
138384512|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
138384513|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384514|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384515|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384516|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
138384518|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384519|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384520|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384521|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
138384522|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138384523|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138384524|NCT03756896|Growth Substances|growth substances|mesh-ancestor
138384525|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138384526|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
138384527|NCT03737955|Calicheamicins|calicheamicins|mesh-list
138384528|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384532|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
138384533|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384534|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384535|NCT03638999|Ketorolac|ketorolac|mesh-list
138384536|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138384537|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384538|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384539|NCT03638999|Analgesics|analgesics|mesh-ancestor
138384540|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
138384541|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384542|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384543|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384544|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384545|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138384546|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384547|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384549|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384552|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384553|NCT03629223|Tepotinib|tepotinib|mesh-list
138384554|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384555|NCT03622775|Daratumumab|daratumumab|mesh-list
138384556|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384557|NCT03568383|Pyridoxine|pyridoxine|mesh-list
138384558|NCT03568383|Pyridoxal|pyridoxal|mesh-list
138384559|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
138384560|NCT03568383|Isoniazid|isoniazid|mesh-list
138384561|NCT03568383|Vitamins|vitamins|mesh-ancestor
138384562|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
138384563|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384564|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
138384565|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
138384566|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138384567|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384568|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138384569|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138384570|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
138384571|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384572|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138384573|NCT03567473|Dexamethasone|dexamethasone|mesh-list
138384574|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
138384575|NCT03567473|Epinephrine|epinephrine|mesh-list
138384576|NCT03567473|Racepinephrine|racepinephrine|mesh-list
138384577|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
138384579|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384580|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
138384581|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
138384582|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384583|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384584|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384585|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
138384586|NCT03567473|Hormones|hormones|mesh-ancestor
138384587|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384588|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384589|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384593|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138384594|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138384595|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138384596|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384597|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138384598|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138384599|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138384600|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138384601|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
138384602|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
138384603|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138384604|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138384605|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138384606|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138384607|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384608|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384609|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
138384610|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384611|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138384612|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138384613|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
138384614|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138384615|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384616|NCT03500328|Interferons|interferons|mesh-list
138384617|NCT03500328|Teriflunomide|teriflunomide|mesh-list
138384618|NCT03500328|Rituximab|rituximab|mesh-list
138384619|NCT03500328|Alemtuzumab|alemtuzumab|mesh-list
138384620|NCT03500328|Ofatumumab|ofatumumab|mesh-list
138384621|NCT03500328|Cladribine|cladribine|mesh-list
138384622|NCT03500328|Glatiramer Acetate|glatiramer acetate|mesh-list
138384623|NCT03500328|Ocrelizumab|ocrelizumab|mesh-list
138384625|NCT03500328|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138384627|NCT03500328|Ozanimod|ozanimod|mesh-list
138384628|NCT03500328|Ponesimod|ponesimod|mesh-list
138384630|NCT03500328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384631|NCT03500328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384632|NCT03500328|Immunologic Factors|immunologic factors|mesh-ancestor
138384634|NCT03500328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384635|NCT03500328|Antiviral Agents|antiviral agents|mesh-ancestor
138384636|NCT03500328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384637|NCT03500328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384638|NCT03500328|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138384639|NCT03500328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384640|NCT03500328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138384641|NCT03500328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384642|NCT03500328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384643|NCT03500328|Analgesics|analgesics|mesh-ancestor
138384644|NCT03500328|Sensory System Agents|sensory system agents|mesh-ancestor
138384645|NCT03500328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384646|NCT03500328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384647|NCT03450343|Azacitidine|azacitidine|mesh-list
138384648|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384649|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
138384650|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384651|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384652|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384654|NCT03435250|Docetaxel|docetaxel|mesh-list
138384655|NCT03435250|Gemcitabine|gemcitabine|mesh-list
138384656|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138384657|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384658|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384659|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
138384660|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
138384661|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384662|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384663|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
138384664|NCT03425669|Methylphenidate|methylphenidate|mesh-list
138384665|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138384666|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384667|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138384668|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138384669|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384670|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384672|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384673|NCT03420014|Doxorubicin|doxorubicin|mesh-list
138384674|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138384675|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384676|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384679|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384680|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384681|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
138384682|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138384683|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384684|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
138384685|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138384686|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
138384687|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384688|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
138384689|NCT03381248|Protective Agents|protective agents|mesh-ancestor
138384691|NCT03357757|Valproic Acid|valproic acid|mesh-list
138384692|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384693|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384694|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
138384695|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384696|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384697|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
138384698|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384699|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384700|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
138384702|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384703|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138384704|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138384705|NCT03233152|Nivolumab|nivolumab|mesh-list
138384706|NCT03233152|Ipilimumab|ipilimumab|mesh-list
138384707|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138384708|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384709|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384710|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384711|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384712|NCT03190967|Trastuzumab|trastuzumab|mesh-list
138384713|NCT03190967|Temozolomide|temozolomide|mesh-list
138384714|NCT03190967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384715|NCT03190967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384716|NCT03190967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384717|NCT03190967|Alkylating Agents|alkylating agents|mesh-ancestor
138384718|NCT03190967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384719|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
138384720|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384721|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384722|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384724|NCT03097939|Nivolumab|nivolumab|mesh-list
138384725|NCT03097939|Ipilimumab|ipilimumab|mesh-list
138384726|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384727|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384728|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384729|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384730|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
138384731|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
138384732|NCT03096782|Melphalan|melphalan|mesh-list
138384733|NCT03096782|Busulfan|busulfan|mesh-list
138384734|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
138384735|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138384736|NCT03096782|Rituximab|rituximab|mesh-list
138384737|NCT03096782|Fludarabine|fludarabine|mesh-list
138384738|NCT03096782|Clofarabine|clofarabine|mesh-list
138384739|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138384740|NCT03096782|Tacrolimus|tacrolimus|mesh-list
138384741|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
138384742|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138384743|NCT03096782|Antibodies|antibodies|mesh-list
138384744|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
138384747|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384748|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
138384749|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384750|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384751|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384752|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
138384753|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384754|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384755|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138384756|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384757|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
138384758|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138384759|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138384760|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384761|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384762|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138384763|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
138384764|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138384765|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384766|NCT03055013|Nivolumab|nivolumab|mesh-list
138384767|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384768|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363104|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363105|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138384772|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384774|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384775|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384777|NCT02966665|Vitamin E|vitamin e|mesh-list
138384778|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
138384779|NCT02966665|Fexofenadine|fexofenadine|mesh-list
138384780|NCT02966665|Valsartan|valsartan|mesh-list
138384781|NCT02966665|Nitroprusside|nitroprusside|mesh-list
138384783|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138384784|NCT02966665|Norepinephrine|norepinephrine|mesh-list
138384785|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
138384786|NCT02966665|Giapreza|giapreza|mesh-list
138384787|NCT02966665|Acetylcholine|acetylcholine|mesh-list
138384788|NCT02966665|Ranitidine|ranitidine|mesh-list
138384791|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384792|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138384793|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138384794|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138384795|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384796|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
138384797|NCT02966665|Protective Agents|protective agents|mesh-ancestor
138384798|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138384799|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138384800|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
138384801|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384802|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
138384803|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
138384804|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384805|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138384806|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
138384807|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138384808|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138384809|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138384810|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
138384811|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
138384812|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
138384813|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138384814|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138384815|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384816|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138384817|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138384818|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384819|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384820|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138384821|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
138384822|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138384823|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138384824|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138384827|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138384828|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384829|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138384831|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384832|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384833|NCT02939573|Dapsone|dapsone|mesh-list
138384834|NCT02939573|Colchicine|colchicine|mesh-list
138384835|NCT02939573|Azathioprine|azathioprine|mesh-list
138384836|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
138384837|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384838|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384839|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138384840|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138384841|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384842|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384843|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
138384844|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384845|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384846|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
138384847|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384848|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384849|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
138384850|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138384851|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138384852|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138384853|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384854|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
138384855|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138384856|NCT02773030|Dexamethasone|dexamethasone|mesh-list
138384857|NCT02773030|Bortezomib|bortezomib|mesh-list
138384858|NCT02773030|Daratumumab|daratumumab|mesh-list
138384859|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384860|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
138384861|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
138384862|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384863|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384864|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384865|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
138384867|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138384868|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138384869|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384870|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
138384873|NCT02681211|Metoclopramide|metoclopramide|mesh-list
138384874|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384875|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384876|NCT02681211|Analgesics|analgesics|mesh-ancestor
138384877|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
138384878|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384879|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384880|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384881|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384884|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384886|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138384887|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384888|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
138384889|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
138384890|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
138384891|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
138384892|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384893|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138384894|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
138384895|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
138384896|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384897|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138384898|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
138384899|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
138384900|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138384901|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138384902|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
138384903|NCT02666768|Interferons|interferons|mesh-list
138384904|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
138384905|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384906|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
138384907|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384908|NCT02632708|Cytarabine|cytarabine|mesh-list
138384909|NCT02632708|Etoposide|etoposide|mesh-list
138384912|NCT02632708|Idarubicin|idarubicin|mesh-list
138384913|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138384914|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384915|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138384916|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138384917|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384918|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384919|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384920|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
138384921|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
138384922|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384938|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384939|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384941|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
138384942|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384943|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384944|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384946|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138384947|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384948|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
138384949|NCT02448420|Trastuzumab|trastuzumab|mesh-list
138384950|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138384951|NCT02448420|Palbociclib|palbociclib|mesh-list
138384952|NCT02448420|Antibodies|antibodies|mesh-list
138384953|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
138384954|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
138384956|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384957|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384958|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384959|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384960|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384962|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138384963|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138384964|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
138384965|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
138384966|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138384967|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
138384968|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
138384969|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138384970|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384971|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138384972|NCT02420002|Analgesics|analgesics|mesh-ancestor
138384973|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
138384977|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138384979|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384980|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138384981|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138384982|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384983|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384984|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138384985|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138384986|NCT02352948|Gemcitabine|gemcitabine|mesh-list
138384987|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138384988|NCT02352948|Durvalumab|durvalumab|mesh-list
138384989|NCT02352948|Vinorelbine|vinorelbine|mesh-list
138384991|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138384992|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384993|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
138384994|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384995|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384996|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384997|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384998|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384999|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
138385000|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385001|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385002|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385003|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385004|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385006|NCT02315326|Methotrexate|methotrexate|mesh-list
138385007|NCT02315326|Procarbazine|procarbazine|mesh-list
138385008|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385009|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385010|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
138385011|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385012|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385013|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138385014|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
138385015|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138385016|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385017|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
138385018|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385021|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138385022|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385023|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138385025|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138385026|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
138385027|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138385028|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
138385029|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385031|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
138385032|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
138385033|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
138385036|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
138385037|NCT02248597|Tacrolimus|tacrolimus|mesh-list
138385038|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385039|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
138385040|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385041|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385042|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385043|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
138385044|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385045|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385046|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138385047|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385048|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
138385049|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138385050|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385051|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138385052|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138385053|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
138385054|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138385055|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385056|NCT02246621|Letrozole|letrozole|mesh-list
138385057|NCT02246621|Anastrozole|anastrozole|mesh-list
138385058|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385059|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138385060|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138385061|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385062|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385063|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138385064|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385065|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385066|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385067|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385068|NCT02227823|Bromides|bromides|mesh-list
138385071|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138385072|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385076|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385077|NCT02197234|Osimertinib|osimertinib|mesh-list
138385078|NCT02197234|Simvastatin|simvastatin|mesh-list
138385079|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138385080|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138385081|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
138385082|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385083|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138385084|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138385085|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385086|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385087|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385089|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385090|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385091|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
138385092|NCT02114229|Carboplatin|carboplatin|mesh-list
138385093|NCT02114229|Methotrexate|methotrexate|mesh-list
138385094|NCT02114229|Etoposide|etoposide|mesh-list
138385095|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
138385096|NCT02114229|Vincristine|vincristine|mesh-list
138385097|NCT02114229|Topotecan|topotecan|mesh-list
138385098|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385099|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
138385100|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385101|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385102|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385103|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
138385104|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385105|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385106|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138385107|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138385108|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
138385109|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138385110|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385111|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
138385112|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385113|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385114|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138385115|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138385116|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385117|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138385118|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138385119|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385120|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385122|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138385123|NCT02096042|Azacitidine|azacitidine|mesh-list
138385124|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138385125|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385126|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
138385127|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385128|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385129|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385130|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385131|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
138385132|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
138385134|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385135|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
138385136|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385137|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385138|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385139|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385140|NCT01848639|Spironolactone|spironolactone|mesh-list
138385141|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138385142|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385143|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385144|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385145|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138385146|NCT01848639|Diuretics|diuretics|mesh-ancestor
138385147|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
138385148|NCT01765400|Clopidogrel|clopidogrel|mesh-list
138385149|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138385150|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138385151|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138385152|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138385153|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138385155|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385156|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385157|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385158|NCT01730937|Sorafenib|sorafenib|mesh-list
138385159|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363115|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363125|NCT01689558|Endostatins|endostatins|mesh-list
138385160|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385161|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385162|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385163|NCT01560416|Fulvestrant|fulvestrant|mesh-list
138385164|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385165|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385166|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138385167|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138385168|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385170|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385171|NCT01551823|Vaccines|vaccines|mesh-list
138385172|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
138385173|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385174|NCT01551810|Vaccines|vaccines|mesh-list
138385175|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
138385176|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385177|NCT01510366|Vaccines|vaccines|mesh-list
138385178|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
138385181|NCT01279850|Analgesics|analgesics|mesh-ancestor
138385182|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
138385183|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385184|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385185|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
138385186|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138385187|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138385188|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385189|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138385190|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138385191|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138385192|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385193|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385195|NCT01068327|Nelfinavir|nelfinavir|mesh-list
138385196|NCT01068327|Gemcitabine|gemcitabine|mesh-list
138385197|NCT01068327|Fluorouracil|fluorouracil|mesh-list
138385198|NCT01068327|Calcium|calcium|mesh-list
138385199|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
138385200|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385201|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
138385202|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385203|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385204|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138385205|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385206|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385207|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
138385208|NCT01068327|Antidotes|antidotes|mesh-ancestor
138385209|NCT01068327|Protective Agents|protective agents|mesh-ancestor
138385211|NCT01068327|Vitamins|vitamins|mesh-ancestor
138385212|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
138385213|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138385214|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138385215|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138385216|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385217|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138385218|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138385219|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
138385220|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385222|NCT01035463|Rituximab|rituximab|mesh-list
138385223|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138385224|NCT01035463|Etoposide|etoposide|mesh-list
138385225|NCT01035463|Lenalidomide|lenalidomide|mesh-list
138385226|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
138385227|NCT01035463|Melphalan|melphalan|mesh-list
138385228|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
138385229|NCT01035463|Carmustine|carmustine|mesh-list
138385239|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385240|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138385241|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138385242|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385243|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385244|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385245|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
138385246|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
138385247|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385248|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385249|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138385250|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138385251|NCT01035463|Growth Substances|growth substances|mesh-ancestor
138385252|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
138385253|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385254|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
138385256|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
138385257|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385258|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385260|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385261|NCT00936390|Leuprolide|leuprolide|mesh-list
138385262|NCT00936390|Goserelin|goserelin|mesh-list
138385263|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138385264|NCT00936390|Flutamide|flutamide|mesh-list
138385265|NCT00936390|Bicalutamide|bicalutamide|mesh-list
138385266|NCT00936390|Buserelin|buserelin|mesh-list
138385267|NCT00936390|Androgens|androgens|mesh-list
138385268|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
138385269|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138385270|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
138385271|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138385272|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385273|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385274|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385275|NCT00936390|Hormones|hormones|mesh-ancestor
138385276|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385277|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385280|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
138385281|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138385282|NCT00572234|Bupropion|bupropion|mesh-list
138385283|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138385284|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
138385285|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385286|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138385287|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138385288|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138385289|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385290|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
138385291|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385292|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385295|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385296|NCT00534430|Cyclosporine|cyclosporine|mesh-list
138385297|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
138385298|NCT00534430|Etoposide|etoposide|mesh-list
138385299|NCT00534430|Busulfan|busulfan|mesh-list
138385300|NCT00534430|Cyclosporins|cyclosporins|mesh-list
138385301|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138363144|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138385302|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385303|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138385304|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138385305|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385306|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385317|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
138385318|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138385319|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
138385320|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385321|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138385322|NCT00411138|Paclitaxel|paclitaxel|mesh-list
138385323|NCT00411138|Carboplatin|carboplatin|mesh-list
138385324|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385325|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385326|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385327|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385328|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385329|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385330|NCT00149149|Indomethacin|indomethacin|mesh-list
138385331|NCT00149149|Polaprezinc|polaprezinc|mesh-list
138385332|NCT00149149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138385333|NCT00149149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138385334|NCT00149149|Analgesics|analgesics|mesh-ancestor
138385335|NCT00149149|Sensory System Agents|sensory system agents|mesh-ancestor
138385336|NCT00149149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385337|NCT00149149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385338|NCT00149149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385339|NCT00149149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385340|NCT00149149|Gout Suppressants|gout suppressants|mesh-ancestor
138385341|NCT00149149|Tocolytic Agents|tocolytic agents|mesh-ancestor
138385342|NCT00149149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138385343|NCT00149149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138385344|NCT00149149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385345|NCT00149149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385346|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138385347|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385348|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
138385349|NCT00085202|Vincristine|vincristine|mesh-list
138385350|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385351|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
138385352|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385353|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385354|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385355|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
138385356|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385357|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385358|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138385359|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385360|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385361|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385362|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385363|NCT01469338|Prednisone|prednisone|mesh-list
138385364|NCT01469338|Octreotide|octreotide|mesh-list
138385365|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385366|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
138385367|NCT01469338|Hormones|hormones|mesh-ancestor
138385368|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385370|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385371|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385372|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385373|NCT01469351|Liraglutide|liraglutide|mesh-list
138385374|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385375|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385376|NCT01469351|Incretins|incretins|mesh-ancestor
138385377|NCT01469351|Hormones|hormones|mesh-ancestor
138385378|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385379|NCT01469416|Clopidogrel|clopidogrel|mesh-list
138363161|NCT05768230|Simendan|simendan|mesh-list
138385380|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138385381|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138385382|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138385383|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138385384|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138385385|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
138385386|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385387|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385388|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385389|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138385390|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138385391|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
138385392|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138385393|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138385395|NCT01469468|Simvastatin|simvastatin|mesh-list
138385396|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138385397|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138385398|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
138385399|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385400|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138385401|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138385403|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
138385404|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385405|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385406|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
138385407|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138385408|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
138385409|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385410|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
138385411|NCT01469507|Protective Agents|protective agents|mesh-ancestor
138385414|NCT01469520|Nevirapine|nevirapine|mesh-list
138385415|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138385416|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138385417|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385418|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385419|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
138385420|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385421|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138385422|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138385423|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
138385424|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138385425|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138385427|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385428|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385429|NCT01469572|Everolimus|everolimus|mesh-list
138385430|NCT01469572|Pasireotide|pasireotide|mesh-list
138385431|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138385432|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385433|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385434|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385435|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385436|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
138385437|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385438|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385439|NCT01469572|Hormones|hormones|mesh-ancestor
138385440|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385441|NCT01469598|Gemcitabine|gemcitabine|mesh-list
138385442|NCT01469598|Docetaxel|docetaxel|mesh-list
138385443|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385445|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385446|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385447|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385448|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385449|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385450|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
138385451|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138385452|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385453|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385454|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138385455|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138385456|NCT01469624|Protective Agents|protective agents|mesh-ancestor
138385457|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385458|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
138385459|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138385461|NCT01469702|Azithromycin|azithromycin|mesh-list
138385462|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138385463|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385464|NCT01469884|Cyclosporine|cyclosporine|mesh-list
138385465|NCT01469884|Everolimus|everolimus|mesh-list
138385466|NCT01469884|Tacrolimus|tacrolimus|mesh-list
138385467|NCT01469884|Cyclosporins|cyclosporins|mesh-list
138385468|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385469|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
138385470|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385471|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138385472|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385474|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
138385475|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385476|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385477|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385479|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385480|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385481|NCT01469975|Edetic Acid|edetic acid|mesh-list
138385482|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
138385483|NCT01469975|Antidotes|antidotes|mesh-ancestor
138385484|NCT01469975|Protective Agents|protective agents|mesh-ancestor
138385485|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385486|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
138385487|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
138385488|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385489|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138385490|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
138385491|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138385492|NCT01469988|Testosterone|testosterone|mesh-list
138385493|NCT01469988|Androgens|androgens|mesh-ancestor
138385494|NCT01469988|Hormones|hormones|mesh-ancestor
138385495|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385498|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138385499|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138385500|NCT01470040|Analgesics|analgesics|mesh-ancestor
138385501|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
138385502|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385503|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385505|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385506|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138385507|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138385508|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385509|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138385510|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138385511|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385512|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
138385513|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
138385514|NCT01470053|Azelastine|azelastine|mesh-list
138385515|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385516|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385517|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138385518|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138385519|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
138385520|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385521|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385522|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138385523|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
138385524|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138385525|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385526|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385527|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138385528|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138385529|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
138385530|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
138385533|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
138385534|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385535|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385536|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385537|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138385538|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385539|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385540|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138385541|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
138385543|NCT01470157|Ketamine|ketamine|mesh-list
138385544|NCT01470157|Analgesics|analgesics|mesh-ancestor
138385545|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
138385546|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385547|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385548|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138385549|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138385550|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
138385551|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
138385552|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385553|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138385554|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138385555|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385556|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385557|NCT01470209|Everolimus|everolimus|mesh-list
138385558|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138385559|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385560|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385561|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385562|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385563|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
138385564|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385565|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385566|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
138385567|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138385570|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385571|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385572|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138385573|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138385574|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138385575|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138385576|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138385577|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385578|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385579|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385581|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
138385582|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385583|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
138385584|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385585|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
138385586|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138385587|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138385588|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138385589|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138385590|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385591|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385592|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385593|NCT01470352|Analgesics|analgesics|mesh-ancestor
138385594|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
138385595|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385596|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138385597|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385598|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
138385599|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
138385600|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385603|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385604|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
138385605|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385606|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385607|NCT01470495|Sorafenib|sorafenib|mesh-list
138385608|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385609|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385611|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385613|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138385614|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385615|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138385616|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385617|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385619|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385621|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385622|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385623|NCT01470794|Flucytosine|flucytosine|mesh-list
138385624|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
138385625|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385626|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
138385627|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385628|NCT01470807|Pancrelipase|pancrelipase|mesh-list
138385629|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385630|NCT01470937|Acarbose|acarbose|mesh-list
138385631|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138385632|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385633|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385634|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385635|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385636|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
138385637|NCT01471067|Rituximab|rituximab|mesh-list
138385638|NCT01471067|Fludarabine|fludarabine|mesh-list
138385639|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
138385640|NCT01471067|Melphalan|melphalan|mesh-list
138385641|NCT01471067|Busulfan|busulfan|mesh-list
138385642|NCT01471067|Clofarabine|clofarabine|mesh-list
138385643|NCT01471067|Tacrolimus|tacrolimus|mesh-list
138385644|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
138385645|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138385646|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385647|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385648|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
138385649|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385650|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385651|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385652|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
138385653|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385654|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138385655|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385656|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138385657|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385658|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138385659|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138385660|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
138385661|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138385662|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138385663|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
138385664|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138385665|NCT01471132|Paclitaxel|paclitaxel|mesh-list
138385666|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
138385667|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138385668|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385669|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385670|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385671|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385672|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385673|NCT01471145|Naltrexone|naltrexone|mesh-list
138385674|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138385676|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385677|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
138385678|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385682|NCT01471158|Brinzolamide|brinzolamide|mesh-list
138385683|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385684|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385685|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138385686|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138385687|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138385688|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385689|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385690|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138385691|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138385692|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138385693|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138385694|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138385695|NCT01471262|Liver Extracts|liver extracts|mesh-list
138385696|NCT01471262|Hematinics|hematinics|mesh-ancestor
138385697|NCT01471275|Metformin|metformin|mesh-list
138385698|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385699|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385700|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138385701|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138385702|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385703|NCT01471470|Bevacizumab|bevacizumab|mesh-list
138385704|NCT01471470|Docetaxel|docetaxel|mesh-list
138385705|NCT01471470|Capecitabine|capecitabine|mesh-list
138385706|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385707|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385708|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138385709|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138385710|NCT01471470|Growth Substances|growth substances|mesh-ancestor
138385711|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385712|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
138385713|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385714|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385715|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385716|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385717|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385718|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
138385719|NCT01471535|Interferons|interferons|mesh-list
138385720|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
138385721|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
138385722|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138385723|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385724|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
138385727|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385729|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
138385730|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385731|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385732|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385733|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
138385734|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138385735|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385736|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385741|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138385742|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
138385743|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385744|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385745|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385746|NCT01471678|Urological Agents|urological agents|mesh-ancestor
138385747|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138385748|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138385749|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385750|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385751|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385753|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138385754|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138385755|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138385756|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385757|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138385758|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385759|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
138385760|NCT01471730|Thrombin|thrombin|mesh-list
138385761|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
138385762|NCT01471730|Coagulants|coagulants|mesh-ancestor
138385763|NCT01471808|Metformin|metformin|mesh-list
138385764|NCT01471808|Pioglitazone|pioglitazone|mesh-list
138385765|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138385766|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385767|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385768|NCT01471808|Incretins|incretins|mesh-ancestor
138385769|NCT01471808|Hormones|hormones|mesh-ancestor
138385770|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385771|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138385773|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385774|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385775|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138385776|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
138385777|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385778|NCT01471847|Capecitabine|capecitabine|mesh-list
138385779|NCT01471847|Trastuzumab|trastuzumab|mesh-list
138385780|NCT01471847|Lapatinib|lapatinib|mesh-list
138385781|NCT01471847|Dactolisib|dactolisib|mesh-list
138385782|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385783|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
138385784|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385785|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385786|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385793|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138385796|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385797|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385798|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385799|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385800|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138385801|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385802|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385803|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
138385805|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138385807|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138385808|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138385809|NCT01471899|Analgesics|analgesics|mesh-ancestor
138385810|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
138385811|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385812|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385813|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385814|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385815|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138385816|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385817|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385818|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
138385819|NCT01471925|Esomeprazole|esomeprazole|mesh-list
138385820|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138385821|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385822|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138385823|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385824|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385825|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138385826|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385827|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385828|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385829|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385830|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138385831|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
138385832|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385833|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
138385834|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138385835|NCT01471990|Protective Agents|protective agents|mesh-ancestor
138385836|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385837|NCT01471990|Growth Substances|growth substances|mesh-ancestor
138385838|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385839|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385840|NCT01472016|Docetaxel|docetaxel|mesh-list
138385841|NCT01472016|Cetuximab|cetuximab|mesh-list
138385842|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138385843|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385845|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385846|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385847|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385848|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385852|NCT01472029|Docetaxel|docetaxel|mesh-list
138385853|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
138385854|NCT01472029|Trastuzumab|trastuzumab|mesh-list
138385855|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385856|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385857|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
138385858|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385859|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385860|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385861|NCT01472029|Antidotes|antidotes|mesh-ancestor
138385862|NCT01472029|Protective Agents|protective agents|mesh-ancestor
138385863|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385864|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
138385865|NCT01472029|Vitamins|vitamins|mesh-ancestor
138385866|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
138385867|NCT01472055|Fludarabine|fludarabine|mesh-list
138385868|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385869|NCT01472146|Doxorubicin|doxorubicin|mesh-list
138385870|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385871|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138385872|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138385873|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138385874|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385875|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385876|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
138385877|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138385878|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385879|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385880|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138385881|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138385882|NCT01472263|Protective Agents|protective agents|mesh-ancestor
138385883|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385884|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
138385885|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138385886|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
138385887|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138385888|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
138385889|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138385891|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138385892|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
138385893|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138385894|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385895|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138385896|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138385897|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138385898|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138385899|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385900|NCT01472406|Pancrelipase|pancrelipase|mesh-list
138385901|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385902|NCT01472497|Pioglitazone|pioglitazone|mesh-list
138385903|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385904|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385905|NCT01472510|Ranibizumab|ranibizumab|mesh-list
138385906|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138385907|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138385908|NCT01472510|Growth Substances|growth substances|mesh-ancestor
138385909|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385910|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
138385911|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385912|NCT01472640|Liraglutide|liraglutide|mesh-list
138385913|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138385914|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385915|NCT01472640|Incretins|incretins|mesh-ancestor
138385917|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385919|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385920|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385921|NCT01472666|Caseins|caseins|mesh-list
138385922|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
138385923|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
138385924|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385925|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138385926|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
138385927|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385928|NCT01472770|Gemcitabine|gemcitabine|mesh-list
138385929|NCT01472770|Capecitabine|capecitabine|mesh-list
138385930|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138385931|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
138385932|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385933|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385934|NCT01472783|Veliparib|veliparib|mesh-list
138385935|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138385936|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385937|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385938|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385939|NCT01472796|Vitamin D|vitamin d|mesh-list
138385940|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
138385942|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
138385943|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385944|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138385945|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138385946|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138385947|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385948|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138385949|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
138385950|NCT01472913|Coagulants|coagulants|mesh-ancestor
138385951|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138385952|NCT01472926|Plasminogen|plasminogen|mesh-list
138385953|NCT01472926|Tenecteplase|tenecteplase|mesh-list
138385954|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138385955|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138385958|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385959|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138385960|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138385961|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138385962|NCT01473043|Axitinib|axitinib|mesh-list
138385963|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385964|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385965|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385966|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385967|NCT01473069|Ketoconazole|ketoconazole|mesh-list
138385968|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
138385969|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385970|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138385971|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138385972|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385973|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385974|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138385975|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
138385976|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385977|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385981|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385982|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138385984|NCT01473147|Hormones|hormones|mesh-ancestor
138385985|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138385986|NCT01473173|Esomeprazole|esomeprazole|mesh-list
138385987|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138385988|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385989|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138385990|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385991|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385992|NCT01473251|Bevacizumab|bevacizumab|mesh-list
138385993|NCT01473251|Ranibizumab|ranibizumab|mesh-list
138385994|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138385995|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385996|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138385997|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138385999|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386002|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138386003|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138386004|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138386005|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138386006|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386007|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
138386008|NCT01473277|Hormones|hormones|mesh-ancestor
138386009|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386010|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386011|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386012|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
138386013|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386015|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138386016|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386017|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386018|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363165|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138386019|NCT01473303|Leucovorin|leucovorin|mesh-list
138386020|NCT01473303|Fluorouracil|fluorouracil|mesh-list
138386021|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
138386023|NCT01473303|Calcium|calcium|mesh-list
138386024|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
138386025|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386026|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386027|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
138386028|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386029|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386030|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386031|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386032|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
138386033|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138386034|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138386035|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386036|NCT01473303|Antidotes|antidotes|mesh-ancestor
138386037|NCT01473303|Protective Agents|protective agents|mesh-ancestor
138386038|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
138386039|NCT01473303|Vitamins|vitamins|mesh-ancestor
138386040|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
138386041|NCT01473316|Ketoconazole|ketoconazole|mesh-list
138386042|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
138386043|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386044|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138386045|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138386046|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386047|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386048|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138386050|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386052|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138386053|NCT01473472|Tenofovir|tenofovir|mesh-list
138386054|NCT01473472|Emtricitabine|emtricitabine|mesh-list
138386055|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138386056|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
138386057|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386058|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138386059|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138386060|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386061|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386062|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138386063|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138386064|NCT01473537|Calcium|calcium|mesh-list
138386066|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386067|NCT01473797|Cladribine|cladribine|mesh-list
138386068|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386069|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386070|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
138386071|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386072|NCT01473810|Endocine|endocine|mesh-list
138386073|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138386074|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
138386075|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386076|NCT01473901|Temozolomide|temozolomide|mesh-list
138386077|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138386078|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
138386079|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386080|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386081|NCT01473914|Vitamins|vitamins|mesh-list
138386082|NCT01473914|Vitamin E|vitamin e|mesh-list
138386083|NCT01473914|Tocopherols|tocopherols|mesh-list
138386084|NCT01473914|Tocotrienols|tocotrienols|mesh-list
138386085|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
138386087|NCT01473914|Selenium|selenium|mesh-list
138386088|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
138386089|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386090|NCT01473914|Trace Elements|trace elements|mesh-ancestor
138386091|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
138386092|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386093|NCT01473914|Protective Agents|protective agents|mesh-ancestor
138386094|NCT01474174|Vaccines|vaccines|mesh-list
138386095|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
138386096|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386097|NCT01474187|Capecitabine|capecitabine|mesh-list
138386098|NCT01474187|Irinotecan|irinotecan|mesh-list
138386099|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386100|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
138386101|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386103|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138386104|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138386105|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386106|NCT01474265|Varenicline|varenicline|mesh-list
138386107|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138386108|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138386109|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386110|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386111|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386117|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386118|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386120|NCT01474330|Pomalidomide|pomalidomide|mesh-list
138386121|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
138386122|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386123|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138386124|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138386125|NCT01474330|Growth Substances|growth substances|mesh-ancestor
138386126|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138386127|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386128|NCT01474382|Phentolamine|phentolamine|mesh-list
138386129|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138386130|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138386131|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386132|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386133|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386136|NCT01474460|Vitamin K|vitamin k|mesh-list
138386137|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
138386139|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
138386140|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386141|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138386142|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138386143|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386144|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
138386145|NCT01474460|Coagulants|coagulants|mesh-ancestor
138386146|NCT01474473|Calpastatin|calpastatin|mesh-list
138386147|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138386148|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138386149|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386150|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386151|NCT01474499|Sorbitol|sorbitol|mesh-list
138386152|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138386153|NCT01474499|Glycerol|glycerol|mesh-list
138386154|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138386155|NCT01474499|Protective Agents|protective agents|mesh-ancestor
138386156|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386157|NCT01474499|Cathartics|cathartics|mesh-ancestor
138386158|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386159|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
138386160|NCT01474642|Capecitabine|capecitabine|mesh-list
138386161|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386162|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386163|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
138386164|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386165|NCT01474902|Enoxaparin|enoxaparin|mesh-list
138386166|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
138386167|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138386168|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138386169|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386170|NCT01474967|Metformin|metformin|mesh-list
138386171|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138386172|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386174|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
138386175|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
138386176|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386177|NCT01475019|Orlistat|orlistat|mesh-list
138386178|NCT01475019|Sibutramine|sibutramine|mesh-list
138386179|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386180|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386181|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138386182|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138386185|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
138386186|NCT01475032|Beclomethasone|beclomethasone|mesh-list
138386187|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
138386188|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138386189|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
138386190|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386191|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386192|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138386193|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
138386194|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138386195|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386196|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386197|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386198|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386199|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386200|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386201|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
138386202|NCT01475032|Hormones|hormones|mesh-ancestor
138386203|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386204|NCT01475227|Zinc|zinc|mesh-list
138386205|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
138386206|NCT01475227|Trace Elements|trace elements|mesh-ancestor
138386207|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
138386208|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386209|NCT01475227|Astringents|astringents|mesh-ancestor
138386210|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138386214|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
138386215|NCT01475318|Letrozole|letrozole|mesh-list
138386216|NCT01475318|Misoprostol|misoprostol|mesh-list
138386217|NCT01475318|Mifepristone|mifepristone|mesh-list
138386218|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386219|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138386220|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138386221|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386222|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386223|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138386226|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386227|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138386228|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
138386229|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138386230|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138386231|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386232|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
138386233|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138386234|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138386235|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138386236|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138386237|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
138386238|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138386239|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138386240|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
138386242|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138386243|NCT01475552|Abciximab|abciximab|mesh-list
138386244|NCT01475552|Clopidogrel|clopidogrel|mesh-list
138386245|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386246|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386247|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138386248|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138386249|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138386251|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
138386252|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386253|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
138386254|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
138386255|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
138386256|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138386257|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138386258|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386259|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386260|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386261|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386262|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
138386263|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
138386264|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
138386265|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
138386266|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
138386268|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
138386269|NCT01475617|Calcium|calcium|mesh-list
138386270|NCT01475617|Vitamins|vitamins|mesh-ancestor
138386271|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
138386272|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386273|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386274|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138386275|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
138386276|NCT01475617|Hematinics|hematinics|mesh-ancestor
138386277|NCT01475656|Levetiracetam|levetiracetam|mesh-list
138386278|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
138386279|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
138386281|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138386282|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386283|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
138386284|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138386287|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138386288|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138386290|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386291|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138386292|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
138386293|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
138386294|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
138386295|NCT01475760|Coagulants|coagulants|mesh-ancestor
138386296|NCT01475877|Bromfenac|bromfenac|mesh-list
138386297|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138386298|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386299|NCT01475877|Analgesics|analgesics|mesh-ancestor
138386300|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
138386301|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386302|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386303|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386304|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386305|NCT01475890|Vitamin D|vitamin d|mesh-list
138386306|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
138386307|NCT01475890|Vitamins|vitamins|mesh-ancestor
138386308|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
138386309|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386310|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138386311|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386312|NCT01476007|Vitamins|vitamins|mesh-list
138386313|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
138386314|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
138386315|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
138386316|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
138386317|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386319|NCT01476124|Morphine|morphine|mesh-list
138386320|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138386322|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386323|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386324|NCT01476124|Analgesics|analgesics|mesh-ancestor
138386325|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
138386326|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386327|NCT01476137|Trametinib|trametinib|mesh-list
138386328|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386329|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138386330|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386331|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386332|NCT01476176|Acetaminophen|acetaminophen|mesh-list
138386333|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386334|NCT01476176|Analgesics|analgesics|mesh-ancestor
138386335|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
138386336|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386337|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386339|NCT01476189|Acetaminophen|acetaminophen|mesh-list
138386340|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386342|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
138386343|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386344|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386345|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
138386346|NCT01476215|Acetaminophen|acetaminophen|mesh-list
138386347|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386348|NCT01476215|Analgesics|analgesics|mesh-ancestor
138386349|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
138386350|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386351|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386352|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
138386353|NCT01476280|Palonosetron|palonosetron|mesh-list
138386354|NCT01476280|Ramosetron|ramosetron|mesh-list
138386355|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
138386356|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
138386357|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386358|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386359|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386360|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138386361|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138386362|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
138386363|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386364|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386365|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138386366|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138386367|NCT01476358|Vitamin A|vitamin a|mesh-list
138386368|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
138386369|NCT01476358|Vitamins|vitamins|mesh-ancestor
138386370|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
138386371|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386372|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
138386373|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386375|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138386376|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386377|NCT01476410|Doxorubicin|doxorubicin|mesh-list
138386378|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138386379|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138386380|NCT01476410|Dacarbazine|dacarbazine|mesh-list
138386381|NCT01476410|Vinblastine|vinblastine|mesh-list
138386382|NCT01476410|Antibodies|antibodies|mesh-list
138386383|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
138386384|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138386385|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138386386|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
138386387|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
138386388|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386389|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138386390|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386391|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138386392|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138386393|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386394|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386395|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138386398|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138386399|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
138386400|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138386401|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386402|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
138386403|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
138386404|NCT01476488|Tacrolimus|tacrolimus|mesh-list
138386405|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386406|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
138386407|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386408|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138386409|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386410|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386411|NCT01476592|Resveratrol|resveratrol|mesh-list
138386412|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
138386413|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386415|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386416|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386417|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138386418|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
138386419|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138386420|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138386421|NCT01476683|Racecadotril|racecadotril|mesh-list
138386422|NCT01476683|Thiorphan|thiorphan|mesh-list
138386423|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
138386424|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386425|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138386426|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386427|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386428|NCT01476774|Buprenorphine|buprenorphine|mesh-list
138386429|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138386430|NCT01476774|Narcotics|narcotics|mesh-ancestor
138386431|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386432|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386433|NCT01476774|Analgesics|analgesics|mesh-ancestor
138386434|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
138386435|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386436|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138386440|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386441|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138386442|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138386443|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386444|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386445|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138386446|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
138386447|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386448|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386449|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138386450|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138386451|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386452|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386453|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386454|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386455|NCT01476800|Urological Agents|urological agents|mesh-ancestor
138386457|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138386458|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138386459|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138386460|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386461|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386462|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386463|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386464|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
138386465|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386466|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
138386467|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386468|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386469|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138386470|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
138386471|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386472|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386473|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138386474|NCT01477034|Vitamin D|vitamin d|mesh-list
138386475|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
138386476|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
138386477|NCT01477034|Vitamins|vitamins|mesh-list
138386478|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
138386479|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386480|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138386481|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386482|NCT01477060|Metformin|metformin|mesh-list
138386483|NCT01477060|Lapatinib|lapatinib|mesh-list
138386484|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138386485|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386486|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386487|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138386488|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386489|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386490|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138386491|NCT01477073|Hormones|hormones|mesh-ancestor
138386492|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386493|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386494|NCT01477112|Beta Carotene|beta carotene|mesh-list
138386495|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386496|NCT01477112|Provitamins|provitamins|mesh-ancestor
138386498|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
138386499|NCT01477151|Anesthetics|anesthetics|mesh-list
138386500|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386501|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386502|NCT01477190|Morphine|morphine|mesh-list
138386503|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138386504|NCT01477190|Narcotics|narcotics|mesh-ancestor
138386505|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386506|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386507|NCT01477190|Analgesics|analgesics|mesh-ancestor
138386508|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
138386509|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386510|NCT01477203|Escitalopram|escitalopram|mesh-list
138386511|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138386513|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386514|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386515|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386516|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
138386517|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386518|NCT01477242|Ondansetron|ondansetron|mesh-list
138386519|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
138386520|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
138386521|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386522|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386523|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386524|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
138386525|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138386526|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138386528|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
138386529|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386530|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386531|NCT01477268|Sertraline|sertraline|mesh-list
138386532|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
138386533|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138386534|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138386535|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138386536|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386537|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386538|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386542|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138386543|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386545|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386546|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386547|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138386548|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138386549|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
138386550|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386551|NCT01477385|Fluorides|fluorides|mesh-list
138386552|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
138386553|NCT01477385|Protective Agents|protective agents|mesh-ancestor
138386554|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386555|NCT01477411|Digoxin|digoxin|mesh-list
138386556|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138386557|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138386558|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386559|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386560|NCT01477411|Protective Agents|protective agents|mesh-ancestor
138386561|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386562|NCT01477424|Warfarin|warfarin|mesh-list
138386563|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
138386564|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138386565|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386566|NCT01477489|Veliparib|veliparib|mesh-list
138386567|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138386568|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386569|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386570|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386573|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
138386574|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386575|NCT01477580|Antacids|antacids|mesh-ancestor
138386576|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386577|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386578|NCT01477606|Cytarabine|cytarabine|mesh-list
138386579|NCT01477606|Daunorubicin|daunorubicin|mesh-list
138386580|NCT01477606|Midostaurin|midostaurin|mesh-list
138386581|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386582|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
138386583|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386584|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386585|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
138386586|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386587|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386588|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
138386589|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386590|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138386591|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138386592|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138386593|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386600|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138386601|NCT01477632|Estrogens|estrogens|mesh-ancestor
138386602|NCT01477632|Hormones|hormones|mesh-ancestor
138386603|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386604|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386605|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138386606|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
138386607|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138386608|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138386609|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138386610|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138386611|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138386612|NCT01477736|Oxybutynin|oxybutynin|mesh-list
138386613|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
138386614|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138386615|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138386616|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138386617|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386618|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386619|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386620|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386621|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386622|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138386623|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386624|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
138386625|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
138386626|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138386627|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138386628|NCT01477736|Urological Agents|urological agents|mesh-ancestor
138386629|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
138386630|NCT01477801|Vitamin D|vitamin d|mesh-list
138386631|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386632|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386633|NCT01477801|Vitamins|vitamins|mesh-ancestor
138386634|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
138386635|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138386636|NCT01477840|Misoprostol|misoprostol|mesh-list
138363174|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
138363179|NCT05768204|Hormones|hormones|mesh-ancestor
138386641|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138386642|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386643|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
138386645|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138386646|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
138386647|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138386648|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138386649|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138386650|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386651|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386652|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
138386653|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386654|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386655|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138386656|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138386657|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386658|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138386659|NCT01477983|Flecainide|flecainide|mesh-list
138386660|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138386661|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138386662|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386663|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386664|NCT01478022|Ibuprofen|ibuprofen|mesh-list
138386665|NCT01478022|Isosorbide|isosorbide|mesh-list
138386666|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138386667|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138386668|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138386669|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386670|NCT01478022|Analgesics|analgesics|mesh-ancestor
138386671|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
138386672|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386673|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386674|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386675|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386676|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138386677|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386678|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386679|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138386680|NCT01478022|Diuretics|diuretics|mesh-ancestor
138386681|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
138386682|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
138386683|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138386684|NCT01478074|Cytarabine|cytarabine|mesh-list
138386685|NCT01478074|Fludarabine|fludarabine|mesh-list
138386686|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386687|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386688|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
138386689|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386691|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
138386692|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386697|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386698|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386699|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
138386700|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
138386701|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386702|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386703|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138386704|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138386705|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
138386706|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386707|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386708|NCT01478230|Nicotine|nicotine|mesh-list
138386709|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138386710|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
138386711|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386712|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386713|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138386714|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138386715|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386716|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386717|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386718|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
138386719|NCT01478282|Dabigatran|dabigatran|mesh-list
138386720|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138386721|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
138386722|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138386723|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
138386725|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386726|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
138386727|NCT01478308|Metformin|metformin|mesh-list
138386728|NCT01478308|Prednisone|prednisone|mesh-list
138386730|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138386731|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386732|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386733|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386734|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138386735|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138386736|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386737|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386738|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
138386739|NCT01478308|Hormones|hormones|mesh-ancestor
138386740|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386741|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138386743|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138386744|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
138386745|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386750|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138386751|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138386752|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
138386753|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
138386754|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386755|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386756|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138386757|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138386758|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138386759|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386760|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386761|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386762|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138386763|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386764|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386765|NCT01478490|Urological Agents|urological agents|mesh-ancestor
138386766|NCT01478503|Mirabegron|mirabegron|mesh-list
138386767|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138386768|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386769|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386770|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386771|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386772|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386773|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386774|NCT01478503|Urological Agents|urological agents|mesh-ancestor
138386775|NCT01478529|Mirabegron|mirabegron|mesh-list
138386776|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138386777|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386778|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386779|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138386780|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386781|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386782|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386783|NCT01478529|Urological Agents|urological agents|mesh-ancestor
138386784|NCT01478568|Desipramine|desipramine|mesh-list
138386785|NCT01478568|Mirabegron|mirabegron|mesh-list
138386786|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138386787|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138386788|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138386790|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386791|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386792|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386793|NCT01478568|Urological Agents|urological agents|mesh-ancestor
138386794|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138386795|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
138386796|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138386797|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386798|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138386807|NCT01478633|Galantamine|galantamine|mesh-list
138386808|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138386809|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386810|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386811|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
138386812|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386813|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386815|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
138386816|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386817|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
138386818|NCT01478685|Paclitaxel|paclitaxel|mesh-list
138386819|NCT01478685|Carboplatin|carboplatin|mesh-list
138386820|NCT01478685|Azacitidine|azacitidine|mesh-list
138386821|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138386823|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138386824|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386825|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386826|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
138386827|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
138386828|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386829|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138386831|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386832|NCT01478724|Caseins|caseins|mesh-list
138386833|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
138386834|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
138386835|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386865|NCT01479036|Endostatins|endostatins|mesh-list
138386866|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386867|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386868|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
138386869|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
138386870|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386871|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138386872|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138386873|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138386874|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386875|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138386876|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138386877|NCT01479036|Growth Substances|growth substances|mesh-ancestor
138386878|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386879|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
138386881|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386882|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386883|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138386884|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
138386885|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386886|NCT01479114|Lenograstim|lenograstim|mesh-list
138386887|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138386888|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
138386889|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386891|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138386892|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386894|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386895|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138386896|NCT01479192|Protective Agents|protective agents|mesh-ancestor
138386897|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386898|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
138386899|NCT01479231|Lansoprazole|lansoprazole|mesh-list
138386900|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138386901|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386902|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138386903|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386904|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386905|NCT01479244|Molgramostim|molgramostim|mesh-list
138386906|NCT01479244|Sargramostim|sargramostim|mesh-list
138386907|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
138386908|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386909|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386910|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138386912|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138386913|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386914|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
138386915|NCT01479296|Vaccines|vaccines|mesh-list
138386916|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
138386917|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386918|NCT01479361|Atovaquone|atovaquone|mesh-list
138386919|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386920|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
138386921|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138386922|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138386923|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386924|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386925|NCT01479504|Cisplatin|cisplatin|mesh-list
138386926|NCT01479504|Docetaxel|docetaxel|mesh-list
138386927|NCT01479504|Nedaplatin|nedaplatin|mesh-list
138386928|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386929|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386930|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
138386931|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
138386932|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386934|NCT01479556|Analgesics|analgesics|mesh-ancestor
138386935|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
138386936|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386937|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386938|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
138386939|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138386940|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386941|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386942|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386943|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138386944|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138386945|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386946|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138386947|NCT01479634|Efavirenz|efavirenz|mesh-list
138386948|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138386949|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138386950|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386951|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386952|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
138386953|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386954|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138386956|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138386957|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138386958|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138386959|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138386961|NCT01479751|Ketamine|ketamine|mesh-list
138386962|NCT01479751|Rocuronium|rocuronium|mesh-list
138386963|NCT01479751|Analgesics|analgesics|mesh-ancestor
138386964|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
138386965|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386966|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386967|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138386968|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138386969|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
138386970|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
138386971|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138386972|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138386973|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138386974|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138386975|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386976|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138386977|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
138386978|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138386979|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386980|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386981|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
138386982|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138386983|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138386984|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138386985|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138386986|NCT01479881|Cyclosporine|cyclosporine|mesh-list
138386987|NCT01479881|Simeprevir|simeprevir|mesh-list
138386988|NCT01479881|Tacrolimus|tacrolimus|mesh-list
138386989|NCT01479881|Cyclosporins|cyclosporins|mesh-list
138386990|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386991|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
138386992|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386993|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138386994|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386997|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386998|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138386999|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387000|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
138387001|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387002|NCT01479920|Fluoxetine|fluoxetine|mesh-list
138387003|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138387004|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138387005|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387006|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387007|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387008|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
138387009|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387010|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138387012|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387013|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138387014|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387015|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387016|NCT01479933|Vitamin D|vitamin d|mesh-list
138387017|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
138387018|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
138387019|NCT01479933|Vitamins|vitamins|mesh-list
138387020|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
138387021|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387022|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138387023|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138387024|NCT01480050|Temozolomide|temozolomide|mesh-list
138387025|NCT01480050|Mibefradil|mibefradil|mesh-list
138387026|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138387027|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
138387028|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387029|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387030|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138387031|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138387032|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387033|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138387034|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387035|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
138387036|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138387037|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387038|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387039|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
138387040|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138387041|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414729|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138387042|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387045|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387046|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387047|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387048|NCT01480323|Aldesleukin|aldesleukin|mesh-list
138387049|NCT01480323|Ipilimumab|ipilimumab|mesh-list
138387050|NCT01480323|Interleukin-2|interleukin-2|mesh-list
138387051|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138387052|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387053|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138387054|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387055|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387056|NCT01480323|Analgesics|analgesics|mesh-ancestor
138387057|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
138387058|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387059|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387060|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138387061|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138387062|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
138387063|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387064|NCT01480336|Amiodarone|amiodarone|mesh-list
138387065|NCT01480336|Ranolazine|ranolazine|mesh-list
138387066|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138387067|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138387068|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138387069|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387070|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387071|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138387072|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138387073|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387074|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387075|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138387076|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138387077|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138387078|NCT01480492|Telbivudine|telbivudine|mesh-list
138387079|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
138387082|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387083|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387084|NCT01480531|Clevidipine|clevidipine|mesh-list
138387085|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138387086|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387089|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387092|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387093|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387094|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
138387095|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138387096|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
138387097|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387099|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
138387101|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138387102|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
138387103|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387104|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138387105|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138387106|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387107|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387108|NCT01480752|Lornoxicam|lornoxicam|mesh-list
138387109|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138387110|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387111|NCT01480752|Analgesics|analgesics|mesh-ancestor
138387112|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
138387113|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387114|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387115|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387116|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387118|NCT01480765|Ketamine|ketamine|mesh-list
138387119|NCT01480765|Analgesics|analgesics|mesh-ancestor
138387120|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
138387121|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387122|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387123|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138387124|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138387125|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
138387126|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
138387127|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387128|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138387129|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138387130|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387131|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387132|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
138387133|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138387134|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387137|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387138|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387139|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138387140|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138387141|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138387142|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138387143|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
138387144|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138387145|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387146|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138387149|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138387150|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138387151|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138387152|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138387153|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138387154|NCT01480791|Diuretics|diuretics|mesh-ancestor
138387155|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
138387156|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387157|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138387158|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387159|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387161|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387162|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387163|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387164|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387165|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
138387166|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
138387167|NCT01480869|Vitamin D|vitamin d|mesh-list
138387168|NCT01480869|Calcium|calcium|mesh-list
138387169|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138387170|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387171|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138387172|NCT01480869|Vitamins|vitamins|mesh-ancestor
138387173|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
138387174|NCT01480986|Irinotecan|irinotecan|mesh-list
138387175|NCT01480986|Octreotide|octreotide|mesh-list
138387176|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387177|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138387178|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138387179|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387180|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387181|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387182|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138387184|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
138387185|NCT01481194|Doxorubicin|doxorubicin|mesh-list
138387186|NCT01481194|Lenalidomide|lenalidomide|mesh-list
138387187|NCT01481194|Bortezomib|bortezomib|mesh-list
138387188|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387189|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
138387190|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387191|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387192|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138387193|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
138387194|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387195|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387196|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138387197|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387198|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
138387199|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
138387200|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387201|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387202|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
138387203|NCT01481194|Hormones|hormones|mesh-ancestor
138387204|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387205|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138387206|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138387207|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138387208|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138387209|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387210|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138387211|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138387212|NCT01481194|Growth Substances|growth substances|mesh-ancestor
138387213|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
138387214|NCT01481233|Colchicine|colchicine|mesh-list
138387215|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
138387216|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387217|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387218|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
138387219|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
138387220|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387221|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387222|NCT01481259|Pemetrexed|pemetrexed|mesh-list
138387223|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387224|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387225|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387226|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138387227|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138387228|NCT01481311|Bromides|bromides|mesh-list
138387229|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
138387230|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
138387231|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
138387232|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138387233|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138387234|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387235|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387236|NCT01481350|Urological Agents|urological agents|mesh-ancestor
138387237|NCT01481389|Theobromine|theobromine|mesh-list
138387238|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138387239|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
138387240|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387241|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387242|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138387243|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138387244|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
138387245|NCT01481454|Vaccines|vaccines|mesh-list
138387246|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
138387247|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387248|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
138387249|NCT01481519|Dexamethasone|dexamethasone|mesh-list
138387250|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
138387251|NCT01481519|Povidone|povidone|mesh-list
138387252|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
138387253|NCT01481519|BB 1101|bb 1101|mesh-list
138387254|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387255|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
138387256|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
138387257|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387258|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387259|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387260|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
138387262|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387264|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387265|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387266|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387267|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387268|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
138387269|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
138387270|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138387271|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387272|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138387273|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138387274|NCT01481610|Diclofenac|diclofenac|mesh-list
138387275|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
138387276|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138387277|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387278|NCT01481610|Analgesics|analgesics|mesh-ancestor
138387279|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
138387280|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387281|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387282|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387283|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387284|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138387285|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387286|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387287|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138387288|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
138387289|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387290|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
138387291|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
138387292|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
138387293|NCT01481714|Citric Acid|citric acid|mesh-list
138387294|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
138387295|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138387296|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
138387297|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
138387298|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387299|NCT01481714|Cathartics|cathartics|mesh-ancestor
138387300|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387301|NCT01481714|Antacids|antacids|mesh-ancestor
138387302|NCT01481831|Palonosetron|palonosetron|mesh-list
138387303|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
138387304|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
138387305|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387306|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387307|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387308|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138387309|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138387310|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
138387311|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387312|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387314|NCT01481844|Metronidazole|metronidazole|mesh-list
138387315|NCT01481844|Clarithromycin|clarithromycin|mesh-list
138387316|NCT01481844|Tetracycline|tetracycline|mesh-list
138387317|NCT01481844|Tinidazole|tinidazole|mesh-list
138387318|NCT01481844|Lansoprazole|lansoprazole|mesh-list
138387319|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
138387320|NCT01481844|Bismuth|bismuth|mesh-list
138387321|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138387322|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138387323|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387324|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138387325|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138387326|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138387328|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387329|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138387330|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387331|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138387332|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387333|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138387335|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
138387336|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138387337|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
138387339|NCT01481870|Sunitinib|sunitinib|mesh-list
138387340|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387341|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387342|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387343|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387344|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138387345|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138387346|NCT01481870|Growth Substances|growth substances|mesh-ancestor
138387347|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387348|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138387349|NCT01482052|Vaccines|vaccines|mesh-list
138387350|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
138387351|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387352|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138387353|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138387354|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138387355|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
138387356|NCT01482117|Cilostazol|cilostazol|mesh-list
138387357|NCT01482117|Clopidogrel|clopidogrel|mesh-list
138387358|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138387359|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138387362|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
138387363|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387364|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387365|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387366|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138387367|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
138387368|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387369|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138387370|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
138387371|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138387372|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138387373|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
138387374|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138387375|NCT01482117|Protective Agents|protective agents|mesh-ancestor
138387376|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138387377|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138387378|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387381|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138387382|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387383|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387384|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387385|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387386|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
138387387|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387388|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387389|NCT01482299|Everolimus|everolimus|mesh-list
138387390|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138387391|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387392|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387393|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387394|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387395|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
138387396|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387397|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387398|NCT01482338|Drospirenone|drospirenone|mesh-list
138387399|NCT01482338|Desogestrel|desogestrel|mesh-list
138387400|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138387401|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
138387402|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387403|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387404|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138387405|NCT01482338|Diuretics|diuretics|mesh-ancestor
138387406|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
138387407|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138387408|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138387409|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138387410|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
138387411|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138387412|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138387413|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138387414|NCT01482338|Progestins|progestins|mesh-ancestor
138387415|NCT01482338|Hormones|hormones|mesh-ancestor
138387416|NCT01482377|Cetuximab|cetuximab|mesh-list
138387417|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138387418|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138387419|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387420|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387422|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387424|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138363199|NCT05767827|Lidocaine|lidocaine|mesh-list
138387426|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387427|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387428|NCT01482442|Sorafenib|sorafenib|mesh-list
138387429|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387430|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387431|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387432|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387433|NCT01482468|Palonosetron|palonosetron|mesh-list
138387434|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
138387435|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
138387436|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387437|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387438|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387439|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138387440|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138387441|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
138387442|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387443|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387444|NCT01482559|Dopamine|dopamine|mesh-list
138387445|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138387446|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
138387447|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
138387448|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387449|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387450|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
138387451|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387452|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387453|NCT01482559|Protective Agents|protective agents|mesh-ancestor
138387454|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
138387455|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138387457|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387458|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
138387459|NCT01482624|Protective Agents|protective agents|mesh-ancestor
138387460|NCT01482728|Dasatinib|dasatinib|mesh-list
138387461|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387462|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387463|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387464|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387465|NCT01482754|Rituximab|rituximab|mesh-list
138387466|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138387467|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387468|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
138387472|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138387473|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
138387474|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138387475|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
138387476|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138387477|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
138387478|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387479|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
138387480|NCT01482897|Hormones|hormones|mesh-ancestor
138387481|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387482|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387483|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138387484|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387485|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
138387487|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387488|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387489|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138387490|NCT01482897|Protective Agents|protective agents|mesh-ancestor
138387491|NCT01482936|Oxycodone|oxycodone|mesh-list
138387492|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138387493|NCT01482936|Narcotics|narcotics|mesh-ancestor
138387494|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387495|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387496|NCT01482936|Analgesics|analgesics|mesh-ancestor
138387497|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
138387498|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387499|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
138387500|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387501|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387502|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387503|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387504|NCT01483053|Agomelatine|agomelatine|mesh-list
138387505|NCT01483053|Escitalopram|escitalopram|mesh-list
138387506|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138387507|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138387508|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387509|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387510|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387511|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
138387512|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387513|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138387514|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387515|NCT01483248|Interferons|interferons|mesh-list
138387516|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138387517|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387518|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
138387519|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387529|NCT01483365|Hormones|hormones|mesh-ancestor
138387530|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387532|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
138387533|NCT01483508|Procyanidin|procyanidin|mesh-list
138387534|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
138387535|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387536|NCT01483508|Protective Agents|protective agents|mesh-ancestor
138387537|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387538|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138387539|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138387540|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387541|NCT01483638|Axitinib|axitinib|mesh-list
138387542|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387543|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387544|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387545|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387546|NCT01483729|Ritonavir|ritonavir|mesh-list
138387547|NCT01483729|Lactams|lactams|mesh-list
138387548|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138387549|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138387550|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387551|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387552|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387553|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138387555|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
138387556|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387557|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138387558|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387559|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138387560|NCT01483781|Canagliflozin|canagliflozin|mesh-list
138387561|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138387562|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387563|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138387564|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387565|NCT01483859|Liver Extracts|liver extracts|mesh-list
138387566|NCT01483859|Hematinics|hematinics|mesh-ancestor
138387567|NCT01483911|Gontivimab|gontivimab|mesh-list
138387568|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
138387569|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387570|NCT01484015|Cefepime|cefepime|mesh-list
138387571|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138387572|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387573|NCT01484080|Paclitaxel|paclitaxel|mesh-list
138387574|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138387575|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138387576|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387577|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387580|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387581|NCT01484145|Terbinafine|terbinafine|mesh-list
138387582|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
138387583|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387584|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387585|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387586|NCT01484171|Idarubicin|idarubicin|mesh-list
138387587|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138387588|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387589|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138387590|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138387591|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387592|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387593|NCT01484184|Levodopa|levodopa|mesh-list
138387594|NCT01484184|Buspirone|buspirone|mesh-list
138387595|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138387596|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138387597|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
138387598|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387599|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387600|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387601|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138387602|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387603|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387604|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387605|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138387607|NCT01484262|Liraglutide|liraglutide|mesh-list
138387608|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138387609|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387610|NCT01484262|Incretins|incretins|mesh-ancestor
138387611|NCT01484262|Hormones|hormones|mesh-ancestor
138387612|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387613|NCT01484457|Pancrelipase|pancrelipase|mesh-list
138387614|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387615|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138387616|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
138387617|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387618|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138387619|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138387620|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
138387621|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138387622|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387623|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138387624|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138387625|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138387626|NCT01484717|Nicotine|nicotine|mesh-list
138387627|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138387628|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
138387629|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387630|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387632|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138387633|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
138387634|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387635|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387636|NCT01484756|Micronutrients|micronutrients|mesh-list
138387637|NCT01484756|Trace Elements|trace elements|mesh-list
138387639|NCT01484964|Peficitinib|peficitinib|mesh-list
138387640|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387641|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387642|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387643|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
138387644|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387646|NCT01484990|Carbidopa|carbidopa|mesh-list
138387647|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138387648|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138387649|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138387650|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
138387651|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387652|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387653|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387654|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138387655|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387656|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138387657|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
138387658|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
138387659|NCT01485003|Natalizumab|natalizumab|mesh-list
138387660|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
138387661|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387662|NCT01485068|Paclitaxel|paclitaxel|mesh-list
138387663|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138387664|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387665|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387666|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
138387667|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
138387668|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387669|NCT01485081|Paclitaxel|paclitaxel|mesh-list
138387670|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138387671|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387672|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387673|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
138387674|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
138387675|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387676|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138387677|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138387678|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
138387679|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387680|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138387681|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387682|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138387683|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387685|NCT01485185|Donepezil|donepezil|mesh-list
138387686|NCT01485185|Analgesics|analgesics|mesh-ancestor
138387687|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
138387688|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387689|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387690|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
138387691|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138387692|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387693|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387694|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387695|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138387696|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138387698|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387699|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
138387700|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138387701|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387702|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138387703|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
138387705|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387706|NCT01485198|Analgesics|analgesics|mesh-ancestor
138387707|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
138387708|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387709|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387710|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
138387712|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
138387713|NCT01485211|Vitamins|vitamins|mesh-ancestor
138387714|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
138387715|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387716|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138387717|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
138387718|NCT01485224|Thalidomide|thalidomide|mesh-list
138387719|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387720|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
138387721|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387722|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
138387723|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138387724|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387725|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138387726|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138387727|NCT01485224|Growth Substances|growth substances|mesh-ancestor
138387728|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
138387729|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387730|NCT01485315|Mannitol|mannitol|mesh-list
138387731|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138387732|NCT01485315|Diuretics|diuretics|mesh-ancestor
138387733|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
138387734|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387735|NCT01485367|Adapalene|adapalene|mesh-list
138387736|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138387737|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387738|NCT01485367|Analgesics|analgesics|mesh-ancestor
138387739|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
138387740|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387741|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387742|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387743|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387744|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
138387745|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138387746|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
138387751|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138387752|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
138387753|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387754|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387755|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138387756|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
138387757|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
138387758|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138387759|NCT01485562|Misoprostol|misoprostol|mesh-list
138387760|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138387761|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
138387762|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138387763|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387764|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138387765|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387766|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
138387767|NCT01485653|Mepivacaine|mepivacaine|mesh-list
138387768|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
138387769|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
138387770|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387771|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387772|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
138387773|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387774|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
138387775|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
138387776|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387777|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
138387778|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387779|NCT01485692|Promethazine|promethazine|mesh-list
138387780|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
138387782|NCT01485692|Haloperidol|haloperidol|mesh-list
138387783|NCT01485692|Olanzapine|olanzapine|mesh-list
138387784|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
138387785|NCT01485692|Ziprasidone|ziprasidone|mesh-list
138387786|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138387787|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138387788|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387789|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387790|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138387791|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387792|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387793|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138387794|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
138387795|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
138387796|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
138387797|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
138387798|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138387799|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387800|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
138387801|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
138387804|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138387805|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138387806|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138387807|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387808|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
138387809|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138387810|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
138387811|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138387812|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138387813|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
138387814|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138387815|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138387816|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
138387817|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
138387818|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138387819|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138387820|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
138387821|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
138387822|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138387823|NCT01485718|Cathartics|cathartics|mesh-ancestor
138387824|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387825|NCT01485731|Nelfinavir|nelfinavir|mesh-list
138387826|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138387827|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138387828|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387829|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387830|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387831|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138387832|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138387833|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
138387834|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387835|NCT01485744|Leucovorin|leucovorin|mesh-list
138387836|NCT01485744|Fluorouracil|fluorouracil|mesh-list
138387837|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
138387838|NCT01485744|Irinotecan|irinotecan|mesh-list
138387839|NCT01485744|Folfirinox|folfirinox|mesh-list
138387840|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
138387841|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387842|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138387843|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387844|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387845|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
138387846|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387847|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138387848|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138387849|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387851|NCT01485744|Protective Agents|protective agents|mesh-ancestor
138387852|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
138387854|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
138387855|NCT01485822|Travoprost|travoprost|mesh-list
138387856|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138387857|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138387862|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
138387863|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
138387864|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387865|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387866|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387867|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
138387868|NCT01485835|Hormones|hormones|mesh-ancestor
138387869|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387870|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138387871|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387872|NCT01485848|Paclitaxel|paclitaxel|mesh-list
138387873|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138387874|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387875|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387876|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
138387877|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
138387878|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387880|NCT01485926|Docetaxel|docetaxel|mesh-list
138387881|NCT01485926|Trastuzumab|trastuzumab|mesh-list
138387882|NCT01485926|Lapatinib|lapatinib|mesh-list
138387883|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387884|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138387885|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138387886|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138387887|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387888|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138387890|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387891|NCT01485939|Lidocaine|lidocaine|mesh-list
138387892|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
138387893|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
138387894|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387895|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387896|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
138387897|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387898|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138387899|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138387900|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138387901|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387902|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387904|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138387906|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387907|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387908|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138387909|NCT01486004|Simeprevir|simeprevir|mesh-list
138387910|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
138387911|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387912|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387913|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387914|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387915|NCT01486017|Peficitinib|peficitinib|mesh-list
138387916|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387917|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387918|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387919|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
138387920|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387927|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387928|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138387929|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387930|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387931|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138387932|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138387933|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138387934|NCT01486251|Axitinib|axitinib|mesh-list
138387935|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387936|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138387937|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387938|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387939|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
138387940|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
138387941|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138387942|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138387943|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387944|NCT01486433|Aspirin|aspirin|mesh-list
138387945|NCT01486433|Simvastatin|simvastatin|mesh-list
138387946|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138387947|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387948|NCT01486433|Analgesics|analgesics|mesh-ancestor
138387949|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
138387950|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387951|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387952|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387953|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387954|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138387955|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138387956|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387957|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138387958|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138387959|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387960|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
138387961|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138387962|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138387963|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
138387964|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138414730|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138387972|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387973|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387974|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387976|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138387977|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138387978|NCT01486485|Analgesics|analgesics|mesh-ancestor
138387979|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
138387980|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387981|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387982|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387983|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387985|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
138387986|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387987|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387988|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138387989|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138387990|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138387991|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387992|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
138387994|NCT01486511|Hematinics|hematinics|mesh-ancestor
138387995|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138363215|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387996|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
138387997|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
138387998|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138387999|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
138388000|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
138388001|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138388002|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
138388003|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
138388005|NCT01486602|Carboplatin|carboplatin|mesh-list
138388006|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138388007|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388008|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388009|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138388010|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138388011|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388012|NCT01486706|Gabapentin|gabapentin|mesh-list
138388013|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
138388014|NCT01486706|Analgesics|analgesics|mesh-ancestor
138388015|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
138388016|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388017|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388018|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
138388019|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138388023|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138388025|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388026|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388028|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138388029|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138388030|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388031|NCT01486706|Urological Agents|urological agents|mesh-ancestor
138388032|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138388033|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
138388034|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388036|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
138388037|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138388038|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388039|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388041|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388042|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388043|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388044|NCT01486901|Insulin|insulin|mesh-list
138388045|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388046|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
138388047|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
138388048|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
138388049|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388050|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388051|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
138388052|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388053|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388054|NCT01486940|Insulin|insulin|mesh-list
138388055|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388056|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
138388057|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
138388058|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
138388059|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
138388060|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
138388061|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388062|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388063|NCT01486953|Sevoflurane|sevoflurane|mesh-list
138388064|NCT01486953|Desflurane|desflurane|mesh-list
138388065|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138388066|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138388067|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
138388068|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
138388069|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388070|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388071|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138388072|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138388073|NCT01486979|Estradiol|estradiol|mesh-list
138388082|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138388083|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
138388084|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138388085|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388086|NCT01487096|Teriflunomide|teriflunomide|mesh-list
138388087|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388088|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388089|NCT01487096|Analgesics|analgesics|mesh-ancestor
138388090|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
138388091|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388092|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388093|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388094|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388095|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388096|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
138388097|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
138388098|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138388099|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388100|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138388101|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138388102|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388103|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388104|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388105|NCT01487226|Paclitaxel|paclitaxel|mesh-list
138388106|NCT01487226|Cisplatin|cisplatin|mesh-list
138388107|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138388108|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388109|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388110|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
138388112|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388113|NCT01487278|Misoprostol|misoprostol|mesh-list
138388114|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138388115|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
138388116|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138388117|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388118|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138388119|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388122|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388123|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388125|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138388126|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388127|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388128|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388129|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388130|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388131|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138388134|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388135|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388136|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
138388137|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388138|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388139|NCT01487395|Donepezil|donepezil|mesh-list
138388140|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138388141|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388142|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388143|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388144|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388145|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388146|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
138388147|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
138388148|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388149|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388150|NCT01487421|Insulin|insulin|mesh-list
138388151|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388152|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
138388153|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
138388154|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388155|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388156|NCT01487512|Hydromorphone|hydromorphone|mesh-list
138388157|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388158|NCT01487512|Narcotics|narcotics|mesh-ancestor
138388159|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388160|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388161|NCT01487512|Analgesics|analgesics|mesh-ancestor
138388162|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
138388163|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388164|NCT01487564|Hydromorphone|hydromorphone|mesh-list
138388165|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388166|NCT01487564|Narcotics|narcotics|mesh-ancestor
138388167|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388168|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388170|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
138388171|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388172|NCT01487629|Bevacizumab|bevacizumab|mesh-list
138388173|NCT01487629|Ranibizumab|ranibizumab|mesh-list
138388174|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138388175|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388176|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138388177|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138388179|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388180|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
138388181|NCT01487785|Gemcitabine|gemcitabine|mesh-list
138388182|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388183|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
138388187|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388188|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
138388189|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
138388190|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138388191|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388192|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388193|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
138388194|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
138388195|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138388196|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388197|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388198|NCT01487993|Metformin|metformin|mesh-list
138388199|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388200|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388201|NCT01488136|Diazoxide|diazoxide|mesh-list
138388202|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138388203|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
138388204|NCT01488201|Brodalumab|brodalumab|mesh-list
138388205|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
138388206|NCT01488227|Vitamin D|vitamin d|mesh-list
138388207|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
138388208|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
138388209|NCT01488227|Vitamins|vitamins|mesh-list
138388210|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
138388211|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388212|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138388213|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138388214|NCT01488253|Sirolimus|sirolimus|mesh-list
138388215|NCT01488253|Temsirolimus|temsirolimus|mesh-list
138388216|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
138388217|NCT01488253|Tacrolimus|tacrolimus|mesh-list
138388218|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388219|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
138388220|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388221|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138388222|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388223|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388225|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388226|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138388227|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388228|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
138388229|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138388230|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138388231|NCT01488266|Milnacipran|milnacipran|mesh-list
138388232|NCT01488266|Aripiprazole|aripiprazole|mesh-list
138388233|NCT01488266|Mirtazapine|mirtazapine|mesh-list
138388235|NCT01488266|Fluoxetine|fluoxetine|mesh-list
138388236|NCT01488266|Paroxetine|paroxetine|mesh-list
138388237|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138388238|NCT01488266|Sertraline|sertraline|mesh-list
138388239|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
138388240|NCT01488266|Escitalopram|escitalopram|mesh-list
138388241|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138388242|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138363226|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
138388243|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388247|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388248|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388249|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138388250|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138388251|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138388252|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
138388253|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138388254|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138388255|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388256|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138388257|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138388258|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388259|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
138388260|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138388261|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138388262|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138388263|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138388264|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138388265|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138388266|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138388268|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
138388269|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138388270|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
138388271|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
138388272|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138388273|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138388274|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138388275|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138388276|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
138388278|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388279|NCT01488305|Micronutrients|micronutrients|mesh-list
138388280|NCT01488305|Trace Elements|trace elements|mesh-list
138388281|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388282|NCT01488344|Nintedanib|nintedanib|mesh-list
138388283|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388284|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138388285|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388286|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388287|NCT01488396|Cyclosporine|cyclosporine|mesh-list
138388288|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138388289|NCT01488396|Cyclosporins|cyclosporins|mesh-list
138388290|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388291|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388292|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388293|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
138388294|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388295|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
138388296|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388302|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
138388303|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388304|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138388305|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138388306|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388307|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388308|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138388309|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138388311|NCT01488552|Paclitaxel|paclitaxel|mesh-list
138388312|NCT01488552|Gemcitabine|gemcitabine|mesh-list
138388313|NCT01488552|Folfirinox|folfirinox|mesh-list
138388314|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138388315|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388316|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388317|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
138388318|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
138388319|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388320|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388321|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
138388322|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388323|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388324|NCT01488565|Azacitidine|azacitidine|mesh-list
138388325|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388327|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388328|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388329|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388330|NCT01488656|Vitamin D|vitamin d|mesh-list
138388331|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138388332|NCT01488656|Antioxidants|antioxidants|mesh-list
138388333|NCT01488656|Vitamins|vitamins|mesh-ancestor
138388334|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
138388335|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388336|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138388337|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388338|NCT01488656|Protective Agents|protective agents|mesh-ancestor
138388339|NCT01488734|Vitamin D|vitamin d|mesh-list
138388340|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
138388341|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
138388342|NCT01488734|Vitamins|vitamins|mesh-list
138388343|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
138388344|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388345|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138388346|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138388347|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138388348|NCT01488773|Montelukast|montelukast|mesh-list
138388349|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138388350|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
138388351|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388352|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388353|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138388354|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138388355|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138388356|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138388357|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138388364|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138388365|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138388366|NCT01488838|Cisplatin|cisplatin|mesh-list
138388367|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388368|NCT01488955|Fosfomycin|fosfomycin|mesh-list
138388369|NCT01488955|Ibuprofen|ibuprofen|mesh-list
138388370|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388371|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388372|NCT01488955|Analgesics|analgesics|mesh-ancestor
138388373|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
138388374|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388375|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388376|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388377|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388378|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138388380|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388381|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138388382|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388383|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
138388384|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
138388385|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388387|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138388388|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388389|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138388390|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388391|NCT01489072|Remifentanil|remifentanil|mesh-list
138388392|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388393|NCT01489072|Narcotics|narcotics|mesh-ancestor
138388394|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388395|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388396|NCT01489072|Analgesics|analgesics|mesh-ancestor
138388397|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
138388398|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388399|NCT01489124|Imipenem|imipenem|mesh-list
138388400|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138388401|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388403|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388404|NCT01489137|Narcotics|narcotics|mesh-ancestor
138388405|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388406|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388407|NCT01489137|Analgesics|analgesics|mesh-ancestor
138388408|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
138388409|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388410|NCT01489202|Cobalt|cobalt|mesh-list
138388411|NCT01489202|Chromium|chromium|mesh-list
138388412|NCT01489202|Everolimus|everolimus|mesh-list
138388417|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388418|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
138388419|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388420|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388422|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
138388423|NCT01489228|Benzonidazole|benzonidazole|mesh-list
138388424|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388425|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
138388426|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388427|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138388428|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138388429|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138388430|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388431|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138388432|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
138388433|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388434|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388435|NCT01489319|Analgesics|analgesics|mesh-ancestor
138388436|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
138388437|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388438|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388439|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388440|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388441|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138388442|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388443|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388444|NCT01489371|Doxorubicin|doxorubicin|mesh-list
138388445|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138388446|NCT01489371|Interleukin-12|interleukin-12|mesh-list
138388447|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138388448|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388449|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138388450|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138388451|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388452|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388453|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138388454|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
138388455|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388456|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138388457|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138388458|NCT01489371|Growth Substances|growth substances|mesh-ancestor
138388459|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
138388460|NCT01489410|Ethanol|ethanol|mesh-list
138388461|NCT01489410|Doxorubicin|doxorubicin|mesh-list
138388462|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138388463|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
138388464|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138388465|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388466|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138388475|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
138388476|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388477|NCT01489566|Fluorouracil|fluorouracil|mesh-list
138388478|NCT01489566|Mitomycins|mitomycins|mesh-list
138388479|NCT01489566|Mitomycin|mitomycin|mesh-list
138388480|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
138388481|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388482|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388483|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388484|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388485|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
138388486|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388487|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138388488|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
138388490|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388491|NCT01489592|Turmeric extract|turmeric extract|mesh-list
138388492|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
138388493|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388494|NCT01489592|Protective Agents|protective agents|mesh-ancestor
138388495|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388496|NCT01489631|Sufentanil|sufentanil|mesh-list
138388497|NCT01489631|Gabapentin|gabapentin|mesh-list
138388498|NCT01489631|Bupivacaine|bupivacaine|mesh-list
138388499|NCT01489631|Ropivacaine|ropivacaine|mesh-list
138388500|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
138388501|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
138388502|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388503|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388504|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
138388505|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388506|NCT01489631|Analgesics|analgesics|mesh-ancestor
138388507|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
138388508|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138388509|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138388510|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138388511|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138388512|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138388513|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388517|NCT01489631|Narcotics|narcotics|mesh-ancestor
138388518|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138388519|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138388520|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
138388521|NCT01489644|Metformin|metformin|mesh-list
138388524|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388525|NCT01489683|Lidocaine|lidocaine|mesh-list
138388526|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
138388527|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
138388528|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388529|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388530|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
138388531|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388532|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138388533|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138388534|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138388535|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388536|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388538|NCT01489696|Mirabegron|mirabegron|mesh-list
138388539|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138388540|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138388541|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138388542|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
138388543|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388544|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388545|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388546|NCT01489696|Urological Agents|urological agents|mesh-ancestor
138388547|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138388548|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138388549|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138388550|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
138388551|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138388552|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138388553|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388554|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388555|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388556|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388557|NCT01489709|Urological Agents|urological agents|mesh-ancestor
138388558|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138388559|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138388560|NCT01489852|Estradiol|estradiol|mesh-list
138388561|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138388562|NCT01489852|Estrogens|estrogens|mesh-ancestor
138388563|NCT01489852|Hormones|hormones|mesh-ancestor
138388564|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388569|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138388571|NCT01489865|Veliparib|veliparib|mesh-list
138388572|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
138388573|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388574|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388575|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388576|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388577|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
138363239|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
138388578|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388579|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138388580|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388581|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
138388582|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138388583|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138388584|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138388585|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388586|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388587|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388588|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388589|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388590|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138388591|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388593|NCT01489917|Hemostatics|hemostatics|mesh-list
138388594|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
138388595|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138388596|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138388597|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388598|NCT01489917|Coagulants|coagulants|mesh-ancestor
138388599|NCT01489943|Pioglitazone|pioglitazone|mesh-list
138388600|NCT01489943|Midazolam|midazolam|mesh-list
138388601|NCT01489943|Omeprazole|omeprazole|mesh-list
138388602|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138388603|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138388609|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138388610|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138388611|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
138388612|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
138388613|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
138388614|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
138388615|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388616|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388617|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138388618|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138388619|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
138388620|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138388621|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138388623|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388624|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138388625|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388626|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138388627|NCT01489982|Zopiclone|zopiclone|mesh-list
138388628|NCT01489982|Doxepin|doxepin|mesh-list
138388629|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138388630|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388631|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388632|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138388633|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138388634|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
138388636|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
138388637|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
138388638|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388639|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388640|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138388641|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
138388642|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388643|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388644|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388645|NCT01490047|Etanercept|etanercept|mesh-list
138388646|NCT01490047|Doxorubicin|doxorubicin|mesh-list
138388647|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138388648|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138388649|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388650|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138388651|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138388652|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388653|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388654|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388655|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388656|NCT01490047|Analgesics|analgesics|mesh-ancestor
138388657|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
138388663|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388664|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
138388665|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
138388666|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388667|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388669|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388670|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388671|NCT01490203|Edetic Acid|edetic acid|mesh-list
138388672|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
138388673|NCT01490203|Antidotes|antidotes|mesh-ancestor
138388674|NCT01490203|Protective Agents|protective agents|mesh-ancestor
138388675|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388676|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
138388677|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
138388678|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388679|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138388680|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
138388681|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138388682|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138388683|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138388684|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388685|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138388686|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138388687|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388688|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388689|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
138388690|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388692|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138388693|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138388694|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
138388695|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388696|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138388699|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138388700|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138388701|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388702|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388703|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138388704|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388705|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
138388706|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138388707|NCT01490268|Sufentanil|sufentanil|mesh-list
138388709|NCT01490268|Hydromorphone|hydromorphone|mesh-list
138388710|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388711|NCT01490268|Narcotics|narcotics|mesh-ancestor
138388712|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388713|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388714|NCT01490268|Analgesics|analgesics|mesh-ancestor
138388715|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
138388716|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388724|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
138388725|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388726|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138388727|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138388728|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138388729|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
138388730|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388731|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138388732|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138388733|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138388734|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
138388735|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388736|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138388737|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138388738|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388739|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
138388740|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
138388741|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388742|NCT01490437|Dexamethasone|dexamethasone|mesh-list
138388743|NCT01490437|Pemetrexed|pemetrexed|mesh-list
138388744|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388745|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388746|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
138388747|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
138388748|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388749|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388750|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
138388751|NCT01490437|Hormones|hormones|mesh-ancestor
138388752|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388753|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138388754|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388755|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388756|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388757|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138388758|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138388759|NCT01490476|Everolimus|everolimus|mesh-list
138388760|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388761|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388762|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
138388767|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388768|NCT01490567|Donepezil|donepezil|mesh-list
138388769|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138388770|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388771|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388772|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388773|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388774|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388775|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
138388776|NCT01490658|Metformin|metformin|mesh-list
138388777|NCT01490658|Repaglinide|repaglinide|mesh-list
138388778|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388779|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388780|NCT01490671|Tenofovir|tenofovir|mesh-list
138388781|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
138388782|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388783|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138388784|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138388785|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388786|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388787|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138388788|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138388789|NCT01490749|Carboplatin|carboplatin|mesh-list
138388790|NCT01490749|Capecitabine|capecitabine|mesh-list
138388791|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
138388792|NCT01490749|Everolimus|everolimus|mesh-list
138388793|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388794|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388795|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
138388796|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388797|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138388798|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138388799|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388800|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138388801|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
138388802|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388804|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388805|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388806|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388807|NCT01490905|Ibuprofen|ibuprofen|mesh-list
138388808|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388809|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388810|NCT01490905|Analgesics|analgesics|mesh-ancestor
138388811|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
138388812|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388813|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388814|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388815|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388816|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138388817|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388818|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388819|NCT01490944|Iron|iron|mesh-list
138388820|NCT01490944|Folic Acid|folic acid|mesh-list
138388821|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
138388822|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
138388823|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
138388824|NCT01490944|Trace Elements|trace elements|mesh-ancestor
138388829|NCT01490996|Curcumin|curcumin|mesh-list
138388830|NCT01490996|Capecitabine|capecitabine|mesh-list
138388831|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138388832|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
138388833|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388834|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388835|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388836|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388837|NCT01490996|Analgesics|analgesics|mesh-ancestor
138388838|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
138388839|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388840|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388841|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388842|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388843|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388844|NCT01491009|Midazolam|midazolam|mesh-list
138388847|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138388848|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388849|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388850|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138388851|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138388852|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138388853|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138388854|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
138388855|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
138388856|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
138388858|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388859|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388860|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138388861|NCT01491009|Narcotics|narcotics|mesh-ancestor
138388862|NCT01491009|Analgesics|analgesics|mesh-ancestor
138388863|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
138388864|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388865|NCT01491048|Tacrine|tacrine|mesh-list
138388866|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138388867|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388868|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388869|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
138388870|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388871|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388881|NCT01491100|Interferon-beta|interferon-beta|mesh-list
138388882|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
138388883|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388884|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
138388885|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388886|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
138388887|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388888|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138388889|NCT01491139|Olaparib|olaparib|mesh-list
138388890|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388891|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138388892|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388893|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388894|NCT01491191|Palmidrol|palmidrol|mesh-list
138388895|NCT01491191|Analgesics|analgesics|mesh-ancestor
138388896|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
138388897|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388898|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388899|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388900|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388901|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388902|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388903|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
138363245|NCT05767723|Analgesics|analgesics|mesh-ancestor
138388904|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388905|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138388906|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138388908|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388909|NCT01491191|Hormones|hormones|mesh-ancestor
138388910|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388911|NCT01491204|Paclitaxel|paclitaxel|mesh-list
138388912|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138388913|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388914|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388915|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138388916|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138388917|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388918|NCT01491217|Paclitaxel|paclitaxel|mesh-list
138388923|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
138388924|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388925|NCT01491256|Atorvastatin|atorvastatin|mesh-list
138388926|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138388927|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138388928|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
138388929|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388930|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138388931|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138388932|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388934|NCT01491295|Lamivudine|lamivudine|mesh-list
138388935|NCT01491295|Adefovir|adefovir|mesh-list
138388936|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
138388937|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388938|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138388939|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138388940|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388941|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388942|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138388943|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138388944|NCT01491321|Loxoprofen|loxoprofen|mesh-list
138388945|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138388946|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138388947|NCT01491321|Analgesics|analgesics|mesh-ancestor
138388948|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
138388949|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388950|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388951|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388953|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138388954|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138388955|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388956|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
138388957|NCT01491503|Cetirizine|cetirizine|mesh-list
138388958|NCT01491503|Montelukast|montelukast|mesh-list
138388959|NCT01491503|Levocetirizine|levocetirizine|mesh-list
138388960|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138388961|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138388962|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138388963|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
138388964|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388965|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388979|NCT01491867|Travoprost|travoprost|mesh-list
138388980|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138388981|NCT01492062|Pancrelipase|pancrelipase|mesh-list
138388982|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388983|NCT01492114|Resveratrol|resveratrol|mesh-list
138388984|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
138388985|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388986|NCT01492114|Protective Agents|protective agents|mesh-ancestor
138388987|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388988|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388989|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138388990|NCT01492153|Insulin|insulin|mesh-list
138388991|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388992|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
138388993|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
138388994|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
138388995|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138388996|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388998|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138388999|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389000|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389001|NCT01492179|Lidocaine|lidocaine|mesh-list
138389002|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389003|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
138389004|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389005|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389006|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
138389007|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389008|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389009|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138389010|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138389019|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389020|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389021|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138389022|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389023|NCT01492504|Asunaprevir|asunaprevir|mesh-list
138389024|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
138389025|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389026|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389027|NCT01492543|Tegafur|tegafur|mesh-list
138389028|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389029|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
138389030|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389031|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389032|NCT01492556|Etoposide|etoposide|mesh-list
138389033|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389034|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389035|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138389036|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138389037|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389038|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389039|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
138389040|NCT01492608|Analgesics|analgesics|mesh-ancestor
138389041|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
138389042|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389043|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389044|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
138389045|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389046|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389047|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
138389048|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138389049|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389050|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389051|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389052|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
138389053|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138389054|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138389055|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138389056|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138389057|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389058|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389059|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389060|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389061|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
138389070|NCT01492725|Plasminogen|plasminogen|mesh-list
138389071|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138389072|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138389073|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389074|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389076|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138389077|NCT01492881|Bortezomib|bortezomib|mesh-list
138389078|NCT01492881|Vorinostat|vorinostat|mesh-list
138389079|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138389080|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389081|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138389082|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138389083|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389084|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389085|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138389086|NCT01492894|Cyclosporine|cyclosporine|mesh-list
138389087|NCT01492894|Sirolimus|sirolimus|mesh-list
138389088|NCT01492894|Tacrolimus|tacrolimus|mesh-list
138389089|NCT01492894|Cyclosporins|cyclosporins|mesh-list
138389090|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389091|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
138389092|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389093|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138389094|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389095|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389096|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
138389097|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389098|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389099|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389100|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389101|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138389102|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389104|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
138389105|NCT01492920|Vitamins|vitamins|mesh-ancestor
138389106|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
138389107|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389108|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
138389109|NCT01492959|Insulin|insulin|mesh-list
138389110|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389111|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389112|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389120|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389122|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389123|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138389124|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
138389125|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
138389126|NCT01493102|Vasopressins|vasopressins|mesh-list
138389127|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
138389128|NCT01493102|Norepinephrine|norepinephrine|mesh-list
138389129|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138389130|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138389131|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
138389132|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389133|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389134|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389135|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
138389136|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
138389137|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389138|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138389139|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
138389140|NCT01493102|Coagulants|coagulants|mesh-ancestor
138389141|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138389142|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
138389144|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389145|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
138389153|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389154|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138389155|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
138389156|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389157|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389158|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138389159|NCT01493310|Paclitaxel|paclitaxel|mesh-list
138389160|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138389161|NCT01493310|Mifepristone|mifepristone|mesh-list
138389162|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389163|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389164|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389165|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389166|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389167|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389168|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138389169|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
138389170|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138389171|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389172|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138389173|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138389174|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138389175|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
138389176|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138389177|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138389178|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
138389179|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389180|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
138389181|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138389182|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138389183|NCT01493336|Capecitabine|capecitabine|mesh-list
138389184|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389185|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
138389186|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389187|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389188|NCT01493388|Insulin|insulin|mesh-list
138389189|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389190|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389191|NCT01493440|Atosiban|atosiban|mesh-list
138389192|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
138389212|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389213|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389214|NCT01493648|Vitamin D|vitamin d|mesh-list
138389215|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
138389216|NCT01493648|Vitamins|vitamins|mesh-ancestor
138389217|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
138389218|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389219|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138389220|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389221|NCT01493674|Folic Acid|folic acid|mesh-list
138389222|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
138389232|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138389234|NCT01493843|Bevacizumab|bevacizumab|mesh-list
138389235|NCT01493843|Carboplatin|carboplatin|mesh-list
138389236|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389237|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389238|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389239|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389240|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389241|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389242|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138389243|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389244|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389245|NCT01493843|Growth Substances|growth substances|mesh-ancestor
138389246|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389247|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
138389248|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138389249|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138389250|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138389251|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138389252|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389254|NCT01493973|Hematinics|hematinics|mesh-ancestor
138389255|NCT01493986|Ropivacaine|ropivacaine|mesh-list
138389256|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389257|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
138389258|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389259|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389260|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
138389261|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389262|NCT01493999|Clopidogrel|clopidogrel|mesh-list
138389263|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138389264|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138389265|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138389266|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138389267|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138389268|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
138389269|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389270|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389271|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389272|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138389273|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138389274|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389275|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138389280|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138389281|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138389282|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389283|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
138389285|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389286|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
138389287|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389288|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389289|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
138389290|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138389291|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138389292|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389293|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389294|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389296|NCT01494259|Bupivacaine|bupivacaine|mesh-list
138389297|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389298|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
138389299|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389300|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389301|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
138389302|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389303|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138389304|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138389305|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
138389306|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389307|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389308|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138389309|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138389311|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138389312|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138389313|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
138389314|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
138389315|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138389316|NCT01494311|Lidocaine|lidocaine|mesh-list
138389317|NCT01494311|Tetracaine|tetracaine|mesh-list
138389318|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389319|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
138389320|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389321|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389322|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
138389328|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389329|NCT01494363|Leucovorin|leucovorin|mesh-list
138389330|NCT01494363|Fluorouracil|fluorouracil|mesh-list
138389331|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
138389332|NCT01494363|Irinotecan|irinotecan|mesh-list
138389333|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
138389334|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389335|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389336|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389337|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389338|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
138389339|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389340|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138389341|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138389342|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389343|NCT01494363|Antidotes|antidotes|mesh-ancestor
138389344|NCT01494363|Protective Agents|protective agents|mesh-ancestor
138389345|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
138389346|NCT01494363|Vitamins|vitamins|mesh-ancestor
138389347|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
138389348|NCT01494402|Aspirin|aspirin|mesh-list
138389349|NCT01494402|Esomeprazole|esomeprazole|mesh-list
138389350|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138389351|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138389352|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138389353|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389354|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389355|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138389356|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138389357|NCT01494402|Analgesics|analgesics|mesh-ancestor
138389358|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
138389359|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389360|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389361|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389362|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389363|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138389364|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389366|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138389367|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
138389368|NCT01494415|Paclitaxel|paclitaxel|mesh-list
138389369|NCT01494415|Carboplatin|carboplatin|mesh-list
138389370|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389371|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389372|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389373|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389380|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389381|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389382|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
138389383|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389384|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
138389385|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389386|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389387|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389388|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138389389|NCT01494636|Lidocaine|lidocaine|mesh-list
138389390|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138389391|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389392|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
138389393|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389394|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389395|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
138389396|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389397|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389398|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138389399|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138389400|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389401|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389402|NCT01494688|Paclitaxel|paclitaxel|mesh-list
138389403|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389404|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389405|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389406|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389407|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389408|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389409|NCT01494714|Petrolatum|petrolatum|mesh-list
138389410|NCT01494714|Emollients|emollients|mesh-ancestor
138389411|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389412|NCT01494727|Amlodipine|amlodipine|mesh-list
138389413|NCT01494727|Valsartan|valsartan|mesh-list
138389415|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138389416|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138389423|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138389424|NCT01494740|Vaccines|vaccines|mesh-list
138389425|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
138389426|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389428|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389429|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389430|NCT01494805|Growth Substances|growth substances|mesh-ancestor
138389431|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389432|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
138389433|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389434|NCT01494857|Adalimumab|adalimumab|mesh-list
138389435|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138389436|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389437|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389438|NCT01495026|Tamsulosin|tamsulosin|mesh-list
138389439|NCT01495026|Dutasteride|dutasteride|mesh-list
138389440|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138389441|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138389442|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138389443|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
138389444|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389445|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389446|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389447|NCT01495026|Urological Agents|urological agents|mesh-ancestor
138389448|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138389449|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138389450|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389451|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
138389452|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389454|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389455|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389456|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
138389457|NCT01495039|Ionophores|ionophores|mesh-ancestor
138389458|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389459|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389460|NCT01495104|Valproic Acid|valproic acid|mesh-list
138389461|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
138389462|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389463|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389464|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
138389465|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389466|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389467|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
138389468|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138389476|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138389477|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138389478|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389479|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
138389480|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389481|NCT01495117|Trace Elements|trace elements|mesh-ancestor
138389482|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
138389483|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389484|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
138389485|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
138389486|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
138389487|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138389488|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138389489|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389490|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389491|NCT01495169|Iloperidone|iloperidone|mesh-list
138389492|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138389493|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138389494|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389495|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389496|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138389498|NCT01495195|Donepezil|donepezil|mesh-list
138389499|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138389500|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389501|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389502|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
138389503|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389504|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389505|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
138389506|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
138389507|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138389508|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138389509|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138389510|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138389511|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138389512|NCT01495195|Protective Agents|protective agents|mesh-ancestor
138389513|NCT01495208|Aflibercept|aflibercept|mesh-list
138389514|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389515|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389516|NCT01495208|Growth Substances|growth substances|mesh-ancestor
138389517|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389519|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389520|NCT01495260|Vitamin E|vitamin e|mesh-list
138389521|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
138389522|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
138389529|NCT01495260|Expectorants|expectorants|mesh-ancestor
138389530|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
138389531|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138389532|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
138389533|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389534|NCT01495260|Protective Agents|protective agents|mesh-ancestor
138389535|NCT01495260|Antidotes|antidotes|mesh-ancestor
138389536|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
138389537|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138389538|NCT01495338|Cetirizine|cetirizine|mesh-list
138389539|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138389540|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138389541|NCT01495338|Analgesics|analgesics|mesh-ancestor
138389542|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
138389543|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389544|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389545|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389546|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389547|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138389548|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138389549|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138389550|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
138389551|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
138389552|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389553|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389554|NCT01495351|Bortezomib|bortezomib|mesh-list
138389555|NCT01495351|Veliparib|veliparib|mesh-list
138389556|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389557|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138389558|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389559|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389560|NCT01495377|Remifentanil|remifentanil|mesh-list
138389563|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389564|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389565|NCT01495377|Analgesics|analgesics|mesh-ancestor
138389566|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
138389567|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389568|NCT01495468|Hormones|hormones|mesh-list
138389569|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389570|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389571|NCT01495520|Ranolazine|ranolazine|mesh-list
138389572|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138389573|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389574|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389575|NCT01495624|Dexamethasone|dexamethasone|mesh-list
138389576|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
138389577|NCT01495624|Ropivacaine|ropivacaine|mesh-list
138389583|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389584|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389585|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138389586|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
138389588|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389589|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138389590|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389591|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
138389592|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389593|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389594|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389595|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389596|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
138389598|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
138389599|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389600|NCT01495715|Protective Agents|protective agents|mesh-ancestor
138389601|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389602|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138389603|NCT01495806|Cathartics|cathartics|mesh-ancestor
138389604|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138389605|NCT01495845|Clopidogrel|clopidogrel|mesh-list
138389606|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138389607|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138389608|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138389609|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138389610|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
138389611|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389612|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389613|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389615|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389616|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389617|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389618|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389619|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
138389625|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389627|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138389628|NCT01495949|Thiopental|thiopental|mesh-list
138389629|NCT01495949|Etomidate|etomidate|mesh-list
138389630|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138389631|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389632|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389633|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138389634|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
138389635|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
138389636|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
138389637|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
138389638|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
138389639|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389640|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389641|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
138389642|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138389643|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138389644|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138389645|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389646|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389647|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
138389648|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389649|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389650|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138389651|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389652|NCT01496105|Lidocaine|lidocaine|mesh-list
138389653|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
138389654|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
138389655|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389656|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389658|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389659|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389660|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138389661|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138389662|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389663|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389664|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
138389665|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138389666|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389667|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389669|NCT01496196|Coagulants|coagulants|mesh-ancestor
138389670|NCT01496261|Aspirin|aspirin|mesh-list
138389671|NCT01496261|Clopidogrel|clopidogrel|mesh-list
138389672|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138389673|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138389674|NCT01496261|Analgesics|analgesics|mesh-ancestor
138389675|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
138389676|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389677|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389678|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389683|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138389684|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138389685|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389686|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
138389687|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138389688|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138389689|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138389690|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
138389691|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389693|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138389694|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138389695|NCT01496326|Analgesics|analgesics|mesh-ancestor
138389696|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
138389697|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389698|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389699|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389700|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389701|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138389702|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389703|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389704|NCT01496417|Abatacept|abatacept|mesh-list
138389705|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138389706|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389707|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138389708|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389709|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389710|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
138389711|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389712|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389713|NCT01496443|Glimepiride|glimepiride|mesh-list
138389714|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389715|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389716|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389717|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389718|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
138389719|NCT01496521|Aspirin|aspirin|mesh-list
138389720|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138389721|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138389722|NCT01496521|Analgesics|analgesics|mesh-ancestor
138389723|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
138389724|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389725|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389726|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389727|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389728|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138389729|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389730|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389731|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138389732|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138389733|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389734|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
138389735|NCT01496534|Carboplatin|carboplatin|mesh-list
138389736|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389737|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
138389743|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389744|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389745|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
138389746|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138389747|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389748|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389749|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389750|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138389751|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138389752|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389753|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138389754|NCT01496742|Paclitaxel|paclitaxel|mesh-list
138389755|NCT01496742|Bevacizumab|bevacizumab|mesh-list
138389756|NCT01496742|Carboplatin|carboplatin|mesh-list
138389758|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389760|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389761|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389762|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389763|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389764|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138389765|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389766|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389767|NCT01496742|Growth Substances|growth substances|mesh-ancestor
138389768|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389769|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
138389770|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389771|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138389772|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138389774|NCT01496911|Levocetirizine|levocetirizine|mesh-list
138389775|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138389776|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138389777|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
138389778|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
138389779|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389780|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389781|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389782|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
138389783|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389784|NCT01496989|Interleukin-12|interleukin-12|mesh-list
138389785|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138389786|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
138389787|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389788|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389789|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389790|NCT01496989|Growth Substances|growth substances|mesh-ancestor
138389799|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389800|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138363346|NCT05642416|Ropivacaine|ropivacaine|mesh-list
138389801|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
138389802|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389803|NCT01497041|Docetaxel|docetaxel|mesh-list
138389804|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
138389805|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389806|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
138389807|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389808|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389809|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389810|NCT01497093|Thalidomide|thalidomide|mesh-list
138389811|NCT01497093|Dexamethasone|dexamethasone|mesh-list
138389812|NCT01497093|Bortezomib|bortezomib|mesh-list
138389813|NCT01497093|Pomalidomide|pomalidomide|mesh-list
138389814|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389815|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
138389816|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
138389817|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389818|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389819|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138389820|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
138389821|NCT01497093|Hormones|hormones|mesh-ancestor
138389822|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389823|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138389824|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389825|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
138389835|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
138389836|NCT01497132|Vitamins|vitamins|mesh-ancestor
138389837|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
138389838|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389839|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138389840|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389841|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
138389842|NCT01497145|Hematinics|hematinics|mesh-ancestor
138389843|NCT01497288|Fentanyl|fentanyl|mesh-list
138389844|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138389845|NCT01497288|Narcotics|narcotics|mesh-ancestor
138389846|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389847|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389848|NCT01497288|Analgesics|analgesics|mesh-ancestor
138389849|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
138389850|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389851|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138389852|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138389853|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
138389854|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
138389855|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
138389856|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
138389857|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389859|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
138389860|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
138389861|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389862|NCT01497431|Protective Agents|protective agents|mesh-ancestor
138389863|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389865|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
138389866|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138389867|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389868|NCT01497444|Sorafenib|sorafenib|mesh-list
138389869|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389870|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389871|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389872|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389873|NCT01497470|Paclitaxel|paclitaxel|mesh-list
138389878|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138389879|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389880|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389881|NCT01497483|Cyclosporine|cyclosporine|mesh-list
138389882|NCT01497483|Pravastatin|pravastatin|mesh-list
138389883|NCT01497483|Cyclosporins|cyclosporins|mesh-list
138389884|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389885|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363358|NCT05631028|Analgesics|analgesics|mesh-ancestor
138389886|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389887|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
138389888|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389889|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
138389890|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389891|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
138389892|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389893|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138389894|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138389895|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138389896|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
138389897|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138389898|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138389899|NCT01497522|Vildagliptin|vildagliptin|mesh-list
138389900|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389901|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389902|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138389903|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
138389904|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389905|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389907|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389908|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
138389909|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
138389910|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389911|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389912|NCT01497548|Methylphenidate|methylphenidate|mesh-list
138389913|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138389914|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389915|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138389916|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138389917|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389918|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389919|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
138389920|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138389922|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389924|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
138389925|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
138389926|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
138389927|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389928|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389929|NCT01497574|Insulin|insulin|mesh-list
138389930|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389931|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
138389932|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
138389933|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389934|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389945|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389946|NCT01497626|Bortezomib|bortezomib|mesh-list
138389947|NCT01497626|Lapatinib|lapatinib|mesh-list
138389948|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389949|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389950|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389951|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389952|NCT01497652|Rasagiline|rasagiline|mesh-list
138389953|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138389954|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389955|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389956|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138389957|NCT01497652|Protective Agents|protective agents|mesh-ancestor
138389958|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389959|NCT01497717|Adalimumab|adalimumab|mesh-list
138389960|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138389961|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389962|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389963|NCT01497873|Topotecan|topotecan|mesh-list
138389964|NCT01497873|Belotecan|belotecan|mesh-list
138389965|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138389966|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138389967|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389968|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389969|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389970|NCT01497912|Atorvastatin|atorvastatin|mesh-list
138389971|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138389972|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138389973|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
138389974|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389975|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138389976|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138389977|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389978|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
138389979|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138389980|NCT01497977|Estrogens|estrogens|mesh-ancestor
138389981|NCT01497977|Hormones|hormones|mesh-ancestor
138389982|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389983|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389984|NCT01497990|Ertapenem|ertapenem|mesh-list
138389985|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389994|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389996|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
138389997|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389998|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138389999|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390000|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138390001|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
138390002|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138390003|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
138390004|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390005|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390007|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
138390008|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
138390009|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138390010|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
138390011|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390012|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390013|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
138390014|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138390015|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390016|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390017|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390018|NCT01498380|Analgesics|analgesics|mesh-ancestor
138390019|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
138390020|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390021|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138390022|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138390023|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138390024|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
138390025|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390026|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390028|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
138390029|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
138390030|NCT01498406|Vitamins|vitamins|mesh-list
138390031|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
138390032|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390033|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138390034|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138390035|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138390041|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390043|NCT01498718|Vaccines|vaccines|mesh-list
138390044|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
138390045|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390046|NCT01498783|Fluorouracil|fluorouracil|mesh-list
138390047|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
138390048|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390049|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390050|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363360|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363361|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138363362|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138390051|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390052|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
138390053|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390054|NCT01498796|Ketorolac|ketorolac|mesh-list
138390055|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138390056|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390057|NCT01498796|Analgesics|analgesics|mesh-ancestor
138390058|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
138390059|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390060|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390061|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390062|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390063|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138390064|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390065|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390066|NCT01498809|Midodrine|midodrine|mesh-list
138390067|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
138390068|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
138390069|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390070|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390071|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138390072|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138390073|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138390074|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138390075|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
138390076|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390077|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390078|NCT01498835|Sunitinib|sunitinib|mesh-list
138390079|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390080|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138390081|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390082|NCT01498835|Growth Substances|growth substances|mesh-ancestor
138390083|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390085|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390086|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390087|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390093|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390094|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390095|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138390096|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138390097|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
138390098|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390099|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390100|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138390101|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390102|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390103|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390104|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390105|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390106|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390107|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138390108|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138390109|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390110|NCT01498900|Repaglinide|repaglinide|mesh-list
138390111|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390112|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390114|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390115|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390116|NCT01498926|Insulin|insulin|mesh-list
138390117|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138390118|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
138390119|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390120|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390121|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
138390122|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390123|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390124|NCT01499004|Tofacitinib|tofacitinib|mesh-list
138390125|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138390126|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390127|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390128|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390129|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
138390130|NCT01499069|Fesoterodine|fesoterodine|mesh-list
138390131|NCT01499069|Propiverine|propiverine|mesh-list
138390132|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138390133|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138390134|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
138390135|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390136|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390137|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390138|NCT01499069|Urological Agents|urological agents|mesh-ancestor
138390139|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
138390140|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
138390141|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390142|NCT01499108|Liraglutide|liraglutide|mesh-list
138390143|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390153|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390155|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390156|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390157|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390158|NCT01499225|Doxycycline|doxycycline|mesh-list
138390159|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390160|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390161|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
138390162|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138390163|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138390164|NCT01499251|Temozolomide|temozolomide|mesh-list
138390165|NCT01499251|Macitentan|macitentan|mesh-list
138390166|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138390167|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
138390168|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390169|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390170|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138390171|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138390172|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138390173|NCT01499407|Abciximab|abciximab|mesh-list
138390174|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
138390175|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138390176|NCT01499433|Caspofungin|caspofungin|mesh-list
138390177|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
138390178|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390179|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390180|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390181|NCT01499446|Fluticasone|fluticasone|mesh-list
138390182|NCT01499446|Xhance|xhance|mesh-list
138390183|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390184|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138390185|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
138390196|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390197|NCT01499485|Diuretics|diuretics|mesh-ancestor
138390198|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
138390199|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390200|NCT01499589|Anesthetics|anesthetics|mesh-list
138390201|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390202|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390204|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
138390205|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390206|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390207|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390208|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390209|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390210|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138390211|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138390212|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138390213|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
138390214|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138390215|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138390216|NCT01499641|Prednisolone|prednisolone|mesh-list
138390217|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
138390218|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138390219|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
138390220|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390221|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
138390222|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
138390223|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390224|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390225|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390226|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
138390227|NCT01499641|Hormones|hormones|mesh-ancestor
138390228|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390237|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390238|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390240|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390241|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390242|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
138390243|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390244|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390245|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138390246|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390247|NCT01499771|Atorvastatin|atorvastatin|mesh-list
138390248|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390249|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390250|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
138390251|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390252|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390253|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138390254|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390256|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390257|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390258|NCT01500005|Vitamin D|vitamin d|mesh-list
138390259|NCT01500005|Vitamins|vitamins|mesh-ancestor
138390260|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
138390261|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390262|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138390264|NCT01500018|Ketamine|ketamine|mesh-list
138390265|NCT01500018|Analgesics|analgesics|mesh-ancestor
138390266|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
138390267|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390268|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390270|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138390271|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
138390272|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
138390273|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390280|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138390281|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
138390282|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
138390283|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
138390284|NCT01500070|Everolimus|everolimus|mesh-list
138390285|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138390286|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390287|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390288|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390289|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390290|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
138390291|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390292|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390293|NCT01500161|Cytarabine|cytarabine|mesh-list
138390294|NCT01500161|Fludarabine|fludarabine|mesh-list
138390295|NCT01500161|Etoposide|etoposide|mesh-list
138390296|NCT01500161|Melphalan|melphalan|mesh-list
138390297|NCT01500161|Busulfan|busulfan|mesh-list
138390298|NCT01500161|Carmustine|carmustine|mesh-list
138390299|NCT01500161|Clofarabine|clofarabine|mesh-list
138390300|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390301|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390302|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
138363369|NCT05604599|Propofol|propofol|mesh-list
138363370|NCT05604599|Isoflurane|isoflurane|mesh-list
138390303|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390304|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390305|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
138390306|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390307|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390308|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138390309|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390310|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390311|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
138390312|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390313|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138390314|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
138390315|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138390316|NCT01500408|Interferons|interferons|mesh-list
138390319|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390320|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
138390321|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390322|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
138390323|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390324|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138390325|NCT01500538|Vorinostat|vorinostat|mesh-list
138390326|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390327|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138390328|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390329|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390330|NCT01500577|Nimesulide|nimesulide|mesh-list
138390331|NCT01500577|Simvastatin|simvastatin|mesh-list
138390332|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390333|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390334|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
138390335|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390336|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390337|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138390338|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390339|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138390340|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390341|NCT01500577|Analgesics|analgesics|mesh-ancestor
138390342|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
138390343|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390344|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390345|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390346|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390347|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138390348|NCT01500590|Ramipril|ramipril|mesh-list
138390349|NCT01500590|Irbesartan|irbesartan|mesh-list
138390350|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138390351|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138390352|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390353|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390354|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138390355|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138390356|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138390357|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
138390358|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
138390359|NCT01500785|Simendan|simendan|mesh-list
138390360|NCT01500785|Vitamins|vitamins|mesh-ancestor
138363387|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
138390361|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
138390362|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390363|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
138390364|NCT01500785|Hematinics|hematinics|mesh-ancestor
138390365|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138390366|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
138390367|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138390368|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138390369|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390370|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390371|NCT01500785|Protective Agents|protective agents|mesh-ancestor
138390377|NCT01500837|Levofloxacin|levofloxacin|mesh-list
138390378|NCT01500837|Ofloxacin|ofloxacin|mesh-list
138390379|NCT01500837|Rifampin|rifampin|mesh-list
138390380|NCT01500837|Clindamycin|clindamycin|mesh-list
138390381|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
138390382|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
138390383|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138390384|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390385|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390386|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138390387|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390388|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390389|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390390|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390391|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138390392|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138390393|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138390394|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
138390395|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
138390396|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138390397|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138390398|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138390399|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138390400|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138390401|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138390402|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138390403|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138390404|NCT01500850|Insulin|insulin|mesh-list
138390405|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138390406|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
138390407|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
138390408|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
138390409|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
138390410|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
138390411|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390412|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390413|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138390414|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138390415|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138390417|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138390418|NCT01500863|Progesterone|progesterone|mesh-list
138390419|NCT01500863|Estrogens|estrogens|mesh-ancestor
138390420|NCT01500863|Hormones|hormones|mesh-ancestor
138390429|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390430|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390432|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138390433|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390434|NCT01500915|Growth Substances|growth substances|mesh-ancestor
138390435|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390436|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
138390437|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390439|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390440|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390441|NCT01500980|Chloroquine|chloroquine|mesh-list
138390442|NCT01500980|Primaquine|primaquine|mesh-list
138390443|NCT01500980|Amebicides|amebicides|mesh-ancestor
138390444|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138390445|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138390446|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390447|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
138390448|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390449|NCT01500993|Capecitabine|capecitabine|mesh-list
138390450|NCT01500993|Fluorouracil|fluorouracil|mesh-list
138390451|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390452|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
138390453|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390454|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390455|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390456|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
138390457|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390458|NCT01501032|Pancrelipase|pancrelipase|mesh-list
138390459|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390460|NCT01501084|Exenatide|exenatide|mesh-list
138390461|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138390462|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390463|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138390464|NCT01501084|Incretins|incretins|mesh-ancestor
138390465|NCT01501084|Hormones|hormones|mesh-ancestor
138390466|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390467|NCT01501123|Midazolam|midazolam|mesh-list
138390468|NCT01501123|Haloperidol|haloperidol|mesh-list
138390469|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
138390477|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138390478|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
138390479|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
138390480|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
138390481|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
138390482|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390483|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390484|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
138390485|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
138390486|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390487|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390488|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138390489|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138390490|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
138390491|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138390492|NCT01501136|Dexamethasone|dexamethasone|mesh-list
138390493|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
138390494|NCT01501136|Cisplatin|cisplatin|mesh-list
138390497|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
138390498|NCT01501136|Ifosfamide|ifosfamide|mesh-list
138390499|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
138390500|NCT01501136|Pegaspargase|pegaspargase|mesh-list
138390501|NCT01501136|Asparaginase|asparaginase|mesh-list
138390502|NCT01501136|BB 1101|bb 1101|mesh-list
138390504|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390505|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
138390506|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
138390507|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363418|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138363419|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
138390508|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390509|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390510|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
138390512|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390513|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390514|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390515|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
138390516|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390517|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390518|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390519|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
138390525|NCT01501136|Protective Agents|protective agents|mesh-ancestor
138390526|NCT01501149|Dexamethasone|dexamethasone|mesh-list
138390527|NCT01501149|Gemcitabine|gemcitabine|mesh-list
138390528|NCT01501149|Etoposide|etoposide|mesh-list
138390529|NCT01501149|Pegaspargase|pegaspargase|mesh-list
138390530|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390531|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
138390532|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
138390533|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390534|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390535|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390536|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
138390537|NCT01501149|Hormones|hormones|mesh-ancestor
138390538|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390539|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390540|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390541|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390542|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
138390543|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390544|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390545|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138390546|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390547|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390549|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
138390550|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390551|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390552|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
138390553|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390554|NCT01501253|Amlodipine|amlodipine|mesh-list
138390555|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138390556|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138390557|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138390558|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390559|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138390560|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390561|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138390562|NCT01501344|Calcium|calcium|mesh-list
138390563|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138390564|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390565|NCT01501370|Dexamethasone|dexamethasone|mesh-list
138390566|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
138390573|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390574|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390575|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390576|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
138390578|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390579|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390580|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390581|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
138390582|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390583|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390584|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
138390585|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138390586|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390587|NCT01501370|Growth Substances|growth substances|mesh-ancestor
138390588|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138390590|NCT01501396|Megestrol|megestrol|mesh-list
138390591|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
138390592|NCT01501396|Mirtazapine|mirtazapine|mesh-list
138390593|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
138390594|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138390595|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138390596|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
138390597|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
138390598|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390599|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390600|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390601|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138390602|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138390603|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390604|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138390605|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138390606|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138390607|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
138390608|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138390609|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138390610|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
138390611|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138390612|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138390613|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138390614|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390615|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390616|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390617|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390618|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138390619|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390620|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390621|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
138390622|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138390623|NCT01501422|Estrogens|estrogens|mesh-list
138390624|NCT01501422|Hormones|hormones|mesh-ancestor
138390628|NCT01501435|Fenofibrate|fenofibrate|mesh-list
138390629|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390630|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390631|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
138390632|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390633|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390634|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138390636|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
138390637|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138390638|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138390640|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138390641|NCT01501448|Estrogens|estrogens|mesh-ancestor
138390643|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390644|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390645|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390646|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390647|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390648|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390649|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138390650|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138390651|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138390652|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138390653|NCT01501487|Paclitaxel|paclitaxel|mesh-list
138390654|NCT01501487|Docetaxel|docetaxel|mesh-list
138390655|NCT01501487|Trastuzumab|trastuzumab|mesh-list
138390656|NCT01501487|Pertuzumab|pertuzumab|mesh-list
138390657|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390658|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390659|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
138390660|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
138390661|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
138390662|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390663|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138390664|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138390665|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138390666|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390667|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390668|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138390674|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
138390675|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390678|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
138390679|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390680|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390681|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390683|NCT01501669|Irinotecan|irinotecan|mesh-list
138390684|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390685|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
138390686|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390687|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390688|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138390689|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390690|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390691|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
138390692|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138390693|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138390694|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390695|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390696|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138390697|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138390698|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
138390699|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390700|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390701|NCT01501708|Voriconazole|voriconazole|mesh-list
138390702|NCT01501708|Amphotericin B|amphotericin b|mesh-list
138390703|NCT01501708|Caspofungin|caspofungin|mesh-list
138390704|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
138390705|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390706|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138390708|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390709|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390710|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138390711|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
138390712|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390713|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390714|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138390715|NCT01501708|Amebicides|amebicides|mesh-ancestor
138390716|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138390717|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138390718|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390719|NCT01501747|Acetaminophen|acetaminophen|mesh-list
138390721|NCT01501747|Ibuprofen|ibuprofen|mesh-list
138390722|NCT01501747|Caffeine|caffeine|mesh-list
138390723|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138390724|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390725|NCT01501747|Analgesics|analgesics|mesh-ancestor
138390726|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
138390727|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390728|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390729|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390731|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138390732|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390733|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390734|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
138390735|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138390736|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138390737|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138390738|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138390739|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
138390740|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390741|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390742|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390744|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138390745|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390746|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138390747|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390748|NCT01501760|Growth Substances|growth substances|mesh-ancestor
138390750|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
138390751|NCT01501786|Ketamine|ketamine|mesh-list
138390752|NCT01501786|Propofol|propofol|mesh-list
138390753|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138390754|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390755|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390756|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138390757|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
138390758|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
138390759|NCT01501786|Analgesics|analgesics|mesh-ancestor
138390760|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
138390761|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390762|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138390763|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138390764|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138390765|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390766|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390767|NCT01501799|Adapalene|adapalene|mesh-list
138390768|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138390773|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
138390774|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390775|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390776|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390777|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390778|NCT01501890|Algestone|algestone|mesh-list
138390779|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138390780|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138390781|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138390782|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
138390783|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390784|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390785|NCT01501890|Progestins|progestins|mesh-ancestor
138390786|NCT01501890|Hormones|hormones|mesh-ancestor
138363478|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390787|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138390788|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138390789|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390790|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390791|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390792|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390793|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138390795|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
138390796|NCT01501916|Vitamins|vitamins|mesh-ancestor
138390797|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
138390798|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390799|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138390800|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138390801|NCT01501942|Glycine|glycine|mesh-list
138390802|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
138390803|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390804|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390805|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390807|NCT01501968|Colistin|colistin|mesh-list
138390808|NCT01501968|Vitamins|vitamins|mesh-ancestor
138390809|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
138390810|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390811|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
138390812|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390813|NCT01501968|Protective Agents|protective agents|mesh-ancestor
138390814|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390815|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390816|NCT01502020|Imiquimod|imiquimod|mesh-list
138390817|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138390818|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
138390819|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390820|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390821|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
138390822|NCT01502046|Dronabinol|dronabinol|mesh-list
138390823|NCT01502046|Cannabidiol|cannabidiol|mesh-list
138390824|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
138390825|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
138390826|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390827|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138390828|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390829|NCT01502046|Analgesics|analgesics|mesh-ancestor
138390830|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
138390831|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390832|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138390833|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138390834|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390835|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390836|NCT01502046|Hormones|hormones|mesh-ancestor
138390837|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390838|NCT01502202|Pemetrexed|pemetrexed|mesh-list
138390839|NCT01502202|Gefitinib|gefitinib|mesh-list
138390840|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390841|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390842|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390843|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138390844|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138390845|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390846|NCT01502241|Temozolomide|temozolomide|mesh-list
138390847|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138390848|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
138390849|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390850|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390852|NCT01502267|Rituximab|rituximab|mesh-list
138390853|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138390854|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390855|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138390856|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
138390857|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390858|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390859|NCT01502358|Vaccines|vaccines|mesh-list
138390860|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
138390861|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390862|NCT01502592|Ipilimumab|ipilimumab|mesh-list
138390863|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138390864|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390865|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138390866|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390867|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138390868|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138390869|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390870|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
138390871|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138390872|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
138390873|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390874|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390875|NCT01502774|Cyclosporine|cyclosporine|mesh-list
138390876|NCT01502774|Cyclosporins|cyclosporins|mesh-list
138390877|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390878|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390879|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390880|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
138390881|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390882|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
138390883|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390885|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390886|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138390887|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
138390888|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390889|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138390890|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138390891|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390892|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390893|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
138390894|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
138390895|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
138390896|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390897|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390898|NCT01502904|Sirolimus|sirolimus|mesh-list
138390899|NCT01502904|Pravastatin|pravastatin|mesh-list
138390900|NCT01502904|Pitavastatin|pitavastatin|mesh-list
138390901|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390902|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390903|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138390904|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390905|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
138390906|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390907|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
138390908|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390909|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390910|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390911|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390912|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390913|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
138390914|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390915|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138390916|NCT01502943|Atorvastatin|atorvastatin|mesh-list
138390917|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390918|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390919|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138390920|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138390921|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
138390922|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138390923|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138390924|NCT01503008|Metformin|metformin|mesh-list
138390925|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138390926|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138390927|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
138390928|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138390929|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390930|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390931|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390932|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
138390934|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
138390935|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
138390937|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390938|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
138390939|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390940|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138390941|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138390942|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138390943|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138390944|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390945|NCT01503216|Vitamin D|vitamin d|mesh-list
138390946|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
138390947|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
138390948|NCT01503216|Vitamins|vitamins|mesh-ancestor
138390949|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
138390950|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390951|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138390952|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138390953|NCT01503242|Cyclosporine|cyclosporine|mesh-list
138390954|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
138390955|NCT01503242|Fludarabine|fludarabine|mesh-list
138390956|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
138390957|NCT01503242|Antibodies|antibodies|mesh-list
138390958|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138390959|NCT01503242|Cyclosporins|cyclosporins|mesh-list
138390960|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
138390961|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390962|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390963|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138390964|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
138390965|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390966|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390967|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390968|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
138390969|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138390970|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390971|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390972|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138390973|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138390974|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138390975|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
138390976|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138390978|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
138390979|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390982|NCT01503372|Leucovorin|leucovorin|mesh-list
138390983|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
138390984|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390985|NCT01503372|Antidotes|antidotes|mesh-ancestor
138390986|NCT01503372|Protective Agents|protective agents|mesh-ancestor
138390987|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390988|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
138390989|NCT01503372|Vitamins|vitamins|mesh-ancestor
138390990|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
138390991|NCT01503385|Celecoxib|celecoxib|mesh-list
138390992|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138390993|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390994|NCT01503385|Analgesics|analgesics|mesh-ancestor
138390995|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
138390996|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390997|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390998|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390999|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391000|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138391001|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138391002|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391003|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391004|NCT01503398|Olanzapine|olanzapine|mesh-list
138391005|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
138391006|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
138391007|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391008|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391009|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391010|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138391011|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391012|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391013|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391014|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138391015|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391016|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391017|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391018|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391019|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
138391020|NCT01503424|Olanzapine|olanzapine|mesh-list
138391021|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
138391022|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
138391023|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391024|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391027|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391028|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391029|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391030|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138391031|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391032|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391033|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391034|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391036|NCT01503437|Olanzapine|olanzapine|mesh-list
138391037|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
138391038|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
138391039|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391040|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391041|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391042|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138391043|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391044|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391046|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138391047|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391049|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391050|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391051|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
138391053|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
138391054|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
138391055|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391056|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391057|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391058|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138391059|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391060|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391061|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391062|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138391063|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391064|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391065|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391066|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391067|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
138391068|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
138391069|NCT01503502|Flumatinib|flumatinib|mesh-list
138391070|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391071|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391072|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391073|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391074|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
138391076|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138391077|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138391078|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391079|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391080|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391081|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391082|NCT01503580|Urological Agents|urological agents|mesh-ancestor
138391083|NCT01503593|Calcium|calcium|mesh-list
138391084|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138391085|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391086|NCT01503658|Aspirin|aspirin|mesh-list
138391087|NCT01503658|Clopidogrel|clopidogrel|mesh-list
138391088|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138391089|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138391090|NCT01503658|Analgesics|analgesics|mesh-ancestor
138391091|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
138391092|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391093|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391094|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391095|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391096|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138391097|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138391098|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391099|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138391100|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138391102|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
138391103|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138391104|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138391105|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138391106|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
138391107|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391108|NCT01503671|Atorvastatin|atorvastatin|mesh-list
138391109|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138391114|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138391115|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391116|NCT01503736|Citric Acid|citric acid|mesh-list
138391117|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
138391118|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
138391119|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
138391120|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138391121|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
138391122|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
138391123|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391124|NCT01503736|Hematinics|hematinics|mesh-ancestor
138391125|NCT01503788|Midazolam|midazolam|mesh-list
138391126|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138391127|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138391128|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391129|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391130|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138391131|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391132|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391133|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138391134|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
138391136|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
138391137|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
138391138|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391139|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391140|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
138391141|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
138391142|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138391143|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
138391144|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391145|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391146|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138391147|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
138391148|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138391149|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
138391150|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391151|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391152|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
138391153|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
138391154|NCT01503801|Protective Agents|protective agents|mesh-ancestor
138391155|NCT01503905|Tamoxifen|tamoxifen|mesh-list
138391156|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
138391157|NCT01503905|Docetaxel|docetaxel|mesh-list
138391158|NCT01503905|Trastuzumab|trastuzumab|mesh-list
138391159|NCT01503905|Epirubicin|epirubicin|mesh-list
138391160|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138391161|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
138391162|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391163|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391164|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138391165|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
138391166|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391167|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391168|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138391169|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
138391170|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
138391171|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
138391172|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391173|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138391174|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138391175|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138391176|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391177|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138391178|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
138391179|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391180|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138391181|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138391182|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138391183|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138391184|NCT01503918|Valacyclovir|valacyclovir|mesh-list
138391185|NCT01503918|Acyclovir|acyclovir|mesh-list
138391186|NCT01503918|Valganciclovir|valganciclovir|mesh-list
138391187|NCT01503918|Ganciclovir|ganciclovir|mesh-list
138391188|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138391189|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
138391190|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391191|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138391193|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391194|NCT01503983|Capecitabine|capecitabine|mesh-list
138391195|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
138391196|NCT01503983|Trastuzumab|trastuzumab|mesh-list
138391197|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138391198|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
138391199|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391200|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391201|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391202|NCT01504074|Triamcinolone|triamcinolone|mesh-list
138391203|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138391204|NCT01504074|Levobunolol|levobunolol|mesh-list
138391205|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138391206|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391207|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
138391208|NCT01504074|Hormones|hormones|mesh-ancestor
138391209|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391210|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391211|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391212|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391213|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138391214|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138391216|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391217|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
138391218|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
138391219|NCT01504126|Propranolol|propranolol|mesh-list
138391220|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138391221|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138391222|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138391224|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391225|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391226|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138391227|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391228|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
138391229|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138391230|NCT01504139|Estradiol|estradiol|mesh-list
138391231|NCT01504139|Progesterone|progesterone|mesh-list
138391232|NCT01504139|Estrogens|estrogens|mesh-ancestor
138391233|NCT01504139|Hormones|hormones|mesh-ancestor
138391234|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391235|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391236|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138391238|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138391239|NCT01504178|Levodopa|levodopa|mesh-list
138391240|NCT01504178|Apomorphine|apomorphine|mesh-list
138391241|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138391242|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138391243|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391244|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391245|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391246|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391247|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391248|NCT01504178|Analgesics|analgesics|mesh-ancestor
138391249|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
138391250|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391251|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
138391252|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391253|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
138391254|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138391255|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138391256|NCT01504178|Emetics|emetics|mesh-ancestor
138391257|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
138391258|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391259|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
138391260|NCT01504256|Leucovorin|leucovorin|mesh-list
138391261|NCT01504256|Docetaxel|docetaxel|mesh-list
138391262|NCT01504256|Fluorouracil|fluorouracil|mesh-list
138391263|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
138391264|NCT01504256|Catumaxomab|catumaxomab|mesh-list
138391265|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138391266|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
138391267|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391269|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138391270|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138391272|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
138391273|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138363542|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363546|NCT04677959|Xhance|xhance|mesh-list
138391274|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138391275|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
138391276|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391277|NCT01504256|Antidotes|antidotes|mesh-ancestor
138391278|NCT01504256|Protective Agents|protective agents|mesh-ancestor
138391279|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138391280|NCT01504256|Vitamins|vitamins|mesh-ancestor
138391281|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
138391282|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391283|NCT01504282|Mitomycins|mitomycins|mesh-list
138391284|NCT01504282|Mitomycin|mitomycin|mesh-list
138391285|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138391286|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391287|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
138391288|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391289|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138391290|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391291|NCT01504295|Metadoxine|metadoxine|mesh-list
138391292|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138391293|NCT01504321|Moxonidine|moxonidine|mesh-list
138391294|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391295|NCT01504334|Pirfenidone|pirfenidone|mesh-list
138391296|NCT01504334|Analgesics|analgesics|mesh-ancestor
138391297|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
138391298|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391299|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391300|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138391301|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138391302|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391303|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391304|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391305|NCT01504347|Vaccines|vaccines|mesh-list
138391306|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
138391307|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391308|NCT01504386|Ropivacaine|ropivacaine|mesh-list
138391309|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
138391310|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
138391311|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391312|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391313|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
138391314|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391315|NCT01504490|Bexarotene|bexarotene|mesh-list
138391316|NCT01504490|Efatutazone|efatutazone|mesh-list
138391317|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391318|NCT01504503|Donepezil|donepezil|mesh-list
138391319|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138391320|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391321|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391322|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391323|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391324|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391325|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
138391327|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138391328|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391329|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391330|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391332|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391333|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
138391334|NCT01504542|Vaccines|vaccines|mesh-list
138391335|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
138391336|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391337|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138391338|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
138391339|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391340|NCT01504620|Insulin|insulin|mesh-list
138391341|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391342|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391343|NCT01504646|Lyprinol|lyprinol|mesh-list
138391344|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138391345|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138391346|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391347|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391349|NCT01504659|Analgesics|analgesics|mesh-ancestor
138391350|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
138391351|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391352|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391353|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138391354|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138391355|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
138391356|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
138391357|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391358|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138391359|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138391360|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391361|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391362|NCT01504724|Bevacizumab|bevacizumab|mesh-list
138391363|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391364|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391365|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138391366|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138391372|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391373|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138391374|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391375|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391376|NCT01504828|Ramipril|ramipril|mesh-list
138391377|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138391378|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
138391379|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391380|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391381|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391382|NCT01504906|Cyclosporine|cyclosporine|mesh-list
138391383|NCT01504906|Ticagrelor|ticagrelor|mesh-list
138391384|NCT01504906|Cyclosporins|cyclosporins|mesh-list
138391385|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391386|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391387|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138391388|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
138391389|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391390|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
138391391|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391392|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138391393|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391394|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138391395|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138391396|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138391397|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138391398|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138391399|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
138363567|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138391400|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391401|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
138391402|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391403|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391404|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391405|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391407|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
138391408|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391409|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138391412|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138391413|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
138391414|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138391415|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
138391416|NCT01505088|Citric Acid|citric acid|mesh-list
138391417|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
138391418|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138391419|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138391420|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138391421|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
138391422|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138391423|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391424|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
138391425|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
138391426|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391427|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391428|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391429|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
138391430|NCT01505088|Hormones|hormones|mesh-ancestor
138391431|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391432|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138391433|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391434|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
138391435|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138391436|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
138391437|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
138391438|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391439|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138391440|NCT01505088|Protective Agents|protective agents|mesh-ancestor
138391441|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138391443|NCT01505127|Amoxicillin|amoxicillin|mesh-list
138391444|NCT01505127|Clarithromycin|clarithromycin|mesh-list
138391445|NCT01505127|Lansoprazole|lansoprazole|mesh-list
138391446|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
138391447|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138391448|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391449|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138391450|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391451|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391452|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138391453|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138391454|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138391455|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391456|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138391457|NCT01505218|Propofol|propofol|mesh-list
138391458|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138391459|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391462|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
138391463|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
138363589|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391464|NCT01505231|Vasopressins|vasopressins|mesh-list
138391465|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
138391466|NCT01505231|Norepinephrine|norepinephrine|mesh-list
138391467|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138391468|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138391469|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
138391470|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391471|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391472|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391473|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
138391474|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
138391475|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391476|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138391477|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
138391478|NCT01505231|Coagulants|coagulants|mesh-ancestor
138391479|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138391480|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
138391481|NCT01505283|Lidocaine|lidocaine|mesh-list
138391482|NCT01505283|Sufentanil|sufentanil|mesh-list
138391483|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138391485|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391486|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391487|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
138391488|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391489|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138391490|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138391491|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138391492|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391493|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391494|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138391495|NCT01505283|Narcotics|narcotics|mesh-ancestor
138391498|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138391499|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
138391500|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138391501|NCT01505413|Gemcitabine|gemcitabine|mesh-list
138391502|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
138391503|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138391504|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138391505|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
138391506|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391507|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391508|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391509|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391510|NCT01505426|Metformin|metformin|mesh-list
138391511|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
138391512|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391513|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391514|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138391515|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391516|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
138391517|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138391518|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138391519|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391520|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391521|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391522|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391523|NCT01505439|Urological Agents|urological agents|mesh-ancestor
138391525|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
138391526|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391527|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391528|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391529|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
138391530|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391531|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391532|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391533|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138391534|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391535|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391536|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138391537|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138391538|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138391543|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138391545|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391546|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138391547|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
138391548|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391549|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391550|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391551|NCT01505790|Clopidogrel|clopidogrel|mesh-list
138391552|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138391553|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138391554|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138391555|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138391556|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138391557|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
138391558|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391559|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391560|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391561|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138391562|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
138391563|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391565|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138391566|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391567|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391569|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
138391570|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
138391571|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391572|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391573|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
138391574|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391575|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138391576|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138391577|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138391578|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391579|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391580|NCT01505946|Thrombin|thrombin|mesh-list
138391581|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
138391582|NCT01505946|Coagulants|coagulants|mesh-ancestor
138391583|NCT01505998|Amlodipine|amlodipine|mesh-list
138391584|NCT01505998|Benazepril|benazepril|mesh-list
138391585|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391586|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138391587|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391588|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391589|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138391592|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138391593|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138391594|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391595|NCT01506011|Amlodipine|amlodipine|mesh-list
138391596|NCT01506011|Benazepril|benazepril|mesh-list
138391597|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391599|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391600|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363617|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138391601|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138391602|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391603|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
138391604|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138391605|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138391606|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391607|NCT01506024|Tacrine|tacrine|mesh-list
138391608|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138391609|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391610|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391611|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391612|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391613|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391614|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138391615|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
138391616|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391617|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
138391618|NCT01506037|Desloratadine|desloratadine|mesh-list
138391619|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138391620|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391621|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391622|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391623|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391625|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391626|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391627|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
138391629|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138391630|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391631|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391632|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391633|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391634|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138391635|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391636|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391638|NCT01506063|Levocetirizine|levocetirizine|mesh-list
138391639|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138391640|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391641|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391642|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
138391643|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391644|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391645|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391646|NCT01506076|Levocetirizine|levocetirizine|mesh-list
138391647|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138391648|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391649|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391650|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
138391651|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391652|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391653|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391654|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138391655|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138391656|NCT01506115|Trioxsalen|trioxsalen|mesh-list
138391657|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391658|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138391659|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138391660|NCT01506167|Leucovorin|leucovorin|mesh-list
138391661|NCT01506167|Folic Acid|folic acid|mesh-list
138391662|NCT01506167|Bevacizumab|bevacizumab|mesh-list
138391665|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
138391667|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
138391668|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391669|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391670|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138391671|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138391672|NCT01506167|Growth Substances|growth substances|mesh-ancestor
138391673|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391675|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138391676|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
138391677|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391678|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138391679|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
138391680|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138391681|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138391682|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391683|NCT01506167|Antidotes|antidotes|mesh-ancestor
138391684|NCT01506167|Protective Agents|protective agents|mesh-ancestor
138391685|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
138391686|NCT01506167|Vitamins|vitamins|mesh-ancestor
138391687|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
138391688|NCT01506167|Hematinics|hematinics|mesh-ancestor
138391689|NCT01506336|Sunitinib|sunitinib|mesh-list
138391691|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138391692|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138391693|NCT01506336|Growth Substances|growth substances|mesh-ancestor
138391694|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391695|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138391696|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391697|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391698|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391699|NCT01506388|Misoprostol|misoprostol|mesh-list
138391700|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138391701|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
138391702|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138391703|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391704|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138391705|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391706|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
138391707|NCT01506414|Rituximab|rituximab|mesh-list
138391708|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391709|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391710|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
138391711|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391712|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391713|NCT01506505|Aspirin|aspirin|mesh-list
138391714|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138391715|NCT01506505|Lisinopril|lisinopril|mesh-list
138391716|NCT01506505|Simvastatin|simvastatin|mesh-list
138391717|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138391718|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138391719|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
138391720|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391721|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138391722|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138391723|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391724|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391725|NCT01506505|Diuretics|diuretics|mesh-ancestor
138391726|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
138391727|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391728|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138391729|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138391730|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138391731|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138391733|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
138391734|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391735|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391736|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391737|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138391738|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138391739|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138391740|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138391741|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
138391742|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138391743|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
138391744|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138391745|NCT01506505|Protective Agents|protective agents|mesh-ancestor
138391746|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
138391747|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391748|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
138391749|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391750|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391751|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138391752|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
138391754|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138391755|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391756|NCT01506557|Vitamins|vitamins|mesh-ancestor
138391757|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
138391758|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138391759|NCT01506570|Vaccines|vaccines|mesh-list
138391760|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
138391761|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391762|NCT01506622|Fentanyl|fentanyl|mesh-list
138391763|NCT01506622|Propofol|propofol|mesh-list
138391764|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138391765|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391766|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391767|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138391769|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
138391770|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138391771|NCT01506622|Narcotics|narcotics|mesh-ancestor
138391772|NCT01506622|Analgesics|analgesics|mesh-ancestor
138391773|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
138391774|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391777|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138391778|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138391780|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391781|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391782|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391783|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138391784|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138391786|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138391787|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138391788|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138391789|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138391790|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
138391791|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391792|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391793|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391794|NCT01506739|Donepezil|donepezil|mesh-list
138391795|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138391796|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391797|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391798|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391799|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391800|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391801|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
138391802|NCT01506752|Donepezil|donepezil|mesh-list
138391805|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391806|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391807|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391808|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391809|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
138391810|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
138391814|NCT01506765|Expectorants|expectorants|mesh-ancestor
138391815|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138391816|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138391817|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
138391818|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391819|NCT01506765|Protective Agents|protective agents|mesh-ancestor
138391820|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391821|NCT01506765|Antidotes|antidotes|mesh-ancestor
138391822|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
138391823|NCT01506791|Ephedrine|ephedrine|mesh-list
138391824|NCT01506791|Desloratadine|desloratadine|mesh-list
138391825|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138391826|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
138391827|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391828|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391829|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391830|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138391831|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138391832|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
138391833|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
138391834|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138391835|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
138391836|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391837|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138391838|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
138391839|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
138391841|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138391842|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
138391843|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
138391844|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
138391845|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138391846|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138391847|NCT01506804|Prednisolone|prednisolone|mesh-list
138391848|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
138391849|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138391850|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
138391851|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138391852|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
138391854|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391855|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391856|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391857|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
138391859|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391861|NCT01506804|Protective Agents|protective agents|mesh-ancestor
138391862|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138391863|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391864|NCT01506895|Darapladib|darapladib|mesh-list
138391865|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138391866|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391867|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391868|NCT01506921|Ketamine|ketamine|mesh-list
138391869|NCT01506921|Esketamine|esketamine|mesh-list
138391870|NCT01506921|Analgesics|analgesics|mesh-ancestor
138391871|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
138391872|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391873|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391874|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138391875|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138391876|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
138391877|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
138391878|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391879|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138391880|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138391881|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391882|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391883|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
138391884|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138391886|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391887|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391888|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391889|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391890|NCT01507077|CKD732|ckd732|mesh-list
138391891|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138391892|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138391893|NCT01507077|Growth Substances|growth substances|mesh-ancestor
138391894|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391895|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
138391896|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391898|NCT01507194|Vestipitant|vestipitant|mesh-list
138391899|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
138391900|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
138363628|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138391901|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391904|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
138391905|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
138391906|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138391907|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138391908|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
138391909|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391910|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391911|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138391912|NCT01507272|Liraglutide|liraglutide|mesh-list
138391913|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391914|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391915|NCT01507272|Incretins|incretins|mesh-ancestor
138391916|NCT01507272|Hormones|hormones|mesh-ancestor
138391917|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391919|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391920|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391921|NCT01507311|Incretins|incretins|mesh-ancestor
138391922|NCT01507311|Hormones|hormones|mesh-ancestor
138391923|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391924|NCT01507337|Liraglutide|liraglutide|mesh-list
138391925|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391926|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391927|NCT01507337|Incretins|incretins|mesh-ancestor
138391928|NCT01507337|Hormones|hormones|mesh-ancestor
138391929|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391930|NCT01507363|Gabapentin|gabapentin|mesh-list
138391931|NCT01507363|Analgesics|analgesics|mesh-ancestor
138391932|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
138391933|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138391934|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391935|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
138391936|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138391937|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391938|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138391940|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138391941|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138391942|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391943|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391944|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
138391945|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138391946|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138391947|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391948|NCT01507389|Liraglutide|liraglutide|mesh-list
138391949|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138391950|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391951|NCT01507389|Incretins|incretins|mesh-ancestor
138391952|NCT01507389|Hormones|hormones|mesh-ancestor
138391953|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391954|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
138391955|NCT01507428|Misonidazole|misonidazole|mesh-list
138391956|NCT01507428|Paclitaxel|paclitaxel|mesh-list
138391957|NCT01507428|Carboplatin|carboplatin|mesh-list
138391958|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138391959|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138391960|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138391961|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391962|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138391963|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138391964|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138391965|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391966|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138391967|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
138391968|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
138391969|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391970|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138391971|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138391972|NCT01507454|Estradiol|estradiol|mesh-list
138391973|NCT01507454|Estrogens|estrogens|mesh-ancestor
138391974|NCT01507454|Hormones|hormones|mesh-ancestor
138391975|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391976|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391978|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138391979|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138391983|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391984|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391985|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138391986|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138391987|NCT01507480|Growth Substances|growth substances|mesh-ancestor
138391988|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391989|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
138391990|NCT01507519|Sirolimus|sirolimus|mesh-list
138391991|NCT01507519|Temsirolimus|temsirolimus|mesh-list
138391992|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
138391993|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138391994|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391995|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138391996|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391997|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
138391998|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138391999|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
138392000|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392001|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392002|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392003|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392004|NCT01507558|Dexamethasone|dexamethasone|mesh-list
138392005|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
138392006|NCT01507558|BB 1101|bb 1101|mesh-list
138392007|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392008|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
138392009|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
138392010|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392011|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392012|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392013|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
138392014|NCT01507558|Hormones|hormones|mesh-ancestor
138392015|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392016|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138392017|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392018|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
138392019|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363665|NCT04469959|Carbidopa|carbidopa|mesh-list
138392020|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392022|NCT01507597|Glucagon|glucagon|mesh-list
138392023|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138392024|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392025|NCT01507597|Hormones|hormones|mesh-ancestor
138414731|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138392028|NCT01507597|Incretins|incretins|mesh-ancestor
138392029|NCT01507701|Clonidine|clonidine|mesh-list
138392030|NCT01507701|Analgesics|analgesics|mesh-ancestor
138392031|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
138392032|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392033|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392034|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138392036|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
138392037|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138392038|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138392039|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138392040|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392041|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392042|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392043|NCT01507727|Tolvaptan|tolvaptan|mesh-list
138392044|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138392045|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392046|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392047|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392048|NCT01507740|Bevacizumab|bevacizumab|mesh-list
138392049|NCT01507740|Sorafenib|sorafenib|mesh-list
138392050|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392051|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392052|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138392053|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138392054|NCT01507740|Growth Substances|growth substances|mesh-ancestor
138392055|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392056|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
138392057|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392058|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392059|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392060|NCT01507792|Loratadine|loratadine|mesh-list
138392061|NCT01507792|Omeprazole|omeprazole|mesh-list
138392062|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138392063|NCT01507792|Histamine|histamine|mesh-list
138392064|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392065|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392066|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392067|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392068|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
138392069|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138392070|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138392071|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138392072|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138392073|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
138392074|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
138363692|NCT04330638|Siltuximab|siltuximab|mesh-list
138392075|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392076|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392078|NCT01507857|Vaccines|vaccines|mesh-list
138392079|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
138392081|NCT01507922|Fenoverine|fenoverine|mesh-list
138392082|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
138392083|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
138392084|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392085|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392086|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138392087|NCT01507974|Amoxicillin|amoxicillin|mesh-list
138392088|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
138392089|NCT01507974|Cephalexin|cephalexin|mesh-list
138392090|NCT01507974|Cefuroxime|cefuroxime|mesh-list
138392091|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
138392092|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138392093|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138392094|NCT01507974|Trimethoprim|trimethoprim|mesh-list
138392095|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
138392096|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392097|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
138392098|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138392099|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
138392100|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138392101|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138392102|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138392103|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392104|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392105|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138392106|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138392107|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138392108|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138392109|NCT01508000|Bevacizumab|bevacizumab|mesh-list
138392110|NCT01508000|Panitumumab|panitumumab|mesh-list
138392111|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392112|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392113|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138392114|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138392115|NCT01508000|Growth Substances|growth substances|mesh-ancestor
138392116|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392117|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
138392122|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392123|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392124|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392125|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
138392126|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392127|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392128|NCT01507610|Sumatriptan|sumatriptan|mesh-list
138392129|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138392130|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138392131|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138392132|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
138392133|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392134|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392135|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392136|NCT01508143|Misoprostol|misoprostol|mesh-list
138392137|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138392138|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
138363722|NCT04280601|Vitamin D|vitamin d|mesh-list
138392139|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392140|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392141|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392142|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392143|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
138392144|NCT01508182|Metformin|metformin|mesh-list
138392145|NCT01508182|Canagliflozin|canagliflozin|mesh-list
138392146|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392147|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392148|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138392149|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392150|NCT01508195|Metformin|metformin|mesh-list
138392151|NCT01508195|Canagliflozin|canagliflozin|mesh-list
138392152|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392153|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392154|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138392155|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392156|NCT01508260|Furosemide|furosemide|mesh-list
138392157|NCT01508260|Diuretics|diuretics|mesh-ancestor
138392158|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392159|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392160|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138392161|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138392162|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392163|NCT01508286|Ribavirin|ribavirin|mesh-list
138392164|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
138392165|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392168|NCT01508364|Sorafenib|sorafenib|mesh-list
138392169|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392170|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392171|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392172|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392173|NCT01508429|Misoprostol|misoprostol|mesh-list
138392174|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138392175|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
138392176|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392177|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392178|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392179|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392180|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
138392182|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
138392183|NCT01508468|Giapreza|giapreza|mesh-list
138392184|NCT01508468|Calcium|calcium|mesh-list
138392185|NCT01508468|Diuretics|diuretics|mesh-list
138392186|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138392187|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138392188|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
138392189|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138392190|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392191|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392192|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
138392193|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392194|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392195|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138392196|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392197|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138392198|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392199|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392200|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392202|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138392203|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
138392204|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
138392205|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363732|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138392206|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138392207|NCT01508494|Galantamine|galantamine|mesh-list
138392208|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138392209|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392210|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392211|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
138392212|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392213|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392219|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392220|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392221|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138392222|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138392223|NCT01508572|Growth Substances|growth substances|mesh-ancestor
138392224|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392225|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
138392227|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
138392228|NCT01508611|Protective Agents|protective agents|mesh-ancestor
138392229|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392231|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138392232|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138392233|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138392234|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392235|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392236|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392237|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392238|NCT01508637|Urological Agents|urological agents|mesh-ancestor
138392239|NCT01508663|Everolimus|everolimus|mesh-list
138392240|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138392241|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138392242|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392243|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392244|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392245|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392246|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
138392247|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392248|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392249|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
138392250|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138392251|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138392252|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
138392253|NCT01508806|Liraglutide|liraglutide|mesh-list
138392254|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392255|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392256|NCT01508806|Incretins|incretins|mesh-ancestor
138392257|NCT01508806|Hormones|hormones|mesh-ancestor
138392259|NCT01508845|Vitamin D|vitamin d|mesh-list
138392260|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
138392261|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
138392262|NCT01508845|Vitamins|vitamins|mesh-list
138392265|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138392266|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138392267|NCT01508858|Liraglutide|liraglutide|mesh-list
138392268|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
138392269|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138392270|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392271|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392272|NCT01508858|Incretins|incretins|mesh-ancestor
138392273|NCT01508858|Hormones|hormones|mesh-ancestor
138392274|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392275|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138392276|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
138392277|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392278|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138392279|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138392280|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138392281|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138392282|NCT01508858|Estrogens|estrogens|mesh-ancestor
138392283|NCT01508884|Imiquimod|imiquimod|mesh-list
138392284|NCT01508884|Vaccines|vaccines|mesh-list
138392285|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
138392286|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392287|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138392288|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392289|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
138392290|NCT01508923|Liraglutide|liraglutide|mesh-list
138392292|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392295|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392296|NCT01509001|Metformin|metformin|mesh-list
138392297|NCT01509001|Glimepiride|glimepiride|mesh-list
138392298|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392299|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392300|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392301|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392306|NCT01509131|Laxatives|laxatives|mesh-ancestor
138392307|NCT01509144|Vaccines|vaccines|mesh-list
138392308|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
138392309|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392310|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
138392311|NCT01509209|Ephedrine|ephedrine|mesh-list
138392312|NCT01509209|Levocetirizine|levocetirizine|mesh-list
138392313|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138392314|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138392315|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
138392316|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
138392317|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392318|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392319|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392320|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138392321|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
138392322|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392323|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138392324|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138392325|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
138392326|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138392327|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138392329|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392330|NCT01509261|Lansoprazole|lansoprazole|mesh-list
138392331|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
138392332|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392333|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392334|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138392335|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392336|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392337|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
138392338|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
138392339|NCT01509300|Rituximab|rituximab|mesh-list
138392340|NCT01509300|Fludarabine|fludarabine|mesh-list
138392341|NCT01509300|Tacrolimus|tacrolimus|mesh-list
138392342|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138392343|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392344|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
138392345|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392346|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392349|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392350|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392351|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138392352|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392353|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138392355|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138392356|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138392357|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
138392358|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138392359|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392360|NCT01509365|Clopidogrel|clopidogrel|mesh-list
138392361|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138392362|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138392363|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138363741|NCT04131309|Dexamethasone|dexamethasone|mesh-list
138392364|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138392365|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
138392366|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392367|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392368|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392369|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138392370|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138392371|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
138392372|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392374|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
138392375|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
138392376|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392377|NCT01509521|Phenylephrine|phenylephrine|mesh-list
138392378|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
138392379|NCT01509521|Ephedrine|ephedrine|mesh-list
138392380|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
138392381|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138392382|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
138392383|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
138392384|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392385|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392386|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
138392388|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
138392389|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
138392390|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138392392|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138392393|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392394|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392395|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392396|NCT01509521|Protective Agents|protective agents|mesh-ancestor
138392397|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138392398|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138392399|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138392401|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138392402|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392403|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392404|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392405|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392406|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
138392407|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392408|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392409|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
138392410|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392411|NCT01509742|Liraglutide|liraglutide|mesh-list
138392412|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392413|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392414|NCT01509742|Incretins|incretins|mesh-ancestor
138392415|NCT01509742|Hormones|hormones|mesh-ancestor
138392416|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392417|NCT01509755|Liraglutide|liraglutide|mesh-list
138392418|NCT01509755|Glimepiride|glimepiride|mesh-list
138392419|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392420|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392421|NCT01509755|Incretins|incretins|mesh-ancestor
138392422|NCT01509755|Hormones|hormones|mesh-ancestor
138392423|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392424|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392425|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392426|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
138392427|NCT01509911|Gemcitabine|gemcitabine|mesh-list
138392428|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138392429|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
138392430|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392431|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392432|NCT01509976|Triclosan|triclosan|mesh-list
138363753|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138392433|NCT01509976|Triclocarban|triclocarban|mesh-list
138392435|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392436|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138392437|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138392438|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
138392440|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138392441|NCT01510015|Risperidone|risperidone|mesh-list
138392442|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138392443|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
138392444|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392445|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392446|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392447|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138392448|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138392449|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392450|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138392451|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138392452|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
138392453|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
138392454|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392455|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392457|NCT01510132|Travoprost|travoprost|mesh-list
138392458|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138392459|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138392460|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392461|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392462|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392463|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392464|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392465|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138392466|NCT01510171|Ticagrelor|ticagrelor|mesh-list
138392467|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138392468|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138392469|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138392470|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138392471|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138392472|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
138392473|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392474|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392475|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392476|NCT01510288|Ipilimumab|ipilimumab|mesh-list
138392477|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392484|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392486|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138392487|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392488|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392489|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392490|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392491|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
138392492|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392493|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392494|NCT01510522|Metformin|metformin|mesh-list
138392495|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392496|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392497|NCT01510548|Adalimumab|adalimumab|mesh-list
138392498|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138392499|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392500|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392501|NCT01510561|Gemcitabine|gemcitabine|mesh-list
138392502|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138392503|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138392504|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138392505|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
138215754|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392506|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392507|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392508|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
138392509|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
138392510|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
138392511|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392512|NCT01510574|Misoprostol|misoprostol|mesh-list
138392513|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138392514|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
138392515|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392516|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392517|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392518|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392519|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
138392520|NCT01510613|Dexamethasone|dexamethasone|mesh-list
138392521|NCT01510613|Pomalidomide|pomalidomide|mesh-list
138392522|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392523|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
138392524|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
138392529|NCT01510613|Hormones|hormones|mesh-ancestor
138392530|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392531|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138392532|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392533|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
138392534|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138392535|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138392536|NCT01510613|Growth Substances|growth substances|mesh-ancestor
138392537|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
138392538|NCT01510626|Omalizumab|omalizumab|mesh-list
138392540|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138392541|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
138392542|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
138392543|NCT01510665|Cathartics|cathartics|mesh-ancestor
138392544|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392545|NCT01510795|Spironolactone|spironolactone|mesh-list
138392546|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138392547|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
138392548|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392549|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392550|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138392551|NCT01510795|Diuretics|diuretics|mesh-ancestor
138392557|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392558|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138392559|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138392560|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392561|NCT01510977|Bisacodyl|bisacodyl|mesh-list
138392562|NCT01510977|Cathartics|cathartics|mesh-ancestor
138392563|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392564|NCT01510977|Laxatives|laxatives|mesh-ancestor
138392565|NCT01510990|Gefitinib|gefitinib|mesh-list
138392566|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392567|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392568|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392569|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392570|NCT01511003|Tacrolimus|tacrolimus|mesh-list
138392571|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392572|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
138392573|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392574|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138392575|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392576|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392578|NCT01511029|Pramipexole|pramipexole|mesh-list
138392579|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138392580|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392581|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138392582|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138392583|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392584|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392585|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392586|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392588|NCT01511029|Protective Agents|protective agents|mesh-ancestor
138392589|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138392590|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138392591|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
138392592|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
138392593|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392594|NCT01511146|Gemcitabine|gemcitabine|mesh-list
138392595|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
138392596|NCT01511146|Mitomycins|mitomycins|mesh-list
138392597|NCT01511146|Mitomycin|mitomycin|mesh-list
138392598|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138392599|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
138392601|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392602|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138392603|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
138392604|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138392605|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392607|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138392608|NCT01511159|Liraglutide|liraglutide|mesh-list
138392609|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392610|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392611|NCT01511159|Incretins|incretins|mesh-ancestor
138392612|NCT01511159|Hormones|hormones|mesh-ancestor
138392613|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392614|NCT01511172|Metformin|metformin|mesh-list
138392615|NCT01511172|Liraglutide|liraglutide|mesh-list
138392616|NCT01511172|Glimepiride|glimepiride|mesh-list
138392617|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392618|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392619|NCT01511172|Incretins|incretins|mesh-ancestor
138392620|NCT01511172|Hormones|hormones|mesh-ancestor
138392621|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392622|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392623|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392624|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
138392625|NCT01511185|Liraglutide|liraglutide|mesh-list
138392626|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392627|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392628|NCT01511185|Incretins|incretins|mesh-ancestor
138392629|NCT01511185|Hormones|hormones|mesh-ancestor
138392630|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392631|NCT01511198|Metformin|metformin|mesh-list
138392633|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392634|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392635|NCT01511198|Incretins|incretins|mesh-ancestor
138392636|NCT01511198|Hormones|hormones|mesh-ancestor
138392637|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392638|NCT01511211|Dexamethasone|dexamethasone|mesh-list
138392639|NCT01511211|Ropivacaine|ropivacaine|mesh-list
138392640|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392641|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
138392642|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
138392643|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363799|NCT03786783|Razoxane|razoxane|mesh-list
138392644|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392645|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392646|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
138392647|NCT01511211|Hormones|hormones|mesh-ancestor
138392650|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392651|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
138392652|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
138392653|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392654|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
138392656|NCT01511237|Zidovudine|zidovudine|mesh-list
138392657|NCT01511237|Nevirapine|nevirapine|mesh-list
138392658|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138392659|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138392660|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392661|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392662|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
138392663|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392664|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138392665|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138392666|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
138392667|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138392668|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138392669|NCT01511263|Amiodarone|amiodarone|mesh-list
138392670|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138392672|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392673|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392674|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
138392675|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138392676|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138392677|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392678|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138392679|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138392680|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138392681|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392682|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138392683|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138392684|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138392686|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392687|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392688|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392689|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392690|NCT01511302|Budesonide|budesonide|mesh-list
138392692|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392693|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138392694|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
138392698|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
138392699|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
138392701|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392702|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138392703|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138392704|NCT01511302|Analgesics|analgesics|mesh-ancestor
138392705|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
138392707|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138392708|NCT01511367|Fluticasone|fluticasone|mesh-list
138392709|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138392710|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138392711|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
138392712|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392713|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392714|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138392715|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
138392716|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
138392717|NCT01511367|Hormones|hormones|mesh-ancestor
138392718|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392719|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
138392720|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392721|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
138392722|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138392723|NCT01511471|Ticagrelor|ticagrelor|mesh-list
138392724|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138392725|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138392726|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138392727|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138392728|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
138392729|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392730|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392731|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392732|NCT01511562|Cytarabine|cytarabine|mesh-list
138392733|NCT01511562|Etoposide|etoposide|mesh-list
138392734|NCT01511562|Thiotepa|thiotepa|mesh-list
138392735|NCT01511562|Carmustine|carmustine|mesh-list
138392736|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138392737|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392738|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138392739|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138392740|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392744|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
138392745|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392746|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392747|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
138392748|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392749|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138392751|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138392753|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392754|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392755|NCT01511692|Liraglutide|liraglutide|mesh-list
138392756|NCT01511692|Glimepiride|glimepiride|mesh-list
138392757|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138392758|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392759|NCT01511692|Incretins|incretins|mesh-ancestor
138392760|NCT01511692|Hormones|hormones|mesh-ancestor
138392761|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392762|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392763|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138392764|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
138392765|NCT01511705|Ondansetron|ondansetron|mesh-list
138392766|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
138392767|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
138392768|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392769|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392770|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392771|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
138392772|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
138392773|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138392774|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138392775|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
138392776|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392777|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392778|NCT01511718|Ondansetron|ondansetron|mesh-list
138392779|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
138392780|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
138392781|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392782|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392783|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392784|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
138392785|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138392786|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138392787|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138392792|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138392793|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138392794|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138392795|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
138392797|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392798|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392799|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392801|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
138392802|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392803|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138392804|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138392805|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392806|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392807|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138392808|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
138392809|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392810|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392811|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138392812|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138392813|NCT01511770|Fluconazole|fluconazole|mesh-list
138392814|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
138392815|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392816|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138392817|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138392818|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392819|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392820|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138392821|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
138392822|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392823|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392824|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138392825|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138392830|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138392831|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138392832|NCT01511822|Estradiol|estradiol|mesh-list
138392833|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138392834|NCT01511822|Estrogens|estrogens|mesh-ancestor
138392835|NCT01511822|Hormones|hormones|mesh-ancestor
138392836|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392837|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392838|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138392839|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
138392840|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392841|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138392842|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138392843|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138392844|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
138392845|NCT01511822|Vitamins|vitamins|mesh-ancestor
138392846|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
138392847|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138392848|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
138392849|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138392850|NCT01511822|Diuretics|diuretics|mesh-ancestor
138392851|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392852|NCT01511835|Folic Acid|folic acid|mesh-list
138392853|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
138392854|NCT01511835|Inositol|inositol|mesh-list
138392855|NCT01511835|Hematinics|hematinics|mesh-ancestor
138392856|NCT01511835|Vitamins|vitamins|mesh-ancestor
138392857|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
138392858|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392859|NCT01511848|Deferasirox|deferasirox|mesh-list
138392860|NCT01511848|Deferiprone|deferiprone|mesh-list
138392861|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138392862|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
138392863|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
138392864|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392865|NCT01511874|Leuprolide|leuprolide|mesh-list
138392866|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138392867|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
138392868|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138392869|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392870|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138392873|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138392875|NCT01511887|Analgesics|analgesics|mesh-ancestor
138392877|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392878|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392879|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138392880|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392881|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138392882|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392883|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392884|NCT01511991|Sevoflurane|sevoflurane|mesh-list
138392885|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138392886|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138392887|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
138392888|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
138392889|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392890|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392891|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138392892|NCT01512004|Propiverine|propiverine|mesh-list
138392893|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138392894|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138392895|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
138392896|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392897|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392898|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392899|NCT01512004|Urological Agents|urological agents|mesh-ancestor
138392900|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
138392901|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
138392902|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392903|NCT01512017|Petrolatum|petrolatum|mesh-list
138392909|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138392910|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392911|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392912|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138392913|NCT01512147|Analgesics|analgesics|mesh-ancestor
138392914|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
138392915|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392916|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138392919|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392920|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392921|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392922|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138392923|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
138392924|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
138392925|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138392926|NCT01512173|Propranolol|propranolol|mesh-list
138392927|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138392928|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138392929|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392930|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392931|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392932|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392933|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138392934|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138392935|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
138392937|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138392938|NCT01512199|Trastuzumab|trastuzumab|mesh-list
138392939|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138392940|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138392941|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392942|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
138392944|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138392945|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392946|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392947|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
138392948|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392949|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
138392950|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138392951|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392952|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392953|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138392955|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
138392956|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392957|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138392958|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138392959|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138392960|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
138392961|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392962|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392963|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138392964|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138392965|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138392966|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138392967|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392968|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392969|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392970|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138392971|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
138392972|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138392974|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138392975|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138392976|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138392977|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138392978|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
138392979|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392980|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392981|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392982|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
138392983|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138392984|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
138392985|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
138392986|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138392987|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392988|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138392994|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
138392995|NCT01512537|Vitamins|vitamins|mesh-list
138392996|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
138392997|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392998|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138392999|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138393000|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138393001|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
138393002|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
138393003|NCT01512680|Insulin|insulin|mesh-list
138393004|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393005|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393006|NCT01512784|Vaccines|vaccines|mesh-list
138393007|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
138393008|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393010|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138393011|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393012|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138393013|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138393014|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393015|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138393016|NCT01512862|Vitamins|vitamins|mesh-ancestor
138393017|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
138393018|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138393019|NCT01512901|Betamethasone|betamethasone|mesh-list
138393020|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
138393021|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138393022|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
138393023|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138393024|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393025|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
138393026|NCT01512901|Hormones|hormones|mesh-ancestor
138393027|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393028|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393029|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138393030|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138393031|NCT01512914|Ropivacaine|ropivacaine|mesh-list
138393032|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
138393033|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
138393034|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393035|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393036|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
138393039|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
138393040|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138393041|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138393042|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138393043|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393044|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393045|NCT01512966|Aflibercept|aflibercept|mesh-list
138393046|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138393047|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138393048|NCT01512966|Growth Substances|growth substances|mesh-ancestor
138393049|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393050|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
138393051|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393052|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
138393053|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393054|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393055|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138393056|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
138393057|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393058|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393059|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393060|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393061|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
138393062|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393063|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393064|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138393065|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
138393066|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393067|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393068|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393069|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393071|NCT01513070|Isosorbide|isosorbide|mesh-list
138393075|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393077|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
138393078|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393079|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393080|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393081|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363853|NCT03426904|Fluorouracil|fluorouracil|mesh-list
138393082|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393083|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138393084|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393085|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138393086|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138393087|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393089|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138393090|NCT01513070|Diuretics|diuretics|mesh-ancestor
138393092|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
138393093|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138393094|NCT01513083|Trastuzumab|trastuzumab|mesh-list
138393095|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138393096|NCT01513083|Maytansine|maytansine|mesh-list
138393097|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138393098|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393099|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393100|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393101|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393102|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138393103|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393104|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
138393105|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
138393106|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
138393107|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393108|NCT01513174|Olaparib|olaparib|mesh-list
138393109|NCT01513174|Gefitinib|gefitinib|mesh-list
138393110|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138393111|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393112|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393115|NCT01513200|Heparin|heparin|mesh-list
138393116|NCT01513200|Calcium heparin|calcium heparin|mesh-list
138393117|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
138393118|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393119|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138393120|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393121|NCT01513499|Oxytocin|oxytocin|mesh-list
138393122|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
138393123|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138393124|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393125|NCT01513525|Liraglutide|liraglutide|mesh-list
138393126|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393127|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393128|NCT01513525|Incretins|incretins|mesh-ancestor
138393129|NCT01513525|Hormones|hormones|mesh-ancestor
138393130|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393131|NCT01513564|Morphine|morphine|mesh-list
138393132|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393133|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393134|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138393135|NCT01513564|Narcotics|narcotics|mesh-ancestor
138393136|NCT01513564|Analgesics|analgesics|mesh-ancestor
138393137|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
138393138|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393139|NCT01513603|Cytarabine|cytarabine|mesh-list
138393140|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
138393141|NCT01513603|Cladribine|cladribine|mesh-list
138393142|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138393143|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
138393144|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393145|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393146|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
138393147|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393148|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393149|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
138393150|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393154|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393155|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393157|NCT01513668|Acetaminophen|acetaminophen|mesh-list
138393158|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393160|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
138393161|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393162|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393163|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
138393164|NCT01513681|Lamotrigine|lamotrigine|mesh-list
138393165|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
138393166|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138393167|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138393168|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393169|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138393170|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393171|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138393172|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393173|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393174|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393175|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138393176|NCT01513720|Lamotrigine|lamotrigine|mesh-list
138393177|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
138393178|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138393179|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138393180|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393181|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138393182|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393183|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138393184|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393185|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393186|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393187|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138393188|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
138393189|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138393190|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393191|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393192|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393193|NCT01513772|Analgesics|analgesics|mesh-ancestor
138393194|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
138393195|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393196|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138393197|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138393198|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138393199|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
138393201|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393203|NCT01513785|Rabeprazole|rabeprazole|mesh-list
138393204|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393205|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393206|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138393207|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138393208|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138393209|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393210|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393211|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138393212|NCT01513863|Metronidazole|metronidazole|mesh-list
138393213|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393214|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393215|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138393216|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138393217|NCT01513941|Interferons|interferons|mesh-list
138393219|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
138393220|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
138393221|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138393222|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393223|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
138393224|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393225|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
138393226|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393227|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
138363870|NCT03287778|Pyridoxine|pyridoxine|mesh-list
138393228|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393229|NCT01514019|Acebutolol|acebutolol|mesh-list
138393230|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138393231|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138393232|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
138393233|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
138393234|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393235|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393236|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138393237|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138393239|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138393240|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393241|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393242|NCT01514110|Paclitaxel|paclitaxel|mesh-list
138393243|NCT01514110|Carboplatin|carboplatin|mesh-list
138393244|NCT01514110|Everolimus|everolimus|mesh-list
138393245|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393246|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393247|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393248|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393249|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138393250|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393251|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138393252|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138393253|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393256|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393258|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138393259|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393260|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138393261|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138393262|NCT01514123|Growth Substances|growth substances|mesh-ancestor
138393263|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393264|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
138393266|NCT01514175|Ketorolac|ketorolac|mesh-list
138393267|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393268|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393269|NCT01514175|Analgesics|analgesics|mesh-ancestor
138393270|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
138393271|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393272|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393273|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393274|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393275|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138393276|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393277|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393278|NCT01514188|Doxorubicin|doxorubicin|mesh-list
138393279|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393280|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393281|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393282|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393283|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393284|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393285|NCT01514227|Aspirin|aspirin|mesh-list
138393286|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393287|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393288|NCT01514227|Analgesics|analgesics|mesh-ancestor
138393289|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
138393290|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393291|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393292|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393293|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393294|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393295|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138414732|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138393297|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138393298|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138393299|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393300|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
138393301|NCT01514266|Curcumin|curcumin|mesh-list
138393302|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393303|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393304|NCT01514266|Analgesics|analgesics|mesh-ancestor
138393305|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
138393306|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393307|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393308|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393309|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393310|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393311|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393312|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393313|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138393314|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138393315|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138393316|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393318|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393319|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393320|NCT01514487|Incretins|incretins|mesh-ancestor
138393321|NCT01514487|Hormones|hormones|mesh-ancestor
138393322|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393323|NCT01514695|Midazolam|midazolam|mesh-list
138393324|NCT01514695|Fentanyl|fentanyl|mesh-list
138393325|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138393326|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138393327|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393328|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393329|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138393330|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393331|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393332|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138393333|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
138393334|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
138393335|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
138393336|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
138393337|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393338|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393339|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138393340|NCT01514695|Narcotics|narcotics|mesh-ancestor
138393341|NCT01514695|Analgesics|analgesics|mesh-ancestor
138393342|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
138393343|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393344|NCT01514721|Timolol|timolol|mesh-list
138393345|NCT01514721|Travoprost|travoprost|mesh-list
138393346|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393347|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138393348|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138393349|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363903|NCT02995252|Liver Extracts|liver extracts|mesh-list
138363904|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
138393350|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393351|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393352|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138393355|NCT01514812|Darexaban|darexaban|mesh-list
138393356|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138393357|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138393358|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393359|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393360|NCT01514812|Protective Agents|protective agents|mesh-ancestor
138393361|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393363|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
138393364|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138393365|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393366|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
138393367|NCT01514825|Darexaban|darexaban|mesh-list
138393368|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138393369|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
138393371|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393372|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393373|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393374|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
138393375|NCT01514838|Acarbose|acarbose|mesh-list
138393376|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
138393377|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138393378|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393379|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393380|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393381|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393382|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138393383|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
138393384|NCT01514851|Calcium|calcium|mesh-list
138393385|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138393386|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393387|NCT01514851|Antacids|antacids|mesh-ancestor
138393388|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393389|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138393390|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
138393391|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393392|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393395|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393396|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393397|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393399|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
138393400|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
138393401|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
138393402|NCT01514942|Inositol|inositol|mesh-list
138393403|NCT01514942|Manganese|manganese|mesh-list
138393404|NCT01514942|Hematinics|hematinics|mesh-ancestor
138393405|NCT01514942|Vitamins|vitamins|mesh-ancestor
138393406|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
138393407|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393408|NCT01514942|Trace Elements|trace elements|mesh-ancestor
138393409|NCT01514968|Cyclosporine|cyclosporine|mesh-list
138393410|NCT01514968|Ritonavir|ritonavir|mesh-list
138393411|NCT01514968|Cyclosporins|cyclosporins|mesh-list
138393412|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393413|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393414|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393415|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
138393416|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393417|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
138393418|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393419|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138363922|NCT02817360|Lisinopril|lisinopril|mesh-list
138393420|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393421|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138393422|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138393423|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138393424|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393425|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138393426|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138393427|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
138393428|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138393429|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138393431|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393432|NCT01515020|Vancomycin|vancomycin|mesh-list
138393433|NCT01515020|Daptomycin|daptomycin|mesh-list
138393434|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393435|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393436|NCT01515228|Paclitaxel|paclitaxel|mesh-list
138393437|NCT01515228|Everolimus|everolimus|mesh-list
138393438|NCT01515228|Cilostazol|cilostazol|mesh-list
138393439|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393440|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393441|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393442|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393443|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
138393444|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393445|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138393446|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138393447|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393450|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393451|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138393452|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
138393453|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393454|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138393455|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
138393456|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393457|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138393458|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138393459|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
138393460|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138393461|NCT01515228|Protective Agents|protective agents|mesh-ancestor
138393462|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138393463|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138393464|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138393465|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138393466|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393467|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393468|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138393469|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138393470|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393471|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
138393472|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393473|NCT01515397|Polygeline|polygeline|mesh-list
138393474|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
138393475|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
138393476|NCT01515553|Liraglutide|liraglutide|mesh-list
138393477|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393478|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393479|NCT01515553|Incretins|incretins|mesh-ancestor
138393480|NCT01515553|Hormones|hormones|mesh-ancestor
138393481|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393482|NCT01515579|Liraglutide|liraglutide|mesh-list
138393483|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393484|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393485|NCT01515579|Incretins|incretins|mesh-ancestor
138393486|NCT01515579|Hormones|hormones|mesh-ancestor
138393487|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393488|NCT01515592|Liraglutide|liraglutide|mesh-list
138393491|NCT01515592|Incretins|incretins|mesh-ancestor
138393492|NCT01515592|Hormones|hormones|mesh-ancestor
138393493|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393494|NCT01515683|Anesthetics|anesthetics|mesh-list
138393495|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393496|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393497|NCT01515774|Pramipexole|pramipexole|mesh-list
138393498|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
138393499|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393500|NCT01515774|Protective Agents|protective agents|mesh-ancestor
138393501|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393502|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138393503|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138393504|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
138393505|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
138393506|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393507|NCT01515813|Tenofovir|tenofovir|mesh-list
138393508|NCT01515813|Emtricitabine|emtricitabine|mesh-list
138393509|NCT01515813|Efavirenz|efavirenz|mesh-list
138393510|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138393511|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138393512|NCT01515813|Pravastatin|pravastatin|mesh-list
138393513|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
138393514|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393515|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138393516|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138393517|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393518|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393519|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138393520|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138393521|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138393522|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138393523|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138393524|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138393525|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138393526|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138393527|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138393528|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138393529|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
138393530|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138393531|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138393532|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
138393533|NCT01515826|Dexamethasone|dexamethasone|mesh-list
138393540|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393541|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
138393542|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
138393543|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393544|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393545|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138393546|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
138393547|NCT01515826|Hormones|hormones|mesh-ancestor
138393548|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393549|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138393550|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393551|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393552|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393553|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393554|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393555|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393556|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393557|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393558|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138393559|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
138393560|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138393561|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138393562|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138393563|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138393565|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
138393566|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
138393567|NCT01515839|Vinpocetine|vinpocetine|mesh-list
138393568|NCT01515839|Huperzine A|huperzine a|mesh-list
138393569|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
138393570|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393571|NCT01515839|Protective Agents|protective agents|mesh-ancestor
138393572|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393573|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
138393574|NCT01515839|Vitamins|vitamins|mesh-ancestor
138393575|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
138393576|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
138393577|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138393578|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393579|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
138393580|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393583|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393584|NCT01515839|Expectorants|expectorants|mesh-ancestor
138393585|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
138393586|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138393587|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138393588|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
138393589|NCT01515852|Anesthetics|anesthetics|mesh-list
138393590|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393591|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393592|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138393593|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
138393594|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138393595|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393596|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138393597|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393598|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393599|NCT01516060|Efavirenz|efavirenz|mesh-list
138393600|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138393601|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138393602|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393603|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393604|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
138393605|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393606|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138393607|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138393608|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138393609|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138393610|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138393611|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138393612|NCT01516138|Insulin|insulin|mesh-list
138393613|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393614|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393615|NCT01516255|Liraglutide|liraglutide|mesh-list
138393616|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
138393617|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393620|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393621|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393622|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393623|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393624|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393625|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393626|NCT01516255|Incretins|incretins|mesh-ancestor
138393627|NCT01516255|Hormones|hormones|mesh-ancestor
138393628|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393629|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
138393630|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
138393631|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138393632|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138393633|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393634|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393635|NCT01514903|Urological Agents|urological agents|mesh-ancestor
138393636|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
138393637|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138393638|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393639|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393640|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393641|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393642|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393643|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393644|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393645|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138393646|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
138393647|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138393648|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393649|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138393650|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138393651|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138393653|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393654|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
138393655|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393656|NCT01516463|Bacitracin|bacitracin|mesh-list
138393657|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138393659|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393660|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
138393661|NCT01516554|Testosterone|testosterone|mesh-list
138393662|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
138393663|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
138393664|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138393665|NCT01516554|Androgens|androgens|mesh-ancestor
138393666|NCT01516554|Hormones|hormones|mesh-ancestor
138393667|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393668|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393669|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138393670|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393671|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
138393672|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
138393674|NCT01516567|Doxorubicin|doxorubicin|mesh-list
138393675|NCT01516567|Etoposide|etoposide|mesh-list
138393676|NCT01516567|Vincristine|vincristine|mesh-list
138393677|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393678|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
138393679|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393680|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393681|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138393682|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
138393683|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393684|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393685|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138393686|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138393687|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393688|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393689|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393690|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393691|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393692|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393693|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393694|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
138363964|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138393696|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
138393697|NCT01516580|Rituximab|rituximab|mesh-list
138393698|NCT01516580|Doxorubicin|doxorubicin|mesh-list
138393699|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138393700|NCT01516580|Methotrexate|methotrexate|mesh-list
138393701|NCT01516580|Vincristine|vincristine|mesh-list
138393702|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393703|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
138393704|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393705|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393706|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138393707|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
138393708|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393709|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393710|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138393711|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138393712|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393713|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393714|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393715|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393716|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138393717|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
138393722|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138393723|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138393725|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393726|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393727|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393728|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393729|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
138393730|NCT01516710|Liver Extracts|liver extracts|mesh-list
138393731|NCT01516710|Hematinics|hematinics|mesh-ancestor
138393732|NCT01516723|Sirolimus|sirolimus|mesh-list
138393733|NCT01516723|Everolimus|everolimus|mesh-list
138393734|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
138393735|NCT01516723|Temsirolimus|temsirolimus|mesh-list
138393736|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138393737|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393738|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393739|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393740|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
138393741|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393742|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393743|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393744|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393745|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393746|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
138393747|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138393748|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393749|NCT01516814|Heparin|heparin|mesh-list
138393750|NCT01516814|Calcium heparin|calcium heparin|mesh-list
138393752|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
138393753|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
138393754|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393755|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138393756|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393757|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138393758|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
138393759|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138393760|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393761|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363985|NCT02659384|Aspirin|aspirin|mesh-list
138393763|NCT01516840|Calcium heparin|calcium heparin|mesh-list
138393764|NCT01516840|Warfarin|warfarin|mesh-list
138393765|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
138393766|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
138393767|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393768|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138393769|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393770|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138393771|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
138393772|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138393779|NCT01516866|Protective Agents|protective agents|mesh-ancestor
138393780|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393781|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138393782|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393783|NCT01516996|Docetaxel|docetaxel|mesh-list
138393784|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
138393785|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393786|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393787|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393789|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393790|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138393791|NCT01517009|Docetaxel|docetaxel|mesh-list
138393792|NCT01517009|Capecitabine|capecitabine|mesh-list
138393793|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393794|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393795|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393796|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
138393797|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393798|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138393799|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
138393800|NCT01517022|Nicotine|nicotine|mesh-list
138393801|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138393802|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
138393803|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393804|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393805|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138393806|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138393807|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
138393808|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393809|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393810|NCT01517165|Pioglitazone|pioglitazone|mesh-list
138393812|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393813|NCT01517308|Interferons|interferons|mesh-list
138393814|NCT01517308|Ribavirin|ribavirin|mesh-list
138393815|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
138393816|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
138393817|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138393818|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393819|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
138393820|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393822|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393823|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
138393824|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393825|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138393826|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393827|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393829|NCT01517321|Hormones|hormones|mesh-ancestor
138393830|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393831|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138393832|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393835|NCT01517334|Minocycline|minocycline|mesh-list
138393836|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393837|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393838|NCT01517347|Interleukin-2|interleukin-2|mesh-list
138393839|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363995|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138363996|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393840|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393841|NCT01517347|Analgesics|analgesics|mesh-ancestor
138393842|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
138393843|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393844|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393845|NCT01517360|Oxytocin|oxytocin|mesh-list
138393846|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
138393847|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138393848|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393849|NCT01517399|Vitamin K|vitamin k|mesh-list
138393850|NCT01517399|Digoxin|digoxin|mesh-list
138393851|NCT01517399|Midazolam|midazolam|mesh-list
138393852|NCT01517399|Caffeine|caffeine|mesh-list
138393853|NCT01517399|Omeprazole|omeprazole|mesh-list
138393854|NCT01517399|Warfarin|warfarin|mesh-list
138393855|NCT01517399|Vitamins|vitamins|mesh-ancestor
138393856|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
138393857|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393858|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138393859|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138393860|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393861|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138393862|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393863|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393864|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138393865|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
138393867|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
138393868|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
138393869|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393870|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393871|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
138393872|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138393873|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138393874|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393875|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138393876|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138393877|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
138393878|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138393879|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138393880|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138393881|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138393882|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138393886|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
138393887|NCT01517399|Coagulants|coagulants|mesh-ancestor
138393889|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138393890|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393891|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393892|NCT01517555|Acetaminophen|acetaminophen|mesh-list
138393893|NCT01517555|Liraglutide|liraglutide|mesh-list
138393894|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393895|NCT01517555|Analgesics|analgesics|mesh-ancestor
138393896|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
138393897|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393898|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393899|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
138393900|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393901|NCT01517555|Incretins|incretins|mesh-ancestor
138393902|NCT01517555|Hormones|hormones|mesh-ancestor
138393903|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393904|NCT01517568|Liraglutide|liraglutide|mesh-list
138393905|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393906|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393907|NCT01517568|Incretins|incretins|mesh-ancestor
138393908|NCT01517568|Hormones|hormones|mesh-ancestor
138393909|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393910|NCT01517607|Mesalamine|mesalamine|mesh-list
138364003|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364004|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138393911|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393912|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393913|NCT01517607|Analgesics|analgesics|mesh-ancestor
138393914|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
138393915|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393916|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393917|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138393918|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138393919|NCT01517724|Bortezomib|bortezomib|mesh-list
138393920|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393921|NCT01517815|Tazobactam|tazobactam|mesh-list
138393922|NCT01517815|Piperacillin|piperacillin|mesh-list
138393923|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138393924|NCT01517815|Doripenem|doripenem|mesh-list
138393925|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393926|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138393927|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138393928|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393929|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393930|NCT01517828|Midazolam|midazolam|mesh-list
138393931|NCT01517828|Ketamine|ketamine|mesh-list
138393932|NCT01517828|Analgesics|analgesics|mesh-ancestor
138393933|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
138393934|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393935|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393936|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138393939|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
138393942|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138393943|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393944|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393945|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138393946|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138393947|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138393948|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393949|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138393951|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
138393952|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
138393953|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
138393954|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138393955|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138393956|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393957|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393958|NCT01517854|Urological Agents|urological agents|mesh-ancestor
138393959|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
138393960|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138393961|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138393962|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393963|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393964|NCT01517932|Analgesics|analgesics|mesh-ancestor
138393965|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
138393966|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393967|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138393968|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138393969|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138393970|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
138393971|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393972|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393974|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393975|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393976|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138393977|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138393978|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364021|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
138393979|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393981|NCT01518062|Hormones|hormones|mesh-ancestor
138393982|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393983|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393984|NCT01518101|Metformin|metformin|mesh-list
138393985|NCT01518101|Liraglutide|liraglutide|mesh-list
138393986|NCT01518101|Vildagliptin|vildagliptin|mesh-list
138393987|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138393988|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393989|NCT01518101|Incretins|incretins|mesh-ancestor
138393990|NCT01518101|Hormones|hormones|mesh-ancestor
138393991|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138393992|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138393993|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393994|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393995|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393997|NCT01516944|Tegafur|tegafur|mesh-list
138393998|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
138393999|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394000|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
138394001|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394002|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394003|NCT01518166|Liraglutide|liraglutide|mesh-list
138394004|NCT01518166|Griseofulvin|griseofulvin|mesh-list
138394005|NCT01518166|Digoxin|digoxin|mesh-list
138394006|NCT01518166|Lisinopril|lisinopril|mesh-list
138394007|NCT01518166|Atorvastatin|atorvastatin|mesh-list
138394008|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138394009|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138394010|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
138394011|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394012|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138394013|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138394014|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394015|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394018|NCT01518166|Hormones|hormones|mesh-ancestor
138394019|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394020|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394021|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138394022|NCT01518166|Protective Agents|protective agents|mesh-ancestor
138394023|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138394024|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394025|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394026|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
138394027|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394028|NCT01518231|Aspirin|aspirin|mesh-list
138394029|NCT01518231|Edaravone|edaravone|mesh-list
138394030|NCT01518231|Warfarin|warfarin|mesh-list
138394031|NCT01518231|Atorvastatin|atorvastatin|mesh-list
138394032|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138394033|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394034|NCT01518231|Analgesics|analgesics|mesh-ancestor
138394035|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
138394036|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394037|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394038|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394039|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138394040|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138394041|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138394042|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394043|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138394044|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138394045|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394046|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
138394047|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138394048|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138394050|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138394051|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138394052|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
138394053|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138394054|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
138394055|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138394056|NCT01518231|Protective Agents|protective agents|mesh-ancestor
138394057|NCT01518413|Irinotecan|irinotecan|mesh-list
138394058|NCT01518413|Sorafenib|sorafenib|mesh-list
138394059|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138394060|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394061|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394062|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394063|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394064|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394066|NCT01518465|Lenalidomide|lenalidomide|mesh-list
138394067|NCT01518465|Dalteparin|dalteparin|mesh-list
138394068|NCT01518465|Tinzaparin|tinzaparin|mesh-list
138394069|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138394071|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
138394072|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
138394073|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394074|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394075|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394076|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
138394077|NCT01518465|Hormones|hormones|mesh-ancestor
138394078|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394079|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138394080|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394081|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
138394082|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138394083|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138394084|NCT01518465|Growth Substances|growth substances|mesh-ancestor
138394085|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
138394086|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
138394087|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138394088|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138394089|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394090|NCT01518569|Urinastatin|urinastatin|mesh-list
138394091|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138394092|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138394093|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394094|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394095|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394096|NCT01518595|Bosentan|bosentan|mesh-list
138394097|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394098|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138394099|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394100|NCT01518608|Alfentanil|alfentanil|mesh-list
138394101|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138394102|NCT01518608|Narcotics|narcotics|mesh-ancestor
138394103|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394104|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394105|NCT01518608|Analgesics|analgesics|mesh-ancestor
138394106|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
138394107|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394109|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
138394110|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
138394111|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138394112|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394113|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394114|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394115|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394116|NCT01518634|Imipramine|imipramine|mesh-list
138394117|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138394118|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
138394119|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394120|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138394121|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138394122|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394123|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394124|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138394125|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394126|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394127|NCT01518712|Metformin|metformin|mesh-list
138394128|NCT01518712|Canagliflozin|canagliflozin|mesh-list
138394129|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394130|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394131|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138394132|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394133|NCT01518725|Vitamin D|vitamin d|mesh-list
138394134|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
138394135|NCT01518725|Vitamins|vitamins|mesh-ancestor
138394136|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
138394137|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394138|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394139|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394140|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138394141|NCT01518790|Laxatives|laxatives|mesh-ancestor
138394142|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394143|NCT01518855|Amlodipine|amlodipine|mesh-list
138394144|NCT01518855|Nifedipine|nifedipine|mesh-list
138394145|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394146|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138394147|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394148|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394149|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394150|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394152|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
138394153|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394154|NCT01518933|Silybin|silybin|mesh-list
138394155|NCT01518933|Silymarin|silymarin|mesh-list
138394156|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
138394157|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394158|NCT01518933|Protective Agents|protective agents|mesh-ancestor
138394159|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394160|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138394163|NCT01518959|Vitamin D|vitamin d|mesh-list
138394164|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394165|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394166|NCT01518959|Vitamins|vitamins|mesh-ancestor
138394167|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
138394168|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394169|NCT01518998|Amlodipine|amlodipine|mesh-list
138394170|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394171|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138394172|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394173|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394174|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394175|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394176|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
138394178|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394179|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
138394180|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394181|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394182|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394183|NCT01519037|Cinacalcet|cinacalcet|mesh-list
138394184|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394185|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394186|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138394187|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
138394188|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394189|NCT01519076|Coal Tar|coal tar|mesh-list
138394190|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
138394191|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
138394192|NCT01519102|Hormones|hormones|mesh-list
138394193|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394194|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394195|NCT01519128|Rilpivirine|rilpivirine|mesh-list
138394196|NCT01519128|Digoxin|digoxin|mesh-list
138394197|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394198|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138394199|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394200|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394201|NCT01519128|Protective Agents|protective agents|mesh-ancestor
138394202|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394203|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138394204|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138394205|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
138394206|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394207|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138394208|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138394210|NCT01519154|Propofol|propofol|mesh-list
138394211|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138394212|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394213|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394214|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138394215|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
138394216|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
138394217|NCT01519154|Analgesics|analgesics|mesh-ancestor
138394220|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138394221|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138394222|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138394223|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394224|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394225|NCT01519297|Irbesartan|irbesartan|mesh-list
138394226|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394227|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138394228|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138394229|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394230|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138394231|NCT01519310|Metronidazole|metronidazole|mesh-list
138394232|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
138394233|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394234|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138394235|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138394236|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138394237|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394238|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394239|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394240|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394241|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138394242|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138394244|NCT01519336|Darunavir|darunavir|mesh-list
138394245|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138394246|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138394247|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394248|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394249|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394250|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138394251|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138394252|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
138394253|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394254|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138394255|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138394256|NCT01519401|Drospirenone|drospirenone|mesh-list
138394257|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138394258|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138394259|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138394261|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138394262|NCT01519401|Estrogens|estrogens|mesh-ancestor
138394263|NCT01519401|Hormones|hormones|mesh-ancestor
138394264|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394265|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364042|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394266|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138394267|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
138394268|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394269|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138394270|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138394271|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138394272|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138394273|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
138394274|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138394276|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
138394277|NCT01519544|Acetazolamide|acetazolamide|mesh-list
138394278|NCT01519544|Temazepam|temazepam|mesh-list
138394279|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
138394280|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138394281|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394282|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394283|NCT01519544|Diuretics|diuretics|mesh-ancestor
138394284|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
138394285|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394286|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138394287|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394288|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138394289|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138394290|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394291|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
138394292|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
138394293|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394295|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
138394296|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394297|NCT01519726|Midazolam|midazolam|mesh-list
138394298|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138394299|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138394300|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394301|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394302|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138394303|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138394304|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394305|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138394306|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
138394307|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
138394308|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
138394309|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
138394310|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394311|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394312|NCT01519752|Oxiconazole|oxiconazole|mesh-list
138394313|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
138394314|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394315|NCT01519856|Piribedil|piribedil|mesh-list
138394316|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138394317|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138394318|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
138394319|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
138394320|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394321|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394322|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394323|NCT01519986|Vitamin D|vitamin d|mesh-list
138394324|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
138394325|NCT01519986|Vitamins|vitamins|mesh-ancestor
138394326|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
138394327|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394330|NCT01520012|Esomeprazole|esomeprazole|mesh-list
138394331|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138394332|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394333|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138394334|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394335|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394336|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138394337|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138394338|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394339|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138394340|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138394341|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138394342|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
138394343|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394344|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138394345|NCT01520103|Everolimus|everolimus|mesh-list
138394346|NCT01520103|Vinorelbine|vinorelbine|mesh-list
138394347|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138394348|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394349|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394350|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394351|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394352|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
138394353|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394355|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138394356|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
138394357|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138394358|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138394359|NCT01520116|Timolol|timolol|mesh-list
138394360|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138394361|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138394362|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138394363|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394364|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394365|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394366|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394367|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394368|NCT01520181|Lactams|lactams|mesh-list
138394369|NCT01520181|beta-Lactams|beta-lactams|mesh-list
138394370|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138394371|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394372|NCT01520285|Felodipine|felodipine|mesh-list
138394373|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394374|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394375|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138394376|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394377|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394378|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394379|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394380|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
138394381|NCT01520298|Acetaminophen|acetaminophen|mesh-list
138394382|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394386|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394387|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
138394388|NCT01520350|Aripiprazole|aripiprazole|mesh-list
138394389|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
138394390|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394391|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138394392|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138394393|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394394|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394395|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
138394396|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
138394397|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394398|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394399|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138394400|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138394402|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138394403|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138394404|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138394405|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138394406|NCT01520389|Irinotecan|irinotecan|mesh-list
138394407|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138394408|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138364063|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394409|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394410|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394411|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394412|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394413|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
138394414|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394415|NCT01520415|Lidocaine|lidocaine|mesh-list
138394416|NCT01520415|Bupivacaine|bupivacaine|mesh-list
138394417|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
138394418|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
138394419|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394420|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394421|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
138394422|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394423|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394424|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138394425|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138394426|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394427|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394428|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138394429|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138394430|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394431|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394432|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138394433|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394434|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394435|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
138394436|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394437|NCT01520467|Anastrozole|anastrozole|mesh-list
138394438|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138394442|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394443|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394444|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138394445|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138394446|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394447|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394448|NCT01520584|Vitamins|vitamins|mesh-list
138394449|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
138394450|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394452|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138394453|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
138394454|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
138394455|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138394456|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
138394458|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394459|NCT01520766|Methamphetamine|methamphetamine|mesh-list
138394460|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138394461|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394462|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
138394463|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
138394464|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394465|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
138394466|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394467|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394468|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
138394469|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138394470|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138394471|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394472|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138394473|NCT01520792|Acetaminophen|acetaminophen|mesh-list
138394474|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394475|NCT01520792|Analgesics|analgesics|mesh-ancestor
138394476|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
138394477|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364071|NCT01850303|Pemetrexed|pemetrexed|mesh-list
138394478|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394479|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
138394480|NCT01520818|Insulin|insulin|mesh-list
138394481|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138394482|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
138394483|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
138394484|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138394485|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
138394486|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394487|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394488|NCT01520831|Insulin|insulin|mesh-list
138394489|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138394490|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
138394491|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
138394492|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138394493|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
138394494|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138394495|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394499|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
138394500|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394501|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138394502|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138394504|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394505|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138394506|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
138394507|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394508|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394509|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138394510|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138394511|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
138394512|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394513|NCT01521130|Levetiracetam|levetiracetam|mesh-list
138394514|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
138394515|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
138394516|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
138394517|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394518|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
138394519|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394520|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394521|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138394522|NCT01521312|Saxagliptin|saxagliptin|mesh-list
138394523|NCT01521312|Incretins|incretins|mesh-ancestor
138394524|NCT01521312|Hormones|hormones|mesh-ancestor
138394525|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394526|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394527|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138394528|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394529|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394530|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394531|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394532|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138394533|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
138394534|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394535|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
138394536|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138394537|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138394538|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394539|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138394540|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394541|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364080|NCT01763671|Docetaxel|docetaxel|mesh-list
138394542|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394543|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394544|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138394545|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
138394546|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394547|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394548|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138394549|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138394550|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138394551|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138394552|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138394553|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
138394554|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394555|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394556|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138394557|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
138394558|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
138394559|NCT01521455|Hormones|hormones|mesh-ancestor
138394560|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394561|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
138394562|NCT01521481|Anesthetics|anesthetics|mesh-list
138394563|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394564|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394565|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138394566|NCT01521520|Hematinics|hematinics|mesh-ancestor
138394567|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138394568|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138394569|NCT01521572|Albuterol|albuterol|mesh-list
138394570|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138394571|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
138394572|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394573|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394574|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138394575|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
138394576|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
138394577|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394578|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138394579|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138394580|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138394581|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
138394582|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394583|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394584|NCT01521624|Metformin|metformin|mesh-list
138394585|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394586|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394587|NCT01521689|Rituximab|rituximab|mesh-list
138394592|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138394593|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138394594|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138394595|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138394596|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
138394597|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215755|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394598|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394599|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394600|NCT01521767|Urological Agents|urological agents|mesh-ancestor
138394601|NCT01521793|Retinol acetate|retinol acetate|mesh-list
138394602|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138394603|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
138394604|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394605|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138394606|NCT01521793|Protective Agents|protective agents|mesh-ancestor
138394607|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394608|NCT01521819|Ranibizumab|ranibizumab|mesh-list
138394609|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138394610|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138394611|NCT01521819|Growth Substances|growth substances|mesh-ancestor
138394612|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394613|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
138394614|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394615|NCT01521936|Vitamin D|vitamin d|mesh-list
138394616|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
138394617|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
138394618|NCT01521936|Vitamins|vitamins|mesh-list
138394619|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
138394620|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394621|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394622|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394623|NCT01521962|Alogliptin|alogliptin|mesh-list
138394624|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394625|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394626|NCT01521962|Incretins|incretins|mesh-ancestor
138394627|NCT01521962|Hormones|hormones|mesh-ancestor
138394628|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394629|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138394630|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394631|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394632|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394634|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138394635|NCT01521975|Telbivudine|telbivudine|mesh-list
138394636|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
138394641|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394642|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
138394643|NCT01522040|Analgesics|analgesics|mesh-ancestor
138394644|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
138394645|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394646|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394647|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
138394648|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394649|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394650|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
138394651|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138394652|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394653|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394654|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394655|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
138394656|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394657|NCT01522092|Escitalopram|escitalopram|mesh-list
138394658|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138394659|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138394660|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394661|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394662|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394663|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
138394664|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394666|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138394667|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394668|NCT01522326|Ibuprofen|ibuprofen|mesh-list
138394669|NCT01522326|Metoclopramide|metoclopramide|mesh-list
138394670|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138394671|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394672|NCT01522326|Analgesics|analgesics|mesh-ancestor
138394673|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
138394674|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394675|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394676|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394677|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138394678|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138394679|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394680|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394682|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
138394683|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394684|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138394685|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138394686|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
138394687|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394688|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138394689|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394694|NCT01522534|Mepivacaine|mepivacaine|mesh-list
138394695|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138394696|NCT01522534|Narcotics|narcotics|mesh-ancestor
138394697|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394698|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394699|NCT01522534|Analgesics|analgesics|mesh-ancestor
138394700|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
138394701|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394702|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
138394703|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
138394704|NCT01522547|Pomalidomide|pomalidomide|mesh-list
138394705|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
138394706|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394707|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138394708|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138394709|NCT01522547|Growth Substances|growth substances|mesh-ancestor
138394710|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
138394711|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394712|NCT01522612|Leucovorin|leucovorin|mesh-list
138394713|NCT01522612|Fluorouracil|fluorouracil|mesh-list
138394714|NCT01522612|Cetuximab|cetuximab|mesh-list
138394715|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
138394716|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394717|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394718|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394719|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394720|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
138394721|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394722|NCT01522612|Antidotes|antidotes|mesh-ancestor
138394723|NCT01522612|Protective Agents|protective agents|mesh-ancestor
138394724|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
138394725|NCT01522612|Vitamins|vitamins|mesh-ancestor
138394726|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
138394727|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138394728|NCT01522625|Tenofovir|tenofovir|mesh-list
138394729|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
138394730|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394731|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138394732|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138394733|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394734|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394735|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138394736|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138394737|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138394738|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138394739|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
138394740|NCT01522729|Fentanyl|fentanyl|mesh-list
138364122|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
138394741|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138394742|NCT01522729|Narcotics|narcotics|mesh-ancestor
138394747|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394748|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138394750|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
138394751|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
138394752|NCT01522820|Sirolimus|sirolimus|mesh-list
138394753|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138394754|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394755|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138394756|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394757|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
138394758|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394759|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
138394760|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394763|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138394764|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138394765|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394766|NCT01522872|Dexamethasone|dexamethasone|mesh-list
138394767|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
138394769|NCT01522872|Pomalidomide|pomalidomide|mesh-list
138394770|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
138394771|NCT01522872|BB 1101|bb 1101|mesh-list
138394772|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394773|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
138394774|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
138394775|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394776|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394777|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394778|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
138394779|NCT01522872|Hormones|hormones|mesh-ancestor
138394780|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394781|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138394782|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394783|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394784|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394790|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
138394791|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138394792|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
138394794|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
138394795|NCT01522989|Palbociclib|palbociclib|mesh-list
138394796|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
138394797|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394799|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394800|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394802|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394803|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394804|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394805|NCT01523015|Docetaxel|docetaxel|mesh-list
138394806|NCT01523015|Fluorouracil|fluorouracil|mesh-list
138394807|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
138394808|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394809|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138394810|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138394811|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138394812|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394813|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
138394814|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394815|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394816|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
138394817|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394818|NCT01523041|Insulin|insulin|mesh-list
138394819|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138394820|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
138394821|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
138394822|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138394823|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
138394824|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394825|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394826|NCT01523054|Metoprolol|metoprolol|mesh-list
138394827|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394828|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138394829|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
138394830|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
138394831|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394832|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414733|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138394834|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138394835|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138394836|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
138394837|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394838|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394839|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
138394840|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
138394841|NCT01523080|Acetaminophen|acetaminophen|mesh-list
138394842|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394843|NCT01523080|Analgesics|analgesics|mesh-ancestor
138394844|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
138394845|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394847|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
138394848|NCT01523093|Ondansetron|ondansetron|mesh-list
138394849|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
138394850|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
138394851|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394852|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394853|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394854|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
138394855|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
138394856|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138394857|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138394858|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
138394859|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394860|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394861|NCT01523119|Ondansetron|ondansetron|mesh-list
138394862|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
138394863|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
138394864|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394865|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394866|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138394867|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
138394868|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
138394869|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138394870|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138394871|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
138394872|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394873|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394874|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
138394875|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394876|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138394885|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394888|NCT01523314|Hormones|hormones|mesh-ancestor
138394889|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394890|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138394891|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394892|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138394893|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138394894|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138394895|NCT01523314|Growth Substances|growth substances|mesh-ancestor
138394896|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
138394897|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138394898|NCT01523327|Uric Acid|uric acid|mesh-list
138394899|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
138394900|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394901|NCT01523327|Protective Agents|protective agents|mesh-ancestor
138394902|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394903|NCT01523379|Parecoxib|parecoxib|mesh-list
138394904|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138394905|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138394906|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394907|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394908|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138394909|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138394910|NCT01523379|Analgesics|analgesics|mesh-ancestor
138394911|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
138394912|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394913|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394914|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394915|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138394916|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
138394917|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138394918|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
138394920|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394921|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394922|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394923|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
138394924|NCT01523431|Leucovorin|leucovorin|mesh-list
138394925|NCT01523431|Fluorouracil|fluorouracil|mesh-list
138394929|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394931|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138394932|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
138394933|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394934|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138394935|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394936|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394937|NCT01523431|Antidotes|antidotes|mesh-ancestor
138394939|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
138394940|NCT01523431|Vitamins|vitamins|mesh-ancestor
138394941|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
138394942|NCT01523483|Progesterone|progesterone|mesh-list
138394943|NCT01523483|Progestins|progestins|mesh-ancestor
138394944|NCT01523483|Hormones|hormones|mesh-ancestor
138394945|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394946|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394948|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
138394949|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394950|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
138394951|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138394952|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394953|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
138394954|NCT01523574|Vitamin E|vitamin e|mesh-list
138394955|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
138394956|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
138394957|NCT01523574|Calcium|calcium|mesh-list
138394958|NCT01523574|Vitamins|vitamins|mesh-ancestor
138394959|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
138394960|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394961|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138394962|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394963|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394964|NCT01523574|Analgesics|analgesics|mesh-ancestor
138394965|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
138394966|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394967|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
138394968|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394969|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138394970|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
138394971|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138394972|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138394973|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394974|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
138394975|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138394976|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
138394983|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138394984|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394985|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
138394986|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
138394987|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
138394988|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394989|NCT01523847|Doxorubicin|doxorubicin|mesh-list
138394990|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138394991|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394992|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138394993|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138394994|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394995|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394997|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138394998|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
138394999|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395000|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395001|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
138395002|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395003|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395004|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138395005|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
138395006|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395007|NCT01523860|Analgesics|analgesics|mesh-ancestor
138395008|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
138395009|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395010|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138395011|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138395012|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395013|NCT01524068|Rituximab|rituximab|mesh-list
138395014|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395015|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395016|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
138395017|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395018|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395019|NCT01524081|Amoxicillin|amoxicillin|mesh-list
138395020|NCT01524081|Metronidazole|metronidazole|mesh-list
138395021|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
138395022|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
138395023|NCT01524081|Cefuroxime|cefuroxime|mesh-list
138395024|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
138395026|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138395027|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138395028|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395029|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138395030|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138395031|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
138395032|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138395033|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138395038|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395039|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395040|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138395041|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138395042|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138395045|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
138395046|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
138395047|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
138395048|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395049|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395050|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395051|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395052|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
138395053|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395054|NCT01524094|Antidotes|antidotes|mesh-ancestor
138395055|NCT01524094|Protective Agents|protective agents|mesh-ancestor
138395056|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
138395057|NCT01524094|Vitamins|vitamins|mesh-ancestor
138395058|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
138395059|NCT01524237|Ketamine|ketamine|mesh-list
138395060|NCT01524237|Analgesics|analgesics|mesh-ancestor
138395061|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
138395062|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395063|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395064|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138395066|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
138395067|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
138395068|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395069|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138395070|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138395071|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395072|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395073|NCT01524315|Vitamins|vitamins|mesh-list
138395074|NCT01524315|Thiamine|thiamine|mesh-list
138395075|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
138395076|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
138395077|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395078|NCT01524354|Anesthetics|anesthetics|mesh-list
138395079|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395080|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395081|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
138395082|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138395083|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395084|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395085|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138395086|NCT01524367|Analgesics|analgesics|mesh-ancestor
138395087|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
138395088|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395089|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138395095|NCT01524432|Clotrimazole|clotrimazole|mesh-list
138395096|NCT01524432|Miconazole|miconazole|mesh-list
138395097|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
138395098|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138395099|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395100|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138395101|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138395102|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395103|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395104|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138395105|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
138395106|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395107|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395108|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138395109|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138395110|NCT01524445|Bortezomib|bortezomib|mesh-list
138395111|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395112|NCT01524497|Trazodone|trazodone|mesh-list
138395113|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138395114|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138395115|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395116|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395117|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138395118|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138215756|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395119|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138395120|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395121|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395122|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395123|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
138395124|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138395125|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
138395126|NCT01524575|Gemcitabine|gemcitabine|mesh-list
138395127|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
138395128|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395129|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
138395130|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395131|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395132|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138395133|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138395134|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138395135|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
138395136|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395137|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138395138|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138395139|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395140|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138395146|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138395148|NCT01524731|Dexamethasone|dexamethasone|mesh-list
138395149|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
138395150|NCT01524731|BB 1101|bb 1101|mesh-list
138395151|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395152|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
138395153|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
138395154|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395155|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395156|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395158|NCT01524731|Hormones|hormones|mesh-ancestor
138395159|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395160|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138395161|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395162|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138395163|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395164|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395166|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138395167|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138364186|NCT04823442|Mirabegron|mirabegron|mesh-list
138395168|NCT01524744|Analgesics|analgesics|mesh-ancestor
138395169|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
138395170|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395171|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395172|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395173|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395174|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395175|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395176|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
138395177|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138395178|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395179|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395180|NCT01524757|Pantoprazole|pantoprazole|mesh-list
138395181|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138395182|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395183|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138395184|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395191|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
138395192|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138395193|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138395194|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395195|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
138395196|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
138395197|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
138395198|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395199|NCT01524861|Protective Agents|protective agents|mesh-ancestor
138395200|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395201|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
138395202|NCT01524861|Vitamins|vitamins|mesh-ancestor
138395203|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
138395204|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
138395205|NCT01524874|Vitamin D|vitamin d|mesh-list
138395206|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
138395207|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
138395208|NCT01524874|Calcitriol|calcitriol|mesh-list
138395209|NCT01524874|Vitamins|vitamins|mesh-list
138395210|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
138395211|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395212|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138395213|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138395214|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138395215|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395216|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395217|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138395218|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
138395219|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138395220|NCT01524939|Antibodies|antibodies|mesh-list
138395221|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
138395230|NCT06053580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138395231|NCT06053580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395232|NCT06053528|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138395233|NCT06053528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395234|NCT06052995|Pimecrolimus|pimecrolimus|mesh-list
138395235|NCT06052995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138395236|NCT06052995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138395237|NCT06052995|Analgesics|analgesics|mesh-ancestor
138395238|NCT06052995|Sensory System Agents|sensory system agents|mesh-ancestor
138395239|NCT06052995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395240|NCT06052995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395241|NCT06052995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395242|NCT06052995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395243|NCT06052995|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395244|NCT06052995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395245|NCT06052995|Immunologic Factors|immunologic factors|mesh-ancestor
138395246|NCT06052995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138395247|NCT06052995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395248|NCT06052995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395249|NCT06052852|Pembrolizumab|pembrolizumab|mesh-list
138395250|NCT06052852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138395251|NCT06052852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395252|NCT06052852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395253|NCT06052852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395254|NCT06052839|Paclitaxel|paclitaxel|mesh-list
138395255|NCT06052839|Carboplatin|carboplatin|mesh-list
138395256|NCT06052839|Pembrolizumab|pembrolizumab|mesh-list
138215757|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
138395257|NCT06052839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138395258|NCT06052839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395259|NCT06052839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395260|NCT06052839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138395261|NCT06052839|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395262|NCT06052839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395263|NCT06052839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395264|NCT06052839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395265|NCT06052826|Coal Tar|coal tar|mesh-list
138395266|NCT06052826|Keratolytic Agents|keratolytic agents|mesh-ancestor
138395267|NCT06052826|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395268|NCT06052163|Bumetanide|bumetanide|mesh-list
138395269|NCT06052163|Diuretics|diuretics|mesh-ancestor
138395270|NCT06052163|Natriuretic Agents|natriuretic agents|mesh-ancestor
138395271|NCT06052163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395272|NCT06052163|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138395273|NCT06052163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395274|NCT06052163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395275|NCT06052111|Fentanyl|fentanyl|mesh-list
138395276|NCT06052111|Dexmedetomidine|dexmedetomidine|mesh-list
138395277|NCT06052111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138395280|NCT06052111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138395282|NCT06052111|Sensory System Agents|sensory system agents|mesh-ancestor
138395283|NCT06052111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395284|NCT06052111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138395285|NCT06052111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138395287|NCT06052111|Adrenergic Agents|adrenergic agents|mesh-ancestor
138395288|NCT06052111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395289|NCT06052111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395290|NCT06052111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138395291|NCT06052111|Narcotics|narcotics|mesh-ancestor
138395292|NCT06052111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138395293|NCT06052111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138395294|NCT06052111|Anesthetics, General|anesthetics, general|mesh-ancestor
138395295|NCT06052111|Anesthetics|anesthetics|mesh-ancestor
138395296|NCT06051981|Listerine|listerine|mesh-list
138395297|NCT06051981|Calcium|calcium|mesh-list
138395298|NCT06051981|Fluorides|fluorides|mesh-list
138395299|NCT06051981|Sodium Fluoride|sodium fluoride|mesh-list
138395300|NCT06051981|Caseins|caseins|mesh-list
138395301|NCT06051981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138395302|NCT06051981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395303|NCT06051981|Cariostatic Agents|cariostatic agents|mesh-ancestor
138395304|NCT06051981|Protective Agents|protective agents|mesh-ancestor
138395305|NCT06051981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138395306|NCT06051981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395307|NCT06051981|Chelating Agents|chelating agents|mesh-ancestor
138395308|NCT06051981|Sequestering Agents|sequestering agents|mesh-ancestor
138395309|NCT06051981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395310|NCT06051955|Sodium sulfate|sodium sulfate|mesh-list
138395311|NCT06051955|Cathartics|cathartics|mesh-ancestor
138395312|NCT06051955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395313|NCT06051890|Buprenorphine|buprenorphine|mesh-list
138395314|NCT06051890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138395315|NCT06051890|Narcotics|narcotics|mesh-ancestor
138395316|NCT06051890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395317|NCT06051890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395318|NCT06051890|Analgesics|analgesics|mesh-ancestor
138395319|NCT06051890|Sensory System Agents|sensory system agents|mesh-ancestor
138395320|NCT06051890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395321|NCT06051890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138395322|NCT06051851|Paclitaxel|paclitaxel|mesh-list
138395328|NCT06051851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395329|NCT06051851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395330|NCT06051851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395331|NCT06051851|Antimetabolites|antimetabolites|mesh-ancestor
138395332|NCT06051786|Fluticasone|fluticasone|mesh-list
138395333|NCT06051786|Azelastine|azelastine|mesh-list
138395334|NCT06051786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395335|NCT06051786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138395336|NCT06051786|Autonomic Agents|autonomic agents|mesh-ancestor
138395337|NCT06051786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395338|NCT06051786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395339|NCT06051786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138395341|NCT06051786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395342|NCT06051786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138395343|NCT06051786|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138395344|NCT06051786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395345|NCT06051786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395346|NCT06051786|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138395347|NCT06051786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138395348|NCT06051786|Histamine Antagonists|histamine antagonists|mesh-ancestor
138395349|NCT06051786|Histamine Agents|histamine agents|mesh-ancestor
138395350|NCT06051786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395351|NCT06051630|Lidocaine|lidocaine|mesh-list
138395352|NCT06051630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138395353|NCT06051630|Anesthetics|anesthetics|mesh-ancestor
138395354|NCT06051630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395355|NCT06051630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395356|NCT06051630|Sensory System Agents|sensory system agents|mesh-ancestor
138395357|NCT06051630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395358|NCT06051630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138395359|NCT06051630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138395360|NCT06051630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138395361|NCT06051630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395362|NCT06051630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395363|NCT06051370|Triamcinolone|triamcinolone|mesh-list
138395364|NCT06051370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138395365|NCT06051370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138395367|NCT06051370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138395372|NCT06051370|Sensory System Agents|sensory system agents|mesh-ancestor
138395373|NCT06051370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395374|NCT06051370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138395375|NCT06051370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138395376|NCT06051370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138395377|NCT06051370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395378|NCT06051370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395379|NCT06051370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395380|NCT06051370|Glucocorticoids|glucocorticoids|mesh-ancestor
138395382|NCT06051370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395383|NCT06051370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395384|NCT06051370|Immunologic Factors|immunologic factors|mesh-ancestor
138395385|NCT06051370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395386|NCT06046248|Rituximab|rituximab|mesh-list
138395387|NCT06046248|Belumosudil|belumosudil|mesh-list
138395388|NCT06046248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395389|NCT06046248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395390|NCT06046248|Immunologic Factors|immunologic factors|mesh-ancestor
138395391|NCT06046248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395392|NCT06046248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395394|NCT06046248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395395|NCT06046248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395396|NCT06045481|Doxycycline|doxycycline|mesh-list
138395397|NCT06045481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138395398|NCT06045481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395399|NCT06045481|Antimalarials|antimalarials|mesh-ancestor
138395400|NCT06045481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138395401|NCT06045481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138395402|NCT06015490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138395403|NCT05973851|Ketamine|ketamine|mesh-list
138395404|NCT05973851|Antidepressive Agents|antidepressive agents|mesh-list
138395405|NCT05973851|Esketamine|esketamine|mesh-list
138395406|NCT05973851|Analgesics|analgesics|mesh-ancestor
138395407|NCT05973851|Sensory System Agents|sensory system agents|mesh-ancestor
138395408|NCT05973851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395410|NCT05973851|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138395411|NCT05973851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138395413|NCT05973851|Anesthetics|anesthetics|mesh-ancestor
138215758|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
138395414|NCT05973851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395415|NCT05973851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138395416|NCT05973851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138395417|NCT05973851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395418|NCT05973851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395419|NCT05973851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138395420|NCT05973786|Lamotrigine|lamotrigine|mesh-list
138395421|NCT05973786|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138395422|NCT05973786|Valproic Acid|valproic acid|mesh-list
138395423|NCT05973786|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138395424|NCT05973786|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138395426|NCT05973786|Escitalopram|escitalopram|mesh-list
138395427|NCT05973786|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138395428|NCT05973786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138395429|NCT05973786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395430|NCT05973786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395431|NCT05973786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395432|NCT05973786|Serotonin Agents|serotonin agents|mesh-ancestor
138395433|NCT05973786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395434|NCT05973786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395435|NCT05973786|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138395436|NCT05973786|Antidepressive Agents|antidepressive agents|mesh-ancestor
138395437|NCT05973786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138395438|NCT05973786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138395439|NCT05973786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138395440|NCT05973786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395441|NCT05973786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138395443|NCT05973786|Sensory System Agents|sensory system agents|mesh-ancestor
138395444|NCT05973786|Dopamine Agents|dopamine agents|mesh-ancestor
138395445|NCT05973786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395446|NCT05973786|Antimanic Agents|antimanic agents|mesh-ancestor
138395447|NCT05973786|Anticonvulsants|anticonvulsants|mesh-ancestor
138395448|NCT05973786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138395449|NCT05973786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138395450|NCT05973786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138395452|NCT05958875|Antipsychotic Agents|antipsychotic agents|mesh-list
138395453|NCT05958875|Clozapine|clozapine|mesh-list
138395454|NCT05958875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138395455|NCT05958875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395457|NCT05958875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138395458|NCT05958875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138395459|NCT05958875|Serotonin Agents|serotonin agents|mesh-ancestor
138395460|NCT05958875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395461|NCT05958875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395462|NCT05958875|GABA Antagonists|gaba antagonists|mesh-ancestor
138395463|NCT05958875|GABA Agents|gaba agents|mesh-ancestor
138395464|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138395465|NCT05891262|Norethindrone|norethindrone|mesh-list
138395466|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138395468|NCT05891262|Estrogens|estrogens|mesh-ancestor
138395469|NCT05891262|Hormones|hormones|mesh-ancestor
138395470|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395471|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395472|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138395473|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
138395474|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138395475|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138395476|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138395477|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138395478|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138395479|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138395480|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138395481|NCT05874570|Metronidazole|metronidazole|mesh-list
138395482|NCT05874570|Doxycycline|doxycycline|mesh-list
138395483|NCT05874570|Tetracycline|tetracycline|mesh-list
138395484|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
138395485|NCT05874570|Esomeprazole|esomeprazole|mesh-list
138395486|NCT05874570|Bismuth|bismuth|mesh-list
138395487|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395488|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395489|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138395490|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138395491|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138395492|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138395493|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395498|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138395500|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
138395501|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395502|NCT05874570|Expectorants|expectorants|mesh-ancestor
138395503|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
138395504|NCT05808608|Axitinib|axitinib|mesh-list
138395505|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395506|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395507|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395508|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395509|NCT05781321|Temozolomide|temozolomide|mesh-list
138395510|NCT05781321|Levodopa|levodopa|mesh-list
138395511|NCT05781321|Fluorides|fluorides|mesh-list
138395512|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138395518|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395519|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
138395520|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395521|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138395522|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138395527|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
138395528|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395529|NCT05603702|Lacosamide|lacosamide|mesh-list
138395530|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
138395531|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138395533|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395534|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395536|NCT05494593|Methotrexate|methotrexate|mesh-list
138395537|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
138395538|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138395539|NCT05494593|Antibodies|antibodies|mesh-list
138395540|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
138395541|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138395542|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395543|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395544|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
138395545|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395546|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395547|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138395548|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
138395549|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138395550|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395551|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
138395552|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395553|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395554|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395555|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138395556|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395557|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138395558|NCT05491356|Plasminogen|plasminogen|mesh-list
138395559|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138395560|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138395561|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138395567|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138395569|NCT05415397|Analgesics|analgesics|mesh-ancestor
138395570|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
138395571|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395572|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395573|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395574|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395575|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138395576|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138395577|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395578|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395579|NCT05414201|Adalimumab|adalimumab|mesh-list
138395580|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138395581|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395582|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395583|NCT05386810|Vaccines|vaccines|mesh-list
138395584|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
138395585|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395586|NCT05368090|Epinephrine|epinephrine|mesh-list
138395587|NCT05368090|Racepinephrine|racepinephrine|mesh-list
138395588|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
138395589|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138395592|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395593|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395594|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395595|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138395596|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138395597|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
138395598|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395599|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138395600|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
138395601|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
138395602|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
138395603|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138395604|NCT05328440|Fulvestrant|fulvestrant|mesh-list
138395605|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138395606|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395607|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138395608|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138395609|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
138395610|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395611|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395612|NCT05300087|Albuterol|albuterol|mesh-list
138395613|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138395614|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
138395615|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395622|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138395623|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138395624|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
138395625|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395626|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395627|NCT05296577|Vinorelbine|vinorelbine|mesh-list
138395628|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138395629|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395630|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395631|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138395632|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395633|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395634|NCT05296564|Aldesleukin|aldesleukin|mesh-list
138395635|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
138395636|NCT05296564|Interleukin-2|interleukin-2|mesh-list
138395637|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395638|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
138395639|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395640|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395641|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138395642|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
138395643|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395644|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395646|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138395647|NCT05296564|Analgesics|analgesics|mesh-ancestor
138395648|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
138395649|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395650|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138395651|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138395652|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
138395653|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395654|NCT05290025|Nicotine|nicotine|mesh-list
138395655|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138395656|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
138364227|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395657|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395658|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395659|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138395660|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138395661|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
138395662|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395663|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395665|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
138395671|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395672|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395675|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
138395676|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395677|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395678|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138395679|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138395680|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
138395681|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
138395682|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395683|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138395684|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138395703|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138395704|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
138395705|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395706|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138395707|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
138395708|NCT05077098|Immunomodulating Agents|immunomodulating agents|mesh-list
138395709|NCT05077098|Immunologic Factors|immunologic factors|mesh-ancestor
138395710|NCT05077098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395729|NCT05017025|Osimertinib|osimertinib|mesh-list
138395730|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395731|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395732|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395733|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395734|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
138395735|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
138395736|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
138395737|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395738|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395739|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
138395740|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395742|NCT04888858|Bupivacaine|bupivacaine|mesh-list
138395743|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
138395765|NCT04837716|Bevacizumab|bevacizumab|mesh-list
138395766|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138395767|NCT04837716|Carboplatin|carboplatin|mesh-list
138395769|NCT04837716|Ensartinib|ensartinib|mesh-list
138395770|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
138395771|NCT04837716|Antibodies|antibodies|mesh-list
138395772|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
138395773|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138395774|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
138395775|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395776|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138395777|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138395781|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
138395782|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395783|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395784|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138395785|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138395786|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395787|NCT04803734|Albuterol|albuterol|mesh-list
138395788|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138395789|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
138395790|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395791|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395792|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138395793|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
138395794|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
138395795|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138395796|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138395797|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138395798|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138395799|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
138395800|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395801|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395802|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
138395804|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395805|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395806|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395807|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395808|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395809|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395810|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138395811|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395812|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395813|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395814|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138395815|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395816|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395817|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395819|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138395820|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395821|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138395823|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
138395826|NCT04593940|Remdesivir|remdesivir|mesh-list
138395827|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
138395828|NCT04593940|Infliximab|infliximab|mesh-list
138395829|NCT04593940|Abatacept|abatacept|mesh-list
138395830|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138395831|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138395832|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
138395833|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395834|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395835|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395836|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395837|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395838|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395839|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395840|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
138395841|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395842|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
138395843|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
138395844|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395845|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138395846|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138395847|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138395848|NCT04562831|Niacinamide|niacinamide|mesh-list
138395850|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
138395851|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
138395852|NCT04562831|Vitamins|vitamins|mesh-ancestor
138395853|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
138395854|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395855|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138395856|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
138395857|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395858|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138395859|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
138395860|NCT04548648|Isavuconazole|isavuconazole|mesh-list
138395861|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
138395862|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395863|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
138395864|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395865|NCT04544111|Trametinib|trametinib|mesh-list
138395866|NCT04544111|Dabrafenib|dabrafenib|mesh-list
138395867|NCT04544111|Spartalizumab|spartalizumab|mesh-list
138395868|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395869|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395870|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395871|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395872|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395877|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138395878|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395879|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138395880|NCT04522739|Diuretics|diuretics|mesh-ancestor
138395881|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
138395883|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
138395884|NCT04522336|Fluorouracil|fluorouracil|mesh-list
138395885|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
138395886|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395887|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395888|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138395890|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395891|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395892|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138395893|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
138395894|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395895|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395896|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
138395897|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395898|NCT04402346|Pancrelipase|pancrelipase|mesh-list
138395899|NCT04402346|Pancreatin|pancreatin|mesh-list
138395900|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395901|NCT04397484|Lidocaine|lidocaine|mesh-list
138395902|NCT04397484|Epinephrine|epinephrine|mesh-list
138395903|NCT04397484|Racepinephrine|racepinephrine|mesh-list
138395904|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
138395905|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
138395906|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
138395907|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
138395908|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395909|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395910|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
138395911|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395912|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138395913|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138395914|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138395915|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138395916|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395917|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138395918|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138395919|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
138395920|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395921|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138395922|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138395923|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
138395924|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138395925|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
138395928|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138395929|NCT04313881|Azacitidine|azacitidine|mesh-list
138395930|NCT04313881|Magrolimab|magrolimab|mesh-list
138395931|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395932|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
138395933|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395934|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395935|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395936|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395937|NCT04262843|Vidarabine|vidarabine|mesh-list
138395938|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
138395939|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
138395940|NCT04262843|Fludarabine|fludarabine|mesh-list
138395941|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
138395942|NCT04262843|Tacrolimus|tacrolimus|mesh-list
138395943|NCT04262843|Lenograstim|lenograstim|mesh-list
138395944|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395945|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
138395946|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395947|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395948|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138395949|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
138395950|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395951|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395952|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138395953|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395954|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
138395955|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
138395956|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395957|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138395958|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395959|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138395960|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138395961|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
138395962|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138395963|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138395964|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
138395965|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395966|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395967|NCT04074746|Vidarabine|vidarabine|mesh-list
138395968|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
138395969|NCT04074746|Fludarabine|fludarabine|mesh-list
138395970|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
138395971|NCT04074746|Antibodies|antibodies|mesh-list
138395972|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138395973|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138395974|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
138395975|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395976|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138395977|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138395978|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
138395979|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395980|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395981|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138395982|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395983|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
138395984|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
138395991|NCT03951831|Cemiplimab|cemiplimab|mesh-list
138395992|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395993|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395994|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
138395995|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395996|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395997|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138395998|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
138395999|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138396000|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396001|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396002|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396003|NCT03884972|Venetoclax|venetoclax|mesh-list
138396004|NCT03884972|Trabectedin|trabectedin|mesh-list
138396005|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396006|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396007|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
138396008|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396009|NCT03819517|Resveratrol|resveratrol|mesh-list
138396010|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
138396011|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396012|NCT03819517|Protective Agents|protective agents|mesh-ancestor
138396013|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396014|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396015|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138396016|NCT03803761|Fulvestrant|fulvestrant|mesh-list
138396017|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396018|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396019|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138396020|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138396021|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396022|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396023|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396024|NCT03772834|Methylphenidate|methylphenidate|mesh-list
138396025|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138396026|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396027|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138396028|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138396029|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396030|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396031|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
138396032|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396033|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138396034|NCT03735095|Trioxsalen|trioxsalen|mesh-list
138396035|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396036|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396037|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138396038|NCT03726879|Paclitaxel|paclitaxel|mesh-list
138396039|NCT03726879|Maytansine|maytansine|mesh-list
138396040|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138396048|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396049|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396050|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396051|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396052|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396053|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
138396054|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396055|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396056|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396057|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
138396058|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396059|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138396060|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396061|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396062|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396063|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396064|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138396065|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
138396066|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
138396068|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
138396069|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138396070|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138396071|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396072|NCT03691051|Capecitabine|capecitabine|mesh-list
138396073|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138396074|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
138396075|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396076|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396078|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
138396079|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396080|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396081|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
138396087|NCT03565991|Talazoparib|talazoparib|mesh-list
138396088|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396089|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396090|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138396091|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396092|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396093|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138396094|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396095|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396096|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396098|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396099|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396100|NCT03354897|Torsemide|torsemide|mesh-list
138396101|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138396102|NCT03354897|Diuretics|diuretics|mesh-ancestor
138396103|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
138396104|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396105|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138396114|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396115|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396116|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396117|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138396118|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396119|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396120|NCT03165292|Topotecan|topotecan|mesh-list
138396121|NCT03165292|Thiotepa|thiotepa|mesh-list
138396122|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138396123|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396124|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396125|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396126|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396127|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396128|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
138396129|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396132|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396133|NCT03140423|Mupirocin|mupirocin|mesh-list
138396134|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138396135|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364309|NCT01385228|Hormones|hormones|mesh-ancestor
138396136|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138396137|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396138|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396139|NCT02998385|Cisplatin|cisplatin|mesh-list
138396140|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396150|NCT02876302|Paclitaxel|paclitaxel|mesh-list
138396151|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
138396152|NCT02876302|Doxorubicin|doxorubicin|mesh-list
138396153|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396154|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396155|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396156|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396157|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396158|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396159|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396160|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
138396161|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396162|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396163|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396164|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
138396165|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396166|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138396167|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396168|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396169|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396170|NCT02846623|Atezolizumab|atezolizumab|mesh-list
138396172|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
138396173|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138396174|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138396175|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396176|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396177|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396178|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
138396179|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396180|NCT02639065|Durvalumab|durvalumab|mesh-list
138396181|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396182|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396183|NCT02620072|Insulin|insulin|mesh-list
138396184|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396185|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396186|NCT02532257|Rituximab|rituximab|mesh-list
138396187|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138396188|NCT02532257|Lenalidomide|lenalidomide|mesh-list
138396189|NCT02532257|Antibodies|antibodies|mesh-list
138396190|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
138396192|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
138396193|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396194|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396195|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396196|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396197|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396198|NCT02532257|Growth Substances|growth substances|mesh-ancestor
138396199|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396201|NCT02420860|Elotuzumab|elotuzumab|mesh-list
138396202|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
138396205|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396206|NCT02420860|Growth Substances|growth substances|mesh-ancestor
138396207|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396208|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396209|NCT02113657|Ipilimumab|ipilimumab|mesh-list
138364333|NCT01385683|Dabigatran|dabigatran|mesh-list
138396210|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396211|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396212|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138396213|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396214|NCT01892371|Cytarabine|cytarabine|mesh-list
138396215|NCT01892371|Azacitidine|azacitidine|mesh-list
138396216|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138396217|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
138396218|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396219|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396220|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
138396221|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396222|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396223|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
138396224|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396225|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396226|NCT01415882|Dexamethasone|dexamethasone|mesh-list
138396227|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
138396228|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
138396229|NCT01415882|Daratumumab|daratumumab|mesh-list
138396230|NCT01415882|Ixazomib|ixazomib|mesh-list
138396231|NCT01415882|Ichthammol|ichthammol|mesh-list
138396232|NCT01415882|BB 1101|bb 1101|mesh-list
138396233|NCT01415882|Glycine|glycine|mesh-list
138396234|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396235|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
138396236|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396237|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396238|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396239|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
138396240|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396241|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396242|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396243|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396244|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
138396245|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
138396246|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396247|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138396248|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
138396250|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396251|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396252|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
138396253|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396254|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396255|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
138396256|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396257|NCT01303341|Sorafenib|sorafenib|mesh-list
138396258|NCT01303341|Riluzole|riluzole|mesh-list
138396259|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396260|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138396261|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215759|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138364347|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396262|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396263|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
138396264|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138396265|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138396266|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396269|NCT01303341|Protective Agents|protective agents|mesh-ancestor
138396271|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138396272|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138396273|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
138396274|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396275|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396276|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396277|NCT00667121|Tamoxifen|tamoxifen|mesh-list
138396278|NCT00667121|Gabapentin|gabapentin|mesh-list
138396279|NCT00667121|Dexetimide|dexetimide|mesh-list
138396280|NCT00667121|Citalopram|citalopram|mesh-list
138396281|NCT00667121|Sertraline|sertraline|mesh-list
138396282|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138396283|NCT00667121|Escitalopram|escitalopram|mesh-list
138396284|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396285|NCT00667121|Analgesics|analgesics|mesh-ancestor
138396286|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
138396287|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396288|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396289|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
138396290|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138396291|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138396292|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396293|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138396294|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138396295|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138396296|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396297|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
138396298|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138396299|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138396300|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396301|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
138396302|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138396303|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138396304|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
138396305|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
138396306|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138396307|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138396308|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
138396309|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138396310|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
138396311|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138396312|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396313|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396314|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396315|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396316|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138396317|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138396318|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138396319|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138396321|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
138396322|NCT00591851|Doxorubicin|doxorubicin|mesh-list
138396323|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138396324|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396325|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396326|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396327|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396336|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396337|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138396338|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396339|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396340|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396343|NCT00336024|Folic Acid|folic acid|mesh-list
138396344|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
138396345|NCT00336024|Thiotepa|thiotepa|mesh-list
138396346|NCT00336024|Cisplatin|cisplatin|mesh-list
138396347|NCT00336024|Carboplatin|carboplatin|mesh-list
138396349|NCT00336024|Etoposide|etoposide|mesh-list
138396350|NCT00336024|Vincristine|vincristine|mesh-list
138396351|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
138396352|NCT00336024|Podophyllotoxin|podophyllotoxin|mesh-list
138396353|NCT00336024|Lenograstim|lenograstim|mesh-list
138396354|NCT00336024|Calcium|calcium|mesh-list
138396355|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
138396356|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396357|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
138396358|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396359|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396360|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396361|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
138396362|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396363|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396364|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396365|NCT00336024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138396366|NCT00336024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138396367|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138396368|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
138396369|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138396370|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138396371|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
138396372|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396373|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396374|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138396375|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138396376|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396377|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396378|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396379|NCT00336024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138396380|NCT00336024|Antidotes|antidotes|mesh-ancestor
138396381|NCT00336024|Protective Agents|protective agents|mesh-ancestor
138396382|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
138396384|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
138396385|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396386|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396387|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396388|NCT00336024|Hematinics|hematinics|mesh-ancestor
138396389|NCT00336024|Keratolytic Agents|keratolytic agents|mesh-ancestor
138396390|NCT00133705|Mifepristone|mifepristone|mesh-list
138396394|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396395|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138396396|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138396397|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138396398|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
138396399|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138396400|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138396401|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396402|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396403|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
138396404|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138396405|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138396408|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138396409|NCT01525043|Analgesics|analgesics|mesh-ancestor
138396410|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
138396411|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396412|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396413|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396414|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396415|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
138396416|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138396417|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396418|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396419|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138396420|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138396421|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138396422|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396424|NCT01525537|Dsuvia|dsuvia|mesh-list
138396425|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138396426|NCT01525537|Narcotics|narcotics|mesh-ancestor
138396427|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396428|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396429|NCT01525537|Analgesics|analgesics|mesh-ancestor
138396430|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
138396431|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396432|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138396433|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138396434|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
138396435|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
138396436|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
138396437|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396438|NCT01525706|Ethanol|ethanol|mesh-list
138396439|NCT01525706|Paclitaxel|paclitaxel|mesh-list
138396440|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138396441|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396442|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396444|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396445|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396446|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396447|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138396448|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396449|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396450|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396451|NCT01525719|Everolimus|everolimus|mesh-list
138396452|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138396453|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138396454|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396455|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396457|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
138396458|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396459|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396460|NCT01525771|Cisplatin|cisplatin|mesh-list
138396461|NCT01525771|Docetaxel|docetaxel|mesh-list
138396462|NCT01525771|Capecitabine|capecitabine|mesh-list
138396463|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396464|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396465|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396466|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396467|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396468|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138396469|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
138396470|NCT01525823|Metformin|metformin|mesh-list
138396471|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396472|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396473|NCT01525836|Rituximab|rituximab|mesh-list
138396474|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396475|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396476|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
138396477|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396478|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396479|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138396480|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138396481|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138396482|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396483|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138396484|NCT01525914|Dutasteride|dutasteride|mesh-list
138396485|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138396486|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138396487|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396488|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396489|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396490|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396491|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396492|NCT01526005|Nicotine|nicotine|mesh-list
138396493|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138396494|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
138396495|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396496|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396497|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138396498|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138396499|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
138396500|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396501|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396502|NCT01526070|Aflibercept|aflibercept|mesh-list
138396503|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396504|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396505|NCT01526070|Growth Substances|growth substances|mesh-ancestor
138396508|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396511|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
138396512|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
138396513|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138396514|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138396515|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396516|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396517|NCT01526122|Aspirin|aspirin|mesh-list
138396518|NCT01526122|Clopidogrel|clopidogrel|mesh-list
138396519|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138396520|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138396521|NCT01526122|Analgesics|analgesics|mesh-ancestor
138396522|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
138396523|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396524|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396525|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396526|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396527|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138396528|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138396529|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396530|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138396531|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138396532|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396533|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
138396534|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138396535|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138396536|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138396537|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
138396538|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396540|NCT01526161|Xhance|xhance|mesh-list
138396541|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138396542|NCT01526161|Montelukast|montelukast|mesh-list
138396543|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396544|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138396545|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
138396546|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396547|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396548|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138396549|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
138396550|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396551|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138396552|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138396553|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138396554|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138396555|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
138396556|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396557|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396558|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138396559|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396560|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396561|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138396562|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138396563|NCT01526174|Golimumab|golimumab|mesh-list
138396564|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138396565|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396566|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396567|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
138396571|NCT01526278|Maxmarvil|maxmarvil|mesh-list
138396572|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138396573|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396574|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138396575|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138396576|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396577|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396578|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138396579|NCT01526278|Vitamins|vitamins|mesh-ancestor
138396580|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
138396581|NCT01526317|Metformin|metformin|mesh-list
138364371|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396582|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138396583|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396584|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396585|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138396586|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138396587|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
138396588|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396589|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396590|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138396591|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396592|NCT01526369|Paclitaxel|paclitaxel|mesh-list
138396593|NCT01526369|Trastuzumab|trastuzumab|mesh-list
138396594|NCT01526369|Lapatinib|lapatinib|mesh-list
138396595|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396596|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396597|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396598|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396599|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396600|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396601|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396602|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138396603|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396604|NCT01526395|Propofol|propofol|mesh-list
138396605|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138396606|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396607|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396608|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138396609|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
138396610|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
138396611|NCT01526460|Atorvastatin|atorvastatin|mesh-list
138396612|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138396613|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138396614|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138396615|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
138396616|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396617|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396618|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138396619|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396621|NCT01526499|Docetaxel|docetaxel|mesh-list
138396622|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396623|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
138396624|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396625|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396626|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396627|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
138396629|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396630|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396631|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396632|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396633|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396634|NCT01526525|Acetaminophen|acetaminophen|mesh-list
138396636|NCT01526525|Ketamine|ketamine|mesh-list
138396637|NCT01526525|Morphine|morphine|mesh-list
138396638|NCT01526525|Tramadol|tramadol|mesh-list
138396639|NCT01526525|Analgesics|analgesics|mesh-ancestor
138396640|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
138396641|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396642|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396643|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138396644|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138396645|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
138396646|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
138396647|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396648|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138396649|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138396650|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396651|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396652|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138396653|NCT01526525|Narcotics|narcotics|mesh-ancestor
138396654|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138396655|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
138396656|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138396657|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138396658|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396659|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138396660|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396661|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396662|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
138396663|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
138396664|NCT01526564|Vitamins|vitamins|mesh-ancestor
138396665|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
138396666|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396667|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
138396668|NCT01526616|Metformin|metformin|mesh-list
138396669|NCT01526616|Spironolactone|spironolactone|mesh-list
138396670|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396671|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396672|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138396673|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396674|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396675|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138396676|NCT01526616|Diuretics|diuretics|mesh-ancestor
138396677|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
138396678|NCT01526694|Thalidomide|thalidomide|mesh-list
138396679|NCT01526694|Dexamethasone|dexamethasone|mesh-list
138396680|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138396681|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396682|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
138396683|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
138396684|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396685|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396686|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138396687|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
138396688|NCT01526694|Hormones|hormones|mesh-ancestor
138396689|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396690|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396691|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396692|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396694|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396695|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396696|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
138396697|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
138396698|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138396699|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396700|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396701|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396702|NCT01526694|Growth Substances|growth substances|mesh-ancestor
138396703|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396704|NCT01526837|Bevacizumab|bevacizumab|mesh-list
138396705|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396706|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396707|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396708|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396709|NCT01526837|Growth Substances|growth substances|mesh-ancestor
138396710|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364388|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
138396711|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396712|NCT01526850|Cyclosporine|cyclosporine|mesh-list
138396713|NCT01526850|Cyclosporins|cyclosporins|mesh-list
138396714|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
138396715|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396716|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396718|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
138396719|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396720|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
138396721|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396722|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396723|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396724|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138396726|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396727|NCT01526876|Clevidipine|clevidipine|mesh-list
138396728|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138396729|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396730|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396731|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138396732|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396733|NCT01526941|Insulin|insulin|mesh-list
138396734|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138396736|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
138396737|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138396738|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
138396739|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138396740|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396741|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396742|NCT01526980|Insulin|insulin|mesh-list
138396743|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138396744|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
138396745|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
138396746|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138396747|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
138396748|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138396750|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396751|NCT01527019|Cephalosporins|cephalosporins|mesh-list
138396752|NCT01527019|Norfloxacin|norfloxacin|mesh-list
138396753|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138396754|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396755|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396756|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396757|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396758|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396759|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396760|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138396761|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138396762|NCT01527032|Thalidomide|thalidomide|mesh-list
138396763|NCT01527032|Dexamethasone|dexamethasone|mesh-list
138396764|NCT01527032|Melphalan|melphalan|mesh-list
138396765|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396767|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
138396768|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396769|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396770|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138396771|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
138396772|NCT01527032|Hormones|hormones|mesh-ancestor
138396773|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396774|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396775|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396776|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396777|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
138396778|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396779|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396780|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396781|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
138396782|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
138396783|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138396784|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396785|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396786|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396787|NCT01527032|Growth Substances|growth substances|mesh-ancestor
138396788|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396789|NCT01527097|Atorvastatin|atorvastatin|mesh-list
138396790|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138396792|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
138396793|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396794|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396795|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138396796|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396798|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138396799|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
138396800|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
138396801|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396802|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396803|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396804|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138396805|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138396806|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138396807|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138396808|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396809|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396810|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138396811|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138396812|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138396813|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
138396814|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396815|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396816|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138396817|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138396818|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
138396820|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138396821|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138396822|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
138396823|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396824|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396826|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
138396827|NCT01527422|Doxorubicin|doxorubicin|mesh-list
138396828|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138396829|NCT01527422|Vincristine|vincristine|mesh-list
138396830|NCT01527422|Sargramostim|sargramostim|mesh-list
138396831|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396832|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
138396833|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396834|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396835|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396836|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
138396837|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396838|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396839|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138396840|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138396841|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138396842|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138396843|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396844|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138396845|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
138396846|NCT01527422|Hormones|hormones|mesh-ancestor
138396847|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396848|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138396849|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396850|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396851|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396852|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396853|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138396854|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
138396855|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138396856|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138396857|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138396858|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396859|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396860|NCT01527474|Escitalopram|escitalopram|mesh-list
138396861|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138396862|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138396863|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396864|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396867|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396869|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
138396870|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138396871|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396872|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396873|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
138396874|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
138396875|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396876|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396877|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
138396878|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
138396879|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396880|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396881|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
138396882|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
138396883|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396884|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396885|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
138396886|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
138396887|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396888|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396890|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
138396891|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396892|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396894|NCT01527669|L 647318|l 647318|mesh-list
138396895|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
138396896|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138396897|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138396898|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
138396899|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396900|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138396901|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138396902|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396903|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
138396904|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
138396905|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
138396906|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396907|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396908|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
138396909|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396910|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138396911|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396912|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396913|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138396914|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138396915|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138396916|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138396919|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396923|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138396924|NCT01527864|Carboplatin|carboplatin|mesh-list
138396925|NCT01527864|Endostatins|endostatins|mesh-list
138396926|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396927|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396928|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138396929|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396930|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364415|NCT01386229|Ketamine|ketamine|mesh-list
138396931|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396932|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138396933|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138396934|NCT01527864|Growth Substances|growth substances|mesh-ancestor
138396935|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396936|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
138396937|NCT01527890|Fentanyl|fentanyl|mesh-list
138396938|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138396939|NCT01527890|Narcotics|narcotics|mesh-ancestor
138396940|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396941|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396942|NCT01527890|Analgesics|analgesics|mesh-ancestor
138396943|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
138396944|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396945|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138396946|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138396947|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
138396948|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
138396949|NCT01527903|Midazolam|midazolam|mesh-list
138396950|NCT01527903|Propofol|propofol|mesh-list
138396951|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138396952|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138396953|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396954|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138396955|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
138396957|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138396958|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138396959|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138396960|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138396961|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
138396962|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
138396963|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396964|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396965|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
138396966|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
138396967|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138396968|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138396969|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396970|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
138396971|NCT01527968|Coagulants|coagulants|mesh-ancestor
138396975|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396976|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396977|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138396978|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138396979|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396980|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396981|NCT01528007|Naltrexone|naltrexone|mesh-list
138396982|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138396983|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138396984|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396985|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
138396986|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396987|NCT01528137|Lactoferrin|lactoferrin|mesh-list
138396988|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
138396989|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396990|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396991|NCT01528163|Methotrexate|methotrexate|mesh-list
138396992|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138396993|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
138396994|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138396995|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396996|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138396997|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
138396998|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396999|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397000|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
138397001|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397002|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138397003|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397004|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
138397006|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397007|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
138397008|NCT01528176|Vitamin D|vitamin d|mesh-list
138397009|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138397010|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397011|NCT01528176|Vitamins|vitamins|mesh-ancestor
138397012|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
138397013|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138397014|NCT01528371|Midazolam|midazolam|mesh-list
138397015|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138397016|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138397017|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397018|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397019|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138397020|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397021|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397022|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138397023|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
138397024|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
138397026|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
138397027|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397028|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397029|NCT01528501|Panobinostat|panobinostat|mesh-list
138397030|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397031|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138397032|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397033|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397035|NCT01528540|Antioxidants|antioxidants|mesh-list
138397036|NCT01528540|Analgesics|analgesics|mesh-ancestor
138397037|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
138397038|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397039|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397040|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
138397041|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138397042|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397043|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397044|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138397045|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138397046|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397047|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397048|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397049|NCT01528540|Protective Agents|protective agents|mesh-ancestor
138397050|NCT01528618|Cisplatin|cisplatin|mesh-list
138397051|NCT01528618|Gemcitabine|gemcitabine|mesh-list
138397052|NCT01528618|Fluorouracil|fluorouracil|mesh-list
138397053|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397054|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397055|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
138397056|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364431|NCT01386242|Interferons|interferons|mesh-list
138397057|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397058|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
138397059|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397060|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
138397061|NCT01528644|Iron|iron|mesh-list
138397062|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
138397063|NCT01528644|Calcium|calcium|mesh-list
138397064|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138397065|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397066|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138397067|NCT01528644|Trace Elements|trace elements|mesh-ancestor
138397068|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
138397069|NCT01528644|Hematinics|hematinics|mesh-ancestor
138397070|NCT01528722|Bupivacaine|bupivacaine|mesh-list
138397071|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
138397072|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
138397073|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397082|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138397083|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138397084|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397086|NCT01528800|Coagulants|coagulants|mesh-ancestor
138397087|NCT01528813|Amorolfine|amorolfine|mesh-list
138397088|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
138397089|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397090|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
138397091|NCT01528826|Vinorelbine|vinorelbine|mesh-list
138397092|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397093|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138397094|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138397095|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138397096|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138397097|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397099|NCT01528865|Lamivudine|lamivudine|mesh-list
138397100|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
138397101|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397102|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138397103|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397104|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397105|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397106|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138397107|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138397108|NCT01528930|Amikacin|amikacin|mesh-list
138397109|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397110|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397111|NCT01528943|Epoprostenol|epoprostenol|mesh-list
138397112|NCT01528943|Tezosentan|tezosentan|mesh-list
138397113|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138397115|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
138397116|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
138397117|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138397118|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397119|NCT01529125|Lamivudine|lamivudine|mesh-list
138397120|NCT01529125|Zidovudine|zidovudine|mesh-list
138397121|NCT01529125|Nevirapine|nevirapine|mesh-list
138397122|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138397123|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397124|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397125|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397127|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397128|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138397129|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138397130|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
138397131|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138397132|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138397133|NCT01529138|Sirolimus|sirolimus|mesh-list
138397134|NCT01529138|Temsirolimus|temsirolimus|mesh-list
138397135|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
138397136|NCT01529138|Axitinib|axitinib|mesh-list
138397137|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397138|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397139|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397140|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397141|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
138397142|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397143|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397144|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397145|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397146|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138397147|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
138397149|NCT01529164|Fluorouracil|fluorouracil|mesh-list
138397150|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
138397151|NCT01529164|Endostar protein|endostar protein|mesh-list
138397152|NCT01529164|Endostatins|endostatins|mesh-list
138397153|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
138397154|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397155|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397156|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397157|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397158|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
138397159|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397160|NCT01529164|Antidotes|antidotes|mesh-ancestor
138397161|NCT01529164|Protective Agents|protective agents|mesh-ancestor
138397162|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
138397163|NCT01529164|Vitamins|vitamins|mesh-ancestor
138397164|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
138397165|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397166|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397167|NCT01529164|Growth Substances|growth substances|mesh-ancestor
138397168|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397169|NCT01529177|Metformin|metformin|mesh-list
138397170|NCT01529177|Citric Acid|citric acid|mesh-list
138397171|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
138397172|NCT01529177|Clomiphene|clomiphene|mesh-list
138397173|NCT01529177|Enclomiphene|enclomiphene|mesh-list
138397174|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
138397175|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397176|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397177|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
138397178|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138397179|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
138397180|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
138397181|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397182|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138397183|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
138397185|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138397186|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
138397187|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138397188|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138397189|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138397191|NCT01529190|Analgesics|analgesics|mesh-ancestor
138397192|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
138397193|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397194|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397195|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
138397196|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138397197|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397198|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397199|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138397200|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138397201|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397202|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397203|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397204|NCT01529229|Prednisolone|prednisolone|mesh-list
138397205|NCT01529229|Betamethasone|betamethasone|mesh-list
138397206|NCT01529229|Desloratadine|desloratadine|mesh-list
138397207|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138397208|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138397209|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
138397210|NCT01529229|Hormones|hormones|mesh-ancestor
138397211|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397212|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397213|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397214|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397215|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138397216|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
138397217|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138397218|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397219|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397220|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397221|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138397222|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138397223|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
138397224|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
138397225|NCT01529242|Prednisolone|prednisolone|mesh-list
138397226|NCT01529242|Betamethasone|betamethasone|mesh-list
138397227|NCT01529242|Desloratadine|desloratadine|mesh-list
138397228|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138397229|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138397230|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
138397231|NCT01529242|Hormones|hormones|mesh-ancestor
138397232|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397233|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397234|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397235|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397236|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138397237|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
138397238|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138397242|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138397243|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138397244|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
138397245|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
138397246|NCT01529255|Telbivudine|telbivudine|mesh-list
138397247|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
138397248|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397249|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397250|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397251|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397252|NCT01529294|Iloperidone|iloperidone|mesh-list
138397253|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138397254|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397255|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397256|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397257|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397258|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
138397259|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138397260|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138397261|NCT01529320|Prednisolone|prednisolone|mesh-list
138397262|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
138397263|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
138397264|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138397265|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
138397266|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138397267|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
138397268|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
138397269|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397270|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397271|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138397272|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
138397274|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397275|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138397276|NCT01529320|Protective Agents|protective agents|mesh-ancestor
138397277|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397278|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397279|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
138397280|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
138397281|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397282|NCT01529476|Levofloxacin|levofloxacin|mesh-list
138397283|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
138397284|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138397285|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397286|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397287|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138397288|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138397293|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138397294|NCT01529528|Anagliptin|anagliptin|mesh-list
138397295|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138397296|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397297|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397298|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397299|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397300|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397301|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138397302|NCT01529541|Anagliptin|anagliptin|mesh-list
138397303|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397304|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397305|NCT01529541|Incretins|incretins|mesh-ancestor
138397306|NCT01529541|Hormones|hormones|mesh-ancestor
138397307|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397308|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138397309|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397310|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397311|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397312|NCT01529554|Everolimus|everolimus|mesh-list
138397313|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138397314|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397315|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397316|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397317|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397318|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
138397319|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397320|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397321|NCT01529619|Rivastigmine|rivastigmine|mesh-list
138397322|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138397323|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397324|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397325|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397326|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397327|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397328|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138397329|NCT01529619|Protective Agents|protective agents|mesh-ancestor
138397330|NCT01529710|Praziquantel|praziquantel|mesh-list
138397331|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
138397332|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138397337|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397338|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397339|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138397340|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397341|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397342|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397343|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397344|NCT01529892|Methamphetamine|methamphetamine|mesh-list
138397345|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138397346|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397347|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
138397348|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
138397349|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397350|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
138397351|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397352|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397353|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397354|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138397355|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138397356|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397357|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138397358|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
138397359|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397360|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397362|NCT01530022|Carbamazepine|carbamazepine|mesh-list
138397363|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
138397364|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138397365|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138397366|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397367|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397368|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
138397369|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397370|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397371|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397372|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397373|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138397374|NCT01530022|Analgesics|analgesics|mesh-ancestor
138397375|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
138397376|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397377|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138397378|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138397379|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
138397380|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397381|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397382|NCT01530126|Becaplermin|becaplermin|mesh-list
138397385|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397386|NCT01530126|Growth Substances|growth substances|mesh-ancestor
138397387|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397389|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
138397391|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397392|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397393|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
138397394|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397395|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138397396|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138397397|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138397398|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397399|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397400|NCT01530217|Ibuprofen|ibuprofen|mesh-list
138397401|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138364489|NCT01386567|Enclomiphene|enclomiphene|mesh-list
138364490|NCT01386567|Clomiphene|clomiphene|mesh-list
138364492|NCT01386567|Testosterone|testosterone|mesh-list
138364493|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
138364494|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
138397402|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138397403|NCT01530217|Analgesics|analgesics|mesh-ancestor
138397404|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
138397405|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397406|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397407|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138397408|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138397409|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138397410|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397411|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397412|NCT01530230|Oxytocin|oxytocin|mesh-list
138397413|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
138397414|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138397415|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397416|NCT01530295|Docetaxel|docetaxel|mesh-list
138397417|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397418|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
138397419|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
138397420|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
138397421|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397423|NCT01530308|Haloperidol|haloperidol|mesh-list
138397424|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
138397425|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
138397426|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
138397427|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
138397428|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
138397429|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397430|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397431|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138397432|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138397433|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397434|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138397435|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
138397436|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397437|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397438|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138397439|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138397440|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
138397441|NCT01530308|Protective Agents|protective agents|mesh-ancestor
138397442|NCT01530386|Lacosamide|lacosamide|mesh-list
138397443|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
138397444|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138397445|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138397451|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138397452|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
138397453|NCT01530451|Coagulants|coagulants|mesh-ancestor
138397454|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138397455|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
138397456|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397457|NCT01530490|Cabergoline|cabergoline|mesh-list
138397458|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138397459|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138397460|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138397461|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
138397462|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
138397463|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397464|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397465|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397466|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
138397467|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
138397468|NCT01530503|Capecitabine|capecitabine|mesh-list
138397471|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397472|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
138397473|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397474|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397475|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138397476|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
138397477|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397478|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397479|NCT01530542|Oxycodone|oxycodone|mesh-list
138397480|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138397481|NCT01530542|Narcotics|narcotics|mesh-ancestor
138397482|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397483|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397484|NCT01530542|Analgesics|analgesics|mesh-ancestor
138397485|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
138397486|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397487|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
138397489|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397490|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397491|NCT01530594|Lenalidomide|lenalidomide|mesh-list
138397492|NCT01530594|Bortezomib|bortezomib|mesh-list
138397493|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
138397494|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397495|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397496|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397497|NCT01530594|Growth Substances|growth substances|mesh-ancestor
138397498|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397499|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397500|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
138397501|NCT01530607|Goserelin|goserelin|mesh-list
138397502|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397503|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
138397504|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397505|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138397506|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138397507|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
138397508|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397515|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397516|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397517|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138397518|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138397519|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397520|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397521|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397522|NCT01530620|Urological Agents|urological agents|mesh-ancestor
138397524|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
138397525|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397526|NCT01530711|Terlipressin|terlipressin|mesh-list
138397527|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138397528|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138397529|NCT01530737|Antithrombins|antithrombins|mesh-list
138397530|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
138397531|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138397532|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397533|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397534|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397535|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
138397536|NCT01530763|Amoxicillin|amoxicillin|mesh-list
138397537|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
138397538|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
138397539|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
138397540|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138397541|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138397542|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397543|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397544|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138397545|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397546|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397547|NCT01530815|Bupivacaine|bupivacaine|mesh-list
138364522|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397548|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
138397549|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
138364526|NCT01386593|Rifampin|rifampin|mesh-list
138397550|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397551|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397552|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
138397553|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397555|NCT01530984|Sargramostim|sargramostim|mesh-list
138397556|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138397557|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397558|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138414734|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397563|NCT01531049|Varenicline|varenicline|mesh-list
138397564|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138397565|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
138397566|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397567|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397568|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138397569|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138397570|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397571|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397572|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397573|NCT01531114|Ticagrelor|ticagrelor|mesh-list
138397574|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138397575|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138397576|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138397577|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138397578|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138397579|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
138397580|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397581|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397582|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397584|NCT01531140|Senna Extract|senna extract|mesh-list
138397585|NCT01531140|Sennosides|sennosides|mesh-list
138397586|NCT01531140|Cathartics|cathartics|mesh-ancestor
138397587|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138397588|NCT01531140|Laxatives|laxatives|mesh-ancestor
138397589|NCT01531166|Interferons|interferons|mesh-list
138397590|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
138397591|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
138397592|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138397593|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397594|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
138397595|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397596|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
138397597|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397598|NCT01531192|Nystatin|nystatin|mesh-list
138397599|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397600|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397601|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
138397602|NCT01531192|Ionophores|ionophores|mesh-ancestor
138397603|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397604|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397605|NCT01531218|Azithromycin|azithromycin|mesh-list
138397606|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397607|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397608|NCT01531244|Dactinomycin|dactinomycin|mesh-list
138397609|NCT01531244|Cactinomycin|cactinomycin|mesh-list
138397610|NCT01531244|Melphalan|melphalan|mesh-list
138397611|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138397612|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
138397613|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397614|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397615|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138397616|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397617|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
138397622|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138397623|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397624|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397625|NCT01531309|Agomelatine|agomelatine|mesh-list
138397626|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138397627|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397628|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397629|NCT01531322|Vaccines|vaccines|mesh-list
138397630|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138397631|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
138397632|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397634|NCT01531361|Vemurafenib|vemurafenib|mesh-list
138397635|NCT01531361|Crizotinib|crizotinib|mesh-list
138397636|NCT01531361|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138397637|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397638|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397639|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397640|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397641|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
138397642|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397643|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
138397644|NCT01531517|Propolis|propolis|mesh-list
138397645|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
138397646|NCT01531517|Vitamins|vitamins|mesh-ancestor
138397647|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
138397648|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397649|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397650|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
138397651|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
138397652|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138397653|NCT01531569|Estrogens|estrogens|mesh-ancestor
138397654|NCT01531569|Hormones|hormones|mesh-ancestor
138397655|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397656|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397657|NCT01531595|Bevacizumab|bevacizumab|mesh-list
138397658|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
138397659|NCT01531595|Irinotecan|irinotecan|mesh-list
138397660|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138397661|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397662|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397663|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397664|NCT01531595|Growth Substances|growth substances|mesh-ancestor
138397665|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397670|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397672|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
138397673|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138397674|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138397675|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397676|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397677|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397678|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138397679|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138397680|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
138397681|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397682|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138397683|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138397684|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138397685|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138397686|NCT01531712|Gemcitabine|gemcitabine|mesh-list
138397687|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
138397688|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138397689|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397690|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
138215760|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138364542|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
138397691|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397692|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397693|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397694|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397697|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138397698|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397699|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
138397700|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
138397701|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
138397702|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397703|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397704|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397705|NCT01531777|Apatinib|apatinib|mesh-list
138397706|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397707|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397708|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397709|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397710|NCT01531790|Carboplatin|carboplatin|mesh-list
138397711|NCT01531790|Pemetrexed|pemetrexed|mesh-list
138397712|NCT01531790|Endostar protein|endostar protein|mesh-list
138397713|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397714|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397715|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397716|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138397717|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397718|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397724|NCT01531829|Plasminogen|plasminogen|mesh-list
138397725|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138397726|NCT01531829|Tinzaparin|tinzaparin|mesh-list
138397727|NCT01531829|Dalteparin|dalteparin|mesh-list
138397728|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138397729|NCT01531829|Nadroparin|nadroparin|mesh-list
138397730|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
138397731|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138397732|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138397733|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397734|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138397735|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397736|NCT01531855|Insulin|insulin|mesh-list
138397737|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
138397738|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
138397739|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397740|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397741|NCT01531920|Ethanol|ethanol|mesh-list
138397742|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138397743|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397744|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397745|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397746|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138397747|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397748|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138397749|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397750|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397751|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138397752|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
138397753|NCT01532076|Coagulants|coagulants|mesh-ancestor
138397754|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
138397755|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397757|NCT01532115|Opicapone|opicapone|mesh-list
138397758|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397759|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397760|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138397761|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138397762|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397763|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397764|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397765|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138397766|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138397767|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138397768|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
138397769|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138397770|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397771|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397772|NCT01532232|Varenicline|varenicline|mesh-list
138397773|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138397774|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138397775|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397776|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397777|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397784|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138397786|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397787|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397788|NCT01532544|Heparin|heparin|mesh-list
138397789|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138397791|NCT01532544|Dalteparin|dalteparin|mesh-list
138397792|NCT01532544|Eptifibatide|eptifibatide|mesh-list
138397793|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
138397794|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138397795|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138397796|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397797|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138397798|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
138397799|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138397800|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138397801|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
138397802|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138397803|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138397804|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397805|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397806|NCT01532804|Bevacizumab|bevacizumab|mesh-list
138397807|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
138397808|NCT01532804|Raltitrexed|raltitrexed|mesh-list
138397809|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138397810|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397811|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397812|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397813|NCT01532804|Growth Substances|growth substances|mesh-ancestor
138397814|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397815|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397816|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138397817|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
138397818|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397819|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138397820|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397821|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138397822|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
138397823|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397824|NCT01532856|Thalidomide|thalidomide|mesh-list
138397825|NCT01532856|Dexamethasone|dexamethasone|mesh-list
138397831|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397832|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
138397833|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397834|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138397835|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138397836|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
138397837|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397838|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397839|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138397840|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364567|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138397842|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
138397843|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397844|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138397845|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
138397846|NCT01532856|Hormones|hormones|mesh-ancestor
138397847|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397848|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397849|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397850|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397851|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
138397852|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397853|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397854|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138397855|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138397856|NCT01532856|Growth Substances|growth substances|mesh-ancestor
138397857|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397858|NCT01532895|Hydromorphone|hydromorphone|mesh-list
138397859|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138397860|NCT01532895|Narcotics|narcotics|mesh-ancestor
138397861|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397862|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397863|NCT01532895|Analgesics|analgesics|mesh-ancestor
138397864|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
138397865|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397867|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
138397868|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
138397869|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397870|NCT01533090|Bisacodyl|bisacodyl|mesh-list
138397871|NCT01533090|Cathartics|cathartics|mesh-ancestor
138397872|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138397873|NCT01533090|Laxatives|laxatives|mesh-ancestor
138397874|NCT01533129|Testosterone|testosterone|mesh-list
138397875|NCT01533129|Androgens|androgens|mesh-ancestor
138397876|NCT01533129|Hormones|hormones|mesh-ancestor
138397877|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397878|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397879|NCT01533155|Quinidine|quinidine|mesh-list
138397880|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
138397881|NCT01533155|Morphine|morphine|mesh-list
138397882|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138397883|NCT01533155|Narcotics|narcotics|mesh-ancestor
138397884|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138397885|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397886|NCT01533155|Analgesics|analgesics|mesh-ancestor
138397887|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
138397891|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397892|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397893|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397894|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138397895|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
138397896|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138397897|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138397898|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397900|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138397901|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138397902|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397903|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138397904|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138397905|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397906|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138397907|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138397908|NCT01533220|Pheniramine|pheniramine|mesh-list
138397909|NCT01533220|Naphazoline|naphazoline|mesh-list
138397910|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397911|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138397912|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138397913|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397914|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397915|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397916|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
138397917|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138397918|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
138397919|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
138397920|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
138397921|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138397922|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
138397923|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
138397924|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138397925|NCT01533272|Tenofovir|tenofovir|mesh-list
138397926|NCT01533272|Emtricitabine|emtricitabine|mesh-list
138397927|NCT01533272|Lopinavir|lopinavir|mesh-list
138397928|NCT01533272|Maraviroc|maraviroc|mesh-list
138397929|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
138397930|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397931|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138397932|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138397933|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397934|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397935|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138397936|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138397937|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138397941|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138397942|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138397943|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138397944|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138397946|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138397948|NCT01533324|Protective Agents|protective agents|mesh-ancestor
138397949|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397950|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
138397951|NCT01533324|Vitamins|vitamins|mesh-ancestor
138397952|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
138397953|NCT01533376|Timolol|timolol|mesh-list
138397954|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
138397955|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138397956|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138397957|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397958|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397959|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397960|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397961|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138397962|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138397963|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138397964|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138397965|NCT01533389|Silodosin|silodosin|mesh-list
138397966|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138397967|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138397968|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138397969|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397970|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397971|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397972|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397973|NCT01533389|Urological Agents|urological agents|mesh-ancestor
138397974|NCT01533441|Vitamin K|vitamin k|mesh-list
138397975|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
138397976|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
138397977|NCT01533441|Vitamins|vitamins|mesh-ancestor
138397978|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
138397979|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397980|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138397981|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138397982|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397983|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
138397984|NCT01533441|Coagulants|coagulants|mesh-ancestor
138397985|NCT01533506|Stiripentol|stiripentol|mesh-list
138397986|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
138397987|NCT01533545|Epinephrine|epinephrine|mesh-list
138397988|NCT01533545|Mepivacaine|mepivacaine|mesh-list
138397989|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138397990|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138397991|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
138397992|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397997|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
138397998|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397999|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138398000|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398002|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
138398003|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138398004|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
138398005|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
138398006|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398007|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
138398008|NCT01533558|Caspofungin|caspofungin|mesh-list
138398009|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
138398010|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398011|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398012|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398014|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
138398015|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138398016|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
138398017|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
138398018|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398019|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398020|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
138398021|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138398023|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398024|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138398025|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138398026|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138398027|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
138398028|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398029|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398030|NCT01533662|Protective Agents|protective agents|mesh-ancestor
138398031|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138398032|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138398033|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398034|NCT01533740|Leucovorin|leucovorin|mesh-list
138398035|NCT01533740|Folic Acid|folic acid|mesh-list
138398036|NCT01533740|Bevacizumab|bevacizumab|mesh-list
138398037|NCT01533740|Fluorouracil|fluorouracil|mesh-list
138398038|NCT01533740|Irinotecan|irinotecan|mesh-list
138398039|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
138398040|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398041|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398042|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138398043|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138398044|NCT01533740|Growth Substances|growth substances|mesh-ancestor
138398045|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398046|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
138398047|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
138398048|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398049|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398050|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398051|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
138398052|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138398053|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398054|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398055|NCT01533740|Antidotes|antidotes|mesh-ancestor
138398056|NCT01533740|Protective Agents|protective agents|mesh-ancestor
138398073|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398074|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138398075|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138398076|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138398077|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138398078|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138398079|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138398081|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398082|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
138398083|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398084|NCT01534026|Aspirin|aspirin|mesh-list
138398085|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398087|NCT01534026|Analgesics|analgesics|mesh-ancestor
138398088|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
138398089|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398090|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398091|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398092|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398093|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138398094|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138398095|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398096|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138398097|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138398098|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398099|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
138398100|NCT01534169|Dexamethasone|dexamethasone|mesh-list
138398109|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398110|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138398111|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398113|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398114|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398115|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138398116|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138398117|NCT01534312|Mesalamine|mesalamine|mesh-list
138398118|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398119|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398120|NCT01534312|Analgesics|analgesics|mesh-ancestor
138398121|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
138398122|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398123|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398124|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398126|NCT01534442|Atropine|atropine|mesh-list
138398127|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138398128|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138398129|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138398130|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
138398131|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398132|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398133|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138398134|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398135|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
138398136|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
138398137|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138398138|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138398139|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
138398140|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398141|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398142|NCT01534455|Lapatinib|lapatinib|mesh-list
138398143|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398144|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398145|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398146|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398147|NCT01534546|Capecitabine|capecitabine|mesh-list
138398148|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
138398149|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398150|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
138398160|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398161|NCT01534702|Cytarabine|cytarabine|mesh-list
138398162|NCT01534702|Clofarabine|clofarabine|mesh-list
138398163|NCT01534702|Idarubicin|idarubicin|mesh-list
138398164|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398165|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
138398166|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398167|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398168|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
138398169|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398170|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364583|NCT01386736|Vitamin D|vitamin d|mesh-list
138364584|NCT01386736|Vitamins|vitamins|mesh-ancestor
138364585|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
138364588|NCT01386853|Atorvastatin|atorvastatin|mesh-list
138398171|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
138398172|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398173|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398174|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138398175|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398176|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398177|NCT01534754|Mesalamine|mesalamine|mesh-list
138398178|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398179|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398181|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
138398182|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398183|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398184|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398185|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398186|NCT01534806|Ketorolac|ketorolac|mesh-list
138398187|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398188|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398189|NCT01534806|Analgesics|analgesics|mesh-ancestor
138398190|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
138398191|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398192|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398193|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398194|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398195|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138398196|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398198|NCT01534845|Temozolomide|temozolomide|mesh-list
138398199|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138398200|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
138398201|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398202|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398203|NCT01534858|Polihexanide|polihexanide|mesh-list
138398204|NCT01534858|Betaine|betaine|mesh-list
138398205|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398206|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
138398207|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138398208|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
138398209|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398210|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138398211|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
138398212|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398213|NCT01534884|Rituximab|rituximab|mesh-list
138398214|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398215|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398216|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
138398217|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398218|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398219|NCT01534949|Rituximab|rituximab|mesh-list
138398220|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398221|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398222|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
138398223|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398224|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398225|NCT01535027|Alendronate|alendronate|mesh-list
138398226|NCT01535027|Teriparatide|teriparatide|mesh-list
138398227|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138398228|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138398229|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398230|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138398231|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138398232|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
138398233|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398234|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138364601|NCT01386879|Methylene Blue|methylene blue|mesh-list
138398235|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138398237|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398238|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398239|NCT01535079|Analgesics|analgesics|mesh-ancestor
138398240|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
138398241|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398242|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398243|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398244|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398245|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138398246|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398247|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398249|NCT01535092|Protective Agents|protective agents|mesh-ancestor
138398250|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398255|NCT01535157|Retinamide|retinamide|mesh-list
138398256|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
138398257|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398258|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138398259|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138398260|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398261|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398262|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138398263|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
138398264|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398265|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398266|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138398267|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398268|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138398269|NCT01535157|Protective Agents|protective agents|mesh-ancestor
138398270|NCT01535170|Lactoferrin|lactoferrin|mesh-list
138398271|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398272|NCT01535183|Irinotecan|irinotecan|mesh-list
138398273|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138398274|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398275|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398276|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398277|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398278|NCT01535417|Celecoxib|celecoxib|mesh-list
138398279|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398280|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398281|NCT01535417|Analgesics|analgesics|mesh-ancestor
138398282|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
138398283|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398284|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398285|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398286|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398287|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138398288|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138398290|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398291|NCT01535469|Fluconazole|fluconazole|mesh-list
138398292|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
138398293|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398294|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138398295|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138398296|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398297|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398298|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138398299|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
138398300|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398301|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398306|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138398307|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
138398308|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398309|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398310|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398311|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138398312|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138398313|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
138398314|NCT01535547|Isavuconazole|isavuconazole|mesh-list
138398315|NCT01535547|Tacrolimus|tacrolimus|mesh-list
138398316|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398317|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
138398318|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398319|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138398320|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398321|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398322|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
138398323|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398324|NCT01535612|Insulin|insulin|mesh-list
138398325|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398326|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398327|NCT01535677|Metformin|metformin|mesh-list
138398328|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
138398329|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398330|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398331|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138398332|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398333|NCT01535690|Methylene Blue|methylene blue|mesh-list
138398334|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398335|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398336|NCT01535768|Travoprost|travoprost|mesh-list
138398337|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138398338|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138398339|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138398340|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138398341|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138398342|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138398343|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138398344|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
138398345|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398346|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398347|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398348|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
138398349|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138398350|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138398351|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398352|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
138398353|NCT01535781|Coagulants|coagulants|mesh-ancestor
138398354|NCT01535820|Ortho Evra|ortho evra|mesh-list
138398355|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138398357|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138398358|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398360|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138398361|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138398362|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
138398363|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
138398364|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398365|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398366|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398367|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138398368|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138398369|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
138398370|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398371|NCT01535989|Sirolimus|sirolimus|mesh-list
138398372|NCT01535989|Temsirolimus|temsirolimus|mesh-list
138398374|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138398375|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398376|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398377|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398378|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398379|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
138398380|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364609|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
138398381|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398382|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398383|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398384|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398385|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
138398386|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398387|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
138398388|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
138398389|NCT01536002|Propofol|propofol|mesh-list
138398390|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138398391|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398392|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398393|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138398394|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
138398395|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
138398396|NCT01536028|Insulin|insulin|mesh-list
138398397|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138398398|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
138398399|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
138398400|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138398401|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
138398402|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398403|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398404|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398405|NCT01536054|Sirolimus|sirolimus|mesh-list
138398406|NCT01536054|Sargramostim|sargramostim|mesh-list
138398407|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398408|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398414|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398416|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138398417|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138398418|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138398419|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138398420|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398421|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398422|NCT01536132|Protective Agents|protective agents|mesh-ancestor
138398423|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398424|NCT01536158|Acetaminophen|acetaminophen|mesh-list
138398426|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398427|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398428|NCT01536158|Analgesics|analgesics|mesh-ancestor
138398429|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
138398430|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398431|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398432|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398433|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398434|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138398435|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398436|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398437|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
138398438|NCT01536223|Cisplatin|cisplatin|mesh-list
138398439|NCT01536223|Docetaxel|docetaxel|mesh-list
138398440|NCT01536223|Fluorouracil|fluorouracil|mesh-list
138398441|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398442|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
138364621|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364623|NCT01387048|Adapalene|adapalene|mesh-list
138398443|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
138398444|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
138398445|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398446|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
138398447|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398448|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398449|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
138398450|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398451|NCT01536249|Pramipexole|pramipexole|mesh-list
138398452|NCT01536249|Cimetidine|cimetidine|mesh-list
138398453|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138398454|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398455|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138398456|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
138398457|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
138398458|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398459|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398460|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398461|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138398462|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138398463|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398464|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
138398465|NCT01536249|Protective Agents|protective agents|mesh-ancestor
138398466|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138398471|NCT01536301|Oxycodone|oxycodone|mesh-list
138398472|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138398473|NCT01536301|Narcotics|narcotics|mesh-ancestor
138398474|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398475|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398476|NCT01536301|Analgesics|analgesics|mesh-ancestor
138398477|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
138398478|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398479|NCT01536314|Memantine|memantine|mesh-list
138398480|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138398481|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138398482|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
138398483|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398484|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398485|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398486|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138398487|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138398488|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138398489|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138398490|NCT01536431|Insulin|insulin|mesh-list
138398491|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138398492|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398493|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398494|NCT01536470|Norepinephrine|norepinephrine|mesh-list
138398495|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138398496|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138398497|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
138398498|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398499|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398500|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364641|NCT01387191|Epoprostenol|epoprostenol|mesh-list
138398501|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
138398502|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
138398503|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398504|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138398505|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
138398506|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
138398507|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398508|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398509|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398510|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
138398511|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
138398512|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398513|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398514|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398515|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
138398516|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
138398517|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398518|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398519|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398520|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
138398525|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
138398526|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
138398527|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398528|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398529|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398530|NCT01536665|Liraglutide|liraglutide|mesh-list
138398531|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398532|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398533|NCT01536665|Incretins|incretins|mesh-ancestor
138398534|NCT01536665|Hormones|hormones|mesh-ancestor
138398535|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398536|NCT01536691|Ondansetron|ondansetron|mesh-list
138398537|NCT01536691|Aprepitant|aprepitant|mesh-list
138398538|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
138398539|NCT01536691|Ramosetron|ramosetron|mesh-list
138398540|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
138398541|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
138398542|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398543|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398544|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398545|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
138398546|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138398547|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138398548|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138398549|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
138398550|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398551|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398552|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138398554|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
138398555|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
138398556|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398557|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398558|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
138398559|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398560|NCT01536743|Palbociclib|palbociclib|mesh-list
138398561|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398562|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398563|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398564|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398565|NCT01536873|Dolutegravir|dolutegravir|mesh-list
138398566|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138398567|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138398568|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398569|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398570|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138398571|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138398572|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
138398573|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398574|NCT01537055|Amoxicillin|amoxicillin|mesh-list
138398575|NCT01537055|Levofloxacin|levofloxacin|mesh-list
138398576|NCT01537055|Ofloxacin|ofloxacin|mesh-list
138398577|NCT01537055|Lansoprazole|lansoprazole|mesh-list
138398578|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
138398579|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398583|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398584|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398585|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398586|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398587|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138398588|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138398589|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138398590|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398591|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138398592|NCT01537094|Vitamins|vitamins|mesh-list
138398593|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
138398594|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
138398595|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398596|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
138398597|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398598|NCT01537094|Protective Agents|protective agents|mesh-ancestor
138398599|NCT01537107|Sirolimus|sirolimus|mesh-list
138398600|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138398601|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398602|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398603|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398604|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398605|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
138398606|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398607|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
138398608|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398609|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398610|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138398612|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
138398613|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
138398614|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398615|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398616|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
138398617|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398618|NCT01537250|Levofloxacin|levofloxacin|mesh-list
138398619|NCT01537250|Ofloxacin|ofloxacin|mesh-list
138398620|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
138398621|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138398622|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398623|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398624|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138398625|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398626|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398627|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398628|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398629|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138398631|NCT01537354|Poractant alfa|poractant alfa|mesh-list
138398632|NCT01537354|Beractant|beractant|mesh-list
138398633|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138398634|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398635|NCT01537380|Cefazolin|cefazolin|mesh-list
138398636|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398637|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398638|NCT01537471|Meclizine|meclizine|mesh-list
138398639|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
138398640|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
138398641|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
138398642|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398643|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398644|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398645|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138398646|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
138398647|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
138398648|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398649|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398650|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138398651|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
138398652|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138398654|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138398655|NCT01537575|Antibodies|antibodies|mesh-list
138398656|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
138398657|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138398658|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
138398659|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398660|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138398661|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
138398662|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398663|NCT01537744|Azacitidine|azacitidine|mesh-list
138398664|NCT01537744|Romidepsin|romidepsin|mesh-list
138398665|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398666|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
138398667|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398668|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398669|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398670|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398671|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138398672|NCT01537770|Lidocaine|lidocaine|mesh-list
138398673|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
138398674|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
138398675|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398676|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398677|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
138398678|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398679|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138398680|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138398681|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138398682|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138398683|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398684|NCT01537809|Vitamin D|vitamin d|mesh-list
138398685|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
138398686|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
138398687|NCT01537809|Vitamins|vitamins|mesh-list
138398688|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
138398689|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398690|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138398696|NCT01537861|Bortezomib|bortezomib|mesh-list
138398697|NCT01537861|Pomalidomide|pomalidomide|mesh-list
138398698|NCT01537861|Lenograstim|lenograstim|mesh-list
138398699|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398700|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
138398701|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398702|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398703|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138398704|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
138398705|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398706|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398707|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138398708|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398709|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
138398710|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
138398711|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398712|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398713|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
138398714|NCT01537861|Hormones|hormones|mesh-ancestor
138398715|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398716|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138398717|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138398718|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138398719|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138398720|NCT01537861|Growth Substances|growth substances|mesh-ancestor
138398721|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138398722|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
138398723|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398724|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398725|NCT01538095|Trebananib|trebananib|mesh-list
138398726|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138398727|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138398728|NCT01538095|Growth Substances|growth substances|mesh-ancestor
138398729|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398730|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
138398731|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398733|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138398734|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398735|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
138398736|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
138398737|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
138398738|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398739|NCT01538225|Nabiximols|nabiximols|mesh-list
138398740|NCT01538225|Analgesics|analgesics|mesh-ancestor
138398741|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
138398742|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398743|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398744|NCT01538316|Genistein|genistein|mesh-list
138398745|NCT01538316|Quercetin|quercetin|mesh-list
138398746|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
138398747|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398748|NCT01538316|Protective Agents|protective agents|mesh-ancestor
138398749|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398755|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138398756|NCT01538316|Estrogens|estrogens|mesh-ancestor
138398757|NCT01538316|Hormones|hormones|mesh-ancestor
138398758|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398759|NCT01538329|Amantadine|amantadine|mesh-list
138398760|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138398761|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138398762|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
138398763|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398764|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
138398765|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398766|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398767|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398768|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138398769|NCT01538329|Analgesics|analgesics|mesh-ancestor
138398770|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
138398771|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398772|NCT01538381|Afatinib|afatinib|mesh-list
138398773|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398774|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398775|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398776|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398777|NCT01538394|Nicotine|nicotine|mesh-list
138398778|NCT01538394|Varenicline|varenicline|mesh-list
138398779|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138398781|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398782|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398783|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138398784|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138398785|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
138398786|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398787|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398789|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138398790|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138398791|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138398792|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138398793|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138398794|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
138398795|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398796|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398797|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398798|NCT01538459|Dexamethasone|dexamethasone|mesh-list
138398799|NCT01538459|Bupivacaine|bupivacaine|mesh-list
138398800|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398801|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
138398802|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
138398803|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398804|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398805|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398812|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
138398813|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138398814|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
138398815|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
138398816|NCT01538485|Vitamin D|vitamin d|mesh-list
138398817|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138398818|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398819|NCT01538485|Vitamins|vitamins|mesh-ancestor
138398820|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
138398821|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138398822|NCT01538511|Insulin|insulin|mesh-list
138398823|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138398825|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
138398826|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138398827|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
138398828|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398829|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398830|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398831|NCT01538537|ON 01910|on 01910|mesh-list
138398832|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398833|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398834|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398835|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398836|NCT01538563|ON 01910|on 01910|mesh-list
138398837|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398838|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398839|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398840|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398841|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
138398842|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398843|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398844|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
138398845|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398846|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398847|NCT01538641|Rituximab|rituximab|mesh-list
138398848|NCT01538641|Gemcitabine|gemcitabine|mesh-list
138398849|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
138398850|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398851|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398852|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
138398853|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398854|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398855|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398856|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
138398857|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398858|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
138398859|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398860|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398865|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398866|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138398867|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138398868|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
138398870|NCT01538693|Citalopram|citalopram|mesh-list
138398871|NCT01538693|Escitalopram|escitalopram|mesh-list
138398872|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138398873|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138398874|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138398875|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398876|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398877|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
138398878|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398879|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138398880|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138398881|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
138398882|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
138398883|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398884|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138398885|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138398886|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
138398887|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138398888|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
138398889|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138398890|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
138398891|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138398892|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398893|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138398894|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
138398895|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
138398896|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138398897|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138398898|NCT01538732|Alitretinoin|alitretinoin|mesh-list
138398899|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398900|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138398901|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
138398904|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138398906|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398907|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138398908|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
138398909|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
138398910|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398911|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398912|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398913|NCT01538849|Esomeprazole|esomeprazole|mesh-list
138398914|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138398915|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398916|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138398917|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398918|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398919|NCT01538875|Labetalol|labetalol|mesh-list
138398920|NCT01538875|Hydralazine|hydralazine|mesh-list
138398921|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138398925|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398926|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398928|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
138398929|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
138398930|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398931|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138398932|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138398933|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
138364710|NCT01388036|Esmolol|esmolol|mesh-list
138398935|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138398936|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
138398937|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398938|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398939|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
138398940|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138398942|NCT01538927|Coagulants|coagulants|mesh-ancestor
138398943|NCT01538940|Vaccines|vaccines|mesh-list
138398944|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
138398945|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398946|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138398947|NCT01538953|Disinfectants|disinfectants|mesh-list
138398948|NCT01538953|Eusol|eusol|mesh-list
138398949|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398950|NCT01539018|Sorafenib|sorafenib|mesh-list
138398951|NCT01539018|Tegafur|tegafur|mesh-list
138398952|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398953|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398954|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398955|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398956|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138398957|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
138398958|NCT01539044|Atropine|atropine|mesh-list
138398959|NCT01539044|Neostigmine|neostigmine|mesh-list
138398960|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138398961|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138398962|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138398963|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
138398964|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398965|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398966|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138398967|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398968|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
138398969|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
138398970|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138398971|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138398972|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
138398973|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398974|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398975|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138398976|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398977|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138398981|NCT01539174|Doxorubicin|doxorubicin|mesh-list
138398982|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138398983|NCT01539174|Vincristine|vincristine|mesh-list
138398984|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398985|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
138398986|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398987|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138398988|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138398989|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
138398990|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398991|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398992|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138398993|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138398994|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398995|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138398996|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398997|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398998|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399001|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399002|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399003|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138399004|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
138364722|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
138399005|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
138399006|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
138399007|NCT01539265|Silodosin|silodosin|mesh-list
138399008|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138399009|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138399010|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138399011|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399012|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399013|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399014|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399015|NCT01539265|Urological Agents|urological agents|mesh-ancestor
138399016|NCT01539330|Voriconazole|voriconazole|mesh-list
138399017|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
138399018|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399019|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138399020|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399021|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399022|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399023|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138399024|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138399025|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399026|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399027|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138399028|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
138399029|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138399030|NCT01539408|Misoprostol|misoprostol|mesh-list
138399031|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138399032|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
138399033|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138399034|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399035|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138399036|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399037|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
138399038|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
138399039|NCT01539473|Tedizolid|tedizolid|mesh-list
138399042|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399043|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
138399044|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
138399045|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399046|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399047|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138399048|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138399049|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399050|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399051|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399052|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399053|NCT01539564|Minocycline|minocycline|mesh-list
138399054|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138399055|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399056|NCT01539577|Dexamethasone|dexamethasone|mesh-list
138399057|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399058|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
138399059|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
138399060|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399061|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399062|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399063|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
138399064|NCT01539577|Hormones|hormones|mesh-ancestor
138399065|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399066|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399067|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399068|NCT01539603|Sirolimus|sirolimus|mesh-list
138399069|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138399070|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399071|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138399072|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399073|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
138399074|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399075|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
138399076|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399077|NCT01539616|Fenofibrate|fenofibrate|mesh-list
138399079|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
138399080|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399082|NCT01539655|Omeprazole|omeprazole|mesh-list
138399083|NCT01539655|Ranitidine|ranitidine|mesh-list
138399084|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138399085|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138399086|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399087|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138399088|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399089|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399090|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138399091|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
138399092|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
138399093|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399094|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399095|NCT01539681|Sorafenib|sorafenib|mesh-list
138399096|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399097|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138399098|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399099|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399100|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
138399101|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138399106|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399107|NCT01539707|Urological Agents|urological agents|mesh-ancestor
138399108|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
138399109|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
138399110|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138399111|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
138399112|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138399113|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399114|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138399115|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138399116|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138399117|NCT01539733|Haloperidol|haloperidol|mesh-list
138399118|NCT01539733|Olanzapine|olanzapine|mesh-list
138399119|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
138399120|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
138399121|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
138399122|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399123|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399124|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399125|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138399126|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399127|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399128|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138399129|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138399130|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138399131|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399132|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399133|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399134|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
138399135|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138399136|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
138399137|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138399138|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138399139|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
138399140|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399141|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
138399142|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399143|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399144|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138399145|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
138399146|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364740|NCT01388088|Spironolactone|spironolactone|mesh-list
138399147|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399148|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138399149|NCT01540032|Salicylates|salicylates|mesh-list
138399150|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138399151|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399152|NCT01540032|Analgesics|analgesics|mesh-ancestor
138399153|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
138399154|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399155|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399159|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399160|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399161|NCT01540084|Propofol|propofol|mesh-list
138399162|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138399163|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399164|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399165|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138399166|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
138399167|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
138399168|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
138399169|NCT01540110|Docetaxel|docetaxel|mesh-list
138399170|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399171|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
138399172|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399173|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399174|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138399175|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
138399176|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399177|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399178|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138399179|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138399180|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138399181|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138399183|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399184|NCT01540240|Zidovudine|zidovudine|mesh-list
138399185|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
138399186|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399187|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138399188|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138399189|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399190|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
138399191|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399192|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138399193|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138399194|NCT01540435|Bevacizumab|bevacizumab|mesh-list
138399195|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138399196|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399197|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138399198|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138399199|NCT01540435|Growth Substances|growth substances|mesh-ancestor
138399200|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399201|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
138399202|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
138399203|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138399204|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399205|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399206|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399207|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138399210|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399211|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399212|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399213|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
138399214|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138399215|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
138399216|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138215761|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399217|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399218|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399219|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138399220|NCT01540526|Axitinib|axitinib|mesh-list
138399221|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399222|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138399223|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399224|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399225|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138399226|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138399227|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138399228|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138399229|NCT01540682|Cetuximab|cetuximab|mesh-list
138399230|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138399231|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399232|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138399233|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138399234|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
138399235|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399236|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399237|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138399238|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
138399239|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
138399240|NCT01540708|Hormones|hormones|mesh-ancestor
138399241|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399242|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
138399243|NCT01540721|Acetaminophen|acetaminophen|mesh-list
138399244|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399245|NCT01540721|Analgesics|analgesics|mesh-ancestor
138399246|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
138399247|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399248|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399249|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
138399250|NCT01540734|Acetaminophen|acetaminophen|mesh-list
138399251|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399252|NCT01540734|Analgesics|analgesics|mesh-ancestor
138399253|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
138399254|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399255|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399256|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
138399257|NCT01540747|Folic Acid|folic acid|mesh-list
138399258|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
138399260|NCT01540747|Melatonin|melatonin|mesh-list
138399261|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
138399262|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399263|NCT01540747|Protective Agents|protective agents|mesh-ancestor
138399264|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399265|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399266|NCT01540747|Hematinics|hematinics|mesh-ancestor
138399267|NCT01540747|Vitamins|vitamins|mesh-ancestor
138399270|NCT01540812|Dexamethasone|dexamethasone|mesh-list
138399271|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
138399273|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
138399274|NCT01540812|Fludarabine|fludarabine|mesh-list
138399275|NCT01540812|Vincristine|vincristine|mesh-list
138399276|NCT01540812|Daunorubicin|daunorubicin|mesh-list
138399277|NCT01540812|Idarubicin|idarubicin|mesh-list
138399278|NCT01540812|Methotrexate|methotrexate|mesh-list
138399279|NCT01540812|Pegaspargase|pegaspargase|mesh-list
138399280|NCT01540812|Asparaginase|asparaginase|mesh-list
138399281|NCT01540812|BB 1101|bb 1101|mesh-list
138364755|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399282|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399283|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
138364756|NCT01388114|Antibodies|antibodies|mesh-list
138399284|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
138399285|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399286|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399287|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399288|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
138399289|NCT01540812|Hormones|hormones|mesh-ancestor
138399290|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399291|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399292|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399293|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
138399294|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399295|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399296|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138399297|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
138399298|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399299|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
138399300|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
138399301|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399302|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138399303|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138399304|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138399305|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138399306|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138399307|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138399308|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138399309|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138399310|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
138399311|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138399312|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138399313|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138399314|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399315|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138399316|NCT01540877|Anesthetics|anesthetics|mesh-list
138399317|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138399318|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
138399319|NCT01540877|Capsaicin|capsaicin|mesh-list
138399320|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399321|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399322|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
138399323|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399324|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
138399325|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138399326|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138399327|NCT01541059|Ropivacaine|ropivacaine|mesh-list
138399328|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
138399332|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
138399333|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399335|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138399336|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
138399337|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399338|NCT01541124|Morphine|morphine|mesh-list
138399339|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138399340|NCT01541124|Narcotics|narcotics|mesh-ancestor
138399341|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399342|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399343|NCT01541124|Analgesics|analgesics|mesh-ancestor
138399344|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
138399345|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399346|NCT01541137|Diclofenac|diclofenac|mesh-list
138399347|NCT01541137|Parecoxib|parecoxib|mesh-list
138399348|NCT01541137|Valdecoxib|valdecoxib|mesh-list
138399349|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138364771|NCT01388322|Enoxaparin|enoxaparin|mesh-list
138399350|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399351|NCT01541137|Analgesics|analgesics|mesh-ancestor
138399352|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
138399353|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399354|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399355|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399356|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399357|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138399358|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399359|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399360|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138399362|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399363|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138399364|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138399365|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399366|NCT01541267|Telmisartan|telmisartan|mesh-list
138399368|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138399369|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138399370|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399371|NCT01541280|Azacitidine|azacitidine|mesh-list
138399372|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138399373|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
138399374|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399375|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399376|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399377|NCT01541293|Lidocaine|lidocaine|mesh-list
138399378|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
138399379|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
138399380|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399381|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399382|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
138399383|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399384|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138399385|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138399386|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138399387|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414735|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138399393|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399394|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
138399395|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
138399396|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399397|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399398|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399399|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
138399400|NCT01541332|Hormones|hormones|mesh-ancestor
138399401|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399402|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399403|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399404|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138399405|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138399406|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138399408|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399409|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
138399410|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138399411|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138399412|NCT01541332|Growth Substances|growth substances|mesh-ancestor
138399413|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138399414|NCT01541436|Capsaicin|capsaicin|mesh-list
138399415|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
138399416|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
138399417|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
138399418|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364782|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399419|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399420|NCT01541475|Dexetimide|dexetimide|mesh-list
138399421|NCT01541475|Citalopram|citalopram|mesh-list
138399422|NCT01541475|Bupropion|bupropion|mesh-list
138399423|NCT01541475|Escitalopram|escitalopram|mesh-list
138399424|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138399425|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138399426|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399427|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399428|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399429|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
138399430|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399431|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138399432|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138399433|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
138399434|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
138399435|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399436|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138399437|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138399438|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
138399439|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138399440|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
138399441|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138399442|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138399444|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138399445|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399446|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399447|NCT01541605|Methylphenidate|methylphenidate|mesh-list
138399448|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138399449|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399450|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138399451|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138399452|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399453|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399455|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399456|NCT01541631|Albendazole|albendazole|mesh-list
138399457|NCT01541631|Praziquantel|praziquantel|mesh-list
138399458|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
138399459|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138399460|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364792|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
138364800|NCT01388517|Emollients|emollients|mesh-ancestor
138399461|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
138399462|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138399463|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138399464|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
138399465|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
138399466|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
138399467|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399468|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399469|NCT01541670|Antibodies|antibodies|mesh-list
138399470|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
138399471|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399472|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138399473|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138399474|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138399475|NCT01541085|Ritonavir|ritonavir|mesh-list
138399476|NCT01541085|Darunavir|darunavir|mesh-list
138399477|NCT01541085|Efavirenz|efavirenz|mesh-list
138399478|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138399479|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138399480|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
138399481|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399482|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399483|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138399484|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138399485|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
138399486|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399487|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138399488|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399489|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138399490|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138399491|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138399492|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138399493|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138399494|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138399495|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138399496|NCT01541943|Losartan|losartan|mesh-list
138399497|NCT01541943|Atorvastatin|atorvastatin|mesh-list
138399498|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138399504|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399505|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138399506|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399507|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138399508|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138399509|NCT01541956|Metformin|metformin|mesh-list
138399510|NCT01541956|Vildagliptin|vildagliptin|mesh-list
138399511|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399512|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364826|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138399513|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138399514|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
138399515|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399516|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399517|NCT01542047|Carboplatin|carboplatin|mesh-list
138399518|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399519|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
138399520|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
138399521|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138399522|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399523|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399524|NCT01542099|Remifentanil|remifentanil|mesh-list
138399525|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138399526|NCT01542099|Narcotics|narcotics|mesh-ancestor
138399527|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399528|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399529|NCT01542099|Analgesics|analgesics|mesh-ancestor
138399530|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
138399531|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399532|NCT01542138|Niacinamide|niacinamide|mesh-list
138399533|NCT01542138|Niacin|niacin|mesh-list
138399534|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
138399535|NCT01542138|Desonide|desonide|mesh-list
138399536|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
138399537|NCT01542138|Vitamins|vitamins|mesh-ancestor
138399538|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
138399539|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399541|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
138399542|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399543|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138399544|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399545|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399546|NCT01542190|Ketorolac|ketorolac|mesh-list
138399547|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138399548|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138399549|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399550|NCT01542190|Analgesics|analgesics|mesh-ancestor
138399551|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
138399552|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399553|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399554|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399555|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399556|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138399557|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399559|NCT01542242|Liraglutide|liraglutide|mesh-list
138399560|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399561|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399562|NCT01542242|Incretins|incretins|mesh-ancestor
138399563|NCT01542242|Hormones|hormones|mesh-ancestor
138399564|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399565|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
138399566|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138399567|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399568|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399569|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138399570|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138399571|NCT01542268|Protective Agents|protective agents|mesh-ancestor
138399572|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399573|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399574|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138399575|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
138399576|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
138399577|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399579|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138399580|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
138399581|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
138399582|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
138399583|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138399584|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399585|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399586|NCT01542437|Afatinib|afatinib|mesh-list
138399587|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399588|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138399589|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399590|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399591|NCT01542450|Insulin|insulin|mesh-list
138399592|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138399593|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
138399594|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
138399595|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
138399596|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
138399597|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399598|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399599|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
138399600|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399601|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399602|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
138399603|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399604|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399605|NCT01542489|Insulin|insulin|mesh-list
138399606|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138399607|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
138399608|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
138399609|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399610|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399611|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
138399612|NCT01542697|Analgesics|analgesics|mesh-ancestor
138399613|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
138399614|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399615|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399616|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
138399617|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399618|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138399619|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
138399620|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138399621|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399623|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138399625|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138399626|NCT01542710|Timolol|timolol|mesh-list
138399627|NCT01542710|Bimatoprost|bimatoprost|mesh-list
138399628|NCT01542710|Travoprost|travoprost|mesh-list
138399629|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138399630|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138399631|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399632|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399633|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399634|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399635|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138364880|NCT01388855|Vitamin D|vitamin d|mesh-list
138399636|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399637|NCT01542723|Nadroparin|nadroparin|mesh-list
138399638|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
138399639|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138399640|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138399641|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399642|NCT01542762|Nadroparin|nadroparin|mesh-list
138399643|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
138399644|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138399645|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138399646|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399647|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
138399648|NCT01542801|Norfloxacin|norfloxacin|mesh-list
138399649|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138399650|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399651|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138399652|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138399653|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399654|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399655|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399656|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138399657|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399658|NCT01542827|Analgesics|analgesics|mesh-list
138399659|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
138399660|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399662|NCT01542918|Rituximab|rituximab|mesh-list
138399663|NCT01542918|Lenalidomide|lenalidomide|mesh-list
138399664|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138399665|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399666|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
138399667|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399668|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399669|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138399670|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138399671|NCT01542918|Growth Substances|growth substances|mesh-ancestor
138399672|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
138399673|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138399674|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
138399675|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399676|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138399677|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138399679|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
138399680|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399681|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399682|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
138399683|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399684|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399685|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
138399686|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399687|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399693|NCT01543165|Nefopam|nefopam|mesh-list
138399694|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138399695|NCT01543165|Narcotics|narcotics|mesh-ancestor
138399696|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399697|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399698|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
138399699|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399700|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138399701|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399702|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399703|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399704|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138399705|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399706|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399707|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
138399708|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138399710|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399711|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399712|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399713|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399714|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399715|NCT01543347|Temocillin|temocillin|mesh-list
138399716|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138399718|NCT01543386|Curcumin|curcumin|mesh-list
138399719|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138399720|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399721|NCT01543386|Analgesics|analgesics|mesh-ancestor
138399722|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
138399723|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399724|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399725|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399726|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399727|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399728|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399729|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399731|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
138399732|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
138399733|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399734|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399735|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399736|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399737|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399738|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138399739|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
138399741|NCT01543464|Temozolomide|temozolomide|mesh-list
138399742|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138399743|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
138399744|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399745|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399746|NCT01543555|Atorvastatin|atorvastatin|mesh-list
138399747|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138399748|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138399750|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399751|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138399752|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138399753|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399754|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
138399755|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
138364902|NCT01389167|Naltrexone|naltrexone|mesh-list
138399756|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138399757|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399758|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399759|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
138399760|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399761|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399762|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399763|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
138399764|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138399765|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
138399766|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399767|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
138399768|NCT01543737|Protective Agents|protective agents|mesh-ancestor
138399769|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
138399770|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138399771|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399772|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399774|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138399775|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
138399776|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399777|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138399778|NCT01543906|Protective Agents|protective agents|mesh-ancestor
138399779|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399780|NCT01543932|Clopidogrel|clopidogrel|mesh-list
138399781|NCT01543932|Ticagrelor|ticagrelor|mesh-list
138399782|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138399783|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138399784|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138399785|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138399786|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138399787|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
138399788|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399789|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399790|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399791|NCT01543945|Dexamethasone|dexamethasone|mesh-list
138399792|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
138399793|NCT01543945|Ondansetron|ondansetron|mesh-list
138399794|NCT01543945|Antiemetics|antiemetics|mesh-list
138399795|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
138399797|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399798|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
138399799|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399800|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399801|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399802|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
138399804|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399805|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138399806|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399807|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
138399808|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399809|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399812|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138399813|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138399814|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
138399815|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399816|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138399817|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
138399818|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
138399819|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138399820|NCT01543971|Lenograstim|lenograstim|mesh-list
138399821|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138399822|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
138399823|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399824|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399825|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399826|NCT01544140|Midazolam|midazolam|mesh-list
138399827|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138399828|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138399829|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399830|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399831|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138399832|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399833|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138399834|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138399835|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
138399836|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
138399837|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
138399838|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
138399839|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399840|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399841|NCT01544192|Tocopherols|tocopherols|mesh-list
138399842|NCT01544192|Vitamin E|vitamin e|mesh-list
138399843|NCT01544192|Tocotrienols|tocotrienols|mesh-list
138399844|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
138399845|NCT01544192|Antioxidants|antioxidants|mesh-list
138399846|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399847|NCT01544192|Protective Agents|protective agents|mesh-ancestor
138399848|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399849|NCT01544192|Vitamins|vitamins|mesh-ancestor
138399850|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
138399851|NCT01544283|Triamcinolone|triamcinolone|mesh-list
138399852|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138399853|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138399854|NCT01544283|Lidocaine|lidocaine|mesh-list
138399855|NCT01544283|Tetracaine|tetracaine|mesh-list
138399856|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138399857|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138399858|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
138399859|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399860|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399861|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
138399862|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399863|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138399864|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138364927|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138399865|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138399866|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138399867|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399868|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399869|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
138364933|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399872|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399873|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
138399874|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399875|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
138399876|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399877|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
138399878|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
138399879|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138399880|NCT01544504|Norepinephrine|norepinephrine|mesh-list
138399881|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138399882|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138399883|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399884|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399885|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399886|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399887|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
138399888|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
138399889|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399890|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138399891|NCT01544517|Amoxicillin|amoxicillin|mesh-list
138399892|NCT01544517|Levofloxacin|levofloxacin|mesh-list
138399893|NCT01544517|Tinidazole|tinidazole|mesh-list
138399894|NCT01544517|Esomeprazole|esomeprazole|mesh-list
138399895|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138399896|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138399897|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399898|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138399899|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138399900|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399901|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399902|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138399903|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138399905|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399906|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138399907|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138399908|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
138399909|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138399910|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138399911|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138399912|NCT01544634|Beclomethasone|beclomethasone|mesh-list
138399913|NCT01544634|Propranolol|propranolol|mesh-list
138399914|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138399915|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138399916|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399917|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399918|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399919|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399920|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138399921|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138399922|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399923|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399924|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
138399925|NCT01544634|Hormones|hormones|mesh-ancestor
138399926|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399927|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138399928|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138399929|NCT01544673|Linezolid|linezolid|mesh-list
138399933|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399934|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399935|NCT01544725|Ketamine|ketamine|mesh-list
138399936|NCT01544725|Propofol|propofol|mesh-list
138399937|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138399938|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399939|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399940|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138399941|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
138399942|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
138399943|NCT01544725|Analgesics|analgesics|mesh-ancestor
138399944|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
138399945|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399946|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138399947|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138399948|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138399949|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399950|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399951|NCT01544751|Metformin|metformin|mesh-list
138399952|NCT01544751|Atorvastatin|atorvastatin|mesh-list
138399953|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399954|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399956|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138399957|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
138399958|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399959|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138399960|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138399961|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399963|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138399964|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
138399965|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399966|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399967|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138399968|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
138399969|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
138399970|NCT01544842|Triamcinolone|triamcinolone|mesh-list
138399971|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138399972|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138399973|NCT01544842|Tacrolimus|tacrolimus|mesh-list
138399974|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138399975|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138399976|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
138399977|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399978|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138399979|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138399980|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399981|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399982|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
138399984|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399986|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138399987|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399988|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138399989|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
138399991|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
138399992|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138399993|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399994|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138399995|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138364964|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138399996|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138399998|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138399999|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400000|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138400002|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138400003|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400004|NCT01544959|Fentanyl|fentanyl|mesh-list
138400005|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138400006|NCT01544959|Esmolol|esmolol|mesh-list
138400007|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400008|NCT01544959|Narcotics|narcotics|mesh-ancestor
138400009|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400010|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400011|NCT01544959|Analgesics|analgesics|mesh-ancestor
138400012|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
138400013|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400014|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138400015|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400016|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
138400017|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
138400018|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138400019|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138400020|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400021|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400022|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138400023|NCT01544972|Acetaminophen|acetaminophen|mesh-list
138400024|NCT01544972|Ibuprofen|ibuprofen|mesh-list
138400025|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138400026|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400027|NCT01544972|Analgesics|analgesics|mesh-ancestor
138400028|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
138400029|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400030|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400031|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400032|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400033|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138400034|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400036|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
138400037|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138400038|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400039|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400040|NCT01545024|Incretins|incretins|mesh-ancestor
138400041|NCT01545024|Hormones|hormones|mesh-ancestor
138400042|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400043|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138400044|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
138400045|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400046|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400047|NCT01545284|Acitretin|acitretin|mesh-list
138400048|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
138400049|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
138400051|NCT01545297|Remifentanil|remifentanil|mesh-list
138400052|NCT01545297|Propofol|propofol|mesh-list
138400053|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400054|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400055|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400056|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400057|NCT01545297|Analgesics|analgesics|mesh-ancestor
138400058|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
138400059|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400060|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138400061|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138400062|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138400063|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
138400064|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400065|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400066|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400067|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
138400068|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
138400069|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400070|NCT01545297|Narcotics|narcotics|mesh-ancestor
138400071|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
138400072|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400073|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400074|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400075|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400076|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138400077|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
138400078|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400079|NCT01545479|Captopril|captopril|mesh-list
138400080|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138400081|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
138400082|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400083|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400084|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400085|NCT01545635|Thrombin|thrombin|mesh-list
138400086|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
138400087|NCT01545635|Coagulants|coagulants|mesh-ancestor
138400088|NCT01545778|Oxycodone|oxycodone|mesh-list
138400089|NCT01545778|Tapentadol|tapentadol|mesh-list
138400092|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400093|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400094|NCT01545778|Analgesics|analgesics|mesh-ancestor
138400095|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
138400096|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400097|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138400098|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138400099|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400100|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400101|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
138400102|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400103|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
138400104|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400105|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400106|NCT01545804|Lenalidomide|lenalidomide|mesh-list
138400107|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
138400108|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400109|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400110|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138400111|NCT01545804|Growth Substances|growth substances|mesh-ancestor
138400112|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400113|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400115|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
138400116|NCT01545830|Vitamins|vitamins|mesh-ancestor
138400117|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
138400118|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400119|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138400120|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400121|NCT01545856|Levodopa|levodopa|mesh-list
138400122|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138400123|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138400124|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
138400125|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400126|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400127|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400128|NCT01545947|Azacitidine|azacitidine|mesh-list
138400129|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138400130|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138400131|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
138400132|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400133|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400134|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400135|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400136|NCT01546051|BCI-838|bci-838|mesh-list
138400137|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138400138|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138400139|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400140|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400141|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400143|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400145|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400147|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138400148|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400149|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
138400150|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
138400151|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400152|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400153|NCT01546103|Vitamin D|vitamin d|mesh-list
138400154|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
138400155|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
138400156|NCT01546103|Vitamins|vitamins|mesh-list
138400157|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
138400158|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400159|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138400160|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400161|NCT01546116|Lamivudine|lamivudine|mesh-list
138400162|NCT01546116|Adefovir|adefovir|mesh-list
138400163|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138400164|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138400165|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138400166|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400167|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400168|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
138400169|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400170|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138400171|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138400172|NCT01546389|Chloroquine|chloroquine|mesh-list
138400173|NCT01546389|Amebicides|amebicides|mesh-ancestor
138400174|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400175|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138400176|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400177|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
138400178|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400179|NCT01546558|Metformin|metformin|mesh-list
138400180|NCT01546558|Ranolazine|ranolazine|mesh-list
138400181|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400182|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400183|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138400184|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400185|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400186|NCT01546597|Metformin|metformin|mesh-list
138400187|NCT01546597|Ranolazine|ranolazine|mesh-list
138400188|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400189|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400190|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138400191|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400192|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400193|NCT01546701|Morphine|morphine|mesh-list
138400194|NCT01546701|Buprenorphine|buprenorphine|mesh-list
138400195|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400196|NCT01546701|Narcotics|narcotics|mesh-ancestor
138400197|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400198|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400199|NCT01546701|Analgesics|analgesics|mesh-ancestor
138400200|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
138400201|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400202|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138400203|NCT01546896|Alprazolam|alprazolam|mesh-list
138400204|NCT01546896|Buspirone|buspirone|mesh-list
138400205|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400206|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400212|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
138400213|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400214|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400215|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138400216|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
138400217|NCT01546935|Oseltamivir|oseltamivir|mesh-list
138400218|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
138400219|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400220|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400221|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400222|NCT01546961|Chloroquine|chloroquine|mesh-list
138400223|NCT01546961|Amebicides|amebicides|mesh-ancestor
138400224|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400225|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138400226|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400227|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
138400228|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400229|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
138400230|NCT01547104|Glimepiride|glimepiride|mesh-list
138400231|NCT01547104|Linagliptin|linagliptin|mesh-list
138400232|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138400233|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400234|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400235|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400236|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
138400238|NCT01547104|Hormones|hormones|mesh-ancestor
138400239|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400240|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138400241|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
138400242|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400243|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400244|NCT01547143|Cyclosporine|cyclosporine|mesh-list
138400245|NCT01547143|Dexamethasone|dexamethasone|mesh-list
138400246|NCT01547143|Etoposide|etoposide|mesh-list
138400247|NCT01547143|Cyclosporins|cyclosporins|mesh-list
138400248|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
138400249|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400250|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
138400251|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
138400252|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400253|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400254|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400255|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
138400256|NCT01547143|Hormones|hormones|mesh-ancestor
138400257|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400258|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138400259|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400260|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400261|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400262|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138400263|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138400264|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138414736|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
138400268|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400269|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138400270|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400271|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138400272|NCT01547169|Insulin|insulin|mesh-list
138400273|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138400274|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
138400275|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400276|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400277|NCT01547221|Clotrimazole|clotrimazole|mesh-list
138400278|NCT01547221|Miconazole|miconazole|mesh-list
138400279|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138400280|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400281|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
138400282|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138400283|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138400284|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400285|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400286|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138400287|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
138400288|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400289|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400290|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138400291|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138400292|NCT01547312|Interferons|interferons|mesh-list
138400293|NCT01547312|Ribavirin|ribavirin|mesh-list
138400294|NCT01547312|Grazoprevir|grazoprevir|mesh-list
138400295|NCT01547312|Liver Extracts|liver extracts|mesh-list
138400296|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400297|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
138400298|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400299|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
138400300|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400301|NCT01547312|Hematinics|hematinics|mesh-ancestor
138400302|NCT01547325|Doxycycline|doxycycline|mesh-list
138400303|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138400304|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400305|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
138400306|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400307|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138400308|NCT01547377|Zinc|zinc|mesh-list
138400309|NCT01547377|Selenium|selenium|mesh-list
138400310|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138400311|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138400312|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138400313|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
138400314|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400315|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400316|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138400317|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400318|NCT01547377|Trace Elements|trace elements|mesh-ancestor
138400319|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
138400320|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400321|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
138400322|NCT01547377|Protective Agents|protective agents|mesh-ancestor
138400324|NCT01547416|Ropivacaine|ropivacaine|mesh-list
138400325|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
138400327|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400328|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400329|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
138400330|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400331|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400333|NCT01547416|Analgesics|analgesics|mesh-ancestor
138400334|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138400335|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400336|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
138400337|NCT01547455|Atorvastatin|atorvastatin|mesh-list
138400338|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138400339|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138400340|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
138400341|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400342|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400343|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138400344|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400346|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
138400347|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400348|NCT01547520|Meperidine|meperidine|mesh-list
138400349|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400350|NCT01547520|Narcotics|narcotics|mesh-ancestor
138364999|NCT01389505|Bevacizumab|bevacizumab|mesh-list
138400351|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400352|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400353|NCT01547520|Analgesics|analgesics|mesh-ancestor
138400354|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
138365008|NCT01389544|Methadone|methadone|mesh-list
138400355|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400356|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138400357|NCT01547546|GDC-0084|gdc-0084|mesh-list
138400358|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400359|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400360|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
138400361|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138400362|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400363|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400364|NCT01548001|Methotrexate|methotrexate|mesh-list
138400365|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138400366|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
138400367|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138400368|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400369|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138400370|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
138400371|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400372|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400373|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138400374|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400375|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138400376|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400377|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
138400378|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400379|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138400380|NCT01548027|Anesthetics|anesthetics|mesh-list
138400381|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
138400387|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
138400388|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400389|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400390|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
138400391|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400392|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400393|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
138400394|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138400395|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400396|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400397|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138400398|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138400399|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400400|NCT01548118|Vaccines|vaccines|mesh-list
138400401|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
138400402|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400403|NCT01548144|Pemetrexed|pemetrexed|mesh-list
138400404|NCT01548144|Crizotinib|crizotinib|mesh-list
138400405|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400406|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400407|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400408|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138400409|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138400410|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400411|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138400412|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138400413|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138400414|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
138400415|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400416|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400417|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138400418|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400419|NCT01548170|Ketoconazole|ketoconazole|mesh-list
138400420|NCT01548170|Sunitinib|sunitinib|mesh-list
138400421|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400422|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400423|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138400424|NCT01548170|Growth Substances|growth substances|mesh-ancestor
138400425|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400426|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400427|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400428|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400429|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400430|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
138400431|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400432|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138400433|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138400434|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138400435|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
138400439|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400440|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400441|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400442|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400443|NCT01548209|Analgesics|analgesics|mesh-ancestor
138400444|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
138400445|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400446|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138400448|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138400449|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
138400450|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400451|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400452|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
138400453|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
138400454|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138400455|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400456|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400457|NCT01548248|Insulin|insulin|mesh-list
138400458|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138400459|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
138400460|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
138400461|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400462|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400463|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
138400464|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138400465|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138400466|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400467|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138400468|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138400469|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
138400470|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400471|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400472|NCT01548326|Atorvastatin|atorvastatin|mesh-list
138400473|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138400474|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138400475|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
138400476|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400477|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400478|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138400479|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400480|NCT01548482|Sirolimus|sirolimus|mesh-list
138400481|NCT01548482|Temsirolimus|temsirolimus|mesh-list
138400482|NCT01548482|Trebananib|trebananib|mesh-list
138400483|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
138400484|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138400485|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365033|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400486|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138400487|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400488|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
138400490|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
138400491|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400492|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400493|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400494|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400495|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400496|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138400497|NCT01548482|Growth Substances|growth substances|mesh-ancestor
138400498|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400500|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
138400501|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138400502|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400504|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138400505|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138400506|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
138400507|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400508|NCT01548612|Nitroprusside|nitroprusside|mesh-list
138400509|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400510|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
138400511|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138400512|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400513|NCT01548677|Trastuzumab|trastuzumab|mesh-list
138400514|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138400515|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400516|NCT01548703|BCI-838|bci-838|mesh-list
138400517|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138400518|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138400519|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400520|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400521|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400522|NCT01548794|Lidocaine|lidocaine|mesh-list
138400523|NCT01548794|Bupivacaine|bupivacaine|mesh-list
138400524|NCT01548794|Anesthetics|anesthetics|mesh-list
138400525|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
138400526|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400527|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400528|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
138400529|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400530|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138400531|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138400532|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138400533|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400534|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400535|NCT01548807|Everolimus|everolimus|mesh-list
138400536|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138400537|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400538|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400539|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400541|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
138400542|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400543|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400544|NCT01548859|Midazolam|midazolam|mesh-list
138400547|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400548|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400549|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400550|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138400551|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138400552|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400553|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400554|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
138400555|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
138400556|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
138400557|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
138400558|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400559|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400560|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138400561|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138400562|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
138400563|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138400565|NCT01548911|Calicheamicins|calicheamicins|mesh-list
138400566|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138400567|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400568|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
138400569|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
138400570|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
138400571|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400572|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138400573|NCT01548924|Paclitaxel|paclitaxel|mesh-list
138400574|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138400575|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400576|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
138400577|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
138400578|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
138400579|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400580|NCT01548950|Bosentan|bosentan|mesh-list
138400581|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
138400582|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
138400583|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138400584|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138400585|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400586|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400587|NCT01548950|Urological Agents|urological agents|mesh-ancestor
138400588|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400589|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138400590|NCT01549093|Carboplatin|carboplatin|mesh-list
138400591|NCT01549093|Gemcitabine|gemcitabine|mesh-list
138400592|NCT01549093|Endostar protein|endostar protein|mesh-list
138400593|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400594|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138400595|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
138400596|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400597|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400599|NCT01549093|Growth Substances|growth substances|mesh-ancestor
138400600|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400601|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400602|NCT01549158|Torsemide|torsemide|mesh-list
138400603|NCT01549158|Furosemide|furosemide|mesh-list
138400604|NCT01549158|Diuretics|diuretics|mesh-ancestor
138400605|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
138400606|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400607|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138400608|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400609|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400610|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400611|NCT01549171|Iloprost|iloprost|mesh-list
138400612|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138400613|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365064|NCT01389778|Metformin|metformin|mesh-list
138365065|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400614|NCT01549236|Benzonidazole|benzonidazole|mesh-list
138400615|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400616|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
138400617|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400618|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138400619|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400620|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138400621|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400622|NCT01549301|Lenograstim|lenograstim|mesh-list
138400623|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138400624|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
138400625|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400626|NCT01549418|Aspirin|aspirin|mesh-list
138400627|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138400628|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400629|NCT01549418|Analgesics|analgesics|mesh-ancestor
138400630|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
138400631|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400632|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400633|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400634|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400635|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138400636|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138400637|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400638|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138400639|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138400640|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400641|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
138400642|NCT01549431|Dexamethasone|dexamethasone|mesh-list
138400643|NCT01549431|Panobinostat|panobinostat|mesh-list
138400644|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400645|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
138400646|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
138400647|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400648|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400649|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400650|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
138400651|NCT01549431|Hormones|hormones|mesh-ancestor
138400652|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400653|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138400654|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400657|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400658|NCT01549496|Amlodipine|amlodipine|mesh-list
138400659|NCT01549496|Diltiazem|diltiazem|mesh-list
138400660|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400661|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138400662|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400663|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400664|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400665|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400666|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138400667|NCT01549548|Ponatinib|ponatinib|mesh-list
138400668|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400669|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400670|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400671|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400672|NCT01549574|Crizotinib|crizotinib|mesh-list
138400673|NCT01549574|Esomeprazole|esomeprazole|mesh-list
138400674|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138400675|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400676|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138400677|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400678|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400679|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400680|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400681|NCT01549600|Psyllium|psyllium|mesh-list
138400683|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400684|NCT01549691|Alprazolam|alprazolam|mesh-list
138400685|NCT01549691|Zopiclone|zopiclone|mesh-list
138400686|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400687|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400688|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400689|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138400690|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138400691|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400692|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
138400693|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
138400694|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400695|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400696|NCT01549704|Ropivacaine|ropivacaine|mesh-list
138400697|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
138400698|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
138400699|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400700|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400701|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
138400702|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400703|NCT01549743|Celecoxib|celecoxib|mesh-list
138400704|NCT01549743|Rebamipide|rebamipide|mesh-list
138400705|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138400706|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400707|NCT01549743|Analgesics|analgesics|mesh-ancestor
138400708|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
138400709|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400710|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400712|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400713|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138400714|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138400715|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400716|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400717|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138400718|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400719|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
138400720|NCT01549743|Protective Agents|protective agents|mesh-ancestor
138400721|NCT01549795|Capecitabine|capecitabine|mesh-list
138400722|NCT01549795|Liver Extracts|liver extracts|mesh-list
138400723|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138400724|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
138400725|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400726|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400727|NCT01549795|Hematinics|hematinics|mesh-ancestor
138400729|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138400730|NCT01549847|Protective Agents|protective agents|mesh-ancestor
138400731|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400732|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
138400733|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
138400734|NCT01549938|Vitamin D|vitamin d|mesh-list
138400735|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400736|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400737|NCT01549938|Vitamins|vitamins|mesh-ancestor
138400738|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
138400739|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138400740|NCT01549990|Sevoflurane|sevoflurane|mesh-list
138400741|NCT01549990|Desflurane|desflurane|mesh-list
138400742|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138400743|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138365078|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400744|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
138400745|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
138400746|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365081|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
138400747|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400749|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138400750|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138400751|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400752|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400753|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400754|NCT01550107|Allopurinol|allopurinol|mesh-list
138400755|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
138400756|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400757|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400758|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
138400759|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400760|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138400761|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
138400762|NCT01550107|Protective Agents|protective agents|mesh-ancestor
138400763|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400764|NCT01550146|Dexamethasone|dexamethasone|mesh-list
138400765|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
138400766|NCT01550146|BB 1101|bb 1101|mesh-list
138400767|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400768|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
138400769|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
138400770|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400771|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400772|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400773|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
138400774|NCT01550146|Hormones|hormones|mesh-ancestor
138400775|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400776|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138400779|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400780|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400781|NCT01550302|Bupivacaine|bupivacaine|mesh-list
138400782|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
138400783|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
138400784|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400785|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400786|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
138400787|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400789|NCT01550354|Propofol|propofol|mesh-list
138400790|NCT01550354|Rocuronium|rocuronium|mesh-list
138400791|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400792|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400793|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400794|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400795|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
138400796|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
138400797|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138400798|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138400799|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138400800|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400801|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400802|NCT01550354|Narcotics|narcotics|mesh-ancestor
138400803|NCT01550354|Analgesics|analgesics|mesh-ancestor
138400804|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
138400805|NCT01550419|Atorvastatin|atorvastatin|mesh-list
138400806|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138400807|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138400808|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
138400809|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400810|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400811|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138400812|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400813|NCT01550445|Prednisolone|prednisolone|mesh-list
138400814|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400815|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
138400816|NCT01550445|Hormones|hormones|mesh-ancestor
138400817|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400818|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400819|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138400820|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400822|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400823|NCT01550640|Narcotics|narcotics|mesh-ancestor
138400824|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400825|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400827|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
138400828|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400832|NCT01550653|Incretins|incretins|mesh-ancestor
138400834|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400836|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400837|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400838|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400839|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400840|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
138400841|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
138400842|NCT01550848|Gemcitabine|gemcitabine|mesh-list
138400843|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138400844|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138400845|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
138400846|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400847|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400848|NCT01550900|Metformin|metformin|mesh-list
138400849|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400850|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400851|NCT01550926|Orlistat|orlistat|mesh-list
138400852|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400853|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400854|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138400855|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138400856|NCT01551004|REP 3123|rep 3123|mesh-list
138400857|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138400858|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400859|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
138400860|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
138400861|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138400862|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138400863|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400864|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400865|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400866|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400867|NCT01550458|Mibefradil|mibefradil|mesh-list
138400868|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400869|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138400870|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400871|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400872|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400873|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400874|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
138400875|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138400876|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138400877|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400878|NCT01551147|Montelukast|montelukast|mesh-list
138400879|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138400880|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
138400881|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138400882|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
138400883|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400884|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400885|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138400886|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138400887|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400888|NCT01551225|Escitalopram|escitalopram|mesh-list
138400889|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138400890|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138400891|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400892|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400893|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400895|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400897|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138400898|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138400899|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
138400900|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400901|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138400902|NCT01551329|Ketamine|ketamine|mesh-list
138400903|NCT01551329|Analgesics|analgesics|mesh-ancestor
138400904|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
138400905|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400906|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400907|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138400908|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138400909|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
138400910|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
138400911|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400912|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138400913|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138400914|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400915|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400916|NCT01551368|Nimodipine|nimodipine|mesh-list
138400917|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138400918|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138400919|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138400920|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400921|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138400922|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400923|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
138400924|NCT01551394|Gentamicins|gentamicins|mesh-list
138400925|NCT01551394|Meropenem|meropenem|mesh-list
138400926|NCT01551394|Ampicillin|ampicillin|mesh-list
138400927|NCT01551394|Cefotaxime|cefotaxime|mesh-list
138400928|NCT01551394|Cefoxitin|cefoxitin|mesh-list
138400929|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138400930|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400931|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138400932|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400933|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400934|NCT01551459|Sunitinib|sunitinib|mesh-list
138400935|NCT01551459|Dacarbazine|dacarbazine|mesh-list
138400936|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400937|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400938|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138400939|NCT01551459|Growth Substances|growth substances|mesh-ancestor
138400940|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400941|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400942|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138400943|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400944|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400946|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
138400947|NCT01551485|Zolpidem|zolpidem|mesh-list
138400948|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138400949|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138400950|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400951|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400952|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138400953|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
138400954|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
138400955|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400956|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400957|NCT01551511|Dronabinol|dronabinol|mesh-list
138400958|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
138400959|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400960|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400961|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138400962|NCT01551511|Analgesics|analgesics|mesh-ancestor
138400963|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
138400964|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400965|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138400966|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138400967|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400968|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400969|NCT01551511|Hormones|hormones|mesh-ancestor
138400970|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400971|NCT01551589|Docetaxel|docetaxel|mesh-list
138400972|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400973|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138400974|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138400975|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138400976|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400977|NCT01551615|Metformin|metformin|mesh-list
138400978|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400979|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400980|NCT01551628|BCT-100|bct-100|mesh-list
138400981|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400982|NCT01551641|Thalidomide|thalidomide|mesh-list
138400983|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400984|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
138400985|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400986|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
138400987|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138400988|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138400989|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138400990|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138400991|NCT01551641|Growth Substances|growth substances|mesh-ancestor
138400992|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
138400993|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400994|NCT01551667|Antibodies|antibodies|mesh-list
138400995|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
138400996|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400997|NCT01551680|Iniparib|iniparib|mesh-list
138400998|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138400999|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401005|NCT01551719|Daptomycin|daptomycin|mesh-list
138401006|NCT01551719|Penicillins|penicillins|mesh-list
138401007|NCT01551719|Tigecycline|tigecycline|mesh-list
138401008|NCT01551719|Cephalosporins|cephalosporins|mesh-list
138401009|NCT01551719|Teicoplanin|teicoplanin|mesh-list
138401011|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138401012|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401013|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401014|NCT01551797|Acetaminophen|acetaminophen|mesh-list
138401015|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401016|NCT01551797|Analgesics|analgesics|mesh-ancestor
138401017|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
138401018|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401019|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401020|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
138401021|NCT01551836|Acetaminophen|acetaminophen|mesh-list
138401022|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401023|NCT01551836|Analgesics|analgesics|mesh-ancestor
138401024|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
138401025|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401026|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401027|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
138401028|NCT01552005|Saxagliptin|saxagliptin|mesh-list
138401029|NCT01552005|Incretins|incretins|mesh-ancestor
138401030|NCT01552005|Hormones|hormones|mesh-ancestor
138401031|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401032|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401033|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138401034|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401035|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401036|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365099|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365102|NCT01390012|Dexamethasone|dexamethasone|mesh-list
138401037|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138401038|NCT01552018|Saxagliptin|saxagliptin|mesh-list
138401039|NCT01552018|Incretins|incretins|mesh-ancestor
138401040|NCT01552018|Hormones|hormones|mesh-ancestor
138401041|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401042|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401043|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138401044|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401045|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401046|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401047|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138401048|NCT01552044|Spironolactone|spironolactone|mesh-list
138401049|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138401050|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401051|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401053|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138401054|NCT01552044|Diuretics|diuretics|mesh-ancestor
138401055|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
138401059|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
138401061|NCT01552122|Vitamins|vitamins|mesh-ancestor
138401062|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
138401063|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401064|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138401065|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138401066|NCT01552122|Antacids|antacids|mesh-ancestor
138401067|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401068|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401069|NCT01552148|Morphine|morphine|mesh-list
138401070|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138401071|NCT01552148|Narcotics|narcotics|mesh-ancestor
138401072|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401073|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401074|NCT01552148|Analgesics|analgesics|mesh-ancestor
138401075|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
138401076|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401077|NCT01552187|Colchicine|colchicine|mesh-list
138401078|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
138401079|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401080|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
138401081|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
138401082|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
138401083|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401086|NCT01552330|Primaquine|primaquine|mesh-list
138401087|NCT01552330|Pyronaridine|pyronaridine|mesh-list
138401088|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138401089|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
138401090|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138401091|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138401092|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401093|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401094|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
138401095|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
138401096|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138401097|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
138401098|NCT01552629|Cyclosporine|cyclosporine|mesh-list
138401099|NCT01552629|Cyclosporins|cyclosporins|mesh-list
138401100|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401101|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401102|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138401103|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
138401104|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401105|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
138401106|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401107|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138401108|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401109|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138401110|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
138401111|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401112|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401113|NCT01552798|Aspirin|aspirin|mesh-list
138401114|NCT01552798|Acetaminophen|acetaminophen|mesh-list
138401115|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401116|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401117|NCT01552798|Analgesics|analgesics|mesh-ancestor
138401118|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
138401119|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401120|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401121|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401122|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401125|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401126|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138401127|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138401128|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401129|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
138401130|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138401131|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
138401132|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138401133|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138401134|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138401135|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401136|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401138|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138401140|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401141|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401142|NCT01552850|Analgesics|analgesics|mesh-ancestor
138401143|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
138401144|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401146|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138401147|NCT01552863|Narcotics|narcotics|mesh-ancestor
138401148|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401149|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401150|NCT01552863|Analgesics|analgesics|mesh-ancestor
138401151|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
138401152|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401153|NCT01552967|Capecitabine|capecitabine|mesh-list
138401154|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401155|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
138401156|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401157|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401158|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
138401159|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401160|NCT01552993|Acetaminophen|acetaminophen|mesh-list
138401161|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401162|NCT01552993|Analgesics|analgesics|mesh-ancestor
138401163|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
138401164|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401165|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401166|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
138401167|NCT01553006|Cefditoren|cefditoren|mesh-list
138401168|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
138401169|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401170|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401171|NCT01553019|Gemcitabine|gemcitabine|mesh-list
138401172|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401173|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
138401174|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401175|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401176|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
138401177|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138401178|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
138401179|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138401180|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401181|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138401182|NCT01553357|Dexamethasone|dexamethasone|mesh-list
138401183|NCT01553357|Lenalidomide|lenalidomide|mesh-list
138401184|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401185|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
138401186|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
138401187|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401188|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401189|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401192|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401193|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138401194|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401195|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
138401196|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401197|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401198|NCT01553357|Growth Substances|growth substances|mesh-ancestor
138401199|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401201|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
138401202|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138401203|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138401204|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138401205|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401206|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401207|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401208|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138401209|NCT01553500|Cathartics|cathartics|mesh-ancestor
138401210|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401211|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138401212|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
138401213|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
138401214|NCT01553721|Udenafil|udenafil|mesh-list
138401215|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138401216|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138401217|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401218|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401219|NCT01553773|Estradiol|estradiol|mesh-list
138401220|NCT01553773|Estrogens|estrogens|mesh-ancestor
138401221|NCT01553773|Hormones|hormones|mesh-ancestor
138401222|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401223|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401224|NCT01553786|Lenalidomide|lenalidomide|mesh-list
138401225|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
138401226|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401227|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401228|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401229|NCT01553786|Growth Substances|growth substances|mesh-ancestor
138401230|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401231|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401232|NCT01553903|Tamoxifen|tamoxifen|mesh-list
138401233|NCT01553903|Letrozole|letrozole|mesh-list
138401234|NCT01553903|Anastrozole|anastrozole|mesh-list
138401235|NCT01553903|Exemestane|exemestane|mesh-list
138401236|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401237|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138401238|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138401239|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401240|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401241|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138401242|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401243|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401244|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401245|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138401246|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138401249|NCT01553942|Pemetrexed|pemetrexed|mesh-list
138401252|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401253|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401254|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138401255|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138401256|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138401257|NCT01553981|Tadalafil|tadalafil|mesh-list
138401258|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
138401259|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138401260|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138401261|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401262|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401263|NCT01553981|Urological Agents|urological agents|mesh-ancestor
138401264|NCT01554059|Bevacizumab|bevacizumab|mesh-list
138401265|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
138401266|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138401267|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401268|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401269|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401270|NCT01554059|Growth Substances|growth substances|mesh-ancestor
138401271|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401272|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401273|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
138401274|NCT01554111|Cathartics|cathartics|mesh-ancestor
138401275|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401276|NCT01554124|Meropenem|meropenem|mesh-list
138401277|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401278|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401279|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138401280|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138401281|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138401282|NCT01554345|Vitamin E|vitamin e|mesh-list
138401283|NCT01554345|Selenium|selenium|mesh-list
138401284|NCT01554345|Vitamins|vitamins|mesh-ancestor
138401285|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
138401286|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401288|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401289|NCT01554345|Protective Agents|protective agents|mesh-ancestor
138401290|NCT01554345|Trace Elements|trace elements|mesh-ancestor
138401292|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401293|NCT01554540|Treprostinil|treprostinil|mesh-list
138401294|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138401295|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138401296|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138401297|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138401298|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
138401299|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401300|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401301|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138401302|NCT01554631|Acarbose|acarbose|mesh-list
138401303|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138401304|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401305|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401306|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138401307|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401308|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138401309|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138401311|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
138401313|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
138401314|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401316|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
138401317|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401319|NCT01554852|Dexamethasone|dexamethasone|mesh-list
138401320|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
138401321|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
138401323|NCT01554852|Lenalidomide|lenalidomide|mesh-list
138401324|NCT01554852|Bortezomib|bortezomib|mesh-list
138401325|NCT01554852|Vorinostat|vorinostat|mesh-list
138401326|NCT01554852|BB 1101|bb 1101|mesh-list
138401327|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138401328|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
138401329|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401330|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401331|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138401332|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
138401333|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401334|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401335|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138401336|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401337|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
138401338|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
138401339|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401340|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401341|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
138401342|NCT01554852|Hormones|hormones|mesh-ancestor
138401343|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401344|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138401345|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401346|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401347|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401348|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401349|NCT01554852|Growth Substances|growth substances|mesh-ancestor
138401350|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401351|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
138401352|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401353|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401354|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138401355|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
138401356|NCT01554930|Mannitol|mannitol|mesh-list
138401357|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
138401358|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401359|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
138401360|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
138401361|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401362|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401363|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401364|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
138401365|NCT01554930|Hormones|hormones|mesh-ancestor
138401366|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401367|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138401368|NCT01554930|Protective Agents|protective agents|mesh-ancestor
138401370|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138401372|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
138401374|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401376|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401377|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401378|NCT01554995|Linezolid|linezolid|mesh-list
138401379|NCT01554995|Delpazolid|delpazolid|mesh-list
138401380|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401381|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401382|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138401383|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401384|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401385|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138401386|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138401387|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401389|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401390|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
138401391|NCT01555060|Hematinics|hematinics|mesh-ancestor
138401393|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401394|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138401395|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
138401396|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401397|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401398|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138401399|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
138401400|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
138401401|NCT01555099|Hormones|hormones|mesh-ancestor
138401402|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401403|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138401404|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138401405|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
138401406|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401407|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401408|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138401409|NCT01555112|Protective Agents|protective agents|mesh-ancestor
138401410|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138401411|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138401412|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401413|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401414|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
138401415|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401416|NCT01555190|Folic Acid|folic acid|mesh-list
138401417|NCT01555190|Inositol|inositol|mesh-list
138401418|NCT01555190|Hematinics|hematinics|mesh-ancestor
138401419|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
138401420|NCT01555190|Vitamins|vitamins|mesh-ancestor
138401421|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
138401422|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401423|NCT01555216|Ropivacaine|ropivacaine|mesh-list
138401425|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
138401426|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401427|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401428|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
138401429|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401430|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
138401431|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138401432|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138401433|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
138401434|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401435|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138401437|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401438|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401439|NCT01555476|Analgesics|analgesics|mesh-ancestor
138401440|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
138401441|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401442|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401443|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401444|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401445|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138401446|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401447|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401448|NCT01555580|Molgramostim|molgramostim|mesh-list
138401449|NCT01555580|Sargramostim|sargramostim|mesh-list
138401450|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
138401452|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401454|NCT01555658|Bivalirudin|bivalirudin|mesh-list
138401455|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
138401456|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138401457|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138401458|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401459|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
138401460|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138401461|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401462|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401463|NCT01555710|Carboplatin|carboplatin|mesh-list
138401464|NCT01555710|Etoposide|etoposide|mesh-list
138401465|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
138401466|NCT01555710|Ifosfamide|ifosfamide|mesh-list
138401467|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401468|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138401469|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138401470|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138401471|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401472|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401473|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138401474|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
138401475|NCT01555788|Pancrelipase|pancrelipase|mesh-list
138401477|NCT01555814|Amisulpride|amisulpride|mesh-list
138401478|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138401479|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138401480|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401481|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401482|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138401483|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138401487|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138401488|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
138401489|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138401490|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365133|NCT01390324|Naratriptan|naratriptan|mesh-list
138365134|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401491|NCT01555866|Isavuconazole|isavuconazole|mesh-list
138401492|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
138401493|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401494|NCT01555879|Abatacept|abatacept|mesh-list
138401495|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138401496|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401497|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138401498|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401499|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138401500|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
138401501|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401502|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401503|NCT01555918|Isavuconazole|isavuconazole|mesh-list
138401504|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
138401505|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401506|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
138401507|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138401508|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
138401509|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401510|NCT01555970|Expectorants|expectorants|mesh-ancestor
138401511|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
138401512|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138401513|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
138401514|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401515|NCT01555970|Protective Agents|protective agents|mesh-ancestor
138401516|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401517|NCT01555970|Antidotes|antidotes|mesh-ancestor
138401518|NCT01556035|Lenalidomide|lenalidomide|mesh-list
138401519|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
138401520|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401521|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401522|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401523|NCT01556035|Growth Substances|growth substances|mesh-ancestor
138401524|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401525|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401526|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138401527|NCT01556191|Fulvestrant|fulvestrant|mesh-list
138401528|NCT01556191|Gefitinib|gefitinib|mesh-list
138401529|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401530|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138401531|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401532|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401533|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138401535|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138401536|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401537|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401538|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401539|NCT01556321|Caffeine|caffeine|mesh-list
138401540|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138401541|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401542|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138401543|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401544|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401545|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138401546|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138401547|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
138401548|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401550|NCT01556334|Erythromycin|erythromycin|mesh-list
138401551|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
138401552|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138401553|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
138401554|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401555|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401556|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401557|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138401558|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401559|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401560|NCT01556477|Lenalidomide|lenalidomide|mesh-list
138401561|NCT01556477|Azacitidine|azacitidine|mesh-list
138401562|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
138401563|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401564|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401565|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401566|NCT01556477|Growth Substances|growth substances|mesh-ancestor
138401567|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401568|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401569|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401570|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
138401571|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401572|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401573|NCT01556529|Unithiol|unithiol|mesh-list
138401574|NCT01556529|Antidotes|antidotes|mesh-ancestor
138401575|NCT01556529|Protective Agents|protective agents|mesh-ancestor
138401576|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401577|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
138401578|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
138401579|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401580|NCT01556542|Paclitaxel|paclitaxel|mesh-list
138401581|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138401582|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401583|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138401584|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138401585|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138401586|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401588|NCT05847660|Progesterone|progesterone|mesh-list
138401589|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
138401590|NCT05847660|Progestins|progestins|mesh-ancestor
138401591|NCT05847660|Hormones|hormones|mesh-ancestor
138401592|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401594|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138401595|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
138401596|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138401597|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401598|NCT05847413|Verapamil|verapamil|mesh-list
138401599|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138401602|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401603|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138401604|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401606|NCT05847257|Ubiquinone|ubiquinone|mesh-list
138401607|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
138401608|NCT05847257|Letrozole|letrozole|mesh-list
138401609|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401610|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138401611|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138401612|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401613|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401614|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138401615|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401616|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401617|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401618|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
138401619|NCT05847257|Vitamins|vitamins|mesh-ancestor
138401620|NCT05847205|Hirudins|hirudins|mesh-list
138401621|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
138401622|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138401623|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401624|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401625|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401626|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
138365156|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365157|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
138365158|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401627|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138401628|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138401629|NCT05847088|Dexamethasone|dexamethasone|mesh-list
138401630|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401631|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
138401632|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
138401633|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401634|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401635|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401636|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
138401637|NCT05847088|Hormones|hormones|mesh-ancestor
138401638|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401639|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138401640|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401641|NCT05847049|Nepafenac|nepafenac|mesh-list
138401642|NCT05847049|Aflibercept|aflibercept|mesh-list
138401643|NCT05847049|Eplerenone|eplerenone|mesh-list
138401644|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138401645|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138401646|NCT05847049|Growth Substances|growth substances|mesh-ancestor
138401647|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401648|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401649|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401650|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138401651|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
138401654|NCT05847049|Diuretics|diuretics|mesh-ancestor
138401655|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
138401656|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138401657|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401658|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401659|NCT05847049|Analgesics|analgesics|mesh-ancestor
138401660|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
138401661|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401662|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401663|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401664|NCT05846867|Leucovorin|leucovorin|mesh-list
138401665|NCT05846867|Fluorouracil|fluorouracil|mesh-list
138401666|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
138401667|NCT05846867|Irinotecan|irinotecan|mesh-list
138401668|NCT05846867|Calcium|calcium|mesh-list
138401669|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
138401670|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138401671|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401672|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
138401673|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401674|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401675|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401676|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138401677|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
138401678|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138401679|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138401680|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401681|NCT05846867|Antidotes|antidotes|mesh-ancestor
138401682|NCT05846867|Protective Agents|protective agents|mesh-ancestor
138401683|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
138401684|NCT05846867|Vitamins|vitamins|mesh-ancestor
138401685|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
138401686|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
138401687|NCT05840744|Antithrombins|antithrombins|mesh-list
138401688|NCT05840744|Thrombin|thrombin|mesh-list
138401689|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
138401690|NCT05840744|Coagulants|coagulants|mesh-ancestor
138401691|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138365174|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
138365175|NCT01390506|Trace Elements|trace elements|mesh-ancestor
138401692|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
138401693|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401694|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401695|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
138401696|NCT05840692|Escitalopram|escitalopram|mesh-list
138365176|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
138365178|NCT01390519|Everolimus|everolimus|mesh-list
138401697|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138401698|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138401699|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401700|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401701|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401702|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
138401703|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401704|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
138401705|NCT05840640|Lenograstim|lenograstim|mesh-list
138401706|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138401707|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
138401708|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401709|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138401710|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401712|NCT05840536|Furosemide|furosemide|mesh-list
138401713|NCT05840536|Diuretics|diuretics|mesh-ancestor
138401714|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
138401715|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401716|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138401717|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401718|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401719|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138401720|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138401721|NCT05840406|Acetaminophen|acetaminophen|mesh-list
138401722|NCT05840406|Ibuprofen|ibuprofen|mesh-list
138401723|NCT05840406|Ketoprofen|ketoprofen|mesh-list
138401724|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
138401725|NCT05840406|Tramadol|tramadol|mesh-list
138401726|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
138401727|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138401728|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401729|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401730|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401731|NCT05840406|Analgesics|analgesics|mesh-ancestor
138401732|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
138401733|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401734|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138401735|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138401736|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138401737|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401738|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401739|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401741|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401742|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401743|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401744|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138401745|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401746|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138401748|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401749|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
138401750|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
138401751|NCT05840328|Bupivacaine|bupivacaine|mesh-list
138401752|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401753|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
138401754|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401755|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401756|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
138401757|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401758|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138401759|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138401761|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138401762|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138401764|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401765|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401766|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401767|NCT05840172|Benzocaine|benzocaine|mesh-list
138401768|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401769|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
138401770|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401771|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401772|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
138401773|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401774|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138401775|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138401776|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401777|NCT05839652|Midodrine|midodrine|mesh-list
138401778|NCT05839652|Droxidopa|droxidopa|mesh-list
138401779|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
138401780|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
138401781|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401782|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401783|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138401784|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138401785|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138401786|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138401787|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401788|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401789|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401790|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138401791|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138401792|NCT05839548|Epinephrine|epinephrine|mesh-list
138401793|NCT05839548|Racepinephrine|racepinephrine|mesh-list
138401794|NCT05839548|Carticaine|carticaine|mesh-list
138401795|NCT05839548|Mepivacaine|mepivacaine|mesh-list
138401796|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
138401797|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138401798|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138401799|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401800|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401801|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401802|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401803|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138401804|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138401805|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
138401806|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401807|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138401808|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
138401810|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
138401811|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138401812|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401813|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
138401814|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401815|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
138401817|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
138401818|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
138401819|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138401820|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
138401821|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401822|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138401823|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
138401824|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401825|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138401826|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138401827|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
138401828|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401829|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401830|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138401831|NCT05839236|Atorvastatin|atorvastatin|mesh-list
138401833|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138401834|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401836|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138401838|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401839|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138401840|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138401841|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401843|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401844|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138401845|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401846|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401847|NCT05839054|Methamphetamine|methamphetamine|mesh-list
138401848|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138401849|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401850|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
138401851|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
138401852|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401853|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
138401854|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401855|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401856|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401857|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138401858|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138401859|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401860|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138401861|NCT05838846|Milrinone|milrinone|mesh-list
138401862|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138401863|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138401864|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138401865|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138401866|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138401867|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401868|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401869|NCT05838846|Protective Agents|protective agents|mesh-ancestor
138401870|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401871|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
138401872|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138401873|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
138401874|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138401875|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138401878|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401879|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
138401880|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401881|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401882|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
138401883|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401884|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401885|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401886|NCT05823753|Cannabidiol|cannabidiol|mesh-list
138401887|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
138401888|NCT05813158|Bupivacaine|bupivacaine|mesh-list
138401889|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401890|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
138401891|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401892|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401893|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
138401894|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401895|NCT05805683|Calcitonin|calcitonin|mesh-list
138401896|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
138401897|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138401898|NCT05805683|Katacalcin|katacalcin|mesh-list
138401899|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138401900|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401901|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138401902|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138401903|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
138401904|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138401905|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138401906|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401907|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
138401908|NCT05686005|Coagulants|coagulants|mesh-ancestor
138401909|NCT05585112|Lidocaine|lidocaine|mesh-list
138401910|NCT05585112|Carticaine|carticaine|mesh-list
138401911|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401912|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
138401913|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401914|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401916|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401917|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138401918|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138401919|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138401920|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401921|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401923|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138401924|NCT05552443|Narcotics|narcotics|mesh-ancestor
138401925|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138401926|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401927|NCT05552443|Analgesics|analgesics|mesh-ancestor
138401928|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
138401929|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401930|NCT05527483|Listerine|listerine|mesh-list
138401931|NCT05527483|Fluorides|fluorides|mesh-list
138401932|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
138401933|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
138401934|NCT05527483|Protective Agents|protective agents|mesh-ancestor
138401935|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401936|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138401937|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401938|NCT05527470|Cisplatin|cisplatin|mesh-list
138401941|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138401943|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401944|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138401945|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
138401946|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401947|NCT05439356|Colchicine|colchicine|mesh-list
138401948|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
138401949|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401950|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
138401951|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
138401952|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
138401953|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401954|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401955|NCT05323487|Bumetanide|bumetanide|mesh-list
138401956|NCT05323487|Diuretics|diuretics|mesh-ancestor
138401957|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
138401958|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401959|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138401960|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401961|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401962|NCT05266807|Vancomycin|vancomycin|mesh-list
138401963|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
138401964|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401965|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401966|NCT05254418|Dulaglutide|dulaglutide|mesh-list
138401967|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138401968|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401969|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138401970|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138401971|NCT05095259|Insulin|insulin|mesh-list
138401972|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138401973|NCT05095259|Epinephrine|epinephrine|mesh-list
138401974|NCT05095259|Glucagon|glucagon|mesh-list
138401975|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138401976|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401977|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138401978|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138401979|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
138401980|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401981|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401982|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138401983|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138401984|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
138401985|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401986|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138401987|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138401989|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
138401990|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138401991|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138401992|NCT05095259|Hormones|hormones|mesh-ancestor
138401993|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401994|NCT05049278|Phenylephrine|phenylephrine|mesh-list
138401996|NCT05049278|Norepinephrine|norepinephrine|mesh-list
138401997|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138402000|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402001|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402003|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138402004|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
138402005|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138402006|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138402007|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138402008|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138402009|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402010|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402011|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402012|NCT05049278|Protective Agents|protective agents|mesh-ancestor
138402013|NCT04982354|Fludarabine|fludarabine|mesh-list
138402014|NCT04982354|Melphalan|melphalan|mesh-list
138402015|NCT04982354|Busulfan|busulfan|mesh-list
138402016|NCT04982354|Midostaurin|midostaurin|mesh-list
138402017|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402018|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402019|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402020|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
138402021|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402022|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138402023|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
138402024|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138402025|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402026|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402027|NCT04932382|Misoprostol|misoprostol|mesh-list
138402028|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138402029|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
138402030|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138402031|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402032|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138402033|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402034|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
138402035|NCT04901715|Albuterol|albuterol|mesh-list
138402036|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138402037|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
138402038|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402039|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402040|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138402041|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
138402042|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
138402043|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138402044|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138402045|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138402046|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138402049|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402050|NCT04895592|Dexamethasone|dexamethasone|mesh-list
138402051|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
138402052|NCT04895592|Ichthammol|ichthammol|mesh-list
138402053|NCT04895592|BB 1101|bb 1101|mesh-list
138402054|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402055|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
138402056|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
138402057|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402058|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402059|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402060|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
138402061|NCT04895592|Hormones|hormones|mesh-ancestor
138402062|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402063|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402064|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402065|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
138402066|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402067|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402068|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
138402069|NCT04861103|Enoxaparin|enoxaparin|mesh-list
138402070|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
138402071|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138402072|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138402073|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402074|NCT04843761|Remdesivir|remdesivir|mesh-list
138402075|NCT04843761|Phentolamine|phentolamine|mesh-list
138402076|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138402077|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
138402078|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402079|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
138402081|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138402082|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138402083|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402084|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402085|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402086|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402087|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402088|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
138402089|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138402090|NCT04843761|Protective Agents|protective agents|mesh-ancestor
138402091|NCT04835129|Dexamethasone|dexamethasone|mesh-list
138402092|NCT04835129|Pomalidomide|pomalidomide|mesh-list
138402093|NCT04835129|Elotuzumab|elotuzumab|mesh-list
138402094|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138402095|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402096|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
138402097|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
138402098|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402099|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402100|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402103|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402104|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402105|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402107|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402108|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402109|NCT04835129|Growth Substances|growth substances|mesh-ancestor
138402110|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
138402111|NCT04699604|Levocetirizine|levocetirizine|mesh-list
138402112|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138402113|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138402114|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
138402115|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
138402116|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402117|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402118|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402119|NCT04571164|Rotigotine|rotigotine|mesh-list
138402120|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
138402121|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
138402122|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402123|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402124|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402125|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
138402126|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138402127|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138402128|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402129|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
138402130|NCT04559880|Coagulants|coagulants|mesh-ancestor
138402131|NCT04542369|Carboplatin|carboplatin|mesh-list
138402132|NCT04542369|Etoposide|etoposide|mesh-list
138402133|NCT04542369|Tislelizumab|tislelizumab|mesh-list
138402134|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402135|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138402136|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402137|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138402138|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402139|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402140|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402142|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
138402143|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
138402144|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138402145|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365202|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402146|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402147|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138402148|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138402149|NCT04312503|Olanzapine|olanzapine|mesh-list
138402150|NCT04312503|Risperidone|risperidone|mesh-list
138402151|NCT04312503|Aripiprazole|aripiprazole|mesh-list
138402152|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138402153|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138402154|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138402157|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402158|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402159|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138402160|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138402161|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402162|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402163|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138402164|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
138402165|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
138402166|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
138402167|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402168|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402169|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138402170|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138402171|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402172|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
138402173|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
138402174|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138402175|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138402176|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138402177|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138402178|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138402179|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138402180|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138402181|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402184|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138402185|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402186|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402187|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402188|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402189|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
138402190|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402191|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402192|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402193|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402194|NCT04305444|Growth Substances|growth substances|mesh-ancestor
138402195|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138402196|NCT04297332|Nicotine|nicotine|mesh-list
138402197|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138402198|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
138402199|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402200|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402201|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138402202|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138402203|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
138402204|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365212|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365222|NCT01390883|PENTA|penta|mesh-list
138402205|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402206|NCT04249063|Lidocaine|lidocaine|mesh-list
138402207|NCT04249063|Anesthetics|anesthetics|mesh-list
138402208|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
138402209|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402210|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402211|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
138402212|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402216|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402217|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402219|NCT04239040|Ipilimumab|ipilimumab|mesh-list
138402220|NCT04239040|Vaccines|vaccines|mesh-list
138402221|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
138402222|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402223|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402224|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402225|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402226|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402227|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138402228|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
138402229|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138402230|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138402231|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
138402232|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402233|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402234|NCT04192955|Salicylates|salicylates|mesh-list
138402235|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138402236|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138402237|NCT04192955|Analgesics|analgesics|mesh-ancestor
138402238|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
138402239|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402240|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402241|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402242|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402243|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138402244|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402245|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402246|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138402247|NCT04184869|Belinostat|belinostat|mesh-list
138402248|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138402249|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138402250|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
138402251|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402252|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402254|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138402255|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
138402256|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402257|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402258|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138402260|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402261|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402262|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402263|NCT04175262|Growth Substances|growth substances|mesh-ancestor
138402264|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402265|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138402266|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402267|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402268|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402269|NCT04149899|Timolol|timolol|mesh-list
138402270|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138402271|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138402272|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402273|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402274|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402275|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402276|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138402277|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402278|NCT04137536|Antibodies|antibodies|mesh-list
138402279|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138402280|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
138402281|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402282|NCT04087421|Glycerol|glycerol|mesh-list
138402283|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138402284|NCT04087421|Protective Agents|protective agents|mesh-ancestor
138402285|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402286|NCT04080531|Vaccines|vaccines|mesh-list
138402287|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
138402288|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402289|NCT04014075|Trastuzumab|trastuzumab|mesh-list
138402290|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138402291|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402292|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402293|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
138402294|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
138402295|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402296|NCT04009109|Dexamethasone|dexamethasone|mesh-list
138402297|NCT04009109|Lenalidomide|lenalidomide|mesh-list
138402298|NCT04009109|Daratumumab|daratumumab|mesh-list
138402299|NCT04009109|Ixazomib|ixazomib|mesh-list
138402300|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402301|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
138402302|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
138402303|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402304|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402305|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402306|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
138402307|NCT04009109|Hormones|hormones|mesh-ancestor
138402308|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402309|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402310|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402311|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
138402312|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402314|NCT04009109|Growth Substances|growth substances|mesh-ancestor
138402315|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
138402316|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
138402317|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402318|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402321|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402322|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402323|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138402324|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402325|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402327|NCT03909152|Onapristone|onapristone|mesh-list
138402328|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402329|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402330|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138402331|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138402332|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402333|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402334|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138402335|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
138402336|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402337|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402338|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138402339|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
138402340|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138402341|NCT03778424|Rufinamide|rufinamide|mesh-list
138402342|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
138402343|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138402344|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138402345|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402346|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402347|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
138402348|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
138402349|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
138402350|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402351|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402352|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402353|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402354|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
138402355|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402356|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138402357|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138402358|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402359|NCT03675412|Caffeine|caffeine|mesh-list
138402360|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138402361|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402365|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138402366|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138402367|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
138402368|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402370|NCT03664180|Calcium heparin|calcium heparin|mesh-list
138402372|NCT03664180|Hirudins|hirudins|mesh-list
138402373|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
138402374|NCT03664180|Bivalirudin|bivalirudin|mesh-list
138402375|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
138402376|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138402377|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138402378|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402379|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
138402380|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138402382|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402383|NCT03652870|Dexetimide|dexetimide|mesh-list
138402384|NCT03652870|Citalopram|citalopram|mesh-list
138402385|NCT03652870|Nortriptyline|nortriptyline|mesh-list
138402386|NCT03652870|Escitalopram|escitalopram|mesh-list
138402387|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138402388|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138402389|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402390|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402391|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402392|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
138402393|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402394|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138402395|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138402396|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
138402397|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
138402398|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402399|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138402400|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138402401|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
138402402|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138402403|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
138402404|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402405|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138402406|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138402407|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402408|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
138402409|NCT03634852|Dexamethasone|dexamethasone|mesh-list
138402410|NCT03634852|Triamcinolone|triamcinolone|mesh-list
138402411|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138402412|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138402413|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138402414|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138402415|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138402416|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402417|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
138402418|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
138402419|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402420|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402428|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402429|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402430|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138402431|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402432|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402433|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138402434|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
138402435|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138402436|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138402437|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138402438|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138402439|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138402440|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402441|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
138402443|NCT03593811|Ondansetron|ondansetron|mesh-list
138402444|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
138402446|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402447|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402448|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402449|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
138402450|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138402451|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138402452|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138402453|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
138402454|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402455|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402456|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138402457|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
138402458|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
138402459|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138402461|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138402462|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402463|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138402464|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138402465|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402466|NCT03528902|Tamoxifen|tamoxifen|mesh-list
138402467|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138402468|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
138402469|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402470|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402471|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402472|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402473|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138402474|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138402480|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402481|NCT03495388|Analgesics|analgesics|mesh-ancestor
138402482|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
138402483|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402484|NCT03463408|Nivolumab|nivolumab|mesh-list
138402485|NCT03463408|Ipilimumab|ipilimumab|mesh-list
138402486|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402487|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402488|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402489|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402490|NCT03420144|Hormones|hormones|mesh-list
138402491|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402494|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138402495|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402496|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402497|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
138402498|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402499|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402500|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138402501|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
138402502|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402503|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
138402504|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
138402505|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402506|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402507|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402508|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402510|NCT03344419|Analgesics|analgesics|mesh-ancestor
138402511|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
138402512|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402513|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402514|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138402515|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138402516|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
138402517|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
138402518|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402519|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138402520|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138402521|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402522|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402523|NCT03321526|Norepinephrine|norepinephrine|mesh-list
138402524|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138402525|NCT03321526|Serotonin|serotonin|mesh-list
138402528|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402529|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138402530|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138402531|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402532|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402533|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138402534|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138402535|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402536|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402537|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402538|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
138402539|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
138402540|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402541|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138402543|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
138402544|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138402545|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402546|NCT03297593|Nivolumab|nivolumab|mesh-list
138402547|NCT03297593|Ipilimumab|ipilimumab|mesh-list
138402548|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402549|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402550|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402551|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402552|NCT03217669|Sirolimus|sirolimus|mesh-list
138402553|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138402554|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402555|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138402556|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402557|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
138402558|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402559|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
138402560|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402561|NCT03196427|Vedolizumab|vedolizumab|mesh-list
138402562|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402563|NCT03185819|Midazolam|midazolam|mesh-list
138402564|NCT03185819|Esketamine|esketamine|mesh-list
138402565|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138402566|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138402567|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402568|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402569|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138402570|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138402571|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402572|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138402573|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
138402574|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
138402575|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
138402576|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
138402577|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402578|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402579|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
138402583|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402584|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138402586|NCT03126435|Paclitaxel|paclitaxel|mesh-list
138402587|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138402588|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
138402589|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402590|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402591|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138402592|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138402593|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138402594|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138402595|NCT03119584|Linaclotide|linaclotide|mesh-list
138402596|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138402597|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
138402598|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402599|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402600|NCT03084939|Capecitabine|capecitabine|mesh-list
138402601|NCT03084939|Trastuzumab|trastuzumab|mesh-list
138402602|NCT03084939|Lapatinib|lapatinib|mesh-list
138402603|NCT03084939|Maytansine|maytansine|mesh-list
138402604|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138402605|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138402606|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
138402607|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402608|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402609|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402610|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402611|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402612|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138402613|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
138402614|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
138402615|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
138402616|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
138402617|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
138402618|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
138402619|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402620|NCT03047005|Naltrexone|naltrexone|mesh-list
138402621|NCT03047005|Bupropion|bupropion|mesh-list
138402622|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138402623|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138402624|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402625|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
138402626|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402627|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138402631|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138402632|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402633|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402634|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
138402635|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402636|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138402637|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138402638|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402639|NCT03011684|Tamoxifen|tamoxifen|mesh-list
138402640|NCT03011684|Letrozole|letrozole|mesh-list
138402641|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402642|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138402643|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138402644|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402645|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402646|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138402647|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
138402648|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402649|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365260|NCT01390935|Diuretics|diuretics|mesh-ancestor
138402650|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402651|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138402652|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138402653|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138402654|NCT02968108|Ustekinumab|ustekinumab|mesh-list
138402655|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
138402656|NCT02947347|Rituximab|rituximab|mesh-list
138402657|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402658|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402659|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
138402660|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402661|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402662|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
138402663|NCT02870907|Thiotepa|thiotepa|mesh-list
138402664|NCT02870907|Carboplatin|carboplatin|mesh-list
138402665|NCT02870907|Etoposide|etoposide|mesh-list
138402666|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
138402667|NCT02870907|Vincristine|vincristine|mesh-list
138402668|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402669|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
138402670|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402671|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402672|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138402673|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
138402674|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402675|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402676|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138402677|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138402678|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402682|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138402683|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138402685|NCT02823574|Ipilimumab|ipilimumab|mesh-list
138402686|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402687|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402688|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402689|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402690|NCT02641028|Aticaprant|aticaprant|mesh-list
138402691|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138402692|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402693|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
138402694|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402695|NCT02525796|Eplerenone|eplerenone|mesh-list
138402696|NCT02525796|Amiloride|amiloride|mesh-list
138402697|NCT02525796|Cinacalcet|cinacalcet|mesh-list
138402698|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138402699|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
138402700|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402701|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402702|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138402703|NCT02525796|Diuretics|diuretics|mesh-ancestor
138402704|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
138402705|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402706|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138402707|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138402708|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138402709|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138402710|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402711|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402712|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138402713|NCT02360280|Midazolam|midazolam|mesh-list
138402714|NCT02360280|Ketamine|ketamine|mesh-list
138402715|NCT02360280|Analgesics|analgesics|mesh-ancestor
138402716|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
138402717|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402718|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402719|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138402720|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138402721|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
138402723|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402724|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138402727|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402728|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138402729|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138402730|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138402731|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138402732|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402735|NCT02201251|Topiramate|topiramate|mesh-list
138402736|NCT02201251|Levetiracetam|levetiracetam|mesh-list
138402737|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
138402738|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138402739|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402740|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
138402741|NCT02192021|Doxorubicin|doxorubicin|mesh-list
138402742|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138402743|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138402744|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402745|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402746|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138402747|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402748|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402749|NCT02174575|Sevoflurane|sevoflurane|mesh-list
138402750|NCT02174575|Desflurane|desflurane|mesh-list
138402751|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138402752|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138402753|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
138402754|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
138402755|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402756|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402757|NCT01889810|Vitamin D|vitamin d|mesh-list
138402758|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
138402759|NCT01889810|Vitamins|vitamins|mesh-ancestor
138402760|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
138402761|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402762|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138402763|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138402764|NCT01840592|Doxorubicin|doxorubicin|mesh-list
138402765|NCT01840592|Sorafenib|sorafenib|mesh-list
138402766|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138402767|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402768|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402769|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138402770|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402771|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402772|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402773|NCT01734694|Vancomycin|vancomycin|mesh-list
138402774|NCT01734694|Linezolid|linezolid|mesh-list
138402775|NCT01734694|Daptomycin|daptomycin|mesh-list
138402776|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138402777|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138402781|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365287|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138402783|NCT01599234|Analgesics|analgesics|mesh-ancestor
138402784|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
138402785|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402786|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402787|NCT00716625|Sunitinib|sunitinib|mesh-list
138402788|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402789|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402790|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402791|NCT00716625|Growth Substances|growth substances|mesh-ancestor
138402792|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402793|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
138402794|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402795|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402796|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402797|NCT00713817|Nabiximols|nabiximols|mesh-list
138402798|NCT00713817|Analgesics|analgesics|mesh-ancestor
138402799|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
138402800|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402801|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402802|NCT00713323|Nabiximols|nabiximols|mesh-list
138402803|NCT00713323|Analgesics|analgesics|mesh-ancestor
138402804|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
138402805|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402806|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402807|NCT00713193|Cyclosporine|cyclosporine|mesh-list
138402808|NCT00713193|Prednisone|prednisone|mesh-list
138402809|NCT00713193|Cyclosporins|cyclosporins|mesh-list
138402810|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402811|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
138402812|NCT00713193|Hormones|hormones|mesh-ancestor
138402813|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402814|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402815|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402816|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402817|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402818|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402819|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402820|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
138402821|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
138402822|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402823|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138402824|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402825|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138402826|NCT00710554|Nabiximols|nabiximols|mesh-list
138402827|NCT00710554|Analgesics|analgesics|mesh-ancestor
138402829|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402830|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402831|NCT00710424|Nabiximols|nabiximols|mesh-list
138402832|NCT00710424|Analgesics|analgesics|mesh-ancestor
138402833|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
138402834|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402837|NCT00674609|Analgesics|analgesics|mesh-ancestor
138402838|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
138402839|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402840|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402841|NCT01556646|Tolvaptan|tolvaptan|mesh-list
138402842|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138402843|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402844|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
138402845|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402846|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
138365297|NCT01391156|Finasteride|finasteride|mesh-list
138402847|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
138402848|NCT01556672|Adalimumab|adalimumab|mesh-list
138365298|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402849|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138402850|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402851|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402852|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
138402853|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138402854|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
138402855|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402856|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402857|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138402858|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
138402859|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138402860|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
138402861|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402862|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402863|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138402864|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
138402865|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
138402866|NCT01556698|Protective Agents|protective agents|mesh-ancestor
138402867|NCT01556737|Genistein|genistein|mesh-list
138402868|NCT01556737|Daidzein|daidzein|mesh-list
138402869|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138402870|NCT01556737|Protective Agents|protective agents|mesh-ancestor
138402871|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402872|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402873|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402874|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402875|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402876|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
138402877|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138402878|NCT01556737|Estrogens|estrogens|mesh-ancestor
138402879|NCT01556737|Hormones|hormones|mesh-ancestor
138402880|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402881|NCT01556815|Sorafenib|sorafenib|mesh-list
138402882|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
138402883|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402884|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402885|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402886|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402887|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138402889|NCT01556815|Hormones|hormones|mesh-ancestor
138402892|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402893|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138402894|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402895|NCT01557075|Atorvastatin|atorvastatin|mesh-list
138402896|NCT01557075|Pravastatin|pravastatin|mesh-list
138402897|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138402898|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138402899|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138402900|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
138402901|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402902|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138402904|NCT01557114|Ipilimumab|ipilimumab|mesh-list
138402905|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402906|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402907|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402908|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402909|NCT01557127|Sorafenib|sorafenib|mesh-list
138402910|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402911|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138402912|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402913|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402914|NCT01557140|Carvedilol|carvedilol|mesh-list
138402915|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138365309|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138402916|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138402917|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402918|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402919|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402920|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402921|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402922|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
138402923|NCT01557140|Protective Agents|protective agents|mesh-ancestor
138402924|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138402925|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402926|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138402927|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
138402928|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138402929|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138402931|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402932|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138402933|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138402934|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402935|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138402942|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402943|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
138402944|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402945|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138402946|NCT01557257|Narcotics|narcotics|mesh-ancestor
138402947|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402948|NCT01557257|Analgesics|analgesics|mesh-ancestor
138402949|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
138402950|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138402951|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402952|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402953|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138402954|NCT01557270|Analgesics|analgesics|mesh-ancestor
138402955|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
138402956|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402957|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138402958|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138402959|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138402960|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402961|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402962|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402964|NCT01557335|Omeprazole|omeprazole|mesh-list
138402965|NCT01557335|Clopidogrel|clopidogrel|mesh-list
138402966|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138402967|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138402968|NCT01557335|Analgesics|analgesics|mesh-ancestor
138402970|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402971|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402972|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138402973|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402974|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138402975|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138402976|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402977|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138402978|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138402979|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402981|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138402982|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138402983|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138402984|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
138402985|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138402986|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138402987|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402988|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138402990|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138402991|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402992|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402993|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402994|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138402995|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
138402996|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402997|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138402998|NCT01557439|Levocetirizine|levocetirizine|mesh-list
138402999|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138403000|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138403001|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
138403002|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
138403003|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403004|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403005|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403006|NCT01557478|Melatonin|melatonin|mesh-list
138403007|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
138403008|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403010|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403011|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403012|NCT01557634|Insulin|insulin|mesh-list
138403013|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138403014|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403015|NCT01557647|Treprostinil|treprostinil|mesh-list
138403016|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403017|NCT01557660|Treprostinil|treprostinil|mesh-list
138403018|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403021|NCT01557712|Analgesics|analgesics|mesh-ancestor
138403022|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
138403023|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403024|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403025|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138403026|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138403027|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
138403028|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
138403029|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403030|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138403031|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138403032|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403033|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403034|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138403035|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138403036|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403037|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403038|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
138403039|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403040|NCT01557764|Trastuzumab|trastuzumab|mesh-list
138403042|NCT01557764|Antibodies|antibodies|mesh-list
138403043|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138403044|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
138403045|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403046|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403047|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403048|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138403049|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403050|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403051|NCT01557816|Naproxen|naproxen|mesh-list
138403052|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403053|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403054|NCT01557816|Analgesics|analgesics|mesh-ancestor
138403055|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
138403056|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403057|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403058|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403059|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403060|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
138403061|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138403062|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403063|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403064|NCT01557829|Silicon|silicon|mesh-list
138403065|NCT01557829|Trace Elements|trace elements|mesh-ancestor
138403066|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
138403069|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138403070|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138403071|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403072|NCT01557985|Bupivacaine|bupivacaine|mesh-list
138403073|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
138403074|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
138403075|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403076|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403077|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
138403078|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403079|NCT01558011|Docetaxel|docetaxel|mesh-list
138403080|NCT01558011|Capecitabine|capecitabine|mesh-list
138403081|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
138403082|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403083|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
138403084|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
138403085|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138403086|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403087|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403088|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
138403089|NCT01558167|Rituximab|rituximab|mesh-list
138403090|NCT01558167|Lenalidomide|lenalidomide|mesh-list
138403091|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138403092|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403093|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403094|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
138403095|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403096|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403097|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138403098|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138403100|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138403101|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138403102|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
138403103|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403104|NCT01558193|Vitamins|vitamins|mesh-list
138403105|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
138403106|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
138403107|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403108|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403109|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403110|NCT01558193|Analgesics|analgesics|mesh-ancestor
138403111|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
138403112|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403113|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403116|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
138403117|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403118|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138403119|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138365342|NCT01391403|Artemisinins|artemisinins|mesh-list
138403121|NCT01558245|Coagulants|coagulants|mesh-ancestor
138403122|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138403123|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
138403124|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138403125|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403126|NCT01558310|Ustekinumab|ustekinumab|mesh-list
138403127|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403128|NCT01558336|Praziquantel|praziquantel|mesh-list
138403129|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
138403130|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403131|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403132|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138403133|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403134|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
138403135|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403136|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
138403137|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
138403138|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138403139|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138403140|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403141|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403142|NCT01558466|Urological Agents|urological agents|mesh-ancestor
138403143|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138403144|NCT01558622|Ketoprofen|ketoprofen|mesh-list
138403145|NCT01558622|Meperidine|meperidine|mesh-list
138403146|NCT01558622|Tramadol|tramadol|mesh-list
138403147|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403148|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403149|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138403150|NCT01558622|Narcotics|narcotics|mesh-ancestor
138403151|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403152|NCT01558622|Analgesics|analgesics|mesh-ancestor
138403153|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
138403154|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403155|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403156|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403159|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138403160|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138403161|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403163|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
138403164|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403165|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365353|NCT01391572|Fluorouracil|fluorouracil|mesh-list
138403166|NCT01558713|Fentanyl|fentanyl|mesh-list
138403167|NCT01558713|Bupivacaine|bupivacaine|mesh-list
138403168|NCT01558713|Ropivacaine|ropivacaine|mesh-list
138403169|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
138403170|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
138403171|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
138403172|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403173|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403174|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
138403175|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403176|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138403177|NCT01558713|Narcotics|narcotics|mesh-ancestor
138403178|NCT01558713|Analgesics|analgesics|mesh-ancestor
138403179|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138403180|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138403182|NCT01558830|Ranolazine|ranolazine|mesh-list
138403183|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138403184|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403185|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403186|NCT01558869|Capecitabine|capecitabine|mesh-list
138403187|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
138403188|NCT01558869|Irinotecan|irinotecan|mesh-list
138403189|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403190|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
138403191|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403192|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403193|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138403194|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403195|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403196|NCT01558934|Lofexidine|lofexidine|mesh-list
138403197|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403198|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138403199|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403202|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138403203|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138403205|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403206|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403207|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403208|NCT01558960|Melphalan|melphalan|mesh-list
138403209|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138403210|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
138403211|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403212|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403213|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138403214|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403215|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
138403216|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403217|NCT01558986|Cefazolin|cefazolin|mesh-list
138403218|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403219|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403220|NCT01559025|Vildagliptin|vildagliptin|mesh-list
138403221|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138403222|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138403223|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403224|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
138403225|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403226|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403227|NCT01559051|Anesthetics|anesthetics|mesh-list
138403228|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403229|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403230|NCT01559142|Infliximab|infliximab|mesh-list
138403231|NCT01559142|Azathioprine|azathioprine|mesh-list
138403232|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138403233|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403234|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403235|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403236|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403237|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
138403238|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403239|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403240|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403241|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403242|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
138403243|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403244|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138403245|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138403248|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403250|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138403251|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138403252|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
138403253|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403254|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403255|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138403256|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138403257|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
138403258|NCT01559285|Ropivacaine|ropivacaine|mesh-list
138403259|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
138403260|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
138403261|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403262|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403263|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
138403264|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403265|NCT01559298|Aspirin|aspirin|mesh-list
138403266|NCT01559298|Clopidogrel|clopidogrel|mesh-list
138403267|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403268|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403269|NCT01559298|Analgesics|analgesics|mesh-ancestor
138403270|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
138403272|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403273|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403274|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403275|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138403276|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138403277|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403278|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138403279|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138403280|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403281|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
138403284|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138403286|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403287|NCT01559480|Desogestrel|desogestrel|mesh-list
138403288|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138403289|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138403290|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138403291|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
138403292|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138403293|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403294|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138403295|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138403296|NCT01559480|Progestins|progestins|mesh-ancestor
138403297|NCT01559480|Hormones|hormones|mesh-ancestor
138403298|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403299|NCT01559545|Metronidazole|metronidazole|mesh-list
138403300|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403301|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403302|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138403303|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403304|NCT01559584|Triamcinolone|triamcinolone|mesh-list
138403305|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138403306|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138403307|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138403308|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403309|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
138403310|NCT01559584|Hormones|hormones|mesh-ancestor
138403311|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403312|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403313|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403314|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
138403315|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403316|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403317|NCT01559727|Prednisone|prednisone|mesh-list
138403318|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403319|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
138403321|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403322|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403324|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403326|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
138403327|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
138403328|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403329|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403330|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
138403331|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403332|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138403333|NCT01559753|Amoxicillin|amoxicillin|mesh-list
138403334|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
138403335|NCT01559753|Tobramycin|tobramycin|mesh-list
138403336|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138403337|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
138403343|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138403344|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403345|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403346|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138403347|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
138403349|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138403350|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403351|NCT01559974|Vitamins|vitamins|mesh-ancestor
138403352|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
138403353|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138403354|NCT01560117|Rituximab|rituximab|mesh-list
138403355|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403356|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403357|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
138403358|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403359|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403361|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
138403362|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
138403363|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403364|NCT05570669|Emollients|emollients|mesh-ancestor
138403365|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403366|NCT05570669|Cathartics|cathartics|mesh-ancestor
138403367|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403368|NCT05570383|Antacids|antacids|mesh-list
138403369|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403370|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403371|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
138403372|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403373|NCT05570084|Tamsulosin|tamsulosin|mesh-list
138403374|NCT05570084|Silodosin|silodosin|mesh-list
138403376|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138403377|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138403378|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403379|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403380|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403381|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403382|NCT05570084|Urological Agents|urological agents|mesh-ancestor
138403383|NCT05569668|Paclitaxel|paclitaxel|mesh-list
138403384|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138403388|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138403389|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403390|NCT05569655|Furosemide|furosemide|mesh-list
138403391|NCT05569655|Tolvaptan|tolvaptan|mesh-list
138403392|NCT05569655|Diuretics|diuretics|mesh-ancestor
138403393|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
138365403|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403394|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365404|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
138365405|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138365407|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403395|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138403396|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403397|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403398|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138403399|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138403400|NCT05569590|Propolis|propolis|mesh-list
138403401|NCT05569590|Fluorides|fluorides|mesh-list
138403402|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
138403403|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
138403404|NCT05569590|Protective Agents|protective agents|mesh-ancestor
138403405|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403406|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138403407|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403408|NCT05569577|Estrogens|estrogens|mesh-list
138403409|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
138403410|NCT05569577|Hormones|hormones|mesh-ancestor
138403411|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403412|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403413|NCT05569577|Progestins|progestins|mesh-ancestor
138403414|NCT05569031|Lofexidine|lofexidine|mesh-list
138403415|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138403416|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138403417|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138403418|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403419|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403420|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403421|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403422|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403423|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
138403424|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403425|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403426|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138403427|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
138403428|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403429|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138403430|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138403431|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138403432|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403433|NCT05564741|Norepinephrine|norepinephrine|mesh-list
138403434|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138403435|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138403436|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403437|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403438|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403439|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403440|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
138403441|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
138403442|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403443|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138403444|NCT05522582|Methotrexate|methotrexate|mesh-list
138403445|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138403446|NCT05522582|Antibodies|antibodies|mesh-list
138403447|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138403448|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
138403449|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403450|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138403451|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
138403452|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138403453|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403454|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
138403455|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403456|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403457|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403458|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403459|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138403460|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403463|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403464|NCT05491304|Dexamethasone|dexamethasone|mesh-list
138403465|NCT05491304|Etoposide|etoposide|mesh-list
138403466|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403467|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
138403468|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
138403469|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403470|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403471|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403472|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
138403473|NCT05491304|Hormones|hormones|mesh-ancestor
138403474|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403475|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138403476|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403477|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138403478|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138403479|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403480|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403481|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403483|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138403484|NCT05391555|Narcotics|narcotics|mesh-ancestor
138403485|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403486|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403487|NCT05391555|Analgesics|analgesics|mesh-ancestor
138403488|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
138403489|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403490|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
138403491|NCT05219604|Promethazine|promethazine|mesh-list
138403492|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138403493|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138403494|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403495|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403496|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
138403497|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
138403498|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
138403499|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403500|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
138403501|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
138403502|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403503|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138403504|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
138403505|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
138403506|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403507|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403510|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403512|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403514|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
138403515|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403516|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403517|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403518|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
138403519|NCT05137080|Hormones|hormones|mesh-ancestor
138403520|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403521|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138403522|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403523|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
138403524|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403525|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403526|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138403527|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403528|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403529|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403530|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403531|NCT04713358|Nalmefene|nalmefene|mesh-list
138403532|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138403533|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403534|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
138403535|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403536|NCT04705051|Venglustat|venglustat|mesh-list
138365412|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
138403538|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403539|NCT04696952|Zopiclone|zopiclone|mesh-list
138403540|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138403541|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403542|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403543|NCT04496999|Midostaurin|midostaurin|mesh-list
138403544|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403545|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138403546|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403547|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403548|NCT04298853|Morphine|morphine|mesh-list
138403549|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138403550|NCT04298853|Narcotics|narcotics|mesh-ancestor
138403551|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403552|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403553|NCT04298853|Analgesics|analgesics|mesh-ancestor
138403554|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
138403555|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403556|NCT04232683|Tamsulosin|tamsulosin|mesh-list
138403557|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138403558|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138403559|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138403560|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403561|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403562|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403563|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403564|NCT04232683|Urological Agents|urological agents|mesh-ancestor
138403565|NCT04101227|Ondansetron|ondansetron|mesh-list
138403566|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
138403567|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
138403569|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403570|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403572|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138403573|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138403574|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138403575|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
138403576|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403577|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403579|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403580|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138403581|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138403582|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403583|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365419|NCT01392157|Copper|copper|mesh-list
138365420|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
138365421|NCT01392157|Trace Elements|trace elements|mesh-ancestor
138403584|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403586|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138403587|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403588|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138403589|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138403590|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403591|NCT03813121|Midazolam|midazolam|mesh-list
138403592|NCT03813121|Ketamine|ketamine|mesh-list
138403593|NCT03813121|Analgesics|analgesics|mesh-ancestor
138403594|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
138403595|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403596|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403597|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138403598|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138403599|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
138403600|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
138403601|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403602|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138403603|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138403604|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403605|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403606|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138403607|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138403608|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138403609|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138403610|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403611|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
138403612|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
138403613|NCT03710590|Nicotine|nicotine|mesh-list
138403614|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138403615|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
138403616|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403617|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403618|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138403619|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138403620|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
138403621|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403622|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403625|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
138403626|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403627|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403629|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403630|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138403631|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138403632|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138403633|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403634|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403635|NCT03468335|Irinotecan|irinotecan|mesh-list
138403636|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138403637|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403638|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403639|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403640|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403641|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
138403642|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403643|NCT03205423|Gabapentin|gabapentin|mesh-list
138403644|NCT03205423|Analgesics|analgesics|mesh-ancestor
138403645|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
138403646|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403647|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403648|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
138403649|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138365449|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138403650|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138403651|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403652|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403653|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138403654|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138403655|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403656|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403657|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
138403658|NCT03008369|Lenvatinib|lenvatinib|mesh-list
138403659|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403660|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138403661|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403662|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403663|NCT02918006|Vaccines|vaccines|mesh-list
138403664|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
138403665|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403666|NCT02917772|Nivolumab|nivolumab|mesh-list
138403667|NCT02917772|Ipilimumab|ipilimumab|mesh-list
138403668|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403669|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403670|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138403671|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403672|NCT02909686|Curcumin|curcumin|mesh-list
138403673|NCT02909686|Resveratrol|resveratrol|mesh-list
138403674|NCT02909686|Pycnogenols|pycnogenols|mesh-list
138403675|NCT02909686|Turmeric extract|turmeric extract|mesh-list
138403679|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
138403680|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403681|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403682|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403683|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403684|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403685|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403686|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403687|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
138403688|NCT02909686|Protective Agents|protective agents|mesh-ancestor
138403689|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138403690|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138403691|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
138403692|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138403693|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
138403696|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
138403698|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
138403699|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403700|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403701|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138403702|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403703|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
138403704|NCT02686593|Clofarabine|clofarabine|mesh-list
138403705|NCT02686593|Analgesics|analgesics|mesh-ancestor
138403706|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
138403707|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403708|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403709|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403710|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138403711|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138403712|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403713|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403714|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403715|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
138403716|NCT02583282|Doxycycline|doxycycline|mesh-list
138403717|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403718|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403719|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
138403720|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138403721|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403722|NCT02553941|Azacitidine|azacitidine|mesh-list
138403723|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403724|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
138403725|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403726|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403727|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403731|NCT02546492|Hormones|hormones|mesh-ancestor
138403732|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403733|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403734|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403735|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403736|NCT02527564|Suvorexant|suvorexant|mesh-list
138403737|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138403738|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138403739|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403740|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403741|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138403742|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403743|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403744|NCT02179749|Mifepristone|mifepristone|mesh-list
138403745|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138403746|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
138403747|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138403748|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403749|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138403750|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138403751|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138403752|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
138403753|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138403754|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138403755|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
138403756|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403757|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
138403758|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138403759|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138403760|NCT02065609|Trastuzumab|trastuzumab|mesh-list
138403761|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138403762|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403764|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138403765|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138403766|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
138403767|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
138403768|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403769|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403770|NCT01561482|Metformin|metformin|mesh-list
138403771|NCT01561482|Simvastatin|simvastatin|mesh-list
138403772|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138403773|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403774|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138403775|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138403776|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
138403777|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403778|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138403779|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138403780|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403781|NCT01561586|Cisplatin|cisplatin|mesh-list
138403782|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403783|NCT01562704|Acetaminophen|acetaminophen|mesh-list
138403784|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403785|NCT01562704|Analgesics|analgesics|mesh-ancestor
138403786|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
138403787|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403788|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403789|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
138403790|NCT01564095|Tryptophan|tryptophan|mesh-list
138403791|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138403792|NCT01564095|Tacrolimus|tacrolimus|mesh-list
138403793|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403794|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
138403795|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403796|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138403797|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403798|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403799|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403800|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
138403801|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403802|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
138403803|NCT01564238|Calcium|calcium|mesh-list
138403804|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138403805|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403806|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138403807|NCT01564576|Bromides|bromides|mesh-list
138403808|NCT01564576|Rocuronium|rocuronium|mesh-list
138403809|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
138403810|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138403811|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138403812|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138403813|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403814|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403815|NCT01564823|Metronidazole|metronidazole|mesh-list
138403816|NCT01564823|Adalimumab|adalimumab|mesh-list
138403817|NCT01564823|Azathioprine|azathioprine|mesh-list
138403818|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138403819|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403821|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403822|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403823|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138403826|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403827|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138403828|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403829|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138403830|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
138403831|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403832|NCT01565239|Thrombin|thrombin|mesh-list
138403833|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
138403834|NCT01565239|Coagulants|coagulants|mesh-ancestor
138403835|NCT01565265|Cetrorelix|cetrorelix|mesh-list
138403836|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138403837|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138403838|NCT01565265|Hormones|hormones|mesh-ancestor
138403839|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403840|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403841|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138403842|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
138403843|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138403844|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
138403845|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
138403846|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138403847|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138403848|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138403849|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403850|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403851|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138403852|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403853|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403855|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403856|NCT01566422|Vancomycin|vancomycin|mesh-list
138403857|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138403858|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403859|NCT01566760|Fesoterodine|fesoterodine|mesh-list
138403860|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138403861|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138403862|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
138403863|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403864|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403865|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403866|NCT01566760|Urological Agents|urological agents|mesh-ancestor
138403867|NCT01566890|Regadenoson|regadenoson|mesh-list
138403868|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138403869|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138403870|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
138403871|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
138403872|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403873|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403874|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403876|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403877|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403878|NCT01567072|Analgesics|analgesics|mesh-ancestor
138403879|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
138403880|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403881|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403882|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403883|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403884|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138403885|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403886|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403887|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138403888|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
138403889|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138403890|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403891|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403892|NCT01568632|Imetelstat|imetelstat|mesh-list
138403893|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
138403894|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403895|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403896|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138403897|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
138403898|NCT01568645|Carvedilol|carvedilol|mesh-list
138403899|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403900|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138403901|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403902|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403903|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138403904|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138403905|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
138403906|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403907|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403908|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403909|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
138403910|NCT01568645|Protective Agents|protective agents|mesh-ancestor
138403911|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138403912|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403913|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138403914|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
138403915|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138403916|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138403919|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138403921|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403923|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
138403924|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403925|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403926|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
138403927|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403929|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138403930|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138403931|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403932|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138403933|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138403934|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403935|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403936|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403937|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
138403938|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403939|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138403940|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403941|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138403942|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138403943|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
138403944|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403945|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403946|NCT01570088|Folic Acid|folic acid|mesh-list
138403947|NCT01570088|Hematinics|hematinics|mesh-ancestor
138403948|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
138403949|NCT01570088|Vitamins|vitamins|mesh-ancestor
138403950|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
138403951|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403952|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138403953|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138403954|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
138403955|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403956|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403957|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138403958|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138403959|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
138403960|NCT01570478|Hormones|hormones|mesh-ancestor
138403961|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403962|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
138403963|NCT01570504|Ivermectin|ivermectin|mesh-list
138403964|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403965|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403966|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138403967|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403968|NCT01570569|Losartan|losartan|mesh-list
138403969|NCT01570569|Midazolam|midazolam|mesh-list
138403970|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
138403972|NCT01570569|Omeprazole|omeprazole|mesh-list
138403973|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138403976|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403977|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138403978|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138403979|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403980|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138403981|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
138403983|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
138403984|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
138403985|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403986|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403987|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138403988|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138403989|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138403990|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138403991|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138403992|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138403993|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138403994|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138403995|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138403996|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
138403997|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138403998|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138403999|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138404000|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
138404001|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
138404002|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138404003|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138404004|NCT01570582|Paclitaxel|paclitaxel|mesh-list
138404005|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138404006|NCT01570582|Carboplatin|carboplatin|mesh-list
138404007|NCT01570582|Gemcitabine|gemcitabine|mesh-list
138404008|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138404009|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404010|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138404011|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138404012|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138404013|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404015|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
138404016|NCT01570608|Ranibizumab|ranibizumab|mesh-list
138404017|NCT01570608|Verteporfin|verteporfin|mesh-list
138404022|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
138404023|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404024|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138404025|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138404026|NCT01570660|Pioglitazone|pioglitazone|mesh-list
138404027|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404028|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404029|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
138404030|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404031|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
138404032|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404033|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404034|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138404035|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
138404036|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404037|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404038|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138404040|NCT01570790|Combretastatin|combretastatin|mesh-list
138404041|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138404042|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404043|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138404044|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
138404045|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
138404046|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404047|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138404048|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404049|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404052|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404053|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404054|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138404055|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404056|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404057|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138404058|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138404059|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404060|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404061|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138404062|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404063|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404064|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138404065|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138404066|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404067|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404068|NCT01570985|Triamcinolone|triamcinolone|mesh-list
138404069|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138404070|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138404071|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138404072|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404073|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
138404074|NCT01570985|Hormones|hormones|mesh-ancestor
138404075|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404076|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404077|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404078|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
138404079|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404080|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404081|NCT01571024|Leucovorin|leucovorin|mesh-list
138404082|NCT01571024|Fluorouracil|fluorouracil|mesh-list
138404083|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
138404084|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
138404085|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404086|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138404087|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404088|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404089|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
138404090|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404091|NCT01571024|Antidotes|antidotes|mesh-ancestor
138404092|NCT01571024|Protective Agents|protective agents|mesh-ancestor
138404093|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
138404094|NCT01571024|Vitamins|vitamins|mesh-ancestor
138404095|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
138404096|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
138404097|NCT01571050|Antacids|antacids|mesh-ancestor
138404098|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404099|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404100|NCT01571063|Vitamin D|vitamin d|mesh-list
138404101|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
138404102|NCT01571063|Vitamins|vitamins|mesh-ancestor
138404103|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
138404104|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404105|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138404106|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138404111|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404112|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404113|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404114|NCT01571206|Infliximab|infliximab|mesh-list
138404115|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138404116|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404119|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404120|NCT01571219|Infliximab|infliximab|mesh-list
138404121|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138404122|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404124|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404125|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404126|NCT01571323|Misoprostol|misoprostol|mesh-list
138404127|NCT01571323|Oxytocin|oxytocin|mesh-list
138404128|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
138404129|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138404130|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404131|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138404132|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
138404133|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138404134|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404135|NCT01571414|Ritonavir|ritonavir|mesh-list
138404136|NCT01571414|Lopinavir|lopinavir|mesh-list
138404137|NCT01571414|Efavirenz|efavirenz|mesh-list
138404138|NCT01571414|Rifampin|rifampin|mesh-list
138404139|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138404140|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138404141|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
138404142|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404143|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404144|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404145|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138404146|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
138404147|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404148|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138404149|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404150|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138404151|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138404152|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138404153|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138404154|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138404155|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138404156|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138404157|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138404158|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
138404159|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404160|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
138404161|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138404162|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138404164|NCT01571570|Simeprevir|simeprevir|mesh-list
138404165|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
138404166|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404167|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
138404169|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404171|NCT01571583|Ribavirin|ribavirin|mesh-list
138404172|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
138404173|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
138404174|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138404175|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404176|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
138404177|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404178|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
138404179|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404180|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
138404181|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404182|NCT01571609|Insulin|insulin|mesh-list
138404183|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404184|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404185|NCT01571648|Azacitidine|azacitidine|mesh-list
138404186|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138404187|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
138404188|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404189|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404190|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404191|NCT01571687|Antioxidants|antioxidants|mesh-list
138404192|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404193|NCT01571687|Protective Agents|protective agents|mesh-ancestor
138404194|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404195|NCT01571791|Ketorolac|ketorolac|mesh-list
138404196|NCT01571791|Lidocaine|lidocaine|mesh-list
138404197|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
138404198|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
138404199|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404200|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404201|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
138404202|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404203|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138404204|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138404205|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138404206|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404207|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404208|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138404209|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138404210|NCT01571791|Analgesics|analgesics|mesh-ancestor
138404211|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404212|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404213|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138404214|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404216|NCT01571804|Analgesics|analgesics|mesh-ancestor
138404217|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
138404218|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404219|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404220|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
138404221|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138404222|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404223|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404224|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138404226|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138404227|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404228|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404229|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
138404230|NCT01571856|Astringents|astringents|mesh-ancestor
138404231|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404232|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
138404233|NCT01571882|Policosanol|policosanol|mesh-list
138404234|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138404235|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138404236|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
138404237|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404238|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138365467|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138404239|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404240|NCT01571921|Tocotrienols|tocotrienols|mesh-list
138404242|NCT01571921|Tocopherols|tocopherols|mesh-list
138404243|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
138404244|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404245|NCT01571921|Protective Agents|protective agents|mesh-ancestor
138404246|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404247|NCT01571921|Vitamins|vitamins|mesh-ancestor
138404248|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
138404249|NCT01571960|Vaccines|vaccines|mesh-list
138404250|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
138404251|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404252|NCT01572012|Ondansetron|ondansetron|mesh-list
138404253|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
138404254|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
138404255|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404256|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404257|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404258|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
138404259|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138404260|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138404261|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138404262|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
138404264|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404265|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138404266|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138404268|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404269|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138404270|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404271|NCT01571908|Rocuronium|rocuronium|mesh-list
138404272|NCT01571908|Succinylcholine|succinylcholine|mesh-list
138404273|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138404274|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138404275|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138404277|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404278|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138404279|NCT01572116|Lidocaine|lidocaine|mesh-list
138404280|NCT01572116|Epinephrine|epinephrine|mesh-list
138404281|NCT01572116|Racepinephrine|racepinephrine|mesh-list
138404282|NCT01572116|Sufentanil|sufentanil|mesh-list
138404283|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
138404284|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138404285|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
138404286|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404287|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404288|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
138404289|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404290|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138404291|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138404292|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138404293|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404294|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404295|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138404296|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138404297|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138404298|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404299|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138404300|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138404301|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
138404302|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138404303|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
138404304|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
138404305|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
138404306|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138404308|NCT01572116|Narcotics|narcotics|mesh-ancestor
138404309|NCT01572116|Analgesics|analgesics|mesh-ancestor
138404310|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138404311|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138404312|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
138404313|NCT01572129|Clopidogrel|clopidogrel|mesh-list
138404314|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404315|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138404316|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138404317|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138404318|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
138404319|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404320|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404321|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404322|NCT01572181|Fludarabine|fludarabine|mesh-list
138404324|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
138404325|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404326|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404327|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404328|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
138404329|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404330|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
138404331|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138404332|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138404333|NCT01572259|Hormones|hormones|mesh-list
138404334|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404335|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404336|NCT01572285|Dexamethasone|dexamethasone|mesh-list
138404337|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
138404338|NCT01572285|BB 1101|bb 1101|mesh-list
138404342|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404343|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404344|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404345|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
138404347|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404348|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138404349|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404350|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
138404351|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404352|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404353|NCT01572324|Leucovorin|leucovorin|mesh-list
138404354|NCT01572324|Capecitabine|capecitabine|mesh-list
138404355|NCT01572324|Fluorouracil|fluorouracil|mesh-list
138404356|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
138404357|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138404358|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
138404359|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404360|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404361|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404362|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
138404363|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404364|NCT01572324|Antidotes|antidotes|mesh-ancestor
138404365|NCT01572324|Protective Agents|protective agents|mesh-ancestor
138404366|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
138404368|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
138404369|NCT01572350|Triamcinolone|triamcinolone|mesh-list
138404370|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138404371|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138404372|NCT01572350|Bevacizumab|bevacizumab|mesh-list
138404373|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138404374|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138404375|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404376|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138404377|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138404378|NCT01572350|Growth Substances|growth substances|mesh-ancestor
138404379|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404380|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138404381|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404382|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
138404384|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404385|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404386|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
138404387|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404388|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365500|NCT01392755|Omeprazole|omeprazole|mesh-list
138404389|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
138404390|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365501|NCT01392755|Ranitidine|ranitidine|mesh-list
138365502|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138404391|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138404392|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138404393|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404397|NCT01572454|Remifentanil|remifentanil|mesh-list
138404398|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138404399|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404400|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404401|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138404402|NCT01572454|Analgesics|analgesics|mesh-ancestor
138404403|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
138404405|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138404406|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138404407|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138404408|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138404409|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404410|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404411|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138404412|NCT01572454|Narcotics|narcotics|mesh-ancestor
138404413|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
138404414|NCT01572545|Denosumab|denosumab|mesh-list
138404415|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138404416|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404417|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
138404418|NCT01572558|Meropenem|meropenem|mesh-list
138404419|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404420|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404421|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138404422|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138404423|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404424|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404425|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404426|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138404427|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404428|NCT01572597|Metronidazole|metronidazole|mesh-list
138404429|NCT01572597|Clarithromycin|clarithromycin|mesh-list
138404430|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
138404431|NCT01572597|Rabeprazole|rabeprazole|mesh-list
138404432|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404433|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404434|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138404435|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138404436|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138404437|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404438|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138404439|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404440|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404441|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138404443|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404444|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
138404445|NCT01572597|Expectorants|expectorants|mesh-ancestor
138404446|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138404447|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138404448|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
138404449|NCT01572597|Protective Agents|protective agents|mesh-ancestor
138404450|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404451|NCT01572623|Clopidogrel|clopidogrel|mesh-list
138404452|NCT01572623|Atorvastatin|atorvastatin|mesh-list
138404453|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138404454|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138404455|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
138404456|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404457|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138404458|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138404459|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404460|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404461|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138365508|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404462|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138404463|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138404464|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
138404465|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404466|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404467|NCT01572649|Lixisenatide|lixisenatide|mesh-list
138404468|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404469|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404470|NCT01572688|Melphalan|melphalan|mesh-list
138404471|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138404472|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
138404473|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404474|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404475|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138404476|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404477|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
138404478|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404479|NCT01572805|Melatonin|melatonin|mesh-list
138404480|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
138404481|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404482|NCT01572805|Protective Agents|protective agents|mesh-ancestor
138404483|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404484|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404485|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
138404486|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
138404488|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404489|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
138404490|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138404492|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
138404493|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404494|NCT01572961|Aspirin|aspirin|mesh-list
138404495|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138404498|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
138404499|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404500|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404501|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404502|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404503|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138404504|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138404505|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404506|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404507|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138404508|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404509|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
138404510|NCT01573013|Iron|iron|mesh-list
138404511|NCT01573013|Trace Elements|trace elements|mesh-ancestor
138404512|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
138404513|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404514|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138404515|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138404516|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138404517|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
138404518|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404519|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138404520|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138404521|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404523|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138404524|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404525|NCT01573286|Hormones|hormones|mesh-ancestor
138404526|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404527|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404528|NCT01573286|Incretins|incretins|mesh-ancestor
138404529|NCT01573338|Carboplatin|carboplatin|mesh-list
138404530|NCT01573338|Etoposide|etoposide|mesh-list
138404531|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404532|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138404535|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404536|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404538|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
138404540|NCT01573377|Cyproterone|cyproterone|mesh-list
138404541|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404542|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404543|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138404544|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138404545|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138404546|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
138404547|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138404548|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138404549|NCT01573377|Estrogens|estrogens|mesh-ancestor
138404550|NCT01573377|Hormones|hormones|mesh-ancestor
138404551|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404552|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
138404553|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
138404554|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404555|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138404556|NCT01573468|Capecitabine|capecitabine|mesh-list
138404557|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138404558|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
138404559|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404560|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404561|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138404562|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404563|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404564|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138404565|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138404566|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404567|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404568|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404569|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
138404570|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404571|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138404572|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138404573|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138404574|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138404575|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
138404576|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404577|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404578|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138404579|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138404580|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138404583|NCT01573663|Expectorants|expectorants|mesh-ancestor
138404584|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
138404585|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
138404586|NCT01573715|Cisatracurium|cisatracurium|mesh-list
138404587|NCT01573715|Atracurium|atracurium|mesh-list
138404588|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138404589|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138404591|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404592|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138404594|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138404595|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
138404596|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404597|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404598|NCT01573741|Ketamine|ketamine|mesh-list
138404599|NCT01573741|Analgesics|analgesics|mesh-ancestor
138404600|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
138404601|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404602|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404603|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138404604|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138404605|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
138404606|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
138404607|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404608|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138404609|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138404610|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404611|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404613|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404614|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404615|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138404616|NCT01573806|Incretins|incretins|mesh-ancestor
138404617|NCT01573806|Hormones|hormones|mesh-ancestor
138404618|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404620|NCT01573975|Rabeprazole|rabeprazole|mesh-list
138404621|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138404622|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404623|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138404624|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404625|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404626|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404627|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404628|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138404629|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138404630|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404631|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
138404632|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404636|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
138404637|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404638|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138404639|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138404640|NCT01574092|Irinotecan|irinotecan|mesh-list
138404641|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404642|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138404643|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138404644|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404645|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404646|NCT01574131|Fenofibrate|fenofibrate|mesh-list
138404647|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138404648|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
138404649|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404650|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138404652|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
138404653|NCT01574261|Vitamins|vitamins|mesh-ancestor
138404654|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
138404655|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404656|NCT01574313|Tocopherols|tocopherols|mesh-list
138404657|NCT01574313|Vitamin E|vitamin e|mesh-list
138404658|NCT01574313|Tocotrienols|tocotrienols|mesh-list
138404659|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
138404660|NCT01574313|Niacin|niacin|mesh-list
138404661|NCT01574313|Diphenidol|diphenidol|mesh-list
138404662|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
138404663|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404664|NCT01574313|Protective Agents|protective agents|mesh-ancestor
138404665|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404666|NCT01574313|Vitamins|vitamins|mesh-ancestor
138404667|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
138404668|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138404669|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
138404670|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138404671|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
138404672|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
138404673|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
138404675|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404676|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404677|NCT01574508|Insulin|insulin|mesh-list
138404678|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138404679|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404680|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404681|NCT01574638|Rifapentine|rifapentine|mesh-list
138404682|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138404683|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
138404684|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404685|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404686|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
138404687|NCT01574742|Minocycline|minocycline|mesh-list
138404688|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404689|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404690|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
138404691|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404692|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404693|NCT01575158|Citalopram|citalopram|mesh-list
138404694|NCT01575158|Clomipramine|clomipramine|mesh-list
138404695|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138404696|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138404697|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404698|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404699|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404700|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
138404701|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404702|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138404703|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404704|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404705|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138404706|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
138404707|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138404708|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404709|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
138404710|NCT01575301|Liraglutide|liraglutide|mesh-list
138404711|NCT01575301|Exenatide|exenatide|mesh-list
138404712|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404713|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404714|NCT01575301|Incretins|incretins|mesh-ancestor
138404715|NCT01575301|Hormones|hormones|mesh-ancestor
138404716|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404717|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138404718|NCT01575405|Tenofovir|tenofovir|mesh-list
138404719|NCT01575405|Glycerol|glycerol|mesh-list
138404720|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
138404721|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404722|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138404723|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138404724|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404725|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404726|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404727|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138404728|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138404729|NCT01575405|Protective Agents|protective agents|mesh-ancestor
138404730|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404731|NCT01575418|Tenofovir|tenofovir|mesh-list
138404732|NCT01575418|Glycerol|glycerol|mesh-list
138404733|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
138404734|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404735|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138404736|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138404737|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404738|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404739|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404740|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138404741|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138404742|NCT01575418|Protective Agents|protective agents|mesh-ancestor
138404743|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404745|NCT01575483|Incretins|incretins|mesh-ancestor
138404746|NCT01575483|Hormones|hormones|mesh-ancestor
138404747|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404748|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404749|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138404750|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
138404751|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404752|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404753|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404754|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138404755|NCT01575613|Lumefantrine|lumefantrine|mesh-list
138365516|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138404756|NCT01575613|Artemether|artemether|mesh-list
138404757|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138404758|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
138404759|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138404760|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138404761|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404762|NCT01575626|Sevoflurane|sevoflurane|mesh-list
138404763|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404764|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138404765|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
138404766|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
138404767|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404768|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404769|NCT01575639|Prednisolone|prednisolone|mesh-list
138404770|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404771|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
138404772|NCT01575639|Hormones|hormones|mesh-ancestor
138404773|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404774|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404775|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138404776|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404777|NCT01575652|Lisinopril|lisinopril|mesh-list
138404778|NCT01575652|Perindopril|perindopril|mesh-list
138404779|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138404783|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138404784|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138404785|NCT01575652|Protective Agents|protective agents|mesh-ancestor
138404786|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404787|NCT01575678|Melatonin|melatonin|mesh-list
138404789|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404790|NCT01575678|Protective Agents|protective agents|mesh-ancestor
138404791|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404792|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404793|NCT01575717|Vitamin D|vitamin d|mesh-list
138404794|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
138404795|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
138404796|NCT01575717|Vitamins|vitamins|mesh-list
138404797|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
138404798|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404799|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138404800|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138404801|NCT01575782|Chloroquine|chloroquine|mesh-list
138404802|NCT01575782|Amebicides|amebicides|mesh-ancestor
138404803|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138404804|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138404805|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404806|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
138404807|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404808|NCT01575795|Ticagrelor|ticagrelor|mesh-list
138404809|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404810|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138404811|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138404812|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138404813|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
138404814|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404815|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404818|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404819|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
138404820|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
138404821|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
138404824|NCT01576094|Milrinone|milrinone|mesh-list
138404825|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138404826|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
138404827|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138404828|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138404829|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404830|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404831|NCT01576094|Protective Agents|protective agents|mesh-ancestor
138404832|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404833|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138404834|NCT01576185|Sorafenib|sorafenib|mesh-list
138404835|NCT01576185|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138404836|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404837|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138404839|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404840|NCT01576263|Ropivacaine|ropivacaine|mesh-list
138404841|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
138404842|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
138404843|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404844|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404845|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
138404846|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404847|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
138404848|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138404849|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404850|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404851|NCT01576419|Celecoxib|celecoxib|mesh-list
138404852|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138404853|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138404854|NCT01576419|Analgesics|analgesics|mesh-ancestor
138404855|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
138404856|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404857|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404858|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404861|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138404862|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404863|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404864|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138404865|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138404866|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404868|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
138404869|NCT01576627|Trace Elements|trace elements|mesh-ancestor
138404870|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
138404871|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404872|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
138404873|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
138404874|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138404875|NCT01576627|Protective Agents|protective agents|mesh-ancestor
138404876|NCT01576640|Bupropion|bupropion|mesh-list
138404878|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
138404879|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138404880|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138404881|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138404882|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404883|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404884|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
138404885|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404886|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404887|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138404888|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404889|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404890|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138404891|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138404892|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138404893|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404894|NCT01576692|Aldesleukin|aldesleukin|mesh-list
138404895|NCT01576692|Antibodies|antibodies|mesh-list
138404896|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
138365551|NCT01392833|Hormones|hormones|mesh-ancestor
138404897|NCT01576692|Sargramostim|sargramostim|mesh-list
138404898|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
138404899|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404900|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404901|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404902|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138404903|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
138404908|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
138404909|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
138404910|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404911|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138404912|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138404913|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404914|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404915|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138404916|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138404917|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138404918|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138404919|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138404920|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138404921|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138404922|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138404923|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138404925|NCT01576770|Tetracaine|tetracaine|mesh-list
138404926|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
138404927|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
138404928|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
138404929|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404930|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404931|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
138404932|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404933|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138404934|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138404935|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138404936|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404937|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404938|NCT01576848|Caseins|caseins|mesh-list
138404939|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
138404940|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
138404941|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404942|NCT01577017|Letrozole|letrozole|mesh-list
138404943|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138404944|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404945|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138404946|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404947|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404948|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138404949|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
138404950|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404951|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404952|NCT01577043|Racecadotril|racecadotril|mesh-list
138404953|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
138404954|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404956|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404957|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404959|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138404960|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138404961|NCT01577121|Analgesics|analgesics|mesh-ancestor
138404962|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
138404963|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404964|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404965|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404966|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138404967|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
138404968|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
138404969|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138404970|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138404971|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404972|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404973|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
138404974|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404975|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404976|NCT01577199|Clomiphene|clomiphene|mesh-list
138404977|NCT01577199|Enclomiphene|enclomiphene|mesh-list
138404978|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
138404979|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138404980|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
138404981|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138404982|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404983|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138404984|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
138404985|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138404986|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138404987|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138404988|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
138404989|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404990|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138404991|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138404992|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138404993|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404994|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404995|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138404996|NCT01577368|Tazobactam|tazobactam|mesh-list
138404997|NCT01577368|Piperacillin|piperacillin|mesh-list
138404998|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138404999|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405000|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405001|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138405002|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405003|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405004|NCT01577407|Nefopam|nefopam|mesh-list
138405005|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405006|NCT01577407|Analgesics|analgesics|mesh-ancestor
138405007|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
138405008|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405009|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405010|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
138405011|NCT01577459|Tedizolid|tedizolid|mesh-list
138405012|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405013|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405014|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
138405016|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
138405017|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
138405018|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138405019|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405020|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138405021|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
138405022|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405023|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138405024|NCT01577589|Cephalosporins|cephalosporins|mesh-list
138405025|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405026|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405027|NCT01577693|Dutasteride|dutasteride|mesh-list
138405028|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138405029|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138405030|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405031|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405032|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
138405033|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405035|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138405036|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
138405037|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405038|NCT01577849|Vitamin D|vitamin d|mesh-list
138405039|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
138405040|NCT01577849|Vitamins|vitamins|mesh-ancestor
138405041|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
138405042|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405043|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138405044|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405045|NCT01577862|Rifampin|rifampin|mesh-list
138405046|NCT01577862|Colistin|colistin|mesh-list
138405047|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138405048|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
138405049|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405050|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405051|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
138405052|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138405053|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405054|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405055|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138405056|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138405057|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138405058|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138405059|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138405060|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138405061|NCT01577914|Carvedilol|carvedilol|mesh-list
138405062|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138405063|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138405064|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
138405065|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405066|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405070|NCT01577914|Protective Agents|protective agents|mesh-ancestor
138405071|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138405072|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405073|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405074|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
138405075|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138405076|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138405077|NCT01577940|Ropivacaine|ropivacaine|mesh-list
138405078|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
138405079|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
138405080|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405081|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365590|NCT01393080|Cisplatin|cisplatin|mesh-list
138365591|NCT01393080|Paclitaxel|paclitaxel|mesh-list
138405082|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
138405083|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405084|NCT01577992|Levodopa|levodopa|mesh-list
138405085|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138405086|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138405087|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
138405088|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405089|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405090|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405091|NCT01578057|Ethanol|ethanol|mesh-list
138405092|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138405093|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405094|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405095|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405096|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
138405097|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405098|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
138405099|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
138405100|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138405101|NCT01578109|Sorafenib|sorafenib|mesh-list
138405102|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405103|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405104|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405105|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405106|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
138405107|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138405108|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405111|NCT01578161|Analgesics|analgesics|mesh-ancestor
138405112|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
138405113|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405114|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138405115|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138405116|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138405117|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
138405118|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405119|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405120|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
138405121|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138405122|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405123|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405124|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405125|NCT01578174|Analgesics|analgesics|mesh-ancestor
138405126|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
138405127|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405128|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138405129|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138405130|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138405131|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
138405132|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405133|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405134|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
138405135|NCT01578200|Calcium|calcium|mesh-list
138405136|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405137|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405138|NCT01578200|Antacids|antacids|mesh-ancestor
138405139|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405140|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405141|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
138405142|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405143|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405144|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405145|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405146|NCT01578252|Ondansetron|ondansetron|mesh-list
138405147|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
138405148|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
138405149|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365606|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
138405150|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405151|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405152|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
138405153|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
138405154|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138405155|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138405156|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
138405157|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405158|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405163|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405164|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405165|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
138405166|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
138405167|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138405168|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138405169|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
138405170|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405171|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405172|NCT01578304|Fesoterodine|fesoterodine|mesh-list
138405173|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138405174|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138405175|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
138405176|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405177|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405178|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405179|NCT01578304|Urological Agents|urological agents|mesh-ancestor
138405180|NCT01578343|Dexamethasone|dexamethasone|mesh-list
138405181|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
138405182|NCT01578343|Fludarabine|fludarabine|mesh-list
138405183|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
138405184|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
138405185|NCT01578343|Vorinostat|vorinostat|mesh-list
138405187|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405188|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
138405189|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
138405190|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405191|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405192|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405193|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
138405194|NCT01578343|Hormones|hormones|mesh-ancestor
138405195|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405196|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405197|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405198|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
138405199|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405200|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405201|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138405202|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
138405203|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405204|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
138405208|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138405209|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138405210|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
138405211|NCT01578434|Vitamin D|vitamin d|mesh-list
138405212|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
138405213|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
138405214|NCT01578434|Vitamins|vitamins|mesh-list
138405215|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
138405216|NCT01578434|Calcium|calcium|mesh-list
138405217|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
138405218|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405219|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405220|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138405221|NCT01578434|Antacids|antacids|mesh-ancestor
138405222|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405223|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405224|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138405225|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
138365613|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138405226|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138405227|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
138405228|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405229|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405230|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138405231|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138405232|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405233|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405234|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138405235|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138405236|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138405237|NCT01578473|Vitamin D|vitamin d|mesh-list
138405238|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
138405239|NCT01578473|Vitamins|vitamins|mesh-list
138405240|NCT01578473|Vitamin E|vitamin e|mesh-list
138405241|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
138405242|NCT01578473|Testosterone|testosterone|mesh-list
138405243|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
138405244|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
138405245|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138405246|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
138405247|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405248|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138405249|NCT01578473|Androgens|androgens|mesh-ancestor
138405250|NCT01578473|Hormones|hormones|mesh-ancestor
138405251|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405252|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405253|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405256|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405257|NCT01578473|Protective Agents|protective agents|mesh-ancestor
138405258|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405260|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405261|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138405262|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405263|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405264|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405265|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405266|NCT01578603|Calcium|calcium|mesh-list
138405267|NCT01578603|Caseins|caseins|mesh-list
138405268|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138405269|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405270|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
138405271|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
138405272|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405273|NCT01578629|Aspirin|aspirin|mesh-list
138405274|NCT01578629|Vitamin E|vitamin e|mesh-list
138405275|NCT01578629|Tocopherols|tocopherols|mesh-list
138405276|NCT01578629|Tocotrienols|tocotrienols|mesh-list
138405277|NCT01578629|Vitamins|vitamins|mesh-ancestor
138405278|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
138405279|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405280|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138405281|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405282|NCT01578629|Analgesics|analgesics|mesh-ancestor
138405283|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
138405284|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405285|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405286|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405287|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138405288|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138405289|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405290|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138405293|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
138405294|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
138405295|NCT01578629|Protective Agents|protective agents|mesh-ancestor
138405296|NCT01578668|Pemetrexed|pemetrexed|mesh-list
138405297|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138405298|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405299|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405300|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405301|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138405302|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138405303|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405304|NCT01578720|Aflibercept|aflibercept|mesh-list
138405305|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138405306|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138405307|NCT01578720|Growth Substances|growth substances|mesh-ancestor
138405308|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405309|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
138405310|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405311|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
138405312|NCT01578824|Miotics|miotics|mesh-ancestor
138405313|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
138405314|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405315|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405316|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138405317|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138405322|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405323|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405325|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
138405326|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405327|NCT01578928|Pasireotide|pasireotide|mesh-list
138405328|NCT01578928|Hormones|hormones|mesh-ancestor
138405329|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405330|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405331|NCT01579019|Ritonavir|ritonavir|mesh-list
138405332|NCT01579019|Ribavirin|ribavirin|mesh-list
138405333|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138405334|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138405335|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138405336|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
138405337|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405338|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405339|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138405340|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138405341|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
138405342|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405343|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138405344|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138405345|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
138405346|NCT01579058|Bisoprolol|bisoprolol|mesh-list
138405347|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138405348|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
138405349|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
138405350|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405351|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365648|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
138405352|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138405354|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138405355|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
138405356|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405357|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405358|NCT01579110|Levamisole|levamisole|mesh-list
138405359|NCT01579110|Prednisone|prednisone|mesh-list
138405360|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405361|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
138405362|NCT01579110|Hormones|hormones|mesh-ancestor
138405363|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405364|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405365|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405366|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405367|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138405368|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
138405369|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
138405370|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
138405371|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138405372|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405373|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405374|NCT01579149|Plerixafor|plerixafor|mesh-list
138405375|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138405376|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138405377|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
138405378|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405379|NCT01579201|Carbetocin|carbetocin|mesh-list
138405380|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
138405381|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405382|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405383|NCT01579227|Tamoxifen|tamoxifen|mesh-list
138405384|NCT01579227|Tocotrienols|tocotrienols|mesh-list
138405385|NCT01579227|Vitamin E|vitamin e|mesh-list
138405386|NCT01579227|Tocopherols|tocopherols|mesh-list
138405387|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138405388|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
138405389|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405390|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405391|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405392|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405393|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138405394|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138405395|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138405400|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
138405401|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138405402|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138405403|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138405404|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405405|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405406|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405407|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405408|NCT01579279|Analgesics|analgesics|mesh-ancestor
138405409|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
138405410|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405411|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
138405412|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138405413|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
138405414|NCT01579383|Sumatriptan|sumatriptan|mesh-list
138405415|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138365654|NCT01393548|Brompheniramine|brompheniramine|mesh-list
138405416|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138405417|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138405418|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
138405419|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405420|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405421|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405422|NCT01579448|Vaccines|vaccines|mesh-list
138405423|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
138405424|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405425|NCT01579461|Mirabegron|mirabegron|mesh-list
138405426|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138405427|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138405428|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138405429|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
138405430|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405431|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405432|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405433|NCT01579461|Urological Agents|urological agents|mesh-ancestor
138405434|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
138405435|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138405436|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138405437|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138405438|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405439|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405442|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405443|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138405444|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405445|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
138405446|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138405447|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138405448|NCT01579539|Prednisolone|prednisolone|mesh-list
138405449|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
138405450|NCT01579539|Esomeprazole|esomeprazole|mesh-list
138405451|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138405452|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
138405453|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405454|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
138405455|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
138405456|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405457|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405458|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405459|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
138405460|NCT01579539|Hormones|hormones|mesh-ancestor
138405461|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405462|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138405464|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405465|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405466|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138405467|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138405468|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405469|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405470|NCT01579630|Pemetrexed|pemetrexed|mesh-list
138405471|NCT01579630|Gefitinib|gefitinib|mesh-list
138405472|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405473|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405474|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405475|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138365670|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138405476|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138405477|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405478|NCT01579695|Tesamorelin|tesamorelin|mesh-list
138405479|NCT01579695|Growth Substances|growth substances|mesh-ancestor
138405480|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405481|NCT01579760|Aflibercept|aflibercept|mesh-list
138405482|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138405483|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138405484|NCT01579760|Growth Substances|growth substances|mesh-ancestor
138405485|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405486|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
138405487|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405488|NCT01579786|Acetaminophen|acetaminophen|mesh-list
138405489|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405492|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405493|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405494|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
138405495|NCT01579838|Eculizumab|eculizumab|mesh-list
138405496|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138405497|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405498|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
138405499|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405500|NCT01579864|Rocuronium|rocuronium|mesh-list
138405501|NCT01579864|Succinylcholine|succinylcholine|mesh-list
138405502|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138405503|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138405504|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138405505|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405506|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405507|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138405508|NCT01579890|Diclofenac|diclofenac|mesh-list
138405509|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138405510|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405511|NCT01579890|Analgesics|analgesics|mesh-ancestor
138405512|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
138405513|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405514|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405515|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405516|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405517|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138405518|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405519|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405520|NCT01579903|Factor VIII|factor viii|mesh-list
138405521|NCT01579903|Coagulants|coagulants|mesh-ancestor
138405522|NCT01579929|Etoposide|etoposide|mesh-list
138405523|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405524|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138405525|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138405526|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138405527|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405528|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405529|NCT01579994|Crizotinib|crizotinib|mesh-list
138405530|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405531|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405532|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405535|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405536|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
138405537|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138405538|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138405539|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
138405540|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138405541|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
138365693|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
138405542|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405543|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405544|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138405545|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405546|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405547|NCT01581476|Quinapril|quinapril|mesh-list
138405548|NCT01581476|Atorvastatin|atorvastatin|mesh-list
138405549|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138405550|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138405551|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138405552|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
138405553|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405554|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138405555|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138405556|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405557|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
138405558|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138405559|NCT01582321|Cantharidin|cantharidin|mesh-list
138405560|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405561|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405562|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
138405563|NCT01582438|Citric Acid|citric acid|mesh-list
138405564|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
138405565|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
138405566|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138405567|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
138405568|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
138405569|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405573|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405574|NCT01582438|Urological Agents|urological agents|mesh-ancestor
138405575|NCT01582711|Isoniazid|isoniazid|mesh-list
138405576|NCT01582711|Rifapentine|rifapentine|mesh-list
138405577|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
138405578|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405579|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405580|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138405581|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138405582|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
138405583|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405584|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138405585|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138405586|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
138405587|NCT01583062|Amoxicillin|amoxicillin|mesh-list
138405588|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
138405589|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
138405590|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405591|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405592|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405593|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405594|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138405595|NCT01583426|Paclitaxel|paclitaxel|mesh-list
138405596|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138405597|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138405598|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405599|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
138405600|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
138405601|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
138405604|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
138405605|NCT01583972|Vitamins|vitamins|mesh-ancestor
138405606|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
138405607|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405608|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
138405609|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405610|NCT01583972|Protective Agents|protective agents|mesh-ancestor
138405611|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138405612|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405613|NCT01584362|Oxfendazole|oxfendazole|mesh-list
138405614|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
138405615|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138405616|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405617|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
138405618|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
138405619|NCT01584921|Hematinics|hematinics|mesh-ancestor
138405620|NCT01586013|Propofol|propofol|mesh-list
138405621|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138405622|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405623|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405624|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138405625|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
138405626|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
138405627|NCT01586845|Cyclosporine|cyclosporine|mesh-list
138405628|NCT01586845|Tacrolimus|tacrolimus|mesh-list
138405629|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405630|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
138405631|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405632|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138405633|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405634|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405635|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
138405636|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405637|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
138405638|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405639|NCT01587339|Pregabalin|pregabalin|mesh-list
138405640|NCT01587339|Zonisamide|zonisamide|mesh-list
138405641|NCT01587339|Lacosamide|lacosamide|mesh-list
138405642|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138405643|NCT01587339|Ezogabine|ezogabine|mesh-list
138405644|NCT01587339|Analgesics|analgesics|mesh-ancestor
138405645|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
138405646|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405647|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405648|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
138405649|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138405650|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405651|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405653|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138405654|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138405655|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405656|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138405657|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138405658|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138405660|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138405661|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405662|NCT01587482|Paclitaxel|paclitaxel|mesh-list
138405663|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138405664|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405665|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
138405666|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
138405667|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
138405668|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405669|NCT01587625|Oxytocin|oxytocin|mesh-list
138405671|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405672|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405673|NCT01587820|Cisplatin|cisplatin|mesh-list
138405674|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405675|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138405676|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138405677|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405678|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
138405679|NCT01588171|Enoxaparin|enoxaparin|mesh-list
138405680|NCT01588171|Bemiparin|bemiparin|mesh-list
138405681|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
138405682|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138405683|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138405684|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405685|NCT01588873|Desogestrel|desogestrel|mesh-list
138405686|NCT01588873|NuvaRing|nuvaring|mesh-list
138405687|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138405688|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138405691|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365699|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405692|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405693|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138405694|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138405695|NCT01588873|Progestins|progestins|mesh-ancestor
138405696|NCT01588873|Hormones|hormones|mesh-ancestor
138405697|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405698|NCT01589367|Metformin|metformin|mesh-list
138405699|NCT01589367|Letrozole|letrozole|mesh-list
138405700|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138405701|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405702|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405703|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138405704|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138405705|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405706|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405707|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138405708|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
138405711|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
138405712|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
138405713|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405714|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405715|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
138405716|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405717|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138405718|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138405719|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138405720|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405721|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405723|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
138405724|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138405725|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
138405726|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405727|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405728|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405729|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138405730|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405731|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405732|NCT01589861|Lapatinib|lapatinib|mesh-list
138405733|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405734|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405735|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405736|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405737|NCT01590173|Prednisolone|prednisolone|mesh-list
138405738|NCT01590173|Heparin|heparin|mesh-list
138405739|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405740|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
138405741|NCT01590173|Hormones|hormones|mesh-ancestor
138405742|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405743|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405744|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405745|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405746|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
138405747|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138405748|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138405749|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405750|NCT01590199|Everolimus|everolimus|mesh-list
138405753|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138405755|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405756|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405757|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
138405758|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405759|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405760|NCT01590199|Hormones|hormones|mesh-ancestor
138405761|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405762|NCT01590225|Ribavirin|ribavirin|mesh-list
138405763|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138405764|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
138405765|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
138405766|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405767|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
138405768|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405769|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
138405770|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405771|NCT01590342|Diclofenac|diclofenac|mesh-list
138405772|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138405773|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138405774|NCT01590342|Analgesics|analgesics|mesh-ancestor
138405775|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
138405776|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405777|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405778|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405779|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405780|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138405782|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405785|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138405786|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
138405787|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405788|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405789|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138405790|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138405791|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138405793|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
138405794|NCT01590641|Vesatolimod|vesatolimod|mesh-list
138405795|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
138405796|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405797|NCT01590654|Vesatolimod|vesatolimod|mesh-list
138405798|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
138405799|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405800|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
138405801|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138405802|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138405803|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138405804|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405805|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405806|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
138405807|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405808|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405809|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138405810|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405813|NCT01590732|Etoposide|etoposide|mesh-list
138405814|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
138405815|NCT01590732|Ifosfamide|ifosfamide|mesh-list
138405816|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
138405817|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
138405818|NCT01590732|Romidepsin|romidepsin|mesh-list
138405819|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405820|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138405821|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138405822|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138405823|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405824|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405825|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405826|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138405827|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
138405828|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
138405834|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138405835|NCT01590823|Dabigatran|dabigatran|mesh-list
138405836|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
138405837|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138405838|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
138405839|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405840|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405843|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138405844|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
138405845|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
138405846|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138405847|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405848|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
138405849|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
138405851|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138405852|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405853|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138405854|NCT01590901|Probucol|probucol|mesh-list
138405855|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138405856|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138405857|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
138405858|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405859|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138405861|NCT01590901|Protective Agents|protective agents|mesh-ancestor
138405862|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405863|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
138405864|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138405865|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405866|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405868|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405869|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138405870|NCT01591031|Sevoflurane|sevoflurane|mesh-list
138405871|NCT01591031|Rocuronium|rocuronium|mesh-list
138405872|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138405873|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138405875|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
138405876|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405878|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138405879|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138405881|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405883|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405884|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
138405885|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405886|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138405887|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405888|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405889|NCT01591083|Esomeprazole|esomeprazole|mesh-list
138405890|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138405891|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405892|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138405893|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405894|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405895|NCT01591122|Prednisone|prednisone|mesh-list
138405896|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
138405897|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138405898|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
138405899|NCT01591122|Hormones|hormones|mesh-ancestor
138405900|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405901|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405902|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138405903|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405904|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138405905|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405906|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405907|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
138405908|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138405909|NCT01591135|Paclitaxel|paclitaxel|mesh-list
138405910|NCT01591135|Fluorouracil|fluorouracil|mesh-list
138405912|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405913|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
138405914|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
138405915|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
138405916|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405918|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138405919|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405920|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
138405921|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405923|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138405924|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405925|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405927|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
138405928|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
138405929|NCT01591226|Mannitol|mannitol|mesh-list
138405930|NCT01591226|Caffeine|caffeine|mesh-list
138405931|NCT01591226|Citric Acid|citric acid|mesh-list
138405932|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
138405933|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
138405934|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138405935|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
138405936|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
138405937|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405938|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138405939|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405940|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138405941|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405942|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138405943|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138405944|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
138405945|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405946|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138405947|NCT01591226|Diuretics|diuretics|mesh-ancestor
138405948|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
138405953|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
138405954|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405955|NCT01591668|Vesatolimod|vesatolimod|mesh-list
138405956|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
138405957|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405958|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138405959|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
138405960|NCT01591850|Ritonavir|ritonavir|mesh-list
138405961|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138405962|NCT01591850|Rifampin|rifampin|mesh-list
138405963|NCT01591850|Ketoconazole|ketoconazole|mesh-list
138405964|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138405965|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138405966|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
138405967|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405968|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405969|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138405970|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138405971|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
138405972|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405973|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138405974|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138405975|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138405976|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
138405977|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405978|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
138405979|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138405980|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138405981|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138405982|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138405983|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138405984|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138405985|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138405986|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
138405987|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138405988|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138405989|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
138405992|NCT01591889|Tinidazole|tinidazole|mesh-list
138405993|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
138405994|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405995|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138405996|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138405997|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138405998|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138405999|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138406000|NCT01591902|Tesamorelin|tesamorelin|mesh-list
138406001|NCT01591902|Growth Substances|growth substances|mesh-ancestor
138406002|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406003|NCT01591980|Pregabalin|pregabalin|mesh-list
138406004|NCT01591980|Analgesics|analgesics|mesh-ancestor
138406005|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
138406006|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406007|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406008|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
138406009|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138406010|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406011|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406012|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138406013|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138406014|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138406015|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406016|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138406017|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138406019|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138406020|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406021|NCT01592019|Analgesics|analgesics|mesh-ancestor
138406022|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
138406023|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406024|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406025|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406026|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406027|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138406028|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406029|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406031|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138406032|NCT01592032|Linezolid|linezolid|mesh-list
138406033|NCT01592032|Daptomycin|daptomycin|mesh-list
138406034|NCT01592032|Tigecycline|tigecycline|mesh-list
138406035|NCT01592032|Teicoplanin|teicoplanin|mesh-list
138406036|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
138406037|NCT01592032|Heparin|heparin|mesh-list
138406038|NCT01592032|Calcium heparin|calcium heparin|mesh-list
138406039|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138406040|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
138406041|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138406042|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138406043|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406044|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138406045|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406046|NCT01592136|Ponatinib|ponatinib|mesh-list
138406047|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406048|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406050|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406053|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138406054|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406055|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406056|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138406057|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
138406059|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138406061|NCT01592162|Analgesics|analgesics|mesh-ancestor
138406062|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
138406063|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406064|NCT01592201|Olanzapine|olanzapine|mesh-list
138406065|NCT01592201|Risperidone|risperidone|mesh-list
138406066|NCT01592201|Aripiprazole|aripiprazole|mesh-list
138406067|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
138406068|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138406069|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
138365739|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138406070|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406071|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406072|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406073|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138406074|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406075|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138406076|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138406077|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
138406078|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
138406079|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
138406080|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406081|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406082|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138406083|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138406084|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406085|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
138406086|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
138406087|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138406088|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138406089|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138406090|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138406091|NCT01592214|Benzocaine|benzocaine|mesh-list
138406092|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
138406093|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
138406094|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406095|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406096|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
138406097|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406098|NCT01592227|Acetaminophen|acetaminophen|mesh-list
138406099|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406100|NCT01592227|Analgesics|analgesics|mesh-ancestor
138406102|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406103|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406105|NCT01592253|Sirolimus|sirolimus|mesh-list
138406106|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406107|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406108|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138406109|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406110|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
138406111|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406112|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
138406113|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406114|NCT01592279|Liraglutide|liraglutide|mesh-list
138406115|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406116|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406117|NCT01592279|Incretins|incretins|mesh-ancestor
138406118|NCT01592279|Hormones|hormones|mesh-ancestor
138406119|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406120|NCT01592305|Ritonavir|ritonavir|mesh-list
138406121|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138406122|NCT01592305|Tenofovir|tenofovir|mesh-list
138406123|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138406124|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138406125|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
138406126|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406127|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406128|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138406129|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138406130|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
138406131|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406132|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138406133|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138406134|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138406135|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406136|NCT01592318|Ritonavir|ritonavir|mesh-list
138406137|NCT01592318|Lactams|lactams|mesh-list
138406138|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138406140|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
138406141|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406142|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406144|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138406145|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
138406146|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406147|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138406148|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138406149|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406150|NCT01592526|Nicotine|nicotine|mesh-list
138406151|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138406152|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
138406153|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406154|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406155|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138406156|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138406157|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
138406158|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406159|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406160|NCT01592630|Ropivacaine|ropivacaine|mesh-list
138406161|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138406162|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
138406163|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406164|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406165|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
138406166|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406167|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
138406168|NCT01592981|Rituximab|rituximab|mesh-list
138406169|NCT01592981|Fludarabine|fludarabine|mesh-list
138406170|NCT01592981|Bortezomib|bortezomib|mesh-list
138406171|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406172|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
138406173|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406174|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406175|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138406176|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
138406177|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406178|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406180|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406181|NCT01593033|Micronutrients|micronutrients|mesh-list
138406184|NCT01593046|Cabotegravir|cabotegravir|mesh-list
138406185|NCT01593046|Rilpivirine|rilpivirine|mesh-list
138406186|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138406187|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138406188|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406189|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406190|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138406191|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138406192|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
138406193|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406194|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138406195|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406198|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138406199|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
138406200|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406201|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406202|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
138406203|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138406204|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138406205|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138406206|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
138406207|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406208|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138406209|NCT01593137|Metformin|metformin|mesh-list
138406210|NCT01593137|Liraglutide|liraglutide|mesh-list
138406211|NCT01593137|Glimepiride|glimepiride|mesh-list
138406212|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406213|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406214|NCT01593137|Incretins|incretins|mesh-ancestor
138406215|NCT01593137|Hormones|hormones|mesh-ancestor
138406216|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406217|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138365748|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138406218|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406219|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
138406220|NCT01593150|Dabigatran|dabigatran|mesh-list
138406221|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
138406222|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138406223|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138406224|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406225|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406226|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
138406227|NCT01593163|Ibuprofen|ibuprofen|mesh-list
138406228|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138406229|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406230|NCT01593163|Analgesics|analgesics|mesh-ancestor
138406231|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
138406232|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406233|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406234|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406236|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138406237|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406240|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138406241|NCT01593280|Narcotics|narcotics|mesh-ancestor
138406242|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406243|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406244|NCT01593280|Analgesics|analgesics|mesh-ancestor
138406245|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
138406246|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406248|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406249|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406250|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406251|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138406252|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406253|NCT01593306|Paclitaxel|paclitaxel|mesh-list
138406254|NCT01593306|Cisplatin|cisplatin|mesh-list
138406255|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138406256|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406257|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
138406258|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
138406259|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
138406260|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406261|NCT01593319|Ropivacaine|ropivacaine|mesh-list
138406262|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
138406263|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
138406264|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406265|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406266|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
138406267|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406268|NCT01593332|Rituximab|rituximab|mesh-list
138406269|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406270|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406271|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
138406272|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406273|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406274|NCT01593371|Metformin|metformin|mesh-list
138406275|NCT01593371|Pioglitazone|pioglitazone|mesh-list
138406276|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406277|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406278|NCT01593397|Fentanyl|fentanyl|mesh-list
138406279|NCT01593397|Propofol|propofol|mesh-list
138406280|NCT01593397|Anesthetics|anesthetics|mesh-list
138406282|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406283|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406284|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138406285|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
138406286|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138406287|NCT01593397|Narcotics|narcotics|mesh-ancestor
138406288|NCT01593397|Analgesics|analgesics|mesh-ancestor
138406289|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
138406290|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406291|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138365759|NCT01394341|Hormones|hormones|mesh-ancestor
138406292|NCT01593410|Dexamethasone|dexamethasone|mesh-list
138406293|NCT01593410|Lenalidomide|lenalidomide|mesh-list
138406295|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
138406296|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
138406297|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406298|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406299|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406300|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
138406301|NCT01593410|Hormones|hormones|mesh-ancestor
138406302|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406303|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138406304|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406305|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
138406306|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138406307|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138406308|NCT01593410|Growth Substances|growth substances|mesh-ancestor
138406309|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
138406310|NCT01593501|Vitamin D|vitamin d|mesh-list
138406311|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
138406312|NCT01593501|Vitamins|vitamins|mesh-ancestor
138406313|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
138406314|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406315|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138406316|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138406317|NCT01593514|Lactitol|lactitol|mesh-list
138406318|NCT01593514|Vaccines|vaccines|mesh-list
138406319|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
138406320|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406321|NCT01593514|Cathartics|cathartics|mesh-ancestor
138406322|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406323|NCT01593566|Bupivacaine|bupivacaine|mesh-list
138406324|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138406325|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
138406326|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406327|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406328|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
138406329|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406330|NCT01593605|Resveratrol|resveratrol|mesh-list
138406331|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
138406334|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406335|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406336|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138406338|NCT01593644|Dipyridamole|dipyridamole|mesh-list
138406339|NCT01593644|Analgesics|analgesics|mesh-ancestor
138406340|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
138406341|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406342|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406343|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138406344|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
138406345|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138406346|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
138406347|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
138406348|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406349|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406350|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138406351|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406352|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138406353|NCT01593774|Melatonin|melatonin|mesh-list
138406354|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
138406355|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406356|NCT01593774|Protective Agents|protective agents|mesh-ancestor
138406357|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406358|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406359|NCT01593826|Budesonide|budesonide|mesh-list
138406361|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138406362|NCT01593826|Charcoal|charcoal|mesh-list
138406363|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406364|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138406365|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
138406366|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406367|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406368|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138406369|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
138406370|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
138406371|NCT01593826|Hormones|hormones|mesh-ancestor
138406373|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138406374|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138406375|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138406376|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
138406377|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406378|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406380|NCT01593826|Protective Agents|protective agents|mesh-ancestor
138406381|NCT01593930|Lidocaine|lidocaine|mesh-list
138406382|NCT01593930|Carticaine|carticaine|mesh-list
138406384|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
138406385|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406386|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406387|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
138406388|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406389|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138406390|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138406391|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138406392|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406393|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406394|NCT01593995|Mitogens|mitogens|mesh-list
138406395|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
138406396|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406397|NCT01594060|Insulin|insulin|mesh-list
138406398|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138406399|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
138406400|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
138406401|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406402|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406403|NCT01594099|Paclitaxel|paclitaxel|mesh-list
138406404|NCT01594099|Cisplatin|cisplatin|mesh-list
138406405|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138406406|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406407|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138406408|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138406409|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138406410|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406411|NCT01594177|Paclitaxel|paclitaxel|mesh-list
138406412|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
138406413|NCT01594177|Trastuzumab|trastuzumab|mesh-list
138406414|NCT01594177|Epirubicin|epirubicin|mesh-list
138406415|NCT01594177|Afatinib|afatinib|mesh-list
138406416|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138406417|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406418|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
138406419|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
138406420|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
138406421|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406422|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406423|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
138406424|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406425|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406427|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
138406428|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138406429|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406430|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138406431|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138406432|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138406433|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406434|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406435|NCT01594229|Rituximab|rituximab|mesh-list
138406436|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138406437|NCT01594229|Venetoclax|venetoclax|mesh-list
138365766|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406438|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406439|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406440|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
138406441|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406442|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406443|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138406444|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
138406445|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406446|NCT01594242|Bortezomib|bortezomib|mesh-list
138406447|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406448|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
138406449|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406450|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406451|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138406452|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138406453|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406454|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406455|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406457|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138406458|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406459|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406460|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406461|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406462|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
138406463|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406464|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406466|NCT01594346|Tocopherols|tocopherols|mesh-list
138406467|NCT01594346|Tocotrienols|tocotrienols|mesh-list
138406468|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
138406469|NCT01594346|Vitamins|vitamins|mesh-ancestor
138406470|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
138406471|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406472|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
138406473|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406474|NCT01594346|Protective Agents|protective agents|mesh-ancestor
138406475|NCT01594489|Aminophylline|aminophylline|mesh-list
138406476|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138406477|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
138406478|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406479|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406480|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138406481|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138406482|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138406483|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138406488|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
138406489|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406490|NCT01594489|Protective Agents|protective agents|mesh-ancestor
138406491|NCT01594502|Dutasteride|dutasteride|mesh-list
138406492|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138406493|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138406494|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215897|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406495|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406496|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
138406497|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406498|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406499|NCT01594619|Diltiazem|diltiazem|mesh-list
138406501|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138406502|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138406503|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406504|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406505|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138406506|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406507|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
138406508|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138406509|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
138406510|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406511|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
138406512|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138406513|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138406514|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406516|NCT01594671|Coagulants|coagulants|mesh-ancestor
138406517|NCT01594697|Metformin|metformin|mesh-list
138406518|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406519|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406520|NCT01594775|Oxytocin|oxytocin|mesh-list
138406521|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
138406522|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406523|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406524|NCT01594866|Dexetimide|dexetimide|mesh-list
138406525|NCT01594866|Citalopram|citalopram|mesh-list
138406526|NCT01594866|Escitalopram|escitalopram|mesh-list
138406527|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138406528|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138406529|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406530|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406531|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406532|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
138406533|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406534|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138406535|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138406536|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
138406537|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
138406538|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406540|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138406541|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
138406542|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138406543|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
138406544|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138406545|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
138406546|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138406547|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
138406548|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406549|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406550|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138406551|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138406552|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138406553|NCT01594905|Tenofovir|tenofovir|mesh-list
138406554|NCT01594905|Entecavir|entecavir|mesh-list
138406555|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
138406556|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406557|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138406558|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138365804|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
138406560|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406561|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138406562|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138406563|NCT01594918|Prednisone|prednisone|mesh-list
138406564|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
138406565|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406566|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
138406567|NCT01594918|Hormones|hormones|mesh-ancestor
138406568|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406571|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406572|NCT01594918|Analgesics|analgesics|mesh-ancestor
138406573|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
138406574|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406575|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138406576|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138406577|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406578|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406579|NCT01595009|Everolimus|everolimus|mesh-list
138406580|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138406581|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406582|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406583|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406584|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406585|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
138406586|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406587|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406588|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
138406589|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
138406590|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406591|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406592|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138406593|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138406594|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138406595|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138406596|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
138406597|NCT01595152|Fesoterodine|fesoterodine|mesh-list
138406598|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138406599|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138406600|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
138406601|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406602|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406603|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406604|NCT01595152|Urological Agents|urological agents|mesh-ancestor
138406605|NCT01595334|Cetrorelix|cetrorelix|mesh-list
138406606|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138406607|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
138406608|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406609|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406610|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
138406611|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406612|NCT01595399|Atropine|atropine|mesh-list
138406613|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138406614|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138406615|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138406616|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
138406617|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406618|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406619|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138406621|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
138406622|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
138406623|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138406624|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138406625|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
138406626|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406627|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406628|NCT01595425|Esomeprazole|esomeprazole|mesh-list
138406629|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138365824|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138406630|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406631|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138406632|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406633|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406634|NCT01595594|Doxycycline|doxycycline|mesh-list
138406635|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406636|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406637|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
138406638|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138406639|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138406640|NCT01595633|Tenofovir|tenofovir|mesh-list
138406641|NCT01595633|Adefovir|adefovir|mesh-list
138406642|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
138406643|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406644|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138406645|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406646|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406647|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406651|NCT01595685|Telbivudine|telbivudine|mesh-list
138406652|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
138406653|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406654|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138406655|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406656|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406657|NCT01595724|Dienogest|dienogest|mesh-list
138406658|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138406659|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
138406660|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406661|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406662|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138406663|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138406664|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138406665|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138406666|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138406667|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406668|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138406669|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406670|NCT01595737|Simendan|simendan|mesh-list
138406671|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138406672|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
138406673|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138406675|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406676|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406677|NCT01595737|Protective Agents|protective agents|mesh-ancestor
138406678|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406679|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
138406680|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138406681|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138406682|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406683|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
138406684|NCT01595763|Coagulants|coagulants|mesh-ancestor
138406685|NCT01595789|Liraglutide|liraglutide|mesh-list
138406686|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406687|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406688|NCT01595789|Incretins|incretins|mesh-ancestor
138406690|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406693|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
138406694|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138406695|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406696|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406697|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406698|NCT01595828|Pitavastatin|pitavastatin|mesh-list
138406699|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215898|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
138365825|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
138406700|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138406701|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138406702|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
138406703|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406705|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138406706|NCT01595867|Naltrexone|naltrexone|mesh-list
138406707|NCT01595867|Morphine|morphine|mesh-list
138406708|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138406709|NCT01595867|Narcotics|narcotics|mesh-ancestor
138406710|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406711|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406712|NCT01595867|Analgesics|analgesics|mesh-ancestor
138406713|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
138406714|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406715|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138406716|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138406717|NCT01595880|Metformin|metformin|mesh-list
138406718|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138406719|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406720|NCT01595893|Vitamin D|vitamin d|mesh-list
138406721|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
138406722|NCT01595893|Vitamins|vitamins|mesh-ancestor
138406723|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
138406724|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406725|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138406726|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138406727|NCT01595958|Cyclosporine|cyclosporine|mesh-list
138406728|NCT01595958|Cyclosporins|cyclosporins|mesh-list
138406729|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406730|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406731|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406732|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
138406733|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406734|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
138406735|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406736|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
138406737|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406739|NCT01595984|Cyclosporine|cyclosporine|mesh-list
138406740|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
138406741|NCT01595984|Everolimus|everolimus|mesh-list
138406742|NCT01595984|Cyclosporins|cyclosporins|mesh-list
138406743|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406744|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406745|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406746|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
138406747|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406748|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
138406749|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406750|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
138406751|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406752|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138406753|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138406754|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406755|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406756|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138406757|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138365831|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365832|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365833|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365834|NCT01394471|Oxytocin|oxytocin|mesh-list
138365835|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
138365836|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365837|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365838|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
138406758|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
138406761|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
138406763|NCT01596010|Estrogens|estrogens|mesh-ancestor
138406764|NCT01596010|Hormones|hormones|mesh-ancestor
138406765|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406766|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406767|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138406768|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
138406769|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406770|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138406771|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138406772|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138406773|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138406775|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
138406776|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
138406777|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
138406778|NCT01596114|Protective Agents|protective agents|mesh-ancestor
138406779|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406780|NCT01596140|Sirolimus|sirolimus|mesh-list
138406781|NCT01596140|Everolimus|everolimus|mesh-list
138406782|NCT01596140|Temsirolimus|temsirolimus|mesh-list
138406783|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
138406784|NCT01596140|Vemurafenib|vemurafenib|mesh-list
138406785|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138406786|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406787|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406788|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138406789|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
138406790|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406791|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406792|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406793|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406794|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138406795|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
138406796|NCT01596166|Ketorolac|ketorolac|mesh-list
138406797|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138406798|NCT01596166|Metoclopramide|metoclopramide|mesh-list
138406799|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138406800|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406803|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406804|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406805|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406806|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406807|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138406808|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406809|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406810|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
138406811|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
138406812|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406813|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138406814|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138406815|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
138406816|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406817|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138406818|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406819|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406820|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
138406821|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
138406822|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
138365845|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365846|NCT01394497|Protective Agents|protective agents|mesh-ancestor
138365847|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365848|NCT01394653|Ramosetron|ramosetron|mesh-list
138365849|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
138365850|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
138365851|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406823|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406824|NCT01596296|Dinoprostone|dinoprostone|mesh-list
138406825|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
138406826|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138406827|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406828|NCT01596387|Propofol|propofol|mesh-list
138406829|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138406830|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406831|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406832|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138406834|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
138406836|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
138406837|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
138406838|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406839|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406840|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406841|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138406842|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138406843|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
138406844|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406845|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406846|NCT01596413|Granisetron|granisetron|mesh-list
138406847|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
138406848|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
138406849|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406850|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406851|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406852|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138406853|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138406854|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
138406855|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406856|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406857|NCT01596426|Granisetron|granisetron|mesh-list
138406858|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
138406859|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
138406860|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406861|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406862|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406863|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138406864|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138406865|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
138406866|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406872|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406873|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
138406874|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406875|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
138406876|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406878|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138406879|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
138406880|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406881|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406882|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138406883|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138406884|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
138406885|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406886|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406887|NCT01596634|Lactoferrin|lactoferrin|mesh-list
138406888|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406889|NCT01596647|Diclofenac|diclofenac|mesh-list
138406890|NCT01596647|Midazolam|midazolam|mesh-list
138406891|NCT01596647|Caffeine|caffeine|mesh-list
138406892|NCT01596647|Omeprazole|omeprazole|mesh-list
138406893|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138406894|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138406895|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406896|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406897|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138406898|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138406899|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138406900|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138406901|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
138406902|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
138406903|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
138406904|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
138406905|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138406906|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406907|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138406908|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138406909|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406910|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138406911|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138406912|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
138406913|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138406914|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406915|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138406916|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138406917|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406918|NCT01596647|Analgesics|analgesics|mesh-ancestor
138406919|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
138406921|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406922|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406923|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138406924|NCT01596660|Bupivacaine|bupivacaine|mesh-list
138406925|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
138406926|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
138406927|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406928|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406929|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
138406930|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406932|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138406933|NCT01596673|Narcotics|narcotics|mesh-ancestor
138406934|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138406935|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406936|NCT01596673|Analgesics|analgesics|mesh-ancestor
138406937|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
138406938|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406939|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
138406940|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
138406941|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
138406942|NCT01596686|Cathartics|cathartics|mesh-ancestor
138406943|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406944|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
138406945|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138406946|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138406947|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406948|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
138406949|NCT01596738|Coagulants|coagulants|mesh-ancestor
138406950|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
138406951|NCT01596764|Naloxone|naloxone|mesh-list
138406952|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
138406954|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
138406955|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138406956|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406957|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
138406958|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406959|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138406960|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406961|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138406962|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138406963|NCT01596764|Analgesics|analgesics|mesh-ancestor
138406964|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406965|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406966|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
138406967|NCT01596777|Naltrexone|naltrexone|mesh-list
138406968|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
138406969|NCT01596777|Loperamide|loperamide|mesh-list
138406970|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
138406976|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
138406977|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138406978|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406979|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138406980|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138406981|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138365854|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138365855|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
138365856|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365857|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406982|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138406983|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
138406984|NCT01596803|Vitamin E|vitamin e|mesh-list
138406985|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
138406987|NCT01596803|Antioxidants|antioxidants|mesh-list
138406988|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406989|NCT01596803|Protective Agents|protective agents|mesh-ancestor
138406990|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406991|NCT01596803|Vitamins|vitamins|mesh-ancestor
138406992|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
138406993|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
138406994|NCT01596855|Hematinics|hematinics|mesh-ancestor
138406995|NCT01596868|Cisplatin|cisplatin|mesh-list
138406996|NCT01596868|Gemcitabine|gemcitabine|mesh-list
138406997|NCT01596868|Docetaxel|docetaxel|mesh-list
138406998|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406999|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138407000|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
138407002|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407003|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407004|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407005|NCT01596894|Azithromycin|azithromycin|mesh-list
138407006|NCT01596894|Metronidazole|metronidazole|mesh-list
138407007|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407008|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407009|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138407010|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138407011|NCT01596907|Ephedrine|ephedrine|mesh-list
138407012|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
138407013|NCT01596907|Caffeine|caffeine|mesh-list
138407014|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138407015|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407016|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138407017|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407018|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407019|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138407020|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138407021|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
138407022|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407023|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
138407024|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
138407025|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407026|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138407027|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407028|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138407029|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138407030|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407032|NCT01596998|Epinephrine|epinephrine|mesh-list
138407033|NCT01596998|Racepinephrine|racepinephrine|mesh-list
138407034|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
138407035|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
138407036|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138407037|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138407038|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407039|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407040|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407041|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407042|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138407043|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138407046|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138407047|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407048|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
138407049|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
138365860|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
138407050|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138407051|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
138407052|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
138407053|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407054|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
138407055|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138407056|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
138407057|NCT01597011|Coagulants|coagulants|mesh-ancestor
138407058|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
138407059|NCT01597167|Analgesics|analgesics|mesh-ancestor
138407060|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
138407061|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407062|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407063|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
138407064|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407065|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138407066|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
138407067|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138407070|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138407072|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138407074|NCT01597206|Trace Elements|trace elements|mesh-ancestor
138407075|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
138407076|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407077|NCT01597232|Chrysarobin|chrysarobin|mesh-list
138407078|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138407079|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138407080|NCT01597232|Analgesics|analgesics|mesh-ancestor
138407081|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
138407082|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407083|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407084|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407085|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407086|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
138407087|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138407088|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138407089|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407091|NCT01597310|Warfarin|warfarin|mesh-list
138407092|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
138407093|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
138407094|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407095|NCT01597310|Protective Agents|protective agents|mesh-ancestor
138407096|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407097|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138407098|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138407099|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
138407100|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
138407101|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407102|NCT01597336|Plasminogen|plasminogen|mesh-list
138407103|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138407104|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138407105|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138407106|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407107|NCT01597427|Clonidine|clonidine|mesh-list
138407108|NCT01597427|Analgesics|analgesics|mesh-ancestor
138407109|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
138407110|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407111|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407112|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138407113|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
138407114|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
138407115|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138407116|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138407117|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138407118|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407119|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407120|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407121|NCT01597518|Riluzole|riluzole|mesh-list
138407122|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
138407123|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138407124|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138407125|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407126|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407127|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407128|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138407129|NCT01597518|Protective Agents|protective agents|mesh-ancestor
138407130|NCT01597531|Liraglutide|liraglutide|mesh-list
138407131|NCT01597531|Orlistat|orlistat|mesh-list
138407132|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407133|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407135|NCT01597531|Hormones|hormones|mesh-ancestor
138407136|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407137|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407138|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407139|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138407140|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407141|NCT01597609|Sibutramine|sibutramine|mesh-list
138407142|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
138407143|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138407144|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
138407145|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138407146|NCT01597648|Maraviroc|maraviroc|mesh-list
138407147|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138407148|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138407149|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138407150|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407151|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138407152|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138407153|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
138407154|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407155|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138407156|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138407157|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138407158|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407160|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
138407161|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138407162|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138407164|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138407165|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138407166|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407167|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
138407168|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407169|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407170|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138407171|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138407172|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407173|NCT01597700|Ezetimibe|ezetimibe|mesh-list
138407174|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138407175|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138407176|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
138407177|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407178|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407179|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
138407180|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407181|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407182|NCT01597726|Misoprostol|misoprostol|mesh-list
138407183|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138407184|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
138407185|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138407186|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407187|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138407188|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407189|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
138407190|NCT01597765|Vitamins|vitamins|mesh-list
138407191|NCT01597765|Vitamin E|vitamin e|mesh-list
138365876|NCT01394757|Esketamine|esketamine|mesh-list
138407192|NCT01597765|Tocopherols|tocopherols|mesh-list
138407193|NCT01597765|Tocotrienols|tocotrienols|mesh-list
138407194|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
138407195|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
138407196|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138407197|NCT01597765|Deferiprone|deferiprone|mesh-list
138407198|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
138407199|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407201|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407202|NCT01597765|Expectorants|expectorants|mesh-ancestor
138407203|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407204|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138407205|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
138407206|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407207|NCT01597765|Protective Agents|protective agents|mesh-ancestor
138407208|NCT01597765|Antidotes|antidotes|mesh-ancestor
138407209|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138407210|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
138407211|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
138407212|NCT01597817|Chitosan|chitosan|mesh-list
138407213|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138407214|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138407215|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
138407216|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407217|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407218|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
138407219|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
138407220|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
138407221|NCT01597817|Coagulants|coagulants|mesh-ancestor
138407222|NCT01597895|Maraviroc|maraviroc|mesh-list
138407223|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138407224|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138407225|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407226|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138407227|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138407228|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
138407229|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407230|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138407231|NCT01597934|Tenofovir|tenofovir|mesh-list
138407232|NCT01597934|Entecavir|entecavir|mesh-list
138407237|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
138407238|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407239|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138407240|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138407241|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407242|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407243|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138407244|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138407245|NCT01597986|Isavuconazole|isavuconazole|mesh-list
138407246|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138365877|NCT01394757|Analgesics|analgesics|mesh-ancestor
138365879|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365880|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365881|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138365882|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138407247|NCT01597986|Norethindrone|norethindrone|mesh-list
138407248|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
138407249|NCT01597986|Norinyl|norinyl|mesh-list
138407250|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
138407251|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
138407252|NCT01597986|Estradiol|estradiol|mesh-list
138407253|NCT01597986|Estrogens|estrogens|mesh-ancestor
138407254|NCT01597986|Hormones|hormones|mesh-ancestor
138407255|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407256|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407257|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138407258|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138407259|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138407260|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138407261|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138407262|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
138407263|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407264|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138407265|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
138407266|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138407267|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138407268|NCT01598012|Analgesics|analgesics|mesh-ancestor
138407269|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
138407270|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407271|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407272|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407273|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407274|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138407275|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407276|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407277|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
138407278|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138407282|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407283|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407284|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
138407285|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
138407286|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138407287|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
138407288|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138407289|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407290|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407291|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407292|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
138407293|NCT01598259|Melatonin|melatonin|mesh-list
138407294|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
138407295|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407296|NCT01598259|Protective Agents|protective agents|mesh-ancestor
138407297|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407298|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407299|NCT01598337|Aspirin|aspirin|mesh-list
138407300|NCT01598337|Tirofiban|tirofiban|mesh-list
138407301|NCT01598337|Clopidogrel|clopidogrel|mesh-list
138407302|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138407303|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138407304|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138407305|NCT01598337|Analgesics|analgesics|mesh-ancestor
138407306|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
138407307|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407308|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407309|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407310|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407311|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138407312|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138365902|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365903|NCT01394796|Protective Agents|protective agents|mesh-ancestor
138407313|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407314|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138407315|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138407316|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407317|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
138407318|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138407319|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138407320|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138407321|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
138407322|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407323|NCT01598402|Amoxicillin|amoxicillin|mesh-list
138407324|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
138407325|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
138407326|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407327|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407328|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407329|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407330|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138407331|NCT01598441|Iloprost|iloprost|mesh-list
138407332|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138407334|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
138407335|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138407336|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138407337|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138407338|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
138407339|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138407340|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138407341|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138407343|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407344|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407345|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
138407346|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407347|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407348|NCT01598584|Gemcitabine|gemcitabine|mesh-list
138407349|NCT01598584|Mirtazapine|mirtazapine|mesh-list
138407350|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138407351|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
138407352|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407353|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407354|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138407355|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138407356|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138407357|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
138407359|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407360|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407361|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138407362|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138407363|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407364|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138407365|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138407366|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138407367|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407368|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138407369|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138407370|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
138407371|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138365912|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138407372|NCT01598623|Oxytocin|oxytocin|mesh-list
138365913|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365914|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365916|NCT01394848|Everolimus|everolimus|mesh-list
138407373|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
138407374|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138407375|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407376|NCT01598649|Mannitol|mannitol|mesh-list
138407378|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138407379|NCT01598649|Diuretics|diuretics|mesh-ancestor
138407380|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
138407381|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407382|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
138407383|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
138407384|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407385|NCT01598675|Methamphetamine|methamphetamine|mesh-list
138407386|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138407389|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
138407390|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407391|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
138407392|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407393|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407394|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407395|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138407396|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138407397|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138407398|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138407399|NCT01598883|Heparin|heparin|mesh-list
138407400|NCT01598883|Calcium heparin|calcium heparin|mesh-list
138407401|NCT01598883|Antithrombins|antithrombins|mesh-list
138407402|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
138407403|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138407404|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138407405|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407406|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138407407|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407408|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407409|NCT01598948|Mipomersen|mipomersen|mesh-list
138407410|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138407411|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138407412|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
138407413|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407414|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407415|NCT01599000|Lumefantrine|lumefantrine|mesh-list
138407416|NCT01599000|Artemether|artemether|mesh-list
138407417|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138407418|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
138407419|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138407420|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138407421|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407422|NCT01599013|Carboplatin|carboplatin|mesh-list
138407423|NCT01599013|Gemcitabine|gemcitabine|mesh-list
138407424|NCT01599013|Vinblastine|vinblastine|mesh-list
138407425|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407426|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138407427|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
138407430|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407431|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407432|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407434|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138407435|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407436|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407437|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407438|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407439|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407440|NCT01599117|Udenafil|udenafil|mesh-list
138407441|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138407442|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138407443|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407444|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407445|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138407446|NCT01599130|Entecavir|entecavir|mesh-list
138407447|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
138407448|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407449|NCT01599273|Triamcinolone|triamcinolone|mesh-list
138407450|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407451|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
138407452|NCT01599273|Hormones|hormones|mesh-ancestor
138407453|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215899|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
138407454|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407455|NCT01599312|Cobalt|cobalt|mesh-list
138407456|NCT01599312|Trace Elements|trace elements|mesh-ancestor
138407457|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
138407458|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407459|NCT01599338|Liraglutide|liraglutide|mesh-list
138407460|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407461|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407462|NCT01599338|Incretins|incretins|mesh-ancestor
138407463|NCT01599338|Hormones|hormones|mesh-ancestor
138407464|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407465|NCT01599364|Ritonavir|ritonavir|mesh-list
138407466|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138407467|NCT01599364|Lamivudine|lamivudine|mesh-list
138407468|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138407469|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138407470|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407471|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407472|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407474|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138407475|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
138407476|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407477|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138407478|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138407479|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138407482|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138407483|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138407484|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407485|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407486|NCT05691088|Acetaminophen|acetaminophen|mesh-list
138407487|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138407488|NCT05691088|Analgesics|analgesics|mesh-ancestor
138407489|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
138407490|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407491|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407493|NCT05690802|Palonosetron|palonosetron|mesh-list
138407494|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
138407495|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
138407496|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407497|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407498|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407499|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138407500|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138407501|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
138407502|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407503|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407505|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138407506|NCT05690321|Narcotics|narcotics|mesh-ancestor
138407507|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407508|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407509|NCT05690321|Analgesics|analgesics|mesh-ancestor
138407510|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
138407511|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407513|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407514|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
138365926|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138365927|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138365928|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365929|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
138407515|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407516|NCT05690191|Rituximab|rituximab|mesh-list
138407517|NCT05690191|Lenalidomide|lenalidomide|mesh-list
138407518|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407519|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407520|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
138407521|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407522|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407523|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138407524|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407525|NCT05690191|Growth Substances|growth substances|mesh-ancestor
138407526|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407527|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138407528|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138407530|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
138407532|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138407533|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
138407534|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407535|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407536|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138407537|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407538|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
138407540|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407541|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138407542|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138407543|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138407544|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
138407545|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407546|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407547|NCT05689957|Rocuronium|rocuronium|mesh-list
138407548|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138407549|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138407551|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407552|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407553|NCT05689632|Vitamin D|vitamin d|mesh-list
138407554|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
138407555|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
138407556|NCT05689632|Vitamins|vitamins|mesh-list
138407557|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
138407558|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407559|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138407560|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138407561|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
138407562|NCT05689242|Nalbuphine|nalbuphine|mesh-list
138407563|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138407564|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407565|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407566|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138407568|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
138407569|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407570|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138407571|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138407575|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407577|NCT05689242|Narcotics|narcotics|mesh-ancestor
138407578|NCT05689229|Colistin|colistin|mesh-list
138407579|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407580|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407581|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138407582|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138407583|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407584|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407585|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407586|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407587|NCT05688046|Growth Substances|growth substances|mesh-ancestor
138407588|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407589|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407590|NCT05618132|Acetylcholine|acetylcholine|mesh-list
138407591|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407592|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138407593|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
138407594|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407595|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407596|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407597|NCT05553808|Docetaxel|docetaxel|mesh-list
138407598|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407599|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407600|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407601|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407602|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407603|NCT05540184|Allopurinol|allopurinol|mesh-list
138407604|NCT05540184|Trimetazidine|trimetazidine|mesh-list
138407605|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
138407606|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407609|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138407610|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138407611|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
138407612|NCT05540184|Protective Agents|protective agents|mesh-ancestor
138407613|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407614|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407615|NCT05473195|Isoniazid|isoniazid|mesh-list
138407616|NCT05473195|Ethionamide|ethionamide|mesh-list
138407617|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
138407618|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407619|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407620|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138407621|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138407622|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
138407623|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407624|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407625|NCT05422053|Insulin|insulin|mesh-list
138407626|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407627|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407628|NCT05344911|Remifentanil|remifentanil|mesh-list
138407629|NCT05344911|Alfentanil|alfentanil|mesh-list
138407630|NCT05344911|Propofol|propofol|mesh-list
138407631|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138407632|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407633|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407634|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138407637|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138407638|NCT05344911|Narcotics|narcotics|mesh-ancestor
138407639|NCT05344911|Analgesics|analgesics|mesh-ancestor
138407640|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
138407641|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407642|NCT05338021|Vancomycin|vancomycin|mesh-list
138407643|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407644|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407645|NCT05338008|Vancomycin|vancomycin|mesh-list
138407646|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407647|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407648|NCT05281328|Octreotide|octreotide|mesh-list
138407649|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407650|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407651|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407652|NCT05251376|Morphine|morphine|mesh-list
138407653|NCT05251376|Methadone|methadone|mesh-list
138407654|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138407655|NCT05251376|Narcotics|narcotics|mesh-ancestor
138407656|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407657|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407658|NCT05251376|Analgesics|analgesics|mesh-ancestor
138407659|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
138407660|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407661|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
138407662|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407664|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407665|NCT04969250|Vaccines|vaccines|mesh-list
138365944|NCT01394913|Analgesics|analgesics|mesh-ancestor
138407666|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
138407668|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
138407669|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407670|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407671|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138215913|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138407672|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407673|NCT04873557|Copper|copper|mesh-list
138407674|NCT04873557|Trace Elements|trace elements|mesh-ancestor
138407675|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
138407676|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407677|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
138407678|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138407679|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407680|NCT04789616|Maraviroc|maraviroc|mesh-list
138407682|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138407683|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407684|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138407685|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138407686|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
138407687|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407688|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138407689|NCT04785300|Dasatinib|dasatinib|mesh-list
138407690|NCT04785300|Quercetin|quercetin|mesh-list
138407691|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407692|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138407693|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407694|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407695|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
138407696|NCT04785300|Protective Agents|protective agents|mesh-ancestor
138407702|NCT04753216|Antibodies|antibodies|mesh-list
138407703|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
138407704|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138407705|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
138407706|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407707|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138407708|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407709|NCT04753216|Growth Substances|growth substances|mesh-ancestor
138407710|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407711|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407712|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
138407713|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138407714|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138407715|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407716|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407717|NCT04714619|Letrozole|letrozole|mesh-list
138407718|NCT04714619|Anastrozole|anastrozole|mesh-list
138407719|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407720|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138407721|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138407722|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407723|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407724|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138407725|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
138407726|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407727|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407728|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407730|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138407731|NCT04689945|Narcotics|narcotics|mesh-ancestor
138407732|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407733|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407734|NCT04689945|Analgesics|analgesics|mesh-ancestor
138407735|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
138407736|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407737|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138407739|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407740|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
138407741|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
138407742|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407743|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407744|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407747|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365951|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365952|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
138365954|NCT01395069|Nepafenac|nepafenac|mesh-list
138407749|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407750|NCT04541173|Bevacizumab|bevacizumab|mesh-list
138407751|NCT04541173|Atezolizumab|atezolizumab|mesh-list
138407752|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407753|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407754|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138407755|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407756|NCT04541173|Growth Substances|growth substances|mesh-ancestor
138407757|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407758|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407759|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138407760|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407762|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407763|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407764|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
138407766|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
138407767|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
138407768|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138407769|NCT04456296|Androgens|androgens|mesh-ancestor
138407770|NCT04456296|Hormones|hormones|mesh-ancestor
138407771|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407772|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407773|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407774|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407775|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
138407776|NCT04403321|Tacrolimus|tacrolimus|mesh-list
138407777|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138407778|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
138407779|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407780|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138407781|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407782|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407783|NCT04265755|Erenumab|erenumab|mesh-list
138407786|NCT04265755|Analgesics|analgesics|mesh-ancestor
138407787|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
138407788|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407789|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407790|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
138407791|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138407792|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138407793|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
138407794|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
138407795|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407796|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407797|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
138407798|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407799|NCT04182334|TEMPO|tempo|mesh-list
138407800|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
138407801|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407802|NCT04182334|Protective Agents|protective agents|mesh-ancestor
138407803|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407804|NCT04123444|Iloprost|iloprost|mesh-list
138407805|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138407806|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407807|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138407808|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
138407809|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407811|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
138407812|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
138407813|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407814|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407815|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
138407816|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407817|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138407818|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138407819|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138407820|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138407821|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407822|NCT03935646|Adderall|adderall|mesh-list
138407823|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138407824|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407825|NCT03547999|Nivolumab|nivolumab|mesh-list
138407826|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407827|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407828|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138407829|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407830|NCT03536728|Eflornithine|eflornithine|mesh-list
138407831|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407832|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138407835|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407836|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138407837|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407838|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407839|NCT03517423|Brivaracetam|brivaracetam|mesh-list
138407840|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
138407841|NCT03462251|Paclitaxel|paclitaxel|mesh-list
138407842|NCT03462251|Bevacizumab|bevacizumab|mesh-list
138407843|NCT03462251|Capecitabine|capecitabine|mesh-list
138407844|NCT03462251|Fulvestrant|fulvestrant|mesh-list
138407845|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138407846|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138407847|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407848|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407849|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407850|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407851|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407852|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407853|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138407854|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407855|NCT03462251|Growth Substances|growth substances|mesh-ancestor
138407856|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407857|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407858|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138407859|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
138407860|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407861|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138407862|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138407863|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
138407864|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407865|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138407866|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407867|NCT03272685|Nicotine|nicotine|mesh-list
138407868|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138407869|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
138407870|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407871|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407872|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138407873|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138407874|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
138407875|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407876|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407877|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
138407878|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407881|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407883|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138407884|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138407885|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138407886|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
138407887|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407888|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138407889|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407891|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138407892|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
138407893|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407894|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365959|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365960|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407895|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138407896|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407897|NCT05705388|Liraglutide|liraglutide|mesh-list
138407898|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407899|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407900|NCT05705388|Incretins|incretins|mesh-ancestor
138407901|NCT05705388|Hormones|hormones|mesh-ancestor
138407902|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138407903|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
138407904|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138407907|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
138407908|NCT05705336|Coagulants|coagulants|mesh-ancestor
138407909|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
138407910|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138407911|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
138407912|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407913|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407914|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407915|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
138407916|NCT05704959|Povidone|povidone|mesh-list
138407917|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
138407918|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
138407919|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138407920|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138407921|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
138407925|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407927|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
138407928|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
138407929|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
138407930|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138407931|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407932|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407933|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407934|NCT05703997|Atezolizumab|atezolizumab|mesh-list
138407935|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138407936|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407937|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138407938|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407939|NCT05703984|Metformin|metformin|mesh-list
138407940|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138407941|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407942|NCT05703555|Maytansine|maytansine|mesh-list
138407943|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138407944|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407945|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407946|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407947|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407948|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407949|NCT05703373|Micronutrients|micronutrients|mesh-list
138407950|NCT05703373|Trace Elements|trace elements|mesh-list
138407951|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407956|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407957|NCT05702190|Analgesics|analgesics|mesh-ancestor
138407958|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
138407959|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407960|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
138407961|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138407962|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
138407963|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407964|NCT05701124|Ranibizumab|ranibizumab|mesh-list
138407965|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138407966|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138407967|NCT05701124|Growth Substances|growth substances|mesh-ancestor
138407968|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407969|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407970|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407971|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
138407972|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
138365969|NCT01395147|Vortioxetine|vortioxetine|mesh-list
138407973|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407974|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
138407975|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
138407976|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407977|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407978|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407979|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
138407980|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
138407981|NCT05476939|Everolimus|everolimus|mesh-list
138407982|NCT05476939|TIC10 compound|tic10 compound|mesh-list
138407983|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138407984|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138407985|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407986|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407987|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138407988|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
138407989|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407990|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407991|NCT05458232|Tadalafil|tadalafil|mesh-list
138407992|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407995|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407996|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407997|NCT05458232|Urological Agents|urological agents|mesh-ancestor
138407999|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138408000|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408001|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
138408002|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138408003|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138408004|NCT05271799|Gepotidacin|gepotidacin|mesh-list
138408005|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138408006|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408007|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408008|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408009|NCT05270733|Ustekinumab|ustekinumab|mesh-list
138408010|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408011|NCT05253417|Cannabidiol|cannabidiol|mesh-list
138408012|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
138408013|NCT05184803|Docetaxel|docetaxel|mesh-list
138408014|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
138408015|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408017|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
138408018|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408019|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408020|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
138408021|NCT05030506|Lenvatinib|lenvatinib|mesh-list
138408022|NCT05030506|Belzutifan|belzutifan|mesh-list
138408023|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408024|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408025|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408026|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408027|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408028|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408029|NCT04911621|Temozolomide|temozolomide|mesh-list
138408033|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408035|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
138408036|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138408037|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138408038|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
138408039|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408040|NCT04764643|Expectorants|expectorants|mesh-ancestor
138408041|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408042|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138365974|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408043|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
138408044|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408045|NCT04764643|Protective Agents|protective agents|mesh-ancestor
138408046|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408047|NCT04764643|Antidotes|antidotes|mesh-ancestor
138408048|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
138408049|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138408050|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
138408051|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
138408052|NCT04558892|Enoxaparin|enoxaparin|mesh-list
138408054|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138408055|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138408057|NCT04077515|Sirolimus|sirolimus|mesh-list
138408058|NCT04077515|Temsirolimus|temsirolimus|mesh-list
138408059|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
138408060|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138408061|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408062|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138408063|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408064|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
138408065|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408066|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
138408067|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408068|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408069|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408071|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
138408073|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
138408074|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
138408075|NCT03841110|Nivolumab|nivolumab|mesh-list
138408076|NCT03841110|Fludarabine|fludarabine|mesh-list
138408077|NCT03841110|Atezolizumab|atezolizumab|mesh-list
138408078|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408079|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
138408080|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408081|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408082|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138408083|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
138408084|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408085|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408086|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138408087|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408088|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408089|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408090|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138408091|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
138408092|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408093|NCT03810313|Aflibercept|aflibercept|mesh-list
138408094|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408095|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408096|NCT03810313|Growth Substances|growth substances|mesh-ancestor
138408097|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408098|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408099|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408100|NCT03802630|Aflibercept|aflibercept|mesh-list
138408101|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408102|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408103|NCT03802630|Growth Substances|growth substances|mesh-ancestor
138408104|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408105|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408106|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365983|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138408107|NCT03785691|Ondansetron|ondansetron|mesh-list
138408108|NCT03785691|Mirtazapine|mirtazapine|mesh-list
138408109|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
138365984|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138365985|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138365993|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408110|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
138408111|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408112|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408113|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408114|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
138408115|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408116|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138408117|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138408118|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
138408119|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408120|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408121|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
138408123|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138408124|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
138408125|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
138408126|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138408127|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138408128|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408129|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138408130|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138408131|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138408132|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138408133|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138408135|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408136|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408137|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408138|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408140|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408141|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408142|NCT03710564|Growth Substances|growth substances|mesh-ancestor
138408143|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408144|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408145|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408146|NCT03624127|Apremilast|apremilast|mesh-list
138408147|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
138408148|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138408149|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408150|NCT03624127|Analgesics|analgesics|mesh-ancestor
138408151|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
138408152|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408153|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408154|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408155|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408156|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138289165|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138289166|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138408157|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138408158|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408159|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408160|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408161|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408162|NCT03499899|Carboplatin|carboplatin|mesh-list
138408163|NCT03499899|Spartalizumab|spartalizumab|mesh-list
138408164|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408165|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408166|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408167|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408168|NCT03481634|Aflibercept|aflibercept|mesh-list
138408169|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408170|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408171|NCT03481634|Growth Substances|growth substances|mesh-ancestor
138408172|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408173|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408174|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408175|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
138408176|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408177|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408178|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408179|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408180|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
138408181|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138408182|NCT03106454|Norethindrone|norethindrone|mesh-list
138408183|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
138408185|NCT03106454|Estrogens|estrogens|mesh-ancestor
138408186|NCT03106454|Hormones|hormones|mesh-ancestor
138408187|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408188|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408189|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138408190|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
138408191|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138408192|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138408193|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138408194|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138408195|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138408196|NCT03106454|Trace Elements|trace elements|mesh-ancestor
138408197|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
138408200|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408201|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408202|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408203|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408204|NCT02420821|Bevacizumab|bevacizumab|mesh-list
138408205|NCT02420821|Atezolizumab|atezolizumab|mesh-list
138408206|NCT02420821|Sunitinib|sunitinib|mesh-list
138408207|NCT02420821|Antibodies|antibodies|mesh-list
138408208|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138408209|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408210|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408211|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408212|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408213|NCT02420821|Growth Substances|growth substances|mesh-ancestor
138408214|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408215|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408216|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
138408217|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408218|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408219|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408220|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408221|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
138408222|NCT02811263|Hematinics|hematinics|mesh-ancestor
138408223|NCT02188121|Losartan|losartan|mesh-list
138408224|NCT02188121|Simvastatin|simvastatin|mesh-list
138408225|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138408226|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138408227|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
138408228|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408229|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138408230|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138408231|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408232|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138408233|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138408234|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138289242|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408237|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138408238|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408239|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
138408240|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408241|NCT01970410|Teriflunomide|teriflunomide|mesh-list
138408242|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138408243|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408244|NCT01970410|Analgesics|analgesics|mesh-ancestor
138408245|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
138365998|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365999|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366000|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138408246|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408247|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408248|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408249|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408250|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408251|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
138408252|NCT01746173|Plerixafor|plerixafor|mesh-list
138408253|NCT01746173|Prednisone|prednisone|mesh-list
138408254|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
138408255|NCT01746173|Melphalan|melphalan|mesh-list
138408256|NCT01746173|Busulfan|busulfan|mesh-list
138408257|NCT01746173|Gemcitabine|gemcitabine|mesh-list
138408258|NCT01746173|Doxorubicin|doxorubicin|mesh-list
138408259|NCT01746173|Etoposide|etoposide|mesh-list
138408260|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
138408261|NCT01746173|Vincristine|vincristine|mesh-list
138408262|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408263|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
138408264|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408265|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408266|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138408267|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
138408268|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408269|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408270|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138408271|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138408272|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
138408273|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138408274|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138408275|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138408276|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408277|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408278|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
138408279|NCT01746173|Hormones|hormones|mesh-ancestor
138408280|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408281|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138408282|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138408283|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138408284|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138408285|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408286|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408287|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138408288|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
138408289|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408290|NCT01694004|Benzocaine|benzocaine|mesh-list
138408291|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
138408292|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
138408293|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408294|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408295|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
138408296|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408297|NCT01545843|Fluoxetine|fluoxetine|mesh-list
138289325|NCT00089414|Progestins|progestins|mesh-ancestor
138408298|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138408299|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408300|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408301|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408302|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408304|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408305|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138408306|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
138408307|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138408308|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138366011|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138366012|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366013|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
138366014|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138366015|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138366016|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
138408309|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138408310|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408311|NCT00843791|Pioglitazone|pioglitazone|mesh-list
138408312|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138408313|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408314|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408315|NCT03187769|Olanzapine|olanzapine|mesh-list
138408316|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
138289366|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
138408318|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408319|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408320|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408321|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138408322|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138408323|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408324|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138408325|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138408326|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408327|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408328|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408329|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408330|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
138408332|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
138408333|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408334|NCT02956382|Venetoclax|venetoclax|mesh-list
138408335|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408336|NCT02855229|Methylphenidate|methylphenidate|mesh-list
138408337|NCT02855229|Modafinil|modafinil|mesh-list
138408338|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138408339|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408340|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138408341|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408342|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408343|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408344|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
138408345|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408346|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138408347|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138408348|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138408349|NCT02829931|Bevacizumab|bevacizumab|mesh-list
138408350|NCT02829931|Nivolumab|nivolumab|mesh-list
138408351|NCT02829931|Ipilimumab|ipilimumab|mesh-list
138408352|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408353|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408354|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138408355|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138408356|NCT02829931|Growth Substances|growth substances|mesh-ancestor
138408357|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408358|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138408359|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408360|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408361|NCT02815566|Tenofovir|tenofovir|mesh-list
138408362|NCT02815566|Emtricitabine|emtricitabine|mesh-list
138408363|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
138408364|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408365|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138408366|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138408367|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408368|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408369|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408370|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138408371|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
138408372|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408373|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
138408374|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408375|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408376|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138408378|NCT02702492|Nivolumab|nivolumab|mesh-list
138408379|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408380|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408381|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408382|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408383|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138408384|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
138408385|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138408386|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408387|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
138408388|NCT02702492|Vitamins|vitamins|mesh-ancestor
138408389|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
138408390|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408391|NCT02652455|Aldesleukin|aldesleukin|mesh-list
138408392|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
138408393|NCT02652455|Nivolumab|nivolumab|mesh-list
138408394|NCT02652455|Fludarabine|fludarabine|mesh-list
138408395|NCT02652455|Interleukin-2|interleukin-2|mesh-list
138408396|NCT02652455|Antibodies|antibodies|mesh-list
138408397|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
138408398|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
138408399|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408400|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
138289455|NCT00000878|Zidovudine|zidovudine|mesh-list
138408402|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408403|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138408404|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
138408405|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408406|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408407|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138408408|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408409|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408410|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408411|NCT02652455|Analgesics|analgesics|mesh-ancestor
138408412|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
138408413|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408414|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408415|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138408416|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
138408417|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408418|NCT02491983|Letrozole|letrozole|mesh-list
138408419|NCT02491983|Fulvestrant|fulvestrant|mesh-list
138408420|NCT02491983|Palbociclib|palbociclib|mesh-list
138408421|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408422|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138408423|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138408424|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408425|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408426|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138408427|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
138408428|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289492|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138408429|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408430|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138408431|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138408433|NCT02467478|Linagliptin|linagliptin|mesh-list
138408434|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408435|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408436|NCT02467478|Incretins|incretins|mesh-ancestor
138408437|NCT02467478|Hormones|hormones|mesh-ancestor
138366017|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
138408438|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366018|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366019|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366020|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366022|NCT01395420|Avibactam|avibactam|mesh-list
138408439|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138408440|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
138408441|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408442|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408443|NCT02466243|Lenabasum|lenabasum|mesh-list
138408444|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138408445|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138408446|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408447|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408448|NCT02466243|Hormones|hormones|mesh-ancestor
138408449|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408450|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408451|NCT02321098|Amorolfine|amorolfine|mesh-list
138408452|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
138408453|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408454|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138408455|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
138408456|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138408457|NCT02185417|Diuretics|diuretics|mesh-ancestor
138408458|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
138289541|NCT04331600|Chloroquine|chloroquine|mesh-list
138408459|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408460|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138408461|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408462|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408463|NCT02158234|Cisplatin|cisplatin|mesh-list
138408464|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
138408465|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408466|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408467|NCT01953926|Trastuzumab|trastuzumab|mesh-list
138408468|NCT01953926|Fulvestrant|fulvestrant|mesh-list
138408469|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408470|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408471|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138408472|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138408473|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138408474|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
138408475|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408476|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408477|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138408478|NCT01859026|Mitogens|mitogens|mesh-list
138408479|NCT01859026|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138408481|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408482|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408483|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408484|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408485|NCT01657591|Vemurafenib|vemurafenib|mesh-list
138408486|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408487|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138289583|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289592|NCT00000920|Ritonavir|ritonavir|mesh-list
138408489|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408491|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138408492|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138408493|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408494|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
138408495|NCT01599468|Coagulants|coagulants|mesh-ancestor
138408496|NCT01599572|Zinc|zinc|mesh-list
138408497|NCT01599572|Trace Elements|trace elements|mesh-ancestor
138408498|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
138408499|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408500|NCT01599598|Imidacloprid|imidacloprid|mesh-list
138408501|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
138408502|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408503|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408504|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408505|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138408506|NCT01599702|Hematinics|hematinics|mesh-ancestor
138408507|NCT01599728|Substance P|substance p|mesh-list
138408508|NCT01599728|Neurokinin A|neurokinin a|mesh-list
138408509|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408510|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408511|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408512|NCT01599819|Factor VIII|factor viii|mesh-list
138408514|NCT01599819|Coagulants|coagulants|mesh-ancestor
138408515|NCT01599858|Omeprazole|omeprazole|mesh-list
138408516|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138408517|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408518|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138408519|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408520|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408521|NCT01599871|Theophylline|theophylline|mesh-list
138289629|NCT00000194|Cycloserine|cycloserine|mesh-list
138408524|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408525|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408526|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138408527|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408528|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138408529|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408530|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408531|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408532|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138408533|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138408534|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
138408535|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408536|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
138408537|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138408538|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
138408539|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408540|NCT01599884|Expectorants|expectorants|mesh-ancestor
138408541|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408542|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138408543|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
138408545|NCT01599884|Protective Agents|protective agents|mesh-ancestor
138408546|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408548|NCT01599923|Antivenins|antivenins|mesh-list
138408549|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
138408550|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408551|NCT01599936|Antivenins|antivenins|mesh-list
138408552|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
138408553|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408554|NCT01599962|Cinacalcet|cinacalcet|mesh-list
138408555|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138408556|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289670|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289671|NCT00000950|Pyridoxine|pyridoxine|mesh-list
138408558|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
138408559|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408560|NCT01599975|Methylphenidate|methylphenidate|mesh-list
138408561|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138408562|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408563|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138408564|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408565|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408566|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408567|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
138408568|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408569|NCT01599988|Caseins|caseins|mesh-list
138408570|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
138408571|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
138408572|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408573|NCT01600430|Vitamin D|vitamin d|mesh-list
138408574|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
138408575|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
138408576|NCT01600430|Vitamins|vitamins|mesh-list
138408577|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
138408578|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408579|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138215914|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138366025|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138366026|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366027|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366029|NCT01395433|Citalopram|citalopram|mesh-list
138408580|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138289711|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408581|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
138408582|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138408583|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138408584|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408585|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
138408586|NCT01600599|Coagulants|coagulants|mesh-ancestor
138408587|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
138408588|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
138408589|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138408590|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138408591|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408592|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408593|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408594|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408595|NCT01602029|Ondansetron|ondansetron|mesh-list
138408597|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138408598|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138408599|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
138408600|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408601|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138408602|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138408603|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408604|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
138408605|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
138408606|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408607|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408608|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408609|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
138408610|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408611|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138408612|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138408613|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
138289774|NCT00000980|Spiramycin|spiramycin|mesh-list
138408614|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408615|NCT01602874|Metronidazole|metronidazole|mesh-list
138408616|NCT01602874|Clarithromycin|clarithromycin|mesh-list
138408617|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
138408618|NCT01602874|Tigecycline|tigecycline|mesh-list
138408619|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408620|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138408621|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138408622|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138408623|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138408624|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408625|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408626|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138408627|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138408628|NCT01602887|Palbociclib|palbociclib|mesh-list
138408629|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408630|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408631|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408632|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408633|NCT01603264|Trastuzumab|trastuzumab|mesh-list
138408634|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408635|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408636|NCT01603680|Anesthetics|anesthetics|mesh-list
138408637|NCT01603680|Mepivacaine|mepivacaine|mesh-list
138408638|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
138408639|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408640|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408641|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
138408642|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408644|NCT01604213|Vildagliptin|vildagliptin|mesh-list
138408645|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408646|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408647|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138408648|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
138408649|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408650|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408651|NCT01605240|Acetaminophen|acetaminophen|mesh-list
138408652|NCT01605240|Ibuprofen|ibuprofen|mesh-list
138408653|NCT01605240|Codeine|codeine|mesh-list
138408654|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408655|NCT01605240|Analgesics|analgesics|mesh-ancestor
138408656|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
138408657|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408658|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408659|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
138408660|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138289804|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138408661|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408663|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138408664|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289806|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
138408665|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408667|NCT01605240|Narcotics|narcotics|mesh-ancestor
138408668|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408669|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
138408670|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408671|NCT01605279|Dobutamine|dobutamine|mesh-list
138408672|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138408673|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
138408674|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
138408675|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408676|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408677|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138408678|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138408679|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138408680|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
138408681|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408682|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408683|NCT01605279|Protective Agents|protective agents|mesh-ancestor
138408684|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138408685|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
138408686|NCT01606072|Coagulants|coagulants|mesh-ancestor
138408687|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138408688|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
138408689|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408690|NCT01606722|Ritonavir|ritonavir|mesh-list
138408691|NCT01606722|Darunavir|darunavir|mesh-list
138408692|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138408693|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138408695|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408696|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408697|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408698|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138408699|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
138408700|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408701|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138408702|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138408704|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138408705|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
138408706|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408707|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408708|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138408709|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408710|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138408711|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
138215915|NCT00601718|Rituximab|rituximab|mesh-list
138366030|NCT01395433|Escitalopram|escitalopram|mesh-list
138366031|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138366032|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138366033|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138366034|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408712|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408713|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408714|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138408715|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408716|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
138408717|NCT01607983|Protective Agents|protective agents|mesh-ancestor
138408718|NCT01608217|Acetaminophen|acetaminophen|mesh-list
138408719|NCT01608217|Dronabinol|dronabinol|mesh-list
138408720|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408721|NCT01608217|Analgesics|analgesics|mesh-ancestor
138408722|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
138408723|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289876|NCT00001028|Dapsone|dapsone|mesh-list
138408726|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
138408727|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138408728|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138408729|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138408730|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408731|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408732|NCT01608217|Hormones|hormones|mesh-ancestor
138408733|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408734|NCT01608594|Ipilimumab|ipilimumab|mesh-list
138408735|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408736|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408737|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138408738|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408739|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138408741|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
138408742|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408743|NCT01608958|Oxytocin|oxytocin|mesh-list
138408744|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
138408745|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138408746|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408747|NCT01609153|Olanzapine|olanzapine|mesh-list
138408748|NCT01609153|Amisulpride|amisulpride|mesh-list
138408749|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
138408750|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
138408751|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408752|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408753|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408754|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138408755|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138408756|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408757|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138408758|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138408759|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138408760|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289924|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
138408761|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408762|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408763|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
138408764|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138408765|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
138408766|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138408767|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
138408768|NCT01610141|Warfarin|warfarin|mesh-list
138408769|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
138408770|NCT01610310|Interferon-beta|interferon-beta|mesh-list
138408771|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408772|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
138408773|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408774|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
138408775|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408776|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
138408777|NCT01610362|Antibodies|antibodies|mesh-list
138408778|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
138408779|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138408780|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138408781|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
138408782|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
138408783|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408784|NCT01610401|Metformin|metformin|mesh-list
138408785|NCT01610401|Caffeine|caffeine|mesh-list
138408786|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408787|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408788|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138408789|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138408790|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408791|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408792|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138408793|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138408794|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
138408795|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408796|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
138408797|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408798|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138408799|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138408800|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408802|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408803|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408804|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289956|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138289963|NCT00000212|Desipramine|desipramine|mesh-list
138408806|NCT01610921|Adenosine|adenosine|mesh-list
138408807|NCT01610921|Analgesics|analgesics|mesh-ancestor
138408808|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
138408809|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408810|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408811|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138408812|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408813|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138408814|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
138408815|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
138408816|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408817|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408819|NCT01610934|Glimepiride|glimepiride|mesh-list
138408820|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408821|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408822|NCT01610934|Incretins|incretins|mesh-ancestor
138408823|NCT01610934|Hormones|hormones|mesh-ancestor
138408824|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138408825|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138408826|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408827|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
138408828|NCT01610947|Adalimumab|adalimumab|mesh-list
138408829|NCT01610947|Infliximab|infliximab|mesh-list
138408830|NCT01610947|Golimumab|golimumab|mesh-list
138408831|NCT01610947|Etanercept|etanercept|mesh-list
138408832|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138408833|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138408834|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408835|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408836|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408837|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408838|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138408839|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408840|NCT01610947|Analgesics|analgesics|mesh-ancestor
138408841|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
138408842|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408843|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408844|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408845|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
138408847|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138408848|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289986|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
138289987|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289988|NCT00001052|Antacids|antacids|mesh-ancestor
138289989|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289990|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138289991|NCT00001058|Ritonavir|ritonavir|mesh-list
138408850|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408851|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
138408852|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138408853|NCT01611038|Protective Agents|protective agents|mesh-ancestor
138408854|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408855|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408856|NCT01611077|Amlodipine|amlodipine|mesh-list
138408857|NCT01611077|Candesartan|candesartan|mesh-list
138408858|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
138408859|NCT01611077|Olmesartan|olmesartan|mesh-list
138408860|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138408861|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138408862|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138408863|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408864|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408865|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138408866|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408867|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
138408868|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138408869|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138408870|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
138290013|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138408871|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408872|NCT01611311|BI 409306|bi 409306|mesh-list
138408873|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138408874|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408875|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408876|NCT01611324|Epinephrine|epinephrine|mesh-list
138408877|NCT01611324|Mepivacaine|mepivacaine|mesh-list
138408878|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138408879|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138408880|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
138408881|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138408882|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408883|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408885|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138408886|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
138408887|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408888|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138408889|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408890|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
138408891|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
138408892|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138408893|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
138408894|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
138408895|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138408896|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
138408897|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
138408898|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138408899|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408901|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408902|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
138408903|NCT01611415|Furosemide|furosemide|mesh-list
138408904|NCT01611415|Diuretics|diuretics|mesh-ancestor
138408905|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
138408906|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408907|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138408908|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408909|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290056|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408911|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408912|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
138408913|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138408914|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408915|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138408916|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408918|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138408919|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
138408920|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408921|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408922|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
138408923|NCT01611506|Capecitabine|capecitabine|mesh-list
138408924|NCT01611506|Cetuximab|cetuximab|mesh-list
138408925|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215916|NCT00601718|Carboplatin|carboplatin|mesh-list
138408926|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138408927|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
138408928|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408929|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138408930|NCT01611675|Vemurafenib|vemurafenib|mesh-list
138408931|NCT01611675|Leflunomide|leflunomide|mesh-list
138408932|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408933|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138408934|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408935|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408936|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408937|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
138408938|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408939|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138408940|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
138408941|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408943|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408944|NCT01611896|Selenium|selenium|mesh-list
138408945|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
138408947|NCT01611896|Protective Agents|protective agents|mesh-ancestor
138408948|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408950|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
138408952|NCT01611909|Expectorants|expectorants|mesh-ancestor
138408953|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
138408954|NCT01611961|Docetaxel|docetaxel|mesh-list
138408955|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408956|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
138408957|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
138408958|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408959|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408960|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138408961|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408962|NCT01612065|Misoprostol|misoprostol|mesh-list
138408963|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138408964|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
138408965|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138408966|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408967|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138408968|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138408969|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
138408970|NCT01612078|Droxidopa|droxidopa|mesh-list
138408971|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138408972|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138408973|NCT01612247|Aspirin|aspirin|mesh-list
138408974|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
138408975|NCT01612247|Methotrexate|methotrexate|mesh-list
138408976|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408977|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
138408978|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290138|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290142|NCT00001094|Lamivudine|lamivudine|mesh-list
138408981|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
138408982|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408983|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138408984|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138408985|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138408986|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
138408987|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138408988|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138408989|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
138408990|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408991|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408992|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138408993|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138408994|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138408995|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138408996|NCT01612247|Analgesics|analgesics|mesh-ancestor
138408997|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
138408998|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138408999|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409000|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138409001|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138409002|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409003|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138409004|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
138409005|NCT01612273|Aspirin|aspirin|mesh-list
138409006|NCT01612273|Triflusal|triflusal|mesh-list
138409007|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409009|NCT01612273|Analgesics|analgesics|mesh-ancestor
138409010|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
138409011|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409012|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409013|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409014|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409015|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138409016|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138409017|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409018|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409019|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138409020|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409021|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
138409022|NCT01612286|Endostatins|endostatins|mesh-list
138409023|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138409024|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138409025|NCT01612286|Growth Substances|growth substances|mesh-ancestor
138409026|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409027|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
138409028|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409029|NCT01612299|Everolimus|everolimus|mesh-list
138409030|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138409031|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138409032|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409033|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409034|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409035|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
138409036|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409037|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409039|NCT01612377|Prednisolone|prednisolone|mesh-list
138409040|NCT01612377|Dipyridamole|dipyridamole|mesh-list
138409041|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409042|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
138409043|NCT01612377|Hormones|hormones|mesh-ancestor
138409044|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409045|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290224|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138409046|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138290225|NCT00000344|Narcotics|narcotics|mesh-ancestor
138290227|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409049|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409050|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409051|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409052|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409053|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
138409054|NCT01612403|Astringents|astringents|mesh-ancestor
138409055|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409056|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409057|NCT01612468|Liraglutide|liraglutide|mesh-list
138409058|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409059|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409060|NCT01612468|Incretins|incretins|mesh-ancestor
138409061|NCT01612468|Hormones|hormones|mesh-ancestor
138409062|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409063|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138409064|NCT01612507|Cephalosporins|cephalosporins|mesh-list
138409065|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409066|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409067|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138409068|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138409069|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409070|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409071|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138409072|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
138409073|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409074|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409075|NCT01612741|Acarbose|acarbose|mesh-list
138409076|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138290258|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138409077|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409078|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409079|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409080|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409081|NCT01612832|Pregabalin|pregabalin|mesh-list
138409082|NCT01612832|Analgesics|analgesics|mesh-ancestor
138409083|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
138409084|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409085|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409086|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
138409087|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138409089|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409091|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138409093|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409094|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409095|NCT01612871|Tamoxifen|tamoxifen|mesh-list
138409096|NCT01612871|Letrozole|letrozole|mesh-list
138409097|NCT01612871|Anastrozole|anastrozole|mesh-list
138409099|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409100|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138409101|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138409103|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409104|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138409105|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
138409106|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409107|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409108|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138409109|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138409110|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138409111|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138409112|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138409113|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138409114|NCT01612910|Protective Agents|protective agents|mesh-ancestor
138409115|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409116|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409117|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138409118|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138409119|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409120|NCT01612975|Naproxen|naproxen|mesh-list
138409121|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409122|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409123|NCT01612975|Analgesics|analgesics|mesh-ancestor
138409124|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
138409125|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409126|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409127|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409128|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409129|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
138290287|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409130|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138409131|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290288|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138409132|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409134|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138409135|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409136|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409137|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138409138|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138409139|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409140|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409141|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409142|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138409143|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
138409144|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409145|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409146|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138409147|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138409148|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138409150|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409151|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138409152|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409153|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409154|NCT01613079|Methotrexate|methotrexate|mesh-list
138409155|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138409156|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
138409157|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409158|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409159|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138409160|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
138290317|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
138409162|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409163|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409164|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409165|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138409166|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409167|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
138409168|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409169|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409171|NCT01613092|Clindamycin|clindamycin|mesh-list
138409172|NCT01613092|Cefazolin|cefazolin|mesh-list
138409173|NCT01613092|Cephalexin|cephalexin|mesh-list
138409174|NCT01613092|Bacitracin|bacitracin|mesh-list
138409176|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409177|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138409178|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409179|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409180|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138409181|NCT01613105|Acarbose|acarbose|mesh-list
138409182|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138409183|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409184|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409185|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409186|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409187|NCT01613170|Estrogens|estrogens|mesh-list
138409188|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138409189|NCT01613170|Hormones|hormones|mesh-ancestor
138409190|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409191|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409192|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
138409193|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
138409194|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409195|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
138409196|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409197|NCT01613209|Candesartan|candesartan|mesh-list
138409198|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
138409199|NCT01613209|Olmesartan|olmesartan|mesh-list
138409200|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138409201|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138409202|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138409203|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409204|NCT01613300|Ofatumumab|ofatumumab|mesh-list
138409205|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409206|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
138409207|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138409208|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138409209|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409210|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
138409211|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409213|NCT01613469|Antidotes|antidotes|mesh-ancestor
138409214|NCT01613469|Protective Agents|protective agents|mesh-ancestor
138409215|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409216|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
138409217|NCT01613469|Vitamins|vitamins|mesh-ancestor
138366056|NCT01395602|Cabergoline|cabergoline|mesh-list
138366057|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138409218|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
138409219|NCT01613482|Trastuzumab|trastuzumab|mesh-list
138409220|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138409221|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409223|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138409224|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138409225|NCT01613547|Amoxicillin|amoxicillin|mesh-list
138290405|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290419|NCT00000458|Sertraline|sertraline|mesh-list
138409230|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409231|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138409232|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
138409233|NCT01613664|Coagulants|coagulants|mesh-ancestor
138409234|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
138409235|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138409236|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138409237|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138409238|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
138409239|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409240|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409241|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409242|NCT01613755|Metformin|metformin|mesh-list
138409243|NCT01613755|Dipyridamole|dipyridamole|mesh-list
138409244|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409245|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409246|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138409247|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409248|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409249|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409250|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409251|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138409252|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138409253|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138409254|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
138409255|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290448|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290449|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409256|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138409257|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138290454|NCT00002102|Leucovorin|leucovorin|mesh-list
138409260|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138409261|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
138409262|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
138409263|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
138409264|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409265|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409266|NCT01613820|Scopolamine|scopolamine|mesh-list
138409267|NCT01613820|Ketamine|ketamine|mesh-list
138409268|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138409269|NCT01613820|Analgesics|analgesics|mesh-ancestor
138409270|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
138409271|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409272|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409273|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138409274|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138409275|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
138409276|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
138409277|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409278|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138409280|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409281|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409282|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138409283|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
138409285|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138409286|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
138409287|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138409288|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
138409289|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138409290|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
138409291|NCT01613846|Sorafenib|sorafenib|mesh-list
138409292|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409293|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138409294|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409295|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409296|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138409297|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409298|NCT01613963|Cyclosporine|cyclosporine|mesh-list
138409299|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
138409300|NCT01613963|Prednisolone|prednisolone|mesh-list
138409301|NCT01613963|Adalimumab|adalimumab|mesh-list
138409302|NCT01613963|Infliximab|infliximab|mesh-list
138409303|NCT01613963|Etanercept|etanercept|mesh-list
138409304|NCT01613963|Methotrexate|methotrexate|mesh-list
138409305|NCT01613963|Azathioprine|azathioprine|mesh-list
138409306|NCT01613963|Cyclosporins|cyclosporins|mesh-list
138409307|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138409308|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409309|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
138409310|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409311|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409312|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138409313|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
138409314|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409315|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138409316|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
138409317|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409318|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409319|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409320|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138409321|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409322|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
138409323|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409324|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138409325|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138409326|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138409327|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
138409328|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409329|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409330|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
138409331|NCT01613963|Hormones|hormones|mesh-ancestor
138409332|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409333|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138409334|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409335|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138409336|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138409337|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409338|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409339|NCT01613963|Analgesics|analgesics|mesh-ancestor
138409340|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
138409341|NCT01613976|Panobinostat|panobinostat|mesh-list
138409342|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409343|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138409344|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409345|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409346|NCT01614041|Tandospirone|tandospirone|mesh-list
138409347|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138409348|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138409349|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409350|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366082|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138366083|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
138366084|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138366086|NCT01395667|Fluorouracil|fluorouracil|mesh-list
138366087|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
138366088|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409351|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409354|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409355|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409356|NCT01614132|Cisplatin|cisplatin|mesh-list
138409357|NCT01614132|Vincristine|vincristine|mesh-list
138409358|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409359|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409360|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138409361|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138409362|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138409363|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138409364|NCT01614223|Betamethasone|betamethasone|mesh-list
138409365|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409366|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
138409367|NCT01614223|Hormones|hormones|mesh-ancestor
138409368|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409369|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409370|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138409371|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409372|NCT01614236|Pregabalin|pregabalin|mesh-list
138409373|NCT01614236|Analgesics|analgesics|mesh-ancestor
138409374|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
138409375|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409376|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409377|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
138409378|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138409379|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409380|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409381|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138409382|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138409383|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138409384|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409385|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409387|NCT01614301|Sirolimus|sirolimus|mesh-list
138409388|NCT01614301|Etoricoxib|etoricoxib|mesh-list
138409389|NCT01614301|Temsirolimus|temsirolimus|mesh-list
138409390|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
138409391|NCT01614301|Dacarbazine|dacarbazine|mesh-list
138409393|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409394|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409395|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138409396|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409397|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409398|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409399|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
138409400|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409401|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409402|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409403|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138409404|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
138409405|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138409406|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
138409407|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409409|NCT01614301|Analgesics|analgesics|mesh-ancestor
138409410|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
138409411|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409412|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409413|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409414|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138409415|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138409417|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138409418|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138366090|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
138409419|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409420|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409421|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138409422|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409423|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409424|NCT01614405|Ritonavir|ritonavir|mesh-list
138409425|NCT01614405|Lopinavir|lopinavir|mesh-list
138409426|NCT01614405|Tenofovir|tenofovir|mesh-list
138409427|NCT01614405|Emtricitabine|emtricitabine|mesh-list
138409428|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138409429|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138409430|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138409431|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138409432|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409433|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409434|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138409435|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138409436|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
138409437|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409438|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138409439|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138409440|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138409441|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409442|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
138409443|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138409444|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
138409445|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409446|NCT01614431|Expectorants|expectorants|mesh-ancestor
138409447|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409448|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138409449|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
138409450|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409451|NCT01614431|Protective Agents|protective agents|mesh-ancestor
138409452|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409453|NCT01614431|Antidotes|antidotes|mesh-ancestor
138409455|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409456|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409457|NCT01614535|Remifentanil|remifentanil|mesh-list
138409458|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138409459|NCT01614535|Narcotics|narcotics|mesh-ancestor
138409460|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409461|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409462|NCT01614535|Analgesics|analgesics|mesh-ancestor
138409463|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
138409464|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409465|NCT01614938|Cisplatin|cisplatin|mesh-list
138409466|NCT01614938|Docetaxel|docetaxel|mesh-list
138409467|NCT01614938|Cetuximab|cetuximab|mesh-list
138409468|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409469|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
138409470|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
138409471|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
138409472|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409473|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138409474|NCT01614964|Lumefantrine|lumefantrine|mesh-list
138409475|NCT01614964|Artemether|artemether|mesh-list
138409476|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138409477|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
138409478|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138409479|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138409480|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409481|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138409482|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138409483|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138366103|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366104|NCT01395849|Fluticasone|fluticasone|mesh-list
138409484|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
138409485|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409486|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138409487|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138409488|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409489|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138409490|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409491|NCT01615042|Lenalidomide|lenalidomide|mesh-list
138409492|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
138290653|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
138409493|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409494|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138409495|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138290654|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409499|NCT01615055|Fluoxetine|fluoxetine|mesh-list
138409500|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138409501|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409502|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409503|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409504|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409505|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
138409506|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409507|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138409509|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409510|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138409511|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138409512|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409514|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409515|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409517|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
138409518|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409519|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409520|NCT01615185|Amisulpride|amisulpride|mesh-list
138409521|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138409522|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138409523|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409524|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409525|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409526|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138409527|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
138409528|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409529|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409530|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138409531|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
138409532|NCT01615211|Letrozole|letrozole|mesh-list
138409533|NCT01615211|Trilostane|trilostane|mesh-list
138409534|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409535|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138409536|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138409537|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409538|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409539|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138290698|NCT00000626|Vinblastine|vinblastine|mesh-list
138290711|NCT03109873|Metformin|metformin|mesh-list
138409541|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409542|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409543|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138409544|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
138409545|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409546|NCT01615224|Misoprostol|misoprostol|mesh-list
138409547|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138409548|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
138409549|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409550|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409551|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138409552|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138409553|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
138409554|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138409555|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138409556|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138409557|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138409558|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
138409559|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409560|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409561|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138409562|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138409563|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138409564|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138409565|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138409566|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138409567|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138409568|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138409569|NCT01615393|Ribavirin|ribavirin|mesh-list
138409570|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
138409571|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409572|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
138409573|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409574|NCT01615445|Resveratrol|resveratrol|mesh-list
138409575|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
138409576|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409577|NCT01615445|Protective Agents|protective agents|mesh-ancestor
138409578|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409579|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290728|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
138409580|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409581|NCT01615601|Ritonavir|ritonavir|mesh-list
138409582|NCT01615601|Darunavir|darunavir|mesh-list
138409583|NCT01615601|Etravirine|etravirine|mesh-list
138409584|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138409585|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138409586|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138409587|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
138409588|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409589|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409590|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138409591|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
138409592|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409593|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138409594|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138409596|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409597|NCT01615614|Rilpivirine|rilpivirine|mesh-list
138409598|NCT01615614|Rifabutin|rifabutin|mesh-list
138409599|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138409600|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409601|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409602|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409603|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
138409604|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409605|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138409606|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138409607|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409608|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138409609|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
138409610|NCT01615627|Treprostinil|treprostinil|mesh-list
138409611|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138290759|NCT00002162|Lamivudine|lamivudine|mesh-list
138409615|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
138409616|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409617|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409618|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
138409619|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409620|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409621|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
138409622|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409623|NCT01615796|Gepotidacin|gepotidacin|mesh-list
138409624|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138409625|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409626|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409627|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409628|NCT01615913|Ketoconazole|ketoconazole|mesh-list
138409629|NCT01615913|Terbinafine|terbinafine|mesh-list
138409630|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
138409631|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409632|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138409633|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138409634|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215917|NCT00601718|Etoposide|etoposide|mesh-list
138409635|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409636|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138409637|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
138409638|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409639|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409640|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138409642|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409643|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409644|NCT01615978|Incretins|incretins|mesh-ancestor
138409646|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409647|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
138409648|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138409649|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
138409650|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
138409651|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409652|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409653|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409654|NCT01616004|Analgesics|analgesics|mesh-ancestor
138409655|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
138290807|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138409658|NCT01616069|Epinephrine|epinephrine|mesh-list
138409659|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138409660|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138409661|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
138409662|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409663|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409664|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409665|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138409666|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138409667|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
138409668|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409669|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138409670|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409671|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
138409672|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
138409673|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138409674|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138409675|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409676|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138409677|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138409678|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409679|NCT01616069|Protective Agents|protective agents|mesh-ancestor
138409680|NCT01616108|Bupivacaine|bupivacaine|mesh-list
138409681|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
138409682|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
138409683|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409684|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409685|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
138290835|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138409687|NCT01616186|Everolimus|everolimus|mesh-list
138409688|NCT01616186|Sorafenib|sorafenib|mesh-list
138409689|NCT01616186|Sunitinib|sunitinib|mesh-list
138409690|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138409691|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138409692|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409693|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366112|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138366113|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
138366114|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366115|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138366116|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138366117|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138409694|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409696|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409697|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409698|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138409699|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138409700|NCT01616186|Growth Substances|growth substances|mesh-ancestor
138409701|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138409702|NCT01616225|Hormones|hormones|mesh-list
138409703|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409704|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409705|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138409706|NCT01616355|Eusol|eusol|mesh-list
138409707|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
138409708|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409709|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
138409710|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409711|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138409712|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138409713|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409714|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409715|NCT01616381|Urological Agents|urological agents|mesh-ancestor
138409716|NCT01616407|Methylphenidate|methylphenidate|mesh-list
138409717|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138409718|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138409719|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409720|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138409721|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409722|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409723|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409725|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409726|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
138409727|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409728|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
138409729|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138409730|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138409731|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
138409732|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
138290882|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409733|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409734|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
138409735|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138409736|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138409737|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409738|NCT01616485|Urological Agents|urological agents|mesh-ancestor
138409739|NCT01616615|Aspirin|aspirin|mesh-list
138409740|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409741|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409742|NCT01616615|Analgesics|analgesics|mesh-ancestor
138409743|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
138409744|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409745|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409746|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409747|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409748|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138409749|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138409750|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409751|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409752|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138409753|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409754|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
138409755|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138409756|NCT01616680|Antibodies|antibodies|mesh-list
138409757|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
138409759|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
138409760|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
138409761|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409762|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138409763|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409764|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
138409765|NCT01616732|Testosterone|testosterone|mesh-list
138409766|NCT01616732|Androgens|androgens|mesh-ancestor
138409768|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215918|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
138409769|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409771|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138409772|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
138409773|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409774|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409775|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
138409776|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409777|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138290911|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
138409780|NCT01616888|Paclitaxel|paclitaxel|mesh-list
138409781|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138409782|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409783|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138409784|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138409785|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138409786|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409787|NCT01616927|Lanreotide|lanreotide|mesh-list
138409788|NCT01616927|Somatostatin|somatostatin|mesh-list
138409789|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409790|NCT01616927|Hormones|hormones|mesh-ancestor
138409791|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409792|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409793|NCT01616966|Remifentanil|remifentanil|mesh-list
138409794|NCT01616966|Propofol|propofol|mesh-list
138409795|NCT01616966|Sevoflurane|sevoflurane|mesh-list
138409796|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138409797|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409798|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409799|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138409800|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
138409801|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
138409802|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138409803|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138409804|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138409805|NCT01616966|Narcotics|narcotics|mesh-ancestor
138409806|NCT01616966|Analgesics|analgesics|mesh-ancestor
138409807|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
138409808|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409809|NCT01616992|Bupivacaine|bupivacaine|mesh-list
138409810|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
138409811|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
138409812|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409813|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409814|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
138409815|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409816|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
138290941|NCT00002198|Abacavir|abacavir|mesh-list
138409817|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138409818|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409821|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138409822|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138409823|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138409824|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
138409825|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409826|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409827|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409828|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138409829|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409830|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138409831|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
138409832|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
138409833|NCT01617200|Olanzapine|olanzapine|mesh-list
138409834|NCT01617200|Asenapine|asenapine|mesh-list
138409835|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
138409836|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
138409837|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409838|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409839|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138409840|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138409841|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138409842|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409843|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409844|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138409845|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409846|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290976|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
138409847|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409848|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409850|NCT01617213|Lenalidomide|lenalidomide|mesh-list
138409851|NCT01617213|Melphalan|melphalan|mesh-list
138409852|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
138409853|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409854|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138409855|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138409856|NCT01617213|Growth Substances|growth substances|mesh-ancestor
138409857|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
138409858|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409861|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409862|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138409863|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409864|NCT01617226|Azacitidine|azacitidine|mesh-list
138409865|NCT01617226|Vorinostat|vorinostat|mesh-list
138409866|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138409867|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
138409868|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409869|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409870|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409871|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138409872|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
138409873|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138409874|NCT01617317|Antibodies|antibodies|mesh-list
138409875|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
138409876|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138409877|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
138409878|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409879|NCT01617356|Lidocaine|lidocaine|mesh-list
138409880|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
138409881|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
138409882|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409883|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409884|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
138409885|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409886|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138409887|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138409888|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138409889|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409890|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291008|NCT03758365|Desonide|desonide|mesh-list
138409892|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138409893|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138409894|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
138409895|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409897|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138409898|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409899|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138409900|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409901|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409902|NCT01617564|Bupivacaine|bupivacaine|mesh-list
138409903|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
138409904|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
138409905|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409906|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409907|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
138409908|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409909|NCT01617590|Methotrexate|methotrexate|mesh-list
138409910|NCT01617590|Leflunomide|leflunomide|mesh-list
138409911|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138409912|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
138409913|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138409914|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366125|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
138215919|NCT00601718|Ifosfamide|ifosfamide|mesh-list
138409915|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138409916|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
138409917|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409918|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409919|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138409920|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409921|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138409922|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138409923|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
138409924|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409925|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138409926|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
138409927|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138409928|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409929|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409930|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409931|NCT01617694|Analgesics|analgesics|mesh-ancestor
138409932|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
138409934|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138409935|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138409936|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138409937|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
138409938|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409939|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409940|NCT01617707|Midazolam|midazolam|mesh-list
138409941|NCT01617707|Propofol|propofol|mesh-list
138409942|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138409943|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409944|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409945|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138409946|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
138409947|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
138409948|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138409949|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138409950|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138409951|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138409952|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
138409953|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
138409954|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138409955|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409956|NCT01617733|Pasireotide|pasireotide|mesh-list
138409957|NCT01617733|Hormones|hormones|mesh-ancestor
138409958|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409959|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409960|NCT01617746|Bosentan|bosentan|mesh-list
138409961|NCT01617746|Ambrisentan|ambrisentan|mesh-list
138409962|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138409963|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138409964|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409965|NCT01617772|Atorvastatin|atorvastatin|mesh-list
138409966|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138409967|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138409968|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
138409969|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409970|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138409971|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138409972|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409973|NCT01617798|Metolazone|metolazone|mesh-list
138409974|NCT01617798|Furosemide|furosemide|mesh-list
138409975|NCT01617798|Diuretics|diuretics|mesh-ancestor
138409976|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
138409977|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366132|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366133|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366134|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138366135|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409978|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138409979|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409980|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409981|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138409982|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138409984|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409985|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409986|NCT01617824|Linagliptin|linagliptin|mesh-list
138409987|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138409988|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409989|NCT01617824|Incretins|incretins|mesh-ancestor
138409990|NCT01617824|Hormones|hormones|mesh-ancestor
138409991|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138409992|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138409993|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291112|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409994|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409995|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409996|NCT01617928|Paclitaxel|paclitaxel|mesh-list
138409997|NCT01617928|Carboplatin|carboplatin|mesh-list
138409998|NCT01617928|Veliparib|veliparib|mesh-list
138409999|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138410000|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410001|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410002|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410004|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410005|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138410006|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410007|NCT01618006|Aspirin|aspirin|mesh-list
138410008|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410009|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410010|NCT01618006|Analgesics|analgesics|mesh-ancestor
138410011|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
138410012|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410013|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410014|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410015|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410016|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138410017|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138410018|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410019|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410020|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138410021|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410023|NCT01618253|Sorafenib|sorafenib|mesh-list
138410024|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410025|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138410026|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410027|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410028|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138410029|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410030|NCT01618396|Midazolam|midazolam|mesh-list
138410031|NCT01618396|Propofol|propofol|mesh-list
138410032|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138410033|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410034|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410035|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138410036|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
138410037|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
138366142|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366144|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
138410040|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410041|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410042|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
138410043|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
138410044|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410045|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410046|NCT01618188|Insulin|insulin|mesh-list
138410047|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138410048|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
138410049|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
138410050|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138410051|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410052|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410053|NCT01618448|Tolvaptan|tolvaptan|mesh-list
138410054|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138410055|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410056|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
138410057|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410059|NCT01618474|Capecitabine|capecitabine|mesh-list
138410060|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410061|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410062|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410063|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410064|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410065|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138410066|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
138410067|NCT01618513|Octreotide|octreotide|mesh-list
138410068|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410069|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138410071|NCT01618539|Propofol|propofol|mesh-list
138410072|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138410073|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410074|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410075|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138410076|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
138410077|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
138410078|NCT01618591|Azithromycin|azithromycin|mesh-list
138410079|NCT01618591|Levofloxacin|levofloxacin|mesh-list
138410080|NCT01618591|Rifaximin|rifaximin|mesh-list
138410081|NCT01618591|Loperamide|loperamide|mesh-list
138410082|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
138410083|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138410084|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291196|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138410086|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138410087|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410088|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410089|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410090|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410091|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138410092|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138410093|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410094|NCT01618643|Acetic Acid|acetic acid|mesh-list
138410095|NCT01618643|Retinol acetate|retinol acetate|mesh-list
138410096|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138410098|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138410099|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
138410100|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410101|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138410102|NCT01618643|Protective Agents|protective agents|mesh-ancestor
138410103|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410104|NCT01618760|Risperidone|risperidone|mesh-list
138410105|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138410106|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
138291220|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291222|NCT00001646|Amebicides|amebicides|mesh-ancestor
138410107|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366155|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366156|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366157|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138366158|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
138410108|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410109|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410110|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138410111|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410112|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410114|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138410115|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
138410116|NCT01618773|Adapalene|adapalene|mesh-list
138410117|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138410118|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
138410119|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410120|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410121|NCT01618773|Analgesics|analgesics|mesh-ancestor
138410122|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
138410123|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410124|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410125|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410126|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410127|NCT01618799|Lamotrigine|lamotrigine|mesh-list
138410128|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
138410129|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138410130|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410131|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410132|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138410133|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410134|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138410135|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410136|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410137|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410138|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138410139|NCT01618825|Lamotrigine|lamotrigine|mesh-list
138410140|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
138410141|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138410142|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410143|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410144|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138410145|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410146|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138410147|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410148|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410149|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410150|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138410151|NCT01618877|Levetiracetam|levetiracetam|mesh-list
138410152|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
138410153|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
138410154|NCT01618890|Propranolol|propranolol|mesh-list
138291322|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410156|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138410157|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410158|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410159|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410160|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410161|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138410162|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138410163|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
138410164|NCT01618903|Levetiracetam|levetiracetam|mesh-list
138410165|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
138410166|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
138410167|NCT01618929|Montelukast|montelukast|mesh-list
138410169|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
138410170|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138410171|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410172|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410173|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410174|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138410175|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138410176|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410177|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
138410178|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138410179|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
138410180|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138410181|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
138410182|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410183|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410184|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
138410185|NCT01619046|Factor VIII|factor viii|mesh-list
138410186|NCT01619046|Coagulants|coagulants|mesh-ancestor
138410187|NCT01619072|Misoprostol|misoprostol|mesh-list
138410188|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138410189|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
138410190|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138410191|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410192|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138410193|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410194|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
138410195|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
138410197|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
138410198|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
138410199|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138410200|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410201|NCT01619150|Etoricoxib|etoricoxib|mesh-list
138410202|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410203|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410205|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
138410206|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410207|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410208|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410209|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410210|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138410211|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138410212|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410213|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410215|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410216|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
138410217|NCT01619163|Hormones|hormones|mesh-ancestor
138410218|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410219|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410220|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138410221|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410222|NCT01619280|Nitroprusside|nitroprusside|mesh-list
138410223|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138410224|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
138410225|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138410226|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410227|NCT01619436|Clonidine|clonidine|mesh-list
138410228|NCT01619436|Analgesics|analgesics|mesh-ancestor
138410229|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
138410230|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410231|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410232|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138410233|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
138410234|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
138410235|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138410236|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138410237|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138410238|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410239|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410243|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410246|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138410247|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138410248|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
138410249|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410250|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410251|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138410252|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138410253|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
138410254|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410255|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138410256|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138410257|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138410258|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138410259|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138410260|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410261|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410262|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410263|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410264|NCT01619566|Analgesics|analgesics|mesh-ancestor
138410265|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
138410266|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410267|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
138410268|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410269|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
138410270|NCT01619644|Valproic Acid|valproic acid|mesh-list
138410271|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
138410272|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410273|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410274|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
138410275|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410277|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
138410278|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138291446|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
138410279|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410281|NCT01619683|Enclomiphene|enclomiphene|mesh-list
138410282|NCT01619683|Clomiphene|clomiphene|mesh-list
138410283|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
138410284|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138410285|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410286|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410287|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410288|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138410289|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
138410290|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138410291|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138410292|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138410293|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
138410294|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
138410295|NCT01619761|Melphalan|melphalan|mesh-list
138410296|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
138410297|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138410298|NCT01619761|Rituximab|rituximab|mesh-list
138410299|NCT01619761|Fludarabine|fludarabine|mesh-list
138410300|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
138410301|NCT01619761|Lenalidomide|lenalidomide|mesh-list
138410302|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138410303|NCT01619761|Tacrolimus|tacrolimus|mesh-list
138410304|NCT01619761|Antibodies|antibodies|mesh-list
138410305|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
138410306|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138410307|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410308|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
138410309|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410310|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410311|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138410312|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
138291481|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410314|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410315|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138410316|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138410318|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138410319|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410320|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138410321|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138410322|NCT01619761|Growth Substances|growth substances|mesh-ancestor
138410323|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
138410325|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138410326|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
138410327|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138410328|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410329|NCT01619891|Vitamin D|vitamin d|mesh-list
138410330|NCT01619891|Vitamins|vitamins|mesh-ancestor
138410331|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
138366168|NCT01395927|Canagliflozin|canagliflozin|mesh-list
138410332|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410333|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138410334|NCT01620112|Lidocaine|lidocaine|mesh-list
138410335|NCT01620112|Clonidine|clonidine|mesh-list
138410336|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
138410337|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
138410338|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410339|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410340|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
138410341|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410342|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138410343|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138410344|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138291526|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
138410346|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410347|NCT01620112|Analgesics|analgesics|mesh-ancestor
138410348|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138410349|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
138410350|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
138410351|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138410352|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138410353|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138410354|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410355|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410356|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138410358|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
138410359|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138410360|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
138410361|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
138410362|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410363|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410364|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410365|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
138410366|NCT01620268|Leflunomide|leflunomide|mesh-list
138410367|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410368|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410369|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410370|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
138410371|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410372|NCT01620307|Sirolimus|sirolimus|mesh-list
138410373|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138410374|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410375|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291566|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138291568|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138291569|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138291570|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138291571|NCT03342157|Sennosides|sennosides|mesh-list
138291572|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
138291573|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291574|NCT03342157|Laxatives|laxatives|mesh-ancestor
138291575|NCT04331210|Diclofenac|diclofenac|mesh-list
138291576|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410378|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410379|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
138410380|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410381|NCT01620320|Dobutamine|dobutamine|mesh-list
138410382|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138410383|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
138410384|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
138410385|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410386|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410387|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138410388|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138410389|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138410390|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410391|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410392|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410393|NCT01620320|Protective Agents|protective agents|mesh-ancestor
138410394|NCT01620333|Insulin|insulin|mesh-list
138410395|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138291602|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291603|NCT05701436|Leucovorin|leucovorin|mesh-list
138291604|NCT05701436|Doxorubicin|doxorubicin|mesh-list
138291606|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
138291607|NCT05701436|Raltitrexed|raltitrexed|mesh-list
138291608|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291609|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291610|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291611|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410396|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
138410397|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
138410398|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138410399|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
138410400|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410401|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410402|NCT01620424|Insulin|insulin|mesh-list
138410403|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138410404|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
138410405|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
138410406|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138410407|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
138410408|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138410409|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410410|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410411|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
138410412|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
138410413|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410414|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410416|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138410417|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410418|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410419|NCT01620463|Liraglutide|liraglutide|mesh-list
138291648|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138291649|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410420|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138291650|NCT02436265|Dexamethasone|dexamethasone|mesh-list
138291651|NCT02436265|Ropivacaine|ropivacaine|mesh-list
138291652|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410421|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410423|NCT01620463|Hormones|hormones|mesh-ancestor
138410424|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410425|NCT01620476|Liraglutide|liraglutide|mesh-list
138410426|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410427|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410428|NCT01620476|Incretins|incretins|mesh-ancestor
138410430|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410431|NCT01620684|Metyrapone|metyrapone|mesh-list
138410432|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
138410433|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410434|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410435|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
138410436|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138410438|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
138410439|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410440|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138410441|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138291696|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138291697|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
138291698|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138410442|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410443|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291699|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410444|NCT01620814|Misoprostol|misoprostol|mesh-list
138410445|NCT01620814|Dinoprostone|dinoprostone|mesh-list
138410446|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138410447|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
138291700|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291704|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
138410449|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410450|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138410451|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410452|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
138410453|NCT01620840|Lacosamide|lacosamide|mesh-list
138410454|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
138410455|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138410456|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138410457|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410458|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410459|NCT01621022|Bupropion|bupropion|mesh-list
138410460|NCT01621022|Nicotine|nicotine|mesh-list
138410462|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
138410463|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410464|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410465|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138410466|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138410467|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
138410468|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410469|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410470|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138410471|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
138410472|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410473|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138410474|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138410475|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410476|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
138410477|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138410478|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138410479|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410480|NCT01621100|Hydromorphone|hydromorphone|mesh-list
138410481|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138410482|NCT01621100|Narcotics|narcotics|mesh-ancestor
138410483|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410484|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410485|NCT01621100|Analgesics|analgesics|mesh-ancestor
138410486|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
138291743|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291744|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291745|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291746|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410487|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410488|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
138410489|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138410490|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410491|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410493|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138410494|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138410495|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138410496|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138410497|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410498|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410499|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410500|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410501|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
138410502|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138410503|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
138410504|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138410505|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
138410506|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410507|NCT01621217|Cetuximab|cetuximab|mesh-list
138410508|NCT01621217|Mitomycins|mitomycins|mesh-list
138410509|NCT01621217|Mitomycin|mitomycin|mesh-list
138410510|NCT01621217|Fluorouracil|fluorouracil|mesh-list
138410511|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410512|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410513|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138410514|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
138410515|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410516|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291773|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291774|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138291775|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291776|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410517|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410518|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
138366173|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410519|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138410520|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410521|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
138410522|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410523|NCT01621256|Ancrod|ancrod|mesh-list
138410524|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
138410525|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138410526|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138410527|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410528|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138410529|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138410530|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410531|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410532|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
138410533|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410534|NCT01621308|Insulin|insulin|mesh-list
138410535|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138291818|NCT02360059|Metformin|metformin|mesh-list
138291819|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138291820|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291821|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
138410536|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410537|NCT01621321|Voriconazole|voriconazole|mesh-list
138291822|NCT00002510|Etoposide|etoposide|mesh-list
138291823|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291824|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
138291825|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291843|NCT00002516|Cobalt|cobalt|mesh-list
138410538|NCT01621321|Prednisolone|prednisolone|mesh-list
138410539|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410540|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
138410541|NCT01621321|Hormones|hormones|mesh-ancestor
138410542|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410543|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410544|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138410545|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410546|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
138410547|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410548|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138410549|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138410550|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410551|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410552|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138410553|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410554|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138410555|NCT01621373|Propofol|propofol|mesh-list
138410556|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138410557|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410558|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410559|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138410560|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
138410561|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
138410562|NCT01621386|Prednisone|prednisone|mesh-list
138410563|NCT01621386|Montelukast|montelukast|mesh-list
138410564|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291865|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410565|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
138410566|NCT01621386|Hormones|hormones|mesh-ancestor
138410567|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410568|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410569|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291866|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410570|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291868|NCT00002516|Trace Elements|trace elements|mesh-ancestor
138410573|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138410574|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410575|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138410576|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138410577|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410579|NCT01621451|Clopidogrel|clopidogrel|mesh-list
138410580|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410581|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410582|NCT01621451|Analgesics|analgesics|mesh-ancestor
138410583|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
138410584|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410585|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410586|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410587|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410588|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138410589|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138410590|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410591|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410592|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138410593|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410594|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
138410595|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138410596|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138410597|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138410598|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
138410599|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410601|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
138410602|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
138291905|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291906|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138291907|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291908|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
138291909|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291910|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291911|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291913|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138410603|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410604|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410605|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138410606|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138410608|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138410609|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410610|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410611|NCT01621620|Urological Agents|urological agents|mesh-ancestor
138410613|NCT01621698|Bupivacaine|bupivacaine|mesh-list
138291941|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410614|NCT01621698|Propofol|propofol|mesh-list
138410615|NCT01621698|Atracurium|atracurium|mesh-list
138410616|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
138410617|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
138410618|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410619|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410620|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
138410621|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410622|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138291942|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138291943|NCT00002534|Protective Agents|protective agents|mesh-ancestor
138410623|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138291944|NCT00002546|Ifosfamide|ifosfamide|mesh-list
138291945|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291949|NCT00378625|Artesunate|artesunate|mesh-list
138410625|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138410626|NCT01621698|Narcotics|narcotics|mesh-ancestor
138410627|NCT01621698|Analgesics|analgesics|mesh-ancestor
138410628|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138410629|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138410630|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138410631|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138410632|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138410633|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138410634|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
138410635|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410636|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410637|NCT01621750|Clopidogrel|clopidogrel|mesh-list
138410638|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410639|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138410640|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138410641|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138410642|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
138410643|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410644|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410645|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410646|NCT01621763|Clopidogrel|clopidogrel|mesh-list
138410647|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410648|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138410649|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138410650|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138410651|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
138410652|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410653|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291990|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
138291991|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291992|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410654|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410655|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
138291993|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291994|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138410657|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138410658|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410659|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138410661|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138410662|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410663|NCT01621971|Milrinone|milrinone|mesh-list
138410664|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138410665|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410666|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
138410667|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138410668|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138410669|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410670|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410671|NCT01621971|Protective Agents|protective agents|mesh-ancestor
138410672|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410673|NCT01622075|Paclitaxel|paclitaxel|mesh-list
138410674|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138410675|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138410676|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410677|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410678|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410679|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410680|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410681|NCT01622283|Cetirizine|cetirizine|mesh-list
138410682|NCT01622283|Levocetirizine|levocetirizine|mesh-list
138410683|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138410684|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138410685|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138292028|NCT00002570|Fluorouracil|fluorouracil|mesh-list
138410686|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
138410687|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
138410688|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410689|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292029|NCT00002570|Calcium|calcium|mesh-list
138292030|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
138292031|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138410690|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410692|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
138292032|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292033|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
138410694|NCT01622361|Doxorubicin|doxorubicin|mesh-list
138410695|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138410696|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410697|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
138410698|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410699|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410700|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138410701|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
138410702|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292063|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292064|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410703|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292065|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410704|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292066|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292069|NCT00002576|Hormones|hormones|mesh-ancestor
138410705|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410706|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410707|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410708|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138410709|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138410710|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410711|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410712|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138410713|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
138410714|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410715|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138410716|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138410718|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138410719|NCT01622439|Prednisone|prednisone|mesh-list
138292121|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138292122|NCT02239627|Clonidine|clonidine|mesh-list
138292123|NCT02239627|Analgesics|analgesics|mesh-ancestor
138292124|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
138292125|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292126|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292127|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138292128|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
138292129|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
138292130|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138292131|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138292132|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138410720|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
138410721|NCT01622439|Rituximab|rituximab|mesh-list
138410722|NCT01622439|Doxorubicin|doxorubicin|mesh-list
138410723|NCT01622439|Vincristine|vincristine|mesh-list
138410724|NCT01622439|Valproic Acid|valproic acid|mesh-list
138410725|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410726|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
138410727|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410728|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410729|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138410730|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
138410731|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410732|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410733|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138410734|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410735|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138410736|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138410737|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410738|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410739|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410740|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
138410741|NCT01622439|Hormones|hormones|mesh-ancestor
138410742|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410743|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292172|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410744|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292173|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138410745|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292174|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
138292175|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292176|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410746|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
138410747|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410748|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
138410749|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
138410750|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410751|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
138410752|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410753|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410754|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410755|NCT01622504|Naloxone|naloxone|mesh-list
138410756|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138410757|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410758|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
138410759|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410760|NCT01622556|Fludarabine|fludarabine|mesh-list
138410762|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
138410763|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410764|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410765|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410766|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
138410767|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410768|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
138410769|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138410770|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138410771|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138410772|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138410773|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138410774|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
138410775|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410776|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138410777|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138410778|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410779|NCT01622790|Lamivudine|lamivudine|mesh-list
138410780|NCT01622790|Abacavir|abacavir|mesh-list
138292218|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410781|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
138410782|NCT01622790|Dolutegravir|dolutegravir|mesh-list
138410783|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138410784|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138410785|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410786|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410787|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
138410789|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138410790|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138410791|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138410792|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138410793|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
138410794|NCT01622881|Nefopam|nefopam|mesh-list
138410795|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292219|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
138292220|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292221|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138410796|NCT01622881|Analgesics|analgesics|mesh-ancestor
138292222|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
138292223|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410797|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
138292224|NCT00002618|Antidotes|antidotes|mesh-ancestor
138292228|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
138410798|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410799|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410800|NCT01622933|Interferons|interferons|mesh-list
138410801|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
138410802|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410803|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
138410804|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410805|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
138410806|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410808|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138410809|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138410810|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410811|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
138292239|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292240|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292241|NCT02145169|Analgesics|analgesics|mesh-ancestor
138292242|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
138292243|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292245|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
138292246|NCT00002630|Melphalan|melphalan|mesh-list
138292247|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138410813|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138410814|NCT01622972|Laxatives|laxatives|mesh-ancestor
138410815|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410816|NCT01623024|Vitamin D|vitamin d|mesh-list
138410817|NCT01623024|Vitamins|vitamins|mesh-ancestor
138410818|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
138410819|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410820|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138410821|NCT01623102|Bevacizumab|bevacizumab|mesh-list
138410822|NCT01623102|Cisplatin|cisplatin|mesh-list
138410823|NCT01623102|Gemcitabine|gemcitabine|mesh-list
138410824|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410825|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410826|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138410827|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138410828|NCT01623102|Growth Substances|growth substances|mesh-ancestor
138410829|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410830|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138410831|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138410832|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
138410833|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292293|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292295|NCT01401049|Propofol|propofol|mesh-list
138410834|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138292296|NCT01401049|Fospropofol|fospropofol|mesh-list
138292297|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
138292298|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
138292320|NCT01402531|Bevacizumab|bevacizumab|mesh-list
138410837|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138410838|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
138410839|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410840|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138410841|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138410842|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410843|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138410844|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138410845|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
138410846|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
138410847|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410848|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
138410849|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410850|NCT01623349|Olaparib|olaparib|mesh-list
138410851|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138410852|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410853|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410854|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410855|NCT01623362|Fluorides|fluorides|mesh-list
138410856|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
138292342|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138410857|NCT01623362|Protective Agents|protective agents|mesh-ancestor
138410858|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410859|NCT01623375|Insulin|insulin|mesh-list
138410860|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138410861|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
138292343|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
138292344|NCT00002678|Hormones|hormones|mesh-ancestor
138410862|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138292345|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410863|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292346|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292347|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410866|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138410867|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410868|NCT01623440|Naltrexone|naltrexone|mesh-list
138410869|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138410870|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138410871|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410872|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
138410873|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410874|NCT01623505|Varenicline|varenicline|mesh-list
138410875|NCT01623505|Nicotine|nicotine|mesh-list
138410876|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138410877|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138410878|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
138410879|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410880|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410881|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410882|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138410883|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
138410885|NCT01623570|Menotropins|menotropins|mesh-list
138410886|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138410887|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
138410888|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138410889|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292380|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410890|NCT01623609|Naloxegol|naloxegol|mesh-list
138292381|NCT05600491|Temozolomide|temozolomide|mesh-list
138410891|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138292382|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292383|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
138410892|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410893|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
138410894|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410895|NCT01623635|Ropivacaine|ropivacaine|mesh-list
138410896|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
138410897|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
138410898|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410899|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410900|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
138410901|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410902|NCT01623713|Risperidone|risperidone|mesh-list
138410903|NCT01623713|Iloperidone|iloperidone|mesh-list
138410904|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138410905|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
138410906|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138410907|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410908|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410909|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138292425|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292426|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
138292427|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138292428|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
138292430|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
138292431|NCT01895959|Protective Agents|protective agents|mesh-ancestor
138410910|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138410911|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410912|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138410913|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138410914|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
138410915|NCT01623778|Interferons|interferons|mesh-list
138410916|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
138410917|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
138410918|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410919|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
138410920|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138410921|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
138410922|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410923|NCT01623817|Vancomycin|vancomycin|mesh-list
138410924|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138292476|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292477|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138292478|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138410925|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292490|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
138410926|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
138410927|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138410928|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410930|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138410931|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138410932|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138410933|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
138410934|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410935|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138410936|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138410937|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410938|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138410939|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138410940|NCT01623921|Analgesics|analgesics|mesh-ancestor
138410941|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
138410942|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410943|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410944|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410945|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138410946|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138410947|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138410948|NCT01624025|Docetaxel|docetaxel|mesh-list
138410949|NCT01624025|Epirubicin|epirubicin|mesh-list
138410950|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410951|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
138410952|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292532|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292533|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
138292534|NCT04706455|Protective Agents|protective agents|mesh-ancestor
138292535|NCT00002744|Cobalt|cobalt|mesh-list
138292536|NCT00002744|Cytarabine|cytarabine|mesh-list
138410954|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410955|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138410956|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138410957|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138410958|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410960|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410962|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410963|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410964|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138410965|NCT01624051|Cisplatin|cisplatin|mesh-list
138410966|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410967|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
138410968|NCT01624064|Enalapril|enalapril|mesh-list
138410969|NCT01624064|Calcium|calcium|mesh-list
138410970|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138410971|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138410972|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138410973|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410974|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138410975|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
138292577|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292578|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292579|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
138292593|NCT01788475|BB 1101|bb 1101|mesh-list
138410976|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410978|NCT01624103|Lidocaine|lidocaine|mesh-list
138410979|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
138410980|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
138410981|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
138410982|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138410983|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410984|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
138410985|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410986|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138410987|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138410988|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138410989|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410990|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410991|NCT01624116|Metformin|metformin|mesh-list
138410992|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138410993|NCT01624116|Acarbose|acarbose|mesh-list
138410994|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138410995|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410996|NCT01624116|Incretins|incretins|mesh-ancestor
138410997|NCT01624116|Hormones|hormones|mesh-ancestor
138410998|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138410999|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138411000|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
138411001|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411002|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411003|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138411004|NCT01624129|Fluticasone|fluticasone|mesh-list
138411005|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411006|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138411007|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
138411008|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411009|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411010|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138292626|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292627|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292628|NCT00002750|Melphalan|melphalan|mesh-list
138292629|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292630|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
138292631|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292637|NCT00002756|Leucovorin|leucovorin|mesh-list
138411011|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
138411012|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
138411013|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138411014|NCT01624207|Atorvastatin|atorvastatin|mesh-list
138411015|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138411016|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138411017|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
138411018|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411019|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138411020|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138411021|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411022|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138411024|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411025|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411026|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138411027|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411028|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411029|NCT01624337|Piperaquine|piperaquine|mesh-list
138411030|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
138411031|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138411032|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138411033|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411034|NCT01624428|Varenicline|varenicline|mesh-list
138411035|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138411036|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138411037|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411038|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411039|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411040|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411042|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138411043|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411044|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138411045|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138411046|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411047|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411048|NCT01624493|Carboplatin|carboplatin|mesh-list
138411049|NCT01624493|Gemcitabine|gemcitabine|mesh-list
138411050|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411051|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411052|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
138411053|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411055|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138411056|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138292659|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411057|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411058|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138411059|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138411060|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292660|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292661|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292662|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
138292667|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
138411062|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
138411063|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411064|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138411065|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138411066|NCT01624675|Risperidone|risperidone|mesh-list
138411067|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138411068|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
138411069|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411070|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411071|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411072|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138411073|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138411074|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411075|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138411076|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138411077|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
138411078|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
138411079|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411080|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411081|NCT01624766|Denosumab|denosumab|mesh-list
138411082|NCT01624766|Everolimus|everolimus|mesh-list
138411083|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138411084|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138411085|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411086|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292681|NCT00002756|Protective Agents|protective agents|mesh-ancestor
138411087|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292682|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292684|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
138292685|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292689|NCT01183429|Tretinoin|tretinoin|mesh-list
138411090|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411091|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411092|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138411093|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411094|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138411095|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138411096|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138411097|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
138411098|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411099|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138411100|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138411101|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411102|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138411104|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411105|NCT01625260|Gemcitabine|gemcitabine|mesh-list
138411106|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411107|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
138411108|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411109|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411110|NCT01625351|Sirolimus|sirolimus|mesh-list
138411111|NCT01625351|Fludarabine|fludarabine|mesh-list
138411112|NCT01625351|Melphalan|melphalan|mesh-list
138411113|NCT01625351|Busulfan|busulfan|mesh-list
138411114|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
138411115|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
138411116|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411117|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411118|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411119|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
138411120|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411121|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411122|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411123|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138411124|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
138411125|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138411126|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
138411127|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138411128|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411130|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138411131|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411132|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138411133|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138411134|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411135|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411136|NCT01625494|Amlodipine|amlodipine|mesh-list
138411137|NCT01625494|Irbesartan|irbesartan|mesh-list
138411138|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138292726|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292727|NCT00002768|Cytarabine|cytarabine|mesh-list
138292728|NCT00002768|Methotrexate|methotrexate|mesh-list
138292729|NCT00002768|Etoposide|etoposide|mesh-list
138292730|NCT00002768|Busulfan|busulfan|mesh-list
138411139|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138292731|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138411140|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292732|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292733|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292734|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411141|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411142|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411143|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411144|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
138411145|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138411146|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138411148|NCT01625520|Pasireotide|pasireotide|mesh-list
138411149|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138411150|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411151|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411152|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411153|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411154|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
138411155|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411156|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411157|NCT01625520|Hormones|hormones|mesh-ancestor
138411158|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411159|NCT01625572|Morphine|morphine|mesh-list
138411160|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138411161|NCT01625572|Narcotics|narcotics|mesh-ancestor
138411162|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411163|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411164|NCT01625572|Analgesics|analgesics|mesh-ancestor
138411165|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
138411166|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411167|NCT01625715|Ketotifen|ketotifen|mesh-list
138411168|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
138411169|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
138411170|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138411171|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
138411172|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
138411173|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411174|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411175|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411176|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138411177|NCT01625741|Rituximab|rituximab|mesh-list
138411178|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411179|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292740|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292741|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292742|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292743|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
138411180|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
138411181|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411182|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411184|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
138411185|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411186|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
138411187|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411188|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
138411189|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411190|NCT01625806|Ketoconazole|ketoconazole|mesh-list
138411191|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
138411192|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411193|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138411194|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138411195|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411196|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411197|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138411198|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411199|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411200|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411201|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138411202|NCT01625871|Lumefantrine|lumefantrine|mesh-list
138411203|NCT01625871|Artemether|artemether|mesh-list
138411204|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138411205|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
138411206|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138411207|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138411208|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411209|NCT01625936|Bevacizumab|bevacizumab|mesh-list
138411210|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411211|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411212|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138411213|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138411215|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411216|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138292771|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292772|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292773|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292774|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
138292775|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411218|NCT01625156|Temsirolimus|temsirolimus|mesh-list
138411219|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
138411220|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411221|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411223|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411224|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
138411225|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411226|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
138411227|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411228|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411229|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411230|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411231|NCT01626222|Everolimus|everolimus|mesh-list
138411232|NCT01626222|Exemestane|exemestane|mesh-list
138411233|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138411234|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411235|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411236|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411237|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411238|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
138411239|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411240|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411241|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138411242|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138411243|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138411244|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411245|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411246|NCT01626339|Bevacizumab|bevacizumab|mesh-list
138411247|NCT01626339|Ranibizumab|ranibizumab|mesh-list
138411248|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411249|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292804|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138292805|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138292806|NCT01122511|Growth Substances|growth substances|mesh-ancestor
138292808|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
138411250|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138411251|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138411252|NCT01626339|Growth Substances|growth substances|mesh-ancestor
138411253|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411254|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
138411256|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
138411257|NCT01626443|Inositol|inositol|mesh-list
138411258|NCT01626443|Hematinics|hematinics|mesh-ancestor
138411259|NCT01626443|Vitamins|vitamins|mesh-ancestor
138411260|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
138411261|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411262|NCT01626469|Captopril|captopril|mesh-list
138411263|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138411264|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
138411265|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411266|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411267|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138411268|NCT01626534|Clopidogrel|clopidogrel|mesh-list
138411269|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138411270|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138411271|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138411272|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138411273|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
138411274|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411275|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411276|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411277|NCT01626560|Vancomycin|vancomycin|mesh-list
138411278|NCT01626560|Daptomycin|daptomycin|mesh-list
138411279|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411280|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292844|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
138292845|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138292846|NCT00378937|Narcotics|narcotics|mesh-ancestor
138292847|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411281|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
138411283|NCT01626651|Ketoconazole|ketoconazole|mesh-list
138411284|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
138292849|NCT00378937|Analgesics|analgesics|mesh-ancestor
138411285|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411286|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138411287|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138411288|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411289|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411290|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138411291|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411292|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411293|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411294|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138411295|NCT01626911|Heparin|heparin|mesh-list
138411296|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138411297|NCT01626911|Tinzaparin|tinzaparin|mesh-list
138411298|NCT01626911|Dalteparin|dalteparin|mesh-list
138411299|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
138411300|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138411301|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138411302|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411303|NCT01627041|Cytarabine|cytarabine|mesh-list
138411304|NCT01627041|Decitabine|decitabine|mesh-list
138411305|NCT01627041|Daunorubicin|daunorubicin|mesh-list
138411306|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411307|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
138411308|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411309|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411310|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
138411311|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411312|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411313|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
138411314|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411315|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138411316|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138411317|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138411319|NCT01627106|Amiodarone|amiodarone|mesh-list
138411320|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138411321|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138411322|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138411323|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292883|NCT01090141|Micafungin|micafungin|mesh-list
138292884|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
138292885|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292886|NCT01048723|Everolimus|everolimus|mesh-list
138292887|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138292888|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138292889|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411325|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138411326|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138411327|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138411328|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411329|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138411330|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138411331|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138411332|NCT01627132|Dasatinib|dasatinib|mesh-list
138411333|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411334|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411335|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411336|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411337|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
138411338|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138411339|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138411340|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411341|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411342|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411343|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411344|NCT01627145|Urological Agents|urological agents|mesh-ancestor
138411346|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
138411347|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138411348|NCT01627158|Charcoal|charcoal|mesh-list
138411349|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411350|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138411351|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
138292914|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
138292915|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292916|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138292917|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138292918|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138292923|NCT05594407|Analgesics|analgesics|mesh-ancestor
138411352|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411353|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411355|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
138411356|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
138411357|NCT01627158|Hormones|hormones|mesh-ancestor
138411358|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411359|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138411360|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138411361|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138411362|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138411363|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411364|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411365|NCT01627158|Antidotes|antidotes|mesh-ancestor
138411366|NCT01627158|Protective Agents|protective agents|mesh-ancestor
138411367|NCT01627171|Bisacodyl|bisacodyl|mesh-list
138411368|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
138411369|NCT01627171|Cathartics|cathartics|mesh-ancestor
138411370|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411371|NCT01627171|Laxatives|laxatives|mesh-ancestor
138411372|NCT01627223|Lamivudine|lamivudine|mesh-list
138411373|NCT01627223|Entecavir|entecavir|mesh-list
138411374|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138411375|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138411377|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411378|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
138411379|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411380|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138411381|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138411382|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
138411383|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138411384|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138411385|NCT01627236|Prednisolone|prednisolone|mesh-list
138411386|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
138292953|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292954|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138292955|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
138292956|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292957|NCT01583647|Vitamins|vitamins|mesh-ancestor
138411387|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138411388|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
138411389|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411390|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
138411391|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
138411392|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411393|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411394|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411395|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
138411397|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411398|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138411399|NCT01627236|Protective Agents|protective agents|mesh-ancestor
138411400|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138411401|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411402|NCT01627262|Mesalamine|mesalamine|mesh-list
138411403|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138411404|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411405|NCT01627262|Analgesics|analgesics|mesh-ancestor
138411406|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
138411407|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411408|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411409|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411410|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411412|NCT01627353|Lidocaine|lidocaine|mesh-list
138411413|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
138411414|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411415|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
138411417|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411418|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411419|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411420|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
138411421|NCT01627353|Hormones|hormones|mesh-ancestor
138411422|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411423|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138411424|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292989|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138292990|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138292991|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292992|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292993|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292994|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411425|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411426|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
138411427|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
138215920|NCT00601718|Vorinostat|vorinostat|mesh-list
138411428|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411429|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
138411430|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138411431|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138411432|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138411433|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411434|NCT01627353|Analgesics|analgesics|mesh-ancestor
138411435|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
138411436|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138411437|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411438|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
138411439|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138411440|NCT01627379|Panitumumab|panitumumab|mesh-list
138411441|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411442|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411443|NCT01627431|Aspirin|aspirin|mesh-list
138411444|NCT01627431|Clopidogrel|clopidogrel|mesh-list
138411445|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138411446|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411447|NCT01627431|Analgesics|analgesics|mesh-ancestor
138411448|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
138411449|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411450|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411452|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411453|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138411454|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138411455|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411456|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138411457|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138411458|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411459|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
138411460|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138411461|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138411462|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138411463|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
138411464|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411465|NCT01627587|Ketoconazole|ketoconazole|mesh-list
138411466|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
138411467|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411468|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138411469|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138293018|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293019|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
138293020|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293021|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411471|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411472|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138411473|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411474|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411475|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411476|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138293044|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411478|NCT01627626|Miotics|miotics|mesh-ancestor
138411479|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
138411480|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411481|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411482|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138411483|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138411484|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411485|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411486|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411488|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
138411489|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138411490|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411491|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411492|NCT01627639|Diuretics|diuretics|mesh-ancestor
138411493|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
138293045|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
138293046|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
138293047|NCT01532635|Tacrolimus|tacrolimus|mesh-list
138293048|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411496|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138411497|NCT01627678|Sargramostim|sargramostim|mesh-list
138411498|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
138411499|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411500|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411501|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138411503|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411504|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411505|NCT01627717|Maraviroc|maraviroc|mesh-list
138411506|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138411507|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138411508|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411510|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138411511|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
138411512|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411513|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138411514|NCT01627834|Ropinirole|ropinirole|mesh-list
138411515|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138411516|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138411517|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
138411518|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
138411519|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411520|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411521|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411522|NCT01627847|Ropinirole|ropinirole|mesh-list
138411524|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138411525|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
138411526|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
138411527|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411528|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293090|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293091|NCT05467514|Incretins|incretins|mesh-ancestor
138411529|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411530|NCT01627873|Fentanyl|fentanyl|mesh-list
138411531|NCT01627873|Remifentanil|remifentanil|mesh-list
138411532|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138411533|NCT01627873|Narcotics|narcotics|mesh-ancestor
138411534|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411535|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411536|NCT01627873|Analgesics|analgesics|mesh-ancestor
138411537|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
138411538|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411539|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138411540|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138411541|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
138411542|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
138411543|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
138411544|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138411545|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411546|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
138411547|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
138411548|NCT01627938|Razoxane|razoxane|mesh-list
138411549|NCT01627938|Analgesics|analgesics|mesh-ancestor
138411550|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
138411551|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411552|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411553|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411554|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138411555|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138411556|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411557|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411558|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138411559|NCT01627938|Protective Agents|protective agents|mesh-ancestor
138293126|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138293127|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
138293128|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293129|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
138411560|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
138411561|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411564|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
138411565|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138411566|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138411567|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
138411568|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
138411569|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411570|NCT01628341|Insulin|insulin|mesh-list
138411571|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411572|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411573|NCT01628354|Ranibizumab|ranibizumab|mesh-list
138411574|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138411575|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138411576|NCT01628354|Growth Substances|growth substances|mesh-ancestor
138411577|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411578|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
138411579|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411581|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411582|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411583|NCT01628445|Incretins|incretins|mesh-ancestor
138411584|NCT01628445|Hormones|hormones|mesh-ancestor
138411585|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411586|NCT01628471|Decitabine|decitabine|mesh-list
138411587|NCT01628471|Genistein|genistein|mesh-list
138411588|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411589|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
138411590|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411591|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411592|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411593|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138411594|NCT01628471|Protective Agents|protective agents|mesh-ancestor
138411595|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411596|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138293167|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138293168|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138293169|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293170|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293171|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
138293172|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
138411597|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
138293173|NCT05136326|Capecitabine|capecitabine|mesh-list
138411598|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138411599|NCT01628471|Estrogens|estrogens|mesh-ancestor
138411600|NCT01628471|Hormones|hormones|mesh-ancestor
138411601|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411602|NCT01628562|Remifentanil|remifentanil|mesh-list
138411603|NCT01628562|Esmolol|esmolol|mesh-list
138411604|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138411605|NCT01628562|Narcotics|narcotics|mesh-ancestor
138411606|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411607|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411608|NCT01628562|Analgesics|analgesics|mesh-ancestor
138411610|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411611|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138411612|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138411613|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138411614|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
138411615|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411616|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411618|NCT01628666|Cefazolin|cefazolin|mesh-list
138411619|NCT01628666|Cephalexin|cephalexin|mesh-list
138411620|NCT01628666|Bacitracin|bacitracin|mesh-list
138411621|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411622|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411623|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138411624|NCT01628731|Furosemide|furosemide|mesh-list
138411625|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
138411626|NCT01628731|Diuretics|diuretics|mesh-ancestor
138411627|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
138411628|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411629|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138411630|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411631|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411632|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293203|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293204|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293205|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138293206|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138293207|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138411633|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138411635|NCT01628783|Escitalopram|escitalopram|mesh-list
138293208|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293209|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293210|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138411638|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411639|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411640|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411641|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
138411642|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411643|NCT01628952|Curare|curare|mesh-list
138411644|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138411645|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138411646|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138411647|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411648|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411649|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138411650|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138411651|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411652|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411653|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411654|NCT01629082|Lenalidomide|lenalidomide|mesh-list
138411655|NCT01629082|Clofarabine|clofarabine|mesh-list
138411656|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
138411657|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411658|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293235|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293236|NCT04713332|Protective Agents|protective agents|mesh-ancestor
138411660|NCT01629082|Growth Substances|growth substances|mesh-ancestor
138411661|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
138411662|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411663|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411664|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
138411665|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411666|NCT01629173|Ethylene|ethylene|mesh-list
138411667|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138411668|NCT01629173|Growth Substances|growth substances|mesh-ancestor
138411669|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411670|NCT01629199|Mitogens|mitogens|mesh-list
138411671|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411672|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411673|NCT01629212|Octylonium|octylonium|mesh-list
138411674|NCT01629212|Bromides|bromides|mesh-list
138411675|NCT01629212|Tiropramide|tiropramide|mesh-list
138411676|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
138411677|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
138411678|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
138411679|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411680|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411681|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138411682|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411683|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411684|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411685|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411686|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138411687|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138411688|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411689|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411691|NCT01629225|Candesartan cilexetil|candesartan cilexetil|mesh-list
138411692|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138411693|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138411694|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138411695|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411697|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411698|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411699|NCT01629277|Insulin|insulin|mesh-list
138293284|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293285|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
138411700|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411701|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293286|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
138293287|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411703|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
138411704|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
138411705|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138411706|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411707|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411709|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411711|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
138411712|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411713|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138411714|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411715|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411716|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138293311|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293312|NCT00323635|Urological Agents|urological agents|mesh-ancestor
138293314|NCT00314353|Capecitabine|capecitabine|mesh-list
138293315|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
138411719|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138411720|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411721|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411722|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
138411723|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411724|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411725|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138411726|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
138411727|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411728|NCT01629446|Lofexidine|lofexidine|mesh-list
138411729|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138411730|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138411731|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411732|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
138411733|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411734|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138411735|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138411736|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138411737|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
138411738|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411739|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411740|NCT01629511|Gemcitabine|gemcitabine|mesh-list
138411741|NCT01629511|Methotrexate|methotrexate|mesh-list
138411742|NCT01629511|Clofarabine|clofarabine|mesh-list
138411743|NCT01629511|Busulfan|busulfan|mesh-list
138411744|NCT01629511|Tacrolimus|tacrolimus|mesh-list
138411745|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
138411746|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138411747|NCT01629511|Lenograstim|lenograstim|mesh-list
138411748|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411749|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
138411750|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411751|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411752|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138411753|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
138411754|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138411755|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293372|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411756|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
138411757|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411758|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138411759|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411760|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
138411761|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411762|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138411763|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138411764|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138411765|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
138411766|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138411767|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138411768|NCT01629628|Adalimumab|adalimumab|mesh-list
138411769|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
138411770|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138411771|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411772|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411773|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
138411774|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411775|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411776|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411777|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411778|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
138411779|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411780|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138411781|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411783|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
138411784|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
138411785|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411786|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411787|NCT01629732|Ribavirin|ribavirin|mesh-list
138411788|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
138411789|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411790|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
138411791|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411792|NCT01629758|Nivolumab|nivolumab|mesh-list
138411793|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138411794|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411795|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138411796|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411797|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138411798|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138411799|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138411800|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411801|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293405|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293406|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411803|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411804|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411806|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411807|NCT01630018|Topotecan|topotecan|mesh-list
138411808|NCT01630018|Belotecan|belotecan|mesh-list
138411809|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138411810|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138411811|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411812|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411813|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411814|NCT01630057|Zonisamide|zonisamide|mesh-list
138411815|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
138411816|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138411817|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411818|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411819|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411820|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411821|NCT01630070|Paclitaxel|paclitaxel|mesh-list
138411822|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138411823|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411824|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138411825|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138411826|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411827|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411828|NCT01630083|Capecitabine|capecitabine|mesh-list
138411829|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
138411830|NCT01630083|Epirubicin|epirubicin|mesh-list
138411831|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293432|NCT04977674|Analgesics|analgesics|mesh-ancestor
138411832|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
138293433|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
138293434|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411833|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411834|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293435|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293436|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138293437|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138293447|NCT00402883|Folic Acid|folic acid|mesh-list
138411835|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138411836|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138411837|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138411839|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138411840|NCT01630096|Laxatives|laxatives|mesh-ancestor
138411841|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411842|NCT01630148|Bemiparin|bemiparin|mesh-list
138411843|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
138411844|NCT01630187|Carbetocin|carbetocin|mesh-list
138411845|NCT01630187|Oxytocin|oxytocin|mesh-list
138411846|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
138411847|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138411848|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411850|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411851|NCT01630278|Ibuprofen|ibuprofen|mesh-list
138411852|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138411853|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411854|NCT01630278|Analgesics|analgesics|mesh-ancestor
138411855|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
138411856|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411857|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411858|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411859|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138411860|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138411861|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411862|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411864|NCT01630343|Tramadol|tramadol|mesh-list
138411865|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411866|NCT01630343|Analgesics|analgesics|mesh-ancestor
138293466|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
138293467|NCT04939844|Lenalidomide|lenalidomide|mesh-list
138293468|NCT04939844|Bortezomib|bortezomib|mesh-list
138293469|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
138411867|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
138293470|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293471|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138411883|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138293504|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
138411885|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411886|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411887|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138411888|NCT01630564|Aldesleukin|aldesleukin|mesh-list
138411889|NCT01630564|Interleukin-2|interleukin-2|mesh-list
138411890|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411891|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138411893|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
138411894|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293505|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
138411895|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293506|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138411896|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138411897|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138411898|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
138293507|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138366180|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138366181|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138366182|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138411902|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138411903|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138411905|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
138411906|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411907|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411908|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411910|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138411911|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138411912|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138411913|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411914|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411915|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411916|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411917|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
138411918|NCT01630720|Vitamin D|vitamin d|mesh-list
138411919|NCT01630720|Vitamins|vitamins|mesh-list
138411920|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
138411921|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411922|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138411923|NCT01630733|Docetaxel|docetaxel|mesh-list
138411924|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411925|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
138411926|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
138411927|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138411928|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411929|NCT01630902|Felodipine|felodipine|mesh-list
138411930|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138411931|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138411932|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138411933|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411934|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411935|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411936|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411937|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
138411939|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138293533|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293535|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138293536|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138293538|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
138411940|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138411941|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138411942|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138411943|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
138411944|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411945|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411946|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411947|NCT01630941|Denosumab|denosumab|mesh-list
138411948|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138411949|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411950|NCT01631058|Prednisone|prednisone|mesh-list
138411951|NCT01631058|Everolimus|everolimus|mesh-list
138411952|NCT01631058|Lactitol|lactitol|mesh-list
138411954|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
138411955|NCT01631058|Hormones|hormones|mesh-ancestor
138411956|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411957|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411958|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138411959|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411960|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138411961|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411962|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411963|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411964|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411965|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
138411966|NCT01631058|Cathartics|cathartics|mesh-ancestor
138411967|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411968|NCT01631097|Tivozanib|tivozanib|mesh-list
138411969|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138411970|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411971|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411972|NCT01631136|Cisplatin|cisplatin|mesh-list
138411973|NCT01631136|Gemcitabine|gemcitabine|mesh-list
138411974|NCT01631136|Pemetrexed|pemetrexed|mesh-list
138411975|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411976|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138411977|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
138411978|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411979|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411980|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138411981|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293561|NCT00000199|Piracetam|piracetam|mesh-list
138411982|NCT01631201|Azithromycin|azithromycin|mesh-list
138293562|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138293563|NCT00000199|Protective Agents|protective agents|mesh-ancestor
138293564|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293566|NCT00668785|Ranibizumab|ranibizumab|mesh-list
138293567|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138411985|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411986|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138411987|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
138411988|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
138411990|NCT01631305|Calcium|calcium|mesh-list
138411991|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138411992|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411993|NCT01631305|Antacids|antacids|mesh-ancestor
138411994|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411995|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138411996|NCT01631357|Cisplatin|cisplatin|mesh-list
138411997|NCT01631357|Gemcitabine|gemcitabine|mesh-list
138411998|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138411999|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412000|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
138412001|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412002|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
138412003|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138412004|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412005|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138412006|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412007|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412008|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412009|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412010|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138412011|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412012|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412013|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412014|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138412015|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
138412016|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412017|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412018|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412020|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
138412021|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293591|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293592|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293593|NCT04358432|Ezetimibe|ezetimibe|mesh-list
138412022|NCT01631396|Neostigmine|neostigmine|mesh-list
138293594|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138412024|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412025|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412026|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412027|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412028|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412029|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138412030|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
138412031|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412032|NCT01631409|Aspirin|aspirin|mesh-list
138412033|NCT01631409|Atenolol|atenolol|mesh-list
138412034|NCT01631409|Enalapril|enalapril|mesh-list
138412035|NCT01631409|Enalaprilat|enalaprilat|mesh-list
138412036|NCT01631409|Amlodipine|amlodipine|mesh-list
138412037|NCT01631409|Isosorbide|isosorbide|mesh-list
138412038|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138412039|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138412040|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
138412041|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138412042|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412043|NCT01631409|Analgesics|analgesics|mesh-ancestor
138412044|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
138412045|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412046|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412047|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412048|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412049|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138293620|NCT00000223|Analgesics|analgesics|mesh-ancestor
138293621|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
138412050|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138293622|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293624|NCT00000229|Buprenorphine|buprenorphine|mesh-list
138293625|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293626|NCT00000229|Narcotics|narcotics|mesh-ancestor
138293627|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293628|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412052|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412053|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138412054|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412055|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
138412056|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138412057|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
138412058|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412059|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138412060|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
138412061|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
138412062|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138412063|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138412064|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138412065|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412066|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412067|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138412068|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412069|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412070|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412071|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138412072|NCT01631409|Diuretics|diuretics|mesh-ancestor
138412073|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
138412074|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138412075|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138412076|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
138412077|NCT01631448|Coagulants|coagulants|mesh-ancestor
138412079|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293662|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412081|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412082|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293663|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
138293664|NCT00000259|Sevoflurane|sevoflurane|mesh-list
138412084|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
138293665|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412085|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293666|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138293667|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
138293668|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
138293675|NCT00379405|Ritonavir|ritonavir|mesh-list
138412089|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412090|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412091|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412092|NCT01631526|Vitamin D|vitamin d|mesh-list
138412093|NCT01631526|Vitamins|vitamins|mesh-ancestor
138412094|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
138412095|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412096|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412097|NCT01631539|Irinotecan|irinotecan|mesh-list
138412098|NCT01631539|Cetuximab|cetuximab|mesh-list
138412099|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138412100|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138412101|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412102|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412103|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412104|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412105|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
138412106|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138412107|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412108|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412109|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412110|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412111|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412112|NCT01631669|Celecoxib|celecoxib|mesh-list
138412113|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138412114|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412115|NCT01631669|Analgesics|analgesics|mesh-ancestor
138412116|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
138412117|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412118|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412119|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412120|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412121|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138412122|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138412123|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412124|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412125|NCT01631838|Tocotrienols|tocotrienols|mesh-list
138412126|NCT01631838|Vitamin E|vitamin e|mesh-list
138412128|NCT01631838|Tocovid|tocovid|mesh-list
138412129|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
138412130|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412131|NCT01631838|Protective Agents|protective agents|mesh-ancestor
138412132|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412133|NCT01631838|Vitamins|vitamins|mesh-ancestor
138293696|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412138|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138412139|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138412140|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412141|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138412143|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412144|NCT01631994|Metoclopramide|metoclopramide|mesh-list
138412145|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
138412146|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
138412147|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412148|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412149|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138412150|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138412151|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138412152|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
138412153|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412154|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412155|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
138412156|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138412157|NCT01632163|Lixisenatide|lixisenatide|mesh-list
138412158|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138412159|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412160|NCT01632189|Varenicline|varenicline|mesh-list
138412161|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138412162|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138412163|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412164|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293722|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
138412166|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412168|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138412169|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138412170|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412171|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
138412172|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
138412173|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
138412174|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412175|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
138412176|NCT01632514|Vitamin D|vitamin d|mesh-list
138412177|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412178|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412180|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
138412181|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412182|NCT01632540|Beclomethasone|beclomethasone|mesh-list
138412183|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412184|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
138412185|NCT01632540|Hormones|hormones|mesh-ancestor
138412186|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138412187|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412188|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138412189|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138412190|NCT01632592|Tesamorelin|tesamorelin|mesh-list
138412191|NCT01632592|Growth Substances|growth substances|mesh-ancestor
138412192|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412193|NCT01632605|Sirolimus|sirolimus|mesh-list
138412196|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138412197|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412198|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
138412199|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412200|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
138412202|NCT01632722|Bevacizumab|bevacizumab|mesh-list
138412203|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412204|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412205|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138412206|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412207|NCT01632722|Growth Substances|growth substances|mesh-ancestor
138412208|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412209|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412210|NCT01632761|Vitamin D|vitamin d|mesh-list
138412211|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
138412212|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
138412213|NCT01632761|Vitamins|vitamins|mesh-list
138412214|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
138412215|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412216|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412217|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412218|NCT01632826|Pomalidomide|pomalidomide|mesh-list
138412219|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
138412220|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412221|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138412222|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293803|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138412226|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
138412227|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138412228|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
138412229|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412230|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412231|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138412232|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
138412233|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138412234|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
138412235|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412236|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412237|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138412238|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412239|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
138412240|NCT01633086|Protective Agents|protective agents|mesh-ancestor
138412241|NCT01633099|Decitabine|decitabine|mesh-list
138412242|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412244|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412245|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412246|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412247|NCT01633203|Capecitabine|capecitabine|mesh-list
138412248|NCT01633203|Epirubicin|epirubicin|mesh-list
138412249|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412250|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412251|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
138412252|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412253|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138412254|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138412255|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138412256|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412258|NCT01633294|Ampicillin|ampicillin|mesh-list
138412259|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138412260|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412261|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138412262|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412263|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412264|NCT01633359|Atorvastatin|atorvastatin|mesh-list
138412265|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138412266|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138412267|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138412268|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
138412269|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412270|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138412271|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412273|NCT01633450|Trace Elements|trace elements|mesh-ancestor
138412274|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
138412275|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412276|NCT01633476|Valacyclovir|valacyclovir|mesh-list
138412277|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
138412278|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412279|NCT01633593|Donepezil|donepezil|mesh-list
138412280|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138412281|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293884|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412285|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412286|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
138412287|NCT01633645|Gemcitabine|gemcitabine|mesh-list
138412288|NCT01633645|Bortezomib|bortezomib|mesh-list
138412289|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412290|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412291|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
138412292|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412293|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
138412295|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412296|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412297|NCT01633658|Vitamins|vitamins|mesh-ancestor
138412298|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
138412299|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412300|NCT01633749|Vaccines|vaccines|mesh-list
138412301|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
138412302|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412303|NCT01633762|Vancomycin|vancomycin|mesh-list
138412305|NCT01633762|Meropenem|meropenem|mesh-list
138412306|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138412307|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412308|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138412309|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412310|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412311|NCT01633957|Warfarin|warfarin|mesh-list
138412312|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
138412313|NCT01633970|Leucovorin|leucovorin|mesh-list
138412314|NCT01633970|Paclitaxel|paclitaxel|mesh-list
138412315|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138412316|NCT01633970|Bevacizumab|bevacizumab|mesh-list
138412317|NCT01633970|Carboplatin|carboplatin|mesh-list
138412318|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
138412319|NCT01633970|Pemetrexed|pemetrexed|mesh-list
138412320|NCT01633970|Atezolizumab|atezolizumab|mesh-list
138412321|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138412322|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412323|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138412324|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138412325|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293923|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
138412329|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412330|NCT01633970|Growth Substances|growth substances|mesh-ancestor
138412331|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412332|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412333|NCT01633970|Antidotes|antidotes|mesh-ancestor
138412334|NCT01633970|Protective Agents|protective agents|mesh-ancestor
138412335|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
138412336|NCT01633970|Vitamins|vitamins|mesh-ancestor
138412337|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
138412338|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412339|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138412340|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138412341|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138412342|NCT01633983|Methotrexate|methotrexate|mesh-list
138412343|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138412344|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
138412345|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138412346|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412347|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412348|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
138293951|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293953|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
138412349|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412350|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412352|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412353|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138412354|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412355|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
138412356|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412357|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138412359|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412360|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
138412361|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412362|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
138412363|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412364|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412365|NCT01634295|Niacin|niacin|mesh-list
138412366|NCT01634295|Amlodipine|amlodipine|mesh-list
138412367|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412368|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138412369|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412370|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412371|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412372|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412373|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412374|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138412375|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
138412376|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138412377|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
138412378|NCT01634295|Vitamins|vitamins|mesh-ancestor
138412379|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
138293993|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138293994|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138412384|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412385|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138412386|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412387|NCT01634347|Propranolol|propranolol|mesh-list
138412388|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138412389|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138412390|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412391|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412392|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412393|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412394|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138412395|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412396|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412397|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138412398|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
138412399|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412400|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138412401|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412402|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412403|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412404|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138412406|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412407|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138412408|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412409|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412410|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412411|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138412412|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
138412413|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412414|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138412415|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412416|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412417|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412419|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
138412420|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138412421|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
138412422|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412423|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138412424|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412431|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
138412432|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138412433|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138412434|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412435|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412436|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412437|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412438|NCT01634438|Heparin|heparin|mesh-list
138412439|NCT01634438|Calcium heparin|calcium heparin|mesh-list
138412440|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
138412441|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138412442|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138412443|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412444|NCT01634594|Nicardipine|nicardipine|mesh-list
138412445|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
138412446|NCT01634594|Remifentanil|remifentanil|mesh-list
138412447|NCT01634594|Sevoflurane|sevoflurane|mesh-list
138412448|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138412449|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412450|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412451|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412452|NCT01634594|Analgesics|analgesics|mesh-ancestor
138412453|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
138412454|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412455|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138412456|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138412457|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138412458|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412459|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412460|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412461|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412462|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138412463|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
138412464|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
138412465|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138412466|NCT01634594|Narcotics|narcotics|mesh-ancestor
138412467|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412468|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138412469|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412470|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412471|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138412472|NCT01634685|Capecitabine|capecitabine|mesh-list
138412473|NCT01634685|Bavituximab|bavituximab|mesh-list
138412474|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412475|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
138412476|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412477|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412478|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412479|NCT01634698|Vitamin A|vitamin a|mesh-list
138412480|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
138412481|NCT01634698|Vitamins|vitamins|mesh-ancestor
138412482|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
138412483|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412484|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
138294132|NCT00000445|Naltrexone|naltrexone|mesh-list
138412486|NCT01634698|Protective Agents|protective agents|mesh-ancestor
138412487|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138412488|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412489|NCT01634763|Ceritinib|ceritinib|mesh-list
138412490|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412491|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138412492|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412493|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412494|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
138412495|NCT01634789|Estrogens|estrogens|mesh-list
138412496|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138412497|NCT01634789|Hormones|hormones|mesh-ancestor
138412498|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138412499|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412500|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138412501|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138412503|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412504|NCT01634880|Panitumumab|panitumumab|mesh-list
138412505|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412506|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412507|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
138412508|NCT01634893|Sorafenib|sorafenib|mesh-list
138412509|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412510|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138412511|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412512|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412513|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
138412514|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294138|NCT00000451|Naltrexone|naltrexone|mesh-list
138412516|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412517|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412519|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138412520|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138412521|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138412522|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
138412523|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412524|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138412525|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138412526|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412529|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
138412530|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412532|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
138412533|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138412534|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412535|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412536|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138412537|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138412538|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
138412539|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412540|NCT01634958|Antacids|antacids|mesh-ancestor
138294179|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138412541|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412542|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138412543|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
138412544|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412545|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
138412546|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138412548|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
138412549|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412550|NCT01635114|Protective Agents|protective agents|mesh-ancestor
138412551|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412552|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412553|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412554|NCT01635205|Anesthetics|anesthetics|mesh-list
138412555|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412556|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412558|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412559|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
138412560|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412561|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412562|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
138412563|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412564|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412565|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
138412566|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412568|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138412569|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138412570|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412571|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294227|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
138412573|NCT01635530|Doxycycline|doxycycline|mesh-list
138412574|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
138412575|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138412576|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412577|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
138412578|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138412579|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412580|NCT01635608|Acetaminophen|acetaminophen|mesh-list
138412581|NCT01635608|Amoxicillin|amoxicillin|mesh-list
138412582|NCT01635608|Talinolol|talinolol|mesh-list
138412583|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412584|NCT01635608|Analgesics|analgesics|mesh-ancestor
138412585|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
138412586|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412587|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412588|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
138412589|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138412590|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412591|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138412592|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138412593|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412594|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412595|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412597|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138412598|NCT01635686|Etanercept|etanercept|mesh-list
138412599|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138412600|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412601|NCT01635686|Analgesics|analgesics|mesh-ancestor
138412602|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
138412603|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412604|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412605|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412606|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412607|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138412608|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412609|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
138412611|NCT01635751|Analgesics|analgesics|mesh-ancestor
138412612|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
138412613|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412614|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412615|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
138294283|NCT03015896|Nivolumab|nivolumab|mesh-list
138412618|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412620|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138412621|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412622|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412623|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412624|NCT01635777|Miltefosine|miltefosine|mesh-list
138412625|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
138412626|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412627|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412628|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138412629|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412630|NCT01635790|Bevacizumab|bevacizumab|mesh-list
138412631|NCT01635790|Ranibizumab|ranibizumab|mesh-list
138412632|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412633|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412634|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138412635|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412636|NCT01635790|Growth Substances|growth substances|mesh-ancestor
138412637|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412638|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412640|NCT01635803|Ranibizumab|ranibizumab|mesh-list
138412641|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412642|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412643|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138412644|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412645|NCT01635803|Growth Substances|growth substances|mesh-ancestor
138294305|NCT00000613|Genistein|genistein|mesh-list
138412650|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412651|NCT01635829|Carbamazepine|carbamazepine|mesh-list
138412653|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
138412654|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
138412655|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412656|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412657|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412658|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412659|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412660|NCT01635829|Analgesics|analgesics|mesh-ancestor
138412661|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
138412662|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412663|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138412664|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294333|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138294334|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138412669|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138412670|NCT01635946|Isavuconazole|isavuconazole|mesh-list
138412671|NCT01635946|Atorvastatin|atorvastatin|mesh-list
138412672|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138412673|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138412674|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
138412675|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412676|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138412677|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138412678|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412679|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
138412681|NCT01635972|Isavuconazole|isavuconazole|mesh-list
138412683|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138412684|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
138412685|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412686|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138412687|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138412688|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412689|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294384|NCT00002948|Topotecan|topotecan|mesh-list
138412692|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412693|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138412694|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138412695|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412696|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
138412697|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412700|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138412701|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138412702|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138412703|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
138412704|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412705|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294414|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294415|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294416|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
138412707|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138412708|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412709|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138412710|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
138412711|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
138412712|NCT01636128|Eflornithine|eflornithine|mesh-list
138412714|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412715|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138412716|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138412717|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412718|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412719|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138412720|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412721|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412722|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138412723|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412724|NCT01636128|Analgesics|analgesics|mesh-ancestor
138412725|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
138412726|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412727|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412728|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412729|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294468|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138412731|NCT01636141|Dapansutrile|dapansutrile|mesh-list
138412732|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412733|NCT01636180|Clopidogrel|clopidogrel|mesh-list
138412734|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412735|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138412736|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138412737|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138412738|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
138412739|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412740|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412741|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412743|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
138412744|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412745|NCT01636271|Darapladib|darapladib|mesh-list
138412746|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138412748|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412749|NCT01636310|Nicotine|nicotine|mesh-list
138412750|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138412751|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
138412752|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412753|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412754|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138412755|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138412756|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412757|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412758|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412759|NCT01636323|Nicotine|nicotine|mesh-list
138412760|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138412761|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
138412762|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412763|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412764|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138412765|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138412766|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412767|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412768|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412769|NCT01636336|Nicotine|nicotine|mesh-list
138412770|NCT01636336|Progesterone|progesterone|mesh-list
138412771|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138412772|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
138412773|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412774|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412775|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138412776|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138412777|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412778|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294564|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
138294565|NCT00000703|Hormones|hormones|mesh-ancestor
138294571|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412780|NCT01636336|Progestins|progestins|mesh-ancestor
138412782|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138412783|NCT01636401|Bromides|bromides|mesh-list
138412784|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
138412785|NCT01636505|Cetrorelix|cetrorelix|mesh-list
138412786|NCT01636505|Buserelin|buserelin|mesh-list
138412787|NCT01636505|Ganirelix|ganirelix|mesh-list
138412788|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138412789|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
138412790|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138412791|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412792|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138412793|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138412794|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138412795|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
138412796|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412797|NCT01636557|Vitamin K|vitamin k|mesh-list
138412798|NCT01636557|Midazolam|midazolam|mesh-list
138412799|NCT01636557|Caffeine|caffeine|mesh-list
138412800|NCT01636557|Omeprazole|omeprazole|mesh-list
138412801|NCT01636557|Warfarin|warfarin|mesh-list
138412802|NCT01636557|Vitamins|vitamins|mesh-ancestor
138412803|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
138412804|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412805|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138412806|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138412807|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412808|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138412809|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138412810|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138412811|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138412812|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
138412813|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
138412817|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412818|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
138412819|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138412820|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138412821|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412822|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138412823|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138412824|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
138412825|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138412826|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138412827|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138412828|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138412829|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138412832|NCT01636570|Vitamin D|vitamin d|mesh-list
138412833|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
138412834|NCT01636570|Vitamins|vitamins|mesh-ancestor
138412835|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
138412836|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412837|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412838|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412839|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
138412840|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138412841|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412842|NCT01636609|Cytarabine|cytarabine|mesh-list
138412843|NCT01636609|Azacitidine|azacitidine|mesh-list
138412844|NCT01636609|Tosedostat|tosedostat|mesh-list
138412845|NCT01636609|Glycine|glycine|mesh-list
138412846|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138412847|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
138412848|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412849|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412850|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
138412851|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412852|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412853|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
138412854|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412855|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412859|NCT01636622|Carboplatin|carboplatin|mesh-list
138412860|NCT01636622|Vemurafenib|vemurafenib|mesh-list
138412861|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138412862|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412863|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138412864|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138412865|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138412866|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412867|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138412868|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412869|NCT01636700|Tramadol|tramadol|mesh-list
138412870|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138412871|NCT01636700|Narcotics|narcotics|mesh-ancestor
138412872|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412873|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412874|NCT01636700|Analgesics|analgesics|mesh-ancestor
138412875|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
138412876|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412877|NCT01635426|Aspirin|aspirin|mesh-list
138412878|NCT01635426|Clopidogrel|clopidogrel|mesh-list
138412879|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138412880|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138294681|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
138294682|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412881|NCT01635426|Analgesics|analgesics|mesh-ancestor
138412882|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
138412883|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412884|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412885|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412886|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138412887|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138412888|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138412889|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412890|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138412891|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138412892|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412893|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
138412894|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138412895|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138412896|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138412898|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412899|NCT01636869|Bupivacaine|bupivacaine|mesh-list
138412900|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
138412901|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
138412902|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412903|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412904|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
138412905|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412906|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
138412909|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
138412910|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138412911|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412912|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412913|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138412914|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412915|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412916|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138412917|NCT01636908|Everolimus|everolimus|mesh-list
138412918|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138412919|NCT01636908|Sorafenib|sorafenib|mesh-list
138412920|NCT01636908|Sunitinib|sunitinib|mesh-list
138412921|NCT01636908|Dasatinib|dasatinib|mesh-list
138412922|NCT01636908|Lapatinib|lapatinib|mesh-list
138412923|NCT01636908|Vemurafenib|vemurafenib|mesh-list
138412924|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138412925|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138412926|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412927|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294774|NCT00001135|Nevirapine|nevirapine|mesh-list
138294775|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294788|NCT00001891|Dobutamine|dobutamine|mesh-list
138412931|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412932|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138412933|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412934|NCT01636908|Growth Substances|growth substances|mesh-ancestor
138412935|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412936|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
138412937|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138412938|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
138412939|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
138412940|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412941|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412942|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138412943|NCT01636999|Analgesics|analgesics|mesh-ancestor
138412944|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
138412945|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412946|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
138412947|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
138412948|NCT01637025|Coagulants|coagulants|mesh-ancestor
138412949|NCT01637155|Vitamin D|vitamin d|mesh-list
138412950|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
138412951|NCT01637155|Vitamins|vitamins|mesh-ancestor
138412952|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
138412953|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412954|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138412955|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138412956|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138412957|NCT01637194|Cetuximab|cetuximab|mesh-list
138412959|NCT01637194|Antibodies|antibodies|mesh-list
138412960|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
138412961|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138412962|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
138412963|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412964|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412965|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138412966|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138412967|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412968|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412969|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412970|NCT01637233|Ritonavir|ritonavir|mesh-list
138412971|NCT01637233|Lopinavir|lopinavir|mesh-list
138412972|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138412973|NCT01637233|Darunavir|darunavir|mesh-list
138412974|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
138412975|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138412976|NCT01637233|Tenofovir|tenofovir|mesh-list
138412977|NCT01637233|Lamivudine|lamivudine|mesh-list
138412978|NCT01637233|Emtricitabine|emtricitabine|mesh-list
138412979|NCT01637233|Zidovudine|zidovudine|mesh-list
138412980|NCT01637233|Maraviroc|maraviroc|mesh-list
138412981|NCT01637233|Abacavir|abacavir|mesh-list
138412982|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
138412983|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138412984|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
138412985|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138412986|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294821|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138412987|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412989|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138412990|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
138412991|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412992|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138412993|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138412994|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138412995|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
138412996|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138412997|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138412998|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138412999|NCT01637259|Ritonavir|ritonavir|mesh-list
138413000|NCT01637259|Lopinavir|lopinavir|mesh-list
138413001|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138413002|NCT01637259|Darunavir|darunavir|mesh-list
138413003|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
138413004|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138413005|NCT01637259|Tenofovir|tenofovir|mesh-list
138413006|NCT01637259|Lamivudine|lamivudine|mesh-list
138413007|NCT01637259|Emtricitabine|emtricitabine|mesh-list
138413008|NCT01637259|Zidovudine|zidovudine|mesh-list
138413009|NCT01637259|Maraviroc|maraviroc|mesh-list
138413010|NCT01637259|Abacavir|abacavir|mesh-list
138413011|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
138294834|NCT00002347|Zidovudine|zidovudine|mesh-list
138413012|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138413013|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
138413014|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138413015|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413016|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413017|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413018|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413019|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
138413020|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413021|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138413022|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413023|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413024|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
138413025|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138413026|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138413027|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138413029|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294878|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413031|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413033|NCT01637454|Norepinephrine|norepinephrine|mesh-list
138413034|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413035|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138413036|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138413037|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138413038|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413039|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413040|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413041|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413042|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
138413043|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
138413044|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413045|NCT01637532|Interferons|interferons|mesh-list
138413046|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
138413047|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
138413048|NCT01637532|Carboplatin|carboplatin|mesh-list
138413049|NCT01637532|Doxorubicin|doxorubicin|mesh-list
138413050|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413051|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138413052|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138413053|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413054|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413055|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413056|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
138413057|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413058|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
138413059|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413061|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
138413062|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
138294928|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413064|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413065|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413066|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138413067|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
138413068|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413069|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413072|NCT01637558|Nevirapine|nevirapine|mesh-list
138413073|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138413074|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138413075|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
138413076|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413077|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413078|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413079|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413080|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
138413081|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413082|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138413083|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413084|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138413085|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413086|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138413087|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138413088|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
138413090|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138413091|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413092|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138413093|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413094|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413095|NCT01637636|Rifampin|rifampin|mesh-list
138413096|NCT01637636|Ketoconazole|ketoconazole|mesh-list
138413097|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138413098|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
138413099|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138413100|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413101|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
138413102|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413103|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413104|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413105|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138413106|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138413107|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138413108|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138413109|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138295017|NCT00002041|Amphotericin B|amphotericin b|mesh-list
138413111|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
138413112|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138413113|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413114|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138413115|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
138413116|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413117|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413118|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138413120|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
138413121|NCT01637675|Citric Acid|citric acid|mesh-list
138413122|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
138413123|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
138413124|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138413125|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
138413126|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
138413127|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413128|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
138413129|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138413130|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138413131|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413132|NCT01637675|Urological Agents|urological agents|mesh-ancestor
138413133|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413134|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138413135|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138413136|NCT01637675|Analgesics|analgesics|mesh-ancestor
138413137|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
138413138|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413140|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413141|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413142|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138413143|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413144|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413145|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
138413146|NCT01637753|Carmustine|carmustine|mesh-list
138366213|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138366214|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366215|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
138366216|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366218|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413147|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138413149|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413150|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413151|NCT01637766|Melphalan|melphalan|mesh-list
138413152|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138413153|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
138413154|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413155|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413156|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138413157|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413158|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
138413159|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413160|NCT01637818|Acetaminophen|acetaminophen|mesh-list
138413161|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138413162|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138413163|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138413164|NCT01637818|Analgesics|analgesics|mesh-ancestor
138413165|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
138413166|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413167|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413168|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
138413169|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413170|NCT01637844|Telbivudine|telbivudine|mesh-list
138413171|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
138413172|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413173|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413174|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413175|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413176|NCT01637883|Benzydamine|benzydamine|mesh-list
138413177|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413178|NCT01637948|Listerine|listerine|mesh-list
138413179|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138295160|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138295161|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
138413183|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138413184|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
138413185|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413186|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413187|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138413189|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413190|NCT01638078|Thalidomide|thalidomide|mesh-list
138413191|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413192|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
138413193|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413194|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
138413195|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138413196|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413197|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138413198|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138413199|NCT01638078|Growth Substances|growth substances|mesh-ancestor
138413200|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
138413201|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413202|NCT01638182|Vitamins|vitamins|mesh-list
138413203|NCT01638182|Vitamin K|vitamin k|mesh-list
138413204|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
138413205|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
138413206|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
138413207|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413208|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138413209|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138413210|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413211|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
138413213|NCT01638234|Melatonin|melatonin|mesh-list
138366223|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366224|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138413214|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
138413218|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413219|NCT01638247|Tamoxifen|tamoxifen|mesh-list
138413220|NCT01638247|Goserelin|goserelin|mesh-list
138413221|NCT01638247|Exemestane|exemestane|mesh-list
138413222|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138413223|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138413224|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
138413225|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413226|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413227|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138413228|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413229|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138413230|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138413231|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138413232|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138413233|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138413234|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413235|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413236|NCT01638247|Hormones|hormones|mesh-ancestor
138413237|NCT01638260|Liraglutide|liraglutide|mesh-list
138413238|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413239|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413240|NCT01638260|Incretins|incretins|mesh-ancestor
138413241|NCT01638260|Hormones|hormones|mesh-ancestor
138413242|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413243|NCT01638273|Pregabalin|pregabalin|mesh-list
138413244|NCT01638273|Analgesics|analgesics|mesh-ancestor
138413245|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
138295243|NCT00002449|Aldesleukin|aldesleukin|mesh-list
138413246|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413247|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413249|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138413250|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413251|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413252|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138413253|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138413254|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138413255|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413256|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138413258|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413259|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413261|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138413262|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
138413263|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413264|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413265|NCT01638364|Ethanol|ethanol|mesh-list
138413266|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138413267|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413269|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413270|NCT01638377|Naltrexone|naltrexone|mesh-list
138413271|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138413272|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138413273|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413274|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
138413275|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413276|NCT01638403|Modafinil|modafinil|mesh-list
138413277|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138413278|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413279|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138413280|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138413281|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138413282|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413283|NCT01638624|Propofol|propofol|mesh-list
138413284|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138413285|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413286|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413287|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138295321|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
138413292|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138413293|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138413294|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138413295|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
138413296|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413297|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413298|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413299|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413300|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
138413301|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413302|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138413303|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413304|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413305|NCT01638663|Tolvaptan|tolvaptan|mesh-list
138413306|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138413307|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413308|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
138413309|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413310|NCT01638676|Metformin|metformin|mesh-list
138413311|NCT01638676|Vemurafenib|vemurafenib|mesh-list
138413312|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413313|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413314|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413315|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138413316|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413317|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413319|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138413320|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138413321|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413322|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413323|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413324|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
138413325|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413327|NCT01638715|Rituximab|rituximab|mesh-list
138413328|NCT01638715|Abatacept|abatacept|mesh-list
138413329|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138413330|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413331|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
138413332|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413333|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413334|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138413335|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413336|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413337|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413338|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138413339|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413340|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413341|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
138413343|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
138413344|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295371|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413347|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138413349|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
138413350|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413351|NCT01638780|Protective Agents|protective agents|mesh-ancestor
138413352|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413353|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413354|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138413356|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138413357|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138413358|NCT01638858|Growth Substances|growth substances|mesh-ancestor
138413359|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413360|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
138295384|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413362|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
138413363|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
138413364|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
138413365|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366234|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366235|NCT01396642|Emollients|emollients|mesh-list
138366236|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413366|NCT01638962|Acetaminophen|acetaminophen|mesh-list
138413367|NCT01638962|Aspirin|aspirin|mesh-list
138413368|NCT01638962|Ibuprofen|ibuprofen|mesh-list
138413369|NCT01638962|Celecoxib|celecoxib|mesh-list
138413370|NCT01638962|Diclofenac|diclofenac|mesh-list
138413371|NCT01638962|Naproxen|naproxen|mesh-list
138413372|NCT01638962|Indomethacin|indomethacin|mesh-list
138413373|NCT01638962|Etoricoxib|etoricoxib|mesh-list
138413374|NCT01638962|Meloxicam|meloxicam|mesh-list
138413375|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138413376|NCT01638962|Etodolac|etodolac|mesh-list
138413377|NCT01638962|Lornoxicam|lornoxicam|mesh-list
138413378|NCT01638962|Nabumetone|nabumetone|mesh-list
138413379|NCT01638962|Tenoxicam|tenoxicam|mesh-list
138413380|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
138413381|NCT01638962|Analgesics|analgesics|mesh-list
138413382|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138413383|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
138413384|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413385|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413386|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
138413387|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138413388|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413389|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413390|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138413391|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413392|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413393|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138413394|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
138413395|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138295436|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295438|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413397|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138413399|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413401|NCT01638988|Clomiphene|clomiphene|mesh-list
138413402|NCT01638988|Enclomiphene|enclomiphene|mesh-list
138413403|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
138413404|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413405|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413406|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138413407|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
138413408|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413409|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138413411|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413412|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138413413|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138413414|NCT01639027|Drotaverin|drotaverin|mesh-list
138413415|NCT01639027|Analgesics|analgesics|mesh-ancestor
138413416|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
138413417|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413418|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413419|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
138413420|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
138413421|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
138413422|NCT01639066|Tenofovir|tenofovir|mesh-list
138413424|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
138413425|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413426|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138413427|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413428|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413429|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413430|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413431|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413432|NCT01639092|Tenofovir|tenofovir|mesh-list
138413433|NCT01639092|Entecavir|entecavir|mesh-list
138413434|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
138413435|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413436|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138413437|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413438|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413439|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413440|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413441|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413442|NCT01639261|Interferons|interferons|mesh-list
138413447|NCT01639326|Irinotecan|irinotecan|mesh-list
138413448|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138413449|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413450|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413451|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413452|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413453|NCT01639456|Aldesleukin|aldesleukin|mesh-list
138413454|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
138413455|NCT01639456|Fludarabine|fludarabine|mesh-list
138413456|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413457|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
138413458|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413459|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413460|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138413461|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
138413462|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413463|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413464|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138413465|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413466|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138413467|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
138413468|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413469|NCT01639521|Gemcitabine|gemcitabine|mesh-list
138413470|NCT01639521|Doxorubicin|doxorubicin|mesh-list
138413472|NCT01639521|Methotrexate|methotrexate|mesh-list
138413473|NCT01639521|Vinblastine|vinblastine|mesh-list
138413474|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413475|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138413476|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
138413477|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413478|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138413479|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138413480|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413481|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413482|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138413483|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
138413484|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413485|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413486|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413487|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138413488|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413489|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
138413490|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413491|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413492|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138413493|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
138413494|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
138413495|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
138413496|NCT01639547|Ribavirin|ribavirin|mesh-list
138413497|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138413498|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
138413499|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413500|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
138413502|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
138413503|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138413504|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138413505|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
138413506|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413507|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413508|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413509|NCT01639794|Urological Agents|urological agents|mesh-ancestor
138413510|NCT01639807|Latanoprost|latanoprost|mesh-list
138413511|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138413512|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138413513|NCT01639885|Interferons|interferons|mesh-list
138413514|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
138413515|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
138413516|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413517|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
138413518|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413519|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
138413520|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413521|NCT01639898|Dexamethasone|dexamethasone|mesh-list
138413522|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
138413523|NCT01639898|Lenalidomide|lenalidomide|mesh-list
138413524|NCT01639898|BB 1101|bb 1101|mesh-list
138413525|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413526|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
138413527|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
138413528|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413529|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413530|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413531|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
138413532|NCT01639898|Hormones|hormones|mesh-ancestor
138295649|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138413533|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413534|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138413535|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413536|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
138413537|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413538|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413540|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138413541|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138413542|NCT01639898|Growth Substances|growth substances|mesh-ancestor
138413543|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
138413544|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
138413545|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138413546|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138413547|NCT01640743|Prednisolone|prednisolone|mesh-list
138413548|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
138413550|NCT01640743|Tacrolimus|tacrolimus|mesh-list
138413551|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138413552|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
138413553|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413554|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
138413555|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413556|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138413557|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413558|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413559|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138413560|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138413561|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413562|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413563|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
138413567|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
138413569|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413570|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138413571|NCT01640743|Protective Agents|protective agents|mesh-ancestor
138413572|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138413573|NCT01641016|Efavirenz|efavirenz|mesh-list
138413574|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138413575|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138413576|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413577|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413578|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
138413579|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413580|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138413581|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413582|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138413583|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138413584|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138413585|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138413587|NCT01642771|Capecitabine|capecitabine|mesh-list
138413588|NCT01642771|Fluorouracil|fluorouracil|mesh-list
138413589|NCT01642771|Epirubicin|epirubicin|mesh-list
138413590|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413591|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138413592|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138413593|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
138295727|NCT00003110|Bleomycin|bleomycin|mesh-list
138413595|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138413597|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413598|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
138413599|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413600|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138413601|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138413602|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413603|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413604|NCT01642979|Cyclosporine|cyclosporine|mesh-list
138413605|NCT01642979|Levamisole|levamisole|mesh-list
138413606|NCT01642979|Cyclosporins|cyclosporins|mesh-list
138413607|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
138413608|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413609|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413611|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
138295768|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
138295779|NCT00002233|Lamivudine|lamivudine|mesh-list
138413612|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413613|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
138413614|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413615|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413616|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413617|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138413618|NCT01642979|Hormones|hormones|mesh-ancestor
138413619|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413620|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138413621|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
138413622|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
138413623|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138413624|NCT01643031|Clopidogrel|clopidogrel|mesh-list
138413625|NCT01643031|Ticagrelor|ticagrelor|mesh-list
138413626|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138413627|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138413628|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138413629|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138413630|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
138413631|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413632|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413633|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413635|NCT01643434|Spironolactone|spironolactone|mesh-list
138413636|NCT01643434|Analgesics|analgesics|mesh-ancestor
138413637|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
138413638|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413639|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413640|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413641|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
138413642|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
138413643|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138295820|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138413648|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413649|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138413650|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
138413651|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413652|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138413653|NCT01643434|Diuretics|diuretics|mesh-ancestor
138413654|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
138413655|NCT01643941|Vaccines|vaccines|mesh-list
138413656|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
138413657|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413658|NCT01643980|Progesterone|progesterone|mesh-list
138413659|NCT01643980|Progestins|progestins|mesh-ancestor
138413660|NCT01643980|Hormones|hormones|mesh-ancestor
138413661|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413662|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413663|NCT01645228|Calcium|calcium|mesh-list
138295856|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295857|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413665|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413666|NCT01645839|Cytarabine|cytarabine|mesh-list
138413667|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138413668|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
138413669|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413670|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413671|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
138413672|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413673|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413674|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
138413675|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413676|NCT01646437|Aspirin|aspirin|mesh-list
138413677|NCT01646437|Vitamin D|vitamin d|mesh-list
138413678|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
138413679|NCT01646437|Vitamins|vitamins|mesh-ancestor
138413680|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
138413681|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413682|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138413683|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138413684|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138413685|NCT01646437|Analgesics|analgesics|mesh-ancestor
138413689|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413690|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138413691|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138413692|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413693|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138413694|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138413695|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413697|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138413698|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
138413699|NCT01646619|Analgesics|analgesics|mesh-ancestor
138413700|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
138413701|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413702|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413703|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
138413704|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413705|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138413706|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
138413707|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138413708|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413709|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413710|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138413711|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
138413712|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413713|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138413714|NCT01647880|Interferon beta-1b|interferon beta-1b|mesh-list
138413715|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138413717|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413718|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
138413719|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413720|NCT01647880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138413721|NCT01648218|Insulin|insulin|mesh-list
138413722|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138413723|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
138413724|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
138413725|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
138413726|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
138413727|NCT01648218|Protamines|protamines|mesh-list
138413728|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413729|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413730|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
138413731|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413732|NCT01648218|Coagulants|coagulants|mesh-ancestor
138413733|NCT01648465|Everolimus|everolimus|mesh-list
138413734|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138413735|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138413736|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413737|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413738|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413739|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
138413742|NCT01648777|Bupivacaine|bupivacaine|mesh-list
138413743|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
138413744|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
138413745|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413746|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413748|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413749|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
138413750|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138413751|NCT01649024|Tremelimumab|tremelimumab|mesh-list
138413752|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413753|NCT01649960|Sirolimus|sirolimus|mesh-list
138413754|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138413755|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413756|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138413757|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413758|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
138413759|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413760|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
138413761|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296038|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138413765|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413766|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413767|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138413768|NCT01650012|Diuretics|diuretics|mesh-ancestor
138413769|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
138413770|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413772|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413773|NCT01650129|Insulin|insulin|mesh-list
138413774|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138413775|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
138413776|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
138413777|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413778|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413779|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
138413780|NCT01650181|Selenium|selenium|mesh-list
138413781|NCT01650181|Metformin|metformin|mesh-list
138413782|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413783|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413784|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
138413785|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413786|NCT01650181|Protective Agents|protective agents|mesh-ancestor
138413787|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
138413789|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
138413790|NCT01650181|Trace Elements|trace elements|mesh-ancestor
138413791|NCT01650272|Minoxidil|minoxidil|mesh-list
138413792|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138413793|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413794|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
138413795|NCT01650376|Paclitaxel|paclitaxel|mesh-list
138413796|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138413797|NCT01650376|Carboplatin|carboplatin|mesh-list
138413798|NCT01650376|Olaparib|olaparib|mesh-list
138413799|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296081|NCT00002551|Fluorouracil|fluorouracil|mesh-list
138413801|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
138413802|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
138413803|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
138413804|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413805|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138413806|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413807|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
138413808|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138413809|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
138413810|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413811|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
138413812|NCT01650415|Hematinics|hematinics|mesh-ancestor
138413813|NCT01650428|Bevacizumab|bevacizumab|mesh-list
138413814|NCT01650428|Fluorouracil|fluorouracil|mesh-list
138413816|NCT01650428|Irinotecan|irinotecan|mesh-list
138413817|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138413819|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138413820|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138413821|NCT01650428|Growth Substances|growth substances|mesh-ancestor
138413822|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413823|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
138413825|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413826|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138413827|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413828|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
138413829|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138413830|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138413831|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413832|NCT01650441|Beclomethasone|beclomethasone|mesh-list
138413833|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
138413834|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138413835|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
138413836|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413837|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413838|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138413839|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
138413840|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138413841|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138413842|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138296169|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413848|NCT01650441|Hormones|hormones|mesh-ancestor
138413849|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138413850|NCT01650493|Listerine|listerine|mesh-list
138413851|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
138413852|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
138413853|NCT01650493|Protective Agents|protective agents|mesh-ancestor
138413854|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413855|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138413856|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413857|NCT01650506|Metformin|metformin|mesh-list
138413858|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138413859|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138413860|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413861|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413862|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138413863|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413864|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413865|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
138413866|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413867|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413868|NCT01650649|Lofexidine|lofexidine|mesh-list
138413869|NCT01650649|Clonidine|clonidine|mesh-list
138413870|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413871|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138413872|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413873|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
138413874|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413875|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138413876|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138413877|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138413878|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413879|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413880|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413882|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
138413883|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
138413884|NCT01650662|Cyclosporine|cyclosporine|mesh-list
138413885|NCT01650662|Cyclosporins|cyclosporins|mesh-list
138413886|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413887|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413888|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138413889|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
138413890|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413891|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
138413892|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413893|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138413894|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413895|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138413897|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138413898|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413899|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
138413900|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413901|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413902|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138413903|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138413904|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138413905|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413906|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413907|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413908|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413910|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
138413911|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413913|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138413914|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
138413915|NCT01650870|Lactulose|lactulose|mesh-list
138413916|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413917|NCT01650883|Vitamin D|vitamin d|mesh-list
138413918|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
138413919|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
138413920|NCT01650883|Vitamins|vitamins|mesh-list
138413921|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
138413922|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413923|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138413924|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138413925|NCT01650961|Palonosetron|palonosetron|mesh-list
138413926|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
138413927|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
138413928|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413929|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413930|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413931|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138413932|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138413933|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
138413934|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413935|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296282|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296285|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413938|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138413939|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413941|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138413942|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413943|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
138413944|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413945|NCT01651169|Methylphenidate|methylphenidate|mesh-list
138413946|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138413947|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413948|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138413949|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138413950|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138413951|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413953|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413954|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
138413955|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138413956|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138413957|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413958|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
138413959|NCT01651182|Coagulants|coagulants|mesh-ancestor
138413960|NCT01651312|Mirabegron|mirabegron|mesh-list
138413961|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138296329|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138413962|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138413963|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138413964|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413965|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413966|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413967|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413968|NCT01651312|Urological Agents|urological agents|mesh-ancestor
138413970|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
138413971|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
138413972|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
138413973|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138413974|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138413975|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413976|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413977|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413978|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
138413979|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413980|NCT01651364|Cabergoline|cabergoline|mesh-list
138413981|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138413982|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138413983|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
138413984|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
138413985|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413986|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413987|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413988|NCT01651377|Pramipexole|pramipexole|mesh-list
138296369|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296370|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296378|NCT00003416|Melphalan|melphalan|mesh-list
138413991|NCT01651377|Protective Agents|protective agents|mesh-ancestor
138413992|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413993|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138413994|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138413995|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
138413996|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
138413997|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413998|NCT01651390|Sirolimus|sirolimus|mesh-list
138413999|NCT01651390|Paclitaxel|paclitaxel|mesh-list
138414000|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138414001|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414002|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
138414003|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
138414004|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414005|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414006|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414007|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414008|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138414009|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
138414010|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414011|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
138414012|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414013|NCT01651416|Lumefantrine|lumefantrine|mesh-list
138414014|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
138414016|NCT01651416|Piperaquine|piperaquine|mesh-list
138414017|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
138296408|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
138414021|NCT01651416|Artenimol|artenimol|mesh-list
138414022|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
138414023|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138414024|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138414025|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414026|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138414027|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414028|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414029|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138414031|NCT01651481|Levocetirizine|levocetirizine|mesh-list
138414032|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414033|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414034|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138414035|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
138414036|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414037|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414038|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138414039|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138414040|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414041|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138414042|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138414043|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
138296441|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138296442|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
138414045|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414046|NCT01651520|Flumazenil|flumazenil|mesh-list
138414047|NCT01651520|Antidotes|antidotes|mesh-ancestor
138414048|NCT01651520|Protective Agents|protective agents|mesh-ancestor
138414049|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414050|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
138414051|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
138414052|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414053|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414054|NCT01651572|Rocuronium|rocuronium|mesh-list
138414055|NCT01651572|Cisatracurium|cisatracurium|mesh-list
138414056|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138414057|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138414058|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138414059|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414060|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414062|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
138414063|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414064|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138414065|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414066|NCT01651715|Antibodies|antibodies|mesh-list
138414067|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
138414068|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414069|NCT01651728|Simvastatin|simvastatin|mesh-list
138414070|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138414071|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138414072|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
138414073|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414074|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138414075|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138414076|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414078|NCT01651923|Calcium heparin|calcium heparin|mesh-list
138414079|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
138414080|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138414081|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138414082|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414083|NCT01651962|Fentanyl|fentanyl|mesh-list
138414084|NCT01651962|Terbutaline|terbutaline|mesh-list
138414085|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138414086|NCT01651962|Narcotics|narcotics|mesh-ancestor
138414087|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414088|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414089|NCT01651962|Analgesics|analgesics|mesh-ancestor
138414090|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
138414091|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414092|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138296531|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414093|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138414095|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
138414096|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138414097|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
138414098|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414099|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414100|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
138414101|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
138414102|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138414103|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138414104|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138414105|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138414106|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414107|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414108|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414109|NCT01651988|Propofol|propofol|mesh-list
138414110|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138414111|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414112|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414113|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138414114|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
138414115|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
138414116|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
138296567|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138296568|NCT00003182|Gemcitabine|gemcitabine|mesh-list
138414117|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
138414118|NCT01652014|Fludarabine|fludarabine|mesh-list
138414119|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
138414120|NCT01652014|Tacrolimus|tacrolimus|mesh-list
138414121|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414122|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
138414123|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414124|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414125|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138414126|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
138414127|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414128|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414129|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138414130|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414131|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
138414132|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138414133|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414134|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138414135|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138414136|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
138414137|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414138|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414139|NCT01652118|Clarithromycin|clarithromycin|mesh-list
138414140|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414141|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414142|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138414143|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414144|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414145|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138414146|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138414147|NCT01652157|Pancrelipase|pancrelipase|mesh-list
138414148|NCT01652157|Pancreatin|pancreatin|mesh-list
138414149|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414150|NCT01652183|Acetaminophen|acetaminophen|mesh-list
138414151|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138414152|NCT01652183|Analgesics|analgesics|mesh-ancestor
138414153|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
138414157|NCT01652196|Leucovorin|leucovorin|mesh-list
138414158|NCT01652196|Fluorouracil|fluorouracil|mesh-list
138414159|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
138414160|NCT01652196|Aflibercept|aflibercept|mesh-list
138414161|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
138414162|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138414163|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
138414164|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414165|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414166|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414167|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414168|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
138414169|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414170|NCT01652196|Antidotes|antidotes|mesh-ancestor
138414171|NCT01652196|Protective Agents|protective agents|mesh-ancestor
138414172|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
138414173|NCT01652196|Vitamins|vitamins|mesh-ancestor
138414174|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
138414175|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138414176|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138414177|NCT01652196|Growth Substances|growth substances|mesh-ancestor
138414178|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
138414179|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138414180|NCT01652313|Rasagiline|rasagiline|mesh-list
138414181|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138414182|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414183|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414184|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138414185|NCT01652313|Protective Agents|protective agents|mesh-ancestor
138414186|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414187|NCT01652326|Diazepam|diazepam|mesh-list
138296660|NCT00002888|Paclitaxel|paclitaxel|mesh-list
138414190|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
138414191|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
138414192|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414193|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414194|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414195|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138414196|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414197|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138414198|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138414199|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138414200|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138414201|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138414202|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138414203|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
138414204|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
138414205|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
138414206|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
138414207|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414208|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414209|NCT01652339|Amlodipine|amlodipine|mesh-list
138414210|NCT01652339|Valsartan|valsartan|mesh-list
138414211|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138414212|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138414213|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138414214|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414215|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414216|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414217|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414218|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
138414219|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138414220|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138296690|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
138414222|NCT01652378|Ondansetron|ondansetron|mesh-list
138414223|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
138414224|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
138414225|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414226|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414227|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
138414228|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414229|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138414230|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138414231|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138414232|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414233|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414234|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
138414235|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
138414236|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414237|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
138414238|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
138414239|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138414240|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138414241|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
138414242|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414243|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
138414244|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138414245|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138414246|NCT01652417|Prednisolone|prednisolone|mesh-list
138414247|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
138414248|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138414249|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
138414250|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138414251|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
138414252|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
138414253|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414254|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414255|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414256|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
138296723|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414259|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138414260|NCT01652417|Protective Agents|protective agents|mesh-ancestor
138414261|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138414262|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414264|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138414265|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138414267|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414268|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
138414269|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414270|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414271|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414272|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138414274|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
138414275|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414276|NCT01652547|Pasireotide|pasireotide|mesh-list
138414277|NCT01652547|Somatostatin|somatostatin|mesh-list
138414278|NCT01652547|Hormones|hormones|mesh-ancestor
138414279|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414280|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414281|NCT01652560|Bevacizumab|bevacizumab|mesh-list
138296760|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138296761|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
138296762|NCT00003212|Doxorubicin|doxorubicin|mesh-list
138414283|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414284|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138414285|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138414286|NCT01652560|Growth Substances|growth substances|mesh-ancestor
138414287|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414288|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
138414289|NCT01652586|Midazolam|midazolam|mesh-list
138414290|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
138414292|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138414293|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414294|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414295|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138414297|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
138414298|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414299|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138414300|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138414301|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138414302|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414303|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414304|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414305|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138414306|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138414307|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138414308|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138414309|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138414310|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
138414311|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
138414312|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
138414313|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
138414316|NCT01652599|Dexamethasone|dexamethasone|mesh-list
138414317|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138414318|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
138414319|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
138414320|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414321|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414322|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414323|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
138414324|NCT01652599|Hormones|hormones|mesh-ancestor
138414325|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414326|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138414327|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414328|NCT01652638|Heparin|heparin|mesh-list
138414329|NCT01652638|Calcium heparin|calcium heparin|mesh-list
138414330|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
138414331|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138414332|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138414333|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414336|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
138414337|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414338|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414339|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414340|NCT01652794|Carboplatin|carboplatin|mesh-list
138414341|NCT01652794|Gemcitabine|gemcitabine|mesh-list
138414342|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414343|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414344|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
138414345|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414346|NCT01652820|Carboplatin|carboplatin|mesh-list
138414347|NCT01652820|Gemcitabine|gemcitabine|mesh-list
138414349|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414350|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414351|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
138414352|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414353|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
138414354|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
138414355|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414356|NCT01652859|Amphotericin B|amphotericin b|mesh-list
138414357|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138414358|NCT01652859|Amebicides|amebicides|mesh-ancestor
138414359|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138296925|NCT05664061|Hormones|hormones|mesh-ancestor
138414362|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414363|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
138414365|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138414366|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138414367|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138414368|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414369|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414370|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414371|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414373|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414374|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414375|NCT01653015|Vaccines|vaccines|mesh-list
138414376|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
138414377|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414378|NCT01653041|Everolimus|everolimus|mesh-list
138414379|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138414380|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138414381|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414382|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414383|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414384|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
138414385|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414386|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414392|NCT01653067|Temsirolimus|temsirolimus|mesh-list
138414393|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
138366242|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366243|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366244|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138366245|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138366246|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138366247|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366248|NCT01396668|Gemcitabine|gemcitabine|mesh-list
138414394|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138414395|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
138414396|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
138414397|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414398|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414399|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414400|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
138414401|NCT01653067|Hormones|hormones|mesh-ancestor
138414402|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414403|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138414404|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414405|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414406|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414407|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138414408|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
138414409|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414410|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414411|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
138414412|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
138414413|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414414|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414415|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138414416|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414417|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138414418|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
138414419|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138414420|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138414421|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138414422|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
138414423|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414424|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138414425|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138414426|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414427|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
138414428|NCT01653171|Simethicone|simethicone|mesh-list
138414429|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138414430|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
138414431|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414432|NCT01653171|Expectorants|expectorants|mesh-ancestor
138414433|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414434|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138414435|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
138414436|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414437|NCT01653171|Protective Agents|protective agents|mesh-ancestor
138414438|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414439|NCT01653171|Antidotes|antidotes|mesh-ancestor
138414440|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
138414441|NCT01653171|Emollients|emollients|mesh-ancestor
138414442|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
138414444|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138414445|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
138414446|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414447|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
138414448|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414449|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
138296982|NCT00002647|Verteporfin|verteporfin|mesh-list
138296983|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138296984|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296985|NCT00002653|Prednisone|prednisone|mesh-list
138414451|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138414452|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414453|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414455|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138414456|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138414457|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
138414458|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414459|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414460|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414461|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138414462|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138414463|NCT01653470|Leucovorin|leucovorin|mesh-list
138414464|NCT01653470|Paclitaxel|paclitaxel|mesh-list
138414465|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138414466|NCT01653470|Carboplatin|carboplatin|mesh-list
138414467|NCT01653470|Fluorouracil|fluorouracil|mesh-list
138414468|NCT01653470|Irinotecan|irinotecan|mesh-list
138414469|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138414470|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414471|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138414472|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138414473|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414474|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414475|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
138414476|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414479|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414481|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138414482|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414483|NCT01653470|Antidotes|antidotes|mesh-ancestor
138414484|NCT01653470|Protective Agents|protective agents|mesh-ancestor
138414485|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
138414487|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
138414488|NCT01653522|Doxycycline|doxycycline|mesh-list
138414489|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414490|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414491|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
138414492|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138414493|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138414494|NCT01653561|Apatinib|apatinib|mesh-list
138414495|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414496|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138414497|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414498|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414500|NCT01653639|Coagulants|coagulants|mesh-ancestor
138414501|NCT01653665|Sargramostim|sargramostim|mesh-list
138414502|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
138414503|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414504|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
138414505|NCT01653717|Fludarabine|fludarabine|mesh-list
138414508|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
138414509|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414510|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414511|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138414512|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
138414513|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414514|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414515|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138414516|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414517|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
138414518|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138414519|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
138414520|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138414521|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414522|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414523|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138414524|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138414526|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414527|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414528|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138414529|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
138414530|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138414531|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414532|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138414533|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138414534|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138414535|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138414536|NCT01654081|Irinotecan|irinotecan|mesh-list
138297076|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414538|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138414540|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414541|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414542|NCT01654120|Liraglutide|liraglutide|mesh-list
138414543|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138414544|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414545|NCT01654120|Incretins|incretins|mesh-ancestor
138414546|NCT01654120|Hormones|hormones|mesh-ancestor
138414547|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414548|NCT01654146|Paclitaxel|paclitaxel|mesh-list
138414549|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138414551|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138414552|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414553|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138414554|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138414555|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414556|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414557|NCT01654185|Letrozole|letrozole|mesh-list
138414558|NCT01654185|Exemestane|exemestane|mesh-list
138414559|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138414560|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414561|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138414562|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414563|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414564|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138414565|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
138297109|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138414568|NCT01654211|Ritonavir|ritonavir|mesh-list
138414569|NCT01654211|Lactams|lactams|mesh-list
138414570|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138414571|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138414572|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
138414573|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414574|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414575|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138414576|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138414577|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
138414578|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414579|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138414580|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138414582|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
138414583|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138414584|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138414585|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414586|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138414587|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414588|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414589|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138414590|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
138414591|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414593|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138414595|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
138414596|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297157|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
138414597|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414598|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414599|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138414600|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138414601|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414602|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414603|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138414604|NCT01654497|Protective Agents|protective agents|mesh-ancestor
138414606|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138414607|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138414608|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
138414609|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414610|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138414611|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138414612|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414613|NCT01654575|Methotrexate|methotrexate|mesh-list
138414614|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138414615|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
138414616|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138414617|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414618|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414619|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
138297196|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138414622|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
138414623|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414624|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138414625|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414626|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
138414627|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414628|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138414630|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138414631|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414632|NCT01654692|Ipilimumab|ipilimumab|mesh-list
138414633|NCT01654692|Fotemustine|fotemustine|mesh-list
138414634|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138414635|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414636|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138414637|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414639|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138414640|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414641|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138414642|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414643|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414644|NCT01654718|Pantoprazole|pantoprazole|mesh-list
138414645|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138414646|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414647|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138414649|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414650|NCT01654809|Vaccines|vaccines|mesh-list
138414651|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
138414652|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414653|NCT01654913|Chrysarobin|chrysarobin|mesh-list
138414654|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138414655|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138414656|NCT01654913|Analgesics|analgesics|mesh-ancestor
138414657|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
138414658|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414659|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297296|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
138414661|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414663|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138414664|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414665|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414666|NCT01654965|Topotecan|topotecan|mesh-list
138414667|NCT01654965|Lenograstim|lenograstim|mesh-list
138414668|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138414669|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
138414670|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414671|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138414672|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138414673|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414674|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414675|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414676|NCT01655004|Exemestane|exemestane|mesh-list
138414677|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414678|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138414679|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138414680|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414681|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414682|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138414683|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138414684|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414685|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414686|NCT01655056|Darexaban|darexaban|mesh-list
138414687|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138414688|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
138297340|NCT00003578|Vincristine|vincristine|mesh-list
138414737|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414738|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414739|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138414741|NCT01655199|Ipratropium|ipratropium|mesh-list
138414742|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138366250|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414744|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414745|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414746|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414747|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414749|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138414750|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138414751|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138414752|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138414753|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414754|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414755|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414756|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138414757|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
138414758|NCT01655212|Valganciclovir|valganciclovir|mesh-list
138414759|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
138414760|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414761|NCT01655303|Propranolol|propranolol|mesh-list
138414763|NCT01655303|Verapamil|verapamil|mesh-list
138414764|NCT01655303|Diltiazem|diltiazem|mesh-list
138414765|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138414766|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138414767|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414768|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414769|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414770|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414771|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138414772|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138414775|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
138414776|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414777|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138414778|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138414779|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414782|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138414783|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138414784|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414785|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414786|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414788|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
138414789|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
138414790|NCT01655524|Aminophylline|aminophylline|mesh-list
138414792|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
138414793|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414794|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414795|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414796|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414797|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138414798|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138414799|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414800|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414801|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138414802|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138414803|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
138414804|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414808|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414809|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414810|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
138414811|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414812|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
138414813|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138414814|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138414818|NCT01655706|Aripiprazole|aripiprazole|mesh-list
138414819|NCT01655706|Escitalopram|escitalopram|mesh-list
138414820|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138414821|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138414822|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414826|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414827|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
138414828|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138414829|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138414830|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138414831|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138414832|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
138414833|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
138414834|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138414835|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138414836|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138414837|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138414838|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138414839|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138414840|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138414841|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138414842|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414843|NCT01655758|Timolol|timolol|mesh-list
138414847|NCT01655758|Latanoprost|latanoprost|mesh-list
138414848|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138414849|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138414850|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414851|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414852|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414853|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414854|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138414855|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138414856|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138414857|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138414858|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138414861|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
138414862|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
138414863|NCT01655810|Vitamins|vitamins|mesh-list
138414864|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
138414865|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
138414866|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414867|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414868|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138414869|NCT01655810|Antacids|antacids|mesh-ancestor
138414870|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414871|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414872|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
138414873|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138414874|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138414875|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138414876|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414877|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414878|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
138414879|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414880|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414882|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414883|NCT01655875|Plerixafor|plerixafor|mesh-list
138414884|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138414885|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138414886|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
138414887|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414889|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414890|NCT01655914|Flumazenil|flumazenil|mesh-list
138414894|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
138414896|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414897|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414898|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
138414899|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138414900|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138414901|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414902|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
138414903|NCT01655927|Coagulants|coagulants|mesh-ancestor
138414904|NCT01655966|Vitamin D|vitamin d|mesh-list
138414905|NCT01655966|Interferons|interferons|mesh-list
138414906|NCT01655966|Ribavirin|ribavirin|mesh-list
138414907|NCT01655966|Vitamins|vitamins|mesh-ancestor
138414908|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
138414909|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414910|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138414911|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414912|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
138414913|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414914|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
138414915|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414916|NCT01655992|Capecitabine|capecitabine|mesh-list
138414917|NCT01655992|Tegafur|tegafur|mesh-list
138414918|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138414919|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
138414920|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414921|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414922|NCT01656005|Beclomethasone|beclomethasone|mesh-list
138414923|NCT01656005|Carvedilol|carvedilol|mesh-list
138414924|NCT01656005|Bisoprolol|bisoprolol|mesh-list
138414925|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
138414926|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
138414927|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138414928|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
138414929|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414930|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414931|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414932|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
138414933|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138414934|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138414935|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138414936|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414937|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414938|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414939|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
138414940|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138414941|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
138414942|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138414943|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138414944|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138414946|NCT01656005|Protective Agents|protective agents|mesh-ancestor
138414947|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138414948|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414949|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414950|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
138414951|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138414952|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138414954|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138414955|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138414957|NCT01656005|Hormones|hormones|mesh-ancestor
138414958|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414959|NCT01656018|Rilpivirine|rilpivirine|mesh-list
138414960|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138414961|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138414962|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414963|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414964|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
138414965|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414966|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138414967|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138414968|NCT01656057|Acetaminophen|acetaminophen|mesh-list
138414969|NCT01656057|Metformin|metformin|mesh-list
138414970|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
138414971|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138414972|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138414973|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414974|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138414975|NCT01656057|Analgesics|analgesics|mesh-ancestor
138414976|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
138414977|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414978|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
138414979|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138414980|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138414981|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
138414982|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414983|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138414984|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138414985|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138414986|NCT01656070|Vitamin D|vitamin d|mesh-list
138414987|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
138414988|NCT01656070|Vitamins|vitamins|mesh-ancestor
138414989|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
138414990|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414991|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138414992|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414993|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138414994|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138414995|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138414996|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
138414997|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414998|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414999|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138415000|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138415001|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
138415002|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415003|NCT01656122|Abacavir|abacavir|mesh-list
138415004|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138415005|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138415006|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415007|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415008|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
138415009|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415010|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138415011|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138415012|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
138415013|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138415014|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415015|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415016|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
138415017|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138415018|NCT01656226|Protective Agents|protective agents|mesh-ancestor
138415019|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415020|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415022|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138415023|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
138415024|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138415025|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415026|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415027|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415028|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
138415029|NCT01656512|Vitamin D|vitamin d|mesh-list
138415030|NCT01656512|Diphosphonates|diphosphonates|mesh-list
138415031|NCT01656512|Calcium|calcium|mesh-list
138415032|NCT01656512|Vitamins|vitamins|mesh-ancestor
138415033|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
138415034|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415035|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138415036|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138415037|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138415038|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
138415039|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415040|NCT01656616|Antidotes|antidotes|mesh-list
138415041|NCT01656616|Protective Agents|protective agents|mesh-ancestor
138415042|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415043|NCT01656642|Atezolizumab|atezolizumab|mesh-list
138415044|NCT01656642|Vemurafenib|vemurafenib|mesh-list
138415045|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138415046|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415047|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138415048|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415049|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138415050|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415051|NCT01656668|Theobromine|theobromine|mesh-list
138415052|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138415053|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
138415054|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415055|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415056|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415057|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415058|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
138415059|NCT01656720|Methoxamine|methoxamine|mesh-list
138366262|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366263|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
138366264|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366265|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366267|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
138415060|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
138415061|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
138415062|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415063|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415064|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138415065|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138415066|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138415068|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415069|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415070|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415071|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
138415072|NCT01656798|Citric Acid|citric acid|mesh-list
138415073|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
138415074|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
138415075|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138415076|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
138415077|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
138415078|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415080|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138415081|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138415082|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415083|NCT01656798|Urological Agents|urological agents|mesh-ancestor
138415084|NCT01656811|Albuterol|albuterol|mesh-list
138415087|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415088|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415089|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415090|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415092|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138415093|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138415094|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138415095|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138415096|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415097|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415098|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415100|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138415101|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
138415102|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415103|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415104|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
138415105|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
138415106|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
138415107|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415108|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415109|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415110|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138415111|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
138415112|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
138415113|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415114|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415115|NCT01657071|Aspirin|aspirin|mesh-list
138415116|NCT01657071|Clopidogrel|clopidogrel|mesh-list
138415117|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415119|NCT01657071|Analgesics|analgesics|mesh-ancestor
138415120|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
138415121|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415122|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415123|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415124|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415125|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138415126|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138415127|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415128|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138415129|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138415130|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415131|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
138415132|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138415133|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138415134|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138415135|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
138415137|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
138415138|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138415139|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415140|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138415141|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138415142|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415143|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415144|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415145|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415146|NCT01657201|Voriconazole|voriconazole|mesh-list
138415147|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
138415148|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415149|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138415150|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138415155|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415156|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415157|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138415158|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138415159|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138415161|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415162|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415163|NCT01657240|Analgesics|analgesics|mesh-ancestor
138415164|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
138415165|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415166|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415167|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415168|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415169|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138415170|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138415171|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138415172|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
138415173|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
138415174|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415175|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415176|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138415177|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415178|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138415179|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138415180|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138415181|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
138415182|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415183|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415184|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138415185|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
138415186|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
138415187|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
138415188|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415189|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
138415190|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138415191|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138415192|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138415193|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138415194|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415195|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415196|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415197|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415198|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415199|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138415200|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415201|NCT01657448|Methenamine|methenamine|mesh-list
138366270|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366271|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415202|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
138415203|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
138415205|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138415206|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415207|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415208|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415209|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415210|NCT01657487|Fluticasone|fluticasone|mesh-list
138415211|NCT01657487|Xhance|xhance|mesh-list
138415212|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138415213|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138415214|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415215|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138415216|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
138415217|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415218|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415219|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415220|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415221|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415222|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138415223|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138415224|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138415225|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138415226|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415227|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415228|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415229|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
138415230|NCT01657487|Hormones|hormones|mesh-ancestor
138415231|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415232|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
138415233|NCT01657578|Omeprazole|omeprazole|mesh-list
138415234|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138415235|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415236|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138415237|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415238|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415239|NCT01657656|Vitamin D|vitamin d|mesh-list
138415240|NCT01657656|Vitamins|vitamins|mesh-ancestor
138415241|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
138415242|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415243|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138415245|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138415246|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138415247|NCT01657669|Growth Substances|growth substances|mesh-ancestor
138415248|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415249|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138415250|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415251|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138415252|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
138415253|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
138415254|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415255|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415256|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138415257|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138415258|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415259|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415260|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415261|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
138415262|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138415263|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138415264|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415265|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415266|NCT01657812|Analgesics|analgesics|mesh-ancestor
138415267|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
138415268|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415269|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138415270|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138415271|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138415272|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415274|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415275|NCT01657825|Isavuconazole|isavuconazole|mesh-list
138415276|NCT01657825|Warfarin|warfarin|mesh-list
138415277|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
138415278|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
138415279|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415281|NCT01657838|Isavuconazole|isavuconazole|mesh-list
138415282|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
138415283|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415284|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138415285|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138415286|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415287|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415288|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138415289|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415290|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415291|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415292|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138415293|NCT01657851|Tamsulosin|tamsulosin|mesh-list
138415294|NCT01657851|Dutasteride|dutasteride|mesh-list
138415295|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138415296|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138415297|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138415298|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415299|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415300|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415301|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415302|NCT01657851|Urological Agents|urological agents|mesh-ancestor
138415303|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138415304|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138415305|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415306|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415307|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415308|NCT01657864|Lamotrigine|lamotrigine|mesh-list
138415309|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
138415310|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138415311|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415312|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415313|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138415314|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415316|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138415317|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138415318|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138415319|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138415320|NCT01657890|Isavuconazole|isavuconazole|mesh-list
138415321|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
138415322|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415323|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138415324|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138415325|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
138415326|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415327|NCT01657929|Antacids|antacids|mesh-ancestor
138415328|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415329|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415330|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138415331|NCT01657955|Chlorambucil|chlorambucil|mesh-list
138415332|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138415333|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
138415334|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415335|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415336|NCT01657513|Adalimumab|adalimumab|mesh-list
138415337|NCT01657513|Infliximab|infliximab|mesh-list
138415338|NCT01657513|Etanercept|etanercept|mesh-list
138415339|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138415340|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415341|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415342|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415343|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415344|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415345|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415346|NCT01657513|Analgesics|analgesics|mesh-ancestor
138415347|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
138415348|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415349|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415350|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415351|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
138415352|NCT01657981|Darexaban|darexaban|mesh-list
138415353|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138415354|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
138415355|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138415356|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415357|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415358|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415359|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
138415360|NCT01658007|Sirolimus|sirolimus|mesh-list
138415361|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415362|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415363|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138415364|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415365|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
138415366|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415367|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
138415368|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415369|NCT01658033|Leucovorin|leucovorin|mesh-list
138415370|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
138415371|NCT01658033|Bevacizumab|bevacizumab|mesh-list
138415372|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415373|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138415374|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138415375|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138415376|NCT01658033|Growth Substances|growth substances|mesh-ancestor
138415377|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415378|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
138415379|NCT01658033|Antidotes|antidotes|mesh-ancestor
138415380|NCT01658033|Protective Agents|protective agents|mesh-ancestor
138415381|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
138415382|NCT01658033|Vitamins|vitamins|mesh-ancestor
138415383|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
138415384|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
138415385|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138415386|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138415387|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415388|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
138415389|NCT01658124|Coagulants|coagulants|mesh-ancestor
138415390|NCT01658176|Exemestane|exemestane|mesh-list
138415391|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415392|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138415393|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138415394|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415395|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415396|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138415397|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415398|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415399|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415400|NCT01658202|Nicotine|nicotine|mesh-list
138415401|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138415402|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
138415403|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415404|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415405|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138415406|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138415407|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415408|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415409|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415411|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138415412|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
138415413|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415414|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415415|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138415416|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138415417|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415418|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415419|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415420|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
138415421|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138415422|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415424|NCT01658319|Fludarabine|fludarabine|mesh-list
138415425|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
138415426|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415427|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138415428|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
138415429|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415430|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415431|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
138415432|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415433|NCT01658358|Doxorubicin|doxorubicin|mesh-list
138415434|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138415435|NCT01658358|Lapatinib|lapatinib|mesh-list
138415436|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138415437|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415438|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138415439|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138415440|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415441|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415442|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138415443|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138415444|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138415445|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138415446|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415447|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
138415448|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138415449|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
138415450|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415451|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
138415452|NCT01658449|Protective Agents|protective agents|mesh-ancestor
138415454|NCT01658462|Nintedanib|nintedanib|mesh-list
138415455|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415456|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138415457|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415458|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138415459|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415460|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138415461|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415462|NCT01658527|Bicalutamide|bicalutamide|mesh-list
138415463|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
138415464|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415465|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415466|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415467|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415468|NCT01658553|Trametinib|trametinib|mesh-list
138415469|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415470|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138415471|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415472|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415473|NCT01658774|Albendazole|albendazole|mesh-list
138415474|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415475|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
138415476|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138415477|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415478|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
138415479|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138415480|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138415481|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
138415482|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415483|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
138415484|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415485|NCT01658852|Metronidazole|metronidazole|mesh-list
138415486|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415487|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415488|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138415489|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138415490|NCT01658891|Beclomethasone|beclomethasone|mesh-list
138415491|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
138415492|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138415494|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415495|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415496|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415497|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415498|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138415499|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138415500|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138415501|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415502|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415503|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415504|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415505|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
138415506|NCT01658891|Hormones|hormones|mesh-ancestor
138415507|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415508|NCT01659008|Estradiol|estradiol|mesh-list
138415509|NCT01659008|Estrogens|estrogens|mesh-ancestor
138415510|NCT01659008|Hormones|hormones|mesh-ancestor
138415511|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415512|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415514|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415515|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415516|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415517|NCT01659086|Vaccines|vaccines|mesh-list
138415518|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
138415519|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415520|NCT01659099|Prednisone|prednisone|mesh-list
138415521|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
138415522|NCT01659099|Rituximab|rituximab|mesh-list
138415523|NCT01659099|Doxorubicin|doxorubicin|mesh-list
138415524|NCT01659099|Vincristine|vincristine|mesh-list
138415525|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
138415526|NCT01659099|Bleomycin|bleomycin|mesh-list
138415527|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415528|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
138415529|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415530|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415531|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138415532|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
138415533|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415534|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415535|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138415536|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138415537|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138415538|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138415539|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138415540|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415541|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415542|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
138415543|NCT01659099|Hormones|hormones|mesh-ancestor
138415544|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415545|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138415546|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138415547|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138415548|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415550|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
138415551|NCT01659190|Antacids|antacids|mesh-ancestor
138415552|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415554|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
138415555|NCT01659242|Methotrexate|methotrexate|mesh-list
138415556|NCT01659242|Leflunomide|leflunomide|mesh-list
138415557|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138415558|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
138415559|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138415560|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415561|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138415562|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
138415563|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415564|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415565|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415566|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415567|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138415568|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415569|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
138415570|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415571|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138415572|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415573|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415574|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415575|NCT01659242|Analgesics|analgesics|mesh-ancestor
138415576|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
138415577|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415578|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415579|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415580|NCT01659281|Artesunate|artesunate|mesh-list
138415581|NCT01659281|Mefloquine|mefloquine|mesh-list
138415582|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
138415583|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138415584|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138415585|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415586|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415587|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
138415588|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
138415589|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138415590|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
138415591|NCT01659346|Carvedilol|carvedilol|mesh-list
138415592|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138415593|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138415594|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415595|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415596|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415597|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415598|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138415599|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
138415600|NCT01659346|Protective Agents|protective agents|mesh-ancestor
138415601|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138415602|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415603|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138415604|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
138415605|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138415606|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138415607|NCT01659359|Lidocaine|lidocaine|mesh-list
138415608|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
138415609|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
138415610|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138415611|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415612|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
138415613|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415614|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138415615|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138415616|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138415617|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415618|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415619|NCT01659372|Naproxen|naproxen|mesh-list
138415620|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415621|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415622|NCT01659372|Analgesics|analgesics|mesh-ancestor
138415623|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
138415624|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415625|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415626|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415627|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415628|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
138415629|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138415630|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415631|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415633|NCT01659437|Streptomycin|streptomycin|mesh-list
138415634|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415635|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415636|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138415637|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415638|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415639|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138415640|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138415641|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
138415643|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
138415644|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415645|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415646|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138415647|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138415648|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415649|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138415650|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138415651|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415652|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415653|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415654|NCT01659515|Arbekacin|arbekacin|mesh-list
138415655|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415656|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415657|NCT01659619|Erythromycin|erythromycin|mesh-list
138415658|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
138415659|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138415660|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
138415661|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138415662|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415663|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415664|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138415665|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415666|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415667|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
138415668|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138415670|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
138415671|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138415672|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
138415673|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415675|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
138415676|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
138415677|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415678|NCT01659788|Vitamins|vitamins|mesh-ancestor
138415679|NCT01659827|Bupivacaine|bupivacaine|mesh-list
138415680|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
138415681|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
138415682|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138415683|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415684|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
138415685|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415686|NCT01659892|Montelukast|montelukast|mesh-list
138415687|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415688|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415689|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138415690|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415691|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415692|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415693|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138415694|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138415695|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415696|NCT01659905|Montelukast|montelukast|mesh-list
138415697|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415698|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415699|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138415700|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415701|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415702|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415703|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138415704|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138415707|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415708|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415709|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138415710|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415711|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415712|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415713|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138415714|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138415715|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415717|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138415718|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
138415719|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138415720|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
138415721|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415722|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415723|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138415724|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138415725|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415726|NCT01659944|Metoprolol|metoprolol|mesh-list
138415727|NCT01659944|Eliglustat|eliglustat|mesh-list
138415728|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138415729|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138415731|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
138415732|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415733|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415734|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138415735|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138415736|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138415737|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138415738|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415739|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415740|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415741|NCT01659775|Ondansetron|ondansetron|mesh-list
138415742|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
138415743|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
138415744|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415745|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415746|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415747|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
138415748|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415749|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138415750|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138415751|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
138415752|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415753|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415754|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138415755|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
138415756|NCT01660295|Certoparin|certoparin|mesh-list
138415757|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
138415758|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138415759|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138415760|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415761|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138415762|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
138415763|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
138415764|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415765|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415766|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415767|NCT01660295|Analgesics|analgesics|mesh-ancestor
138415768|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
138415773|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138415774|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138415775|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138415776|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
138415777|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415778|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415779|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415781|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138415782|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138415783|NCT01660386|Glimepiride|glimepiride|mesh-list
138415784|NCT01660386|Saxagliptin|saxagliptin|mesh-list
138415785|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138415786|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415787|NCT01660386|Incretins|incretins|mesh-ancestor
138415788|NCT01660386|Hormones|hormones|mesh-ancestor
138415789|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415790|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138415791|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415792|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415793|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415794|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138415795|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415796|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
138415797|NCT01660399|Docetaxel|docetaxel|mesh-list
138415798|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415799|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
138415800|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415801|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138415802|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415803|NCT01660477|Ritonavir|ritonavir|mesh-list
138415804|NCT01660477|Lopinavir|lopinavir|mesh-list
138415805|NCT01660477|Isavuconazole|isavuconazole|mesh-list
138415806|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138415807|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138415808|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415809|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415810|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415811|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138415812|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138415813|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
138415814|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415815|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138415816|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138415817|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
138415818|NCT01660542|Docetaxel|docetaxel|mesh-list
138415819|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415820|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138415821|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415822|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138415823|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415824|NCT01660594|Calcium|calcium|mesh-list
138415825|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138415826|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415827|NCT01660620|Betaxolol|betaxolol|mesh-list
138415828|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138415829|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
138415830|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
138415831|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415832|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415833|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138415834|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138415837|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415838|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415840|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
138415841|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415842|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
138415843|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415844|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415845|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138415846|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
138415847|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415848|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415849|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138415850|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415851|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
138415852|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
138415853|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415854|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415855|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
138415856|NCT01660750|Hormones|hormones|mesh-ancestor
138415857|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415858|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138415859|NCT01660854|Proguanil|proguanil|mesh-list
138415860|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138415861|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
138415862|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138415863|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138415864|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415865|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
138415866|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415867|NCT01660867|Dexamethasone|dexamethasone|mesh-list
138415868|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415869|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
138415870|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
138415871|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415872|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415873|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415874|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
138415875|NCT01660867|Hormones|hormones|mesh-ancestor
138415876|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415877|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138415878|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415879|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138415880|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138415881|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138415882|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
138415883|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415884|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138415885|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138415886|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415887|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138415888|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138415889|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138415890|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
138415891|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415892|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138415893|NCT01660997|Dexamethasone|dexamethasone|mesh-list
138415894|NCT01660997|Ixazomib|ixazomib|mesh-list
138415895|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415896|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
138415897|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
138415898|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415899|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415900|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415903|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415904|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138415905|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415906|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415907|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415908|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415909|NCT01661101|Omeprazole|omeprazole|mesh-list
138415910|NCT01661101|Dabigatran|dabigatran|mesh-list
138415911|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138415912|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415913|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138415914|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415915|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415916|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
138415917|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138415918|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415919|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
138415920|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138415921|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
138415922|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138415923|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138415924|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415925|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415926|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415927|NCT01661257|Infliximab|infliximab|mesh-list
138415928|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138415929|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415930|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415931|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415932|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415933|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138415934|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138415935|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138415936|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415937|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
138415938|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138415939|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
138415940|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
138415941|NCT01661309|Vitamins|vitamins|mesh-ancestor
138415942|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
138415943|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415944|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
138415945|NCT01661322|Aspirin|aspirin|mesh-list
138415946|NCT01661322|Clopidogrel|clopidogrel|mesh-list
138415947|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138415948|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138415949|NCT01661322|Analgesics|analgesics|mesh-ancestor
138415950|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
138415951|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415952|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415953|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415954|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415955|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138415956|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138415957|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415958|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138415959|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138415960|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415961|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
138415962|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138415963|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138415964|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138415966|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415967|NCT01661335|Dexamethasone|dexamethasone|mesh-list
138415968|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
138415969|NCT01661335|Ondansetron|ondansetron|mesh-list
138415971|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
138415972|NCT01661335|BB 1101|bb 1101|mesh-list
138415973|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138415974|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
138415975|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
138415976|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415977|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415978|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138415979|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
138415980|NCT01661335|Hormones|hormones|mesh-ancestor
138415981|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138415982|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138415984|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
138415985|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415986|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415987|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
138415988|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138415989|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138415990|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138415991|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
138415992|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415993|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138415994|NCT01661439|Heparin|heparin|mesh-list
138415995|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138415996|NCT01661439|Tinzaparin|tinzaparin|mesh-list
138415997|NCT01661439|Dalteparin|dalteparin|mesh-list
138415998|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
138415999|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138416000|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138416001|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416002|NCT01661530|Vitamin E|vitamin e|mesh-list
138416003|NCT01661530|Vitamins|vitamins|mesh-ancestor
138416004|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
138416005|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416006|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
138416007|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416008|NCT01661530|Protective Agents|protective agents|mesh-ancestor
138416009|NCT01661556|Miconazole|miconazole|mesh-list
138416010|NCT01661556|Hydroquinone|hydroquinone|mesh-list
138416011|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
138416012|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416013|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138416014|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138416015|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416016|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416017|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138416018|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
138416019|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416020|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416021|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138416022|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138416023|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
138416024|NCT01661556|Protective Agents|protective agents|mesh-ancestor
138416025|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138416027|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
138416028|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416029|NCT01661777|Diuretics|diuretics|mesh-list
138416030|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
138416031|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138416032|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
138416033|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416034|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
138416035|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416036|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416037|NCT01661855|Riluzole|riluzole|mesh-list
138416038|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
138416039|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138366281|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138366282|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138366283|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366284|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138416040|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138416041|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416042|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416043|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416044|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138416045|NCT01661855|Protective Agents|protective agents|mesh-ancestor
138416046|NCT01661868|Olaparib|olaparib|mesh-list
138416047|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138416048|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416049|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416050|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416051|NCT01662037|Bosentan|bosentan|mesh-list
138416052|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138416053|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138416054|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416056|NCT01662089|Trace Elements|trace elements|mesh-ancestor
138416057|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
138416058|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416059|NCT01662128|Capecitabine|capecitabine|mesh-list
138416060|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138416061|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
138416062|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416063|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416064|NCT01662180|Hormones|hormones|mesh-list
138416065|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138416066|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416067|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416068|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
138416070|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
138416071|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
138416072|NCT01662193|Vitamins|vitamins|mesh-list
138416073|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
138416074|NCT01662193|Calcium|calcium|mesh-list
138416075|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
138416076|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416077|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138416078|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138416079|NCT01662193|Antacids|antacids|mesh-ancestor
138416080|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416081|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416082|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
138416083|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138416084|NCT01662401|Bupivacaine|bupivacaine|mesh-list
138416085|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
138416086|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
138416087|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416088|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416089|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
138416090|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416091|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
138416092|NCT01662466|Testosterone|testosterone|mesh-list
138416093|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
138416094|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
138416095|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138416096|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138416097|NCT01662466|Androgens|androgens|mesh-ancestor
138416098|NCT01662466|Hormones|hormones|mesh-ancestor
138416099|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416100|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416101|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138416102|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416103|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
138416104|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138416106|NCT01662518|Dexamethasone|dexamethasone|mesh-list
138416107|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416108|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
138416109|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
138416110|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416111|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416112|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416113|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
138416115|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416116|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138416117|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416118|NCT01662622|Sevoflurane|sevoflurane|mesh-list
138416119|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138416120|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138416121|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
138416122|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
138416123|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416124|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416125|NCT01662674|Metformin|metformin|mesh-list
138416126|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416127|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416128|NCT01662687|Granisetron|granisetron|mesh-list
138416129|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
138416130|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
138416131|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416132|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416133|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416134|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138416135|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138416137|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416138|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416139|NCT01662700|Artesunate|artesunate|mesh-list
138416140|NCT01662700|Chloroquine|chloroquine|mesh-list
138416141|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
138416142|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138416143|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138416144|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416145|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416146|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
138416147|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
138416148|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138416149|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
138416150|NCT01662700|Amebicides|amebicides|mesh-ancestor
138416151|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416152|NCT01662804|Interleukin-2|interleukin-2|mesh-list
138416153|NCT01662804|Antibodies|antibodies|mesh-list
138416154|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138416155|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
138416156|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416157|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416158|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416160|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
138416161|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416162|NCT01662869|Leucovorin|leucovorin|mesh-list
138416163|NCT01662869|Folic Acid|folic acid|mesh-list
138416164|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
138416165|NCT01662869|Fluorouracil|fluorouracil|mesh-list
138416166|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
138416167|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416168|NCT01662869|Antidotes|antidotes|mesh-ancestor
138416169|NCT01662869|Protective Agents|protective agents|mesh-ancestor
138416170|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416171|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
138416173|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
138416174|NCT01662869|Hematinics|hematinics|mesh-ancestor
138416175|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
138416176|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416178|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138416179|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
138416180|NCT01662921|Insulin|insulin|mesh-list
138416181|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138416182|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
138416183|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
138416184|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
138416185|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416186|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416187|NCT01663038|Aspirin|aspirin|mesh-list
138416188|NCT01663038|Clopidogrel|clopidogrel|mesh-list
138416189|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416190|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416191|NCT01663038|Analgesics|analgesics|mesh-ancestor
138416192|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
138416193|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416194|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416195|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416196|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416197|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138416198|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138416199|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416200|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138416201|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416202|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416203|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
138416204|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138416205|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138416206|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138416207|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
138416208|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416209|NCT01663077|Clozapine|clozapine|mesh-list
138416210|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138416211|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
138416212|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416213|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416214|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416215|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138416216|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138416217|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416218|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138416219|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
138416220|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
138416221|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138416222|NCT01663090|Hematinics|hematinics|mesh-ancestor
138416223|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138416224|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138416225|NCT01663168|Rifabutin|rifabutin|mesh-list
138416226|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416227|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416228|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138416229|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
138416230|NCT01663441|Oprelvekin|oprelvekin|mesh-list
138416231|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416232|NCT01661985|Azithromycin|azithromycin|mesh-list
138416233|NCT01661985|Doxycycline|doxycycline|mesh-list
138416234|NCT01661985|Lymecycline|lymecycline|mesh-list
138416235|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416236|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416237|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
138416238|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138416239|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138416240|NCT01663558|Imiquimod|imiquimod|mesh-list
138416241|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138416242|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
138416243|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416247|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138416248|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416250|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416251|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138416252|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138416253|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416254|NCT01663805|Everolimus|everolimus|mesh-list
138416255|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138416256|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416257|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416258|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416259|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138416261|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416262|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416264|NCT01663961|Mirabegron|mirabegron|mesh-list
138416265|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138416266|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138416267|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366288|NCT01396733|Protective Agents|protective agents|mesh-ancestor
138416268|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416269|NCT01663961|Protective Agents|protective agents|mesh-ancestor
138416270|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416271|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138416272|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138416273|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138416274|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416275|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416276|NCT01663961|Urological Agents|urological agents|mesh-ancestor
138416277|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
138416278|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138416279|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138416280|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138416281|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138416282|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416283|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
138416284|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416285|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416286|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138416287|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416288|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138416289|NCT01664065|Cephalosporins|cephalosporins|mesh-list
138416290|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416291|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416292|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
138416293|NCT01664195|Hematinics|hematinics|mesh-ancestor
138416294|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
138416295|NCT01664221|Hematinics|hematinics|mesh-ancestor
138416296|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
138416297|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138416298|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
138416299|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416300|NCT01664260|Expectorants|expectorants|mesh-ancestor
138416301|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
138416302|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138416303|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
138416304|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416305|NCT01664260|Protective Agents|protective agents|mesh-ancestor
138416306|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416307|NCT01664260|Antidotes|antidotes|mesh-ancestor
138416308|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
138416309|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138416310|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416311|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416314|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
138416315|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416316|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138416317|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138416318|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138416319|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416320|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416321|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416323|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138416324|NCT01664650|Protective Agents|protective agents|mesh-ancestor
138416325|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416326|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416327|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416328|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416329|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416330|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
138416331|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138416332|NCT01664650|Estrogens|estrogens|mesh-ancestor
138416334|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416335|NCT01664676|Liraglutide|liraglutide|mesh-list
138416336|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416337|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416339|NCT01664676|Hormones|hormones|mesh-ancestor
138416340|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416341|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
138416342|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
138416343|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416344|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138416345|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416346|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416347|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
138416348|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416349|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416350|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138416351|NCT01664728|Hormones|hormones|mesh-ancestor
138416352|NCT01664754|Carboplatin|carboplatin|mesh-list
138416353|NCT01664754|Pemetrexed|pemetrexed|mesh-list
138416354|NCT01664754|Exemestane|exemestane|mesh-list
138416355|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416356|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416357|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416358|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138416359|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138416360|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138416361|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138416362|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138416363|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
138416364|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416365|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416366|NCT01664819|Antioxidants|antioxidants|mesh-list
138416367|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416368|NCT01664819|Protective Agents|protective agents|mesh-ancestor
138416369|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416372|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416373|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416374|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
138416375|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416376|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
138416377|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416378|NCT01664871|Fluorides|fluorides|mesh-list
138416379|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
138416381|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416382|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138416383|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138416384|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416385|NCT01665066|Nicotine|nicotine|mesh-list
138416386|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138416387|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
138416388|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416389|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416390|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138416391|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138416392|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
138416393|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416394|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416395|NCT01665079|Propofol|propofol|mesh-list
138416396|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138416397|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416398|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416399|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138416400|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
138416401|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
138416402|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
138416403|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138416404|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138416405|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416406|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
138416407|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
138416408|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416410|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138416411|NCT01665209|Narcotics|narcotics|mesh-ancestor
138416412|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416413|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416414|NCT01665209|Analgesics|analgesics|mesh-ancestor
138416415|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
138416416|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416418|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138416419|NCT01665222|Narcotics|narcotics|mesh-ancestor
138416420|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416421|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416423|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
138416424|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416425|NCT01665235|Aspirin|aspirin|mesh-list
138416426|NCT01665235|Amlodipine|amlodipine|mesh-list
138416427|NCT01665235|Clopidogrel|clopidogrel|mesh-list
138416428|NCT01665235|Atorvastatin|atorvastatin|mesh-list
138416429|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416430|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416431|NCT01665235|Analgesics|analgesics|mesh-ancestor
138416432|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
138416433|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416434|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416435|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416436|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416437|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138416438|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138416439|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416440|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138416441|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416442|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416443|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
138416444|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138416445|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138416446|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
138416447|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138416448|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138416449|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138416450|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138416451|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138416452|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
138416453|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416454|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138416455|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138416456|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138416457|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138416458|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
138416461|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
138416462|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
138416463|NCT01665248|Protective Agents|protective agents|mesh-ancestor
138416464|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416465|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138416466|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416467|NCT01665378|Folic Acid|folic acid|mesh-list
138416468|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
138416469|NCT01665378|Micronutrients|micronutrients|mesh-list
138416470|NCT01665378|Trace Elements|trace elements|mesh-list
138416471|NCT01665378|Hematinics|hematinics|mesh-ancestor
138416472|NCT01665378|Vitamins|vitamins|mesh-ancestor
138416473|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416474|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
138416475|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138416476|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138416477|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416478|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416479|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138416480|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138416481|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138416482|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138416483|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416484|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416485|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
138416486|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138416487|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
138416488|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138416489|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138416490|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416491|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138416492|NCT01665417|Docetaxel|docetaxel|mesh-list
138416493|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416494|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138416495|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138416496|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138416497|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416498|NCT01665469|Lycopene|lycopene|mesh-list
138416499|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416500|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
138416501|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416502|NCT01665469|Protective Agents|protective agents|mesh-ancestor
138416503|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416504|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138416505|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138416506|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416507|NCT01664507|Epinephrine|epinephrine|mesh-list
138416508|NCT01664507|Racepinephrine|racepinephrine|mesh-list
138416509|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
138416510|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138416511|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138416512|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416513|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416514|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416515|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416516|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138416517|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138416518|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
138416519|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416520|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138416521|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
138416522|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
138416523|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
138416524|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138416525|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
138416526|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138416527|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416528|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416529|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416530|NCT01665586|Analgesics|analgesics|mesh-ancestor
138416531|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
138416532|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416533|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138416534|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138416535|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138416536|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416537|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416538|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416539|NCT01665638|Canagliflozin|canagliflozin|mesh-list
138416540|NCT01665638|Somatostatin|somatostatin|mesh-list
138416541|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138416542|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416543|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416544|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416545|NCT01665638|Hormones|hormones|mesh-ancestor
138416546|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416547|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138416548|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138416549|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416550|NCT01665742|Tocopherols|tocopherols|mesh-list
138416551|NCT01665742|Vitamin E|vitamin e|mesh-list
138416552|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
138416553|NCT01665742|Lycopene|lycopene|mesh-list
138416554|NCT01665742|Vitamins|vitamins|mesh-ancestor
138416555|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
138416556|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416558|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416559|NCT01665742|Protective Agents|protective agents|mesh-ancestor
138416560|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416561|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138416562|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138416563|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416564|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
138416565|NCT01665781|Hematinics|hematinics|mesh-ancestor
138416566|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138416567|NCT01665846|Hematinics|hematinics|mesh-ancestor
138416568|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138416569|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138416570|NCT01666041|Fenofibrate|fenofibrate|mesh-list
138416571|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138416572|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
138416573|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416574|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138416575|NCT01666067|Simvastatin|simvastatin|mesh-list
138416576|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138416577|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138416578|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138416579|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
138416580|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416581|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138416582|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138416583|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416584|NCT01666171|Metformin|metformin|mesh-list
138416585|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416586|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416587|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138416588|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138416589|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138416590|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138416592|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416593|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138416595|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416596|NCT01666236|Triamcinolone|triamcinolone|mesh-list
138416597|NCT01666236|Ranibizumab|ranibizumab|mesh-list
138416598|NCT01666236|Verteporfin|verteporfin|mesh-list
138416599|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138416600|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138416601|NCT01666236|Growth Substances|growth substances|mesh-ancestor
138416602|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416603|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138416604|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416605|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416606|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
138416607|NCT01666236|Hormones|hormones|mesh-ancestor
138416608|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416609|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138416610|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416611|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
138416612|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138416613|NCT01666249|Antibodies|antibodies|mesh-list
138416614|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
138416615|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416617|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
138416618|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416619|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
138416620|NCT01666301|Hematinics|hematinics|mesh-ancestor
138416621|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138416622|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138416623|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416624|NCT01666379|Fentanyl|fentanyl|mesh-list
138416625|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138416626|NCT01666379|Narcotics|narcotics|mesh-ancestor
138416627|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416628|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416629|NCT01666379|Analgesics|analgesics|mesh-ancestor
138416630|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
138416631|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416632|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138416633|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138416634|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
138416635|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
138416636|NCT01666418|Paclitaxel|paclitaxel|mesh-list
138416637|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138416638|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416639|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
138416640|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
138416641|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
138416642|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416643|NCT01666431|Lapatinib|lapatinib|mesh-list
138416644|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416645|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416646|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416647|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416648|NCT01666522|Vitamin D|vitamin d|mesh-list
138416649|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
138416650|NCT01666522|Vitamins|vitamins|mesh-ancestor
138416651|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
138416652|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416653|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138416654|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138416656|NCT01666587|Antioxidants|antioxidants|mesh-list
138416657|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
138416658|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416659|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416663|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416664|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416665|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416666|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416667|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416668|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416669|NCT01666587|Protective Agents|protective agents|mesh-ancestor
138416670|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
138416671|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416673|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416674|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416675|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416676|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416677|NCT01666665|Metformin|metformin|mesh-list
138416678|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138416679|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416680|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
138416681|NCT01666678|Promethazine|promethazine|mesh-list
138416682|NCT01666678|Naproxen|naproxen|mesh-list
138416683|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416684|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416685|NCT01666678|Analgesics|analgesics|mesh-ancestor
138416686|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
138416687|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416688|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416690|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416691|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
138416692|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416693|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416694|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416695|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138416696|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138416697|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416698|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
138416700|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
138416701|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
138416702|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416703|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138416704|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
138416705|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
138416706|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416707|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138416708|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
138416709|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416711|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138416712|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138416713|NCT01666691|Growth Substances|growth substances|mesh-ancestor
138416714|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416715|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
138416716|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416717|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138416718|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416719|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416720|NCT01666756|Sorafenib|sorafenib|mesh-list
138416721|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416722|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416723|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416724|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416726|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
138416729|NCT01667094|Tazobactam|tazobactam|mesh-list
138416730|NCT01667094|Piperacillin|piperacillin|mesh-list
138416731|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
138416732|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
138416733|NCT01667094|Ceftazidime|ceftazidime|mesh-list
138416734|NCT01667094|Cefepime|cefepime|mesh-list
138416735|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138416736|NCT01667094|Ticarcillin|ticarcillin|mesh-list
138416737|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
138416738|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416739|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416740|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138416741|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416742|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416744|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138416745|NCT01667211|Nedaplatin|nedaplatin|mesh-list
138416746|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138416747|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416748|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138416749|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138416750|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138416751|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416752|NCT01667263|Tretinoin|tretinoin|mesh-list
138416753|NCT01667263|Danazol|danazol|mesh-list
138416754|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416755|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
138416756|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416757|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138416758|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
138416759|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416760|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416761|NCT01667315|Bupivacaine|bupivacaine|mesh-list
138416762|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
138416763|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
138416764|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416765|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416766|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
138416767|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416768|NCT01667445|Morphine|morphine|mesh-list
138416769|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138416771|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138416772|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416773|NCT01667445|Analgesics|analgesics|mesh-ancestor
138416774|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
138416775|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416776|NCT01667484|Adderall|adderall|mesh-list
138416777|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138416778|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416779|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
138416780|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138416781|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138416782|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416783|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
138416784|NCT01667523|Capsaicin|capsaicin|mesh-list
138416785|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
138416786|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416787|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
138416788|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416789|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416790|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138416791|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416792|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138416793|NCT01667523|Protective Agents|protective agents|mesh-ancestor
138416794|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138416795|NCT01667575|Amoxicillin|amoxicillin|mesh-list
138416798|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
138416799|NCT01667575|Esomeprazole|esomeprazole|mesh-list
138416800|NCT01667575|Bismuth|bismuth|mesh-list
138416801|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138416802|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416803|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416804|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
138416805|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138416806|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416807|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416808|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138416809|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138416810|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138416811|NCT01667575|Antacids|antacids|mesh-ancestor
138416812|NCT01667575|Diuretics|diuretics|mesh-ancestor
138416813|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
138416814|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416815|NCT01667575|Expectorants|expectorants|mesh-ancestor
138416816|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
138416817|NCT01667614|Losartan|losartan|mesh-list
138416818|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138416819|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138416820|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138416821|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138416822|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416823|NCT01667692|Azithromycin|azithromycin|mesh-list
138416824|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416825|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416826|NCT01667718|Amoxicillin|amoxicillin|mesh-list
138416827|NCT01667718|Levofloxacin|levofloxacin|mesh-list
138416828|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
138416829|NCT01667718|Lansoprazole|lansoprazole|mesh-list
138416830|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
138416831|NCT01667718|Bismuth|bismuth|mesh-list
138416832|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138416833|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416834|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416835|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416836|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138416837|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138416838|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138416839|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416840|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416841|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138416842|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138416843|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138416844|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416845|NCT01667718|Antacids|antacids|mesh-ancestor
138416846|NCT01667718|Diuretics|diuretics|mesh-ancestor
138416847|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
138416848|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416849|NCT01667718|Expectorants|expectorants|mesh-ancestor
138416850|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
138416851|NCT01667874|Gentamicins|gentamicins|mesh-list
138416852|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416853|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416854|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138416855|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416856|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416858|NCT01668043|Antibodies|antibodies|mesh-list
138416859|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
138416860|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416861|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138416862|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
138416863|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416864|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138416867|NCT01668069|Ondansetron|ondansetron|mesh-list
138416868|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
138416869|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
138416870|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416871|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416872|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416873|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
138416874|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416875|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138416876|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138416877|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
138416878|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416879|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416881|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
138416882|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138416883|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416884|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138416885|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
138416886|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416887|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416888|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138416889|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
138416890|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
138416891|NCT01668121|Hormones|hormones|mesh-ancestor
138416893|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138416895|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138416896|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416897|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138416898|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416899|NCT01668433|Primaquine|primaquine|mesh-list
138416900|NCT01668433|Methylene Blue|methylene blue|mesh-list
138416901|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
138416902|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138416903|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138416904|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416905|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416906|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416907|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
138416908|NCT01668446|Estradiol|estradiol|mesh-list
138416909|NCT01668446|Estrogens|estrogens|mesh-ancestor
138416910|NCT01668446|Hormones|hormones|mesh-ancestor
138416911|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138416912|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416913|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
138416914|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138416915|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138416916|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416917|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416918|NCT01668446|Urological Agents|urological agents|mesh-ancestor
138416919|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138416920|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416921|NCT01668498|Doxycycline|doxycycline|mesh-list
138416922|NCT01668498|Erythromycin|erythromycin|mesh-list
138416923|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
138416924|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138416925|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
138416926|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416927|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416928|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
138416929|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138416930|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138416931|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138416932|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138416933|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416934|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416935|NCT01668550|AZD-0424|azd-0424|mesh-list
138416936|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138416938|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416939|NCT01668615|Tretinoin|tretinoin|mesh-list
138416940|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416941|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
138416942|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416943|NCT01668680|Celecoxib|celecoxib|mesh-list
138416944|NCT01668680|Capecitabine|capecitabine|mesh-list
138416945|NCT01668680|Methotrexate|methotrexate|mesh-list
138416946|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138416947|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
138416948|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416949|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416950|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138416951|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
138416952|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138416953|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416954|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138416955|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416956|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138416957|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138416958|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
138416959|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416960|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138416961|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416962|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416963|NCT01668680|Analgesics|analgesics|mesh-ancestor
138416964|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
138416965|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416966|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416967|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138416968|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416969|NCT01668901|Aspirin|aspirin|mesh-list
138416970|NCT01668901|Warfarin|warfarin|mesh-list
138416971|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138416972|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416973|NCT01668901|Analgesics|analgesics|mesh-ancestor
138416974|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
138416975|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416976|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416977|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138416978|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416979|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138416980|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138416981|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416982|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138416983|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138416984|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138416985|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
138416987|NCT01668927|Amoxicillin|amoxicillin|mesh-list
138416988|NCT01668927|Metronidazole|metronidazole|mesh-list
138416989|NCT01668927|Tetracycline|tetracycline|mesh-list
138416990|NCT01668927|Furazolidone|furazolidone|mesh-list
138416991|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
138416992|NCT01668927|Lansoprazole|lansoprazole|mesh-list
138416993|NCT01668927|Bismuth|bismuth|mesh-list
138416994|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138416995|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138416996|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138416997|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416998|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138416999|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138417000|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138417001|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417002|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417003|NCT01668927|Antacids|antacids|mesh-ancestor
138417004|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138417005|NCT01668927|Diuretics|diuretics|mesh-ancestor
138417006|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
138417007|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417008|NCT01668927|Expectorants|expectorants|mesh-ancestor
138417009|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138417010|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138417011|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138417012|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138417013|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138417014|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
138417015|NCT01669044|Propofol|propofol|mesh-list
138417016|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138417017|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417018|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417019|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417020|NCT01669044|Analgesics|analgesics|mesh-ancestor
138417021|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
138417022|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417023|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138417024|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138417025|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138417026|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
138417028|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417029|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417030|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
138417031|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
138417032|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
138417033|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417034|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417035|NCT01669135|Anesthetics|anesthetics|mesh-list
138417036|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417037|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417038|NCT01669213|Ondansetron|ondansetron|mesh-list
138417039|NCT01669213|Ramosetron|ramosetron|mesh-list
138417040|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
138417042|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417043|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417044|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417045|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
138417046|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
138417047|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138417048|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138417049|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
138417050|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417051|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417052|NCT01669226|Taxane|taxane|mesh-list
138417053|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417054|NCT01669239|Doxorubicin|doxorubicin|mesh-list
138417055|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138417056|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138417057|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417058|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138417059|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138417060|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417061|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417062|NCT01669291|Leuprolide|leuprolide|mesh-list
138417063|NCT01669291|Cetrorelix|cetrorelix|mesh-list
138417064|NCT01669291|Menotropins|menotropins|mesh-list
138417065|NCT01669291|Ganirelix|ganirelix|mesh-list
138417066|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138417067|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
138417068|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138417069|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417070|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138417071|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417072|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
138417073|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417074|NCT01669304|Verapamil|verapamil|mesh-list
138417075|NCT01669304|Sertraline|sertraline|mesh-list
138417076|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
138417080|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417081|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417082|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417083|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
138417084|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417085|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138417086|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138417087|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138417088|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
138417089|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
138417090|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
138417091|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417092|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417093|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417094|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
138417095|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417096|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417097|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417099|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138417100|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138417101|NCT01669447|Growth Substances|growth substances|mesh-ancestor
138417102|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417103|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
138417104|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417105|NCT01669499|Dexamethasone|dexamethasone|mesh-list
138417106|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
138417107|NCT01669499|BB 1101|bb 1101|mesh-list
138417108|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417109|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
138417110|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
138417111|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417112|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417114|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
138417115|NCT01669499|Hormones|hormones|mesh-ancestor
138417116|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417117|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138417118|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417119|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
138417120|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417121|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417122|NCT01669707|Endostar protein|endostar protein|mesh-list
138417123|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138417124|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138417125|NCT01669707|Growth Substances|growth substances|mesh-ancestor
138417126|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417127|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138417128|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417129|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138417130|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
138417131|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138417132|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138417133|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417134|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
138417136|NCT01669967|Lidocaine|lidocaine|mesh-list
138417137|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
138417138|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
138417139|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417140|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417141|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
138417142|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417143|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138417144|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138417145|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138417146|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417147|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417149|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138417150|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
138417151|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
138417152|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417153|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138417154|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
138417155|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
138417156|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417157|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138417158|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
138417159|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
138417161|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417162|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417163|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417164|NCT01670370|Gemcitabine|gemcitabine|mesh-list
138417165|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
138417166|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417167|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138417168|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
138417169|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417170|NCT01670552|Naproxen|naproxen|mesh-list
138417171|NCT01670552|Nimesulide|nimesulide|mesh-list
138417172|NCT01670552|Esomeprazole|esomeprazole|mesh-list
138417173|NCT01670552|Pantoprazole|pantoprazole|mesh-list
138417174|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138417175|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417176|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138417177|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417178|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417179|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138417180|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417181|NCT01670552|Analgesics|analgesics|mesh-ancestor
138417182|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
138417183|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417184|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417185|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417186|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417187|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
138417188|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138417189|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
138417190|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138417191|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
138417192|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417193|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
138417194|NCT01670578|Protective Agents|protective agents|mesh-ancestor
138417195|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
138417197|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417198|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417199|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
138417200|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417201|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417202|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417203|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
138417204|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
138417205|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417206|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417207|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
138417208|NCT01670812|Hormones|hormones|mesh-ancestor
138417209|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417211|NCT01670812|Protective Agents|protective agents|mesh-ancestor
138417212|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
138417213|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417214|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138417215|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138417216|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138417217|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417218|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417219|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
138417220|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417221|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417223|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
138417224|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138417225|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
138417226|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417227|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417228|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138417229|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
138417230|NCT01673308|Lenalidomide|lenalidomide|mesh-list
138417231|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
138417232|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417233|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138417234|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138417235|NCT01673308|Growth Substances|growth substances|mesh-ancestor
138417236|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138417237|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417238|NCT01673737|Vemurafenib|vemurafenib|mesh-list
138417239|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417240|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138417241|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417242|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417243|NCT01674556|Gemcitabine|gemcitabine|mesh-list
138417244|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138417245|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
138417246|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417247|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417248|NCT01675115|Aspirin|aspirin|mesh-list
138417249|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138417250|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417251|NCT01675115|Analgesics|analgesics|mesh-ancestor
138417252|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
138417253|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417254|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417255|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417256|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417257|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138417258|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138417259|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417260|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138417261|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138417262|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417263|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
138417264|NCT01675310|Metformin|metformin|mesh-list
138417265|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417266|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417267|NCT01676649|Paclitaxel|paclitaxel|mesh-list
138417268|NCT01676649|Carboplatin|carboplatin|mesh-list
138417269|NCT01676649|Ipilimumab|ipilimumab|mesh-list
138417270|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138417271|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417272|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417273|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
138417274|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138417275|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417276|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417277|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138417278|NCT01676987|Budesonide|budesonide|mesh-list
138417279|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
138417280|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417281|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138417282|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
138417283|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417284|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417285|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138417287|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
138417288|NCT01676987|Hormones|hormones|mesh-ancestor
138417289|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417290|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138417291|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138417292|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138417293|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
138417294|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215921|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417295|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417296|NCT01677039|Ethanol|ethanol|mesh-list
138417297|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138417298|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417299|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417300|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417301|NCT01677065|Oxycodone|oxycodone|mesh-list
138417302|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138417303|NCT01677065|Narcotics|narcotics|mesh-ancestor
138417304|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417305|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417306|NCT01677065|Analgesics|analgesics|mesh-ancestor
138417307|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
138417308|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417309|NCT01677247|Glimepiride|glimepiride|mesh-list
138417310|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138417311|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417312|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417313|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417314|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
138417315|NCT01677260|Metformin|metformin|mesh-list
138417316|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417317|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417318|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
138417319|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
138417320|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417321|NCT01677650|Methadone|methadone|mesh-list
138417322|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138417323|NCT01677650|Narcotics|narcotics|mesh-ancestor
138417324|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417325|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417326|NCT01677650|Analgesics|analgesics|mesh-ancestor
138417327|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
138417328|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417329|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
138417330|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
138417331|NCT01678053|Omeprazole|omeprazole|mesh-list
138417332|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
138417333|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138417335|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138417336|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138417337|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417338|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417339|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
138417340|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417341|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417342|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138417343|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417344|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417345|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138417346|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417348|NCT01678937|Sirolimus|sirolimus|mesh-list
138417349|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
138417350|NCT01678937|Temsirolimus|temsirolimus|mesh-list
138417351|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
138417352|NCT01678937|Tacrolimus|tacrolimus|mesh-list
138417353|NCT01678937|Cyclosporins|cyclosporins|mesh-list
138417354|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417355|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
138417359|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417361|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417362|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138417363|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417364|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138417365|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417366|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138417367|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
138417368|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417369|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138417370|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
138417371|NCT01679041|Fludarabine|fludarabine|mesh-list
138417372|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
138417373|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417374|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
138417375|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417376|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417377|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138417378|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
138417379|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417380|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417381|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138417382|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417383|NCT01679093|Dexamethasone|dexamethasone|mesh-list
138417384|NCT01679093|Droperidol|droperidol|mesh-list
138417385|NCT01679093|Ondansetron|ondansetron|mesh-list
138417386|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417387|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
138417388|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
138417389|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417390|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417391|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417392|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
138417393|NCT01679093|Hormones|hormones|mesh-ancestor
138417394|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417395|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138417396|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417397|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
138417398|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
138417399|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138417400|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138417401|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
138417402|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417403|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417404|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138417405|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138417406|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417407|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417408|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417410|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138417411|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
138417412|NCT01679743|Trastuzumab|trastuzumab|mesh-list
138417413|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417414|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417415|NCT01680094|Panobinostat|panobinostat|mesh-list
138417416|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417417|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138417418|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366299|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138366300|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138366301|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366302|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138366303|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138366304|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417419|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417421|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417422|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417424|NCT01680198|Vitamins|vitamins|mesh-ancestor
138417425|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
138417426|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417427|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138417428|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138417429|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138417430|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417431|NCT05596981|Sorafenib|sorafenib|mesh-list
138417432|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417433|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138417434|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417435|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417436|NCT05596968|Sorafenib|sorafenib|mesh-list
138417437|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417439|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417440|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417441|NCT05596890|Paclitaxel|paclitaxel|mesh-list
138417442|NCT05596890|Carboplatin|carboplatin|mesh-list
138417443|NCT05596890|Tislelizumab|tislelizumab|mesh-list
138417444|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138417445|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417446|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417447|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138417448|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138417449|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417450|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417452|NCT05596669|Morphine|morphine|mesh-list
138417453|NCT05596669|Analgesics|analgesics|mesh-ancestor
138417454|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
138417455|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417456|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417457|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138417458|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417459|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
138417460|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
138417461|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417462|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138417463|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138417464|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417465|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417467|NCT05596669|Narcotics|narcotics|mesh-ancestor
138417468|NCT05596617|Melatonin|melatonin|mesh-list
138417469|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
138417470|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417471|NCT05596617|Protective Agents|protective agents|mesh-ancestor
138417472|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417473|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417475|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
138417476|NCT05596552|Bupivacaine|bupivacaine|mesh-list
138417477|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
138417478|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
138366327|NCT01397175|Everolimus|everolimus|mesh-list
138366328|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138366329|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138366330|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366331|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366332|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417479|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417480|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417481|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
138417482|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417483|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138417484|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417485|NCT05596552|Analgesics|analgesics|mesh-ancestor
138417486|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138417487|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138417488|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138417489|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
138417491|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417492|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138417493|NCT05596552|Narcotics|narcotics|mesh-ancestor
138417494|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138417495|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417496|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
138417497|NCT05596227|Fentanyl|fentanyl|mesh-list
138417498|NCT05596227|Narcotics|narcotics|mesh-list
138417499|NCT05596227|Propofol|propofol|mesh-list
138417500|NCT05596227|Anesthetics|anesthetics|mesh-list
138417501|NCT05596227|Sevoflurane|sevoflurane|mesh-list
138417502|NCT05596227|Rocuronium|rocuronium|mesh-list
138417503|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138417504|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417505|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417506|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417507|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
138417508|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138417509|NCT05596227|Analgesics|analgesics|mesh-ancestor
138417510|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
138417511|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417512|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138417513|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138417514|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138417515|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138417516|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138417517|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138417518|NCT05596149|Listerine|listerine|mesh-list
138417519|NCT05596149|Fluorides|fluorides|mesh-list
138417520|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
138417521|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
138417522|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
138417523|NCT05596149|Protective Agents|protective agents|mesh-ancestor
138417524|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417525|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138417526|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417527|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
138417528|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417529|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138417530|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417531|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417532|NCT05596071|Sufentanil|sufentanil|mesh-list
138417534|NCT05596071|Ropivacaine|ropivacaine|mesh-list
138417535|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
138417536|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
138417537|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417538|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417540|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417541|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138417542|NCT05596071|Narcotics|narcotics|mesh-ancestor
138417543|NCT05596071|Analgesics|analgesics|mesh-ancestor
138417544|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138417545|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417546|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
138417547|NCT05595824|Molnupiravir|molnupiravir|mesh-list
138417548|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
138417549|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417550|NCT05595590|Tislelizumab|tislelizumab|mesh-list
138417551|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417552|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417553|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
138417554|NCT05595447|Nivolumab|nivolumab|mesh-list
138417555|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138417556|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417557|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417558|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138417559|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417560|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
138417561|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
138417562|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
138417563|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417564|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
138417565|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
138417566|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417568|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138417569|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138417570|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138417571|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138417572|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417573|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417574|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417575|NCT05557253|Anesthetics|anesthetics|mesh-list
138417577|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417578|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
138417579|NCT05539924|Pregabalin|pregabalin|mesh-list
138417580|NCT05539924|Gabapentin|gabapentin|mesh-list
138417581|NCT05539924|Vitamins|vitamins|mesh-ancestor
138417582|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
138417583|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417584|NCT05539924|Analgesics|analgesics|mesh-ancestor
138417585|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
138417586|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417587|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
138417588|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138417589|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417590|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417591|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138417592|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138417593|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417594|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417595|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417596|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138417597|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138417598|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417599|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
138417600|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
138417601|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
138417602|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138417603|NCT05514782|Protective Agents|protective agents|mesh-ancestor
138417604|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417605|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
138417606|NCT05479370|Vaccines|vaccines|mesh-list
138417607|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
138417608|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417609|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
138417610|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
138417611|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
138417612|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417613|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417614|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417615|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138417616|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417617|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417618|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417619|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138417620|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
138417621|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417622|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417624|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138417625|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138417626|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417627|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417628|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417629|NCT05226923|Meropenem|meropenem|mesh-list
138417630|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417631|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417632|NCT05057949|Itraconazole|itraconazole|mesh-list
138417633|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138417635|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
138417636|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417637|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138417638|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138417639|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417640|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417641|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138417642|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
138417643|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417644|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417645|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138417646|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138417647|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
138417648|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417649|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
138417650|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138417651|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138417652|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138417653|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138417654|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138417655|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138417656|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138417657|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
138417659|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417660|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417661|NCT04901312|Analgesics|analgesics|mesh-ancestor
138417662|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
138417663|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417664|NCT04886297|Resveratrol|resveratrol|mesh-list
138417665|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
138417666|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417667|NCT04886297|Protective Agents|protective agents|mesh-ancestor
138417668|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417669|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417670|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138417671|NCT04810793|Amoxicillin|amoxicillin|mesh-list
138417672|NCT04810793|Levofloxacin|levofloxacin|mesh-list
138417673|NCT04810793|Ofloxacin|ofloxacin|mesh-list
138417674|NCT04810793|Tetracycline|tetracycline|mesh-list
138417675|NCT04810793|Furazolidone|furazolidone|mesh-list
138417676|NCT04810793|Esomeprazole|esomeprazole|mesh-list
138417677|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417678|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417679|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138417680|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417681|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138417682|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417683|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417684|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138417685|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138417686|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138417687|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417688|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138417689|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138366341|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138366342|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366343|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138366345|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138366346|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
138366347|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138417690|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138417691|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138417692|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138417693|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138417694|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138417695|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138417696|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
138417697|NCT04797832|Hematinics|hematinics|mesh-ancestor
138417698|NCT04684511|Rofecoxib|rofecoxib|mesh-list
138417699|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138417700|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138417701|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417702|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417703|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138417704|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417705|NCT04684511|Analgesics|analgesics|mesh-ancestor
138417706|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
138417707|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417708|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417709|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417710|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417712|NCT04624854|Clopidogrel|clopidogrel|mesh-list
138417713|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138417714|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417715|NCT04624854|Analgesics|analgesics|mesh-ancestor
138417716|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
138417717|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417718|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417719|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417720|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417721|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138417722|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138417723|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417724|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138417725|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138417726|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417727|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
138417728|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138417729|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138417730|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138417731|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
138417732|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417733|NCT04565171|Yimitasvir|yimitasvir|mesh-list
138417734|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
138417735|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417736|NCT04450407|Insulin|insulin|mesh-list
138417737|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417738|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417739|NCT04231838|Nicotine|nicotine|mesh-list
138417740|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138417741|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
138417742|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417743|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417744|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138417745|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138417746|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138417747|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417748|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417749|NCT04218266|Apixaban|apixaban|mesh-list
138417750|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138417751|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
138417752|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138417753|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
138417754|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417755|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417756|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
138417758|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417759|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138417760|NCT04074603|Insulin|insulin|mesh-list
138417761|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417762|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417763|NCT04068246|Metformin|metformin|mesh-list
138417764|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417765|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417766|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
138417767|NCT04063033|Hematinics|hematinics|mesh-ancestor
138417775|NCT03907800|Trastuzumab|trastuzumab|mesh-list
138417776|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138417777|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417778|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417779|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138417780|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138417781|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417782|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417784|NCT03894904|Papaverine|papaverine|mesh-list
138417785|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
138417786|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138417787|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138417788|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417789|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138417790|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417791|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
138417792|NCT03894904|Urological Agents|urological agents|mesh-ancestor
138417793|NCT03797833|Anesthetics|anesthetics|mesh-list
138417794|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417795|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417796|NCT03749174|Anesthetics|anesthetics|mesh-list
138417797|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417798|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417799|NCT03722927|Bupivacaine|bupivacaine|mesh-list
138417800|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
138417801|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
138417802|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417803|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417804|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
138417805|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417806|NCT03578198|Rituximab|rituximab|mesh-list
138417807|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417808|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417809|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
138417810|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417811|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417812|NCT03554200|Empagliflozin|empagliflozin|mesh-list
138417813|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138417814|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417815|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138417816|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417817|NCT03517176|Paclitaxel|paclitaxel|mesh-list
138417818|NCT03517176|Gemcitabine|gemcitabine|mesh-list
138417819|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138417820|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417821|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417822|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
138417823|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
138417824|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417825|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138417826|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
138417827|NCT03512964|Tenofovir|tenofovir|mesh-list
138417828|NCT03512964|Emtricitabine|emtricitabine|mesh-list
138417829|NCT03512964|Dolutegravir|dolutegravir|mesh-list
138417830|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138417831|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
138417832|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417833|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138417834|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138417835|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417836|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417838|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138417839|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138417840|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138417841|NCT03476109|Omalizumab|omalizumab|mesh-list
138417842|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138417843|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138417844|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
138417845|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
138417846|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138417847|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
138417848|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417849|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
138417850|NCT03463499|Protective Agents|protective agents|mesh-ancestor
138417851|NCT03366974|Clarithromycin|clarithromycin|mesh-list
138417852|NCT03366974|Midazolam|midazolam|mesh-list
138417853|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138417854|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138417855|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417856|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417857|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138417858|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417859|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417860|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138417861|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
138417862|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
138417863|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
138417864|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
138417865|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417866|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417867|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417868|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417869|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138417870|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417871|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138417872|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138417873|NCT03294083|Cemiplimab|cemiplimab|mesh-list
138417874|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138417875|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417876|NCT03128398|Domperidone|domperidone|mesh-list
138417877|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
138417878|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
138417879|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417880|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417881|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138417882|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138417883|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
138417884|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417885|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417886|NCT03119038|Ketorolac|ketorolac|mesh-list
138417887|NCT03119038|Clonidine|clonidine|mesh-list
138417888|NCT03119038|Epinephrine|epinephrine|mesh-list
138417889|NCT03119038|Bupivacaine|bupivacaine|mesh-list
138417890|NCT03119038|Ropivacaine|ropivacaine|mesh-list
138417891|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
138417892|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
138417893|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417894|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417895|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
138417896|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417897|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138417898|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138417899|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138417900|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417901|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417902|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138417903|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138417904|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
138417905|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138417906|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
138417907|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
138417908|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
138417909|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138417910|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138417911|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138417912|NCT03119038|Analgesics|analgesics|mesh-ancestor
138417913|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138417914|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417915|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138417916|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417917|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138417918|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
138417919|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138417920|NCT03099265|Leucovorin|leucovorin|mesh-list
138417921|NCT03099265|Fluorouracil|fluorouracil|mesh-list
138417922|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
138417923|NCT03099265|Irinotecan|irinotecan|mesh-list
138417924|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
138417925|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417926|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138417927|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417928|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417929|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
138417930|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417931|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138417932|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138417933|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417934|NCT03099265|Antidotes|antidotes|mesh-ancestor
138417935|NCT03099265|Protective Agents|protective agents|mesh-ancestor
138417936|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
138417937|NCT03099265|Vitamins|vitamins|mesh-ancestor
138417938|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
138417939|NCT02975037|Clarithromycin|clarithromycin|mesh-list
138417940|NCT02975037|Itraconazole|itraconazole|mesh-list
138417941|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
138417942|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
138417943|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138417944|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138417945|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417946|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417947|NCT02975037|Urological Agents|urological agents|mesh-ancestor
138417948|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138417949|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138417950|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138417951|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138417952|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138417953|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
138417954|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138417955|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138417956|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
138417957|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138417958|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417960|NCT02931890|Docetaxel|docetaxel|mesh-list
138417961|NCT02931890|Carboplatin|carboplatin|mesh-list
138417962|NCT02931890|Capecitabine|capecitabine|mesh-list
138417963|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
138417964|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138417965|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138417966|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417967|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138417969|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417970|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138417971|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
138417972|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
138417973|NCT02812862|Olodaterol|olodaterol|mesh-list
138417974|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138417975|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
138417976|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417977|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417978|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138417979|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138417980|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
138417981|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138417982|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
138417983|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417984|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417985|NCT02587312|Nicotine|nicotine|mesh-list
138417986|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138417987|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
138417988|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417989|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417990|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138417991|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138417992|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138417994|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417995|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
138417997|NCT02549677|Epirubicin|epirubicin|mesh-list
138417998|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138417999|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
138418000|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418001|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418002|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138418003|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
138418004|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418005|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418006|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138418007|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418008|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418009|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418010|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138418011|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138418012|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138418013|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418015|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138418016|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138418017|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138418018|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418019|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418020|NCT02450253|Urological Agents|urological agents|mesh-ancestor
138418021|NCT02257970|Ketoprofen|ketoprofen|mesh-list
138418022|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138418023|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138418025|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
138418026|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418027|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418028|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418029|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418030|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138418031|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418032|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418033|NCT05838599|Imiquimod|imiquimod|mesh-list
138418034|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138418035|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
138418036|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418037|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418038|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
138418039|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138418040|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418041|NCT05838105|Progesterone|progesterone|mesh-list
138418042|NCT05838105|Progestins|progestins|mesh-ancestor
138418044|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418045|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418046|NCT05838066|Docetaxel|docetaxel|mesh-list
138418047|NCT05838066|Trastuzumab|trastuzumab|mesh-list
138418048|NCT05838066|Pertuzumab|pertuzumab|mesh-list
138418049|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418050|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418051|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418052|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418053|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418054|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418055|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138418056|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138418057|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
138418059|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418060|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418061|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418062|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418063|NCT05837936|Anesthetics|anesthetics|mesh-list
138418064|NCT05837936|Sevoflurane|sevoflurane|mesh-list
138418065|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418066|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418067|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138418068|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138418069|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
138418070|NCT05837689|Blinatumomab|blinatumomab|mesh-list
138418071|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418072|NCT05837286|Cortisone|cortisone|mesh-list
138418073|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418074|NCT05836857|Cannabidiol|cannabidiol|mesh-list
138418075|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
138418076|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
138418077|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138418078|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138418079|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418080|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
138418081|NCT05836831|Coagulants|coagulants|mesh-ancestor
138418082|NCT05836545|Midazolam|midazolam|mesh-list
138418083|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138418084|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418085|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418088|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138418089|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418090|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138418091|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
138418092|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
138418093|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
138418094|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
138418096|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418097|NCT05836441|Tacrolimus|tacrolimus|mesh-list
138418098|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418099|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
138418100|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418101|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138418102|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418103|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418104|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
138418106|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418107|NCT05834049|Midazolam|midazolam|mesh-list
138418108|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
138418109|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418110|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418111|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138418112|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418113|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138418114|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138418115|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418116|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138418117|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
138418118|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
138418119|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
138418120|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418121|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418122|NCT05833217|Insulin|insulin|mesh-list
138418123|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418124|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418125|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
138418126|NCT05814744|Bupivacaine|bupivacaine|mesh-list
138418127|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
138418128|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
138418129|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418130|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418131|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
138418132|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418133|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418134|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138418136|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138418137|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138418138|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138418139|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
138418140|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418141|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418143|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138418144|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
138418145|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
138418146|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418147|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418148|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138418149|NCT05797558|Diuretics|diuretics|mesh-ancestor
138418150|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
138418151|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138418152|NCT05797558|Hormones|hormones|mesh-ancestor
138418153|NCT05786820|Pycnogenols|pycnogenols|mesh-list
138418154|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138418155|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
138418156|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418157|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
138418158|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418159|NCT05786820|Protective Agents|protective agents|mesh-ancestor
138418160|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138418161|NCT05781308|Paclitaxel|paclitaxel|mesh-list
138418162|NCT05781308|Bevacizumab|bevacizumab|mesh-list
138418163|NCT05781308|Atezolizumab|atezolizumab|mesh-list
138418164|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138418165|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418166|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418167|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418168|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418169|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418170|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418171|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418172|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418173|NCT05781308|Growth Substances|growth substances|mesh-ancestor
138418174|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418175|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418176|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418178|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
138418179|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138418180|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418181|NCT05769868|Esmolol|esmolol|mesh-list
138418182|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138418183|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138418185|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
138418186|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418187|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418188|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418190|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138418191|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418192|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418193|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418194|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
138418195|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
138418196|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418198|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138418199|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
138418200|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418201|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418202|NCT05597254|Niacin|niacin|mesh-list
138418203|NCT05597254|Niacinamide|niacinamide|mesh-list
138418204|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
138418205|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138418206|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
138418207|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418208|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138418209|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138418211|NCT05597254|Vitamins|vitamins|mesh-ancestor
138418212|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
138418213|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418214|NCT05576415|Varenicline|varenicline|mesh-list
138418215|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138418216|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138418217|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
138418218|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418219|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418220|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418222|NCT05324761|Gabapentin|gabapentin|mesh-list
138418223|NCT05324761|Analgesics|analgesics|mesh-ancestor
138418224|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
138418225|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418226|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418227|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
138418228|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138418229|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418230|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418231|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138418232|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138418233|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138418234|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418235|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418236|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138418237|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138418238|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418239|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
138418240|NCT05317403|Cytarabine|cytarabine|mesh-list
138418241|NCT05317403|Fludarabine|fludarabine|mesh-list
138418242|NCT05317403|Venetoclax|venetoclax|mesh-list
138418243|NCT05317403|Vorinostat|vorinostat|mesh-list
138418245|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418246|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
138418247|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418248|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418249|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
138418250|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418251|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
138418252|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418254|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418256|NCT05312242|Micronutrients|micronutrients|mesh-list
138418257|NCT05312242|Trace Elements|trace elements|mesh-list
138418258|NCT05312242|Hematinics|hematinics|mesh-ancestor
138418259|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
138418260|NCT05312242|Vitamins|vitamins|mesh-ancestor
138418261|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418262|NCT05288829|Ravulizumab|ravulizumab|mesh-list
138418263|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138418264|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418265|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
138418266|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418267|NCT05233566|Ketamine|ketamine|mesh-list
138418268|NCT05233566|Analgesics|analgesics|mesh-ancestor
138418269|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
138418270|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418271|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418272|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138418273|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138418274|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
138418275|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
138418276|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418277|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138418278|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138418279|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418280|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418281|NCT05210517|Empagliflozin|empagliflozin|mesh-list
138418282|NCT05210517|Benzbromarone|benzbromarone|mesh-list
138418283|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138418284|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418285|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418286|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418287|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
138418288|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
138418289|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418290|NCT05180994|Infliximab|infliximab|mesh-list
138418291|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138418292|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418293|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
138418294|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418295|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418296|NCT05118685|Estrogens|estrogens|mesh-list
138418297|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138418298|NCT05118685|Hormones|hormones|mesh-ancestor
138418299|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418300|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418301|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138418302|NCT05109650|Antibodies|antibodies|mesh-list
138418303|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
138418304|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
138418305|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418307|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138418308|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418309|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418310|NCT05032118|Ketamine|ketamine|mesh-list
138418311|NCT05032118|Propofol|propofol|mesh-list
138418312|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418313|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418314|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418315|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138418316|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
138418317|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
138418318|NCT05032118|Analgesics|analgesics|mesh-ancestor
138418319|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
138418320|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418321|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138418322|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138418323|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138418324|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418325|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418327|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
138418328|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418329|NCT04862234|Dulaglutide|dulaglutide|mesh-list
138418330|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418331|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418332|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
138418333|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
138418334|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418335|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
138418336|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418337|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
138418338|NCT04505878|Vitamins|vitamins|mesh-ancestor
138418339|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
138418341|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
138418342|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418343|NCT04505878|Protective Agents|protective agents|mesh-ancestor
138418344|NCT04505189|Psilocybin|psilocybin|mesh-list
138418345|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
138418346|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418347|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418348|NCT04404881|Bevacizumab|bevacizumab|mesh-list
138418349|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418350|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418351|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418352|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418353|NCT04404881|Growth Substances|growth substances|mesh-ancestor
138418354|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418355|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418357|NCT04335058|Lactoferrin|lactoferrin|mesh-list
138418358|NCT04335058|Trace Elements|trace elements|mesh-ancestor
138418359|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
138418360|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418361|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418362|NCT04319224|Nivolumab|nivolumab|mesh-list
138418363|NCT04319224|Ipilimumab|ipilimumab|mesh-list
138418364|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418365|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418366|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418367|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418368|NCT04257448|Paclitaxel|paclitaxel|mesh-list
138418369|NCT04257448|Gemcitabine|gemcitabine|mesh-list
138418370|NCT04257448|Lenalidomide|lenalidomide|mesh-list
138418371|NCT04257448|Azacitidine|azacitidine|mesh-list
138418372|NCT04257448|Durvalumab|durvalumab|mesh-list
138418373|NCT04257448|Romidepsin|romidepsin|mesh-list
138418374|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138418375|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418376|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418378|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418379|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418380|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418382|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
138418383|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418384|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418385|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418386|NCT04257448|Growth Substances|growth substances|mesh-ancestor
138418387|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418388|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418389|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418390|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138418391|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138418392|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
138418393|NCT03959566|Bedaquiline|bedaquiline|mesh-list
138418394|NCT03959566|Midazolam|midazolam|mesh-list
138418395|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138418396|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418397|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418402|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138418403|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
138418404|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
138418405|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
138418406|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
138418407|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418408|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418409|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138418410|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418411|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138418412|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138418413|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418414|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418415|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
138418416|NCT03909529|Digoxin|digoxin|mesh-list
138418417|NCT03909529|Spironolactone|spironolactone|mesh-list
138418418|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138418419|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
138418420|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418421|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418422|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138418423|NCT03909529|Diuretics|diuretics|mesh-ancestor
138418424|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
138418425|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138418426|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138418427|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418428|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418429|NCT03909529|Protective Agents|protective agents|mesh-ancestor
138418431|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
138418432|NCT03875755|Vitamins|vitamins|mesh-ancestor
138418433|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
138418434|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418435|NCT03380546|Insulin|insulin|mesh-list
138418436|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138418437|NCT03380546|Acarbose|acarbose|mesh-list
138418438|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
138418439|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418440|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418441|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138418442|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418443|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418444|NCT03318094|Nitroprusside|nitroprusside|mesh-list
138418445|NCT03318094|Phentolamine|phentolamine|mesh-list
138418446|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138418447|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138418448|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138418449|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
138418450|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138418451|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418452|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138418453|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418454|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418456|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418457|NCT03250624|Ivermectin|ivermectin|mesh-list
138418458|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138418459|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418460|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
138418461|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138418462|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138418463|NCT03069326|Thalidomide|thalidomide|mesh-list
138418464|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418465|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
138418466|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418467|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
138418468|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138418469|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418471|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418472|NCT03069326|Growth Substances|growth substances|mesh-ancestor
138418473|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418474|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418475|NCT03015740|Nivolumab|nivolumab|mesh-list
138418476|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418477|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418478|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418479|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418482|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138418483|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418484|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418486|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138418487|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
138418488|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
138418489|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366357|NCT01397331|Isoflurane|isoflurane|mesh-list
138418490|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418491|NCT02376699|Paclitaxel|paclitaxel|mesh-list
138418492|NCT02376699|Gemcitabine|gemcitabine|mesh-list
138418493|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
138418494|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138418495|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418496|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418497|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418498|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418499|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418500|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418501|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
138418502|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418503|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418504|NCT02141542|Tremelimumab|tremelimumab|mesh-list
138418505|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418506|NCT01930955|Amoxicillin|amoxicillin|mesh-list
138418507|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138418508|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418509|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
138418510|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
138418511|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138418512|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418513|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418514|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138418515|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418516|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418517|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
138418518|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
138418519|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
138418520|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418521|NCT02066636|Nivolumab|nivolumab|mesh-list
138418522|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418523|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418524|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418525|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418551|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418552|NCT01681875|Nicotine|nicotine|mesh-list
138418553|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138418554|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
138418555|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418556|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418557|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138418558|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138418559|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
138418560|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418561|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418580|NCT06225310|Methylprednisolone|methylprednisolone|mesh-list
138418581|NCT06225310|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138418582|NCT06225310|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138418583|NCT06225310|Prednisolone|prednisolone|mesh-list
138418584|NCT06225310|Prednisolone acetate|prednisolone acetate|mesh-list
138418585|NCT06225310|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138418586|NCT06225310|Prednisolone phosphate|prednisolone phosphate|mesh-list
138418587|NCT06225310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418588|NCT06225310|Antiemetics|antiemetics|mesh-ancestor
138418589|NCT06225310|Autonomic Agents|autonomic agents|mesh-ancestor
138418590|NCT06225310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418591|NCT06225310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418592|NCT06225310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418593|NCT06225310|Glucocorticoids|glucocorticoids|mesh-ancestor
138418594|NCT06225310|Hormones|hormones|mesh-ancestor
138418622|NCT06225258|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418624|NCT06225232|Hallucinogens|hallucinogens|mesh-ancestor
138418625|NCT06225232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418626|NCT06225232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418648|NCT06225011|Fluoxetine|fluoxetine|mesh-list
138418649|NCT06225011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138418650|NCT06225011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138418651|NCT06225011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418652|NCT06225011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418653|NCT06225011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418654|NCT06225011|Serotonin Agents|serotonin agents|mesh-ancestor
138418655|NCT06225011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418656|NCT06225011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138418657|NCT06225011|Antidepressive Agents|antidepressive agents|mesh-ancestor
138418658|NCT06225011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418659|NCT06225011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138418660|NCT06225011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138418661|NCT06225011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418662|NCT06224946|Mitogens|mitogens|mesh-list
138418663|NCT06224946|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418664|NCT06224946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418665|NCT06224894|Antiemetics|antiemetics|mesh-list
138418681|NCT06224842|Mitoxantrone|mitoxantrone|mesh-list
138418682|NCT06224842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418683|NCT06224842|Antimetabolites|antimetabolites|mesh-ancestor
138418684|NCT06224842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418685|NCT06224842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418686|NCT06224842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418687|NCT06224842|Analgesics|analgesics|mesh-ancestor
138418688|NCT06224842|Sensory System Agents|sensory system agents|mesh-ancestor
138418689|NCT06224842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418690|NCT06224842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418691|NCT06224842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138418692|NCT06224842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138418693|NCT06224790|Pirfenidone|pirfenidone|mesh-list
138418694|NCT06224790|Analgesics|analgesics|mesh-ancestor
138418695|NCT06224790|Sensory System Agents|sensory system agents|mesh-ancestor
138418696|NCT06224790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418703|NCT06224777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138418714|NCT06224673|Immunologic Factors|immunologic factors|mesh-ancestor
138418715|NCT06224673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418717|NCT06224569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138418718|NCT06224569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418719|NCT06224569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138418720|NCT06224569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418721|NCT06224569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418722|NCT06224569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138418723|NCT06224569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138418724|NCT06224569|Purinergic Agents|purinergic agents|mesh-ancestor
138418725|NCT06224569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418726|NCT06224530|Levetiracetam|levetiracetam|mesh-list
138418727|NCT06224530|Anticonvulsants|anticonvulsants|mesh-ancestor
138418728|NCT06224530|Nootropic Agents|nootropic agents|mesh-ancestor
138418729|NCT06224439|Anesthetics|anesthetics|mesh-list
138418730|NCT06224439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418731|NCT06224439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418732|NCT06224348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138418743|NCT06224049|Cyclophosphamide|cyclophosphamide|mesh-list
138418744|NCT06224049|Fludarabine|fludarabine|mesh-list
138418745|NCT06224049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418746|NCT06224049|Immunologic Factors|immunologic factors|mesh-ancestor
138418747|NCT06224049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418748|NCT06224049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418749|NCT06224049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138418750|NCT06224049|Alkylating Agents|alkylating agents|mesh-ancestor
138418752|NCT06224049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418753|NCT06224049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138418754|NCT06223958|Aflibercept|aflibercept|mesh-list
138418755|NCT06223958|Axitinib|axitinib|mesh-list
138418756|NCT06223958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418757|NCT06223958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418758|NCT06223958|Growth Substances|growth substances|mesh-ancestor
138418759|NCT06223958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418760|NCT06223958|Growth Inhibitors|growth inhibitors|mesh-ancestor
138418761|NCT06223958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418762|NCT06223958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138418763|NCT06223958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418764|NCT06223958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418765|NCT06223932|Molnupiravir|molnupiravir|mesh-list
138418766|NCT06223932|Antiviral Agents|antiviral agents|mesh-ancestor
138418767|NCT06223932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418768|NCT06223880|Bupropion|bupropion|mesh-list
138418769|NCT06223880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138418770|NCT06223880|Antidepressive Agents|antidepressive agents|mesh-ancestor
138418771|NCT06223880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418772|NCT06223880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138418773|NCT06223880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138418774|NCT06223880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418775|NCT06223880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418776|NCT06223880|Dopamine Agents|dopamine agents|mesh-ancestor
138418777|NCT06223880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418778|NCT06223880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418779|NCT06223880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138418780|NCT06223880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138418781|NCT06223880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418788|NCT06223828|Azithromycin|azithromycin|mesh-list
138418789|NCT06223828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138418790|NCT06223828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418792|NCT06223711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418793|NCT06223711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418794|NCT06223698|Tamoxifen|tamoxifen|mesh-list
138418795|NCT06223698|Letrozole|letrozole|mesh-list
138418804|NCT06223698|Hormone Antagonists|hormone antagonists|mesh-ancestor
138418805|NCT06223698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418806|NCT06223698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418807|NCT06223698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138418808|NCT06223698|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138418809|NCT06223698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138418810|NCT06223698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138418812|NCT06223685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138418813|NCT06223685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418814|NCT06223685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418815|NCT06223659|Lidocaine|lidocaine|mesh-list
138418816|NCT06223659|Anesthetics, Local|anesthetics, local|mesh-list
138418817|NCT06223659|Prilocaine|prilocaine|mesh-list
138418818|NCT06223659|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138418820|NCT06223659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418821|NCT06223659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418822|NCT06223659|Sensory System Agents|sensory system agents|mesh-ancestor
138418823|NCT06223659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418824|NCT06223659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138418825|NCT06223659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138418826|NCT06223659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138418827|NCT06223659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418828|NCT06223659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418829|NCT06223659|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138418836|NCT06223477|Vitamin D|vitamin d|mesh-list
138418837|NCT06223477|Cholecalciferol|cholecalciferol|mesh-list
138418838|NCT06223477|Vitamins|vitamins|mesh-ancestor
138418839|NCT06223477|Micronutrients|micronutrients|mesh-ancestor
138418840|NCT06223477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418841|NCT06223477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138418842|NCT06223477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138418843|NCT06223360|Thiamine|thiamine|mesh-list
138418844|NCT06223360|Benphothiamine|benphothiamine|mesh-list
138418845|NCT06223360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138418846|NCT06223360|Immunologic Factors|immunologic factors|mesh-ancestor
138418847|NCT06223360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418848|NCT06223360|Chelating Agents|chelating agents|mesh-ancestor
138418849|NCT06223360|Sequestering Agents|sequestering agents|mesh-ancestor
138418850|NCT06223360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418851|NCT06223360|Vitamin B Complex|vitamin b complex|mesh-ancestor
138418853|NCT06223360|Micronutrients|micronutrients|mesh-ancestor
138418854|NCT06223243|Chlorhexidine|chlorhexidine|mesh-list
138418855|NCT06223243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138418856|NCT06223243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418857|NCT06223243|Disinfectants|disinfectants|mesh-ancestor
138418858|NCT06223074|Methylprednisolone|methylprednisolone|mesh-list
138418859|NCT06223074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138418860|NCT06223074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138418861|NCT06223074|Prednisolone|prednisolone|mesh-list
138418862|NCT06223074|Prednisolone acetate|prednisolone acetate|mesh-list
138418863|NCT06223074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138418864|NCT06223074|Prednisolone phosphate|prednisolone phosphate|mesh-list
138418865|NCT06223074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418866|NCT06223074|Antiemetics|antiemetics|mesh-ancestor
138418867|NCT06223074|Autonomic Agents|autonomic agents|mesh-ancestor
138418868|NCT06223074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418869|NCT06223074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418870|NCT06223074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418872|NCT06223074|Hormones|hormones|mesh-ancestor
138418873|NCT06223074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418876|NCT06223074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138418877|NCT06223074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418878|NCT06222944|Paclitaxel|paclitaxel|mesh-list
138418879|NCT06222944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138418880|NCT06222944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138418881|NCT06222944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418882|NCT06222944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418883|NCT06222944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418884|NCT06222944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418885|NCT06222944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418886|NCT06222801|Interferons|interferons|mesh-list
138418887|NCT06222801|Interferon-gamma|interferon-gamma|mesh-list
138418888|NCT06222801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418889|NCT06222801|Antiviral Agents|antiviral agents|mesh-ancestor
138418890|NCT06222801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418891|NCT06222749|Oxytocin|oxytocin|mesh-list
138418892|NCT06222749|Oxytocics|oxytocics|mesh-ancestor
138418893|NCT06222749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138418894|NCT06222749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418895|NCT06222723|Ribavirin|ribavirin|mesh-list
138418896|NCT06222723|Dexamethasone|dexamethasone|mesh-list
138418897|NCT06222723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138418898|NCT06222723|Antiemetics|antiemetics|mesh-ancestor
138418899|NCT06222723|Autonomic Agents|autonomic agents|mesh-ancestor
138418900|NCT06222723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418901|NCT06222723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418902|NCT06222723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418903|NCT06222723|Glucocorticoids|glucocorticoids|mesh-ancestor
138418904|NCT06222723|Hormones|hormones|mesh-ancestor
138418905|NCT06222723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418906|NCT06222723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138418907|NCT06222723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418908|NCT06222723|Antimetabolites|antimetabolites|mesh-ancestor
138418909|NCT06222723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418910|NCT06222723|Antiviral Agents|antiviral agents|mesh-ancestor
138418911|NCT06222723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418912|NCT06222697|Factor VIII|factor viii|mesh-list
138418913|NCT06222697|Coagulants|coagulants|mesh-ancestor
138418914|NCT06221683|Cytarabine|cytarabine|mesh-list
138418915|NCT06221683|Etoposide|etoposide|mesh-list
138418916|NCT06221683|Homoharringtonine|homoharringtonine|mesh-list
138418917|NCT06221683|Mitoxantrone|mitoxantrone|mesh-list
138418918|NCT06221683|Idarubicin|idarubicin|mesh-list
138418919|NCT06221683|Etoposide phosphate|etoposide phosphate|mesh-list
138418920|NCT06221683|Sorafenib|sorafenib|mesh-list
138418921|NCT06221683|Venetoclax|venetoclax|mesh-list
138418922|NCT06221683|Lenograstim|lenograstim|mesh-list
138418923|NCT06221683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138418924|NCT06221683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418925|NCT06221683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138418926|NCT06221683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138418927|NCT06221683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418928|NCT06221683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418929|NCT06221683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418930|NCT06221683|Antimetabolites|antimetabolites|mesh-ancestor
138418931|NCT06221683|Antiviral Agents|antiviral agents|mesh-ancestor
138418932|NCT06221683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418933|NCT06221683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418934|NCT06221683|Immunologic Factors|immunologic factors|mesh-ancestor
138418935|NCT06221683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418936|NCT06221683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138418937|NCT06221683|Analgesics|analgesics|mesh-ancestor
138418939|NCT06221683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418940|NCT06221683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138418941|NCT06221683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138418942|NCT06221683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138418943|NCT06220344|Iodine|iodine|mesh-list
138418945|NCT06220344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418946|NCT06220344|Trace Elements|trace elements|mesh-ancestor
138418947|NCT06220344|Micronutrients|micronutrients|mesh-ancestor
138418948|NCT06220344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418949|NCT06218758|Anesthetics|anesthetics|mesh-list
138418950|NCT06218758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418951|NCT06218758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418952|NCT06218745|Anesthetics|anesthetics|mesh-list
138418953|NCT06218745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418954|NCT06218745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418955|NCT06217120|Colchicine|colchicine|mesh-list
138418957|NCT06217120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418958|NCT06217120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138418959|NCT06217120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138418960|NCT06217120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138418961|NCT06217120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418962|NCT06217120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418963|NCT06212388|Interferons|interferons|mesh-list
138418964|NCT06212388|Pembrolizumab|pembrolizumab|mesh-list
138418965|NCT06212388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418966|NCT06212388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418967|NCT06212388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138418968|NCT06212388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418969|NCT06212388|Antiviral Agents|antiviral agents|mesh-ancestor
138418970|NCT06212388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138418971|NCT06212284|Citalopram|citalopram|mesh-list
138418972|NCT06212284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138418973|NCT06212284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138418974|NCT06212284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418975|NCT06212284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418976|NCT06212284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418977|NCT06212284|Serotonin Agents|serotonin agents|mesh-ancestor
138418978|NCT06212284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418979|NCT06212284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138418980|NCT06212284|Antidepressive Agents|antidepressive agents|mesh-ancestor
138418981|NCT06212284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138418982|NCT06207734|Palbociclib|palbociclib|mesh-list
138418983|NCT06207734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418986|NCT06207734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418988|NCT06199232|Tislelizumab|tislelizumab|mesh-list
138418989|NCT06199232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138418990|NCT06199232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138418991|NCT06199232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418992|NCT06199232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418993|NCT06193889|Cyclophosphamide|cyclophosphamide|mesh-list
138418994|NCT06193889|Fludarabine|fludarabine|mesh-list
138418995|NCT06193889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138418997|NCT06193889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418998|NCT06193889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418999|NCT06193889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419000|NCT06193889|Alkylating Agents|alkylating agents|mesh-ancestor
138419001|NCT06193889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419002|NCT06193889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419003|NCT06193889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419005|NCT06192160|Isoniazid|isoniazid|mesh-list
138419006|NCT06192160|Linezolid|linezolid|mesh-list
138419007|NCT06192160|Pyrazinamide|pyrazinamide|mesh-list
138419008|NCT06192160|Ethambutol|ethambutol|mesh-list
138419009|NCT06192160|Bedaquiline|bedaquiline|mesh-list
138419010|NCT06192160|Oxazolidinones|oxazolidinones|mesh-list
138419011|NCT06192160|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138419012|NCT06192160|Antitubercular Agents|antitubercular agents|mesh-ancestor
138419013|NCT06192160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138419014|NCT06192160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419015|NCT06192160|Leprostatic Agents|leprostatic agents|mesh-ancestor
138419016|NCT06192160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419017|NCT06192160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419018|NCT06192160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419019|NCT06192160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138419020|NCT06192160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138419021|NCT06192160|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138419022|NCT06192160|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138419023|NCT06192160|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138419024|NCT06192160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138419025|NCT06192160|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138419027|NCT06192160|Antimetabolites|antimetabolites|mesh-ancestor
138419028|NCT06192160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138419029|NCT06192160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138419031|NCT06184399|Albendazole|albendazole|mesh-list
138419032|NCT06184399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138419033|NCT06184399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419034|NCT06184399|Anthelmintics|anthelmintics|mesh-ancestor
138419035|NCT06184399|Anticestodal Agents|anticestodal agents|mesh-ancestor
138419036|NCT06184399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138419037|NCT06184399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138419038|NCT06184399|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419039|NCT06184399|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419040|NCT06184399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138419041|NCT06184399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419042|NCT06184399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419082|NCT06144944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419083|NCT06144944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138419084|NCT06144944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138419085|NCT06144944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138419086|NCT06144944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419088|NCT06143891|Prednisolone|prednisolone|mesh-list
138419089|NCT06143891|Belumosudil|belumosudil|mesh-list
138419090|NCT06143891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419091|NCT06143891|Glucocorticoids|glucocorticoids|mesh-ancestor
138419092|NCT06143891|Hormones|hormones|mesh-ancestor
138419093|NCT06143891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419094|NCT06143891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419095|NCT06143891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138419096|NCT06143891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419097|NCT06143891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138419098|NCT06143891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419099|NCT06143891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419101|NCT06136559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419102|NCT06131801|Venetoclax|venetoclax|mesh-list
138419103|NCT06131801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419105|NCT06118905|Denosumab|denosumab|mesh-list
138419106|NCT06118905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138419107|NCT06118905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419108|NCT06111781|Relugolix|relugolix|mesh-list
138419109|NCT06111781|Androgen Antagonists|androgen antagonists|mesh-ancestor
138419110|NCT06111781|Hormone Antagonists|hormone antagonists|mesh-ancestor
138419187|NCT06058377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419188|NCT06058377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419189|NCT06058377|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419190|NCT06058377|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419191|NCT06058377|Mitosis Modulators|mitosis modulators|mesh-ancestor
138419192|NCT06058377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419193|NCT06058377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419194|NCT06058377|Immunologic Factors|immunologic factors|mesh-ancestor
138419195|NCT06058377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419196|NCT06058377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419197|NCT06058377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419198|NCT06058377|Alkylating Agents|alkylating agents|mesh-ancestor
138419199|NCT06058377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419200|NCT06058377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138419201|NCT06058377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138419202|NCT06058377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138419203|NCT06058377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419204|NCT06058377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419205|NCT06056596|Lamivudine|lamivudine|mesh-list
138419206|NCT06056596|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138419207|NCT06056596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419208|NCT06056596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419209|NCT06056596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419210|NCT06056596|Antiviral Agents|antiviral agents|mesh-ancestor
138419211|NCT06056596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419212|NCT06056596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138419213|NCT06056596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138419214|NCT06051617|Seladelpar|seladelpar|mesh-list
138419215|NCT06051617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138419216|NCT06051617|Antimetabolites|antimetabolites|mesh-ancestor
138419217|NCT06051617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419218|NCT06051617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138419219|NCT06044935|Niacinamide|niacinamide|mesh-list
138419221|NCT06044935|Nicotinic Acids|nicotinic acids|mesh-list
138419222|NCT06044935|Vitamin B Complex|vitamin b complex|mesh-ancestor
138419223|NCT06044935|Vitamins|vitamins|mesh-ancestor
138419224|NCT06044935|Micronutrients|micronutrients|mesh-ancestor
138419225|NCT06044935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419226|NCT06044935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138419227|NCT06044935|Antimetabolites|antimetabolites|mesh-ancestor
138419228|NCT06044935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419229|NCT06044935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138419300|NCT06023641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138419301|NCT06023641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419302|NCT06023641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138419303|NCT06023641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138419304|NCT06023641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419305|NCT06009055|Propofol|propofol|mesh-list
138419306|NCT06009055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138419307|NCT06009055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138419308|NCT06009055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419309|NCT06009055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138419310|NCT06009055|Anesthetics, General|anesthetics, general|mesh-ancestor
138419311|NCT06009055|Anesthetics|anesthetics|mesh-ancestor
138419312|NCT06007508|Insulin Glargine|insulin glargine|mesh-list
138419313|NCT06007508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138419314|NCT06007508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419315|NCT05995535|Lofexidine|lofexidine|mesh-list
138419316|NCT05995535|Clonidine|clonidine|mesh-list
138419317|NCT05995535|Pregabalin|pregabalin|mesh-list
138419318|NCT05995535|Analgesics|analgesics|mesh-ancestor
138419319|NCT05995535|Sensory System Agents|sensory system agents|mesh-ancestor
138419320|NCT05995535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419321|NCT05995535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419322|NCT05995535|Anticonvulsants|anticonvulsants|mesh-ancestor
138419323|NCT05995535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138419324|NCT05995535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138419325|NCT05995535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419326|NCT05995535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138419327|NCT05995535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138419328|NCT05995535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138419329|NCT05995535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138419330|NCT05995535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138419331|NCT05995535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138419332|NCT05995535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138419333|NCT05995535|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138419334|NCT05995535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138419335|NCT05995535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138419336|NCT05995535|Adrenergic Agents|adrenergic agents|mesh-ancestor
138419337|NCT05995535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419338|NCT05995535|Sympatholytics|sympatholytics|mesh-ancestor
138419346|NCT05994287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138419347|NCT05994287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138419349|NCT05994287|Sensory System Agents|sensory system agents|mesh-ancestor
138419350|NCT05994287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419351|NCT05994287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419352|NCT05994287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419357|NCT05994287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138419358|NCT05994287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138419359|NCT05994287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419360|NCT05994287|Antipyretics|antipyretics|mesh-ancestor
138419361|NCT05994287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138419362|NCT05992428|Paroxetine|paroxetine|mesh-list
138419363|NCT05992428|Mirabegron|mirabegron|mesh-list
138419364|NCT05992428|DA-8010|da-8010|mesh-list
138419365|NCT05992428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138419366|NCT05992428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138419367|NCT05992428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138419368|NCT05992428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419369|NCT05992428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419370|NCT05992428|Serotonin Agents|serotonin agents|mesh-ancestor
138419371|NCT05992428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419372|NCT05992428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138419373|NCT05992428|Antidepressive Agents|antidepressive agents|mesh-ancestor
138419374|NCT05992428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138419375|NCT05992428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138419376|NCT05992428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138419377|NCT05992428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419378|NCT05992428|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138419390|NCT05991401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419391|NCT05991401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138419392|NCT05991401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419393|NCT05991401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419394|NCT05991401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138419395|NCT05991401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138419396|NCT05991401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138419397|NCT05991401|Antitubercular Agents|antitubercular agents|mesh-ancestor
138419398|NCT05991401|Leprostatic Agents|leprostatic agents|mesh-ancestor
138419399|NCT05991401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419400|NCT05991401|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138419401|NCT05991401|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138419402|NCT05991401|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138419403|NCT05991401|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138419404|NCT05991401|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138419405|NCT05991401|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138419406|NCT05991401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138419407|NCT05991401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138419408|NCT05991401|Cholinergic Agents|cholinergic agents|mesh-ancestor
138419409|NCT05991401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419410|NCT05991401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419422|NCT05972720|Fludarabine|fludarabine|mesh-list
138419423|NCT05972720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419424|NCT05972720|Immunologic Factors|immunologic factors|mesh-ancestor
138419425|NCT05972720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419426|NCT05972720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419427|NCT05972720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419428|NCT05972720|Alkylating Agents|alkylating agents|mesh-ancestor
138419461|NCT05944016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138419462|NCT05944016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419463|NCT05944016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138419464|NCT05944016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419465|NCT05933577|Pembrolizumab|pembrolizumab|mesh-list
138419466|NCT05933577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419467|NCT05933577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419468|NCT05933577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419469|NCT05933577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419477|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419478|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419479|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419480|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419483|NCT05899127|Lidocaine|lidocaine|mesh-list
138419484|NCT05899127|Sufentanil|sufentanil|mesh-list
138419485|NCT05899127|Remifentanil|remifentanil|mesh-list
138419486|NCT05899127|Dsuvia|dsuvia|mesh-list
138419487|NCT05899127|Propofol|propofol|mesh-list
138419488|NCT05899127|Etomidate|etomidate|mesh-list
138419489|NCT05899127|Rocuronium|rocuronium|mesh-list
138419490|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
138419491|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
138419492|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138419493|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419494|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
138419495|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419530|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419531|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138419532|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
138419538|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138419539|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138419551|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
138419553|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419554|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
138419555|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419580|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419581|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138419582|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138419583|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138419584|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
138419585|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419586|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419587|NCT05854784|Afamelanotide|afamelanotide|mesh-list
138419588|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138419605|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419606|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419607|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419608|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419698|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419699|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419700|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419709|NCT05694364|Fludarabine|fludarabine|mesh-list
138419710|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419711|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
138419712|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419724|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138419725|NCT05683691|Analgesics|analgesics|mesh-ancestor
138419726|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
138419727|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419728|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419729|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419730|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419810|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138419811|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138419812|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138419813|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419814|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
138419815|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
138419816|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419817|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419818|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138419821|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138419822|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138419823|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138419824|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138419825|NCT05660746|Infliximab|infliximab|mesh-list
138419826|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138419827|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419828|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138419829|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138419830|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419831|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
138419832|NCT05655689|Vancomycin|vancomycin|mesh-list
138419833|NCT05655689|Gentamicins|gentamicins|mesh-list
138419834|NCT05655689|Ceftazidime|ceftazidime|mesh-list
138419835|NCT05655689|Natamycin|natamycin|mesh-list
138419836|NCT05655689|Voriconazole|voriconazole|mesh-list
138419851|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138419852|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
138419853|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419854|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138419855|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138419868|NCT05652205|Linaclotide|linaclotide|mesh-list
138419869|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138419870|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
138419871|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419872|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138419873|NCT05649722|Treprostinil|treprostinil|mesh-list
138419874|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138419880|NCT05633667|Docetaxel|docetaxel|mesh-list
138419881|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138419882|NCT05633667|Carboplatin|carboplatin|mesh-list
138419883|NCT05633667|Nivolumab|nivolumab|mesh-list
138419884|NCT05633667|Pemetrexed|pemetrexed|mesh-list
138419885|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138419886|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419887|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419888|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419889|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419890|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
138419891|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419892|NCT05633667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419893|NCT05633667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419894|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419895|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138419896|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419897|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
138419899|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419900|NCT05630872|Lamivudine|lamivudine|mesh-list
138419901|NCT05630872|Dolutegravir|dolutegravir|mesh-list
138419902|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138419903|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419904|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419905|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419906|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
138419907|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419908|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138419909|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138419910|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138419912|NCT05626257|Omalizumab|omalizumab|mesh-list
138419913|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138419914|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138419915|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
138419916|NCT05625932|Tinzaparin|tinzaparin|mesh-list
138419917|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138419918|NCT05625932|Dalteparin|dalteparin|mesh-list
138419919|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
138419924|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138419926|NCT05624554|Fludarabine|fludarabine|mesh-list
138419927|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419928|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
138419929|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419930|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419931|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419932|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
138419933|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419934|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419935|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419936|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419937|NCT05618808|Enoxaparin|enoxaparin|mesh-list
138419938|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
138419939|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138419940|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138419941|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419947|NCT05605899|Prednisone|prednisone|mesh-list
138419948|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
138419949|NCT05605899|Rituximab|rituximab|mesh-list
138419950|NCT05605899|Doxorubicin|doxorubicin|mesh-list
138419951|NCT05605899|Fludarabine|fludarabine|mesh-list
138419952|NCT05605899|Etoposide|etoposide|mesh-list
138419953|NCT05605899|Vincristine|vincristine|mesh-list
138419954|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138419955|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419956|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
138419957|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419958|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419959|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419960|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
138419961|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419962|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419963|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419964|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419965|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138419966|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138419967|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138419968|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419969|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419970|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
138419971|NCT05605899|Hormones|hormones|mesh-ancestor
138419972|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419973|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138419974|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419975|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419976|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419977|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
138420038|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420040|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420041|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138420042|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138420049|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138420050|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138420051|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
138420053|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420054|NCT05534620|Fludarabine|fludarabine|mesh-list
138420073|NCT05493709|Leuprolide|leuprolide|mesh-list
138420074|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138420075|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
138420076|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138420077|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420078|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420079|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420080|NCT05477576|Everolimus|everolimus|mesh-list
138420081|NCT05477576|Sunitinib|sunitinib|mesh-list
138420082|NCT05477576|Octreotide|octreotide|mesh-list
138420083|NCT05477576|Lanreotide|lanreotide|mesh-list
138420084|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138420085|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420086|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420087|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420088|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420089|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
138420090|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420091|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420092|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138420093|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138420094|NCT05477576|Growth Substances|growth substances|mesh-ancestor
138420095|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
138420096|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420097|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420099|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420100|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420101|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
138420102|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138420103|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138420105|NCT05466279|Propofol|propofol|mesh-list
138420106|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138420107|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420108|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420109|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138420110|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
138420111|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
138420112|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138420113|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138420114|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138420115|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138420116|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
138420117|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
138420118|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420129|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420130|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138420131|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420132|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420133|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138420134|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
138420135|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138420136|NCT05456256|Carboplatin|carboplatin|mesh-list
138420137|NCT05456256|Pemetrexed|pemetrexed|mesh-list
138420138|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420139|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420140|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420141|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138420142|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138420143|NCT05438602|Ritonavir|ritonavir|mesh-list
138420144|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
138420145|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138420146|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138420147|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
138420148|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420149|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420150|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138420151|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138420152|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
138420153|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420154|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138420155|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138420156|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138420157|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138420158|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420159|NCT05428826|Prednisone|prednisone|mesh-list
138420160|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420161|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
138420175|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
138420176|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420177|NCT05414474|Protective Agents|protective agents|mesh-ancestor
138420178|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420179|NCT05414474|Vitamins|vitamins|mesh-ancestor
138420180|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
138420181|NCT05413304|Temozolomide|temozolomide|mesh-list
138420182|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
138420183|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138420184|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
138420185|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420186|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420187|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138420218|NCT05364424|Etoposide|etoposide|mesh-list
138420219|NCT05364424|Ifosfamide|ifosfamide|mesh-list
138420220|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420221|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420222|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
138420223|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420224|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420225|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138420226|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138420227|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138420228|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420229|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420230|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138420231|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
138420233|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138420234|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138420235|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420236|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
138420237|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420238|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
138420239|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
138420240|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420242|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138420243|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138420244|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420245|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420246|NCT05357482|Sirolimus|sirolimus|mesh-list
138420247|NCT05357482|Plerixafor|plerixafor|mesh-list
138420248|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
138420249|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
138420250|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
138420251|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420252|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420253|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420254|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138420255|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420256|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
138420257|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420258|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420259|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420260|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420261|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
138420262|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138420263|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138420264|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138420265|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
138420266|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
138420267|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420268|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420269|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420270|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420271|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138420272|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138420273|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420274|NCT05317416|Lenalidomide|lenalidomide|mesh-list
138420275|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
138420276|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420277|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138420278|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138420280|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
138420298|NCT05308654|Hormones|hormones|mesh-ancestor
138420299|NCT05308654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420300|NCT05308654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420301|NCT05308654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420302|NCT05308654|Immunologic Factors|immunologic factors|mesh-ancestor
138420303|NCT05308654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138420304|NCT05308654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138420305|NCT05308654|Growth Substances|growth substances|mesh-ancestor
138420306|NCT05308654|Growth Inhibitors|growth inhibitors|mesh-ancestor
138420307|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
138420308|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420310|NCT05298423|Etoposide|etoposide|mesh-list
138420311|NCT05298423|Carboplatin|carboplatin|mesh-list
138420312|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
138420313|NCT05298423|Pemetrexed|pemetrexed|mesh-list
138420314|NCT05298423|Durvalumab|durvalumab|mesh-list
138420315|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138420316|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420317|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138420318|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138420319|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
138420320|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420321|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420322|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420323|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138420324|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138420325|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420326|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138420327|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138420329|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138420331|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
138420332|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138420333|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138420334|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420394|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420395|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420396|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420397|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420398|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
138420399|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138420400|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420401|NCT05226663|Fluorides|fluorides|mesh-list
138420402|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
138420403|NCT05226663|Protective Agents|protective agents|mesh-ancestor
138420404|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420405|NCT05225558|Vancomycin|vancomycin|mesh-list
138420406|NCT05225558|Delpazolid|delpazolid|mesh-list
138420407|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
138420408|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420409|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420410|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138420412|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420413|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
138420414|NCT05203445|Olaparib|olaparib|mesh-list
138420415|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420416|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420417|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420418|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420419|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138420420|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420421|NCT05163808|BPN14770|bpn14770|mesh-list
138420422|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138420423|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138420424|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420425|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420426|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
138420427|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
138420428|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138420429|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420430|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420431|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
138420432|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138420433|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420434|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420435|NCT05098210|Poly I-C|poly i-c|mesh-list
138420436|NCT05098210|Nivolumab|nivolumab|mesh-list
138420437|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138420439|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420446|NCT05098210|Laxatives|laxatives|mesh-ancestor
138420447|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420448|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
138420449|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420450|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
138420451|NCT05096390|Axitinib|axitinib|mesh-list
138420452|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420453|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420454|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420455|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420456|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420457|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420465|NCT05067283|Carboplatin|carboplatin|mesh-list
138420466|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
138420467|NCT05067283|Fluorouracil|fluorouracil|mesh-list
138420468|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
138420469|NCT05067283|Pemetrexed|pemetrexed|mesh-list
138420470|NCT05067283|Cetuximab|cetuximab|mesh-list
138420471|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420472|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420473|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420474|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420475|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
138420476|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420477|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420478|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
138420479|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420480|NCT05067283|Antidotes|antidotes|mesh-ancestor
138420481|NCT05067283|Protective Agents|protective agents|mesh-ancestor
138420482|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
138420483|NCT05067283|Vitamins|vitamins|mesh-ancestor
138420484|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
138420485|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420486|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138420487|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138420488|NCT05065905|Interferons|interferons|mesh-list
138420491|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
138420492|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420493|NCT05017571|Colchicine|colchicine|mesh-list
138366366|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
138366367|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366368|NCT05268835|Clindamycin|clindamycin|mesh-list
138366369|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366370|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420494|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
138420495|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420496|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138420497|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138420498|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138420499|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420500|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420502|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420503|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
138420504|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420512|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138420513|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138420514|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
138420515|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420516|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
138420517|NCT04976634|Lenvatinib|lenvatinib|mesh-list
138420518|NCT04976634|Belzutifan|belzutifan|mesh-list
138420519|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420520|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420521|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420522|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420523|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420524|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420525|NCT04967469|Calcitriol|calcitriol|mesh-list
138420526|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
138420527|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138420528|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138420529|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420530|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138420531|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138420532|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420533|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138420534|NCT04967469|Vitamins|vitamins|mesh-ancestor
138420535|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
138420536|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138420537|NCT04960709|Durvalumab|durvalumab|mesh-list
138420538|NCT04960709|Tremelimumab|tremelimumab|mesh-list
138420539|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420540|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420541|NCT04958226|Midazolam|midazolam|mesh-list
138420542|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138420543|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138420544|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420545|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420546|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138420547|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138420548|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138420549|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138420550|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
138420552|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
138420553|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
138420554|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420555|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420556|NCT04924075|Belzutifan|belzutifan|mesh-list
138420557|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420558|NCT04923542|Hormones|hormones|mesh-list
138420559|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420560|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420579|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420580|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138420581|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
138420583|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420584|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138420585|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138420586|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138420587|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420588|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138420589|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
138420590|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420601|NCT04883346|Liraglutide|liraglutide|mesh-list
138420602|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138420603|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420604|NCT04883346|Incretins|incretins|mesh-ancestor
138420606|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420607|NCT04863885|Nivolumab|nivolumab|mesh-list
138420608|NCT04863885|Ipilimumab|ipilimumab|mesh-list
138420609|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138420610|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420611|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420612|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420613|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420614|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
138420615|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
138420616|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420617|NCT04858334|Olaparib|olaparib|mesh-list
138420618|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138420619|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420620|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420621|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420622|NCT04848688|Ivermectin|ivermectin|mesh-list
138420623|NCT04848688|Moxidectin|moxidectin|mesh-list
138420624|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138420625|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420626|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
138420628|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138420629|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
138420630|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138420631|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
138420632|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420633|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420634|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420635|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138420636|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420637|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
138420638|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420639|NCT04799288|Teriflunomide|teriflunomide|mesh-list
138420640|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138420641|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138420642|NCT04799288|Analgesics|analgesics|mesh-ancestor
138420643|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
138420644|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420645|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420646|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420647|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420648|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420649|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
138420650|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
138420651|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420652|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420653|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420654|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420655|NCT04763343|Ketamine|ketamine|mesh-list
138420656|NCT04763343|Analgesics|analgesics|mesh-ancestor
138420657|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
138420741|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420742|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420743|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
138420745|NCT04736706|Belzutifan|belzutifan|mesh-list
138420746|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420747|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420748|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420749|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420750|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420751|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420752|NCT04731363|Erythritol|erythritol|mesh-list
138420754|NCT04729959|Atezolizumab|atezolizumab|mesh-list
138420755|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
138420756|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138420757|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
138420758|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420759|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420760|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420761|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420762|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
138420763|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420764|NCT04710134|Reslizumab|reslizumab|mesh-list
138420765|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138420766|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
138420767|NCT04708886|Alendronate|alendronate|mesh-list
138420768|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138420769|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420770|NCT04693468|Palbociclib|palbociclib|mesh-list
138420771|NCT04693468|Axitinib|axitinib|mesh-list
138420772|NCT04693468|Crizotinib|crizotinib|mesh-list
138420773|NCT04693468|Talazoparib|talazoparib|mesh-list
138420774|NCT04693468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138420775|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420776|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420777|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420778|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420779|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138420780|NCT04693169|Choline|choline|mesh-list
138420781|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
138420782|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138420783|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
138420784|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420785|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420786|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138420787|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
138420788|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
138420789|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
138420790|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
138420791|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420792|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420793|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420794|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420795|NCT04648358|Dexamethasone|dexamethasone|mesh-list
138420796|NCT04648358|Bupivacaine|bupivacaine|mesh-list
138420797|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420798|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
138420799|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
138420800|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420801|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420802|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420806|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420807|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420808|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
138420810|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420811|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
138420812|NCT04632238|Metronidazole|metronidazole|mesh-list
138420813|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420814|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420815|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138420816|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138420817|NCT04562129|Aldesleukin|aldesleukin|mesh-list
138366374|NCT05268718|Voriconazole|voriconazole|mesh-list
138420819|NCT04562129|Ipilimumab|ipilimumab|mesh-list
138420820|NCT04562129|Interleukin-2|interleukin-2|mesh-list
138366375|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138366376|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138366377|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
138420821|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420822|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420823|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420824|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420825|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138420826|NCT04562129|Analgesics|analgesics|mesh-ancestor
138420827|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
138420828|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420829|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420830|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138420831|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138420832|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
138420833|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420834|NCT04560725|Choline|choline|mesh-list
138420835|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
138420836|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138420837|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
138420838|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420840|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138420841|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
138420842|NCT04553536|Sufentanil|sufentanil|mesh-list
138420843|NCT04553536|Remifentanil|remifentanil|mesh-list
138420844|NCT04553536|Dsuvia|dsuvia|mesh-list
138420845|NCT04553536|Bromides|bromides|mesh-list
138420846|NCT04553536|Propofol|propofol|mesh-list
138420847|NCT04553536|Esketamine|esketamine|mesh-list
138420848|NCT04553536|Rocuronium|rocuronium|mesh-list
138420849|NCT04553536|Cisatracurium|cisatracurium|mesh-list
138420850|NCT04553536|Atracurium|atracurium|mesh-list
138420851|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138420852|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420853|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420854|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138420855|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
138420856|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
138420857|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138420858|NCT04553536|Narcotics|narcotics|mesh-ancestor
138420859|NCT04553536|Analgesics|analgesics|mesh-ancestor
138420860|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
138420861|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420862|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
138420863|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138420864|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138420865|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138420866|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
138420867|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138420868|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138420869|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138420870|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
138420871|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420872|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420881|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420882|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420883|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138420884|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420885|NCT04533750|Deoxyglucose|deoxyglucose|mesh-list
138420886|NCT04533750|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138420887|NCT04533750|Peposertib|peposertib|mesh-list
138420888|NCT04533750|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138420889|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420890|NCT04533750|Antimetabolites|antimetabolites|mesh-ancestor
138420892|NCT04533750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420893|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420894|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420895|NCT04523818|Capecitabine|capecitabine|mesh-list
138420896|NCT04523818|Fluorouracil|fluorouracil|mesh-list
138420897|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420898|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
138420899|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420900|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420901|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420902|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
138420903|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420904|NCT04474847|Abatacept|abatacept|mesh-list
138420905|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420906|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420907|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420908|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420909|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420910|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
138420911|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420912|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420913|NCT04428151|Paclitaxel|paclitaxel|mesh-list
138420914|NCT04428151|Docetaxel|docetaxel|mesh-list
138420915|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
138420916|NCT04428151|Capecitabine|capecitabine|mesh-list
138420917|NCT04428151|Cetuximab|cetuximab|mesh-list
138420918|NCT04428151|Lenvatinib|lenvatinib|mesh-list
138420919|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138420920|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420921|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
138420922|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
138420923|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
138420924|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420925|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297381|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297382|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297383|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
138297392|NCT00002701|Tretinoin|tretinoin|mesh-list
138297393|NCT00002701|Thioguanine|thioguanine|mesh-list
138297394|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297395|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
138297396|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297397|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297398|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297399|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
138297400|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297401|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297402|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297403|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297404|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297405|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297406|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297407|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
138297408|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297409|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297410|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297411|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297412|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297413|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297414|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297418|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
138297420|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297421|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
138297422|NCT00004070|Interleukin-12|interleukin-12|mesh-list
138297423|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138297424|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
138297425|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297426|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138297427|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138297428|NCT00004070|Growth Substances|growth substances|mesh-ancestor
138297429|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
138297430|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297431|NCT00004082|Carboplatin|carboplatin|mesh-list
138297432|NCT00004082|Gemcitabine|gemcitabine|mesh-list
138297434|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297435|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297436|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
138297437|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297438|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297439|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297440|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297441|NCT00002707|Tamoxifen|tamoxifen|mesh-list
138297442|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
138297443|NCT00002707|Docetaxel|docetaxel|mesh-list
138297444|NCT00002707|Doxorubicin|doxorubicin|mesh-list
138297445|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297446|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
138297447|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297448|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297449|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297450|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
138297451|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297452|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297453|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297454|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297455|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297457|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297458|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297459|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297460|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297461|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138297463|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297464|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297465|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138297466|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138297467|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138297471|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297472|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
138297473|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297474|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297475|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297476|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
138297477|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297478|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297479|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
138297480|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297481|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297482|NCT00002719|Cytarabine|cytarabine|mesh-list
138297483|NCT00002719|Etoposide|etoposide|mesh-list
138297484|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
138297485|NCT00002719|Idarubicin|idarubicin|mesh-list
138297486|NCT00002719|Carmustine|carmustine|mesh-list
138297487|NCT00002719|Amsacrine|amsacrine|mesh-list
138297488|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297489|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297490|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297491|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297492|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297493|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297494|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297495|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
138297497|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297498|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297500|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297501|NCT00002719|Analgesics|analgesics|mesh-ancestor
138297502|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
138297503|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297504|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297505|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297506|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
138297507|NCT00003326|Paclitaxel|paclitaxel|mesh-list
138297508|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297509|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297510|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297511|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297512|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297513|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297514|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
138297515|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138297516|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
138297517|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297518|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297519|NCT00003602|Cytarabine|cytarabine|mesh-list
138297520|NCT00003602|Etoposide|etoposide|mesh-list
138297521|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
138297522|NCT00003602|Idarubicin|idarubicin|mesh-list
138297523|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297524|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297525|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297526|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297527|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297528|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297529|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297530|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
138297531|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
138297532|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297533|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297534|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
138297535|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297536|NCT00003602|Analgesics|analgesics|mesh-ancestor
138297537|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
138297538|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297539|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297540|NCT04609423|Vitamin D|vitamin d|mesh-list
138297541|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
138297542|NCT04609423|Vitamins|vitamins|mesh-ancestor
138297543|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
138297544|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297545|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138297546|NCT00003332|Gemcitabine|gemcitabine|mesh-list
138297547|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297548|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297549|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
138297550|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297551|NCT00004094|Paclitaxel|paclitaxel|mesh-list
138297552|NCT00004094|Carboplatin|carboplatin|mesh-list
138297553|NCT00004094|Fluorouracil|fluorouracil|mesh-list
138297554|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
138297555|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297556|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297557|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297558|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297559|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297560|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297561|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
138297562|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297563|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297564|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
138297565|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297567|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297568|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297569|NCT00004100|Gemcitabine|gemcitabine|mesh-list
138297570|NCT00004100|Vinorelbine|vinorelbine|mesh-list
138297571|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297572|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297573|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
138297574|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297575|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297576|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297577|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297578|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297579|NCT00002737|Interferons|interferons|mesh-list
138297580|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
138297581|NCT00002737|Isotretinoin|isotretinoin|mesh-list
138297582|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297583|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
138297584|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297585|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
138297586|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297587|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297588|NCT00003338|Epratuzumab|epratuzumab|mesh-list
138297589|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297590|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297592|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297593|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
138297594|NCT00003620|Growth Substances|growth substances|mesh-ancestor
138297595|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297596|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138297597|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297598|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297601|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297602|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297603|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297604|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297605|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
138297606|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297607|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297608|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297609|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297610|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297612|NCT00003632|Methotrexate|methotrexate|mesh-list
138297613|NCT00003632|Etoposide|etoposide|mesh-list
138297614|NCT00003632|Melphalan|melphalan|mesh-list
138297615|NCT00003632|Carmustine|carmustine|mesh-list
138297616|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297617|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297618|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297619|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297620|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297621|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
138297622|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297623|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297624|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297625|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297626|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297627|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297628|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
138297629|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297630|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297631|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297632|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297633|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297634|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
138297635|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297636|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297637|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
138297638|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297639|NCT00003350|Paclitaxel|paclitaxel|mesh-list
138297640|NCT00003350|Doxorubicin|doxorubicin|mesh-list
138297641|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297642|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297643|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297644|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297645|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297646|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297647|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297648|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297649|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297650|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297651|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297652|NCT00003356|Aldesleukin|aldesleukin|mesh-list
138297654|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297655|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297656|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
138297657|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297658|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297659|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138297660|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138297661|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
138297662|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297663|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
138297664|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138297665|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
138297672|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297674|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297675|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138297676|NCT00004142|Fluorouracil|fluorouracil|mesh-list
138297677|NCT00004142|Floxuridine|floxuridine|mesh-list
138297678|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
138297679|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297680|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297681|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297682|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297683|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
138297684|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297686|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297687|NCT00003362|Sargramostim|sargramostim|mesh-list
138297688|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
138297689|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
138297690|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297691|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138297693|NCT00003650|Dexamethasone|dexamethasone|mesh-list
138297694|NCT00003650|Prednisone|prednisone|mesh-list
138297695|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
138297696|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
138297697|NCT00003650|Methotrexate|methotrexate|mesh-list
138297698|NCT00003650|Etoposide|etoposide|mesh-list
138297699|NCT00003650|Vincristine|vincristine|mesh-list
138297700|NCT00003650|Daunorubicin|daunorubicin|mesh-list
138297701|NCT00003650|Asparaginase|asparaginase|mesh-list
138297702|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
138297703|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
138297704|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297705|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
138297706|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297707|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297708|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297709|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
138297710|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297711|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297712|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297713|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297714|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
138297715|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
138297716|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297717|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297718|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
138297719|NCT00003650|Hormones|hormones|mesh-ancestor
138297720|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297721|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297722|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297723|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297728|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297729|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297730|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297731|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297732|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297733|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297734|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
138297735|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297736|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297737|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297738|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297739|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138297740|NCT00003650|Protective Agents|protective agents|mesh-ancestor
138297741|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297742|NCT00003650|Analgesics|analgesics|mesh-ancestor
138297743|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
138297744|NCT00002755|Tamoxifen|tamoxifen|mesh-list
138297745|NCT00002755|Cobalt|cobalt|mesh-list
138297746|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
138297747|NCT00002755|Thiotepa|thiotepa|mesh-list
138297748|NCT00002755|Doxorubicin|doxorubicin|mesh-list
138297749|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297750|NCT00002755|Fluorouracil|fluorouracil|mesh-list
138297751|NCT00002755|Methotrexate|methotrexate|mesh-list
138297752|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297753|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
138297754|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297755|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297756|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297757|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
138297758|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297759|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297760|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297761|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297762|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297763|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297764|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297765|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
138297766|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297767|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297768|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297769|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297770|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297771|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297772|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297773|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138297774|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
138297775|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297777|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138297778|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138297779|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138297780|NCT00002755|Trace Elements|trace elements|mesh-ancestor
138297781|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
138297782|NCT00002761|Interferons|interferons|mesh-list
138297783|NCT00002761|Cytarabine|cytarabine|mesh-list
138297784|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
138297785|NCT00002761|Cyclosporine|cyclosporine|mesh-list
138297792|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297793|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297794|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297795|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
138297796|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297797|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297798|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297799|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
138297800|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297801|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297802|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
138297803|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297804|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
138297805|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297806|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138297807|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297808|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297809|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297810|NCT00382135|Tadalafil|tadalafil|mesh-list
138297811|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
138297812|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138297813|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138297815|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297816|NCT00382135|Urological Agents|urological agents|mesh-ancestor
138297817|NCT00003662|Cyclosporine|cyclosporine|mesh-list
138297818|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
138297819|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
138297821|NCT00003662|Busulfan|busulfan|mesh-list
138297822|NCT00003662|Cyclosporins|cyclosporins|mesh-list
138297823|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138297824|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297825|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
138297826|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297827|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297828|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297829|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
138297830|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297832|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297833|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297834|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
138297835|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297836|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297837|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138297838|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297839|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
138297840|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
138297841|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297842|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297843|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
138297844|NCT00003662|Hormones|hormones|mesh-ancestor
138297845|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297846|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138297847|NCT00003662|Protective Agents|protective agents|mesh-ancestor
138297848|NCT00004154|Fenretinide|fenretinide|mesh-list
138297849|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297850|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138297851|NCT00004154|Protective Agents|protective agents|mesh-ancestor
138297852|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297853|NCT00002767|Interferons|interferons|mesh-list
138297854|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
138297855|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
138297856|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297857|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
138297858|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297859|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
138297860|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297861|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138297862|NCT00002773|Interferons|interferons|mesh-list
138297863|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
138297864|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
138297865|NCT00002773|Sargramostim|sargramostim|mesh-list
138297866|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297867|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
138297868|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297869|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297870|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297871|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
138297872|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297873|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297874|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297875|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
138297876|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297878|NCT00004160|Gemcitabine|gemcitabine|mesh-list
138297879|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297880|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297881|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297882|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297883|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297885|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297886|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
138297887|NCT00003368|Irinotecan|irinotecan|mesh-list
138297888|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138297889|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297890|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297891|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297892|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297893|NCT00003674|Dalteparin|dalteparin|mesh-list
138297894|NCT00003674|Tinzaparin|tinzaparin|mesh-list
138297895|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138297896|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
138297897|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138297898|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138297899|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297900|NCT00003380|Doxorubicin|doxorubicin|mesh-list
138297901|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297902|NCT00003380|Etoposide|etoposide|mesh-list
138297903|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297904|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297905|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297906|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297907|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297908|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297909|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297910|NCT00002779|Fludarabine|fludarabine|mesh-list
138297911|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
138297914|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297915|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
138297916|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297917|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297918|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
138297919|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297920|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297921|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297922|NCT00003680|Tamoxifen|tamoxifen|mesh-list
138297923|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
138297935|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297936|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
138297937|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297938|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297939|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297940|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297941|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297942|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297943|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297944|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297945|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138297946|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
138297947|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297948|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297949|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138297950|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138297951|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138297952|NCT00002785|Leucovorin|leucovorin|mesh-list
138297953|NCT00002785|Cobalt|cobalt|mesh-list
138297954|NCT00002785|Cytarabine|cytarabine|mesh-list
138297955|NCT00002785|Cyclosporine|cyclosporine|mesh-list
138297956|NCT00002785|Dexamethasone|dexamethasone|mesh-list
138297957|NCT00002785|Prednisone|prednisone|mesh-list
138297958|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
138297959|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
138297960|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138297961|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138297962|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138297963|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
138297964|NCT00002785|Methotrexate|methotrexate|mesh-list
138297966|NCT00002785|Vincristine|vincristine|mesh-list
138297967|NCT00002785|Daunorubicin|daunorubicin|mesh-list
138297968|NCT00002785|Asparaginase|asparaginase|mesh-list
138297969|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
138297970|NCT00002785|Pegaspargase|pegaspargase|mesh-list
138297971|NCT00002785|Cyclosporins|cyclosporins|mesh-list
138297972|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
138297973|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297974|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
138297975|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297976|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297977|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297978|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
138297979|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297980|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297987|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
138297989|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297990|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297991|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297992|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297993|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297994|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297995|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
138297996|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297997|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297998|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297999|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298000|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298001|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298002|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298003|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
138298004|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298005|NCT00002785|Antidotes|antidotes|mesh-ancestor
138298006|NCT00002785|Protective Agents|protective agents|mesh-ancestor
138298007|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
138298008|NCT00002785|Vitamins|vitamins|mesh-ancestor
138298009|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
138298010|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298011|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298012|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298013|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
138298014|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138298015|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138298016|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298017|NCT00002785|Trace Elements|trace elements|mesh-ancestor
138298018|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138298019|NCT00004184|Antibodies|antibodies|mesh-list
138298020|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138298021|NCT00004184|Sargramostim|sargramostim|mesh-list
138298022|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
138298023|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
138298024|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298025|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138298026|NCT00004184|Antacids|antacids|mesh-ancestor
138298027|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298028|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298029|NCT00003386|Paclitaxel|paclitaxel|mesh-list
138298030|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
138298031|NCT00003386|Carboplatin|carboplatin|mesh-list
138298032|NCT00003386|Vaccines|vaccines|mesh-list
138298033|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
138298034|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
138298035|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298036|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298037|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298038|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298039|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298040|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298050|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138298051|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138298052|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
138298053|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
138298054|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298055|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298056|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138298057|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138298059|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
138298060|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298061|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298062|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
138298063|NCT00384566|Protective Agents|protective agents|mesh-ancestor
138298064|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138298065|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138298066|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298067|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
138298068|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138298069|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138298070|NCT00004832|Amifampridine|amifampridine|mesh-list
138298071|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138298072|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298073|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298074|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138298075|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138298077|NCT00002791|Doxorubicin|doxorubicin|mesh-list
138298078|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138298079|NCT00002791|Ifosfamide|ifosfamide|mesh-list
138298080|NCT00002791|Dacarbazine|dacarbazine|mesh-list
138298081|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298083|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298084|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298085|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298086|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298087|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298088|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
138298089|NCT00004190|Gemcitabine|gemcitabine|mesh-list
138298090|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
138298091|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298092|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
138298093|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298094|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298095|NCT00004196|Interferons|interferons|mesh-list
138298096|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
138298097|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298098|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
138298099|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298115|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298116|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298117|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298118|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
138298119|NCT00003686|Pilocarpine|pilocarpine|mesh-list
138298120|NCT00003686|Miotics|miotics|mesh-ancestor
138298121|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
138298122|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298123|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298124|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138298125|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138298126|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
138298127|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298128|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298130|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298132|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
138298133|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298134|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298135|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298136|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
138298138|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298139|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298140|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298141|NCT00004856|Trastuzumab|trastuzumab|mesh-list
138298142|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138298143|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298144|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
138298145|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298146|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298147|NCT00004862|Cytarabine|cytarabine|mesh-list
138298148|NCT00004862|Fludarabine|fludarabine|mesh-list
138298149|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
138298150|NCT00004862|Oblimersen|oblimersen|mesh-list
138298151|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298152|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298154|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298157|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298159|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298160|NCT00004220|Gemcitabine|gemcitabine|mesh-list
138298161|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
138298162|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298163|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
138298164|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298165|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298166|NCT00003704|Capecitabine|capecitabine|mesh-list
138298167|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298168|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
138298169|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298170|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298171|NCT00004868|Semaxinib|semaxinib|mesh-list
138298172|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138298173|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138298174|NCT00004868|Growth Substances|growth substances|mesh-ancestor
138298175|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298176|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
138298177|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298178|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138298179|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298180|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298182|NCT00003710|Mitomycins|mitomycins|mesh-list
138298183|NCT00003710|Mitomycin|mitomycin|mesh-list
138298184|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138298185|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298186|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298187|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298188|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298189|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298190|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
138366386|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366387|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138366388|NCT05268627|Liraglutide|liraglutide|mesh-list
138366389|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138298191|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298192|NCT00004232|Cyclosporine|cyclosporine|mesh-list
138298193|NCT00004232|Prednisone|prednisone|mesh-list
138298194|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
138298195|NCT00004232|Cyclosporins|cyclosporins|mesh-list
138298196|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298197|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
138298198|NCT00004232|Hormones|hormones|mesh-ancestor
138298199|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298200|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298201|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298202|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298203|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
138298204|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298205|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298207|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
138298208|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298209|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298210|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298211|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138298212|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
138298213|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
138298214|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298215|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298216|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138298218|NCT00004874|Iodine|iodine|mesh-list
138298219|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
138298220|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138298221|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298222|NCT00004874|Trace Elements|trace elements|mesh-ancestor
138298223|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
138298233|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298234|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138298235|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138298236|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138298237|NCT00004244|Growth Substances|growth substances|mesh-ancestor
138298238|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
138298239|NCT00004880|Vaccines|vaccines|mesh-list
138298240|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
138298241|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298242|NCT00004250|Dactinomycin|dactinomycin|mesh-list
138298243|NCT00004250|Melphalan|melphalan|mesh-list
138366398|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366399|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138366400|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
138298244|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298245|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
138366401|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366402|NCT05267977|Cephalosporins|cephalosporins|mesh-list
138366403|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366404|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366405|NCT05186558|Rituximab|rituximab|mesh-list
138366406|NCT05186558|Gemcitabine|gemcitabine|mesh-list
138366407|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
138366408|NCT05186558|Lenalidomide|lenalidomide|mesh-list
138366409|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366410|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298246|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298247|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298249|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298250|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
138298251|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298252|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138298253|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298254|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298255|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138298257|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298259|NCT00003728|Cytarabine|cytarabine|mesh-list
138298260|NCT00003728|Dexamethasone|dexamethasone|mesh-list
138298261|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
138298262|NCT00003728|Prednisolone|prednisolone|mesh-list
138298263|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
138298264|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138298265|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138298267|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
138298268|NCT00003728|Doxorubicin|doxorubicin|mesh-list
138298269|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138298270|NCT00003728|Methotrexate|methotrexate|mesh-list
138298271|NCT00003728|Etoposide|etoposide|mesh-list
138298272|NCT00003728|Vincristine|vincristine|mesh-list
138298273|NCT00003728|Daunorubicin|daunorubicin|mesh-list
138298274|NCT00003728|Asparaginase|asparaginase|mesh-list
138298275|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
138298276|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
138298278|NCT00003728|Vindesine|vindesine|mesh-list
138298279|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
138298280|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298281|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
138298282|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298283|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298284|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298285|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
138298286|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298287|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298288|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138298289|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298297|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298298|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298299|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298300|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298301|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298302|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138298303|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
138298304|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138298305|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298306|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
138298307|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298308|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138298309|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298310|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298312|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298314|NCT00003728|Protective Agents|protective agents|mesh-ancestor
138298315|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
138298316|NCT00003728|Vitamins|vitamins|mesh-ancestor
138298317|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
138298318|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298319|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298320|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298321|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138298322|NCT00003728|Analgesics|analgesics|mesh-ancestor
138298323|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
138298324|NCT00004886|Docetaxel|docetaxel|mesh-list
138298325|NCT00004886|Dofequidar|dofequidar|mesh-list
138298326|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298327|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298328|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298329|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298330|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298331|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138298332|NCT00003734|Flutamide|flutamide|mesh-list
138298333|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
138298334|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138298335|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
138298336|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138298337|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298338|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138298339|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298340|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298341|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
138298342|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
138298343|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298344|NCT00003740|Trastuzumab|trastuzumab|mesh-list
138298345|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138298346|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298347|NCT05477875|Acetaminophen|acetaminophen|mesh-list
138298349|NCT05477875|Codeine|codeine|mesh-list
138298350|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138298351|NCT05477875|Analgesics|analgesics|mesh-ancestor
138298352|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
138298353|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298357|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138298358|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138298359|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138298360|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298361|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298363|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298364|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138298365|NCT05477875|Narcotics|narcotics|mesh-ancestor
138298366|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138298367|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
138298368|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
138298369|NCT00004256|Sargramostim|sargramostim|mesh-list
138298370|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
138298371|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298372|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
138298373|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298374|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138298375|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298376|NCT00004892|Carmustine|carmustine|mesh-list
138298377|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138298378|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298379|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
138298380|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298381|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298382|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298383|NCT00004268|Midodrine|midodrine|mesh-list
138298386|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298387|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298388|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138298389|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138298390|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138298391|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138298392|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
138298393|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298394|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298395|NCT00004274|Estrogens|estrogens|mesh-list
138298396|NCT00004274|Hormones|hormones|mesh-ancestor
138298397|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298398|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298400|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
138298401|NCT00004904|Etoposide|etoposide|mesh-list
138298402|NCT00004904|Cladribine|cladribine|mesh-list
138298403|NCT00004904|Tacrolimus|tacrolimus|mesh-list
138298404|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138298405|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298406|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
138298407|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298408|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298409|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298410|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
138298411|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298412|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366421|NCT05092698|Vitamin D|vitamin d|mesh-list
138298413|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138298414|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298415|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298416|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298417|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298418|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138298419|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298420|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
138298421|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
138298422|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298423|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298424|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
138298426|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298427|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138298428|NCT00004904|Protective Agents|protective agents|mesh-ancestor
138298429|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
138298430|NCT00004286|Antibodies|antibodies|mesh-list
138298431|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
138298432|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138298433|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138298434|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
138298435|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298436|NCT00003746|Cladribine|cladribine|mesh-list
138298437|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298438|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298439|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
138298440|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298442|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298443|NCT00003758|Cytarabine|cytarabine|mesh-list
138298444|NCT00003758|Idarubicin|idarubicin|mesh-list
138298445|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298446|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
138298447|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298448|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298449|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
138298450|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298451|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298452|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
138298453|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298454|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298455|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298456|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298457|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298458|NCT00004310|Clomipramine|clomipramine|mesh-list
138298459|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138298460|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
138298461|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138298462|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138298463|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138298464|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138298465|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298466|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298467|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
138298468|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298470|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138298471|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298472|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298473|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298474|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298476|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
138298477|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298478|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
138298479|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298480|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298481|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
138298482|NCT00004928|Calcitriol|calcitriol|mesh-list
138298483|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138298484|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298485|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298486|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138298487|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138298488|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298489|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138298496|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298497|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298498|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138298499|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
138298500|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
138298501|NCT00004934|Paclitaxel|paclitaxel|mesh-list
138298502|NCT00004934|Carboplatin|carboplatin|mesh-list
138298503|NCT00004934|Epirubicin|epirubicin|mesh-list
138298504|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298505|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298506|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298507|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298508|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298509|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298510|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298511|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298512|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298513|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298515|NCT00003776|Trimetrexate|trimetrexate|mesh-list
138298516|NCT00003776|Doxorubicin|doxorubicin|mesh-list
138298517|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138298518|NCT00003776|Methotrexate|methotrexate|mesh-list
138298519|NCT00003776|Ifosfamide|ifosfamide|mesh-list
138298520|NCT00003776|Calcium|calcium|mesh-list
138298521|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
138298522|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298523|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298524|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298525|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298526|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298527|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298528|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298529|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298530|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138298532|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138298533|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298534|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
138298535|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298536|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138298537|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298538|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
138298539|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298540|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298541|NCT00003776|Antidotes|antidotes|mesh-ancestor
138298542|NCT00003776|Protective Agents|protective agents|mesh-ancestor
138298543|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
138298544|NCT00003776|Vitamins|vitamins|mesh-ancestor
138298545|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
138298546|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298547|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
138298548|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
138298549|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298550|NCT00003788|Carmustine|carmustine|mesh-list
138366425|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298551|NCT00003788|Lomustine|lomustine|mesh-list
138298552|NCT00003788|Procarbazine|procarbazine|mesh-list
138298553|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138298554|NCT00003788|Trioxsalen|trioxsalen|mesh-list
138366426|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138366427|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298555|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298556|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
138298557|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298559|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138298560|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138298566|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138298567|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138298568|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298569|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138298571|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
138298572|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138298573|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138298574|NCT00004346|Lovastatin|lovastatin|mesh-list
138298575|NCT00004346|L 647318|l 647318|mesh-list
138298576|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
138298577|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138298578|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138298579|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
138298580|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298581|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138298582|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138298583|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298584|NCT00004346|Cathartics|cathartics|mesh-ancestor
138298585|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298586|NCT00384800|Thalidomide|thalidomide|mesh-list
138298588|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298589|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
138298590|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298591|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
138298592|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138298593|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298594|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138298595|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138298596|NCT00384800|Growth Substances|growth substances|mesh-ancestor
138298597|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138298598|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298599|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298600|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
138298601|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298604|NCT00384878|Cetuximab|cetuximab|mesh-list
138298605|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298606|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
138298607|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298608|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298609|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298610|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
138298611|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298612|NCT00384878|Antidotes|antidotes|mesh-ancestor
138298613|NCT00384878|Protective Agents|protective agents|mesh-ancestor
138298614|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
138298615|NCT00384878|Vitamins|vitamins|mesh-ancestor
138298616|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
138298617|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138298618|NCT02972762|Propofol|propofol|mesh-list
138298619|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138298620|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138298621|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298622|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138298624|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
138298625|NCT00004358|Calcitonin|calcitonin|mesh-list
138298626|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
138298627|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138298628|NCT00004358|Katacalcin|katacalcin|mesh-list
138298629|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298630|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298631|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138298632|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
138298633|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138298634|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
138298635|NCT00004364|Coagulants|coagulants|mesh-ancestor
138298636|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138298637|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
138298638|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298639|NCT00005000|Lamivudine|lamivudine|mesh-list
138298640|NCT00005000|Zidovudine|zidovudine|mesh-list
138298641|NCT00005000|Efavirenz|efavirenz|mesh-list
138298642|NCT00005000|Didanosine|didanosine|mesh-list
138298643|NCT00005000|Stavudine|stavudine|mesh-list
138298644|NCT00005000|Nelfinavir|nelfinavir|mesh-list
138298645|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138298646|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138298647|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298649|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298650|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
138298651|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298652|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138298653|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138298655|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138298656|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138298657|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138298658|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138298659|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138298660|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138298661|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138298662|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138298663|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
138298664|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138298665|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
138298666|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298668|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138298669|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138298670|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138298671|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138298672|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138298673|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298674|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298676|NCT00005006|Alendronate|alendronate|mesh-list
138298677|NCT00005006|Teriparatide|teriparatide|mesh-list
138298678|NCT00005006|Hormones|hormones|mesh-list
138298679|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
138298680|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298681|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298682|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138298692|NCT00004400|Hormones|hormones|mesh-ancestor
138298693|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298694|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298695|NCT00003812|Paclitaxel|paclitaxel|mesh-list
138298696|NCT00003812|Etoposide|etoposide|mesh-list
138298697|NCT00003812|Carboplatin|carboplatin|mesh-list
138298698|NCT00003812|Topotecan|topotecan|mesh-list
138298699|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298701|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298702|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298703|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298704|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298705|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298706|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298707|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298708|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138298709|NCT00005018|Efavirenz|efavirenz|mesh-list
138298710|NCT00005018|Abacavir|abacavir|mesh-list
138298711|NCT00005018|Didanosine|didanosine|mesh-list
138298712|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
138298713|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138298714|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138298715|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366440|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298716|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298717|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
138298718|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298719|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138298720|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138298721|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138298722|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138298723|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138298724|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138298725|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298726|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
138298727|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138298728|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138298729|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
138298730|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138298731|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
138298732|NCT00003824|Cephalexin|cephalexin|mesh-list
138298733|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298734|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298735|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298736|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298737|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298738|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298739|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138298740|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138298741|NCT00004406|Hormones|hormones|mesh-list
138298742|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
138298743|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298744|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298745|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298746|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
138298748|NCT00005024|Doxorubicin|doxorubicin|mesh-list
138298749|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138298750|NCT00005024|Granisetron|granisetron|mesh-list
138298751|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298752|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
138298753|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298754|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298755|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298756|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
138298757|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298758|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298759|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138298760|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138298761|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298762|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298763|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298765|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
138298766|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298767|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298768|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138298769|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138298770|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
138298771|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298772|NCT00005030|Lonafarnib|lonafarnib|mesh-list
138298773|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298774|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298775|NCT00004424|Midazolam|midazolam|mesh-list
138298776|NCT00004424|Fentanyl|fentanyl|mesh-list
138298777|NCT00004424|Propofol|propofol|mesh-list
138298778|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138298779|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138298780|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298781|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138298782|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
138298783|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
138298784|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138298785|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138298786|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138298787|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138298788|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
138298789|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
138298790|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298791|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298792|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138298793|NCT00004424|Narcotics|narcotics|mesh-ancestor
138298794|NCT00004424|Analgesics|analgesics|mesh-ancestor
138298795|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
138298796|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298797|NCT00004430|Prednisolone|prednisolone|mesh-list
138298798|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298799|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
138298800|NCT00004430|Hormones|hormones|mesh-ancestor
138298801|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298802|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298803|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298804|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298805|NCT00003842|Interleukin-4|interleukin-4|mesh-list
138298806|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138298807|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
138298808|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298809|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298810|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298818|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298819|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
138298820|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298821|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298822|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298823|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298824|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
138298825|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138298826|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298827|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298828|NCT00005036|Antidotes|antidotes|mesh-ancestor
138298829|NCT00005036|Protective Agents|protective agents|mesh-ancestor
138298830|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
138298832|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
138298833|NCT00004436|Prednisone|prednisone|mesh-list
138298834|NCT00004436|Leuprolide|leuprolide|mesh-list
138298835|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298836|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
138298837|NCT00004436|Hormones|hormones|mesh-ancestor
138298838|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298839|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298840|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298841|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298842|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138298843|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
138298844|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138298845|NCT00005042|Semaxinib|semaxinib|mesh-list
138298846|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138298847|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138298848|NCT00005042|Growth Substances|growth substances|mesh-ancestor
138298849|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298850|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
138298851|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298852|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138298853|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298854|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298857|NCT00004442|Cholic Acids|cholic acids|mesh-list
138298858|NCT00004442|Cathartics|cathartics|mesh-ancestor
138298859|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298860|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138298861|NCT05444569|Liraglutide|liraglutide|mesh-list
138298862|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138298863|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298864|NCT05444569|Incretins|incretins|mesh-ancestor
138298865|NCT05444569|Hormones|hormones|mesh-ancestor
138298866|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298867|NCT00004448|Prednisone|prednisone|mesh-list
138298868|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298869|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
138366449|NCT06105008|Immunologic Factors|immunologic factors|mesh-ancestor
138298870|NCT00004448|Hormones|hormones|mesh-ancestor
138298871|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298872|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298873|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298874|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298875|NCT00003860|Carboplatin|carboplatin|mesh-list
138298876|NCT00003860|Etoposide|etoposide|mesh-list
138298885|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
138298886|NCT00005048|Paclitaxel|paclitaxel|mesh-list
138298887|NCT00005048|Estramustine|estramustine|mesh-list
138298888|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298889|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298890|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298891|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298892|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298893|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298894|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298895|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
138298896|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298897|NCT04756765|Talazoparib|talazoparib|mesh-list
138298898|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138298899|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298900|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298901|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298902|NCT00004466|Atorvastatin|atorvastatin|mesh-list
138298903|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138298904|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138298905|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
138298906|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298907|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138298908|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138298910|NCT00005054|Temozolomide|temozolomide|mesh-list
138298911|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298912|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
138298913|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298914|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298915|NCT00004478|Droxidopa|droxidopa|mesh-list
138298916|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138298917|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138298918|NCT00003878|Carmustine|carmustine|mesh-list
138298919|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298920|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
138298921|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298922|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298923|NCT00005060|Docetaxel|docetaxel|mesh-list
138298924|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298926|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298927|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298928|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298929|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
138298930|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138298931|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298932|NCT00005066|Carmustine|carmustine|mesh-list
138298933|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138298934|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298935|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
138298936|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298937|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298938|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366450|NCT06105008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366451|NCT06104644|Deucravacitinib|deucravacitinib|mesh-list
138366452|NCT06104644|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366453|NCT06104644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138366456|NCT06104423|Ramipril|ramipril|mesh-list
138298939|NCT00005072|Interleukin-2|interleukin-2|mesh-list
138298940|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298941|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138298942|NCT00005072|Analgesics|analgesics|mesh-ancestor
138298943|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
138298944|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298945|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298946|NCT00004496|Hormones|hormones|mesh-list
138298947|NCT00004496|alpha-MSH|alpha-msh|mesh-list
138298948|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138298949|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138298950|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
138298951|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298952|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298953|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298954|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298955|NCT00003902|Capecitabine|capecitabine|mesh-list
138298956|NCT00003902|Vinorelbine|vinorelbine|mesh-list
138298957|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298958|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
138298959|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298960|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298961|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298962|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298963|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298964|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298965|NCT00003908|Carboplatin|carboplatin|mesh-list
138298967|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298968|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298969|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298970|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298971|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298973|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138298974|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298975|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
138298976|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298977|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298978|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298979|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298980|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298981|NCT00005078|Paclitaxel|paclitaxel|mesh-list
138298982|NCT00005078|Carboplatin|carboplatin|mesh-list
138298983|NCT00005078|Tirapazamine|tirapazamine|mesh-list
138298984|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298985|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298986|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138298987|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138298988|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298989|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298990|NCT04698031|Aspirin|aspirin|mesh-list
138298991|NCT04698031|Clopidogrel|clopidogrel|mesh-list
138298992|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138298993|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138298994|NCT04698031|Analgesics|analgesics|mesh-ancestor
138298995|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
138298996|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298997|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298998|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138298999|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299000|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138299001|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138299002|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299003|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138299004|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138299005|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299006|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
138299007|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138299008|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138299009|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138299010|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
138299011|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299012|NCT00003920|Cyclosporine|cyclosporine|mesh-list
138299015|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
138299016|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138299017|NCT00003920|Cyclosporins|cyclosporins|mesh-list
138299018|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
138299019|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299021|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299022|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299023|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299024|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
138299025|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299026|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299027|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299028|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138299029|NCT00003926|Melphalan|melphalan|mesh-list
138299030|NCT00003926|Busulfan|busulfan|mesh-list
138299031|NCT00003926|Thiotepa|thiotepa|mesh-list
138299032|NCT00003926|Lenograstim|lenograstim|mesh-list
138299033|NCT00003926|Amifostine|amifostine|mesh-list
138299034|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138299035|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
138299036|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299037|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299038|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
138299039|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299040|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299041|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299042|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299043|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138299044|NCT00003926|Protective Agents|protective agents|mesh-ancestor
138299045|NCT05122819|Anesthetics|anesthetics|mesh-list
138299046|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299047|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299048|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
138299049|NCT00005090|Dacarbazine|dacarbazine|mesh-list
138299050|NCT00005090|Carmustine|carmustine|mesh-list
138299051|NCT00005090|Doxorubicin|doxorubicin|mesh-list
138299052|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138299053|NCT00005090|Etoposide|etoposide|mesh-list
138299054|NCT00005090|Bleomycin|bleomycin|mesh-list
138299055|NCT00005090|Vinblastine|vinblastine|mesh-list
138299056|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299057|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
138299058|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299059|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299060|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299061|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
138299062|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299063|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299064|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299065|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138299066|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138299067|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138299068|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299069|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299070|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299071|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299072|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299073|NCT00004580|Ritonavir|ritonavir|mesh-list
138299074|NCT00004580|Lopinavir|lopinavir|mesh-list
138299075|NCT00004580|Nevirapine|nevirapine|mesh-list
138299076|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138299077|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138299078|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
138299079|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299080|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299081|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299082|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299083|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
138299084|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299085|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138299086|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299087|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299088|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299089|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138299090|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138299091|NCT00005096|Docetaxel|docetaxel|mesh-list
138299092|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299093|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299094|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299095|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299096|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299097|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
138299098|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138299099|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299100|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
138299101|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138299102|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138299103|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299105|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299106|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
138299108|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299109|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299110|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299111|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299112|NCT00005108|Estradiol|estradiol|mesh-list
138299113|NCT00005108|Progesterone|progesterone|mesh-list
138299114|NCT00005108|Estrogens|estrogens|mesh-ancestor
138299115|NCT00005108|Hormones|hormones|mesh-ancestor
138299116|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299117|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299118|NCT00005108|Progestins|progestins|mesh-ancestor
138299120|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138299121|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138299122|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299123|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299124|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138299125|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138299126|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
138299127|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299128|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299130|NCT00005120|Calanolide A|calanolide a|mesh-list
138299131|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299132|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299133|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
138299134|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299135|NCT00004664|Megestrol|megestrol|mesh-list
138299136|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138299137|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138299138|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138299139|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
138299140|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299141|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299142|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138299143|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138299144|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299145|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299146|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
138299147|NCT00004682|Antibodies|antibodies|mesh-list
138299148|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
138299149|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138299150|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138299151|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
138299152|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299153|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
138299154|NCT00004688|Carmustine|carmustine|mesh-list
138299155|NCT00004688|Streptozocin|streptozocin|mesh-list
138299156|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
138299157|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299158|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299159|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299160|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299161|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
138299162|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299163|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299164|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299165|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299166|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
138299167|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138299168|NCT00004694|Heparin|heparin|mesh-list
138299169|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
138299170|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138299171|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138299172|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299173|NCT04608409|Paclitaxel|paclitaxel|mesh-list
138299174|NCT04608409|Lapatinib|lapatinib|mesh-list
138299175|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299176|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299177|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299178|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299179|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299180|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299181|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138299182|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299183|NCT00004700|Mitogens|mitogens|mesh-list
138299184|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299185|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299186|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
138299187|NCT00004730|Analgesics|analgesics|mesh-ancestor
138299188|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
138299189|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299190|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299192|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299194|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
138299195|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138299196|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138299197|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299198|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138299199|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
138299200|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299201|NCT00004736|Lamivudine|lamivudine|mesh-list
138299202|NCT00004736|Zidovudine|zidovudine|mesh-list
138299203|NCT00004736|Stavudine|stavudine|mesh-list
138299204|NCT00004736|Nelfinavir|nelfinavir|mesh-list
138299205|NCT00004736|Isoniazid|isoniazid|mesh-list
138299206|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
138299207|NCT00004736|Ethambutol|ethambutol|mesh-list
138299208|NCT00004736|Rifabutin|rifabutin|mesh-list
138299209|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299210|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299211|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299212|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299213|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
138299214|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299215|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299216|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299217|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
138299218|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
138299219|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138299220|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138299221|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138299222|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138299223|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138299224|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138299225|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
138299226|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138299227|NCT00004748|Methotrexate|methotrexate|mesh-list
138299228|NCT00004748|Colchicine|colchicine|mesh-list
138299229|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138299230|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138299231|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
138299232|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299233|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299234|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299235|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
138299236|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299238|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299239|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299240|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138299241|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299242|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
138299243|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299244|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299245|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
138299246|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299247|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299248|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299249|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138299250|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299252|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138299253|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299256|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138299257|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138299258|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
138299259|NCT00005576|Aldesleukin|aldesleukin|mesh-list
138299260|NCT00005576|Interleukin-2|interleukin-2|mesh-list
138299261|NCT00005576|Dinutuximab|dinutuximab|mesh-list
138299262|NCT00005576|Isotretinoin|isotretinoin|mesh-list
138299263|NCT00005576|Antibodies|antibodies|mesh-list
138299264|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138299265|NCT00005576|Sargramostim|sargramostim|mesh-list
138299266|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
138299267|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299268|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299269|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138299270|NCT00005576|Analgesics|analgesics|mesh-ancestor
138299271|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
138299272|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299273|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299274|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299275|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
138299276|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299278|NCT04713163|Vaccines|vaccines|mesh-list
138299279|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
138299280|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299281|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
138299282|NCT00004772|Antibodies|antibodies|mesh-list
138299283|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
138299284|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138299285|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138299286|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
138299287|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299288|NCT04712929|Fluconazole|fluconazole|mesh-list
138299289|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
138299290|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299291|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138299292|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299293|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299294|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299295|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138299297|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299298|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299299|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138299300|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138299301|NCT00004784|Methotrexate|methotrexate|mesh-list
138299302|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138299303|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138299304|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
138299305|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299306|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299307|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299308|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
138299309|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299310|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299311|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299312|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299313|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138299314|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299316|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299317|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299318|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138299319|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299321|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299322|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
138299323|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138299324|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299325|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299327|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
138299328|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299329|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138299330|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299331|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299332|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299333|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138299334|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299335|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299336|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299337|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138299338|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138299340|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
138299341|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138299342|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
138299343|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299344|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299345|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299346|NCT00004826|Clozapine|clozapine|mesh-list
138299347|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138299348|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
138299349|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299350|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299351|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299352|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138299353|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138299354|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299355|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138299357|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
138299358|NCT04552327|Diclofenac|diclofenac|mesh-list
138299359|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138299360|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138299361|NCT04552327|Analgesics|analgesics|mesh-ancestor
138299362|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
138299363|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299364|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299365|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299366|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299367|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138299368|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299369|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299371|NCT00004778|Betamethasone|betamethasone|mesh-list
138299372|NCT00004778|Hormones|hormones|mesh-list
138299373|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
138299374|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299375|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
138299376|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
138299377|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299378|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299379|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299380|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
138299381|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299382|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299383|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299384|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138299385|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
138299386|NCT00005612|Paclitaxel|paclitaxel|mesh-list
138299387|NCT00005612|Etoposide|etoposide|mesh-list
138299388|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
138299389|NCT00005612|Carboplatin|carboplatin|mesh-list
138299390|NCT00005612|Topotecan|topotecan|mesh-list
138299391|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299392|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299393|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299394|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299395|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299396|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299397|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299398|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
138299399|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299401|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299402|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
138299403|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299404|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138299405|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138299406|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299407|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138299408|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
138299409|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299410|NCT00005624|Tacedinaline|tacedinaline|mesh-list
138299411|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138299412|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299413|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299414|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299415|NCT00385502|Econazole|econazole|mesh-list
138299416|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
138299417|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299418|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138299419|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299421|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299422|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138299423|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299424|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299425|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299426|NCT00005630|Sargramostim|sargramostim|mesh-list
138299427|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
138299428|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299429|NCT00005636|Pemetrexed|pemetrexed|mesh-list
138299430|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299431|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299432|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299433|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138299434|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299435|NCT00005642|Semaxinib|semaxinib|mesh-list
138299436|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138299438|NCT00005642|Growth Substances|growth substances|mesh-ancestor
138299441|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299442|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138299443|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299444|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299445|NCT00005648|Gemcitabine|gemcitabine|mesh-list
138299446|NCT00005648|Tipifarnib|tipifarnib|mesh-list
138299447|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299448|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
138299449|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299450|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299451|NCT00005654|Metformin|metformin|mesh-list
138299452|NCT00005654|Clomiphene|clomiphene|mesh-list
138299453|NCT00005654|Enclomiphene|enclomiphene|mesh-list
138299454|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
138299455|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138299456|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299457|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138299458|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299459|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299460|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138299461|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
138299462|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299463|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138299464|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138299465|NCT00005684|Heparin|heparin|mesh-list
138299466|NCT00005684|Warfarin|warfarin|mesh-list
138299467|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
138299468|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138299469|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138299470|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299471|NCT00386282|Misoprostol|misoprostol|mesh-list
138299472|NCT00386282|Mifepristone|mifepristone|mesh-list
138299473|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138299474|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
138299475|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299476|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299477|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138299478|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299479|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
138299480|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138299481|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138299482|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138299484|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
138299485|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138299486|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138299487|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299488|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299489|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
138299490|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138299491|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138299494|NCT00385658|Fenofibrate|fenofibrate|mesh-list
138299495|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138299496|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138299497|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
138299498|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299499|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138299500|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138299501|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299502|NCT00005762|Ritonavir|ritonavir|mesh-list
138299503|NCT00005762|Nelfinavir|nelfinavir|mesh-list
138299504|NCT00005762|Indinavir|indinavir|mesh-list
138299506|NCT00005762|Amprenavir|amprenavir|mesh-list
138299507|NCT00005762|Efavirenz|efavirenz|mesh-list
138299508|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138299509|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138299510|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
138299511|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299512|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299513|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299514|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299515|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
138299516|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299517|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138299518|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299519|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299520|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299521|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138299522|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138299523|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138299524|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138299525|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138299526|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138299527|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
138299528|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138299530|NCT00005768|Hormones|hormones|mesh-ancestor
138299531|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299532|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299533|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138299534|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
138299535|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
138299536|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299537|NCT00005792|Etoposide|etoposide|mesh-list
138299538|NCT00005792|Melphalan|melphalan|mesh-list
138299539|NCT00005792|Topotecan|topotecan|mesh-list
138299540|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
138299541|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299542|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299543|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138299544|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138299545|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299546|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299547|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299548|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
138299549|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299550|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299551|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
138299552|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299553|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138299554|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
138299555|NCT00005798|Thiotepa|thiotepa|mesh-list
138299556|NCT00005798|Carboplatin|carboplatin|mesh-list
138299557|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299558|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
138299560|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299561|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299562|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
138299563|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299564|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299565|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299568|NCT00005810|Estramustine|estramustine|mesh-list
138299569|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299570|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299571|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299572|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299573|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299574|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299575|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
138299576|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299577|NCT00385970|Leucovorin|leucovorin|mesh-list
138299578|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
138299579|NCT00385970|Tegafur|tegafur|mesh-list
138299580|NCT00385970|Calcium|calcium|mesh-list
138299581|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
138299582|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138299583|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299584|NCT00385970|Antidotes|antidotes|mesh-ancestor
138299585|NCT00385970|Protective Agents|protective agents|mesh-ancestor
138299586|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
138299588|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
138299589|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299590|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
138299591|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299592|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299593|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138299594|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
138299595|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138299596|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
138299597|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299598|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
138299599|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138299601|NCT05006677|Anticoagulants|anticoagulants|mesh-list
138299602|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138299603|NCT05006677|Vitamins|vitamins|mesh-ancestor
138299604|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
138299605|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299606|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138299607|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138299608|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299609|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
138299610|NCT05006677|Coagulants|coagulants|mesh-ancestor
138299611|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138299613|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
138299614|NCT04569890|Prednisone|prednisone|mesh-list
138299615|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
138299616|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299617|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
138299618|NCT04569890|Hormones|hormones|mesh-ancestor
138299619|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299620|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299621|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299622|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299623|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
138299624|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138299625|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138299626|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299627|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299628|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299629|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299630|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138299631|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299632|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
138299633|NCT00423163|Voriconazole|voriconazole|mesh-list
138299634|NCT00423163|Micafungin|micafungin|mesh-list
138299635|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
138299636|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299637|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138299638|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138299639|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299640|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299641|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138299642|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299643|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299644|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299645|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138299653|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299654|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299655|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
138299656|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299657|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138299658|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138299659|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299660|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299662|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299663|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138299664|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138299665|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138299666|NCT02210702|Norethindrone|norethindrone|mesh-list
138299667|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
138299668|NCT02210702|Estradiol|estradiol|mesh-list
138299669|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138299670|NCT02210702|Estrogens|estrogens|mesh-ancestor
138299671|NCT02210702|Hormones|hormones|mesh-ancestor
138299672|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299673|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299674|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138299675|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
138299676|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138299677|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138299678|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138299679|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138299680|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138299681|NCT04568096|Tamoxifen|tamoxifen|mesh-list
138299682|NCT04568096|Tretinoin|tretinoin|mesh-list
138299683|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138299684|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
138299685|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299686|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299687|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299688|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299689|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138299690|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138299691|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138299692|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
138299693|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299694|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138299695|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
138299696|NCT02278172|Vitamin D|vitamin d|mesh-list
138299697|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
138299698|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
138299700|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
138299701|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299702|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138299703|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138299704|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138299705|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138299706|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
138299707|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
138299708|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299709|NCT02210858|Tipifarnib|tipifarnib|mesh-list
138299710|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299711|NCT04565678|Mitapivat|mitapivat|mesh-list
138299712|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
138299713|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299714|NCT04564430|Clonidine|clonidine|mesh-list
138299715|NCT04564430|Analgesics|analgesics|mesh-ancestor
138299716|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
138299717|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299718|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299719|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138299720|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
138299721|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
138299722|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138299723|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138299724|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138299725|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138299726|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299727|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299728|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
138299729|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299730|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
138299731|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299732|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
138299733|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299734|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299735|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299736|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
138299737|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299738|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299739|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299740|NCT04563962|Methamphetamine|methamphetamine|mesh-list
138299741|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138299742|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299743|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
138299744|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
138299745|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299746|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
138299747|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299748|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299749|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
138299750|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138299751|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138299752|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138299753|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138299755|NCT02211482|Dolutegravir|dolutegravir|mesh-list
138299756|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299757|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299758|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299759|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299760|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
138299761|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299762|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299763|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299764|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138299765|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138299769|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
138299770|NCT04561934|Protective Agents|protective agents|mesh-ancestor
138299771|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299772|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
138299773|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
138299774|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138299775|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138299776|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299777|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299778|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299779|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299780|NCT04563260|Palonosetron|palonosetron|mesh-list
138299781|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
138366462|NCT06104423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138366463|NCT06104423|Vasodilator Agents|vasodilator agents|mesh-ancestor
138366464|NCT06104423|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138366465|NCT06104423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138299782|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
138299783|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299784|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299785|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299786|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138299787|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138299788|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
138299789|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299790|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299791|NCT04173793|Ezetimibe|ezetimibe|mesh-list
138299793|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138299794|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
138299796|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138299798|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
138299799|NCT04561856|BB 1101|bb 1101|mesh-list
138299800|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299801|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
138299802|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
138299803|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299804|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299805|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299806|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
138299807|NCT04561856|Hormones|hormones|mesh-ancestor
138299808|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299809|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138299810|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299811|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
138299812|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299813|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299814|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138299815|NCT04173403|Ezetimibe|ezetimibe|mesh-list
138299816|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138299817|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138299818|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
138299819|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299820|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138299821|NCT03539887|Ketamine|ketamine|mesh-list
138299822|NCT03539887|Analgesics|analgesics|mesh-ancestor
138299823|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
138299824|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299825|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299826|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138299827|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138299828|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
138299829|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
138299830|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299831|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138299832|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138299833|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299834|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299835|NCT04123717|Acetaminophen|acetaminophen|mesh-list
138299838|NCT04123717|Analgesics|analgesics|mesh-ancestor
138299839|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
138299840|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299841|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299842|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
138299843|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138299844|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299845|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299846|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138366471|NCT06104111|Cholecalciferol|cholecalciferol|mesh-list
138366472|NCT06104111|Vitamins|vitamins|mesh-ancestor
138366473|NCT06104111|Micronutrients|micronutrients|mesh-ancestor
138366474|NCT06104111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366475|NCT06104111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138299847|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299848|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299849|NCT03472495|Diltiazem|diltiazem|mesh-list
138299850|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138299851|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138299852|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138299853|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299854|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138299855|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299856|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
138299857|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
138299858|NCT04094701|Narcotics|narcotics|mesh-ancestor
138299859|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299860|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299861|NCT04094701|Analgesics|analgesics|mesh-ancestor
138299862|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
138299863|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299864|NCT03351361|Nivolumab|nivolumab|mesh-list
138299865|NCT03351361|Ipilimumab|ipilimumab|mesh-list
138299866|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138299867|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299868|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138299869|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299870|NCT03234907|Vedolizumab|vedolizumab|mesh-list
138299871|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138299873|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299874|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299875|NCT00002893|Leucovorin|leucovorin|mesh-list
138299876|NCT00002893|Fluorouracil|fluorouracil|mesh-list
138299877|NCT00002893|Raltitrexed|raltitrexed|mesh-list
138299878|NCT00002893|Calcium|calcium|mesh-list
138299879|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
138299880|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138299881|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299882|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
138299883|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299884|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299885|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299886|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299887|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
138299888|NCT00002893|Antidotes|antidotes|mesh-ancestor
138299889|NCT00002893|Protective Agents|protective agents|mesh-ancestor
138299890|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
138299891|NCT00002893|Vitamins|vitamins|mesh-ancestor
138299892|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
138299893|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138299894|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299895|NCT03818581|Suvorexant|suvorexant|mesh-list
138299896|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138299897|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138299898|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138299899|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299900|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138299901|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138299902|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299904|NCT00002905|Didanosine|didanosine|mesh-list
138299905|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
138299906|NCT00002905|Prednimustine|prednimustine|mesh-list
138366481|NCT06104059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366482|NCT06104059|Analgesics|analgesics|mesh-ancestor
138366483|NCT06104059|Sensory System Agents|sensory system agents|mesh-ancestor
138366484|NCT06104059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366485|NCT06104059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138366486|NCT06104059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138366487|NCT06104059|Anesthetics, General|anesthetics, general|mesh-ancestor
138366488|NCT06104059|Anesthetics|anesthetics|mesh-ancestor
138299907|NCT00002905|Doxorubicin|doxorubicin|mesh-list
138299908|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138299909|NCT00002905|Etoposide|etoposide|mesh-list
138299910|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
138299911|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299912|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
138299913|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299914|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299915|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299916|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
138299917|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299918|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299919|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138299920|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138299921|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138299922|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138299923|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299924|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299925|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
138299926|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299927|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138299929|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299930|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138299931|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138299933|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
138299934|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299936|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299937|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299938|NCT00002917|Paclitaxel|paclitaxel|mesh-list
138299939|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138299940|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299941|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
138299942|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
138299943|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
138299944|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299946|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
138299947|NCT00383695|Cetuximab|cetuximab|mesh-list
138299948|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138299949|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
138299950|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299951|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299952|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138299953|NCT00383851|Temozolomide|temozolomide|mesh-list
138299954|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138299955|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299956|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
138299957|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299958|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299959|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
138299960|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
138299963|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138299964|NCT00383851|Growth Substances|growth substances|mesh-ancestor
138299965|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299966|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
138299967|NCT00002923|KRN 5500|krn 5500|mesh-list
138299968|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299969|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138299970|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299971|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299972|NCT02636569|Diclofenac|diclofenac|mesh-list
138299973|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138299974|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138299975|NCT02636569|Analgesics|analgesics|mesh-ancestor
138366492|NCT06103747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366493|NCT06103747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138366494|NCT06103747|Protease Inhibitors|protease inhibitors|mesh-ancestor
138299978|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299979|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138299980|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299981|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138299982|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299983|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299984|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138299986|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138299987|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299988|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138299989|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
138299990|NCT00002941|Carmustine|carmustine|mesh-list
138299991|NCT00002941|Etoposide|etoposide|mesh-list
138299992|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138299993|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
138299994|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299995|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138299996|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138299997|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
138299998|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138299999|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300000|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300001|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300002|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300003|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300004|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300005|NCT00002953|Paclitaxel|paclitaxel|mesh-list
138300006|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
138300007|NCT00002953|Epirubicin|epirubicin|mesh-list
138300008|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300009|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300010|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300011|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300012|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300013|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300014|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300015|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
138300016|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300017|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300018|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300019|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
138300020|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300021|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300022|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300023|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300024|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300026|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
138300027|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300028|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300029|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300030|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300031|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300032|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300033|NCT02283853|Interferons|interferons|mesh-list
138300034|NCT02283853|Interferon-beta|interferon-beta|mesh-list
138300035|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
138300036|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138300037|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300038|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
138300039|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300040|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300041|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300042|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
138300043|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300058|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300059|NCT00003391|Antibodies|antibodies|mesh-list
138300060|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138300061|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
138300062|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300063|NCT00003397|Dexamethasone|dexamethasone|mesh-list
138300064|NCT00003397|Paclitaxel|paclitaxel|mesh-list
138300065|NCT00003397|Etoposide|etoposide|mesh-list
138300066|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
138300067|NCT00003397|Rituximab|rituximab|mesh-list
138300068|NCT00003397|Gemcitabine|gemcitabine|mesh-list
138300069|NCT00003397|Melphalan|melphalan|mesh-list
138300070|NCT00003397|Carmustine|carmustine|mesh-list
138300071|NCT00003397|Sargramostim|sargramostim|mesh-list
138300072|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300073|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300074|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300075|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300076|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300077|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300079|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
138300080|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300081|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300082|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300083|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
138300084|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300085|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300086|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
138300087|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
138300088|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138300090|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
138300092|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300093|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300094|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138300098|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300099|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300100|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
138300101|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300102|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138300103|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300104|NCT00003415|Topotecan|topotecan|mesh-list
138300105|NCT00003415|Amifostine|amifostine|mesh-list
138300106|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300107|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300108|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300109|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300110|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300111|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138300113|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300114|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
138300115|NCT00002989|Melphalan|melphalan|mesh-list
138300116|NCT00002989|Busulfan|busulfan|mesh-list
138300117|NCT00002989|Idarubicin|idarubicin|mesh-list
138300118|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300119|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
138300120|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300121|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300122|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300123|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
138300124|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300125|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300126|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300127|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300128|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300129|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300130|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300131|NCT00002995|Dactinomycin|dactinomycin|mesh-list
138300132|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
138300133|NCT00002995|Vincristine|vincristine|mesh-list
138300134|NCT00002995|Sargramostim|sargramostim|mesh-list
138300135|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300136|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
138300137|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300138|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300139|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300140|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
138300141|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300142|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300143|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300144|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300145|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300146|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300147|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300148|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138300150|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300151|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138300152|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300153|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300154|NCT00003001|Leucovorin|leucovorin|mesh-list
138300155|NCT00003001|Gemcitabine|gemcitabine|mesh-list
138300156|NCT00003001|Fluorouracil|fluorouracil|mesh-list
138300157|NCT00003001|Calcium|calcium|mesh-list
138300158|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
138300159|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300160|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
138300161|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300164|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300165|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300166|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
138300167|NCT00003001|Antidotes|antidotes|mesh-ancestor
138300168|NCT00003001|Protective Agents|protective agents|mesh-ancestor
138300169|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
138300170|NCT00003001|Vitamins|vitamins|mesh-ancestor
138300171|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
138300172|NCT00003421|Prednisolone|prednisolone|mesh-list
138300173|NCT00003421|Doxorubicin|doxorubicin|mesh-list
138300174|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300175|NCT00003421|Bleomycin|bleomycin|mesh-list
138300176|NCT00003421|Etoposide|etoposide|mesh-list
138300177|NCT00003421|Vincristine|vincristine|mesh-list
138300178|NCT00003421|Dacarbazine|dacarbazine|mesh-list
138300179|NCT00003421|Vinblastine|vinblastine|mesh-list
138300180|NCT00003421|Procarbazine|procarbazine|mesh-list
138300181|NCT00003421|Chlorambucil|chlorambucil|mesh-list
138300182|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300183|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300184|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300185|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300186|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300187|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300188|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300189|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300190|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300191|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300192|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300193|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
138300194|NCT00003421|Hormones|hormones|mesh-ancestor
138300195|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300196|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300197|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300198|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300199|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
138300200|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
138300201|NCT00003427|Irinotecan|irinotecan|mesh-list
138300202|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300203|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300204|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300205|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300206|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300207|NCT00003439|Interleukin-12|interleukin-12|mesh-list
138300208|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138300209|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
138300210|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300211|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138300212|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138300213|NCT00003439|Growth Substances|growth substances|mesh-ancestor
138300214|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
138300215|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300216|NCT00003007|Interferons|interferons|mesh-list
138300217|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
138300218|NCT00003007|Dexamethasone|dexamethasone|mesh-list
138300219|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
138300220|NCT00003007|Melphalan|melphalan|mesh-list
138300221|NCT00003007|Sargramostim|sargramostim|mesh-list
138300222|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300223|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
138300224|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300225|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300227|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
138300228|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300229|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300235|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138300236|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
138300238|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300239|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300240|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
138300241|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300243|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
138300244|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138300245|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138300246|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138300247|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300248|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138300249|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138300251|NCT00003013|Paclitaxel|paclitaxel|mesh-list
138300252|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
138300253|NCT00003013|Doxorubicin|doxorubicin|mesh-list
138300254|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300255|NCT00003013|Fluorouracil|fluorouracil|mesh-list
138300256|NCT00003013|Methotrexate|methotrexate|mesh-list
138300257|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300258|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300259|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300260|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300261|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300262|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300263|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300264|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
138300265|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300266|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300267|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300268|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
138300269|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300271|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300272|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300273|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300274|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
138300275|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300276|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300277|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300278|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300279|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300280|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300281|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300282|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138300283|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
138300284|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300285|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300286|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138300287|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138300288|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138300290|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300291|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300292|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300293|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300299|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
138300300|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300301|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
138300302|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300303|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138300304|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138300305|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138300307|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138300309|NCT00003463|Carmustine|carmustine|mesh-list
138300310|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300311|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300312|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300313|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300314|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300315|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300316|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
138300318|NCT00003019|Vinblastine|vinblastine|mesh-list
138300319|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300320|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300321|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300322|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300323|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300324|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
138300325|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300326|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300327|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300328|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300329|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300330|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300331|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
138300332|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300333|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300334|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300335|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300336|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300337|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300338|NCT00003493|Dexamethasone|dexamethasone|mesh-list
138300339|NCT00003493|Doxorubicin|doxorubicin|mesh-list
138300340|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300342|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300343|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
138300344|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
138300345|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138300346|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300347|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138300348|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
138300349|NCT00003493|Hormones|hormones|mesh-ancestor
138300350|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300351|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300352|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300353|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300354|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300355|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300356|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300357|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300358|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300359|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300368|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300369|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138300370|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138300371|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300372|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300373|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138300375|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300376|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300377|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138300378|NCT00003031|Amebicides|amebicides|mesh-ancestor
138300379|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138300380|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138300381|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138300382|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138300383|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138300384|NCT00003517|Leuprolide|leuprolide|mesh-list
138300385|NCT00003517|Flutamide|flutamide|mesh-list
138300386|NCT00003517|Bicalutamide|bicalutamide|mesh-list
138300387|NCT00003517|Hormones|hormones|mesh-list
138300388|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
138300389|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300390|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300391|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138300393|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300394|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300395|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300396|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
138300397|NCT00003037|Gemcitabine|gemcitabine|mesh-list
138300398|NCT00003037|Docetaxel|docetaxel|mesh-list
138300399|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300400|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300401|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
138300402|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300403|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300404|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300405|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300406|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
138300407|NCT00002803|Doxorubicin|doxorubicin|mesh-list
138300408|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300409|NCT00002803|Vincristine|vincristine|mesh-list
138300410|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300411|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
138300412|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300413|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300414|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300415|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
138300416|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300417|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300418|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300419|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300420|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300424|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300425|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300426|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300427|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138300428|NCT00383929|Candesartan|candesartan|mesh-list
138300429|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
138300430|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138300431|NCT00383929|Diuretics|diuretics|mesh-ancestor
138300432|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
138300433|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300434|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138300435|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138300436|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300437|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138300438|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138300439|NCT00003541|Prednisone|prednisone|mesh-list
138300440|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
138300441|NCT00003541|Ifosfamide|ifosfamide|mesh-list
138300442|NCT00003541|Carboplatin|carboplatin|mesh-list
138300443|NCT00003541|Doxorubicin|doxorubicin|mesh-list
138300444|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300445|NCT00003541|Etoposide|etoposide|mesh-list
138300446|NCT00003541|Vincristine|vincristine|mesh-list
138300447|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300448|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
138300449|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300450|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300451|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300452|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
138300453|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300454|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300455|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300456|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300457|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300458|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300460|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300461|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
138300462|NCT00003541|Hormones|hormones|mesh-ancestor
138300463|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300464|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300465|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300466|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300467|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300468|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300469|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
138300470|NCT00002809|Methotrexate|methotrexate|mesh-list
138300471|NCT00002809|Tacrolimus|tacrolimus|mesh-list
138300472|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138300473|NCT00002809|Sargramostim|sargramostim|mesh-list
138300474|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
138300475|NCT00002809|Antibodies|antibodies|mesh-list
138300476|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
138300477|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138300478|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138300479|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300480|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
138300481|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300482|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300483|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300484|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
138300485|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300486|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300487|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300489|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300490|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300491|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300492|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
138300493|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300494|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300495|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300496|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300497|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138300498|NCT00383539|Vaccines|vaccines|mesh-list
138300499|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
138300500|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300502|NCT00002827|Doxorubicin|doxorubicin|mesh-list
138300503|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300504|NCT00002827|Bleomycin|bleomycin|mesh-list
138300505|NCT00002827|Etoposide|etoposide|mesh-list
138300506|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
138300507|NCT00002827|Vincristine|vincristine|mesh-list
138300509|NCT00002827|Lenograstim|lenograstim|mesh-list
138300510|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300511|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300512|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300513|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300514|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300515|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300516|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300517|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138300518|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
138300519|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300520|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300521|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300522|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300523|NCT00002827|Trace Elements|trace elements|mesh-ancestor
138300524|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
138300525|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138300526|NCT00002827|Protective Agents|protective agents|mesh-ancestor
138300527|NCT00384475|Ciclesonide|ciclesonide|mesh-list
138300528|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
138300529|NCT00384475|Hormones|hormones|mesh-ancestor
138300530|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300531|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300532|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138300533|NCT00003565|Docetaxel|docetaxel|mesh-list
138300534|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300535|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300536|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300537|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300538|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300539|NCT00003049|Leucovorin|leucovorin|mesh-list
138300540|NCT00003049|Fluorouracil|fluorouracil|mesh-list
138300541|NCT00003049|Calcium|calcium|mesh-list
138300542|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
138300543|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138300544|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300545|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
138300546|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300547|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300548|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300549|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300550|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
138300551|NCT00003049|Antidotes|antidotes|mesh-ancestor
138300552|NCT00003049|Protective Agents|protective agents|mesh-ancestor
138300553|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
138300554|NCT00003049|Vitamins|vitamins|mesh-ancestor
138300555|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
138300556|NCT00003055|Irinotecan|irinotecan|mesh-list
138300557|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300558|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300559|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300560|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300561|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300562|NCT00002833|Cytarabine|cytarabine|mesh-list
138300563|NCT00002833|Cyclosporine|cyclosporine|mesh-list
138300564|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
138300565|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138300566|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138300567|NCT00002833|Prednisolone|prednisolone|mesh-list
138300568|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
138300569|NCT00002833|Fludarabine|fludarabine|mesh-list
138300570|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
138300571|NCT00002833|Idarubicin|idarubicin|mesh-list
138300572|NCT00002833|Cladribine|cladribine|mesh-list
138300573|NCT00002833|Cyclosporins|cyclosporins|mesh-list
138300574|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138300575|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
138300576|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300577|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300578|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
138300579|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300580|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300581|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
138300582|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300583|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
138300584|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300585|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300586|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
138300587|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300588|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300589|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138300590|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300591|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
138300592|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
138300593|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138300594|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138300595|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
138300597|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300599|NCT00002833|Protective Agents|protective agents|mesh-ancestor
138300600|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300601|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300602|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300603|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300604|NCT00003061|Cytarabine|cytarabine|mesh-list
138300605|NCT00003061|Methotrexate|methotrexate|mesh-list
138300606|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300607|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300608|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300609|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300610|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300611|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
138300612|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300613|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300614|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300615|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300616|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300617|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300618|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
138300619|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300620|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300621|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
138300622|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300623|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
138300624|NCT00003577|Fluorouracil|fluorouracil|mesh-list
138300625|NCT00003577|Methotrexate|methotrexate|mesh-list
138300626|NCT00003577|Epirubicin|epirubicin|mesh-list
138300627|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300628|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
138300629|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300630|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300631|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300633|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300634|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300635|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300636|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
138300637|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300638|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300639|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300640|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300642|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300643|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300644|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300645|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300646|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300647|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300648|NCT00002839|Fluorouracil|fluorouracil|mesh-list
138300649|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300650|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
138300651|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300652|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300653|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300654|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
138300655|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300656|NCT00003583|Etoposide|etoposide|mesh-list
138300657|NCT00003583|Amifostine|amifostine|mesh-list
138300658|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300659|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300660|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300661|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300662|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300663|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300664|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138300665|NCT00003583|Protective Agents|protective agents|mesh-ancestor
138300667|NCT00002845|Aldesleukin|aldesleukin|mesh-list
138300668|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300669|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138300670|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138300671|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
138300672|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300673|NCT00003067|Aldesleukin|aldesleukin|mesh-list
138300674|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300675|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138300676|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138300677|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
138300678|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300679|NCT00003589|Paclitaxel|paclitaxel|mesh-list
138300680|NCT00003589|Gemcitabine|gemcitabine|mesh-list
138300681|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300682|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300683|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300684|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300685|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300686|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300687|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300688|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
138300690|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
138300691|NCT00003595|Rituximab|rituximab|mesh-list
138300692|NCT00003595|Doxorubicin|doxorubicin|mesh-list
138300699|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300700|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
138300701|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300702|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300703|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300704|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138300705|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300706|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300707|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300708|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300709|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300711|NCT00003595|Hormones|hormones|mesh-ancestor
138300712|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300715|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300716|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300717|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300719|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300720|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
138300721|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300722|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300723|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
138300724|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300725|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300726|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
138300727|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300728|NCT00003079|Cytarabine|cytarabine|mesh-list
138300729|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
138300730|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300731|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
138300732|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300733|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300734|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
138300735|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300736|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300737|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
138300738|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300739|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138300740|NCT00002869|Interferons|interferons|mesh-list
138300741|NCT00002869|Cytarabine|cytarabine|mesh-list
138300742|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
138300743|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
138300744|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300745|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
138300746|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300747|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300748|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
138300749|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300750|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300751|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
138300753|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
138300754|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300755|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300756|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
138300758|NCT00002875|Cisplatin|cisplatin|mesh-list
138300766|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300768|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300769|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300770|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300771|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300772|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300774|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138300775|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300776|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
138300777|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300778|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300779|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300780|NCT00002881|Suramin|suramin|mesh-list
138300781|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
138300782|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138300783|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138300784|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138300785|NCT00002881|Leuprolide|leuprolide|mesh-list
138300786|NCT00002881|Goserelin|goserelin|mesh-list
138300787|NCT00002881|Flutamide|flutamide|mesh-list
138300788|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300789|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138300790|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
138300791|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300792|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300793|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138300794|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300795|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
138300796|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
138300797|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300798|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
138300799|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
138300800|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138300801|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300802|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138300803|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138300805|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
138300806|NCT00003091|Aldesleukin|aldesleukin|mesh-list
138300807|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300808|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
138300809|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300811|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300812|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138300813|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138300814|NCT00003619|Vitamin E|vitamin e|mesh-list
138300815|NCT00003619|Cytarabine|cytarabine|mesh-list
138300816|NCT00003619|Fludarabine|fludarabine|mesh-list
138300817|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
138300818|NCT00003619|Etoposide|etoposide|mesh-list
138300819|NCT00003619|Busulfan|busulfan|mesh-list
138300820|NCT00003619|Topotecan|topotecan|mesh-list
138300821|NCT00003619|Isotretinoin|isotretinoin|mesh-list
138300831|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300833|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300834|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300835|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
138300836|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300837|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
138300838|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300839|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300840|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300841|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
138300842|NCT00003619|Protective Agents|protective agents|mesh-ancestor
138300843|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300844|NCT00002887|Etoposide|etoposide|mesh-list
138300845|NCT00002887|Vinorelbine|vinorelbine|mesh-list
138300846|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
138300847|NCT00002887|Vinblastine|vinblastine|mesh-list
138300848|NCT00002887|Vindesine|vindesine|mesh-list
138300850|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300851|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300853|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300854|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300855|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300856|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300857|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300858|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
138300859|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300860|NCT00003937|Cisplatin|cisplatin|mesh-list
138300861|NCT00003937|Doxorubicin|doxorubicin|mesh-list
138300862|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138300863|NCT00003937|Methotrexate|methotrexate|mesh-list
138300864|NCT00003937|Etoposide|etoposide|mesh-list
138300865|NCT00003937|Ifosfamide|ifosfamide|mesh-list
138300866|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
138300867|NCT00003937|Razoxane|razoxane|mesh-list
138300868|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300869|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300870|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300871|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300872|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300873|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300874|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300875|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
138300876|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300877|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300878|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300879|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
138300880|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300881|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300882|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300883|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
138300884|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300885|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300891|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300892|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300894|NCT00003625|Etoposide|etoposide|mesh-list
138300895|NCT00003625|Vincristine|vincristine|mesh-list
138300896|NCT00003625|Cyclosporins|cyclosporins|mesh-list
138300897|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300898|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300899|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300900|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300901|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300902|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300903|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300904|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300905|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300906|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300907|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
138300908|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300909|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
138300910|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300911|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
138300912|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300913|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138300914|NCT00003637|Fluorouracil|fluorouracil|mesh-list
138300915|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300916|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
138300917|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300918|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300919|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300920|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
138300921|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300924|NCT00003943|Carboplatin|carboplatin|mesh-list
138300925|NCT00003943|Topotecan|topotecan|mesh-list
138300926|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300927|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300928|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300929|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300930|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300931|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300932|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300933|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
138300934|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300935|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300936|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300937|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
138300938|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300939|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300940|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300941|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300942|NCT00003955|Dactinomycin|dactinomycin|mesh-list
138300943|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
138300944|NCT00003955|Irinotecan|irinotecan|mesh-list
138300945|NCT00003955|Vincristine|vincristine|mesh-list
138300946|NCT00003955|Sargramostim|sargramostim|mesh-list
138300947|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300948|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
138300949|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300950|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300955|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300957|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300959|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300960|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300961|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300962|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300963|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138300964|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138300965|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300966|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138300967|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138300968|NCT00003103|Docetaxel|docetaxel|mesh-list
138300969|NCT00003103|Oblimersen|oblimersen|mesh-list
138300970|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300971|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300972|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300973|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300974|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300976|NCT00003109|Raltitrexed|raltitrexed|mesh-list
138300977|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138300978|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300979|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300980|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300981|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300982|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300983|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
138300984|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300986|NCT00003643|Etoposide|etoposide|mesh-list
138300987|NCT00003643|Bleomycin|bleomycin|mesh-list
138300988|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300989|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300990|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138300991|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300992|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300993|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300994|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138300995|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300996|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300997|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138300998|NCT00003961|Sargramostim|sargramostim|mesh-list
138300999|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
138301000|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301001|NCT00003661|Cyclosporine|cyclosporine|mesh-list
138301002|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
138301003|NCT00003661|Melphalan|melphalan|mesh-list
138301004|NCT00003661|Busulfan|busulfan|mesh-list
138301005|NCT00003661|Cyclosporins|cyclosporins|mesh-list
138301006|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138301007|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301008|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301009|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301010|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
138301011|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301012|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
138301013|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301014|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301015|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301018|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
138301019|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
138301020|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301021|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301022|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
138301023|NCT00003661|Hormones|hormones|mesh-ancestor
138301024|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301025|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138301026|NCT00003661|Protective Agents|protective agents|mesh-ancestor
138301027|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301028|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301029|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
138301030|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301031|NCT00003967|Etoposide|etoposide|mesh-list
138301032|NCT00003967|Topotecan|topotecan|mesh-list
138301033|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301034|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301035|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301036|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301037|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301038|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301039|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301040|NCT00003115|Hydromorphone|hydromorphone|mesh-list
138301041|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138301042|NCT00003115|Narcotics|narcotics|mesh-ancestor
138301043|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138301044|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301045|NCT00003115|Analgesics|analgesics|mesh-ancestor
138301046|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
138301047|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301048|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
138301049|NCT00003667|Doxorubicin|doxorubicin|mesh-list
138301050|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301051|NCT00003667|Vincristine|vincristine|mesh-list
138301052|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
138301053|NCT00003667|Razoxane|razoxane|mesh-list
138301054|NCT00003667|Glycerol|glycerol|mesh-list
138301055|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301056|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
138301057|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301058|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301059|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301060|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
138301061|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301062|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301063|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301064|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301065|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301066|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301067|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301068|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301069|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301070|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301071|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301072|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138301073|NCT00003667|Protective Agents|protective agents|mesh-ancestor
138301074|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138301075|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
138301076|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301077|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301078|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
138301079|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
138301080|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
138301081|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301083|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
138301084|NCT00003679|Docetaxel|docetaxel|mesh-list
138301085|NCT00003679|Doxorubicin|doxorubicin|mesh-list
138301091|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301092|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
138301093|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301094|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301095|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301096|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301097|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301098|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301099|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301100|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301101|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301103|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138301104|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
138301105|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301106|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138301107|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138301108|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138301109|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138301110|NCT00003985|KRN 7000|krn 7000|mesh-list
138301111|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138301112|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
138301113|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301114|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301115|NCT00384553|Rituximab|rituximab|mesh-list
138301116|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301118|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
138301119|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301120|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301121|NCT00003991|Aldesleukin|aldesleukin|mesh-list
138301122|NCT00003991|Histamine|histamine|mesh-list
138301123|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
138301124|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301125|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138301126|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138301127|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
138301128|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301129|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
138301130|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
138301131|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138301132|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301133|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301134|NCT00003997|Irofulven|irofulven|mesh-list
138301135|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301137|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301138|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301140|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301141|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301142|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138301143|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138301144|NCT00384631|Growth Substances|growth substances|mesh-ancestor
138301145|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301146|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
138301147|NCT00003127|Paclitaxel|paclitaxel|mesh-list
138301148|NCT00003127|Carboplatin|carboplatin|mesh-list
138301151|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301152|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301153|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301154|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301155|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301156|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138301157|NCT00003127|Protective Agents|protective agents|mesh-ancestor
138301158|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301160|NCT00004003|Fluorouracil|fluorouracil|mesh-list
138301161|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301162|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301164|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301165|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301166|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
138301167|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301168|NCT00004009|Tipifarnib|tipifarnib|mesh-list
138301169|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301170|NCT00003133|Paclitaxel|paclitaxel|mesh-list
138301171|NCT00003133|Gemcitabine|gemcitabine|mesh-list
138301172|NCT00003133|Doxorubicin|doxorubicin|mesh-list
138301173|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301174|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301175|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301176|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301177|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301179|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301180|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301181|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
138301182|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301183|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301184|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301185|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301186|NCT00003691|Paclitaxel|paclitaxel|mesh-list
138301187|NCT00003691|Doxorubicin|doxorubicin|mesh-list
138301188|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301189|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301190|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301191|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301192|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301193|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301194|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301195|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301196|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301197|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301198|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301199|NCT00003139|Pilocarpine|pilocarpine|mesh-list
138301201|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
138301202|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301203|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301204|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138301205|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138301206|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
138301207|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138301208|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301209|NCT00003697|Vadimezan|vadimezan|mesh-list
138301210|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301211|NCT02972983|Daptomycin|daptomycin|mesh-list
138301212|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138301213|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301214|NCT00003709|Carbendazim|carbendazim|mesh-list
138301215|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
138301216|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
138301217|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138301218|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301219|NCT00003145|Cyclosporine|cyclosporine|mesh-list
138301220|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
138301221|NCT00003145|Fludarabine|fludarabine|mesh-list
138301222|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
138301223|NCT00003145|Cyclosporins|cyclosporins|mesh-list
138301224|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301225|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301226|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
138301227|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301228|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301229|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
138301230|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301231|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301232|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
138301233|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301234|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301235|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301236|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138301237|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301238|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138301239|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
138301240|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138301241|NCT00004039|Interferons|interferons|mesh-list
138301242|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
138301244|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
138301245|NCT00004039|Rituximab|rituximab|mesh-list
138301246|NCT00004039|Doxorubicin|doxorubicin|mesh-list
138301247|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301248|NCT00004039|Vincristine|vincristine|mesh-list
138301250|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
138301251|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301252|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301253|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301254|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
138301255|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301256|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301257|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301258|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301259|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301260|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301261|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301262|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301263|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301264|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
138301265|NCT00004039|Hormones|hormones|mesh-ancestor
138301266|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301267|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138301268|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
138301269|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301270|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301271|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301272|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301273|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301274|NCT00003151|Amoxicillin|amoxicillin|mesh-list
138301275|NCT00003151|Metronidazole|metronidazole|mesh-list
138301277|NCT00003151|Tetracycline|tetracycline|mesh-list
138301278|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138301280|NCT00003151|Bismuth|bismuth|mesh-list
138301281|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138301282|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301283|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138301284|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138301285|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138301286|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301287|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138301288|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301289|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301290|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138301291|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138301292|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138301293|NCT00003151|Antacids|antacids|mesh-ancestor
138301294|NCT00004045|Exatecan|exatecan|mesh-list
138301295|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301296|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301297|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301298|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301299|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301301|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
138301302|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
138301303|NCT00003715|Vaccines|vaccines|mesh-list
138301304|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
138301305|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
138301306|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301307|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301308|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301309|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301310|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
138301311|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301312|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301313|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301314|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
138301315|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301316|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138301317|NCT00004051|Irinotecan|irinotecan|mesh-list
138301318|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301319|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301320|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301321|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301322|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301323|NCT00003727|Interferons|interferons|mesh-list
138301324|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
138301325|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
138301326|NCT00003727|Melphalan|melphalan|mesh-list
138301327|NCT00003727|Carmustine|carmustine|mesh-list
138301328|NCT00003727|Gemcitabine|gemcitabine|mesh-list
138301329|NCT00003727|Etoposide|etoposide|mesh-list
138301330|NCT00003727|Sargramostim|sargramostim|mesh-list
138301331|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301332|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
138301333|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301334|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301335|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301336|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
138301337|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301338|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301339|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301340|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301341|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
138301342|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301343|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301344|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301345|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301346|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
138301347|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301349|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301350|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301351|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
138301352|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301353|NCT00004057|Paclitaxel|paclitaxel|mesh-list
138301354|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301355|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301356|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301357|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301358|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301359|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301360|NCT00004063|Interferons|interferons|mesh-list
138301361|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
138301362|NCT00004063|Gemcitabine|gemcitabine|mesh-list
138301363|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301364|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301365|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
138301366|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301367|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
138366500|NCT06103188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366502|NCT06103188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301368|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301369|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
138301370|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301371|NCT00003733|Paclitaxel|paclitaxel|mesh-list
138301372|NCT00003733|Carboplatin|carboplatin|mesh-list
138301373|NCT00003733|Topotecan|topotecan|mesh-list
138301374|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301375|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301376|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301377|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301378|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301379|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301380|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301381|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301382|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301383|NCT00003739|Lenograstim|lenograstim|mesh-list
138301384|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138301385|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
138301386|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301387|NCT00003745|Topotecan|topotecan|mesh-list
138301388|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301390|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301391|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301392|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301393|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
138301394|NCT00003163|Melphalan|melphalan|mesh-list
138301395|NCT00003163|Sargramostim|sargramostim|mesh-list
138301396|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301397|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
138301398|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301399|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301400|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301401|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
138301402|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301403|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301404|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301405|NCT00004081|Docetaxel|docetaxel|mesh-list
138301406|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301407|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301408|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301409|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301410|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301411|NCT00003751|Penicillamine|penicillamine|mesh-list
138301412|NCT00003751|Antidotes|antidotes|mesh-ancestor
138301413|NCT00003751|Protective Agents|protective agents|mesh-ancestor
138301414|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301415|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
138301416|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
138301417|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301418|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301419|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138301420|NCT00004087|Antibodies|antibodies|mesh-list
138301421|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
138301422|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138301423|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
138301424|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301425|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301426|NCT00003757|Rituximab|rituximab|mesh-list
138301427|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301428|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301429|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
138301430|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301431|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301432|NCT00003175|Fluorouracil|fluorouracil|mesh-list
138301433|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
138301434|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301435|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301436|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301437|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301438|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
138301439|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301440|NCT00004099|Leucovorin|leucovorin|mesh-list
138301441|NCT00004099|Fluorouracil|fluorouracil|mesh-list
138301442|NCT00004099|Calcium|calcium|mesh-list
138301443|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
138301444|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301445|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138301446|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301448|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301449|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301450|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301451|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
138301452|NCT00004099|Antidotes|antidotes|mesh-ancestor
138301453|NCT00004099|Protective Agents|protective agents|mesh-ancestor
138301454|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
138301455|NCT00004099|Vitamins|vitamins|mesh-ancestor
138301456|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
138301457|NCT00003763|Folic Acid|folic acid|mesh-list
138301458|NCT00003763|Hematinics|hematinics|mesh-ancestor
138301459|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
138301460|NCT00003763|Vitamins|vitamins|mesh-ancestor
138301462|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301463|NCT00003181|Aldesleukin|aldesleukin|mesh-list
138301464|NCT00003181|Vinblastine|vinblastine|mesh-list
138301465|NCT00003181|Sargramostim|sargramostim|mesh-list
138301466|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
138301467|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301468|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301469|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138301470|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138301471|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
138301472|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301473|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301474|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301475|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301476|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301477|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301478|NCT00004105|Paclitaxel|paclitaxel|mesh-list
138301479|NCT00004105|Vinorelbine|vinorelbine|mesh-list
138301480|NCT00004105|Estramustine|estramustine|mesh-list
138301481|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301483|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301484|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301485|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301486|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301487|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301489|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138301491|NCT00003187|Cyclosporine|cyclosporine|mesh-list
138301492|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
138301493|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
138301494|NCT00003187|Methotrexate|methotrexate|mesh-list
138301495|NCT00003187|Cyclosporins|cyclosporins|mesh-list
138301496|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301497|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
138301498|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301499|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301500|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301501|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
138301502|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301503|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301504|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301505|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138301506|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
138301507|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138301508|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301509|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
138301510|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301511|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301512|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138301513|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138301514|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
138301515|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301516|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
138301517|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138301518|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301519|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
138301521|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301522|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301523|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
138215922|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301525|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301526|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138301527|NCT00003187|Protective Agents|protective agents|mesh-ancestor
138301528|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
138301529|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301530|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301531|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301533|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301534|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301535|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301536|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
138301537|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301538|NCT00004123|Doxorubicin|doxorubicin|mesh-list
138301539|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301540|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301541|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301542|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301543|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301544|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301545|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301547|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301548|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301549|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301550|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301551|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301553|NCT00003193|Amifostine|amifostine|mesh-list
138301554|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301555|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301556|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301557|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301558|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301559|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301560|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138301561|NCT00003193|Protective Agents|protective agents|mesh-ancestor
138301562|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301563|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
138301564|NCT00004135|Fludarabine|fludarabine|mesh-list
138301565|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
138301566|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301567|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
138301568|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301569|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301570|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301571|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
138301572|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301573|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301574|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301575|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301576|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
138301577|NCT00004141|Dacarbazine|dacarbazine|mesh-list
138301578|NCT00004141|Molgramostim|molgramostim|mesh-list
138301579|NCT00004141|Sargramostim|sargramostim|mesh-list
138301580|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301581|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301582|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
138301583|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301584|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
138301597|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
138301598|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301599|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301600|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301601|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301602|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
138301603|NCT00003799|Antidotes|antidotes|mesh-ancestor
138301604|NCT00003799|Protective Agents|protective agents|mesh-ancestor
138301605|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
138301606|NCT00003799|Vitamins|vitamins|mesh-ancestor
138301607|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
138301608|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
138301609|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138301610|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
138301611|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301612|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301613|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
138301614|NCT00003211|Vincristine|vincristine|mesh-list
138301615|NCT00003211|Amifostine|amifostine|mesh-list
138301616|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301617|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
138301618|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301619|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301620|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301621|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
138301622|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301623|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301624|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301625|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301626|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301627|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301628|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301629|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138301630|NCT00003211|Protective Agents|protective agents|mesh-ancestor
138301631|NCT00003805|Vancomycin|vancomycin|mesh-list
138301632|NCT00003805|Tazobactam|tazobactam|mesh-list
138301633|NCT00003805|Piperacillin|piperacillin|mesh-list
138301634|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138301635|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138301637|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138301638|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301639|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301640|NCT00004159|Paclitaxel|paclitaxel|mesh-list
138301641|NCT00004159|Gemcitabine|gemcitabine|mesh-list
138301643|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301644|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301645|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301646|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301647|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301648|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301650|NCT00003811|Etoposide|etoposide|mesh-list
138301651|NCT00003811|Bleomycin|bleomycin|mesh-list
138301652|NCT00003811|Amifostine|amifostine|mesh-list
138301653|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301654|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301655|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301656|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301657|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301658|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301659|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301660|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138301661|NCT00003811|Protective Agents|protective agents|mesh-ancestor
138301662|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301663|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138301664|NCT00004177|Antibodies|antibodies|mesh-list
138301665|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
138301666|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138301667|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
138301668|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301669|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301670|NCT00003817|Ondansetron|ondansetron|mesh-list
138301671|NCT00003817|Granisetron|granisetron|mesh-list
138301672|NCT00003817|Tropisetron|tropisetron|mesh-list
138301673|NCT00003817|Dolasetron|dolasetron|mesh-list
138301674|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
138301675|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
138301676|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301677|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301678|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301680|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301681|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138301682|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138301684|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138301685|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301686|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
138301688|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
138301689|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301690|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
138215923|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
138301691|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301692|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301693|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301694|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
138301695|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301696|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301697|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301698|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301699|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
138301700|NCT04329403|Adapalene|adapalene|mesh-list
138301701|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138301702|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138301703|NCT04329403|Analgesics|analgesics|mesh-ancestor
138301704|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
138301705|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301706|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301707|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301708|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301709|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301716|NCT00003217|Vincristine|vincristine|mesh-list
138301717|NCT00003217|Lenograstim|lenograstim|mesh-list
138301718|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301719|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
138301720|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301721|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301722|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301723|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
138301724|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301727|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301728|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
138301729|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
138301730|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301731|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301732|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
138301733|NCT00003217|Hormones|hormones|mesh-ancestor
138301734|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301735|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138301736|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301737|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301738|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301739|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301740|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138301741|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
138301742|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138301743|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301744|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
138301745|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
138301746|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138301747|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138301748|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
138301749|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301751|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301752|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301753|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301754|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301755|NCT00004183|Capecitabine|capecitabine|mesh-list
138301756|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301757|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
138301758|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301759|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301760|NCT00003223|Fenretinide|fenretinide|mesh-list
138301761|NCT00003223|Retinamide|retinamide|mesh-list
138301762|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301763|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138301764|NCT00003223|Protective Agents|protective agents|mesh-ancestor
138301765|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301766|NCT00004189|Cisplatin|cisplatin|mesh-list
138301767|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301768|NCT00003229|Aldesleukin|aldesleukin|mesh-list
138301769|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301770|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138301771|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138301772|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
138301773|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301774|NCT00003835|Leucovorin|leucovorin|mesh-list
138301776|NCT00003835|Irinotecan|irinotecan|mesh-list
138301777|NCT00003835|Calcium|calcium|mesh-list
138301778|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
138301785|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301786|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
138301787|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138301788|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301789|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301790|NCT00003835|Antidotes|antidotes|mesh-ancestor
138301791|NCT00003835|Protective Agents|protective agents|mesh-ancestor
138301792|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
138301794|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
138301795|NCT00003847|Doxorubicin|doxorubicin|mesh-list
138301796|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301797|NCT00003847|Vincristine|vincristine|mesh-list
138301798|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301799|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301800|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301801|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301802|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301803|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301804|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301805|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301806|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301807|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301809|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301810|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301811|NCT00003853|Esorubicin|esorubicin|mesh-list
138301812|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301813|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301814|NCT00385021|Leucovorin|leucovorin|mesh-list
138301815|NCT00385021|Fluorouracil|fluorouracil|mesh-list
138301816|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
138301817|NCT00385021|Bevacizumab|bevacizumab|mesh-list
138301818|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
138301819|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301820|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301821|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301822|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301823|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
138301824|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301825|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301826|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138301827|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138301828|NCT00385021|Growth Substances|growth substances|mesh-ancestor
138301829|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
138301830|NCT00385021|Antidotes|antidotes|mesh-ancestor
138301831|NCT00385021|Protective Agents|protective agents|mesh-ancestor
138301832|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
138301833|NCT00385021|Vitamins|vitamins|mesh-ancestor
138301834|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
138301835|NCT00004201|Carboplatin|carboplatin|mesh-list
138301836|NCT00004201|Gemcitabine|gemcitabine|mesh-list
138301837|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301838|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301839|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
138301840|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301841|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
138301842|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138301850|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301851|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
138301852|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301853|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301854|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301855|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
138301856|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301857|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301858|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301859|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301860|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301861|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301862|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301863|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301864|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301865|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301866|NCT00003865|Toremifene|toremifene|mesh-list
138301868|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301869|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138301870|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138301871|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
138301872|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301873|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301874|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138301875|NCT00004207|Daunorubicin|daunorubicin|mesh-list
138301876|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301877|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301878|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301879|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301880|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301881|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301882|NCT00004219|Granisetron|granisetron|mesh-list
138301883|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
138301884|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
138301885|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301886|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301887|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301888|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138301889|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138301890|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
138301891|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138301894|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
138301895|NCT00003877|Carboplatin|carboplatin|mesh-list
138301896|NCT00003877|Thiotepa|thiotepa|mesh-list
138301897|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301898|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301899|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301900|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301901|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301902|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301903|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301904|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
138301905|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301910|NCT00003883|Itraconazole|itraconazole|mesh-list
138301911|NCT00003883|Fluconazole|fluconazole|mesh-list
138301912|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
138301913|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138301914|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138301915|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138301916|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301917|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301918|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138301919|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
138301920|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301921|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301922|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138301923|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138301924|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138301925|NCT00003253|Paclitaxel|paclitaxel|mesh-list
138301926|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
138301927|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301928|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301929|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301930|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301931|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301932|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
138301933|NCT00004237|Doxorubicin|doxorubicin|mesh-list
138301934|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301935|NCT00004237|Vinorelbine|vinorelbine|mesh-list
138301936|NCT00004237|Epirubicin|epirubicin|mesh-list
138301937|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
138301938|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301939|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
138301940|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301941|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301942|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301943|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
138301944|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301945|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301946|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301947|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138301948|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138301949|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138301950|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301952|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301953|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301954|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301955|NCT00004237|Analgesics|analgesics|mesh-ancestor
138301957|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301958|NCT00003259|Vinorelbine|vinorelbine|mesh-list
138301959|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301960|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301961|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301962|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301969|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301970|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
138301971|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301972|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301973|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301974|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
138301975|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301976|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301977|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138301978|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138301979|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
138301980|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
138301981|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138301982|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138301985|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138301987|NCT00003913|Protective Agents|protective agents|mesh-ancestor
138301988|NCT00004243|Docetaxel|docetaxel|mesh-list
138301989|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
138301990|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301991|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138301992|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138301993|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301994|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301995|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138301996|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138301997|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
138301998|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301999|NCT00003925|Leucovorin|leucovorin|mesh-list
138302000|NCT00003925|Gemcitabine|gemcitabine|mesh-list
138302001|NCT00003925|Tegafur|tegafur|mesh-list
138302002|NCT00003925|Calcium|calcium|mesh-list
138302003|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
138302004|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302005|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
138302006|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302007|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302008|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302009|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302011|NCT00003925|Protective Agents|protective agents|mesh-ancestor
138302012|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
138302014|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
138302015|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
138302016|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
138302017|NCT00004255|Fludarabine|fludarabine|mesh-list
138302018|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
138302019|NCT00004255|Tacrolimus|tacrolimus|mesh-list
138302020|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138302021|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302022|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
138302023|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302024|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302025|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302026|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
138302027|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302028|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302029|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302031|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
138302037|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302038|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302039|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
138302040|NCT00004255|Hormones|hormones|mesh-ancestor
138302041|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302042|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138302043|NCT00004255|Protective Agents|protective agents|mesh-ancestor
138302045|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
138302046|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302047|NCT00004297|Diazepam|diazepam|mesh-list
138302048|NCT00004297|Lorazepam|lorazepam|mesh-list
138302049|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
138302050|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
138302051|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
138302052|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302053|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302054|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302055|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138302056|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138302057|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138302058|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138302059|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138302060|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
138302061|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
138302062|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302063|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302064|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138302065|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138302066|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138302067|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138302068|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
138302069|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
138302071|NCT00004855|Lopinavir|lopinavir|mesh-list
138302072|NCT00004855|Lamivudine|lamivudine|mesh-list
138302073|NCT00004855|Nevirapine|nevirapine|mesh-list
138302074|NCT00004855|Abacavir|abacavir|mesh-list
138302075|NCT00004855|Stavudine|stavudine|mesh-list
138302076|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138302077|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138302078|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138302079|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302080|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302081|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302082|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302083|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
138302084|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302085|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138302086|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138302087|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302088|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302089|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138302090|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138302091|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
138302092|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138302093|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366509|NCT06103188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138366510|NCT06103188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138366511|NCT06103188|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138366512|NCT06103188|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138302094|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138302095|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302096|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302097|NCT00004861|Gemcitabine|gemcitabine|mesh-list
138302098|NCT00004861|Tacedinaline|tacedinaline|mesh-list
138302102|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302106|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138302107|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302109|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302110|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302111|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302112|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302113|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302115|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302116|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302117|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302118|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302119|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302121|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138302122|NCT00003307|Protective Agents|protective agents|mesh-ancestor
138302123|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302124|NCT00004327|Octreotide|octreotide|mesh-list
138302125|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302126|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302127|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302128|NCT00003313|Paclitaxel|paclitaxel|mesh-list
138302129|NCT00003313|Carboplatin|carboplatin|mesh-list
138302130|NCT00003313|Amifostine|amifostine|mesh-list
138302131|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302132|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302133|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302134|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302135|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302136|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302137|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302138|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138302139|NCT00003313|Protective Agents|protective agents|mesh-ancestor
138302140|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138302141|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138302142|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302143|NCT00004873|Docetaxel|docetaxel|mesh-list
138302144|NCT00004873|Fluorouracil|fluorouracil|mesh-list
138302145|NCT00004873|Epirubicin|epirubicin|mesh-list
138302146|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302147|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302148|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302149|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302150|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302152|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302153|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302154|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
138302155|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302156|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302157|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302158|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302159|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302160|NCT00004879|Panitumumab|panitumumab|mesh-list
138302161|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302162|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366518|NCT06103188|Anesthetics|anesthetics|mesh-ancestor
138302163|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138302164|NCT00004339|Trientine|trientine|mesh-list
138302165|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
138302166|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
138302167|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302168|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302171|NCT00004339|Growth Substances|growth substances|mesh-ancestor
138302172|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302173|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
138302174|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302175|NCT00003331|Leucovorin|leucovorin|mesh-list
138302176|NCT00003331|Fluorouracil|fluorouracil|mesh-list
138302177|NCT00003331|Topotecan|topotecan|mesh-list
138302178|NCT00003331|Calcium|calcium|mesh-list
138302179|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
138302180|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302181|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302182|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
138302183|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302184|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302185|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302186|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302187|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
138302189|NCT00003331|Protective Agents|protective agents|mesh-ancestor
138302190|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
138302191|NCT00003331|Vitamins|vitamins|mesh-ancestor
138302192|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
138302193|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302194|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302195|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302196|NCT00004885|Leucovorin|leucovorin|mesh-list
138302197|NCT00004885|Fluorouracil|fluorouracil|mesh-list
138302198|NCT00004885|Irinotecan|irinotecan|mesh-list
138302199|NCT00004885|Calcium|calcium|mesh-list
138302200|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
138302201|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302202|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302203|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
138302204|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302205|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302206|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302207|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302208|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
138302209|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302210|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302211|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302212|NCT00004885|Antidotes|antidotes|mesh-ancestor
138302213|NCT00004885|Protective Agents|protective agents|mesh-ancestor
138302214|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
138302215|NCT00004885|Vitamins|vitamins|mesh-ancestor
138302216|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
138302217|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138302218|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138302219|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302220|NCT00003337|Epratuzumab|epratuzumab|mesh-list
138302221|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302222|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302223|NCT00003343|Prednisone|prednisone|mesh-list
138302224|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
138302225|NCT00003343|Prinomastat|prinomastat|mesh-list
138302227|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
138302229|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302230|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302231|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302232|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302233|NCT00003343|Analgesics|analgesics|mesh-ancestor
138302234|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
138302235|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302236|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302237|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302238|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302242|NCT00004903|Interferons|interferons|mesh-list
138302243|NCT00004903|Cytarabine|cytarabine|mesh-list
138302244|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
138302245|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
138302246|NCT00004903|Melphalan|melphalan|mesh-list
138302247|NCT00004903|Etoposide|etoposide|mesh-list
138302248|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302249|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
138302250|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302251|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302252|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302253|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
138302254|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302255|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302256|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302257|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302258|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302259|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302260|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302261|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
138302262|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302263|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302264|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
138302265|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
138302266|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138302267|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138302268|NCT00004357|Prednisolone|prednisolone|mesh-list
138302269|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
138302270|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138302271|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
138302272|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302273|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
138302274|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
138302275|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302276|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302277|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302278|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
138302279|NCT00004357|Hormones|hormones|mesh-ancestor
138302280|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302282|NCT00004357|Protective Agents|protective agents|mesh-ancestor
138302283|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302284|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302285|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
138302286|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138302287|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
138302288|NCT00004363|Coagulants|coagulants|mesh-ancestor
138302289|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138302290|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
138302291|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302292|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138302293|NCT04069117|Letrozole|letrozole|mesh-list
138302294|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302295|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138302296|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138302297|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302298|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302299|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138302300|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
138302301|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302302|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302303|NCT00004921|Paclitaxel|paclitaxel|mesh-list
138302304|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
138302305|NCT00004921|Carboplatin|carboplatin|mesh-list
138302316|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302317|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302318|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
138302319|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302320|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
138302321|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
138302322|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302323|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
138302324|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302325|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302326|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302327|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302328|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138302330|NCT00004981|Zidovudine|zidovudine|mesh-list
138302331|NCT00004981|Abacavir|abacavir|mesh-list
138302332|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
138302333|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138302335|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302336|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302337|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302338|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
138302339|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302340|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302341|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302342|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
138302344|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
138302345|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302346|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302347|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302348|NCT00004999|Lamivudine|lamivudine|mesh-list
138302349|NCT00004999|Zidovudine|zidovudine|mesh-list
138302350|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138302351|NCT00004999|Capravirine|capravirine|mesh-list
138302353|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302354|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302355|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302356|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302357|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
138302358|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302359|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302360|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302361|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
138302362|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138302363|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138302364|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
138302365|NCT00003361|Decitabine|decitabine|mesh-list
138302366|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302368|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302369|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302376|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302378|NCT00003379|Paclitaxel|paclitaxel|mesh-list
138302379|NCT00003379|Cisplatin|cisplatin|mesh-list
138302380|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302381|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302382|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302383|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302384|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302385|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302386|NCT00003385|Paclitaxel|paclitaxel|mesh-list
138302387|NCT00003385|Carboplatin|carboplatin|mesh-list
138302388|NCT00003385|Doxorubicin|doxorubicin|mesh-list
138302389|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138302390|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302391|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302392|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302393|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302394|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302395|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302396|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302397|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302398|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302399|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302400|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138302401|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302402|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302403|NCT00005005|Alendronate|alendronate|mesh-list
138302404|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138302405|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302407|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138302408|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
138302409|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302410|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302411|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302412|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138302413|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138302414|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138302415|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138302416|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138302417|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
138302418|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
138302419|NCT00004399|Nimodipine|nimodipine|mesh-list
138302420|NCT00004399|Analgesics|analgesics|mesh-ancestor
138302422|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302423|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302424|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
138302425|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138302426|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138302427|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
138302428|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138302429|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138302430|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302431|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302432|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
138302439|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302441|NCT00005017|Amprenavir|amprenavir|mesh-list
138302442|NCT00005017|Lamivudine|lamivudine|mesh-list
138302443|NCT00005017|Abacavir|abacavir|mesh-list
138302445|NCT00005017|Efavirenz|efavirenz|mesh-list
138302446|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138302447|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138302449|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302450|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302451|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302452|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302453|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
138302454|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302455|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138302456|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138302457|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302458|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302459|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138302460|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138302461|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138302462|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138302463|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138302464|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
138302465|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138302466|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
138302467|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138302468|NCT00005023|Sargramostim|sargramostim|mesh-list
138302469|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
138302470|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302472|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302473|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302474|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302475|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302476|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302478|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302479|NCT00004429|Hormones|hormones|mesh-list
138302480|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302481|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302482|NCT00005041|Tipifarnib|tipifarnib|mesh-list
138302483|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302484|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138302485|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138302486|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138302487|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302489|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302490|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
138302491|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138302492|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302493|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302494|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138302495|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
138302496|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
138302497|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302500|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302501|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302502|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
138302503|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302504|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138302505|NCT00005575|Imipramine|imipramine|mesh-list
138302506|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138302507|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
138302508|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138302509|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138302510|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138302511|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138302512|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302513|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
138302515|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302516|NCT00005059|Paclitaxel|paclitaxel|mesh-list
138302517|NCT00005059|Carboplatin|carboplatin|mesh-list
138302518|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302519|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302520|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302521|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302522|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302523|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302524|NCT00005065|Paclitaxel|paclitaxel|mesh-list
138302525|NCT00005065|Carboplatin|carboplatin|mesh-list
138302526|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
138302527|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302528|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302529|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302530|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302532|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302533|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138302534|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
138302536|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138302537|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138302538|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138302539|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138302540|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
138302541|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302542|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302543|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302545|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138302547|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138302548|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302549|NCT00386269|Analgesics|analgesics|mesh-ancestor
138302550|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
138302551|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302552|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
138302553|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
138302554|NCT00005581|Paclitaxel|paclitaxel|mesh-list
138302555|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
138302556|NCT00005581|Fluorouracil|fluorouracil|mesh-list
138302557|NCT00005581|Epirubicin|epirubicin|mesh-list
138302558|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302559|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302560|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302561|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302562|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302563|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302564|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302565|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
138302566|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302572|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302573|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302574|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302575|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302576|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302577|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
138302578|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302579|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
138302580|NCT00004489|Vitamin D|vitamin d|mesh-list
138302581|NCT00004489|Alendronate|alendronate|mesh-list
138302582|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
138302583|NCT00004489|Calcium|calcium|mesh-list
138302584|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302585|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302586|NCT00004489|Vitamins|vitamins|mesh-ancestor
138302587|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
138302588|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138302589|NCT00004489|Antacids|antacids|mesh-ancestor
138302590|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302591|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302592|NCT00005593|Carboplatin|carboplatin|mesh-list
138302593|NCT00005593|Fludarabine|fludarabine|mesh-list
138302594|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
138302595|NCT00005593|Topotecan|topotecan|mesh-list
138302596|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302597|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302598|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
138302599|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302600|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302601|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
138302602|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302603|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302604|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302605|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302606|NCT00004495|Folic Acid|folic acid|mesh-list
138302607|NCT00004495|Pyridoxine|pyridoxine|mesh-list
138302609|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
138302611|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
138302612|NCT00004495|Vitamins|vitamins|mesh-ancestor
138302613|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
138302614|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302615|NCT00005089|Prednisone|prednisone|mesh-list
138302616|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
138302617|NCT00005089|Rituximab|rituximab|mesh-list
138302618|NCT00005089|Doxorubicin|doxorubicin|mesh-list
138302619|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138302620|NCT00005089|Vincristine|vincristine|mesh-list
138302621|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302622|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
138302623|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302624|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302625|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302626|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
138302627|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302629|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302630|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302631|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302632|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302633|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302634|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302635|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302636|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
138302637|NCT00005089|Hormones|hormones|mesh-ancestor
138302638|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302639|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302640|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302641|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302642|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302643|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302644|NCT00005599|Paclitaxel|paclitaxel|mesh-list
138302645|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
138302646|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302647|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302648|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302649|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302650|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302651|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302652|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138302653|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
138302654|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302655|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
138302656|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302657|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302658|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138302659|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
138302660|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138302661|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302662|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302663|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302665|NCT00005113|Sirolimus|sirolimus|mesh-list
138302666|NCT00005113|Tacrolimus|tacrolimus|mesh-list
138302667|NCT00005113|Cyclosporins|cyclosporins|mesh-list
138302668|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302669|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
138302670|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302671|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138302672|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302673|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302674|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
138302675|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302676|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
138302677|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302678|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138302679|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138302680|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302681|NCT00004573|Ganciclovir|ganciclovir|mesh-list
138302682|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138302683|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
138302684|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302685|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302686|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302687|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302688|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
138302689|NCT00005623|Cyproterone|cyproterone|mesh-list
138302690|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
138302691|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138302692|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302693|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302694|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302695|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138302696|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
138302697|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138302698|NCT00005119|Calcium|calcium|mesh-list
138302699|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138302700|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302701|NCT00004585|Lamivudine|lamivudine|mesh-list
138302702|NCT00004585|Zidovudine|zidovudine|mesh-list
138302703|NCT00004585|Efavirenz|efavirenz|mesh-list
138302704|NCT00004585|Abacavir|abacavir|mesh-list
138302705|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
138302706|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138302707|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302708|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302710|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302712|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302713|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302714|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302715|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
138302716|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138302717|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138302718|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138302719|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138302720|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138302721|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138302722|NCT00005635|Paclitaxel|paclitaxel|mesh-list
138302723|NCT00005635|Trastuzumab|trastuzumab|mesh-list
138302724|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302725|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302726|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302727|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302728|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302729|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302730|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302731|NCT00005641|Leucovorin|leucovorin|mesh-list
138302732|NCT00005641|Cyclosporine|cyclosporine|mesh-list
138302733|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
138302734|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
138302735|NCT00005641|Busulfan|busulfan|mesh-list
138302736|NCT00005641|Methotrexate|methotrexate|mesh-list
138302737|NCT00005641|Cyclosporins|cyclosporins|mesh-list
138302738|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138302739|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
138302740|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302741|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
138302742|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302743|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302744|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302745|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
138302746|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302747|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302748|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302749|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138302750|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
138302751|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138302752|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302753|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
138302754|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
138302755|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302756|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138302757|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302758|NCT00005641|Antidotes|antidotes|mesh-ancestor
138302759|NCT00005641|Protective Agents|protective agents|mesh-ancestor
138302760|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
138302761|NCT00005641|Vitamins|vitamins|mesh-ancestor
138302762|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
138302763|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
138302764|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302765|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138302766|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302767|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
138302768|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
138302769|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302770|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302771|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
138302772|NCT00005641|Hormones|hormones|mesh-ancestor
138302773|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302779|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302780|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302781|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302784|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138302785|NCT00005647|Growth Substances|growth substances|mesh-ancestor
138302786|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302787|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
138302788|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138302789|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302791|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
138302792|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302793|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
138302794|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302795|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
138302796|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302797|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
138302798|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302799|NCT00385411|Valproic Acid|valproic acid|mesh-list
138302800|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
138302801|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302802|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302803|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
138302804|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302805|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302806|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
138302807|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138302808|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138302809|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138302811|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302812|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302813|NCT00004705|Amiloride|amiloride|mesh-list
138302814|NCT00004705|Diuretics|diuretics|mesh-ancestor
138302815|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
138302816|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302817|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138302818|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138302819|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138302820|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302821|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138302822|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138302823|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
138302824|NCT00004747|Antibodies|antibodies|mesh-list
138302826|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138302827|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138302828|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
138302829|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302830|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
138302831|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138302832|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138302833|NCT00004759|Prednisolone|prednisolone|mesh-list
138302834|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
138302836|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138302837|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
138302838|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302839|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
138302840|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
138302841|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302842|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302843|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138302844|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
138302846|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302847|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138302848|NCT00004759|Protective Agents|protective agents|mesh-ancestor
138302849|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302850|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302851|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
138302852|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302853|NCT00004771|Leuprolide|leuprolide|mesh-list
138302854|NCT00004771|Testosterone|testosterone|mesh-list
138302855|NCT00004771|Androgens|androgens|mesh-ancestor
138302856|NCT00004771|Hormones|hormones|mesh-ancestor
138302857|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138302858|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302859|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138302860|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302861|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138302862|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
138302863|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138302864|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138302865|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302866|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302867|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138302868|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138302869|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
138302870|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302871|NCT00004807|Topiramate|topiramate|mesh-list
138302872|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
138302873|NCT00004807|Donepezil|donepezil|mesh-list
138302874|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138302878|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302879|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302881|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
138302882|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138302883|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
138302884|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
138302885|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138302886|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138302888|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138302889|NCT00004825|Mitogens|mitogens|mesh-list
138302890|NCT00004825|Mecasermin|mecasermin|mesh-list
138302891|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138302892|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302893|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302894|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302895|NCT00004825|Growth Substances|growth substances|mesh-ancestor
138302896|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138302897|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138302898|NCT00385645|Zidovudine|zidovudine|mesh-list
138302899|NCT00385645|Lamivudine|lamivudine|mesh-list
138302900|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138302901|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138302902|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
138302903|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302904|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302905|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302906|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302907|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
138302908|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302909|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302910|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302911|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
138302912|NCT00385957|Lamivudine|lamivudine|mesh-list
138302913|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138302914|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138302915|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302916|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302917|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
138302918|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302919|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138302920|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138302921|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138302922|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302923|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302924|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
138302925|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138302926|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
138302927|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138302928|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302929|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138302930|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138302931|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138302932|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
138302933|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302934|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138302935|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138302936|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
138302937|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
138302938|NCT00005773|Protective Agents|protective agents|mesh-ancestor
138302939|NCT00005779|Interleukin-12|interleukin-12|mesh-list
138302940|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138302941|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
138302942|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302943|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138302944|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138302945|NCT00005779|Growth Substances|growth substances|mesh-ancestor
138302946|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
138302947|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302948|NCT00005791|Fluorouracil|fluorouracil|mesh-list
138302950|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302951|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
138302952|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302953|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138302954|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302955|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
138302956|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302957|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138302958|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302959|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302960|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
138302961|NCT00005797|Busulfan|busulfan|mesh-list
138302962|NCT00005797|Etoposide|etoposide|mesh-list
138302963|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302964|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
138302965|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302966|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302967|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302968|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
138302969|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302970|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302971|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302972|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302973|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138302974|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302975|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302976|NCT00005815|Thalidomide|thalidomide|mesh-list
138302977|NCT00005815|Temozolomide|temozolomide|mesh-list
138302978|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138302979|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
138302980|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302981|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302982|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302983|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
138302984|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302985|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
138302986|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138302987|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302988|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138302989|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138302990|NCT00005815|Growth Substances|growth substances|mesh-ancestor
138302991|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
138302992|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
138302993|NCT02132754|MK-4166|mk-4166|mesh-list
138302994|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302996|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138302997|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302998|NCT02151786|Lansoprazole|lansoprazole|mesh-list
138302999|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
138303000|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138303001|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303002|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138303003|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303004|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303005|NCT02106156|Interferons|interferons|mesh-list
138303006|NCT02106156|Ribavirin|ribavirin|mesh-list
138303007|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
138303008|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
138303009|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138303010|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303011|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
138303012|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303013|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
138303014|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303015|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
138303016|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303017|NCT02131272|Insulin|insulin|mesh-list
138303018|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138303019|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
138303020|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
138303021|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
138303022|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
138303023|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303024|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303025|NCT02130882|Benralizumab|benralizumab|mesh-list
138303026|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303027|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303028|NCT02149836|Ezogabine|ezogabine|mesh-list
138303029|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
138303030|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303031|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303032|NCT02130024|Ranibizumab|ranibizumab|mesh-list
138303033|NCT02130024|Aflibercept|aflibercept|mesh-list
138303034|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138303035|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138303036|NCT02130024|Growth Substances|growth substances|mesh-ancestor
138303037|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303038|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
138303039|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303041|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
138303042|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303043|NCT02105454|Ribavirin|ribavirin|mesh-list
138303044|NCT02105454|Grazoprevir|grazoprevir|mesh-list
138303045|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
138303046|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303047|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
138303048|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303049|NCT02104752|Curcumin|curcumin|mesh-list
138303050|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138303051|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303052|NCT02104752|Analgesics|analgesics|mesh-ancestor
138303053|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
138303054|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303055|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303056|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303057|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303058|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303059|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303060|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303061|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
138303062|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303063|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303065|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
138303066|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303067|NCT02127372|Cisplatin|cisplatin|mesh-list
138303068|NCT02127372|Docetaxel|docetaxel|mesh-list
138303069|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
138303070|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303071|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138303072|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303073|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138303074|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303075|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138303076|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303077|NCT02125734|Bromides|bromides|mesh-list
138303078|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
138303079|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138303080|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
138303081|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303082|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303083|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303084|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303085|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
138303086|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138303087|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303088|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303089|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303090|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
138303091|NCT02124798|Belimumab|belimumab|mesh-list
138303092|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303093|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
138303094|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303095|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138303096|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
138303097|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
138303098|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
138303099|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138303100|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138303101|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303102|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138303103|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138303104|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138303105|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138303106|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138303107|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138303108|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303110|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
138303111|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138303112|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138303113|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303114|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303115|NCT02100696|Etrolizumab|etrolizumab|mesh-list
138303116|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303117|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
138303118|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303119|NCT02123472|Cephalexin|cephalexin|mesh-list
138303120|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303121|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303124|NCT02145078|Pemetrexed|pemetrexed|mesh-list
138303125|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303126|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
138303127|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303128|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303129|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138303130|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303131|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138303132|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303133|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138303134|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138303135|NCT02100228|Vitamin K|vitamin k|mesh-list
138303136|NCT02100228|Heparin|heparin|mesh-list
138303137|NCT02100228|Apixaban|apixaban|mesh-list
138303138|NCT02100228|Vitamins|vitamins|mesh-ancestor
138303139|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
138303140|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303141|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
138303142|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138303143|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138303144|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303145|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138303146|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
138303147|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138303148|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138303149|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303150|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138303151|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
138303152|NCT02100228|Coagulants|coagulants|mesh-ancestor
138303153|NCT02099838|Metformin|metformin|mesh-list
138303154|NCT02099838|Pioglitazone|pioglitazone|mesh-list
138303155|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303156|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303157|NCT02099682|Lansoprazole|lansoprazole|mesh-list
138303158|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
138303159|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138303160|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303161|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138303162|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303163|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303164|NCT02098746|Pioglitazone|pioglitazone|mesh-list
138303166|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303167|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303168|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138303169|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303170|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
138303171|NCT02122770|Itraconazole|itraconazole|mesh-list
138303172|NCT02122770|Fluconazole|fluconazole|mesh-list
138303173|NCT02122770|Paclitaxel|paclitaxel|mesh-list
138303174|NCT02122770|Docetaxel|docetaxel|mesh-list
138303175|NCT02122770|Carboplatin|carboplatin|mesh-list
138303176|NCT02122770|Pevonedistat|pevonedistat|mesh-list
138303177|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138303178|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303179|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
138303180|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303181|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
138303182|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303183|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
138303184|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303185|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138303186|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138303187|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303188|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138303189|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
138303190|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303191|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303192|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138303193|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138303194|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138303195|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138303196|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303197|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303199|NCT02122380|Hormones|hormones|mesh-ancestor
138303200|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303201|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138303202|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138303203|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303204|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303205|NCT02121756|Dipyridamole|dipyridamole|mesh-list
138303206|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138303207|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303208|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303209|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138303210|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
138303211|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138303213|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138303214|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138303215|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
138303216|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138303217|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138303218|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
138303219|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303220|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138303221|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138303222|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303223|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303224|NCT02096952|Methylphenidate|methylphenidate|mesh-list
138303225|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138303226|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303227|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138303228|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138303229|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303230|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303231|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
138303232|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303233|NCT02120898|Imiquimod|imiquimod|mesh-list
138303234|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138303235|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
138303236|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303237|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303238|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
138303239|NCT02120664|Corticosterone|corticosterone|mesh-list
138303240|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303242|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
138303243|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303244|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303245|NCT01627782|Ketamine|ketamine|mesh-list
138303246|NCT01627782|Analgesics|analgesics|mesh-ancestor
138303247|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
138303248|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303249|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303250|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138303251|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138303252|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
138303253|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
138303254|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303255|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138303256|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138303257|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303258|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303259|NCT02119650|Pemetrexed|pemetrexed|mesh-list
138303260|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303261|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303262|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303263|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138303264|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138303266|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138303267|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303268|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138303269|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303270|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303271|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138303272|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138303273|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
138303274|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303275|NCT02140164|Minocycline|minocycline|mesh-list
138303276|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303277|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303278|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138303279|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138303280|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
138303281|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303282|NCT02119026|Bevacizumab|bevacizumab|mesh-list
138303283|NCT02119026|Capecitabine|capecitabine|mesh-list
138303284|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
138303286|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138303287|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303288|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138303289|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138303290|NCT02119026|Growth Substances|growth substances|mesh-ancestor
138303291|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303292|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
138303293|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303294|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
138303295|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303296|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138303298|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303299|NCT02095158|Phenylephrine|phenylephrine|mesh-list
138303300|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
138303301|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138303302|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138303303|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303304|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303305|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303306|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303307|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
138303308|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
138303309|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303310|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
138303311|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138303312|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303313|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138303315|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138303316|NCT02095158|Protective Agents|protective agents|mesh-ancestor
138303318|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303319|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138303320|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138303321|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303322|NCT02138916|Benralizumab|benralizumab|mesh-list
138303323|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303324|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303325|NCT02118012|Ribavirin|ribavirin|mesh-list
138303326|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
138303327|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303328|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
138303329|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303330|NCT02138838|Cinacalcet|cinacalcet|mesh-list
138303331|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138303332|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303333|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138303334|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
138303335|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303336|NCT02092350|Grazoprevir|grazoprevir|mesh-list
138303339|NCT02138136|Lubiprostone|lubiprostone|mesh-list
138303340|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138303341|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303342|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303343|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
138303344|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
138303345|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
138303346|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138303347|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303348|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138303349|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303350|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303352|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138303353|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303354|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138303355|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303356|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303358|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
138303359|NCT02091414|Cyclosporins|cyclosporins|mesh-list
138303360|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303361|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303362|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303363|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
138303364|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303365|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
138303366|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303368|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303369|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138303370|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138303371|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303372|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138303373|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
138303374|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303375|NCT04731558|Enoxaparin|enoxaparin|mesh-list
138303376|NCT04731558|Dalteparin|dalteparin|mesh-list
138303377|NCT04731558|Tinzaparin|tinzaparin|mesh-list
138303378|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138303379|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
138303380|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138303381|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138303382|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303383|NCT02116530|Dexamethasone|dexamethasone|mesh-list
138303384|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
138303385|NCT02116530|Doxorubicin|doxorubicin|mesh-list
138303386|NCT02116530|Ondansetron|ondansetron|mesh-list
138303387|NCT02116530|Olanzapine|olanzapine|mesh-list
138303388|NCT02116530|Aprepitant|aprepitant|mesh-list
138303389|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
138303390|NCT02116530|Palonosetron|palonosetron|mesh-list
138303391|NCT02116530|Granisetron|granisetron|mesh-list
138303392|NCT02116530|Antiemetics|antiemetics|mesh-list
138303393|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303394|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
138303395|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303396|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303397|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138303398|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
138303399|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303400|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303402|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303403|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
138303404|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303405|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303406|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
138303407|NCT02116530|Hormones|hormones|mesh-ancestor
138303408|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303409|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138303410|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138303411|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138303412|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138303413|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303414|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
138303415|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303416|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138303417|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138303418|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
138303419|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303420|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138303421|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138303422|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303423|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138303424|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138303425|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138303426|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303427|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138303428|NCT02072226|Aspirin|aspirin|mesh-list
138303429|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138303430|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138303431|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303432|NCT02072226|Analgesics|analgesics|mesh-ancestor
138303433|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
138303434|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303435|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303436|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303437|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303438|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138303440|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303441|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138303442|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138303444|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
138303445|NCT04730856|Tinzaparin|tinzaparin|mesh-list
138303446|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138303447|NCT04730856|Dalteparin|dalteparin|mesh-list
138303448|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
138303449|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138303450|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138303451|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303452|NCT02114892|Resveratrol|resveratrol|mesh-list
138303453|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
138303454|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303455|NCT02114892|Protective Agents|protective agents|mesh-ancestor
138303456|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303457|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303458|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138303459|NCT02070744|Ivacaftor|ivacaftor|mesh-list
138303460|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138303461|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303462|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303463|NCT04741698|Propranolol|propranolol|mesh-list
138303464|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138303465|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138303466|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303467|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303468|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303469|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303470|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138303471|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138303472|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
138303473|NCT02111850|Aldesleukin|aldesleukin|mesh-list
138303474|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
138303475|NCT02111850|Fludarabine|fludarabine|mesh-list
138303476|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303477|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
138303478|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303479|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303480|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138303481|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
138303482|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303483|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303484|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138303485|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138303486|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138303487|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
138303488|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303489|NCT02085252|Bicalutamide|bicalutamide|mesh-list
138303490|NCT02085252|Leuprolide|leuprolide|mesh-list
138303491|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
138303492|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138303493|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303494|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303495|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303496|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138303498|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138303499|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138303500|NCT02084238|Interleukin-2|interleukin-2|mesh-list
138303501|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303502|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303503|NCT02084238|Analgesics|analgesics|mesh-ancestor
138303504|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
138303505|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303506|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303507|NCT02084082|Metformin|metformin|mesh-list
138303508|NCT02084082|Linagliptin|linagliptin|mesh-list
138303509|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303510|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303511|NCT02084082|Incretins|incretins|mesh-ancestor
138303512|NCT02084082|Hormones|hormones|mesh-ancestor
138303513|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303514|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138303515|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
138303516|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303517|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303518|NCT02083926|Ketamine|ketamine|mesh-list
138303519|NCT02083926|Analgesics|analgesics|mesh-ancestor
138303520|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
138303521|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303522|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303523|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138303524|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138303525|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
138303526|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
138303527|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303528|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138303529|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138303530|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303531|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303532|NCT02083380|Piperaquine|piperaquine|mesh-list
138303533|NCT02083380|Artefenomel|artefenomel|mesh-list
138303534|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
138303535|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138303536|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138303537|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303538|NCT02109744|Decitabine|decitabine|mesh-list
138303539|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303544|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
138303545|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
138303546|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138303547|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
138303548|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303549|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303550|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303551|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303552|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
138303553|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138303554|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303555|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303556|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303557|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303558|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303559|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138303560|NCT02082912|Cycloserine|cycloserine|mesh-list
138303561|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138303562|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303563|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138303564|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
138303566|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
138303567|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303568|NCT02082522|Cisplatin|cisplatin|mesh-list
138303569|NCT02082522|Gemcitabine|gemcitabine|mesh-list
138303570|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138303571|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138303572|NCT02082522|Trioxsalen|trioxsalen|mesh-list
138303573|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303574|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303575|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
138303576|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303577|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303578|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138303579|NCT02082210|Ramucirumab|ramucirumab|mesh-list
138303580|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303581|NCT02107014|Naltrexone|naltrexone|mesh-list
138303582|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138303583|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138303584|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303585|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
138303586|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303587|NCT01624974|Montelukast|montelukast|mesh-list
138303588|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303589|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303590|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138303591|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
138303592|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303593|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303594|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138303595|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138303596|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303597|NCT01624662|Fluticasone|fluticasone|mesh-list
138303598|NCT01624662|Xhance|xhance|mesh-list
138303599|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303600|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138303601|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
138303602|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303603|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303604|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303605|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303606|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303607|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138303608|NCT02106390|Vaccines|vaccines|mesh-list
138303609|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
138303610|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303611|NCT02064894|Ibuprofen|ibuprofen|mesh-list
138303612|NCT02064894|Morphine|morphine|mesh-list
138303613|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138303614|NCT02064894|Narcotics|narcotics|mesh-ancestor
138303615|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303616|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303617|NCT02064894|Analgesics|analgesics|mesh-ancestor
138303618|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
138303619|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303620|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138303621|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303622|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303623|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303624|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138303625|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303626|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303627|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
138303628|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138303629|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
138303630|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303631|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303632|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
138303633|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303634|NCT01624194|Oxytocin|oxytocin|mesh-list
138303635|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
138303636|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138303637|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303638|NCT02079636|Gemcitabine|gemcitabine|mesh-list
138303639|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
138303640|NCT02079636|Pemetrexed|pemetrexed|mesh-list
138303642|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303643|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
138303644|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303645|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303646|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138303647|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138303648|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303649|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138303650|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138303651|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138303652|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138303653|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
138303654|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303655|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303656|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303657|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138303658|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
138303660|NCT02045862|Mirabegron|mirabegron|mesh-list
138303661|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
138303662|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138303663|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138303664|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138303665|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303666|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303667|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303668|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303669|NCT02045862|Urological Agents|urological agents|mesh-ancestor
138303670|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138303678|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138303679|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138303680|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303681|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
138303682|NCT04182984|Hormones|hormones|mesh-ancestor
138303683|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303684|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303685|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138303686|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303687|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
138303688|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138303689|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303690|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303691|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138303692|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138303693|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
138303694|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303695|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303696|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
138303697|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
138303698|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303699|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303700|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138303701|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303702|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303703|NCT02044302|Morphine|morphine|mesh-list
138303704|NCT02044302|Narcotics|narcotics|mesh-list
138303705|NCT02044302|Analgesics|analgesics|mesh-list
138303706|NCT02044302|Bupivacaine|bupivacaine|mesh-list
138303707|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
138303708|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
138303709|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
138303710|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303711|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303712|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
138303713|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303714|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138303715|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138303716|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303717|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303718|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303719|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303720|NCT02062944|Sirolimus|sirolimus|mesh-list
138303721|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138303722|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303723|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303724|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138303725|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303727|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
138303728|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303729|NCT02062632|Doxepin|doxepin|mesh-list
138303730|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138303731|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138303732|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303733|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303734|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138303736|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138303737|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
138303738|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
138303739|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303740|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303741|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
138303742|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138303743|NCT02043366|Sufentanil|sufentanil|mesh-list
138303744|NCT02043366|Remifentanil|remifentanil|mesh-list
138303745|NCT02043366|Butorphanol|butorphanol|mesh-list
138303746|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138303747|NCT02043366|Narcotics|narcotics|mesh-ancestor
138303748|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303750|NCT02043366|Analgesics|analgesics|mesh-ancestor
138303751|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
138303752|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303753|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138303754|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138303755|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
138303756|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
138303757|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138303758|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303759|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303760|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303761|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138303762|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303763|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303764|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
138303765|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303766|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138303768|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303769|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138303770|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138303771|NCT02060370|Growth Substances|growth substances|mesh-ancestor
138303772|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303773|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138303774|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138303775|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303776|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303777|NCT01622088|Pramipexole|pramipexole|mesh-list
138303778|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
138303779|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303780|NCT01622088|Protective Agents|protective agents|mesh-ancestor
138303781|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303782|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138303783|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138303784|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
138303785|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
138303786|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303787|NCT02021292|Macitentan|macitentan|mesh-list
138303788|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138303789|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138303790|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303791|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138303792|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
138303793|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
138303794|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138303795|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303796|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
138303797|NCT02043132|Coagulants|coagulants|mesh-ancestor
138303798|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
138303799|NCT02059434|LAS190792|las190792|mesh-list
138303800|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138303801|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
138303802|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303803|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303807|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138303808|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303809|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303810|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303811|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138303812|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138303813|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138303814|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138303815|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303816|NCT02059278|Latanoprost|latanoprost|mesh-list
138303817|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138303818|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138303819|NCT02020512|Bimatoprost|bimatoprost|mesh-list
138303820|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138303822|NCT02019420|Tedizolid|tedizolid|mesh-list
138303823|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
138303824|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138303825|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303826|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138303827|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303828|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303829|NCT02058966|Entacapone|entacapone|mesh-list
138303830|NCT02058966|Methamphetamine|methamphetamine|mesh-list
138303831|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138303832|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138303833|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138303834|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303835|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303836|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138303837|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303838|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
138303839|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
138303840|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303841|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
138303842|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303843|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303844|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138303845|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138303846|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138303847|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138303848|NCT02017860|Everolimus|everolimus|mesh-list
138303849|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138303850|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138303851|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303852|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303853|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303854|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
138303855|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303857|NCT02040870|Ceritinib|ceritinib|mesh-list
138303858|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303859|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138303860|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303861|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303862|NCT04720716|Sorafenib|sorafenib|mesh-list
138303863|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303864|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138303865|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303866|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303867|NCT02039778|Temozolomide|temozolomide|mesh-list
138303868|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138303870|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303871|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303872|NCT02015676|Paclitaxel|paclitaxel|mesh-list
138303873|NCT02015676|Trastuzumab|trastuzumab|mesh-list
138303875|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303876|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138303877|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303878|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138303879|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303880|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138303882|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
138303883|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303884|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138303885|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303886|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303887|NCT04678362|Avelumab|avelumab|mesh-list
138303888|NCT04678362|Talazoparib|talazoparib|mesh-list
138303889|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138303890|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303891|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138303892|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303893|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303894|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
138303895|NCT04678050|Ketamine|ketamine|mesh-list
138303896|NCT04678050|Propofol|propofol|mesh-list
138303897|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138303898|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138303899|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303900|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303901|NCT04678050|Analgesics|analgesics|mesh-ancestor
138303902|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
138303903|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303904|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138303905|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138303906|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138303907|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303908|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303909|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303910|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138303911|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
138303912|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
138303913|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138303914|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138303915|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138303916|NCT02038920|Vedolizumab|vedolizumab|mesh-list
138303917|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303918|NCT02014740|Metformin|metformin|mesh-list
138303919|NCT02014740|Liraglutide|liraglutide|mesh-list
138303920|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138303921|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303922|NCT02014740|Incretins|incretins|mesh-ancestor
138303923|NCT02014740|Hormones|hormones|mesh-ancestor
138303924|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303925|NCT02014584|Dutasteride|dutasteride|mesh-list
138303926|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138303927|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138303928|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303929|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303930|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
138303931|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303932|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303933|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138303934|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
138303935|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303938|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303939|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
138303940|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
138303941|NCT02057250|Methotrexate|methotrexate|mesh-list
138303942|NCT02057250|Leflunomide|leflunomide|mesh-list
138303944|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
138303945|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138303946|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303947|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138303948|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
138303949|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303950|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303951|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138303952|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138303953|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138303954|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138303955|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
138303956|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138303957|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138303958|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
138303959|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138303960|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138303961|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303962|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138303963|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138303964|NCT02057250|Analgesics|analgesics|mesh-ancestor
138303965|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
138303966|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303967|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303968|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303970|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
138303971|NCT02036502|Lenalidomide|lenalidomide|mesh-list
138303972|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138303973|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
138303974|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
138303975|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303976|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303977|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303978|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
138303980|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138303981|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138303982|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303983|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138303984|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138303985|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303986|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
138303987|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138303988|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138303989|NCT02036502|Growth Substances|growth substances|mesh-ancestor
138303990|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
138303991|NCT02056626|Carvedilol|carvedilol|mesh-list
138303992|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138303993|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138303994|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
138303995|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138303996|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303997|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138303998|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138303999|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
138304000|NCT02056626|Protective Agents|protective agents|mesh-ancestor
138304004|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
138304005|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138304006|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138304008|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304009|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304010|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138304011|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138304012|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304013|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304014|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304015|NCT02034552|Prednisone|prednisone|mesh-list
138304016|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
138304017|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138304018|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304019|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
138304021|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304022|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304023|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138304025|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138304027|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304028|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
138304029|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138304030|NCT02011386|Golimumab|golimumab|mesh-list
138304031|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138304032|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304033|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304034|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
138304035|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304036|NCT02034162|Mebendazole|mebendazole|mesh-list
138304037|NCT02034162|Piperazine|piperazine|mesh-list
138304038|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
138304039|NCT02034162|DMP 777|dmp 777|mesh-list
138304040|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
138304041|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
138304042|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138304043|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304044|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
138304045|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304046|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138304047|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304048|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304049|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304050|NCT02034006|Ranibizumab|ranibizumab|mesh-list
138304051|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304052|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304053|NCT02034006|Growth Substances|growth substances|mesh-ancestor
138304054|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304055|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304056|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304057|NCT02052960|Cisplatin|cisplatin|mesh-list
138304058|NCT02052960|Fluorouracil|fluorouracil|mesh-list
138304059|NCT02052960|Cetuximab|cetuximab|mesh-list
138304060|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304061|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
138304062|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304063|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304064|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304065|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
138304066|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304067|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304068|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138304069|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
138304070|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304071|NCT02052414|Gabapentin|gabapentin|mesh-list
138304072|NCT02052414|Analgesics|analgesics|mesh-ancestor
138304073|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
138304074|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304075|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304076|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
138304077|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138304078|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138304079|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304080|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138304081|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138304082|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138304083|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304084|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304085|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
138304086|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138304087|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
138304088|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304089|NCT01363440|Aflibercept|aflibercept|mesh-list
138304090|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304091|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304092|NCT01363440|Growth Substances|growth substances|mesh-ancestor
138304093|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304094|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304095|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304096|NCT02007096|Bupivacaine|bupivacaine|mesh-list
138304097|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138304098|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
138304099|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304100|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304104|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138304105|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138304106|NCT02006706|Prednisolone|prednisolone|mesh-list
138304107|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
138304108|NCT02006706|Rituximab|rituximab|mesh-list
138304109|NCT02006706|Methotrexate|methotrexate|mesh-list
138304110|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138304111|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
138304112|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304113|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304114|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
138304115|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304116|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304117|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138304118|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
138304119|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138304120|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304121|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
138304122|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304123|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304124|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304125|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138304126|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304127|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138304128|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304129|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
138304130|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
138304131|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304132|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138304133|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
138304134|NCT02006706|Hormones|hormones|mesh-ancestor
138304135|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304136|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138304137|NCT02006706|Protective Agents|protective agents|mesh-ancestor
138304139|NCT02049138|Upadacitinib|upadacitinib|mesh-list
138304140|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138304141|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304142|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304143|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304145|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138304146|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304147|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304148|NCT02048904|Incretins|incretins|mesh-ancestor
138304149|NCT02048904|Hormones|hormones|mesh-ancestor
138304150|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304151|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138304152|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304153|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304154|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304155|NCT02006628|Cannabidiol|cannabidiol|mesh-list
138304156|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
138304157|NCT02029638|Acetaminophen|acetaminophen|mesh-list
138304158|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
138304159|NCT02029638|Promethazine|promethazine|mesh-list
138304160|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
138304161|NCT02029638|Prednisone|prednisone|mesh-list
138304162|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
138304163|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
138304164|NCT02029638|Fludarabine|fludarabine|mesh-list
138304165|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
138304166|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138304167|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304168|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
138304169|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304170|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304171|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138304172|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
138304173|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304174|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304175|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138304176|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304177|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
138304178|NCT02029638|Hormones|hormones|mesh-ancestor
138304179|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304180|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138304181|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138304182|NCT02029638|Analgesics|analgesics|mesh-ancestor
138304183|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
138304184|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304185|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
138304186|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138304187|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138304188|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
138304189|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304190|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304191|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304192|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
138304193|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
138304194|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138304195|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138304196|NCT02029638|Protective Agents|protective agents|mesh-ancestor
138304197|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138304198|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138304199|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304200|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
138304201|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
138304202|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138304203|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
138304204|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
138304205|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304206|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138304207|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
138304208|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304210|NCT02047734|Interferon-beta|interferon-beta|mesh-list
138304211|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
138304212|NCT02047734|Ozanimod|ozanimod|mesh-list
138304213|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304217|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304218|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138304219|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138304220|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304221|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304222|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138304223|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304224|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304225|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
138304226|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
138304227|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
138304228|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304229|NCT01994382|Rituximab|rituximab|mesh-list
138304230|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304231|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304232|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
138304233|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304234|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304235|NCT02003898|Insulin|insulin|mesh-list
138304236|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304237|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304239|NCT01994226|Colchicine|colchicine|mesh-list
138304240|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138304241|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138304242|NCT01994226|Analgesics|analgesics|mesh-ancestor
138304243|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
138304244|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304245|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304246|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304247|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304248|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
138304249|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138304250|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304251|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304252|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
138304253|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304255|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304256|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
138304258|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138304259|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138304260|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138304261|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304262|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304263|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304264|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304265|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304266|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138304267|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304268|NCT02023866|Cysteamine|cysteamine|mesh-list
138304269|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138304271|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138304272|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138304273|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138304274|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138304275|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304276|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304277|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304278|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138304279|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138304280|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
138304281|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304282|NCT01990560|Mifepristone|mifepristone|mesh-list
138304283|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138304286|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304287|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138304288|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138304289|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138304290|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
138304291|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138304293|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
138304294|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304295|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
138304296|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138304297|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138304299|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
138304300|NCT01967628|Vitamins|vitamins|mesh-ancestor
138304301|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
138304302|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304303|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138304304|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138304306|NCT01998906|Doxorubicin|doxorubicin|mesh-list
138304307|NCT01998906|Trastuzumab|trastuzumab|mesh-list
138304308|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138304309|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304310|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
138304311|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304312|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
138304313|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304314|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138304315|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138304316|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138304317|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304318|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304319|NCT01967550|Diclofenac|diclofenac|mesh-list
138304320|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138304321|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138304322|NCT01967550|Analgesics|analgesics|mesh-ancestor
138304323|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
138304324|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304325|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304326|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304327|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304328|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138304329|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304330|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304331|NCT01989546|Talazoparib|talazoparib|mesh-list
138304332|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138304333|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304334|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304335|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304336|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138304337|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
138304340|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
138304341|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304342|NCT01965834|Fenofibrate|fenofibrate|mesh-list
138304343|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
138304344|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138304345|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
138304346|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304347|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138304348|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138304349|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138304350|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304351|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304352|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304353|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304354|NCT01987596|Lenograstim|lenograstim|mesh-list
138304355|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138304356|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
138304357|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304359|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138304360|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
138304361|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304362|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304363|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138304364|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138304365|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304366|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304367|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304368|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
138304370|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138304371|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
138304372|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304375|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
138304376|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
138304377|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138304378|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304379|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304380|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304381|NCT01946412|Ivacaftor|ivacaftor|mesh-list
138304382|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138304383|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304384|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304385|NCT01945866|Dexamethasone|dexamethasone|mesh-list
138304386|NCT01945866|Ranibizumab|ranibizumab|mesh-list
138304387|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304388|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
138304389|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
138304390|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304391|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304392|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138304393|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
138304394|NCT01945866|Hormones|hormones|mesh-ancestor
138304395|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304396|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138304397|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304398|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304399|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304400|NCT01945866|Growth Substances|growth substances|mesh-ancestor
138304401|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304402|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138304403|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138304404|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138304405|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304406|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304407|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138304408|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138304409|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138304410|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138304411|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
138304412|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304413|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304414|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138304415|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138304416|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
138304417|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138304418|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138304419|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
138304421|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304422|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304423|NCT01945242|Incretins|incretins|mesh-ancestor
138304425|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304426|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138304431|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304433|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138304434|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
138304435|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
138304436|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
138304437|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
138304438|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304439|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304441|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138304442|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304443|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138304444|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304445|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138304446|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304447|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
138304448|NCT01985334|Bromides|bromides|mesh-list
138304449|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
138304450|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304451|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138304452|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138304453|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138304454|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304455|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304456|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304457|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
138304458|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
138304459|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304460|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304461|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138304463|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304464|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304465|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304466|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138304467|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
138304468|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304469|NCT01942590|Clenbuterol|clenbuterol|mesh-list
138304470|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138304471|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138304472|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
138304473|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304474|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304475|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304476|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138304477|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
138304478|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304479|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138304480|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
138304481|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
138304483|NCT01984242|Atezolizumab|atezolizumab|mesh-list
138304484|NCT01984242|Sunitinib|sunitinib|mesh-list
138304485|NCT01984242|Antibodies|antibodies|mesh-list
138304486|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138304487|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304488|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304490|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304492|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304493|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304494|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
138304495|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138304496|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304497|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304498|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304499|NCT01960842|Levodopa|levodopa|mesh-list
138304500|NCT01960842|Carbidopa|carbidopa|mesh-list
138304501|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138304502|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138304503|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138304504|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
138304505|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304506|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304507|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304508|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138304509|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304510|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138304511|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
138304512|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
138304514|NCT01984164|Candesartan cilexetil|candesartan cilexetil|mesh-list
138304515|NCT01984164|Lisinopril|lisinopril|mesh-list
138304516|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138304517|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138304518|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138304519|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304520|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138304521|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304522|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304523|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138304524|NCT01984164|Protective Agents|protective agents|mesh-ancestor
138304525|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304526|NCT01983774|Esomeprazole|esomeprazole|mesh-list
138304527|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138304528|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138304529|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138304530|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304531|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304532|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
138304533|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
138304534|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304535|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
138304536|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304537|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304538|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138304539|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
138304540|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304542|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138304543|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138304544|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138304545|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
138304546|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304547|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304548|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304551|NCT01960296|Clopidogrel|clopidogrel|mesh-list
138304552|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138304553|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138304554|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138304555|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138304556|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
138304557|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304558|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304559|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304560|NCT01939314|Bupivacaine|bupivacaine|mesh-list
138304561|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
138304562|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
138304563|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304564|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304565|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
138304566|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304567|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138304568|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
138304569|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304570|NCT01939002|Interferons|interferons|mesh-list
138304571|NCT01939002|Interferon-beta|interferon-beta|mesh-list
138304572|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
138304573|NCT01939002|Naproxen|naproxen|mesh-list
138304574|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138304575|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138304576|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304577|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
138304578|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304579|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138304580|NCT01939002|Analgesics|analgesics|mesh-ancestor
138304581|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
138304582|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304583|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304584|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304585|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
138304586|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138304587|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304588|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304589|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
138304590|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138304591|NCT01938846|Paclitaxel|paclitaxel|mesh-list
138304592|NCT01938846|Exemestane|exemestane|mesh-list
138304593|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138304594|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304595|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
138304596|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304597|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
138304598|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304599|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138304600|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138304601|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304602|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138304603|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215924|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304604|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304605|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304606|NCT01960140|Simvastatin|simvastatin|mesh-list
138304607|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138304608|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138304609|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
138304610|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304611|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138304612|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138304613|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304614|NCT01980888|Rituximab|rituximab|mesh-list
138304615|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138304616|NCT01980888|Idelalisib|idelalisib|mesh-list
138304617|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304618|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304619|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
138304620|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304622|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138304623|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
138304626|NCT04650282|Lidocaine|lidocaine|mesh-list
138304627|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
138304628|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
138304629|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304630|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304631|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
138304632|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304633|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138304634|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138304635|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138304636|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304637|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304638|NCT01937364|Baclofen|baclofen|mesh-list
138304639|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138304640|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304641|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138304642|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304643|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138304644|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
138304645|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
138304646|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304647|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304648|NCT01979952|Nintedanib|nintedanib|mesh-list
138304649|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304650|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304651|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304652|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304653|NCT01999218|Metformin|metformin|mesh-list
138304654|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138304655|NCT01999218|Glimepiride|glimepiride|mesh-list
138304656|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
138304657|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304658|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304659|NCT01999218|Incretins|incretins|mesh-ancestor
138304660|NCT01999218|Hormones|hormones|mesh-ancestor
138304661|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304662|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138304663|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304664|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304665|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304666|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138304667|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304668|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
138304669|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138304670|NCT01936974|Bevacizumab|bevacizumab|mesh-list
138304671|NCT01936974|Carboplatin|carboplatin|mesh-list
138304672|NCT01936974|Gemcitabine|gemcitabine|mesh-list
138304673|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
138304674|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304675|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304676|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304677|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304678|NCT01936974|Growth Substances|growth substances|mesh-ancestor
138304679|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304680|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304681|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304682|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
138304683|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304684|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
138304685|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
138304686|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138304689|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304690|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138304691|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
138304692|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
138304693|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138304695|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304696|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304697|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138304698|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138304699|NCT01979016|Emollients|emollients|mesh-list
138304700|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304701|NCT01935336|Ponatinib|ponatinib|mesh-list
138304702|NCT01935336|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138304703|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304704|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304705|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304706|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304707|NCT01978236|Trametinib|trametinib|mesh-list
138304708|NCT01978236|Dabrafenib|dabrafenib|mesh-list
138304709|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304710|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304711|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304712|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304713|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138304714|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304716|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304717|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138304718|NCT01934556|Growth Substances|growth substances|mesh-ancestor
138304719|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304720|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
138304721|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304722|NCT04411212|Lenograstim|lenograstim|mesh-list
138304723|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138304724|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
138304725|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304726|NCT01620138|Cabergoline|cabergoline|mesh-list
138304727|NCT01620138|Pasireotide|pasireotide|mesh-list
138304728|NCT01620138|Hormones|hormones|mesh-ancestor
138304729|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304730|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304731|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138304732|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138304733|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
138304734|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
138304735|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215925|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366519|NCT06103188|GABA Modulators|gaba modulators|mesh-ancestor
138366520|NCT06103188|GABA Agents|gaba agents|mesh-ancestor
138366521|NCT06103188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366522|NCT06100497|Paclitaxel|paclitaxel|mesh-list
138366523|NCT06100497|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138366524|NCT06100497|Pembrolizumab|pembrolizumab|mesh-list
138366525|NCT06100497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138366526|NCT06100497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366527|NCT06100497|Tubulin Modulators|tubulin modulators|mesh-ancestor
138366528|NCT06100497|Antimitotic Agents|antimitotic agents|mesh-ancestor
138304736|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304738|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138304739|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
138304740|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304741|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304742|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138304743|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138304744|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304745|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304746|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304747|NCT01932762|Ribavirin|ribavirin|mesh-list
138304748|NCT01932762|Grazoprevir|grazoprevir|mesh-list
138304749|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
138304750|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304751|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
138304752|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304753|NCT01977456|Eptifibatide|eptifibatide|mesh-list
138304754|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138304755|NCT01957644|Azacitidine|azacitidine|mesh-list
138304756|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304757|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
138304758|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304759|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304760|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304761|NCT01931202|Escitalopram|escitalopram|mesh-list
138304762|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138304763|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138304764|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304765|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304766|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304767|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
138304768|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304769|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
138304770|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138304771|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304772|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138304773|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
138304774|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304775|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304776|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304777|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304778|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138304779|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304780|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304781|NCT01930188|Incretins|incretins|mesh-ancestor
138304782|NCT01930188|Hormones|hormones|mesh-ancestor
138304783|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304784|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138304785|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304786|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304787|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304789|NCT01976364|Tofacitinib|tofacitinib|mesh-list
138304790|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138304791|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
138304792|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138304793|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304794|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304795|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
138304796|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304797|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304798|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
138304799|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304800|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138304802|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
138304803|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304804|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138304806|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304808|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
138304809|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304810|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138304811|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138304812|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304813|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304814|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138304815|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
138304816|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304817|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304818|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138304819|NCT01928940|Trametinib|trametinib|mesh-list
138304820|NCT01928940|Dabrafenib|dabrafenib|mesh-list
138304821|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304822|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138304823|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304824|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304825|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
138304829|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
138304830|NCT01975272|Trace Elements|trace elements|mesh-ancestor
138304831|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
138304832|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304833|NCT01975272|Hematinics|hematinics|mesh-ancestor
138304834|NCT03965039|Fluorides|fluorides|mesh-list
138304835|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
138304836|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
138304837|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
138304838|NCT03965039|Protective Agents|protective agents|mesh-ancestor
138304839|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304840|NCT03961295|Vedolizumab|vedolizumab|mesh-list
138304841|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138304842|NCT03935399|Oxytocin|oxytocin|mesh-list
138304843|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
138304844|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138304845|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304846|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138304847|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
138304848|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304849|NCT03993119|Anticoagulants|anticoagulants|mesh-list
138304850|NCT03910439|Avelumab|avelumab|mesh-list
138304851|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304852|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304853|NCT03895307|Anesthetics|anesthetics|mesh-list
138304854|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
138304855|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304856|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366532|NCT06100497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138366533|NCT06073184|Progestins|progestins|mesh-list
138366534|NCT06073184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366535|NCT06073184|Hormones|hormones|mesh-ancestor
138366536|NCT06073184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366537|NCT06066905|Azacitidine|azacitidine|mesh-list
138366538|NCT06066905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366539|NCT06066905|Antimetabolites|antimetabolites|mesh-ancestor
138366540|NCT06066905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304857|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
138304858|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366541|NCT06066905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366542|NCT06066905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366543|NCT06049576|Nivolumab|nivolumab|mesh-list
138366544|NCT06049576|Ipilimumab|ipilimumab|mesh-list
138304859|NCT03888755|Icatibant|icatibant|mesh-list
138304860|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138304861|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138304863|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
138304864|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304865|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304866|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304867|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138304868|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138304869|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138304870|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304871|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138304872|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138304873|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
138304874|NCT00378755|Bortezomib|bortezomib|mesh-list
138304875|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304877|NCT00378833|Niacinamide|niacinamide|mesh-list
138304878|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
138304879|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138304880|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
138304881|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304882|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138304883|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
138304885|NCT00378833|Vitamins|vitamins|mesh-ancestor
138304886|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
138304887|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304888|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
138304889|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138304890|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138304891|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138304892|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304893|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304894|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304895|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304898|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304899|NCT03888365|Treprostinil|treprostinil|mesh-list
138304900|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138304901|NCT00377975|Pioglitazone|pioglitazone|mesh-list
138304902|NCT00377975|Ephedrine|ephedrine|mesh-list
138304903|NCT00377975|Caffeine|caffeine|mesh-list
138304904|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138304905|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304906|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138304907|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138304908|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304909|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304910|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138304911|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138304912|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
138304913|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304914|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
138304915|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
138304916|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304917|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138304918|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138304919|NCT02994251|Gemcitabine|gemcitabine|mesh-list
138304920|NCT02994251|Doxorubicin|doxorubicin|mesh-list
138304921|NCT02994251|Mitomycins|mitomycins|mesh-list
138304922|NCT02994251|Mitomycin|mitomycin|mesh-list
138304923|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304924|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138304925|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
138304926|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304927|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138304928|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138304929|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138304930|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304931|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
138304932|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138304933|NCT02936999|Vitamin D|vitamin d|mesh-list
138304934|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
138304935|NCT02936999|Vitamins|vitamins|mesh-ancestor
138304936|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
138304937|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304939|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138304941|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
138304942|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
138304943|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304944|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304945|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
138304946|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304947|NCT00378443|Prednisone|prednisone|mesh-list
138304948|NCT00378443|Losartan|losartan|mesh-list
138304949|NCT00378443|Cilazapril|cilazapril|mesh-list
138304950|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304951|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
138304952|NCT00378443|Hormones|hormones|mesh-ancestor
138304953|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138304954|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304955|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138304956|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304957|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138304958|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138304959|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138304960|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138304961|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304962|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138304963|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304964|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304965|NCT01340573|Interferons|interferons|mesh-list
138304966|NCT01340573|Ribavirin|ribavirin|mesh-list
138304967|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138304968|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304969|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
138304970|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304971|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
138304972|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304973|NCT01340885|Rivastigmine|rivastigmine|mesh-list
138304974|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138304975|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138304976|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138304977|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304978|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304979|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
138304980|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304982|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138304983|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304984|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138304985|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138304986|NCT01340885|Protective Agents|protective agents|mesh-ancestor
138304987|NCT01326923|Cetuximab|cetuximab|mesh-list
138304988|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138304989|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138304990|NCT03855059|Dexamethasone|dexamethasone|mesh-list
138304991|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
138304992|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138304993|NCT03855059|BB 1101|bb 1101|mesh-list
138304994|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304995|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
138304996|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
138304997|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304998|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304999|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305000|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
138305001|NCT03855059|Hormones|hormones|mesh-ancestor
138305002|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305003|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305004|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305006|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305007|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305009|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138305010|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305011|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
138305012|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305013|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
138305014|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138305015|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138305016|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305017|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305018|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
138305019|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305020|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305021|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138305022|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305023|NCT02708849|Lamotrigine|lamotrigine|mesh-list
138305024|NCT02708849|Ketamine|ketamine|mesh-list
138305025|NCT02708849|Analgesics|analgesics|mesh-ancestor
138305026|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
138305027|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305028|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305029|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138305030|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138305031|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
138305032|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
138305033|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305034|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138305035|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138305036|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305037|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305038|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
138305039|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138305040|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305041|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138305042|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138305043|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138305044|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138305045|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138305046|NCT01222871|Triamcinolone|triamcinolone|mesh-list
138305047|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305048|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
138305049|NCT01222871|Hormones|hormones|mesh-ancestor
138305050|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305051|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305052|NCT01219673|Minocycline|minocycline|mesh-list
138305053|NCT01219673|Modafinil|modafinil|mesh-list
138305054|NCT01219673|Bupropion|bupropion|mesh-list
138305056|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
138305057|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138305058|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138305059|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138305060|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305061|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305062|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
138305063|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305064|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305065|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138305066|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138305067|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305068|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305069|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305070|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305071|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138305072|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138305073|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138305074|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
138305075|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138305076|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138305077|NCT01216631|Prednisolone|prednisolone|mesh-list
138305078|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
138305080|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138305081|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
138305082|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305083|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
138305084|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
138305085|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305088|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
138305089|NCT01216631|Hormones|hormones|mesh-ancestor
138305090|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305091|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138305092|NCT01216631|Protective Agents|protective agents|mesh-ancestor
138305093|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305094|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305095|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138305096|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305097|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305098|NCT02693717|Pemetrexed|pemetrexed|mesh-list
138305099|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305100|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305101|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305102|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138305103|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305104|NCT03860753|Pioglitazone|pioglitazone|mesh-list
138305105|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138305106|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305107|NCT02687165|Cycloserine|cycloserine|mesh-list
138305108|NCT02687165|Milnacipran|milnacipran|mesh-list
138305109|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
138305110|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138305111|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305112|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138305114|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305115|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
138305116|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305117|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138305118|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138305119|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305121|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305122|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305123|NCT02687165|Analgesics|analgesics|mesh-ancestor
138305124|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
138305125|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305126|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
138305127|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138305128|NCT01169753|Modafinil|modafinil|mesh-list
138305129|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305130|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305131|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138305132|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138305133|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138305134|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305135|NCT02654639|Bevacizumab|bevacizumab|mesh-list
138305136|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305137|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305138|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305139|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305140|NCT02654639|Growth Substances|growth substances|mesh-ancestor
138305141|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305142|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305144|NCT02634827|Midostaurin|midostaurin|mesh-list
138305145|NCT02634827|Staurosporine|staurosporine|mesh-list
138305146|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138305147|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
138305148|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305149|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305150|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305151|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305152|NCT02506985|Warfarin|warfarin|mesh-list
138305153|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
138305154|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
138305155|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138305157|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138305158|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
138305159|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305160|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305161|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
138305162|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305163|NCT01133639|Ketorolac|ketorolac|mesh-list
138305164|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138305166|NCT01133639|Analgesics|analgesics|mesh-ancestor
138305167|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
138305168|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305169|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305170|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305171|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305172|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138305173|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305174|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305176|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305177|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305178|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305179|NCT00378911|Growth Substances|growth substances|mesh-ancestor
138305180|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305181|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305182|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305183|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305184|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305185|NCT03822377|Ticagrelor|ticagrelor|mesh-list
138305186|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138305187|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138305188|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138305189|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138305190|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
138305191|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305192|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305193|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305194|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
138305195|NCT02501759|Antidotes|antidotes|mesh-ancestor
138305196|NCT02501759|Protective Agents|protective agents|mesh-ancestor
138305197|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305198|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
138305199|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
138305200|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305201|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138305202|NCT02499887|Prednisone|prednisone|mesh-list
138305203|NCT02499887|Albuterol|albuterol|mesh-list
138305204|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305205|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
138305206|NCT02499887|Hormones|hormones|mesh-ancestor
138305207|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305208|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305210|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305211|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138305212|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
138305213|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305214|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138305215|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
138305216|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
138305217|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138305218|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138305220|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138305221|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
138305222|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305223|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305225|NCT02504099|Ribavirin|ribavirin|mesh-list
138305226|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138305227|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138305228|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
138305229|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305230|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305231|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138305232|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305233|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
138305234|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305235|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138305236|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138305237|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
138305238|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138305239|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305240|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305241|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305242|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305243|NCT01094561|Secretin|secretin|mesh-list
138305244|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305245|NCT01094561|Hormones|hormones|mesh-ancestor
138305246|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305247|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305248|NCT01074437|Prednisolone|prednisolone|mesh-list
138305249|NCT01074437|Propranolol|propranolol|mesh-list
138305250|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305251|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
138305252|NCT01074437|Hormones|hormones|mesh-ancestor
138305253|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305254|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305255|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305256|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305257|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138305258|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138305259|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138305260|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305261|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305262|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138305263|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138305264|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
138305266|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138305267|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
138305268|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305269|NCT03807245|Antacids|antacids|mesh-ancestor
138305270|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305271|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305272|NCT03796013|Entrectinib|entrectinib|mesh-list
138305273|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305274|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305275|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305276|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
138305277|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138305278|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305279|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305280|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305281|NCT03793751|Analgesics|analgesics|mesh-ancestor
138305282|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
138305283|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305284|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138305285|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138305286|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138305288|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305289|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305290|NCT01016561|Cisplatin|cisplatin|mesh-list
138305291|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305292|NCT01009931|Dexamethasone|dexamethasone|mesh-list
138305293|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
138305294|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
138305295|NCT01009931|Choline|choline|mesh-list
138305296|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138305297|NCT01009931|BB 1101|bb 1101|mesh-list
138305298|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305299|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
138305300|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
138305301|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305302|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305306|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305307|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305308|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305309|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
138305310|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305311|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305312|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
138305313|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305314|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
138305315|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305316|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
138305317|NCT01009931|Analgesics|analgesics|mesh-ancestor
138305318|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
138305319|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138305320|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305321|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305322|NCT03792191|Fentanyl|fentanyl|mesh-list
138305323|NCT03792191|Bupivacaine|bupivacaine|mesh-list
138305324|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
138305325|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
138305326|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305327|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305328|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
138305329|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305330|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138305331|NCT03792191|Narcotics|narcotics|mesh-ancestor
138305332|NCT03792191|Analgesics|analgesics|mesh-ancestor
138305333|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138305334|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138305335|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
138305336|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138305337|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138305338|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305339|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
138305340|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305341|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305342|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138305343|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305344|NCT00983645|Cyclosporine|cyclosporine|mesh-list
138305346|NCT00983645|Cyclosporins|cyclosporins|mesh-list
138305347|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138305348|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
138305349|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305350|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138305351|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305352|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305353|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
138305354|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305355|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305356|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305359|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305360|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
138305361|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305362|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305363|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138305364|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305365|NCT00957827|Cephalexin|cephalexin|mesh-list
138305366|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305367|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305368|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
138305369|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
138305370|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305371|NCT00962429|Protective Agents|protective agents|mesh-ancestor
138305372|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305373|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
138305374|NCT00962429|Vitamins|vitamins|mesh-ancestor
138305375|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
138305376|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138305377|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305378|NCT00920309|Sirolimus|sirolimus|mesh-list
138305379|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305380|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305381|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138305382|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305383|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
138305384|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138305385|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
138305386|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366553|NCT06048809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366554|NCT06044142|Curcumin|curcumin|mesh-list
138305387|NCT02075411|Bupivacaine|bupivacaine|mesh-list
138305388|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
138366555|NCT06044142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138366556|NCT06044142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305389|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
138305390|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305391|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305392|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
138305393|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305394|NCT03753113|Minoxidil|minoxidil|mesh-list
138305395|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138305396|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
138305397|NCT02075021|Paclitaxel|paclitaxel|mesh-list
138305398|NCT02075021|Lenalidomide|lenalidomide|mesh-list
138305399|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138305400|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305401|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138305402|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138305403|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138305404|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305405|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
138305406|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305407|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305408|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305409|NCT02075021|Growth Substances|growth substances|mesh-ancestor
138305410|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305411|NCT02057237|Mitotane|mitotane|mesh-list
138305412|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305413|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305414|NCT00378677|Cyclosporine|cyclosporine|mesh-list
138305415|NCT00378677|Cyclosporins|cyclosporins|mesh-list
138305416|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305417|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305418|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138305419|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
138305420|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305421|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
138305422|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305423|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305425|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138305426|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
138305427|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138305428|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138305429|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138305430|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305431|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305432|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138305433|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305434|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305435|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138305436|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305437|NCT02017379|Erythromycin|erythromycin|mesh-list
138305438|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
138305439|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138305440|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
138305441|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305442|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305443|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305444|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138305446|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305448|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
138305449|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
138305450|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305451|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305452|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
138305453|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305454|NCT00825227|Modafinil|modafinil|mesh-list
138305455|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305456|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305457|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138305458|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138305459|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138305460|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305462|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138305463|NCT01978535|Trace Elements|trace elements|mesh-ancestor
138305464|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
138305465|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305466|NCT01978535|Hematinics|hematinics|mesh-ancestor
138305467|NCT00808769|Omeprazole|omeprazole|mesh-list
138305468|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138305469|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138305470|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305471|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138305472|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305473|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305474|NCT00379067|Tamsulosin|tamsulosin|mesh-list
138305475|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138305476|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138305477|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138305478|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
138305479|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305480|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305481|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305482|NCT00379067|Urological Agents|urological agents|mesh-ancestor
138305483|NCT00378287|Rabeprazole|rabeprazole|mesh-list
138305484|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138305485|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305486|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138305487|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305488|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305489|NCT01938833|Paclitaxel|paclitaxel|mesh-list
138305490|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138305491|NCT01938833|Romidepsin|romidepsin|mesh-list
138305492|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138305493|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305494|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138305495|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138305496|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138305497|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305498|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138305499|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138305500|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305501|NCT01893359|Riboflavin|riboflavin|mesh-list
138305502|NCT01893359|Dextrans|dextrans|mesh-list
138305503|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138305504|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138305505|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
138305506|NCT01893359|Vitamins|vitamins|mesh-ancestor
138305507|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
138305508|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305509|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138305510|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305511|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
138305512|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
138305513|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
138305514|NCT00795665|Bevacizumab|bevacizumab|mesh-list
138305515|NCT00795665|Carmustine|carmustine|mesh-list
138305516|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305517|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305518|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305519|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305520|NCT00795665|Growth Substances|growth substances|mesh-ancestor
138305521|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305522|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305523|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138305524|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
138305525|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305526|NCT00791843|Hormones|hormones|mesh-list
138305527|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138305528|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305529|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305530|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138305531|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
138305532|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305533|NCT00780455|Interferons|interferons|mesh-list
138305534|NCT00780455|Interferon-beta|interferon-beta|mesh-list
138305535|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
138305536|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305539|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
138305540|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305541|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138305543|NCT00755261|Doxorubicin|doxorubicin|mesh-list
138305544|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305545|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305546|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305547|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305548|NCT00755261|Growth Substances|growth substances|mesh-ancestor
138305549|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305550|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305551|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138305552|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138305553|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138305554|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305555|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305556|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
138305557|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
138305558|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305559|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305560|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305561|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138305562|NCT00746603|Simvastatin|simvastatin|mesh-list
138305563|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138305564|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305565|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
138305566|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305567|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305568|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138305569|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305570|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138305571|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305572|NCT00716807|Nalbuphine|nalbuphine|mesh-list
138305573|NCT00716807|Naloxone|naloxone|mesh-list
138305574|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138305575|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305576|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
138305577|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305578|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138305579|NCT00716807|Narcotics|narcotics|mesh-ancestor
138305580|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305581|NCT00716807|Analgesics|analgesics|mesh-ancestor
138305584|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138305585|NCT03426137|Narcotics|narcotics|mesh-ancestor
138305586|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305587|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305588|NCT03426137|Analgesics|analgesics|mesh-ancestor
138305589|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
138305590|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305591|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138305592|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305593|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305594|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305595|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138305596|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305597|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305598|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138305599|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305600|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305601|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138305602|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138305603|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305604|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305605|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
138305606|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305607|NCT00669461|Lubiprostone|lubiprostone|mesh-list
138305608|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138305609|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305610|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305611|NCT00673595|Varenicline|varenicline|mesh-list
138305612|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138305613|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138305614|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
138305615|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305616|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305617|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305618|NCT03248141|Factor VIII|factor viii|mesh-list
138305619|NCT03248141|Coagulants|coagulants|mesh-ancestor
138305620|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
138305621|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305622|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138305623|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138305624|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
138305626|NCT01754987|Vitamins|vitamins|mesh-ancestor
138305627|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
138305628|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305629|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305630|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305631|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305632|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305633|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
138305634|NCT01754987|Protective Agents|protective agents|mesh-ancestor
138305635|NCT00652457|Memantine|memantine|mesh-list
138305636|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138305637|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138305638|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
138305639|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305640|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305641|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305642|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138305643|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138305645|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305646|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305647|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138305648|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305649|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305650|NCT00616577|Ropivacaine|ropivacaine|mesh-list
138305651|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
138305652|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
138305653|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305654|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305655|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
138305656|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305657|NCT00616343|Zonisamide|zonisamide|mesh-list
138305658|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
138305659|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138305660|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305661|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305662|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138305663|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305664|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
138305665|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138305666|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
138305667|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305668|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305669|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138305670|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
138305671|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138305672|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
138305673|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305674|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305675|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138305676|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
138305677|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
138305678|NCT05599919|Protective Agents|protective agents|mesh-ancestor
138305680|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138305681|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138305682|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138305683|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305684|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138305685|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305686|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
138305688|NCT00608465|Eplerenone|eplerenone|mesh-list
138305689|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138305690|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
138305691|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305692|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305693|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138305694|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138305695|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138305696|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305697|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305698|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138305699|NCT00608465|Diuretics|diuretics|mesh-ancestor
138305700|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
138305701|NCT00608777|Betamethasone|betamethasone|mesh-list
138305702|NCT00608777|Calcipotriene|calcipotriene|mesh-list
138305703|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305704|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
138305705|NCT00608777|Hormones|hormones|mesh-ancestor
138305706|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305707|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305708|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138305709|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
138305710|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305711|NCT00379457|Dactinomycin|dactinomycin|mesh-list
138305712|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
138305713|NCT00379457|Ifosfamide|ifosfamide|mesh-list
138305714|NCT00379457|Carboplatin|carboplatin|mesh-list
138305715|NCT00379457|Doxorubicin|doxorubicin|mesh-list
138305716|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138305717|NCT00379457|Etoposide|etoposide|mesh-list
138305718|NCT00379457|Vincristine|vincristine|mesh-list
138305719|NCT00379457|Topotecan|topotecan|mesh-list
138305720|NCT00379457|Vinorelbine|vinorelbine|mesh-list
138305721|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138305722|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
138305723|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305724|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305725|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138305727|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305728|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305729|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138305730|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138305731|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138305732|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138305733|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305734|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138305735|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
138305736|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
138305737|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
138305738|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138305739|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305740|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305741|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138305742|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305744|NCT01629329|Acetaminophen|acetaminophen|mesh-list
138305745|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
138305746|NCT01629329|Caffeine|caffeine|mesh-list
138305747|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138305748|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305749|NCT01629329|Analgesics|analgesics|mesh-ancestor
138305750|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
138305751|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305752|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305753|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305754|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305755|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138305756|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138305757|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305758|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138305759|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138305760|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305761|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
138305762|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305764|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138305765|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138305766|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
138305767|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305768|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
138305769|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
138305770|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138305771|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138305772|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138305773|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305774|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138305775|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138305776|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
138305777|NCT01606709|Leuprolide|leuprolide|mesh-list
138305778|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138305779|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
138305780|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138305781|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305782|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305783|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305784|NCT00423059|Bevacizumab|bevacizumab|mesh-list
138305785|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305787|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305788|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305789|NCT00423059|Growth Substances|growth substances|mesh-ancestor
138305790|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305791|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305792|NCT00585611|Atorvastatin|atorvastatin|mesh-list
138305793|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138305794|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305795|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
138305796|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305797|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305798|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138305799|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305800|NCT00379691|Phenylephrine|phenylephrine|mesh-list
138305801|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
138305802|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138305803|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
138305804|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
138305805|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305806|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305807|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
138305808|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138305809|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
138305810|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
138305811|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138305812|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138305813|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138305814|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138305815|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305816|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305818|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
138305819|NCT01685333|Hematinics|hematinics|mesh-ancestor
138305820|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138305821|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138305822|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305823|NCT00546455|Fenretinide|fenretinide|mesh-list
138305824|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305825|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138305826|NCT00546455|Protective Agents|protective agents|mesh-ancestor
138305827|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305828|NCT00000737|Megestrol|megestrol|mesh-list
138305829|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
138305830|NCT00000737|Dronabinol|dronabinol|mesh-list
138305831|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
138305832|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305833|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138305834|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305835|NCT00000737|Analgesics|analgesics|mesh-ancestor
138305836|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
138305837|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305838|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138305839|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138305840|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305841|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305842|NCT00000737|Hormones|hormones|mesh-ancestor
138305843|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305844|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138305845|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138305846|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138305847|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
138305848|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138305849|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138305850|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138305851|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138305852|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305853|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
138305854|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138305856|NCT00528437|Temozolomide|temozolomide|mesh-list
138305857|NCT00528437|Thiotepa|thiotepa|mesh-list
138305858|NCT00528437|Tretinoin|tretinoin|mesh-list
138305859|NCT00528437|Isotretinoin|isotretinoin|mesh-list
138305861|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138305862|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
138305863|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305864|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138305865|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138305866|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
138305867|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305868|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
138305869|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138305870|NCT00000743|Zidovudine|zidovudine|mesh-list
138305871|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
138305872|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305873|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138305874|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305875|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305876|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
138305877|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305878|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138305879|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305880|NCT00506909|Oxytocin|oxytocin|mesh-list
138305881|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
138305882|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138305883|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305885|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
138305887|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138305888|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
138305889|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305890|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138305891|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138305892|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
138305893|NCT00500045|Vitamins|vitamins|mesh-ancestor
138305894|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
138305895|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305896|NCT00000767|Vaccines|vaccines|mesh-list
138305897|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
138305898|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305899|NCT05383547|Bortezomib|bortezomib|mesh-list
138305900|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305901|NCT00456989|Docetaxel|docetaxel|mesh-list
138305902|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305903|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
138305904|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
138305905|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
138305906|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305907|NCT00000773|Atovaquone|atovaquone|mesh-list
138305908|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305909|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
138305911|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138305912|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305913|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305915|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138305917|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
138305918|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138305919|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
138305920|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138305921|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305922|NCT00000791|Zidovudine|zidovudine|mesh-list
138305923|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
138305924|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305925|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138305926|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305927|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305928|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
138305929|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305930|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138305931|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305932|NCT00379847|Conivaptan|conivaptan|mesh-list
138305933|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138305934|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305935|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
138305936|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305937|NCT00374543|Ziprasidone|ziprasidone|mesh-list
138305938|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138305939|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
138305940|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305941|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305942|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305943|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138305944|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138305945|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138305947|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138305948|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
138305949|NCT00000803|Zidovudine|zidovudine|mesh-list
138305950|NCT00000803|Didanosine|didanosine|mesh-list
138305951|NCT00000803|Delavirdine|delavirdine|mesh-list
138305952|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
138305953|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305954|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138305955|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305956|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305957|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
138305958|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138305959|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138305960|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138305961|NCT00299195|Sulindac|sulindac|mesh-list
138305962|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138305963|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138305964|NCT00299195|Analgesics|analgesics|mesh-ancestor
138305965|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
138305966|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138305967|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305968|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305969|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138305970|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305971|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138305972|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305973|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305974|NCT01351415|Bevacizumab|bevacizumab|mesh-list
138305976|NCT01351415|Pemetrexed|pemetrexed|mesh-list
138305977|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138305978|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305979|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138305980|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138305981|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138305982|NCT01351415|Growth Substances|growth substances|mesh-ancestor
138305983|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305984|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
138305985|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138305986|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138305987|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138305988|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305989|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138305990|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138305991|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138305992|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138305993|NCT00281879|Cytarabine|cytarabine|mesh-list
138305994|NCT00281879|Cyclosporine|cyclosporine|mesh-list
138305995|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
138305996|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
138305997|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
138305998|NCT00281879|Melphalan|melphalan|mesh-list
138305999|NCT00281879|Busulfan|busulfan|mesh-list
138306000|NCT00281879|Carmustine|carmustine|mesh-list
138306001|NCT00281879|Methotrexate|methotrexate|mesh-list
138306002|NCT00281879|Fludarabine|fludarabine|mesh-list
138306003|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
138306005|NCT00281879|Tacrolimus|tacrolimus|mesh-list
138306006|NCT00281879|Cyclosporins|cyclosporins|mesh-list
138306007|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138306008|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306009|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
138306010|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306011|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306012|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138306013|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
138306014|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306015|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306016|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138306017|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138306018|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
138306019|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138306020|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138306021|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
138306022|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
138306023|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306024|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138306025|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306026|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138306027|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138306028|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138306029|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
138306030|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306031|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138306032|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
138306033|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138306034|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138306035|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
138306036|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138306037|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138306038|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
138306039|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
138306040|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306041|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306042|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
138306043|NCT00281879|Hormones|hormones|mesh-ancestor
138306044|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306045|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138306046|NCT00281879|Protective Agents|protective agents|mesh-ancestor
138306047|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138306048|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138306060|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138306061|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138306064|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
138306065|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306066|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306067|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306068|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
138306069|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138306070|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306071|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306072|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138306073|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138306074|NCT00205049|Protective Agents|protective agents|mesh-ancestor
138306075|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306076|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306077|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138306078|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
138306079|NCT00000833|Ribavirin|ribavirin|mesh-list
138306080|NCT00000833|Didanosine|didanosine|mesh-list
138306081|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
138306082|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306083|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
138306084|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306085|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306086|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306087|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306088|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306089|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306090|NCT00000839|Didanosine|didanosine|mesh-list
138306091|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
138306092|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306093|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306094|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306096|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
138306097|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306098|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306099|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306100|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
138306101|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306102|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138306103|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138306104|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306105|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306106|NCT00133679|Urological Agents|urological agents|mesh-ancestor
138306107|NCT00000875|Acetaminophen|acetaminophen|mesh-list
138306108|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
138306109|NCT00000875|Promethazine|promethazine|mesh-list
138306110|NCT00000875|Lamivudine|lamivudine|mesh-list
138306111|NCT00000875|Zidovudine|zidovudine|mesh-list
138306112|NCT00000875|Aldesleukin|aldesleukin|mesh-list
138306113|NCT00000875|Indinavir|indinavir|mesh-list
138306114|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306115|NCT00000875|Analgesics|analgesics|mesh-ancestor
138306116|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
138306117|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306118|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306119|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
138306120|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306121|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306122|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306123|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306124|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
138306125|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306126|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306127|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306128|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
138306129|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306130|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138306131|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138306132|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306133|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
138306134|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
138306135|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
138306136|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
138306137|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306138|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138306139|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
138306140|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
138306141|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306143|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
138306144|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138306145|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138306146|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138306147|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
138306148|NCT04941833|Desogestrel|desogestrel|mesh-list
138306149|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138306150|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138306151|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138306152|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
138306153|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138306154|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306155|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138306156|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138306158|NCT04941833|Hormones|hormones|mesh-ancestor
138306159|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306160|NCT04841369|Vaccines|vaccines|mesh-list
138306161|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
138306162|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306163|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138306164|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138306165|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
138306166|NCT00521885|Enoxaparin|enoxaparin|mesh-list
138306167|NCT00521885|Fondaparinux|fondaparinux|mesh-list
138306168|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
138306169|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138306170|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138306171|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306172|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138306173|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
138306174|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138306176|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306177|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
138306178|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306179|NCT00000881|Cidofovir|cidofovir|mesh-list
138306180|NCT00000881|Probenecid|probenecid|mesh-list
138306181|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
138306182|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
138306183|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306184|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
138306185|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306186|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306187|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306188|NCT00000887|Lamivudine|lamivudine|mesh-list
138306189|NCT00000887|Zidovudine|zidovudine|mesh-list
138306190|NCT00000887|Nelfinavir|nelfinavir|mesh-list
138306191|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306192|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306193|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306194|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306195|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
138306196|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306197|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306198|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306199|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
138306200|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138306201|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138306202|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
138306203|NCT00000119|Heparin|heparin|mesh-list
138306204|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
138306205|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138306206|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138306207|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306208|NCT00000923|Lamivudine|lamivudine|mesh-list
138306209|NCT00000923|Zidovudine|zidovudine|mesh-list
138306210|NCT00000923|Didanosine|didanosine|mesh-list
138306211|NCT00000923|Stavudine|stavudine|mesh-list
138306212|NCT00000923|Aldesleukin|aldesleukin|mesh-list
138306213|NCT00000923|Indinavir|indinavir|mesh-list
138306214|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306215|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306216|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306217|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306218|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
138306219|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306220|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306221|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306222|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
138306223|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306224|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138306225|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138306226|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
138306227|NCT00000161|Aspirin|aspirin|mesh-list
138306228|NCT00000161|Vitamins|vitamins|mesh-list
138306229|NCT00000161|Vitamin E|vitamin e|mesh-list
138306231|NCT00000161|Carotenoids|carotenoids|mesh-list
138306232|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
138306233|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306234|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138306235|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306236|NCT00000161|Analgesics|analgesics|mesh-ancestor
138306237|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
138306238|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306239|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138306240|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306241|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138306242|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138306243|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306244|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138306245|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138306246|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306247|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
138306248|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
138306250|NCT00000161|Provitamins|provitamins|mesh-ancestor
138306251|NCT00000929|Nonoxynol|nonoxynol|mesh-list
138306252|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138306253|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138306254|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306255|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138306256|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
138306257|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138306258|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138306259|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
138306260|NCT00000935|Antibodies|antibodies|mesh-list
138306261|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
138306262|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138306263|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138306264|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
138306265|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306266|NCT00000197|Propranolol|propranolol|mesh-list
138306267|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138306268|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138306269|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
138306270|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306271|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306272|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306273|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138306274|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138306275|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306276|NCT00000947|Azithromycin|azithromycin|mesh-list
138306277|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138306278|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306279|NCT00000203|Buprenorphine|buprenorphine|mesh-list
138306280|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306282|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306283|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306284|NCT00000203|Analgesics|analgesics|mesh-ancestor
138306285|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
138306286|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306287|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306288|NCT00000209|Buprenorphine|buprenorphine|mesh-list
138306289|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306290|NCT00000209|Narcotics|narcotics|mesh-ancestor
138306291|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306292|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306294|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
138306295|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306296|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306297|NCT00000215|Pergolide|pergolide|mesh-list
138306298|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
138306299|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
138306300|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306301|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306302|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306303|NCT00000953|Acyclovir|acyclovir|mesh-list
138306304|NCT00000953|Sorivudine|sorivudine|mesh-list
138306305|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
138306306|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306307|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306308|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306309|NCT00000983|Zidovudine|zidovudine|mesh-list
138306310|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
138306311|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306312|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306313|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306314|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306315|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
138306316|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306317|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306318|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306319|NCT00000227|Buprenorphine|buprenorphine|mesh-list
138306320|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306321|NCT00000227|Narcotics|narcotics|mesh-ancestor
138306322|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306323|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306324|NCT00000227|Analgesics|analgesics|mesh-ancestor
138306325|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
138306326|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306327|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306328|NCT00000233|Buprenorphine|buprenorphine|mesh-list
138306329|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306330|NCT00000233|Narcotics|narcotics|mesh-ancestor
138306331|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306332|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306333|NCT00000233|Analgesics|analgesics|mesh-ancestor
138306334|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
138306335|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306336|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306337|NCT00000239|Buprenorphine|buprenorphine|mesh-list
138306338|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306339|NCT00000239|Narcotics|narcotics|mesh-ancestor
138306340|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306341|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306342|NCT00000239|Analgesics|analgesics|mesh-ancestor
138306343|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
138306344|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306345|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306346|NCT00000245|Desipramine|desipramine|mesh-list
138306347|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138306348|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
138306349|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306350|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306351|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306352|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138306353|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138306354|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306355|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
138306356|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306357|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306359|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
138306360|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138306361|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306362|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306363|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306364|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138306365|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
138306366|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
138306367|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306369|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
138306370|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306371|NCT00000269|Pergolide|pergolide|mesh-list
138306372|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
138306373|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
138306374|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306375|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306376|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306377|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
138306378|NCT03967223|Fludarabine|fludarabine|mesh-list
138306379|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306381|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306382|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306383|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138306384|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
138306385|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306386|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306387|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138306388|NCT00000989|Zidovudine|zidovudine|mesh-list
138306389|NCT00000989|Ganciclovir|ganciclovir|mesh-list
138306390|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138306391|NCT00000989|Sargramostim|sargramostim|mesh-list
138306392|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
138306393|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306394|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306395|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306396|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306397|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
138306398|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306399|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306400|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306401|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
138306402|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306403|NCT00000995|Zidovudine|zidovudine|mesh-list
138306404|NCT00000995|Ganciclovir|ganciclovir|mesh-list
138306405|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138306406|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
138306407|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306408|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306409|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306410|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306411|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
138306412|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306413|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306414|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306415|NCT00001025|Zidovudine|zidovudine|mesh-list
138306416|NCT00001025|Didanosine|didanosine|mesh-list
138306417|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
138306418|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306419|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306420|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306421|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306422|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
138306423|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306425|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306426|NCT03055247|Ibuprofen|ibuprofen|mesh-list
138306427|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138306428|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306429|NCT03055247|Analgesics|analgesics|mesh-ancestor
138306430|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
138306431|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306432|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306433|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138306434|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306435|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138306436|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306437|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306438|NCT00001049|Zidovudine|zidovudine|mesh-list
138306439|NCT00001049|Didanosine|didanosine|mesh-list
138306440|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
138306441|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306442|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306443|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306444|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306445|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
138306446|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306447|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306448|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306449|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
138306450|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138306451|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
138306452|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306453|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138306454|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306455|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
138306456|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306457|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
138306458|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138306459|NCT00001055|Protective Agents|protective agents|mesh-ancestor
138306460|NCT00000275|Flupenthixol|flupenthixol|mesh-list
138306461|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138306462|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138306463|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138306464|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306465|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306467|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138306468|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
138306469|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306470|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306471|NCT00001061|Ganciclovir|ganciclovir|mesh-list
138306472|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138306473|NCT00001061|Foscarnet|foscarnet|mesh-list
138306474|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138306475|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
138306476|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306477|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306478|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306479|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306480|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306481|NCT00000281|Amantadine|amantadine|mesh-list
138306482|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138306483|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138306484|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
138306485|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306486|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
138306487|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306488|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306489|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306490|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306491|NCT00000281|Analgesics|analgesics|mesh-ancestor
138306492|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
138306493|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306495|NCT00001067|Zidovudine|zidovudine|mesh-list
138306496|NCT00001067|Stavudine|stavudine|mesh-list
138306497|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306498|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306500|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306501|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
138306502|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306503|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306504|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306505|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
138306506|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
138306507|NCT00001079|Megestrol|megestrol|mesh-list
138306508|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
138306509|NCT00001079|Testosterone|testosterone|mesh-list
138306510|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
138306511|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
138306512|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138306513|NCT00001079|Androgens|androgens|mesh-ancestor
138306514|NCT00001079|Hormones|hormones|mesh-ancestor
138306515|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306516|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306517|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138306518|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306519|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
138306520|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138306521|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138306522|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138306523|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
138306524|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138306525|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138306526|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138306527|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
138306528|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138306530|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138306531|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138306532|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306533|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306534|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306535|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306536|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138306537|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
138306538|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306539|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138306540|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138306541|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
138306542|NCT00001091|Ritonavir|ritonavir|mesh-list
138306543|NCT00001091|Nelfinavir|nelfinavir|mesh-list
138306544|NCT00001091|Lamivudine|lamivudine|mesh-list
138306545|NCT00001091|Nevirapine|nevirapine|mesh-list
138306546|NCT00001091|Stavudine|stavudine|mesh-list
138306547|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138306548|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138306549|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138306550|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306551|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306552|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306553|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306554|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
138306555|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306556|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138306557|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138366565|NCT06044142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366567|NCT06037876|Albendazole|albendazole|mesh-list
138366568|NCT06037876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138306558|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306559|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306560|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138306561|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138306562|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
138306565|NCT00000299|Narcotics|narcotics|mesh-ancestor
138306566|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306567|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306568|NCT00000299|Analgesics|analgesics|mesh-ancestor
138306569|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
138306570|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306571|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306572|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
138306573|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138306574|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306575|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138306576|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138306577|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306578|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306579|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
138306580|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306582|NCT00000311|Methadone|methadone|mesh-list
138306583|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306584|NCT00000311|Narcotics|narcotics|mesh-ancestor
138306585|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306586|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306587|NCT00000311|Analgesics|analgesics|mesh-ancestor
138306588|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
138306589|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306590|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306591|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
138306592|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
138306593|NCT00000317|Risperidone|risperidone|mesh-list
138306594|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138306595|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
138306596|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306597|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306598|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306599|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138306600|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138306601|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306602|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306603|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138306604|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
138306606|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
138306607|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306608|NCT00001757|Voriconazole|voriconazole|mesh-list
138306609|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
138306610|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306611|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138306612|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138306613|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306614|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306615|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138306616|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
138306617|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306618|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306619|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138306620|NCT00001133|Ritonavir|ritonavir|mesh-list
138306621|NCT00001133|Indinavir|indinavir|mesh-list
138306622|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138306623|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138306624|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
138306625|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306626|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306627|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306628|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306630|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306631|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138306632|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138306633|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
138306635|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306637|NCT00000329|Analgesics|analgesics|mesh-ancestor
138306638|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
138306639|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306640|NCT00000335|Morphine|morphine|mesh-list
138306641|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306642|NCT00000335|Narcotics|narcotics|mesh-ancestor
138306643|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306644|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306645|NCT00000335|Analgesics|analgesics|mesh-ancestor
138306646|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
138306647|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306648|NCT00000341|Buprenorphine|buprenorphine|mesh-list
138306649|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306650|NCT00000341|Narcotics|narcotics|mesh-ancestor
138306651|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306652|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306653|NCT00000341|Analgesics|analgesics|mesh-ancestor
138306654|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
138306655|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306656|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306657|NCT00000347|Risperidone|risperidone|mesh-list
138306658|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138306659|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
138306660|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306661|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306662|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306664|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138306665|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306666|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306667|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138306668|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
138306669|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
138306670|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306671|NCT00001193|Melphalan|melphalan|mesh-list
138306672|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138306673|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
138306674|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306675|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306676|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138306677|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306678|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
138306679|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306680|NCT00000353|Buprenorphine|buprenorphine|mesh-list
138306681|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138306682|NCT00000353|Naloxone|naloxone|mesh-list
138306683|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138306684|NCT00000353|Narcotics|narcotics|mesh-ancestor
138306685|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306686|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306687|NCT00000353|Analgesics|analgesics|mesh-ancestor
138306688|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
138306689|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306690|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306691|NCT00000377|Nortriptyline|nortriptyline|mesh-list
138306692|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138306693|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138306694|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306695|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138306696|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138306701|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306702|NCT00001865|Daclizumab|daclizumab|mesh-list
138306703|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306704|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
138306705|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306706|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
138306707|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138306708|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138306709|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306710|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306711|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306712|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138306713|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138306714|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306715|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306716|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306717|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
138306718|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138306719|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
138306720|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138306721|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138306722|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306723|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138306724|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
138306725|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138306726|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306727|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306728|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138306729|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138306730|NCT00001877|Protective Agents|protective agents|mesh-ancestor
138306731|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306732|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306733|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138306734|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
138306735|NCT00380939|Atorvastatin|atorvastatin|mesh-list
138306736|NCT00380939|Pravastatin|pravastatin|mesh-list
138306737|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138306738|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138306739|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
138306740|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306741|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138306742|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138306743|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306745|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138306746|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
138306747|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
138306748|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306749|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306750|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138306751|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138306752|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138306753|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
138306754|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306755|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306756|NCT00001889|Protective Agents|protective agents|mesh-ancestor
138306757|NCT00001901|Etanercept|etanercept|mesh-list
138306758|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138306759|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306760|NCT00001901|Analgesics|analgesics|mesh-ancestor
138306761|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
138306762|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306763|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306764|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138306765|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306766|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306767|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306768|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
138306769|NCT00000437|Naltrexone|naltrexone|mesh-list
138306770|NCT00000437|Nicotine|nicotine|mesh-list
138306771|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138306772|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
138306773|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306774|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306775|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138306776|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138306777|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
138306778|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306779|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306780|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138306781|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306782|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
138306783|NCT00000443|Ondansetron|ondansetron|mesh-list
138306784|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
138306785|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
138306786|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306787|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306788|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306789|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
138306791|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138306793|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
138306794|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306795|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306796|NCT00000449|Naltrexone|naltrexone|mesh-list
138306797|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138306798|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306799|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306800|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
138306801|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306802|NCT00000455|Naltrexone|naltrexone|mesh-list
138306803|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138306804|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138306805|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306806|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
138306807|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306808|NCT00001307|Capsaicin|capsaicin|mesh-list
138306809|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
138306810|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138306811|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
138306812|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306813|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306814|NCT04713761|Carboplatin|carboplatin|mesh-list
138306815|NCT04713761|Pemetrexed|pemetrexed|mesh-list
138306816|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306817|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306818|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306819|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138306820|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306821|NCT00001937|Fluconazole|fluconazole|mesh-list
138306822|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
138306823|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306824|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138306825|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138306826|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306827|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306828|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138306829|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
138306830|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306831|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306832|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138306833|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138306834|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138306835|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138306836|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306838|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
138306839|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306840|NCT00001955|Celecoxib|celecoxib|mesh-list
138306841|NCT00001955|Etanercept|etanercept|mesh-list
138306842|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138306843|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306844|NCT00001955|Analgesics|analgesics|mesh-ancestor
138306845|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
138306846|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306847|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306848|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138306849|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138306850|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138306851|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138306852|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306853|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306854|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138306855|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138306856|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
138306857|NCT04943783|Atorvastatin|atorvastatin|mesh-list
138306858|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138306859|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138306860|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
138306861|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306862|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138306863|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138306864|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306865|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138306866|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
138306867|NCT00000605|Hormones|hormones|mesh-list
138306868|NCT00000605|Estrogens|estrogens|mesh-list
138306869|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138306870|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306871|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138306872|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138306873|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138306874|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
138306875|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138306876|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138306877|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138306878|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138306879|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138306880|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306881|NCT00000617|Azithromycin|azithromycin|mesh-list
138306882|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138306883|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306885|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
138306886|NCT00000623|Deferiprone|deferiprone|mesh-list
138306887|NCT00000623|Deferoxamine|deferoxamine|mesh-list
138306888|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138306889|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
138306890|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306891|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306892|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306893|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
138306894|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138306895|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138306896|NCT00000623|Urological Agents|urological agents|mesh-ancestor
138306897|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138306898|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
138306899|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
138306900|NCT00000623|Siderophores|siderophores|mesh-ancestor
138306902|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306903|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
138306904|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138306905|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138306906|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306907|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306908|NCT00001997|Zidovudine|zidovudine|mesh-list
138306909|NCT00001997|Didanosine|didanosine|mesh-list
138306910|NCT00001997|Interleukin-2|interleukin-2|mesh-list
138306911|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306912|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306913|NCT00001997|Analgesics|analgesics|mesh-ancestor
138306914|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
138306915|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306916|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306917|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
138306918|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306919|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306920|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306921|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306922|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
138306923|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306924|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306925|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306926|NCT00002003|Etoposide|etoposide|mesh-list
138306927|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
138306928|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138306929|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306930|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138306931|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138306932|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306933|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306934|NCT00002003|Analgesics|analgesics|mesh-ancestor
138306935|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
138306936|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306937|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306938|NCT00002009|Sargramostim|sargramostim|mesh-list
138306939|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
138306940|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306941|NCT00000629|Zidovudine|zidovudine|mesh-list
138306942|NCT00000629|Valproic Acid|valproic acid|mesh-list
138306944|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306945|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306946|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306947|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306948|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
138306949|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306950|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306951|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306952|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
138306954|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138306955|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306956|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
138306957|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138306958|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138306959|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138306960|NCT00000647|Interferons|interferons|mesh-list
138306961|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
138306962|NCT00000647|Zidovudine|zidovudine|mesh-list
138306963|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138306964|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306965|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
138306966|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306967|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
138306968|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306969|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
138306970|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306971|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306972|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306973|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306974|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306975|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306976|NCT00000653|Zalcitabine|zalcitabine|mesh-list
138306977|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
138306978|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306980|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306982|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
138306983|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306984|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138306985|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138306986|NCT00001409|Interleukin-2|interleukin-2|mesh-list
138306987|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138306988|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138306989|NCT00001409|Analgesics|analgesics|mesh-ancestor
138306991|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138306992|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138306994|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
138306995|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306996|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306997|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138306998|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138306999|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
138307000|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307001|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307002|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307003|NCT00381017|Interferons|interferons|mesh-list
138307004|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
138307005|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
138307006|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138307007|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307008|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
138307009|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307010|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
138307011|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307012|NCT00002015|Ganciclovir|ganciclovir|mesh-list
138307013|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138307014|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
138307015|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307016|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307017|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307018|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307019|NCT00002021|Foscarnet|foscarnet|mesh-list
138307020|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138307021|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
138307022|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307023|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307024|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307025|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307026|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307027|NCT00002027|Diclazuril|diclazuril|mesh-list
138307028|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
138307029|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138307030|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138307031|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307032|NCT00000695|Interferons|interferons|mesh-list
138307033|NCT00000695|Zidovudine|zidovudine|mesh-list
138307034|NCT00000695|Interferon-beta|interferon-beta|mesh-list
138307035|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
138307036|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307037|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
138307039|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
138307040|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307041|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307042|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307043|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307044|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307045|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307046|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
138307047|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307048|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307049|NCT00000701|Zidovudine|zidovudine|mesh-list
138307050|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
138307051|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307052|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307053|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307054|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307055|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
138307056|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307057|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307058|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307059|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138307060|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
138307061|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307062|NCT00000725|Interferons|interferons|mesh-list
138307063|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
138307064|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
138307065|NCT00000725|Zidovudine|zidovudine|mesh-list
138307066|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307067|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
138307068|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307069|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
138307070|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307071|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
138307072|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307073|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307074|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307075|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307076|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307077|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307078|NCT00002033|Zidovudine|zidovudine|mesh-list
138307080|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307082|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307084|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
138307085|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307086|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307087|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307089|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138307090|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
138307091|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307092|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307093|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307094|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307095|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307096|NCT00000731|Acetaminophen|acetaminophen|mesh-list
138307097|NCT00000731|Zidovudine|zidovudine|mesh-list
138307098|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138307099|NCT00000731|Analgesics|analgesics|mesh-ancestor
138307100|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
138307101|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307102|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307103|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
138307104|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
138307105|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307106|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307107|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307108|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307109|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
138307110|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307111|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307112|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307113|NCT00002045|Zidovudine|zidovudine|mesh-list
138307114|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
138307115|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307116|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307117|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307118|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307119|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
138307120|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307121|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307122|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307123|NCT00002051|Thymopentin|thymopentin|mesh-list
138307124|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307125|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
138307126|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307127|NCT00001499|Paclitaxel|paclitaxel|mesh-list
138307129|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307130|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307131|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307132|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307133|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307134|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307135|NCT00002057|Nystatin|nystatin|mesh-list
138307136|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307137|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307138|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
138307139|NCT00002057|Ionophores|ionophores|mesh-ancestor
138307140|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138307141|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307142|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
138307143|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307144|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
138307145|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307146|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
138307147|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307148|NCT00001535|Interleukin-2|interleukin-2|mesh-list
138307149|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307150|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138307151|NCT00001535|Analgesics|analgesics|mesh-ancestor
138307152|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
138307153|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307154|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307155|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
138307156|NCT00002303|Hematinics|hematinics|mesh-ancestor
138307157|NCT00002063|Zidovudine|zidovudine|mesh-list
138307158|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
138307159|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307160|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307161|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307162|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307163|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
138307164|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307165|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307166|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307167|NCT00002069|Ditiocarb|ditiocarb|mesh-list
138307168|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307169|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
138307170|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307172|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307173|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
138307174|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
138307175|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307176|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138307177|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307178|NCT00002309|Azithromycin|azithromycin|mesh-list
138307179|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307180|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307181|NCT00002315|Acyclovir|acyclovir|mesh-list
138307182|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
138307183|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
138307184|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307185|NCT00002075|Fluconazole|fluconazole|mesh-list
138307186|NCT00002075|Amphotericin B|amphotericin b|mesh-list
138307187|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138307188|NCT00002075|Flucytosine|flucytosine|mesh-list
138307189|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
138307190|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307191|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138307192|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307193|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307194|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307198|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307199|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307200|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307201|NCT00002075|Amebicides|amebicides|mesh-ancestor
138307202|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138307203|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138307204|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307205|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
138307206|NCT00001577|Melphalan|melphalan|mesh-list
138307207|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307208|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
138307209|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307210|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307211|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307212|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307213|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
138307214|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307215|NCT00002081|Zidovudine|zidovudine|mesh-list
138307216|NCT00002081|Zalcitabine|zalcitabine|mesh-list
138307217|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
138307218|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307219|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307220|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307221|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307222|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
138307223|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307225|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307226|NCT00002093|Doxorubicin|doxorubicin|mesh-list
138307227|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307228|NCT00002093|Daunorubicin|daunorubicin|mesh-list
138307229|NCT00002093|Bleomycin|bleomycin|mesh-list
138307230|NCT00002093|Vincristine|vincristine|mesh-list
138307231|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307232|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307233|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307234|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307235|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307236|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307237|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307238|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307239|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307240|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307241|NCT00002099|Didanosine|didanosine|mesh-list
138307242|NCT00002099|Lentinan|lentinan|mesh-list
138307243|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
138307244|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307245|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307246|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307248|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
138307249|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307250|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307251|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307252|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307253|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
138307254|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307255|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307256|NCT00002321|Aldesleukin|aldesleukin|mesh-list
138307257|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307258|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307259|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307260|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
138307261|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307263|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
138307264|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307265|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307266|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307267|NCT00002333|Saquinavir|saquinavir|mesh-list
138307268|NCT00002333|Zalcitabine|zalcitabine|mesh-list
138307269|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307270|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307271|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307272|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307273|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307277|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307278|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138307279|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307280|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
138307281|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307282|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307283|NCT00002339|Fluconazole|fluconazole|mesh-list
138307284|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
138307285|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307286|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138307287|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307288|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307289|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307290|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138307291|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
138307292|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138307293|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307294|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307295|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307296|NCT00002105|Doxorubicin|doxorubicin|mesh-list
138307297|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307299|NCT00002105|Vincristine|vincristine|mesh-list
138307300|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307301|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307302|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307303|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307304|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307305|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307306|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307307|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307308|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307309|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307310|NCT00002345|Megestrol|megestrol|mesh-list
138307311|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
138307312|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138307313|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138307314|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138307315|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
138307316|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138307317|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307318|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138307319|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138307320|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138307321|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307322|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
138307323|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138307325|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307326|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307327|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307328|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307329|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307331|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307332|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
138307333|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307334|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138307335|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307337|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307338|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307339|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307340|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307341|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307342|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307343|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307344|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
138307345|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307346|NCT00002357|Zidovudine|zidovudine|mesh-list
138307347|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
138307348|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307349|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307350|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307351|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307352|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
138307353|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307354|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307355|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307356|NCT00002117|Zidovudine|zidovudine|mesh-list
138307357|NCT00002117|Zalcitabine|zalcitabine|mesh-list
138307358|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
138307359|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307360|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307361|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307362|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307363|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
138307364|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307365|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307366|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307367|NCT00002123|Didanosine|didanosine|mesh-list
138307368|NCT00002123|Delavirdine|delavirdine|mesh-list
138307369|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
138307370|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307371|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307372|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307373|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307374|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
138307375|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307376|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307377|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307378|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
138307379|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307380|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
138307381|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307382|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307383|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307384|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
138307385|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307386|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307387|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307389|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138307390|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
138307391|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307392|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307393|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
138307394|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307395|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138307396|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138307397|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307398|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307399|NCT00002129|Protective Agents|protective agents|mesh-ancestor
138307401|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138307402|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
138307403|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307404|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307405|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307406|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307408|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307409|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307410|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307411|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307412|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
138307413|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307414|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307415|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307416|NCT00002369|Lamivudine|lamivudine|mesh-list
138307417|NCT00002369|Zidovudine|zidovudine|mesh-list
138307418|NCT00002369|Stavudine|stavudine|mesh-list
138307419|NCT00002369|Indinavir|indinavir|mesh-list
138307420|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307421|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307422|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307423|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307424|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
138307425|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307426|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307427|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307428|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
138307429|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307430|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307431|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307432|NCT00002375|Nelfinavir|nelfinavir|mesh-list
138307433|NCT00002375|Indinavir|indinavir|mesh-list
138307434|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307435|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307437|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307438|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307439|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307440|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307441|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
138307442|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307443|NCT00002381|Nevirapine|nevirapine|mesh-list
138307444|NCT00002381|Stavudine|stavudine|mesh-list
138307445|NCT00002381|Nelfinavir|nelfinavir|mesh-list
138307446|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307447|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307448|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307449|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307450|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
138307451|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307452|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307453|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307454|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307455|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138307456|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307457|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307458|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307459|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
138307460|NCT00002387|Efavirenz|efavirenz|mesh-list
138307461|NCT00002387|Indinavir|indinavir|mesh-list
138307462|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307463|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307464|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307465|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307466|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
138307467|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307468|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307469|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307470|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307471|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138307473|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307474|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307475|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307476|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307477|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307478|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307479|NCT00002393|Efavirenz|efavirenz|mesh-list
138307480|NCT00002393|Indinavir|indinavir|mesh-list
138307481|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307482|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307483|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307484|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307485|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
138307486|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307487|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307488|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307489|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307490|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138307491|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138307492|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307493|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307494|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307495|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307496|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307497|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307498|NCT00002399|Fluconazole|fluconazole|mesh-list
138307499|NCT00002399|Posaconazole|posaconazole|mesh-list
138307500|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
138307501|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307502|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138307503|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307504|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307505|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307506|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138307507|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
138307508|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138307509|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307510|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307511|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307512|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138307513|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138307514|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138307515|NCT00002405|Amprenavir|amprenavir|mesh-list
138307516|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138307517|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307518|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307519|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307520|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307521|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307522|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307523|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307524|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307525|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307526|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307527|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
138307528|NCT00002417|Amprenavir|amprenavir|mesh-list
138307529|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138307530|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307531|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307532|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307533|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307534|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307535|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307536|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307537|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307538|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307539|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307540|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
138307547|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307549|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307550|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
138307551|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307552|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307553|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307554|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307555|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307556|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307557|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138307558|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307559|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307561|NCT02973581|Dipyrone|dipyrone|mesh-list
138307562|NCT02973581|Lidocaine|lidocaine|mesh-list
138307563|NCT02973581|Bupivacaine|bupivacaine|mesh-list
138307564|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
138307565|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
138307566|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
138307567|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138307568|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307569|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
138307570|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307571|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138307572|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138307573|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138307574|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138307575|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307576|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138307577|NCT02973581|Analgesics|analgesics|mesh-ancestor
138307578|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
138307579|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138307580|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138307581|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307582|NCT00002435|Zidovudine|zidovudine|mesh-list
138307583|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
138307584|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307585|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307586|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307587|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307588|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
138307589|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307590|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307591|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307592|NCT00002447|Ritonavir|ritonavir|mesh-list
138307593|NCT00002447|Saquinavir|saquinavir|mesh-list
138307594|NCT00002447|Efavirenz|efavirenz|mesh-list
138307595|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307596|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307597|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307598|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307599|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307600|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307601|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307602|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
138307603|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307604|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138307605|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307606|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307608|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307609|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307611|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138307612|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307614|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
138307615|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307616|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307617|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307618|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307619|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307620|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307621|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307623|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
138307624|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138307625|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138307626|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138307627|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
138307628|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138307629|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307630|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138307631|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138307632|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138307633|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307634|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
138307635|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138307637|NCT00002471|Cytarabine|cytarabine|mesh-list
138307639|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
138307640|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
138307641|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138307642|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138307643|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138307644|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
138307645|NCT00002471|Thiotepa|thiotepa|mesh-list
138307646|NCT00002471|Methotrexate|methotrexate|mesh-list
138307647|NCT00002471|Etoposide|etoposide|mesh-list
138307648|NCT00002471|Vincristine|vincristine|mesh-list
138307649|NCT00002471|Daunorubicin|daunorubicin|mesh-list
138307650|NCT00002471|Asparaginase|asparaginase|mesh-list
138307651|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
138307652|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307653|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
138307654|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307655|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307656|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307657|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
138307658|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307659|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307660|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307661|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138307662|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
138307663|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
138307664|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307665|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138307666|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
138307667|NCT00002471|Hormones|hormones|mesh-ancestor
138307668|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138307669|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138307670|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138307671|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
138307672|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138307673|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138307674|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
138307676|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307677|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138307678|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307679|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307680|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307681|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307682|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
138307683|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307684|NCT00002471|Antidotes|antidotes|mesh-ancestor
138307685|NCT00002471|Protective Agents|protective agents|mesh-ancestor
138307686|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
138307688|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
138307689|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307690|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307692|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138307693|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307694|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
138307695|NCT00002477|Carboplatin|carboplatin|mesh-list
138307696|NCT00002477|Doxorubicin|doxorubicin|mesh-list
138307697|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307698|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307699|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
138307700|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307701|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307702|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307703|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
138307704|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307705|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307706|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307707|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307708|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307709|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307710|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307711|NCT00002489|Leucovorin|leucovorin|mesh-list
138307712|NCT00002489|Dactinomycin|dactinomycin|mesh-list
138307713|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
138307714|NCT00002489|Carboplatin|carboplatin|mesh-list
138307715|NCT00002489|Doxorubicin|doxorubicin|mesh-list
138307716|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307717|NCT00002489|Methotrexate|methotrexate|mesh-list
138307719|NCT00002489|Vincristine|vincristine|mesh-list
138307720|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
138307721|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307722|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
138307723|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307724|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307725|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307726|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
138307727|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307728|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307729|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307730|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307731|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307732|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307733|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307734|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138307735|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
138307736|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138307737|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138307738|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
138307739|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
138307740|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138307741|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307742|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307743|NCT00002489|Antidotes|antidotes|mesh-ancestor
138307744|NCT00002489|Protective Agents|protective agents|mesh-ancestor
138307746|NCT00002489|Vitamins|vitamins|mesh-ancestor
138307747|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
138307748|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307749|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307750|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307751|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307752|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307753|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138307755|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307756|NCT00002495|Vinblastine|vinblastine|mesh-list
138307757|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307758|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307759|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307760|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307761|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307762|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307763|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307764|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307765|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307766|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307767|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
138307768|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138307769|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
138307770|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307771|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307772|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138307773|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
138307774|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307775|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307776|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138307777|NCT00002147|Doxorubicin|doxorubicin|mesh-list
138307778|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138307779|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307780|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307781|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138307782|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307783|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307784|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307785|NCT00002159|Itraconazole|itraconazole|mesh-list
138307786|NCT00002159|Amphotericin B|amphotericin b|mesh-list
138307787|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138307788|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
138307789|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307790|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138307791|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307792|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307793|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307794|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138307795|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
138307796|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138307797|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307798|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138307799|NCT00002159|Amebicides|amebicides|mesh-ancestor
138307800|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138307801|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138307802|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307803|NCT00002165|Nelfinavir|nelfinavir|mesh-list
138307804|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307805|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307806|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307807|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307808|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307809|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307810|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307817|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307818|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307819|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307820|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307821|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
138307822|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307823|NCT00002177|Nelfinavir|nelfinavir|mesh-list
138307824|NCT00002177|Didanosine|didanosine|mesh-list
138307825|NCT00002177|Stavudine|stavudine|mesh-list
138307826|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
138307827|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307828|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
138307829|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307830|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307831|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307832|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307833|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307834|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307835|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307836|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307837|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
138307838|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307839|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
138307840|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307841|NCT00002183|Lamivudine|lamivudine|mesh-list
138307842|NCT00002183|Zidovudine|zidovudine|mesh-list
138307843|NCT00002183|Abacavir|abacavir|mesh-list
138307844|NCT00002183|Amprenavir|amprenavir|mesh-list
138307845|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307846|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307847|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307848|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307849|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
138307850|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307851|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307852|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307853|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
138307854|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138307855|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307856|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307857|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307858|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307859|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307861|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138307862|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307863|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
138307864|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
138307865|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
138307866|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307867|NCT00002195|Lamivudine|lamivudine|mesh-list
138307868|NCT00002195|Zidovudine|zidovudine|mesh-list
138307869|NCT00002195|Amprenavir|amprenavir|mesh-list
138307870|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307871|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307872|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307873|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307876|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307884|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307885|NCT00002201|Ritonavir|ritonavir|mesh-list
138307886|NCT00002201|Nelfinavir|nelfinavir|mesh-list
138307887|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307888|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307889|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307890|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307891|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307892|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307893|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307894|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
138307895|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307896|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138307897|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307898|NCT00002213|Efavirenz|efavirenz|mesh-list
138307899|NCT00002213|Abacavir|abacavir|mesh-list
138307900|NCT00002213|Amprenavir|amprenavir|mesh-list
138307901|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307902|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307903|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307904|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307905|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
138307906|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307907|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307908|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307909|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307910|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138307911|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138307912|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307913|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307914|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307916|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307917|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307918|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307919|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307920|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307921|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138307922|NCT00381251|Estrogens|estrogens|mesh-ancestor
138307923|NCT00381251|Hormones|hormones|mesh-ancestor
138307924|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138307925|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307927|NCT00002219|Adefovir|adefovir|mesh-list
138307928|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138307929|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307930|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307931|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
138307932|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307933|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307934|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307935|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307936|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
138307937|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307939|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307941|NCT00002225|Didanosine|didanosine|mesh-list
138307942|NCT00002225|Stavudine|stavudine|mesh-list
138307943|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307944|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307945|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307946|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307947|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
138307948|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307949|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138307950|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307951|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138307952|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138307953|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138307954|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138307955|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
138307956|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307957|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307958|NCT00002243|Calanolide A|calanolide a|mesh-list
138307959|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307960|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307961|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
138307962|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307964|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138307965|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307966|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307968|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138307969|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307970|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307971|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307972|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138307973|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138307976|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
138307977|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307978|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307979|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307980|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307981|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
138307982|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307983|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138307984|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138307985|NCT00002255|Hematinics|hematinics|mesh-ancestor
138307987|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
138307988|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307989|NCT00002507|Mitomycins|mitomycins|mesh-list
138307990|NCT00002507|Mitomycin|mitomycin|mesh-list
138307991|NCT00002507|Porfiromycin|porfiromycin|mesh-list
138307992|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138307993|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307994|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
138307995|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138307996|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307997|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138307998|NCT00002519|Paclitaxel|paclitaxel|mesh-list
138307999|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308000|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308001|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308002|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308003|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308004|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308006|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138308007|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308009|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
138308011|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138308012|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
138308013|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308014|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308015|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308016|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308017|NCT00002279|Zalcitabine|zalcitabine|mesh-list
138308018|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
138308019|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308020|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138308021|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308022|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308023|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
138308024|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308025|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308026|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308028|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
138308029|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308030|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138308031|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308032|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308033|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
138308034|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308035|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308036|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308037|NCT00002531|Leucovorin|leucovorin|mesh-list
138308038|NCT00002531|Cytarabine|cytarabine|mesh-list
138308039|NCT00002531|Dexamethasone|dexamethasone|mesh-list
138308040|NCT00002531|Prednisolone|prednisolone|mesh-list
138308041|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
138308042|NCT00002531|Ifosfamide|ifosfamide|mesh-list
138308043|NCT00002531|Doxorubicin|doxorubicin|mesh-list
138308044|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138308045|NCT00002531|Methotrexate|methotrexate|mesh-list
138308046|NCT00002531|Etoposide|etoposide|mesh-list
138308047|NCT00002531|Vincristine|vincristine|mesh-list
138308048|NCT00002531|Daunorubicin|daunorubicin|mesh-list
138308049|NCT00002531|Asparaginase|asparaginase|mesh-list
138308050|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
138308051|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
138308052|NCT00002531|Thioguanine|thioguanine|mesh-list
138308053|NCT00002531|Vindesine|vindesine|mesh-list
138308054|NCT00002531|Teniposide|teniposide|mesh-list
138308055|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
138308056|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308057|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
138308058|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308059|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308060|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308061|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
138308062|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308063|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308064|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308065|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308066|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
138308067|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
138308069|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138308070|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
138308071|NCT00002531|Hormones|hormones|mesh-ancestor
138308072|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308073|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308074|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308075|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308076|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308077|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308078|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138308079|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
138308080|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308081|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308083|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308084|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138308085|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308086|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308087|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
138308088|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308089|NCT00002531|Antidotes|antidotes|mesh-ancestor
138308090|NCT00002531|Protective Agents|protective agents|mesh-ancestor
138308091|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
138308092|NCT00002531|Vitamins|vitamins|mesh-ancestor
138308093|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
138308094|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308095|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308096|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308097|NCT00002531|Analgesics|analgesics|mesh-ancestor
138308098|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
138308099|NCT00002537|Topotecan|topotecan|mesh-list
138308100|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308101|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308102|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308103|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308104|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308105|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
138308106|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138308107|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308108|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308109|NCT00002291|Pentamidine|pentamidine|mesh-list
138308110|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
138308111|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308112|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138308113|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308114|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138308115|NCT00002549|Cytarabine|cytarabine|mesh-list
138308116|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
138308117|NCT00002549|Busulfan|busulfan|mesh-list
138308118|NCT00002549|Etoposide|etoposide|mesh-list
138308119|NCT00002549|Daunorubicin|daunorubicin|mesh-list
138308120|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
138308121|NCT00002549|Idarubicin|idarubicin|mesh-list
138308122|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308123|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
138308124|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308125|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308127|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
138308128|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308129|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308130|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308131|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308132|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308133|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308134|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308135|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308136|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
138308137|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
138308138|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308139|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308140|NCT00002549|Analgesics|analgesics|mesh-ancestor
138308141|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
138308143|NCT00002555|Cobalt|cobalt|mesh-list
138308144|NCT00002555|Trace Elements|trace elements|mesh-ancestor
138308145|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
138308146|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308147|NCT00002561|Doxorubicin|doxorubicin|mesh-list
138308148|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138308149|NCT00002561|Bleomycin|bleomycin|mesh-list
138308150|NCT00002561|Dacarbazine|dacarbazine|mesh-list
138308151|NCT00002561|Vinblastine|vinblastine|mesh-list
138308152|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308153|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308154|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308155|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308156|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308160|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308161|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308162|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308163|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308164|NCT00002567|Etoposide|etoposide|mesh-list
138308165|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308166|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308167|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308168|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308169|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308170|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308171|NCT00002579|Tamoxifen|tamoxifen|mesh-list
138308172|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
138308173|NCT00002579|Fluorouracil|fluorouracil|mesh-list
138308174|NCT00002579|Methotrexate|methotrexate|mesh-list
138308175|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308176|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
138308177|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308178|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308179|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308180|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
138308182|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308184|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
138308185|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308186|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138308187|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
138308188|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308189|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308190|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308191|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138308192|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308193|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138308194|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
138308195|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308196|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308197|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138308198|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138308199|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138308200|NCT00002585|NSC 366140|nsc 366140|mesh-list
138308201|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308202|NCT00002609|Cytarabine|cytarabine|mesh-list
138308203|NCT00002609|Idarubicin|idarubicin|mesh-list
138308204|NCT00002609|Lintuzumab|lintuzumab|mesh-list
138308205|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308206|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
138308207|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308208|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308209|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
138308210|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308211|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308212|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
138308213|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308214|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308215|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308216|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308217|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308218|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138308219|NCT00002615|Fluorouracil|fluorouracil|mesh-list
138308220|NCT00002615|Epirubicin|epirubicin|mesh-list
138308221|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308222|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
138308224|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308225|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308226|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
138308227|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308228|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308229|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308230|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308231|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308232|NCT00002621|Interferons|interferons|mesh-list
138308233|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
138308234|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
138308235|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308236|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
138308237|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308238|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
138308239|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308240|NCT00002627|Paclitaxel|paclitaxel|mesh-list
138308241|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
138308242|NCT00002627|Carboplatin|carboplatin|mesh-list
138308243|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308244|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308245|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308246|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308247|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308248|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308249|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308250|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
138308251|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308252|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308253|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308254|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
138308255|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308256|NCT00002633|Leuprolide|leuprolide|mesh-list
138308257|NCT00002633|Goserelin|goserelin|mesh-list
138308258|NCT00002633|Flutamide|flutamide|mesh-list
138308259|NCT00002633|Bicalutamide|bicalutamide|mesh-list
138308260|NCT00002633|Nilutamide|nilutamide|mesh-list
138308261|NCT00002633|Buserelin|buserelin|mesh-list
138308262|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138308263|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
138308264|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308265|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308266|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308267|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308268|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
138308269|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
138308270|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308271|NCT00002639|Suramin|suramin|mesh-list
138308272|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
138308273|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
138308274|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308276|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308277|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138308278|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138308279|NCT00002657|Interferons|interferons|mesh-list
138308280|NCT00002657|Cytarabine|cytarabine|mesh-list
138308281|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
138308282|NCT00002657|Prednisone|prednisone|mesh-list
138308283|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
138308284|NCT00002657|Doxorubicin|doxorubicin|mesh-list
138308285|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138308286|NCT00002657|Methotrexate|methotrexate|mesh-list
138308287|NCT00002657|Etoposide|etoposide|mesh-list
138308288|NCT00002657|Vincristine|vincristine|mesh-list
138308289|NCT00002657|Bleomycin|bleomycin|mesh-list
138308290|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308291|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
138308292|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308293|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308294|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308295|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
138308296|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308297|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308298|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308299|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308300|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308301|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308302|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308303|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308304|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
138308306|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308307|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308308|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138308309|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
138308310|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308311|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308312|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
138308313|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308314|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138308315|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308316|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308317|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
138308318|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308319|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308320|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308321|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308322|NCT05673785|Prednisone|prednisone|mesh-list
138308323|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
138308325|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138308326|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308327|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
138308328|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308329|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308330|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308331|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
138308332|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308333|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308334|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308335|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308336|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308337|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308338|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308339|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308340|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
138308342|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308343|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308344|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138308345|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
138308346|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
138308347|NCT00381875|Sargramostim|sargramostim|mesh-list
138308348|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
138308349|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
138308350|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308351|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138308352|NCT00002669|Interferons|interferons|mesh-list
138308353|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
138308354|NCT00002669|Aldesleukin|aldesleukin|mesh-list
138308355|NCT00002669|Dacarbazine|dacarbazine|mesh-list
138308356|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308357|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
138308358|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308359|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
138308360|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308361|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308362|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308363|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308364|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
138308365|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308366|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
138308367|NCT00002675|Carboplatin|carboplatin|mesh-list
138308368|NCT00002675|Etoposide|etoposide|mesh-list
138308369|NCT00002675|Vincristine|vincristine|mesh-list
138308372|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308373|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308374|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308375|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
138308376|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308377|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308378|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308379|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308381|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308382|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308383|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308384|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308385|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308386|NCT00002681|Aldesleukin|aldesleukin|mesh-list
138308387|NCT00002681|Daclizumab|daclizumab|mesh-list
138308388|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308389|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308390|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308391|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
138308392|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308393|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308394|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
138308395|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308396|NCT02973113|Nivolumab|nivolumab|mesh-list
138308397|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138308398|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308399|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138308400|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308401|NCT00002687|Aldesleukin|aldesleukin|mesh-list
138308402|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308403|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308404|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308405|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
138308406|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308407|NCT00002693|Carboplatin|carboplatin|mesh-list
138308408|NCT00002693|Topotecan|topotecan|mesh-list
138308409|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308410|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308411|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308412|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308413|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308414|NCT00002705|Topotecan|topotecan|mesh-list
138308415|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308416|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308417|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308418|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308419|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308420|NCT00002711|Paclitaxel|paclitaxel|mesh-list
138308421|NCT00002711|Cisplatin|cisplatin|mesh-list
138308422|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308423|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308424|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308430|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308431|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308432|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308433|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308434|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308435|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308436|NCT00002723|Suramin|suramin|mesh-list
138308437|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
138308438|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
138308439|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308442|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138308443|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138308444|NCT00002735|Cobalt|cobalt|mesh-list
138308445|NCT00002735|Cisplatin|cisplatin|mesh-list
138308446|NCT00002735|Fluorouracil|fluorouracil|mesh-list
138308447|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308448|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
138308449|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308450|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308451|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308452|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
138308453|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308454|NCT00002735|Trace Elements|trace elements|mesh-ancestor
138308455|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
138308456|NCT00002747|Cobalt|cobalt|mesh-list
138308457|NCT00002747|Fluorouracil|fluorouracil|mesh-list
138308458|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308459|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
138308460|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308461|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308463|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
138308464|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308465|NCT00002747|Trace Elements|trace elements|mesh-ancestor
138308466|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
138308467|NCT02973035|Amlodipine|amlodipine|mesh-list
138308468|NCT02973035|Valsartan|valsartan|mesh-list
138308469|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138308470|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138308471|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138308472|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308473|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138308474|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308475|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
138308476|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138308477|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138308478|NCT00002753|Antibodies|antibodies|mesh-list
138308479|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138308480|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
138308481|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308482|NCT00002759|Cyclosporine|cyclosporine|mesh-list
138308483|NCT00002759|Irinotecan|irinotecan|mesh-list
138308484|NCT00002759|Phenobarbital|phenobarbital|mesh-list
138308485|NCT00002759|Cyclosporins|cyclosporins|mesh-list
138308486|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308487|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308488|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308489|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308490|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308491|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308495|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308496|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308497|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308498|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138308500|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138308501|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308502|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138308504|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308505|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
138308506|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
138308507|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138308508|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138308509|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138308510|NCT00002765|Immunotoxins|immunotoxins|mesh-list
138308511|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
138308512|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
138308513|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308514|NCT00002771|Interferons|interferons|mesh-list
138308515|NCT00002771|Cytarabine|cytarabine|mesh-list
138308516|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
138308517|NCT00002771|Busulfan|busulfan|mesh-list
138308518|NCT00002771|Idarubicin|idarubicin|mesh-list
138308519|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
138308520|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308521|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
138308522|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308523|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308524|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
138308525|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308526|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308527|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
138308528|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308529|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
138308530|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308531|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308532|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308533|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138308534|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308536|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
138308537|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308538|NCT00002777|Tamoxifen|tamoxifen|mesh-list
138308539|NCT00002777|Exemestane|exemestane|mesh-list
138308540|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308541|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138308542|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
138308543|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308544|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308545|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308546|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308547|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138308548|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138308549|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138308550|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138308551|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138308552|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308554|NCT00002783|Fluorouracil|fluorouracil|mesh-list
138308555|NCT00002783|Floxuridine|floxuridine|mesh-list
138308556|NCT00002783|Calcium|calcium|mesh-list
138308557|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
138308558|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308559|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138308560|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308561|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
138308562|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308563|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308564|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308565|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
138308566|NCT00002783|Antidotes|antidotes|mesh-ancestor
138308567|NCT00002783|Protective Agents|protective agents|mesh-ancestor
138308568|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
138308569|NCT00002783|Vitamins|vitamins|mesh-ancestor
138308570|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
138308571|NCT00002789|Cyclosporine|cyclosporine|mesh-list
138308572|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
138308573|NCT00002789|Busulfan|busulfan|mesh-list
138308574|NCT00002789|Methotrexate|methotrexate|mesh-list
138308575|NCT00002789|Cyclosporins|cyclosporins|mesh-list
138308576|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308577|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
138308578|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308579|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308580|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308581|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
138308582|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308583|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308584|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308585|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138308586|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
138308587|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308588|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308589|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
138308590|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308591|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308592|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138308593|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308595|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308596|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138308597|NCT00381953|Interferons|interferons|mesh-list
138308599|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
138308600|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
138308601|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138308602|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308603|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
138308604|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308605|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
138308606|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308607|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
138308608|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308609|NCT00382343|Trimethoprim|trimethoprim|mesh-list
138308610|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138308612|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138308613|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308614|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
138308615|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138308616|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308617|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138308621|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138308622|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138308624|NCT05749445|Ritonavir|ritonavir|mesh-list
138308625|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
138308626|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138308627|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138308628|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138308629|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
138308630|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308631|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308632|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308633|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308634|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
138308635|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308636|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138308637|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138308638|NCT05749367|Ropivacaine|ropivacaine|mesh-list
138308639|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138308640|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
138308641|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
138308642|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308643|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308644|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
138308645|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308646|NCT05749289|Octreotide|octreotide|mesh-list
138308647|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138308648|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308649|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308652|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308653|NCT05545319|Ritonavir|ritonavir|mesh-list
138308654|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
138308655|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138308657|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
138308658|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308659|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308660|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308661|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308662|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
138308663|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308664|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138308665|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138308666|NCT05523869|Topotecan|topotecan|mesh-list
138308667|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308668|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308669|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308670|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308671|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308672|NCT05522465|Dexamethasone|dexamethasone|mesh-list
138308673|NCT05522465|Prednisone|prednisone|mesh-list
138308674|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308675|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
138308676|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
138308677|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308678|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308679|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138308680|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
138308681|NCT05522465|Hormones|hormones|mesh-ancestor
138308682|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308683|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138308684|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308685|NCT05215691|Morphine|morphine|mesh-list
138308689|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308690|NCT05215691|Analgesics|analgesics|mesh-ancestor
138308691|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
138308692|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308693|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138308694|NCT05204147|Antibodies|antibodies|mesh-list
138308695|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
138308697|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138308698|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
138308699|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308700|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308701|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
138308702|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
138308703|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308704|NCT04824053|Selenium|selenium|mesh-list
138308705|NCT04824053|Caseins|caseins|mesh-list
138308706|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
138308707|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308708|NCT04824053|Protective Agents|protective agents|mesh-ancestor
138308709|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308710|NCT04824053|Trace Elements|trace elements|mesh-ancestor
138308711|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
138308712|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
138308713|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
138308714|NCT04811339|Bismuth|bismuth|mesh-list
138308715|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138308716|NCT04811339|Antacids|antacids|mesh-ancestor
138308717|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308718|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138308719|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
138308720|NCT04331093|Apatinib|apatinib|mesh-list
138308721|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308722|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138308723|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308724|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308725|NCT00382421|Aspirin|aspirin|mesh-list
138308726|NCT00382421|Amlodipine|amlodipine|mesh-list
138308727|NCT00382421|Bisoprolol|bisoprolol|mesh-list
138308728|NCT00382421|Molsidomine|molsidomine|mesh-list
138308729|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138308730|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138308731|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138308732|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308733|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138308734|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308735|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
138308736|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138308737|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138308738|NCT00382421|Analgesics|analgesics|mesh-ancestor
138308740|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308741|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308742|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308743|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138308744|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138308745|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138308746|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138308747|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308748|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
138308749|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
138308751|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138308752|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138308753|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138308754|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138308755|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308756|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138308757|NCT05007509|Vaccines|vaccines|mesh-list
138308758|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
138308759|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308760|NCT00382499|Lidocaine|lidocaine|mesh-list
138308761|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
138308762|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
138308763|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308764|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308765|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
138308766|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308767|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138308768|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138308769|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138308770|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138308771|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308773|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
138308774|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308775|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308776|NCT00382889|Beclomethasone|beclomethasone|mesh-list
138308777|NCT00382889|Albuterol|albuterol|mesh-list
138308778|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138308779|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
138308780|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308781|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308782|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138308783|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
138308784|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
138308785|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308786|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138308787|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138308788|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138308789|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
138308790|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308791|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308792|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308793|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
138308794|NCT00382889|Hormones|hormones|mesh-ancestor
138308795|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138308796|NCT04482959|Carbetocin|carbetocin|mesh-list
138308797|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
138308798|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308799|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308800|NCT04571879|Lidocaine|lidocaine|mesh-list
138308801|NCT04571879|Midazolam|midazolam|mesh-list
138308802|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
138308803|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
138308804|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308805|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308806|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
138308807|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138308808|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138308809|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138308810|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138308811|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138308812|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308813|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138308814|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138308815|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138308816|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138308817|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138308818|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138308819|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
138308820|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
138308821|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
138308822|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308823|NCT04563533|Vaccines|vaccines|mesh-list
138308824|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
138308825|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308826|NCT04332107|Azithromycin|azithromycin|mesh-list
138308827|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138308828|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308829|NCT04328285|Ritonavir|ritonavir|mesh-list
138308830|NCT04328285|Lopinavir|lopinavir|mesh-list
138308831|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
138308832|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138308833|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138308834|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
138308835|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308836|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308837|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308838|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308839|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
138308840|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308841|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138308842|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138308844|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138308845|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308846|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308848|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138308849|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308850|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138308851|NCT00002897|Fluorouracil|fluorouracil|mesh-list
138308852|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308853|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
138308854|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308855|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308856|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308857|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
138308858|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308859|NCT00002903|Docetaxel|docetaxel|mesh-list
138308860|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308861|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308862|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308863|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308864|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308865|NCT03375203|Zolpidem|zolpidem|mesh-list
138308866|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138308867|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138308868|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308869|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308870|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138308871|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
138308872|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
138308873|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308874|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308875|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138308876|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308877|NCT00002915|Penclomedine|penclomedine|mesh-list
138308878|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308879|NCT00002921|Suramin|suramin|mesh-list
138308880|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
138308881|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138308882|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138308883|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138308884|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138308885|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
138308886|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
138308887|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308888|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308889|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308890|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138308892|NCT00383045|Naltrexone|naltrexone|mesh-list
138308893|NCT00383045|Buprenorphine|buprenorphine|mesh-list
138308894|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138308895|NCT00383045|Narcotics|narcotics|mesh-ancestor
138308896|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138308897|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308898|NCT00383045|Analgesics|analgesics|mesh-ancestor
138308899|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
138308905|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308906|NCT00002933|Irinotecan|irinotecan|mesh-list
138308907|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138308908|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308909|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308910|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308911|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308913|NCT00002939|Irinotecan|irinotecan|mesh-list
138308914|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308915|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308916|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308917|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308918|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308919|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308921|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138308922|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308923|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
138308924|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138308925|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308926|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138308927|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308928|NCT03085823|Sirolimus|sirolimus|mesh-list
138308929|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138308930|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308931|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308932|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308933|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
138308934|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308935|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
138308936|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308937|NCT00002945|Cytarabine|cytarabine|mesh-list
138308938|NCT00002945|Aldesleukin|aldesleukin|mesh-list
138308939|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
138308940|NCT00002945|Melphalan|melphalan|mesh-list
138366574|NCT06037876|Tubulin Modulators|tubulin modulators|mesh-ancestor
138366575|NCT06037876|Antimitotic Agents|antimitotic agents|mesh-ancestor
138366576|NCT06037876|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366577|NCT06037876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366578|NCT06037876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366579|NCT06037590|Levodopa|levodopa|mesh-list
138308941|NCT00002945|Etoposide|etoposide|mesh-list
138308942|NCT00002945|Idarubicin|idarubicin|mesh-list
138308943|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308944|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
138308945|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308946|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138308947|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308948|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
138308949|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308950|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308951|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308952|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308955|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308956|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308957|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
138308958|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
138308959|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138308960|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138308961|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138308962|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138308963|NCT00002951|Fluorouracil|fluorouracil|mesh-list
138308964|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
138308965|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
138308966|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308967|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138308968|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308969|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308970|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
138308971|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308972|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
138308973|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308974|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308975|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
138308977|NCT03058289|Antibodies|antibodies|mesh-list
138308978|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
138308979|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
138308980|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308981|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138308982|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308983|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138308984|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308985|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138308986|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138308987|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138308988|NCT00002969|Paclitaxel|paclitaxel|mesh-list
138308989|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138308990|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308991|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
138308992|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308993|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308994|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308995|NCT00002987|Prednisolone|prednisolone|mesh-list
138308996|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
138308997|NCT00002987|Doxorubicin|doxorubicin|mesh-list
138308998|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309000|NCT00002987|Vincristine|vincristine|mesh-list
138366585|NCT06037590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366586|NCT06029907|Varenicline|varenicline|mesh-list
138366587|NCT06029907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138366588|NCT06029907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138366589|NCT06029907|Cholinergic Agents|cholinergic agents|mesh-ancestor
138366590|NCT06029907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309001|NCT00002987|Bleomycin|bleomycin|mesh-list
138309002|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309003|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
138309004|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309005|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309006|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309007|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
138309008|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309009|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309010|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309011|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309012|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309013|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309014|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309015|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309016|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309017|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309018|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309019|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309020|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
138309022|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309023|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309024|NCT02919683|Nivolumab|nivolumab|mesh-list
138309025|NCT02919683|Ipilimumab|ipilimumab|mesh-list
138309026|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138309027|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309028|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138309029|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309031|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138309032|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138309033|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
138309034|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309035|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138309036|NCT00002993|Doxorubicin|doxorubicin|mesh-list
138309038|NCT00002993|Mitomycins|mitomycins|mesh-list
138309039|NCT00002993|Mitomycin|mitomycin|mesh-list
138309040|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309041|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309042|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309043|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309044|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309045|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309046|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
138309047|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309048|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138309049|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138309050|NCT01928082|Estradiol|estradiol|mesh-list
138309051|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138309052|NCT01928082|Estrogens|estrogens|mesh-ancestor
138309053|NCT01928082|Hormones|hormones|mesh-ancestor
138309054|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309055|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309056|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138309058|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309059|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138309061|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309062|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
138309063|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309064|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309065|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309066|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
138309067|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309068|NCT00003005|Cordycepin|cordycepin|mesh-list
138309069|NCT00003005|Pentostatin|pentostatin|mesh-list
138309070|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309071|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138309072|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309073|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309074|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
138309075|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309076|NCT00003011|Marimastat|marimastat|mesh-list
138309077|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309078|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309079|NCT00003017|Interleukin-12|interleukin-12|mesh-list
138309080|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309081|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
138309082|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309083|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138309084|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138309085|NCT00003017|Growth Substances|growth substances|mesh-ancestor
138309086|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
138309087|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309088|NCT00003023|Vaccines|vaccines|mesh-list
138309089|NCT00003023|Antibodies|antibodies|mesh-list
138309090|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138309091|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
138309092|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
138309093|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309094|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309095|NCT03850067|Carboplatin|carboplatin|mesh-list
138309096|NCT03850067|Nivolumab|nivolumab|mesh-list
138309097|NCT03850067|Etoposide|etoposide|mesh-list
138309098|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
138309099|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309100|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138309101|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138309102|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309103|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309104|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309105|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309112|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309114|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309115|NCT00003035|Tamoxifen|tamoxifen|mesh-list
138309116|NCT00003035|Paclitaxel|paclitaxel|mesh-list
138309117|NCT00003035|Doxorubicin|doxorubicin|mesh-list
138309118|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309119|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309120|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309121|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309122|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309123|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309124|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309125|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309126|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309127|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309128|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309129|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309130|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138309131|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
138309132|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309133|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309134|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138309135|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138309136|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138309137|NCT00003041|NSC 366140|nsc 366140|mesh-list
138309138|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309139|NCT00003053|Etoposide|etoposide|mesh-list
138309140|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309141|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309142|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309143|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309144|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309145|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309146|NCT00003065|Paclitaxel|paclitaxel|mesh-list
138309147|NCT00003065|Topotecan|topotecan|mesh-list
138309148|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309149|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309150|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309151|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309152|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309153|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309154|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138309155|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309156|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309157|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
138309158|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
138309159|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138309160|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138309162|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309163|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309164|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309166|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138309167|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138309168|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138309169|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309170|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138309171|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
138309172|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
138309173|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309178|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309180|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309181|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309182|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309183|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309184|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138309185|NCT00003089|Protective Agents|protective agents|mesh-ancestor
138309186|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309187|NCT00003101|Vincristine|vincristine|mesh-list
138309188|NCT00003101|Busulfan|busulfan|mesh-list
138309189|NCT00003101|Thiotepa|thiotepa|mesh-list
138309190|NCT00003101|Lomustine|lomustine|mesh-list
138309191|NCT00003101|Procarbazine|procarbazine|mesh-list
138309192|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
138309193|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309194|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309195|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309196|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309197|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309198|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309199|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309200|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
138309201|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309202|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309203|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309204|NCT00003107|Interleukin-12|interleukin-12|mesh-list
138309205|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309206|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
138309207|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309208|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138309209|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138309210|NCT00003107|Growth Substances|growth substances|mesh-ancestor
138309212|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309214|NCT00003113|Lomustine|lomustine|mesh-list
138309215|NCT00003113|Etoposide|etoposide|mesh-list
138309216|NCT00003113|Procarbazine|procarbazine|mesh-list
138309217|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309218|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
138309219|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309220|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309221|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309222|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
138309223|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309224|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309225|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309226|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309227|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309228|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309229|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309231|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
138309232|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
138309233|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
138366599|NCT06011798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366600|NCT05988710|Oxycodone|oxycodone|mesh-list
138309234|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138309235|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309236|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
138309237|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309238|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138309240|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138309241|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138309242|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309243|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309246|NCT01545557|Protective Agents|protective agents|mesh-ancestor
138309247|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
138309248|NCT00003119|Carboplatin|carboplatin|mesh-list
138309249|NCT00003119|Doxorubicin|doxorubicin|mesh-list
138309250|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309251|NCT00003119|Etoposide|etoposide|mesh-list
138309252|NCT00003119|Sargramostim|sargramostim|mesh-list
138309253|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309254|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
138309255|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309256|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309257|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309258|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
138309259|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309260|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309261|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309262|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309263|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309264|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309265|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309266|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309267|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
138309268|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309269|NCT00003401|Dexamethasone|dexamethasone|mesh-list
138309270|NCT00003401|Paclitaxel|paclitaxel|mesh-list
138309271|NCT00003401|Etoposide|etoposide|mesh-list
138309272|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
138309273|NCT00003401|Gemcitabine|gemcitabine|mesh-list
138309274|NCT00003401|Melphalan|melphalan|mesh-list
138309275|NCT00003401|Carmustine|carmustine|mesh-list
138309276|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309277|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309278|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309279|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309280|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309281|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309282|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309283|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
138309284|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309285|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309286|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309287|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
138309288|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309289|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309290|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
138309291|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
138309292|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309293|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309294|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
138309295|NCT00003401|Hormones|hormones|mesh-ancestor
138309296|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309297|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309298|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309299|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
138309300|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309301|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309302|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309303|NCT00003125|Aldesleukin|aldesleukin|mesh-list
138309304|NCT00003125|Vaccines|vaccines|mesh-list
138309305|NCT00003125|Sargramostim|sargramostim|mesh-list
138309306|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
138309307|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309308|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309309|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138309310|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138309311|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
138309312|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309314|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138309315|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309317|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
138309318|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
138309319|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309320|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
138309321|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138309322|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138309323|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138309324|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138309325|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309326|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
138309327|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309328|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309329|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138309330|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309331|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
138309332|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138309333|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309334|NCT00003413|Paclitaxel|paclitaxel|mesh-list
138309335|NCT00003413|Melphalan|melphalan|mesh-list
138309336|NCT00003413|Carmustine|carmustine|mesh-list
138309337|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309338|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309339|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309340|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309341|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309342|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309343|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
138309344|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309345|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309346|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
138309347|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309348|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309349|NCT00003137|Irinotecan|irinotecan|mesh-list
138309350|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138309351|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309352|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309353|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309354|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309355|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
138309356|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309357|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
138309358|NCT00003425|Melphalan|melphalan|mesh-list
138309359|NCT00003425|Amifostine|amifostine|mesh-list
138309360|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309361|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
138309362|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309368|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309369|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138309370|NCT00003425|Protective Agents|protective agents|mesh-ancestor
138309371|NCT00330551|Risperidone|risperidone|mesh-list
138309372|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138309373|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
138309374|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309375|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309376|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309377|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138309378|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138309379|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138309380|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138309381|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138309386|NCT00001259|Estrogens|estrogens|mesh-ancestor
138309387|NCT00001259|Hormones|hormones|mesh-ancestor
138309388|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309389|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309390|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309391|NCT00001259|Progestins|progestins|mesh-ancestor
138309392|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138309393|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
138309394|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309395|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309396|NCT00003143|Amifostine|amifostine|mesh-list
138309397|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138309398|NCT00003143|Protective Agents|protective agents|mesh-ancestor
138309399|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309400|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
138309401|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309402|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
138309403|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309404|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138309405|NCT00003431|Protective Agents|protective agents|mesh-ancestor
138309406|NCT00003149|Interleukin-12|interleukin-12|mesh-list
138309407|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309408|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
138309409|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309410|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138309411|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138309412|NCT00003149|Growth Substances|growth substances|mesh-ancestor
138309413|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
138309414|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309415|NCT00003437|Cytarabine|cytarabine|mesh-list
138309418|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
138309419|NCT00003437|Doxorubicin|doxorubicin|mesh-list
138309420|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309421|NCT00003437|Methotrexate|methotrexate|mesh-list
138309422|NCT00003437|Vincristine|vincristine|mesh-list
138309423|NCT00003437|Daunorubicin|daunorubicin|mesh-list
138309424|NCT00003437|Asparaginase|asparaginase|mesh-list
138309425|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
138309426|NCT00003437|Pegaspargase|pegaspargase|mesh-list
138309427|NCT00003437|Thioguanine|thioguanine|mesh-list
138309428|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309429|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
138309430|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309431|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309432|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309433|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
138309434|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309435|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309436|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309437|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309438|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
138309439|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
138309440|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309441|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309442|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
138309443|NCT00003437|Hormones|hormones|mesh-ancestor
138309444|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309445|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309446|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309447|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309448|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309449|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309450|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309451|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309452|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309453|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309454|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
138309455|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309456|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309457|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309458|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
138309459|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309460|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309461|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309462|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309463|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309464|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
138309465|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138309467|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309468|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309469|NCT00003449|Dexamethasone|dexamethasone|mesh-list
138309470|NCT00003449|Paclitaxel|paclitaxel|mesh-list
138309471|NCT00003449|Gemcitabine|gemcitabine|mesh-list
138309472|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309473|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309474|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309475|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309476|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309477|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309478|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309479|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
138309480|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
138309481|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309482|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309483|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309484|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
138309486|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309487|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309488|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309489|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
138309490|NCT00002801|Leucovorin|leucovorin|mesh-list
138309491|NCT00002801|Tegafur|tegafur|mesh-list
138309492|NCT00002801|Calcium|calcium|mesh-list
138309493|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
138309494|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138309495|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309496|NCT00002801|Antidotes|antidotes|mesh-ancestor
138309497|NCT00002801|Protective Agents|protective agents|mesh-ancestor
138309498|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
138309499|NCT00002801|Vitamins|vitamins|mesh-ancestor
138309500|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
138309501|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309502|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
138309503|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309504|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309505|NCT00002813|Vinorelbine|vinorelbine|mesh-list
138309507|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309508|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309509|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309510|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309511|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309512|NCT00002819|Paclitaxel|paclitaxel|mesh-list
138309513|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
138309514|NCT00002819|Carboplatin|carboplatin|mesh-list
138309515|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
138309516|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309517|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309520|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309521|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309522|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309523|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
138309524|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309525|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309526|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309527|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
138309528|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309529|NCT00002819|Analgesics|analgesics|mesh-ancestor
138309530|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
138309531|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309532|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309533|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309534|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309535|NCT00002825|Docetaxel|docetaxel|mesh-list
138309536|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309537|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309538|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309539|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309542|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
138309543|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138309544|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138309545|NCT00002831|Prednisolone|prednisolone|mesh-list
138309546|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
138309547|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
138309548|NCT00002831|Busulfan|busulfan|mesh-list
138309549|NCT00002831|Methotrexate|methotrexate|mesh-list
138309550|NCT00002831|Decitabine|decitabine|mesh-list
138309551|NCT00002831|Tacrolimus|tacrolimus|mesh-list
138309552|NCT00002831|Cyclosporins|cyclosporins|mesh-list
138309553|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138309554|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
138309555|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309556|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
138309557|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309558|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309559|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309560|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
138309561|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309562|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309564|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309565|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309566|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309567|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309568|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
138309569|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309570|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309571|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309572|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309573|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138309574|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
138309575|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309576|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309577|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
138309578|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
138309579|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309580|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309581|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
138309582|NCT00002831|Hormones|hormones|mesh-ancestor
138309583|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309584|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138309585|NCT00002831|Protective Agents|protective agents|mesh-ancestor
138309586|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309587|NCT00002837|Paclitaxel|paclitaxel|mesh-list
138309588|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
138309604|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309605|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309606|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309607|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309609|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138309611|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309612|NCT00003467|Carmustine|carmustine|mesh-list
138309613|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309614|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
138309615|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309616|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309617|NCT00002849|Interferons|interferons|mesh-list
138309618|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
138309619|NCT00002849|Dexamethasone|dexamethasone|mesh-list
138309620|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309621|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
138309622|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
138309623|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309624|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309625|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309626|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
138309627|NCT00002849|Hormones|hormones|mesh-ancestor
138309628|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309629|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309631|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
138309632|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309633|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
138309634|NCT00002855|Ketoconazole|ketoconazole|mesh-list
138309635|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
138309636|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138309637|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138309638|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138309639|NCT00002855|Doxorubicin|doxorubicin|mesh-list
138309640|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309641|NCT00002855|Bicalutamide|bicalutamide|mesh-list
138309642|NCT00002855|Vinblastine|vinblastine|mesh-list
138309643|NCT00002855|Flutamide|flutamide|mesh-list
138309644|NCT00002855|Estramustine|estramustine|mesh-list
138309645|NCT00002855|Nilutamide|nilutamide|mesh-list
138309646|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309655|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138309656|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138309657|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138309658|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
138309659|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309660|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309661|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138309662|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
138309663|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309664|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309665|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309666|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309667|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309668|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309671|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
138309672|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309673|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309674|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
138309675|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309676|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309677|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309678|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309679|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138309680|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
138309681|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138309682|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138309683|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138309684|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
138309685|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309686|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309687|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138309688|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138309689|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138309690|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309691|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309692|NCT00002879|Cladribine|cladribine|mesh-list
138309693|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309694|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309695|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
138309696|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309697|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
138309698|NCT00003185|Sargramostim|sargramostim|mesh-list
138309699|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309700|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
138309701|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309702|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309703|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309707|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309708|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
138309709|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309710|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309711|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309712|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309713|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309715|NCT00003935|Vincristine|vincristine|mesh-list
138309716|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309717|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309718|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309719|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309720|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309721|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309722|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309723|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309724|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309725|NCT00003191|Fenretinide|fenretinide|mesh-list
138309726|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309727|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138309728|NCT00003191|Protective Agents|protective agents|mesh-ancestor
138309729|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309730|NCT00003941|Etoposide|etoposide|mesh-list
138309731|NCT00003941|Ifosfamide|ifosfamide|mesh-list
138309732|NCT00003941|Bleomycin|bleomycin|mesh-list
138309733|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309734|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309735|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309737|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309738|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309739|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309740|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
138309741|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309742|NCT00384527|Vancomycin|vancomycin|mesh-list
138309743|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
138309744|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138309745|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309746|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138309747|NCT00003569|Paclitaxel|paclitaxel|mesh-list
138309748|NCT00003569|Cisplatin|cisplatin|mesh-list
138309749|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309750|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309751|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309752|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309754|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309756|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
138309757|NCT00003953|Docetaxel|docetaxel|mesh-list
138309758|NCT00003953|Doxorubicin|doxorubicin|mesh-list
138309759|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309760|NCT00003953|Fluorouracil|fluorouracil|mesh-list
138309761|NCT00003953|Methotrexate|methotrexate|mesh-list
138309762|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309763|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
138309764|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309765|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309766|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309767|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
138309768|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309769|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309770|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309777|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309779|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309780|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309781|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309782|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309783|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309784|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309785|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309786|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138309787|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
138309788|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309789|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309790|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138309791|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138309792|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138309793|NCT00003959|Sargramostim|sargramostim|mesh-list
138309794|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
138309795|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309796|NCT02972723|Metformin|metformin|mesh-list
138309797|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138309798|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309799|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
138309800|NCT00003203|Cisplatin|cisplatin|mesh-list
138309801|NCT00003203|Carboplatin|carboplatin|mesh-list
138309802|NCT00003203|Vincristine|vincristine|mesh-list
138309803|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309804|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
138309805|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309806|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309807|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309808|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
138309809|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309810|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309811|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309812|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309813|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309814|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309815|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309817|NCT00003575|Ifosfamide|ifosfamide|mesh-list
138309818|NCT00003575|Interleukin-12|interleukin-12|mesh-list
138309819|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309820|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309821|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309822|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309823|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309824|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309826|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
138309827|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309828|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309829|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
138309830|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138309831|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138309832|NCT00003575|Growth Substances|growth substances|mesh-ancestor
138309834|NCT00003539|Paclitaxel|paclitaxel|mesh-list
138309835|NCT00003539|Trastuzumab|trastuzumab|mesh-list
138309836|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309837|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309838|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309839|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309840|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309841|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309842|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138309843|NCT00003209|Fluorouracil|fluorouracil|mesh-list
138309844|NCT00003209|Methotrexate|methotrexate|mesh-list
138309845|NCT00003209|Ifosfamide|ifosfamide|mesh-list
138309846|NCT00003209|Mitomycins|mitomycins|mesh-list
138309847|NCT00003209|Mitomycin|mitomycin|mesh-list
138309848|NCT00003209|Bleomycin|bleomycin|mesh-list
138309849|NCT00003209|Vinblastine|vinblastine|mesh-list
138309850|NCT00003209|Vindesine|vindesine|mesh-list
138309851|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309852|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
138309853|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309854|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309855|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309856|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
138309857|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309858|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309859|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309860|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309861|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309862|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309863|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309864|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309865|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309866|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309867|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
138309868|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309869|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309870|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309871|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309872|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309873|NCT00003587|Paclitaxel|paclitaxel|mesh-list
138309874|NCT00003587|Vinorelbine|vinorelbine|mesh-list
138309875|NCT00003587|Docetaxel|docetaxel|mesh-list
138309876|NCT00003587|Carboplatin|carboplatin|mesh-list
138309877|NCT00003587|Gemcitabine|gemcitabine|mesh-list
138309878|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309879|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309880|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309881|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309882|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309883|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309884|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309885|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
138309886|NCT00003215|Leucovorin|leucovorin|mesh-list
138309887|NCT00003215|Cytarabine|cytarabine|mesh-list
138309888|NCT00003215|Prednisone|prednisone|mesh-list
138309889|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
138309890|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
138309891|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138309892|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138309893|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138309894|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
138309895|NCT00003215|Melphalan|melphalan|mesh-list
138309896|NCT00003215|Doxorubicin|doxorubicin|mesh-list
138309897|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138309898|NCT00003215|Methotrexate|methotrexate|mesh-list
138309899|NCT00003215|Etoposide|etoposide|mesh-list
138309901|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
138309902|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
138309903|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309904|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
138309906|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309907|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309908|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
138309909|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309910|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309911|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138309912|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309913|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309914|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309915|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309916|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309917|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
138309918|NCT00003215|Hormones|hormones|mesh-ancestor
138309919|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138309920|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138309921|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309922|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309923|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309924|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309925|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
138309926|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309927|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309928|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309929|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309931|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309932|NCT00003215|Antidotes|antidotes|mesh-ancestor
138309933|NCT00003215|Protective Agents|protective agents|mesh-ancestor
138309934|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
138309936|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
138309937|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309938|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309939|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309940|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
138309941|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
138309942|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309943|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138309944|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138309945|NCT00003215|Analgesics|analgesics|mesh-ancestor
138309946|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
138309947|NCT00003995|Trastuzumab|trastuzumab|mesh-list
138309949|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138309950|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309951|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138309952|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309953|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309954|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309956|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
138309957|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138309958|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138309959|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138309960|NCT00003593|Methotrexate|methotrexate|mesh-list
138309961|NCT00003593|Thioguanine|thioguanine|mesh-list
138309962|NCT00003593|Daunorubicin|daunorubicin|mesh-list
138309963|NCT00003593|Asparaginase|asparaginase|mesh-list
138309964|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138309965|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
138309966|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138309967|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309968|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309969|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
138309970|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309971|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309972|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309973|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309978|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138309979|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
138309980|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309981|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309982|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138309983|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309984|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309985|NCT00003599|Vitamin E|vitamin e|mesh-list
138309986|NCT00003599|Tocopherols|tocopherols|mesh-list
138309987|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
138309988|NCT00003599|Isotretinoin|isotretinoin|mesh-list
138309989|NCT00003599|Vitamins|vitamins|mesh-ancestor
138309990|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
138309991|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309992|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
138309993|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309994|NCT00003599|Protective Agents|protective agents|mesh-ancestor
138309995|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309996|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
138309997|NCT00003605|Rituximab|rituximab|mesh-list
138309998|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309999|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
138310000|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310001|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310002|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310003|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
138310004|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310005|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310006|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310007|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310008|NCT00003611|Acitretin|acitretin|mesh-list
138310009|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
138310010|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
138310011|NCT00003617|Clarithromycin|clarithromycin|mesh-list
138310012|NCT00003617|Tinidazole|tinidazole|mesh-list
138310013|NCT00003617|Chlorambucil|chlorambucil|mesh-list
138310014|NCT00003617|Omeprazole|omeprazole|mesh-list
138310015|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138310016|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310017|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138310018|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310019|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310020|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138310021|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310022|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138310023|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138310024|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138310025|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310026|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
138310027|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310028|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138310029|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138310030|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138310031|NCT00004001|Prednisone|prednisone|mesh-list
138310032|NCT00004001|Docetaxel|docetaxel|mesh-list
138310033|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
138310034|NCT00004001|Estramustine|estramustine|mesh-list
138310035|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310036|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310037|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310038|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310039|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310040|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310041|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
138310042|NCT00004001|Hormones|hormones|mesh-ancestor
138310043|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310047|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
138310048|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310049|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310050|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310051|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310052|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310053|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
138310054|NCT00004013|Paclitaxel|paclitaxel|mesh-list
138310055|NCT00004013|Trastuzumab|trastuzumab|mesh-list
138310056|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310057|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310058|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310059|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310060|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310061|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310062|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310063|NCT00004025|Aldesleukin|aldesleukin|mesh-list
138310064|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310065|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138310066|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138310067|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
138310068|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310069|NCT00004037|Docetaxel|docetaxel|mesh-list
138310070|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310071|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310072|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310073|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310074|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310075|NCT00004043|Calcitriol|calcitriol|mesh-list
138310076|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310077|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310078|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138310079|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138310080|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310081|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138310083|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
138310084|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138310085|NCT00004055|Paclitaxel|paclitaxel|mesh-list
138310086|NCT00004055|Topotecan|topotecan|mesh-list
138310087|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310088|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310089|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310090|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310091|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310092|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310093|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310094|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310095|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310096|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
138310097|NCT00004061|Ifosfamide|ifosfamide|mesh-list
138310098|NCT00004061|Etoposide|etoposide|mesh-list
138310099|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310100|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
138310101|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310102|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310103|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310104|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
138310105|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310106|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310107|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310108|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310114|NCT00004067|Doxorubicin|doxorubicin|mesh-list
138310115|NCT00004067|Trastuzumab|trastuzumab|mesh-list
138310116|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138310117|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310118|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310120|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310121|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310122|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310123|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310124|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
138310125|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310126|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310127|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310128|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
138310129|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310130|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138310131|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310132|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310133|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310134|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310135|NCT00004073|Suramin|suramin|mesh-list
138310136|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
138310137|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
138310138|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138310139|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310140|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310141|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138310142|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138310144|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138310145|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
138310146|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310147|NCT00004091|Antibodies|antibodies|mesh-list
138310148|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
138310149|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310150|NCT00004097|Paclitaxel|paclitaxel|mesh-list
138310151|NCT00004097|Gemcitabine|gemcitabine|mesh-list
138310152|NCT00004097|Fluorouracil|fluorouracil|mesh-list
138310153|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310154|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310155|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310156|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310157|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310159|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310160|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
138310161|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310162|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
138310163|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310165|NCT00004103|Floxuridine|floxuridine|mesh-list
138310166|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310167|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310168|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310169|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310170|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310171|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310172|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
138310173|NCT00004109|Doxorubicin|doxorubicin|mesh-list
138310174|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138310175|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138310176|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310177|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310178|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310179|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310180|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310181|NCT00003239|Interferons|interferons|mesh-list
138310182|NCT00003239|Cytarabine|cytarabine|mesh-list
138310183|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
138310184|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
138310185|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
138310186|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310187|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
138310188|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310189|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310190|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
138310191|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310192|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310193|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
138310194|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310195|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310196|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138310197|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310198|NCT00004115|Antibodies|antibodies|mesh-list
138310199|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138310200|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
138310201|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310202|NCT00003245|Irinotecan|irinotecan|mesh-list
138310203|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310204|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310205|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310206|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310209|NCT00004127|Fluorouracil|fluorouracil|mesh-list
138310210|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
138310211|NCT00004127|Calcium|calcium|mesh-list
138310212|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
138310213|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310214|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310215|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
138310216|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310217|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310218|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310219|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310220|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
138310221|NCT00004127|Antidotes|antidotes|mesh-ancestor
138310222|NCT00004127|Protective Agents|protective agents|mesh-ancestor
138310223|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310224|NCT00004127|Vitamins|vitamins|mesh-ancestor
138310225|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
138310226|NCT00003251|Paclitaxel|paclitaxel|mesh-list
138310227|NCT00003251|Amifostine|amifostine|mesh-list
138310228|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310229|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310230|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310231|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310232|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310233|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310234|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138310235|NCT00003251|Protective Agents|protective agents|mesh-ancestor
138310236|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310237|NCT00004139|Gemcitabine|gemcitabine|mesh-list
138310238|NCT00004139|Docetaxel|docetaxel|mesh-list
138310239|NCT00004139|Irinotecan|irinotecan|mesh-list
138310240|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310241|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
138310242|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310243|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310244|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310245|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310246|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310247|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310248|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310249|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310250|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
138310254|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310255|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
138310256|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310257|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310258|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310259|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
138310260|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310261|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310262|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310263|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310264|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
138310265|NCT00003263|Interferons|interferons|mesh-list
138310266|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
138310267|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310268|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
138310269|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310271|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310272|NCT00004157|Oprelvekin|oprelvekin|mesh-list
138310273|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310274|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
138310275|NCT00003269|Etoposide|etoposide|mesh-list
138310276|NCT00003269|Sargramostim|sargramostim|mesh-list
138310277|NCT00003269|Amifostine|amifostine|mesh-list
138310278|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310279|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
138310280|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310281|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310282|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310283|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
138310284|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310285|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310286|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310287|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310288|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310289|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310290|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310291|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138310292|NCT00003269|Protective Agents|protective agents|mesh-ancestor
138310293|NCT00004163|Trastuzumab|trastuzumab|mesh-list
138310294|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310295|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310296|NCT00003281|Paclitaxel|paclitaxel|mesh-list
138310297|NCT00003281|Topotecan|topotecan|mesh-list
138310298|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310299|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310300|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310301|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310303|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310304|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310305|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310306|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310307|NCT00003287|Leucovorin|leucovorin|mesh-list
138310308|NCT00003287|Fluorouracil|fluorouracil|mesh-list
138310309|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
138310310|NCT00003287|Calcium|calcium|mesh-list
138310311|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
138310312|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310313|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310314|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
138310315|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310316|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310317|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310318|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310325|NCT00004187|Capecitabine|capecitabine|mesh-list
138310326|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
138310327|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310328|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
138310329|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310330|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310331|NCT00384137|Tacrolimus|tacrolimus|mesh-list
138310332|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310333|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
138310334|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310335|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138310336|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310337|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310338|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
138310339|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138310340|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310341|NCT00003293|Procarbazine|procarbazine|mesh-list
138310342|NCT00003293|Leflunomide|leflunomide|mesh-list
138310343|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310344|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310345|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310346|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
138310347|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310348|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310349|NCT00004199|Gemcitabine|gemcitabine|mesh-list
138310350|NCT00004199|Prinomastat|prinomastat|mesh-list
138310351|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310354|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310355|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138310356|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
138310357|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310359|NCT00003299|Etoposide|etoposide|mesh-list
138310360|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310361|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310362|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310363|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310364|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310365|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310366|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310367|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310368|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310369|NCT00004205|Tamoxifen|tamoxifen|mesh-list
138310370|NCT00004205|Letrozole|letrozole|mesh-list
138310371|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310372|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310373|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138310374|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138310375|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310376|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138310377|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
138310378|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310380|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310381|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138310382|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138310383|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138310384|NCT00003305|Leucovorin|leucovorin|mesh-list
138310385|NCT00003305|Calcium|calcium|mesh-list
138310386|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
138310392|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310393|NCT00003305|Vitamins|vitamins|mesh-ancestor
138310394|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
138310395|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138310396|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310397|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310398|NCT00003311|Cytarabine|cytarabine|mesh-list
138310399|NCT00003311|Dexamethasone|dexamethasone|mesh-list
138310400|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
138310401|NCT00003311|Doxorubicin|doxorubicin|mesh-list
138310402|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138310403|NCT00003311|Methotrexate|methotrexate|mesh-list
138310404|NCT00003311|Vincristine|vincristine|mesh-list
138310405|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310406|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
138310407|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310408|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310409|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310410|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
138310411|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310412|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310413|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310414|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310415|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
138310416|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
138310417|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310418|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310419|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
138310420|NCT00003311|Hormones|hormones|mesh-ancestor
138310421|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310422|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310423|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138310424|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310425|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310426|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310427|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138310428|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
138310429|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138310430|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310431|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
138310432|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
138310433|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138310434|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138310435|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
138310436|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310437|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310438|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310439|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310440|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310441|NCT00003317|Paclitaxel|paclitaxel|mesh-list
138310442|NCT00003317|Carboplatin|carboplatin|mesh-list
138310443|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310444|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310445|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310446|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310447|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310448|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310449|NCT00004217|Cytarabine|cytarabine|mesh-list
138310456|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
138310457|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310458|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310459|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
138310460|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310461|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138310462|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310463|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310464|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310465|NCT00003323|Flutamide|flutamide|mesh-list
138310466|NCT00003323|Finasteride|finasteride|mesh-list
138310467|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138310468|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138310469|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310470|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310471|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
138310472|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310473|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310474|NCT00003323|Urological Agents|urological agents|mesh-ancestor
138310475|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
138310476|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310477|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310479|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310480|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138310481|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138310482|NCT00004229|Growth Substances|growth substances|mesh-ancestor
138310483|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310484|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138310485|NCT00004235|Docetaxel|docetaxel|mesh-list
138310486|NCT00004235|Irinotecan|irinotecan|mesh-list
138310487|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310488|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310489|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310490|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310491|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310492|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310493|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310494|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310495|NCT00003335|Cyclosporine|cyclosporine|mesh-list
138310496|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
138310497|NCT00003335|Melphalan|melphalan|mesh-list
138310498|NCT00003335|Busulfan|busulfan|mesh-list
138310499|NCT00003335|Cyclosporins|cyclosporins|mesh-list
138310500|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138310501|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310502|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310503|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310504|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
138310505|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310506|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
138310507|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310508|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138310509|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310510|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138310511|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310512|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
138310522|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310523|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
138310524|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138310526|NCT00003341|Hematinics|hematinics|mesh-ancestor
138310528|NCT00004253|Carboplatin|carboplatin|mesh-list
138310529|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310530|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310531|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310532|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310533|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310534|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310536|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310537|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310538|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310539|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310540|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310541|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310543|NCT00003365|Sulindac|sulindac|mesh-list
138310544|NCT00003365|Quercetin|quercetin|mesh-list
138310545|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138310546|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138310547|NCT00003365|Analgesics|analgesics|mesh-ancestor
138310548|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
138310549|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310550|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310551|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310552|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310553|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310554|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310555|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310557|NCT00003365|Protective Agents|protective agents|mesh-ancestor
138310558|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138310559|NCT00004829|Tobramycin|tobramycin|mesh-list
138310560|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138310561|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310562|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138310563|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138310564|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
138310565|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310567|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138310568|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
138310569|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310570|NCT00004865|Paclitaxel|paclitaxel|mesh-list
138310571|NCT00004865|Fluorouracil|fluorouracil|mesh-list
138310572|NCT00004865|Cetuximab|cetuximab|mesh-list
138310573|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310574|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310575|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310576|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310577|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310580|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310581|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310583|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310584|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310585|NCT00004361|Citric Acid|citric acid|mesh-list
138310586|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
138310587|NCT00004361|Calcium|calcium|mesh-list
138310588|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310589|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310590|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
138310591|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138310592|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
138310593|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
138310594|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310595|NCT00004373|Alprazolam|alprazolam|mesh-list
138310596|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138310597|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138310598|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310599|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138310600|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138310601|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138310602|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
138310603|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
138310604|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310605|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310606|NCT00004871|Azacitidine|azacitidine|mesh-list
138310607|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138310608|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310609|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
138310610|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310611|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310612|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310613|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138310614|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310615|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310616|NCT00004883|Trastuzumab|trastuzumab|mesh-list
138310617|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310618|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310619|NCT00004403|Albendazole|albendazole|mesh-list
138310620|NCT00004403|Dexamethasone|dexamethasone|mesh-list
138310621|NCT00004403|Phenytoin|phenytoin|mesh-list
138310622|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310623|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
138310624|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
138310625|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310626|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310627|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310628|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
138310629|NCT00004403|Hormones|hormones|mesh-ancestor
138310630|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310631|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310632|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310634|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138310635|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310636|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
138310637|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138310638|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138310639|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310640|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310641|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310642|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310643|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
138310648|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138310650|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310651|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310652|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
138310653|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310654|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310655|NCT00385307|Amibegron|amibegron|mesh-list
138310657|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138310658|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138310659|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
138310660|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310661|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310662|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310663|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138310664|NCT00004901|Fluorouracil|fluorouracil|mesh-list
138310665|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
138310666|NCT00004901|Eniluracil|eniluracil|mesh-list
138310667|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
138310668|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310669|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310670|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310671|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310672|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
138310673|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310674|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
138310675|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310676|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138310678|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
138310679|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
138310680|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310681|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310682|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310683|NCT00004913|Leucovorin|leucovorin|mesh-list
138310684|NCT00004913|Docetaxel|docetaxel|mesh-list
138310685|NCT00004913|Fluorouracil|fluorouracil|mesh-list
138310686|NCT00004913|Calcium|calcium|mesh-list
138310688|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310689|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310690|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310691|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310692|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310693|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310694|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310695|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
138310696|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310697|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310698|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
138310699|NCT00004913|Antidotes|antidotes|mesh-ancestor
138310700|NCT00004913|Protective Agents|protective agents|mesh-ancestor
138310701|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310702|NCT00004913|Vitamins|vitamins|mesh-ancestor
138310703|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
138310704|NCT00004919|Irinotecan|irinotecan|mesh-list
138310705|NCT00004919|Amifostine|amifostine|mesh-list
138310706|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310707|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310708|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310709|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310714|NCT00004925|Doxorubicin|doxorubicin|mesh-list
138310715|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138310716|NCT00004925|Trastuzumab|trastuzumab|mesh-list
138310717|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138310718|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310719|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310720|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310721|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310722|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310723|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310724|NCT00004931|Leucovorin|leucovorin|mesh-list
138310725|NCT00004931|Fluorouracil|fluorouracil|mesh-list
138310727|NCT00004931|Calcium|calcium|mesh-list
138310728|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
138310729|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310730|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310731|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
138310732|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310733|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310734|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310735|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310736|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
138310737|NCT00004931|Antidotes|antidotes|mesh-ancestor
138310738|NCT00004931|Protective Agents|protective agents|mesh-ancestor
138310739|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310740|NCT00004931|Vitamins|vitamins|mesh-ancestor
138310741|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
138310742|NCT00004979|Paclitaxel|paclitaxel|mesh-list
138310743|NCT00004979|Topotecan|topotecan|mesh-list
138366612|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138310744|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310745|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310746|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310747|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310748|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310749|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310750|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310751|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310752|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310754|NCT00004985|Capravirine|capravirine|mesh-list
138310755|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138310756|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138310757|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
138310758|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310759|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310760|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138310761|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138310762|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
138310763|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310764|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138310765|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138310768|NCT00004997|Protective Agents|protective agents|mesh-ancestor
138310769|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310770|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310771|NCT00004997|Vitamins|vitamins|mesh-ancestor
138310772|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
138310773|NCT00005009|Vaccines|vaccines|mesh-list
138310774|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
138310775|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310776|NCT00004583|Ritonavir|ritonavir|mesh-list
138310777|NCT00004583|Lopinavir|lopinavir|mesh-list
138310781|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138310783|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
138310784|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310785|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310786|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138310787|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138310788|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
138310789|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310790|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138310791|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138310792|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138310793|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138310794|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
138310795|NCT00005015|Fluoxetine|fluoxetine|mesh-list
138310796|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138310797|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138310798|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138310799|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310800|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310801|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
138310802|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310803|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138310804|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
138310805|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138310807|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138366619|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366620|NCT05878288|Cemiplimab|cemiplimab|mesh-list
138366621|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366622|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366623|NCT05876273|Pancrelipase|pancrelipase|mesh-list
138310808|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310809|NCT00004637|Vitamin E|vitamin e|mesh-list
138310810|NCT00004637|Vitamins|vitamins|mesh-ancestor
138310811|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
138310812|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310813|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
138310814|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310815|NCT00004637|Protective Agents|protective agents|mesh-ancestor
138310816|NCT00005021|Paclitaxel|paclitaxel|mesh-list
138310817|NCT00005021|Carboplatin|carboplatin|mesh-list
138310818|NCT00005021|Topotecan|topotecan|mesh-list
138310819|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310820|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310821|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310822|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310823|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310824|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310825|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310826|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310827|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310828|NCT00004643|Cytarabine|cytarabine|mesh-list
138310829|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310830|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
138310831|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310832|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310833|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
138310834|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310835|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138310836|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
138310837|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310838|NCT00005033|Trastuzumab|trastuzumab|mesh-list
138310839|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138310840|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310841|NCT00005039|Vaccines|vaccines|mesh-list
138310843|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310845|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138310846|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
138310847|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310848|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310849|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138310850|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
138310851|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
138310852|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138310853|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138310854|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138310855|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138310856|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
138310857|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310858|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310859|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138310860|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310861|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138310862|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138310863|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310864|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310865|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310866|NCT00005051|Paclitaxel|paclitaxel|mesh-list
138310867|NCT00005051|Carboplatin|carboplatin|mesh-list
138310868|NCT00005051|Topotecan|topotecan|mesh-list
138310869|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310870|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310871|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310872|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310873|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310874|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310875|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138310876|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310877|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310878|NCT00004697|Choline|choline|mesh-list
138310879|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
138310880|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138310881|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
138310882|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310883|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310884|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138310885|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
138310886|NCT00004727|Aspirin|aspirin|mesh-list
138310887|NCT00004727|Ticlopidine|ticlopidine|mesh-list
138310888|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138310890|NCT00004727|Analgesics|analgesics|mesh-ancestor
138310891|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
138310892|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310893|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310894|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310895|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138310896|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138310897|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138310898|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310899|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138310900|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138310901|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310902|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
138310903|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138310904|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138310905|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138310906|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
138310908|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138310909|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138310910|NCT00004733|Levodopa|levodopa|mesh-list
138310911|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138310912|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138310913|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
138310914|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138310915|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310916|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310917|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138310918|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
138310919|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310920|NCT00005057|Ganciclovir|ganciclovir|mesh-list
138310921|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138310922|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
138310923|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310924|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138310925|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310926|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310927|NCT00004757|Acyclovir|acyclovir|mesh-list
138310928|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
138310929|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310930|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
138310931|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310932|NCT00004763|Leuprolide|leuprolide|mesh-list
138310933|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138310934|NCT00004763|Norethindrone|norethindrone|mesh-list
138310935|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
138310936|NCT00004763|Norinyl|norinyl|mesh-list
138310937|NCT00004763|Estradiol|estradiol|mesh-list
138310938|NCT00004763|Estrogens|estrogens|mesh-ancestor
138310939|NCT00004763|Hormones|hormones|mesh-ancestor
138310940|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310941|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310942|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138310943|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
138310944|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138310945|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138310946|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138310947|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
138310948|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310949|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310950|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138310952|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138310953|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138310954|NCT00004787|Lenograstim|lenograstim|mesh-list
138310955|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138310956|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
138310957|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310958|NCT00005081|Carmustine|carmustine|mesh-list
138310959|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138310960|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138310961|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
138310962|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310963|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310964|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310966|NCT00005087|Cisplatin|cisplatin|mesh-list
138310967|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138310968|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310969|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138310970|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138310971|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310972|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310973|NCT00004799|Vaccines|vaccines|mesh-list
138310974|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
138310975|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310979|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
138310980|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310981|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310982|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138310983|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310984|NCT00004811|Itraconazole|itraconazole|mesh-list
138310985|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
138310986|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138310987|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138310988|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138310989|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310990|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310991|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138310993|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310994|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310995|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138310997|NCT00004817|Valproic Acid|valproic acid|mesh-list
138310998|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
138310999|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311000|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311001|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
138311002|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311003|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311004|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
138311005|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138311006|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311007|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138311008|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138311009|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138311010|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311011|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138311014|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138311015|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311016|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
138311017|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311018|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311019|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311020|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311022|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138311023|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
138311024|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138311025|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311026|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
138311027|NCT00385463|Montelukast|montelukast|mesh-list
138311028|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138311029|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138311030|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138311031|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138311032|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138311033|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311034|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311036|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138366636|NCT05834244|Venetoclax|venetoclax|mesh-list
138311037|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311038|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138311039|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
138311040|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311041|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
138311043|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
138311044|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
138311045|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138311046|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
138311047|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311048|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
138311049|NCT00423371|Protective Agents|protective agents|mesh-ancestor
138311050|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
138311051|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311052|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311053|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311054|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311055|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311056|NCT00005585|Leucovorin|leucovorin|mesh-list
138311057|NCT00005585|Cytarabine|cytarabine|mesh-list
138311058|NCT00005585|Dexamethasone|dexamethasone|mesh-list
138311059|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
138311060|NCT00005585|Methotrexate|methotrexate|mesh-list
138311061|NCT00005585|Vincristine|vincristine|mesh-list
138311062|NCT00005585|Daunorubicin|daunorubicin|mesh-list
138311063|NCT00005585|Asparaginase|asparaginase|mesh-list
138311064|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
138311065|NCT00005585|Pegaspargase|pegaspargase|mesh-list
138311066|NCT00005585|Thioguanine|thioguanine|mesh-list
138311067|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
138311068|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311069|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
138311070|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311071|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311072|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311073|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
138311074|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311075|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311076|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311077|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311078|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
138311079|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
138311080|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311081|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311082|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
138311084|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311085|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311086|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138311087|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
138311088|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138311089|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311090|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
138311091|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138311092|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311093|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138311094|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311095|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
138311096|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311097|NCT00005585|Antidotes|antidotes|mesh-ancestor
138311098|NCT00005585|Protective Agents|protective agents|mesh-ancestor
138311099|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
138311102|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311103|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311104|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311105|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311106|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138311107|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311108|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311109|NCT00005591|Gemcitabine|gemcitabine|mesh-list
138311110|NCT00005591|Cetuximab|cetuximab|mesh-list
138311111|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311112|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
138311113|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311114|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311115|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311116|NCT01926444|Trimebutine|trimebutine|mesh-list
138311117|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311118|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
138311119|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
138311120|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311126|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311128|NCT00005603|Dexamethasone|dexamethasone|mesh-list
138311129|NCT00005603|Prednisone|prednisone|mesh-list
138311130|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
138311131|NCT00005603|Doxorubicin|doxorubicin|mesh-list
138311132|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138311133|NCT00005603|Methotrexate|methotrexate|mesh-list
138311134|NCT00005603|Vincristine|vincristine|mesh-list
138311135|NCT00005603|Daunorubicin|daunorubicin|mesh-list
138311136|NCT00005603|Asparaginase|asparaginase|mesh-list
138311137|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
138311138|NCT00005603|Thioguanine|thioguanine|mesh-list
138311139|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311140|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
138311141|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311142|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311143|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311144|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
138311145|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311146|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311147|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311148|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311149|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
138311150|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
138311151|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311152|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311153|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
138311154|NCT00005603|Hormones|hormones|mesh-ancestor
138311155|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311156|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311157|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138311158|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311159|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311160|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311161|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138311162|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
138311163|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138311164|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311165|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
138311166|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138311167|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138311168|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311169|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
138311170|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311171|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311172|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311173|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311174|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311175|NCT00005609|Rituximab|rituximab|mesh-list
138311176|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311177|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311180|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311182|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
138311183|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311184|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
138311185|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311186|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
138311187|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366638|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
138311188|NCT00005627|Carboplatin|carboplatin|mesh-list
138311189|NCT00005627|Docetaxel|docetaxel|mesh-list
138311190|NCT00005627|Estramustine|estramustine|mesh-list
138366639|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366640|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311191|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311192|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311193|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311194|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311195|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311196|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311197|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
138311198|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311199|NCT00005639|Azacitidine|azacitidine|mesh-list
138311200|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138311201|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311202|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
138311203|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311204|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311205|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311206|NCT00005663|Valacyclovir|valacyclovir|mesh-list
138311207|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
138311208|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311209|NCT00385853|Temozolomide|temozolomide|mesh-list
138311211|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311212|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
138311213|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311214|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311215|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138311216|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311218|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138311219|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
138311220|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311221|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311222|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138311223|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138311224|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
138311225|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311226|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311228|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311229|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
138311230|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
138311231|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311232|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311234|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
138311235|NCT00005777|Hormones|hormones|mesh-ancestor
138311236|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311237|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311238|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311239|NCT00385931|Valsartan|valsartan|mesh-list
138311240|NCT00385931|Simvastatin|simvastatin|mesh-list
138311241|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138311242|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311243|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
138311244|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311245|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311246|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311247|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311250|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138311252|NCT00386399|Mitomycin|mitomycin|mesh-list
138311253|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138311254|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311255|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
138311256|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311257|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311258|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311259|NCT00005807|Epothilones|epothilones|mesh-list
138311260|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311261|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311262|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311263|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311264|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311265|NCT00005813|Antibodies|antibodies|mesh-list
138311266|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138311267|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
138311268|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311269|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
138311270|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311271|NCT00003647|Dacarbazine|dacarbazine|mesh-list
138311272|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311273|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
138311274|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311275|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311276|NCT05895526|Fluorides|fluorides|mesh-list
138311277|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
138311278|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
138311279|NCT05895526|Protective Agents|protective agents|mesh-ancestor
138311280|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311281|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
138311282|NCT05895448|Velpatasvir|velpatasvir|mesh-list
138311283|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
138311284|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311285|NCT05895370|Interleukin-2|interleukin-2|mesh-list
138311286|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311287|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138311288|NCT05895370|Analgesics|analgesics|mesh-ancestor
138311289|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
138311291|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311292|NCT05895305|Paclitaxel|paclitaxel|mesh-list
138311293|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311294|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311295|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311296|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311297|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311298|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311299|NCT05895240|Urinastatin|urinastatin|mesh-list
138311300|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138311301|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138311302|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
138311303|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311304|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311306|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
138311307|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138311308|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138311309|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344259|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311310|NCT05895123|Atorvastatin|atorvastatin|mesh-list
138311311|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138311312|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138311313|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138344260|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138344261|NCT03556384|Temozolomide|temozolomide|mesh-list
138344262|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344263|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
138344264|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344265|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311314|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
138344266|NCT03259503|Rituximab|rituximab|mesh-list
138311320|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311321|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311323|NCT05894889|Carboplatin|carboplatin|mesh-list
138311325|NCT05894889|Pemetrexed|pemetrexed|mesh-list
138311326|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311327|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311328|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311329|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311330|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311331|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311332|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311333|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311334|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311335|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138311336|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311338|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311339|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138311340|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138311341|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311342|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
138311343|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
138311344|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
138311345|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311346|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311347|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311348|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311349|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
138311350|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
138311351|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311352|NCT05894200|Fluorides|fluorides|mesh-list
138311353|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
138311354|NCT05894200|Protective Agents|protective agents|mesh-ancestor
138311355|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311357|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138311358|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311359|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138311360|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311361|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311362|NCT05893654|Melphalan|melphalan|mesh-list
138311363|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311364|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
138311365|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311366|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311367|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311368|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311369|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
138311370|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311371|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138311372|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311373|NCT05893472|Venetoclax|venetoclax|mesh-list
138311374|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311375|NCT05892913|Atropine|atropine|mesh-list
138311376|NCT05892913|Ephedrine|ephedrine|mesh-list
138311378|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138311379|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138311380|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
138311381|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311382|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311383|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138311384|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
138311385|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
138311386|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
138311387|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138311388|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138311389|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
138311390|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311391|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311392|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138311393|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
138311394|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138311395|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138311396|NCT05887830|Nivolumab|nivolumab|mesh-list
138311397|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311398|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311399|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311400|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311402|NCT05885230|Bupivacaine|bupivacaine|mesh-list
138311403|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138311404|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
138311405|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311406|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311407|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
138311408|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311409|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138311410|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138311411|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138311412|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311413|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311414|NCT05861258|Minocycline|minocycline|mesh-list
138311415|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138311416|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311417|NCT05784571|Insulin|insulin|mesh-list
138311418|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138311419|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311420|NCT05779943|Furosemide|furosemide|mesh-list
138311421|NCT05779943|Fluorides|fluorides|mesh-list
138311422|NCT05779943|Diuretics|diuretics|mesh-ancestor
138311423|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
138311424|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215926|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311425|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138311426|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311427|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311430|NCT05727098|Ketamine|ketamine|mesh-list
138311431|NCT05727098|Bupivacaine|bupivacaine|mesh-list
138311432|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
138311433|NCT05727098|Anesthetics|anesthetics|mesh-list
138311434|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311435|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311436|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
138311437|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311438|NCT05727098|Analgesics|analgesics|mesh-ancestor
138311439|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138311440|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138311441|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
138311442|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138311443|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138311444|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311445|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311447|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138311448|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138311449|NCT05656352|Analgesics|analgesics|mesh-ancestor
138311450|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
138311451|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311452|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311453|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311455|NCT05610527|Etonogestrel|etonogestrel|mesh-list
138311456|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138311457|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
138311458|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138311459|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311460|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138311461|NCT05590468|Niacinamide|niacinamide|mesh-list
138311463|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
138311464|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
138311465|NCT05590468|Vitamins|vitamins|mesh-ancestor
138311466|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
138311469|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
138311470|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311471|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311472|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
138311473|NCT05565560|Apremilast|apremilast|mesh-list
138311474|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138311475|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138311476|NCT05565560|Analgesics|analgesics|mesh-ancestor
138311477|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
138311479|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311480|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311481|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311482|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138311483|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138311484|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311485|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311486|NCT05527808|Carboplatin|carboplatin|mesh-list
138311487|NCT05527808|Pemetrexed|pemetrexed|mesh-list
138311488|NCT05527808|Tislelizumab|tislelizumab|mesh-list
138311489|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311490|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311491|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311492|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138311493|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311494|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311495|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138311496|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138311497|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311498|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311499|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138311500|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311501|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311502|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
138311504|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138311505|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311506|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138311507|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138311508|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138311509|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138311510|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311511|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311512|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311514|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
138311515|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311516|NCT05426031|Coagulants|coagulants|mesh-ancestor
138311517|NCT05423106|Tenofovir|tenofovir|mesh-list
138311519|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
138311520|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311521|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138311522|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311523|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311524|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311525|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138311526|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138311528|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138311529|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
138311530|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138311531|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
138311532|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311533|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311534|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
138311535|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138311536|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138311537|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138311538|NCT05319873|Carboplatin|carboplatin|mesh-list
138311539|NCT05319873|Docetaxel|docetaxel|mesh-list
138311540|NCT05319873|Trastuzumab|trastuzumab|mesh-list
138311541|NCT05319873|Fulvestrant|fulvestrant|mesh-list
138311542|NCT05319873|Pertuzumab|pertuzumab|mesh-list
138311543|NCT05319873|Tucatinib|tucatinib|mesh-list
138311544|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138311545|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138311546|NCT05319873|Antibodies|antibodies|mesh-list
138311547|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
138311548|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138311549|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
138311550|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311551|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311552|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311553|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311554|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311555|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311556|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311557|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138311558|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138311559|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
138311560|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311561|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138311562|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311563|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
138311564|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311565|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
138311566|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311567|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311568|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138311569|NCT05188326|Azacitidine|azacitidine|mesh-list
138311570|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311571|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
138311572|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311573|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311574|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311575|NCT05180942|Atorvastatin|atorvastatin|mesh-list
138311576|NCT05180942|Calcium|calcium|mesh-list
138311577|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138311578|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311580|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311581|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
138311582|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311583|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311584|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311585|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311586|NCT05164653|Valsartan|valsartan|mesh-list
138311587|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
138311590|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138311591|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311592|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138311593|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311594|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138311595|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
138311596|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311597|NCT05160896|Bevacizumab|bevacizumab|mesh-list
138311598|NCT05160896|Cetuximab|cetuximab|mesh-list
138311599|NCT05160896|Irinotecan|irinotecan|mesh-list
138311600|NCT05160896|Raltitrexed|raltitrexed|mesh-list
138311601|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311602|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311603|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138311604|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138311605|NCT05160896|Growth Substances|growth substances|mesh-ancestor
138311607|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138311608|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138311609|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311610|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311611|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311612|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311613|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
138311614|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138311615|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
138311616|NCT05129670|Antacids|antacids|mesh-ancestor
138311617|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311618|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311619|NCT05128617|Paclitaxel|paclitaxel|mesh-list
138311620|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
138311621|NCT05128617|Epirubicin|epirubicin|mesh-list
138311622|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311623|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311624|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311625|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311626|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311627|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311628|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311629|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
138311630|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311631|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311632|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311633|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
138311634|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311635|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138311636|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311637|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311638|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311639|NCT05107375|Vaccines|vaccines|mesh-list
138311640|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
138311641|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311643|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138311644|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
138311645|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311647|NCT05031520|Metoprolol|metoprolol|mesh-list
138311648|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
138311649|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138311650|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311651|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
138311652|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
138311653|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311654|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311657|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138311658|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138311659|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311660|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311661|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
138311663|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138311664|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311665|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138311666|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311667|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311668|NCT04988035|Remdesivir|remdesivir|mesh-list
138311669|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
138311670|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311672|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138311673|NCT04939792|Vitamin D|vitamin d|mesh-list
138311674|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
138311675|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
138311676|NCT04939792|Vitamins|vitamins|mesh-list
138311677|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
138311678|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311679|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138311680|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138311682|NCT04850495|Cortisone|cortisone|mesh-list
138311683|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
138311684|NCT04850495|Rituximab|rituximab|mesh-list
138311685|NCT04850495|Doxorubicin|doxorubicin|mesh-list
138311686|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138311688|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
138311689|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138311690|NCT04850495|Antibodies|antibodies|mesh-list
138311691|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
138311692|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138311693|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311694|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
138311695|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311696|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311697|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311698|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
138311699|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311700|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311702|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138311703|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138311704|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138311705|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311706|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311707|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
138311708|NCT04850495|Hormones|hormones|mesh-ancestor
138311709|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311710|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311711|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311712|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311713|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311714|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311715|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138311716|NCT04763135|Mirtazapine|mirtazapine|mesh-list
138311717|NCT04763135|Escitalopram|escitalopram|mesh-list
138311718|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138311719|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138311720|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311721|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311722|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311723|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
138311724|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311725|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
138311726|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138311727|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138311728|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
138311729|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
138311730|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138311731|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138311732|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311733|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138311734|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138311735|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138311736|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138311737|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138311738|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138311739|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138311740|NCT04762979|Fulvestrant|fulvestrant|mesh-list
138311741|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138311742|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311743|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311744|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138311745|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138311746|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
138311747|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311748|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311749|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138311750|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311751|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311754|NCT04723134|Calcium|calcium|mesh-list
138311756|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138311757|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311759|NCT04723134|Protective Agents|protective agents|mesh-ancestor
138311760|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
138311761|NCT04723134|Vitamins|vitamins|mesh-ancestor
138311762|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
138311763|NCT04723134|Hematinics|hematinics|mesh-ancestor
138311764|NCT04666272|Trametinib|trametinib|mesh-list
138311765|NCT04666272|Dabrafenib|dabrafenib|mesh-list
138311766|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311767|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138311768|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311769|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311771|NCT04649060|Melphalan|melphalan|mesh-list
138311772|NCT04649060|Daratumumab|daratumumab|mesh-list
138311773|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311774|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
138311775|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
138311776|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311777|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311778|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138311779|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
138311780|NCT04649060|Hormones|hormones|mesh-ancestor
138311781|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138311782|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311783|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311784|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311785|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
138311786|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311787|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311788|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311789|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
138311790|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
138311791|NCT04608487|Fludarabine|fludarabine|mesh-list
138311792|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138311793|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138311799|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311800|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311801|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138311802|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311804|NCT04602767|Vasopressins|vasopressins|mesh-list
138311805|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
138311806|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
138311807|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138311808|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
138311809|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
138311810|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311811|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311812|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
138311813|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138311814|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
138311815|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
138311816|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138311817|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138311819|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138311820|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311821|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311822|NCT04602767|Protective Agents|protective agents|mesh-ancestor
138311824|NCT04602767|Coagulants|coagulants|mesh-ancestor
138311825|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138311826|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
138311827|NCT04581447|Metformin|metformin|mesh-list
138311828|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138311829|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311830|NCT04520685|Cannabidiol|cannabidiol|mesh-list
138311831|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
138311832|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
138311833|NCT04519151|Lenvatinib|lenvatinib|mesh-list
138311834|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311835|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311836|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311837|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311838|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138311839|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311840|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138311841|NCT04497012|Iron|iron|mesh-list
138311842|NCT04497012|Trace Elements|trace elements|mesh-ancestor
138311843|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
138311844|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311845|NCT04484259|Aspirin|aspirin|mesh-list
138311846|NCT04484259|Clopidogrel|clopidogrel|mesh-list
138311850|NCT04484259|Analgesics|analgesics|mesh-ancestor
138311851|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
138311852|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311853|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311854|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138311855|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138311856|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138311857|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138311875|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311876|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311877|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311878|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311879|NCT04299113|Vinorelbine|vinorelbine|mesh-list
138311880|NCT04299113|Mocetinostat|mocetinostat|mesh-list
138311881|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311882|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311883|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311884|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311885|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311886|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311887|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138311888|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311889|NCT04285580|Bimatoprost|bimatoprost|mesh-list
138311890|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311891|NCT04245371|Lidocaine|lidocaine|mesh-list
138311892|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
138311893|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
138311894|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311895|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311896|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
138311897|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311898|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138311899|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138311900|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138311901|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138311902|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311903|NCT04231539|Nicotine|nicotine|mesh-list
138311904|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138311905|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
138311906|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311907|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311909|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138311910|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
138311911|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311912|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311913|NCT04200248|Aflibercept|aflibercept|mesh-list
138311914|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138311915|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138311916|NCT04200248|Growth Substances|growth substances|mesh-ancestor
138311917|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311918|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
138311919|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311920|NCT04137887|Vaccines|vaccines|mesh-list
138311922|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311924|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138311925|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311926|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138311927|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311928|NCT03954366|Rucaparib|rucaparib|mesh-list
138311929|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138311930|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
138311931|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
138311932|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138311933|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311934|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
138311935|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311936|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311937|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311938|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311939|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138311940|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311941|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138311942|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138311943|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311944|NCT03912220|Niacinamide|niacinamide|mesh-list
138311946|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
138311947|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
138311948|NCT03912220|Vitamins|vitamins|mesh-ancestor
138311949|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
138311950|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311951|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311952|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
138311953|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311954|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311955|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
138311956|NCT03872791|Paclitaxel|paclitaxel|mesh-list
138311957|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138311958|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311959|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
138311960|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
138311961|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
138311962|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311963|NCT03864042|Losartan|losartan|mesh-list
138311964|NCT03864042|Midazolam|midazolam|mesh-list
138311965|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
138311966|NCT03864042|Caffeine|caffeine|mesh-list
138311967|NCT03864042|Modafinil|modafinil|mesh-list
138311968|NCT03864042|Bupropion|bupropion|mesh-list
138311969|NCT03864042|Omeprazole|omeprazole|mesh-list
138311970|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138311971|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138311972|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138311973|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311974|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311975|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138311979|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
138311980|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
138311981|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
138311982|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
138311983|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311984|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311985|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138311986|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138311987|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
138311988|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311989|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311990|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311991|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138311992|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311993|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138311994|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138311995|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138311996|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138311997|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138311998|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138311999|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
138312000|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138312001|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312002|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138312003|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138312004|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
138312005|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138312006|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138312008|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
138312009|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138312010|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138312011|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138312012|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138312013|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138312014|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
138312015|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
138312016|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138312017|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138312018|NCT03737604|Bupivacaine|bupivacaine|mesh-list
138312019|NCT03737604|Ropivacaine|ropivacaine|mesh-list
138312020|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
138312021|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
138312022|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312023|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312024|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
138312025|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312026|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
138312027|NCT03676504|Fludarabine|fludarabine|mesh-list
138312028|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312029|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
138312030|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312031|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312032|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312033|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
138312034|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312035|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312036|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312037|NCT03597594|Fludarabine|fludarabine|mesh-list
138312039|NCT03597594|Thiotepa|thiotepa|mesh-list
138312040|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
138312045|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
138312046|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312047|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
138312048|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312049|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312050|NCT03563690|Celecoxib|celecoxib|mesh-list
138312051|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138312052|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138312053|NCT03563690|Analgesics|analgesics|mesh-ancestor
138312054|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
138312055|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312056|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312057|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312058|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312059|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138312060|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138312061|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312062|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312064|NCT03557008|Vancomycin|vancomycin|mesh-list
138312065|NCT03557008|Neomycin|neomycin|mesh-list
138312066|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312067|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312068|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138312069|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138312070|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138312071|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312072|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312074|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138312075|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138312076|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312077|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138312078|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312079|NCT03347617|Hematinics|hematinics|mesh-ancestor
138312080|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138312081|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138312082|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
138312083|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312084|NCT03136029|Antioxidants|antioxidants|mesh-list
138312085|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312086|NCT03136029|Protective Agents|protective agents|mesh-ancestor
138312087|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312088|NCT03040999|Cisplatin|cisplatin|mesh-list
138312089|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
138312090|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312091|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138312092|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138312093|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312094|NCT02366728|Temozolomide|temozolomide|mesh-list
138312095|NCT02366728|Basiliximab|basiliximab|mesh-list
138312097|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312098|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312099|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
138312100|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312101|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312102|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312104|NCT02333370|Letrozole|letrozole|mesh-list
138312105|NCT02333370|Fulvestrant|fulvestrant|mesh-list
138312106|NCT02333370|Goserelin|goserelin|mesh-list
138312107|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312108|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138312109|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138312111|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312112|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138312113|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
138312114|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312115|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312116|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312117|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138312118|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138312119|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138312120|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138312122|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312123|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312124|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312125|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312126|NCT02246920|Fluticasone|fluticasone|mesh-list
138312128|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312129|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138312130|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
138312131|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312132|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312133|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138312134|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
138312135|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312136|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138312138|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138312139|NCT01832402|Narcotics|narcotics|mesh-ancestor
138312141|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312143|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
138312144|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312145|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138312146|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138312147|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
138312148|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
138312150|NCT01210625|Cathartics|cathartics|mesh-ancestor
138312151|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312152|NCT01009190|Carboplatin|carboplatin|mesh-list
138312153|NCT01009190|Rucaparib|rucaparib|mesh-list
138312154|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312155|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138312156|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312157|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312160|NCT00003653|Flutamide|flutamide|mesh-list
138312161|NCT00003653|Bicalutamide|bicalutamide|mesh-list
138312162|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
138312163|NCT00003653|Nilutamide|nilutamide|mesh-list
138312164|NCT00003653|Buserelin|buserelin|mesh-list
138312165|NCT00003653|Cyproterone|cyproterone|mesh-list
138312166|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138312167|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
138312168|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138312169|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312170|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312171|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312172|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
138312173|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
138312179|NCT00003671|Dexamethasone|dexamethasone|mesh-list
138312180|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
138312181|NCT00003671|Methotrexate|methotrexate|mesh-list
138312182|NCT00003671|Vincristine|vincristine|mesh-list
138312183|NCT00003671|Daunorubicin|daunorubicin|mesh-list
138312184|NCT00003671|Asparaginase|asparaginase|mesh-list
138312185|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
138312186|NCT00003671|Thioguanine|thioguanine|mesh-list
138312187|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
138312188|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312189|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
138312190|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312191|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312192|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312193|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
138312194|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312195|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312196|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312197|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312198|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
138312199|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
138312200|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312201|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312204|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312205|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312209|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312210|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
138312211|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312212|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312213|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138312214|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312215|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
138312216|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312218|NCT00003671|Protective Agents|protective agents|mesh-ancestor
138312219|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
138312220|NCT00003671|Vitamins|vitamins|mesh-ancestor
138312221|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
138312222|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312224|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312225|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312226|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138312227|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138312228|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312230|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312231|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312232|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312233|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312234|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312235|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138312236|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138312237|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138312241|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312242|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312243|NCT00003683|Doxorubicin|doxorubicin|mesh-list
138312244|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138312245|NCT00003683|Ifosfamide|ifosfamide|mesh-list
138312246|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138312247|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312248|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138312249|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312250|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312251|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312252|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312255|NCT00003707|Tipifarnib|tipifarnib|mesh-list
138312256|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312257|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
138312258|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312259|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312260|NCT00003719|Irinotecan|irinotecan|mesh-list
138312261|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312264|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312265|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312266|NCT00003725|Valrubicin|valrubicin|mesh-list
138312267|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312268|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138312270|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312271|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312274|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
138312275|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312276|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312278|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312279|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138312280|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138312281|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
138312282|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312283|NCT00384917|Ketoconazole|ketoconazole|mesh-list
138312284|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
138312285|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312286|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138312287|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138312288|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312289|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312290|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138312291|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
138312295|NCT05444153|Empagliflozin|empagliflozin|mesh-list
138312296|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138312297|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312298|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138312299|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312300|NCT00003797|Gemcitabine|gemcitabine|mesh-list
138312301|NCT00003797|Trastuzumab|trastuzumab|mesh-list
138312302|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312303|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
138312306|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138312307|NCT00003803|Gemcitabine|gemcitabine|mesh-list
138312308|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312309|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312310|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
138312311|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312312|NCT00003815|Cytarabine|cytarabine|mesh-list
138312313|NCT00003815|Prednisolone|prednisolone|mesh-list
138312314|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
138312315|NCT00003815|Melphalan|melphalan|mesh-list
138312316|NCT00003815|Carmustine|carmustine|mesh-list
138312317|NCT00003815|Doxorubicin|doxorubicin|mesh-list
138312318|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138312319|NCT00003815|Etoposide|etoposide|mesh-list
138312321|NCT00003815|Bleomycin|bleomycin|mesh-list
138312322|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312325|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312326|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312327|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
138312328|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312329|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312330|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312331|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138312332|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138312333|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312334|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312335|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312336|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312342|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312343|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312344|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
138312345|NCT00003815|Hormones|hormones|mesh-ancestor
138312349|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138312350|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312351|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312352|NCT00003827|Cytarabine|cytarabine|mesh-list
138312353|NCT00003827|Topotecan|topotecan|mesh-list
138312354|NCT00003827|Amifostine|amifostine|mesh-list
138312355|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312356|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
138312357|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312359|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
138312360|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312361|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312362|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
138312363|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312364|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312365|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312366|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312367|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138312368|NCT00003827|Protective Agents|protective agents|mesh-ancestor
138312369|NCT00003851|Gemcitabine|gemcitabine|mesh-list
138312370|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312371|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
138312372|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312373|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312374|NCT00003881|Paclitaxel|paclitaxel|mesh-list
138312375|NCT00003881|Carboplatin|carboplatin|mesh-list
138312376|NCT00003881|Trastuzumab|trastuzumab|mesh-list
138312377|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312378|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312379|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312380|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312381|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312382|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312383|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138312385|NCT00003893|Doxorubicin|doxorubicin|mesh-list
138312386|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138312387|NCT00003893|Fluorouracil|fluorouracil|mesh-list
138312388|NCT00003893|Methotrexate|methotrexate|mesh-list
138312389|NCT00003893|Epirubicin|epirubicin|mesh-list
138312390|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
138312391|NCT00003893|Mitomycins|mitomycins|mesh-list
138312392|NCT00003893|Mitomycin|mitomycin|mesh-list
138312393|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312394|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
138312395|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312396|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312397|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312398|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
138312399|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312400|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312401|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312402|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138312403|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138312404|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312406|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
138312408|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138312409|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
138312410|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138312411|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312412|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138312413|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312414|NCT00003893|Analgesics|analgesics|mesh-ancestor
138312416|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312417|NCT00003899|Paclitaxel|paclitaxel|mesh-list
138312418|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
138312419|NCT00003899|Melphalan|melphalan|mesh-list
138312420|NCT00003899|Thiotepa|thiotepa|mesh-list
138312421|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312422|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312423|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312424|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312425|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312426|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312427|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312428|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
138312429|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312430|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312431|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312432|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
138312433|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138312435|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312436|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312437|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312438|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312439|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312440|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138312441|NCT00003923|Trioxsalen|trioxsalen|mesh-list
138312442|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312443|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312444|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138312445|NCT00003929|Lomustine|lomustine|mesh-list
138312446|NCT00003929|Procarbazine|procarbazine|mesh-list
138312447|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138312448|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
138312450|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312451|NCT02210663|Veliparib|veliparib|mesh-list
138312452|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138312453|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312454|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312455|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312456|NCT04568837|Dexamethasone|dexamethasone|mesh-list
138312457|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
138312463|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
138312464|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312465|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312466|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312467|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
138312468|NCT04568837|Hormones|hormones|mesh-ancestor
138312469|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312470|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312471|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312473|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312474|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312475|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
138312476|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138312477|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
138312478|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138312479|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
138312480|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312484|NCT04564469|Diuretics|diuretics|mesh-ancestor
138312485|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
138312486|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312487|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138312488|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138312489|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312492|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312493|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312494|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312495|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312496|NCT04563299|Prednisolone|prednisolone|mesh-list
138312497|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138312498|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
138312501|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138312502|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
138312503|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312504|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
138312505|NCT04563299|Hormones|hormones|mesh-ancestor
138312506|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312507|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312508|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312509|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312510|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
138312511|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
138312512|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312513|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312514|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138312515|NCT04563299|Protective Agents|protective agents|mesh-ancestor
138312516|NCT04561817|Paclitaxel|paclitaxel|mesh-list
138312517|NCT04561817|Ipatasertib|ipatasertib|mesh-list
138312518|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312519|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312520|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312521|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312522|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312523|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312524|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312525|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312526|NCT02211833|Pemetrexed|pemetrexed|mesh-list
138312527|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312533|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138312534|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
138312535|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312536|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
138312537|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138312538|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
138312540|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
138312541|NCT02211521|Protective Agents|protective agents|mesh-ancestor
138312542|NCT01597908|Trametinib|trametinib|mesh-list
138312543|NCT01597908|Dabrafenib|dabrafenib|mesh-list
138312544|NCT01597908|Vemurafenib|vemurafenib|mesh-list
138312545|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312546|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312547|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312548|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312549|NCT01948908|Midazolam|midazolam|mesh-list
138312550|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138312553|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312555|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138312556|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138312557|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138312558|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
138312559|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
138312560|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
138312561|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
138312562|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312563|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312565|NCT01925274|Cetuximab|cetuximab|mesh-list
138312566|NCT01925274|Gedatolisib|gedatolisib|mesh-list
138312567|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312568|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312569|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312570|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312571|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312572|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138312573|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312575|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138312576|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138312577|NCT01948830|Growth Substances|growth substances|mesh-ancestor
138312578|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312579|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
138312580|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312582|NCT01972464|Progestins|progestins|mesh-ancestor
138312583|NCT01972464|Hormones|hormones|mesh-ancestor
138312584|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312585|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312586|NCT01924182|Morphine|morphine|mesh-list
138312588|NCT01924182|Narcotics|narcotics|mesh-ancestor
138312589|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312590|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312591|NCT01924182|Analgesics|analgesics|mesh-ancestor
138312592|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
138312593|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312594|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
138312595|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
138312596|NCT01946880|Chloroquine|chloroquine|mesh-list
138312597|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138312598|NCT01946880|Prednisone|prednisone|mesh-list
138312599|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312600|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
138312601|NCT01946880|Hormones|hormones|mesh-ancestor
138312602|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312603|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312604|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312606|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138312607|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138312608|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
138312609|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312610|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312611|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312612|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312613|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
138312614|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138312615|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138312616|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138312617|NCT01946880|Amebicides|amebicides|mesh-ancestor
138312619|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138312621|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
138312622|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312624|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
138312625|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
138312626|NCT01972152|Glucagon|glucagon|mesh-list
138312627|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312628|NCT01972152|Hormones|hormones|mesh-ancestor
138312629|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312630|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312631|NCT01972074|Memantine|memantine|mesh-list
138312632|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138312633|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138312634|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
138312635|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312637|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312638|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138312640|NCT01618266|Dexamethasone|dexamethasone|mesh-list
138312641|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312642|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
138312643|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
138312644|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312649|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312650|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138312651|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312654|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138312655|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138312656|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
138312658|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312659|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138312660|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312661|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138312662|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138312663|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138312664|NCT01922934|Topiramate|topiramate|mesh-list
138312665|NCT01922934|Phentermine|phentermine|mesh-list
138312666|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
138312667|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138312668|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312669|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138312670|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
138312671|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138312672|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
138312674|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312675|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312676|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312677|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312678|NCT01921140|Olaparib|olaparib|mesh-list
138312679|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138312680|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312681|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312682|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312683|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
138312684|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138312686|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138312687|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138312688|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312689|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
138312690|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312691|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312692|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138312693|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312696|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138312698|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
138312699|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
138312700|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312701|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312702|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312703|NCT01915914|Fluticasone|fluticasone|mesh-list
138312704|NCT01915914|Xhance|xhance|mesh-list
138312705|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138312706|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138312707|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
138312708|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312709|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312712|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
138312713|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138312714|NCT01968954|Bococizumab|bococizumab|mesh-list
138312715|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138312716|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138312717|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
138312718|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312719|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312720|NCT01919190|Bupivacaine|bupivacaine|mesh-list
138312721|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
138312722|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
138312723|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312724|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312725|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
138312727|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138312728|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138312729|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138312730|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312731|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312732|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138312733|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138312734|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138312735|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138312736|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312737|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312738|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312739|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138312740|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138312743|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138312744|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
138312745|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138312746|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138312747|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138312748|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138312749|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312750|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312751|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312752|NCT01914666|Analgesics|analgesics|mesh-ancestor
138312753|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
138312754|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312755|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
138312756|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138312757|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
138312758|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
138312759|NCT01913340|Hematinics|hematinics|mesh-ancestor
138312762|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
138312764|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138312765|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
138312766|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312767|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312768|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138312769|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
138312770|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
138312772|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312773|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138312774|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138312778|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312780|NCT01911780|Amlodipine|amlodipine|mesh-list
138312781|NCT01911780|Telmisartan|telmisartan|mesh-list
138312782|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138312783|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138312784|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138312785|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138312786|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312787|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138312788|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312790|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138312791|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138312792|NCT01911780|Diuretics|diuretics|mesh-ancestor
138312793|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
138312794|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138312795|NCT01911546|Everolimus|everolimus|mesh-list
138312796|NCT01911546|Tacrolimus|tacrolimus|mesh-list
138312797|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138312798|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
138312799|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312800|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138312804|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312805|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312806|NCT01908816|Ranibizumab|ranibizumab|mesh-list
138312807|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138312808|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138312809|NCT01908816|Growth Substances|growth substances|mesh-ancestor
138312810|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312811|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
138312812|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312813|NCT01908582|Rifampin|rifampin|mesh-list
138312814|NCT01908582|Evacetrapib|evacetrapib|mesh-list
138312815|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138312816|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
138312817|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312818|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312819|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
138312820|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312821|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312823|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138312824|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138312825|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138312826|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138312827|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138312828|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138312829|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138312830|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138312831|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
138312832|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312834|NCT01907100|Pemetrexed|pemetrexed|mesh-list
138312835|NCT01907100|Nintedanib|nintedanib|mesh-list
138312836|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312837|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312838|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312839|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138312840|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312841|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138312842|NCT01889862|Dextrans|dextrans|mesh-list
138312843|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
138312844|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
138312845|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
138312848|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312850|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312851|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312852|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138312853|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138312854|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312855|NCT01887288|Protective Agents|protective agents|mesh-ancestor
138312857|NCT03405714|Brivaracetam|brivaracetam|mesh-list
138312858|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
138312859|NCT01885182|Oxycodone|oxycodone|mesh-list
138312860|NCT01885182|Naloxone|naloxone|mesh-list
138312861|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138312862|NCT01885182|Narcotics|narcotics|mesh-ancestor
138312863|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312864|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312865|NCT01885182|Analgesics|analgesics|mesh-ancestor
138312866|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
138312867|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312868|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138312869|NCT01885104|Bisacodyl|bisacodyl|mesh-list
138312870|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138366649|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366650|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138366651|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138366652|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312871|NCT01885104|Laxatives|laxatives|mesh-list
138312872|NCT01885104|Cathartics|cathartics|mesh-ancestor
138312873|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312874|NCT01906008|Minocycline|minocycline|mesh-list
138312875|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138312876|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138312877|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
138312878|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138312879|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312880|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312881|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138312882|NCT01904760|Analgesics|analgesics|mesh-ancestor
138312883|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
138312884|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312885|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138312886|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138312887|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138312888|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312889|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312890|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312891|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138312892|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138312893|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312894|NCT01881126|Timolol|timolol|mesh-list
138312895|NCT01881126|Bimatoprost|bimatoprost|mesh-list
138312896|NCT01881126|Travoprost|travoprost|mesh-list
138312897|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312898|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138312899|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138312900|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312901|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312902|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312906|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138312907|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
138312908|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138312909|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312911|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138312912|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
138312913|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312914|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312915|NCT01862874|Vaccines|vaccines|mesh-list
138312916|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
138312917|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312918|NCT01903434|Evacetrapib|evacetrapib|mesh-list
138312919|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138312920|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138312921|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
138312922|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312923|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138312925|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138312926|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312928|NCT01903356|Hormones|hormones|mesh-ancestor
138312929|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312930|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138312931|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
138312932|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312933|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312934|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
138312935|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
138312936|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312937|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312938|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312939|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
138312940|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
138312941|NCT01902966|Propranolol|propranolol|mesh-list
138312942|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138312943|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138312944|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312945|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312947|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312948|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138312949|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138312950|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
138312951|NCT01862328|Paclitaxel|paclitaxel|mesh-list
138312952|NCT01862328|Docetaxel|docetaxel|mesh-list
138312953|NCT01862328|Carboplatin|carboplatin|mesh-list
138312954|NCT01862328|Gemcitabine|gemcitabine|mesh-list
138312955|NCT01862328|Pevonedistat|pevonedistat|mesh-list
138312956|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138312957|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312958|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
138312959|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
138312960|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
138312961|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312962|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138312963|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
138312964|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312965|NCT01862250|Clonidine|clonidine|mesh-list
138312966|NCT01862250|Analgesics|analgesics|mesh-ancestor
138312967|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
138312968|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312969|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312970|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138312971|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
138312972|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
138312973|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138312974|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138312975|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138312976|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312977|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312978|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312979|NCT01876446|Irinotecan|irinotecan|mesh-list
138312980|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138312981|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312983|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312984|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312985|NCT04414800|Fentanyl|fentanyl|mesh-list
138312986|NCT04414800|Ketamine|ketamine|mesh-list
138312987|NCT04414800|Analgesics|analgesics|mesh-ancestor
138312988|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
138312989|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138312990|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312991|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138312992|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138312993|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
138312994|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
138312995|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138312996|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138312997|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138312998|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312999|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313000|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138313001|NCT04414800|Narcotics|narcotics|mesh-ancestor
138313002|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138313004|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138313005|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138313006|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138366653|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366654|NCT05806060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366655|NCT05806060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138366656|NCT05806060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138366657|NCT05806060|Growth Substances|growth substances|mesh-ancestor
138366658|NCT05806060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366659|NCT05806060|Growth Inhibitors|growth inhibitors|mesh-ancestor
138366660|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313007|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138313008|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
138313009|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313010|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313013|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138313014|NCT01898130|Bevacizumab|bevacizumab|mesh-list
138313015|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138313016|NCT01898130|Antibodies|antibodies|mesh-list
138313017|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
138313018|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138313019|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313020|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138313021|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138313022|NCT01898130|Growth Substances|growth substances|mesh-ancestor
138313023|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313024|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
138313025|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
138313026|NCT01876368|Olmesartan|olmesartan|mesh-list
138313027|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138313028|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138313029|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138313030|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138313031|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138313032|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313033|NCT01873950|Quinidine|quinidine|mesh-list
138313034|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
138313035|NCT01873950|Verapamil|verapamil|mesh-list
138313036|NCT01873950|Dofetilide|dofetilide|mesh-list
138313037|NCT01873950|Ranolazine|ranolazine|mesh-list
138313038|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138313039|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138313040|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313043|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313044|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
138313045|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138313046|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138313047|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138313048|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138313049|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313050|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
138313051|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138313052|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138313053|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313054|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313055|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138313056|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138313057|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
138313058|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138313059|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138313063|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138313064|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138313066|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138313068|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138313070|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138313071|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138313072|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138313073|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138313074|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138313075|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138313076|NCT01856790|Liraglutide|liraglutide|mesh-list
138313077|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313078|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313079|NCT01856790|Incretins|incretins|mesh-ancestor
138313080|NCT01856790|Hormones|hormones|mesh-ancestor
138313081|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313082|NCT01856322|Sulindac|sulindac|mesh-list
138313083|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138313084|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313085|NCT01856322|Analgesics|analgesics|mesh-ancestor
138313086|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
138313087|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313088|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313089|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313090|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313091|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313092|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138313093|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313094|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313095|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138313096|NCT01871532|Hormones|hormones|mesh-ancestor
138313097|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313098|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313099|NCT01855074|Risperidone|risperidone|mesh-list
138313100|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138313101|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
138313102|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313104|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313105|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138313106|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138313107|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313108|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313109|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138313110|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
138313111|NCT01895322|Tolvaptan|tolvaptan|mesh-list
138313112|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138313114|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
138313115|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313117|NCT01894776|Rifabutin|rifabutin|mesh-list
138313118|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138313119|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138313120|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313121|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138313122|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138313123|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
138313124|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313125|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138313126|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313127|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138313128|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
138313130|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138313131|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138313132|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138313133|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
138313134|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313135|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138313138|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138313140|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138313141|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313143|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313144|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313145|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
138313146|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313147|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313148|NCT01854528|Interferons|interferons|mesh-list
138313149|NCT01854528|Ribavirin|ribavirin|mesh-list
138313150|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313151|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
138313152|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313153|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
138313154|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313155|NCT01853982|Tazobactam|tazobactam|mesh-list
138313156|NCT01853982|Piperacillin|piperacillin|mesh-list
138313157|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138313158|NCT01853982|Ceftolozane|ceftolozane|mesh-list
138313159|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138313160|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313161|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313162|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138313163|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313164|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313165|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138313166|NCT01853280|Methylphenidate|methylphenidate|mesh-list
138313167|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138313168|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313169|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138313170|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138313171|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313172|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313173|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
138313174|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313175|NCT01891890|Lamotrigine|lamotrigine|mesh-list
138313176|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
138313177|NCT01891890|Levetiracetam|levetiracetam|mesh-list
138313178|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
138313179|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
138313182|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313184|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313185|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138313186|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138313187|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313188|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313189|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138313190|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138313191|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138313192|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138313194|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138313195|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138313196|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138313197|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
138313198|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313199|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313200|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138313201|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138313202|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313203|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
138313204|NCT01869192|Docetaxel|docetaxel|mesh-list
138313205|NCT01869192|Capecitabine|capecitabine|mesh-list
138313206|NCT01869192|Epirubicin|epirubicin|mesh-list
138313207|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313208|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
138313209|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313210|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313211|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138313212|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
138313215|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138313216|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
138313217|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
138313218|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
138313219|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313222|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138313223|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138313224|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313225|NCT01851720|Fentanyl|fentanyl|mesh-list
138313226|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138313227|NCT01851720|Narcotics|narcotics|mesh-ancestor
138313228|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313229|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313230|NCT01851720|Analgesics|analgesics|mesh-ancestor
138313231|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
138313232|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313233|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138313234|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138313235|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
138313236|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
138313240|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
138313241|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313242|NCT01868022|Paclitaxel|paclitaxel|mesh-list
138313243|NCT01868022|Docetaxel|docetaxel|mesh-list
138313244|NCT01868022|Carboplatin|carboplatin|mesh-list
138313245|NCT01868022|Pemetrexed|pemetrexed|mesh-list
138313246|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138313247|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313248|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138313249|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138313250|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138313251|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313252|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313253|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138313254|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138313255|NCT01850004|Dasatinib|dasatinib|mesh-list
138313256|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313257|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313258|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313259|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313261|NCT01867710|Prednisone|prednisone|mesh-list
138313262|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
138313263|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313264|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
138313265|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
138313266|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313267|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313268|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138313269|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
138313270|NCT01867710|Hormones|hormones|mesh-ancestor
138313272|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138313273|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313274|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138313275|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313276|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313280|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
138313281|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313282|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313283|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313284|NCT01832766|Analgesics|analgesics|mesh-ancestor
138313285|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
138313286|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313287|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138313288|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138313289|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313290|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313291|NCT01832766|Hormones|hormones|mesh-ancestor
138313292|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313293|NCT01832532|Liraglutide|liraglutide|mesh-list
138313294|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313295|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313296|NCT01832532|Incretins|incretins|mesh-ancestor
138313302|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
138313303|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313304|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138313305|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138313306|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313307|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
138313308|NCT04414956|Coagulants|coagulants|mesh-ancestor
138313309|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
138313310|NCT01848990|Insulin|insulin|mesh-list
138313311|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138313312|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
138313313|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
138313314|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
138313315|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313316|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313317|NCT01867086|Carboplatin|carboplatin|mesh-list
138313318|NCT01867086|Vaccines|vaccines|mesh-list
138313319|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
138313320|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313321|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313322|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
138313337|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313338|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138313339|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313340|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313342|NCT01846104|Vaccines|vaccines|mesh-list
138313343|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
138313347|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138313348|NCT01803282|Bevacizumab|bevacizumab|mesh-list
138313349|NCT01803282|Carboplatin|carboplatin|mesh-list
138313350|NCT01803282|Gemcitabine|gemcitabine|mesh-list
138313351|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
138313352|NCT01803282|Irinotecan|irinotecan|mesh-list
138313353|NCT01803282|Pemetrexed|pemetrexed|mesh-list
138313354|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138313355|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313356|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
138313357|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
138313358|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
138313359|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313360|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313361|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138313362|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138313364|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313365|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
138313368|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138313369|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138313370|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313371|NCT01803282|Antidotes|antidotes|mesh-ancestor
138313372|NCT01803282|Protective Agents|protective agents|mesh-ancestor
138313376|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138313377|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138313378|NCT01844778|Tobramycin|tobramycin|mesh-list
138313379|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313380|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313381|NCT01802580|Fluocinonide|fluocinonide|mesh-list
138313382|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313387|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138313389|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138313390|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313391|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313392|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
138313393|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313394|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313395|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138313396|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
138313397|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313398|NCT01844700|Risperidone|risperidone|mesh-list
138313399|NCT01844700|Aripiprazole|aripiprazole|mesh-list
138313400|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138313401|NCT01844700|Ziprasidone|ziprasidone|mesh-list
138313402|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138313403|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
138313404|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313405|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313406|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313407|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138313408|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138313409|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313410|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313411|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138313412|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
138313413|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138313414|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
138313415|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138313418|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138313419|NCT01844076|Quinacrine|quinacrine|mesh-list
138313420|NCT01844076|Capecitabine|capecitabine|mesh-list
138313421|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313422|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
138313423|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313424|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313425|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
138313426|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138313427|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
138313428|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138313429|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313430|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
138313431|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138313432|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
138313433|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313434|NCT01826448|Vemurafenib|vemurafenib|mesh-list
138313435|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313436|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313438|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313439|NCT01826370|Linagliptin|linagliptin|mesh-list
138313440|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313446|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
138313447|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313448|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313450|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138313451|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313452|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138313455|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313456|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138313457|NCT01798056|Vaccines|vaccines|mesh-list
138313458|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
138313459|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313460|NCT01824342|Denosumab|denosumab|mesh-list
138313461|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138313462|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313463|NCT01823328|Ketamine|ketamine|mesh-list
138313464|NCT01823328|Etomidate|etomidate|mesh-list
138313465|NCT01823328|Analgesics|analgesics|mesh-ancestor
138313466|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
138313467|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313468|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313469|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138313470|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138313471|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
138313472|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
138313473|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313474|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138313491|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
138313492|NCT01797432|Hormones|hormones|mesh-ancestor
138313495|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313497|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313498|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313499|NCT01797120|Everolimus|everolimus|mesh-list
138313500|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
138313501|NCT01797120|Fulvestrant|fulvestrant|mesh-list
138313502|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313503|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313504|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313505|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313506|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
138313507|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313508|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313510|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138313511|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138313512|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
138313513|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313514|NCT01796964|Aflibercept|aflibercept|mesh-list
138313515|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138313519|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
138313520|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313521|NCT01794780|Fluticasone|fluticasone|mesh-list
138313522|NCT01794780|Budesonide|budesonide|mesh-list
138313523|NCT01794780|Theophylline|theophylline|mesh-list
138313524|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
138313525|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
138313526|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138313527|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313528|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138313529|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
138313530|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313531|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313532|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138313533|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
138313534|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313537|NCT01794780|Hormones|hormones|mesh-ancestor
138313538|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313539|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138313540|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138313541|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138313542|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
138313543|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313544|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313545|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
138313546|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138313547|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
138313548|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138313549|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313550|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
138313551|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138313552|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138313553|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
138313554|NCT01838616|Oxycodone|oxycodone|mesh-list
138313555|NCT01838616|Tapentadol|tapentadol|mesh-list
138313556|NCT01838616|Naloxone|naloxone|mesh-list
138313557|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138313558|NCT01838616|Narcotics|narcotics|mesh-ancestor
138313559|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313560|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313561|NCT01838616|Analgesics|analgesics|mesh-ancestor
138313562|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
138313563|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313564|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138313565|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138313566|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138313567|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313568|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313569|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138313570|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313571|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138313573|NCT01609218|Charcoal|charcoal|mesh-list
138313574|NCT01609218|Antidotes|antidotes|mesh-ancestor
138313575|NCT01609218|Protective Agents|protective agents|mesh-ancestor
138313576|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313577|NCT04580472|Clindamycin|clindamycin|mesh-list
138313578|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
138313579|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
138313580|NCT04580472|Cephalexin|cephalexin|mesh-list
138313581|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313582|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313583|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138313584|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313585|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313586|NCT01611558|Ipilimumab|ipilimumab|mesh-list
138313587|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313588|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313589|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138313590|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313591|NCT01818726|Deferasirox|deferasirox|mesh-list
138313592|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138313593|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
138313594|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
138313595|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313596|NCT01818336|Amoxicillin|amoxicillin|mesh-list
138313597|NCT01818336|Penicillins|penicillins|mesh-list
138313598|NCT01818336|Penicillin G|penicillin g|mesh-list
138313599|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313600|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313604|NCT01818258|Zidovudine|zidovudine|mesh-list
138313605|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138313606|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138313607|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
138313608|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313609|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313610|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138313611|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138313613|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313614|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138313615|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138313616|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138313617|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138313618|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
138313619|NCT01817790|Fluticasone|fluticasone|mesh-list
138313620|NCT01817790|Xhance|xhance|mesh-list
138313621|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313622|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138313623|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
138313624|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313625|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313626|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138313627|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138313628|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313629|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138313630|NCT01793688|Ampicillin|ampicillin|mesh-list
138313631|NCT01793688|Sulbactam|sulbactam|mesh-list
138313632|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313633|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313634|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138313635|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313636|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313638|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
138313639|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313640|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313641|NCT01792518|Linagliptin|linagliptin|mesh-list
138313642|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313643|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313644|NCT01792518|Incretins|incretins|mesh-ancestor
138313645|NCT01792518|Hormones|hormones|mesh-ancestor
138313646|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313647|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138313648|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138313649|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313650|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313651|NCT01792284|Insulin|insulin|mesh-list
138313652|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138313653|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
138313654|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313655|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313656|NCT04414566|Cisplatin|cisplatin|mesh-list
138313657|NCT04414566|Gemcitabine|gemcitabine|mesh-list
138313658|NCT04414566|Docetaxel|docetaxel|mesh-list
138313659|NCT04414566|Fluorouracil|fluorouracil|mesh-list
138313663|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313665|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
138313666|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
138313667|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313668|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
138313669|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313671|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313672|NCT04592016|Diclofenac|diclofenac|mesh-list
138313673|NCT04592016|Coal Tar|coal tar|mesh-list
138313674|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138313675|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313676|NCT04592016|Analgesics|analgesics|mesh-ancestor
138313677|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
138313678|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313679|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313680|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313681|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313682|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138313684|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313685|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
138313686|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313687|NCT01837680|Insulin|insulin|mesh-list
138313688|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138313689|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138313690|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313691|NCT01836276|Varenicline|varenicline|mesh-list
138313692|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138313693|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138313694|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
138313695|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313696|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313697|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313698|NCT01790568|Methotrexate|methotrexate|mesh-list
138313699|NCT01790568|Vorinostat|vorinostat|mesh-list
138313700|NCT01790568|Tacrolimus|tacrolimus|mesh-list
138313701|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138313703|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138313704|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313705|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313706|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
138313707|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313708|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313710|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313711|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138313712|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313713|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
138313714|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313715|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138313716|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138313717|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138313718|NCT01836198|Clarithromycin|clarithromycin|mesh-list
138313719|NCT01836198|Ketoconazole|ketoconazole|mesh-list
138313720|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
138313721|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313722|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313723|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138313724|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313725|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313726|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138313727|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138313728|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
138313729|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138313730|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138313731|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138313732|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313733|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313734|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138313735|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
138313736|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138313737|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138313738|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138313739|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138313740|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313741|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138313742|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138313744|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313746|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313747|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
138313748|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313749|NCT01789320|Triamcinolone|triamcinolone|mesh-list
138313750|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138313751|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138313752|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138313755|NCT01789320|Hormones|hormones|mesh-ancestor
138313756|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313757|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313758|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313759|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
138313760|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313761|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313762|NCT01788228|Vaccines|vaccines|mesh-list
138313763|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
138313764|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313765|NCT01607346|Ezogabine|ezogabine|mesh-list
138313766|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
138313767|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313768|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313769|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138313770|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138313771|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313772|NCT01606800|Ribavirin|ribavirin|mesh-list
138313773|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
138313774|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138313775|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
138313776|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313777|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
138313778|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313782|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313783|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
138313784|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138313785|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138313786|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138313787|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313788|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313789|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
138313790|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313791|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313792|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138313793|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313794|NCT01814046|Aldesleukin|aldesleukin|mesh-list
138313795|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
138313796|NCT01814046|Fludarabine|fludarabine|mesh-list
138313797|NCT01814046|Interleukin-2|interleukin-2|mesh-list
138313798|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313799|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
138313800|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313801|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313802|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138313803|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
138313804|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313805|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313808|NCT01814046|Analgesics|analgesics|mesh-ancestor
138313809|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
138313810|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313811|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138313812|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138313813|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
138313814|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313815|NCT01813890|Tapentadol|tapentadol|mesh-list
138313816|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138313817|NCT01813890|Narcotics|narcotics|mesh-ancestor
138313821|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
138313822|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313823|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138313824|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138313825|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313826|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313827|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138313828|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313830|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138313831|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138313834|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313835|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138313837|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313838|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138313839|NCT01786668|Tofacitinib|tofacitinib|mesh-list
138313840|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138313841|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313842|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313843|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313845|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138313846|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313847|NCT01770912|Triamcinolone|triamcinolone|mesh-list
138313848|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138313852|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
138313853|NCT01770912|Hormones|hormones|mesh-ancestor
138313854|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313855|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313856|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313857|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
138313858|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313859|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313860|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
138313861|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138313862|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313863|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313864|NCT01811238|Oxycodone|oxycodone|mesh-list
138313865|NCT01811238|Naloxone|naloxone|mesh-list
138313866|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138313867|NCT01811238|Narcotics|narcotics|mesh-ancestor
138313868|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313869|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313870|NCT01811238|Analgesics|analgesics|mesh-ancestor
138313871|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
138313872|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313873|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138313875|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
138313877|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
138313878|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313879|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313880|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313881|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313882|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
138313883|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313884|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138313885|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313886|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138313887|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
138313888|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
138313889|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313890|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138313891|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138313892|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313893|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313894|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
138313895|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138313898|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
138313899|NCT01810302|Nicardipine|nicardipine|mesh-list
138313900|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138313901|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138313902|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138313903|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313904|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138313905|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313906|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138313907|NCT01783938|Nivolumab|nivolumab|mesh-list
138313908|NCT01783938|Ipilimumab|ipilimumab|mesh-list
138313909|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138313910|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313911|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138313912|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313913|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
138313914|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
138313915|NCT01768572|Methotrexate|methotrexate|mesh-list
138313916|NCT01768572|Leflunomide|leflunomide|mesh-list
138313917|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138313918|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
138313919|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138313920|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313921|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313922|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
138313923|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313924|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313925|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313926|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313929|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
138313930|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313931|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138313932|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
138313933|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138313934|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138313935|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138313936|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138313937|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138313938|NCT01768572|Analgesics|analgesics|mesh-ancestor
138366667|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138366668|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366669|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366670|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138366671|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138313939|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
138313940|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138313943|NCT01783548|Beclomethasone|beclomethasone|mesh-list
138313944|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313945|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
138313946|NCT01783548|Hormones|hormones|mesh-ancestor
138313947|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313948|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313950|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
138313952|NCT01809210|Gemcitabine|gemcitabine|mesh-list
138313953|NCT01809210|Pemetrexed|pemetrexed|mesh-list
138313954|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313955|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138313956|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
138313957|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313958|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313959|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138313962|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
138313963|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138313964|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138313965|NCT01809132|Prednisolone|prednisolone|mesh-list
138313966|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
138313967|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138313968|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
138313969|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
138313970|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138313971|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
138313972|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138313973|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
138313974|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
138313976|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313977|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138313978|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
138313980|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313981|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138313982|NCT01809132|Protective Agents|protective agents|mesh-ancestor
138313983|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138313984|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138313985|NCT01809132|Trace Elements|trace elements|mesh-ancestor
138313986|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
138313987|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138313988|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138313989|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138313990|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313991|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138313992|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138313993|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138313994|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138313995|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
138313996|NCT01809132|Astringents|astringents|mesh-ancestor
138313997|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
138313998|NCT01766778|Metformin|metformin|mesh-list
138314000|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314001|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314002|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138314003|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
138314004|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314005|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314006|NCT01808196|Losartan|losartan|mesh-list
138314007|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
138314008|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138314009|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138314010|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138314011|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138314012|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314013|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138314014|NCT01808118|Adalimumab|adalimumab|mesh-list
138314015|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138314016|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314017|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314018|NCT01782690|Gemcitabine|gemcitabine|mesh-list
138314019|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138314024|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138314025|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314027|NCT01766310|Hematinics|hematinics|mesh-ancestor
138314028|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
138314030|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
138314031|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314032|NCT01782222|Rotigotine|rotigotine|mesh-list
138314033|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
138314034|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
138314036|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314037|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314038|NCT01807182|Aldesleukin|aldesleukin|mesh-list
138314040|NCT01807182|Fludarabine|fludarabine|mesh-list
138314041|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
138314042|NCT01807182|Interleukin-2|interleukin-2|mesh-list
138314043|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138314044|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
138314045|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314046|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314047|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314048|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
138314049|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314050|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314051|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138314052|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314053|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
138314054|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314055|NCT01807182|Analgesics|analgesics|mesh-ancestor
138314056|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
138314057|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314058|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314059|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314060|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
138314061|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314062|NCT01765764|Bimatoprost|bimatoprost|mesh-list
138314063|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138314064|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138314065|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
138314066|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
138314067|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314068|NCT01780974|Protective Agents|protective agents|mesh-ancestor
138314069|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314070|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
138314071|NCT01780974|Vitamins|vitamins|mesh-ancestor
138314072|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
138314073|NCT01780662|Gemcitabine|gemcitabine|mesh-list
138314074|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138314075|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138314077|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
138314078|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138314079|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
138314080|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
138314081|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314082|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314083|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
138314084|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314085|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314086|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
138314087|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138314088|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314094|NCT01762800|Bromides|bromides|mesh-list
138314095|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
138314096|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138314097|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138314098|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314099|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138314100|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
138314101|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314102|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314103|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138314104|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
138314105|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314106|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138314107|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
138314111|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314112|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138314114|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138314115|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314116|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
138314117|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
138314118|NCT01762800|Hormones|hormones|mesh-ancestor
138314119|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314120|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
138314121|NCT01778010|Cocaine|cocaine|mesh-list
138314122|NCT01778010|Modafinil|modafinil|mesh-list
138314123|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138314124|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314125|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138314128|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314130|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
138314131|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314132|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
138314133|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314134|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138314135|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138314136|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138314137|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138314138|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
138314139|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314141|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138314142|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138314143|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138314144|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314145|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314146|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
138314147|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138314150|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138314151|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314153|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314154|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314155|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138314156|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314158|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138314159|NCT01777542|Mitogens|mitogens|mesh-list
138314160|NCT01777542|Mecasermin|mecasermin|mesh-list
138314161|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314162|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314163|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314164|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314165|NCT01777542|Growth Substances|growth substances|mesh-ancestor
138314166|NCT01777152|Prednisone|prednisone|mesh-list
138314167|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
138314168|NCT01777152|Doxorubicin|doxorubicin|mesh-list
138314170|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138314171|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138314172|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
138314173|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314174|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314175|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314181|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138314182|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138314183|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314184|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314185|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
138314186|NCT01777152|Hormones|hormones|mesh-ancestor
138314187|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314188|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138314189|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138314190|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138314191|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138314192|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314193|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314195|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
138314196|NCT01775124|Ranibizumab|ranibizumab|mesh-list
138314197|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138314198|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138314199|NCT01775124|Growth Substances|growth substances|mesh-ancestor
138314200|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314201|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138314202|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314203|NCT01733316|Cysteamine|cysteamine|mesh-list
138314204|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138314205|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314206|NCT01732926|Rituximab|rituximab|mesh-list
138314207|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138314208|NCT01732926|Idelalisib|idelalisib|mesh-list
138314212|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314213|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314214|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314215|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
138314216|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314217|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314218|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
138314220|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138314221|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314222|NCT01774968|Insulin|insulin|mesh-list
138314223|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314224|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314225|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
138314226|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314227|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314228|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138314229|NCT01755702|Acetaminophen|acetaminophen|mesh-list
138314230|NCT01755702|Ibuprofen|ibuprofen|mesh-list
138314231|NCT01755702|Caffeine|caffeine|mesh-list
138314237|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314238|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314239|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314240|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138314241|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314242|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314243|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
138314244|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138314245|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138314246|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138314247|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138314248|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
138314249|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314258|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
138314259|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314260|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138314261|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138314262|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
138314263|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314264|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314265|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138314267|NCT01708902|Linagliptin|linagliptin|mesh-list
138314268|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314269|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314270|NCT01708902|Incretins|incretins|mesh-ancestor
138314271|NCT01708902|Hormones|hormones|mesh-ancestor
138314272|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314273|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138314274|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
138314275|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314276|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314277|NCT01755546|Buprenorphine|buprenorphine|mesh-list
138314278|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138314279|NCT01755546|Narcotics|narcotics|mesh-ancestor
138314282|NCT01755546|Analgesics|analgesics|mesh-ancestor
138314283|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
138314284|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314285|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138314286|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
138314287|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138314288|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314289|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314290|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314291|NCT04413864|Analgesics|analgesics|mesh-ancestor
138314292|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
138314293|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314294|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138314295|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138314296|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138314297|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314298|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314299|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314300|NCT01755234|Propofol|propofol|mesh-list
138314303|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314304|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314305|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138314306|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
138314307|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
138314308|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138314309|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138314310|NCT01730586|Paclitaxel|paclitaxel|mesh-list
138314319|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
138314320|NCT01755156|Glimepiride|glimepiride|mesh-list
138314321|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314322|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314323|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138314324|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138314326|NCT01754376|Aldesleukin|aldesleukin|mesh-list
138314327|NCT01754376|Interleukin-2|interleukin-2|mesh-list
138314328|NCT01754376|Vemurafenib|vemurafenib|mesh-list
138314330|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314331|NCT01754376|Analgesics|analgesics|mesh-ancestor
138314332|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
138314333|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314334|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314335|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314336|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314337|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
138314338|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314339|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138314340|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314341|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314343|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314344|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138314345|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138314346|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314347|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314348|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138314349|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
138314350|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314351|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314353|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314354|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314355|NCT01730040|Atorvastatin|atorvastatin|mesh-list
138314356|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138314357|NCT01730040|Ezetimibe|ezetimibe|mesh-list
138314358|NCT01730040|Alirocumab|alirocumab|mesh-list
138314361|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
138314362|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314363|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138314364|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138314365|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314366|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138314367|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138314368|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138314369|NCT01706328|Fluticasone|fluticasone|mesh-list
138314371|NCT01706328|Albuterol|albuterol|mesh-list
138314372|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138314373|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314376|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314377|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314378|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138314379|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
138314380|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314381|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138314382|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138314383|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138314384|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138314385|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314386|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314387|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314393|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
138314394|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
138314395|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314396|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138314397|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314398|NCT01706250|Analgesics|analgesics|mesh-ancestor
138314399|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
138314400|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314401|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314402|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314403|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314404|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138314410|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314411|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314412|NCT01729728|Analgesics|analgesics|mesh-ancestor
138314413|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
138314414|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314415|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138314416|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138314417|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138314418|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314419|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314420|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314423|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314427|NCT01728246|Tramadol|tramadol|mesh-list
138314428|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314429|NCT01728246|Analgesics|analgesics|mesh-ancestor
138314430|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
138314431|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314432|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314433|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
138314434|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138314435|NCT01728246|Narcotics|narcotics|mesh-ancestor
138314436|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314437|NCT04414020|Progesterone|progesterone|mesh-list
138314444|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314445|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138314446|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
138314447|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314448|NCT01751802|Ecopipam|ecopipam|mesh-list
138314449|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138314450|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138314451|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314452|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314453|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314454|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138314455|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
138314456|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314457|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314478|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314479|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
138314480|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
138314481|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314482|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314483|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138314484|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138314485|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
138314486|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138314487|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138314488|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138314489|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138314490|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138314491|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
138314492|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314493|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138314500|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314501|NCT01725126|Incretins|incretins|mesh-ancestor
138215927|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138314503|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314504|NCT01751724|Caffeine|caffeine|mesh-list
138314505|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
138314506|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314507|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138314508|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314509|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138314510|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314511|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138314512|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138314513|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
138314514|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314515|NCT01751646|Vitamin D|vitamin d|mesh-list
138314516|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
138314517|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
138314518|NCT01751646|Vitamins|vitamins|mesh-list
138314523|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
138314524|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314525|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314526|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
138314527|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314528|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138314529|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138314530|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314531|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314533|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
138314534|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138314536|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314537|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314538|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314539|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
138314540|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314541|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138314542|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138314543|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138314544|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314545|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314546|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314547|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138314551|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314552|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138314553|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138314555|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
138314556|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
138314557|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314558|NCT01722162|Bevacizumab|bevacizumab|mesh-list
138314559|NCT01722162|Capecitabine|capecitabine|mesh-list
138314560|NCT01722162|Levocetirizine|levocetirizine|mesh-list
138314561|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314563|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138314564|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138314565|NCT01722162|Growth Substances|growth substances|mesh-ancestor
138314566|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314567|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
138314568|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314569|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
138314570|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314571|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138314572|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138314573|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
138314574|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
138314575|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314577|NCT01721772|Dacarbazine|dacarbazine|mesh-list
138314578|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314579|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314580|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138314582|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314583|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
138314584|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138314585|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
138314587|NCT01701258|Amisulpride|amisulpride|mesh-list
138314588|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138314589|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138314590|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314591|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314592|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314593|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138314594|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
138314595|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314596|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314597|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138314598|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
138314600|NCT01700946|Aldesleukin|aldesleukin|mesh-list
138314601|NCT01700946|Dexamethasone|dexamethasone|mesh-list
138314602|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
138314606|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
138314607|NCT01700946|Rituximab|rituximab|mesh-list
138314608|NCT01700946|Methotrexate|methotrexate|mesh-list
138314609|NCT01700946|Etoposide|etoposide|mesh-list
138314610|NCT01700946|Vincristine|vincristine|mesh-list
138314611|NCT01700946|Asparaginase|asparaginase|mesh-list
138314612|NCT01700946|Interleukin-2|interleukin-2|mesh-list
138314613|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
138314614|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
138314615|NCT01700946|Clofarabine|clofarabine|mesh-list
138314616|NCT01700946|Vinblastine|vinblastine|mesh-list
138314617|NCT01700946|Pegaspargase|pegaspargase|mesh-list
138314621|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314622|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314623|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314624|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
138314625|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314626|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314627|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138314628|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314629|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
138314630|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
138314631|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314632|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138314634|NCT01700946|Hormones|hormones|mesh-ancestor
138314635|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314636|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138314637|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314638|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138314639|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
138314640|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138314641|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314642|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
138314643|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314644|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314645|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138314646|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138314647|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138314648|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138314649|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138314650|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
138314651|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314652|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
138314653|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
138314654|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314655|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138314656|NCT01700946|Analgesics|analgesics|mesh-ancestor
138314657|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
138314658|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314659|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314666|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138314667|NCT01721070|Narcotics|narcotics|mesh-ancestor
138314668|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314669|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314670|NCT01721070|Analgesics|analgesics|mesh-ancestor
138314671|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
138314672|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314673|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138314674|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138314675|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
138314677|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
138314678|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314679|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138314680|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138314685|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314686|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138314687|NCT01748292|Ranibizumab|ranibizumab|mesh-list
138314688|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138314689|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138314690|NCT01748292|Growth Substances|growth substances|mesh-ancestor
138314691|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314692|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
138314693|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314695|NCT01720602|Anastrozole|anastrozole|mesh-list
138314696|NCT01720602|Vorinostat|vorinostat|mesh-list
138314697|NCT01720602|Exemestane|exemestane|mesh-list
138314698|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138314699|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314700|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138314701|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138314702|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314703|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314706|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314707|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314708|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138314709|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138314710|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138314711|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
138314712|NCT01746732|Evacetrapib|evacetrapib|mesh-list
138314713|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138314714|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138314718|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138314719|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138314720|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314721|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138314722|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138314723|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314724|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314725|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138314726|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
138314727|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138314728|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314729|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138314731|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138314732|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
138314733|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138314734|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138314735|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138314736|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314737|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314738|NCT01720524|Urological Agents|urological agents|mesh-ancestor
138314739|NCT01717638|Vaccines|vaccines|mesh-list
138314740|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
138314741|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314742|NCT01745094|Mirabegron|mirabegron|mesh-list
138314743|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
138314744|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138314745|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138314746|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138314747|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314748|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314749|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314750|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314751|NCT01745094|Urological Agents|urological agents|mesh-ancestor
138314752|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138314753|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138314754|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
138314755|NCT01717326|Ribavirin|ribavirin|mesh-list
138314756|NCT01717326|Grazoprevir|grazoprevir|mesh-list
138314757|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
138314758|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314759|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
138314760|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314761|NCT01744782|Cysteamine|cysteamine|mesh-list
138314764|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
138314765|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
138314766|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314767|NCT01742286|Ceritinib|ceritinib|mesh-list
138314768|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314769|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138314770|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314771|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314772|NCT01716234|Posaconazole|posaconazole|mesh-list
138314773|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
138314774|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314775|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138314776|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138314777|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138314778|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138314779|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138314780|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314781|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314782|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138314783|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
138314784|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314785|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314786|NCT01716156|Ribavirin|ribavirin|mesh-list
138314787|NCT01716156|Grazoprevir|grazoprevir|mesh-list
138314789|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314790|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
138314791|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314792|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
138314793|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138314794|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
138314795|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314796|NCT01739790|Expectorants|expectorants|mesh-ancestor
138314797|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138314798|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138314799|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
138314800|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314801|NCT01739790|Protective Agents|protective agents|mesh-ancestor
138314802|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314803|NCT01739790|Antidotes|antidotes|mesh-ancestor
138314805|NCT01696032|Carboplatin|carboplatin|mesh-list
138314806|NCT01696032|Gemcitabine|gemcitabine|mesh-list
138314807|NCT01696032|Doxorubicin|doxorubicin|mesh-list
138314808|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138314809|NCT01696032|Topotecan|topotecan|mesh-list
138314810|NCT01696032|Guadecitabine|guadecitabine|mesh-list
138314811|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138314813|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138314814|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138314815|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314816|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314817|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314818|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
138314819|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138314820|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138314821|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138314822|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314823|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138314824|NCT01695954|Ritonavir|ritonavir|mesh-list
138314825|NCT01695954|Darunavir|darunavir|mesh-list
138314826|NCT01695954|Efavirenz|efavirenz|mesh-list
138314827|NCT01695954|Pitavastatin|pitavastatin|mesh-list
138314828|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138314829|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138314830|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
138314831|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366678|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
138366679|NCT05775809|Serotonin|serotonin|mesh-list
138366680|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138366681|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138314832|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314834|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314835|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
138314836|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314837|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138314838|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138314839|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138314840|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138314841|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138314845|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138314848|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138314849|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
138314850|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138314851|NCT01694706|Omeprazole|omeprazole|mesh-list
138314852|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138314853|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138314854|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138314855|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314856|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314857|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
138314858|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138314859|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138314860|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138314861|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138314862|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314863|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314864|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314866|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138314867|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138314868|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314869|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138314871|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138314872|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314873|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314874|NCT01693068|Dacarbazine|dacarbazine|mesh-list
138314875|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314876|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
138314877|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314878|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314880|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
138314881|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138314882|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
138314884|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314885|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
138314886|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314887|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138314888|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
138314889|NCT01711866|Rotigotine|rotigotine|mesh-list
138314890|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
138314891|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
138314892|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314893|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314894|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314895|NCT01691508|Prednisone|prednisone|mesh-list
138314896|NCT01691508|Prednisolone|prednisolone|mesh-list
138314901|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314902|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138314903|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314904|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138314905|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
138314906|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138314907|NCT01709838|Deferasirox|deferasirox|mesh-list
138314908|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138314909|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
138314910|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
138314917|NCT01688466|Growth Substances|growth substances|mesh-ancestor
138314918|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
138314919|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314920|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
138314921|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138314922|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138314923|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138314924|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138314925|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314928|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314929|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138314930|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314931|NCT01681992|Vaccines|vaccines|mesh-list
138314932|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
138314933|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314934|NCT01737840|Pantoprazole|pantoprazole|mesh-list
138314935|NCT01737840|Ranitidine|ranitidine|mesh-list
138314936|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138314937|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138314939|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138314940|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314941|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314942|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138314943|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
138314944|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
138314945|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314947|NCT01687998|Evacetrapib|evacetrapib|mesh-list
138314948|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138314949|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138314950|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
138314951|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314952|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138314953|NCT01681212|Ipilimumab|ipilimumab|mesh-list
138314954|NCT01681212|Dacarbazine|dacarbazine|mesh-list
138314955|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314956|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314957|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138314958|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314959|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138314963|NCT01687296|Prednisone|prednisone|mesh-list
138314964|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138314965|NCT01687296|Albuterol|albuterol|mesh-list
138314966|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314967|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
138314968|NCT01687296|Hormones|hormones|mesh-ancestor
138314969|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138314970|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314971|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138314972|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138314973|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138314974|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
138314975|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138314976|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138314977|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
138314978|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
138314979|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138314980|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
138314985|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314986|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366687|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138366688|NCT05769855|Ropivacaine|ropivacaine|mesh-list
138366689|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
138366690|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
138366691|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366692|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366693|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
138366695|NCT05656911|Zabedosertib|zabedosertib|mesh-list
138314987|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314988|NCT01568892|Dolutegravir|dolutegravir|mesh-list
138314989|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138314990|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138314991|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314992|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314993|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138314994|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138314995|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
138314996|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314997|NCT01568112|Aspirin|aspirin|mesh-list
138314998|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138314999|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138315000|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138315002|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
138315003|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315004|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315005|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315006|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315007|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138315008|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138315009|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315010|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138315011|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138315012|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315013|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
138315014|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315015|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315016|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
138315019|NCT01568034|Opicapone|opicapone|mesh-list
138315020|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138315021|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138315022|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
138315024|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315026|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138315027|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315028|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138315030|NCT01687218|Emtricitabine|emtricitabine|mesh-list
138315031|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138315032|NCT01687218|Glycerol|glycerol|mesh-list
138315033|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
138315034|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315035|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138315036|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138315037|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315038|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315039|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138315040|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138315041|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138315042|NCT01687218|Protective Agents|protective agents|mesh-ancestor
138315043|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315044|NCT01686828|Letrozole|letrozole|mesh-list
138315048|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
138315049|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
138315050|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138315051|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315052|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138315053|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138315054|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315055|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315056|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138315057|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
138366705|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366706|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366707|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138366708|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138366710|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
138315058|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315059|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315060|NCT01686828|Androgens|androgens|mesh-ancestor
138315061|NCT01686828|Hormones|hormones|mesh-ancestor
138315062|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138315063|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
138315064|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
138315066|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138315067|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138315068|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315069|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315070|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315071|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315072|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315073|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138315075|NCT01684878|Paclitaxel|paclitaxel|mesh-list
138315076|NCT01684878|Gemcitabine|gemcitabine|mesh-list
138315077|NCT01684878|Topotecan|topotecan|mesh-list
138315078|NCT01684878|Pertuzumab|pertuzumab|mesh-list
138315079|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138315080|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315084|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315085|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315087|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138315088|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138315089|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315090|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315091|NCT01684722|Vitamin D|vitamin d|mesh-list
138315092|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
138315093|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
138315095|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
138315096|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315097|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138315098|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138315099|NCT01592292|Adalimumab|adalimumab|mesh-list
138315100|NCT01592292|Infliximab|infliximab|mesh-list
138315101|NCT01592292|Etanercept|etanercept|mesh-list
138315102|NCT01592292|Rituximab|rituximab|mesh-list
138315103|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315104|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315105|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
138315106|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315107|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315108|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138315109|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315110|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315111|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138315112|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138315113|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138315115|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
138315116|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315117|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315118|NCT01565850|Darunavir|darunavir|mesh-list
138315119|NCT01565850|Cobicistat|cobicistat|mesh-list
138315120|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315121|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315122|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
138315123|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315124|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138315125|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138315126|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138315129|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138315130|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315131|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
138315132|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138315133|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138366712|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138315134|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315135|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315136|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315137|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315138|NCT01565694|Urological Agents|urological agents|mesh-ancestor
138315139|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
138315140|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315141|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
138315144|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138315145|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
138315146|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315147|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315150|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138315151|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315152|NCT01565148|Growth Substances|growth substances|mesh-ancestor
138315153|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315154|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138315155|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315157|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
138315158|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315159|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
138315160|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315162|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138315163|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315164|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138315165|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315166|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315167|NCT01589094|Gemcitabine|gemcitabine|mesh-list
138315168|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315169|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315170|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
138315171|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315172|NCT01563354|Everolimus|everolimus|mesh-list
138315173|NCT01563354|Pasireotide|pasireotide|mesh-list
138315174|NCT01563354|Somatostatin|somatostatin|mesh-list
138315175|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138315176|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315177|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315178|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315179|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315180|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
138315181|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315182|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315183|NCT01563354|Hormones|hormones|mesh-ancestor
138315184|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315185|NCT03027960|Empagliflozin|empagliflozin|mesh-list
138315188|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315189|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315190|NCT01539642|Sufentanil|sufentanil|mesh-list
138315191|NCT01539642|Dsuvia|dsuvia|mesh-list
138315192|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138315193|NCT01539642|Narcotics|narcotics|mesh-ancestor
138315194|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315195|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315196|NCT01539642|Analgesics|analgesics|mesh-ancestor
138315197|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
138315198|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315199|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138315200|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138315205|NCT01538472|Melphalan|melphalan|mesh-list
138315206|NCT01538472|Carmustine|carmustine|mesh-list
138315207|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138315208|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315209|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315210|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
138315211|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315212|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315213|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315214|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
138315215|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315216|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
138315217|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315218|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315219|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138315220|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
138315221|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138315222|NCT01562028|Bevacizumab|bevacizumab|mesh-list
138315231|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315232|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315233|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315234|NCT04767828|Capecitabine|capecitabine|mesh-list
138315235|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315236|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
138315237|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315238|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315239|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
138315240|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315241|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315242|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138315243|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138315244|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138315245|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315257|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315258|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138315259|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
138315260|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315261|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315262|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138315263|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138315264|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138315265|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
138315266|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315267|NCT01585272|Rivastigmine|rivastigmine|mesh-list
138315268|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138315269|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315273|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315274|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138315275|NCT01585272|Protective Agents|protective agents|mesh-ancestor
138315276|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138315277|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138315279|NCT01585038|Rilpivirine|rilpivirine|mesh-list
138315280|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138315281|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138315282|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315283|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315284|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
138315285|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315286|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138315287|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315288|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138315289|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138315290|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138315291|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138315293|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138315295|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
138315296|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
138315301|NCT01584648|Dabrafenib|dabrafenib|mesh-list
138315302|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315303|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315304|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315305|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315306|NCT01559454|Buprenorphine|buprenorphine|mesh-list
138315307|NCT01559454|Methadone|methadone|mesh-list
138315308|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138315309|NCT01559454|Naloxone|naloxone|mesh-list
138315310|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138315311|NCT01559454|Narcotics|narcotics|mesh-ancestor
138315312|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315313|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315314|NCT01559454|Analgesics|analgesics|mesh-ancestor
138315315|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
138315316|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315317|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138315318|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
138315319|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315322|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
138315323|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
138315324|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315325|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315326|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
138315327|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315328|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138315329|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138315330|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315331|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315332|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315333|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138315334|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138315335|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
138315336|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138315337|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315338|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
138315339|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
138315340|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138315342|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138315346|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
138315347|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315348|NCT01582854|Protective Agents|protective agents|mesh-ancestor
138315349|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138315350|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138315352|NCT01582308|Saxagliptin|saxagliptin|mesh-list
138315353|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315354|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315355|NCT01582308|Incretins|incretins|mesh-ancestor
138315356|NCT01582308|Hormones|hormones|mesh-ancestor
138315357|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315358|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138315359|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315360|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315362|NCT01558674|Torsemide|torsemide|mesh-list
138315363|NCT01558674|Furosemide|furosemide|mesh-list
138315364|NCT01558674|Diuretics|diuretics|mesh-ancestor
138315365|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
138315366|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315367|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138315368|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315369|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315370|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138315371|NCT01535040|Memantine|memantine|mesh-list
138315372|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138315373|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138315374|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
138315376|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315377|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315378|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138315379|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138315380|NCT01534962|Ranolazine|ranolazine|mesh-list
138315382|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315383|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315384|NCT01582152|Bevacizumab|bevacizumab|mesh-list
138315385|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315386|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315387|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138315388|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315389|NCT01582152|Growth Substances|growth substances|mesh-ancestor
138315390|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315391|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138315392|NCT01557504|Metformin|metformin|mesh-list
138315393|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138315394|NCT01557504|Hormones|hormones|mesh-list
138315395|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315397|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315399|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138315400|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315401|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315402|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315403|NCT01580670|Infliximab|infliximab|mesh-list
138315404|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138315405|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315406|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315407|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138315408|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315410|NCT01534260|Sorafenib|sorafenib|mesh-list
138315411|NCT01534260|Vorinostat|vorinostat|mesh-list
138315412|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315413|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315414|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315415|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315416|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138315417|NCT01534182|Interferons|interferons|mesh-list
138315418|NCT01534182|Interferon-beta|interferon-beta|mesh-list
138315419|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
138315420|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138315421|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
138315422|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315423|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
138315424|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315425|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
138315426|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315427|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138315428|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315429|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315430|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138315431|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315432|NCT01579812|Metformin|metformin|mesh-list
138315433|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315434|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315436|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138315437|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315438|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138315439|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138315440|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138315441|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315442|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138315443|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138315444|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138315445|NCT01578486|Analgesics|analgesics|mesh-ancestor
138315446|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
138315447|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315448|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315449|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315450|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315451|NCT01555164|Metformin|metformin|mesh-list
138315452|NCT01555164|Ranolazine|ranolazine|mesh-list
138315453|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315454|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315455|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138315456|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315457|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315458|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
138315459|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138315460|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
138315461|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315462|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
138315464|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138315465|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138315466|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315467|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315468|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
138315469|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315470|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138315471|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138315472|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138315473|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315474|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315475|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138315476|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138315477|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138315478|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
138315480|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315481|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138315482|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138315483|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
138315484|NCT01554618|Exenatide|exenatide|mesh-list
138315485|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315486|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315487|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138315488|NCT01554618|Incretins|incretins|mesh-ancestor
138315489|NCT01554618|Hormones|hormones|mesh-ancestor
138315490|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315491|NCT01531998|Dexamethasone|dexamethasone|mesh-list
138315492|NCT01531998|Lenalidomide|lenalidomide|mesh-list
138315493|NCT01531998|Bortezomib|bortezomib|mesh-list
138315494|NCT01531998|Siltuximab|siltuximab|mesh-list
138315495|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315496|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
138315497|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
138315498|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315499|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315503|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315504|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138315506|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
138315507|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138315508|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315509|NCT01531998|Growth Substances|growth substances|mesh-ancestor
138315510|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138315511|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
138315512|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
138315513|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138315514|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315515|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315516|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
138315517|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138315518|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315519|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315520|NCT01553136|Varenicline|varenicline|mesh-list
138315521|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138315522|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138315525|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315526|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315527|NCT01552902|Methylphenidate|methylphenidate|mesh-list
138315528|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138315529|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138315530|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315531|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138315532|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138315533|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315534|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315536|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315537|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
138315538|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138315540|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138315541|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315542|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315543|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315544|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315545|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315546|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138315547|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315548|NCT01529346|Ibuprofen|ibuprofen|mesh-list
138315549|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138315550|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138315551|NCT01529346|Analgesics|analgesics|mesh-ancestor
138315552|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
138315554|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315556|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315557|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138315558|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315559|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315560|NCT01529268|Cysteamine|cysteamine|mesh-list
138315561|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138315562|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315563|NCT01529112|Lenvatinib|lenvatinib|mesh-list
138315564|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315565|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315566|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315567|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315568|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
138315569|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138315570|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138315571|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138315572|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315573|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315574|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315575|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315576|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315577|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138315578|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315579|NCT01528254|Metformin|metformin|mesh-list
138315580|NCT01528254|Vildagliptin|vildagliptin|mesh-list
138315581|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315582|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315583|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138315584|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315585|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315586|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315587|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138315588|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
138315589|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
138315590|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138315591|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138315592|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138315593|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315594|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315595|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315596|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315597|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
138315599|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138315600|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315601|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138315602|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138315603|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138315604|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315606|NCT01549002|Morphine|morphine|mesh-list
138315607|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138315608|NCT01549002|Narcotics|narcotics|mesh-ancestor
138315609|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315610|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315614|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138315616|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
138315617|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
138315618|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138315619|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
138315620|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315621|NCT01572792|Bromides|bromides|mesh-list
138315622|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
138315623|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138315624|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
138315625|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315626|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315627|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138315628|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315629|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138315630|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138315631|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138315632|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315633|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315634|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315635|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
138315636|NCT01547598|Timolol|timolol|mesh-list
138315637|NCT01547598|Bimatoprost|bimatoprost|mesh-list
138315638|NCT01547598|Travoprost|travoprost|mesh-list
138315639|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138315640|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138315641|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138315642|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138315643|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315644|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315645|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315646|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315647|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138315648|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138315649|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
138315650|NCT01547286|Miotics|miotics|mesh-ancestor
138315651|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
138315652|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315653|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315654|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138315655|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138315656|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315657|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138315658|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138315659|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315660|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315661|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315662|NCT01524978|Cetuximab|cetuximab|mesh-list
138315663|NCT01524978|Vemurafenib|vemurafenib|mesh-list
138315664|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315665|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315666|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138315667|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315668|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315670|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315671|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138315673|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315674|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315675|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138315676|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315677|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
138315678|NCT01524198|Hormones|hormones|mesh-ancestor
138315679|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315680|NCT01523886|Rocuronium|rocuronium|mesh-list
138315681|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138315682|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138315683|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138315684|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315685|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315686|NCT01546038|Cytarabine|cytarabine|mesh-list
138315691|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315692|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315693|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
138315694|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315695|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315696|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
138315697|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315698|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138315699|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138315700|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138315701|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315702|NCT01571232|Dexamethasone|dexamethasone|mesh-list
138315703|NCT01571232|Bevacizumab|bevacizumab|mesh-list
138315704|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315705|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315706|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138315707|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315708|NCT01571232|Growth Substances|growth substances|mesh-ancestor
138315709|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315710|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138315711|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315712|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
138315713|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
138315714|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315715|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138315716|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
138315717|NCT01571232|Hormones|hormones|mesh-ancestor
138315718|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315729|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138315730|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138315731|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315732|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315733|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315734|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
138315735|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138315736|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138315737|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138315738|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138315739|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138315740|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138315741|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315749|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315750|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315751|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
138315752|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315753|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315754|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315755|NCT01518192|Doxycycline|doxycycline|mesh-list
138315756|NCT01518192|Cefuroxime|cefuroxime|mesh-list
138315757|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
138315758|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138315759|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315760|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
138315761|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138315762|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138315763|NCT01517802|Prednisone|prednisone|mesh-list
138315764|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
138315765|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315766|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
138315767|NCT01517802|Hormones|hormones|mesh-ancestor
138315768|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315769|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315770|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138315771|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315772|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138315774|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315775|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
138315776|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138315777|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
138315778|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138315779|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
138315780|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315781|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315782|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138315783|NCT04714710|Diuretics|diuretics|mesh-ancestor
138315784|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
138315785|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138315786|NCT01520922|Ofatumumab|ofatumumab|mesh-list
138315787|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138315788|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
138315789|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315790|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315791|NCT01517412|Metformin|metformin|mesh-list
138315792|NCT01517412|Lixisenatide|lixisenatide|mesh-list
138315793|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315794|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315795|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138315796|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
138315797|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138315798|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138315799|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
138315800|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315801|NCT01516008|Tapentadol|tapentadol|mesh-list
138315802|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138315803|NCT01516008|Narcotics|narcotics|mesh-ancestor
138315804|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315805|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315806|NCT01516008|Analgesics|analgesics|mesh-ancestor
138315807|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
138315808|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315809|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138315810|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138315811|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138315813|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315814|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315815|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
138315816|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
138315817|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138315818|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
138315819|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315820|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315821|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315822|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
138315823|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
138315824|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315825|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138315830|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315831|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315832|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
138315833|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315834|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315835|NCT01514370|Interferons|interferons|mesh-list
138315836|NCT01514370|Interferon-beta|interferon-beta|mesh-list
138315837|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
138315839|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315840|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
138315841|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315842|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138315843|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138315844|NCT01514370|Analgesics|analgesics|mesh-ancestor
138315845|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
138315846|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315847|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315848|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315849|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315850|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315851|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315852|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
138315853|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138315854|NCT01519674|Insulin|insulin|mesh-list
138315855|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138315856|NCT01519674|Metformin|metformin|mesh-list
138315857|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
138315858|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
138315859|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138315860|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138315861|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
138315862|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138315863|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
138315864|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315865|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315868|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315869|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138315870|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315871|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315872|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315874|NCT01519518|Calcium heparin|calcium heparin|mesh-list
138315875|NCT01519518|Bivalirudin|bivalirudin|mesh-list
138315876|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
138315877|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138315878|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138315879|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315880|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
138315881|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138315882|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315883|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315884|NCT01518972|Prazosin|prazosin|mesh-list
138315885|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138315886|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138315889|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315890|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315891|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315892|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315894|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
138315895|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315896|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315897|NCT04672512|Prednisone|prednisone|mesh-list
138315898|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315899|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
138315900|NCT04672512|Hormones|hormones|mesh-ancestor
138315901|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315902|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315903|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138315904|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315907|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315908|NCT01512108|Incretins|incretins|mesh-ancestor
138315909|NCT01512108|Hormones|hormones|mesh-ancestor
138315910|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315911|NCT01486758|Azithromycin|azithromycin|mesh-list
138315912|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138315913|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315914|NCT01463982|Capecitabine|capecitabine|mesh-list
138315915|NCT01463982|Irinotecan|irinotecan|mesh-list
138315916|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138315918|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315919|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315920|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138315921|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138315922|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315923|NCT01510158|Allopurinol|allopurinol|mesh-list
138315924|NCT01510158|Lesinurad|lesinurad|mesh-list
138315925|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
138315926|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315927|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315928|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
138315929|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315930|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138315931|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
138315932|NCT01510158|Protective Agents|protective agents|mesh-ancestor
138315933|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315934|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
138315935|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138315936|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138315937|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138315939|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315941|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315942|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315943|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138315944|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315946|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138315947|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
138315948|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315949|NCT01509846|Vaccines|vaccines|mesh-list
138315950|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
138315951|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315952|NCT01462344|Fluticasone|fluticasone|mesh-list
138315953|NCT01462344|Xhance|xhance|mesh-list
138315954|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138315955|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138315956|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
138315957|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315960|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315961|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
138315965|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138315966|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
138315967|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138315969|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
138315970|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138315971|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138315972|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315973|NCT01462266|Incretins|incretins|mesh-ancestor
138315975|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138315976|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138315977|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
138315978|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315979|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315980|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
138315981|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
138315982|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138315983|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
138315984|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138315985|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315986|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138315987|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
138315988|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138315989|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138315990|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138315991|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
138315992|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138315993|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315994|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138315997|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
138315998|NCT01508676|Diclofenac|diclofenac|mesh-list
138315999|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138316001|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138316002|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316004|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
138316005|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316006|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316007|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316008|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138316009|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316010|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316011|NCT02985372|Cytarabine|cytarabine|mesh-list
138316012|NCT02985372|Decitabine|decitabine|mesh-list
138316013|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138316014|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
138316015|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316016|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316017|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
138316018|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316019|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316020|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
138316021|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316022|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316023|NCT02985216|Pregabalin|pregabalin|mesh-list
138316024|NCT02985216|Analgesics|analgesics|mesh-ancestor
138316026|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316027|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316028|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
138316029|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138316030|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316031|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316032|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316033|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138316034|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138316035|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316036|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138316037|NCT01461096|Vaccines|vaccines|mesh-list
138316038|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
138316039|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316040|NCT01480674|Trastuzumab|trastuzumab|mesh-list
138316041|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316042|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316043|NCT01506882|Levetiracetam|levetiracetam|mesh-list
138316044|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
138316045|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
138316046|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
138316047|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138316048|NCT01506726|Salicylates|salicylates|mesh-list
138316049|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138316050|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316051|NCT01506726|Analgesics|analgesics|mesh-ancestor
138316052|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
138316053|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316054|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316055|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316057|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138316058|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316059|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316061|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
138316062|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
138316063|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316064|NCT01505868|Carboplatin|carboplatin|mesh-list
138316065|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316066|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
138316067|NCT01505634|Imipenem|imipenem|mesh-list
138316068|NCT01505634|Relebactam|relebactam|mesh-list
138316069|NCT01505634|Cilastatin|cilastatin|mesh-list
138316070|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138316071|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316072|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138316073|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138316074|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316075|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316077|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138316078|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138316079|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
138316080|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138316081|NCT01460628|Modafinil|modafinil|mesh-list
138316082|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138316083|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316084|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138316085|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138316086|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138316087|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316088|NCT01480596|Belimumab|belimumab|mesh-list
138316089|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316090|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
138316091|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316092|NCT01459614|Gemcitabine|gemcitabine|mesh-list
138316093|NCT01459614|Docetaxel|docetaxel|mesh-list
138316094|NCT01459614|Capecitabine|capecitabine|mesh-list
138316095|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316096|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138316097|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
138316098|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316099|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316100|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
138316101|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316102|NCT01458522|Lacosamide|lacosamide|mesh-list
138316104|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
138316105|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138316106|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138316108|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316110|NCT03026946|Alitretinoin|alitretinoin|mesh-list
138316111|NCT03026946|Cyclosporins|cyclosporins|mesh-list
138316112|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316113|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316114|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316115|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
138316116|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316117|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
138316118|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316119|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316120|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316121|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138316122|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316123|NCT01458210|Dulaglutide|dulaglutide|mesh-list
138316124|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
138316125|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138316126|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316127|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316128|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138316129|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316130|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138316131|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138316132|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316133|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316134|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316135|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138316136|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
138316137|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138316138|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138316139|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138316140|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138316142|NCT06175403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138316143|NCT06175403|Antimetabolites|antimetabolites|mesh-ancestor
138316144|NCT06175403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316145|NCT06175403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138316146|NCT06175403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138316147|NCT06175403|Vitamin B Complex|vitamin b complex|mesh-ancestor
138316148|NCT06175403|Vitamins|vitamins|mesh-ancestor
138316149|NCT06175403|Micronutrients|micronutrients|mesh-ancestor
138316150|NCT06175403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316151|NCT06175377|Aspirin|aspirin|mesh-list
138316153|NCT06175377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138316154|NCT06175377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316155|NCT06175377|Analgesics|analgesics|mesh-ancestor
138316156|NCT06175377|Sensory System Agents|sensory system agents|mesh-ancestor
138316157|NCT06175377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316158|NCT06175377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316159|NCT06175377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316160|NCT06175377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316161|NCT06175377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138316162|NCT06175377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138316163|NCT06175377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316164|NCT06175377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138316165|NCT06175377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138316166|NCT06175377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316183|NCT06175273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138316184|NCT06175273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316185|NCT06175273|Analgesics|analgesics|mesh-ancestor
138316186|NCT06175273|Sensory System Agents|sensory system agents|mesh-ancestor
138316187|NCT06175273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316188|NCT06175273|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138316189|NCT06175273|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138316190|NCT06175273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316191|NCT06175273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316192|NCT06175273|Hormones|hormones|mesh-ancestor
138316193|NCT06175273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316194|NCT06175273|Antipruritics|antipruritics|mesh-ancestor
138316195|NCT06175273|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316196|NCT06175273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138316197|NCT06175273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138316198|NCT06175273|Histamine Antagonists|histamine antagonists|mesh-ancestor
138316199|NCT06175273|Histamine Agents|histamine agents|mesh-ancestor
138316200|NCT06175273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138316201|NCT06175273|Serotonin Agents|serotonin agents|mesh-ancestor
138316202|NCT06175273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138316203|NCT06175156|Anesthetics|anesthetics|mesh-list
138316204|NCT06175156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316205|NCT06175156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316206|NCT06175117|Cortisone|cortisone|mesh-list
138316207|NCT06175117|Ferrous succinate|ferrous succinate|mesh-list
138316208|NCT06175117|Hematinics|hematinics|mesh-ancestor
138316209|NCT06175117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316210|NCT06175000|Obinutuzumab|obinutuzumab|mesh-list
138316211|NCT06175000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316212|NCT06175000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316213|NCT06174987|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138316214|NCT06174987|Immunoconjugates|immunoconjugates|mesh-ancestor
138316215|NCT06174987|Immunologic Factors|immunologic factors|mesh-ancestor
138316216|NCT06174987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316217|NCT06174935|Atropine|atropine|mesh-list
138316218|NCT06174935|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138316219|NCT06174935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138316220|NCT06174935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138316221|NCT06174935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138316222|NCT06174935|Autonomic Agents|autonomic agents|mesh-ancestor
138316223|NCT06174935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316224|NCT06174935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316225|NCT06174935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138316226|NCT06174935|Respiratory System Agents|respiratory system agents|mesh-ancestor
138316227|NCT06174935|Mydriatics|mydriatics|mesh-ancestor
138316228|NCT06174935|Parasympatholytics|parasympatholytics|mesh-ancestor
138316229|NCT06174935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138316230|NCT06174935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138316233|NCT06174935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316235|NCT06174922|Itraconazole|itraconazole|mesh-list
138316236|NCT06174922|Prednisolone|prednisolone|mesh-list
138316237|NCT06174922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316238|NCT06174922|Glucocorticoids|glucocorticoids|mesh-ancestor
138316239|NCT06174922|Hormones|hormones|mesh-ancestor
138316240|NCT06174922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316241|NCT06174922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316242|NCT06174922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138316244|NCT06174922|Antifungal Agents|antifungal agents|mesh-ancestor
138316245|NCT06174922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316246|NCT06174922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138316247|NCT06174922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138316248|NCT06174922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316249|NCT06174922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316250|NCT06174922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138316251|NCT06174922|Hormone Antagonists|hormone antagonists|mesh-ancestor
138316252|NCT06174922|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138316253|NCT06174909|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138316254|NCT06174909|Calcium|calcium|mesh-list
138316255|NCT06174909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316256|NCT06174909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316257|NCT06174909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316258|NCT06174792|Drospirenone|drospirenone|mesh-list
138316259|NCT06174792|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138316260|NCT06174792|Hormone Antagonists|hormone antagonists|mesh-ancestor
138316261|NCT06174792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316262|NCT06174792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316263|NCT06174792|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138316264|NCT06174792|Diuretics|diuretics|mesh-ancestor
138316265|NCT06174792|Natriuretic Agents|natriuretic agents|mesh-ancestor
138316266|NCT06174753|Dapagliflozin|dapagliflozin|mesh-list
138316267|NCT06174753|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138316268|NCT06174753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316269|NCT06174753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316270|NCT06174753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316271|NCT06174298|Lenograstim|lenograstim|mesh-list
138316272|NCT06174298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138316273|NCT06174298|Immunologic Factors|immunologic factors|mesh-ancestor
138316274|NCT06174298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316275|NCT06174285|Hallucinogens|hallucinogens|mesh-list
138316278|NCT06174012|Listerine|listerine|mesh-list
138316279|NCT06174012|Fluorides|fluorides|mesh-list
138316280|NCT06174012|Sodium Fluoride|sodium fluoride|mesh-list
138316281|NCT06174012|Cariostatic Agents|cariostatic agents|mesh-ancestor
138316282|NCT06174012|Protective Agents|protective agents|mesh-ancestor
138316283|NCT06174012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316284|NCT06174012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138316285|NCT06174012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316287|NCT06173986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138316289|NCT06173986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316292|NCT06173986|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316293|NCT06173986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316294|NCT06173986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316296|NCT06173934|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138316297|NCT06173934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316298|NCT06173934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316299|NCT06173778|Nicotine|nicotine|mesh-list
138316300|NCT06173778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138316301|NCT06173778|Autonomic Agents|autonomic agents|mesh-ancestor
138316302|NCT06173778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316303|NCT06173778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316304|NCT06173778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138316305|NCT06173778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138316306|NCT06173778|Cholinergic Agents|cholinergic agents|mesh-ancestor
138316307|NCT06173778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316308|NCT06173778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316309|NCT06166654|Metolazone|metolazone|mesh-list
138316310|NCT06166654|Acetazolamide|acetazolamide|mesh-list
138316311|NCT06166654|Diuretics|diuretics|mesh-list
138316312|NCT06166654|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138316313|NCT06166654|Natriuretic Agents|natriuretic agents|mesh-ancestor
138316314|NCT06166654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316315|NCT06166654|Anticonvulsants|anticonvulsants|mesh-ancestor
138316316|NCT06166654|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138316317|NCT06166654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316318|NCT06166654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316319|NCT06166654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316320|NCT06166654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138316321|NCT06166654|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138316322|NCT06155331|Cyclophosphamide|cyclophosphamide|mesh-list
138316323|NCT06155331|Doxorubicin|doxorubicin|mesh-list
138316324|NCT06155331|Fenofibrate|fenofibrate|mesh-list
138316325|NCT06155331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316326|NCT06155331|Immunologic Factors|immunologic factors|mesh-ancestor
138316327|NCT06155331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316328|NCT06155331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316329|NCT06155331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138316330|NCT06155331|Alkylating Agents|alkylating agents|mesh-ancestor
138316331|NCT06155331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316332|NCT06155331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316333|NCT06155331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138316335|NCT06155331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138316336|NCT06155331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138316337|NCT06155331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316338|NCT06155331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138316339|NCT06155331|Antimetabolites|antimetabolites|mesh-ancestor
138316340|NCT06155331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138316341|NCT06138691|Ketamine|ketamine|mesh-list
138316344|NCT06138691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316345|NCT06138691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316346|NCT06138691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138316347|NCT06138691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316348|NCT06138691|Anesthetics, General|anesthetics, general|mesh-ancestor
138316349|NCT06138691|Anesthetics|anesthetics|mesh-ancestor
138316350|NCT06138691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316351|NCT06138691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138316353|NCT06138691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316354|NCT06138691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316355|NCT06131905|Magnesium Sulfate|magnesium sulfate|mesh-list
138316357|NCT06131905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138316359|NCT06131905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316360|NCT06131905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316361|NCT06131905|Anesthetics, General|anesthetics, general|mesh-ancestor
138316362|NCT06131905|Anesthetics|anesthetics|mesh-ancestor
138316363|NCT06131905|Analgesics|analgesics|mesh-ancestor
138316364|NCT06131905|Sensory System Agents|sensory system agents|mesh-ancestor
138316365|NCT06131905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316366|NCT06131905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138316367|NCT06131905|Anticonvulsants|anticonvulsants|mesh-ancestor
138316368|NCT06131905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138316369|NCT06131905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316370|NCT06131905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316371|NCT06131905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316373|NCT06131905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138316375|NCT06087328|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138316376|NCT06087328|Autonomic Agents|autonomic agents|mesh-ancestor
138316377|NCT06087328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316378|NCT06087328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316379|NCT06087328|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138316391|NCT06078904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316392|NCT06076018|Fentanyl|fentanyl|mesh-list
138316396|NCT06076018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316397|NCT06076018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316399|NCT06076018|Sensory System Agents|sensory system agents|mesh-ancestor
138316400|NCT06076018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316401|NCT06076018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138316402|NCT06076018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316404|NCT06076018|Anesthetics|anesthetics|mesh-ancestor
138316416|NCT06061926|Magnesium Oxide|magnesium oxide|mesh-list
138316417|NCT06061926|Antacids|antacids|mesh-ancestor
138316418|NCT06061926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316419|NCT06061926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138316420|NCT06061809|Bevacizumab|bevacizumab|mesh-list
138316421|NCT06061809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316423|NCT06061809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138316425|NCT06061809|Growth Substances|growth substances|mesh-ancestor
138316426|NCT06061809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316427|NCT06061809|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316428|NCT06055621|Dasatinib|dasatinib|mesh-list
138316429|NCT06055621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316430|NCT06055621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138316431|NCT06055621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316432|NCT06055621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316433|NCT06034314|Dronabinol|dronabinol|mesh-list
138316434|NCT06034314|Hallucinogens|hallucinogens|mesh-ancestor
138316435|NCT06034314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316436|NCT06034314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138316437|NCT06034314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316438|NCT06034314|Analgesics|analgesics|mesh-ancestor
138316439|NCT06034314|Sensory System Agents|sensory system agents|mesh-ancestor
138316440|NCT06034314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316441|NCT06034314|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138316442|NCT06034314|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138316443|NCT06034314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316444|NCT06034314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316445|NCT06034314|Hormones|hormones|mesh-ancestor
138316448|NCT06002217|Anesthetics, Local|anesthetics, local|mesh-ancestor
138316449|NCT06002217|Anesthetics|anesthetics|mesh-ancestor
138316450|NCT06002217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316451|NCT06002217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316452|NCT06002217|Sensory System Agents|sensory system agents|mesh-ancestor
138316453|NCT06002217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316454|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
138316455|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316456|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316458|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
138316459|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138316460|NCT05894603|Molnupiravir|molnupiravir|mesh-list
138316461|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138316462|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138316463|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138316467|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316468|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
138316469|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316470|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138316471|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138316472|NCT05890963|Ibalizumab|ibalizumab|mesh-list
138316473|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316474|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
138316475|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316476|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138316477|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
138316480|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316481|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316483|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316484|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316485|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
138316486|NCT05846724|Lenvatinib|lenvatinib|mesh-list
138316487|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316488|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316489|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316490|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316491|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138316497|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
138316498|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316499|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
138316500|NCT05834777|Icatibant|icatibant|mesh-list
138316501|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138316502|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316503|NCT05834777|Analgesics|analgesics|mesh-ancestor
138316504|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
138316505|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316506|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316507|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316508|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316509|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138316511|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316512|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138316513|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316514|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
138316515|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
138316516|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138316517|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
138316518|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316520|NCT05824806|Protective Agents|protective agents|mesh-ancestor
138316521|NCT05786365|Ketamine|ketamine|mesh-list
138316522|NCT05786365|Analgesics|analgesics|mesh-ancestor
138316523|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
138316524|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316525|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316526|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138316527|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316528|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
138316533|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316534|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316535|NCT05773846|Ropivacaine|ropivacaine|mesh-list
138316537|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
138316538|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316539|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316540|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
138316543|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138316544|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316545|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316546|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316547|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316548|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
138316549|NCT05757063|Propofol|propofol|mesh-list
138316550|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138316551|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316552|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316553|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316554|NCT05757063|Analgesics|analgesics|mesh-ancestor
138316555|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
138316556|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316557|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138316558|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138316559|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138316560|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
138316561|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316562|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316563|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316564|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
138316566|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138316567|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
138316568|NCT05755035|Antibodies|antibodies|mesh-list
138316576|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
138316577|NCT05660213|Bevacizumab|bevacizumab|mesh-list
138316578|NCT05660213|Atezolizumab|atezolizumab|mesh-list
138316579|NCT05660213|Apatinib|apatinib|mesh-list
138316580|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316581|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316582|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138316583|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138316585|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316586|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316587|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316588|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316589|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138316590|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316591|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138316592|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316594|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138316596|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316597|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
138316598|NCT05644873|Analgesics|analgesics|mesh-ancestor
138316599|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
138316600|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316603|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316604|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138316606|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138316607|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316608|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316609|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138316610|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
138316611|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138316612|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
138316613|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316614|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
138316615|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316616|NCT05628363|Androgens|androgens|mesh-list
138316617|NCT05628363|Hormones|hormones|mesh-ancestor
138316618|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316621|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
138316622|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316623|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138316624|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138316625|NCT05626322|Growth Substances|growth substances|mesh-ancestor
138316626|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316627|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316638|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138316639|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316640|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
138316641|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316643|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
138316644|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316645|NCT05546879|Bevacizumab|bevacizumab|mesh-list
138316646|NCT05546879|Atezolizumab|atezolizumab|mesh-list
138316647|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316648|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316649|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138316650|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138316651|NCT05546879|Growth Substances|growth substances|mesh-ancestor
138316652|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316653|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316654|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316655|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316657|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
138316658|NCT05546853|Irinotecan|irinotecan|mesh-list
138316659|NCT05546853|Calcium|calcium|mesh-list
138316660|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
138316663|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316664|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138316665|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138316666|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316667|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316668|NCT05546853|Antidotes|antidotes|mesh-ancestor
138316669|NCT05546853|Protective Agents|protective agents|mesh-ancestor
138316670|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
138316672|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
138316673|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
138316674|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316675|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316676|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316677|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316678|NCT05500690|Folic Acid|folic acid|mesh-list
138316679|NCT05500690|Hematinics|hematinics|mesh-ancestor
138316680|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
138316681|NCT05500690|Vitamins|vitamins|mesh-ancestor
138316682|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
138316684|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138316685|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
138316686|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316687|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316688|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
138316690|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
138316691|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316692|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
138316694|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316695|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316696|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316698|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138316699|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138316701|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316703|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138316704|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
138316705|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316706|NCT05289349|Propofol|propofol|mesh-list
138316707|NCT05289349|Sevoflurane|sevoflurane|mesh-list
138316708|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138316709|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316710|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316711|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138316712|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
138316713|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
138316714|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138316715|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138316716|NCT05267626|Aldesleukin|aldesleukin|mesh-list
138316717|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316718|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138316719|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316720|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
138316721|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316724|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138316725|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138316726|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138316727|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316728|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
138316731|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138316732|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316733|NCT05194293|Durvalumab|durvalumab|mesh-list
138316734|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
138316735|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138316737|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316738|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316739|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
138316740|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316741|NCT05183048|Panitumumab|panitumumab|mesh-list
138316742|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316743|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316744|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
138316745|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138316746|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316747|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316748|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316749|NCT05150938|Vitamin K|vitamin k|mesh-list
138316751|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138316752|NCT05150938|Tinzaparin|tinzaparin|mesh-list
138316753|NCT05150938|Dalteparin|dalteparin|mesh-list
138316754|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
138316755|NCT05150938|Vitamins|vitamins|mesh-ancestor
138316756|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
138316757|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316758|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
138316759|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138316760|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138316761|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316762|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138316763|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
138316764|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138316766|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316767|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138316769|NCT05150938|Coagulants|coagulants|mesh-ancestor
138316770|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
138316771|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138316772|NCT05110001|Natamycin|natamycin|mesh-list
138316773|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
138316774|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138316775|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316776|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
138316777|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316778|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138316779|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138316780|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138316781|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316782|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316783|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316784|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
138316797|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138316798|NCT05031234|Narcotics|narcotics|mesh-ancestor
138316799|NCT05031234|Analgesics|analgesics|mesh-ancestor
138316800|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
138316801|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316802|NCT05005260|Bupivacaine|bupivacaine|mesh-list
138316803|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
138316804|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
138316805|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316806|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316807|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
138316808|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316809|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
138316812|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316813|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316814|NCT04965298|Lansoprazole|lansoprazole|mesh-list
138316815|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
138316816|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138316817|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138316818|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138316819|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316820|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316821|NCT04964947|Tobramycin|tobramycin|mesh-list
138316822|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138316823|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316824|NCT04964466|Becaplermin|becaplermin|mesh-list
138316825|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
138316826|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138316827|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138316828|NCT04964466|Growth Substances|growth substances|mesh-ancestor
138316829|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316831|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138316832|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316833|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316834|NCT04937881|Tenofovir|tenofovir|mesh-list
138316835|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
138316836|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316837|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138316838|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138316839|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316840|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316842|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316843|NCT04842604|Azacitidine|azacitidine|mesh-list
138316844|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138316845|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
138316846|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316847|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316848|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316850|NCT04827576|Magrolimab|magrolimab|mesh-list
138316851|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316852|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316853|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138316854|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316855|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316856|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316857|NCT04789668|Atezolizumab|atezolizumab|mesh-list
138316858|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316859|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316860|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316863|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138316864|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138316865|NCT04782115|Growth Substances|growth substances|mesh-ancestor
138316866|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316867|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
138316868|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316869|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
138316870|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
138316871|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138316872|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138316873|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316874|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138316875|NCT04756401|Dexamethasone|dexamethasone|mesh-list
138316876|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
138316877|NCT04756401|Daratumumab|daratumumab|mesh-list
138316879|NCT04756401|BB 1101|bb 1101|mesh-list
138316880|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316881|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
138316882|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
138316883|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316885|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138316888|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316889|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138316890|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316891|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
138316892|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316893|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316894|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316895|NCT04716634|Tislelizumab|tislelizumab|mesh-list
138316896|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316897|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316898|NCT04642391|Cosyntropin|cosyntropin|mesh-list
138316900|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138316901|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316902|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
138316903|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
138316904|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138316905|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316906|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316907|NCT04588727|Aspirin|aspirin|mesh-list
138316908|NCT04588727|Ticagrelor|ticagrelor|mesh-list
138316909|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138316910|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316911|NCT04588727|Analgesics|analgesics|mesh-ancestor
138316912|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
138316914|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316915|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316916|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316917|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138316918|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138316919|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316920|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138316921|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138316922|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316924|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138316925|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138316926|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138316927|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
138316940|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316941|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138316942|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138316943|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138316944|NCT04559607|Apatinib|apatinib|mesh-list
138316945|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316946|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138316947|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316949|NCT04515329|Cyclosporine|cyclosporine|mesh-list
138316950|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
138316951|NCT04515329|Cyclosporins|cyclosporins|mesh-list
138316952|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316953|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316954|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138316955|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
138316956|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316957|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
138316961|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138316962|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138316963|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138316964|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
138316965|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138316966|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
138316967|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138316968|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138316969|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316970|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138316971|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138316972|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138316973|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316974|NCT04506554|Nivolumab|nivolumab|mesh-list
138316975|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316976|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316977|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138316978|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316980|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316981|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316983|NCT04498117|Carboplatin|carboplatin|mesh-list
138316984|NCT04498117|Oregovomab|oregovomab|mesh-list
138316985|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138316987|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316988|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138316989|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316990|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316991|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138316992|NCT04394858|Temozolomide|temozolomide|mesh-list
138316993|NCT04394858|Olaparib|olaparib|mesh-list
138316994|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138316995|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138316996|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
138316997|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316998|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138316999|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317001|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
138317002|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
138317003|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317004|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317005|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
138317006|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317007|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138317008|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138317009|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138317010|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138317011|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317012|NCT04273776|Zolpidem|zolpidem|mesh-list
138317013|NCT04273776|Suvorexant|suvorexant|mesh-list
138317014|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138317015|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138317016|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317017|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317018|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138317019|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
138317020|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
138317023|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138317025|NCT04258488|Warfarin|warfarin|mesh-list
138317026|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
138317027|NCT04258488|Vitamins|vitamins|mesh-ancestor
138317028|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
138317029|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317030|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
138317031|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138317032|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
138317033|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138317034|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
138317035|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317037|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138317038|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138317039|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
138317040|NCT04258488|Coagulants|coagulants|mesh-ancestor
138317041|NCT04228965|Varenicline|varenicline|mesh-list
138317042|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138317043|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138317044|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
138317045|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317046|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317047|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317048|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138317049|NCT04197687|Trastuzumab|trastuzumab|mesh-list
138317050|NCT04197687|Pertuzumab|pertuzumab|mesh-list
138317051|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138317052|NCT04197687|Maytansine|maytansine|mesh-list
138317053|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138317054|NCT04197687|Vaccines|vaccines|mesh-list
138317056|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
138317057|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138317058|NCT04197687|Sargramostim|sargramostim|mesh-list
138317059|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
138317060|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
138317061|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317062|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317063|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317064|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317065|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317066|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317067|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317068|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
138317069|NCT04186494|Liraglutide|liraglutide|mesh-list
138317070|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138317071|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317072|NCT04186494|Incretins|incretins|mesh-ancestor
138317074|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317075|NCT04185883|Docetaxel|docetaxel|mesh-list
138317076|NCT04185883|Bevacizumab|bevacizumab|mesh-list
138317077|NCT04185883|Carboplatin|carboplatin|mesh-list
138317078|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
138317079|NCT04185883|Pemetrexed|pemetrexed|mesh-list
138317080|NCT04185883|Everolimus|everolimus|mesh-list
138317083|NCT04185883|Panitumumab|panitumumab|mesh-list
138317084|NCT04185883|Trametinib|trametinib|mesh-list
138317085|NCT04185883|Afatinib|afatinib|mesh-list
138317086|NCT04185883|Sotorasib|sotorasib|mesh-list
138317087|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317088|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317091|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317093|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138317094|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138317095|NCT04185883|Growth Substances|growth substances|mesh-ancestor
138317096|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317097|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
138317098|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317099|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317102|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138317103|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317104|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317105|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
138317106|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138317108|NCT04117945|Panitumumab|panitumumab|mesh-list
138317109|NCT04117945|Irinotecan|irinotecan|mesh-list
138317110|NCT04117945|Antibodies|antibodies|mesh-list
138317111|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
138317112|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138317113|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
138317114|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317115|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317116|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138317120|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138317121|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
138317122|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138317123|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138317124|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138317125|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317126|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317127|NCT04110132|Bupivacaine|bupivacaine|mesh-list
138317128|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138317130|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317131|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317132|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
138317133|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317134|NCT04105270|Carboplatin|carboplatin|mesh-list
138317135|NCT04105270|Pemetrexed|pemetrexed|mesh-list
138317136|NCT04105270|Durvalumab|durvalumab|mesh-list
138317137|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317138|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317139|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317140|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138317141|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138317142|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317143|NCT04073602|Trastuzumab|trastuzumab|mesh-list
138317144|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317145|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317146|NCT04060277|Acetic Acid|acetic acid|mesh-list
138317147|NCT04060277|Letermovir|letermovir|mesh-list
138317148|NCT04060277|Vaccines|vaccines|mesh-list
138317149|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
138317150|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317156|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317157|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
138317159|NCT04043520|Estrogens|estrogens|mesh-list
138317160|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138317161|NCT04043520|Hormones|hormones|mesh-ancestor
138317162|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317163|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317164|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
138317165|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317166|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317167|NCT03943537|Insulin|insulin|mesh-list
138317168|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138317169|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317171|NCT03935256|Carboplatin|carboplatin|mesh-list
138317172|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317173|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317174|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317175|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317176|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317177|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317178|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138317182|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138317183|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317184|NCT03837353|Docetaxel|docetaxel|mesh-list
138317185|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317186|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317187|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317189|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317190|NCT03832010|Triamcinolone|triamcinolone|mesh-list
138317191|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
138317192|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138317193|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
138317195|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317196|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317197|NCT03794583|Treprostinil|treprostinil|mesh-list
138317198|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138317199|NCT03774732|Paclitaxel|paclitaxel|mesh-list
138317200|NCT03774732|Cisplatin|cisplatin|mesh-list
138317201|NCT03774732|Carboplatin|carboplatin|mesh-list
138317202|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
138317203|NCT03774732|Pemetrexed|pemetrexed|mesh-list
138317204|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317205|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317206|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317207|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317208|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317209|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317210|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317211|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317212|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317213|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138317214|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138317215|NCT03759366|Eculizumab|eculizumab|mesh-list
138317216|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138317217|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317218|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
138317219|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317220|NCT03725059|Paclitaxel|paclitaxel|mesh-list
138317221|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
138317222|NCT03725059|Doxorubicin|doxorubicin|mesh-list
138317225|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317226|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317227|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317228|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317229|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317230|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317231|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317232|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
138317233|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317234|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317235|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138317236|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
138317242|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317243|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317245|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138317248|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317249|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138317250|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317252|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317255|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317257|NCT03607656|Capecitabine|capecitabine|mesh-list
138317258|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
138317259|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317260|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317261|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317262|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317263|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317264|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138317266|NCT03586609|Cytarabine|cytarabine|mesh-list
138317267|NCT03586609|Azacitidine|azacitidine|mesh-list
138317268|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138317269|NCT03586609|Venetoclax|venetoclax|mesh-list
138317270|NCT03586609|Cladribine|cladribine|mesh-list
138317271|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138317272|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
138317273|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317274|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317275|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
138317276|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317277|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317278|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
138317279|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317280|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317281|NCT03584373|Acetaminophen|acetaminophen|mesh-list
138317282|NCT03584373|Ketorolac|ketorolac|mesh-list
138317283|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138317284|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138317287|NCT03584373|Analgesics|analgesics|mesh-ancestor
138317288|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
138317289|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317290|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317291|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
138317292|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138317294|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317295|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138317296|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138317297|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317298|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138317299|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317300|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317301|NCT03582124|Panitumumab|panitumumab|mesh-list
138317302|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317303|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317304|NCT03569839|Propofol|propofol|mesh-list
138317305|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138317306|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317307|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317308|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138317309|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
138317310|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
138317311|NCT03558789|Lactoferrin|lactoferrin|mesh-list
138317312|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317313|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
138317314|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
138317315|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317328|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138317330|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317331|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138317333|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138317334|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138317335|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138317336|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
138317337|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
138317338|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317339|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317340|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317341|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138317342|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138317343|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317345|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138317346|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138317347|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138317348|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
138317349|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
138317351|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317352|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317353|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138317354|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138317355|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317356|NCT03386929|Palbociclib|palbociclib|mesh-list
138317357|NCT03386929|Avelumab|avelumab|mesh-list
138317358|NCT03386929|Axitinib|axitinib|mesh-list
138317361|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317362|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317363|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317364|NCT03335839|Plasminogen|plasminogen|mesh-list
138317365|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138317366|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138317367|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138317368|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317370|NCT03245658|Analgesics|analgesics|mesh-ancestor
138317371|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
138317372|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317373|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317374|NCT03223220|Midazolam|midazolam|mesh-list
138317375|NCT03223220|Ketamine|ketamine|mesh-list
138317376|NCT03223220|Analgesics|analgesics|mesh-ancestor
138317377|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
138317378|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317379|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317380|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138317381|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138317382|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
138317384|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317385|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138317386|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138317387|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317388|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317389|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138317390|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138317391|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138317392|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138317393|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138317394|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
138317399|NCT02969083|Cisplatin|cisplatin|mesh-list
138317400|NCT02969083|Gemcitabine|gemcitabine|mesh-list
138317401|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317402|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138317403|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
138317404|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317405|NCT02943590|Atorvastatin|atorvastatin|mesh-list
138317406|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138317407|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138317408|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
138317409|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317410|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138317414|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138317415|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138317416|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
138317417|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138317418|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317419|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
138317420|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
138317421|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317422|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
138317424|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317425|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
138317426|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317427|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138317428|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317431|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317432|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138317433|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
138317434|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317435|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317436|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
138317437|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317438|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317439|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317440|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317441|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
138317442|NCT02619253|Vorinostat|vorinostat|mesh-list
138317443|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317444|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317445|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317448|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317449|NCT02598661|Imetelstat|imetelstat|mesh-list
138317450|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
138317451|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317452|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317454|NCT02544815|Digoxin|digoxin|mesh-list
138317455|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138317456|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138317457|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317458|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317459|NCT02544815|Protective Agents|protective agents|mesh-ancestor
138317460|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317461|NCT02476786|Tamoxifen|tamoxifen|mesh-list
138317462|NCT02476786|Fulvestrant|fulvestrant|mesh-list
138317463|NCT02476786|Anastrozole|anastrozole|mesh-list
138317464|NCT02476786|Goserelin|goserelin|mesh-list
138317465|NCT02476786|Exemestane|exemestane|mesh-list
138317466|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138317469|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317470|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138317474|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138317475|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138317476|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138317477|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138317478|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317479|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317481|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317483|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138317484|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138317485|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138317486|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138317487|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317488|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
138317489|NCT02161783|Fludarabine|fludarabine|mesh-list
138317491|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
138317492|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317493|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317494|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138317495|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
138317496|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317497|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317498|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138317499|NCT01868438|Artesunate|artesunate|mesh-list
138317500|NCT01868438|Pyronaridine|pyronaridine|mesh-list
138317501|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138317502|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
138317503|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138317504|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138317505|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317506|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317507|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
138317508|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
138317509|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138317513|NCT01585805|Veliparib|veliparib|mesh-list
138317514|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317515|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138317516|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
138317517|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317518|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138317520|NCT01554046|Methylphenidate|methylphenidate|mesh-list
138317521|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138317522|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317523|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138317524|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138317525|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138317526|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317528|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317529|NCT01208662|Dexamethasone|dexamethasone|mesh-list
138317530|NCT01208662|Lenalidomide|lenalidomide|mesh-list
138317531|NCT01208662|Bortezomib|bortezomib|mesh-list
138317532|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138317533|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
138317534|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
138317535|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317536|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317537|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138317538|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
138317539|NCT01208662|Hormones|hormones|mesh-ancestor
138317540|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317541|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138317543|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
138317547|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
138317549|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317550|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317551|NCT00636519|Antitoxins|antitoxins|mesh-list
138317552|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
138317560|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138317561|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138317563|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317565|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138317566|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
138317567|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317568|NCT01501110|Expectorants|expectorants|mesh-ancestor
138317569|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138317570|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138317571|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
138317572|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317573|NCT01501110|Protective Agents|protective agents|mesh-ancestor
138317574|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317575|NCT01501110|Antidotes|antidotes|mesh-ancestor
138317576|NCT01500720|Topotecan|topotecan|mesh-list
138317577|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138317578|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138317579|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317580|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317582|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138317583|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138317584|NCT01455012|Rotigotine|rotigotine|mesh-list
138317585|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
138317586|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
138317587|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317588|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317589|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317590|NCT01454778|Paclitaxel|paclitaxel|mesh-list
138317591|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317592|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317593|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317594|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317595|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317597|NCT01454076|Clarithromycin|clarithromycin|mesh-list
138317598|NCT01454076|Rifampin|rifampin|mesh-list
138317599|NCT01454076|Ketoconazole|ketoconazole|mesh-list
138317602|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317603|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317604|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138317605|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317606|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317607|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138317608|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138317609|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138317610|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
138317611|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
138317612|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138317613|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138317614|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138317615|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138317616|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138317617|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138317618|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138317619|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
138317620|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138317621|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138317622|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
138317623|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317624|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317625|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317626|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138317628|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317629|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138317630|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
138317631|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317632|NCT01453374|Naltrexone|naltrexone|mesh-list
138317633|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138317634|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138317638|NCT01453140|Sirolimus|sirolimus|mesh-list
138317639|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
138317640|NCT01453140|Temsirolimus|temsirolimus|mesh-list
138317641|NCT01453140|Interleukin-2|interleukin-2|mesh-list
138317642|NCT01453140|Azacitidine|azacitidine|mesh-list
138317643|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
138317644|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317645|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
138317646|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317647|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317648|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138317649|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
138317650|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317651|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317652|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138317653|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317654|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317655|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138317656|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
138317657|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317658|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317659|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138317660|NCT01453140|Analgesics|analgesics|mesh-ancestor
138317661|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
138317662|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317663|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138317664|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
138317665|NCT01499940|Vitamin D|vitamin d|mesh-list
138317666|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
138317667|NCT01499940|Vitamins|vitamins|mesh-ancestor
138317668|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
138317669|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317670|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138317671|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138317672|NCT01499160|Everolimus|everolimus|mesh-list
138317673|NCT01499160|Letrozole|letrozole|mesh-list
138317674|NCT01499160|Lapatinib|lapatinib|mesh-list
138317675|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138317676|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317677|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317679|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317680|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
138317681|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317682|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317683|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138317684|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138317685|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138317686|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
138366713|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138366714|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366715|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317687|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317688|NCT01498068|Interferons|interferons|mesh-list
138317689|NCT01498068|Ribavirin|ribavirin|mesh-list
138317690|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
138317691|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
138317692|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138317693|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317694|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
138317695|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317696|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
138317697|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317698|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
138317699|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317703|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138317704|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
138317705|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317706|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138317707|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138317708|NCT01451814|Nicotine|nicotine|mesh-list
138317709|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138317710|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
138317711|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317712|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317713|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138317718|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138317719|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138317720|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138317721|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317722|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138317723|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
138317724|NCT04408326|Giapreza|giapreza|mesh-list
138317725|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
138317726|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317727|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138317728|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138317729|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
138317730|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317731|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317732|NCT01474746|Sertraline|sertraline|mesh-list
138317733|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
138317734|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138317735|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138317739|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317740|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
138317741|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317742|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
138317743|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138317744|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317745|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138317746|NCT01474512|Ixekizumab|ixekizumab|mesh-list
138317747|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138317748|NCT02985606|Caffeine|caffeine|mesh-list
138317749|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138317750|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317751|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138317752|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317753|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317754|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138317755|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138366718|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138366719|NCT05597878|Narcotics|narcotics|mesh-ancestor
138366720|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138366721|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366722|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366723|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138366724|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317756|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
138317757|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317758|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
138317759|NCT01473732|Everolimus|everolimus|mesh-list
138317760|NCT01473732|Tacrolimus|tacrolimus|mesh-list
138317761|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317762|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
138317763|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317764|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138317765|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317766|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317767|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138317768|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317774|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317775|NCT01450098|Evacetrapib|evacetrapib|mesh-list
138317776|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
138317777|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138317778|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138317780|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317781|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138317782|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
138317783|NCT01450098|Protective Agents|protective agents|mesh-ancestor
138317784|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317785|NCT01449630|Celecoxib|celecoxib|mesh-list
138317786|NCT01449630|LY3031207|ly3031207|mesh-list
138317789|NCT01449630|Analgesics|analgesics|mesh-ancestor
138317791|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317792|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317793|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138317794|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138317795|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138317796|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138317797|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317798|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317799|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
138317800|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
138317801|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317802|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
138317803|NCT01473420|Hematinics|hematinics|mesh-ancestor
138317804|NCT04674774|Lansoprazole|lansoprazole|mesh-list
138317805|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
138317806|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138317807|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138317808|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138317809|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317810|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317812|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138317813|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
138317814|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317815|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138317816|NCT01492686|Protective Agents|protective agents|mesh-ancestor
138317818|NCT01449006|Maraviroc|maraviroc|mesh-list
138317820|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138317821|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317822|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138317823|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138317824|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
138317825|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317826|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138317827|NCT01491672|Everolimus|everolimus|mesh-list
138317828|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138317829|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317830|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317831|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317832|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138317833|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
138317834|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317835|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317837|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
138317838|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
138317839|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138317840|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138317841|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138317842|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
138317843|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317844|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
138317845|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138317846|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
138317847|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317848|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317849|NCT01471782|Blinatumomab|blinatumomab|mesh-list
138317851|NCT01490580|Atropine|atropine|mesh-list
138317852|NCT01490580|Sufentanil|sufentanil|mesh-list
138317853|NCT01490580|Propofol|propofol|mesh-list
138317854|NCT01490580|Atracurium|atracurium|mesh-list
138317855|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138317856|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317857|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317858|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138317859|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
138317860|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
138317861|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138317862|NCT01490580|Narcotics|narcotics|mesh-ancestor
138317863|NCT01490580|Analgesics|analgesics|mesh-ancestor
138317864|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
138317866|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138317868|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138317869|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
138317870|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138317871|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
138317872|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
138317873|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
138317874|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138317875|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138317876|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
138317877|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317878|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317879|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138317880|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138317881|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138317882|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138317883|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138317884|NCT01490190|Etonogestrel|etonogestrel|mesh-list
138317886|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138317887|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138317891|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317892|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138317893|NCT01490190|Estrogens|estrogens|mesh-ancestor
138317894|NCT01490190|Hormones|hormones|mesh-ancestor
138317895|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317896|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
138317897|NCT01446042|Testosterone|testosterone|mesh-list
138317898|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
138317899|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
138317900|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138317901|NCT01446042|Androgens|androgens|mesh-ancestor
138317902|NCT01446042|Hormones|hormones|mesh-ancestor
138317903|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138317904|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317905|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138317906|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317909|NCT01445886|Calcipotriene|calcipotriene|mesh-list
138317910|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138317915|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317919|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138317921|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138317922|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317923|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317924|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317925|NCT04073316|Warfarin|warfarin|mesh-list
138317926|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
138317927|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
138317928|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138317929|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
138317930|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138317931|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
138317932|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317933|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317935|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138317936|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
138317937|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
138317938|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317939|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317940|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138317941|NCT04089852|Analgesics|analgesics|mesh-ancestor
138317942|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
138317943|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317944|NCT03026244|Vitamin D|vitamin d|mesh-list
138317946|NCT03026244|Vitamins|vitamins|mesh-ancestor
138317947|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
138317969|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
138317970|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138317971|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138317972|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
138317973|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
138317974|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138317976|NCT01443078|Carboplatin|carboplatin|mesh-list
138317978|NCT01443078|Docetaxel|docetaxel|mesh-list
138317979|NCT01443078|Pemetrexed|pemetrexed|mesh-list
138317980|NCT01443078|Vinorelbine|vinorelbine|mesh-list
138317981|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317983|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
138317984|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317985|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138317986|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138317987|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138317988|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317989|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138317990|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138317991|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138317993|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138317994|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138317995|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138317996|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
138317997|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317998|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138317999|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318000|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318001|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138318002|NCT01469364|Aztreonam|aztreonam|mesh-list
138318003|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318004|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342925|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138342926|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138343234|NCT06019130|Interferons|interferons|mesh-list
138344747|NCT00304070|Lenograstim|lenograstim|mesh-list
138345039|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345698|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345708|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
138346085|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138346088|NCT01988922|Ketamine|ketamine|mesh-list
138347152|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
138347153|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
138347407|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
138348496|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348497|NCT02529072|Nivolumab|nivolumab|mesh-list
138344267|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138344268|NCT03259503|Gemcitabine|gemcitabine|mesh-list
138344269|NCT03259503|Melphalan|melphalan|mesh-list
138344271|NCT03259503|Olaparib|olaparib|mesh-list
138344272|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
138353273|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353815|NCT00058188|Vitamin D|vitamin d|mesh-list
138353817|NCT00058188|Calcium|calcium|mesh-list
138344279|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344280|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354606|NCT00001122|Efavirenz|efavirenz|mesh-list
138354784|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138354785|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355134|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138159517|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159518|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138159519|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
138159520|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
138159521|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
138159523|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138159524|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
138159525|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159526|NCT04750616|Niacinamide|niacinamide|mesh-list
138159528|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
138159529|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
138159530|NCT04750616|Vitamins|vitamins|mesh-ancestor
138159531|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
138159532|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159533|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138159534|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
138159535|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159536|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138159537|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
138159538|NCT04734652|Tenofovir|tenofovir|mesh-list
138159539|NCT04734652|Lamivudine|lamivudine|mesh-list
138159540|NCT04734652|Dolutegravir|dolutegravir|mesh-list
138159541|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
138159542|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159543|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138159544|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138159545|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159546|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159547|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138159548|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138159549|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138159550|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138159551|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
138159553|NCT04697576|Ipilimumab|ipilimumab|mesh-list
138159554|NCT04697576|Relatlimab|relatlimab|mesh-list
138159555|NCT04697576|Vaccines|vaccines|mesh-list
138159556|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
138159557|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159558|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159559|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362531|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
138159560|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159561|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159563|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138159564|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138159565|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138159566|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138159567|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159568|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159569|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138159570|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138159571|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159572|NCT04646356|Tacrolimus|tacrolimus|mesh-list
138159573|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138159574|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
138159575|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159576|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138159577|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159578|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159579|NCT04618016|Vitamins|vitamins|mesh-list
138159580|NCT04618016|Vitamin E|vitamin e|mesh-list
138159581|NCT04618016|Tocopherols|tocopherols|mesh-list
138159584|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
138159585|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159586|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
138159587|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159588|NCT04618016|Protective Agents|protective agents|mesh-ancestor
138159589|NCT04515472|Hormones|hormones|mesh-list
138159590|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159591|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159592|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
138159593|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138159594|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
138159595|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138159596|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
138159597|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159598|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159599|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
138159600|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138159601|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138159602|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138159603|NCT04489732|Interferons|interferons|mesh-list
138159604|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
138159605|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159606|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
138159607|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159608|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
138159609|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
138159610|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138159611|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138159612|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159613|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138159614|NCT04425018|Paclitaxel|paclitaxel|mesh-list
138159615|NCT04425018|Trastuzumab|trastuzumab|mesh-list
138159616|NCT04425018|Pertuzumab|pertuzumab|mesh-list
138159617|NCT04425018|Margetuximab|margetuximab|mesh-list
138159618|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138159619|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159620|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138159621|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138159622|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138159623|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159624|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159625|NCT04300595|Anesthetics|anesthetics|mesh-list
138159626|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138159627|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159628|NCT04212026|Nivolumab|nivolumab|mesh-list
138159630|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159631|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159632|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159633|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
138159634|NCT04187144|Gepotidacin|gepotidacin|mesh-list
138362533|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
138159635|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138159636|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159637|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159638|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138159640|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159641|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159643|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159644|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159645|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159646|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159648|NCT04027946|LMB-100|lmb-100|mesh-list
138159649|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159650|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159651|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159652|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159653|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
138159654|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
138159655|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159656|NCT04017468|Vancomycin|vancomycin|mesh-list
138159657|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159658|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159659|NCT03976310|Benralizumab|benralizumab|mesh-list
138159660|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138159661|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
138159662|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
138159663|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138159664|NCT03949764|Velpatasvir|velpatasvir|mesh-list
138159665|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
138159667|NCT03930212|Progesterone|progesterone|mesh-list
138159668|NCT03930212|Progestins|progestins|mesh-ancestor
138159670|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159671|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159672|NCT03893617|Propranolol|propranolol|mesh-list
138159673|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138159674|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138159675|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
138159676|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138159677|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159678|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159679|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138159680|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138159681|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
138159683|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138159684|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159685|NCT03856047|Incretins|incretins|mesh-ancestor
138159686|NCT03856047|Hormones|hormones|mesh-ancestor
138159687|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159688|NCT03737136|Bortezomib|bortezomib|mesh-list
138159689|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159690|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
138159691|NCT03647163|Nivolumab|nivolumab|mesh-list
138159692|NCT03647163|Ipilimumab|ipilimumab|mesh-list
138159693|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159694|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159695|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159696|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159697|NCT03635749|Atorvastatin|atorvastatin|mesh-list
138159698|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138159699|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159700|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159701|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138159702|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138159703|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
138159704|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138159705|NCT03599453|Interferons|interferons|mesh-list
138159706|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
138159707|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
138159708|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138159711|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
138159712|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
138159713|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
138159714|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
138159715|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159716|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159717|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159718|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159719|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
138159720|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159721|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
138159722|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159723|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138159724|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138159725|NCT03599453|Analgesics|analgesics|mesh-ancestor
138159726|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
138159728|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138159729|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138159730|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138159731|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138159732|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159733|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
138159734|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138159735|NCT03573960|Lenvatinib|lenvatinib|mesh-list
138159736|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159737|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138159738|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159739|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159740|NCT03554291|Famotidine|famotidine|mesh-list
138159741|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138159742|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138159743|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138159744|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
138159745|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
138159746|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138159747|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159748|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159749|NCT03464461|Ketorolac|ketorolac|mesh-list
138159750|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138159751|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138159752|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138159753|NCT03464461|Analgesics|analgesics|mesh-ancestor
138159754|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
138159755|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138159756|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159757|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138159758|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138159759|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138159760|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159761|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159763|NCT03440437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138159765|NCT03440437|Tubulin Modulators|tubulin modulators|mesh-ancestor
138159766|NCT03440437|Antimitotic Agents|antimitotic agents|mesh-ancestor
138159767|NCT03440437|Mitosis Modulators|mitosis modulators|mesh-ancestor
138159768|NCT03440437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159769|NCT03374956|Liraglutide|liraglutide|mesh-list
138159770|NCT03374956|Topiramate|topiramate|mesh-list
138159771|NCT03374956|Phentermine|phentermine|mesh-list
138159772|NCT03374956|Naltrexone|naltrexone|mesh-list
138159773|NCT03374956|Bupropion|bupropion|mesh-list
138159774|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138159775|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138362539|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362540|NCT02243826|Analgesics|analgesics|mesh-ancestor
138159776|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159777|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
138159778|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138159779|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138159781|NCT03374956|Hormones|hormones|mesh-ancestor
138159782|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159783|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138159784|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
138159785|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138159786|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138159787|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138159788|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138159789|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159790|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
138159791|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138159792|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138159793|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138159794|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159795|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
138159796|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138159797|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
138159798|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138159799|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
138159800|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
138159801|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
138159802|NCT03334682|Doxycycline|doxycycline|mesh-list
138159803|NCT03334682|Spironolactone|spironolactone|mesh-list
138159804|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159805|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159806|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
138159807|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138159808|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138159809|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138159810|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
138159811|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159813|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138159814|NCT03334682|Diuretics|diuretics|mesh-ancestor
138159815|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
138159816|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
138159818|NCT03112603|Infliximab|infliximab|mesh-list
138159819|NCT03112603|Rituximab|rituximab|mesh-list
138159820|NCT03112603|Methotrexate|methotrexate|mesh-list
138159821|NCT03112603|Everolimus|everolimus|mesh-list
138159822|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
138159823|NCT03112603|Pentostatin|pentostatin|mesh-list
138159824|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159825|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159826|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
138159827|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159828|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138159830|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
138159831|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138159832|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138159834|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159835|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138159836|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159837|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138159839|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138159840|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138159841|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138159842|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138159843|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138159844|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
138159845|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159846|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159847|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
138159848|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138159849|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362548|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138159850|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138159851|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138159853|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
138159854|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159855|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
138159856|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159857|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159858|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159859|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159860|NCT02627963|Sorafenib|sorafenib|mesh-list
138159861|NCT02627963|Tivozanib|tivozanib|mesh-list
138159862|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159863|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138159864|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159865|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159866|NCT02589691|Rocuronium|rocuronium|mesh-list
138159867|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138159868|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138159869|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138159870|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138159871|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159872|NCT02585258|Prednisolone|prednisolone|mesh-list
138159873|NCT02585258|Glucocorticoids|glucocorticoids|mesh-list
138159874|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138159875|NCT02585258|Hormones|hormones|mesh-ancestor
138159876|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159877|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159878|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138159879|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159880|NCT02203604|Aldesleukin|aldesleukin|mesh-list
138159882|NCT02203604|Ipilimumab|ipilimumab|mesh-list
138159883|NCT02203604|Interleukin-2|interleukin-2|mesh-list
138159884|NCT02203604|Antibodies|antibodies|mesh-list
138159885|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
138159886|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138159887|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
138159888|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159889|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159890|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138159891|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159892|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138159893|NCT02203604|Analgesics|analgesics|mesh-ancestor
138159894|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
138159895|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138159896|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138159897|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138159898|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
138159899|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159901|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138159902|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159903|NCT00701220|Atorvastatin|atorvastatin|mesh-list
138159904|NCT00701220|Calcium|calcium|mesh-list
138159905|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138159906|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159907|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138159908|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138159909|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
138159910|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159912|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138159913|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159914|NCT00677924|Zalutumumab|zalutumumab|mesh-list
138159915|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159916|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159917|NCT00251303|Riluzole|riluzole|mesh-list
138159918|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
138159919|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138159920|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138159921|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138159922|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159923|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159924|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138159925|NCT00251303|Protective Agents|protective agents|mesh-ancestor
138159926|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138159928|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159929|NCT00303823|Protective Agents|protective agents|mesh-ancestor
138159930|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159931|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138159932|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138159933|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159934|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138159935|NCT00300677|Voriconazole|voriconazole|mesh-list
138159936|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
138159938|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138159939|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138159940|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159941|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159942|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138159943|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
138159944|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159945|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159946|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138159947|NCT00559845|Paclitaxel|paclitaxel|mesh-list
138159948|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
138159949|NCT00559845|Bevacizumab|bevacizumab|mesh-list
138159950|NCT00559845|Fluorouracil|fluorouracil|mesh-list
138159951|NCT00559845|Epirubicin|epirubicin|mesh-list
138159952|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138159953|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159954|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138159955|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138159956|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138159957|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159958|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138159959|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
138159960|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159961|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138159962|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138159963|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
138159964|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138159965|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138159966|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138159967|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138159968|NCT00559845|Growth Substances|growth substances|mesh-ancestor
138159969|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
138159970|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
138159971|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138159972|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138159973|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138159974|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138159975|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138159976|NCT00304187|Erythromycin|erythromycin|mesh-list
138159977|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
138159978|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138159979|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
138159982|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138159983|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138159984|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366726|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138159985|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159986|NCT00334633|Metronidazole|metronidazole|mesh-list
138159988|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138159989|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138159990|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138159991|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138159992|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
138159993|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138159994|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138159995|NCT01393964|Dexamethasone|dexamethasone|mesh-list
138159996|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
138159997|NCT01393964|Lenalidomide|lenalidomide|mesh-list
138362556|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
138159998|NCT01393964|Elotuzumab|elotuzumab|mesh-list
138159999|NCT01393964|BB 1101|bb 1101|mesh-list
138160000|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160001|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
138160002|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
138160003|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160004|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160005|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160006|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
138160007|NCT01393964|Hormones|hormones|mesh-ancestor
138160008|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160009|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160010|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160011|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
138160012|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160013|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160014|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
138160015|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138160016|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138160017|NCT01393964|Growth Substances|growth substances|mesh-ancestor
138160020|NCT01790555|Dronabinol|dronabinol|mesh-list
138160021|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138160022|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
138160023|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
138160024|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
138160025|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160026|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160027|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160028|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138160029|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160030|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138160031|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138160032|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138160033|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160034|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160035|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138160036|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
138160037|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
138160038|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
138160039|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
138160040|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160041|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160042|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
138160044|NCT01790555|Analgesics|analgesics|mesh-ancestor
138160045|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
138160046|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138160047|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138160048|NCT01790555|Hormones|hormones|mesh-ancestor
138160049|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160050|NCT00335725|Hormones|hormones|mesh-list
138160051|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138160052|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160053|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160054|NCT01393730|Prednisone|prednisone|mesh-list
138160055|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
138160057|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160058|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
138160059|NCT01393730|Hormones|hormones|mesh-ancestor
138160060|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160061|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160062|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160063|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160064|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138160065|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160066|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160067|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
138160068|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138160069|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138160070|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
138160071|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160072|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160073|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138160074|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
138160075|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160077|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160078|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160079|NCT00337987|Prednisone|prednisone|mesh-list
138160080|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
138160081|NCT00337987|Vincristine|vincristine|mesh-list
138160082|NCT00337987|Doxorubicin|doxorubicin|mesh-list
138160083|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138160084|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
138160085|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160086|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
138160087|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160088|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160089|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138160090|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
138160092|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160093|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138160094|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160095|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
138160097|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160098|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160099|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138160100|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138160101|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138160102|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138160103|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160104|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138160105|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138160106|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160107|NCT01393106|Idelalisib|idelalisib|mesh-list
138160108|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160109|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160110|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160111|NCT00553059|Dexamethasone|dexamethasone|mesh-list
138160112|NCT00553059|Dronabinol|dronabinol|mesh-list
138160113|NCT00553059|Palonosetron|palonosetron|mesh-list
138160114|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160117|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160118|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160119|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160121|NCT00553059|Hormones|hormones|mesh-ancestor
138160122|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160123|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160125|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138160126|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138160127|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
138160128|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160129|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160130|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
138160131|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160132|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138160133|NCT00553059|Analgesics|analgesics|mesh-ancestor
138160134|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
138160135|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138160136|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138160137|NCT02989311|Iron|iron|mesh-list
138160138|NCT02989311|Trace Elements|trace elements|mesh-ancestor
138160139|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
138160140|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160141|NCT02015611|Vitamin D|vitamin d|mesh-list
138160142|NCT02015611|Vitamins|vitamins|mesh-ancestor
138160143|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
138160144|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160145|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138160146|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
138160147|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138160148|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138160149|NCT01413542|Enalaprilat|enalaprilat|mesh-list
138362563|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138160150|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138160151|NCT01413542|Bradykinin|bradykinin|mesh-list
138160152|NCT01413542|Glucagon|glucagon|mesh-list
138160153|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138160154|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138160155|NCT01413542|Substance P|substance p|mesh-list
138160156|NCT01413542|Neurokinin A|neurokinin a|mesh-list
138160157|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138160158|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160159|NCT01413542|Incretins|incretins|mesh-ancestor
138160160|NCT01413542|Hormones|hormones|mesh-ancestor
138160161|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160162|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
138160163|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160164|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160165|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160166|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
138160167|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
138160168|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138160169|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160170|NCT01873989|Testosterone|testosterone|mesh-list
138160171|NCT01873989|Androgens|androgens|mesh-ancestor
138160173|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160174|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160176|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
138160177|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160178|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138160179|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160180|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138160181|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160182|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138160183|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138160184|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
138160185|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160186|NCT01432574|Vaccines|vaccines|mesh-list
138160187|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
138160188|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160189|NCT00339079|Fluoxetine|fluoxetine|mesh-list
138160190|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138160191|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138160192|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160193|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160194|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160195|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
138160196|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160197|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138160198|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
138160199|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160200|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138160201|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138160202|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160203|NCT01392560|Empagliflozin|empagliflozin|mesh-list
138160204|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138160205|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160206|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138160207|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160208|NCT00342355|Ritonavir|ritonavir|mesh-list
138160209|NCT00342355|Lopinavir|lopinavir|mesh-list
138160210|NCT00342355|Lamivudine|lamivudine|mesh-list
138160211|NCT00342355|Zidovudine|zidovudine|mesh-list
138160212|NCT00342355|Stavudine|stavudine|mesh-list
138366738|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
138160213|NCT00342355|Didanosine|didanosine|mesh-list
138160214|NCT00342355|Efavirenz|efavirenz|mesh-list
138160215|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138160216|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138160217|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362566|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160218|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160219|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160220|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138160221|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138160222|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
138160223|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160224|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138160225|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138160226|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138160227|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138160228|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
138160229|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138160230|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138160231|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138160232|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138160233|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138160234|NCT00306163|Fluticasone|fluticasone|mesh-list
138160235|NCT00306163|Ciclesonide|ciclesonide|mesh-list
138160236|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160237|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138160238|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
138160239|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160240|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160241|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138160242|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160243|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
138160244|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138160245|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
138160246|NCT00306163|Hormones|hormones|mesh-ancestor
138160247|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160248|NCT01861665|Bupivacaine|bupivacaine|mesh-list
138160249|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
138160250|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
138160251|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160252|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160253|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
138160254|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160257|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138160258|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160259|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160260|NCT00552279|Vaccines|vaccines|mesh-list
138160261|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
138160262|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160263|NCT00309751|Atorvastatin|atorvastatin|mesh-list
138160264|NCT00309751|Pitavastatin|pitavastatin|mesh-list
138160265|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138160266|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138160268|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160269|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138160270|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138160271|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160272|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138160273|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160274|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160276|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
138160277|NCT00313729|Temozolomide|temozolomide|mesh-list
138160278|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138160279|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
138366745|NCT05584657|Probenecid|probenecid|mesh-list
138366746|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366747|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366748|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138160280|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160281|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160282|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138160283|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138160284|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160286|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
138160287|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138362574|NCT02244528|Urological Agents|urological agents|mesh-ancestor
138160288|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138160289|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160290|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160291|NCT05266651|Urological Agents|urological agents|mesh-ancestor
138160292|NCT05746689|Sirolimus|sirolimus|mesh-list
138160293|NCT05746689|Prednisone|prednisone|mesh-list
138160294|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160295|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
138160296|NCT05746689|Hormones|hormones|mesh-ancestor
138160297|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160298|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160299|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160300|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160301|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160302|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160303|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160305|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160306|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
138160307|NCT01412060|Cariprazine|cariprazine|mesh-list
138160308|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138160309|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160310|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160311|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160312|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160313|NCT00345865|Cytarabine|cytarabine|mesh-list
138160314|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
138160315|NCT00345865|Carmustine|carmustine|mesh-list
138160316|NCT00345865|Etoposide|etoposide|mesh-list
138160317|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160318|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
138160319|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160320|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160321|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138160322|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
138160323|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160325|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138160326|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138160327|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138160328|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138160329|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160330|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160331|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
138160332|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
138160333|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160334|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138160335|NCT00551421|Cetuximab|cetuximab|mesh-list
138160336|NCT00551421|Pertuzumab|pertuzumab|mesh-list
138160337|NCT00551421|Irinotecan|irinotecan|mesh-list
138160338|NCT00551421|Antibodies|antibodies|mesh-list
138160339|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
138160340|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138160341|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
138160342|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160343|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366749|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366750|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366754|NCT05568615|Edaravone|edaravone|mesh-list
138160344|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138160345|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138160346|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160347|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160348|NCT01791751|Clomiphene|clomiphene|mesh-list
138160349|NCT01791751|Enclomiphene|enclomiphene|mesh-list
138160350|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
138160351|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138160352|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
138160353|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160354|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160355|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138160356|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
138160357|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160358|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138160359|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138160361|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
138160362|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
138160363|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138160364|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160365|NCT05266261|Vitamins|vitamins|mesh-ancestor
138160366|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
138160367|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138160368|NCT05266261|Antacids|antacids|mesh-ancestor
138160369|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160370|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160371|NCT05266105|Palbociclib|palbociclib|mesh-list
138160372|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160373|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138160374|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160375|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160376|NCT01891643|Dexamethasone|dexamethasone|mesh-list
138160377|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
138160378|NCT01891643|Lenalidomide|lenalidomide|mesh-list
138160379|NCT01891643|Elotuzumab|elotuzumab|mesh-list
138160380|NCT01891643|BB 1101|bb 1101|mesh-list
138160381|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160382|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
138160383|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
138160384|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160385|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160386|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160387|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
138160388|NCT01891643|Hormones|hormones|mesh-ancestor
138160389|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160390|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160391|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160392|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
138160393|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160394|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160395|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
138160396|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138160397|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138160398|NCT01891643|Growth Substances|growth substances|mesh-ancestor
138160399|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138160400|NCT05265793|Apatinib|apatinib|mesh-list
138160401|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160402|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138160403|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160405|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
138160406|NCT04005599|Remifentanil|remifentanil|mesh-list
138160407|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138160408|NCT04005599|Narcotics|narcotics|mesh-ancestor
138160409|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160410|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160412|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
138160413|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160414|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
138160415|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138160416|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
138160417|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138160418|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160419|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160420|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138160421|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
138160422|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160424|NCT00330863|Risperidone|risperidone|mesh-list
138160425|NCT00330863|Aripiprazole|aripiprazole|mesh-list
138160426|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138160427|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138160428|NCT00330863|Ziprasidone|ziprasidone|mesh-list
138160429|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138160430|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
138160431|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160432|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160433|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160434|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138160435|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160436|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160437|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160438|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138160439|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
138160440|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
138160441|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
138160442|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160443|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160444|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138160445|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138160446|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160447|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
138160448|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
138160449|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138160450|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138160451|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138160452|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138160454|NCT01899521|Astringents|astringents|mesh-ancestor
138160455|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160456|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
138160457|NCT01790009|Acetaminophen|acetaminophen|mesh-list
138160458|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138160459|NCT01790009|Analgesics|analgesics|mesh-ancestor
138160460|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
138160461|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160462|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160463|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
138160464|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138160465|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138160467|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138160468|NCT05737329|Estrogens|estrogens|mesh-ancestor
138160469|NCT05737329|Hormones|hormones|mesh-ancestor
138160470|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160471|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160472|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138160473|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
138160474|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160475|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138160476|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
138160477|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138160478|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
138160479|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160480|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
138160481|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160482|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160483|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138160484|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138160485|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160486|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160487|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160489|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138160490|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138160491|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160492|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
138160493|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160494|NCT00318409|Bupropion|bupropion|mesh-list
138160495|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138160496|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138160497|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160498|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138160499|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138160500|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160501|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160502|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
138160503|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160504|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160505|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138160506|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362582|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138160507|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160508|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
138160509|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160510|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160511|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138160512|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
138160513|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160514|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160515|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160516|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160518|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138160519|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
138160521|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160522|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160523|NCT00353119|Etanercept|etanercept|mesh-list
138160524|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138160525|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138160526|NCT00353119|Analgesics|analgesics|mesh-ancestor
138160527|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
138160528|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160529|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160530|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160531|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160532|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160533|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160534|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
138160535|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
138160536|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138160537|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160538|NCT00353977|Vaccines|vaccines|mesh-list
138160539|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
138160540|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160541|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
138160542|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138160543|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138160544|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138160545|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160546|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160547|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
138160548|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160549|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160550|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138160551|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160552|NCT01792375|Dinoprostone|dinoprostone|mesh-list
138160553|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
138160554|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160555|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160556|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138366760|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366761|NCT05509634|Dexamethasone|dexamethasone|mesh-list
138366762|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
138366763|NCT05509634|Palonosetron|palonosetron|mesh-list
138160557|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
138160558|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160559|NCT00320671|Risperidone|risperidone|mesh-list
138160560|NCT00320671|Aripiprazole|aripiprazole|mesh-list
138160561|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138160562|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
138160563|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160564|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160565|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160566|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138160567|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160568|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160569|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160570|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138160571|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
138160572|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138160573|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
138160574|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138160575|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138160576|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138160577|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138160578|NCT00320749|Gemcitabine|gemcitabine|mesh-list
138160579|NCT00320749|Capecitabine|capecitabine|mesh-list
138160581|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160582|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
138160583|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160584|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160585|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
138160586|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
138160587|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
138160588|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
138160589|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
138160590|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160591|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138160592|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160593|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160594|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
138160595|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138160597|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138160598|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
138160599|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160600|NCT00322309|Mirtazapine|mirtazapine|mesh-list
138160601|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
138160602|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160604|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
138160605|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
138160606|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160607|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160608|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160610|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160611|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160612|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138160613|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138160614|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138160615|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
138160616|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138160617|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138160618|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
138160619|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138160621|NCT04046744|Analgesics|analgesics|mesh-list
138160622|NCT04046744|Ropivacaine|ropivacaine|mesh-list
138160623|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
138160624|NCT04046744|Anesthetics|anesthetics|mesh-list
138160625|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160626|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160627|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
138160628|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160629|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138160630|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138160631|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138160632|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160633|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160634|NCT01431950|Fluticasone|fluticasone|mesh-list
138160636|NCT01431950|Albuterol|albuterol|mesh-list
138160637|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160638|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138160639|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
138160640|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160641|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160642|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138160643|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160644|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138160645|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138160646|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
138160647|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138160648|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138160649|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138160650|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138160651|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138160652|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160655|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
138160656|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160657|NCT01431716|Epoprostenol|epoprostenol|mesh-list
138160658|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138160659|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138160661|NCT00550953|Telmisartan|telmisartan|mesh-list
138160662|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138160663|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138160664|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138160665|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160666|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160667|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138160668|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160669|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
138160670|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138160671|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138160672|NCT00322465|Azithromycin|azithromycin|mesh-list
138160673|NCT00322465|Doxycycline|doxycycline|mesh-list
138160674|NCT00322465|Tinidazole|tinidazole|mesh-list
138160675|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160676|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160677|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
138160678|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138160679|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138160680|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
138160681|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160682|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138160683|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138160684|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
138160685|NCT03021993|Nivolumab|nivolumab|mesh-list
138160686|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138160687|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160688|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138160690|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138160691|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
138160692|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160693|NCT00558753|Pregabalin|pregabalin|mesh-list
138160694|NCT00558753|Analgesics|analgesics|mesh-ancestor
138160695|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
138160696|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160697|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160698|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
138160699|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138160700|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160701|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160702|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138160703|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138160704|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160705|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160706|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160707|NCT00324259|Estradiol|estradiol|mesh-list
138160708|NCT00324259|Estrogens|estrogens|mesh-ancestor
138160709|NCT00324259|Hormones|hormones|mesh-ancestor
138160710|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160711|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160712|NCT04600141|Heparin|heparin|mesh-list
138160713|NCT04600141|Calcium heparin|calcium heparin|mesh-list
138160714|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
138160715|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138160716|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138160717|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160718|NCT00324415|Fluorouracil|fluorouracil|mesh-list
138160719|NCT00324415|Cetuximab|cetuximab|mesh-list
138160720|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160721|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
138362595|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160722|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160723|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160724|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160725|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
138160726|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160727|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138160728|NCT00390559|Nicotine|nicotine|mesh-list
138160729|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138160730|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
138160731|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160732|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160733|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138160735|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
138160736|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160737|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160738|NCT02107339|Methadone|methadone|mesh-list
138160739|NCT02107339|Hydromorphone|hydromorphone|mesh-list
138160740|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138160741|NCT02107339|Narcotics|narcotics|mesh-ancestor
138160742|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160743|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160744|NCT02107339|Analgesics|analgesics|mesh-ancestor
138160745|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
138160746|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160747|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
138160748|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160750|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138160751|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160752|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160753|NCT01390844|Ribavirin|ribavirin|mesh-list
138160754|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138160755|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
138160756|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160757|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
138160758|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160759|NCT00395161|Selenium|selenium|mesh-list
138160760|NCT00395161|Metoclopramide|metoclopramide|mesh-list
138160761|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
138160762|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160763|NCT00395161|Protective Agents|protective agents|mesh-ancestor
138160764|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160765|NCT00395161|Trace Elements|trace elements|mesh-ancestor
138160766|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
138160767|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
138160768|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
138160769|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160770|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160771|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138160772|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138160773|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
138160774|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160775|NCT01409564|Cilostazol|cilostazol|mesh-list
138160776|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138160777|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
138160778|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160779|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366775|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160780|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138160781|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160782|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138160783|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138160784|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160785|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138160786|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
138160787|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138160788|NCT01409564|Protective Agents|protective agents|mesh-ancestor
138160790|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138160791|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160793|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138344284|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160795|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160796|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160797|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138160799|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
138160800|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138160801|NCT01794169|Cytarabine|cytarabine|mesh-list
138160802|NCT01794169|Azacitidine|azacitidine|mesh-list
138160803|NCT01794169|Daunorubicin|daunorubicin|mesh-list
138160804|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160805|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
138160806|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160807|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160808|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
138160809|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160810|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160811|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
138160812|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160813|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160814|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160815|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138160816|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138160817|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138160818|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
138160819|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160820|NCT01390220|Midazolam|midazolam|mesh-list
138160821|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138160822|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138160823|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160824|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160825|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138160826|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138160827|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138160828|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138160829|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
138160830|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
138160831|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
138160832|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
138160833|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160834|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160835|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
138160836|NCT00357331|Diuretics|diuretics|mesh-ancestor
138160837|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
138160838|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160840|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160842|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138160843|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160844|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160845|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160846|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138160847|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138160848|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138160851|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138160852|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
138160853|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
138160854|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160855|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160856|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138160857|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
138160859|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160860|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138160861|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160862|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
138160863|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138160864|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138160865|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160866|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160867|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160868|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160870|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138160871|NCT01429298|Narcotics|narcotics|mesh-ancestor
138362610|NCT02247414|Tinzaparin|tinzaparin|mesh-list
138160872|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138160873|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160874|NCT01429298|Analgesics|analgesics|mesh-ancestor
138160875|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
138160876|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160877|NCT01408628|Insulin|insulin|mesh-list
138160878|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138160879|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160880|NCT01389752|Charcoal|charcoal|mesh-list
138160881|NCT01389752|Antidotes|antidotes|mesh-ancestor
138160882|NCT01389752|Protective Agents|protective agents|mesh-ancestor
138160883|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160884|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
138160885|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160886|NCT00358501|Defibrotide|defibrotide|mesh-list
138160887|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138160888|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138160889|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160890|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138160891|NCT01427972|Eplerenone|eplerenone|mesh-list
138160892|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138160893|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
138160894|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138160895|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160896|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138160897|NCT01427972|Diuretics|diuretics|mesh-ancestor
138160898|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
138160899|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138160900|NCT00336323|Bevacizumab|bevacizumab|mesh-list
138160902|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160903|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138160904|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138160905|NCT00336323|Growth Substances|growth substances|mesh-ancestor
138160906|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160907|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
138160909|NCT01427738|Gentian Violet|gentian violet|mesh-list
138366797|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366798|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366799|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
138366800|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138366801|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138366802|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160910|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160911|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160912|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
138160913|NCT01427738|Ionophores|ionophores|mesh-ancestor
138160914|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138160915|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160916|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138160917|NCT01426958|Ritonavir|ritonavir|mesh-list
138160918|NCT01426958|Afatinib|afatinib|mesh-list
138160919|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138160920|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138160921|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
138160922|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160923|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160924|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138160925|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138160926|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
138160927|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160928|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138160929|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138160930|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160931|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138160932|NCT00397813|Cyclosporine|cyclosporine|mesh-list
138160933|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
138160934|NCT00397813|Fludarabine|fludarabine|mesh-list
138160935|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
138160936|NCT00397813|Cyclosporins|cyclosporins|mesh-list
138160937|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160938|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160939|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
138160940|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160941|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160942|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
138160943|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160944|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160945|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
138160946|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138160947|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
138160948|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138160950|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138160951|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138160952|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
138160953|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138160955|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160956|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
138160957|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160958|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160959|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138160960|NCT00358579|Vasopressins|vasopressins|mesh-list
138160961|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
138160962|NCT00358579|Epinephrine|epinephrine|mesh-list
138160963|NCT00358579|Racepinephrine|racepinephrine|mesh-list
138160964|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
138160965|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138160966|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138160967|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138160968|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
138160969|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138160970|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160971|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138160972|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138160973|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
138160974|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138160975|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138160976|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
138160977|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
138160978|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
138160979|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138160980|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
138160981|NCT00358579|Coagulants|coagulants|mesh-ancestor
138160982|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138160983|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
138160984|NCT00338039|Gemcitabine|gemcitabine|mesh-list
138160985|NCT00338039|Capecitabine|capecitabine|mesh-list
138160986|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
138160988|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138160989|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
138160990|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138160991|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138160992|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138160994|NCT00358657|Sirolimus|sirolimus|mesh-list
138160995|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
138160996|NCT00358657|Fludarabine|fludarabine|mesh-list
138160997|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
138362622|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138160998|NCT00358657|Tacrolimus|tacrolimus|mesh-list
138160999|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161000|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
138161001|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161002|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161003|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161004|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
138161005|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161006|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161007|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161008|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161011|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161012|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161013|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138161014|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
138161015|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161016|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161017|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
138161018|NCT00340379|Haloperidol|haloperidol|mesh-list
138161019|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
138161020|NCT00340379|Ziprasidone|ziprasidone|mesh-list
138161021|NCT00340379|Sertraline|sertraline|mesh-list
138161022|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
138161023|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161024|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138161026|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161027|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161028|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161029|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
138161030|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161031|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
138161032|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
138161033|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161034|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138161035|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138161036|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161037|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161038|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138161039|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
138161040|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138161041|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138161042|NCT00342563|Mecamylamine|mecamylamine|mesh-list
138161043|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138161044|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138161045|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
138161046|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161047|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161048|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138161049|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138161050|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161051|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161052|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161053|NCT00358735|Enoxaparin|enoxaparin|mesh-list
138161054|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
138161055|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138161056|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138161057|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161058|NCT01793519|Adalimumab|adalimumab|mesh-list
138161059|NCT01793519|Infliximab|infliximab|mesh-list
138161060|NCT01793519|Etanercept|etanercept|mesh-list
138161061|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138161062|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161063|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161064|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161066|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161067|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161068|NCT01793519|Analgesics|analgesics|mesh-ancestor
138161069|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
138161070|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161071|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161072|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161075|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
138161076|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161077|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161078|NCT03006276|Celecoxib|celecoxib|mesh-list
138161079|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161080|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161081|NCT03006276|Analgesics|analgesics|mesh-ancestor
138161082|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
138161083|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161084|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161085|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161086|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161087|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138161088|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138161089|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161090|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161092|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161093|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161094|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138161095|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138161096|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138161097|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138161098|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161099|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161100|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161101|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
138161102|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138161103|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161104|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161105|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161107|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
138161108|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161109|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138161110|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138161111|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138161118|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161119|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161120|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161121|NCT00352001|Growth Substances|growth substances|mesh-ancestor
138161122|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138161123|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161124|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161126|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161127|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161128|NCT00401401|Zalutumumab|zalutumumab|mesh-list
138161129|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161130|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161131|NCT00352781|Nicotine|nicotine|mesh-list
138161132|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138161133|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
138161134|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161135|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161136|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138161137|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138161138|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161139|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161140|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161146|NCT01793753|Propofol|propofol|mesh-list
138161147|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138161149|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366803|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
138366804|NCT05370820|Coagulants|coagulants|mesh-ancestor
138366805|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138366806|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
138161150|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138161151|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
138161153|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
138161154|NCT00360685|Methotrexate|methotrexate|mesh-list
138161155|NCT00360685|Tacrolimus|tacrolimus|mesh-list
138362641|NCT02248428|Thalidomide|thalidomide|mesh-list
138362642|NCT02248428|Dexamethasone|dexamethasone|mesh-list
138161156|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138161157|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
138161158|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138161159|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161160|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161162|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161163|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161164|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161165|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161166|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138161167|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161168|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
138161169|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161170|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138161171|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138161172|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161175|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161176|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161178|NCT05487456|Nicotine|nicotine|mesh-list
138161179|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138161180|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
138161181|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161182|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161183|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138161184|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138161185|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161186|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161187|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161188|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
138161189|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161190|NCT00558519|Cytarabine|cytarabine|mesh-list
138161191|NCT00558519|Dexamethasone|dexamethasone|mesh-list
138161192|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
138161193|NCT00558519|Doxorubicin|doxorubicin|mesh-list
138161194|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138161195|NCT00558519|Methotrexate|methotrexate|mesh-list
138161196|NCT00558519|Vincristine|vincristine|mesh-list
138161199|NCT00558519|Pegaspargase|pegaspargase|mesh-list
138161200|NCT00558519|Thioguanine|thioguanine|mesh-list
138161201|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161202|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
138161203|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161204|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161205|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161206|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
138161207|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161208|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161209|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161210|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161211|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
138161212|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
138161213|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161214|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138161215|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
138161216|NCT00558519|Hormones|hormones|mesh-ancestor
138161217|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161219|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161220|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138161221|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138161223|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138161224|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
138161226|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161227|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
138161228|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161229|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138161230|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138161231|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
138161232|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161233|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138161234|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
138161235|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
138161236|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
138161237|NCT00403117|Naltrexone|naltrexone|mesh-list
138161238|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138161239|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138161240|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161241|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
138161242|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161243|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
138161244|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138161245|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138161246|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138161247|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161248|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161249|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161250|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161251|NCT01389596|Pregabalin|pregabalin|mesh-list
138161252|NCT01389596|Analgesics|analgesics|mesh-ancestor
138161253|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
138161254|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161255|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161256|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
138161257|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138161258|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161259|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161260|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138161261|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138161262|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161263|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161264|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161265|NCT00558207|Gemcitabine|gemcitabine|mesh-list
138161266|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161267|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
138161268|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161269|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161270|NCT00407485|Aflibercept|aflibercept|mesh-list
138161271|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161272|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161273|NCT00407485|Growth Substances|growth substances|mesh-ancestor
138161274|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161276|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161277|NCT00354887|Capecitabine|capecitabine|mesh-list
138161278|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
138161279|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161280|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
138161281|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161282|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161283|NCT02111863|Aldesleukin|aldesleukin|mesh-list
138161284|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
138161286|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161287|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
138161288|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161289|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161290|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161291|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
138161292|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161293|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161294|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161296|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138161297|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
138161298|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161299|NCT02660411|Propofol|propofol|mesh-list
138161300|NCT02660411|Sevoflurane|sevoflurane|mesh-list
138161301|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138161302|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161303|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161304|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138161305|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
138161306|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
138161307|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138161308|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138161309|NCT02078492|Ketorolac|ketorolac|mesh-list
138161310|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138161311|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161312|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161313|NCT02078492|Analgesics|analgesics|mesh-ancestor
138161314|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
138161315|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161316|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161317|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161319|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138161320|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161321|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161323|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138161324|NCT04528563|Morphine|morphine|mesh-list
138161325|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138161326|NCT04528563|Narcotics|narcotics|mesh-ancestor
138161327|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161328|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161329|NCT04528563|Analgesics|analgesics|mesh-ancestor
138161330|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
138161331|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161332|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161333|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161334|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161335|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161336|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138161337|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161338|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161340|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161341|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161342|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
138161343|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161344|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161345|NCT01791647|Inositol|inositol|mesh-list
138161346|NCT01791647|Metformin|metformin|mesh-list
138161347|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161348|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161349|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
138161350|NCT01791647|Vitamins|vitamins|mesh-ancestor
138161351|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
138161352|NCT00363883|Vorinostat|vorinostat|mesh-list
138161353|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161354|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138161355|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161356|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362673|NCT02248506|Clotrimazole|clotrimazole|mesh-list
138161358|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161359|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161361|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161362|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161363|NCT04524351|Phenserine|phenserine|mesh-list
138161364|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138161365|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161366|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161367|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161368|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161369|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161370|NCT04523961|Lidocaine|lidocaine|mesh-list
138161371|NCT04523961|Tetracaine|tetracaine|mesh-list
138161372|NCT04523961|Prilocaine|prilocaine|mesh-list
138161373|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138161374|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
138161375|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
138161376|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161377|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161378|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
138161379|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161380|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138161381|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138161382|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138161383|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161384|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161385|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138161386|NCT01792505|Imiquimod|imiquimod|mesh-list
138161387|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138161388|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
138161389|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161390|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161391|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
138161392|NCT00365053|Belinostat|belinostat|mesh-list
138161393|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161394|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138161395|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161396|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161397|NCT00555789|Tacrolimus|tacrolimus|mesh-list
138161398|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161399|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
138161401|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138161402|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161403|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161404|NCT04288895|Vortioxetine|vortioxetine|mesh-list
138161405|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
138161406|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161407|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138161408|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161409|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161410|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161411|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138161412|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138161413|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161414|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161415|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161416|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
138161417|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138161418|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138161419|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138362676|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362677|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
138362680|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161420|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138161422|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161423|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161424|NCT00365209|Analgesics|analgesics|mesh-ancestor
138161425|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
138161426|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161427|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161428|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161429|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161430|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161431|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161432|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161433|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138161434|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138161435|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138161436|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
138161437|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161438|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161440|NCT00409825|Hormones|hormones|mesh-ancestor
138161441|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138161442|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161443|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138161444|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161445|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161446|NCT04749069|Remifentanil|remifentanil|mesh-list
138161447|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138161449|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161450|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161451|NCT04749069|Analgesics|analgesics|mesh-ancestor
138161452|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
138161453|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161454|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138161455|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
138161456|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161458|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161459|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161460|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161463|NCT03239015|Olaparib|olaparib|mesh-list
138161464|NCT03239015|Palbociclib|palbociclib|mesh-list
138161465|NCT03239015|Gefitinib|gefitinib|mesh-list
138161466|NCT03239015|Afatinib|afatinib|mesh-list
138161467|NCT03239015|Vemurafenib|vemurafenib|mesh-list
138161468|NCT03239015|Dabrafenib|dabrafenib|mesh-list
138161469|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138161471|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161472|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138161473|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138161474|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161475|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161476|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161477|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
138161478|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161479|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138161480|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161481|NCT03239015|Growth Substances|growth substances|mesh-ancestor
138161482|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
138161483|NCT00356993|Nicotine|nicotine|mesh-list
138161484|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138161485|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
138161486|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161487|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161488|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138161489|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138161490|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161491|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344285|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138362688|NCT02248896|Telmisartan|telmisartan|mesh-list
138161492|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161493|NCT01793077|Leuprolide|leuprolide|mesh-list
138161494|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138161495|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
138161496|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138161497|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161498|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138161499|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161500|NCT00555477|Anastrozole|anastrozole|mesh-list
138161501|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138161502|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161505|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161506|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161507|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138161508|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
138161509|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161510|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161511|NCT00365599|Tamoxifen|tamoxifen|mesh-list
138161512|NCT00365599|Vorinostat|vorinostat|mesh-list
138161513|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161514|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138161515|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
138161516|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161517|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161518|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138161519|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161520|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138366810|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366811|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138366812|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138366814|NCT05324358|Ketorolac|ketorolac|mesh-list
138366815|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138366816|NCT05324358|Morphine|morphine|mesh-list
138366817|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138366818|NCT05324358|Narcotics|narcotics|mesh-ancestor
138161521|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138161522|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138161523|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138161524|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161525|NCT00554619|Ambrisentan|ambrisentan|mesh-list
138161526|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138161527|NCT02104739|Exenatide|exenatide|mesh-list
138161528|NCT02104739|Saxagliptin|saxagliptin|mesh-list
138161529|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161530|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161531|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138161532|NCT02104739|Incretins|incretins|mesh-ancestor
138161533|NCT02104739|Hormones|hormones|mesh-ancestor
138161534|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161535|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138161536|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
138161537|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161538|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161540|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138161541|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138161542|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161543|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161544|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161545|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
138161546|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161547|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161548|NCT00412087|Vitamin D|vitamin d|mesh-list
138161549|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
138161550|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
138161551|NCT00412087|Vitamins|vitamins|mesh-list
138161552|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
138161553|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161554|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138161555|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138161556|NCT00312923|Policosanol|policosanol|mesh-list
138161557|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138161558|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138161559|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
138161560|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161561|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138161562|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138161563|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
138161565|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161566|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
138161567|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161568|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161569|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161570|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
138161571|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161572|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161573|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161574|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161575|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
138161576|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138161577|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
138161578|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161579|NCT00315341|Buprenorphine|buprenorphine|mesh-list
138366824|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138366825|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366826|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161580|NCT00315341|Methadone|methadone|mesh-list
138161582|NCT00315341|Naloxone|naloxone|mesh-list
138161583|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138161584|NCT00315341|Narcotics|narcotics|mesh-ancestor
138161585|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161586|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161587|NCT00315341|Analgesics|analgesics|mesh-ancestor
138161588|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
138161589|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161590|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138161591|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
138161592|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
138161593|NCT02277249|Digoxin|digoxin|mesh-list
138161594|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138161595|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138161596|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161597|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161598|NCT02277249|Protective Agents|protective agents|mesh-ancestor
138161599|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161600|NCT04767542|Acetaminophen|acetaminophen|mesh-list
138161601|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161602|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161603|NCT04767542|Analgesics|analgesics|mesh-ancestor
138161604|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
138161605|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161606|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
138161607|NCT01794533|Lidocaine|lidocaine|mesh-list
138161608|NCT01794533|Epinephrine|epinephrine|mesh-list
138161609|NCT01794533|Racepinephrine|racepinephrine|mesh-list
138161610|NCT01794533|Fentanyl|fentanyl|mesh-list
138161611|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
138161612|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
138161613|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
138161614|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161615|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161616|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
138161617|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161618|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138161619|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138161620|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138161621|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161622|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161623|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138161624|NCT01794533|Narcotics|narcotics|mesh-ancestor
138161625|NCT01794533|Analgesics|analgesics|mesh-ancestor
138161626|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138161627|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138161628|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
138344286|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
138161629|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138161630|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138161631|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138161632|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161634|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138161635|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
138161636|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138161637|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
138161638|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
138161639|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
138161640|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138161641|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138161642|NCT00412867|Plasminogen|plasminogen|mesh-list
138161643|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138161644|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138161645|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161646|NCT01730833|Paclitaxel|paclitaxel|mesh-list
138161647|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138161648|NCT01730833|Trastuzumab|trastuzumab|mesh-list
138161649|NCT01730833|Pertuzumab|pertuzumab|mesh-list
138161650|NCT01730833|Antibodies|antibodies|mesh-list
138161651|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
138161652|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138161653|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161654|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138161655|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138161656|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138161657|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161658|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
138161659|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161660|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161661|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
138161662|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161663|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161664|NCT00414271|Docetaxel|docetaxel|mesh-list
138161665|NCT00414271|Capecitabine|capecitabine|mesh-list
138161666|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161667|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138161668|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138161669|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138161670|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161671|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161672|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
138161674|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161675|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
138161676|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138161677|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138161678|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138161680|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161681|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
138161682|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161683|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161684|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138161685|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161686|NCT03636503|Rituximab|rituximab|mesh-list
138161687|NCT03636503|Avelumab|avelumab|mesh-list
138161688|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161689|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161690|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
138161691|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161692|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161693|NCT03448159|Fluoxetine|fluoxetine|mesh-list
138161694|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138161695|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138161696|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161697|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161698|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161699|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
138161700|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161701|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138161702|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
138161703|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161704|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138161705|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138161706|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161707|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
138161708|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161709|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161710|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138161711|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
138161712|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138161716|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161717|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138161718|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161719|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161720|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
138161721|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138161722|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138161723|NCT01792037|Prednisolone|prednisolone|mesh-list
138161724|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
138161725|NCT01792037|Midazolam|midazolam|mesh-list
138161726|NCT01792037|Etomidate|etomidate|mesh-list
138161727|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138161728|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
138161729|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138161730|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138161731|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161732|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161733|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138161734|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161735|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161736|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138161737|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
138161738|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
138161739|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
138161740|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
138161741|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161742|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161743|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161744|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
138161745|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
138161746|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161747|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138161748|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
138161749|NCT01792037|Hormones|hormones|mesh-ancestor
138161750|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161751|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138161752|NCT01792037|Protective Agents|protective agents|mesh-ancestor
138161753|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138161755|NCT00373399|Dronabinol|dronabinol|mesh-list
138161756|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
138161757|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161758|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161759|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161760|NCT00373399|Analgesics|analgesics|mesh-ancestor
138161761|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
138161762|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161763|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138161764|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138161765|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161766|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161767|NCT00373399|Hormones|hormones|mesh-ancestor
138161768|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161769|NCT00318929|Valproic Acid|valproic acid|mesh-list
138161770|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
138161771|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161772|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161773|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
138161774|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161775|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161776|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
138161777|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138161778|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161779|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161780|NCT00418093|Bevacizumab|bevacizumab|mesh-list
138161781|NCT00418093|Gemcitabine|gemcitabine|mesh-list
138161782|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
138161783|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161784|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161785|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161786|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161787|NCT00418093|Growth Substances|growth substances|mesh-ancestor
138161788|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161790|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161791|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
138161792|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161795|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161796|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
138161797|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161798|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161799|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161801|NCT03284723|Palbociclib|palbociclib|mesh-list
138161802|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161803|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138161804|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138161805|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161806|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161807|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138161808|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
138161809|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161810|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161811|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138161812|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
138161813|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161814|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161815|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138161816|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
138161817|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161818|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161819|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161820|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161821|NCT00418951|Voriconazole|voriconazole|mesh-list
138161822|NCT00418951|Amphotericin B|amphotericin b|mesh-list
138161823|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138161824|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
138161825|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161826|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138161827|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138161828|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161829|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161830|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138161831|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
138161832|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138161833|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161834|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138161835|NCT00418951|Amebicides|amebicides|mesh-ancestor
138161836|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138161837|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138161838|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161839|NCT00363077|Vaccines|vaccines|mesh-list
138161840|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
138161841|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161843|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138161844|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138161845|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138161846|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161847|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138161848|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161850|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
138161851|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161852|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
138161853|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138161854|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
138161855|NCT00421603|Topiramate|topiramate|mesh-list
138161856|NCT00421603|Adderall|adderall|mesh-list
138161857|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
138161858|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161859|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161860|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138161861|NCT00363779|Cyclosporine|cyclosporine|mesh-list
138161862|NCT00363779|Cyclosporins|cyclosporins|mesh-list
138161863|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161864|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161865|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161866|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
138161867|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161868|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
138161869|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161870|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161871|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161872|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138161873|NCT01405820|Natalizumab|natalizumab|mesh-list
138161874|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
138161875|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161876|NCT01405742|Factor VIII|factor viii|mesh-list
138161877|NCT01405742|Coagulants|coagulants|mesh-ancestor
138161879|NCT01794767|Calcium heparin|calcium heparin|mesh-list
138161880|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
138161881|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138161882|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138161883|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161884|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
138161885|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138161886|NCT02076152|Bevacizumab|bevacizumab|mesh-list
138161887|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161888|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161889|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161890|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138161891|NCT02076152|Growth Substances|growth substances|mesh-ancestor
138161892|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161893|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138161894|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
138161895|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161896|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161897|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138161898|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161899|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138161900|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161903|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
138161904|NCT00426283|Fluticasone|fluticasone|mesh-list
138161905|NCT00426283|Xhance|xhance|mesh-list
138161906|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161907|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138161908|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
138161909|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161910|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161911|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138161912|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138161913|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138161914|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138161916|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138161917|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138161918|NCT00322439|Analgesics|analgesics|mesh-ancestor
138161919|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
138161920|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138161921|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161922|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138161923|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161924|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138161925|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161926|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
138161927|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
138161928|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161929|NCT00365261|Eszopiclone|eszopiclone|mesh-list
138161930|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138161931|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138161932|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161933|NCT00426517|Sirolimus|sirolimus|mesh-list
138161935|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
138161936|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138161937|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161938|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161939|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161940|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
138161941|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161942|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
138161943|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161944|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161945|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
138161946|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161947|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161948|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161949|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
138161950|NCT00365417|Bevacizumab|bevacizumab|mesh-list
138161951|NCT00365417|Docetaxel|docetaxel|mesh-list
138161952|NCT00365417|Doxorubicin|doxorubicin|mesh-list
138161953|NCT00365417|Capecitabine|capecitabine|mesh-list
138161954|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138161955|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
138161956|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161957|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138161958|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138161960|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161961|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138161962|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138161963|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161964|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138161967|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
138161968|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138161969|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138161970|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138161971|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138161972|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138161973|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138161974|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161975|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138161978|NCT00427297|Lopinavir|lopinavir|mesh-list
138161979|NCT00427297|Tenofovir|tenofovir|mesh-list
138161980|NCT00427297|Lamivudine|lamivudine|mesh-list
138161981|NCT00427297|Zidovudine|zidovudine|mesh-list
138161982|NCT00427297|Nevirapine|nevirapine|mesh-list
138161983|NCT00427297|Abacavir|abacavir|mesh-list
138161984|NCT00427297|Stavudine|stavudine|mesh-list
138161985|NCT00427297|Didanosine|didanosine|mesh-list
138161986|NCT00427297|Efavirenz|efavirenz|mesh-list
138161987|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
138161988|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138161989|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138161990|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
138161991|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138161992|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138161993|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138161994|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138161995|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
138161996|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138161997|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138161998|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138161999|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138162000|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162001|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
138162002|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138162003|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138162004|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138162005|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138162006|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138162007|NCT00427765|Melphalan|melphalan|mesh-list
138162008|NCT00427765|Busulfan|busulfan|mesh-list
138162009|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138162011|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162012|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162013|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138162014|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162015|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
138162017|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
138162018|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
138162019|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162020|NCT00384865|Aspirin|aspirin|mesh-list
138162021|NCT00384865|Simvastatin|simvastatin|mesh-list
138162022|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138162023|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138162024|NCT00384865|Analgesics|analgesics|mesh-ancestor
138162025|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
138162026|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162027|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162028|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162029|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162030|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138162031|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138162032|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162033|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138162034|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138162035|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162036|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
138162037|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138162038|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138162039|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
138162040|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138162041|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138162042|NCT00367601|Bevacizumab|bevacizumab|mesh-list
138162043|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138162044|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162045|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162046|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162047|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162048|NCT00367601|Growth Substances|growth substances|mesh-ancestor
138162049|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162050|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162051|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162052|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162053|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162054|NCT00385801|Risperidone|risperidone|mesh-list
138162055|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138162056|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
138162058|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162059|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162060|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138162061|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138162062|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162063|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162064|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138162065|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
138162066|NCT00429403|Goserelin|goserelin|mesh-list
138162067|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162068|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162069|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
138162070|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138162071|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162072|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138162073|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138162074|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162075|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162076|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162077|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138162078|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138162079|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138162080|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138162081|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
138162082|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162083|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162084|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138162085|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138162086|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138162088|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162089|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162090|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162091|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162093|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138162094|NCT02078726|Hormones|hormones|mesh-ancestor
138162095|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162097|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
138162098|NCT00431041|Oxybutynin|oxybutynin|mesh-list
138162099|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138162101|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
138162102|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162103|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162104|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162105|NCT00431041|Urological Agents|urological agents|mesh-ancestor
138162106|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
138162107|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
138162108|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162110|NCT00390611|Carboplatin|carboplatin|mesh-list
138162111|NCT00390611|Sorafenib|sorafenib|mesh-list
138162112|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162113|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162114|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162115|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
138162116|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162117|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162118|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162119|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162120|NCT00391079|Nabiximols|nabiximols|mesh-list
138162121|NCT00391079|Analgesics|analgesics|mesh-ancestor
138162122|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
138162123|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162124|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162125|NCT00387751|Bevacizumab|bevacizumab|mesh-list
138162126|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138162127|NCT00387751|Sorafenib|sorafenib|mesh-list
138162128|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
138162129|NCT00387751|Antibodies|antibodies|mesh-list
138162130|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
138162131|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138162132|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
138162133|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162134|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162135|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162136|NCT00387751|Growth Substances|growth substances|mesh-ancestor
138162137|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162138|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162139|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
138162140|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162141|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162142|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162144|NCT01795235|Glucagon|glucagon|mesh-list
138162145|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138162146|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138162147|NCT01795235|Hormones|hormones|mesh-ancestor
138162148|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162149|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162151|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138162152|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138162153|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
138162154|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
138162155|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162156|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138162157|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138162158|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138162159|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162160|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162161|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162162|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138162163|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138162165|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138162166|NCT00387829|Estrogens|estrogens|mesh-ancestor
138162167|NCT00387829|Hormones|hormones|mesh-ancestor
138162168|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162169|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162170|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138162171|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
138162172|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162173|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138162174|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
138162175|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162176|NCT00392951|Sirolimus|sirolimus|mesh-list
138162177|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138162178|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162179|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138162180|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162181|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
138162182|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162183|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
138162184|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162185|NCT01424930|Prednisone|prednisone|mesh-list
138162186|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162187|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
138162188|NCT01424930|Hormones|hormones|mesh-ancestor
138162189|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162191|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162193|NCT00389857|Vaccines|vaccines|mesh-list
138162194|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
138162195|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162196|NCT01795183|Amisulpride|amisulpride|mesh-list
138162197|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138162198|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138162200|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162201|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162202|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138162203|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
138162204|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162205|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162206|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138162207|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
138162208|NCT01424228|Prucalopride|prucalopride|mesh-list
138162209|NCT01424228|Laxatives|laxatives|mesh-ancestor
138162210|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138162211|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138162212|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138162213|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
138162214|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162215|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162216|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162217|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
138162218|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
138162219|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162220|NCT04750603|Fluticasone|fluticasone|mesh-list
138162221|NCT04750603|Xhance|xhance|mesh-list
138162222|NCT04750603|Albuterol|albuterol|mesh-list
138162223|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362776|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162224|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138162225|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
138162226|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162227|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162228|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138162229|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
138162230|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138162231|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138162232|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
138162233|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162234|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138162235|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138162236|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138162237|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162238|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162239|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162240|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
138162241|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138162242|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162243|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138162244|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138162245|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162246|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162247|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162248|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
138162249|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138162250|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
138162251|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162252|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
138162253|NCT00436969|Protective Agents|protective agents|mesh-ancestor
138162255|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138162256|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
138162257|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162258|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162259|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162260|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162262|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138162263|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
138162264|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
138162265|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162266|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
138162267|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162268|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
138162269|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162270|NCT00395057|Ranibizumab|ranibizumab|mesh-list
138162271|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162272|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162274|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162275|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162276|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162277|NCT00438451|Lamotrigine|lamotrigine|mesh-list
138162278|NCT00438451|Carbamazepine|carbamazepine|mesh-list
138162279|NCT00438451|Levetiracetam|levetiracetam|mesh-list
138162280|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
138162281|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
138162282|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138162283|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162284|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162285|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138162286|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162287|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138162288|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138162289|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162290|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162291|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138162292|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
138162293|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138162294|NCT00438451|Analgesics|analgesics|mesh-ancestor
138162295|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
138162296|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162297|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138162298|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138162300|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
138162301|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162302|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138162303|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138162304|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138162305|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138162306|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138162307|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162308|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162309|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162310|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162311|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138162312|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
138162313|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138162314|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
138162315|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162316|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162317|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138162318|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162319|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162321|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162322|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
138162323|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162324|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162325|NCT01402544|Ranibizumab|ranibizumab|mesh-list
138162326|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162327|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162328|NCT01402544|Growth Substances|growth substances|mesh-ancestor
138162329|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162330|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162331|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162332|NCT00460993|Eszopiclone|eszopiclone|mesh-list
138162333|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138162334|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162335|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162336|NCT00441883|Latanoprost|latanoprost|mesh-list
138162337|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138162338|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138162339|NCT00461773|Bevacizumab|bevacizumab|mesh-list
138162340|NCT00461773|Letrozole|letrozole|mesh-list
138162341|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162342|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162343|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162344|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162345|NCT00461773|Growth Substances|growth substances|mesh-ancestor
138162346|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162347|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162348|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138162349|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138162350|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162351|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162352|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138162353|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138162354|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162355|NCT00461851|Carboplatin|carboplatin|mesh-list
138162356|NCT00461851|Gemcitabine|gemcitabine|mesh-list
138162357|NCT00461851|Sorafenib|sorafenib|mesh-list
138162359|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162360|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
138162361|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162362|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162363|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162364|NCT00442507|Bevacizumab|bevacizumab|mesh-list
138162365|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138162366|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162367|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162368|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162369|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162370|NCT00442507|Growth Substances|growth substances|mesh-ancestor
138162371|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162372|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162373|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162374|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162375|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162376|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
138162377|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162378|NCT01387022|Tenofovir|tenofovir|mesh-list
138162379|NCT01387022|Lamivudine|lamivudine|mesh-list
138162380|NCT01387022|Efavirenz|efavirenz|mesh-list
138162381|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
138162382|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162383|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138162384|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162385|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162386|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162387|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138162388|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138162389|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138162390|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138162391|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138162392|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138162393|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138162394|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138162395|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
138162396|NCT00374231|Prednisone|prednisone|mesh-list
138162397|NCT00374231|Tacrolimus|tacrolimus|mesh-list
138162398|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162399|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
138162400|NCT00374231|Hormones|hormones|mesh-ancestor
138162401|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162402|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162403|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162404|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162407|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138162408|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162409|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162411|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138162412|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
138162413|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138162414|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162416|NCT00400205|Fluorouracil|fluorouracil|mesh-list
138162417|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162418|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162419|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138162420|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162421|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162423|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162424|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162425|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
138162426|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162427|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138162429|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162430|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162431|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
138162432|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138162433|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138162434|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
138162435|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162436|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138162437|NCT00448201|Methotrexate|methotrexate|mesh-list
138162438|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
138162439|NCT00448201|Fludarabine|fludarabine|mesh-list
138162440|NCT00448201|Busulfan|busulfan|mesh-list
138162441|NCT00448201|Tacrolimus|tacrolimus|mesh-list
138162442|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138162443|NCT00448201|Sargramostim|sargramostim|mesh-list
138162444|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138162445|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
138162446|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162447|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162448|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162449|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
138162450|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162451|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162452|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
138162453|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162454|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138162455|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162456|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
138162457|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162458|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162459|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138162461|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138162462|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138162464|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
138162465|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162466|NCT05287607|Protective Agents|protective agents|mesh-ancestor
138162467|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162468|NCT00375713|Cetirizine|cetirizine|mesh-list
138162469|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
138162470|NCT00375713|Levocetirizine|levocetirizine|mesh-list
138162471|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162472|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138162473|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138162474|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138162475|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
138162476|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
138162477|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162478|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162479|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162480|NCT00465595|Psilocybin|psilocybin|mesh-list
138162481|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138162482|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
138162483|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162484|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162485|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138162486|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
138162487|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162488|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162489|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138162490|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
138162491|NCT00376805|Fludarabine|fludarabine|mesh-list
138162492|NCT00376805|Interleukin-2|interleukin-2|mesh-list
138162493|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162494|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
138162495|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162496|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162497|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138162498|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
138162499|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162500|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162501|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138162502|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138162503|NCT00376805|Analgesics|analgesics|mesh-ancestor
138162504|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
138162505|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162529|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
138162530|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138162531|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138162533|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
138162534|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
138162538|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138162539|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138162540|NCT00467077|Interferons|interferons|mesh-list
138162541|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
138162542|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
138162543|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138162544|NCT00467077|Gefitinib|gefitinib|mesh-list
138366840|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162545|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162546|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
138162547|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162548|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
138162549|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162550|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162551|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162552|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162553|NCT00467389|Donepezil|donepezil|mesh-list
138162554|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138162555|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162556|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162557|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
138162558|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162559|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162560|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
138162561|NCT00377741|Valganciclovir|valganciclovir|mesh-list
138162562|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
138162563|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162564|NCT00379145|Trabectedin|trabectedin|mesh-list
138162565|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138162567|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162568|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162569|NCT00382031|Zalutumumab|zalutumumab|mesh-list
138162570|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138162571|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162572|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162573|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
138162574|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162576|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138162577|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138162578|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138162579|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162580|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162581|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162582|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162583|NCT00382265|Urological Agents|urological agents|mesh-ancestor
138162584|NCT00383747|Nicotine|nicotine|mesh-list
138162585|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138162586|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
138162587|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162588|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162589|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138162590|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138162591|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
138162592|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162593|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162595|NCT01421342|Bupropion|bupropion|mesh-list
138162596|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
138162598|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162599|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138162600|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138162601|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162602|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162603|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
138162604|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162605|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162606|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138162607|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138162608|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162611|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162613|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138162614|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138162615|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
138162616|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138162617|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138162618|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138162619|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138162620|NCT00403403|Bevacizumab|bevacizumab|mesh-list
138162621|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162623|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162624|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162625|NCT00403403|Growth Substances|growth substances|mesh-ancestor
138162626|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162627|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162628|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
138162629|NCT00405353|Testosterone|testosterone|mesh-list
138162630|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
138162631|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
138162632|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138162633|NCT00405353|Androgens|androgens|mesh-ancestor
138162635|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162636|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162637|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162639|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
138162640|NCT01384292|Naloxegol|naloxegol|mesh-list
138362812|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
138162642|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162643|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
138162644|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162645|NCT00450463|Metronidazole|metronidazole|mesh-list
138162646|NCT00450463|Molgramostim|molgramostim|mesh-list
138162647|NCT00450463|Flutamide|flutamide|mesh-list
138162648|NCT00450463|Sargramostim|sargramostim|mesh-list
138162649|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
138162650|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162651|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162652|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162653|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138162654|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138162655|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138162656|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
138162657|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138162658|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138162659|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138162660|NCT00407381|Ranibizumab|ranibizumab|mesh-list
138162661|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162662|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162663|NCT00407381|Growth Substances|growth substances|mesh-ancestor
138162664|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162665|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162666|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162667|NCT00384449|Ranibizumab|ranibizumab|mesh-list
138162668|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162669|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162670|NCT00384449|Growth Substances|growth substances|mesh-ancestor
138162671|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162672|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162673|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162675|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138162676|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162677|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162678|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
138162679|NCT00386243|Analgesics|analgesics|mesh-list
138162680|NCT00386243|Narcotics|narcotics|mesh-ancestor
138162681|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162682|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162683|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
138162684|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162685|NCT01400516|Vitamin D|vitamin d|mesh-list
138162686|NCT01400516|Teriparatide|teriparatide|mesh-list
138162687|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138162688|NCT01400516|Calcium|calcium|mesh-list
138162689|NCT01400516|Vitamins|vitamins|mesh-ancestor
138162690|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
138162691|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162692|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138162693|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138162694|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162695|NCT01383356|Metformin|metformin|mesh-list
138162696|NCT01383356|Linagliptin|linagliptin|mesh-list
138162697|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138162698|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162699|NCT01383356|Incretins|incretins|mesh-ancestor
138162700|NCT01383356|Hormones|hormones|mesh-ancestor
138162701|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362833|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162703|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
138162704|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162705|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162707|NCT02111447|Sevoflurane|sevoflurane|mesh-list
138162708|NCT02111447|Isoflurane|isoflurane|mesh-list
138162709|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138162710|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162711|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162712|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138162713|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
138162714|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
138162715|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138162716|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138162718|NCT05966454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138162719|NCT05966454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162720|NCT05966454|Antitubercular Agents|antitubercular agents|mesh-ancestor
138162721|NCT05966441|Curcumin|curcumin|mesh-list
138162722|NCT05966441|Paclitaxel|paclitaxel|mesh-list
138162723|NCT05966441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162724|NCT05966441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162725|NCT05966441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162726|NCT05966441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138162727|NCT05966441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162728|NCT05966441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162729|NCT05966441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138162730|NCT05966441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138162731|NCT05966441|Analgesics|analgesics|mesh-ancestor
138162732|NCT05966441|Sensory System Agents|sensory system agents|mesh-ancestor
138162733|NCT05966441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162734|NCT05966441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162735|NCT05966441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138162736|NCT05966441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162737|NCT05966441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162739|NCT05966064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138162740|NCT05966064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162741|NCT05966012|Tranexamic Acid|tranexamic acid|mesh-list
138162743|NCT05966012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138162744|NCT05966012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162745|NCT05966012|Hemostatics|hemostatics|mesh-ancestor
138162746|NCT05966012|Coagulants|coagulants|mesh-ancestor
138162747|NCT05965934|Dapagliflozin|dapagliflozin|mesh-list
138162748|NCT05965934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138162749|NCT05965934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162750|NCT05965934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138162751|NCT05965934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162752|NCT05965388|Interferons|interferons|mesh-list
138162753|NCT05965388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162754|NCT05965388|Antiviral Agents|antiviral agents|mesh-ancestor
138162755|NCT05965388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162756|NCT05965284|Azathioprine|azathioprine|mesh-list
138162757|NCT05965284|Antimetabolites|antimetabolites|mesh-ancestor
138162758|NCT05965284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162759|NCT05965284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162760|NCT05965284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162761|NCT05965284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162762|NCT05965284|Immunologic Factors|immunologic factors|mesh-ancestor
138162763|NCT05965284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162764|NCT05965284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138162766|NCT05965154|Capecitabine|capecitabine|mesh-list
138162767|NCT05965154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162768|NCT05965154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162769|NCT05965154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162770|NCT05965154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162771|NCT05965154|Growth Substances|growth substances|mesh-ancestor
138162772|NCT05965154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162773|NCT05965154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138366850|NCT05286528|Dasatinib|dasatinib|mesh-list
138162774|NCT05965154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162775|NCT05965154|Antimetabolites|antimetabolites|mesh-ancestor
138162776|NCT05965154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162777|NCT05965141|Bevacizumab|bevacizumab|mesh-list
138162778|NCT05965141|Carboplatin|carboplatin|mesh-list
138162779|NCT05965141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162780|NCT05965141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162781|NCT05965141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138162782|NCT05965141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138162783|NCT05965141|Growth Substances|growth substances|mesh-ancestor
138162784|NCT05965141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162785|NCT05965141|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162787|NCT05965076|Glycine Agents|glycine agents|mesh-ancestor
138162789|NCT05965076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162790|NCT05965076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162791|NCT05964985|Lidocaine|lidocaine|mesh-list
138162792|NCT05964985|Ropivacaine|ropivacaine|mesh-list
138162793|NCT05964985|Esketamine|esketamine|mesh-list
138162794|NCT05964985|Anesthetics, Local|anesthetics, local|mesh-ancestor
138162795|NCT05964985|Anesthetics|anesthetics|mesh-ancestor
138162796|NCT05964985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162797|NCT05964985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162798|NCT05964985|Sensory System Agents|sensory system agents|mesh-ancestor
138162799|NCT05964985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162800|NCT05964985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138162801|NCT05964985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138162802|NCT05964985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138162803|NCT05964985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162804|NCT05964985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162805|NCT05964985|Antidepressive Agents|antidepressive agents|mesh-ancestor
138162806|NCT05964985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138162807|NCT05964738|Diuretics|diuretics|mesh-list
138162808|NCT05964738|Natriuretic Agents|natriuretic agents|mesh-ancestor
138162809|NCT05964738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162810|NCT05964543|Capecitabine|capecitabine|mesh-list
138162811|NCT05964543|Oxaliplatin|oxaliplatin|mesh-list
138162812|NCT05964543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138162813|NCT05964543|Antimetabolites|antimetabolites|mesh-ancestor
138162814|NCT05964543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162815|NCT05964543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162816|NCT05961644|Cladribine|cladribine|mesh-list
138162817|NCT05961644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162818|NCT05961644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138162819|NCT05961644|Immunologic Factors|immunologic factors|mesh-ancestor
138162820|NCT05961644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162821|NCT05939245|Furosemide|furosemide|mesh-list
138162822|NCT05939245|Diuretics|diuretics|mesh-ancestor
138162824|NCT05939245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162825|NCT05939245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138162826|NCT05939245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162827|NCT05939245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162828|NCT05899933|Erythritol|erythritol|mesh-list
138162829|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
138162830|NCT05783921|Paclitaxel|paclitaxel|mesh-list
138162831|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138162832|NCT05783921|Cisplatin|cisplatin|mesh-list
138162833|NCT05783921|Carboplatin|carboplatin|mesh-list
138162834|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162835|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162836|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162837|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138366856|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
138366857|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138366858|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162838|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162839|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162841|NCT05741372|Digoxin|digoxin|mesh-list
138162842|NCT05741372|Furosemide|furosemide|mesh-list
138162843|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138162844|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138162845|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162846|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138162847|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138162848|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
138162849|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162850|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138162851|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138162852|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162853|NCT05741372|Diuretics|diuretics|mesh-ancestor
138162854|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
138162855|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138162856|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138162857|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138162858|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138162859|NCT05741372|Protective Agents|protective agents|mesh-ancestor
138162860|NCT05740098|Nicotine|nicotine|mesh-list
138162861|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138162862|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
138162863|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162864|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162865|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138162866|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138162867|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
138162868|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162869|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162870|NCT05730413|Bisoprolol|bisoprolol|mesh-list
138162871|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138162872|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
138162873|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
138162874|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162875|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162876|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138162877|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138162880|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162881|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162882|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138162883|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138162884|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138162885|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
138162886|NCT05720455|Fexofenadine|fexofenadine|mesh-list
138162887|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
138162888|NCT05720455|Ephedrine|ephedrine|mesh-list
138162890|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138162891|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138162892|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
138162894|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162895|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162896|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162897|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138162898|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
138162899|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162900|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138162901|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
138162902|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
138162903|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138162904|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138162906|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
138162907|NCT05641753|Atorvastatin|atorvastatin|mesh-list
138366868|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366869|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366870|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138366871|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138366872|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138162908|NCT05641753|Ezetimibe|ezetimibe|mesh-list
138162909|NCT05641753|Evolocumab|evolocumab|mesh-list
138162910|NCT05641753|Calcium|calcium|mesh-list
138162911|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138162912|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162913|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138162914|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138162915|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
138162916|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162917|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138162918|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138162919|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162920|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138162921|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138162922|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
138162923|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
138162926|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138162927|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138162928|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138162929|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
138162930|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162931|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162932|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138162933|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138162934|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138162935|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138162936|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162937|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138162938|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138162939|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
138162940|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
138162941|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162942|NCT05593094|Trastuzumab|trastuzumab|mesh-list
138162943|NCT05593094|Pertuzumab|pertuzumab|mesh-list
138162944|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138162945|NCT05593094|Maytansine|maytansine|mesh-list
138162946|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138162947|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138162948|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
138162949|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
138162950|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
138162951|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162952|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
138162953|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
138162954|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
138162955|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162956|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162957|NCT05591118|Anticoagulants|anticoagulants|mesh-list
138162959|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
138162960|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162961|NCT05541276|Protective Agents|protective agents|mesh-ancestor
138162962|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162963|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138162964|NCT05517174|Vaccines|vaccines|mesh-list
138162965|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
138162966|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162967|NCT05493761|Denosumab|denosumab|mesh-list
138162969|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138162970|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162972|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
138162973|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366873|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366874|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162974|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
138162975|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138162976|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162977|NCT05434663|Granisetron|granisetron|mesh-list
138162978|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
138162979|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
138162980|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138162981|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162982|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138162983|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138162984|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138162985|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
138162987|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162988|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138162989|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138162990|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
138162991|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162993|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
138162994|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138162995|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138162996|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138162997|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138162998|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138162999|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163001|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
138163002|NCT05375630|Vitamins|vitamins|mesh-ancestor
138163003|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
138163004|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163005|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138163006|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138163007|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163008|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
138163009|NCT05375630|Coagulants|coagulants|mesh-ancestor
138163010|NCT05358535|Propofol|propofol|mesh-list
138163011|NCT05358535|Etomidate|etomidate|mesh-list
138163012|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138163013|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138163015|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138163016|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
138163017|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
138163018|NCT05349188|Melatonin|melatonin|mesh-list
138163019|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
138163020|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163021|NCT05349188|Protective Agents|protective agents|mesh-ancestor
138163022|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163023|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138163024|NCT05307627|Naltrexone|naltrexone|mesh-list
138163025|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138163026|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138163027|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163028|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
138163031|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
138163032|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138163033|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163034|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138163035|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163036|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163038|NCT05268237|Liraglutide|liraglutide|mesh-list
138163039|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138163040|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163041|NCT05268237|Incretins|incretins|mesh-ancestor
138163043|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163044|NCT05177796|Paclitaxel|paclitaxel|mesh-list
138163045|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
138163046|NCT05177796|Carboplatin|carboplatin|mesh-list
138163047|NCT05177796|Doxorubicin|doxorubicin|mesh-list
138163048|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138163049|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
138163050|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138163051|NCT05177796|Daunorubicin|daunorubicin|mesh-list
138163052|NCT05177796|Panitumumab|panitumumab|mesh-list
138163053|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138163054|NCT05177796|Antibodies|antibodies|mesh-list
138163055|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
138163056|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138163057|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138163058|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163059|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138163060|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138163061|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138163062|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163063|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163064|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
138163065|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163066|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163067|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163068|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
138163069|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138163070|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138163072|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163073|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163074|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163077|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163078|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163079|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163080|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163081|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163082|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163083|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
138163084|NCT05077215|Lenvatinib|lenvatinib|mesh-list
138163085|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163086|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163087|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163088|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163089|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163090|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163091|NCT05028829|Atorvastatin|atorvastatin|mesh-list
138163092|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138163093|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138163094|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
138163095|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163097|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138163098|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163100|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138163101|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138163102|NCT04912505|Analgesics|analgesics|mesh-ancestor
138163103|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
138163104|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163105|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163106|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163107|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163108|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138163109|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138163110|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163111|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138163112|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138163113|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163114|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
138163115|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138163116|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
138163117|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138163118|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163124|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163125|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163126|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138163127|NCT04879407|Warfarin|warfarin|mesh-list
138163128|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
138163129|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
138163130|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138163131|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
138163132|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138163133|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163134|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163135|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163136|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
138163137|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138163138|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
138163139|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163140|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
138163141|NCT04839692|Protective Agents|protective agents|mesh-ancestor
138163142|NCT04736420|Warfarin|warfarin|mesh-list
138163143|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
138163144|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
138163145|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138163146|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
138163149|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163150|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163153|NCT04691817|Atezolizumab|atezolizumab|mesh-list
138163154|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163155|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163156|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163157|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163158|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138163159|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163160|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163161|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163162|NCT04641351|Triamcinolone|triamcinolone|mesh-list
138163163|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138163164|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138163165|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138362903|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163166|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163167|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
138163168|NCT04641351|Hormones|hormones|mesh-ancestor
138163169|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163170|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163171|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163172|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
138163173|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163174|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163175|NCT04594811|Nivolumab|nivolumab|mesh-list
138163176|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163177|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163179|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163180|NCT04593056|Warfarin|warfarin|mesh-list
138163181|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
138163182|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
138163183|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138163184|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
138163185|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138163186|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163187|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163188|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163189|NCT04566380|Bevacizumab|bevacizumab|mesh-list
138163190|NCT04566380|Nivolumab|nivolumab|mesh-list
138163191|NCT04566380|Capecitabine|capecitabine|mesh-list
138163192|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
138163193|NCT04566380|Temozolomide|temozolomide|mesh-list
138163194|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163195|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163196|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163197|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163198|NCT04566380|Growth Substances|growth substances|mesh-ancestor
138163199|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163200|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163201|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163202|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
138163203|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163206|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163208|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163209|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
138163210|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
138163211|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163212|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163213|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163214|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
138163215|NCT04561180|Hormones|hormones|mesh-ancestor
138163216|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163217|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163218|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163219|NCT04500665|Colchicine|colchicine|mesh-list
138163220|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
138163221|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163222|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138163223|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138163224|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138163225|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163226|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163227|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138163228|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138163236|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163238|NCT04486625|Avibactam|avibactam|mesh-list
138163239|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163240|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163241|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138163243|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163245|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138163246|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
138163247|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163248|NCT04329728|Dexamethasone|dexamethasone|mesh-list
138163249|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138163250|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163251|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
138163252|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
138163253|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163254|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163255|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163256|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
138163258|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163260|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163261|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138163262|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138163263|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138163264|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163265|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163266|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
138163267|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163268|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138163273|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138163274|NCT04241601|Analgesics|analgesics|mesh-ancestor
138163275|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
138163276|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163277|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163278|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138163279|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138163280|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
138163281|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163282|NCT04200651|Dexamethasone|dexamethasone|mesh-list
138163283|NCT04200651|Prednisolone|prednisolone|mesh-list
138163284|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138163285|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
138163286|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138163287|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
138163288|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138163289|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
138163290|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163291|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
138163292|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
138163295|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163297|NCT04200651|Hormones|hormones|mesh-ancestor
138163298|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163299|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163300|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163301|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138163302|NCT04200651|Protective Agents|protective agents|mesh-ancestor
138163303|NCT04162015|Carboplatin|carboplatin|mesh-list
138163304|NCT04162015|Nivolumab|nivolumab|mesh-list
138163305|NCT04162015|Pemetrexed|pemetrexed|mesh-list
138163306|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163307|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163308|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163309|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163310|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163311|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138163312|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138163313|NCT04150965|Thalidomide|thalidomide|mesh-list
138163314|NCT04150965|Dexamethasone|dexamethasone|mesh-list
138163315|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
138163316|NCT04150965|Pomalidomide|pomalidomide|mesh-list
138163317|NCT04150965|Elotuzumab|elotuzumab|mesh-list
138163318|NCT04150965|Relatlimab|relatlimab|mesh-list
138163319|NCT04150965|BB 1101|bb 1101|mesh-list
138163320|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163321|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
138163322|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
138163323|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163324|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163325|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163326|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
138163327|NCT04150965|Hormones|hormones|mesh-ancestor
138163328|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163329|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163330|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163334|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
138163335|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163336|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163337|NCT04150965|Growth Substances|growth substances|mesh-ancestor
138163338|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163339|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163340|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
138163341|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163342|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163343|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163344|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163346|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138163347|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163348|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163349|NCT04072822|Prednisone|prednisone|mesh-list
138163350|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138163352|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
138163353|NCT04072822|Hormones|hormones|mesh-ancestor
138163354|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163355|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163356|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163357|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163358|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163359|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138163360|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
138163361|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163362|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138163363|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
138163364|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163365|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138163366|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
138163367|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163368|NCT03667846|Topiramate|topiramate|mesh-list
138163369|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
138163370|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138163371|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163372|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
138163373|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163374|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163375|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163376|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163377|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138163378|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
138163379|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163381|NCT03531762|Omeprazole|omeprazole|mesh-list
138163382|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138163383|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163384|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138163385|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163386|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163387|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163388|NCT03464045|Empagliflozin|empagliflozin|mesh-list
138163389|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138163390|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138163391|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163392|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138163393|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163394|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163395|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163396|NCT03462459|Vancomycin|vancomycin|mesh-list
138163397|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163398|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163399|NCT03443869|Acyclovir|acyclovir|mesh-list
138163400|NCT03443869|Valganciclovir|valganciclovir|mesh-list
138163401|NCT03443869|Letermovir|letermovir|mesh-list
138163402|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
138163404|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138163405|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163406|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163407|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163408|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
138163410|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163411|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163412|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163413|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163414|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163415|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163416|NCT03253796|Golimumab|golimumab|mesh-list
138163417|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138163418|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163419|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163420|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
138163421|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163422|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
138163423|NCT03241940|Fludarabine|fludarabine|mesh-list
138163424|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
138163425|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163426|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
138163427|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163428|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163429|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163430|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
138163431|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163432|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163433|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138163434|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163435|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
138163436|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
138163437|NCT03233854|Fludarabine|fludarabine|mesh-list
138163438|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
138163439|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163440|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
138163441|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163442|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163443|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163444|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
138163445|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163446|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163447|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138163448|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163449|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
138163450|NCT03132116|Gentamicins|gentamicins|mesh-list
138163451|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163452|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163453|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138163454|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163457|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163458|NCT02959164|Gemcitabine|gemcitabine|mesh-list
138163460|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163461|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
138163462|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163463|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163464|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163465|NCT02803502|Thrombin|thrombin|mesh-list
138163466|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
138163467|NCT02803502|Coagulants|coagulants|mesh-ancestor
138163468|NCT02763579|Carboplatin|carboplatin|mesh-list
138163469|NCT02763579|Etoposide|etoposide|mesh-list
138163470|NCT02763579|Atezolizumab|atezolizumab|mesh-list
138163471|NCT02763579|Antibodies|antibodies|mesh-list
138163472|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138163473|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
138163474|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163475|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163476|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138163477|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138163478|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163479|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163480|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163481|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163482|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163483|NCT02618577|Edoxaban|edoxaban|mesh-list
138163484|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138163485|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
138163486|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138163487|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163488|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163489|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163490|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
138163491|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
138163492|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138163493|NCT02572791|Mupirocin|mupirocin|mesh-list
138163494|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138163495|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163496|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
138163497|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163498|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163499|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138163500|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163501|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163502|NCT02281084|Azacitidine|azacitidine|mesh-list
138163503|NCT02281084|Durvalumab|durvalumab|mesh-list
138163506|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163508|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163509|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163510|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138163511|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138163512|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163513|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138163514|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163515|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
138163516|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138163517|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
138163518|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138163519|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138163520|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163522|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
138163523|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138163524|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163525|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
138163526|NCT00453193|Pentostatin|pentostatin|mesh-list
138163527|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163528|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163529|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138163530|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163531|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163532|NCT00387023|Rituximab|rituximab|mesh-list
138163533|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163534|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163535|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
138163536|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163537|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163538|NCT00472849|Cytarabine|cytarabine|mesh-list
138163539|NCT00472849|Rituximab|rituximab|mesh-list
138163540|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
138163541|NCT00472849|Fludarabine|fludarabine|mesh-list
138163542|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163545|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163547|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163548|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
138163549|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163550|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163551|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
138163552|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163553|NCT00453895|Sunitinib|sunitinib|mesh-list
138163554|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163555|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163556|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163559|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163560|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163561|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163562|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163563|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
138163564|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138163565|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138163566|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138163567|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163568|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163569|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
138163570|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163571|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163572|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138163573|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163574|NCT00409565|Bevacizumab|bevacizumab|mesh-list
138163576|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163577|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163578|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163579|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163580|NCT00409565|Growth Substances|growth substances|mesh-ancestor
138163581|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163582|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163583|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
138163584|NCT00475501|Finasteride|finasteride|mesh-list
138163585|NCT00475501|Testosterone|testosterone|mesh-list
138163586|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
138163587|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
138163588|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138163589|NCT00475501|Androgens|androgens|mesh-ancestor
138163590|NCT00475501|Hormones|hormones|mesh-ancestor
138163591|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163592|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163593|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163594|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163595|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
138163596|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138163597|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138163598|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163599|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163600|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
138163601|NCT00475501|Urological Agents|urological agents|mesh-ancestor
138163604|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163605|NCT00387335|Sunitinib|sunitinib|mesh-list
138163606|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163607|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163608|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163609|NCT00387335|Growth Substances|growth substances|mesh-ancestor
138163610|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163611|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163612|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163613|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163614|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163615|NCT01797757|Orlistat|orlistat|mesh-list
138163616|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163617|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163619|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138163620|NCT01796899|Brivaracetam|brivaracetam|mesh-list
138163621|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
138163623|NCT00477451|Doxapram|doxapram|mesh-list
138163624|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138163625|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138163626|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163627|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138163628|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366886|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366887|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366888|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138366889|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
138366891|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163629|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138163630|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
138163631|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
138163632|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163633|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163634|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138163635|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
138163636|NCT00530803|Lidocaine|lidocaine|mesh-list
138163637|NCT00530803|Tetracaine|tetracaine|mesh-list
138163638|NCT00530803|Prilocaine|prilocaine|mesh-list
138163639|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138163640|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
138163641|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
138163642|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138163643|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163644|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
138163645|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163646|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138163647|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138163648|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138163649|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163650|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163651|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138163653|NCT04372927|Etoposide|etoposide|mesh-list
138163654|NCT04372927|Pemetrexed|pemetrexed|mesh-list
138163655|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
138163656|NCT04372927|Durvalumab|durvalumab|mesh-list
138163657|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
138163658|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
138163659|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138163660|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
138163661|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163662|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138163663|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138163664|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163665|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163666|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163667|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138163671|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163673|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163674|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
138163675|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
138163676|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
138163677|NCT01381874|Prednisone|prednisone|mesh-list
138163678|NCT01381874|Prednisolone|prednisolone|mesh-list
138163679|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138163680|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
138163681|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138163682|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
138163683|NCT01381874|Exemestane|exemestane|mesh-list
138163684|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
138163685|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138163686|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
138163687|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163688|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
138163689|NCT01381874|Hormones|hormones|mesh-ancestor
138163690|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163691|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163692|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138366892|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138366893|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366894|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138366895|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138366896|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138366897|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366898|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163693|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163694|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
138163695|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
138163696|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163697|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163698|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138163699|NCT01381874|Protective Agents|protective agents|mesh-ancestor
138163700|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138163701|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138163702|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163703|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163704|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138163706|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138163707|NCT01399190|Bevacizumab|bevacizumab|mesh-list
138163708|NCT01399190|Capecitabine|capecitabine|mesh-list
138163709|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
138163710|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163711|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163713|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163714|NCT01399190|Growth Substances|growth substances|mesh-ancestor
138163715|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163716|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163717|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163718|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
138163719|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163720|NCT01381718|Modafinil|modafinil|mesh-list
138163721|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138163722|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163723|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138163724|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138163725|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138163726|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163727|NCT00479089|Dexamethasone|dexamethasone|mesh-list
138163728|NCT00479089|Docetaxel|docetaxel|mesh-list
138163729|NCT00479089|Gefitinib|gefitinib|mesh-list
138163730|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163731|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
138163732|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
138163733|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163734|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163735|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163736|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
138163737|NCT00479089|Hormones|hormones|mesh-ancestor
138163738|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163739|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138163740|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163741|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138163742|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138163743|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138163744|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163745|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163746|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163747|NCT01398956|Levetiracetam|levetiracetam|mesh-list
138163748|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
138163749|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
138163751|NCT00410423|Etoposide|etoposide|mesh-list
138163752|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
138163753|NCT00410423|Bortezomib|bortezomib|mesh-list
138163754|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138163755|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163757|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163758|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163759|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163760|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163761|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
138163762|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
138163763|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163765|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
138163766|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163767|NCT00410423|Analgesics|analgesics|mesh-ancestor
138163768|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
138163769|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163770|NCT00387959|Cyclosporine|cyclosporine|mesh-list
138163771|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
138163772|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
138163774|NCT00387959|Fludarabine|fludarabine|mesh-list
138163775|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
138163776|NCT00387959|Cyclosporins|cyclosporins|mesh-list
138163777|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163778|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
138163779|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163780|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163781|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163782|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
138163783|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163784|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163785|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138163786|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163787|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138163788|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
138163789|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163790|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
138163791|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163792|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
138163793|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138163794|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138163795|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138163796|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
138163797|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163799|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163800|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163801|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138163802|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138163803|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138163804|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138163805|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163806|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163807|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163809|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138163810|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163811|NCT01381016|Hormones|hormones|mesh-list
138163812|NCT01381016|Estradiol|estradiol|mesh-list
138163813|NCT01381016|Progesterone|progesterone|mesh-list
138163814|NCT01381016|Estrogens|estrogens|mesh-list
138163815|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138163816|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163817|NCT01381016|Progestins|progestins|mesh-ancestor
138163818|NCT00412451|Plasminogen|plasminogen|mesh-list
138163820|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138163821|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163822|NCT01398410|Rabeprazole|rabeprazole|mesh-list
138163823|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138163824|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163825|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138163826|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163827|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163828|NCT00412529|Entecavir|entecavir|mesh-list
138163829|NCT00412529|Telbivudine|telbivudine|mesh-list
138163830|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
138163831|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163832|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138163833|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163834|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163835|NCT00412841|Atorvastatin|atorvastatin|mesh-list
138163836|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138163837|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138163838|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
138163839|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163840|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138163841|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138163842|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163843|NCT01796483|Clonidine|clonidine|mesh-list
138163844|NCT01796483|Analgesics|analgesics|mesh-ancestor
138163845|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
138163846|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163847|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163848|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138163850|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
138163851|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138163852|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138163853|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138163854|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
138163855|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163856|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163858|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138163859|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
138163860|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138163861|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138163862|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138163863|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163864|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163865|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
138163866|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163867|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163868|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138163869|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138163870|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163871|NCT01380782|Nintedanib|nintedanib|mesh-list
138163872|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163873|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163874|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163875|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163876|NCT00534001|Bupropion|bupropion|mesh-list
138163877|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138163878|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
138163879|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138163880|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138163881|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138163882|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163883|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163884|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
138163885|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138163888|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138163889|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163893|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138163894|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
138163895|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163896|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138163897|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138163898|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163899|NCT00455975|Bevacizumab|bevacizumab|mesh-list
138163900|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163901|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163902|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163903|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163904|NCT00455975|Growth Substances|growth substances|mesh-ancestor
138163905|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163906|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163907|NCT05366192|Ritonavir|ritonavir|mesh-list
138163908|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
138163909|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138163910|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138163911|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
138163912|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163913|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163914|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138163915|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138163916|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
138163917|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138163918|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138163919|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138163920|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
138163921|NCT04013672|Sargramostim|sargramostim|mesh-list
138163922|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138163923|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163924|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163926|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163928|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163929|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138163930|NCT02078882|Abatacept|abatacept|mesh-list
138163931|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138163932|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163933|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163934|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163935|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163936|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
138163937|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163938|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163939|NCT00458237|Trastuzumab|trastuzumab|mesh-list
138163940|NCT00458237|Everolimus|everolimus|mesh-list
138163941|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163942|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163943|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138163944|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163945|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163946|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163947|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163948|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
138163949|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163950|NCT00418457|Anesthetics|anesthetics|mesh-list
138163951|NCT00418457|Propofol|propofol|mesh-list
138163952|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138163953|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163954|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138163955|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138163956|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
138163957|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
138163960|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138163961|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
138163962|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138163963|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138163964|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138163965|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
138163966|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163967|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163968|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138163969|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138163970|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138163971|NCT00482911|Growth Substances|growth substances|mesh-ancestor
138163972|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138163973|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138163974|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163975|NCT01397162|Fluticasone|fluticasone|mesh-list
138163976|NCT01397162|Xhance|xhance|mesh-list
138163977|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138163978|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138163987|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138163988|NCT01397084|Esomeprazole|esomeprazole|mesh-list
138163989|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138163990|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138163991|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138163992|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163993|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138163995|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138163996|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
138163997|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138163998|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163999|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164000|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138164001|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138164003|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164004|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138164005|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138164006|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138164008|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164009|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
138164010|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164011|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164012|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
138164013|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164014|NCT00485485|Docetaxel|docetaxel|mesh-list
138164015|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
138164016|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164017|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
138164018|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
138164019|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164020|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164021|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138164022|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164023|NCT00422201|Mifepristone|mifepristone|mesh-list
138164024|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138164025|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
138164028|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138164029|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138164030|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138164031|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
138164032|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138164033|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138164035|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164036|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
138164037|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138164038|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138164039|NCT01396148|Sunitinib|sunitinib|mesh-list
138164040|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164041|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164042|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164043|NCT01396148|Growth Substances|growth substances|mesh-ancestor
138164044|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164045|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138164046|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138164047|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164048|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164049|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
138164050|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138164051|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164052|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164053|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164054|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164055|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164056|NCT00486031|Balsalazide|balsalazide|mesh-list
138164057|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138164058|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164059|NCT00486031|Analgesics|analgesics|mesh-ancestor
138164060|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
138164061|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164062|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164063|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164064|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164065|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164066|NCT04019834|Bupivacaine|bupivacaine|mesh-list
138164067|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164068|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
138164069|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164070|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164071|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
138164074|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138164075|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164076|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164077|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164078|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
138164079|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164084|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
138164085|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
138164086|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164087|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
138164088|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138164089|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164090|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164091|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164092|NCT02108171|Analgesics|analgesics|mesh-ancestor
138164093|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
138164094|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164095|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138164096|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138363007|NCT04278846|Bupivacaine|bupivacaine|mesh-list
138164097|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164098|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164099|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164100|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164101|NCT03940807|Estradiol|estradiol|mesh-list
138164102|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138164103|NCT03940807|Estrogens|estrogens|mesh-ancestor
138164104|NCT03940807|Hormones|hormones|mesh-ancestor
138164105|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164106|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164107|NCT00535873|Lenalidomide|lenalidomide|mesh-list
138164108|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
138164109|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164110|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164111|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164112|NCT00535873|Growth Substances|growth substances|mesh-ancestor
138164114|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164115|NCT00487669|Paclitaxel|paclitaxel|mesh-list
138164116|NCT00487669|Pemetrexed|pemetrexed|mesh-list
138164117|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138164118|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164119|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164120|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138164121|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138164122|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164123|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164124|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164125|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138164126|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138164128|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
138164129|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
138164130|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138164131|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138164132|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164133|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138164134|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138164135|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
138164136|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164137|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164138|NCT00536341|Rituximab|rituximab|mesh-list
138164139|NCT00536341|Fludarabine|fludarabine|mesh-list
138164140|NCT00536341|Lenalidomide|lenalidomide|mesh-list
138164141|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164142|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164143|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
138164144|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164145|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164146|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164147|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164148|NCT00536341|Growth Substances|growth substances|mesh-ancestor
138164149|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
138164150|NCT02122471|Plecanatide|plecanatide|mesh-list
138164151|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138164152|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
138164153|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164154|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164155|NCT00461591|Apaziquone|apaziquone|mesh-list
138164156|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164157|NCT00423683|PENTA|penta|mesh-list
138164158|NCT00423683|Fondaparinux|fondaparinux|mesh-list
138164159|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138164160|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
138164161|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138164162|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138164163|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164164|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164165|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
138164167|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138164169|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
138164170|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
138164172|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
138164173|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164174|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164175|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164177|NCT00425477|Sargramostim|sargramostim|mesh-list
138164178|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
138164179|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164180|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164181|NCT00427037|Vitamin D|vitamin d|mesh-list
138164182|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
138164183|NCT00427037|Vitamins|vitamins|mesh-ancestor
138164184|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
138164185|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164186|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164187|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164188|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
138164189|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138164190|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164191|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138164192|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164193|NCT00427661|Cyclosporine|cyclosporine|mesh-list
138164194|NCT00427661|Fludarabine|fludarabine|mesh-list
138164195|NCT00427661|Busulfan|busulfan|mesh-list
138164196|NCT00427661|Cyclosporins|cyclosporins|mesh-list
138164197|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164198|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164199|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138164200|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
138164201|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164202|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164203|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
138164205|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164206|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164207|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138164208|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
138164209|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138164210|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138164211|NCT00427973|Cediranib|cediranib|mesh-list
138164212|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164213|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164214|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164215|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138164216|NCT01795703|Prednisolone|prednisolone|mesh-list
138164217|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164218|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
138164219|NCT01795703|Hormones|hormones|mesh-ancestor
138366915|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138366916|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366917|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366918|NCT05086692|Analgesics|analgesics|mesh-ancestor
138366919|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
138366920|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366921|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164220|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164221|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164222|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164223|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164224|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
138164225|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
138164226|NCT00429143|Tacrolimus|tacrolimus|mesh-list
138164227|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138164229|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164230|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164231|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138164232|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
138164233|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164234|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164235|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138164236|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138164237|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164238|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138164239|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138164240|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
138164242|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164243|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
138164244|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138164245|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138164246|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138164247|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164248|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164249|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
138164250|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164251|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164252|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138164253|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164254|NCT00433745|Vaccines|vaccines|mesh-list
138164255|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
138164256|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164257|NCT01395758|Gemcitabine|gemcitabine|mesh-list
138164258|NCT01395758|Docetaxel|docetaxel|mesh-list
138164259|NCT01395758|Pemetrexed|pemetrexed|mesh-list
138164260|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138164263|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164264|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164265|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138164266|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138164267|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164268|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164269|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138164270|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138164271|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138164273|NCT00462605|Sargramostim|sargramostim|mesh-list
138164274|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138164275|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
138164276|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164277|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164278|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164279|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164280|NCT02120287|Bevacizumab|bevacizumab|mesh-list
138164281|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164282|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164283|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164284|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164285|NCT02120287|Growth Substances|growth substances|mesh-ancestor
138164286|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164287|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
138164288|NCT00534833|Vaccines|vaccines|mesh-list
138164289|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
138164290|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164291|NCT00434993|Albuterol|albuterol|mesh-list
138164292|NCT00434993|Dimercaprol|dimercaprol|mesh-list
138164293|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138164294|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
138164295|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164297|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138164298|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
138164299|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
138164300|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138164302|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138164303|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164304|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164305|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164306|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164307|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
138164308|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
138164309|NCT01395524|Naloxegol|naloxegol|mesh-list
138164310|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138164311|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363019|NCT03839160|Morphine|morphine|mesh-list
138164312|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
138164313|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164314|NCT04338698|Azithromycin|azithromycin|mesh-list
138164315|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
138164316|NCT04338698|Oseltamivir|oseltamivir|mesh-list
138164317|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138164318|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164320|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138164321|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138164322|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164323|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164324|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164325|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
138164326|NCT00435539|Plasminogen|plasminogen|mesh-list
138164327|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
138164328|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138164329|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138164330|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164331|NCT00464711|Escitalopram|escitalopram|mesh-list
138164332|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138164334|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164335|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164336|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164337|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
138164338|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164340|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138164341|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
138164342|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138164343|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138164344|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138164345|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164346|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164347|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
138164348|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164349|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164350|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138164351|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138164352|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164353|NCT00535613|Propofol|propofol|mesh-list
138164354|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138164355|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164356|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164357|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138164359|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
138164360|NCT00466661|Acamprosate|acamprosate|mesh-list
138164361|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138164362|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138164363|NCT05360576|Etonogestrel|etonogestrel|mesh-list
138164364|NCT05360576|NuvaRing|nuvaring|mesh-list
138164365|NCT05360576|Estradiol|estradiol|mesh-list
138164366|NCT05360576|Estrogens|estrogens|mesh-ancestor
138164367|NCT05360576|Hormones|hormones|mesh-ancestor
138164368|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164369|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164370|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138164371|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
138164372|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138164374|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138164376|NCT00535925|Aspirin|aspirin|mesh-list
138164377|NCT00535925|Atenolol|atenolol|mesh-list
138164378|NCT00535925|Amlodipine|amlodipine|mesh-list
138164379|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138164380|NCT00535925|Clonidine|clonidine|mesh-list
138164381|NCT00535925|Ramipril|ramipril|mesh-list
138164382|NCT00535925|Irbesartan|irbesartan|mesh-list
138164383|NCT00535925|Doxazosin|doxazosin|mesh-list
138164385|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
138164386|NCT00535925|Simvastatin|simvastatin|mesh-list
138164387|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164388|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138164389|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164390|NCT00535925|Analgesics|analgesics|mesh-ancestor
138164391|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
138164392|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164393|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164394|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164395|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138164396|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138164397|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164398|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138164401|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
138164402|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138164403|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138164404|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164405|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164406|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
138164407|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138164408|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138164409|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
138164410|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138164411|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138164412|NCT00535925|Diuretics|diuretics|mesh-ancestor
138164413|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
138164414|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138164415|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138164416|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
138164417|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
138164418|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138164419|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138164420|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164421|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164422|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164424|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138164425|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
138164426|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138164427|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138164428|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138164429|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138164430|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138164431|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138164432|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138164433|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138164434|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138164435|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138164436|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164437|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164438|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164439|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164441|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138164442|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138164443|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164444|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164445|NCT01796093|Protective Agents|protective agents|mesh-ancestor
138363036|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
138164447|NCT00537511|Etoposide|etoposide|mesh-list
138164448|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
138164449|NCT00537511|Pomalidomide|pomalidomide|mesh-list
138164450|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164451|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164452|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164453|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138164454|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164455|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164456|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
138164457|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164458|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164459|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164460|NCT00537511|Growth Substances|growth substances|mesh-ancestor
138164461|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138164462|NCT00435929|Ritonavir|ritonavir|mesh-list
138164463|NCT00435929|Saquinavir|saquinavir|mesh-list
138164464|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138164465|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138164466|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
138164467|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164468|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164469|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138164470|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138164471|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
138164472|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164474|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138164475|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
138164476|NCT00436475|Vitamin D|vitamin d|mesh-list
138164477|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
138164478|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
138164479|NCT00436475|Vitamins|vitamins|mesh-list
138164480|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
138164481|NCT00436475|Calcium|calcium|mesh-list
138164482|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
138164483|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164484|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164485|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164486|NCT00436475|Antacids|antacids|mesh-ancestor
138164487|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164488|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164490|NCT00210626|Hematinics|hematinics|mesh-ancestor
138164491|NCT03595514|Dexamethasone|dexamethasone|mesh-list
138164492|NCT03595514|Lidocaine|lidocaine|mesh-list
138164493|NCT03595514|Epinephrine|epinephrine|mesh-list
138164494|NCT03595514|Bupivacaine|bupivacaine|mesh-list
138164495|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164496|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
138164497|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
138164498|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164499|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164500|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164501|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
138164502|NCT03595514|Hormones|hormones|mesh-ancestor
138164503|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164504|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164505|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164506|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164507|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
138164508|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164509|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
138164510|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138164511|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138164512|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138164513|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164514|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164515|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138164516|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164517|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164518|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164519|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138164520|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138164521|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138164522|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
138164523|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
138164524|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
138164525|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138164526|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
138164527|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
138164528|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164529|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
138164530|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164531|NCT03595046|Dexamethasone|dexamethasone|mesh-list
138164532|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
138164533|NCT03595046|Ropivacaine|ropivacaine|mesh-list
138164535|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164536|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
138164537|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
138164538|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164539|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164540|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164541|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
138164542|NCT03595046|Hormones|hormones|mesh-ancestor
138164543|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164544|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164545|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164546|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
138164547|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164548|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164549|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164550|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
138164551|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164552|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
138164553|NCT00217022|Budesonide|budesonide|mesh-list
138164554|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164555|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138164556|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
138363113|NCT05440578|Bevacizumab|bevacizumab|mesh-list
138164557|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164558|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164559|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138164560|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
138164561|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
138164563|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164566|NCT03594968|Hormones|hormones|mesh-ancestor
138164567|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164568|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164570|NCT00538915|Antibodies|antibodies|mesh-list
138164571|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
138164572|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138164573|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138164574|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
138164575|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164579|NCT00490009|Promethazine|promethazine|mesh-list
138164580|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
138164581|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
138164582|NCT00490009|Lugol's solution|lugol's solution|mesh-list
138164583|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138164584|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164586|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
138164587|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164588|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363435|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138164589|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
138164590|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138164591|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164593|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
138164594|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138164595|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138363573|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138164596|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164597|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164598|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
138164599|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
138164600|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
138164601|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164602|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138164603|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
138164604|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
138164606|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363790|NCT03786783|Etoposide|etoposide|mesh-list
138164607|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138164608|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
138164609|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164610|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164611|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
138164612|NCT00490009|Coagulants|coagulants|mesh-ancestor
138164613|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
138164614|NCT03769532|Azacitidine|azacitidine|mesh-list
138366932|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366933|NCT05020821|Analgesics|analgesics|mesh-ancestor
138164615|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164616|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363945|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
138164617|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138164618|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164619|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138164620|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
138164621|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164622|NCT00490477|Polymyxins|polymyxins|mesh-list
138164623|NCT00490477|Polymyxin B|polymyxin b|mesh-list
138164624|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364079|NCT01763671|Paclitaxel|paclitaxel|mesh-list
138164625|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164627|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
138164628|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138164635|NCT00492973|Bupivacaine|bupivacaine|mesh-list
138164636|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138164637|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
138164638|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164639|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
138164640|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164641|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164642|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
138164643|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164644|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138164645|NCT00492973|Narcotics|narcotics|mesh-ancestor
138164646|NCT00492973|Analgesics|analgesics|mesh-ancestor
138164647|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164648|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
138164649|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
138164650|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164651|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
138164652|NCT00492973|Hormones|hormones|mesh-ancestor
138164653|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164654|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138164655|NCT00492973|Protective Agents|protective agents|mesh-ancestor
138164656|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164657|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164658|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138164659|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164660|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344287|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138164662|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164663|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138164664|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138164665|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138164666|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
138164669|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138164670|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138164671|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
138164672|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138164673|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364714|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164676|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138164677|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164679|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164680|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164681|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138164682|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138164683|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164684|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364931|NCT01389271|Iloprost|iloprost|mesh-list
138164686|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366939|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
138366940|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366941|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366942|NCT05010772|Decitabine|decitabine|mesh-list
138366943|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138366945|NCT05010772|Ivosidenib|ivosidenib|mesh-list
138164687|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164689|NCT00539695|Interleukin-2|interleukin-2|mesh-list
138164690|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365007|NCT01389544|Ritonavir|ritonavir|mesh-list
138164691|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164692|NCT00539695|Analgesics|analgesics|mesh-ancestor
138164693|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
138164694|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164695|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164696|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138365151|NCT01390337|Cytarabine|cytarabine|mesh-list
138164697|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138164699|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164700|NCT03593954|Ritonavir|ritonavir|mesh-list
138164704|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164705|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164706|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138164707|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138164709|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164710|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138164711|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138164713|NCT03590210|Trabectedin|trabectedin|mesh-list
138164714|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164715|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164716|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138365425|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
138164717|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164718|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138164719|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
138164720|NCT05632328|Paclitaxel|paclitaxel|mesh-list
138164721|NCT05632328|Gemcitabine|gemcitabine|mesh-list
138164722|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138164723|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164724|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164725|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
138164726|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
138164727|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
138164728|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164731|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
138164732|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164733|NCT03599726|Donepezil|donepezil|mesh-list
138164734|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138164735|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164736|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164737|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
138164738|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164739|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164740|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
138164741|NCT00466817|Valganciclovir|valganciclovir|mesh-list
138164742|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
138164743|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164744|NCT04406870|Sirolimus|sirolimus|mesh-list
138365782|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138164745|NCT04406870|Propranolol|propranolol|mesh-list
138164746|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138164747|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164748|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138164749|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164750|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
138164751|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138164752|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
138164753|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164754|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164755|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138164756|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138164758|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164759|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138164760|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138164761|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138164762|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138164763|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
138164765|NCT03985514|Piperacillin|piperacillin|mesh-list
138164766|NCT03985514|Metronidazole|metronidazole|mesh-list
138164767|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138164768|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138164769|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164771|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164772|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138164773|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164774|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164775|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164776|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138164777|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138164778|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138164779|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138164780|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138164781|NCT00540007|Lenalidomide|lenalidomide|mesh-list
138164782|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
138164783|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164784|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164785|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164786|NCT00540007|Growth Substances|growth substances|mesh-ancestor
138164787|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
138164788|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164789|NCT02982889|Bupivacaine|bupivacaine|mesh-list
138164790|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
138164791|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138164792|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
138164793|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164794|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164795|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
138164796|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164800|NCT02982889|Protective Agents|protective agents|mesh-ancestor
138164801|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138164802|NCT03592082|Bismuth|bismuth|mesh-list
138164803|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138164804|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164805|NCT03592082|Antacids|antacids|mesh-ancestor
138164806|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164807|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164808|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
138164809|NCT03598868|Vortioxetine|vortioxetine|mesh-list
138164810|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
138164811|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138164812|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138164813|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138164814|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164815|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164816|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138164817|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138164818|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138164819|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164820|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164821|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
138164822|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138164823|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138164824|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138164825|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138164826|NCT00501631|Naltrexone|naltrexone|mesh-list
138366968|NCT04983901|Meropenem|meropenem|mesh-list
138366969|NCT04983901|Tazobactam|tazobactam|mesh-list
138366970|NCT04983901|Linezolid|linezolid|mesh-list
138366971|NCT04983901|Piperacillin|piperacillin|mesh-list
138366972|NCT04983901|Daptomycin|daptomycin|mesh-list
138366973|NCT04983901|Imipenem|imipenem|mesh-list
138366974|NCT04983901|Cefepime|cefepime|mesh-list
138164827|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138164828|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138164829|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164830|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
138164831|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164832|NCT05631704|Midazolam|midazolam|mesh-list
138164833|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138164834|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138164835|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164836|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164837|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138164838|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138164839|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138164840|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138164842|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
138164843|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
138164844|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
138164845|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164846|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164847|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
138164848|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138164849|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164850|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164851|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138164852|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138164853|NCT03591536|Protective Agents|protective agents|mesh-ancestor
138164854|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164855|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
138164856|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138164857|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
138164858|NCT00501943|Interferons|interferons|mesh-list
138164859|NCT00501943|Interferon-beta|interferon-beta|mesh-list
138164860|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
138164861|NCT00501943|Riluzole|riluzole|mesh-list
138164862|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164863|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
138164864|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164865|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
138164866|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164867|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138164868|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
138164869|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138164870|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138365844|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
138164872|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164874|NCT00501943|Protective Agents|protective agents|mesh-ancestor
138164875|NCT03598634|Riboflavin|riboflavin|mesh-list
138164876|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
138164877|NCT03598634|Vitamins|vitamins|mesh-ancestor
138164878|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
138164879|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164880|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138164881|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164882|NCT03598556|Vitamin D|vitamin d|mesh-list
138164883|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
138164884|NCT03598556|Vitamins|vitamins|mesh-ancestor
138164885|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
138164886|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164887|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164888|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138164889|NCT03024476|Olmesartan|olmesartan|mesh-list
138164890|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138164891|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138164893|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164894|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
138164895|NCT03590912|Cetirizine|cetirizine|mesh-list
138164896|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138164897|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
138164898|NCT03590912|Prednisolone|prednisolone|mesh-list
138164899|NCT03590912|Phenylephrine|phenylephrine|mesh-list
138164900|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
138164901|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
138164902|NCT03590912|Levocetirizine|levocetirizine|mesh-list
138164903|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
138164904|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138164905|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164906|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164907|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
138164908|NCT03590912|Hormones|hormones|mesh-ancestor
138164909|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164910|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164911|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164912|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164913|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
138164914|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164915|NCT03590912|Protective Agents|protective agents|mesh-ancestor
138164916|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138164917|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138164918|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138164919|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
138164920|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164921|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164922|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138164923|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164924|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
138164925|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
138164926|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138164927|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
138164928|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138164929|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
138164930|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138164931|NCT00503113|Alendronate|alendronate|mesh-list
138164932|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
138164933|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138164934|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164936|NCT00542971|Sorafenib|sorafenib|mesh-list
138164937|NCT00542971|Idarubicin|idarubicin|mesh-list
138365858|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
138164938|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138164939|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
138164941|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164942|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
138164943|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164944|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138164945|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
138164946|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164947|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138164948|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164949|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138164950|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164951|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138164953|NCT00504751|Rituximab|rituximab|mesh-list
138164954|NCT00504751|Etoposide|etoposide|mesh-list
138164955|NCT00504751|Bortezomib|bortezomib|mesh-list
138164956|NCT00504751|Ifosfamide|ifosfamide|mesh-list
138164957|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138164958|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
138164959|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
138164960|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138164961|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164962|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138164963|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
138164964|NCT00504751|Hormones|hormones|mesh-ancestor
138164965|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138164966|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138164967|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164968|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164969|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
138164970|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138164971|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164972|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164973|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138164974|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164975|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164976|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138164977|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
138164978|NCT01013779|Carboplatin|carboplatin|mesh-list
138164980|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164981|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138164982|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138164983|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138164984|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138164985|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164987|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
138164988|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164989|NCT00506155|Bevacizumab|bevacizumab|mesh-list
138164990|NCT00506155|Cisplatin|cisplatin|mesh-list
138164991|NCT00506155|Doxorubicin|doxorubicin|mesh-list
138164992|NCT00506155|Methotrexate|methotrexate|mesh-list
138164993|NCT00506155|Vinblastine|vinblastine|mesh-list
138164994|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138164995|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164996|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138164997|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138164998|NCT00506155|Growth Substances|growth substances|mesh-ancestor
138164999|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165000|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
138165001|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165002|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138165003|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165004|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165005|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165006|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138165007|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
138165008|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165009|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165010|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
138165011|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
138165012|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138165013|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165014|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
138165015|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165016|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165017|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165018|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165019|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165020|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165021|NCT03590444|Ranibizumab|ranibizumab|mesh-list
138165022|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138165023|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138165025|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165027|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165029|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
138165031|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165032|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165033|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
138165034|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165035|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165036|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
138165037|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165038|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
138165039|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138165040|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138165045|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165046|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165047|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165048|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165050|NCT03597308|Ibuprofen|ibuprofen|mesh-list
138165051|NCT03597308|Oxycodone|oxycodone|mesh-list
138165052|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165053|NCT03597308|Analgesics|analgesics|mesh-ancestor
138165054|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
138165055|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165056|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165057|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
138165058|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138165059|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165060|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165061|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138165062|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165063|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165064|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138165065|NCT03597308|Narcotics|narcotics|mesh-ancestor
138165066|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165067|NCT04750135|Metformin|metformin|mesh-list
138365870|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
138165068|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138165069|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165070|NCT04003922|Adalimumab|adalimumab|mesh-list
138165071|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138165072|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165073|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165074|NCT00558571|Empagliflozin|empagliflozin|mesh-list
138165075|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138165076|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165077|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138165078|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165079|NCT03970382|Aldesleukin|aldesleukin|mesh-list
138165080|NCT03970382|Nivolumab|nivolumab|mesh-list
138165081|NCT03970382|Interleukin-2|interleukin-2|mesh-list
138165082|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165083|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165084|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138165085|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165086|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165087|NCT03970382|Analgesics|analgesics|mesh-ancestor
138165091|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138165092|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138165093|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
138165094|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165095|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138165096|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138165097|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165098|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
138165100|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165102|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165103|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165104|NCT03596294|Rifampin|rifampin|mesh-list
138165105|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138165106|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
138165107|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165108|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165109|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
138165110|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138165111|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165112|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165113|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138165114|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138165115|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138165116|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138165117|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138165118|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138165119|NCT00537407|Ribavirin|ribavirin|mesh-list
138165120|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138165121|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
138165122|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165123|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
138165124|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165125|NCT00214916|Insulin|insulin|mesh-list
138165126|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138165127|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138165128|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165129|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138165130|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138165132|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138165133|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165134|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165135|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165136|NCT00438971|Analgesics|analgesics|mesh-ancestor
138365875|NCT01394757|Ketamine|ketamine|mesh-list
138165137|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
138165138|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165139|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
138165140|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165141|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
138165143|NCT00219284|Carbidopa|carbidopa|mesh-list
138165144|NCT00219284|Entacapone|entacapone|mesh-list
138165145|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138165146|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138165147|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138165148|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
138165149|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165150|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165151|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165152|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138165153|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165154|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138165155|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138165156|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
138165157|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
138165158|NCT00509041|Dasatinib|dasatinib|mesh-list
138165159|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165160|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138165161|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165162|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165163|NCT00439673|Azacitidine|azacitidine|mesh-list
138165164|NCT00439673|Valproic Acid|valproic acid|mesh-list
138165165|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165166|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
138165167|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165168|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165169|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165170|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
138165171|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
138165172|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165173|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165177|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165179|NCT03596060|Morphine|morphine|mesh-list
138165180|NCT03596060|Propofol|propofol|mesh-list
138165181|NCT03596060|Rocuronium|rocuronium|mesh-list
138165182|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138165183|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165184|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165186|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
138165187|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
138165188|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138165189|NCT03596060|Narcotics|narcotics|mesh-ancestor
138165190|NCT03596060|Analgesics|analgesics|mesh-ancestor
138165191|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
138165192|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165193|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138165194|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138165198|NCT00473837|Amebicides|amebicides|mesh-ancestor
138165199|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138165200|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138165201|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165202|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
138165203|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165204|NCT00509197|Fluticasone|fluticasone|mesh-list
138165205|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165206|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138165207|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
138165208|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165209|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165210|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138165211|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365892|NCT01394770|Amlodipine|amlodipine|mesh-list
138165214|NCT00442013|Lansoprazole|lansoprazole|mesh-list
138165215|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
138165216|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138165217|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138366976|NCT04983901|Relebactam|relebactam|mesh-list
138165218|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138165219|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165220|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165221|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
138165222|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138165224|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165225|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165226|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138165227|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138165228|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138165229|NCT00509665|Gemcitabine|gemcitabine|mesh-list
138165230|NCT00509665|Doxorubicin|doxorubicin|mesh-list
138165231|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138165232|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165233|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
138165234|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165235|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165236|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165237|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138165238|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165239|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165240|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
138165241|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138165243|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138165244|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165245|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
138165246|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138165247|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165248|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138165249|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165250|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165251|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138165252|NCT00216476|Risperidone|risperidone|mesh-list
138165253|NCT00216476|Aripiprazole|aripiprazole|mesh-list
138165254|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138165255|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138165256|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
138165257|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165258|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165259|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165260|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138165261|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138165262|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165263|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165264|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138165265|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
138165266|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
138165267|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
138165269|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138165270|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138165271|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138165272|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138165273|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
138165274|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138165275|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138165276|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138165277|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138165278|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165279|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
138165281|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165282|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138366993|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366994|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
138366998|NCT04920708|Palbociclib|palbociclib|mesh-list
138165283|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165284|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138165287|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165288|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
138165289|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165290|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165291|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138165292|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165293|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165294|NCT00474851|Norethindrone|norethindrone|mesh-list
138165295|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
138165296|NCT00474851|Estrogens|estrogens|mesh-list
138165297|NCT00474851|Hormones|hormones|mesh-ancestor
138165298|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165299|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165300|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138165301|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138165302|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138165303|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
138165304|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138165305|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138165306|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138165307|NCT00215150|Ziprasidone|ziprasidone|mesh-list
138165308|NCT00215150|Sertraline|sertraline|mesh-list
138165309|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
138165310|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165311|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138165312|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138165313|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138165315|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165316|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
138165317|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165318|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138165319|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138165320|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138165321|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165322|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138165323|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
138165324|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138165325|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165329|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138165330|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
138165331|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138165332|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
138165333|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165334|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165335|NCT03023852|Oseltamivir|oseltamivir|mesh-list
138165336|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
138165337|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165338|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165339|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165340|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
138165341|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138165342|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165343|NCT00516217|Galiximab|galiximab|mesh-list
138165344|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165345|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165346|NCT04001504|Vaccines|vaccines|mesh-list
138165347|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
138165348|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165349|NCT00516919|Orlistat|orlistat|mesh-list
138165350|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165351|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165353|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138165354|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138367005|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367006|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367007|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138367008|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165355|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165356|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138165357|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165358|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165359|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138165360|NCT04195100|Pilocarpine|pilocarpine|mesh-list
138165361|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138165362|NCT04195100|Miotics|miotics|mesh-ancestor
138165363|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
138165364|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165365|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165366|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138165367|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138165368|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138165369|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165370|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165371|NCT06069453|Hyaluronic Acid|hyaluronic acid|mesh-list
138165372|NCT06069453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138165373|NCT06069453|Immunologic Factors|immunologic factors|mesh-ancestor
138165374|NCT06069453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165375|NCT06069453|Viscosupplements|viscosupplements|mesh-ancestor
138165376|NCT06069453|Protective Agents|protective agents|mesh-ancestor
138165377|NCT06069219|Sufentanil|sufentanil|mesh-list
138165379|NCT06069219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138165380|NCT06069219|Narcotics|narcotics|mesh-ancestor
138165381|NCT06069219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165382|NCT06069219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165383|NCT06069219|Analgesics|analgesics|mesh-ancestor
138165384|NCT06069219|Sensory System Agents|sensory system agents|mesh-ancestor
138165385|NCT06069219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165386|NCT06069219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138165387|NCT06069219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138165388|NCT06069219|Anesthetics, General|anesthetics, general|mesh-ancestor
138165389|NCT06069219|Anesthetics|anesthetics|mesh-ancestor
138165390|NCT06069141|Doxycycline|doxycycline|mesh-list
138165391|NCT06069141|Penicillins|penicillins|mesh-list
138165392|NCT06069141|Penicillin G|penicillin g|mesh-list
138165393|NCT06069141|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138165394|NCT06069141|Penicillin G Procaine|penicillin g procaine|mesh-list
138165395|NCT06069141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165396|NCT06069141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165397|NCT06069141|Antimalarials|antimalarials|mesh-ancestor
138165398|NCT06069141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138165399|NCT06069141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138165400|NCT06068829|Rituximab|rituximab|mesh-list
138165401|NCT06068829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165402|NCT06068829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165403|NCT06068829|Immunologic Factors|immunologic factors|mesh-ancestor
138165404|NCT06068829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165405|NCT06068829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165406|NCT06068686|Glimepiride|glimepiride|mesh-list
138165407|NCT06068686|Vildagliptin|vildagliptin|mesh-list
138165408|NCT06068686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138165409|NCT06068686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138165411|NCT06068686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165412|NCT06068686|Immunologic Factors|immunologic factors|mesh-ancestor
138165413|NCT06068686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138165414|NCT06068686|Protease Inhibitors|protease inhibitors|mesh-ancestor
138165419|NCT06068621|Venetoclax|venetoclax|mesh-list
138165420|NCT06068621|Aclacinomycins|aclacinomycins|mesh-list
138165421|NCT06068621|Lenograstim|lenograstim|mesh-list
138165422|NCT06068621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367009|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367010|NCT04732065|Dopamine|dopamine|mesh-list
138367011|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138367012|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
138367013|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
138367016|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
138165423|NCT06068621|Antimetabolites|antimetabolites|mesh-ancestor
138165424|NCT06068621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165425|NCT06068621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165426|NCT06068621|Antiviral Agents|antiviral agents|mesh-ancestor
138165427|NCT06068621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165428|NCT06068621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165429|NCT06068621|Immunologic Factors|immunologic factors|mesh-ancestor
138165430|NCT06068621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165431|NCT06068621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165432|NCT06068621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138165433|NCT06068621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165434|NCT06068465|Pimavanserin|pimavanserin|mesh-list
138165435|NCT06068465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138165436|NCT06068465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138165437|NCT06068465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138165438|NCT06068465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138165439|NCT06068465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165440|NCT06068465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165441|NCT06068465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165442|NCT06068465|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138165443|NCT06068465|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138165444|NCT06068465|Serotonin Agents|serotonin agents|mesh-ancestor
138165445|NCT06068465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165446|NCT06068465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165448|NCT06068439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138165449|NCT06068439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165450|NCT06068439|Analgesics|analgesics|mesh-ancestor
138165451|NCT06068439|Sensory System Agents|sensory system agents|mesh-ancestor
138165452|NCT06068439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165453|NCT06068439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165454|NCT06068439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165455|NCT06068439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138165457|NCT06068439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138165458|NCT06068439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165459|NCT06068439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138165460|NCT06068439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138165461|NCT06068439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165462|NCT06068439|Antipyretics|antipyretics|mesh-ancestor
138165463|NCT06068179|Mycophenolic Acid|mycophenolic acid|mesh-list
138165464|NCT06068179|Methimazole|methimazole|mesh-list
138165465|NCT06068179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138165466|NCT06068179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165467|NCT06068179|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138165468|NCT06068179|Antitubercular Agents|antitubercular agents|mesh-ancestor
138165469|NCT06068179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138165470|NCT06068179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165471|NCT06068179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165472|NCT06068179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165473|NCT06068179|Antithyroid Agents|antithyroid agents|mesh-ancestor
138165474|NCT06068179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138165475|NCT06068179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165476|NCT06068179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165477|NCT06068023|Leucovorin|leucovorin|mesh-list
138165478|NCT06068023|Capecitabine|capecitabine|mesh-list
138165479|NCT06068023|Fluorouracil|fluorouracil|mesh-list
138165481|NCT06068023|Irinotecan|irinotecan|mesh-list
138165482|NCT06068023|Folfirinox|folfirinox|mesh-list
138165483|NCT06068023|Levoleucovorin|levoleucovorin|mesh-list
138165484|NCT06068023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165485|NCT06068023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138165486|NCT06068023|Antimetabolites|antimetabolites|mesh-ancestor
138165487|NCT06068023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165488|NCT06068023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165489|NCT06068023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138165490|NCT06068023|Immunologic Factors|immunologic factors|mesh-ancestor
138165491|NCT06068023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138165492|NCT06068023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138165493|NCT06068023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165494|NCT06068023|Antidotes|antidotes|mesh-ancestor
138165495|NCT06068023|Protective Agents|protective agents|mesh-ancestor
138165496|NCT06068023|Vitamin B Complex|vitamin b complex|mesh-ancestor
138165499|NCT06067893|Dexmedetomidine|dexmedetomidine|mesh-list
138165500|NCT06067893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138165501|NCT06067893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165502|NCT06067893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165503|NCT06067893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165504|NCT06067893|Analgesics|analgesics|mesh-ancestor
138165505|NCT06067893|Sensory System Agents|sensory system agents|mesh-ancestor
138165506|NCT06067893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165507|NCT06067893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138165508|NCT06067893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138165509|NCT06067893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138165510|NCT06067893|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165511|NCT06067893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165512|NCT06067893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165513|NCT06067854|Anesthetics|anesthetics|mesh-list
138165514|NCT06067854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165515|NCT06067854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165516|NCT06067789|Anesthetics|anesthetics|mesh-list
138165517|NCT06067789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165518|NCT06067789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165519|NCT06067776|Cetuximab|cetuximab|mesh-list
138165520|NCT06067776|Osimertinib|osimertinib|mesh-list
138165521|NCT06067776|Tucatinib|tucatinib|mesh-list
138165522|NCT06067776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165523|NCT06067776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165524|NCT06067776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138165525|NCT06067776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165526|NCT06067776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165527|NCT06067529|Hormones|hormones|mesh-list
138165528|NCT06067529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165529|NCT06067529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165530|NCT06067477|Vitamin D|vitamin d|mesh-list
138165531|NCT06067477|Vitamins|vitamins|mesh-ancestor
138165532|NCT06067477|Micronutrients|micronutrients|mesh-ancestor
138165533|NCT06067477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165534|NCT06067477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138165535|NCT06065163|Diuretics|diuretics|mesh-list
138165536|NCT06065163|Natriuretic Agents|natriuretic agents|mesh-ancestor
138165537|NCT06065163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165538|NCT06055491|Vitamin D|vitamin d|mesh-list
138165541|NCT06055491|Micronutrients|micronutrients|mesh-ancestor
138165542|NCT06055491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165543|NCT06055491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138165544|NCT06055491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138165546|NCT05940545|Favipiravir|favipiravir|mesh-list
138165547|NCT05940545|Antimetabolites|antimetabolites|mesh-ancestor
138165548|NCT05940545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165549|NCT05940545|Antiviral Agents|antiviral agents|mesh-ancestor
138165550|NCT05940545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165552|NCT05923970|Antibodies|antibodies|mesh-list
138165553|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
138165554|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
138165555|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165556|NCT05907213|Ketamine|ketamine|mesh-list
138165557|NCT05907213|Analgesics|analgesics|mesh-ancestor
138165558|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
138165559|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165560|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165561|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138165562|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138165563|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
138165564|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
138165565|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165566|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138165567|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138165568|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165569|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165570|NCT05890352|Lenalidomide|lenalidomide|mesh-list
138165571|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
138165572|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
138165573|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
138165574|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165575|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138165576|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138165578|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
138165579|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165580|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138165581|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165582|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165583|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
138165584|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138165585|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138165586|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165587|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165588|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165589|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165590|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
138165591|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
138165592|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165593|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
138165594|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138165595|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138165596|NCT05799612|Interferons|interferons|mesh-list
138165597|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
138165598|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
138165599|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138165600|NCT05799612|Paclitaxel|paclitaxel|mesh-list
138165601|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165602|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165603|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165604|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165605|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165606|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165607|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
138165608|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138165609|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
138165610|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165611|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138165613|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165614|NCT05726370|Carboplatin|carboplatin|mesh-list
138165615|NCT05726370|Docetaxel|docetaxel|mesh-list
138165616|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
138165618|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165619|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165620|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165621|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165622|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165623|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138165624|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
138165625|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138165626|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138165627|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138165628|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138165629|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165630|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
138165631|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165632|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165644|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165646|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
138165647|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165648|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
138165649|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138165650|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165651|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165652|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138165654|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
138367026|NCT04723862|Diuretics|diuretics|mesh-ancestor
138367028|NCT04720105|Halobetasol|halobetasol|mesh-list
138165655|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165664|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165665|NCT05594784|Prednisone|prednisone|mesh-list
138165666|NCT05594784|Vincristine|vincristine|mesh-list
138165667|NCT05594784|Venetoclax|venetoclax|mesh-list
138165668|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165669|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
138165670|NCT05594784|Hormones|hormones|mesh-ancestor
138165671|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138165672|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165673|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138165674|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165675|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138165676|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138165677|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138165678|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138165679|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165680|NCT05550402|Bromides|bromides|mesh-list
138165681|NCT05550402|Albuterol|albuterol|mesh-list
138165682|NCT05550402|Ipratropium|ipratropium|mesh-list
138165683|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
138165684|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138165685|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
138165686|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165687|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165688|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138165689|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
138165690|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
138165692|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138165693|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138165694|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138165695|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138165696|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165697|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165698|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138165699|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
138165701|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138165702|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138165703|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138165704|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138165705|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
138165706|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
138165707|NCT05509647|Heparin|heparin|mesh-list
138165708|NCT05509647|Calcium heparin|calcium heparin|mesh-list
138165709|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
138365946|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165710|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138165711|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138165712|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329267|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138329268|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138329270|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
138329271|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
138329272|NCT01796106|Protective Agents|protective agents|mesh-ancestor
138329273|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329274|NCT00541242|Bimatoprost|bimatoprost|mesh-list
138329275|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138329276|NCT00541242|Latanoprost|latanoprost|mesh-list
138329277|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138329278|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138329279|NCT00438204|Bevacizumab|bevacizumab|mesh-list
138329280|NCT00438204|Gemcitabine|gemcitabine|mesh-list
138329281|NCT00438204|Pemetrexed|pemetrexed|mesh-list
138329282|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329283|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329284|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329285|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329286|NCT00438204|Growth Substances|growth substances|mesh-ancestor
138329287|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329288|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329289|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329290|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
138329291|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329292|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329293|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138329294|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138329295|NCT00439296|Cytarabine|cytarabine|mesh-list
138329296|NCT00439296|Dexamethasone|dexamethasone|mesh-list
138329297|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
138329298|NCT00439296|Doxorubicin|doxorubicin|mesh-list
138329299|NCT00439296|Methotrexate|methotrexate|mesh-list
138329300|NCT00439296|Asparaginase|asparaginase|mesh-list
138329301|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
138329302|NCT00439296|Thioguanine|thioguanine|mesh-list
138329303|NCT00439296|Pegaspargase|pegaspargase|mesh-list
138329304|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329305|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
138329306|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329307|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329308|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329309|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
138329310|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329311|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329312|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329313|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329314|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
138329315|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
138329316|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329317|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329318|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
138329319|NCT00439296|Hormones|hormones|mesh-ancestor
138329320|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329321|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138329322|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329323|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138329324|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138329325|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329326|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138329327|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
138329328|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138329329|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329330|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
138329331|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329332|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138329333|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138365957|NCT01395069|Analgesics|analgesics|mesh-ancestor
138329336|NCT03117660|Vitamin A|vitamin a|mesh-list
138329337|NCT03117660|Vitamins|vitamins|mesh-ancestor
138329338|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
138329339|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329340|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138329341|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138329342|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138329343|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
138329344|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329345|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329346|NCT00439374|Progestins|progestins|mesh-ancestor
138329347|NCT00439374|Hormones|hormones|mesh-ancestor
138329348|NCT00439608|Paclitaxel|paclitaxel|mesh-list
138329349|NCT00439608|Carboplatin|carboplatin|mesh-list
138329350|NCT00439608|Cetuximab|cetuximab|mesh-list
138329351|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329352|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329353|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329354|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329355|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329356|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329357|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329358|NCT04750122|Carboplatin|carboplatin|mesh-list
138329359|NCT04750122|Docetaxel|docetaxel|mesh-list
138329361|NCT04750122|Pertuzumab|pertuzumab|mesh-list
138329362|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329363|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329364|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329365|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329366|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329367|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329368|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138329369|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138329370|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138329371|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138329372|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329373|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329374|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329375|NCT00443352|Analgesics|analgesics|mesh-ancestor
138329376|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
138329377|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329378|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138329379|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329380|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
138329381|NCT00445302|Plerixafor|plerixafor|mesh-list
138329382|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138329383|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138329384|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
138329385|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329387|NCT00504504|Doxorubicin|doxorubicin|mesh-list
138329388|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138329389|NCT00504504|Dacarbazine|dacarbazine|mesh-list
138329390|NCT00504504|Bleomycin|bleomycin|mesh-list
138329391|NCT00504504|Vinblastine|vinblastine|mesh-list
138329392|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329393|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329394|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
138329395|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329396|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329397|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329398|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138329399|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138329400|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329401|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329403|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
138329404|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329405|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329406|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329407|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329409|NCT00504660|Capecitabine|capecitabine|mesh-list
138329410|NCT00504660|Thioguanine|thioguanine|mesh-list
138329411|NCT00504660|Temozolomide|temozolomide|mesh-list
138329412|NCT00504660|Lomustine|lomustine|mesh-list
138329413|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329414|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
138329415|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329416|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329417|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329418|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
138329419|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138329420|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138329421|NCT00504660|Analgesics|analgesics|mesh-ancestor
138329422|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
138329423|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329424|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329425|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329426|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329427|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138329428|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138329429|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329430|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
138329431|NCT00544908|Dasatinib|dasatinib|mesh-list
138329432|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329433|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138329434|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329435|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329436|NCT00447330|Bevacizumab|bevacizumab|mesh-list
138329437|NCT00447330|Capecitabine|capecitabine|mesh-list
138329438|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
138329439|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329440|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329441|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329442|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329443|NCT00447330|Growth Substances|growth substances|mesh-ancestor
138367034|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367035|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329444|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329445|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329446|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329447|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
138329448|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329450|NCT02115048|Afatinib|afatinib|mesh-list
138329451|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329452|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138329453|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138329454|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329455|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329456|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138329457|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
138329458|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329459|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329460|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138329461|NCT00546156|Paclitaxel|paclitaxel|mesh-list
138329462|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
138329463|NCT00546156|Bevacizumab|bevacizumab|mesh-list
138329464|NCT00546156|Doxorubicin|doxorubicin|mesh-list
138329465|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329466|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329468|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329469|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329470|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329471|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329473|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329474|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329475|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329476|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
138329477|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329478|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329479|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329480|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329484|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138329486|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329487|NCT00449046|Fluticasone|fluticasone|mesh-list
138329488|NCT00449046|Xhance|xhance|mesh-list
138329489|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138329490|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329491|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138329492|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
138329493|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329494|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329495|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138329496|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329497|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329498|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138329499|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138329500|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138329501|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138329502|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
138329503|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329504|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329505|NCT00509496|Aldesleukin|aldesleukin|mesh-list
138329506|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
138329507|NCT00509496|Fludarabine|fludarabine|mesh-list
138329508|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
138329509|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329510|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
138329511|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329512|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329513|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329514|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
138329515|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329516|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329517|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329518|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329519|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
138329520|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138329521|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138329522|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
138329523|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329524|NCT00548418|Bevacizumab|bevacizumab|mesh-list
138329525|NCT00548418|Topotecan|topotecan|mesh-list
138329526|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329527|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329531|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329532|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329533|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138329534|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138329535|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329536|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329538|NCT00511992|Bevacizumab|bevacizumab|mesh-list
138329539|NCT00511992|Cisplatin|cisplatin|mesh-list
138329540|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329541|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329542|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329543|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329544|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329545|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329546|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329547|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329548|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329549|NCT00511992|Growth Substances|growth substances|mesh-ancestor
138329550|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329551|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329552|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
138329553|NCT00451698|Hematinics|hematinics|mesh-ancestor
138329554|NCT00549042|Hydromorphone|hydromorphone|mesh-list
138329555|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138329556|NCT00549042|Narcotics|narcotics|mesh-ancestor
138329557|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329558|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329559|NCT00549042|Analgesics|analgesics|mesh-ancestor
138329560|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
138329561|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329562|NCT00452868|Donepezil|donepezil|mesh-list
138329563|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138329564|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329565|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329566|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
138329567|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329568|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329569|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
138329570|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138329571|NCT00453336|Trioxsalen|trioxsalen|mesh-list
138329572|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329573|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329574|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138329575|NCT00549822|Letrozole|letrozole|mesh-list
138329576|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329577|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138329578|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138329580|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329581|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138329582|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
138329583|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329584|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329585|NCT00550290|Cefazolin|cefazolin|mesh-list
138329586|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138365997|NCT01395251|Hormones|hormones|mesh-ancestor
138329591|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329592|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138329593|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
138329594|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329595|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138329596|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138329597|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138329598|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329599|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
138329600|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138329601|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
138329602|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329603|NCT00552786|Expectorants|expectorants|mesh-ancestor
138329604|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329605|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138329606|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
138329607|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329608|NCT00552786|Protective Agents|protective agents|mesh-ancestor
138329609|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329610|NCT00552786|Antidotes|antidotes|mesh-ancestor
138329611|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
138329612|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329613|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329614|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138329615|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138329616|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329617|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329618|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
138329619|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329620|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329621|NCT00553098|Cyclosporine|cyclosporine|mesh-list
138329622|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
138329623|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138329624|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
138329625|NCT00553098|Fludarabine|fludarabine|mesh-list
138329626|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
138329627|NCT00553098|Antibodies|antibodies|mesh-list
138329628|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
138329629|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138329630|NCT00553098|Cyclosporins|cyclosporins|mesh-list
138329631|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
138329632|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329634|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329635|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
138329636|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329637|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329638|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329639|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
138329640|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329641|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329642|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329643|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138329644|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329645|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138329646|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
138329647|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329649|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329650|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138329651|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138329652|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329653|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329654|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138329655|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
138329656|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329657|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329658|NCT00554970|Budesonide|budesonide|mesh-list
138329659|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329660|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138329661|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
138329662|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329663|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329664|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138329665|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329666|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
138329667|NCT00554970|Hormones|hormones|mesh-ancestor
138329668|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329670|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138329671|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138329672|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329673|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
138329674|NCT00555048|Busulfan|busulfan|mesh-list
138329676|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
138329677|NCT00555048|Tacrolimus|tacrolimus|mesh-list
138329678|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329679|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
138329680|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329681|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329682|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329683|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
138329684|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329685|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329686|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329687|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138329688|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
138329689|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138329690|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329691|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
138329692|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329693|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329694|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138366021|NCT01395420|Ceftazidime|ceftazidime|mesh-list
138329695|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138329696|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138329697|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329698|NCT00525798|Calcitonin|calcitonin|mesh-list
138329699|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
138329700|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138329701|NCT00525798|Katacalcin|katacalcin|mesh-list
138329702|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138329703|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329704|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138329705|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
138329706|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
138329707|NCT00525876|Rituximab|rituximab|mesh-list
138329708|NCT00525876|Fludarabine|fludarabine|mesh-list
138329709|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
138329710|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
138329711|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329712|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
138329713|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329714|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329715|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329716|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
138329717|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329718|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329719|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329720|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329721|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329722|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
138329723|NCT00555750|Eszopiclone|eszopiclone|mesh-list
138329724|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138329725|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329726|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329727|NCT00556140|Aripiprazole|aripiprazole|mesh-list
138329728|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
138329729|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329730|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138329731|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138329732|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329733|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329735|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
138329736|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329737|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329738|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138329739|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138329740|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
138329741|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138329742|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138329743|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138329744|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138329745|NCT00527124|Prednisone|prednisone|mesh-list
138329746|NCT00527124|Docetaxel|docetaxel|mesh-list
138329749|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329750|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329751|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329752|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329753|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329754|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
138329755|NCT00527124|Hormones|hormones|mesh-ancestor
138329756|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329757|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329758|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138329759|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329760|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138329761|NCT00527592|Travoprost|travoprost|mesh-list
138329762|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138329763|NCT00527592|Latanoprost|latanoprost|mesh-list
138329764|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138329765|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138329766|NCT00556452|Busulfan|busulfan|mesh-list
138329767|NCT00556452|Clofarabine|clofarabine|mesh-list
138329768|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
138329769|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329770|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329771|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
138329772|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329773|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329774|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329775|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329776|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138329777|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
138329778|NCT03158376|Gabapentin|gabapentin|mesh-list
138329779|NCT03158376|Analgesics|analgesics|mesh-ancestor
138329780|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
138329781|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329782|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329783|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
138329784|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138329785|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138329786|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329787|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329788|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138329789|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138329790|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329791|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329792|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
138329793|NCT01797900|Paclitaxel|paclitaxel|mesh-list
138329794|NCT01797900|Cisplatin|cisplatin|mesh-list
138329795|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329796|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329797|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329800|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329801|NCT03572790|Prucalopride|prucalopride|mesh-list
138329802|NCT03572790|Laxatives|laxatives|mesh-ancestor
138329803|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329804|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138329805|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138329806|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
138329807|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329808|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329809|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329810|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
138329811|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329812|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329813|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138329814|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329815|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138329816|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329817|NCT02319486|Carboplatin|carboplatin|mesh-list
138329818|NCT02319486|Etoposide|etoposide|mesh-list
138329819|NCT02319486|Vincristine|vincristine|mesh-list
138329820|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329821|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329822|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138329823|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138329824|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329825|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329826|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
138329827|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329828|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
138329829|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138329830|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
138329831|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329832|NCT00558012|Vitamin D|vitamin d|mesh-list
138329833|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
138329834|NCT00558012|Calcium|calcium|mesh-list
138329835|NCT00558012|Vitamins|vitamins|mesh-ancestor
138329836|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
138329837|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329838|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138329839|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138329840|NCT00561834|Ranibizumab|ranibizumab|mesh-list
138329841|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329842|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329843|NCT00561834|Growth Substances|growth substances|mesh-ancestor
138329844|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329845|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329846|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329847|NCT04388202|Sertraline|sertraline|mesh-list
138329848|NCT04388202|Escitalopram|escitalopram|mesh-list
138329849|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138329850|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138329852|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329853|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329854|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
138329855|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329856|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
138329857|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138329858|NCT02128230|Thalidomide|thalidomide|mesh-list
138329859|NCT02128230|Dexamethasone|dexamethasone|mesh-list
138329860|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
138329861|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
138329862|NCT02128230|Melphalan|melphalan|mesh-list
138329863|NCT02128230|Cisplatin|cisplatin|mesh-list
138329865|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138329866|NCT02128230|Etoposide|etoposide|mesh-list
138329867|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
138329868|NCT02128230|Lenalidomide|lenalidomide|mesh-list
138329869|NCT02128230|Lenograstim|lenograstim|mesh-list
138329870|NCT02128230|BB 1101|bb 1101|mesh-list
138329871|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138329872|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
138329873|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329874|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138329875|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329876|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
138329877|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329878|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329879|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138329880|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329881|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
138329882|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
138329883|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329884|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329885|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
138329886|NCT02128230|Hormones|hormones|mesh-ancestor
138329887|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329888|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138329889|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
138329890|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329891|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138329892|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138329893|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138329894|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138329895|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329896|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138329897|NCT02128230|Growth Substances|growth substances|mesh-ancestor
138329898|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
138329900|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329901|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329902|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138329904|NCT03416244|Ipilimumab|ipilimumab|mesh-list
138329905|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329906|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329907|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138329908|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329909|NCT05560620|Caffeine|caffeine|mesh-list
138329910|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138329911|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329912|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138329913|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329914|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329915|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138329916|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138329917|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
138329918|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329919|NCT04388124|Bosentan|bosentan|mesh-list
138329920|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138329921|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138329922|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329923|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
138329924|NCT03172416|Nivolumab|nivolumab|mesh-list
138329925|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329926|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329927|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138329928|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329929|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
138329930|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138329931|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
138329932|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329933|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
138329934|NCT05559996|Protective Agents|protective agents|mesh-ancestor
138329935|NCT02812212|Diuretics|diuretics|mesh-list
138329936|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
138329937|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329938|NCT05559450|Blinatumomab|blinatumomab|mesh-list
138329939|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138329940|NCT00564954|Methylphenidate|methylphenidate|mesh-list
138329941|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138329942|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138329943|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329944|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138329945|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138329946|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138329947|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329948|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
138329949|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329950|NCT00565266|Beclomethasone|beclomethasone|mesh-list
138329951|NCT00565266|Bromides|bromides|mesh-list
138329952|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
138329953|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138329954|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138329955|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
138329956|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329957|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329958|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138329959|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329960|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
138329961|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138329962|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
138367065|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138367066|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
138367067|NCT04585542|Laxatives|laxatives|mesh-ancestor
138329963|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138329964|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329965|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138329966|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138329967|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138329968|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
138329969|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
138329970|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329971|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
138329972|NCT00565266|Hormones|hormones|mesh-ancestor
138329973|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138329974|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138329975|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
138329976|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138329977|NCT01797978|Methylene Blue|methylene blue|mesh-list
138329978|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329979|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329980|NCT05363202|Fluticasone|fluticasone|mesh-list
138329982|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138329983|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138329984|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
138329985|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329986|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329987|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138329988|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
138329989|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
138329990|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138329991|NCT02129478|Olanzapine|olanzapine|mesh-list
138329992|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
138329993|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
138329994|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138329995|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329996|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138329997|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138329998|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138329999|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330000|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330001|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138330002|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138330003|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330004|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330005|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330007|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
138330008|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330010|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138330011|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330012|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
138330013|NCT05362500|Glycolic acid|glycolic acid|mesh-list
138330014|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
138330015|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138330016|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138330017|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330018|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
138330019|NCT05362500|Coagulants|coagulants|mesh-ancestor
138330020|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
138330021|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330022|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
138330023|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330024|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138330025|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330026|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138330027|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138330028|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330029|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330030|NCT05161806|Aflibercept|aflibercept|mesh-list
138330031|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138330032|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138330033|NCT05161806|Growth Substances|growth substances|mesh-ancestor
138330034|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330035|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
138330036|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330037|NCT05362188|Niacinamide|niacinamide|mesh-list
138330038|NCT05362188|Niacin|niacin|mesh-list
138330039|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
138330040|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
138330041|NCT05362188|Vitamins|vitamins|mesh-ancestor
138330042|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
138330043|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330044|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138330045|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
138330046|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330047|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138330048|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138330049|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
138330050|NCT05353374|Petrolatum|petrolatum|mesh-list
138330051|NCT05353374|Emollients|emollients|mesh-ancestor
138330052|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330053|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138330054|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330055|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138330056|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330057|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330058|NCT05214222|Paclitaxel|paclitaxel|mesh-list
138330059|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138330060|NCT05214222|Cisplatin|cisplatin|mesh-list
138366140|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138366141|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330061|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138330063|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
138330064|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
138330065|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
138330066|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330067|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
138330069|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
138330070|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330071|NCT05198232|Protective Agents|protective agents|mesh-ancestor
138330072|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330073|NCT05198232|Antacids|antacids|mesh-ancestor
138330074|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330075|NCT04747236|Gemcitabine|gemcitabine|mesh-list
138330076|NCT04747236|Azacitidine|azacitidine|mesh-list
138330077|NCT04747236|Romidepsin|romidepsin|mesh-list
138330078|NCT04747236|Belinostat|belinostat|mesh-list
138330079|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330081|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330082|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330083|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330084|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330085|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138330086|NCT01797666|Pioglitazone|pioglitazone|mesh-list
138330087|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330088|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330089|NCT05017194|Emodepside|emodepside|mesh-list
138330090|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138330091|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330092|NCT04501380|Rifamycins|rifamycins|mesh-list
138330093|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
138330094|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138330095|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330096|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330097|NCT04465734|Sorafenib|sorafenib|mesh-list
138330098|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330099|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138330100|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330101|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330102|NCT03856632|Liraglutide|liraglutide|mesh-list
138330103|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138330104|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330105|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330106|NCT03856632|Incretins|incretins|mesh-ancestor
138330107|NCT03856632|Hormones|hormones|mesh-ancestor
138330108|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330109|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138330110|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138330111|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138330114|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138330115|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138330116|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330117|NCT02783430|Ketamine|ketamine|mesh-list
138330118|NCT02783430|Milnacipran|milnacipran|mesh-list
138330119|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
138330120|NCT02783430|Analgesics|analgesics|mesh-ancestor
138330121|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
138330122|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330123|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330124|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138330125|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138330127|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
138330128|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330129|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138330130|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138330131|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330132|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330133|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138330134|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138330135|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330136|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330137|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
138330138|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330139|NCT03642366|Tadalafil|tadalafil|mesh-list
138330140|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
138330141|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138330142|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138330143|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330144|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330145|NCT03642366|Urological Agents|urological agents|mesh-ancestor
138330146|NCT00604968|Doxorubicin|doxorubicin|mesh-list
138330147|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138330148|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330149|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330150|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330152|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330153|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330154|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138330155|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138330156|NCT00605202|Diuretics|diuretics|mesh-ancestor
138330157|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
138330158|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330159|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138330160|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330161|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330162|NCT00605904|Acamprosate|acamprosate|mesh-list
138330163|NCT00605904|Yohimbine|yohimbine|mesh-list
138330164|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138330165|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
138330166|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
138330167|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330168|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330169|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138330170|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138330171|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138330172|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330173|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330174|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330175|NCT00605904|Urological Agents|urological agents|mesh-ancestor
138330177|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330179|NCT05175768|Niacinamide|niacinamide|mesh-list
138330181|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
138330182|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
138330183|NCT05175768|Vitamins|vitamins|mesh-ancestor
138330184|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
138330185|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330186|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138330187|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
138330188|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330189|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138330190|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
138330191|NCT05097846|Amoxicillin|amoxicillin|mesh-list
138330192|NCT05097846|Doxycycline|doxycycline|mesh-list
138330193|NCT05097846|Furazolidone|furazolidone|mesh-list
138330194|NCT05097846|Esomeprazole|esomeprazole|mesh-list
138330195|NCT05097846|Bismuth|bismuth|mesh-list
138330196|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138330197|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330198|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138330199|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330200|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138330201|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330202|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330203|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
138330204|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138330205|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138330206|NCT05097846|Antacids|antacids|mesh-ancestor
138330207|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138330208|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138330209|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138330210|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138330212|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330213|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330214|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330215|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
138330216|NCT02897700|Doxorubicin|doxorubicin|mesh-list
138330217|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138330218|NCT02897700|Fluorouracil|fluorouracil|mesh-list
138330219|NCT02897700|Methotrexate|methotrexate|mesh-list
138330220|NCT02897700|Epirubicin|epirubicin|mesh-list
138330221|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366187|NCT01395953|Buspirone|buspirone|mesh-list
138366194|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
138330222|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
138330223|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330224|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330225|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330226|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
138330227|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330228|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330229|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330230|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330231|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330232|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330233|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330235|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330236|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138330237|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
138330238|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138330239|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330240|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138330241|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138330242|NCT02889666|Cisplatin|cisplatin|mesh-list
138330243|NCT02889666|Carboplatin|carboplatin|mesh-list
138330244|NCT02889666|Gemcitabine|gemcitabine|mesh-list
138330245|NCT02889666|Docetaxel|docetaxel|mesh-list
138330246|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
138330247|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330248|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330249|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
138330250|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330251|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
138330252|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
138330253|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
138330254|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138330255|NCT00609804|Sorafenib|sorafenib|mesh-list
138330256|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330257|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138330258|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330259|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330260|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
138330261|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
138330262|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
138330263|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330264|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330265|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330266|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138330267|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138330268|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330269|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330270|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138330271|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
138330272|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330273|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366217|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
138330292|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330293|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330294|NCT02136420|Promethazine|promethazine|mesh-list
138330295|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
138330296|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
138330297|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330298|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138330299|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
138330302|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330303|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330304|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138330305|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138330306|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330307|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330308|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
138330309|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
138330310|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
138330311|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330313|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
138330315|NCT02136498|Varenicline|varenicline|mesh-list
138330316|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138330317|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138330318|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
138330319|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330320|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330321|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330322|NCT00612222|Aldesleukin|aldesleukin|mesh-list
138330323|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
138330324|NCT00612222|Fludarabine|fludarabine|mesh-list
138330325|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
138330327|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330328|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
138330329|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330330|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330331|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330332|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
138330333|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330334|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330335|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330336|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330337|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
138330338|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330339|NCT00612222|Analgesics|analgesics|mesh-ancestor
138330345|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330346|NCT01711242|Capecitabine|capecitabine|mesh-list
138330347|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
138330348|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330349|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
138330350|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330351|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330352|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138330353|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
138330354|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
138330355|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138330356|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
138330357|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330358|NCT04405908|Antacids|antacids|mesh-ancestor
138330359|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330360|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330361|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138330362|NCT04304274|Morphine|morphine|mesh-list
138330363|NCT04304274|Ropivacaine|ropivacaine|mesh-list
138330364|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138330366|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330367|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330369|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
138330370|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330371|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
138330372|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
138330373|NCT02132832|Buspirone|buspirone|mesh-list
138330374|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138330375|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138330376|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330377|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330378|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330379|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138330380|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
138330381|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330382|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330383|NCT00614406|Celecoxib|celecoxib|mesh-list
138330384|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138330385|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330386|NCT00614406|Analgesics|analgesics|mesh-ancestor
138330387|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
138330388|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330389|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330390|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330391|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330392|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138330393|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138330394|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330395|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330396|NCT00614484|Paclitaxel|paclitaxel|mesh-list
138330397|NCT00614484|Carboplatin|carboplatin|mesh-list
138330398|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138330399|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330400|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
138330401|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
138330402|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
138330403|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330404|NCT04159974|Durvalumab|durvalumab|mesh-list
138330405|NCT04159974|Tremelimumab|tremelimumab|mesh-list
138330407|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330408|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
138330410|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330411|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330412|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330413|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138330414|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
138330415|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
138330416|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330417|NCT04142502|Analgesics|analgesics|mesh-ancestor
138330418|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
138330419|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330420|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138330421|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138330422|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138330423|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330424|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330425|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330427|NCT00569010|Azacitidine|azacitidine|mesh-list
138330428|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330429|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
138330430|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330431|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330432|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
138330433|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330434|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330435|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
138330436|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330437|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330439|NCT00616122|Methotrexate|methotrexate|mesh-list
138330440|NCT00616122|Sunitinib|sunitinib|mesh-list
138330441|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330442|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
138330443|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330445|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330446|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
138330447|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330448|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330449|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330450|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138330451|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
138330452|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138330453|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330454|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
138330455|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330456|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330457|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138330458|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138330459|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138330460|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138330461|NCT00616122|Growth Substances|growth substances|mesh-ancestor
138330462|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
138330464|NCT00617058|Metformin|metformin|mesh-list
138330466|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330467|NCT00618540|Fludarabine|fludarabine|mesh-list
138330468|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
138330469|NCT00618540|Melphalan|melphalan|mesh-list
138330470|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
138330471|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330472|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330473|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
138330474|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330475|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330476|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
138330477|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330478|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330479|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
138330480|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330481|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330483|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
138330484|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
138330485|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
138330486|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138330487|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
138330488|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138330489|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
138330490|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330491|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330492|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138330493|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
138330494|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138330495|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138330496|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138330497|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330498|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330499|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330500|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138330501|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138330502|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330503|NCT00574236|Doxorubicin|doxorubicin|mesh-list
138330504|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330505|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330506|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330507|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330508|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330509|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330510|NCT00574548|Vaccines|vaccines|mesh-list
138330511|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138330512|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
138330513|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330514|NCT01168219|Methotrexate|methotrexate|mesh-list
138330515|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
138330516|NCT01168219|Azacitidine|azacitidine|mesh-list
138330517|NCT01168219|Fludarabine|fludarabine|mesh-list
138330518|NCT01168219|Busulfan|busulfan|mesh-list
138330519|NCT01168219|Tacrolimus|tacrolimus|mesh-list
138330520|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138330521|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138330522|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
138330523|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138330524|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330525|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330526|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
138330527|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330528|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330529|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367070|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
138367071|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367073|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138330530|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330531|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138330532|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330533|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
138330534|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330535|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138330536|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138330537|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
138330538|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330539|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330540|NCT01115803|Everolimus|everolimus|mesh-list
138330541|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138330542|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138330543|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138330544|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330545|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330546|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330547|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
138330548|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330549|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330551|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138330552|NCT01115569|Narcotics|narcotics|mesh-ancestor
138330553|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330554|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330555|NCT01115569|Analgesics|analgesics|mesh-ancestor
138330556|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
138330557|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330558|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
138330559|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
138330560|NCT01107886|Saxagliptin|saxagliptin|mesh-list
138330561|NCT01107886|Incretins|incretins|mesh-ancestor
138330563|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330564|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330565|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138330566|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
138330567|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366285|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
138330568|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330569|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330570|NCT01107457|Ixekizumab|ixekizumab|mesh-list
138330571|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330572|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
138330573|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138330574|NCT05767008|Protective Agents|protective agents|mesh-ancestor
138330575|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330576|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
138330578|NCT05766605|Doxorubicin|doxorubicin|mesh-list
138330579|NCT05766605|Fluorouracil|fluorouracil|mesh-list
138330580|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
138330581|NCT05766605|Raltitrexed|raltitrexed|mesh-list
138330582|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330583|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138330584|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330585|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330586|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330587|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330588|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
138330589|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330590|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330591|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
138330592|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330594|NCT05766605|Protective Agents|protective agents|mesh-ancestor
138330595|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
138330596|NCT05766605|Vitamins|vitamins|mesh-ancestor
138330597|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
138367075|NCT04585334|Analgesics|analgesics|mesh-ancestor
138330598|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138330599|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
138330601|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330602|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330603|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330604|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330605|NCT05766436|Analgesics|analgesics|mesh-ancestor
138330606|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
138330607|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330608|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138330609|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138330610|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138330611|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330612|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330613|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330615|NCT05766436|Protective Agents|protective agents|mesh-ancestor
138330616|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
138330617|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138330618|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
138330619|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
138330620|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330621|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330622|NCT05766384|Xenon|xenon|mesh-list
138330623|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138330624|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
138330625|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
138330626|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330627|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330628|NCT05766176|Antibodies|antibodies|mesh-list
138330629|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
138330630|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
138330631|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330632|NCT05766085|Dexamethasone|dexamethasone|mesh-list
138330633|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330634|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
138330635|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
138330636|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330637|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330638|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330639|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
138330641|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330642|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330643|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330644|NCT05765825|Carboplatin|carboplatin|mesh-list
138330645|NCT05765825|Etoposide|etoposide|mesh-list
138330646|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330647|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138330648|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330649|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330650|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330651|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330653|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138330654|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330655|NCT05765747|Analgesics|analgesics|mesh-ancestor
138330656|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
138330657|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330658|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330659|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330660|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330661|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138330662|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138330663|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330664|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330665|NCT05765617|Calcitriol|calcitriol|mesh-list
138330666|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138330667|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330668|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138330669|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330670|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330671|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138330672|NCT05765617|Vitamins|vitamins|mesh-ancestor
138330673|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
138330674|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138330675|NCT05765357|Trastuzumab|trastuzumab|mesh-list
138330676|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330677|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330679|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138330680|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
138330681|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330683|NCT05765240|Protective Agents|protective agents|mesh-ancestor
138330684|NCT05765110|Dopamine|dopamine|mesh-list
138330685|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
138330686|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138330687|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
138330688|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
138330689|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330690|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330691|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
138330692|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330693|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330695|NCT05765097|Pancrelipase|pancrelipase|mesh-list
138330697|NCT05764811|Canagliflozin|canagliflozin|mesh-list
138330698|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138330699|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330700|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330701|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330702|NCT05764798|Zolpidem|zolpidem|mesh-list
138330703|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138330704|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330705|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330706|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330707|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138330708|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
138330710|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330711|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330712|NCT05764746|Artesunate|artesunate|mesh-list
138330713|NCT05764746|Lumefantrine|lumefantrine|mesh-list
138330714|NCT05764746|Artemether|artemether|mesh-list
138330715|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138330716|NCT05764746|Amodiaquine|amodiaquine|mesh-list
138330717|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
138330718|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138330719|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138330720|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330721|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330722|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
138330723|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
138330724|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138330725|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
138330726|NCT05764707|Acetaminophen|acetaminophen|mesh-list
138330727|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330728|NCT05764707|Analgesics|analgesics|mesh-ancestor
138330729|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
138330730|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330731|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330732|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
138330733|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
138330734|NCT05763602|Povidone|povidone|mesh-list
138330735|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
138330736|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
138330737|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138330738|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330739|NCT05757622|Remifentanil|remifentanil|mesh-list
138330740|NCT05757622|Propofol|propofol|mesh-list
138330741|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330742|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330743|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330744|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138330745|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
138367086|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367087|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367089|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367090|NCT04574947|Lidocaine|lidocaine|mesh-list
138330747|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138330748|NCT05757622|Narcotics|narcotics|mesh-ancestor
138330749|NCT05757622|Analgesics|analgesics|mesh-ancestor
138330750|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
138330751|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330752|NCT05746650|Hormones|hormones|mesh-list
138330753|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330754|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330755|NCT05731726|Celecoxib|celecoxib|mesh-list
138330756|NCT05731726|Capecitabine|capecitabine|mesh-list
138330757|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
138330758|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330759|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
138330760|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330761|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330762|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138330763|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138330765|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
138330766|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330767|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330768|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330769|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330770|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138330771|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138330772|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330773|NCT05715931|Leucovorin|leucovorin|mesh-list
138330774|NCT05715931|Docetaxel|docetaxel|mesh-list
138330775|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
138330776|NCT05715931|Trastuzumab|trastuzumab|mesh-list
138330777|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330778|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
138330779|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
138330780|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
138330781|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330782|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330784|NCT05715931|Protective Agents|protective agents|mesh-ancestor
138330785|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330786|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
138330787|NCT05715931|Vitamins|vitamins|mesh-ancestor
138330788|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
138330789|NCT05708183|Micronutrients|micronutrients|mesh-list
138330790|NCT05708183|Trace Elements|trace elements|mesh-list
138330791|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330792|NCT05594823|Furosemide|furosemide|mesh-list
138330793|NCT05594823|Diuretics|diuretics|mesh-list
138366356|NCT01397331|Propofol|propofol|mesh-list
138330794|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
138330795|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330796|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138330797|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330798|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330799|NCT05581797|Psilocybin|psilocybin|mesh-list
138330800|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
138330801|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330802|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330803|NCT05510544|Plerixafor|plerixafor|mesh-list
138330804|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138330805|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138330806|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
138330807|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367091|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
138367092|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
138367093|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367094|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330808|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138330809|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330810|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330811|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330812|NCT05327647|Bicalutamide|bicalutamide|mesh-list
138330813|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
138330814|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
138330815|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
138330816|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330817|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330818|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330819|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
138330821|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330822|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138330823|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330824|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330826|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138330827|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330828|NCT05171660|Bevacizumab|bevacizumab|mesh-list
138330829|NCT05171660|Capecitabine|capecitabine|mesh-list
138330830|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
138330831|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330832|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330833|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138330834|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138330835|NCT05171660|Growth Substances|growth substances|mesh-ancestor
138330836|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330837|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
138330838|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330839|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
138330840|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330841|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
138330842|NCT05133258|Dexamethasone|dexamethasone|mesh-list
138330843|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330844|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
138330845|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
138330846|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330847|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330848|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330849|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
138330850|NCT05133258|Hormones|hormones|mesh-ancestor
138330851|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330852|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330854|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138330855|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330856|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330857|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330858|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330859|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330860|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138330861|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138330863|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330864|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
138330865|NCT05059873|Hormones|hormones|mesh-ancestor
138330866|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330867|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330868|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330869|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330870|NCT05055024|Mazindol|mazindol|mesh-list
138330871|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138330872|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330873|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138330874|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138330875|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330876|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330877|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330878|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330879|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138330880|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
138330881|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
138330882|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138330884|NCT05037552|Hemostatics|hemostatics|mesh-list
138330885|NCT05037552|Coagulants|coagulants|mesh-ancestor
138330890|NCT05012631|Losartan|losartan|mesh-list
138330891|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138330892|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138330893|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138330894|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138330895|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330896|NCT04954196|Amlodipine|amlodipine|mesh-list
138330897|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138330898|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138330899|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138330900|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330901|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138330902|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330903|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
138330904|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138330905|NCT04944290|Brinzolamide|brinzolamide|mesh-list
138330906|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138330907|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138330908|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138330909|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138330910|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
138330911|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330912|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330913|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330914|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138330915|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330916|NCT04937166|Azacitidine|azacitidine|mesh-list
138330917|NCT04937166|Venetoclax|venetoclax|mesh-list
138330918|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330919|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
138366392|NCT05268627|Hormones|hormones|mesh-ancestor
138330920|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330921|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330922|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330924|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138330925|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138330926|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330927|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330928|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330930|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138330931|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138330932|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330933|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330935|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138330936|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330937|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138330938|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
138330939|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
138330940|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
138330941|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
138330942|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138330943|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330944|NCT04882540|Brivaracetam|brivaracetam|mesh-list
138330945|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
138330946|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
138330947|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138330948|NCT04859829|Antibodies|antibodies|mesh-list
138330949|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
138330950|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138330951|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
138330952|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330953|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138330954|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138330955|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330956|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
138367103|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367104|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138367105|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138367107|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
138330957|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138330958|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
138330959|NCT04788043|Magrolimab|magrolimab|mesh-list
138330960|NCT04788043|Antibodies|antibodies|mesh-list
138330961|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
138330962|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138330963|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
138330964|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330965|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330966|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138330967|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330969|NCT04778267|Bupivacaine|bupivacaine|mesh-list
138330970|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138330971|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138330972|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
138330973|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
138330974|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330975|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330976|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330977|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
138330979|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138330980|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330981|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330982|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
138330983|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
138330984|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138330985|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
138330986|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
138330987|NCT04735471|Fludarabine|fludarabine|mesh-list
138330990|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330991|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138330992|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138330993|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
138330994|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330995|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330996|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138330997|NCT04718181|Omeprazole|omeprazole|mesh-list
138330999|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138331000|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138331001|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138331002|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331003|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331004|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138331005|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331006|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331007|NCT04682366|Tamsulosin|tamsulosin|mesh-list
138331008|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138331009|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138331010|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138331011|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
138331012|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331013|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331014|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331015|NCT04682366|Urological Agents|urological agents|mesh-ancestor
138331017|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
138331018|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331019|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138331020|NCT04573504|Clindamycin|clindamycin|mesh-list
138331021|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
138331022|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
138331023|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138331024|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331025|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331026|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138331027|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331028|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331029|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138331030|NCT04560972|Carboplatin|carboplatin|mesh-list
138331031|NCT04560972|Etoposide|etoposide|mesh-list
138331032|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
138331033|NCT04560972|Atezolizumab|atezolizumab|mesh-list
138331034|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
138331035|NCT04560972|LB100|lb100|mesh-list
138331036|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138331037|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331038|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331039|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138331040|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138331041|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331042|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331043|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331044|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331046|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331047|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
138331048|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331049|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331050|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331051|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331053|NCT04521335|Disulfiram|disulfiram|mesh-list
138331054|NCT04521335|Trace Elements|trace elements|mesh-ancestor
138331055|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
138331056|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331057|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138331058|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138331059|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331060|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331062|NCT04515615|Tegafur|tegafur|mesh-list
138331063|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331064|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331065|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
138331066|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331067|NCT04247126|Paclitaxel|paclitaxel|mesh-list
138331068|NCT04247126|Gemcitabine|gemcitabine|mesh-list
138331069|NCT04247126|Fulvestrant|fulvestrant|mesh-list
138331070|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331071|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331072|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331073|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331074|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331075|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331076|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331077|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
138331078|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331079|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138331080|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138331081|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331082|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331083|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331085|NCT04163432|Pemetrexed|pemetrexed|mesh-list
138331086|NCT04163432|Durvalumab|durvalumab|mesh-list
138331087|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331088|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331089|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331090|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331091|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331092|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331093|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
138331094|NCT04151706|Busulfan|busulfan|mesh-list
138331095|NCT04151706|Thiotepa|thiotepa|mesh-list
138331096|NCT04151706|Fludarabine|fludarabine|mesh-list
138331097|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331098|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
138331099|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331100|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331101|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138331102|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
138331103|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331104|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331105|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138331109|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331110|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331111|NCT04006119|Cemiplimab|cemiplimab|mesh-list
138331112|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331113|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331114|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
138331115|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138331116|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331117|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138331118|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331120|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
138331121|NCT04002011|Dabigatran|dabigatran|mesh-list
138331122|NCT04002011|Apixaban|apixaban|mesh-list
138331123|NCT04002011|Edoxaban|edoxaban|mesh-list
138331124|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
138331125|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138331126|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
138331127|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138331128|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331129|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331130|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331131|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138331132|NCT03903692|Laxatives|laxatives|mesh-ancestor
138331133|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138331134|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
138331135|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331136|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
138331137|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331138|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331139|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331140|NCT03783026|Apremilast|apremilast|mesh-list
138331141|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138331142|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138331143|NCT03783026|Analgesics|analgesics|mesh-ancestor
138331144|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
138331145|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331146|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331147|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331148|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331149|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138331150|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138331151|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366431|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
138331152|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331154|NCT03775460|Methotrexate|methotrexate|mesh-list
138331155|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138331156|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
138331157|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331158|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331159|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331160|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
138331161|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331162|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331163|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331164|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331165|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331166|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331167|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
138331168|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331169|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331170|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331171|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
138331172|NCT03775460|Hormones|hormones|mesh-ancestor
138331173|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331174|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331175|NCT03591731|Nivolumab|nivolumab|mesh-list
138331176|NCT03591731|Ipilimumab|ipilimumab|mesh-list
138331177|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331178|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331179|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331180|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331181|NCT03439033|Edetic Acid|edetic acid|mesh-list
138331182|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
138331183|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
138331184|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
138331185|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331186|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
138331187|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138331188|NCT03330886|Atezolizumab|atezolizumab|mesh-list
138331189|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331190|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331191|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331192|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331194|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138331196|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331197|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331198|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138331199|NCT02987543|Olaparib|olaparib|mesh-list
138331200|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
138331201|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138331202|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331203|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331204|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331205|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138331206|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331207|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331208|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331209|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331210|NCT02983045|Paclitaxel|paclitaxel|mesh-list
138331211|NCT02983045|Cisplatin|cisplatin|mesh-list
138331212|NCT02983045|Carboplatin|carboplatin|mesh-list
138331213|NCT02983045|Nivolumab|nivolumab|mesh-list
138331214|NCT02983045|Pemetrexed|pemetrexed|mesh-list
138331215|NCT02983045|Ipilimumab|ipilimumab|mesh-list
138331216|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331217|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331218|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331219|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331220|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331221|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331222|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331223|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331224|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331225|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331226|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331228|NCT02894398|Fulvestrant|fulvestrant|mesh-list
138331229|NCT02894398|Palbociclib|palbociclib|mesh-list
138331230|NCT02894398|Anastrozole|anastrozole|mesh-list
138331231|NCT02894398|Exemestane|exemestane|mesh-list
138331232|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331233|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138331234|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138331235|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331236|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331237|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138331238|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331239|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331240|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331241|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331242|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138331243|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138331244|NCT02678052|Vedolizumab|vedolizumab|mesh-list
138366489|NCT06103747|Metformin|metformin|mesh-list
138331259|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331260|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331261|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331262|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331263|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331264|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138331265|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138331266|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331268|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331269|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331270|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331271|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331272|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331273|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331274|NCT02423265|Ranolazine|ranolazine|mesh-list
138331275|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138366501|NCT06103188|Protective Agents|protective agents|mesh-ancestor
138331276|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138331277|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331280|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
138331281|NCT02368886|Hormones|hormones|mesh-ancestor
138331282|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331283|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331284|NCT02301286|Aspirin|aspirin|mesh-list
138331285|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138331286|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138331287|NCT02301286|Analgesics|analgesics|mesh-ancestor
138331288|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
138331289|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331290|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331291|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331292|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331293|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138331294|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138331295|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331296|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138331297|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138331298|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331299|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
138331300|NCT02126969|Carboplatin|carboplatin|mesh-list
138331301|NCT02126969|Docetaxel|docetaxel|mesh-list
138331302|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331303|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331304|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331305|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331306|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331307|NCT02099188|Leucovorin|leucovorin|mesh-list
138331308|NCT02099188|Docetaxel|docetaxel|mesh-list
138331309|NCT02099188|Doxorubicin|doxorubicin|mesh-list
138331310|NCT02099188|Fluorouracil|fluorouracil|mesh-list
138331311|NCT02099188|Etoposide|etoposide|mesh-list
138331312|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138331313|NCT02099188|Ifosfamide|ifosfamide|mesh-list
138331314|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331315|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331316|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331317|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331318|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331321|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138331323|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
138331324|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331325|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331326|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
138331327|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331328|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331330|NCT02099188|Protective Agents|protective agents|mesh-ancestor
138331331|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
138331332|NCT02099188|Vitamins|vitamins|mesh-ancestor
138331333|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
138331334|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138331335|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
138331336|NCT02099175|Leucovorin|leucovorin|mesh-list
138331337|NCT02099175|Docetaxel|docetaxel|mesh-list
138331338|NCT02099175|Doxorubicin|doxorubicin|mesh-list
138331339|NCT02099175|Fluorouracil|fluorouracil|mesh-list
138331340|NCT02099175|Etoposide|etoposide|mesh-list
138331341|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138331342|NCT02099175|Ifosfamide|ifosfamide|mesh-list
138331343|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331344|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331345|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331346|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215928|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138367109|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
138367110|NCT04473911|Melphalan|melphalan|mesh-list
138367111|NCT04473911|Fludarabine|fludarabine|mesh-list
138367112|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367113|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
138331347|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331348|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138331349|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138331350|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138331351|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331352|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
138331353|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331354|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331355|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
138331356|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331357|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331359|NCT02099175|Protective Agents|protective agents|mesh-ancestor
138331360|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
138331362|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
138331363|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138331364|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
138331365|NCT01715285|Prednisone|prednisone|mesh-list
138331366|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
138331367|NCT01715285|Androgens|androgens|mesh-list
138331368|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331369|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
138331370|NCT01715285|Hormones|hormones|mesh-ancestor
138331371|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331372|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331373|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331374|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331375|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138331376|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331377|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331378|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331379|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331380|NCT01705184|Bevacizumab|bevacizumab|mesh-list
138331381|NCT01705184|Pemetrexed|pemetrexed|mesh-list
138331382|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331383|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366550|NCT06048809|Tin Fluorides|tin fluorides|mesh-list
138331386|NCT01705184|Growth Substances|growth substances|mesh-ancestor
138331387|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331388|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
138331389|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331390|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331391|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331392|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331393|NCT01285817|Celecoxib|celecoxib|mesh-list
138331394|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
138331395|NCT01285817|Methotrexate|methotrexate|mesh-list
138331396|NCT01285817|Vinblastine|vinblastine|mesh-list
138331397|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331398|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
138331399|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331400|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331401|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138331402|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
138331403|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331404|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331405|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138331406|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138331408|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331409|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331410|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
138331411|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331412|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331413|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331414|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331415|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138331416|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138331417|NCT01285817|Analgesics|analgesics|mesh-ancestor
138331418|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
138331419|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331420|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331421|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138331422|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138331423|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331424|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331425|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331426|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331427|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138331428|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138331429|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331430|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331431|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
138331432|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331434|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138331435|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
138331436|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331437|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331438|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138331439|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
138331440|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138331441|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138331442|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331443|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331444|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138331445|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138331446|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
138331447|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331448|NCT01250496|Protective Agents|protective agents|mesh-ancestor
138331449|NCT01105975|Atorvastatin|atorvastatin|mesh-list
138366558|NCT06044142|Sensory System Agents|sensory system agents|mesh-ancestor
138331453|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138331454|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138331455|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
138331456|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331457|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138331458|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138331459|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331460|NCT00651456|Bevacizumab|bevacizumab|mesh-list
138331462|NCT00651456|Pemetrexed|pemetrexed|mesh-list
138331463|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331464|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331465|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138331466|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138331467|NCT00651456|Growth Substances|growth substances|mesh-ancestor
138331468|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331469|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
138331470|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331471|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331472|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331473|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331474|NCT00280202|Dimercaprol|dimercaprol|mesh-list
138331475|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
138331476|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
138331477|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331478|NCT00079417|Iodine|iodine|mesh-list
138331480|NCT00079417|Carboplatin|carboplatin|mesh-list
138331481|NCT00079417|Vincristine|vincristine|mesh-list
138331482|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331483|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331484|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331485|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331486|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367123|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
138367124|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138367125|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331487|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331488|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138331489|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331490|NCT00079417|Trace Elements|trace elements|mesh-ancestor
138331491|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
138331492|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331494|NCT04386876|Lopinavir|lopinavir|mesh-list
138331495|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138331496|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138331497|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331498|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331499|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331500|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138331501|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138331502|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
138331504|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138331505|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331506|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
138331507|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138331508|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138331509|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331510|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
138331511|NCT04386642|Coagulants|coagulants|mesh-ancestor
138331512|NCT04385550|Paclitaxel|paclitaxel|mesh-list
138331513|NCT04385550|Docetaxel|docetaxel|mesh-list
138331514|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331515|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366566|NCT06037876|Ivermectin|ivermectin|mesh-list
138331519|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331520|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331521|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
138331522|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331523|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331524|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331525|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331526|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331527|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331528|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331529|NCT04384458|Ivermectin|ivermectin|mesh-list
138331530|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
138331531|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331532|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331533|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331534|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331535|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331536|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331537|NCT04383990|Insulin|insulin|mesh-list
138331538|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138331539|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331540|NCT04381884|Ivermectin|ivermectin|mesh-list
138331541|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331542|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331543|NCT04381962|Azithromycin|azithromycin|mesh-list
138331544|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331545|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331546|NCT04381104|Acetaminophen|acetaminophen|mesh-list
138331547|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138331548|NCT04381104|Analgesics|analgesics|mesh-ancestor
138331549|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
138331550|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331551|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331552|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
138331553|NCT04380402|Atorvastatin|atorvastatin|mesh-list
138331554|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138331555|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138331556|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
138367144|NCT04410406|Filaricides|filaricides|mesh-ancestor
138331557|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331558|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138331559|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138331560|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331561|NCT04380012|Trastuzumab|trastuzumab|mesh-list
138331562|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331563|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331564|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
138331566|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138331567|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138331568|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331569|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331570|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331574|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
138331575|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331576|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
138331577|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331578|NCT04376970|Fluorometholone|fluorometholone|mesh-list
138331579|NCT04376970|Cyclosporine|cyclosporine|mesh-list
138331580|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138331581|NCT04376970|Cyclosporins|cyclosporins|mesh-list
138331582|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331583|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331584|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331585|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
138331586|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331587|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
138331588|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331589|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331590|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331591|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138331592|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138331593|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331594|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
138331595|NCT04376970|Hormones|hormones|mesh-ancestor
138331596|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331597|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138331598|NCT04377048|Gemcitabine|gemcitabine|mesh-list
138331599|NCT04377048|Tegafur|tegafur|mesh-list
138331600|NCT04377048|Nivolumab|nivolumab|mesh-list
138331601|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331602|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
138331603|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331604|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331605|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331606|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331607|NCT04376814|Ritonavir|ritonavir|mesh-list
138331608|NCT04376814|Lopinavir|lopinavir|mesh-list
138331609|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331610|NCT04376814|Favipiravir|favipiravir|mesh-list
138331611|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138331612|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138331613|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331614|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331615|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331616|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138331617|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138331618|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
138331619|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331620|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138331621|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331622|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
138331623|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331624|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331625|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331626|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331627|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
138331628|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331629|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331630|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331631|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331632|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331633|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331634|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
138331635|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138331636|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138331637|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331638|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138331639|NCT04374318|Analgesics|analgesics|mesh-ancestor
138331640|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
138331641|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331642|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138331643|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138331644|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138331645|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
138331646|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331647|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331648|NCT04374552|Azithromycin|azithromycin|mesh-list
138331649|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331650|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331651|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331652|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
138331653|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331654|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331655|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331656|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331657|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331659|NCT04374006|Dienogest|dienogest|mesh-list
138331660|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331661|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138331662|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
138331663|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331664|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331665|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138331666|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138331667|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138331668|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138331669|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331670|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331671|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331672|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331673|NCT04372836|Vasopressins|vasopressins|mesh-list
138331674|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
138331675|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
138331676|NCT04372836|Coagulants|coagulants|mesh-ancestor
138331677|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138331678|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138331679|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
138331680|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331681|NCT04371978|Linagliptin|linagliptin|mesh-list
138331682|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138331683|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331685|NCT04371978|Hormones|hormones|mesh-ancestor
138331686|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331687|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138331688|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331689|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331690|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331691|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
138331692|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
138331693|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138331694|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331695|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331696|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331698|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138331699|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138331700|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138331701|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
138331703|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331704|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331705|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331707|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331708|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138331709|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138331710|NCT04368546|Growth Substances|growth substances|mesh-ancestor
138331711|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331712|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
138331713|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138331714|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331715|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331717|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331718|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331719|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331720|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331721|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331722|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331723|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
138331724|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
138331725|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331726|NCT04365582|Ritonavir|ritonavir|mesh-list
138331727|NCT04365582|Lopinavir|lopinavir|mesh-list
138331728|NCT04365582|Azithromycin|azithromycin|mesh-list
138331729|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331730|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138331731|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138331732|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331733|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331734|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331735|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138331736|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138331737|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
138331738|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331739|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138331740|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331741|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331743|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331744|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331745|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331746|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
138331747|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138331748|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
138331749|NCT04365270|Chitosan|chitosan|mesh-list
138331750|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138331751|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331753|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331754|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138331755|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138331756|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
138331757|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331758|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138331759|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
138331760|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
138331761|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
138331762|NCT04365270|Coagulants|coagulants|mesh-ancestor
138331764|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138331765|NCT04365270|Protective Agents|protective agents|mesh-ancestor
138331766|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331767|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138331768|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
138331769|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
138331770|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331771|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331772|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138331773|NCT04365036|Gemcitabine|gemcitabine|mesh-list
138331774|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
138331775|NCT04365036|Pegaspargase|pegaspargase|mesh-list
138331776|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331777|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
138331778|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331779|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331780|NCT04364022|Ritonavir|ritonavir|mesh-list
138331781|NCT04364022|Lopinavir|lopinavir|mesh-list
138331782|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138331783|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138331784|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331785|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331786|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331787|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138331788|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138331789|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
138331790|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331791|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138331792|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331793|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331794|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
138331795|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331796|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331797|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331798|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331799|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331800|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331802|NCT04362384|Prednisolone|prednisolone|mesh-list
138331803|NCT04362384|Vitamins|vitamins|mesh-ancestor
138331804|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
138331805|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331806|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331807|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
138331808|NCT04362384|Hormones|hormones|mesh-ancestor
138331809|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331810|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331811|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331812|NCT04362384|Protective Agents|protective agents|mesh-ancestor
138331813|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
138331814|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331815|NCT04361214|Leflunomide|leflunomide|mesh-list
138331816|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331817|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331818|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331819|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
138331820|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331821|NCT04361370|Bevacizumab|bevacizumab|mesh-list
138331822|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
138331823|NCT04361370|Olaparib|olaparib|mesh-list
138331824|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331825|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331826|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138331827|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138331829|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331830|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138331831|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138331832|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331833|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138331834|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331836|NCT04359966|Metronidazole|metronidazole|mesh-list
138331837|NCT04359966|Clarithromycin|clarithromycin|mesh-list
138331838|NCT04359966|Levofloxacin|levofloxacin|mesh-list
138331839|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138331840|NCT04359966|Esomeprazole|esomeprazole|mesh-list
138331841|NCT04359966|Bismuth|bismuth|mesh-list
138331842|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331843|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331844|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331845|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331846|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138331847|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138331848|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138331849|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331850|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331851|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138331852|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138331853|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138331854|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138331857|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331858|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138331859|NCT04359966|Antacids|antacids|mesh-ancestor
138331860|NCT04360122|Levamisole|levamisole|mesh-list
138331861|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
138331862|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138331863|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
138331864|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331865|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
138331866|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
138331867|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331868|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331869|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331870|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
138331871|NCT04360356|Ivermectin|ivermectin|mesh-list
138331872|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
138331874|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331875|NCT04359576|Hemostatics|hemostatics|mesh-list
138331876|NCT04359576|Coagulants|coagulants|mesh-ancestor
138331877|NCT04358796|Perflubron|perflubron|mesh-list
138331878|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138331879|NCT04358718|Anesthetics|anesthetics|mesh-list
138331880|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138331881|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331882|NCT04358562|Gefitinib|gefitinib|mesh-list
138331883|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331884|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138331885|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331886|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331887|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138331888|NCT04358016|Terlipressin|terlipressin|mesh-list
138331889|NCT04358016|Somatostatin|somatostatin|mesh-list
138331890|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138331891|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138331892|NCT04358016|Hormones|hormones|mesh-ancestor
138331893|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331894|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331895|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138331896|NCT04357392|Prednisone|prednisone|mesh-list
138331897|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331898|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138331899|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
138331900|NCT04357392|Hormones|hormones|mesh-ancestor
138331901|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331902|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331903|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331904|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
138331905|NCT04357002|Dinoprostone|dinoprostone|mesh-list
138331906|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138331907|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138331908|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331910|NCT04357002|Coagulants|coagulants|mesh-ancestor
138331911|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
138331912|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138331913|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331914|NCT04356222|Methotrexate|methotrexate|mesh-list
138331915|NCT04356222|Durvalumab|durvalumab|mesh-list
138331916|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138331917|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
138331918|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138367167|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331919|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331920|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331921|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
138331922|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331923|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331924|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138331925|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331926|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138331927|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331928|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
138331929|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331930|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138331931|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138331932|NCT04356144|Thrombin|thrombin|mesh-list
138331933|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
138331934|NCT04356144|Coagulants|coagulants|mesh-ancestor
138331935|NCT04355598|Lidocaine|lidocaine|mesh-list
138331936|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
138331937|NCT04355598|Prilocaine|prilocaine|mesh-list
138331938|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138331939|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
138331940|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
138331941|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138331942|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331943|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
138331944|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331945|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138331946|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138331947|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138331948|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138331949|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331950|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
138331951|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138331953|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138331954|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331955|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138331956|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138331957|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
138331958|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138331959|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331961|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
138331962|NCT04355052|Camostat|camostat|mesh-list
138331963|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331964|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331965|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
138331966|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331967|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138331968|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138331969|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331973|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138331974|NCT04354662|Leucovorin|leucovorin|mesh-list
138331975|NCT04354662|Docetaxel|docetaxel|mesh-list
138331976|NCT04354662|Fluorouracil|fluorouracil|mesh-list
138331977|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
138331978|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331979|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331980|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331981|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
138331982|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331983|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
138331984|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138331985|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138331986|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
138331987|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331988|NCT04354662|Antidotes|antidotes|mesh-ancestor
138331989|NCT04354662|Protective Agents|protective agents|mesh-ancestor
138331990|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
138331991|NCT04354662|Vitamins|vitamins|mesh-ancestor
138331992|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
138331993|NCT04354350|Telmisartan|telmisartan|mesh-list
138331994|NCT04354350|Ramipril|ramipril|mesh-list
138331995|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138331996|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138331997|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138331998|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331999|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138332000|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332001|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332002|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332003|NCT04353336|Chloroquine|chloroquine|mesh-list
138332004|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138332005|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
138332006|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332007|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332008|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332009|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332010|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332011|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332012|NCT04353336|Amebicides|amebicides|mesh-ancestor
138332013|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332014|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332015|NCT04353336|Analgesics|analgesics|mesh-ancestor
138332016|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
138332017|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332018|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332019|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332020|NCT04353336|Filaricides|filaricides|mesh-ancestor
138332021|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
138332022|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
138332023|NCT04353180|Tretinoin|tretinoin|mesh-list
138332024|NCT04353180|Isotretinoin|isotretinoin|mesh-list
138332025|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332027|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
138332028|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332029|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
138332030|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332031|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332032|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332033|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332034|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332035|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332036|NCT04351308|Apatinib|apatinib|mesh-list
138332037|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332038|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332039|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332040|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332041|NCT04351152|Lenzilumab|lenzilumab|mesh-list
138332042|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332043|NCT04350528|Pentobarbital|pentobarbital|mesh-list
138332044|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
138332045|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
138332046|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
138332047|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332048|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332049|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332050|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138332051|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138332052|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332053|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138332054|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138332055|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
138332056|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332057|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332058|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138332059|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138332060|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
138332061|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
138332062|NCT04350684|Interferons|interferons|mesh-list
138332063|NCT04350684|Ritonavir|ritonavir|mesh-list
138332065|NCT04350684|Interferon-beta|interferon-beta|mesh-list
138332066|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
138332067|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332068|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332069|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
138332070|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332071|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138366700|NCT05597878|Ketorolac|ketorolac|mesh-list
138332073|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332074|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332075|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332076|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138332077|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138332078|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138332079|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138332080|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
138332081|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332082|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332083|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332084|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
138332085|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332086|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138332088|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
138332089|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332090|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332091|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332092|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332093|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332094|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332095|NCT04349592|Azithromycin|azithromycin|mesh-list
138332096|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332097|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138332098|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332099|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
138332100|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332101|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332102|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332103|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332104|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332105|NCT04347252|Glucagon|glucagon|mesh-list
138332106|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332107|NCT04347252|Hormones|hormones|mesh-ancestor
138332108|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332109|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332110|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
138332111|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
138332112|NCT04346862|Vitamins|vitamins|mesh-ancestor
138332113|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
138332114|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332115|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
138332117|NCT04345848|Enoxaparin|enoxaparin|mesh-list
138332118|NCT04345848|Calcium heparin|calcium heparin|mesh-list
138332119|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
138332120|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138332121|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138332122|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332123|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332124|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
138332125|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332126|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332127|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332128|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332129|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332130|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332131|NCT04345458|Etanercept|etanercept|mesh-list
138332132|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332133|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332135|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
138332136|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332137|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332138|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332139|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332140|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332141|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332142|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
138332144|NCT04344756|Calcium heparin|calcium heparin|mesh-list
138332145|NCT04344756|Tinzaparin|tinzaparin|mesh-list
138332146|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138332147|NCT04344756|Dalteparin|dalteparin|mesh-list
138332148|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
138332149|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138332150|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138332151|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332152|NCT04344288|Prednisone|prednisone|mesh-list
138332153|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332154|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
138332155|NCT04344288|Hormones|hormones|mesh-ancestor
138332156|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332157|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332158|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138332159|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332160|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
138332161|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
138332162|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
138332163|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332164|NCT04342728|Vitamins|vitamins|mesh-list
138332165|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
138332166|NCT04342728|Zinc|zinc|mesh-list
138332167|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
138332168|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332169|NCT04342728|Trace Elements|trace elements|mesh-ancestor
138332170|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
138332171|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332172|NCT04342728|Protective Agents|protective agents|mesh-ancestor
138332173|NCT04342650|Chloroquine|chloroquine|mesh-list
138332174|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138332176|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332177|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332178|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332179|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
138332180|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332181|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332182|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332183|NCT04342650|Analgesics|analgesics|mesh-ancestor
138332187|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332188|NCT04342650|Filaricides|filaricides|mesh-ancestor
138332189|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
138332190|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
138332191|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
138332192|NCT04341402|Clotrimazole|clotrimazole|mesh-list
138332193|NCT04341402|Miconazole|miconazole|mesh-list
138332194|NCT04341402|Diclofenac|diclofenac|mesh-list
138332195|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332196|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332197|NCT04341402|Analgesics|analgesics|mesh-ancestor
138332198|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
138332199|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332200|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332201|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332202|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332203|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138332204|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332205|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332206|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332207|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138332208|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138332209|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138332210|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138332211|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
138332212|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332213|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138332214|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138332215|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332216|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
138332217|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332218|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332219|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332220|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332221|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332222|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332224|NCT04340778|Prilocaine|prilocaine|mesh-list
138332225|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138332226|NCT04340778|Dinoprostone|dinoprostone|mesh-list
138332227|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
138332228|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
138332229|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332230|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332231|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
138332232|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332233|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138332234|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138332235|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138332236|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332237|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332238|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
138332239|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138332240|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138332242|NCT04340388|Lamivudine|lamivudine|mesh-list
138332243|NCT04340388|Zidovudine|zidovudine|mesh-list
138332244|NCT04340388|Dolutegravir|dolutegravir|mesh-list
138332245|NCT04340388|Darunavir|darunavir|mesh-list
138332246|NCT04340388|Abacavir|abacavir|mesh-list
138332247|NCT04340388|Cobicistat|cobicistat|mesh-list
138332248|NCT04340388|Rilpivirine|rilpivirine|mesh-list
138332249|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138332250|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
138332251|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332252|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138332253|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138332254|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332255|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332257|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
138332258|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138332259|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138332260|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138332261|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138332262|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332263|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138332264|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138332265|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332266|NCT04338906|Camostat|camostat|mesh-list
138332267|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
138332268|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332269|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332270|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332271|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332272|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332273|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332274|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332275|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138332276|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138332277|NCT04338438|Apatinib|apatinib|mesh-list
138332278|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332279|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332280|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332281|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332282|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
138332283|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138332284|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138332285|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332286|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
138332287|NCT04338126|Coagulants|coagulants|mesh-ancestor
138332288|NCT04337658|Capecitabine|capecitabine|mesh-list
138332289|NCT04337658|Trastuzumab|trastuzumab|mesh-list
138332290|NCT04337658|Fulvestrant|fulvestrant|mesh-list
138332291|NCT04337658|Pertuzumab|pertuzumab|mesh-list
138332292|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138332293|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
138332294|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332295|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332296|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332299|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138332300|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
138332301|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332302|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332304|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138332305|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332307|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332308|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332309|NCT04337268|Incretins|incretins|mesh-ancestor
138332310|NCT04336566|Melatonin|melatonin|mesh-list
138332312|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332313|NCT04336566|Protective Agents|protective agents|mesh-ancestor
138332314|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332315|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332316|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138332317|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
138332318|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332319|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
138332320|NCT04336488|Hormones|hormones|mesh-ancestor
138332321|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332322|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332323|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332324|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
138332325|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332326|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332327|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332329|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138332330|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138332331|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138332332|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332333|NCT04334928|Tenofovir|tenofovir|mesh-list
138332334|NCT04334928|Emtricitabine|emtricitabine|mesh-list
138332335|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138332336|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332337|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
138332338|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332339|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138332340|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138332341|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332342|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332343|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138332344|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138332345|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
138332346|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332347|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332348|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332349|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138332350|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332351|NCT04334382|Azithromycin|azithromycin|mesh-list
138332352|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332353|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138332354|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332355|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
138332356|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332357|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332358|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332359|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332360|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332361|NCT04333992|Remifentanil|remifentanil|mesh-list
138332362|NCT04333992|Propofol|propofol|mesh-list
138332363|NCT04333992|Sevoflurane|sevoflurane|mesh-list
138332364|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138332365|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332366|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332367|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138332368|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
138332369|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
138332370|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138332371|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138332372|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138332373|NCT04333992|Narcotics|narcotics|mesh-ancestor
138332374|NCT04333992|Analgesics|analgesics|mesh-ancestor
138332375|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
138332376|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332377|NCT04332978|Fluticasone|fluticasone|mesh-list
138332379|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332380|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138332381|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
138332382|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332383|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332384|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138332385|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138332386|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138332387|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138332388|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138332389|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138332390|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
138332391|NCT04332276|Dopamine|dopamine|mesh-list
138332392|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138332393|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
138332394|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
138332396|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332398|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332399|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332401|NCT04332042|Tofacitinib|tofacitinib|mesh-list
138332402|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138332403|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332404|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332405|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332406|NCT04341870|Azithromycin|azithromycin|mesh-list
138332407|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332408|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138332409|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332410|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
138332411|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332412|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332413|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332414|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332415|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332417|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332418|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332419|NCT04330872|Analgesics|analgesics|mesh-ancestor
138332420|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
138332421|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332422|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332423|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332424|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332425|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138332426|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138332427|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332428|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138332429|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138332430|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332431|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
138332432|NCT04330326|Sorbitol|sorbitol|mesh-list
138332433|NCT04330326|Cathartics|cathartics|mesh-ancestor
138332434|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332435|NCT04329858|Methamphetamine|methamphetamine|mesh-list
138332436|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138332437|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332438|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
138332439|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
138332440|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332441|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
138332442|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332443|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332444|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
138332445|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138332446|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138332447|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332448|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138332449|NCT00704106|Entecavir|entecavir|mesh-list
138332452|NCT05614752|Fexuprazan|fexuprazan|mesh-list
138332453|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332454|NCT05278884|Anesthetics|anesthetics|mesh-list
138332455|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332456|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332457|NCT05136690|Nicotine|nicotine|mesh-list
138332458|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138332459|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
138332460|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332461|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332462|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138332463|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138332464|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
138332465|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332466|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332467|NCT05035680|Vaccines|vaccines|mesh-list
138332468|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
138332469|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332471|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332472|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215929|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332473|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138332474|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332476|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332477|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332478|NCT03035214|Dexamethasone|dexamethasone|mesh-list
138332479|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
138332480|NCT03035214|BB 1101|bb 1101|mesh-list
138332481|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332482|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
138332483|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
138332484|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332485|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332486|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332487|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
138332488|NCT03035214|Hormones|hormones|mesh-ancestor
138332489|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332490|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138332491|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332492|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332493|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332494|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332496|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332497|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
138332498|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138332499|NCT03033654|Protective Agents|protective agents|mesh-ancestor
138332500|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332502|NCT03033732|Buprenorphine|buprenorphine|mesh-list
138332504|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138332505|NCT03033732|Naloxone|naloxone|mesh-list
138332506|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138332507|NCT03033732|Narcotics|narcotics|mesh-ancestor
138332508|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332509|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332510|NCT03033732|Analgesics|analgesics|mesh-ancestor
138332511|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
138332512|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332513|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138332514|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
138332515|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
138332516|NCT03033264|Dinoprostone|dinoprostone|mesh-list
138332517|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
138332518|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138332519|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332520|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138332521|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138332522|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138332523|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332524|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332525|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
138332526|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332527|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138332528|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138332529|NCT03030690|Methamphetamine|methamphetamine|mesh-list
138332530|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138332531|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332532|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
138332533|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
138332534|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332535|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
138332536|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332537|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332538|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
138332539|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138332540|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138332541|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332542|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138332543|NCT03030300|Metformin|metformin|mesh-list
138332545|NCT03030300|Insulin|insulin|mesh-list
138332546|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138332547|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332548|NCT03029442|Denosumab|denosumab|mesh-list
138332549|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138332550|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332551|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
138332552|NCT03023514|Progesterone|progesterone|mesh-list
138332553|NCT03023514|Progestins|progestins|mesh-ancestor
138332554|NCT03023514|Hormones|hormones|mesh-ancestor
138332555|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332556|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332557|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
138332558|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332559|NCT03023514|Protective Agents|protective agents|mesh-ancestor
138332560|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
138332561|NCT03023514|Vitamins|vitamins|mesh-ancestor
138332562|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
138332563|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
138332564|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
138332565|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138332566|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138332567|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332568|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332569|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332570|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332571|NCT03019848|Curcumin|curcumin|mesh-list
138332572|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332573|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332574|NCT03019848|Analgesics|analgesics|mesh-ancestor
138332575|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
138332576|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332577|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332578|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332579|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332580|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332581|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332582|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332583|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
138332584|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332585|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138332586|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138332587|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332588|NCT03018990|Ethanol|ethanol|mesh-list
138332589|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138332590|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332591|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332592|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332594|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138332595|NCT03018756|Narcotics|narcotics|mesh-ancestor
138332596|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332597|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332598|NCT03018756|Analgesics|analgesics|mesh-ancestor
138332599|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
138332600|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332601|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138332602|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138367190|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367191|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367192|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367193|NCT04149574|Nivolumab|nivolumab|mesh-list
138367194|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
138367195|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367196|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367197|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367198|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367199|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138367200|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
138332603|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
138332604|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
138332605|NCT03018444|Atorvastatin|atorvastatin|mesh-list
138332606|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138332607|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138332608|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
138332609|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332610|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138332611|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138332612|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332613|NCT03017430|Ketorolac|ketorolac|mesh-list
138332615|NCT03017430|Clonidine|clonidine|mesh-list
138332616|NCT03017430|Pregabalin|pregabalin|mesh-list
138332617|NCT03017430|Metoclopramide|metoclopramide|mesh-list
138332618|NCT03017430|Loperamide|loperamide|mesh-list
138332619|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
138332620|NCT03017430|Analgesics|analgesics|mesh-ancestor
138332621|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
138332622|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332623|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332624|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
138332625|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138332626|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332627|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332628|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332629|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138332630|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138332631|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332632|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138332633|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332634|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332635|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332636|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332637|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138332638|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332639|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138332640|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
138332641|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
138332642|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138332643|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138332644|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138332645|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138332646|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332647|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
138332648|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332649|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138332650|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138332651|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
138332652|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138332653|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
138332654|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138332655|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
138332656|NCT03017352|Exenatide|exenatide|mesh-list
138332657|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138332658|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332659|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138332660|NCT03017352|Incretins|incretins|mesh-ancestor
138332661|NCT03017352|Hormones|hormones|mesh-ancestor
138332662|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332663|NCT03016884|Vaccines|vaccines|mesh-list
138332664|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
138332665|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332666|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
138332667|NCT03016806|Melphalan|melphalan|mesh-list
138332668|NCT03016806|Busulfan|busulfan|mesh-list
138332669|NCT03016806|Fludarabine|fludarabine|mesh-list
138332670|NCT03016806|Mesna|mesna|mesh-list
138332671|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332675|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138332676|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
138332677|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332678|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332679|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138332680|NCT03016806|Protective Agents|protective agents|mesh-ancestor
138332681|NCT03016650|Acetaminophen|acetaminophen|mesh-list
138332682|NCT03016650|Ibuprofen|ibuprofen|mesh-list
138332683|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332684|NCT03016650|Analgesics|analgesics|mesh-ancestor
138332685|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
138332686|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332687|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332688|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
138332689|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332690|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332691|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332692|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138332693|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332694|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332695|NCT03016260|Adalimumab|adalimumab|mesh-list
138332696|NCT03016260|Infliximab|infliximab|mesh-list
138332697|NCT03016260|Golimumab|golimumab|mesh-list
138332698|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
138332699|NCT03016260|Etanercept|etanercept|mesh-list
138332700|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138332701|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332702|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332704|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332705|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332706|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332707|NCT03016260|Analgesics|analgesics|mesh-ancestor
138367203|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138367204|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138332708|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
138332709|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332710|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332711|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332712|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
138332713|NCT03015246|Morphine|morphine|mesh-list
138332714|NCT03015246|Buprenorphine|buprenorphine|mesh-list
138332715|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138332716|NCT03015246|Naloxone|naloxone|mesh-list
138332717|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138332718|NCT03015246|Narcotics|narcotics|mesh-ancestor
138332719|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332720|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332721|NCT03015246|Analgesics|analgesics|mesh-ancestor
138332723|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332724|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138332726|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138332727|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
138367256|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367257|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367258|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138367259|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138367260|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367261|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138367262|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138367263|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367264|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
138332728|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332729|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332730|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
138332731|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138332732|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
138332733|NCT03014778|Povidone|povidone|mesh-list
138332734|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138332735|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332736|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
138332737|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138332738|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
138367306|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367307|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138367308|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138367309|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367310|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
138367311|NCT03766425|Aflibercept|aflibercept|mesh-list
138367312|NCT03766425|Mitomycins|mitomycins|mesh-list
138367313|NCT03766425|Mitomycin|mitomycin|mesh-list
138367314|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367315|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367316|NCT03766425|Growth Substances|growth substances|mesh-ancestor
138367317|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367318|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
138367319|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332739|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
138332740|NCT03014076|Trastuzumab|trastuzumab|mesh-list
138332741|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332742|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332743|NCT03013140|Anesthetics|anesthetics|mesh-list
138332744|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332745|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332746|NCT03011970|Oxytocin|oxytocin|mesh-list
138332747|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
138332748|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138332749|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332750|NCT03010098|Remifentanil|remifentanil|mesh-list
138332751|NCT03010098|Propofol|propofol|mesh-list
138332752|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138332753|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332754|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332755|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138332756|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
138332757|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
138332758|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138332759|NCT03010098|Narcotics|narcotics|mesh-ancestor
138332760|NCT03010098|Analgesics|analgesics|mesh-ancestor
138332761|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
138332762|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332763|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138332764|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138332765|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138332766|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138332767|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
138332768|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332769|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138332770|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138332771|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332772|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138332773|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
138332776|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332777|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332778|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138332779|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138332780|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332782|NCT03008148|Temozolomide|temozolomide|mesh-list
138332783|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138332784|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
138332785|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332786|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332787|NCT03007992|Vinorelbine|vinorelbine|mesh-list
138332788|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138332789|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332790|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138332791|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138332792|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138332793|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332794|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
138332796|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332797|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332798|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332799|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332800|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
138332801|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138332802|NCT03007524|Calcium|calcium|mesh-list
138332803|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332804|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332805|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138332806|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138332807|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138332808|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
138332809|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332810|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138332811|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138332812|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332813|NCT03006042|Bupivacaine|bupivacaine|mesh-list
138332814|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
138332815|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
138332816|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332817|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332818|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
138332819|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332820|NCT03005496|Vitamin D|vitamin d|mesh-list
138332821|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
138332822|NCT03005496|Beta Carotene|beta carotene|mesh-list
138332823|NCT03005496|Zinc|zinc|mesh-list
138332824|NCT03005496|Dexamethasone|dexamethasone|mesh-list
138332825|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
138332826|NCT03005496|Nifedipine|nifedipine|mesh-list
138332827|NCT03005496|BB 1101|bb 1101|mesh-list
138332828|NCT03005496|Carotenoids|carotenoids|mesh-list
138332829|NCT03005496|Picolinic acid|picolinic acid|mesh-list
138332830|NCT03005496|Vitamins|vitamins|mesh-ancestor
138332831|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
138332832|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332833|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332834|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
138332835|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
138332836|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366931|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332837|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332838|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
138332839|NCT03005496|Hormones|hormones|mesh-ancestor
138332840|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332841|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138332842|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332843|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332844|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332845|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332846|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138332847|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332848|NCT03005496|Trace Elements|trace elements|mesh-ancestor
138332849|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138332850|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332851|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138332852|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
138332853|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138332855|NCT03005496|Protective Agents|protective agents|mesh-ancestor
138332856|NCT03005496|Provitamins|provitamins|mesh-ancestor
138332857|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138332858|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
138332859|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
138332860|NCT03005808|Ropivacaine|ropivacaine|mesh-list
138332861|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
138332862|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
138332863|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332864|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332865|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
138332866|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332867|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
138332868|NCT03005340|Vitamin D|vitamin d|mesh-list
138332869|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
138332870|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332871|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332872|NCT03005340|Vitamins|vitamins|mesh-ancestor
138332873|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
138332874|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138332875|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138332876|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138332877|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
138332878|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332880|NCT03005184|Valsartan|valsartan|mesh-list
138332881|NCT03005184|Enalapril|enalapril|mesh-list
138332882|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138332883|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138332884|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138332885|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138332886|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332887|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138332888|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
138332889|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366944|NCT05010772|Venetoclax|venetoclax|mesh-list
138332891|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138332893|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
138332894|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332895|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332896|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138332897|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138332898|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138332899|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138332900|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138332901|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332902|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
138332903|NCT03004014|Propofol|propofol|mesh-list
138332904|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138332905|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332906|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332907|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138332908|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
138332909|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
138332910|NCT03002844|Carboplatin|carboplatin|mesh-list
138332911|NCT03002844|Gemcitabine|gemcitabine|mesh-list
138332912|NCT03002844|Pemetrexed|pemetrexed|mesh-list
138332913|NCT03002844|Gefitinib|gefitinib|mesh-list
138332914|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332915|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138332916|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
138332917|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332918|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332919|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138332920|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138332921|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138332922|NCT03002376|Cemiplimab|cemiplimab|mesh-list
138332923|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138332924|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332925|NCT03002064|Docetaxel|docetaxel|mesh-list
138332926|NCT03002064|Fluorouracil|fluorouracil|mesh-list
138332927|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332928|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
138332929|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
138332930|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
138332931|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332932|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
138332933|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138332934|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138332935|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
138332936|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332937|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138332938|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
138332939|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332940|NCT03000660|Dexamethasone|dexamethasone|mesh-list
138332941|NCT03000660|Venetoclax|venetoclax|mesh-list
138332944|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
138332945|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332946|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332947|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138332948|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
138332949|NCT03000660|Hormones|hormones|mesh-ancestor
138332950|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138332951|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138332952|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332953|NCT03000036|Doxorubicin|doxorubicin|mesh-list
138332954|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138332955|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138332956|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332957|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138332958|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138332959|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138332960|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332961|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
138332962|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
138332963|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
138332964|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138332965|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138332966|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
138332967|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138332968|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138332969|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138332971|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332972|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
138332973|NCT02989272|Analgesics|analgesics|mesh-ancestor
138332974|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
138332975|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332976|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332977|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
138332978|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138332979|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138332980|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
138332981|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138332982|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332983|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332984|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138332986|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138332988|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138332989|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
138332990|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332991|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332992|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138332993|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138332994|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
138367392|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
138332995|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332996|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138332997|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138332998|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138333000|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333001|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333002|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333003|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333004|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333005|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333007|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138333008|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333009|NCT02987400|Venetoclax|venetoclax|mesh-list
138333010|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
138333011|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333012|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333013|NCT02987244|Prednisone|prednisone|mesh-list
138333014|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
138333015|NCT02987244|Etoposide|etoposide|mesh-list
138333016|NCT02987244|Epirubicin|epirubicin|mesh-list
138333017|NCT02987244|Vindesine|vindesine|mesh-list
138333018|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333019|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
138333020|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333021|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333022|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138333023|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
138333024|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333025|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333026|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138333027|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333028|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
138333029|NCT02987244|Hormones|hormones|mesh-ancestor
138333030|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333031|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138333032|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333033|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138333034|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333035|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333036|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138333037|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
138333038|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
138333039|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
138333040|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
138333041|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333042|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333043|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138333044|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333045|NCT02982486|Nivolumab|nivolumab|mesh-list
138333046|NCT02982486|Ipilimumab|ipilimumab|mesh-list
138333047|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333048|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333049|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138333050|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333052|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333053|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333058|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
138333059|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
138333060|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333061|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333062|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
138333063|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333064|NCT02980458|Deferiprone|deferiprone|mesh-list
138333065|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138333066|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
138333067|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
138333068|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333069|NCT02978976|Betamethasone|betamethasone|mesh-list
138333070|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333071|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
138333072|NCT02978976|Hormones|hormones|mesh-ancestor
138333073|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333074|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333075|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138333076|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333077|NCT02979132|Iron|iron|mesh-list
138333078|NCT02979132|Trace Elements|trace elements|mesh-ancestor
138333079|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
138333080|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333081|NCT02978040|Tirofiban|tirofiban|mesh-list
138333082|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138333083|NCT02978040|Cangrelor|cangrelor|mesh-list
138333084|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138333085|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138333086|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138333087|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333088|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138333089|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138333090|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138333091|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
138333092|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333093|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333094|NCT02976246|Vitamin K|vitamin k|mesh-list
138333095|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
138333096|NCT02976246|Vitamins|vitamins|mesh-ancestor
138333097|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
138333098|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333099|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138333100|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138333101|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333102|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
138333103|NCT02976246|Coagulants|coagulants|mesh-ancestor
138333104|NCT02976012|Aflibercept|aflibercept|mesh-list
138333105|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333106|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333109|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333110|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333111|NCT02975076|Aspirin|aspirin|mesh-list
138333112|NCT02975076|Clopidogrel|clopidogrel|mesh-list
138333113|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333114|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333115|NCT02975076|Analgesics|analgesics|mesh-ancestor
138333116|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
138333117|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333118|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333119|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333120|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333121|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138333122|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138333123|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333124|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138333125|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333126|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333127|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
138333128|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138333129|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138333130|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138333131|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
138333132|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333133|NCT02974920|Aspirin|aspirin|mesh-list
138333134|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
138333135|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333136|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333137|NCT02974920|Analgesics|analgesics|mesh-ancestor
138333138|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
138333139|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333140|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333141|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333142|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333143|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138333144|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138333145|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333146|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138333147|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333148|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333149|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
138333150|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138333151|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
138333152|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138333153|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
138333154|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
138333156|NCT02973204|Sorafenib|sorafenib|mesh-list
138333157|NCT02973204|Octreotide|octreotide|mesh-list
138333158|NCT02973204|Lanreotide|lanreotide|mesh-list
138333159|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138333160|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333161|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333162|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333163|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333165|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333166|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333167|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138333168|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138333169|NCT02959476|Ropivacaine|ropivacaine|mesh-list
138333170|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
138333171|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
138333172|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333173|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333174|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
138333175|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333176|NCT02958852|Letrozole|letrozole|mesh-list
138333177|NCT02958852|Fulvestrant|fulvestrant|mesh-list
138333178|NCT02958852|Atorvastatin|atorvastatin|mesh-list
138333179|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138333180|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138333181|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
138333182|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333183|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138333184|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138333185|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333186|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333187|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138333188|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138333189|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138333190|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
138333191|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333192|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333193|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138333194|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138333195|NCT02641782|Aldesleukin|aldesleukin|mesh-list
138333196|NCT02641782|Interleukin-2|interleukin-2|mesh-list
138333197|NCT02641782|Tretinoin|tretinoin|mesh-list
138333198|NCT02641782|Dinutuximab|dinutuximab|mesh-list
138333199|NCT02641782|Isotretinoin|isotretinoin|mesh-list
138333200|NCT02641782|Antibodies|antibodies|mesh-list
138333201|NCT02641782|Sargramostim|sargramostim|mesh-list
138333202|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
138333203|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333204|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333205|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333207|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
138333208|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333209|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
138333210|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
138333211|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138333212|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138333213|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
138333214|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333215|NCT02641314|Celecoxib|celecoxib|mesh-list
138333216|NCT02641314|Propranolol|propranolol|mesh-list
138333217|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333218|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333219|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333221|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333222|NCT02641314|Analgesics|analgesics|mesh-ancestor
138333223|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
138333224|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333225|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333226|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138333227|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333228|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333229|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138333230|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138333231|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
138333232|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333233|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138333234|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333235|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
138333236|NCT04769778|Valsartan|valsartan|mesh-list
138333237|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333238|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138333239|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138333240|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333241|NCT04769076|Paclitaxel|paclitaxel|mesh-list
138333242|NCT04769076|Cisplatin|cisplatin|mesh-list
138333243|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138333244|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333245|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333246|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
138333247|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
138333248|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
138333249|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333250|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333251|NCT04768764|Bupivacaine|bupivacaine|mesh-list
138333252|NCT04768764|Anesthetics|anesthetics|mesh-list
138333253|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
138333254|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333255|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333256|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
138333257|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333258|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
138333259|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138333260|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333261|NCT04748562|Progesterone|progesterone|mesh-list
138333262|NCT04748562|Progestins|progestins|mesh-ancestor
138333263|NCT04748562|Hormones|hormones|mesh-ancestor
138333264|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333265|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333266|NCT04745286|Ketamine|ketamine|mesh-list
138333267|NCT04745286|Esketamine|esketamine|mesh-list
138333268|NCT04745286|Analgesics|analgesics|mesh-ancestor
138333269|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
138333270|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333271|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333272|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138367072|NCT04585334|Diclofenac|diclofenac|mesh-list
138333273|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138333274|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
138333275|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
138333276|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333277|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138333278|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138333279|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367430|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367431|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367432|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
138367433|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333280|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333281|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333282|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333283|NCT04745442|Antithrombins|antithrombins|mesh-list
138333284|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
138333285|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138333286|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
138333287|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333288|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333289|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
138333290|NCT04743180|Paclitaxel|paclitaxel|mesh-list
138333291|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333292|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333293|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138333294|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138333295|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138333296|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333297|NCT04740840|Amlodipine|amlodipine|mesh-list
138333298|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333299|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138333300|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333301|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333302|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138333303|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333304|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
138333305|NCT04739202|Bevacizumab|bevacizumab|mesh-list
138333306|NCT04739202|Atezolizumab|atezolizumab|mesh-list
138333307|NCT04739202|Ipatasertib|ipatasertib|mesh-list
138333308|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138333309|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333310|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333311|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333312|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333313|NCT04739202|Growth Substances|growth substances|mesh-ancestor
138333314|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333315|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333316|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138333317|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333318|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
138333319|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333320|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333321|NCT04738188|Epirubicin|epirubicin|mesh-list
138333322|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138333323|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333324|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138333325|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333326|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333327|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333328|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138333329|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138367088|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
138333330|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138333331|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
138333332|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333333|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138333334|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138333335|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333336|NCT05314140|Calcium|calcium|mesh-list
138333337|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138333338|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333339|NCT05313906|Cisplatin|cisplatin|mesh-list
138333340|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333341|NCT05313828|Fluorometholone|fluorometholone|mesh-list
138333342|NCT05313828|Tobramycin|tobramycin|mesh-list
138333343|NCT05313828|Acyclovir|acyclovir|mesh-list
138333344|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
138333345|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138333346|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
138333347|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333348|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
138333349|NCT05313828|Protective Agents|protective agents|mesh-ancestor
138333350|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138333351|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333352|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
138333353|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333354|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
138333356|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333357|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138333358|NCT05313750|Levofloxacin|levofloxacin|mesh-list
138333359|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
138333360|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
138333361|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138333362|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138333363|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138333364|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333365|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333366|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333367|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333368|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138367445|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138333369|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138333370|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
138333372|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
138333373|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138333374|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138333375|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333376|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333377|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
138333379|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
138333380|NCT05139966|Protective Agents|protective agents|mesh-ancestor
138333381|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333382|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138333383|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138333384|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333385|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
138333386|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138333387|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138333388|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138333389|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333390|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333391|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
138333392|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333393|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333394|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138333395|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333396|NCT00577590|Metformin|metformin|mesh-list
138333397|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
138333398|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138333399|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333400|NCT00578214|Midazolam|midazolam|mesh-list
138333401|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
138333402|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333403|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333404|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138333405|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138333406|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138333407|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138333408|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333409|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138333410|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
138333411|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
138333413|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333414|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333415|NCT00580398|Varenicline|varenicline|mesh-list
138333416|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138333417|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138333418|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
138333419|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333420|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333421|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333422|NCT00582660|Celecoxib|celecoxib|mesh-list
138333423|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333424|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333425|NCT00582660|Analgesics|analgesics|mesh-ancestor
138333426|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
138333427|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333428|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333429|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333430|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333431|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138333432|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333433|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333434|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333435|NCT00582894|Fludarabine|fludarabine|mesh-list
138333436|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
138333437|NCT00582894|Busulfan|busulfan|mesh-list
138333438|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333439|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333440|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333441|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
138333442|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333443|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333444|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
138333445|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138333446|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138333447|NCT00585780|Prazosin|prazosin|mesh-list
138333448|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333449|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138333450|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138333451|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138333452|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
138333453|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333454|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333455|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333456|NCT00586482|Nicotine|nicotine|mesh-list
138333457|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138333458|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
138333459|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333460|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333461|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138333462|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138333463|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
138333464|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333465|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333466|NCT03708354|Tocotrienols|tocotrienols|mesh-list
138333467|NCT03708354|Vitamin E|vitamin e|mesh-list
138333468|NCT03708354|Tocopherols|tocopherols|mesh-list
138333469|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
138333470|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333471|NCT03708354|Protective Agents|protective agents|mesh-ancestor
138333472|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333473|NCT03708354|Vitamins|vitamins|mesh-ancestor
138333474|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
138333475|NCT03297684|Aflibercept|aflibercept|mesh-list
138333476|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333477|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333478|NCT03297684|Growth Substances|growth substances|mesh-ancestor
138333479|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333480|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333481|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333482|NCT01685424|Etoricoxib|etoricoxib|mesh-list
138333483|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333484|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333485|NCT01685424|Analgesics|analgesics|mesh-ancestor
138333486|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
138333487|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333488|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333489|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333490|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333491|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138333492|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333493|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333494|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333495|NCT01327638|Etoricoxib|etoricoxib|mesh-list
138333496|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138333497|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333498|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333499|NCT01327638|Analgesics|analgesics|mesh-ancestor
138333500|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
138333501|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333502|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333503|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333504|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333505|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333506|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333507|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333508|NCT00393354|Etoricoxib|etoricoxib|mesh-list
138333509|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333510|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333511|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333512|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333513|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138333514|NCT00393354|Analgesics|analgesics|mesh-ancestor
138333515|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
138333516|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333517|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333518|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138333519|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138333520|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333524|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138333525|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138333526|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
138333527|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333528|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138333529|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138333530|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333532|NCT00588900|Cediranib|cediranib|mesh-list
138333533|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138333534|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333535|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333536|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333537|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333538|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333539|NCT00589056|Nelfinavir|nelfinavir|mesh-list
138333540|NCT00589056|Etoposide|etoposide|mesh-list
138333541|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333542|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333543|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138333544|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333545|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333547|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138333548|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138333549|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
138333550|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138333551|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138333552|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
138333553|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333554|NCT00590226|Insulin|insulin|mesh-list
138333555|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138333556|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
138333557|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
138333558|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
138333559|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
138333560|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138333561|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333562|NCT00590460|Fludarabine|fludarabine|mesh-list
138333563|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
138333564|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333565|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333566|NCT00590772|Montelukast|montelukast|mesh-list
138333567|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138333568|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333569|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138333571|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333572|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333573|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138333574|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138333575|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333576|NCT00592176|Bevacizumab|bevacizumab|mesh-list
138333577|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333578|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333579|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333580|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333581|NCT00592176|Growth Substances|growth substances|mesh-ancestor
138333582|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333583|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333584|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
138333587|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
138333588|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333589|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
138333590|NCT00595530|Ketamine|ketamine|mesh-list
138333591|NCT00595530|Analgesics|analgesics|mesh-ancestor
138333592|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
138333593|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333594|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333595|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138333596|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138333597|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
138333598|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
138333599|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333600|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138333601|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138333602|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333603|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333604|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
138333605|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333606|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333607|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333608|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333609|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
138333610|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138333611|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333612|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333613|NCT00597402|Bevacizumab|bevacizumab|mesh-list
138333614|NCT00597402|Irinotecan|irinotecan|mesh-list
138333615|NCT00597402|Temozolomide|temozolomide|mesh-list
138333616|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333617|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333618|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333619|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333620|NCT00597402|Growth Substances|growth substances|mesh-ancestor
138333621|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333622|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333623|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138333624|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333625|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333626|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333627|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138333628|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
138333629|NCT00598806|Apaziquone|apaziquone|mesh-list
138333630|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333631|NCT00601926|Bevacizumab|bevacizumab|mesh-list
138333632|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333633|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333634|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333635|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333636|NCT00601926|Growth Substances|growth substances|mesh-ancestor
138333637|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333638|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333639|NCT00603018|Fluoxetine|fluoxetine|mesh-list
138333640|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138333641|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138333642|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333643|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333644|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333645|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
138333647|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138333648|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333649|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333650|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138333651|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138333652|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333653|NCT00603408|Cisplatin|cisplatin|mesh-list
138333654|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333655|NCT00603720|Phenylephrine|phenylephrine|mesh-list
138333656|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
138333657|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
138333658|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138333659|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
138333660|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
138333661|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333662|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333663|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
138333664|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138333665|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
138333666|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333667|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138333668|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138333669|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138333671|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333672|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333673|NCT00603720|Protective Agents|protective agents|mesh-ancestor
138333674|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333675|NCT00625404|Tenofovir|tenofovir|mesh-list
138333676|NCT00625404|Emtricitabine|emtricitabine|mesh-list
138333677|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138333678|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
138333679|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333680|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138333681|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138333682|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333683|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333684|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138333685|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138333686|NCT00626340|Fluoxetine|fluoxetine|mesh-list
138333687|NCT00626340|Estrogens|estrogens|mesh-list
138333688|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138333689|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138333690|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333691|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333692|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333693|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
138333694|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333695|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138333696|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333697|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333698|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138333699|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138333700|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333704|NCT00626574|Hematinics|hematinics|mesh-ancestor
138333705|NCT00626886|Bupivacaine|bupivacaine|mesh-list
138333706|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
138333707|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
138333708|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333709|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333710|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
138333711|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333712|NCT00628134|Calfactant|calfactant|mesh-list
138333713|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138333714|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333715|NCT00632814|Factor VIII|factor viii|mesh-list
138333716|NCT00632814|Coagulants|coagulants|mesh-ancestor
138333717|NCT00632970|Ritonavir|ritonavir|mesh-list
138333718|NCT00632970|Lopinavir|lopinavir|mesh-list
138333719|NCT00632970|Tenofovir|tenofovir|mesh-list
138333720|NCT00632970|Emtricitabine|emtricitabine|mesh-list
138333721|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138333722|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
138333723|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138333724|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138333725|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
138333726|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333727|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333728|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138333729|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138333730|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
138333731|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333732|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138333733|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138333734|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138333735|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138333737|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138333738|NCT00635232|Irbesartan|irbesartan|mesh-list
138333739|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333740|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138333741|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138333742|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333744|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138333745|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
138333746|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138333747|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333748|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138333749|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138333750|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138333751|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
138333752|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138333753|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138333754|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
138333755|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333756|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
138333757|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138333758|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138333760|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
138333761|NCT00638820|Clofarabine|clofarabine|mesh-list
138333762|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
138333763|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333764|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333765|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
138333766|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333767|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138333768|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333769|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138333770|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333771|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138333772|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
138333773|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
138333774|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
138333775|NCT00641862|Vitamins|vitamins|mesh-ancestor
138333776|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
138333777|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333778|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
138333779|NCT00641862|Hematinics|hematinics|mesh-ancestor
138333780|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
138333781|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138333782|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
138333783|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333784|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333785|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138333786|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333787|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138333788|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138333789|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138333790|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138333791|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333792|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333793|NCT00644592|Fenofibrate|fenofibrate|mesh-list
138333794|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138333795|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
138333796|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333797|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138333798|NCT00645450|Propranolol|propranolol|mesh-list
138333799|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138333800|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138333801|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
138333803|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333804|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333805|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138333806|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138333807|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
138333808|NCT00647400|Adalimumab|adalimumab|mesh-list
138333809|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138333810|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333811|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333812|NCT00652314|Thrombin|thrombin|mesh-list
138333813|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
138333814|NCT00652314|Coagulants|coagulants|mesh-ancestor
138333815|NCT00654030|Vaccines|vaccines|mesh-list
138333816|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
138333817|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333818|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
138333819|NCT00656448|Hematinics|hematinics|mesh-ancestor
138333820|NCT00660504|Etoposide|etoposide|mesh-list
138333821|NCT00660504|Amrubicin|amrubicin|mesh-list
138333822|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333823|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333824|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138333825|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333826|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333827|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333828|NCT00661674|Palonosetron|palonosetron|mesh-list
138333829|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
138333830|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
138333831|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
138333832|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333833|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333834|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138333835|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138333836|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138333838|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333839|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333840|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
138333841|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
138333842|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138333843|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
138333844|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
138333845|NCT00662298|Prednisolone|prednisolone|mesh-list
138333846|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333847|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
138333848|NCT00662298|Hormones|hormones|mesh-ancestor
138333849|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333850|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333851|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138333852|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333853|NCT00666666|Acetic Acid|acetic acid|mesh-list
138333854|NCT00666666|Bicalutamide|bicalutamide|mesh-list
138333855|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
138333856|NCT00666666|Gossypol|gossypol|mesh-list
138333857|NCT00666666|Hormones|hormones|mesh-list
138333858|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333859|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333861|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
138333862|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333863|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138333864|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333865|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138333866|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138333867|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
138333868|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138333869|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138333870|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138333871|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138367349|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
138333874|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
138333875|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138333876|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138333877|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138333878|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138333879|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333880|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
138333881|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333882|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333883|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138333884|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138333886|NCT00670956|Betamethasone|betamethasone|mesh-list
138333887|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333888|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
138333890|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333891|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333892|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138333893|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333894|NCT00671502|Carisoprodol|carisoprodol|mesh-list
138333895|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138333896|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333897|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138333898|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333899|NCT00671970|Bevacizumab|bevacizumab|mesh-list
138333900|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138333901|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138333902|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333903|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138333904|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333905|NCT00671970|Growth Substances|growth substances|mesh-ancestor
138333906|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333907|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333908|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333909|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333910|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333911|NCT00672204|Sirolimus|sirolimus|mesh-list
138333912|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
138333913|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138333914|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138333915|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333916|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138367415|NCT03281369|Leucovorin|leucovorin|mesh-list
138333917|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333919|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333920|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
138333921|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333922|NCT00672438|Alfentanil|alfentanil|mesh-list
138333923|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138333924|NCT00672438|Narcotics|narcotics|mesh-ancestor
138333925|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138333926|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333928|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
138333929|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333930|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138333931|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
138333933|NCT00672594|Sunitinib|sunitinib|mesh-list
138333934|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333936|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138333937|NCT00672594|Growth Substances|growth substances|mesh-ancestor
138333938|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333939|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138333940|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138333941|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333942|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333943|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138333944|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
138333945|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138333946|NCT00675792|Bromides|bromides|mesh-list
138333947|NCT00675792|Rocuronium|rocuronium|mesh-list
138333948|NCT00675792|Neostigmine|neostigmine|mesh-list
138333949|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
138333950|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138333951|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138333952|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138333953|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333954|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333955|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138333956|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333957|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333958|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
138333959|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138333960|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138333961|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
138333962|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
138333963|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138333964|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
138333965|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333966|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138333967|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138333968|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
138333969|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333970|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138333971|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138333972|NCT00678834|Tocopherols|tocopherols|mesh-list
138333973|NCT00678834|Vitamin E|vitamin e|mesh-list
138333974|NCT00678834|Tocotrienols|tocotrienols|mesh-list
138333975|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
138333976|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
138333977|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333978|NCT00678834|Protective Agents|protective agents|mesh-ancestor
138333979|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333980|NCT00678834|Vitamins|vitamins|mesh-ancestor
138333981|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
138333983|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138333984|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138333986|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333987|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333988|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138333989|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
138333990|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
138333992|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333993|NCT00680706|Thiamine|thiamine|mesh-list
138333994|NCT00680706|Vitamins|vitamins|mesh-ancestor
138333995|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
138333996|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333997|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
138333998|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
138333999|NCT00682734|Promethazine|promethazine|mesh-list
138334000|NCT00682734|Metoclopramide|metoclopramide|mesh-list
138334001|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138334002|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138334003|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334004|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334005|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
138334006|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
138334007|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
138334008|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334009|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
138334010|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
138334011|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334012|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138334013|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
138334014|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
138334015|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334016|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334017|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138334018|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
138334019|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334020|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138334021|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138334022|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
138334023|NCT00683046|Fludarabine|fludarabine|mesh-list
138334024|NCT00683046|Melphalan|melphalan|mesh-list
138334025|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
138334026|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334027|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334028|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334029|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
138334030|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334031|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334032|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
138334033|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334034|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334035|NCT00687102|Tamoxifen|tamoxifen|mesh-list
138334036|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138334037|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138334039|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334040|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334041|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334042|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334043|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138334044|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138334047|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334049|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138334050|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334051|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334052|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138334053|NCT00690924|Vitamins|vitamins|mesh-ancestor
138334054|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
138334055|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138334056|NCT00691002|Calcitriol|calcitriol|mesh-list
138334057|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
138334058|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138334059|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138334060|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138334061|NCT00691002|Calcipotriene|calcipotriene|mesh-list
138334062|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334063|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334064|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334065|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334066|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138334067|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334068|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334069|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138334071|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
138334072|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138334073|NCT00695292|Carboplatin|carboplatin|mesh-list
138334074|NCT00695292|Irinotecan|irinotecan|mesh-list
138334075|NCT00695292|Sunitinib|sunitinib|mesh-list
138334076|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334077|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138334078|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138334079|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334080|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334081|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138334082|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138334083|NCT00695292|Growth Substances|growth substances|mesh-ancestor
138334084|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334085|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
138334086|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334087|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
138334088|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138334089|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138334090|NCT00700440|Cetuximab|cetuximab|mesh-list
138334091|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334092|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334094|NCT00701376|Hematinics|hematinics|mesh-ancestor
138334095|NCT00702780|Escitalopram|escitalopram|mesh-list
138334096|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138334097|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138334098|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334099|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334100|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334102|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334104|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
138334105|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
138334106|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
138334107|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
138334108|NCT00704028|Hematinics|hematinics|mesh-ancestor
138334109|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
138334110|NCT00704262|Calcipotriene|calcipotriene|mesh-list
138334111|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334112|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334113|NCT00706446|Fluticasone|fluticasone|mesh-list
138334115|NCT00706446|Budesonide|budesonide|mesh-list
138334116|NCT00706446|Bromides|bromides|mesh-list
138334117|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
138334118|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
138334119|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138334120|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334121|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138334122|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
138334123|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334124|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334125|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138334126|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138334127|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334128|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138334129|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
138334130|NCT00706446|Hormones|hormones|mesh-ancestor
138334131|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334132|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138334133|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138334134|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138334135|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
138334136|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334137|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334138|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
138334139|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138334140|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
138334141|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
138334142|NCT00706836|Pregabalin|pregabalin|mesh-list
138334143|NCT00706836|Analgesics|analgesics|mesh-ancestor
138334144|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
138334145|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334146|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334147|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
138334148|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138334149|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334150|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334151|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334152|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138334156|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138334157|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138334158|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334159|NCT00711828|Dexamethasone|dexamethasone|mesh-list
138334160|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
138334161|NCT00711828|Rituximab|rituximab|mesh-list
138334162|NCT00711828|Bortezomib|bortezomib|mesh-list
138334163|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334164|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
138334165|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334166|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334167|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334168|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
138334169|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334170|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334171|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334172|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334174|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
138334175|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334176|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334177|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
138334179|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334180|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334181|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334182|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138334184|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334186|NCT00715884|Temsirolimus|temsirolimus|mesh-list
138334187|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
138334188|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138334189|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334190|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138334191|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334192|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
138334193|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334194|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
138334195|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334196|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334197|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334198|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334199|NCT00716586|Dorzolamide|dorzolamide|mesh-list
138334200|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334201|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138334202|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334203|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334204|NCT00716742|Bimatoprost|bimatoprost|mesh-list
138334205|NCT00716742|Travoprost|travoprost|mesh-list
138334206|NCT00716742|Latanoprost|latanoprost|mesh-list
138334207|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138334208|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138334209|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334210|NCT00716820|Sunitinib|sunitinib|mesh-list
138334211|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334213|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138334214|NCT00716820|Growth Substances|growth substances|mesh-ancestor
138334215|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334216|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138334217|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334218|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334219|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334221|NCT00717054|Aprepitant|aprepitant|mesh-list
138334222|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138334223|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
138334224|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
138334225|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334226|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334227|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334228|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138334230|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334231|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138334233|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138334234|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
138334235|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138334236|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
138334237|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
138334238|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138334239|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334240|NCT00719160|Esomeprazole|esomeprazole|mesh-list
138334241|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138334242|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334243|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138334244|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334245|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334246|NCT00720330|Lidocaine|lidocaine|mesh-list
138334247|NCT00720330|Ketamine|ketamine|mesh-list
138334249|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
138334250|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
138334251|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334252|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334253|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
138334254|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334255|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138334256|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138334257|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138334258|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334259|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334260|NCT00720330|Analgesics|analgesics|mesh-ancestor
138334261|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138334262|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138334263|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
138334264|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138334265|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138334266|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334267|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138334268|NCT00721188|Hematinics|hematinics|mesh-ancestor
138334269|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
138334270|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138334273|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
138334274|NCT00722436|Coagulants|coagulants|mesh-ancestor
138334275|NCT00724464|Interferons|interferons|mesh-list
138334276|NCT00724464|Ribavirin|ribavirin|mesh-list
138334277|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
138334278|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
138334279|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138334280|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334281|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
138334282|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334283|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
138334284|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334285|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
138334286|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334287|NCT00726414|Quinine|quinine|mesh-list
138334288|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
138334289|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138334290|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138334291|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334292|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138334293|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334295|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334296|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138334297|NCT00726414|Analgesics|analgesics|mesh-ancestor
138334298|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
138334299|NCT00727740|Indomethacin|indomethacin|mesh-list
138334300|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138334301|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138334302|NCT00727740|Analgesics|analgesics|mesh-ancestor
138334303|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
138334304|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334305|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334306|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334307|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334308|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
138334309|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
138334310|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334311|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138334312|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334313|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334315|NCT00728910|Atorvastatin|atorvastatin|mesh-list
138334316|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138334317|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138334318|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
138334319|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334320|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138334321|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138334323|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
138334324|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
138334326|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
138334327|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334328|NCT00729846|Bevacizumab|bevacizumab|mesh-list
138334329|NCT00729846|Verteporfin|verteporfin|mesh-list
138334330|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334331|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334332|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138334333|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138334334|NCT00729846|Growth Substances|growth substances|mesh-ancestor
138334335|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334336|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
138334337|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138334338|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334339|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
138334340|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138334341|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138334342|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
138334343|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334344|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138334345|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138334346|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334347|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334348|NCT00731874|Tacrolimus|tacrolimus|mesh-list
138334349|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334350|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
138334351|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334352|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138334353|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334354|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334355|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
138334356|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
138334357|NCT00732654|Caseins|caseins|mesh-list
138334358|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334359|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
138334360|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
138334361|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334362|NCT00733278|Copper|copper|mesh-list
138334363|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
138334364|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334365|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334366|NCT00733278|Trace Elements|trace elements|mesh-ancestor
138334367|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
138334368|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138334369|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138334370|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334371|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138334372|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138334373|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334374|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334375|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
138334376|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334378|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138334379|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334380|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334381|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138334382|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138334383|NCT00735306|Growth Substances|growth substances|mesh-ancestor
138334384|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334385|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
138334386|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334387|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367502|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138334388|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334391|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
138334392|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334393|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334394|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
138334395|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138334396|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
138334397|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
138334398|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334399|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334401|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
138334402|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
138334403|NCT00736632|Vitamins|vitamins|mesh-list
138334404|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
138334405|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334406|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138334408|NCT00737178|Copper|copper|mesh-list
138334409|NCT00737178|Trace Elements|trace elements|mesh-ancestor
138334410|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
138334411|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334412|NCT00741156|Enalaprilat|enalaprilat|mesh-list
138334413|NCT00741156|Enalapril|enalapril|mesh-list
138334414|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138334415|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
138334416|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334417|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334418|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334420|NCT00741468|Midazolam|midazolam|mesh-list
138334421|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
138334422|NCT00741468|Caffeine|caffeine|mesh-list
138334423|NCT00741468|Omeprazole|omeprazole|mesh-list
138334424|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138334425|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138334426|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334427|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334428|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138334429|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138334430|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138334431|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138334432|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
138334433|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
138334434|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
138334435|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
138334436|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334437|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334438|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138334439|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138334441|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138334442|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138334443|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
138334444|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138334445|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334446|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138334447|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
138334448|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
138334449|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138334450|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138334451|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138334452|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138334453|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138334454|NCT00741858|Estradiol|estradiol|mesh-list
138334455|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138334456|NCT00741858|Estrogens|estrogens|mesh-ancestor
138334457|NCT00741858|Hormones|hormones|mesh-ancestor
138334458|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334459|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334460|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138334461|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
138334462|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334463|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138334464|NCT00742872|Mosapride|mosapride|mesh-list
138367626|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
138334467|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138334468|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
138334469|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334470|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334473|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
138334474|NCT00743574|Vitamins|vitamins|mesh-list
138334475|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138334476|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
138334477|NCT00743574|Calcium|calcium|mesh-list
138334478|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
138334479|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334480|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334481|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138334482|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138334483|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138334484|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138334485|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
138334486|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334487|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138334488|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138334489|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138334490|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334491|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334492|NCT00743730|Morphine|morphine|mesh-list
138334493|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138334494|NCT00743730|Narcotics|narcotics|mesh-ancestor
138334495|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334496|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334497|NCT00743730|Analgesics|analgesics|mesh-ancestor
138334498|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
138334499|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334500|NCT00745290|Bupivacaine|bupivacaine|mesh-list
138334501|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138334502|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
138334503|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334504|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334505|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
138334506|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334508|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138334509|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138334510|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
138334511|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334512|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138334513|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138334514|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334515|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334517|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334518|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138334519|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334520|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334521|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334522|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334523|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
138334524|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138334526|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334527|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334528|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334529|NCT00755040|Cyclosporine|cyclosporine|mesh-list
138334530|NCT00755040|Cyclosporins|cyclosporins|mesh-list
138334531|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334532|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334533|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334534|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
138334535|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334536|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
138334537|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334538|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334539|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334540|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138334541|NCT00755274|Vaccines|vaccines|mesh-list
138334542|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
138334543|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334544|NCT00756600|Anesthetics|anesthetics|mesh-list
138334545|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334546|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334547|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138334548|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
138334549|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138334551|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138334552|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138334553|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138334554|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138334555|NCT00758784|Analgesics|analgesics|mesh-ancestor
138334556|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
138334557|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334558|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334559|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334560|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334561|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
138334562|NCT00759330|Analgesics|analgesics|mesh-ancestor
138334563|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
138334564|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334565|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334566|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138334567|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138334568|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334569|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334570|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138334571|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334572|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334573|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138334574|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334575|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138334576|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334577|NCT00759642|Lapatinib|lapatinib|mesh-list
138334578|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334579|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138334580|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334581|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334582|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
138334583|NCT00759798|Rituximab|rituximab|mesh-list
138334584|NCT00759798|Fludarabine|fludarabine|mesh-list
138334585|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334586|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
138334587|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334588|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334589|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334590|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
138334591|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334594|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334596|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138334597|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334598|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138334599|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
138334600|NCT00761202|Glycerol|glycerol|mesh-list
138334601|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138334602|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
138334603|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334604|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
138334605|NCT00761202|Protective Agents|protective agents|mesh-ancestor
138334606|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138334607|NCT00761202|Laxatives|laxatives|mesh-ancestor
138334608|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334609|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
138334610|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138334611|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138334612|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138334613|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334614|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334615|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
138334616|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334617|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334618|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138334619|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334620|NCT00762450|Triclosan|triclosan|mesh-list
138334621|NCT00762450|Fluorides|fluorides|mesh-list
138334622|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
138334623|NCT00762450|Protective Agents|protective agents|mesh-ancestor
138334624|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334625|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138334626|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334627|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138334628|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138334629|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
138334630|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334631|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138334632|NCT00762528|Triclosan|triclosan|mesh-list
138334633|NCT00762528|Fluorides|fluorides|mesh-list
138334634|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
138334635|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
138334636|NCT00762528|Protective Agents|protective agents|mesh-ancestor
138334637|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334638|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138334639|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334640|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138334642|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
138334643|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334644|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138334645|NCT00765648|Labetalol|labetalol|mesh-list
138334646|NCT00765648|Nicardipine|nicardipine|mesh-list
138334647|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138334648|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138334649|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
138334650|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334651|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334652|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334653|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138334655|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
138334656|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334658|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138334659|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138334660|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334661|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138334664|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
138334665|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138334666|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
138334667|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334668|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334669|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334670|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334671|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
138334672|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
138334673|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
138334674|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334675|NCT00767364|Vaccines|vaccines|mesh-list
138334676|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
138334677|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334678|NCT00769314|Acyclovir|acyclovir|mesh-list
138334679|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
138334680|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334681|NCT00769392|Lidocaine|lidocaine|mesh-list
138334682|NCT00769392|Tetracaine|tetracaine|mesh-list
138334683|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
138334684|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
138334685|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
138334686|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334687|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334688|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
138334689|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334690|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138334691|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138334692|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138334693|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334694|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334696|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334697|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
138334698|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138334699|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138334700|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
138334701|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334702|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138334703|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138334704|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334705|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334708|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
138334709|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334710|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334711|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138334712|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138334713|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138334714|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334715|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334716|NCT00780234|Pioglitazone|pioglitazone|mesh-list
138334717|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138334718|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334719|NCT00784524|Aldesleukin|aldesleukin|mesh-list
138334720|NCT00784524|Interleukin-2|interleukin-2|mesh-list
138334721|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334722|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138334723|NCT00784524|Analgesics|analgesics|mesh-ancestor
138334724|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
138334725|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334726|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334727|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138334728|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138334729|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
138334730|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334731|NCT00785772|Gabapentin|gabapentin|mesh-list
138334732|NCT00785772|Analgesics|analgesics|mesh-ancestor
138334733|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
138334734|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334735|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334736|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
138334737|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138334738|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138334739|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334740|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138334741|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138334742|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138334743|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334744|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334745|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
138334748|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
138334749|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138334750|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
138334751|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334752|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334753|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
138334754|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138334755|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138334756|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138334757|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
138334758|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138334759|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138334760|NCT00787722|Prednisolone|prednisolone|mesh-list
138334761|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
138367803|NCT05274113|Hormones|hormones|mesh-ancestor
138334763|NCT00787722|Rituximab|rituximab|mesh-list
138334764|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
138334765|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138334766|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138334767|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
138334768|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334769|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
138334770|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334771|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334772|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334773|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
138334774|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334775|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334776|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334777|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138334778|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334780|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
138334781|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334782|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334783|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
138334784|NCT00787722|Hormones|hormones|mesh-ancestor
138334785|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334786|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138334787|NCT00787722|Protective Agents|protective agents|mesh-ancestor
138334788|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334791|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138334792|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
138334793|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334794|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334795|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
138334796|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334797|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334798|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
138334799|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334800|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138334801|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138334802|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138334803|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334804|NCT00789672|Levodopa|levodopa|mesh-list
138334805|NCT00789672|Carbidopa|carbidopa|mesh-list
138334806|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138334807|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138334808|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
138334809|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334810|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334811|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334812|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138334813|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334814|NCT00789750|Pioglitazone|pioglitazone|mesh-list
138334815|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138334816|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138334817|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334818|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138334819|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138334823|NCT00790062|Oxytocin|oxytocin|mesh-list
138334824|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
138334825|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334826|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334827|NCT00793572|Cyclosporine|cyclosporine|mesh-list
138334828|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
138334829|NCT00793572|Fludarabine|fludarabine|mesh-list
138334830|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
138334831|NCT00793572|Bortezomib|bortezomib|mesh-list
138334832|NCT00793572|Melphalan|melphalan|mesh-list
138334833|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
138334834|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138334835|NCT00793572|Cyclosporins|cyclosporins|mesh-list
138334836|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334837|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138334838|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
138334839|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334840|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334841|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
138334843|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334844|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
138334845|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334846|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334847|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334848|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138334849|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138334850|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138334851|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
138334852|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138334853|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334854|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
138334855|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334857|NCT00793650|Melphalan|melphalan|mesh-list
138334858|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334859|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138334860|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
138334861|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334862|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334863|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334864|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
138334865|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334866|NCT00795210|Hormones|hormones|mesh-list
138334867|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138334868|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334869|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334870|NCT00795288|Simvastatin|simvastatin|mesh-list
138334871|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138334872|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138334873|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
138334874|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334875|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138334876|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138334877|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334879|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
138334880|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
138334881|NCT00795366|Coagulants|coagulants|mesh-ancestor
138334882|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138334883|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138334884|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
138334885|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334886|NCT00796302|Risperidone|risperidone|mesh-list
138334887|NCT00796302|Methylphenidate|methylphenidate|mesh-list
138334888|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138334889|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
138334890|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334891|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334892|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334893|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138334894|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138334895|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334896|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138334897|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138334898|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
138334899|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138334900|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138334901|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138334902|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334903|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138334904|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138334906|NCT00798018|Tetracaine|tetracaine|mesh-list
138334907|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
138334908|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
138334909|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334910|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334911|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
138334912|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334913|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138334914|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138334915|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138334916|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138334917|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334919|NCT00798720|Vorinostat|vorinostat|mesh-list
138334920|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334921|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138334922|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334923|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334925|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138334926|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334927|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138334928|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138334929|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334930|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334931|NCT00801138|Dexamethasone|dexamethasone|mesh-list
138334932|NCT00801138|Bupivacaine|bupivacaine|mesh-list
138334933|NCT00801138|Ropivacaine|ropivacaine|mesh-list
138334934|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138334935|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
138334936|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
138334937|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334938|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334939|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334940|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
138334941|NCT00801138|Hormones|hormones|mesh-ancestor
138334942|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138334946|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
138334947|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334948|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
138334949|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138334950|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
138334951|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138334952|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
138334953|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334954|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334955|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138334956|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
138334957|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138334958|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138334959|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138334960|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
138334961|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138334962|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334963|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
138334964|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138334965|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
138334966|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138334967|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138334968|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334969|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334971|NCT00803010|Methotrexate|methotrexate|mesh-list
138334972|NCT00803010|Tacrolimus|tacrolimus|mesh-list
138334973|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138334974|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
138334976|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334977|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138334978|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
138334979|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334980|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334981|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
138334982|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138334983|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138334984|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334985|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
138334986|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138334987|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138334988|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138334989|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138334990|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334991|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138334992|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
138334994|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138334995|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334996|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334997|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138334998|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138334999|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335000|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
138335002|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335003|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335004|NCT00804648|Timolol|timolol|mesh-list
138335005|NCT00804648|Maleic acid|maleic acid|mesh-list
138335007|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335008|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138335009|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138335010|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335011|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335012|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335013|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138335014|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138335015|NCT00806598|Cyclosporine|cyclosporine|mesh-list
138335016|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
138335017|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138335018|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138335019|NCT00806598|Prednisolone|prednisolone|mesh-list
138335020|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
138335021|NCT00806598|Cyclosporins|cyclosporins|mesh-list
138335022|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
138335023|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138335024|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138335025|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
138335026|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335027|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335028|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335029|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
138335030|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335031|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
138335032|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335033|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335034|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335035|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138335036|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138335037|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
138335038|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
138335039|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335041|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
138335043|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335044|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138335045|NCT00806598|Protective Agents|protective agents|mesh-ancestor
138335046|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335047|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335048|NCT00807768|Paclitaxel|paclitaxel|mesh-list
138335049|NCT00807768|Carboplatin|carboplatin|mesh-list
138335050|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138335051|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138335052|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335054|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367932|NCT05271045|Vitamins|vitamins|mesh-ancestor
138335055|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
138335056|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335057|NCT00808470|Beta Carotene|beta carotene|mesh-list
138335058|NCT00808470|Carotenoids|carotenoids|mesh-list
138335059|NCT00808470|Vitamins|vitamins|mesh-ancestor
138335060|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
138335061|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335062|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
138335063|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335064|NCT00808470|Protective Agents|protective agents|mesh-ancestor
138335065|NCT00808470|Provitamins|provitamins|mesh-ancestor
138335066|NCT00810576|Bortezomib|bortezomib|mesh-list
138335067|NCT00810576|Vorinostat|vorinostat|mesh-list
138335068|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335069|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138335070|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335071|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335072|NCT00811434|Lactulose|lactulose|mesh-list
138335074|NCT00812604|Analgesics|analgesics|mesh-list
138335075|NCT00812604|Petrolatum|petrolatum|mesh-list
138335076|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
138335077|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335078|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335079|NCT00812604|Emollients|emollients|mesh-ancestor
138335080|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335081|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
138335082|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138335083|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138335084|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138335085|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335086|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335087|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138335088|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335089|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335090|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138335091|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335093|NCT00814788|Bicalutamide|bicalutamide|mesh-list
138335094|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138367506|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
138367507|NCT02402920|Etoposide|etoposide|mesh-list
138367508|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
138367509|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
138367517|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335095|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335096|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335097|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335098|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335099|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
138335100|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335101|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335102|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
138335103|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335104|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335105|NCT00820872|Carboplatin|carboplatin|mesh-list
138335106|NCT00820872|Docetaxel|docetaxel|mesh-list
138335107|NCT00820872|Trastuzumab|trastuzumab|mesh-list
138335108|NCT00820872|Lapatinib|lapatinib|mesh-list
138335109|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335110|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
138335111|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
138335112|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367945|NCT05270434|Dipyrone|dipyrone|mesh-list
138335114|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335115|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335117|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
138335118|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138335119|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138335120|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
138335121|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335122|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335123|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335124|NCT00821184|Urological Agents|urological agents|mesh-ancestor
138335125|NCT05206812|Durvalumab|durvalumab|mesh-list
138335126|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335127|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335128|NCT05131152|Cyclosporine|cyclosporine|mesh-list
138335129|NCT05131152|Cyclosporins|cyclosporins|mesh-list
138335130|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335131|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335132|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335133|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
138335134|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335136|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335137|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335138|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335139|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138335140|NCT04900116|Bupivacaine|bupivacaine|mesh-list
138335141|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138335142|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
138335143|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335144|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335145|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
138335146|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335147|NCT04603248|Nivolumab|nivolumab|mesh-list
138335148|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335149|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335150|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138335151|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335154|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335155|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138335156|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335157|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335158|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335159|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138335160|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335161|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335162|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335163|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335165|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335166|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
138335167|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335168|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335169|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138335170|NCT02682888|Oxytocin|oxytocin|mesh-list
138335171|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
138335172|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335173|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335174|NCT02641236|Vancomycin|vancomycin|mesh-list
138335175|NCT02641236|Polymyxins|polymyxins|mesh-list
138335176|NCT02641236|Polymyxin B|polymyxin b|mesh-list
138335177|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335178|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335179|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
138335180|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335181|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335182|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138335183|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138335184|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335185|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335186|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335187|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138335188|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138335190|NCT00821886|Trastuzumab|trastuzumab|mesh-list
138335191|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335192|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335193|NCT00821964|Paclitaxel|paclitaxel|mesh-list
138335194|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138335195|NCT00821964|Imiquimod|imiquimod|mesh-list
138335196|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138335197|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335198|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
138335199|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
138335200|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
138335201|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335202|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138335203|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
138335204|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335205|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
138335206|NCT00822354|Tadalafil|tadalafil|mesh-list
138335207|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
138335208|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138335209|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138335210|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335211|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335212|NCT00822354|Urological Agents|urological agents|mesh-ancestor
138335213|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
138335214|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
138335215|NCT00824070|Besifloxacin|besifloxacin|mesh-list
138367990|NCT05250141|Carbidopa|carbidopa|mesh-list
138367991|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138335217|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335218|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335219|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138335220|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138335221|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335222|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335224|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138335225|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
138335226|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335227|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335228|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138335229|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138335230|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138335231|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138335232|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138335234|NCT00824460|Sevelamer|sevelamer|mesh-list
138335235|NCT00824460|Trace Elements|trace elements|mesh-ancestor
138335236|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
138335237|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335238|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
138335239|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
138335240|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335241|NCT00824538|Sunitinib|sunitinib|mesh-list
138335242|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335243|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138335244|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138335245|NCT00824538|Growth Substances|growth substances|mesh-ancestor
138335246|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335247|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138335248|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335249|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335250|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335251|NCT00825786|Ropivacaine|ropivacaine|mesh-list
138335252|NCT00825786|Mepivacaine|mepivacaine|mesh-list
138335253|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
138335254|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
138335255|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335256|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335257|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
138335258|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335259|NCT00826800|Bevacizumab|bevacizumab|mesh-list
138335260|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335261|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335262|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138335263|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138335264|NCT00826800|Growth Substances|growth substances|mesh-ancestor
138335265|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335266|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138335268|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138335269|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138335270|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335273|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335274|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138335275|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138335276|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335277|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335279|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
138335280|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335281|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138335282|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138335283|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335284|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335285|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335287|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335288|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335289|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138335290|NCT00831480|Everolimus|everolimus|mesh-list
138335291|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138335292|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335293|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335294|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335295|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335296|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
138335297|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335298|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335299|NCT00832338|Dexamethasone|dexamethasone|mesh-list
138335300|NCT00832338|Docetaxel|docetaxel|mesh-list
138335301|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
138335302|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138335303|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
138335305|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335306|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335307|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335308|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
138335309|NCT00832338|Hormones|hormones|mesh-ancestor
138335310|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335311|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335312|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335313|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
138335314|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
138335315|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
138335316|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335317|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335318|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
138335319|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335320|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138335321|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
138335322|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138335323|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
138335324|NCT00834210|Dapsone|dapsone|mesh-list
138335325|NCT00834210|Tazarotene|tazarotene|mesh-list
138335326|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335327|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
138335328|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138335329|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138335330|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138335331|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335332|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335333|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
138335334|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335335|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335336|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
138335337|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
138335338|NCT00834210|Vitamins|vitamins|mesh-ancestor
138335339|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
138335340|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335341|NCT00834288|Tramadol|tramadol|mesh-list
138335342|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138335343|NCT00834288|Narcotics|narcotics|mesh-ancestor
138335344|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335345|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335346|NCT00834288|Analgesics|analgesics|mesh-ancestor
138335347|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
138335348|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335349|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138335350|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138335351|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335352|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335353|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335354|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335355|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138335356|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
138335358|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
138335359|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
138335360|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335361|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335362|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138335363|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138335364|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138335365|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138335366|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335367|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335368|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335369|NCT00835926|Vaccines|vaccines|mesh-list
138335370|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
138335371|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335373|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138335374|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335375|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335376|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335377|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335378|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335379|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335380|NCT00837252|Urological Agents|urological agents|mesh-ancestor
138335381|NCT00839982|Cytarabine|cytarabine|mesh-list
138335382|NCT00839982|Clofarabine|clofarabine|mesh-list
138335383|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138335384|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
138335385|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335386|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335387|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
138335388|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335389|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335390|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
138335391|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335392|NCT00845130|Vitamins|vitamins|mesh-list
138335393|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
138335394|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
138368031|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
138335397|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335398|NCT00845130|Protective Agents|protective agents|mesh-ancestor
138335399|NCT00848016|Acetic Acid|acetic acid|mesh-list
138335400|NCT00848016|Retinol acetate|retinol acetate|mesh-list
138335401|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
138335402|NCT00848016|Gossypol|gossypol|mesh-list
138335403|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335404|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335405|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138335406|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
138335407|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335408|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138335409|NCT00848016|Protective Agents|protective agents|mesh-ancestor
138335410|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335411|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138335412|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
138335413|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335414|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138335415|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138335416|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138335417|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138335418|NCT00849810|Metoprolol|metoprolol|mesh-list
138335419|NCT00849810|Nebivolol|nebivolol|mesh-list
138335420|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138335421|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138335422|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
138335423|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
138335424|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335425|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335426|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138335427|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138335428|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138335429|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335430|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335431|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335432|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
138335433|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138335434|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138335436|NCT00856050|Letrozole|letrozole|mesh-list
138335437|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335438|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138335439|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335440|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335441|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335442|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138335443|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335444|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335445|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335446|NCT00858468|Vaccines|vaccines|mesh-list
138335447|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
138335448|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335449|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138335450|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138335451|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335452|NCT00866034|Cetrorelix|cetrorelix|mesh-list
138335453|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138335454|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
138335455|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335456|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335457|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335458|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335459|NCT00868140|Pioglitazone|pioglitazone|mesh-list
138335460|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138335461|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335463|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
138335464|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335465|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138335466|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138335467|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335468|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335470|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
138335471|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138335472|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
138335473|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335474|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335475|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335476|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
138335477|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138335478|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335479|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335480|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
138335481|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
138335482|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335483|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138335484|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138335485|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138335486|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138335487|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335488|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138335489|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138335490|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
138335491|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138335492|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138335493|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
138335494|NCT00869622|Vitamin D|vitamin d|mesh-list
138335495|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
138335496|NCT00869622|Calcium|calcium|mesh-list
138335497|NCT00869622|Vitamins|vitamins|mesh-ancestor
138335498|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
138335499|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335500|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138335501|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138335502|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138335503|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335504|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335506|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138335507|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138335508|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
138335509|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
138335510|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368053|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
138335512|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335513|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138335514|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335515|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335516|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335517|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138335519|NCT00875550|Fentanyl|fentanyl|mesh-list
138335520|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
138335521|NCT00875550|Morphine|morphine|mesh-list
138335522|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138335523|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335524|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335525|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138335526|NCT00875550|Analgesics|analgesics|mesh-ancestor
138335527|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
138335528|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335529|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138335530|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138335531|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138335532|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335533|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335534|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335535|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138335536|NCT00875550|Narcotics|narcotics|mesh-ancestor
138335537|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138335538|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138335540|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335541|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138335542|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
138335543|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
138335544|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
138335545|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
138335546|NCT00878436|Bicalutamide|bicalutamide|mesh-list
138335547|NCT00878436|Panobinostat|panobinostat|mesh-list
138335548|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
138335549|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335550|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335551|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335552|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335553|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138335554|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335555|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335556|NCT00878826|Enoxaparin|enoxaparin|mesh-list
138335557|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
138335558|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138335559|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138335560|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368068|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335561|NCT00879060|Spironolactone|spironolactone|mesh-list
138335564|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335566|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138335568|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
138335569|NCT00882102|Decitabine|decitabine|mesh-list
138335570|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
138335571|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138335572|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
138335573|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335574|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335575|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335576|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335577|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
138335578|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
138335579|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
138335580|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335581|NCT00884052|Levetiracetam|levetiracetam|mesh-list
138335582|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
138335583|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
138335584|NCT00886236|Gabapentin|gabapentin|mesh-list
138335585|NCT00886236|Analgesics|analgesics|mesh-ancestor
138335586|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
138335587|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335588|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335589|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
138335590|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138335591|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138335592|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335593|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335594|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138335596|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335597|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335598|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
138335599|NCT00886626|Exenatide|exenatide|mesh-list
138335600|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138335601|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335602|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138335603|NCT00886626|Incretins|incretins|mesh-ancestor
138335604|NCT00886626|Hormones|hormones|mesh-ancestor
138335605|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335606|NCT00887562|Ubiquinone|ubiquinone|mesh-list
138335607|NCT00887562|Idebenone|idebenone|mesh-list
138335608|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
138335609|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335610|NCT00887562|Protective Agents|protective agents|mesh-ancestor
138335611|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335612|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
138335613|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
138335614|NCT00887640|Promethazine|promethazine|mesh-list
138335616|NCT00887640|Temsirolimus|temsirolimus|mesh-list
138335617|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
138335618|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335619|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335620|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335621|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335622|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
138335623|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335624|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335625|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138368086|NCT05138029|Hormones|hormones|mesh-ancestor
138335627|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138335628|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
138335629|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138367522|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367523|NCT02273375|Durvalumab|durvalumab|mesh-list
138367524|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367525|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367526|NCT02113202|Bevacizumab|bevacizumab|mesh-list
138335630|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138335631|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335632|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
138335633|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
138335634|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
138335635|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335636|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
138335637|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
138335638|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335639|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138335640|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
138335642|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335643|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138335644|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
138335645|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335646|NCT00889200|Eszopiclone|eszopiclone|mesh-list
138335647|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138335648|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335649|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335650|NCT00892710|Bevacizumab|bevacizumab|mesh-list
138335651|NCT00892710|Carboplatin|carboplatin|mesh-list
138335652|NCT00892710|Pemetrexed|pemetrexed|mesh-list
138335653|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335654|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335655|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138335656|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138335657|NCT00892710|Growth Substances|growth substances|mesh-ancestor
138335658|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335659|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138335660|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335661|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335662|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138335663|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138335664|NCT00894504|Carboplatin|carboplatin|mesh-list
138335665|NCT00894504|Gemcitabine|gemcitabine|mesh-list
138335666|NCT00894504|Panitumumab|panitumumab|mesh-list
138335667|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335668|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138335669|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
138335670|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335671|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138335673|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
138335674|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138335675|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138335676|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335677|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335678|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335679|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138335680|NCT00895752|Protective Agents|protective agents|mesh-ancestor
138335682|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138335683|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
138335686|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
138335688|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138335689|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335690|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335691|NCT00899574|Imiquimod|imiquimod|mesh-list
138335692|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138335693|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
138335694|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335695|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335696|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
138335697|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
138335698|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138335699|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138335700|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138335701|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335702|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335703|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
138335704|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335705|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335706|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138335707|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335708|NCT00902226|Escitalopram|escitalopram|mesh-list
138335709|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138335710|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138335711|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335712|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335713|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335714|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
138335715|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335716|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
138335717|NCT00903162|Letrozole|letrozole|mesh-list
138335718|NCT00903162|Leuprolide|leuprolide|mesh-list
138335719|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335720|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138335721|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335722|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335723|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335724|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138335725|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335727|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335728|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138335729|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138335730|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
138335731|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335732|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335733|NCT00904488|Metolazone|metolazone|mesh-list
138335734|NCT00904488|Furosemide|furosemide|mesh-list
138335735|NCT00904488|Diuretics|diuretics|mesh-ancestor
138335736|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
138335737|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335738|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138335739|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335740|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335741|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138335742|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138335744|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335746|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
138335747|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335748|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
138335749|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138335750|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335751|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335752|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138335753|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138335754|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138335755|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335756|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138335758|NCT00908466|Temsirolimus|temsirolimus|mesh-list
138335759|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
138335760|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335761|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335762|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138335763|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335764|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
138335765|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335766|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
138335767|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335768|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335769|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335770|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335771|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
138335772|NCT00911586|Testosterone|testosterone|mesh-list
138335773|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
138335774|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
138335775|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138335776|NCT00911586|Androgens|androgens|mesh-ancestor
138335777|NCT00911586|Hormones|hormones|mesh-ancestor
138335778|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335779|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335780|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335781|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335786|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335787|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335788|NCT00911742|Analgesics|analgesics|mesh-ancestor
138335789|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
138335790|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335791|NCT00912990|Cisatracurium|cisatracurium|mesh-list
138335792|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138335793|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138335794|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335795|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335797|NCT00913068|Ropivacaine|ropivacaine|mesh-list
138335798|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
138335799|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
138335800|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335801|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335802|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
138335803|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335804|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138335805|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138335806|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138335807|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138335808|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335810|NCT00916032|Coagulants|coagulants|mesh-ancestor
138335811|NCT00922194|Metformin|metformin|mesh-list
138335812|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138335813|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335814|NCT00923910|Acetaminophen|acetaminophen|mesh-list
138335815|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
138335816|NCT00923910|Promethazine|promethazine|mesh-list
138335817|NCT00923910|Interleukin-4|interleukin-4|mesh-list
138335818|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138335819|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138335820|NCT00923910|Analgesics|analgesics|mesh-ancestor
138335821|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
138335822|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335823|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335824|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
138335825|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138335826|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138335827|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335829|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
138335830|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
138335831|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
138335832|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335833|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138335834|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
138368145|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
138335837|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335838|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138335840|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335842|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
138335843|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335844|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335845|NCT00924066|Epothilones|epothilones|mesh-list
138335846|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138335847|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138335848|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138335849|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335850|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335851|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
138335852|NCT00924612|Testosterone|testosterone|mesh-list
138335853|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
138335854|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
138335855|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138335856|NCT00924612|Androgens|androgens|mesh-ancestor
138335857|NCT00924612|Hormones|hormones|mesh-ancestor
138335858|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335859|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335860|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335861|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335862|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
138335863|NCT00925782|Melphalan|melphalan|mesh-list
138335864|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138335865|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
138335866|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335867|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335868|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138335869|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335870|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
138335872|NCT00925938|Misoprostol|misoprostol|mesh-list
138335873|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138335874|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
138335875|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335876|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335877|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138335878|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335879|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
138335880|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138335881|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138335882|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335883|NCT00927888|Bupivacaine|bupivacaine|mesh-list
138335884|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
138335885|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
138335886|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335887|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335888|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
138335889|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335890|NCT00928200|Cytarabine|cytarabine|mesh-list
138335891|NCT00928200|Dexamethasone|dexamethasone|mesh-list
138335892|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
138335893|NCT00928200|Doxorubicin|doxorubicin|mesh-list
138335894|NCT00928200|Methotrexate|methotrexate|mesh-list
138335895|NCT00928200|Vincristine|vincristine|mesh-list
138335896|NCT00928200|Asparaginase|asparaginase|mesh-list
138335897|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
138335899|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138335900|NCT00928200|BB 1101|bb 1101|mesh-list
138335901|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138335903|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
138335904|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335905|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335906|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138335907|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
138335908|NCT00928200|Hormones|hormones|mesh-ancestor
138335909|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335910|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138335911|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335912|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
138335913|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335914|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335915|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138335916|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138335917|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138335918|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138335919|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
138335920|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138335921|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138335922|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
138335923|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138335924|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138335925|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335926|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
138335927|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335928|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138335929|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
138335930|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335931|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138335932|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138335933|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138335934|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138335935|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138335936|NCT00928200|Protective Agents|protective agents|mesh-ancestor
138335937|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
138335938|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138335939|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138335940|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
138335941|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
138368163|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
138335942|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335943|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335945|NCT00931242|Apremilast|apremilast|mesh-list
138335946|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138335947|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138335948|NCT00931242|Analgesics|analgesics|mesh-ancestor
138335949|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
138335950|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335951|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335952|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138335953|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138335954|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138335955|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138335956|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335957|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335958|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335959|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
138335960|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
138335961|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138335962|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138335963|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138335964|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138335965|NCT00931242|Growth Substances|growth substances|mesh-ancestor
138335966|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138335967|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138335968|NCT00932022|Trospium chloride|trospium chloride|mesh-list
138335969|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
138335970|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
138335971|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138335972|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335973|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138335974|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138335975|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
138335976|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335977|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335978|NCT00932022|Urological Agents|urological agents|mesh-ancestor
138335979|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138335981|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138335982|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138335983|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335984|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335985|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335986|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335987|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335988|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138335989|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138335990|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
138335991|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335997|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138335998|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138335999|NCT00943098|Analgesics|analgesics|mesh-ancestor
138336000|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
138336001|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336002|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336003|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336004|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336005|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138336006|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336007|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336008|NCT00943800|Vidarabine|vidarabine|mesh-list
138336009|NCT00943800|Fludarabine|fludarabine|mesh-list
138336010|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
138336011|NCT00943800|Melphalan|melphalan|mesh-list
138336012|NCT00943800|Busulfan|busulfan|mesh-list
138336013|NCT00943800|Thiotepa|thiotepa|mesh-list
138336014|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138336015|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
138336016|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336017|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336018|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
138336019|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336020|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336021|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
138336022|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336023|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
138336024|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336025|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336027|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336028|NCT00943878|Vaccines|vaccines|mesh-list
138336029|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
138336030|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336031|NCT00945282|Ritonavir|ritonavir|mesh-list
138336032|NCT00945282|Lopinavir|lopinavir|mesh-list
138336033|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138336034|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138336035|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
138336036|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336037|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336038|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138336039|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336040|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
138336041|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336042|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138336043|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138336045|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138336046|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336047|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138336048|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
138336050|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336051|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336052|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336053|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
138336054|NCT00948090|Busulfan|busulfan|mesh-list
138336055|NCT00948090|Etoposide|etoposide|mesh-list
138336056|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336057|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
138336058|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336059|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336060|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336061|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
138336062|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336063|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336064|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336065|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138336066|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138336067|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138336068|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336070|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138336071|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
138336072|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138336073|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
138336074|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336075|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336076|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138336077|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
138336078|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138336079|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138336080|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138336081|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336082|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336083|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
138336084|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336085|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336086|NCT00955266|Calcium|calcium|mesh-list
138336087|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138336088|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336089|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138336090|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
138336091|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138336092|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138336093|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336094|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336095|NCT00961662|Tagatose|tagatose|mesh-list
138336096|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138336097|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
138336098|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
138336099|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336100|NCT00964548|Dantrolene|dantrolene|mesh-list
138336101|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138336102|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336103|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138336104|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336105|NCT00905268|Idebenone|idebenone|mesh-list
138336106|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
138336107|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336108|NCT00905268|Protective Agents|protective agents|mesh-ancestor
138336109|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336110|NCT00967044|Everolimus|everolimus|mesh-list
138336111|NCT00967044|Panobinostat|panobinostat|mesh-list
138336112|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138336113|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336114|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336115|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336117|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
138336118|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336119|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336120|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138336122|NCT00973752|Prednisone|prednisone|mesh-list
138336123|NCT00973752|Doxorubicin|doxorubicin|mesh-list
138336124|NCT00973752|Methotrexate|methotrexate|mesh-list
138336125|NCT00973752|Vincristine|vincristine|mesh-list
138336126|NCT00973752|Asparaginase|asparaginase|mesh-list
138336127|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
138336128|NCT00973752|Clofarabine|clofarabine|mesh-list
138336129|NCT00973752|Pegaspargase|pegaspargase|mesh-list
138336130|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138336131|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336132|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138336133|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138336134|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336135|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336136|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336137|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
138336138|NCT00973752|Hormones|hormones|mesh-ancestor
138336139|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336140|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336141|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138336142|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138336143|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
138336144|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138336145|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336147|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336148|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138336149|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336150|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
138336151|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336152|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138336153|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
138336154|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336155|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138336156|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336157|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336158|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336159|NCT00974142|Cyclosporine|cyclosporine|mesh-list
138336160|NCT00974142|Cyclosporins|cyclosporins|mesh-list
138336161|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336162|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336163|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336164|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
138336165|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336167|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336168|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336169|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336170|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138336171|NCT00974376|Gabapentin|gabapentin|mesh-list
138336172|NCT00974376|Analgesics|analgesics|mesh-ancestor
138336173|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
138336174|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336175|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336176|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
138336177|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138336178|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138336179|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336180|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138336181|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138336182|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138336183|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336184|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336185|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
138336186|NCT00976248|Everolimus|everolimus|mesh-list
138336187|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138336188|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336189|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336190|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336191|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336192|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
138336193|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336194|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336195|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
138336196|NCT00976404|Maraviroc|maraviroc|mesh-list
138336197|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138336198|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336200|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336201|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138336202|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138336203|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336204|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336205|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138336206|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138336207|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138336208|NCT00983346|Bortezomib|bortezomib|mesh-list
138336209|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336210|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
138336211|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138336212|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336213|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138336214|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336215|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336216|NCT00987480|Cyclosporine|cyclosporine|mesh-list
138336217|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
138336218|NCT00987480|Busulfan|busulfan|mesh-list
138336219|NCT00987480|Fludarabine|fludarabine|mesh-list
138336220|NCT00987480|Cyclosporins|cyclosporins|mesh-list
138336221|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336222|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
138336223|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336224|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336225|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336227|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336228|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336229|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336230|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336231|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
138336232|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336233|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336234|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138336235|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138336236|NCT00987558|Simvastatin|simvastatin|mesh-list
138336237|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138336238|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138336239|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
138336240|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336241|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138336242|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138336243|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336244|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
138336245|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138336246|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138336247|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336248|NCT00987948|Maraviroc|maraviroc|mesh-list
138336249|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138336250|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138336251|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336253|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336254|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
138336255|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336256|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138336257|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138336259|NCT00989586|Antibodies|antibodies|mesh-list
138336260|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
138336261|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138336262|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
138336263|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336264|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336265|NCT00990288|Hemostatics|hemostatics|mesh-list
138336266|NCT00990288|Thrombin|thrombin|mesh-list
138336267|NCT00990288|Coagulants|coagulants|mesh-ancestor
138336268|NCT00991458|Cyclosporine|cyclosporine|mesh-list
138336269|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138336270|NCT00991458|Cyclosporins|cyclosporins|mesh-list
138336271|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336272|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336273|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336274|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
138336275|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336276|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
138368247|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368248|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138368249|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
138368256|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
138336284|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
138336285|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336286|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336287|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
138336288|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336289|NCT00997620|Fluticasone|fluticasone|mesh-list
138336290|NCT00997620|Xhance|xhance|mesh-list
138336291|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336292|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138336293|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
138336295|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336296|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138336297|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
138336298|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336299|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138336300|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
138336301|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
138336302|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138336303|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336304|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138336305|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138336306|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138336307|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138336308|NCT00998010|Temozolomide|temozolomide|mesh-list
138336309|NCT00998010|Bortezomib|bortezomib|mesh-list
138336310|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336311|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
138336312|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336313|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336315|NCT00999102|Nebivolol|nebivolol|mesh-list
138336316|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138336317|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138336318|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
138336319|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
138336320|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336321|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336322|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138336323|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138336324|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138336325|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
138336326|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336327|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336328|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
138336329|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138336330|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138336331|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138336332|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
138336334|NCT01000818|Famotidine|famotidine|mesh-list
138368271|NCT04783376|Insulin|insulin|mesh-list
138368272|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138368273|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138336336|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336337|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138336338|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336339|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336340|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138336341|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336342|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
138336343|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336344|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138336345|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138336346|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138336347|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
138336348|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
138336349|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336350|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336351|NCT01001052|Colchicine|colchicine|mesh-list
138336352|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
138336353|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336354|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336355|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336356|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336357|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336358|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336359|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
138336360|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
138336361|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
138336362|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336363|NCT01003080|Hemostatics|hemostatics|mesh-list
138336364|NCT01003080|Coagulants|coagulants|mesh-ancestor
138336365|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138336366|NCT01003938|Topotecan|topotecan|mesh-list
138336367|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336368|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336369|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336370|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336371|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138336372|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138336373|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
138336374|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138336375|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138336376|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336378|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
138336379|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336380|NCT01005576|Fludarabine|fludarabine|mesh-list
138336381|NCT01005576|Melphalan|melphalan|mesh-list
138336382|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
138336383|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336384|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336385|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336386|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
138368274|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336387|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336389|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
138336390|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336391|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336392|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
138336394|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
138336395|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336396|NCT01005810|Expectorants|expectorants|mesh-ancestor
138336397|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
138336398|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138336399|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
138336400|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336401|NCT01005810|Protective Agents|protective agents|mesh-ancestor
138336402|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336403|NCT01005810|Antidotes|antidotes|mesh-ancestor
138336404|NCT01005888|Complement C1s|complement c1s|mesh-list
138336405|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138336406|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138336407|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
138336408|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336409|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138336410|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336411|NCT01007994|Propranolol|propranolol|mesh-list
138336412|NCT01007994|Enalapril|enalapril|mesh-list
138336413|NCT01007994|Isradipine|isradipine|mesh-list
138336414|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138336415|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138336416|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
138336417|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367533|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336418|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336419|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336420|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138336421|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138336422|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
138336423|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138336424|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
138336425|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336426|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138336427|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336428|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138336429|NCT01008462|Cytarabine|cytarabine|mesh-list
138336430|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
138336431|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
138336432|NCT01008462|Melphalan|melphalan|mesh-list
138336433|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
138336434|NCT01008462|Carmustine|carmustine|mesh-list
138336435|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138336436|NCT01008462|Fludarabine|fludarabine|mesh-list
138336437|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
138336438|NCT01008462|Etoposide|etoposide|mesh-list
138336439|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
138336440|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
138336441|NCT01008462|Tacrolimus|tacrolimus|mesh-list
138336442|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336444|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336445|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336446|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336447|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
138336448|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336449|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336450|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336451|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336452|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
138336453|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138336454|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138336455|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138336456|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336457|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
138336458|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336459|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138336460|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138336461|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138336462|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
138336463|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138336464|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
138336465|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336466|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336467|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336468|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336469|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138336470|NCT01010568|Ofatumumab|ofatumumab|mesh-list
138336471|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138336472|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336473|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
138336474|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336475|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336476|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
138336477|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336478|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138336480|NCT01011816|Coagulants|coagulants|mesh-ancestor
138336481|NCT01011894|Lenalidomide|lenalidomide|mesh-list
138336482|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
138336483|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336484|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138336485|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336486|NCT01011894|Growth Substances|growth substances|mesh-ancestor
138336487|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336488|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336489|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138336490|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
138336491|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
138336492|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336493|NCT01015170|Bupropion|bupropion|mesh-list
138336494|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138336495|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
138336496|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138336497|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138336498|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138336499|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336500|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336501|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
138336502|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336503|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336504|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138336505|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138336506|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336507|NCT01017042|Colchicine|colchicine|mesh-list
138336508|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
138336509|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336510|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336511|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336512|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336513|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336514|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336515|NCT01018056|Riluzole|riluzole|mesh-list
138336516|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
138336517|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138336518|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138336519|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336520|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336521|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336523|NCT01018056|Protective Agents|protective agents|mesh-ancestor
138336524|NCT01018134|Desoximetasone|desoximetasone|mesh-list
138336525|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336526|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
138336527|NCT01018134|Hormones|hormones|mesh-ancestor
138336528|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336529|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336530|NCT01020006|Gemcitabine|gemcitabine|mesh-list
138336531|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336532|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
138336533|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336534|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336536|NCT05395962|Bleomycin|bleomycin|mesh-list
138336537|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336538|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138336539|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
138336540|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336541|NCT05017584|Bupivacaine|bupivacaine|mesh-list
138336542|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
138336543|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
138336544|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336545|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336546|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
138336547|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336548|NCT04147416|Propofol|propofol|mesh-list
138336549|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138336550|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368319|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
138336551|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336552|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138336553|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
138336554|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
138336555|NCT02406222|Dexamethasone|dexamethasone|mesh-list
138336556|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
138336557|NCT02406222|Pomalidomide|pomalidomide|mesh-list
138336558|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336559|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
138336560|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368331|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
138336562|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336563|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
138336564|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336565|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336566|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336567|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336569|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
138336570|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336571|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336572|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
138336574|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336575|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138336576|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138336577|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336578|NCT02406222|Growth Substances|growth substances|mesh-ancestor
138336579|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336580|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
138336581|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138336582|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336583|NCT01022190|Etoricoxib|etoricoxib|mesh-list
138336584|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138336585|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138336586|NCT01022190|Analgesics|analgesics|mesh-ancestor
138336587|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
138336588|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336589|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336590|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336591|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336592|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138336593|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138336594|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336595|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336597|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
138336598|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336599|NCT01027806|Montelukast|montelukast|mesh-list
138336601|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
138336602|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138336603|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
138336604|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336605|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336606|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138336607|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138336608|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336609|NCT01029054|Dexamethasone|dexamethasone|mesh-list
138336610|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
138336611|NCT01029054|Lenalidomide|lenalidomide|mesh-list
138336612|NCT01029054|BB 1101|bb 1101|mesh-list
138336613|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336614|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
138336615|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
138336616|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336617|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336618|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336619|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
138336621|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336622|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138336623|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336624|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
138336625|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336626|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336628|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138336629|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336630|NCT01029054|Growth Substances|growth substances|mesh-ancestor
138336631|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336632|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
138336633|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138336634|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336635|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336636|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
138336638|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336641|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
138336642|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336643|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
138336644|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336645|NCT05402826|Protective Agents|protective agents|mesh-ancestor
138336646|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
138336647|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138336648|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336649|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138336650|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336651|NCT04316910|Anesthetics|anesthetics|mesh-list
138336652|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
138336653|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336654|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336655|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
138336656|NCT01842672|Clofarabine|clofarabine|mesh-list
138336657|NCT01842672|Analgesics|analgesics|mesh-ancestor
138336658|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
138336659|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336660|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336661|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336662|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138336663|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138336664|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336665|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336666|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368526|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
138336670|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336672|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336673|NCT01034592|Growth Substances|growth substances|mesh-ancestor
138336674|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336675|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336676|NCT01037790|Palbociclib|palbociclib|mesh-list
138336677|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336678|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336679|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336680|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336681|NCT01043094|Pitavastatin|pitavastatin|mesh-list
138336682|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138336683|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138336685|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
138336686|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336687|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336688|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138336689|NCT01043640|Cyclosporine|cyclosporine|mesh-list
138336690|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
138336691|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
138336692|NCT01043640|Busulfan|busulfan|mesh-list
138336693|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
138336694|NCT01043640|Cyclosporins|cyclosporins|mesh-list
138336695|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336696|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
138336697|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336698|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336699|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336700|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
138336701|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336702|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336703|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138336704|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336705|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
138336706|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336707|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336708|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138336709|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138336710|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138336711|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
138336712|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138336713|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336714|NCT01044966|Temozolomide|temozolomide|mesh-list
138336715|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336716|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
138344288|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336717|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336718|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336719|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
138336720|NCT01045122|Propofol|propofol|mesh-list
138336721|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138336722|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336723|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336724|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138336725|NCT01045122|Analgesics|analgesics|mesh-ancestor
138336726|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
138336727|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336728|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138336729|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138336730|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138336731|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138336732|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336733|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336734|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138336735|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
138336736|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
138336737|NCT01050582|Risperidone|risperidone|mesh-list
138336738|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
138336739|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138336740|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
138336741|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336742|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336743|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336744|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138336745|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336746|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138336747|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138336748|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
138336749|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138336750|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138336751|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138336752|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138336753|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138336754|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138336755|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336756|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138336757|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138336758|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336759|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336760|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
138336761|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336762|NCT01051596|Temozolomide|temozolomide|mesh-list
138336763|NCT01051596|Veliparib|veliparib|mesh-list
138336764|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138336765|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
138336766|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336767|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336768|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138336769|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336771|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336772|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
138336773|NCT05822453|Gemcitabine|gemcitabine|mesh-list
138336774|NCT05822453|Tislelizumab|tislelizumab|mesh-list
138336775|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336776|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
138336777|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336779|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336780|NCT01028820|Aripiprazole|aripiprazole|mesh-list
138336781|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
138336782|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138336783|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138336784|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138336785|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336786|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336787|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
138336788|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
138336789|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336790|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336791|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138336792|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138336793|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
138336794|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138336795|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138336796|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138336797|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138336798|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138336799|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138336801|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336802|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336803|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138336804|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336805|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336806|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
138336807|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336808|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
138336809|NCT05821751|Nivolumab|nivolumab|mesh-list
138336810|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336811|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336812|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138336813|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336814|NCT05821712|Listerine|listerine|mesh-list
138336815|NCT05821712|Fluorides|fluorides|mesh-list
138336816|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
138336817|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
138336818|NCT05821712|Protective Agents|protective agents|mesh-ancestor
138336819|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336820|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138336821|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336822|NCT05821452|Paclitaxel|paclitaxel|mesh-list
138336823|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138336824|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138336825|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336826|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336827|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336828|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336829|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336830|NCT05821361|Bevacizumab|bevacizumab|mesh-list
138336831|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336832|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336833|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138336834|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336835|NCT05821361|Growth Substances|growth substances|mesh-ancestor
138336837|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336840|NCT05821192|Gemcitabine|gemcitabine|mesh-list
138336841|NCT05821192|Antibodies|antibodies|mesh-list
138336842|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138336843|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
138336844|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336845|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336846|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
138336847|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
138336848|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336849|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138336851|NCT05821192|Hormones|hormones|mesh-ancestor
138336852|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336853|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138336854|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336855|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336856|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336857|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336858|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
138336859|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336860|NCT05821153|Aldesleukin|aldesleukin|mesh-list
138336861|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336862|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138336863|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336864|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
138336865|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336866|NCT05821062|Aspirin|aspirin|mesh-list
138336868|NCT05821062|Ticagrelor|ticagrelor|mesh-list
138336869|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138336870|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138336871|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138336872|NCT05821062|Analgesics|analgesics|mesh-ancestor
138336873|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
138336874|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336875|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336876|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336877|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336878|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138336879|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138336880|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336881|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138336882|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138336883|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336884|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
138336885|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138336886|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138336887|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138368617|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
138336889|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336891|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
138336892|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
138336893|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336894|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336895|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
138336896|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336897|NCT05809180|Rituximab|rituximab|mesh-list
138336898|NCT05809180|Pomalidomide|pomalidomide|mesh-list
138336899|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336900|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336901|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
138336902|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336903|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336904|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138336905|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138336906|NCT05809180|Growth Substances|growth substances|mesh-ancestor
138336907|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
138336908|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
138336909|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138336910|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138336911|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336912|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
138336913|NCT05802238|Coagulants|coagulants|mesh-ancestor
138336914|NCT05796570|Decitabine|decitabine|mesh-list
138336915|NCT05796570|Lenograstim|lenograstim|mesh-list
138336916|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138336917|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
138336918|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336919|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336920|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
138336921|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336922|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336923|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336924|NCT05668286|Triamcinolone|triamcinolone|mesh-list
138336925|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138336926|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138336927|NCT05668286|Prilocaine|prilocaine|mesh-list
138336928|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138336929|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336930|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
138336931|NCT05668286|Hormones|hormones|mesh-ancestor
138336932|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336933|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336934|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138336935|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
138336936|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336937|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336938|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
138336939|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
138336940|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336941|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
138336942|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336943|NCT06024031|Acetylcysteine|acetylcysteine|mesh-list
138336944|NCT06024031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138336945|NCT06024031|Antiviral Agents|antiviral agents|mesh-ancestor
138336946|NCT06024031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336947|NCT06024031|Expectorants|expectorants|mesh-ancestor
138336948|NCT06024031|Respiratory System Agents|respiratory system agents|mesh-ancestor
138336949|NCT06024031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138367541|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
138367542|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138367543|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138367544|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336950|NCT06024031|Antioxidants|antioxidants|mesh-ancestor
138336951|NCT06024031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336952|NCT06024031|Protective Agents|protective agents|mesh-ancestor
138368641|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
138336953|NCT06024031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336955|NCT06024005|Solifenacin Succinate|solifenacin succinate|mesh-list
138336956|NCT06024005|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138336957|NCT06024005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138336958|NCT06024005|Cholinergic Agents|cholinergic agents|mesh-ancestor
138336959|NCT06024005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138336960|NCT06024005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336961|NCT06024005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336962|NCT06024005|Urological Agents|urological agents|mesh-ancestor
138336963|NCT06023875|Docetaxel|docetaxel|mesh-list
138336964|NCT06023875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138336965|NCT06023875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138336966|NCT06023875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138336967|NCT06023875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336968|NCT06023875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336969|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138336970|NCT05557877|Aspirin|aspirin|mesh-list
138336971|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138336972|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138336973|NCT05557877|Analgesics|analgesics|mesh-ancestor
138336974|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
138336975|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336976|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336977|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336978|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336979|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138336980|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138336981|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336982|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138336983|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138336984|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336985|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
138336986|NCT05549661|Onvansertib|onvansertib|mesh-list
138336987|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138336988|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336989|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336990|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
138336991|NCT05297396|Narcotics|narcotics|mesh-ancestor
138336992|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138336993|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138336994|NCT05297396|Analgesics|analgesics|mesh-ancestor
138336995|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
138336996|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138336997|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
138336998|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138336999|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337000|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337001|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337002|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
138337003|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138337004|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138337005|NCT02464696|Prednisolone|prednisolone|mesh-list
138337006|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
138368649|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368650|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337008|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
138337009|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337010|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
138337011|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
138337012|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337013|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337014|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337016|NCT02464696|Hormones|hormones|mesh-ancestor
138337017|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337018|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138337019|NCT02464696|Protective Agents|protective agents|mesh-ancestor
138337020|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337021|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337022|NCT02389309|Sirolimus|sirolimus|mesh-list
138337023|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
138337024|NCT02389309|Temsirolimus|temsirolimus|mesh-list
138337025|NCT02389309|Dasatinib|dasatinib|mesh-list
138337026|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
138337027|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337028|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
138337029|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337030|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337031|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337032|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
138337033|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337034|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337035|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138337037|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337038|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138337039|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
138337040|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337041|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337042|NCT02231775|Trametinib|trametinib|mesh-list
138337043|NCT02231775|Dabrafenib|dabrafenib|mesh-list
138337044|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337045|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337046|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337047|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337048|NCT02135874|Cytarabine|cytarabine|mesh-list
138337049|NCT02135874|Dexamethasone|dexamethasone|mesh-list
138337050|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
138337051|NCT02135874|Rituximab|rituximab|mesh-list
138337052|NCT02135874|Vincristine|vincristine|mesh-list
138337053|NCT02135874|Sorafenib|sorafenib|mesh-list
138337054|NCT02135874|Idarubicin|idarubicin|mesh-list
138337055|NCT02135874|Clofarabine|clofarabine|mesh-list
138337056|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138337057|NCT02135874|Antibodies|antibodies|mesh-list
138337058|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
138337059|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138337060|NCT02135874|BB 1101|bb 1101|mesh-list
138337061|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
138337062|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337063|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337064|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
138337065|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
138337066|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368662|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
138337069|NCT02135874|Hormones|hormones|mesh-ancestor
138337070|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337071|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337072|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337073|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
138337074|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337075|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337076|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337077|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138337078|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
138337079|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
138337080|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337082|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138337083|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337084|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337085|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337086|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337087|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138337088|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138337089|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138337090|NCT01738139|Ipilimumab|ipilimumab|mesh-list
138337091|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
138337092|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337093|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337094|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337095|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337096|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337097|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337098|NCT00501826|Cytarabine|cytarabine|mesh-list
138337099|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
138337100|NCT00501826|Dexamethasone|dexamethasone|mesh-list
138337101|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
138337102|NCT00501826|Prednisone|prednisone|mesh-list
138337103|NCT00501826|Cortisone|cortisone|mesh-list
138337104|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
138337105|NCT00501826|Doxorubicin|doxorubicin|mesh-list
138337106|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138337107|NCT00501826|Methotrexate|methotrexate|mesh-list
138337108|NCT00501826|Vincristine|vincristine|mesh-list
138337109|NCT00501826|Venetoclax|venetoclax|mesh-list
138337110|NCT00501826|Asparaginase|asparaginase|mesh-list
138337111|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
138337112|NCT00501826|Pegaspargase|pegaspargase|mesh-list
138337113|NCT00501826|BB 1101|bb 1101|mesh-list
138337114|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337115|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
138337116|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337117|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337118|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337119|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
138337120|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337121|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337122|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138337123|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337124|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
138337125|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
138337126|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337127|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337128|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
138337129|NCT00501826|Hormones|hormones|mesh-ancestor
138368677|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337131|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337133|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337134|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138337135|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138337136|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138337137|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138337138|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
138337139|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138337140|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138337141|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
138337142|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337143|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138337144|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138337146|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337147|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138337148|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337149|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337150|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337151|NCT05581823|Carbamazepine|carbamazepine|mesh-list
138337152|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
138367545|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138367546|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138367547|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367548|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367549|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337153|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
138337154|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138337155|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337156|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337157|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138337158|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337159|NCT05581823|Analgesics|analgesics|mesh-ancestor
138337160|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
138337161|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337162|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138337163|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337164|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337165|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138337166|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138337168|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337169|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337170|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138337171|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
138337172|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337173|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337174|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138337175|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138337176|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337178|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337179|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337180|NCT05398484|Niacin|niacin|mesh-list
138337181|NCT05398484|Psilocybin|psilocybin|mesh-list
138337182|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138337183|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
138337184|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337185|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138337186|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337187|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
138337188|NCT05398484|Vitamins|vitamins|mesh-ancestor
138337189|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
138337190|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337191|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
138337192|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138337193|NCT05327296|Propofol|propofol|mesh-list
138337194|NCT05327296|Isoflurane|isoflurane|mesh-list
138337195|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138337196|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337197|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337198|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337199|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
138337200|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
138337201|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138337202|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138337203|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
138337204|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138337205|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138337206|NCT05292755|Laxatives|laxatives|mesh-ancestor
138337207|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337208|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138337209|NCT05283395|Latanoprost|latanoprost|mesh-list
138337210|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138337211|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138337212|NCT05270863|Carbachol|carbachol|mesh-list
138337213|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138337214|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138337215|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138337216|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138337217|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138337218|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337219|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337220|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337221|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138337222|NCT05270863|Miotics|miotics|mesh-ancestor
138337223|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
138337224|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337225|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138337226|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
138337227|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337228|NCT05270863|Analgesics|analgesics|mesh-ancestor
138337229|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
138337230|NCT05270863|Protective Agents|protective agents|mesh-ancestor
138337231|NCT05237141|Etonogestrel|etonogestrel|mesh-list
138337232|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138337233|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
138337234|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138337235|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337236|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138337237|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
138337238|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337239|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337240|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337241|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337244|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138337245|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337246|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
138337247|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
138337248|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138337250|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337251|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337252|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337253|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337254|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337256|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337257|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138337258|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337259|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337260|NCT05014087|Protective Agents|protective agents|mesh-ancestor
138337261|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337262|NCT04955678|Sorbitol|sorbitol|mesh-list
138337263|NCT04955678|Calcium|calcium|mesh-list
138337264|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337265|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337266|NCT04955678|Cathartics|cathartics|mesh-ancestor
138337267|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337268|NCT05175547|Clevidipine|clevidipine|mesh-list
138337269|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138337270|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337271|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337272|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337273|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337274|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
138337275|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337276|NCT04908371|Lidocaine|lidocaine|mesh-list
138337277|NCT04908371|Epinephrine|epinephrine|mesh-list
138337278|NCT04908371|Racepinephrine|racepinephrine|mesh-list
138337279|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
138337280|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
138337281|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
138337282|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
138337283|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337284|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337285|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
138337286|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337287|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337288|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138337289|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138337290|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337291|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337292|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138337293|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138337294|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138337295|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337296|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138337297|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138337298|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
138337299|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337300|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337301|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
138337302|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
138337303|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138337304|NCT04838379|Dexamethasone|dexamethasone|mesh-list
138368716|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138337308|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
138337309|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
138337310|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337311|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337312|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337313|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
138337315|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337316|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337317|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337318|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337319|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138337320|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
138337321|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337322|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
138337323|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138337324|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337325|NCT04838379|Analgesics|analgesics|mesh-ancestor
138337326|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138337327|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138337328|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138337329|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138337330|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337331|NCT04830878|Methotrexate|methotrexate|mesh-list
138337332|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138337333|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
138337334|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138337338|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337340|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337341|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337342|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138337343|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337344|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
138337345|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337346|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138337347|NCT04812366|Prednisone|prednisone|mesh-list
138337348|NCT04812366|Docetaxel|docetaxel|mesh-list
138337349|NCT04812366|Atezolizumab|atezolizumab|mesh-list
138337350|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
138337351|NCT04812366|Niraparib|niraparib|mesh-list
138337352|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337353|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337354|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337355|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337356|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337357|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337358|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
138337360|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337361|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337362|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337363|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337365|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138337366|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337367|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
138337368|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138337369|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138337370|NCT04800107|Curcumin|curcumin|mesh-list
138337371|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138337372|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337373|NCT04800107|Analgesics|analgesics|mesh-ancestor
138337374|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
138337375|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337376|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337377|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337378|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337379|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337380|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337381|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337382|NCT04786574|Tolvaptan|tolvaptan|mesh-list
138337383|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138337384|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337385|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
138337386|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337387|NCT04783857|Progesterone|progesterone|mesh-list
138337388|NCT04783857|Progestins|progestins|mesh-ancestor
138337389|NCT04783857|Hormones|hormones|mesh-ancestor
138337390|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337391|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337393|NCT04761159|Analgesics|analgesics|mesh-ancestor
138337395|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337396|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337397|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138337398|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337399|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
138337400|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
138337401|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337402|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138337403|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138337404|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337405|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337406|NCT04716296|Ketamine|ketamine|mesh-list
138337407|NCT04716296|Analgesics|analgesics|mesh-ancestor
138337408|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
138337409|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337410|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337411|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138337412|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337414|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
138337415|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337416|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138337417|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138337418|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337419|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337420|NCT04704141|Hormones|hormones|mesh-list
138337421|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337422|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337423|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
138337424|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138337425|NCT04682041|Antibodies|antibodies|mesh-list
138337426|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
138337427|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337428|NCT04652661|Midazolam|midazolam|mesh-list
138337429|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
138337430|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138337431|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337432|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337433|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337434|NCT04652661|Analgesics|analgesics|mesh-ancestor
138337435|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
138337436|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337437|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138337438|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138337439|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138367583|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367584|NCT01545141|Analgesics|analgesics|mesh-ancestor
138367585|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
138367587|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337440|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138337441|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337442|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337443|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138337444|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138337445|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138337446|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138337447|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337448|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
138368781|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138337451|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
138337452|NCT04623931|Temozolomide|temozolomide|mesh-list
138337453|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337454|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
138337455|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337456|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337457|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
138337458|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337459|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337460|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337461|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337462|NCT04573751|Verapamil|verapamil|mesh-list
138337463|NCT04573751|Epinephrine|epinephrine|mesh-list
138337464|NCT04573751|Racepinephrine|racepinephrine|mesh-list
138337465|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
138337466|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138337469|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337470|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337471|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337472|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138337473|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138337474|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
138337475|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337476|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337477|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337478|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
138337479|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
138337480|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138337481|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337482|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138337483|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337484|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337485|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337486|NCT04522622|Teriparatide|teriparatide|mesh-list
138337487|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337488|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337489|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138337490|NCT04474483|Melatonin|melatonin|mesh-list
138337491|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
138337492|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337493|NCT04474483|Protective Agents|protective agents|mesh-ancestor
138337494|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337495|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337496|NCT04432207|Atezolizumab|atezolizumab|mesh-list
138337497|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138337498|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337500|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337501|NCT04425447|Anesthetics|anesthetics|mesh-list
138337503|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337504|NCT04345718|Buprenorphine|buprenorphine|mesh-list
138337505|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
138337506|NCT04345718|Narcotics|narcotics|mesh-ancestor
138337507|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337508|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337509|NCT04345718|Analgesics|analgesics|mesh-ancestor
138337511|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337513|NCT04298541|Edotreotide|edotreotide|mesh-list
138337514|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138337515|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337516|NCT04148105|Cilostazol|cilostazol|mesh-list
138337517|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138337518|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
138337519|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337520|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337521|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337522|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337523|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138337524|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138337525|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337526|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138337527|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337528|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138337529|NCT04148105|Protective Agents|protective agents|mesh-ancestor
138337530|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138337531|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138337532|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337534|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337535|NCT04033419|Memantine|memantine|mesh-list
138337536|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138337537|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138337538|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
138337539|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337540|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337541|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337542|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138337543|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138337545|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
138337546|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337547|NCT04014283|Protective Agents|protective agents|mesh-ancestor
138337548|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337549|NCT04014283|Trace Elements|trace elements|mesh-ancestor
138337550|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
138337551|NCT03912233|Ivacaftor|ivacaftor|mesh-list
138337552|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138337553|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337554|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337555|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
138337556|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
138337557|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337559|NCT03781817|Analgesics|analgesics|mesh-ancestor
138337560|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
138337561|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337562|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367595|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138367596|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367597|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367598|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367599|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138367600|NCT01422759|Diuretics|diuretics|mesh-ancestor
138367601|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367602|NCT01421797|Dexamethasone|dexamethasone|mesh-list
138367603|NCT01421797|Cosyntropin|cosyntropin|mesh-list
138367604|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367605|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
138337563|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138337564|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337565|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
138337566|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
138337567|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368805|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
138337568|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138337569|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138337570|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337571|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337572|NCT03636451|Lidocaine|lidocaine|mesh-list
138337573|NCT03636451|Vasopressins|vasopressins|mesh-list
138337574|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
138337575|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
138337576|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
138337577|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337578|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337579|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
138337580|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337581|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337582|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138337583|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138337584|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337585|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337586|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
138337587|NCT03636451|Coagulants|coagulants|mesh-ancestor
138337588|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138337589|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138337590|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
138337591|NCT03576989|Mineral Oil|mineral oil|mesh-list
138337592|NCT03576989|Emollients|emollients|mesh-ancestor
138337593|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337594|NCT03539952|Penicillamine|penicillamine|mesh-list
138337595|NCT03539952|Trientine|trientine|mesh-list
138337596|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
138337597|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
138337598|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337599|NCT03539952|Antidotes|antidotes|mesh-ancestor
138337600|NCT03539952|Protective Agents|protective agents|mesh-ancestor
138337601|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337602|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337608|NCT03278691|Ketorolac|ketorolac|mesh-list
138337609|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138337610|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337611|NCT03278691|Analgesics|analgesics|mesh-ancestor
138337613|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337614|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337616|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337617|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138337618|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337619|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337620|NCT02621489|Metformin|metformin|mesh-list
138337621|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
138337622|NCT02621489|Exenatide|exenatide|mesh-list
138337623|NCT02621489|Biguanides|biguanides|mesh-list
138337624|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138337625|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337626|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138337627|NCT02621489|Incretins|incretins|mesh-ancestor
138337628|NCT02621489|Hormones|hormones|mesh-ancestor
138344289|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138337631|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
138337632|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
138337633|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337635|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337636|NCT02474368|Cisplatin|cisplatin|mesh-list
138337637|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337638|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
138337639|NCT01995344|Fludarabine|fludarabine|mesh-list
138337640|NCT01995344|Interleukin-2|interleukin-2|mesh-list
138337641|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337642|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
138337643|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337644|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337645|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337646|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
138337647|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337648|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337649|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138337650|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337651|NCT01995344|Analgesics|analgesics|mesh-ancestor
138337652|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
138337653|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337654|NCT01845688|Losartan|losartan|mesh-list
138337655|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337656|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138337657|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138337659|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337660|NCT01591291|Ondansetron|ondansetron|mesh-list
138337661|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
138337662|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
138337663|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337664|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337665|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337666|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
138337667|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337668|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138337669|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138337671|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337672|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337673|NCT01093300|Paclitaxel|paclitaxel|mesh-list
138337674|NCT01093300|Everolimus|everolimus|mesh-list
138337675|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138337676|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337677|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337678|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337679|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337680|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337681|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138337682|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337683|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337684|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337685|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
138337686|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337687|NCT01053078|Naltrexone|naltrexone|mesh-list
138337688|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138337689|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138368836|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138337691|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
138337692|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337693|NCT01053156|Minocycline|minocycline|mesh-list
138337694|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138337695|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337696|NCT01053312|Flutemetamol|flutemetamol|mesh-list
138337697|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138337698|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337699|NCT01054404|Furosemide|furosemide|mesh-list
138337700|NCT01054404|Diuretics|diuretics|mesh-ancestor
138337701|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367618|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337702|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337703|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138337704|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337705|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337706|NCT01055184|Vaccines|vaccines|mesh-list
138337708|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337709|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
138337710|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337711|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138337712|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138337713|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337714|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337715|NCT01060020|Urological Agents|urological agents|mesh-ancestor
138337716|NCT01060098|Adalimumab|adalimumab|mesh-list
138337717|NCT01060098|Etanercept|etanercept|mesh-list
138337718|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138337719|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337721|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138337723|NCT01060098|Analgesics|analgesics|mesh-ancestor
138337724|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
138337725|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337726|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337727|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337728|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337729|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
138337730|NCT01061034|Aspirin|aspirin|mesh-list
138337731|NCT01061034|Omeprazole|omeprazole|mesh-list
138337732|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138337733|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337734|NCT01061034|Analgesics|analgesics|mesh-ancestor
138337735|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
138337736|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337737|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337738|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337739|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337740|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138337741|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138337742|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337743|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138368850|NCT02666794|Sufentanil|sufentanil|mesh-list
138337744|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138337745|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337746|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
138337747|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138337748|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337749|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138337750|NCT01065558|Ecopipam|ecopipam|mesh-list
138337751|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138337752|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138337753|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337754|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337755|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138337756|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138337757|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
138337758|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337759|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337760|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
138337761|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138337762|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
138337763|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337764|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
138337765|NCT01066026|Protective Agents|protective agents|mesh-ancestor
138337766|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
138337767|NCT01072188|Calcium|calcium|mesh-list
138337768|NCT01072188|Fluorides|fluorides|mesh-list
138337769|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337770|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337771|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
138337772|NCT01072188|Protective Agents|protective agents|mesh-ancestor
138337773|NCT01072188|Antacids|antacids|mesh-ancestor
138337774|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337775|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337776|NCT01083732|Dabigatran|dabigatran|mesh-list
138337777|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
138337778|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138337779|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
138337780|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337781|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337783|NCT01084278|Colchicine|colchicine|mesh-list
138337784|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
138337785|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337786|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138337787|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138337788|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138337789|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337790|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337791|NCT01085760|Metronidazole|metronidazole|mesh-list
138337792|NCT01085760|Vancomycin|vancomycin|mesh-list
138337793|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337794|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138337795|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138337796|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138337797|NCT01090752|Metformin|metformin|mesh-list
138337798|NCT01090752|Pioglitazone|pioglitazone|mesh-list
138337799|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138337800|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337801|NCT01093794|Metformin|metformin|mesh-list
138337802|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138337803|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138337804|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337805|NCT01093794|Incretins|incretins|mesh-ancestor
138337806|NCT01093794|Hormones|hormones|mesh-ancestor
138337807|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337808|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138337809|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
138337810|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337811|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337812|NCT01094106|Ropivacaine|ropivacaine|mesh-list
138337813|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
138337814|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
138337815|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337816|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337817|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
138337818|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337819|NCT01094574|Propranolol|propranolol|mesh-list
138337820|NCT01094574|Alfentanil|alfentanil|mesh-list
138337821|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138337822|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138337823|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
138337824|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337825|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337826|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337827|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138337828|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138337829|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337830|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138337832|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138337833|NCT01094574|Analgesics|analgesics|mesh-ancestor
138337834|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
138337835|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337836|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138337837|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
138337838|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
138337839|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138367644|NCT04453449|Midazolam|midazolam|mesh-list
138337840|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138337841|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337842|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
138337843|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337844|NCT01096290|Lubiprostone|lubiprostone|mesh-list
138337845|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138337846|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337847|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337848|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138337849|NCT01096680|Modafinil|modafinil|mesh-list
138337850|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138337851|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337852|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138337853|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138337854|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337855|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337856|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
138337857|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337858|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138337859|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138337860|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138337861|NCT01096992|Rituximab|rituximab|mesh-list
138337862|NCT01096992|Fludarabine|fludarabine|mesh-list
138337863|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
138337864|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138337865|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337866|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337867|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
138368877|NCT02619552|Hormones|hormones|mesh-ancestor
138337868|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337869|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337870|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138337871|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
138337872|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337873|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337874|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337875|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
138337876|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138337877|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138337878|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337879|NCT01097460|Trastuzumab|trastuzumab|mesh-list
138337880|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138337881|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337882|NCT01098318|Sertraline|sertraline|mesh-list
138337883|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
138337884|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138337885|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138337886|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138337887|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337888|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337889|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337891|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337892|NCT01100112|Budesonide|budesonide|mesh-list
138337893|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337894|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138337895|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
138337896|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337897|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337898|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337899|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337900|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
138337901|NCT01100112|Hormones|hormones|mesh-ancestor
138337902|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337903|NCT01100268|Methylphenidate|methylphenidate|mesh-list
138337904|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138337905|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337906|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138337907|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138337908|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138337909|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337911|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138337912|NCT01101750|Vaccines|vaccines|mesh-list
138337913|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
138337914|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337916|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
138337917|NCT01102218|Hematinics|hematinics|mesh-ancestor
138337918|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138337919|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337920|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337921|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138337923|NCT01102218|Protective Agents|protective agents|mesh-ancestor
138337924|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337929|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
138337930|NCT01103934|Fluticasone|fluticasone|mesh-list
138337931|NCT01103934|Xhance|xhance|mesh-list
138337932|NCT01103934|Vitamins|vitamins|mesh-ancestor
138337933|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
138337934|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337935|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138337936|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337937|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138337938|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
138337939|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337940|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138337941|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
138337942|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337943|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138337944|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337945|NCT01105650|Cyclosporine|cyclosporine|mesh-list
138337946|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
138337947|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138337948|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138337949|NCT01105650|Prednisolone|prednisolone|mesh-list
138337950|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
138337951|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
138337952|NCT01105650|Fludarabine|fludarabine|mesh-list
138337953|NCT01105650|Interleukin-2|interleukin-2|mesh-list
138337954|NCT01105650|Cyclosporins|cyclosporins|mesh-list
138337955|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138337956|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
138337957|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138337958|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
138337959|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337960|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337961|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337962|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
138337963|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337964|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337965|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138337966|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337967|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
138337968|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138337969|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
138337970|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138337971|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337973|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
138337974|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337975|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337976|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
138337978|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368904|NCT02526017|Nivolumab|nivolumab|mesh-list
138337980|NCT01105650|Protective Agents|protective agents|mesh-ancestor
138337981|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138337982|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138337984|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
138337985|NCT01110876|Temozolomide|temozolomide|mesh-list
138337986|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138337988|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138337989|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
138337990|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337991|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337992|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138337993|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337994|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138337995|NCT01112358|Cetrorelix|cetrorelix|mesh-list
138337996|NCT01112358|Progesterone|progesterone|mesh-list
138337997|NCT01112358|Progestins|progestins|mesh-ancestor
138337998|NCT01112358|Hormones|hormones|mesh-ancestor
138216070|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138337999|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338000|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338001|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138338002|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
138338003|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338004|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338005|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138338006|NCT01112670|Atorvastatin|atorvastatin|mesh-list
138338007|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138338008|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138338009|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
138338010|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338011|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338012|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138338013|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338014|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138338015|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338016|NCT01112670|Incretins|incretins|mesh-ancestor
138338017|NCT01112670|Hormones|hormones|mesh-ancestor
138338018|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338019|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138338020|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
138338021|NCT01115556|Ranibizumab|ranibizumab|mesh-list
138338022|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338023|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338024|NCT01115556|Growth Substances|growth substances|mesh-ancestor
138338025|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338026|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338027|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338028|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138338029|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
138338030|NCT01119222|Promethazine|promethazine|mesh-list
138338031|NCT01119222|Morphine|morphine|mesh-list
138338032|NCT01119222|Gabapentin|gabapentin|mesh-list
138338033|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138338034|NCT01119222|Narcotics|narcotics|mesh-ancestor
138338035|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338036|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338038|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
138338039|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338040|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
138368931|NCT02369653|Anticoagulants|anticoagulants|mesh-list
138338041|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138338042|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138338043|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138338044|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138338045|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138338046|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338047|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338048|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
138338049|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138338050|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138338051|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
138338052|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
138338053|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
138338054|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
138338055|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338056|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138338057|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
138338058|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
138338059|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138338060|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
138338061|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338062|NCT01120236|Leuprolide|leuprolide|mesh-list
138338063|NCT01120236|Goserelin|goserelin|mesh-list
138338064|NCT01120236|Bicalutamide|bicalutamide|mesh-list
138338065|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138338066|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138338067|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
138338068|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338069|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338070|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338071|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338072|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
138338073|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338074|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338075|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
138338076|NCT01120704|Nicotine|nicotine|mesh-list
138338077|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138338078|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
138338079|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338080|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338081|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138338082|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138338083|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
138338084|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368939|NCT02293109|Cytarabine|cytarabine|mesh-list
138338090|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
138338091|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338092|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338094|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
138338095|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138338098|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138338099|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138338100|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
138338101|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338102|NCT04974138|Folic Acid|folic acid|mesh-list
138338103|NCT04974138|Amlodipine|amlodipine|mesh-list
138338104|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338105|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138338106|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338107|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338108|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138338109|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338110|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
138338111|NCT04974138|Hematinics|hematinics|mesh-ancestor
138338112|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
138338113|NCT04974138|Vitamins|vitamins|mesh-ancestor
138338114|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
138338115|NCT04973982|Tacrolimus|tacrolimus|mesh-list
138338116|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338117|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
138338118|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338119|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138338120|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338121|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338122|NCT04142892|Onapristone|onapristone|mesh-list
138338123|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338124|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138338125|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
138338126|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338127|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338128|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338129|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338130|NCT03697356|Dexamethasone|dexamethasone|mesh-list
138338131|NCT03697356|Rituximab|rituximab|mesh-list
138338132|NCT03697356|Lenalidomide|lenalidomide|mesh-list
138338134|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338135|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
138338136|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
138338137|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338138|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338139|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338140|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
138338141|NCT03697356|Hormones|hormones|mesh-ancestor
138338142|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338143|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338144|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338145|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338146|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
138338147|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338148|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338149|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338150|NCT03697356|Growth Substances|growth substances|mesh-ancestor
138338151|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338152|NCT03616782|Ixazomib|ixazomib|mesh-list
138338153|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338154|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
138338155|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338156|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338157|NCT02410512|Atezolizumab|atezolizumab|mesh-list
138338158|NCT02410512|Antibodies|antibodies|mesh-list
138338159|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
138338160|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138338161|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
138338163|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138338164|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338165|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338166|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338167|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138338168|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138338169|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138338170|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338171|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338172|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338173|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338174|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338175|NCT01128192|Pasireotide|pasireotide|mesh-list
138338176|NCT01128192|Hormones|hormones|mesh-ancestor
138338177|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338178|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338179|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
138338180|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138338182|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338184|NCT01128972|Fluorides|fluorides|mesh-list
138338185|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
138338186|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
138368991|NCT02293109|Vitamins|vitamins|mesh-ancestor
138338188|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338190|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338191|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
138338192|NCT01129206|Docetaxel|docetaxel|mesh-list
138338193|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138338194|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338196|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138338197|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138338198|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338199|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138338200|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
138338201|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
138338202|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338203|NCT01129440|Fluorides|fluorides|mesh-list
138338204|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
138338205|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
138338206|NCT01129440|Protective Agents|protective agents|mesh-ancestor
138338207|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338208|NCT01130844|Mesalamine|mesalamine|mesh-list
138338209|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138338210|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338211|NCT01130844|Analgesics|analgesics|mesh-ancestor
138338212|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
138338213|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338214|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338215|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338216|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338217|NCT01134198|Mifepristone|mifepristone|mesh-list
138338218|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138338219|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
138338220|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338221|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338222|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138338223|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138338224|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138338225|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
138338226|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138338227|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138338228|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338229|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338230|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
138338231|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138338232|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138338233|NCT01135368|Lansoprazole|lansoprazole|mesh-list
138338234|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
138338235|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138338236|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338237|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138338238|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338239|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338240|NCT01136226|Leuprolide|leuprolide|mesh-list
138338241|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138338242|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
138338243|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338244|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338245|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338246|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338247|NCT01137396|Modafinil|modafinil|mesh-list
138338248|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138338249|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338250|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138338251|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138338252|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138338253|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338255|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138338256|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338257|NCT01139190|Analgesics|analgesics|mesh-ancestor
138338258|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
138338259|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338260|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338261|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338262|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338263|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
138338264|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138338265|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338266|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338267|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
138338268|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338269|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138338270|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338271|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338272|NCT01142310|Lamotrigine|lamotrigine|mesh-list
138338273|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
138338274|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138338275|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338276|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338277|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138338278|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338279|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138338280|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138338281|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338282|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138338283|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138338284|NCT01144338|Exenatide|exenatide|mesh-list
138338285|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138338286|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338287|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138338288|NCT01144338|Incretins|incretins|mesh-ancestor
138338289|NCT01144338|Hormones|hormones|mesh-ancestor
138338290|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338291|NCT01146600|Clarithromycin|clarithromycin|mesh-list
138338292|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138338293|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338294|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138338295|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338296|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338297|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138338298|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138338299|NCT01146834|Plerixafor|plerixafor|mesh-list
138338300|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
138338301|NCT01146834|Bortezomib|bortezomib|mesh-list
138338302|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338303|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
138338304|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338305|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338306|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138338307|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
138338308|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338309|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338310|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138338311|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138338312|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138338313|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
138338314|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338316|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138338317|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138338318|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
138369016|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138338319|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338320|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138338322|NCT01149876|Tretinoin|tretinoin|mesh-list
138338323|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338324|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
138338325|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338326|NCT01150500|Sirolimus|sirolimus|mesh-list
138338327|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138338328|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338329|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138338330|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338331|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
138338332|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338333|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
138338334|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338335|NCT01151046|Exemestane|exemestane|mesh-list
138338336|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338337|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138338338|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138338339|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338340|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338341|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138338342|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
138338343|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338344|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338345|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
138338346|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138338347|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
138338348|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338349|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
138338350|NCT01151436|Protective Agents|protective agents|mesh-ancestor
138338351|NCT01153620|Polihexanide|polihexanide|mesh-list
138338352|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
138338353|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338354|NCT01163214|Ropivacaine|ropivacaine|mesh-list
138338355|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
138338356|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
138338357|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338358|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338359|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
138338360|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338361|NCT01163604|Argatroban|argatroban|mesh-list
138338362|NCT01163604|Clopidogrel|clopidogrel|mesh-list
138338363|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338364|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338365|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138338366|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338367|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138338368|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138338369|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138338370|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
138338371|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338372|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
138369081|NCT01595620|Hormones|hormones|mesh-ancestor
138338373|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138338374|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
138338375|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
138338376|NCT01168674|Ziprasidone|ziprasidone|mesh-list
138338377|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138338378|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
138338379|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338380|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338381|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338382|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138338384|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338385|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138338386|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138338388|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
138338389|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
138338390|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138338391|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138338393|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338395|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138338396|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138338397|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
138338398|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138338399|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138338400|NCT01170390|Estradiol|estradiol|mesh-list
138338401|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138338402|NCT01170390|Estrogens|estrogens|mesh-ancestor
138338403|NCT01170390|Hormones|hormones|mesh-ancestor
138338404|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338405|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338406|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138338407|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
138338408|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338409|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138338410|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138338411|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138338412|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138338413|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138338414|NCT01134510|Complement C1s|complement c1s|mesh-list
138338415|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138338416|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138338417|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
138338418|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338419|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138338420|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338422|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138338423|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338424|NCT01171794|Analgesics|analgesics|mesh-ancestor
138338425|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
138338426|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338427|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338428|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338429|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338430|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138338431|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338432|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338434|NCT01175148|Calcium|calcium|mesh-list
138338435|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138338436|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338437|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138338438|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138338439|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
138338440|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338441|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338442|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138338443|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338444|NCT01177098|Timolol|timolol|mesh-list
138338445|NCT01177098|Bimatoprost|bimatoprost|mesh-list
138338446|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138338447|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138338448|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138338449|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138338450|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338451|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338452|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338453|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338454|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138338455|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338456|NCT01177956|Fluorouracil|fluorouracil|mesh-list
138338458|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338460|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338461|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138338462|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338463|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
138338464|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338465|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338466|NCT01183650|Tadalafil|tadalafil|mesh-list
138338467|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
138338468|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138338469|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138338470|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338471|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338472|NCT01183650|Urological Agents|urological agents|mesh-ancestor
138338473|NCT01184898|Cytarabine|cytarabine|mesh-list
138338474|NCT01184898|Sirolimus|sirolimus|mesh-list
138338475|NCT01184898|Etoposide|etoposide|mesh-list
138338476|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
138338477|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
138338478|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138338479|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338480|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138369250|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
138338481|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138338482|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338483|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338484|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138338485|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
138338486|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
138338487|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338488|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338489|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
138338490|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338491|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138338492|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138338493|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
138338495|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
138338496|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338498|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
138338499|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
138338500|NCT01188876|Carboplatin|carboplatin|mesh-list
138338501|NCT01188876|Vitamins|vitamins|mesh-ancestor
138338502|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
138338503|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338504|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338505|NCT01188876|Hematinics|hematinics|mesh-ancestor
138338506|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
138338507|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138338508|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138338509|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338510|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338511|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
138338512|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138338513|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338514|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338515|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338516|NCT01195116|Analgesics|analgesics|mesh-ancestor
138338517|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
138338518|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338519|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138338520|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138338521|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138338522|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338523|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338524|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338526|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338527|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138338528|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
138338529|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338530|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338531|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138338532|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
138338533|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
138338535|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338537|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138338538|NCT01198158|Everolimus|everolimus|mesh-list
138338539|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
138338540|NCT01198158|Antibodies|antibodies|mesh-list
138338541|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
138338542|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138338543|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
138338544|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338545|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338546|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338547|NCT01198158|Growth Substances|growth substances|mesh-ancestor
138338548|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338549|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338550|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
138338551|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138338552|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138338553|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338554|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338555|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338556|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
138338557|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138338558|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338559|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
138338560|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138338561|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338562|NCT01206660|Desoximetasone|desoximetasone|mesh-list
138338563|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338564|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
138338565|NCT01206660|Hormones|hormones|mesh-ancestor
138338566|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338567|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338568|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138338569|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
138338570|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138338572|NCT01207908|Growth Substances|growth substances|mesh-ancestor
138338573|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338574|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
138338575|NCT01208922|Rifamycins|rifamycins|mesh-list
138338576|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
138338577|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138338578|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338579|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138338580|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138338581|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338582|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338583|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338584|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138338585|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138338586|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338587|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
138338588|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338589|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338590|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138338591|NCT01210560|Tolvaptan|tolvaptan|mesh-list
138338592|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138338593|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338594|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
138338595|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338596|NCT01211730|Insulin|insulin|mesh-list
138338597|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138338599|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338600|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138338601|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138338602|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138338604|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338605|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338606|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338607|NCT01215318|Silicon|silicon|mesh-list
138338608|NCT01215318|Trace Elements|trace elements|mesh-ancestor
138338609|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
138338610|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338611|NCT01215786|Timolol|timolol|mesh-list
138338612|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138338613|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138338614|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138338615|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138338616|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338617|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338618|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338619|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338620|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138338621|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338622|NCT01216410|Phenylephrine|phenylephrine|mesh-list
138338623|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
138338624|NCT01216410|Ondansetron|ondansetron|mesh-list
138338625|NCT01216410|Metoclopramide|metoclopramide|mesh-list
138338626|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
138338627|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
138338628|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338629|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338630|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338631|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
138338632|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338633|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138338634|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138338635|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
138338636|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338637|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338638|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138338639|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
138338640|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
138338641|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138338642|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
138338643|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138338644|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138338645|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138338646|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138338647|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338648|NCT01216410|Protective Agents|protective agents|mesh-ancestor
138338649|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138338650|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138338651|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
138338652|NCT01218048|Carboplatin|carboplatin|mesh-list
138338653|NCT01218048|Cetuximab|cetuximab|mesh-list
138338654|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338655|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338656|NCT01218984|Naltrexone|naltrexone|mesh-list
138338657|NCT01218984|Hydromorphone|hydromorphone|mesh-list
138338658|NCT01218984|Naloxone|naloxone|mesh-list
138338659|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138338660|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138338661|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369299|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
138338662|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
138338663|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338664|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138338666|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338669|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138338670|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338671|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
138338672|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
138338673|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338674|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338675|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338676|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
138338677|NCT01222260|Hormones|hormones|mesh-ancestor
138338678|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338679|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338680|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338681|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138338682|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
138338683|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338684|NCT01222572|Etoposide|etoposide|mesh-list
138338685|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338686|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138338687|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138338688|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138338689|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338690|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338691|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138338692|NCT01222884|Hematinics|hematinics|mesh-ancestor
138338693|NCT01223352|Bosentan|bosentan|mesh-list
138338694|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338695|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138338696|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338697|NCT01224210|Ambrisentan|ambrisentan|mesh-list
138338698|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338699|NCT01224678|Vitamin D|vitamin d|mesh-list
138338700|NCT01224678|Vitamins|vitamins|mesh-ancestor
138338701|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
138338702|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338703|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138338704|NCT01225068|Milnacipran|milnacipran|mesh-list
138338705|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
138338706|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138338707|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138338708|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338709|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338710|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338711|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338712|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338713|NCT01225068|Analgesics|analgesics|mesh-ancestor
138338714|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
138344290|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338716|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
138338717|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138338718|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
138338719|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138338720|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138338721|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138338722|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338723|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338724|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
138338725|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338726|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338727|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138338728|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338729|NCT01231230|Fluticasone|fluticasone|mesh-list
138338731|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138338732|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138338733|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338734|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138338735|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
138338736|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338737|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338738|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138338739|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
138338740|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338741|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138338742|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138338743|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138338744|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138338745|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
138338746|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338747|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338750|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338751|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
138338752|NCT01232946|Insulin|insulin|mesh-list
138338753|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138338754|NCT01232946|Liraglutide|liraglutide|mesh-list
138338755|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
138338757|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338759|NCT01232946|Hormones|hormones|mesh-ancestor
138338760|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338761|NCT01235910|Cyclosporine|cyclosporine|mesh-list
138338762|NCT01235910|Cyclosporins|cyclosporins|mesh-list
138338763|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338764|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338765|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338766|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
138338767|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338768|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
138338769|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338770|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138338771|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338772|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138338773|NCT01236378|Sirolimus|sirolimus|mesh-list
138338774|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138338775|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338776|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138338777|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338778|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
138338779|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338780|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
138338781|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338782|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
138338783|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
138338784|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
138338785|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338786|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338787|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138338788|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138338789|NCT01238640|Nicotine|nicotine|mesh-list
138338790|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138338791|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
138338793|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338794|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138338795|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138338796|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
138338797|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338798|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338799|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138338800|NCT01247220|Ranibizumab|ranibizumab|mesh-list
138338801|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338802|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338803|NCT01247220|Growth Substances|growth substances|mesh-ancestor
138338804|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338805|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338806|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338807|NCT01249872|Morphine|morphine|mesh-list
138338808|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
138338809|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138338810|NCT01249872|Narcotics|narcotics|mesh-ancestor
138338811|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338816|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
138338819|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
138338820|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
138338821|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338822|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338823|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
138338824|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338826|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138338827|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138338828|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338829|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338830|NCT01250730|Crizotinib|crizotinib|mesh-list
138338831|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338832|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138338833|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338834|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338835|NCT01251978|Ranibizumab|ranibizumab|mesh-list
138338836|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338837|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338838|NCT01251978|Growth Substances|growth substances|mesh-ancestor
138338839|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338840|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338841|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338842|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
138338843|NCT01253460|Rituximab|rituximab|mesh-list
138338844|NCT01253460|Sapacitabine|sapacitabine|mesh-list
138338845|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338846|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
138338847|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338848|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338850|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
138338851|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338852|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338853|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138338854|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338855|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
138338856|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
138338857|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138338858|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138338859|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338860|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338861|NCT01254396|Urological Agents|urological agents|mesh-ancestor
138338862|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138369370|NCT01398202|Vitamins|vitamins|mesh-ancestor
138338868|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138338869|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338870|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338872|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
138338873|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338874|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
138338875|NCT01258374|Darunavir|darunavir|mesh-list
138338876|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138338877|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138338878|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
138338879|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138338880|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138338881|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138338882|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338883|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338884|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138338885|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138338886|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
138338888|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138338889|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138338890|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338891|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338892|NCT01263132|Thiamine|thiamine|mesh-list
138338893|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
138338894|NCT01263132|Gabapentin|gabapentin|mesh-list
138338895|NCT01263132|Analgesics|analgesics|mesh-ancestor
138338896|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
138338897|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338898|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338900|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138338901|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138338902|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138338903|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138338904|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138338905|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138338906|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338907|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338916|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138338917|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338918|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138338919|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138338920|NCT01270542|Growth Substances|growth substances|mesh-ancestor
138338921|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338922|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
138338923|NCT01271244|Escitalopram|escitalopram|mesh-list
138338924|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138338925|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138338926|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138338927|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338928|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338929|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
138338930|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338931|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
138338932|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138338933|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
138338934|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138338935|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338936|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138338937|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138338939|NCT01275300|Aspirin|aspirin|mesh-list
138338940|NCT01275300|Niacin|niacin|mesh-list
138338941|NCT01275300|Niacinamide|niacinamide|mesh-list
138338942|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
138338943|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138338944|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338945|NCT01275300|Analgesics|analgesics|mesh-ancestor
138338946|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
138338947|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338948|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338949|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338950|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338951|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138338952|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138338953|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338954|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138338955|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138338956|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338957|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
138338958|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138338959|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
138338960|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338961|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
138338962|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
138338963|NCT01275300|Vitamins|vitamins|mesh-ancestor
138338964|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
138338965|NCT01276314|Prednisolone|prednisolone|mesh-list
138338966|NCT01276314|Etanercept|etanercept|mesh-list
138338967|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138338968|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
138338969|NCT01276314|Hormones|hormones|mesh-ancestor
138338977|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138338978|NCT01276314|Analgesics|analgesics|mesh-ancestor
138338979|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
138338980|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138338981|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138338984|NCT01280058|Carboplatin|carboplatin|mesh-list
138338985|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138338986|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138338987|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338988|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
138338989|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
138338990|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
138338991|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338992|NCT01280604|Fenofibrate|fenofibrate|mesh-list
138338993|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138338994|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
138338995|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338996|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138338997|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138338998|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138338999|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138367679|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138367680|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138367682|NCT03129321|Econazole|econazole|mesh-list
138339000|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339001|NCT01285050|Tenofovir|tenofovir|mesh-list
138339002|NCT01285050|Emtricitabine|emtricitabine|mesh-list
138339003|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
138339004|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138339005|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
138339006|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339007|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138339008|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138339009|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339010|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339011|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138339012|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138339013|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138339014|NCT01286454|Fesoterodine|fesoterodine|mesh-list
138339015|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138339016|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138339017|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
138339018|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339019|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339020|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339021|NCT01286454|Urological Agents|urological agents|mesh-ancestor
138339022|NCT01287078|Cyclosporine|cyclosporine|mesh-list
138339023|NCT01287078|Cyclosporins|cyclosporins|mesh-list
138339028|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339029|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
138339030|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339031|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339032|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339033|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138339034|NCT01291056|Clomiphene|clomiphene|mesh-list
138339035|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138339036|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
138339037|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339038|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339039|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138339040|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
138339041|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339042|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138339043|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138339045|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138339046|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339047|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
138339048|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339049|NCT01293396|Insulin|insulin|mesh-list
138339050|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138339051|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
138339052|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
138339053|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138339054|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138339055|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138339056|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339057|NCT01294098|Bupivacaine|bupivacaine|mesh-list
138339058|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339059|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
138339060|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339061|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339062|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
138339063|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339064|NCT01295112|Dexamethasone|dexamethasone|mesh-list
138339065|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
138339066|NCT01295112|Bevacizumab|bevacizumab|mesh-list
138339067|NCT01295112|BB 1101|bb 1101|mesh-list
138367693|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
138367694|NCT03107611|Tacrolimus|tacrolimus|mesh-list
138367695|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367696|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367697|NCT03107611|Analgesics|analgesics|mesh-ancestor
138339068|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138339069|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339071|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138339072|NCT01295112|Growth Substances|growth substances|mesh-ancestor
138339073|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339074|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
138339075|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339076|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
138339077|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
138339078|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339079|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339080|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
138339081|NCT01295112|Hormones|hormones|mesh-ancestor
138339082|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339087|NCT01301742|Empagliflozin|empagliflozin|mesh-list
138339088|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
138339089|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138339090|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339091|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138339092|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339093|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138339094|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
138339095|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138339096|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138339097|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138339098|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339100|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339103|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339104|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
138339105|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339106|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138339107|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138339108|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138339109|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339110|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339112|NCT01304238|Lepirudin|lepirudin|mesh-list
138339113|NCT01304238|Danaparoid|danaparoid|mesh-list
138339114|NCT01304238|Fondaparinux|fondaparinux|mesh-list
138339115|NCT01304238|Argatroban|argatroban|mesh-list
138339116|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138339117|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
138339118|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138339119|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339120|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339121|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339122|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
138339123|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138339124|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138339125|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138339126|NCT01305252|Treprostinil|treprostinil|mesh-list
138339127|NCT01305252|Tadalafil|tadalafil|mesh-list
138339128|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
138339137|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138339138|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138339139|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339140|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339141|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
138339142|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339143|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339144|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138339145|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339146|NCT01308294|Vaccines|vaccines|mesh-list
138339147|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138339148|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
138339149|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339150|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138339151|NCT01308840|Gemcitabine|gemcitabine|mesh-list
138339152|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
138339153|NCT01308840|Panitumumab|panitumumab|mesh-list
138339154|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138339156|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339157|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339158|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138339159|NCT01311102|Lidocaine|lidocaine|mesh-list
138339160|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339161|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
138339162|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339163|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339164|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
138339165|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339166|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138339167|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138339168|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138339169|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339170|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339171|NCT01312038|Simethicone|simethicone|mesh-list
138339173|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339175|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339176|NCT01312272|Oxytocin|oxytocin|mesh-list
138339177|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
138339178|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339179|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339180|NCT01312818|Dexamethasone|dexamethasone|mesh-list
138339181|NCT01312818|Methotrexate|methotrexate|mesh-list
138339182|NCT01312818|Bortezomib|bortezomib|mesh-list
138339188|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339189|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339190|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339192|NCT01312818|Hormones|hormones|mesh-ancestor
138339193|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339195|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339196|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138339197|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
138339198|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339199|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138339200|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
138339201|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339202|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339203|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339204|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138339205|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339206|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
138339207|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339208|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138339209|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138339210|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138339211|NCT01313520|Infliximab|infliximab|mesh-list
138339212|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138339213|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339214|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339215|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339216|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339218|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138339219|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
138339220|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339221|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339222|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138339223|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138339224|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
138339225|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339226|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339227|NCT01315158|Midazolam|midazolam|mesh-list
138339228|NCT01315158|Fentanyl|fentanyl|mesh-list
138339229|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
138339230|NCT01315158|Propofol|propofol|mesh-list
138339231|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138339238|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138339239|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138339240|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138339242|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
138339243|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339244|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339245|NCT01315158|Narcotics|narcotics|mesh-ancestor
138339246|NCT01315158|Analgesics|analgesics|mesh-ancestor
138339247|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
138339248|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339249|NCT01318278|Dopamine|dopamine|mesh-list
138339250|NCT01318278|Vasopressins|vasopressins|mesh-list
138339251|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
138339252|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339253|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
138339254|NCT01318278|Coagulants|coagulants|mesh-ancestor
138339255|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138339256|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138339257|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
138339258|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138339260|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
138339261|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339262|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
138339263|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339264|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339265|NCT01318278|Protective Agents|protective agents|mesh-ancestor
138339266|NCT01318356|Doxycycline|doxycycline|mesh-list
138339267|NCT01318356|Tetracycline|tetracycline|mesh-list
138339268|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339269|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339271|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138339272|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138339273|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138339274|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339275|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339276|NCT01324128|Iron|iron|mesh-list
138339277|NCT01324128|Sevelamer|sevelamer|mesh-list
138339278|NCT01324128|Trace Elements|trace elements|mesh-ancestor
138339280|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339281|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
138339282|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
138339283|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339284|NCT01328184|Empagliflozin|empagliflozin|mesh-list
138339285|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
138339286|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138369492|NCT01399151|Vitamin D|vitamin d|mesh-list
138339294|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138339296|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138339297|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339298|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138339299|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138339300|NCT01328184|Estrogens|estrogens|mesh-ancestor
138339301|NCT01328184|Hormones|hormones|mesh-ancestor
138339302|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339303|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138339304|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138339305|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138339306|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138339307|NCT01328964|Fluticasone|fluticasone|mesh-list
138339308|NCT01328964|Xhance|xhance|mesh-list
138339309|NCT01328964|Budesonide|budesonide|mesh-list
138339310|NCT01328964|Montelukast|montelukast|mesh-list
138339311|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339312|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138339313|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
138339314|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339315|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339316|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138339317|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
138339318|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339319|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138339320|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
138339322|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339323|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138339324|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
138339325|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138339326|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138339327|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339328|NCT01330134|Lidocaine|lidocaine|mesh-list
138339329|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339330|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
138339331|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339332|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339333|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
138339334|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339336|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138339337|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138339338|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216071|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138339339|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339341|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
138339342|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
138339343|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339344|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339345|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339346|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138339347|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
138339348|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138339349|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138339350|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138339351|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339352|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339353|NCT01331694|Fluticasone|fluticasone|mesh-list
138339354|NCT01331694|Bromides|bromides|mesh-list
138339355|NCT01331694|Albuterol|albuterol|mesh-list
138339356|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
138339357|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138339358|NCT01331694|Ipratropium|ipratropium|mesh-list
138339359|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138339360|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339361|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138339362|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
138339363|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339364|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339365|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138339366|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
138339367|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339368|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138339369|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
138339370|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138339371|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
138339372|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339373|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339374|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138339376|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138339377|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
138339378|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
138339379|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
138339380|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339381|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
138339382|NCT01331694|Hormones|hormones|mesh-ancestor
138339387|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
138339388|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339389|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339390|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138339391|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138339392|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138339393|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
138339394|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138339395|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138339396|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
138339397|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339398|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
138339399|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138339400|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138339401|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
138339402|NCT01333488|Analgesics|analgesics|mesh-ancestor
138339403|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
138339404|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339405|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339406|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
138339407|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339408|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138339409|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
138339411|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339412|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339413|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138339414|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
138339415|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339417|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138339418|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339419|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138339420|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
138339421|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138339422|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339423|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138339424|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
138339425|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339426|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339427|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339428|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339429|NCT01337700|Milnacipran|milnacipran|mesh-list
138339430|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
138339431|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138339432|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138339433|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339434|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339435|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339436|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339437|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339438|NCT01337700|Analgesics|analgesics|mesh-ancestor
138369537|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
138339446|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
138339447|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
138339448|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339449|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339450|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339451|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
138339453|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339454|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339455|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339456|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138339457|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138339458|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
138339459|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339460|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339461|NCT01340586|Apixaban|apixaban|mesh-list
138339462|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138339463|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
138339464|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138339465|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339466|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339467|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339468|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
138339469|NCT01342770|Pioglitazone|pioglitazone|mesh-list
138339470|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138339471|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339472|NCT01343004|Teriparatide|teriparatide|mesh-list
138339473|NCT01343004|Abaloparatide|abaloparatide|mesh-list
138339474|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138339475|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339476|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138339477|NCT01347060|Fluticasone|fluticasone|mesh-list
138339479|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138339480|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339481|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138339482|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
138339483|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339484|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339485|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138339486|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
138339487|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339488|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138339489|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138339490|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138339491|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138339492|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
138367698|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
138367699|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367700|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339493|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339494|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339496|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138339497|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138339498|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138339499|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339500|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339501|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339502|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138339503|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138339504|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
138339505|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339506|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138339507|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138339509|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339510|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339511|NCT01353144|Analgesics|analgesics|mesh-ancestor
138339512|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
138339513|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339514|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339515|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339516|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339517|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138339518|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138339519|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339520|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138339521|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138339522|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339523|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
138339524|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
138339525|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138339526|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138339527|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339528|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
138339529|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339530|NCT01363050|Ketorolac|ketorolac|mesh-list
138339531|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138339532|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339533|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339535|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
138339536|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339537|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339538|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339539|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339540|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138339541|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339542|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339543|NCT01363128|Cytarabine|cytarabine|mesh-list
138339544|NCT01363128|Dexamethasone|dexamethasone|mesh-list
138339545|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
138339546|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
138339547|NCT01363128|Doxorubicin|doxorubicin|mesh-list
138339548|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138339549|NCT01363128|Methotrexate|methotrexate|mesh-list
138339550|NCT01363128|Vincristine|vincristine|mesh-list
138339551|NCT01363128|Ofatumumab|ofatumumab|mesh-list
138339552|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138339553|NCT01363128|BB 1101|bb 1101|mesh-list
138339554|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339555|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
138339556|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339557|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339558|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138339559|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
138369557|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138339560|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339562|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138339563|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339565|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
138339566|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339567|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339568|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
138339570|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339571|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339573|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138339574|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138339575|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339576|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138339577|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
138339578|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339579|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138339580|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
138339581|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339582|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138339583|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138339584|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
138339585|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339586|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138339587|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138339588|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138339589|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138339590|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339591|NCT01365624|Ketorolac|ketorolac|mesh-list
138339592|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138339593|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339594|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339595|NCT01365624|Analgesics|analgesics|mesh-ancestor
138339596|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
138339597|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339598|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339599|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339600|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339601|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138339602|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339603|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339605|NCT01371786|Ciclesonide|ciclesonide|mesh-list
138339606|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339607|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339608|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138339609|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
138339610|NCT01371786|Hormones|hormones|mesh-ancestor
138339611|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339612|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339614|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138339615|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138339616|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
138339617|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339618|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339619|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339620|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138339621|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
138339622|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339623|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138339624|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
138339625|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138339626|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
138339627|NCT01377636|Protective Agents|protective agents|mesh-ancestor
138339631|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339633|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339634|NCT01379664|Sevoflurane|sevoflurane|mesh-list
138339636|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138339637|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138339638|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
138339639|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
138339640|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339641|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339642|NCT01380366|Hormones|hormones|mesh-list
138339643|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339644|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367704|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367705|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
138367706|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138339645|NCT01387464|Bromfenac|bromfenac|mesh-list
138339646|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339647|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339648|NCT01387464|Analgesics|analgesics|mesh-ancestor
138339649|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
138339650|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339651|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339652|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339653|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339654|NCT01388946|Ropivacaine|ropivacaine|mesh-list
138339655|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339656|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
138339657|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339658|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339659|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
138339660|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339661|NCT01390818|Niacinamide|niacinamide|mesh-list
138339662|NCT01390818|Sirolimus|sirolimus|mesh-list
138339663|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
138339664|NCT01390818|Temsirolimus|temsirolimus|mesh-list
138339666|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339667|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339668|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339669|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
138339670|NCT01390818|Vitamins|vitamins|mesh-ancestor
138339671|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
138339672|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339673|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138339674|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339675|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
138339676|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339677|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339678|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339679|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138339680|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
138339681|NCT01391286|Bimatoprost|bimatoprost|mesh-list
138339682|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138339683|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138339684|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138339685|NCT01393392|Methadone|methadone|mesh-list
138339686|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138339687|NCT01393392|Narcotics|narcotics|mesh-ancestor
138339688|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339689|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339690|NCT01393392|Analgesics|analgesics|mesh-ancestor
138339691|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
138339692|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339693|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
138339694|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
138339695|NCT01393704|Vasopressins|vasopressins|mesh-list
138339696|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
138339697|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
138339698|NCT01393704|Coagulants|coagulants|mesh-ancestor
138339699|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138339700|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138339701|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
138339702|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339703|NCT01399008|Colchicine|colchicine|mesh-list
138339704|NCT01399008|Allopurinol|allopurinol|mesh-list
138339705|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
138339706|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339707|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138339708|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138339709|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138339710|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339711|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339712|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
138339713|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339714|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138339715|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
138339721|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138339722|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
138339723|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339724|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
138339725|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339726|NCT01402050|Dinoprostone|dinoprostone|mesh-list
138339727|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
138339728|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339729|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339730|NCT01403376|Interferons|interferons|mesh-list
138339731|NCT01403376|Interferon-beta|interferon-beta|mesh-list
138339732|NCT01403376|Teriflunomide|teriflunomide|mesh-list
138339733|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
138339734|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339735|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
138339736|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339737|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339738|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339739|NCT01403376|Analgesics|analgesics|mesh-ancestor
138339740|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
138339741|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339742|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339743|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339744|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339745|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339746|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
138339747|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138339749|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
138339750|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
138339751|NCT01404936|Doxorubicin|doxorubicin|mesh-list
138339752|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138339753|NCT01404936|Bleomycin|bleomycin|mesh-list
138339754|NCT01404936|Dacarbazine|dacarbazine|mesh-list
138339755|NCT01404936|Vinblastine|vinblastine|mesh-list
138339756|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138339757|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339758|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138339759|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138339760|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339761|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339762|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
138339763|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339764|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
138339765|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339766|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138339767|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
138367717|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
138339768|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138339769|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
138339771|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
138339773|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
138339774|NCT01410084|Vitamins|vitamins|mesh-list
138339775|NCT01410084|Vitamin E|vitamin e|mesh-list
138339776|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
138339777|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339778|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138339779|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138339780|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
138339781|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339782|NCT01410084|Protective Agents|protective agents|mesh-ancestor
138339783|NCT01413750|Paclitaxel|paclitaxel|mesh-list
138339784|NCT01413750|Carboplatin|carboplatin|mesh-list
138339785|NCT01413750|Vorinostat|vorinostat|mesh-list
138339786|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138339787|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339788|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138339789|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138339790|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138339791|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339792|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138339793|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339794|NCT01417026|Oxytocin|oxytocin|mesh-list
138339795|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
138339796|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339797|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339798|NCT01420146|Trastuzumab|trastuzumab|mesh-list
138339799|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138339800|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339801|NCT01421472|Paclitaxel|paclitaxel|mesh-list
138339802|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138339803|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339804|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138339805|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138339806|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138339807|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339808|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138339809|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138339810|NCT01428336|Cosyntropin|cosyntropin|mesh-list
138339811|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
138339812|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339813|NCT01428336|Hormones|hormones|mesh-ancestor
138339814|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339815|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339816|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339817|NCT01429272|Aspirin|aspirin|mesh-list
138339818|NCT01429272|Minocycline|minocycline|mesh-list
138339819|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339820|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339821|NCT01429272|Analgesics|analgesics|mesh-ancestor
138369714|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
138339822|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
138339823|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339824|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339826|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339827|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138339828|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138339829|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339830|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138339831|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138339832|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339834|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339835|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339836|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138339837|NCT01429350|Plasminogen|plasminogen|mesh-list
138339838|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138339839|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138339840|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339841|NCT01432236|Pregabalin|pregabalin|mesh-list
138339842|NCT01432236|Analgesics|analgesics|mesh-ancestor
138339843|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
138339844|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339845|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339846|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
138339847|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138339848|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339849|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339850|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138339851|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138339852|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138339853|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339854|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138339856|NCT01434186|Saxagliptin|saxagliptin|mesh-list
138339857|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138339858|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339859|NCT01434186|Incretins|incretins|mesh-ancestor
138339860|NCT01434186|Hormones|hormones|mesh-ancestor
138339861|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339862|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138339863|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339864|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339865|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339867|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138339868|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
138339869|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339870|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339871|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138339872|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138339873|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
138339874|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339875|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339876|NCT01435824|Amoxicillin|amoxicillin|mesh-list
138339877|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138339878|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339879|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
138339880|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138339881|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
138339882|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138339883|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339884|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369726|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
138339885|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339886|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
138339887|NCT01438710|Tacrolimus|tacrolimus|mesh-list
138339888|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339889|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
138339890|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339891|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138339892|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339893|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339894|NCT01443546|Leuprolide|leuprolide|mesh-list
138339895|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138339896|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
138339897|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339898|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339899|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339900|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339901|NCT01444716|Ofatumumab|ofatumumab|mesh-list
138339902|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138339903|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339904|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
138339905|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339906|NCT01445028|Isotretinoin|isotretinoin|mesh-list
138339907|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138339908|NCT01452126|Ropivacaine|ropivacaine|mesh-list
138339909|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
138339910|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
138339911|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339912|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339913|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
138339914|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339915|NCT01457430|Icatibant|icatibant|mesh-list
138339916|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138339917|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138339918|NCT01457430|Analgesics|analgesics|mesh-ancestor
138339919|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
138339920|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339921|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339922|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339923|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138339924|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138339925|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138339926|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339927|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138339928|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339929|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
138339930|NCT01458990|Omeprazole|omeprazole|mesh-list
138339931|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138339932|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138339933|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138339934|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339935|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339936|NCT01460940|Lenalidomide|lenalidomide|mesh-list
138339938|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138339939|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
138369740|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138339941|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138339942|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138339943|NCT01460940|Growth Substances|growth substances|mesh-ancestor
138339944|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
138339945|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339946|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339947|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339948|NCT01462812|Sumatriptan|sumatriptan|mesh-list
138339949|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138339950|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138339951|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138339952|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
138339953|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339954|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339955|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339956|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138339957|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
138339958|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138339959|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138339960|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138339961|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
138339962|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339963|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339964|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138339965|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138339966|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138339967|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339968|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339969|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138367763|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367764|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138339970|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
138339971|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138339972|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
138339973|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339974|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339975|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138339976|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339977|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138339978|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
138339979|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138339980|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138339981|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339983|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138339984|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
138339985|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339986|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
138339987|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138339988|NCT01472874|Trientine|trientine|mesh-list
138339989|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
138339990|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
138339991|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339992|NCT01474122|Macitentan|macitentan|mesh-list
138339993|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138339994|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138339995|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339996|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138339998|NCT01474590|Isotretinoin|isotretinoin|mesh-list
138339999|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340000|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340001|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
138340002|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138340003|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138340004|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138340005|NCT01477320|Pantoprazole|pantoprazole|mesh-list
138340006|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138340007|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340008|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138340009|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340010|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340012|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
138340013|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138340014|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
138340015|NCT01478256|Besifloxacin|besifloxacin|mesh-list
138340016|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340017|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340018|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340019|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138340020|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340021|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340022|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138340023|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138340024|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340026|NCT01479270|Ropivacaine|ropivacaine|mesh-list
138340027|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340028|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
138340029|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340030|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340031|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
138340032|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340033|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138340034|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138340035|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
138340036|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340037|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340038|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138340039|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138340040|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
138340041|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138340042|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
138340044|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
138340045|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138340046|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
138340047|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
138340050|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340051|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340052|NCT01484340|Nicotine|nicotine|mesh-list
138340053|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138340054|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
138340055|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340056|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340057|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138340058|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138340059|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
138340060|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340061|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340062|NCT01485588|hI-con1|hi-con1|mesh-list
138340063|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
138340064|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
138340065|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340066|NCT01488318|Cetuximab|cetuximab|mesh-list
138340067|NCT01488318|Dasatinib|dasatinib|mesh-list
138340068|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340069|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340070|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340071|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340072|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340073|NCT01495572|Aldesleukin|aldesleukin|mesh-list
138340074|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
138340075|NCT01495572|Fludarabine|fludarabine|mesh-list
138340076|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340077|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
138340078|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340079|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138340080|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138340081|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
138340082|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340083|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340084|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138340085|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138340086|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138340087|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
138340088|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340089|NCT01504854|Resveratrol|resveratrol|mesh-list
138340091|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340093|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340094|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340095|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138340096|NCT01508832|Lidocaine|lidocaine|mesh-list
138340097|NCT01508832|Bupivacaine|bupivacaine|mesh-list
138340098|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340100|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340101|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340102|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
138340103|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340104|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138340105|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138340106|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138340107|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340108|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340109|NCT01511640|Pregabalin|pregabalin|mesh-list
138340110|NCT01511640|Analgesics|analgesics|mesh-ancestor
138340111|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
138340112|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340113|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340114|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
138340115|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138340116|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340117|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340118|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138340119|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138340120|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138340121|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340122|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340123|NCT01513122|Ritonavir|ritonavir|mesh-list
138340124|NCT01513122|Lopinavir|lopinavir|mesh-list
138340125|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
138340126|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138340127|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138340128|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
138340129|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340130|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340131|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138340132|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138340133|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
138340134|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340135|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138340136|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138340137|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138340138|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138340139|NCT01513902|Tofacitinib|tofacitinib|mesh-list
138340140|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138340141|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340142|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340143|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340144|NCT01515540|Lidocaine|lidocaine|mesh-list
138340145|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340146|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
138340147|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340148|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340149|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
138340150|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340151|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138340152|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138340153|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138340154|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340155|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340160|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138340161|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138340162|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
138340163|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340164|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340165|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340166|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138340167|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340168|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138340169|NCT01520454|Heparin|heparin|mesh-list
138340170|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138340171|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
138340172|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138340173|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138340174|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340175|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138340176|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138340177|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138340178|NCT01520688|Fluticasone|fluticasone|mesh-list
138340179|NCT01520688|Xhance|xhance|mesh-list
138340180|NCT01520688|Budesonide|budesonide|mesh-list
138340181|NCT01520688|Beclomethasone|beclomethasone|mesh-list
138340182|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138340183|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138340184|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
138340185|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340186|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340187|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138340188|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
138340189|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
138340190|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138340191|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
138340193|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340194|NCT01521546|Eplerenone|eplerenone|mesh-list
138340195|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138340196|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367769|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367770|NCT05274139|Cytarabine|cytarabine|mesh-list
138367771|NCT05274139|Dexamethasone|dexamethasone|mesh-list
138340197|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340198|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340199|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138340200|NCT01521546|Diuretics|diuretics|mesh-ancestor
138340201|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
138340202|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138340203|NCT01523496|Vitamin D|vitamin d|mesh-list
138340204|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
138340205|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
138340206|NCT01523496|Calcifediol|calcifediol|mesh-list
138340207|NCT01523496|Vitamins|vitamins|mesh-list
138340208|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
138340209|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340210|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138340211|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138340212|NCT01526538|Cycloserine|cycloserine|mesh-list
138340216|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
138340217|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340218|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
138340219|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340220|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
138340221|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138340222|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
138340223|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340224|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340225|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138340226|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
138340227|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138340229|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340230|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340231|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138340232|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
138340233|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
138340234|NCT01529502|Protective Agents|protective agents|mesh-ancestor
138340236|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340238|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340239|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340240|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340241|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340242|NCT01534416|Bupivacaine|bupivacaine|mesh-list
138340243|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340244|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
138340245|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340246|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340247|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
138340248|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340249|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
138340250|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138340251|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340252|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340253|NCT01535976|Ketamine|ketamine|mesh-list
138340254|NCT01535976|Analgesics|analgesics|mesh-ancestor
138340255|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
138340256|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340257|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340258|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138340259|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138340260|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
138340261|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
138340262|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340263|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138340264|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138340265|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340266|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340267|NCT01536366|Repaglinide|repaglinide|mesh-list
138340268|NCT01536366|Opicapone|opicapone|mesh-list
138340270|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340271|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138340272|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340273|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340274|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138340275|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138340276|NCT06115174|Pentoxifylline|pentoxifylline|mesh-list
138340277|NCT06115174|Antibodies|antibodies|mesh-list
138340278|NCT06115174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138340279|NCT06115174|Immunologic Factors|immunologic factors|mesh-ancestor
138340280|NCT06115174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340281|NCT06115174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138340282|NCT06115174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340283|NCT06115174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340284|NCT06115174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138340285|NCT06115174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138340286|NCT06115174|Protective Agents|protective agents|mesh-ancestor
138340287|NCT06115174|Vasodilator Agents|vasodilator agents|mesh-ancestor
138340288|NCT06115174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138340289|NCT06115174|Antioxidants|antioxidants|mesh-ancestor
138340290|NCT06115070|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138340291|NCT06115070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138340292|NCT06115070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138340293|NCT06115070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340301|NCT06115005|Mitogens|mitogens|mesh-list
138340302|NCT06115005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138340303|NCT06115005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340304|NCT06114979|Silodosin|silodosin|mesh-list
138340305|NCT06114979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138340306|NCT06114979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138340307|NCT06114979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138340308|NCT06114979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138340309|NCT06114979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340310|NCT06114979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340311|NCT06114979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340312|NCT06114979|Urological Agents|urological agents|mesh-ancestor
138340313|NCT06114953|Mycophenolic Acid|mycophenolic acid|mesh-list
138340314|NCT06114953|Mizoribine|mizoribine|mesh-list
138340315|NCT06114953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138340316|NCT06114953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340317|NCT06114953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138340318|NCT06114953|Antitubercular Agents|antitubercular agents|mesh-ancestor
138340319|NCT06114953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340320|NCT06114953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340321|NCT06114953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369845|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
138340323|NCT06114953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138340324|NCT06114953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138340325|NCT06114953|Analgesics|analgesics|mesh-ancestor
138340326|NCT06114953|Sensory System Agents|sensory system agents|mesh-ancestor
138340327|NCT06114953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340328|NCT06114953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340329|NCT06114953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138340330|NCT06114953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138340331|NCT06114953|Antimalarials|antimalarials|mesh-ancestor
138340334|NCT06114953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340335|NCT06114953|Immunologic Factors|immunologic factors|mesh-ancestor
138340336|NCT06114940|Sunitinib|sunitinib|mesh-list
138340337|NCT06114940|Lenvatinib|lenvatinib|mesh-list
138340338|NCT06114940|Axitinib|axitinib|mesh-list
138340339|NCT06114940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340340|NCT06114940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138340341|NCT06114940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138340342|NCT06114940|Growth Substances|growth substances|mesh-ancestor
138340343|NCT06114940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340344|NCT06114940|Growth Inhibitors|growth inhibitors|mesh-ancestor
138340345|NCT06114940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340346|NCT06114940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340347|NCT06114940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340348|NCT06114758|Tranylcypromine|tranylcypromine|mesh-list
138340349|NCT06114758|Misoprostol|misoprostol|mesh-list
138340350|NCT06114758|Tranexamic Acid|tranexamic acid|mesh-list
138340351|NCT06114758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138340352|NCT06114758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138340353|NCT06114758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340354|NCT06114758|Hemostatics|hemostatics|mesh-ancestor
138340355|NCT06114758|Coagulants|coagulants|mesh-ancestor
138340356|NCT06114758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138340357|NCT06114758|Abortifacient Agents|abortifacient agents|mesh-ancestor
138340358|NCT06114758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138340359|NCT06114758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340360|NCT06114758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138340361|NCT06114758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340362|NCT06114758|Oxytocics|oxytocics|mesh-ancestor
138340363|NCT06114758|Antidepressive Agents|antidepressive agents|mesh-ancestor
138340364|NCT06114758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340365|NCT06114758|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138340366|NCT06114758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340367|NCT06114758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138340368|NCT06114758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138340369|NCT06114758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340371|NCT06114641|Enoxaparin sodium|enoxaparin sodium|mesh-list
138340372|NCT06114641|Anticoagulants|anticoagulants|mesh-ancestor
138340373|NCT06114641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138340374|NCT06114641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138340375|NCT06114641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340376|NCT06114576|Vitamin D|vitamin d|mesh-list
138340377|NCT06114576|Cholecalciferol|cholecalciferol|mesh-list
138340378|NCT06114576|Vitamins|vitamins|mesh-ancestor
138340379|NCT06114576|Micronutrients|micronutrients|mesh-ancestor
138340380|NCT06114576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340381|NCT06114576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138340382|NCT06114576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138340384|NCT06114537|Anticonvulsants|anticonvulsants|mesh-ancestor
138340385|NCT06114537|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138340386|NCT06114537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340387|NCT06114537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340388|NCT06114537|Diuretics|diuretics|mesh-ancestor
138340389|NCT06114537|Natriuretic Agents|natriuretic agents|mesh-ancestor
138340390|NCT06114537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340391|NCT06114381|Vitamin D|vitamin d|mesh-list
138340392|NCT06114381|Cholecalciferol|cholecalciferol|mesh-list
138340393|NCT06114381|Vitamins|vitamins|mesh-ancestor
138340394|NCT06114381|Micronutrients|micronutrients|mesh-ancestor
138340395|NCT06114381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340396|NCT06114381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138340397|NCT06114381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138340398|NCT06114225|Gemcitabine|gemcitabine|mesh-list
138340399|NCT06114225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138340400|NCT06114225|Antimetabolites|antimetabolites|mesh-ancestor
138340401|NCT06114225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340402|NCT06114225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340403|NCT06114173|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138340404|NCT06114173|Immunologic Factors|immunologic factors|mesh-ancestor
138340405|NCT06114173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340406|NCT06114121|Morphine|morphine|mesh-list
138340407|NCT06114121|Bupivacaine|bupivacaine|mesh-list
138340408|NCT06114121|Ropivacaine|ropivacaine|mesh-list
138340409|NCT06114121|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340410|NCT06114121|Anesthetics|anesthetics|mesh-ancestor
138340411|NCT06114121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340412|NCT06114121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340413|NCT06114121|Sensory System Agents|sensory system agents|mesh-ancestor
138340414|NCT06114121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340415|NCT06114121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138340416|NCT06114121|Narcotics|narcotics|mesh-ancestor
138340417|NCT06114121|Analgesics|analgesics|mesh-ancestor
138340418|NCT06114082|Doxorubicin|doxorubicin|mesh-list
138340419|NCT06114082|Idarubicin|idarubicin|mesh-list
138340420|NCT06114082|Chlorotrianisene|chlorotrianisene|mesh-list
138340421|NCT06114082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138340422|NCT06114082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340423|NCT06114082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138340424|NCT06114082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138340425|NCT06114082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340426|NCT06114082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340427|NCT06114082|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138340428|NCT06114082|Estrogens|estrogens|mesh-ancestor
138340429|NCT06114082|Hormones|hormones|mesh-ancestor
138340430|NCT06114082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340431|NCT06114082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340432|NCT06114082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138340433|NCT06114030|Lithium Carbonate|lithium carbonate|mesh-list
138340434|NCT06114030|Antidepressive Agents|antidepressive agents|mesh-ancestor
138340436|NCT06114030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340437|NCT06114030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340438|NCT06114030|Antimanic Agents|antimanic agents|mesh-ancestor
138340439|NCT06114030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138340440|NCT06114030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340441|NCT06114030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340442|NCT06114004|Gemcitabine|gemcitabine|mesh-list
138340443|NCT06114004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138340444|NCT06114004|Antimetabolites|antimetabolites|mesh-ancestor
138340445|NCT06114004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340446|NCT06114004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340447|NCT06113900|Dapagliflozin|dapagliflozin|mesh-list
138340448|NCT06113900|Empagliflozin|empagliflozin|mesh-list
138340449|NCT06113900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138340450|NCT06113900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340451|NCT06113900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340452|NCT06113900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369882|NCT01402089|Sunitinib|sunitinib|mesh-list
138340456|NCT06113809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340457|NCT06113809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138340458|NCT06113809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340459|NCT06113809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340460|NCT06113809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340461|NCT06113367|Immunomodulating Agents|immunomodulating agents|mesh-list
138340462|NCT06113367|Immunologic Factors|immunologic factors|mesh-ancestor
138340463|NCT06113367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340464|NCT06113289|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138340465|NCT06113289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138340466|NCT06113289|Antimetabolites|antimetabolites|mesh-ancestor
138340467|NCT06113289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340468|NCT06113289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340469|NCT06112938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138340470|NCT06112938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340472|NCT06110130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138340473|NCT06110130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340474|NCT06110130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340475|NCT06110130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340476|NCT06108895|Morphine|morphine|mesh-list
138340477|NCT06108895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138340478|NCT06108895|Narcotics|narcotics|mesh-ancestor
138340479|NCT06108895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340480|NCT06108895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340481|NCT06108895|Analgesics|analgesics|mesh-ancestor
138340482|NCT06108895|Sensory System Agents|sensory system agents|mesh-ancestor
138340483|NCT06108895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340484|NCT06090266|Cemiplimab|cemiplimab|mesh-list
138340485|NCT06090266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340486|NCT06090266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340488|NCT06087419|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138340489|NCT06087419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340490|NCT06087419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340491|NCT06087419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138340492|NCT06087419|Immunotoxins|immunotoxins|mesh-ancestor
138340493|NCT06087419|Immunoconjugates|immunoconjugates|mesh-ancestor
138340494|NCT06087419|Immunologic Factors|immunologic factors|mesh-ancestor
138340495|NCT06087419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340496|NCT06074263|Dexamethasone|dexamethasone|mesh-list
138340497|NCT06074263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138340498|NCT06074263|Antiemetics|antiemetics|mesh-ancestor
138340499|NCT06074263|Autonomic Agents|autonomic agents|mesh-ancestor
138340500|NCT06074263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340501|NCT06074263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340502|NCT06074263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340503|NCT06074263|Glucocorticoids|glucocorticoids|mesh-ancestor
138340504|NCT06074263|Hormones|hormones|mesh-ancestor
138340505|NCT06074263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340506|NCT06074263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138340507|NCT06074263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340508|NCT06048107|Teniposide|teniposide|mesh-list
138340509|NCT06048107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340510|NCT06048107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138340511|NCT06048107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138340512|NCT06048107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340513|NCT06048107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340514|NCT06038617|Vaccines|vaccines|mesh-list
138340515|NCT06038617|Immunologic Factors|immunologic factors|mesh-ancestor
138340516|NCT06038617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340517|NCT06004336|Pembrolizumab|pembrolizumab|mesh-list
138340518|NCT06004336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340519|NCT06004336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340520|NCT06004336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138340521|NCT06004336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340522|NCT05997732|Propranolol|propranolol|mesh-list
138340523|NCT05997732|Phentolamine|phentolamine|mesh-list
138340524|NCT05997732|Phenylephrine|phenylephrine|mesh-list
138340525|NCT05997732|Isoproterenol|isoproterenol|mesh-list
138340526|NCT05997732|Oxymetazoline|oxymetazoline|mesh-list
138340527|NCT05997732|Norepinephrine|norepinephrine|mesh-list
138340528|NCT05997732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138340529|NCT05997732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138340530|NCT05997732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138340531|NCT05997732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340532|NCT05997732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340533|NCT05997732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340534|NCT05997732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138340535|NCT05997732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138340536|NCT05997732|Vasodilator Agents|vasodilator agents|mesh-ancestor
138340537|NCT05997732|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138340538|NCT05997732|Mydriatics|mydriatics|mesh-ancestor
138340539|NCT05997732|Autonomic Agents|autonomic agents|mesh-ancestor
138340540|NCT05997732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340541|NCT05997732|Sympathomimetics|sympathomimetics|mesh-ancestor
138340542|NCT05997732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138340543|NCT05997732|Nasal Decongestants|nasal decongestants|mesh-ancestor
138340544|NCT05997732|Respiratory System Agents|respiratory system agents|mesh-ancestor
138340545|NCT05997732|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138340546|NCT05997732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138340547|NCT05997732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138340548|NCT05997732|Protective Agents|protective agents|mesh-ancestor
138340549|NCT05997732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138340550|NCT05997732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138340551|NCT05997732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138340552|NCT05997732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138340553|NCT05941858|Nicotine|nicotine|mesh-list
138340555|NCT05941858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138340556|NCT05941858|Autonomic Agents|autonomic agents|mesh-ancestor
138340557|NCT05941858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340558|NCT05941858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340559|NCT05941858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138340560|NCT05941858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138340561|NCT05941858|Cholinergic Agents|cholinergic agents|mesh-ancestor
138340562|NCT05941858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340563|NCT05941858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340564|NCT05941858|Antimetabolites|antimetabolites|mesh-ancestor
138340565|NCT05941858|Gasotransmitters|gasotransmitters|mesh-ancestor
138340566|NCT05935917|Brincidofovir|brincidofovir|mesh-list
138340568|NCT05935917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340569|NCT05918302|Everolimus|everolimus|mesh-list
138340570|NCT05918302|Edotreotide|edotreotide|mesh-list
138340571|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
138340572|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138340573|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340574|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340575|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340576|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340577|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
138340578|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340579|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340580|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138340581|NCT05891548|Aflibercept|aflibercept|mesh-list
138340582|NCT05891548|Axitinib|axitinib|mesh-list
138340583|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138340584|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138340585|NCT05891548|Growth Substances|growth substances|mesh-ancestor
138340586|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340587|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
138340588|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340589|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340590|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340591|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340592|NCT05891249|Luspatercept|luspatercept|mesh-list
138340594|NCT05862792|Bupivacaine|bupivacaine|mesh-list
138340595|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
138340596|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
138340597|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340598|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340599|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
138340600|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340601|NCT05835999|Everolimus|everolimus|mesh-list
138340602|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138340603|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340604|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340605|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340606|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340607|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
138340608|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340609|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340610|NCT05829603|Harmine|harmine|mesh-list
138340611|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
138340612|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340613|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340614|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138340615|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340616|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340617|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138369925|NCT01402245|Vaccines|vaccines|mesh-list
138340625|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138340628|NCT05800275|Tucatinib|tucatinib|mesh-list
138340629|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138340630|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
138340631|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340632|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340633|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340634|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340635|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340636|NCT05769478|Amifampridine|amifampridine|mesh-list
138340637|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138340638|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340639|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340640|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138340641|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340642|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340643|NCT05729282|Diazoxide|diazoxide|mesh-list
138340644|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138340645|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
138340647|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
138340649|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
138340650|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340651|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138340652|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138340653|NCT05724134|Insulin|insulin|mesh-list
138340654|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138340655|NCT05724134|Octreotide|octreotide|mesh-list
138340656|NCT05724134|Glucagon|glucagon|mesh-list
138340657|NCT05724134|Hormones|hormones|mesh-list
138340658|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340659|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340660|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340661|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340662|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138340663|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340664|NCT05723588|Nicotine|nicotine|mesh-list
138340665|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138340666|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
138340667|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340668|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340669|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138340670|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138340671|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
138340672|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340673|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340690|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138340691|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138340692|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340693|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340694|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138340695|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138340696|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340697|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340698|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340699|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
138340700|NCT05704543|Buprenorphine|buprenorphine|mesh-list
138340701|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138340702|NCT05704543|Narcotics|narcotics|mesh-ancestor
138340703|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340704|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340705|NCT05704543|Analgesics|analgesics|mesh-ancestor
138340706|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
138340707|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340708|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138340709|NCT05627375|Anticoagulants|anticoagulants|mesh-list
138340710|NCT05557578|Gemcitabine|gemcitabine|mesh-list
138340711|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
138340712|NCT05557578|Tislelizumab|tislelizumab|mesh-list
138340713|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138340714|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
138340715|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340716|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340717|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340718|NCT05500586|Glucagon|glucagon|mesh-list
138340719|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340720|NCT05500586|Hormones|hormones|mesh-ancestor
138340721|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340722|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340723|NCT05482516|Bevacizumab|bevacizumab|mesh-list
138340724|NCT05482516|Atezolizumab|atezolizumab|mesh-list
138340725|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340726|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340727|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138340728|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138340729|NCT05482516|Growth Substances|growth substances|mesh-ancestor
138340730|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340731|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
138340732|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138340733|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340734|NCT05475873|Ondansetron|ondansetron|mesh-list
138340735|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
138340736|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
138340737|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369948|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
138340739|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340740|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
138340741|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
138340742|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138340743|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138340744|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
138340745|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340746|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340747|NCT05470595|Atezolizumab|atezolizumab|mesh-list
138340748|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138340749|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340750|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340751|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340752|NCT05412875|Nicotine|nicotine|mesh-list
138340753|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138340754|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
138340755|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340756|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340757|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138340759|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
138340760|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216072|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367779|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340761|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340763|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138340764|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340765|NCT05288283|Cannabidiol|cannabidiol|mesh-list
138340766|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
138340767|NCT05242029|Psilocybin|psilocybin|mesh-list
138340768|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
138340769|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340770|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340771|NCT05220410|Psilocybin|psilocybin|mesh-list
138340772|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
138340773|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340774|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340775|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
138340776|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
138340778|NCT05186363|Amodiaquine|amodiaquine|mesh-list
138340779|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
138340781|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138340782|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340783|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138340784|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340785|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340786|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138340787|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138340788|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
138340789|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340790|NCT05094804|Docetaxel|docetaxel|mesh-list
138340791|NCT05094804|Cemiplimab|cemiplimab|mesh-list
138340792|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340793|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138340794|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138340795|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138340796|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340797|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340798|NCT05045872|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138340799|NCT05045872|Hematinics|hematinics|mesh-ancestor
138340800|NCT05045872|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138340801|NCT05045872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138340802|NCT05030415|Ixekizumab|ixekizumab|mesh-list
138340803|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
138340804|NCT05021562|Niraparib|niraparib|mesh-list
138340805|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138340807|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340808|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340809|NCT04995029|Buprenorphine|buprenorphine|mesh-list
138340810|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138340811|NCT04995029|Narcotics|narcotics|mesh-ancestor
138340812|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340813|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340814|NCT04995029|Analgesics|analgesics|mesh-ancestor
138340815|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
138340816|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340817|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138340819|NCT04982874|Diuretics|diuretics|mesh-ancestor
138340820|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
138340821|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340822|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138340823|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340824|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340825|NCT04966585|Posaconazole|posaconazole|mesh-list
138340826|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
138340827|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340828|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138340829|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138340830|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138340832|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138340833|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340834|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340835|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138340836|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
138340837|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340838|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340839|NCT04935177|Antibodies|antibodies|mesh-list
138340840|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
138340841|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138340842|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
138340843|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138340844|NCT04935177|Eculizumab|eculizumab|mesh-list
138340845|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
138340846|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340847|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138340848|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340849|NCT04919369|Vitamins|vitamins|mesh-list
138340851|NCT04919369|Atezolizumab|atezolizumab|mesh-list
138340852|NCT04919369|Tretinoin|tretinoin|mesh-list
138369967|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
138340853|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
138340854|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138340855|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
138340856|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340857|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138340858|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340859|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340860|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340861|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
138340862|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
138340863|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
138340864|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
138340865|NCT04919369|Protective Agents|protective agents|mesh-ancestor
138340866|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138340867|NCT04908956|Osimertinib|osimertinib|mesh-list
138340868|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340869|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138340870|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340871|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340872|NCT04812379|Aripiprazole|aripiprazole|mesh-list
138340873|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
138340874|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340875|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138340876|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138340877|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138340878|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340879|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
138340880|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
138340881|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340882|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340883|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138340884|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138340886|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138340887|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138340888|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138340889|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138340890|NCT04809311|Insulin|insulin|mesh-list
138340891|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138340892|NCT04809311|Glucagon|glucagon|mesh-list
138340893|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138340894|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340895|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340896|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340897|NCT04809311|Hormones|hormones|mesh-ancestor
138340898|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340899|NCT04809311|Incretins|incretins|mesh-ancestor
138340900|NCT04681833|Vaccines|vaccines|mesh-list
138340901|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
138340902|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340903|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
138340904|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138340905|NCT04629729|Fludarabine|fludarabine|mesh-list
138340906|NCT04629729|Interleukin-2|interleukin-2|mesh-list
138340907|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138340908|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
138340909|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340910|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138340911|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138340912|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
138369992|NCT01402674|Phentermine|phentermine|mesh-list
138340914|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340915|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138340916|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138340917|NCT04629729|Analgesics|analgesics|mesh-ancestor
138340918|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
138340919|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340920|NCT04597099|Flutamide|flutamide|mesh-list
138340921|NCT04597099|Estradiol|estradiol|mesh-list
138340922|NCT04597099|Progesterone|progesterone|mesh-list
138340923|NCT04597099|Estrogens|estrogens|mesh-ancestor
138340924|NCT04597099|Hormones|hormones|mesh-ancestor
138340925|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340926|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340927|NCT04597099|Progestins|progestins|mesh-ancestor
138340928|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
138340929|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
138340930|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138340931|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340932|NCT04582383|Doxycycline|doxycycline|mesh-list
138340933|NCT04582383|Spironolactone|spironolactone|mesh-list
138340934|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138340935|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340936|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
138340937|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138340938|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138340939|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138340940|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
138340941|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340942|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340943|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138340944|NCT04582383|Diuretics|diuretics|mesh-ancestor
138340945|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
138340946|NCT04573920|Atrasentan|atrasentan|mesh-list
138340947|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340948|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138340949|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138340950|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340951|NCT04546672|Neostigmine|neostigmine|mesh-list
138340952|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138340953|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340954|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340955|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
138340956|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340957|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340958|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138340959|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
138340960|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340961|NCT04738292|Fulvestrant|fulvestrant|mesh-list
138340962|NCT04738292|Onapristone|onapristone|mesh-list
138370003|NCT01402843|Valsartan|valsartan|mesh-list
138340964|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340965|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138340966|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138340967|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
138340968|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340969|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340970|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138340971|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
138340972|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138340973|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
138340974|NCT04537923|Tirzepatide|tirzepatide|mesh-list
138340975|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138340976|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340977|NCT04537923|Incretins|incretins|mesh-ancestor
138340978|NCT04537923|Hormones|hormones|mesh-ancestor
138340979|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340980|NCT04484623|Dexamethasone|dexamethasone|mesh-list
138340981|NCT04484623|Bortezomib|bortezomib|mesh-list
138340982|NCT04484623|Pomalidomide|pomalidomide|mesh-list
138340983|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138340984|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
138340986|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340988|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138340989|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
138340990|NCT04484623|Hormones|hormones|mesh-ancestor
138340991|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340992|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138340993|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138340994|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
138340995|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138340996|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138340997|NCT04484623|Growth Substances|growth substances|mesh-ancestor
138340998|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
138340999|NCT04437485|Norepinephrine|norepinephrine|mesh-list
138341001|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
138341002|NCT04437485|Serotonin|serotonin|mesh-list
138341003|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138341004|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138341005|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341006|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138341007|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138341008|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341009|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341010|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
138341011|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341012|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341013|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138341014|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341015|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341016|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138341017|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138341018|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341021|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341022|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138341023|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138341024|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
138341025|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
138341026|NCT04428333|Fluorouracil|fluorouracil|mesh-list
138341027|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341028|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341029|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341030|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341031|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
138341032|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341033|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341034|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
138341035|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341036|NCT04338399|Paclitaxel|paclitaxel|mesh-list
138341037|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341038|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341039|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341040|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341041|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341042|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341043|NCT04306510|Antibodies|antibodies|mesh-list
138341044|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
138341045|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138341046|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
138341047|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341048|NCT04232306|Bupivacaine|bupivacaine|mesh-list
138341049|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341050|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
138341051|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341052|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341053|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
138341054|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341055|NCT04082442|Evolocumab|evolocumab|mesh-list
138341056|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138341057|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138341058|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138341059|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
138341060|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341061|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138341062|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
138341063|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341064|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138341066|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138341067|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138341068|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
138341069|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341070|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138341071|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341072|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341073|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341075|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
138341076|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341079|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341080|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341082|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
138341083|NCT03967288|Procaine|procaine|mesh-list
138341084|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341085|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
138341086|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341087|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341088|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
138341089|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341090|NCT03924856|Gemcitabine|gemcitabine|mesh-list
138341091|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
138341092|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341093|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341095|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341096|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341097|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341098|NCT03884101|Paclitaxel|paclitaxel|mesh-list
138341099|NCT03884101|Carboplatin|carboplatin|mesh-list
138341100|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
138341101|NCT03884101|Lenvatinib|lenvatinib|mesh-list
138341102|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341103|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341104|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341105|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341106|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341107|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341108|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341109|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341110|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138341111|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341112|NCT03834766|Amphetamine|amphetamine|mesh-list
138341113|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138341114|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341115|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
138341116|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
138341117|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341118|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
138341119|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341120|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341121|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341122|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138341123|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138370045|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341127|NCT03761056|Fludarabine|fludarabine|mesh-list
138341128|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138341129|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341130|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
138341131|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341132|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341133|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341134|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
138341135|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341136|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341137|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341138|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341139|NCT03747120|Paclitaxel|paclitaxel|mesh-list
138341140|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
138341141|NCT03747120|Trastuzumab|trastuzumab|mesh-list
138341142|NCT03747120|Pertuzumab|pertuzumab|mesh-list
138341143|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341144|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341145|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341146|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341147|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341148|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341149|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341150|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341151|NCT03586089|Diazepam|diazepam|mesh-list
138341152|NCT03586089|Phenobarbital|phenobarbital|mesh-list
138341153|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
138341154|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138341155|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341156|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341157|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138341158|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138341159|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341160|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341161|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
138341162|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
138341163|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138341164|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138341165|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138341166|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138341167|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
138341168|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
138341169|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341170|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138341172|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138341173|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138341174|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138341175|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341178|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
138341179|NCT03546686|Pembrolizumab|pembrolizumab|mesh-list
138341180|NCT03546686|Nivolumab|nivolumab|mesh-list
138341181|NCT03546686|Ipilimumab|ipilimumab|mesh-list
138341182|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341183|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341184|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341185|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341186|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138341187|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138341188|NCT03508921|Trimethoprim|trimethoprim|mesh-list
138341189|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
138341190|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138341191|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138341192|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341193|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
138341194|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138341195|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341196|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341197|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138341198|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341199|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341200|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
138341201|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341202|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138341203|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
138341204|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138341205|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138341206|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138341207|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341208|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138341209|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138341210|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341211|NCT03401047|Estradiol|estradiol|mesh-list
138341212|NCT03401047|Estrogens|estrogens|mesh-ancestor
138341213|NCT03401047|Hormones|hormones|mesh-ancestor
138341214|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341215|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341216|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
138341217|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
138341218|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341219|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
138341220|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341221|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341222|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341223|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
138341224|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341225|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341226|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341227|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341228|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341229|NCT03315026|Siltuximab|siltuximab|mesh-list
138341230|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341231|NCT03307616|Nivolumab|nivolumab|mesh-list
138341232|NCT03307616|Ipilimumab|ipilimumab|mesh-list
138341233|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341234|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341235|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341236|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341237|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138341238|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138341239|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341240|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
138341241|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138341242|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138341243|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341244|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138341245|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138341246|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341247|NCT03200236|Nicotine|nicotine|mesh-list
138341248|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138341249|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
138341250|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341251|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341252|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138341253|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138341254|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138341255|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341256|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341257|NCT03125642|Cytarabine|cytarabine|mesh-list
138341258|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
138341259|NCT03125642|Melphalan|melphalan|mesh-list
138341260|NCT03125642|Carmustine|carmustine|mesh-list
138341261|NCT03125642|Etoposide|etoposide|mesh-list
138341262|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341263|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
138341264|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341265|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341266|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341267|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
138341268|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341269|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341270|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341271|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341272|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138341273|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138341274|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341275|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341276|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
138341277|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
138341278|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341279|NCT03105843|Mannitol|mannitol|mesh-list
138341280|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
138341281|NCT03105843|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138341282|NCT03105843|Diuretics|diuretics|mesh-ancestor
138341283|NCT03105843|Natriuretic Agents|natriuretic agents|mesh-ancestor
138341284|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341286|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
138341287|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341288|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138341289|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138370103|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370104|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
138370105|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341290|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341293|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
138341294|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341295|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341296|NCT03068910|Spironolactone|spironolactone|mesh-list
138341297|NCT03068910|Progesterone|progesterone|mesh-list
138341298|NCT03068910|Progestins|progestins|mesh-ancestor
138341299|NCT03068910|Hormones|hormones|mesh-ancestor
138341300|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341301|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341302|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138341303|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138341304|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138341305|NCT03068910|Diuretics|diuretics|mesh-ancestor
138341306|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
138341307|NCT02925195|Vitamin D|vitamin d|mesh-list
138341308|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
138341309|NCT02925195|Vitamins|vitamins|mesh-ancestor
138341310|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
138341311|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341312|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138341313|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138341314|NCT02793375|Montelukast|montelukast|mesh-list
138341315|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138341316|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341317|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138341319|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341320|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341321|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138341322|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138341323|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341324|NCT02616185|Tremelimumab|tremelimumab|mesh-list
138341325|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341326|NCT02520362|Denosumab|denosumab|mesh-list
138341327|NCT02520362|Diphosphonates|diphosphonates|mesh-list
138341328|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138341329|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341330|NCT02486718|Gemcitabine|gemcitabine|mesh-list
138341331|NCT02486718|Docetaxel|docetaxel|mesh-list
138341332|NCT02486718|Pemetrexed|pemetrexed|mesh-list
138341333|NCT02486718|Atezolizumab|atezolizumab|mesh-list
138341334|NCT02486718|Vinorelbine|vinorelbine|mesh-list
138341335|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341336|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341337|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
138341338|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341339|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341340|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341341|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341342|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341343|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138341344|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138341345|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341346|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341347|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341348|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
138341349|NCT02346747|Immunologic Factors|immunologic factors|mesh-ancestor
138341350|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341351|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138341352|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138341353|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341354|NCT02267252|Antibodies|antibodies|mesh-list
138341355|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
138341356|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341357|NCT02266329|Prazosin|prazosin|mesh-list
138341358|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138341359|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138341360|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138341361|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138341362|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341363|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341364|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341365|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341366|NCT01961219|Anesthetics|anesthetics|mesh-list
138341367|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341368|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341369|NCT01873131|Timolol|timolol|mesh-list
138341370|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341371|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138341372|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138341373|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341374|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341375|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341376|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138341377|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138341379|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341380|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341381|NCT01508949|Incretins|incretins|mesh-ancestor
138341382|NCT01508949|Hormones|hormones|mesh-ancestor
138341383|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341384|NCT01507285|Liraglutide|liraglutide|mesh-list
138341385|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341386|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341387|NCT01507285|Incretins|incretins|mesh-ancestor
138341388|NCT01507285|Hormones|hormones|mesh-ancestor
138341389|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341390|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
138341391|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
138341392|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138341393|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341394|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341395|NCT01428089|Progesterone|progesterone|mesh-list
138341396|NCT01428089|Progestins|progestins|mesh-ancestor
138341397|NCT01428089|Hormones|hormones|mesh-ancestor
138341398|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370127|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
138341399|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341400|NCT01425541|Progesterone|progesterone|mesh-list
138341401|NCT01425541|Estradiol|estradiol|mesh-list
138341402|NCT01425541|Estrogens|estrogens|mesh-list
138341403|NCT01425541|Progestins|progestins|mesh-ancestor
138341404|NCT01425541|Hormones|hormones|mesh-ancestor
138341405|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341406|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341407|NCT00930228|Flutamide|flutamide|mesh-list
138341408|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
138341409|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
138341410|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341411|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341412|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138341413|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341415|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341416|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341417|NCT00745433|Metformin|metformin|mesh-list
138341418|NCT00745433|Repaglinide|repaglinide|mesh-list
138341419|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341420|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341421|NCT00712478|Insulin|insulin|mesh-list
138341422|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341423|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341424|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
138341425|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341426|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341427|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
138341428|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341429|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341430|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
138341431|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341432|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341433|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
138341436|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
138341438|NCT00653068|Cisplatin|cisplatin|mesh-list
138341439|NCT00653068|Carboplatin|carboplatin|mesh-list
138341440|NCT00653068|Methotrexate|methotrexate|mesh-list
138341441|NCT00653068|Etoposide|etoposide|mesh-list
138341442|NCT00653068|Vincristine|vincristine|mesh-list
138341443|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
138341444|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
138341445|NCT00653068|Lenograstim|lenograstim|mesh-list
138367786|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367787|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
138367788|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
138367789|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367790|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367791|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
138341446|NCT00653068|Calcium|calcium|mesh-list
138341447|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
138341448|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341450|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341451|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341452|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341453|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
138341454|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341455|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341456|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341457|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138341458|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138341460|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
138341461|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138341462|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341464|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
138341465|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341466|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138341467|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138341468|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341469|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138341470|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138341471|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138341472|NCT00653068|Antidotes|antidotes|mesh-ancestor
138341473|NCT00653068|Protective Agents|protective agents|mesh-ancestor
138341474|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
138341476|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
138341477|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341478|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341479|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341480|NCT00653068|Hematinics|hematinics|mesh-ancestor
138341481|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
138341482|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
138341483|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341484|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341485|NCT00504673|Insulin|insulin|mesh-list
138341486|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138341487|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
138341488|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
138341489|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
138341490|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
138341491|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
138341492|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341493|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341494|NCT00476437|Insulin|insulin|mesh-list
138341495|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138341496|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
138341497|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
138341498|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341499|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341500|NCT00414648|Sirolimus|sirolimus|mesh-list
138341501|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138341502|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341503|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138341504|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341505|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
138341506|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341507|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
138341508|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341509|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138341510|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341511|NCT00313742|Insulin|insulin|mesh-list
138341512|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138341513|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
138341514|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
138341515|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
138370158|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341516|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
138341517|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
138341519|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341520|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
138341522|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341523|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341524|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
138341525|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
138341526|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341527|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341528|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
138341529|NCT00077285|Ifosfamide|ifosfamide|mesh-list
138341530|NCT00077285|Carboplatin|carboplatin|mesh-list
138341531|NCT00077285|Doxorubicin|doxorubicin|mesh-list
138341532|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138341533|NCT00077285|Irinotecan|irinotecan|mesh-list
138341534|NCT00077285|Etoposide|etoposide|mesh-list
138341535|NCT00077285|Vincristine|vincristine|mesh-list
138341536|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
138341537|NCT00077285|Razoxane|razoxane|mesh-list
138341538|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341539|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
138341540|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341541|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341542|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341544|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341545|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341546|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341547|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138341548|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138341549|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138341550|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341551|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138341552|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138341553|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341554|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138341555|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138341556|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138341557|NCT00077285|Protective Agents|protective agents|mesh-ancestor
138341558|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
138341559|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138341560|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
138341561|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341562|NCT01537926|Expectorants|expectorants|mesh-ancestor
138341563|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341564|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138341566|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341567|NCT01537926|Protective Agents|protective agents|mesh-ancestor
138341568|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341569|NCT01537926|Antidotes|antidotes|mesh-ancestor
138341570|NCT01538862|Lenograstim|lenograstim|mesh-list
138341571|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138341572|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
138341573|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341574|NCT01541358|Listerine|listerine|mesh-list
138341575|NCT01541358|Fluorides|fluorides|mesh-list
138341576|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
138341577|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
138341578|NCT01541358|Protective Agents|protective agents|mesh-ancestor
138341579|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341580|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138341582|NCT01542372|Prazosin|prazosin|mesh-list
138341583|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370172|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
138341584|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138341585|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138341586|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138341587|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341588|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341589|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341590|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341592|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341593|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
138341594|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341595|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341596|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341597|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
138341598|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
138341599|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341600|NCT01543074|Protective Agents|protective agents|mesh-ancestor
138341601|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341602|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138341603|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341604|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341605|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341606|NCT01545336|Anastrozole|anastrozole|mesh-list
138341607|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138341608|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341609|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138341610|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138341611|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341612|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341613|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138341614|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
138341615|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341616|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341617|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
138341618|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138341619|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
138341620|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341621|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341622|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
138341623|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138341624|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
138341628|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341629|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138341630|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138341631|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138341632|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341633|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341634|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341636|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138341637|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138341638|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341639|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138341640|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341641|NCT01556724|Ropivacaine|ropivacaine|mesh-list
138341642|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341643|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
138341644|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341645|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341646|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
138341647|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341649|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138341650|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
138341651|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138341652|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341653|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341654|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138341655|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138341656|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341657|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341658|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138341659|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138341660|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138341661|NCT01559064|Lidocaine|lidocaine|mesh-list
138341662|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
138341663|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341664|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
138341665|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341666|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341667|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
138341668|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341669|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138341670|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138341671|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138341672|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341673|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341674|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138341675|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
138341676|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
138341677|NCT01559064|Protective Agents|protective agents|mesh-ancestor
138341678|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138341679|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
138341680|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138341682|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341683|NCT01560624|Treprostinil|treprostinil|mesh-list
138341684|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138341686|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138341687|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138341688|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341689|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341690|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
138341691|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341692|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138341693|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138341694|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138341695|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341696|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341698|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341699|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341700|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138341701|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138341703|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341704|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
138341706|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138341707|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341708|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341709|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341710|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138341711|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138341712|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138341713|NCT01565616|Fludarabine|fludarabine|mesh-list
138341714|NCT01565616|Busulfan|busulfan|mesh-list
138341715|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
138341716|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138341717|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341718|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341719|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138341720|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
138341721|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341722|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
138341723|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138341724|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138341725|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138341726|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138341727|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138341728|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341729|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341730|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341731|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138341732|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138341733|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138341734|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341735|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341736|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341737|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138341739|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
138341740|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138341741|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138341742|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
138341743|NCT01569126|Fluoxetine|fluoxetine|mesh-list
138341744|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138341745|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138341746|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341747|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341749|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
138341750|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341751|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138341752|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
138341753|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341754|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138341755|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341756|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341757|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138341758|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138341759|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341761|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
138341762|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138341763|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341764|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341765|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138341766|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138341767|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341768|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
138341769|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
138341770|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341771|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341772|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138341773|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138341775|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341776|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
138341777|NCT01580592|Omalizumab|omalizumab|mesh-list
138341778|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138341779|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138341780|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138341781|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341782|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
138341783|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341784|NCT01588158|Acetaminophen|acetaminophen|mesh-list
138341785|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138341786|NCT01588158|Hydrocodone|hydrocodone|mesh-list
138341787|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138341788|NCT01588158|Analgesics|analgesics|mesh-ancestor
138341789|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
138341790|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341797|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341798|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138341799|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138341800|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341801|NCT01588470|Pioglitazone|pioglitazone|mesh-list
138341802|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341803|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341804|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
138341805|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138341806|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138341808|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341809|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341810|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
138341811|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341812|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341813|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138341814|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341815|NCT05565924|Biguanides|biguanides|mesh-list
138341816|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341817|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341818|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138341819|NCT05564832|Pilocarpine|pilocarpine|mesh-list
138341820|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138341821|NCT05564832|Miotics|miotics|mesh-ancestor
138341823|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341824|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341825|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138341826|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138341827|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
138341828|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341829|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341830|NCT05564442|Benzocaine|benzocaine|mesh-list
138341831|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341832|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
138341833|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341834|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341835|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
138341837|NCT05493540|Ibuprofen|ibuprofen|mesh-list
138341838|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138341839|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138341840|NCT05493540|Analgesics|analgesics|mesh-ancestor
138341841|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
138341842|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341843|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341844|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138341845|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138341847|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341848|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341849|NCT05672472|Sivelestat|sivelestat|mesh-list
138341850|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138341851|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
138341852|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341853|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341854|NCT05672394|Lidocaine|lidocaine|mesh-list
138341855|NCT05672394|Epinephrine|epinephrine|mesh-list
138341856|NCT05672394|Bupivacaine|bupivacaine|mesh-list
138341857|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
138341858|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
138341859|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341860|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341861|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
138341862|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341863|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138341864|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138341865|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138341866|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341867|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341868|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138341869|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138341870|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341871|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341872|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138341873|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138341874|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
138341875|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138341876|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
138341877|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
138341878|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
138341879|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138341881|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138341882|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138341883|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341884|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341885|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138341909|NCT03729258|Amantadine|amantadine|mesh-list
138341910|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138341911|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138341912|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
138341913|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341914|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
138341916|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341917|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341918|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138341919|NCT03729258|Analgesics|analgesics|mesh-ancestor
138341920|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
138341921|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341922|NCT03355170|Domperidone|domperidone|mesh-list
138341923|NCT03355170|Lansoprazole|lansoprazole|mesh-list
138341924|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
138341925|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138341926|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138341927|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138341928|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341929|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341930|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
138341931|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
138341932|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341933|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341934|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138341935|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
138341936|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341937|NCT02538666|Nivolumab|nivolumab|mesh-list
138341938|NCT02538666|Ipilimumab|ipilimumab|mesh-list
138341939|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341940|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341941|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341942|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341943|NCT02407236|Ustekinumab|ustekinumab|mesh-list
138341944|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138341945|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
138341946|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138341947|NCT05120076|Dexamethasone|dexamethasone|mesh-list
138341948|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
138341949|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138341950|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
138341951|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
138341952|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341953|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341954|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138341955|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
138341956|NCT05120076|Hormones|hormones|mesh-ancestor
138341957|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341958|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138341959|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341961|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138341962|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341963|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138341964|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341965|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
138341966|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
138341967|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138341968|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341969|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341970|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138341971|NCT04508166|Analgesics|analgesics|mesh-ancestor
138341972|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
138341973|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370299|NCT01404364|Hormones|hormones|mesh-ancestor
138370303|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
138341974|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138341975|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138341976|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138341977|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
138341978|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138341979|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341980|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138341981|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138341982|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
138341983|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
138341984|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
138341985|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138341986|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341987|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138341988|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138341989|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341990|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341991|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138341992|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138341993|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138341994|NCT04175964|Metformin|metformin|mesh-list
138341995|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138341996|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341997|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
138341998|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
138341999|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
138342000|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342001|NCT03624270|Protective Agents|protective agents|mesh-ancestor
138342002|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342003|NCT03624270|Vitamins|vitamins|mesh-ancestor
138342004|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
138342005|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342006|NCT03455088|Fluoxetine|fluoxetine|mesh-list
138342007|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138342008|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138342009|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342010|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342011|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342013|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342014|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138342016|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342017|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138342018|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138342019|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342020|NCT01600170|Atorvastatin|atorvastatin|mesh-list
138342021|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138342022|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138342023|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
138342024|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342025|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138342026|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138342027|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342028|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
138342029|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188498|NCT00990769|Anesthetics|anesthetics|mesh-list
138188499|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188500|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188501|NCT00991081|Bupropion|bupropion|mesh-list
138188502|NCT00991081|Nicotine|nicotine|mesh-list
138188503|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138188504|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
138188505|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188506|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188507|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138188508|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138188509|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188510|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188511|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188512|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138188513|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
138188515|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138188516|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188517|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188519|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138188520|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138188521|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188522|NCT03168022|Amitriptyline|amitriptyline|mesh-list
138188523|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
138188524|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138188525|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
138188526|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188527|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138188528|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188529|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138188530|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188531|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138188532|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188533|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138188535|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
138188536|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138188537|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188538|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188539|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188540|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188541|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188542|NCT03102190|Verapamil|verapamil|mesh-list
138188543|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138188544|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138188545|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188546|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188547|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138188548|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188549|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188550|NCT03254667|Brodalumab|brodalumab|mesh-list
138188551|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138188552|NCT03102736|Nitroprusside|nitroprusside|mesh-list
138188553|NCT03102736|Ketamine|ketamine|mesh-list
138188554|NCT03102736|Analgesics|analgesics|mesh-ancestor
138188555|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
138188557|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188558|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138188559|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138188561|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
138188562|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188563|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138188564|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138188565|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188566|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188567|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188568|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188569|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138188571|NCT03743103|Esmolol|esmolol|mesh-list
138188575|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188576|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138188577|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138188578|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138188579|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188580|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188581|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188582|NCT04049266|Aflibercept|aflibercept|mesh-list
138188583|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138188584|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138188585|NCT04049266|Growth Substances|growth substances|mesh-ancestor
138188586|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188587|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
138188588|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188589|NCT00362505|Clevudine|clevudine|mesh-list
138188590|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
138188591|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188592|NCT00993187|Metformin|metformin|mesh-list
138188593|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138188594|NCT00993187|Glimepiride|glimepiride|mesh-list
138188595|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188596|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188597|NCT00993187|Incretins|incretins|mesh-ancestor
138188598|NCT00993187|Hormones|hormones|mesh-ancestor
138188599|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188600|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138188601|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
138188602|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188603|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188604|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138188605|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138188607|NCT03173170|Itraconazole|itraconazole|mesh-list
138188608|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
138188609|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188610|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138188611|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138188612|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188613|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188614|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138188615|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
138188616|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188618|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138188620|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138188621|NCT03106870|Metformin|metformin|mesh-list
138188622|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
138188623|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188624|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188625|NCT00375310|Gemcitabine|gemcitabine|mesh-list
138188626|NCT00375310|Sorafenib|sorafenib|mesh-list
138188627|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138188628|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
138188629|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188630|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188631|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138188632|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188633|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138188634|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138188635|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
138188636|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188637|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138188638|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138188639|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
138188640|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
138188641|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188642|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188644|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188645|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138188646|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188647|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188649|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138188650|NCT00362583|Narcotics|narcotics|mesh-ancestor
138188651|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188652|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188653|NCT00362583|Analgesics|analgesics|mesh-ancestor
138188654|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
138188655|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188656|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138188657|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138188658|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
138188659|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
138188661|NCT00657241|Carvedilol|carvedilol|mesh-list
138188662|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188663|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138188664|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138188665|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188666|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138188667|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138188668|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188669|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188670|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188671|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
138188672|NCT00657241|Protective Agents|protective agents|mesh-ancestor
138188673|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138188674|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188675|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138188677|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138188678|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138188680|NCT04342065|Pregabalin|pregabalin|mesh-list
138188681|NCT04342065|Analgesics|analgesics|mesh-ancestor
138188682|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
138188683|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188684|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188685|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
138188686|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138188687|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188688|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188689|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138188690|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138188691|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138188692|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188693|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188694|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138188695|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138188696|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188697|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188698|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138188699|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138188700|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188701|NCT03179410|Avelumab|avelumab|mesh-list
138188702|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188703|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188704|NCT00478465|Valganciclovir|valganciclovir|mesh-list
138188705|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
138188706|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188707|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
138188708|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138188709|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
138188710|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188711|NCT00421785|Expectorants|expectorants|mesh-ancestor
138188712|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188713|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138188714|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
138188715|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188716|NCT00421785|Protective Agents|protective agents|mesh-ancestor
138188717|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188718|NCT00421785|Antidotes|antidotes|mesh-ancestor
138188719|NCT00421863|Amlodipine|amlodipine|mesh-list
138188720|NCT00421863|Telmisartan|telmisartan|mesh-list
138188721|NCT00421863|Clonidine|clonidine|mesh-list
138188722|NCT00421863|Ramipril|ramipril|mesh-list
138188723|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188724|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138188725|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188726|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188727|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138188728|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188729|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188730|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138188731|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138188733|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
138188734|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188735|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
138188736|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
138188737|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138370403|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138188738|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138188739|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138188740|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188741|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188742|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138188743|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
138188744|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188745|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138188746|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138188747|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188748|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188749|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188750|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188751|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188752|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188754|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188755|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188756|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138188757|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138188758|NCT05363722|Growth Substances|growth substances|mesh-ancestor
138188759|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188760|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
138188761|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138370429|NCT01404767|Metoprolol|metoprolol|mesh-list
138188762|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188763|NCT03127137|Triamcinolone|triamcinolone|mesh-list
138188764|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138188765|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138188767|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138188768|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
138188769|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
138188770|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188771|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188772|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
138188774|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138188775|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138188776|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138188777|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188778|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188779|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188781|NCT03127137|Hormones|hormones|mesh-ancestor
138188782|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188783|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138188784|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
138188785|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188786|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
138188787|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138188788|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138188789|NCT03122847|Prednisolone|prednisolone|mesh-list
138188790|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
138188791|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138188792|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
138188793|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188794|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
138188795|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
138188796|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188797|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188798|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188799|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
138188801|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188802|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138188803|NCT03122847|Protective Agents|protective agents|mesh-ancestor
138188804|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188805|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188806|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
138188807|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
138188808|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138188809|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138188810|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188811|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188812|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188813|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188814|NCT03525028|Metformin|metformin|mesh-list
138188815|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188816|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188817|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138188818|NCT00754312|Entinostat|entinostat|mesh-list
138188819|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188820|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138188821|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188822|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188823|NCT03623373|Cytarabine|cytarabine|mesh-list
138188824|NCT03623373|Rituximab|rituximab|mesh-list
138188825|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138188826|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
138188827|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188828|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188829|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
138188830|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188831|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188832|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138188834|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188835|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
138188836|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188837|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138188838|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138188839|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
138188841|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
138188842|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188844|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138188845|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138188846|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138188847|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188848|NCT03410446|Ketamine|ketamine|mesh-list
138188849|NCT03410446|Analgesics|analgesics|mesh-ancestor
138188850|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
138188851|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188852|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188853|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138188854|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138188855|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
138188856|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
138188857|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188858|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138188859|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138188860|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188861|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188862|NCT00375388|Metformin|metformin|mesh-list
138188863|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188864|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188866|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138188867|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138188868|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
138188869|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188870|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188871|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188872|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138188873|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138188874|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138188875|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188876|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138188877|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188878|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188879|NCT03001726|Docetaxel|docetaxel|mesh-list
138188880|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
138188881|NCT03001726|Tegafur|tegafur|mesh-list
138188882|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188883|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188884|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188885|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188886|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188887|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138188888|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
138188890|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
138188891|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
138188892|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188893|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188894|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
138188895|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188896|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
138188897|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138188898|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188899|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138188900|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
138188901|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138188902|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188903|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188904|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188905|NCT04353193|Octreotide|octreotide|mesh-list
138188906|NCT04353193|Terlipressin|terlipressin|mesh-list
138188907|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188908|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188909|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188910|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188911|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138188912|NCT01023841|Bimatoprost|bimatoprost|mesh-list
138188913|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138188914|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138188915|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188916|NCT00635648|Caspofungin|caspofungin|mesh-list
138188917|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
138188918|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188919|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188920|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188921|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
138188922|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138188924|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
138188925|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
138188926|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138188927|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188928|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188929|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188930|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188931|NCT05240456|Urological Agents|urological agents|mesh-ancestor
138188932|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138188933|NCT03574779|Paclitaxel|paclitaxel|mesh-list
138188934|NCT03574779|Bevacizumab|bevacizumab|mesh-list
138188935|NCT03574779|Carboplatin|carboplatin|mesh-list
138188936|NCT03574779|Niraparib|niraparib|mesh-list
138188937|NCT03574779|Dostarlimab|dostarlimab|mesh-list
138188938|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188939|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188940|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188941|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188942|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188943|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370565|NCT01405235|Paclitaxel|paclitaxel|mesh-list
138188946|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138188948|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188949|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
138188950|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138188951|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188953|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138188954|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188955|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188956|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188957|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188958|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188959|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188960|NCT00995761|Cisplatin|cisplatin|mesh-list
138188961|NCT00995761|Docetaxel|docetaxel|mesh-list
138188962|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188963|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188964|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188965|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188966|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188967|NCT00362271|Aripiprazole|aripiprazole|mesh-list
138188968|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138188970|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188971|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138188972|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138188973|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188974|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188975|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
138188976|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
138188977|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188978|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188979|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138188980|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138188981|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
138188982|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138188983|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138188984|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138188985|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138188986|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138188987|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188988|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188989|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138188990|NCT00635102|Cycloserine|cycloserine|mesh-list
138188991|NCT00635102|Glycine|glycine|mesh-list
138188992|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138188993|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370581|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188999|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
138189000|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189001|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189002|NCT03041883|Riboflavin|riboflavin|mesh-list
138189003|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
138189005|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
138189006|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189007|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138189008|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
138189009|NCT03034005|Budesonide|budesonide|mesh-list
138189010|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189011|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138189012|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
138189013|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189014|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189015|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138189016|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189017|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
138189019|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189020|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138189021|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138189022|NCT00635024|Melphalan|melphalan|mesh-list
138189023|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138189024|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138189025|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
138189026|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189027|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189028|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138189029|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189030|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
138189031|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189032|NCT03182920|Lasmiditan|lasmiditan|mesh-list
138189033|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138189034|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
138189035|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189036|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189037|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189038|NCT03485547|Venetoclax|venetoclax|mesh-list
138189039|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189040|NCT03187678|Selexipag|selexipag|mesh-list
138189041|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138189042|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138189043|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
138189044|NCT03192826|Dipivefrin|dipivefrin|mesh-list
138189045|NCT03192826|Brinzolamide|brinzolamide|mesh-list
138370602|NCT01405430|Bevacizumab|bevacizumab|mesh-list
138189048|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138189049|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138189051|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189052|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189053|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189054|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138189055|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138189056|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138189057|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189058|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
138189060|NCT03287674|Fludarabine|fludarabine|mesh-list
138189061|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
138189062|NCT03287674|Ipilimumab|ipilimumab|mesh-list
138189063|NCT03287674|Interleukin-2|interleukin-2|mesh-list
138189064|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189065|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
138189066|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189067|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189068|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138189069|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
138189070|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189071|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189072|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138189073|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138189074|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138189075|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138189076|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
138189077|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189078|NCT03287674|Analgesics|analgesics|mesh-ancestor
138189079|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
138189080|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189081|NCT00634244|Cytarabine|cytarabine|mesh-list
138189082|NCT00634244|Sirolimus|sirolimus|mesh-list
138189083|NCT00634244|Carboplatin|carboplatin|mesh-list
138189084|NCT00634244|Etoposide|etoposide|mesh-list
138189085|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
138189086|NCT00634244|Topotecan|topotecan|mesh-list
138189087|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
138189088|NCT00634244|Alvocidib|alvocidib|mesh-list
138189089|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189090|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138189092|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138189093|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189094|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189095|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138189096|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
138189097|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
138189098|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189099|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189100|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
138189101|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189102|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189103|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138189104|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
138189105|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189106|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138189107|NCT00634244|Analgesics|analgesics|mesh-ancestor
138189108|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
138189109|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189110|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189111|NCT00634244|Growth Substances|growth substances|mesh-ancestor
138189113|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
138189114|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189115|NCT03289858|Bupivacaine|bupivacaine|mesh-list
138189116|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189117|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
138189118|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189120|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
138189121|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189122|NCT03418714|Salvinorin A|salvinorin a|mesh-list
138189123|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
138189124|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189125|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189126|NCT03421210|Nicotine|nicotine|mesh-list
138189127|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138189128|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
138189129|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189130|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189131|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138189132|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138189133|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
138189134|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189135|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189137|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189138|NCT00996931|Lenalidomide|lenalidomide|mesh-list
138189139|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
138189140|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189141|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189142|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138189143|NCT00996931|Growth Substances|growth substances|mesh-ancestor
138189144|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189145|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189146|NCT00634088|Capecitabine|capecitabine|mesh-list
138189147|NCT00634088|Lapatinib|lapatinib|mesh-list
138189148|NCT00634088|Epothilones|epothilones|mesh-list
138189149|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138189150|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
138189151|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189152|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189153|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189154|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189155|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138189156|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138189157|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138189158|NCT03428230|Acetaminophen|acetaminophen|mesh-list
138189159|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
138189160|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138189161|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189162|NCT03428230|Analgesics|analgesics|mesh-ancestor
138189163|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
138189164|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189165|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189167|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189169|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189170|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
138189171|NCT03296800|Rifampin|rifampin|mesh-list
138189172|NCT03296800|Probenecid|probenecid|mesh-list
138189173|NCT03296800|Verapamil|verapamil|mesh-list
138189174|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138370621|NCT01405573|Sorafenib|sorafenib|mesh-list
138189177|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189178|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
138189179|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138189180|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189181|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189182|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138189183|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138189184|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138189185|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138189186|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138189187|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138189188|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138189189|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138189190|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189191|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138189192|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189194|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
138189195|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
138189196|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189197|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138189198|NCT00634010|Morphine|morphine|mesh-list
138189199|NCT00634010|Methadone|methadone|mesh-list
138189200|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189202|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189203|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189204|NCT00634010|Analgesics|analgesics|mesh-ancestor
138189205|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
138189206|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189207|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
138189208|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189209|NCT00633932|Esomeprazole|esomeprazole|mesh-list
138189210|NCT00633932|Omeprazole|omeprazole|mesh-list
138189211|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138189212|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189213|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138189214|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189215|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189216|NCT01028677|Oxytocin|oxytocin|mesh-list
138189217|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
138189218|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138189219|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189220|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
138189221|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189222|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
138189224|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
138189225|NCT01000285|Doxorubicin|doxorubicin|mesh-list
138189226|NCT01000285|Etoposide|etoposide|mesh-list
138189227|NCT01000285|Vincristine|vincristine|mesh-list
138189228|NCT01000285|Bortezomib|bortezomib|mesh-list
138189229|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189230|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
138189231|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189232|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370633|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189233|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138189235|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189236|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189237|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138189238|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138189239|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138189240|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138189241|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189242|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189243|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
138189245|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189246|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189247|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138189248|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138189249|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138189250|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138189251|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138189252|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138189253|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
138189254|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189255|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138189256|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138189258|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138189259|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138189260|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
138189261|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189262|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189263|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189265|NCT00633464|Epothilones|epothilones|mesh-list
138189266|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138189267|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189268|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
138189269|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
138189270|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
138189271|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189272|NCT03437044|Clopidogrel|clopidogrel|mesh-list
138189273|NCT03437044|Ticagrelor|ticagrelor|mesh-list
138189275|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138189276|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138189277|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138189278|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
138189279|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189280|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189281|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189282|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138189284|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189285|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189286|NCT03303196|Pancrelipase|pancrelipase|mesh-list
138189287|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189289|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138189290|NCT00633152|Cephalosporins|cephalosporins|mesh-list
138189291|NCT00633152|Aztreonam|aztreonam|mesh-list
138189292|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189293|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189294|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138189295|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189296|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189297|NCT01030783|Sorafenib|sorafenib|mesh-list
138189298|NCT01030783|Tivozanib|tivozanib|mesh-list
138189299|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189300|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189301|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189302|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189303|NCT00633074|Vaccines|vaccines|mesh-list
138189304|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
138189305|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189306|NCT03304054|Amifampridine|amifampridine|mesh-list
138189307|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138189308|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189309|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189310|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138189311|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189312|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189313|NCT01929278|Clindamycin|clindamycin|mesh-list
138189314|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
138189315|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
138189316|NCT01929278|Tretinoin|tretinoin|mesh-list
138189317|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189318|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189319|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138189320|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189321|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189322|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189323|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
138189324|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
138189326|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189327|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138189328|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189329|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189331|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189332|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138189333|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
138189334|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189336|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138189337|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138189339|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138189340|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138189341|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
138189342|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189343|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138189344|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138189345|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189346|NCT03211234|Ranibizumab|ranibizumab|mesh-list
138189347|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138189348|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189349|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138189350|NCT03211234|Growth Substances|growth substances|mesh-ancestor
138189351|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189352|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189353|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189354|NCT03105518|Acetaminophen|acetaminophen|mesh-list
138189356|NCT03105518|Oxycodone|oxycodone|mesh-list
138367800|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367801|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367802|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
138367804|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189357|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189358|NCT03105518|Narcotics|narcotics|mesh-ancestor
138189359|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189360|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189361|NCT03105518|Analgesics|analgesics|mesh-ancestor
138189362|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
138189363|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189364|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138189365|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138189366|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
138189367|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
138189368|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189369|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
138189370|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
138189371|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
138189372|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189373|NCT01929668|Protective Agents|protective agents|mesh-ancestor
138189374|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189376|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
138189377|NCT01929746|Daclizumab|daclizumab|mesh-list
138189378|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189379|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
138189380|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189381|NCT03506048|Lenvatinib|lenvatinib|mesh-list
138189382|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189383|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189384|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189385|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189386|NCT02161705|Ropivacaine|ropivacaine|mesh-list
138189387|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189388|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
138189389|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189390|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189391|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
138189392|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189393|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
138189395|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
138370687|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138189396|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189397|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189398|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138189399|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189400|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138189402|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189403|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189404|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138189405|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
138189406|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
138189407|NCT01929824|Protective Agents|protective agents|mesh-ancestor
138189408|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
138189410|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
138189411|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
138189412|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189413|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189414|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189415|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138189416|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189417|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189418|NCT01923584|Ubiquinone|ubiquinone|mesh-list
138189419|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
138189420|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189421|NCT00630344|Everolimus|everolimus|mesh-list
138189422|NCT00630344|Bicalutamide|bicalutamide|mesh-list
138189423|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138189424|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189425|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189426|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189427|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189428|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
138189429|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189430|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189431|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
138189432|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
138189433|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189434|NCT01923818|Aspirin|aspirin|mesh-list
138189435|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
138189436|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138189437|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189438|NCT01923818|Analgesics|analgesics|mesh-ancestor
138189439|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
138189440|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189441|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189442|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189443|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189444|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138189445|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138189446|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189447|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138189448|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138189449|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189451|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138189452|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
138370702|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189454|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
138189455|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
138189457|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138189458|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138189459|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138189460|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189461|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
138189462|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189464|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189465|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
138189466|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
138189467|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
138342030|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189468|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189469|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
138189471|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138189472|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
138189473|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189474|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189475|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138189476|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189477|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138189478|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138189479|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138189480|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189481|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189482|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189483|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189484|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
138189485|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138189486|NCT03316378|Ropivacaine|ropivacaine|mesh-list
138189487|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189488|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
138189489|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189490|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189491|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
138189492|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189494|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138189495|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138189496|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138189497|NCT02847559|Bevacizumab|bevacizumab|mesh-list
138189498|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138189499|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
138189500|NCT02847559|Antibodies|antibodies|mesh-list
138189501|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
138189502|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138189503|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
138189504|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189505|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189506|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138189507|NCT02847559|Growth Substances|growth substances|mesh-ancestor
138189508|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370723|NCT01406171|Isavuconazole|isavuconazole|mesh-list
138189509|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189510|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
138189512|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
138189513|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
138189514|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189515|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189516|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
138189517|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
138189519|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
138189520|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189521|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
138189522|NCT02150785|Streptokinase|streptokinase|mesh-list
138189523|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138189524|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138189525|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189526|NCT01926158|Denosumab|denosumab|mesh-list
138189527|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138189528|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189529|NCT03445390|Acetaminophen|acetaminophen|mesh-list
138189530|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189531|NCT03445390|Analgesics|analgesics|mesh-ancestor
138189532|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
138189533|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189534|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189536|NCT00981890|Sunitinib|sunitinib|mesh-list
138189537|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189538|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189539|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138189540|NCT00981890|Growth Substances|growth substances|mesh-ancestor
138189541|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189542|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189543|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189545|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189546|NCT03221764|Amiodarone|amiodarone|mesh-list
138189547|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138189548|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
138189549|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138189550|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189551|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189552|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138189553|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138189554|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138189555|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189556|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138189557|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138189558|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138189559|NCT03122444|Imipramine|imipramine|mesh-list
138189560|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138189561|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
138189562|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189563|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138189564|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138189565|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189566|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189568|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370736|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
138189569|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189571|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138189572|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189573|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189574|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138189575|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138189576|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
138189577|NCT03454048|Piperaquine|piperaquine|mesh-list
138189578|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
138189579|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138189580|NCT03454048|Atovaquone|atovaquone|mesh-list
138189581|NCT03454048|Proguanil|proguanil|mesh-list
138189582|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138189584|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138189585|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138189586|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189587|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138189588|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189589|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189590|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138189591|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
138189592|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138189593|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138189594|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
138189595|NCT01924286|Prednisone|prednisone|mesh-list
138189596|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189597|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
138189598|NCT01924286|Hormones|hormones|mesh-ancestor
138189599|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189600|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189601|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189603|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
138189604|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138189605|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
138189606|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189607|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189608|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138189609|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
138189610|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138189611|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
138189612|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189613|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189614|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138189615|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
138189617|NCT03455218|Protective Agents|protective agents|mesh-ancestor
138189618|NCT01050907|Miltefosine|miltefosine|mesh-list
138189619|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
138189620|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189621|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189622|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138189623|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138189624|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138189626|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189627|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138189628|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138189629|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189630|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189631|NCT04433845|Psilocybin|psilocybin|mesh-list
138189632|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
138189633|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189634|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189635|NCT01920386|Acetaminophen|acetaminophen|mesh-list
138189636|NCT01920386|Tramadol|tramadol|mesh-list
138189637|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189638|NCT01920386|Analgesics|analgesics|mesh-ancestor
138189639|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
138189640|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189641|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189642|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
138189643|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189644|NCT01920386|Narcotics|narcotics|mesh-ancestor
138189645|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189646|NCT03460990|Ivacaftor|ivacaftor|mesh-list
138189647|NCT03460990|VX-659|vx-659|mesh-list
138189648|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138189649|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189650|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189651|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138189652|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138189653|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189654|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
138189655|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189656|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
138189657|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138189658|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189659|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189660|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189662|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
138189663|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189664|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138189665|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138189666|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138189667|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189668|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189669|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189670|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
138189671|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138189672|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138189673|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
138189674|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189676|NCT01052701|Abacavir|abacavir|mesh-list
138189677|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
138189678|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189680|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189681|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138189682|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138189683|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189684|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138189685|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138189686|NCT01921010|Niacin|niacin|mesh-list
138189687|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
138189688|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138189689|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
138189690|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189691|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138189692|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
138189693|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
138189694|NCT01921010|Vitamins|vitamins|mesh-ancestor
138189695|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
138189696|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189697|NCT03325816|Nivolumab|nivolumab|mesh-list
138189698|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138189699|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138189700|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189701|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138189702|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189703|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138189704|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
138189705|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138189706|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138189707|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138189708|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189709|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189710|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
138189711|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189712|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189713|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138189714|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189715|NCT00986258|Tapentadol|tapentadol|mesh-list
138189716|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189717|NCT00986258|Narcotics|narcotics|mesh-ancestor
138189718|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189719|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189720|NCT00986258|Analgesics|analgesics|mesh-ancestor
138189721|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
138189722|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189723|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138189724|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138189725|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189726|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189727|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189728|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189729|NCT00986180|Oxycodone|oxycodone|mesh-list
138189730|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189731|NCT00986180|Narcotics|narcotics|mesh-ancestor
138189732|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189733|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189734|NCT00986180|Analgesics|analgesics|mesh-ancestor
138189735|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
138189736|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189737|NCT01056601|Bortezomib|bortezomib|mesh-list
138189738|NCT01056601|Panobinostat|panobinostat|mesh-list
138189739|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189740|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138189741|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189742|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189743|NCT03014947|Adalimumab|adalimumab|mesh-list
138189744|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138189745|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189746|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189747|NCT01057225|Thalidomide|thalidomide|mesh-list
138189748|NCT01057225|Dexamethasone|dexamethasone|mesh-list
138189749|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
138189750|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138189751|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
138189752|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189753|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189754|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138189755|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
138189756|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189757|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189758|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138189759|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189760|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
138189761|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
138189762|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189763|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189764|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
138189765|NCT01057225|Hormones|hormones|mesh-ancestor
138342031|NCT01605942|Dexamethasone|dexamethasone|mesh-list
138189766|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189767|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189768|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
138189769|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189770|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189771|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189772|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138189773|NCT01057225|Growth Substances|growth substances|mesh-ancestor
138189774|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
138189775|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
138189776|NCT01057381|Morphine|morphine|mesh-list
138189777|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138189778|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189779|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189780|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189781|NCT01057381|Analgesics|analgesics|mesh-ancestor
138189782|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
138189783|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189784|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138189785|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138189786|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138189787|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189788|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189789|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189790|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138189791|NCT01057381|Narcotics|narcotics|mesh-ancestor
138189792|NCT00986102|Doripenem|doripenem|mesh-list
138189793|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189794|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189795|NCT01058239|Rituximab|rituximab|mesh-list
138189796|NCT01058239|Bortezomib|bortezomib|mesh-list
138189797|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138189798|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189799|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
138189800|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189801|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189802|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
138189803|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
138189804|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189805|NCT01058941|Protective Agents|protective agents|mesh-ancestor
138189806|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189808|NCT01058941|Vitamins|vitamins|mesh-ancestor
138189809|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
138189810|NCT00985946|Panobinostat|panobinostat|mesh-list
138189811|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189812|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138189813|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189814|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189815|NCT02170519|Iloprost|iloprost|mesh-list
138189816|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138189817|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138189818|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
138189819|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138189820|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189821|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138189822|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
138189823|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189824|NCT01924910|Vitamin D|vitamin d|mesh-list
138189825|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
138189826|NCT01924910|Vitamins|vitamins|mesh-ancestor
138189827|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
138189828|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189829|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138189830|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138189831|NCT04395638|Vitamin D|vitamin d|mesh-list
138189832|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
138189833|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
138189834|NCT04395638|Vitamins|vitamins|mesh-list
138189836|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189837|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138189838|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138189839|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
138189840|NCT04347980|Dexamethasone|dexamethasone|mesh-list
138189841|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189842|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
138189843|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
138189844|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189845|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189846|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189847|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
138189848|NCT04347980|Hormones|hormones|mesh-ancestor
138189849|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189850|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189851|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189852|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
138189853|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138189854|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138189855|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189856|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189857|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189858|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138189859|NCT01925300|Bisoprolol|bisoprolol|mesh-list
138189860|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138189861|NCT01925300|Calcium|calcium|mesh-list
138189862|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138189863|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189864|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138189865|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138189866|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
138189867|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189869|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138189870|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189871|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138189872|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
138189873|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
138189874|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189875|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138189876|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138189877|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138189878|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
138189879|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189880|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138189881|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138189882|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138189883|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
138189884|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189886|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138189887|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189889|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138189891|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138189892|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189893|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189894|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138189895|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138189896|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
138189897|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138189898|NCT01925456|Fesoterodine|fesoterodine|mesh-list
138189899|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138189900|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138189901|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
138189902|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189903|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189904|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189905|NCT01925456|Urological Agents|urological agents|mesh-ancestor
138189906|NCT02226159|Dexamethasone|dexamethasone|mesh-list
138189907|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
138189910|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189911|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
138189912|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
138189913|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189914|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189915|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189916|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
138189917|NCT02226159|Hormones|hormones|mesh-ancestor
138189918|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189919|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189920|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189921|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
138189922|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189923|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189924|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189925|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
138189926|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189927|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
138189928|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138189929|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138189930|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138189931|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189932|NCT03241030|Acetaminophen|acetaminophen|mesh-list
138189933|NCT03241030|Ibuprofen|ibuprofen|mesh-list
138189934|NCT03241030|Sucralfate|sucralfate|mesh-list
138189935|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138189936|NCT03241030|Analgesics|analgesics|mesh-ancestor
138189937|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
138189938|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138189939|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189940|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
138189941|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138189942|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138189944|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138189945|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189946|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189947|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138189948|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138189949|NCT03241810|Fulvestrant|fulvestrant|mesh-list
138189950|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189951|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189952|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138189953|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138189954|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138189955|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189956|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189957|NCT02129751|Bupropion|bupropion|mesh-list
138189958|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138189959|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
138189960|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138189961|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138189962|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138189963|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189964|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189965|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
138189967|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189968|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138189969|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138189970|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189971|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
138189972|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138189973|NCT03242590|Testosterone|testosterone|mesh-list
138189974|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
138189975|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
138189976|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138189977|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189978|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
138189980|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138189981|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189982|NCT03242590|Androgens|androgens|mesh-ancestor
138189983|NCT03247738|Cangrelor|cangrelor|mesh-list
138189984|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138189985|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138189986|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138189987|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138189988|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
138189989|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138189990|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189991|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189992|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
138189993|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
138189994|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189995|NCT01567605|Lidocaine|lidocaine|mesh-list
138189996|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
138189997|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
138189998|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138189999|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190000|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
138190001|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367839|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138371359|NCT01410630|Telbivudine|telbivudine|mesh-list
138190002|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138190003|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138190004|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138371502|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190005|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138190006|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190008|NCT02604537|Betamethasone|betamethasone|mesh-list
138190009|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190010|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190012|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
138190013|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190014|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190015|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190016|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190017|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138190018|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190019|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190020|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
138190021|NCT02604537|Hormones|hormones|mesh-ancestor
138190022|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371859|NCT01414868|Montelukast|montelukast|mesh-list
138190023|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138190024|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
138190025|NCT01384773|Riboflavin|riboflavin|mesh-list
138190026|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138371945|NCT01415505|Valsartan|valsartan|mesh-list
138190027|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138190028|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
138190030|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
138190032|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138190033|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
138190034|NCT01063075|Carboplatin|carboplatin|mesh-list
138190035|NCT01063075|Cetuximab|cetuximab|mesh-list
138190036|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190037|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190038|NCT01341405|Celecoxib|celecoxib|mesh-list
138190039|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190040|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190041|NCT01341405|Analgesics|analgesics|mesh-ancestor
138190042|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
138190043|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372222|NCT01417065|Sirolimus|sirolimus|mesh-list
138190044|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190045|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190046|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190047|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138190048|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138190049|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190050|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190052|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138190053|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
138190054|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138190055|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190056|NCT01921790|Dexamethasone|dexamethasone|mesh-list
138372361|NCT01417897|Insulin|insulin|mesh-list
138190057|NCT01921790|Gemcitabine|gemcitabine|mesh-list
138190058|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
138190059|NCT01921790|Bevacizumab|bevacizumab|mesh-list
138190060|NCT01921790|Pegaspargase|pegaspargase|mesh-list
138190061|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190062|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
138190063|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
138190064|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190065|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190067|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
138344291|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138190069|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190070|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190071|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190072|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138190073|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
138190074|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190075|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344292|NCT03242915|Carboplatin|carboplatin|mesh-list
138190076|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138190077|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138372791|NCT01420666|Acetaminophen|acetaminophen|mesh-list
138190078|NCT01921790|Growth Substances|growth substances|mesh-ancestor
138190079|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138190080|NCT02153541|Antipyrine|antipyrine|mesh-list
138190081|NCT02153541|Benzocaine|benzocaine|mesh-list
138190082|NCT02153541|Glycerol|glycerol|mesh-list
138190083|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138190084|NCT02153541|Protective Agents|protective agents|mesh-ancestor
138190085|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190087|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
138190088|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190089|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
138190090|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190091|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190092|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373296|NCT01423539|Rituximab|rituximab|mesh-list
138190094|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190095|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190096|NCT03487276|Vilobelimab|vilobelimab|mesh-list
138190097|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138190098|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190099|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
138190100|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190101|NCT03489850|Ibudilast|ibudilast|mesh-list
138190104|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190105|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190106|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138190107|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
138190108|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138190109|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190110|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190111|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138190112|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
138190114|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138190115|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190116|NCT03490942|Hormones|hormones|mesh-ancestor
138190117|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190118|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190119|NCT03490942|Incretins|incretins|mesh-ancestor
138190120|NCT00376870|Pioglitazone|pioglitazone|mesh-list
138190121|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138190122|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190123|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
138190124|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
138190125|NCT03256162|Midazolam|midazolam|mesh-list
138190126|NCT03256162|Ketamine|ketamine|mesh-list
138190127|NCT03256162|Analgesics|analgesics|mesh-ancestor
138190128|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
138190129|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190130|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190131|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138190132|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138190133|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
138190134|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
138190135|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190136|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138190137|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138190138|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344293|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
138190139|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190140|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138190141|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138190142|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138190143|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138190144|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138190145|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
138190146|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
138190147|NCT03493828|Bupivacaine|bupivacaine|mesh-list
138190148|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
138190149|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
138190150|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190151|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190152|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
138190153|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190155|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190156|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190157|NCT03496324|Analgesics|analgesics|mesh-ancestor
138190158|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
138190159|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190160|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344294|NCT03242915|Pemetrexed|pemetrexed|mesh-list
138190162|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190163|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138190164|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190165|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190168|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190169|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190170|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138190171|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190172|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190173|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190174|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190175|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138190176|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138190177|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
138190178|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
138190179|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190180|NCT02169895|Opicapone|opicapone|mesh-list
138190181|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
138190182|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138190183|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190184|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190185|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138190186|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138190189|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190190|NCT01072669|Ambrisentan|ambrisentan|mesh-list
138190191|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138190192|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
138190193|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
138190194|NCT03014713|Dezocine|dezocine|mesh-list
138190195|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138190196|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190197|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190198|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190199|NCT03014713|Analgesics|analgesics|mesh-ancestor
138190200|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
138190201|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190202|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138190204|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138190205|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
138190206|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190207|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190208|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138190209|NCT03014713|Narcotics|narcotics|mesh-ancestor
138190210|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190211|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190212|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190213|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138190214|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190215|NCT01074463|Pramipexole|pramipexole|mesh-list
138190216|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
138344295|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190217|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190218|NCT01074463|Protective Agents|protective agents|mesh-ancestor
138190219|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190220|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138190221|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138190222|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
138190223|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
138190224|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190225|NCT01075087|Ropivacaine|ropivacaine|mesh-list
138190226|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
138190227|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
138190237|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
138190238|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
138190239|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
138190240|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138190241|NCT03358576|Ertapenem|ertapenem|mesh-list
138190242|NCT03358576|Lactams|lactams|mesh-list
138190243|NCT03358576|Probenecid|probenecid|mesh-list
138190245|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190246|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138190247|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138190248|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138190249|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190250|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190251|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190252|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190253|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138190255|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138190257|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
138190258|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190259|NCT03822013|Miglustat|miglustat|mesh-list
138190260|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190261|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190262|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138190265|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190266|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138190267|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138190268|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190269|NCT00376324|Tigecycline|tigecycline|mesh-list
138190270|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190271|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190272|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138190273|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190274|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190276|NCT00376480|Fludarabine|fludarabine|mesh-list
138190277|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
138190278|NCT00376480|Thiotepa|thiotepa|mesh-list
138190279|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138190280|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190282|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
138190283|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190284|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190285|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
138190286|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190287|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190289|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
138190290|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190291|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190292|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
138190293|NCT00376480|Hormones|hormones|mesh-ancestor
138190294|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190295|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138190296|NCT00376480|Protective Agents|protective agents|mesh-ancestor
138190297|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138190298|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
138190299|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138190300|NCT03016039|Curcumin|curcumin|mesh-list
138190301|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190302|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190303|NCT03016039|Analgesics|analgesics|mesh-ancestor
138190304|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
138190305|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190306|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190307|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190308|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190309|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190310|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190311|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190312|NCT03498196|Avelumab|avelumab|mesh-list
138190313|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190314|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367866|NCT05271539|Growth Substances|growth substances|mesh-ancestor
138190315|NCT03500302|Evolocumab|evolocumab|mesh-list
138190316|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138190317|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138190318|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138190319|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
138190320|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190321|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138190322|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138190323|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190324|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138190325|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138190326|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
138190327|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190328|NCT03503578|Ketamine|ketamine|mesh-list
138190329|NCT03503578|Sevoflurane|sevoflurane|mesh-list
138190330|NCT03503578|Analgesics|analgesics|mesh-ancestor
138190331|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
138190332|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190333|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190334|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138190337|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
138190338|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190339|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138190340|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138190341|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344296|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190343|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138190344|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138190345|NCT03270514|Bupivacaine|bupivacaine|mesh-list
138190346|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
138190348|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190350|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
138190351|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190353|NCT02178241|Halichondrin B|halichondrin b|mesh-list
138190354|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138190356|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190357|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190358|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
138190359|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
138190360|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
138190362|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190363|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138190365|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138190366|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190367|NCT01077973|Ibuprofen|ibuprofen|mesh-list
138190368|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190369|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190370|NCT01077973|Analgesics|analgesics|mesh-ancestor
138190371|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
138190372|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190373|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190374|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190375|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190376|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138190377|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190378|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190379|NCT02973646|Tenofovir|tenofovir|mesh-list
138190380|NCT02973646|Entecavir|entecavir|mesh-list
138190381|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138190382|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
138190383|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190384|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138190385|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138190386|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190387|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190388|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138190389|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138190390|NCT01078363|Ramipril|ramipril|mesh-list
138190391|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138190392|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
138190394|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190396|NCT03371836|Clobazam|clobazam|mesh-list
138190397|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
138190398|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138190399|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138190400|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190401|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190403|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138190404|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
138190405|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
138190406|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344297|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138190407|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190408|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138190409|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
138190410|NCT01078753|Coagulants|coagulants|mesh-ancestor
138190411|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138190412|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
138190413|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190416|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190417|NCT03372382|Analgesics|analgesics|mesh-ancestor
138190418|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
138190419|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190420|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190421|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
138190422|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190423|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190424|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190426|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190427|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190431|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190432|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190433|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138190434|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138190435|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190436|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
138190437|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190438|NCT03374176|Amoxicillin|amoxicillin|mesh-list
138190439|NCT03374176|Metronidazole|metronidazole|mesh-list
138190441|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
138190442|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
138190443|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190444|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190445|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138190446|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138190447|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138190448|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190449|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190450|NCT03281200|Nintedanib|nintedanib|mesh-list
138190451|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
138190452|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
138190453|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
138190454|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190455|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190457|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190458|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
138190459|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
138190461|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
138190462|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190463|NCT03380026|Triamcinolone|triamcinolone|mesh-list
138190464|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138190465|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138190466|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
138190467|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138190468|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190469|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
138190470|NCT03380026|Hormones|hormones|mesh-ancestor
138190471|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190472|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190473|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190474|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
138190475|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190476|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190477|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
138190478|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138190479|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190480|NCT01079143|Cyclosporine|cyclosporine|mesh-list
138190481|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
138190482|NCT01079143|Everolimus|everolimus|mesh-list
138190483|NCT01079143|Cyclosporins|cyclosporins|mesh-list
138190487|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190488|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
138190489|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190490|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
138190491|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190492|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138190493|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190494|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138190495|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138190496|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138190497|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190498|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138190500|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
138190501|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190502|NCT03381742|Clopidogrel|clopidogrel|mesh-list
138190503|NCT03381742|Ticagrelor|ticagrelor|mesh-list
138190504|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138190505|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138190506|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138190507|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138190508|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
138190509|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190510|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190511|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190513|NCT04735042|Empagliflozin|empagliflozin|mesh-list
138190514|NCT04735042|Linagliptin|linagliptin|mesh-list
138190516|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138190517|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190519|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190520|NCT04735042|Incretins|incretins|mesh-ancestor
138190521|NCT04735042|Hormones|hormones|mesh-ancestor
138190522|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190523|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138190525|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190526|NCT00376012|Rifampin|rifampin|mesh-list
138190528|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
138190530|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138190531|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
138190532|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190533|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190534|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
138190535|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138190536|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190537|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190538|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138190539|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138190540|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138190541|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138190542|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138190543|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138190544|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138190545|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138190546|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
138190547|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138190548|NCT02171611|Dabigatran|dabigatran|mesh-list
138190549|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
138190551|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
138190552|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190553|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190554|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
138190555|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
138190556|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
138190557|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138190558|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138190559|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190560|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138190562|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190563|NCT00942305|Brincidofovir|brincidofovir|mesh-list
138190564|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
138190565|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190567|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
138190568|NCT01084759|Testosterone|testosterone|mesh-list
138190573|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190574|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138190575|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190576|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190577|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190578|NCT01084759|Androgens|androgens|mesh-ancestor
138190581|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190582|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190583|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
138190585|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
138190586|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
138190588|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138190589|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138190590|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190591|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138190592|NCT01110421|Amoxicillin|amoxicillin|mesh-list
138190593|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
138190594|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
138190596|NCT01110421|Doripenem|doripenem|mesh-list
138190597|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138190599|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190600|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138190601|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190602|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190603|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
138190604|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138190605|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190606|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190607|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138190608|NCT04358627|Analgesics|analgesics|mesh-ancestor
138190609|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
138190610|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190611|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138190612|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138190613|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138190615|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190616|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190617|NCT04356677|Ribavirin|ribavirin|mesh-list
138190618|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
138190619|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190620|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
138190621|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190622|NCT04356833|Plasminogen|plasminogen|mesh-list
138190623|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138190624|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138190626|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190628|NCT05620277|Vitamin E|vitamin e|mesh-list
138190629|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
138190630|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
138190632|NCT05620277|Protective Agents|protective agents|mesh-ancestor
138190633|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190634|NCT05620277|Vitamins|vitamins|mesh-ancestor
138190637|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138190638|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138190639|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138190640|NCT02174419|Nalbuphine|nalbuphine|mesh-list
138190641|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138190642|NCT02174419|Narcotics|narcotics|mesh-ancestor
138190643|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190644|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190645|NCT02174419|Analgesics|analgesics|mesh-ancestor
138190646|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
138190647|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190648|NCT05620589|Amoxicillin|amoxicillin|mesh-list
138190649|NCT05620589|Tetracycline|tetracycline|mesh-list
138190650|NCT05620589|Esomeprazole|esomeprazole|mesh-list
138190651|NCT05620589|Bismuth|bismuth|mesh-list
138190652|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190653|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190654|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138342034|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
138190655|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190656|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138190657|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190658|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190659|NCT05620589|Antacids|antacids|mesh-ancestor
138190660|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138190662|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138190663|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190664|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138190665|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
138190666|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138190667|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
138190668|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190670|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138190671|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138190672|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
138190673|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190674|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190675|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190676|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138190677|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138190678|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
138190679|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138190681|NCT04355273|Calcium heparin|calcium heparin|mesh-list
138190682|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
138190683|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138190684|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138190685|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190686|NCT04355429|Captopril|captopril|mesh-list
138190687|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138190688|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
138190690|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190691|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138190692|NCT01114555|Bevacizumab|bevacizumab|mesh-list
138190693|NCT01114555|Irinotecan|irinotecan|mesh-list
138190694|NCT01114555|Temozolomide|temozolomide|mesh-list
138190696|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190697|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138190698|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138190699|NCT01114555|Growth Substances|growth substances|mesh-ancestor
138190700|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190702|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138190703|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190704|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190705|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190706|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138190707|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
138190708|NCT01115101|Pirinitramide|pirinitramide|mesh-list
138190709|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138190710|NCT01115101|Narcotics|narcotics|mesh-ancestor
138190711|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190712|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190713|NCT01115101|Analgesics|analgesics|mesh-ancestor
138190714|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
138190715|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190717|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138367876|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367877|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
138367878|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367879|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
138367880|NCT05271253|Bupivacaine|bupivacaine|mesh-list
138190718|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138190721|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190722|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190723|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190724|NCT02245529|Urological Agents|urological agents|mesh-ancestor
138190725|NCT00947765|Prednisolone|prednisolone|mesh-list
138190726|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138190727|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
138190728|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138190730|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138190731|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
138190732|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190733|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
138190734|NCT00947765|Hormones|hormones|mesh-ancestor
138190735|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190736|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190737|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190738|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190740|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
138190741|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190742|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190744|NCT00947765|Protective Agents|protective agents|mesh-ancestor
138190746|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138190747|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138190748|NCT01089517|Growth Substances|growth substances|mesh-ancestor
138190749|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190750|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
138190751|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190752|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138190753|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138190754|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190755|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
138190756|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190757|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138190758|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190759|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190761|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
138190762|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
138190763|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190764|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190765|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138190766|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138190767|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
138190769|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190770|NCT01089751|Urological Agents|urological agents|mesh-ancestor
138190772|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138190773|NCT03032315|Telmisartan|telmisartan|mesh-list
138190774|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138190775|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138190776|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138190777|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138190778|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190782|NCT03032315|Diuretics|diuretics|mesh-ancestor
138190783|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
138190784|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138190785|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138190786|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138190787|NCT01090921|Bortezomib|bortezomib|mesh-list
138190788|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190790|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
138190791|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
138190792|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138190793|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190794|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
138190795|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190807|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138190808|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
138190809|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190811|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138190812|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138190818|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
138190819|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190820|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138190821|NCT04355039|Dexamethasone|dexamethasone|mesh-list
138190822|NCT04355039|Pomalidomide|pomalidomide|mesh-list
138190824|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
138190825|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
138190826|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190827|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190828|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190830|NCT04355039|Hormones|hormones|mesh-ancestor
138190831|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190832|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190833|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190834|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
138190835|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138190837|NCT04355039|Growth Substances|growth substances|mesh-ancestor
138190838|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
138190839|NCT02524405|Corticosterone|corticosterone|mesh-list
138190840|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190841|NCT03014323|Galantamine|galantamine|mesh-list
138190842|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138190843|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190844|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190845|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
138190846|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190847|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190848|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138190850|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190852|NCT03393208|Metformin|metformin|mesh-list
138190853|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138190854|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190855|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
138190856|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138190858|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190859|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190860|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138190861|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
138190862|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138190864|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190865|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190866|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138190867|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
138190868|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
138190869|NCT01092559|Protective Agents|protective agents|mesh-ancestor
138190873|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190875|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138190876|NCT03398278|Narcotics|narcotics|mesh-ancestor
138190877|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190878|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190879|NCT03398278|Analgesics|analgesics|mesh-ancestor
138190880|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
138190881|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190882|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
138190883|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138190892|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138190893|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
138190896|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190897|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138190898|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138190899|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
138190900|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190901|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190902|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138190903|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190904|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190905|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
138190906|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
138190907|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190908|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190909|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
138190910|NCT03593902|Hormones|hormones|mesh-ancestor
138190911|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190912|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138190913|NCT03593902|Protective Agents|protective agents|mesh-ancestor
138190914|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190915|NCT00948935|Gemcitabine|gemcitabine|mesh-list
138190916|NCT00948935|Irinotecan|irinotecan|mesh-list
138190917|NCT00948935|Panitumumab|panitumumab|mesh-list
138190918|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138190919|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
138190920|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190921|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190922|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138190923|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190924|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190925|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138190928|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
138190931|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190932|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138190933|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138190934|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190935|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138190939|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190941|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138190943|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
138190945|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190946|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138190947|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138190948|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138190949|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190950|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138190951|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138190952|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138190953|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
138190954|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190955|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190956|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
138190957|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190959|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
138190960|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190961|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
138190962|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190963|NCT02430103|Goserelin|goserelin|mesh-list
138190964|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190965|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190966|NCT03031535|Octreotide|octreotide|mesh-list
138190967|NCT03031535|Hormones|hormones|mesh-list
138190968|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138190969|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190970|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190972|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138190973|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190974|NCT01093417|Vitamin D|vitamin d|mesh-list
138190975|NCT01093417|Vitamins|vitamins|mesh-ancestor
138190976|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
138190977|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190978|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138190979|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138190980|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138190981|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190982|NCT01093651|Incretins|incretins|mesh-ancestor
138367904|NCT05271136|Protective Agents|protective agents|mesh-ancestor
138367905|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367906|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367907|NCT05271058|Dexamethasone|dexamethasone|mesh-list
138190984|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190987|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190988|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190989|NCT00362895|Tobramycin|tobramycin|mesh-list
138190990|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138190991|NCT00362895|Dexamethasone|dexamethasone|mesh-list
138190992|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
138190993|NCT00362895|BB 1101|bb 1101|mesh-list
138190996|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
138190997|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190998|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190999|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191000|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
138191002|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191003|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191004|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191005|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
138191006|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191007|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191008|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191009|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191010|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138191011|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138191012|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
138191014|NCT04744623|Prednisolone|prednisolone|mesh-list
138191015|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138191016|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
138191017|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138191018|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
138191019|NCT04744623|Triamcinolone|triamcinolone|mesh-list
138191020|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138191021|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138191023|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138191025|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138191026|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191027|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138191028|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
138191029|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191030|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191031|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191032|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191034|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
138191035|NCT04744623|Hormones|hormones|mesh-ancestor
138191036|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191037|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191038|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191039|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
138191040|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
138191041|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191042|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191043|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138191044|NCT04744623|Protective Agents|protective agents|mesh-ancestor
138191045|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191046|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
138191047|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
138191048|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138191049|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138191050|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138191052|NCT00939731|Crizotinib|crizotinib|mesh-list
138191053|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191054|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191055|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191056|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191057|NCT00633945|Lenalidomide|lenalidomide|mesh-list
138191058|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
138367908|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
138367909|NCT05271058|Triamcinolone|triamcinolone|mesh-list
138191059|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191060|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138191061|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138191062|NCT00633945|Growth Substances|growth substances|mesh-ancestor
138191063|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
138191064|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191065|NCT01118845|Rituximab|rituximab|mesh-list
138191066|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138191071|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191072|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138191073|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
138191077|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191079|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138191080|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191081|NCT03030911|Midazolam|midazolam|mesh-list
138191082|NCT03030911|Fentanyl|fentanyl|mesh-list
138191087|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191088|NCT03030911|Analgesics|analgesics|mesh-ancestor
138191089|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
138191090|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191091|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138191092|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138191093|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138191094|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
138191095|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191097|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138191098|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138191099|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138191100|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138191101|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191102|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
138191104|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
138191107|NCT03030911|Narcotics|narcotics|mesh-ancestor
138191108|NCT01120405|Sevoflurane|sevoflurane|mesh-list
138191109|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138191110|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138191111|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
138191112|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
138191115|NCT03013387|Octreotide|octreotide|mesh-list
138191116|NCT03013387|Edotreotide|edotreotide|mesh-list
138191117|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191118|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191119|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191120|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138191121|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191122|NCT01782989|Doxycycline|doxycycline|mesh-list
138191123|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191124|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191125|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
138191126|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138191127|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138191133|NCT01095757|Plerixafor|plerixafor|mesh-list
138191134|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138191135|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138191136|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
138191138|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138191139|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138191140|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191141|NCT02245451|Ritonavir|ritonavir|mesh-list
138191142|NCT02245451|Tipranavir|tipranavir|mesh-list
138191143|NCT02245451|Methadone|methadone|mesh-list
138191144|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138191145|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138191147|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191148|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191149|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138191153|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138191154|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138367917|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367918|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191156|NCT02245451|Narcotics|narcotics|mesh-ancestor
138191157|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191158|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191160|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
138191161|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191162|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
138191163|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
138191167|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138191168|NCT00951899|Metformin|metformin|mesh-list
138191169|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138191170|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138191171|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191172|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138191175|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191177|NCT01097395|Ribavirin|ribavirin|mesh-list
138191178|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
138191179|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191180|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
138191186|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191188|NCT00433589|Docetaxel|docetaxel|mesh-list
138191189|NCT00433589|Capecitabine|capecitabine|mesh-list
138191190|NCT00433589|Letrozole|letrozole|mesh-list
138191191|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191192|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138191193|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138191197|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
138191198|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138191199|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138191200|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191201|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138191202|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
138191203|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191207|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138191208|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138191209|NCT03013075|Morphine|morphine|mesh-list
138191211|NCT03013075|Anesthetics|anesthetics|mesh-list
138191212|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
138191214|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191215|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191216|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
138191217|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191218|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191219|NCT03013075|Narcotics|narcotics|mesh-ancestor
138191220|NCT03013075|Analgesics|analgesics|mesh-ancestor
138191221|NCT03030677|Lidocaine|lidocaine|mesh-list
138191222|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
138191223|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
138191224|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191225|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191226|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
138191227|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191228|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138191230|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138191231|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191232|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191233|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138191234|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138191235|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191238|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138191239|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138191240|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
138191241|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191242|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138191243|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138191244|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191246|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138191247|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138191248|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191250|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
138191251|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
138191254|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191256|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191257|NCT00940589|Melatonin|melatonin|mesh-list
138191259|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191260|NCT00940589|Protective Agents|protective agents|mesh-ancestor
138191261|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191262|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191263|NCT02574078|Paclitaxel|paclitaxel|mesh-list
138191264|NCT02574078|Docetaxel|docetaxel|mesh-list
138191265|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138191266|NCT02574078|Bevacizumab|bevacizumab|mesh-list
138191267|NCT02574078|Carboplatin|carboplatin|mesh-list
138191268|NCT02574078|Gemcitabine|gemcitabine|mesh-list
138191269|NCT02574078|Nivolumab|nivolumab|mesh-list
138191270|NCT02574078|Pemetrexed|pemetrexed|mesh-list
138191271|NCT02574078|Crizotinib|crizotinib|mesh-list
138191272|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138191273|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191276|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138191277|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191278|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191279|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138191280|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138191281|NCT02574078|Growth Substances|growth substances|mesh-ancestor
138191282|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191283|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
138191284|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138191285|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
138191286|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138191287|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191289|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138191290|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191291|NCT03605914|Acetaminophen|acetaminophen|mesh-list
138191292|NCT03605914|Diclofenac|diclofenac|mesh-list
138191293|NCT03605914|Hydrocodone|hydrocodone|mesh-list
138191294|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191295|NCT03605914|Analgesics|analgesics|mesh-ancestor
138191296|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
138191297|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191298|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191299|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
138191300|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191301|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191302|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191303|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191304|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191305|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191306|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191309|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
138191310|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138191311|NCT04353479|Decitabine|decitabine|mesh-list
138191312|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138191313|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138191314|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
138191315|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191316|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191318|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191320|NCT03608488|Vitamins|vitamins|mesh-ancestor
138191322|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191323|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138191324|NCT03035045|Acetaminophen|acetaminophen|mesh-list
138191325|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191326|NCT03035045|Analgesics|analgesics|mesh-ancestor
138191327|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
138191328|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191329|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191330|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
138191331|NCT03034733|Dexamethasone|dexamethasone|mesh-list
138191332|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191333|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
138191334|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
138191335|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191336|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191337|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191338|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
138191340|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191341|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191342|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191343|NCT05512416|Letrozole|letrozole|mesh-list
138191344|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191347|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191348|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191349|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138191350|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
138191351|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191352|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191353|NCT03403504|Oxycodone|oxycodone|mesh-list
138191354|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191355|NCT03403504|Narcotics|narcotics|mesh-ancestor
138191356|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191357|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191358|NCT03403504|Analgesics|analgesics|mesh-ancestor
138191359|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
138191360|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191361|NCT05512728|Midazolam|midazolam|mesh-list
138191362|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138191363|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138191364|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191376|NCT02565810|Adalimumab|adalimumab|mesh-list
138191377|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138191378|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191379|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191380|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
138191381|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
138191395|NCT03565666|Pancreatin|pancreatin|mesh-list
138191396|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138191397|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191398|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191399|NCT03620890|Protamines|protamines|mesh-list
138191400|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
138191401|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191403|NCT05507112|Capecitabine|capecitabine|mesh-list
138191404|NCT05507112|Tislelizumab|tislelizumab|mesh-list
138191405|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138191406|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138191407|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
138191408|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191409|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191410|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191411|NCT00952133|Dexamethasone|dexamethasone|mesh-list
138191412|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
138191413|NCT00952133|Palonosetron|palonosetron|mesh-list
138191414|NCT00952133|BB 1101|bb 1101|mesh-list
138191415|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191416|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
138191422|NCT00952133|Hormones|hormones|mesh-ancestor
138191423|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191424|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191425|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191426|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
138191427|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191432|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191433|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
138191434|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191436|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138191437|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191439|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138191440|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138191444|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
138191445|NCT02561832|Carboplatin|carboplatin|mesh-list
138191446|NCT02561832|Olaparib|olaparib|mesh-list
138191447|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191448|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
138191449|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191450|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191451|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138191452|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
138191453|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191454|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191455|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138191456|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138191457|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191458|NCT02982161|Celecoxib|celecoxib|mesh-list
138191459|NCT02982161|Tramadol|tramadol|mesh-list
138191460|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191461|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191462|NCT02982161|Analgesics|analgesics|mesh-ancestor
138191463|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
138191465|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191466|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191467|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191468|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138191469|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191470|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191471|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191476|NCT05506488|Quercetin|quercetin|mesh-list
138191477|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191478|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191479|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191480|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191481|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
138191482|NCT05506488|Protective Agents|protective agents|mesh-ancestor
138191484|NCT00942149|Daptomycin|daptomycin|mesh-list
138191485|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191486|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191487|NCT03023111|Miltefosine|miltefosine|mesh-list
138191488|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138191489|NCT03023111|Molgramostim|molgramostim|mesh-list
138191490|NCT03023111|Sargramostim|sargramostim|mesh-list
138191491|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
138191492|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191493|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191494|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
138191495|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191496|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138191504|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191505|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191506|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191507|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191508|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191516|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
138191517|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191518|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191520|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191521|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138191522|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191523|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
138191524|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138191525|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191526|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191528|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
138191529|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191530|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
138191531|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138191532|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138191534|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191535|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191536|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
138191537|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191539|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138191540|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191541|NCT03017495|Midazolam|midazolam|mesh-list
138191542|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138191543|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138191544|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367923|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367924|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367925|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
138367926|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367928|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191545|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191546|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138191547|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138191548|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138191549|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191550|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
138191559|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
138191560|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138191561|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
138191562|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191563|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191564|NCT01125163|Iron|iron|mesh-list
138191566|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
138191567|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191569|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138191570|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138191572|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191573|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191574|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138191575|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138191576|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
138191577|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191578|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138191579|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138191580|NCT05307835|Molgramostim|molgramostim|mesh-list
138191583|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191584|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191585|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138191586|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191588|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138191589|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191590|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191591|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
138191592|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191593|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191594|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138191596|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191598|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191599|NCT00955877|Narcotics|narcotics|mesh-ancestor
138191600|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191601|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191603|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
138191604|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191606|NCT03960658|Analgesics|analgesics|mesh-ancestor
138191607|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
138191608|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191609|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191610|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138191611|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191613|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
138191614|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191617|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191618|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191619|NCT01005407|Vaccines|vaccines|mesh-list
138191620|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
138191621|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191625|NCT03633448|Expectorants|expectorants|mesh-ancestor
138191626|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
138191627|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138191628|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138191629|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
138191630|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191631|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191632|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191633|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
138191634|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138191635|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
138191636|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
138191637|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191638|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
138191639|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138191640|NCT05313958|Cytarabine|cytarabine|mesh-list
138191641|NCT05313958|Sorafenib|sorafenib|mesh-list
138191642|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
138191643|NCT05313958|Idarubicin|idarubicin|mesh-list
138191645|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138191647|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191648|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191649|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
138191650|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191651|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191652|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
138191653|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191654|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191655|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191657|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
138191658|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191659|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138191660|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138191661|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138191662|NCT01006655|Beclomethasone|beclomethasone|mesh-list
138191663|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191664|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
138191665|NCT01006655|Hormones|hormones|mesh-ancestor
138191666|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191667|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191669|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138191671|NCT03633526|VX-659|vx-659|mesh-list
138191672|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138191673|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191674|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191675|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
138191676|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191678|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138191679|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191680|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138191681|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191682|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191683|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138191684|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138191685|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
138191686|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191687|NCT01008059|Alfentanil|alfentanil|mesh-list
138191688|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191691|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191692|NCT01008059|Analgesics|analgesics|mesh-ancestor
138191693|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
138191694|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191695|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191696|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
138191697|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
138191698|NCT01009619|Azithromycin|azithromycin|mesh-list
138191699|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191704|NCT01010009|Protective Agents|protective agents|mesh-ancestor
138191705|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191706|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191707|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138191708|NCT04467424|Lidocaine|lidocaine|mesh-list
138191709|NCT04467424|Ketamine|ketamine|mesh-list
138191710|NCT04467424|Propofol|propofol|mesh-list
138191711|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
138191712|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
138191714|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191715|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
138191716|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191717|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138191718|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138191719|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138191720|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191721|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191722|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138191723|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191724|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
138191725|NCT04467424|Analgesics|analgesics|mesh-ancestor
138191726|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138191728|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138191729|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191730|NCT03016715|Sirolimus|sirolimus|mesh-list
138191731|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191732|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191733|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138191734|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191735|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
138191736|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191737|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
138191738|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191740|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191741|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
138191742|NCT00377104|Growth Substances|growth substances|mesh-ancestor
138191743|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191744|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191745|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191746|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191747|NCT03016793|Puerarin|puerarin|mesh-list
138191748|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
138191749|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138191750|NCT03928522|Vancomycin|vancomycin|mesh-list
138191757|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138191758|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191759|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191769|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191770|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191771|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191775|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
138191776|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138191777|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138191778|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138191779|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191782|NCT01041781|Gemcitabine|gemcitabine|mesh-list
138191784|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191787|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191788|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191789|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138191792|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191793|NCT01041781|Analgesics|analgesics|mesh-ancestor
138191794|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
138191795|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191796|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191797|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191798|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191799|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138191800|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191801|NCT01010477|Nicotine|nicotine|mesh-list
138191802|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138191803|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
138191804|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191805|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191806|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138191807|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138367933|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
138367934|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367935|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138367936|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138367937|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138367938|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367939|NCT05270889|Tislelizumab|tislelizumab|mesh-list
138367940|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367941|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367942|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
138367943|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
138191808|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
138191812|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191813|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191814|NCT00953849|Calcitriol|calcitriol|mesh-list
138191815|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138191816|NCT00953849|Vitamin D|vitamin d|mesh-list
138191817|NCT00953849|Celecoxib|celecoxib|mesh-list
138191818|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191820|NCT00953849|Analgesics|analgesics|mesh-ancestor
138191821|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
138191822|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191823|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191824|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191825|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191826|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138191827|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138191828|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191829|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191832|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191833|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138191835|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
138191836|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138191837|NCT04425850|Ivermectin|ivermectin|mesh-list
138191838|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138191839|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191840|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138191841|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138191842|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138191843|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191844|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191846|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191847|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191848|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138191849|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191851|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191852|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138191854|NCT01042795|Growth Substances|growth substances|mesh-ancestor
138191855|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191856|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
138191857|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191858|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191859|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191864|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191865|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138191866|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138191868|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138191869|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
138191870|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191871|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191875|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191876|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191877|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
138191878|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191882|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138191883|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138191884|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138191885|NCT03889444|Dexamethasone|dexamethasone|mesh-list
138191886|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191887|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
138191888|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
138191889|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191890|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191891|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191892|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
138191893|NCT03889444|Hormones|hormones|mesh-ancestor
138191894|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191895|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191896|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191898|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
138191899|NCT01104025|Methotrexate|methotrexate|mesh-list
138191900|NCT01104025|Etoposide|etoposide|mesh-list
138191902|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191903|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
138191904|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
138191905|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191906|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191907|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191908|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
138191909|NCT01104025|Hormones|hormones|mesh-ancestor
138191910|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191911|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191913|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138191914|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
138191915|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138191917|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
138191918|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191919|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
138191920|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191921|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138191922|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138191923|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
138191924|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138191925|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138191930|NCT03649750|Expectorants|expectorants|mesh-ancestor
138191931|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
138191933|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138191934|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191935|NCT01105117|Epoprostenol|epoprostenol|mesh-list
138191936|NCT01105117|Tezosentan|tezosentan|mesh-list
138191937|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138191938|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138191939|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
138191941|NCT03885154|Valproic Acid|valproic acid|mesh-list
138191942|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
138191944|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191945|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
138191947|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191948|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
138191949|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138191950|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191951|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138191958|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191960|NCT01106833|Prednisone|prednisone|mesh-list
138191961|NCT01106833|Temsirolimus|temsirolimus|mesh-list
138191963|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138191964|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191965|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
138191966|NCT01106833|Hormones|hormones|mesh-ancestor
138191967|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191968|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191969|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191971|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138191972|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191973|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138191974|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
138191975|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367959|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192011|NCT04322968|Ketorolac|ketorolac|mesh-list
138192012|NCT04322968|Ketamine|ketamine|mesh-list
138192013|NCT04322968|Analgesics|analgesics|mesh-ancestor
138192015|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192016|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192025|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192026|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192028|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192029|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192030|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138192031|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192032|NCT03018899|Anesthetics|anesthetics|mesh-list
138192037|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138192038|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192039|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
138192040|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192041|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192042|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192044|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138192045|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138192046|NCT04323592|Prednisolone|prednisolone|mesh-list
138192047|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
138192048|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138192049|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
138192050|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192051|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
138192052|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
138192078|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138192079|NCT01047241|Narcotics|narcotics|mesh-ancestor
138192113|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138192114|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192115|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138192116|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192117|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192118|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138192119|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138192129|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138192131|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138192132|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
138192144|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192145|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192146|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192147|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138192148|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
138192151|NCT03018665|Exenatide|exenatide|mesh-list
138192152|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138192153|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192154|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138192155|NCT03018665|Incretins|incretins|mesh-ancestor
138192156|NCT03018665|Hormones|hormones|mesh-ancestor
138192157|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192158|NCT03012763|Acetaminophen|acetaminophen|mesh-list
138192171|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192173|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138192174|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138192175|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
138192176|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
138192177|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192178|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192179|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192180|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192181|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367968|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138367974|NCT05270343|Vitamin D|vitamin d|mesh-list
138192182|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192183|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138192185|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138192186|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192187|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192188|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
138192189|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192190|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138192218|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192219|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192220|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
138192221|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192222|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192225|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192227|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138192228|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192229|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138192230|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192231|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
138192232|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192233|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
138192255|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138192256|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138192257|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192258|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192260|NCT05314270|Copper|copper|mesh-list
138192261|NCT05314270|Trace Elements|trace elements|mesh-ancestor
138192262|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
138192263|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192265|NCT01167829|Acyline|acyline|mesh-list
138192266|NCT01167829|Androgens|androgens|mesh-ancestor
138192267|NCT01167829|Hormones|hormones|mesh-ancestor
138192269|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192270|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138192271|NCT02066623|Everolimus|everolimus|mesh-list
138192272|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138192273|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138192274|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192275|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192276|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192277|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
138192278|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192279|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192281|NCT04974151|Amlodipine|amlodipine|mesh-list
138192282|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192283|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138192284|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192285|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192286|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138192287|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192288|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
138192289|NCT04974151|Hematinics|hematinics|mesh-ancestor
138192290|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
138192291|NCT04974151|Vitamins|vitamins|mesh-ancestor
138192292|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
138192293|NCT01924819|Leucovorin|leucovorin|mesh-list
138192294|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138192296|NCT01924819|Docetaxel|docetaxel|mesh-list
138192297|NCT01924819|Capecitabine|capecitabine|mesh-list
138192298|NCT01924819|Fluorouracil|fluorouracil|mesh-list
138192299|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
138192300|NCT01924819|Epirubicin|epirubicin|mesh-list
138192301|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
138192302|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192303|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192304|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
138192305|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
138192308|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
138192309|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367980|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
138192310|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
138192311|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192312|NCT01924819|Antidotes|antidotes|mesh-ancestor
138192313|NCT01924819|Protective Agents|protective agents|mesh-ancestor
138192314|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
138192316|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
138192317|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138192318|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138192319|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138192320|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192322|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
138192323|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
138192324|NCT03685396|Hemostatics|hemostatics|mesh-list
138192325|NCT03685396|Coagulants|coagulants|mesh-ancestor
138192326|NCT01126255|Clobetasol|clobetasol|mesh-list
138192327|NCT01126255|Progesterone|progesterone|mesh-list
138192328|NCT01126255|Progestins|progestins|mesh-ancestor
138192329|NCT01126255|Hormones|hormones|mesh-ancestor
138192330|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192331|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192332|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192333|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
138192334|NCT04198948|Gliclazide|gliclazide|mesh-list
138192335|NCT04198948|Omeprazole|omeprazole|mesh-list
138192336|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138192337|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192338|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138192339|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192340|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192341|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138192342|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192343|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
138192344|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138192345|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192346|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192347|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192351|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138192352|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138192353|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138192354|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192355|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192357|NCT04822363|Aspirin|aspirin|mesh-list
138192358|NCT04822363|Clopidogrel|clopidogrel|mesh-list
138192359|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192360|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192361|NCT04822363|Analgesics|analgesics|mesh-ancestor
138192362|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
138192363|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192365|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192366|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192367|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138192368|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138192369|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192370|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138192371|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138192372|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192373|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
138192374|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138192375|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138192376|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138192377|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
138192378|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192381|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
138192382|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192383|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192384|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138192385|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138367987|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367988|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192386|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
138192387|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
138192388|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192391|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192392|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192394|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192395|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138192396|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138192397|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138192399|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192400|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192401|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192402|NCT01170715|Etanercept|etanercept|mesh-list
138192403|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192404|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192407|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192408|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192409|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192411|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192412|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192413|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
138192414|NCT03809182|Fentanyl|fentanyl|mesh-list
138192415|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
138192416|NCT03809182|Morphine|morphine|mesh-list
138192417|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138192418|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192419|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192420|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192421|NCT03809182|Analgesics|analgesics|mesh-ancestor
138192422|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
138192424|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138192425|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138192426|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138192427|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192428|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192429|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192430|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138192431|NCT03809182|Narcotics|narcotics|mesh-ancestor
138192432|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138192433|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138192434|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
138192435|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
138192437|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
138192438|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192439|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192440|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138192441|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138192442|NCT03805672|Enoxaparin|enoxaparin|mesh-list
138192443|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
138192444|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
138192445|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138192446|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138192447|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192448|NCT03802864|Bupivacaine|bupivacaine|mesh-list
138192449|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
138192450|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
138192451|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192453|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
138192454|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192455|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
138192456|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
138192457|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138367996|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367997|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138367998|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367999|NCT05248724|Ketorolac|ketorolac|mesh-list
138192458|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138192459|NCT03797872|Prednisolone|prednisolone|mesh-list
138192460|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
138192461|NCT03797872|Triamcinolone|triamcinolone|mesh-list
138192462|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138192463|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138192465|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138192466|NCT03797872|Leflunomide|leflunomide|mesh-list
138192468|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
138192469|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138192470|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
138192471|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192472|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192473|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192475|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192476|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192477|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138192478|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192479|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138192480|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192481|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
138192483|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138192484|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192485|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
138192486|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
138192487|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192489|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
138192490|NCT03797872|Hormones|hormones|mesh-ancestor
138192491|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192493|NCT03797872|Protective Agents|protective agents|mesh-ancestor
138192494|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192495|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192496|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192497|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192499|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
138192500|NCT01127581|Dinoprostone|dinoprostone|mesh-list
138192501|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
138192502|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192503|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192504|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
138192505|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138192506|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138192508|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192510|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
138192512|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192513|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192514|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192515|NCT04498351|Analgesics|analgesics|mesh-ancestor
138192516|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
138192517|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192518|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138192519|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138192520|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138192521|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192522|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192523|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192524|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
138192525|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138192526|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
138192527|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138192528|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192529|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138192530|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
138192531|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192532|NCT02186665|Calcitriol|calcitriol|mesh-list
138192534|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192535|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138192536|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192537|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192538|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138192540|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
138192541|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138192542|NCT01172197|Ropivacaine|ropivacaine|mesh-list
138192543|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
138192544|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
138192545|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
138192546|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192547|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192548|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
138192549|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192550|NCT04141930|Baloxavir|baloxavir|mesh-list
138192551|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
138192553|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192554|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192555|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138192556|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138192557|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192558|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138192559|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138192560|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192561|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192562|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
138192563|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192565|NCT03746002|Furosemide|furosemide|mesh-list
138192568|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192569|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138192570|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192571|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192572|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192573|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138192575|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138192576|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138192577|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
138192578|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192579|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192580|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192581|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138192582|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
138192583|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138192584|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
138192585|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192586|NCT03783130|Antacids|antacids|mesh-ancestor
138192587|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192588|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192589|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138192590|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138192591|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
138192592|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192593|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192595|NCT00983918|Sevoflurane|sevoflurane|mesh-list
138192596|NCT00983918|Desflurane|desflurane|mesh-list
138192597|NCT00983918|Isoflurane|isoflurane|mesh-list
138192598|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138192599|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192600|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192601|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138192602|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
138192604|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138192605|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138192606|NCT01926236|Leucovorin|leucovorin|mesh-list
138192607|NCT01926236|Folic Acid|folic acid|mesh-list
138192608|NCT01926236|Fluorouracil|fluorouracil|mesh-list
138192611|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
138192612|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192613|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192615|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192616|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
138192617|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192618|NCT01926236|Antidotes|antidotes|mesh-ancestor
138192619|NCT01926236|Protective Agents|protective agents|mesh-ancestor
138192620|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
138192622|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
138192623|NCT01926236|Hematinics|hematinics|mesh-ancestor
138192624|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
138192625|NCT00983528|Clofarabine|clofarabine|mesh-list
138192626|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138192627|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192628|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192630|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192631|NCT00983372|Colchicine|colchicine|mesh-list
138192632|NCT00983372|Diltiazem|diltiazem|mesh-list
138192633|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
138192634|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192635|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192636|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138192637|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138192638|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192639|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192640|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192641|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138192642|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192643|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138192644|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192645|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
138192646|NCT01173211|Vaccines|vaccines|mesh-list
138192647|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
138192648|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192658|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192659|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192661|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138192662|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138192663|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192664|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138192665|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138192666|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
138192667|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138192668|NCT05601830|Cytarabine|cytarabine|mesh-list
138192669|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
138192670|NCT05601830|Fludarabine|fludarabine|mesh-list
138192672|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
138192673|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192674|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192675|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138192676|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
138192677|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192678|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192679|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138192680|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192681|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
138192682|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
138192683|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192684|NCT00982280|Tapentadol|tapentadol|mesh-list
138192685|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138192686|NCT00982280|Narcotics|narcotics|mesh-ancestor
138192687|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192688|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192689|NCT00982280|Analgesics|analgesics|mesh-ancestor
138192690|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
138192691|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192692|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138192693|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138192694|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192695|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192696|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192697|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192698|NCT01175395|Triamcinolone|triamcinolone|mesh-list
138192699|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138192700|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138192701|NCT01175395|Ranibizumab|ranibizumab|mesh-list
138192702|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138192705|NCT01175395|Hormones|hormones|mesh-ancestor
138192706|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192707|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192708|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192709|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
138192710|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192711|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192712|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138192713|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138192714|NCT01175395|Growth Substances|growth substances|mesh-ancestor
138192715|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
138192716|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192717|NCT03011905|Acetaminophen|acetaminophen|mesh-list
138192721|NCT03011905|Ropivacaine|ropivacaine|mesh-list
138192722|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192723|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
138192724|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
138192725|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192726|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192727|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192728|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
138192729|NCT03011905|Hormones|hormones|mesh-ancestor
138192730|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192731|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192732|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192733|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
138192734|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
138192735|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192736|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
138192737|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192738|NCT03011905|Analgesics|analgesics|mesh-ancestor
138192739|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
138192740|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138192741|NCT03011905|Narcotics|narcotics|mesh-ancestor
138192742|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192743|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192744|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138192745|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138192746|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192747|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192749|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192750|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138192751|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192752|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192753|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138192754|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
138192756|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138192757|NCT00980798|Narcotics|narcotics|mesh-ancestor
138192758|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192759|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192760|NCT00980798|Analgesics|analgesics|mesh-ancestor
138192761|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
138192762|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192763|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
138192764|NCT01177189|Vitamins|vitamins|mesh-ancestor
138192765|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
138192767|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
138192768|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192769|NCT01177189|Protective Agents|protective agents|mesh-ancestor
138192770|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
138192771|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138192772|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
138192773|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192774|NCT01177735|Pomalidomide|pomalidomide|mesh-list
138192776|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192777|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138192778|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138192779|NCT01177735|Growth Substances|growth substances|mesh-ancestor
138192780|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
138192781|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192782|NCT01135069|Tretinoin|tretinoin|mesh-list
138192783|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192784|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
138192785|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
138192786|NCT01178281|Thalidomide|thalidomide|mesh-list
138192787|NCT01178281|Pomalidomide|pomalidomide|mesh-list
138192788|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
138192789|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192790|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138192791|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138192792|NCT01178281|Growth Substances|growth substances|mesh-ancestor
138192793|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
138192794|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192795|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192796|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
138192797|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138192798|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192799|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
138192800|NCT01178827|Oxybutynin|oxybutynin|mesh-list
138192801|NCT01178827|Trospium chloride|trospium chloride|mesh-list
138192802|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
138192803|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
138192804|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192805|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192806|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138192807|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138192808|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
138192809|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192810|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192811|NCT01178827|Urological Agents|urological agents|mesh-ancestor
138192812|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138192813|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192815|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138192816|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
138192817|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192818|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192819|NCT02181517|Ranibizumab|ranibizumab|mesh-list
138192820|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138192821|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138192822|NCT02181517|Growth Substances|growth substances|mesh-ancestor
138192823|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192824|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
138192825|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192826|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138192828|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138192829|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192830|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192831|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138192832|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138192833|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138192834|NCT01181323|Vaccines|vaccines|mesh-list
138192835|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
138192836|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192837|NCT02246881|Factor VIII|factor viii|mesh-list
138192838|NCT02246881|Coagulants|coagulants|mesh-ancestor
138192839|NCT00980330|Ribavirin|ribavirin|mesh-list
138192840|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138192841|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
138192842|NCT00980330|Simeprevir|simeprevir|mesh-list
138192843|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
138192844|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192845|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
138192846|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192847|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192849|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192850|NCT01138735|Adapalene|adapalene|mesh-list
138192851|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138192852|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138192853|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
138192854|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192855|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192856|NCT01138735|Analgesics|analgesics|mesh-ancestor
138192857|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
138192858|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192859|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192860|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192861|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192862|NCT00980174|Denosumab|denosumab|mesh-list
138192863|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138192864|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192866|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138192867|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192868|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138192872|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138192873|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
138192874|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192875|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192876|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192877|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138192878|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138192879|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138192880|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192881|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192882|NCT00987272|Analgesics|analgesics|mesh-ancestor
138192883|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
138192884|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192885|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192886|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192887|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192888|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138192889|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138192890|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138192891|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
138192892|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
138192893|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192894|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192895|NCT00986882|Ibuprofen|ibuprofen|mesh-list
138192896|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192897|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192898|NCT00986882|Analgesics|analgesics|mesh-ancestor
138192899|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
138192901|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192902|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192903|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192904|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138192905|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192906|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192908|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138192909|NCT04395170|Antibodies|antibodies|mesh-list
138192910|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
138192911|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192912|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138192913|NCT01927328|Hematinics|hematinics|mesh-ancestor
138192914|NCT04552808|Yimitasvir|yimitasvir|mesh-list
138192915|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
138192916|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192917|NCT01927406|Timolol|timolol|mesh-list
138192918|NCT01927406|Bimatoprost|bimatoprost|mesh-list
138192919|NCT01927406|Travoprost|travoprost|mesh-list
138192920|NCT01927406|Latanoprost|latanoprost|mesh-list
138192921|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192922|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138192923|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138192924|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138192925|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192926|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192927|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138192928|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192929|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138192930|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138192931|NCT01182493|Insulin|insulin|mesh-list
138192933|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192934|NCT01927484|Methotrexate|methotrexate|mesh-list
138192935|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138192936|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
138192937|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192938|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192939|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192940|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
138192941|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192942|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192943|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138192944|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192945|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138192946|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138192947|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
138192948|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192949|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138192950|NCT05607446|Montelukast|montelukast|mesh-list
138192951|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138192952|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138192953|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138192954|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138192955|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192956|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192957|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138192958|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138192959|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192961|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138192962|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138192963|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138192964|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192965|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192967|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138192968|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192972|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192973|NCT04558502|Amoxicillin|amoxicillin|mesh-list
138192974|NCT04558502|Clarithromycin|clarithromycin|mesh-list
138192975|NCT04558502|Minocycline|minocycline|mesh-list
138192976|NCT04558502|Esomeprazole|esomeprazole|mesh-list
138192977|NCT04558502|Bismuth|bismuth|mesh-list
138192979|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192980|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138192981|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192982|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138192983|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192984|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192985|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138192987|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138192989|NCT01218997|Naltrexone|naltrexone|mesh-list
138192990|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138192991|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138192992|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192993|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
138192994|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192995|NCT01219777|Paclitaxel|paclitaxel|mesh-list
138192996|NCT01219777|Bevacizumab|bevacizumab|mesh-list
138192997|NCT01219777|Carboplatin|carboplatin|mesh-list
138192998|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138192999|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193000|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
138193001|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
138193002|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
138193003|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193004|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193005|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138193006|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193007|NCT01219777|Growth Substances|growth substances|mesh-ancestor
138193008|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193009|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
138368006|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138368007|NCT05248724|Narcotics|narcotics|mesh-ancestor
138368008|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368009|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368010|NCT05248724|Analgesics|analgesics|mesh-ancestor
138368011|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
138193010|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138193011|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193012|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193013|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138193015|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
138193016|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
138193017|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193019|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
138193020|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
138193021|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193022|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193023|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
138193024|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193025|NCT01928888|Famotidine|famotidine|mesh-list
138193026|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
138193027|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138193028|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193029|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138193030|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
138193031|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
138193032|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193033|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193034|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193035|NCT01928888|Antacids|antacids|mesh-ancestor
138193036|NCT04556084|Blinatumomab|blinatumomab|mesh-list
138193037|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193038|NCT04394234|Warfarin|warfarin|mesh-list
138193039|NCT04394234|Anticoagulants|anticoagulants|mesh-list
138193040|NCT02569710|Simeprevir|simeprevir|mesh-list
138193041|NCT02569710|Odalasvir|odalasvir|mesh-list
138193042|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
138193043|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193044|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
138193045|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193046|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193048|NCT04550624|Lenvatinib|lenvatinib|mesh-list
138193049|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193050|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193051|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193052|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193053|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193056|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193057|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193058|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
138193059|NCT04550546|Ionophores|ionophores|mesh-ancestor
138193060|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193061|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193062|NCT02984072|Menthol|menthol|mesh-list
138193063|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
138193064|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193065|NCT05506410|Cytarabine|cytarabine|mesh-list
138193066|NCT05506410|Prednisone|prednisone|mesh-list
138193067|NCT05506410|Rituximab|rituximab|mesh-list
138193068|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138193069|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193070|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193071|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
138193072|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193073|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193075|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
138193076|NCT05506410|Hormones|hormones|mesh-ancestor
138193077|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193078|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193079|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193080|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
138193081|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193082|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
138193084|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193085|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138193086|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
138193087|NCT05506332|Venetoclax|venetoclax|mesh-list
138193089|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193090|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
138193091|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193092|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193093|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193094|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
138193095|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193096|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138193097|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193098|NCT01927874|Bupivacaine|bupivacaine|mesh-list
138193100|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
138193101|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193102|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193103|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
138193104|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193105|NCT05604638|Tenecteplase|tenecteplase|mesh-list
138193106|NCT05604638|Tirofiban|tirofiban|mesh-list
138193107|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138193108|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138193109|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193110|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138193111|NCT03033758|Budesonide|budesonide|mesh-list
138193112|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
138193113|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193114|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138193115|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
138193116|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193117|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193118|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193119|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193121|NCT03033758|Hormones|hormones|mesh-ancestor
138193122|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193123|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138193124|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138193125|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138193126|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193127|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193128|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193130|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193131|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
138193132|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193133|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193134|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
138193135|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
138193136|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193137|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193138|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193140|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193142|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138193143|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138193144|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138193145|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138193146|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193147|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193148|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193149|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193150|NCT04394390|Vitamin D|vitamin d|mesh-list
138368029|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138368030|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
138368032|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
138368033|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138368034|NCT05232006|Niraparib|niraparib|mesh-list
138368035|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138193151|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
138193152|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
138193153|NCT04394390|Vitamins|vitamins|mesh-list
138193154|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
138193155|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193157|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193158|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138193159|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
138193160|NCT04120454|Ramucirumab|ramucirumab|mesh-list
138193161|NCT04120454|Antibodies|antibodies|mesh-list
138193162|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
138193163|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138193164|NCT04120454|Lexatumumab|lexatumumab|mesh-list
138193165|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
138193166|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193167|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193168|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193169|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193172|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138193173|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138193174|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193176|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193177|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193178|NCT00966641|Naproxen|naproxen|mesh-list
138193179|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138193180|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138193181|NCT00966641|Analgesics|analgesics|mesh-ancestor
138193182|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
138193183|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193184|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193185|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193186|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193187|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
138193188|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138193189|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193190|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193191|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
138193192|NCT00970073|Tacrolimus|tacrolimus|mesh-list
138193193|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
138193194|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138193195|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193196|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
138193197|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193198|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138193199|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193200|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193202|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193203|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138193204|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
138193205|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193206|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193208|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
138193209|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
138193210|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193211|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193212|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193213|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
138193214|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193215|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138193216|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138193217|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
138193218|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193219|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193220|NCT00971789|Sirolimus|sirolimus|mesh-list
138193221|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138193222|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193223|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193224|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138193225|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193227|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193228|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
138193229|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193230|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193232|NCT05510778|Charcoal|charcoal|mesh-list
138193233|NCT05510778|Antidotes|antidotes|mesh-ancestor
138193234|NCT05510778|Protective Agents|protective agents|mesh-ancestor
138193235|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193236|NCT00972335|Bevacizumab|bevacizumab|mesh-list
138193237|NCT00972335|Everolimus|everolimus|mesh-list
138193238|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193239|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193240|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138193241|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193243|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193244|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193245|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138193246|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193247|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193248|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193249|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193250|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
138193251|NCT02337530|Carboplatin|carboplatin|mesh-list
138193252|NCT02337530|Pemetrexed|pemetrexed|mesh-list
138193253|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193254|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193255|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193256|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138193257|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138193259|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
138193260|NCT03341156|Coagulants|coagulants|mesh-ancestor
138193261|NCT04122560|Fluconazole|fluconazole|mesh-list
138193262|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
138193263|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193264|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138193265|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138193267|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193268|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138193269|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
138193270|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193271|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193273|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138193274|NCT02569242|Paclitaxel|paclitaxel|mesh-list
138193275|NCT02569242|Docetaxel|docetaxel|mesh-list
138193276|NCT02569242|Nivolumab|nivolumab|mesh-list
138193277|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138193278|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193279|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138193280|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138193281|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138193282|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193284|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193285|NCT04124588|Hemostatics|hemostatics|mesh-list
138193286|NCT04124588|Coagulants|coagulants|mesh-ancestor
138193287|NCT05501340|Molgramostim|molgramostim|mesh-list
138193289|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193290|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
138193291|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193293|NCT00972725|Amebicides|amebicides|mesh-ancestor
138193294|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138193295|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138193296|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193297|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
138193298|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193299|NCT05600660|Rituximab|rituximab|mesh-list
138193300|NCT05600660|Methotrexate|methotrexate|mesh-list
138193301|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193302|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193303|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
138193304|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193305|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193306|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138193307|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
138193308|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193309|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193310|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
138193311|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193312|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193313|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193314|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138193315|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193316|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138193317|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
138193318|NCT00972959|Dexamethasone|dexamethasone|mesh-list
138193319|NCT00972959|Bortezomib|bortezomib|mesh-list
138193320|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193321|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
138193322|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
138193323|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193324|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193325|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193327|NCT00972959|Hormones|hormones|mesh-ancestor
138193328|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193329|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193330|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193331|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138193332|NCT00973739|Lapatinib|lapatinib|mesh-list
138193333|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193334|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193335|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193336|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193338|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138193339|NCT00974051|Terbutaline|terbutaline|mesh-list
138193341|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138193342|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193343|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193344|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193345|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193346|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138193347|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
138193348|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193349|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193350|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193351|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
138193352|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
138193353|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193354|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138193355|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138193356|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
138193357|NCT03017963|Antidotes|antidotes|mesh-ancestor
138193358|NCT03017963|Protective Agents|protective agents|mesh-ancestor
138193361|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193362|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
138193363|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193364|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193366|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
138193367|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138193368|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
138193369|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193370|NCT00977171|Droxidopa|droxidopa|mesh-list
138193371|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138193372|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138193373|NCT04129424|Insulin|insulin|mesh-list
138193374|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138193375|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193376|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
138193377|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138193378|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
138193379|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193380|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193381|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193382|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193383|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138193384|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
138193385|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193386|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193387|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138193388|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138193389|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
138193390|NCT00955487|Protective Agents|protective agents|mesh-ancestor
138193391|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
138193392|NCT04120922|Calcium|calcium|mesh-list
138193393|NCT04120922|Sevelamer|sevelamer|mesh-list
138193394|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193395|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193396|NCT04120922|Antacids|antacids|mesh-ancestor
138193397|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193398|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193399|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
138193400|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
138193401|NCT01663740|Valganciclovir|valganciclovir|mesh-list
138193402|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
138193403|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193404|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
138193405|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138193406|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
138193407|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193409|NCT02984228|Protective Agents|protective agents|mesh-ancestor
138193410|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138193411|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138193412|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138193413|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
138193414|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193415|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138193416|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138193417|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193419|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138193420|NCT03828032|Diuretics|diuretics|mesh-ancestor
138193421|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
138193422|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193423|NCT03827876|Calcitriol|calcitriol|mesh-list
138193424|NCT03827876|Betamethasone|betamethasone|mesh-list
138193425|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138193426|NCT03827876|Calcipotriene|calcipotriene|mesh-list
138193427|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193428|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
138193429|NCT03827876|Hormones|hormones|mesh-ancestor
138193430|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193431|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193432|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193433|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193434|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193435|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138193436|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193437|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193438|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138193440|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
138193441|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138193442|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193443|NCT03898934|Vitamin D|vitamin d|mesh-list
138193444|NCT03898934|Vitamins|vitamins|mesh-ancestor
138193445|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
138193446|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193447|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138193448|NCT04128800|Apatinib|apatinib|mesh-list
138193449|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193450|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193451|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193452|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193454|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
138193455|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193456|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193457|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138193458|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138193459|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
138193460|NCT01608893|Metoprolol|metoprolol|mesh-list
138193461|NCT01608893|Carvedilol|carvedilol|mesh-list
138193462|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138193464|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
138193465|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
138193466|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368045|NCT05173142|Docetaxel|docetaxel|mesh-list
138368046|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193467|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193468|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138193469|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138193470|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138193471|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193473|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193474|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
138193475|NCT01608893|Protective Agents|protective agents|mesh-ancestor
138193476|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138193477|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193478|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193479|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
138193480|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138193481|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138193482|NCT04128878|Sotalol|sotalol|mesh-list
138193483|NCT04128878|Dofetilide|dofetilide|mesh-list
138193484|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138193485|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138193486|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
138193487|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193488|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193489|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193490|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138193493|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193494|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138193495|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193496|NCT00979745|Afamelanotide|afamelanotide|mesh-list
138193497|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193498|NCT00042341|Clofarabine|clofarabine|mesh-list
138193499|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193500|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
138193501|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193502|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193503|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138193504|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
138193505|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
138193506|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193507|NCT04759196|Topiramate|topiramate|mesh-list
138193508|NCT04759196|Levetiracetam|levetiracetam|mesh-list
138193509|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
138193510|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138193511|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193512|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
138193513|NCT04128254|Apixaban|apixaban|mesh-list
138193514|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138193515|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
138193517|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
138193518|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193519|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193520|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
138193521|NCT04128020|Nivolumab|nivolumab|mesh-list
138193522|NCT04128020|Azacitidine|azacitidine|mesh-list
138193526|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193527|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193529|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193530|NCT03827642|Naloxone|naloxone|mesh-list
138193531|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138193532|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193533|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
138193534|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193535|NCT05510310|Oxytocin|oxytocin|mesh-list
138193536|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
138193538|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193539|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138193540|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
138193541|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138193542|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138193543|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193544|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193547|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193548|NCT04411524|Capecitabine|capecitabine|mesh-list
138193549|NCT04411524|Irinotecan|irinotecan|mesh-list
138193550|NCT04411524|Antibodies|antibodies|mesh-list
138193551|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
138193552|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193553|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193555|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193559|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193562|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
138193563|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193564|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193565|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193566|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193567|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138193568|NCT04127396|Estrogens|estrogens|mesh-ancestor
138193569|NCT04127396|Hormones|hormones|mesh-ancestor
138193570|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193571|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193572|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193574|NCT04120064|Vitamin D|vitamin d|mesh-list
138193575|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193576|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193577|NCT04120064|Vitamins|vitamins|mesh-ancestor
138193578|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
138193579|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138193580|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
138193581|NCT00982007|Hematinics|hematinics|mesh-ancestor
138193582|NCT04814940|Menotropins|menotropins|mesh-list
138193585|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193586|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193587|NCT05042934|Irinotecan|irinotecan|mesh-list
138193588|NCT05042934|Camptothecin|camptothecin|mesh-list
138193589|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138193590|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138193592|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193593|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193594|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138193595|NCT05505006|Folic Acid|folic acid|mesh-list
138193596|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
138193597|NCT05505006|Hematinics|hematinics|mesh-ancestor
138193598|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
138193599|NCT05505006|Vitamins|vitamins|mesh-ancestor
138193601|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193602|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
138193603|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
138193604|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193605|NCT02979548|Ondansetron|ondansetron|mesh-list
138193606|NCT02979548|Aprepitant|aprepitant|mesh-list
138193607|NCT02979548|Metoclopramide|metoclopramide|mesh-list
138193608|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
138193609|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
138193610|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193612|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193613|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
138193614|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193615|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138193616|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138193617|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
138193618|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193619|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193622|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138193623|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
138193625|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138193626|NCT03826316|Narcotics|narcotics|mesh-ancestor
138193627|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193628|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193629|NCT03826316|Analgesics|analgesics|mesh-ancestor
138193630|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
138193631|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193633|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
138193634|NCT04393610|Fentanyl|fentanyl|mesh-list
138193635|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
138193636|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
138193637|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193638|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193639|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
138193640|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193641|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138193642|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138193644|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193645|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193647|NCT04393610|Narcotics|narcotics|mesh-ancestor
138193648|NCT04393610|Analgesics|analgesics|mesh-ancestor
138193649|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138193654|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138193655|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
138193656|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193657|NCT03820466|Aspirin|aspirin|mesh-list
138193658|NCT03820466|Atorvastatin|atorvastatin|mesh-list
138193659|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138193660|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138193661|NCT03820466|Analgesics|analgesics|mesh-ancestor
138193662|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
138193663|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193664|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193665|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193666|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193668|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138193669|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193670|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138193671|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138193672|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193673|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
138193674|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138193675|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138193676|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
138193677|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138193678|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138193680|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
138193681|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193682|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138193683|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
138193684|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
138193685|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193689|NCT02338076|Petrolatum|petrolatum|mesh-list
138193690|NCT02338076|Emollients|emollients|mesh-ancestor
138193691|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193693|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
138193694|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138193695|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138193696|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138193697|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193698|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193699|NCT01222117|Plasminogen|plasminogen|mesh-list
138193700|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138193702|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138193703|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138193704|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193705|NCT01222195|Lenalidomide|lenalidomide|mesh-list
138368065|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368066|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368067|NCT05162118|Nivolumab|nivolumab|mesh-list
138368069|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368070|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368075|NCT05138029|Dexamethasone|dexamethasone|mesh-list
138193706|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
138193707|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
138193708|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193710|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193711|NCT01222195|Growth Substances|growth substances|mesh-ancestor
138193712|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193713|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193714|NCT01222195|Hematinics|hematinics|mesh-ancestor
138193716|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
138193717|NCT01222273|Vitamins|vitamins|mesh-ancestor
138193718|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
138193719|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193720|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138193724|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193725|NCT03161912|Growth Substances|growth substances|mesh-ancestor
138193726|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193727|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193728|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193730|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193731|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193732|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138193733|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138193734|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138193735|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193736|NCT03829592|Misoprostol|misoprostol|mesh-list
138193737|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138193738|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
138193739|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193740|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193741|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138193742|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193743|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
138193745|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138193746|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
138193747|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193748|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138193749|NCT01142947|Beclomethasone|beclomethasone|mesh-list
138193750|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193751|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
138193752|NCT01142947|Hormones|hormones|mesh-ancestor
138193753|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193754|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193755|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193756|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193759|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138193760|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
138193761|NCT02972294|Trace Elements|trace elements|mesh-ancestor
138193762|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
138193763|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193764|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138193765|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138193766|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193767|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
138193768|NCT02972294|Coagulants|coagulants|mesh-ancestor
138193769|NCT02972294|Hematinics|hematinics|mesh-ancestor
138193771|NCT02983214|Clopidogrel|clopidogrel|mesh-list
138193772|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138193773|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138193774|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138193775|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138193776|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
138193777|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193778|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193779|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193780|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138193781|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
138193782|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193783|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138193784|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193785|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138193786|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138193787|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
138193788|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138193794|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
138193795|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193796|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193797|NCT03824834|Morphine|morphine|mesh-list
138193798|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138193799|NCT03824834|Narcotics|narcotics|mesh-ancestor
138193801|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193802|NCT03824834|Analgesics|analgesics|mesh-ancestor
138193803|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
138193804|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193805|NCT03829124|Ketamine|ketamine|mesh-list
138193806|NCT03829124|Propofol|propofol|mesh-list
138193807|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138193809|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193810|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138193811|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
138193812|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
138193813|NCT03829124|Analgesics|analgesics|mesh-ancestor
138193814|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
138193816|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138193817|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138193819|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193820|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193821|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
138193822|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138193823|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138193824|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138193825|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138193826|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138193827|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193828|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
138193829|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193830|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193831|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138193832|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193833|NCT04393220|Bevacizumab|bevacizumab|mesh-list
138193835|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193836|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193837|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138193838|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193839|NCT04393220|Growth Substances|growth substances|mesh-ancestor
138193840|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193841|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193842|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193843|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193844|NCT01025453|Sirolimus|sirolimus|mesh-list
138193848|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193849|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193850|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193851|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193852|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138193853|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
138193854|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193855|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193856|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193857|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138193858|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
138193859|NCT05394233|Bevacizumab|bevacizumab|mesh-list
138193860|NCT05394233|Tislelizumab|tislelizumab|mesh-list
138193861|NCT05394233|Pemetrexed|pemetrexed|mesh-list
138193862|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193863|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193865|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193866|NCT05394233|Growth Substances|growth substances|mesh-ancestor
138193867|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193869|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193870|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193871|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138193873|NCT03823976|Anesthetics|anesthetics|mesh-list
138193874|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193875|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193876|NCT00982553|Ribavirin|ribavirin|mesh-list
138193880|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
138193881|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193882|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138193883|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138193884|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138193885|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138193886|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193887|NCT02939300|Nivolumab|nivolumab|mesh-list
138193888|NCT02939300|Ipilimumab|ipilimumab|mesh-list
138193889|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193890|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193891|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193892|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193894|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
138193895|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138193896|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193897|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
138193898|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138193899|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138193901|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193902|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193903|NCT02565186|Lasmiditan|lasmiditan|mesh-list
138193904|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138193905|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
138193906|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193907|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193908|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193909|NCT04274816|Tremelimumab|tremelimumab|mesh-list
138193915|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
138193916|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193917|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193918|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138193919|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
138193920|NCT05509374|Hormones|hormones|mesh-ancestor
138193921|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193922|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193923|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193924|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
138193926|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193928|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193930|NCT04124822|Piroxicam|piroxicam|mesh-list
138193931|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138193932|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
138193933|NCT04124822|Hormones|hormones|mesh-ancestor
138193934|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138193935|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193936|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138193937|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193938|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193939|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138193940|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138193941|NCT04124822|Analgesics|analgesics|mesh-ancestor
138193942|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
138193943|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193944|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138193945|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193946|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193948|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193949|NCT02854670|Capsaicin|capsaicin|mesh-list
138193950|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
138193951|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193952|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
138193953|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138193954|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193955|NCT03519308|Paclitaxel|paclitaxel|mesh-list
138193956|NCT03519308|Gemcitabine|gemcitabine|mesh-list
138193959|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193960|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138193961|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138193962|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138193963|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193964|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193967|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193968|NCT02565108|Cannabidiol|cannabidiol|mesh-list
138193969|NCT02565108|Clobazam|clobazam|mesh-list
138193970|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
138193971|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138193972|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138193973|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193974|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193975|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138193976|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138193977|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
138193978|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
138193979|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138193981|NCT03821168|Bevacizumab|bevacizumab|mesh-list
138193982|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
138193983|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193984|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193985|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138193986|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138193987|NCT03821168|Growth Substances|growth substances|mesh-ancestor
138193988|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193989|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138193990|NCT03821168|Hematinics|hematinics|mesh-ancestor
138193993|NCT01454180|Capecitabine|capecitabine|mesh-list
138193994|NCT01454180|Fluorouracil|fluorouracil|mesh-list
138193995|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138193996|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
138193997|NCT01454180|Folfirinox|folfirinox|mesh-list
138193998|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138193999|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
138194000|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194001|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194002|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194004|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138194005|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
138194006|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194007|NCT01454180|Antidotes|antidotes|mesh-ancestor
138194008|NCT01454180|Protective Agents|protective agents|mesh-ancestor
138194009|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
138194010|NCT01454180|Vitamins|vitamins|mesh-ancestor
138194011|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
138194013|NCT02564952|Clobazam|clobazam|mesh-list
138194014|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
138194015|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138194016|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138194018|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194019|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194020|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138194021|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
138194022|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
138194023|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194024|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194025|NCT05564286|Dexamethasone|dexamethasone|mesh-list
138194026|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
138194027|NCT05564286|Aprepitant|aprepitant|mesh-list
138194028|NCT05564286|Tropisetron|tropisetron|mesh-list
138194029|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194031|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
138194032|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194033|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194035|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
138194036|NCT05564286|Hormones|hormones|mesh-ancestor
138368079|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368080|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
138368081|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
138368082|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368083|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368084|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368085|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
138368087|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368088|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368089|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194037|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194039|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194040|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138194041|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194042|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194043|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138194044|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138194046|NCT01454804|Trastuzumab|trastuzumab|mesh-list
138194047|NCT01454804|Lapatinib|lapatinib|mesh-list
138194048|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194050|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194051|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194052|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194053|NCT03820622|Paclitaxel|paclitaxel|mesh-list
138194054|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138194055|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138194056|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194057|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194058|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194059|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194060|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194062|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194063|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194067|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194068|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194069|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194070|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
138194071|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194072|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194078|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138194079|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
138194080|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194082|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138194083|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
138194084|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
138194085|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138194086|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138194088|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194089|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194090|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194091|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194092|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138194093|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138194094|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138194095|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138194096|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194097|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194098|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194100|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
138194103|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194104|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
138194105|NCT01455506|Fludarabine|fludarabine|mesh-list
138194107|NCT01455506|Decitabine|decitabine|mesh-list
138194108|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194109|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138194111|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194113|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
138194116|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138194117|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138194118|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194119|NCT02564796|Iron|iron|mesh-list
138194120|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
138194121|NCT02564796|Trace Elements|trace elements|mesh-ancestor
138194122|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
138194123|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194124|NCT02564796|Hematinics|hematinics|mesh-ancestor
138194130|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194131|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138194132|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138194133|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194134|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138194135|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
138194136|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
138194137|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
138194138|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
138194139|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194140|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194141|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138194142|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194143|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138194144|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194146|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194147|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194148|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194149|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194151|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138194152|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
138194153|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138194154|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
138194155|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194159|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194160|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138194162|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194163|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194164|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138194165|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138194166|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
138194167|NCT01453946|Hormones|hormones|mesh-ancestor
138194168|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194171|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194172|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138194173|NCT01455896|Incretins|incretins|mesh-ancestor
138194174|NCT01455896|Hormones|hormones|mesh-ancestor
138194175|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194176|NCT05562882|Daratumumab|daratumumab|mesh-list
138194177|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194178|NCT05560542|Dexamethasone|dexamethasone|mesh-list
138194180|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194181|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
138194182|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
138194183|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194184|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194186|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
138194188|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194189|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138194190|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194191|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138194192|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138194193|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138194194|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138194196|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
138194197|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
138194198|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138194199|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138194200|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
138194201|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194202|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194204|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138194205|NCT05560308|Trastuzumab|trastuzumab|mesh-list
138194206|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138194207|NCT05560308|Maytansine|maytansine|mesh-list
138194208|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194209|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194210|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194211|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138194212|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194213|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194214|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194216|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
138194217|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
138194218|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194220|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
138194221|NCT01456208|Giapreza|giapreza|mesh-list
138194222|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
138194223|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194224|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194225|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194226|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194227|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194231|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194232|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138194233|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138194235|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194238|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194239|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194241|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
138194242|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
138194244|NCT03780010|Carboplatin|carboplatin|mesh-list
138194245|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138194246|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194247|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194248|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194249|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194250|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194252|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194253|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194256|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194257|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194258|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194259|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194260|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194262|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194264|NCT05325762|Propofol|propofol|mesh-list
138194265|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138194266|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194267|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194268|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194270|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
138194271|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194272|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138194273|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194274|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194275|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194276|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194277|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194279|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
138194280|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
138194283|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138194284|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194285|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138194286|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138194288|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138194290|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194291|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194292|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194295|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
138194296|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138194297|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194298|NCT01456364|Ticagrelor|ticagrelor|mesh-list
138194299|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138194300|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194302|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138194303|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138194304|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
138194305|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194306|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194307|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194310|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
138194311|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194312|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138194313|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
138194314|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
138194315|NCT04281420|Vitamins|vitamins|mesh-ancestor
138194316|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
138194317|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194318|NCT03765502|Glucagon|glucagon|mesh-list
138194319|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138194329|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194330|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194331|NCT01450046|Vitamin E|vitamin e|mesh-list
138194332|NCT01450046|Tocopherols|tocopherols|mesh-list
138194333|NCT01450046|Tocotrienols|tocotrienols|mesh-list
138194334|NCT01450046|Vitamins|vitamins|mesh-ancestor
138194347|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194348|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194349|NCT03751124|Norethindrone|norethindrone|mesh-list
138194350|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
138194351|NCT03751124|Estradiol|estradiol|mesh-list
138194352|NCT03751124|Relugolix|relugolix|mesh-list
138194353|NCT03751124|Estrogens|estrogens|mesh-ancestor
138194354|NCT03751124|Hormones|hormones|mesh-ancestor
138194355|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194357|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138194358|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
138194359|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138194360|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138194361|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138194362|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138194363|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138194365|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138194366|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
138194367|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194368|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194369|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194370|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194371|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138194372|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194373|NCT04081324|Lasmiditan|lasmiditan|mesh-list
138194374|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138194375|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
138194376|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194377|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194378|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194382|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194383|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138194384|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138194386|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138194388|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138194390|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194391|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194392|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194393|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
138194394|NCT04842422|Imiquimod|imiquimod|mesh-list
138194395|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138194396|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
138194397|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194398|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194399|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
138194401|NCT04066426|Dexamethasone|dexamethasone|mesh-list
138194402|NCT04066426|Naproxen|naproxen|mesh-list
138194403|NCT04066426|Codeine|codeine|mesh-list
138194405|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
138194406|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
138194407|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194408|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194409|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194411|NCT04066426|Hormones|hormones|mesh-ancestor
138194413|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138194414|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194415|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194416|NCT04066426|Analgesics|analgesics|mesh-ancestor
138194417|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
138194418|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
138194419|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194420|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194421|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
138194422|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194423|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194424|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194427|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194428|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
138194429|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
138194430|NCT01450514|Pipamperone|pipamperone|mesh-list
138194431|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138194432|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
138194433|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194434|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194435|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194436|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138194437|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138194439|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194440|NCT04758728|Epinephrine|epinephrine|mesh-list
138194441|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194443|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194444|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194445|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194454|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
138194456|NCT02559570|Linaclotide|linaclotide|mesh-list
138194457|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138194458|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
138194459|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194460|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194461|NCT04051684|Ropivacaine|ropivacaine|mesh-list
138194462|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
138194464|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194465|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194466|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
138194467|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194468|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
138194469|NCT04840238|Vitamin D|vitamin d|mesh-list
138194472|NCT04840238|Vitamins|vitamins|mesh-ancestor
138194473|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
138194474|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138194475|NCT03829618|Lidocaine|lidocaine|mesh-list
138194476|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
138194482|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138194483|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138194484|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138194485|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138194486|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194488|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138194490|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138194491|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194492|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194493|NCT01457690|Tocopherols|tocopherols|mesh-list
138194495|NCT01457690|Tocotrienols|tocotrienols|mesh-list
138194500|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194502|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
138194503|NCT05497206|Metronidazole|metronidazole|mesh-list
138194504|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194505|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138194506|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138194507|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138194508|NCT01451060|Ephedrine|ephedrine|mesh-list
138194509|NCT01451060|Metaraminol|metaraminol|mesh-list
138194510|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138194511|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194512|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
138194513|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
138194517|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194518|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194519|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138194520|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194521|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194522|NCT01143181|Brincidofovir|brincidofovir|mesh-list
138194523|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
138194524|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194526|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
138194528|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138194529|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
138194530|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
138194531|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194532|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194533|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
138194535|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
138194536|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
138194537|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138194538|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194539|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194540|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194541|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194542|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194543|NCT01451294|Protective Agents|protective agents|mesh-ancestor
138194544|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138194545|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
138194549|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194550|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194551|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138194552|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
138194553|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194554|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194555|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138194558|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
138194559|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
138194560|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194561|NCT01224145|Bupivacaine|bupivacaine|mesh-list
138194562|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
138194563|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
138194564|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194565|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194566|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
138194569|NCT01451840|Remifentanil|remifentanil|mesh-list
138194570|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
138194571|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
138194572|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194573|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194574|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
138194575|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194576|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138194577|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138194580|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194582|NCT01451840|Narcotics|narcotics|mesh-ancestor
138194585|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
138194586|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194587|NCT01451918|Protective Agents|protective agents|mesh-ancestor
138194588|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194589|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194590|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194591|NCT00378196|Ranibizumab|ranibizumab|mesh-list
138194592|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138194593|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138194594|NCT00378196|Growth Substances|growth substances|mesh-ancestor
138194595|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194596|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
138194597|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194598|NCT01188109|Gemcitabine|gemcitabine|mesh-list
138194599|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194600|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138194601|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
138194602|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194603|NCT01458236|Beraprost|beraprost|mesh-list
138194604|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194605|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
138194606|NCT01146457|Morphine|morphine|mesh-list
138194607|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138194609|NCT01146457|Narcotics|narcotics|mesh-ancestor
138194610|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368099|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368100|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368101|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368102|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
138368103|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138194611|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194612|NCT01146457|Analgesics|analgesics|mesh-ancestor
138194614|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194616|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138194617|NCT05495958|Vitamins|vitamins|mesh-ancestor
138194621|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138194623|NCT04011592|Analgesics|analgesics|mesh-ancestor
138194624|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
138194625|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194626|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194627|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138194628|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138194629|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
138194630|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
138194631|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194633|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138194634|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194635|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194636|NCT01458470|Memantine|memantine|mesh-list
138194637|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138194638|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138194639|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
138194640|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194641|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194642|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194643|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138194644|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138194646|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
138194647|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
138194648|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194649|NCT01452542|Eliglustat|eliglustat|mesh-list
138194650|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194651|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194652|NCT01458548|Rituximab|rituximab|mesh-list
138194653|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194654|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194655|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
138194656|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194658|NCT05027204|Docetaxel|docetaxel|mesh-list
138194659|NCT05027204|Nivolumab|nivolumab|mesh-list
138194660|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194661|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194662|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194663|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194666|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194668|NCT01458626|Paroxetine|paroxetine|mesh-list
138194670|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138194671|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138194672|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194675|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194676|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138194677|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
138194678|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194679|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138194680|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138194684|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
138194685|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138194686|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138194687|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194689|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138194690|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138194691|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194692|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138194693|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138194694|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138194696|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194697|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194698|NCT00377806|Analgesics|analgesics|mesh-ancestor
138194699|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
138194700|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194701|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194702|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194707|NCT05495724|Tislelizumab|tislelizumab|mesh-list
138194708|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
138194709|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194711|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
138194712|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
138194713|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194715|NCT02559414|Clopidogrel|clopidogrel|mesh-list
138194716|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194718|NCT02559414|Analgesics|analgesics|mesh-ancestor
138194720|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194721|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194722|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194723|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194724|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138194725|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138194726|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194727|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194728|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194731|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138194732|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138194734|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
138194735|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194736|NCT03527264|Nivolumab|nivolumab|mesh-list
138194744|NCT04713904|Estradiol|estradiol|mesh-list
138194745|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138194746|NCT04713904|Estrogens|estrogens|mesh-ancestor
138194747|NCT04713904|Hormones|hormones|mesh-ancestor
138194748|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138194749|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194750|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138194751|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
138194752|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138194753|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138194754|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138194755|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138194757|NCT03995680|Piperazine|piperazine|mesh-list
138194759|NCT03995680|DMP 777|dmp 777|mesh-list
138194760|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
138194761|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
138194762|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138194763|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194765|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194766|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194767|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194768|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194769|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194770|NCT01452698|Lansoprazole|lansoprazole|mesh-list
138194771|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
138194772|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138194773|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194774|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138194776|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194777|NCT05029856|Vaccines|vaccines|mesh-list
138194778|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
138194779|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194780|NCT05490342|Antibodies|antibodies|mesh-list
138194781|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
138194782|NCT05490342|Paraproteins|paraproteins|mesh-list
138194783|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
138194784|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194785|NCT05495100|Azacitidine|azacitidine|mesh-list
138194786|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
138368113|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
138194787|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138194788|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
138194789|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194790|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194792|NCT05495100|Analgesics|analgesics|mesh-ancestor
138194793|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
138194794|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194795|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194796|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138194797|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138194799|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138194800|NCT03325114|Diuretics|diuretics|mesh-ancestor
138194801|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
138194802|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194803|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138194805|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194806|NCT01453400|Aspirin|aspirin|mesh-list
138194807|NCT01453400|Acetaminophen|acetaminophen|mesh-list
138194808|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194809|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194810|NCT01453400|Analgesics|analgesics|mesh-ancestor
138194811|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
138194812|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194813|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194814|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194815|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194816|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138194817|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138194818|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194819|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138194820|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194821|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194822|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
138194823|NCT05025644|Dobutamine|dobutamine|mesh-list
138194825|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
138194826|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
138194827|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194828|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194829|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138194831|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194832|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194834|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194835|NCT05025644|Protective Agents|protective agents|mesh-ancestor
138194837|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138194838|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194839|NCT03810066|Osimertinib|osimertinib|mesh-list
138194840|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194841|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194842|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194843|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194844|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
138194846|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
138194847|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138194848|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138194849|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
138194850|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194851|NCT00377494|Vaccines|vaccines|mesh-list
138194852|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
138194853|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194856|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194857|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194859|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
138194860|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194861|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194862|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194863|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138194864|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138194865|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138194866|NCT04390334|Efavirenz|efavirenz|mesh-list
138194867|NCT04390334|Famotidine|famotidine|mesh-list
138194868|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138194869|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138194870|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194871|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194872|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
138194873|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194874|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138194875|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138194877|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138194878|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138194879|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138194880|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138194881|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138194882|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138194883|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
138194884|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
138194888|NCT02880020|Ipilimumab|ipilimumab|mesh-list
138194889|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194890|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194891|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138194895|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138194896|NCT03150160|Brinzolamide|brinzolamide|mesh-list
138194897|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138194898|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138194899|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138194900|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138194901|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138194902|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
138194904|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194906|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138194907|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194909|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194911|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138194912|NCT05489952|Trace Elements|trace elements|mesh-ancestor
138194913|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
138194914|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194916|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
138194917|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138194918|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
138194919|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194921|NCT01459640|Protective Agents|protective agents|mesh-ancestor
138194922|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
138194923|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138194924|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194925|NCT01500772|Ribavirin|ribavirin|mesh-list
138194926|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138194927|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
138194928|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194930|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194931|NCT04272476|Fluoxetine|fluoxetine|mesh-list
138194932|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138194933|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138194934|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138194935|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194936|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194938|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194939|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138194940|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
138194941|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138194942|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138194947|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
138368121|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194948|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138194949|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138194950|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194951|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194953|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138194954|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
138194955|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138194960|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194961|NCT01890902|Analgesics|analgesics|mesh-ancestor
138194962|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
138194963|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194964|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194965|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194967|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194968|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194970|NCT04423926|Prednisolone|prednisolone|mesh-list
138194971|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
138194972|NCT04423926|Doxorubicin|doxorubicin|mesh-list
138194973|NCT04423926|Vincristine|vincristine|mesh-list
138194974|NCT04423926|Lenalidomide|lenalidomide|mesh-list
138194975|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138194976|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
138194977|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194978|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138194979|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138194980|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
138194981|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194982|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194983|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138194984|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138194985|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138194986|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138194987|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194988|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138194990|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194991|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138194992|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138194993|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138194994|NCT04423926|Growth Substances|growth substances|mesh-ancestor
138194995|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
138194996|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138194997|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
138194998|NCT04423926|Hormones|hormones|mesh-ancestor
138194999|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195000|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195002|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138195003|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195004|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195005|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195006|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
138195007|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195008|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138195009|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195012|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195013|NCT00378820|Caseins|caseins|mesh-list
138195014|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
138195015|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
138195016|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195017|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138195019|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138195020|NCT04758260|Antioxidants|antioxidants|mesh-list
138195021|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195022|NCT04758260|Protective Agents|protective agents|mesh-ancestor
138195023|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195026|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
138195027|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195028|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
138195029|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195030|NCT05493618|Dexamethasone|dexamethasone|mesh-list
138195031|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
138195032|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195033|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
138195034|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
138195035|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195036|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195037|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195038|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
138195040|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195041|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195044|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138195045|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195046|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
138195047|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195048|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195050|NCT02936206|Fulvestrant|fulvestrant|mesh-list
138195051|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138195052|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
138195053|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195054|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195055|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195057|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138195058|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138195059|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138195060|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138195063|NCT01891526|Isotretinoin|isotretinoin|mesh-list
138195064|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195065|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
138195066|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
138195068|NCT01406860|Promethazine|promethazine|mesh-list
138195069|NCT01406860|Droperidol|droperidol|mesh-list
138195070|NCT01406860|Metoclopramide|metoclopramide|mesh-list
138195071|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138195072|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138195073|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195074|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195076|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
138195078|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195079|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
138195082|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138195083|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
138195085|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195087|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138195089|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
138195090|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138195091|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138195092|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
138195093|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138195094|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138195095|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138195097|NCT04138212|Paclitaxel|paclitaxel|mesh-list
138195098|NCT04138212|Cisplatin|cisplatin|mesh-list
138195099|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138195100|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195101|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
138195102|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
138195104|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195105|NCT02773576|Risperidone|risperidone|mesh-list
138195106|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138195107|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
138195108|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195109|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195110|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195111|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138195112|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138195113|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195114|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138195115|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138195116|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
138195117|NCT05021978|Pramoxine|pramoxine|mesh-list
138195120|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195121|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195123|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195124|NCT04280406|Azithromycin|azithromycin|mesh-list
138195125|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138195126|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195127|NCT05599828|Sotorasib|sotorasib|mesh-list
138195128|NCT05599828|Omeprazole|omeprazole|mesh-list
138195129|NCT05599828|Famotidine|famotidine|mesh-list
138195131|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195132|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138195133|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195134|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195135|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138195136|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138195137|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
138195138|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195139|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195140|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138195141|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195142|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195143|NCT01350232|Cytarabine|cytarabine|mesh-list
138195147|NCT01350232|Bortezomib|bortezomib|mesh-list
138195149|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
138195151|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195152|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138195153|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
138195156|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138195157|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195158|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195159|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
138195160|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
138195161|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195162|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
138195163|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138195164|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195165|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195166|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195167|NCT05493228|Analgesics|analgesics|mesh-ancestor
138195168|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
138195169|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195170|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138195171|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138195177|NCT02758132|Prednisone|prednisone|mesh-list
138195178|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195179|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
138195180|NCT02758132|Hormones|hormones|mesh-ancestor
138195181|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195182|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195183|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195184|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195185|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138195186|NCT01891916|Caseins|caseins|mesh-list
138195187|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
138195188|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
138195189|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195193|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195195|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
138195196|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195198|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
138195199|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
138195200|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
138195201|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195203|NCT05499234|Meperidine|meperidine|mesh-list
138195204|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195205|NCT05499234|Analgesics|analgesics|mesh-ancestor
138195207|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195208|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195212|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368141|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195213|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138195215|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138195218|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
138195219|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
138195220|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195221|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195222|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138195223|NCT01269034|Incretins|incretins|mesh-ancestor
138195225|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195227|NCT05599126|Mianserin|mianserin|mesh-list
138195228|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
138195229|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
138195230|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
138195231|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195232|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195233|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195234|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138195235|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195236|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138195237|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138195238|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138195239|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
138195242|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195243|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138195244|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138195245|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195246|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138195247|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
138195248|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
138195250|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
138195251|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138195252|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
138195253|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
138195254|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138195255|NCT01892150|Protective Agents|protective agents|mesh-ancestor
138195256|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195260|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
138195261|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
138195262|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195263|NCT01253668|Antibodies|antibodies|mesh-list
138195264|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138195265|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
138195266|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195269|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
138195270|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195271|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
138195272|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195273|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138195274|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138195275|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138195276|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195277|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195278|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138195279|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138195281|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
138195283|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195284|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138195285|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138195288|NCT05586620|Mitomycin|mitomycin|mesh-list
138195289|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138195290|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195291|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
138195292|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195293|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138195294|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195295|NCT01893788|Eplerenone|eplerenone|mesh-list
138195297|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
138195298|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195299|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195300|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138195301|NCT01893788|Diuretics|diuretics|mesh-ancestor
138195303|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138195304|NCT01231750|Capsaicin|capsaicin|mesh-list
138195305|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
138195306|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138195307|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
138195308|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195309|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195313|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138195314|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
138195315|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138195318|NCT05488860|Hormones|hormones|mesh-ancestor
138195319|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195320|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195321|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195322|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
138195323|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195325|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368142|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138368143|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138368144|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138368146|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368147|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138368148|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138368149|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138368150|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138368151|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138368152|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138368153|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368155|NCT05064137|Fluorides|fluorides|mesh-list
138368156|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
138368157|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
138368158|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
138368159|NCT05064137|Protective Agents|protective agents|mesh-ancestor
138368160|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368161|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138368162|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368164|NCT05052528|Rituximab|rituximab|mesh-list
138368165|NCT05052528|Fludarabine|fludarabine|mesh-list
138368166|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
138368182|NCT05051150|Epinephrine|epinephrine|mesh-list
138368183|NCT05051150|Racepinephrine|racepinephrine|mesh-list
138368184|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
138368185|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368186|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368187|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368188|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368189|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368197|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
138195327|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195328|NCT02549716|Analgesics|analgesics|mesh-ancestor
138195329|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
138195330|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195331|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195332|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
138195333|NCT01207726|Azacitidine|azacitidine|mesh-list
138195334|NCT01207726|Entinostat|entinostat|mesh-list
138195335|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138195336|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195338|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195339|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368233|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368234|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
138368235|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368236|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138368237|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138368239|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138368240|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368241|NCT04870333|Ciclesonide|ciclesonide|mesh-list
138368242|NCT04870333|Sotrovimab|sotrovimab|mesh-list
138368243|NCT04870333|Niclosamide|niclosamide|mesh-list
138368244|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
138368245|NCT04870333|Hormones|hormones|mesh-ancestor
138368246|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368250|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368251|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
138368252|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138368253|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
138368254|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138368255|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
138368257|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368258|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368259|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368260|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368275|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
138368276|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138368277|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368290|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368291|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
138368292|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368293|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368294|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
138368295|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368296|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368297|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368298|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368299|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368345|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
138368346|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368347|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
138368348|NCT04399746|Vitamin D|vitamin d|mesh-list
138368349|NCT04399746|Azithromycin|azithromycin|mesh-list
138368350|NCT04399746|Ivermectin|ivermectin|mesh-list
138368351|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138368352|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368416|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368492|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368493|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138368494|NCT03704285|Propofol|propofol|mesh-list
138368495|NCT03704285|Anesthetics|anesthetics|mesh-list
138368496|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
138368497|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138368498|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368562|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368563|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368564|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368565|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368566|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
138368567|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138368568|NCT03328676|Protective Agents|protective agents|mesh-ancestor
138368569|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368570|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138368571|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138195341|NCT02534038|Quinidine|quinidine|mesh-list
138195342|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
138195343|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
138195345|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138195346|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138195347|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195348|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195349|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195350|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138368625|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
138368626|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138368627|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138368628|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138368629|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368630|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368631|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
138368688|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368689|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368690|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368691|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
138368692|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138368693|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
138368694|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368696|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138368756|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138368757|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368758|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368759|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138368760|NCT03011775|Diuretics|diuretics|mesh-ancestor
138368761|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
138368762|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138368763|NCT02960997|Sirolimus|sirolimus|mesh-list
138368764|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138368765|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368772|NCT02924480|Lidocaine|lidocaine|mesh-list
138368816|NCT02810457|Carboplatin|carboplatin|mesh-list
138368817|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138368818|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368819|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368820|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368821|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368822|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368823|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368824|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138368878|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368879|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368880|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368881|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368882|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138368883|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
138368884|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368885|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138368893|NCT02539225|Paclitaxel|paclitaxel|mesh-list
138368942|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138368943|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138368945|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
138368946|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
138368947|NCT02293109|Rituximab|rituximab|mesh-list
138368948|NCT02293109|Doxorubicin|doxorubicin|mesh-list
138368949|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138368950|NCT02293109|Methotrexate|methotrexate|mesh-list
138368951|NCT02293109|Vincristine|vincristine|mesh-list
138368952|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138195351|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138195352|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195353|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138195355|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138195356|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138195357|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195358|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195359|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138195361|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
138195362|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138195363|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138195364|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369005|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369007|NCT01982630|Hormones|hormones|mesh-ancestor
138369008|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369009|NCT01951469|Pemetrexed|pemetrexed|mesh-list
138369010|NCT01951469|Gefitinib|gefitinib|mesh-list
138369011|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195365|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138195366|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138195367|NCT01202110|Propranolol|propranolol|mesh-list
138195368|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138195369|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138195370|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195371|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195372|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369065|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
138369066|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369067|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369068|NCT01595620|Dronabinol|dronabinol|mesh-list
138369069|NCT01595620|Capsaicin|capsaicin|mesh-list
138195373|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195374|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138195375|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138195376|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
138195378|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138195379|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
138195380|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138195381|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
138195383|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195384|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369129|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369130|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369131|NCT01354977|Resveratrol|resveratrol|mesh-list
138369132|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
138369134|NCT01354977|Protective Agents|protective agents|mesh-ancestor
138369190|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
138369191|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369192|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138369193|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138369194|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369195|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369196|NCT00678730|Hormones|hormones|mesh-ancestor
138369197|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369255|NCT01397500|Androgens|androgens|mesh-ancestor
138369256|NCT01397500|Hormones|hormones|mesh-ancestor
138369257|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369258|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369259|NCT01397513|Aspirin|aspirin|mesh-list
138369260|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138369261|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369262|NCT01397513|Analgesics|analgesics|mesh-ancestor
138369274|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
138369319|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
138369320|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138369321|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
138369322|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138369323|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
138369324|NCT01398072|Azithromycin|azithromycin|mesh-list
138369325|NCT01398072|Doxycycline|doxycycline|mesh-list
138369326|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369327|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369328|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138369336|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
138369381|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138369382|NCT01398267|Protective Agents|protective agents|mesh-ancestor
138369383|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369384|NCT01398293|Ritonavir|ritonavir|mesh-list
138369385|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
138369386|NCT01398293|Lactams|lactams|mesh-list
138369387|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138369388|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138369389|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138369431|NCT01398384|Protective Agents|protective agents|mesh-ancestor
138369432|NCT01398501|Sorafenib|sorafenib|mesh-list
138369433|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369434|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369435|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369436|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369437|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138369438|NCT01398592|Vildagliptin|vildagliptin|mesh-list
138369439|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369498|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138369499|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138369500|NCT01399216|Fucoidan|fucoidan|mesh-list
138369501|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138369502|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369503|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
138369504|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369505|NCT01399242|Everolimus|everolimus|mesh-list
138369506|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138369553|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369554|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369555|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369556|NCT01399645|Insulin|insulin|mesh-list
138369558|NCT01399645|Metformin|metformin|mesh-list
138369559|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
138369560|NCT01399645|Liraglutide|liraglutide|mesh-list
138369561|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369562|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369563|NCT01399645|Incretins|incretins|mesh-ancestor
138369564|NCT01399645|Hormones|hormones|mesh-ancestor
138369620|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369621|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
138369622|NCT01400217|Hormones|hormones|mesh-ancestor
138369623|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369624|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369625|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138369626|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
138369627|NCT01400256|Valsartan|valsartan|mesh-list
138369628|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138369632|NCT01400308|Mupirocin|mupirocin|mesh-list
138369685|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369686|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
138369687|NCT01400685|Rituximab|rituximab|mesh-list
138369688|NCT01400685|Lenalidomide|lenalidomide|mesh-list
138369689|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138369690|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138369691|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369692|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
138369694|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138369752|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369753|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369754|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138369755|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369756|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369757|NCT01400945|Pantoprazole|pantoprazole|mesh-list
138369758|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138369759|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369760|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138369761|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369762|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369763|NCT01401036|Umirolimus|umirolimus|mesh-list
138369811|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
138369812|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138369813|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
138369814|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369815|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369816|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369817|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138369818|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369865|NCT01402076|Midazolam|midazolam|mesh-list
138369866|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138369867|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138369868|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369869|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369870|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138369871|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369875|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
138369930|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138369931|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369932|NCT01402297|Analgesics|analgesics|mesh-ancestor
138369933|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
138369934|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369935|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369936|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369989|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138369990|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138369991|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
138369993|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138369994|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369995|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
138369996|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138369997|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
138369998|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
138369999|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370048|NCT01403285|Imiquimod|imiquimod|mesh-list
138370049|NCT01403285|Sargramostim|sargramostim|mesh-list
138370050|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370051|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
138370052|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370053|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370054|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138370055|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
138370057|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370115|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138370116|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138370117|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370118|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370119|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138370120|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
138370121|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370122|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370123|NCT01403415|Analgesics|analgesics|mesh-ancestor
138370124|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
138370125|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138370126|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138370128|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138370129|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
138370130|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370131|NCT01403506|Expectorants|expectorants|mesh-ancestor
138370132|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
138370133|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138370171|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370173|NCT01403818|Mitiglinide|mitiglinide|mesh-list
138370174|NCT01403818|Calcium|calcium|mesh-list
138370175|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138370176|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370177|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138370178|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370233|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370235|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
138370236|NCT01404156|Leucovorin|leucovorin|mesh-list
138370237|NCT01404156|Paclitaxel|paclitaxel|mesh-list
138370238|NCT01404156|Docetaxel|docetaxel|mesh-list
138370239|NCT01404156|Carboplatin|carboplatin|mesh-list
138370240|NCT01404156|Fluorouracil|fluorouracil|mesh-list
138370241|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
138370242|NCT01404156|Epirubicin|epirubicin|mesh-list
138370243|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138370244|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370300|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370301|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370302|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370304|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
138370305|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370306|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370307|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138370321|NCT01404442|Midazolam|midazolam|mesh-list
138370355|NCT01404507|Abciximab|abciximab|mesh-list
138370356|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
138370357|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138370358|NCT01404598|Naproxen|naproxen|mesh-list
138370359|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138370360|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138370361|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138370362|NCT01404598|Analgesics|analgesics|mesh-ancestor
138370363|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
138370364|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370365|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370366|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370367|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370368|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
138370369|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138370370|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370411|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138370412|NCT01404702|Analgesics|analgesics|mesh-ancestor
138370413|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
138370414|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370415|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370416|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138370417|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138370418|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
138195385|NCT02556918|Incretins|incretins|mesh-ancestor
138195386|NCT02556918|Hormones|hormones|mesh-ancestor
138195387|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195388|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138195389|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138195390|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195391|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195392|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138195393|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
138195394|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138195395|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138195396|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195397|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195398|NCT00379756|Urological Agents|urological agents|mesh-ancestor
138370478|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138370538|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
138370539|NCT01405157|Hormones|hormones|mesh-ancestor
138370540|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370541|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138370542|NCT01405157|Protective Agents|protective agents|mesh-ancestor
138370543|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138370544|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370545|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
138370548|NCT01405170|Prednisolone|prednisolone|mesh-list
138370600|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138370601|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138370603|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138370604|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370605|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138370606|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138370607|NCT01405430|Growth Substances|growth substances|mesh-ancestor
138370609|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
138370663|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370664|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138370665|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
138370666|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370667|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370668|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138370674|NCT01406002|Rifampin|rifampin|mesh-list
138370725|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138370726|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138370727|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370728|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370729|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138370730|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138370731|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138370732|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138370733|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
138370788|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370789|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138370791|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138370792|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
138370793|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370794|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138370795|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
138370797|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
138370798|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138370799|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138370850|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370851|NCT01407016|Metronidazole|metronidazole|mesh-list
138370852|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370853|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370854|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138370855|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138370924|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138370925|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370933|NCT01408004|Everolimus|everolimus|mesh-list
138370998|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371075|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138371076|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
138371147|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138371148|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371151|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
138371222|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
138371223|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
138371224|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371296|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138371370|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371372|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371449|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
138371532|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
138195399|NCT02518750|Cytarabine|cytarabine|mesh-list
138195400|NCT02518750|Dexamethasone|dexamethasone|mesh-list
138195402|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
138195403|NCT02518750|Methotrexate|methotrexate|mesh-list
138195404|NCT02518750|Etoposide|etoposide|mesh-list
138195405|NCT02518750|Vincristine|vincristine|mesh-list
138195406|NCT02518750|Bortezomib|bortezomib|mesh-list
138195407|NCT02518750|Asparaginase|asparaginase|mesh-list
138195408|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
138195409|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
138195410|NCT02518750|Clofarabine|clofarabine|mesh-list
138195411|NCT02518750|Panobinostat|panobinostat|mesh-list
138195412|NCT02518750|Pegaspargase|pegaspargase|mesh-list
138195413|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195414|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
138371675|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371741|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138371742|NCT01413477|Vitamins|vitamins|mesh-ancestor
138371743|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
138371744|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138371745|NCT01413490|Rimantadine|rimantadine|mesh-list
138371746|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
138371749|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371811|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138195415|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195416|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195417|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138195418|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
138195419|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195420|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195421|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138195422|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195424|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
138195425|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371887|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371889|NCT01415011|Afatinib|afatinib|mesh-list
138195426|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195427|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
138195429|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195430|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195431|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138195432|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
138195433|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138195434|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195435|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
138195436|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138195437|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195438|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138195439|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138372029|NCT01415765|Hormones|hormones|mesh-ancestor
138372030|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195440|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138195441|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138195442|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138195445|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138195446|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138195447|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195449|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
138195450|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138195454|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138195455|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138195456|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
138195457|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372087|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138195458|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195460|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138195461|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
138195462|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195463|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138195464|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138195465|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138195466|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138195467|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138195468|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138195469|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138372152|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195470|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138195471|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138195472|NCT01182610|Paclitaxel|paclitaxel|mesh-list
138195473|NCT01182610|Carboplatin|carboplatin|mesh-list
138195474|NCT01182610|Fluorouracil|fluorouracil|mesh-list
138195475|NCT01182610|Panitumumab|panitumumab|mesh-list
138195476|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138195477|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195478|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138195479|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138195480|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195481|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195483|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195484|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195485|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
138195486|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195487|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195488|NCT05491902|Flutemetamol|flutemetamol|mesh-list
138195490|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195492|NCT05485896|Lenvatinib|lenvatinib|mesh-list
138195493|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195494|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195495|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138195496|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195500|NCT05507398|Atorvastatin|atorvastatin|mesh-list
138195501|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195502|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195504|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138342035|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195506|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195507|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138195508|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138195509|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195511|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138195512|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138195513|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
138195514|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195515|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372278|NCT01417429|Nicotine|nicotine|mesh-list
138372279|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138372280|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
138195516|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195518|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
138195519|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195520|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
138195521|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195522|NCT05485272|Fluorides|fluorides|mesh-list
138195523|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
138195524|NCT05485272|Protective Agents|protective agents|mesh-ancestor
138195525|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195527|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138195528|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138195529|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
138195530|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195532|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138195533|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138372329|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195534|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
138195535|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195536|NCT02317276|Triamcinolone|triamcinolone|mesh-list
138195537|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138195538|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138195540|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195541|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
138195542|NCT02317276|Hormones|hormones|mesh-ancestor
138195543|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372391|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
138195544|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195545|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195546|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
138195547|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195548|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195549|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
138195550|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138195551|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138195554|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195555|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
138195556|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195557|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195558|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138195560|NCT00378976|Valacyclovir|valacyclovir|mesh-list
138195561|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
138195562|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195563|NCT02297230|Paclitaxel|paclitaxel|mesh-list
138195564|NCT02297230|Capecitabine|capecitabine|mesh-list
138372462|NCT01418443|Pantoprazole|pantoprazole|mesh-list
138195565|NCT02297230|Trastuzumab|trastuzumab|mesh-list
138195566|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138195567|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195568|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138195570|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195571|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195572|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195573|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
138195574|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195575|NCT02282332|Ticagrelor|ticagrelor|mesh-list
138195576|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138195577|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138195578|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138195579|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138195581|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372515|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195583|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195584|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138195585|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138195586|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195587|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
138195588|NCT02253394|Ambrisentan|ambrisentan|mesh-list
138195589|NCT02253394|Spironolactone|spironolactone|mesh-list
138195590|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138195591|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
138195592|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195593|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372573|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138372577|NCT01419119|Vitamin D|vitamin d|mesh-list
138195594|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138195595|NCT02253394|Diuretics|diuretics|mesh-ancestor
138195596|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
138195597|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138195598|NCT05479032|Amantadine|amantadine|mesh-list
138195599|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138195600|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138195601|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
138195602|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195603|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
138195604|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195605|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195607|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195608|NCT05479032|Analgesics|analgesics|mesh-ancestor
138195609|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
138195610|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195611|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
138195612|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138195613|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138195614|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195615|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
138195618|NCT05484648|Dexamethasone|dexamethasone|mesh-list
138372706|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372707|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138372712|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195619|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
138195620|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195621|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
138195622|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
138195623|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195624|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195625|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195626|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
138195627|NCT05484648|Hormones|hormones|mesh-ancestor
138195628|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372768|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138372769|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138195629|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195630|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195631|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138195633|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195635|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
138195636|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138195637|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138372834|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372844|NCT01421043|Triazolam|triazolam|mesh-list
138195638|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138195639|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195640|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195641|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195642|NCT02137096|Carboplatin|carboplatin|mesh-list
138195643|NCT02137096|Etoposide|etoposide|mesh-list
138195644|NCT02137096|Ifosfamide|ifosfamide|mesh-list
138195645|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
138195646|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195647|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138195648|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138195649|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372904|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372905|NCT01421368|Tenofovir|tenofovir|mesh-list
138372906|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138195650|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195651|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195652|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138195654|NCT02130622|Promethazine|promethazine|mesh-list
138195655|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
138195656|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
138195657|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138195658|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138195659|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
138195660|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
138195661|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195662|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195663|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195665|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138195666|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138195667|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195669|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
138195670|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
138195671|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195672|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
138195673|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
138195674|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195675|NCT02134912|Pemetrexed|pemetrexed|mesh-list
138195676|NCT02134912|Crizotinib|crizotinib|mesh-list
138195677|NCT02134912|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138372965|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372967|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
138195678|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195679|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195680|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195682|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138195684|NCT02094352|Ketamine|ketamine|mesh-list
138195685|NCT02094352|Analgesics|analgesics|mesh-ancestor
138195686|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
138195687|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195689|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138195690|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138195691|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
138195692|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
138195693|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195694|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138195695|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138195696|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195697|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195698|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
138373016|NCT01422109|Aspirin|aspirin|mesh-list
138195700|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195703|NCT01188421|Tramadol|tramadol|mesh-list
138195704|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138195705|NCT01188421|Naloxone|naloxone|mesh-list
138195706|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138195707|NCT01188421|Narcotics|narcotics|mesh-ancestor
138195708|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195709|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195710|NCT01188421|Analgesics|analgesics|mesh-ancestor
138195711|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
138195712|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195713|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138195714|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138195715|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
138195716|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
138195717|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138195718|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138195719|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138195720|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195721|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195722|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195723|NCT01006018|Pioglitazone|pioglitazone|mesh-list
138195724|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138373070|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
138373071|NCT01422330|Etravirine|etravirine|mesh-list
138373078|NCT01422460|Mitogens|mitogens|mesh-list
138195725|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195726|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195727|NCT01006018|Incretins|incretins|mesh-ancestor
138195729|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195730|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138195731|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
138195732|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195738|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195739|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195740|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138195741|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138195742|NCT00996502|Growth Substances|growth substances|mesh-ancestor
138195743|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195744|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373127|NCT01422616|Analgesics|analgesics|mesh-ancestor
138195745|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
138195746|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
138195747|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
138195748|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195749|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195750|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
138195751|NCT00996502|Hormones|hormones|mesh-ancestor
138195752|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373189|NCT01423019|Synephrine|synephrine|mesh-list
138195753|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195754|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138195755|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195756|NCT00984490|Metformin|metformin|mesh-list
138195757|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138195758|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195759|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138195760|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195761|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195762|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195763|NCT02027272|Dexamethasone|dexamethasone|mesh-list
138195764|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
138195765|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195766|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
138373252|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
138195767|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
138195768|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195769|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195770|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195771|NCT02027272|Hormones|hormones|mesh-ancestor
138195772|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195773|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195774|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195775|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
138195776|NCT05475444|Chitosan|chitosan|mesh-list
138195777|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138195778|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195779|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138195780|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138216074|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373313|NCT01423695|Paclitaxel|paclitaxel|mesh-list
138195782|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195783|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195784|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138195785|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138195787|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138195788|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
138195789|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138195790|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
138195791|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
138195793|NCT05475444|Coagulants|coagulants|mesh-ancestor
138195794|NCT03472092|Amitriptyline|amitriptyline|mesh-list
138195795|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138195796|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
138195797|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138195798|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138195800|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
138195801|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195802|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195804|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138195805|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138195806|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373373|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138195807|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195808|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195809|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
138195810|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195811|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
138195812|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138195813|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138195814|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195815|NCT01996852|Urological Agents|urological agents|mesh-ancestor
138195817|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
138195818|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138216075|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373423|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
138373424|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195819|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195820|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195821|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195822|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195823|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138195824|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138195825|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195828|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195829|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
138195830|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195831|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373485|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195832|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195833|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138195834|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138195835|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138195836|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138195837|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
138195838|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195839|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138195840|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138195842|NCT01973062|Rituximab|rituximab|mesh-list
138195843|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138195844|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195860|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
138195861|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195862|NCT00979810|Alovudine|alovudine|mesh-list
138195863|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
138373550|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195864|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195865|NCT00947284|Nalbuphine|nalbuphine|mesh-list
138195866|NCT00947284|Naloxone|naloxone|mesh-list
138195868|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195869|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
138195870|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195871|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138195872|NCT00947284|Narcotics|narcotics|mesh-ancestor
138195873|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195874|NCT00947284|Analgesics|analgesics|mesh-ancestor
138195875|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138195877|NCT00932152|Fulvestrant|fulvestrant|mesh-list
138195878|NCT00932152|Anastrozole|anastrozole|mesh-list
138195879|NCT00932152|Analgesics|analgesics|mesh-list
138195880|NCT00932152|Antiemetics|antiemetics|mesh-list
138373606|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
138195881|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195882|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195883|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138195884|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138195885|NCT00932152|Growth Substances|growth substances|mesh-ancestor
138195886|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195888|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138195889|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138195890|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138373666|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138195892|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
138195893|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195894|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138195895|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138195896|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195897|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195898|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
138195899|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195900|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
138195901|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373733|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373734|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373798|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
138373807|NCT05386121|Meperidine|meperidine|mesh-list
138195902|NCT01916590|Bupivacaine|bupivacaine|mesh-list
138195903|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
138195905|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195906|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195907|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
138195908|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195909|NCT01890694|Tolvaptan|tolvaptan|mesh-list
138195910|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138195911|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195912|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
138195913|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195916|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
138195917|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195918|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195919|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
138195920|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195921|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138373873|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373877|NCT05379374|Morphine|morphine|mesh-list
138195922|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
138195923|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138195924|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138195925|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195926|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138195927|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
138195928|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138195929|NCT03428958|Leucovorin|leucovorin|mesh-list
138195930|NCT03428958|Bevacizumab|bevacizumab|mesh-list
138195931|NCT03428958|Cetuximab|cetuximab|mesh-list
138195932|NCT03428958|Panitumumab|panitumumab|mesh-list
138195933|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
138195934|NCT03428958|Irinotecan|irinotecan|mesh-list
138195935|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
138195937|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195938|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138373933|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138195939|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138195940|NCT03428958|Growth Substances|growth substances|mesh-ancestor
138195941|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195942|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
138195943|NCT03428958|Antidotes|antidotes|mesh-ancestor
138195948|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138195951|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195952|NCT01844206|Morphine|morphine|mesh-list
138195953|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138195954|NCT01844206|Narcotics|narcotics|mesh-ancestor
138373994|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138373995|NCT04072146|Varenicline|varenicline|mesh-list
138195955|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195956|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195957|NCT01844206|Analgesics|analgesics|mesh-ancestor
138195958|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
138195959|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195960|NCT03626454|Norepinephrine|norepinephrine|mesh-list
138195961|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138195962|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138195963|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138195964|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195965|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195966|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195967|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195968|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
138195970|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195971|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138195972|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
138195973|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195974|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138195975|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138195976|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138195977|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195978|NCT01830790|Urological Agents|urological agents|mesh-ancestor
138195979|NCT01662102|Rituximab|rituximab|mesh-list
138195980|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138195981|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195982|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
138195983|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374120|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138195984|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138195985|NCT03950076|Edoxaban|edoxaban|mesh-list
138195986|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138195988|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138195989|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138195990|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195991|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195992|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
138195993|NCT05292976|Albuterol|albuterol|mesh-list
138195994|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
138195995|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138195996|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
138195997|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195998|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195999|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138196000|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
138196001|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
138196002|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138196003|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138216076|NCT02997800|Labetalol|labetalol|mesh-list
138374246|NCT01426490|Folic Acid|folic acid|mesh-list
138374247|NCT01426490|Pyridoxine|pyridoxine|mesh-list
138374248|NCT01426490|Pyridoxal|pyridoxal|mesh-list
138196004|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138196005|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138196006|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
138196007|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196008|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196009|NCT05292976|Miotics|miotics|mesh-ancestor
138196010|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138196011|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138196012|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138374311|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374318|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
138196018|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138196020|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196021|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
138196023|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138196024|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138196025|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
138196026|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196028|NCT00843310|Lenalidomide|lenalidomide|mesh-list
138196029|NCT00843310|Melphalan|melphalan|mesh-list
138196030|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196031|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
138196032|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
138196033|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374372|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374373|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
138374374|NCT01427114|Hormones|hormones|mesh-ancestor
138374375|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374376|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374377|NCT01427192|Acetazolamide|acetazolamide|mesh-list
138374378|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
138374379|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138374380|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374381|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374382|NCT01427192|Diuretics|diuretics|mesh-ancestor
138374383|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
138374384|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374385|NCT01427205|Cetuximab|cetuximab|mesh-list
138374386|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374387|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374388|NCT01427244|Trastuzumab|trastuzumab|mesh-list
138374389|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374390|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374391|NCT01427270|Oxycodone|oxycodone|mesh-list
138374392|NCT01427270|Naloxone|naloxone|mesh-list
138196034|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196036|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
138196037|NCT00843310|Hormones|hormones|mesh-ancestor
138196038|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196039|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138196040|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196041|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
138196042|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196043|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196044|NCT00843310|Growth Substances|growth substances|mesh-ancestor
138196045|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196046|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138196047|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
138196048|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196049|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138196050|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196051|NCT00809458|Vitamin E|vitamin e|mesh-list
138196052|NCT00809458|Tocopherols|tocopherols|mesh-list
138196053|NCT00809458|Tocotrienols|tocotrienols|mesh-list
138196054|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
138196055|NCT00809458|Vitamins|vitamins|mesh-ancestor
138196056|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
138196057|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196058|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
138196059|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196060|NCT00809458|Protective Agents|protective agents|mesh-ancestor
138196061|NCT01701622|Febuxostat|febuxostat|mesh-list
138196065|NCT01675960|Analgesics|analgesics|mesh-ancestor
138196066|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
138196067|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196068|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196069|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
138196070|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138196071|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138196072|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196073|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138196074|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138196075|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138196076|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196077|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196078|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
138196079|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138196080|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138196081|NCT01607320|Clomiphene|clomiphene|mesh-list
138196082|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
138196083|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138196084|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
138196085|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196086|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196087|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138196088|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
138196089|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138196090|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138196091|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138196092|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138196094|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138196095|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138196096|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138196097|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196098|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138196099|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138196101|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138196103|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
138196105|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196106|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196107|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
138196108|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196109|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138196110|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138196111|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138196112|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196113|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196115|NCT01602016|Folic Acid|folic acid|mesh-list
138196116|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
138196117|NCT01602016|Antidotes|antidotes|mesh-ancestor
138196118|NCT01602016|Protective Agents|protective agents|mesh-ancestor
138196119|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196120|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
138196121|NCT01602016|Vitamins|vitamins|mesh-ancestor
138196122|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
138196123|NCT01602016|Hematinics|hematinics|mesh-ancestor
138196124|NCT00731770|Fluticasone|fluticasone|mesh-list
138196126|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138196127|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138196128|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196129|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138196131|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196132|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196133|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138196134|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
138196135|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138196136|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138196137|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138196138|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138196139|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138196140|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216077|NCT02997800|Fentanyl|fentanyl|mesh-list
138196141|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196142|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196143|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
138196144|NCT00731770|Hormones|hormones|mesh-ancestor
138196145|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196146|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
138196147|NCT00719914|Eptifibatide|eptifibatide|mesh-list
138196148|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138196149|NCT01566370|Zonisamide|zonisamide|mesh-list
138196150|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
138196151|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138196152|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196153|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196154|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138196155|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196157|NCT01558492|Carboplatin|carboplatin|mesh-list
138196158|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196159|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196160|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138196161|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138196162|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196163|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196164|NCT03579472|Halichondrin B|halichondrin b|mesh-list
138196165|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196167|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138196168|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138196170|NCT05286190|Bupivacaine|bupivacaine|mesh-list
138196171|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
138196172|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
138196173|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196174|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196176|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196177|NCT00691444|Melatonin|melatonin|mesh-list
138196179|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196180|NCT00691444|Protective Agents|protective agents|mesh-ancestor
138196181|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196182|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196184|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
138196185|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
138196186|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196187|NCT01530880|Acetaminophen|acetaminophen|mesh-list
138196188|NCT01530880|Ibuprofen|ibuprofen|mesh-list
138196189|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138196190|NCT01530880|Analgesics|analgesics|mesh-ancestor
138196191|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
138196192|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196193|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196194|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
138196195|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138196197|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196198|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138196199|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196200|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196201|NCT05482074|Olaparib|olaparib|mesh-list
138196202|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138196203|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196204|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196205|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196206|NCT00678574|Fluoxetine|fluoxetine|mesh-list
138196207|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138196208|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138196209|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196210|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196211|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196212|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
138196213|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196214|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138196215|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
138196216|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138196220|NCT02551692|Nicotine|nicotine|mesh-list
138196221|NCT02551692|Varenicline|varenicline|mesh-list
138196222|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138196223|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
138196224|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196225|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196227|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138196228|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
138196229|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196230|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196231|NCT00542542|Midazolam|midazolam|mesh-list
138196232|NCT00542542|Fentanyl|fentanyl|mesh-list
138196233|NCT00542542|Propofol|propofol|mesh-list
138196234|NCT00542542|Ropivacaine|ropivacaine|mesh-list
138196235|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138196236|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196237|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196238|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138196239|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
138196241|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
138196242|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
138196243|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196244|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138196245|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138196246|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138196247|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138196248|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
138196249|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
138196250|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196251|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196252|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138196253|NCT00542542|Narcotics|narcotics|mesh-ancestor
138196254|NCT00542542|Analgesics|analgesics|mesh-ancestor
138196255|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
138196256|NCT03333486|Fludarabine|fludarabine|mesh-list
138196257|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
138196259|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
138196260|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196261|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196262|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138196263|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
138196264|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196266|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138196267|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196268|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
138196269|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
138196270|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138196272|NCT02598778|Fluorides|fluorides|mesh-list
138196273|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
138196277|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138196278|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196279|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
138196280|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138196281|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
138196282|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138196283|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
138196284|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196285|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
138196287|NCT05476380|Paclitaxel|paclitaxel|mesh-list
138196288|NCT05476380|Cisplatin|cisplatin|mesh-list
138196289|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196290|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196291|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138196292|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138196293|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196294|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196295|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138196296|NCT00634972|Ketorolac|ketorolac|mesh-list
138196297|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138196298|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138196299|NCT00634972|Analgesics|analgesics|mesh-ancestor
138196300|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
138196301|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216078|NCT02997800|Esmolol|esmolol|mesh-list
138216079|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138216080|NCT02997800|Narcotics|narcotics|mesh-ancestor
138216081|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216103|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216104|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
138216107|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138216108|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138216109|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
138196302|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196303|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196304|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196305|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138196306|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196307|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196308|NCT00529282|Vancomycin|vancomycin|mesh-list
138196310|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
138196311|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138196312|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196313|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196314|NCT00623974|Teriparatide|teriparatide|mesh-list
138196315|NCT00623974|Calcitriol|calcitriol|mesh-list
138196316|NCT00623974|Calcium|calcium|mesh-list
138196317|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
138196318|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138196319|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196320|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138196321|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138196322|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196323|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196324|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138196328|NCT02550288|Ezetimibe|ezetimibe|mesh-list
138196329|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138196330|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138196331|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
138196332|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196333|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138196334|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138196335|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196337|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
138196338|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138196339|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
138196340|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138196341|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138196342|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196344|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196345|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196346|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138196347|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
138196349|NCT00500890|Etoposide|etoposide|mesh-list
138196350|NCT00500890|Vincristine|vincristine|mesh-list
138196351|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196352|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
138196353|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196354|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196355|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138196356|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
138196357|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196358|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196359|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138196360|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196362|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138196363|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196364|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138196365|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138196366|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196367|NCT00000736|Zidovudine|zidovudine|mesh-list
138196368|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
138196369|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196370|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196371|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196372|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196373|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
138196374|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196375|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196376|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196377|NCT00379522|Vasopressins|vasopressins|mesh-list
138196378|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
138196379|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
138196380|NCT00379522|Coagulants|coagulants|mesh-ancestor
138196383|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
138196384|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196385|NCT00421954|Ziprasidone|ziprasidone|mesh-list
138196386|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138196387|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
138196388|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196389|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196390|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196391|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138196392|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138196393|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196394|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138196395|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138196397|NCT01662336|Ritonavir|ritonavir|mesh-list
138196398|NCT01662336|Lopinavir|lopinavir|mesh-list
138196401|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196402|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196403|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196405|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196406|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
138196407|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196408|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138196409|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196410|NCT00000766|Ganciclovir|ganciclovir|mesh-list
138196411|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138196412|NCT00000766|Foscarnet|foscarnet|mesh-list
138196413|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138196414|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
138196415|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196416|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196417|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196418|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196419|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196420|NCT00000772|Ribavirin|ribavirin|mesh-list
138196421|NCT00000772|Didanosine|didanosine|mesh-list
138196422|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
138196423|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196424|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
138196425|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196426|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196427|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196428|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196429|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196430|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196431|NCT00572260|Daptomycin|daptomycin|mesh-list
138196432|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196433|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196434|NCT00000778|Pyridoxine|pyridoxine|mesh-list
138196435|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
138196436|NCT00000778|Levofloxacin|levofloxacin|mesh-list
138196437|NCT00000778|Isoniazid|isoniazid|mesh-list
138196438|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138196439|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196440|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196441|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138196442|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138196443|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196444|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196445|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196446|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138196447|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196448|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
138196449|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138196450|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138196451|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
138196452|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138196453|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
138196455|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
138196456|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196457|NCT00000796|Pyridoxine|pyridoxine|mesh-list
138196458|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
138196459|NCT00000796|Levofloxacin|levofloxacin|mesh-list
138196460|NCT00000796|Cycloserine|cycloserine|mesh-list
138196461|NCT00000796|Rifampin|rifampin|mesh-list
138196462|NCT00000796|Isoniazid|isoniazid|mesh-list
138196463|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
138196464|NCT00000796|Amikacin|amikacin|mesh-list
138196465|NCT00000796|Ethambutol|ethambutol|mesh-list
138196466|NCT00000796|Clofazimine|clofazimine|mesh-list
138196467|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138196468|NCT00000796|Streptomycin|streptomycin|mesh-list
138196469|NCT00000796|Ethionamide|ethionamide|mesh-list
138196470|NCT00000796|Capreomycin|capreomycin|mesh-list
138196471|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138196472|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196473|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196474|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138196475|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138196476|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196479|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138196480|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196481|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138196482|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
138196483|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
138196484|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196485|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138196486|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138196487|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138196488|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138196489|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138196490|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138196491|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138196493|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
138196494|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138196495|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
138196497|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
138196498|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196499|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196500|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138196503|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196504|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
138196505|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138196506|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138196507|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138196508|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196509|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196511|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196513|NCT02389946|Everolimus|everolimus|mesh-list
138196514|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138196515|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138196516|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196517|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196518|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196519|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
138196520|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196521|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196522|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196523|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196524|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138196525|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
138196526|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
138196527|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196528|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138196529|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196534|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196535|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196538|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196539|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196540|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138196541|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196542|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196543|NCT00268450|Growth Substances|growth substances|mesh-ancestor
138196544|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196545|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196546|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196548|NCT00000808|Nevirapine|nevirapine|mesh-list
138196550|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196551|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196552|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196553|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
138196554|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196555|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196556|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196557|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138196561|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196562|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196563|NCT00000814|Zidovudine|zidovudine|mesh-list
138196564|NCT00000814|Nevirapine|nevirapine|mesh-list
138196565|NCT00000814|Didanosine|didanosine|mesh-list
138196566|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
138196567|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196568|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196569|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196570|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196571|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
138196572|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196573|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196574|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196575|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138196576|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138196577|NCT02661932|Letrozole|letrozole|mesh-list
138196578|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196581|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196582|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196583|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138196584|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
138196585|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196586|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196588|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138196589|NCT00177970|Antibodies|antibodies|mesh-list
138196590|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
138196591|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
138196592|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138196593|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
138196594|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196595|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138196596|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
138196597|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196599|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138196600|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138196601|NCT00088972|Analgesics|analgesics|mesh-ancestor
138196602|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
138196603|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196604|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196605|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196606|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196607|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138196608|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138196609|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196610|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196611|NCT00089128|Gemcitabine|gemcitabine|mesh-list
138196612|NCT00089128|Irinotecan|irinotecan|mesh-list
138196613|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196614|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
138196615|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196616|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196617|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138196618|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138196619|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196620|NCT00000838|Lamivudine|lamivudine|mesh-list
138196621|NCT00000838|Zidovudine|zidovudine|mesh-list
138196622|NCT00000838|Stavudine|stavudine|mesh-list
138196623|NCT00000838|Didanosine|didanosine|mesh-list
138196624|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196625|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196626|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196629|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196630|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196631|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196632|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
138196633|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
138196634|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138196637|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138196639|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196641|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
138196642|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196643|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
138196644|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196645|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
138196646|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196647|NCT00014560|Antibodies|antibodies|mesh-list
138196648|NCT00014560|Sargramostim|sargramostim|mesh-list
138196649|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138196650|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
138196651|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196652|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
138196653|NCT00020722|Ifosfamide|ifosfamide|mesh-list
138196654|NCT00020722|Thiotepa|thiotepa|mesh-list
138196655|NCT00020722|Carboplatin|carboplatin|mesh-list
138196656|NCT00020722|Etoposide|etoposide|mesh-list
138196657|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
138196659|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
138196660|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196661|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196662|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138196663|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
138196664|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196665|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196666|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138196667|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196668|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138196669|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138196670|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196671|NCT04051996|Decitabine|decitabine|mesh-list
138196672|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196673|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
138196674|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196675|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196676|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196677|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138196678|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196679|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
138196680|NCT02126878|Hormones|hormones|mesh-ancestor
138196682|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196683|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344298|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196688|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138196689|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196690|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196691|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196692|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138196693|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196694|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
138196695|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196696|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138196697|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196698|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
138196699|NCT00000850|Indinavir|indinavir|mesh-list
138196700|NCT00000850|Sargramostim|sargramostim|mesh-list
138196701|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
138196702|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196703|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138196704|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138196705|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196706|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196707|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196709|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196710|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
138196711|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196712|NCT00000856|Ganciclovir|ganciclovir|mesh-list
138196713|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138196714|NCT00000856|Foscarnet|foscarnet|mesh-list
138196715|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138196716|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
138196717|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196718|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196719|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196720|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196721|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196722|NCT00001810|Voriconazole|voriconazole|mesh-list
138196723|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
138196724|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196725|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138196726|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196727|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196728|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196729|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138196730|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138344299|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196731|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196733|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138196734|NCT00000862|Zidovudine|zidovudine|mesh-list
138196735|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
138196736|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196737|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196743|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196744|NCT02344472|Paclitaxel|paclitaxel|mesh-list
138196745|NCT02344472|Vinorelbine|vinorelbine|mesh-list
138196747|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138196748|NCT02344472|Capecitabine|capecitabine|mesh-list
138196749|NCT02344472|Trastuzumab|trastuzumab|mesh-list
138196750|NCT02344472|Letrozole|letrozole|mesh-list
138196751|NCT02344472|Fulvestrant|fulvestrant|mesh-list
138196752|NCT02344472|Pertuzumab|pertuzumab|mesh-list
138196753|NCT02344472|Anastrozole|anastrozole|mesh-list
138196754|NCT02344472|Exemestane|exemestane|mesh-list
138196755|NCT02344472|Goserelin|goserelin|mesh-list
138196756|NCT02344472|Leuprolide|leuprolide|mesh-list
138196757|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138196758|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196759|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138196760|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138196761|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196762|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196763|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196764|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
138196765|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138196766|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138196767|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138196768|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196769|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138196770|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
138196771|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196772|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196773|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138196774|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138196775|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138196776|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
138196777|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138196779|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138196780|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138196781|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138196782|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196783|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
138196784|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138196785|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196786|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196787|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
138196788|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196790|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138196791|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138196792|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
138196793|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196794|NCT00000868|Antacids|antacids|mesh-ancestor
138196795|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196796|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138196797|NCT05586464|Bismuth|bismuth|mesh-list
138196798|NCT05586464|Antacids|antacids|mesh-ancestor
138196799|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196801|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
138196802|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138196803|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196804|NCT00000880|Cyclosporine|cyclosporine|mesh-list
138196805|NCT00000880|Cyclosporins|cyclosporins|mesh-list
138196806|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196808|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196809|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
138196810|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196811|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
138196812|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196814|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196815|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138196816|NCT02279654|Lenalidomide|lenalidomide|mesh-list
138196817|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
138196818|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196819|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196820|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196821|NCT02279654|Growth Substances|growth substances|mesh-ancestor
138196822|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196823|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196825|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138196826|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196827|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196828|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138196829|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
138196830|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
138196831|NCT02564978|Minocycline|minocycline|mesh-list
138196832|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138196833|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196834|NCT02554890|Valsartan|valsartan|mesh-list
138196835|NCT02554890|Enalapril|enalapril|mesh-list
138196836|NCT02554890|Enalaprilat|enalaprilat|mesh-list
138196837|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138196838|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138344300|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138196842|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138196843|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196844|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196845|NCT00001864|Atropine|atropine|mesh-list
138196846|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138196847|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138196848|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138196849|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
138196850|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196859|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196860|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196861|NCT00001870|Acetylcholine|acetylcholine|mesh-list
138196862|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138196863|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138196864|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
138196865|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196866|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196867|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196868|NCT03252600|Dexamethasone|dexamethasone|mesh-list
138196869|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
138196870|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
138196871|NCT03252600|Lenalidomide|lenalidomide|mesh-list
138196872|NCT03252600|Elotuzumab|elotuzumab|mesh-list
138196873|NCT03252600|Ichthammol|ichthammol|mesh-list
138196874|NCT03252600|BB 1101|bb 1101|mesh-list
138196875|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196876|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
138196877|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196878|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196879|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138196880|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
138196881|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196882|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196883|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138196884|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196886|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
138196887|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196888|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138196889|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
138196890|NCT03252600|Hormones|hormones|mesh-ancestor
138196896|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196897|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196898|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196899|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
138196901|NCT02749526|Endostar protein|endostar protein|mesh-list
138196902|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196903|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196904|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
138196905|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196906|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196907|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196908|NCT02749526|Growth Substances|growth substances|mesh-ancestor
138196909|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196910|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196911|NCT00000916|Lamivudine|lamivudine|mesh-list
138196912|NCT00000916|Zidovudine|zidovudine|mesh-list
138196913|NCT00000916|Stavudine|stavudine|mesh-list
138196914|NCT00000916|Didanosine|didanosine|mesh-list
138196915|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138196916|NCT00000916|Indinavir|indinavir|mesh-list
138196917|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
138196918|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196919|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138196920|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196921|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196922|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
138196923|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196925|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138196926|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
138196927|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196928|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
138196929|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138196930|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138196931|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
138196932|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138196933|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196934|NCT00000160|Xenon|xenon|mesh-list
138196935|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138196936|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
138196937|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
138196938|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138196939|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196940|NCT00000178|Prednisone|prednisone|mesh-list
138196941|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196944|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196945|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196946|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138196947|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196948|NCT05480280|Leucovorin|leucovorin|mesh-list
138196949|NCT05480280|Fluorouracil|fluorouracil|mesh-list
138196951|NCT05480280|Calcium|calcium|mesh-list
138196952|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
138196953|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138196955|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
138196956|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196957|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138196958|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196959|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138196960|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
138196961|NCT05480280|Antidotes|antidotes|mesh-ancestor
138196962|NCT05480280|Protective Agents|protective agents|mesh-ancestor
138196963|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
138196965|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
138196966|NCT00001906|Interleukin-12|interleukin-12|mesh-list
138196967|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138196968|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138196969|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
138196970|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196971|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196972|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196973|NCT00001906|Growth Substances|growth substances|mesh-ancestor
138196974|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
138196975|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196976|NCT00001906|Antacids|antacids|mesh-ancestor
138196977|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196978|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138196979|NCT00000196|Naltrexone|naltrexone|mesh-list
138196980|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138196981|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138196982|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196983|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
138196984|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196985|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
138196986|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138196987|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
138196988|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196989|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138196990|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196991|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
138196992|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196993|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
138196994|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138196997|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138196998|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138196999|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138197000|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
138197001|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
138197002|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197003|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197004|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197005|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138197009|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197010|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
138197011|NCT04390100|Protective Agents|protective agents|mesh-ancestor
138197012|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
138197013|NCT04390100|Coagulants|coagulants|mesh-ancestor
138197014|NCT00000202|Buprenorphine|buprenorphine|mesh-list
138197015|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197016|NCT00000202|Narcotics|narcotics|mesh-ancestor
138197017|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197018|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197019|NCT00000202|Analgesics|analgesics|mesh-ancestor
138197020|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
138197021|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197022|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197023|NCT00000208|Buprenorphine|buprenorphine|mesh-list
138197024|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197025|NCT00000208|Narcotics|narcotics|mesh-ancestor
138197026|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197027|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197028|NCT00000208|Analgesics|analgesics|mesh-ancestor
138197029|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
138197030|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197031|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197033|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138197034|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138197035|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
138197036|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197039|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197041|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197042|NCT00001930|Analgesics|analgesics|mesh-ancestor
138197043|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
138197044|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197045|NCT00000964|Foscarnet|foscarnet|mesh-list
138197046|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138197047|NCT00000964|Ranitidine|ranitidine|mesh-list
138197048|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138197049|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138197050|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138197051|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138197052|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
138197055|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197058|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197059|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197060|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197062|NCT00000976|Zidovudine|zidovudine|mesh-list
138197063|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138197064|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
138197065|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197066|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197067|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197068|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197069|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
138197070|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197071|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197072|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197073|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
138197074|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197076|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197077|NCT00000226|Narcotics|narcotics|mesh-ancestor
138197081|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
138197082|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197083|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197085|NCT00000982|Didanosine|didanosine|mesh-list
138197086|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
138197087|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197088|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197089|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197090|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197091|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
138197092|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197093|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197094|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197095|NCT02549196|Donepezil|donepezil|mesh-list
138197096|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
138197097|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138197098|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197099|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197100|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
138197101|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197102|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197103|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
138197104|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138197105|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138197106|NCT02549196|Urological Agents|urological agents|mesh-ancestor
138197107|NCT00000988|Stavudine|stavudine|mesh-list
138197108|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
138197109|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197110|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197113|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
138197114|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197115|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197116|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197117|NCT00000232|Buprenorphine|buprenorphine|mesh-list
138197118|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197119|NCT00000232|Narcotics|narcotics|mesh-ancestor
138197120|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197121|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197122|NCT00000232|Analgesics|analgesics|mesh-ancestor
138197123|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
138197124|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197125|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197126|NCT00000238|Buprenorphine|buprenorphine|mesh-list
138197127|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197128|NCT00000238|Narcotics|narcotics|mesh-ancestor
138197129|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197130|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197131|NCT00000238|Analgesics|analgesics|mesh-ancestor
138197132|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
138197133|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197134|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197135|NCT00000244|Dynorphins|dynorphins|mesh-list
138197136|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197137|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197141|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197142|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197143|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197144|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197145|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
138197147|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197148|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197149|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138197150|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197151|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
138197152|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197153|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197154|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138197155|NCT00001006|Protective Agents|protective agents|mesh-ancestor
138197156|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197157|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197158|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197159|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197161|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197162|NCT00001954|Etanercept|etanercept|mesh-list
138197163|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138197164|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197166|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
138197167|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197168|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197169|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197171|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138197172|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138197173|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
138197174|NCT02904954|Durvalumab|durvalumab|mesh-list
138197175|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138197176|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138197177|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197178|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
138197179|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197180|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
138197181|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138197182|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
138197183|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
138197184|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197185|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197186|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197187|NCT00000250|Analgesics|analgesics|mesh-ancestor
138197188|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
138197189|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197190|NCT03244020|Aspirin|aspirin|mesh-list
138197191|NCT03244020|Enoxaparin|enoxaparin|mesh-list
138197192|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138197193|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197194|NCT03244020|Analgesics|analgesics|mesh-ancestor
138197195|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
138197201|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138197202|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197203|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138197204|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138197205|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197206|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
138197207|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
138197208|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
138197209|NCT00000262|Sevoflurane|sevoflurane|mesh-list
138197210|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138197211|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138197212|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
138197213|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
138197214|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197215|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197216|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197217|NCT00000262|Analgesics|analgesics|mesh-ancestor
138197218|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
138197219|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197220|NCT00001024|Zidovudine|zidovudine|mesh-list
138197221|NCT00001024|Didanosine|didanosine|mesh-list
138197222|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
138197223|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197224|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197225|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197226|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197227|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
138197228|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197229|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197230|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197232|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138197233|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
138197235|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138197236|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197237|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197238|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197239|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
138197240|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197241|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197242|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138197243|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138197244|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197245|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138197246|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138197247|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
138197248|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197249|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
138197250|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197251|NCT00001042|Antacids|antacids|mesh-ancestor
138197252|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197253|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138197255|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
138197256|NCT00982865|Vitamins|vitamins|mesh-ancestor
138197259|NCT00001054|Valacyclovir|valacyclovir|mesh-list
138197260|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
138197261|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197263|NCT01226719|Fluorouracil|fluorouracil|mesh-list
138197264|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
138197266|NCT01226719|Panitumumab|panitumumab|mesh-list
138197267|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
138197268|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197269|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138197270|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197271|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138197272|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
138197273|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197274|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138197275|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138197276|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197277|NCT01226719|Antidotes|antidotes|mesh-ancestor
138197278|NCT01226719|Protective Agents|protective agents|mesh-ancestor
138197279|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
138197280|NCT01226719|Vitamins|vitamins|mesh-ancestor
138197281|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
138197282|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138197283|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
138197284|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197285|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
138197286|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197287|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138197288|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197289|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
138197290|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197291|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
138197292|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138197293|NCT00001072|Protective Agents|protective agents|mesh-ancestor
138197294|NCT04331470|Ritonavir|ritonavir|mesh-list
138197295|NCT04331470|Lopinavir|lopinavir|mesh-list
138197296|NCT04331470|Chloroquine|chloroquine|mesh-list
138197297|NCT04331470|Levamisole|levamisole|mesh-list
138197298|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
138197299|NCT04331470|Budesonide|budesonide|mesh-list
138197300|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
138197302|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138197303|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
138197304|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197305|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197306|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197307|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197308|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
138197311|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138197312|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197313|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138197315|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197316|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197317|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138197318|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
138197319|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
138197321|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197322|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138197323|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138197324|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138197325|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197326|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197328|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138197330|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
138197331|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138197332|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
138197333|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
138197334|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197335|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
138197336|NCT00001090|Sargramostim|sargramostim|mesh-list
138197337|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
138197338|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197339|NCT01147627|Insulin|insulin|mesh-list
138197340|NCT01147627|Pioglitazone|pioglitazone|mesh-list
138197341|NCT01147627|Exenatide|exenatide|mesh-list
138197342|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
138197343|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138197344|NCT01147627|Protamines|protamines|mesh-list
138197345|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138197346|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197347|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138197348|NCT01147627|Incretins|incretins|mesh-ancestor
138197349|NCT01147627|Hormones|hormones|mesh-ancestor
138197350|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197351|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
138197352|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197353|NCT01147627|Coagulants|coagulants|mesh-ancestor
138197354|NCT02548962|Dexamethasone|dexamethasone|mesh-list
138197355|NCT02548962|Pomalidomide|pomalidomide|mesh-list
138197356|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197357|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
138197358|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
138197359|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197360|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197362|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
138197363|NCT02548962|Hormones|hormones|mesh-ancestor
138197364|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197365|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138197366|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197367|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
138197368|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138197369|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138197370|NCT02548962|Growth Substances|growth substances|mesh-ancestor
138197371|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138197373|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138197374|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138197375|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138197376|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197377|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197378|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138197379|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138197381|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197382|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197383|NCT02743598|Liraglutide|liraglutide|mesh-list
138197384|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138197385|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197386|NCT02743598|Incretins|incretins|mesh-ancestor
138197387|NCT02743598|Hormones|hormones|mesh-ancestor
138197388|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197389|NCT00000280|Nimodipine|nimodipine|mesh-list
138197390|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138197391|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138197392|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197393|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197394|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138197395|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197396|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
138197398|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138197399|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197400|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197401|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197402|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197403|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197404|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138197405|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
138197406|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138197407|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138197408|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138197409|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
138197411|NCT01188577|Racepinephrine|racepinephrine|mesh-list
138197412|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
138197413|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138197414|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138197415|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197416|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197417|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197418|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197426|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
138197427|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138197428|NCT02507336|Thalidomide|thalidomide|mesh-list
138197429|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138197430|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
138197431|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197432|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
138197433|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138197434|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197436|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138197437|NCT02507336|Growth Substances|growth substances|mesh-ancestor
138197438|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138197439|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197441|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
138197442|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
138197443|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197444|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197445|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
138197446|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197447|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138197448|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138197449|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197450|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197451|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197452|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
138197453|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197454|NCT00000298|Buprenorphine|buprenorphine|mesh-list
138197455|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138197457|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197458|NCT00000298|Narcotics|narcotics|mesh-ancestor
138197459|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197460|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197463|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197465|NCT00000304|Amphetamine|amphetamine|mesh-list
138197466|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
138197467|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138197469|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
138197470|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
138197471|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197472|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
138197473|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197474|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197475|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197476|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138197477|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197478|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197479|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138197481|NCT02548650|Clopidogrel|clopidogrel|mesh-list
138197482|NCT02548650|Vorapaxar|vorapaxar|mesh-list
138197483|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138197484|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197485|NCT02548650|Analgesics|analgesics|mesh-ancestor
138197486|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
138197487|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197488|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197489|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197490|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138197491|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138197492|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138197493|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197494|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138197495|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138197496|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197497|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
138197498|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138197499|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138197500|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138197501|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
138197503|NCT00000310|Risperidone|risperidone|mesh-list
138197504|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138197505|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
138197506|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197507|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197508|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197509|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138197510|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138197513|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138197514|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
138197515|NCT01227655|Levodopa|levodopa|mesh-list
138197516|NCT01227655|Carbidopa|carbidopa|mesh-list
138197517|NCT01227655|Opicapone|opicapone|mesh-list
138197518|NCT01227655|Benserazide|benserazide|mesh-list
138197520|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138197521|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
138197522|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197523|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197524|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197525|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138197526|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197527|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138197528|NCT00000316|Cocaine|cocaine|mesh-list
138197530|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
138197531|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197532|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197533|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
138197534|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197535|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138197536|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138197537|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197538|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197539|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197540|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
138197541|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197542|NCT05459532|Molnupiravir|molnupiravir|mesh-list
138197543|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
138197544|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197546|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197547|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
138197548|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138197549|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138197550|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197551|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197552|NCT01026623|Sirolimus|sirolimus|mesh-list
138197553|NCT01026623|Temsirolimus|temsirolimus|mesh-list
138197554|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
138197555|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138197556|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138197557|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197558|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138197559|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197560|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
138197561|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138197562|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
138197563|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197568|NCT00001996|Pentamidine|pentamidine|mesh-list
138197569|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197570|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
138197571|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138197573|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197574|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197575|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
138197576|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138197577|NCT02725424|Docetaxel|docetaxel|mesh-list
138197578|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
138197579|NCT02725424|Trastuzumab|trastuzumab|mesh-list
138197580|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197581|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
138197582|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
138197583|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
138197584|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197585|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138197586|NCT01189279|Bimatoprost|bimatoprost|mesh-list
138197587|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138197588|NCT00001108|Ritonavir|ritonavir|mesh-list
138197589|NCT00001108|Nelfinavir|nelfinavir|mesh-list
138197590|NCT00001108|Saquinavir|saquinavir|mesh-list
138197591|NCT00001108|Lamivudine|lamivudine|mesh-list
138197592|NCT00001108|Nevirapine|nevirapine|mesh-list
138197593|NCT00001108|Stavudine|stavudine|mesh-list
138197595|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138197596|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138197597|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
138197598|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197599|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197600|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197601|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197602|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
138197603|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197605|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138197606|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197607|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197608|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138197609|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138197611|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
138197613|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197614|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197615|NCT00000328|Analgesics|analgesics|mesh-ancestor
138197616|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
138197618|NCT00380224|Olanzapine|olanzapine|mesh-list
138197619|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
138197620|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
138197621|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197622|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197623|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138197624|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138197625|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138197629|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197630|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138344301|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197632|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197633|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
138197634|NCT00002002|Leucovorin|leucovorin|mesh-list
138197635|NCT00002002|Trimethoprim|trimethoprim|mesh-list
138197636|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
138197637|NCT00002002|Calcium|calcium|mesh-list
138197638|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
138197639|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138197640|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197641|NCT00002002|Antidotes|antidotes|mesh-ancestor
138197642|NCT00002002|Protective Agents|protective agents|mesh-ancestor
138197643|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
138197644|NCT00002002|Vitamins|vitamins|mesh-ancestor
138197645|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
138197646|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138197647|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197648|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
138197649|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138197650|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138197651|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138197652|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197653|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197654|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138197655|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138197656|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138197657|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138197658|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138197659|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197660|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197662|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197663|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197664|NCT02535000|Analgesics|analgesics|mesh-ancestor
138197665|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
138197666|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197667|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
138197668|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138197669|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
138197670|NCT00380380|Vildagliptin|vildagliptin|mesh-list
138197671|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138197672|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197673|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138197674|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138197675|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197676|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197677|NCT01228903|Allopurinol|allopurinol|mesh-list
138197678|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
138197679|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197681|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
138197682|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138197683|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138197684|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
138197685|NCT01228903|Protective Agents|protective agents|mesh-ancestor
138197686|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197687|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138197689|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138197690|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197691|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197692|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138197693|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197694|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197695|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
138197696|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197697|NCT00001126|Cidofovir|cidofovir|mesh-list
138197698|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
138197699|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197700|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197701|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197702|NCT00002008|Sargramostim|sargramostim|mesh-list
138197703|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
138197704|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197705|NCT00001132|Abacavir|abacavir|mesh-list
138197706|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197707|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197708|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344302|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
138197710|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
138197711|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197712|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197713|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197715|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138197716|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138197720|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197722|NCT01149733|Urological Agents|urological agents|mesh-ancestor
138197723|NCT00002014|Zidovudine|zidovudine|mesh-list
138197733|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197734|NCT00000334|Buprenorphine|buprenorphine|mesh-list
138197735|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197736|NCT00000334|Narcotics|narcotics|mesh-ancestor
138197737|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197738|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197739|NCT00000334|Analgesics|analgesics|mesh-ancestor
138197740|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
138197741|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197742|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197744|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138197745|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197746|NCT00002020|Zidovudine|zidovudine|mesh-list
138197747|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
138197748|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197749|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197750|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197752|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
138197753|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197754|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197755|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197756|NCT00002026|Acyclovir|acyclovir|mesh-list
138197757|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
138197758|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197760|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
138197761|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
138197762|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138197763|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138197764|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197765|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197773|NCT01229527|Remifentanil|remifentanil|mesh-list
138197774|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138197780|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197781|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138197782|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
138197783|NCT02723162|Varenicline|varenicline|mesh-list
138197784|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138197786|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138197787|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
138197788|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197789|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197790|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197792|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197793|NCT02723162|Expectorants|expectorants|mesh-ancestor
138197794|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
138197795|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138197796|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
138197797|NCT02723162|Protective Agents|protective agents|mesh-ancestor
138197798|NCT02723162|Antidotes|antidotes|mesh-ancestor
138197800|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138197801|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197802|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197803|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
138197804|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197806|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138197807|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138197808|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197809|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197810|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197812|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138197813|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
138197815|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197816|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197817|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138197820|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197821|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197822|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197824|NCT02143388|Capecitabine|capecitabine|mesh-list
138197825|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197826|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138197827|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
138197828|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197829|NCT00001228|Interferons|interferons|mesh-list
138197830|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197831|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
138197832|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197833|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138197835|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138197836|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
138197837|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138197838|NCT02483936|Diuretics|diuretics|mesh-ancestor
138197839|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
138197840|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197843|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197844|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138197845|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138197847|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
138197848|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197849|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138197850|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138197851|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197852|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197853|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138197854|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
138216208|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138197855|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197856|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197857|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138197858|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138197859|NCT01894334|Edaravone|edaravone|mesh-list
138197860|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
138197861|NCT01894334|Urinastatin|urinastatin|mesh-list
138197862|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138197863|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138197864|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197865|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
138197866|NCT01894334|Coagulants|coagulants|mesh-ancestor
138197867|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138197868|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
138197869|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138197870|NCT01894334|Protective Agents|protective agents|mesh-ancestor
138197871|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197872|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138197873|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138197874|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
138197875|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197879|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197881|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197883|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197884|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197885|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197887|NCT00001282|Interleukin-2|interleukin-2|mesh-list
138197888|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197889|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138197890|NCT00001282|Analgesics|analgesics|mesh-ancestor
138197891|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
138197892|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197893|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197894|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
138197895|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197896|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197897|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197898|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197899|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
138197900|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197901|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197902|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197903|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
138197904|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138197905|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197906|NCT00001300|Doxorubicin|doxorubicin|mesh-list
138197907|NCT00001300|Ifosfamide|ifosfamide|mesh-list
138197908|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138197910|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138197911|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138197912|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197913|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197914|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138197915|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
138197916|NCT00000400|Alendronate|alendronate|mesh-list
138197918|NCT00000400|Hormones|hormones|mesh-list
138197919|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
138201748|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197920|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197921|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197922|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138197923|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138197924|NCT01195597|Nicotine|nicotine|mesh-list
138197925|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138197926|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
138197927|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197928|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197929|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138197932|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197933|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197934|NCT00002050|Thymopentin|thymopentin|mesh-list
138197935|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197936|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
138216209|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
138197937|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197938|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
138197939|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197940|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
138197941|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197942|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
138197943|NCT04389866|Protective Agents|protective agents|mesh-ancestor
138197946|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138197947|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197948|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138197950|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197951|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197952|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138197953|NCT00000412|Vitamins|vitamins|mesh-ancestor
138197954|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
138197955|NCT00002056|Pentamidine|pentamidine|mesh-list
138197956|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
138197958|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138197959|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138197960|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138197961|NCT03110562|Dexamethasone|dexamethasone|mesh-list
138197962|NCT03110562|Bortezomib|bortezomib|mesh-list
138197963|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197965|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
138197966|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197967|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197969|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
138197970|NCT03110562|Hormones|hormones|mesh-ancestor
138197971|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197972|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138197975|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197976|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197977|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197978|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197979|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
138197980|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197981|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138197982|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138197983|NCT00000430|Alendronate|alendronate|mesh-list
138197986|NCT00000430|Hormones|hormones|mesh-ancestor
138197987|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197988|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197989|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138197991|NCT00380770|Stavudine|stavudine|mesh-list
138197993|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197994|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197995|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197996|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197997|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
138197998|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197999|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198000|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198001|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
138198002|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
138198004|NCT01231399|Fluorouracil|fluorouracil|mesh-list
138198005|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
138198006|NCT01231399|Everolimus|everolimus|mesh-list
138198007|NCT01231399|Calcium|calcium|mesh-list
138198008|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
138198009|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138198010|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198011|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138198013|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198014|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198015|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198016|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198017|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
138198018|NCT01231399|Antidotes|antidotes|mesh-ancestor
138198019|NCT01231399|Protective Agents|protective agents|mesh-ancestor
138198020|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
138198022|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
138198023|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138198024|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138198025|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198027|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198028|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198029|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
138198030|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138198031|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198032|NCT01231633|Dexamethasone|dexamethasone|mesh-list
138198033|NCT01231633|Bevacizumab|bevacizumab|mesh-list
138198034|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138198035|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198036|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138198037|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138198038|NCT01231633|Growth Substances|growth substances|mesh-ancestor
138198039|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198040|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
138198041|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198042|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
138198043|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
138198044|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198045|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198046|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
138198047|NCT01231633|Hormones|hormones|mesh-ancestor
138198048|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198049|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198050|NCT00000442|Naltrexone|naltrexone|mesh-list
138198051|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138198052|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138198053|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198054|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
138198055|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198056|NCT00002068|Fluconazole|fluconazole|mesh-list
138198057|NCT00002068|Amphotericin B|amphotericin b|mesh-list
138198059|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
138198060|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198061|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138198062|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198063|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198064|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198065|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138198066|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
138198067|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198070|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138198071|NCT00002068|Amebicides|amebicides|mesh-ancestor
138198072|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138198073|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198074|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198075|NCT00000448|Naltrexone|naltrexone|mesh-list
138198076|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138198077|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138198078|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198079|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
138198080|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198081|NCT00001318|Interferons|interferons|mesh-list
138198082|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
138198083|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198084|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
138198085|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198086|NCT00002074|Fluconazole|fluconazole|mesh-list
138198087|NCT00002074|Amphotericin B|amphotericin b|mesh-list
138198088|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138198089|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
138198090|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198091|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138198092|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198093|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198094|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198095|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138198096|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
138198097|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198098|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198099|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138198100|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138198102|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138198103|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198104|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198110|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
138198111|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198131|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198132|NCT00002080|Rifabutin|rifabutin|mesh-list
138198133|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198139|NCT00000484|Diuretics|diuretics|mesh-ancestor
138198140|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
138198142|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138198143|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138198147|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138198148|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198149|NCT00000496|Analgesics|analgesics|mesh-ancestor
138198150|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
138198151|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198152|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198153|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198155|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138198156|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138198157|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198158|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138198159|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138198160|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198161|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
138198167|NCT00002086|Zalcitabine|zalcitabine|mesh-list
138198174|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198175|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198176|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198180|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138198181|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138198183|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198184|NCT00001384|Paclitaxel|paclitaxel|mesh-list
138198185|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
138198190|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
138198191|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
138198192|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198197|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198198|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198199|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
138198200|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198201|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198202|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138198204|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198205|NCT01151761|Cisplatin|cisplatin|mesh-list
138198206|NCT01151761|Carboplatin|carboplatin|mesh-list
138198207|NCT01151761|Gemcitabine|gemcitabine|mesh-list
138198209|NCT01151761|Fluorouracil|fluorouracil|mesh-list
138198210|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198211|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198212|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
138198221|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
138198235|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198236|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
138198237|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198239|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198241|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
138198242|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198243|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198245|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138198246|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
138198247|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198248|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198249|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138198252|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198253|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138198254|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138198255|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138198256|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
138198257|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198258|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198265|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198266|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198267|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198268|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
138198269|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198270|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198271|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198272|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
138198273|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198274|NCT00002104|Thalidomide|thalidomide|mesh-list
138198275|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198276|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
138198277|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198278|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
138198279|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198280|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198281|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138198282|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138198283|NCT00002104|Growth Substances|growth substances|mesh-ancestor
138198284|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
138198285|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198286|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
138198287|NCT00001438|Tretinoin|tretinoin|mesh-list
138198288|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198289|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
138198290|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198291|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
138198293|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138198294|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198295|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138198299|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138198300|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198301|NCT00000574|Analgesics|analgesics|mesh-ancestor
138198302|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
138198303|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198304|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198305|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198306|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198307|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138198308|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198312|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
138198313|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198314|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198315|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198331|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138198332|NCT00000580|Antibodies|antibodies|mesh-list
138198335|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
138198336|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198338|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
138198339|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198340|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344303|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138198343|NCT00001498|Paclitaxel|paclitaxel|mesh-list
138198344|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
138198345|NCT00001498|Doxorubicin|doxorubicin|mesh-list
138198346|NCT00001498|Fluorouracil|fluorouracil|mesh-list
138198347|NCT00001498|Methotrexate|methotrexate|mesh-list
138198348|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198349|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198350|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
138198351|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
138198352|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198353|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198354|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198355|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
138198356|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198357|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198358|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198361|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198362|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138198363|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138198365|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
138198366|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198367|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138198371|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138198372|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198373|NCT00001498|Antidotes|antidotes|mesh-ancestor
138198374|NCT00001498|Protective Agents|protective agents|mesh-ancestor
138198375|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
138198377|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
138198379|NCT00001504|Alitretinoin|alitretinoin|mesh-list
138198380|NCT00001504|Isotretinoin|isotretinoin|mesh-list
138198381|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198382|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
138198383|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198384|NCT02688140|Cytarabine|cytarabine|mesh-list
138198385|NCT02688140|Methotrexate|methotrexate|mesh-list
138198386|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
138198387|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
138198388|NCT02688140|Idarubicin|idarubicin|mesh-list
138198389|NCT02688140|Tretinoin|tretinoin|mesh-list
138198390|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
138198392|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
138198393|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198394|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198395|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198396|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
138198397|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198398|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198399|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198400|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198401|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138198402|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198403|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
138198404|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198405|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198406|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
138198407|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198409|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
138198410|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198411|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138198412|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138198413|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198414|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
138198417|NCT00002122|Fluconazole|fluconazole|mesh-list
138198424|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198426|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
138198427|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198429|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138198430|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138198436|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138198437|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138198438|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198439|NCT01027559|Sertraline|sertraline|mesh-list
138198440|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
138198441|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138198442|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138198443|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138198444|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138198445|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198446|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198447|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
138198448|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198449|NCT00002128|Adefovir|adefovir|mesh-list
138198450|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138198452|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198453|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198454|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198455|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198456|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198457|NCT00001570|Vinblastine|vinblastine|mesh-list
138198458|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198459|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198461|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
138198462|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201749|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138198463|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198464|NCT00000628|Zidovudine|zidovudine|mesh-list
138198465|NCT00000628|L-697661|l-697661|mesh-list
138198466|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
138198467|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198468|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198469|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198470|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198471|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
138198472|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198473|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198474|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198475|NCT00000634|Nevirapine|nevirapine|mesh-list
138198476|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198477|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198479|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198480|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
138198481|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198482|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198484|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138198485|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138198487|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138198488|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198496|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
138198497|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198498|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198499|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216290|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198500|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198502|NCT00985907|Melphalan|melphalan|mesh-list
138198503|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138198504|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198505|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198507|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198508|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198509|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198511|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198512|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198513|NCT00002140|Azithromycin|azithromycin|mesh-list
138198514|NCT00002140|Clarithromycin|clarithromycin|mesh-list
138198515|NCT00002140|Ethambutol|ethambutol|mesh-list
138198516|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198517|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198518|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138198519|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198528|NCT00000658|Doxorubicin|doxorubicin|mesh-list
138198529|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138198530|NCT00000658|Methotrexate|methotrexate|mesh-list
138198531|NCT00000658|Vincristine|vincristine|mesh-list
138198532|NCT00000658|Bleomycin|bleomycin|mesh-list
138198533|NCT00000658|Allopurinol|allopurinol|mesh-list
138198535|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
138198536|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198537|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
138198538|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198539|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198540|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198541|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
138198547|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
138198548|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198549|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198550|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
138198552|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198553|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198554|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198555|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138198556|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138198557|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198558|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138198559|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
138198560|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198561|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198563|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198564|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138198565|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198566|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
138198567|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198568|NCT00000658|Antidotes|antidotes|mesh-ancestor
138198572|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
138198573|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198576|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198577|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
138198578|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138198579|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
138198580|NCT01027793|Tretinoin|tretinoin|mesh-list
138198581|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198582|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
138198583|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198584|NCT00002146|Foscarnet|foscarnet|mesh-list
138198585|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138198586|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
138198587|NCT00002146|Analgesics|analgesics|mesh-ancestor
138198588|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
138198589|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198590|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198592|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138198593|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138198594|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
138198595|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138198596|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138198597|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198598|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138198600|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198601|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
138198602|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198603|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198604|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198606|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
138198607|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138198608|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138198609|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198610|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
138198611|NCT04389554|Coagulants|coagulants|mesh-ancestor
138198612|NCT03051516|Vaccines|vaccines|mesh-list
138198613|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
138198614|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198620|NCT00000664|Zidovudine|zidovudine|mesh-list
138198621|NCT00000664|Interleukin-2|interleukin-2|mesh-list
138198622|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198623|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198625|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
138198626|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198627|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198628|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
138198629|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198630|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198631|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198632|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198633|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
138198634|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198639|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
138216291|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198640|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198641|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198642|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198643|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198644|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
138198645|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198646|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198647|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198648|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
138198649|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
138198650|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198651|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
138198652|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198653|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198654|NCT00000694|Interferons|interferons|mesh-list
138198655|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
138198656|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
138198657|NCT00000694|Zidovudine|zidovudine|mesh-list
138198658|NCT00000694|Sargramostim|sargramostim|mesh-list
138198663|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198664|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
138198665|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198666|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198667|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198668|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198670|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198671|NCT01894412|Etanercept|etanercept|mesh-list
138344304|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138198675|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
138198676|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198677|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198678|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198679|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198680|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198685|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198686|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198687|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198688|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198689|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
138198690|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198691|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198692|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198693|NCT00002164|Nelfinavir|nelfinavir|mesh-list
138198698|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198699|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198700|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198701|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
138198702|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198703|NCT00000706|Zidovudine|zidovudine|mesh-list
138198704|NCT00000706|Quinine|quinine|mesh-list
138198705|NCT00000706|Probenecid|probenecid|mesh-list
138198706|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
138198707|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198708|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198709|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198713|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198714|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198717|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198718|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138198719|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198720|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138198721|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198722|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198723|NCT00000706|Analgesics|analgesics|mesh-ancestor
138198724|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
138198725|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
138198726|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
138198727|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198728|NCT00988325|Oseltamivir|oseltamivir|mesh-list
138198729|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
138198730|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198731|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198732|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198733|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
138198734|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138198735|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
138198738|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198739|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
138198740|NCT00002302|Hematinics|hematinics|mesh-ancestor
138198741|NCT00002170|Nelfinavir|nelfinavir|mesh-list
138198742|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138198743|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138198744|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
138198745|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198748|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198749|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
138198750|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198751|NCT00002308|Stavudine|stavudine|mesh-list
138198752|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
138198753|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198754|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198755|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198756|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198758|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198767|NCT00000724|Antidotes|antidotes|mesh-ancestor
138198768|NCT00000724|Protective Agents|protective agents|mesh-ancestor
138198769|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
138198770|NCT00000724|Vitamins|vitamins|mesh-ancestor
138198771|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
138198772|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
138198773|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198774|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198775|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
138198779|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198780|NCT00000730|Leucovorin|leucovorin|mesh-list
138198781|NCT00000730|Trimethoprim|trimethoprim|mesh-list
138198782|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138198783|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
138198784|NCT00000730|Pentamidine|pentamidine|mesh-list
138198785|NCT00000730|Trimetrexate|trimetrexate|mesh-list
138198786|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
138198787|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
138198788|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198789|NCT00000730|Antidotes|antidotes|mesh-ancestor
138198790|NCT00000730|Protective Agents|protective agents|mesh-ancestor
138198791|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
138198792|NCT00000730|Vitamins|vitamins|mesh-ancestor
138198795|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
138198796|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
138198797|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198798|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198799|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
138198801|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198802|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138198808|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138198809|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138198810|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198811|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198812|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138198813|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138198814|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198815|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
138198817|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198824|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198825|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
138198826|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198827|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198828|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198829|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138198830|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138198831|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
138198832|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198833|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198834|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
138198835|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198836|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
138198837|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198838|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
138198839|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138198840|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198842|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
138198843|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138198844|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138198845|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138198846|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
138198847|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198849|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138198850|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138198851|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198858|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198860|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198861|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
138198862|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198863|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198864|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198865|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
138198866|NCT02167217|Prednisolone|prednisolone|mesh-list
138198867|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138198868|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
138198869|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138198870|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
138198873|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198874|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
138198875|NCT02167217|Hormones|hormones|mesh-ancestor
138198876|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198877|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198878|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198879|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198880|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
138198883|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198884|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138198885|NCT02167217|Protective Agents|protective agents|mesh-ancestor
138198891|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198893|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
138198894|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198896|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198897|NCT01152697|Haloperidol|haloperidol|mesh-list
138198898|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
138198899|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
138198900|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
138198901|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198902|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198903|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198908|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138198909|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
138198910|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198911|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198912|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138198913|NCT00002188|Alitretinoin|alitretinoin|mesh-list
138198914|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198915|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138198916|NCT00002332|Thymopentin|thymopentin|mesh-list
138198917|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138198918|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
138198919|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198920|NCT03011281|Tofacitinib|tofacitinib|mesh-list
138198921|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138198922|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138198923|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198926|NCT00002194|Erythromycin|erythromycin|mesh-list
138198935|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198936|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138198937|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198939|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198941|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198942|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198943|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138198944|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138198945|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198947|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138198948|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
138198949|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198951|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
138198952|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138198953|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
138198954|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198955|NCT04756622|Protective Agents|protective agents|mesh-ancestor
138198956|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198957|NCT04756622|Antidotes|antidotes|mesh-ancestor
138198958|NCT00002344|Azithromycin|azithromycin|mesh-list
138198959|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198960|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198961|NCT01198327|Ranibizumab|ranibizumab|mesh-list
138198962|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138198963|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138198964|NCT01198327|Growth Substances|growth substances|mesh-ancestor
138198965|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198967|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198968|NCT00002200|Abacavir|abacavir|mesh-list
138198969|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198970|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198971|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198976|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198977|NCT00002356|Fomivirsen|fomivirsen|mesh-list
138198978|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
138198979|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198980|NCT00994175|Pioglitazone|pioglitazone|mesh-list
138198981|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138198982|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198983|NCT00002206|Adefovir|adefovir|mesh-list
138198985|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
138198990|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198992|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
138198993|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
138198994|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138198995|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198996|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
138198997|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198998|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138198999|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138199000|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138199001|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138199002|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199003|NCT00002212|Bexarotene|bexarotene|mesh-list
138199004|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199007|NCT00002362|Abacavir|abacavir|mesh-list
138199008|NCT00002362|Stavudine|stavudine|mesh-list
138199009|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
138199010|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199011|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199012|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199013|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199014|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199015|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199019|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138199020|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138199021|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138199024|NCT02168309|Labetalol|labetalol|mesh-list
138199026|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138199027|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138199031|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
138199032|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
138199033|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199034|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138199035|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138199036|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
138199037|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199038|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138199039|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
138199040|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
138199044|NCT00002368|Lamivudine|lamivudine|mesh-list
138199045|NCT00002368|Nevirapine|nevirapine|mesh-list
138199046|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199047|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199048|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199049|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199051|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199052|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199053|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199054|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138199055|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138199056|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
138199057|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138199058|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
138199059|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
138199060|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199061|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199062|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199063|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199064|NCT01199965|Analgesics|analgesics|mesh-ancestor
138199068|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138199069|NCT00995501|Dexamethasone|dexamethasone|mesh-list
138199070|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
138199071|NCT00995501|Anesthetics|anesthetics|mesh-list
138199072|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
138199073|NCT00995501|BB 1101|bb 1101|mesh-list
138199074|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138199075|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199077|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
138199078|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
138199079|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199082|NCT00995501|Hormones|hormones|mesh-ancestor
138199083|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199084|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199086|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199087|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199088|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199089|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138199090|NCT00995501|Cathartics|cathartics|mesh-ancestor
138199091|NCT00002374|Ritonavir|ritonavir|mesh-list
138199092|NCT00002374|Nelfinavir|nelfinavir|mesh-list
138199093|NCT00002374|Saquinavir|saquinavir|mesh-list
138199094|NCT00002374|Stavudine|stavudine|mesh-list
138199095|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199096|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199097|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199098|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344305|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199112|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199113|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199114|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199115|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199116|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199117|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199118|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
138199119|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199120|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138199121|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199122|NCT00002386|Lamivudine|lamivudine|mesh-list
138199123|NCT00002386|Zidovudine|zidovudine|mesh-list
138199124|NCT00002386|Stavudine|stavudine|mesh-list
138199125|NCT00002386|Didanosine|didanosine|mesh-list
138199126|NCT00002386|Zalcitabine|zalcitabine|mesh-list
138199127|NCT00002386|Indinavir|indinavir|mesh-list
138199128|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199129|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199130|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199131|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199132|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
138199133|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199134|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199135|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199137|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199138|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199139|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199140|NCT01942694|Vitamin D|vitamin d|mesh-list
138199141|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
138199142|NCT01942694|Vitamins|vitamins|mesh-ancestor
138199143|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
138199144|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199145|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138199146|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138344306|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138199148|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
138199149|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199150|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138216379|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216380|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
138216382|NCT00661544|Protective Agents|protective agents|mesh-ancestor
138216384|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
138216385|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216386|NCT02979392|Paclitaxel|paclitaxel|mesh-list
138216388|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216389|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216390|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
138216391|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216392|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216393|NCT02999906|Treprostinil|treprostinil|mesh-list
138216394|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216395|NCT01238471|Propranolol|propranolol|mesh-list
138216396|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138216397|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138216398|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216399|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216400|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216401|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216402|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138216403|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216404|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
138216405|NCT00664430|Calcitriol|calcitriol|mesh-list
138215234|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138215235|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138215236|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215237|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215238|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215239|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215241|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
138215242|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215243|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
138215244|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215245|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
138215246|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138215247|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
138215248|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138215249|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138215250|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138215251|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215252|NCT00624416|Prednisolone|prednisolone|mesh-list
138215253|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138215254|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
138215255|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138215256|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
138215257|NCT00624416|Cortisone|cortisone|mesh-list
138199156|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199158|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138199160|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138199161|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
138199162|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199163|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199166|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
138199167|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199168|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199169|NCT05751850|Leucovorin|leucovorin|mesh-list
138199170|NCT05751850|Paclitaxel|paclitaxel|mesh-list
138199173|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
138199174|NCT05751850|Calcium|calcium|mesh-list
138199175|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
138199176|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199177|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199179|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
138199182|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199184|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138199185|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199186|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199187|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
138199188|NCT05751850|Antidotes|antidotes|mesh-ancestor
138199189|NCT05751850|Protective Agents|protective agents|mesh-ancestor
138199190|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
138199191|NCT05751850|Vitamins|vitamins|mesh-ancestor
138199192|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
138199193|NCT00002230|Efavirenz|efavirenz|mesh-list
138199194|NCT00002230|Stavudine|stavudine|mesh-list
138199195|NCT00002230|Didanosine|didanosine|mesh-list
138199196|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
138199197|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138344307|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199203|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138199204|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199205|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138199206|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138199208|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138199209|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199210|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
138199211|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
138199212|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199213|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199217|NCT03009877|Rocuronium|rocuronium|mesh-list
138199218|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138199219|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138199220|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199222|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
138199223|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
138199224|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138199225|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138199226|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138199227|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138199228|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
138199229|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
138199230|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199231|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199232|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138199233|NCT03009877|Narcotics|narcotics|mesh-ancestor
138199234|NCT03009877|Analgesics|analgesics|mesh-ancestor
138199236|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199237|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138199238|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138199240|NCT00002392|Thalidomide|thalidomide|mesh-list
138199241|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199249|NCT00002392|Growth Substances|growth substances|mesh-ancestor
138199250|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
138199251|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199254|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
138199255|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199258|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199259|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199260|NCT00997139|Polymyxins|polymyxins|mesh-list
138199262|NCT00997139|Bacitracin|bacitracin|mesh-list
138199263|NCT00997139|Polymyxin B|polymyxin b|mesh-list
138199264|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
138199265|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199266|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199267|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138199268|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344308|NCT03229499|Anastrozole|anastrozole|mesh-list
138199269|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199270|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138199272|NCT00002236|Delavirdine|delavirdine|mesh-list
138199273|NCT00002236|Indinavir|indinavir|mesh-list
138199275|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199276|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199278|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199280|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344309|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199283|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199284|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199287|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
138199288|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138199289|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199290|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199291|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199292|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
138199299|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199300|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138199301|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
138199302|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
138199303|NCT02393690|Iodine|iodine|mesh-list
138199304|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
138199305|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138199306|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199307|NCT02393690|Trace Elements|trace elements|mesh-ancestor
138199308|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
138199309|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199311|NCT01200433|Propofol|propofol|mesh-list
138199312|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138199314|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199315|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199318|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199319|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138199320|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138199321|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138199322|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138199323|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199324|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199325|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138199326|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
138199328|NCT00002410|Lamivudine|lamivudine|mesh-list
138199329|NCT00002410|Zidovudine|zidovudine|mesh-list
138199330|NCT00002410|Indinavir|indinavir|mesh-list
138199334|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199336|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199337|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199338|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199339|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
138199340|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199341|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199342|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199344|NCT01243333|Alovudine|alovudine|mesh-list
138199345|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
138199346|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138199353|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199354|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199356|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138199357|NCT01924052|Katacalcin|katacalcin|mesh-list
138199358|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138199359|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199360|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138199361|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
138199362|NCT00002416|Lamivudine|lamivudine|mesh-list
138199363|NCT00002416|Emtricitabine|emtricitabine|mesh-list
138199364|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199366|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199367|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199368|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
138199369|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199370|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199371|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199372|NCT00002254|Alovudine|alovudine|mesh-list
138199376|NCT01243567|Bimatoprost|bimatoprost|mesh-list
138199377|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138199378|NCT01243567|Latanoprost|latanoprost|mesh-list
138199379|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138199380|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138199381|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138199382|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138199383|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199384|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199385|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199386|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138199387|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138199391|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138199393|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138199394|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138199395|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
138199396|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
138199397|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199398|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199399|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199400|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138199401|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138199402|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138199403|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138199404|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
138199405|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138199406|NCT01001975|Protective Agents|protective agents|mesh-ancestor
138199407|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199408|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199411|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199412|NCT01444040|Travoprost|travoprost|mesh-list
138199421|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199422|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199423|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199424|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199425|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
138199426|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199427|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
138199431|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199432|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199433|NCT05751304|Analgesics|analgesics|mesh-ancestor
138199434|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
138199435|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199436|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138199437|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138199438|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138199439|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
138199440|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199441|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199442|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138199443|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138199444|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
138199446|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138199447|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138199448|NCT01202071|Rabeprazole|rabeprazole|mesh-list
138199449|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138199450|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199451|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138199452|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199453|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199454|NCT00002428|Vaccines|vaccines|mesh-list
138199455|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
138199456|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199457|NCT01422746|Metformin|metformin|mesh-list
138199458|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138215258|NCT00624416|Isoproterenol|isoproterenol|mesh-list
138199459|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199460|NCT00002272|Foscarnet|foscarnet|mesh-list
138199465|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199466|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199467|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199483|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199484|NCT00002434|Antidotes|antidotes|mesh-ancestor
138199485|NCT00002434|Protective Agents|protective agents|mesh-ancestor
138199486|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
138199487|NCT00002434|Vitamins|vitamins|mesh-ancestor
138199488|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
138199489|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
138199490|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199491|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199492|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
138199493|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199494|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199495|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138199496|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199497|NCT00002278|Diclazuril|diclazuril|mesh-list
138199498|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
138199499|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138199500|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138199501|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199502|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
138199503|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
138199504|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
138199505|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199506|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199507|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199508|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138199509|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
138199510|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
138199511|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199512|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199513|NCT01003301|Omalizumab|omalizumab|mesh-list
138199514|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138199515|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138199516|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
138199517|NCT00002440|Ritonavir|ritonavir|mesh-list
138199518|NCT00002440|Nelfinavir|nelfinavir|mesh-list
138199519|NCT00002440|Indinavir|indinavir|mesh-list
138199521|NCT00002440|Amprenavir|amprenavir|mesh-list
138199522|NCT00002440|Abacavir|abacavir|mesh-list
138199523|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199535|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199536|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138199537|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
138199538|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199540|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199542|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
138199543|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199544|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199545|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199546|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
138199547|NCT01421810|Hormones|hormones|mesh-ancestor
138199548|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199549|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199550|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199552|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
138199553|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199554|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199555|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199556|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199557|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
138199558|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199559|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199560|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199563|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138199564|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138199565|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199566|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199568|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199569|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138199570|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
138199571|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138199572|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138199573|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199574|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199575|NCT00002446|Fluconazole|fluconazole|mesh-list
138199576|NCT00002446|Posaconazole|posaconazole|mesh-list
138199577|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
138199578|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199579|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138199580|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199581|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199582|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199583|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138199584|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138199585|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199586|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199587|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138199588|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138199589|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138199590|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138199591|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138199592|NCT01884740|Bevacizumab|bevacizumab|mesh-list
138199593|NCT01884740|Cetuximab|cetuximab|mesh-list
138199594|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138199595|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199596|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138199597|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138199598|NCT01884740|Growth Substances|growth substances|mesh-ancestor
138199599|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199600|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
138199601|NCT00002290|Zidovudine|zidovudine|mesh-list
138199602|NCT00002290|Acyclovir|acyclovir|mesh-list
138199603|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
138199604|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199605|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199606|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199607|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199608|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
138199609|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199610|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199611|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199612|NCT01003769|Acetic Acid|acetic acid|mesh-list
138199613|NCT01003769|Lenalidomide|lenalidomide|mesh-list
138199614|NCT01003769|Retinol acetate|retinol acetate|mesh-list
138199615|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
138199616|NCT01003769|Gossypol|gossypol|mesh-list
138199617|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
138199618|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199619|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138199620|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138199621|NCT01003769|Growth Substances|growth substances|mesh-ancestor
138199622|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
138199623|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199624|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199626|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138199628|NCT01003769|Protective Agents|protective agents|mesh-ancestor
138199629|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138199632|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199634|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138199635|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138199636|NCT00002452|Indinavir|indinavir|mesh-list
138199637|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138199638|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199639|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199641|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199643|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199644|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
138199645|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199646|NCT01004393|Bromides|bromides|mesh-list
138199647|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
138199648|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
138199649|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138199650|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199651|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
138199652|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199653|NCT00002458|Antibodies|antibodies|mesh-list
138199654|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138199655|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
138199656|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199657|NCT00002470|Interferons|interferons|mesh-list
138199658|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
138199659|NCT00002470|Fluorouracil|fluorouracil|mesh-list
138199660|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
138215259|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138199661|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199662|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199663|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199664|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199665|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
138199666|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199667|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
138199672|NCT00002476|Methotrexate|methotrexate|mesh-list
138199673|NCT00002476|Vincristine|vincristine|mesh-list
138199674|NCT00002476|Bleomycin|bleomycin|mesh-list
138199675|NCT00002476|Calcium|calcium|mesh-list
138199676|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
138199677|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138199678|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199679|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
138199680|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199681|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199682|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199691|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199692|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199694|NCT00002476|Protective Agents|protective agents|mesh-ancestor
138199695|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
138199696|NCT00002476|Vitamins|vitamins|mesh-ancestor
138199697|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
138199700|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
138199701|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199703|NCT00002476|Trace Elements|trace elements|mesh-ancestor
138199705|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
138199706|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
138199707|NCT01876628|Floxacillin|floxacillin|mesh-list
138199708|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199709|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199710|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138199711|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344310|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199712|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199713|NCT01004705|Aspirin|aspirin|mesh-list
138199714|NCT01004705|Ramipril|ramipril|mesh-list
138199716|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138199717|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138199718|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
138199719|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199720|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138199721|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138199722|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199724|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199725|NCT01004705|Analgesics|analgesics|mesh-ancestor
138344311|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138199727|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199728|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199729|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199731|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138199732|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138215260|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
138199733|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138199734|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138199735|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
138199736|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138199737|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199738|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138199739|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
138199740|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
138199741|NCT00002482|Antibodies|antibodies|mesh-list
138199742|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199743|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
138199745|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199746|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138199747|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
138199748|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199752|NCT01004939|Fondaparinux|fondaparinux|mesh-list
138199754|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
138199755|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138199756|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199758|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199759|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
138199760|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138199761|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138199762|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
138199763|NCT00002488|Etoposide|etoposide|mesh-list
138199764|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199765|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
138199766|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199767|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199768|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138199769|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
138199770|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199771|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199772|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138199773|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199775|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138199778|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138199779|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
138199780|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199781|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199785|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138199786|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199787|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199788|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138199789|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138199791|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199792|NCT01245595|Protective Agents|protective agents|mesh-ancestor
138199793|NCT01864772|Cetuximab|cetuximab|mesh-list
138199795|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199796|NCT00002494|Leucovorin|leucovorin|mesh-list
138199797|NCT00002494|Cobalt|cobalt|mesh-list
138199798|NCT00002494|Cytarabine|cytarabine|mesh-list
138199799|NCT00002494|Dexamethasone|dexamethasone|mesh-list
138199800|NCT00002494|Prednisone|prednisone|mesh-list
138199801|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
138344312|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138344313|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199802|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138199804|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138199805|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
138199806|NCT00002494|Ifosfamide|ifosfamide|mesh-list
138199809|NCT00002494|Methotrexate|methotrexate|mesh-list
138199810|NCT00002494|Etoposide|etoposide|mesh-list
138199813|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199815|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199816|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199817|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138199818|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
138199819|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199820|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199821|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138199822|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199824|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
138199825|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199826|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199827|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
138199828|NCT00002494|Hormones|hormones|mesh-ancestor
138199829|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199830|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199831|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138199832|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138199833|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138199834|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199835|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138199836|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
138199837|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199838|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199839|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
138199841|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138199842|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199843|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199844|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
138199845|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199846|NCT00002494|Antidotes|antidotes|mesh-ancestor
138199847|NCT00002494|Protective Agents|protective agents|mesh-ancestor
138199848|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
138199849|NCT00002494|Vitamins|vitamins|mesh-ancestor
138199850|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
138199851|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
138199852|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
138199853|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199854|NCT00002494|Trace Elements|trace elements|mesh-ancestor
138199855|NCT00002506|Interferons|interferons|mesh-list
138199856|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
138199857|NCT00002506|Isotretinoin|isotretinoin|mesh-list
138199858|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199859|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
138199866|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199867|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138199868|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
138199869|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199870|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199871|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199872|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199873|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
138199874|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138199875|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138199876|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138199877|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138199878|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199879|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
138199880|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138199881|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199882|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138199883|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199884|NCT05750446|Riociguat|riociguat|mesh-list
138199885|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
138199886|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199887|NCT05750290|Irinotecan|irinotecan|mesh-list
138199888|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138199889|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138199890|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199891|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199892|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199893|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
138199894|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199895|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
138199896|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
138199897|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199898|NCT01840046|Interleukin-2|interleukin-2|mesh-list
138199899|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199901|NCT01840046|Analgesics|analgesics|mesh-ancestor
138199902|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
138199903|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199904|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199906|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199907|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
138199908|NCT00437216|Hormones|hormones|mesh-ancestor
138199909|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199910|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199911|NCT00002524|Leucovorin|leucovorin|mesh-list
138199912|NCT00002524|Cytarabine|cytarabine|mesh-list
138199913|NCT00002524|Zidovudine|zidovudine|mesh-list
138199914|NCT00002524|Trimethoprim|trimethoprim|mesh-list
138199915|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
138199916|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138199918|NCT00002524|Prednisone|prednisone|mesh-list
138199919|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
138199920|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138199921|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138199924|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
138199925|NCT00002524|Ifosfamide|ifosfamide|mesh-list
138199926|NCT00002524|Doxorubicin|doxorubicin|mesh-list
138199927|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138199928|NCT00002524|Fluorouracil|fluorouracil|mesh-list
138199929|NCT00002524|Methotrexate|methotrexate|mesh-list
138199930|NCT00002524|Etoposide|etoposide|mesh-list
138199931|NCT00002524|Vincristine|vincristine|mesh-list
138199932|NCT00002524|Bleomycin|bleomycin|mesh-list
138199933|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138199934|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
138199935|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
138199936|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199937|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
138199938|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199939|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199940|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138199941|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
138199942|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199943|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199944|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138199945|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138199946|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138199947|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138199948|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199949|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
138199950|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138199951|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199953|NCT00002524|Hormones|hormones|mesh-ancestor
138199954|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138199955|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138199956|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138199957|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
138199958|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199961|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199962|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199963|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
138199964|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199965|NCT00002524|Antidotes|antidotes|mesh-ancestor
138199966|NCT00002524|Protective Agents|protective agents|mesh-ancestor
138199967|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
138199968|NCT00002524|Vitamins|vitamins|mesh-ancestor
138199970|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138199971|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138199972|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199973|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
138199974|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
138199975|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199976|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138199977|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138199978|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199979|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199980|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199981|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138199982|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
138199983|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138199984|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138199985|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138199986|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138199987|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199988|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199989|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
138199990|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138199992|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199993|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138199994|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
138199996|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199997|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199999|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
138200000|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200001|NCT01344200|Celecoxib|celecoxib|mesh-list
138200003|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200004|NCT01344200|Analgesics|analgesics|mesh-ancestor
138200005|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
138200006|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200007|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200008|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200009|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200010|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138200011|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138200012|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200013|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200015|NCT01204255|Promethazine|promethazine|mesh-list
138200016|NCT01204255|Lorazepam|lorazepam|mesh-list
138200020|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138200021|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200022|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200023|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138200024|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
138200025|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
138200026|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200027|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
138200029|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200030|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138200031|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
138200032|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
138200033|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200034|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200035|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138200036|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
138200038|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138200039|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138200040|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138200041|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138200042|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
138200045|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138200046|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
138200047|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
138200049|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
138200050|NCT00002542|Doxorubicin|doxorubicin|mesh-list
138200051|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138200052|NCT00002542|Fluorouracil|fluorouracil|mesh-list
138200053|NCT00002542|Methotrexate|methotrexate|mesh-list
138200054|NCT00002542|Epirubicin|epirubicin|mesh-list
138200055|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200056|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
138200057|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200058|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200059|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200060|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
138200061|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200062|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200063|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200064|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200065|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200067|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200069|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200070|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138200072|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200073|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200076|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138200078|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200080|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138200081|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138200082|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138200084|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138200085|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200087|NCT03011125|Lansoprazole|lansoprazole|mesh-list
138200088|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138200089|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200090|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138200091|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200092|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200093|NCT05749900|Gemcitabine|gemcitabine|mesh-list
138200094|NCT05749900|Nivolumab|nivolumab|mesh-list
138200095|NCT05749900|Trastuzumab|trastuzumab|mesh-list
138200097|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200117|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
138200118|NCT05749666|Tofacitinib|tofacitinib|mesh-list
138200119|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200122|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200123|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200124|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200125|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200127|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
138200128|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200129|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200130|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138200131|NCT05749666|Protective Agents|protective agents|mesh-ancestor
138200132|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138200134|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200135|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200143|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200149|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200150|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138200151|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138200152|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
138200153|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
138200155|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138200156|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138200157|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200159|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138200161|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138200162|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200163|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200164|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
138200165|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200166|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138200167|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
138200168|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138200171|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200172|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
138200173|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138200174|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200175|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200176|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138200183|NCT02144831|Aspirin|aspirin|mesh-list
138200184|NCT02144831|Clopidogrel|clopidogrel|mesh-list
138200185|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138200186|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200187|NCT02144831|Analgesics|analgesics|mesh-ancestor
138200188|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
138200189|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200190|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200191|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200192|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200193|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138200200|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138200207|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138200208|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200209|NCT05232461|Analgesics|analgesics|mesh-ancestor
138200210|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
138200211|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200212|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200217|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200218|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200219|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138200220|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200221|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200225|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138200227|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200228|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
138200229|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200233|NCT01313702|Simvastatin|simvastatin|mesh-list
138200234|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138200235|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138200236|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
138200237|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200238|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138200239|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138200240|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200255|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200257|NCT04868708|Bevacizumab|bevacizumab|mesh-list
138200258|NCT04868708|Carboplatin|carboplatin|mesh-list
138200259|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200260|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200262|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200263|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200264|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200265|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138200266|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138200267|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138200268|NCT04868708|Growth Substances|growth substances|mesh-ancestor
138200269|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200270|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
138200271|NCT05732272|Bupropion|bupropion|mesh-list
138200272|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138200273|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
138200274|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138200275|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138200276|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138200277|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200278|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200279|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
138200280|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200281|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200282|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138200283|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138200285|NCT05513872|Nicotine|nicotine|mesh-list
138200288|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200289|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200290|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138200291|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138200292|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
138200293|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200294|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200295|NCT00382330|Ciclopirox|ciclopirox|mesh-list
138200297|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200298|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
138200299|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138200300|NCT05520892|Antibodies|antibodies|mesh-list
138200301|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
138200302|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138200303|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
138200304|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200305|NCT05397964|Calcium|calcium|mesh-list
138200306|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200307|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200308|NCT00002548|Interferons|interferons|mesh-list
138200309|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
138200310|NCT00002548|Dexamethasone|dexamethasone|mesh-list
138200311|NCT00002548|Prednisone|prednisone|mesh-list
138200312|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
138200313|NCT00002548|Melphalan|melphalan|mesh-list
138200314|NCT00002548|Carmustine|carmustine|mesh-list
138200315|NCT00002548|Doxorubicin|doxorubicin|mesh-list
138200316|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138200317|NCT00002548|Vincristine|vincristine|mesh-list
138200318|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200320|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200322|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200323|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
138200324|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200325|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200326|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200327|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200328|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
138200329|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
138200330|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200331|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200332|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
138200333|NCT00002548|Hormones|hormones|mesh-ancestor
138200334|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200335|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200336|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200337|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200338|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200339|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200340|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
138200354|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200355|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200356|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200357|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
138200358|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200359|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200360|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200361|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138200362|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
138200363|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200364|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200366|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200367|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200368|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138200369|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138200371|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138200372|NCT00002560|Sargramostim|sargramostim|mesh-list
138200373|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
138200374|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200375|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
138200376|NCT00002566|Ifosfamide|ifosfamide|mesh-list
138200377|NCT00002566|Carboplatin|carboplatin|mesh-list
138200378|NCT00002566|Etoposide|etoposide|mesh-list
138200379|NCT00002566|Vinblastine|vinblastine|mesh-list
138200380|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200381|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
138200382|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200383|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200384|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200385|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
138200386|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200388|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200389|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200390|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200392|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200394|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200395|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200396|NCT00002572|Aldesleukin|aldesleukin|mesh-list
138200403|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
138200404|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200405|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200406|NCT00002578|Leucovorin|leucovorin|mesh-list
138200407|NCT00002578|Cytarabine|cytarabine|mesh-list
138200408|NCT00002578|Methotrexate|methotrexate|mesh-list
138200409|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
138200410|NCT00002578|Calcium|calcium|mesh-list
138200411|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
138200412|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200414|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138200415|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
138200416|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200417|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200418|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
138200419|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200429|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200431|NCT00002578|Protective Agents|protective agents|mesh-ancestor
138200432|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
138200433|NCT00002578|Vitamins|vitamins|mesh-ancestor
138200434|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
138200435|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
138200436|NCT00002596|Carboplatin|carboplatin|mesh-list
138200437|NCT00002596|Etoposide|etoposide|mesh-list
138200438|NCT00002596|Bleomycin|bleomycin|mesh-list
138200440|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
138200441|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200442|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200443|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200445|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200446|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200447|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200449|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200450|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200458|NCT00199082|Rituximab|rituximab|mesh-list
138200459|NCT00199082|Methotrexate|methotrexate|mesh-list
138200460|NCT00199082|Vincristine|vincristine|mesh-list
138200465|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200466|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200467|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200468|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
138200469|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200476|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200477|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
138200479|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200480|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200481|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138200482|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138200483|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
138200484|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200485|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200486|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
138200487|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200488|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200489|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138200490|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138200491|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
138200492|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200494|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200495|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200499|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200500|NCT00194090|Celecoxib|celecoxib|mesh-list
138200501|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138200502|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200503|NCT00194090|Analgesics|analgesics|mesh-ancestor
138200504|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
138200505|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200509|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138200510|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138200511|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200512|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200513|NCT00002608|Tamoxifen|tamoxifen|mesh-list
138200514|NCT00002608|Doxorubicin|doxorubicin|mesh-list
138200515|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138200516|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200517|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200518|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200519|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200521|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200522|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138200523|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
138200524|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200525|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200532|NCT00002620|Mitolactol|mitolactol|mesh-list
138200535|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200537|NCT00002620|Trace Elements|trace elements|mesh-ancestor
138200538|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
138200539|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200540|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138200541|NCT00002638|Cytarabine|cytarabine|mesh-list
138200542|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
138200543|NCT00002638|Carmustine|carmustine|mesh-list
138200544|NCT00002638|Etoposide|etoposide|mesh-list
138200552|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200553|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200557|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200558|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200559|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200560|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
138200561|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
138200562|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200563|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138200564|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138200565|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200566|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200567|NCT01896440|Ondansetron|ondansetron|mesh-list
138200568|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
138200571|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200572|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200573|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
138200574|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200575|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138200576|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138200578|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200579|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200581|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200582|NCT00002662|Paclitaxel|paclitaxel|mesh-list
138200583|NCT00002662|Docetaxel|docetaxel|mesh-list
138200584|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200585|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200586|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200588|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200589|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200591|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200592|NCT00002674|Cytarabine|cytarabine|mesh-list
138200593|NCT00002674|Etoposide|etoposide|mesh-list
138200595|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
138200596|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200598|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200599|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200600|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200601|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200602|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200603|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
138200604|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
138200605|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200606|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200607|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
138200608|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200609|NCT00002674|Analgesics|analgesics|mesh-ancestor
138200610|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
138200611|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200612|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
138200613|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138200614|NCT01743872|Dextrans|dextrans|mesh-list
138200615|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
138200616|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
138200617|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
138200618|NCT00002680|Tamoxifen|tamoxifen|mesh-list
138200619|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
138200620|NCT00002680|Melphalan|melphalan|mesh-list
138200621|NCT00002680|Thiotepa|thiotepa|mesh-list
138200622|NCT00002680|Megestrol|megestrol|mesh-list
138200623|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
138200624|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200625|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
138200626|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200627|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200634|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
138200635|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200636|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200639|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138200640|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138200641|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138200642|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138200643|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
138200644|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200645|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138200646|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138200647|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
138200648|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138200649|NCT00002692|Leucovorin|leucovorin|mesh-list
138200653|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200654|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200655|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
138200656|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200657|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200658|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200659|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200661|NCT00002692|Antidotes|antidotes|mesh-ancestor
138200662|NCT00002692|Protective Agents|protective agents|mesh-ancestor
138200663|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
138200664|NCT00002692|Vitamins|vitamins|mesh-ancestor
138200665|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
138200666|NCT05293210|Dexamethasone|dexamethasone|mesh-list
138200667|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200668|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
138200671|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200672|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200673|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
138200674|NCT05293210|Hormones|hormones|mesh-ancestor
138200675|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200676|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200683|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200684|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200685|NCT01895348|Analgesics|analgesics|mesh-ancestor
138200686|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
138200687|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200688|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138200689|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138200692|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200693|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200694|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138200696|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
138200697|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138200698|NCT01895348|Narcotics|narcotics|mesh-ancestor
138200700|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138200701|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200702|NCT05073718|Analgesics|analgesics|mesh-ancestor
138200703|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
138200704|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200706|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200707|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200708|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138200709|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138200710|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200711|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138200712|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138200713|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200714|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
138200715|NCT04784000|Carbamazepine|carbamazepine|mesh-list
138200716|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
138200717|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
138200718|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138200719|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200720|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200721|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138200722|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200723|NCT04784000|Analgesics|analgesics|mesh-ancestor
138200725|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200727|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200728|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200729|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138200732|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200733|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138200734|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200735|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200736|NCT01113476|Paclitaxel|paclitaxel|mesh-list
138200737|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138200738|NCT01113476|Bevacizumab|bevacizumab|mesh-list
138200739|NCT01113476|Gemcitabine|gemcitabine|mesh-list
138200740|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200741|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200742|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200743|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200745|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200746|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138200747|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138200748|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138200753|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
138200754|NCT01107236|Naproxen|naproxen|mesh-list
138200755|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138200756|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200757|NCT01107236|Analgesics|analgesics|mesh-ancestor
138200758|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
138200759|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200760|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200761|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200762|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200763|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
138200764|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138200765|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200766|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200767|NCT00002704|Leucovorin|leucovorin|mesh-list
138200768|NCT00002704|Cytarabine|cytarabine|mesh-list
138200769|NCT00002704|Dexamethasone|dexamethasone|mesh-list
138200771|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138200772|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138200773|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138200776|NCT00002704|Methotrexate|methotrexate|mesh-list
138200778|NCT00002704|Vincristine|vincristine|mesh-list
138200779|NCT00002704|Daunorubicin|daunorubicin|mesh-list
138200780|NCT00002704|Asparaginase|asparaginase|mesh-list
138200781|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
138200782|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
138200783|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200784|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
138200785|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200786|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200789|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200790|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200791|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200792|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200793|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
138200794|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
138200795|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200798|NCT00002704|Hormones|hormones|mesh-ancestor
138200799|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200800|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200801|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138200802|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
138200803|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138200804|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200807|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200808|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138200809|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138200810|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200811|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200812|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200814|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200816|NCT00002704|Protective Agents|protective agents|mesh-ancestor
138200817|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
138200819|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
138200821|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200822|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200823|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200824|NCT00002716|Leucovorin|leucovorin|mesh-list
138200825|NCT00002716|Dexamethasone|dexamethasone|mesh-list
138200826|NCT00002716|Fluorouracil|fluorouracil|mesh-list
138200827|NCT00002716|Floxuridine|floxuridine|mesh-list
138200829|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
138200830|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200831|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
138200832|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
138200833|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200834|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200835|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200836|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
138200838|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200839|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200840|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200843|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200844|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200845|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200846|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
138200847|NCT00002716|Antidotes|antidotes|mesh-ancestor
138200848|NCT00002716|Protective Agents|protective agents|mesh-ancestor
138200849|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
138200850|NCT00002716|Vitamins|vitamins|mesh-ancestor
138200851|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
138200852|NCT02533674|Gemcitabine|gemcitabine|mesh-list
138200853|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200854|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
138200855|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200856|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200857|NCT00002722|Leucovorin|leucovorin|mesh-list
138200858|NCT00002722|Fluorouracil|fluorouracil|mesh-list
138200859|NCT00002722|Calcium|calcium|mesh-list
138200860|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
138200861|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200862|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200863|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200864|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
138200866|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200867|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200868|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
138200869|NCT00002722|Antidotes|antidotes|mesh-ancestor
138200870|NCT00002722|Protective Agents|protective agents|mesh-ancestor
138200871|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
138200872|NCT00002722|Vitamins|vitamins|mesh-ancestor
138200873|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
138200874|NCT00002734|Interferons|interferons|mesh-list
138200875|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
138200876|NCT00002734|Paclitaxel|paclitaxel|mesh-list
138200878|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138200879|NCT00002734|Antibodies|antibodies|mesh-list
138200880|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
138200881|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138200882|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200883|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200884|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200885|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200886|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200887|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200888|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
138200889|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200890|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
138200891|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200892|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138200894|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200895|NCT04783610|Ethanol|ethanol|mesh-list
138200896|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138200897|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200898|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200899|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200900|NCT00002740|Cobalt|cobalt|mesh-list
138200901|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
138200902|NCT00002740|Carboplatin|carboplatin|mesh-list
138200903|NCT00002740|Doxorubicin|doxorubicin|mesh-list
138200904|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138200905|NCT00002740|Etoposide|etoposide|mesh-list
138200908|NCT00002740|Mesna|mesna|mesh-list
138200909|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200910|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
138200911|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200912|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200913|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200914|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
138200915|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200916|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200917|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200918|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200919|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200920|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200921|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200922|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200923|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138200924|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200928|NCT00002740|Trace Elements|trace elements|mesh-ancestor
138200929|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
138200930|NCT00002746|Aldesleukin|aldesleukin|mesh-list
138200931|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200932|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138200933|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138200934|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
138200935|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200936|NCT01049945|Dexamethasone|dexamethasone|mesh-list
138200937|NCT01049945|Lenalidomide|lenalidomide|mesh-list
138200938|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138200939|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200940|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
138200943|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200944|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200945|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
138200947|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200948|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200949|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200950|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
138200951|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138200952|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138200953|NCT01049945|Growth Substances|growth substances|mesh-ancestor
138200954|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
138200955|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200956|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
138200957|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200958|NCT00002752|Antibodies|antibodies|mesh-list
138200959|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138200960|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
138200969|NCT01050647|Progestins|progestins|mesh-ancestor
138200970|NCT01050647|Hormones|hormones|mesh-ancestor
138200972|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200974|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138200975|NCT00002764|Ifosfamide|ifosfamide|mesh-list
138200976|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200977|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200978|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200979|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138200980|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200981|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200982|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200983|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
138200995|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200996|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200997|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138200998|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
138200999|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138201001|NCT00002590|Cytarabine|cytarabine|mesh-list
138201002|NCT00002590|Prednisone|prednisone|mesh-list
138201003|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
138201004|NCT00002590|Doxorubicin|doxorubicin|mesh-list
138201005|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138201006|NCT00002590|Methotrexate|methotrexate|mesh-list
138201008|NCT00002590|Vincristine|vincristine|mesh-list
138201009|NCT00002590|Daunorubicin|daunorubicin|mesh-list
138201010|NCT00002590|Asparaginase|asparaginase|mesh-list
138201011|NCT00002590|Pegaspargase|pegaspargase|mesh-list
138201012|NCT00002590|Thioguanine|thioguanine|mesh-list
138201013|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
138201014|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201015|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
138201016|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201017|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201018|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201019|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
138201020|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201021|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201022|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138201023|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201024|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138201025|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138201026|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201027|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201028|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
138201029|NCT00002590|Hormones|hormones|mesh-ancestor
138201030|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201031|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201032|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138201033|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
138201034|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201035|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201036|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
138201037|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201038|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138201039|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138201040|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138201041|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
138201042|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201043|NCT00002590|Antidotes|antidotes|mesh-ancestor
138201044|NCT00002590|Protective Agents|protective agents|mesh-ancestor
138201045|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
138201046|NCT00002590|Vitamins|vitamins|mesh-ancestor
138201047|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
138201048|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
138201049|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
138201050|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201053|NCT00002788|Etoposide|etoposide|mesh-list
138201054|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201055|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
138201056|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201057|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201058|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201062|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138201063|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201065|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
138201066|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201067|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201068|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
138201071|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201072|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138201073|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138201074|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138201075|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201076|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
138201079|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138201080|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201081|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201082|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201083|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201088|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201089|NCT04783792|Vitamins|vitamins|mesh-ancestor
138201090|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
138201092|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
138201093|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201094|NCT01052831|Naltrexone|naltrexone|mesh-list
138201095|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138201096|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138201097|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201098|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
138201099|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201100|NCT04330300|Losartan|losartan|mesh-list
138201109|NCT04330300|Olmesartan|olmesartan|mesh-list
138201110|NCT04330300|Enalapril|enalapril|mesh-list
138201111|NCT04330300|Lisinopril|lisinopril|mesh-list
138201112|NCT04330300|Irbesartan|irbesartan|mesh-list
138201113|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
138201114|NCT04330300|Perindopril|perindopril|mesh-list
138201115|NCT04330300|Diltiazem|diltiazem|mesh-list
138201120|NCT04330300|Nimodipine|nimodipine|mesh-list
138201121|NCT04330300|Quinapril|quinapril|mesh-list
138201122|NCT04330300|Metolazone|metolazone|mesh-list
138201123|NCT04330300|Trandolapril|trandolapril|mesh-list
138201124|NCT04330300|Fosinopril|fosinopril|mesh-list
138201125|NCT04330300|Eprosartan|eprosartan|mesh-list
138201128|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
138201129|NCT04330300|Nifedipine|nifedipine|mesh-list
138201130|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
138201131|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138201132|NCT04330300|Diuretics|diuretics|mesh-list
138201133|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138201134|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138201135|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201140|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138201142|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
138201143|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138201144|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
138201145|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201146|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
138201147|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201148|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138201156|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138201157|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201158|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201159|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138201160|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
138201161|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138201162|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201164|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201165|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201166|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201167|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
138201168|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138201169|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
138201170|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201171|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201172|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138201173|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138201174|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138201175|NCT00382642|Ondansetron|ondansetron|mesh-list
138201176|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
138201177|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
138201178|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201179|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201180|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201181|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
138201182|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201183|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138201184|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138201185|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
138201186|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201187|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201188|NCT01054079|Cinacalcet|cinacalcet|mesh-list
138201189|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138201190|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201191|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138201192|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
138201193|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201194|NCT02544750|Cannabidiol|cannabidiol|mesh-list
138201206|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201207|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
138201208|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201209|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201210|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201211|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
138201213|NCT04748848|Venetoclax|venetoclax|mesh-list
138201214|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
138201215|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201216|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
138201217|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201218|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201219|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201220|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138201221|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
138201222|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138201223|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138201224|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201225|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201226|NCT01620788|Losartan|losartan|mesh-list
138201227|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138201231|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138201232|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138201233|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201234|NCT01620788|Diuretics|diuretics|mesh-ancestor
138201235|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
138201236|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201246|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201248|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
138201249|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138201250|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138201254|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201255|NCT03852797|Ketamine|ketamine|mesh-list
138201256|NCT03852797|Propofol|propofol|mesh-list
138201257|NCT03852797|Etomidate|etomidate|mesh-list
138201258|NCT03852797|Oxytocin|oxytocin|mesh-list
138201259|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138201260|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201261|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201262|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138201263|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
138201264|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
138201265|NCT03852797|Analgesics|analgesics|mesh-ancestor
138201266|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
138201267|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201268|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138201269|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138201270|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138201271|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201274|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201275|NCT01055171|Propranolol|propranolol|mesh-list
138201276|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138201277|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138201278|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
138201279|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201286|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138201287|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138201288|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201289|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201290|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201298|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201299|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201300|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201303|NCT04349722|Scopolamine|scopolamine|mesh-list
138201304|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138201305|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138201306|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
138201307|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
138201308|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201309|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201310|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201311|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
138201312|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138201313|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
138201316|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138201317|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
138201319|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138201320|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138201321|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
138201322|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201324|NCT04652518|Analgesics|analgesics|mesh-ancestor
138201325|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
138201326|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201327|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201328|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138201329|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138201330|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201331|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201332|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201333|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138201334|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201335|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138201336|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201337|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201350|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138201351|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138201352|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201353|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201357|NCT04199572|Acetaminophen|acetaminophen|mesh-list
138201358|NCT04199572|Diclofenac|diclofenac|mesh-list
138201359|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138201360|NCT04199572|Analgesics|analgesics|mesh-ancestor
138201361|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
138201362|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201365|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138201366|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201367|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201368|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138201369|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201370|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201372|NCT02169479|Opicapone|opicapone|mesh-list
138201373|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138201374|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
138201375|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201376|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138201377|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138201378|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
138201379|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
138201380|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201381|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201389|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201390|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201392|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138201393|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138201394|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201395|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201396|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138201399|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
138201400|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138201401|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
138201402|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201403|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201405|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138201406|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138201408|NCT01059929|Fentanyl|fentanyl|mesh-list
138201409|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
138201410|NCT01059929|Propofol|propofol|mesh-list
138201411|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138201412|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201413|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201414|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138201415|NCT01059929|Analgesics|analgesics|mesh-ancestor
138201416|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
138201417|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201418|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138201419|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138201420|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138201421|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
138201422|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215277|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201423|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201424|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138201425|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
138201426|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
138201427|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138201428|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138201429|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138201430|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138201444|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
138201445|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
138201446|NCT04896658|Dexamethasone|dexamethasone|mesh-list
138201447|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
138201448|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201449|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
138201450|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201451|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201452|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201453|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
138201454|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201455|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201456|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138201457|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201458|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
138201459|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
138201460|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201461|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201462|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
138201464|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201465|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201466|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
138201467|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138201468|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138201470|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201471|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138201472|NCT04156828|Dexamethasone|dexamethasone|mesh-list
138201473|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
138201474|NCT04156828|Rituximab|rituximab|mesh-list
138201475|NCT04156828|Carboplatin|carboplatin|mesh-list
138201476|NCT04156828|Gemcitabine|gemcitabine|mesh-list
138201477|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138201478|NCT04156828|Antibodies|antibodies|mesh-list
138201479|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
138201480|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138201481|NCT04156828|Lenograstim|lenograstim|mesh-list
138201482|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
138201483|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201484|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201485|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
138201486|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
138201487|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201488|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201489|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
138201490|NCT04156828|Hormones|hormones|mesh-ancestor
138201491|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201492|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201493|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201495|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201496|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
138201497|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201498|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138201499|NCT01063049|Bisacodyl|bisacodyl|mesh-list
138201500|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138201501|NCT01063049|Cathartics|cathartics|mesh-ancestor
138201502|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201503|NCT01063049|Laxatives|laxatives|mesh-ancestor
138201505|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
138201506|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
138201507|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138201508|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201509|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138201510|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201511|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201512|NCT03661138|Upadacitinib|upadacitinib|mesh-list
138201513|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138201514|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138201519|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201521|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138201522|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
138201523|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201524|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201525|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201526|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
138201527|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201528|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201529|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201530|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201531|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138201532|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201533|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
138201534|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201536|NCT05426304|Agomelatine|agomelatine|mesh-list
138201537|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138201538|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201539|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201541|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201542|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201544|NCT00382954|Idarubicin|idarubicin|mesh-list
138201545|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201546|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201547|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138201552|NCT01246063|Doxorubicin|doxorubicin|mesh-list
138201553|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138201554|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201555|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
138201556|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
138201557|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201558|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201559|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201560|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
138201562|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201563|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201564|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201572|NCT03836014|Lenalidomide|lenalidomide|mesh-list
138201573|NCT03836014|Daratumumab|daratumumab|mesh-list
138201574|NCT03836014|BB 1101|bb 1101|mesh-list
138201575|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138201576|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201577|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
138201578|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
138201579|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201580|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201581|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201582|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
138201586|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201587|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
138201588|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201589|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201590|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
138201591|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138201592|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201593|NCT03836014|Growth Substances|growth substances|mesh-ancestor
138201597|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201598|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
138201599|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201600|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201601|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201602|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
138201609|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201610|NCT03187834|Amoxicillin|amoxicillin|mesh-list
138201611|NCT03187834|Azithromycin|azithromycin|mesh-list
138201612|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138201613|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138201615|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138201621|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
138201622|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201623|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201624|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
138201626|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138201627|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138201628|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201629|NCT01158703|Aspirin|aspirin|mesh-list
138201630|NCT01158703|Clopidogrel|clopidogrel|mesh-list
138201631|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138201632|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138201634|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
138201642|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138201643|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138201644|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201645|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
138201646|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138201647|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138201648|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138201649|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
138201650|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201651|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
138201652|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138201653|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
138201654|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201655|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201656|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138201657|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
138201658|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138201660|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201661|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201662|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138201663|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
138201664|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
138201665|NCT03009643|Protective Agents|protective agents|mesh-ancestor
138201666|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138201667|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
138201668|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201670|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138201671|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201672|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201673|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201674|NCT03089866|Midazolam|midazolam|mesh-list
138201675|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138201676|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138201677|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201678|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201679|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138201680|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138201681|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138201682|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138201683|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
138201684|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
138201685|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
138201688|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201690|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201691|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201692|NCT00002896|Leucovorin|leucovorin|mesh-list
138201694|NCT00002896|Fluorouracil|fluorouracil|mesh-list
138201695|NCT00002896|Calcium|calcium|mesh-list
138201696|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
138215887|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
138215888|NCT00639158|Fenofibrate|fenofibrate|mesh-list
138215889|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138215890|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215891|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
138215892|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215893|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215894|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215895|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215896|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
138201757|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201758|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201759|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201760|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201761|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138201762|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138201763|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138201770|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138201771|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138201773|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138201774|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201775|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201776|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
138201777|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201778|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201779|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
138201780|NCT01161121|Adenosine|adenosine|mesh-list
138201781|NCT01161121|Regadenoson|regadenoson|mesh-list
138201782|NCT01161121|Analgesics|analgesics|mesh-ancestor
138201783|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
138201784|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201785|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201786|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138201787|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
138201788|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138201789|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
138201790|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
138201791|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201792|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201793|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138201794|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
138201795|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
138201796|NCT03010579|Hematinics|hematinics|mesh-list
138201797|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
138201798|NCT01214083|Naltrexone|naltrexone|mesh-list
138201799|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138201800|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138201801|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138201802|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201803|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
138201804|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201805|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
138201806|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201813|NCT01214083|Antidotes|antidotes|mesh-ancestor
138201814|NCT01254877|Ondansetron|ondansetron|mesh-list
138201815|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
138201816|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
138201817|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201818|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201819|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201820|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
138201821|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201822|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138201823|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138201832|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
138201833|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201834|NCT03713944|Bevacizumab|bevacizumab|mesh-list
138201835|NCT03713944|Atezolizumab|atezolizumab|mesh-list
138201836|NCT03713944|Carboplatin|carboplatin|mesh-list
138201837|NCT03713944|Pemetrexed|pemetrexed|mesh-list
138201838|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201840|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138216057|NCT00651482|Growth Substances|growth substances|mesh-ancestor
138216058|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216059|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
138216061|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216062|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216063|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216064|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216065|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
138216066|NCT00654836|Bevacizumab|bevacizumab|mesh-list
138216067|NCT00654836|Carboplatin|carboplatin|mesh-list
138216068|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138216069|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201841|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201842|NCT03713944|Growth Substances|growth substances|mesh-ancestor
138201843|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201844|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201845|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201847|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138201848|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138201849|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138201850|NCT01214161|Lidocaine|lidocaine|mesh-list
138201851|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
138201852|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
138201853|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201854|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201855|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
138201856|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201863|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201864|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201865|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
138201866|NCT01214317|Analgesics|analgesics|mesh-ancestor
138201867|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
138201871|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138201872|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138201874|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201875|NCT00383812|Bevacizumab|bevacizumab|mesh-list
138201876|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201877|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201878|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138201886|NCT00002926|Etoposide|etoposide|mesh-list
138201887|NCT00002926|Idarubicin|idarubicin|mesh-list
138201892|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201893|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201894|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201895|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
138201896|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
138201901|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201903|NCT01281007|Famciclovir|famciclovir|mesh-list
138201904|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
138201905|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201906|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138201907|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201908|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201910|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
138201911|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201912|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138201913|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138201914|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201915|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201916|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201917|NCT01281475|Levodopa|levodopa|mesh-list
138201918|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138201919|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138201930|NCT01572662|Tacrolimus|tacrolimus|mesh-list
138216195|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138216196|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216197|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216199|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138216201|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
138216202|NCT01230593|BB 1101|bb 1101|mesh-list
138216203|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216206|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216207|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201931|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138201933|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201934|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201935|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201936|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
138201937|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201938|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201939|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201940|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201941|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138201942|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201943|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
138201945|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138201946|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138201947|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
138201948|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201949|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138201950|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138201952|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138201953|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
138201954|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201955|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201956|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138201957|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
138201959|NCT01555268|Trebananib|trebananib|mesh-list
138201960|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201961|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
138201968|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201969|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138201970|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201971|NCT01555268|Growth Substances|growth substances|mesh-ancestor
138201972|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201973|NCT04781270|Bevacizumab|bevacizumab|mesh-list
138201974|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201975|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201976|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138201977|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201978|NCT04781270|Growth Substances|growth substances|mesh-ancestor
138201979|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201980|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201981|NCT00003394|Paclitaxel|paclitaxel|mesh-list
138201982|NCT00003394|Carboplatin|carboplatin|mesh-list
138201983|NCT00003394|Leuprolide|leuprolide|mesh-list
138201984|NCT00003394|Goserelin|goserelin|mesh-list
138201985|NCT00003394|Estramustine|estramustine|mesh-list
138201986|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138201987|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201988|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
138201989|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
138201990|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201991|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201992|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138201993|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
138201994|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201995|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201996|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201997|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201998|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
138201999|NCT00003400|Melphalan|melphalan|mesh-list
138202000|NCT00003400|Vinorelbine|vinorelbine|mesh-list
138202001|NCT00003400|Carmustine|carmustine|mesh-list
138202002|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202003|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
138202004|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202005|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202006|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
138202007|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202008|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202009|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202010|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202011|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202012|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202013|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202015|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
138202016|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
138202017|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202018|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202019|NCT00002944|Carboplatin|carboplatin|mesh-list
138202020|NCT00002944|Vincristine|vincristine|mesh-list
138202021|NCT00002944|Thioguanine|thioguanine|mesh-list
138202022|NCT00002944|Lomustine|lomustine|mesh-list
138202023|NCT00002944|Procarbazine|procarbazine|mesh-list
138202024|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202027|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202028|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289173|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
138289174|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138289175|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
138289178|NCT00329732|Bupivacaine|bupivacaine|mesh-list
138289179|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
138289180|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
138289181|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289182|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289183|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
138289184|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289185|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138289186|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138289187|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138289188|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289189|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289190|NCT00000782|Vaccines|vaccines|mesh-list
138289191|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
138289192|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289193|NCT00000800|Zidovudine|zidovudine|mesh-list
138289194|NCT00000800|Methadone|methadone|mesh-list
138289195|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
138289196|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289197|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289198|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289199|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289200|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
138289201|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289202|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289203|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202029|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202030|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202032|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202033|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
138202035|NCT04778072|Trace Elements|trace elements|mesh-ancestor
138202039|NCT00002950|Sargramostim|sargramostim|mesh-list
138202040|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138202041|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202042|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202043|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202044|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202045|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
138289204|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289205|NCT00000800|Narcotics|narcotics|mesh-ancestor
138289206|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289207|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289208|NCT00000800|Analgesics|analgesics|mesh-ancestor
138289209|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
138289210|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289211|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
138289212|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
138289214|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
138289215|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138289217|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289218|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289219|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289220|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138289223|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289224|NCT03684265|Meloxicam|meloxicam|mesh-list
138289225|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138289226|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289227|NCT03684265|Analgesics|analgesics|mesh-ancestor
138289228|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
138289229|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202046|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202047|NCT00777140|Deferoxamine|deferoxamine|mesh-list
138202048|NCT00777140|Siderophores|siderophores|mesh-ancestor
138202049|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138202050|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
138202051|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
138202052|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202053|NCT00003406|Carboplatin|carboplatin|mesh-list
138202054|NCT00003406|Docetaxel|docetaxel|mesh-list
138202055|NCT00003406|Ifosfamide|ifosfamide|mesh-list
138202056|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202057|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202058|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202059|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202060|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202062|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
138202063|NCT00003412|Interleukin-12|interleukin-12|mesh-list
138202064|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202065|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
138202066|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202067|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138202068|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138202069|NCT00003412|Growth Substances|growth substances|mesh-ancestor
138202070|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202071|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202072|NCT04780958|Vitamin A|vitamin a|mesh-list
138202073|NCT04780958|Vitamins|vitamins|mesh-ancestor
138202074|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
138202075|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202076|NCT00002968|Edrecolomab|edrecolomab|mesh-list
138202077|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202078|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
138202079|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202086|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138202087|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138202088|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
138202089|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138202090|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
138202091|NCT04780412|Urological Agents|urological agents|mesh-ancestor
138202092|NCT00002974|Carboplatin|carboplatin|mesh-list
138202093|NCT00002974|Etoposide|etoposide|mesh-list
138202108|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
138202111|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138202112|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202113|NCT02612896|Praziquantel|praziquantel|mesh-list
138202114|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
138202115|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138202116|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202117|NCT00002980|Decitabine|decitabine|mesh-list
138289577|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289658|NCT00000944|Indinavir|indinavir|mesh-list
138289659|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289660|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289661|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289662|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289663|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
138289664|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289665|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289666|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289667|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
138289668|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289669|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289672|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
138289673|NCT00000950|Rifampin|rifampin|mesh-list
138289674|NCT00000950|Isoniazid|isoniazid|mesh-list
138289677|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138289678|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
138289679|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289680|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289681|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
138289682|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289683|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289684|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289685|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138289686|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289687|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138289688|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138289689|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138289690|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289691|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138289692|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138289693|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
138202118|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202119|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
138202120|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202121|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202122|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202123|NCT00002986|Topotecan|topotecan|mesh-list
138202124|NCT00002986|Carmustine|carmustine|mesh-list
138202125|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138289966|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289967|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289968|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289969|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138289970|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138289971|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289972|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138289973|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289974|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289975|NCT00000302|Buprenorphine|buprenorphine|mesh-list
138289976|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289977|NCT00000302|Narcotics|narcotics|mesh-ancestor
138289978|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346280|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
138202126|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202127|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202134|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202161|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138202162|NCT04777838|Analgesics|analgesics|mesh-ancestor
138202163|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
138202164|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138202165|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
138202166|NCT00003424|Tamoxifen|tamoxifen|mesh-list
138202167|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138202168|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
138202169|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202170|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202171|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202172|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202173|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138202174|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138202182|NCT00003004|Alvocidib|alvocidib|mesh-list
138202183|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202184|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202185|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202186|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202187|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202188|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202189|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202190|NCT00003004|Growth Substances|growth substances|mesh-ancestor
138202191|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202192|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138202193|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202194|NCT04776512|Bupivacaine|bupivacaine|mesh-list
138202195|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
138202196|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
138202197|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202198|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290551|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290552|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138290553|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138290554|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
138290555|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138290556|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138290557|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290558|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
138290559|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138290560|NCT00000542|Protective Agents|protective agents|mesh-ancestor
138290561|NCT00000542|Diuretics|diuretics|mesh-ancestor
138290562|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
138290563|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138290564|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138290565|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138290566|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138290567|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290568|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290569|NCT00002120|Leucovorin|leucovorin|mesh-list
138290570|NCT00002120|Trimethoprim|trimethoprim|mesh-list
138290571|NCT00002120|Dapsone|dapsone|mesh-list
138202199|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
138202200|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202201|NCT04776590|Tislelizumab|tislelizumab|mesh-list
138202202|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138202203|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202205|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
138202206|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138202207|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138202208|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138202209|NCT00003436|Methotrexate|methotrexate|mesh-list
138202210|NCT00003436|Etoposide|etoposide|mesh-list
138202211|NCT00003436|Daunorubicin|daunorubicin|mesh-list
138202212|NCT00003436|Asparaginase|asparaginase|mesh-list
138202213|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
138202214|NCT00003436|Amsacrine|amsacrine|mesh-list
138202215|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138202216|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
138202217|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138290572|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
138202218|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202219|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202220|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
138202221|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202222|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202224|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202225|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138202226|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202227|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
138202228|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202229|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202230|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202231|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202232|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202233|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
138202234|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290573|NCT00002120|Trimetrexate|trimetrexate|mesh-list
138290574|NCT00002120|Calcium|calcium|mesh-list
138290575|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
138290576|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138290577|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290578|NCT00002120|Antidotes|antidotes|mesh-ancestor
138290579|NCT00002120|Protective Agents|protective agents|mesh-ancestor
138290580|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
138290581|NCT00002120|Vitamins|vitamins|mesh-ancestor
138290582|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
138290583|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138290584|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202235|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138202236|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202237|NCT00003436|Analgesics|analgesics|mesh-ancestor
138202238|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
138202239|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202240|NCT02432378|Celecoxib|celecoxib|mesh-list
138202241|NCT02432378|Cisplatin|cisplatin|mesh-list
138202242|NCT02432378|Vaccines|vaccines|mesh-list
138202243|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
138290585|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
138290586|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138290587|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138290588|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138290589|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290590|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290591|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138202250|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202251|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138202252|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202253|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138202254|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138202255|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202256|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202258|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202259|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
138202260|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202261|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202262|NCT00003478|Antibodies|antibodies|mesh-list
138202263|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202264|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
138202265|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202266|NCT00003016|Tamoxifen|tamoxifen|mesh-list
138202267|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138202268|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
138202269|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202270|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202271|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202272|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202273|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138202274|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138202275|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138202277|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202278|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
138202279|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202281|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202282|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202283|NCT00003484|Irinotecan|irinotecan|mesh-list
138202284|NCT00003484|Carmustine|carmustine|mesh-list
138202285|NCT00003484|Antibodies|antibodies|mesh-list
138202286|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202287|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
138202288|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202289|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138202290|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202293|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202294|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202295|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
138202296|NCT00003490|Prednisone|prednisone|mesh-list
138202297|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
138202298|NCT00003490|Vincristine|vincristine|mesh-list
138202299|NCT00003490|Sargramostim|sargramostim|mesh-list
138202300|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202301|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
138202302|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202303|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202304|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202305|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
138202306|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202307|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202308|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202309|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138202311|NCT00003490|Hormones|hormones|mesh-ancestor
138202312|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202313|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202314|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202315|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202316|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202317|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202318|NCT00003034|Doxorubicin|doxorubicin|mesh-list
138202319|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202320|NCT00003034|Ranpirnase|ranpirnase|mesh-list
138202321|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202322|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202323|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202326|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202327|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138202328|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
138202329|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138202331|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202332|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138202333|NCT00383890|Analgesics|analgesics|mesh-ancestor
138202334|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
138202335|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202336|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138202337|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138202338|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138202339|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138202340|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202341|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202342|NCT00003046|Interleukin-12|interleukin-12|mesh-list
138202343|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202344|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
138202345|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202346|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138202347|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138202349|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202350|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202351|NCT00003052|Doxorubicin|doxorubicin|mesh-list
138202352|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202353|NCT00003052|Etoposide|etoposide|mesh-list
138202354|NCT00003052|Ifosfamide|ifosfamide|mesh-list
138202355|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202356|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202357|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202358|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202359|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202360|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202361|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202362|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202363|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
138202364|NCT00003058|Troglitazone|troglitazone|mesh-list
138290836|NCT00002168|Lamivudine|lamivudine|mesh-list
138290837|NCT00002168|Zidovudine|zidovudine|mesh-list
138290838|NCT00002168|Didanosine|didanosine|mesh-list
138290839|NCT00002168|Stavudine|stavudine|mesh-list
138290840|NCT00002168|Indinavir|indinavir|mesh-list
138290841|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290842|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290843|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290844|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290845|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
138290846|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290847|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290848|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202371|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138202373|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138202374|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138202375|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138202376|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202377|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202378|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138290849|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
138202379|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138202380|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138202382|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202383|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202384|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138202386|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
138202387|NCT00003064|Paclitaxel|paclitaxel|mesh-list
138202388|NCT00003064|Etoposide|etoposide|mesh-list
138202389|NCT00003064|Carboplatin|carboplatin|mesh-list
138202390|NCT00003064|Topotecan|topotecan|mesh-list
138202391|NCT00003064|Thiotepa|thiotepa|mesh-list
138202392|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
138202393|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202394|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202396|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202397|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202398|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202399|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202400|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202401|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202402|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
138202403|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202404|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138290934|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290935|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290936|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138290937|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290938|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
138290939|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138290942|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138202405|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202406|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
138202407|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202408|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202409|NCT00003544|Irinotecan|irinotecan|mesh-list
138202410|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138202414|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202415|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
138202418|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
138202419|NCT01269424|Temozolomide|temozolomide|mesh-list
138202420|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138291096|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202421|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202422|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
138202423|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202424|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202425|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202426|NCT03395912|Anesthetics|anesthetics|mesh-list
138202427|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
138202428|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202429|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202434|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138202435|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202436|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202437|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202439|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202440|NCT00003562|Carboplatin|carboplatin|mesh-list
138202441|NCT00003562|Docetaxel|docetaxel|mesh-list
138202442|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202443|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202444|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202445|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202446|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202447|NCT04775576|Anesthetics|anesthetics|mesh-list
138202448|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202449|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202450|NCT00003568|Aldesleukin|aldesleukin|mesh-list
138202451|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
138202452|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202453|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138202454|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202455|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
138202456|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202457|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202458|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
138202460|NCT00003070|Enalapril|enalapril|mesh-list
138202461|NCT00003070|Enalaprilat|enalaprilat|mesh-list
138202462|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202463|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202464|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138202465|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138202466|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138202467|NCT00003076|Eflornithine|eflornithine|mesh-list
138202469|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138202470|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138202471|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138202472|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291097|NCT00002318|Bleomycin|bleomycin|mesh-list
138202473|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138202474|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202475|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202476|NCT01896518|Nicotine|nicotine|mesh-list
138202477|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138202478|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
138202479|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291098|NCT00002318|Vincristine|vincristine|mesh-list
138291099|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291100|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291101|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291102|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291103|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291104|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291105|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291106|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138291107|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202480|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202481|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138202482|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138202483|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
138202484|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202486|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138202488|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
138202489|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202490|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
138291108|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202491|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202492|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202493|NCT00003088|Paclitaxel|paclitaxel|mesh-list
138202494|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
138202495|NCT00003088|Doxorubicin|doxorubicin|mesh-list
138202496|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202497|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202498|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202499|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202501|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202502|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202503|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202504|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
138202505|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202506|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202519|NCT00755560|Albendazole|albendazole|mesh-list
138202520|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
138202521|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138202522|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202523|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
138202524|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138202525|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138202526|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202527|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202528|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202529|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202530|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202531|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
138202532|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138202533|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202534|NCT00003118|Fluorouracil|fluorouracil|mesh-list
138202535|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202536|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
138202537|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202538|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202539|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202540|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
138202541|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202544|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138202545|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
138202546|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202547|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202548|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202549|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202550|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
138202551|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138202552|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202553|NCT00003580|Amifostine|amifostine|mesh-list
138202554|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138202555|NCT00003580|Protective Agents|protective agents|mesh-ancestor
138202556|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202557|NCT00056498|Risperidone|risperidone|mesh-list
138202558|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138202559|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
138202560|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202561|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202562|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202564|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138202565|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202566|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138202567|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138202568|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
138202569|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
138202570|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
138202571|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138202572|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138202574|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202575|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202576|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202578|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202579|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202580|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202581|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202582|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202583|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202584|NCT00058370|Vincristine|vincristine|mesh-list
138202585|NCT00058370|Lomustine|lomustine|mesh-list
138202586|NCT00058370|Antibodies|antibodies|mesh-list
138202587|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202588|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
138202589|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202590|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202595|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202596|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202597|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
138202598|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138202599|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138202601|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138202602|NCT00059228|Estrogens|estrogens|mesh-ancestor
138202603|NCT00059228|Hormones|hormones|mesh-ancestor
138202604|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202605|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202606|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138202607|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
138202608|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202609|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138202610|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138202613|NCT00062738|Paroxetine|paroxetine|mesh-list
138202614|NCT00062738|Nortriptyline|nortriptyline|mesh-list
138202615|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138202616|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138202617|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202618|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202619|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202620|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
138202621|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202622|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138202623|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
138202625|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138202626|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138202627|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202628|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138202629|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138202630|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
138202631|NCT00063362|Lamotrigine|lamotrigine|mesh-list
138202632|NCT00063362|Valproic Acid|valproic acid|mesh-list
138202633|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
138202634|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
138202635|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138202636|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202637|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202638|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
138202639|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138202640|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202641|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202642|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
138202643|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138202644|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202645|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138202646|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138202647|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138202649|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202653|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202654|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202655|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138202656|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138202657|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
138202658|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202659|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202660|NCT00067028|Cytarabine|cytarabine|mesh-list
138202663|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202664|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
138202665|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202666|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202667|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
138202668|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202672|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202673|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202674|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202675|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202676|NCT00067808|Decitabine|decitabine|mesh-list
138202677|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202678|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
138202679|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202680|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202681|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202682|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
138202683|NCT00493870|Docetaxel|docetaxel|mesh-list
138202684|NCT00493870|Doxorubicin|doxorubicin|mesh-list
138202685|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202686|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
138202687|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202688|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202689|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202690|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
138202691|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202692|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202693|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202694|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202695|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202705|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
138202706|NCT03287336|Coagulants|coagulants|mesh-ancestor
138202707|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
138202708|NCT00003136|Carboplatin|carboplatin|mesh-list
138202709|NCT00003136|Amifostine|amifostine|mesh-list
138202710|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202711|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
138202712|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202713|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202714|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202715|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
138202716|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202717|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202718|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202719|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138202720|NCT00003136|Protective Agents|protective agents|mesh-ancestor
138202722|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202736|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202737|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202738|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202740|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
138202741|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
138202742|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
138202743|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202744|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202745|NCT00003616|Irinotecan|irinotecan|mesh-list
138202746|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138202747|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202748|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202749|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202750|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202751|NCT01063829|Letermovir|letermovir|mesh-list
138202752|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138202753|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214608|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214609|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214610|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
138214611|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
138214612|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138214613|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138214614|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214615|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214626|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
138214628|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214629|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214630|NCT04224194|Adalimumab|adalimumab|mesh-list
138214631|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138214632|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214633|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214634|NCT00584948|Memantine|memantine|mesh-list
138214635|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138214636|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138214637|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
138202754|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202755|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202756|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
138202761|NCT00072566|Antibodies|antibodies|mesh-list
138202762|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
138202763|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138202764|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
138202765|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
138202766|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202767|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
138202768|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202769|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202770|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202771|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
138202772|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202773|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202774|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202775|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138202776|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138202777|NCT00072566|Growth Substances|growth substances|mesh-ancestor
138202778|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202779|NCT00003622|Paclitaxel|paclitaxel|mesh-list
138202780|NCT00003622|Vinorelbine|vinorelbine|mesh-list
138202781|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291191|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291799|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
138291800|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291801|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138291802|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291803|NCT00002498|Analgesics|analgesics|mesh-ancestor
138291804|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
138291805|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291806|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291807|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291808|NCT00002504|Interferons|interferons|mesh-list
138291809|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
138291810|NCT00002504|Aldesleukin|aldesleukin|mesh-list
138291811|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291812|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
138291813|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291814|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
138291815|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291816|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291817|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291826|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291827|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291828|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
138291829|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291831|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291832|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291833|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291834|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291835|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291836|NCT01500109|Acetaminophen|acetaminophen|mesh-list
138291837|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138291838|NCT01500109|Analgesics|analgesics|mesh-ancestor
138291839|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
138291840|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291841|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291844|NCT00002516|Dactinomycin|dactinomycin|mesh-list
138214638|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214639|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214640|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214641|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138214644|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138214645|NCT00605072|Candesartan|candesartan|mesh-list
138214646|NCT00605072|Candesartan cilexetil|candesartan cilexetil|mesh-list
138214647|NCT00605072|Lisinopril|lisinopril|mesh-list
138214648|NCT00605072|Nifedipine|nifedipine|mesh-list
138214649|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138214650|NCT00605072|Diuretics|diuretics|mesh-ancestor
138214651|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
138214652|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214653|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138202786|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202787|NCT00003148|Aldesleukin|aldesleukin|mesh-list
138202794|NCT00384046|Androgens|androgens|mesh-ancestor
138202796|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202797|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202798|NCT00002800|Cytarabine|cytarabine|mesh-list
138202799|NCT00002800|Etoposide|etoposide|mesh-list
138202800|NCT00002800|Idarubicin|idarubicin|mesh-list
138202801|NCT00002800|Lintuzumab|lintuzumab|mesh-list
138202802|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291845|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
138291846|NCT00002516|Ifosfamide|ifosfamide|mesh-list
138291847|NCT00002516|Doxorubicin|doxorubicin|mesh-list
138291848|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138291849|NCT00002516|Etoposide|etoposide|mesh-list
138291850|NCT00002516|Vincristine|vincristine|mesh-list
138291851|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291852|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
138291853|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291854|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291855|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291856|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
138291857|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291858|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291859|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291860|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291861|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291862|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291863|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291864|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291867|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
138291869|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
138291870|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291871|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291872|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138291873|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291874|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
138291875|NCT00002522|Etoposide|etoposide|mesh-list
138291876|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291877|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
138291878|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291879|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202803|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202804|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202805|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202806|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202807|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202808|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202809|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
138202811|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202812|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202813|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
138202814|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202815|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202816|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138202817|NCT00002806|Vincristine|vincristine|mesh-list
138202818|NCT00002806|Lomustine|lomustine|mesh-list
138202819|NCT00002806|Procarbazine|procarbazine|mesh-list
138202820|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202821|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202825|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202826|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202827|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
138202828|NCT00003160|Paclitaxel|paclitaxel|mesh-list
138202834|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202836|NCT00002812|Dexamethasone|dexamethasone|mesh-list
138202837|NCT00002812|Prednisone|prednisone|mesh-list
138202838|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
138202839|NCT00002812|Doxorubicin|doxorubicin|mesh-list
138202840|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202841|NCT00002812|Methotrexate|methotrexate|mesh-list
138202842|NCT00002812|Vincristine|vincristine|mesh-list
138202843|NCT00002812|Daunorubicin|daunorubicin|mesh-list
138202844|NCT00002812|Asparaginase|asparaginase|mesh-list
138202845|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
138202846|NCT00002812|Idarubicin|idarubicin|mesh-list
138202847|NCT00002812|Pegaspargase|pegaspargase|mesh-list
138202848|NCT00002812|Thioguanine|thioguanine|mesh-list
138202849|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202850|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
138202851|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202852|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202853|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202854|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
138202859|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
138202860|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
138202861|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202862|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138202863|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
138202864|NCT00002812|Hormones|hormones|mesh-ancestor
138202865|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202866|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202867|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202869|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202870|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202871|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138202872|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
138202873|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202874|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202875|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
138202876|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138202882|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202883|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202884|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202885|NCT01258855|Aldesleukin|aldesleukin|mesh-list
138202886|NCT01258855|Aflibercept|aflibercept|mesh-list
138202887|NCT01258855|Interleukin-2|interleukin-2|mesh-list
138202888|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
138202889|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138202890|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138202891|NCT01258855|Growth Substances|growth substances|mesh-ancestor
138202892|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202893|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202894|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202895|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138202896|NCT01258855|Analgesics|analgesics|mesh-ancestor
138202897|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
138202898|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202899|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138202900|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202901|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
138202902|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202903|NCT00003166|Vincristine|vincristine|mesh-list
138202904|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
138202905|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202907|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202908|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202909|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202910|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202911|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202912|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
138202913|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202914|NCT00003172|Interferons|interferons|mesh-list
138202915|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
138202916|NCT00003172|Docetaxel|docetaxel|mesh-list
138202917|NCT00003172|Doxorubicin|doxorubicin|mesh-list
138202918|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202919|NCT00003172|Fluorouracil|fluorouracil|mesh-list
138202920|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
138202921|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202922|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202923|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202924|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202925|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202926|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202927|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202928|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202929|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202930|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
138202931|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202932|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202933|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
138202934|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202935|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
138202936|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202937|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
138202938|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202942|NCT02191033|Nicotine|nicotine|mesh-list
138202943|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138202944|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
138202945|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202946|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202947|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138202948|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138202949|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
138202952|NCT00002818|Cytarabine|cytarabine|mesh-list
138202953|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202955|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202956|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202957|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
138202958|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202959|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202960|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
138202961|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202962|NCT00003640|Doxorubicin|doxorubicin|mesh-list
138202963|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138202964|NCT00003640|Methotrexate|methotrexate|mesh-list
138202965|NCT00003640|Vinblastine|vinblastine|mesh-list
138202966|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202967|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202968|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202969|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202970|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202971|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202972|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138202973|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
138202974|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202975|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202976|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202977|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
138202978|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
138202979|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138202980|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138202981|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
138202982|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202983|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202984|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202985|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202986|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202987|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202988|NCT00002824|Ganciclovir|ganciclovir|mesh-list
138202989|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138202990|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
138202991|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291979|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
138202992|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202993|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202994|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202995|NCT00003178|Idarubicin|idarubicin|mesh-list
138202996|NCT00003178|Cladribine|cladribine|mesh-list
138202997|NCT00003178|Lenograstim|lenograstim|mesh-list
138202998|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202999|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
138203000|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203001|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203002|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203003|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203004|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203009|NCT01260649|Anesthetics|anesthetics|mesh-list
138203010|NCT01260649|Analgesics|analgesics|mesh-ancestor
138203011|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
138203012|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203017|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138203018|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138203019|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138203020|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203021|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203023|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138203024|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138203025|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138203026|NCT01260883|Analgesics|analgesics|mesh-ancestor
138203027|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
138203028|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203029|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203030|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203031|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203032|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138203033|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203034|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203035|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
138203036|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138203037|NCT00423202|Ambrisentan|ambrisentan|mesh-list
138291980|NCT00002552|Carmustine|carmustine|mesh-list
138291981|NCT00002552|Methotrexate|methotrexate|mesh-list
138291982|NCT00002552|Etoposide|etoposide|mesh-list
138291983|NCT00002552|Sargramostim|sargramostim|mesh-list
138291984|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
138291985|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291986|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
138291987|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291988|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291989|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291995|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
138291996|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138291997|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291998|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
138291999|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292000|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292186|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
138292187|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292188|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292191|NCT00002618|Cytarabine|cytarabine|mesh-list
138292192|NCT00002618|Prednisone|prednisone|mesh-list
138292193|NCT00002618|Doxorubicin|doxorubicin|mesh-list
138292194|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292195|NCT00002618|Methotrexate|methotrexate|mesh-list
138292196|NCT00002618|Vincristine|vincristine|mesh-list
138292197|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
138292198|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
138292199|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203038|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138203039|NCT00003184|Vaccines|vaccines|mesh-list
138203040|NCT00003184|Sargramostim|sargramostim|mesh-list
138203041|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
138203042|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
138203043|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203044|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138203045|NCT00003190|Cytarabine|cytarabine|mesh-list
138203046|NCT00003190|Etoposide|etoposide|mesh-list
138203047|NCT00003190|Daunorubicin|daunorubicin|mesh-list
138203048|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
138203049|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203050|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203051|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203052|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203053|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203054|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203055|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203056|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
138203057|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
138203058|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292472|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
138203059|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203060|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
138203061|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203062|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203063|NCT00003652|Fluorouracil|fluorouracil|mesh-list
138203064|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203065|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
138203066|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203067|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203070|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203073|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
138203075|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203076|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
138203077|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203078|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138203079|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138203081|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138203082|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203083|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
138203084|NCT00003658|Rituximab|rituximab|mesh-list
138203085|NCT00003658|Pentostatin|pentostatin|mesh-list
138203088|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203089|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203090|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203091|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
138203092|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203093|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203094|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203095|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138203096|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138203098|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
138203100|NCT00002836|Carmustine|carmustine|mesh-list
138203101|NCT00002836|Cisplatin|cisplatin|mesh-list
138203102|NCT00002836|Etoposide|etoposide|mesh-list
138203103|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203104|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
138292941|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292942|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292943|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
138292944|NCT04706377|Vitamins|vitamins|mesh-ancestor
138292945|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
138292946|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292947|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292948|NCT01583647|Niacin|niacin|mesh-list
138292949|NCT01583647|Niacinamide|niacinamide|mesh-list
138292950|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
138292951|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138292963|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
138292964|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138292965|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
138292966|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138203105|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203106|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203107|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203108|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
138203109|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203110|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203111|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203112|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203113|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203115|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203117|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
138203118|NCT00003664|Aldesleukin|aldesleukin|mesh-list
138203119|NCT00003664|Gemcitabine|gemcitabine|mesh-list
138203121|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203122|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
138203123|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203124|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203126|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
138203127|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203128|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
138203129|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203130|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138203131|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138203132|NCT00003196|Cyclosporine|cyclosporine|mesh-list
138203133|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
138203134|NCT00003196|Cyclosporins|cyclosporins|mesh-list
138203135|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203136|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203137|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203138|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
138203139|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203140|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
138203141|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203142|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138203143|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203144|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138203145|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203146|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203147|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138203148|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
138203149|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203151|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203152|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214654|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214655|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214656|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138214657|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
138214658|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
138214659|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214660|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138214661|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138214662|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138214663|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138214664|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214665|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138214666|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138214667|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138214668|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138214669|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
138214671|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138214672|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138214674|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214676|NCT00605072|Protective Agents|protective agents|mesh-ancestor
138214677|NCT00585104|Simendan|simendan|mesh-list
138214678|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138214679|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
138214680|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138214681|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138214682|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214683|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214684|NCT00585104|Protective Agents|protective agents|mesh-ancestor
138214685|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214686|NCT00585182|Enoxaparin|enoxaparin|mesh-list
138214687|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
138214688|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138214689|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138214690|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214691|NCT04856228|Lidocaine|lidocaine|mesh-list
138214692|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138214693|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
138214694|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214695|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214696|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
138214697|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214698|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138214699|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138214700|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138214701|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214702|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214704|NCT00605384|Lamivudine|lamivudine|mesh-list
138214705|NCT00605384|Entecavir|entecavir|mesh-list
138214706|NCT00605384|Adefovir|adefovir|mesh-list
138214707|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
138214708|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214709|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138214710|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138214711|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214712|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214713|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138214714|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138203154|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203155|NCT00002854|Paclitaxel|paclitaxel|mesh-list
138203156|NCT00002854|Etoposide|etoposide|mesh-list
138203157|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
138203158|NCT00002854|Carboplatin|carboplatin|mesh-list
138203159|NCT00002854|Ifosfamide|ifosfamide|mesh-list
138203160|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203161|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203162|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203163|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203164|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203165|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203166|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203167|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
138203168|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203169|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203170|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203171|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
138203172|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203173|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203174|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203175|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203176|NCT02308202|Perindopril|perindopril|mesh-list
138203177|NCT02308202|Doxazosin|doxazosin|mesh-list
138203178|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138203179|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
138203180|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203181|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203182|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138203183|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138203184|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138203185|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138203186|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
138203187|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203188|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203189|NCT00003214|Paclitaxel|paclitaxel|mesh-list
138203190|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
138203191|NCT00003214|Carboplatin|carboplatin|mesh-list
138203192|NCT00003214|Doxorubicin|doxorubicin|mesh-list
138203193|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203194|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203195|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203196|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203197|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203198|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203199|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203200|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203201|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
138203202|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203203|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203204|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203205|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
138203206|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203207|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203208|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203212|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138203213|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138203214|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138203215|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203216|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203217|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
138214715|NCT00586196|Donepezil|donepezil|mesh-list
138214716|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138214717|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214718|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214719|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214720|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214721|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214722|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
138203218|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138203219|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
138203220|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203221|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203224|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203225|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203226|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203227|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203228|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203229|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203230|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203231|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203232|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203233|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
138203234|NCT00003232|Prednisone|prednisone|mesh-list
138203235|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
138203239|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203240|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203241|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138203242|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203244|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
138203245|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203246|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203247|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203248|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203249|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203250|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138203253|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203254|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203255|NCT00002884|Fluorouracil|fluorouracil|mesh-list
138203256|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203257|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
138203258|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203259|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203260|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203261|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
138203262|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203263|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
138203264|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138203265|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138203266|NCT00003682|Prednisolone|prednisolone|mesh-list
138203267|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
138203281|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203282|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203283|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138203284|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
138203285|NCT00003682|Hormones|hormones|mesh-ancestor
138203286|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203287|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138203288|NCT00003682|Protective Agents|protective agents|mesh-ancestor
138203291|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203292|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203293|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203294|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203295|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138203297|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203298|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203300|NCT00003934|Methotrexate|methotrexate|mesh-list
138203301|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
138203302|NCT00003934|Daunorubicin|daunorubicin|mesh-list
138203303|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
138203305|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138203306|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
138203307|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138203308|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203309|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203310|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
138203311|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203312|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203314|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203315|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138203316|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203317|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
138203318|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203319|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203320|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
138203322|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203323|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203324|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203325|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
138203327|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
138203328|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203329|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
138203330|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203331|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203333|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203334|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203335|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
138203336|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203337|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203338|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138203339|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203340|NCT00003250|Fenretinide|fenretinide|mesh-list
138203341|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203342|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138203346|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203347|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
138203348|NCT00003256|Growth Substances|growth substances|mesh-ancestor
138203349|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203350|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138203351|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203352|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203353|NCT00003946|Danazol|danazol|mesh-list
138203354|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138203355|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138203356|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203357|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203358|NCT04679480|Cemiplimab|cemiplimab|mesh-list
138203359|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138203360|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203361|NCT00003262|Prednisone|prednisone|mesh-list
138203362|NCT00003262|Doxorubicin|doxorubicin|mesh-list
138203363|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203364|NCT00003262|Epirubicin|epirubicin|mesh-list
138203365|NCT00003262|Bleomycin|bleomycin|mesh-list
138203366|NCT00003262|Etoposide|etoposide|mesh-list
138203367|NCT00003262|Vincristine|vincristine|mesh-list
138203369|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
138203370|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203371|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203372|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203373|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203374|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203375|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203376|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203377|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
138203378|NCT00003262|Hormones|hormones|mesh-ancestor
138203379|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203380|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203381|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138203382|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203383|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203384|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203385|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203386|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
138203387|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203388|NCT00003700|Leucovorin|leucovorin|mesh-list
138203389|NCT00003700|Cytarabine|cytarabine|mesh-list
138203390|NCT00003700|Prednisone|prednisone|mesh-list
138203391|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
138203392|NCT00003700|Methotrexate|methotrexate|mesh-list
138203393|NCT00003700|Vincristine|vincristine|mesh-list
138203394|NCT00003700|Daunorubicin|daunorubicin|mesh-list
138203395|NCT00003700|Asparaginase|asparaginase|mesh-list
138203396|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
138203397|NCT00003700|Allopurinol|allopurinol|mesh-list
138203398|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
138203399|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203400|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
138203401|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203402|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203403|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203407|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203408|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203409|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
138344314|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203414|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
138203415|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138203416|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203417|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
138203418|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
138203419|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203420|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138203421|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203422|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
138203423|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203424|NCT00003700|Antidotes|antidotes|mesh-ancestor
138203425|NCT00003700|Protective Agents|protective agents|mesh-ancestor
138203426|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
138203427|NCT00003700|Vitamins|vitamins|mesh-ancestor
138203428|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
138203430|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203431|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203432|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203433|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203434|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203435|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203436|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
138203437|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138203438|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
138203439|NCT00003706|Pemetrexed|pemetrexed|mesh-list
138203440|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203441|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203442|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203443|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138203444|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203445|NCT00003958|Dactinomycin|dactinomycin|mesh-list
138203446|NCT00003958|Cactinomycin|cactinomycin|mesh-list
138203447|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
138203448|NCT00003958|Vincristine|vincristine|mesh-list
138203449|NCT00003958|Topotecan|topotecan|mesh-list
138203450|NCT00003958|Sargramostim|sargramostim|mesh-list
138203451|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203452|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
138203453|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203454|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203455|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203456|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
138203457|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203458|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203459|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203460|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203461|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203462|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203463|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203464|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203465|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203466|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203467|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203468|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203469|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203470|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138203471|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203472|NCT00003712|Sirolimus|sirolimus|mesh-list
138203473|NCT00003712|Temsirolimus|temsirolimus|mesh-list
138203474|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
138344315|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138203475|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138203476|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203477|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203478|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203479|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
138203480|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203482|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203483|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203484|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203485|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
138203486|NCT00003268|Cytarabine|cytarabine|mesh-list
138203487|NCT00003268|Idarubicin|idarubicin|mesh-list
138203488|NCT00003268|Amifostine|amifostine|mesh-list
138203490|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
138203491|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203492|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203493|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
138203494|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203495|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203496|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
138203498|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203499|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203500|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203501|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203502|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138203503|NCT00003268|Protective Agents|protective agents|mesh-ancestor
138203504|NCT00083720|Cetuximab|cetuximab|mesh-list
138203505|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138203508|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
138203509|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
138203510|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203511|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138203512|NCT00003280|Rituximab|rituximab|mesh-list
138203513|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138203514|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203515|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
138203516|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203517|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203518|NCT00384124|Imiquimod|imiquimod|mesh-list
138203519|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138203520|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
138203521|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203522|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203523|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
138203524|NCT00003718|Temozolomide|temozolomide|mesh-list
138203525|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203526|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
138203527|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203528|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203529|NCT00003970|Irinotecan|irinotecan|mesh-list
138203530|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203531|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203532|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203534|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203538|NCT00085436|Aldesleukin|aldesleukin|mesh-list
138203539|NCT00085436|Vaccines|vaccines|mesh-list
138203540|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
138203541|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203542|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203543|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
138203544|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203545|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138203546|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138203547|NCT00384202|Tacrolimus|tacrolimus|mesh-list
138203548|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203549|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
138203550|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203551|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138203552|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203553|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203556|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138203557|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138203558|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138203559|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138203560|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203561|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203562|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
138203563|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203564|NCT04329130|Lenalidomide|lenalidomide|mesh-list
138203565|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
138203566|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203567|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138203568|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138203569|NCT04329130|Growth Substances|growth substances|mesh-ancestor
138203570|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
138203571|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203572|NCT00384280|Rifampin|rifampin|mesh-list
138203577|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
138203578|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138203579|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203580|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203581|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138203586|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138203587|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138203588|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214723|NCT00605696|Insulin|insulin|mesh-list
138203589|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138203590|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203591|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203592|NCT00003730|Fluorouracil|fluorouracil|mesh-list
138203593|NCT00003730|Vinorelbine|vinorelbine|mesh-list
138203594|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
138203595|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203596|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203597|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214724|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138203598|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203599|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
138203601|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203602|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203603|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203604|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203605|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138203606|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
138203607|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203608|NCT00003292|Ifosfamide|ifosfamide|mesh-list
138203609|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203610|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
138203611|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203612|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203613|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138203614|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138203616|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138203617|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203618|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138203619|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138203620|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138203621|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138203622|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138203623|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203624|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203625|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138203626|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138203627|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
138292967|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
138203628|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138203629|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138203630|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
138203631|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
138203632|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203633|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138203634|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138203636|NCT00003994|Fluorouracil|fluorouracil|mesh-list
138203637|NCT00003994|Vincristine|vincristine|mesh-list
138203639|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203640|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
138203641|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203642|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203643|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203644|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
138203645|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203647|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203648|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203649|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203650|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138203651|NCT00003994|Protective Agents|protective agents|mesh-ancestor
138203654|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203656|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203657|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203658|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203659|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203660|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203661|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203662|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203663|NCT00003304|Temozolomide|temozolomide|mesh-list
138203664|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203665|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
138203666|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203667|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203668|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
138203669|NCT00004006|Carboplatin|carboplatin|mesh-list
138203670|NCT00004006|Doxorubicin|doxorubicin|mesh-list
138203672|NCT00004006|Etoposide|etoposide|mesh-list
138203673|NCT00004006|Topotecan|topotecan|mesh-list
138203674|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203677|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203678|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203679|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
138203680|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203681|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203684|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203685|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203686|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203687|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203689|NCT00003316|Gemcitabine|gemcitabine|mesh-list
138203690|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203691|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
138203692|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203693|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203695|NCT00003322|Cisplatin|cisplatin|mesh-list
138203696|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203697|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203698|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203699|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203700|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203701|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203702|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
138203703|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138203704|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138203705|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138203707|NCT00003748|Irinotecan|irinotecan|mesh-list
138203708|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203709|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203710|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203711|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203712|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203713|NCT00089102|Gemcitabine|gemcitabine|mesh-list
138203714|NCT00089102|Irinotecan|irinotecan|mesh-list
138203715|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203716|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
138203717|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203718|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203719|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203720|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203721|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203722|NCT00004012|Capecitabine|capecitabine|mesh-list
138203723|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203724|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
138203725|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203727|NCT00003754|Thalidomide|thalidomide|mesh-list
138203728|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
138203729|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203730|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
138203731|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203732|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203733|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203734|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
138203735|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203736|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203737|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203738|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
138203739|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203740|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203741|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138203742|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138203743|NCT00003754|Growth Substances|growth substances|mesh-ancestor
138203744|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
138203745|NCT00003328|Porfiromycin|porfiromycin|mesh-list
138203746|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203747|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203748|NCT00004024|Aldesleukin|aldesleukin|mesh-list
138203749|NCT00004024|Sargramostim|sargramostim|mesh-list
138203750|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
138203751|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
138203752|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203753|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203754|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138203755|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138203756|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
138203757|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203758|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203759|NCT00003334|Paclitaxel|paclitaxel|mesh-list
138203760|NCT00003334|Doxorubicin|doxorubicin|mesh-list
138203761|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203762|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203763|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203764|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203765|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203766|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344316|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138203767|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203768|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203769|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203770|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203771|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203773|NCT00093782|Temsirolimus|temsirolimus|mesh-list
138203774|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
138203775|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138203776|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203777|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203778|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203780|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293246|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203781|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203782|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203783|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203784|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203785|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
138203786|NCT00003760|Irofulven|irofulven|mesh-list
138203787|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203788|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
138203789|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203790|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203791|NCT04771754|Dolutegravir|dolutegravir|mesh-list
138203792|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138203793|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138203794|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214725|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203795|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203796|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138203797|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138203798|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
138203799|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203800|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138203801|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203803|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203805|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203806|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203807|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203808|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203809|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203810|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203811|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203812|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
138203813|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
138203814|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138203815|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138203816|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203817|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203818|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203819|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203820|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
138203821|NCT00003340|Topotecan|topotecan|mesh-list
138203822|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203823|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
138203824|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203825|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203826|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203827|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
138203828|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203829|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203830|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203831|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203832|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203833|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203834|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
138203835|NCT00004036|Carboplatin|carboplatin|mesh-list
138203836|NCT00004036|Sargramostim|sargramostim|mesh-list
138203838|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203840|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203841|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203842|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203843|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
138203844|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203845|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203846|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203847|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138203848|NCT00004036|Protective Agents|protective agents|mesh-ancestor
138203849|NCT00003346|Acetaminophen|acetaminophen|mesh-list
138203850|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
138203851|NCT00003346|Carmustine|carmustine|mesh-list
138203852|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138203853|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138203854|NCT00003346|Analgesics|analgesics|mesh-ancestor
138203855|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
138203856|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203857|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203860|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203861|NCT00003346|Expectorants|expectorants|mesh-ancestor
138203862|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
138203863|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138203864|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
138203865|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203866|NCT00003346|Protective Agents|protective agents|mesh-ancestor
138203867|NCT00003346|Antidotes|antidotes|mesh-ancestor
138203868|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203869|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
138203870|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203872|NCT00096122|Idarubicin|idarubicin|mesh-list
138203873|NCT00096122|Tipifarnib|tipifarnib|mesh-list
138203874|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203875|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
138203876|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203877|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203878|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
138203879|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138203880|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203881|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
138203882|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203883|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203884|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203885|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203886|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203887|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
138203888|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203889|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203890|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203891|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203892|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214726|NCT00587132|Secretin|secretin|mesh-list
138203893|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138203894|NCT00004042|Antibodies|antibodies|mesh-list
138203895|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
138203896|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138203897|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
138203898|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203899|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203900|NCT00003784|Prednisone|prednisone|mesh-list
138203901|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
138203902|NCT00003784|Doxorubicin|doxorubicin|mesh-list
138203903|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138293247|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293248|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293249|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293250|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293251|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293253|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293254|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293255|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293256|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
138293257|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138293258|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203906|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203907|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
138203908|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203909|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203910|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203911|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
138203912|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203913|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203916|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203917|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203918|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203919|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203920|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
138203921|NCT00003784|Hormones|hormones|mesh-ancestor
138203922|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203923|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138203924|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203925|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203926|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203927|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203928|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
138203929|NCT00003352|Docetaxel|docetaxel|mesh-list
138203930|NCT00003352|Doxorubicin|doxorubicin|mesh-list
138203931|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203932|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203933|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
138203934|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203935|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203936|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203937|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
138203938|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203939|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203940|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203941|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203942|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203943|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203944|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203945|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203946|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203947|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203948|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138203950|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203952|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
138203953|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138203954|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
138203955|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203956|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203957|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203958|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138203959|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138203960|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203961|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203962|NCT00003358|Gemcitabine|gemcitabine|mesh-list
138203963|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203964|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138203965|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
138203966|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203967|NCT00004060|Exatecan|exatecan|mesh-list
138203968|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138203970|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203971|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203976|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138203978|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138203979|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203980|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138203981|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203982|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138203983|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203984|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
138203985|NCT00003364|Doxorubicin|doxorubicin|mesh-list
138203986|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138203987|NCT00003364|Etoposide|etoposide|mesh-list
138203988|NCT00003364|Vincristine|vincristine|mesh-list
138203989|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138203990|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
138203991|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203992|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138203993|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138203994|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
138203995|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203996|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203997|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203998|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138203999|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204005|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204007|NCT00004066|Docetaxel|docetaxel|mesh-list
138204008|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204009|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
138204010|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204011|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204012|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204013|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204014|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204015|NCT00003370|Irofulven|irofulven|mesh-list
138204016|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204017|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
138204018|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204019|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204020|NCT00003382|Gemcitabine|gemcitabine|mesh-list
138204021|NCT00003382|Topotecan|topotecan|mesh-list
138204022|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204023|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
138204024|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204025|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204026|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138204034|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138204035|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138204036|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204037|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138204038|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204039|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204041|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
138204042|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204043|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204045|NCT00004852|Zidovudine|zidovudine|mesh-list
138204046|NCT00004852|Efavirenz|efavirenz|mesh-list
138204047|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138204048|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138204049|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204050|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204051|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
138204052|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204053|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138204054|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138204055|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
138204056|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138204057|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138204058|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138204061|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138204063|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
138204064|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138204065|NCT00004858|Protective Agents|protective agents|mesh-ancestor
138204068|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138204069|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204070|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204071|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
138204072|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138204074|NCT00004858|Hormones|hormones|mesh-ancestor
138204075|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204076|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
138204077|NCT00004864|Docetaxel|docetaxel|mesh-list
138204078|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204079|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204080|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204081|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204082|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204083|NCT00003796|Irofulven|irofulven|mesh-list
138204084|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204085|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
138204086|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204088|NCT00003802|NSC 366140|nsc 366140|mesh-list
138204089|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204090|NCT02972866|Budesonide|budesonide|mesh-list
138204091|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204092|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138204093|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
138204094|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204095|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204096|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138204097|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138204100|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204103|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138204104|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138204105|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138204106|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204107|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138204108|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204109|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204110|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
138204111|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
138204112|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
138204113|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204114|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204115|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204116|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
138204117|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204119|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204120|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
138204121|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204122|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
138204123|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138204124|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204125|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138204126|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138204127|NCT00003850|Growth Substances|growth substances|mesh-ancestor
138204128|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
138204129|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204130|NCT00004072|Carmustine|carmustine|mesh-list
138204131|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138204132|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204133|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
138204134|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204135|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204136|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204137|NCT00004078|Irinotecan|irinotecan|mesh-list
138204138|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138204139|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204142|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204143|NCT00003856|Temoporfin|temoporfin|mesh-list
138293259|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293260|NCT00459121|Paclitaxel|paclitaxel|mesh-list
138293261|NCT00459121|Carboplatin|carboplatin|mesh-list
138293262|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138293263|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293264|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
138293265|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
138293266|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293267|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293268|NCT00904423|Vitamin D|vitamin d|mesh-list
138293269|NCT00904423|Vitamins|vitamins|mesh-ancestor
138293271|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293272|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138293273|NCT05328895|Betahistine|betahistine|mesh-list
138293274|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
138293275|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
138293276|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
138293277|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204144|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204145|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138204146|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
138204147|NCT00014222|Paclitaxel|paclitaxel|mesh-list
138204148|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
138204149|NCT00014222|Doxorubicin|doxorubicin|mesh-list
138204150|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138204151|NCT00014222|Fluorouracil|fluorouracil|mesh-list
138204152|NCT00014222|Epirubicin|epirubicin|mesh-list
138204153|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
138293456|NCT00402883|Growth Substances|growth substances|mesh-ancestor
138204154|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204155|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204156|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204157|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204158|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204159|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204160|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204161|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
138204162|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204163|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204164|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204165|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
138204166|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204167|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138204168|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204172|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204173|NCT00014222|Hematinics|hematinics|mesh-ancestor
138204174|NCT00004870|Irinotecan|irinotecan|mesh-list
138204175|NCT00004870|Oblimersen|oblimersen|mesh-list
138204176|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138204177|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204178|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204179|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204180|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204181|NCT00004084|Epratuzumab|epratuzumab|mesh-list
138204182|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204183|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204185|NCT00004876|Carboplatin|carboplatin|mesh-list
138204186|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204187|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204188|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
138204189|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204190|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
138204191|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138204192|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204193|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138204194|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138204195|NCT00004876|Growth Substances|growth substances|mesh-ancestor
138204196|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
138204199|NCT00003862|Fluorouracil|fluorouracil|mesh-list
138204200|NCT00003862|Calcium|calcium|mesh-list
138204201|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
138204202|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204203|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204204|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204208|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138204209|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204210|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
138204211|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204212|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204213|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
138204214|NCT00003862|Antidotes|antidotes|mesh-ancestor
138204215|NCT00003862|Protective Agents|protective agents|mesh-ancestor
138204216|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
138204218|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
138204219|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
138204220|NCT00003868|Methotrexate|methotrexate|mesh-list
138204221|NCT00003868|Antibodies|antibodies|mesh-list
138204222|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138204223|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204224|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
138204225|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204226|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204227|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204228|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
138204229|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204230|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204231|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204232|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138204233|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
138204234|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138204237|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138204238|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204239|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138204240|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138204241|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138204243|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
138204244|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138204245|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
138204246|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204247|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204248|NCT00004090|Gemcitabine|gemcitabine|mesh-list
138204249|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204250|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204251|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
138204255|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
138204257|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
138204258|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138204259|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204260|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
138204261|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204262|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204263|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204264|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204265|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
138204266|NCT00004102|Antidotes|antidotes|mesh-ancestor
138204267|NCT00004102|Protective Agents|protective agents|mesh-ancestor
138204270|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
138204272|NCT00003880|Carboplatin|carboplatin|mesh-list
138204273|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204274|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204275|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204276|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204277|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204278|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204279|NCT00004108|Exatecan|exatecan|mesh-list
138204280|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138204281|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204282|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204283|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204284|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204285|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
138204286|NCT00004900|Thiotepa|thiotepa|mesh-list
138204287|NCT00004900|Carboplatin|carboplatin|mesh-list
138204288|NCT00004900|Etoposide|etoposide|mesh-list
138204289|NCT00004900|Anastrozole|anastrozole|mesh-list
138204292|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204293|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204294|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204295|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
138204296|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204297|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204298|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204302|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204303|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204304|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138204305|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138204306|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138204307|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
138204310|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
138204311|NCT00004114|Fludarabine|fludarabine|mesh-list
138204312|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
138204313|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204314|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
138204315|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204316|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204317|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204318|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
138204319|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204320|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204321|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204322|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204323|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
138204324|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
138204325|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204326|NCT00004906|Pamidronate|pamidronate|mesh-list
138204327|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
138204329|NCT00004906|Carboplatin|carboplatin|mesh-list
138204330|NCT00004906|Docetaxel|docetaxel|mesh-list
138204331|NCT00004906|Doxorubicin|doxorubicin|mesh-list
138204332|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138204333|NCT00004906|Etoposide|etoposide|mesh-list
138204334|NCT00004906|Anastrozole|anastrozole|mesh-list
138204335|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204336|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
138204337|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204338|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204339|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204340|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
138204341|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204342|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204343|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204344|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204345|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204346|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204347|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138204348|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204349|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204350|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204351|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204352|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204353|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138204354|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138204355|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138204357|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204358|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138204360|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138204361|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
138204362|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204363|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138204365|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204366|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204367|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204368|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
138204369|NCT00004132|Ifosfamide|ifosfamide|mesh-list
138204370|NCT00004132|Etoposide|etoposide|mesh-list
138204371|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204372|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
138293648|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293649|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138293650|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
138293651|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293652|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293653|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
138293654|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138293655|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
138293656|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
138293657|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293658|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293659|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293660|NCT00000253|Analgesics|analgesics|mesh-ancestor
138293661|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
138293669|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293670|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293671|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293672|NCT00000259|Analgesics|analgesics|mesh-ancestor
138293673|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
138293674|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293676|NCT00379405|Saquinavir|saquinavir|mesh-list
138293677|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138293678|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138293679|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138293680|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346434|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204373|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204374|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204375|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204376|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
138204377|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204382|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204383|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204384|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138204385|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138204386|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204387|NCT05776940|Dexamethasone|dexamethasone|mesh-list
138204388|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
138204389|NCT05776940|Bortezomib|bortezomib|mesh-list
138204390|NCT05776940|Daratumumab|daratumumab|mesh-list
138204392|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138204393|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204394|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
138204400|NCT05776940|Hormones|hormones|mesh-ancestor
138204401|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204402|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204403|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204404|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138204405|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204406|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204407|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
138204409|NCT05776407|Fludarabine|fludarabine|mesh-list
138204410|NCT05776407|Etoposide|etoposide|mesh-list
138204411|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204412|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
138204413|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204414|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204415|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204416|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
138204417|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293935|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293936|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138293937|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
138293938|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293939|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293941|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138293942|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
138293943|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293944|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293945|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204418|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204419|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204420|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204421|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204422|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204428|NCT05776186|Bupivacaine|bupivacaine|mesh-list
138204429|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204430|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
138204431|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204432|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204433|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
138204437|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138204438|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204439|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138204440|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204441|NCT05775965|Aspirin|aspirin|mesh-list
138204442|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
138214727|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214728|NCT00587132|Hormones|hormones|mesh-ancestor
138214729|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214730|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214732|NCT00587678|Ezetimibe|ezetimibe|mesh-list
138214733|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138214734|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138214735|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
138214736|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214737|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138214747|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
138214748|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214750|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
138214751|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138214752|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
138214753|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204443|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138204444|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204445|NCT05775965|Analgesics|analgesics|mesh-ancestor
138204446|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
138204447|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204448|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204449|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204450|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204451|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138204452|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138204453|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204454|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138204455|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138204456|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204457|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
138204458|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138204459|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
138204460|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138204463|NCT05775900|Capecitabine|capecitabine|mesh-list
138204464|NCT05775900|Cetuximab|cetuximab|mesh-list
138204465|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204466|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
138204467|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204468|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204489|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204502|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138204508|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204509|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138204510|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138204512|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138204513|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204514|NCT05775536|Analgesics|analgesics|mesh-ancestor
138204515|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
138204516|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204524|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138204525|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204526|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
138204528|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
138204529|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204530|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204531|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204532|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204533|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204534|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204535|NCT05774964|Folic Acid|folic acid|mesh-list
138204536|NCT05774964|Vitamin A|vitamin a|mesh-list
138204537|NCT05774964|Metronidazole|metronidazole|mesh-list
138204538|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
138204539|NCT05774964|Cetuximab|cetuximab|mesh-list
138204540|NCT05774964|Tegafur|tegafur|mesh-list
138204541|NCT05774964|Vitamins|vitamins|mesh-ancestor
138204542|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
138204543|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204544|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204545|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204546|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204547|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138204548|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138204549|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138204550|NCT05774964|Hematinics|hematinics|mesh-ancestor
138204551|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
138204552|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204553|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204554|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
138204555|NCT05773222|Apixaban|apixaban|mesh-list
138204556|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138204557|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
138204558|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138204559|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
138204560|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204561|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204562|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
138204563|NCT05638594|Carboplatin|carboplatin|mesh-list
138204564|NCT05638594|Docetaxel|docetaxel|mesh-list
138204565|NCT05638594|Trastuzumab|trastuzumab|mesh-list
138204566|NCT05638594|Letrozole|letrozole|mesh-list
138204567|NCT05638594|Pertuzumab|pertuzumab|mesh-list
138204568|NCT05638594|Hormones|hormones|mesh-list
138204569|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204570|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204571|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204572|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204573|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204574|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214754|NCT04545008|Protective Agents|protective agents|mesh-ancestor
138214755|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214756|NCT04545008|Antidotes|antidotes|mesh-ancestor
138214758|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214759|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138214760|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
138214762|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214765|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214766|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
138214767|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
138214768|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214769|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214770|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214771|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
138214772|NCT04527770|Hormones|hormones|mesh-ancestor
138214773|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214774|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138214775|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214776|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138214777|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138214778|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214779|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138214780|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138214781|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214782|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138214783|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
138214785|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
138214786|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
138214787|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214788|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214789|NCT01798940|Pioglitazone|pioglitazone|mesh-list
138214790|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138214791|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214792|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138214793|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138214794|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138214795|NCT00609128|Analgesics|analgesics|mesh-ancestor
138214796|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
138214798|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214799|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214800|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214801|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138214812|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
138214813|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214814|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214815|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214816|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
138214817|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214818|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294034|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
138204575|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204576|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204577|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138204578|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138204579|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204580|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138204581|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
138204582|NCT05493475|Fentanyl|fentanyl|mesh-list
138204583|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138204584|NCT05493475|Narcotics|narcotics|mesh-ancestor
138204585|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204586|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204587|NCT05493475|Analgesics|analgesics|mesh-ancestor
138204588|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
138204589|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204590|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138204591|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138204592|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
138204593|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
138204595|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138204596|NCT05463341|Narcotics|narcotics|mesh-ancestor
138204597|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204603|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138204604|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
138204605|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
138204606|NCT05429970|Etodolac|etodolac|mesh-list
138204607|NCT05429970|Propofol|propofol|mesh-list
138204608|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138204609|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204610|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204611|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138204612|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
138204613|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
138204614|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138204615|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204616|NCT05429970|Analgesics|analgesics|mesh-ancestor
138204617|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
138204624|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204626|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204627|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
138204628|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204631|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204634|NCT05298670|Interferon-beta|interferon-beta|mesh-list
138204635|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
138204636|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138204637|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204638|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204639|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
138204640|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204641|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
138204642|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138204643|NCT05297851|Niacinamide|niacinamide|mesh-list
138204644|NCT05297851|Niacin|niacin|mesh-list
138204645|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
138204646|NCT05297851|Riboflavin|riboflavin|mesh-list
138204647|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
138204648|NCT05297851|Vitamins|vitamins|mesh-ancestor
138204649|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
138204650|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204651|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138204656|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138204657|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138204659|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
138204660|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204661|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138204662|NCT05180006|Bevacizumab|bevacizumab|mesh-list
138204663|NCT05180006|Trastuzumab|trastuzumab|mesh-list
138204664|NCT05180006|Atezolizumab|atezolizumab|mesh-list
138204665|NCT05180006|Pertuzumab|pertuzumab|mesh-list
138204666|NCT05180006|Ipatasertib|ipatasertib|mesh-list
138204667|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204668|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204669|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138204670|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138204671|NCT05180006|Growth Substances|growth substances|mesh-ancestor
138204672|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204673|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
138204674|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138204675|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204676|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138204677|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204678|NCT05148884|Befiradol|befiradol|mesh-list
138204679|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138204680|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138204681|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
138204682|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204683|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204684|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204685|NCT05042817|Sufentanil|sufentanil|mesh-list
138204686|NCT05042817|Morphine|morphine|mesh-list
138204687|NCT05042817|Prilocaine|prilocaine|mesh-list
138204688|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138204689|NCT05042817|Narcotics|narcotics|mesh-ancestor
138204690|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204691|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204692|NCT05042817|Analgesics|analgesics|mesh-ancestor
138204693|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
138204694|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204695|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138204696|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138204697|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
138204698|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
138204699|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
138204700|NCT04914234|Metoprolol|metoprolol|mesh-list
138204701|NCT04914234|Atenolol|atenolol|mesh-list
138204702|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138204703|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138204704|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
138204705|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
138204712|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204726|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214819|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138294116|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
138294117|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294118|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294119|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138294120|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138294121|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294136|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
138294137|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294139|NCT00000451|Sertraline|sertraline|mesh-list
138204727|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204742|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204744|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138204745|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204746|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204747|NCT04500158|Lidocaine|lidocaine|mesh-list
138204751|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204752|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
138204753|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204754|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138204755|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138204756|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138204757|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138204758|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204759|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
138204760|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138204763|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138204764|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138204765|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204766|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204767|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
138204768|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204769|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138204770|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138204771|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204772|NCT04041128|Olaparib|olaparib|mesh-list
138204773|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138204790|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204791|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204792|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
138204793|NCT03941964|Azacitidine|azacitidine|mesh-list
138204794|NCT03941964|Decitabine|decitabine|mesh-list
138204795|NCT03941964|Venetoclax|venetoclax|mesh-list
138204796|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204797|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
138204798|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204799|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204800|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204801|NCT03837509|Daratumumab|daratumumab|mesh-list
138204802|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204804|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138204805|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138204806|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138204807|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204808|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204817|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204818|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138204819|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204820|NCT03507452|BAY 2287411|bay 2287411|mesh-list
138204821|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138204824|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138204825|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204827|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
138204828|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204829|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204830|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204838|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204839|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204840|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204841|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138204842|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204843|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204844|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
138204845|NCT03298087|Leuprolide|leuprolide|mesh-list
138204846|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138204847|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
138204848|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138204849|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204850|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204851|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204852|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
138204853|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204854|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204855|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138204856|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204857|NCT02889081|Vitamin D|vitamin d|mesh-list
138204858|NCT02889081|Vitamins|vitamins|mesh-ancestor
138204859|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
138204860|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204861|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138204862|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
138204863|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138204864|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204865|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204866|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138204867|NCT02856594|Analgesics|analgesics|mesh-ancestor
138204868|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
138204869|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204870|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138204871|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138204872|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138204873|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
138204874|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204875|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204876|NCT02840539|Cytarabine|cytarabine|mesh-list
138204877|NCT02840539|Dexamethasone|dexamethasone|mesh-list
138204878|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
138204879|NCT02840539|Bortezomib|bortezomib|mesh-list
138204880|NCT02840539|BB 1101|bb 1101|mesh-list
138204881|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204882|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
138204883|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
138204884|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204885|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204886|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138204887|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
138204888|NCT02840539|Hormones|hormones|mesh-ancestor
138204889|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204890|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204891|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204895|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204896|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
138204897|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
138204898|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204899|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204900|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
138204901|NCT02342782|Cytarabine|cytarabine|mesh-list
138204902|NCT02342782|Etoposide|etoposide|mesh-list
138204903|NCT02342782|Melphalan|melphalan|mesh-list
138204904|NCT02342782|Carmustine|carmustine|mesh-list
138204905|NCT02342782|Basiliximab|basiliximab|mesh-list
138204906|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204907|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204908|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204909|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204910|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204911|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204912|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138204916|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204917|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
138204918|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204919|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204920|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
138204921|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138204922|NCT02291055|Durvalumab|durvalumab|mesh-list
138204923|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204924|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204925|NCT02112864|Dexamethasone|dexamethasone|mesh-list
138204929|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204930|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204931|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138204932|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
138204933|NCT02112864|Hormones|hormones|mesh-ancestor
138204937|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138204938|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138204939|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204940|NCT00723697|Buprenorphine|buprenorphine|mesh-list
138204941|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138204942|NCT00723697|Narcotics|narcotics|mesh-ancestor
138204943|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204944|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204946|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
138204947|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204948|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138204949|NCT00684073|Buprenorphine|buprenorphine|mesh-list
138204950|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138204951|NCT00684073|Naloxone|naloxone|mesh-list
138204952|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138204953|NCT00684073|Narcotics|narcotics|mesh-ancestor
138204954|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138204955|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204956|NCT00684073|Analgesics|analgesics|mesh-ancestor
138204957|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
138204958|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204959|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138204960|NCT00603109|Rimonabant|rimonabant|mesh-list
138204961|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138204962|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138204975|NCT00199095|Doxorubicin|doxorubicin|mesh-list
138204976|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
138204977|NCT00199095|Idarubicin|idarubicin|mesh-list
138204978|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204979|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
138204980|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204981|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138204982|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138204983|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
138204987|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138204988|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
138204989|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
138204990|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204991|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138204992|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
138204993|NCT00199095|Hormones|hormones|mesh-ancestor
138204994|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204995|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138204996|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138204997|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
138204998|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138204999|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205000|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
138205001|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205002|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205003|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205004|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205005|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
138205010|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205011|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205012|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205013|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205014|NCT00199056|Cytarabine|cytarabine|mesh-list
138205015|NCT00199056|Dexamethasone|dexamethasone|mesh-list
138205016|NCT00199056|Prednisolone|prednisolone|mesh-list
138205017|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
138205018|NCT00199056|Ifosfamide|ifosfamide|mesh-list
138205019|NCT00199056|Methotrexate|methotrexate|mesh-list
138205020|NCT00199056|Fludarabine|fludarabine|mesh-list
138205021|NCT00199056|Vincristine|vincristine|mesh-list
138205022|NCT00199056|Doxorubicin|doxorubicin|mesh-list
138205030|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
138205031|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205032|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205033|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205034|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
138205035|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205036|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205043|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
138205044|NCT00199056|Hormones|hormones|mesh-ancestor
138205045|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205046|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205047|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138205051|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
138205052|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205053|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205054|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205055|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205056|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
138205057|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205058|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205059|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205060|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205061|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205062|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205063|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205064|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205065|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
138205068|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205069|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205070|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
138205071|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205072|NCT00198978|Cytarabine|cytarabine|mesh-list
138205073|NCT00198978|Dexamethasone|dexamethasone|mesh-list
138205074|NCT00198978|Prednisolone|prednisolone|mesh-list
138205075|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
138205076|NCT00198978|Rituximab|rituximab|mesh-list
138205077|NCT00198978|Methotrexate|methotrexate|mesh-list
138205078|NCT00198978|Vincristine|vincristine|mesh-list
138205079|NCT00198978|Asparaginase|asparaginase|mesh-list
138205080|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
138205081|NCT00198978|Idarubicin|idarubicin|mesh-list
138205082|NCT00198978|Lenograstim|lenograstim|mesh-list
138205083|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205084|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
138205085|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205086|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205102|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138205103|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
138205112|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205113|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205114|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205115|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205116|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205117|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138205118|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205119|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205120|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205123|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138205124|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138205125|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205126|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205127|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138205128|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138205129|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205138|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
138205139|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
138205140|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205141|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205142|NCT01215643|Ribavirin|ribavirin|mesh-list
138205143|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138205153|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205154|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205155|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205156|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138205157|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205158|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205160|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
138205161|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205162|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
138205163|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205164|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205165|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138205166|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
138205167|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205176|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205177|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205178|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205179|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
138205180|NCT00004150|Antidotes|antidotes|mesh-ancestor
138205181|NCT00004150|Protective Agents|protective agents|mesh-ancestor
138205182|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
138205183|NCT00004150|Vitamins|vitamins|mesh-ancestor
138205184|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
138205185|NCT00004930|Doxorubicin|doxorubicin|mesh-list
138205186|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138205187|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205188|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205189|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205190|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205191|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205195|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205197|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205198|NCT00004162|Doxorubicin|doxorubicin|mesh-list
138205199|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138205200|NCT00004162|Methotrexate|methotrexate|mesh-list
138205201|NCT00004162|Vincristine|vincristine|mesh-list
138205202|NCT00004162|Sargramostim|sargramostim|mesh-list
138205203|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138205204|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205205|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205206|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205207|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205208|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205209|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138205210|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
138205211|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205212|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205213|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205214|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
138205215|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205216|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205217|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205218|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
138205219|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205220|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205221|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205222|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205223|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205224|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205225|NCT00004984|Insulin|insulin|mesh-list
138205226|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138205227|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138205228|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205229|NCT00004174|Paclitaxel|paclitaxel|mesh-list
138205230|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
138205231|NCT00004174|Thiotepa|thiotepa|mesh-list
138205232|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205233|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205234|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205235|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205236|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205240|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205241|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205242|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205249|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205250|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205251|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138294140|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138205252|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138205253|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138205254|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
138205255|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205256|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205257|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138205258|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138205259|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
138205260|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138205264|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205265|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
138205266|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
138205267|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205268|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205269|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205270|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
138205271|NCT00004990|Hormones|hormones|mesh-ancestor
138205279|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294141|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138205280|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205281|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138205282|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
138205283|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205284|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138205296|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205297|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
138205298|NCT00005002|Lamivudine|lamivudine|mesh-list
138205299|NCT00005002|Zidovudine|zidovudine|mesh-list
138205300|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138205301|NCT00005002|Nelfinavir|nelfinavir|mesh-list
138205302|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138205303|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205304|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205305|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205306|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
138205307|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205308|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205309|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205310|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
138205311|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138205312|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138205313|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
138205314|NCT01264705|Sorafenib|sorafenib|mesh-list
138205315|NCT01264705|Bavituximab|bavituximab|mesh-list
138205332|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205333|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205334|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205337|NCT00005014|Risperidone|risperidone|mesh-list
138205338|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138205339|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
138205340|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205341|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205342|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205343|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138205344|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138205345|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205354|NCT00005026|Topotecan|topotecan|mesh-list
138205355|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205356|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205357|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205358|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205359|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205366|NCT00016718|Didanosine|didanosine|mesh-list
138205367|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
138205368|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205369|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138205370|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205371|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205372|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205377|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138205378|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138205379|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138205380|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138205381|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
138205382|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
138205383|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
138205384|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138205385|NCT00004216|Cefixime|cefixime|mesh-list
138205386|NCT00004216|Trimethoprim|trimethoprim|mesh-list
138205395|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138205396|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138205397|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138205398|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
138205399|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138205400|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138205401|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205402|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138205403|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138205406|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205407|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205408|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205409|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205410|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205411|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205412|NCT00005038|Aldesleukin|aldesleukin|mesh-list
138205413|NCT00005038|Histamine|histamine|mesh-list
138205414|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
138205415|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205416|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205417|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205418|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
138205419|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205420|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
138205421|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
138205422|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205423|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205424|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205425|NCT00019682|Aldesleukin|aldesleukin|mesh-list
138205426|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138205427|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205428|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205429|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205430|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
138205431|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205432|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138205433|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
138205434|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205435|NCT00005050|Fluorouracil|fluorouracil|mesh-list
138205436|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
138205437|NCT00005050|Eniluracil|eniluracil|mesh-list
138205438|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
138205439|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205440|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205441|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205442|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205443|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
138205444|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205445|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205446|NCT00005578|Prednisone|prednisone|mesh-list
138205447|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
138205448|NCT00005578|Doxorubicin|doxorubicin|mesh-list
138205449|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138205456|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205457|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
138205458|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205459|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205460|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205474|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138205475|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138205480|NCT00005578|Protective Agents|protective agents|mesh-ancestor
138205482|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
138205483|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205484|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
138205485|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205486|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205487|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
138205490|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
138205491|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205492|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138205493|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205494|NCT00386230|Zidovudine|zidovudine|mesh-list
138205495|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205496|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
138205497|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138205498|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205499|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205500|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
138205501|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205509|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
138205510|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138205511|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
138205512|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205513|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
138205514|NCT00097448|Hormones|hormones|mesh-ancestor
138205515|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205519|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
138205520|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
138205521|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205522|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205523|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138205524|NCT00097448|Protective Agents|protective agents|mesh-ancestor
138205526|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
138205527|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205528|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205529|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
138205530|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205534|NCT00028262|Cysteamine|cysteamine|mesh-list
138205535|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138205536|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205537|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
138205538|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138205539|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
138205540|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205541|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205542|NCT00004252|Leucovorin|leucovorin|mesh-list
138205543|NCT00004252|Fluorouracil|fluorouracil|mesh-list
138205544|NCT00004252|Calcium|calcium|mesh-list
138205545|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
138205546|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205547|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205548|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
138205549|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205550|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205551|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205552|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205553|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
138205554|NCT00004252|Antidotes|antidotes|mesh-ancestor
138205555|NCT00004252|Protective Agents|protective agents|mesh-ancestor
138205556|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
138205557|NCT00004252|Vitamins|vitamins|mesh-ancestor
138205558|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
138205559|NCT00005590|Levofloxacin|levofloxacin|mesh-list
138205560|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138205561|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205562|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138205563|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205564|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205565|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205566|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205567|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205568|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138205569|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138205570|NCT00005596|Leucovorin|leucovorin|mesh-list
138205571|NCT00005596|Cytarabine|cytarabine|mesh-list
138205572|NCT00005596|Dexamethasone|dexamethasone|mesh-list
138205573|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
138205574|NCT00005596|Methotrexate|methotrexate|mesh-list
138205575|NCT00005596|Vincristine|vincristine|mesh-list
138205577|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
138205578|NCT00005596|Pegaspargase|pegaspargase|mesh-list
138205579|NCT00005596|Thioguanine|thioguanine|mesh-list
138205580|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
138205581|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205582|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
138205583|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205584|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205585|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138205586|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
138205587|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205588|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205589|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205590|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205591|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
138205592|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
138205594|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205600|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
138205601|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138294229|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
138205602|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205604|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205605|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205606|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205607|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205608|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
138205609|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205611|NCT00005596|Protective Agents|protective agents|mesh-ancestor
138205617|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205618|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205620|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138205621|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205622|NCT00005068|Leucovorin|leucovorin|mesh-list
138205623|NCT00005068|Fluorouracil|fluorouracil|mesh-list
138205624|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
138205625|NCT00005068|Irinotecan|irinotecan|mesh-list
138205626|NCT00005068|Calcium|calcium|mesh-list
138205627|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
138205632|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205634|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205635|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
138205636|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138205637|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205638|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205639|NCT00005068|Antidotes|antidotes|mesh-ancestor
138205652|NCT00004264|Protective Agents|protective agents|mesh-ancestor
138205653|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205655|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205656|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
138205658|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205659|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138205660|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205661|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205663|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205664|NCT00004276|Thalidomide|thalidomide|mesh-list
138205665|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205666|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
138205667|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205668|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
138205669|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138205670|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205671|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138205672|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138205674|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
138205675|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205677|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138205678|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138205680|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
138205684|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205685|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205687|NCT00005086|Docetaxel|docetaxel|mesh-list
138205688|NCT00005086|Methotrexate|methotrexate|mesh-list
138205689|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205690|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205691|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
138205692|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205693|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138205694|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138205695|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138205700|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205701|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205702|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138205703|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205704|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
138205705|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205706|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205707|NCT00005614|Gemcitabine|gemcitabine|mesh-list
138205708|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138205709|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
138205710|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205712|NCT00101036|Lapatinib|lapatinib|mesh-list
138205713|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205714|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138205715|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205716|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205717|NCT00004300|Bromocriptine|bromocriptine|mesh-list
138205718|NCT00004300|Sertraline|sertraline|mesh-list
138205719|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
138205720|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138205721|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138205722|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138205723|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205724|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205731|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205734|NCT00005626|Irinotecan|irinotecan|mesh-list
138205735|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138205736|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138205738|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205739|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205740|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
138205742|NCT00005092|Methoxsalen|methoxsalen|mesh-list
138205743|NCT00005092|Furocoumarins|furocoumarins|mesh-list
138205744|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205745|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
138205749|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
138205750|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205751|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205752|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138205753|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138205754|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
138205756|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205761|NCT00005104|Metformin|metformin|mesh-list
138205762|NCT00005104|Clomiphene|clomiphene|mesh-list
138205763|NCT00005104|Enclomiphene|enclomiphene|mesh-list
138205764|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
138205765|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138205766|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205767|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138205768|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
138205769|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205770|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138205771|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
138205772|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205773|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138205774|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138205776|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138205777|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138205778|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
138205779|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205780|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205781|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138205782|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138205783|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138294410|NCT00000661|Oxazepam|oxazepam|mesh-list
138294411|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
138294412|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294413|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294417|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294418|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294419|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294420|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138294421|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138294422|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294423|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138205784|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138205786|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
138205787|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205788|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205789|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
138205790|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205791|NCT00004330|Hormones|hormones|mesh-list
138205792|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205793|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205794|NCT00005668|Itraconazole|itraconazole|mesh-list
138205795|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
138205796|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205797|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138205798|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138205799|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205800|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205801|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138205802|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
138205803|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205804|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205805|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138205806|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
138205808|NCT00030992|Ranitidine|ranitidine|mesh-list
138205809|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138205810|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138205811|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138205812|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205813|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205814|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
138205816|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
138205817|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205818|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
138205819|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
138205820|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138205831|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
138205832|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138205833|NCT00004360|Diuretics|diuretics|mesh-ancestor
138205834|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
138205835|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205836|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138205837|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205838|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205839|NCT00385450|Nelfinavir|nelfinavir|mesh-list
138205840|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138205841|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138205842|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138205843|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205844|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205845|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138205846|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138205847|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
138205848|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205849|NCT00004390|Morphine|morphine|mesh-list
138205850|NCT00004390|Methadone|methadone|mesh-list
138205851|NCT00004390|Nortriptyline|nortriptyline|mesh-list
138205852|NCT00004390|Desipramine|desipramine|mesh-list
138205853|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138205861|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
138205862|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138205863|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
138205873|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205874|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205875|NCT00004402|Calcitriol|calcitriol|mesh-list
138205876|NCT00004402|Interferons|interferons|mesh-list
138205877|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
138205879|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
138205880|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205881|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205882|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205883|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138205886|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138205887|NCT00004402|Vitamins|vitamins|mesh-ancestor
138205888|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
138205889|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138205890|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
138205891|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138294424|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138294425|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294426|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
138294427|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
138294428|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294430|NCT00000979|Didanosine|didanosine|mesh-list
138294431|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
138294432|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294433|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294434|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138205892|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138205893|NCT00004420|Analgesics|analgesics|mesh-ancestor
138205894|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
138205895|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138205896|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205897|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205898|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138205899|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138205900|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
138205911|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205912|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205914|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138205915|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
138205916|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138205917|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205918|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138205919|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205920|NCT01217749|Ofatumumab|ofatumumab|mesh-list
138205921|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205922|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138205923|NCT02197273|Epinephrine|epinephrine|mesh-list
138205924|NCT02197273|Fentanyl|fentanyl|mesh-list
138205925|NCT02197273|Morphine|morphine|mesh-list
138205927|NCT02197273|Ropivacaine|ropivacaine|mesh-list
138205928|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
138205929|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
138205930|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138205931|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205932|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
138205945|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138205946|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138205948|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138205949|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
138205950|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
138205951|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
138205952|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138205953|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138205954|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
138205955|NCT02197273|Hormones|hormones|mesh-ancestor
138205956|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138205957|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138205967|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138205969|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205970|NCT00004450|Interferons|interferons|mesh-list
138205971|NCT00004450|Interferon-beta|interferon-beta|mesh-list
138205972|NCT00004450|Thalidomide|thalidomide|mesh-list
138205973|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205974|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
138205975|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138205976|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138205977|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
138205978|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205979|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
138205980|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138205981|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138205982|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138205983|NCT00004450|Growth Substances|growth substances|mesh-ancestor
138205984|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138205985|NCT00004468|Calcitriol|calcitriol|mesh-list
138294613|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
138294614|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294615|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294616|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294617|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138294619|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
138294620|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
138294621|NCT00000727|Trimethoprim|trimethoprim|mesh-list
138294622|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
138294623|NCT00000727|Pentamidine|pentamidine|mesh-list
138205986|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138205987|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205988|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138205989|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205990|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138205991|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138205992|NCT00004468|Vitamins|vitamins|mesh-ancestor
138205993|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
138205999|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206000|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206001|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206002|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138206003|NCT01288807|Analgesics|analgesics|mesh-ancestor
138206005|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206006|NCT00005764|Lamivudine|lamivudine|mesh-list
138206007|NCT00005764|Zidovudine|zidovudine|mesh-list
138206008|NCT00005764|Abacavir|abacavir|mesh-list
138295152|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295153|NCT00002077|Fluconazole|fluconazole|mesh-list
138295154|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
138295155|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295156|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138295157|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295158|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295159|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295302|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206009|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138206010|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138206011|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206015|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206016|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138206017|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138206018|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
138206019|NCT01289275|Nicotine|nicotine|mesh-list
138206020|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138206021|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
138206022|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206023|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206037|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206039|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138206040|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
138206041|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138206042|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138206043|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138206044|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206045|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206046|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
138206047|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206055|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206056|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206057|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
138206058|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206059|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138206060|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
138206061|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138206063|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138206065|NCT00004492|Clotrimazole|clotrimazole|mesh-list
138206067|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
138206068|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206069|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
138206070|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206071|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206072|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206073|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138206074|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206075|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
138206082|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138206083|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138206084|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
138206091|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138206092|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
138206093|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206094|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206095|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138206096|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138206097|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
138206098|NCT00005776|Protective Agents|protective agents|mesh-ancestor
138206108|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138206109|NCT00101660|Dasatinib|dasatinib|mesh-list
138206110|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206112|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206113|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206114|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
138206115|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138206116|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206117|NCT00005800|Docetaxel|docetaxel|mesh-list
138206119|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138206120|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206121|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138206122|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138206123|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138206124|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206125|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206126|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138206127|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138206128|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206129|NCT00004564|Clopidogrel|clopidogrel|mesh-list
138206130|NCT00004564|Atorvastatin|atorvastatin|mesh-list
138206135|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206136|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138206137|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206138|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138206149|NCT00005806|Gefitinib|gefitinib|mesh-list
138206155|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206156|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138206157|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206158|NCT00005812|Temozolomide|temozolomide|mesh-list
138206160|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
138206161|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206162|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206163|NCT01270555|Bupropion|bupropion|mesh-list
138206164|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138206165|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
138206166|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138206167|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138206168|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138206173|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206174|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138206175|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138206176|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206177|NCT00004582|Ritonavir|ritonavir|mesh-list
138206178|NCT00004582|Lopinavir|lopinavir|mesh-list
138206179|NCT00004582|Efavirenz|efavirenz|mesh-list
138206180|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138206181|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138206184|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206186|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138206187|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
138206188|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206189|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138206190|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138206191|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138206192|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206193|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138206194|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138206195|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138206196|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138206197|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138206198|NCT00004690|Monolaurin|monolaurin|mesh-list
138206199|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
138206200|NCT00004690|Protective Agents|protective agents|mesh-ancestor
138206201|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206202|NCT00004696|Morphine|morphine|mesh-list
138206203|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138206204|NCT00004696|Narcotics|narcotics|mesh-ancestor
138206226|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138206227|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
138206228|NCT00004762|Cladribine|cladribine|mesh-list
138206229|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206230|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206231|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
138206236|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138206237|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206238|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206239|NCT01272583|Incretins|incretins|mesh-ancestor
138206240|NCT01272583|Hormones|hormones|mesh-ancestor
138206241|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206242|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138206243|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
138206244|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206245|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206249|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
138206250|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206251|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
138206252|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206253|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
138206254|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138206255|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
138206256|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
138206257|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206258|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138206259|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206260|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206261|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206263|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138206264|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
138206265|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206274|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
138206275|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206276|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206277|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138206278|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138206279|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206280|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206281|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138206282|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206283|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206284|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206285|NCT01273207|Cyclosporine|cyclosporine|mesh-list
138206286|NCT01273207|Cyclosporins|cyclosporins|mesh-list
138206287|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206288|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206289|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206290|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
138206297|NCT01342549|Naltrexone|naltrexone|mesh-list
138206298|NCT01342549|Valproic Acid|valproic acid|mesh-list
138206299|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138206300|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138206301|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206305|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206306|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206307|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
138206308|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206309|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
138206310|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138206311|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206312|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138206313|NCT01295515|Interferons|interferons|mesh-list
138206314|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
138206315|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
138206316|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138206317|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206318|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
138206319|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206320|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
138206321|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206322|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
138206323|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138206324|NCT00101816|Dasatinib|dasatinib|mesh-list
138206325|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206327|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206328|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206329|NCT00102518|Aripiprazole|aripiprazole|mesh-list
138206330|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
138206331|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138206343|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138206345|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138206346|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138206348|NCT00103376|Androgens|androgens|mesh-list
138206349|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138206355|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
138206356|NCT00042224|Clozapine|clozapine|mesh-list
138206357|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138206358|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
138206359|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206360|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206361|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206362|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138206363|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138206374|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138206388|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
138206389|NCT00103844|Dasatinib|dasatinib|mesh-list
138206390|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206391|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138206392|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206393|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206394|NCT01402375|Acetaminophen|acetaminophen|mesh-list
138206395|NCT01402375|Oxycodone|oxycodone|mesh-list
138206396|NCT01402375|Hydrocodone|hydrocodone|mesh-list
138206397|NCT01402375|Codeine|codeine|mesh-list
138206398|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138206399|NCT01402375|Analgesics|analgesics|mesh-ancestor
138206400|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
138206401|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206402|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206403|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
138206404|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138206405|NCT01402375|Narcotics|narcotics|mesh-ancestor
138206406|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206407|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
138206408|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
138206409|NCT01302379|Metformin|metformin|mesh-list
138206410|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206411|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206412|NCT01351753|Metformin|metformin|mesh-list
138206413|NCT01351753|Topiramate|topiramate|mesh-list
138206414|NCT01351753|Orlistat|orlistat|mesh-list
138206415|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206416|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206417|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
138206418|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206419|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206420|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138206421|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206422|NCT00104858|Cyclosporine|cyclosporine|mesh-list
138206423|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
138206424|NCT00104858|Rituximab|rituximab|mesh-list
138206425|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138206426|NCT00104858|Fludarabine|fludarabine|mesh-list
138206427|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
138206434|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206435|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206436|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138206438|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206439|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206441|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
138206442|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206443|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206444|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138206445|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206446|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138206447|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206448|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206449|NCT01407523|Levetiracetam|levetiracetam|mesh-list
138206450|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
138206451|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
138206458|NCT01304641|Simvastatin|simvastatin|mesh-list
138206459|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138206460|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138206461|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
138206462|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206463|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138206464|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138206468|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138206469|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138206470|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138206471|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206472|NCT01409239|Insulin|insulin|mesh-list
138206473|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138206474|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206475|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206476|NCT00108524|Orlistat|orlistat|mesh-list
138206477|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206478|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206479|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138206487|NCT01410409|Pantoprazole|pantoprazole|mesh-list
138206488|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138206489|NCT01410409|Analgesics|analgesics|mesh-ancestor
138206490|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
138206491|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206492|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206498|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206500|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206502|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138206507|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206509|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
138206510|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206511|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206512|NCT02324335|Brilacidin|brilacidin|mesh-list
138295262|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
138295263|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295264|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138295265|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295266|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295267|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
138295268|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295269|NCT00001579|Antidotes|antidotes|mesh-ancestor
138295270|NCT00001579|Protective Agents|protective agents|mesh-ancestor
138295271|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
138295272|NCT00001579|Vitamins|vitamins|mesh-ancestor
138295273|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
138295274|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295275|NCT00003020|Immunotoxins|immunotoxins|mesh-list
138206513|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206514|NCT01411501|Mosapride|mosapride|mesh-list
138206515|NCT01411501|Citric Acid|citric acid|mesh-list
138206516|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
138206517|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
138206518|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138206522|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138206523|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138206525|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206526|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206527|NCT01310179|Fludarabine|fludarabine|mesh-list
138206528|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
138206529|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206530|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138206531|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
138206532|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206533|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206534|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
138206535|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206536|NCT01412281|Vaccines|vaccines|mesh-list
138206537|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
138206538|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206539|NCT01359007|Leucovorin|leucovorin|mesh-list
138206540|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
138206541|NCT01359007|Irinotecan|irinotecan|mesh-list
138206542|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206552|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
138206553|NCT01414153|Bevacizumab|bevacizumab|mesh-list
138206554|NCT01414153|Ranibizumab|ranibizumab|mesh-list
138206555|NCT01414153|Aflibercept|aflibercept|mesh-list
138206558|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206559|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206560|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138206561|NCT01414153|Growth Substances|growth substances|mesh-ancestor
138206562|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206563|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
138206564|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
138206565|NCT01311895|Hydromorphone|hydromorphone|mesh-list
138206566|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138206567|NCT01311895|Narcotics|narcotics|mesh-ancestor
138206568|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206569|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206570|NCT01311895|Analgesics|analgesics|mesh-ancestor
138206571|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
138206572|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206573|NCT01362127|Cisplatin|cisplatin|mesh-list
138206580|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206581|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138206583|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
138206584|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206585|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138295276|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
138206586|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138206587|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138206588|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
138206589|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206592|NCT00052910|Fluorouracil|fluorouracil|mesh-list
138206593|NCT00052910|Epirubicin|epirubicin|mesh-list
138206594|NCT00052910|Calcium|calcium|mesh-list
138206595|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
138206596|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206597|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138206598|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206599|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
138206600|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206601|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138206602|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206603|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
138206604|NCT00052910|Antidotes|antidotes|mesh-ancestor
138206605|NCT00052910|Protective Agents|protective agents|mesh-ancestor
138206606|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
138206607|NCT00052910|Vitamins|vitamins|mesh-ancestor
138206614|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
138206615|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206616|NCT01363843|Antidotes|antidotes|mesh-ancestor
138206617|NCT01363843|Protective Agents|protective agents|mesh-ancestor
138206621|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
138206622|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
138206623|NCT02092298|Cisplatin|cisplatin|mesh-list
138206624|NCT02092298|Mitomycins|mitomycins|mesh-list
138206625|NCT02092298|Mitomycin|mitomycin|mesh-list
138206626|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206627|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206628|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
138206629|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206630|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206631|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206632|NCT02092298|Antidotes|antidotes|mesh-ancestor
138206633|NCT02092298|Protective Agents|protective agents|mesh-ancestor
138206638|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206639|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
138206640|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
138206641|NCT00151814|Olmesartan|olmesartan|mesh-list
138206642|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138206643|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138206644|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138206645|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138206646|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206654|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206655|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138206656|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138206657|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
138206658|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206659|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206660|NCT01363999|Atorvastatin|atorvastatin|mesh-list
138206661|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
138206662|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138206663|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138206664|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
138206665|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206682|NCT00258128|Analgesics|analgesics|mesh-ancestor
138206683|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
138206684|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206685|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206686|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138206687|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206688|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
138206689|NCT01364623|Testosterone|testosterone|mesh-list
138206690|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
138206699|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
138206700|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
138206701|NCT00258206|Rituximab|rituximab|mesh-list
138206702|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206703|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
138206704|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206705|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206706|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138206707|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
138206708|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206709|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206710|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138206711|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206712|NCT01063907|Bortezomib|bortezomib|mesh-list
138206713|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206725|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
138206726|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206727|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138206728|NCT03015857|Narcotics|narcotics|mesh-ancestor
138206729|NCT03015857|Analgesics|analgesics|mesh-ancestor
138206730|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138206736|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
138206737|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138206739|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
138206740|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138206741|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138206742|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138206743|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138206744|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206748|NCT03295487|Hormones|hormones|mesh-ancestor
138206749|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206750|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206751|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
138206752|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206755|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206756|NCT03015701|Mifepristone|mifepristone|mesh-list
138206757|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138206758|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
138206764|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
138206765|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138206766|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138206767|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
138206768|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206769|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
138206770|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138206771|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138206772|NCT04780061|Vitamin D|vitamin d|mesh-list
138206773|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
138206774|NCT04780061|Vitamins|vitamins|mesh-list
138206775|NCT04780061|Vitamin K|vitamin k|mesh-list
138206776|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
138206777|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
138206778|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206779|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138206780|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138206781|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206782|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138206783|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138206784|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
138206785|NCT04780061|Coagulants|coagulants|mesh-ancestor
138206786|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138206787|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
138206788|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138206789|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138206790|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206791|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206792|NCT02973737|Capecitabine|capecitabine|mesh-list
138206793|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138206794|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
138206795|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206796|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206803|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206804|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206809|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138206810|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138206812|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
138206813|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138206814|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206816|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
138206817|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
138206818|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206822|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206823|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206824|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
138206825|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
138206826|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
138206827|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
138206833|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206834|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206835|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138206836|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138206837|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206842|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206843|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206844|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206845|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138206846|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
138206861|NCT00166166|Kininogens|kininogens|mesh-list
138206862|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
138206863|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138206864|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138206865|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138206866|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206867|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206868|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138206869|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
138206870|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206871|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206877|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138206878|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138206895|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206896|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206899|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206907|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138206908|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138206909|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
138206910|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138206911|NCT01111331|Empagliflozin|empagliflozin|mesh-list
138206912|NCT01111331|Warfarin|warfarin|mesh-list
138206913|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
138206914|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138206917|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206918|NCT00167102|Alefacept|alefacept|mesh-list
138206924|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138206925|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206926|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
138206927|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206934|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206936|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138206937|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138206940|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138206941|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
138206942|NCT02176031|Natalizumab|natalizumab|mesh-list
138206943|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138206944|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
138206945|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
138206946|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206947|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206948|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138206949|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
138206951|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206957|NCT03013361|Bupivacaine|bupivacaine|mesh-list
138206958|NCT03013361|Ropivacaine|ropivacaine|mesh-list
138206959|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
138206960|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
138206961|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138206962|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206963|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
138206964|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206965|NCT01077401|Ranibizumab|ranibizumab|mesh-list
138206966|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138206967|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138206968|NCT01077401|Growth Substances|growth substances|mesh-ancestor
138206969|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206970|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
138206971|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206972|NCT01316341|Empagliflozin|empagliflozin|mesh-list
138206973|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138206974|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206975|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206976|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206977|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138206978|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
138206979|NCT01112735|Coagulants|coagulants|mesh-ancestor
138206981|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
138206982|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138206983|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138206984|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138206985|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138206986|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138206987|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
138206988|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206989|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138206990|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138206991|NCT01034111|Metformin|metformin|mesh-list
138206992|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138206993|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138206994|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138206995|NCT01034111|Incretins|incretins|mesh-ancestor
138206996|NCT01034111|Hormones|hormones|mesh-ancestor
138206997|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206998|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138206999|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
138207000|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207001|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207002|NCT01114997|Lidocaine|lidocaine|mesh-list
138207003|NCT01114997|Esmolol|esmolol|mesh-list
138207004|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
138207005|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
138207009|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207010|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138207011|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138207012|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138207013|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207014|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207019|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207020|NCT00118742|Cyclosporine|cyclosporine|mesh-list
138207022|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
138207023|NCT00118742|Tacrolimus|tacrolimus|mesh-list
138207024|NCT00118742|Cyclosporins|cyclosporins|mesh-list
138207025|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207026|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
138207027|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207028|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138207036|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207037|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138207038|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
138207039|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207040|NCT01317667|Vaccines|vaccines|mesh-list
138207041|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
138207044|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207045|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
138207046|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207047|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207048|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207049|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
138207050|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207051|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207052|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138207053|NCT01317901|Rituximab|rituximab|mesh-list
138207054|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138207055|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207056|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207057|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
138207058|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207059|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207060|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207061|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
138207062|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207065|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207066|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207070|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
138207072|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
138207073|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207074|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138207075|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138207076|NCT01899170|Carfentanil|carfentanil|mesh-list
138207077|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138207078|NCT01899170|Narcotics|narcotics|mesh-ancestor
138207079|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207080|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207081|NCT01899170|Analgesics|analgesics|mesh-ancestor
138207082|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
138207083|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207084|NCT01425229|Bosentan|bosentan|mesh-list
138207085|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138207086|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138207087|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207088|NCT00258362|Carboplatin|carboplatin|mesh-list
138207089|NCT00258362|Docetaxel|docetaxel|mesh-list
138207090|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207091|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
138207092|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
138207093|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
138207094|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207095|NCT00258830|Vaccines|vaccines|mesh-list
138207096|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
138207097|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207098|NCT02539368|Infliximab|infliximab|mesh-list
138207099|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138207113|NCT00123110|Metformin|metformin|mesh-list
138207114|NCT00123110|Leuprolide|leuprolide|mesh-list
138207115|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207119|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295277|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
138207120|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207121|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207123|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138207124|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138207126|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
138207127|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207128|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207129|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207130|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207131|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138207132|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138207133|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207134|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207135|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138207136|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138207137|NCT01426867|Brinzolamide|brinzolamide|mesh-list
138207138|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138207139|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138207140|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138207141|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138207164|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
138207166|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207167|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
138207168|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207169|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207176|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
138207177|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207178|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
138207179|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207180|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207181|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138207183|NCT01319773|Cyclosporins|cyclosporins|mesh-list
138207184|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207185|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207186|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207187|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
138207188|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207190|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207191|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207192|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207193|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138207203|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138207204|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138207205|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207206|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207212|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207213|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207214|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
138207215|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
138207216|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207217|NCT04262934|Vitamin D|vitamin d|mesh-list
138207218|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
138207228|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207229|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138207230|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
138207231|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
138207232|NCT00262964|Vitamins|vitamins|mesh-ancestor
138207248|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
138207249|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
138207250|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207251|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207252|NCT01322815|Leucovorin|leucovorin|mesh-list
138207253|NCT01322815|Fluorouracil|fluorouracil|mesh-list
138207254|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
138207255|NCT01322815|Irinotecan|irinotecan|mesh-list
138207256|NCT01322815|Bevacizumab|bevacizumab|mesh-list
138207257|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
138207258|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
138207259|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207260|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207261|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207262|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207263|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
138207264|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207280|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138207281|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207282|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207283|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138207284|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207285|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138207286|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138207287|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207288|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138207293|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207294|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138207295|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138207297|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207298|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207299|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138207300|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138207302|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138207303|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
138207304|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207305|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207319|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207320|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138207322|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
138207324|NCT00176852|Fludarabine|fludarabine|mesh-list
138207325|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
138207326|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
138207327|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138207335|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207336|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207370|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207371|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207384|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207385|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207386|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207388|NCT03009097|Atorvastatin|atorvastatin|mesh-list
138207389|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138207390|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138207391|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
138295284|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
138295285|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295286|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138295287|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138295288|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295289|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295290|NCT00002131|Protective Agents|protective agents|mesh-ancestor
138295291|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138295292|NCT00380887|Estrogens|estrogens|mesh-ancestor
138295294|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295295|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295296|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
138295297|NCT00002461|Carmustine|carmustine|mesh-list
138295298|NCT00002461|Etoposide|etoposide|mesh-list
138295299|NCT00002461|Sargramostim|sargramostim|mesh-list
138295300|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295301|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
138207421|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207422|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138207423|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207424|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207425|NCT01080677|Propranolol|propranolol|mesh-list
138207426|NCT01080677|Caffeine|caffeine|mesh-list
138207427|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138207428|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295303|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207429|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138207430|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207455|NCT01116401|Leuprolide|leuprolide|mesh-list
138207456|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138207457|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
138207458|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207459|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207460|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207461|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207462|NCT03008317|Chromium|chromium|mesh-list
138207463|NCT03008317|Trace Elements|trace elements|mesh-ancestor
138207464|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
138207476|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207477|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
138207478|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207479|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207480|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207481|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
138207498|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207499|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138207500|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138207501|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138207502|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138207503|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
138295474|NCT00002179|Lamivudine|lamivudine|mesh-list
138207504|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207505|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207506|NCT05422092|Pioglitazone|pioglitazone|mesh-list
138207507|NCT05422092|Canagliflozin|canagliflozin|mesh-list
138207508|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207509|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207510|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138207519|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
138207520|NCT05448378|Vitamins|vitamins|mesh-ancestor
138207521|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
138207522|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207532|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207534|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138207535|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207536|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138207537|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207538|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138207539|NCT01084265|Hormones|hormones|mesh-list
138207540|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138207559|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138207561|NCT01118273|Analgesics|analgesics|mesh-ancestor
138207562|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
138207563|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207564|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207565|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207581|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207582|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138207583|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
138207584|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207586|NCT01085903|Modafinil|modafinil|mesh-list
138207587|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138207588|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207589|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138207590|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138207591|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138207592|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207599|NCT01439815|Xhance|xhance|mesh-list
138207600|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207601|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138207602|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
138207603|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207604|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207605|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138207606|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
138207607|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138207608|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138207609|NCT01332253|Ibuprofen|ibuprofen|mesh-list
138207610|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138207611|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138207618|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138207619|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207620|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207621|NCT01332721|Bevacizumab|bevacizumab|mesh-list
138207622|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207623|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207624|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138207625|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138207626|NCT01332721|Growth Substances|growth substances|mesh-ancestor
138207648|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138207649|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138207650|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207658|NCT00265850|Irinotecan|irinotecan|mesh-list
138207659|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
138207660|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207661|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295475|NCT00002179|Zidovudine|zidovudine|mesh-list
138295476|NCT00002179|Indinavir|indinavir|mesh-list
138295477|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295478|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295479|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295480|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295481|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
138295482|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295483|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295484|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295485|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
138295486|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138207662|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138207663|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138207664|NCT00265850|Growth Substances|growth substances|mesh-ancestor
138207665|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207666|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
138207667|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
138207668|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207669|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138207670|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207684|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138207685|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295759|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295760|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138295761|NCT00002227|Lamivudine|lamivudine|mesh-list
138295762|NCT00002227|Efavirenz|efavirenz|mesh-list
138295763|NCT00002227|Stavudine|stavudine|mesh-list
138295764|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295765|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295766|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295767|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295769|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295770|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295771|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295772|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295773|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295774|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138207686|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207688|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138207689|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207701|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207702|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138207703|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138207704|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138207705|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138207706|NCT01042145|Dexamethasone|dexamethasone|mesh-list
138207707|NCT01042145|Prednisone|prednisone|mesh-list
138207712|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207714|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
138207715|NCT01042145|Hormones|hormones|mesh-ancestor
138296040|NCT00002804|Protective Agents|protective agents|mesh-ancestor
138296041|NCT00002804|Trace Elements|trace elements|mesh-ancestor
138296042|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
138296044|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
138296045|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296046|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296047|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
138296048|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296049|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296051|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296053|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207716|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207717|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207718|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207719|NCT01043393|Desoximetasone|desoximetasone|mesh-list
138207720|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207721|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
138207722|NCT01043393|Hormones|hormones|mesh-ancestor
138207723|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207750|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207752|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138207753|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
138207754|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207763|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
138207764|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207765|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207766|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
138207767|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207768|NCT01441843|Lorazepam|lorazepam|mesh-list
138207769|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
138207770|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
138207780|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
138207781|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
138207782|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207783|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207784|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
138207785|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138207786|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138296054|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138296055|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138296056|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296057|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296058|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138296059|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138296060|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296061|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296062|NCT00003392|Paclitaxel|paclitaxel|mesh-list
138296063|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
138296064|NCT00003392|Carboplatin|carboplatin|mesh-list
138296065|NCT00003392|Melphalan|melphalan|mesh-list
138207787|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138207788|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138207789|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207805|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138207807|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
138207821|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207823|NCT01121939|Bevacizumab|bevacizumab|mesh-list
138207824|NCT01121939|Pertuzumab|pertuzumab|mesh-list
138207825|NCT01121939|Octreotide|octreotide|mesh-list
138207842|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207843|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207844|NCT00131378|Hormones|hormones|mesh-list
138207850|NCT01445821|Fludarabine|fludarabine|mesh-list
138207851|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
138207852|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138207853|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
138207854|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207855|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138207866|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
138207868|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207869|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138207870|NCT01445821|Protective Agents|protective agents|mesh-ancestor
138207871|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138207872|NCT00182000|Cycloserine|cycloserine|mesh-list
138296155|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
138207873|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138207874|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207875|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138207877|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138207878|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
138207879|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207880|NCT01092923|Sevoflurane|sevoflurane|mesh-list
138207881|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138207882|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138207883|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
138207884|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
138207885|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207886|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207887|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138207888|NCT03013439|Hematinics|hematinics|mesh-ancestor
138207889|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138207890|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138207891|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138207892|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138296235|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296236|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296237|NCT05751421|Meloxicam|meloxicam|mesh-list
138296238|NCT05751421|Bupivacaine|bupivacaine|mesh-list
138296239|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138296240|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
138296241|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
138296242|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138296243|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296244|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
138296245|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296246|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138296247|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138207893|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207912|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138207913|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
138207914|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207915|NCT00183092|Quinacrine|quinacrine|mesh-list
138207916|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
138207917|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138207918|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
138207919|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138207920|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207933|NCT00183794|Docetaxel|docetaxel|mesh-list
138207938|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138207939|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138207940|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138207941|NCT00270296|Ritonavir|ritonavir|mesh-list
138207942|NCT00270296|Lopinavir|lopinavir|mesh-list
138207943|NCT00270296|Lamivudine|lamivudine|mesh-list
138207944|NCT00270296|Zidovudine|zidovudine|mesh-list
138207953|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138207954|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
138207955|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207959|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296333|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296334|NCT00002557|Etoposide|etoposide|mesh-list
138296335|NCT00002557|Methotrexate|methotrexate|mesh-list
138296336|NCT00002557|Calcium|calcium|mesh-list
138296337|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
138296338|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296339|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296340|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296341|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296342|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296343|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296344|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296345|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296346|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138296347|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
138296348|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207961|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138207962|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138207964|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138207965|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
138207966|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207967|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207968|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138207969|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138207970|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
138207971|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138207972|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207973|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
138296721|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
138207974|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138207975|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207976|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138207977|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207986|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207987|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138207989|NCT03013205|Triamcinolone|triamcinolone|mesh-list
138207990|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138207991|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138207992|NCT03013205|Lidocaine|lidocaine|mesh-list
138207993|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138207994|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138207995|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
138208015|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
138208016|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138208017|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138208018|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138208019|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
138208020|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208021|NCT01095887|Eculizumab|eculizumab|mesh-list
138208024|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
138208025|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208026|NCT03110315|Suvorexant|suvorexant|mesh-list
138208027|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138208028|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138208029|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208030|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208031|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138208033|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208035|NCT05307341|Dsuvia|dsuvia|mesh-list
138208036|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138208037|NCT05307341|Narcotics|narcotics|mesh-ancestor
138208038|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208039|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208040|NCT05307341|Analgesics|analgesics|mesh-ancestor
138208041|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
138208042|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208044|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138208045|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
138208046|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
138208047|NCT01100255|Ketamine|ketamine|mesh-list
138208048|NCT01100255|Analgesics|analgesics|mesh-ancestor
138208049|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
138208050|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208051|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208052|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138208053|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138208054|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
138208055|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
138208062|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138208064|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208065|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
138208066|NCT01100723|Vitamin D|vitamin d|mesh-list
138208067|NCT01100723|Calcitriol|calcitriol|mesh-list
138208068|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138208069|NCT01100723|Cinacalcet|cinacalcet|mesh-list
138208070|NCT01100723|Vitamins|vitamins|mesh-ancestor
138208071|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
138208072|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208073|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138208074|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208075|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138208076|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208077|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208078|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138208079|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138208080|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208081|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208082|NCT05306405|Misoprostol|misoprostol|mesh-list
138208083|NCT05306405|Estradiol|estradiol|mesh-list
138208084|NCT05306405|Estrogens|estrogens|mesh-ancestor
138208085|NCT05306405|Hormones|hormones|mesh-ancestor
138208086|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208087|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208088|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208089|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138208090|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
138208091|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138208092|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208094|NCT04352621|Ketamine|ketamine|mesh-list
138208095|NCT04352621|Analgesics|analgesics|mesh-ancestor
138208096|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
138208097|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208098|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208099|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138208100|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138208101|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
138208102|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
138208103|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208104|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138208105|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138208106|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208107|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208108|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
138208109|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138208110|NCT02246855|Antibodies|antibodies|mesh-list
138208111|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
138208116|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138208117|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138208118|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208119|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208121|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208123|NCT00185900|Nifedipine|nifedipine|mesh-list
138208124|NCT00185900|Analgesics|analgesics|mesh-ancestor
138208125|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
138208126|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208127|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208128|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
138208129|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208130|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138208131|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
138208132|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138208133|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208134|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208135|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208136|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
138208137|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208139|NCT00186056|Mifepristone|mifepristone|mesh-list
138208140|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138208142|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208143|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208144|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138208145|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138208146|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138208147|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
138208148|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138208149|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138208150|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208151|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208152|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
138208153|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138208154|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138208155|NCT00186446|Bupropion|bupropion|mesh-list
138208156|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138208157|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
138208158|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208164|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208165|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208166|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138208167|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138208168|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208170|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138208171|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
138208172|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208173|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138208174|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138208175|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208176|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208177|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
138208178|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208179|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208180|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138208181|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138208182|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208184|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138208185|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
138208186|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138208187|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208188|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
138208189|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138208190|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138208191|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138208192|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208193|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208194|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138208195|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138208196|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138208197|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208198|NCT00145418|Docetaxel|docetaxel|mesh-list
138208199|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
138208200|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208201|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
138208202|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208203|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208204|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208205|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138208206|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138208207|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138208208|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208209|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208210|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208211|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208212|NCT04751318|Analgesics|analgesics|mesh-ancestor
138208213|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
138208217|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
138296722|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208219|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208220|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208221|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138208222|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208223|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208224|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208225|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
138208226|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208227|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208228|NCT01447225|Carboplatin|carboplatin|mesh-list
138208229|NCT01447225|Gemcitabine|gemcitabine|mesh-list
138208231|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208232|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208233|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
138208234|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208235|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208236|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138208237|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138208238|NCT01447849|Lubiprostone|lubiprostone|mesh-list
138208239|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138208240|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208241|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208243|NCT00277394|Tinzaparin|tinzaparin|mesh-list
138208244|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
138208245|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138208246|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138208247|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208248|NCT01450189|Tenofovir|tenofovir|mesh-list
138208249|NCT01450189|Emtricitabine|emtricitabine|mesh-list
138208250|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
138208251|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138208252|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
138208253|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208254|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138296813|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296814|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296815|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
138296816|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296817|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138296818|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296819|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296820|NCT00003950|Cyclosporine|cyclosporine|mesh-list
138296821|NCT00003950|Irinotecan|irinotecan|mesh-list
138296822|NCT00003950|Cyclosporins|cyclosporins|mesh-list
138296823|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138296824|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296825|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296826|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296827|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296828|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296829|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
138296830|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208255|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138208256|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208257|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208258|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138208259|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138208260|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138208261|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138208262|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
138208263|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208264|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138208265|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214820|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208266|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208267|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
138208269|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138208270|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208271|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208272|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138208273|NCT01474213|Analgesics|analgesics|mesh-ancestor
138208274|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
138208275|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208276|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138208279|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208280|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208281|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208282|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138208283|NCT01474213|Narcotics|narcotics|mesh-ancestor
138208284|NCT00147212|Trabectedin|trabectedin|mesh-list
138208285|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138208286|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
138208287|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208288|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208289|NCT01474915|Promethazine|promethazine|mesh-list
138208290|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
138208291|NCT01474915|Dexamethasone|dexamethasone|mesh-list
138208292|NCT01474915|Ondansetron|ondansetron|mesh-list
138208295|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
138208296|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
138208297|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208298|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208299|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208300|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
138208301|NCT01474915|Hormones|hormones|mesh-ancestor
138208302|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208303|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138208304|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208305|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
138208306|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138208307|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138208308|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138208309|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
138208310|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208311|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208312|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138208313|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138208314|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
138208315|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
138208316|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138208317|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138208318|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138208319|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208320|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
138208322|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
138208323|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
138208324|NCT01899794|Oxybutynin|oxybutynin|mesh-list
138208325|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
138208326|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
138208327|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208328|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208329|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138208330|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138208331|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
138208332|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208333|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208334|NCT01899794|Urological Agents|urological agents|mesh-ancestor
138208335|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138208336|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208337|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
138208338|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138208339|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138208340|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138208341|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208342|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208343|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
138208349|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208350|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138208351|NCT02099084|Protective Agents|protective agents|mesh-ancestor
138208352|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208354|NCT00281918|Rituximab|rituximab|mesh-list
138208355|NCT00281918|Fludarabine|fludarabine|mesh-list
138208356|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
138208357|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138208358|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
138208359|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208360|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208361|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138208362|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
138214821|NCT00610688|Vitamin D|vitamin d|mesh-list
138214823|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
138214824|NCT00610688|Vitamins|vitamins|mesh-list
138214825|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
138214826|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214827|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138214828|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138214829|NCT00669578|Pomalidomide|pomalidomide|mesh-list
138214830|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
138214831|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214832|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214833|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138214834|NCT00669578|Growth Substances|growth substances|mesh-ancestor
138214835|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214836|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214837|NCT02137382|Pancrelipase|pancrelipase|mesh-list
138214839|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214840|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138214841|NCT00611468|Topotecan|topotecan|mesh-list
138214842|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214843|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214844|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214845|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214846|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138214847|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138214848|NCT00670202|Fasudil|fasudil|mesh-list
138214849|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138208363|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208364|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208365|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138208366|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208367|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208368|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
138208369|NCT00201734|Paclitaxel|paclitaxel|mesh-list
138208370|NCT00201734|Carboplatin|carboplatin|mesh-list
138208371|NCT00201734|Capecitabine|capecitabine|mesh-list
138208372|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208373|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208374|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138208375|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208376|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208377|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208378|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208379|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
138208380|NCT00203216|Levetiracetam|levetiracetam|mesh-list
138208381|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
138208382|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
138208383|NCT05156060|Ketamine|ketamine|mesh-list
138208384|NCT05156060|Gabapentin|gabapentin|mesh-list
138208385|NCT05156060|Analgesics|analgesics|mesh-ancestor
138208386|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
138208387|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208388|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208389|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138208390|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138208391|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
138208392|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
138208393|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208394|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138208395|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138208396|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208398|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
138208399|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138208400|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208401|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208402|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
138208404|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
138208405|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138208406|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208408|NCT00210470|Indomethacin|indomethacin|mesh-list
138208409|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
138208410|NCT00210470|Omeprazole|omeprazole|mesh-list
138208411|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138208412|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
138208413|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208414|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208415|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138208416|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
138208417|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208418|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208419|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138208420|NCT00210470|Trace Elements|trace elements|mesh-ancestor
138208421|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
138208422|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138208423|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208424|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138208425|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208426|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138208427|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138208428|NCT00210470|Analgesics|analgesics|mesh-ancestor
138208429|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
138208430|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296831|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
138296832|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296833|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296834|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296835|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138296836|NCT00003464|Temozolomide|temozolomide|mesh-list
138296837|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296839|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296840|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296841|NCT00003230|Paclitaxel|paclitaxel|mesh-list
138296842|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296843|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296844|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296845|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208431|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138208432|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
138208433|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
138208434|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208435|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138208436|NCT01108445|Everolimus|everolimus|mesh-list
138208437|NCT01108445|Sunitinib|sunitinib|mesh-list
138208438|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138208439|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138208440|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208441|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208442|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138208443|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
138208444|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208445|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208446|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138208447|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138208448|NCT01108445|Growth Substances|growth substances|mesh-ancestor
138208449|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
138208450|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138208451|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138208452|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208453|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208454|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
138208455|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138208456|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138208457|NCT04352153|Febuxostat|febuxostat|mesh-list
138208458|NCT04352153|Citric Acid|citric acid|mesh-list
138208459|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
138208460|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138208461|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
138208462|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
138208463|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208465|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208469|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208470|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208471|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208472|NCT01162733|Vancomycin|vancomycin|mesh-list
138208473|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208474|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208476|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
138208477|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208478|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
138208479|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208480|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208481|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
138208483|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
138208484|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138208485|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138208486|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
138208487|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208488|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138208489|NCT01165541|Mirtazapine|mirtazapine|mesh-list
138208490|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
138208491|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208492|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138208493|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208495|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208496|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138208497|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
138208498|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
138208499|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208500|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208501|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138208502|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138208503|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138208504|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208505|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208506|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138208507|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138208508|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
138208509|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138208510|NCT00284180|Trastuzumab|trastuzumab|mesh-list
138208511|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208512|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208513|NCT04087460|Vaccines|vaccines|mesh-list
138208514|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138208515|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
138208516|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208517|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138208518|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138208519|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138208520|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138208521|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208522|NCT00287222|Bevacizumab|bevacizumab|mesh-list
138208524|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208525|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208526|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138208527|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138208528|NCT00287222|Growth Substances|growth substances|mesh-ancestor
138208529|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208530|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138208531|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138208532|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208535|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138208536|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138208537|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208538|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
138208539|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208540|NCT01134575|Rituximab|rituximab|mesh-list
138208541|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138208542|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208543|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208544|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
138208545|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208546|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208547|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138208548|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
138208549|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
138208550|NCT01790672|Ethanol|ethanol|mesh-list
138208551|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138208552|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208553|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208554|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208555|NCT00223262|Lamotrigine|lamotrigine|mesh-list
138208556|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
138208557|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138208558|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208559|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208560|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208561|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208562|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138208563|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208564|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208565|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208566|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138208568|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138208569|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208570|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208571|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208572|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138208573|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208574|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138208575|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138208576|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138208577|NCT00290810|Bevacizumab|bevacizumab|mesh-list
138208578|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138208579|NCT00290810|Antibodies|antibodies|mesh-list
138208580|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
138208581|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138208582|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208583|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138208584|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138208585|NCT00290810|Growth Substances|growth substances|mesh-ancestor
138208586|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208587|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138208588|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
138208589|NCT04042142|Glucagon|glucagon|mesh-list
138208593|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208594|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
138208595|NCT01138475|Vitamin D|vitamin d|mesh-list
138208596|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208597|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208598|NCT01138475|Vitamins|vitamins|mesh-ancestor
138208599|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
138208600|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138208601|NCT00293540|Tamoxifen|tamoxifen|mesh-list
138208602|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138208603|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208604|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208605|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208606|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138208607|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208608|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138208609|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138208610|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138208611|NCT03012113|Mirabegron|mirabegron|mesh-list
138208612|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138208613|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138208614|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138208615|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208616|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208617|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208618|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208619|NCT03012113|Urological Agents|urological agents|mesh-ancestor
138208620|NCT01139801|Misoprostol|misoprostol|mesh-list
138208621|NCT01139801|Oxytocin|oxytocin|mesh-list
138208622|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
138208623|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138208624|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208625|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138208626|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
138208627|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138208628|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208629|NCT00294632|Rituximab|rituximab|mesh-list
138208630|NCT00294632|Lenalidomide|lenalidomide|mesh-list
138208631|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208632|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208633|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
138208634|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208635|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208636|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138208637|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138208638|NCT00294632|Growth Substances|growth substances|mesh-ancestor
138208639|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
138208640|NCT01898624|Mirabegron|mirabegron|mesh-list
138208641|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138208642|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138208643|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138208644|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208645|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208646|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208647|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208649|NCT01140191|Gentamicins|gentamicins|mesh-list
138208650|NCT01140191|Paromomycin|paromomycin|mesh-list
138208651|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208652|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208653|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138208663|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
138208664|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138208665|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138208666|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208667|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138208668|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138208669|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138208670|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214850|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138296846|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296847|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296848|NCT00003956|Leucovorin|leucovorin|mesh-list
138296849|NCT00003956|Fluorouracil|fluorouracil|mesh-list
138296850|NCT00003956|Calcium|calcium|mesh-list
138296851|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
138296852|NCT00003956|Lonafarnib|lonafarnib|mesh-list
138296853|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296854|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296855|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
138296856|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296857|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296858|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296859|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296860|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
138296861|NCT00003956|Antidotes|antidotes|mesh-ancestor
138296862|NCT00003956|Protective Agents|protective agents|mesh-ancestor
138296863|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296864|NCT00003956|Vitamins|vitamins|mesh-ancestor
138208671|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208672|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
138208673|NCT01141595|Verapamil|verapamil|mesh-list
138208674|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138208675|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138208676|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208677|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208678|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208679|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208680|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
138208681|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
138208682|NCT01167569|Vitamins|vitamins|mesh-ancestor
138208683|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
138208684|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208685|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
138208686|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208687|NCT01167569|Protective Agents|protective agents|mesh-ancestor
138208688|NCT00296192|Rotigotine|rotigotine|mesh-list
138208689|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
138208690|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
138296865|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
138296866|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296867|NCT00002623|Carboplatin|carboplatin|mesh-list
138296868|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296869|NCT00003962|Aldesleukin|aldesleukin|mesh-list
138296870|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296871|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296872|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296873|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
138296874|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208691|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208692|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208693|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208694|NCT04312139|Lincomycin|lincomycin|mesh-list
138208696|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208697|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208698|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208699|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208700|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138208701|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208702|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208704|NCT00297596|Trastuzumab|trastuzumab|mesh-list
138208705|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208706|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208707|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138208708|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
138208709|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208710|NCT00298610|Artesunate|artesunate|mesh-list
138208711|NCT00298610|Atovaquone|atovaquone|mesh-list
138208712|NCT00298610|Proguanil|proguanil|mesh-list
138208716|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138208717|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138208718|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208719|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208721|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
138208722|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138208723|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
138208724|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208725|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208726|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
138208727|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138208728|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208729|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208730|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208731|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208732|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138208733|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138208734|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138208735|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
138208736|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138208737|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138208738|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208739|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138208740|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138208742|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138208743|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138208744|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208745|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208746|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208747|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208748|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208749|NCT01144949|Urological Agents|urological agents|mesh-ancestor
138208750|NCT00215930|Carboplatin|carboplatin|mesh-list
138208751|NCT00215930|Gemcitabine|gemcitabine|mesh-list
138208752|NCT00215930|Docetaxel|docetaxel|mesh-list
138208753|NCT00215930|Vinorelbine|vinorelbine|mesh-list
138208754|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208755|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138208756|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
138208757|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208758|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138208767|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208768|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208769|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208771|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138208772|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208773|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138208774|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208775|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208776|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
138208777|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138208778|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138208779|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138208780|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208781|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208782|NCT01169519|Urological Agents|urological agents|mesh-ancestor
138208783|NCT04071977|Antioxidants|antioxidants|mesh-list
138208784|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208785|NCT04071977|Protective Agents|protective agents|mesh-ancestor
138208786|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208787|NCT02101190|Opicapone|opicapone|mesh-list
138208788|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138208789|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208790|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208791|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138208792|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138208793|NCT01170533|Omeprazole|omeprazole|mesh-list
138208794|NCT01170533|Pantoprazole|pantoprazole|mesh-list
138208795|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138208796|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138208797|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138208798|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208799|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208800|NCT01147601|Timolol|timolol|mesh-list
138208801|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138208802|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208803|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208804|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208805|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208806|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208807|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138208808|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138208809|NCT03011645|Ziprasidone|ziprasidone|mesh-list
138208810|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138208811|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
138208812|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208813|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208814|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208820|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
138208821|NCT01149785|Ketoconazole|ketoconazole|mesh-list
138208822|NCT01149785|Crizotinib|crizotinib|mesh-list
138208823|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
138208824|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208825|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138208826|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138208827|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208828|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208829|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138208830|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208831|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208832|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208833|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138208834|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208835|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138208836|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138208837|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208838|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
138208839|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
138208841|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138208842|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138208843|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138208844|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138208845|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208846|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208847|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
138208848|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208851|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138208852|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
138208853|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208854|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138208855|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
138208856|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138208857|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138208858|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138208859|NCT03886649|Venetoclax|venetoclax|mesh-list
138208860|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208861|NCT01151813|Varenicline|varenicline|mesh-list
138208862|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138208863|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138208864|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
138208865|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208866|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208867|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208868|NCT03877991|Cannabidiol|cannabidiol|mesh-list
138208869|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
138208870|NCT03835949|Atezolizumab|atezolizumab|mesh-list
138208871|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138208872|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208873|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138208874|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208875|NCT01177709|Metformin|metformin|mesh-list
138208880|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138208881|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138208882|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208883|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208884|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208885|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208886|NCT01152515|Remifentanil|remifentanil|mesh-list
138208887|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138208888|NCT01152515|Narcotics|narcotics|mesh-ancestor
138208889|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138208890|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208891|NCT01152515|Analgesics|analgesics|mesh-ancestor
138208892|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
138208893|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208894|NCT03011177|Linagliptin|linagliptin|mesh-list
138208895|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138208896|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208897|NCT03011177|Incretins|incretins|mesh-ancestor
138208898|NCT03011177|Hormones|hormones|mesh-ancestor
138296875|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
138296876|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296877|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
138296878|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296879|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296880|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
138296881|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296882|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
138296893|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296895|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
138296896|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296897|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296898|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296899|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296900|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296901|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296902|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296903|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
138296904|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296905|NCT05664061|Fluticasone|fluticasone|mesh-list
138296907|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138296908|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138296909|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138208899|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208900|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138208901|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
138208902|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208903|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208904|NCT03465527|Prednisolone|prednisolone|mesh-list
138208905|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138208906|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
138208907|NCT03465527|Hormones|hormones|mesh-ancestor
138208908|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208909|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297096|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297344|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297345|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297346|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
138297347|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297348|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297349|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297350|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297351|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297352|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297353|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297354|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297355|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
138297356|NCT00003578|Hormones|hormones|mesh-ancestor
138297357|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297358|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297359|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297361|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
138297362|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
138297363|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297364|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297365|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297366|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297367|NCT00003584|Prednisone|prednisone|mesh-list
138342053|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342055|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342056|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342057|NCT01610154|Incretins|incretins|mesh-ancestor
138342058|NCT01610154|Hormones|hormones|mesh-ancestor
138342059|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138208910|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138208911|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208913|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138208914|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138208915|NCT03418805|Analgesics|analgesics|mesh-ancestor
138208916|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
138208917|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138208918|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208919|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138208920|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208921|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138208922|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208923|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208924|NCT01156571|Clopidogrel|clopidogrel|mesh-list
138208925|NCT01156571|Cangrelor|cangrelor|mesh-list
138208926|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138208927|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138208928|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138208929|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138208930|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
138208931|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208932|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208933|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208934|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
138208935|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138208936|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
138208944|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215376|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208945|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138208946|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
138208948|NCT01220687|Protective Agents|protective agents|mesh-ancestor
138208949|NCT03010865|Butyric Acid|butyric acid|mesh-list
138208950|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
138208951|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
138208952|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138208953|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208954|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208955|NCT01157429|Cycloserine|cycloserine|mesh-list
138208956|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138208957|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138208958|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138208959|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
138208960|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138208961|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
138208962|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208963|NCT00234884|Adalimumab|adalimumab|mesh-list
138208964|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138208965|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138208966|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138208967|NCT01602666|Carboplatin|carboplatin|mesh-list
138208968|NCT01602666|Etoposide|etoposide|mesh-list
138208969|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
138208970|NCT01602666|Ifosfamide|ifosfamide|mesh-list
138208971|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
138208974|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138208975|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138208976|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138208977|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208978|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208979|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138208980|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
138208981|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
138208982|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138208983|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
138208984|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
138208985|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
138208988|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138208989|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138208990|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138208991|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138208992|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
138208993|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342141|NCT01621776|Insulin|insulin|mesh-list
138342142|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138342143|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
138342144|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
138342145|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
138342146|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342147|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342148|NCT01631682|Propranolol|propranolol|mesh-list
138342149|NCT01631682|Oxytocin|oxytocin|mesh-list
138342150|NCT01631682|Mifepristone|mifepristone|mesh-list
138342151|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
138342152|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138342153|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342154|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138342155|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138342156|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
138208994|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138208995|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138208996|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138208997|NCT00301028|Paclitaxel|paclitaxel|mesh-list
138208998|NCT00301028|Carboplatin|carboplatin|mesh-list
138208999|NCT00301028|Cetuximab|cetuximab|mesh-list
138209000|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138209002|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138209003|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138209004|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138209005|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209006|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209007|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138209008|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209009|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209010|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209011|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209012|NCT05414214|Anesthetics|anesthetics|mesh-list
138209013|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209014|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209015|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
138209016|NCT05014230|Narcotics|narcotics|mesh-ancestor
138209017|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209018|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209019|NCT05014230|Analgesics|analgesics|mesh-ancestor
138209020|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
138209021|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209022|NCT01896284|Aflibercept|aflibercept|mesh-list
138209023|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138209024|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138209025|NCT01896284|Growth Substances|growth substances|mesh-ancestor
138209026|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209027|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138209028|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209029|NCT05438160|Coal Tar|coal tar|mesh-list
138209030|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
138209031|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
138209032|NCT01478581|Dexamethasone|dexamethasone|mesh-list
138209033|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209034|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
138209035|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
138209036|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209037|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209043|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209044|NCT00239642|Iron|iron|mesh-list
138209045|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138209046|NCT00239642|Trace Elements|trace elements|mesh-ancestor
138209047|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
138209048|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209049|NCT00239642|Hematinics|hematinics|mesh-ancestor
138209050|NCT00241904|Propranolol|propranolol|mesh-list
138209051|NCT00241904|Metoprolol|metoprolol|mesh-list
138209052|NCT00241904|Atenolol|atenolol|mesh-list
138209053|NCT00241904|Lisinopril|lisinopril|mesh-list
138209054|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138209055|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138209056|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138209057|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138209058|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138209059|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342316|NCT01652976|Protective Agents|protective agents|mesh-ancestor
138209060|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209061|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209062|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138209063|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209064|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
138209065|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
138209066|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
138209067|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209068|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138209069|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
138209070|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209071|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138209072|NCT00241904|Protective Agents|protective agents|mesh-ancestor
138209073|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
138209074|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138209075|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209076|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209077|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209078|NCT01791296|Analgesics|analgesics|mesh-ancestor
138209079|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
138209080|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209081|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138209082|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138209083|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138209084|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342317|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
138209085|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209086|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209087|NCT01479127|Silicon|silicon|mesh-list
138209088|NCT01479127|Levodopa|levodopa|mesh-list
138209089|NCT01479127|Carbidopa|carbidopa|mesh-list
138209090|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138209091|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138209092|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
138209093|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209094|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209095|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209096|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138209097|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209098|NCT01479127|Trace Elements|trace elements|mesh-ancestor
138209102|NCT03917966|Nedaplatin|nedaplatin|mesh-list
138209103|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209104|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
138209105|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
138209106|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
138209107|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209108|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209109|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209110|NCT00243152|Lamotrigine|lamotrigine|mesh-list
138209111|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
138209112|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138209113|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215377|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209114|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209115|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138209116|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209117|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138209118|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138209119|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209120|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138209121|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138209123|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
138209124|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209125|NCT01791374|Rilotumumab|rilotumumab|mesh-list
138209126|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138209127|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209128|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209129|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
138209130|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209131|NCT03783416|Ixazomib|ixazomib|mesh-list
138209132|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209133|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
138209134|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209135|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209136|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
138209137|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138209138|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138209139|NCT00248534|Prednisolone|prednisolone|mesh-list
138209140|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
138209141|NCT00248534|Rituximab|rituximab|mesh-list
138209142|NCT00248534|Temozolomide|temozolomide|mesh-list
138209143|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138209144|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
138209145|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209146|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209147|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
138209148|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209149|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209150|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138209151|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
138209152|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209153|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209154|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
138209155|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
138209156|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209163|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138209164|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138209165|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138209166|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138209167|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138209168|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209169|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209170|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209171|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138209172|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
138209173|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138209174|NCT05266820|Thalidomide|thalidomide|mesh-list
138215378|NCT03006211|Analgesics|analgesics|mesh-ancestor
138215379|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
138215380|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215381|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215382|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
138215383|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138215385|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138215386|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
138215387|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215389|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138209175|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209176|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
138209177|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209178|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
138209179|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209180|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209181|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138209182|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138209183|NCT05266820|Growth Substances|growth substances|mesh-ancestor
138209184|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138209185|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209186|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
138209187|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
138209188|NCT01454791|Diclofenac|diclofenac|mesh-list
138209189|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209190|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209191|NCT01454791|Analgesics|analgesics|mesh-ancestor
138209192|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
138209193|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209194|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209195|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209196|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209197|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138209198|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209199|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209200|NCT02099006|Ketoprofen|ketoprofen|mesh-list
138209202|NCT02099006|Gabapentin|gabapentin|mesh-list
138209203|NCT02099006|Amitriptyline|amitriptyline|mesh-list
138209204|NCT02099006|Baclofen|baclofen|mesh-list
138209205|NCT02099006|Loperamide|loperamide|mesh-list
138209206|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
138209207|NCT02099006|Analgesics|analgesics|mesh-ancestor
138209208|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
138209209|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209210|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209212|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138209214|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
138209215|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209216|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138209217|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138209218|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209219|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209225|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138209226|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138209227|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138209228|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
138209230|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209231|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209232|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209233|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209234|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138209235|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209236|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138215390|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
138215391|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
138215392|NCT03006211|Protective Agents|protective agents|mesh-ancestor
138215394|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215395|NCT02247505|Tadalafil|tadalafil|mesh-list
138215396|NCT02247505|Tamsulosin|tamsulosin|mesh-list
138215397|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
138215398|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138215399|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138215400|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215401|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215402|NCT02247505|Urological Agents|urological agents|mesh-ancestor
138215403|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138215404|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138215405|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138215406|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215407|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215408|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215409|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138215410|NCT02248129|Telmisartan|telmisartan|mesh-list
138215411|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138215412|NCT02248129|Diuretics|diuretics|mesh-ancestor
138215413|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
138215414|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215429|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215430|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
138215431|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215432|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342318|NCT01652976|Vitamins|vitamins|mesh-ancestor
138209237|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
138209238|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138209239|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138209240|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138209241|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
138209242|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209243|NCT05266274|Azacitidine|azacitidine|mesh-list
138209244|NCT05266274|Antibodies|antibodies|mesh-list
138209245|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138209246|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
138209247|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209248|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138209249|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
138209250|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209251|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209252|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209253|NCT05265962|Decitabine|decitabine|mesh-list
138342319|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
138342320|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138342321|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342322|NCT01656252|Cytarabine|cytarabine|mesh-list
138342323|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138342325|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342326|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342327|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
138342328|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342329|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342330|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
138209254|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138209255|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
138209256|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209257|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209258|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209259|NCT00324896|Eszopiclone|eszopiclone|mesh-list
138209260|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138209261|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209262|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209263|NCT01479517|Tetracaine|tetracaine|mesh-list
138209264|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
138209265|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
138209266|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209267|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209268|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
138209269|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209270|NCT01480219|Voriconazole|voriconazole|mesh-list
138209271|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
138209272|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209273|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138209274|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138209275|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342412|NCT01692756|Triamcinolone|triamcinolone|mesh-list
138342414|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138342415|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138342416|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138342417|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342418|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
138342419|NCT01692756|Hormones|hormones|mesh-ancestor
138342420|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342421|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342422|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342423|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
138342424|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209276|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209277|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138209278|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
138209279|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209280|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209281|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138209282|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138209289|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209291|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209292|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138209293|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209294|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209295|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
138209296|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209297|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209299|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209300|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209301|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209302|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209303|NCT01392859|Levocetirizine|levocetirizine|mesh-list
138209304|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138209305|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138209306|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
138209307|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
138209308|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209309|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209310|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209311|NCT01457521|Ibuprofen|ibuprofen|mesh-list
138209312|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209314|NCT01457521|Analgesics|analgesics|mesh-ancestor
138209315|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
138209316|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209317|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209318|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209319|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209320|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138209321|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209322|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209323|NCT00325442|Treprostinil|treprostinil|mesh-list
138209324|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209325|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138209326|NCT01393717|Antibodies|antibodies|mesh-list
138209327|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
138209328|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138209329|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
138209330|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
138209331|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209332|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209333|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209334|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
138209335|NCT01460875|Interferons|interferons|mesh-list
138209336|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
138209337|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
138209338|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209339|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
138209340|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209341|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
138209342|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209347|NCT01481545|Raltitrexed|raltitrexed|mesh-list
138209348|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
138209349|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209350|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209351|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138209352|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138209353|NCT01481545|Growth Substances|growth substances|mesh-ancestor
138209354|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209355|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
138209356|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
138209357|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342507|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
138209358|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138209359|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209360|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
138209361|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138209362|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209363|NCT01481545|Antidotes|antidotes|mesh-ancestor
138209364|NCT01481545|Protective Agents|protective agents|mesh-ancestor
138209365|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
138209366|NCT01481545|Vitamins|vitamins|mesh-ancestor
138209367|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
138209368|NCT01482091|Fentanyl|fentanyl|mesh-list
138209369|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138209370|NCT01482091|Narcotics|narcotics|mesh-ancestor
138209371|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209372|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209373|NCT01482091|Analgesics|analgesics|mesh-ancestor
138209374|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
138209375|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209376|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138209377|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138209378|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
138209379|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
138209381|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138209382|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209383|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209386|NCT01791608|Trace Elements|trace elements|mesh-ancestor
138209387|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
138209388|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209389|NCT01791608|Astringents|astringents|mesh-ancestor
138209390|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138209391|NCT04346030|Triamcinolone|triamcinolone|mesh-list
138209392|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138209393|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138209395|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138209396|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
138209397|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
138209398|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209399|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209400|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
138209401|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209402|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138209403|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138209404|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138209405|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138209406|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209407|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209408|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
138209409|NCT04346030|Hormones|hormones|mesh-ancestor
138209410|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209417|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209418|NCT05075330|Analgesics|analgesics|mesh-ancestor
138209419|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
138209420|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209421|NCT02108288|Carteolol|carteolol|mesh-list
138209422|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138209423|NCT02108288|Latanoprost|latanoprost|mesh-list
138209424|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138209425|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138209426|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138209427|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
138209428|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209429|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209430|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209431|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138209432|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209433|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
138209434|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
138209435|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209436|NCT02106494|Dexamethasone|dexamethasone|mesh-list
138209437|NCT02106494|Ondansetron|ondansetron|mesh-list
138209438|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
138209439|NCT02106494|Aprepitant|aprepitant|mesh-list
138209440|NCT02106494|Granisetron|granisetron|mesh-list
138209442|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
138209443|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
138209444|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209445|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209446|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209447|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
138209448|NCT02106494|Hormones|hormones|mesh-ancestor
138209449|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209450|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138209451|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209452|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
138209453|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138209454|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138209455|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138209456|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
138209457|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209458|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209459|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138209460|NCT00335504|Sulindac|sulindac|mesh-list
138209461|NCT00335504|Atorvastatin|atorvastatin|mesh-list
138209462|NCT00335504|Calcium|calcium|mesh-list
138209463|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138209464|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209465|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138209466|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138209467|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
138209468|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209469|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138209470|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138209471|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209472|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209473|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209474|NCT00335504|Analgesics|analgesics|mesh-ancestor
138209475|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
138209476|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209485|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
138209486|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209487|NCT01183481|Aprepitant|aprepitant|mesh-list
138209488|NCT01183481|Granisetron|granisetron|mesh-list
138209489|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
138209490|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
138209491|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209492|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209493|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209494|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138209495|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209496|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209497|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138209498|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138209499|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
138209500|NCT01183559|Paclitaxel|paclitaxel|mesh-list
138209501|NCT01183559|Carboplatin|carboplatin|mesh-list
138209502|NCT01183559|Fluorouracil|fluorouracil|mesh-list
138209503|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138209504|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209505|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
138209506|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
138209507|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
138209508|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209509|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
138209510|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138209512|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
138209513|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209515|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
138209516|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138209517|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209526|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138209527|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138209528|NCT01159067|Deferasirox|deferasirox|mesh-list
138209529|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138209530|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
138209531|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
138209532|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209533|NCT01222091|Propranolol|propranolol|mesh-list
138209534|NCT01222091|Remifentanil|remifentanil|mesh-list
138209535|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138209536|NCT01222091|Narcotics|narcotics|mesh-ancestor
138209537|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209538|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209539|NCT01222091|Analgesics|analgesics|mesh-ancestor
138209540|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
138209541|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209542|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138209543|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138209544|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
138209545|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209546|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209547|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138209548|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209549|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
138209550|NCT01225055|Teriparatide|teriparatide|mesh-list
138209551|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138209552|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209553|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138209554|NCT01336140|Aminophylline|aminophylline|mesh-list
138209555|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138209556|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
138209557|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209558|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209559|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138209560|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
138209561|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138209562|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138209563|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209564|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209565|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138209566|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138209567|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
138209568|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209569|NCT01336140|Protective Agents|protective agents|mesh-ancestor
138209574|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209575|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209576|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209577|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
138209578|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209579|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
138209580|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209581|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209582|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138209583|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
138209584|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138209585|NCT01187381|Trastuzumab|trastuzumab|mesh-list
138209586|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209587|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209588|NCT01225289|Vitamin A|vitamin a|mesh-list
138209589|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
138209590|NCT01225289|Vitamins|vitamins|mesh-ancestor
138209591|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
138209592|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209593|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
138209595|NCT01225289|Protective Agents|protective agents|mesh-ancestor
138209596|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138209597|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209598|NCT01161563|Leuprolide|leuprolide|mesh-list
138209599|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138209600|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138209601|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
138209602|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138209603|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209604|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138209605|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209606|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
138209607|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138209608|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
138209609|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138209610|NCT01189409|Sennosides|sennosides|mesh-list
138209611|NCT01189409|Laxatives|laxatives|mesh-ancestor
138209612|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209613|NCT03010475|Furosemide|furosemide|mesh-list
138209614|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138209615|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138209616|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138209617|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
138209618|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209619|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138209620|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138209621|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209622|NCT03010475|Diuretics|diuretics|mesh-ancestor
138209623|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
138209624|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209625|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138209626|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138209627|NCT02191865|Nintedanib|nintedanib|mesh-list
138209628|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209629|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209636|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209637|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138209639|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209641|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
138209642|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209643|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138209644|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209645|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
138209646|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209647|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138209649|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209650|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209651|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
138209652|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
138209653|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138209654|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209655|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138209656|NCT01192139|Metformin|metformin|mesh-list
138209657|NCT01192139|Saxagliptin|saxagliptin|mesh-list
138209658|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209659|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209660|NCT01192139|Incretins|incretins|mesh-ancestor
138209661|NCT01192139|Hormones|hormones|mesh-ancestor
138209662|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209663|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138209665|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209666|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209667|NCT04892186|Inositol|inositol|mesh-list
138209668|NCT04892186|Metformin|metformin|mesh-list
138209669|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209671|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
138209672|NCT04892186|Vitamins|vitamins|mesh-ancestor
138209673|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
138209674|NCT01229423|Bimatoprost|bimatoprost|mesh-list
138209675|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209676|NCT01229891|Vitamin D|vitamin d|mesh-list
138209677|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
138209678|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
138209679|NCT01229891|Vitamins|vitamins|mesh-list
138209680|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
138209681|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209682|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138209683|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138209684|NCT01283555|Tenofovir|tenofovir|mesh-list
138209685|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
138209686|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209687|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138209688|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138209694|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138209695|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
138209696|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209697|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209698|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138209700|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
138209701|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209702|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209703|NCT01650350|Naltrexone|naltrexone|mesh-list
138209704|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138209705|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138209706|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209707|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
138209708|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209709|NCT00349388|Mesalamine|mesalamine|mesh-list
138209710|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138209711|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138209712|NCT00349388|Analgesics|analgesics|mesh-ancestor
138209713|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
138209714|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209715|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209716|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209717|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209718|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
138209719|NCT00349778|Melphalan|melphalan|mesh-list
138209720|NCT00349778|Carmustine|carmustine|mesh-list
138209721|NCT00349778|Etoposide|etoposide|mesh-list
138209722|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
138209723|NCT00349778|Lenograstim|lenograstim|mesh-list
138209724|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209725|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
138209726|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209727|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209728|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138209729|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
138209730|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209731|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209732|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138342508|NCT01708278|Vitamins|vitamins|mesh-ancestor
138342509|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
138342510|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342511|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
138342512|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342513|NCT01708278|Protective Agents|protective agents|mesh-ancestor
138342514|NCT01708590|Brodalumab|brodalumab|mesh-list
138342515|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138342516|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138342517|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
138342518|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342519|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
138342520|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138342521|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138342522|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342523|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
138342524|NCT05710146|Coagulants|coagulants|mesh-ancestor
138342525|NCT05683548|Interferons|interferons|mesh-list
138342526|NCT05683548|Tenofovir|tenofovir|mesh-list
138342527|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
138209733|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138209734|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138209735|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138209736|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209737|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138209738|NCT00305084|Doxorubicin|doxorubicin|mesh-list
138209739|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138209740|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209741|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138209742|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138209743|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209744|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209745|NCT00305162|Clopidogrel|clopidogrel|mesh-list
138209746|NCT00305162|Cangrelor|cangrelor|mesh-list
138209747|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138209748|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138209749|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138209750|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138209751|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
138209764|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209766|NCT00305942|Carboplatin|carboplatin|mesh-list
138209767|NCT00305942|Topotecan|topotecan|mesh-list
138209768|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209769|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138209770|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138209771|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209772|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209773|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
138209774|NCT00352976|Sirolimus|sirolimus|mesh-list
138209775|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
138209776|NCT00352976|Fludarabine|fludarabine|mesh-list
138209777|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209778|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
138209779|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209781|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138209782|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
138209783|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209784|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209785|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138209786|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138209787|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138209788|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
138209789|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209790|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209791|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209792|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
138209793|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138209794|NCT00306488|Antioxidants|antioxidants|mesh-list
138209795|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138342528|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
138209796|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209797|NCT00306488|Protective Agents|protective agents|mesh-ancestor
138209798|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209799|NCT01793636|Everolimus|everolimus|mesh-list
138209800|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138209801|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209802|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209803|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209804|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209805|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
138342529|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138342530|NCT05683548|REP 2139|rep 2139|mesh-list
138342531|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342532|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
138342533|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342535|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138342536|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342537|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342538|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138209806|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209807|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209808|NCT00343460|Dexamethasone|dexamethasone|mesh-list
138209818|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209820|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209821|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138209822|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138209823|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
138209824|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209825|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209826|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
138209827|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138209828|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138209829|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
138209830|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209831|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138209832|NCT00310076|Thalidomide|thalidomide|mesh-list
138209833|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138209834|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
138209835|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209836|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
138209837|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209838|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209839|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138209840|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138209841|NCT00310076|Growth Substances|growth substances|mesh-ancestor
138209842|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
138209843|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209844|NCT00353834|Insulin|insulin|mesh-list
138209845|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138209846|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
138209847|NCT00353834|Exenatide|exenatide|mesh-list
138209848|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209849|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209850|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138209851|NCT00353834|Incretins|incretins|mesh-ancestor
138209852|NCT00353834|Hormones|hormones|mesh-ancestor
138209853|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138209854|NCT05344404|Niacinamide|niacinamide|mesh-list
138209855|NCT05344404|Niacin|niacin|mesh-list
138209856|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
138209857|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
138209858|NCT05344404|Vitamins|vitamins|mesh-ancestor
138209859|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
138209860|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209861|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138209862|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
138209863|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209864|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138209865|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
138209866|NCT00354224|Capecitabine|capecitabine|mesh-list
138209867|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
138209869|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
138209870|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209871|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209872|NCT01792388|Vitamin D|vitamin d|mesh-list
138209873|NCT01792388|Vitamins|vitamins|mesh-ancestor
138209874|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
138209875|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209876|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138209877|NCT01793870|Carvedilol|carvedilol|mesh-list
138209878|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138209879|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138209880|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138209881|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209882|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209883|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209884|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138209885|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
138209886|NCT01793870|Protective Agents|protective agents|mesh-ancestor
138209887|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138209888|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138209889|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138209890|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138209891|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138209892|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138209893|NCT01793948|Metformin|metformin|mesh-list
138209894|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209895|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209896|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
138209897|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
138209898|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209899|NCT00355394|Metoclopramide|metoclopramide|mesh-list
138209900|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
138209901|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
138209902|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138209903|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209904|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209905|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138209906|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138209907|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
138209908|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209909|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209910|NCT00311246|Adalimumab|adalimumab|mesh-list
138209911|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138209912|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138209913|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138209914|NCT02105324|Pancrelipase|pancrelipase|mesh-list
138209915|NCT02105324|Pancreatin|pancreatin|mesh-list
138209916|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209917|NCT02105558|Anesthetics|anesthetics|mesh-list
138209918|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209919|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209920|NCT02106962|Bacitracin|bacitracin|mesh-list
138209921|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
138209922|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138209923|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138209924|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209925|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
138209926|NCT02106962|Coagulants|coagulants|mesh-ancestor
138209927|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138209928|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209929|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138209930|NCT00315146|Pioglitazone|pioglitazone|mesh-list
138209931|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138209932|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209933|NCT01792700|Amoxicillin|amoxicillin|mesh-list
138209934|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
138209935|NCT01792700|Metronidazole|metronidazole|mesh-list
138209939|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138209940|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138209941|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138209942|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209943|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209944|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209945|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138209946|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138209947|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138209948|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138209949|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138209950|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138209952|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138209953|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138209954|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138209955|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
138209956|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342622|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
138209957|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138209958|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138209959|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
138209960|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
138209961|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
138209962|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138209963|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138209965|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138209966|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209968|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209969|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138209970|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138209971|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209972|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209974|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209975|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138209976|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209977|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209978|NCT00357734|Gefitinib|gefitinib|mesh-list
138209979|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342700|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
138342701|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342702|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
138342703|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138342704|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342705|NCT05316246|Tislelizumab|tislelizumab|mesh-list
138342706|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138342707|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138342708|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342709|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
138342710|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
138342711|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
138342712|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342714|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
138342715|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342716|NCT04894188|Goserelin|goserelin|mesh-list
138342717|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342718|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342719|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
138342800|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
138342801|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342802|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342803|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138342804|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
138342805|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138342806|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342807|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342808|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138342809|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
138342810|NCT01740726|Fluoxetine|fluoxetine|mesh-list
138342811|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138342812|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138342813|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342814|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342815|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342816|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
138342817|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342818|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138342819|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
138209980|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138209981|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209982|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209983|NCT00318812|Iron|iron|mesh-list
138209984|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138209985|NCT00318812|Trace Elements|trace elements|mesh-ancestor
138209986|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
138209988|NCT00318812|Hematinics|hematinics|mesh-ancestor
138209989|NCT00362882|Docetaxel|docetaxel|mesh-list
138209990|NCT00362882|Bortezomib|bortezomib|mesh-list
138209991|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209992|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138209993|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138209994|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138209995|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138209996|NCT00365144|Bevacizumab|bevacizumab|mesh-list
138209997|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138209998|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138209999|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210011|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210012|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
138210013|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210014|NCT00367016|Omalizumab|omalizumab|mesh-list
138210015|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138210016|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138210017|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
138210018|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
138210019|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210020|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210021|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210022|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210023|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138210024|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
138210025|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210026|NCT05334654|Enoxaparin|enoxaparin|mesh-list
138210027|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
138210028|NCT05334654|Bivalirudin|bivalirudin|mesh-list
138210029|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
138210030|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138210031|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138210032|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210033|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
138210034|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138210035|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
138210036|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210037|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
138210038|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210039|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138210041|NCT03561584|Analgesics|analgesics|mesh-ancestor
138210042|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
138210043|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210044|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210045|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210046|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210047|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210048|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138210049|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210050|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210051|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210052|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210053|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138210054|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
138210055|NCT00324272|Coagulants|coagulants|mesh-ancestor
138210056|NCT00369590|Aflibercept|aflibercept|mesh-list
138210061|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210062|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
138210063|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210064|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138210065|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138210066|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210067|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138210068|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138210069|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
138210070|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210071|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210072|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138210073|NCT00390182|Gemcitabine|gemcitabine|mesh-list
138210074|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138210075|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
138210076|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210077|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210078|NCT05366868|Metformin|metformin|mesh-list
138210079|NCT05366868|Vildagliptin|vildagliptin|mesh-list
138210080|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210081|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210082|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138210083|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
138210084|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210085|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210086|NCT05610774|Dexmedetomidine|dexmedetomidine|mesh-list
138210087|NCT05610774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138210088|NCT05610774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210089|NCT05610774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210090|NCT05610774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210091|NCT05610774|Analgesics|analgesics|mesh-ancestor
138210092|NCT05610774|Sensory System Agents|sensory system agents|mesh-ancestor
138210093|NCT05610774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210094|NCT05610774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138210095|NCT05610774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210096|NCT05610774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210097|NCT05610774|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210098|NCT05610774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210099|NCT05610774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210100|NCT00369746|Citalopram|citalopram|mesh-list
138210101|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138210102|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138210103|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210104|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210105|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210106|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
138210107|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210108|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138210109|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
138210110|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210111|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138210114|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210115|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
138210116|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210118|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
138210119|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
138210120|NCT05329428|Vitamins|vitamins|mesh-list
138210121|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
138210122|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210123|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138210124|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210125|NCT01794572|Melphalan|melphalan|mesh-list
138210126|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138210127|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
138210128|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210129|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210130|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138210131|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210132|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
138342820|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342821|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138342822|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138342823|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342824|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138342825|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138342826|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342827|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342828|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342830|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
138342832|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
138342833|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342914|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138342915|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342916|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342917|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342918|NCT01763346|Metformin|metformin|mesh-list
138342919|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342920|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342921|NCT01766466|Ticagrelor|ticagrelor|mesh-list
138210133|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210135|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210136|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138210137|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138210138|NCT00392444|Growth Substances|growth substances|mesh-ancestor
138210139|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210140|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138210141|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210142|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210143|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210145|NCT02528214|Prednisolone|prednisolone|mesh-list
138210146|NCT02528214|Albuterol|albuterol|mesh-list
138210147|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210148|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
138210149|NCT02528214|Hormones|hormones|mesh-ancestor
138210150|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210151|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210152|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138210153|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210154|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
138210155|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210156|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138210157|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138210158|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138210159|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
138210160|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138210161|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138210162|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138210163|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210164|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210165|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210166|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210167|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138210168|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
138210169|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138210170|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210171|NCT00392678|Analgesics|analgesics|mesh-ancestor
138210172|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
138210179|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210180|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138210181|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210182|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
138210183|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
138210184|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210185|NCT05902221|Amoxicillin|amoxicillin|mesh-list
138210186|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
138210187|NCT05902221|Rifampin|rifampin|mesh-list
138210188|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138210189|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138210190|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210191|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138210192|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138210193|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210194|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210196|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138210197|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
138210198|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138210199|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210200|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138210201|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138210202|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138210203|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138210204|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
138210205|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
138210206|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138210207|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138210208|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138210209|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138342922|NCT01766466|Cangrelor|cangrelor|mesh-list
138342923|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138342924|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138342927|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
138342928|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342929|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342930|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342931|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
138210210|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138210211|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138210212|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138210215|NCT05902169|Lomustine|lomustine|mesh-list
138210216|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210217|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138210218|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
138210219|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210220|NCT05902078|Calcitriol|calcitriol|mesh-list
138210221|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
138210222|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210223|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210226|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210228|NCT05902078|Vitamins|vitamins|mesh-ancestor
138210229|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
138210230|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138210231|NCT05901935|Capecitabine|capecitabine|mesh-list
138210232|NCT05901935|Trastuzumab|trastuzumab|mesh-list
138210233|NCT05901935|Vinorelbine|vinorelbine|mesh-list
138210234|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138210235|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
138210236|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210237|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210238|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210239|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138210241|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
138210242|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
138210243|NCT05901766|Micronutrients|micronutrients|mesh-list
138210244|NCT05901766|Trace Elements|trace elements|mesh-list
138210245|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210246|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
138342932|NCT01769586|Promethazine|promethazine|mesh-list
138342933|NCT01769586|Midazolam|midazolam|mesh-list
138342934|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138342935|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138342936|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342937|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342938|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138342940|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342941|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342942|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
138342943|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
138342944|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
138342945|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
138342946|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342947|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346435|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
138343121|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
138343122|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138343123|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343124|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138343125|NCT01813734|Ponatinib|ponatinib|mesh-list
138343126|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343127|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343128|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343129|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343130|NCT01818414|Vitamins|vitamins|mesh-list
138343131|NCT01818414|Folic Acid|folic acid|mesh-list
138343132|NCT01818414|Misoprostol|misoprostol|mesh-list
138343133|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
138343134|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343135|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138343136|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
138343137|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138343138|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138343139|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138343140|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
138343141|NCT01818414|Hematinics|hematinics|mesh-ancestor
138343142|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
138343143|NCT06020560|Dalteparin|dalteparin|mesh-list
138343144|NCT06020560|Tinzaparin|tinzaparin|mesh-list
138210247|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210248|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
138210249|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
138210250|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210251|NCT05901571|Dexetimide|dexetimide|mesh-list
138210252|NCT05901571|Citalopram|citalopram|mesh-list
138210253|NCT05901571|Escitalopram|escitalopram|mesh-list
138210254|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138210255|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138210256|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210257|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210258|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210260|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210261|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138210263|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
138210264|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
138210265|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210266|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138210267|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138210268|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
138210269|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138210277|NCT05901441|Ropivacaine|ropivacaine|mesh-list
138210278|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210279|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
138210280|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210281|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210282|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
138210283|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210284|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138210285|NCT05901441|Narcotics|narcotics|mesh-ancestor
138210286|NCT05901441|Analgesics|analgesics|mesh-ancestor
138210287|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138210288|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138210289|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
138210290|NCT05901389|Lidocaine|lidocaine|mesh-list
138210291|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210292|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
138210293|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210294|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210295|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
138210296|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210297|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138210298|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138210299|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138210300|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210301|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210302|NCT05901194|Lenvatinib|lenvatinib|mesh-list
138210303|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210304|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210305|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210306|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210307|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138210308|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
138210309|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210310|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210311|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138210312|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
138210313|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210314|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210315|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138210316|NCT05900921|Paclitaxel|paclitaxel|mesh-list
138210317|NCT05900921|Carboplatin|carboplatin|mesh-list
138210318|NCT05900921|Tislelizumab|tislelizumab|mesh-list
138210319|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138210320|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210321|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138210322|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138210323|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138210324|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210325|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210326|NCT05899699|Adapalene|adapalene|mesh-list
138210327|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138210328|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210329|NCT05899699|Analgesics|analgesics|mesh-ancestor
138210335|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210341|NCT05898854|FAPI-46|fapi-46|mesh-list
138210342|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138210351|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210352|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210353|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210354|NCT05895162|Fluconazole|fluconazole|mesh-list
138210355|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
138210356|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210357|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138210358|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138210359|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210360|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210361|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138210362|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138343459|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
138210363|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210364|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210365|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138210366|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138210367|NCT05877326|Anesthetics|anesthetics|mesh-list
138210368|NCT05877326|Propofol|propofol|mesh-list
138210369|NCT05877326|Sevoflurane|sevoflurane|mesh-list
138210370|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210371|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210372|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138210373|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138210374|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
138210375|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138210376|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138210377|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
138210378|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
138210379|NCT05837000|Ketamine|ketamine|mesh-list
138210380|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138210381|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210382|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210383|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210384|NCT05837000|Analgesics|analgesics|mesh-ancestor
138210385|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
138210386|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210387|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138210388|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210389|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210390|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210391|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210392|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210393|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138210394|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138210395|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
138210396|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
138210397|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138210398|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138210399|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138210400|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
138210408|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210409|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138210411|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210412|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210413|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138210414|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
138210415|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210417|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138210418|NCT05821296|Methamphetamine|methamphetamine|mesh-list
138210419|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138210420|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210421|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
138210422|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
138210423|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210424|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
138210425|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210426|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210427|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210428|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138210429|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138210430|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210431|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138210433|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138210434|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210435|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
138210436|NCT05707273|Fludarabine|fludarabine|mesh-list
138210437|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210438|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
138210439|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210440|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210441|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138210442|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
138210443|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210444|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210445|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138210446|NCT05705856|Ustekinumab|ustekinumab|mesh-list
138210447|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210448|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
138210449|NCT05672173|Nivolumab|nivolumab|mesh-list
138210450|NCT05672173|Fludarabine|fludarabine|mesh-list
138210451|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210452|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
138210453|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210454|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210455|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138210456|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
138210457|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210458|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210459|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138210460|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210478|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
138210479|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
138210480|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210481|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210482|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210483|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
138210484|NCT05654649|Hormones|hormones|mesh-ancestor
138210485|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210486|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138210487|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210488|NCT05519111|Dronabinol|dronabinol|mesh-list
138210489|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
138210490|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210491|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210492|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210493|NCT05519111|Analgesics|analgesics|mesh-ancestor
138210494|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
138210495|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210496|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138210497|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138210498|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210499|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210500|NCT05519111|Hormones|hormones|mesh-ancestor
138210501|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210502|NCT05427474|Propranolol|propranolol|mesh-list
138210503|NCT05427474|Gabapentin|gabapentin|mesh-list
138210504|NCT05427474|Analgesics|analgesics|mesh-ancestor
138210505|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
138343460|NCT05711628|Vinorelbine|vinorelbine|mesh-list
138210506|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210507|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210508|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
138210509|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138210513|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138210514|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138210515|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210516|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210517|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
138210518|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138210519|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138210520|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210521|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138210522|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138210523|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
138210524|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
138210525|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138210527|NCT05340673|Mineral Oil|mineral oil|mesh-list
138210528|NCT05340673|Emollients|emollients|mesh-ancestor
138210529|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210531|NCT05320406|Relugolix|relugolix|mesh-list
138210532|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138210533|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
138210534|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138210535|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210536|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138210537|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210538|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
138210539|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
138210540|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210541|NCT05312151|Psilocybin|psilocybin|mesh-list
138210542|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
138210543|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210544|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210545|NCT05299073|Denosumab|denosumab|mesh-list
138210546|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138210547|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210548|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138210549|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210550|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210551|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210552|NCT05213221|Lenvatinib|lenvatinib|mesh-list
138210553|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210554|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210555|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210557|NCT05212337|Denosumab|denosumab|mesh-list
138210564|NCT05123040|Hormones|hormones|mesh-ancestor
138210565|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210566|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210567|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138210568|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210569|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
138210570|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
138210571|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210572|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210573|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138210574|NCT05123040|Protective Agents|protective agents|mesh-ancestor
138210575|NCT05096702|Primaquine|primaquine|mesh-list
138210576|NCT05096702|Tafenoquine|tafenoquine|mesh-list
138210578|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138210579|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138210580|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210581|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
138210582|NCT05017454|Valproic Acid|valproic acid|mesh-list
138210583|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210584|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210585|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138210586|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
138210587|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210588|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210589|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
138210590|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210591|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210592|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
138210593|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138210594|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210595|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210596|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138210597|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138210598|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138210599|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210600|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210601|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138210602|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210603|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210604|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
138210605|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210606|NCT04999215|Choline|choline|mesh-list
138210607|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
138210608|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138210609|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
138210610|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210611|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210612|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138210613|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
138210614|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
138210615|NCT04991025|Carboplatin|carboplatin|mesh-list
138210616|NCT04991025|Gemcitabine|gemcitabine|mesh-list
138210617|NCT04991025|Nivolumab|nivolumab|mesh-list
138210618|NCT04991025|Pemetrexed|pemetrexed|mesh-list
138210619|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210625|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210626|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138210627|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138210628|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138210629|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210630|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210631|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
138210632|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210633|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210634|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138210635|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210636|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210638|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210639|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138210640|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210641|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210642|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138210645|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
138210646|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138210647|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138210648|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210650|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
138210651|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138210652|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138210653|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210654|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210655|NCT04757662|Urological Agents|urological agents|mesh-ancestor
138210656|NCT04756050|Epinephrine|epinephrine|mesh-list
138210657|NCT04756050|Racepinephrine|racepinephrine|mesh-list
138210658|NCT04756050|Bupivacaine|bupivacaine|mesh-list
138210659|NCT04756050|Prilocaine|prilocaine|mesh-list
138210660|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138210661|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
138210662|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210663|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
138210664|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210665|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210666|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
138210667|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210668|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210669|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210670|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210671|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210672|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210673|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138210674|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138210675|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
138210676|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138210677|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138210678|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
138210695|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138210696|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210697|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138210698|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
138210699|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210700|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210701|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210702|NCT04680221|Bupivacaine|bupivacaine|mesh-list
138210703|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210704|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
138210705|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210706|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210707|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
138210708|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210711|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138210712|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138210713|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138210714|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138210715|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
138210716|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210717|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210723|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210724|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
138343623|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138210725|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210726|NCT04621929|Topiramate|topiramate|mesh-list
138210727|NCT04621929|Phentermine|phentermine|mesh-list
138210728|NCT04621929|Allopurinol|allopurinol|mesh-list
138210729|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210730|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
138210731|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210732|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210733|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
138210734|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210735|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
138210736|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210737|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138210738|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
138210739|NCT04621929|Protective Agents|protective agents|mesh-ancestor
138210740|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138210758|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
138210759|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210760|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138210761|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
138210762|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138210763|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
138343624|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138210764|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210765|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138210766|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210767|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
138210768|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210769|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
138210770|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138210771|NCT04535882|Protective Agents|protective agents|mesh-ancestor
138210772|NCT04535687|Fluzoparib|fluzoparib|mesh-list
138210773|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138210774|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210775|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210776|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210777|NCT04527887|Dexamethasone|dexamethasone|mesh-list
138210778|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210779|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
138210780|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
138210781|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210782|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210783|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210784|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
138210785|NCT04527887|Hormones|hormones|mesh-ancestor
138210786|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210788|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210801|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343625|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
138210803|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
138210804|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210805|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
138210812|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
138210813|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210814|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
138210815|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138210816|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210817|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210818|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210819|NCT04385602|Analgesics|analgesics|mesh-ancestor
138343626|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
138210820|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
138210821|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210822|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138210823|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210824|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210825|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210826|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344104|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
138210827|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210828|NCT04379713|Vaccines|vaccines|mesh-list
138210829|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138210830|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
138210831|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210832|NCT04218773|Phenylephrine|phenylephrine|mesh-list
138210833|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
138210834|NCT04218773|Norepinephrine|norepinephrine|mesh-list
138210835|NCT04218773|Synephrine|synephrine|mesh-list
138210836|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138210837|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
138210838|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
138210839|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210840|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210841|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
138210842|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138210843|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
138210844|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138210845|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138210846|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138210847|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138210848|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210849|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210850|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210851|NCT04218773|Protective Agents|protective agents|mesh-ancestor
138210852|NCT04126031|Ceftazidime|ceftazidime|mesh-list
138210854|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138210855|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138210856|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210857|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138210858|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210859|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210860|NCT04100824|Nimodipine|nimodipine|mesh-list
138210861|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138210862|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138210863|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138210864|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210865|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138210882|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138210883|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138210884|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210885|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138210886|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138210887|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
138210888|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138210889|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138210890|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
138210891|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
138210892|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138210893|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138210894|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138210895|NCT04074265|Analgesics|analgesics|mesh-ancestor
138210896|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210897|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210898|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138210899|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210900|NCT04058067|Aflibercept|aflibercept|mesh-list
138210901|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138210902|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138210903|NCT04058067|Growth Substances|growth substances|mesh-ancestor
138210904|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210905|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
138210906|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210907|NCT03983057|Antibodies|antibodies|mesh-list
138210908|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138210909|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
138210910|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210922|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138210923|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138210924|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210925|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210926|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138210927|NCT03759028|Narcotics|narcotics|mesh-ancestor
138344105|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344334|NCT03150693|Pegaspargase|pegaspargase|mesh-list
138344335|NCT03150693|Allopurinol|allopurinol|mesh-list
138344336|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344337|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
138344338|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344339|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344340|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344342|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344344|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138344345|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344347|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
138210928|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210929|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138210930|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138210931|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210932|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
138210933|NCT03693560|Metformin|metformin|mesh-list
138210934|NCT03693560|Glimepiride|glimepiride|mesh-list
138210935|NCT03693560|Vildagliptin|vildagliptin|mesh-list
138210936|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210937|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210938|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138210939|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138210940|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
138210941|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138210942|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
138210943|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210944|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210946|NCT03675893|Letrozole|letrozole|mesh-list
138210947|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210948|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210949|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210950|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138210951|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138210952|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210953|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210954|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138210955|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
138210961|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138210962|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210963|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138210964|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210965|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210966|NCT03417544|Trastuzumab|trastuzumab|mesh-list
138210967|NCT03417544|Atezolizumab|atezolizumab|mesh-list
138210968|NCT03417544|Pertuzumab|pertuzumab|mesh-list
138210969|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210970|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210971|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138210972|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210973|NCT03363464|Empagliflozin|empagliflozin|mesh-list
138210974|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138210975|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138210976|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138210977|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138210978|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210979|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
138210980|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138210981|NCT03113851|Molgramostim|molgramostim|mesh-list
138210982|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210983|NCT02903381|Dexamethasone|dexamethasone|mesh-list
138210984|NCT02903381|Nivolumab|nivolumab|mesh-list
138210985|NCT02903381|Lenalidomide|lenalidomide|mesh-list
138210986|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138210988|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
138210989|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138210990|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210991|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138210992|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
138210993|NCT02903381|Hormones|hormones|mesh-ancestor
138210994|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138210995|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138210996|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138210997|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138210998|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138210999|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211000|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
138211001|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138211002|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138211003|NCT02903381|Growth Substances|growth substances|mesh-ancestor
138211004|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211005|NCT02744391|Levodopa|levodopa|mesh-list
138211006|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138211007|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138211008|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
138211009|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211010|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211011|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211012|NCT02462837|Mirabegron|mirabegron|mesh-list
138344587|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344588|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344589|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344590|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344591|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138344592|NCT02055456|Nandrolone|nandrolone|mesh-list
138344593|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138344594|NCT02055456|Androgens|androgens|mesh-ancestor
138344595|NCT02055456|Hormones|hormones|mesh-ancestor
138344596|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344597|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344598|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
138344599|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138344600|NCT02031250|Carboplatin|carboplatin|mesh-list
138344601|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344602|NCT01995669|Lenalidomide|lenalidomide|mesh-list
138344603|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
138344604|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
138344605|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346685|NCT02206776|Analgesics|analgesics|mesh-ancestor
138344700|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344701|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138344702|NCT01231906|Protective Agents|protective agents|mesh-ancestor
138344703|NCT00788164|Imiquimod|imiquimod|mesh-list
138344704|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138344705|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
138344706|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344707|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211013|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138211014|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138211015|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211016|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211017|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211018|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211019|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211021|NCT02346201|Methylphenidate|methylphenidate|mesh-list
138211022|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138211023|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211024|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138211027|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211028|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
138211029|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211031|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138211032|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211033|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211034|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211035|NCT01866930|Interferons|interferons|mesh-list
138211036|NCT01866930|Ribavirin|ribavirin|mesh-list
138211037|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211038|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
138211039|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211041|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211042|NCT01682187|Lomustine|lomustine|mesh-list
138211043|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211044|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
138211045|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211046|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211047|NCT01621568|Sunitinib|sunitinib|mesh-list
138211048|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211049|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138211050|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138211051|NCT01621568|Growth Substances|growth substances|mesh-ancestor
138211052|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211053|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211054|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211055|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211056|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211057|NCT01366612|Vidarabine|vidarabine|mesh-list
138211058|NCT01366612|Fludarabine|fludarabine|mesh-list
138211059|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
138211060|NCT01366612|Busulfan|busulfan|mesh-list
138211061|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211062|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138211063|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
138211064|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211065|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211066|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
138211067|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211068|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
138211069|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211070|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
138211071|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211072|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211073|NCT00813293|Sorafenib|sorafenib|mesh-list
138211074|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211075|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211076|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211077|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211079|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211080|NCT00003641|Interferons|interferons|mesh-list
138211081|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
138211082|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
138211083|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211084|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
138211085|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211086|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
138211087|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211088|NCT00392834|Leucovorin|leucovorin|mesh-list
138211089|NCT00392834|Cytarabine|cytarabine|mesh-list
138211090|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
138211091|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138211101|NCT00392834|Vincristine|vincristine|mesh-list
138211102|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
138211103|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211104|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
138211105|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211106|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211107|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211108|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
138211109|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211110|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211111|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211112|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211113|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138211114|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138211115|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211116|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211117|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138211118|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
138211119|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138211120|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138211121|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
138211122|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138211123|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138211124|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138211125|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138211127|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211128|NCT00392834|Antidotes|antidotes|mesh-ancestor
138211129|NCT00392834|Protective Agents|protective agents|mesh-ancestor
138211130|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
138211131|NCT00392834|Vitamins|vitamins|mesh-ancestor
138211132|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
138211133|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
138211134|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
138211135|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
138211136|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211137|NCT00393380|Teriparatide|teriparatide|mesh-list
138211138|NCT00393380|Hormones|hormones|mesh-list
138211139|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
138211140|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211141|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344708|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
138344709|NCT00468234|Nicotine|nicotine|mesh-list
138344710|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138344711|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
138344712|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344713|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344714|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138344715|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138344716|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
138215433|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138215434|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
138215435|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138215436|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215437|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215438|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215439|NCT00684242|Lenalidomide|lenalidomide|mesh-list
138215440|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
138215441|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215442|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215443|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138215444|NCT00684242|Growth Substances|growth substances|mesh-ancestor
138215445|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211142|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211143|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138211144|NCT05361642|Lidocaine|lidocaine|mesh-list
138211145|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
138211146|NCT05361642|Bupivacaine|bupivacaine|mesh-list
138211147|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
138211148|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
138211149|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211150|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211151|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
138211152|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211153|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138211156|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211157|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211158|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138211159|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138211161|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138211162|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138211163|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211164|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211165|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211166|NCT00395876|Tenecteplase|tenecteplase|mesh-list
138211167|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138211168|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138211169|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211171|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138211172|NCT02662634|Cisplatin|cisplatin|mesh-list
138211173|NCT02662634|Carboplatin|carboplatin|mesh-list
138211174|NCT02662634|Pemetrexed|pemetrexed|mesh-list
138211175|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138211176|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211177|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138211178|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138211179|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138211180|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211181|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211182|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138211183|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138211184|NCT00396032|Tenecteplase|tenecteplase|mesh-list
138211185|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138211186|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138211187|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211188|NCT02277782|Fentanyl|fentanyl|mesh-list
138211189|NCT02277782|Hydromorphone|hydromorphone|mesh-list
138211190|NCT02277782|Bupivacaine|bupivacaine|mesh-list
138211191|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
138211192|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
138211193|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211194|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211195|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
138211196|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211197|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138211198|NCT02277782|Narcotics|narcotics|mesh-ancestor
138211199|NCT02277782|Analgesics|analgesics|mesh-ancestor
138211200|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138211201|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138211202|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
138211203|NCT02271230|Vitamin D|vitamin d|mesh-list
138211204|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
138211205|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
138211206|NCT02271230|Vitamins|vitamins|mesh-list
138211207|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
138211208|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211209|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138211210|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211211|NCT00396266|Plerixafor|plerixafor|mesh-list
138211212|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138211213|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138211214|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
138211215|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211216|NCT05610384|Ibuprofen|ibuprofen|mesh-list
138211217|NCT05610384|Ketorolac|ketorolac|mesh-list
138211218|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138211219|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138211220|NCT05610384|Analgesics|analgesics|mesh-ancestor
138211221|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
138211222|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211223|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211241|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211242|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211243|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211244|NCT05380752|Tecovirimat|tecovirimat|mesh-list
138211245|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
138211246|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211247|NCT00401414|Warfarin|warfarin|mesh-list
138211248|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
138211249|NCT00370838|Clonidine|clonidine|mesh-list
138211250|NCT00370838|Levetiracetam|levetiracetam|mesh-list
138211252|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
138211253|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211254|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211255|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138211256|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
138211257|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
138211258|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138211259|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138211271|NCT01795430|Ifosfamide|ifosfamide|mesh-list
138211272|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138211273|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211274|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138211275|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211276|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211277|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211278|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211279|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
138211280|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211281|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211282|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
138211283|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211284|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138211285|NCT04750382|Gemcitabine|gemcitabine|mesh-list
138211286|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211287|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138211288|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
138211289|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211290|NCT00401882|Metoprolol|metoprolol|mesh-list
138211291|NCT00401882|Epinephrine|epinephrine|mesh-list
138211292|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138211293|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211294|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211295|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211296|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211297|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211298|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138211299|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138211301|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211302|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138211303|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211304|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
138211305|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
138211306|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138211307|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138211308|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138211309|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
138211310|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138211311|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138211312|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138211313|NCT00373334|Nizatidine|nizatidine|mesh-list
138211314|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138211326|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138211327|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
138211328|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211329|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138211330|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138211331|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211332|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
138211333|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138211334|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
138211335|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
138211336|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138211337|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
138211338|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211339|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211340|NCT00402194|Losartan|losartan|mesh-list
138211341|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138211342|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138211343|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138211344|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138211345|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211346|NCT05305404|Dexamethasone|dexamethasone|mesh-list
138211347|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
138211349|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211350|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
138211351|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
138211352|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211353|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211354|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138211355|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
138211356|NCT05305404|Hormones|hormones|mesh-ancestor
138211357|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211358|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138211359|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211360|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
138211361|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211362|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211363|NCT00402896|Mitogens|mitogens|mesh-list
138211364|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
138211365|NCT00402896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138211366|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
138211367|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211368|NCT00402896|Growth Substances|growth substances|mesh-ancestor
138211369|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211370|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211371|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211372|NCT00405704|Trimethoprim|trimethoprim|mesh-list
138211377|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
138211378|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138211379|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138211380|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138211381|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211382|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211383|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138211384|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138211385|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138211386|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138211388|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138211389|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138211390|NCT01657266|Analgesics|analgesics|mesh-ancestor
138211391|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
138211392|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211393|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211394|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211395|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211396|NCT05286008|Dexamethasone|dexamethasone|mesh-list
138211397|NCT05286008|Ropivacaine|ropivacaine|mesh-list
138211398|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211399|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
138211400|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
138211401|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211402|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211404|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
138211405|NCT05286008|Hormones|hormones|mesh-ancestor
138211406|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211407|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138211408|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211409|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
138211410|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
138211411|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211412|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
138211413|NCT05302284|Carboplatin|carboplatin|mesh-list
138211414|NCT05302284|Gemcitabine|gemcitabine|mesh-list
138211415|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
138211416|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211417|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138211418|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
138211419|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211420|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
138211421|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
138211422|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211423|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
138211424|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138211425|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211441|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138211442|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138211443|NCT05299476|Growth Substances|growth substances|mesh-ancestor
138211444|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211445|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211447|NCT00405938|Fulvestrant|fulvestrant|mesh-list
138211448|NCT00405938|Anastrozole|anastrozole|mesh-list
138211449|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138211450|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211451|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138211452|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138211453|NCT00405938|Growth Substances|growth substances|mesh-ancestor
138211454|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211455|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211456|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138211457|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138211458|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138211459|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
138211460|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211461|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138211462|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138211463|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211464|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211466|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138211467|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138211468|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211469|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211470|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211471|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138211472|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211473|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211474|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211511|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211512|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138211513|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138211514|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211515|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211517|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
138211518|NCT00379574|Doxorubicin|doxorubicin|mesh-list
138211519|NCT00379574|Vincristine|vincristine|mesh-list
138211520|NCT00379574|Bortezomib|bortezomib|mesh-list
138211521|NCT00379574|Lenograstim|lenograstim|mesh-list
138211523|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
138211524|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211525|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211533|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211534|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211535|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138211536|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
138211537|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
138211538|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
138211541|NCT00379574|Hormones|hormones|mesh-ancestor
138211542|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211543|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138211544|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138211545|NCT05256108|Oxycodone|oxycodone|mesh-list
138211546|NCT05256108|Tramadol|tramadol|mesh-list
138211547|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138211549|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211550|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211552|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
138211553|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211554|NCT00407654|Aflibercept|aflibercept|mesh-list
138211555|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
138211556|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138211557|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138211558|NCT00407654|Growth Substances|growth substances|mesh-ancestor
138211559|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211560|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211561|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211563|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211564|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211565|NCT00407888|Paclitaxel|paclitaxel|mesh-list
138344960|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138211566|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138211567|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
138211568|NCT00407888|Doxorubicin|doxorubicin|mesh-list
138211569|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138211570|NCT00407888|Trastuzumab|trastuzumab|mesh-list
138211571|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138211572|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211573|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138211574|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138211575|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138211576|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211577|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211599|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
138211600|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211601|NCT00407966|Analgesics|analgesics|mesh-ancestor
138211602|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
138211603|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211604|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138211605|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211606|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211607|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
138211608|NCT00407966|Growth Substances|growth substances|mesh-ancestor
138211609|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211611|NCT00408200|Flecainide|flecainide|mesh-list
138211612|NCT00408200|Propafenone|propafenone|mesh-list
138211613|NCT00408200|Dofetilide|dofetilide|mesh-list
138211614|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138211615|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138211616|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211617|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211618|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211619|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211620|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138211621|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
138211622|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
138211623|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211624|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138211625|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138211636|NCT05250050|Tetracycline|tetracycline|mesh-list
138211637|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
138211638|NCT05250050|Esomeprazole|esomeprazole|mesh-list
138211639|NCT05250050|Bismuth|bismuth|mesh-list
138211640|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211641|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138211642|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211643|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138211644|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138211645|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138211646|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138211647|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138211648|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211649|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138211650|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138211651|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138211652|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138211653|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138211654|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138211655|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211656|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138211658|NCT05250050|Diuretics|diuretics|mesh-ancestor
138211659|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
138211660|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211661|NCT05250050|Expectorants|expectorants|mesh-ancestor
138211662|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211664|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138211665|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138211666|NCT05294328|Aceclidine|aceclidine|mesh-list
138211667|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138211668|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138211669|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138211670|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138211671|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211672|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211673|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211674|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211675|NCT05294328|Miotics|miotics|mesh-ancestor
138211676|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
138211677|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211678|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138211679|NCT05292690|Caffeine|caffeine|mesh-list
138211680|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138211681|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211682|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138211683|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211698|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211699|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
138211700|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138211701|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215446|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211702|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211703|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211704|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138211705|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138211706|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211707|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211708|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138211709|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211710|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211711|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
138211712|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
138211713|NCT04270994|Misoprostol|misoprostol|mesh-list
138211714|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138211715|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
138211716|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138211717|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211718|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138211719|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138211720|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
138211721|NCT02111798|Bupropion|bupropion|mesh-list
138211722|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138211723|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138211724|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211725|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138211726|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211727|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211739|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211740|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138211741|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138211742|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
138211743|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211744|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211745|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138211748|NCT05143502|Prednisolone|prednisolone|mesh-list
138211749|NCT05143502|Montelukast|montelukast|mesh-list
138211750|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211751|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138211752|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
138211753|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211754|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211755|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138211756|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211757|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
138211758|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138211759|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
138211760|NCT05143502|Hormones|hormones|mesh-ancestor
138211761|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138211762|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138211763|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211764|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138211765|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
138211766|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138211789|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211797|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211798|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
138211800|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138211801|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
138211802|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138211803|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211805|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138211807|NCT05288400|Amlodipine|amlodipine|mesh-list
138211808|NCT05288400|Bisoprolol|bisoprolol|mesh-list
138211809|NCT05288400|Perindopril|perindopril|mesh-list
138211810|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138211811|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138211812|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138211813|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211814|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138211815|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211816|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
138211817|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
138211818|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
138211819|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211820|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138211821|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138211822|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138211823|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
138211824|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211825|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138211826|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138211827|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211828|NCT05474040|Morphine|morphine|mesh-list
138211829|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138211830|NCT05474040|Narcotics|narcotics|mesh-ancestor
138211831|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211832|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211833|NCT05474040|Analgesics|analgesics|mesh-ancestor
138211834|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
138211835|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211836|NCT00410150|Albuterol|albuterol|mesh-list
138211837|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138211838|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
138211839|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211840|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211841|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138211842|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211843|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
138211844|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138211877|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211878|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211880|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138211881|NCT05238948|Midazolam|midazolam|mesh-list
138211882|NCT05238948|CKD-506|ckd-506|mesh-list
138211883|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138211884|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138211885|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211886|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211887|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138211888|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138211889|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211890|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138211891|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
138211892|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
138211893|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
138211894|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
138211895|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211896|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211897|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138211898|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211900|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138211901|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138211902|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211903|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211904|NCT05236530|Metformin|metformin|mesh-list
138211905|NCT05236530|Repaglinide|repaglinide|mesh-list
138211906|NCT05236530|Dolutegravir|dolutegravir|mesh-list
138211907|NCT05236530|Lumefantrine|lumefantrine|mesh-list
138211908|NCT05236530|Midazolam|midazolam|mesh-list
138211909|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
138211910|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138211911|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138211912|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211913|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138211914|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138211915|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138211916|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138211917|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138211918|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138211919|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138211920|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
138211921|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
138211922|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
138211924|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138211925|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138211926|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138211927|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138211928|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
138211929|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138211930|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138211931|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138211932|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138211933|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138211934|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138211935|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138211936|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
138211937|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211938|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
138211939|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138211940|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138211941|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
138211942|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
138211943|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138211944|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138211945|NCT00455702|Cycloserine|cycloserine|mesh-list
138211946|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138211947|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138211948|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138211990|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
138211991|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138211992|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
138211994|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
138211995|NCT00458822|Dexamethasone|dexamethasone|mesh-list
138211997|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138211998|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
138211999|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
138212000|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212001|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212002|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212003|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
138212004|NCT00458822|Hormones|hormones|mesh-ancestor
138212005|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212006|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138212007|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212008|NCT00389168|Atenolol|atenolol|mesh-list
138212009|NCT00389168|Irbesartan|irbesartan|mesh-list
138212010|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138212011|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138212012|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138212013|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212014|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138212015|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
138212016|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
138212017|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212018|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212019|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138212020|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138212021|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138212022|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212023|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212024|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138212025|NCT00462020|Metronidazole|metronidazole|mesh-list
138212026|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
138212027|NCT00462020|Ampicillin|ampicillin|mesh-list
138212028|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
138212029|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
138212030|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138212031|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212032|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
138212033|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138212034|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138212035|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212036|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212051|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212053|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212054|NCT04241640|Analgesics|analgesics|mesh-ancestor
138212055|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
138212056|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212057|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212058|NCT00462332|Vidarabine|vidarabine|mesh-list
138212059|NCT00462332|Fludarabine|fludarabine|mesh-list
138212060|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
138212062|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212063|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212064|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
138212065|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212066|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212067|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
138212068|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212069|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
138212070|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212071|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212072|NCT00462644|Midazolam|midazolam|mesh-list
138212073|NCT00462644|Fentanyl|fentanyl|mesh-list
138212074|NCT00462644|Etomidate|etomidate|mesh-list
138212075|NCT00462644|Succinylcholine|succinylcholine|mesh-list
138212076|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138212077|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138212078|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212079|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212080|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138212081|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212082|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212083|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138212084|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
138212085|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
138212086|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
138212087|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
138212088|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212089|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212090|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138212091|NCT00462644|Narcotics|narcotics|mesh-ancestor
138212092|NCT00462644|Analgesics|analgesics|mesh-ancestor
138212093|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
138212114|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212115|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212116|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
138212117|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212118|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212119|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
138212120|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212121|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138212122|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138212123|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138212124|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212125|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138212126|NCT00528788|Vitamins|vitamins|mesh-ancestor
138212127|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
138212130|NCT00414518|Ritonavir|ritonavir|mesh-list
138212131|NCT00414518|Lopinavir|lopinavir|mesh-list
138212132|NCT00414518|Tenofovir|tenofovir|mesh-list
138212157|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
138212158|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212159|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138212160|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138212161|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138212162|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138212163|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212164|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212165|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212166|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
138212167|NCT01795664|Hormones|hormones|mesh-ancestor
138212168|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212169|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
138212170|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
138212171|NCT05271084|Dexetimide|dexetimide|mesh-list
138212172|NCT05271084|Citalopram|citalopram|mesh-list
138212173|NCT05271084|Escitalopram|escitalopram|mesh-list
138212174|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138212175|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138212176|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212177|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212178|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212179|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
138212180|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212181|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138212182|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212183|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212184|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138212185|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138212186|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
138212187|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
138212188|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212189|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138212190|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138212191|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
138212192|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138212193|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212194|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138212195|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138212196|NCT05271084|Protective Agents|protective agents|mesh-ancestor
138212197|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
138212198|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138212200|NCT00531518|Lamotrigine|lamotrigine|mesh-list
138212201|NCT00531518|Aripiprazole|aripiprazole|mesh-list
138212219|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212220|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212221|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
138212222|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138212223|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138212224|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
138212225|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138212226|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138212227|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138212228|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138212229|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138212230|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
138212231|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138212232|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212233|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138212234|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138212236|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
138212237|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138212238|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138212239|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212240|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212241|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138212242|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138212243|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212245|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
138212246|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212247|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212248|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212249|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212250|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138212251|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138212272|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212273|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138212274|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
138212275|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
138212277|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
138212278|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138212279|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212280|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212281|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138212282|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138212283|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212284|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212285|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212286|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138212288|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212289|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212290|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138212291|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212292|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212294|NCT00466310|Aripiprazole|aripiprazole|mesh-list
138212295|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138212296|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
138212297|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212302|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212303|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212304|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138212315|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212316|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138212317|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212318|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138212319|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138212320|NCT03463460|Growth Substances|growth substances|mesh-ancestor
138212321|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212322|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
138212323|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138212324|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212326|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212327|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212328|NCT00418028|Capecitabine|capecitabine|mesh-list
138212330|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
138212331|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212332|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212334|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212335|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212336|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
138212337|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212338|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212339|NCT00538304|Bimatoprost|bimatoprost|mesh-list
138212340|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138212341|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138212342|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138212343|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
138212344|NCT00538616|Propofol|propofol|mesh-list
138212345|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138212346|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212347|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212348|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212349|NCT00538616|Analgesics|analgesics|mesh-ancestor
138212350|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
138212351|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212367|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212368|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138212369|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138212370|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138212371|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212373|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
138212374|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212375|NCT00470600|Ibuprofen|ibuprofen|mesh-list
138212376|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138212377|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212378|NCT00470600|Analgesics|analgesics|mesh-ancestor
138212379|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
138212380|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212381|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212382|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212383|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212384|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138212385|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212386|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212387|NCT00471068|Timolol|timolol|mesh-list
138212388|NCT00471068|Travoprost|travoprost|mesh-list
138212389|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138212390|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138212391|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212419|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138212420|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138212421|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
138212422|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
138212423|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138212424|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138215447|NCT00651560|Simvastatin|simvastatin|mesh-list
138212425|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138212426|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212427|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212428|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212429|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212430|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212456|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212457|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212458|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138212459|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212460|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212461|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138212462|NCT00419666|Vitamins|vitamins|mesh-ancestor
138212463|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
138212464|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138212465|NCT00540722|Acetic Acid|acetic acid|mesh-list
138212466|NCT00540722|Retinol acetate|retinol acetate|mesh-list
138212467|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
138212468|NCT00540722|Gossypol|gossypol|mesh-list
138212469|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212470|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212471|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138212472|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
138212473|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212474|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138212488|NCT00542750|Expectorants|expectorants|mesh-ancestor
138212489|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
138212490|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138212491|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
138212492|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212493|NCT00542750|Protective Agents|protective agents|mesh-ancestor
138212494|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212495|NCT00542750|Antidotes|antidotes|mesh-ancestor
138212496|NCT00475904|Gabapentin|gabapentin|mesh-list
138212497|NCT00475904|Analgesics|analgesics|mesh-ancestor
138212498|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
138212499|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212500|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212501|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
138212502|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138212503|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212504|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212505|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212506|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138212507|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138212508|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212509|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212510|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
138212511|NCT00420992|Naltrexone|naltrexone|mesh-list
138212513|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138212514|NCT00420992|Narcotics|narcotics|mesh-ancestor
138212515|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212516|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212517|NCT00420992|Analgesics|analgesics|mesh-ancestor
138212518|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
138212519|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212520|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138212521|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138212522|NCT00423878|Olanzapine|olanzapine|mesh-list
138212523|NCT00423878|Risperidone|risperidone|mesh-list
138212524|NCT00423878|Aripiprazole|aripiprazole|mesh-list
138212525|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138212540|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212541|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138212542|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138212543|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212544|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212545|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
138212546|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138212547|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138212548|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138212549|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138212550|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
138212551|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138212552|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212553|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212554|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212555|NCT00480740|Analgesics|analgesics|mesh-ancestor
138212556|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
138212557|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212558|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138212559|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138212561|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138212562|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212563|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212564|NCT00424502|Rituximab|rituximab|mesh-list
138212565|NCT00424502|Methotrexate|methotrexate|mesh-list
138212582|NCT00425672|Interleukin-2|interleukin-2|mesh-list
138212583|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
138212584|NCT00425672|Immunotoxins|immunotoxins|mesh-list
138212585|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212586|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212587|NCT00425672|Analgesics|analgesics|mesh-ancestor
138212588|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
138212589|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212590|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212591|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
138212592|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
138212593|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
138212594|NCT00544076|Alprostadil|alprostadil|mesh-list
138212595|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212596|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
138212597|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138212598|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138212599|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212600|NCT00544076|Urological Agents|urological agents|mesh-ancestor
138212601|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138212602|NCT00544778|Doxorubicin|doxorubicin|mesh-list
138212603|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138212605|NCT00544778|Irinotecan|irinotecan|mesh-list
138212606|NCT00544778|Ifosfamide|ifosfamide|mesh-list
138212633|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212634|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138212635|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212636|NCT00486824|Analgesics|analgesics|mesh-ancestor
138212637|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
138212638|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212639|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212640|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212641|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
138212642|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138212643|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212644|NCT00489086|Tazarotene|tazarotene|mesh-list
138212645|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212646|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
138212647|NCT00489866|Aripiprazole|aripiprazole|mesh-list
138212648|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
138212649|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212650|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212651|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212652|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212653|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212654|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
138212655|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
138212656|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212657|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212658|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138212659|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138212660|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
138212661|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138212662|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138212663|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138212664|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138212666|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212667|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138212668|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212669|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212670|NCT00546728|Metformin|metformin|mesh-list
138212671|NCT00546728|Exenatide|exenatide|mesh-list
138212672|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138212673|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212674|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138212675|NCT00546728|Incretins|incretins|mesh-ancestor
138212676|NCT00546728|Hormones|hormones|mesh-ancestor
138212677|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212679|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
138212680|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
138212681|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138212682|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212683|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
138212684|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212685|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
138212686|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138212687|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212688|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
138212689|NCT00490100|Mecasermin|mecasermin|mesh-list
138212690|NCT00490100|Growth Substances|growth substances|mesh-ancestor
138212691|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212692|NCT00490802|Oxytocin|oxytocin|mesh-list
138212693|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
138212716|NCT00431132|Estrogens|estrogens|mesh-ancestor
138212717|NCT00431132|Hormones|hormones|mesh-ancestor
138212718|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212719|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212721|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
138212722|NCT00493064|Niacinamide|niacinamide|mesh-list
138212724|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138212725|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
138212726|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138212727|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
138212728|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138212729|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
138212730|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212732|NCT00493064|Hormones|hormones|mesh-ancestor
138212733|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212734|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212735|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138212759|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138212760|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212763|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212764|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
138212765|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212766|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
138212767|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138212768|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138212769|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138212770|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138212771|NCT00432458|Growth Substances|growth substances|mesh-ancestor
138212772|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
138212773|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212774|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138212776|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
138212785|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
138212786|NCT02208037|Maraviroc|maraviroc|mesh-list
138212787|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
138212788|NCT02208037|Methotrexate|methotrexate|mesh-list
138212789|NCT02208037|Bortezomib|bortezomib|mesh-list
138212790|NCT02208037|Tacrolimus|tacrolimus|mesh-list
138212791|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212792|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
138212793|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212794|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212795|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138212796|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
138212797|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212798|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212799|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138212800|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138212801|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
138212802|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138212803|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138212804|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
138212805|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212806|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212807|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138212808|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138212809|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138212810|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138212811|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138212828|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212830|NCT03007927|Hormones|hormones|mesh-ancestor
138212831|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212832|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138212833|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212834|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
138212835|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
138212836|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212837|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
138212838|NCT05150496|Vaccines|vaccines|mesh-list
138212839|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
138212840|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212841|NCT00496340|Rituximab|rituximab|mesh-list
138212842|NCT00496340|Busulfan|busulfan|mesh-list
138212843|NCT00496340|Pentostatin|pentostatin|mesh-list
138212844|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212845|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212846|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
138212847|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212848|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138212849|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
138212850|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212851|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138212852|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138212853|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138212854|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138212855|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212856|NCT00496808|Trastuzumab|trastuzumab|mesh-list
138212857|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138212858|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212859|NCT01795820|Ticagrelor|ticagrelor|mesh-list
138212879|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212880|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215448|NCT00651560|Ezetimibe|ezetimibe|mesh-list
138212882|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212883|NCT00555464|Prednisone|prednisone|mesh-list
138212884|NCT00555464|Prednisolone|prednisolone|mesh-list
138212885|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138212886|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
138212887|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138212889|NCT00555464|Vincristine|vincristine|mesh-list
138212890|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138212891|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
138212892|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138212893|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
138212895|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138212896|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212897|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138212898|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212899|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138212900|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
138212901|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
138212902|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
138212903|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212904|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
138212905|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
138212906|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212907|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212908|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138212918|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
138212919|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212920|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138212921|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138212922|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138212923|NCT01795976|Analgesics|analgesics|mesh-ancestor
138212924|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
138212925|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212926|NCT01461733|Amiodarone|amiodarone|mesh-list
138212927|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138212928|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
138212929|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138212930|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138212931|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138212932|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138212933|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138212934|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138212935|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138212936|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138212937|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138212938|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138212939|NCT01462279|Thiamine|thiamine|mesh-list
138212940|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
138212941|NCT01462279|Vitamins|vitamins|mesh-ancestor
138212942|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
138212944|NCT00435812|Vaccines|vaccines|mesh-list
138212945|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
138212946|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212947|NCT05081466|Vitamin D|vitamin d|mesh-list
138212948|NCT05081466|Calcium|calcium|mesh-list
138212950|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
138212951|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212952|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138212953|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138212954|NCT01464229|Iloperidone|iloperidone|mesh-list
138212955|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212956|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212957|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212958|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212959|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138212960|NCT00556478|Lidocaine|lidocaine|mesh-list
138212961|NCT00556478|Prilocaine|prilocaine|mesh-list
138212962|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138212963|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
138212964|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
138212965|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138212966|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212967|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
138212968|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212969|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138212989|NCT03246620|Haloperidol|haloperidol|mesh-list
138212991|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
138212992|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
138212993|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
138212994|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138212995|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138212996|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138212997|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138212998|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138212999|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213000|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213001|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138213002|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213003|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213004|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213005|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213006|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
138213007|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138213021|NCT01470859|Levodopa|levodopa|mesh-list
138213022|NCT01470859|Carbidopa|carbidopa|mesh-list
138213023|NCT01470859|Pramipexole|pramipexole|mesh-list
138213024|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138213025|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138213026|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138213027|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
138213028|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213029|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213030|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213031|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138213032|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213033|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
138213034|NCT01470859|Protective Agents|protective agents|mesh-ancestor
138213035|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
138213036|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138213037|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
138213038|NCT00436046|Interferons|interferons|mesh-list
138213039|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213040|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
138213041|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213043|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213044|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213045|NCT01471639|Analgesics|analgesics|mesh-ancestor
138213046|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
138213047|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213048|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213049|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213050|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213051|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138213052|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213053|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213054|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
138213055|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138213056|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213057|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213058|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213059|NCT05622656|Analgesics|analgesics|mesh-ancestor
138213060|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
138213061|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213062|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138213063|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138213064|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138213065|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213066|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213076|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
138213077|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138213078|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138213079|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213080|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213082|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
138213083|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138213084|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
138213085|NCT00436904|Rituximab|rituximab|mesh-list
138213086|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
138213087|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138213088|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213089|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
138213090|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213091|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213092|NCT00438854|Dasatinib|dasatinib|mesh-list
138213093|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213095|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213096|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213097|NCT01485055|Infliximab|infliximab|mesh-list
138213098|NCT01485055|Basiliximab|basiliximab|mesh-list
138213099|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138213100|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213101|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
138213102|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213103|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213104|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213105|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
138213106|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213107|NCT05028348|Dexamethasone|dexamethasone|mesh-list
138213108|NCT05028348|Pomalidomide|pomalidomide|mesh-list
138213110|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213111|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
138213112|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
138213113|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213114|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213115|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213116|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
138213117|NCT05028348|Hormones|hormones|mesh-ancestor
138213118|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213119|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213120|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213121|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
138213122|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213123|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213124|NCT05028348|Growth Substances|growth substances|mesh-ancestor
138213125|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
138213126|NCT01486615|Melatonin|melatonin|mesh-list
138213127|NCT01486615|Alprazolam|alprazolam|mesh-list
138213128|NCT01486615|Azaperone|azaperone|mesh-list
138213129|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
138213139|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
138213140|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213141|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138213143|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
138213144|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138213145|NCT00503750|Vinorelbine|vinorelbine|mesh-list
138213146|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213147|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138213148|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138213149|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138213150|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138213151|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213152|NCT00508118|Nicardipine|nicardipine|mesh-list
138213153|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138213154|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138213155|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213156|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213157|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138213158|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213159|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
138213160|NCT05139030|Bupivacaine|bupivacaine|mesh-list
138213161|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
138213162|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
138213163|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213164|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213165|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
138213166|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213167|NCT00440180|Anastrozole|anastrozole|mesh-list
138213168|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213169|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213170|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138213171|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138213172|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213173|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213174|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138213175|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
138213190|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138213192|NCT01364298|Pregabalin|pregabalin|mesh-list
138213193|NCT01364298|Gabapentin|gabapentin|mesh-list
138213194|NCT01364298|Analgesics|analgesics|mesh-ancestor
138213195|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
138213196|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213197|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213198|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
138213199|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138213200|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213201|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213202|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138213203|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138213204|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138213205|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213206|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213207|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138213208|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138213209|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213211|NCT04421742|Beclomethasone|beclomethasone|mesh-list
138213212|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
138213213|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138213214|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
138213215|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213216|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213217|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138213223|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213224|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213225|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213226|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
138213227|NCT04421742|Hormones|hormones|mesh-ancestor
138213228|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213229|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
138213230|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138213231|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
138213233|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213234|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138213235|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
138213236|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138213237|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138213238|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138213239|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213240|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213241|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213243|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138213244|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
138213245|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213246|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138213247|NCT01488877|Spironolactone|spironolactone|mesh-list
138213248|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138213249|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215449|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138213250|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213251|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213252|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138213253|NCT01488877|Diuretics|diuretics|mesh-ancestor
138213254|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
138213255|NCT01364922|Acetaminophen|acetaminophen|mesh-list
138213256|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138213257|NCT01364922|Hydrocodone|hydrocodone|mesh-list
138213258|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213259|NCT01364922|Analgesics|analgesics|mesh-ancestor
138213260|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
138213261|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213262|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213263|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
138213264|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138213265|NCT01364922|Narcotics|narcotics|mesh-ancestor
138213266|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213267|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
138213268|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
138213269|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213270|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213271|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213272|NCT01489969|Melatonin|melatonin|mesh-list
138213273|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
138213274|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213275|NCT01489969|Protective Agents|protective agents|mesh-ancestor
138213276|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213277|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213278|NCT00509288|Aldesleukin|aldesleukin|mesh-list
138213296|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138213298|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213299|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213300|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213301|NCT00511706|Dexamethasone|dexamethasone|mesh-list
138213302|NCT00511706|Ranibizumab|ranibizumab|mesh-list
138213303|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213304|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
138213305|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
138213306|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213307|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213308|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213309|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
138213310|NCT00511706|Hormones|hormones|mesh-ancestor
138213311|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213312|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213313|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213314|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213315|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213316|NCT00511706|Growth Substances|growth substances|mesh-ancestor
138213317|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
138213319|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
138213320|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213321|NCT01493947|Metronidazole|metronidazole|mesh-list
138213322|NCT01493947|Ivermectin|ivermectin|mesh-list
138213323|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213324|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138213325|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138213326|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138213327|NCT00445484|Lenalidomide|lenalidomide|mesh-list
138213328|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138213329|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
138213330|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213331|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213332|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213345|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138213346|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213347|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213348|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138213349|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213350|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215450|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215451|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
138215452|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215453|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215454|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215455|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215457|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138213351|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213352|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
138213354|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138213356|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213357|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213358|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138213359|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138213360|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
138213361|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213362|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213363|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
138213364|NCT04214886|Fludarabine|fludarabine|mesh-list
138213365|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213366|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
138213367|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213368|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213388|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213389|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213390|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
138213391|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
138213392|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138213393|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138213394|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
138213395|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213396|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213397|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138213398|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
138213399|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138213400|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213401|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138213402|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138213403|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
138213404|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
138213405|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
138213407|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
138213408|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213409|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213411|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213423|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213424|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213425|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
138213426|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213428|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
138213429|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
138213430|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213431|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213432|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
138213433|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213434|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138213435|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138213436|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138213437|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215458|NCT00684554|Narcotics|narcotics|mesh-ancestor
138215459|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215460|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215461|NCT00684554|Analgesics|analgesics|mesh-ancestor
138215462|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
138215463|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215464|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138215465|NCT00551876|Simvastatin|simvastatin|mesh-list
138213438|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213439|NCT00517010|Ranibizumab|ranibizumab|mesh-list
138213440|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213441|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138213442|NCT00517010|Growth Substances|growth substances|mesh-ancestor
138213443|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213444|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
138213445|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213446|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
138213447|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
138213448|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138213449|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213450|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138213451|NCT00519584|Bupivacaine|bupivacaine|mesh-list
138213452|NCT00519584|Ropivacaine|ropivacaine|mesh-list
138213453|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
138213454|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
138213455|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213456|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213457|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
138213458|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213459|NCT05122884|Milrinone|milrinone|mesh-list
138213460|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138213461|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138213462|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
138213463|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138213471|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213472|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138213473|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138213474|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138213475|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213476|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138213477|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213478|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138213479|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213480|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213483|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
138213484|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
138213485|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213486|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213487|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
138213488|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213489|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138213490|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138213491|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213492|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213493|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213494|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138213495|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138213496|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
138213497|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138213498|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
138213499|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
138213500|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
138213501|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138213502|NCT00521456|Ketorolac|ketorolac|mesh-list
138213503|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138213504|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138213505|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213506|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213507|NCT00521456|Analgesics|analgesics|mesh-ancestor
138213508|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
138213509|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213510|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213511|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213512|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213513|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138213514|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213515|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213517|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138213518|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
138213519|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138213520|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213521|NCT03326180|Bupivacaine|bupivacaine|mesh-list
138213529|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138213530|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138213531|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213532|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213533|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
138213534|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213535|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213536|NCT01796444|Hormones|hormones|mesh-list
138213537|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215466|NCT00551876|Ezetimibe|ezetimibe|mesh-list
138215477|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215478|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215480|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215481|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215482|NCT00251576|Heparin|heparin|mesh-list
138215483|NCT00251576|Calcium heparin|calcium heparin|mesh-list
138215484|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138215485|NCT00251576|Tinzaparin|tinzaparin|mesh-list
138215486|NCT00251576|Dalteparin|dalteparin|mesh-list
138215487|NCT00251576|Tirofiban|tirofiban|mesh-list
138215488|NCT00251576|Simvastatin|simvastatin|mesh-list
138215489|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
138215490|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138215491|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138215492|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215493|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138215494|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215495|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
138215496|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215497|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215498|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213538|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213539|NCT01542541|Rifaximin|rifaximin|mesh-list
138213540|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138213541|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213542|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213543|NCT00524264|Ketorolac|ketorolac|mesh-list
138213544|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213545|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213546|NCT00524264|Analgesics|analgesics|mesh-ancestor
138213563|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213564|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138213565|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213566|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213567|NCT00524342|Oprelvekin|oprelvekin|mesh-list
138213568|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213569|NCT00524576|Vaccines|vaccines|mesh-list
138213570|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
138213571|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213572|NCT02516202|Estradiol|estradiol|mesh-list
138213573|NCT02516202|Estrogens|estrogens|mesh-ancestor
138213574|NCT02516202|Hormones|hormones|mesh-ancestor
138213587|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
138213588|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213589|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213590|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138213591|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138213594|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213595|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
138213596|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213597|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213598|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213599|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
138213600|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213601|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213602|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213603|NCT02124044|Asunaprevir|asunaprevir|mesh-list
138213604|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
138213605|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213606|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213607|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
138213608|NCT01502761|Analgesics|analgesics|mesh-ancestor
138213609|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
138213610|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213611|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213612|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
138213613|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213614|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138213615|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
138213616|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138213617|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213618|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213619|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138213620|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
138213621|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138213622|NCT01504477|Bortezomib|bortezomib|mesh-list
138213623|NCT01504477|Panitumumab|panitumumab|mesh-list
138213624|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213638|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213639|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213641|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213642|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138213643|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138213644|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138213645|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
138213646|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138213647|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138213648|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138213649|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
138213650|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213651|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213652|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213653|NCT01505179|Ranolazine|ranolazine|mesh-list
138213654|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138213655|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213656|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213657|NCT01797848|Ribavirin|ribavirin|mesh-list
138213658|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138213659|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
138213660|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213661|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
138213662|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213663|NCT01398943|Antioxidants|antioxidants|mesh-list
138213664|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213665|NCT01398943|Protective Agents|protective agents|mesh-ancestor
138213666|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213667|NCT01550341|Buprenorphine|buprenorphine|mesh-list
138213668|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138213670|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138213671|NCT01550341|Narcotics|narcotics|mesh-ancestor
138213672|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213673|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213674|NCT01550341|Analgesics|analgesics|mesh-ancestor
138213675|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
138213676|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213677|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138213678|NCT02125292|Mesalamine|mesalamine|mesh-list
138213679|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213686|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213688|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138213689|NCT01653912|Carboplatin|carboplatin|mesh-list
138213690|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138213691|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213692|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138213693|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
138213694|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
138213695|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213696|NCT04132388|Adalimumab|adalimumab|mesh-list
138213697|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138213698|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213699|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213700|NCT02514174|Afatinib|afatinib|mesh-list
138213701|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213723|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213724|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138213725|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138213726|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138213727|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215711|NCT03977233|Leucovorin|leucovorin|mesh-list
138215712|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
138215713|NCT03977233|Irinotecan|irinotecan|mesh-list
138215714|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215715|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138215717|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215718|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215719|NCT03977233|Antidotes|antidotes|mesh-ancestor
138213728|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213729|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213730|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138213732|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138213733|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138213734|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138213735|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213736|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138213737|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
138213738|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
138213739|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
138213740|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
138213741|NCT01509625|Fulvestrant|fulvestrant|mesh-list
138213742|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213743|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213744|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138213745|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138213746|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
138213754|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
138213756|NCT01510327|Everolimus|everolimus|mesh-list
138213757|NCT01510327|Ticlopidine|ticlopidine|mesh-list
138213758|NCT01510327|Clopidogrel|clopidogrel|mesh-list
138213759|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138213760|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138213761|NCT01510327|Analgesics|analgesics|mesh-ancestor
138213762|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
138213763|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213764|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213765|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213766|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213767|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138213768|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138213769|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213770|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138213772|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213773|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
138213774|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138213775|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138213776|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138213777|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
138213778|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213779|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138213780|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138213795|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213796|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138213797|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138213798|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
138213799|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
138213800|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213801|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138213802|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138213803|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
138213804|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138213805|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
138213806|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138213807|NCT01511809|Ritonavir|ritonavir|mesh-list
138213808|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138213809|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138213810|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138213811|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
138213812|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213813|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213814|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138213815|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138213816|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
138213817|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213818|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138213819|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138213820|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
138213821|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138213822|NCT02480712|Velpatasvir|velpatasvir|mesh-list
138213823|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
138213824|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213825|NCT03916094|Trastuzumab|trastuzumab|mesh-list
138213826|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138213827|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213840|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213841|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138213842|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138213843|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138213844|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138213845|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138213846|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213848|NCT00115700|Hormones|hormones|mesh-ancestor
138213849|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213850|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213851|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138213852|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138213853|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
138213855|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
138213857|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
138213858|NCT03243890|Vitamins|vitamins|mesh-ancestor
138213859|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
138213860|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213861|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138213862|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138213863|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138213864|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213865|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
138213867|NCT00560612|Paroxetine|paroxetine|mesh-list
138213868|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138213902|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138213903|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
138215720|NCT03977233|Protective Agents|protective agents|mesh-ancestor
138215721|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215722|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138215723|NCT03977233|Vitamins|vitamins|mesh-ancestor
138215724|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
138215725|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
138215726|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215727|NCT02219503|Ritonavir|ritonavir|mesh-list
138215728|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138215729|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138215748|NCT02221219|Indomethacin|indomethacin|mesh-list
138215749|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138215750|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215751|NCT02221219|Analgesics|analgesics|mesh-ancestor
138215752|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
138344961|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138213904|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213905|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213906|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138213907|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138213909|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
138213910|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213911|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138213912|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
138213913|NCT03236792|Hormones|hormones|mesh-ancestor
138213914|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213915|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138213916|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
138213917|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213918|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
138213919|NCT03725384|Iron|iron|mesh-list
138213920|NCT03725384|Vitamins|vitamins|mesh-ancestor
138213921|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
138213922|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213923|NCT03725384|Trace Elements|trace elements|mesh-ancestor
138213924|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
138213925|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213926|NCT03725384|Protective Agents|protective agents|mesh-ancestor
138213927|NCT01556425|Naltrexone|naltrexone|mesh-list
138213928|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138213929|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138213930|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213931|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
138213932|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213933|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
138213934|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138213935|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138213936|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213937|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213938|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
138213939|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138213940|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213941|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138213964|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138213965|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138213966|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138213967|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138213968|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
138213969|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
138213970|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138213971|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138213972|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138213973|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213974|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213975|NCT03641846|Tadalafil|tadalafil|mesh-list
138213976|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138213977|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138213978|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138213979|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213980|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213981|NCT03641846|Urological Agents|urological agents|mesh-ancestor
138213982|NCT01516957|Brodalumab|brodalumab|mesh-list
138213983|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138213999|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138214001|NCT01559857|Pioglitazone|pioglitazone|mesh-list
138214002|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138214003|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214004|NCT01562041|Ranolazine|ranolazine|mesh-list
138214005|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138214006|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214007|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214008|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
138214009|NCT00634166|Amphotericin B|amphotericin b|mesh-list
138214010|NCT00634166|Clotrimazole|clotrimazole|mesh-list
138214011|NCT00634166|Miconazole|miconazole|mesh-list
138214012|NCT00634166|Bacitracin|bacitracin|mesh-list
138214013|NCT00634166|Mafenide|mafenide|mesh-list
138214022|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214023|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214024|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138214025|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
138214026|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214027|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214028|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138214029|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138214030|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138214031|NCT00565370|Capecitabine|capecitabine|mesh-list
138214032|NCT00565370|Sorafenib|sorafenib|mesh-list
138214033|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214034|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214036|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214037|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214038|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214039|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
138214040|NCT03303950|Busulfan|busulfan|mesh-list
138214041|NCT03303950|Fludarabine|fludarabine|mesh-list
138214042|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214043|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
138214044|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214045|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214046|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214047|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
138214048|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214049|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214050|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138214051|NCT01563055|Ofatumumab|ofatumumab|mesh-list
138214052|NCT01563055|Chlorambucil|chlorambucil|mesh-list
138214053|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214054|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214055|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
138214056|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214057|NCT00565916|Estradiol|estradiol|mesh-list
138214058|NCT00565916|Estrogens|estrogens|mesh-list
138214059|NCT00565916|Progesterone|progesterone|mesh-list
138214060|NCT00565916|Hormones|hormones|mesh-ancestor
138214061|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214062|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214063|NCT00565916|Progestins|progestins|mesh-ancestor
138214064|NCT03258320|Docetaxel|docetaxel|mesh-list
138214065|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
138214066|NCT03258320|Satraplatin|satraplatin|mesh-list
138214067|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214068|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138214069|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214086|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214087|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
138214088|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138214089|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138214090|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138214091|NCT03008083|Clopidogrel|clopidogrel|mesh-list
138214092|NCT03008083|Ticagrelor|ticagrelor|mesh-list
138214093|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138214094|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138214095|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138214096|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138214097|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
138214098|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214099|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214100|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214101|NCT05559398|Glenzocimab|glenzocimab|mesh-list
138214102|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
138214103|NCT00566150|Levetiracetam|levetiracetam|mesh-list
138214105|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
138214106|NCT00566540|Paclitaxel|paclitaxel|mesh-list
138214107|NCT00566540|Cisplatin|cisplatin|mesh-list
138214108|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214109|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214132|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214134|NCT00568022|Capecitabine|capecitabine|mesh-list
138214135|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214136|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
138214137|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214138|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214140|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138214142|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214143|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214144|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138214145|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138214146|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214147|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214148|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214149|NCT03094286|Durvalumab|durvalumab|mesh-list
138214150|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214151|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214153|NCT03071666|Vitamins|vitamins|mesh-ancestor
138214154|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
138214155|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214168|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138214169|NCT05533580|Narcotics|narcotics|mesh-ancestor
138214171|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
138214172|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214173|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138214174|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138214175|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138214176|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138214177|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138215884|NCT00639158|Choline|choline|mesh-list
138214178|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138214179|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214180|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214181|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214183|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
138214184|NCT02129426|Ketamine|ketamine|mesh-list
138214185|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138214186|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214187|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214188|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138214189|NCT02129426|Analgesics|analgesics|mesh-ancestor
138214190|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
138214191|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214192|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138214193|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138214195|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
138214196|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214197|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214198|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138214199|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138214200|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
138214201|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
138214202|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138214203|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138214204|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138214205|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138214206|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138214216|NCT05409716|Hemostatics|hemostatics|mesh-list
138214217|NCT05409716|Coagulants|coagulants|mesh-ancestor
138214219|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214220|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214221|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138214222|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214223|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214224|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214225|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138214226|NCT01566409|Laxatives|laxatives|mesh-ancestor
138214227|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214228|NCT02184416|Everolimus|everolimus|mesh-list
138214229|NCT02184416|Temsirolimus|temsirolimus|mesh-list
138214231|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138214232|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214233|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214234|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214235|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214236|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
138214237|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214238|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214239|NCT01568905|Nicotine|nicotine|mesh-list
138214240|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138214241|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
138214242|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214243|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214244|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138214245|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138214246|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214247|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214248|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214249|NCT01569451|Rituximab|rituximab|mesh-list
138214250|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
138214251|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
138214252|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214253|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214254|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
138214255|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214257|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138214258|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214259|NCT02132936|Calcipotriene|calcipotriene|mesh-list
138214260|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138214261|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
138214278|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138214279|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138214280|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214281|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214282|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214283|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214284|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138214285|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214286|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
138214287|NCT01529827|Methotrexate|methotrexate|mesh-list
138214288|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
138214289|NCT01529827|Fludarabine|fludarabine|mesh-list
138214290|NCT01529827|Melphalan|melphalan|mesh-list
138214291|NCT01529827|Tacrolimus|tacrolimus|mesh-list
138214292|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138214293|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
138214294|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138214295|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214296|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214297|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
138214298|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214299|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214300|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
138214301|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214302|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138214303|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214304|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
138214305|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214306|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138214307|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138214320|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214321|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214322|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214323|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
138214325|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214326|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138214327|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214328|NCT00569660|Azacitidine|azacitidine|mesh-list
138214329|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214330|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
138214331|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214332|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214333|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214334|NCT01573273|Oxytocin|oxytocin|mesh-list
138214350|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138214351|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214352|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214353|NCT05085626|Fluzoparib|fluzoparib|mesh-list
138214354|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138214355|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214356|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214357|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214358|NCT05041946|Methylphenidate|methylphenidate|mesh-list
138214359|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138214360|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214361|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138215885|NCT00639158|Atorvastatin|atorvastatin|mesh-list
138214362|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138214364|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214365|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
138214366|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214367|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138214368|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214369|NCT05004896|Midazolam|midazolam|mesh-list
138214370|NCT05004896|Ketamine|ketamine|mesh-list
138214371|NCT05004896|Analgesics|analgesics|mesh-ancestor
138214372|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
138214373|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214374|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214375|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138214376|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138214377|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
138214410|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214411|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214412|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
138214413|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138214414|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138214415|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138214416|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
138214444|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
138214445|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214446|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214447|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138214448|NCT01532089|Growth Substances|growth substances|mesh-ancestor
138214449|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214450|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214451|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
138214453|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214454|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214455|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138214457|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138214458|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
138214480|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214481|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138214483|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214484|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215886|NCT00639158|Ezetimibe|ezetimibe|mesh-list
138214485|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214486|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138214487|NCT05245604|Cyclosporine|cyclosporine|mesh-list
138214488|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138214489|NCT05245604|Cyclosporins|cyclosporins|mesh-list
138214490|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214491|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214492|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214493|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
138214494|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214495|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
138214496|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214497|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138214498|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214499|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138214500|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138214502|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
138214503|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138214504|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138214505|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214506|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138214507|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214508|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
138214526|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138214527|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214528|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138214529|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
138214530|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
138214531|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214532|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214533|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214534|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138214535|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138214536|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214537|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
138214538|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138214539|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138214540|NCT01579513|Prednisolone|prednisolone|mesh-list
138214541|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
138214542|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138214543|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
138214544|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
138214545|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138214546|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
138214547|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
138214548|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214549|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214550|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214552|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214553|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138214554|NCT01579513|Protective Agents|protective agents|mesh-ancestor
138214556|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214557|NCT01534897|Dabrafenib|dabrafenib|mesh-list
138214558|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214559|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214574|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214576|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214577|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138214578|NCT00583622|Growth Substances|growth substances|mesh-ancestor
138214579|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214580|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
138214581|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138214582|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
138214583|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214584|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138214585|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138214586|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138214587|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214588|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
138214589|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138214590|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214591|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
138214592|NCT00583700|Vitamin E|vitamin e|mesh-list
138214593|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
138214594|NCT00583700|Vitamins|vitamins|mesh-ancestor
138214595|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
138214596|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214597|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
138214598|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214600|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138214602|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138214603|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138214604|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138214605|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138214606|NCT05540743|Adalimumab|adalimumab|mesh-list
138214607|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138215278|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215279|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215280|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138215281|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
138215283|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
138215285|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138215286|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215287|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138215288|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138215289|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138215290|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215293|NCT00653276|Cyclosporins|cyclosporins|mesh-list
138215294|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215295|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215296|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138215297|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
138215298|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215299|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
138215300|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215301|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215302|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215303|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138215304|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138215305|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215306|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
138215307|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215308|NCT00683852|Aripiprazole|aripiprazole|mesh-list
138215309|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
138215310|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215311|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138215322|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138215323|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138215324|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138215325|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138215326|NCT03006835|Clopidogrel|clopidogrel|mesh-list
138215327|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138215328|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138215329|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138215330|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138215331|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
138215332|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215333|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215334|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215335|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
138215336|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
138215337|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138215338|NCT03006757|Protective Agents|protective agents|mesh-ancestor
138215339|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215340|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215341|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138215342|NCT05566405|Anesthetics|anesthetics|mesh-list
138215343|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215344|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215345|NCT03000127|Testosterone|testosterone|mesh-list
138215346|NCT03000127|Androgens|androgens|mesh-ancestor
138215347|NCT03000127|Hormones|hormones|mesh-ancestor
138215348|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215349|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215350|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
138215351|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138215352|NCT02999815|Antibodies|antibodies|mesh-list
138215353|NCT02999815|Antitoxins|antitoxins|mesh-list
138215354|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
138215355|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215357|NCT03006679|Tazobactam|tazobactam|mesh-list
138215358|NCT03006679|Piperacillin|piperacillin|mesh-list
138215359|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138215360|NCT03006679|Vaborbactam|vaborbactam|mesh-list
138215361|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138215370|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
138215371|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
138215372|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138215373|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
138215374|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
138215375|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215511|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215512|NCT03005665|Diuretics|diuretics|mesh-ancestor
138215513|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
138215514|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215515|NCT00628628|Rasburicase|rasburicase|mesh-list
138215516|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
138215517|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215518|NCT04386811|Calcitriol|calcitriol|mesh-list
138215519|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138215520|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215525|NCT04386811|Vitamins|vitamins|mesh-ancestor
138215526|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
138215527|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138215528|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
138215529|NCT04357873|Vorinostat|vorinostat|mesh-list
138215530|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215531|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215532|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138215533|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215534|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138215535|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215536|NCT00630734|Ritonavir|ritonavir|mesh-list
138215537|NCT00630734|Darunavir|darunavir|mesh-list
138215538|NCT00630734|Pravastatin|pravastatin|mesh-list
138215539|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138215540|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138215541|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
138215542|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215543|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215544|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138215545|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138215546|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
138215547|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215548|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138215549|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138215550|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138215551|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138215552|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
138215553|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138215554|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138215555|NCT05644249|Doxorubicin|doxorubicin|mesh-list
138215556|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215557|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215558|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138215559|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138215560|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215561|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215562|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138215563|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
138215564|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215565|NCT00631358|Dexamethasone|dexamethasone|mesh-list
138215566|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215567|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
138215568|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
138215569|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215570|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215579|NCT02248753|Amiodarone|amiodarone|mesh-list
138215580|NCT02248753|Verapamil|verapamil|mesh-list
138215581|NCT02248753|Flecainide|flecainide|mesh-list
138215582|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138215583|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138215584|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
138215585|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
138215586|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215587|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215588|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138215589|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138215590|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138215591|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215592|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215593|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215594|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138215595|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215596|NCT02248753|Protective Agents|protective agents|mesh-ancestor
138215597|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
138215607|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138215608|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138215609|NCT00687674|Dexamethasone|dexamethasone|mesh-list
138215610|NCT00687674|Lenalidomide|lenalidomide|mesh-list
138215611|NCT00687674|Sorafenib|sorafenib|mesh-list
138215612|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215613|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
138215615|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215616|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215617|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215618|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
138215619|NCT00687674|Hormones|hormones|mesh-ancestor
138215620|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215621|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215622|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215634|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138215636|NCT00687908|Analgesics|analgesics|mesh-ancestor
138215638|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215639|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215640|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215641|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215642|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138215645|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
138215646|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138215647|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
138215648|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
138215649|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138215650|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
138215651|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215652|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
138215654|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215655|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215656|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215657|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215658|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
138215659|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
138215660|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215661|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215662|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138215663|NCT00689078|Protective Agents|protective agents|mesh-ancestor
138215675|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138215676|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138215677|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215678|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215679|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138215680|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215681|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215682|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215683|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138215684|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138215686|NCT00588536|Methotrexate|methotrexate|mesh-list
138215687|NCT00588536|Thioguanine|thioguanine|mesh-list
138215688|NCT00588536|Calcium|calcium|mesh-list
138215689|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
138215691|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215692|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138215693|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
138215694|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138215695|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138215696|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
138215697|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215698|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215699|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215700|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215701|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138215702|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138215703|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
138215704|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215705|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138215706|NCT00588536|Antidotes|antidotes|mesh-ancestor
138215707|NCT00588536|Protective Agents|protective agents|mesh-ancestor
138215708|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
138215709|NCT00588536|Vitamins|vitamins|mesh-ancestor
138215710|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
138215762|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215764|NCT00593450|Ranibizumab|ranibizumab|mesh-list
138215765|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215766|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215767|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215768|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138215769|NCT00593450|Growth Substances|growth substances|mesh-ancestor
138215770|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215771|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138215772|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138215773|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
138215774|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215793|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215794|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138215795|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
138215796|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215797|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215798|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138215799|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215800|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
138215801|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215802|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215803|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138215804|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215805|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138215806|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
138215807|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138215818|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215819|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138215821|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
138215822|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138215823|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215824|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215825|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138215826|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215828|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
138215829|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215830|NCT00595946|Lubiprostone|lubiprostone|mesh-list
138215831|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138215832|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215833|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215834|NCT00597038|Dasatinib|dasatinib|mesh-list
138215835|NCT00597038|Dacarbazine|dacarbazine|mesh-list
138215836|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215837|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215838|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215839|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215840|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138215841|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
138215842|NCT00597428|Lubiprostone|lubiprostone|mesh-list
138215843|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138215844|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215845|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215846|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138215847|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138215848|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215849|NCT00597818|Analgesics|analgesics|mesh-ancestor
138215850|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
138215851|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215869|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215870|NCT01790282|Progestins|progestins|mesh-ancestor
138215871|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
138215872|NCT03843541|Ambroxol|ambroxol|mesh-list
138215874|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
138215875|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215876|NCT03843541|Expectorants|expectorants|mesh-ancestor
138215877|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
138215878|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138215879|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
138215880|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215881|NCT03843541|Protective Agents|protective agents|mesh-ancestor
138215882|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215883|NCT03843541|Antidotes|antidotes|mesh-ancestor
138215930|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215931|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138215932|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
138215933|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138215942|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
138215943|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215944|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215945|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138215946|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
138215947|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215948|NCT00693992|Sunitinib|sunitinib|mesh-list
138215949|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215950|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215951|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138215952|NCT00693992|Growth Substances|growth substances|mesh-ancestor
138215953|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215954|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138215955|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215956|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215957|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215958|NCT00645710|Gemcitabine|gemcitabine|mesh-list
138215959|NCT00645710|Floxuridine|floxuridine|mesh-list
138215960|NCT00645710|Antibodies|antibodies|mesh-list
138215962|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
138215983|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215984|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215985|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215986|NCT00646646|Analgesics|analgesics|mesh-ancestor
138215987|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
138215988|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215989|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138215990|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138215991|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138215992|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215993|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215994|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215995|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138215996|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
138215997|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
138215998|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138215999|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216000|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216001|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216002|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
138216003|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
138216020|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138216021|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216022|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216024|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216025|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
138216027|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216028|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216029|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138216030|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216031|NCT01799486|Adefovir|adefovir|mesh-list
138216032|NCT01799486|Telbivudine|telbivudine|mesh-list
138216033|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
138216034|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216035|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138216036|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138216037|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216038|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216039|NCT00650546|Exenatide|exenatide|mesh-list
138216040|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138216041|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216042|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138216044|NCT00650546|Hormones|hormones|mesh-ancestor
138216045|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216046|NCT00650858|Plasminogen|plasminogen|mesh-list
138216047|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138216048|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138216049|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138216056|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138216110|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216111|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216112|NCT00656630|Naltrexone|naltrexone|mesh-list
138216113|NCT00656630|Acamprosate|acamprosate|mesh-list
138216115|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138216116|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216117|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
138216118|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216119|NCT01362998|Fentanyl|fentanyl|mesh-list
138216120|NCT01362998|Morphine|morphine|mesh-list
138216121|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138216122|NCT01362998|Narcotics|narcotics|mesh-ancestor
138216123|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216124|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216125|NCT01362998|Analgesics|analgesics|mesh-ancestor
138216126|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
138216127|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216128|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216129|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138216130|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
138216131|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
138216132|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
138216133|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
138216134|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216139|NCT02997332|Durvalumab|durvalumab|mesh-list
138216140|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216141|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216142|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138216143|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216144|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216146|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216147|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138216148|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
138216149|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216150|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216151|NCT04345094|Hydroquinone|hydroquinone|mesh-list
138216152|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
138216153|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216154|NCT04345094|Protective Agents|protective agents|mesh-ancestor
138216155|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216156|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138216158|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216159|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138216160|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138216161|NCT00702884|Growth Substances|growth substances|mesh-ancestor
138216162|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216163|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
138216164|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216165|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216166|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216168|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138216169|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216170|NCT01284335|Gemcitabine|gemcitabine|mesh-list
138216172|NCT01284335|Temozolomide|temozolomide|mesh-list
138216173|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138216174|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216175|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138216176|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
138216177|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216178|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216180|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216181|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138216182|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
138216183|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138216184|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216185|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
138216186|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138216187|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
138216188|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216189|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216190|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138216191|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
138216192|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138216193|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138216194|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138216211|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216212|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138216213|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216214|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216215|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216216|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216217|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138216218|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138216219|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138216220|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138216222|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138216223|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138216224|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138216225|NCT01195025|Analgesics|analgesics|mesh-ancestor
138216226|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
138216227|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216228|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216229|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216230|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216231|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
138216232|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
138216234|NCT00703664|Vorinostat|vorinostat|mesh-list
138216235|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216236|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138216237|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216238|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216240|NCT00658736|Bupivacaine|bupivacaine|mesh-list
138216241|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
138216242|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
138216243|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216244|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216245|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
138216247|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216248|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
138216249|NCT00658736|Hormones|hormones|mesh-ancestor
138216250|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216251|NCT00659360|Saracatinib|saracatinib|mesh-list
138216252|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216253|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216255|NCT01197833|Polidocanol|polidocanol|mesh-list
138216256|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138216257|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138216258|NCT04270370|Atorvastatin|atorvastatin|mesh-list
138216259|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138216260|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138216261|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
138216262|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216263|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216264|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138216265|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216266|NCT01288781|Acetazolamide|acetazolamide|mesh-list
138216267|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
138216268|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138216269|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216270|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216271|NCT01288781|Diuretics|diuretics|mesh-ancestor
138216272|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
138216273|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216274|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
138216275|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216276|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138216277|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138216278|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138216279|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216280|NCT02990078|Urological Agents|urological agents|mesh-ancestor
138216281|NCT01288859|Curcumin|curcumin|mesh-list
138216282|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138216283|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138216285|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
138216286|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216287|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216288|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216289|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216292|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216294|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
138216295|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216296|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138216297|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138216298|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216299|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216301|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
138216302|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216303|NCT02996942|Factor VIII|factor viii|mesh-list
138216304|NCT02996942|Coagulants|coagulants|mesh-ancestor
138216305|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
138216306|NCT01199237|Sevoflurane|sevoflurane|mesh-list
138216307|NCT01199237|Desflurane|desflurane|mesh-list
138216310|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138216311|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138216312|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
138216313|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
138216314|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216315|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216317|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138216319|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216322|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216323|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
138216325|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138216326|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
138216327|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138216328|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138216329|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138216330|NCT01235897|Paclitaxel|paclitaxel|mesh-list
138216331|NCT01235897|Trastuzumab|trastuzumab|mesh-list
138216332|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138216333|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216334|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
138216335|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
138216336|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
138216337|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216338|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216339|NCT01236053|Gabapentin|gabapentin|mesh-list
138216340|NCT01236053|Analgesics|analgesics|mesh-ancestor
138216341|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
138216342|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216343|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216345|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138216346|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138216347|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216348|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216349|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138216350|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138216351|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216352|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216356|NCT00703976|Pemetrexed|pemetrexed|mesh-list
138216357|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138216358|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216359|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138216360|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138216361|NCT00703976|Growth Substances|growth substances|mesh-ancestor
138216362|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216364|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216365|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216366|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138216367|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138216368|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
138216369|NCT00661544|Melphalan|melphalan|mesh-list
138216370|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
138216371|NCT00661544|Vitamins|vitamins|mesh-ancestor
138216372|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
138216373|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216374|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138216375|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
138216376|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216377|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138216378|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138216406|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138216408|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138216409|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216410|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216411|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138216412|NCT00664430|Vitamins|vitamins|mesh-ancestor
138216413|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
138216415|NCT01292447|Lidocaine|lidocaine|mesh-list
138216416|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
138216417|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
138216418|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138216419|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216420|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
138216421|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216423|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138216424|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138216425|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216426|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216427|NCT00704912|Orlistat|orlistat|mesh-list
138216428|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
138216429|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138216431|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138216432|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216433|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138216434|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216435|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216437|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216438|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138216439|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138216440|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138216441|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138216442|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138216443|NCT02195921|Antiemetics|antiemetics|mesh-list
138216444|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
138216445|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216446|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216447|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216449|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
138216450|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216451|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138216453|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138216454|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216469|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138216470|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216473|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138216475|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
138216476|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216477|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216478|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138216479|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138216481|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138216482|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
138216483|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216484|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216485|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138216486|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138216487|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138216488|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138216489|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216490|NCT01511042|Norepinephrine|norepinephrine|mesh-list
138216491|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
138216492|NCT01511042|Giapreza|giapreza|mesh-list
138289162|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289163|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138289164|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289167|NCT00000776|Amebicides|amebicides|mesh-ancestor
138289168|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289169|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289170|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289171|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
138289172|NCT04283773|Antibodies|antibodies|mesh-list
138289236|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289237|NCT00218036|Dexetimide|dexetimide|mesh-list
138289238|NCT00218036|Modafinil|modafinil|mesh-list
138289239|NCT00218036|Citalopram|citalopram|mesh-list
138289240|NCT00218036|Escitalopram|escitalopram|mesh-list
138289241|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138289243|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289244|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289245|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289246|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
138289247|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289248|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138289249|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
138289250|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289251|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138289252|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138289253|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
138289254|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
138289255|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289256|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138289257|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138289258|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
138289259|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138289260|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138289261|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289262|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289263|NCT00233090|Modafinil|modafinil|mesh-list
138289264|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138289265|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289266|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138289267|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289268|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289269|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289270|NCT02921906|Acetaminophen|acetaminophen|mesh-list
138289274|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289275|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289277|NCT00000812|Thalidomide|thalidomide|mesh-list
138289278|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289279|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
138289280|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289281|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
138289282|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289283|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289284|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138289285|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138289286|NCT00000812|Growth Substances|growth substances|mesh-ancestor
138289287|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
138289288|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289289|NCT00000818|Zidovudine|zidovudine|mesh-list
138289290|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
138289291|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289292|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289293|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289294|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289295|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
138289296|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289297|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289298|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289299|NCT00177866|Celecoxib|celecoxib|mesh-list
138289300|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138289301|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289302|NCT00177866|Analgesics|analgesics|mesh-ancestor
138289303|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
138289304|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289305|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289306|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138289307|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289308|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138289309|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138289310|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289311|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289312|NCT00089414|Drospirenone|drospirenone|mesh-list
138289313|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138344962|NCT01843920|Trimethoprim|trimethoprim|mesh-list
138289314|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138289315|NCT00089414|Estradiol|estradiol|mesh-list
138289316|NCT00089414|Progesterone|progesterone|mesh-list
138289317|NCT00089414|Estrogens|estrogens|mesh-ancestor
138289318|NCT00089414|Hormones|hormones|mesh-ancestor
138289319|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289320|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289321|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138289322|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
138289323|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138289324|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138289326|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138289327|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138289328|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138289329|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289330|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138289331|NCT00089414|Diuretics|diuretics|mesh-ancestor
138289332|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
138289333|NCT00075608|Melphalan|melphalan|mesh-list
138289334|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
138289335|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289336|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138289337|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
138289338|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289339|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289340|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138289341|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289342|NCT03704467|Carboplatin|carboplatin|mesh-list
138289343|NCT03704467|Avelumab|avelumab|mesh-list
138289344|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289345|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138289347|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289348|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289350|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138289351|NCT00000848|Indinavir|indinavir|mesh-list
138289352|NCT00000848|Saquinavir|saquinavir|mesh-list
138289353|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289354|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289355|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289357|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289358|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289359|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289360|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
138289361|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289362|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289363|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289364|NCT01795586|Carboplatin|carboplatin|mesh-list
138289365|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289367|NCT02212574|Lomustine|lomustine|mesh-list
138289368|NCT02212574|Vincristine|vincristine|mesh-list
138289369|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289370|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
138289371|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289372|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289373|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138289374|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
138289375|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289376|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289377|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138289378|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138289379|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
138289380|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
138289381|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
138289382|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138289384|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138289385|NCT00000854|Androgens|androgens|mesh-ancestor
138289386|NCT00000854|Hormones|hormones|mesh-ancestor
138289387|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289388|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289389|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
138289390|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138289391|NCT04298918|Trastuzumab|trastuzumab|mesh-list
138289392|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138289393|NCT04298918|Venetoclax|venetoclax|mesh-list
138289394|NCT04298918|Maytansine|maytansine|mesh-list
138289495|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289496|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
138289497|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289498|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289499|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289500|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
138289501|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
138289502|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289503|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289504|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289505|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289506|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289507|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289508|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289509|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138289510|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138289511|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138289512|NCT00000896|Growth Substances|growth substances|mesh-ancestor
138289513|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138289515|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
138289516|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289517|NCT00000902|Ritonavir|ritonavir|mesh-list
138289518|NCT00000902|Nelfinavir|nelfinavir|mesh-list
138289519|NCT00000902|Lamivudine|lamivudine|mesh-list
138289520|NCT00000902|Zidovudine|zidovudine|mesh-list
138289521|NCT00000902|Nevirapine|nevirapine|mesh-list
138289522|NCT00000902|Didanosine|didanosine|mesh-list
138289523|NCT00000902|Stavudine|stavudine|mesh-list
138289524|NCT00000902|Zalcitabine|zalcitabine|mesh-list
138289525|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289526|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289527|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289528|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289529|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289530|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289531|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289532|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
138289533|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289534|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289536|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289537|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289538|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
138289539|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289540|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289542|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138289543|NCT04331600|Amebicides|amebicides|mesh-ancestor
138289544|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289545|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138289546|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289547|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
138289548|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289550|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289551|NCT04331600|Analgesics|analgesics|mesh-ancestor
138289552|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
138289553|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289554|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289555|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138289556|NCT04331600|Filaricides|filaricides|mesh-ancestor
138289557|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
138289558|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
138289559|NCT00000188|Selegiline|selegiline|mesh-list
138289560|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
138289561|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289562|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138289563|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138289564|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138289565|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289566|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289567|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138289568|NCT00000188|Protective Agents|protective agents|mesh-ancestor
138289569|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289570|NCT00000914|Ritonavir|ritonavir|mesh-list
138289571|NCT00000914|Nelfinavir|nelfinavir|mesh-list
138289572|NCT00000914|Indinavir|indinavir|mesh-list
138289573|NCT00000914|Efavirenz|efavirenz|mesh-list
138289574|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289575|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289576|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289578|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289579|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138289580|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289581|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
138289582|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289584|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289585|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289586|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289587|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138289588|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138289589|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138289590|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138289591|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289593|NCT00000920|Saquinavir|saquinavir|mesh-list
138289594|NCT00000920|Lamivudine|lamivudine|mesh-list
138289595|NCT00000920|Zidovudine|zidovudine|mesh-list
138289596|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138289597|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138289598|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289599|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289600|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289602|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138289603|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
138289604|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289605|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289606|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138289607|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138289608|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289609|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
138289610|NCT00000938|Doxycycline|doxycycline|mesh-list
138289611|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
138289612|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289613|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289614|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
138289615|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138289617|NCT00001862|Etanercept|etanercept|mesh-list
138289618|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138289619|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138289620|NCT00001862|Analgesics|analgesics|mesh-ancestor
138289621|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
138289622|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289623|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289624|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138289625|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289626|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138289627|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289628|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
138289630|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138289631|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289632|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138289633|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
138289634|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289635|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
138289636|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289637|NCT00000200|Methadone|methadone|mesh-list
138289638|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289639|NCT00000200|Narcotics|narcotics|mesh-ancestor
138289640|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289641|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289642|NCT00000200|Analgesics|analgesics|mesh-ancestor
138289643|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
138289644|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289645|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
138289646|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138289647|NCT00000206|Buprenorphine|buprenorphine|mesh-list
138289648|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138289649|NCT00000206|Narcotics|narcotics|mesh-ancestor
138289650|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289651|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289652|NCT00000206|Analgesics|analgesics|mesh-ancestor
138289653|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
138289654|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289655|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138289656|NCT00000944|Lamivudine|lamivudine|mesh-list
138289657|NCT00000944|Zidovudine|zidovudine|mesh-list
138289884|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289885|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
138289886|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289887|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
138289888|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138289890|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
138289891|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289895|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289896|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138289897|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
138289898|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138289899|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289900|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138289901|NCT03907033|Bupivacaine|bupivacaine|mesh-list
138289902|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
138289903|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
138289904|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289905|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289906|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
138289907|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289908|NCT00001034|Ganciclovir|ganciclovir|mesh-list
138289909|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138289910|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
138289911|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289912|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289913|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289914|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289915|NCT03818815|Amoxicillin|amoxicillin|mesh-list
138289916|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
138289917|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
138289918|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138289919|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138289920|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138289921|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138289922|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289923|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289925|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289926|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
138289927|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289928|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289929|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138289930|NCT00001964|Cyclosporine|cyclosporine|mesh-list
138289931|NCT00001964|Cyclosporins|cyclosporins|mesh-list
138289932|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289933|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289934|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138289935|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
138289939|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
138289940|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138289941|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138289942|NCT03801265|Ropivacaine|ropivacaine|mesh-list
138289943|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
138289944|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
138289945|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289946|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289947|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
138289948|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289949|NCT00000290|Cocaine|cocaine|mesh-list
138289950|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138289951|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
138289952|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138289953|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138289954|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
138289955|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138289957|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138289958|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138289959|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289960|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289961|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
138289962|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289964|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138289965|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
138290115|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290116|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
138290117|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138290118|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138290119|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290120|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290121|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
138290122|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138290123|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290124|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290125|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138290126|NCT03799783|Analgesics|analgesics|mesh-ancestor
138290127|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
138290128|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290129|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138290130|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138290131|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138290132|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290133|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290134|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290137|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
138290139|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290140|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
138290141|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290143|NCT00001094|Zidovudine|zidovudine|mesh-list
138290144|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138290145|NCT00001094|Delavirdine|delavirdine|mesh-list
138290146|NCT00001094|Nelfinavir|nelfinavir|mesh-list
138290147|NCT00001094|Saquinavir|saquinavir|mesh-list
138290148|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290149|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290150|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290151|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290152|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
138290153|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290154|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290155|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290156|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
138290157|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138290158|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138290159|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138290160|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138290161|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290162|NCT00001100|Ganciclovir|ganciclovir|mesh-list
138290163|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290164|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
138290165|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290166|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290167|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290168|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290169|NCT00000332|Nimodipine|nimodipine|mesh-list
138290170|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138290171|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138290172|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290173|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290174|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138290175|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290176|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290177|NCT00000338|Lisuride|lisuride|mesh-list
138290178|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138290179|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138290180|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138290181|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
138290182|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290183|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290184|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290186|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
138290187|NCT04085341|Sunitinib|sunitinib|mesh-list
138290188|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290189|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138290190|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138290471|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138290472|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290473|NCT00002108|Lamivudine|lamivudine|mesh-list
138290474|NCT00002108|Zidovudine|zidovudine|mesh-list
138290475|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290476|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290477|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290478|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290481|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290482|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290483|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
138290485|NCT00381134|Spironolactone|spironolactone|mesh-list
138290486|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138290487|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138290488|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138290489|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138290490|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290491|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138290492|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
138290493|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290494|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290495|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138290496|NCT00381134|Diuretics|diuretics|mesh-ancestor
138290497|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
138290498|NCT00000506|Phentermine|phentermine|mesh-list
138290499|NCT00000506|Fenfluramine|fenfluramine|mesh-list
138290500|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138290501|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290502|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
138290503|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138290504|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
138290505|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
138290506|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290507|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290508|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290509|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290510|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138290511|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290512|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290513|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
138290515|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
138290516|NCT00000512|Lovastatin|lovastatin|mesh-list
138290517|NCT00000512|L 647318|l 647318|mesh-list
138290518|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
138290519|NCT00000512|Colestipol|colestipol|mesh-list
138290520|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138290521|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
138290522|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290523|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138290524|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290525|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
138290526|NCT00000512|Vitamins|vitamins|mesh-ancestor
138290527|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
138290528|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290529|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138290530|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138290531|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290532|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
138290534|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290535|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290536|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138290537|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290538|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138290539|NCT00000542|Amlodipine|amlodipine|mesh-list
138290540|NCT00000542|Lisinopril|lisinopril|mesh-list
138290541|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
138290542|NCT00000542|Doxazosin|doxazosin|mesh-list
138290543|NCT00000542|Pravastatin|pravastatin|mesh-list
138290544|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138290545|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138290546|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138290548|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290549|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138290550|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290592|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138290593|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290594|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
138290595|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290596|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
138290597|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138290598|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
138290599|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290600|NCT00002126|Lenograstim|lenograstim|mesh-list
138290601|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138290602|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
138290603|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290604|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138290605|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138290606|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290608|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138290609|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290610|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138290611|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290612|NCT00002132|Itraconazole|itraconazole|mesh-list
138290613|NCT00002132|Fluconazole|fluconazole|mesh-list
138290616|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138290617|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290618|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290619|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290620|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138290621|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
138290622|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290623|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290624|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138290625|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138290626|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138290628|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138290629|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
138290630|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290631|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290632|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290633|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290634|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290635|NCT00000578|Beclomethasone|beclomethasone|mesh-list
138290636|NCT00000578|Theophylline|theophylline|mesh-list
138290637|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138290638|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
138290639|NCT00000578|Hormones|hormones|mesh-ancestor
138290640|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290641|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290642|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138290643|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138290644|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138290645|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
138290646|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290647|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138290648|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290649|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290650|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290651|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138290652|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138290655|NCT03774745|Mifepristone|mifepristone|mesh-list
138290656|NCT03774745|Progesterone|progesterone|mesh-list
138290657|NCT03774745|Progestins|progestins|mesh-ancestor
138290658|NCT03774745|Hormones|hormones|mesh-ancestor
138290659|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290660|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290661|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138290662|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
138290663|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138290664|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138290665|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138290666|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138290667|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
138290668|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138290669|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138290670|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
138290671|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
138290672|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138290673|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138290674|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
138290675|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138290677|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
138290679|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
138290680|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138290682|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
138290683|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290684|NCT00000614|Warfarin|warfarin|mesh-list
138290685|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
138290686|NCT02973464|Valganciclovir|valganciclovir|mesh-list
138290687|NCT02973464|Ganciclovir|ganciclovir|mesh-list
138290688|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290689|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
138290690|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290691|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290692|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290693|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290694|NCT00000626|Doxorubicin|doxorubicin|mesh-list
138290695|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138290696|NCT00000626|Bleomycin|bleomycin|mesh-list
138290697|NCT00000626|Dacarbazine|dacarbazine|mesh-list
138290699|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138290700|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290701|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138290702|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138290703|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290704|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290705|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138290706|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
138290707|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138290708|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138290709|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138290710|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138290712|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138290713|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290714|NCT04713254|Metoprolol|metoprolol|mesh-list
138290715|NCT04713254|Midazolam|midazolam|mesh-list
138290716|NCT04713254|Bupropion|bupropion|mesh-list
138290717|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138290718|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138290719|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290720|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290721|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138290722|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138290723|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138290724|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138290725|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
138290726|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
138290727|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
138290729|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290730|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290731|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138290732|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
138290733|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138290734|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290735|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290736|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
138290737|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138290738|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290739|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290740|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138290741|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138290742|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
138290744|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290745|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138290746|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138290747|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138290748|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290751|NCT00002156|Fomivirsen|fomivirsen|mesh-list
138290752|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
138290753|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290754|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290755|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290756|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290757|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138290758|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138290760|NCT00002162|Zidovudine|zidovudine|mesh-list
138290761|NCT00002162|Didanosine|didanosine|mesh-list
138290762|NCT00002162|Stavudine|stavudine|mesh-list
138290763|NCT00002162|Zalcitabine|zalcitabine|mesh-list
138290764|NCT00002162|Saquinavir|saquinavir|mesh-list
138290765|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290766|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290767|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290769|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
138290770|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290771|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290772|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290773|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
138290774|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138290775|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138290776|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
138290777|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138290778|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290779|NCT00000638|Pyridoxine|pyridoxine|mesh-list
138290780|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
138290781|NCT00000638|Rifampin|rifampin|mesh-list
138290782|NCT00000638|Isoniazid|isoniazid|mesh-list
138290783|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
138290784|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138290785|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
138290786|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290787|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290788|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
138290789|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290790|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290791|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290792|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138290793|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138290794|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138290795|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138290796|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138290797|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138290798|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138290799|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138290800|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
138290801|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138290802|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
138290803|NCT00000638|Vitamins|vitamins|mesh-ancestor
138290804|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
138290805|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290808|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
138290809|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290810|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
138290811|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290812|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
138290813|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
138290814|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290816|NCT00000656|Didanosine|didanosine|mesh-list
138290817|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
138290818|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290819|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290820|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290821|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290822|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
138290823|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290824|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290825|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290826|NCT00000662|Zidovudine|zidovudine|mesh-list
138290827|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
138290828|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290829|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290830|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290831|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290832|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
138290833|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290834|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290850|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138290851|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138290852|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
138290853|NCT00001442|Paclitaxel|paclitaxel|mesh-list
138290854|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138290855|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290856|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
138290857|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138290858|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
138290859|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290860|NCT00002174|Thalidomide|thalidomide|mesh-list
138290861|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138290862|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
138290863|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290864|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
138290865|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290866|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290867|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138290869|NCT00002174|Growth Substances|growth substances|mesh-ancestor
138290871|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290872|NCT00000668|Ganciclovir|ganciclovir|mesh-list
138290873|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290874|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
138290875|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290876|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290877|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290878|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290879|NCT00000680|Zidovudine|zidovudine|mesh-list
138290880|NCT00000680|Aldesleukin|aldesleukin|mesh-list
138290881|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
138290883|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290884|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290885|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290886|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
138290887|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290888|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290889|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290890|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290891|NCT00000692|Miglustat|miglustat|mesh-list
138290892|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290896|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
138290897|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290898|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138290899|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138290900|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290901|NCT00000698|Ganciclovir|ganciclovir|mesh-list
138290902|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290903|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
138290904|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290905|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290906|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290907|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290908|NCT03764449|Balovaptan|balovaptan|mesh-list
138290909|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138290910|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290912|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290913|NCT00002180|Tenofovir|tenofovir|mesh-list
138290914|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
138290915|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290916|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290917|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290918|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290919|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290921|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290922|NCT00002186|Acyclovir|acyclovir|mesh-list
138290923|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
138290924|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290925|NCT00001502|Carboplatin|carboplatin|mesh-list
138290926|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290927|NCT00002192|Azithromycin|azithromycin|mesh-list
138290928|NCT00002192|Clarithromycin|clarithromycin|mesh-list
138290929|NCT00002192|Ethambutol|ethambutol|mesh-list
138290930|NCT00002192|Rifapentine|rifapentine|mesh-list
138290931|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290932|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290933|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138290943|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290944|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290945|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290946|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
138290947|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290948|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290949|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290950|NCT00000704|Zalcitabine|zalcitabine|mesh-list
138290951|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
138290952|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290953|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290954|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290955|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290956|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
138290957|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290959|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290960|NCT00000728|Zidovudine|zidovudine|mesh-list
138290961|NCT00000728|Aldesleukin|aldesleukin|mesh-list
138290962|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
138290963|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290964|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290965|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290966|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290967|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
138290968|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290969|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290970|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290971|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290972|NCT00001520|Neostigmine|neostigmine|mesh-list
138290973|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138290974|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290975|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290977|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290978|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290979|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138290980|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
138290981|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290982|NCT00001526|Daclizumab|daclizumab|mesh-list
138290983|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138290984|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
138290985|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290986|NCT00002294|Fluconazole|fluconazole|mesh-list
138290987|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
138290988|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290989|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138290990|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290991|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290992|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290993|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138290994|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
138290995|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290996|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290997|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138290998|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138290999|NCT03758365|Triamcinolone|triamcinolone|mesh-list
138291000|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138291001|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138291002|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
138291003|NCT03758365|Betamethasone|betamethasone|mesh-list
138291004|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
138291005|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138291006|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
138291007|NCT03758365|Clobetasol|clobetasol|mesh-list
138291009|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138291010|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138291011|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138291012|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291013|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
138291014|NCT03758365|Hormones|hormones|mesh-ancestor
138291015|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291016|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291017|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291018|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
138291019|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291020|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291021|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138291022|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
138291023|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
138291025|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
138291026|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138291027|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138291028|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138291029|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
138291030|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138291031|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291032|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138291033|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138291034|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291035|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291036|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
138291037|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138291038|NCT00002306|Fluconazole|fluconazole|mesh-list
138291039|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
138291040|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291041|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138291042|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291043|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291044|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291045|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138291046|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291047|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291048|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291049|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138291050|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138291051|NCT00002210|Delavirdine|delavirdine|mesh-list
138291052|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291053|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291054|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291055|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291056|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
138291057|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291058|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291059|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291060|NCT00002216|Lamivudine|lamivudine|mesh-list
138291061|NCT00002216|Zidovudine|zidovudine|mesh-list
138291062|NCT00002216|Abacavir|abacavir|mesh-list
138291063|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138291064|NCT00002216|Nelfinavir|nelfinavir|mesh-list
138291065|NCT00002216|Amprenavir|amprenavir|mesh-list
138291066|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291067|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291068|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291069|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291070|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
138291071|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291072|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291073|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291074|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
138291075|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138291076|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138291077|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291078|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138291079|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
138291080|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291082|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
138291083|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291084|NCT00002312|Zidovudine|zidovudine|mesh-list
138291086|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
138291087|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291088|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291089|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291090|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291091|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
138291092|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291093|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291094|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291095|NCT00002318|Doxorubicin|doxorubicin|mesh-list
138291110|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138291111|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138291113|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291114|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291115|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
138291116|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291118|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138291119|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
138291120|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291121|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138291122|NCT04714177|Protective Agents|protective agents|mesh-ancestor
138291123|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291124|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
138291125|NCT00001628|Giapreza|giapreza|mesh-list
138291126|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
138291127|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
138291128|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138291129|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138291130|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291131|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291132|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291133|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138291134|NCT00002234|Lamivudine|lamivudine|mesh-list
138291135|NCT00002234|Efavirenz|efavirenz|mesh-list
138291136|NCT00002234|Didanosine|didanosine|mesh-list
138291137|NCT00002234|Adefovir|adefovir|mesh-list
138291138|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138291139|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291140|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291141|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291142|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291144|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291145|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291146|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291147|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138291148|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291149|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138291150|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138291151|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138291152|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138291153|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
138291154|NCT00002324|Zidovudine|zidovudine|mesh-list
138291155|NCT00002324|Nevirapine|nevirapine|mesh-list
138291156|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
138291157|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291158|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291159|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291160|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291161|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
138291162|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291163|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291164|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291165|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138291166|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138291167|NCT00002330|Ganciclovir|ganciclovir|mesh-list
138291168|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138291169|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
138291170|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291171|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291172|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291173|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291177|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
138291179|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291180|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
138291181|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
138291182|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291183|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291184|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291185|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
138291186|NCT03740659|Hormones|hormones|mesh-ancestor
138291187|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291188|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291189|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291190|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291192|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291193|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138291194|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291195|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291197|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291198|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138291199|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291200|NCT00002336|Clarithromycin|clarithromycin|mesh-list
138291201|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291202|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291203|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138291204|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291205|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291206|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291207|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291208|NCT00001646|Voriconazole|voriconazole|mesh-list
138291209|NCT00001646|Amphotericin B|amphotericin b|mesh-list
138291210|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138291211|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
138291212|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291213|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138291214|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291215|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291216|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291217|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138291218|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291219|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291221|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291223|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138291224|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138291225|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291226|NCT00001658|Amoxicillin|amoxicillin|mesh-list
138291227|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291228|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291229|NCT00002252|Octreotide|octreotide|mesh-list
138291230|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291231|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291232|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291233|NCT00002348|Mitoguazone|mitoguazone|mesh-list
138291234|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291235|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291236|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291237|NCT02721277|SMOFlipid|smoflipid|mesh-list
138291238|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138291239|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138291240|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138291241|NCT00378235|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138291242|NCT00378235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291243|NCT00002270|Interferons|interferons|mesh-list
138291244|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
138291245|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
138291246|NCT00002270|Zidovudine|zidovudine|mesh-list
138291247|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291248|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
138291250|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
138291251|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291252|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
138291253|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291254|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291255|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291256|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291257|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291258|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291260|NCT00002354|Indinavir|indinavir|mesh-list
138291261|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
138291262|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291263|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291264|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291265|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291266|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
138291267|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291268|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291269|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291270|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138291271|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138291272|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291273|NCT00002360|Didanosine|didanosine|mesh-list
138291274|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
138291275|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291276|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291277|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291278|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291279|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
138291280|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291281|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291282|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291283|NCT00002276|Zidovudine|zidovudine|mesh-list
138291284|NCT00002276|Ibuprofen|ibuprofen|mesh-list
138291285|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138291286|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138291287|NCT00002276|Analgesics|analgesics|mesh-ancestor
138291288|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
138291289|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291290|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291291|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291292|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291293|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138291294|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291295|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291296|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
138291297|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291298|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291299|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
138291300|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291301|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291302|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291303|NCT00378547|Acetaminophen|acetaminophen|mesh-list
138291304|NCT00378547|Dexamethasone|dexamethasone|mesh-list
138291305|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
138291306|NCT00378547|Pregabalin|pregabalin|mesh-list
138291307|NCT00378547|BB 1101|bb 1101|mesh-list
138291308|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291309|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
138291311|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291312|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291313|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291314|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
138291315|NCT00378547|Hormones|hormones|mesh-ancestor
138291316|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291317|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291318|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291319|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291320|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291321|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291324|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
138291325|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
138291326|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
138291327|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138291328|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138291329|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138291330|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138291331|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138291332|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138291333|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138291334|NCT00002282|Fluconazole|fluconazole|mesh-list
138291335|NCT00002282|Clotrimazole|clotrimazole|mesh-list
138291336|NCT00002282|Miconazole|miconazole|mesh-list
138291337|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
138291338|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291339|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138291340|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291341|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291342|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291343|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138291344|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291345|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291346|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291347|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138291348|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138291349|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138291350|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291351|NCT02658877|Omalizumab|omalizumab|mesh-list
138291352|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138291353|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138291354|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
138291356|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
138291357|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291358|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291359|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291360|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291361|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
138291362|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291363|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291364|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291365|NCT00002366|Ritonavir|ritonavir|mesh-list
138291366|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138291367|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138291368|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291369|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291370|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291371|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291372|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291373|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
138291374|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291375|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291376|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291377|NCT00378313|Paclitaxel|paclitaxel|mesh-list
138291378|NCT00378313|Gemcitabine|gemcitabine|mesh-list
138291379|NCT00378313|Epirubicin|epirubicin|mesh-list
138291380|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291381|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291382|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
138291384|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
138291385|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291386|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291387|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
138291388|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291389|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291390|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291391|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291394|NCT00002372|Saquinavir|saquinavir|mesh-list
138291395|NCT00002372|Amprenavir|amprenavir|mesh-list
138291396|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138291397|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138291398|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291399|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291400|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291401|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291402|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291403|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
138291404|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291405|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291406|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291407|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138291408|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
138291409|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291412|NCT00002378|Saquinavir|saquinavir|mesh-list
138291413|NCT00002378|Lamivudine|lamivudine|mesh-list
138291414|NCT00002378|Zidovudine|zidovudine|mesh-list
138291415|NCT00002378|Stavudine|stavudine|mesh-list
138291416|NCT00002378|Delavirdine|delavirdine|mesh-list
138291417|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138291418|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138291419|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138291420|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291421|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291422|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291423|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291424|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
138291425|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291426|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291427|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291428|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291429|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291430|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
138291431|NCT02589145|Pyridoxine|pyridoxine|mesh-list
138291432|NCT02589145|Dexamethasone|dexamethasone|mesh-list
138291433|NCT02589145|Rituximab|rituximab|mesh-list
138291434|NCT02589145|Gemcitabine|gemcitabine|mesh-list
138291435|NCT02589145|Lenalidomide|lenalidomide|mesh-list
138291436|NCT02589145|Melphalan|melphalan|mesh-list
138291437|NCT02589145|Busulfan|busulfan|mesh-list
138291438|NCT02589145|Vorinostat|vorinostat|mesh-list
138291439|NCT02589145|Enoxaparin|enoxaparin|mesh-list
138291440|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291441|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
138291442|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
138291443|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291444|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291445|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291447|NCT02589145|Hormones|hormones|mesh-ancestor
138291448|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291449|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291450|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291451|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138291452|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
138291453|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291454|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291455|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
138291456|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291457|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138291458|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138291459|NCT02589145|Growth Substances|growth substances|mesh-ancestor
138291460|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
138291461|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291462|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
138291463|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291465|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
138291466|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138291467|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138291468|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138291469|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291470|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
138291471|NCT02589145|Vitamins|vitamins|mesh-ancestor
138291472|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
138291473|NCT00002384|Cidofovir|cidofovir|mesh-list
138291474|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
138291475|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291476|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291477|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291478|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
138291479|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
138291480|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
138291482|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138291483|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
138291484|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
138291485|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138291486|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291487|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291488|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138291489|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
138291490|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138291491|NCT00002390|Abacavir|abacavir|mesh-list
138291492|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291493|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291494|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291495|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291496|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
138291497|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291498|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291499|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291501|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
138291502|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291503|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291504|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291505|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291506|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291507|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291508|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291509|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138291510|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138291511|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
138291512|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291513|NCT00002402|Antacids|antacids|mesh-ancestor
138291514|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291515|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291516|NCT00002420|Didanosine|didanosine|mesh-list
138291517|NCT00002420|Stavudine|stavudine|mesh-list
138291518|NCT00002420|Delavirdine|delavirdine|mesh-list
138291519|NCT00002420|Emivirine|emivirine|mesh-list
138291520|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
138291521|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291522|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
138291523|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291524|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291525|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291527|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291528|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
138291533|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138291534|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291535|NCT04024501|Verinurad|verinurad|mesh-list
138291536|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
138291537|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291539|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138291540|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138291541|NCT05709626|Analgesics|analgesics|mesh-ancestor
138291542|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
138291543|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291544|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291545|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291546|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291547|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138291548|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138291549|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291550|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138291551|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138291552|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291553|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
138291554|NCT03538015|Carvedilol|carvedilol|mesh-list
138291555|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138291556|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138291557|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
138291558|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138291559|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291560|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291561|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138291562|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
138291563|NCT03538015|Protective Agents|protective agents|mesh-ancestor
138291564|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138291565|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138291577|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138291578|NCT04331210|Analgesics|analgesics|mesh-ancestor
138291579|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
138291580|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291581|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291582|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291583|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291584|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138291585|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291586|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291587|NCT00002426|Adefovir|adefovir|mesh-list
138291589|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
138291590|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291591|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291592|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291593|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291594|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291595|NCT00002432|Foscarnet|foscarnet|mesh-list
138291596|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138291597|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
138291598|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291599|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291600|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291601|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344963|NCT01843920|Polymyxins|polymyxins|mesh-list
138291613|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291614|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
138291616|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291617|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
138291618|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291619|NCT05701436|Antidotes|antidotes|mesh-ancestor
138291620|NCT05701436|Protective Agents|protective agents|mesh-ancestor
138291621|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
138291622|NCT05701436|Vitamins|vitamins|mesh-ancestor
138291623|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
138291624|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138291625|NCT02487277|Paclitaxel|paclitaxel|mesh-list
138291626|NCT02487277|Gemcitabine|gemcitabine|mesh-list
138291627|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291628|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291629|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138291630|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138291631|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138291632|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291633|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291634|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
138291635|NCT00002438|Itraconazole|itraconazole|mesh-list
138291636|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
138291637|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291638|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138291639|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291640|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291641|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291642|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138291643|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291644|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291645|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291646|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138291647|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
138291653|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
138291654|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
138291655|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291656|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291657|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291658|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
138291660|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291661|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291662|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291663|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
138291664|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
138291665|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138291666|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
138291667|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
138291668|NCT05751746|Analgesics|analgesics|mesh-ancestor
138291669|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
138291670|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291671|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291672|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
138291673|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138291674|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138291675|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
138291676|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138291677|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138291678|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291679|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138291680|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
138291681|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138291682|NCT00002450|Tenofovir|tenofovir|mesh-list
138291683|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
138291684|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291685|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138291686|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291687|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291688|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291689|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138291690|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138291691|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
138291692|NCT03277183|Hematinics|hematinics|mesh-ancestor
138291693|NCT00002456|Cyclosporine|cyclosporine|mesh-list
138291710|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291711|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
138291712|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291713|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138291715|NCT01525927|Carboplatin|carboplatin|mesh-list
138291716|NCT01525927|Etoposide|etoposide|mesh-list
138291717|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291718|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291719|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291720|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291721|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291722|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291724|NCT00002474|Carboplatin|carboplatin|mesh-list
138291725|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
138291726|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291727|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
138291728|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291729|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291730|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291731|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
138291732|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291733|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291734|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291735|NCT00002474|Analgesics|analgesics|mesh-ancestor
138291736|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
138291737|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291738|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291739|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291740|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291741|NCT00002492|Doxorubicin|doxorubicin|mesh-list
138291742|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138291747|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291748|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291749|NCT05751512|Methotrexate|methotrexate|mesh-list
138291750|NCT05751512|Cetuximab|cetuximab|mesh-list
138291751|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138291752|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
138291754|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291755|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291756|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
138291757|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291758|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291759|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138291760|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291761|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138291762|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291763|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
138291764|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291765|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138291766|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138291767|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138291768|NCT02373865|Glimepiride|glimepiride|mesh-list
138291770|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291771|NCT02373865|Incretins|incretins|mesh-ancestor
138291772|NCT02373865|Hormones|hormones|mesh-ancestor
138291777|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291778|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138291779|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291780|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
138291781|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
138291782|NCT00002498|Fluorouracil|fluorouracil|mesh-list
138291783|NCT00002498|Methotrexate|methotrexate|mesh-list
138291784|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
138291785|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291786|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
138291787|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291789|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291791|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291792|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291793|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291795|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291796|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138291797|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
138291798|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138291880|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291881|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
138291882|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291883|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291884|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291885|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138291886|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138291887|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138291888|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291889|NCT00002528|Tamoxifen|tamoxifen|mesh-list
138291890|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138291891|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291892|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138291893|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291894|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291895|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291896|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138291897|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138291898|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138291915|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
138291917|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
138291918|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
138291919|NCT00002534|Thiotepa|thiotepa|mesh-list
138291920|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138291921|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138291922|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
138291923|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291924|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138291925|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291926|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
138291927|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291928|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291929|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138291930|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138291931|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
138291932|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
138291933|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291934|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138291935|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
138291936|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
138291937|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138291938|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291939|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
138291940|NCT00002534|Hormones|hormones|mesh-ancestor
138291946|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138291947|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
138291948|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138291950|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
138291951|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138291952|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138291953|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138291954|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291955|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
138291956|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
138291957|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138291958|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
138291959|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138291960|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
138291961|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
138291962|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
138291963|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138291964|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291965|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138291966|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138291967|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138291968|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138291969|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138291970|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138291971|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291972|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291975|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
138291976|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138291977|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138291978|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138292001|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292002|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292003|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292004|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292005|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292006|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
138292007|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292009|NCT00002552|Protective Agents|protective agents|mesh-ancestor
138292010|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292012|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
138292013|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292014|NCT00378781|Minocycline|minocycline|mesh-list
138292015|NCT00378781|Heparin|heparin|mesh-list
138292016|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
138292017|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138292018|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138292019|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292020|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138292021|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292022|NCT00377923|Progesterone|progesterone|mesh-list
138292023|NCT00377923|Progestins|progestins|mesh-ancestor
138292024|NCT00377923|Hormones|hormones|mesh-ancestor
138292025|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292026|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292027|NCT00002570|Leucovorin|leucovorin|mesh-list
138292034|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292035|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292036|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292037|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292038|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
138292039|NCT00002570|Antidotes|antidotes|mesh-ancestor
138292040|NCT00002570|Protective Agents|protective agents|mesh-ancestor
138292041|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292042|NCT00002570|Vitamins|vitamins|mesh-ancestor
138292043|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
138292044|NCT00002576|Prednisolone|prednisolone|mesh-list
138292045|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
138292046|NCT00002576|Doxorubicin|doxorubicin|mesh-list
138292047|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292049|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
138292050|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292051|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
138292052|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292053|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292054|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292055|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
138292056|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292057|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292058|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292059|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292060|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292061|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292062|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292067|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292068|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
138292070|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292071|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292072|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292073|NCT00002576|Analgesics|analgesics|mesh-ancestor
138292074|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
138292075|NCT00002582|Tamoxifen|tamoxifen|mesh-list
138292076|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
138292077|NCT00002582|Doxorubicin|doxorubicin|mesh-list
138292078|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292079|NCT00002582|Fluorouracil|fluorouracil|mesh-list
138292080|NCT00002582|Methotrexate|methotrexate|mesh-list
138292081|NCT00002582|Leuprolide|leuprolide|mesh-list
138292082|NCT00002582|Goserelin|goserelin|mesh-list
138292083|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292084|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
138292085|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292086|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292087|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292088|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
138292089|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292090|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292091|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292092|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292093|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292094|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292095|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292096|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
138292097|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292098|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138292099|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292100|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292101|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292102|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292103|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292104|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138292105|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
138292106|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292107|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292108|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138292109|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138292110|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138292111|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138292112|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
138292113|NCT00002588|Etoposide|etoposide|mesh-list
138292114|NCT00002588|Topotecan|topotecan|mesh-list
138292115|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292116|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292117|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292118|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292119|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292120|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292133|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138292134|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292135|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292136|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
138292137|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138292138|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292139|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
138292140|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
138292141|NCT00002594|Melphalan|melphalan|mesh-list
138292142|NCT00002594|Molgramostim|molgramostim|mesh-list
138292143|NCT00002594|Sargramostim|sargramostim|mesh-list
138292144|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292145|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
138292146|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292147|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292148|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292150|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292151|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292153|NCT02234011|Ketamine|ketamine|mesh-list
138292154|NCT02234011|Analgesics|analgesics|mesh-ancestor
138292155|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
138292156|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292157|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292159|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138292160|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
138292161|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
138292162|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138292163|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138292164|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138292165|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292166|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292167|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
138292168|NCT00002600|Carboplatin|carboplatin|mesh-list
138292169|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292170|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
138292171|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292177|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292178|NCT02177773|Octreotide|octreotide|mesh-list
138292179|NCT02177773|Edotreotide|edotreotide|mesh-list
138292180|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292181|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292182|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292183|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138292184|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292185|NCT02144155|Oxytocin|oxytocin|mesh-list
138292200|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292201|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292202|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292203|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292204|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292205|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292206|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292207|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
138292208|NCT00002618|Hormones|hormones|mesh-ancestor
138292209|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292210|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292211|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138292212|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292213|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292214|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292215|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
138292216|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292217|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292225|NCT00002618|Protective Agents|protective agents|mesh-ancestor
138292226|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292229|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292230|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292231|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292232|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292233|NCT00002618|Trace Elements|trace elements|mesh-ancestor
138292234|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
138292235|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138292236|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
138292237|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
138292238|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138292248|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
138292249|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292251|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292252|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
138292253|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292254|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292255|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292257|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
138292258|NCT00002642|Cobalt|cobalt|mesh-list
138292259|NCT00002642|Etoposide|etoposide|mesh-list
138292260|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292261|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292262|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292263|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292264|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292265|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292266|NCT00002642|Trace Elements|trace elements|mesh-ancestor
138292267|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
138292268|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292269|NCT03983941|Ropivacaine|ropivacaine|mesh-list
138292270|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
138292271|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
138292272|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138292273|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292274|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
138292275|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292276|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138292277|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138292278|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
138292279|NCT00002654|Cobalt|cobalt|mesh-list
138292280|NCT00002654|Trace Elements|trace elements|mesh-ancestor
138292281|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
138292282|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292283|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
138292284|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138292285|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292286|NCT01434745|Simvastatin|simvastatin|mesh-list
138292287|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138292289|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
138292290|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292291|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138292292|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138292299|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344964|NCT01843920|Polymyxin B|polymyxin b|mesh-list
138292300|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292301|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
138292302|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292303|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138292304|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138292305|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138292306|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292307|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292308|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138292309|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138292310|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
138292311|NCT00381758|Methylphenidate|methylphenidate|mesh-list
138292312|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138292313|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292314|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138292315|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138292316|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292317|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292318|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
138292319|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292321|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138292322|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292323|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138292324|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138292325|NCT01402531|Growth Substances|growth substances|mesh-ancestor
138292326|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292327|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
138292328|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
138292329|NCT00381836|Hematinics|hematinics|mesh-ancestor
138292330|NCT01971853|Analgesics|analgesics|mesh-list
138292331|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
138292332|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292333|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292334|NCT00002678|Dexamethasone|dexamethasone|mesh-list
138292335|NCT00002678|Prednisone|prednisone|mesh-list
138292336|NCT00002678|Melphalan|melphalan|mesh-list
138292337|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292338|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
138292339|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
138292340|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292341|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292348|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292349|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
138292350|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292351|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292352|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292353|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
138292354|NCT01397695|Bevacizumab|bevacizumab|mesh-list
138292355|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138292356|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292357|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138292358|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138292359|NCT01397695|Growth Substances|growth substances|mesh-ancestor
138292360|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292361|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
138292362|NCT00002684|Paclitaxel|paclitaxel|mesh-list
138292363|NCT00002684|Ifosfamide|ifosfamide|mesh-list
138292364|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292365|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292366|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292367|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292368|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292369|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292370|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292371|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
138292372|NCT02972918|Simendan|simendan|mesh-list
138292373|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138292374|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
138292375|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138292376|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138292377|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292378|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292379|NCT02972918|Protective Agents|protective agents|mesh-ancestor
138292384|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292385|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292386|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
138292387|NCT00002696|Doxorubicin|doxorubicin|mesh-list
138292388|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292389|NCT00002696|Fluorouracil|fluorouracil|mesh-list
138292390|NCT00002696|Methotrexate|methotrexate|mesh-list
138292391|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292392|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
138292393|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292394|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292395|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292396|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
138292397|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292398|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292400|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292401|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292403|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292404|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
138292405|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292406|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138292407|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292408|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292409|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292410|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292411|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292412|NCT00002702|Aldesleukin|aldesleukin|mesh-list
138292413|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292414|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138292415|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138292416|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
138292417|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292418|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
138292419|NCT01890577|Hematinics|hematinics|mesh-ancestor
138292421|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138292422|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292423|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292424|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
138292433|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292434|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
138292435|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
138292436|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292437|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292438|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292439|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
138292441|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292442|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292443|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292444|NCT00002714|Prednisone|prednisone|mesh-list
138292445|NCT00002714|Doxorubicin|doxorubicin|mesh-list
138292446|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292447|NCT00002714|Bleomycin|bleomycin|mesh-list
138292448|NCT00002714|Etoposide|etoposide|mesh-list
138292449|NCT00002714|Vincristine|vincristine|mesh-list
138292450|NCT00002714|Vinblastine|vinblastine|mesh-list
138292451|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
138292452|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292453|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292454|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292455|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292456|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292457|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292458|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292459|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
138292460|NCT00002714|Hormones|hormones|mesh-ancestor
138292461|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292462|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292463|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292464|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292465|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292466|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292467|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292468|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
138292469|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292470|NCT00002720|Tamoxifen|tamoxifen|mesh-list
138292471|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138292473|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292474|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292475|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292479|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138292481|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138292482|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138292483|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292484|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138292485|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138292486|NCT01821859|Growth Substances|growth substances|mesh-ancestor
138292487|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292488|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
138292489|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138292491|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292492|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138292493|NCT01194427|Tamoxifen|tamoxifen|mesh-list
138292494|NCT01194427|Vorinostat|vorinostat|mesh-list
138292495|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138292496|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
138292497|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292498|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292499|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292500|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292501|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138292502|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138292504|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138292505|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292506|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292507|NCT05599555|Vaccines|vaccines|mesh-list
138292508|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
138292509|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292510|NCT00002738|Leucovorin|leucovorin|mesh-list
138292511|NCT00002738|Trimetrexate|trimetrexate|mesh-list
138292512|NCT00002738|Calcium|calcium|mesh-list
138292513|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
138292514|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138292515|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292516|NCT00002738|Antidotes|antidotes|mesh-ancestor
138292517|NCT00002738|Protective Agents|protective agents|mesh-ancestor
138292518|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138292519|NCT00002738|Vitamins|vitamins|mesh-ancestor
138292520|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
138292521|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
138292522|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292523|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292524|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
138292525|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292526|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292527|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292528|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292529|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
138292530|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138292531|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
138292537|NCT00002744|Dexamethasone|dexamethasone|mesh-list
138292538|NCT00002744|Prednisone|prednisone|mesh-list
138292539|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
138292540|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138292541|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138292542|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138292543|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
138292544|NCT00002744|Doxorubicin|doxorubicin|mesh-list
138292545|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138292546|NCT00002744|Methotrexate|methotrexate|mesh-list
138292547|NCT00002744|Vincristine|vincristine|mesh-list
138292548|NCT00002744|Daunorubicin|daunorubicin|mesh-list
138292549|NCT00002744|Asparaginase|asparaginase|mesh-list
138292550|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
138292551|NCT00002744|Pegaspargase|pegaspargase|mesh-list
138292552|NCT00002744|Thioguanine|thioguanine|mesh-list
138292553|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292554|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
138292555|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292556|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292557|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292558|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
138292559|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292560|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292561|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292562|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292563|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
138292564|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
138292565|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292566|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292567|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
138292568|NCT00002744|Hormones|hormones|mesh-ancestor
138292569|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292570|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292571|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292576|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292580|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292581|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292582|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292584|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292585|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292586|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292587|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292588|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292589|NCT00002744|Trace Elements|trace elements|mesh-ancestor
138292590|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
138292591|NCT01788475|Dexamethasone|dexamethasone|mesh-list
138292592|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
138292594|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292595|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
138292596|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
138292597|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292598|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292599|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292600|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
138292601|NCT01788475|Hormones|hormones|mesh-ancestor
138292602|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292603|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292604|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292605|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
138292606|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292607|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292608|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
138292609|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
138292610|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292611|NCT00381914|Vitamin D|vitamin d|mesh-list
138292612|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
138292613|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
138292614|NCT00381914|Vitamins|vitamins|mesh-list
138292615|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
138292616|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292617|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138292618|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138292619|NCT00423007|Bromfenac|bromfenac|mesh-list
138292620|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138292621|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292622|NCT00423007|Analgesics|analgesics|mesh-ancestor
138292623|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
138292624|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292625|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292632|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292633|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292634|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292635|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
138292636|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292638|NCT00002756|Cytarabine|cytarabine|mesh-list
138292639|NCT00002756|Prednisone|prednisone|mesh-list
138292640|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
138292641|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138292642|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138292643|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138292644|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
138292645|NCT00002756|Methotrexate|methotrexate|mesh-list
138292646|NCT00002756|Etoposide|etoposide|mesh-list
138292647|NCT00002756|Vincristine|vincristine|mesh-list
138292648|NCT00002756|Daunorubicin|daunorubicin|mesh-list
138292649|NCT00002756|Asparaginase|asparaginase|mesh-list
138292650|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
138292651|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
138292652|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292653|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
138292654|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292655|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292656|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292657|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
138292658|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292664|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292665|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292666|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138292668|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292669|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292670|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
138292671|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292672|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292673|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292674|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292675|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292676|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292677|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292678|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
138292679|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292680|NCT00002756|Antidotes|antidotes|mesh-ancestor
138292686|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292687|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292688|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138292690|NCT01183429|Isotretinoin|isotretinoin|mesh-list
138292691|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292692|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
138292693|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292694|NCT01157533|Vancomycin|vancomycin|mesh-list
138292695|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138292696|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292697|NCT05749016|Paclitaxel|paclitaxel|mesh-list
138292698|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138292699|NCT05749016|Carboplatin|carboplatin|mesh-list
138292700|NCT05749016|Pertuzumab|pertuzumab|mesh-list
138292701|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292702|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292703|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292704|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292705|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292706|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292707|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138292708|NCT01756573|Bupivacaine|bupivacaine|mesh-list
138292709|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
138292710|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
138292711|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138292712|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292713|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
138292714|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292715|NCT01126801|Estradiol|estradiol|mesh-list
138292716|NCT01126801|Estrogens|estrogens|mesh-ancestor
138292717|NCT01126801|Hormones|hormones|mesh-ancestor
138292718|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292719|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292720|NCT01702909|Interleukin-2|interleukin-2|mesh-list
138292721|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292722|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292723|NCT01702909|Analgesics|analgesics|mesh-ancestor
138292724|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
138292725|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292738|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292739|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292744|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292745|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292746|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138292747|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138292748|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138292749|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
138292750|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292751|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
138292752|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292753|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292754|NCT00002774|Cisplatin|cisplatin|mesh-list
138292755|NCT00002774|Fluorouracil|fluorouracil|mesh-list
138292756|NCT00002774|Tirapazamine|tirapazamine|mesh-list
138292757|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292758|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
138292759|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292760|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292761|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292762|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
138292763|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292764|NCT00002780|Aldesleukin|aldesleukin|mesh-list
138292765|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
138292766|NCT00002780|Thiotepa|thiotepa|mesh-list
138292767|NCT00002780|Carboplatin|carboplatin|mesh-list
138292768|NCT00002780|Sargramostim|sargramostim|mesh-list
138292769|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292770|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
138292776|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292777|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292779|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138292781|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292782|NCT01692691|Dacarbazine|dacarbazine|mesh-list
138292783|NCT01692691|Carmustine|carmustine|mesh-list
138292784|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292785|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
138292786|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292787|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292788|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
138292789|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292790|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292791|NCT01122511|Dexamethasone|dexamethasone|mesh-list
138292792|NCT01122511|Ranibizumab|ranibizumab|mesh-list
138292793|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292794|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
138292796|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292797|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292798|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292800|NCT01122511|Hormones|hormones|mesh-ancestor
138292801|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292802|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292803|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292807|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138292809|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138292810|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138292811|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292812|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138292813|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292814|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
138292815|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
138292816|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292817|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
138292818|NCT05531708|Fludarabine|fludarabine|mesh-list
138292819|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292820|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
138292821|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292822|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292823|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292824|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
138292825|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292826|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292827|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292828|NCT01663285|Gemcitabine|gemcitabine|mesh-list
138292829|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292830|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292831|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
138292832|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292833|NCT00002786|Aldesleukin|aldesleukin|mesh-list
138292834|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292835|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138292836|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138292837|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
138292838|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292839|NCT00378937|Acetaminophen|acetaminophen|mesh-list
138292840|NCT00378937|Morphine|morphine|mesh-list
138292841|NCT00378937|Oxycodone|oxycodone|mesh-list
138292842|NCT00378937|Codeine|codeine|mesh-list
138292843|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
138292848|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292850|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
138292851|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292852|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292853|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
138292854|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
138292855|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
138292856|NCT00002792|Cyclosporine|cyclosporine|mesh-list
138292857|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
138292858|NCT00002792|Busulfan|busulfan|mesh-list
138292859|NCT00002792|Methotrexate|methotrexate|mesh-list
138292860|NCT00002792|Tacrolimus|tacrolimus|mesh-list
138292861|NCT00002792|Cyclosporins|cyclosporins|mesh-list
138292862|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292863|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
138292864|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292865|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292866|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292867|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
138292868|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292870|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292871|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138292872|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
138292873|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138292874|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138292875|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
138292876|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138292877|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138292878|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138292879|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138292880|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138292881|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
138292882|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138292890|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292891|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292892|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
138292893|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292894|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292895|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
138292896|NCT05513612|Fludarabine|fludarabine|mesh-list
138292897|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138292898|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
138292899|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292900|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138292901|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138292902|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
138292903|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292904|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292905|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138292906|NCT05594407|Lidocaine|lidocaine|mesh-list
138292907|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
138292908|NCT05594407|Ketamine|ketamine|mesh-list
138292909|NCT05594407|Remifentanil|remifentanil|mesh-list
138292910|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
138292911|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
138292912|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138292913|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292919|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138292920|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292921|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138292922|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138292924|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138292925|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138292926|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138292927|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138292928|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292929|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138292930|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138292931|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
138292932|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138292933|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138292934|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138292935|NCT05594407|Narcotics|narcotics|mesh-ancestor
138292936|NCT00379717|Docetaxel|docetaxel|mesh-list
138292937|NCT00379717|Cisplatin|cisplatin|mesh-list
138292938|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292939|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138292940|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138292968|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138292970|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
138292971|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292972|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292973|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138292974|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
138292975|NCT04403516|Hormones|hormones|mesh-ancestor
138292976|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292977|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138292978|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138292979|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138292980|NCT04403516|Protective Agents|protective agents|mesh-ancestor
138292981|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
138292982|NCT01555489|Vitamins|vitamins|mesh-ancestor
138292983|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
138292984|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138292986|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138292987|NCT01555489|Protective Agents|protective agents|mesh-ancestor
138292988|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138292995|NCT01035073|Analgesics|analgesics|mesh-ancestor
138292996|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
138292997|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138292998|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
138292999|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293000|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
138293001|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
138293002|NCT04331743|Analgesics|analgesics|mesh-ancestor
138293003|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
138293004|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293005|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293006|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293007|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138293008|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138293009|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293010|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293011|NCT05296759|Gabapentin|gabapentin|mesh-list
138293012|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138293013|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
138293014|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138293015|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138293016|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138293017|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293022|NCT05296759|Analgesics|analgesics|mesh-ancestor
138293023|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
138293024|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293025|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
138293026|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138293027|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293028|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293029|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293030|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138293032|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
138293033|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138293034|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293035|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293036|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
138293037|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138293038|NCT05546047|Tacrolimus|tacrolimus|mesh-list
138293039|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293040|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
138293041|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293042|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138293043|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293049|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
138293050|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293051|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293052|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138293053|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
138293054|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293055|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293056|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138293057|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138293058|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293059|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138293060|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138293061|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
138293062|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138293063|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293064|NCT00986947|Rituximab|rituximab|mesh-list
138293065|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293066|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293067|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
138293068|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293069|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293070|NCT00539617|Leucovorin|leucovorin|mesh-list
138293071|NCT00539617|Fluorouracil|fluorouracil|mesh-list
138293072|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
138293073|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138293074|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
138293075|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293076|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293077|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293078|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293079|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
138293080|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293081|NCT00539617|Antidotes|antidotes|mesh-ancestor
138293082|NCT00539617|Protective Agents|protective agents|mesh-ancestor
138293083|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
138293085|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
138293086|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138293087|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293088|NCT05467514|Liraglutide|liraglutide|mesh-list
138293089|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138293092|NCT05467514|Hormones|hormones|mesh-ancestor
138293093|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293094|NCT00976339|Vitamin D|vitamin d|mesh-list
138293095|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
138293096|NCT00976339|Vitamins|vitamins|mesh-ancestor
138293097|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
138293098|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293099|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138293100|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138293101|NCT04579640|Vitamin D|vitamin d|mesh-list
138293102|NCT04579640|Vitamins|vitamins|mesh-ancestor
138293103|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
138293104|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293105|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138293106|NCT00523939|Cytarabine|cytarabine|mesh-list
138293107|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293108|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
138293109|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293110|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293111|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
138293112|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293113|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293117|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138293118|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
138293119|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138293120|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293121|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138293122|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138293123|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138293124|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
138293125|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138293130|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138293131|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138293133|NCT00954187|Gabapentin|gabapentin|mesh-list
138293134|NCT00954187|Analgesics|analgesics|mesh-ancestor
138293135|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
138293136|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293137|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293138|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
138293139|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138293140|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293141|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293142|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138293143|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138293144|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293145|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293146|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293147|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138293148|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138293149|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293150|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
138293152|NCT00947791|Ketamine|ketamine|mesh-list
138293153|NCT00947791|Analgesics|analgesics|mesh-ancestor
138293154|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
138293155|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293156|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293157|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138293158|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138293159|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
138293160|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
138293161|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293162|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138293163|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138293164|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293165|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293166|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138293174|NCT05136326|Temozolomide|temozolomide|mesh-list
138293175|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293176|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
138293177|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293178|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293179|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138293180|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
138293181|NCT05387941|Dexamethasone|dexamethasone|mesh-list
138293182|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138293183|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
138293184|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
138293185|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293186|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293187|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138293188|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
138293189|NCT05387941|Hormones|hormones|mesh-ancestor
138293192|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293193|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
138293194|NCT00379015|Docetaxel|docetaxel|mesh-list
138293195|NCT00379015|Trastuzumab|trastuzumab|mesh-list
138293197|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293198|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
138293199|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293200|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293201|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138293202|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
138293211|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138293212|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138293213|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293214|NCT00911053|Melatonin|melatonin|mesh-list
138293215|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
138293216|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293217|NCT00911053|Protective Agents|protective agents|mesh-ancestor
138293218|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293219|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293220|NCT04713410|Prednisolone|prednisolone|mesh-list
138293221|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138293222|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
138293223|NCT04713410|Hormones|hormones|mesh-ancestor
138293224|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293225|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293226|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138293227|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293228|NCT04713332|Vitamin E|vitamin e|mesh-list
138293229|NCT04713332|Tocopherols|tocopherols|mesh-list
138293230|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
138293231|NCT04713332|Vitamins|vitamins|mesh-ancestor
138293232|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
138293233|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293234|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
138293238|NCT00476827|Vinorelbine|vinorelbine|mesh-list
138293239|NCT00476827|Docetaxel|docetaxel|mesh-list
138293240|NCT00476827|Bevacizumab|bevacizumab|mesh-list
138293241|NCT00476827|Gemcitabine|gemcitabine|mesh-list
138293242|NCT00476827|Irinotecan|irinotecan|mesh-list
138293243|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138293244|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293245|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138293278|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293279|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293281|NCT00879619|Cortisone|cortisone|mesh-list
138293282|NCT00879619|Docetaxel|docetaxel|mesh-list
138293283|NCT00879619|Sunitinib|sunitinib|mesh-list
138293288|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293289|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138293290|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
138293291|NCT00879619|Hormones|hormones|mesh-ancestor
138293292|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293293|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293294|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138293295|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293296|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293297|NCT00879619|Growth Substances|growth substances|mesh-ancestor
138293298|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293299|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138293300|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293301|NCT00822679|Eszopiclone|eszopiclone|mesh-list
138293302|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138293303|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293304|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293305|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138293306|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138293307|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138293308|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
138293309|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293310|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293316|NCT00314353|Irinotecan|irinotecan|mesh-list
138293317|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293318|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293319|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293320|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293321|NCT00314353|Growth Substances|growth substances|mesh-ancestor
138293322|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293323|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293324|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293325|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
138293326|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293327|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138293328|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138293329|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293331|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293332|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293333|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138293334|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293335|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293336|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293337|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
138293338|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
138293339|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293340|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293341|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138293342|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138293343|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
138293344|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138293345|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138293346|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138293347|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138293348|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138293349|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138293352|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293353|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138293354|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138293355|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293356|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
138293358|NCT00801931|Busulfan|busulfan|mesh-list
138293359|NCT00801931|Thiotepa|thiotepa|mesh-list
138293360|NCT00801931|Fludarabine|fludarabine|mesh-list
138293361|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
138293362|NCT00801931|Phenytoin|phenytoin|mesh-list
138293363|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
138293364|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
138293365|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138293366|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293367|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
138293368|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293369|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293370|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138293371|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
138293373|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293374|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138293375|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293376|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
138293377|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138293378|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138293379|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293380|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138293381|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138293382|NCT00780481|Bradykinin|bradykinin|mesh-list
138293384|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
138293385|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138293386|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
138293387|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293388|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293389|NCT00019747|Thalidomide|thalidomide|mesh-list
138293390|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293391|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
138293392|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293393|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
138293394|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138293395|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293396|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293397|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293402|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138293403|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138293404|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
138293407|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293408|NCT00759577|Urological Agents|urological agents|mesh-ancestor
138293409|NCT00746239|Dexetimide|dexetimide|mesh-list
138293410|NCT00746239|Citalopram|citalopram|mesh-list
138293411|NCT00746239|Escitalopram|escitalopram|mesh-list
138293412|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138293413|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293414|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293415|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293416|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293417|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
138293418|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293419|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138293420|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138293421|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
138293422|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
138293423|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293424|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138293425|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138293426|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
138293427|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138293428|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293429|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293430|NCT04977674|Naltrexone|naltrexone|mesh-list
138293431|NCT04977674|Ketamine|ketamine|mesh-list
138293438|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
138293440|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293441|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138293442|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138293443|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293444|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293445|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138293446|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293448|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
138293449|NCT00402883|Bevacizumab|bevacizumab|mesh-list
138293450|NCT00402883|Carboplatin|carboplatin|mesh-list
138293451|NCT00402883|Pemetrexed|pemetrexed|mesh-list
138293452|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293453|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293454|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293455|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293457|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293458|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293459|NCT00402883|Vitamins|vitamins|mesh-ancestor
138293460|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
138293461|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293462|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293463|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138293464|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293465|NCT00402883|Hematinics|hematinics|mesh-ancestor
138293472|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293473|NCT04939844|Growth Substances|growth substances|mesh-ancestor
138293474|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293475|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293476|NCT05295212|Atezolizumab|atezolizumab|mesh-list
138293477|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138293478|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293479|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293480|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293481|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
138293482|NCT05286320|Lenvatinib|lenvatinib|mesh-list
138293483|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293484|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293485|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138293486|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293487|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138293488|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293489|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
138293491|NCT00728845|Bevacizumab|bevacizumab|mesh-list
138293492|NCT00728845|Carboplatin|carboplatin|mesh-list
138293493|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138293494|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293495|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138293496|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138293497|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293498|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293499|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293500|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293501|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293502|NCT00728845|Growth Substances|growth substances|mesh-ancestor
138293503|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293508|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293509|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293510|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293511|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
138293512|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293514|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138293515|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293516|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293517|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138293518|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293519|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293520|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
138293521|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
138293522|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293523|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293524|NCT00703339|Treprostinil|treprostinil|mesh-list
138293525|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138293526|NCT04330586|Ciclesonide|ciclesonide|mesh-list
138293527|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
138293528|NCT04330586|Hormones|hormones|mesh-ancestor
138293529|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293530|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293531|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138293532|NCT00382694|Fludarabine|fludarabine|mesh-list
138293537|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293539|NCT04508036|Coagulants|coagulants|mesh-ancestor
138293540|NCT04828057|Timolol|timolol|mesh-list
138293541|NCT04828057|Bimatoprost|bimatoprost|mesh-list
138293542|NCT04828057|Travoprost|travoprost|mesh-list
138293543|NCT04828057|Latanoprost|latanoprost|mesh-list
138293544|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293545|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138293546|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138293547|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
138293548|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293549|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293550|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138293551|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138293552|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138293553|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138293554|NCT02973451|Bupivacaine|bupivacaine|mesh-list
138293555|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
138293556|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
138293557|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293558|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293559|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
138293560|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293568|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293569|NCT00668785|Growth Substances|growth substances|mesh-ancestor
138293570|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293575|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293576|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293577|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293579|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
138293580|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293581|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138293582|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293583|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293584|NCT00000211|Buprenorphine|buprenorphine|mesh-list
138293585|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293586|NCT00000211|Narcotics|narcotics|mesh-ancestor
138293587|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293588|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293589|NCT00000211|Analgesics|analgesics|mesh-ancestor
138293590|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
138293595|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138293596|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
138293597|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293598|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138293599|NCT00000217|Carbamazepine|carbamazepine|mesh-list
138293600|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
138293601|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
138293602|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293603|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293604|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293605|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293606|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293607|NCT00000217|Analgesics|analgesics|mesh-ancestor
138293608|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
138293609|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293610|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138293611|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293612|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293613|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138293614|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138293615|NCT00000223|Buprenorphine|buprenorphine|mesh-list
138293616|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293617|NCT00000223|Narcotics|narcotics|mesh-ancestor
138293618|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293619|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293629|NCT00000229|Analgesics|analgesics|mesh-ancestor
138293630|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
138293631|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293632|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293633|NCT00000235|Buprenorphine|buprenorphine|mesh-list
138293634|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293635|NCT00000235|Narcotics|narcotics|mesh-ancestor
138293636|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293637|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293638|NCT00000235|Analgesics|analgesics|mesh-ancestor
138293639|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
138293640|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293641|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293642|NCT00000241|Flupenthixol|flupenthixol|mesh-list
138293643|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138293644|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138293645|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293646|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293647|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293681|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293682|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138293683|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138293684|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
138293685|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293686|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138293687|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138293688|NCT00379483|Deferasirox|deferasirox|mesh-list
138293689|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138293690|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
138293691|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
138293692|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293693|NCT00607477|Minoxidil|minoxidil|mesh-list
138293694|NCT00607477|Hydralazine|hydralazine|mesh-list
138293695|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138293697|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
138293698|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138293699|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293700|NCT00000271|Desipramine|desipramine|mesh-list
138293701|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138293702|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293703|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293704|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293705|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293706|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138293707|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293708|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293709|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138293710|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293711|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293712|NCT00000277|Mazindol|mazindol|mesh-list
138293713|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138293714|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293715|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138293716|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293717|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293718|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293720|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293721|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138293723|NCT00599131|Docetaxel|docetaxel|mesh-list
138293724|NCT00599131|Fluorouracil|fluorouracil|mesh-list
138293725|NCT00599131|Cetuximab|cetuximab|mesh-list
138293726|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293727|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
138293728|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
138293729|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
138293730|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293731|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
138293732|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293733|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293734|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
138293735|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293736|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293737|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
138293738|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138293739|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
138293740|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
138293741|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293742|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293743|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293744|NCT04302350|Analgesics|analgesics|mesh-ancestor
138293745|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
138293746|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293748|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293749|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293750|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
138293751|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293752|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293754|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138293755|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293756|NCT04295486|Analgesics|analgesics|mesh-ancestor
138293757|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
138293758|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293759|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293760|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138293761|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293762|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138293763|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138293764|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293765|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138293766|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138293767|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293768|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
138293769|NCT00000289|Ondansetron|ondansetron|mesh-list
138293770|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
138293771|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
138293772|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293773|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293774|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138293775|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
138293776|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138293777|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138293778|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138293779|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
138293780|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293781|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293782|NCT00000295|Progesterone|progesterone|mesh-list
138293783|NCT00000295|Progestins|progestins|mesh-ancestor
138293784|NCT00000295|Hormones|hormones|mesh-ancestor
138293785|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293786|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293787|NCT00000733|Ribavirin|ribavirin|mesh-list
138293788|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
138293789|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293790|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
138293791|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293792|NCT04246723|Ritonavir|ritonavir|mesh-list
138293793|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
138293794|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138293795|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138293796|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
138293797|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293798|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293799|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138293800|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138293811|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293812|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293813|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293814|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293815|NCT00000301|Analgesics|analgesics|mesh-ancestor
138293816|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
138293817|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293818|NCT00000307|Naltrexone|naltrexone|mesh-list
138293819|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138293820|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293821|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293822|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
138293823|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293824|NCT00000313|Fenfluramine|fenfluramine|mesh-list
138293825|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138293826|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138293827|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293828|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293829|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293830|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
138293831|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293832|NCT00000319|Buprenorphine|buprenorphine|mesh-list
138293833|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293834|NCT00000319|Narcotics|narcotics|mesh-ancestor
138293835|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293836|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293837|NCT00000319|Analgesics|analgesics|mesh-ancestor
138293838|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
138293839|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293840|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293841|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138293842|NCT00000325|Hormones|hormones|mesh-ancestor
138293843|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293844|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293845|NCT04181203|Leuprolide|leuprolide|mesh-list
138293846|NCT04181203|Goserelin|goserelin|mesh-list
138293847|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138293848|NCT04181203|Hormones|hormones|mesh-list
138293849|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138293850|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293851|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138293852|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
138293853|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138293858|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
138293859|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138293861|NCT03521102|Hydromorphone|hydromorphone|mesh-list
138293862|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138293863|NCT03521102|Analgesics|analgesics|mesh-ancestor
138293864|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
138293865|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293866|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293867|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
138293868|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293869|NCT03521102|Narcotics|narcotics|mesh-ancestor
138293870|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293871|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
138293872|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138293873|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293874|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138293875|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138293876|NCT00000763|Growth Substances|growth substances|mesh-ancestor
138293877|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293878|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138293879|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
138293880|NCT00380263|Growth Substances|growth substances|mesh-ancestor
138293881|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293882|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
138293883|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293886|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138293887|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
138293888|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293889|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293890|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293891|NCT05440591|Metformin|metformin|mesh-list
138293892|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
138293893|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138293894|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293895|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138293896|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293897|NCT04099303|Vaccines|vaccines|mesh-list
138293898|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
138293899|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293900|NCT00379951|Ertapenem|ertapenem|mesh-list
138293901|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138293902|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293903|NCT00000337|Selegiline|selegiline|mesh-list
138293904|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
138293905|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138293906|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138293907|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138293916|NCT00000781|Didanosine|didanosine|mesh-list
138293917|NCT00000781|Zalcitabine|zalcitabine|mesh-list
138293918|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
138293919|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293920|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138293921|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293922|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293924|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138293925|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138293926|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138293927|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138293928|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138293929|NCT00000349|Flupenthixol|flupenthixol|mesh-list
138293930|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138293931|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138293932|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138293933|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293934|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293946|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293947|NCT00000355|Buprenorphine|buprenorphine|mesh-list
138293948|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138293949|NCT00000355|Narcotics|narcotics|mesh-ancestor
138293950|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138293954|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293955|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138293956|NCT04022785|Azacitidine|azacitidine|mesh-list
138293957|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293958|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
138293959|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293960|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293961|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293962|NCT00000361|Methotrexate|methotrexate|mesh-list
138293963|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138293964|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
138293965|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138293966|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138293967|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138293968|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
138293969|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293970|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293971|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138293972|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293973|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138293974|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138293975|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
138293976|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138293977|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138293986|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
138293987|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138293988|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138293989|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138293990|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293991|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293992|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138293997|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
138293998|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
138293999|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294000|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294001|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138294002|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138294003|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138294004|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138294005|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294006|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138294007|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138294008|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294009|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294011|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
138294012|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138294013|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
138294014|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138294015|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294016|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294017|NCT00000823|Zidovudine|zidovudine|mesh-list
138294018|NCT00000823|Didanosine|didanosine|mesh-list
138294019|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
138294020|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294021|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294022|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294023|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294024|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
138294025|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294026|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294027|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294028|NCT00000379|Fluoxetine|fluoxetine|mesh-list
138294029|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138294030|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138294031|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294032|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294033|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294035|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294036|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138294037|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
138294038|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294039|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138294040|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294041|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294042|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
138294043|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
138294044|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294045|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294046|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294047|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
138294048|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138294049|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138294050|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294051|NCT00002894|Paclitaxel|paclitaxel|mesh-list
138294052|NCT00002894|Carboplatin|carboplatin|mesh-list
138294053|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294054|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294055|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
138294058|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294060|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138294061|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
138294062|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294063|NCT03282344|Nivolumab|nivolumab|mesh-list
138294064|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138294065|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294066|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138294067|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294068|NCT00000403|Doxycycline|doxycycline|mesh-list
138294069|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294070|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294071|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
138294072|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294073|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294074|NCT00000841|Lamivudine|lamivudine|mesh-list
138294075|NCT00000841|Zidovudine|zidovudine|mesh-list
138294076|NCT00000841|Stavudine|stavudine|mesh-list
138294077|NCT00000841|Indinavir|indinavir|mesh-list
138294078|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294079|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294080|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294081|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294082|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
138294083|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294084|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294085|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294086|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
138294087|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138294088|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138294089|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294091|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138294092|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294093|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
138294094|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138294095|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
138294096|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294097|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138294098|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294100|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294101|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
138294102|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138294103|NCT00000847|Protective Agents|protective agents|mesh-ancestor
138294104|NCT00000439|Valproic Acid|valproic acid|mesh-list
138294105|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
138294106|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294107|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294108|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
138294109|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294110|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294112|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138294113|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138294114|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294115|NCT00002912|Etoposide|etoposide|mesh-list
138294142|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294143|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
138294144|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294145|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
138294146|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294147|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138294148|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138294149|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294150|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294151|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294152|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
138294153|NCT00000865|Lamivudine|lamivudine|mesh-list
138294154|NCT00000865|Zidovudine|zidovudine|mesh-list
138294155|NCT00000865|Abacavir|abacavir|mesh-list
138294156|NCT00000865|Didanosine|didanosine|mesh-list
138294157|NCT00000865|Stavudine|stavudine|mesh-list
138294158|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294159|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294160|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294161|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294162|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
138294163|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294164|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294165|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294166|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
138294167|NCT00000469|Aspirin|aspirin|mesh-list
138294168|NCT00000469|Lovastatin|lovastatin|mesh-list
138294169|NCT00000469|L 647318|l 647318|mesh-list
138294170|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
138294171|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138294172|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138294173|NCT00000469|Analgesics|analgesics|mesh-ancestor
138294175|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294176|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294177|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138294178|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294184|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294186|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138294187|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138294188|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
138294189|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138294190|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138294191|NCT00000889|Aldesleukin|aldesleukin|mesh-list
138294192|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294193|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294194|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294195|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
138294196|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294197|NCT00000505|Plasminogen|plasminogen|mesh-list
138294198|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138294199|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138294200|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138294201|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294202|NCT00000901|Lamivudine|lamivudine|mesh-list
138294203|NCT00000901|Stavudine|stavudine|mesh-list
138294204|NCT00000901|Indinavir|indinavir|mesh-list
138294205|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294206|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294207|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294208|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294209|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
138294210|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294211|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294212|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294213|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
138294214|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138294215|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138294216|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294217|NCT00000541|Vitamins|vitamins|mesh-list
138294218|NCT00000541|Folic Acid|folic acid|mesh-list
138294219|NCT00000541|Vitamin E|vitamin e|mesh-list
138294220|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
138294221|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
138294222|NCT00000541|Pyridoxal|pyridoxal|mesh-list
138294223|NCT00000541|Pyridoxine|pyridoxine|mesh-list
138294224|NCT00000541|Beta Carotene|beta carotene|mesh-list
138294225|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
138294226|NCT00000541|Carotenoids|carotenoids|mesh-list
138294228|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294230|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294231|NCT00000541|Protective Agents|protective agents|mesh-ancestor
138294232|NCT00000541|Hematinics|hematinics|mesh-ancestor
138294233|NCT00000541|Provitamins|provitamins|mesh-ancestor
138294234|NCT00000913|Ritonavir|ritonavir|mesh-list
138294235|NCT00000913|Nelfinavir|nelfinavir|mesh-list
138294236|NCT00000913|Saquinavir|saquinavir|mesh-list
138294237|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138294238|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138294239|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294240|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294241|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294242|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294243|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294244|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
138294245|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294246|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294247|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294248|NCT00000547|Enalapril|enalapril|mesh-list
138294249|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138294250|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294251|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294252|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294253|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138294255|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138294256|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294258|NCT00000577|Albuterol|albuterol|mesh-list
138294259|NCT00000577|Hormones|hormones|mesh-list
138294260|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
138294261|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
138294262|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138294263|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294264|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138294265|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
138294266|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294267|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138294268|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
138294269|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
138294270|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138294271|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138294272|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138294273|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294274|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294275|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
138294276|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294277|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138294278|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294279|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294280|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294281|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
138294282|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138294284|NCT03015896|Lenalidomide|lenalidomide|mesh-list
138294285|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138294286|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294287|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138294288|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294289|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
138294290|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294291|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138294292|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138294293|NCT03015896|Growth Substances|growth substances|mesh-ancestor
138294294|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138294296|NCT02994836|Infliximab|infliximab|mesh-list
138294297|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138294298|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138294299|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138294300|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294301|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
138294302|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138294303|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138294304|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294306|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138294307|NCT00000613|Protective Agents|protective agents|mesh-ancestor
138294308|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294309|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294310|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138294311|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294312|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294313|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
138294314|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138294315|NCT00000613|Estrogens|estrogens|mesh-ancestor
138294316|NCT00000613|Hormones|hormones|mesh-ancestor
138294317|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138294318|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
138294319|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138294320|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294321|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138294335|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294336|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294337|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138294338|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
138294339|NCT00000649|Zidovudine|zidovudine|mesh-list
138294340|NCT00000649|Nevirapine|nevirapine|mesh-list
138294341|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
138294342|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294343|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294344|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294345|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294346|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
138294347|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294348|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294349|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294350|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138294351|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138294352|NCT00000961|Zidovudine|zidovudine|mesh-list
138294353|NCT00000961|Immune Sera|immune sera|mesh-list
138294354|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
138294355|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294356|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294357|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294358|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294359|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
138294360|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294361|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294362|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294363|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
138294364|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294365|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138294366|NCT04048304|Vancomycin|vancomycin|mesh-list
138294367|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294368|NCT00000655|Trimethoprim|trimethoprim|mesh-list
138294369|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138294370|NCT00000655|Atovaquone|atovaquone|mesh-list
138294371|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
138294372|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138294373|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294374|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
138294375|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294376|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294377|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138294378|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294389|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294390|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138294391|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
138294392|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294393|NCT00000967|Interferons|interferons|mesh-list
138294394|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
138294395|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
138294397|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294398|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
138294399|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294400|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
138294401|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294402|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
138294403|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294404|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294405|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294406|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294407|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294408|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294409|NCT00000661|Zidovudine|zidovudine|mesh-list
138294439|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294440|NCT00000991|Zidovudine|zidovudine|mesh-list
138294441|NCT00000991|Trimethoprim|trimethoprim|mesh-list
138294442|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
138294443|NCT00000991|Dapsone|dapsone|mesh-list
138294444|NCT00000991|Pentamidine|pentamidine|mesh-list
138294445|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138294446|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
138294447|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294448|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294449|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294450|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294452|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294453|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294454|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294455|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138294456|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
138294457|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294458|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294459|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138294460|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138294461|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138294462|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294463|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
138294464|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294465|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
138294466|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138294467|NCT00000673|Ganciclovir|ganciclovir|mesh-list
138294469|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
138294470|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294471|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294472|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294473|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294474|NCT00000685|Zidovudine|zidovudine|mesh-list
138294475|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
138294476|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294477|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294478|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294479|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294480|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
138294481|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294482|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294483|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294484|NCT00002972|Paclitaxel|paclitaxel|mesh-list
138294485|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294486|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294488|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294489|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294490|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294491|NCT00000691|Foscarnet|foscarnet|mesh-list
138294492|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138294493|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
138294494|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294495|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294496|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294497|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294501|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294503|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
138294504|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294505|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294506|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294507|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
138294508|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138294509|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138294510|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
138294511|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294512|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
138294513|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138294514|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
138294515|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294516|NCT00000997|Zalcitabine|zalcitabine|mesh-list
138294517|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
138294518|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294519|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138344965|NCT01843920|Prednisolone|prednisolone|mesh-list
138294520|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294521|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294522|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
138294523|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294524|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294525|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294527|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138294528|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
138294529|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294530|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294531|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294532|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294533|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294534|NCT00001009|Dextrans|dextrans|mesh-list
138294535|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
138294536|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
138294537|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
138294538|NCT00000703|Leucovorin|leucovorin|mesh-list
138294539|NCT00000703|Cytarabine|cytarabine|mesh-list
138294540|NCT00000703|Zidovudine|zidovudine|mesh-list
138294541|NCT00000703|Dexamethasone|dexamethasone|mesh-list
138294542|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
138294543|NCT00000703|Doxorubicin|doxorubicin|mesh-list
138294544|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138294545|NCT00000703|Methotrexate|methotrexate|mesh-list
138294546|NCT00000703|Vincristine|vincristine|mesh-list
138294547|NCT00000703|Bleomycin|bleomycin|mesh-list
138294548|NCT00000703|Allopurinol|allopurinol|mesh-list
138294549|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
138294550|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138294551|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
138294552|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294553|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294554|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138294555|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
138294556|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294557|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294558|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138294559|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138294560|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
138294561|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
138294562|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294563|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138294575|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138294576|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
138294577|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
138294578|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138294579|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294580|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
138294581|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294583|NCT00000703|Protective Agents|protective agents|mesh-ancestor
138294584|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
138294585|NCT00000703|Vitamins|vitamins|mesh-ancestor
138294586|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
138294587|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294588|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
138294589|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294590|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294591|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294592|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294593|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294594|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
138294595|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138294597|NCT00001015|Ribavirin|ribavirin|mesh-list
138294598|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
138294599|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294600|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
138294601|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294602|NCT00000709|Zidovudine|zidovudine|mesh-list
138294603|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
138294604|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294605|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294606|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294607|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294608|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
138294609|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294610|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294611|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294612|NCT00001027|Pentamidine|pentamidine|mesh-list
138294624|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138294625|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
138294626|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294627|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294628|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294629|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294630|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
138294631|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294632|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294633|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294634|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
138294635|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294636|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294637|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138294638|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138294639|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138294640|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138294641|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294642|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
138294643|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138294644|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294646|NCT00001039|Ethambutol|ethambutol|mesh-list
138294647|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294648|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294649|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138294650|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294651|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294652|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294653|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294654|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
138294656|NCT00001057|Didanosine|didanosine|mesh-list
138294657|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
138294658|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294659|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294660|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294661|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294662|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
138294663|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294664|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294665|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294666|NCT00002293|Nystatin|nystatin|mesh-list
138294667|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294668|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294669|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
138294670|NCT00002293|Ionophores|ionophores|mesh-ancestor
138294671|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138294672|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294673|NCT00002299|Interferons|interferons|mesh-list
138294674|NCT00002299|Interferon-beta|interferon-beta|mesh-list
138294675|NCT00002299|Ganciclovir|ganciclovir|mesh-list
138294676|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138294677|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
138294678|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294679|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
138294680|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294683|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294684|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294685|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294686|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138294693|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294695|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
138294696|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294697|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294698|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294699|NCT00002305|Fluconazole|fluconazole|mesh-list
138294700|NCT00002305|Amphotericin B|amphotericin b|mesh-list
138294701|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138294702|NCT00002305|Flucytosine|flucytosine|mesh-list
138294703|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
138294704|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294705|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138294706|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294707|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294708|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294709|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138294710|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
138294711|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138294712|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294713|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138294714|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138294715|NCT00002305|Amebicides|amebicides|mesh-ancestor
138294716|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294717|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294718|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138294719|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
138294720|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
138294721|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294722|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294723|NCT00002311|Wobenzym|wobenzym|mesh-list
138294724|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138294725|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
138294726|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294727|NCT00002317|Leucovorin|leucovorin|mesh-list
138294728|NCT00002317|Trimetrexate|trimetrexate|mesh-list
138294729|NCT00002317|Calcium|calcium|mesh-list
138294730|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
138294731|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138294732|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294733|NCT00002317|Antidotes|antidotes|mesh-ancestor
138294734|NCT00002317|Protective Agents|protective agents|mesh-ancestor
138294735|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
138294736|NCT00002317|Vitamins|vitamins|mesh-ancestor
138294737|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
138294738|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
138294739|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294740|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138294741|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
138294742|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294743|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294744|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138294745|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294746|NCT00001123|Ribavirin|ribavirin|mesh-list
138294747|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
138294748|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294749|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
138294757|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294758|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
138294759|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294760|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294761|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294762|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138294763|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138294764|NCT00380965|Nabilone|nabilone|mesh-list
138294765|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
138294766|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
138294767|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294768|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294769|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138294770|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138294771|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138294772|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138294773|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294776|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294777|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294778|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294779|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
138294780|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294781|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294782|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294783|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138294784|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138294785|NCT00003002|Sargramostim|sargramostim|mesh-list
138294786|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
138294787|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294789|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138294790|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
138294791|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
138294792|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294793|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294794|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138294795|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138294796|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138294797|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138294798|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138294799|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294800|NCT00001891|Protective Agents|protective agents|mesh-ancestor
138294801|NCT00383864|Interferons|interferons|mesh-list
138294802|NCT00383864|Ribavirin|ribavirin|mesh-list
138294803|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294804|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
138294805|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294806|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
138294807|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294808|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
138294809|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138294810|NCT00001903|Antibodies|antibodies|mesh-list
138294811|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
138294812|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294813|NCT00002335|Emtricitabine|emtricitabine|mesh-list
138294814|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
138294815|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294816|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294818|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294819|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294820|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294822|NCT00002341|Itraconazole|itraconazole|mesh-list
138294823|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
138294824|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294830|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
138294831|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138294832|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294833|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294835|NCT00002347|Nevirapine|nevirapine|mesh-list
138294836|NCT00002347|Zalcitabine|zalcitabine|mesh-list
138294837|NCT00002347|Saquinavir|saquinavir|mesh-list
138294838|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
138294839|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294840|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294841|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294842|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294843|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
138294844|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294845|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294846|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294847|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138294848|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138294849|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138294850|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138294851|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294852|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294853|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294854|NCT00001237|Molgramostim|molgramostim|mesh-list
138294855|NCT00001237|Sargramostim|sargramostim|mesh-list
138294856|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
138294857|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294858|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294859|NCT00001933|Nefiracetam|nefiracetam|mesh-list
138294860|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138294861|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138294862|NCT00001933|Protective Agents|protective agents|mesh-ancestor
138294863|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294864|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
138294865|NCT00001249|Antibodies|antibodies|mesh-list
138294866|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
138294867|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294868|NCT00380575|Conivaptan|conivaptan|mesh-list
138294869|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138294870|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294871|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
138294872|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294873|NCT00001963|Chrysarobin|chrysarobin|mesh-list
138294874|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
138294875|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138294876|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
138294888|NCT00001963|Protective Agents|protective agents|mesh-ancestor
138294889|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138294890|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138294891|NCT00001963|Analgesics|analgesics|mesh-ancestor
138294892|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
138294893|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138294894|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294895|NCT00002377|Valganciclovir|valganciclovir|mesh-list
138294896|NCT00002377|Ganciclovir|ganciclovir|mesh-list
138294897|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138294898|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
138294899|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294900|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294901|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294902|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294903|NCT00001339|Doxorubicin|doxorubicin|mesh-list
138294904|NCT00001339|Etoposide|etoposide|mesh-list
138294905|NCT00001339|Vincristine|vincristine|mesh-list
138294906|NCT00001339|Mitotane|mitotane|mesh-list
138294907|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138294908|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294909|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138294910|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138294911|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294912|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294913|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138294914|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
138294915|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
138294916|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
138294917|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138294918|NCT00001993|Miglustat|miglustat|mesh-list
138294919|NCT00001993|Zidovudine|zidovudine|mesh-list
138294920|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
138294921|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294922|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294923|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294924|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294925|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
138294926|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294927|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294929|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138294933|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138294934|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
138294936|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
138294937|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294938|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294939|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294940|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294941|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
138294942|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294943|NCT00002383|Saquinavir|saquinavir|mesh-list
138294944|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138294945|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138294946|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
138294947|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294948|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294949|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294950|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294952|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294953|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294954|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138294955|NCT00002389|Lamivudine|lamivudine|mesh-list
138294956|NCT00002389|Zidovudine|zidovudine|mesh-list
138294957|NCT00002389|Abacavir|abacavir|mesh-list
138294958|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294959|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294960|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294961|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294962|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
138294963|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294964|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138294965|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138294966|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
138294967|NCT00001357|Interleukin-2|interleukin-2|mesh-list
138294968|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294969|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138294971|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
138294972|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294973|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294974|NCT00001381|Suramin|suramin|mesh-list
138294975|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
138294976|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
138294977|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138294978|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138294979|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294980|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138294981|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138294982|NCT00002011|Methoxsalen|methoxsalen|mesh-list
138294983|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138294984|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
138294985|NCT00002017|Interleukin-2|interleukin-2|mesh-list
138294986|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294987|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138294988|NCT00002017|Analgesics|analgesics|mesh-ancestor
138294989|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
138294990|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138294991|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138294992|NCT00002023|Zidovudine|zidovudine|mesh-list
138294993|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
138294994|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138294995|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138294996|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138294997|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138294998|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
138294999|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295000|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295001|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295002|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138295003|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138295004|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138295011|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295013|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
138295014|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295015|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295016|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295018|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138295019|NCT00002041|Amebicides|amebicides|mesh-ancestor
138295020|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138295021|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138295022|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295023|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295024|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
138295025|NCT00002047|Zidovudine|zidovudine|mesh-list
138295026|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
138295027|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295028|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295029|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295030|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295031|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
138295032|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295033|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295034|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295035|NCT00002053|Pentamidine|pentamidine|mesh-list
138295036|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
138295037|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295038|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138295039|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138295040|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138295041|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
138295042|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138295043|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
138295044|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295045|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
138295046|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295048|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138295049|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138295050|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295051|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295052|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
138295053|NCT00002071|Hematinics|hematinics|mesh-ancestor
138295054|NCT00002395|Topotecan|topotecan|mesh-list
138295055|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138295056|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295057|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295058|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295059|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295060|NCT00002401|Lamivudine|lamivudine|mesh-list
138295061|NCT00002401|Zidovudine|zidovudine|mesh-list
138295062|NCT00002401|Delavirdine|delavirdine|mesh-list
138295063|NCT00002401|Indinavir|indinavir|mesh-list
138295064|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295065|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295066|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295067|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295068|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
138295069|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295070|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295076|NCT00002407|Lamivudine|lamivudine|mesh-list
138295077|NCT00002407|Nevirapine|nevirapine|mesh-list
138295078|NCT00002407|Didanosine|didanosine|mesh-list
138295079|NCT00002407|Stavudine|stavudine|mesh-list
138295080|NCT00002407|Indinavir|indinavir|mesh-list
138295081|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295082|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295083|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295084|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295085|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
138295086|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295087|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295088|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295089|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138295090|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138295091|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
138295092|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295093|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295094|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295095|NCT00002413|Emivirine|emivirine|mesh-list
138295096|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295097|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295098|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295099|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295100|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
138295101|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295102|NCT00002419|Efavirenz|efavirenz|mesh-list
138295103|NCT00002419|Abacavir|abacavir|mesh-list
138295104|NCT00002419|Adefovir|adefovir|mesh-list
138295105|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138295106|NCT00002419|Amprenavir|amprenavir|mesh-list
138295107|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295108|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295109|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295110|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295111|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
138295112|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295113|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295114|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295115|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138295116|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138295117|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138295118|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138295120|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295121|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295122|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
138295123|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295124|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295125|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295126|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295128|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138295129|NCT00381511|Tinzaparin|tinzaparin|mesh-list
138295130|NCT00381511|Dalteparin|dalteparin|mesh-list
138295132|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138295133|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138295134|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295135|NCT00002425|Saquinavir|saquinavir|mesh-list
138295145|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138295146|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295147|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
138295148|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138295149|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138295150|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295151|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
138295162|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295163|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295164|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295165|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138295166|NCT00002089|Azithromycin|azithromycin|mesh-list
138295167|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295168|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295169|NCT00002095|Ganciclovir|ganciclovir|mesh-list
138295170|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138295171|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
138295172|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295173|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295174|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295175|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295176|NCT00002101|Clarithromycin|clarithromycin|mesh-list
138295177|NCT00002101|Ethambutol|ethambutol|mesh-list
138295178|NCT00002101|Rifabutin|rifabutin|mesh-list
138295179|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295180|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295181|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138295182|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295183|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295184|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138295185|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295186|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
138295187|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295188|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
138295189|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138295190|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295191|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138295192|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295200|NCT00002113|Flucytosine|flucytosine|mesh-list
138295201|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
138295202|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295203|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138295204|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295205|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295206|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295207|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138295208|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295209|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295210|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295211|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295212|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138295213|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
138295214|NCT00002437|Cidofovir|cidofovir|mesh-list
138295215|NCT00002437|Probenecid|probenecid|mesh-list
138295216|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
138295217|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
138295218|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295219|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
138295220|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295221|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295222|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295223|NCT00002443|Zidovudine|zidovudine|mesh-list
138295224|NCT00002443|Indinavir|indinavir|mesh-list
138295225|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
138295226|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295227|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295246|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295247|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
138295248|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295249|NCT00003014|Carboplatin|carboplatin|mesh-list
138295250|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295251|NCT00002125|Foscarnet|foscarnet|mesh-list
138295252|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138295253|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
138295255|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295256|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295257|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295258|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295259|NCT00001579|Leucovorin|leucovorin|mesh-list
138295260|NCT00001579|Fluorouracil|fluorouracil|mesh-list
138295261|NCT00001579|Eniluracil|eniluracil|mesh-list
138295304|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295305|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
138295306|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295307|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295308|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295309|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295310|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295311|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295312|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295313|NCT00003026|Bicalutamide|bicalutamide|mesh-list
138295314|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138295315|NCT00003026|Flutamide|flutamide|mesh-list
138295316|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
138295317|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295318|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295319|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295320|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295322|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138295323|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
138295324|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295325|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138295326|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138295327|NCT00002143|Acitretin|acitretin|mesh-list
138295328|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
138295329|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295330|NCT00002149|Amoxicillin|amoxicillin|mesh-list
138295331|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
138295332|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
138295333|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
138295334|NCT00002149|Ephedrine|ephedrine|mesh-list
138295335|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295336|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295337|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138295338|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295340|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138295341|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
138295342|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295343|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295344|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138295345|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
138295346|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
138295347|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138295348|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138295349|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
138295350|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
138295351|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295352|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138295353|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295354|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138295355|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295356|NCT02973295|Silymarin|silymarin|mesh-list
138295357|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
138295358|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295359|NCT02973295|Protective Agents|protective agents|mesh-ancestor
138295360|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295361|NCT00003032|Tamoxifen|tamoxifen|mesh-list
138295362|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
138295363|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
138295364|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295365|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
138295366|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295367|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295368|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295369|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
138295370|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295372|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295374|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295375|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295376|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138295377|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138295378|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138295379|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138295380|NCT00003032|Analgesics|analgesics|mesh-ancestor
138295381|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
138295382|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295383|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295385|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295386|NCT00002155|Lamivudine|lamivudine|mesh-list
138295387|NCT00002155|Zidovudine|zidovudine|mesh-list
138295388|NCT00002155|Indinavir|indinavir|mesh-list
138295389|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295390|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295392|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295393|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
138295394|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295395|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295396|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295397|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
138295398|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295399|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295400|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295401|NCT00003038|Suramin|suramin|mesh-list
138295402|NCT00003038|Doxorubicin|doxorubicin|mesh-list
138295403|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138295404|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295405|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295406|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295407|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295408|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295409|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295410|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
138295423|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295424|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295425|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295426|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
138295427|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138295428|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295429|NCT03805022|Doxorubicin|doxorubicin|mesh-list
138295430|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138295431|NCT03805022|Ifosfamide|ifosfamide|mesh-list
138295432|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
138295433|NCT03805022|Dacarbazine|dacarbazine|mesh-list
138295434|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295435|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295437|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295439|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295440|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295441|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
138295442|NCT05752435|Bleomycin|bleomycin|mesh-list
138295443|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295444|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295445|NCT00003050|Tamoxifen|tamoxifen|mesh-list
138295446|NCT00003050|Paclitaxel|paclitaxel|mesh-list
138295447|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
138295448|NCT00003050|Doxorubicin|doxorubicin|mesh-list
138295449|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138295450|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295451|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295452|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138295453|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138295454|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138295455|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295456|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295457|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
138295458|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295459|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295460|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295461|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
138295462|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295463|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295464|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295465|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295466|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295467|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138295468|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295469|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295470|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138295471|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138295473|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138295487|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295488|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295489|NCT00003056|Cyclosporine|cyclosporine|mesh-list
138295490|NCT00003056|Methotrexate|methotrexate|mesh-list
138295491|NCT00003056|Cyclosporins|cyclosporins|mesh-list
138295492|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138295493|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
138295494|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295495|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295496|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138295497|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
138295498|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295499|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295500|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295501|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295502|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138295503|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295504|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
138295505|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295506|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295507|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
138295508|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295509|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138295511|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295512|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295513|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295514|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295515|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295516|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295517|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295518|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
138295519|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295520|NCT00003062|Temozolomide|temozolomide|mesh-list
138295521|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295522|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
138295523|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295524|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295525|NCT00002191|Albendazole|albendazole|mesh-list
138295526|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
138295527|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138295528|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295529|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
138295530|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138295531|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138295532|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138295533|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138295534|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138295535|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295545|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295546|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295547|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295548|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138295550|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295551|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295552|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295553|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295554|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
138295555|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295556|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295557|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295558|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
138295560|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
138295561|NCT00003068|Amifostine|amifostine|mesh-list
138295562|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295563|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
138295564|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295565|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295566|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295567|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
138295568|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295569|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295570|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295571|NCT00003068|Analgesics|analgesics|mesh-ancestor
138295572|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
138295573|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295574|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295575|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295576|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295577|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138295578|NCT00003068|Protective Agents|protective agents|mesh-ancestor
138295579|NCT00003080|Tamoxifen|tamoxifen|mesh-list
138295580|NCT00003080|Melphalan|melphalan|mesh-list
138295581|NCT00003080|Thiotepa|thiotepa|mesh-list
138295582|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
138295583|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295584|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295585|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
138295586|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295587|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295588|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295589|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
138295590|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295591|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138295592|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295593|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295594|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138295595|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138295596|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138295597|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138295598|NCT00003080|Analgesics|analgesics|mesh-ancestor
138295599|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
138295600|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295601|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295602|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295603|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295604|NCT00002203|Lamivudine|lamivudine|mesh-list
138295605|NCT00002203|Zidovudine|zidovudine|mesh-list
138295606|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138295618|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138295619|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138295620|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
138295621|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295622|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295623|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295624|NCT01568918|Urological Agents|urological agents|mesh-ancestor
138295625|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
138295626|NCT00003086|Carboplatin|carboplatin|mesh-list
138295627|NCT00003086|Doxorubicin|doxorubicin|mesh-list
138295628|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138295629|NCT00003086|Fluorouracil|fluorouracil|mesh-list
138295630|NCT00003086|Melphalan|melphalan|mesh-list
138295631|NCT00003086|Ifosfamide|ifosfamide|mesh-list
138295632|NCT00003086|Thiotepa|thiotepa|mesh-list
138295633|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138295634|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295635|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295636|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295637|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
138295638|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295639|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295640|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295641|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
138295642|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295643|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295644|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295645|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295646|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295647|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
138295648|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138295650|NCT00003086|Analgesics|analgesics|mesh-ancestor
138295651|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
138295652|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295653|NCT00003092|Paclitaxel|paclitaxel|mesh-list
138295654|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295655|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295656|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138295657|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138295659|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295660|NCT00381199|Amitriptyline|amitriptyline|mesh-list
138295661|NCT00381199|Nabilone|nabilone|mesh-list
138295662|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138295663|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
138295664|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138295665|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138295666|NCT00381199|Analgesics|analgesics|mesh-ancestor
138295667|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
138295668|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295669|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295670|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138295671|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138295672|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138295685|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295686|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
138295687|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295688|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295689|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295690|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
138295691|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295692|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295693|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295694|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295695|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295696|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295697|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295698|NCT00002515|Carboplatin|carboplatin|mesh-list
138295700|NCT00002515|Thiotepa|thiotepa|mesh-list
138295701|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295702|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
138295703|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295704|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138295705|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295706|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295707|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295708|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295709|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
138295710|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295711|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295712|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
138295713|NCT00002521|Etoposide|etoposide|mesh-list
138295714|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295715|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
138295716|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295717|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295718|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295719|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
138295720|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295721|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295722|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295723|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295732|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295733|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295734|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295735|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295736|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295738|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295740|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295741|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295742|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295743|NCT00003116|Cyclosporine|cyclosporine|mesh-list
138295744|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
138295745|NCT00003116|Busulfan|busulfan|mesh-list
138295746|NCT00003116|Cyclosporins|cyclosporins|mesh-list
138295747|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295748|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
138295749|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295750|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295751|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295752|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
138295753|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295754|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295755|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295756|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295757|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
138295758|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295775|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138295776|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138295777|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138295780|NCT00002233|Abacavir|abacavir|mesh-list
138295781|NCT00002233|Indinavir|indinavir|mesh-list
138295782|NCT00002233|Amprenavir|amprenavir|mesh-list
138295783|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295784|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295785|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295786|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295787|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
138295788|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295789|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295790|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295791|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295792|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295793|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295794|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295795|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
138295796|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295808|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295809|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138295810|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138295811|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295812|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
138295813|NCT00002533|Fluconazole|fluconazole|mesh-list
138295814|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
138295817|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295818|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295819|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295821|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295822|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295823|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295824|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138295825|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138295826|NCT00002539|Doxorubicin|doxorubicin|mesh-list
138295827|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138295828|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295829|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138295830|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295831|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295832|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295833|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295834|NCT00381589|Bromides|bromides|mesh-list
138295835|NCT00381589|Ipratropium|ipratropium|mesh-list
138295836|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
138295837|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138295838|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
138295839|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295840|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295841|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138295842|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
138295843|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138295844|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
138295845|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295846|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295847|NCT00002239|Ritonavir|ritonavir|mesh-list
138295848|NCT00002239|Amprenavir|amprenavir|mesh-list
138295849|NCT00002239|Abacavir|abacavir|mesh-list
138295850|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
138295851|NCT00002239|Efavirenz|efavirenz|mesh-list
138295852|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295853|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295854|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295855|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295858|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295859|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
138295860|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295861|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138295862|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138295863|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295870|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138295871|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138295872|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295873|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
138295874|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295877|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295878|NCT00002245|Lamivudine|lamivudine|mesh-list
138295879|NCT00002245|Abacavir|abacavir|mesh-list
138295880|NCT00002245|Amprenavir|amprenavir|mesh-list
138295881|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138295882|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295883|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295884|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295885|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
138295886|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295887|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295888|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295889|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295890|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
138295891|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138295892|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138295893|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138295894|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
138295896|NCT00003128|Ifosfamide|ifosfamide|mesh-list
138295897|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295898|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295899|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138295900|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138295901|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138295902|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295903|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295904|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
138295905|NCT04331197|Letrozole|letrozole|mesh-list
138295906|NCT04331197|Clomiphene|clomiphene|mesh-list
138295907|NCT04331197|Enclomiphene|enclomiphene|mesh-list
138295908|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
138295909|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295910|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295911|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138295912|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138295913|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295914|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138295915|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295916|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295917|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295918|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138295919|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
138295920|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295925|NCT05751733|Apatinib|apatinib|mesh-list
138295926|NCT05751733|Dasatinib|dasatinib|mesh-list
138295927|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295928|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138295929|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138295930|NCT05751733|Growth Substances|growth substances|mesh-ancestor
138295931|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295932|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
138295933|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138295934|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295935|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295936|NCT00002798|Cytarabine|cytarabine|mesh-list
138295937|NCT00002798|Aldesleukin|aldesleukin|mesh-list
138295938|NCT00002798|Dexamethasone|dexamethasone|mesh-list
138295939|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
138295940|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138295941|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138295942|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138295943|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
138295944|NCT00002798|Busulfan|busulfan|mesh-list
138295945|NCT00002798|Methotrexate|methotrexate|mesh-list
138295946|NCT00002798|Fludarabine|fludarabine|mesh-list
138295947|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
138295948|NCT00002798|Etoposide|etoposide|mesh-list
138295949|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
138295950|NCT00002798|Daunorubicin|daunorubicin|mesh-list
138295951|NCT00002798|Asparaginase|asparaginase|mesh-list
138295952|NCT00002798|Interleukin-2|interleukin-2|mesh-list
138295954|NCT00002798|Thioguanine|thioguanine|mesh-list
138295955|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138295956|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
138295957|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295958|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138295959|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138295960|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
138295961|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138295962|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138295963|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138295964|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138295965|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
138295966|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
138295967|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138295968|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138295969|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
138295970|NCT00002798|Hormones|hormones|mesh-ancestor
138295971|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138295972|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138295973|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138295974|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
138295975|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138295976|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138295977|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
138295978|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138295979|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295980|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138295981|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295982|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138295983|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138295984|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138295985|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
138295991|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138295992|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138295994|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138295995|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
138295996|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138295997|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138295998|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138295999|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296000|NCT00002257|Ganciclovir|ganciclovir|mesh-list
138296001|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138296002|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
138296003|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296004|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296005|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296006|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296007|NCT00003134|Irinotecan|irinotecan|mesh-list
138296008|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138296009|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296010|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296011|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296012|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296013|NCT00002545|Carmustine|carmustine|mesh-list
138296014|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296015|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
138296016|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296017|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296018|NCT00002804|Cobalt|cobalt|mesh-list
138296019|NCT00002804|Doxorubicin|doxorubicin|mesh-list
138296020|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296021|NCT00002804|Vincristine|vincristine|mesh-list
138296022|NCT00002804|Ifosfamide|ifosfamide|mesh-list
138296023|NCT00002804|Lenograstim|lenograstim|mesh-list
138296024|NCT00002804|Mesna|mesna|mesh-list
138296025|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296026|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296027|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296028|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296029|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296030|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296031|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296032|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
138296033|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296034|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296035|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296036|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296037|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296039|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
138296066|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296067|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296068|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296069|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296070|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296071|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296072|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296073|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
138296075|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296076|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296077|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
138296078|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296079|NCT00002551|Leucovorin|leucovorin|mesh-list
138296080|NCT00002551|Levamisole|levamisole|mesh-list
138296082|NCT00002551|Calcium|calcium|mesh-list
138296083|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
138296084|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296085|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296086|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
138296087|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296088|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296089|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296090|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296091|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
138296092|NCT00002551|Antidotes|antidotes|mesh-ancestor
138296093|NCT00002551|Protective Agents|protective agents|mesh-ancestor
138296094|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296095|NCT00002551|Vitamins|vitamins|mesh-ancestor
138296096|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
138296097|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296098|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
138296099|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
138296100|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138296101|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296102|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296103|NCT00003146|Melphalan|melphalan|mesh-list
138296104|NCT00003146|Busulfan|busulfan|mesh-list
138296105|NCT00003146|Thiotepa|thiotepa|mesh-list
138296106|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296107|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
138296113|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296114|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
138296115|NCT00003398|Thiotepa|thiotepa|mesh-list
138296116|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138296117|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296118|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
138296119|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296120|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296121|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296122|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
138296123|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296124|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296125|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296127|NCT00002263|Sargramostim|sargramostim|mesh-list
138296128|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
138296129|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296130|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138296131|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296132|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296133|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
138296134|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296135|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296136|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296137|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
138296138|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296139|NCT00002816|Leucovorin|leucovorin|mesh-list
138296141|NCT00002816|Cytarabine|cytarabine|mesh-list
138296142|NCT00002816|Dexamethasone|dexamethasone|mesh-list
138296143|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
138296144|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138296145|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138296146|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138296147|NCT00002816|Methotrexate|methotrexate|mesh-list
138296149|NCT00002816|Vincristine|vincristine|mesh-list
138296150|NCT00002816|Asparaginase|asparaginase|mesh-list
138296151|NCT00002816|Ifosfamide|ifosfamide|mesh-list
138296152|NCT00002816|Idarubicin|idarubicin|mesh-list
138296153|NCT00002816|Pegaspargase|pegaspargase|mesh-list
138296154|NCT00002816|Thioguanine|thioguanine|mesh-list
138296156|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138296157|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
138296158|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
138296159|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296160|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296161|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138296162|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
138296163|NCT00002816|Hormones|hormones|mesh-ancestor
138296164|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296165|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296166|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296167|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138296168|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
138296170|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296172|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296174|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296175|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138296176|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296177|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
138296178|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296179|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296180|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296181|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296182|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296183|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
138296184|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296185|NCT00002816|Antidotes|antidotes|mesh-ancestor
138296186|NCT00002816|Protective Agents|protective agents|mesh-ancestor
138296187|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296188|NCT00002816|Vitamins|vitamins|mesh-ancestor
138296189|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
138296190|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296191|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296192|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296193|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296194|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
138296195|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296196|NCT00002816|Trace Elements|trace elements|mesh-ancestor
138296197|NCT00002269|Zidovudine|zidovudine|mesh-list
138296198|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138296199|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
138296200|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296201|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138296202|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296203|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296204|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
138296205|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296206|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296207|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296208|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138296209|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138296210|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138296211|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138296212|NCT00003152|Interferons|interferons|mesh-list
138296213|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
138296214|NCT00003152|Prednisone|prednisone|mesh-list
138296215|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
138296216|NCT00003152|Vincristine|vincristine|mesh-list
138296217|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296218|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
138296219|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296220|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296221|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296222|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
138296223|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296224|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296225|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296226|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138296227|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
138296229|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296230|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296231|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
138296232|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296233|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296234|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296249|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138296250|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296251|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138296252|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138296253|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296254|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296255|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
138296256|NCT00002822|Ifosfamide|ifosfamide|mesh-list
138296257|NCT00002822|Carboplatin|carboplatin|mesh-list
138296258|NCT00002822|Doxorubicin|doxorubicin|mesh-list
138296259|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296260|NCT00002822|Etoposide|etoposide|mesh-list
138296261|NCT00002822|Vincristine|vincristine|mesh-list
138296262|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296263|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
138296264|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296265|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296266|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296267|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
138296268|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296269|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296270|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296271|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296272|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296273|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296274|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296275|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296276|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296277|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296278|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296279|NCT00002281|Zidovudine|zidovudine|mesh-list
138296280|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
138296281|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
138296283|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138296284|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296286|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
138296287|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296288|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296289|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296290|NCT00002281|Hematinics|hematinics|mesh-ancestor
138296292|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
138296293|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296294|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138296295|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296296|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296297|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
138296298|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296299|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296300|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296302|NCT00002828|Raltitrexed|raltitrexed|mesh-list
138296303|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
138296304|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296305|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296306|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296307|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296308|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
138296309|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296310|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138296313|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296314|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138296315|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296318|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138296319|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138296320|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138296321|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296322|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138296323|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
138296324|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296325|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138296326|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
138296327|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138296328|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138296330|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296331|NCT00002557|Leucovorin|leucovorin|mesh-list
138296332|NCT00002557|Doxorubicin|doxorubicin|mesh-list
138296349|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296350|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
138296351|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296352|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138296353|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296354|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
138296355|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296356|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296357|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296358|NCT00002557|Antidotes|antidotes|mesh-ancestor
138296359|NCT00002557|Protective Agents|protective agents|mesh-ancestor
138296360|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296361|NCT00002557|Vitamins|vitamins|mesh-ancestor
138296362|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
138296363|NCT00003158|Paclitaxel|paclitaxel|mesh-list
138296364|NCT00003158|Etoposide|etoposide|mesh-list
138296365|NCT00003158|Carboplatin|carboplatin|mesh-list
138296366|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296367|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296368|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296371|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296372|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296373|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296374|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296375|NCT00003416|Interferons|interferons|mesh-list
138296376|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
138296377|NCT00003416|Dexamethasone|dexamethasone|mesh-list
138296379|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138296386|NCT00003416|Hormones|hormones|mesh-ancestor
138296387|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296388|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296389|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296390|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
138296391|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296393|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296394|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
138296395|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296396|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296397|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296398|NCT00002569|Vincristine|vincristine|mesh-list
138296399|NCT00002569|Lomustine|lomustine|mesh-list
138296400|NCT00002569|Procarbazine|procarbazine|mesh-list
138296401|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296402|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296403|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296404|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296405|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296406|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296407|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296409|NCT00002840|Vincristine|vincristine|mesh-list
138296410|NCT00002840|Lomustine|lomustine|mesh-list
138296411|NCT00002840|Procarbazine|procarbazine|mesh-list
138296412|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296413|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296414|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296415|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296416|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296417|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296418|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296419|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
138296420|NCT00002846|Aldesleukin|aldesleukin|mesh-list
138296421|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296422|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296423|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296424|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
138296425|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296426|NCT05720767|Itraconazole|itraconazole|mesh-list
138296427|NCT05720767|Rifampin|rifampin|mesh-list
138296428|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
138296429|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296430|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138296431|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138296432|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296433|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296434|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138296435|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
138296436|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296454|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296455|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138296456|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138296457|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296458|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296459|NCT00002852|Paclitaxel|paclitaxel|mesh-list
138296460|NCT00002852|Carboplatin|carboplatin|mesh-list
138296461|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296462|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296463|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296464|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296465|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296466|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296467|NCT00003422|Leucovorin|leucovorin|mesh-list
138296468|NCT00003422|Fluorouracil|fluorouracil|mesh-list
138296469|NCT00003422|Calcium|calcium|mesh-list
138296470|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
138296471|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296472|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296473|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
138296474|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296475|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296476|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296477|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296478|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
138296479|NCT00003422|Antidotes|antidotes|mesh-ancestor
138296480|NCT00003422|Protective Agents|protective agents|mesh-ancestor
138296481|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296482|NCT00003422|Vitamins|vitamins|mesh-ancestor
138296483|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
138296484|NCT00003176|Temozolomide|temozolomide|mesh-list
138296485|NCT00003176|Carmustine|carmustine|mesh-list
138296486|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296487|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
138296494|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296495|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
138296496|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296497|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296498|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296499|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
138296500|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296501|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296502|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296503|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296504|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296505|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296506|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296507|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296509|NCT00002864|Octreotide|octreotide|mesh-list
138296510|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138296511|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
138296512|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296513|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296514|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296515|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296516|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138296517|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138296518|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138296519|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138296520|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
138296521|NCT00002870|Thiotepa|thiotepa|mesh-list
138296522|NCT00002870|Fluorouracil|fluorouracil|mesh-list
138296523|NCT00002870|Epirubicin|epirubicin|mesh-list
138296524|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296525|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
138296526|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296527|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296528|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296529|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
138296530|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296532|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296533|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
138296534|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296535|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296536|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296537|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296538|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296539|NCT00002581|Tamoxifen|tamoxifen|mesh-list
138296540|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
138296541|NCT00002581|Fluorouracil|fluorouracil|mesh-list
138296542|NCT00002581|Methotrexate|methotrexate|mesh-list
138296543|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296544|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
138296545|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296546|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296547|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296548|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
138296549|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296550|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296551|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296552|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
138296553|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296554|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138296555|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
138296556|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138296557|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296570|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296572|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296573|NCT00002587|Paclitaxel|paclitaxel|mesh-list
138296574|NCT00002587|Topotecan|topotecan|mesh-list
138296575|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296576|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296577|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296578|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296579|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296580|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296581|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138296582|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296583|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296584|NCT00002876|Etoposide|etoposide|mesh-list
138296585|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296586|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296587|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296588|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296589|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296590|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296591|NCT00002593|Leucovorin|leucovorin|mesh-list
138296592|NCT00002593|Levamisole|levamisole|mesh-list
138296593|NCT00002593|Fluorouracil|fluorouracil|mesh-list
138296594|NCT00002593|Calcium|calcium|mesh-list
138296595|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
138296596|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138296597|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296598|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
138296599|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296600|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296601|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296602|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296603|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
138296604|NCT00002593|Antidotes|antidotes|mesh-ancestor
138296605|NCT00002593|Protective Agents|protective agents|mesh-ancestor
138296606|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296607|NCT00002593|Vitamins|vitamins|mesh-ancestor
138296608|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
138296609|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138296610|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
138296611|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
138296612|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138296613|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296614|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296621|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
138296622|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296623|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296624|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296625|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
138296626|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296627|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296628|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138344966|NCT01843920|Timolol|timolol|mesh-list
138296629|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296630|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296631|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296632|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296633|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138296634|NCT00002882|Interferons|interferons|mesh-list
138296635|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
138296636|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
138296637|NCT00002882|Aldesleukin|aldesleukin|mesh-list
138296638|NCT00002882|Cisplatin|cisplatin|mesh-list
138296639|NCT00002882|Interleukin-2|interleukin-2|mesh-list
138296640|NCT00002882|Dacarbazine|dacarbazine|mesh-list
138296641|NCT00002882|Vinblastine|vinblastine|mesh-list
138296642|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296643|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
138296644|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296645|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
138296646|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296647|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138296648|NCT00002882|Analgesics|analgesics|mesh-ancestor
138296649|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
138296650|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296651|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138296652|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138296653|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296654|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
138296655|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296656|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296657|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296658|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296659|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296661|NCT00002888|Fluorouracil|fluorouracil|mesh-list
138296662|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296672|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296674|NCT00002599|Interferons|interferons|mesh-list
138296675|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
138296677|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
138296678|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
138296679|NCT00002599|Melphalan|melphalan|mesh-list
138296680|NCT00002599|Carmustine|carmustine|mesh-list
138296681|NCT00002599|Doxorubicin|doxorubicin|mesh-list
138296682|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296683|NCT00002599|Vincristine|vincristine|mesh-list
138296684|NCT00002599|Sargramostim|sargramostim|mesh-list
138296685|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296686|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
138296687|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296688|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296689|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296691|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296692|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296693|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296694|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296695|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296696|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296698|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138296699|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
138296700|NCT00002599|Hormones|hormones|mesh-ancestor
138296701|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296702|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296703|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
138296704|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296705|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296706|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296707|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296708|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296709|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
138296710|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
138296711|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296712|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138296713|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138296714|NCT00002599|Protective Agents|protective agents|mesh-ancestor
138296715|NCT00002599|Trace Elements|trace elements|mesh-ancestor
138296716|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
138296717|NCT00003440|Paclitaxel|paclitaxel|mesh-list
138296718|NCT00003440|Trastuzumab|trastuzumab|mesh-list
138296719|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296720|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296724|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296725|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138296726|NCT00003200|Docetaxel|docetaxel|mesh-list
138296727|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296728|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296729|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296730|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296731|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296732|NCT00003446|Leucovorin|leucovorin|mesh-list
138296733|NCT00003446|Trimetrexate|trimetrexate|mesh-list
138296734|NCT00003446|Fluorouracil|fluorouracil|mesh-list
138296736|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
138296744|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
138296745|NCT00003446|Antidotes|antidotes|mesh-ancestor
138296746|NCT00003446|Protective Agents|protective agents|mesh-ancestor
138296747|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
138296748|NCT00003446|Vitamins|vitamins|mesh-ancestor
138296749|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
138296750|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
138296751|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296752|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138296753|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296754|NCT00003938|Amphotericin B|amphotericin b|mesh-list
138296755|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138296756|NCT00003938|Amebicides|amebicides|mesh-ancestor
138296757|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138296758|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138296759|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296763|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296764|NCT00003212|Ifosfamide|ifosfamide|mesh-list
138296765|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296766|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296767|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296768|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296769|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296770|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296771|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296772|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
138296773|NCT00002611|Dactinomycin|dactinomycin|mesh-list
138296774|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
138296775|NCT00002611|Doxorubicin|doxorubicin|mesh-list
138296776|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296777|NCT00002611|Etoposide|etoposide|mesh-list
138296778|NCT00002611|Vincristine|vincristine|mesh-list
138296779|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296780|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
138296781|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296782|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296783|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296784|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
138296785|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296786|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296787|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138296788|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296789|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296790|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296791|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296792|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296793|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296794|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296795|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296796|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138296797|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138296798|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138296799|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138296800|NCT00003944|Paclitaxel|paclitaxel|mesh-list
138296801|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
138296802|NCT00003944|Carboplatin|carboplatin|mesh-list
138296803|NCT00003944|Topotecan|topotecan|mesh-list
138296804|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296805|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296806|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296807|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296808|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296809|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296810|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296811|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
138296812|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296910|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138296911|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
138296912|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138296913|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296914|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138296915|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
138296916|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
138296917|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138296918|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138296919|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138296920|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138296921|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138296922|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138296923|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296936|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138296938|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296939|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296940|NCT00002641|Doxorubicin|doxorubicin|mesh-list
138296941|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296942|NCT00002641|Ifosfamide|ifosfamide|mesh-list
138296943|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138296944|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296945|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138296946|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138296947|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296948|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296949|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296950|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
138296951|NCT00003992|Tamoxifen|tamoxifen|mesh-list
138296952|NCT00003992|Paclitaxel|paclitaxel|mesh-list
138296953|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
138296954|NCT00003992|Doxorubicin|doxorubicin|mesh-list
138296955|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296957|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138296958|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296959|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138296960|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138296961|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138296962|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296963|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296975|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138296976|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
138296977|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138296978|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138296979|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138296980|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138296981|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138296987|NCT00002653|Melphalan|melphalan|mesh-list
138296988|NCT00002653|Carmustine|carmustine|mesh-list
138296989|NCT00002653|Doxorubicin|doxorubicin|mesh-list
138296990|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138296991|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138296992|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
138296993|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138296994|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296995|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138296996|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
138296997|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138296998|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138296999|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297000|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297001|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297002|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297003|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297004|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297005|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
138297006|NCT00002653|Hormones|hormones|mesh-ancestor
138297007|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297008|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297009|NCT00003254|Fluorouracil|fluorouracil|mesh-list
138297010|NCT00003254|Eniluracil|eniluracil|mesh-list
138297011|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
138297012|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297014|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297015|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297016|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
138297017|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297018|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297019|NCT00002659|Cisplatin|cisplatin|mesh-list
138297020|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297021|NCT00003998|Paclitaxel|paclitaxel|mesh-list
138297022|NCT00003998|Docetaxel|docetaxel|mesh-list
138297023|NCT00003998|Carboplatin|carboplatin|mesh-list
138297024|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297025|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297026|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297027|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297028|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297029|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297030|NCT00004004|Procarbazine|procarbazine|mesh-list
138297031|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297032|NCT00003260|Leucovorin|leucovorin|mesh-list
138297033|NCT00003260|Fluorouracil|fluorouracil|mesh-list
138297034|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
138297035|NCT00003260|Irinotecan|irinotecan|mesh-list
138297036|NCT00003260|Calcium|calcium|mesh-list
138297037|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
138297038|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138297039|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297040|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
138297041|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297042|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297043|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297044|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297045|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
138297046|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138297047|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297048|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297049|NCT00003260|Antidotes|antidotes|mesh-ancestor
138297050|NCT00003260|Protective Agents|protective agents|mesh-ancestor
138297051|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
138297052|NCT00003260|Vitamins|vitamins|mesh-ancestor
138297053|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
138297054|NCT00002665|Leucovorin|leucovorin|mesh-list
138297055|NCT00002665|Cytarabine|cytarabine|mesh-list
138297056|NCT00002665|Dexamethasone|dexamethasone|mesh-list
138297057|NCT00002665|Prednisone|prednisone|mesh-list
138297058|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
138297059|NCT00002665|Doxorubicin|doxorubicin|mesh-list
138297060|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297061|NCT00002665|Methotrexate|methotrexate|mesh-list
138297062|NCT00002665|Etoposide|etoposide|mesh-list
138297063|NCT00002665|Vincristine|vincristine|mesh-list
138297064|NCT00002665|Daunorubicin|daunorubicin|mesh-list
138297065|NCT00002665|Asparaginase|asparaginase|mesh-list
138297066|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
138297067|NCT00002665|Thioguanine|thioguanine|mesh-list
138297068|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
138297069|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297070|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
138297071|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297072|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297073|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297074|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
138297075|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297077|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297078|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297079|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
138297080|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
138297081|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297082|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297083|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
138297084|NCT00002665|Hormones|hormones|mesh-ancestor
138297085|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297086|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297087|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297088|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297089|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297090|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297091|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297092|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297093|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297094|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297095|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
138297098|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297099|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297100|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
138297101|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297103|NCT00002665|Protective Agents|protective agents|mesh-ancestor
138297104|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
138297106|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
138297107|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297108|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297110|NCT00003536|Methotrexate|methotrexate|mesh-list
138297111|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138297112|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
138297113|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297114|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297115|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297116|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
138297117|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297118|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297119|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138297120|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297121|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138297122|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297123|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
138297124|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297125|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138297126|NCT00003542|Interferons|interferons|mesh-list
138297127|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
138297128|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297129|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
138297130|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297131|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
138297132|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297133|NCT00004010|Prednisone|prednisone|mesh-list
138297134|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
138297135|NCT00004010|Dacarbazine|dacarbazine|mesh-list
138297136|NCT00004010|Doxorubicin|doxorubicin|mesh-list
138297137|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297138|NCT00004010|Etoposide|etoposide|mesh-list
138297140|NCT00004010|Bleomycin|bleomycin|mesh-list
138297141|NCT00004010|Vinblastine|vinblastine|mesh-list
138297142|NCT00004010|Procarbazine|procarbazine|mesh-list
138297143|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297144|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
138297145|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297146|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297147|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297148|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
138297149|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297150|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297151|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297152|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297153|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297154|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297155|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297156|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297158|NCT00004010|Hormones|hormones|mesh-ancestor
138297159|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297160|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297161|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297162|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297163|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297164|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297165|NCT00004016|Interferons|interferons|mesh-list
138297166|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
138297167|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297168|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
138297169|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297170|NCT00004022|Aldesleukin|aldesleukin|mesh-list
138297171|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
138297172|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297174|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138297175|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
138297176|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297177|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
138297178|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297179|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297180|NCT00381901|Trastuzumab|trastuzumab|mesh-list
138297181|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297182|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297183|NCT00003278|Dexamethasone|dexamethasone|mesh-list
138297184|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297185|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
138297186|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
138297187|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297188|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297189|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297190|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
138297191|NCT00003278|Hormones|hormones|mesh-ancestor
138297192|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297193|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297194|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297195|NCT00004028|Carmustine|carmustine|mesh-list
138297197|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
138297198|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297199|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297200|NCT00003554|Prednisone|prednisone|mesh-list
138297201|NCT00003554|Rituximab|rituximab|mesh-list
138297202|NCT00003554|Melphalan|melphalan|mesh-list
138297203|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297204|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297205|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
138297206|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297207|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297208|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297209|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
138297210|NCT00003554|Hormones|hormones|mesh-ancestor
138297211|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297212|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297213|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297214|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
138297215|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297216|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138297217|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297218|NCT00003284|Paclitaxel|paclitaxel|mesh-list
138297219|NCT00003284|Etoposide|etoposide|mesh-list
138297220|NCT00003284|Carboplatin|carboplatin|mesh-list
138297221|NCT00003284|Ifosfamide|ifosfamide|mesh-list
138297222|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138297223|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297224|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297225|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297226|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297227|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297228|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138297229|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297230|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297231|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297232|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
138297233|NCT00384410|Nabilone|nabilone|mesh-list
138297234|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
138297235|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
138297236|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297237|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297238|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297239|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138297240|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138297241|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138297242|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138297243|NCT00004040|Interferons|interferons|mesh-list
138297244|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
138297245|NCT00004040|Rituximab|rituximab|mesh-list
138297246|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297247|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297248|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
138297249|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297250|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297251|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
138297252|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297253|NCT00004046|Exatecan|exatecan|mesh-list
138297254|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138297255|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297256|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297257|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297258|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297259|NCT00003560|Carboplatin|carboplatin|mesh-list
138297260|NCT00003560|Docetaxel|docetaxel|mesh-list
138297262|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
138297263|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
138297264|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297265|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297266|NCT00003290|Hormones|hormones|mesh-list
138297267|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297268|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297269|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
138297270|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138297271|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297272|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138297273|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297274|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
138297275|NCT00003572|Tacrolimus|tacrolimus|mesh-list
138297276|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297277|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
138297278|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297279|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138297280|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297281|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297282|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138297283|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297284|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138297285|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
138297286|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138297287|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138297288|NCT00002689|Dexamethasone|dexamethasone|mesh-list
138297289|NCT00002689|Fluorouracil|fluorouracil|mesh-list
138297290|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297291|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
138297292|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
138297293|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297294|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297295|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138297298|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297299|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297300|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297301|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
138297302|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297303|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297311|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138297312|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297313|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297314|NCT00004064|Oregovomab|oregovomab|mesh-list
138297315|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138297316|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297317|NCT00382057|Anastrozole|anastrozole|mesh-list
138297318|NCT00382057|Goserelin|goserelin|mesh-list
138297319|NCT00382057|Testosterone|testosterone|mesh-list
138297320|NCT00382057|Androgens|androgens|mesh-ancestor
138297321|NCT00382057|Hormones|hormones|mesh-ancestor
138297322|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138297323|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297324|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138297325|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297326|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138297327|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138297328|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297329|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297330|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138297331|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
138297332|NCT00003578|Cytarabine|cytarabine|mesh-list
138297333|NCT00003578|Prednisone|prednisone|mesh-list
138297334|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
138297335|NCT00003578|Melphalan|melphalan|mesh-list
138297336|NCT00003578|Carmustine|carmustine|mesh-list
138297337|NCT00003578|Doxorubicin|doxorubicin|mesh-list
138297338|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138297339|NCT00003578|Etoposide|etoposide|mesh-list
138297341|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138297342|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
138297343|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342060|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138342061|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138342062|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342063|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342064|NCT01611948|Aprepitant|aprepitant|mesh-list
138342065|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
138342066|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
138342067|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342068|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342069|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342070|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138342071|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342072|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342073|NCT01612884|Clopidogrel|clopidogrel|mesh-list
138342074|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138342075|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138342076|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138342077|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138342078|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138342080|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342081|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342082|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342084|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138342085|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
138342086|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342087|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342088|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342089|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342090|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138342091|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138342092|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138342094|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138342095|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342096|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
138342097|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138342098|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
138342099|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
138342100|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342101|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342102|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342103|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342105|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342106|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
138342107|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138342108|NCT01619982|Vancomycin|vancomycin|mesh-list
138342109|NCT01619982|Cefazolin|cefazolin|mesh-list
138342110|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342111|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342112|NCT01620216|Sorafenib|sorafenib|mesh-list
138342113|NCT01620216|Sunitinib|sunitinib|mesh-list
138342114|NCT01620216|Dasatinib|dasatinib|mesh-list
138342115|NCT01620216|Ponatinib|ponatinib|mesh-list
138342116|NCT01620216|Idelalisib|idelalisib|mesh-list
138342117|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
138342118|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138342119|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138342120|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342121|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342122|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138342123|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342124|NCT01620216|Growth Substances|growth substances|mesh-ancestor
138342125|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342126|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
138342127|NCT01621230|Fentanyl|fentanyl|mesh-list
138342128|NCT01621230|Bupivacaine|bupivacaine|mesh-list
138342129|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342130|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
138342131|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342132|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342133|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
138342134|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342135|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342139|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342140|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
138342157|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342158|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342159|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138342160|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138342161|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
138342162|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138342163|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
138342164|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138342165|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138342166|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138342167|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
138342168|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138342169|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138342170|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
138342171|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342172|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
138342173|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138342174|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138342175|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
138342176|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138342177|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138342178|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138342179|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342180|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342181|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
138342182|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342183|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342184|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138342185|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342186|NCT01636206|Lifitegrast|lifitegrast|mesh-list
138342187|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138342188|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138342189|NCT01639872|Risperidone|risperidone|mesh-list
138342190|NCT01639872|Clozapine|clozapine|mesh-list
138342191|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138342192|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
138342193|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342194|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342195|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342196|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138342197|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138342198|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342199|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342202|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
138342203|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
138342204|NCT01640340|Dexamethasone|dexamethasone|mesh-list
138342205|NCT01640340|Ondansetron|ondansetron|mesh-list
138342206|NCT01640340|Aprepitant|aprepitant|mesh-list
138342207|NCT01640340|Palonosetron|palonosetron|mesh-list
138342208|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342209|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
138342210|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
138342211|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342212|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342213|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342214|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
138342215|NCT01640340|Hormones|hormones|mesh-ancestor
138342216|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342217|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342218|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342219|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
138342220|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
138342221|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138342222|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138342223|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
138342224|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342225|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342226|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138342227|NCT01641120|Interferons|interferons|mesh-list
138342228|NCT01641120|Interferon-beta|interferon-beta|mesh-list
138342229|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
138342230|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342231|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
138342232|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342233|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
138342234|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342235|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138342236|NCT01643382|Insulin|insulin|mesh-list
138342237|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138342238|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342239|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342240|NCT01643616|Midazolam|midazolam|mesh-list
138342241|NCT01643616|Ropivacaine|ropivacaine|mesh-list
138342242|NCT01643616|Prilocaine|prilocaine|mesh-list
138342243|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342244|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
138342245|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342246|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342247|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
138342248|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342249|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138342250|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138342251|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138342252|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138342253|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342254|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342255|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
138342256|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
138342258|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342259|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342261|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138342262|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342263|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138342264|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
138342265|NCT01645098|Ketamine|ketamine|mesh-list
138342266|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138342267|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342268|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342269|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138342270|NCT01645098|Analgesics|analgesics|mesh-ancestor
138342272|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342273|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138342274|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138342275|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138342276|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342277|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342278|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342279|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138342280|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342281|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
138342282|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
138342283|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138342284|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138342285|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
138342286|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
138342287|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138342288|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138342289|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342290|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
138342291|NCT01651806|Coagulants|coagulants|mesh-ancestor
138342293|NCT01652040|Testosterone|testosterone|mesh-list
138342294|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
138342295|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
138342296|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138342297|NCT01652040|Androgens|androgens|mesh-ancestor
138342299|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342300|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342301|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342302|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342303|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
138342305|NCT01652976|Fluorouracil|fluorouracil|mesh-list
138342306|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
138342307|NCT01652976|Dasatinib|dasatinib|mesh-list
138342308|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
138342309|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342310|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138342311|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342312|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342313|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
138342314|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342315|NCT01652976|Antidotes|antidotes|mesh-ancestor
138342331|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342332|NCT01661088|Folfirinox|folfirinox|mesh-list
138342333|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342336|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138342337|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342338|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138342339|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342340|NCT01661946|Growth Substances|growth substances|mesh-ancestor
138342341|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342342|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
138342343|NCT01663272|Gemcitabine|gemcitabine|mesh-list
138342344|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138342345|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
138342346|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342349|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
138342351|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
138342352|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342353|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138342354|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138342355|NCT01668030|Bacitracin|bacitracin|mesh-list
138342356|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138342357|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342358|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342359|NCT01669434|Ramipril|ramipril|mesh-list
138342360|NCT01669434|Enalapril|enalapril|mesh-list
138342361|NCT01669434|Enalaprilat|enalaprilat|mesh-list
138342362|NCT01669434|Lisinopril|lisinopril|mesh-list
138342363|NCT01669434|Perindopril|perindopril|mesh-list
138342364|NCT01669434|Benazepril|benazepril|mesh-list
138342365|NCT01669434|Captopril|captopril|mesh-list
138342366|NCT01669434|Quinapril|quinapril|mesh-list
138342367|NCT01669434|Trandolapril|trandolapril|mesh-list
138342368|NCT01669434|Fosinopril|fosinopril|mesh-list
138342369|NCT01669434|Moexipril|moexipril|mesh-list
138342370|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138342371|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
138342372|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342373|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342374|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138342375|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138342376|NCT01669434|Protective Agents|protective agents|mesh-ancestor
138342377|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342378|NCT01678794|Candesartan|candesartan|mesh-list
138342379|NCT01678794|Candesartan cilexetil|candesartan cilexetil|mesh-list
138342380|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138342381|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138342382|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138342383|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342384|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138342385|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138342386|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342387|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138342388|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138342389|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342390|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342391|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342392|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
138342393|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342394|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138342395|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138342396|NCT01682538|Nitisinone|nitisinone|mesh-list
138342397|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342398|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342399|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138342400|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
138342401|NCT01684020|Coagulants|coagulants|mesh-ancestor
138342402|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
138342403|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138342404|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
138342405|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342406|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342407|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138342408|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138342409|NCT01689324|Vaccines|vaccines|mesh-list
138342410|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
138342411|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342425|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342426|NCT01695330|Bortezomib|bortezomib|mesh-list
138342427|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342428|NCT01701102|Fentanyl|fentanyl|mesh-list
138342429|NCT01701102|Mepivacaine|mepivacaine|mesh-list
138342430|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342431|NCT01701102|Narcotics|narcotics|mesh-ancestor
138342432|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342433|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342434|NCT01701102|Analgesics|analgesics|mesh-ancestor
138342435|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
138342436|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342437|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138342438|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342439|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
138342440|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
138342441|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342442|NCT01701414|Bupivacaine|bupivacaine|mesh-list
138342443|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342444|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
138342445|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342446|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342447|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
138342448|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342449|NCT01706952|Epinephrine|epinephrine|mesh-list
138342450|NCT01706952|Racepinephrine|racepinephrine|mesh-list
138342451|NCT01706952|Cocaine|cocaine|mesh-list
138342452|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138342453|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
138342454|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138342455|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138342456|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342457|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342458|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342459|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342460|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138342461|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138342462|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
138342463|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342464|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138342465|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
138342466|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
138342469|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342470|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
138342471|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342472|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
138342473|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138342474|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138342475|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342476|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
138342477|NCT01707420|Gabapentin|gabapentin|mesh-list
138342481|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342482|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
138342483|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138342484|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138342485|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342486|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342487|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138342488|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138342489|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342490|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342491|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
138342492|NCT01708122|Fentanyl|fentanyl|mesh-list
138342493|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342494|NCT01708122|Narcotics|narcotics|mesh-ancestor
138342495|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342496|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342497|NCT01708122|Analgesics|analgesics|mesh-ancestor
138342498|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
138342499|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342500|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138342501|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138342502|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
138342503|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
138342504|NCT01708278|Folic Acid|folic acid|mesh-list
138342505|NCT01708278|Quercetin|quercetin|mesh-list
138342506|NCT01708278|Hematinics|hematinics|mesh-ancestor
138342539|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138342540|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
138342541|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342542|NCT05661942|Calcium|calcium|mesh-list
138342543|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138342544|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342545|NCT05636436|Vaccines|vaccines|mesh-list
138342546|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
138342547|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342548|NCT05463354|Vaccines|vaccines|mesh-list
138342549|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
138342550|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342551|NCT05293548|Vaccines|vaccines|mesh-list
138342552|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
138342553|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342554|NCT05157360|Vitamins|vitamins|mesh-list
138342555|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
138342556|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
138342557|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342558|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342559|NCT05136066|Peppermint oil|peppermint oil|mesh-list
138342560|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
138342561|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
138342562|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342563|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342564|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342565|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
138342567|NCT04676802|Narcotics|narcotics|mesh-ancestor
138342568|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342569|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342570|NCT04676802|Analgesics|analgesics|mesh-ancestor
138342571|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
138342572|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342573|NCT01309074|Pregabalin|pregabalin|mesh-list
138342574|NCT01309074|Sertraline|sertraline|mesh-list
138342575|NCT01309074|Analgesics|analgesics|mesh-ancestor
138342576|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
138342577|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342578|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342579|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
138342580|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138342581|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138342582|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342583|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138342584|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138342585|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138342586|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342587|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342588|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
138342589|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138342590|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138342591|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342592|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
138342593|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
138342594|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
138342595|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342596|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342597|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342598|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
138342599|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
138342600|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
138342601|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342602|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342603|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138342610|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342611|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
138342612|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
138342613|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138342614|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
138342615|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342616|NCT01721226|Narcotics|narcotics|mesh-ancestor
138342617|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342618|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342619|NCT01721226|Analgesics|analgesics|mesh-ancestor
138342620|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
138342621|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342623|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138342624|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342625|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342626|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138342627|NCT01721460|Analgesics|analgesics|mesh-ancestor
138342628|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
138342629|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342630|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138342631|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138342632|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138342633|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342634|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342635|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342636|NCT01722318|Plecanatide|plecanatide|mesh-list
138342637|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138342638|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
138342639|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342640|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342642|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342643|NCT01723722|Narcotics|narcotics|mesh-ancestor
138342644|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342645|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342646|NCT01723722|Analgesics|analgesics|mesh-ancestor
138342647|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
138342648|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342649|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
138342650|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
138342651|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
138342652|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138342653|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138342654|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342655|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
138342656|NCT01728636|Coagulants|coagulants|mesh-ancestor
138342657|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
138342658|NCT01729338|Lenalidomide|lenalidomide|mesh-list
138342659|NCT01729338|Bortezomib|bortezomib|mesh-list
138342660|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342661|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
138342662|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342663|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138342664|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138342665|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
138342666|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342667|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342668|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138342669|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138342670|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342671|NCT01729338|Growth Substances|growth substances|mesh-ancestor
138342672|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
138342673|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
138342674|NCT01729494|Prednisone|prednisone|mesh-list
138342675|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
138342676|NCT01729494|Abatacept|abatacept|mesh-list
138342677|NCT01729494|Tacrolimus|tacrolimus|mesh-list
138342678|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
138342679|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138342680|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342681|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
138342682|NCT01729494|Hormones|hormones|mesh-ancestor
138342683|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342684|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342685|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342686|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342687|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342688|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
138342689|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138342690|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342691|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342692|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138342693|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138342695|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342696|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342697|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138342698|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138342699|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138342720|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138342721|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138342722|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342723|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
138342724|NCT04724772|Coagulants|coagulants|mesh-ancestor
138342725|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
138342726|NCT03878472|Apatinib|apatinib|mesh-list
138342727|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342728|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138342729|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342730|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342731|NCT03162510|Paclitaxel|paclitaxel|mesh-list
138342732|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138342733|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
138342734|NCT03162510|Tegafur|tegafur|mesh-list
138342735|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138342736|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342737|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
138342738|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
138342739|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
138342740|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342741|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138342742|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
138342743|NCT02996760|Mitogens|mitogens|mesh-list
138342744|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
138342745|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342746|NCT02987946|Nadroparin|nadroparin|mesh-list
138342747|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
138342749|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138342750|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342751|NCT02394132|Imiquimod|imiquimod|mesh-list
138342752|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138342753|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
138342754|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342755|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342756|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
138342757|NCT00700596|Salvinorin A|salvinorin a|mesh-list
138342758|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
138342759|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342760|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138342761|NCT01733472|Remifentanil|remifentanil|mesh-list
138342762|NCT01733472|Propofol|propofol|mesh-list
138342763|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138342764|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138342765|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342768|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
138342769|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138342770|NCT01733472|Narcotics|narcotics|mesh-ancestor
138342771|NCT01733472|Analgesics|analgesics|mesh-ancestor
138342772|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
138342773|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342775|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138342776|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138342777|NCT01736358|Analgesics|analgesics|mesh-ancestor
138342778|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
138342779|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342780|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342781|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342782|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138342783|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138342784|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342785|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342786|NCT01740258|Bevacizumab|bevacizumab|mesh-list
138342787|NCT01740258|Temozolomide|temozolomide|mesh-list
138342788|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138342789|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342790|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138342791|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342792|NCT01740258|Growth Substances|growth substances|mesh-ancestor
138342793|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342794|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
138342795|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138342796|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
138342797|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342798|NCT01740414|Ibudilast|ibudilast|mesh-list
138342799|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138342834|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138342835|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138342837|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
138342838|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138342839|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342840|NCT01746420|Growth Substances|growth substances|mesh-ancestor
138342841|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342842|NCT01749930|Timolol|timolol|mesh-list
138342843|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138342844|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138342845|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
138342846|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342847|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342848|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342849|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138342850|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138342851|NCT01750086|Denosumab|denosumab|mesh-list
138342852|NCT01750086|Alendronate|alendronate|mesh-list
138342853|NCT01750086|Teriparatide|teriparatide|mesh-list
138342854|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138342855|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342856|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138342857|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
138342858|NCT01750398|Leuprolide|leuprolide|mesh-list
138342859|NCT01750398|Goserelin|goserelin|mesh-list
138342860|NCT01750398|Testosterone|testosterone|mesh-list
138342861|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
138342862|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
138342863|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138342864|NCT01750398|Androgens|androgens|mesh-ancestor
138342865|NCT01750398|Hormones|hormones|mesh-ancestor
138342866|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342867|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342868|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138342869|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342870|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
138342871|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138342872|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
138342873|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138342874|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
138342875|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342876|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138342877|NCT01752426|Protective Agents|protective agents|mesh-ancestor
138342878|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342880|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138342881|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342882|NCT01753362|Incretins|incretins|mesh-ancestor
138342883|NCT01753362|Hormones|hormones|mesh-ancestor
138342884|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342885|NCT01758588|Interferons|interferons|mesh-list
138342886|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
138342887|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138342888|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342889|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
138342890|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342891|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
138342892|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342894|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138342895|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138342896|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
138342897|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342898|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138342899|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138342900|NCT01760304|Budesonide|budesonide|mesh-list
138342901|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
138342902|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138342903|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138342904|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
138342905|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342906|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342907|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138342910|NCT01760304|Hormones|hormones|mesh-ancestor
138342911|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342912|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138342913|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138342948|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138342949|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138342950|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
138342951|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342952|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
138342953|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
138342954|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342955|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138342956|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
138342957|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
138342958|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138342959|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
138342960|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
138342961|NCT01773954|Aflibercept|aflibercept|mesh-list
138342962|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138342963|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138342964|NCT01773954|Growth Substances|growth substances|mesh-ancestor
138342965|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342966|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
138342967|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138342968|NCT01778634|Azithromycin|azithromycin|mesh-list
138342969|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342970|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342971|NCT01783236|Acetaminophen|acetaminophen|mesh-list
138342972|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138342973|NCT01783236|Analgesics|analgesics|mesh-ancestor
138342975|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342976|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342977|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
138342978|NCT01783470|Mirabegron|mirabegron|mesh-list
138342979|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
138342980|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
138342981|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138342982|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138342983|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138342984|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342985|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342986|NCT01783470|Urological Agents|urological agents|mesh-ancestor
138342987|NCT01783860|Azithromycin|azithromycin|mesh-list
138342988|NCT01783860|Doxycycline|doxycycline|mesh-list
138342989|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342990|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138342991|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
138342992|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138342993|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138342994|NCT01785186|Pyridoxine|pyridoxine|mesh-list
138342995|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
138342997|NCT01785186|Isoniazid|isoniazid|mesh-list
138342998|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
138342999|NCT01785186|Ethambutol|ethambutol|mesh-list
138343000|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343001|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343002|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138343003|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138343004|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343005|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343006|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343007|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343008|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138343009|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
138343010|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
138343011|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138343012|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138343013|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138343014|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138343015|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138343016|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138343017|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138343018|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138343019|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138343020|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
138343021|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138343022|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
138343024|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
138343026|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138343027|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138344967|NCT01843920|Dorzolamide|dorzolamide|mesh-list
138343028|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343029|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138343030|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138343031|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
138343032|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343033|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138343035|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343036|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343037|NCT01787916|Liraglutide|liraglutide|mesh-list
138343038|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138343039|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343040|NCT01787916|Incretins|incretins|mesh-ancestor
138343041|NCT01787916|Hormones|hormones|mesh-ancestor
138343042|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343043|NCT01790490|Ketamine|ketamine|mesh-list
138343044|NCT01790490|Lorazepam|lorazepam|mesh-list
138343045|NCT01790490|Analgesics|analgesics|mesh-ancestor
138343046|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
138343047|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343048|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343049|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138343050|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343051|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
138343058|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
138343059|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
138343064|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138343065|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343066|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
138343067|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
138343069|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138343070|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
138343071|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343072|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343073|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138343074|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343075|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
138343076|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138343077|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138343078|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138343079|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138343080|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
138343081|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343082|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343085|NCT01794702|Clofarabine|clofarabine|mesh-list
138343087|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343088|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
138343089|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343090|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343091|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
138343092|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343093|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343094|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
138343095|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343096|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343097|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138343098|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138343099|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138343100|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
138343101|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343102|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343103|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343104|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343105|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
138343106|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343107|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
138343108|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138343109|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
138343112|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138343113|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343114|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
138343115|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138343116|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
138343117|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343118|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343120|NCT01811940|Adderall|adderall|mesh-list
138343145|NCT06020560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138343146|NCT06020560|Anticoagulants|anticoagulants|mesh-ancestor
138343147|NCT06020560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138343148|NCT06020560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138343149|NCT06020560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343150|NCT06020456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138343151|NCT06020456|Hemostatics|hemostatics|mesh-ancestor
138343152|NCT06020456|Coagulants|coagulants|mesh-ancestor
138343153|NCT06020456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138343154|NCT06020456|Natriuretic Agents|natriuretic agents|mesh-ancestor
138343155|NCT06020456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343156|NCT06020378|Hydroxychloroquine|hydroxychloroquine|mesh-list
138343157|NCT06020378|Antimalarials|antimalarials|mesh-ancestor
138343158|NCT06020378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138343159|NCT06020378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138343160|NCT06020378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343161|NCT06020378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343162|NCT06020378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343163|NCT06020378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343164|NCT06020352|Axitinib|axitinib|mesh-list
138343165|NCT06020352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343166|NCT06020352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343167|NCT06020352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343170|NCT06020313|Antioxidants|antioxidants|mesh-ancestor
138343171|NCT06020313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343172|NCT06020313|Protective Agents|protective agents|mesh-ancestor
138343173|NCT06020313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343174|NCT06020313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343175|NCT06020313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138343178|NCT06020300|Vitamin B 6|vitamin b 6|mesh-list
138343179|NCT06020300|Colchicine|colchicine|mesh-list
138343180|NCT06020300|Gout Suppressants|gout suppressants|mesh-ancestor
138343181|NCT06020300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343182|NCT06020300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138343183|NCT06020300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138343184|NCT06020300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138343185|NCT06020300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343186|NCT06020300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343187|NCT06020300|Vitamin B Complex|vitamin b complex|mesh-ancestor
138343188|NCT06020300|Vitamins|vitamins|mesh-ancestor
138343189|NCT06020300|Micronutrients|micronutrients|mesh-ancestor
138343190|NCT06020300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343191|NCT06020196|Anesthetics|anesthetics|mesh-list
138343192|NCT06020196|Anesthetics, Local|anesthetics, local|mesh-list
138343193|NCT06020196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343194|NCT06020196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343195|NCT06020196|Sensory System Agents|sensory system agents|mesh-ancestor
138343196|NCT06020196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343197|NCT06019858|Vitamins|vitamins|mesh-list
138343198|NCT06019858|Micronutrients|micronutrients|mesh-ancestor
138343199|NCT06019858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343200|NCT06019520|Acetylcysteine|acetylcysteine|mesh-list
138343201|NCT06019520|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138343202|NCT06019520|Antiviral Agents|antiviral agents|mesh-ancestor
138343203|NCT06019520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343204|NCT06019520|Expectorants|expectorants|mesh-ancestor
138343205|NCT06019520|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343206|NCT06019520|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138343208|NCT06019520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343209|NCT06019520|Protective Agents|protective agents|mesh-ancestor
138343210|NCT06019520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343211|NCT06019520|Antidotes|antidotes|mesh-ancestor
138343212|NCT06019507|Mycophenolic Acid|mycophenolic acid|mesh-list
138343213|NCT06019507|Cyclophosphamide|cyclophosphamide|mesh-list
138343214|NCT06019507|Tacrolimus|tacrolimus|mesh-list
138343215|NCT06019507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343216|NCT06019507|Immunologic Factors|immunologic factors|mesh-ancestor
138343217|NCT06019507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343218|NCT06019507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343219|NCT06019507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343220|NCT06019507|Alkylating Agents|alkylating agents|mesh-ancestor
138343221|NCT06019507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343222|NCT06019507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343223|NCT06019507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138343224|NCT06019507|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138343225|NCT06019507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343226|NCT06019507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138343227|NCT06019507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138343228|NCT06019507|Antitubercular Agents|antitubercular agents|mesh-ancestor
138343229|NCT06019507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343230|NCT06019507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343231|NCT06019286|Hormones|hormones|mesh-list
138343232|NCT06019286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343233|NCT06019286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343235|NCT06019130|Interferon-beta|interferon-beta|mesh-list
138343236|NCT06019130|Interferon beta-1a|interferon beta-1a|mesh-list
138343237|NCT06019130|Cisplatin|cisplatin|mesh-list
138343238|NCT06019130|Gemcitabine|gemcitabine|mesh-list
138343239|NCT06019130|Fluorouracil|fluorouracil|mesh-list
138343240|NCT06019130|Nivolumab|nivolumab|mesh-list
138343241|NCT06019130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343242|NCT06019130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343243|NCT06019130|Antimetabolites|antimetabolites|mesh-ancestor
138343244|NCT06019130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343245|NCT06019130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343247|NCT06019130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343248|NCT06019130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343249|NCT06019130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138343250|NCT06019130|Antiviral Agents|antiviral agents|mesh-ancestor
138343251|NCT06019130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343252|NCT06019130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138343253|NCT06018948|Dexmedetomidine|dexmedetomidine|mesh-list
138343254|NCT06018948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343255|NCT06018948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343256|NCT06018948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343257|NCT06018948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343258|NCT06018948|Analgesics|analgesics|mesh-ancestor
138343259|NCT06018948|Sensory System Agents|sensory system agents|mesh-ancestor
138343260|NCT06018948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343261|NCT06018948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138343262|NCT06018948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138343263|NCT06018948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138343264|NCT06018948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138343265|NCT06018948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343266|NCT06018948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343267|NCT06018805|Anesthetics|anesthetics|mesh-list
138343268|NCT06018805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343269|NCT06018805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343270|NCT06018675|Lidocaine|lidocaine|mesh-list
138343271|NCT06018675|Anesthetics, Local|anesthetics, local|mesh-ancestor
138343272|NCT06018675|Anesthetics|anesthetics|mesh-ancestor
138343273|NCT06018675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343274|NCT06018675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343275|NCT06018675|Sensory System Agents|sensory system agents|mesh-ancestor
138343276|NCT06018675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343277|NCT06018675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138343278|NCT06018675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138343279|NCT06018675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138343280|NCT06018675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343281|NCT06018675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343282|NCT06014944|Antibodies|antibodies|mesh-list
138343283|NCT06014944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138343284|NCT06014944|Immunologic Factors|immunologic factors|mesh-ancestor
138343285|NCT06014944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343286|NCT06014359|Dexmedetomidine|dexmedetomidine|mesh-list
138343287|NCT06014359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343288|NCT06014359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343289|NCT06014359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343290|NCT06014359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343291|NCT06014359|Analgesics|analgesics|mesh-ancestor
138343292|NCT06014359|Sensory System Agents|sensory system agents|mesh-ancestor
138343293|NCT06014359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343294|NCT06014359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138343295|NCT06014359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138343296|NCT06014359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138343297|NCT06014359|Adrenergic Agents|adrenergic agents|mesh-ancestor
138343298|NCT06014359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343299|NCT06014359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343300|NCT06011746|Ketamine|ketamine|mesh-list
138343301|NCT06011746|Levobupivacaine|levobupivacaine|mesh-list
138343302|NCT06011746|Analgesics|analgesics|mesh-ancestor
138343303|NCT06011746|Sensory System Agents|sensory system agents|mesh-ancestor
138343304|NCT06011746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343305|NCT06011746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343306|NCT06011746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138343307|NCT06011746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343308|NCT06011746|Anesthetics, General|anesthetics, general|mesh-ancestor
138343309|NCT06011746|Anesthetics|anesthetics|mesh-ancestor
138343310|NCT06011746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343311|NCT06011746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138343312|NCT06011746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138343313|NCT06011746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343314|NCT06011746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343315|NCT06011746|Anesthetics, Local|anesthetics, local|mesh-ancestor
138343317|NCT05997134|Analgesics|analgesics|mesh-ancestor
138343319|NCT05997134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343320|NCT05997134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343321|NCT05997134|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138343322|NCT05997134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343323|NCT05997134|Anesthetics, General|anesthetics, general|mesh-ancestor
138343324|NCT05997134|Anesthetics|anesthetics|mesh-ancestor
138343325|NCT05997134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343326|NCT05997134|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138343327|NCT05997134|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138343328|NCT05997134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343329|NCT05997134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343330|NCT05982990|Fluticasone|fluticasone|mesh-list
138343331|NCT05982990|Xhance|xhance|mesh-list
138343332|NCT05982990|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138343333|NCT05982990|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138343334|NCT05982990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343335|NCT05982990|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138343336|NCT05982990|Autonomic Agents|autonomic agents|mesh-ancestor
138343337|NCT05982990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343338|NCT05982990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343339|NCT05982990|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138343340|NCT05982990|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343341|NCT05982990|Dermatologic Agents|dermatologic agents|mesh-ancestor
138343342|NCT05982990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138343343|NCT05982990|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138343344|NCT05982990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138343345|NCT05982990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138343346|NCT05982990|Adrenergic Agents|adrenergic agents|mesh-ancestor
138343347|NCT05982990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343348|NCT05982990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343349|NCT05982990|Glucocorticoids|glucocorticoids|mesh-ancestor
138343350|NCT05982990|Hormones|hormones|mesh-ancestor
138343351|NCT05982990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343352|NCT05982990|Sympathomimetics|sympathomimetics|mesh-ancestor
138343353|NCT05979740|Disitamab vedotin|disitamab vedotin|mesh-list
138343354|NCT05979740|Immunoconjugates|immunoconjugates|mesh-ancestor
138343355|NCT05979740|Immunologic Factors|immunologic factors|mesh-ancestor
138343356|NCT05979740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343357|NCT05972655|Capecitabine|capecitabine|mesh-list
138343358|NCT05972655|Oxaliplatin|oxaliplatin|mesh-list
138343359|NCT05972655|Antibodies|antibodies|mesh-list
138343360|NCT05972655|Immunologic Factors|immunologic factors|mesh-ancestor
138343361|NCT05972655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343362|NCT05972655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343363|NCT05972655|Antimetabolites|antimetabolites|mesh-ancestor
138343364|NCT05972655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343365|NCT05972655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343366|NCT05971719|Glycerol|glycerol|mesh-list
138343367|NCT05971719|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138343368|NCT05971719|Protective Agents|protective agents|mesh-ancestor
138343369|NCT05971719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343370|NCT05962502|Irinotecan|irinotecan|mesh-list
138343371|NCT05962502|Cetuximab|cetuximab|mesh-list
138343372|NCT05962502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138343373|NCT05962502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138343374|NCT05962502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343376|NCT05962502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343377|NCT05962502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343378|NCT05957757|Tislelizumab|tislelizumab|mesh-list
138343379|NCT05957757|Disitamab vedotin|disitamab vedotin|mesh-list
138345048|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
138343380|NCT05957757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343381|NCT05957757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343382|NCT05957757|Immunoconjugates|immunoconjugates|mesh-ancestor
138343383|NCT05957757|Immunologic Factors|immunologic factors|mesh-ancestor
138343384|NCT05957757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343385|NCT05934227|Amoxicillin|amoxicillin|mesh-list
138343386|NCT05934227|Metronidazole|metronidazole|mesh-list
138343387|NCT05934227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343388|NCT05934227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343389|NCT05934227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138343390|NCT05934227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138343391|NCT05880706|Osimertinib|osimertinib|mesh-list
138343392|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343393|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343394|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343395|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343396|NCT05877820|Lenvatinib|lenvatinib|mesh-list
138343397|NCT05877820|Tislelizumab|tislelizumab|mesh-list
138343398|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343399|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343400|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343401|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343402|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343403|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
138343404|NCT05875077|Propofol|propofol|mesh-list
138343405|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343406|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343407|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343408|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343409|NCT05875077|Analgesics|analgesics|mesh-ancestor
138343410|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
138343411|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343412|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138343413|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138343414|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138343415|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138343416|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343417|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343418|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343419|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
138343421|NCT05852158|Cefazolin|cefazolin|mesh-list
138343422|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343423|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343424|NCT05833529|Cocaine|cocaine|mesh-list
138343425|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
138343426|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
138343427|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343428|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343429|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
138343430|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343431|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138343432|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138343433|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343434|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343435|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343438|NCT05776979|Lenalidomide|lenalidomide|mesh-list
138343439|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
138343440|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343441|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138343442|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138343443|NCT05776979|Growth Substances|growth substances|mesh-ancestor
138343444|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
138343445|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343446|NCT05727397|Aflibercept|aflibercept|mesh-list
138343447|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138343448|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138343449|NCT05727397|Growth Substances|growth substances|mesh-ancestor
138343450|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343451|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
138343452|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343453|NCT05711628|Carboplatin|carboplatin|mesh-list
138343454|NCT05711628|Gemcitabine|gemcitabine|mesh-list
138343455|NCT05711628|Doxorubicin|doxorubicin|mesh-list
138343456|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138343457|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
138343458|NCT05711628|Etoposide|etoposide|mesh-list
138343461|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138343462|NCT05711628|Ifosfamide|ifosfamide|mesh-list
138343463|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
138343464|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138343465|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
138343466|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138343467|NCT05711628|Antibodies|antibodies|mesh-list
138343468|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
138343469|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138343470|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
138343471|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
138343472|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343473|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343474|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343475|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
138343476|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343477|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138343478|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138343479|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138343480|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343481|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138343482|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138343483|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
138343484|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
138343485|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138343486|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343487|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
138343488|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
138343489|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
138343490|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
138343491|NCT05704634|Cemiplimab|cemiplimab|mesh-list
138343492|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343493|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343494|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
138343495|NCT05677490|Leucovorin|leucovorin|mesh-list
138343496|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
138343497|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138343498|NCT05677490|Fluorouracil|fluorouracil|mesh-list
138343499|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
138343500|NCT05677490|Nivolumab|nivolumab|mesh-list
138343501|NCT05677490|Irinotecan|irinotecan|mesh-list
138343502|NCT05677490|Calcium|calcium|mesh-list
138343503|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
138343504|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138343505|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343506|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138343508|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343509|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343511|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343512|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
138343513|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343514|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138343515|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138343516|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138343517|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343518|NCT05677490|Antidotes|antidotes|mesh-ancestor
138343519|NCT05677490|Protective Agents|protective agents|mesh-ancestor
138343520|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
138343521|NCT05677490|Vitamins|vitamins|mesh-ancestor
138343522|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
138343523|NCT05656664|Folic Acid|folic acid|mesh-list
138343524|NCT05656664|Hematinics|hematinics|mesh-ancestor
138343525|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
138343526|NCT05656664|Vitamins|vitamins|mesh-ancestor
138343527|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
138343528|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343529|NCT05644223|Edaravone|edaravone|mesh-list
138343530|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138343531|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
138343532|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343533|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138343534|NCT05644223|Protective Agents|protective agents|mesh-ancestor
138343535|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343536|NCT05633147|Clarithromycin|clarithromycin|mesh-list
138343537|NCT05633147|Midazolam|midazolam|mesh-list
138343538|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138343539|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343540|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345954|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138343541|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343542|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138343543|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138343544|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343545|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343546|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
138343549|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
138343550|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343551|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343552|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343553|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343554|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138343555|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343556|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138343557|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343558|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
138343559|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
138343561|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343562|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
138343563|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343564|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343565|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343566|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
138343567|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343568|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343569|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138343570|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138343571|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343572|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138343573|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138343574|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
138343575|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343576|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343581|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138343582|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343583|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
138343584|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343585|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138343586|NCT05528848|Narcotics|narcotics|mesh-ancestor
138343587|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343588|NCT05528848|Analgesics|analgesics|mesh-ancestor
138343589|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138343590|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138343591|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
138343592|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
138343593|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
138343595|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343596|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343598|NCT05420948|Carboplatin|carboplatin|mesh-list
138343599|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
138343600|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138343601|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343602|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138343603|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138343604|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138343605|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343606|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343607|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138343608|NCT05418348|Nimodipine|nimodipine|mesh-list
138343609|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138343610|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138343611|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343612|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343613|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138343614|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343615|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
138343616|NCT05416320|Calcipotriene|calcipotriene|mesh-list
138343617|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138343618|NCT05377606|Temazepam|temazepam|mesh-list
138343619|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138343620|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343621|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343622|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138343627|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343628|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343629|NCT05372367|Itraconazole|itraconazole|mesh-list
138343630|NCT05372367|Rifampin|rifampin|mesh-list
138343631|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
138343632|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343633|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138343634|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343635|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343636|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343637|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138343638|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
138343639|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343640|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343641|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138343642|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138343643|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
138343644|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343645|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
138343646|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138343647|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138343648|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138343649|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138343650|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138343651|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138343652|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138343654|NCT05350371|Analgesics|analgesics|mesh-ancestor
138343655|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
138343656|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343657|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343658|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138343659|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343660|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343661|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343662|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343664|NCT05348200|Lidocaine|lidocaine|mesh-list
138343665|NCT05348200|Halobetasol|halobetasol|mesh-list
138343666|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
138343667|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
138343668|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138343669|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343670|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
138343671|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343673|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138343675|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343676|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343677|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138343678|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343679|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
138343680|NCT05348200|Hormones|hormones|mesh-ancestor
138343681|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343682|NCT05325502|Mannitol|mannitol|mesh-list
138343683|NCT05325502|Caffeine|caffeine|mesh-list
138343684|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138343685|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343686|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138343687|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343688|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343689|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138343690|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138343691|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
138343692|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343693|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138343694|NCT05325502|Diuretics|diuretics|mesh-ancestor
138343695|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
138343696|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
138343697|NCT05285384|Paraproteins|paraproteins|mesh-list
138343698|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
138343699|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343700|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
138343701|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343702|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343703|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138343704|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343710|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138343711|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343712|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343713|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343715|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
138343716|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343717|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138343718|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
138343719|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343720|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138343721|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343722|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343723|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
138343724|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138343725|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138343726|NCT05133791|Annexin A5|annexin a5|mesh-list
138343727|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343728|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343729|NCT05115513|Dronabinol|dronabinol|mesh-list
138343730|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
138343731|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343732|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343733|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343734|NCT05115513|Analgesics|analgesics|mesh-ancestor
138343735|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
138343736|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343737|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138343739|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343740|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343741|NCT05115513|Hormones|hormones|mesh-ancestor
138343742|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138343743|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
138343744|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343745|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343746|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343747|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138343748|NCT05041036|Nirogacestat|nirogacestat|mesh-list
138343749|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343750|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343751|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
138343752|NCT05027945|Sirolimus|sirolimus|mesh-list
138343753|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
138343754|NCT05027945|Busulfan|busulfan|mesh-list
138343755|NCT05027945|Fludarabine|fludarabine|mesh-list
138343756|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343757|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
138343758|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343760|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343761|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
138343762|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343763|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343764|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138343765|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138343766|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138343767|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
138343768|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343769|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343770|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343771|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
138343774|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138343775|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343776|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343777|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
138343778|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343779|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
138343780|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343781|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138343782|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343783|NCT04975919|Decitabine|decitabine|mesh-list
138346036|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
138343784|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138343785|NCT04975919|Venetoclax|venetoclax|mesh-list
138343786|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343787|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
138343788|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343789|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343790|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343793|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138343794|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343795|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
138343796|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
138343797|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
138343798|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343799|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343800|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343801|NCT04913220|Cemiplimab|cemiplimab|mesh-list
138343802|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343803|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343804|NCT04902378|Insulin|insulin|mesh-list
138343805|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138343806|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343807|NCT04898504|Floxuridine|floxuridine|mesh-list
138343808|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343809|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
138343810|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343811|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343812|NCT04876079|Insulin|insulin|mesh-list
138343813|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138343814|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343818|NCT04845035|Ponatinib|ponatinib|mesh-list
138343819|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138343820|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
138343821|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138343822|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343823|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343824|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
138343825|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343826|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343827|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
138343828|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343829|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138343830|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343831|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
138343832|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343833|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138343835|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343836|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343837|NCT04811573|Thalidomide|thalidomide|mesh-list
138343838|NCT04811573|Apremilast|apremilast|mesh-list
138343839|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138343840|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343841|NCT04811573|Analgesics|analgesics|mesh-ancestor
138343842|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
138343843|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343844|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343845|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343846|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343847|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138343848|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138343849|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343850|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343852|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
138343853|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
138343854|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343855|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343856|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138343857|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138343858|NCT04811573|Growth Substances|growth substances|mesh-ancestor
138343859|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
138343860|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343862|NCT04774094|Avibactam|avibactam|mesh-list
138343863|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138343864|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343865|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343866|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138343867|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343868|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343869|NCT04753437|Amoxicillin|amoxicillin|mesh-list
138343870|NCT04753437|Clarithromycin|clarithromycin|mesh-list
138343871|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
138343872|NCT04753437|Esomeprazole|esomeprazole|mesh-list
138343873|NCT04753437|Bismuth|bismuth|mesh-list
138343874|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343875|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138343876|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343877|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138343878|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138343879|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138343883|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343884|NCT04753437|Antacids|antacids|mesh-ancestor
138343885|NCT04753437|Diuretics|diuretics|mesh-ancestor
138343886|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
138343887|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343888|NCT04753437|Expectorants|expectorants|mesh-ancestor
138343889|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343890|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
138343891|NCT04613557|Fludarabine|fludarabine|mesh-list
138343892|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
138343893|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138343894|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
138343895|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343896|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343897|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138343898|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
138343899|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343900|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343901|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138343902|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343903|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
138343904|NCT04605094|Benralizumab|benralizumab|mesh-list
138343905|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138343906|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138343907|NCT04605081|Naltrexone|naltrexone|mesh-list
138343908|NCT04605081|Bupropion|bupropion|mesh-list
138343909|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138343910|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138343911|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343912|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
138343913|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343914|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138343915|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
138343916|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343917|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138343918|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343919|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343920|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343922|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343923|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138343924|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343925|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343926|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138343927|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138343928|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343929|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138343930|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343931|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343932|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343934|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343935|NCT04599478|Naltrexone|naltrexone|mesh-list
138343936|NCT04599478|Bupropion|bupropion|mesh-list
138343937|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138343938|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138343939|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343940|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
138343941|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343942|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138343943|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
138343944|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343945|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138343946|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343947|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343948|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343949|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
138343950|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343951|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138343952|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343953|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343954|NCT04578639|Rituximab|rituximab|mesh-list
138343955|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
138343956|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343957|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343958|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
138343959|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343960|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138343961|NCT04555577|Temozolomide|temozolomide|mesh-list
138343965|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343966|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138343967|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138343968|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343970|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138343971|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138343972|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
138343973|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138343974|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
138343975|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343976|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343977|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343978|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138343979|NCT04530006|Analgesics|analgesics|mesh-ancestor
138343980|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
138343981|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138343983|NCT04526210|Choline|choline|mesh-list
138343984|NCT04526210|Bupropion|bupropion|mesh-list
138343985|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138343986|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
138343987|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138343988|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138343989|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138343990|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343991|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343992|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
138343993|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138343994|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343995|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138343996|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138343997|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138343998|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
138343999|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138344000|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
138344001|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344002|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138344003|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
138344004|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
138344005|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
138344006|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138344007|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138344008|NCT04526210|Growth Substances|growth substances|mesh-ancestor
138344009|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344010|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344011|NCT04435691|Azacitidine|azacitidine|mesh-list
138344012|NCT04435691|Venetoclax|venetoclax|mesh-list
138344013|NCT04435691|Magrolimab|magrolimab|mesh-list
138344014|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344015|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
138344016|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344017|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344018|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344019|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344020|NCT04422652|Bupropion|bupropion|mesh-list
138344021|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138344022|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
138344023|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138344024|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138344025|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138344026|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138344027|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344028|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
138344029|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344030|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344031|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138344032|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138344033|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344034|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
138344036|NCT04384692|Melphalan|melphalan|mesh-list
138344037|NCT04384692|Busulfan|busulfan|mesh-list
138344038|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
138344039|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138344040|NCT04384692|Methotrexate|methotrexate|mesh-list
138344041|NCT04384692|Fludarabine|fludarabine|mesh-list
138344042|NCT04384692|Tacrolimus|tacrolimus|mesh-list
138344043|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344044|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
138344045|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344046|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344047|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344048|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
138344049|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344050|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344051|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138344055|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344056|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
138344057|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344058|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344059|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344060|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344061|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138344062|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138344063|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138344064|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
138344065|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138344066|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344067|NCT04377451|Metformin|metformin|mesh-list
138344068|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344069|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344071|NCT04367311|Pemetrexed|pemetrexed|mesh-list
138344072|NCT04367311|Atezolizumab|atezolizumab|mesh-list
138344073|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344074|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344075|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344076|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344077|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344078|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344079|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344080|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344081|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138344082|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344083|NCT04329325|Dexamethasone|dexamethasone|mesh-list
138344084|NCT04329325|Methotrexate|methotrexate|mesh-list
138344085|NCT04329325|Dasatinib|dasatinib|mesh-list
138344086|NCT04329325|Blinatumomab|blinatumomab|mesh-list
138344087|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344088|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
138344089|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
138344090|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344091|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344092|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344093|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
138344094|NCT04329325|Hormones|hormones|mesh-ancestor
138344095|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344096|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344097|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344098|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138344099|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
138344100|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138344101|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344102|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
138344103|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344106|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344107|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344108|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
138344109|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344110|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344111|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138344112|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138344113|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138344115|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
138344116|NCT04190056|Vorinostat|vorinostat|mesh-list
138344117|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344118|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344119|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138344120|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344121|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138344122|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
138344123|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344124|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344125|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344126|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138344127|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138344128|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138344129|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138344130|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344131|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
138344132|NCT04189757|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138344133|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344134|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138344135|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344136|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344137|NCT04149964|Acetaminophen|acetaminophen|mesh-list
138344138|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138344140|NCT04149964|Hydrocodone|hydrocodone|mesh-list
138344141|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138344142|NCT04149964|Analgesics|analgesics|mesh-ancestor
138344143|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
138344144|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344145|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344146|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
138344147|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138344148|NCT04149964|Narcotics|narcotics|mesh-ancestor
138344149|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344150|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
138344151|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
138344152|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138344153|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344154|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344162|NCT04076579|Olaparib|olaparib|mesh-list
138344163|NCT04076579|Trabectedin|trabectedin|mesh-list
138344164|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138344165|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344166|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344167|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344168|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344169|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
138344170|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138344171|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344172|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344173|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
138344174|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138344175|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344176|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344177|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344178|NCT03974932|Acetaminophen|acetaminophen|mesh-list
138344179|NCT03974932|Ibuprofen|ibuprofen|mesh-list
138344180|NCT03974932|Celecoxib|celecoxib|mesh-list
138344181|NCT03974932|Bupivacaine|bupivacaine|mesh-list
138344182|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
138344183|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
138344184|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344185|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344191|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138344193|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344194|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138344195|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344196|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344197|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138344202|NCT03777813|Leucovorin|leucovorin|mesh-list
138344203|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
138344204|NCT03777813|Durvalumab|durvalumab|mesh-list
138344205|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
138344206|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344207|NCT03777813|Antidotes|antidotes|mesh-ancestor
138344208|NCT03777813|Protective Agents|protective agents|mesh-ancestor
138344209|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344210|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
138344211|NCT03777813|Vitamins|vitamins|mesh-ancestor
138344212|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
138344213|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344214|NCT03754933|Fludarabine|fludarabine|mesh-list
138344215|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
138344216|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344217|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344218|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
138344219|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344220|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344221|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
138344222|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344223|NCT03725878|Folic Acid|folic acid|mesh-list
138344224|NCT03725878|Hematinics|hematinics|mesh-ancestor
138344225|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
138344226|NCT03725878|Vitamins|vitamins|mesh-ancestor
138344227|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
138344228|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344229|NCT03694262|Bevacizumab|bevacizumab|mesh-list
138344230|NCT03694262|Atezolizumab|atezolizumab|mesh-list
138344231|NCT03694262|Rucaparib|rucaparib|mesh-list
138344232|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344233|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344234|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138344235|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138344236|NCT03694262|Growth Substances|growth substances|mesh-ancestor
138344237|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344238|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344239|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138344240|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344241|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138344242|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344243|NCT03639935|Nivolumab|nivolumab|mesh-list
138344244|NCT03639935|Rucaparib|rucaparib|mesh-list
138344245|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344246|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344247|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138344248|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344249|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138344250|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344251|NCT03624231|Durvalumab|durvalumab|mesh-list
138344252|NCT03624231|Tremelimumab|tremelimumab|mesh-list
138344253|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344254|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344255|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138344256|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138344257|NCT03564509|Hormones|hormones|mesh-ancestor
138344258|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344317|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344318|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344320|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344321|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344322|NCT03150693|Cytarabine|cytarabine|mesh-list
138344323|NCT03150693|Dexamethasone|dexamethasone|mesh-list
138344324|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
138344325|NCT03150693|Rituximab|rituximab|mesh-list
138344326|NCT03150693|Doxorubicin|doxorubicin|mesh-list
138344327|NCT03150693|Methotrexate|methotrexate|mesh-list
138344328|NCT03150693|Vincristine|vincristine|mesh-list
138344329|NCT03150693|Daunorubicin|daunorubicin|mesh-list
138344330|NCT03150693|Asparaginase|asparaginase|mesh-list
138344331|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
138344332|NCT03150693|Thioguanine|thioguanine|mesh-list
138344333|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138344348|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344349|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344351|NCT03150693|Hormones|hormones|mesh-ancestor
138344352|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344353|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344354|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344355|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138344356|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138344357|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138344358|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344359|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138344360|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
138344361|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138344362|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344363|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
138344364|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344365|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344366|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344367|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
138344368|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344369|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344370|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344371|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344372|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344373|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
138344374|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138344375|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
138344376|NCT03150693|Protective Agents|protective agents|mesh-ancestor
138344377|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
138344378|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
138344379|NCT03118037|Zaleplon|zaleplon|mesh-list
138344381|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138344382|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344383|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344384|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
138344385|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
138344386|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344387|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344388|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138344389|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138344390|NCT03007030|Antibodies|antibodies|mesh-list
138344391|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
138344392|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138344393|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
138344394|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
138344397|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
138344398|NCT02938520|Rilpivirine|rilpivirine|mesh-list
138344399|NCT02938520|Cabotegravir|cabotegravir|mesh-list
138344400|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138344401|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344403|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344404|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
138344405|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344406|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138344407|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138344408|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138344409|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138344410|NCT02830360|Amiodarone|amiodarone|mesh-list
138344411|NCT02830360|Sotalol|sotalol|mesh-list
138344412|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138344413|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
138344414|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138344415|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138344416|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344417|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138344418|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138344419|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138344420|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344421|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138344422|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138344423|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138344424|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138344425|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344426|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344427|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344428|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344429|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
138344430|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
138344431|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344433|NCT02764541|Letrozole|letrozole|mesh-list
138344434|NCT02764541|Palbociclib|palbociclib|mesh-list
138344435|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344436|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138344437|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138344438|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344439|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344440|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138344441|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
138344442|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344443|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344444|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344445|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138344446|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138344447|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138344448|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138344449|NCT02649790|Dexamethasone|dexamethasone|mesh-list
138344450|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138344451|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344453|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
138344454|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344455|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344456|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344457|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
138344458|NCT02649790|Hormones|hormones|mesh-ancestor
138344459|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344460|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344461|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344462|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344463|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
138344464|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344465|NCT02595060|Molgramostim|molgramostim|mesh-list
138344466|NCT02595060|Sargramostim|sargramostim|mesh-list
138344467|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344468|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
138344469|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344470|NCT02587065|Interferons|interferons|mesh-list
138344471|NCT02587065|Interferon-beta|interferon-beta|mesh-list
138344472|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
138344473|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344474|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
138344475|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344477|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344478|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138344479|NCT02492867|Paclitaxel|paclitaxel|mesh-list
138344480|NCT02492867|Carboplatin|carboplatin|mesh-list
138344481|NCT02492867|Durvalumab|durvalumab|mesh-list
138344482|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344483|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344484|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344485|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344486|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344487|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344488|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344489|NCT02375204|Paclitaxel|paclitaxel|mesh-list
138344490|NCT02375204|Etoposide|etoposide|mesh-list
138344491|NCT02375204|Carboplatin|carboplatin|mesh-list
138344492|NCT02375204|Ifosfamide|ifosfamide|mesh-list
138344493|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
138344494|NCT02375204|Lenograstim|lenograstim|mesh-list
138344495|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344496|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344497|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344498|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344499|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344500|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344502|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138344503|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344504|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138344505|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
138344506|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344507|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344508|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
138344509|NCT02343042|Clarithromycin|clarithromycin|mesh-list
138344510|NCT02343042|Dexamethasone|dexamethasone|mesh-list
138344511|NCT02343042|Lenalidomide|lenalidomide|mesh-list
138344512|NCT02343042|Bortezomib|bortezomib|mesh-list
138344513|NCT02343042|Daratumumab|daratumumab|mesh-list
138344514|NCT02343042|Pomalidomide|pomalidomide|mesh-list
138344517|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344518|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
138344519|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
138344520|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344521|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344522|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344523|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
138344524|NCT02343042|Hormones|hormones|mesh-ancestor
138344525|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344526|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344527|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344528|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
138344529|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138344530|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138344531|NCT02343042|Growth Substances|growth substances|mesh-ancestor
138344532|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344533|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138344534|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344535|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138344536|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344537|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344538|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138344539|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138344540|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
138344541|NCT02339168|Metformin|metformin|mesh-list
138344542|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344543|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344545|NCT02276495|Clonidine|clonidine|mesh-list
138344546|NCT02276495|Epinephrine|epinephrine|mesh-list
138344547|NCT02276495|Ropivacaine|ropivacaine|mesh-list
138344548|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
138344549|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
138344550|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344551|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344552|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
138344553|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344554|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138344555|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138344556|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344557|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344558|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344559|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138344560|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138344561|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
138344562|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138344563|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
138344564|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
138344565|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
138344566|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138344567|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138344569|NCT02276495|Analgesics|analgesics|mesh-ancestor
138344570|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344571|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344572|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138344573|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344574|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138344575|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
138344576|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138344577|NCT02269319|Linezolid|linezolid|mesh-list
138344578|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138344579|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344581|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344582|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344583|NCT02120404|Esmolol|esmolol|mesh-list
138344584|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138344585|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138344586|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344606|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138344607|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138344608|NCT01995669|Growth Substances|growth substances|mesh-ancestor
138344609|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344610|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344611|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344612|NCT01880567|Rituximab|rituximab|mesh-list
138344613|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138344614|NCT01880567|Antibodies|antibodies|mesh-list
138344615|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
138344616|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138344617|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
138344618|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344619|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344620|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344621|NCT01750567|Metformin|metformin|mesh-list
138344622|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344623|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344625|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
138344626|NCT01740557|Fludarabine|fludarabine|mesh-list
138344627|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
138344628|NCT01740557|Interleukin-2|interleukin-2|mesh-list
138344629|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344630|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
138344631|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344632|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344633|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344634|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
138344635|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344636|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344637|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138344638|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344639|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
138344640|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138344641|NCT01740557|Analgesics|analgesics|mesh-ancestor
138344642|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
138344643|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344644|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138344645|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138344661|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344662|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344663|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344664|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
138344665|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344666|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344667|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344668|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
138344669|NCT01231906|Ifosfamide|ifosfamide|mesh-list
138344670|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
138344671|NCT01231906|Doxorubicin|doxorubicin|mesh-list
138344672|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138344673|NCT01231906|Etoposide|etoposide|mesh-list
138344674|NCT01231906|Vincristine|vincristine|mesh-list
138344675|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
138344676|NCT01231906|Topotecan|topotecan|mesh-list
138344677|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
138344679|NCT01231906|Razoxane|razoxane|mesh-list
138344680|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
138344681|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344682|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
138344683|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344684|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344685|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138344686|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
138344687|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344688|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344689|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138344690|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138344691|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138344692|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138344693|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344694|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344695|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344696|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344697|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344698|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138344699|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
138344717|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344718|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344719|NCT00354393|Methotrexate|methotrexate|mesh-list
138344720|NCT00354393|Vinorelbine|vinorelbine|mesh-list
138344721|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344722|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138344723|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
138344724|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138344725|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344726|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344727|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
138344728|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344729|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344730|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344731|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344732|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344733|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
138344734|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344735|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138344736|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344737|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344738|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344739|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344740|NCT00304070|Cisplatin|cisplatin|mesh-list
138344741|NCT00304070|Doxorubicin|doxorubicin|mesh-list
138344742|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138344743|NCT00304070|Etoposide|etoposide|mesh-list
138344744|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
138344745|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
138344746|NCT00304070|Mitotane|mitotane|mesh-list
138344748|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344749|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138344750|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138344751|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138344753|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344754|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344755|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138344756|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
138344757|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344758|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
138344759|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138344760|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344761|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344762|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344763|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344765|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138344766|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138344767|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
138344768|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
138344769|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344770|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344771|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344772|NCT01820754|Paclitaxel|paclitaxel|mesh-list
138344773|NCT01820754|Carboplatin|carboplatin|mesh-list
138344774|NCT01820754|Ipilimumab|ipilimumab|mesh-list
138344775|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138344776|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344777|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
138344778|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
138344779|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
138344780|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344781|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344782|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138344783|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138344784|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138344785|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138344786|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344787|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344789|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138344790|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138344791|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344792|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344793|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344794|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344795|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138344796|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138344797|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
138344798|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138344799|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138344800|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
138344802|NCT01822548|Vildagliptin|vildagliptin|mesh-list
138344803|NCT01822548|Glyburide|glyburide|mesh-list
138344804|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344805|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344806|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138344807|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
138344808|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344809|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344810|NCT01825122|Nadolol|nadolol|mesh-list
138344811|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138344812|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344813|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344814|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344815|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344816|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344817|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138344818|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138344819|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
138344820|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
138344821|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344822|NCT01825512|Deferasirox|deferasirox|mesh-list
138344823|NCT01825512|Deferiprone|deferiprone|mesh-list
138344824|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138344825|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
138344826|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
138344827|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344828|NCT01827462|Vaccines|vaccines|mesh-list
138344829|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
138344830|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344831|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
138344832|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344833|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138344834|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344835|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344836|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
138344837|NCT01828476|Navitoclax|navitoclax|mesh-list
138344838|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
138344839|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138344840|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138344841|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344842|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344843|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344844|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344845|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344846|NCT01828554|Capecitabine|capecitabine|mesh-list
138344847|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344848|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
138344852|NCT01834404|Phentermine|phentermine|mesh-list
138344853|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
138344854|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138344855|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344856|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138344857|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
138344858|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138344861|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344862|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344863|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344864|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344866|NCT01835262|Morphine|morphine|mesh-list
138344867|NCT01835262|Analgesics|analgesics|mesh-ancestor
138344868|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
138344869|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344870|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344871|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138344872|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138344873|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
138344874|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
138344875|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138344876|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138346037|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
138344877|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138344878|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344879|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344880|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138344881|NCT01835262|Narcotics|narcotics|mesh-ancestor
138344882|NCT01835496|Deferiprone|deferiprone|mesh-list
138344883|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138344884|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
138344885|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
138344886|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344887|NCT01766076|Atorvastatin|atorvastatin|mesh-list
138344888|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138344889|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138344890|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
138344891|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344892|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138344893|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138344894|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344895|NCT01767792|Bevacizumab|bevacizumab|mesh-list
138344896|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
138344897|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138344899|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138344900|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138344901|NCT01767792|Growth Substances|growth substances|mesh-ancestor
138344902|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344903|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
138344904|NCT01797822|Dexamethasone|dexamethasone|mesh-list
138344905|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
138344906|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344907|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
138344908|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
138344909|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344910|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344911|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344912|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
138344914|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344915|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344916|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344917|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138344918|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138344920|NCT01809054|Fondaparinux|fondaparinux|mesh-list
138344921|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138344922|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138344927|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344928|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344929|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138344930|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138344931|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344932|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138344933|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138344934|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344935|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
138344936|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138344937|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
138344938|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138344939|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
138344940|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
138344942|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138344943|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
138344944|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344945|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344947|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
138344948|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138344949|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344950|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138344951|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344952|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
138344953|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138344954|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
138344955|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344956|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344957|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344958|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
138344959|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138344968|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138344969|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
138344970|NCT01843920|Hormones|hormones|mesh-ancestor
138344971|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138344972|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344973|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138344974|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344975|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138344976|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344977|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
138344978|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344979|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344980|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138344981|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138344982|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138344983|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138344984|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
138344985|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138344986|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138344987|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138344988|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138344989|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138344990|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138344991|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138344992|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138344993|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138344994|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138344995|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138344996|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138344997|NCT01844388|Laxatives|laxatives|mesh-ancestor
138344998|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138344999|NCT01845636|Atropine|atropine|mesh-list
138345000|NCT01845636|Donepezil|donepezil|mesh-list
138345001|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138345002|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138345003|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138345004|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345009|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
138345010|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138345011|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345012|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138345013|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
138345014|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345015|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138345016|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
138345017|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
138345018|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
138345019|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138345020|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138345021|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
138345022|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345023|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138345024|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345025|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345026|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
138345027|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345028|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345029|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138345030|NCT01846728|Estrogens|estrogens|mesh-list
138345031|NCT01846728|Hormones|hormones|mesh-ancestor
138345032|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345033|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345034|NCT01848054|Buprenorphine|buprenorphine|mesh-list
138345035|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138345036|NCT01848054|Naloxone|naloxone|mesh-list
138345037|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138345038|NCT01848054|Narcotics|narcotics|mesh-ancestor
138345040|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345041|NCT01848054|Analgesics|analgesics|mesh-ancestor
138345042|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
138345043|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345044|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138345045|NCT01849068|Ezetimibe|ezetimibe|mesh-list
138345046|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138345047|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138345049|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345050|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138345051|NCT01849692|Ranibizumab|ranibizumab|mesh-list
138345052|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138345053|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138345054|NCT01849692|Growth Substances|growth substances|mesh-ancestor
138345055|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345056|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
138345057|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345058|NCT01849770|Mexiletine|mexiletine|mesh-list
138345059|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345060|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138345061|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138345062|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345063|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345064|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
138345065|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138345066|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138345067|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345068|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
138345069|NCT01850394|Coagulants|coagulants|mesh-ancestor
138345070|NCT01852344|Methylphenidate|methylphenidate|mesh-list
138345071|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138345072|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345073|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138345074|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138345075|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345076|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345077|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
138345078|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345079|NCT01856712|Naltrexone|naltrexone|mesh-list
138345080|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138345081|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138345082|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345083|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
138345084|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345085|NCT01858428|Paclitaxel|paclitaxel|mesh-list
138345086|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138345087|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345088|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138345089|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345090|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345091|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345092|NCT01861002|Cytarabine|cytarabine|mesh-list
138345093|NCT01861002|Methotrexate|methotrexate|mesh-list
138345094|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
138345095|NCT01861002|Azacitidine|azacitidine|mesh-list
138345096|NCT01861002|Fludarabine|fludarabine|mesh-list
138345097|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138345098|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
138345099|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345100|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345101|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345102|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
138345103|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345104|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345105|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345106|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345107|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138345108|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345109|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
138345110|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345111|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138345112|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
138345113|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345114|NCT01870596|Cytarabine|cytarabine|mesh-list
138345115|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345116|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
138345117|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345118|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345119|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
138345120|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345121|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345122|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
138345123|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345124|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138345125|NCT01875510|SMOFlipid|smoflipid|mesh-list
138345126|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138345127|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138345128|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138345129|NCT01876212|Dasatinib|dasatinib|mesh-list
138345130|NCT01876212|Vaccines|vaccines|mesh-list
138345131|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
138345132|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345133|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345134|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345135|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345136|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345137|NCT01876992|Metformin|metformin|mesh-list
138345138|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138345139|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345140|NCT01877538|Donepezil|donepezil|mesh-list
138345141|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138345142|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345143|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345144|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345145|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345146|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345147|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
138345148|NCT01878006|Morphine|morphine|mesh-list
138345149|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138345151|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345152|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345153|NCT01878006|Analgesics|analgesics|mesh-ancestor
138345154|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
138345155|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345156|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138345157|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
138345158|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138345160|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345161|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345162|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
138345163|NCT05327088|Nalbuphine|nalbuphine|mesh-list
138345164|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138345165|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345166|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345167|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345168|NCT05327088|Analgesics|analgesics|mesh-ancestor
138345169|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
138345170|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345171|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138345172|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138345173|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138345174|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345175|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345176|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345177|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138345178|NCT05327088|Narcotics|narcotics|mesh-ancestor
138345179|NCT05290194|Capecitabine|capecitabine|mesh-list
138345180|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138345181|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345182|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
138345183|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345185|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345186|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138345188|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345189|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138345190|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345191|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138345192|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345193|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345194|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138345195|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
138345198|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
138345199|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345201|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
138345202|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345203|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
138345204|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345205|NCT01643460|Ethanol|ethanol|mesh-list
138345206|NCT01643460|Paclitaxel|paclitaxel|mesh-list
138345207|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138345214|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138345215|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345216|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345217|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345218|NCT00954876|Capecitabine|capecitabine|mesh-list
138345227|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345228|NCT05714670|Curcumin|curcumin|mesh-list
138345229|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138345230|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345231|NCT05714670|Analgesics|analgesics|mesh-ancestor
138345232|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
138345233|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345234|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345235|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345236|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345237|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345238|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345239|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345240|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
138345241|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138345242|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345243|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138345244|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345245|NCT05472948|Capecitabine|capecitabine|mesh-list
138345246|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345247|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
138345248|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345249|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345250|NCT05215470|Nivolumab|nivolumab|mesh-list
138345251|NCT05215470|Ipilimumab|ipilimumab|mesh-list
138345252|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345253|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345254|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138345255|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345287|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
138345288|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345289|NCT04929834|Emollients|emollients|mesh-list
138345290|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345291|NCT04470804|Cyclosporine|cyclosporine|mesh-list
138345292|NCT04470804|Sirolimus|sirolimus|mesh-list
138345293|NCT04470804|Temsirolimus|temsirolimus|mesh-list
138345294|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
138345295|NCT04470804|Cyclosporins|cyclosporins|mesh-list
138345296|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345297|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345298|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345299|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
138345300|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345301|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
138345302|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345303|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345304|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345305|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138345306|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138345307|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138345308|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345309|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345310|NCT04418466|Risperidone|risperidone|mesh-list
138345311|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138345312|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
138345313|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345314|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345315|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345316|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138345317|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138345318|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345319|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138345320|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138345321|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
138345323|NCT04360044|Cannabidiol|cannabidiol|mesh-list
138345324|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
138345325|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
138345326|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345327|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138345328|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345329|NCT04360044|Analgesics|analgesics|mesh-ancestor
138345330|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
138345331|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345332|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138345333|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138345334|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345335|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345336|NCT04360044|Hormones|hormones|mesh-ancestor
138345337|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345338|NCT04337814|Ibuprofen|ibuprofen|mesh-list
138345339|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138345340|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138345341|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345342|NCT04337814|Analgesics|analgesics|mesh-ancestor
138345343|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
138345344|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345345|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345346|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345347|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345348|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138345349|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345350|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345351|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
138345352|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
138345353|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345354|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138345355|NCT04336332|Azithromycin|azithromycin|mesh-list
138345356|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
138345357|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138345358|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345359|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
138345360|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138345361|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138345362|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345363|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345364|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345366|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
138345367|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
138345368|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345369|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345370|NCT01430442|Sumatriptan|sumatriptan|mesh-list
138345372|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138345373|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138345374|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
138345375|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345376|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345377|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345378|NCT01420926|Bortezomib|bortezomib|mesh-list
138345379|NCT01420926|Decitabine|decitabine|mesh-list
138345380|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345381|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345382|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
138345383|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345384|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345385|NCT01881828|Metformin|metformin|mesh-list
138345386|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138345387|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345388|NCT01887132|Donepezil|donepezil|mesh-list
138345389|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138345391|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345392|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345393|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345394|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345395|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
138345396|NCT01887990|Ketamine|ketamine|mesh-list
138345397|NCT01887990|Analgesics|analgesics|mesh-ancestor
138345398|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
138345399|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345400|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345401|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138345402|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138345403|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
138345404|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
138345405|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345406|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138345407|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138345408|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345409|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345410|NCT01890642|Lidocaine|lidocaine|mesh-list
138345411|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
138345413|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345414|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345415|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
138345416|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345417|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345418|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138345419|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138345420|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345421|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345422|NCT01891968|Bortezomib|bortezomib|mesh-list
138345423|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345424|NCT01901250|Fluorides|fluorides|mesh-list
138345425|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
138345426|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
138345427|NCT01901250|Protective Agents|protective agents|mesh-ancestor
138345428|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345429|NCT01904526|Guanfacine|guanfacine|mesh-list
138345430|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138345431|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138345432|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138345434|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345435|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345436|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345437|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345438|NCT01906866|Melatonin|melatonin|mesh-list
138345439|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
138345440|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345441|NCT01906866|Protective Agents|protective agents|mesh-ancestor
138345442|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345443|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345448|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138345449|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
138345450|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345451|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138345452|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
138345453|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345454|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345455|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138345456|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
138345457|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345458|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138345459|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138345460|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138345461|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138345462|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345463|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345464|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345465|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
138345466|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345467|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
138345468|NCT01907334|Hormones|hormones|mesh-ancestor
138345469|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345470|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
138345471|NCT01907334|Miotics|miotics|mesh-ancestor
138345472|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138345473|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138345474|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138345476|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345477|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
138345478|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
138345479|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
138345481|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345482|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
138346038|NCT01967862|Protective Agents|protective agents|mesh-ancestor
138345483|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345484|NCT01908972|Prednisolone|prednisolone|mesh-list
138345485|NCT01908972|Propranolol|propranolol|mesh-list
138345486|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345487|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
138345488|NCT01908972|Hormones|hormones|mesh-ancestor
138345489|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345490|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345491|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138345492|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345493|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138345494|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138345495|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345496|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345497|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345498|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345499|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138345500|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
138345501|NCT01910064|Adapalene|adapalene|mesh-list
138345502|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138345503|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345504|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138345505|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345506|NCT01910064|Analgesics|analgesics|mesh-ancestor
138345507|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
138345508|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345509|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345510|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345511|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345512|NCT01912716|Indomethacin|indomethacin|mesh-list
138345513|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138345514|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345516|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
138345517|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345518|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345519|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345520|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345521|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
138345522|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
138345523|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345524|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138345525|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345526|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345528|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138345529|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
138345530|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138345531|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138345532|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138345533|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345534|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345535|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345536|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345537|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
138345538|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138345539|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
138345540|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138345541|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138345542|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345544|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345545|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138345546|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345547|NCT01929642|Sirolimus|sirolimus|mesh-list
138345548|NCT01929642|Everolimus|everolimus|mesh-list
138345549|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138345550|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345551|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345552|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345553|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345554|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
138345555|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345556|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345557|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138345558|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346279|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138345559|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138345560|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
138345561|NCT01932060|Oxytocin|oxytocin|mesh-list
138345562|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
138345563|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345564|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345566|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138345567|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
138345568|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345569|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138345570|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345571|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138345572|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138345573|NCT01933776|Vaccines|vaccines|mesh-list
138345574|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
138345575|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345576|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138345577|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
138345578|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138345579|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138345580|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
138345581|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345582|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345583|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138345584|NCT01937598|Liraglutide|liraglutide|mesh-list
138345586|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345588|NCT01937598|Hormones|hormones|mesh-ancestor
138345589|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345590|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138345591|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
138345592|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345593|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345594|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138345595|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138345596|NCT01942668|Estradiol|estradiol|mesh-list
138345597|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138345598|NCT01942668|Progesterone|progesterone|mesh-list
138345599|NCT01942668|Estrogens|estrogens|mesh-ancestor
138345600|NCT01942668|Hormones|hormones|mesh-ancestor
138345601|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345602|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345603|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138345604|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
138345605|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345607|NCT01942668|Progestins|progestins|mesh-ancestor
138345608|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
138345609|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
138345610|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138345611|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138345612|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345613|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345615|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
138345616|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138345617|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345618|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138345619|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345620|NCT01949844|Regadenoson|regadenoson|mesh-list
138345621|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138345622|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138345623|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
138345624|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
138345625|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345626|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345627|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345628|NCT01951950|Nicardipine|nicardipine|mesh-list
138345629|NCT01951950|Esmolol|esmolol|mesh-list
138345630|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138345631|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138345632|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138345633|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345634|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345635|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345636|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345637|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138345638|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138345639|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345640|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138345641|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
138345642|NCT01953432|Doxazosin|doxazosin|mesh-list
138345643|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138345644|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138345645|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138345646|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138345647|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345654|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
138345655|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138345656|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138345657|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345658|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345659|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
138345660|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
138345661|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138345662|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
138345663|NCT01955382|Antidotes|antidotes|mesh-ancestor
138345664|NCT01955382|Protective Agents|protective agents|mesh-ancestor
138345665|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345666|NCT01957410|Ketamine|ketamine|mesh-list
138345667|NCT01957410|Analgesics|analgesics|mesh-ancestor
138345668|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
138345669|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345670|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345671|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138345672|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138345673|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
138345674|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
138345675|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345676|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138345677|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138345678|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345679|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345680|NCT01958112|Trametinib|trametinib|mesh-list
138345681|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345682|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345683|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345684|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345685|NCT05739786|Vitamin D|vitamin d|mesh-list
138345686|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
138345687|NCT05739786|Vitamins|vitamins|mesh-ancestor
138345688|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
138345689|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345690|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138345691|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138345692|NCT05739630|Cytarabine|cytarabine|mesh-list
138345693|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
138345694|NCT05739630|Busulfan|busulfan|mesh-list
138345695|NCT05739630|Fludarabine|fludarabine|mesh-list
138345696|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
138345699|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
138345700|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345701|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345702|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138345703|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
138345704|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345705|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345706|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138345707|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345709|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
138345710|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345711|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138345712|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345713|NCT05739630|Analgesics|analgesics|mesh-ancestor
138345714|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
138345715|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345716|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138345717|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138345718|NCT05738616|Lenvatinib|lenvatinib|mesh-list
138345719|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345720|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345721|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345722|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345723|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138345724|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138345725|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345726|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
138345727|NCT05738382|Cetrorelix|cetrorelix|mesh-list
138345728|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138345729|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
138345730|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345731|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345732|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
138345733|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345734|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
138345735|NCT05737680|Colchicine|colchicine|mesh-list
138345736|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
138345737|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138345738|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138345739|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345740|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345741|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345742|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345743|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
138345744|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
138345745|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345746|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345747|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345749|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345750|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345751|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345752|NCT05725200|Gemcitabine|gemcitabine|mesh-list
138345753|NCT05725200|Methotrexate|methotrexate|mesh-list
138345754|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
138345755|NCT05725200|Trastuzumab|trastuzumab|mesh-list
138345756|NCT05725200|Cetuximab|cetuximab|mesh-list
138345757|NCT05725200|Everolimus|everolimus|mesh-list
138345758|NCT05725200|Venetoclax|venetoclax|mesh-list
138345759|NCT05725200|Dasatinib|dasatinib|mesh-list
138345760|NCT05725200|Palbociclib|palbociclib|mesh-list
138345761|NCT05725200|Crizotinib|crizotinib|mesh-list
138345762|NCT05725200|Panobinostat|panobinostat|mesh-list
138345763|NCT05725200|Talazoparib|talazoparib|mesh-list
138345764|NCT05725200|Idelalisib|idelalisib|mesh-list
138345765|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345766|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
138345767|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345768|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345769|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345770|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138345771|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138345772|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
138345773|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138345774|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345775|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345776|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345777|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138345778|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345779|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
138345780|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345781|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138345783|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345784|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138345785|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138345787|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345788|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345789|NCT05530278|Midazolam|midazolam|mesh-list
138345790|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138345791|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138345792|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345793|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345794|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138345795|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138345796|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138345797|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138345799|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
138345800|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
138345801|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
138345802|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345803|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345804|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
138345805|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138345806|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
138345807|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345808|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
138345809|NCT05436288|Protective Agents|protective agents|mesh-ancestor
138345810|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
138345811|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138345812|NCT05245734|Antibodies|antibodies|mesh-list
138345813|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
138345814|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138345815|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
138345816|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345817|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
138345818|NCT05242692|Ketamine|ketamine|mesh-list
138345819|NCT05242692|Esketamine|esketamine|mesh-list
138345820|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138345821|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345822|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345823|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345825|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
138345826|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345827|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138345828|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138345829|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138345830|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
138345831|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345832|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345833|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138345834|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138345835|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
138345836|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
138345837|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138345838|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138345840|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138345841|NCT05087940|Diuretics|diuretics|mesh-list
138345842|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138345843|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
138345844|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345845|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345846|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345847|NCT04922658|Vinorelbine|vinorelbine|mesh-list
138345848|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138345849|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345850|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
138345851|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345852|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345853|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345854|NCT04438902|Osimertinib|osimertinib|mesh-list
138345855|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345856|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138345857|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345858|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345859|NCT04329390|Anticoagulants|anticoagulants|mesh-list
138345860|NCT04177602|Trifluridine|trifluridine|mesh-list
138345861|NCT04177602|Capecitabine|capecitabine|mesh-list
138345862|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345863|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
138345864|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345865|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345866|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
138345867|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345868|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
138345869|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138345870|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345871|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138345872|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345873|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345875|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138345876|NCT03616236|Naloxone|naloxone|mesh-list
138345877|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138345878|NCT03616236|Narcotics|narcotics|mesh-ancestor
138345879|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345880|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345881|NCT03616236|Analgesics|analgesics|mesh-ancestor
138345882|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
138345883|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345884|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138345885|NCT03551730|Enoxaparin|enoxaparin|mesh-list
138345886|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
138345887|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
138345888|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138345889|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138345890|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345891|NCT03366480|Paclitaxel|paclitaxel|mesh-list
138345892|NCT03366480|Carboplatin|carboplatin|mesh-list
138345893|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138345894|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345895|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
138345896|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345897|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345898|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345899|NCT02867124|Naltrexone|naltrexone|mesh-list
138345900|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345901|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
138345902|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345903|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138345904|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138345905|NCT02534376|Simvastatin|simvastatin|mesh-list
138345906|NCT02534376|Ezetimibe|ezetimibe|mesh-list
138345907|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138345908|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138345909|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
138345910|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345911|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138345912|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138345913|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345914|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
138345915|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138345916|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138345917|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138345918|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345919|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345920|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345921|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345922|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345923|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138345924|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345925|NCT02065596|Fludarabine|fludarabine|mesh-list
138345926|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
138345927|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345928|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345929|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
138345930|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345931|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138345932|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
138345933|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345934|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
138345935|NCT01976286|Salicylates|salicylates|mesh-list
138345936|NCT01976286|Glycolic acid|glycolic acid|mesh-list
138345937|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345938|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
138345939|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
138345940|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
138345941|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138345942|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345943|NCT01976286|Analgesics|analgesics|mesh-ancestor
138345944|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
138345945|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345946|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345947|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345948|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345949|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138345950|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138345951|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345952|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
138345953|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138345955|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138345956|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345957|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345958|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
138345959|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345960|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345961|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138345962|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345963|NCT01239030|Methylphenidate|methylphenidate|mesh-list
138345964|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138345965|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345966|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138345967|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138345968|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138345969|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345970|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
138345971|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138345973|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
138345975|NCT01086540|Prednisone|prednisone|mesh-list
138345976|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
138345977|NCT01086540|Rituximab|rituximab|mesh-list
138345978|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138345979|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345980|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
138345981|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345982|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138345983|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345984|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
138345985|NCT01086540|Hormones|hormones|mesh-ancestor
138345986|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138345987|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138345988|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138345989|NCT01086540|Analgesics|analgesics|mesh-ancestor
138345990|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
138345991|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345992|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
138345993|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
138345994|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
138345995|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138345996|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138345997|NCT01086540|Protective Agents|protective agents|mesh-ancestor
138345999|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346000|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346001|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346003|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138346004|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
138346005|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
138346006|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346007|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346008|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138346009|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
138346010|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346011|NCT01962870|Vasopressins|vasopressins|mesh-list
138346012|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
138346013|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
138346014|NCT01962870|Coagulants|coagulants|mesh-ancestor
138346015|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346016|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138346017|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
138346018|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346019|NCT01965366|Dexamethasone|dexamethasone|mesh-list
138346020|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346021|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
138346022|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
138346023|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346024|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346025|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346026|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
138346028|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346029|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346030|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346031|NCT01965756|Metformin|metformin|mesh-list
138346032|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138346033|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346034|NCT01967862|Listerine|listerine|mesh-list
138346035|NCT01967862|Fluorides|fluorides|mesh-list
138346039|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346040|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138346041|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346042|NCT01976988|Heparin|heparin|mesh-list
138346043|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
138346044|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138346045|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138346046|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346047|NCT01980654|Rituximab|rituximab|mesh-list
138346048|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138346049|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346050|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
138346051|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346052|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138346053|NCT01984398|Citric Acid|citric acid|mesh-list
138346054|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
138346055|NCT01984398|Enclomiphene|enclomiphene|mesh-list
138346056|NCT01984398|Clomiphene|clomiphene|mesh-list
138346057|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
138346058|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
138346059|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138346060|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
138346061|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
138346062|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346063|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138346064|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
138346065|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346066|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346067|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138346068|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
138346069|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138346070|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138346071|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138346072|NCT01987752|Timolol|timolol|mesh-list
138346073|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138346074|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138346076|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138346077|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346078|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138346079|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138346080|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346081|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346082|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346083|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346084|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138346086|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346087|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346089|NCT01988922|Analgesics|analgesics|mesh-ancestor
138346090|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
138346091|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346092|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346093|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138346094|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138346095|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
138346096|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
138346097|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346098|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138346099|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138346100|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346101|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346103|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346104|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346105|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346106|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346107|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346108|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346109|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
138346110|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
138346111|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346112|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
138346113|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346114|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
138346115|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
138346116|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138346117|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138346118|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346119|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
138346120|NCT01998438|Coagulants|coagulants|mesh-ancestor
138346121|NCT01999530|Prazosin|prazosin|mesh-list
138346122|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138346123|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138346124|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138346125|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138346126|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346127|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346128|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346129|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346133|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138346134|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138346135|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346136|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346137|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346138|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
138346139|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346140|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138346141|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138346142|NCT02002650|Indomethacin|indomethacin|mesh-list
138346143|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138346144|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346145|NCT02002650|Analgesics|analgesics|mesh-ancestor
138346146|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
138346147|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346148|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346149|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346150|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138346151|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
138346152|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
138346153|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138346154|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138346155|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346156|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346158|NCT02004132|Androgens|androgens|mesh-ancestor
138346159|NCT02004132|Hormones|hormones|mesh-ancestor
138346160|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346161|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346162|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
138346163|NCT02004366|Linagliptin|linagliptin|mesh-list
138346164|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138346165|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346166|NCT02004366|Incretins|incretins|mesh-ancestor
138346167|NCT02004366|Hormones|hormones|mesh-ancestor
138346168|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346169|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138346170|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138346171|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346172|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346173|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
138346175|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
138346176|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
138346177|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138346178|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346179|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
138346180|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138346181|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346182|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346183|NCT02011464|Bupivacaine|bupivacaine|mesh-list
138346184|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346185|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
138346186|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346190|NCT02058420|Tocotrienols|tocotrienols|mesh-list
138346192|NCT02058420|Tocopherols|tocopherols|mesh-list
138346193|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
138346194|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346197|NCT02058420|Vitamins|vitamins|mesh-ancestor
138346198|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
138346199|NCT02020278|Tolvaptan|tolvaptan|mesh-list
138346200|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138346201|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346202|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
138346203|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346204|NCT02024646|Brodalumab|brodalumab|mesh-list
138346205|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138346206|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346207|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
138346208|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346209|NCT02024724|Dexamethasone|dexamethasone|mesh-list
138346210|NCT02024724|Triamcinolone|triamcinolone|mesh-list
138346211|NCT02024724|Bupivacaine|bupivacaine|mesh-list
138346212|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346213|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
138346214|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
138346215|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346216|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346217|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346218|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
138346219|NCT02024724|Hormones|hormones|mesh-ancestor
138346220|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346221|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346222|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346223|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346224|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
138346225|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346226|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
138346227|NCT02025426|Phenylephrine|phenylephrine|mesh-list
138346228|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
138346229|NCT02025426|Ephedrine|ephedrine|mesh-list
138346230|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138346231|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
138346232|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
138346233|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346234|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346236|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346237|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
138346238|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
138346239|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138346240|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346241|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346242|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346243|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346244|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346245|NCT02025426|Protective Agents|protective agents|mesh-ancestor
138346246|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138346247|NCT02028780|Dabigatran|dabigatran|mesh-list
138346248|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
138346249|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138346250|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
138346251|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346252|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346253|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
138346254|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
138346255|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138346256|NCT02029872|Mupirocin|mupirocin|mesh-list
138346257|NCT02029872|Calcium|calcium|mesh-list
138346258|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138346259|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346261|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346262|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
138346263|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346264|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346265|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138346266|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346267|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346268|NCT02030574|Gemcitabine|gemcitabine|mesh-list
138346269|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346270|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138346271|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
138346272|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346273|NCT02032212|Nicotine|nicotine|mesh-list
138346274|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138346275|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
138346276|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346277|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346278|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138346281|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346282|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346283|NCT02032758|Propranolol|propranolol|mesh-list
138346284|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138346285|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138346286|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346287|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346288|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346289|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346290|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346291|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138346292|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138346293|NCT02036424|Dexamethasone|dexamethasone|mesh-list
138346294|NCT02036424|Bevacizumab|bevacizumab|mesh-list
138346295|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138346296|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346297|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138346298|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138346299|NCT02036424|Growth Substances|growth substances|mesh-ancestor
138346300|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346301|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
138346302|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346303|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
138346304|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
138346305|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346306|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346307|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
138346308|NCT02036424|Hormones|hormones|mesh-ancestor
138346309|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346310|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346311|NCT02044380|Afatinib|afatinib|mesh-list
138346312|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346313|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138346314|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346315|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346316|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
138346317|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138346318|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138346319|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
138346320|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346321|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346322|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346323|NCT02047032|Urological Agents|urological agents|mesh-ancestor
138346325|NCT02047500|Gemcitabine|gemcitabine|mesh-list
138346326|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138346327|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346328|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
138346329|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
138346330|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
138346331|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346332|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138346333|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
138346335|NCT02054754|Dronabinol|dronabinol|mesh-list
138346336|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346337|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
138346338|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
138346339|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346340|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346341|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346342|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138346343|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138346344|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346345|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346346|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138346347|NCT02054754|Protective Agents|protective agents|mesh-ancestor
138346348|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
138346349|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138346350|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346351|NCT02054754|Analgesics|analgesics|mesh-ancestor
138346352|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
138346353|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138346354|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138346355|NCT02054754|Hormones|hormones|mesh-ancestor
138346433|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346356|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346357|NCT02057640|Dexamethasone|dexamethasone|mesh-list
138346358|NCT02057640|Ixazomib|ixazomib|mesh-list
138346359|NCT02057640|Panobinostat|panobinostat|mesh-list
138346360|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346361|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
138346362|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
138346363|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346364|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346365|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346366|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
138346367|NCT02057640|Hormones|hormones|mesh-ancestor
138346368|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346369|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346370|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346371|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
138346372|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346373|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346374|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138346375|NCT02059902|Lidocaine|lidocaine|mesh-list
138346376|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346377|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
138346378|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346379|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346380|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
138346381|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346382|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346383|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346384|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346385|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346386|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346388|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138346389|NCT02061384|Tretinoin|tretinoin|mesh-list
138346390|NCT02061384|Isotretinoin|isotretinoin|mesh-list
138346391|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346392|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
138346393|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346394|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138346395|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346396|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138346397|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346398|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346399|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346400|NCT02061384|Vitamins|vitamins|mesh-ancestor
138346401|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
138346402|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138346403|NCT02061774|Acetaminophen|acetaminophen|mesh-list
138346404|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346405|NCT02061774|Analgesics|analgesics|mesh-ancestor
138346406|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
138346407|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346408|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346409|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
138346410|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
138346411|NCT02062710|Promethazine|promethazine|mesh-list
138346412|NCT02062710|Phenylephrine|phenylephrine|mesh-list
138346413|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
138346414|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
138346415|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138346416|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
138346417|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
138346418|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346419|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346420|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
138346421|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346422|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
138346423|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
138346424|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138346425|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346427|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346428|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346429|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346430|NCT02062710|Protective Agents|protective agents|mesh-ancestor
138346431|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138346432|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346436|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
138346437|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
138346438|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346439|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138346440|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
138346441|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
138346442|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138346443|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
138346444|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346445|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
138346446|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138346447|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138346449|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138346450|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
138346451|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138346452|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346459|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346460|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346462|NCT02134314|Complement C1s|complement c1s|mesh-list
138346463|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138346466|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346467|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138346468|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138346470|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346471|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
138346472|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346473|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346474|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
138346475|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346476|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346477|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346478|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346479|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346480|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346481|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
138346482|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346483|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346484|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346485|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346486|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346487|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346489|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
138346490|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346491|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
138346492|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138346493|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138346494|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
138346495|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138346496|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
138346497|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
138346498|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346499|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346500|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346501|NCT02139540|Analgesics|analgesics|mesh-ancestor
138346502|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
138346503|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346504|NCT02148588|Lidocaine|lidocaine|mesh-list
138346505|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346506|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
138346507|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346508|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346509|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
138346510|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346511|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346512|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346513|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346514|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346515|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346516|NCT02149524|Trastuzumab|trastuzumab|mesh-list
138346517|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138346518|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346519|NCT02154048|Dexamethasone|dexamethasone|mesh-list
138346520|NCT02154048|Ropivacaine|ropivacaine|mesh-list
138347092|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138346521|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346522|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
138346524|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346525|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346527|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
138346528|NCT02154048|Hormones|hormones|mesh-ancestor
138346529|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346530|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346531|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346532|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346534|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346535|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
138346536|NCT02156154|Acetaminophen|acetaminophen|mesh-list
138346537|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346538|NCT02156154|Analgesics|analgesics|mesh-ancestor
138346539|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
138346540|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346541|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346542|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
138346543|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
138346544|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138346545|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346547|NCT02159976|Metronidazole|metronidazole|mesh-list
138346548|NCT02159976|Clarithromycin|clarithromycin|mesh-list
138346549|NCT02159976|Tetracycline|tetracycline|mesh-list
138346550|NCT02159976|Pantoprazole|pantoprazole|mesh-list
138346551|NCT02159976|Bismuth|bismuth|mesh-list
138346552|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346553|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346554|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138346555|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138346556|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138346557|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346558|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346559|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138346560|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138346561|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138346562|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346563|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138346564|NCT02159976|Antacids|antacids|mesh-ancestor
138346565|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
138346566|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138346567|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138346568|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138346569|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346570|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346571|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
138346572|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346573|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346574|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138346575|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346576|NCT02160990|Exenatide|exenatide|mesh-list
138346577|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138346578|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346579|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138346580|NCT02160990|Incretins|incretins|mesh-ancestor
138346582|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346583|NCT02164422|Guanfacine|guanfacine|mesh-list
138346584|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138346585|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138346586|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346594|NCT02173392|Brodalumab|brodalumab|mesh-list
138346595|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
138346596|NCT02178540|Tobramycin|tobramycin|mesh-list
138346597|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346598|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346599|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
138346600|NCT02178696|Citalopram|citalopram|mesh-list
138346601|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138346602|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138346603|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138346604|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346605|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346606|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346607|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
138346608|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346609|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138346610|NCT02179788|Metformin|metformin|mesh-list
138346611|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138346612|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346613|NCT02180100|Fluconazole|fluconazole|mesh-list
138346614|NCT02180100|Terconazole|terconazole|mesh-list
138346615|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
138346616|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346617|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138346618|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138346619|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346620|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346621|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138346622|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
138346623|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346624|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346625|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138346626|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138346628|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138346629|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346630|NCT02181426|Analgesics|analgesics|mesh-ancestor
138346631|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
138346632|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346633|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346634|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346635|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138346636|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138346637|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346638|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346639|NCT02192814|Lacosamide|lacosamide|mesh-list
138346640|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
138346641|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346642|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346643|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346644|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346645|NCT02195232|Quercetin|quercetin|mesh-list
138346646|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
138346647|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346648|NCT02195232|Protective Agents|protective agents|mesh-ancestor
138346649|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346650|NCT02196168|Cisplatin|cisplatin|mesh-list
138346651|NCT02196168|Adavosertib|adavosertib|mesh-list
138346652|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346653|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346654|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346655|NCT02201394|Aspirin|aspirin|mesh-list
138346656|NCT02201394|Ticagrelor|ticagrelor|mesh-list
138346657|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138346658|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346659|NCT02201394|Analgesics|analgesics|mesh-ancestor
138346660|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
138346661|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346662|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346663|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346665|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138346666|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138346667|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346668|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138346672|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138346673|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138346674|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138346675|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
138346676|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346677|NCT02203578|Romidepsin|romidepsin|mesh-list
138346678|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138346679|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346680|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138346681|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346682|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346683|NCT02206776|Midazolam|midazolam|mesh-list
138346684|NCT02206776|Ketamine|ketamine|mesh-list
138346686|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
138346687|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346688|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346689|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138346690|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138346691|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
138346692|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
138346693|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346694|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138346695|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138346696|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346697|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346698|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138346699|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346700|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138346701|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138346702|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138346703|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
138346704|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
138346705|NCT02209272|Lidocaine|lidocaine|mesh-list
138346706|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
138346707|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346708|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
138346709|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346710|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346711|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
138346712|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346713|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346714|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346715|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346716|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346717|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346718|NCT02214420|Ribavirin|ribavirin|mesh-list
138346719|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
138346720|NCT02214420|Simeprevir|simeprevir|mesh-list
138346721|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
138346722|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346723|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
138346724|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346725|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
138346726|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346727|NCT02215200|Lenograstim|lenograstim|mesh-list
138346728|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
138346729|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138346730|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138346732|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346733|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138346734|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
138346736|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138346737|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138346738|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
138346739|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346740|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138346741|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138346742|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346743|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346744|NCT02222610|Ranibizumab|ranibizumab|mesh-list
138346745|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138346746|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138346747|NCT02222610|Growth Substances|growth substances|mesh-ancestor
138346748|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346749|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
138346750|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346751|NCT02223702|Amoxicillin|amoxicillin|mesh-list
138346752|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
138346753|NCT02223702|Metronidazole|metronidazole|mesh-list
138346754|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346755|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346756|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138346757|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138346758|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346759|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346760|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346761|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138346762|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138346763|NCT02225106|Methylphenidate|methylphenidate|mesh-list
138346764|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138346765|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346766|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138346767|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138346768|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346769|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346771|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346773|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138346774|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
138346775|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346776|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346777|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346778|NCT02233998|Listerine|listerine|mesh-list
138346779|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
138346780|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138346781|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346782|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
138346783|NCT02233998|Protective Agents|protective agents|mesh-ancestor
138346784|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346786|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
138346803|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
138346804|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
138346805|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346806|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346807|NCT02239770|Nicotine|nicotine|mesh-list
138346808|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138346809|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
138346810|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346811|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346812|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138346813|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138346814|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
138346815|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346816|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346817|NCT02241486|Fentanyl|fentanyl|mesh-list
138346818|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138346819|NCT02241486|Narcotics|narcotics|mesh-ancestor
138346820|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346821|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346822|NCT02241486|Analgesics|analgesics|mesh-ancestor
138346823|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
138346824|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346825|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138346826|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138346827|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
138346828|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
138346829|NCT02244918|Nicotine|nicotine|mesh-list
138346830|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138346831|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
138346832|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346833|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346834|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138346835|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138346836|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
138346837|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346838|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346839|NCT02250612|Timolol|timolol|mesh-list
138346840|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346841|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138346842|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138346843|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346844|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346845|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346846|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138346847|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138346848|NCT02251236|Tenofovir|tenofovir|mesh-list
138346849|NCT02251236|Emtricitabine|emtricitabine|mesh-list
138346850|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138346851|NCT02251236|Cobicistat|cobicistat|mesh-list
138346852|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138346853|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138346854|NCT02251236|Elvitegravir|elvitegravir|mesh-list
138346855|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
138346856|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346857|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138346858|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138346859|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346860|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346861|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138346862|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138346863|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138346864|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138346865|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138346867|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346868|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346869|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138346870|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346871|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
138346872|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138346873|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
138346874|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346876|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138346877|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
138346878|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346879|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346880|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346881|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
138346882|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
138346883|NCT02260440|Azacitidine|azacitidine|mesh-list
138346884|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138346885|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346886|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138346887|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346888|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138346889|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
138346890|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346892|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138346893|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346894|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346895|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346896|NCT02267538|Analgesics|analgesics|mesh-ancestor
138346897|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
138346898|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346899|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138346900|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138346901|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138346902|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
138346903|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346904|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346905|NCT02267772|Acetaminophen|acetaminophen|mesh-list
138346907|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138346908|NCT02267772|Narcotics|narcotics|mesh-ancestor
138346909|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346910|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346911|NCT02267772|Analgesics|analgesics|mesh-ancestor
138346912|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
138346913|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346914|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138346915|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
138346916|NCT02271906|Afatinib|afatinib|mesh-list
138346917|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346918|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138346919|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346920|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346921|NCT02274870|Bupivacaine|bupivacaine|mesh-list
138346922|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346923|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
138346924|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346925|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346926|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
138346927|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346928|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138346930|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346931|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346932|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347093|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
138346933|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346934|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
138346935|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138346936|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
138346937|NCT02282514|Rituximab|rituximab|mesh-list
138346938|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
138346939|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138346940|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
138346941|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346942|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138346943|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138346944|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
138346945|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346946|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346947|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138346948|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138346949|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346950|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
138346951|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
138346952|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346953|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138346954|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
138346955|NCT02282514|Hormones|hormones|mesh-ancestor
138346956|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346959|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346960|NCT02282904|Sirolimus|sirolimus|mesh-list
138346961|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
138346962|NCT02282904|Busulfan|busulfan|mesh-list
138346963|NCT02282904|Fludarabine|fludarabine|mesh-list
138346964|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138346965|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
138346966|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346968|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138346969|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
138346970|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346971|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346973|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346974|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346975|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138346976|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
138346977|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138346978|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
138346979|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138346980|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138346981|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138346982|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138346983|NCT02284386|Bupivacaine|bupivacaine|mesh-list
138346984|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
138346985|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
138346986|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138346987|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346988|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
138346989|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138346990|NCT02284464|Prednisone|prednisone|mesh-list
138346991|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138346992|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
138346993|NCT02284464|Hormones|hormones|mesh-ancestor
138346994|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138346995|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346996|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138346997|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346998|NCT02284854|Carbamazepine|carbamazepine|mesh-list
138346999|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138347000|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
138347001|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
138347002|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138347003|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347004|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347005|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347006|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347007|NCT02284854|Analgesics|analgesics|mesh-ancestor
138347008|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
138347009|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347010|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138347011|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347012|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347013|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138347014|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138347015|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138347016|NCT02285634|Lidocaine|lidocaine|mesh-list
138347020|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
138347021|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
138347022|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347023|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347024|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
138347025|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347026|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138347027|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138347028|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138347029|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347030|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347031|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138347032|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347033|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347034|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347035|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138347036|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138347037|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
138347038|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138347039|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138347040|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
138347041|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
138347042|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138347043|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138347044|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
138347045|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138347046|NCT02285634|Protective Agents|protective agents|mesh-ancestor
138347047|NCT02287350|Diclofenac|diclofenac|mesh-list
138347048|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138347049|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347050|NCT02287350|Analgesics|analgesics|mesh-ancestor
138347051|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
138347052|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347053|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347054|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347055|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347056|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347057|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347058|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347059|NCT02288364|Lidocaine|lidocaine|mesh-list
138347060|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
138347061|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
138347062|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347063|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347064|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
138347065|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347066|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138347067|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138347068|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138347069|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347070|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347071|NCT02289222|Dexamethasone|dexamethasone|mesh-list
138347072|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
138347073|NCT02289222|Pomalidomide|pomalidomide|mesh-list
138347074|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347075|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
138347076|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
138347077|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347082|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347084|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347085|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347086|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138347087|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347089|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138347090|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138347091|NCT02289222|Growth Substances|growth substances|mesh-ancestor
138347094|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138347095|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
138347096|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347097|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347098|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138347099|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
138347100|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138347101|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138347102|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347103|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347104|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347105|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347106|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
138347107|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
138347108|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347109|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347110|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347111|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138347112|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138347113|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138347114|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347115|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347116|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138347117|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347118|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347119|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138347120|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347121|NCT02299050|Bromocriptine|bromocriptine|mesh-list
138347122|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138347123|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138347124|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138347125|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347129|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347130|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347131|NCT02302092|Cefepime|cefepime|mesh-list
138347132|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138347133|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347134|NCT02303184|Aflibercept|aflibercept|mesh-list
138347135|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138347136|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138347137|NCT02303184|Growth Substances|growth substances|mesh-ancestor
138347138|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347139|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
138347140|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347141|NCT02304432|Cycloserine|cycloserine|mesh-list
138347142|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138347143|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347144|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138347145|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
138347146|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138347147|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
138347148|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347149|NCT02307318|Hemostatics|hemostatics|mesh-list
138347150|NCT02307318|Coagulants|coagulants|mesh-ancestor
138347151|NCT02314104|Ropivacaine|ropivacaine|mesh-list
138347154|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347155|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347156|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
138347157|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347158|NCT02321748|Montelukast|montelukast|mesh-list
138347159|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138347160|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138347161|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138347162|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
138347163|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347164|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347165|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138347166|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138347167|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347168|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138347169|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138347170|NCT02330094|Gabapentin|gabapentin|mesh-list
138347172|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
138347173|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347174|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347175|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
138347176|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138347177|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138347178|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347179|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347180|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138347181|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138347182|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347183|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347184|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
138347185|NCT02330172|Neostigmine|neostigmine|mesh-list
138347186|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138347187|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347188|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347189|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
138347190|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347191|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347192|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138347193|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
138347194|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347195|NCT02331108|Propofol|propofol|mesh-list
138347196|NCT02331108|Anesthetics|anesthetics|mesh-list
138347197|NCT02331108|Sevoflurane|sevoflurane|mesh-list
138347198|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347200|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347201|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138347202|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
138347203|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138347204|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138347205|NCT02340156|Temozolomide|temozolomide|mesh-list
138347206|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347207|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
138347208|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347209|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347211|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
138347212|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138347213|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138347214|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138347215|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347217|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138347218|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347219|NCT02351700|Analgesics|analgesics|mesh-ancestor
138347220|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
138347221|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347222|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347223|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347224|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347225|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347226|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347227|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347228|NCT02353806|Amlodipine|amlodipine|mesh-list
138347229|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138347230|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138347231|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347232|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347233|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138347234|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347235|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
138347236|NCT02354352|Eplerenone|eplerenone|mesh-list
138347237|NCT02354352|Spironolactone|spironolactone|mesh-list
138347238|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138347239|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138347240|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347241|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347242|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138347243|NCT02354352|Diuretics|diuretics|mesh-ancestor
138347244|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
138347245|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138347246|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
138347247|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347248|NCT02357706|Acetaminophen|acetaminophen|mesh-list
138347249|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347250|NCT02357706|Analgesics|analgesics|mesh-ancestor
138347251|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
138347252|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347253|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347254|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
138347255|NCT02359110|Gabapentin|gabapentin|mesh-list
138347256|NCT02359110|Analgesics|analgesics|mesh-ancestor
138347257|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
138347258|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347259|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347260|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
138347261|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138347264|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347265|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138347266|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138347267|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347268|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347269|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
138347270|NCT02360124|Fluorides|fluorides|mesh-list
138347271|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
138347272|NCT02360124|Protective Agents|protective agents|mesh-ancestor
138347273|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347275|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138347276|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
138347277|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347278|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138347279|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138347280|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347281|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347282|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
138347283|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347284|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347285|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138347286|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138347287|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347288|NCT02374164|Febuxostat|febuxostat|mesh-list
138347289|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
138347290|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347291|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
138347292|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138347293|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138347294|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347295|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
138347296|NCT02374398|Coagulants|coagulants|mesh-ancestor
138347297|NCT02377752|Doxorubicin|doxorubicin|mesh-list
138347298|NCT02377752|Olaratumab|olaratumab|mesh-list
138347299|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138347300|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347301|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138347302|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138347303|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347304|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347305|NCT02379858|Alvimopan|alvimopan|mesh-list
138347306|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347307|NCT02384070|Aspirin|aspirin|mesh-list
138347308|NCT02384070|Bivalirudin|bivalirudin|mesh-list
138347309|NCT02384070|Clopidogrel|clopidogrel|mesh-list
138347310|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138347311|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347312|NCT02384070|Analgesics|analgesics|mesh-ancestor
138347313|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
138347314|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347315|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347316|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347317|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347318|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138347319|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138347320|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347321|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138347322|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347323|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347324|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
138347325|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138347326|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138347327|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138347328|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
138347329|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347330|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
138347331|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138347332|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138347333|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
138347334|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138347341|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347342|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347344|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
138347345|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
138347347|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138347348|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347349|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
138347350|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
138347351|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
138347352|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138347353|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
138347354|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
138347355|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347356|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347357|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347358|NCT02391714|Analgesics|analgesics|mesh-ancestor
138347359|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
138347360|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347361|NCT02395692|Temozolomide|temozolomide|mesh-list
138347362|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347363|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
138347364|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347365|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347366|NCT02397954|Ranibizumab|ranibizumab|mesh-list
138347367|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138347368|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138347369|NCT02397954|Growth Substances|growth substances|mesh-ancestor
138347370|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347371|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
138347372|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347373|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138347374|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138347375|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138347376|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347377|NCT02401542|Docetaxel|docetaxel|mesh-list
138347378|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347379|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347380|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347381|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347382|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347383|NCT02411916|Misoprostol|misoprostol|mesh-list
138347384|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138347385|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
138347386|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138347387|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347388|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138347389|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347390|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
138347391|NCT02413320|Paclitaxel|paclitaxel|mesh-list
138347392|NCT02413320|Docetaxel|docetaxel|mesh-list
138347393|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
138347394|NCT02413320|Carboplatin|carboplatin|mesh-list
138347395|NCT02413320|Doxorubicin|doxorubicin|mesh-list
138347396|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138347397|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347398|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347401|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347403|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
138347404|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347405|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347406|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347408|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138347409|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138347410|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138347895|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
138347411|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138347412|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347414|NCT05718492|Fluorouracil|fluorouracil|mesh-list
138347415|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
138347416|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
138347417|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347418|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138347419|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347420|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138347421|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
138347422|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347423|NCT05718492|Antidotes|antidotes|mesh-ancestor
138347424|NCT05718492|Protective Agents|protective agents|mesh-ancestor
138347425|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
138347426|NCT05718492|Vitamins|vitamins|mesh-ancestor
138347427|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
138347428|NCT05717790|Gemcitabine|gemcitabine|mesh-list
138347429|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
138347430|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347431|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138347432|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
138347433|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347434|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347436|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347437|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347438|NCT05543694|Bupivacaine|bupivacaine|mesh-list
138347439|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
138347440|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
138347441|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347442|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347443|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
138347444|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347446|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138347447|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347448|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347449|NCT05358834|Melatonin|melatonin|mesh-list
138347450|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
138347451|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347452|NCT05358834|Protective Agents|protective agents|mesh-ancestor
138347453|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347454|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347455|NCT05273346|Analgesics|analgesics|mesh-list
138347456|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
138347457|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347458|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347459|NCT05105256|Prednisolone|prednisolone|mesh-list
138347460|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347461|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
138347463|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347464|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347465|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138347466|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347467|NCT04916886|Vaccines|vaccines|mesh-list
138347468|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
138347469|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347470|NCT04907682|Ribavirin|ribavirin|mesh-list
138347471|NCT04907682|Favipiravir|favipiravir|mesh-list
138347472|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
138347473|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347474|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
138347475|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347476|NCT04840992|Vaccines|vaccines|mesh-list
138347477|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
138347478|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347479|NCT04793022|Anesthetics|anesthetics|mesh-list
138347480|NCT04793022|Propofol|propofol|mesh-list
138347481|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347482|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347483|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347484|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138347485|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
138347486|NCT04621500|Vitamin D|vitamin d|mesh-list
138347487|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
138347488|NCT04621500|Vitamins|vitamins|mesh-ancestor
138347489|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
138347490|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347491|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138347492|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138347493|NCT04567524|Risperidone|risperidone|mesh-list
138347494|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138347495|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
138347496|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347497|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347498|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347499|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138347500|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138347501|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347502|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347503|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138347504|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
138347505|NCT04481412|Cetirizine|cetirizine|mesh-list
138347506|NCT04481412|Ethanol|ethanol|mesh-list
138347507|NCT04481412|Minoxidil|minoxidil|mesh-list
138347508|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138347509|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347510|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347511|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347512|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138347513|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138347514|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138347515|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
138347516|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
138347517|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347518|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347519|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138347520|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
138347522|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138347523|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138347524|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
138347525|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347526|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347527|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347529|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138347530|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347531|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
138347532|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138347534|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138347535|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
138347536|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347537|NCT03252522|Micronutrients|micronutrients|mesh-list
138347538|NCT03252522|Trace Elements|trace elements|mesh-list
138347539|NCT03252522|Antioxidants|antioxidants|mesh-list
138347540|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347541|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347542|NCT03252522|Protective Agents|protective agents|mesh-ancestor
138347543|NCT03191370|Anesthetics|anesthetics|mesh-list
138347544|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
138347545|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347546|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347547|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
138347548|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347549|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
138347550|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347551|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347552|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138347553|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347555|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
138347556|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347559|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138347560|NCT02834052|Poly ICLC|poly iclc|mesh-list
138347561|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347562|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347563|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138347564|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347565|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
138347566|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
138347567|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347568|NCT02834052|Laxatives|laxatives|mesh-ancestor
138347569|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347570|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
138347571|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347572|NCT02756364|Fulvestrant|fulvestrant|mesh-list
138347573|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138347574|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347575|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138347576|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138347577|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138347578|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347579|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347580|NCT02519322|Nivolumab|nivolumab|mesh-list
138347581|NCT02519322|Ipilimumab|ipilimumab|mesh-list
138347582|NCT02519322|Relatlimab|relatlimab|mesh-list
138347583|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
138347584|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
138347585|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347586|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347587|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138347588|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347589|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
138347590|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347591|NCT02460042|Paclitaxel|paclitaxel|mesh-list
138347592|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138347593|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347594|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347595|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347597|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347599|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138347600|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347601|NCT05722548|Analgesics|analgesics|mesh-ancestor
138347602|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
138347603|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347604|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347605|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347606|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347607|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
138347608|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
138347609|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138347610|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347611|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347612|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347614|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347615|NCT05722002|Analgesics|analgesics|mesh-ancestor
138347616|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
138347617|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347618|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347619|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
138347620|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138347621|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
138347622|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347623|NCT05721300|Interferons|interferons|mesh-list
138347624|NCT05721300|Tenofovir|tenofovir|mesh-list
138347625|NCT05721300|Entecavir|entecavir|mesh-list
138347626|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347627|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
138347628|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347629|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138347630|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138347631|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347632|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347633|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138347634|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138347636|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347637|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347638|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138347639|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
138347640|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347641|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347642|NCT05719818|Diphosphonates|diphosphonates|mesh-list
138347643|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138347644|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347645|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
138347646|NCT05719506|Ketamine|ketamine|mesh-list
138347647|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347648|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347649|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347650|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347651|NCT05719506|Analgesics|analgesics|mesh-ancestor
138347652|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
138347653|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347657|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347658|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347659|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347660|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138347661|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138347662|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
138347663|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
138347664|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138347665|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138347666|NCT05716932|Ranibizumab|ranibizumab|mesh-list
138347667|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138347668|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138347669|NCT05716932|Growth Substances|growth substances|mesh-ancestor
138347670|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347671|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
138347672|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347674|NCT05715840|Bevacizumab|bevacizumab|mesh-list
138347675|NCT05715840|Carboplatin|carboplatin|mesh-list
138347676|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138347677|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347678|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347679|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347680|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347681|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347682|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347683|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138347684|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138347685|NCT05715840|Growth Substances|growth substances|mesh-ancestor
138347686|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347687|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
138347688|NCT05713734|Thrombin|thrombin|mesh-list
138347689|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
138347690|NCT05713734|Coagulants|coagulants|mesh-ancestor
138347691|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
138347692|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347693|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347694|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347695|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347696|NCT05698758|Analgesics|analgesics|mesh-ancestor
138347697|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
138347698|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347699|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138347700|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138347701|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347702|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347703|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347704|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347705|NCT05557812|Eugenol|eugenol|mesh-list
138347706|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
138347707|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
138347708|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138347709|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
138347710|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138347711|NCT05557812|Protective Agents|protective agents|mesh-ancestor
138347712|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347713|NCT05557812|Hematinics|hematinics|mesh-ancestor
138347714|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347715|NCT05549466|Gemcitabine|gemcitabine|mesh-list
138347716|NCT05549466|Capecitabine|capecitabine|mesh-list
138347717|NCT05549466|Docetaxel|docetaxel|mesh-list
138347720|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
138347721|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347722|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347723|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347724|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347725|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347726|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138347727|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347728|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
138347729|NCT05436678|Celecoxib|celecoxib|mesh-list
138347730|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138347731|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347732|NCT05436678|Analgesics|analgesics|mesh-ancestor
138347733|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
138347734|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347735|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347736|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138347737|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347738|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138347739|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347740|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347741|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347742|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138347743|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347744|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138347745|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138347746|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347747|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138347748|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138347750|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138347751|NCT05352282|Narcotics|narcotics|mesh-ancestor
138347752|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347753|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347754|NCT05352282|Analgesics|analgesics|mesh-ancestor
138347755|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
138347756|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347757|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138347758|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138347759|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
138347760|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
138347761|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
138347762|NCT05322330|Fludarabine|fludarabine|mesh-list
138347763|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138347764|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
138347765|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347766|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347767|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138347768|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
138347769|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347770|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347771|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138347772|NCT05312892|Amlodipine|amlodipine|mesh-list
138347773|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
138347774|NCT05312892|Moxonidine|moxonidine|mesh-list
138347775|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138347776|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347781|NCT05251038|Leucovorin|leucovorin|mesh-list
138347782|NCT05251038|Paclitaxel|paclitaxel|mesh-list
138347783|NCT05251038|Gemcitabine|gemcitabine|mesh-list
138347784|NCT05251038|Fluorouracil|fluorouracil|mesh-list
138347785|NCT05251038|Irinotecan|irinotecan|mesh-list
138347786|NCT05251038|Sotorasib|sotorasib|mesh-list
138347787|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138347788|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347789|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138347790|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138347791|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347792|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347793|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138347794|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
138347795|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138347796|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
138347797|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347798|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138347799|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138347800|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347801|NCT05251038|Antidotes|antidotes|mesh-ancestor
138347802|NCT05251038|Protective Agents|protective agents|mesh-ancestor
138347803|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
138347804|NCT05251038|Vitamins|vitamins|mesh-ancestor
138347805|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
138347806|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138347807|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347808|NCT05027646|Granisetron|granisetron|mesh-list
138347809|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
138347810|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
138347811|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347812|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347813|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138347814|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138347815|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138347816|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
138347817|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347818|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347819|NCT04988646|Acyclovir|acyclovir|mesh-list
138347820|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
138347821|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347823|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138347824|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347825|NCT04754334|Insulin|insulin|mesh-list
138347826|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138347827|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347828|NCT04748796|Landiolol|landiolol|mesh-list
138347829|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138347830|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138347831|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347832|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347833|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347834|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347835|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138347836|NCT04599816|Simendan|simendan|mesh-list
138347837|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138347838|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
138347839|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138347840|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138347841|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347842|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347843|NCT04599816|Protective Agents|protective agents|mesh-ancestor
138347844|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347845|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138347846|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347847|NCT04509414|Midazolam|midazolam|mesh-list
138347848|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
138347849|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347850|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347851|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347852|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138347853|NCT04509414|Analgesics|analgesics|mesh-ancestor
138347854|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
138347855|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347856|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138347857|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138347858|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347859|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347860|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347861|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347862|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138347863|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138347864|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138347865|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138347866|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138347867|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
138347868|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
138347869|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
138347870|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
138347871|NCT04320342|Beclomethasone|beclomethasone|mesh-list
138347872|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
138347873|NCT04320342|Bromides|bromides|mesh-list
138347874|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
138347875|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138347877|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347878|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347879|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138347880|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
138347881|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138347882|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138347883|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138347884|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
138347886|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347891|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347892|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138347893|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138347894|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138347899|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347900|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347901|NCT04095858|Methotrexate|methotrexate|mesh-list
138347902|NCT04095858|Tacrolimus|tacrolimus|mesh-list
138347903|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138347904|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
138347905|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138347907|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138347908|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
138347909|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347910|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347911|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
138347912|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347913|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138347914|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138347915|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
138347916|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138347917|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138347918|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138347919|NCT03937986|Cocaine|cocaine|mesh-list
138347920|NCT03937986|Suvorexant|suvorexant|mesh-list
138347921|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
138347922|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
138347923|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347924|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347925|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
138347926|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347927|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138347928|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138347929|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138347930|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347931|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347932|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
138347933|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347934|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138347935|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138347936|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138347937|NCT03813030|Lidocaine|lidocaine|mesh-list
138347938|NCT03813030|Prilocaine|prilocaine|mesh-list
138347940|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
138347941|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347942|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347948|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138347949|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347950|NCT03778944|Dopamine|dopamine|mesh-list
138347951|NCT03778944|Mannitol|mannitol|mesh-list
138347952|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138347953|NCT03778944|Diuretics|diuretics|mesh-ancestor
138347954|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
138347955|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347956|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138347957|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
138347958|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
138347959|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138347961|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138347962|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347963|NCT03778944|Protective Agents|protective agents|mesh-ancestor
138347964|NCT03653052|Durvalumab|durvalumab|mesh-list
138347965|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347966|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347967|NCT03640728|Tenofovir|tenofovir|mesh-list
138347968|NCT03640728|Entecavir|entecavir|mesh-list
138347969|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
138347970|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347971|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138347972|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138347973|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347974|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347975|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138347976|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138347977|NCT03436368|Anesthetics|anesthetics|mesh-list
138347978|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138347979|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347980|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138347981|NCT03393780|Hormones|hormones|mesh-ancestor
138347982|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138347983|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138347984|NCT03202758|Durvalumab|durvalumab|mesh-list
138347985|NCT03202758|Tremelimumab|tremelimumab|mesh-list
138347986|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138347987|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347988|NCT03122262|Tenofovir|tenofovir|mesh-list
138347989|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138347990|NCT03122262|Dolutegravir|dolutegravir|mesh-list
138347991|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138347992|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
138347993|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138347994|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138347995|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138347996|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347997|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138347998|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138347999|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138348000|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138348001|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138348002|NCT03051282|Enalapril|enalapril|mesh-list
138348003|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138348004|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
138348005|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348008|NCT03042546|Calcium|calcium|mesh-list
138348009|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138348010|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348011|NCT02420652|Aspirin|aspirin|mesh-list
138348012|NCT02420652|Metformin|metformin|mesh-list
138348013|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138348014|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348015|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138348016|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348017|NCT02420652|Analgesics|analgesics|mesh-ancestor
138348018|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
138348019|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348020|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348021|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348022|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138348023|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138348024|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348025|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138348026|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138348027|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348028|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
138348029|NCT02257242|Rituximab|rituximab|mesh-list
138348030|NCT02257242|Vincristine|vincristine|mesh-list
138348031|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138348032|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348033|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348034|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
138348035|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348036|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348037|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138348038|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348039|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348040|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348041|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348042|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138348044|NCT02034630|Busulfan|busulfan|mesh-list
138348045|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
138348046|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348047|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138348048|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
138348049|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348050|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138348051|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348052|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138348053|NCT02025036|Capecitabine|capecitabine|mesh-list
138348054|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
138348055|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348056|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
138348057|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348058|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348059|NCT01768338|Ofatumumab|ofatumumab|mesh-list
138348060|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348061|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138348062|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
138348063|NCT00596154|Busulfan|busulfan|mesh-list
138348064|NCT00596154|Thiotepa|thiotepa|mesh-list
138348065|NCT00596154|Rituximab|rituximab|mesh-list
138348066|NCT00596154|Methotrexate|methotrexate|mesh-list
138348067|NCT00596154|Vincristine|vincristine|mesh-list
138348068|NCT00596154|Procarbazine|procarbazine|mesh-list
138348069|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138348070|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
138348077|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138348078|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348079|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138348081|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348082|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348083|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
138348084|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
138348085|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348086|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138348087|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138348088|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138348089|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348090|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348091|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348092|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348094|NCT00281658|Lapatinib|lapatinib|mesh-list
138348095|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138348096|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348097|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348098|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348099|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348100|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348101|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348102|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348103|NCT02417844|Tamsulosin|tamsulosin|mesh-list
138348104|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138348105|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138348106|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138348107|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348108|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348109|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348110|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348111|NCT02417844|Urological Agents|urological agents|mesh-ancestor
138348113|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
138348114|NCT02418312|Histamine|histamine|mesh-list
138348115|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138348116|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348117|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
138348118|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
138348119|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348120|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348121|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348122|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
138348123|NCT02421354|Nivolumab|nivolumab|mesh-list
138348124|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348125|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348126|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138348127|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348128|NCT02422290|Ketamine|ketamine|mesh-list
138348129|NCT02422290|Analgesics|analgesics|mesh-ancestor
138348130|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
138348131|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348132|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348133|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138348134|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348135|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
138348136|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
138348137|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348138|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138348139|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138348140|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348141|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348148|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348149|NCT02430090|Analgesics|analgesics|mesh-ancestor
138348150|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
138348151|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348152|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348153|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348154|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
138348155|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
138348156|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348157|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
138348158|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
138348159|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348160|NCT02431650|Primaquine|primaquine|mesh-list
138348161|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
138348162|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138348163|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138348164|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348165|NCT02437344|Naltrexone|naltrexone|mesh-list
138348166|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138348167|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138348168|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348169|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
138348170|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348171|NCT02440308|Bombesin|bombesin|mesh-list
138348172|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348173|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348174|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348175|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
138348176|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138348177|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138348178|NCT02448654|Tolcapone|tolcapone|mesh-list
138348179|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138348180|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138348181|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138348182|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348183|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348184|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138348185|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138348186|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138348187|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348189|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138348190|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138348191|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348192|NCT02462148|Dexamethasone|dexamethasone|mesh-list
138348193|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
138348194|NCT02462148|Epinephrine|epinephrine|mesh-list
138348195|NCT02462148|Bupivacaine|bupivacaine|mesh-list
138348196|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138348197|NCT02462148|BB 1101|bb 1101|mesh-list
138348198|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348199|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
138348200|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
138348202|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348203|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348204|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
138348205|NCT02462148|Hormones|hormones|mesh-ancestor
138348206|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348207|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348208|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348209|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
138348210|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348211|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348212|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348213|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
138348214|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348215|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
138348216|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348217|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138348218|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348219|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348220|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138348221|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138348222|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138348223|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
138348224|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
138348225|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
138348226|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138348227|NCT02462382|Ropivacaine|ropivacaine|mesh-list
138348228|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348229|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
138348230|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348231|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348232|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
138348233|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348234|NCT02464176|Dexamethasone|dexamethasone|mesh-list
138348235|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
138348236|NCT02464176|Epinephrine|epinephrine|mesh-list
138348237|NCT02464176|Bupivacaine|bupivacaine|mesh-list
138348238|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138348239|NCT02464176|BB 1101|bb 1101|mesh-list
138348240|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348241|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
138348242|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
138348243|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348244|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348246|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
138348247|NCT02464176|Hormones|hormones|mesh-ancestor
138348248|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348249|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348250|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348251|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
138348252|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348253|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348254|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348255|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
138348256|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348257|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
138348258|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348259|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138348263|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138348264|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138348265|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138348266|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
138348267|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
138348268|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138348269|NCT02468700|Dexamethasone|dexamethasone|mesh-list
138348270|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348271|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
138348272|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
138348273|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348274|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348275|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348276|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
138348277|NCT02468700|Hormones|hormones|mesh-ancestor
138348278|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348279|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348280|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348281|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
138348282|NCT02472522|Ropivacaine|ropivacaine|mesh-list
138348283|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
138348284|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138348285|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348286|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348287|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348288|NCT02472522|Analgesics|analgesics|mesh-ancestor
138348289|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
138348291|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138348292|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348293|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348294|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348295|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348296|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348297|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
138348298|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138348299|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
138348300|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348301|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
138348302|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
138348303|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348305|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138348307|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348308|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348309|NCT02484222|Analgesics|analgesics|mesh-ancestor
138348310|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
138348311|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348312|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348313|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348314|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
138348315|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
138348316|NCT02486016|Fentanyl|fentanyl|mesh-list
138348317|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138348318|NCT02486016|Narcotics|narcotics|mesh-ancestor
138348319|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348320|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348321|NCT02486016|Analgesics|analgesics|mesh-ancestor
138348324|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348325|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348326|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
138348327|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
138348328|NCT02486328|Midazolam|midazolam|mesh-list
138348329|NCT02486328|Meperidine|meperidine|mesh-list
138348330|NCT02486328|Remifentanil|remifentanil|mesh-list
138348331|NCT02486328|Propofol|propofol|mesh-list
138348332|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138348333|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348334|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348335|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348336|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
138348337|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
138348338|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348339|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138348340|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138348341|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138348342|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
138348343|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
138348344|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348345|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348346|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138348347|NCT02486328|Narcotics|narcotics|mesh-ancestor
138348348|NCT02486328|Analgesics|analgesics|mesh-ancestor
138348349|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
138348350|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348351|NCT02491788|Suvorexant|suvorexant|mesh-list
138348352|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138348353|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138348354|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348355|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348356|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138348357|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348358|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348359|NCT02491944|Osimertinib|osimertinib|mesh-list
138348360|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348361|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348362|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348363|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348364|NCT02492802|Posaconazole|posaconazole|mesh-list
138348365|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
138348366|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348367|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138348368|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138348369|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138348370|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138348371|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138348372|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348373|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348374|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138348375|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
138348376|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348377|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348380|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348381|NCT02500602|Doxazosin|doxazosin|mesh-list
138348382|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138348383|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138348384|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138348385|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138348386|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348387|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348388|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348389|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348390|NCT02500836|Cocaine|cocaine|mesh-list
138348391|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138348392|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348393|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
138348394|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348395|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348396|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
138348397|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348398|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138348399|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138348400|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138348401|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348402|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348403|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
138348404|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348405|NCT02508636|Leuprolide|leuprolide|mesh-list
138348406|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138348407|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
138348408|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348409|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348410|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348411|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348412|NCT02513940|Ibutilide|ibutilide|mesh-list
138348413|NCT02513940|Testosterone|testosterone|mesh-list
138348414|NCT02513940|Progesterone|progesterone|mesh-list
138348415|NCT02513940|Androgens|androgens|mesh-ancestor
138348416|NCT02513940|Hormones|hormones|mesh-ancestor
138348417|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348418|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348419|NCT02513940|Progestins|progestins|mesh-ancestor
138348420|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138348421|NCT02515890|Midazolam|midazolam|mesh-list
138348422|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
138348423|NCT02515890|Ketamine|ketamine|mesh-list
138348424|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138348425|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348426|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348427|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348428|NCT02515890|Analgesics|analgesics|mesh-ancestor
138348429|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
138348430|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348431|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138348432|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348433|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138348434|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348435|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348436|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348440|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
138348441|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138348442|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138348443|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348444|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138348445|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138348446|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138348447|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
138348448|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
138348449|NCT02517996|Lidocaine|lidocaine|mesh-list
138348450|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348451|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
138348452|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348453|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348454|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
138348455|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348456|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138348457|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138348458|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138348459|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348460|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348462|NCT02525718|Epinephrine|epinephrine|mesh-list
138348463|NCT02525718|Bupivacaine|bupivacaine|mesh-list
138348464|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348465|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
138348467|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348468|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348469|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348470|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
138348471|NCT02525718|Hormones|hormones|mesh-ancestor
138348472|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348473|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348474|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348475|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348476|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
138348477|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348478|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
138348479|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348481|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348482|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348483|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348484|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138348485|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138348486|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138348487|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
138348488|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
138348489|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
138348490|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138348491|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
138348492|NCT02527512|Povidone|povidone|mesh-list
138348493|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
138348499|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
138348500|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348501|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348502|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348503|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138348504|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348506|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348507|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348508|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348509|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348510|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
138348511|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138348512|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138348513|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348514|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
138348515|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
138348516|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138348517|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138348518|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348519|NCT02536248|Incretins|incretins|mesh-ancestor
138348520|NCT02536248|Hormones|hormones|mesh-ancestor
138348521|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348522|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138348523|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
138348524|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348525|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348526|NCT02538042|Nicotine|nicotine|mesh-list
138348527|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138348528|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
138348529|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348530|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348531|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138348532|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138348533|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
138348534|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348535|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348536|NCT02538354|Riboflavin|riboflavin|mesh-list
138348537|NCT02538354|Vitamins|vitamins|mesh-ancestor
138348538|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
138348539|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348540|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
138348541|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138348542|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
138348543|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
138348544|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138348545|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138348546|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348547|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
138348563|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138348564|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138348565|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138348566|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348567|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138348568|NCT02541864|Antacids|antacids|mesh-ancestor
138348569|NCT02542410|Cabergoline|cabergoline|mesh-list
138348570|NCT02542410|Norethindrone|norethindrone|mesh-list
138348571|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
138348572|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138348573|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138348574|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138348575|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
138348576|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348577|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348578|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138348579|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138348580|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138348584|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348585|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348586|NCT02544984|Azithromycin|azithromycin|mesh-list
138348587|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138348588|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348589|NCT02547012|Amoxicillin|amoxicillin|mesh-list
138348590|NCT02547012|Levofloxacin|levofloxacin|mesh-list
138348592|NCT02547012|Tetracycline|tetracycline|mesh-list
138348593|NCT02547012|Esomeprazole|esomeprazole|mesh-list
138348594|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138348595|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348596|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138348597|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348598|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138348599|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348600|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348601|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138348602|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138348603|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138348604|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348605|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138348606|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138348607|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138348609|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
138348610|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348611|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348612|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
138348613|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138348614|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138348615|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138348616|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
138348617|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348618|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348619|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348620|NCT02560038|Paclitaxel|paclitaxel|mesh-list
138348621|NCT02560038|Gemcitabine|gemcitabine|mesh-list
138348622|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138348623|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348624|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348625|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348626|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348627|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348628|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348629|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
138348630|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138348631|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138348635|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
138348636|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138348637|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348638|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138348639|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348640|NCT02562066|Amifampridine|amifampridine|mesh-list
138348641|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138348642|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348643|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348644|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138348645|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348646|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348648|NCT02562924|Budesonide|budesonide|mesh-list
138348649|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348650|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
138348651|NCT02562924|Hormones|hormones|mesh-ancestor
138348652|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348653|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348654|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348655|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348656|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138348657|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
138348658|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348659|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138348660|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
138348661|NCT02563860|Lovastatin|lovastatin|mesh-list
138348662|NCT02563860|L 647318|l 647318|mesh-list
138348663|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
138348664|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138348665|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138348666|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
138348667|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348668|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138348669|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138348670|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348671|NCT02568852|Anesthetics|anesthetics|mesh-list
138348672|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348673|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348674|NCT02570022|Bupivacaine|bupivacaine|mesh-list
138348675|NCT02570022|Ropivacaine|ropivacaine|mesh-list
138348676|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
138348677|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
138348678|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348679|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348680|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
138348681|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348682|NCT02572752|Nintedanib|nintedanib|mesh-list
138348683|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348684|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138348685|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348686|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348687|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
138348688|NCT02577042|Atorvastatin|atorvastatin|mesh-list
138348689|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138348690|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138348691|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
138348694|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138348696|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138348697|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138348698|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
138348699|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348700|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138348701|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138348702|NCT02582970|Bevacizumab|bevacizumab|mesh-list
138348703|NCT02582970|Fluorouracil|fluorouracil|mesh-list
138348704|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
138348705|NCT02582970|Irinotecan|irinotecan|mesh-list
138348706|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348707|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348708|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138348709|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138348710|NCT02582970|Growth Substances|growth substances|mesh-ancestor
138348711|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348712|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138348713|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
138348715|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348716|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138348717|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
138348718|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138348719|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138348720|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348721|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
138348722|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
138348723|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348724|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
138348725|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138348727|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138348728|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348729|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348730|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
138348731|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348732|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348733|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138348734|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348737|NCT05248152|Pregabalin|pregabalin|mesh-list
138348738|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138348739|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348740|NCT05248152|Analgesics|analgesics|mesh-ancestor
138348741|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
138348742|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348743|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348744|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348745|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348746|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138348747|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348748|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348749|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
138348750|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138348751|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348752|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138348753|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138348754|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138348755|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348761|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348762|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348763|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348764|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348765|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348766|NCT04808466|Paclitaxel|paclitaxel|mesh-list
138348767|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138348768|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348769|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138348770|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138348771|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138348772|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348773|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138348774|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138348775|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
138348776|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348777|NCT03907176|Acetaminophen|acetaminophen|mesh-list
138348778|NCT03907176|Ibuprofen|ibuprofen|mesh-list
138348779|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348780|NCT03907176|Analgesics|analgesics|mesh-ancestor
138348781|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
138348782|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348783|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348784|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
138348785|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138348786|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348787|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348788|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138348789|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348790|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348791|NCT03675672|Misoprostol|misoprostol|mesh-list
138348792|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138348793|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
138348794|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348795|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348796|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138348797|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348798|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
138348799|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
138348800|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138348801|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
138348802|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348803|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
138348804|NCT02108496|Protective Agents|protective agents|mesh-ancestor
138348806|NCT02056236|Levetiracetam|levetiracetam|mesh-list
138348807|NCT02056236|Valproic Acid|valproic acid|mesh-list
138348808|NCT02056236|Lorazepam|lorazepam|mesh-list
138348809|NCT02056236|Thiopental|thiopental|mesh-list
138348813|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348814|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348815|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138348816|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
138348817|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
138348821|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138348822|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
138348823|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
138348824|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348825|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348826|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
138348827|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348828|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
138348829|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
138348830|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
138348831|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348832|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348833|NCT01962246|Capecitabine|capecitabine|mesh-list
138348834|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
138348835|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348836|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
138348837|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348838|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348839|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138348840|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
138348841|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348844|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348845|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
138348846|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138348847|NCT04945122|Atorvastatin|atorvastatin|mesh-list
138348848|NCT04945122|Pitavastatin|pitavastatin|mesh-list
138348849|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138348850|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138348851|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
138348852|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348853|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138348854|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138348855|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348856|NCT04227366|Methotrexate|methotrexate|mesh-list
138348857|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138348858|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
138348859|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138348860|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348861|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348862|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
138348863|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348864|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348865|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138348866|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348867|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138348868|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138348869|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
138348870|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348871|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138348873|NCT03560466|Prednisolone|prednisolone|mesh-list
138348874|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138348875|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
138348876|NCT03560466|Hormones|hormones|mesh-ancestor
138348877|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138348878|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348879|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138348880|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348881|NCT03376698|Colchicine|colchicine|mesh-list
138348882|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
138348883|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138348887|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348888|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348889|NCT03295734|Losartan|losartan|mesh-list
138348890|NCT03295734|Perindopril|perindopril|mesh-list
138348891|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138348892|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138348895|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348896|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138348898|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348899|NCT02595684|Tadalafil|tadalafil|mesh-list
138348901|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138348902|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138348903|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348904|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348905|NCT02595684|Urological Agents|urological agents|mesh-ancestor
138348906|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
138348911|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
138348912|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
138348913|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348914|NCT02607618|Vancomycin|vancomycin|mesh-list
138348915|NCT02607618|Iclaprim|iclaprim|mesh-list
138348916|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138348917|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348918|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138348919|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348920|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348921|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
138348922|NCT05732064|Esketamine|esketamine|mesh-list
138348923|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138348924|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138348925|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348926|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138348927|NCT05732064|Analgesics|analgesics|mesh-ancestor
138348928|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
138348929|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348930|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138348931|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138348932|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138348933|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138348934|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348935|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348936|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
138348937|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138348938|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138348939|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
138348940|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348941|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
138348942|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138348943|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348944|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348945|NCT05730660|Quercetin|quercetin|mesh-list
138348946|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
138348947|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348948|NCT05730660|Protective Agents|protective agents|mesh-ancestor
138348949|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348950|NCT05419674|Amoxicillin|amoxicillin|mesh-list
138348951|NCT05419674|Clarithromycin|clarithromycin|mesh-list
138348952|NCT05419674|Rabeprazole|rabeprazole|mesh-list
138348953|NCT05419674|Bismuth|bismuth|mesh-list
138348954|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138348955|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348956|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138348957|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348958|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348959|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138348960|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138348961|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138348962|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138348963|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138348964|NCT05419674|Antacids|antacids|mesh-ancestor
138348965|NCT05386524|Bevacizumab|bevacizumab|mesh-list
138348966|NCT05386524|Doxorubicin|doxorubicin|mesh-list
138348967|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138348968|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348969|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348970|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138348971|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138348972|NCT05386524|Growth Substances|growth substances|mesh-ancestor
138348973|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348974|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
138348975|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138348976|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138348977|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138348978|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349140|NCT02632812|Protective Agents|protective agents|mesh-ancestor
138348979|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348980|NCT04965714|Nivolumab|nivolumab|mesh-list
138348981|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138348982|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348983|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138348984|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348985|NCT04787562|Imipenem|imipenem|mesh-list
138348986|NCT04787562|Cilastatin|cilastatin|mesh-list
138348988|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138348989|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
138348990|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138348991|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138348992|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
138348993|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
138348994|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348995|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
138348996|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
138348997|NCT04355130|Vitamins|vitamins|mesh-ancestor
138348998|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
138348999|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349000|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
138349001|NCT04355130|Hematinics|hematinics|mesh-ancestor
138349002|NCT04107168|Bevacizumab|bevacizumab|mesh-list
138349003|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
138349004|NCT04107168|Nivolumab|nivolumab|mesh-list
138349005|NCT04107168|Ipilimumab|ipilimumab|mesh-list
138349006|NCT04107168|Atezolizumab|atezolizumab|mesh-list
138349007|NCT04107168|Durvalumab|durvalumab|mesh-list
138349008|NCT04107168|Tremelimumab|tremelimumab|mesh-list
138349009|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349010|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349011|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138349012|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138349013|NCT04107168|Growth Substances|growth substances|mesh-ancestor
138349014|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349015|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138349016|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138349017|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349018|NCT03958344|Prednisolone|prednisolone|mesh-list
138349019|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138349020|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
138349021|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138349022|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
138349023|NCT03958344|Triamcinolone|triamcinolone|mesh-list
138349024|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138349025|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
138349026|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349027|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
138349029|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349030|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349031|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138349032|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349033|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
138349034|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
138349035|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349036|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349037|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138349038|NCT03958344|Protective Agents|protective agents|mesh-ancestor
138349039|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
138349040|NCT02960646|Melphalan|melphalan|mesh-list
138349041|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
138349042|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138349043|NCT02960646|Rituximab|rituximab|mesh-list
138349044|NCT02960646|Fludarabine|fludarabine|mesh-list
138349045|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
138349046|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138349047|NCT02960646|Tacrolimus|tacrolimus|mesh-list
138349048|NCT02960646|Antibodies|antibodies|mesh-list
138349049|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
138349051|NCT02960646|Lenograstim|lenograstim|mesh-list
138349052|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138349053|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
138349054|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349055|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138349056|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138349057|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
138349058|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349059|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349060|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138349061|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349062|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
138349063|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138349064|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138349065|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349067|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
138349068|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349069|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138349070|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138349072|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349073|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138349074|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138349075|NCT00074412|Nevirapine|nevirapine|mesh-list
138349076|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138349077|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138349078|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349079|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349080|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
138349081|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349082|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138349083|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138349084|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138349085|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138349087|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138349088|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349089|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349090|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349091|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138349092|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349093|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349094|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138349095|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
138349096|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
138349097|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
138349098|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
138349099|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349100|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349101|NCT02620878|Pancrelipase|pancrelipase|mesh-list
138349102|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349103|NCT02624700|Pemetrexed|pemetrexed|mesh-list
138349104|NCT02624700|Sorafenib|sorafenib|mesh-list
138349105|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349106|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349107|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349108|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138349109|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138349110|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349115|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349116|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349117|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349118|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349119|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
138349120|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349121|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349122|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138349123|NCT02632812|Naproxen|naproxen|mesh-list
138349124|NCT02632812|Rebamipide|rebamipide|mesh-list
138349125|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138349126|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138349127|NCT02632812|Analgesics|analgesics|mesh-ancestor
138349128|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
138349129|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349130|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349131|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349132|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138349133|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
138349134|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138349135|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349136|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349137|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138349138|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349139|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
138349144|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349145|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
138349146|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
138349147|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349148|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
138349149|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349150|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349151|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349152|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138349153|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349154|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349156|NCT02635542|Cisatracurium|cisatracurium|mesh-list
138349157|NCT02635542|Succinylcholine|succinylcholine|mesh-list
138349158|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138349159|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138349160|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349161|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349162|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138349163|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
138349164|NCT05585658|Hematinics|hematinics|mesh-ancestor
138349165|NCT05510856|Lacosamide|lacosamide|mesh-list
138349166|NCT05510856|Gabapentin|gabapentin|mesh-list
138349167|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138349168|NCT05510856|Analgesics|analgesics|mesh-ancestor
138349169|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
138349170|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349171|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349172|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
138349173|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138349174|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349175|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349180|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349182|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138349183|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349203|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349204|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138349206|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138349207|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349208|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349209|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349227|NCT03693846|Nivolumab|nivolumab|mesh-list
138349228|NCT03693846|Ipilimumab|ipilimumab|mesh-list
138349229|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349230|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349231|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138349232|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349233|NCT03529890|Nivolumab|nivolumab|mesh-list
138349234|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349235|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349236|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138349237|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349238|NCT02649192|Vitamin D|vitamin d|mesh-list
138349241|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
138349242|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349243|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138349248|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
138349249|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138349250|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
138349251|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349252|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
138349253|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
138349254|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349255|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349256|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349257|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
138349258|NCT02652390|Hormones|hormones|mesh-ancestor
138349259|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349260|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138349261|NCT02652390|Protective Agents|protective agents|mesh-ancestor
138349262|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138349263|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349264|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
138349265|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
138349267|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
138349269|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138349270|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
138349271|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
138349272|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349273|NCT02653560|Diuretics|diuretics|mesh-ancestor
138349274|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
138349275|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349276|NCT02653560|Expectorants|expectorants|mesh-ancestor
138349277|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
138349278|NCT02653560|Cathartics|cathartics|mesh-ancestor
138349279|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349280|NCT02653872|Itraconazole|itraconazole|mesh-list
138349283|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
138349284|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349285|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138349286|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349287|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349288|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349289|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349290|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
138349291|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349292|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349293|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138349294|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138349295|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138349296|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349297|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138349298|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
138349299|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138349300|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
138349301|NCT02655354|Promethazine|promethazine|mesh-list
138349302|NCT02655354|Prazosin|prazosin|mesh-list
138349303|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138349304|NCT02655354|Mirtazapine|mirtazapine|mesh-list
138349306|NCT02655354|Trazodone|trazodone|mesh-list
138349307|NCT02655354|Sertraline|sertraline|mesh-list
138349308|NCT02655354|Fluoxetine|fluoxetine|mesh-list
138349311|NCT02655354|Citalopram|citalopram|mesh-list
138349312|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138349313|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349314|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349315|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349316|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349317|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349318|NCT02655354|Analgesics|analgesics|mesh-ancestor
138349319|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
138349320|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349321|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
138349322|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349323|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
138349324|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138349325|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
138349326|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138349327|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138349328|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349330|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
138349331|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138349332|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349333|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349334|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
138349335|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
138349336|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
138349337|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349338|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138349339|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
138349340|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
138349341|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138349342|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
138349343|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
138349344|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138349345|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349346|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138349347|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138349348|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138349350|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138349351|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138349352|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138349353|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138349354|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138349355|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138349356|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138349358|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349359|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138349360|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349361|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349362|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349363|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138349364|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
138349369|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
138349371|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349372|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349373|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
138349376|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138349377|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349378|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349379|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349380|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138349381|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138349383|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138349384|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
138349385|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
138349386|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
138349387|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138349388|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
138349389|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
138349390|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349391|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
138349392|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349393|NCT02665260|Cantharidin|cantharidin|mesh-list
138349394|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349395|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349397|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349398|NCT02666352|Ruzasvir|ruzasvir|mesh-list
138349399|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
138349400|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
138349401|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349402|NCT02673138|Canagliflozin|canagliflozin|mesh-list
138349403|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138349404|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349405|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138349406|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349407|NCT02673372|Ketamine|ketamine|mesh-list
138349408|NCT02673372|Morphine|morphine|mesh-list
138349409|NCT02673372|Analgesics|analgesics|mesh-ancestor
138349410|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
138349411|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349412|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349413|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138349414|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138349415|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
138349416|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
138349417|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349418|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138349419|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138349420|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349421|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349422|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138349423|NCT02673372|Narcotics|narcotics|mesh-ancestor
138349424|NCT02682498|Bupivacaine|bupivacaine|mesh-list
138349425|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
138349426|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
138349427|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349428|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349429|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
138349430|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349432|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138349433|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349434|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349435|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349437|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349438|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349440|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349441|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349442|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349443|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349445|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138349446|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349447|NCT02698566|Ranibizumab|ranibizumab|mesh-list
138349448|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138349449|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138349450|NCT02698566|Growth Substances|growth substances|mesh-ancestor
138349451|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349452|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
138349453|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349454|NCT02701062|Warfarin|warfarin|mesh-list
138349455|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
138349456|NCT02701062|Dabigatran|dabigatran|mesh-list
138349457|NCT02701062|Apixaban|apixaban|mesh-list
138349458|NCT02701062|Anticoagulants|anticoagulants|mesh-list
138349459|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138349460|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
138349461|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138349462|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
138349463|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349464|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349465|NCT02704104|Hemostatics|hemostatics|mesh-list
138349466|NCT02704104|Coagulants|coagulants|mesh-ancestor
138349467|NCT02705352|Fluorouracil|fluorouracil|mesh-list
138349468|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
138349469|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349470|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349471|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349472|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138349473|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
138349474|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349475|NCT02708238|Simethicone|simethicone|mesh-list
138349476|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
138349477|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349478|NCT02708238|Emollients|emollients|mesh-ancestor
138349479|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
138349480|NCT02709018|Losartan|losartan|mesh-list
138349481|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138349482|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138349483|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138349484|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138349485|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349486|NCT02713230|Bupivacaine|bupivacaine|mesh-list
138349487|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138349488|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
138349489|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349490|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349491|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
138349492|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349493|NCT02713698|Propofol|propofol|mesh-list
138349494|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349495|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349496|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349497|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138349498|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
138349500|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138349501|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138349502|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349503|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349504|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349505|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349506|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349507|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138349511|NCT02716818|Prednisone|prednisone|mesh-list
138349512|NCT02716818|Prednisolone|prednisolone|mesh-list
138349513|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
138349514|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138349515|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138349516|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138349517|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
138349518|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349519|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
138349520|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
138349521|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349522|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349523|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349524|NCT02716818|Hormones|hormones|mesh-ancestor
138349525|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349526|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138349527|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349528|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
138349529|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138349530|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349531|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138349532|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138349533|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349534|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349535|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349536|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138349537|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349538|NCT02726178|Ibuprofen|ibuprofen|mesh-list
138349539|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138349540|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138349541|NCT02726178|Analgesics|analgesics|mesh-ancestor
138349542|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
138349543|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349544|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349545|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349546|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138349547|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138349548|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349549|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349550|NCT02733588|Glucagon|glucagon|mesh-list
138349551|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138349552|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349553|NCT02733588|Hormones|hormones|mesh-ancestor
138349554|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349555|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349556|NCT02733588|Incretins|incretins|mesh-ancestor
138349557|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
138349558|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349559|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349560|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349561|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349563|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349564|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349565|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349566|NCT05444088|Bevacizumab|bevacizumab|mesh-list
138349567|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349568|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349569|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138349570|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138349571|NCT05444088|Growth Substances|growth substances|mesh-ancestor
138349572|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349573|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
138349574|NCT05443308|Acetazolamide|acetazolamide|mesh-list
138349575|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
138349576|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138349577|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349578|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349579|NCT05443308|Diuretics|diuretics|mesh-ancestor
138349580|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
138349581|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349582|NCT05442996|Antibodies|antibodies|mesh-list
138349583|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
138349584|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138349585|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
138349586|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349587|NCT05441046|Tislelizumab|tislelizumab|mesh-list
138349588|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349589|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349590|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138349591|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349592|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349593|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349594|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138349596|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138349597|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349599|NCT05266404|Hormones|hormones|mesh-ancestor
138349600|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349601|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138349602|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
138349603|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349604|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349605|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138349606|NCT05122494|Capecitabine|capecitabine|mesh-list
138349607|NCT05122494|Lapatinib|lapatinib|mesh-list
138349608|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349609|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
138349610|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349612|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349613|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349614|NCT05063604|Citalopram|citalopram|mesh-list
138349615|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138349616|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349617|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349618|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349619|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349620|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
138349621|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349622|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138349623|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
138349624|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349625|NCT04978428|Cannabidiol|cannabidiol|mesh-list
138349626|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
138349627|NCT04780464|Prednisone|prednisone|mesh-list
138349628|NCT04780464|Prednisolone|prednisolone|mesh-list
138349629|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
138349630|NCT04780464|Doxorubicin|doxorubicin|mesh-list
138349631|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138349632|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138349633|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
138349634|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349635|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138349636|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138349637|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
138349638|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349639|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349640|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138349641|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138349642|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138349643|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138349644|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349645|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349646|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
138349647|NCT04780464|Hormones|hormones|mesh-ancestor
138349648|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349649|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138349651|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349652|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349653|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349654|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138349656|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
138349657|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349658|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138349659|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138349660|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138349661|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349662|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349663|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349664|NCT05452434|Mirabegron|mirabegron|mesh-list
138349665|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138349666|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138349670|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349671|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349672|NCT05452434|Urological Agents|urological agents|mesh-ancestor
138349673|NCT05450328|Epoprostenol|epoprostenol|mesh-list
138349674|NCT05450328|Milrinone|milrinone|mesh-list
138349675|NCT05450328|Tezosentan|tezosentan|mesh-list
138349676|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138349677|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138349678|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
138349679|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138349680|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138349681|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349682|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349683|NCT05450328|Protective Agents|protective agents|mesh-ancestor
138349684|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349685|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138349686|NCT05448924|Hormones|hormones|mesh-list
138349687|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349688|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349689|NCT05447364|Pregabalin|pregabalin|mesh-list
138349690|NCT05447364|Analgesics|analgesics|mesh-ancestor
138349691|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
138349692|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349693|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349695|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138349696|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349697|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349698|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138349699|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138349700|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349701|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349702|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349703|NCT05418036|Sotalol|sotalol|mesh-list
138349704|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138349705|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138349706|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349707|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349708|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349709|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349710|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138349711|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
138349712|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
138349713|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349714|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138349715|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138349716|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138349717|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138349718|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349719|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349720|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349721|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138349722|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
138349723|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349724|NCT04522206|Oxycodone|oxycodone|mesh-list
138349725|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138349726|NCT04522206|Narcotics|narcotics|mesh-ancestor
138349727|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349728|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349729|NCT04522206|Analgesics|analgesics|mesh-ancestor
138349730|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
138349731|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349732|NCT04505592|Tenecteplase|tenecteplase|mesh-list
138349733|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138349735|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349736|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
138349737|NCT04415892|Capsaicin|capsaicin|mesh-list
138349738|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
138349739|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
138349740|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
138349741|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349742|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349751|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349753|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349754|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138349755|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
138349756|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349757|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349758|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349760|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138349761|NCT04128540|Narcotics|narcotics|mesh-ancestor
138349762|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349763|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349764|NCT04128540|Analgesics|analgesics|mesh-ancestor
138349765|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
138349766|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349767|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138349768|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138349769|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
138349770|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
138349771|NCT04104438|Everolimus|everolimus|mesh-list
138349772|NCT04104438|Basiliximab|basiliximab|mesh-list
138349773|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138349774|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349775|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349776|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349777|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138349778|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
138349779|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349780|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349781|NCT03703206|Anesthetics|anesthetics|mesh-list
138349783|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349784|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349785|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
138349786|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349787|NCT03086616|Irinotecan|irinotecan|mesh-list
138349788|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138349789|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138349791|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349792|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349793|NCT02952924|Midazolam|midazolam|mesh-list
138349795|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138349796|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138349797|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349798|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138349799|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349800|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138349801|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138349802|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
138349803|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
138349804|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
138349805|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
138349806|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349807|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349808|NCT00677586|Liver Extracts|liver extracts|mesh-list
138349809|NCT00677586|Hematinics|hematinics|mesh-ancestor
138349810|NCT05453448|Tenofovir|tenofovir|mesh-list
138349811|NCT05453448|Entecavir|entecavir|mesh-list
138349812|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
138349813|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138349814|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138349815|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138349816|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349817|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349818|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138349819|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138349820|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
138349821|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138349822|NCT05354466|Neostigmine|neostigmine|mesh-list
138349823|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138349824|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349825|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349826|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
138349827|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349828|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349829|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138349830|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
138349831|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349850|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349857|NCT03121716|Gemcitabine|gemcitabine|mesh-list
138349859|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349860|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
138349861|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349862|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349863|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
138349864|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
138349865|NCT02714634|Methotrexate|methotrexate|mesh-list
138349866|NCT02714634|Leflunomide|leflunomide|mesh-list
138349867|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138349868|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
138349869|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138349870|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349871|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138349872|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
138349873|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349874|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349875|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
138349876|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349877|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138349878|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138349879|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
138349880|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138349881|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138349882|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
138349883|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138349890|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349892|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138349893|NCT00553800|Bevacizumab|bevacizumab|mesh-list
138349894|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138349895|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349896|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349897|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138349903|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349904|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349906|NCT02747628|Nicotine|nicotine|mesh-list
138349922|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349933|NCT02765256|Neomycin|neomycin|mesh-list
138349938|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138349939|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138349940|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349941|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349942|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349943|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138349944|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138349945|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
138349946|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138349947|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138349948|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
138349949|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349950|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349951|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138349952|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138349954|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138349955|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138349956|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
138349957|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
138349958|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349959|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138349960|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138349973|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
138349974|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
138349975|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138349976|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
138349977|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
138349978|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349979|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138349981|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138349982|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349983|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138349984|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349985|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138349986|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349987|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138349988|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
138349989|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
138349990|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349991|NCT02773758|Fluorides|fluorides|mesh-list
138349992|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
138349993|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
138349994|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
138349995|NCT02773758|Protective Agents|protective agents|mesh-ancestor
138349996|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349997|NCT02774226|Vitamins|vitamins|mesh-list
138349999|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
138350000|NCT02774226|Antioxidants|antioxidants|mesh-list
138350001|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
138350002|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350003|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350004|NCT02774226|Protective Agents|protective agents|mesh-ancestor
138350005|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
138350006|NCT02775240|Maribavir|maribavir|mesh-list
138350007|NCT02775240|Digoxin|digoxin|mesh-list
138350008|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
138350009|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138350010|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138350011|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350012|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350013|NCT02775240|Protective Agents|protective agents|mesh-ancestor
138350014|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350015|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
138350016|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
138350017|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138350018|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138350019|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350020|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
138350021|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350022|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
138350023|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350024|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
138350025|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138350026|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138350027|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138350028|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350029|NCT05349396|Eszopiclone|eszopiclone|mesh-list
138350030|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138350031|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350032|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350033|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
138350034|NCT05348148|Cetirizine|cetirizine|mesh-list
138350035|NCT05348148|Phenylephrine|phenylephrine|mesh-list
138350036|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
138350037|NCT05348148|Levocetirizine|levocetirizine|mesh-list
138350038|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350039|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350040|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138350041|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138350042|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138350043|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
138350044|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
138350045|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350046|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350047|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350048|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138350049|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138350050|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138350051|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
138350052|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
138350053|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350054|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
138350055|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138350056|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
138350057|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138350060|NCT05348148|Protective Agents|protective agents|mesh-ancestor
138350061|NCT05456022|Doxorubicin|doxorubicin|mesh-list
138350062|NCT05456022|Quercetin|quercetin|mesh-list
138350063|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350064|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350140|NCT06084858|Dialysis Solutions|dialysis solutions|mesh-list
138350065|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138350066|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138350067|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350068|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350069|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
138350070|NCT05456022|Protective Agents|protective agents|mesh-ancestor
138350071|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350072|NCT05273814|Bevacizumab|bevacizumab|mesh-list
138350073|NCT05273814|Tislelizumab|tislelizumab|mesh-list
138350074|NCT05273814|Pemetrexed|pemetrexed|mesh-list
138350075|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138350076|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350078|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138350079|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138350080|NCT05273814|Growth Substances|growth substances|mesh-ancestor
138350081|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350082|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
138350083|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350084|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350085|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138350086|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138350087|NCT04784208|Hormones|hormones|mesh-list
138350088|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350089|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350090|NCT04024878|Nivolumab|nivolumab|mesh-list
138350091|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350092|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350093|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350094|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350095|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
138350096|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138350097|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138350098|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138350099|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138350100|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350101|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
138350102|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350103|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350104|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138350105|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350106|NCT02529930|Vaccines|vaccines|mesh-list
138350107|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
138350108|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350109|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
138350110|NCT00039780|Protective Agents|protective agents|mesh-ancestor
138350111|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350112|NCT04763226|Furosemide|furosemide|mesh-list
138350114|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
138350115|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350116|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138350117|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138350118|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350119|NCT04549428|Atezolizumab|atezolizumab|mesh-list
138350120|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350121|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350122|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350123|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350124|NCT06085378|Kallikreins|kallikreins|mesh-list
138350125|NCT06085378|Coagulants|coagulants|mesh-ancestor
138350126|NCT06085378|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138350127|NCT06085378|Fertility Agents|fertility agents|mesh-ancestor
138350128|NCT06085378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350129|NCT06085378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350130|NCT06085365|Fluorouracil|fluorouracil|mesh-list
138350131|NCT06085365|Antimetabolites|antimetabolites|mesh-ancestor
138350132|NCT06085365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350133|NCT06085365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350134|NCT06085365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350135|NCT06085365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350136|NCT06085365|Immunologic Factors|immunologic factors|mesh-ancestor
138350137|NCT06085365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350139|NCT06085079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350141|NCT06084858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138350143|NCT06084819|Azacitidine|azacitidine|mesh-list
138350144|NCT06084819|Venetoclax|venetoclax|mesh-list
138350145|NCT06084819|Aclacinomycins|aclacinomycins|mesh-list
138350146|NCT06084819|Lenograstim|lenograstim|mesh-list
138350147|NCT06084819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350148|NCT06084819|Antimetabolites|antimetabolites|mesh-ancestor
138350149|NCT06084819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350150|NCT06084819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350151|NCT06084819|Antiviral Agents|antiviral agents|mesh-ancestor
138350152|NCT06084819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350153|NCT06084819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350154|NCT06084819|Immunologic Factors|immunologic factors|mesh-ancestor
138350155|NCT06084819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350156|NCT06084819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350157|NCT06084819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138350158|NCT06084819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350159|NCT06084780|Sirolimus|sirolimus|mesh-list
138350162|NCT06084780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350163|NCT06084780|Immunologic Factors|immunologic factors|mesh-ancestor
138350164|NCT06084780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350165|NCT06084780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138350166|NCT06084780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350167|NCT06084780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350168|NCT06084780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138350169|NCT06084780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350170|NCT06084780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350171|NCT06084780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350172|NCT06084780|Antifungal Agents|antifungal agents|mesh-ancestor
138350173|NCT06084780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350179|NCT06084624|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138350180|NCT06084624|Betamethasone benzoate|betamethasone benzoate|mesh-list
138350181|NCT06084624|Rebamipide|rebamipide|mesh-list
138350182|NCT06084624|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138350183|NCT06084624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350184|NCT06084624|Glucocorticoids|glucocorticoids|mesh-ancestor
138350185|NCT06084624|Hormones|hormones|mesh-ancestor
138350186|NCT06084624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350187|NCT06084624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350188|NCT06084624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138350189|NCT06084624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138350190|NCT06084624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138350191|NCT06084624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350193|NCT06084624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350194|NCT06084624|Protective Agents|protective agents|mesh-ancestor
138350195|NCT06084624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350196|NCT06084507|Ritonavir|ritonavir|mesh-list
138350197|NCT06084507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138350198|NCT06084507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138350199|NCT06084507|Protease Inhibitors|protease inhibitors|mesh-ancestor
138350201|NCT06084507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350203|NCT06084507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138350204|NCT06084507|Antiviral Agents|antiviral agents|mesh-ancestor
138350205|NCT06084507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350206|NCT06084507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138350207|NCT06084507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138350208|NCT06084156|Metformin|metformin|mesh-list
138350209|NCT06084156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138350210|NCT06084156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350212|NCT06084130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138350213|NCT06084130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138350214|NCT06084130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350215|NCT06084130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350216|NCT06084130|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138350217|NCT06084130|GABA Agonists|gaba agonists|mesh-ancestor
138350219|NCT06084130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350220|NCT06084130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350221|NCT06083961|Alirocumab|alirocumab|mesh-list
138350222|NCT06083961|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138350223|NCT06083961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138350224|NCT06083961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138350225|NCT06083961|Antimetabolites|antimetabolites|mesh-ancestor
138350226|NCT06083961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350227|NCT06083961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138350234|NCT06083935|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138350235|NCT06083935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138350236|NCT06083935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350237|NCT06083935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350238|NCT06083935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138350239|NCT06083688|Hydroxychloroquine|hydroxychloroquine|mesh-list
138350240|NCT06083688|Chloroquine|chloroquine|mesh-list
138350241|NCT06083688|Pyrimethamine|pyrimethamine|mesh-list
138350242|NCT06083688|Piperaquine|piperaquine|mesh-list
138350243|NCT06083688|Sulfadoxine|sulfadoxine|mesh-list
138350244|NCT06083688|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138350245|NCT06083688|Amodiaquine|amodiaquine|mesh-list
138350246|NCT06083688|Artenimol|artenimol|mesh-list
138350247|NCT06083688|Antimalarials|antimalarials|mesh-ancestor
138350248|NCT06083688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138350249|NCT06083688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138350250|NCT06083688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350251|NCT06083688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350252|NCT06083688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350254|NCT06083688|Amebicides|amebicides|mesh-ancestor
138350255|NCT06083688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138350256|NCT06083688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138350257|NCT06083415|Endocrine Disruptors|endocrine disruptors|mesh-list
138350258|NCT06083415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350259|NCT06082817|Methyltestosterone|methyltestosterone|mesh-list
138350260|NCT06082817|Testosterone|testosterone|mesh-list
138350261|NCT06082817|Testosterone undecanoate|testosterone undecanoate|mesh-list
138350262|NCT06082817|Testosterone enanthate|testosterone enanthate|mesh-list
138350263|NCT06082817|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138350265|NCT06082817|Hormones|hormones|mesh-ancestor
138350266|NCT06082817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350267|NCT06082817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350268|NCT06082817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138350269|NCT06082817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350270|NCT06082817|Anabolic Agents|anabolic agents|mesh-ancestor
138350272|NCT06082232|Dexmedetomidine|dexmedetomidine|mesh-list
138350273|NCT06082232|Bupivacaine|bupivacaine|mesh-list
138350274|NCT06082232|Anesthetics, Local|anesthetics, local|mesh-ancestor
138350275|NCT06082232|Anesthetics|anesthetics|mesh-ancestor
138350277|NCT06082232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350278|NCT06082232|Sensory System Agents|sensory system agents|mesh-ancestor
138350279|NCT06082232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350280|NCT06082232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138350281|NCT06082232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138350282|NCT06082232|Analgesics|analgesics|mesh-ancestor
138350283|NCT06082232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138350284|NCT06082232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138350285|NCT06082232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138350293|NCT06082232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138350294|NCT06082232|Anesthetics, General|anesthetics, general|mesh-ancestor
138350295|NCT06082232|GABA Modulators|gaba modulators|mesh-ancestor
138350297|NCT06077214|Bupivacaine|bupivacaine|mesh-list
138350298|NCT06077214|Anesthetics, Local|anesthetics, local|mesh-ancestor
138350299|NCT06077214|Anesthetics|anesthetics|mesh-ancestor
138350300|NCT06077214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350301|NCT06077214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350302|NCT06077214|Sensory System Agents|sensory system agents|mesh-ancestor
138350303|NCT06077214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350304|NCT06077032|Chlorhexidine|chlorhexidine|mesh-list
138350305|NCT06077032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138350306|NCT06077032|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138350307|NCT06077032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350308|NCT06077032|Disinfectants|disinfectants|mesh-ancestor
138350309|NCT06058572|Rifaximin|rifaximin|mesh-list
138350310|NCT06058572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138350312|NCT06058572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350313|NCT05985954|Cetuximab|cetuximab|mesh-list
138350314|NCT05985954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350315|NCT05985954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350316|NCT05942352|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
138350317|NCT05942352|Vasodilator Agents|vasodilator agents|mesh-ancestor
138350318|NCT05936489|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138350320|NCT05936489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138350321|NCT05936489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138350322|NCT05936489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138350323|NCT05936489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138350324|NCT05936489|Adrenergic Agents|adrenergic agents|mesh-ancestor
138350325|NCT05936489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350326|NCT05936489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350327|NCT05936489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350328|NCT05936489|Miotics|miotics|mesh-ancestor
138350329|NCT05936489|Autonomic Agents|autonomic agents|mesh-ancestor
138350330|NCT05936489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350331|NCT05936489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138350332|NCT05901545|Panitumumab|panitumumab|mesh-list
138350333|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350349|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350350|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350351|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350352|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
138350354|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350355|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138350356|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
138350357|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138350358|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350359|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350360|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350361|NCT05779020|Vaccines|vaccines|mesh-list
138350362|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
138350363|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350364|NCT05637216|Losartan|losartan|mesh-list
138350365|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138350366|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138350367|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138350368|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138350369|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350371|NCT05612984|Folic Acid|folic acid|mesh-list
138350372|NCT05612984|Micronutrients|micronutrients|mesh-list
138350373|NCT05612984|Trace Elements|trace elements|mesh-list
138350374|NCT05612984|Calcium|calcium|mesh-list
138350375|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138350376|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350377|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138350378|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138350379|NCT05612984|Analgesics|analgesics|mesh-ancestor
138350380|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
138350381|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350382|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350383|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350384|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138350385|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138350386|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350387|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138350388|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138350389|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350391|NCT05612984|Hematinics|hematinics|mesh-ancestor
138350392|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
138350394|NCT05594017|Scopolamine|scopolamine|mesh-list
138350395|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138350396|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138350397|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
138350398|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
138350399|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350400|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350401|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350402|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
138350403|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138350404|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
138350405|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350406|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350407|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138350408|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
138350409|NCT05576038|Tryptophan|tryptophan|mesh-list
138350410|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138350411|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
138350412|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138350413|NCT05529069|Venetoclax|venetoclax|mesh-list
138350414|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
138350415|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350416|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138350417|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350496|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350418|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350419|NCT05523596|Benzonidazole|benzonidazole|mesh-list
138350420|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350421|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
138350422|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350423|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138350424|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138350425|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138350426|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350427|NCT05476796|Trifluridine|trifluridine|mesh-list
138350428|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
138350429|NCT05476796|Nivolumab|nivolumab|mesh-list
138350430|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350431|NCT05476796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350432|NCT05476796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350433|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350434|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
138350435|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
138350436|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350437|NCT05427084|Canagliflozin|canagliflozin|mesh-list
138350438|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138350439|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350440|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138350441|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350442|NCT05384821|Irinotecan|irinotecan|mesh-list
138350443|NCT05384821|Etoposide|etoposide|mesh-list
138350444|NCT05384821|Vincristine|vincristine|mesh-list
138350445|NCT05384821|Temozolomide|temozolomide|mesh-list
138350446|NCT05384821|Tretinoin|tretinoin|mesh-list
138350447|NCT05384821|Isotretinoin|isotretinoin|mesh-list
138350448|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138350449|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138350450|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350451|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350452|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350453|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138350454|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138350455|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350456|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350457|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350458|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138350459|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
138350460|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
138350461|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350462|NCT05199285|Nivolumab|nivolumab|mesh-list
138350463|NCT05199285|Ipilimumab|ipilimumab|mesh-list
138350464|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350465|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350466|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138350467|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350468|NCT05136976|Rituximab|rituximab|mesh-list
138350469|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350470|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350471|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
138350472|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350473|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350474|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138350475|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138350476|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350477|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138350478|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350479|NCT05040282|Etonogestrel|etonogestrel|mesh-list
138350480|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138350481|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
138350482|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350483|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350484|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138350485|NCT05039801|Paclitaxel|paclitaxel|mesh-list
138350487|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138350488|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138350489|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
138350491|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
138350492|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138350493|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
138350494|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138350495|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350524|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138350525|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
138350526|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350527|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350528|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138350529|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
138350530|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350531|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350532|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138350533|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138350534|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
138350535|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
138350536|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350538|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
138350539|NCT05032183|Hormones|hormones|mesh-ancestor
138350540|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350541|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138350543|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350544|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138350545|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
138350546|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350547|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350549|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350550|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138350551|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138350552|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
138350553|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350554|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138350555|NCT05032183|Antidotes|antidotes|mesh-ancestor
138350556|NCT05032183|Protective Agents|protective agents|mesh-ancestor
138350557|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
138350559|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
138350560|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138350561|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350562|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350563|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350564|NCT05026125|Remifentanil|remifentanil|mesh-list
138350565|NCT05026125|Anesthetics|anesthetics|mesh-list
138350566|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350567|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350568|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138350569|NCT05026125|Narcotics|narcotics|mesh-ancestor
138350570|NCT05026125|Analgesics|analgesics|mesh-ancestor
138350571|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
138350572|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350573|NCT05012943|Vaccines|vaccines|mesh-list
138350574|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
138350575|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350576|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138350577|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138350578|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138350579|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350580|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350581|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138350582|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138350583|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350585|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350587|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
138350588|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350589|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138350590|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138350591|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138350592|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350593|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350594|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138350596|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350598|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350600|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
138350601|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350602|NCT04947189|Dexamethasone|dexamethasone|mesh-list
138350603|NCT04947189|Docetaxel|docetaxel|mesh-list
138350604|NCT04947189|Seviteronel|seviteronel|mesh-list
138350606|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
138350607|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
138350608|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350609|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350610|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350611|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
138350612|NCT04947189|Hormones|hormones|mesh-ancestor
138350613|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350614|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138350615|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350616|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350617|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350618|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350619|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350621|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350622|NCT04821310|Pantoprazole|pantoprazole|mesh-list
138350623|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138350624|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138350625|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138350626|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350627|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350628|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
138350629|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
138350630|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350631|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138350632|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
138350633|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
138350634|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350635|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350636|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350637|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138350638|NCT04677049|Niacin|niacin|mesh-list
138350639|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
138350640|NCT04677049|Vitamins|vitamins|mesh-ancestor
138350641|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
138350642|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350643|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
138350644|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138350645|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
138350646|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350647|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138350648|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138350649|NCT04551170|Theophylline|theophylline|mesh-list
138350650|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138350651|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
138350652|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350653|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350654|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138350655|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
138350656|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138350657|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350658|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350659|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
138350662|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
138350663|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350664|NCT04520503|Propofol|propofol|mesh-list
138350665|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138350666|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350667|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350668|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138350669|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
138350670|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
138350671|NCT04482621|Decitabine|decitabine|mesh-list
138350672|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138350673|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
138350674|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350675|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350676|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350677|NCT04423211|Leuprolide|leuprolide|mesh-list
138350678|NCT04423211|Goserelin|goserelin|mesh-list
138350679|NCT04423211|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138350680|NCT04423211|Tryptophan|tryptophan|mesh-list
138350681|NCT04423211|Relugolix|relugolix|mesh-list
138350682|NCT04423211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138350684|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138350685|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
138350686|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138350687|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138350688|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350699|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138350700|NCT04404088|Lenalidomide|lenalidomide|mesh-list
138350701|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
138350702|NCT04404088|Antibodies|antibodies|mesh-list
138350703|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
138350705|NCT04404088|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138350706|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
138350707|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350708|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350709|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138350710|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138350711|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138350712|NCT04404088|Growth Substances|growth substances|mesh-ancestor
138350713|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
138350714|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138350715|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350716|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350717|NCT04335292|Pemetrexed|pemetrexed|mesh-list
138350718|NCT04335292|Osimertinib|osimertinib|mesh-list
138350719|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350720|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350721|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350722|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138350723|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138350724|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138350725|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
138350726|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350727|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350729|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350731|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
138350732|NCT04260607|Ketamine|ketamine|mesh-list
138350733|NCT04260607|Analgesics|analgesics|mesh-ancestor
138350734|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
138350735|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350736|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350737|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138350738|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138350740|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
138350741|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138350742|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138350743|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138350744|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350745|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350746|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138350747|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138350748|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138350749|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350750|NCT04207190|Talazoparib|talazoparib|mesh-list
138350751|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
138350752|NCT04207190|Calicheamicins|calicheamicins|mesh-list
138350753|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138350754|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350755|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350756|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350757|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138350758|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
138350759|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
138350760|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
138350761|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350762|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138350763|NCT04172259|Paclitaxel|paclitaxel|mesh-list
138350764|NCT04172259|Docetaxel|docetaxel|mesh-list
138350765|NCT04172259|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138350766|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
138350767|NCT04172259|Doxorubicin|doxorubicin|mesh-list
138350768|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138350769|NCT04172259|Trastuzumab|trastuzumab|mesh-list
138350770|NCT04172259|Epirubicin|epirubicin|mesh-list
138350771|NCT04172259|Pertuzumab|pertuzumab|mesh-list
138350772|NCT04172259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138350773|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138350774|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
138350775|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
138350776|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
138350779|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
138350780|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350993|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138350994|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
138350995|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138350996|NCT03382834|Tamoxifen|tamoxifen|mesh-list
138350997|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138350998|NCT03382834|Vorinostat|vorinostat|mesh-list
138350999|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138351000|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351001|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351002|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351003|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351004|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351005|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138351006|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138351007|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138351008|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138351009|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351010|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351011|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
138351012|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351013|NCT03360721|Prednisone|prednisone|mesh-list
138351014|NCT03360721|Cortisone|cortisone|mesh-list
138351015|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
138351016|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351017|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
138351018|NCT03360721|Hormones|hormones|mesh-ancestor
138351019|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351021|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351022|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351023|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138351024|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351025|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351026|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351027|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351028|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
138351029|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
138351030|NCT03350516|Calcium|calcium|mesh-list
138351031|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138351032|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351033|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138351035|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351036|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351039|NCT03348670|Relugolix|relugolix|mesh-list
138351040|NCT03348670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351041|NCT03348670|Glucocorticoids|glucocorticoids|mesh-ancestor
138351042|NCT03348670|Hormones|hormones|mesh-ancestor
138351043|NCT03348670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351044|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351045|NCT03348670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351046|NCT03348670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351047|NCT03348670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138351048|NCT03348670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351049|NCT03348670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351050|NCT03348670|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351051|NCT03348670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351052|NCT03348670|Androgen Antagonists|androgen antagonists|mesh-ancestor
138351053|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
138351054|NCT03308942|Niraparib|niraparib|mesh-list
138351056|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351057|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351058|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351059|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351060|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138351061|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351062|NCT03301857|Denosumab|denosumab|mesh-list
138351063|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
138351064|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
138351065|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
138351066|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351067|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138351068|NCT03289949|Ketanserin|ketanserin|mesh-list
138351069|NCT03289949|Psilocybin|psilocybin|mesh-list
138351070|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
138351071|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351142|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138351145|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351147|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351148|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351149|NCT02726997|Paclitaxel|paclitaxel|mesh-list
138351150|NCT02726997|Carboplatin|carboplatin|mesh-list
138351151|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138351152|NCT02726997|Durvalumab|durvalumab|mesh-list
138351153|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
138351154|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138351155|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
138351156|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138351157|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351158|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138351159|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138351160|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138351161|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351162|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351163|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
138351164|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351165|NCT02718911|Durvalumab|durvalumab|mesh-list
138351166|NCT02718911|Tremelimumab|tremelimumab|mesh-list
138351167|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351168|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351169|NCT02573896|Lenalidomide|lenalidomide|mesh-list
138351170|NCT02573896|Dinutuximab|dinutuximab|mesh-list
138351171|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
138351172|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351173|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351174|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138351176|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
138351177|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351178|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
138351179|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138351180|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
138351196|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351198|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351200|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
138351201|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
138351202|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351203|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351204|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138351205|NCT02416128|Protective Agents|protective agents|mesh-ancestor
138351206|NCT02218606|Prednisone|prednisone|mesh-list
138351207|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
138351208|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351209|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
138351210|NCT02218606|Hormones|hormones|mesh-ancestor
138351211|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351212|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351213|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351215|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138351216|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351217|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351218|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351219|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351220|NCT02096055|Idarubicin|idarubicin|mesh-list
138351221|NCT02096055|Cladribine|cladribine|mesh-list
138351222|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138351223|NCT02096055|Guadecitabine|guadecitabine|mesh-list
138351224|NCT02096055|Azacitidine|azacitidine|mesh-list
138351225|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138351226|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351227|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138351228|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138351229|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351230|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351231|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351232|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
138351233|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351234|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138351235|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
138351236|NCT02017717|Bevacizumab|bevacizumab|mesh-list
138351237|NCT02017717|Nivolumab|nivolumab|mesh-list
138351241|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351327|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
138351242|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138351243|NCT02017717|Growth Substances|growth substances|mesh-ancestor
138351244|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351245|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
138351246|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351248|NCT01940094|Prednisone|prednisone|mesh-list
138351249|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
138351250|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351251|NCT01940094|Hormones|hormones|mesh-ancestor
138351252|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351253|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351254|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351255|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351256|NCT01445509|Bevacizumab|bevacizumab|mesh-list
138351257|NCT01445509|Dasatinib|dasatinib|mesh-list
138351258|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351259|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351260|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351262|NCT01445509|Growth Substances|growth substances|mesh-ancestor
138351263|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351264|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
138351265|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351266|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351267|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351269|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138351270|NCT00942331|Cisplatin|cisplatin|mesh-list
138351271|NCT00942331|Gemcitabine|gemcitabine|mesh-list
138351272|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
138351273|NCT00942331|Antibodies|antibodies|mesh-list
138351274|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
138351275|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138351276|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
138351277|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351281|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351282|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
138351283|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
138351284|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138351285|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
138351286|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351287|NCT00828919|Axitinib|axitinib|mesh-list
138351288|NCT00828919|Crizotinib|crizotinib|mesh-list
138351289|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351290|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351291|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351292|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351294|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351295|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351296|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351297|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351299|NCT00577122|Methotrexate|methotrexate|mesh-list
138351300|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138351301|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
138351302|NCT00577122|Progesterone|progesterone|mesh-list
138351303|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351304|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
138351305|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351306|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138351307|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138351308|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
138351309|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351310|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351311|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138351312|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138351314|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351315|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138351316|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
138351317|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
138351318|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351319|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138351320|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138351323|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351324|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138351325|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138351326|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138351328|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138351329|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138351330|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138351331|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351332|NCT00419770|Amphotericin B|amphotericin b|mesh-list
138351333|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138351336|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138351337|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138351338|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351339|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138351340|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
138351341|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138351342|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
138351343|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
138351344|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351348|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351349|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138351350|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138351351|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138351352|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351353|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351354|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351356|NCT04340856|Laxatives|laxatives|mesh-list
138351357|NCT04340856|Cathartics|cathartics|mesh-ancestor
138351358|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351359|NCT04040790|Phenylephrine|phenylephrine|mesh-list
138351360|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
138351361|NCT04040790|Tropicamide|tropicamide|mesh-list
138351362|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138351363|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
138351364|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
138351365|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351366|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351367|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
138351368|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138351370|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138351371|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138351372|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138351373|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138351374|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
138351375|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351376|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351377|NCT04040790|Protective Agents|protective agents|mesh-ancestor
138351378|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138351379|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138351380|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
138351381|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138351382|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138351384|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138351385|NCT03556800|Estrogens|estrogens|mesh-ancestor
138351386|NCT03556800|Hormones|hormones|mesh-ancestor
138351387|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351388|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351389|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138351391|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351392|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138351393|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
138351394|NCT04741620|Capsaicin|capsaicin|mesh-list
138351395|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
138351396|NCT04741620|Citric Acid|citric acid|mesh-list
138351397|NCT04741620|Piperine|piperine|mesh-list
138351398|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
138351399|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
138351402|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351403|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
138351404|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138351405|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
138351406|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
138351409|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351410|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138351411|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351412|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138351413|NCT04741620|Protective Agents|protective agents|mesh-ancestor
138351414|NCT00800514|Amantadine|amantadine|mesh-list
138351415|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138351416|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138351417|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
138351418|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351419|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
138351420|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351423|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138351424|NCT00800514|Analgesics|analgesics|mesh-ancestor
138351425|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
138351426|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351427|NCT02780622|Oseltamivir|oseltamivir|mesh-list
138351428|NCT02780622|Warfarin|warfarin|mesh-list
138351429|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
138351430|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
138351431|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351432|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351433|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351434|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
138351435|NCT02791308|Tacrolimus|tacrolimus|mesh-list
138351436|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138351437|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138351438|NCT02791308|Analgesics|analgesics|mesh-ancestor
138351439|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
138351440|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351442|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351443|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138351444|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
138351445|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351446|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
138351447|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138351448|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351449|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351452|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351453|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
138351454|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138351455|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351456|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138351457|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138351458|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351459|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351460|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351461|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138351462|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351465|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351467|NCT02815644|Linagliptin|linagliptin|mesh-list
138351468|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138351469|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351470|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138351471|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351472|NCT02815644|Incretins|incretins|mesh-ancestor
138351474|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351476|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351477|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351478|NCT02820324|Morphine|morphine|mesh-list
138351479|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138351480|NCT02820324|Narcotics|narcotics|mesh-ancestor
138351484|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
138351485|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351486|NCT02821338|Lamotrigine|lamotrigine|mesh-list
138351487|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
138351488|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138351489|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138351490|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351491|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138351492|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351493|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138351494|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138351495|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351496|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138351497|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138351502|NCT02844582|Prednisone|prednisone|mesh-list
138351503|NCT02844582|Cortisone|cortisone|mesh-list
138351504|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351505|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
138351506|NCT02844582|Hormones|hormones|mesh-ancestor
138351507|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351512|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
138351513|NCT02845752|Olodaterol|olodaterol|mesh-list
138351514|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138351515|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
138351516|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351517|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351518|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138351519|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
138351524|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351526|NCT02849184|Suvorexant|suvorexant|mesh-list
138351527|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138351528|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138351529|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351530|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351531|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138351532|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351533|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351534|NCT02862912|Fentanyl|fentanyl|mesh-list
138351535|NCT02862912|Bupivacaine|bupivacaine|mesh-list
138351536|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
138351537|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
138351538|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
138351539|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351540|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351541|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
138351542|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351543|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138351544|NCT02862912|Narcotics|narcotics|mesh-ancestor
138351545|NCT02862912|Analgesics|analgesics|mesh-ancestor
138351546|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138351547|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138351548|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
138351553|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351554|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351555|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351556|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
138351557|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351558|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
138351560|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138351561|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138351562|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138351563|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138351564|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351565|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351566|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138351567|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138351568|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
138351569|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138351570|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138351571|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138351572|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351573|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
138351574|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351575|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
138351576|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351577|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351578|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138351579|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
138351580|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351581|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138351582|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138351583|NCT02880228|Dexamethasone|dexamethasone|mesh-list
138351584|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
138351585|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
138351586|NCT02880228|Lenalidomide|lenalidomide|mesh-list
138351588|NCT02880228|BB 1101|bb 1101|mesh-list
138351589|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351590|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
138351591|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
138351592|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351593|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351594|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351595|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
138351596|NCT02880228|Hormones|hormones|mesh-ancestor
138351599|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351600|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351601|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351602|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351603|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
138351604|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351605|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138351607|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138351608|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351609|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351611|NCT02880852|Belimumab|belimumab|mesh-list
138351612|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351613|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
138351614|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351615|NCT02887404|Analgesics|analgesics|mesh-list
138351616|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
138351617|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351618|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351619|NCT02889510|Liraglutide|liraglutide|mesh-list
138351620|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138351621|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351622|NCT02889510|Incretins|incretins|mesh-ancestor
138351624|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351626|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138351627|NCT02902770|Lidocaine|lidocaine|mesh-list
138351628|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
138351629|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
138351630|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351631|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351632|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
138351633|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351634|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138351635|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138351636|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138351637|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138351638|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351639|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138351640|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138351642|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351643|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138351644|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138351645|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351646|NCT02907918|Trastuzumab|trastuzumab|mesh-list
138351647|NCT02907918|Letrozole|letrozole|mesh-list
138351648|NCT02907918|Palbociclib|palbociclib|mesh-list
138351649|NCT02907918|Goserelin|goserelin|mesh-list
138351650|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138351651|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351652|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138351653|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138351656|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138351657|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351658|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351659|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351660|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138351661|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351663|NCT02908620|Tetracaine|tetracaine|mesh-list
138351664|NCT02908620|Benzocaine|benzocaine|mesh-list
138351665|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351666|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351667|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138351668|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
138351669|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351671|NCT02911818|Phentermine|phentermine|mesh-list
138351672|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138351676|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351677|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138351678|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
138351679|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138351680|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
138351681|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
138351682|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351683|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
138351684|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351685|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351688|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
138351689|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
138351703|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138351704|NCT02913924|Clonazepam|clonazepam|mesh-list
138351705|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
138351706|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
138351709|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351711|NCT02917122|Sertraline|sertraline|mesh-list
138351712|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
138351714|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138351715|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138351716|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138351717|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351718|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351719|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
138351720|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351721|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
138351722|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138351723|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138351724|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351725|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
138351726|NCT02922582|Coagulants|coagulants|mesh-ancestor
138351728|NCT02925858|Analgesics|analgesics|mesh-ancestor
138351729|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
138351730|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351731|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351732|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138351733|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138351734|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
138351735|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
138351738|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138351739|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351740|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351741|NCT02933034|Manganese|manganese|mesh-list
138351742|NCT02933034|Trace Elements|trace elements|mesh-ancestor
138351743|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
138351744|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351745|NCT02937168|Reslizumab|reslizumab|mesh-list
138351746|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138351747|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138351748|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351749|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138351750|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
138351752|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138351753|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351754|NCT02937558|Hormones|hormones|mesh-ancestor
138351755|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351756|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351757|NCT02937558|Incretins|incretins|mesh-ancestor
138351758|NCT02938494|Tazarotene|tazarotene|mesh-list
138351759|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138351760|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
138351761|NCT02941692|Oxytocin|oxytocin|mesh-list
138351762|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
138351763|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138351768|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138351769|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138351770|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
138351772|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351774|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138351775|NCT02956044|Glimepiride|glimepiride|mesh-list
138351776|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
138351777|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138351778|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351779|NCT02956044|Incretins|incretins|mesh-ancestor
138351780|NCT02956044|Hormones|hormones|mesh-ancestor
138351781|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351783|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351784|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351785|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351786|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138351787|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138351788|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
138351789|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
138351793|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
138351794|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138351795|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
138351839|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351840|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351841|NCT02968368|Ferric maltol|ferric maltol|mesh-list
138351842|NCT02968368|Hematinics|hematinics|mesh-ancestor
138351843|NCT02968914|Benralizumab|benralizumab|mesh-list
138351845|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138351846|NCT02970162|Amifampridine|amifampridine|mesh-list
138351847|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138351848|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351849|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351850|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138351851|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138351852|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351854|NCT02970552|Progestins|progestins|mesh-ancestor
138351855|NCT02970552|Hormones|hormones|mesh-ancestor
138351856|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351857|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351859|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351860|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351862|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
138351863|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351864|NCT02988882|Dexamethasone|dexamethasone|mesh-list
138351867|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
138351868|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351869|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351870|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138351873|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138351874|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138351875|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351876|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
138351877|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138351878|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138351879|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351881|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138351883|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351884|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351885|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351887|NCT03009396|Rifabutin|rifabutin|mesh-list
138351888|NCT03009396|Clofazimine|clofazimine|mesh-list
138351889|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138351890|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351891|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138351892|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351893|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351894|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138351895|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351896|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138351897|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
138351898|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138351901|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351902|NCT03017508|Riluzole|riluzole|mesh-list
138351903|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
138351904|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138351905|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138351906|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351907|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351908|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351909|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138351910|NCT03017508|Protective Agents|protective agents|mesh-ancestor
138351911|NCT03020004|Ritonavir|ritonavir|mesh-list
138351912|NCT03020004|Ribavirin|ribavirin|mesh-list
138351914|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138351915|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138351916|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351917|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351918|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351919|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138351920|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138351921|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
138351922|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351923|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138352188|NCT03137160|Ixekizumab|ixekizumab|mesh-list
138351924|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351925|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
138351926|NCT03020082|Ritonavir|ritonavir|mesh-list
138351927|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138351928|NCT03020082|Ribavirin|ribavirin|mesh-list
138351929|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138351930|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138351931|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351932|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351933|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351934|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138351935|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138351936|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
138351937|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351938|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138351939|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138351940|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
138351941|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
138351942|NCT03026556|Apixaban|apixaban|mesh-list
138351943|NCT03026556|Dabigatran|dabigatran|mesh-list
138351944|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138351945|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
138351946|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138351947|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
138351950|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
138351951|NCT03035760|Oxfendazole|oxfendazole|mesh-list
138351952|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
138351953|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138351954|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138351955|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
138351956|NCT03036384|Sufentanil|sufentanil|mesh-list
138351957|NCT03036384|Morphine|morphine|mesh-list
138351958|NCT03036384|Prilocaine|prilocaine|mesh-list
138351959|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138351960|NCT03036384|Narcotics|narcotics|mesh-ancestor
138351961|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351962|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351963|NCT03036384|Analgesics|analgesics|mesh-ancestor
138351964|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
138351965|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138351966|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138351967|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138351968|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
138351969|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
138351970|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
138351971|NCT03040362|Lasmiditan|lasmiditan|mesh-list
138351972|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138351973|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
138351974|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138351976|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351977|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138351978|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
138351979|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
138351980|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351981|NCT03044418|Propofol|propofol|mesh-list
138351982|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
138351983|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138351984|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351985|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138351986|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138351988|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138351989|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
138351990|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
138351991|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351994|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138351995|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138351996|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138351997|NCT03057132|Protective Agents|protective agents|mesh-list
138351998|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351999|NCT03057366|Paclitaxel|paclitaxel|mesh-list
138352000|NCT03057366|Docetaxel|docetaxel|mesh-list
138352001|NCT03057366|Carboplatin|carboplatin|mesh-list
138352002|NCT03057366|Pevonedistat|pevonedistat|mesh-list
138352003|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138352004|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352005|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
138352006|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
138352008|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352009|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352011|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
138352012|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
138352013|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352014|NCT03061812|Dexamethasone|dexamethasone|mesh-list
138352015|NCT03061812|Topotecan|topotecan|mesh-list
138352016|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
138352017|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352018|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
138352019|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
138352020|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352021|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352022|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352023|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
138352024|NCT03061812|Hormones|hormones|mesh-ancestor
138352026|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138352027|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352028|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138352029|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138352030|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352031|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352032|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
138352033|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
138352035|NCT03070470|Lopinavir|lopinavir|mesh-list
138352036|NCT03070470|Chloroquine|chloroquine|mesh-list
138352037|NCT03070470|Verapamil|verapamil|mesh-list
138352038|NCT03070470|Dofetilide|dofetilide|mesh-list
138352039|NCT03070470|Diltiazem|diltiazem|mesh-list
138352040|NCT03070470|Ranolazine|ranolazine|mesh-list
138352041|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138352042|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138352043|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
138352044|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352045|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352047|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138352049|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352050|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138352051|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138352052|NCT03070470|Amebicides|amebicides|mesh-ancestor
138352053|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138352054|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138352055|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
138352056|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352057|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352058|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352059|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138352060|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352063|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138352064|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138352065|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138352066|NCT03070548|Talazoparib|talazoparib|mesh-list
138352067|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138352068|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352069|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352070|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352071|NCT03080142|Bupivacaine|bupivacaine|mesh-list
138352075|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352076|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352077|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
138352078|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352079|NCT03088800|Ibuprofen|ibuprofen|mesh-list
138352080|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138352084|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352085|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352087|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352089|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352092|NCT03096444|Ketamine|ketamine|mesh-list
138352093|NCT03096444|Amitriptyline|amitriptyline|mesh-list
138352094|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352095|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
138352096|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352097|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352098|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
138352099|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352100|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352101|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138352102|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138352103|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352104|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352108|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
138352109|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138352110|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138352111|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352112|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138352113|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
138352114|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138352118|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352121|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352122|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352123|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352124|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
138352126|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352127|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138352128|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138352129|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352130|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352131|NCT03124758|Chrysarobin|chrysarobin|mesh-list
138352132|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138352133|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352134|NCT03124758|Analgesics|analgesics|mesh-ancestor
138352135|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
138352136|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352137|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352138|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352139|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352140|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
138352141|NCT03148236|Vitamins|vitamins|mesh-ancestor
138352142|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
138352143|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352145|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352147|NCT03174366|Denosumab|denosumab|mesh-list
138352148|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138352149|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352150|NCT03177798|Icatibant|icatibant|mesh-list
138352151|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138352152|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352153|NCT03177798|Analgesics|analgesics|mesh-ancestor
138352154|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
138352156|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352157|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352158|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352159|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138352160|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138352161|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352162|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138352163|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138352165|NCT04933344|Daptomycin|daptomycin|mesh-list
138352166|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352167|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352168|NCT05406180|Vaccines|vaccines|mesh-list
138352169|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
138352170|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352171|NCT05405478|Omalizumab|omalizumab|mesh-list
138352172|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138352173|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138352174|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138352175|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138352176|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352177|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138352178|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
138352179|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352180|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
138352181|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138352182|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352183|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352184|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138352185|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138352186|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
138352187|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138352234|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352235|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
138352236|NCT03883074|Protective Agents|protective agents|mesh-ancestor
138352237|NCT03883074|Antacids|antacids|mesh-ancestor
138352238|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352239|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352240|NCT03670836|Misoprostol|misoprostol|mesh-list
138352241|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138352244|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352245|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138352246|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352248|NCT03409614|Cemiplimab|cemiplimab|mesh-list
138352249|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138352250|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352251|NCT02651844|Mifepristone|mifepristone|mesh-list
138352252|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138352253|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
138352254|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352255|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352256|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138352257|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138352258|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138352259|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
138352260|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138352261|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138352262|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
138352263|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352264|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
138352266|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138352267|NCT01463670|Lenalidomide|lenalidomide|mesh-list
138352268|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
138352269|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352270|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138352271|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138352272|NCT01463670|Growth Substances|growth substances|mesh-ancestor
138352274|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352275|NCT00151398|Donepezil|donepezil|mesh-list
138352276|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138352277|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352278|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352279|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352280|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352283|NCT03181308|Nivolumab|nivolumab|mesh-list
138352284|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138352285|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352286|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138352287|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352288|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
138352289|NCT03202134|Anesthetics|anesthetics|mesh-list
138352290|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352293|NCT03202134|Analgesics|analgesics|mesh-ancestor
138352294|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
138352295|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352296|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138352297|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
138352298|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138352300|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138352301|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352302|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352303|NCT03218592|Tenofovir|tenofovir|mesh-list
138352304|NCT03218592|Emtricitabine|emtricitabine|mesh-list
138352305|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138352306|NCT03218592|Dolutegravir|dolutegravir|mesh-list
138352318|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138352319|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138352320|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138352322|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
138352323|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
138352324|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138352326|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138352327|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352328|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352329|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138352330|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138352331|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352332|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352333|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352335|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138352336|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352337|NCT03223272|Reserpine|reserpine|mesh-list
138352338|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138352339|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138352340|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138352341|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352342|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352343|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138352344|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138352345|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138352346|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352347|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352349|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352350|NCT03239106|Apremilast|apremilast|mesh-list
138352351|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138352352|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352353|NCT03239106|Analgesics|analgesics|mesh-ancestor
138352356|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352357|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352358|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352359|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138352360|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138352361|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352362|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352363|NCT03257202|Clindamycin|clindamycin|mesh-list
138352364|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
138352365|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
138352366|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138352367|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352368|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352369|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138352370|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352373|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138352375|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352377|NCT03278886|Nalmefene|nalmefene|mesh-list
138352378|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138352379|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138352380|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352381|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
138352382|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352383|NCT03285984|Listerine|listerine|mesh-list
138352384|NCT03285984|Fluorides|fluorides|mesh-list
138352389|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138352390|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352392|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138352394|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352395|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352396|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138352397|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
138352398|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
138352399|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352400|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138352401|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138352403|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352404|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352405|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352406|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138352407|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138352408|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138352409|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352410|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352411|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138352412|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352413|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352414|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352417|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352418|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352419|NCT03334734|Isoniazid|isoniazid|mesh-list
138352461|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352462|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352463|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138352464|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138352465|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352466|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352467|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
138352480|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352481|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352485|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
138352486|NCT03395886|Remifentanil|remifentanil|mesh-list
138352487|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138352488|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352489|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352490|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352491|NCT03395886|Analgesics|analgesics|mesh-ancestor
138352492|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
138352493|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352494|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138352495|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138352496|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138352497|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352498|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352499|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352500|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138352501|NCT03395886|Narcotics|narcotics|mesh-ancestor
138352502|NCT03426228|Progesterone|progesterone|mesh-list
138352503|NCT03426228|Estrogens|estrogens|mesh-list
138352504|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352505|NCT03426228|Hormones|hormones|mesh-ancestor
138352506|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352508|NCT03430050|Progesterone|progesterone|mesh-list
138352509|NCT03430050|Progestins|progestins|mesh-ancestor
138352510|NCT03430050|Hormones|hormones|mesh-ancestor
138352511|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352512|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352513|NCT03440424|Lemborexant|lemborexant|mesh-list
138352514|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138352515|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352516|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352517|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138352518|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138352519|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352520|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352521|NCT03448068|Ketamine|ketamine|mesh-list
138352522|NCT03448068|Analgesics|analgesics|mesh-ancestor
138352523|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
138352524|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352525|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352526|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138352527|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138352528|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
138352529|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
138352530|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352531|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138352532|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138352533|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352534|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352535|NCT03453060|Thrombin|thrombin|mesh-list
138352536|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
138352537|NCT03453060|Coagulants|coagulants|mesh-ancestor
138352538|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
138352540|NCT03459612|Lasmiditan|lasmiditan|mesh-list
138352541|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138352542|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138352543|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352544|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352547|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
138352548|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352549|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
138352550|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
138352551|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352552|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138352553|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
138352661|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352662|NCT03610464|Amphetamine|amphetamine|mesh-list
138352664|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352665|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
138352666|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
138352667|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352668|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
138352669|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352671|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352672|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138352673|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138352674|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352675|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138352676|NCT03630198|Lidocaine|lidocaine|mesh-list
138352677|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352678|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
138352679|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352680|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352681|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
138352682|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352684|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138352685|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138352686|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352687|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352688|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138352689|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138352690|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352692|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138352693|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138352694|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352696|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
138352697|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
138352698|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352699|NCT03674970|Nicotine|nicotine|mesh-list
138352700|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138352701|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
138352702|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352703|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352704|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138352705|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138352706|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352707|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352708|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352710|NCT03704376|Ropivacaine|ropivacaine|mesh-list
138352711|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352712|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
138352713|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352714|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352715|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
138352716|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352720|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
138352721|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138352722|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138352723|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138352724|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352725|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352726|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352727|NCT03716076|Carbetocin|carbetocin|mesh-list
138352728|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
138352729|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352730|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352732|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
138352733|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352734|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
138352735|NCT03889158|Vaccines|vaccines|mesh-list
138352736|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
138352737|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352738|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
138352739|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352741|NCT03889158|Vitamins|vitamins|mesh-ancestor
138352742|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
138352743|NCT04138758|Bromides|bromides|mesh-list
138352744|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
138352745|NCT04138758|Olodaterol|olodaterol|mesh-list
138352746|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138352761|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352762|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138352763|NCT04420572|Betamethasone|betamethasone|mesh-list
138352764|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352765|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
138352768|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352769|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138352770|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
138352771|NCT03541980|Acetaminophen|acetaminophen|mesh-list
138352772|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138352773|NCT03541980|Analgesics|analgesics|mesh-ancestor
138352774|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
138352775|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352776|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352777|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
138352778|NCT04511520|Trimetazidine|trimetazidine|mesh-list
138352779|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
138352780|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
138352781|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352782|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
138352783|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352784|NCT04335552|Azithromycin|azithromycin|mesh-list
138352786|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352787|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352789|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138352790|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138352791|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352792|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352793|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352795|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352796|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
138352797|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352798|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352799|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
138352800|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352801|NCT04267770|Insulin|insulin|mesh-list
138352802|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138352803|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352804|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352805|NCT04204200|Vitamins|vitamins|mesh-list
138352806|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
138352807|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
138352808|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352809|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
138352810|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352812|NCT04179474|Erenumab|erenumab|mesh-list
138352813|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138352814|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352815|NCT04179474|Analgesics|analgesics|mesh-ancestor
138352816|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
138352817|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352818|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352819|NCT04150224|Macozinone|macozinone|mesh-list
138352820|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
138352821|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138352822|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138352823|NCT04102956|Kallikreins|kallikreins|mesh-list
138352824|NCT04102956|Coagulants|coagulants|mesh-ancestor
138352825|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138352826|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
138352827|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352828|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352829|NCT04053270|Afamelanotide|afamelanotide|mesh-list
138352830|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352831|NCT03976752|Tenofovir|tenofovir|mesh-list
138352832|NCT03976752|Emtricitabine|emtricitabine|mesh-list
138352833|NCT03976752|Cobicistat|cobicistat|mesh-list
138352834|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138352835|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138352839|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138352840|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138352841|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352842|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352843|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138352844|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138352845|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138352846|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138352848|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
138352849|NCT03962634|Tetracaine|tetracaine|mesh-list
138352850|NCT03962634|Carticaine|carticaine|mesh-list
138352851|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
138352852|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
138352853|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352855|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
138352856|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352857|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138352858|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138352859|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352860|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352861|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352863|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
138352864|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
138352865|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138352866|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138352867|NCT03933774|Tretinoin|tretinoin|mesh-list
138352868|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352869|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
138352870|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
138352871|NCT03933618|Anastrozole|anastrozole|mesh-list
138352872|NCT03933618|Clomiphene|clomiphene|mesh-list
138352873|NCT03933618|Enclomiphene|enclomiphene|mesh-list
138352874|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
138352875|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352876|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138352877|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352878|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138352879|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138352880|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352881|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138352884|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352885|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138352886|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
138352887|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138352888|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138352889|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138352890|NCT03930264|Azathioprine|azathioprine|mesh-list
138352891|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
138352892|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352893|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138352894|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352895|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138352896|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
138352897|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352898|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138352899|NCT03861000|BPN14770|bpn14770|mesh-list
138352900|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138352901|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138352902|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352903|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352905|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138352906|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
138352907|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138352908|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138352910|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
138352911|NCT03856164|Coagulants|coagulants|mesh-ancestor
138352912|NCT03849690|Esomeprazole|esomeprazole|mesh-list
138352913|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138352914|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138352915|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138352916|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352918|NCT03822078|Denosumab|denosumab|mesh-list
138352920|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352922|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138352923|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138352924|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352926|NCT03806556|Coagulants|coagulants|mesh-ancestor
138352927|NCT03812328|Enoxaparin|enoxaparin|mesh-list
138352928|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
138352937|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
138352938|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352939|NCT03796260|Entrectinib|entrectinib|mesh-list
138352940|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138352941|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352942|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352943|NCT03796182|Metformin|metformin|mesh-list
138352944|NCT03796182|Abrocitinib|abrocitinib|mesh-list
138352945|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352946|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352947|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138352948|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352949|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352951|NCT03730116|Perindopril|perindopril|mesh-list
138352954|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
138352955|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352956|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352957|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138352958|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138352959|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138352960|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352961|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352962|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352963|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138352964|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
138352965|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138352967|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352969|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138352970|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138352971|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
138352972|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352973|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352974|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352975|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138352976|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138352977|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
138352978|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
138352979|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138352980|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138352981|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138352982|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138352983|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352984|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352985|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352986|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352987|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138352988|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138352990|NCT03042780|Lenograstim|lenograstim|mesh-list
138352993|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138352994|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138352995|NCT02985840|Dexamethasone|dexamethasone|mesh-list
138352996|NCT02985840|Ondansetron|ondansetron|mesh-list
138352997|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138352998|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
138352999|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
138353000|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353001|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353002|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138353003|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
138353005|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353006|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138353007|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353008|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
138353009|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
138353011|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138353012|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
138353013|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353014|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353015|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
138353016|NCT02974686|Everolimus|everolimus|mesh-list
138353017|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138353018|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353020|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353021|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353022|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
138353023|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353024|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353025|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138353026|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138353027|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
138353028|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138353029|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353031|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138353032|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
138353033|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353034|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353035|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138353036|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353037|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
138353038|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138353039|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138353040|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138353041|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138353042|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353045|NCT02744352|Ropivacaine|ropivacaine|mesh-list
138353046|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
138353047|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
138353048|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353049|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353050|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
138353051|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353052|NCT02587650|Ceritinib|ceritinib|mesh-list
138353053|NCT02587650|Entrectinib|entrectinib|mesh-list
138353054|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353055|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353056|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353058|NCT02514252|Fentanyl|fentanyl|mesh-list
138353059|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353060|NCT02514252|Narcotics|narcotics|mesh-ancestor
138353061|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353062|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353063|NCT02514252|Analgesics|analgesics|mesh-ancestor
138353064|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
138353066|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138353067|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138353068|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
138353071|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
138353072|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138353073|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
138353074|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
138353075|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353076|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353077|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
138353078|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138353080|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353081|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138353082|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138353084|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353089|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
138353090|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353091|NCT02345460|Leucovorin|leucovorin|mesh-list
138353092|NCT02345460|Fluorouracil|fluorouracil|mesh-list
138353093|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
138353094|NCT02345460|Irinotecan|irinotecan|mesh-list
138353095|NCT02345460|Calcium|calcium|mesh-list
138353096|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
138353097|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353098|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353099|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
138353100|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353101|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353102|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353103|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353104|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
138353105|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138353106|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138353107|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353108|NCT02345460|Antidotes|antidotes|mesh-ancestor
138353109|NCT02345460|Protective Agents|protective agents|mesh-ancestor
138353110|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
138353111|NCT02345460|Vitamins|vitamins|mesh-ancestor
138353112|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
138353113|NCT02345772|Docetaxel|docetaxel|mesh-list
138353114|NCT02345772|Trastuzumab|trastuzumab|mesh-list
138353115|NCT02345772|Fulvestrant|fulvestrant|mesh-list
138353116|NCT02345772|Pertuzumab|pertuzumab|mesh-list
138353117|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353130|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138353131|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353132|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
138353133|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353135|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353136|NCT02133534|Atorvastatin|atorvastatin|mesh-list
138353138|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138353139|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
138353140|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353141|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138353142|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138353145|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138353148|NCT02015910|Hormones|hormones|mesh-ancestor
138353150|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138353151|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
138353152|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353153|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353154|NCT01980342|Efavirenz|efavirenz|mesh-list
138353155|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138353156|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138353157|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353158|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353159|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
138353160|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353161|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138353162|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138353163|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138353165|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138353166|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138353168|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138353169|NCT01881984|Protective Agents|protective agents|mesh-ancestor
138353170|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353171|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
138353172|NCT01878786|Everolimus|everolimus|mesh-list
138353173|NCT01878786|Tacrolimus|tacrolimus|mesh-list
138353174|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353175|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
138353176|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353177|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138353178|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353179|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353180|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138353181|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353182|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353183|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138353184|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138353185|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
138353186|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138353189|NCT01851174|Gemcitabine|gemcitabine|mesh-list
138353190|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138353191|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353192|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
138353193|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
138353194|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
138353195|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353196|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353197|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
138353198|NCT01846182|Pregabalin|pregabalin|mesh-list
138353199|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138353201|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
138353202|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353203|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353204|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
138353205|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138353206|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353207|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353208|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353209|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138353210|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138353211|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353212|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353213|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138353214|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138353215|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353216|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
138353217|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
138353218|NCT01800162|Methotrexate|methotrexate|mesh-list
138353219|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138353220|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
138353221|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138353222|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353223|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353225|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353226|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353227|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138353228|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353229|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138353230|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353232|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138353233|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138353234|NCT01756560|Bupivacaine|bupivacaine|mesh-list
138353235|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
138353236|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
138353237|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353238|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353239|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
138353240|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353242|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138353243|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353244|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138353245|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138353246|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353247|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353249|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353252|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353253|NCT01702896|Interleukin-2|interleukin-2|mesh-list
138353254|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353255|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353256|NCT01702896|Analgesics|analgesics|mesh-ancestor
138353257|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
138353258|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353259|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353260|NCT01683864|Cisplatin|cisplatin|mesh-list
138353261|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353263|NCT01608906|Calcium heparin|calcium heparin|mesh-list
138353264|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
138353265|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138353266|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138353267|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353268|NCT01602198|Rivastigmine|rivastigmine|mesh-list
138353269|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138353270|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353271|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353274|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353275|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138353276|NCT01602198|Protective Agents|protective agents|mesh-ancestor
138353277|NCT01545648|Denosumab|denosumab|mesh-list
138353278|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138353279|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353284|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353285|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353286|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
138353287|NCT01507584|Bimatoprost|bimatoprost|mesh-list
138353288|NCT01507584|Brinzolamide|brinzolamide|mesh-list
138353289|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353290|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138353292|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353293|NCT01483872|Tigecycline|tigecycline|mesh-list
138353294|NCT01483872|Heparin|heparin|mesh-list
138353295|NCT01483872|Calcium heparin|calcium heparin|mesh-list
138353296|NCT01483872|Anticoagulants|anticoagulants|mesh-list
138353297|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353298|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138353299|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138353301|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353302|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138353303|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353304|NCT01385280|Exemestane|exemestane|mesh-list
138353305|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138353306|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138353307|NCT01385280|Estradiol|estradiol|mesh-list
138353308|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138353310|NCT01385280|Hormones|hormones|mesh-ancestor
138353311|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353312|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353313|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138353314|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
138353316|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138353317|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353318|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138353319|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138353320|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353321|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353322|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138353323|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
138353324|NCT01350258|Fludarabine|fludarabine|mesh-list
138353325|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
138353326|NCT01350258|Melphalan|melphalan|mesh-list
138353327|NCT01350258|Thiotepa|thiotepa|mesh-list
138353328|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353329|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138353330|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
138353331|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353332|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353333|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
138353334|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353335|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138353336|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
138353337|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138353338|NCT01302444|Tadalafil|tadalafil|mesh-list
138353339|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
138353340|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138353341|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138353343|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353344|NCT01302444|Urological Agents|urological agents|mesh-ancestor
138353349|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353350|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353351|NCT01284504|Celecoxib|celecoxib|mesh-list
138353352|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138353353|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353355|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
138353356|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353357|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353359|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138353361|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138353362|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353363|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353364|NCT01183416|Tretinoin|tretinoin|mesh-list
138353365|NCT01183416|Isotretinoin|isotretinoin|mesh-list
138353367|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138353368|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
138353371|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
138353372|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
138353373|NCT01169610|Varenicline|varenicline|mesh-list
138353374|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138353375|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138353376|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
138353377|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353379|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353380|NCT01166724|Sirolimus|sirolimus|mesh-list
138353381|NCT01166724|Tacrolimus|tacrolimus|mesh-list
138353382|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353383|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
138353384|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353385|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138353386|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353387|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353388|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138353389|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353390|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138353391|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353392|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
138353393|NCT01151904|Timolol|timolol|mesh-list
138353396|NCT01151904|Latanoprost|latanoprost|mesh-list
138353397|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138353398|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138353399|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138353400|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353401|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353403|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353404|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138353405|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353406|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138353407|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138353408|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138353410|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353411|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
138353412|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138353413|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138353414|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138353415|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353416|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353417|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
138353418|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138353421|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138353422|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353423|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353424|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138353425|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
138353426|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
138353427|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138353428|NCT00986310|Fluoxetine|fluoxetine|mesh-list
138353429|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138353432|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353433|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353434|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
138353435|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353436|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138353437|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
138353438|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353441|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353442|NCT00907218|Varenicline|varenicline|mesh-list
138353443|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138353444|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138353445|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
138353446|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353447|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353448|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353449|NCT00903396|Palonosetron|palonosetron|mesh-list
138353450|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
138353451|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
138353452|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353453|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353454|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138353455|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138353456|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138353457|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
138353458|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353459|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353460|NCT00875394|Metformin|metformin|mesh-list
138353461|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138353462|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138353463|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353464|NCT00875394|Incretins|incretins|mesh-ancestor
138353466|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353467|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138353468|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
138353469|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353470|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353471|NCT00832572|Ranolazine|ranolazine|mesh-list
138353472|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138353473|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353474|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353476|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138353477|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353478|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353479|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353480|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138353481|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
138353482|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353483|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353484|NCT00749658|Bupropion|bupropion|mesh-list
138353485|NCT00749658|Varenicline|varenicline|mesh-list
138353486|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138353487|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
138353488|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353489|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138353490|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138353491|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353492|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353493|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
138353494|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353497|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138353498|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353499|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138353500|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138353501|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
138353502|NCT00738972|Valsartan|valsartan|mesh-list
138353503|NCT00738972|Simvastatin|simvastatin|mesh-list
138353504|NCT00738972|Ezetimibe|ezetimibe|mesh-list
138353505|NCT00738972|Pravastatin|pravastatin|mesh-list
138353506|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138353507|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138353508|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
138353509|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353510|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138353511|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138353512|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353513|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138353514|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138353515|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138353516|NCT00726180|Trastuzumab|trastuzumab|mesh-list
138353517|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353518|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353519|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
138353520|NCT00704496|Ephedrine|ephedrine|mesh-list
138353521|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138353522|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
138353523|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353524|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353525|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138353526|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353527|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
138353528|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138353529|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138353531|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353532|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353533|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353534|NCT00692094|Melatonin|melatonin|mesh-list
138353535|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
138353536|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353537|NCT00692094|Protective Agents|protective agents|mesh-ancestor
138353538|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353539|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353540|NCT00676026|Zolpidem|zolpidem|mesh-list
138353541|NCT00676026|Fluoxetine|fluoxetine|mesh-list
138353542|NCT00676026|Progesterone|progesterone|mesh-list
138353543|NCT00676026|Progestins|progestins|mesh-ancestor
138353544|NCT00676026|Hormones|hormones|mesh-ancestor
138353545|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138353546|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353547|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138353548|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138353549|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353551|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353553|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138353554|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
138353630|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353631|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353632|NCT05403762|Protective Agents|protective agents|mesh-list
138353633|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353634|NCT05164614|Teriparatide|teriparatide|mesh-list
138353635|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353636|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353637|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138353638|NCT05001048|Phenylephrine|phenylephrine|mesh-list
138353641|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138353642|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
138353643|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
138353644|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353645|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353646|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
138353647|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138353648|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
138353649|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353650|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138353651|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138353652|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138353653|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353657|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138353658|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
138353660|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
138353661|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353662|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
138353663|NCT04810572|Silymarin|silymarin|mesh-list
138353664|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
138353665|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353666|NCT04810572|Protective Agents|protective agents|mesh-ancestor
138353667|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353668|NCT04575090|Simvastatin|simvastatin|mesh-list
138353670|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138353671|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
138353672|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353673|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138353674|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138353675|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353676|NCT04100772|Vaccines|vaccines|mesh-list
138353677|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
138353678|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353679|NCT03472872|Acetaminophen|acetaminophen|mesh-list
138353680|NCT03472872|Ketorolac|ketorolac|mesh-list
138353681|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353682|NCT03472872|Analgesics|analgesics|mesh-ancestor
138353683|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
138353684|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353685|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353686|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
138353687|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138353688|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138353689|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138353694|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138353695|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
138353697|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353698|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353699|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138353700|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138353701|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353702|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138353703|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138353704|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
138353706|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353709|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353712|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353713|NCT00558870|Narcotics|narcotics|mesh-ancestor
138353714|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353715|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353716|NCT00558870|Analgesics|analgesics|mesh-ancestor
138353717|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
138353718|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353723|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138353724|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138353725|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353726|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353731|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353732|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138353733|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
138353734|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
138353735|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
138353736|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138353738|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353739|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353740|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353741|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353743|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353744|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138353745|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353746|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353747|NCT00506064|Melatonin|melatonin|mesh-list
138353748|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
138353749|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353750|NCT00506064|Protective Agents|protective agents|mesh-ancestor
138353751|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353752|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353754|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353755|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138353756|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138353757|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
138353758|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353759|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138353760|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353761|NCT00145704|Vitamin D|vitamin d|mesh-list
138353762|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
138353764|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
138353765|NCT00145704|Diphosphonates|diphosphonates|mesh-list
138353766|NCT00145704|Vitamins|vitamins|mesh-list
138353767|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
138353768|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353769|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138353770|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138353771|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138353772|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353773|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353775|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138353777|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353778|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353779|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138353780|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138353781|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
138353782|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353783|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353784|NCT00090870|Interferons|interferons|mesh-list
138353785|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
138353786|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
138353787|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138353788|NCT00090870|Thalidomide|thalidomide|mesh-list
138353789|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353790|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
138353791|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353792|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
138353804|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
138353805|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353806|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353807|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138353816|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
138353842|NCT04422210|Carboplatin|carboplatin|mesh-list
138353843|NCT04422210|Etoposide|etoposide|mesh-list
138353844|NCT04422210|Atezolizumab|atezolizumab|mesh-list
138353845|NCT04422210|Venetoclax|venetoclax|mesh-list
138353846|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138353847|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138353848|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138353849|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138353850|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353851|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353852|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138353853|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138353927|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353928|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353929|NCT00000210|Analgesics|analgesics|mesh-ancestor
138353930|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
138353931|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353932|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353933|NCT00000222|Buprenorphine|buprenorphine|mesh-list
138353934|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353935|NCT00000222|Narcotics|narcotics|mesh-ancestor
138353936|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353937|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353940|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353941|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353942|NCT00000228|Buprenorphine|buprenorphine|mesh-list
138353943|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353944|NCT00000228|Narcotics|narcotics|mesh-ancestor
138353945|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353946|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353947|NCT00000228|Analgesics|analgesics|mesh-ancestor
138353948|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
138353952|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138353953|NCT00000234|Narcotics|narcotics|mesh-ancestor
138353954|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353955|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353956|NCT00000234|Analgesics|analgesics|mesh-ancestor
138353957|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
138353958|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353959|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353960|NCT00000240|Buprenorphine|buprenorphine|mesh-list
138353964|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353967|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353968|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138353969|NCT00000246|Flumazenil|flumazenil|mesh-list
138353970|NCT00000246|Antidotes|antidotes|mesh-ancestor
138353971|NCT00000246|Protective Agents|protective agents|mesh-ancestor
138353972|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353973|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
138353974|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
138353975|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353976|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353977|NCT00000264|Ethanol|ethanol|mesh-list
138353978|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
138353979|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138353980|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138353982|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353983|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138353984|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
138353985|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
138353986|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138353987|NCT00000264|Analgesics|analgesics|mesh-ancestor
138353988|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
138353989|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138353990|NCT00000270|Cocaine|cocaine|mesh-list
138353991|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
138353992|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
138353993|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138353994|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353995|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
138353999|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138354000|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354001|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354003|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354005|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138354006|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
138354007|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138354008|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138354009|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138354010|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354011|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354012|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
138354013|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354014|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354015|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138354016|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354067|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138354068|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354069|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354070|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138354071|NCT00000336|Protective Agents|protective agents|mesh-ancestor
138354072|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354074|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138354075|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
138354076|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354077|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354078|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354079|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138354080|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138354081|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138354083|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138354084|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
138354085|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
138354086|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
138354087|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
138354088|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354089|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354090|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354091|NCT00000354|Lofexidine|lofexidine|mesh-list
138354092|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138354093|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138354094|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354096|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354097|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138354098|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138354099|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138354100|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138354101|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354102|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354103|NCT00000372|Cycloserine|cycloserine|mesh-list
138354104|NCT00000372|Clozapine|clozapine|mesh-list
138354105|NCT00000372|Glycine|glycine|mesh-list
138354106|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138354107|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354108|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138354109|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
138354111|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
138354112|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354113|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138354114|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
138354115|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354116|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354117|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138354118|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138354119|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138354120|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138354125|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
138354126|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138354127|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138354128|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138354129|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354130|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354131|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354132|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
138354133|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354134|NCT00000390|Imipramine|imipramine|mesh-list
138354135|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138354136|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
138354137|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138354138|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138354139|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138354140|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354141|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354142|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
138354143|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354144|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354145|NCT00000402|Calcium|calcium|mesh-list
138354146|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138354147|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354148|NCT00000438|Naltrexone|naltrexone|mesh-list
138354149|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138354150|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138354154|NCT00000444|Nicotine|nicotine|mesh-list
138354155|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138354156|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
138354157|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354158|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354159|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138354160|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138354161|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
138354162|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354163|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354165|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138354166|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138354167|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354168|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
138354169|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354171|NCT00000510|Dipyridamole|dipyridamole|mesh-list
138354178|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138354181|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138354196|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354197|NCT00000600|Protective Agents|protective agents|mesh-ancestor
138354198|NCT00000636|Pyridoxine|pyridoxine|mesh-list
138354199|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
138354200|NCT00000636|Rifampin|rifampin|mesh-list
138354201|NCT00000636|Isoniazid|isoniazid|mesh-list
138354202|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
138354203|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138354204|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
138354205|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354206|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354207|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
138354208|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354209|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354210|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354211|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138354212|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354215|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138354216|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354217|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138354218|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138354219|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
138354220|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138354221|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
138354222|NCT00000636|Vitamins|vitamins|mesh-ancestor
138354223|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
138354227|NCT00000648|Penicillin G|penicillin g|mesh-list
138354228|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138354229|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
138354230|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354231|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354232|NCT00000654|Fialuridine|fialuridine|mesh-list
138354233|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
138354234|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354235|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354236|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354237|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354239|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138354240|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354241|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138354242|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138354243|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354244|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354246|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
138354247|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354248|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354249|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354250|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354251|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
138354252|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354253|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354254|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354255|NCT00000714|Leucovorin|leucovorin|mesh-list
138354473|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354474|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354475|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
138354476|NCT00000936|Cyclosporine|cyclosporine|mesh-list
138354477|NCT00000936|Cyclosporins|cyclosporins|mesh-list
138354478|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354479|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354481|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
138354482|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354483|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
138354484|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354485|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138354489|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354490|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354491|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354492|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354493|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
138354494|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354496|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354497|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354498|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354499|NCT00000948|Aldesleukin|aldesleukin|mesh-list
138354500|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354501|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354502|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354503|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
138354504|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354505|NCT00000954|Didanosine|didanosine|mesh-list
138354506|NCT00000954|Zalcitabine|zalcitabine|mesh-list
138354508|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138354509|NCT00000954|Bleomycin|bleomycin|mesh-list
138354510|NCT00000954|Vincristine|vincristine|mesh-list
138354511|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138354512|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354513|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138354514|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138354515|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354516|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354517|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138354519|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
138354520|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
138354522|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354523|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354524|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
138354525|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354526|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354527|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354528|NCT00000960|Zidovudine|zidovudine|mesh-list
138354529|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
138354530|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354531|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354532|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354533|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354534|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
138354535|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354536|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354537|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354539|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
138354540|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354541|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354542|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354543|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354545|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354546|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354547|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354548|NCT00000996|Doxorubicin|doxorubicin|mesh-list
138354549|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138354550|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138354551|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354552|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138354553|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138354554|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354555|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354556|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138354557|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138354571|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354572|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354573|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354574|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354575|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
138354576|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354577|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354578|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354579|NCT00001080|Lamivudine|lamivudine|mesh-list
138354580|NCT00001080|Vaccines|vaccines|mesh-list
138354582|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
138354583|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354584|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354585|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354586|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354587|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354590|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354591|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354592|NCT00001104|Zidovudine|zidovudine|mesh-list
138354593|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
138354594|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354595|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354596|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354597|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354599|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354600|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354601|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354602|NCT00001110|Dimercaprol|dimercaprol|mesh-list
138354603|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
138354604|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
138354605|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354607|NCT00001122|Didanosine|didanosine|mesh-list
138354608|NCT00001122|Stavudine|stavudine|mesh-list
138354609|NCT00001122|Nelfinavir|nelfinavir|mesh-list
138354610|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354611|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354612|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354615|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354616|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354617|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354618|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354619|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138354620|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138354621|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138354622|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138354623|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138354624|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
138354625|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354626|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354627|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
138354628|NCT00001128|Azithromycin|azithromycin|mesh-list
138354629|NCT00001128|Paromomycin|paromomycin|mesh-list
138354630|NCT00001128|Interleukin-12|interleukin-12|mesh-list
138354631|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354633|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138354634|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
138354635|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354636|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138354637|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138354638|NCT00001128|Growth Substances|growth substances|mesh-ancestor
138354639|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
138354640|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354641|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138354642|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138354644|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
138354647|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
138354648|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354649|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138354650|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
138354651|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354652|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138354655|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354657|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354658|NCT00001428|Fluorouracil|fluorouracil|mesh-list
138354659|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
138354660|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354662|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354663|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354664|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
138354665|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354667|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354668|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138354669|NCT00001440|Analgesics|analgesics|mesh-ancestor
138354670|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
138354671|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354672|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354673|NCT00001446|Thalidomide|thalidomide|mesh-list
138354674|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354675|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
138354676|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354679|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354680|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138354681|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138354682|NCT00001446|Growth Substances|growth substances|mesh-ancestor
138354683|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
138354684|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354685|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
138354686|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138354687|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
138354688|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354689|NCT00001626|Cyclosporine|cyclosporine|mesh-list
138354690|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
138354691|NCT00001626|Cyclosporins|cyclosporins|mesh-list
138354692|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138354693|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354694|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
138354695|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354696|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138354697|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138354698|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
138354699|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354700|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138354701|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138354702|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354703|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
138354704|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354705|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
138354707|NCT00001680|Thalidomide|thalidomide|mesh-list
138354708|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138354709|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
138354710|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354711|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
138354712|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354713|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354714|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138354715|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138354716|NCT00001680|Growth Substances|growth substances|mesh-ancestor
138354719|NCT00001698|Ketorolac|ketorolac|mesh-list
138354720|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138354721|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138354722|NCT00001698|Analgesics|analgesics|mesh-ancestor
138354723|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
138354724|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354725|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354726|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138354727|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138354728|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138354729|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354730|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354732|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
138354733|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138354734|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
138354735|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138354736|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354739|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138354740|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
138354741|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354742|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138354743|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138354813|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354814|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138354815|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
138354816|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354818|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354819|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354820|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
138354821|NCT00001998|Ionophores|ionophores|mesh-ancestor
138354822|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354823|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354824|NCT00002010|Fluconazole|fluconazole|mesh-list
138354825|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
138354826|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354827|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138354828|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354829|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354832|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
138354833|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354834|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354835|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354836|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354837|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
138354838|NCT00002022|Hematinics|hematinics|mesh-ancestor
138354840|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
138354841|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354842|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354843|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354846|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354847|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354848|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354849|NCT00002034|Zidovudine|zidovudine|mesh-list
138354851|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138354852|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
138354853|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354854|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354856|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354857|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
138354858|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354859|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354860|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354861|NCT00002040|Fluconazole|fluconazole|mesh-list
138354862|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
138354863|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354864|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138354865|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138354866|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354867|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354868|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138354870|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138354871|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354872|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354873|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354875|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
138354876|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354877|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354878|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354879|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354880|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
138354881|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354882|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354883|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354884|NCT00002052|Amoxicillin|amoxicillin|mesh-list
138354885|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
138354886|NCT00002052|Ampicillin|ampicillin|mesh-list
138354887|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354888|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354889|NCT00002058|Clofazimine|clofazimine|mesh-list
138354890|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138354891|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
138354892|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354893|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354894|NCT00002064|Clindamycin|clindamycin|mesh-list
138354895|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
138354968|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138354969|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138354970|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138354972|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138354973|NCT00002118|Zalcitabine|zalcitabine|mesh-list
138354974|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
138354975|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354976|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354977|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354978|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354980|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354981|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354982|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354983|NCT00002124|Lamivudine|lamivudine|mesh-list
138354984|NCT00002124|Zidovudine|zidovudine|mesh-list
138354985|NCT00002124|Delavirdine|delavirdine|mesh-list
138354986|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138354987|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138354988|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354989|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354990|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
138354991|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138354992|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138354993|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138354994|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
138354995|NCT00002130|Vesnarinone|vesnarinone|mesh-list
138354996|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138354997|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
138354998|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354999|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355000|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
138355001|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355002|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138355003|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138355004|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355005|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355006|NCT00002130|Protective Agents|protective agents|mesh-ancestor
138355008|NCT00002142|Probenecid|probenecid|mesh-list
138355009|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
138355010|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
138355011|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355012|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
138355013|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355014|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355015|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355016|NCT00002148|OPC 14117|opc 14117|mesh-list
138355017|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138355018|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
138355019|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355020|NCT00002148|Protective Agents|protective agents|mesh-ancestor
138355021|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355022|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
138355023|NCT00002154|Selegiline|selegiline|mesh-list
138355024|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
138355025|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138355026|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138355027|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138355028|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138355029|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355030|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355031|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138355032|NCT00002154|Protective Agents|protective agents|mesh-ancestor
138355033|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355034|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
138355036|NCT00002154|Vitamins|vitamins|mesh-ancestor
138355037|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
138355038|NCT00002160|Ziconotide|ziconotide|mesh-list
138355039|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138355040|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138355041|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355042|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138355043|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355044|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138355045|NCT00002160|Protective Agents|protective agents|mesh-ancestor
138355046|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138355047|NCT00002160|Analgesics|analgesics|mesh-ancestor
138355049|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138355050|NCT00002166|Nevirapine|nevirapine|mesh-list
138355051|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355052|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355053|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355054|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355055|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
138355076|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355077|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355079|NCT00002184|Zidovudine|zidovudine|mesh-list
138355080|NCT00002184|Stavudine|stavudine|mesh-list
138355081|NCT00002184|Adefovir|adefovir|mesh-list
138355082|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138355083|NCT00002184|Nelfinavir|nelfinavir|mesh-list
138355086|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355087|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355088|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355089|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
138355090|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355091|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355092|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355093|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
138355094|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355095|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355096|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355097|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355098|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355101|NCT00002190|Saquinavir|saquinavir|mesh-list
138355102|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355103|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355104|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355105|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355106|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
138355110|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
138355111|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355112|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355113|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355114|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355115|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355118|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355119|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355120|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355121|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355122|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355124|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355127|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138355128|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
138355129|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138355130|NCT00002208|Lamivudine|lamivudine|mesh-list
138355131|NCT00002208|Zidovudine|zidovudine|mesh-list
138355132|NCT00002208|Stavudine|stavudine|mesh-list
138355133|NCT00002208|Indinavir|indinavir|mesh-list
138355135|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355136|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355137|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355138|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
138355139|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355140|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355141|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355142|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
138355143|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355144|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355145|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355146|NCT00002214|Capravirine|capravirine|mesh-list
138355147|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355148|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355149|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355150|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355151|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
138355152|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355153|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355154|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355156|NCT00002220|Adefovir|adefovir|mesh-list
138355157|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138355158|NCT00002220|Indinavir|indinavir|mesh-list
138355509|NCT00002442|Stavudine|stavudine|mesh-list
138355159|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355160|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355161|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355162|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355163|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
138355164|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355165|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138355166|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355167|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138355169|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138355170|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138355171|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355172|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355173|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355174|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355175|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355177|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138355178|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138355179|NCT00002226|Growth Substances|growth substances|mesh-ancestor
138355181|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
138355182|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355183|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138355184|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355185|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355186|NCT00002238|Interferons|interferons|mesh-list
138355187|NCT00002238|Zidovudine|zidovudine|mesh-list
138355188|NCT00002238|Interferon-beta|interferon-beta|mesh-list
138355189|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
138355190|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355191|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
138355192|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355193|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
138355194|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355195|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355196|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355197|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355198|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355199|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355200|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
138355201|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355202|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138355203|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138355204|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
138355205|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355206|NCT00002256|Zalcitabine|zalcitabine|mesh-list
138355207|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
138355208|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355209|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355210|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355211|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355212|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
138355213|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355214|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355215|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355216|NCT00002274|Didanosine|didanosine|mesh-list
138355217|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
138355219|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355220|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355221|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355222|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
138355223|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355224|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355225|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355226|NCT00002280|Didanosine|didanosine|mesh-list
138355227|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
138355228|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355229|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355230|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355231|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355234|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355235|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355237|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
138355238|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355239|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355240|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355241|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355242|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
138355243|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355244|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355245|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355246|NCT00002292|Pentamidine|pentamidine|mesh-list
138355247|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
138355248|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355249|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138355250|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138355251|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138355252|NCT00002298|Ribavirin|ribavirin|mesh-list
138355253|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
138355254|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355255|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
138355256|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355257|NCT00002304|Fluconazole|fluconazole|mesh-list
138355260|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355261|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138355262|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355264|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355265|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138355267|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355268|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355269|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138355270|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138355271|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355272|NCT00002316|Amphotericin B|amphotericin b|mesh-list
138355273|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138355274|NCT00002316|Amebicides|amebicides|mesh-ancestor
138355275|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138355276|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138355278|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138355279|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
138355281|NCT00002322|Atevirdine|atevirdine|mesh-list
138355282|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
138355283|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355284|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355285|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355286|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355290|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355291|NCT00002328|Azithromycin|azithromycin|mesh-list
138355292|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138355293|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355294|NCT00002334|Zidovudine|zidovudine|mesh-list
138355295|NCT00002334|Zalcitabine|zalcitabine|mesh-list
138355296|NCT00002334|Saquinavir|saquinavir|mesh-list
138355297|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
138355298|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355299|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355300|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355301|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355302|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
138355305|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355306|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355307|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355308|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355309|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355310|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355312|NCT00002340|Pentamidine|pentamidine|mesh-list
138355314|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
138355315|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138355316|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138355317|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355318|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355319|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
138355320|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138355321|NCT00002346|Adefovir|adefovir|mesh-list
138355322|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138355323|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
138355324|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355325|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355326|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355327|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355328|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355330|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355331|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355332|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355333|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355335|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355336|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355337|NCT00002358|Sorivudine|sorivudine|mesh-list
138355338|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
138355340|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355341|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355343|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355344|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355345|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355346|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355347|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
138355348|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355351|NCT00002370|Itraconazole|itraconazole|mesh-list
138355352|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
138355353|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355354|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138355355|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138355356|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355357|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355358|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138355359|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
138355360|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355361|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355362|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138355367|NCT00002376|Indinavir|indinavir|mesh-list
138355368|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355369|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355370|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355371|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355372|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
138355373|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355374|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355375|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355376|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
138355377|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355378|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355379|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355380|NCT00002382|Saquinavir|saquinavir|mesh-list
138355381|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355382|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355383|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355384|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355385|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355386|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355387|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355388|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
138355389|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355392|NCT00002388|Abacavir|abacavir|mesh-list
138355393|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355394|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355395|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355396|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355397|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
138355398|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355399|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355400|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355401|NCT00002394|Terbinafine|terbinafine|mesh-list
138355402|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
138355413|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355415|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355416|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355417|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355418|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
138355419|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355420|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355421|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355422|NCT00002406|Indinavir|indinavir|mesh-list
138355423|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355424|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355425|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355426|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355427|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355428|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355429|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355430|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
138355431|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355432|NCT00002412|Didanosine|didanosine|mesh-list
138355433|NCT00002412|Stavudine|stavudine|mesh-list
138355434|NCT00002412|Emivirine|emivirine|mesh-list
138355435|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
138355436|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355437|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
138355438|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355439|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355440|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355441|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
138355442|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355443|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
138355444|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355445|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355446|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355447|NCT00002418|Nevirapine|nevirapine|mesh-list
138355450|NCT00002418|Emivirine|emivirine|mesh-list
138355452|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355453|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355454|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355455|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355456|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
138355457|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355458|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355459|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355460|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138355461|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138355462|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355464|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
138355466|NCT00002424|Stavudine|stavudine|mesh-list
138355467|NCT00002424|Indinavir|indinavir|mesh-list
138355468|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355469|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355470|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355471|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355472|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
138355473|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355474|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355475|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355476|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
138355477|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355478|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355479|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355480|NCT00002430|Lamivudine|lamivudine|mesh-list
138355481|NCT00002430|Stavudine|stavudine|mesh-list
138355482|NCT00002430|Nelfinavir|nelfinavir|mesh-list
138355483|NCT00002430|Indinavir|indinavir|mesh-list
138355484|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355485|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355487|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355488|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
138355489|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355490|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355491|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355492|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138355493|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138355494|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
138355495|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
138355496|NCT00002436|Lamivudine|lamivudine|mesh-list
138355497|NCT00002436|Zidovudine|zidovudine|mesh-list
138355499|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138355500|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355501|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355502|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355503|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
138355504|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355505|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138355506|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138355507|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
138355508|NCT00002442|Lamivudine|lamivudine|mesh-list
138355582|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355583|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355584|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355585|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355586|NCT00002478|Etoposide|etoposide|mesh-list
138355587|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355588|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355589|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355590|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355591|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355592|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355594|NCT00002490|Mitomycin|mitomycin|mesh-list
138355595|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
138355596|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355597|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355598|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
138355599|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355600|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355601|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355602|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138355603|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
138355604|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355605|NCT00002496|Cobalt|cobalt|mesh-list
138355606|NCT00002496|Fluorouracil|fluorouracil|mesh-list
138355608|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
138355609|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355610|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355611|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355612|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
138355613|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355614|NCT00002496|Trace Elements|trace elements|mesh-ancestor
138355615|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
138355617|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
138355618|NCT00002502|Busulfan|busulfan|mesh-list
138355619|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355620|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
138355621|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355622|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355623|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355624|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
138355625|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355626|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355627|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355628|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355629|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
138355630|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
138355631|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355633|NCT00002508|Etoposide|etoposide|mesh-list
138355634|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355635|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355636|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355637|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355638|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355639|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355640|NCT00002526|Doxorubicin|doxorubicin|mesh-list
138355641|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138355643|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355644|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355645|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355646|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355647|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355648|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355649|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355650|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
138355652|NCT00002532|Cytarabine|cytarabine|mesh-list
138355653|NCT00002532|Dexamethasone|dexamethasone|mesh-list
138355654|NCT00002532|Prednisolone|prednisolone|mesh-list
138355655|NCT00002532|Methotrexate|methotrexate|mesh-list
138355656|NCT00002532|Etoposide|etoposide|mesh-list
138355657|NCT00002532|Daunorubicin|daunorubicin|mesh-list
138355658|NCT00002532|Asparaginase|asparaginase|mesh-list
138355659|NCT00002532|Ifosfamide|ifosfamide|mesh-list
138355660|NCT00002532|Idarubicin|idarubicin|mesh-list
138355661|NCT00002532|Vindesine|vindesine|mesh-list
138355662|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
138355663|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138355664|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
138355676|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138355677|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355678|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
138355679|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355680|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
138355681|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355682|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138355683|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355684|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
138355685|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355686|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355687|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355688|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355689|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355690|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
138355691|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355692|NCT00002532|Antidotes|antidotes|mesh-ancestor
138355693|NCT00002532|Protective Agents|protective agents|mesh-ancestor
138355694|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
138355695|NCT00002532|Vitamins|vitamins|mesh-ancestor
138355696|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
138355697|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355698|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355699|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
138355700|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355701|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355702|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355703|NCT00002544|Docetaxel|docetaxel|mesh-list
138355704|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
138355705|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355706|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355708|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355709|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355710|NCT00002544|Analgesics|analgesics|mesh-ancestor
138355711|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
138355712|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138355713|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355714|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355715|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355716|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355717|NCT00002550|Etoposide|etoposide|mesh-list
138355718|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355719|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355721|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355722|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355723|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355724|NCT00002556|Interferons|interferons|mesh-list
138355725|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
138355726|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
138355727|NCT00002556|Prednisone|prednisone|mesh-list
138355728|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
138355729|NCT00002556|Melphalan|melphalan|mesh-list
138355730|NCT00002556|Carmustine|carmustine|mesh-list
138355731|NCT00002556|Vincristine|vincristine|mesh-list
138355732|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355733|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
138355734|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355735|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355736|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355737|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
138355738|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355741|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138355743|NCT00002556|Hormones|hormones|mesh-ancestor
138355744|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355745|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138355746|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
138355747|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355748|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355749|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355751|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355752|NCT00002562|Paclitaxel|paclitaxel|mesh-list
138355753|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355754|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355755|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355756|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355757|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355758|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355760|NCT00002568|Cisplatin|cisplatin|mesh-list
138355761|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355762|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355763|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355764|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355765|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355766|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355767|NCT00002574|Interferons|interferons|mesh-list
138355768|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
138355769|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
138355772|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355773|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
138355774|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355775|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355776|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138355777|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355778|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355780|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
138355782|NCT00002580|Methotrexate|methotrexate|mesh-list
138355783|NCT00002580|Leuprolide|leuprolide|mesh-list
138355784|NCT00002580|Goserelin|goserelin|mesh-list
138355785|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355786|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
138355787|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355788|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355789|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355790|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
138355791|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355792|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355793|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355794|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
138355796|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138355797|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
138355798|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138355799|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138355800|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355801|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138355802|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138355803|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138355804|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
138355805|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355806|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138355807|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138355808|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138355809|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138355810|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138355811|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
138355812|NCT00002586|Vitamin E|vitamin e|mesh-list
138355813|NCT00002586|Tocopherols|tocopherols|mesh-list
138355814|NCT00002586|Tocotrienols|tocotrienols|mesh-list
138355815|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
138355816|NCT00002586|Tretinoin|tretinoin|mesh-list
138355817|NCT00002586|Isotretinoin|isotretinoin|mesh-list
138355818|NCT00002586|Vitamins|vitamins|mesh-ancestor
138355819|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
138355820|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355821|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
138355822|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355823|NCT00002586|Protective Agents|protective agents|mesh-ancestor
138355824|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355825|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
138355826|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
138355827|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
138355828|NCT00002592|Busulfan|busulfan|mesh-list
138355829|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355830|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
138355832|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355833|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355834|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
138355835|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355836|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355837|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355838|NCT00002598|Interferons|interferons|mesh-list
138355839|NCT00002598|Cytarabine|cytarabine|mesh-list
138355840|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
138355915|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355916|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355927|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
138355929|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138355930|NCT00002634|Etoposide|etoposide|mesh-list
138355931|NCT00002634|Vincristine|vincristine|mesh-list
138355932|NCT00002634|Antibodies|antibodies|mesh-list
138355933|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138355934|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138355935|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
138355936|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355937|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355938|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355939|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
138355940|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355941|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355942|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355943|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138355944|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355945|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355946|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355947|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355948|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138355949|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138355950|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355951|NCT00002634|Trace Elements|trace elements|mesh-ancestor
138355952|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
138355953|NCT00002646|Tamoxifen|tamoxifen|mesh-list
138355954|NCT00002646|Fenretinide|fenretinide|mesh-list
138355955|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138355956|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138355957|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355958|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355959|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138355960|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355961|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138355962|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138355963|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138355964|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138355965|NCT00002646|Protective Agents|protective agents|mesh-ancestor
138355967|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
138355968|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
138355970|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138355971|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355972|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138355974|NCT00002658|Cytarabine|cytarabine|mesh-list
138355975|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
138355976|NCT00002658|Etoposide|etoposide|mesh-list
138355977|NCT00002658|Daunorubicin|daunorubicin|mesh-list
138355978|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
138355979|NCT00002658|Idarubicin|idarubicin|mesh-list
138355980|NCT00002658|Tretinoin|tretinoin|mesh-list
138355981|NCT00002658|Thioguanine|thioguanine|mesh-list
138355982|NCT00002658|Amsacrine|amsacrine|mesh-list
138355985|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138355986|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138355987|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138355988|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
138355989|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355990|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138355991|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138355992|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138355993|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138355994|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138355995|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138355996|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138355997|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
138355998|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
138355999|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356000|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356001|NCT00002658|Analgesics|analgesics|mesh-ancestor
138356002|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
138356003|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356004|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
138356005|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356006|NCT00002664|Sargramostim|sargramostim|mesh-list
138356007|NCT00002664|Edrecolomab|edrecolomab|mesh-list
138356008|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
138356009|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356010|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138356012|NCT00002670|Trace Elements|trace elements|mesh-ancestor
138356013|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
138356014|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356017|NCT00002676|Dexamethasone|dexamethasone|mesh-list
138356018|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
138356019|NCT00002676|Carmustine|carmustine|mesh-list
138356020|NCT00002676|Doxorubicin|doxorubicin|mesh-list
138356021|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138356022|NCT00002676|Methotrexate|methotrexate|mesh-list
138356023|NCT00002676|Vincristine|vincristine|mesh-list
138356024|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356025|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
138356026|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356027|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356028|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356029|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
138356030|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356031|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356032|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356033|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356035|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
138356036|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356037|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356038|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
138356039|NCT00002676|Hormones|hormones|mesh-ancestor
138356040|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356041|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356042|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356043|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356044|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356045|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356046|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356047|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356048|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356049|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356050|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
138356051|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356052|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356053|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356054|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
138356055|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356056|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356057|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356058|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356059|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356060|NCT00002676|Trace Elements|trace elements|mesh-ancestor
138356061|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
138356062|NCT00002682|Amoxicillin|amoxicillin|mesh-list
138356063|NCT00002682|Metronidazole|metronidazole|mesh-list
138356064|NCT00002682|Clarithromycin|clarithromycin|mesh-list
138356065|NCT00002682|Tetracycline|tetracycline|mesh-list
138356066|NCT00002682|Omeprazole|omeprazole|mesh-list
138356067|NCT00002682|Bismuth|bismuth|mesh-list
138356068|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138356077|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356078|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138356079|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138356080|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138356082|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
138356083|NCT00002688|Cyclosporine|cyclosporine|mesh-list
138356084|NCT00002688|Etoposide|etoposide|mesh-list
138356085|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
138356086|NCT00002688|Cyclosporins|cyclosporins|mesh-list
138356087|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356088|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356089|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356090|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356091|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356095|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356096|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
138356097|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356098|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356099|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356100|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138356101|NCT00002688|Analgesics|analgesics|mesh-ancestor
138356193|NCT00002718|Protective Agents|protective agents|mesh-ancestor
138356102|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
138356104|NCT00002700|Leucovorin|leucovorin|mesh-list
138356105|NCT00002700|Cytarabine|cytarabine|mesh-list
138356106|NCT00002700|Dexamethasone|dexamethasone|mesh-list
138356107|NCT00002700|Prednisone|prednisone|mesh-list
138356108|NCT00002700|Prednisolone|prednisolone|mesh-list
138356109|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
138356110|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138356111|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138356112|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138356113|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
138356114|NCT00002700|Doxorubicin|doxorubicin|mesh-list
138356115|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138356118|NCT00002700|Daunorubicin|daunorubicin|mesh-list
138356119|NCT00002700|Asparaginase|asparaginase|mesh-list
138356120|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
138356121|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
138356122|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
138356123|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356124|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
138356125|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356126|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356127|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356128|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
138356129|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356130|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356131|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356132|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356133|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
138356134|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
138356135|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356136|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356137|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
138356139|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356140|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356141|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356142|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356144|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356145|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356146|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356147|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356148|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356150|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356153|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
138356154|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356156|NCT00002700|Protective Agents|protective agents|mesh-ancestor
138356157|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
138356159|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
138356160|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356161|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356162|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356163|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356164|NCT00002700|Analgesics|analgesics|mesh-ancestor
138356165|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
138356168|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
138356169|NCT00002718|Thiotepa|thiotepa|mesh-list
138356170|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138356171|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356172|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
138356173|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356174|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356175|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356176|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
138356177|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356178|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356179|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356180|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356181|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
138356182|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
138356183|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356184|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356185|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
138356186|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
138356187|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356189|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
138356191|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356192|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138356362|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356365|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356366|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356367|NCT00002628|Paclitaxel|paclitaxel|mesh-list
138356368|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
138356369|NCT00002628|Carboplatin|carboplatin|mesh-list
138356370|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356371|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356372|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356373|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356376|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356377|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
138356378|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356379|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356381|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
138356382|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356383|NCT05749614|Lidocaine|lidocaine|mesh-list
138356384|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
138356385|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
138356386|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356387|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356388|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
138356389|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356390|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138356391|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138356392|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138356393|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138356394|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356395|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138356396|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
138356397|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356398|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138356399|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138356400|NCT05677698|Peppermint oil|peppermint oil|mesh-list
138356401|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
138356404|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356405|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356406|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
138356407|NCT05516628|Bevacizumab|bevacizumab|mesh-list
138356408|NCT05516628|Atezolizumab|atezolizumab|mesh-list
138356409|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138356410|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356411|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138356412|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138356413|NCT05516628|Growth Substances|growth substances|mesh-ancestor
138356414|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356415|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
138356416|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138356417|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356418|NCT05497674|Rifampin|rifampin|mesh-list
138356419|NCT05497674|Probenecid|probenecid|mesh-list
138356420|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138356424|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
138356425|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356426|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356427|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356428|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138356431|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138356432|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138356433|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138356435|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
138356436|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356437|NCT05360628|Allopurinol|allopurinol|mesh-list
138356438|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
138356439|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356440|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356441|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
138356442|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356443|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138356444|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
138356445|NCT05360628|Protective Agents|protective agents|mesh-ancestor
138356446|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356448|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356449|NCT05218668|Fasudil|fasudil|mesh-list
138356811|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356450|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138356451|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138356452|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356456|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138356457|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356459|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
138356460|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356461|NCT04836780|Dexamethasone|dexamethasone|mesh-list
138356462|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356463|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
138356464|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
138356465|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356466|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356467|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138356468|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
138356469|NCT04836780|Hormones|hormones|mesh-ancestor
138356470|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356471|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356472|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356473|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
138356474|NCT04740294|Analgesics|analgesics|mesh-ancestor
138356475|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
138356476|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356479|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356480|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138356481|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
138356482|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138356483|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138356484|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356485|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138356486|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
138356487|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356490|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356492|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356493|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
138356494|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356495|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356504|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138356505|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138356506|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
138356507|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356509|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356510|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
138356511|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138356512|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356513|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138356514|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356515|NCT04360824|Enoxaparin|enoxaparin|mesh-list
138356516|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
138356517|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138356518|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138356519|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356520|NCT04331652|Anesthetics|anesthetics|mesh-list
138356521|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356522|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356524|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
138356525|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
138356526|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356527|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356528|NCT03846570|Beclomethasone|beclomethasone|mesh-list
138356532|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356533|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356534|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138356535|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
138356536|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138356537|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138356538|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138356539|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
138356540|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138356541|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356542|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356543|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
138356812|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356559|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356560|NCT03745170|Capecitabine|capecitabine|mesh-list
138356561|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
138356562|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356563|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
138356564|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356565|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356567|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356568|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356569|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356570|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356571|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356572|NCT03701490|Progesterone|progesterone|mesh-list
138356573|NCT03701490|Progestins|progestins|mesh-ancestor
138356574|NCT03701490|Hormones|hormones|mesh-ancestor
138356575|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356576|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356577|NCT03691974|Fasinumab|fasinumab|mesh-list
138356578|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138356579|NCT03691974|Analgesics|analgesics|mesh-ancestor
138356580|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
138356581|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356582|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356583|NCT03652428|Paclitaxel|paclitaxel|mesh-list
138356584|NCT03652428|Gemcitabine|gemcitabine|mesh-list
138356585|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356586|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356587|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356588|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356589|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356590|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356591|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356593|NCT03580044|Aztreonam|aztreonam|mesh-list
138356594|NCT03580044|Avibactam|avibactam|mesh-list
138356595|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138356596|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356607|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
138356608|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356609|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356610|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
138356611|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356612|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356613|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
138356614|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356626|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138356627|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356628|NCT01394016|Fulvestrant|fulvestrant|mesh-list
138356629|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138356630|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356631|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138356632|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138356633|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
138356634|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356635|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356636|NCT00978822|Clevidipine|clevidipine|mesh-list
138356637|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138356638|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138356639|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356655|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
138356657|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138356658|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356659|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138356660|NCT00577200|Narcotics|narcotics|mesh-ancestor
138356661|NCT00577200|Analgesics|analgesics|mesh-ancestor
138356662|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
138356665|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
138356667|NCT00002796|Fluorouracil|fluorouracil|mesh-list
138356668|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138356669|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
138356670|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356671|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356672|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356673|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356674|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
138356675|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356676|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
138356695|NCT00002802|Carboplatin|carboplatin|mesh-list
138356696|NCT00002802|Doxorubicin|doxorubicin|mesh-list
138356697|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138356698|NCT00002802|Etoposide|etoposide|mesh-list
138356699|NCT00002802|Vincristine|vincristine|mesh-list
138356700|NCT00002802|Vindesine|vindesine|mesh-list
138356701|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356702|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
138356703|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356704|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356705|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356707|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356708|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356709|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356710|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356711|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356712|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356713|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356714|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356715|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356716|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356717|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356718|NCT00002802|Trace Elements|trace elements|mesh-ancestor
138356719|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
138356720|NCT00002814|Paclitaxel|paclitaxel|mesh-list
138356721|NCT00002814|Topotecan|topotecan|mesh-list
138356722|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356723|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356724|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356725|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356726|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356727|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356728|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138356729|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356730|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356734|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
138356735|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356736|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356737|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356738|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356739|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
138356740|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356741|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356742|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356743|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138356744|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356745|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
138356746|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356747|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
138356748|NCT00002838|Fludarabine|fludarabine|mesh-list
138356749|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
138356750|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356751|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
138356752|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356753|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356754|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356755|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
138356756|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356757|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356758|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356766|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356783|NCT00002892|Interferons|interferons|mesh-list
138356784|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
138356785|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356786|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
138356787|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356803|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356804|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356805|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356806|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138356807|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356808|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356809|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356810|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356813|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356821|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356822|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356835|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356836|NCT00002946|Penclomedine|penclomedine|mesh-list
138356837|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356838|NCT00002952|Interleukin-12|interleukin-12|mesh-list
138356839|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138356840|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
138356841|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356842|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138356850|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356851|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138356852|NCT00002970|Cytarabine|cytarabine|mesh-list
138356853|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
138356854|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138356855|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138356856|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138356857|NCT00002970|Methotrexate|methotrexate|mesh-list
138356858|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356860|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356861|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356863|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
138356864|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356865|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356866|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356867|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356868|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356869|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356870|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
138356871|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356872|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356873|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
138356874|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356875|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138356876|NCT00002976|Estrogens|estrogens|mesh-list
138356877|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138356879|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138356880|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356881|NCT00002982|Cytarabine|cytarabine|mesh-list
138356882|NCT00002982|Carboplatin|carboplatin|mesh-list
138356883|NCT00002982|Etoposide|etoposide|mesh-list
138356884|NCT00002982|Melphalan|melphalan|mesh-list
138356885|NCT00002982|Ifosfamide|ifosfamide|mesh-list
138356886|NCT00002982|Carmustine|carmustine|mesh-list
138356887|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356895|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
138356896|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138356897|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356898|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
138356899|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356900|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356923|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356924|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356926|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
138356927|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138356928|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138356929|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138356930|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
138356931|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
138356932|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
138356933|NCT00003012|Fluorouracil|fluorouracil|mesh-list
138356934|NCT00003012|Methotrexate|methotrexate|mesh-list
138356936|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356937|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
138356938|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356939|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356940|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356941|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
138356942|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356943|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356944|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356945|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
138356946|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138356947|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138356949|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138356950|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138356951|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138356952|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138356953|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138356954|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138356955|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138356956|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138356963|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356964|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
138356965|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356966|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
138356967|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356968|NCT00003060|Cyclosporine|cyclosporine|mesh-list
138356969|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
138356970|NCT00003060|Busulfan|busulfan|mesh-list
138356972|NCT00003060|Cyclosporins|cyclosporins|mesh-list
138356973|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138356974|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
138356975|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356976|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138356977|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138356978|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
138356979|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356980|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356981|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138356993|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138356998|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356999|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357000|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357001|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357002|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
138357003|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357004|NCT00003072|Paclitaxel|paclitaxel|mesh-list
138357005|NCT00003072|Carboplatin|carboplatin|mesh-list
138357007|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357008|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357009|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357010|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357011|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357012|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357013|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138357015|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357016|NCT00003078|Fluorouracil|fluorouracil|mesh-list
138357017|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357018|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
138357019|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357020|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357021|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357022|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
138357023|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357024|NCT00003084|Ketoconazole|ketoconazole|mesh-list
138357025|NCT00003084|Paclitaxel|paclitaxel|mesh-list
138357026|NCT00003084|Etoposide|etoposide|mesh-list
138357027|NCT00003084|Vinblastine|vinblastine|mesh-list
138357028|NCT00003084|Doxorubicin|doxorubicin|mesh-list
138357029|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138357030|NCT00003084|Estramustine|estramustine|mesh-list
138357031|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357032|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357033|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357034|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357035|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357036|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357037|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357044|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138357045|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138357046|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
138357047|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138357048|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357049|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138357050|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357061|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357062|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
138357063|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357064|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
138357066|NCT00003114|Etoposide|etoposide|mesh-list
138357067|NCT00003114|Procarbazine|procarbazine|mesh-list
138357068|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357069|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
138357070|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357071|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357072|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357073|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
138357074|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357075|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357076|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357077|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357078|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357079|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357080|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357081|NCT00003120|Paclitaxel|paclitaxel|mesh-list
138357083|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357084|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357085|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357086|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357087|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357089|NCT00003126|Interleukin-2|interleukin-2|mesh-list
138357090|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357091|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138357092|NCT00003126|Analgesics|analgesics|mesh-ancestor
138357093|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
138357094|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357108|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357110|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357111|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138357112|NCT00003144|Protective Agents|protective agents|mesh-ancestor
138357113|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357114|NCT00003150|Prednisone|prednisone|mesh-list
138357115|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
138357116|NCT00003150|Rituximab|rituximab|mesh-list
138357117|NCT00003150|Doxorubicin|doxorubicin|mesh-list
138357118|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138357125|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
138357126|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357127|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357128|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357129|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138357133|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357134|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138357135|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
138357136|NCT00003150|Hormones|hormones|mesh-ancestor
138357137|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138357138|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357139|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357140|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357141|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357142|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357143|NCT00003156|Topotecan|topotecan|mesh-list
138357144|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357145|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357146|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357147|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357148|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357149|NCT00003174|Cladribine|cladribine|mesh-list
138357150|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
138357151|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357152|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357153|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
138357154|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357155|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357156|NCT00003018|Leucovorin|leucovorin|mesh-list
138357157|NCT00003018|Fluorouracil|fluorouracil|mesh-list
138357158|NCT00003018|Mitomycins|mitomycins|mesh-list
138357159|NCT00003018|Mitomycin|mitomycin|mesh-list
138357160|NCT00003018|Dipyridamole|dipyridamole|mesh-list
138357161|NCT00003018|Calcium|calcium|mesh-list
138357162|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
138357163|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138357164|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357165|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
138357166|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357167|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357168|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357169|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357170|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
138357171|NCT00003018|Antidotes|antidotes|mesh-ancestor
138357172|NCT00003018|Protective Agents|protective agents|mesh-ancestor
138357173|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
138357174|NCT00003018|Vitamins|vitamins|mesh-ancestor
138357175|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
138357176|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357178|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138357179|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357180|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138357181|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138357182|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
138357184|NCT00003198|Ifosfamide|ifosfamide|mesh-list
138357185|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357186|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357187|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357188|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357189|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357190|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357191|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
138357192|NCT00003204|Prednisone|prednisone|mesh-list
138357193|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
138357194|NCT00003204|Rituximab|rituximab|mesh-list
138357195|NCT00003204|Fludarabine|fludarabine|mesh-list
138357196|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
138357197|NCT00003204|Vincristine|vincristine|mesh-list
138357198|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357208|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138357212|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357213|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357214|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
138357215|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357216|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357217|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357218|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357220|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357221|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
138357222|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357223|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138357224|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138357225|NCT00003210|Growth Substances|growth substances|mesh-ancestor
138357226|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138357227|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357228|NCT00003216|Gemcitabine|gemcitabine|mesh-list
138357229|NCT00003216|Fluorouracil|fluorouracil|mesh-list
138357230|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357231|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
138357232|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357233|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357234|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357235|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
138357239|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357240|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357241|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357242|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357243|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357244|NCT00003240|Vinorelbine|vinorelbine|mesh-list
138357245|NCT00003240|Ifosfamide|ifosfamide|mesh-list
138357246|NCT00003240|Mitomycins|mitomycins|mesh-list
138357247|NCT00003240|Mitomycin|mitomycin|mesh-list
138357248|NCT00003240|Vinblastine|vinblastine|mesh-list
138357249|NCT00003240|Vindesine|vindesine|mesh-list
138357250|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357251|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357252|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357253|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357254|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357266|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357267|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357268|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
138357269|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357270|NCT00003276|Irinotecan|irinotecan|mesh-list
138357271|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357272|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357274|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357275|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357277|NCT00003288|Tirapazamine|tirapazamine|mesh-list
138357278|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357279|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
138357280|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357281|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357282|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357283|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
138357284|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357285|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357286|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357287|NCT00003294|Paclitaxel|paclitaxel|mesh-list
138357288|NCT00003294|Carboplatin|carboplatin|mesh-list
138357289|NCT00003294|Amifostine|amifostine|mesh-list
138357290|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357291|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357307|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357308|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
138357309|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
138357335|NCT00003342|Doxorubicin|doxorubicin|mesh-list
138357336|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138357337|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357338|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357339|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357340|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357341|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357342|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357343|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357344|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
138357345|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357346|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357347|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357348|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357349|NCT00003348|Carmustine|carmustine|mesh-list
138357351|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357352|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
138357353|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357354|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357355|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357356|NCT00003360|Antibodies|antibodies|mesh-list
138357357|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138357358|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
138357362|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357363|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357364|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357365|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357367|NCT00003378|Carboplatin|carboplatin|mesh-list
138357368|NCT00003378|Gemcitabine|gemcitabine|mesh-list
138357369|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357370|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357371|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357374|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357375|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357377|NCT00003390|Irofulven|irofulven|mesh-list
138357378|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357379|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
138357380|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357381|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357382|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
138357385|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357386|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
138357387|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357388|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357389|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357390|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
138357391|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357392|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357396|NCT00003402|Etoposide|etoposide|mesh-list
138357397|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
138357398|NCT00003402|Melphalan|melphalan|mesh-list
138357399|NCT00003402|Carmustine|carmustine|mesh-list
138357400|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357401|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357564|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138357565|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357566|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
138357567|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357568|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357569|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357570|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357572|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357574|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357575|NCT00003594|Antidotes|antidotes|mesh-ancestor
138357576|NCT00003594|Protective Agents|protective agents|mesh-ancestor
138357577|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
138357578|NCT00003594|Vitamins|vitamins|mesh-ancestor
138357579|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
138357580|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
138357581|NCT00003600|Hematinics|hematinics|mesh-ancestor
138357582|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
138357583|NCT00003606|Etoposide|etoposide|mesh-list
138357584|NCT00003606|Epirubicin|epirubicin|mesh-list
138357585|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357586|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
138357587|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357588|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357589|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357590|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
138357591|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357592|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357593|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357594|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357595|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357596|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357597|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357598|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357600|NCT00003612|Carboplatin|carboplatin|mesh-list
138357601|NCT00003612|Trastuzumab|trastuzumab|mesh-list
138357602|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357603|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357604|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357605|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357606|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357607|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357608|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138357609|NCT00003624|Paclitaxel|paclitaxel|mesh-list
138357610|NCT00003624|Amifostine|amifostine|mesh-list
138357611|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357612|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357613|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357614|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357615|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357616|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357617|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138357618|NCT00003624|Protective Agents|protective agents|mesh-ancestor
138357620|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
138357621|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357622|NCT00003636|Carboplatin|carboplatin|mesh-list
138357623|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357624|NCT00003642|Fluorouracil|fluorouracil|mesh-list
138357625|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357626|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
138357628|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357629|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357630|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
138357631|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357632|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138357633|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138357634|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357636|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357637|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
138357638|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357639|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357640|NCT00003678|Tamoxifen|tamoxifen|mesh-list
138357641|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138357642|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
138357643|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358225|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
138357644|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357645|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357646|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357647|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138357648|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138357649|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138357650|NCT00003684|Theophylline|theophylline|mesh-list
138357651|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138357652|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
138357653|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357654|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357655|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138357656|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
138357657|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138357658|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357659|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357660|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
138357661|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138357662|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138357663|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
138357664|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138357665|NCT00003690|Carboplatin|carboplatin|mesh-list
138357666|NCT00003690|Alvocidib|alvocidib|mesh-list
138357667|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357668|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
138357669|NCT00003690|Growth Substances|growth substances|mesh-ancestor
138357670|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357672|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357673|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357674|NCT00003696|Paclitaxel|paclitaxel|mesh-list
138357675|NCT00003696|Etoposide|etoposide|mesh-list
138357676|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
138357677|NCT00003696|Carboplatin|carboplatin|mesh-list
138357678|NCT00003696|Doxorubicin|doxorubicin|mesh-list
138357679|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138357680|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357681|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357682|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357683|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357684|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357685|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357686|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357688|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357689|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357690|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357691|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
138357692|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357693|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357694|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357695|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357696|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357698|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357699|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
138357700|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357701|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357703|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357704|NCT00003720|Semaxinib|semaxinib|mesh-list
138357705|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138357706|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138357708|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357709|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
138357710|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357711|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138357712|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357713|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357714|NCT00003732|Paclitaxel|paclitaxel|mesh-list
138357715|NCT00003732|Carboplatin|carboplatin|mesh-list
138357716|NCT00003732|Topotecan|topotecan|mesh-list
138357717|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357718|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357719|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357720|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357721|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357722|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357723|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357724|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357725|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357726|NCT00003744|Gemcitabine|gemcitabine|mesh-list
138357727|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357728|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
138357729|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357730|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357731|NCT00003762|Gemcitabine|gemcitabine|mesh-list
138357733|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357734|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
138357735|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357736|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357737|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357738|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357739|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357740|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
138357741|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357742|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357743|NCT00003780|Gemcitabine|gemcitabine|mesh-list
138357744|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357745|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
138357746|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357747|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357748|NCT00003786|Irofulven|irofulven|mesh-list
138357749|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357750|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
138357758|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357759|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138357760|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357761|NCT00003804|Dactinomycin|dactinomycin|mesh-list
138357762|NCT00003804|Vincristine|vincristine|mesh-list
138357763|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357764|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357765|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357766|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357767|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357768|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357769|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138357770|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357771|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357772|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138357773|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357774|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138357775|NCT00003828|Vinorelbine|vinorelbine|mesh-list
138357776|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357777|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357778|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357779|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357781|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357783|NCT00003834|Fluorouracil|fluorouracil|mesh-list
138357784|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
138357785|NCT00003834|Calcium|calcium|mesh-list
138357786|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
138357787|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138357788|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357789|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
138357790|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357791|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357793|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357794|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
138357795|NCT00003834|Antidotes|antidotes|mesh-ancestor
138357796|NCT00003834|Protective Agents|protective agents|mesh-ancestor
138357797|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
138357798|NCT00003834|Vitamins|vitamins|mesh-ancestor
138357799|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
138357800|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
138357801|NCT00003846|Thiotepa|thiotepa|mesh-list
138357802|NCT00003846|Carboplatin|carboplatin|mesh-list
138357803|NCT00003846|Vincristine|vincristine|mesh-list
138357804|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357805|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
138357806|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357807|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357808|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357809|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
138357810|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357811|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357812|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357813|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357814|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357815|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357816|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357817|NCT00003852|Paclitaxel|paclitaxel|mesh-list
138357818|NCT00003852|Etoposide|etoposide|mesh-list
138357819|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
138357820|NCT00003852|Carboplatin|carboplatin|mesh-list
138357821|NCT00003852|Epirubicin|epirubicin|mesh-list
138357822|NCT00003852|Ifosfamide|ifosfamide|mesh-list
138357823|NCT00003852|Thiotepa|thiotepa|mesh-list
138357824|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357825|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357826|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357833|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357834|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357835|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
138357836|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357837|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357838|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357839|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357840|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357842|NCT00003858|Analgesics|analgesics|mesh-ancestor
138357843|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
138357844|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357845|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357846|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357847|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357848|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357849|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357850|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357851|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
138357852|NCT00003870|Methotrexate|methotrexate|mesh-list
138357854|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138357855|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357856|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
138357857|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357858|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357859|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357860|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
138357861|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357862|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357863|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357864|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138357865|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
138357866|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138357867|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357869|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357870|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357871|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138357872|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138357873|NCT00003876|Carmustine|carmustine|mesh-list
138357874|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357875|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
138357876|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357877|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357879|NCT00003888|Fluorouracil|fluorouracil|mesh-list
138357880|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357881|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357882|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357883|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357884|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357885|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
138357886|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138357887|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357889|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357890|NCT00003894|Thalidomide|thalidomide|mesh-list
138357891|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357892|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
138357893|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357894|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
138357895|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138357896|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357897|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138357898|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138357899|NCT00003894|Growth Substances|growth substances|mesh-ancestor
138357900|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138357901|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357903|NCT00003900|Irinotecan|irinotecan|mesh-list
138357904|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357905|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357906|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357907|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357909|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138357910|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357911|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357913|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138357914|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138357915|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
138357916|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138357917|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357918|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357919|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357920|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138357921|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138357922|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138357924|NCT00003912|Doxorubicin|doxorubicin|mesh-list
138357925|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138357926|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357927|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357928|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138357929|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357930|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357931|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357932|NCT00003924|Interferons|interferons|mesh-list
138357933|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
138357934|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357935|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
138357936|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357937|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
138357938|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357939|NCT00003930|Paclitaxel|paclitaxel|mesh-list
138357940|NCT00003930|Gemcitabine|gemcitabine|mesh-list
138357941|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138357942|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357943|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138357944|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138357945|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138357946|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357948|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
138357949|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
138357950|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138357951|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
138357952|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357953|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357954|NCT00003954|Cyclosporine|cyclosporine|mesh-list
138357955|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
138357956|NCT00003954|Melphalan|melphalan|mesh-list
138357957|NCT00003954|Cyclosporins|cyclosporins|mesh-list
138357958|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138357959|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357960|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357961|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
138357962|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357963|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
138357964|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138357965|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138357966|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357967|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138357968|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138357969|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357970|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138357971|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
138357972|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138357974|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
138357975|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357976|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
138357977|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138357978|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138357979|NCT00003960|Prednisolone|prednisolone|mesh-list
138357980|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
138357981|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
138357983|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138357984|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
138357985|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138357986|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
138357987|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357988|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138357989|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138357990|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
138357991|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357992|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138357993|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138357994|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138357995|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
138357996|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
138357997|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138357998|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138357999|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
138358000|NCT00003960|Hormones|hormones|mesh-ancestor
138358001|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358002|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138358003|NCT00003960|Protective Agents|protective agents|mesh-ancestor
138358004|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358005|NCT00003966|Defibrotide|defibrotide|mesh-list
138358006|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138358007|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138358008|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358009|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138358011|NCT00003972|Paclitaxel|paclitaxel|mesh-list
138358012|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
138358013|NCT00003972|Carboplatin|carboplatin|mesh-list
138358014|NCT00003972|Melphalan|melphalan|mesh-list
138358015|NCT00003972|Busulfan|busulfan|mesh-list
138358016|NCT00003972|Thiotepa|thiotepa|mesh-list
138358017|NCT00003972|Sargramostim|sargramostim|mesh-list
138358018|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358019|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358020|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358021|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358022|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358023|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358024|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358026|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358027|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358028|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358029|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
138358030|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358031|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138358032|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
138358033|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358034|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358035|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138358036|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138358037|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138358038|NCT00003984|Lintuzumab|lintuzumab|mesh-list
138358039|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138358040|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358042|NCT00003996|Carmustine|carmustine|mesh-list
138358043|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358044|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358045|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358046|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358047|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358048|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358049|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358050|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
138358051|NCT00004002|Bortezomib|bortezomib|mesh-list
138358052|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358053|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
138358054|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358055|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
138358056|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358057|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358058|NCT00004014|Doxorubicin|doxorubicin|mesh-list
138358059|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138358060|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358061|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358062|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358063|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358064|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358065|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358066|NCT00004032|Interferons|interferons|mesh-list
138358067|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
138358068|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358069|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
138358070|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358072|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358073|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358074|NCT00004050|Analgesics|analgesics|mesh-ancestor
138358075|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
138358076|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358077|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358079|NCT00004056|Thioguanine|thioguanine|mesh-list
138358080|NCT00004056|Melphalan|melphalan|mesh-list
138358081|NCT00004056|Daunorubicin|daunorubicin|mesh-list
138358082|NCT00004056|Asparaginase|asparaginase|mesh-list
138358083|NCT00004056|Lenograstim|lenograstim|mesh-list
138358084|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358085|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
138358086|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358087|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358089|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358090|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358091|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
138358092|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358093|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358094|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358095|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
138358096|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358097|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358098|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358099|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358100|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358101|NCT00004062|Azacitidine|azacitidine|mesh-list
138358102|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358103|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
138358104|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358105|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358106|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358108|NCT00004068|Temozolomide|temozolomide|mesh-list
138358109|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138358110|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358111|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358113|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358114|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358116|NCT00004074|Carboplatin|carboplatin|mesh-list
138358117|NCT00004074|Trastuzumab|trastuzumab|mesh-list
138358118|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138358119|NCT00004074|Interleukin-12|interleukin-12|mesh-list
138358120|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358121|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138358122|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358123|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
138358124|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358125|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138358127|NCT00004074|Growth Substances|growth substances|mesh-ancestor
138358128|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
138358129|NCT00004086|Cytarabine|cytarabine|mesh-list
138358130|NCT00004086|Etoposide|etoposide|mesh-list
138358131|NCT00004086|Ifosfamide|ifosfamide|mesh-list
138358132|NCT00004086|Epratuzumab|epratuzumab|mesh-list
138358133|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358135|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358136|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358137|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358138|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358139|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358140|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
138358141|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
138358142|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358143|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358144|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
138358145|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358146|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358147|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
138358148|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138358150|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
138358151|NCT00004104|Interleukin-2|interleukin-2|mesh-list
138358152|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358153|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
138358154|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358155|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
138358156|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358157|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358158|NCT00004104|Analgesics|analgesics|mesh-ancestor
138358159|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
138358160|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358163|NCT00004110|Antibodies|antibodies|mesh-list
138358164|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138358165|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
138358166|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358167|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358168|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358169|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358170|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358171|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358172|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358173|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
138358174|NCT00004122|Interferons|interferons|mesh-list
138358175|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
138358176|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
138358177|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358178|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
138358179|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358180|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
138358181|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358182|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358183|NCT00004128|Cytarabine|cytarabine|mesh-list
138358184|NCT00004128|Aldesleukin|aldesleukin|mesh-list
138358185|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
138358186|NCT00004128|Busulfan|busulfan|mesh-list
138358187|NCT00004128|Etoposide|etoposide|mesh-list
138358188|NCT00004128|Daunorubicin|daunorubicin|mesh-list
138358189|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358190|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
138358191|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358192|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358193|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358194|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
138358195|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358196|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358197|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358199|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358200|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358201|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358202|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358203|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
138358204|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
138358205|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358206|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358207|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138358208|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358209|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138358210|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138358211|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358212|NCT00004158|Melphalan|melphalan|mesh-list
138358213|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358214|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
138358215|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358216|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358217|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358218|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358220|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358222|NCT00004164|Docetaxel|docetaxel|mesh-list
138358223|NCT00004164|Fluorouracil|fluorouracil|mesh-list
138358224|NCT00004164|Calcium|calcium|mesh-list
138358226|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358227|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358228|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358229|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358230|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358231|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358232|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358233|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
138358234|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358235|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358236|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
138358237|NCT00004164|Antidotes|antidotes|mesh-ancestor
138358238|NCT00004164|Protective Agents|protective agents|mesh-ancestor
138358239|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
138358240|NCT00004164|Vitamins|vitamins|mesh-ancestor
138358242|NCT00004176|Etoposide|etoposide|mesh-list
138358243|NCT00004176|Amifostine|amifostine|mesh-list
138358244|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358245|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358246|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358247|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358248|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358249|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358250|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138358251|NCT00004176|Protective Agents|protective agents|mesh-ancestor
138358252|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358254|NCT00004188|Melphalan|melphalan|mesh-list
138358255|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
138358256|NCT00004188|Cisplatin|cisplatin|mesh-list
138358257|NCT00004188|Carboplatin|carboplatin|mesh-list
138358258|NCT00004188|Doxorubicin|doxorubicin|mesh-list
138358259|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138358260|NCT00004188|Etoposide|etoposide|mesh-list
138358261|NCT00004188|Vincristine|vincristine|mesh-list
138358262|NCT00004188|Topotecan|topotecan|mesh-list
138358263|NCT00004188|Isotretinoin|isotretinoin|mesh-list
138358264|NCT00004188|Lenograstim|lenograstim|mesh-list
138358265|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358266|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
138358267|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358268|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358269|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358270|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
138358271|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358272|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358274|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358275|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358276|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358277|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358278|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358279|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358280|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358281|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358282|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358283|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138358284|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138358286|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
138358287|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358288|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358289|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
138358290|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358291|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358292|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
138358293|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358294|NCT00004200|Temozolomide|temozolomide|mesh-list
138358295|NCT00004200|Prinomastat|prinomastat|mesh-list
138358296|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358297|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
138358298|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358299|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358300|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138358301|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
138358302|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358304|NCT00004206|Fluorouracil|fluorouracil|mesh-list
138358305|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
138358306|NCT00004206|Calcium|calcium|mesh-list
138358307|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
138358308|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358309|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358310|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
138358311|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358312|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358313|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358314|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358315|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
138358316|NCT00004206|Antidotes|antidotes|mesh-ancestor
138358317|NCT00004206|Protective Agents|protective agents|mesh-ancestor
138358319|NCT00004206|Vitamins|vitamins|mesh-ancestor
138358320|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
138358321|NCT00004212|Exatecan|exatecan|mesh-list
138358322|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138358323|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358324|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358325|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358326|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358327|NCT00004218|Prednisolone|prednisolone|mesh-list
138358328|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
138358329|NCT00004218|Chlorambucil|chlorambucil|mesh-list
138358330|NCT00004218|Doxorubicin|doxorubicin|mesh-list
138358331|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138358332|NCT00004218|Fludarabine|fludarabine|mesh-list
138358333|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
138358334|NCT00004218|Vincristine|vincristine|mesh-list
138358335|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358336|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
138358337|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358338|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358339|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358340|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
138358342|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358343|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358344|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358345|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358346|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358347|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358348|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358349|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
138358350|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358351|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358352|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358353|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358354|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358355|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
138358356|NCT00004218|Hormones|hormones|mesh-ancestor
138358357|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358358|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358359|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
138358360|NCT00004224|Etoposide|etoposide|mesh-list
138358361|NCT00004224|Vincristine|vincristine|mesh-list
138358362|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358363|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
138358364|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358365|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358366|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358367|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
138358368|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358369|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358370|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138358371|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358372|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358373|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358374|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358375|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358376|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358377|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358378|NCT00004236|Doxorubicin|doxorubicin|mesh-list
138358379|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138358380|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358381|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358382|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358383|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358385|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358386|NCT00004242|Gemcitabine|gemcitabine|mesh-list
138358404|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358405|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138358406|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358407|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
138358408|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358409|NCT00004254|Raltitrexed|raltitrexed|mesh-list
138358410|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358411|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
138358412|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358413|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358414|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138358415|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358417|NCT00004260|Interleukin-12|interleukin-12|mesh-list
138358418|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138358419|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358420|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
138358421|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358422|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358423|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358424|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138358425|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138358426|NCT00004260|Growth Substances|growth substances|mesh-ancestor
138358427|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
138358428|NCT00004266|Lisinopril|lisinopril|mesh-list
138358429|NCT00004266|Nifedipine|nifedipine|mesh-list
138358430|NCT00004266|Simvastatin|simvastatin|mesh-list
138358431|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138358433|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
138358434|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358435|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138358436|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138358438|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138358439|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358440|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358441|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358442|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
138358443|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
138358444|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138358445|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138358446|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
138358447|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138358448|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138358449|NCT00004266|Protective Agents|protective agents|mesh-ancestor
138358450|NCT00004278|Ganciclovir|ganciclovir|mesh-list
138358451|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138358452|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
138358453|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358454|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358455|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358456|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358457|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
138358458|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
138358459|NCT00004284|Diuretics|diuretics|mesh-ancestor
138358460|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
138358461|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358462|NCT00004284|Expectorants|expectorants|mesh-ancestor
138358463|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
138358464|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
138358465|NCT00004284|Protective Agents|protective agents|mesh-ancestor
138358466|NCT00004344|Leuprolide|leuprolide|mesh-list
138358467|NCT00004344|Testosterone|testosterone|mesh-list
138358468|NCT00004344|Androgens|androgens|mesh-ancestor
138358469|NCT00004344|Hormones|hormones|mesh-ancestor
138358470|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358471|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358472|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358473|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358474|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138358475|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
138358476|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138358477|NCT00004368|Colchicine|colchicine|mesh-list
138358478|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
138358479|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358480|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358481|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358482|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358483|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358484|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358487|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358488|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138358489|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358490|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138358491|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358492|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358493|NCT00004404|Clotrimazole|clotrimazole|mesh-list
138358494|NCT00004404|Miconazole|miconazole|mesh-list
138358495|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
138358496|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358497|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
138358498|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358499|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358500|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358501|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138358502|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358503|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
138358504|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138358505|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138358506|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138358507|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
138358508|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358509|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358510|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138358511|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138358514|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358515|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138358516|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138358517|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
138358518|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138358519|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138358520|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138358521|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358522|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358523|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
138358525|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358526|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138358527|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358528|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
138358529|NCT00004422|Antibodies|antibodies|mesh-list
138358530|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
138358531|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138358532|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138358534|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358535|NCT00004440|Ibuprofen|ibuprofen|mesh-list
138358536|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138358537|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358538|NCT00004440|Analgesics|analgesics|mesh-ancestor
138358539|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
138358540|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358541|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358542|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358543|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358544|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138358545|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358546|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358548|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138358549|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138358550|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358551|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358552|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358553|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
138358554|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358555|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138358556|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
138358557|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138358558|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138358559|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138358560|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358584|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358586|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
138358587|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
138358588|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358589|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
138358590|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358591|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138358592|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
138358593|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
138358595|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138358596|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138358597|NCT00004482|Protective Agents|protective agents|mesh-ancestor
138358598|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
138358601|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
138358602|NCT00004488|Calcium|calcium|mesh-list
138358603|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358604|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358606|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
138358607|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138358608|NCT00004488|Antacids|antacids|mesh-ancestor
138358609|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358610|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138358612|NCT00004554|Sertraline|sertraline|mesh-list
138358614|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138358615|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358616|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
138358617|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358618|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
138358619|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138358620|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138358621|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138358622|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358623|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358624|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358625|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
138358626|NCT00004578|Ritonavir|ritonavir|mesh-list
138358627|NCT00004578|Lopinavir|lopinavir|mesh-list
138358628|NCT00004578|Lamivudine|lamivudine|mesh-list
138358629|NCT00004578|Stavudine|stavudine|mesh-list
138358630|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138358631|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138358632|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
138358633|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358634|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358635|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138358636|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358637|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
138358638|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358639|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138358640|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138358642|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358643|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
138358644|NCT00004644|Acyclovir|acyclovir|mesh-list
138358645|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
138358646|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358647|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138358648|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
138358650|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138358651|NCT00004650|Hormones|hormones|mesh-ancestor
138358652|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358653|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358654|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138358655|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138358656|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138358657|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
138358658|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138358659|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138358660|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138358661|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138358662|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358663|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358664|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138358665|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358666|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
138358988|NCT00005106|Stavudine|stavudine|mesh-list
138358667|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358668|NCT00004686|Prednisone|prednisone|mesh-list
138358669|NCT00004686|Methotrexate|methotrexate|mesh-list
138358670|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358671|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
138358672|NCT00004686|Hormones|hormones|mesh-ancestor
138358673|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358674|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358675|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138358676|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358677|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138358679|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138358680|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358682|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358683|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
138358684|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358685|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138358686|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358687|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
138358688|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358690|NCT00004728|Aspirin|aspirin|mesh-list
138358691|NCT00004728|Warfarin|warfarin|mesh-list
138358692|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138358693|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358694|NCT00004728|Analgesics|analgesics|mesh-ancestor
138358695|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
138358696|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358697|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358698|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358699|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358700|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138358701|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138358702|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358703|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138358704|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138358705|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358706|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
138358707|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
138358708|NCT00004734|Folic Acid|folic acid|mesh-list
138358709|NCT00004734|Pyridoxine|pyridoxine|mesh-list
138358710|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
138358711|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
138358712|NCT00004734|Hematinics|hematinics|mesh-ancestor
138358713|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
138358714|NCT00004734|Vitamins|vitamins|mesh-ancestor
138358715|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
138358716|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358717|NCT00004740|Isoniazid|isoniazid|mesh-list
138358718|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
138358719|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138358720|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358721|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138358722|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138358723|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
138358724|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358727|NCT00004758|Carbamazepine|carbamazepine|mesh-list
138358728|NCT00004758|Valproic Acid|valproic acid|mesh-list
138358729|NCT00004758|Nitrazepam|nitrazepam|mesh-list
138358730|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138358731|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
138358732|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358733|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358734|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
138358735|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358736|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358737|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
138358738|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138358739|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138358740|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138358741|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358742|NCT00004758|Analgesics|analgesics|mesh-ancestor
138358743|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
138358744|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358745|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138358746|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358747|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138359150|NCT00005802|Cytarabine|cytarabine|mesh-list
138358748|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138358749|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
138358750|NCT00004758|Vitamins|vitamins|mesh-ancestor
138358751|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
138358752|NCT00004758|Hormones|hormones|mesh-ancestor
138358753|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358754|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138358755|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138358756|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
138358758|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
138358759|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358760|NCT00004770|Protective Agents|protective agents|mesh-ancestor
138358761|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358762|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
138358763|NCT00004770|Vitamins|vitamins|mesh-ancestor
138358764|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
138358765|NCT00004776|Topiramate|topiramate|mesh-list
138358766|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
138358767|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138358768|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358769|NCT00004794|Cidofovir|cidofovir|mesh-list
138358770|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
138358772|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358773|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358775|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
138358776|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358777|NCT00004842|Budesonide|budesonide|mesh-list
138358778|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358779|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138358780|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
138358781|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358782|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358784|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
138358785|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
138358786|NCT00004842|Hormones|hormones|mesh-ancestor
138358787|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358788|NCT00004854|Carvedilol|carvedilol|mesh-list
138358789|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138358790|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138358791|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
138358792|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358793|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358794|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358795|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138358796|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
138358798|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138358799|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138358800|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358801|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
138358802|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138358803|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138358805|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138358806|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358807|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358808|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358809|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358810|NCT00004872|Endostatins|endostatins|mesh-list
138358811|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358812|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138358813|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138358814|NCT00004872|Growth Substances|growth substances|mesh-ancestor
138358815|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358816|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
138358817|NCT00004878|Cytarabine|cytarabine|mesh-list
138358818|NCT00004878|Methotrexate|methotrexate|mesh-list
138358819|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
138358820|NCT00004878|Fludarabine|fludarabine|mesh-list
138358821|NCT00004878|Idarubicin|idarubicin|mesh-list
138358822|NCT00004878|Tacrolimus|tacrolimus|mesh-list
138358823|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138358824|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
138358825|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138358826|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358827|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358828|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
138359069|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358829|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358830|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358831|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138358832|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358833|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138358834|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138358835|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
138358836|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358837|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358838|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
138358839|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358840|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138358841|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138358843|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358844|NCT00004884|Gemcitabine|gemcitabine|mesh-list
138358845|NCT00004884|Docetaxel|docetaxel|mesh-list
138358846|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358847|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358848|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
138358849|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358850|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358851|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358852|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358853|NCT00004890|Aldesleukin|aldesleukin|mesh-list
138358854|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358856|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358857|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
138358858|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358860|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358861|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138358862|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
138358863|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358864|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138358865|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358866|NCT00004926|Vitamin D|vitamin d|mesh-list
138358867|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
138358868|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
138358869|NCT00004926|Vitamins|vitamins|mesh-ancestor
138358870|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
138358871|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358872|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138358873|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138358874|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358875|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
138358876|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358877|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138358878|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358879|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358880|NCT00004938|Fluconazole|fluconazole|mesh-list
138358881|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
138358882|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358883|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138358884|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138358885|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358886|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358887|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138358888|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
138358889|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138358890|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358891|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138358892|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138358893|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
138358894|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138358895|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358896|NCT00004992|Metformin|metformin|mesh-list
138358897|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138358898|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358899|NCT00004998|Lamivudine|lamivudine|mesh-list
138358900|NCT00004998|Zidovudine|zidovudine|mesh-list
138358901|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138358903|NCT00004998|Nelfinavir|nelfinavir|mesh-list
138358904|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138358905|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358906|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359070|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
138358907|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358908|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
138358909|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358910|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138358911|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358912|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
138358913|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138358914|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138358915|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138358916|NCT00005010|Irbesartan|irbesartan|mesh-list
138358917|NCT00005010|Pravastatin|pravastatin|mesh-list
138358918|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138358919|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138358920|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
138358921|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358922|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138358923|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138358925|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138358926|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138358927|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138358928|NCT00005022|Etoposide|etoposide|mesh-list
138358929|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358930|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358931|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138358932|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358933|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358934|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358935|NCT00005028|Paclitaxel|paclitaxel|mesh-list
138358936|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
138358937|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358938|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358939|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358940|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358941|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358942|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358943|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138358944|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
138358945|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358947|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358949|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138358950|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358951|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138358952|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138358953|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138358954|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358955|NCT00005064|Bortezomib|bortezomib|mesh-list
138358958|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138358960|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358961|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358962|NCT00005076|Irinotecan|irinotecan|mesh-list
138358963|NCT00005076|Cetuximab|cetuximab|mesh-list
138358964|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138358965|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138358966|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358967|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358968|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358969|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138358970|NCT00005088|Cisplatin|cisplatin|mesh-list
138358971|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138358973|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138358974|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138358975|NCT00005094|Analgesics|analgesics|mesh-ancestor
138358976|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
138358977|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138358978|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358979|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138358980|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138358981|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138358982|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138358983|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358984|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358985|NCT00005106|Lamivudine|lamivudine|mesh-list
138358986|NCT00005106|Zidovudine|zidovudine|mesh-list
138358987|NCT00005106|Abacavir|abacavir|mesh-list
138358989|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138358990|NCT00005106|Nelfinavir|nelfinavir|mesh-list
138358991|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138358992|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138358993|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358994|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358995|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
138358996|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138358997|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138358998|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138358999|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
138359000|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138359001|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138359002|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359003|NCT00005118|Ritonavir|ritonavir|mesh-list
138359004|NCT00005118|Indinavir|indinavir|mesh-list
138359005|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138359006|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138359007|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359008|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359009|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359011|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359013|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359014|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138359015|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138359016|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138359017|NCT00005520|Candesartan|candesartan|mesh-list
138359018|NCT00005520|Candesartan cilexetil|candesartan cilexetil|mesh-list
138359019|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138359020|NCT00005520|Diuretics|diuretics|mesh-ancestor
138359021|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
138359022|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359023|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138359024|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359025|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359026|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138359027|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138359028|NCT00005574|Gentamicins|gentamicins|mesh-list
138359029|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359030|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359031|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138359033|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359034|NCT00005580|Fludarabine|fludarabine|mesh-list
138359035|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
138359036|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
138359037|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359038|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359040|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359041|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359042|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
138359043|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359044|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138359046|NCT00005586|Fluorouracil|fluorouracil|mesh-list
138359047|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
138359048|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
138359049|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359050|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359051|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359052|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359053|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
138359054|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359055|NCT00005586|Antidotes|antidotes|mesh-ancestor
138359056|NCT00005586|Protective Agents|protective agents|mesh-ancestor
138359057|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
138359058|NCT00005586|Vitamins|vitamins|mesh-ancestor
138359059|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
138359060|NCT00005592|Rituximab|rituximab|mesh-list
138359061|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138359062|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359063|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359064|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
138359065|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359066|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359067|NCT00005598|Azacitidine|azacitidine|mesh-list
138359068|NCT00005598|Amifostine|amifostine|mesh-list
138359071|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359072|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359073|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359074|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138359075|NCT00005598|Protective Agents|protective agents|mesh-ancestor
138359076|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359077|NCT00005604|Aldesleukin|aldesleukin|mesh-list
138359078|NCT00005604|Interleukin-2|interleukin-2|mesh-list
138359079|NCT00005604|Interleukin-12|interleukin-12|mesh-list
138359080|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359081|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359082|NCT00005604|Analgesics|analgesics|mesh-ancestor
138359083|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
138359084|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359085|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359086|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138359087|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359088|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
138359089|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359090|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138359091|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
138359092|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138359093|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138359095|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
138359096|NCT00005610|Sargramostim|sargramostim|mesh-list
138359097|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
138359098|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359099|NCT00005616|Antibodies|antibodies|mesh-list
138359100|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138359101|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
138359102|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359103|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
138359104|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359105|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
138359106|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359107|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359108|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138359109|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
138359110|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359112|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138359114|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359115|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138359116|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359117|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359118|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138359119|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138359120|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359121|NCT00005646|Paclitaxel|paclitaxel|mesh-list
138359122|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359123|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359124|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
138359125|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
138359126|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138359127|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359128|NCT00005652|Rituximab|rituximab|mesh-list
138359129|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359130|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359131|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
138359133|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359134|NCT00005658|Glycine|glycine|mesh-list
138359135|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
138359136|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359137|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359138|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359139|NCT00005796|Vincristine|vincristine|mesh-list
138359140|NCT00005796|Lomustine|lomustine|mesh-list
138359141|NCT00005796|Procarbazine|procarbazine|mesh-list
138359142|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359143|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359144|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138359145|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138359146|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138359147|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359148|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138359149|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
138359164|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359165|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359166|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
138359167|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359168|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359169|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359170|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359171|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138359172|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359173|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
138359174|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359175|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138359176|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359177|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138359178|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138359180|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359181|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359182|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138359183|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359185|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
138359186|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359187|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
138359188|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138359189|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359191|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359192|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359194|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
138359195|NCT00354900|Coagulants|coagulants|mesh-ancestor
138359196|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138359197|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138359198|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359199|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359200|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359202|NCT00355290|Vitamins|vitamins|mesh-ancestor
138359203|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
138359204|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359205|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138359206|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138359207|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359208|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
138359209|NCT00355290|Coagulants|coagulants|mesh-ancestor
138359210|NCT00355446|Bimatoprost|bimatoprost|mesh-list
138359211|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138359212|NCT00355524|Ritonavir|ritonavir|mesh-list
138359213|NCT00355524|Darunavir|darunavir|mesh-list
138359214|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138359215|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138359216|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359217|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359218|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359220|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359221|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
138359222|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359223|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138359224|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138359226|NCT00355602|Vancomycin|vancomycin|mesh-list
138359227|NCT00355602|Clarithromycin|clarithromycin|mesh-list
138359228|NCT00355602|Doxycycline|doxycycline|mesh-list
138359229|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
138359230|NCT00355602|Rifaximin|rifaximin|mesh-list
138359231|NCT00355602|Cefuroxime|cefuroxime|mesh-list
138359232|NCT00355602|Neomycin|neomycin|mesh-list
138359233|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138359234|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138359235|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359236|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359237|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138359238|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138359239|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138359240|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359241|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359242|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138359244|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
138359245|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138359246|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138359247|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359248|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138359249|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359250|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138359251|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138359252|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138359253|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138359254|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138359255|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359256|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359257|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359258|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359259|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359260|NCT00356226|Clonidine|clonidine|mesh-list
138359261|NCT00356226|Analgesics|analgesics|mesh-ancestor
138359262|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
138359263|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359264|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359265|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138359266|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
138359267|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
138359268|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138359269|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138359270|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138359271|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359272|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359273|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359274|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138359275|NCT00356460|Antibodies|antibodies|mesh-list
138359276|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
138359277|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138359278|NCT00356460|Mitogens|mitogens|mesh-list
138359279|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
138359280|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359281|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359282|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138359283|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359285|NCT00356616|Abacavir|abacavir|mesh-list
138359286|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
138359287|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359288|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138359289|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138359290|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359291|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359292|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138359293|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359295|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359296|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359298|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359299|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359300|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
138359301|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359302|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
138359303|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359304|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359305|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138359306|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
138359307|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359308|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359309|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138359310|NCT00357084|Prednisone|prednisone|mesh-list
138359311|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
138359312|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138359313|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138359314|NCT00357084|Prednisolone|prednisolone|mesh-list
138359315|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
138359316|NCT00357084|Methotrexate|methotrexate|mesh-list
138359317|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138359318|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
138359319|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359320|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
138359321|NCT00357084|Hormones|hormones|mesh-ancestor
138359322|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359323|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359324|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138359325|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359326|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138359327|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
138359328|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138359329|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359330|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
138359331|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359332|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359333|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359334|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138359335|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359336|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
138359337|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359338|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138359340|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
138359341|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359342|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359343|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138359344|NCT00357084|Protective Agents|protective agents|mesh-ancestor
138359345|NCT00357240|Ritonavir|ritonavir|mesh-list
138359346|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138359347|NCT00357240|Omeprazole|omeprazole|mesh-list
138359348|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138359349|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138359350|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359351|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359352|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359353|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138359354|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359355|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
138359356|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359357|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138359358|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138359359|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138359360|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359361|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138359362|NCT00357318|Bevacizumab|bevacizumab|mesh-list
138359363|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138359364|NCT00357318|Sunitinib|sunitinib|mesh-list
138359365|NCT00357318|Antibodies|antibodies|mesh-list
138359366|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
138359367|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138359368|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359369|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138359370|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138359371|NCT00357318|Growth Substances|growth substances|mesh-ancestor
138359372|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359373|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
138359374|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
138359375|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138359376|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359377|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359379|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138359380|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359381|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359382|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359383|NCT00357630|Gemcitabine|gemcitabine|mesh-list
138359384|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359385|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
138359386|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359387|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359388|NCT00357708|Decitabine|decitabine|mesh-list
138359389|NCT00357708|Azacitidine|azacitidine|mesh-list
138359390|NCT00357708|Vorinostat|vorinostat|mesh-list
138359391|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359392|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
138359393|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359394|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359395|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359396|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138359397|NCT00357864|Carbachol|carbachol|mesh-list
138359398|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138359399|NCT00357864|Miotics|miotics|mesh-ancestor
138359400|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
138359401|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360196|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359402|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359403|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138359404|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
138359405|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359406|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359407|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359409|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
138359410|NCT00357864|Protective Agents|protective agents|mesh-ancestor
138359411|NCT00357942|Morphine|morphine|mesh-list
138359413|NCT00357942|Narcotics|narcotics|mesh-ancestor
138359414|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359415|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359416|NCT00357942|Analgesics|analgesics|mesh-ancestor
138359417|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
138359418|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359419|NCT00358020|Thalidomide|thalidomide|mesh-list
138359420|NCT00358020|Bortezomib|bortezomib|mesh-list
138359421|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359422|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359423|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
138359424|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359425|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
138359426|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359427|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359428|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138359429|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138359430|NCT00358020|Growth Substances|growth substances|mesh-ancestor
138359431|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
138359432|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
138359433|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138359434|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359435|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359436|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138359437|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359438|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138359439|NCT00358410|Casopitant|casopitant|mesh-list
138359440|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
138359441|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
138359442|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359443|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359444|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359445|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138359446|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359447|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359449|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138359450|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138359451|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
138359452|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359453|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359454|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138359455|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
138359456|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138359457|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138359458|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138359459|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359460|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359461|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359462|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
138359463|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138359465|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359466|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
138359467|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359468|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359470|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359471|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359473|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359474|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138359475|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359477|NCT00359658|Cyclosporine|cyclosporine|mesh-list
138359478|NCT00359658|Prednisolone|prednisolone|mesh-list
138359479|NCT00359658|Cyclosporins|cyclosporins|mesh-list
138359480|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359481|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359482|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359483|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
138359484|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359485|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
138359486|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359487|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359488|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359489|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138359490|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359491|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
138359492|NCT00359658|Hormones|hormones|mesh-ancestor
138359493|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359494|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138359495|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359498|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359499|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359500|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359501|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
138359502|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359503|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
138359504|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359505|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359506|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359507|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138359508|NCT00359892|Obatoclax|obatoclax|mesh-list
138359509|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359510|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359511|NCT00359970|Azithromycin|azithromycin|mesh-list
138359512|NCT00359970|Loperamide|loperamide|mesh-list
138359513|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
138359514|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359515|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359516|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359518|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
138359519|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138359520|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359521|NCT00360438|Rasburicase|rasburicase|mesh-list
138359522|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
138359523|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359524|NCT00360594|Acamprosate|acamprosate|mesh-list
138359525|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138359526|NCT00360750|Cytarabine|cytarabine|mesh-list
138359527|NCT00360750|Carboplatin|carboplatin|mesh-list
138359528|NCT00360750|Etoposide|etoposide|mesh-list
138359529|NCT00360750|Vincristine|vincristine|mesh-list
138359530|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359531|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359532|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138359534|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359535|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359536|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359537|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
138359538|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
138359539|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359541|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
138359542|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359543|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138359544|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138359545|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138359547|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138359548|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
138359549|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359550|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359551|NCT00361452|Epinephrine|epinephrine|mesh-list
138359552|NCT00361452|Albuterol|albuterol|mesh-list
138359553|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138359554|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138359555|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359556|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359557|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359558|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359559|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138359560|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138359562|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359564|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
138359565|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
138359566|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
138359567|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138359568|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
138359569|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138359570|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138359571|NCT00361686|Tramadol|tramadol|mesh-list
138359572|NCT00361686|Remifentanil|remifentanil|mesh-list
138359573|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138359574|NCT00361686|Narcotics|narcotics|mesh-ancestor
138359575|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359576|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359577|NCT00361686|Analgesics|analgesics|mesh-ancestor
138359578|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
138359579|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359580|NCT00361920|Prednisone|prednisone|mesh-list
138359581|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359582|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
138359583|NCT00361920|Hormones|hormones|mesh-ancestor
138359584|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359585|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359586|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138359587|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359588|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
138359589|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138359590|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359591|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138359593|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138359594|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138359595|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359596|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359597|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359598|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138359599|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138359600|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
138359601|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359602|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138359603|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
138359604|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359605|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138359606|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138359608|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
138359609|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359610|NCT00362778|Insulin|insulin|mesh-list
138359611|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359612|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359613|NCT00362934|Atorvastatin|atorvastatin|mesh-list
138359614|NCT00362934|Simvastatin|simvastatin|mesh-list
138359615|NCT00362934|Fenofibrate|fenofibrate|mesh-list
138359616|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138359617|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138359618|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
138359619|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359620|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138359621|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138359622|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359623|NCT00363090|Prednisone|prednisone|mesh-list
138359624|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
138359625|NCT00363090|Doxorubicin|doxorubicin|mesh-list
138359626|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138359627|NCT00363090|Vincristine|vincristine|mesh-list
138359628|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
138359629|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359630|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
138359631|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359632|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359633|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138359634|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
138359635|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359636|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359637|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138359638|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138359639|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138359640|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138359642|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359643|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
138359644|NCT00363090|Hormones|hormones|mesh-ancestor
138359645|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359646|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138359647|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359648|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
138359649|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
138359650|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
138359652|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
138359653|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
138359654|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138359655|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359656|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359657|NCT00363948|Incretins|incretins|mesh-ancestor
138359658|NCT00363948|Hormones|hormones|mesh-ancestor
138359659|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359660|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138359661|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359662|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359663|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359665|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138359666|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359667|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
138359668|NCT00364260|Hematinics|hematinics|mesh-ancestor
138359669|NCT00364572|Etanercept|etanercept|mesh-list
138359670|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138359671|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359672|NCT00364572|Analgesics|analgesics|mesh-ancestor
138359673|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
138359674|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359675|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359676|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359677|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359678|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359679|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138359680|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
138359682|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
138359683|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
138359684|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
138359685|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359686|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359687|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359688|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138359689|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138359691|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359692|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359693|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138359694|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138359695|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359696|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138359697|NCT00365040|Mitomycins|mitomycins|mesh-list
138359698|NCT00365040|Mitomycin|mitomycin|mesh-list
138359699|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138359700|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359701|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
138359702|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359703|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138359704|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359705|NCT00365586|Ketoprofen|ketoprofen|mesh-list
138359706|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138359707|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359708|NCT00365586|Analgesics|analgesics|mesh-ancestor
138359709|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
138359710|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359711|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359712|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359713|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359714|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138359715|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359716|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359717|NCT00365742|Simvastatin|simvastatin|mesh-list
138359718|NCT00365742|Red yeast rice|red yeast rice|mesh-list
138359719|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138359720|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138359721|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
138359722|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359723|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138359724|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138359725|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359726|NCT00365820|Tegaserod|tegaserod|mesh-list
138359727|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138359728|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
138359729|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359730|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359731|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359732|NCT00365898|Hydromorphone|hydromorphone|mesh-list
138359733|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138359734|NCT00365898|Narcotics|narcotics|mesh-ancestor
138359735|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359736|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359737|NCT00365898|Analgesics|analgesics|mesh-ancestor
138359738|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
138359739|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359740|NCT00366834|Dexamethasone|dexamethasone|mesh-list
138359741|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
138359742|NCT00366834|Ondansetron|ondansetron|mesh-list
138359743|NCT00366834|Casopitant|casopitant|mesh-list
138359744|NCT00366834|BB 1101|bb 1101|mesh-list
138359745|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359746|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
138359747|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
138359748|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359749|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359750|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359751|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
138359753|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359754|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138359756|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
138359757|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359758|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359759|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
138359760|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359761|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138359762|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138359763|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
138359764|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359765|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138359766|NCT00367068|Baclofen|baclofen|mesh-list
138359767|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138359768|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359769|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138359770|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359771|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138359772|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
138359773|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
138359774|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359775|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359778|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138359779|NCT00367302|Narcotics|narcotics|mesh-ancestor
138359780|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359781|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359782|NCT00367302|Analgesics|analgesics|mesh-ancestor
138359783|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
138359784|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359785|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138359786|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
138359787|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
138359788|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
138359789|NCT00367536|Estrogens|estrogens|mesh-list
138359790|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138359791|NCT00367536|Hormones|hormones|mesh-ancestor
138359792|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359793|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359794|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138359795|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138359796|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
138359797|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138359798|NCT00367614|Pantoprazole|pantoprazole|mesh-list
138359799|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138359800|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138359801|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138359802|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359803|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359806|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138359807|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359808|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359809|NCT00368238|Aspirin|aspirin|mesh-list
138359811|NCT00368238|Clopidogrel|clopidogrel|mesh-list
138359812|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138359813|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359814|NCT00368238|Analgesics|analgesics|mesh-ancestor
138359815|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
138359816|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359817|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359818|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359819|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359820|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138359821|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138359822|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359823|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138359824|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138359825|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359826|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
138359827|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138359828|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138359829|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138359830|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
138359831|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359832|NCT00368238|Hematinics|hematinics|mesh-ancestor
138359833|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
138359834|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359835|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359836|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
138359837|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138359838|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138359839|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138359840|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
138359841|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359842|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359843|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359844|NCT00368706|Urological Agents|urological agents|mesh-ancestor
138359846|NCT00368862|Escitalopram|escitalopram|mesh-list
138359847|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138359848|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138359849|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359850|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359851|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359852|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
138359853|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359855|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138359856|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
138359857|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138359858|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138359859|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138359860|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138359862|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359864|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
138359865|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
138359866|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359867|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359869|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359870|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359872|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138359873|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138359874|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359875|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
138359876|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359877|NCT00369798|Rolipram|rolipram|mesh-list
138359878|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138359879|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138359880|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138359881|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138359882|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138359884|NCT00369954|Carboplatin|carboplatin|mesh-list
138359885|NCT00369954|Gemcitabine|gemcitabine|mesh-list
138359886|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359887|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138359888|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
138359889|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359890|NCT00370188|Topiramate|topiramate|mesh-list
138359891|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
138359892|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138359893|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359894|NCT00370266|Triamcinolone|triamcinolone|mesh-list
138359895|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359896|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
138359897|NCT00370266|Hormones|hormones|mesh-ancestor
138359898|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359899|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359900|NCT00370422|Triamcinolone|triamcinolone|mesh-list
138359901|NCT00370422|Bevacizumab|bevacizumab|mesh-list
138359902|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359903|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359904|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138359905|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138359906|NCT00370422|Growth Substances|growth substances|mesh-ancestor
138359907|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359908|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
138359909|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138359910|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
138359912|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359913|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138359914|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
138359915|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138359916|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138359917|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138359918|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359919|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359920|NCT00370656|Pregabalin|pregabalin|mesh-list
138359921|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138359922|NCT00370656|Amitriptyline|amitriptyline|mesh-list
138359923|NCT00370656|Analgesics|analgesics|mesh-ancestor
138359924|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
138359925|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359926|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359927|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
138359928|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138359929|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359930|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359931|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138359932|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138359933|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138359934|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359935|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138359936|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138359937|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138359938|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359939|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
138359940|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
138359941|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138359942|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138359943|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138359944|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
138359945|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
138359946|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138359947|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138359948|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138359949|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138359950|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359951|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
138359952|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359953|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359954|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138359955|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359957|NCT00370968|Astringents|astringents|mesh-ancestor
138359958|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359959|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138359961|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138359962|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138359963|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138359964|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138359965|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138359966|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
138359967|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138359968|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359969|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138359970|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
138359971|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
138359972|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
138359973|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138359974|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138359975|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
138359976|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359977|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359979|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
138359980|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138359982|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138359983|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138359984|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
138359985|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359986|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138359987|NCT00372138|Thrombin|thrombin|mesh-list
138359989|NCT00372138|Coagulants|coagulants|mesh-ancestor
138359990|NCT00372216|Clopidogrel|clopidogrel|mesh-list
138359991|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138359992|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138359993|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138359994|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138359995|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
138359996|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359997|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359998|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359999|NCT00372294|Clindamycin|clindamycin|mesh-list
138360000|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
138360001|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
138360002|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
138360003|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
138360004|NCT00372294|Dexamethasone|dexamethasone|mesh-list
138360005|NCT00372294|Prednisolone|prednisolone|mesh-list
138360006|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360007|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
138360008|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
138360009|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360010|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360011|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360012|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
138360014|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360015|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360016|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360017|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360018|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360019|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138360020|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360021|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360022|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
138360023|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138360024|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138360025|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138360026|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
138360027|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
138360028|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138360029|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360030|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360031|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138360032|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360033|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360034|NCT00372762|Furosemide|furosemide|mesh-list
138360035|NCT00372762|Bumetanide|bumetanide|mesh-list
138360036|NCT00372762|Diuretics|diuretics|mesh-ancestor
138360037|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
138360038|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360039|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138360040|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360041|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360042|NCT00373464|Etoricoxib|etoricoxib|mesh-list
138360043|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138360044|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138360045|NCT00373464|Analgesics|analgesics|mesh-ancestor
138360046|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
138360047|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360048|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360049|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360050|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360051|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138360052|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138360053|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360054|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360055|NCT00373620|Paclitaxel|paclitaxel|mesh-list
138360056|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360057|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360058|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360059|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360060|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360061|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360062|NCT00373776|Miltefosine|miltefosine|mesh-list
138360063|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
138360064|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360065|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360066|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138360067|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138360068|NCT00374478|Scopolamine|scopolamine|mesh-list
138360069|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138360070|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138360072|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
138360073|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360074|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360075|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360076|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
138360077|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138360078|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360079|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360080|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360081|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138360082|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
138360084|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138360085|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138360086|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
138360088|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360089|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360090|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360092|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138360093|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138360094|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360095|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
138360096|NCT00375258|Coagulants|coagulants|mesh-ancestor
138360097|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
138360098|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360099|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360100|NCT00376038|Metformin|metformin|mesh-list
138360101|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138360102|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360103|NCT00376272|Valsartan|valsartan|mesh-list
138360104|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138360105|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138360106|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138360107|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360108|NCT00376428|Gentamicins|gentamicins|mesh-list
138360109|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360110|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360111|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138360112|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360113|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360114|NCT00376584|Niacin|niacin|mesh-list
138360115|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138360116|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
138360117|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360118|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138360119|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
138360120|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
138360121|NCT00376584|Vitamins|vitamins|mesh-ancestor
138360122|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
138360123|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360124|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
138360125|NCT00376662|Hormones|hormones|mesh-list
138360126|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360127|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360128|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360129|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
138360130|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360131|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360132|NCT00376818|Hormones|hormones|mesh-list
138360133|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360134|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360136|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138360137|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138360138|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
138360139|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360140|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138360141|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138360142|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360143|NCT00377910|Lidocaine|lidocaine|mesh-list
138360144|NCT00377910|Polidocanol|polidocanol|mesh-list
138360145|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
138360146|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
138360147|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360148|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360149|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
138360150|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360151|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138360152|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138360153|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138360154|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360155|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360157|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138360158|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
138360159|NCT00377988|Norgestimate|norgestimate|mesh-list
138360160|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
138360161|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138360162|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360163|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138360164|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138360165|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138360166|NCT00378066|Bevacizumab|bevacizumab|mesh-list
138360167|NCT00378066|Capecitabine|capecitabine|mesh-list
138360169|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360170|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360171|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138360172|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138360173|NCT00378066|Growth Substances|growth substances|mesh-ancestor
138360174|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360175|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
138360177|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
138360178|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360179|NCT00378144|Acetaminophen|acetaminophen|mesh-list
138360180|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
138360181|NCT00378144|Ephedrine|ephedrine|mesh-list
138360182|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138360183|NCT00378144|Analgesics|analgesics|mesh-ancestor
138360184|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
138360185|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360186|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360187|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
138360188|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138360189|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
138360190|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138360191|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360192|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
138360193|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138360194|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138360195|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
138360198|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360199|NCT00378456|Vitamins|vitamins|mesh-list
138360200|NCT00378456|Leucovorin|leucovorin|mesh-list
138360201|NCT00378456|Folic Acid|folic acid|mesh-list
138360202|NCT00378456|Vitamin A|vitamin a|mesh-list
138360203|NCT00378456|Zinc|zinc|mesh-list
138360204|NCT00378456|Selenium|selenium|mesh-list
138360205|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
138360206|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
138360207|NCT00378456|Antioxidants|antioxidants|mesh-list
138360208|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
138360209|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360210|NCT00378456|Trace Elements|trace elements|mesh-ancestor
138360211|NCT00378456|Antidotes|antidotes|mesh-ancestor
138360212|NCT00378456|Protective Agents|protective agents|mesh-ancestor
138360213|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
138360214|NCT00378456|Hematinics|hematinics|mesh-ancestor
138360215|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360216|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138360217|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360218|NCT00378612|Sirolimus|sirolimus|mesh-list
138360219|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360220|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360221|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138360222|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360223|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
138360224|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138360225|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
138360226|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360228|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138360229|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
138360230|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138360231|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360232|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360233|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360234|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138360235|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
138360236|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360237|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138360238|NCT00379158|Micronutrients|micronutrients|mesh-list
138360239|NCT00379158|Trace Elements|trace elements|mesh-list
138360240|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360241|NCT00379626|Hormones|hormones|mesh-list
138360242|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360243|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360244|NCT00380406|Leuprolide|leuprolide|mesh-list
138360245|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138360246|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
138360247|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138360248|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360249|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360250|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360252|NCT00380484|Montelukast|montelukast|mesh-list
138360253|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360254|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138360255|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
138360256|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360257|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360258|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138360259|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360260|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
138360261|NCT00380484|Hormones|hormones|mesh-ancestor
138360262|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360263|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138360264|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
138360265|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138360266|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138360267|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360268|NCT00380640|Trimethoprim|trimethoprim|mesh-list
138360269|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138360270|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360271|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
138360272|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138360273|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138360274|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138360275|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360276|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360277|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138360278|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138360279|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138360280|NCT00381030|Carvedilol|carvedilol|mesh-list
138360281|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138360282|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138360283|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360284|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360285|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360286|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360287|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138360288|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
138360289|NCT00381030|Protective Agents|protective agents|mesh-ancestor
138360290|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138360291|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360292|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138360293|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
138360294|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138360295|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138360296|NCT00381264|Nabilone|nabilone|mesh-list
138360297|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
138360298|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
138360299|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360301|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360303|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138360304|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360305|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138360306|NCT00381342|Exenatide|exenatide|mesh-list
138360307|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138360308|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360309|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138360311|NCT00381342|Hormones|hormones|mesh-ancestor
138360312|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360314|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360315|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360316|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360317|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360318|NCT00381732|Tadalafil|tadalafil|mesh-list
138360319|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
138360320|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138360321|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138360322|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360323|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360324|NCT00381732|Urological Agents|urological agents|mesh-ancestor
138360325|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
138360326|NCT00382044|Hematinics|hematinics|mesh-ancestor
138360327|NCT00382356|Dutasteride|dutasteride|mesh-list
138360328|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138360329|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138360331|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360332|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
138360333|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360334|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360336|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360337|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360338|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360339|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360340|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138360341|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138360342|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
138360343|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360344|NCT00382980|Antacids|antacids|mesh-ancestor
138360345|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360346|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360348|NCT00383136|Abciximab|abciximab|mesh-list
138360349|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
138360350|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138360351|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138360352|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138360353|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360354|NCT00383214|Epratuzumab|epratuzumab|mesh-list
138360355|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360356|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360358|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138360359|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138360360|NCT00383370|Growth Substances|growth substances|mesh-ancestor
138360361|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360362|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138360363|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360365|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
138360366|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360367|NCT00383682|Mexiletine|mexiletine|mesh-list
138360368|NCT00383682|Morphine|morphine|mesh-list
138360369|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138360370|NCT00383682|Narcotics|narcotics|mesh-ancestor
138360371|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360372|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360375|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360376|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138360377|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138360378|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138360379|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360380|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360381|NCT00383916|Pantoprazole|pantoprazole|mesh-list
138360382|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138360383|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360384|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138360385|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360386|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360387|NCT00383994|Rituximab|rituximab|mesh-list
138360388|NCT00383994|Sargramostim|sargramostim|mesh-list
138360389|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360390|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360391|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
138360392|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360393|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360394|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
138360395|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138360396|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138360397|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
138360398|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360399|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360400|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360401|NCT00384306|Prednisolone|prednisolone|mesh-list
138360402|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360403|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
138360405|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360406|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360407|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360408|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360409|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
138360410|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360411|NCT00384540|Dobutamine|dobutamine|mesh-list
138360412|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138360413|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
138360414|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
138360415|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360416|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360417|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138360418|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138360419|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138360420|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360421|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360422|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360423|NCT00384540|Protective Agents|protective agents|mesh-ancestor
138360425|NCT00384618|Pravastatin|pravastatin|mesh-list
138360426|NCT00384618|Vitamins|vitamins|mesh-ancestor
138360427|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
138360428|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360429|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
138360430|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360431|NCT00384618|Protective Agents|protective agents|mesh-ancestor
138360432|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138360433|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138360434|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
138360435|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138360519|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138360436|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138360437|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360438|NCT00384696|Nicotine|nicotine|mesh-list
138360439|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138360440|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
138360441|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360442|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360443|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138360444|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138360445|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360447|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360448|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138360449|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360450|NCT00385398|Temozolomide|temozolomide|mesh-list
138360451|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138360452|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138360453|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
138360454|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360455|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360456|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360457|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360459|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138360460|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
138360461|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360462|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138360464|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360465|NCT00385710|Valproic Acid|valproic acid|mesh-list
138360466|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
138360467|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360468|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360469|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
138360470|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360471|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360474|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360476|NCT00386178|Vitamin E|vitamin e|mesh-list
138360477|NCT00386178|Tocopherols|tocopherols|mesh-list
138360478|NCT00386178|Tocotrienols|tocotrienols|mesh-list
138360479|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
138360480|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
138360481|NCT00386178|Vitamins|vitamins|mesh-ancestor
138360482|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
138360483|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360484|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
138360485|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360486|NCT00386178|Protective Agents|protective agents|mesh-ancestor
138360487|NCT00421824|Capecitabine|capecitabine|mesh-list
138360488|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
138360489|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138360490|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
138360491|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360492|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360494|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138360495|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138360496|NCT00421980|Analgesics|analgesics|mesh-ancestor
138360497|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
138360498|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360499|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360500|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360501|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360502|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360503|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138360504|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
138360505|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138360506|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
138360507|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138360508|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138360509|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138360510|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360511|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360512|NCT00422526|Progesterone|progesterone|mesh-list
138360513|NCT00422526|Progestins|progestins|mesh-ancestor
138360515|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360516|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360517|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
138360518|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138360526|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138360527|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360528|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360529|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360530|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138360531|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138360532|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138360533|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360534|NCT00422682|Paclitaxel|paclitaxel|mesh-list
138360535|NCT00422682|Carboplatin|carboplatin|mesh-list
138360536|NCT00422682|Gemcitabine|gemcitabine|mesh-list
138360537|NCT00422682|Temozolomide|temozolomide|mesh-list
138360538|NCT00422682|Topotecan|topotecan|mesh-list
138360539|NCT00422682|Iniparib|iniparib|mesh-list
138360540|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360541|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360542|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360543|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360544|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360545|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360546|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138360547|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
138360548|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138360549|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
138360550|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138360551|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138360552|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360553|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138360554|NCT00422994|Ropinirole|ropinirole|mesh-list
138360555|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138360556|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138360557|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
138360558|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
138360559|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360560|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360561|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360562|NCT00423228|Donepezil|donepezil|mesh-list
138360563|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138360564|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360565|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360566|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360567|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360568|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360569|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
138360570|NCT01799616|Pamidronate|pamidronate|mesh-list
138360571|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138360572|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360573|NCT01799850|Pioglitazone|pioglitazone|mesh-list
138360574|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138360575|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360577|NCT01792050|Docetaxel|docetaxel|mesh-list
138360578|NCT01792050|Tryptophan|tryptophan|mesh-list
138360579|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360580|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360581|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360582|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360583|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360584|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360585|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138360586|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
138360587|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138360588|NCT01790100|Ribavirin|ribavirin|mesh-list
138360589|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
138360590|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360592|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360593|NCT01799460|Cyclosporine|cyclosporine|mesh-list
138360594|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
138360595|NCT01799460|Tacrolimus|tacrolimus|mesh-list
138360596|NCT01799460|Cyclosporins|cyclosporins|mesh-list
138360597|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138360598|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
138360599|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
138360600|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360601|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360602|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138360603|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
138360604|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360605|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360606|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138360607|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138360608|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360609|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
138360610|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360611|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138360612|NCT01799460|Hormones|hormones|mesh-ancestor
138360613|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360614|NCT02999724|Gabapentin|gabapentin|mesh-list
138360615|NCT02999724|Analgesics|analgesics|mesh-ancestor
138360616|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
138360617|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360618|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360619|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
138360620|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138360621|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138360622|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360623|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138360624|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138360626|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360627|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360628|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
138360629|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138360630|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138360632|NCT02998242|Apatinib|apatinib|mesh-list
138360633|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360634|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360635|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360636|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360637|NCT02998398|Infliximab|infliximab|mesh-list
138360638|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138360639|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360640|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
138360641|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360642|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360643|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138360644|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138360645|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138360646|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
138360647|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360648|NCT02996916|Amlodipine|amlodipine|mesh-list
138360649|NCT02996916|Olmesartan|olmesartan|mesh-list
138360650|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138360651|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138360652|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360653|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360654|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138360655|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360656|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
138360657|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138360658|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138360659|NCT02996214|Paclitaxel|paclitaxel|mesh-list
138360660|NCT02996214|Gemcitabine|gemcitabine|mesh-list
138360661|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138360662|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360663|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360664|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360665|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360666|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360667|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138360668|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
138360669|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
138360670|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138360671|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360672|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360675|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
138360676|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360677|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138360678|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138360679|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138360680|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360681|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360682|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360683|NCT02995512|Colchicine|colchicine|mesh-list
138360684|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
138360685|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360686|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360687|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360689|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360690|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360691|NCT02994888|Cetuximab|cetuximab|mesh-list
138360692|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360693|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360694|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
138360695|NCT02993718|Propofol|propofol|mesh-list
138360696|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138360697|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360698|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360699|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138360700|NCT02993718|Analgesics|analgesics|mesh-ancestor
138360701|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
138360702|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360703|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138360704|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138360705|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138360706|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360707|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360708|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360709|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138360710|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
138360711|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
138360712|NCT02993640|Vasopressins|vasopressins|mesh-list
138360713|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
138360714|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
138360715|NCT02993640|Coagulants|coagulants|mesh-ancestor
138360716|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138360717|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138360718|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
138360719|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360721|NCT02993094|Ixazomib|ixazomib|mesh-list
138360722|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360723|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138360724|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360725|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360726|NCT02992938|Acetazolamide|acetazolamide|mesh-list
138360727|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
138360728|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138360729|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360730|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360731|NCT02992938|Diuretics|diuretics|mesh-ancestor
138360732|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
138360733|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360734|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138360735|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
138360736|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360737|NCT02992548|Pravastatin|pravastatin|mesh-list
138360738|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138360739|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138360740|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
138360741|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360743|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138360744|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360746|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
138360747|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
138360748|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
138360749|NCT02991768|Budesonide|budesonide|mesh-list
138360750|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360751|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138360752|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
138360753|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360754|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360755|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138360756|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360757|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
138360759|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360760|NCT02991612|Rifaximin|rifaximin|mesh-list
138360761|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360762|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360763|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360764|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
138360765|NCT02990286|Rituximab|rituximab|mesh-list
138360766|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360767|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360768|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
138360769|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360770|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360771|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138360772|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138360773|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
138360774|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360775|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360776|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360777|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360778|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
138360779|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
138360782|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138360783|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360784|NCT02999958|Protective Agents|protective agents|mesh-ancestor
138360785|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360786|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
138360788|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
138360789|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
138360790|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
138360791|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360793|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360794|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138360795|NCT02999958|Antidotes|antidotes|mesh-ancestor
138360796|NCT02995746|Dexamethasone|dexamethasone|mesh-list
138360797|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138360798|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
138360799|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
138360800|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360801|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360802|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360803|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
138360805|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138360806|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138360807|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360808|NCT02990364|Lidocaine|lidocaine|mesh-list
138360809|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
138360810|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138360811|NCT02990364|Anesthetics|anesthetics|mesh-list
138360812|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360813|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360814|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
138360815|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360816|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138360817|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138360818|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138360819|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360820|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360821|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138360822|NCT01270074|Azithromycin|azithromycin|mesh-list
138360823|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138360824|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360825|NCT01270308|Lansoprazole|lansoprazole|mesh-list
138360826|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
138360827|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138360828|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138360829|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138360830|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360831|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360832|NCT01270386|Apatinib|apatinib|mesh-list
138360833|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360834|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360835|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360836|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360837|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
138360838|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138360839|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138360840|NCT01270932|Dexamethasone|dexamethasone|mesh-list
138360841|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
138360859|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138360860|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138360861|NCT01270932|Growth Substances|growth substances|mesh-ancestor
138360862|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
138360863|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
138360864|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138360865|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
138360866|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360867|NCT01271088|Expectorants|expectorants|mesh-ancestor
138360868|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360870|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
138360871|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360872|NCT01271088|Protective Agents|protective agents|mesh-ancestor
138360873|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360874|NCT01271088|Antidotes|antidotes|mesh-ancestor
138360876|NCT01271166|Bevacizumab|bevacizumab|mesh-list
138360877|NCT01271166|Fluorouracil|fluorouracil|mesh-list
138360878|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
138360879|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
138360880|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138360881|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360882|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138360883|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138360884|NCT01271166|Growth Substances|growth substances|mesh-ancestor
138360885|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360886|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
138360887|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
138360888|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360889|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138360890|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138360891|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
138360893|NCT01271166|Protective Agents|protective agents|mesh-ancestor
138360894|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
138360896|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
138360897|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360898|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360899|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138360900|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
138360901|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
138360902|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360903|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360904|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138360905|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
138360906|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138360907|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138360908|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138360909|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360910|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360911|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360913|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138360914|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138360915|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360916|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138360917|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138360918|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
138360919|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360920|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
138360921|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138360922|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138360923|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138360924|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360925|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360926|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360927|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360928|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360929|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138360930|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360931|NCT01273506|Tapentadol|tapentadol|mesh-list
138360932|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138360933|NCT01273506|Narcotics|narcotics|mesh-ancestor
138360934|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138360935|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360936|NCT01273506|Analgesics|analgesics|mesh-ancestor
138360937|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
138360938|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360939|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138360940|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138360941|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360942|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360943|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
138360944|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360946|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360947|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138360948|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360949|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360950|NCT01273974|Vaccines|vaccines|mesh-list
138360951|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
138360952|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360953|NCT01274130|Metformin|metformin|mesh-list
138360954|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138360955|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360956|NCT01276080|Donepezil|donepezil|mesh-list
138360957|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138360958|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360959|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360960|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360961|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360962|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360963|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
138360964|NCT01276548|Carboplatin|carboplatin|mesh-list
138360965|NCT01276548|genexol-PM|genexol-pm|mesh-list
138360966|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360967|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
138360968|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
138360969|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
138360970|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360971|NCT01277172|Rituximab|rituximab|mesh-list
138360972|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138360973|NCT01277172|Antibodies|antibodies|mesh-list
138360974|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
138360975|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138360976|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
138360977|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360978|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360979|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138360981|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138360982|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138360983|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
138360984|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138360985|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
138360986|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138360987|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138360988|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138360989|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138360990|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138360991|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
138360992|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138360993|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360994|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138360995|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138360997|NCT01279434|Vitamin E|vitamin e|mesh-list
138360998|NCT01279434|Tocopherols|tocopherols|mesh-list
138360999|NCT01279434|Tocotrienols|tocotrienols|mesh-list
138361000|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
138361001|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
138361002|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361003|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
138361004|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361005|NCT01279434|Protective Agents|protective agents|mesh-ancestor
138361006|NCT01279512|Metformin|metformin|mesh-list
138361007|NCT01279512|Acarbose|acarbose|mesh-list
138361008|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138361009|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361010|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138361011|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361012|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361013|NCT01279668|Montelukast|montelukast|mesh-list
138361014|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138361015|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
138361016|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138361017|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
138361018|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361019|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361020|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138361021|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138361022|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361023|NCT01279902|Rituximab|rituximab|mesh-list
138361024|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361025|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361027|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361028|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361030|NCT01278342|Cabergoline|cabergoline|mesh-list
138361031|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361032|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138361033|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361034|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138361035|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138361036|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
138361037|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
138361038|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361039|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361040|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361041|NCT01277718|Rabeprazole|rabeprazole|mesh-list
138361042|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138361043|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361044|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138361045|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361046|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361047|NCT01276236|Maraviroc|maraviroc|mesh-list
138361049|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138361050|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361051|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138361052|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138361053|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
138361054|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361055|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138361057|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
138361058|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138361059|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361060|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361061|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361062|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361063|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
138361064|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361065|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361066|NCT01275144|Lorazepam|lorazepam|mesh-list
138361067|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
138361068|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
138361069|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
138361070|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361071|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361072|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361073|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138361074|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361075|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138361076|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361077|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361078|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
138361079|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
138361080|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361081|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361083|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
138361084|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361085|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
138361087|NCT01271010|Fludarabine|fludarabine|mesh-list
138361088|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361089|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
138361090|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361091|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361092|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138361093|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
138361094|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361095|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361096|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138361097|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361099|NCT01270620|Desflurane|desflurane|mesh-list
138361100|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138361101|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361102|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361103|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138361104|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
138361105|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
138361106|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138361107|NCT01270464|Reslizumab|reslizumab|mesh-list
138361108|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138361109|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138361110|NCT01279590|Atorvastatin|atorvastatin|mesh-list
138361111|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138361112|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138361113|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
138361114|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361115|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138361116|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138361117|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361118|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138361119|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
138361120|NCT01271790|Ribavirin|ribavirin|mesh-list
138361121|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
138361122|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361123|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
138361124|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361125|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
138361126|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361127|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
138361128|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
138361129|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361130|NCT01270152|Protective Agents|protective agents|mesh-ancestor
138361131|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361132|NCT01270152|Vitamins|vitamins|mesh-ancestor
138361133|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
138361134|NCT01274988|Methadone|methadone|mesh-list
138361135|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138361137|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361138|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361140|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
138361141|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361142|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
138361143|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
138361144|NCT01278498|Escitalopram|escitalopram|mesh-list
138361145|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138361146|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138361147|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361148|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361149|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361150|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
138361151|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361152|NCT01279980|Anesthetics|anesthetics|mesh-list
138361153|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
138361154|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361155|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361156|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
138361157|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361158|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138361159|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138361160|NCT00249834|Hormones|hormones|mesh-ancestor
138361161|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361162|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361163|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361164|NCT00249444|Mirtazapine|mirtazapine|mesh-list
138361165|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
138361166|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361167|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138361168|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
138361169|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
138361170|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361171|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361172|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361173|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138361274|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138361275|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361276|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361277|NCT03804840|Hormones|hormones|mesh-ancestor
138361278|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361279|NCT03804372|Tenofovir|tenofovir|mesh-list
138361280|NCT03804372|Rituximab|rituximab|mesh-list
138361281|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361284|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361285|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361286|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
138361287|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361288|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138361289|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138361291|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361292|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138361293|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138361294|NCT03803124|Tolvaptan|tolvaptan|mesh-list
138361296|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361298|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361299|NCT03802032|Lidocaine|lidocaine|mesh-list
138361300|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
138361301|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
138361302|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361303|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361305|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361306|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138361307|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138361308|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138361309|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361310|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361312|NCT03801252|Cefazolin|cefazolin|mesh-list
138361314|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361315|NCT03800550|Clarithromycin|clarithromycin|mesh-list
138361316|NCT03800550|Bedaquiline|bedaquiline|mesh-list
138361317|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138361322|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138361323|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138361324|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
138361326|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361327|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361329|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361331|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138361332|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361333|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
138361336|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138361337|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361338|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361340|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
138361342|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361343|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361344|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138361345|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138361346|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138361347|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138361350|NCT03467256|Dexamethasone|dexamethasone|mesh-list
138361351|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
138361352|NCT03467256|Fludarabine|fludarabine|mesh-list
138361353|NCT03467256|Etoposide|etoposide|mesh-list
138361354|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361355|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
138361356|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361357|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361358|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138361359|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
138361360|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361361|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361362|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138361363|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361364|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
138361365|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
138361366|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361367|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138361369|NCT03467256|Hormones|hormones|mesh-ancestor
138361370|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361372|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361374|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138361375|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138361376|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138361377|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361378|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
138361379|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361381|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361382|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361383|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138361384|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361386|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361387|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361388|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361389|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361390|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
138361391|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138361392|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
138361393|NCT05311722|Ketamine|ketamine|mesh-list
138361395|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138361396|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361397|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361398|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361399|NCT05311722|Analgesics|analgesics|mesh-ancestor
138361400|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
138361401|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361402|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138361404|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138361405|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
138361406|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361407|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361408|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138361409|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138361410|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
138361411|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
138361412|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138361413|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138361414|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138361415|NCT05311722|Narcotics|narcotics|mesh-ancestor
138361416|NCT03215940|Dronabinol|dronabinol|mesh-list
138361417|NCT03215940|Cannabidiol|cannabidiol|mesh-list
138361418|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
138361419|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
138361421|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361423|NCT03215940|Analgesics|analgesics|mesh-ancestor
138361424|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
138361425|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361426|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138361428|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361429|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361431|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361435|NCT03218514|Tinzaparin|tinzaparin|mesh-list
138361436|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138361438|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138361439|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138361440|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361441|NCT03218124|Remifentanil|remifentanil|mesh-list
138361442|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138361443|NCT03218124|Narcotics|narcotics|mesh-ancestor
138361444|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361445|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361446|NCT03218124|Analgesics|analgesics|mesh-ancestor
138361447|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
138361448|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361449|NCT03217734|Adalimumab|adalimumab|mesh-list
138361450|NCT03217734|Methotrexate|methotrexate|mesh-list
138361451|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138361453|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361454|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361456|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
138361646|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361457|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361458|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361459|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
138361460|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361461|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138361462|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361464|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361465|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138361466|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138361467|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361468|NCT03216876|Ursolic acid|ursolic acid|mesh-list
138361470|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138361471|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361472|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138361473|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361474|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361475|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138361476|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361477|NCT03216876|Analgesics|analgesics|mesh-ancestor
138361478|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
138361479|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361480|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361482|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361483|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138361484|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361485|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
138361486|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138361487|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138361489|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361490|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361491|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
138361492|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361493|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361494|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138361495|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361499|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
138361500|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361501|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361502|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138361503|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138361504|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361505|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361506|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138361508|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138361510|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361514|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361515|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361516|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
138361517|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
138361518|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361519|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
138361521|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138361523|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361524|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138361525|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138361526|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138361527|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361528|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
138361529|NCT03213444|Fluorouracil|fluorouracil|mesh-list
138361530|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361531|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
138361532|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361533|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361534|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361536|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361537|NCT03212820|Methamphetamine|methamphetamine|mesh-list
138361538|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138361539|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361541|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
138361542|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361543|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
138361544|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361545|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361546|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
138361547|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138361549|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361550|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138361554|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361555|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361556|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
138361557|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138361558|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361559|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361560|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138361561|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138361562|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361563|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361566|NCT03211572|Anastrozole|anastrozole|mesh-list
138361567|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138361568|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
138361570|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361571|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138361572|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361573|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138361574|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138361575|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361576|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138361577|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138361578|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361580|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
138361582|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
138361585|NCT03211650|Protective Agents|protective agents|mesh-ancestor
138361587|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138361588|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361592|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361593|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361594|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361595|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361596|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361597|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361598|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138361599|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138361600|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138361601|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
138361602|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361603|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361604|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138361605|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138361606|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138361607|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138361608|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138361610|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138361611|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138361612|NCT03210324|Mifepristone|mifepristone|mesh-list
138361613|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138361614|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
138361616|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361619|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138361620|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
138361621|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138361622|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138361624|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361625|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
138361633|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
138361639|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361640|NCT01832922|Rituximab|rituximab|mesh-list
138361641|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138361642|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361643|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361644|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
138361645|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361647|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138361648|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
138361649|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361653|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361654|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361655|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361656|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361657|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138361658|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
138361659|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361660|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361661|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138361664|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
138361665|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361666|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138361667|NCT01834014|Bevacizumab|bevacizumab|mesh-list
138361668|NCT01834014|Cetuximab|cetuximab|mesh-list
138361669|NCT01834014|Fluorouracil|fluorouracil|mesh-list
138361671|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361672|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361678|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
138361679|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361681|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361682|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
138361683|NCT01834170|Gemcitabine|gemcitabine|mesh-list
138361684|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361685|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
138361686|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361687|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361689|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361690|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361691|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361692|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361694|NCT01835340|Propofol|propofol|mesh-list
138361695|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361696|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361697|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138361698|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138361700|NCT01836120|Docetaxel|docetaxel|mesh-list
138361701|NCT01836120|Raltitrexed|raltitrexed|mesh-list
138361702|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361703|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138361704|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138361705|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138361706|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361707|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361708|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
138361709|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138361710|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361713|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
138361714|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361726|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361727|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361728|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138361729|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138361730|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
138361737|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138361738|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361741|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
138361742|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361743|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361744|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138361745|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138361746|NCT01838538|Growth Substances|growth substances|mesh-ancestor
138361748|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138361750|NCT01838772|Ribavirin|ribavirin|mesh-list
138361751|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361752|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
138361753|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361754|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
138361756|NCT01838928|Bupivacaine|bupivacaine|mesh-list
138361757|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
138361758|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
138362162|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
138361759|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361760|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361761|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
138361764|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138361765|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
138361766|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
138361767|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361768|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361770|NCT01839240|Azacitidine|azacitidine|mesh-list
138361774|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361775|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361776|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
138361777|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361778|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361780|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361781|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361782|NCT01839240|Analgesics|analgesics|mesh-ancestor
138361783|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
138361786|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138361787|NCT01839552|Fentanyl|fentanyl|mesh-list
138361788|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138361789|NCT01839552|Narcotics|narcotics|mesh-ancestor
138361790|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361791|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361792|NCT01839552|Analgesics|analgesics|mesh-ancestor
138361793|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
138361794|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361795|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138361796|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138361803|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361805|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138361806|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138361807|NCT01839864|Analgesics|analgesics|mesh-ancestor
138361808|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
138361809|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361810|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361812|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361815|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138361816|NCT01834248|Poly ICLC|poly iclc|mesh-list
138361817|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361818|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
138361819|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361821|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361822|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
138361823|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
138361827|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
138361828|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361829|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138361830|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361831|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361832|NCT01836432|Leucovorin|leucovorin|mesh-list
138361833|NCT01836432|Paclitaxel|paclitaxel|mesh-list
138361834|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138361835|NCT01836432|Gemcitabine|gemcitabine|mesh-list
138361836|NCT01836432|Capecitabine|capecitabine|mesh-list
138361837|NCT01836432|Fluorouracil|fluorouracil|mesh-list
138361838|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
138361839|NCT01836432|Irinotecan|irinotecan|mesh-list
138361842|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361843|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
138361844|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
138361845|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
138361846|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361847|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361848|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
138361849|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361850|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
138361851|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361852|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138361853|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138361854|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361855|NCT01836432|Antidotes|antidotes|mesh-ancestor
138361856|NCT01836432|Protective Agents|protective agents|mesh-ancestor
138361857|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
138361859|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
138361860|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138361861|NCT01720056|Verapamil|verapamil|mesh-list
138361862|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361865|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361867|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361868|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
138361874|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
138361876|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138361878|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138361879|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138361880|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361881|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361882|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361883|NCT01720212|Urological Agents|urological agents|mesh-ancestor
138361885|NCT01720290|Repaglinide|repaglinide|mesh-list
138361886|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138361887|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361888|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138361889|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138361891|NCT01721382|Incretins|incretins|mesh-ancestor
138361892|NCT01721382|Hormones|hormones|mesh-ancestor
138361893|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361894|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138361895|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
138361896|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361897|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361898|NCT01721616|Azithromycin|azithromycin|mesh-list
138361899|NCT01721616|Cefazolin|cefazolin|mesh-list
138361901|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361902|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138361903|NCT01721694|Azithromycin|azithromycin|mesh-list
138361904|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138361905|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361906|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138361909|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
138361910|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361911|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361912|NCT01722630|Dopamine|dopamine|mesh-list
138361913|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138361914|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
138361915|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
138361916|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361917|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361918|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
138361919|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361920|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361921|NCT01722630|Protective Agents|protective agents|mesh-ancestor
138361922|NCT01722942|Amiodarone|amiodarone|mesh-list
138361923|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138361924|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
138361925|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138361926|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361927|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361928|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138361929|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138361930|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138361931|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361932|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138361933|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138361934|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138361935|NCT01723800|Carboplatin|carboplatin|mesh-list
138361936|NCT01723800|Pemetrexed|pemetrexed|mesh-list
138361937|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361945|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
138361946|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361947|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138361948|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138361949|NCT01724268|Prednisolone|prednisolone|mesh-list
138361950|NCT01724268|Methotrexate|methotrexate|mesh-list
138361951|NCT01724268|Methamphetamine|methamphetamine|mesh-list
138361952|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138361953|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
138361954|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361955|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361956|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361957|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
138361958|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361960|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
138361961|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361962|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138361963|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361964|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
138361965|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138361966|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138361967|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361968|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
138361970|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138361990|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138361991|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361994|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138361995|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138361996|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361997|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361998|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362000|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362001|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138362002|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
138362003|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138362004|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138362005|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
138362006|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
138362009|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362010|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138362011|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138362012|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138362013|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362016|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138362017|NCT01725204|Dasatinib|dasatinib|mesh-list
138362018|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362019|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362020|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362021|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362023|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138362024|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362025|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138362026|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138362027|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362028|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362029|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138362030|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138362031|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362032|NCT01725672|Metformin|metformin|mesh-list
138362037|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362038|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
138362039|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138362040|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138362046|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362047|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362048|NCT01726530|Analgesics|analgesics|mesh-ancestor
138362052|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138362053|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
138362054|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
138362055|NCT01726686|Ropivacaine|ropivacaine|mesh-list
138362056|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
138362058|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362059|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362060|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
138362061|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362062|NCT01726764|Metformin|metformin|mesh-list
138362063|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138362066|NCT01726920|Naratriptan|naratriptan|mesh-list
138362067|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362068|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362069|NCT01726920|Analgesics|analgesics|mesh-ancestor
138362070|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
138362071|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362078|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362079|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138362080|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138362081|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138362082|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
138362083|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362084|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138362085|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138362086|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362087|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
138362088|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138362089|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362090|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
138362092|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362093|NCT01728948|Sorafenib|sorafenib|mesh-list
138362094|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362095|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362096|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362097|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362098|NCT01729104|Rituximab|rituximab|mesh-list
138362100|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362101|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362102|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
138362103|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362104|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362105|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138362106|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138362107|NCT01729104|Growth Substances|growth substances|mesh-ancestor
138362108|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
138362110|NCT01729260|Piperazine|piperazine|mesh-list
138362111|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
138362112|NCT01729260|DMP 777|dmp 777|mesh-list
138362113|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
138362114|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
138362115|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138362116|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362117|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
138362118|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
138362119|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
138362120|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362121|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362122|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362123|NCT01729806|Rituximab|rituximab|mesh-list
138362124|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138362126|NCT01729806|Antibodies|antibodies|mesh-list
138362129|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
138362130|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362131|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362132|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362133|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138362134|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362135|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
138362136|NCT01724658|Testosterone|testosterone|mesh-list
138362137|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
138362138|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
138362139|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138362140|NCT01724658|Androgens|androgens|mesh-ancestor
138362142|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362143|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362144|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138362145|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362146|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
138362147|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
138362148|NCT01049334|Analgesics|analgesics|mesh-ancestor
138362149|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
138362150|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362151|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362152|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362153|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362154|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362155|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362156|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138362157|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362158|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362159|NCT01048944|Bupropion|bupropion|mesh-list
138362161|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138362163|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362164|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362165|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138362167|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138362168|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362169|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362170|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138362173|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138362174|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138362175|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362176|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
138362178|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362179|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362180|NCT01048866|Acetaminophen|acetaminophen|mesh-list
138362181|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
138362182|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362183|NCT01048866|Analgesics|analgesics|mesh-ancestor
138362184|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
138362188|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362189|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362190|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362191|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138362197|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
138362198|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362199|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138362200|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362201|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362202|NCT01046682|Analgesics|analgesics|mesh-ancestor
138362203|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
138362204|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362205|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362206|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362207|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362210|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138362211|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138362212|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
138362213|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362214|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362215|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138362216|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138362217|NCT01042938|Curcumin|curcumin|mesh-list
138362218|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362219|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362220|NCT01042938|Analgesics|analgesics|mesh-ancestor
138362221|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
138362222|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362223|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362224|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362225|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362226|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362227|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362228|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362229|NCT01042158|Ambrisentan|ambrisentan|mesh-list
138362230|NCT01042158|Tadalafil|tadalafil|mesh-list
138362231|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
138362232|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138362233|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138362234|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362235|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362236|NCT01042158|Urological Agents|urological agents|mesh-ancestor
138362237|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362241|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138362242|NCT03409068|Anesthetics|anesthetics|mesh-list
138362243|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362244|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362245|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
138362247|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
138362248|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362249|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362250|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
138362252|NCT03407976|Apatinib|apatinib|mesh-list
138362253|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362254|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362255|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138362257|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362260|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138362261|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362265|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138362266|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362267|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362268|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
138362269|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362270|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362271|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
138362272|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138362273|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138362274|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362275|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138362277|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362278|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362279|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362280|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138362281|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
138362282|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362284|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138362285|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138362286|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138362288|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362289|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362290|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362291|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362293|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362294|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362296|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
138362297|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362298|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362299|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362300|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362301|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362303|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
138362305|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138362306|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362307|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362309|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362310|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362311|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362313|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362314|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362315|NCT03402204|Ubenimex|ubenimex|mesh-list
138362316|NCT03402204|Simvastatin|simvastatin|mesh-list
138362317|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138362318|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138362319|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
138362320|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362321|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138362322|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138362323|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362324|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138362325|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
138362327|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138362328|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362329|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138362330|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362331|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362333|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138362334|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
138362335|NCT03402048|Carboplatin|carboplatin|mesh-list
138362336|NCT03402048|Gemcitabine|gemcitabine|mesh-list
138362338|NCT03402048|Pemetrexed|pemetrexed|mesh-list
138362339|NCT03402048|Vinorelbine|vinorelbine|mesh-list
138362340|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362341|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362342|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
138362343|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362423|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362424|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362425|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138362426|NCT02241174|Eusol|eusol|mesh-list
138362427|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
138362428|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362429|NCT02241564|Sirolimus|sirolimus|mesh-list
138362430|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
138362432|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138362433|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362434|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362435|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362436|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362437|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
138362438|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362439|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362440|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138362441|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362442|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138362443|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
138362444|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
138362445|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138362447|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362448|NCT02241876|Expectorants|expectorants|mesh-ancestor
138362449|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362450|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138362451|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
138362452|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362453|NCT02241876|Protective Agents|protective agents|mesh-ancestor
138362454|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362456|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138362457|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138362458|NCT02242344|Telmisartan|telmisartan|mesh-list
138362459|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362460|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138362461|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138362462|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362464|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362465|NCT02242656|Narcotics|narcotics|mesh-ancestor
138362466|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362467|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362468|NCT02242656|Analgesics|analgesics|mesh-ancestor
138362469|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
138362471|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
138362473|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
138362475|NCT02242812|Metoprolol|metoprolol|mesh-list
138362476|NCT02242812|Telmisartan|telmisartan|mesh-list
138362478|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138362479|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138362480|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362482|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
138362483|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
138362484|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362485|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362486|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138362487|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138362488|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138362489|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362490|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362491|NCT02243124|Dexamethasone|dexamethasone|mesh-list
138362492|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362493|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
138362494|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
138362495|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362496|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362497|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362498|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
138362499|NCT02243124|Hormones|hormones|mesh-ancestor
138362500|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362502|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362503|NCT02243436|Cytarabine|cytarabine|mesh-list
138362504|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
138362505|NCT02243436|Etoposide|etoposide|mesh-list
138362507|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362508|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138362509|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138362510|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138362511|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362512|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362513|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362514|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
138362515|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
138362516|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362517|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362519|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362521|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
138362523|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362524|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362526|NCT02243436|Hormones|hormones|mesh-ancestor
138362527|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362528|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138362529|NCT02243436|Protective Agents|protective agents|mesh-ancestor
138362530|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362532|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
138362534|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138362535|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
138362536|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
138362537|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362538|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362541|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
138362542|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362543|NCT02244216|Fenoterol|fenoterol|mesh-list
138362544|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138362545|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
138362546|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362547|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362549|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362550|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
138362551|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
138362552|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138362553|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138362554|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138362555|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138362557|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362558|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362560|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138362561|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138362562|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138362564|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362565|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362567|NCT02244294|Urological Agents|urological agents|mesh-ancestor
138362568|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
138362569|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
138362570|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138362571|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138362572|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362573|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362576|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362577|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138362578|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138362579|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362581|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138362583|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362584|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362585|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362586|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
138362587|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362589|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362590|NCT02246712|Narcotics|narcotics|mesh-ancestor
138362591|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362592|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362593|NCT02246712|Analgesics|analgesics|mesh-ancestor
138362594|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
138362596|NCT02246868|Factor VIII|factor viii|mesh-list
138362600|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362601|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362602|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362603|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362604|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
138362605|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362606|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362607|NCT02247414|Aspirin|aspirin|mesh-list
138362608|NCT02247414|Heparin|heparin|mesh-list
138362609|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138362611|NCT02247414|Dalteparin|dalteparin|mesh-list
138362612|NCT02247414|Dipyridamole|dipyridamole|mesh-list
138362613|NCT02247414|Warfarin|warfarin|mesh-list
138362614|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138362615|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362616|NCT02247414|Analgesics|analgesics|mesh-ancestor
138362617|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
138362618|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362619|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362620|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362632|NCT02247648|Tramadol|tramadol|mesh-list
138362633|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362635|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362636|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362637|NCT02247648|Analgesics|analgesics|mesh-ancestor
138362638|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
138362639|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362640|NCT02248428|Clarithromycin|clarithromycin|mesh-list
138362643|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
138362644|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362645|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
138362646|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362647|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362648|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138362649|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
138362650|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362651|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362652|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138362653|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362655|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
138362656|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362657|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362658|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
138362665|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362666|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138362667|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362668|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
138362669|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138362670|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138362671|NCT02248428|Growth Substances|growth substances|mesh-ancestor
138362672|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
138362674|NCT02248506|Miconazole|miconazole|mesh-list
138362675|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138362678|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138362679|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362681|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362682|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138362684|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362685|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362687|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138362690|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138362691|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138362692|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138362693|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138362694|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362695|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362696|NCT02249130|Ritonavir|ritonavir|mesh-list
138362697|NCT02249130|Lamivudine|lamivudine|mesh-list
138362698|NCT02249130|Zidovudine|zidovudine|mesh-list
138362699|NCT02249130|Stavudine|stavudine|mesh-list
138362700|NCT02249130|Tipranavir|tipranavir|mesh-list
138362701|NCT02249130|Delavirdine|delavirdine|mesh-list
138362702|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138362703|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138362704|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362705|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362706|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362708|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138362709|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
138362710|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362711|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138362712|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362713|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138362714|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138362715|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
138362716|NCT02249364|Propofol|propofol|mesh-list
138362717|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138362723|NCT02249442|Ritonavir|ritonavir|mesh-list
138362724|NCT02249442|Tipranavir|tipranavir|mesh-list
138362725|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138362726|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138362727|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362728|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362729|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362730|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138362731|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138362732|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
138362733|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362734|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138362736|NCT02244762|Hydrocodone|hydrocodone|mesh-list
138362737|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362738|NCT02244762|Narcotics|narcotics|mesh-ancestor
138362739|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362740|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362741|NCT02244762|Analgesics|analgesics|mesh-ancestor
138362742|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
138362743|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362744|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
138362745|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362746|NCT02242734|Hydrocodone|hydrocodone|mesh-list
138362747|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362748|NCT02242734|Narcotics|narcotics|mesh-ancestor
138362749|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362753|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362754|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
138362755|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
138362767|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362768|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362769|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138362784|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138362785|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138362786|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138362789|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138362790|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362791|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362792|NCT02243358|Gemcitabine|gemcitabine|mesh-list
138362793|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138362794|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
138362795|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362796|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362797|NCT00559962|Atorvastatin|atorvastatin|mesh-list
138362798|NCT00559962|Ezetimibe|ezetimibe|mesh-list
138362799|NCT00559962|Fenofibrate|fenofibrate|mesh-list
138362800|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138362805|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138362806|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362807|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
138362808|NCT00559104|Carmustine|carmustine|mesh-list
138362809|NCT00559104|Etoposide|etoposide|mesh-list
138362810|NCT00559104|Lenograstim|lenograstim|mesh-list
138362811|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138362815|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138362817|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362818|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362819|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138362820|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138362821|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138362822|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138362823|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362824|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138362825|NCT00558636|Paclitaxel|paclitaxel|mesh-list
138362826|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138362847|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362848|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362850|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362851|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138362852|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
138362853|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138362854|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138362855|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362856|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362857|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
138362858|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138362859|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
138362862|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138362866|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138362867|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362871|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138362873|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138362874|NCT00555438|PENTA|penta|mesh-list
138362875|NCT00555438|Fondaparinux|fondaparinux|mesh-list
138362876|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138362877|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
138362878|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138362879|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362880|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362881|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362882|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
138362883|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138362890|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138362891|NCT00553644|Growth Substances|growth substances|mesh-ancestor
138362892|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
138362893|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362894|NCT00552240|Ritonavir|ritonavir|mesh-list
138362895|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138362896|NCT00552240|Tenofovir|tenofovir|mesh-list
138362898|NCT00552240|Nevirapine|nevirapine|mesh-list
138362899|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138362900|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138362901|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362902|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362904|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138362905|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138362906|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
138362907|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362908|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138362909|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138362910|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138362911|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138362912|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138362920|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138362921|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138362922|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362923|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362925|NCT00550680|Hematinics|hematinics|mesh-ancestor
138362926|NCT00556920|Carvedilol|carvedilol|mesh-list
138362927|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138362928|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138362929|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362930|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138362932|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362933|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362934|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
138362935|NCT00556920|Protective Agents|protective agents|mesh-ancestor
138362936|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138362937|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362938|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138362939|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
138362940|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138362941|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138362942|NCT00552708|Lisinopril|lisinopril|mesh-list
138362943|NCT00552708|Carvedilol|carvedilol|mesh-list
138362944|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138362945|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
138362946|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362947|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362948|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138363094|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138363095|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138363096|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363097|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363098|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138363099|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138363100|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363101|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
138363102|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138363103|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138363106|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138363107|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363108|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138363109|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138363110|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363111|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138363112|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138363114|NCT05440578|Olaparib|olaparib|mesh-list
138363116|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363117|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138363118|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138363119|NCT05440578|Growth Substances|growth substances|mesh-ancestor
138363120|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363121|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
138363122|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138363123|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363124|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363126|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363127|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138363128|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138363129|NCT01689558|Growth Substances|growth substances|mesh-ancestor
138363130|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363131|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
138363132|NCT01689870|Ipilimumab|ipilimumab|mesh-list
138363133|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363134|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363135|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138363136|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363137|NCT05768542|Metoprolol|metoprolol|mesh-list
138363138|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138363139|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138363140|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
138363141|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
138363142|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363143|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363145|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138363146|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138363147|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363148|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363149|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363151|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363152|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138363153|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363154|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363155|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
138363156|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138363157|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
138363158|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363159|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
138363160|NCT05768243|Protective Agents|protective agents|mesh-ancestor
138363162|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138363163|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
138363164|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138363166|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363167|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363168|NCT05768230|Protective Agents|protective agents|mesh-ancestor
138363169|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363170|NCT05768204|Prednisolone|prednisolone|mesh-list
138363171|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138363172|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
138363173|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138363175|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138363176|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
138363177|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363178|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
138363180|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363181|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363182|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138363183|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363184|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
138363185|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
138363186|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363187|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138363188|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138363189|NCT05768204|Protective Agents|protective agents|mesh-ancestor
138363190|NCT05768126|Rivastigmine|rivastigmine|mesh-list
138363191|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138363192|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363193|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363194|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363195|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363196|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363197|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138363198|NCT05768126|Protective Agents|protective agents|mesh-ancestor
138363200|NCT05767827|Epinephrine|epinephrine|mesh-list
138363201|NCT05767827|Racepinephrine|racepinephrine|mesh-list
138363202|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
138363203|NCT05767827|Ropivacaine|ropivacaine|mesh-list
138363204|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
138363205|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
138363206|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
138363207|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363208|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363209|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
138363210|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363211|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138363212|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138363213|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138363214|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363216|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138363217|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363218|NCT05767827|Analgesics|analgesics|mesh-ancestor
138363219|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138363220|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138363221|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363222|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363223|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363224|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138363225|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138363227|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138363228|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363229|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
138363230|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
138363231|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138363232|NCT05767723|Aspirin|aspirin|mesh-list
138363233|NCT05767723|Ticagrelor|ticagrelor|mesh-list
138363234|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138363235|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138363236|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138363237|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138363238|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138363240|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363241|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363242|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363243|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363244|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363246|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
138363247|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363248|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363249|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363250|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138363251|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138363252|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138363253|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363254|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
138363255|NCT05767671|Dimercaprol|dimercaprol|mesh-list
138363256|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
138363257|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
138363258|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363259|NCT05767632|Mirabegron|mirabegron|mesh-list
138363260|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
138363261|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138363262|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138363263|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363264|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363265|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363266|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363267|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363268|NCT05767632|Urological Agents|urological agents|mesh-ancestor
138363269|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138363270|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138363271|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363272|NCT05767515|Inositol|inositol|mesh-list
138363273|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
138363274|NCT05767515|Metformin|metformin|mesh-list
138363275|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363276|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363277|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
138363278|NCT05767515|Vitamins|vitamins|mesh-ancestor
138363279|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
138363280|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
138363281|NCT05767255|Insulin|insulin|mesh-list
138363282|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138363283|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
138363284|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
138363285|NCT05767255|Liraglutide|liraglutide|mesh-list
138363286|NCT05767255|Xultophy|xultophy|mesh-list
138363287|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363288|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363289|NCT05767255|Incretins|incretins|mesh-ancestor
138363290|NCT05767255|Hormones|hormones|mesh-ancestor
138363291|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363293|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138363294|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138363295|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363296|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363297|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363298|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363299|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138363300|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
138363301|NCT05767229|Protective Agents|protective agents|mesh-ancestor
138363302|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138363303|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363304|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138363305|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
138363306|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138363307|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138363308|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138363309|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
138363310|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363311|NCT05753267|Mesalamine|mesalamine|mesh-list
138363312|NCT05753267|Fenofibrate|fenofibrate|mesh-list
138363313|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138363314|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
138363315|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363316|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363317|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363318|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363319|NCT05753267|Analgesics|analgesics|mesh-ancestor
138363320|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
138363321|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363322|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363323|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363324|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363325|NCT05751343|Bevacizumab|bevacizumab|mesh-list
138363326|NCT05751343|Atezolizumab|atezolizumab|mesh-list
138363327|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363328|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363329|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138363330|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138363331|NCT05751343|Growth Substances|growth substances|mesh-ancestor
138363332|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363333|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
138363334|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138363335|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363336|NCT05647681|Acetaminophen|acetaminophen|mesh-list
138363337|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363338|NCT05647681|Analgesics|analgesics|mesh-ancestor
138363339|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
138363340|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363341|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363342|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
138363343|NCT05644145|Vaccines|vaccines|mesh-list
138363344|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
138363345|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363347|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
138363348|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
138363349|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363350|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363351|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
138363352|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363353|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
138363354|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138363355|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363356|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363357|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363359|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
138363363|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363364|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363365|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363366|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363367|NCT05604599|Fentanyl|fentanyl|mesh-list
138363368|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
138363371|NCT05604599|Atracurium|atracurium|mesh-list
138363372|NCT05604599|Cisatracurium|cisatracurium|mesh-list
138363373|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138363374|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363375|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363376|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363377|NCT05604599|Analgesics|analgesics|mesh-ancestor
138363378|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
138363379|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363380|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138363381|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138363382|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363383|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363384|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363385|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363386|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138363388|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
138363389|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138363390|NCT05604599|Narcotics|narcotics|mesh-ancestor
138363391|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138363392|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138363393|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138363394|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138363395|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138363396|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138363397|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138363398|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363400|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
138363401|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
138363402|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
138363403|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363404|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363405|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138363406|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138363407|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138363408|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138363409|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138363410|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363411|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363412|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363413|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363414|NCT05486026|Analgesics|analgesics|mesh-ancestor
138363415|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
138363416|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363417|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
138363420|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363421|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363422|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
138363423|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
138363424|NCT05468099|Povidone|povidone|mesh-list
138363425|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138363426|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363427|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
138363428|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
138363429|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
138363430|NCT05334472|Ofatumumab|ofatumumab|mesh-list
138363431|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363432|NCT05332067|Omalizumab|omalizumab|mesh-list
138363433|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138363434|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138363436|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363437|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
138363438|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363439|NCT05323890|Tislelizumab|tislelizumab|mesh-list
138363440|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363441|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363442|NCT05284019|Erenumab|erenumab|mesh-list
138363443|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138363444|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138363445|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138363446|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363447|NCT05284019|Analgesics|analgesics|mesh-ancestor
138363448|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
138363449|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363450|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363451|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138363452|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138363453|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363454|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363455|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363456|NCT05249634|Testosterone|testosterone|mesh-list
138363457|NCT05249634|Androgens|androgens|mesh-ancestor
138363458|NCT05249634|Hormones|hormones|mesh-ancestor
138363459|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363460|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363461|NCT05217342|Diuretics|diuretics|mesh-list
138363462|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
138363463|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363464|NCT05193370|Vasopressins|vasopressins|mesh-list
138363465|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
138363466|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
138363467|NCT05193370|Giapreza|giapreza|mesh-list
138363468|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
138363469|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
138363470|NCT05193370|Coagulants|coagulants|mesh-ancestor
138363471|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138363472|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138363473|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
138363474|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363475|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138363476|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
138363477|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363479|NCT05172947|Resveratrol|resveratrol|mesh-list
138363480|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
138363481|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363482|NCT05172947|Protective Agents|protective agents|mesh-ancestor
138363483|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363484|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363485|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138363486|NCT05170607|Antibodies|antibodies|mesh-list
138363487|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
138363488|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363489|NCT05078827|Fluorouracil|fluorouracil|mesh-list
138363490|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
138363491|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363492|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138363493|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363494|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138363495|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
138363496|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363497|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138363577|NCT04612920|Ibuprofen|ibuprofen|mesh-list
138363498|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138363499|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363500|NCT05065164|Denosumab|denosumab|mesh-list
138363501|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138363502|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363503|NCT05057819|Empagliflozin|empagliflozin|mesh-list
138363504|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138363505|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363506|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363507|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363508|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138363509|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138363510|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138363511|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138363512|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363513|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363514|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363515|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363517|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363518|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363519|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
138363520|NCT04804072|Narcotics|narcotics|mesh-ancestor
138363521|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138363522|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363523|NCT04804072|Analgesics|analgesics|mesh-ancestor
138363524|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
138363525|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363527|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138363528|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
138363529|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
138363530|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138363531|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363532|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363533|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138363534|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363535|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363536|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363538|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138363539|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138363540|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
138363541|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363543|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138363544|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363545|NCT04677959|Fluticasone|fluticasone|mesh-list
138363547|NCT04677959|Albuterol|albuterol|mesh-list
138363548|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138363549|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363550|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138363551|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
138363552|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138363553|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363554|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138363555|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
138363556|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
138363557|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138363558|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138363559|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138363560|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138363561|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138363562|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363563|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363564|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
138363565|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138363566|NCT04671043|Caffeine|caffeine|mesh-list
138363568|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363569|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138363570|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363571|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363572|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138363574|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
138363575|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363576|NCT04612920|Acetaminophen|acetaminophen|mesh-list
138363833|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138363834|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363835|NCT03654833|Bevacizumab|bevacizumab|mesh-list
138363836|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
138363837|NCT03654833|Atezolizumab|atezolizumab|mesh-list
138363838|NCT03654833|Niraparib|niraparib|mesh-list
138363839|NCT03654833|Dostarlimab|dostarlimab|mesh-list
138363840|NCT03654833|Rucaparib|rucaparib|mesh-list
138363841|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363842|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363843|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138363844|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138363845|NCT03654833|Growth Substances|growth substances|mesh-ancestor
138363846|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363847|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138363848|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138363849|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363850|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138363851|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363852|NCT03426904|Leucovorin|leucovorin|mesh-list
138363854|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
138363855|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
138363856|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363857|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138363858|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363859|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138363860|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
138363861|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363863|NCT03426904|Protective Agents|protective agents|mesh-ancestor
138363866|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
138363867|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
138363868|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
138363869|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363871|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
138363872|NCT03287778|Vitamins|vitamins|mesh-ancestor
138363873|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
138363874|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363875|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
138363876|NCT03273413|Pravastatin|pravastatin|mesh-list
138363877|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138363878|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138363879|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
138363880|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363881|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138363882|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138363883|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363884|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138363885|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138363886|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
138363887|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363888|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138363889|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138363890|NCT03074539|Riociguat|riociguat|mesh-list
138363891|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
138363892|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363893|NCT03030131|Durvalumab|durvalumab|mesh-list
138363894|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363895|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363896|NCT03011021|Liraglutide|liraglutide|mesh-list
138363897|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363898|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363899|NCT03011021|Incretins|incretins|mesh-ancestor
138363900|NCT03011021|Hormones|hormones|mesh-ancestor
138363901|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138363902|NCT02995252|Tenofovir|tenofovir|mesh-list
138363905|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138363906|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138363907|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138363908|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138363909|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138363910|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138363911|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138363912|NCT02995252|Hematinics|hematinics|mesh-ancestor
138363914|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138363915|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363984|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138363986|NCT02659384|Bevacizumab|bevacizumab|mesh-list
138363987|NCT02659384|Atezolizumab|atezolizumab|mesh-list
138363988|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138363989|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138363990|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138363991|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138363992|NCT02659384|Growth Substances|growth substances|mesh-ancestor
138363993|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138363994|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
138363997|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363998|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138363999|NCT02659384|Analgesics|analgesics|mesh-ancestor
138364000|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
138364001|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364002|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364005|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138364006|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364007|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138364008|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364010|NCT02659306|Metformin|metformin|mesh-list
138364011|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138364012|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364013|NCT02591147|Fluorides|fluorides|mesh-list
138364014|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
138364015|NCT02591147|Protective Agents|protective agents|mesh-ancestor
138364016|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364018|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138364019|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
138364020|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364022|NCT02588872|Protective Agents|protective agents|mesh-ancestor
138364023|NCT02387203|Amoxicillin|amoxicillin|mesh-list
138364024|NCT02387203|Clarithromycin|clarithromycin|mesh-list
138364025|NCT02387203|Lansoprazole|lansoprazole|mesh-list
138364026|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364027|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364028|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138364029|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364030|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364031|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138364032|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364033|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138364034|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138364035|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138364036|NCT02381353|Bupivacaine|bupivacaine|mesh-list
138364037|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
138364038|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
138364039|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364040|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364041|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
138364043|NCT01992653|Prednisone|prednisone|mesh-list
138364044|NCT01992653|Prednisolone|prednisolone|mesh-list
138364045|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
138364046|NCT01992653|Rituximab|rituximab|mesh-list
138364047|NCT01992653|Doxorubicin|doxorubicin|mesh-list
138364048|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
138364049|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138364050|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364051|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
138364052|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364053|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364054|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138364055|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
138364056|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364057|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364058|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138364059|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364060|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138364061|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364062|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364064|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364065|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
138364066|NCT01992653|Hormones|hormones|mesh-ancestor
138364067|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364068|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138364069|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
138364123|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364124|NCT00590122|Levodopa|levodopa|mesh-list
138364125|NCT00590122|Carbidopa|carbidopa|mesh-list
138364126|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138364127|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138364128|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138364129|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
138364130|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364131|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364132|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364133|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138364134|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364135|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138364136|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
138364137|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
138364138|NCT00309192|Triamcinolone|triamcinolone|mesh-list
138364139|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138364140|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138364141|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138364142|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364143|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
138364144|NCT00309192|Hormones|hormones|mesh-ancestor
138364145|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364146|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364147|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364148|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
138364149|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364150|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364151|NCT00110591|Leronlimab|leronlimab|mesh-list
138364152|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138364153|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138364154|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364155|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138364156|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138364157|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
138364158|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364159|NCT01689246|Methylene Blue|methylene blue|mesh-list
138364160|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364161|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364162|NCT01685268|Prednisone|prednisone|mesh-list
138364163|NCT01685268|Prednisolone|prednisolone|mesh-list
138364164|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
138364165|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364166|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
138364167|NCT01685268|Hormones|hormones|mesh-ancestor
138364168|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364169|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364170|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138364171|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364172|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138364173|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364174|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364175|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
138364176|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364177|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138364178|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
138364179|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364180|NCT01683084|Telmisartan|telmisartan|mesh-list
138364181|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364182|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138364183|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138364184|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364187|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138364188|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138364189|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138364190|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364191|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364192|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364193|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364194|NCT04823442|Urological Agents|urological agents|mesh-ancestor
138364195|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364196|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
138364197|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
138364198|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364199|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138364200|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138364201|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138364202|NCT01384448|Dobutamine|dobutamine|mesh-list
138364203|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138364205|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
138364206|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364207|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364208|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138364209|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138364210|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138364211|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364212|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364213|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364214|NCT01384448|Protective Agents|protective agents|mesh-ancestor
138364215|NCT01384578|Vitamins|vitamins|mesh-list
138364216|NCT01384578|Vitamin E|vitamin e|mesh-list
138364217|NCT01384578|Tocopherols|tocopherols|mesh-list
138364218|NCT01384578|Tocotrienols|tocotrienols|mesh-list
138364219|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
138364220|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
138364221|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
138364222|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364223|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
138364224|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364225|NCT01384578|Protective Agents|protective agents|mesh-ancestor
138364226|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138364228|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364229|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138364230|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
138364231|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138364232|NCT01384643|Propofol|propofol|mesh-list
138364233|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138364234|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364235|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364236|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138364237|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
138364238|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
138364239|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138364240|NCT01384682|Maraviroc|maraviroc|mesh-list
138364241|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138364242|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138364243|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364244|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138364245|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138364246|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
138364247|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364248|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138364250|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138364251|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364252|NCT01384708|Proflavine|proflavine|mesh-list
138364253|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138364254|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364255|NCT01384799|Cisplatin|cisplatin|mesh-list
138364256|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364257|NCT01384812|Dinoprostone|dinoprostone|mesh-list
138364258|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
138364259|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138364260|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364261|NCT01384864|Proflavine|proflavine|mesh-list
138364262|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138364263|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364264|NCT01384903|Antithrombins|antithrombins|mesh-list
138364265|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
138364266|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138364267|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138364268|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364269|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364270|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
138364271|NCT01384994|Folic Acid|folic acid|mesh-list
138364272|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
138364273|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
138364274|NCT01384994|Fluorouracil|fluorouracil|mesh-list
138364276|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364277|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
138364278|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364279|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364280|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364281|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
138364282|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364283|NCT01384994|Hematinics|hematinics|mesh-ancestor
138364284|NCT01384994|Vitamins|vitamins|mesh-ancestor
138364285|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
138364286|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364287|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
138364288|NCT01385020|Red yeast rice|red yeast rice|mesh-list
138364289|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138364290|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
138364291|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364292|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138364293|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138364294|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364295|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364296|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138364297|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138364298|NCT01385124|Cannabidiol|cannabidiol|mesh-list
138364299|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
138364300|NCT01385228|Prednisone|prednisone|mesh-list
138364301|NCT01385228|Docetaxel|docetaxel|mesh-list
138364302|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364303|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
138364304|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
138364305|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364306|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364307|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364308|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
138364310|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364311|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364312|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138364313|NCT01385345|Vitamin D|vitamin d|mesh-list
138364314|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
138364315|NCT01385345|Vitamins|vitamins|mesh-ancestor
138364316|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
138364317|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364318|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138364319|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138364320|NCT01385527|Triamcinolone|triamcinolone|mesh-list
138364321|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364322|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
138364323|NCT01385527|Hormones|hormones|mesh-ancestor
138364324|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364325|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364326|NCT01385631|Ezetimibe|ezetimibe|mesh-list
138364327|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138364328|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138364329|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
138364330|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364331|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138364332|NCT01385683|Clarithromycin|clarithromycin|mesh-list
138364334|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364335|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364336|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138364338|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364339|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138364340|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364341|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
138364342|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138364343|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138364344|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
138364345|NCT01385735|Rasagiline|rasagiline|mesh-list
138364346|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138364348|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364349|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138364350|NCT01385735|Protective Agents|protective agents|mesh-ancestor
138364351|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364352|NCT01385826|Antibodies|antibodies|mesh-list
138364353|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138364354|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
138364355|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364356|NCT01385891|Etoposide|etoposide|mesh-list
138364357|NCT01385891|Clofarabine|clofarabine|mesh-list
138364358|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138364359|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364360|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364361|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364362|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364363|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364364|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364365|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
138364366|NCT01385956|Gemcitabine|gemcitabine|mesh-list
138364367|NCT01385956|Pasireotide|pasireotide|mesh-list
138364368|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364369|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
138364370|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364372|NCT01385956|Hormones|hormones|mesh-ancestor
138364373|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364374|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364375|NCT01386086|Aripiprazole|aripiprazole|mesh-list
138364376|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
138364377|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138364378|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138364379|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138364380|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364381|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364382|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
138364383|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
138364384|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364385|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364386|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138364387|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138364389|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138364390|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138364391|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138364392|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138364393|NCT01386151|Mitogens|mitogens|mesh-list
138364394|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364395|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364396|NCT01386164|Vaccines|vaccines|mesh-list
138364397|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
138364398|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364399|NCT01386177|Doxazosin|doxazosin|mesh-list
138364400|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138364401|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
138364402|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364403|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138364404|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
138364405|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364406|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364407|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138364408|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138364409|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138364410|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364411|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364412|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138364413|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138364414|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138364416|NCT01386229|Etomidate|etomidate|mesh-list
138364417|NCT01386229|Analgesics|analgesics|mesh-ancestor
138364418|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
138364419|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364420|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364421|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138364422|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138364423|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
138364424|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
138364425|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364426|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138364427|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138364428|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364429|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364430|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138364432|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364433|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
138364434|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364436|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138364437|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364438|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138364439|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364440|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138364442|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
138364443|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364444|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364445|NCT01386268|Factor VIII|factor viii|mesh-list
138364446|NCT01386268|Coagulants|coagulants|mesh-ancestor
138364448|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
138364449|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364450|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138364451|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138364452|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364453|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364454|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138364455|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138364456|NCT01386333|Oxytocin|oxytocin|mesh-list
138364457|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
138364458|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138364459|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364460|NCT01386346|Capecitabine|capecitabine|mesh-list
138364461|NCT01386346|Azacitidine|azacitidine|mesh-list
138364462|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
138364463|NCT01386346|Epirubicin|epirubicin|mesh-list
138364464|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364465|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
138364466|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364467|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364468|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364469|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138364470|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364471|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364472|NCT01386372|Tolvaptan|tolvaptan|mesh-list
138364473|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138364474|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364475|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
138364476|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364477|NCT01386398|Bortezomib|bortezomib|mesh-list
138364478|NCT01386398|Vorinostat|vorinostat|mesh-list
138364479|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364480|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138364481|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364482|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364483|NCT01386502|Pidilizumab|pidilizumab|mesh-list
138364484|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364485|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364486|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
138364487|NCT01386567|Citric Acid|citric acid|mesh-list
138364488|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
138364495|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138364496|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
138364497|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138364498|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
138364499|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
138364500|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364501|NCT01386567|Androgens|androgens|mesh-ancestor
138364502|NCT01386567|Hormones|hormones|mesh-ancestor
138364503|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364504|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364505|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138364506|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364507|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
138364508|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138364509|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
138364510|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138364511|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
138364512|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138364513|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138364514|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138364515|NCT01386580|Doxorubicin|doxorubicin|mesh-list
138364516|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138364517|NCT01386580|Trastuzumab|trastuzumab|mesh-list
138364597|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
138364518|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138364519|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364520|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364521|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364523|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364524|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364525|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
138364527|NCT01386593|Fluconazole|fluconazole|mesh-list
138364528|NCT01386593|Paroxetine|paroxetine|mesh-list
138364529|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364530|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364531|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364532|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364533|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364534|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364535|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364536|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138364537|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138364538|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138364539|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138364541|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364543|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364544|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138364545|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
138364546|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138364547|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138364548|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138364549|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
138364550|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
138364551|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138364552|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138364553|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138364554|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138364555|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138364556|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138364557|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138364558|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
138364559|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138364560|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138364561|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
138364562|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364563|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138364564|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138364566|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138364568|NCT01386658|Analgesics|analgesics|mesh-ancestor
138364569|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
138364570|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364571|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364572|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364573|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364574|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138364575|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138364576|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364577|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138364578|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364579|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
138364580|NCT01386671|Metformin|metformin|mesh-list
138364581|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138364582|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364586|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364587|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138364589|NCT01386853|Pitavastatin|pitavastatin|mesh-list
138364590|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138364591|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138364592|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
138364593|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364594|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138364595|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138364596|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364598|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138364599|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364600|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364602|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364603|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364605|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
138364606|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138364607|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364608|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138364610|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364611|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364612|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138364613|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
138364614|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
138364616|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364617|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138364618|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138364619|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138364620|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364622|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364624|NCT01387048|Azelaic acid|azelaic acid|mesh-list
138364625|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138364626|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138364627|NCT01387048|Analgesics|analgesics|mesh-ancestor
138364628|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
138364629|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364630|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364631|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364632|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364633|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
138364634|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364635|NCT01387087|Peficitinib|peficitinib|mesh-list
138364636|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364637|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364638|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364639|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
138364640|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364642|NCT01387191|Tezosentan|tezosentan|mesh-list
138364643|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364644|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364646|NCT01387204|Trametinib|trametinib|mesh-list
138364647|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364648|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138364649|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364650|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364651|NCT01387243|Orlistat|orlistat|mesh-list
138364652|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364653|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364654|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138364655|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138364656|NCT01387373|Capecitabine|capecitabine|mesh-list
138364657|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
138364658|NCT01387373|Trastuzumab|trastuzumab|mesh-list
138364659|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364660|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
138364661|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364662|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364663|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364665|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364666|NCT01387425|Varenicline|varenicline|mesh-list
138364667|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138364668|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138364669|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
138364670|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364671|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364672|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364673|NCT01387568|Lidocaine|lidocaine|mesh-list
138364674|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
138364675|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
138364676|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138364677|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364678|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
138365166|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
138364679|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364680|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138364681|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138364682|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138364683|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138364684|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364685|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
138364686|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138364687|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
138364688|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364689|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
138364690|NCT01387620|Protective Agents|protective agents|mesh-ancestor
138364691|NCT01387880|Everolimus|everolimus|mesh-list
138364692|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138364693|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138364694|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364695|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364696|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364697|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
138364698|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364699|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364700|NCT01387906|Bimatoprost|bimatoprost|mesh-list
138364701|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364702|NCT01387997|Antibodies|antibodies|mesh-list
138364703|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
138364704|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364705|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
138364706|NCT01388023|Listerine|listerine|mesh-list
138364707|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138364708|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364709|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
138364711|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138364712|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138364713|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138364715|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364716|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364717|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364718|NCT01388049|Antibodies|antibodies|mesh-list
138364719|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
138364720|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364721|NCT01388062|Antibodies|antibodies|mesh-list
138364723|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364724|NCT01388075|Rifampin|rifampin|mesh-list
138364725|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138364726|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
138364727|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364728|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364729|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
138364730|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138364731|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364732|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364733|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138364734|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138364735|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138364736|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138364737|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138364738|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138364741|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138364742|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
138364743|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364744|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364745|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138364746|NCT01388088|Diuretics|diuretics|mesh-ancestor
138364747|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138364748|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138364749|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138364750|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138364751|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364752|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138364753|NCT01388101|Antibodies|antibodies|mesh-list
138364754|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
138364757|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
138364758|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364759|NCT01388153|Acarbose|acarbose|mesh-list
138364760|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138364761|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364762|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364763|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138364764|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364765|NCT01388270|Heparin|heparin|mesh-list
138364766|NCT01388270|Calcium heparin|calcium heparin|mesh-list
138364767|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
138364768|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138364769|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138364770|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364772|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
138364773|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138364774|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138364775|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364776|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138364777|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364778|NCT01388439|Oseltamivir|oseltamivir|mesh-list
138364779|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
138364780|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364781|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364783|NCT01388517|Vitamin D|vitamin d|mesh-list
138364784|NCT01388517|Calcitriol|calcitriol|mesh-list
138364786|NCT01388517|Tacrolimus|tacrolimus|mesh-list
138364787|NCT01388517|Vitamins|vitamins|mesh-ancestor
138364788|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
138364789|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364790|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138364791|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364793|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138364794|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364795|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364796|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138364797|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138364798|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138364799|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138364801|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138364802|NCT01388582|Copper|copper|mesh-list
138364803|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
138364804|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
138364805|NCT01388582|Etonogestrel|etonogestrel|mesh-list
138364806|NCT01388582|Desogestrel|desogestrel|mesh-list
138364807|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
138364808|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138364809|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364810|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138364812|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
138364813|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138364814|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138364815|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138364816|NCT01388582|Progestins|progestins|mesh-ancestor
138364817|NCT01388582|Hormones|hormones|mesh-ancestor
138364818|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364819|NCT01388595|Fluticasone|fluticasone|mesh-list
138364820|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138364821|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364822|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138364823|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
138364824|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364825|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364827|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
138364828|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138364829|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138364830|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138364831|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138364832|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138364833|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
138364834|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364835|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364836|NCT01388621|Carboplatin|carboplatin|mesh-list
138364837|NCT01388621|Gemcitabine|gemcitabine|mesh-list
138364838|NCT01388621|Doxorubicin|doxorubicin|mesh-list
138364839|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138364840|NCT01388621|Panitumumab|panitumumab|mesh-list
138364841|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364842|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364843|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
138364844|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364845|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138364846|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364847|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364848|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364849|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364850|NCT01388660|Clopidogrel|clopidogrel|mesh-list
138364851|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364852|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138364853|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138364854|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138364855|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
138364856|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364857|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364858|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364859|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
138364860|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138364861|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
138364862|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138364863|NCT01388738|Protective Agents|protective agents|mesh-ancestor
138364864|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364865|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
138364866|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138364867|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
138364868|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364869|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364870|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138364871|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
138364872|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138364874|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364875|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138364876|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138364877|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
138364878|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
138364879|NCT01388842|Protective Agents|protective agents|mesh-ancestor
138364881|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
138364882|NCT01388855|Vitamins|vitamins|mesh-ancestor
138364883|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
138364884|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364885|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138364886|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138364887|NCT01388959|Rituximab|rituximab|mesh-list
138364888|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364889|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364890|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
138364891|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364892|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364893|NCT01389063|Maraviroc|maraviroc|mesh-list
138364894|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138364895|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138364896|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364897|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138364898|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138364899|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
138364900|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364901|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138364903|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138364904|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138364905|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364906|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
138364907|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364908|NCT01389193|Ibudilast|ibudilast|mesh-list
138364909|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138364910|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
138364911|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364912|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364913|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138364914|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
138364915|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138364916|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364917|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364918|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364919|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
138364920|NCT01389206|Bosentan|bosentan|mesh-list
138364921|NCT01389206|Selexipag|selexipag|mesh-list
138364922|NCT01389206|Iloprost|iloprost|mesh-list
138364923|NCT01389206|Macitentan|macitentan|mesh-list
138364924|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364925|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
138364926|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138364928|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364929|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138364930|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138364932|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138364934|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138364935|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138364936|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138364937|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
138364938|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364939|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138364940|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138364942|NCT01389401|Omeprazole|omeprazole|mesh-list
138364943|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138364944|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138364945|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138364946|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364947|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364948|NCT01389414|Gemcitabine|gemcitabine|mesh-list
138364949|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
138364950|NCT01389414|Panitumumab|panitumumab|mesh-list
138364951|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364952|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
138364953|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364954|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364955|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364956|NCT01389427|Sirolimus|sirolimus|mesh-list
138364957|NCT01389427|Prednisone|prednisone|mesh-list
138364958|NCT01389427|Temsirolimus|temsirolimus|mesh-list
138364959|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
138364960|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
138364961|NCT01389427|Vincristine|vincristine|mesh-list
138364962|NCT01389427|Rituximab|rituximab|mesh-list
138364963|NCT01389427|Doxorubicin|doxorubicin|mesh-list
138364965|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364966|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364967|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138364968|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
138364969|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138364971|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138364972|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138364973|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138364974|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
138364975|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138364976|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138364977|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
138364978|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138364979|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138364980|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
138364981|NCT01389427|Hormones|hormones|mesh-ancestor
138364982|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138364983|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138364984|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138364985|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138364986|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138364987|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138364988|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138364989|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138364990|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138364991|NCT01389440|Gemcitabine|gemcitabine|mesh-list
138364992|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138364993|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138364994|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
138364995|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138364996|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138364997|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138364998|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365000|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365001|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365002|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138365003|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138365004|NCT01389505|Growth Substances|growth substances|mesh-ancestor
138365005|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365006|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
138365009|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138365010|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138365012|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365013|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365015|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138365016|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
138365017|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365018|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138365019|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138365020|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138365021|NCT01389544|Narcotics|narcotics|mesh-ancestor
138365022|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365023|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365024|NCT01389544|Analgesics|analgesics|mesh-ancestor
138365025|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
138365026|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365027|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
138365028|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365029|NCT01389557|Piperaquine|piperaquine|mesh-list
138365030|NCT01389557|Primaquine|primaquine|mesh-list
138365031|NCT01389557|Artenimol|artenimol|mesh-list
138365032|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
138365034|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138365035|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365036|NCT01389609|Doxazosin|doxazosin|mesh-list
138365037|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138365038|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138365039|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138365040|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138365041|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
138365042|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365043|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365044|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365045|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138365046|NCT01389713|Clomiphene|clomiphene|mesh-list
138365047|NCT01389713|Enclomiphene|enclomiphene|mesh-list
138365048|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
138365049|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138365050|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138365051|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365052|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365053|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138365054|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
138365055|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365056|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138365057|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138365058|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
138365059|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138365060|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
138365061|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138365062|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138365063|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365066|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365067|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
138365068|NCT01389791|Rocuronium|rocuronium|mesh-list
138365069|NCT01389791|Analgesics|analgesics|mesh-ancestor
138365070|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
138365071|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365072|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365073|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
138365074|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365075|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138365076|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
138365077|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138365079|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365080|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365082|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365083|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138365084|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138365085|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138365086|NCT01389908|Olanzapine|olanzapine|mesh-list
138365087|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
138365088|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
138365089|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365090|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365091|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365092|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138365093|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138365094|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365095|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138365096|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138365097|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138365098|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365100|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365101|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
138365103|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
138365104|NCT01390012|BB 1101|bb 1101|mesh-list
138365105|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365106|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
138365107|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
138365108|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365109|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365110|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365111|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
138365112|NCT01390012|Hormones|hormones|mesh-ancestor
138365113|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365114|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138365115|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365116|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365117|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365118|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365120|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138365121|NCT01390051|Dalteparin|dalteparin|mesh-list
138365122|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
138365123|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138365124|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138365125|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365126|NCT01390311|Azacitidine|azacitidine|mesh-list
138365127|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138365128|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
138365129|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365130|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365131|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365132|NCT01390324|Naproxen|naproxen|mesh-list
138365135|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138365136|NCT01390324|Analgesics|analgesics|mesh-ancestor
138365137|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
138365138|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365139|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365140|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365141|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365142|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
138365143|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138365144|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365145|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365146|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138365147|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138365148|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138365149|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
138365150|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365152|NCT01390337|Daunorubicin|daunorubicin|mesh-list
138365153|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138365154|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
138365155|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365159|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365160|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
138365161|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365162|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138365163|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138365164|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138365165|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365300|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138365301|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138365302|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365303|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365304|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
138365305|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365306|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365307|NCT01391156|Urological Agents|urological agents|mesh-ancestor
138365308|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138365310|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138365311|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365312|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365313|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365314|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365315|NCT01391221|Analgesics|analgesics|mesh-ancestor
138365316|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
138365317|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365318|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
138365319|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138365320|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
138365321|NCT01391260|Gefitinib|gefitinib|mesh-list
138365322|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365323|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138365324|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365325|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365326|NCT01391377|Niacin|niacin|mesh-list
138365327|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138365328|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
138365329|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365330|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138365331|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365332|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
138365333|NCT01391377|Vitamins|vitamins|mesh-ancestor
138365334|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
138365335|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365336|NCT01391390|Melatonin|melatonin|mesh-list
138365337|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
138365338|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365339|NCT01391390|Protective Agents|protective agents|mesh-ancestor
138365340|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365341|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365343|NCT01391403|Artemisinin|artemisinin|mesh-list
138365344|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
138365345|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138365346|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138365347|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365348|NCT01391520|Deferiprone|deferiprone|mesh-list
138365349|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138365350|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
138365351|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
138365352|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365354|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365355|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
138365356|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365357|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138365358|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365359|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
138365360|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365362|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
138365363|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
138365364|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365365|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365366|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
138365367|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365368|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138365369|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138365370|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138365372|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365373|NCT01391624|Mineral Oil|mineral oil|mesh-list
138365374|NCT01391624|Emollients|emollients|mesh-ancestor
138365376|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138365377|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138365378|NCT01391689|Protective Agents|protective agents|mesh-ancestor
138365379|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365380|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365381|NCT01391715|Rabeprazole|rabeprazole|mesh-list
138365382|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138365383|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365384|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138365386|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365387|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
138365388|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138365389|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
138365390|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365391|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365392|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138365393|NCT01392014|Piperaquine|piperaquine|mesh-list
138365394|NCT01392014|Primaquine|primaquine|mesh-list
138365395|NCT01392014|Artenimol|artenimol|mesh-list
138365396|NCT01392014|Artemisinins|artemisinins|mesh-list
138365397|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
138365398|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138365399|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138365400|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365402|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365408|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365409|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138365410|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365411|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138365413|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365414|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365415|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138365416|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365417|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
138365418|NCT01392144|Protective Agents|protective agents|mesh-ancestor
138365422|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
138365423|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365424|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138365426|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365427|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138365428|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138365429|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138365430|NCT01392209|Bevacizumab|bevacizumab|mesh-list
138365431|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365432|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365433|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138365434|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138365435|NCT01392209|Growth Substances|growth substances|mesh-ancestor
138365436|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365437|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
138365438|NCT01392287|Memantine|memantine|mesh-list
138365439|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138365440|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138365441|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
138365442|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365443|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365444|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365445|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138365446|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138365447|NCT01392430|Azithromycin|azithromycin|mesh-list
138365448|NCT01392430|Dapsone|dapsone|mesh-list
138365450|NCT01392430|Itraconazole|itraconazole|mesh-list
138365451|NCT01392430|Fluconazole|fluconazole|mesh-list
138365452|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138365453|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365454|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
138365455|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138365456|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138365457|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365458|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365459|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138365460|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138365461|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365462|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365463|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138365464|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138365465|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138365468|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138365469|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138365470|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
138365471|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138365472|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138365473|NCT01392534|Telmisartan|telmisartan|mesh-list
138365474|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138365475|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138365476|NCT01392534|Diuretics|diuretics|mesh-ancestor
138365477|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
138365478|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365479|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138365480|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365481|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365482|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138365483|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138365484|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
138365485|NCT01392612|Hematinics|hematinics|mesh-ancestor
138365486|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
138365487|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365488|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138365489|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138365490|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365491|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365492|NCT01392638|Urological Agents|urological agents|mesh-ancestor
138365493|NCT01392716|Rituximab|rituximab|mesh-list
138365494|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365495|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365496|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
138365497|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365498|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365499|NCT01392755|Ritonavir|ritonavir|mesh-list
138365503|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138365504|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138365505|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365506|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365507|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365509|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138365510|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
138365511|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365512|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138365513|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138365514|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138365515|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365517|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138365518|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
138365519|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
138365520|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365521|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365522|NCT01392768|Levetiracetam|levetiracetam|mesh-list
138365523|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
138365524|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
138365525|NCT01392794|Ramosetron|ramosetron|mesh-list
138365526|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
138365527|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
138365528|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365529|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365530|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365531|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138365532|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
138365533|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365534|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365536|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138365537|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365538|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
138365539|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365540|NCT01392833|Prednisone|prednisone|mesh-list
138365541|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
138365542|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138365543|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138365544|NCT01392833|Prednisolone|prednisolone|mesh-list
138365545|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
138365546|NCT01392833|Azathioprine|azathioprine|mesh-list
138365547|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138365608|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365609|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138365610|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365611|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
138365612|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138365614|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138365615|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138365616|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
138365617|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365618|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365619|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
138365620|NCT01393145|Hormones|hormones|mesh-ancestor
138365621|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365622|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
138365623|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
138365624|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365625|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365627|NCT01393288|Ondansetron|ondansetron|mesh-list
138365628|NCT01393288|Aprepitant|aprepitant|mesh-list
138365629|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
138365630|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
138365631|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365632|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365633|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365634|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
138365635|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
138365636|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138365637|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138365638|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
138365639|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365640|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365641|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138365642|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
138365643|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138365644|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365645|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138365646|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138365647|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138365649|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
138365650|NCT01393340|Omalizumab|omalizumab|mesh-list
138365651|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138365652|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138365653|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365655|NCT01393548|Phenylephrine|phenylephrine|mesh-list
138365656|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
138365657|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
138365658|NCT01393548|Ephedrine|ephedrine|mesh-list
138365659|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138365660|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
138365661|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
138365662|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365663|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365664|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
138365665|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138365666|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
138365667|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365668|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138365669|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138365671|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
138365672|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365673|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365674|NCT01393548|Protective Agents|protective agents|mesh-ancestor
138365675|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138365676|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138365677|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138365678|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138365679|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
138365680|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
138365681|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138365682|NCT01393574|Melatonin|melatonin|mesh-list
138365683|NCT01393574|Methylphenidate|methylphenidate|mesh-list
138365684|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
138365685|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365686|NCT01393574|Protective Agents|protective agents|mesh-ancestor
138365687|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365688|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365689|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138365690|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138365691|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138365692|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365694|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365695|NCT01393769|Melphalan|melphalan|mesh-list
138365696|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138365697|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
138365698|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365700|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138365701|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365702|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
138365703|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365704|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
138365705|NCT01393782|Giapreza|giapreza|mesh-list
138365706|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
138365707|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138365708|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138365709|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365710|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365711|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365712|NCT01393912|Crenolanib|crenolanib|mesh-list
138365713|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365714|NCT01393925|Parecoxib|parecoxib|mesh-list
138365715|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138365716|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138365717|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365718|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365719|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138365720|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138365721|NCT01393925|Analgesics|analgesics|mesh-ancestor
138365722|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
138365723|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365724|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365725|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365726|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365727|NCT01394029|Deferasirox|deferasirox|mesh-list
138365728|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138365729|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
138365730|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
138365731|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365732|NCT01394094|Calcium|calcium|mesh-list
138365733|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365734|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365735|NCT01394133|Ritonavir|ritonavir|mesh-list
138365736|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138365737|NCT01394133|Tenofovir|tenofovir|mesh-list
138365738|NCT01394133|Emtricitabine|emtricitabine|mesh-list
138365740|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138365741|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365742|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365743|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365744|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138365745|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138365746|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
138365747|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365749|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138365750|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138365751|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138365752|NCT01394224|Levetiracetam|levetiracetam|mesh-list
138365753|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
138365754|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
138365755|NCT01394341|Liraglutide|liraglutide|mesh-list
138365756|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138365757|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365758|NCT01394341|Incretins|incretins|mesh-ancestor
138365760|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365761|NCT01394354|Dexamethasone|dexamethasone|mesh-list
138365762|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
138365763|NCT01394354|Doxorubicin|doxorubicin|mesh-list
138365764|NCT01394354|Bortezomib|bortezomib|mesh-list
138365765|NCT01394354|Vorinostat|vorinostat|mesh-list
138365767|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
138365768|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
138365769|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365770|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365771|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365772|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
138365773|NCT01394354|Hormones|hormones|mesh-ancestor
138365774|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365775|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138365776|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365777|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138365778|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138365779|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138365780|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365781|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365783|NCT01394406|Ketamine|ketamine|mesh-list
138365784|NCT01394406|Analgesics|analgesics|mesh-ancestor
138365785|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
138365786|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365787|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365788|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138365789|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138365790|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
138365791|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
138365792|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365793|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138365794|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138365795|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365796|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365797|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
138365798|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138365799|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
138365800|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365801|NCT01394419|Expectorants|expectorants|mesh-ancestor
138365802|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365803|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138365805|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365806|NCT01394419|Protective Agents|protective agents|mesh-ancestor
138365807|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365808|NCT01394419|Antidotes|antidotes|mesh-ancestor
138365809|NCT01394445|Physostigmine|physostigmine|mesh-list
138365810|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138365811|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365812|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365813|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
138365814|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365815|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365816|NCT01394445|Miotics|miotics|mesh-ancestor
138365817|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
138365818|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365819|NCT01394458|Ethanol|ethanol|mesh-list
138365820|NCT01394458|Heparin|heparin|mesh-list
138365821|NCT01394458|Citric Acid|citric acid|mesh-list
138365822|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
138365823|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
138365826|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
138365827|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365828|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138365829|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138365830|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138365839|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
138365840|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365841|NCT01394497|Expectorants|expectorants|mesh-ancestor
138365842|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365843|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138365852|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365853|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365859|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365861|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
138365862|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365863|NCT01394731|Acetaminophen|acetaminophen|mesh-list
138365864|NCT01394731|Meperidine|meperidine|mesh-list
138365865|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138365866|NCT01394731|Analgesics|analgesics|mesh-ancestor
138365867|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
138365868|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365869|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365871|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138365872|NCT01394731|Narcotics|narcotics|mesh-ancestor
138366313|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365873|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365874|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138365883|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
138365884|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
138365885|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138365886|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138365887|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138365889|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365890|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
138365891|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138365893|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138365894|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138365895|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365896|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365897|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365898|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365899|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365900|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138365904|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365905|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138365906|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138365907|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365908|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138365909|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138365910|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
138365911|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138365915|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365917|NCT01394848|Clopidogrel|clopidogrel|mesh-list
138365918|NCT01394848|Atorvastatin|atorvastatin|mesh-list
138365919|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138365920|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138365921|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
138365922|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365923|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138365924|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138365925|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365930|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365931|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365932|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138365933|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138365934|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138365935|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138365936|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
138365937|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365938|NCT01394887|Metformin|metformin|mesh-list
138365939|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138365940|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365941|NCT01394913|Etanercept|etanercept|mesh-list
138365942|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138365943|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138365945|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
138365947|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365948|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365949|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365950|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365955|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138365956|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138365958|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
138365961|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365962|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365963|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138365964|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365965|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365966|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
138365967|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138365968|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365970|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
138365971|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138365972|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138365973|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138365975|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365976|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138365977|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138365978|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365979|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365980|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365981|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
138365982|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138365987|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138365988|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138365989|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365990|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365991|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138365992|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365994|NCT01395251|Prednisolone|prednisolone|mesh-list
138365995|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
138365996|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366001|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366002|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
138366003|NCT01395290|Vitamin D|vitamin d|mesh-list
138366004|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138366005|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366006|NCT01395290|Vitamins|vitamins|mesh-ancestor
138366007|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
138366008|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138366009|NCT01395381|Albendazole|albendazole|mesh-list
138366010|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
138366023|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366024|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366035|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366037|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366038|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138366039|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138366040|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
138366041|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
138366042|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366043|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138366044|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138366045|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
138366046|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138366047|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
138366048|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366049|NCT01395485|Brodalumab|brodalumab|mesh-list
138366050|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366051|NCT01395589|Vitamin D|vitamin d|mesh-list
138366052|NCT01395589|Vitamins|vitamins|mesh-ancestor
138366053|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
138366054|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366055|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138366058|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138366059|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
138366061|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366062|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366063|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366064|NCT01395654|Rifampin|rifampin|mesh-list
138366065|NCT01395654|Isoniazid|isoniazid|mesh-list
138366066|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
138366067|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138366068|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
138366069|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366070|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366071|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
138366072|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138366073|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366074|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366075|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138366076|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138366077|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138366078|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138366079|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138366080|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138366081|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138366089|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366091|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366092|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366093|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366094|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
138366095|NCT01395667|Antidotes|antidotes|mesh-ancestor
138366097|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
138366098|NCT01395667|Vitamins|vitamins|mesh-ancestor
138366099|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
138366100|NCT01395732|Bosentan|bosentan|mesh-list
138366101|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138366102|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138366105|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138366106|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138366107|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366108|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138366109|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
138366110|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366111|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366118|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138366119|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
138366120|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366121|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366122|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
138366123|NCT01395849|Hormones|hormones|mesh-ancestor
138366124|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366126|NCT01395862|Fluticasone|fluticasone|mesh-list
138366127|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138366128|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138366129|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366130|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138366131|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
138366136|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366137|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138366138|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138366139|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138366143|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366145|NCT01395862|Hormones|hormones|mesh-ancestor
138366146|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366147|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
138366148|NCT01395875|Fluticasone|fluticasone|mesh-list
138366149|NCT01395875|Xhance|xhance|mesh-list
138366150|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138366151|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138366152|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366153|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138366154|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
138366159|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366160|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138366161|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138366162|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138366163|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138366164|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
138366165|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366166|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366167|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
138366169|NCT01395927|Rifampin|rifampin|mesh-list
138366170|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138366171|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
138366172|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366174|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
138366175|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138366176|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366177|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366178|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138366179|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138366183|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138366184|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138366186|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366188|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138366189|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366190|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366191|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366192|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366193|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138366195|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366311|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138366196|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366197|NCT01395992|Asenapine|asenapine|mesh-list
138366198|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138366199|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366200|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366201|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366202|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366203|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
138366204|NCT01396200|Sirolimus|sirolimus|mesh-list
138366205|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
138366206|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138366207|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138366208|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366209|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366210|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366211|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366212|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366219|NCT01396291|Asenapine|asenapine|mesh-list
138366220|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138366221|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366222|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366225|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138366226|NCT01396304|Calcium|calcium|mesh-list
138366227|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138366228|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366229|NCT01396304|Laxatives|laxatives|mesh-ancestor
138366230|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138366231|NCT01396564|Metformin|metformin|mesh-list
138366232|NCT01396564|Pioglitazone|pioglitazone|mesh-list
138366233|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138366237|NCT01396655|Docetaxel|docetaxel|mesh-list
138366238|NCT01396655|Doxorubicin|doxorubicin|mesh-list
138366239|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366240|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
138366241|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
138366249|NCT01396668|Capecitabine|capecitabine|mesh-list
138366251|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366252|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
138366253|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366254|NCT01396681|Gemcitabine|gemcitabine|mesh-list
138366255|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366256|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366257|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
138366258|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366259|NCT01396707|Capecitabine|capecitabine|mesh-list
138366260|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
138366261|NCT01396707|Trastuzumab|trastuzumab|mesh-list
138366266|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366268|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138366269|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366272|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366273|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138366274|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138366275|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138366276|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366277|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366278|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
138366279|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138366280|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
138366286|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
138366287|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366289|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366290|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
138366291|NCT01396733|Vitamins|vitamins|mesh-ancestor
138366292|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
138366293|NCT01397006|Pregabalin|pregabalin|mesh-list
138366294|NCT01397006|Analgesics|analgesics|mesh-ancestor
138366295|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
138366296|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366297|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366298|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
138366305|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366306|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366307|NCT01397019|Leucovorin|leucovorin|mesh-list
138366308|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
138366309|NCT01397019|Irinotecan|irinotecan|mesh-list
138366310|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366314|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366315|NCT01397019|Antidotes|antidotes|mesh-ancestor
138366316|NCT01397019|Protective Agents|protective agents|mesh-ancestor
138366317|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366318|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
138366319|NCT01397019|Vitamins|vitamins|mesh-ancestor
138366320|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
138366321|NCT01397097|Etonogestrel|etonogestrel|mesh-list
138366322|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138366323|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
138366324|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138366325|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366326|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138366333|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
138366334|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366335|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366336|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
138366337|NCT01397214|Megestrol|megestrol|mesh-list
138366338|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138366339|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366340|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
138366348|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138366349|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138366350|NCT01397305|Pemetrexed|pemetrexed|mesh-list
138366351|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366352|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366353|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366354|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138366355|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138366358|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138366359|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366360|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366361|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138366362|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
138366363|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
138366364|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138366365|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
138366371|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138366372|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366373|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366378|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366379|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138366380|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138366381|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366382|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366383|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138366384|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
138366385|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366390|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366391|NCT05268627|Incretins|incretins|mesh-ancestor
138366393|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366394|NCT05268601|Sotrovimab|sotrovimab|mesh-list
138366395|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
138366396|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138366397|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
138366411|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
138366412|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366413|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366414|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366415|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
138366416|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366417|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138366418|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138366419|NCT05186558|Growth Substances|growth substances|mesh-ancestor
138366422|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
138366423|NCT05092698|Vitamins|vitamins|mesh-ancestor
138366424|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
138366428|NCT04965870|Trifluridine|trifluridine|mesh-list
138366429|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
138366430|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366432|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366433|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
138366434|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
138366569|NCT06037876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366570|NCT06037876|Anthelmintics|anthelmintics|mesh-ancestor
138366571|NCT06037876|Anticestodal Agents|anticestodal agents|mesh-ancestor
138366572|NCT06037876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138366573|NCT06037876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138366580|NCT06037590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138366581|NCT06037590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138366582|NCT06037590|Dopamine Agents|dopamine agents|mesh-ancestor
138366583|NCT06037590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366584|NCT06037590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366591|NCT06029907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366592|NCT06029907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366593|NCT06011798|Aflibercept|aflibercept|mesh-list
138366594|NCT06011798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138366595|NCT06011798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138366596|NCT06011798|Growth Substances|growth substances|mesh-ancestor
138366597|NCT06011798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366598|NCT06011798|Growth Inhibitors|growth inhibitors|mesh-ancestor
138366601|NCT05988710|Buprenorphine|buprenorphine|mesh-list
138366602|NCT05988710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138366603|NCT05988710|Narcotics|narcotics|mesh-ancestor
138366604|NCT05988710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366605|NCT05988710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366606|NCT05988710|Analgesics|analgesics|mesh-ancestor
138366607|NCT05988710|Sensory System Agents|sensory system agents|mesh-ancestor
138366608|NCT05988710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366609|NCT05988710|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138366610|NCT05882357|Ivacaftor|ivacaftor|mesh-list
138366611|NCT05882357|Elexacaftor|elexacaftor|mesh-list
138366613|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138366614|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366615|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
138366616|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366617|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366618|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138366624|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138366625|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
138366626|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366627|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
138366628|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366629|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366630|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138366631|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
138366632|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366633|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366634|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138366635|NCT05834244|Azacitidine|azacitidine|mesh-list
138366637|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366641|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366642|NCT05806060|Paclitaxel|paclitaxel|mesh-list
138366643|NCT05806060|Vinorelbine|vinorelbine|mesh-list
138366644|NCT05806060|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138366645|NCT05806060|Bevacizumab|bevacizumab|mesh-list
138366646|NCT05806060|Carboplatin|carboplatin|mesh-list
138366647|NCT05806060|Capecitabine|capecitabine|mesh-list
138366648|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138366661|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
138366663|NCT05795647|Vitamin E|vitamin e|mesh-list
138366664|NCT05795647|Tocotrienols|tocotrienols|mesh-list
138366665|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
138366666|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
138366672|NCT05795647|Protective Agents|protective agents|mesh-ancestor
138366673|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366674|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
138366675|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138366676|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
138366677|NCT05795647|Vitamins|vitamins|mesh-ancestor
138366682|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
138366683|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366684|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366685|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366686|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138366694|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366696|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138366697|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366698|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366796|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138366807|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138366808|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
138366809|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138366819|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366820|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366821|NCT05324358|Analgesics|analgesics|mesh-ancestor
138366822|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
138366823|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366827|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366828|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138366829|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366830|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366831|NCT05312645|Diclofenac|diclofenac|mesh-list
138366832|NCT05312645|Petrolatum|petrolatum|mesh-list
138366833|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138366834|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366836|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
138366837|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366838|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366839|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366841|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138366842|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366843|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366844|NCT05312645|Emollients|emollients|mesh-ancestor
138366845|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366846|NCT05301322|Vaccines|vaccines|mesh-list
138366847|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
138366848|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366849|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
138366851|NCT05286528|Ponatinib|ponatinib|mesh-list
138366852|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366853|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138366854|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366855|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366859|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138366860|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
138366861|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366862|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366863|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366864|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366866|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138366867|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
138366875|NCT05234112|Acetic Acid|acetic acid|mesh-list
138366876|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366877|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366878|NCT05201248|Prednisone|prednisone|mesh-list
138366879|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
138366880|NCT05201248|Rituximab|rituximab|mesh-list
138366881|NCT05201248|Doxorubicin|doxorubicin|mesh-list
138366882|NCT05201248|Vincristine|vincristine|mesh-list
138366883|NCT05201248|Lenalidomide|lenalidomide|mesh-list
138366884|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366885|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
138366890|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366899|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
138366901|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138366902|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138366903|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138366904|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138366905|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138366906|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366907|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138366908|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138366909|NCT05201248|Growth Substances|growth substances|mesh-ancestor
138366910|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
138366911|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
138366912|NCT05086692|Interleukin-2|interleukin-2|mesh-list
138366913|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366914|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366922|NCT05048212|Nivolumab|nivolumab|mesh-list
138366923|NCT05048212|Ipilimumab|ipilimumab|mesh-list
138366924|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366925|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366926|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138366927|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366928|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
138366929|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138366930|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366934|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
138366935|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366936|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138366937|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138366938|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138366946|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366947|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
138366948|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366949|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366950|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366951|NCT05007873|Decitabine|decitabine|mesh-list
138366952|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138366958|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366959|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138366975|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138366977|NCT04983901|Cilastatin|cilastatin|mesh-list
138366978|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138366979|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366980|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138366981|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366982|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366983|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138366984|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
138366985|NCT04980404|Decitabine|decitabine|mesh-list
138366986|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366987|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
138366988|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366989|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366990|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366991|NCT04956575|Vaccines|vaccines|mesh-list
138366992|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
138366995|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
138366996|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
138366999|NCT04920708|Ipatasertib|ipatasertib|mesh-list
138367000|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367001|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367002|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138367003|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138367004|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367014|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367015|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367017|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367018|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367019|NCT04732065|Protective Agents|protective agents|mesh-ancestor
138367020|NCT04723862|Spironolactone|spironolactone|mesh-list
138367021|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138367022|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367023|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367024|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367025|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138367027|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367029|NCT04720105|Tazarotene|tazarotene|mesh-list
138367030|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367031|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
138367032|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138367033|NCT04693234|Tislelizumab|tislelizumab|mesh-list
138367068|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367069|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
138367074|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367076|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
138367077|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367078|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367080|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367081|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138367082|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367083|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367084|NCT04574960|Carboplatin|carboplatin|mesh-list
138367085|NCT04574960|Gemcitabine|gemcitabine|mesh-list
138367095|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
138367096|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367097|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138367098|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138367099|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138367100|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138367101|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367102|NCT04554693|Metronidazole|metronidazole|mesh-list
138367108|NCT04473911|Sirolimus|sirolimus|mesh-list
138367114|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367115|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367116|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138367117|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
138367118|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367119|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367120|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138367121|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138367122|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138367126|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367127|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
138367128|NCT04410406|Ivermectin|ivermectin|mesh-list
138367129|NCT04410406|Albendazole|albendazole|mesh-list
138367130|NCT04410406|Moxidectin|moxidectin|mesh-list
138367131|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
138367132|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367133|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138367134|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367135|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
138367136|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
138367137|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138367138|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138367139|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138367140|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367141|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367142|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367143|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
138367145|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138367146|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367147|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138367148|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367149|NCT04338269|Atezolizumab|atezolizumab|mesh-list
138367150|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367151|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367152|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367153|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367154|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138367155|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138367156|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367157|NCT04323189|Incretins|incretins|mesh-ancestor
138367158|NCT04323189|Hormones|hormones|mesh-ancestor
138367159|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367160|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138367161|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
138367162|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367163|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367164|NCT04321330|Atezolizumab|atezolizumab|mesh-list
138367165|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367166|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367168|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367169|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
138367170|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367171|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367172|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367173|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367174|NCT04170946|Talazoparib|talazoparib|mesh-list
138367175|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138367176|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367177|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367178|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367179|NCT04170283|Tislelizumab|tislelizumab|mesh-list
138367180|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
138367181|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367183|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138367184|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367185|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367186|NCT04160052|Azacitidine|azacitidine|mesh-list
138367187|NCT04160052|Venetoclax|venetoclax|mesh-list
138367188|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367189|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
138367201|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367202|NCT04115384|Insulin|insulin|mesh-list
138367205|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367206|NCT04075149|Spironolactone|spironolactone|mesh-list
138367207|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138367208|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367209|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367210|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367211|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138367212|NCT04075149|Diuretics|diuretics|mesh-ancestor
138367213|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367214|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138367216|NCT04025372|Bicalutamide|bicalutamide|mesh-list
138367217|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
138367218|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367219|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367220|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367221|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367222|NCT04004611|Mirikizumab|mirikizumab|mesh-list
138367223|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367224|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367225|NCT04004611|Analgesics|analgesics|mesh-ancestor
138367226|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
138367227|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367228|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367229|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367230|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367231|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138367232|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367233|NCT03939767|Aflibercept|aflibercept|mesh-list
138367234|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367235|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367236|NCT03939767|Growth Substances|growth substances|mesh-ancestor
138367237|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367238|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
138367239|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367241|NCT03914820|Mitomycin|mitomycin|mesh-list
138367242|NCT03914820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138367243|NCT03914820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367244|NCT03914820|Alkylating Agents|alkylating agents|mesh-ancestor
138367245|NCT03914820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367246|NCT03914820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138367247|NCT03914820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367248|NCT03907046|Aspirin|aspirin|mesh-list
138367249|NCT03907046|Apixaban|apixaban|mesh-list
138367250|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367251|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367252|NCT03907046|Analgesics|analgesics|mesh-ancestor
138367253|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
138367254|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367255|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367265|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138367266|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
138367267|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138367268|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
138367269|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
138367270|NCT03884439|Infliximab|infliximab|mesh-list
138367271|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138367273|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367274|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367275|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367276|NCT03859427|Dexamethasone|dexamethasone|mesh-list
138367277|NCT03859427|Lenalidomide|lenalidomide|mesh-list
138367278|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367279|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
138367280|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
138367281|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367282|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367283|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367284|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
138367285|NCT03859427|Hormones|hormones|mesh-ancestor
138367286|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367287|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367288|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367289|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
138367290|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367291|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367292|NCT03859427|Growth Substances|growth substances|mesh-ancestor
138367293|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
138367294|NCT03824938|Aspirin|aspirin|mesh-list
138367295|NCT03824938|Acetaminophen|acetaminophen|mesh-list
138367296|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367297|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367298|NCT03824938|Analgesics|analgesics|mesh-ancestor
138367299|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
138367300|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367301|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367302|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367303|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367304|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138367305|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138367320|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138367321|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
138367322|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367323|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138367324|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367325|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
138367326|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
138367327|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367328|NCT03636373|Triamcinolone|triamcinolone|mesh-list
138367329|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138367330|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138367331|NCT03636373|Etanercept|etanercept|mesh-list
138367332|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138367333|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367334|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
138367335|NCT03636373|Hormones|hormones|mesh-ancestor
138367336|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367337|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367338|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367339|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
138367340|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367341|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367342|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367343|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367345|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
138367346|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367347|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367348|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367350|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367351|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367352|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367353|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367354|NCT03560310|Ticagrelor|ticagrelor|mesh-list
138367355|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138367356|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138367357|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138367358|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138367359|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
138367360|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367361|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367362|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367364|NCT03470675|Morphine|morphine|mesh-list
138367365|NCT03470675|Analgesics|analgesics|mesh-ancestor
138367366|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
138367367|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367368|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367369|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138367370|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138367371|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
138367372|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
138367373|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367374|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138367375|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138367376|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367377|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367378|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138367379|NCT03470675|Narcotics|narcotics|mesh-ancestor
138367380|NCT03456063|Paclitaxel|paclitaxel|mesh-list
138367381|NCT03456063|Carboplatin|carboplatin|mesh-list
138367382|NCT03456063|Gemcitabine|gemcitabine|mesh-list
138367383|NCT03456063|Pemetrexed|pemetrexed|mesh-list
138367384|NCT03456063|Atezolizumab|atezolizumab|mesh-list
138367385|NCT03456063|Antibodies|antibodies|mesh-list
138367386|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138367387|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367388|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
138367389|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367391|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367393|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367394|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367395|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
138367396|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367397|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138367398|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138367399|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367400|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367401|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138367402|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138367403|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367405|NCT03417284|Lenograstim|lenograstim|mesh-list
138367406|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138367407|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
138367408|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367409|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138367410|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
138367411|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367412|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367413|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138367414|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367416|NCT03281369|Linagliptin|linagliptin|mesh-list
138367417|NCT03281369|Paclitaxel|paclitaxel|mesh-list
138367418|NCT03281369|Fluorouracil|fluorouracil|mesh-list
138367419|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
138367420|NCT03281369|Atezolizumab|atezolizumab|mesh-list
138367421|NCT03281369|Ramucirumab|ramucirumab|mesh-list
138367422|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138367423|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138367424|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367425|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138367426|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367427|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367428|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367434|NCT03281369|Antidotes|antidotes|mesh-ancestor
138367435|NCT03281369|Protective Agents|protective agents|mesh-ancestor
138367436|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
138367438|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
138367439|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367440|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367441|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138367442|NCT03281369|Incretins|incretins|mesh-ancestor
138367443|NCT03281369|Hormones|hormones|mesh-ancestor
138367444|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367446|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
138367447|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367448|NCT03264079|Itraconazole|itraconazole|mesh-list
138367449|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
138367450|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367451|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138367452|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138367453|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367454|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367455|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138367456|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367457|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367458|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367459|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138367461|NCT03195478|Ipilimumab|ipilimumab|mesh-list
138367462|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367463|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367464|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367465|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367466|NCT03016871|Carboplatin|carboplatin|mesh-list
138367468|NCT03016871|Etoposide|etoposide|mesh-list
138367469|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
138367470|NCT03016871|Ifosfamide|ifosfamide|mesh-list
138367471|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
138367472|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
138367473|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367474|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367475|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367476|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367477|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138367478|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138367479|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138367480|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367481|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138367482|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
138367483|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
138367484|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367485|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138367486|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367487|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138367489|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138367490|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367491|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367492|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367493|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367494|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
138367495|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
138367496|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
138367497|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367498|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367499|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
138367500|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367501|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138367503|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367504|NCT02402920|Cisplatin|cisplatin|mesh-list
138367505|NCT02402920|Carboplatin|carboplatin|mesh-list
138367510|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367511|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367512|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367513|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367514|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138367515|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138367516|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138367518|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
138367519|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367520|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
138367521|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
138367527|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367528|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367529|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367530|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367531|NCT02113202|Growth Substances|growth substances|mesh-ancestor
138367532|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367534|NCT01781468|Modafinil|modafinil|mesh-list
138367535|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138367536|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367537|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138367538|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138367539|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138367540|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367550|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138367551|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
138367552|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138367553|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367554|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138367555|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138367556|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138367557|NCT01598363|Digoxin|digoxin|mesh-list
138367640|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367641|NCT00188539|Anesthetics|anesthetics|mesh-list
138367642|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367643|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367645|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138367646|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138367647|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367648|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367649|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138367650|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138367651|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138367652|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138367653|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
138367654|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
138367655|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
138367656|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
138367657|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367658|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367659|NCT03524170|Atezolizumab|atezolizumab|mesh-list
138367660|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367661|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367662|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367663|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367664|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
138367665|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138367666|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367668|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
138367669|NCT03283813|Vitamins|vitamins|mesh-ancestor
138367670|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
138367671|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367672|NCT03245827|Clomiphene|clomiphene|mesh-list
138367673|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138367674|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367675|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367676|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367677|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138367678|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
138367681|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138367683|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
138367684|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367685|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138367686|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138367687|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367688|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367689|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138367690|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367691|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367692|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367701|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367702|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367703|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
138367707|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367708|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367709|NCT02607956|Dolutegravir|dolutegravir|mesh-list
138367710|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138367711|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138367712|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138367713|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367714|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367715|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138367716|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138367718|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367719|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138367720|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138367721|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138367722|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
138367723|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367724|NCT02499666|Clopidogrel|clopidogrel|mesh-list
138367725|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138367726|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138367727|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138367728|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138367729|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
138367730|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367731|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367732|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367733|NCT02420912|Nivolumab|nivolumab|mesh-list
138367734|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367735|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367736|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138367737|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367738|NCT02094716|Permethrin|permethrin|mesh-list
138367739|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367740|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367741|NCT01460810|Silicon|silicon|mesh-list
138367742|NCT01460810|Trace Elements|trace elements|mesh-ancestor
138367743|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
138367744|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367745|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
138367746|NCT00667329|Rituximab|rituximab|mesh-list
138367747|NCT00667329|Cladribine|cladribine|mesh-list
138367748|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367749|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
138367750|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367751|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367752|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138367753|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
138367754|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367755|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367756|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138367757|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138367758|NCT00492167|Antibodies|antibodies|mesh-list
138367759|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138367760|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
138367761|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367762|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
138367765|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367766|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367767|NCT05274191|Maleic acid|maleic acid|mesh-list
138367768|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367773|NCT05274139|Fotemustine|fotemustine|mesh-list
138367774|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367775|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
138367776|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
138367777|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367778|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367780|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
138367781|NCT05274139|Hormones|hormones|mesh-ancestor
138367782|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367783|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367784|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367785|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367792|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138367793|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
138367794|NCT05274113|Dexamethasone|dexamethasone|mesh-list
138367795|NCT05274113|Ropivacaine|ropivacaine|mesh-list
138367796|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367797|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
138367798|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
138367799|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367805|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367806|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367807|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138367808|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
138367809|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367810|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
138367812|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
138367813|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367814|NCT05273944|Doxorubicin|doxorubicin|mesh-list
138367815|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138367816|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138367817|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367818|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138367819|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138367820|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367821|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367894|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367895|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367896|NCT05271188|Anesthetics|anesthetics|mesh-list
138367897|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
138367898|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367899|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367900|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
138367901|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367902|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
138367903|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138367910|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138367911|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138367912|NCT05271058|BB 1101|bb 1101|mesh-list
138367913|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138367914|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367915|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
138367916|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
138367919|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367920|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
138367921|NCT05271058|Hormones|hormones|mesh-ancestor
138367922|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367927|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367929|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
138367930|NCT05271045|Vitamin D|vitamin d|mesh-list
138367931|NCT05271045|Vitamin A|vitamin a|mesh-list
138367944|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367946|NCT05270434|Meperidine|meperidine|mesh-list
138367947|NCT05270434|Morphine|morphine|mesh-list
138367948|NCT05270434|Buprenorphine|buprenorphine|mesh-list
138367949|NCT05270434|Analgesics|analgesics|mesh-list
138367950|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138367951|NCT05270434|Narcotics|narcotics|mesh-ancestor
138367952|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367953|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367954|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
138367955|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367956|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138367957|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138367958|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367960|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367961|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367962|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
138367963|NCT05270421|Furosemide|furosemide|mesh-list
138367964|NCT05270421|Diuretics|diuretics|mesh-ancestor
138367965|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
138367966|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367967|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138367969|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367970|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
138367971|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138367972|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367973|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
138367975|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138367976|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367977|NCT05270343|Vitamins|vitamins|mesh-ancestor
138367978|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
138367979|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138367981|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138367982|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
138367983|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367984|NCT05269654|Mannitol|mannitol|mesh-list
138367985|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138367986|NCT05269654|Diuretics|diuretics|mesh-ancestor
138367989|NCT05250141|Levodopa|levodopa|mesh-list
138367992|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138367993|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
138367994|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367995|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368000|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138368001|NCT05248724|Epinephrine|epinephrine|mesh-list
138368002|NCT05248724|Racepinephrine|racepinephrine|mesh-list
138368003|NCT05248724|Morphine|morphine|mesh-list
138368004|NCT05248724|Ropivacaine|ropivacaine|mesh-list
138368005|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
138368012|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368013|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368014|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
138368380|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368015|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138368016|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138368017|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368018|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368019|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138368020|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368021|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368022|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368023|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368024|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368025|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368026|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138368027|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138368028|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
138368036|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368037|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368038|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368039|NCT05209841|Heparin|heparin|mesh-list
138368040|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
138368041|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138368042|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138368043|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368044|NCT05173142|Gemcitabine|gemcitabine|mesh-list
138368047|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368048|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
138368049|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368050|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368051|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368052|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368054|NCT05165875|Lidocaine|lidocaine|mesh-list
138368055|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368056|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
138368057|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368058|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368059|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
138368060|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368061|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368062|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368063|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368064|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368071|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368073|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368074|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368076|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
138368077|NCT05138029|Ranibizumab|ranibizumab|mesh-list
138368078|NCT05138029|BB 1101|bb 1101|mesh-list
138368090|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
138368091|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368092|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368093|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138368094|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138368095|NCT05138029|Growth Substances|growth substances|mesh-ancestor
138368096|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138368097|NCT05135039|Canagliflozin|canagliflozin|mesh-list
138368098|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138368104|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
138368105|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138368107|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368108|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368109|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
138368110|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
138368111|NCT05088928|Apixaban|apixaban|mesh-list
138368112|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138368114|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138368115|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
138368116|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368117|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368118|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
138368119|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
138368120|NCT05075122|Sargramostim|sargramostim|mesh-list
138368122|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368123|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368124|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368125|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
138368126|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368127|NCT05067439|Efavirenz|efavirenz|mesh-list
138368128|NCT05067439|Caffeine|caffeine|mesh-list
138368129|NCT05067439|Omeprazole|omeprazole|mesh-list
138368130|NCT05067439|Abrocitinib|abrocitinib|mesh-list
138368131|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138368132|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368133|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138368134|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368135|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368136|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138368137|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138368138|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
138368139|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368140|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138368167|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138368168|NCT05052528|Antibodies|antibodies|mesh-list
138368169|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
138368170|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138368171|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368172|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
138368173|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368174|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368175|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138368176|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
138368177|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368178|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368179|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138368180|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368181|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
138368190|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368191|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138368192|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138368193|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
138368194|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368195|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138368196|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
138368198|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
138368199|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138368200|NCT05045313|Probenecid|probenecid|mesh-list
138368201|NCT05045313|Digoxin|digoxin|mesh-list
138368202|NCT05045313|Warfarin|warfarin|mesh-list
138368203|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
138368204|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368205|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138368206|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368207|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368208|NCT05045313|Protective Agents|protective agents|mesh-ancestor
138368209|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368210|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
138368211|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
138368212|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368214|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138368215|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138368216|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368217|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
138368218|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368219|NCT04961801|Methotrexate|methotrexate|mesh-list
138368220|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
138368221|NCT04961801|Tacrolimus|tacrolimus|mesh-list
138368222|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138368223|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
138368224|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138368225|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368226|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368227|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
138368228|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368229|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368230|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368231|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368232|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138368278|NCT04760912|Bromides|bromides|mesh-list
138368280|NCT04760912|Rocuronium|rocuronium|mesh-list
138368281|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368282|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368283|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
138368284|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138368285|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138368286|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138368287|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368288|NCT04706767|Lidocaine|lidocaine|mesh-list
138368289|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
138368300|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368301|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138368302|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138368303|NCT04706767|Analgesics|analgesics|mesh-ancestor
138368304|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138368305|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368306|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368307|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368308|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368309|NCT04690686|Paclitaxel|paclitaxel|mesh-list
138368310|NCT04690686|Atezolizumab|atezolizumab|mesh-list
138368311|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138368312|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368313|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368314|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368315|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368316|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368317|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368318|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368320|NCT04682626|Vitamin D|vitamin d|mesh-list
138368321|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138368322|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368323|NCT04682626|Vitamins|vitamins|mesh-ancestor
138368324|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
138368325|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138368326|NCT04604691|Blinatumomab|blinatumomab|mesh-list
138368327|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368328|NCT04580381|Natalizumab|natalizumab|mesh-list
138368329|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
138368330|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368332|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138368333|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
138368334|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368335|NCT04476745|Vitamin D|vitamin d|mesh-list
138368336|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
138368337|NCT04476745|Vitamins|vitamins|mesh-ancestor
138368338|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
138368339|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368340|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138368341|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138368342|NCT04433390|Naloxegol|naloxegol|mesh-list
138368343|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138368344|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368353|NCT04399746|Vitamins|vitamins|mesh-ancestor
138368354|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
138368355|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138368356|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138368357|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368358|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138368359|NCT04391608|Tenofovir|tenofovir|mesh-list
138368360|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
138368361|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368362|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138368363|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138368364|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368365|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368366|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138368367|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138368368|NCT04368091|Sirolimus|sirolimus|mesh-list
138368369|NCT04368091|Temsirolimus|temsirolimus|mesh-list
138368370|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
138368371|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138368372|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368373|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138368374|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368375|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
138368376|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368377|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
138368378|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368379|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368381|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368382|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
138368383|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138368384|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138368386|NCT04245644|Aspirin|aspirin|mesh-list
138368387|NCT04245644|Metformin|metformin|mesh-list
138368388|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138368389|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368390|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368391|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138368392|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138368394|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
138368395|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368396|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368397|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368398|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138368399|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138368400|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368401|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138368402|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138368403|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368404|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
138368405|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
138368406|NCT04238845|Vitamin A|vitamin a|mesh-list
138368407|NCT04238845|Vitamins|vitamins|mesh-ancestor
138368408|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
138368409|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368410|NCT04223037|Vaccines|vaccines|mesh-list
138368411|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
138368412|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368413|NCT04186663|Fluorides|fluorides|mesh-list
138368414|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
138368415|NCT04186663|Protective Agents|protective agents|mesh-ancestor
138368417|NCT04095104|Topiramate|topiramate|mesh-list
138368418|NCT04095104|Phentermine|phentermine|mesh-list
138368419|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
138368420|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368421|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368422|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138368423|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
138368424|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138368425|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
138368426|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
138368427|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368428|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368429|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368430|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368431|NCT04044729|Cannabidiol|cannabidiol|mesh-list
138368432|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
138368433|NCT04008082|Lenvatinib|lenvatinib|mesh-list
138368434|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368435|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368436|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368437|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368438|NCT03974243|Chiauranib|chiauranib|mesh-list
138368439|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368440|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368441|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368442|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368443|NCT03967925|Prednisone|prednisone|mesh-list
138368444|NCT03967925|Prednisolone|prednisolone|mesh-list
138368445|NCT03967925|Rituximab|rituximab|mesh-list
138368446|NCT03967925|Belimumab|belimumab|mesh-list
138368447|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368448|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368449|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
138368450|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368451|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368452|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368453|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
138368454|NCT03967925|Hormones|hormones|mesh-ancestor
138368455|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368456|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368457|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368458|NCT03954743|Vaccines|vaccines|mesh-list
138368459|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
138368460|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368699|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138368700|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
138368701|NCT03012672|Cladribine|cladribine|mesh-list
138368702|NCT03012672|Lenograstim|lenograstim|mesh-list
138368703|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368704|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
138368705|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368706|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368707|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
138368708|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368709|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368710|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
138368711|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368712|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138368713|NCT03012672|Analgesics|analgesics|mesh-ancestor
138368714|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
138368715|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368717|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138368718|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368719|NCT03011775|Aspirin|aspirin|mesh-list
138368720|NCT03011775|Pioglitazone|pioglitazone|mesh-list
138368721|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138368722|NCT03011775|Ramipril|ramipril|mesh-list
138368723|NCT03011775|Bisoprolol|bisoprolol|mesh-list
138368724|NCT03011775|Isosorbide|isosorbide|mesh-list
138368725|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138368726|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138368727|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
138368728|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138368729|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138368730|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368731|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138368732|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138368733|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
138368734|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368735|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138368736|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138368737|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368738|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138368739|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138368741|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
138368742|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368743|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368744|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368745|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138368746|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138368747|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138368748|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
138368749|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138368750|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
138368751|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138368752|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
138368753|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
138368754|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138368755|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138368766|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138368767|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368768|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
138368769|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368770|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
138368771|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368773|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368774|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
138368775|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368776|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368777|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
138368778|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368779|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368780|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368782|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368783|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368784|NCT02924064|Metformin|metformin|mesh-list
138368785|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368786|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368787|NCT02889900|Olaparib|olaparib|mesh-list
138368788|NCT02889900|Cediranib|cediranib|mesh-list
138368789|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138368790|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368791|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368792|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368793|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368794|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138368795|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
138368796|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138368797|NCT02879942|Growth Substances|growth substances|mesh-ancestor
138368798|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368799|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
138368800|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368801|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
138368802|NCT02873819|Sargramostim|sargramostim|mesh-list
138368803|NCT02873819|Poly ICLC|poly iclc|mesh-list
138368804|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368806|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368807|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368808|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138368810|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368811|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368812|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138368813|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
138368814|NCT02810457|Paclitaxel|paclitaxel|mesh-list
138368815|NCT02810457|Bevacizumab|bevacizumab|mesh-list
138368825|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138368826|NCT02810457|Growth Substances|growth substances|mesh-ancestor
138368827|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368828|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
138368829|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
138368830|NCT02745535|Velpatasvir|velpatasvir|mesh-list
138368831|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138368832|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
138368833|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368834|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
138368835|NCT02729701|Estrogens|estrogens|mesh-list
138368837|NCT02729701|Hormones|hormones|mesh-ancestor
138368838|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368839|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368840|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138368841|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138368842|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
138368843|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138368845|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368846|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368847|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368848|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368849|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138368851|NCT02666794|Morphine|morphine|mesh-list
138368852|NCT02666794|Dsuvia|dsuvia|mesh-list
138368853|NCT02666794|Bupivacaine|bupivacaine|mesh-list
138368854|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368855|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
138368856|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368857|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368858|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
138368859|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368860|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138368861|NCT02666794|Narcotics|narcotics|mesh-ancestor
138368862|NCT02666794|Analgesics|analgesics|mesh-ancestor
138368863|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138368864|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138368865|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
138368866|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
138368867|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
138368868|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368869|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368870|NCT02619552|Prednisone|prednisone|mesh-list
138368871|NCT02619552|Budesonide|budesonide|mesh-list
138368872|NCT02619552|Adalimumab|adalimumab|mesh-list
138368873|NCT02619552|Infliximab|infliximab|mesh-list
138368874|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
138368875|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368876|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
138368886|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
138368887|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138368888|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368971|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368972|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368973|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368974|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138368975|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138368976|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138368977|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368978|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138368979|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
138368980|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138368981|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368982|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
138368983|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368984|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138368985|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138368986|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
138368987|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368988|NCT02293109|Antidotes|antidotes|mesh-ancestor
138368989|NCT02293109|Protective Agents|protective agents|mesh-ancestor
138368990|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
138368992|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
138368993|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138368994|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368995|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368996|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368997|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138368998|NCT02195986|Estradiol|estradiol|mesh-list
138368999|NCT02195986|Estrogens|estrogens|mesh-ancestor
138369000|NCT02195986|Hormones|hormones|mesh-ancestor
138369001|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369002|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369003|NCT01982630|Liraglutide|liraglutide|mesh-list
138369004|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369012|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369013|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369014|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138369015|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138369017|NCT01940809|Nivolumab|nivolumab|mesh-list
138369018|NCT01940809|Ipilimumab|ipilimumab|mesh-list
138369019|NCT01940809|Trametinib|trametinib|mesh-list
138369020|NCT01940809|Dabrafenib|dabrafenib|mesh-list
138369021|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138369022|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369023|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138369024|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369025|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369026|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369027|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138369028|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369029|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369030|NCT01879228|Incretins|incretins|mesh-ancestor
138369032|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369033|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138369034|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369035|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369036|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369037|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
138369038|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138369039|NCT01740297|Ipilimumab|ipilimumab|mesh-list
138369040|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138369041|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138369042|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369043|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138369044|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369045|NCT01729754|Etanercept|etanercept|mesh-list
138369046|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138369047|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138369048|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369049|NCT01729754|Analgesics|analgesics|mesh-ancestor
138369050|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
138369051|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369052|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369053|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369054|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138369055|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369056|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138369057|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
138369059|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138369060|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
138369061|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369062|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369063|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138369064|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138369070|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
138369071|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369072|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369073|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369074|NCT01595620|Analgesics|analgesics|mesh-ancestor
138369075|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
138369076|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369077|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138369078|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138369079|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369080|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369082|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369083|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
138369084|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
138369085|NCT01591629|Dronabinol|dronabinol|mesh-list
138369086|NCT01591629|Naloxone|naloxone|mesh-list
138369087|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138369088|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369089|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
138369090|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369092|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369093|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369094|NCT01591629|Analgesics|analgesics|mesh-ancestor
138369095|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138369096|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138369097|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369098|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369099|NCT01591629|Hormones|hormones|mesh-ancestor
138369100|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369101|NCT01515306|Paclitaxel|paclitaxel|mesh-list
138369102|NCT01515306|Ramucirumab|ramucirumab|mesh-list
138369103|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138369104|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369105|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
138369106|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
138369107|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
138369108|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369109|NCT01513187|Interferons|interferons|mesh-list
138369110|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
138369111|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
138369112|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369113|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
138369114|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369115|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
138369116|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369117|NCT01433965|Lenalidomide|lenalidomide|mesh-list
138369118|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
138369119|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369120|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138369121|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138369122|NCT01433965|Growth Substances|growth substances|mesh-ancestor
138369123|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138369124|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369125|NCT01360593|Gemcitabine|gemcitabine|mesh-list
138369126|NCT01360593|Capecitabine|capecitabine|mesh-list
138369127|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369128|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
138369133|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369135|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369136|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369137|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138369138|NCT01334606|Insulin|insulin|mesh-list
138369139|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369140|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369141|NCT01226732|Capecitabine|capecitabine|mesh-list
138369142|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369207|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138369208|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369209|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369210|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369211|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
138369212|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369213|NCT00447122|Gemcitabine|gemcitabine|mesh-list
138369214|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
138369215|NCT00447122|Lapatinib|lapatinib|mesh-list
138369216|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369217|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
138369218|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369219|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369220|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369221|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369222|NCT00430040|Carvedilol|carvedilol|mesh-list
138369223|NCT00430040|Lisinopril|lisinopril|mesh-list
138369224|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138369225|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138369226|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
138369227|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369228|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369229|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369230|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138369232|NCT00430040|Protective Agents|protective agents|mesh-ancestor
138369233|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138369234|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369235|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138369236|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
138369237|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138369238|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138369239|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138369241|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369242|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138369243|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
138369244|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138369245|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
138369246|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138369247|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369248|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138369249|NCT00066963|Fluorides|fluorides|mesh-list
138369251|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
138369252|NCT00066963|Protective Agents|protective agents|mesh-ancestor
138369253|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369254|NCT01397500|Testosterone|testosterone|mesh-list
138369263|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
138369264|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369265|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369266|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369267|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138369268|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138369269|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138369270|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369271|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138369272|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138369273|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369275|NCT01397630|Oxytocin|oxytocin|mesh-list
138369276|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
138369277|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138369278|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369280|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369281|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
138369282|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369283|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369284|NCT01397994|Nicorandil|nicorandil|mesh-list
138369285|NCT01397994|Atenolol|atenolol|mesh-list
138369286|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138369288|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
138369290|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369291|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369292|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138369293|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138369294|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138369295|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
138369296|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369297|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369298|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
138369300|NCT01397994|Vitamins|vitamins|mesh-ancestor
138369301|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
138369302|NCT01398033|Paclitaxel|paclitaxel|mesh-list
138369303|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138369304|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369305|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
138369306|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
138369307|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
138369308|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369309|NCT01398046|Dasatinib|dasatinib|mesh-list
138369310|NCT01398046|Rabeprazole|rabeprazole|mesh-list
138369311|NCT01398046|Betaine|betaine|mesh-list
138369312|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369313|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369314|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369315|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369316|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138369317|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369318|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138369329|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138369330|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369331|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369332|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369334|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138369335|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138369337|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
138369338|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138369339|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
138369340|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369341|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369342|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138369343|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
138369344|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138369345|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138369346|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138369347|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
138369348|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369349|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369350|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138369351|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138369352|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138369353|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
138369354|NCT01398189|Clozapine|clozapine|mesh-list
138369355|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138369356|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
138369357|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369358|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369359|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369360|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138369361|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369362|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369363|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369364|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
138369365|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
138369368|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138369369|NCT01398202|Calcifediol|calcifediol|mesh-list
138369371|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
138369372|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369373|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138369374|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138369375|NCT01398267|Lisinopril|lisinopril|mesh-list
138369376|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138369377|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369378|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369379|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369380|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138369390|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369391|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369392|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369393|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138369394|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138369463|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138369464|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138369465|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138369466|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
138369467|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138369468|NCT01398657|Androgens|androgens|mesh-list
138369469|NCT01398657|Hormones|hormones|mesh-ancestor
138369470|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369471|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369472|NCT01398670|Insulin|insulin|mesh-list
138369473|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138369474|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
138369475|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369476|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369477|NCT01398722|Insulin|insulin|mesh-list
138369478|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138369479|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369480|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369481|NCT01398995|Insulin|insulin|mesh-list
138369482|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369483|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369484|NCT01399086|Fulvestrant|fulvestrant|mesh-list
138369485|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138369486|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369487|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138369488|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138369489|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138369490|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369491|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369493|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
138369494|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
138369495|NCT01399151|Vitamins|vitamins|mesh-list
138369496|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
138369497|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369507|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
138369508|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369509|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369510|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369511|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369512|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138369513|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369514|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
138369515|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369516|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369517|NCT01399346|Insulin|insulin|mesh-list
138369518|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138369519|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
138369520|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
138369521|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138369522|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369523|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369524|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138369525|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138369526|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369527|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369528|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369529|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369530|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138369531|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138369532|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
138369533|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369534|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369535|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138369536|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138369538|NCT01399463|Paclitaxel|paclitaxel|mesh-list
138369539|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138369540|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369541|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
138369542|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
138369543|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
138369544|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369545|NCT01399515|Valproic Acid|valproic acid|mesh-list
138369546|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
138369547|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369548|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369590|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369591|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138369592|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369593|NCT01400165|Pindolol|pindolol|mesh-list
138369594|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138369595|NCT01400165|Trazodone|trazodone|mesh-list
138369596|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
138369597|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369598|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138369599|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369600|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369601|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369602|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138369603|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138369604|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369605|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369606|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369607|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369609|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138369610|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138369611|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138369612|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138369613|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138369614|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138369615|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
138369616|NCT01400191|Metformin|metformin|mesh-list
138369617|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369618|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369619|NCT01400217|Beclomethasone|beclomethasone|mesh-list
138369629|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138369630|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138369631|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369633|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369634|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369635|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138369636|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369637|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369638|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
138369639|NCT01400464|Prednisone|prednisone|mesh-list
138369640|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369641|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
138369642|NCT01400464|Hormones|hormones|mesh-ancestor
138369643|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369644|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369645|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138369646|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369647|NCT01400568|Fluticasone|fluticasone|mesh-list
138369648|NCT01400568|Xhance|xhance|mesh-list
138369649|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369650|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138369651|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
138369652|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369653|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369654|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138369655|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
138369656|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
138369657|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138369658|NCT01400633|Decitabine|decitabine|mesh-list
138369659|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369660|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
138369661|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369662|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369663|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369664|NCT01400646|Vitamins|vitamins|mesh-list
138369665|NCT01400646|Vitamin K|vitamin k|mesh-list
138369666|NCT01400646|Warfarin|warfarin|mesh-list
138369667|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
138369668|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
138369669|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369670|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
138369671|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138369672|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
138369673|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138369674|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369675|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369676|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369677|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138369678|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138369679|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
138369680|NCT01400646|Coagulants|coagulants|mesh-ancestor
138369681|NCT01400672|Imiquimod|imiquimod|mesh-list
138369682|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138369683|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
138369684|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369693|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369695|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138369696|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138369697|NCT01400685|Growth Substances|growth substances|mesh-ancestor
138369698|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
138369699|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138369700|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
138369701|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369702|NCT01400737|Ibuprofen|ibuprofen|mesh-list
138369703|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138369704|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369705|NCT01400737|Analgesics|analgesics|mesh-ancestor
138369706|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
138369707|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369708|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369709|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369710|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138369711|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138369712|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369713|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369715|NCT01400750|Tobramycin|tobramycin|mesh-list
138369716|NCT01400750|Colistin|colistin|mesh-list
138369717|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369718|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369719|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138369720|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138369721|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369722|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369723|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369724|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138369725|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138369727|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
138369728|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369729|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369730|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
138369731|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369732|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369733|NCT01400828|Desloratadine|desloratadine|mesh-list
138369734|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138369735|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
138369736|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369737|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369738|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369739|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138369741|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138369745|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
138369746|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
138369747|NCT01400867|Cefazolin|cefazolin|mesh-list
138369748|NCT01400867|Linezolid|linezolid|mesh-list
138369749|NCT01400867|Cephalexin|cephalexin|mesh-list
138369750|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138369751|NCT01400867|Aztreonam|aztreonam|mesh-list
138369764|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369765|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138369766|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
138369767|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369768|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
138369769|NCT01401075|Doxifluridine|doxifluridine|mesh-list
138369770|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369771|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138369772|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138369773|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
138369774|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369775|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369776|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
138370042|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
138369777|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369778|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138369779|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
138369780|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369781|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
138369782|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138369783|NCT01401179|Clarithromycin|clarithromycin|mesh-list
138369784|NCT01401179|Cefazolin|cefazolin|mesh-list
138369785|NCT01401179|Erythromycin|erythromycin|mesh-list
138369786|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
138369787|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138369788|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
138369789|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369790|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369791|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138369792|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369793|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369794|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138369795|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138369796|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369797|NCT01401192|Cisplatin|cisplatin|mesh-list
138369798|NCT01401192|Gemcitabine|gemcitabine|mesh-list
138369799|NCT01401192|Pemetrexed|pemetrexed|mesh-list
138369800|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369801|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138369802|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
138369803|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369804|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369805|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138369806|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138369807|NCT01401387|Pancreatin|pancreatin|mesh-list
138369808|NCT01401387|Pancrelipase|pancrelipase|mesh-list
138369809|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369810|NCT01401491|Clozapine|clozapine|mesh-list
138369819|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369820|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369821|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
138369822|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
138369823|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138369824|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138369825|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369826|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369827|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138369828|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
138369830|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138369831|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369832|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138369833|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138369834|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138369835|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369836|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369837|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
138369838|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369839|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369840|NCT01401933|Rifampin|rifampin|mesh-list
138369841|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138369842|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
138369843|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369844|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369846|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138369847|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369848|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369849|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138369850|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138369851|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138369852|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138369853|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138369854|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138369855|NCT01402024|Aprepitant|aprepitant|mesh-list
138369856|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
138369857|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
138369858|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369859|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369860|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138369861|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138369862|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369863|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369864|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
138369872|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369873|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138369874|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
138369876|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
138369877|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
138369878|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369879|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369880|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369881|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138369883|NCT01402089|Midazolam|midazolam|mesh-list
138369884|NCT01402089|Caffeine|caffeine|mesh-list
138369885|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138369886|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138369887|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369888|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369890|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369891|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369892|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138369893|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
138369894|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
138369895|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
138369896|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
138369897|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369898|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369899|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369900|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369901|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369902|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138369903|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138369904|NCT01402089|Growth Substances|growth substances|mesh-ancestor
138369905|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138369906|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138369908|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138369909|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138369910|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
138369911|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
138369912|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138369913|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369914|NCT01402193|Anastrozole|anastrozole|mesh-list
138369915|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138369916|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369917|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138369918|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138369919|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369920|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369921|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138369922|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
138369923|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369924|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369926|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138369927|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
138369928|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369929|NCT01402297|Acetovanillone|acetovanillone|mesh-list
138369937|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138369938|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
138369939|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369940|NCT01402297|Protective Agents|protective agents|mesh-ancestor
138369941|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369942|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138369943|NCT01402336|Cetrorelix|cetrorelix|mesh-list
138369944|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138369945|NCT01402336|Hormones|hormones|mesh-ancestor
138369946|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369947|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369949|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138369950|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
138369951|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138369952|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138370154|NCT01403740|Cyclosporine|cyclosporine|mesh-list
138369953|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138369954|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369955|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138369956|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
138369957|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
138369958|NCT01402479|Ramipril|ramipril|mesh-list
138369959|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138369960|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369961|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369962|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369964|NCT01402583|Ribavirin|ribavirin|mesh-list
138369965|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
138369966|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369968|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369969|NCT01402596|Midazolam|midazolam|mesh-list
138369970|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
138369971|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138369972|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138369973|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369974|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369975|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138369976|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369977|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369978|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138369979|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
138369980|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
138369981|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
138369982|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
138369983|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369984|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369985|NCT01402622|Propofol|propofol|mesh-list
138369986|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
138369987|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369988|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370000|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370001|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370002|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370004|NCT01402843|Pitavastatin|pitavastatin|mesh-list
138370005|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370006|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138370007|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138370008|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370009|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138370010|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138370011|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138370012|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
138370013|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370014|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138370015|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
138370016|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138370017|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138370018|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370019|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
138370020|NCT01402882|Coagulants|coagulants|mesh-ancestor
138370021|NCT01403025|Liraglutide|liraglutide|mesh-list
138370022|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370023|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370024|NCT01403025|Incretins|incretins|mesh-ancestor
138370025|NCT01403025|Hormones|hormones|mesh-ancestor
138370026|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370027|NCT01403103|Vitamin D|vitamin d|mesh-list
138370028|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
138370029|NCT01403103|Vitamins|vitamins|mesh-ancestor
138370030|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
138370031|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370032|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138370033|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138370034|NCT01403168|Analgesics|analgesics|mesh-list
138370035|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
138370036|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370037|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370038|NCT01403181|Ribavirin|ribavirin|mesh-list
138370039|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138370040|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
138370041|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370043|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370044|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
138370046|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
138370047|NCT01403285|Molgramostim|molgramostim|mesh-list
138370056|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370058|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138370059|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138370060|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
138370061|NCT01403363|Fentanyl|fentanyl|mesh-list
138370062|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138370063|NCT01403363|Narcotics|narcotics|mesh-ancestor
138370064|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370065|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370066|NCT01403363|Analgesics|analgesics|mesh-ancestor
138370067|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
138370068|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370069|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138370070|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138370071|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
138370072|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
138370073|NCT01403389|Eculizumab|eculizumab|mesh-list
138370074|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138370075|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370076|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
138370077|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370078|NCT01403415|Sirolimus|sirolimus|mesh-list
138370079|NCT01403415|Dexamethasone|dexamethasone|mesh-list
138370080|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
138370082|NCT01403415|Vincristine|vincristine|mesh-list
138370083|NCT01403415|Asparaginase|asparaginase|mesh-list
138370084|NCT01403415|Temsirolimus|temsirolimus|mesh-list
138370085|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
138370086|NCT01403415|Pegaspargase|pegaspargase|mesh-list
138370087|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
138370088|NCT01403415|BB 1101|bb 1101|mesh-list
138370089|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370090|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
138370091|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
138370092|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370093|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370094|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370095|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
138370096|NCT01403415|Hormones|hormones|mesh-ancestor
138370097|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370098|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138370099|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370100|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138370101|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
138370102|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138370106|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
138370107|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370108|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138370109|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370110|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
138370111|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370112|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138370113|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138370114|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138370134|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
138370135|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370136|NCT01403506|Protective Agents|protective agents|mesh-ancestor
138370137|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370138|NCT01403506|Antidotes|antidotes|mesh-ancestor
138370139|NCT01403545|Curcumin|curcumin|mesh-list
138370140|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138370141|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138370142|NCT01403545|Analgesics|analgesics|mesh-ancestor
138370143|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
138370144|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370145|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370146|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370147|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370148|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370149|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370150|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370152|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370153|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370182|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370183|NCT01403844|Protective Agents|protective agents|mesh-ancestor
138370185|NCT01403896|Plerixafor|plerixafor|mesh-list
138370186|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138370187|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138370188|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
138370189|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370190|NCT01403948|BI 836826|bi 836826|mesh-list
138370191|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138370192|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370193|NCT01404000|Charcoal|charcoal|mesh-list
138370194|NCT01404000|Antidotes|antidotes|mesh-ancestor
138370195|NCT01404000|Protective Agents|protective agents|mesh-ancestor
138370196|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370197|NCT01404013|Montelukast|montelukast|mesh-list
138370198|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138370199|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138370200|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
138370201|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138370202|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
138370203|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370204|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370205|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138370206|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138370207|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370208|NCT01404104|Sirolimus|sirolimus|mesh-list
138370209|NCT01404104|Temsirolimus|temsirolimus|mesh-list
138370210|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
138370211|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370212|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370213|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370214|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370215|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
138370216|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370217|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370218|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370219|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370220|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138370221|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
138370222|NCT01404117|Interferons|interferons|mesh-list
138370223|NCT01404117|Interferon-beta|interferon-beta|mesh-list
138370224|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
138370225|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
138370226|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370227|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
138370228|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370229|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
138370230|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370231|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138370232|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370245|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
138370246|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
138370248|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370249|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
138370250|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370251|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370252|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
138370253|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370254|NCT01404156|Antidotes|antidotes|mesh-ancestor
138370255|NCT01404156|Protective Agents|protective agents|mesh-ancestor
138370256|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
138370257|NCT01404156|Vitamins|vitamins|mesh-ancestor
138370258|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
138370259|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138370260|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138370261|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138370262|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370263|NCT01404169|Donepezil|donepezil|mesh-list
138370264|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138370265|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370266|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370267|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
138370268|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370269|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370270|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
138370271|NCT01404182|Vaccines|vaccines|mesh-list
138370294|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138370295|NCT01404364|Triamcinolone|triamcinolone|mesh-list
138370296|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
138370297|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370298|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
138370308|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138370309|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370310|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138370311|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138370312|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
138370313|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370314|NCT01404377|Ropivacaine|ropivacaine|mesh-list
138370315|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
138370316|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
138370317|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370318|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370319|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
138370320|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370322|NCT01404442|Ketamine|ketamine|mesh-list
138370323|NCT01404442|Analgesics|analgesics|mesh-ancestor
138370324|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
138370325|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370326|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370327|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138370328|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138370329|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
138370330|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
138370331|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370332|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138370333|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138370334|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370335|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370336|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138370337|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138370338|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138370339|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138370340|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138370341|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
138370342|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
138370343|NCT01404468|Lidocaine|lidocaine|mesh-list
138370344|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
138370345|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
138370346|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370347|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370348|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
138370349|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370350|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138370351|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138370352|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138370353|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138370354|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370371|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370372|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138370373|NCT01404637|Tamsulosin|tamsulosin|mesh-list
138370374|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138370375|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138370376|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138370377|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370378|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370379|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370380|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370381|NCT01404637|Urological Agents|urological agents|mesh-ancestor
138370382|NCT01404676|Glimepiride|glimepiride|mesh-list
138370383|NCT01404676|Vildagliptin|vildagliptin|mesh-list
138370384|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138370385|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370386|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370387|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370388|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
138370389|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138370390|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370391|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370392|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370393|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
138370394|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138370395|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370396|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370397|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138370398|NCT01404689|Analgesics|analgesics|mesh-ancestor
138370399|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
138370400|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370401|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138370402|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138370404|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370405|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370406|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370407|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
138370408|NCT01404702|Aldesleukin|aldesleukin|mesh-list
138370409|NCT01404702|Interleukin-2|interleukin-2|mesh-list
138370410|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370419|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370420|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138370421|NCT01404715|Metformin|metformin|mesh-list
138370422|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
138370423|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370424|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370425|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370426|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370427|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370428|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370430|NCT01404767|Esmolol|esmolol|mesh-list
138370431|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138370432|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370433|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
138370434|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
138370435|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370436|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370437|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138370438|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138370439|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138370440|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370441|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370442|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370443|NCT01404793|Rocuronium|rocuronium|mesh-list
138370444|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138370445|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138370446|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138370447|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370448|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370449|NCT01404806|Dolutegravir|dolutegravir|mesh-list
138370450|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138370451|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138370452|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370453|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370454|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138370455|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138370456|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
138370457|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370458|NCT01404819|Anesthetics|anesthetics|mesh-list
138370459|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370460|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370461|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138370462|NCT01404871|Clomipramine|clomipramine|mesh-list
138370463|NCT01404871|Escitalopram|escitalopram|mesh-list
138370464|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138370465|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138370466|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138370467|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370468|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370469|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
138370470|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370471|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370472|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
138370473|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138370474|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138370475|NCT01404871|Analgesics|analgesics|mesh-ancestor
138370476|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
138370496|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370497|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
138370498|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138370499|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138370500|NCT01405131|Prednisolone|prednisolone|mesh-list
138370501|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
138370502|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138370503|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
138370504|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370505|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
138370506|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
138370507|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370508|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370509|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370510|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
138370511|NCT01405131|Hormones|hormones|mesh-ancestor
138370512|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370513|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138370514|NCT01405131|Protective Agents|protective agents|mesh-ancestor
138370515|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138370516|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370517|NCT01405144|Fluorouracil|fluorouracil|mesh-list
138370518|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
138370519|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370520|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370521|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370522|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370523|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
138370524|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370525|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
138370526|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138370527|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138370528|NCT01405157|Prednisolone|prednisolone|mesh-list
138370529|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
138370530|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138370531|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
138370533|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
138370534|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
138370535|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370536|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370537|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370546|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138370547|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138370549|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
138370550|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138370551|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
138370552|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370553|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
138370554|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
138370555|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370556|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370557|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370558|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
138370559|NCT01405170|Hormones|hormones|mesh-ancestor
138370560|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370561|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138370562|NCT01405170|Protective Agents|protective agents|mesh-ancestor
138370563|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138370564|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370566|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138370567|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138370568|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370569|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138370570|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138370571|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138370572|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370573|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138370574|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138370575|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138370576|NCT01405248|Protective Agents|protective agents|mesh-ancestor
138370577|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370579|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138370580|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370582|NCT01405339|Budesonide|budesonide|mesh-list
138370583|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370584|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138370585|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
138370586|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370587|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370588|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138370589|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
138370590|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
138370591|NCT01405339|Hormones|hormones|mesh-ancestor
138370592|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370593|NCT01405352|Vitamin A|vitamin a|mesh-list
138370594|NCT01405352|Vitamins|vitamins|mesh-ancestor
138370595|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
138370596|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370597|NCT01405365|Metronidazole|metronidazole|mesh-list
138370598|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370599|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370608|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370610|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
138370612|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138370613|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138370614|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138370615|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370616|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
138370617|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370618|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370619|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138370620|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370622|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370623|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370624|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370625|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370626|NCT01405612|Midazolam|midazolam|mesh-list
138370627|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138370628|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138370629|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138370630|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370631|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138370632|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138370634|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138370635|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
138370637|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
138370638|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
138370639|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370640|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370641|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
138370642|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138370643|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370644|NCT01405846|Gefitinib|gefitinib|mesh-list
138370645|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370646|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370647|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370648|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370649|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
138370650|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138370651|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
138370652|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370653|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370654|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
138370655|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370656|NCT01405989|Ketoconazole|ketoconazole|mesh-list
138370658|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
138370659|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370660|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138370661|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138370662|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370669|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138370670|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
138370671|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138370672|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370673|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
138370675|NCT01406002|Darexaban|darexaban|mesh-list
138370676|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138370677|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
138370678|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370679|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370701|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
138370703|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370704|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370705|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370706|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
138370707|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370708|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
138370709|NCT01406132|Peficitinib|peficitinib|mesh-list
138370710|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370711|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370712|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370713|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
138370714|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370715|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
138370716|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138370717|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138370718|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
138370719|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370720|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370721|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370722|NCT01406158|Urological Agents|urological agents|mesh-ancestor
138370724|NCT01406171|Midazolam|midazolam|mesh-list
138370734|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
138370735|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
138370737|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370738|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370739|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
138370740|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370741|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
138370742|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
138370743|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370744|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370745|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138370746|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138370747|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370748|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370749|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370750|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370751|NCT01406262|Incretins|incretins|mesh-ancestor
138370752|NCT01406262|Hormones|hormones|mesh-ancestor
138370753|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370754|NCT01406275|Amoxicillin|amoxicillin|mesh-list
138370755|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
138370756|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
138370757|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370758|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370759|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138370760|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370761|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370762|NCT01406301|PENTA|penta|mesh-list
138370763|NCT01406301|Fondaparinux|fondaparinux|mesh-list
138370764|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138370765|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
138370766|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138370767|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370768|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370769|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370770|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
138370771|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138370772|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138370773|NCT01406327|Ambrisentan|ambrisentan|mesh-list
138370774|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370775|NCT01406392|Misoprostol|misoprostol|mesh-list
138370776|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138370777|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
138370778|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138370779|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370780|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138370781|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370782|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
138370783|NCT01406431|Valsartan|valsartan|mesh-list
138370784|NCT01406431|Pitavastatin|pitavastatin|mesh-list
138370785|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370786|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138370787|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138370800|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
138370820|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138370821|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138370822|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370823|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370824|NCT01406535|Urological Agents|urological agents|mesh-ancestor
138370825|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138370826|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138370827|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370828|NCT01406639|Ranibizumab|ranibizumab|mesh-list
138370829|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138370830|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138370831|NCT01406639|Growth Substances|growth substances|mesh-ancestor
138370832|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370833|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
138370834|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370835|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
138370836|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
138370837|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370838|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370839|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
138370840|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370841|NCT01406704|Protective Agents|protective agents|mesh-ancestor
138370842|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
138370843|NCT01406704|Vitamins|vitamins|mesh-ancestor
138370844|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
138370845|NCT01406782|Rituximab|rituximab|mesh-list
138370846|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138370847|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370848|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
138370849|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370856|NCT01407211|Vitamin A|vitamin a|mesh-list
138370857|NCT01407211|Vitamins|vitamins|mesh-ancestor
138370858|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
138370859|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370860|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
138370861|NCT01407237|Giapreza|giapreza|mesh-list
138370862|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
138370863|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138370864|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138370865|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370866|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370867|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370868|NCT01407289|Insulin|insulin|mesh-list
138370869|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
138370870|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
138370871|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370872|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370874|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
138370875|NCT01407432|Hematinics|hematinics|mesh-ancestor
138370876|NCT01407432|Vitamins|vitamins|mesh-ancestor
138370877|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
138370878|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370879|NCT01407471|Clobetasol|clobetasol|mesh-list
138370880|NCT01407471|Spironolactone|spironolactone|mesh-list
138370881|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138370882|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
138370883|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370884|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370885|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138370886|NCT01407471|Diuretics|diuretics|mesh-ancestor
138370887|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
138370888|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370889|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
138370890|NCT01407471|Hormones|hormones|mesh-ancestor
138370891|NCT01407484|Prednisone|prednisone|mesh-list
138370892|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138370893|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
138370894|NCT01407484|Hormones|hormones|mesh-ancestor
138370895|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370896|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370897|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138370898|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370899|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138370900|NCT01407679|Alitretinoin|alitretinoin|mesh-list
138370901|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370902|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
138370903|NCT01407822|Cisplatin|cisplatin|mesh-list
138370904|NCT01407822|Gemcitabine|gemcitabine|mesh-list
138370905|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138370906|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370907|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370908|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
138370909|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370910|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370911|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370912|NCT01407848|Furosemide|furosemide|mesh-list
138370913|NCT01407848|Diuretics|diuretics|mesh-ancestor
138370914|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
138370915|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370916|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138370917|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138370918|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370919|NCT01407887|Artesunate|artesunate|mesh-list
138370920|NCT01407887|Amodiaquine|amodiaquine|mesh-list
138370921|NCT01407887|Methylene Blue|methylene blue|mesh-list
138370922|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
138370923|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138370926|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370927|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
138370928|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
138370929|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138370930|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
138370931|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370932|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370934|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138370935|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370936|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370937|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370938|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370939|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
138370940|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370941|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370942|NCT01408056|Mupirocin|mupirocin|mesh-list
138370943|NCT01408056|Timolol|timolol|mesh-list
138370944|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138370945|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138370946|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
138370947|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370948|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370949|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370950|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138370951|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138370952|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370953|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370954|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138370955|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370956|NCT01408095|Glimepiride|glimepiride|mesh-list
138370957|NCT01408095|Globalagliatin|globalagliatin|mesh-list
138370958|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138370959|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370960|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370961|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370962|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
138370963|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
138370964|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370965|NCT01408160|Cytarabine|cytarabine|mesh-list
138370966|NCT01408160|Immunotoxins|immunotoxins|mesh-list
138370967|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138370968|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
138370969|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370971|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
138370972|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370973|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370974|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
138370975|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370976|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
138370977|NCT01408173|Caffeine|caffeine|mesh-list
138370978|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
138370979|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370980|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138370981|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370982|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138370983|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370984|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138370985|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138370986|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
138370987|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370988|NCT01408186|Rabeprazole|rabeprazole|mesh-list
138370989|NCT01408186|Famotidine|famotidine|mesh-list
138370990|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138370991|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138370992|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138370993|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370994|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370995|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138370996|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
138370997|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
138370999|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371000|NCT01408199|Lenalidomide|lenalidomide|mesh-list
138371001|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
138371002|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371003|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138371004|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138371005|NCT01408199|Growth Substances|growth substances|mesh-ancestor
138371006|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
138371008|NCT01408342|Rituximab|rituximab|mesh-list
138371009|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
138371010|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138371011|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371012|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
138371013|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371014|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371015|NCT01408394|Ecopipam|ecopipam|mesh-list
138371016|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138371017|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138371018|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371019|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371020|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138371021|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138371022|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
138371023|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371024|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371025|NCT01408446|Menthol|menthol|mesh-list
138371026|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
138371027|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371028|NCT01408498|Testosterone|testosterone|mesh-list
138371029|NCT01408498|Androgens|androgens|mesh-ancestor
138371030|NCT01408498|Hormones|hormones|mesh-ancestor
138371031|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371032|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371033|NCT01408524|Diltiazem|diltiazem|mesh-list
138371034|NCT01408524|Labetalol|labetalol|mesh-list
138371035|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371036|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138371037|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371038|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371039|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371040|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371041|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138371042|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138371043|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138371044|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371045|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371047|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
138371048|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371049|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138371050|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138371051|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138371052|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138371053|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138371054|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371055|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371056|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371057|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371058|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371059|NCT01408680|Ubiquinone|ubiquinone|mesh-list
138371060|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
138371061|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
138371062|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371063|NCT01408680|Vitamins|vitamins|mesh-ancestor
138371064|NCT01408797|Bortezomib|bortezomib|mesh-list
138371065|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371066|NCT01408810|Infliximab|infliximab|mesh-list
138371067|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138371068|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371069|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371070|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371071|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371072|NCT01408836|Prednisolone|prednisolone|mesh-list
138371073|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138371074|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
138371077|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138371078|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
138371079|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371080|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
138371081|NCT01408836|Hormones|hormones|mesh-ancestor
138371082|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371083|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371084|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138371085|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371086|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
138371087|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
138371088|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371089|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371090|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138371091|NCT01408836|Protective Agents|protective agents|mesh-ancestor
138371092|NCT01408849|Omeprazole|omeprazole|mesh-list
138371093|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138371094|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371095|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138371096|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371097|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371098|NCT01408927|Aspirin|aspirin|mesh-list
138371099|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138371100|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371101|NCT01408927|Analgesics|analgesics|mesh-ancestor
138371102|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
138371103|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371104|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371105|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371106|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371107|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138371108|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138371109|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371110|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138371111|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138371112|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371113|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
138371114|NCT01408953|Bevacizumab|bevacizumab|mesh-list
138371115|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138371116|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371117|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138371118|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138371119|NCT01408953|Growth Substances|growth substances|mesh-ancestor
138371120|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371121|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
138371122|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
138371123|NCT01408979|Analgesics|analgesics|mesh-ancestor
138371124|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
138371125|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371126|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371127|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
138371128|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371129|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138371130|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
138371131|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138371132|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371133|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371134|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371135|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
138371136|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138371137|NCT01409005|Gemcitabine|gemcitabine|mesh-list
138371138|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371141|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371142|NCT01409018|Itraconazole|itraconazole|mesh-list
138371143|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138371144|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
138371145|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371146|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138371149|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371150|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138371152|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371153|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371154|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138371155|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138371156|NCT01409148|Antibodies|antibodies|mesh-list
138371157|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138371158|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
138371159|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371160|NCT01409174|Interferons|interferons|mesh-list
138371161|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
138371162|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
138371163|NCT01409174|Aldesleukin|aldesleukin|mesh-list
138371164|NCT01409174|Cisplatin|cisplatin|mesh-list
138371165|NCT01409174|Temozolomide|temozolomide|mesh-list
138371166|NCT01409174|Ipilimumab|ipilimumab|mesh-list
138371167|NCT01409174|Interleukin-2|interleukin-2|mesh-list
138371168|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371169|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
138371170|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371171|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138371172|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
138371173|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371174|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138371175|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138371176|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
138371177|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371178|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371180|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
138371181|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371182|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138371183|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138371184|NCT01409187|Interferons|interferons|mesh-list
138371185|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
138371186|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
138371187|NCT01409187|Aldesleukin|aldesleukin|mesh-list
138371188|NCT01409187|Ipilimumab|ipilimumab|mesh-list
138371189|NCT01409187|Interleukin-2|interleukin-2|mesh-list
138371190|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371191|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
138371192|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371193|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138371194|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138371195|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371196|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
138371197|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371198|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371199|NCT01409187|Analgesics|analgesics|mesh-ancestor
138371200|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
138371201|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371202|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138371203|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138371204|NCT01409278|Ropivacaine|ropivacaine|mesh-list
138371205|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
138371206|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
138371207|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371208|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371209|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
138371210|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371211|NCT01409369|Charcoal|charcoal|mesh-list
138371212|NCT01409369|Antidotes|antidotes|mesh-ancestor
138371213|NCT01409369|Protective Agents|protective agents|mesh-ancestor
138371214|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371215|NCT01409395|Metformin|metformin|mesh-list
138371216|NCT01409395|Nizatidine|nizatidine|mesh-list
138371217|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138371218|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371219|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138371220|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371221|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138371225|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371226|NCT01409408|Amlodipine|amlodipine|mesh-list
138371227|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371228|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138371229|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371230|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371231|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371232|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371233|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
138371234|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138371235|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138371236|NCT01409603|Naproxen|naproxen|mesh-list
138371237|NCT01409603|Darexaban|darexaban|mesh-list
138371238|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138371239|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371240|NCT01409603|Analgesics|analgesics|mesh-ancestor
138371241|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
138371242|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371243|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371244|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371245|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371246|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
138371247|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138371248|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371249|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371250|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138371251|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
138371252|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138371253|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138371254|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
138371255|NCT01409616|Aspirin|aspirin|mesh-list
138371256|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
138371257|NCT01409616|Salicylates|salicylates|mesh-list
138371258|NCT01409616|Darexaban|darexaban|mesh-list
138371259|NCT01409616|Clopidogrel|clopidogrel|mesh-list
138371260|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138371261|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371262|NCT01409616|Analgesics|analgesics|mesh-ancestor
138371263|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
138371264|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371265|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371266|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371267|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371268|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138371269|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138371270|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371271|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138371272|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138371273|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371274|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
138371275|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138371276|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138371277|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138371278|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
138371279|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371280|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371281|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
138371282|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
138371283|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371284|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138371285|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
138371286|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138371287|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
138371288|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
138371289|NCT01409694|Vitamin D|vitamin d|mesh-list
138371290|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
138371291|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
138371292|NCT01409694|Vitamins|vitamins|mesh-list
138371293|NCT01409694|Memantine|memantine|mesh-list
138371294|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
138371295|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371297|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371298|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138371299|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138371300|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
138371301|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371302|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371303|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138371304|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138371305|NCT01409733|Doxorubicin|doxorubicin|mesh-list
138371306|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138371307|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371308|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138371309|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138371310|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371311|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371312|NCT01409499|Sorafenib|sorafenib|mesh-list
138371313|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371314|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371315|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371316|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371317|NCT01410162|Tacrolimus|tacrolimus|mesh-list
138371318|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371319|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
138371320|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371321|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138371322|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371323|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371324|NCT01410201|Dexamethasone|dexamethasone|mesh-list
138371325|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
138371326|NCT01410201|BB 1101|bb 1101|mesh-list
138371327|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371328|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
138371329|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
138371330|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371331|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371332|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371333|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
138371334|NCT01410201|Hormones|hormones|mesh-ancestor
138371335|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371336|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138371337|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371338|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138371339|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371340|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371341|NCT01410214|Cisplatin|cisplatin|mesh-list
138371342|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138371343|NCT01410214|Vinorelbine|vinorelbine|mesh-list
138371344|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371345|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371346|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371347|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371348|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138371349|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138371350|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138371351|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
138371352|NCT01410370|Endostar protein|endostar protein|mesh-list
138371353|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138371354|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138371355|NCT01410370|Growth Substances|growth substances|mesh-ancestor
138371356|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371357|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138371358|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371360|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
138371361|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371362|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138371363|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371364|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371365|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
138371366|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138371367|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371368|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
138371369|NCT01410708|Dasatinib|dasatinib|mesh-list
138371371|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371373|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371374|NCT01410747|Tacrolimus|tacrolimus|mesh-list
138371375|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371376|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
138371377|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371378|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138371380|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371381|NCT01410916|Eculizumab|eculizumab|mesh-list
138371382|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138371383|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371384|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
138371385|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371386|NCT01410968|Poly ICLC|poly iclc|mesh-list
138371387|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
138371388|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
138371389|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371390|NCT01411072|Gemcitabine|gemcitabine|mesh-list
138371391|NCT01411072|Fluorouracil|fluorouracil|mesh-list
138371392|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371393|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
138371394|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371395|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371396|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371397|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
138371398|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371399|NCT01411098|Etoposide|etoposide|mesh-list
138371400|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
138371401|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371402|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138371403|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138371404|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138371405|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371406|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371407|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138371408|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138371409|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138371410|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
138371411|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371412|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138371413|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138371414|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371415|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
138371419|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
138371420|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371421|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371422|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
138371423|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138371424|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138371425|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371426|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138371427|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138371428|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138371429|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371430|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371431|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
138371432|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138371433|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138371434|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
138371435|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
138371436|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
138371437|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
138371438|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371439|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138371440|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
138371441|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
138371442|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138371443|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
138371444|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371446|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
138371447|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371450|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371451|NCT01411202|Doxycycline|doxycycline|mesh-list
138371452|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138371453|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371454|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
138371455|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138371456|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138371457|NCT01411254|Betamethasone|betamethasone|mesh-list
138371458|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
138371459|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138371460|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
138371461|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138371462|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371463|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
138371464|NCT01411254|Hormones|hormones|mesh-ancestor
138371465|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371466|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371467|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138371468|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
138371469|NCT01411280|Methylphenidate|methylphenidate|mesh-list
138371470|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138371471|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371472|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138371473|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138371474|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371475|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371476|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
138371477|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371478|NCT01411410|Paclitaxel|paclitaxel|mesh-list
138371479|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138371481|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
138371482|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
138371483|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
138371484|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371485|NCT01411423|Sorafenib|sorafenib|mesh-list
138371486|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371487|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371488|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371489|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371490|NCT01411436|Sorafenib|sorafenib|mesh-list
138371491|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371492|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371493|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371494|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371495|NCT01411514|Prednisone|prednisone|mesh-list
138371496|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371497|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
138371498|NCT01411514|Hormones|hormones|mesh-ancestor
138371499|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371500|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371501|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138371503|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138371505|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
138371506|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138371507|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138371508|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371509|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371510|NCT01411735|Enalapril|enalapril|mesh-list
138371511|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138371512|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
138371513|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371514|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371515|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371516|NCT01411930|Olanzapine|olanzapine|mesh-list
138371517|NCT01411930|Aripiprazole|aripiprazole|mesh-list
138371518|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
138371519|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
138371520|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371521|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371522|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371523|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138371524|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138371525|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371526|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138371527|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138371528|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138371529|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371530|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371531|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371533|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
138371534|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
138371535|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
138371536|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138371537|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138371538|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138371539|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138371540|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138371541|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138371542|NCT01411969|Phenylephrine|phenylephrine|mesh-list
138371543|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
138371544|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138371545|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138371546|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371547|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371548|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371549|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371550|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
138371551|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
138371552|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371553|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
138371554|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138371555|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
138371556|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138371557|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
138371558|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138371559|NCT01411969|Protective Agents|protective agents|mesh-ancestor
138371560|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
138371561|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138371562|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371563|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371564|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
138371565|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371566|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371567|NCT01412073|Misoprostol|misoprostol|mesh-list
138371568|NCT01412073|Oxytocin|oxytocin|mesh-list
138371569|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
138371570|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138371571|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371572|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138371573|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
138371574|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138371575|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371576|NCT01412294|Capecitabine|capecitabine|mesh-list
138371577|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371578|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371579|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
138371580|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371581|NCT01412307|Lenalidomide|lenalidomide|mesh-list
138371582|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138371583|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
138371584|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371585|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138371586|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138371587|NCT01412307|Growth Substances|growth substances|mesh-ancestor
138371588|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
138371589|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371590|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138371591|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
138371592|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371593|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
138371594|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138371596|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
138371597|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138371598|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
138371599|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
138371600|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371601|NCT01412411|Micronutrients|micronutrients|mesh-list
138371602|NCT01412411|Trace Elements|trace elements|mesh-list
138371603|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371604|NCT01412437|Verapamil|verapamil|mesh-list
138371605|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138371606|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138371607|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371608|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371609|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371610|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371611|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
138371612|NCT01412515|Everolimus|everolimus|mesh-list
138371613|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138371614|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371615|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371616|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371617|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371618|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
138371619|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371620|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371621|NCT01412567|Vaccines|vaccines|mesh-list
138371622|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
138371623|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371624|NCT01412632|Remifentanil|remifentanil|mesh-list
138371625|NCT01412632|Propofol|propofol|mesh-list
138371626|NCT01412632|Prilocaine|prilocaine|mesh-list
138371627|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138371628|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138371629|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371631|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
138371633|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138371634|NCT01412632|Narcotics|narcotics|mesh-ancestor
138371635|NCT01412632|Analgesics|analgesics|mesh-ancestor
138371636|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
138371637|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371638|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
138371639|NCT01412645|Resveratrol|resveratrol|mesh-list
138371640|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
138371641|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371642|NCT01412645|Protective Agents|protective agents|mesh-ancestor
138371643|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371645|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138371646|NCT01412658|Caseins|caseins|mesh-list
138371647|NCT01412658|Glycerol|glycerol|mesh-list
138371648|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
138371649|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
138371650|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371651|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138371652|NCT01412658|Protective Agents|protective agents|mesh-ancestor
138371653|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371654|NCT01412671|Sorafenib|sorafenib|mesh-list
138371655|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371656|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371657|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371658|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371659|NCT01412840|Diclofenac|diclofenac|mesh-list
138371660|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138371661|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371662|NCT01412840|Analgesics|analgesics|mesh-ancestor
138371663|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
138371664|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371665|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371666|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371667|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371668|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138371669|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371670|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371671|NCT01412892|Everolimus|everolimus|mesh-list
138371672|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138371673|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371674|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371676|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371677|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
138371678|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371679|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371680|NCT01413022|Leucovorin|leucovorin|mesh-list
138371681|NCT01413022|Fluorouracil|fluorouracil|mesh-list
138371682|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
138371683|NCT01413022|Irinotecan|irinotecan|mesh-list
138371684|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
138371685|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371686|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371687|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371688|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371689|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
138371690|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371691|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138371692|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138371693|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371709|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138371710|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371711|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371712|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
138371713|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138371714|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138371715|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
138371716|NCT01413230|Vitamin D|vitamin d|mesh-list
138371717|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371718|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371719|NCT01413230|Vitamins|vitamins|mesh-ancestor
138371720|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
138371721|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138371722|NCT01413477|Calcitriol|calcitriol|mesh-list
138371723|NCT01413477|Betamethasone|betamethasone|mesh-list
138371724|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
138371725|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138371726|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
138371727|NCT01413477|Calcipotriene|calcipotriene|mesh-list
138371728|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138371729|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371730|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
138371731|NCT01413477|Hormones|hormones|mesh-ancestor
138371732|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371733|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371734|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138371735|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
138371736|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
138371737|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138371738|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138371739|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371740|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371747|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371748|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138371750|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371751|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
138371752|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371753|NCT01413620|Vitamins|vitamins|mesh-list
138371754|NCT01413620|Vitamin E|vitamin e|mesh-list
138371755|NCT01413620|Tocopherols|tocopherols|mesh-list
138371756|NCT01413620|Tocotrienols|tocotrienols|mesh-list
138371757|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
138371758|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
138371759|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371760|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
138371761|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371762|NCT01413620|Protective Agents|protective agents|mesh-ancestor
138371763|NCT01413711|Vigabatrin|vigabatrin|mesh-list
138371764|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
138371765|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371766|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371767|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
138371768|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371769|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371770|NCT01413763|Imiquimod|imiquimod|mesh-list
138371771|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138371772|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
138371773|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371774|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371775|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
138371776|NCT01413854|Diclofenac|diclofenac|mesh-list
138371777|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138371778|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138371779|NCT01413854|Analgesics|analgesics|mesh-ancestor
138371780|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
138371781|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371782|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371783|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371784|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371785|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138371786|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371787|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371788|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
138371789|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138371790|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
138371791|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138371792|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371793|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138371794|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138371795|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138371796|NCT01414231|Cytarabine|cytarabine|mesh-list
138371797|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371798|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
138371799|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371800|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371801|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
138371802|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371803|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371804|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
138371805|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371806|NCT01414465|Orlistat|orlistat|mesh-list
138371807|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371808|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371809|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138371810|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138371812|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
138371813|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371814|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
138371815|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
138371816|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138371817|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371818|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138371819|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138371820|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371821|NCT01414556|Incretins|incretins|mesh-ancestor
138371822|NCT01414556|Hormones|hormones|mesh-ancestor
138371823|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371824|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371825|NCT01414569|Dexamethasone|dexamethasone|mesh-list
138371826|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
138371827|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138371828|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
138371829|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
138371830|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371831|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371832|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371833|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
138371834|NCT01414569|Hormones|hormones|mesh-ancestor
138371835|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371836|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138371837|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371838|NCT01414608|Paclitaxel|paclitaxel|mesh-list
138371839|NCT01414608|Cisplatin|cisplatin|mesh-list
138371840|NCT01414608|Carboplatin|carboplatin|mesh-list
138371841|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138371842|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138371843|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371844|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
138371845|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
138371846|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
138371847|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371848|NCT01414816|Interferons|interferons|mesh-list
138371849|NCT01414816|Interferon-beta|interferon-beta|mesh-list
138371850|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
138371851|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371852|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
138371853|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371854|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
138371855|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371856|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138371857|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
138371858|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138371860|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138371861|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138371862|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
138371863|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
138371864|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371865|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371866|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138372262|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
138371867|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138371868|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371870|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138371871|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138371872|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
138371873|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371874|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138371876|NCT01414972|Vitamins|vitamins|mesh-ancestor
138371877|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
138371878|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371879|NCT01414998|Nicotine|nicotine|mesh-list
138371880|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138371881|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
138371882|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371883|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371884|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138371885|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138371886|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
138371888|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371890|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371891|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138371892|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371893|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371894|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
138371895|NCT01415128|Desipramine|desipramine|mesh-list
138371896|NCT01415128|Omeprazole|omeprazole|mesh-list
138371897|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138371898|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371899|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138371900|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371901|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371902|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138371903|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371904|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138371905|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
138371906|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138371907|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138371908|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138371909|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371910|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371911|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371912|NCT01415141|Ribavirin|ribavirin|mesh-list
138371913|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138371914|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
138371915|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371916|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
138371917|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138371918|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138371919|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
138371920|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
138371921|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
138371922|NCT01415336|Doxorubicin|doxorubicin|mesh-list
138371923|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138371924|NCT01415336|Capecitabine|capecitabine|mesh-list
138371925|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138371926|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
138371927|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371928|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138371929|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138371930|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
138371931|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371932|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138371933|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138371934|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138371935|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138371936|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138371937|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138371938|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371939|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
138371940|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138371941|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371942|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138371943|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138372023|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138371944|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371946|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138371947|NCT01415505|Nebivolol|nebivolol|mesh-list
138371948|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371949|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138371950|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138371951|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371952|NCT01415505|Diuretics|diuretics|mesh-ancestor
138371953|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
138371954|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371955|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138371956|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138371957|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
138371958|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138371959|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138371960|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138371961|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371962|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371963|NCT01415557|Micronutrients|micronutrients|mesh-list
138371964|NCT01415557|Trace Elements|trace elements|mesh-list
138371965|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371966|NCT01415596|Albuterol|albuterol|mesh-list
138371967|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138371968|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
138371969|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138371970|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371971|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138371972|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
138371973|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
138371974|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138371975|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138371976|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138371977|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138371978|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371979|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371980|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371981|NCT01415687|Bisacodyl|bisacodyl|mesh-list
138371982|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
138371983|NCT01415687|Citric Acid|citric acid|mesh-list
138371984|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
138371985|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
138371986|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138371987|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
138371988|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
138371989|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371990|NCT01415687|Cathartics|cathartics|mesh-ancestor
138371991|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138371992|NCT01415687|Laxatives|laxatives|mesh-ancestor
138371993|NCT01415713|Leucovorin|leucovorin|mesh-list
138371994|NCT01415713|Gemcitabine|gemcitabine|mesh-list
138371995|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
138371996|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138371997|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
138371998|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371999|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372000|NCT01415713|Antidotes|antidotes|mesh-ancestor
138372001|NCT01415713|Protective Agents|protective agents|mesh-ancestor
138372002|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372004|NCT01415713|Vitamins|vitamins|mesh-ancestor
138372005|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
138372006|NCT01415765|Prednisone|prednisone|mesh-list
138372007|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
138372008|NCT01415765|Rituximab|rituximab|mesh-list
138372009|NCT01415765|Doxorubicin|doxorubicin|mesh-list
138372010|NCT01415765|Etoposide|etoposide|mesh-list
138372011|NCT01415765|Vincristine|vincristine|mesh-list
138372012|NCT01415765|Pevonedistat|pevonedistat|mesh-list
138372013|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372014|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
138372015|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372016|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372017|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138372018|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
138372019|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372020|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372021|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138372022|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138372024|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138372025|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372026|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372027|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372031|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138372032|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138372033|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
138372034|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
138372035|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
138372036|NCT01415778|Bicalutamide|bicalutamide|mesh-list
138372037|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
138372038|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
138372039|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372040|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372041|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372042|NCT01415791|Bicalutamide|bicalutamide|mesh-list
138372043|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
138372044|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
138372045|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372046|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372047|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372048|NCT01415895|Clonidine|clonidine|mesh-list
138372049|NCT01415895|Naltrexone|naltrexone|mesh-list
138372050|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138372051|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138372052|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372053|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
138372054|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372055|NCT01415895|Analgesics|analgesics|mesh-ancestor
138372056|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138372057|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
138372058|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
138372059|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138372060|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138372061|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138372062|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138372063|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372064|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372065|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
138372066|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372067|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
138372068|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372069|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372070|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138372071|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
138372072|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372073|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372074|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138372075|NCT01416116|Lidocaine|lidocaine|mesh-list
138372076|NCT01416116|Tramadol|tramadol|mesh-list
138372077|NCT01416116|Capsaicin|capsaicin|mesh-list
138372078|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138372079|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
138372080|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372081|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372082|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
138372083|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372084|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138372085|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138372086|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138372088|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372089|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138372091|NCT01416116|Analgesics|analgesics|mesh-ancestor
138372092|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
138372093|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
138372094|NCT01416207|Interferons|interferons|mesh-list
138372095|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
138372096|NCT01416207|Interferon-beta|interferon-beta|mesh-list
138372097|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372098|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
138372099|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372100|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138372101|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
138372102|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372103|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
138372105|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
138372106|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372107|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372108|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372109|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
138372110|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138372111|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372112|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372113|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138372114|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372115|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372116|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372117|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
138372118|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138372119|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138372120|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138372121|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
138372122|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138372124|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372125|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138372126|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372127|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372128|NCT01416350|Azithromycin|azithromycin|mesh-list
138372129|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372130|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372131|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138372132|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138372133|NCT01416480|Theobromine|theobromine|mesh-list
138372134|NCT01416480|Dipropizine|dipropizine|mesh-list
138372135|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138372136|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
138372137|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372138|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372139|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138372140|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
138372141|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
138372142|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
138372144|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138372145|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372146|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
138372147|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
138372148|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
138372149|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372150|NCT01416649|Exenatide|exenatide|mesh-list
138372151|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372154|NCT01416649|Incretins|incretins|mesh-ancestor
138372155|NCT01416649|Hormones|hormones|mesh-ancestor
138372156|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372157|NCT01416662|Gemcitabine|gemcitabine|mesh-list
138372158|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138372159|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
138372160|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372161|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372162|NCT01416701|Vitamin D|vitamin d|mesh-list
138372163|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
138372164|NCT01416701|Vitamins|vitamins|mesh-list
138372165|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
138372166|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372167|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372168|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372169|NCT01416870|Bicalutamide|bicalutamide|mesh-list
138372170|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
138372171|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
138372172|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372173|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372174|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372175|NCT01416883|Bicalutamide|bicalutamide|mesh-list
138372176|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
138372177|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
138372178|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372179|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372180|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372181|NCT01416909|Laxatives|laxatives|mesh-list
138372182|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138372183|NCT01416948|Methylphenidate|methylphenidate|mesh-list
138372184|NCT01416948|Galantamine|galantamine|mesh-list
138372185|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138372186|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372187|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138372188|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372189|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372190|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372191|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
138372192|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372193|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138372194|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372195|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
138372196|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138372197|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
138372198|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372200|NCT01416961|Etoposide|etoposide|mesh-list
138372201|NCT01416961|Cisplatin|cisplatin|mesh-list
138372202|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
138372203|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138372204|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372205|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138372206|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372207|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372208|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372209|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
138372210|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372211|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
138372212|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372213|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372214|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138372215|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
138372216|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372217|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372218|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138372219|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138372220|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
138372221|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138372223|NCT01417065|Temsirolimus|temsirolimus|mesh-list
138372224|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
138372225|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138372226|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372227|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372228|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372229|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
138372230|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372231|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372232|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372233|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372234|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138372235|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
138372237|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
138372238|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372239|NCT01417273|Vitamin A|vitamin a|mesh-list
138372240|NCT01417273|Vitamins|vitamins|mesh-ancestor
138372241|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
138372242|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372243|NCT01417351|Vitamin D|vitamin d|mesh-list
138372244|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
138372245|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
138372247|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
138372248|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372249|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372250|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372251|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
138372252|NCT01417364|Testosterone|testosterone|mesh-list
138372253|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
138372254|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
138372255|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138372257|NCT01417364|Hormones|hormones|mesh-ancestor
138372258|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372259|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372260|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138372261|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372273|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372274|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372275|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372276|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372277|NCT01417429|Galantamine|galantamine|mesh-list
138372281|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372282|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372283|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138372284|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138372285|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
138372286|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372287|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372288|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138372290|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138372291|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
138372292|NCT01417494|Leucovorin|leucovorin|mesh-list
138372293|NCT01417494|Bevacizumab|bevacizumab|mesh-list
138372294|NCT01417494|Fluorouracil|fluorouracil|mesh-list
138372295|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
138372296|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138372297|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372298|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138372299|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138372300|NCT01417494|Growth Substances|growth substances|mesh-ancestor
138372301|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372302|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
138372303|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
138372304|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372305|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138372306|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372307|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
138372308|NCT01417494|Antidotes|antidotes|mesh-ancestor
138372309|NCT01417494|Protective Agents|protective agents|mesh-ancestor
138372310|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
138372312|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
138372313|NCT01417572|Lidocaine|lidocaine|mesh-list
138372314|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
138372315|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
138372316|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372317|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372318|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
138372319|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372320|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138372321|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138372322|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138372323|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372324|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372325|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138372326|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138372327|NCT01417754|Toremifene|toremifene|mesh-list
138372328|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138372330|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138372331|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138372332|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
138372333|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372334|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372335|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372336|NCT01417767|Decitabine|decitabine|mesh-list
138372337|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138372338|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
138372339|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372340|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372341|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372342|NCT01417806|Topotecan|topotecan|mesh-list
138372343|NCT01417806|Pasireotide|pasireotide|mesh-list
138372344|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138372345|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372346|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372347|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372348|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372349|NCT01417806|Hormones|hormones|mesh-ancestor
138372350|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372351|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372382|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372383|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372385|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138372386|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138372387|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
138372388|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372389|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138372390|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138372392|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
138372393|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138372394|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138372395|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138372396|NCT01418118|Protective Agents|protective agents|mesh-ancestor
138372397|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
138372398|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
138372400|NCT01418131|Tacrolimus|tacrolimus|mesh-list
138372401|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138372402|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372403|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
138372404|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372405|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372407|NCT01418144|Ropivacaine|ropivacaine|mesh-list
138372408|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
138372409|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
138372410|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372411|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372412|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
138372413|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372414|NCT01418157|Acetazolamide|acetazolamide|mesh-list
138372415|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
138372416|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138372417|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372418|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372419|NCT01418157|Diuretics|diuretics|mesh-ancestor
138372420|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
138372421|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372422|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
138372423|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
138372424|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
138372425|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372426|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372427|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
138372428|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372429|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138372430|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138372431|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
138372432|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372433|NCT01418274|Ritonavir|ritonavir|mesh-list
138372434|NCT01418274|Escitalopram|escitalopram|mesh-list
138372435|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138372436|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138372437|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
138372438|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372439|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372440|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138372441|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138372442|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
138372443|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372444|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138372445|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138372446|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138372447|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372448|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372449|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372450|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
138372451|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372452|NCT01418417|Pantoprazole|pantoprazole|mesh-list
138372453|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138372454|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138372455|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138372456|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372457|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372459|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372460|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
138372775|NCT01420575|Olanzapine|olanzapine|mesh-list
138372461|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372463|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138372464|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138372465|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138372466|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372467|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372468|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138372469|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372470|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138372472|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138372473|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138372474|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138372475|NCT01418534|Diuretics|diuretics|mesh-ancestor
138372476|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
138372477|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372478|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
138372479|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138372480|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372481|NCT01418547|Isosorbide|isosorbide|mesh-list
138372482|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138372483|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138372484|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138372485|NCT01418547|Diuretics|diuretics|mesh-ancestor
138372486|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
138372487|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372488|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
138372489|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138372490|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372491|NCT01418586|Alfuzosin|alfuzosin|mesh-list
138372492|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138372493|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138372494|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138372495|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
138372496|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372497|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372498|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372499|NCT01418586|Urological Agents|urological agents|mesh-ancestor
138372500|NCT01418599|Alfuzosin|alfuzosin|mesh-list
138372501|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138372502|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138372503|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138372504|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
138372505|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372506|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372507|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372508|NCT01418599|Urological Agents|urological agents|mesh-ancestor
138372509|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138372510|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138372511|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372512|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372513|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372514|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372516|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138372517|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
138372518|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372519|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138372520|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138372521|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372522|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372523|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372524|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372525|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372526|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138372527|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
138372528|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372530|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138372531|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372532|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372533|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372534|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372535|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372536|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138372537|NCT01418651|Analgesics|analgesics|mesh-ancestor
138372538|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
138372539|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372540|NCT01418729|Pravastatin|pravastatin|mesh-list
138372541|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138372542|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138372543|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
138372544|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372545|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138372546|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138372547|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372548|NCT01418742|Doxycycline|doxycycline|mesh-list
138372549|NCT01418742|Panitumumab|panitumumab|mesh-list
138372550|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372551|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372552|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
138372554|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138372555|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138372556|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372557|NCT01418794|Sirolimus|sirolimus|mesh-list
138372558|NCT01418794|Temsirolimus|temsirolimus|mesh-list
138372559|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
138372560|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372561|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372562|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138372563|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372564|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
138372565|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372566|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
138372567|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372568|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138372569|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372570|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372572|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372574|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372575|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372576|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
138372578|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138372579|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372580|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372581|NCT01419119|Vitamins|vitamins|mesh-ancestor
138372582|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
138372583|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372584|NCT01419132|Furosemide|furosemide|mesh-list
138372585|NCT01419132|Diuretics|diuretics|mesh-list
138372586|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
138372587|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372588|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138372589|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372590|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372591|NCT01419262|Vitamin D|vitamin d|mesh-list
138372592|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
138372593|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
138372594|NCT01419262|Vitamins|vitamins|mesh-list
138372595|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
138372596|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372597|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372598|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372599|NCT01419340|Donepezil|donepezil|mesh-list
138372600|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138372601|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372602|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372603|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
138372604|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372605|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372606|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
138372607|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138372608|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138372610|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138372611|NCT01419353|Estrogens|estrogens|mesh-ancestor
138372612|NCT01419353|Hormones|hormones|mesh-ancestor
138372613|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372614|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372615|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138372616|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
138372617|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138372618|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138372620|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138372621|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372622|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372623|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
138372624|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372625|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372626|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
138372627|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
138372628|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372629|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
138372630|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138372631|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138372632|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372633|NCT01419392|Urological Agents|urological agents|mesh-ancestor
138372634|NCT01419405|Pregabalin|pregabalin|mesh-list
138372635|NCT01419405|Remifentanil|remifentanil|mesh-list
138372636|NCT01419405|Analgesics|analgesics|mesh-ancestor
138372637|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
138372638|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372639|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372640|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
138372641|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138372642|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372643|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372644|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372645|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138372646|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138372647|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372648|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372649|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138372650|NCT01419405|Narcotics|narcotics|mesh-ancestor
138372651|NCT01419457|Favipiravir|favipiravir|mesh-list
138372652|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
138372653|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372654|NCT01419548|Paclitaxel|paclitaxel|mesh-list
138372655|NCT01419548|Carboplatin|carboplatin|mesh-list
138372656|NCT01419548|Veliparib|veliparib|mesh-list
138372657|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138372658|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372659|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
138372661|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
138372662|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372663|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138372664|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372665|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138372666|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372667|NCT01419691|Auranofin|auranofin|mesh-list
138372668|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372669|NCT01419730|Vitamin D|vitamin d|mesh-list
138372670|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
138372671|NCT01419730|Vitamins|vitamins|mesh-ancestor
138372672|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
138372673|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372674|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372675|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372676|NCT01419821|Vitamin D|vitamin d|mesh-list
138372677|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
138372679|NCT01419821|Vitamins|vitamins|mesh-list
138372680|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
138372681|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372682|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372683|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372684|NCT01419847|Ciclopirox|ciclopirox|mesh-list
138372685|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
138372686|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372687|NCT01419873|Insulin|insulin|mesh-list
138372688|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138372689|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372690|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372691|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138372692|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138372774|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138372693|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372694|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372695|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
138372696|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372697|NCT01420094|Aspirin|aspirin|mesh-list
138372698|NCT01420094|Acetaminophen|acetaminophen|mesh-list
138372699|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138372700|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138372701|NCT01420094|Analgesics|analgesics|mesh-ancestor
138372702|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
138372703|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372704|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372705|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372708|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138372709|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372710|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138372711|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138372713|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
138372714|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
138372715|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138372716|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
138372717|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
138372718|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372719|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372721|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138372722|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372723|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372724|NCT01420328|Simvastatin|simvastatin|mesh-list
138372725|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138372726|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138372727|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138372728|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
138372729|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372730|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138372731|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138372732|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372733|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138372734|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138372735|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372736|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372737|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
138372738|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138372739|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138372740|NCT01420367|Metronidazole|metronidazole|mesh-list
138372741|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372742|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372743|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138372744|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138372745|NCT01420406|Vitamin A|vitamin a|mesh-list
138372746|NCT01420406|Vitamins|vitamins|mesh-ancestor
138372747|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
138372748|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372749|NCT01420471|Triamcinolone|triamcinolone|mesh-list
138372750|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138372751|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138372753|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372754|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
138372755|NCT01420471|Hormones|hormones|mesh-ancestor
138372756|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372757|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372758|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372759|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
138372760|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372761|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372762|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
138372763|NCT01420523|Maraviroc|maraviroc|mesh-list
138372764|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138372765|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138372766|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
138372767|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372770|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372771|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372772|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138372773|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138372783|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372784|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372785|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138372786|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372787|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372788|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372789|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372790|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
138372792|NCT01420666|Ibuprofen|ibuprofen|mesh-list
138372793|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138372794|NCT01420666|Analgesics|analgesics|mesh-ancestor
138372796|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372797|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372798|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
138372799|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138372800|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372801|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372802|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138372803|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372804|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372805|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
138372807|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372808|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372809|NCT01420822|Fluticasone|fluticasone|mesh-list
138372810|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372811|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138372812|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
138372813|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372814|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372815|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138372816|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
138372817|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
138372818|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138372819|NCT01420900|Tacrine|tacrine|mesh-list
138372820|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138372821|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372822|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372823|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
138372824|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372825|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372826|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138372827|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
138372828|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372829|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
138372831|NCT01420913|Analgesics|analgesics|mesh-ancestor
138372832|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
138372833|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372835|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
138372836|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138372837|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372838|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372839|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138372841|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138372842|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372843|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372845|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138372846|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138372847|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138372848|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138372849|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372850|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372851|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
138372852|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
138372853|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372854|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372855|NCT01421121|Vaccines|vaccines|mesh-list
138372856|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
138372857|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372858|NCT01421160|Citric Acid|citric acid|mesh-list
138372859|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
138372860|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
138372861|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138372862|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
138372863|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
138372864|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372865|NCT01421173|Dexamethasone|dexamethasone|mesh-list
138372866|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
138372867|NCT01421173|Rituximab|rituximab|mesh-list
138372868|NCT01421173|Gemcitabine|gemcitabine|mesh-list
138372869|NCT01421173|Melphalan|melphalan|mesh-list
138372870|NCT01421173|Busulfan|busulfan|mesh-list
138372871|NCT01421173|Vorinostat|vorinostat|mesh-list
138372872|NCT01421173|BB 1101|bb 1101|mesh-list
138372873|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372874|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
138372875|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
138372876|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372877|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372878|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138372879|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
138372880|NCT01421173|Hormones|hormones|mesh-ancestor
138372881|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372882|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138372883|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372884|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138372885|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
138372886|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138372887|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138372888|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
138372889|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372891|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
138372892|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138372893|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372894|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138372895|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372896|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
138372897|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
138372898|NCT01421212|Antibodies|antibodies|mesh-list
138372899|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
138372900|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138372901|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138372902|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
138372903|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
138372907|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
138372908|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
138372909|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
138372910|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
138372911|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372912|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138372913|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138372914|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372915|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372916|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138372917|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138372918|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138372919|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372920|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138372921|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138372922|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138372923|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138372924|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138372925|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138372926|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372927|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
138372928|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
138372929|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372930|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372931|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138372932|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138372933|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138372934|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138372935|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372936|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372937|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372938|NCT01421706|Clarithromycin|clarithromycin|mesh-list
138372939|NCT01421706|Sibutramine|sibutramine|mesh-list
138372940|NCT01421706|Clopidogrel|clopidogrel|mesh-list
138372941|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138372942|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138372943|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138372944|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138372946|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372947|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372948|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372949|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372950|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372951|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138372952|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372953|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138372954|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138372955|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
138372956|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372957|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
138372958|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138372960|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138372961|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372962|NCT01421914|Bupivacaine|bupivacaine|mesh-list
138372963|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
138372964|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
138372966|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372968|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372969|NCT01421927|Lenalidomide|lenalidomide|mesh-list
138372970|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
138372971|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372972|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138372973|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138372974|NCT01421927|Growth Substances|growth substances|mesh-ancestor
138372975|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
138372976|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372977|NCT01421940|Udenafil|udenafil|mesh-list
138372978|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138372979|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138372980|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372981|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372982|NCT01421979|Caffeine|caffeine|mesh-list
138372983|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138372984|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372985|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138372986|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138372987|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372988|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138372989|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138372990|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
138372991|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372992|NCT01421992|Methylphenidate|methylphenidate|mesh-list
138372993|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138372994|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372995|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138372996|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138372997|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138372998|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372999|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
138373000|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373001|NCT01422018|Bevacizumab|bevacizumab|mesh-list
138373002|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373003|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373004|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138373005|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138373007|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373008|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373010|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138373011|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
138373012|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138373013|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373014|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373015|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373017|NCT01422109|Clopidogrel|clopidogrel|mesh-list
138373018|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373019|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373020|NCT01422109|Analgesics|analgesics|mesh-ancestor
138373021|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
138373022|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373023|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373024|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373025|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373026|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138373027|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138373028|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373029|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138373030|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138373031|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373032|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
138373033|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138373034|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138373035|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138373036|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
138373037|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373038|NCT01422122|Vitamin D|vitamin d|mesh-list
138373039|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
138373040|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
138373041|NCT01422122|Vitamins|vitamins|mesh-list
138373042|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
138373043|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373044|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138373045|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373046|NCT01422291|Acetaminophen|acetaminophen|mesh-list
138373047|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138373048|NCT01422291|Morphine|morphine|mesh-list
138373049|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138373050|NCT01422291|Narcotics|narcotics|mesh-ancestor
138373051|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373052|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373053|NCT01422291|Analgesics|analgesics|mesh-ancestor
138373054|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
138373055|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373056|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373057|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
138373058|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373059|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373060|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373061|NCT01422317|Tocopherols|tocopherols|mesh-list
138373062|NCT01422317|Vitamin E|vitamin e|mesh-list
138373063|NCT01422317|Tocotrienols|tocotrienols|mesh-list
138373064|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
138373065|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
138373066|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373067|NCT01422317|Protective Agents|protective agents|mesh-ancestor
138373068|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373069|NCT01422317|Vitamins|vitamins|mesh-ancestor
138373072|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138373073|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138373074|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373075|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373077|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373079|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138373080|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373081|NCT01422499|Vorinostat|vorinostat|mesh-list
138373082|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373083|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138373084|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373085|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373086|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138373087|NCT01422590|Mitiglinide|mitiglinide|mesh-list
138373088|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138373089|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373090|NCT01422590|Incretins|incretins|mesh-ancestor
138373091|NCT01422590|Hormones|hormones|mesh-ancestor
138373092|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373093|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138373094|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373095|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373096|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373097|NCT01422603|Clofarabine|clofarabine|mesh-list
138373098|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138373099|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
138373100|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373101|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373102|NCT01422616|Metoprolol|metoprolol|mesh-list
138373103|NCT01422616|Clonidine|clonidine|mesh-list
138373104|NCT01422616|Labetalol|labetalol|mesh-list
138373105|NCT01422616|Hydralazine|hydralazine|mesh-list
138373106|NCT01422616|Nicardipine|nicardipine|mesh-list
138373107|NCT01422616|Phentolamine|phentolamine|mesh-list
138373108|NCT01422616|Urapidil|urapidil|mesh-list
138373109|NCT01422616|Enalaprilat|enalaprilat|mesh-list
138373110|NCT01422616|Enalapril|enalapril|mesh-list
138373111|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138373112|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
138373113|NCT01422616|Esmolol|esmolol|mesh-list
138373114|NCT01422616|Glycerol|glycerol|mesh-list
138373115|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138373116|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138373117|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
138373118|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
138373119|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373120|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373121|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138373122|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138373123|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138373124|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373125|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373126|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373128|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
138373129|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138373130|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138373131|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138373132|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138373133|NCT01422616|Protective Agents|protective agents|mesh-ancestor
138373134|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
138373135|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138373136|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138373137|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
138373138|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138373139|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373140|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373141|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138373142|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138373143|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138373144|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
138373145|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138373146|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373147|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373148|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
138373149|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373150|NCT01422733|Dexamethasone|dexamethasone|mesh-list
138373151|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
138373152|NCT01422733|Cosyntropin|cosyntropin|mesh-list
138373153|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373154|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
138373155|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
138373156|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373157|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373158|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373159|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
138373160|NCT01422733|Hormones|hormones|mesh-ancestor
138373161|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373162|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373163|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373164|NCT01422785|Clindamycin|clindamycin|mesh-list
138373165|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
138373166|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
138373167|NCT01422785|Tretinoin|tretinoin|mesh-list
138373169|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138373170|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373171|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138373172|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373173|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373174|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373175|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373176|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
138373177|NCT01422954|Chloroquine|chloroquine|mesh-list
138373178|NCT01422954|Mefloquine|mefloquine|mesh-list
138373179|NCT01422954|Proguanil|proguanil|mesh-list
138373180|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138373181|NCT01422954|Amebicides|amebicides|mesh-ancestor
138373194|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373195|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373196|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
138373197|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
138373198|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373199|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138373200|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
138373201|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373202|NCT01423032|Fludarabine|fludarabine|mesh-list
138373203|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138373204|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373205|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373206|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373207|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
138373209|NCT01423123|Trastuzumab|trastuzumab|mesh-list
138373210|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373211|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373212|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
138373213|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
138373214|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
138373215|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373216|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373217|NCT01423175|Clofarabine|clofarabine|mesh-list
138373218|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138373219|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
138373220|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373221|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373222|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138373223|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138373224|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138373225|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373226|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373227|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138373228|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138373229|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138373230|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138373231|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373232|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373233|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373234|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138373235|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138373236|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
138373237|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138373238|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138373239|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
138373240|NCT01423292|Bupivacaine|bupivacaine|mesh-list
138373241|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
138373242|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
138373243|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373244|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373245|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
138373246|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373248|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
138373249|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138373250|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373251|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138373253|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373254|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373255|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138373256|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373257|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
138373258|NCT01423305|Hormones|hormones|mesh-ancestor
138373259|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373260|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138373261|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138373262|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138373263|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373264|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373265|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373266|NCT01423370|Tadalafil|tadalafil|mesh-list
138373267|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
138373268|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138373269|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138373270|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373271|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373272|NCT01423370|Urological Agents|urological agents|mesh-ancestor
138373273|NCT01423435|Beraprost|beraprost|mesh-list
138373274|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138373275|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
138373276|NCT01423487|Metformin|metformin|mesh-list
138373277|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138373278|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373279|NCT01423500|Fludarabine|fludarabine|mesh-list
138373280|NCT01423500|Etoposide|etoposide|mesh-list
138373281|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
138373282|NCT01423500|Thiotepa|thiotepa|mesh-list
138373283|NCT01423500|Treosulfan|treosulfan|mesh-list
138373284|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373285|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373286|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373287|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
138373288|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373289|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373290|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138373291|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138373292|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373293|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373294|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
138373295|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138373297|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138373298|NCT01423539|Navitoclax|navitoclax|mesh-list
138373299|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373300|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373301|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
138373302|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373303|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373304|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373305|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
138373306|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373307|NCT01423591|Infliximab|infliximab|mesh-list
138373308|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138373309|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373310|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373311|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373312|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373314|NCT01423695|Trastuzumab|trastuzumab|mesh-list
138373315|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373316|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373317|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
138373318|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
138373319|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138373320|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373321|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373323|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138373324|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138373325|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373326|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373327|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373328|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
138373329|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373330|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373331|NCT01423747|Fludarabine|fludarabine|mesh-list
138373332|NCT01423747|Etoposide|etoposide|mesh-list
138373333|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
138373334|NCT01423747|Thiotepa|thiotepa|mesh-list
138373335|NCT01423747|Treosulfan|treosulfan|mesh-list
138373336|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373337|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373338|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373339|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
138373340|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373341|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373342|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138373343|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138373344|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373345|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373346|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
138373347|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138373348|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
138373349|NCT01423838|Oxybutynin|oxybutynin|mesh-list
138373350|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138373351|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138373352|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138373353|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373354|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373355|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373356|NCT01423838|Urological Agents|urological agents|mesh-ancestor
138373357|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
138373358|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
138373359|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373360|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138373361|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138373362|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
138373363|NCT01423864|Prednisolone|prednisolone|mesh-list
138373364|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
138373365|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138373366|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138373367|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
138373368|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373369|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
138373371|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373372|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373374|NCT01423864|Protective Agents|protective agents|mesh-ancestor
138373375|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373376|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373377|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
138373378|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
138373379|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373380|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373381|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
138373382|NCT01423955|Hematinics|hematinics|mesh-ancestor
138373383|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
138373384|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138373385|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373386|NCT01424111|Escitalopram|escitalopram|mesh-list
138373387|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138373388|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138373389|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373390|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373391|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373392|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
138373393|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373394|NCT01424124|Montelukast|montelukast|mesh-list
138373395|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138373396|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373397|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138373398|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138373399|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373400|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373401|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138373402|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138373403|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373404|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138373405|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138373406|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
138373407|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373408|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373409|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138373410|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373411|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
138373412|NCT01424137|Hormones|hormones|mesh-ancestor
138373413|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373414|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
138373415|NCT01424176|Pramipexole|pramipexole|mesh-list
138373416|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
138373417|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373418|NCT01424176|Protective Agents|protective agents|mesh-ancestor
138373419|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373420|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138373421|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138373433|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373434|NCT01424332|Aspirin|aspirin|mesh-list
138373435|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
138373436|NCT01424332|Salicylates|salicylates|mesh-list
138373437|NCT01424332|Darexaban|darexaban|mesh-list
138373438|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373439|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373440|NCT01424332|Analgesics|analgesics|mesh-ancestor
138373441|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
138373442|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373443|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373444|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373445|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373446|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138373447|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138373448|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373449|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138373450|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138373451|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373452|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
138373453|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373454|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
138373455|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
138373456|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373457|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138373458|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
138373459|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138373460|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373461|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
138373462|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138373463|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
138373464|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373465|NCT01424384|Citalopram|citalopram|mesh-list
138373466|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138373467|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138373468|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373469|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373470|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373471|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
138373472|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373473|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138373474|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
138373475|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138373476|NCT01424449|Aripiprazole|aripiprazole|mesh-list
138373477|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
138373478|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138373479|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138373480|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138373481|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373482|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373483|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
138373484|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
138373486|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373487|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138373488|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138373489|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
138373490|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138373491|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138373492|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138373493|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138373494|NCT01424618|Leuprolide|leuprolide|mesh-list
138373495|NCT01424618|Ganirelix|ganirelix|mesh-list
138373496|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138373497|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
138373498|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138373499|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373500|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373501|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373502|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
138373503|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373504|NCT01424709|Cisplatin|cisplatin|mesh-list
138373505|NCT01424709|Gemcitabine|gemcitabine|mesh-list
138373506|NCT01424709|Docetaxel|docetaxel|mesh-list
138373507|NCT01424709|Irinotecan|irinotecan|mesh-list
138373508|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373509|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138373510|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
138373511|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373512|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138373513|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138373514|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138373515|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138373516|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138373517|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373520|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
138373521|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373522|NCT01424761|Vitamins|vitamins|mesh-ancestor
138373523|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
138373524|NCT01424826|Rifampin|rifampin|mesh-list
138373525|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138373526|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138373527|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
138373528|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373529|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138373530|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138373531|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373532|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373533|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138373534|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
138373535|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138373536|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
138373537|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138373538|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138373539|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138373540|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138373541|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138373542|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138373543|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138373545|NCT01424839|Carboplatin|carboplatin|mesh-list
138373546|NCT01424839|Etoposide|etoposide|mesh-list
138373547|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
138373548|NCT01424839|Ifosfamide|ifosfamide|mesh-list
138373549|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
138373551|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138373552|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138373553|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138373554|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373555|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373556|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138373557|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
138373558|NCT01424891|Simvastatin|simvastatin|mesh-list
138373559|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138373560|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138373561|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
138373562|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373563|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138373564|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138373565|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373566|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
138373567|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138373568|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373569|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138373570|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138373571|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373572|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138373573|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
138373574|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138373575|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138373576|NCT01425099|Dolutegravir|dolutegravir|mesh-list
138373577|NCT01425099|Prednisone|prednisone|mesh-list
138373578|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373579|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
138373580|NCT01425099|Hormones|hormones|mesh-ancestor
138373581|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373582|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373583|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373584|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373585|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138373586|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138373600|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138373601|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373602|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373603|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373604|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373605|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138373607|NCT01425164|Protective Agents|protective agents|mesh-ancestor
138373608|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138373609|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373610|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373611|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
138373612|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138373613|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138373614|NCT01425216|Sorafenib|sorafenib|mesh-list
138373615|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373616|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138373617|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373618|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373619|NCT01425242|Amlodipine|amlodipine|mesh-list
138373620|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138373621|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138373622|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373623|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373624|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373625|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373626|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
138373627|NCT01425320|Dapsone|dapsone|mesh-list
138373628|NCT01425320|Adapalene|adapalene|mesh-list
138373629|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373630|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373631|NCT01425320|Analgesics|analgesics|mesh-ancestor
138373632|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
138373633|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373634|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373635|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373636|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373637|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373638|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373639|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
138373640|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138373641|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138373642|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138373643|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373644|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373645|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
138373646|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138373647|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138373648|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138373649|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138373651|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373652|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138373653|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138373654|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373655|NCT01425411|Valsartan|valsartan|mesh-list
138373656|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138373657|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138373658|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138373659|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373660|NCT01425424|Vitamin D|vitamin d|mesh-list
138373661|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
138373662|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
138373663|NCT01425424|Vitamins|vitamins|mesh-list
138373664|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
138373665|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373667|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373668|NCT01425476|Vitamin D|vitamin d|mesh-list
138373669|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
138373670|NCT01425476|Celecoxib|celecoxib|mesh-list
138373671|NCT01425476|Vitamins|vitamins|mesh-ancestor
138373672|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
138373673|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373674|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138373675|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373998|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
138373676|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373677|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373678|NCT01425476|Analgesics|analgesics|mesh-ancestor
138373679|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
138373680|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373681|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373682|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373683|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138373684|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138373685|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373686|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373687|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138373688|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138373689|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138373690|NCT01425580|Metformin|metformin|mesh-list
138373691|NCT01425580|Liraglutide|liraglutide|mesh-list
138373692|NCT01425580|Glimepiride|glimepiride|mesh-list
138373693|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138373694|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373695|NCT01425580|Incretins|incretins|mesh-ancestor
138373696|NCT01425580|Hormones|hormones|mesh-ancestor
138373697|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373698|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138373699|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373700|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
138373701|NCT01425619|Lidocaine|lidocaine|mesh-list
138373702|NCT01425619|Prilocaine|prilocaine|mesh-list
138373703|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
138373704|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
138373705|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373706|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373707|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
138373708|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373709|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138373710|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138373711|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138373712|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373713|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373716|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138373717|NCT01425658|Narcotics|narcotics|mesh-ancestor
138373718|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373719|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373720|NCT01425658|Analgesics|analgesics|mesh-ancestor
138373721|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
138373722|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373723|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138373724|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138373726|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
138373727|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138373728|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
138373729|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
138373730|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138373731|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138373732|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138373735|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373736|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
138373737|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138373738|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138373739|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373740|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
138373741|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373742|NCT01425736|Cisplatin|cisplatin|mesh-list
138373743|NCT01425736|Docetaxel|docetaxel|mesh-list
138373744|NCT01425736|Fluorouracil|fluorouracil|mesh-list
138373745|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
138373746|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373747|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
138373748|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
138373749|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
138373750|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373751|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
138373752|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138373753|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373754|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
138373755|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374151|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
138373756|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373757|NCT01425775|Vitamin D|vitamin d|mesh-list
138373758|NCT01425775|Vitamins|vitamins|mesh-ancestor
138373759|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
138373760|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373761|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138373762|NCT05386446|Interferons|interferons|mesh-list
138373763|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
138373764|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373765|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
138373766|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373767|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138373768|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
138373769|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373770|NCT05386290|Infliximab|infliximab|mesh-list
138373771|NCT05386290|Mesalamine|mesalamine|mesh-list
138373772|NCT05386290|Ustekinumab|ustekinumab|mesh-list
138373773|NCT05386290|Vedolizumab|vedolizumab|mesh-list
138373774|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138373775|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373776|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373777|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373778|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373779|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373780|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373781|NCT05386290|Analgesics|analgesics|mesh-ancestor
138373782|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
138373783|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373784|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373785|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138373786|NCT05386186|Glimepiride|glimepiride|mesh-list
138373787|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138373789|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373790|NCT05386186|Incretins|incretins|mesh-ancestor
138373791|NCT05386186|Hormones|hormones|mesh-ancestor
138373792|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373793|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373794|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373795|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373796|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138373797|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373799|NCT05386160|Ranibizumab|ranibizumab|mesh-list
138373800|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138373801|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138373802|NCT05386160|Growth Substances|growth substances|mesh-ancestor
138373803|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373804|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373805|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373808|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138373809|NCT05386121|Narcotics|narcotics|mesh-ancestor
138373810|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373811|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373812|NCT05386121|Analgesics|analgesics|mesh-ancestor
138373813|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
138373814|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373815|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138373816|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138373817|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
138373818|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
138373819|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
138373820|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373821|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373822|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138373823|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373824|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
138373825|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373826|NCT05385861|Carboplatin|carboplatin|mesh-list
138373828|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373829|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138373830|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138373831|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373832|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373833|NCT05385744|Teriflunomide|teriflunomide|mesh-list
138373834|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138373835|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138373836|NCT05385744|Analgesics|analgesics|mesh-ancestor
138373837|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
138373838|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373839|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373840|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373841|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373842|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138373843|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
138373844|NCT05385185|Endostatins|endostatins|mesh-list
138373845|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373846|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138373847|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138373848|NCT05385185|Growth Substances|growth substances|mesh-ancestor
138373849|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373850|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373851|NCT05385094|Cystatins|cystatins|mesh-list
138373852|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138373853|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373854|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373855|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373856|NCT05385068|Niraparib|niraparib|mesh-list
138373857|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138373858|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373859|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373860|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373861|NCT05385029|Carbimazole|carbimazole|mesh-list
138373862|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
138373863|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
138373864|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373865|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373866|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
138373867|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138373868|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138373869|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138373870|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373871|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373872|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
138373874|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373876|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373878|NCT05379374|Bupivacaine|bupivacaine|mesh-list
138373879|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
138373880|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
138373881|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138373882|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373883|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
138373884|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373885|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138373886|NCT05379374|Narcotics|narcotics|mesh-ancestor
138373887|NCT05379374|Analgesics|analgesics|mesh-ancestor
138373888|NCT05375708|Bevacizumab|bevacizumab|mesh-list
138373889|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138373890|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373891|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138373892|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138373893|NCT05375708|Growth Substances|growth substances|mesh-ancestor
138373894|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373895|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
138373897|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
138373898|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138373899|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
138373900|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373901|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373902|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138373903|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373904|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
138373905|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138373906|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
138373907|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138373908|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373909|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
138373910|NCT04850378|Dalteparin|dalteparin|mesh-list
138373911|NCT04850378|Tinzaparin|tinzaparin|mesh-list
138373912|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138373913|NCT04850378|Apixaban|apixaban|mesh-list
138373914|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138373915|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
138373916|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138373917|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373918|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373919|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373920|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
138373921|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138373922|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138373924|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373925|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138373926|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138373927|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373928|NCT04765371|Dexamethasone|dexamethasone|mesh-list
138373929|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
138373930|NCT04765371|Prednisolone|prednisolone|mesh-list
138373931|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138373932|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
138373934|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
138373935|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138373936|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
138373937|NCT04765371|BB 1101|bb 1101|mesh-list
138373938|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373939|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
138373940|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
138373941|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373942|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373943|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373944|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
138373945|NCT04765371|Hormones|hormones|mesh-ancestor
138373946|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373947|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373948|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373949|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
138373950|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373951|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373953|NCT04765371|Protective Agents|protective agents|mesh-ancestor
138373954|NCT04744363|Ustekinumab|ustekinumab|mesh-list
138373955|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
138373956|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
138373957|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138373958|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138373959|NCT04673162|Prednisolone|prednisolone|mesh-list
138373960|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
138373961|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138373962|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
138373963|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373964|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
138373965|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
138373966|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373967|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373968|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373969|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
138373970|NCT04673162|Hormones|hormones|mesh-ancestor
138373971|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373972|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138373973|NCT04673162|Protective Agents|protective agents|mesh-ancestor
138373974|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373975|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373976|NCT04560556|Antibodies|antibodies|mesh-list
138373977|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
138373978|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373979|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138373980|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373981|NCT04311762|Cisplatin|cisplatin|mesh-list
138373982|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373983|NCT04203472|Budesonide|budesonide|mesh-list
138373984|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138373985|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138373986|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
138373987|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138373988|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373989|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138373990|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
138373991|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
138373992|NCT04203472|Hormones|hormones|mesh-ancestor
138373993|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138373996|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138373997|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138373999|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374000|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374001|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374002|NCT03945084|Niraparib|niraparib|mesh-list
138374003|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138374004|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374005|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374006|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374008|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374009|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374010|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
138374011|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374012|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
138374013|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374014|NCT03821649|Naloxone|naloxone|mesh-list
138374015|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138374016|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374017|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
138374018|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374019|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
138374020|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
138374021|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
138374022|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374023|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374024|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
138374025|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374026|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
138374027|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138374028|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138374029|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374031|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138374032|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
138374033|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374034|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374035|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
138374036|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374037|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
138374038|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138374039|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374040|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374041|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138374042|NCT03444753|Nivolumab|nivolumab|mesh-list
138374043|NCT03444753|Ipilimumab|ipilimumab|mesh-list
138374044|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374045|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374046|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138374047|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374048|NCT03142035|Dienogest|dienogest|mesh-list
138374049|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138374050|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
138374051|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374052|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374053|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138374054|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138374055|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138374056|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138374057|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
138374058|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374059|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374060|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374061|NCT02786875|Vitamin D|vitamin d|mesh-list
138374062|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
138374063|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
138374064|NCT02786875|Vitamins|vitamins|mesh-list
138374065|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
138374066|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374067|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138374068|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374069|NCT02767882|Dexamethasone|dexamethasone|mesh-list
138374070|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374071|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
138374072|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
138374073|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374074|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374075|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374076|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
138374078|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374079|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374080|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374081|NCT02246257|Metformin|metformin|mesh-list
138374082|NCT02246257|Losartan|losartan|mesh-list
138374083|NCT02246257|Simvastatin|simvastatin|mesh-list
138374084|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374085|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374086|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138374087|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138374088|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
138374089|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374090|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138374091|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138374092|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374093|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374094|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138374095|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138374096|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138374097|NCT02197221|Bortezomib|bortezomib|mesh-list
138374098|NCT02197221|Melphalan|melphalan|mesh-list
138374099|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374100|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138374101|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
138374102|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374103|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138374104|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374105|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
138374106|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374108|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374109|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374110|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374111|NCT01949714|Epinephrine|epinephrine|mesh-list
138374112|NCT01949714|Racepinephrine|racepinephrine|mesh-list
138374113|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
138374114|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138374115|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138374116|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138374117|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374118|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374119|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374121|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138374122|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
138374123|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374124|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138374125|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
138374126|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
138374127|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
138374128|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138374129|NCT00223145|Goserelin|goserelin|mesh-list
138374130|NCT00223145|Bicalutamide|bicalutamide|mesh-list
138374131|NCT00223145|Androgens|androgens|mesh-list
138374132|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138374133|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374134|NCT00223145|Hormones|hormones|mesh-ancestor
138374135|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374136|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374137|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
138374138|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
138374139|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138374140|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138374141|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138374142|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374143|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374144|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374145|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374147|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
138374148|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374149|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
138374150|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138374155|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374156|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374157|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
138374158|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374159|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374160|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138374161|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138374162|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374163|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374164|NCT01425996|Camptothecin|camptothecin|mesh-list
138374165|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138374166|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374167|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138374168|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138374169|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374170|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374171|NCT01426022|Ethanol|ethanol|mesh-list
138374172|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138374173|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374174|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374175|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374176|NCT01426074|Bevacizumab|bevacizumab|mesh-list
138374177|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374178|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374179|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138374180|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138374181|NCT01426074|Growth Substances|growth substances|mesh-ancestor
138374182|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374183|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
138374184|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138374185|NCT01426087|Somatostatin|somatostatin|mesh-list
138374186|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374187|NCT01426087|Hormones|hormones|mesh-ancestor
138374188|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374189|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374190|NCT01426100|Telmisartan|telmisartan|mesh-list
138374191|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138374192|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138374193|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138374194|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374195|NCT01426126|genexol-PM|genexol-pm|mesh-list
138374196|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374197|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138374198|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138374199|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138374200|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374201|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
138374202|NCT01426165|Analgesics|analgesics|mesh-ancestor
138374203|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
138374204|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374205|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374206|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
138374207|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374208|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138374209|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
138374210|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138374211|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374212|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374213|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374214|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
138374215|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138374216|NCT01426256|Vitamin D|vitamin d|mesh-list
138374217|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
138374218|NCT01426256|Vitamins|vitamins|mesh-ancestor
138374219|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
138374220|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374221|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138374222|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138374223|NCT01426334|Cyclosporine|cyclosporine|mesh-list
138374224|NCT01426334|Dasatinib|dasatinib|mesh-list
138374225|NCT01426334|Cyclosporins|cyclosporins|mesh-list
138374226|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374308|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
138374227|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374228|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374229|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
138374230|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374231|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
138374232|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374233|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
138374234|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374235|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138374236|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374237|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374238|NCT01426399|Metformin|metformin|mesh-list
138374239|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374240|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374241|NCT01426464|Latanoprost|latanoprost|mesh-list
138374242|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138374243|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138374244|NCT01426490|Vitamins|vitamins|mesh-list
138374245|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
138374249|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
138374250|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
138374251|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
138374252|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374253|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
138374254|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374255|NCT01426490|Protective Agents|protective agents|mesh-ancestor
138374256|NCT01426490|Hematinics|hematinics|mesh-ancestor
138374257|NCT01426542|Topiramate|topiramate|mesh-list
138374258|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
138374259|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374260|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374261|NCT01426633|Gemcitabine|gemcitabine|mesh-list
138374262|NCT01426633|Trabectedin|trabectedin|mesh-list
138374263|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138374264|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
138374265|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374266|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374267|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138374268|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
138374270|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374271|NCT01426737|Vildagliptin|vildagliptin|mesh-list
138374272|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374273|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374274|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138374275|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
138374276|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374277|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374278|NCT01426802|Vildagliptin|vildagliptin|mesh-list
138374279|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138374280|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374281|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138374282|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
138374283|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374284|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374285|NCT01426815|Golimumab|golimumab|mesh-list
138374286|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138374287|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374288|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374289|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
138374290|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374291|NCT01426880|Paclitaxel|paclitaxel|mesh-list
138374292|NCT01426880|Carboplatin|carboplatin|mesh-list
138374293|NCT01426880|Lapatinib|lapatinib|mesh-list
138374294|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138374295|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374296|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
138374297|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
138374298|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
138374299|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374300|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138374301|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374302|NCT01426906|Rifampin|rifampin|mesh-list
138374303|NCT01426906|Ketoconazole|ketoconazole|mesh-list
138374304|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138374305|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
138374306|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138374307|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138374309|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138374310|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374312|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138374313|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138374314|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138374315|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138374316|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138374317|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138374319|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138374320|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138374321|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138374323|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374324|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374325|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138374326|NCT01426971|Ibuprofen|ibuprofen|mesh-list
138374327|NCT01426971|Caffeine|caffeine|mesh-list
138374328|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138374329|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374330|NCT01426971|Analgesics|analgesics|mesh-ancestor
138374331|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
138374332|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374333|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374334|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138374335|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374336|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138374337|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374338|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374339|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138374340|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138374341|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138374342|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138374343|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
138374344|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374345|NCT01426984|Methylphenidate|methylphenidate|mesh-list
138374346|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138374347|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374348|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138374349|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138374350|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138374351|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374352|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
138374353|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374354|NCT01427114|Prednisolone|prednisolone|mesh-list
138374355|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
138374356|NCT01427114|Rituximab|rituximab|mesh-list
138374357|NCT01427114|Vincristine|vincristine|mesh-list
138374358|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138374359|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
138374360|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374361|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138374362|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138374363|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
138374364|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374365|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374366|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138374367|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138374368|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138374369|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
138374370|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
138374371|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
